<SEC-DOCUMENT>0001564590-22-005228.txt : 20220215
<SEC-HEADER>0001564590-22-005228.hdr.sgml : 20220215
<ACCEPTANCE-DATETIME>20220215163138
ACCESSION NUMBER:		0001564590-22-005228
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220215
DATE AS OF CHANGE:		20220215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptive Biotechnologies Corp
		CENTRAL INDEX KEY:			0001478320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				270907024
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38957
		FILM NUMBER:		22639627

	BUSINESS ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
		BUSINESS PHONE:		206-659-0067

	MAIL ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptive TCR Corp
		DATE OF NAME CHANGE:	20091209
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>adpt-10k_20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-15T03:53:06.3040341+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:adpt="http://www.adaptivebiotech.com/20211231" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
adpt-10k_20211231.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001478320_20210101_20211231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001478320_20210101_20211231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0001478320_20210101_20211231">0001478320</ix:nonNumeric>
			<ix:nonNumeric id="F_000009" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001478320_20210101_20211231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000658" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000660" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831">2032-10</ix:nonNumeric>
			<ix:nonNumeric id="F_000667" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001478320_20190801_20190831">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000678" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_20191001_20191031">2029-10</ix:nonNumeric>
			<ix:nonNumeric id="F_000686" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001478320_20180401_20180430">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000696" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001478320_20210101_20211231">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000687" name="adpt:LesseeOperatingLeaseExtendedTermOfContract" contextRef="C_0001478320_20180401_20180430">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000752" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001478320_srtTitleOfIndividualAxis_adptNonEmployeeDirectorsMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000844" name="adpt:MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231">P7Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000083" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001478320_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000084" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001478320_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000085" name="us-gaap:PreferredStockValue" contextRef="C_0001478320_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000086" name="us-gaap:PreferredStockValue" contextRef="C_0001478320_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonNumeric id="F_000237" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_0001478320_20200101_20201231">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</ix:nonNumeric>
			<ix:nonNumeric id="F_000705" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001478320_20211231">P10Y6M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000706" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001478320_20201231">P11Y3M29D</ix:nonNumeric>
			<ix:nonNumeric id="F_000805" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231">P5Y3M7D</ix:nonNumeric>
			<ix:nonNumeric id="F_000806" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231">P5Y3M7D</ix:nonNumeric>
			<ix:nonNumeric id="F_000807" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231">P5Y3M7D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001478320_20210101_20211231" decimals="3">0.005</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000812" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001478320_20200101_20201231" decimals="3">0.004</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000813" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001478320_20190101_20191231" decimals="3">0.014</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000817" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001478320_20210101_20211231" decimals="3">0.671</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000818" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001478320_20200101_20201231" decimals="3">0.705</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000819" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001478320_20190101_20191231" decimals="3">0.643</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000799" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231" decimals="2">30.86</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000800" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231" decimals="2">17.68</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000801" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231" decimals="2">7.80</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000802" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231" decimals="2">66.50</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000803" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231" decimals="2">55.23</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000804" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231" decimals="2">47.81</ix:nonFraction>
			<ix:nonNumeric id="F_000808" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231">P6Y29D</ix:nonNumeric>
			<ix:nonNumeric id="F_000809" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231">P6Y29D</ix:nonNumeric>
			<ix:nonNumeric id="F_000810" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231">P6Y29D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000814" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001478320_20210101_20211231" decimals="3">0.014</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000815" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001478320_20200101_20201231" decimals="3">0.017</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000816" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001478320_20190101_20191231" decimals="3">0.025</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000820" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001478320_20210101_20211231" decimals="3">0.700</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000821" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001478320_20200101_20201231" decimals="3">0.733</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000822" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001478320_20190101_20191231" decimals="3">0.729</ix:nonFraction>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="adpt-20211231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001478320_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_20220210">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-02-10</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:OwnershipAxis">adpt:DigitalBiotechnologiesIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerBMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerBMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_adptPerformance_Obligation">
				<xbrli:measure>adpt:Performance_Obligation</xbrli:measure>
			</xbrli:unit>
			<xbrli:unit id="U_adptSegment">
				<xbrli:measure>adpt:Segment</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190201_20190228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-02-01</xbrli:startDate>
					<xbrli:endDate>2019-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptRegulatoryMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:RegulatoryMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptDevelopmentMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:DevelopmentMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptCommercialMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:CommercialMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerSoftwareMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerSoftwareMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20151231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMinimumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMaximumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtMajorCustomersAxis_adptSpecificPatientsMember_srtProductOrServiceAxis_adptMedicareRevenueMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:SpecificPatientsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:MedicareRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20211230_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-12-30</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrsqft">
				<xbrli:measure>utr:sqft</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_srtStatementGeographicalAxis_stprWA_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20191001_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20180430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20180401_20180430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-04-01</xbrli:startDate>
					<xbrli:endDate>2018-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20200229">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-02-29</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20200201_20200229">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-02-01</xbrli:startDate>
					<xbrli:endDate>2020-02-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_20191201_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-12-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_adptLease">
				<xbrli:measure>adpt:Lease</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_adptVote">
				<xbrli:measure>adpt:Vote</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_adptCommonStockOptionsAndRestrictedStockUnitsGrantedMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">adpt:CommonStockOptionsAndRestrictedStockUnitsGrantedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20200101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20200101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20210101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20140101_20141231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-01-01</xbrli:startDate>
					<xbrli:endDate>2014-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:SequentaTwoThousandAndEightStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtTitleOfIndividualAxis_adptNonEmployeeDirectorsMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">adpt:NonEmployeeDirectorsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MicrosoftCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-12-01</xbrli:startDate>
					<xbrli:endDate>2017-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapStatementClassOfStockAxis_adptSeriesFOneConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">adpt:SeriesFOneConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MicrosoftCollaborationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptConvertiblePreferredStockWarrantsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:ConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="line-height:2pt;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, DC 20549</p>
<p style="text-align:center;margin-bottom:6pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001478320_20210101_20211231">10-K</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:6pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark One)</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000029" name="dei:DocumentAnnualReport" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001478320_20210101_20211231" format="ixt:datemonthdayyearen">December 31, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001478320_20210101_20211231">2021</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OR</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000030" name="dei:DocumentTransitionReport" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the transition period from _____to _____</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number: <ix:nonNumeric id="F_000021" name="dei:EntityFileNumber" contextRef="C_0001478320_20210101_20211231">001-38957</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0001478320_20210101_20211231">ADAPTIVE BIOTECHNOLOGIES CORPORATION</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in its Charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:1.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1.5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000031" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:stateprovnameen">Washington</ix:nonNumeric></p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001478320_20210101_20211231">27-0907024</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br />Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:EntityAddressAddressLine1" contextRef="C_0001478320_20210101_20211231">1165 Eastlake Avenue East</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000024" name="dei:EntityAddressCityOrTown" contextRef="C_0001478320_20210101_20211231">Seattle</ix:nonNumeric>,<ix:nonNumeric id="F_000025" name="dei:EntityAddressStateOrProvince" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:stateprovnameen"> Washington</ix:nonNumeric></p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:EntityAddressPostalZipCode" contextRef="C_0001478320_20210101_20211231">98109</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric id="F_000027" name="dei:CityAreaCode" contextRef="C_0001478320_20210101_20211231">(206)</ix:nonNumeric> <ix:nonNumeric id="F_000028" name="dei:LocalPhoneNumber" contextRef="C_0001478320_20210101_20211231">659-0067</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:4.54%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:35%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:2.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="width:2.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:35%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr style="height:14.35pt;">
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;"><ix:nonNumeric id="F_000015" name="dei:Security12bTitle" contextRef="C_0001478320_20210101_20211231">Common stock, par value $0.0001 per share</ix:nonNumeric></span></p></td>
<td valign="top" style="width:2.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:8%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0001478320_20210101_20211231">ADPT</ix:nonNumeric></p></td>
<td valign="top" style="width:2.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SecurityExchangeName" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act: <span style="font-weight:bold;">None </span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000011" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0001478320_20210101_20211231">Yes</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> <span style="text-transform:uppercase;">No</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act. &#160;<span style="text-transform:uppercase;">Yes</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> <span style="text-transform:uppercase;"><ix:nonNumeric id="F_000008" name="dei:EntityVoluntaryFilers" contextRef="C_0001478320_20210101_20211231">No</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. &#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000018" name="dei:EntityCurrentReportingStatus" contextRef="C_0001478320_20210101_20211231">Yes</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> <span style="text-transform:uppercase;">No</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the Registrant was required to submit such files). &#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000020" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001478320_20210101_20211231">Yes</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> <span style="text-transform:uppercase;">No</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1.5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:12.5pt;">
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityFilerCategory" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:entityfilercategoryen">Large&#160;accelerated&#160;filer</ix:nonNumeric></p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr style="height:3.3pt;">
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:56.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:21.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntitySmallBusiness" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000032" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span><span style="font-size:10pt;">&#160;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000019" name="dei:EntityShellCompany" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The NASDAQ Global Select Market on June 30, 2021 (the last business day of the Registrant&#8217;s most recently completed second fiscal quarter), was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000012" name="dei:EntityPublicFloat" contextRef="C_0001478320_20210630" decimals="0" format="ixt:numdotdecimal">3,951,000,000</ix:nonFraction>. </p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of February 10, 2022, the Registrant had <ix:nonFraction unitRef="U_xbrlishares" id="F_000017" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001478320_20220210" decimals="INF" format="ixt:numdotdecimal">141,583,720</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000033" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0001478320_20210101_20211231">The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated herein by reference from the registrant&#8217;s definitive proxy statement relating to the Annual Meeting of Shareholders to be held in 2022.</ix:nonNumeric></p>
<p style="text-align:center;line-height:2pt;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:4pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Table of Contents</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_I"><span style="text-decoration:underline;">PART I</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:underline;">Business</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:underline;">Risk Factors</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:underline;">Unresolved Staff Comments</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:underline;">Properties</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_LEGAL_PROCEEDINGS"><span style="text-decoration:underline;">Legal Proceedings</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:underline;">Mine Safety Disclosures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_II"><span style="text-decoration:underline;">PART&#160;II</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:underline;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;6.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_RESERVED"><span style="text-decoration:underline;">[Reserved]</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU"><span style="text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;8.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENTS_AND_SUPPLEME"><span style="text-decoration:underline;">Financial Statements and Supplementary Data</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:underline;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:underline;">Controls and Procedures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OR_INFORMATION"><span style="text-decoration:underline;">Other Information</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9C.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9C"><span style="text-decoration:underline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_III"><span style="text-decoration:underline;">PART&#160;III</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;10.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO"><span style="text-decoration:underline;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;11.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11_EXECUTIVE_COMPENSATION"><span style="text-decoration:underline;">Executive Compensation</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;12.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF"><span style="text-decoration:underline;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;13.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR"><span style="text-decoration:underline;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;14.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC"><span style="text-decoration:underline;">Principal Accounting Fees and Services</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_IV"><span style="text-decoration:underline;">PART&#160;IV</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:underline;">Exhibits, Financial Statement Schedules</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;16.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16_FORM_10K_SUMMARY"><span style="text-decoration:underline;">Form 10-K Summary</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">SIGNATURES</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORWARD-LOOKING STATEMENTS</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Annual Report on Form 10-K contains forward-looking statements that are based on management&#8217;s beliefs and assumptions and on information currently available to management. Some of the statements in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections and elsewhere in this Annual Report on Form 10-K contain forward-looking statements. In some cases, you can identify forward-looking statements by the following words: &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing&#8221; or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe we have a reasonable basis for each forward-looking statement contained in this Annual Report on Form 10-K, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements expressed or implied in this Annual Report on Form 10-K include, but are not limited to, statements about:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success of our significant investments in our continued research and development of new products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success of developing, commercializing and achieving commercial market acceptance of clonoSEQ, T-Detect, immunoSEQ, our TCR-Antigen Map, T cell receptor (&#8220;TCR&#8221;)-based cellular therapies, neutralizing antibody products or processes, such as TruAB, and additional products and services beyond our current portfolio&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential for our identified research priorities to advance our proprietary immune medicine platform or our future products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success, cost and timing of our research development activities, preclinical and clinical studies and, in certain instances, clinical trials and clinical validations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential benefits of collaborations, our ability to enter into collaborations or arrangements and our ability to attract collaborators with development, manufacturing, regulatory and commercialization expertise&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability and willingness of our collaborators to continue development, manufacturing, distribution and commercialization activities relating to our jointly developed products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to identify research priorities and apply a risk-mitigated strategy to efficiently discover and develop products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain and maintain regulatory approval of our products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the pricing and reimbursement of our products and services following approval where required&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability, and that of our collaborators, to commercialize our products and services, including products related to COVID-19&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain equipment and materials (including reagents or other materials that may also require additional internal validation) from our suppliers, and in some cases single suppliers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to generate revenue and obtain funding for our operations, including funding necessary to complete further development of our current and future products and services, and if successful, commercialization&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the size and growth potential of the markets for our products and services, and our ability to serve those markets, either alone or in combination with others&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the rate and degree of market acceptance of our products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential adverse effect on our business, operations and plans or timelines (including those plans and timelines related to expansion initiatives and clinical development) resulting from a health epidemic or pandemic, including the COVID-19 pandemic and future variants of the SARS-CoV-2 virus&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our financial performance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding our ability to obtain and maintain intellectual property protection for our immune medicine platform, products, services and related technologies and the direction of such protection&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory developments in the United States (&#8220;U.S.&#8221;) and foreign countries&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success of competing products or services that are or may become available&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">developments relating to our competitors and our industry&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to attract and retain key scientific or management personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the impact of laws and regulations&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, you should refer to the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K for a discussion of other important factors that may cause actual results to differ materially from those expressed or implied by the&#160;forward-looking&#160;statements. As a result of these factors, we cannot assure you that the&#160;forward-looking&#160;statements in this Annual Report on Form 10-K will prove to be accurate. Furthermore, if the&#160;forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these&#160;forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The&#160;forward-looking&#160;statements herein represent our views as of the date of this Annual Report on Form 10-K. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these&#160;forward-looking&#160;statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these&#160;forward-looking&#160;statements as representing our views as of any date subsequent to the date of this Annual Report on Form 10-K.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In this Annual Report on Form 10-K, unless the context requires otherwise, all references to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Adaptive&#8221; and the &#8220;Company&#8221; refer to Adaptive Biotechnologies Corporation.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_I">PART I</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">Item 1. Business </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#8217;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient&#8217;s immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use these insights to develop and commercialize clinical products and services that we are tailoring to each individual patient. We have three commercial products and services and a robust pipeline of clinical products and services that we are designing to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune disorders and infectious diseases. Since our inception in 2009, we have characterized over 58 billion immune receptors, established partnerships and commercial relationships with 175 biopharmaceutical companies and launched three product lines. Our goal is to understand the adaptive immune system and translate it into new products with unprecedented scale, precision and speed. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immune medicine platform is the foundation for our expanding suite of products and services. The cornerstone of our platform and core immunosequencing product, immunoSEQ, serves as our underlying research and development engine and generates revenue from academic and biopharmaceutical customers. Our first clinical diagnostic product, clonoSEQ, is the first test authorized by the Food and Drug Administration (&#8220;FDA&#8221;) for the detection and monitoring of minimal residual disease (&#8220;MRD&#8221;) in patients with multiple myeloma (&#8220;MM&#8221;), B cell acute lymphoblastic leukemia (&#8220;ALL&#8221;) and chronic lymphocytic leukemia (&#8220;CLL&#8221;) and is also available as a CLIA-validated laboratory developed test (&#8220;LDT&#8221;) for patients with other lymphoid cancers. Leveraging our collaboration with Microsoft Corporation (&#8220;Microsoft&#8221;), we are creating a map of the interaction between the immune system and disease (our &#8220;TCR-Antigen Map&#8221;). We are using this map to develop research solutions by disease called immunoSEQ T-MAP and a diagnostic product for many diseases from a single blood test called T-Detect.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T-Detect COVID, the first indication for the T-Detect product line, received Emergency Use Authorization (&#8220;EUA&#8221;) for confirmation of recent or prior SARS-CoV-2 infection, the virus that causes COVID-19, in March 2021. We confirmed signals in Crohn&#8217;s disease, celiac disease, and multiple sclerosis, identified new signals in ulcerative colitis, and rheumatoid arthritis, and are focusing on generating additional signals in autoimmune disease states. In addition, we have completed our clinical validation of the immuneSense Lyme study, which represents another technical proof point in our ability to map T cells to disease specific antigens. Our therapeutic product candidates, being developed under our collaboration agreement with Genentech, Inc. (&#8220;Genentech&#8221;), leverage our platform to identify specific receptors on immune cells to develop into cellular therapies in oncology. We believe this approach has the potential to be applicable to patients across a wide range of cancers. In addition, we extended our platform to inform vaccine design and development through our licensing agreement with Vaccibody AS, now known as Nykode Therapeutics AS (&#8220;Nykode&#8221;). We believe there is potential to apply our platform to vaccine development and design across multiple disease states. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Immune medicine is one of the largest global addressable markets in healthcare. We estimate the potential global market opportunity for our portfolio to be approximately $54&#160;billion, including approximately $6 billion for products and services related to the detection of MRD and approximately $48 billion for diagnostic and drug discovery applications driven by mapping immune receptors to disease-specific antigens. This currently includes T-Detect and cellular therapy in oncology and is expected to grow with additional opportunities stemming from our platform. We use multiple sources and assumptions to estimate the total addressable market for immune medicine. While we believe them to be reasonable, these sources and assumptions may be incorrect or subject to change due to any number of factors. In particular, the indications we choose to commercialize for T-Detect may vary depending on ongoing signal validation and market considerations. In addition, our drug discovery initiatives are still in the early stages of development and the market opportunity excludes neutralizing antibodies, which may make our assumptions and estimates more uncertain. Despite the novelty of this area, we believe we are uniquely positioned to develop and commercialize a pipeline of immune-driven diagnostic and therapeutic products across multiple disease states by leveraging the cumulative learning from our immune medicine platform.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were able to achieve and progress towards many key milestones in 2021 in each business area: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">In March 2021, T-Detect COVID was granted EUA by the Food and Drug Administration, becoming the first-in-class test to confirm recent or prior COVID-19 infection. Data demonstrates that T-Detect COVID can detect prior infection nearly 12 months after diagnosis in some patients. T-Detect COVID was ordered by over 30,000 consumers and providers on behalf of their patients. In addition, we received a positive technical assessment from Palmetto GBA&#8217;s Molecular Diagnostics Program (&#8220;MolDX&#8221;), followed by a coverage decision from Noridian Mutual Insurance Company providing a path to reimbursement in 2022 for immunocompromised patients.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">immunoSEQ T-MAP COVID, another byproduct of leveraging the TCR-Antigen Map collaboration, continues to be a source of valuable insight as we advance towards an understanding of the T cell response to SarS-CoV-2 at scale and with precision, including with respect to emerging variants of concern</span><span style="color:#000000;">. </span><span style="color:#000000;">For new variants of concern, such as Delta or Omicron, we have demonstrated the ability to identify mutations and connect them to our large-scale antigen-specific datasets in order to measure T-cell response to vaccination and determine the role of cellular immunity.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The T-Detect product continued to make significant advances in the autoimmune space. With respect to autoimmune diseases, we confirmed signals in Crohn&#8217;s disease and multiple sclerosis and identified new signals in ulcerative colitis and rheumatoid arthritis. These clinical signals were identified in a series of well-characterized case-control sample sets from collaborating institutions, including over 5,000 samples in inflammatory bowel disease (&#8220;IBD&#8221;), and we plan to advance some of these signals to blinded clinical validation studies in the near future.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our clinical diagnostics business continued to grow year over year. For our clonoSEQ product, we grew our test volume by 48% to 22,516 tests delivered. We increased the all-time number of unique patients tested by more than 46% to over 22,000 patients by the end of 2021. We have filed to expand our existing label for ALL in bone marrow to include blood, and we enhanced the clinical report for CLL patients to include immunoglobulin heavy chain &#8211; V (&#8220;IGHV&#8221;) mutation status, which has been well received by our clinical customers.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">In drug discovery, we continue to make good progress with our shared and private product programs under our Genentech collaboration. Regarding the shared product, we delivered to Genentech efficacy and safety data for our TCR candidate that targets a shared cancer neoantigen. Following review of data generated by both us and Genentech using this TCR candidate, Genentech recently selected this TCR candidate to progress as a potential therapeutic product candidate. Also, in 2022, we&#8217;re on track to deliver to Genentech up to two additional TCR data packages for consideration by Genentech. Regarding our private program, we conducted initial proof of concept&#160;screens by successfully processing blood from approximately 60 cancer patients. We continue to work closely with Genentech to establish the private product specifications and to build our private product data package. The personalized data that we generate in 2022 with Genentech will help start to define steps toward early product development by Genentech. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We also extended our drug discovery efforts by establishing a new worldwide licensing agreement in July 2021 with Nykode, whereby virus-specific T cell epitopes identified by our platform will be used to inform the design and development of novel SARS-CoV-2 vaccine candidates. The Nykode 2-arm Phase I/II trial started in the fourth quarter of 2021 and is currently enrolling individuals in Norway who are already vaccinated. This T cell-based vaccine is intended to address SARS-CoV-2 variants of concern and may be used as a potential universal booster to available vaccines. The Nykode collaboration represents a significant extension of the platform into vaccine design and development.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Key financial highlights for 2021 include full year revenue up 57% to $154.3 million, cash, cash equivalents and marketable securities of $570.2 million and clinical sequencing volume up 48% to 22,516 tests, excluding T-Detect COVID volume. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">In addition, we moved into our new corporate headquarters in Seattle, Washington in September 2021, increased warehouse space in the Seattle area, and opened a new office in New York City in 2021. These facilities are designed to allow for continued scaling and growth, as well as laboratory and operational optimization in the Seattle area.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Immune Medicine Platform </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adaptive immune system is comprised of specialized cells, called T&#160;cells and B&#160;cells, which hold the instructions for diagnosing and treating most diseases. These instructions enable these cells to identify, bind and destroy pathogens or human cells presenting foreign signals of disease (&#8220;antigens&#8221;) using receptors on their cell surface. Unlike all other genes in the human genome, the genetic sequences of TCRs and B cell receptors (&#8220;BCRs&#8221;) rearrange over time creating massive genetic diversity. The resulting diversity of the adaptive immune repertoire, which consists of over 100&#160;million different genes in a healthy adult compared to approximately 30,000 genes in the static human genome, gives the immune system the ability to detect and respond to millions of different antigens associated with human disease. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immune medicine platform combines a suite of proprietary chemistry, computational biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. It extracts and interprets insights from the adaptive immune system with the scale, precision and speed required to enable the design of clinical products tailored to the specific genetics of each patient&#8217;s immune system.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000001.jpg" title="" alt="" style="width:314px;height:314px;" /><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immune medicine platform performs the following key functions related to immune receptors: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Sequence.</span><span style="color:#000000;"> immunoSEQ sequences single chains of &#8220;Y-shaped&#8221; TCRs or BCRs using next generation sequencing (&#8220;NGS&#8221;), enabling us to understand the quantity and diversity of T and B cells in a biological sample. This provides deep insights into individual and collective immune responses at a scale that is thousands of times greater than was previously possible. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Map.</span><span style="color:#000000;"> MIRA (Multiplexed Identification of T cell Receptor Antigen Specificity) maps millions of TCRs to thousands of clinically relevant antigens. Combined with immunoSEQ, MIRA elucidates what potential diseases a patient&#8217;s immune system has been exposed to or is actively fighting. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Pair.</span><span style="color:#000000;"> pairSEQ builds on immunoSEQ by using a combinatorial strategy to accurately pair both chains of Y-shaped immune cell receptors at high-throughput, which is challenging to do at scale using other methods because the two chains of the Y-shaped receptors are located on different chromosomes. The ability to accurately pair both chains of the receptors in a sample enables us to reconstruct receptors for therapeutic purposes. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Characterize.</span><span style="color:#000000;"> TruTCR characterizes binding, cytotoxicity and safety properties of antigen-specific, paired TCRs to identify a subset that is therapeutic-grade, enabling the discovery and development of optimal clinical candidates to be engineered into TCR-mediated cellular therapies. </span><span style="Background-color:#FFFFFF;color:#000000;">TruAB is our high-throughput antibody discovery process that enables the selection of potent, naturally occurring, full length antibodies for therapeutic or prophylactic development.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The massive amount of data generated by our immune medicine platform is stored in our dynamic clinical immunomics database. We believe the application of machine learning, supported by our collaboration with Microsoft, has the potential to exponentially accelerate our ability to derive novel insights from this database and use them to inform our robust product development efforts. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The current coronavirus pandemic is highlighting the critical importance of understanding the immune response to disease broadly, making our technology more relevant than ever. In 2020, together with Microsoft, we created the ImmuneCODE program to map the T cell response to SARS-CoV-2 across the global population. Our goal was to leverage the existing capabilities of our high throughput platform to generate an unprecedented amount of T cell data from over 9,000 samples to understand the adaptive immune response to COVID-19. From these samples, we have mapped over 160,000 high-confidence TCRs to all parts of the virus which we have shown to be most immunogenic. We have published several papers over the past year that demonstrate the correlation between the T cell response and real world efficacy of vaccination as the virus has mutated. This mapping effort has enabled us to develop and commercialize multiple products that have supported the fight against COVID-19. In our research business, we offered a product called immunoSEQ T-MAP COVID to provide a better way for vaccine developers and researchers to include the T-cell response in their studies. We are pleased to see top-tier vaccine developers such as Johnson &#38; Johnson, Moderna, and AstraZeneca continue to recognize the power of this product. Leveraging the same data, we launched a clinical diagnostic called T-Detect COVID to confirm recent or prior infection. T-Detect is the only T cell-based test for COVID authorized by the FDA pursuant to the EUA pathway. Additionally, we signed a drug discovery agreement with NyKode of the design and development of a next-generation DNA-based T cell mediated vaccine for COVID and the first patient was dosed in December 2021.  Importantly, we believe we can leverage what we accomplished for COVID-19 using disease-specific immune receptor data across other disease states going forward. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000002.jpg" title="" alt="" style="width:480px;height:310px;" /><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the opportunities driven from <span style="color:#000000;">understanding</span><span style="color:#000000;font-size:9.5pt;"> the T cell response to SARS-CoV-2, </span><span style="color:#000000;">we </span>also extended our platform to identify highly potent neutralizing antibodies against the virus. We currently have a portfolio of highly potent neutralizing antibodies against SARS-CoV-2 and continue to explore potential partnerships. We are exploring the potential of leveraging this differentiated antibody discovery capability across multiple disease states.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe COVID-19 brought the role of the immune system to the forefront of society and has created the opportunity for us to be positioned as the &#8220;go to&#8221; company to rapidly and reproducibly assess the T-cell response to any pathogen, including future pandemics.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Current Products and Pipeline </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current portfolio includes commercial products and services in clinical diagnostics and life sciences research, and we are developing products and services in both clinical diagnostics and drug discovery. We plan to continue to invest in our immune medicine platform to develop additional clinical products, which we prioritize based on clinical actionability, unmet medical need and commercial viability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Clinical Diagnostics &#8211; clonoSEQ and T-Detect </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our clonoSEQ diagnostic test detects and monitors the remaining number of cancer cells that are present in a patient&#8217;s body during and after treatment, known as MRD. In September 2018, clonoSEQ was granted marketing authorization from the FDA, under the <span style="font-style:italic;">de novo</span> process, for patients with MM and ALL to monitor their MRD from bone marrow samples. In August 2020, the clonoSEQ label was expanded to include patients with CLL from bone marrow and blood samples. clonoSEQ is also available for use in other lymphoid cancers as an LDT. In January 2019, clonoSEQ received Medicare coverage aligned with the FDA label and National Comprehensive Cancer Network (&#8220;NCCN&#8221;) guidelines for longitudinal monitoring in MM and ALL. We secured additional payor coverage for clonoSEQ aligned with our FDA label with Medicare, national private payors and large regional plans for a total of over 240&#160;million covered lives for ALL and MM and over 150 million covered lives for CLL. In November 2021, MolDX published its LCD for MRD testing. This LCD not only affirms the importance of MRD and clonoSEQ coverage in ALL, MM and CLL in bone marrow and blood, but also provides a clear and efficient pathway for seeking expanded clonoSEQ coverage through technical assessments in Non-Hodgkin&#8217;s Lymphoma (&#8220;NHL&#8221;). </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clonoSEQ testing has been ordered by clinicians for over 22,000 unique patients and used by more than 60 biopharmaceutical companies in over 150 clinical trials.&#160;We continue to deepen our commercial investments to expand clinical adoption of clonoSEQ and have increased the strength of our specialized sales and customer support organization and supporting infrastructure in the United States, and we have successfully transferred the technology to seven labs in other parts of the world. We believe clonoSEQ has broad applicability across all lymphoid malignancies. We submitted a 510(k) premarket notification for ALL from blood samples in February 2021 and are actively advancing validation studies in certain NHL sub-types. We are also awaiting results from a clinical study using clonoSEQ to assess MRD in blood for multiple myeloma. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we continue to develop product improvements for clonoSEQ</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the third quarter of 2021, we launched an enhanced version of our clonoSEQ B-cell Clonality (ID) reports, which now include</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IGHV</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> mutation status for patients with CLL</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The presence of IGHV mutations have been proven prognostic of better outcomes in CLL patients</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that this improvement strengthens the clonoSEQ product by aiding clinicians in evaluating prognosis, simplifying diagnosis, and improving overall patient management by providing additional clinically valuable CLL information, and preliminary feedback indicates these improvements have been well received</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to T-Detect, we developed this diagnostic product by leveraging Microsoft&#8217;s machine learning capabilities to create the TCR-Antigen Map, which may enable early or accurate detection of many diseases from a single blood test. Initially, we are validating detection of a set of discrete diseases for which there is a significant unmet medical need for better diagnostic testing and early intervention, and where antigen specificity is well-known. These include infectious diseases, autoimmune disorders and certain prevalent cancer types. We launched the first indication, T-Detect COVID, to confirm recent or prior SARS-CoV-2 infection, which represents a stepping-stone to the long-term vision of T-Detect where a single blood sample can provide information about what diseases a person&#8217;s immune system has seen or is currently fighting. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We launched T-Detect COVID in the fourth quarter of 2020 and the product received EUA in March 2021. We are in the process of working with the FDA to extend the label to include a semi-quantitative measure to enable the test to monitor T cell response over time. We are concurrently working with select biopharmaceutical collaborators to try to establish a correlate of protection. Leveraging the infrastructure built to support this initial indication, we are on track to make T-Detect Lyme available in our CLIA lab during the 2022 Lyme season. Additionally, <span style="color:#000000;">we confirmed </span>signals in Crohn&#8217;s disease, celiac disease, and multiple sclerosis, identified new signals in ulcerative colitis and rheumatoid arthritis, and are focusing on generating additional signals in autoimmune disease states. Our immune medicine platform enables parallel development because it can work with retrospective sample sets and uses machine learning and computational statistics to continuously improve our detection and accuracy which is applied to all of the diagnostic algorithms.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For T-Detect COVID, our T-cell based test shows higher sensitivity than multiple antibody serology tests to confirm recent or prior infection. Data demonstrates that T-Detect COVID can detect prior infection nearly 12 months after diagnosis in some patients. Additionally, T-cell testing can be used to distinguish natural SARS-CoV-2 infection from COVID-19 vaccine response, an important advantage over antibody tests. The sensitivity of T-Detect COVID is equivalent to or greater than serology testing in RT-PCR-confirmed SARS-CoV-2 cases, and the product has demonstrated a percent positive agreement (&#8220;PPA&#8221;) of 100% in individuals with RT-PCR&#8211;confirmed SARS-CoV-2. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With T-Detect COVID, we initially targeted groups and individuals for whom knowledge of past infection or exposure is valuable, including self-pay consumers, employers and concierge medicine physician groups. Our market research showed that there are many people who were unable to access testing in spring of 2020 or had unexpected results from antibody or PCR testing, and are still curious or skeptical about a previous infection. This is particularly true for individuals who were asymptomatic or had mild symptoms, in whom antibody testing may be less reliable.&#160;Additionally, our research indicates high interest among consumers in understanding immunity to COVID-19.We believe there is a significant need to for clinicians to manage patient care, including vaccine or booster regimens, by assessing the immune responses of immunocompromised patients.&#160;&#160;We also believe we are uniquely suited to assess and provide insights to clinicians as to the immune responses of those patient whose immunocompromised status is the result of prior cancer infection, a market that is complementary to our oncology expertise. We continue to offer the ability to contribute to on-market research to quantitatively assess the duration of immunity as defined by the persistence of SARS-CoV-2 specific T cells. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we have completed our clinical validation for our immuneSense Lyme study, which represents another technical proof point in our ability to map T cells to disease specific antigens We expect to leverage the infrastructure built for T-Detect COVID with an anticipated market availability during the 2022 Lyme season. There are approximately 3.4 million Lyme diagnostic tests performed annually. Initially, we are focused on market entry for early and more accurate diagnosis of Lyme disease for patients with non-descript symptoms that are suspected to be caused by Lyme.&#160;This population is over 600,000 patients in the United States each year. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Learnings from T-Detect COVID and Lyme efforts have helped us accelerate our assessment of various diseases in parallel across the different</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">stages of our research and development pipeline. We begin the process with diseases that meet key market attractiveness criteria such as high unmet medical need, understanding of the antigenic space, and our access to samples with metadata. We then seek early clinical signals in prioritized disease states and continue to refine our modeling for those that appear promising. For each signal, we generate data in several ways: run na&#239;ve blood to map receptors to antigens, collaborate on studies with control groups, and leverage a database of unlabeled samples. Once a signal is confirmed in additional independent cohorts and the product profile is deemed attractive, we proceed with a full commercial validation and generation of a locked-down algorithm to take into clinical validation and regulatory submission.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are many economic advantages of T-Detect both in the research and development stage and as a commercial product. For the research and development pipeline, we leverage the same capital expenditures and workflow for signal generation across all diseases allowing us to study multiple diseases in parallel without requiring substantial workflow adjustments or significant new capital expenditures for specific new disease states. Once commercialized, again, we use the same blood sample and the same underlying chemistry for all diseases with a small incremental investment in software for each individual disease, enabling a long-term high margin profile. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Life Sciences Research </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immunoSEQ research service and kits are used to answer translational research questions and discover new prognostic and diagnostic signals. Our technology has been used for research purposes by over 2,400 academic researchers and 175 biopharmaceutical companies and incorporated into over 650 clinical trials since our inception in 2009. Importantly, immunoSEQ is analytically validated so that all research data generated using immunoSEQ can be used for clinical validation of potential diagnostic applications.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We launched immunoSEQ T-MAP COVID in August 2020 for vaccine developers and researchers to accurately and reproducibly measure the T-cell immune response to vaccines and track the persistence of that response over time, including with respect to emerging variants of concern. immunoSEQ T-MAP COVID combines the sequencing and mapping capabilities of Adaptive&#8217;s immune medicine platform to show how T cells respond to different parts of the virus, including the various parts of the spike protein. A key objective with T-MAP COVID is to answer many outstanding questions about durability of COVID-19 vaccines, especially in light of new variants of the virus. For new variants of concern, such as Delta or Omicron, we have demonstrated the ability to identify mutations and connect them to our large-scale antigen-specific datasets in order to measure T-cell response to vaccination and determine the role of cellular immunity. Our T-MAP product offers significant advantages over other technologies to detect and monitor T cells at scale using a small amount of blood without the need for live cells that require special sample handling. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have sequenced a subset of patient samples (pre- and post-vaccination) from clinical trials sponsored by several top-tier vaccine developers, including Moderna, Johnson &#38; Johnson, AstraZeneca, University of Oxford, and the Bill and Melinda Gates Foundation among others. Using our immunoSEQ T-MAP COVID product, we can identify and track expanded T cells induced by a vaccine, which can be distinguished from a natural infection, in order to monitor vaccine efficacy. With some partners, we are working towards understanding how T cell activation may provide a correlate of protection.<span style="font-size:7.5pt;"> </span>This has become increasingly critical in the wake of variants since the antibody response is increasingly off-target and T cells are correlating more closely with real-world vaccine efficacy.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In an effort to understand immunity for immunocompromised patients, we have also collaborated with the Leukemia and Lymphoma Society and other prestigious academic labs in order to study the T cell response of this subset of patients who do not always have the ability to mount an antibody response to vaccination. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Drug Discovery </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our drug discovery efforts to date are focused on identifying therapeutic-grade TCRs and antibody-secreting BCRs to enable our partners to engineer, manufacture and commercialize therapeutic candidates, as well as to design and develop vaccines. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our TruTCR process characterizes TCRs against shared antigens for use in the development of therapeutics. In December&#160;2018, we entered into an exclusive collaboration with Genentech to&#160;leverage this capability for the development of cellular therapies in oncology. We are pursuing two product development pathways for novel T&#160;cell immunotherapies in which Genentech intends to use TCRs screened by our immune medicine platform to engineer and manufacture cellular medicines: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Shared Products.</span><span style="color:#000000;"> The shared products will use &#8220;off-the-shelf&#8221; TCRs identified against cancer antigens shared among patients (&#8220;Shared Products&#8221;). We completed an assessment of efficacy and safety data to enable a decision to select our lead TCR candidate. Following review of this data by both us and Genentech, Genentech recently selected this TCR candidate to progress as a potential therapeutic product candidate. Meanwhile, we continue to screen and characterize TCRs against clinically relevant targets in solid tumors. We are on track to deliver to Genentech up to two additional TCR data packages for consideration by Genentech.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Personalized Product.</span><span style="color:#000000;"> </span><span style="color:#000000;">The personalized product will use patient-specific TCRs identified by real-time screening of TCRs against cancer antigens in each patient (&#8220;Personalized Product&#8221;). In the second half of 2020, we started screening blood from cancer patients to identify TCRs specific to a patient&#8217;s tumor mutations. W</span><span style="color:#000000;">e </span><span style="color:#000000;">conducted</span><span style="color:#000000;"> initial proof of concept </span><span style="color:#000000;">screens </span><span style="color:#000000;">by successfully processing blood from approximately 60 cancer patients, </span><span style="color:#000000;">demonstrating that in certain of these patients </span><span style="color:#000000;">we </span><span style="color:#000000;">were able to</span><span style="color:#000000;"> identify naturally-occurring TCRs from </span><span style="color:#000000;">the</span><span style="color:#000000;"> cancer patient&#8217;s own blood that are specific to that patient&#8217;s unique tumor mutations. </span><span style="color:#000000;">To support our near-term and long-term objectives for the Personalized Product, we opened our dedicated prototype lab in South San Francisco in 2021, which will have capacity to perform first-in-human clinical trials. </span><span style="color:#000000;">We believe the lab positions us to potentially pursue additional opportunities outside of this collaboration, including cellular therapy in other disease states and cancer vaccines.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also extended our drug discovery efforts by establishing a new worldwide licensing agreement in July 2021 with Nykode, whereby virus-specific T cell epitopes identified by our platform will be used to inform the design and development of novel SARS-CoV-2 vaccine candidates. The Nykode 2-arm Phase I/II trial is currently in progress with individuals in Norway who are already vaccinated. This T cell-based vaccine is intended to address SARS-CoV-2 variants of concern and may be used as a potential universal booster to available vaccines. The Nykode collaboration represents a significant extension of the platform into vaccine design and development. The platform is being deployed to both design and develop the vaccine, potentially creating opportunity for a new commercial product. Although this is the first licensing agreement we have entered into with vaccine design and development as the primary goal, we believe it may provide a useful proof of concept for extending the platform&#8217;s ability to design vaccines that may be applicable to other disease states as well. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our TruAB process, similar to our TruTCR process, leverages our high-throughput capabilities to screen millions of BCRs to identify unique antibodies from the blood of COVID-19 patients. In several months, we used blood from over 300 patients to identify hundreds of thousands of antibodies, of which we synthesized and characterized over 3,300 antibodies that bind to various parts of the SARS-CoV-2 virus. Our lead TruAB candidates that neutralize live virus at very low concentrations, which means that a very small amount of each of these antibodies is able to block the virus from infecting cells. Importantly, our drug discovery approach is differentiated from other groups because of the scale and throughput of our TruAB approach that allows us to identify a much broader set of naturally-occurring, fully human antibody candidates to select the best ones for clinical development. The first potential clinical application of our antibodies is to treat patients who are actively fighting or have recently recovered from COVID-19.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Clinical Portfolio and Pipeline</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our clonoSEQ pipeline</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000003.jpg" title="" alt="" style="width:720px;height:328px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our T-Detect pipeline</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000004.jpg" title="" alt="" style="width:720px;height:329px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Drug Discovery Pipeline</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000005.jpg" title="" alt="" style="width:720px;height:329px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Competitive Strengths </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We aim to harness the inherent biology of the adaptive immune system to develop clinical products and services that improve human health by leveraging our core competitive strengths. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Our immune medicine platform is uniquely capable of supporting clinical products.</span><span style="color:#000000;"> We have developed a platform that is capable of reading and translating the massive genetic diversity of the adaptive immune system and its selective response to disease. Specifically, our platform</span><span style="font-style:italic;color:#000000;"> sequences</span><span style="color:#000000;"> immune receptors and</span><span style="font-style:italic;color:#000000;"> maps</span><span style="color:#000000;"> them to antigens for diagnostic applications,</span><span style="font-style:italic;color:#000000;"> pairs</span><span style="color:#000000;"> receptor chains and</span><span style="font-style:italic;color:#000000;"> characterizes</span><span style="color:#000000;"> antigen-specific, paired receptors to identify optimal clinical targets for therapeutic use. We are the only company that can perform all of these functions&#8212;and we do so at an unprecedented scale to develop novel clinical diagnostic and therapeutic products.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Our clinical immunomics database provides a robust product development engine.</span><span style="color:#000000;"> </span><span style="color:#000000;">Using the adaptive immune system as our </span><span style="color:#000000;">product </span><span style="color:#000000;">source-code, we are building a dynamic clinical immunomics database</span><span style="color:#000000;">, now</span><span style="color:#000000;"> being annotated with antigens using machine learning, that drives our ability to rapidly discover and develop potential diagnostic and therapeutic applications. Our aim is to translate the natural capabilities of the immune system into the clinic by capturing the millions of diverse unique receptors present in a patient&#8217;s blood</span><span style="color:#000000;">, then leveraging the resultant data set into multiple products and services.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Clinical applicability spans diagnostic and therapeutic product potential.</span><span style="color:#000000;"> Our ability to accumulate, synthesize and process billions of immunomic datapoints to generate multiple clinical diagnostic and therapeutic applications across disease areas provides optionality to our commercial pipeline. Each of our products also has broad applicability, enabling robust product lifecycle extensions. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Expanding regulatory and reimbursement expertise will help inform future clinical product development.</span><span style="color:#000000;"> Having successfully obtained EUA for T-Detect COVID, FDA marketing authorization and expanded coverage for multiple indications of clonoSEQ from Medicare and several national private payors, we believe we have developed valuable core capabilities that will facilitate future product development through to regulatory approval and reimbursement. We believe this capability will inform future development of other clinical products, including early detection tests. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Transformational collaborations with industry leaders validate our platform.</span><span style="color:#000000;"> Our collaborations with industry-defining leaders such as Genentech and Microsoft validate our unique approach to advancing the promise of immune medicine. We will continue to seek opportunities to optimize our ever-growing clinical immunomics database to drive product development and commercial success and facilitate efficient use of capital. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Strong intellectual property protects our immune medicine platform and its applications.</span><span style="color:#000000;"> As of December 31, 2021, we had filed 471 patent applications, 420 of which had issued as of that date, covering improvements in sequencing methods and new ways to leverage adaptive immune receptors for life sciences research, clinical diagnostic and drug discovery applications. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Strategy </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our focus is to leverage our immune medicine platform and competitive strengths to develop transformative clinical solutions accessible to patients around the world. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Powering the age of immune medicine.</span><span style="color:#000000;"> We facilitate the development of the immune medicine field by providing a platform to encourage generation of immunomics data to facilitate a deeper understanding of, and biological discovery from, the adaptive immune system. We leverage the unique capability of our platform to translate the genetics of a patient&#8217;s immune system with the scale, precision and speed required to enable the development of personalized products, including clinical diagnostic tests for disease monitoring and early detection, as well as immune-based therapeutics.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Entrench our products and services in clinical drug development with biopharmaceutical collaborators.</span><span style="color:#000000;"> Position our platform as the gold standard for the validation of potential immune-driven clinical discoveries in late-stage clinical trials. Since inception, our products and services have been used by 175 biopharmaceutical companies and incorporated into hundreds of clinical trials, and clonoSEQ has proven to be the MRD test of choice for select registrational trials. To deepen our established position as a partner of choice, we provide end-to-end support, including hypothesis-driven trial design, extensive data analyses, parallel regulatory support, compliant data transfers and novel target screening. These synergistic relationships advance the development and adoption of our own clinical products and inform drug development for our partners. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Rapidly identify and advance new products, leveraging foundational technology to generate revenue and address clinical diagnostic challenges in key disease states, such as autoimmune, cancer, and COVID-19.</span><span style="color:#000000;"> We integrate proven chemistry into our clinical products in development, avoiding the need to re-engineer new products for every clinical application. We do this by serially identifying new applications of T-Detect for early detection of disease using retrospective datasets without requiring live cells from large cohorts of patients, and by characterizing TCRs for therapeutic use. As our platform focuses on cancer, autoimmune disorders and infectious diseases, we believe we will benefit from economies of scale and drive margin improvement over time. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Drive the commercial adoption of distributed, reimbursed and regulated clinical products.</span><span style="color:#000000;"> Expand distribution and drive usage of our products and services. Leverage the commercial infrastructure built for clonoSEQ and T-Detect COVID to submit clinical data for regulatory clearance of our products and services, expand current payor coverage and provide robust billing and patient access infrastructure for multiple clinical applications. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Maintain an entrepreneurial, scientifically rigorous, data-driven and inclusive corporate culture.</span><span style="color:#000000;"> </span><span style="color:#000000;">Fuel the promise and potential that our platform offers to help patients better manage their disease by translating insights </span><span style="color:#000000;">from our world-class team, which includes </span><span style="color:#000000;">1</span><span style="color:#000000;">80</span><span style="color:#000000;"> people with medical or doctoral degrees with expertise in biology, chemistry, bioinformatics, software, drug discovery, development and commercialization, into clinical products and services.</span><span style="color:#000000;"> We plan to continue to expand our team to advance the promise of immune medicine.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A Primer: The Adaptive Immune System </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over millions of years, the adaptive immune system has evolved an elegant solution to keeping people healthy. It recognizes and responds to most antigens, whether they come from outside the body, such as a virus, or inside the body, such as mutations that drive cancer. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The innate and adaptive immune systems both play a role in human immunity, but only the adaptive immune system provides a specific response to signals of disease, or antigens. These disease specific antigens are primarily fragments of proteins that are recognized as foreign, such as proteins from a virus. However, antigens can be recognized as foreign even if they are not from a pathogen. In cancer cells, antigens are generated from neoantigens, which are derived from mutations specific only to the cancer, or tumor associated antigens (&#8220;TAAs&#8221;), which are from aberrantly expressed normal proteins. For autoimmune disorders, the immune system mistakenly recognizes normal protein fragments as foreign antigens and attacks otherwise healthy tissue. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The Adaptive Immune Response </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The key cells of the adaptive immune system that enable our bodies to mount responses against antigens are called T&#160;cells and B&#160;cells. T&#160;cells can destroy target cells directly, and B&#160;cells secrete antibodies, activating other parts of the immune system to destroy targets. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each T and B&#160;cell has a unique Y-shaped receptor, which can recognize one or a small number of the millions of antigens to which our bodies are continuously exposed. When an adaptive immune response is initiated against a particular disease, the T&#160;cells and B&#160;cells encoding the disease-specific targeting receptors rapidly multiply through clonal expansion, allowing for a powerful immune response. Some of these expanded cells directly attack the disease, and others form long-term memory to allow rapid recognition of the same antigens in the future and protect against reinfection. Unlike all other genes in the human genome, the genetic sequences of TCRs and BCRs rearrange over time through a complex biological process resulting in massive diversity. The diversity of these receptors is made possible by a unique reshuffling of their genetic code known as V(D)J recombination (V&#61;Variable, D&#61;Diversity, J&#61;Joining). This recombination process only occurs in T&#160;cells and B&#160;cells, and it results in each cell clone having a unique receptor-associated deoxyribonucleic acid (&#8220;DNA&#8221;) sequence. This unique DNA sequence acts like a barcode that can be used to identify and track an individual receptor over time, as shown in the figure below: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000006.jpg" title="" alt="" style="width:668px;height:260px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adaptive immune response requires millions of these unique receptors to be widely distributed and present in the blood at all times in order to have the ability to rapidly respond to many different diseases simultaneously. Even after a specific TCR binds to an antigen and clonally expands, the frequency of these expanded T-cell clones containing the TCR remains relatively low in relation to the estimated trillions of other T cells that are circulating. We have demonstrated this by sequencing thousands of healthy individuals for control cohorts for our research and development efforts. We now know that disease-specific TCRs that are clonally expanded in a patient&#8217;s blood are present, on average, at less than 1 cell out of 100,000 cells. Despite their relatively low abundance, disease-specific TCRs can mount a systemic, persistent response to most perturbations because of the highly specialized properties of the immune response summarized in the table below: </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000007.jpg" title="" alt="" style="width:682px;height:304px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to fully leverage these inherent properties of the immune system to develop clinical products, this enormous diversity and scale must be taken into consideration to be able to reliably and repeatedly measure the relative frequency of each disease-specific T&#160;cell in the blood. For example, cancer-specific TCRs circulating in the blood of a cancer patient are only present at 1 out of 100,000 cells. Auto-reactive T&#160;cells specific to any given autoimmune disorder circulating in the blood are only present at 1 out of 1,000,000 cells. Accordingly, the ability to detect disease-specific T&#160;cells requires a technology that can quantitatively probe a minimum of hundreds of thousands to millions of blood cells from each sample. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Immune Medicine Platform </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We built a platform that can reveal and translate these properties of the adaptive immune system with the scale, precision and speed required to enable the development of personalized products, including disease monitoring, clinical diagnostic tests for early detection and immune-based therapeutics. Our immune medicine platform combines a suite of proprietary chemistry, computational biology and machine learning to generate clinical immunomics data to decode the adaptive immune system and transform the diagnosis and treatment of disease. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The massive amount of data generated by our immune medicine platform is stored in our dynamic clinical immunomics database. We believe the application of machine learning with Microsoft has the potential to exponentially accelerate the growth of novel insights from this database, which we expect will further inform our product development efforts, as demonstrated by the growing number of clinical signals we are generating, including signals for SarS-CoV-2 and Lyme disease for our current products. We have also confirmed signals in Crohn&#8217;s disease, celiac disease, and multiple sclerosis and identified new signals in ulcerative colitis and rheumatoid arthritis.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sequence with immunoSEQ </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">immunoSEQ sequences single chains of Y-shaped TCRs and BCRs using NGS. NGS generally describes several modern sequencing technologies that enable more efficient DNA and ribonucleic acid (&#8220;RNA&#8221;) sequencing than prior technologies. The key innovation in the development of immunoSEQ, pioneered by Dr.&#160;Harlan Robins and a team of leading immunologists at the Fred Hutchinson Cancer Research Center (&#8220;Fred Hutch&#8221;), was a novel approach utilizing PCR, hybridization and sequencing of rearranged TCRs to determine the sequences in millions of rearranged TCR genes, as shown in the figure below. We apply a similar approach for BCR sequencing. All of the data generated by immunoSEQ is uploaded to our clinical immunomics database and accessed through our proprietary cloud-based visualization and analytic tool called the immunoSEQ Analyzer.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000008.jpg" title="" alt="" style="width:703px;height:425px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One of the biggest challenges of any multiplex PCR technique is controlling for PCR amplification bias, which is critical for accuracy. We solved for this problem by creating a synthetic immune repertoire that mimics rearranged immune receptor loci for all V and J genes. By identifying specific primers that are either under or over amplified, titrating the primer concentrations and computationally adjusting residual bias, we optimize quantitation. The accuracy and reproducibility of our bias control methodology was demonstrated in our lab and independently in a multi-center, lab-to-lab concordance study using our immunoSEQ RUO kit. The ability to generate an unbiased TCR or BCR sequencing read-out is paramount for any clinical product and will be required for the utility and reliability of clinical kits. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">immunoSEQ enables us to observe the majority of receptors involved in a real human immune response, providing deep insights into a complex biological system that was previously challenging to understand. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Map with MIRA </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our proprietary MIRA technology enables the identification of TCRs specific to thousands of antigens simultaneously. The MIRA technology leverages a multiplexed, combinatorial approach to mapping TCRs to antigens in four steps: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Identify and query antigens of interest which can include neoantigens, tumor-associated, viral, infectious, autoimmune or other antigens. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pool the antigens of interest and incubate them with immune cells from multiple donors whereby antigen specificities are determined based on the antigen pool design. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Sort T cells by marker of interest. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Match T cell clones to specific antigens based on the presence of specific sequences in designated pools. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Combined with immunoSEQ, MIRA elucidates what diseases a patient&#8217;s immune system has been exposed to or is actively fighting at a scale that is one thousand times more sensitive than standard immunological techniques such as ELISPOT, or enzyme-linked immunospot. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Pair with pairSEQ </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our proprietary pairSEQ technology builds on immunosequencing by using a combinatorial strategy to accurately pair the two chains of Y-shaped immune cell receptors at higher throughput than can be achieved with single cell sequencing. Pairing is difficult because the two chains of the Y-shaped receptor are located on different chromosomes, which get separated when DNA is extracted from a cell for sequencing. By pairing TCRs or BCRs, we rapidly detect thousands of complete chain sequences to develop new TCR-mediated cellular therapies or to develop differentiated antibodies.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Characterize with TruTCR </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TruTCR characterizes binding, cytotoxicity and safety properties of antigen-specific, paired TCRs to identify a select subset that are therapeutic-grade, enabling the development of optimal clinical candidates to be engineered into TCR-mediated cellular therapies. Our comprehensive TCR characterization process utilizes advanced cellular immunology to measure TCRs against a variety of metrics to determine the optimal clinical candidates. Antigen-specific, paired TCRs undergo evaluation for avidity, cytokine release, cytotoxicity and safety. Those TCRs that pass the first safety filter are then evaluated for TCR reactivity against T&#160;cell lines and primary cells. To date, we have identified and characterized to different stages more than 5,000 unique antigen-specific TCRs against 600 different clinically relevant targets, constituting our pipeline of possible clinical candidates. TCR characterization using TruTCR is summarized in the figure below: </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000009.jpg" title="" alt="" style="width:719px;height:214px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In collaboration with Genentech, we plan to apply a similar process to screen, identify and characterize in real-time what we believe are the most promising patient-specific TCRs targeting the patient&#8217;s specific cancer antigens, advancing the next generation of cellular therapy in oncology. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Discover with TruAB</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TruAB enables the discovery and characterization of BCRs for use as therapeutic antibodies. Our key differentiator is the ability to tap into the massive diversity of the B-cell repertoire to identify naturally-occurring, fully human antibodies at unprecedented scale. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, we deployed our platform to identify neutralizing antibodies to the SARS-CoV-2 virus that causes COVID-19. We processed blood from more than 300 recovered and symptomatic COVID-19 patients. We then applied our high-throughput BCR pairing technology and paired more than 490,000 antibody heavy and light chains. We evaluated these BCR sequences <span style="font-style:italic;">in silico</span> and selected more than 3,300 likely attractive antibody candidates for downstream functional characterization, including affinity binding and live virus neutralization.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000010.jpg" title="" alt="" style="width:720px;height:263px;" /><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beyond COVID-19, we believe these efforts represent a differentiated platform extension that will position us to pursue additional potential antibody discovery opportunities in a variety of disease states, including in autoimmunity where there is an unmet need.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Clinical Immunomics Database </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing a large, dynamic clinical immunomics database. We use our proprietary software and core competency in computational biology to structure and store immune receptor data and to create tools for rapid analysis and easy visualization. All immunosequencing data is processed and uploaded to a secure cloud-based database. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The record of diseases a person has encountered, both past and present, is recorded in their TCR repertoire. This comprehensive disease information is contained in the immunosequencing data that we generate from each sample, which we believe will be revealed over time by our TCR-Antigen Map. We plan to map, both directly and through machine learning, an estimated 10<sup style="font-size:85%;line-height:120%;vertical-align:top">15</sup> TCRs to thousands of clinically relevant antigens, which we believe will allow us to annotate this immunosequencing data with information about disease states, increasing the value of the data over time. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We leverage our database to fuel our pipeline of immune medicine products. With over 58 billion immune receptors, our platform enables us to work with retrospective samples which serve as training sets to which our Microsoft collaborators apply machine learning and computational statistics to improve the accuracy of certain of our clinical products and services. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our Products and Services </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current portfolio includes commercial products and services in clinical diagnostics and life sciences research, and we are developing products and services in both clinical diagnostics and drug discovery. Our commercial research product, immunoSEQ, primarily serves as our underlying research and development engine to develop and validate our clinical pipeline. Our first commercial diagnostic product, clonoSEQ, is our FDA-cleared test to monitor MRD in patients with select blood cancers. In 2020 we launched T-Detect COVID, for the confirmation of recent or prior COVID-19 infection. Our commercial research and clinical products leverage the sequencing and mapping capabilities of our immune medicine platform and the revenue generated by these products largely contributes to sequencing revenues. Our pipeline of clinical diagnostics for the early and accurate detection of many diseases will be commercialized under the expanding T-Detect product line and will continue to grow our sequencing revenues over time. Our drug discovery efforts to date are focused on identifying therapeutic-grade TCRs (TruTCR) and antibody-secreting BCRs (TruAB) to enable our partners to engineer, manufacture and commercialize therapeutic candidates. With Genentech, we are advancing our pipeline of both shared and personalized TCR-mediated cellular therapies for cancer patients. We also extended our platform to identify highly potent neutralizing antibodies against SARS-CoV-2 and this differentiated approach can be leveraged across other disease states. Our drug discovery pipeline leverages the sequencing, mapping, pairing and characterization components of our platform and generates most of our development revenue. We further extended our platform in drug discovery by establishing a new worldwide licensing agreement with Nykode, whereby virus-specific T cell epitopes identified by our platform will be used to inform the design and development of novel SARS-CoV-2 vaccine candidates. We plan to continue to invest in our platform to develop additional clinical applications, which we prioritize based on rigorous data requirements for clinically actionability, unmet medical need and commercial viability. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Clinical Diagnostics </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We aim to be a global leader in immune-driven diagnostics for early detection, prognosis and monitoring of disease. To achieve this long-term goal, we are focused on leveraging the sequencing and mapping functions of our immune medicine platform to develop diagnostic tests that meet regulatory standards, are widely reimbursed and are accessible to patients all around the world. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Monitoring MRD with clonoSEQ </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our first diagnostic product, clonoSEQ, is an FDA-authorized NGS test for the detection and monitoring of MRD in bone marrow or blood samples in patients with select lymphoid malignancies in which the malignant cell is derived from a T cell or a B cell. MRD refers to the presence and number of these malignant T&#160;or B cells that may remain in a patient&#8217;s body during and following treatment. Because our technology quantifies the frequency of every T&#160;cell or B&#160;cell in a sample, we can monitor MRD accurately at a sensitivity of 1 out of 1,000,000 cells, given sufficient sample input. By taking a baseline measurement prior to starting therapy and then tracking the number of cells at several time points following therapy initiation, hematologists can improve their ability to assess treatment response, predict long-term patient outcomes, monitor disease burden over time and detect potential relapse. clonoSEQ is FDA-authorized for patients with MM and ALL from bone marrow samples and for patients with CLL from bone marrow and blood samples. clonoSEQ is also currently available as an LDT for use across lymphoid malignancies and sample types, including those which have not been authorized by the FDA.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NCCN Guidelines recommend using a validated test to measure MRD to define the burden of disease and assess response to therapy in MM and ALL after each treatment stage. NGS MRD testing has been added to these guidelines and we plan to seek expansion of the recommendations to include additional time points in each disease state and to incorporate clonoSEQ specific data. To that end, in 2021, NCCN updated the adult ALL guidelines to emphasize the importance of achieving MRD negativity and incorporate recommendations on MRD actionability post-induction.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MRD monitoring is becoming increasingly important in the hematologic oncology field because highly effective new therapies are extending survival. This has created a need for more sensitive tools to monitor the disease status of patients over longer periods of time and has introduced the potential for MRD to be included as a surrogate or primary endpoint in registrational clinical trials. We believe we are uniquely positioned to benefit from these industry dynamics with both our clinical and biopharmaceutical customers. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the clinic, clonoSEQ testing has been ordered by clinicians at centers all around the country, including all 31 NCCN centers, for over 22,000 unique patients. We believe increased adoption of clonoSEQ will now be possible due to the extensive coverage policies granted by Medicare to assess MRD at multiple time points throughout therapy in MM, ALL and CLL, and several national private payors and large regional payors, together representing over 240&#160;million total covered lives in ALL and MM and over 150 million covered lives in CLL. We are in active discussions with other large private national and regional payors. To further develop the mounting real-world evidence demonstrating the actionability of MRD monitoring, we launched a clinical registry in 2020. This prospective, multicenter, observational study will include approximately 500 adult patients with lymphoid malignancies in the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Among biopharmaceutical companies, we believe clonoSEQ remains the preferred commercial test for MRD monitoring in their registrational trials. To that end, clonoSEQ is now being used by more than 60 biopharmaceutical companies in over 150 clinical trials. To continue demonstrating clinical utility across disease settings and lines of therapy, clonoSEQ is also being used in 95 ongoing prospective investigator-led clinical trials, and our MRD data have been included in over 110 peer-reviewed publications.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe clonoSEQ has broad applicability across all lymphoid malignancies. Specifically, we submitted a 510(k) premarket notification for ALL from blood samples in February 2021 and are actively validating the test for patients with NHL disease types. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We continue to deepen our commercial investments to expand clinical adoption of clonoSEQ and have increased the size of our specialized sales and customer support organization and supporting infrastructure. We have continued to expand our team of demand generation representatives who are hematology specialists and are focusing their efforts on expanding access to clonoSEQ in community oncology settings.&#160;Outside of the United States, we have successfully transferred the technology to seven labs across France, Germany, Italy, UK, Spain, Australia and Japan which provide local testing options, primarily in support of collaborative group and investigator-sponsored studies.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The Technology </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clonoSEQ is our FDA-authorized, NGS MRD technology that is designed to sequence all rearranged receptor sequences in a tumor in parallel to ensure accurate, sensitive and robust MRD monitoring. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of the steps for FDA-authorized usage is as follows: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">gDNA is extracted from bone marrow. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Extracted DNA quality is assessed, and rearranged immune receptors are amplified using a multiplex PCR. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Reaction-specific index barcode sequences for sample identification are added to the amplified receptor sequences by PCR. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Sequencing libraries are prepared from barcoded amplified DNA which are then sequenced by synthesis using NGS. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Raw sequence data are uploaded from the sequencing instrument to our analysis pipeline. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">6.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Sequence data is analyzed in a multi-step process, where a sample&#8217;s sequence data is first identified using the sample index sequences and the data is then processed using a proprietary algorithm with in-line controls to remove amplification bias. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">7.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Following completion of these data processing steps, a report is issued. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Adaptive Assist: Patient support program </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Assist is our patient support program to facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by NGS MRD testing. Patients can call to discuss their individual circumstances with one of our dedicated patient support representatives in order to better understand their coverage prior to clonoSEQ testing and to navigate the insurance process, including appeals for denied claims. We also offer financial assistance for qualified uninsured and under-insured patients who cannot afford their patient financial responsibility for clonoSEQ. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Validation in FDA Filing for MM, ALL and CLL </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our clonoSEQ test has been shown to help better predict patient outcomes and add insight to the evaluation of disease response to therapy because we have clinically validated clonoSEQ&#8217;s ability to detect MRD at a sensitivity greater than the current clinical standard for all lymphoid malignancies. clonoSEQ has demonstrated sensitivity of 1 out of 1,000,000 cells (10<sup style="font-size:85%;line-height:120%;vertical-align:top">-6</sup>), given sufficient sample input, which is a deeper resolution than the current accepted standard of 1 out of 100,000 cells (10<sup style="font-size:85%;line-height:120%;vertical-align:top">-5</sup>), 1 out of 10,000 cells (10<sup style="font-size:85%;line-height:120%;vertical-align:top">-4</sup>) or 1 out of 10,000 cells (10<sup style="font-size:85%;line-height:120%;vertical-align:top">-4</sup>) for MM, ALL and CLL, respectively. Based on these results, as further illustrated below, we believe clinical standards for MRD sensitivity may be increased to 10<sup style="font-size:85%;line-height:120%;vertical-align:top">-6</sup> to better predict patient outcomes. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical validation in MM was demonstrated in two studies. The first study, a 720 patient, randomized phase III trial conducted at the Dana Farber Cancer Institute (DFCI 10-106), evaluated the ability to predict progression-free survival (&#8220;PFS&#8221;) and disease-free survival in patients who achieved complete response (&#8220;CR&#8221;) and the ability to predict PFS in all evaluable patients. This study demonstrates that MRD negativity for patients in CR significantly predicts PFS. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The second study, a 706 patient, randomized phase III trial sponsored by Janssen Biotech, Inc. (&#8220;ALCYONE&#8221;), evaluated Darzalex in patients with newly diagnosed MM who were transplant ineligible and served as the basis of the approval of Darzalex in combination with Bortezomib, Melphalan and Prednisone (&#8220;VMP&#8221;) in this patient population. This study provides evidence that our clonoSEQ diagnostic test is predictive of PFS, regardless of treatment received. Patients who were MRD negative at less than or equal to 10<sup style="font-size:85%;line-height:120%;vertical-align:top">-5</sup> had longer PFS and the group with persistent MRD negativity had the longest PFS overall. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patients who were MRD negative by the clonoSEQ Assay had longer PFS </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">compared to MRD positive patients regardless of treatment. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000011.jpg" title="" alt="" style="width:546px;height:328px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical validation in ALL was demonstrated in two Children&#8217;s Oncology Group studies, AALL0232 (high risk) and AALL0331 (standard risk) by evaluating the ability of clonoSEQ to predict event-free survival (&#8220;EFS&#8221;) at a primary cutoff of 10<sup style="font-size:85%;line-height:120%;vertical-align:top">-4</sup> and across a continuous MRD measure. Results demonstrate that patients with the lowest levels of MRD have better outcomes than patients with higher disease burden regardless of risk stratification. </p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patients with lower levels of MRD (less than 1/100,000 cells), using the increased </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">sensitivity of clonoSEQ, have a higher probability of EFS. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000012.jpg" title="" alt="" style="width:378px;height:332px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical validation in CLL was demonstrated in two studies. The first, a 337 patient randomized phase III registrational study in previously untreated CLL patients sponsored by Roche (CLL14), evaluated the ability of clonoSEQ to predict PFS at a primary cutoff of 10<sup style="font-size:85%;line-height:120%;vertical-align:top">-5 </sup>and across continuous<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup>MRD measures from blood. The study demonstrates that MRD negative patients had significantly better PFS, independent of treatment regimen.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The second was a prospective, phase 2 clinical trial in previously untreated CLL patients in which MRD was assessed from both blood and bone marrow. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MRD negativity at multiple cutoffs (10</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">-4</sup></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 10</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">-5</sup></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and 10</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">-6</sup></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) was significantly associated with better PFS. MRD was also prognostic of PFS when disease burden was assessed as a continuous measure (no MRD threshold).</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> This study demonstrates that MRD is predictive of better PFS and can be assessed from either bone marrow or blood.</span></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CLL Patients with lower levels of MRD in blood have a higher probability of EFS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000013.jpg" title="" alt="" style="width:382px;height:318px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Evolution of MRD into Clinical Decision Making Tool</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While clinical utility has been a barrier to adoption in the past, this is changing quickly as we see multiple studies reading out that clearly demonstrate the value of MRD testing for patients. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">For example, the MASTER trial presented at ASH 2021 and published in the Journal of Clinical Oncology (JCO) showed 98% of standard and high-risk patients who discontinued treatment after two negative clonoSEQ MRD tests did not progress after 12 months of treatment discontinuation. This data supports the goal of adapting treatment regimens to give relief to patients from side effects and saving substantial costs for the health care system.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Martinez-Lopez<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup>published a retrospective cohort analysis of 400 newly diagnosed myeloma patients in which MRD was used interventionaly to escalate, change, or stop therapy for 67 of those patients. Data showed that for MRD negative patients who stopped therapy, progression-free survival (PFS) was not negatively impacted. Also, for MRD positive patients in whom therapy was changed or intensified, PFS was significantly better than in patients who remained on the same course of therapy. This analysis supports the potential for use of MRD to modify treatment.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Strategy to Achieve Market Leadership</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We aim to drive adoption and achieve market leadership for MRD monitoring with clonoSEQ for all lymphoid malignancies. To do so, we are executing upon the following strategic initiatives: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Invest in commercial initiatives to increase awareness and usage in the clinic.</span><span style="color:#000000;"> We are expanding our sales organization to target key customer segments, including academic centers, integrated health networks and community clinicians, in a tiered manner based on patient volume. Importantly, clonoSEQ is now being used clinically at all 31 NCCN institutions. In 2021, we also drove significant uptake in Tier 2-3 community accounts. We will continue to increase the strength of our specialized sales organization and supporting infrastructure, including building out our teams focused on community oncology centers and integrated delivery networks. We are also focusing on deeper penetration of the patient opportunity within academic institutions currently using clonoSEQ. We also continue to build advocacy on an educational basis through a variety of patient educational initiatives and peer to peer programming about the impact of MRD status on clinical decision-making. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Expand reimbursement with public and private payors. </span><span style="color:#000000;">We are working with new payors to develop appropriate coverage policies, generate healthcare economic information and provide robust billing and patient access infrastructure. As of December 31, 2021, we secured Medicare and private payor coverage for clonoSEQ for over 240&#160;million covered lives for MM and ALL and over 150 million covered lives for CLL. In November 2021, </span><span style="color:#000000;">MolDX published </span><span style="color:#000000;">its LCD for MRD testing. This LCD not only affirms the importance of MRD and clonoSEQ coverage in ALL, MM and CLL in bone marrow and blood, but also provides a clear and efficient pathway </span><span style="color:#000000;">for seeking</span><span style="color:#000000;"> expanded clonoSEQ coverage through technical assessments in </span><span style="color:#000000;">NHL</span><span style="color:#000000;">.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Entrench clonoSEQ in biopharmaceutical clinical trials.</span><span style="color:#000000;"> As the industry pursues the inclusion of MRD as a potential surrogate or primary endpoint in clinical trials for lymphoid malignancies, having a standardized and highly accurate and sensitive method for MRD testing to guide clinical decisions in late-stage trials, including registrational trials, is valuable. Our goal is to position clonoSEQ for use by our biopharmaceutical collaborators as the MRD test of choice for these clinical trials. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Validate clonoSEQ in additional indications for use.</span><span style="color:#000000;"> With the end goal of clonoSEQ becoming a universal MRD test for all lymphoid malignancies, we have developed a robust lifecycle development plan to generate sufficient clinical evidence to support the extension of the FDA label across lymphoid malignancies. We are already cleared in ALL and MM from bone marrow and CLL from bone marrow and blood. At the same time, we are increasing marketing support for clonoSEQ usage as a CLIA-validated lab-developed testing service, where samples for any lymphoid cancer indication and a range of sample types (including blood) are acceptable, and payer coverage is already in place for blood-based testing in ALL, MM and CLL. Going forward, we will continue to evaluate the optimal commercial path (FDA or CLIA) for each additional indication, with an increasing focus on NHL.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Validate clonoSEQ in blood to offer a minimally invasive alternative.</span><span style="color:#000000;"> Testing with blood is less invasive for patients and less expensive as compared to MRD testing from bone marrow samples, and it may only be possible because of the deep sensitivity of our clonoSEQ diagnostic test. Therefore, blood-based MRD testing may enable more frequent monitoring of patients over longer periods of time. We have already received FDA clearance for clonoSEQ from blood samples for patients with CLL, we submitted for FDA clearance for ALL from blood samples and are evaluating the path forward, and we will continue to expand testing with blood to other indications over time. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Invest in product and customer experience improvements. </span><span style="color:#000000;">For 2022, we are making significant investments to support our field force, including providing enhanced selling direction, data and training.&#160;&#160;We are also making significant investments in improving our assay&#8217;s performance for evaluation of ctDNA in plasma, and, with respect to the process of ordering malignancies clonoSEQ testing and obtaining test results, aiming to continue to enhance our customer-facing software interface and user experience. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Early or Accurate Detection with T-Detect </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By learning to read the antigen specificity of a patient&#8217;s immune system, we are developing the T-Detect test for early or accurate detection across a broad range of diseases, including infectious diseases, autoimmune disorders, and certain prevalent cancer types. We believe the adaptive immune system presents an ideal model for diagnostic tools for early or accurate detection of disease. In many cases, treatment is typically most effective early in the course of a disease, when there is a minimal amount of disease-specific antigen present. TCRs recognize this very small amount of antigen before it is detectable by conventional methods and then they expand exponentially. Given this large response in proportion to the amount of antigen present, we believe we will be able to see this signal of disease much sooner than is possible with other methods of early disease detection. Additionally, in some disease states, knowledge of prior infection from certain pathogens, e.g., COVID-19 and Lyme, may inform the basis of clinical decision-making or ongoing patient care. Finally, the ability to rapidly and accurately identify the cause of non-descript symptoms may increase efficiency and compress the timeline between symptom and diagnosis, thus reducing the diagnostic odyssey that patients often endure in the current diagnostic paradigm.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are leveraging our existing immunoSEQ technology to develop T-Detect for the early or accurate detection of many diseases simultaneously. This is possible because our platform works with retrospective sample sets and uses machine learning and computational statistics to continuously improve accuracy without requiring large cohorts of prospective patients. We began by developing T-Detect for the early detection of specific disease states that meet the following criteria: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Clinically relevant antigens are known and understood. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">High unmet medical need for diagnosis. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Potential to improve patient outcomes with early intervention. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Availability of sample sets with patient outcomes. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Using these data, we aim to simulate the natural diagnostic capability of the immune system into the clinic where we will use the map for the early or accurate detection of many diseases.&#160;The potential economic model for T-Detect of becoming "one test with many results" is very compelling. When multiple tests are ordered at the same time, the marginal cost for each additional test result is negligible.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through iterative data generation efforts, we continue to improve the accuracy of the TCR signatures of each disease by running blood samples from healthy donors, collaborating on retrospective studies with control groups in select disease states, and leveraging our database for additional sequences to include in the TCR signatures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We see the evolution of T-Detect in three phases over time:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Phase I: Launch T-Detect disease by disease with a more accurate test versus the current standard of care.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Phase II: Introduce T-Detect panel(s) for the differentiated diagnosis of disease when the symptoms are shared among several diseases. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Phase III: Enable T-Detect for population immunomics, where anything we map, we will be able to diagnose from a single blood sample.&#160;</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">First Commercial Indication: T-Detect COVID </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In response to the COVID-19 pandemic, we collaborated with Microsoft to create the ImmuneCODE program to map the T cell response to SARS-CoV-2 across the global population. Our goal was to leverage the existing capabilities of our high throughput platform to generate an unprecedented amount of T cell data from over 9,000 samples to understand the adaptive immune response to COVID. From these samples, we have mapped over 160,000 high-confidence TCRs to all parts of the virus which we have shown to be most immunogenic.&#160;&#160;T-Detect COVID received EUA for confirmation of recent or prior SARS-CoV-2 infection in March 2021.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This represents a stepping-stone to the long-term vision of T-Detect where a single blood sample can provide information about what diseases a person&#8217;s immune system has seen or is currently fighting. Data demonstrates that the T-cell response is more persistent than the antibody response to the virus, persisting to at least twelve months following initial infection, and performance of T-Detect COVID is equivalent to or better than antibody testing at all timepoints evaluated. &#160;&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Validation of Detection of Recent or Prior SARS-CoV-2 Infection </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our T-Detect COVID test is a novel T-cell based assay that has demonstrated high percent positive and percent negative agreement (PPA and NPA) to identify or exclude prior SARS-CoV-2 infection in PCR-confirmed SARS-CoV-2 cases and lack of cross-reactivity to several viral and/or respiratory pathogens.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PPA was demonstrated in two studies: 1) a primary PPA study evaluating residual blood samples (N&#61;205) from subjects diagnosed with SARS-CoV-2 infection based on the EUA Abbott RealTime SARS-CoV-2 RT-PCR test from a single U.S. reference lab (Discovery Life Sciences, New York)&#59; and 2) a secondary PPA study using both retrospectively and prospectively collected samples from multiple cohorts (N&#61;77&#59; ImmuneRACE and ImmuneSense&#8482; COVID-19) and identified as positive based on a variety of EUA testing methods performed by a number of different labs. T-Detect COVID demonstrated high PPA particularly in the timeframe of &#8805;15 days since diagnosis (97.1%) as well as &#8805;15 days since symptom onset (94.5%), as shown in Table 1.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Table 1. Positive Percent Agreement (PPA) of T-Detect COVID Assay with SARS-CoV-2 RT-PCR according to days since symptom onset or days since diagnosis.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:487.5pt;;">
<tr>
<td style="width:114pt;"></td>
<td style="width:67.9pt;"></td>
<td style="width:148.5pt;"></td>
<td style="width:157.1pt;"></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Days&#160;Since&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Diagnosis<span style="font-weight:normal;">&#160;</span></p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RT-PCR+ Samples (N)</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">T-Detect Positive (N)</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">T-Detect PPA&#160;(95% CI)</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0-7 days&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.4 (53.7 - 85.4)</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-14 days&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.9&#160;(92.7 - 99.3)&#160;</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8805;15 days&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.1&#160;(92.7 - 99.2)</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All&#160;(range 0-91 days)</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A&#160;</p></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Days&#160;Since&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symptom&#160;Onset<span style="font-weight:normal;">&#160;</span></p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0-7 days&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53.8&#160;(25.1 - 80.8)</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-14 days&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77.8 (40.0 - 97.2)</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8805;15 days&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.5&#160;(84.9&#160;-&#160;98.9)</p></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All&#160;(range 0-106 days)</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NPA was demonstrated in two studies: 1) a primary NPA including 124 retrospective frozen clinical remnant blood samples collected prior to December 2019 and thus presumed negative for SARS-CoV-2 infection&#59; and 2) a secondary NPA study using blood samples from subjects enrolled prospectively (ImmuneSense COVID-19) from October through November 2020 who presented with SARS-CoV-2 symptoms but tested negative for SARS-CoV-2 using RT-PCR EUA, BioFire RP V2.1, and EUA antibody tests. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T-Detect COVID demonstrated NPA of approximately 100% in individuals who had compatible symptoms of infection but were either presumed or confirmed negative for SARS-CoV-2 by PCR and antibody testing, as shown in Table 2.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Table 2. Negative Percent Agreement (NPA) of T-Detect COVID Assay with pre-pandemic samples sourced retrospectively (DLS) and prospectively enrolled subjects (ImmuneSense COVID-19) negative for SARS-CoV-2 by EUA RT-PCR and antibody testing.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:91.41%;">
<tr>
<td style="width:24.37%;"></td>
<td style="width:17.02%;"></td>
<td style="width:25.19%;"></td>
<td style="width:24.63%;"></td>
<td style="width:0.19%;"></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cohort&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Samples&#160;(N)</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">T-Detect Negative Results&#160;(N)</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NPA&#160;(95% CI)&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DLS&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100 (95.8&#160;&#8211;&#160;100)&#160;</p></td>
<td valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmuneSense&#160;COVID-19&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78&#160;</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98.7 (93.1&#160;&#8211; 99.97)&#160;</p></td>
<td valign="middle" style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Second Indication: T-Detect Lyme</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We previously established proof of concept in acute Lyme disease from two independent, retrospective cohorts of over 200 patients with early Lyme disease.&#160;&#160;The TCR repertoire sequencing demonstrated a near doubling in sensitivity for identifying disease compared to STTT (56% vs. 30%) in patients tested within 30 days of symptom onset (2/3 of patients were tested within 8 days of symptom onset), with the sensitivity over STTT being most significant in the four days following the onset of symptoms (44% vs 14%). TCR repertoire sequencing was approximately 99% specific in an independent set of control samples that had all tested STTT-negative. 37% of early Lyme cases that initially tested STTT negative were identified. Additionally, the relative abundance of T-cell signatures was found to correlate with disease severity markers, such as abnormal liver function tests, disseminated rashes, and several other Lyme disease-associated symptoms. The signal in Lyme further demonstrates that machine learning can be leveraged to develop diagnostic signals, even without the large cohorts of prospective patient data often required for diagnostics development.&#160;&#160;We completed the ImmuneSENSE Lyme study and expect to launch as a CLIA-service offering during the 2022 Lyme season, leveraging the infrastructure built for T-Detect COVID.&#160;&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">T-Detect Pipeline </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To achieve our goal of developing a diagnostic test for early detection across a broad range of diseases, we are pursuing the following strategic plan: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Apply machine learning to high-throughput mapping to generate the TCR-Antigen Map. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Demonstrate clinical signals for early detection using mapped TCRs in select indications. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Launch one TCR sequencing technology, T-Detect, for initial indications. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Broaden utility to a wide range of diseases without requiring large prospective trials.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have optimized our research and development funnel and expanded our lab capacity to expedite our ability to move many diseases through the funnel in parallel. We start by prioritizing diseases that meet key market attractiveness criteria such as high unmet medical need, understanding of the antigenic space, and our access to samples with metadata. Once an early signal is identified, we refine our modeling with additional case control studies and by leveraging our clinical immunomics dataset. Once we confirm a signal, we proceed with a full commercial validation and generation of a locked-down algorithm to take into clinical validation and regulatory submission. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In terms of other T-Detect indications in the pipeline, we continue to advance T-Detect in multiple autoimmune indications in parallel. In 2021, we confirmed signals in Crohn&#8217;s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> disease</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and multiple sclerosis and identified new signals in </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ulcerative </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">colitis and rheumatoid arthritis. These clinical signals were identified in a series of well-characterized case-control sample sets from collaborating institutions, including </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">over </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000 samples in IBD, and we plan to advance some of these signals to blinded clinical validation studies in the near future. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For new indications, there are many economic advantages of T-Detect both in the research and development stage and as a commercial product. For the research and development pipeline, we use the same capital expenditures and workflow for signal generation across all diseases allowing us to study multiple diseases in parallel. Once commercialized, again, we use the same blood sample and the same underlying chemistry for all diseases with a small incremental investment in software for each individual disease, enabling a long-term high margin profile. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Life Sciences Research </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">immunoSEQ for Research Use Only </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immunoSEQ technology, which we offer to customers as a service and a kit, is the core of our immune medicine platform. immunoSEQ utilizes multiplex, bias-controlled PCR to accurately and quantitatively sequence millions of immune receptors at high-throughput directly from DNA. We believe immunoSEQ is positioned to become the global standard for immunosequencing due to the quality and reliability of our data and the analytics and data visualization tools that are easily accessible to customers in the immunoSEQ Analyzer, whether sequenced as a service or a kit. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since inception, immunoSEQ has been used for research purposes by over 2,400 academic researchers and 175 biopharmaceutical companies and incorporated into over 650 clinical trials to answer translational research questions relating to the adaptive immune system, monitor response to therapies and discover new prognostic and diagnostic signals. These research questions are answered by using the data generated by immunoSEQ and uploaded to the immunoSEQ Analyzer to study different properties and dynamics of all of the sequences in an immune repertoire, such as frequency or abundance, and by tracking specific sequences over time in clinical trials. Graphical representations of the Analyzer output are shown in the figure below: </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000014.jpg" title="" alt="" style="width:720px;height:160px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">immunoSEQ provides a growing revenue stream. However, we also use immunoSEQ as the foundational technology for our clinical diagnostic and therapeutic products. To fuel innovation, we also provide immunoSEQ to select research and development collaborators who gain access to immunoSEQ and significant computational and analytical support, co-share and co-publish the data with us, and contribute to the validation of potential clinical diagnostic discoveries. For example, we work closely with our collaborators to conduct translational research to explore the use of immunosequencing to predict responders to novel immunotherapies such as checkpoint inhibitors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immunoSEQ Analyzer is housed on a secure cloud-based database and is the visualization gateway to our clinical immunomics database that currently has billions of TCR and BCR sequences which are often annotated and accompanied by samples with associated metadata. We offer computational services to assist our customers in realizing the power of their data and to compare their data to other publicly available datasets in our clinical immunomics database. We contribute some of our own research and development sequences into the publicly available datasets and customers are offered the option to make their data public using one of our tools on our immunoSEQ Analyzer, called immuneACCESS, through which researchers can expedite and streamline the peer-review process by sharing their data with reviewers prior to manuscript submission.&#160;&#160;The ongoing analysis of immune receptor data from an expanding database tagged with clinical metadata, when possible, has led to over 650 peer-reviewed publications referencing immunoSEQ and potential clinical signals to explore.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">immunoSEQ T-MAP </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, we identified some key opportunities to expand our research product offering to include mapping data generated by our platform. Sequences mapped to clinically relevant antigens have many benefits beyond just repertoire sequencing dynamics and we plan to offer immunoSEQ T-MAP across many disease states in the future. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We launched immunoSEQ T-MAP COVID in August 2020 for vaccine developers and researchers to accurately and reproducibly measure the T-cell immune response to vaccines and track the persistence of that response over time, including with respect to emerging variants of concern. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">immunoSEQ T-MAP COVID combines the sequencing and mapping capabilities of Adaptive&#8217;s immune medicine platform to show how T cells respond to different parts of the virus, including the various parts of the spike protein</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A key objective with T-MAP COVID is to answer many outstanding questions about durability of COVID-19 vaccines, especially in light of new variants of the virus. For new variants of concern, such as Delta or Omicron, we have demonstrated the ability to identify mutations and connect them to our large-scale antigen-specific datasets in order to measure T-cell response to vaccination and determine the role of cellular immunity</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our T-MAP product offers significant advantages over other technologies to detect and monitor T cells at scale using a small amount of blood without the need for live cells that require special sample handling</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have sequenced a subset of patient samples (pre- and post-vaccination) from clinical trials sponsored by several top-tier vaccine developers, including Moderna, Johnson &#38; Johnson, AstraZeneca, University of Oxford, Bill and Melinda Gates Foundation among others. Using our immunoSEQ T-MAP COVID product, we can identify and track expanded T cells induced by a vaccine, which can be distinguished from a natural infection, in order to monitor vaccine efficacy. With some partners, we are working towards understanding how T cell activation may provide a correlate of protection.<span style="font-size:7.5pt;"> </span>This has become increasingly critical in the wake of variants since the antibody response is increasingly off-target and T cells are correlating more closely with real-world vaccine efficacy.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In an effort to understand immunity for immunocompromised patients, we have also collaborated with the Leukemia and Lymphoma Society and other prestigious academic labs in order to study the T cell response of this subset of patients who do not always have the ability to mount an antibody response to vaccination. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Drug Discovery </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our aim is to develop immune-mediated therapies in oncology and other disease areas by using the full functionality of our immune medicine platform, including TruTCR and TruAB for TCR and antibody characterization, respectively. We are currently working to leverage our immune receptor discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our own end-to-end capabilities for the further development of our own portfolio of therapeutic candidates.</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000015.jpg" title="" alt="" style="width:664px;height:343px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">TCR Discovery for Cellular Therapy using TruTCR </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed a high-throughput TCR screening process that allows for the discovery of antigen-specific TCRs that occur in low frequencies in healthy individuals. We believe this provides a set of naturally-occurring TCRs with a more favorable safety profile in comparison to engineered TCRs. We then further characterize these naturally-occurring TCRs for binding avidity and cytotoxic potency. To date, we have identified and characterized to different stages more than 5,000 unique antigen-specific, paired TCRs against 600 different clinically relevant targets, constituting our pipeline of possible clinical candidates. We complete a data package for each characterized TCR that we believe meets the thresholds for therapeutic evaluation. These thresholds are divided into a series of seven key steps covering antigen specificity, functional avidity, cytolysis and safety assessment. A package is considered complete when the TCR meets the rigorous criteria for all seven steps and the data are compiled to support an IND package. As a proof of concept, we compared our fully characterized TCR against WT-1, a TAA often overexpressed in various cancers, to a benchmark WT-1 TCR. A gold standard for testing TCR efficacy is killing of cells that naturally express the target antigen at low levels. Using a cancer cell line that is known to express low levels of WT-1, our candidate WT-1 TCR was over four times more effective at killing cancer cells than the benchmark TCR. The complete data package for our lead WT-1 TCR candidate demonstrates improved avidity, cytolysis and a promising safety profile. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our high-throughput screening technologies enable us to discover TCRs against any type of antigen which opens up the potential to develop novel TCR-mediated cellular therapies for any type of cancer. As compared to cellular therapies that target T&#160;cell surface antigens that are not specific to cancer, we believe our approach to TCR cellular therapies may mitigate the risk of off-target side effects. Therefore, we believe our approach may be applicable to the vast majority of solid tumors, even those where the tissue of origin is vital to survival such as lung or renal. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2018, Genentech selected our platform to develop, manufacture and commercialize novel neoantigen directed T&#160;cell therapies for the treatment of a broad range of cancers. Our ultimate goal is to harness the vast majority of therapeutically relevant, patient-specific TCRs against neoantigens and advance the next generation of cellular therapies in oncology. We believe our TCR discovery capabilities may also facilitate the development of cellular therapies in disease areas beyond cancer, which we can commercialize outside of the Genentech collaboration. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to cellular therapy applications, we believe our TCR screening capabilities can guide the design and development of next generation vaccines by characterizing the immunogenicity of hundreds of antigens at a time. Our platform can also be used to then monitor early signs of antigen-specific immune response in patients treated with novel vaccines. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Strategic Collaboration with Genentech </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through our worldwide collaboration and license agreement with Genentech, we plan to develop, manufacture and commercialize novel neoantigen directed T&#160;cell therapies for the treatment of a broad range of cancers to advance the next generation of cellular therapies in oncology. We are pursuing two product development pathways for novel T&#160;cell immunotherapies in which Genentech intends to use TCRs screened by our immune medicine platform to engineer and manufacture cellular medicines: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Shared Products.</span><span style="color:#000000;"> The Shared Products will use &#8220;off-the-shelf&#8221; TCRs identified against cancer antigens shared among patients. We completed an assessment of efficacy and safety data to enable a decision to select our lead TCR candidate. Following review of this data by both us and Genentech, Genentech recently selected this TCR candidate to progress as a potential therapeutic product candidate. Meanwhile, we continue to screen and characterize TCRs against clinically relevant targets in solid tumors. We are on track to deliver to Genentech up to two additional TCR data packages for consideration by Genentech.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Personalized Product.</span><span style="color:#000000;"> The Personalized Product will use patient-specific TCRs identified by real-time screening of TCRs against cancer antigens in each patient.&#160;&#160;In the second half of 2020, we started screening blood from cancer patients to identify TCRs specific to a patient&#8217;s tumor mutations. We conducted initial proof of concept screens by successfully processing blood from approximately 60 cancer patients, demonstrating that in certain of these patients we were able to identify naturally-occurring TCRs from the cancer patient&#8217;s own blood that are specific to that patient&#8217;s unique tumor mutations. To support our near-term and long-term objectives for the Personalized Product, we opened our dedicated prototype lab in South San Francisco in 2021, which will have capacity to perform first-in-human clinical trials. We believe the lab positions us to potentially pursue additional opportunities outside of this collaboration, including cellular therapy in other disease states and cancer vaccines.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:10.14%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000016.jpg" title="" alt="" style="width:725px;height:297px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, we received a $300.0&#160;million initial upfront payment in February 2019, and we may be eligible to receive approximately $1.8&#160;billion in aggregate milestone payments upon achievement of specified development, regulatory and commercial milestones. Additionally, we may receive royalties on sales of products commercialized under that agreement. Genentech will be responsible for clinical, regulatory and commercialization efforts. We will be responsible for the screening and identification of TCRs that can most effectively recognize and directly target specific cancer antigens, including neoantigens. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In parallel, we plan to evaluate an investment in additional facilities that would allow us to scale our end-to-end screening of patient-specific TCRs for potential future late-stage clinical trials and commercialization of the Personalized Product. We believe this investment would position us to potentially pursue additional opportunities outside of this collaboration, including developing and commercializing vaccines and cellular therapies in other disease states. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Vaccine Development with Nykode</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also extended our drug discovery efforts by establishing a new worldwide licensing agreement in July 2021 with Nykode, whereby virus-specific T cell epitopes identified by our platform will be used to inform the design and development of novel SARS-CoV-2 vaccine candidates. The Nykode 2-arm Phase I/II trial is currently enrolling individuals in Norway who are already vaccinated. This T cell-based vaccine is intended to address SARS-CoV-2 variants of concern and may be used as a potential universal booster to available vaccines. The Nykode collaboration represents a significant extension of the platform into vaccine design and development. The platform is being deployed to both design and develop the vaccine as opposed to an evaluative use of our data following infection, as well as in direct support of a new commercial product. Although this is the first licensing agreement we have entered into with vaccine design and development as a primary goal, we believe it may provide a useful proof of concept for extending the platform&#8217;s ability to design vaccines for other disease states. </p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Developing neutralizing antibodies using TruAB</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our TruAB process, similar to our TruTCR process, leverages our high-throughput capabilities to screen millions of BCRs to identify unique antibodies from human blood. Our first proof of concept is for patients who are actively fighting or have recently recovered from COVID-19. In just several months, we collected blood from over 300 patients and hundreds of thousands of antibodies, of which we synthesized and characterized over 3,300 antibodies to various parts of the SARS-CoV-2 virus. To date, we identified several candidates that neutralize live virus at very low concentrations, which means that a very small amount of each of these antibodies is able to block the virus from infecting cells. <span style="color:#000000;">Using our TruAB antibody discovery approach, we identified several lead antibody candidates that strongly bind to different parts of the virus. Our growing portfolio of novel antibodies includes candidates that don&#8217;t bind the classic RBD region and instead bind to S1, Trimer or S2.&#160;We believe we are one of the only groups that has identified S2-specific antibodies that neutralize the virus. This could have important advantages in a cocktail strategy that targets different mechanisms of action to inhibit the virus and potentially virus variants.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000017.jpg" title="" alt="" style="width:705px;height:323px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Importantly, our drug discovery approach is differentiated from other groups because of the scale and throughput of our TruAB approach that allows us to identify a much broader set of naturally-occurring, fully human antibody candidates to select the best ones for clinical development. Beyond COVID-19, we are exploring applications of TruAB discovery in other diseases, including autoimmunity.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Our People and Culture </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our employees, internally referred to as &#8220;Adapters,&#8221; are passionate about immune medicine, empowered by scientific discipline and fueled by our foresight and curiosity about the adaptive immune system.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we had 858 full-time employees of which 180 hold medical or doctoral degrees. None of our employees are subject to a collective bargaining agreement and we have not experienced any work stoppages. We believe relations with our employees are good.</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our talented employees drive our mission and share core values that both stem from and define our culture. This plays an invaluable role in our ability to execute at all levels in our organization. Our core values are used in candidate screening, rewards and recognition criteria, and in employee evaluations to help reinforce their importance in our organization:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Make it happen.</span><span style="color:#000000;"> Individual ownership and accountability keep us moving forward</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Innovate fearlessly.</span><span style="color:#000000;"> Push against boundaries and think boldly to achieve world-changing results</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Debate openly.</span><span style="color:#000000;"> Value discussions inspired by different points of view</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Work together.</span><span style="color:#000000;"> Demonstrate you care about the success of others. The same goes for our partners and customers&#8212;together we can achieve more</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Follow True North.</span><span style="color:#000000;"> Show up with integrity and do the right thing</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Have fun.</span><span style="color:#000000;"> Fun makes everything better</span><span style="font-style:italic;color:#000000;">.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe our employees are highly engaged, and we were recognized consecutively from 2018 to 2021 by the Puget Sound Business Journal as one of Washington State&#8217;s Best Places to Work. We were also nationally certified as a 2021 Great Place to Work.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Diversity and Inclusion</span></p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We pride ourselves on inclusive team building, product design and gender diversity at all levels of management. We are committed to creating and maintaining a culture of belonging. In 2021, we expanded and implemented several diversity and inclusion initiatives. We continued to provide quality DEI programming through Employee Resource Groups (&#8220;ERGs&#8221;) including Women&#64;Adaptive, Adaptive PRIDE, Black Adapter Network and Working Life and Wellness, and in 2021 launched two new ERGs: Asian Pacific&#64;Adaptive and Sustainability&#64;Adaptive. We continued to explore diversity sourcing programs and partnerships, and we expanded our diversity training to a growing population of hiring managers. We also integrated hidden bias training into our Leader of People Program. Our Equity Advisory Council of senior leaders maintained a strategic focus on clinical studies, commercial engagement, recruiting, and retention through a diversity and inclusion lens. In November 2021, we received a Corporate Equality Index (CEI) score of 95/100 from the Human Rights Commission. Our score of 95 is an increase of 20 points from last year&#8217;s previous CEI score. We successfully executed a second year of our STEM minority mentoring partnership with University of Washington. During the grand opening of our new Seattle headquarters building, and with the help of Governor Jay Inslee, we also announced our partnership with SPIN Girls, a transformative local program that builds leadership and provides immersive STEM experiences, while pairing students with female-identifying mentors of color from across King County.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Compensation and Benefits</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We strive to provide compensation and benefits that are competitive to market and create incentives to attract and retain employees. Our compensation package includes market-competitive base pay, performance-based short-term incentives, health care, retirement benefits, paid time off and family leave. In addition, we offer employees the benefit of equity ownership in the Company through restricted stock unit awards. We also provide access to a variety of health and wellness resources, with special attention paid to mental health in 2021. This year also saw the inaugural winners of our Adaptive Leadership Awards announced, recognizing and celebrating those who best embody our Adaptive Leadership Principles. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employee Development &#38; Training</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We prioritize employee development and training and have established programs to support a culture of employee development. Specifically, in 2021, we offered multiple learning solutions, including our Leader Orientation Program, our Leader of People Program, and our L-re:combinator Fellowship Program. We launched Leader of Leaders for employees at or above Director level. We also completely reworked and relaunched our employee onboarding program, DayOne. All of our leadership development programs are multi-week, blended learning courses that feature self-paced online learning and live virtual training. DayOne focuses not just on HR and compliance orientation, but cultural onboarding with small group interactions among our Chief Executive Officer, cultural ambassadors and fellow new Adapters.</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, over 130 Adapters attended leadership development programs and consumed approximately 2,400 hours of training. Over 200 Adapters completed DayOne. In our annual employee survey, Adaptive Listens, Adapters generally judged our managerial corps as one of Adaptive&#8217;s strengths, a sign that investing in their development is translating into real-world results. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">COVID-19 Preparedness</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since the emergence of COVID-19, our cross-functional COVID-19 preparedness committee has been meeting at least weekly to monitor the progress of the disease, stay apprised of expert external guidance, discuss and implement preparedness plans as needed, and provide clear communication to all Adapters. We implemented measures to reduce the risk of exposure of&#160;COVID-19 to the employees who continue to work on site, including the implementation of work-from-home policies for certain employees, as well as the implementation of shifts and zones to physically distance employees who remain on site, including extra sanitation measures. For those employees working remotely, we provided additional equipment to support their ergonomic and technology needs. Beginning in 2022, our offices and infrastructure are now set up to support and enable a hybrid workforce, with safety and other factors related to on site work continually evaluated by our Covid-19 preparedness committee.&#160; </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Strategic Collaborations and Other Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Genentech Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December&#160;2018, we entered into an agreement with Genentech (&#8220;Genentech Agreement&#8221;) to develop, manufacture and commercialize novel neoantigen directed T&#160;cell therapies for the treatment of a broad range of cancers. Pursuant to the Genentech Agreement, we are responsible for the screening and identification of TCRs that can most effectively recognize and directly target specific neoantigens, while Genentech is responsible for clinical, regulatory and commercialization efforts. During the term of the Genentech Agreement, we have agreed to certain defined exclusivity obligations or restrictions with respect to the development and commercialization of certain cell therapies. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2019, we received a $300.0&#160;million upfront payment from Genentech. We also may be eligible to receive approximately $1.8&#160;billion over time, including payments of up to $75.0&#160;million upon the achievement of specified regulatory milestones, up to $300.0&#160;million upon the achievement of specified development milestones, and up to $1.4&#160;billion upon the achievement of specified commercial milestones. Genentech will also pay us tiered royalties at a rate ranging from the mid-single digits to the mid-teens on aggregate worldwide net sales of the Shared Products and the Personalized Product arising from the strategic collaboration, subject to certain reductions, with aggregate minimum floors. For the year ended December 31, 2021</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 2019</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Genentech Agreement accounted for 40.2%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53.7%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.3%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of our revenue, respectively.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Genentech Agreement will continue until the expiration of all royalty payments, but may be terminated by mutual agreement, upon an uncured material breach by either party, upon insolvency of either party, or by Genentech for convenience upon prior written notice. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Microsoft Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December&#160;2017, we entered into a strategic collaboration agreement with Microsoft (&#8220;Microsoft Agreement&#8221;) to map TCR sequences to the antigens they bind with the goal of developing diagnostic tests for early detection of many diseases from a single blood test. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Microsoft Agreement, Microsoft applies machine learning and computational statistics to our clinical immunomics data in order to produce predictive models that allow us to map TCR sequences to the antigens they bind. Under the Microsoft Agreement, we retain all rights to these predictive models and the data underlying our TCR-Antigen Map, including the right to commercialize clinical products using our TCR-Antigen Map. We and Microsoft have granted each other certain licenses to one another&#8217;s intellectual property rights and have agreed to certain defined exclusivity obligations with respect to collaborations and projects that are substantially similar to the Microsoft Agreement. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the term of the Microsoft Agreement, we have agreed to exclusively use Microsoft&#8217;s Azure cloud services at standard volume pricing with a minimum Azure consumption requirement. We have also agreed to host each diagnostic product developed as a direct result of the Microsoft Agreement on Azure throughout the term of the Microsoft Agreement and for a period of five years thereafter. In addition, we&#160;have agreed to exclusively use Microsoft&#8217;s immunomics artificial intelligence services for TCR-antigen mapping in connection with all of our technology, products and services developed as a direct result of our collaboration with Microsoft throughout the term of the Microsoft Agreement. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Microsoft Agreement has a seven-year term and may be terminated by mutual agreement or by either party upon an uncured material breach. Concurrently with entry into the Microsoft Agreement, Microsoft purchased shares of our Series F-1 convertible preferred stock which were converted into common stock upon the closing of our initial public offering in July 2019.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Processing and Manufacturing </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We process both clinical and research use samples in our laboratory in Seattle, Washington. Our Seattle laboratory is CLIA-certified, CAP-accredited and ISO 13485-certified. After we intake samples sent to us from healthcare providers or research and biopharmaceutical customers, we extract DNA from the sample if required, amplify it and otherwise prepare it for our sequencing and data analysis. Throughout our processes, we apply a rigorous quality management system, which is designed to comply with the Quality System Regulation (&#8220;QSR&#8221;) and the requirements of CLIA, CAP and other applicable state licensing and accreditation requirements. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to process samples submitted to us using immunoSEQ or clonoSEQ, we utilize a combination of proprietary primer mixes and commercial materials, including a multiplex PCR master mix, enzymes, high throughput multi-cycle sequencing reagents and other materials, which we obtain and assemble as needed from various third-party vendors on customary terms. A number of our processing steps utilize automated equipment to help ensure consistency and efficiency. Sequencing is performed using the Illumina NextSeq System, which we have appropriately qualified for the intended uses of our products and services. We also work with a third-party vendor to manufacture our immunoSEQ RUO kit using our proprietary primer mix and other materials. We also use Illumina to develop IVD kits and provide related support for clonoSEQ and T-Detect, pursuant to a September 2019 development and supply agreement with a six-year term and payments to Illumina based on Illumina achieving milestones and revenue share payments ranging from a low to mid-single digit percentage of future net sales, subject to customary reductions.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our TCR-Antigen Map and drug discovery initiatives, we conduct our current operations at our laboratories in Seattle, Washington and South San Francisco, California. These laboratories have cell sorting, tissue culture and other processing equipment. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use a limited number of suppliers, or in some cases single suppliers, for our laboratory equipment and materials. We manage this concentration risk by targeting </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or building to </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">levels of surplus stock that, we believe, would allow us to locate alternative suppliers if needed. However, if one of our suppliers fails to perform adequately or fulfill our needs, we may be required to incur significant costs and devote significant efforts to find new suppliers and may face delays in processing samples or developing and commercializing our products and services. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">W</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e have</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> occasionally</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> faced delays in the form of longer lead times for equipment that is subject to increased demand due to public health measures taken to combat the COVID-19 pandemic. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In particular, we have purchased the Illumina NextSeq System, and Illumina also supplies us with reagents that have been designed for use solely with this sequencer. While we acquire these reagents from Illumina on customary terms, if we had to replace the reagents we use we may also need to acquire and qualify a replacement sequencer, validate the reagents and potentially revalidate aspects of our existing assays. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distribution </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We processed our first immunoSEQ samples in 2011 and issued our first clonoSEQ report in 2013. Since then, we have focused on expanding our customer base. We sell our products and services primarily through our own internal sales force. Our sales and marketing efforts are targeted at department heads, laboratory directors, principal investigators, core facility directors, clinicians, payors and research scientists and pathologists at leading academic institutions, biopharmaceutical companies, research institutions and contract research organizations. We seek to increase awareness of our products and services among our target customers through direct sales calls, trade shows, seminars, academic conferences, web presence and other forms of internet marketing. Our drug discovery efforts are focused on large biopharmaceutical companies.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intellectual Property </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have an extensive global portfolio of intellectual property rights to protect our immune medicine platform, the products and services that draw on it and our reputation in the industry. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, we owned or controlled 471 active patents and patent applications whose claims are intended to cover what we do, what we plan to do and what others might do to compete with us. From our earliest patent filings in 2009, our portfolio has been tailored to reflect our efforts to harness the adaptive immune system for research, diagnostic and therapeutic applications. Our patent claims extend to not only adaptive immune receptor molecules, but also to uniquely powerful techniques for sequencing immune cell receptors, determining clonality and immune competency, diagnosing disease, predicting responses to immunotherapy and identifying new drug candidates. Our patent protection generally expires in years ranging from 2029 to 2040. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Critical know-how we develop is protected by a trade secrecy program to ensure against inappropriate disclosure or use. Encompassed in our know-how is our proprietary database of coding sequences, antigen reactivities and safety profiles for immune receptors, which is vast and growing. Even with collaborators, access to our immune medicine platform technology is limited and tightly controlled through contracts and careful communication. We own our immune medicine platform, including improvements we or collaborators make to it, and retain rights in data resulting from its use. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also pursue trademark registration for our product and service names and promotional slogans in our existing and projected markets. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Intellectual Property Portfolio by the Numbers </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, our intellectual property portfolio consisted of the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">471 patent applications filed worldwide directly or in conjunction with a co-owner or licensor since 2009&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">51 pending patent applications&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">420 issued patents across our immune medicine platform&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">24 patent families directed to methods and tools useful in our immune medicine platform for non-target specific immunosequencing and research, including immunoSEQ&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">17 patent families directed to methods and tools useful in diagnosis, prognosis and disease monitoring, including clonoSEQ, T-Detect and the TCR-Antigen Map&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">12 patent families directed to methods and tools useful in drug discovery, including TruTCR, MIRA and pairSEQ&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">1 patent family directed to therapeutic antibodies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">1 patent family directed to gene sequencing technology&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">28 trademarks registered and pending registration worldwide. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Patent Portfolio </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed an expansive patent portfolio in commercially important markets with claims to critical aspects of our technology, beginning with our first patent applications exclusively licensed from Fred Hutch in 2009. Our ongoing patent strategy is to generate a return on our patenting investments, which values substantive quality over volume to build a defensible moat around technology we use as well as what others might develop to design around our position. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We prioritize pursuing patent claims with a reasonable likelihood of being granted. Where patentability for a particular invention is questionable, we often choose to protect it as a trade secret instead. In some instances, however, we may seek to push the patentability envelope when the state of the applicable patent laws are in flux, such as patent eligibility for naturally occurring molecules, including TCRs, in the United States. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Methods of Measuring Adaptive Immunity </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2009, a U.S. provisional patent application was filed to pursue protection for immunosequencing by our co-founder, Dr.&#160;Harlan Robins. The invention broadly relates to methods for assessing the adaptive immune system status of individuals. Rearranged V and J&#160;segment genes of TCRs or BCRs are targeted as biomarkers for assessing the status of the immune system at one or more points in time. Granted claims extend to the use of particular sets of amplification primers, while pending claims are being pursued to capture additional assessment techniques. Licensed exclusively to us by Fred Hutch, the application has since spawned more than 31 additional patent applications, many of which have been granted as of December&#160;31, 2021, including U.S. Patent No.&#160;9,809,813. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Optimizing Nucleic Acid Amplification Reactions </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amplification of nucleic acids can result in over- or under-representation of the amplified molecules, misrepresenting the number present in the source material, such as a blood sample. Dr.&#160;Robins invented a method to correct for such bias, thereby improving the precision of PCR-based quantification of TCR and BCR coding sequences in a sample. The claimed approach utilizes synthetic templates, reflecting nucleic acid sequences for rearranged V and J receptor segments in the sampled cells. More than twenty-eight related patent applications have since been filed, many of which have been granted as of December&#160;31, 2021, including U.S. Patent Nos. 9,371,558 and 10,214,770.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Diagnosing and Monitoring Disease </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our acquisition (&#8220;Sequenta Acquisition&#8221;) of Sequenta, Inc (&#8220;Sequenta&#8221;) in 2015, we purchased Sequenta&#8217;s extensive patent portfolio. The portfolio includes 124 patent applications which disclose and claim methods to identify and quantify T&#160;cell-based immune responses to antigen exposure using NGS. TCR and BCR DNA, RNA or cell-free DNA from samples, including blood and bone marrow, are used to detect, prognose and monitor disease, including autoimmune disease, infection and cancer. More than one hundred twelve patents have been granted in the portfolio as of December&#160;31, 2021, including U.S. Patent Nos. 8,628,927 and 8,236,503. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our diagnostic methods also apply to the detection of MRD (the target of our B cell-based clonoSEQ diagnostic test for assessing how disease burden changes in response to treatment or during remission) and T-Detect (our T cell-based diagnostic tests). Multiple patents have been granted from additional applications relating to diagnostic methods and diagnostically significant TCRs filed by us, including U.S.&#160;Patent No.&#160;9,824,179. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">TCR-Antigen Map </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our Microsoft collaboration, we are developing a diagnostic product to detect cancer and other diseases at their earliest stage by learning the signals and responses of the activated immune receptors in a patient&#8217;s blood. Pre-collaboration, we filed 10&#160;related patent applications for methods to produce antigen-exposed enriched T&#160;cell populations and identify their antigen specificities by comparison to a pre-exposure population of cells or by use of an algorithm. We have filed additional patent applications relating to algorithmic-based methods to characterize antigen specificities and will continue to do so as our work proceeds with Microsoft. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">MIRA</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We developed and are pursuing patent protection for bioinformatic-based methods to determine the antigen specificity of TCRs by exposing T&#160;cells to a panel of multiple antigens. Antigen exposure can be performed by incubation or presentation&#59; for example, it can be performed via recombinant expression in another cell. These methods may also be used to pair the two TCR chains as well as to identify high avidity TCRs. Several patents have been granted as of December&#160;31, 2021, including U.S. Patent No.&#160;10,066,265. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">pairSEQ </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In nature, TCRs and BCRs exist as a heterodimer of paired chains, each of which is encoded on a different chromosome. Immunosequencing reveals the nucleotide structure of each individual chain, but not which chains match as cognate pairs. We developed and are pursuing patent protection for multiple bioinformatic-based approaches to pairing the two chains of TCRs and BCRs, including one deployed in our pairSEQ technique. Our methods also allow for identification of receptor chain pairs which are specific to particular antigen targets. Over fifty related patent applications have been filed, nearly half of which have matured into granted patents as of December&#160;31, 2021, including U.S. Patent No.&#160;10,077,478. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Assessing Responsiveness to Immunotherapy </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leveraging our immunosequencing technologies, we developed methods for predicting responses to immunotherapy, vaccines and infection. To those ends, rearranged TCR or BCR sequences are quantified and their levels or frequencies compared at different points in time. More than 20 related patent applications have been filed, most of which have been granted as of December&#160;31, 2021, including U.S. Patent No.&#160;10,221,461. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Therapeutic Antibodies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We developed a therapeutic antibody discovery process called TruAB from which neutralizing antibodies to SARS-CoV-2 have been produced. A patent application to these antibodies was filed in 2020 and is pending.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">In-Licensed and Acquired Intellectual Property Rights </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we have developed the majority of our immune medicine platform, products and services, we occasionally license or acquire third-party owned inventions to bolster the strength of our patent estate and ensure freedom to operate. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Early work by Dr.&#160;Robins with Fred Hutch led to discoveries around immunosequencing methods and tools covered by 128 patents and patent applications in the United States and abroad which we exclusively licensed. Our rights are for all fields of use worldwide and are sublicensable. To the extent any licensed granted patent rights extend to products or services sold by us, we pay Fred Hutch a royalty rate of 0.75% of net sales on licensed products. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through our Sequenta Acquisition, we also obtained an exclusive paid-up license, with rights to sublicense, to patents filed in the United States, Europe, Australia and China owned by iRepertoire, Inc. The license is for worldwide use in diagnosis, prognosis, treatment and monitoring of any proliferative disorder for which rearranged nucleic acids capable of encoding an immune receptor, whether productive or unproductive, or functional or nonfunctional, of a cell, excluding tumor infiltrating lymphocytes, of the proliferative disorder can be used as markers for the disorder, including, but not limited to, lymphoid and myeloid proliferative disorders, such as ALL, CLL, acute myeloid leukemia, chronic myelogenous leukemia, Hodgkin&#8217;s and NHL, plasma cell neoplasms, such as MM, monoclonal gammopathy of undetermined significance, monoclonal B&#160;cell lymphocytosis and myelodysplastic syndromes. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the patent estate acquired from Sequenta, we also acquired ownership of immunosequencing-related patent portfolios from Imdaptive, Inc. and ImmunID S.A.S. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Trademarks </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We own various trademarks, applications and unregistered trademarks in the United States and other commercially important markets, including our company name, product and service names and other trade or service marks. Our trademark portfolio is designed to protect the brands for our products and services, both current and in the pipeline. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Trade Secrecy Program </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have a trade secrecy program to prevent disclosure of our trade secrets to others, except under stringent conditions of confidentiality when disclosure is critical to our business. Our trade secrets include the composition of certain reagents, assay protocols and immunosequencing-related data, such as immune receptor sequences. We protect trade secrets and&#160;know-how&#160;by establishing confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and collaborators. These agreements provide that all confidential information developed or made known during the course of an individual or entities&#8217; relationship with us must be kept confidential during and after the relationship. These agreements also provide that all inventions resulting from work performed for us or relating to our business and conceived or completed during the period of employment or assignment, as applicable, shall be our exclusive property. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary information by third parties. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although we take steps to protect our proprietary information and trade secrets, including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology. Accordingly, we may not be able to meaningfully protect our trade secrets. For more information regarding the risks related to our intellectual property, see &#8220;<span style="font-style:italic;">Risk Factors&#8212;Risks Related to Our Intellectual Property</span>.&#8221; </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Competition </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biotechnology and pharmaceutical industries, including the fields of life sciences research, clinical diagnostics and drug discovery, are characterized by rapidly advancing technologies, intense competition and a strong emphasis on intellectual property. Given the breadth and promise of immune medicine, we face substantial competition from many different sources, including life sciences tools, diagnostics, pharmaceutical and biotechnology companies, academic research institutions and governmental agencies and public and private research institutions across various components of our platform and product and service offerings. Due to the significant interest and growth in immune medicine more broadly, we expect the intensity of the competition to increase. However, we believe our scale, precision and speed, and the resulting clinical applicability, distinguish us from our competitors. In life sciences research, immunoSEQ faces competition from a number of companies. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In clinical diagnostics, clonoSEQ faces competition primarily from institutions performing flow cytometry in-house, particularly outside of the United States. We may also face competition from companies developing early cancer detection testing products for indications that do not currently compete with clonoSEQ.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In drug discovery, clinical trials in the field of immune medicine are being pursued by a number of industry and academic players. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Immune medicine is being pursued by several biotechnology companies as well as by large-cap biopharmaceutical companies. Many of our current or potential competitors, either alone or with their collaboration partners, have significantly greater financial resources and expertise in research and development, manufacturing, regulatory approval and compliance, and sales and distribution than we do. Mergers and acquisitions involving life sciences research, clinical diagnostics or drug discovery companies in the immune medicine space may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and in acquiring technologies complementary to, or necessary for, our programs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize research or diagnostic products or services that are more accurate, more convenient to use or more cost-effective than our products or services. Competitor therapeutic products could also prove safer, more effective, more convenient to administer or more cost-effective than any therapeutic products we may develop with our collaborators. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the relevant market. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Government Regulation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Life Sciences Research Use Only Technologies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our core research product, immunoSEQ, is a RUO tool in the United States that provides data to third parties such as biopharmaceutical companies that are themselves engaged in the research and development of potential diagnostic and therapeutic products and services for which they may later pursue investigation and clearance, authorization or approval from regulatory authorities, such as the FDA. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RUO products belong to a separate regulatory classification under a long-standing FDA regulation. From an FDA perspective, products that are intended for research use only and are labeled as RUO are </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">exempt from most regulatory controls, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and are therefore not subject to the regulatory requirements discussed below for clinical diagnostic products. Thus, RUO products may be used or distributed for research use without first obtaining FDA clearance, authorization or approval. The products must bear the statement: &#8220;For Research Use Only. Not for </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">u</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">se in </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">iagnostic </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">p</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rocedures.&#8221; RUO products cannot make any claims related to safety, effectiveness or diagnostic utility, and they cannot be intended for human clinical diagnostic use. Accordingly, a product labeled RUO but intended or promoted for clinical diagnostic use may be viewed by the FDA as adulterated and misbranded under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and subject to FDA enforcement action. The FDA will consider the totality of the circumstances surrounding distribution and use of an RUO product, including how the product is marketed and to whom, when determining its intended use. If the FDA disagrees with a company&#8217;s RUO status for its product, the company may be subject to FDA enforcement activities, including, without limitation, requiring the company to seek clearance, authorization or approval for the products. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the FDA determines an RUO product is adulterated and misbranded, enforcement may also include a warning letter, seizure, an injunction and/or criminal fines for FDCA violations.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Clinical Diagnostics in the United States</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our first diagnostic product, clonoSEQ, was granted marketing authorization by the FDA for the detection and monitoring of MRD in bone marrow samples in patients with MM and ALL under the <span style="font-style:italic;">de novo</span> process in September 2018, which classified clonoSEQ and future DNA-based tests to measure MRD in hematological malignancies as Class II devices, as explained further below. In August 2020, we received our third FDA clearance for clonoSEQ, following a 510(k) submission, for CLL in bone marrow as well as blood samples.&#160;&#160;We submitted a 510(k) premarket notification for ALL from blood samples in February 2021 and are actively advancing validation studies in certain NHL sub-types.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, medical devices are subject to extensive regulation by the FDA under the FDCA and its implementing regulations, and other federal and state statutes and regulations. The FDA regulates the design, development, preclinical, analytical and clinical testing, manufacture, safety, effectiveness, clearance, authorization or approval, record-keeping, packaging, labeling, storage, adverse event reporting, advertising, promotion, marketing, sales, distribution and import and export of medical devices. IVDs are a type of medical device and include reagents and instruments used in the diagnosis or detection of diseases, conditions or infections, including, without limitation, the presence of certain chemicals, genetic information or other biomarkers. Predictive, prognostic and screening tests can also be IVDs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After a medical device is placed on the market, numerous regulatory requirements apply.&#160;These include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">compliance with the FDA&#8217;s QSR, which requires manufacturers to follow stringent design, testing, control, documentation, record maintenance, including maintenance of complaint and related investigation files, and other quality assurance controls during the manufacturing process&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">labeling regulations, which prohibit the promotion of products for uncleared, or unapproved uses, or &#8220;off-label&#8221; uses, and impose other restrictions on labeling&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obligations to investigate and report to the FDA adverse events, including deaths, or serious injuries that may have been or were caused by a medical device and malfunctions in the device that would likely cause or contribute to a death or serious injury if it were to recur.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include sanctions, including but not limited to, warning letters&#59; fines, injunctions, and civil penalties&#59; recall or seizure of the device&#59; operating restrictions, partial suspension or total shutdown of production&#59; refusal to grant 510(k) clearance or premarket approvals (&#8220;PMAs&#8221;) of new devices&#59; withdrawal of clearance or approval&#59; and civil or criminal prosecution.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Position in the European Union </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the EU, IVDs can be placed on the market by obtaining a &#8220;CE mark,&#8221; which demonstrates conformity via a self-certification with the<span style="font-style:italic;"> In vitro</span> Diagnostic Medical Device Directive (&#8220;IVDD&#8221;). clonoSEQ obtained a CE mark in May 2019 for all B-cell malignancies with blood and bone marrow. The requirements under the Directive include: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Essential Requirements</span><span style="color:#000000;">. The IVDD specifies &#8220;essential requirements&#8221; that all medical devices must meet to demonstrate the product is safe and effective under normal conditions of use. The requirements are similar to those adopted by the FDA relating to quality systems and product labeling. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Conformity Assessment</span><span style="color:#000000;">. The requirements to obtain a CE mark are risk-based, and follow a similar classification system as in the United States. However, unlike the United States, which requires virtually all devices to undergo some level of premarket review by the FDA, the IVDD currently allows manufacturers to bring many devices to market using a process in which the manufacturer self-certifies that the device conforms to the applicable essential requirements. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Vigilance</span><span style="color:#000000;">. The IVDD specifies requirements for post market reporting similar to those adopted by the FDA. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May&#160;26, 2017, the EU released a new regulatory framework, the<span style="font-style:italic;"> In vitro</span> Diagnostic Medical Device Regulation (&#8220;IVDR&#8221;), which will replace the IVDD. Our products in the EU will have to comply with the IVDR requirements by May&#160;2026, subject to the applicable transitional provisions before full compliance is required. The IVDR is considerably stricter in regulatory oversight than the IVDD and will require more IVD devices to be reviewed by a notified body before being placed on the market. Until that time, our products must continue to meet the requirements of IVDD for commercialization in the EU.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">U.S. Federal and State Regulation of Laboratories </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given that aspects of our business at certain facilities involve acting as a clinical laboratory, we are required to hold certain federal and state licenses, certifications and permits to conduct our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As to federal certifications, CLIA establishes rigorous quality standards for all laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease, or the impairment of, or assessment of health. As a clinical laboratory, we must obtain a CLIA certificate based on the complexity of testing performed at the laboratory, such as a Certificate of Compliance for high-complexity testing. CLIA also mandates compliance with various operational, personnel, facilities administration, quality and proficiency requirements, intended to ensure that their clinical laboratory testing services are accurate, reliable and timely. CLIA compliance and certification is also a prerequisite to be eligible to bill for services provided to government payors and for many private payors. Furthermore, we are subject to survey and inspection every two years to assess compliance with program standards, and may be subject to additional unannounced inspections. Laboratories performing high-complexity testing are required to meet more stringent requirements than laboratories performing less complex tests. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to CLIA requirements, we elect to participate in the accreditation program of the CAP. The U.S. Centers for Medicare &#38; Medicaid Services (&#8220;CMS&#8221;), the agency that oversees CLIA, has deemed CAP standards to be equally or more stringent than CLIA regulations and has approved CAP as a recognized accrediting organization. Inspection by CAP is performed in lieu of CMS inspections for accredited laboratories. Therefore, because we are accredited by the CAP Laboratory Accreditation Program, we are deemed to also comply with CLIA. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CLIA provides that a state may adopt laboratory regulations that are more stringent than those under federal law, and a number of states have implemented their own more stringent laboratory regulatory requirements. Select states, including Washington, have laboratory regulations that have been deemed by the federal government to be at least as stringent as CLIA, and thus laboratories licensed under those state regimes are exempt from CLIA and the state Department of Health is permitted to issue a CLIA number, along with a state Medical Test Site license, rather than a certificate being issued by CMS. Our laboratory holds the required Washington license. State laws may require that laboratory personnel meet certain qualifications, specify certain quality control procedures, facility requirements or prescribe record maintenance requirements. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Several states additionally require the licensure of out-of-state laboratories that accept specimens from those states. For example, New York requires a laboratory to hold a permit which is issued after an on-site inspection and approval of each LDT offered by a laboratory, and has various, more stringent requirements than CLIA and CAP, including those for personnel qualifications, proficiency testing, physical facility and equipment and quality control standards. Our laboratory holds the required licenses for Maryland, Rhode Island, Pennsylvania, New York and California. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, other states may require out-of-state laboratories to obtain licensure in order to accept specimens from the state. If we identify any other state with such requirements, or if we are contacted by any other state advising us of such requirements, we intend to follow instructions from the state regulators as to how we should comply with such requirements. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a clinical laboratory is found to be out of compliance with CLIA certification, CAP accreditation or a state license or permit, the applicable regulatory agency may, among other things, suspend, restrict or revoke the certification, accreditation, license or permit to operate the clinical laboratory, assess civil monetary penalties and impose specific corrective action plans, among other sanctions. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Laboratory Developed Tests in the United States</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA has historically exercised enforcement discretion to not regulate most LDTs. As such, LDTs have not been subject to FDA&#8217;s marketing clearance and approval processes, or post-marketing controls, for medical devices. LDTs are generally considered to be tests that are designed, developed, validated and used within a single laboratory. Laboratories certified as &#8220;high complexity&#8221; under CLIA may develop, manufacture, validate and run LDTs. clonoSEQ is available as an LDT for use in assessing MRD for other lymphoid malignancies, including&#160;&#160;NHL and use in other specimen types, at our Seattle, Washington laboratory.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In that respect, Congress introduced legislation to establish a framework for FDA to oversee marketing of </span><span style="font-style:italic;">in vitro</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> clinical tests (&#8220;IVCTs&#8221;), such as test kits and LDTs (the Verifying Accurate Leading-edge IVCT Development Act, or &#8220;VALID Act&#8221;). Under the VALID Act, FDA would oversee IVCTs, requiring pre-market review for high-risk IVCTs which expose patients to serious or irreversible harm and novel IVCTs. As currently drafted, existing LDTs at the time of VALID Act passage would be grandfathered as approved. For new low risk IVCTs, developers would submit a representative IVCT to FDA for review and issuance of a technology certification for the specific IVCT reviewed and later developed test within the scope of the certification. It is not certain whether or in what form the VALID Act bill will pass Congress, but passage could increase the stringency of regulatory review required for our LDT products. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the VALID Act does not pass, the FDA may decide to exercise enforcement discretion for LDTs, especially if it perceives a LDT as posing a risk to patients. Therefore, the regulatory path for marketing of LDTs is subject to uncertainty given the FDA&#8217;s latitude in interpreting and applying its laws and policies. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2020, the U.S. Department of Health and Human Services advised that the FDA did not have authority to require LDTs related to COVID to obtain an EUA prior to marketing. HHS also instructed the FDA to review voluntary EUA submissions of LDTs for COVID-19 in order to extend certain statutory immunities to liability for those laboratories under the federal Public Readiness and Emergency Preparedness Act (&#8220;PREP Act&#8221;). In March 2021, the FDA issued an EUA for T-Detect COVID to confirm recent or prior SARS-CoV-2 infection. In November 2021, HHS rescinded its previous statement that the FDA did not have authority over LDTs. The FDA modified its policy and has required all COVID related LDTs on the market to submit an EUA request within 60 days of the policy, and has also made clear that no additional COVID related LDTs may come onto the market prior to issuance of an EUA. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Federal and State Privacy, Security and Breach Notification Laws </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;" id="page31">Many state and federal laws govern the processing of personal information or individually identifiable health information. At the federal level, under the administrative simplification provisions of the <span style="Background-color:#FFFFFF;color:#000000;">Health Insurance Portability and Accountability Act of 1996</span> (&#8220;HIPAA&#8221;) and <span style="Background-color:#FFFFFF;color:#000000;">the Health Information Technology for Economic and Clinical Health Act of 2009</span> (&#8220;HITECH&#8221;), the U<span style="Background-color:#FFFFFF;color:#000000;">.S. Department of Health and Human Services</span> (&#8220;HHS&#8221;) issued regulations that establish standards for protecting the privacy and security of &#8220;protected health information&#8221; used or disclosed by certain healthcare providers and other &#8220;covered entities&#8221; and their &#8220;business associates.&#8221; Three principal data protection-related regulations with which we are required to comply have been issued in final form under HIPAA and HITECH: privacy regulations, security regulations and security breach notification regulations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The privacy regulations govern the use and disclosure of &#8220;protected&#8221; health information by covered healthcare providers, as well as health insurance plans. They also set forth certain rights that an individual has with respect to his or her protected health information maintained by a covered health care provider, including the right to access or amend certain records containing protected health information or to request restrictions on the use or disclosure of protected health information. The security regulations establish requirements for safeguarding the confidentiality, integrity and availability of protected health information that is electronically transmitted or electronically stored. HITECH, among other things, established certain health information security breach notification requirements. A covered entity must notify HHS and each affected individual of a breach of unsecured protected health information as well as the media if the breach involves more than 500 individuals. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HIPAA violations are subject to civil and criminal penalties. Additionally, to the extent that we submit electronic healthcare claims and payment transactions that do not comply with the electronic data transmission standards established under HIPAA and HITECH, payments to us may be delayed or denied. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;5(a) of the Federal Trade Commission Act (&#8220;FTCA&#8221;) has also been used to regulate data privacy and security at the federal level. According to the <span style="Background-color:#FFFFFF;color:#000000;">U.S. Federal Trade Commission</span> (&#8220;FTC&#8221;), failing to take appropriate steps to keep consumers&#8217; personal information secure or using or disclosing personal information in violation of a company&#8217;s privacy notice may constitute unfair or deceptive acts or practices in or affecting commerce in violation of the FTCA. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business and the cost of available tools to improve security and reduce vulnerabilities. Although we have and maintain a system for compliance with privacy laws and regulations, failure to comply with them could expose us to potential FTC enforcement action and fines.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, certain state laws govern the privacy and security of health information and personal information. Some of the state laws governing health information privacy and security are more stringent than HIPAA (including providing for patient enforcement of these state laws) and often differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. There has also recently been an influx of state privacy and security laws that introduce similar compliance complexities, including the California Consumer Privacy Act (&#8220;CCPA&#8221;), the Colorado Privacy Act (&#8220;CPA&#8221;) and the Virginia Consumer Data Protection Act (&#8220;VCDPA&#8221;). In addition, there are state breach notification laws in every state, as well as D.C., Guam and Puerto Rico. Failure to comply with these laws, where applicable, can result in the imposition of significant civil or criminal penalties and private litigation. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General Data Protection Regulation in the EU </span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">and Internationally</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The General Data Protection Regulation (&#8220;GDPR&#8221;) is a legal framework that sets requirements for the collection and processing of personal information of individuals within the European Economic Area (&#8220;EEA&#8221;). The GDPR sets out the principles for data management and the rights of the individual, while also imposing very significant fines that can be revenue-based. It applies to U.S. companies that process personal information of persons in the EEA in connection with the offer of products or services to those persons, or the monitoring of such persons&#8217; behavior. It may also apply when a U.S. company processes personal information in the context of the activities of an entity established in the EEA. The GDPR became enforceable on May&#160;25, 2018. The regulation is a comprehensive privacy law, meaning that it applies to all types of personal information, including the human resources record of employees and even the Internet Protocol addresses of people using online services. The GDPR builds upon data rights that the EU had previously advocated, such as the right of an individual to be forgotten and the right to data portability. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many other countries and regions also have privacy and data protection laws, some of which are modeled after the European framework. This includes countries within Europe that are not part of the EEA, such as the United Kingdom and Switzerland, and therefore operate under different privacy and data protection frameworks. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to laws that directly impose privacy and data protection obligations on companies, there is also a growing interest in laws and regulations that govern data areas that are related to, but not completely related to data privacy. One area of these laws relates to use and testing of genetic and genomic data. In addition to the federal Genetic Information Nondiscrimination Act , there are a number of state laws that have recently passed (e.g., the California Genetic Information Privacy Act) and that continue to make appearances on states&#8217; legislative schedules. There have been similar draft bills at the state level that would regulate machine learning, artificial intelligence, the Internet of Things, and human specimen use. There have been similar trends internationally, such as ongoing public consultations in the European Union on the Digital Governance Act and an Artificial Intelligence Regulation. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Federal, State and Foreign Fraud and Abuse Laws </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, there are various fraud and abuse laws with which we must comply and we are subject to regulation by various federal, state and local authorities, including CMS, other divisions of HHS, such as the <span style="Background-color:#FFFFFF;color:#000000;">Office of Inspector General</span> (&#8220;OIG&#8221;), the <span style="Background-color:#FFFFFF;color:#000000;">U.S. Department of Justice</span> (&#8220;DOJ&#8221;) and individual U.S. Attorney offices within the DOJ, and state and local governments. We also may be subject to foreign fraud and abuse laws. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, the Anti-Kickback Statute (&#8220;AKS&#8221;) prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or in return for patient referrals for, or purchasing, leasing, ordering or arranging for the purchase, lease or order of, any healthcare item or service reimbursable under a governmental payor program. Courts have stated that a financial arrangement may violate the AKS if any one purpose of the arrangement is to encourage patient referrals or other federal healthcare program business, regardless of whether there are other legitimate purposes for the arrangement. The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including gifts, discounts, meals, travel, credit arrangements, payments of cash, consulting fees, waivers of co-payments, ownership interests and providing anything at less than its fair market value. Recognizing that the AKS is broad and may technically prohibit many innocuous or beneficial arrangements within the healthcare industry, the OIG issued a series of regulatory &#8220;safe harbors.&#8221; These safe harbor regulations set forth certain provisions, which, if met, will assure healthcare providers and other parties that they will not be prosecuted under the AKS. The failure of a transaction or arrangement to fit within a specific safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the AKS will be pursued. In those instances, arrangements will be evaluated on a case-by-case basis to determine whether enforcement will be pursued. Penalties for AKS violations are severe and can include imprisonment, criminal fines, civil monetary penalties and exclusion from participation in federal healthcare programs. The regulations establishing safe harbor protection are subject to change and could affect future operations. Many states also have anti-kickback statutes, some of which may apply to items or services reimbursed by any third-party payor, including commercial insurers as well as patient self-pay. A violation of the AKS may be grounds for the government or a whistleblower to assert that a claim for payment of items or services resulting from such violation constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The civil monetary penalties statute is another potential statute under which a clinical laboratory may be subject to enforcement. Among other things, the civil monetary penalties statute imposes fines against any person who is determined to have presented, or caused to be presented, claims to a federal healthcare program that the person knows, or should know, is for an item or service that was not provided as claimed or is false or fraudulent. The civil monetary penalties statute also prohibits a person from offering or providing remuneration to any Medicare or Medicaid beneficiary that is likely to influence the individual to order or receive its items or services from a particular provider or supplier. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The exclusion statute requires the exclusion of entities and individuals who have been convicted of federal-program related crimes or healthcare felony fraud or controlled substance charges. The statute also permits the exclusion of those that have been convicted of any form of fraud, the AKS, for obstructing an investigation or audit, certain controlled substance offenses, those whose healthcare license has been revoked or suspended and those who have filed claims for excessive charges or unnecessary services. If we were to be excluded, our products and services would be ineligible for reimbursement from any federal programs, including Medicare and Medicaid, and no other entity participating in those programs would be permitted to enter into contracts with us. In order to preserve access to beneficial healthcare items and services, the government may elect to exclude officers and key employees of manufacturers, rather than excluding the organization. Such enforcement actions would prohibit us from engaging those individuals, which could adversely affect operations and result in significant reputational harm. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Congress has also enacted statutes that impose criminal liability for healthcare fraud and abuse. The Health Care Fraud Statute prohibits knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from governmental payor programs such as the Medicare and Medicaid programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefit programs, items or services-public or private. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from governmental payor programs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal governmental payor program. The<span style="font-style:italic;"> qui tam</span> provisions of the False Claims Act allow a private individual to bring actions on behalf of the federal government alleging that the defendant has defrauded the federal government by submitting a false claim to the federal government and permit such individuals to share in any amounts paid by the entity to the government in fines or settlement.<span style="font-style:italic;"> Qui tam</span> complaints are filed under seal, and the cases may progress for a number of years before a complaint is unsealed and a healthcare provider or supplier becomes aware of its existence. When an entity is determined to have violated the False Claims Act, it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties ranging from $11,803 to $23,607 for each false claim. The False Claims Act is the federal government&#8217;s primary civil tool in healthcare fraud cases. False Claims Act liability is not limited to direct providers of health items or services. The government has asserted liability under the False Claims Act against manufacturers and other third parties who caused another party to file a false claim. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, various states have enacted false claim laws analogous to the federal False Claims Act, although many of these state laws apply where a claim is submitted to any third-party payor and not merely a governmental payor program. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October&#160;25, 2018, the Substance Use-Disorder Prevention that Promoted Opioid Recovery and Treatment for Patients and Communities Act of 2018 (&#8220;SUPPORT Act&#8221;) was enacted. The SUPPORT Act included the Eliminating Kickbacks in Recovery Act of 2018 (&#8220;EKRA&#8221;), which establishes an all-payor anti-kickback prohibition that extends to arrangements with recovery homes, clinical laboratories and clinical treatment facilities. EKRA includes a number of statutory exceptions, and directs agencies to develop further exceptions. Current exceptions in some cases reference and in others differ from the AKS safe harbors. Significantly, the prohibitions apply with respect to the soliciting or receipt of remuneration for&#160;any&#160;referrals to recovery homes, clinical treatment facilities, or clinical laboratories, whether or not related to treating substance use disorders. Further, the prohibitions cover the payment or offer of remuneration to induce a referral to, or in exchange for, an individual using the services of, such providers. This law creates additional risk that relationships with referral sources could be problematic. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For anti-corruption legislation, the <span style="Background-color:#FFFFFF;color:#000000;">U.S. Foreign Corrupt Practices Act (&#8220;</span>FCPA&#8221;) is the most widely enforced law. It is the first to introduce corporate liability, responsibility for third parties and extraterritoriality for corruption offences, meaning companies and persons can be held criminally and civilly responsible for corruption offences committed abroad. It was enacted for the purpose of making it unlawful for certain classes of persons and entities to make payments to foreign government officials to assist in obtaining or retaining business. With the enactment of certain amendments in 1998, the anti-bribery provisions of the FCPA now also apply to foreign firms and persons who cause, directly or through agents, an act in furtherance of such a corrupt payment to take place within the territory of the United States. The FCPA also requires companies whose securities are listed in the United States to meet its accounting provisions, which were designed to operate in tandem with the anti-bribery provisions, require corporations covered by the provisions to (a)&#160;make and keep books and records that accurately and fairly reflect the transactions of the corporation and (b)&#160;devise and maintain an adequate system of internal accounting controls. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In Europe, various countries have adopted anti-bribery laws providing for severe consequences, in the form of criminal penalties or significant fines, for individuals or companies committing a bribery offence. Violations of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation. For instance, in the United Kingdom, under the Bribery Act 2010, which came into effect in July&#160;2011, a bribery offense occurs when a person offers, gives or promises to give a financial or other advantage to induce or reward another individual to improperly perform certain functions or activities, including any function of a public nature. Bribery of foreign public officials also falls within the scope of the Bribery Act 2010. Under this regime, an individual found in breach of the Bribery Act 2010 faces imprisonment of up to 10 years. In addition, the individual can be subject to an unlimited fine, if found to have committed an offense, as can commercial organizations that are found to have failed to prevent bribery. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2016</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, France passed an anti-bribery and compliance law (&#8220;Sapin II&#8221;), and the French anti-corruption agency (&#8220;AFA&#8221;) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> established. The Sapin II law makes it compulsory for companies within the scope of the law to implement internal procedures to fight corruption. One of the items that must be prepared is a corruption risk map, as well as an anti-corruption code of conduct. These documents are subject to investigation by the AFA and failure to comply with the requirements can lead to a fine of up to &#8364;1.0&#160;million for a company and &#8364;200,000 for executives. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, Adaptive expanded its European presence and hired employees within the UK and as such, has a potential for the UK Bribery Act to apply as it can be triggered by any act committed within the UK. Currently, we are not subject to the jurisdictional requirements of Sapin II as we do not have offices in France. If we were to have future growth in the European market, this law could potentially become applicable to us. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">U.S. Physician Referral Prohibitions</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Physician Self-Referral Law (&#8220;Stark Law&#8221;) prohibits physicians from referring patients to entities with which the physician or an immediate family member has a financial relationship, such as ownership, investment or compensation, for designed health services (&#8220;DHS&#8221;) payable by Medicare and Medicaid, unless the financial arrangement meets an applicable exception. DHS includes clinical laboratory tests. Penalties for violating the Stark Law include the return of funds received for all prohibited referrals, fines, civil monetary penalties and possible exclusion from federal health care programs.&#160;In addition to the Stark Law, many states have their own self-referral bans, which may extend to all self-referrals, regardless of the payor. See &#8220;<span style="font-style:italic;">Risk Factors&#8212;Risks Relating to Government Regulation&#8212;We are subject to various laws and regulations, such as healthcare fraud and</span> <span style="font-style:italic;">abuse laws, false claim laws and health information privacy and security laws, among others, and failure to comply with these laws and regulations may have an adverse effect on our business</span>.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Corporate Practice of Medicine in the United States </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerous states have enacted laws prohibiting business corporations, such as us, from practicing medicine and employing or engaging physicians to practice medicine, generally referred to as the prohibition against the corporate practice of medicine. These laws are designed to prevent interference in the medical decision-making process by anyone who is not a licensed physician. For example, California&#8217;s Medical Board has indicated that determining what diagnostic tests are appropriate for a particular condition and taking responsibility for the ultimate overall care of the patient, including providing treatment options available to the patient, would constitute the unlicensed practice of medicine if performed by an unlicensed person. Violation of these corporate practice of medicine laws may result in civil or criminal fines, as well as sanctions imposed against us or the professional through licensure proceedings. Typically such laws are only applicable to entities that have a physical presence in the state. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other Regulatory Requirements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our laboratory is subject to federal, state and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste and biohazardous waste, including chemical, biological agents and compounds, blood and bone marrow samples and other human tissue. Typically, we use outside vendors who are contractually obligated to comply with applicable laws and regulations to dispose of such waste. These vendors are licensed or otherwise qualified to handle and dispose of such waste. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our partners in the development of therapeutic agents are responsible for developing and manufacturing those products. In so doing, they are subject to FDA and Medicare regulatory requirements related to, among other things, manufacture, promotion, price reporting and fraud and abuse laws. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our laboratories are subject to extensive requirements related to workplace safety established by the U.S. Occupational Safety and Health Administration. These include requirements to develop and implement programs to protect workers from exposure to blood-borne pathogens by preventing or minimizing any exposure through needle stick or similar penetrating injuries. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">U.S. Healthcare Reform </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, a number of recent legislative and regulatory changes at the federal and state levels have sought to reduce healthcare costs and improve the quality of healthcare. For example, in March&#160;2010, the <span style="Background-color:#FFFFFF;color:#000000;">Affordable Care Act (&#8220;</span>ACA&#8221;) became law. This law substantially changed the way healthcare is financed by both commercial and government payors, and it has significantly impacted our industry. Since 2016 there have been efforts to repeal all or part of the ACA. For example, the <span style="Background-color:#FFFFFF;color:#000000;">Tax Cuts and Jobs Act (&#8220;</span>TCJA&#8221;), among other things, removes penalties for not complying with the ACA&#8217;s individual mandate to carry health insurance. The U.S. Congress may take further action regarding the ACA, including, but not limited to, repeal or replacement. Additionally, all or a portion of the ACA and related subsequent legislation may be modified, repealed or otherwise invalidated through judicial challenge, which could result in lower numbers of insured individuals, or reduced coverage for insured individuals, and which could adversely affect our business. However, it remains to be seen whether or when new legislation modifying the ACA will be enacted, what any such the new legislation might provide and what impact it might have on the size and coverage of the insured population or on efforts to contain or lower the cost of healthcare. We cannot predict the implications, if any, of such legislation on our and our collaborators&#8217; businesses and financial conditions. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate there will continue to be proposals by legislators at both the federal and state levels, regulators and commercial payors to reduce costs while trying to expand individual healthcare benefits. If enacted, some such proposals could expand or contract the insured population, increasing or decreasing demand for our products and services. On the other hand, some proposals could impose additional limitations on the prices we will be able to charge for our tests or on the coverage of or the amounts of reimbursement available for our tests from payors, including commercial payors and government payors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal physician payment transparency requirements (&#8220;Physician Payments Sunshine Act&#8221;) and its implementing regulations, which requires applicable manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the State Children&#8217;s Health Insurance Program, with certain exceptions, to annually report to HHS information related to certain payments or other transfers of value made or distributed to covered recipients, defined to include doctors, dentists, optometrists, podiatrists, chiropractors, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and anesthesiologist assistants, certified nurse-midwives, and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are also state transparency and gift ban laws that require manufacturers to provide reports to state governments on pricing and marketing information.&#160;Several states have enacted legislation requiring medical device manufacturers to, among other things, establish marketing compliance programs, file periodic reports with the state, make periodic public disclosures on sales and marketing activities, and such laws may also prohibit or limit certain other sales and marketing practices.&#160;These laws may adversely affect our sales, marketing, and other activities by imposing administrative and compliance burdens on us.&#160;Although we have a system for tracking and reporting &#8220;sunshine&#8221; law required information, if we fail to do so as required, we could be subject to government enforcement action and potential penalties.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Coverage and Reimbursement Generally</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reimbursement and billing requirements of applicable laws and payors for diagnostic services are highly complex.&#160;Laboratories must bill various payors, such as private third-party payors, including managed care organizations (&#8220;MCO&#8221;), and state and federal health care programs, such as Medicare and Medicaid, and each may have different billing requirements.&#160;Depending on the reimbursement arrangement and applicable law, the party that reimburses us for our services may be a third party who provides coverage to the patient, such as an insurance company or MCO&#59; a state or federal healthcare program&#59; or the patient. Additionally, the audit requirements we must meet to ensure compliance with applicable laws and regulations, as well as our internal compliance policies and procedures, add further complexity to the billing process.&#160;As such, we are at risk of being paid less or no part of our price for our products for reasons including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">variability in coverage and information requirements among various payors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">patient financial assistance programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">missing, incomplete or inaccurate billing information provided by ordering physicians&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">billings to payors with whom we do not have contracts&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">disputes with payors as to which party is responsible for payment&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">disputes with payors as to the appropriate level of reimbursement.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we may not be free to determine the price charged for our products. For instance, the&#160;No Surprises Act&#160;(&#8220;NSA&#8221;) was enacted on December 27, 2020 and took effect on January 1, 2022. One of the goals of the NSA is to protect patients from &#8220;surprise&#8221; medical bills resulting from gaps in coverage for services provided by out-of-network providers, such as laboratories, related to patient visits at in-network facilities. The NSA limits the amount out-of-network laboratories may charge a patient for laboratory services ordered during an in-network facility visit. In addition, the NSA establishes an independent dispute resolution process for determining the amount of reimbursement for the laboratory service in the event that the laboratory and insurer cannot agree on a rate.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain countries, including a number of member states of the EU, set prices and make reimbursement decisions for diagnostics and pharmaceutical products. Additionally, some countries require approval of the maximum sale price of a product before it can be marketed, and this price may be reviewed during the product lifecycle, or mandatory discounts or profit caps may be applied. In many countries, the pricing review period begins after marketing or product licensing approval is granted or the CE mark is obtained. We may therefore be constrained in our pricing strategies in markets outside of the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information on coverage and reimbursement in the United States, see &#8220;<span style="font-style:italic;">Risk Factors&#8212;Risks Relating to Government Regulation&#8212;Future Medicare payment</span> <span style="font-style:italic;">rates are uncertain</span>.&#8221; </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our Compliance Program </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our compliance program is intended to prevent and detect violations of law or our policies. It was developed in view of both adopting the principles of the AdvaMed Code of Ethics and addressing the HHS OIG&#8217;s elements of a compliance program. We have designed our compliance program to fit the size, resources, market position and other unique aspects of our company. Our code of conduct is our statement of ethical and compliance principles that guide our daily operations. In addition, we have developed policies and procedures, and corresponding education and training, to effectively communicate our standards to employees as it relates to job functions and legal obligations under applicable state and federal healthcare program requirements, as well as those outside the United States. We regularly perform live and process monitoring activities on a risk-based approach, and audit capabilities are built into our transparency procedures. We maintain a hotline available via multiple channels to report any known or suspected compliance violations, and we have a strict non-retaliation policy for all claims brought forward in good faith. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Corporate Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in the State of Washington on September&#160;8, 2009 under the name Adaptive TCR Corporation. On December&#160;21, 2011, we changed our name to Adaptive Biotechnologies Corporation. In January&#160;2015, we acquired Sequenta, Inc. (&#8220;Sequenta&#8221;), a San&#160;Francisco, California-based company that was also developing an NGS test for MRD (&#8220;Sequenta Acquisition&#8221;). Our principal executive offices are located at 1165 Eastlake Avenue East, Seattle, Washington 98109, and our telephone number is (206) 659-0067.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Available Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain a website at www.adaptivebiotech.com. The contents of our website are not incorporated in, or otherwise to be regarded as part of, this Annual Report on Form 10-K. We make available, free of charge on our website, access to our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as soon as reasonably practicable after we file or furnish them electronically with the Securities and Exchange Commission (&#8220;SEC&#8221;). Investors and others should note that we announce material financial information to our investors using our investor relations website (http://investors.adaptivebiotech.com), SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media to communicate with our members and the public about our company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company to review the information we post on social media channels.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_1A_RISK_FACTORS">Item 1A. Risk Factors</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Investing in our Company involves a high degree of risk. You should carefully consider the following risks and uncertainties, together with all other information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes and the &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; section, before investing in our Company. Any of the risk factors we describe below could adversely affect our business, financial condition, results of operations, prospects or the trading price of our securities. The risks described below are not the only ones we face and additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business, financial condition, operating results, prospects and the trading price of our securities. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Summary of Risk Factors</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Generally, the risks described below relate to the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the effects of health epidemics, including the COVID-19 pandemic or future variants of the SARS-CoV-2 virus, in regions where we or third parties on which we rely have significant laboratory operations, manufacturing facilities, concentrations of clinical trial sites or other business operations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our significant net losses since inception, expected net losses in the future and need for significant investments in products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to leverage our immune medicine platform to discover, develop, commercialize and obtain regulatory clearance, authorization and approval for our products and services, particularly in light of the novelty of immune medicine and our methods&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to develop our TCR-Antigen Map and yield additional insights from it that are commercially viable&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our collaboration with Genentech and ability to develop and commercialize cellular therapeutics, including our ability to achieve milestones and realize the intended benefits of the collaboration&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to leverage our immune medicine platform to discover, develop and commercialize additional products and services, including those related to COVID-19, may not be successful&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our laboratory operations, including errors or defects in our products or services and our reliance on a limited number of suppliers, and in some cases single suppliers, for our equipment and materials, some of which include reagents or other materials that may also require additional internal validation prior to use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our limited experience with the development and commercialization of cellular therapeutics&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">market acceptance of our products and services, and our limited sales and marketing experience&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expected reliance on collaborators for development and clinical testing of therapeutic product candidates, which may fail at any time due to a number of possible unforeseen events&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to increase our capacity, manage the evolution of our products and services, stay current in our rapidly changing industry, expand our workforce and otherwise manage our growth&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the loss of any member of our senior management team, or of the support of key opinion leaders&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the extensive regulation of our industry, including reimbursement coverage decisions&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the validity of our patents, protection of our trade secrets and related intellectual property matters.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Business </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have incurred significant losses since inception, we expect to incur losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have incurred significant losses since our inception. For the year ended December&#160;31, 2021, 2020 and 2019, we incurred a net loss of $207.3 million, $146.2 million and $68.6&#160;million, respectively. As of December&#160;31, 2021, we had an accumulated deficit of $718.9 million. We have funded our operations to date principally from the sale of convertible preferred stock and common stock, including the sale of common stock in our initial public offering, and, to a lesser extent, sequencing and development revenue. We expect to continue to incur significant expenses and operating losses for the foreseeable future as we continue to invest in the development of products and services utilizing our immune medicine platform to support the validation of additional clinical diagnostic and therapeutic products and services. We will need to generate significant additional revenue to achieve and sustain profitability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We expect to make significant investments in our continued research and development of new products and services, which may not be successful. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are seeking to leverage our immune medicine platform to develop a pipeline of future disease-specific research, diagnostic and therapeutic products and services. For example, we are developing our TCR-Antigen Map with a view toward continually advancing the development of T-Detect, a diagnostic test that may enable early and accurate detection of multiple diseases from a single blood test, into further indications. In addition, we are developing certain therapeutic product candidates under our collaboration agreement with Genentech by leveraging our platform to identify TCRs that can be engineered into personalized cellular immunotherapies. We expect to incur significant expenses to advance these development efforts, but they may not be successful. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developing new products and services is a speculative and risky endeavor. Products or services that initially show promise may fail to achieve the desired results or may not achieve acceptable levels of analytical accuracy or clinical utility. We may need to alter our products in development and repeat clinical studies before we identify a potentially successful product or service. Product development is expensive, may take years to complete and can have uncertain outcomes. Failure can occur at any stage of the development. If, after development, a product or service appears successful, we or our collaborators may, depending on the nature of the product or service, still need to obtain FDA and other regulatory clearances, authorizations or approvals before we can market it. The FDA&#8217;s clearance, authorization or approval pathways, including seeking EUA for new indications of T-Detect or other products, are likely to involve significant time, as well as additional research, development and clinical study expenditures. The FDA may not clear, authorize or approve any future product or service we develop. Even if we develop a product or service that receives regulatory clearance, authorization or approval, we or our collaborators would need to commit substantial resources to commercialize, sell and market it before it could be profitable, and the product or service may never be commercially successful. Additionally, development of any product or service may be disrupted or made less viable by the development of competing products or services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New potential products and services may fail at any stage of development or commercialization and if we determine that any of our current or future products or services are unlikely to succeed, we may abandon them without any return on our investment. If we are unsuccessful in developing additional products or services, our potential for growth may be impaired. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we are not successful in leveraging our immune medicine platform to discover, develop and commercialize additional products and services, our ability to expand our business and achieve our strategic objectives would be impaired. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A key element of our strategy is to leverage our immune medicine platform to discover, develop and potentially commercialize additional products and services beyond our current portfolio to diagnose and treat various disease states. In particular, for clonoSEQ we are attempting to generate sufficient clinical evidence to support the utility of MRD in additional lymphoid cancers beyond ALL, MM and CLL, while also demonstrating the clinical utility of blood as a <span style="text-decoration:line-through;">s</span>ample type for all lymphoid cancers. If we are unable to generate compelling evidence supporting clonoSEQ use in other indications or sample types, our platform may face a broader obstacle to using our immunosequencing data for commercially viable products and services.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Identifying new products and services requires substantial technical, financial and human resources, whether or not any products or services are ultimately developed or commercialized. We may pursue what we believe is a promising opportunity to leverage our platform only to discover that certain of our risk or resource allocation decisions were incorrect or insufficient, or that individual products, services or our science in general has technology or biology risks that were previously unknown or underappreciated. Our strategy of pursuing the value of our immune medicine platform over a long time horizon and across a broad array of human diseases may not be effective. In the event material decisions in any of these areas turn out to be incorrect or sub-optimal, we may experience a material adverse impact on our business and ability to fund our operations and we may never realize what we believe is the potential of our immune medicine platform. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our efforts to develop our TCR-Antigen Map may not be successful, and it may not yield the insights we expect at all or on a timetable that allows us to develop or commercialize any new diagnostic products. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are leveraging our collaboration with Microsoft to develop our TCR-Antigen Map. Together we are using immunosequencing, proprietary computational modeling and machine learning to map TCR sequences to the antigens they bind. However, we may not be successful in developing a comprehensive TCR-Antigen Map for any number of reasons including difficulty accessing required sample sets to validate signals and complications in advancing algorithmic-based methods that accurately define TCR signatures to be validated. As a result, it may require significantly more time and resources for us to determine how to use machine learning to accelerate our mapping process, which could adversely impact our ability to develop or commercialize new diagnostic products or services. In addition, even with the aid of machine learning, we expect the TCR-Antigen Map to take us several years to develop. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The TCR-Antigen Map we are developing may not yield clinically actionable insights on a timetable that is commercially viable, or at all. Our goal is to leverage the TCR-Antigen Map in connection with the development of T-Detect to enable early or accurate detection across a broad range of diseases. We have confirmed signals for SARS-CoV-2, acute Lyme disease, Crohn&#8217;s disease, celiac disease and multiple sclerosis. We have also identified early signals in ulcerative colitis and rheumatoid arthritis and we will seek to confirm those signals in ongoing validation work. We will also seek to identify new signals in other select autoimmune disorders or other diseases. If our computational modeling and machine learning efforts do not accelerate the pace at which we can validate association of TCR sequences to the antigens they bind, the timetable for our business model may not be commercially viable. Even if we can accelerate this timeline, our products and services derived from our novel technologies may have product or service level errors. If we are unable to make meaningful progress in our TCR-Antigen Map and successfully use it to develop and commercialize new diagnostic products or services, our business and results of operations will suffer. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are exposed to risks associated with our agreement with Genentech, and we may not realize the advantages we expect from it. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2018, we entered into a worldwide collaboration and license agreement with Genentech (&#8220;Genentech Agreement&#8221;), with the goal of accelerating the development and commercialization of novel cancer-specific antigen and neoantigen directed T cell therapies for the treatment of a broad range of tumor types. Under the terms of the Genentech Agreement, we received $300.0&#160;million in an initial upfront payment in February 2019 and may be eligible to receive approximately $1.8&#160;billion in additional payments over time upon achievement of specified development, regulatory and commercial milestones. In addition, Genentech will pay us royalties on sales of products commercialized under the agreement. We may not be successful in achieving these milestones, and products developed under the Genentech Agreement may not be commercialized in the timeframe we expect, achieve significant sales, or be commercialized at all. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to numerous risks associated with the Genentech Agreement, including sharing a measure of control over the operations of our research and development portions of the collaboration with Genentech and Genentech having sole control over the commercialization of any products developed via the collaboration. For instance, in 2021, Genentech suspended development of a drug against our first shared antigen target candidate in response to published data. The Genentech Agreement also prevents us from, among other things, developing or commercializing TCR-based cellular therapies outside the scope of the collaboration in the field of oncology on our own or with any third party. Our collaboration involves risks that are different from the risks involved in independently conducting operations, including that Genentech may: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">have or develop economic or business interests that are inconsistent with ours&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">take actions contrary to our instructions, requests, policies or objectives&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">take actions that reduce our return on investment for this collaboration&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fail to distinguish itself from biosimilar competition&#59; or </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">take actions that harm our reputation or restrict our ability to run our business. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Genentech&#8217;s degree of control over collaboration development and commercialization efforts may impact the amounts we receive under the Genentech Agreement. For example, Genentech may suspend development of product candidates or decide not to pursue commercialization of product candidates at all, or it may agree to pay royalties to third parties or adopt a pricing model that reduces the amount of royalties we might otherwise expect. It is also possible that effective cell therapies will not be developed under the Genentech Agreement or, if developed, approved by the FDA or comparable regulatory authorities outside of the United States. Genentech may also terminate the Genentech Agreement at its convenience, at any time and without cause. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not be able to perform our product research, development and commercialization related obligations under the Genentech Agreement, including performing TCR screening activities for product candidates being developed and commercialized under that agreement. For example, in the event a product is commercialized under the Genentech Agreement, as the volume of product sales grows, we will likely need to continue to increase our workflow capacity for sample intake, customer service and general process improvements, and expand our internal quality assurance program to support TCR screening on a larger scale within expected turnaround times. We will likely need additional certified laboratory scientists and other scientific and technical personnel for the Personalized Product to identify and target therapeutically relevant, patient-specific neoantigens. We will likely also need to acquire additional laboratory space and equipment, which can take several months or more to procure, set up and validate. These process enhancements and increases in scale, expansion of personnel, laboratory space and equipment may not be successfully implemented, and we may not have adequate laboratory facilities or resources to accommodate all the requirements that we currently anticipate needing to be successful. If we cannot satisfy our obligations, Genentech is entitled to trigger a technology transfer of our TCR screening process (specific to the Personalized Product) or terminate the Genentech Agreement. In addition, due to our significant obligations under the Genentech Agreement, we may face challenges in meeting the needs of existing customers, collaborators and suppliers and securing new customers, including any biopharmaceutical customers that are actual or potential competitors with Genentech. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we support the commercialization of one or more products under the Genentech Agreement, we may need to incorporate new equipment, implement new technology systems and laboratory processes and hire new personnel with different qualifications. Failure to manage this growth or transition could result in turnaround time delays, higher product costs, declining product quality, deteriorating customer service and slower responses to competitive challenges. A failure in any one of these areas could make it difficult for us to meet market expectations for our products and could damage our reputation and the prospects for our business, both under the Genentech Agreement and otherwise. As a result, our relationship with Genentech may not result in the realization of its anticipated benefits. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have limited experience with the development and commercialization of cellular therapeutics, and future TCR-based cellular therapies may never be successfully developed and commercialized as part of our Genentech collaboration. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have limited experience with the development of cellular therapeutics, and no experience with the commercialization, marketing and distribution of cellular therapeutics. Our therapeutic product candidates are at an early stage of discovery and development under our Genentech collaboration, and we are continuing to develop our TruTCR process being used under that collaboration to develop TCR-based cellular therapies for the treatment of cancer. Under our Genentech collaboration, Genentech has invested significant financial resources to develop future TCR-based cellular therapies, including conducting preclinical studies and other&#160;early&#160;research and development&#160;activities, and providing general and administrative support for these operations.&#160;Our future success is dependent on our and Genentech&#8217;s ability to successfully develop therapeutic product candidates and advance those product candidates into the clinic, and Genentech&#8217;s ability, where applicable, to obtain regulatory and marketing approval for, and then successfully commercialize, cellular therapeutics. We and Genentech have not yet developed and commercialized any cellular therapeutics, and we may not be able to do so. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We currently use, and in the future expect to increase our use of, collaborators for several aspects of our operations, and if we cannot maintain current and enter new relationships with collaborators, our business will suffer. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have limited resources to conduct our life sciences research, clinical diagnostics and drug discovery operations and have not yet fully established infrastructure for sales, marketing or distribution in connection with our products and services. Accordingly, we have entered into collaboration agreements under which our collaborators have provided, and may in the future provide, funding and other resources for developing and potentially commercializing our products and services. In particular, we have entered into the Genentech Agreement, with the goal of accelerating the development and commercialization of T&#160;cell therapies for the treatment of a broad range of tumor types, and a strategic collaboration agreement with Microsoft (&#8220;Microsoft Agreement&#8221;), which provides us with access to Microsoft&#8217;s research and machine learning technologies that we are using to develop our TCR-Antigen Map. We are pursuing several additional industry and academic collaborations to access patient cohorts that could accelerate our TCR-Antigen Map signal generation and validation for our immune-based diagnostics or drug discovery product or services pipeline. These collaborations may result in our incurring significant expenses in pursuit of potential products and services, and we may not be successful in identifying, developing or commercializing any potential products or services. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future success depends in part on our ability to maintain these relationships and to establish new relationships. Many factors may impact the success of such collaborations, including our ability to perform our obligations, our collaborators&#8217; satisfaction with our products and services, our collaborators&#8217; performance of their obligations to us, our collaborators&#8217; internal priorities, resource allocation decisions and competitive opportunities, the ability to obtain regulatory approvals, disagreements with collaborators, the costs required of either party to the collaboration and related financing needs, and operating, legal and other risks in any relevant jurisdiction. In addition to reducing our revenue or delaying the development of our future products and services, the loss of one or more of these relationships may reduce our exposure to research, data, clinical trials or computing technologies that facilitate the collection and incorporation of new information into our clinical immunomics database. All of the risks relating to product and service development, regulatory clearance, authorization or approval and commercialization described herein apply to us derivatively through the activities of our collaborators. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We engage in conversations with companies regarding potential collaborations on an ongoing basis. These conversations may not result in a commercial agreement. Even if an agreement is reached, the resulting relationship may not be successful, and any products and services developed as part of the collaboration may not produce successful outcomes. Speculation in the industry about our existing or potential collaborations can be a catalyst for adverse speculation about us, or our products or services, which can adversely affect our reputation and our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Significant additional research and development and, in certain instances, clinical trials or validation will be required before we can potentially seek regulatory clearance, authorization or approval for, or commercialize any of our products or services in development. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing a pipeline of immune-driven diagnostics and therapeutics, including T-Detect and cellular therapies in oncology, but significant additional research and development activities and clinical trials or validations could be required before we and our collaborators will have a chance to achieve additional commercially viable products. Our research and development efforts remain subject to all of the risks associated with the development of new products and services based on immune-driven diagnostics and immune-mediated therapies. Development of the underlying technology may be affected by unanticipated technical or other problems, among other research and development issues, and the possible insufficiency of funds needed to complete development of these products and services. Safety, regulatory and efficacy issues, clinical hurdles or other challenges may result in delays and cause us to incur additional expenses that would increase our losses. If we and our collaborators cannot complete, or if we experience significant delays in developing, our clinical diagnostics or therapeutics, including cellular therapies, T-cell based vaccines or antibody discoveries, particularly after incurring significant expenditures, our business may fail and investors may lose the entirety of their investment. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to obtaining regulatory clearances, authorizations or approvals for the commercial sale of any new products or services, we must demonstrate that our products and services are both safe and effective for use in each target disease indication. Clinical studies may be necessary to demonstrate that a product or service is safe and effective. Clinical testing or validation is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time. For therapeutics, the results of preclinical studies and early clinical trials of products and services in development may not be predictive of the results of later-stage clinical trials, and initial success in clinical trials may not be indicative of results obtained when clinical trials are completed. There is typically an extremely high rate of failure as therapeutic products in development proceed through clinical trials. Products in later stages of clinical trials or validation also may fail to show the desired safety and efficacy profile despite having progressed through non-clinical studies and initial clinical trials or validations. Any delays in the development of our products and services may harm our business, financial condition and prospects significantly. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Errors or defects in our products or services could harm our reputation, decrease market acceptance of our products or services or expose us to product liability claims. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are creating new products and services, many of which are initially based on largely untested technologies. As all of our products and services progress, we or others may determine that we made product or service level scientific or technological mistakes or omissions. The testing processes utilize a number of complex and sophisticated biochemical, informatics, optical and mechanical processes, many of which are highly sensitive to external factors and variation between testing runs. Refinements to our processes may initially result in unanticipated issues that reduce the efficiency or increase variability. In particular, sequencing, which is a key component of these processes, could be inefficient with higher than expected variability thereby increasing total sequencing costs and reducing the number of samples we can process in a given time period, which may negatively impact customer turnaround time. Therefore, inefficient or variable processes can cause variability in our operating results and damage our reputation. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, our laboratory operations could result in any number of errors or defects. Our quality assurance system or product development processes may fail to prevent us from inadvertent problems with samples, sample quality, lab processes including sequencing, software, data upload or analysis, raw materials, reagent manufacturing, assay quality or design, or other components or processes. In addition, our assays may have quality or design errors, and we may have inadequate procedures or instrumentation to process samples, assemble our proprietary primer mixes and commercial materials, upload and analyze data, or otherwise conduct our laboratory operations. If we provide products or services with undiscovered errors to our customers, our clinical diagnostics may falsely indicate a patient has a disease or fail to detect disease in a patient who requires treatment. We believe our customers are likely to be particularly sensitive to product and service defects, errors and delays, including if our products and services fail to indicate the presence of residual disease with high accuracy from clinical specimens or if we fail to list or inaccurately indicate the presence or absence of disease in our test report. In drug discovery, such errors may interfere with our collaborators&#8217; clinical studies or result in adverse safety or efficacy profiles for their products in development. This may harm our customers&#8217; businesses and may cause us to incur significant costs, divert the attention of key personnel, encourage regulatory enforcement action against us, create a significant customer relations problem for us and cause our reputation to suffer. We may also be subject to warranty and liability claims for damages related to errors or defects in our products or services. Any of these developments could harm our business and operating results. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our current and future products and services may never achieve significant commercial market acceptance. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends on the market&#8217;s confidence that we can provide immune-driven research, diagnostic and therapeutic products and services that improve clinical outcomes, lower healthcare costs and enable better biopharmaceutical development. Failure of our products and services, or those jointly developed with our collaborators, to perform as expected could significantly impair our operating results and our reputation. We believe patients, clinicians, academic institutions and biopharmaceutical companies are likely to be particularly sensitive to defects, errors, inaccuracies, delays and toxicities in or associated with our products and services. Furthermore, inadequate performance of these products or services may result in lower confidence in our immune medicine platform in general. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and our collaborators may not succeed in achieving significant commercial market acceptance for our current or future products and services due to a number of factors, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to demonstrate the clinical utility of our immune medicine platform and related products and services and their potential advantages over existing life sciences research, clinical diagnostic and drug discovery technologies to academic institutions, biopharmaceutical companies and the medical community&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability, and that of our collaborators, to secure and maintain FDA and other regulatory clearance, authorization or approval for our products&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the agreement by third-party payors to reimburse our diagnostics, the scope and extent of which will affect patients&#8217; willingness or ability to pay for our diagnostics, even in markets that we expect to be primarily self-pay, and will likely heavily influence physicians&#8217; decisions to recommend our tests&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the rate of adoption of our immune medicine platform and related products and services by academic institutions, clinicians, key opinion leaders, advocacy groups and biopharmaceutical companies&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the impact of our investments in product innovation and commercial growth. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, our customers and collaborators may decide to decrease or discontinue their use of our products and services due to changes in their research and development plans, failures in their clinical trials, financial constraints, the regulatory environment, negative publicity about our products and services, competing products or the reimbursement landscape, all of which are circumstances outside of our control. We may not be successful in addressing these or other factors that might affect the market acceptance of our products, services and technologies. Failure to achieve widespread market acceptance of our immune medicine platform and related products and services would materially harm our business, financial condition and results of operations. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We rely on a limited number of suppliers or, in many cases, single suppliers, for laboratory equipment and materials and may not be able to find replacements or immediately transition to alternative suppliers. </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on a limited number of suppliers, or in many cases single suppliers, to provide certain sequencers and equipment that we use in our laboratory operations, as well as reagents and other laboratory materials for our products and services. An interruption in our laboratory operations, kit distribution or technology transfer could occur if we encounter delays, quality issues or other difficulties in securing these sequencers, equipment, reagents or other materials, and if we cannot then obtain an acceptable substitute. In addition, we would likely be required to incur significant costs and devote significant efforts to find new suppliers, acquire and qualify new equipment, validate new reagents and revalidate aspects of our existing assays, which may cause delays in our processing of samples or development and commercialization of products and services. Any such interruption could significantly affect our business, financial condition, results of operations and reputation. Internal changes in processes or compositions of our reagents or other materials may also require validation efforts by us and supply of new materials from our suppliers which could impact timing of production and levels of inventory while such changes are being implemented. Further, as a result of the COVID-19 pandemic, the overall demand for supplies and equipment used in vaccine development and distribution or other public health or disease prevention initiatives may continue to increase lead times for purchased supplies and equipment, thus potentially lowering our production capacity. Combined with lowered production capacity, any significantly increased demand for existing or new products or services, such as T-Detect COVID, may affect our ability to fulfill orders, resulting in a material adverse effect on volume or revenue.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In particular, we have purchased and rely on the Illumina NextSeq System. Illumina supplies us with reagents that have been designed for use solely with this sequencer and Illumina is the sole provider of maintenance and repair services for the Illumina NextSeq System. We also license our laboratory information management software from Illumina and receive services from Illumina related to that software. We believe there are only a few other equipment manufacturers that are currently capable of supplying the equipment necessary for our laboratory operations, including sequencers and various associated reagents.&#160;The use of sequencers manufactured by a company other than Illumina would require us to alter our laboratory operations. Transitioning to and qualifying a new sequencer would be time-consuming and expensive, may result in interruptions in our laboratory operations, could affect the performance specifications of our laboratory operations or could require that we revalidate the reagents of our immunoSEQ kits, immunoSEQ services, T-Detect or clonoSEQ diagnostic testing services, and could require us to obtain additional clearance, authorization, approval, accreditation, or licensure for the changes. We may not be able to secure and implement alternative sequencers, associated reagents and other materials without experiencing interruptions in our workflow. In the case of an alternative supplier to Illumina, any replacement sequencers and various associated reagents may not be available or may not meet our quality control and performance requirements for our laboratory operations. If we should encounter delays or difficulties in securing, reconfiguring or revalidating the equipment and reagents we require for our products and services, our business, financial condition, results of operations and reputation could be adversely affected. In addition, Illumina is not obligated to meet all of our requirements for reagent supply.&#160;In the event Illumina ceases or slows its production of, or is otherwise unwilling or unable to continue to supply the sequencer reagents necessary for and currently used in our business at or near current pricing, we may be required to purchase different reagents from Illumina or to purchase from a different reagent vendor under terms and conditions which could be less favorable to us. Any disruption in Illumina&#8217;s operations or the suppliers of our reagents, materials or other equipment could impact our supply chain and laboratory operations of our immune medicine platform and our ability to conduct our business and generate revenue. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have limited experience in marketing and selling products and services, and if we are unable to expand our direct sales and marketing force or partner with collaborators in certain product areas and markets to adequately address our customers&#8217; needs, our business may be adversely affected. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have limited experience in marketing and selling our research and diagnostic products and services and no experience marketing and selling therapeutic products and services. Accordingly, we or our collaborators may not be able to market and sell our current or future products and services effectively enough to support our planned growth. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and diagnostic sales and marketing efforts are targeted at a large and diverse market with highly specialized segments, including department heads, laboratory directors, principal investigators, core facility directors, clinicians, payors and research scientists and pathologists at leading academic institutions, biopharmaceutical companies, research institutions and contract research organizations. As a result, we believe it is necessary for our sales representatives to have relevant, specialized market experience. Competition for experienced sales and marketing personnel is intense, and new members of our sales organization may require intense training to apply their experience and expertise to our products and services. We may not be able to attract and retain personnel or be able to build or adequately train an efficient and effective sales organization, which could negatively impact sales and market acceptance of our clinical diagnostics and limit our revenue growth and potential profitability. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We established a collaboration with Genentech for the research, development, marketing, promotion, distribution and sale of TCR-based cellular therapies for the treatment of cancer. Under the Genentech Agreement, Genentech has the sole right and authority to commercialize products developed under that agreement. It will be Genentech&#8217;s responsibility to locate, qualify and engage distribution partners, clinicians and local hospitals with industry experience and knowledge to effectively market and sell products developed under that agreement. Genentech may not be able to engage distribution partners, clinicians or hospitals on favorable terms, or at all. If Genentech&#8217;s sales and marketing efforts with respect to products developed under the Genentech Agreement are not successful, we may not achieve significant market acceptance for our drug discovery services and platform, which would materially and adversely impact our business operations</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we or our collaborators experience any of a number of possible unforeseen events in connection with clinical trials, our or their ability to conduct further clinical trials of, obtain regulatory clearance, authorization or approval of or commercialize future products and services or improvements to current products and services, could be delayed or prevented. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We or our collaborators may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our or their ability to conduct further clinical trials or obtain regulatory clearance, authorization or approval of or commercialize future products and services or improvements to current products and services, including: </p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Evolving Regulatory Requirements and Policies </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the area of &#8220;precision medicine&#8221; or &#8220;personalized medicine&#8221; and its regulation may be subject to ongoing changes in terms of regulatory requirements and governmental policies, in ways we cannot predict&#59; </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.26%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trial Design </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory authorities or ethical review boards, including IRBs, may not authorize commencement of a clinical trial or conduct a clinical trial at a prospective trial site&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">there may be delays in reaching or failure to reach agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA or other regulatory authorities may disagree with a clinical trial design or a sponsor&#8217;s interpretation of data and may change the requirements for product clearance, authorization or approval even after they have reviewed and commented on the clinical trial design&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">differences in trial design between early stage clinical trials and later-stage clinical trials may make it difficult to extrapolate the results of earlier clinical trials to later clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA or other regulatory authorities may disagree about whether study endpoints are clinically meaningful&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of patients, or amount of data, required for clinical trials, or improvements to current products, may be larger than anticipated, patient enrollment in these clinical trials may be slower than anticipated or patients may drop out of clinical trials at a higher rate than anticipated&#59; </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Testing </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes may be made to product candidates after commencing clinical trials, which may require that previously completed stages of clinical testing be repeated or delay later stages of testing, for example, we, or our collaborators, may pursue one or more different product development pathways for our T cell immunotherapies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials may fail to satisfy the applicable regulatory requirements of the FDA or other regulatory authorities responsible for oversight of the conduct of clinical trials in other countries&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulators may elect to impose a clinical hold, or governing IRBs, data safety monitoring board or ethics committees may elect to suspend or terminate our clinical research or trials for various reasons, including non-compliance with regulatory requirements or a finding that the participants are being exposed to unacceptable risks to their health or the privacy of their health information being disclosed&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost of clinical trials of future products and services, or improvements to current products and services, may be greater than we anticipate&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may not have sufficient capacity in our laboratories to perform testing as requested or volumes requested or with the requested turnaround times necessary for clinical trials&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">the supply or quality of materials or data necessary to conduct clinical trials of future products and services, or improvements to current products and services, may be insufficient or inadequate&#59; </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trial Outcomes </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the outcome of our collaborators&#8217; preclinical studies and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product candidates may be associated with negative or inconclusive results in clinical trials, and we or our collaborators may decide to deprioritize or abandon these product candidates, or regulatory authorities may require us to abandon them or impose onerous changes or requirements, which could lead to deprioritization or abandonment&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product candidates may have undesirable side effects which could lead to serious adverse events, or other unexpected characteristics. One or more of such effects or events could cause regulators to impose a clinical hold on the applicable trial, or cause us, our collaborators or their investigators, IRBs or ethics committees to suspend or terminate the trial of that product candidate&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials may suggest or demonstrate that products or services are not as efficacious or safe as other similar diagnostics or therapies&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">preclinical and clinical data are often susceptible to varying interpretations and analyses, and our products and services in development may fail to obtain regulatory clearance, authorization or approval, even if they perform satisfactorily in preclinical studies and clinical trials. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delays of this nature could also allow competitors to bring products to market before we or our collaborators do, potentially impairing our ability to successfully commercialize our products and services in development and harming our business and results of operations. Any delays in the development of our products and services or those jointly developed with our collaborators may significantly harm our business, financial condition and prospects. Many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory clearance, authorization or approval of products and services in development. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We will need to develop and expand our workforce, commercial infrastructure and laboratory operations to support anticipated growth in demand for our products and services. We may encounter difficulties in managing this and in meeting fluctuations in this demand. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will need to expand our workforce, commercial infrastructure and laboratory operations to support anticipated growth in demand for our products and services. If we are unable to support fluctuations in the demand for our products and services, including ensuring that we have adequate capacity to meet increased demand as well as other customer requirements (such as turnaround time and service level), our business could suffer. As of December&#160;31, 2021, we had 858 full-time employees and we expect to increase the number of employees, including potential contingent employees as needed to address demand fluctuations, and the scope of our operations as we continue to develop our clinical diagnostic products and services. As we and our collaborators commercialize additional products and services, we will need to incorporate new equipment, implement new technology systems and laboratory processes and hire new personnel with different qualifications. Failure to manage this growth or transition could result in turnaround time delays, higher service costs, declining service quality, deteriorating customer service and slower responses to competitive challenges. A failure in any one of these areas could make it difficult for us to meet market expectations for our products and services and could damage our reputation and the prospects for our business. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To manage our anticipated expansion, we must continue to implement and improve our managerial, operational and financial systems, continue to expand our facilities and continue to recruit and train additional qualified personnel. Also, our management and operations teams may need to divert a disproportionate amount of their attention away from their&#160;day-to-day&#160;activities and devote a substantial amount of time to managing these development and improvement activities. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to our limited resources and early stage of growth, we may not be able to effectively manage this simultaneous execution and the expansion of our operations or recruit, train, and retain additional qualified personnel. This may result in weaknesses in our infrastructure, operational mistakes, slower development of our products and services, missed or delayed milestone achievement, significant cost overruns, loss of business opportunities, loss of employees and contingent workers, inability to execute on hiring plans and reduced productivity among remaining employees and contingent workers. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance, and our ability to develop and commercialize our products and services and compete effectively, will depend, in part, on our ability to effectively manage our future development and expansion. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our business could be adversely affected by the effects of health epidemics, including the recent COVID</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">&#8209;19 pandemic, in regions where we or third parties on which we rely have significant laboratory operations, manufacturing facilities, concentrations of clinical trial sites or other business operations. The COVID-19 pandemic could materially affect our operations, including at our headquarters in Seattle and at our offices in South San Francisco, each subject to COVID-19 related government restrictions, as well as the business or operations of our manufacturers, contract research organizations or other third parties with whom we conduct business.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business could be adversely affected by global pandemics or health epidemics in regions where we have concentrations of clinical trial sites or other business operations, and such pandemics or epidemics could cause significant disruption in the operations of third-party manufacturers, suppliers, general contractors and sub-contractors related to capital projects and CROs upon whom we rely. The global pandemic of COVID-19 continues to rapidly evolve. We do not yet know the full extent of potential delays or impacts on our business, clinical trials, sales force expansion plans and other initiatives, or the impacts to healthcare systems or the global economy as a whole. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Most of our facilities and employees are based in Seattle, Washington at our corporate headquarters, where the state government has imposed &#8220;stay at home&#8221; restrictions designed to slow the spread of COVID-19, which have disrupted our normal operations. Similarly, San Mateo County, California had a &#8220;shelter-in-place&#8221; order with restrictions that have disrupted our normal operations in our South San Francisco office. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to our laboratory operations, we intend to rely on the measures implemented in early 2020 to reduce the risk of exposure of COVID-19 to the employees who continue to work on site as part of government-defined essential services, including the implementation of work-from-home policies for certain employees, as well as physical distancing and contact tracing those employees who remain on site. We have also required all on-site employees to be vaccinated, subject to applicable religious and medical exemptions. We work with a variety of materials and samples from COVID-19 patients that could be hazardous to human health. We intend to continue to adhere to the safety measures implemented to reduce the risk of exposure to our on-site staff. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have experienced a number of staffing and supply chain disruptions due to COVID-19 and anticipate these will continue into the future. The effects of the stay-at-home orders or similar government orders and internal protective measures may negatively impact productivity, disrupt our business and delay our clinical programs and corporate expansion initiatives, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations regarding our ability to conduct our business in the ordinary course. Confirmed positive cases, close contacts, and other identified risks have resulted in disruptions to regular on-site staffing, and these disruptions may continue to negatively impact our research and production. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effects of government restrictions such as the stay at home orders and our other operational safety measures may negatively impact productivity, disrupt our business and delay our clinical programs and corporate expansion initiatives, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations regarding our ability to conduct our business in the ordinary course. These and similar, and perhaps more severe, disruptions in our operations could negatively impact our business, operating results and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Quarantines, stay at home orders and similar government orders, or the perception that such orders, shutdowns or other restrictions on business operations could occur, whether related to COVID-19 or other infectious diseases, could impact personnel at third-party manufacturing or supplier facilities in the United States and other countries, or the availability or cost of materials, which would disrupt our supply chain. In addition, public health measures undertaken to combat the COVID-19 pandemic or vaccine development and distribution efforts may increase demand for equipment or supplies, which we use in the ordinary course of our business. This increased demand has resulted in longer lead times for equipment purchases and may result in internal conservation of supplies, which may slow production. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;While the potential economic impact brought by, and the duration of, COVID-19 may be difficult to assess or predict, a widespread pandemic could result in significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ultimate impact of the COVID-19 pandemic or a similar health epidemic is highly uncertain and subject to change. However, these effects could have a material impact on our operations, and we will continue to monitor the COVID-19 situation closely.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The COVID-19 pandemic could adversely impact portions of our business that rely on research and development activities or clinical trials and delay or disrupt our pipeline, which may adversely impact revenue.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The extent to which the COVID-19 pandemic may impact our business with respect to research and development and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, vaccine distribution, variants of the virus, the duration of the outbreak, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions, and the effectiveness of actions taken in the United States and other countries to contain and treat the disease.&#160;As the COVID-19 pandemic continues to spread around the globe, we will likely experience disruptions that could severely impact our business with respect to research and development and clinical trials, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">delays or difficulties in enrolling patients or maintaining scheduled study visits in our clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">negative impact on interactions necessary for commercial testing, due to restricted access for industry employees&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">patient and clinician avoidance of &#8220;elective&#8221; procedures that may encompass our products and services, and general reluctance of patients to seek in-person care&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">challenges in providing clinical education with respect to our novel products and services in a virtual setting, and restrictions on clinician and provider travel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">diversion of healthcare resources, clinical staff, physicians and advanced practice providers in oncology, including hospitals serving as our clinical trial sites, away from the conduct of clinical trials related to our non-COVID-19 related products and services&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">interruption of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">limitations in employee resources that would otherwise be focused on the conduct of our business with respect to research and development or clinical trials, including due to illness of our employees or their families, an increase in childcare responsibilities for certain employees, the desire of our employees to avoid close contact or contact with large groups of people or as a result of the governmental imposition of stay at home orders or similar working restrictions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">delays in receiving approval from local regulatory authorities to initiate our planned clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">delays in clinical sites receiving the supplies and materials needed to conduct clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">interruption in global shipping that may affect the transport of clinical trial materials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">changes in regulations as part of a response to the COVID-19 pandemic, which may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or discontinuing clinical trials altogether&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">delays in necessary interactions and anticipated timelines with local and federal regulators (including the FDA), ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">refusal of the FDA to accept data from clinical trials in affected geographies outside the United States.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, regulatory milestones represent a substantial part of our business strategy and are a key component of development revenue.&#160;The disruptions set forth above may materially affect our ability to achieve regulatory milestones, resulting in delays in our clinical pipeline and a material adverse effect on revenues.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our efforts to discover and develop products and services related to COVID-19 may not be successful from either a platform extension or commercialization perspective.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are attempting to leverage our immune medicine platform to discover and develop potential antibody therapies and We are attempting to leverage our immune medicine platform to discover and develop potential antibody therapies and diagnostics for COVID-19. Our efforts in this area are early and continue to evolve and mature continuously as we augment our databases and pool of knowledge. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we believe quantifying virus-specific T cells may provide important research and diagnostic advantages because T cells appear </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">persist longer</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and protect against severity of disease</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the data upon which such belief is based is limited and our analyses are preliminary. As we continue to collect and analyze additional data, we may find that our initial hypotheses are not applicable to new variants of the SARS-CoV-2 virus or are not supported by a larger data set or further analysis. If our beliefs regarding the effectiveness of our current products and services related to COVID-19 are incorrect, or if we are unable to establish a correlate of protection between the T cell response and immunity to COVID-19, that could have a material adverse effect on the market for our products and services related to COVID-19 as well as collaborations for which a correlate of protection is a vital element. Accordingly, our revenue, reputation, financial condition, and our stock price would be adversely impacted. </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our efforts to further develop and commercialize T-Detect COVID, neutralizing antibodies for COVID-19 or other products related to COVID-19, including efforts by our partners or collaborators, involve a high degree of risk, and our efforts may fail for many reasons, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">failure of our products to be effective against new variants of COVID-19&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">failure of T-Detect COVID or TruAB neutralizing antibodies to perform as expected against current strains of COVID-19 or new variants, as well as the possibility of defects and errors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">failure to obtain a suitable partner for neutralizing antibody therapeutics or failure of our collaborators in vaccine development to bring products to market&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">lack of validation data, particularly as new variants of COVID-19 arise&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">failure to demonstrate the analytical accuracy or clinical utility of existing antibody therapies and diagnostic tests&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">failure to obtain the necessary regulatory approvals or clearances&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">commercial disruption caused by the development of competing products or services. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, there can be no assurances as to the commercial success of either T-Detect COVID, neutralizing antibodies, vaccines or diagnostic tests. Our investments in the discovery and development of products and services related to COVID-19 may not be accretive to our future financial results and if we determine that any product or service is unlikely to succeed, we may abandon them without any return on our investment. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our financial condition and operating results have varied in the past and will continue to fluctuate from quarter-to-quarter and year-to-year in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following, as well as other factors described elsewhere in this Annual Report on Form 10-K: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of upfront payments from our collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability and that of our collaborators to develop and successfully commercialize our products and services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to achieve collaboration-based milestones on currently contemplated timelines, or at all&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">availability and extent of reimbursement by governmental and private payors for our products and services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability of our clinical sales teams to convert physicians from using incumbent products in the market to clonoSEQ and new diagnostic products and services we may develop, such as T-Detect COVID and other T-Detect products&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to drive repeat usage of the clonoSEQ diagnostic test by physicians and get reimbursed for that repeat usage by commercial and government payors for monitoring of MRD&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to drive repeat usage of T-Detect COVID by physicians serving immunocompromised patients and get reimbursed for that usage by commercial and government payors for determination of recent or prior infection&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the outcomes of research initiatives, clinical trials or other product development or approval processes conducted by us or our collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the level of demand for our products and services, which may vary significantly or be unknown for our newest products and services, such as T-Detect or immunoSEQ T-MAP COVID&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our relationships, and any associated exclusivity terms, with collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to manage our growth&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our contractual or other obligations to provide resources to fund our products and services and to provide resources to our collaborations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">delays or failures in advancement of future products in clinical trials by us or our collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">risks associated with the future international expansion of our business, including the potential to conduct clinical trials and commercialize our products and services in multiple international locations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability and that of our collaborators to consistently manufacture our products&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our dependence on, and the need to attract and retain, key management and other personnel&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain, protect and enforce our intellectual property rights&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to prevent the theft or misappropriation of our intellectual property, know-how or technologies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain additional capital that may be necessary to expand our business&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to accurately report our financial results in a timely manner&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">business interruptions such as power outages, strikes, acts of terrorism or natural disasters&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to use our net operating loss (&#8220;NOL&#8221;) carryforwards to offset future taxable income. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cumulative effects of factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance. In any particular period, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While as a general matter we intend to periodically report on the status of our development initiatives, including anticipated next steps, we may not provide forward-looking guidance on the timing of those next steps. In addition, we do not control the timing of disclosure of any such milestones related to any of our products and services that are managed by our collaborators. Any disclosure by us or our collaborators of data that is perceived as negative may have a material adverse impact on our stock price or overall valuation. Our stock price may decline as a result of unexpected clinical trial results in one or more of our products and services, including adverse safety events reported for any of our products or services. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have estimated the sizes of the markets for our current and future products and services, and these markets may be smaller than we estimate. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our estimates of the annual addressable markets for our current products and services and those under development are based on a number of internal and third-party estimates, including, without limitation, the number of patients who have developed one or more of a broad range of cancers, the number of individuals who are at a higher risk for developing one or more of a broad range of cancers, the number of individuals who have developed or are at a higher risk of developing certain autoimmune disorders, the number of individuals with certain infectious diseases we or our collaborators are able to treat through our products and services, <span style="Background-color:#FFFFFF;">the proportion of patients in each market whose needs can be addressed by our or our collaborators&#8217; products and services, </span>the number of potential tests utilized per treatment course per patient and the assumed prices at which we can sell our current and future products and services for markets that have not been established. While we believe our assumptions and the data underlying our estimates are reasonable, these assumptions and estimates may not be correct and the conditions supporting our assumptions or estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. As a result, our estimates of the annual addressable market for our current or future products and services may prove to be incorrect. If the actual number of patients who would benefit from our products or services, the price at which we can sell future products and services or the annual addressable market for our products or services is smaller than we have estimated, it may impair our sales growth and have an adverse impact on our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we do not compete effectively with scientific and commercial competitors, we may not be able to successfully commercialize our products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biotechnology and pharmaceutical industries, including the fields of life sciences research, clinical diagnostics and drug discovery are intense and highly competitive. These fields are characterized by rapidly advancing technologies and a strong emphasis on intellectual property. Given the breadth and promise of immune medicine, we face substantial competition from many different sources, including life sciences tools, diagnostics, pharmaceutical and biotechnology companies, academic research institutions and governmental agencies and public and private research institutions across various components of our platform and product and service offerings. Due to the significant interest and growth in immune medicine more broadly, we expect the intensity of the competition to increase. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For instance, in life sciences research, immunoSEQ faces competition from a number of companies, including Thermo Fisher Scientific Inc. and 10X Genomics, Inc., among others. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In clinical diagnostics, our clonoSEQ MRD test faces competition from both conventional and next-generation flow cytometry performed either in-house by our target customers or by reference labs, as well as from labs and institutions advancing research-use-only MRD technologies for clinical applications</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and commercial-stage oncology diagnostics companies extending the application of their solid tumor (</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ctDNA</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) MRD products into the hematology MRD space</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, our T-cell based diagnostic, T-Detect COVID, may face competition from other manufacturers such as Qiagen, who are seeking to commercialize T</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cell testing to consumers. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In drug discovery, clinical trials of immune medicines are being undertaken by a number of industry and academic players.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our competitors may have or obtain the knowledge necessary to generate and characterize similar data to our known data for the purpose of identifying and developing products or services that could compete with any of our products or services. Further, immune medicine is being pursued by several biotechnology companies as well as by large-cap biopharmaceutical companies. Many of our current or potential competitors, either alone or with their collaboration partners, have significantly greater financial resources and expertise in research and development, manufacturing, regulatory approval and compliance, and sales and distribution than we do. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We could be adversely affected if we do not develop our life sciences research, clinical diagnostic and drug discovery products and services, obtain required regulatory and other clearances, authorizations or approvals, obtain or enforce patents covering our discoveries and launch our products and services before our competitors. Moreover, our competitors may succeed in developing immunosequencing-based life sciences research, clinical diagnostics and drug discoveries that circumvent our technologies, products or services. Our competitors may succeed in developing and commercializing research or diagnostic products or services that are more accurate, more convenient to use or more cost-effective than our products or services or therapeutic products that prove to be safer, more effective, more convenient to administer or more cost-effective than any therapeutic products we may develop with our collaborators or that would render our technologies, products and services less competitive or obsolete. We expect competition to intensify in the fields in which we are involved as technical advances in these fields occur and become more widely known. For additional information regarding our competition, see the &#8220;<span style="font-style:italic;">Business&#8212;Competition</span>&#8221; section of this Annual Report on Form 10-K. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The life sciences industry is subject to rapid change, which could make our immune medicine platform and related products and services that we develop obsolete. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our industry is characterized by rapid changes, including technological and scientific breakthroughs, frequent new product and service introductions and enhancements and evolving industry standards, all of which could make our current and future products and services obsolete. Our future success will depend on our ability to keep pace with the evolving needs of our customers on a timely and cost-effective basis and to pursue new market opportunities that develop as a result of scientific and technological advances. In recent years, there have been numerous advances in technologies relating to life sciences research and the diagnosis and treatment of cancer, infectious disease such as COVID-19, and autoimmune disorders. There have also been advances in technologies used to computationally analyze very large amounts of biologic information. If we do not update our products and services to reflect new scientific knowledge about immunosequencing, immunology, computational biology, software development, new disease diagnostics and therapies or the diseases we seek to treat, our products and services could become obsolete and sales of our current products and services and any future products and services we develop based on our immune medicine platform could decline or fail to grow as expected. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The loss of any member of our senior management team or our inability to attract and retain highly skilled scientists, clinicians and salespeople could adversely affect our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends on the skills, experience and performance of key members of our senior management team, including our co-founders and executive officers. The individual and collective efforts of these employees will be important as we continue to develop products and services based on our immune medicine platform. The loss or incapacity of existing members of our executive management team could adversely affect our operations if we experience difficulties in hiring qualified successors. Our executive officers have signed employment agreements with us, but their service is at-will and may end at any point in time. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development initiatives and laboratory operations depend on our ability to attract and retain highly skilled scientists, technicians and software engineers. We may not be able to attract or retain qualified scientists, technicians or software engineers in the future due to the competition for qualified personnel among life sciences and technology businesses, particularly near our headquarters located in Seattle, Washington and our laboratory facilities located in South San Francisco, California. We also face competition from universities and public and private research institutions in recruiting and retaining highly qualified scientific personnel. We may have difficulties locating, recruiting or retaining qualified salespeople. Recruiting, training and retention difficulties can limit our ability to support our research and development and commercialization efforts. We also employ a number of workers on work authorization visas. We may have difficulty recruiting and retaining these workers as immigration regulations continue to change and as a result of the backlog of processing of immigration applications at the federal level. All of our employees are at-will, which means that either we or the employee may terminate their employment at any time. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we rely on consultants, contractors and advisors, including scientific and clinical advisors, to assist us in formulating our research and development, regulatory and commercialization strategy. Our consultants and advisors may provide services to other organizations and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. The loss of the services of one or more of our current consultants or advisors might impede the achievement of our research, development, regulatory and commercialization objectives. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> have flexibly grown our workforce through the use of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">contingent workers, temporary employees,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and part-time workers. We may not be able to retain the services of such personnel which might result in delays in the operation of our business. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we lose the support of key thought leaders, it may be difficult to establish products and services enabled by our immune medicine platform as industry standards, which may limit our revenue growth and ability to achieve profitability. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have established relationships with leading oncology, hematology, immunology, autoimmunity or inflammatory disease, transplantation and solid tumor thought leaders at premier academic and research institutions. If these key thought leaders determine that our immune medicine platform or our current or future products or services are not clinically effective, determine that alternative technologies are more effective or elect to use internally developed services, we could encounter significant difficulty validating our products or services, driving adoption or establishing our immune medicine platform as an industry standard, which would limit our revenue growth and our ability to achieve profitability. In addition, negative publications or reviews by clinicians, industry groups or other important stakeholders may negatively impact our revenue growth and ability to achieve profitability. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We depend on our information technology systems and any failure of these systems could harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We depend on information technology and telecommunications systems, including third-party cloud computing infrastructure, operating systems and artificial intelligence platforms, for significant elements of our operations, including our laboratory information management system, clinical immunomics database, immunoSEQ Analyzer, TCR-Antigen Map, laboratory workflow tools, customer and collaborator reporting and related functions. We also depend on our proprietary workflow software to&#160;support new product and service launches and regulatory&#160;compliance. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use complex software processes and pipelines to manage samples and evaluate sequencing result data. These are subject to initial design or ongoing modifications which may result in unanticipated issues that could cause variability in patient results, leading to service disruptions or errors, resulting in liability. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have installed, and expect to expand, a number of enterprise software systems that affect a broad range of business processes and functional areas, including systems handling human resources, financial controls and reporting, contract management, regulatory compliance and other infrastructure operations. In addition to these business systems, we have installed, and intend to extend, the capabilities of both our preventative and detective security controls by augmenting the monitoring and alerting functions, the network design and the automatic countermeasure operations of our technical systems. These information technology and telecommunications systems support a variety of functions, including laboratory operations, test validation, sample tracking, quality control, customer service support, billing and reimbursement, research and development activities, scientific and medical curation and general administrative activities. In addition, our third-party billing and collections provider depends upon technology and telecommunications systems provided by outside vendors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the risks directly relevant to our vendors, systems, and information technology, there are risks associated with the outside vendors and third parties with whom they subcontract. For example, our third-party billing and collections provider depends upon technology and telecommunications systems provided by outside vendors. Subcontractors can be a vector of vulnerability, as any weaknesses in their organization&#8217;s technical and organizational controls could affect vendor operations as well as data management, in turn impacting our own operations and ability to safeguard critical data. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information technology and telecommunications systems are vulnerable to attack in a variety of forms and from a variety of sources, including telecommunications or network failures, malicious human acts (such as ransomware) and natural disasters. Moreover, despite network security and back-up measures, some of our servers are potentially vulnerable to physical or electronic break-ins, computer viruses and similar disruptive problems. Despite the precautionary measures we have taken to prevent unanticipated problems that could affect our information technology and telecommunications systems, failures or significant downtime of these systems or those used by our collaborators or subcontractors could prevent us from conducting our comprehensive immunosequencing analysis, clinical diagnostics and drug discovery, preparing and providing reports to researchers, clinicians and our collaborators, billing payors, handling physician inquiries, conducting research and development activities and managing the administrative aspects of our business. Any disruption or loss of information technology or telecommunications systems on which critical aspects of our operations depend could have an adverse effect on our business and our reputation, and we may be unable to regain or repair our reputation in the future. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we and our collaborators currently market our products and services outside of the United States and may market future products and services outside of the United States, if cleared, authorized or approved, our business is subject to risks associated with doing business outside of the United States, including an increase in our expenses and diversion of our management&#8217;s attention from the development of future products and services. Accordingly, our business and financial results in the future could be adversely affected due to a variety of factors, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">multiple, conflicting and changing laws and regulations such as privacy, security and data use regulations, tax laws, export and import restrictions, economic sanctions and embargoes, employment laws, anticorruption laws, regulatory requirements, reimbursement or payor regimes and other governmental approvals, permits and licenses&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">failure by us, our collaborators or our distributors to obtain regulatory clearance, authorization or approval for the use of our products and services in various countries&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">additional potentially relevant third-party patent rights&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">complexities and difficulties in obtaining intellectual property protection and enforcing our intellectual property&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in staffing and managing foreign operations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">complexities associated with managing multiple payor reimbursement regimes, government payors or patient self-pay systems&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in negotiating favorable reimbursement negotiations with governmental authorities&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">logistics and regulations associated with shipping samples, including infrastructure conditions and transportation delays&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">limits in our ability to penetrate international markets if we are not able to conduct our immunosequencing or clinical diagnostic services locally&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our products and services and exposure to foreign currency exchange rate fluctuations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">natural disasters, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; activities that may fall within the purview of the FCPA, its books and records provisions, or its anti-bribery provisions, or laws similar to the FCPA in other jurisdictions in which we may now or in the future operate, such as the United Kingdom&#8217;s Bribery Act of 2010&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">anti-bribery requirements of several member states in the European Union (&#8220;EU&#8221;) and other countries, such as the&#160;United Kingdom&#8217;s Bribery Act of 2010, that are constantly changing and require disclosure of information to which U.S. legal privilege may not extend. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may never obtain approval in the EU or in any other foreign country for any of our products or services and, even if we do, we or our collaborators may never be able to commercialize them in any other jurisdiction, which would limit our ability to realize their full market potential. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to eventually market any of our current or future products and services in any particular foreign jurisdiction, we must establish and comply with numerous and varying regulatory requirements on a jurisdiction-by-jurisdiction basis regarding quality, safety, performance and efficacy. In addition, clinical trials or clinical investigations conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory clearance, authorization or approval in one country does not guarantee regulatory clearance, authorization or approval in any other country. Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seeking foreign regulatory clearance, authorization or approval could result in difficulties and costs for us and our collaborators and require additional preclinical studies, clinical trials or clinical investigations which could be costly and time-consuming. Regulatory requirements and ethical approval obligations can vary widely from country to country and could delay or prevent the introduction of our products and services in those countries. The foreign regulatory clearance, authorization or approval process involves all of the risks and uncertainties associated with FDA clearance, authorization or approval. We currently sell our RUO kits outside of the United States and have completed a technology transfer process for research use to sites in France, Germany, Italy, the United Kingdom, Spain, and Australia, but have no experience in obtaining regulatory clearance, authorization or approval in international markets. If we or our collaborators fail to comply with regulatory requirements in international markets or to obtain and maintain required regulatory clearances, authorizations or approvals in international markets, or if those approvals are delayed, our target market will be reduced and our ability to realize the full market potential of our products and services will be unrealized. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our laboratory facilities become damaged or inoperable or we are required to vacate our existing facilities, our ability to conduct our laboratory processes and analysis and pursue our research and development efforts may be jeopardized. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We operate laboratory facilities located in Seattle, Washington and South San Francisco, California. Our facilities and equipment could be harmed or rendered inoperable by natural or man-made disasters, including war, fire, earthquake, power loss, communications failure or terrorism, which may render it difficult or impossible for us to operate our immune medicine platform for some period of time. The inability to perform our laboratory processes or to reduce the backlog of sequences that could develop if our facilities are inoperable, for even a short period of time, or to replace or repair inventory such as reagents or customer samples may result in the loss of customers or harm to our reputation, and we may be unable to regain those customers or repair our reputation in the future. In addition, the expansion of our corporate headquarters, laboratory space and warehousing facilities in the Seattle, Washington area has increased the volume of material and sample transfers between and among local facilities, increasing risk to materials and customer samples.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, our facilities and the equipment we use to perform our research and development work could be unavailable or costly and time-consuming to repair or replace. It would be difficult, time-consuming and expensive to rebuild our facilities, to locate and qualify new facilities or license or transfer our proprietary technologies to a third party, particularly in light of licensure and accreditation requirements. Even in the unlikely event we are able to find a third party with such qualifications to enable us to conduct our laboratory processes, we may be unable to negotiate commercially reasonable terms. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We carry insurance for damage to our property and the disruption of our business, but this insurance may not cover all of the risks associated with damage or disruption to our business, may not provide coverage in amounts sufficient to cover our potential losses and may not continue to be available to us on acceptable terms, if at all.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may need to raise additional capital to fund our existing operations, develop additional products and services, commercialize new products and services or expand our operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on our current business plan, we believe our current cash, cash equivalents and marketable securities and anticipated cash flow from operations, will be sufficient to meet our anticipated cash requirements over at least the next 12&#160;months. If our available cash and investment balances and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements, including because of lower demand for our products and services as a result of risks described herein, we may seek to sell common or preferred equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may consider raising additional capital in the future to expand our business, to pursue strategic investments, to take advantage of financing opportunities or for other reasons, including to: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">increase our sales and marketing efforts to drive market adoption of our life sciences research, clinical diagnostics and therapeutics&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fund development efforts for our current and future products and services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expand our products and services into other disease indications and clinical applications&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">acquire, license or invest in technologies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">acquire or invest in complementary businesses or assets&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">finance capital expenditures, such as our corporate headquarters expansion, and general and administrative expenses. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our present and future funding requirements will depend on many factors, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to achieve revenue growth&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our rate of progress in establishing payor coverage and reimbursement arrangements with domestic and international commercial third-party payors and government payors&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">the cost of expanding our laboratory operations and offerings, including our sales and marketing efforts&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our immunoSEQ research services and kits, and reimbursement for our clonoSEQ diagnostic test, T-Detect COVID and cellular therapies developed under the Genentech Agreement&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our rate of progress in, and research and development expenses associated with, products and services in research and early development&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the effect of competing technological, product and market developments&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">costs related to international expansion&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential cost of and delays in product development as a result of any regulatory oversight applicable to our products and services. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The various ways we could raise additional capital carry potential risks. If we raise funds by issuing equity securities, dilution to our shareholders could result. Any preferred equity securities issued also could provide for rights, preferences or privileges senior to those of holders of our common stock. If we raise funds by issuing debt securities, those debt securities would have rights, preferences and privileges senior to those of holders of our common stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on our operations. If we raise funds through collaborations and licensing arrangements, we might be required to relinquish significant rights to our platform technologies or products and services or grant licenses on terms that are not favorable to us. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our ability to use our NOL carryforwards and certain other tax attributes may be limited.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have incurred net losses since our inception and we may never achieve or sustain profitability. Generally, losses incurred will carry forward until such losses expire (for losses generated prior to January&#160;1, 2018) or are used to offset future taxable income, if any. Utilization of our NOL carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986 (&#8220;Section 382&#8221;) and similar state provisions. The annual limitation may result in the expiration of NOL carryforwards and credits before utilization. If there should be an ownership change, our ability to utilize our NOL carryforwards and credits could be limited. We have completed a Section 382 analysis for changes in ownership through December 31, 2020 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of our federal NOLs. Under the TCJA, federal NOLs incurred in 2018 and future years may be carried forward indefinitely, but the deductibility of such federal NOLs is subject to an annual limitation. NOLs generated prior to 2018 are eligible to be carried forward up to 20 years. Based on the available objective evidence, management determined that it was more likely than not that the net deferred tax assets would not be realizable as of December 31, 2021. Accordingly, management applied a full valuation allowance against net deferred tax assets as of December 31, 2021.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may experience ownership changes in the future as a result of shifts in our stock ownership, which may be outside of our control. As a result, if we earn net taxable income, our ability to use our pre-ownership change NOL carryforwards to offset such taxable income will be subject to limitations. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. As a result, even if we attain profitability, we may be unable to use a material portion of our NOL carryforwards and other tax attributes, which could adversely affect our future cash flows. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We could be adversely affected by violations of the FCPA and other worldwide anti-bribery laws. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As we expand geographically, commercialize our products and services, and attempt to obtain required clearances, authorizations or approvals required to offer products and services for sale, we or our collaborators may be deemed to do business outside the United States, including because international customers may be able to order our products and services. As a result, we or our collaborators would be subject to the FCPA, which prohibits companies and their intermediaries from making payments in violation of law to non-U.S. government officials for the purpose of obtaining or retaining business or securing any other improper advantage. In addition, our collaborators or any third-party distributors could be deemed to be our agents and we could be held responsible for their actions, including violations of the FCPA. Other U.S. companies in the life sciences industry have faced criminal penalties under the FCPA for allowing their agents to deviate from appropriate practices in doing business with non-U.S. government officials. We may also become subject to similar anti-bribery laws in the jurisdictions in which we may operate, including the United Kingdom&#8217;s Bribery Act of 2010, which also prohibits commercial bribery and makes it a crime for companies to fail to prevent bribery. These laws are complex and far-reaching in nature, and we may be required in the future to alter one or more of our practices to be in compliance with these laws. Accordingly, our expansion internationally will demand a high degree of vigilance, and any violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction, involve significant costs and expenses, including legal fees, and could result in a material adverse effect on our business, prospects, financial condition or results of operations. We could also suffer severe penalties, including criminal and civil penalties, disgorgement and other remedial measures. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may acquire other businesses or form joint ventures or make investments in other companies or technologies that could negatively affect our operating results, dilute our shareholders&#8217; ownership, increase our debt or cause us to incur significant expense. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may pursue acquisitions of businesses and assets. We also may pursue joint ventures or investments that leverage our immune medicine platform and industry experience to expand our offerings or distribution. We have no experience forming joint ventures and limited experience investing in or acquiring other companies. We may not be able to find suitable joint ventures, investment or acquisition candidates, and we may not be able to complete such transactions on favorable terms, if at all. If we make any acquisitions, we may not be able to integrate the acquired company successfully into our existing business, and we could assume unknown or contingent liabilities, including regulatory violations such as the FCPA or similar laws. Any future acquisitions also could result in the incurrence of debt, contingent liabilities or future write-offs of intangible assets or goodwill, any of which could have a material adverse effect on our financial condition, results of operations and cash flows. Integration of an acquired company also may disrupt ongoing operations and require management resources that we would otherwise focus on developing our existing business. We may experience losses related to investments in other companies, which could have a material negative effect on our results of operations and financial condition. We may not realize the anticipated benefits of any acquisition, technology license, collaboration or joint venture. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To finance any acquisitions or joint ventures, we may choose to issue shares of our common stock as consideration, which would dilute the ownership of our shareholders. Additional funds may not be available on terms that are favorable to us, or at all. If the price of our common stock is low or volatile, we may not be able to acquire other companies or fund a joint venture project using our stock as consideration. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Unfavorable U.S. or global economic conditions could adversely affect our business, financial condition or results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our results of operations could be adversely affected by general conditions in the global economy and financial markets. A severe or prolonged economic downturn, as result of a global pandemic or otherwise, could result in a variety of risks to our business, including weakened demand for our products and services and our ability to raise additional capital when needed on favorable terms, if at all. A weak or declining economy could strain our collaborators, possibly resulting in supply disruption, or cause delays in their payments to us. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We use biological and hazardous materials that require considerable expertise and expense for handling, storage and disposal and may result in claims against us. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We work with materials, including chemicals, biological agents and compounds and samples that could be hazardous to human health and safety or the environment. Our operations also produce hazardous and biological waste products. Federal, state and local laws and regulations govern the use, generation, manufacture, storage, handling and disposal of these materials and wastes. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental laws and regulations may restrict our operations. If we do not comply with applicable regulations, we may be subject to fines and penalties. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we cannot eliminate the risk of accidental injury or contamination from these materials or wastes, which increase with the volume of material and sample transfers and could cause an interruption of our commercialization efforts, research and development programs, and business operations, as well as environmental damage resulting in costly&#160;cleanup&#160;and liabilities under applicable laws and regulations. Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the impact of such changes and cannot be certain of our future compliance. While our property insurance policy provides limited coverage in the event of contamination from hazardous and biological products and the resulting cleanup costs, we do not currently have any additional insurance coverage for legal liability for claims arising from the handling, storage or disposal of hazardous materials. Accordingly, in the event of contamination or injury, we could be liable for damages or penalized with fines in an amount exceeding our resources and our operations could be suspended or otherwise adversely affected. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we were to be sued for product liability or professional liability, we could face substantial liabilities that exceed our resources. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The marketing, sale and use of our products and services could lead to the filing of product or professional liability claims were someone to allege that our products or services identified inaccurate, incomplete or untimely information regarding the sequence or antigen specificities of TCRs, BCRs or antigens analyzed or the clonality characterized, or MRD or malignancy detected, or that our products or services otherwise failed to perform as designed or intended. We could also be potentially exposed to claims relating to therapeutic failures of products commercialized under our collaborations, such as a cellular therapy marketed by Genentech that is manufactured based on TCR-related sequences and data we provide. We may also be subject to liability for errors in, a misunderstanding of or inappropriate reliance upon, the information we provide in the ordinary course of our business activities. A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. Regardless of merit or eventual outcome, product liability and professional liability claims may result in: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">decreased demand for any products, services or clinical solutions that we have developed or may develop&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">loss of revenue&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">substantial monetary awards to patients or their families&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">significant time and costs to defend related litigation&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">withdrawal of clinical trial participants&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability to commercialize any products, services or clinical solutions that we have developed or may develop&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">injury to our reputation and significant negative media attention. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain product and professional liability insurance, but this insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could cause current collaborators to terminate existing agreements or potential collaborators to seek other companies, any of which could impact our results of operations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We or our collaborators may be adversely affected by natural or man-made disasters or other business interruptions, such as cybersecurity attacks, and our business continuity and disaster recovery plans, or those of our collaborators, may not adequately protect us from the effects of a serious disaster. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Natural and man-made disasters and other events beyond our control could severely disrupt our operations, or those of our collaborators, and have a material adverse impact on our business, results of operations, financial condition and prospects. If a natural disaster, power outage, cybersecurity attack or other event occurred that prevented us from using all or a significant portion of our headquarters, damaged critical infrastructure, such as our laboratory facilities or those of our collaborators, limited our or our collaborators&#8217; ability to access or use our respective digital information systems or that otherwise disrupted our respective operations, it may be difficult or, in certain cases, impossible for us or our collaborators to continue our respective businesses for a substantial period of time. The disaster recovery and business continuity plans we and our collaborators currently have in place are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. Our cybersecurity liability insurance may not cover any or all damages, depending on the severity and extent, we or our collaborators could sustain based on any breach of our respective computer security protocols or other cybersecurity attack, including potential liability arising out of third parties&#8217; negatively impacted data privacy rights. We may incur substantial expenses as a result of the limited nature of our respective disaster recovery and business continuity plans, which could have a material adverse impact on our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Government Regulation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We conduct our business in a heavily regulated industry, and changes in regulations or violations of regulations may, directly or indirectly, reduce our revenue, adversely affect our results of operations and financial condition and harm our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The life sciences industry is highly regulated, and the regulatory environment in which we and our collaborators operate may change significantly and adversely to us in the future. Areas of the regulatory environment that may affect our ability to conduct business include, without limitation, federal and state laws relating to: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">laboratory testing, including CLIA and state laboratory licensing laws&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the development, testing, use, distribution, promotion and advertising of research services, kits, clinical diagnostics and cellular therapies, including certain LDTs, which are regulated by the FDA under the FDCA and the FTC&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">test ordering, documentation of tests ordered, billing practices and claims payment under CMS and the HHS OIG enforcing those laws and regulations&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">cellular therapies, medical device and</span><span style="font-style:italic;color:#000000;"> in vitro</span><span style="color:#000000;"> diagnostic clearance, marketing authorization or approval&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">laboratory anti-mark-up laws&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the handling and disposal of medical and hazardous waste&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fraud and abuse laws such as the False Claims Act, the AKS, EKRA, and the Stark Law&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Occupational Safety and Health Administration rules and regulations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">HIPAA and other federal and state medical data privacy and security laws&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the Genetic Information Nondiscrimination Act (&#8220;GINA&#8221;) and similar state laws&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">coverage and restrictions on coverage and reimbursement for research services, kits, clinical diagnostics and cellular therapies and Medicare, Medicaid, other governmental payors and private insurers reimbursement levels. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In particular, the laws, regulations and policies governing the marketing of RUO products, LDTs and clinical diagnostic tests and services are extremely complex and are subject to interpretation by the courts and governmental agencies. Our failure to comply could lead to civil or criminal penalties, exclusion from participation in state and federal health care programs, or prohibitions or restrictions on our laboratories&#8217; ability to provide or receive payment for our services.&#160;We believe that we are in material compliance with all statutory and regulatory requirements, but there is a risk that one or more government agencies could take a contrary position, or that a private party could file suit under the qui tam provisions of the federal False Claims Act or a similar state law.&#160;Such occurrences, regardless of their outcome, could damage our reputation and adversely affect important business relationships with third parties, including managed care organizations, and other private third-party payors. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The insurance coverage and reimbursement status of newly approved products and services, in a new category of diagnostics and therapeutics, is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for current or future products and services could limit our ability, and that of our collaborators, to fully commercialize our products and services and decrease our ability to generate revenue. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford the clinical diagnostic tests and cellular therapeutics that we and our collaborators currently or plan to develop and sell. In addition, because our clinical diagnostics and therapeutic products and services represent new approaches to the research, diagnosis, detection and treatment of diseases, we cannot accurately estimate how our products and services, and those jointly created with our collaborators, would be priced, whether reimbursement could be obtained or any potential revenue generated. Sales of our products and services will depend substantially, both domestically and internationally, on the extent to which the costs of our products and services are paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize some of our products or services. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment in any of our products or services. If we adopt a self-pay strategy with respect to any products or services, we may experience similar difficulties in the establishment or maintenance of sufficiently high pricing. Changes in the reimbursement landscape may occur, which are outside of our control, and may impact the commercial viability of our products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is significant uncertainty related to the insurance coverage and reimbursement of newly cleared, authorized or approved products and services. In the United States, many significant decisions about reimbursement for new diagnostics and medicines are typically made by CMS, an agency within the HHS, and its contractors. CMS and its contractors decide whether and to what extent a new diagnostic or medicine will be covered and reimbursed under Medicare. Private payors tend to follow CMS policies to a substantial degree. It is difficult to predict what CMS and its contractors will decide with respect to reimbursement for novel products and services such as ours. Additionally, reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the United States and have not been approved for reimbursement, or have been approved under restricted conditions, in certain European countries. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outside the United States, the reimbursement process and timelines vary significantly. Certain countries, including a number of member states of the EU, set prices and make reimbursement decisions for diagnostics and pharmaceutical products, or medicinal products, as they are commonly referred to in the EU, with limited participation from the marketing authorization or </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conformit&#233;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europ&#233;ene</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (&#8220;CE&#8221;) mark holders, or may take decisions that are unfavorable to the authorization or CE mark holder where they have participated in the process. We cannot be sure that such prices and reimbursement decisions will be acceptable to us or our collaborators. If the regulatory authorities in these foreign jurisdictions set prices or make reimbursement criteria that are not commercially attractive for us or our collaborators, our revenues and the potential profitability of our products and services in those countries would be negatively affected. An increasing number of countries are taking initiatives to attempt to control the healthcare budget by focusing cost-cutting efforts on medicinal products, and to a lesser extent, medical devices, provided under their state-run healthcare systems. These international price control efforts have impacted all regions of the world, but have been most prominent in the EU. Additionally, some countries require approval of the sale price of a product before it can be marketed or mandatory discounts or profit caps may be applied. Further, after the sale price is approved, it remains subject to review during the product lifecycle. In many countries, the pricing review period begins after marketing or product licensing approval is granted or the CE mark is obtained. As a result, we or our collaborators might obtain marketing approval for a product or service in a particular country, but then may experience delays in the reimbursement approval or be subject to price regulations that would delay the commercial launch of our product or service, possibly for lengthy time periods, which could negatively impact the revenues we are able to generate from the sale of that product or service in that particular country. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, increasing efforts by governmental and third-party payors, in the United States and abroad, to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for newly cleared, authorized or approved devices and medicines and, as a result, they may not cover or provide adequate payment for our clinical diagnostics or the cellular therapies to be sold by us or our collaborators. For example, the U.S. government introduced the Lower Drug Costs Now Act of 2019 to reduce the cost of drugs. This blueprint contains certain measures that HHS is already working to implement. In addition, t<span style="Background-color:#FFFFFF;">he&#160;</span>No Surprises Act&#160;(&#8220;NSA&#8221;) took effect in January 2022. One of the goals of the NSA is to protect patients from &#8220;surprise&#8221; medical bills resulting from gaps in coverage for services provided by out-of-network providers, such as laboratories, related to patient visits at in-network facilities. The NSA limits the amount out-of-network laboratories may charge a patient for laboratory services ordered during an in-network facility visit and establishes an independent dispute resolution process for determining the amount of reimbursement for the laboratory service in the event that the laboratory and insurer cannot agree on a rate. To the extent the NSA limits the price charged for our diagnostic products or cellular therapeutics, the commercial viability of those products may be adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological program pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, which are, in some cases, designed to encourage importation from other countries and bulk purchasing. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect to experience pricing pressures on our clinical diagnostics and cellular therapies sold by us and our collaborators due to the trend toward value-based pricing and coverage, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our business could be harmed by the loss, suspension or other restriction on a license, certification or accreditation, or by the imposition of a fine or penalties, under CLIA, its implementing regulations or other state, federal and foreign laws and regulations affecting licensure or certification, or by future changes in these laws or regulations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal law requires virtually all clinical laboratories to comply with CLIA, which generally involves becoming certified by the federal and state government for the testing that will be performed and complying with various operational, personnel, facilities administration, quality and proficiency testing requirements intended to ensure that testing services are accurate and reliable. CLIA certification is also a prerequisite to be eligible to bill state and federal healthcare programs, as well as many private third-party payors, for laboratory research and clinical diagnostic testing services. As a condition of our CLIA certification, our Seattle, Washington laboratory is subject to survey and inspection every other year, additional random inspections and surprise inspections based on complaints received by state or federal regulators. The biennial survey and inspection is conducted by CMS, a CMS agent or, if the laboratory holds a CLIA certificate of accreditation, a CMS-approved accreditation organization, such as CAP. Sanctions for failure to comply with CLIA requirements, including proficiency testing violations, may include suspension, revocation or limitation of a laboratory&#8217;s CLIA certificate, which is necessary to conduct business, as well as the imposition of significant civil, administrative or criminal sanctions against the lab, its owners and other individuals. In addition, we are subject to regulation under certain state laws and regulations governing laboratory licensure. Some states, including Washington, have enacted laboratory licensure and compliance laws that are more stringent than CLIA. Changes in state licensure laws that affect our ability to offer and provide research and diagnostic products and services across state or foreign country lines could materially and adversely affect our business.&#160;In addition, state and foreign requirements for laboratory certification may be costly or difficult to meet and could affect our ability to receive specimens from certain states or foreign countries.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any sanction imposed under CLIA, its implementing regulations or state or foreign laws or regulations governing licensure, or our failure to renew a CLIA certificate, a state or foreign license or accreditation, could have a material adverse effect on our business. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Changes in law relating to health insurance coverage and payment may adversely affect our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, in March 2010, the ACA was passed, which substantially changes the way healthcare is financed by both governmental and private insurers, and significantly impacts the U.S. clinical diagnostic and biopharmaceutical industries. The ACA, among other things, increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program, extended the rebate program to individuals enrolled in Medicaid managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs and medical devices, including laboratory kits, and promoted a new Medicare Part&#160;D coverage gap discount program. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some of the provisions of the ACA have been subject to judicial and Congressional challenges. It is also unclear how regulatory provisions and sub-regulatory guidance, both of which fluctuate continually, may affect interpretation and implementation of the ACA and its practical effects on our business. In addition, changes in the number of patients that can look to third-party payment to help afford our products and services may affect the demand for these products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot predict what healthcare reform initiatives may be adopted in the future. Further federal, state and foreign legislative and regulatory developments are likely, and we expect ongoing initiatives to increase downward pressure on drug and device pricing. Such reforms could have an adverse effect on anticipated revenues from our products and services, including those that we jointly develop with our collaborators, and may affect our overall financial condition and ability to develop or obtain regulatory clearance, authorization or approval for our products and services. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Inadequate funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ability of the FDA to review and clear, authorize or approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel, and statutory, regulatory and policy changes. In addition, government funding of agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs and devices to be reviewed and cleared, authorized or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities. If a prolonged&#160;government shutdown&#160;occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We must maintain compliance with FDA requirements for our products and services and failure to maintain compliance with FDA requirements may prevent or delay the marketing of our products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even after we have obtained marketing authorization, as we have for clonoSEQ and T-Detect COVID under an EUA, we must comply with the scope of that clearance, authorization or approval. Failure to comply with those limitations or the additional, extensive and ongoing post-marketing obligations imposed by the FDA or other regulatory requirements of other regulatory agencies could result in unanticipated compliance expenditures, a range of administrative enforcement actions, injunctions and criminal prosecution. FDA post-market obligations include, among other things, compliance with the FDA QSR, establishing registration and device listings, labeling requirements, reporting of certain adverse events and malfunctions, and reporting of certain recalls. In addition, circumstances may arise that cause us to recall equipment used in connection with our products and services. Such recalls could have an adverse effect on our ability to provide those products and services, which in turn would adversely affect our financial condition. Our collaborators will also be required to maintain FDA clearance, authorization or approval for the products and services that we jointly develop. Any failure by us or our collaborators to maintain such clearance, authorization or approval could impair or cause a delay in our ability to profit from these collaborations. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Products and services offered RUO may be subject to regulatory scrutiny. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of our products are currently labeled and sold for RUO and not for the diagnosis or treatment of disease. Because such products are not intended for diagnostic use, and the products do not include clinical or diagnostic claims or provide directions for use as diagnostic products, they are not subject to the same level of regulation by the FDA as medical devices. In particular, while the FDA regulations require that RUO products be appropriately labeled, &#8220;For Research Use Only,&#8221; the regulations do not subject such products to the FDA&#8217;s pre- and post-market controls for medical devices. Pursuant to FDA guidance on RUO products, a company may not make clinical or diagnostic claims about an RUO product or provide clinical directions or clinical support services to customers of RUO products. A product labeled RUO but deemed by the FDA to be intended for clinical diagnostic use may be viewed by the FDA as adulterated and misbranded under the FDCA and subject to FDA enforcement action. The FDA considers the totality of the circumstances surrounding distribution and use of a product labeled as RUO, including how the product is marketed and to whom, when determining its intended use. If the FDA were to disagree with our RUO classification or modify its approach to regulating products labeled for RUO, we could experience reduced revenue or increased compliance and other costs, which could adversely affect our business, prospects, results of operations and financial condition. In the event that the FDA requires marketing authorization of our RUO products in the future, the FDA may not ultimately grant any clearance, authorization or approval requested by us in a timely manner, or at all. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future changes in FDA enforcement discretion for LDTs could subject our operations to much more significant regulatory requirements. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to offering the cleared version of clonoSEQ as a test for MRD in certain blood cancers, we also currently offer an LDT version of this test. Further, we offer our T-Detect COVID test as an LDT. The FDA has a policy of enforcement discretion with respect to LDTs whereby the FDA does not actively enforce its medical device regulatory requirements for such tests. However, in October 2014, the FDA issued two draft guidance documents stating that the FDA intended to modify its policy of enforcement discretion with respect to LDTs in a risk-based manner consistent with the existing classification of medical devices. Although the FDA halted finalization of the guidance in November 2016 to allow for further public discussion on an appropriate oversight approach to LDTs and to give Congressional authorizing committees the opportunity to develop a legislative solution, it is unclear if Congress or the FDA will modify the current approach to the regulation of LDTs in a way that would subject our current or future services marketed as LDTs to the enforcement of FDA regulatory requirements. The FDA Commissioner and the Director of the Center for Devices and Radiological Health (&#8220;CDRH&#8221;) have expressed significant concerns regarding disparities between some LDTs and<span style="font-style:italic;"> in vitro</span> diagnostics that have been reviewed, cleared, authorized or approved by the FDA. If the FDA were to determine that T-Detect COVID and NGS MRD tests offered as LDTs are not within the policy for LDTs for any reason, including new rules, policies or guidance, or due to changes in statute, our tests may become subject to extensive FDA requirements or our business may otherwise be adversely affected. If the FDA were to disagree with our LDT status or modify its approach to regulating LDTs, we could experience reduced revenue or increased costs, which could adversely affect our business, prospects, results of operations and financial condition. If required, the regulatory marketing authorization process required to bring our current or future LDTs into compliance may involve, among other things, successfully completing additional clinical validations and submitting to and obtaining clearance from the FDA for a premarket clearance (510(k)) submission or authorization for a<span style="font-style:italic;"> de novo</span> or approval of a PMA. Furthermore, recently introduced legislation, if passed, such as the VALID Act, could create new or different regulatory and compliance burdens on us and could have a negative effect on our ability to develop new products, which could have a material effect on our business. In the event that the FDA requires marketing authorization of our LDTs in the future, the FDA may not ultimately grant any clearance, authorization or approval requested by us in a timely manner, or at all. In addition, if the FDA inspects our laboratory in relation to the marketing of our FDA-cleared clonoSEQ test, any enforcement action the FDA takes might not be limited to the FDA-cleared clonoSEQ test and could encompass our LDT testing service. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">For each product and service we are developing that requires FDA premarket review, the FDA may not grant clearance, authorization or premarket approval and failure to obtain necessary approvals for our future products and services would adversely affect our ability to grow our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before we begin to manufacture, label and market additional clinical diagnostic products for commercial diagnostic use in the United States, we may be required to obtain either clearance, marketing authorization or approval from the FDA, unless an exemption applies or the FDA exercises its enforcement discretion and refrains from enforcing its requirements. For example, the FDA currently has a policy of refraining from enforcing its medical device requirements with respect to LDTs, which the FDA considers to be a type of<span style="font-style:italic;"> in vitro</span> diagnostic test that is designed, manufactured and used within a single properly licensed laboratory. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process of obtaining PMA is much more rigorous, costly, lengthy and uncertain than the 510(k) clearance process. In the PMA approval process, the FDA must determine that a proposed device is safe and effective for its intended use based, in part, on extensive data, including, but not limited to, technical, preclinical, clinical trial, manufacturing and labeling data. Conversely, in the 510(k) clearance process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a legally marketed &#8220;predicate&#8221; device in order for the product to be cleared for marketing. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics or if it has different technological characteristics as the predicate device, the proposed device must be as safe and effective as, and not raise different questions of safety or effectiveness than, the predicate device. Clinical data is sometimes required to support substantial equivalence. For lower-risk devices that would otherwise automatically be placed into Class&#160;III, which require a PMA because no predicate device is available and the devices do not fall within an existing 510(k)-exempt classification, an applicant may submit a</span><span style="font-style:italic;"> de novo</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> request to down classify the device into Class&#160;II or Class&#160;I, which would not require a PMA. In the</span><span style="font-style:italic;"> de novo</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> process, the FDA must determine that general and special controls are sufficient to provide reasonable assurance of the safety and effectiveness of a device, which is low to moderate risk and has no predicate. In other words, the applicant must justify the &#8220;down-classification&#8221; to Class&#160;I or II for a new product type that would otherwise automatically be placed into Class&#160;III, but is lower risk. Clinical data may be required. For laboratory tests for which FDA clearance, authorization or approval is required, the FDA may also require data to support analytical and clinical validity. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 510(k),<span style="font-style:italic;"> de novo</span> and PMA processes can be expensive and lengthy and require the payment of significant fees, unless an exemption applies. The FDA&#8217;s 510(k) clearance pathway usually takes from three to nine months from submission, but it can take longer for a novel type of product. The FDA&#8217;s<span style="font-style:italic;"> de novo</span> classification pathway usually takes from six to 12 months, but for many applicants can take up to 18 months or more. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process of obtaining a PMA generally takes from one to three years, or even longer, from the time the PMA is submitted to the FDA until an approval is obtained. Any delay or failure to obtain necessary regulatory clearances, authorizations or approvals would have a material adverse effect on our business, financial condition and prospects. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA can delay, limit or deny clearance, authorization or approval of a device for many reasons, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability to demonstrate to the satisfaction of the FDA that the products are safe or effective for their intended uses&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the disagreement of the FDA with the design, conduct or implementation of the clinical trials or the analysis or interpretation of data from preclinical studies, analytical studies or clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">serious and unexpected adverse device effects experienced by participants in clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the data from preclinical studies, analytical studies and clinical trials may be insufficient to support clearance, authorization or approval, where required&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability to demonstrate that the clinical and other benefits of the device outweigh the risks&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">an advisory committee, if convened by the FDA, may recommend against approval of a PMA or other application or may recommend that the FDA require, as a condition of approval, additional preclinical studies or clinical trials, limitations on approved labeling or distribution and use restrictions, or even if an advisory committee makes a favorable recommendation, the FDA may still not approve the product&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA may identify deficiencies in our marketing application&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA may identify deficiencies in our or our collaborators&#8217; manufacturing processes, facilities or analytical methods&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential for policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering clinical data or regulatory filings insufficient for clearance, authorization or approval&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA or foreign regulatory authorities may audit clinical trial data and conclude that the data is not sufficiently reliable to support a PMA. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are numerous FDA personnel assigned to review different aspects of marketing submissions, which can present uncertainties based on their ability to exercise judgment and discretion during the review process. During the course of review, the FDA may request or require additional data and information, and the development and provision of these data and information may be time-consuming and expensive. The process of obtaining regulatory clearances, authorizations or approvals to market a medical device can be costly and time-consuming, and we may not be able to obtain these clearances, authorizations or approvals on a timely basis, or at all for our products in development. If we are unable to obtain clearance, authorization or approval for any products for which we plan to seek clearance, authorization or approval, our business may be harmed. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Modifications to our products with FDA clearance may require new FDA clearances, authorizations or approvals, or may require us to cease marketing or recall the modified clinical diagnostic products or future clinical products until clearances are obtained. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any modification to a 510(k)-cleared device that significantly affects its safety or effectiveness, or that constitutes a major change in its intended use, could require a new 510(k) clearance, a new<span style="font-style:italic;"> de novo</span> authorization or approval of a PMA. The FDA requires every manufacturer to make this determination in the first instance, but the FDA may review any manufacturer&#8217;s decision. The FDA may not agree with our decisions regarding whether new clearances, authorizations or approvals are necessary. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For any product approved pursuant to a PMA, we would be required to seek supplemental approval for many types of modifications to the approved product. The FDA requires manufacturers in the first instance to determine whether a PMA supplement or other regulatory filing is needed or whether the change may be reported via the PMA Annual Report, but may disagree with a company&#8217;s assessment. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the FDA disagrees with our determination, which it may not review until we submit an annual report or the FDA conducts an inspection or other inquiry, and requires us to seek new clearances, authorizations or approvals for modifications to our previously cleared, authorized or approved clinical diagnostic products for which we have concluded new clearances, authorizations or approvals are unnecessary, we may be required to cease marketing or distribution of these clinical diagnostic products or to recall the modified products until we obtain clearance, authorization or approval. We may also be subject to enforcement action, including, among other things, significant regulatory fines or penalties. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our employees, principal investigators, consultants and collaborators may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to the risk of fraud or other misconduct by our employees, consultants and those of our collaborators. Misconduct by these parties could include intentional failures to comply with the regulations of the FDA and non-U.S. regulators, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent improper marketing, fraud, misconduct, kickbacks, bribery, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct could also involve the improper use of information obtained in the course of clinical studies, which could result in regulatory sanctions and cause serious harm to our reputation. We currently have a code of conduct applicable to all of our employees, but it is not always possible to identify and deter employee misconduct. In addition, our code of conduct and the other precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses, or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such investigations or actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of significant fines or other sanctions, which could have a significant impact on our business. We currently have a compliance program in accordance with the elements of an effective program outlined by the HHS OIG, which could help mitigate damages, but cannot prevent all misconduct. Whether or not we are successful in defending against such actions or investigations, we could incur substantial costs, including legal fees, suffer adverse publicity and reputational harm, and have the attention of management diverted in defending ourselves against any of these claims or investigations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If third-party payors, including private payors and government healthcare programs, do not provide coverage of, or adequate reimbursement for, our clinical diagnostic products, our commercial success will be negatively affected. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue depends in part on achieving broad coverage and reimbursement for our diagnostic tests from payors, including both private and government payors. Certain large private payors have issued policies that decline to cover testing methods that they regard as experimental or investigational. Other payors may issue similar non-coverage policies. If payors do not provide coverage of, or do not provide adequate reimbursement for, a substantial portion of the price of our diagnostic tests, we may need to seek payment from the patient where this is not precluded by law or contract, which may adversely affect demand for our tests. Coverage determinations by a payor may depend on a number of factors, including, but not limited to, a payor&#8217;s determination that a certain diagnostic test is appropriate, medically necessary or cost-effective. If we are unable to provide payors with sufficient evidence of the clinical utility and validity of our diagnostic tests, they may not provide coverage, or may provide limited coverage, which will adversely affect our revenues and our ability to succeed. To the extent that more competitors enter our markets, the availability of coverage and the reimbursement rate for our tests and new diagnostic products may decrease as we encounter pricing pressure from our competitors. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each payor makes its own decision regarding coverage of our tests and the applicable payment rates, and payors may not provide adequate coverage or reimbursement for our current or future products. Although we may contract with certain payors, working with payors through contract or otherwise to assure reimbursement is time-consuming and costly and outcomes are uncertain. In addition, the determinations by a payor whether to cover our clinical diagnostic product and the amount it will reimburse for them are often made on an indication-by-indication basis. In cases where there is no coverage policy or we do not have a contracted rate for reimbursement as a participating provider, the patient is typically responsible for a greater share of the cost of the test, which may result in further delay of our revenue, increase our collection costs or decrease the likelihood of collection. Through our Adaptive Assist patient support program, we provide clonoSEQ diagnostic tests for reduced rates or without charge to eligible low-income patients that may result in payors requiring us to provide evidence of eligibility of such patients to pay reduced out-of-pocket amounts. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our claims for reimbursement from payors may be denied upon submission, and we may need to take additional steps to receive payment, such as appealing the denials. Such appeals and other processes are time-consuming, expensive and may not result in payment. Payors may perform audits of historically paid claims and attempt to recoup funds years after the funds were initially distributed if the payors believe the funds were paid in error or determine that our clonoSEQ diagnostic tests or other clinical diagnostic products were medically unnecessary. In addition, similar to federal payors, state and federal laws permit commercial payors to seek civil and criminal penalties against a manufacturer if they feel they have been defrauded. If a payor audits our claims and issues a negative audit finding, and we are not able to overturn the audit findings through appeal, the recoupment may result in a material adverse effect on our revenue. Additionally, in some cases commercial payors for whom we are not a participating provider may elect at any time to review claims previously paid and determine the amount they paid was too much. In these situations, the payor will typically notify us of their decision and then offset whatever amount they determine they overpaid against amounts they owe us on current claims. We do not have a mechanism to dispute these retroactive adjustments and we cannot predict when, or how often, a payor might engage in these reviews. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future Medicare payment rates are uncertain.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2020, CMS revised the National Coverage Determination (&#8220;NCD&#8221;) for molecular diagnostic laboratory testing services utilizing a NGS methodology, which includes our clinical diagnostic products, for Medicare beneficiaries with advanced cancer. CMS revised the NCD to extend specific coverage for germline (inherited) testing. CMS stated that it is continuing to make other technical, clarifying and conforming changes in the NCD manual and they are also clarifying the existing policy related to diagnostic tests for Somatic (Acquired) Cancer. If CMS were to make material revisions to policy, this could potentially impact the scope of clonoSEQ coverage. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Medicare Part B, payment for most diagnostic laboratory tests is made under the Clinical Laboratory Fee Schedule (&#8220;CLFS&#8221;), which assigns payment amounts to tests based on billing codes. Under the Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), certain laboratories that receive the majority of their Medicare revenue from payments made under the CLFS or Medicare&#8217;s Physician Fee Schedule are required to report to CMS every three years, or annually for &#8220;advanced diagnostic laboratory tests,&#8221; commercial payor payment rates and volumes for tests they perform and that are assigned specific billing codes. PAMA has special provisions relating to &#8220;advanced diagnostic laboratory tests,&#8221; as defined by the statute, and these provisions affect the rate-setting at the time of launch and the periodicity of rate reporting and revision. Laboratories that fail to report the required payment information may be subject to substantial civil monetary penalties. If, in the future, clonoSEQ or any of our tests are assigned a specific code we would be required to report commercial payor payment data on those tests. Payments for tests billed under miscellaneous codes are determined by the MACs, which also have discretion to change those payment rates. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CMS uses the data reported by laboratories to calculate a payment rate for each CLFS test, other than those coded with miscellaneous codes and certain others, based on the volume-weighted median of the private payor rates. These rates apply for three years, except that payment rates for advanced diagnostic laboratory tests apply for one year. If we offer tests with specific codes, this apparatus would apply. Under these circumstances, Medicare&#8217;s payment rates would be determined by the rates we and other laboratories, if any, with tests that share the specific codes we use, obtain from commercial payors. In that case, if we are unable to obtain and maintain adequate reimbursement rates from commercial payors, this may adversely affect our Medicare rates. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In some circumstances, our tests may be furnished to hospital inpatients and paid by Medicare under different rules. For example, when a specimen is obtained from a patient who is at the time classified by Medicare as a hospital inpatient, Medicare would not make a separate payment for the test and we would have to look to the hospital for payment. We do not know how often this will occur or whether hospitals will resist paying us for our tests. In this situation, Medicare coverage would be determined by the MAC for the jurisdiction where the hospital is located, which may not cover our tests. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our RUO, clinical diagnostic and therapeutic products or services, and those jointly developed with our collaborators, may in the future be subject to product or service recalls. A recall of products or services, either voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our or our collaborators&#8217; products or services, could have a significant adverse impact on us. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA has the authority to require the recall of commercialized products or services that are subject to FDA regulation. Manufacturers may, under their own initiative, recall a product or service if any deficiency is found. The FDA requires that certain corrections and removals, including recalls intended to reduce a health risk, be reported to the FDA within ten working days of initiating such correction or removal. For reportable corrections and removals, companies are required to make additional periodic submissions to the FDA after initiating the recall, and often engage with the FDA on their recall strategy prior to initiating the recall. A government-mandated or voluntary recall by us, one of our distributors or our collaborators could occur as a result of an unacceptable health risk, component failures, failures in laboratory processes, malfunctions, manufacturing errors, design or labeling defects, or other deficiencies and issues. Recalls of any of our commercialized products or services or those jointly developed with our collaborators would divert managerial and financial resources and adversely affect our reputation, results of operations and financial condition. We may also be subject to liability claims, be required to bear other costs or take other actions that may negatively impact our future sales and our ability to generate profits. Companies are also required to maintain certain records of corrections and removals, even if these do not require reporting to the FDA. We or our collaborators may initiate voluntary recalls involving our commercialized products or services in the future that we determine do not require FDA notification. If the FDA disagrees with our determinations, they may require us to report those actions as recalls. A future recall announcement by us or our collaborators could harm our reputation with customers and negatively affect our results of operations and financial condition. In addition, the FDA or other agency could take enforcement action for failing to report the recalls when they were conducted. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we or our collaborators initiate a recall, including a correction or removal, for one of our commercialized products or services, issue a safety alert, or undertake a field action or recall to reduce a health risk, this could lead to increased scrutiny by the FDA, other governmental and regulatory enforcement bodies, and our or our collaborators&#8217; customers regarding the quality and safety of our products and services, and to negative publicity, including FDA alerts, press releases, or administrative or judicial actions. Furthermore, the submission of these reports could be used against us by competitors and cause customers to delay purchase decisions or cancel orders, which would harm our reputation. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Any additional commercialized products and services or any future products and services that obtain regulatory clearance, authorization, approval, accreditation or licensure will remain subject to regulatory scrutiny and our failure to maintain our regulatory clearances, authorizations, approvals, accreditations or licensures could adversely affect our reputation, business and results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we or our collaborators obtain regulatory clearance, authorization, approval, accreditation or licensure in a jurisdiction for our products and services, the applicable regulatory authority may still impose significant restrictions on the indicated uses or marketing of our products and services, or impose ongoing requirements for potentially costly post-approval studies or post-market surveillance of our or our collaborators&#8217; manufacturing and distribution. Advertising for certain devices and labeling, including promotional labeling, for all devices must comply with FDA requirements. In addition, device advertising and promotion may also be subject to other federal and state laws. For example, the FDA shares jurisdiction over the regulation of device advertising with the FTC. Advertising for devices characterized as restricted by the FDA is subject to specified FDA requirements, while advertising for non-restricted devices is regulated by the FTC. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we or our collaborators fail to comply with applicable regulatory requirements following clearance, authorization, approval, accreditation or licensure of any of our products and services, a regulatory agency may: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">initiate an inspection of our or our collaborators&#8217; facilities&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">issue an untitled or warning letter asserting that we or our collaborators are in violation of law&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seek an injunction or impose civil or criminal penalties or monetary fines&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">suspend or withdraw regulatory clearance, authorization or approval, or revoke a license or accreditation&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">suspend any ongoing clinical studies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">delay or refuse clearance, authorization or approval of a pending regulatory submission or supplement submitted by us or our collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">impose restrictions on our or our collaborators&#8217; cleared, authorized, approved, accredited or licensed products or services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seize or recall the product or service&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">partially suspend or entirely shut down our or our collaborators&#8217; manufacturing or laboratory operations&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">issue advisories or other field actions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">impose operating restrictions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">refuse to allow us or our collaborators to enter into supply contracts, including government contracts&#59; or </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">refer matters to the DOJ or other enforcement or regulatory bodies. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our and our collaborators&#8217; ability to commercialize any cleared, authorized or approved products and services and generate revenues. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If any of our diagnostic products or services cause or contribute to a death or serious injury, or malfunction in certain ways, we will be required to report such death, serious injury or malfunction under applicable medical device reporting regulations, and such events can result in voluntary corrective actions or agency enforcement actions. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under FDA medical device reporting regulations, medical device manufacturers are required to report to the FDA information that a device has or may have caused or contributed to a death or serious injury or has malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction of the device or one of our similar devices were to recur. If such a death, serious injury or malfunction were to occur, and we or our collaborators are unable to demonstrate that the adverse events were caused by factors other than our or our collaborator&#8217;s products and services, regulatory authorities could order us to cease further development of, or deny clearance, authorization or approval of, any of our or our collaborators&#8217; products and services for any or all targeted indications. Even if we and our collaborators are able to demonstrate that any serious adverse events are not related to our products and services, such occurrences could affect patient recruitment or the ability of enrolled trial participants to complete the trial. Moreover, if we or our collaborators elect, or are required, to delay, suspend or terminate any clinical trial of any product in development, the commercial prospects of such product in development may be harmed and our ability to generate product revenues may be delayed or eliminated. Any of these occurrences may harm our and our collaborators&#8217; ability to identify and develop future products and services, and may significantly harm our business, financial condition, result of operations and prospects. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are subject to various laws and regulations, such as healthcare fraud and abuse laws, false claim laws and health information privacy and security laws, among others, and failure to comply with these laws and regulations may have an adverse effect on our business. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Healthcare providers, physicians, hospitals and third-party payors often play a primary role in the recommendation and prescription of any currently marketed products and services for which we may obtain clearance, authorization or approval. Our current and future arrangements with healthcare providers, physicians, hospitals and third-party payors, and our sales, marketing and educational activities related to our products and services, may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations at the federal and state level that may constrain our business or financial arrangements, and the relationships through which we market, sell and distribute our products and services. In addition, our operations are also subject to various federal and state fraud and abuse, physician payment transparency, and privacy and security laws, including, without limitation: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The AKS, which prohibits, among other things, persons and entities, including clinical laboratories, from knowingly and willfully soliciting, receiving, offering or paying remuneration, whether directly or indirectly, overtly or covertly, in case or in kind, to induce or reward or in return for either the referral of an individual or the purchase, lease, order or recommendation of an item or service reimbursable, in whole or in part, under a federal healthcare program such as Medicare or Medicaid. The AKS has been interpreted broadly to apply to, among other things, arrangements between clinical laboratories and prescribers and purchasers of our tests. The term &#8220;remuneration&#8221; expressly includes kickbacks, bribes or rebates and has been broadly interpreted to include anything of value, including gifts, discounts, waivers of payment, ownership interests and any goods or services provided at less than their fair market value. There are several statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution or other regulatory sanctions, however, these exceptions and safe harbors are drawn narrowly, and practices that do not fit squarely within an exception or safe harbor may be subject to scrutiny. The failure to meet all of the requirements of a particular statutory exception or regulatory safe harbor does not make the conduct</span><span style="font-style:italic;color:#000000;"> per se</span><span style="color:#000000;"> illegal under the AKS. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of the facts and circumstances to determine whether one purpose of the remuneration in the arrangement was to induce referrals or generate business that is payable by a federal healthcare program. A violation of the AKS may be grounds for the government or a whistleblower to assert that a claim for payment of items or services resulting from such violation constitutes a false or fraudulent claim for purposes of the False Claims Act. Moreover, certain AKS safe harbors currently protecting rebates paid by device manufacturers to third parties and other arrangements between device manufacturers and third parties may later be modified or repealed pursuant to a pending regulatory proposal, which could require us to revisit or modify our business practices. Our practices may not meet all of the criteria for safe harbor protection from AKS liability in all cases. A person or entity does not need to have actual knowledge of the AKS or specific intent to violate any AKS provisions to have committed a violation. In addition, renumeration may not be offered or provided to beneficiaries under the vili monetary penalty law provision prohibiting inducements to beneficiaries.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Section&#160;8122 of the SUPPORT Act, EKRA, which establishes an all-payor anti-kickback prohibition that extends to arrangements with recovery homes, clinical laboratories and clinical treatment facilities. EKRA includes a number of statutory exceptions, and directs agencies to develop further exceptions. Current EKRA exceptions in some cases reference, and in others differ from, the AKS safe harbors. Significantly, the EKRA prohibitions apply to the soliciting or receipt of remuneration for any referrals to recovery homes, clinical treatment facilities or clinical laboratories, whether or not related to the treatment of substance use disorders. Further, the EKRA prohibitions cover the payment or offer of remuneration to induce a referral to, or in exchange for, an individual using the services of such providers. EKRA creates additional risk that relationships with referral sources could be problematic. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Federal civil and criminal false claims laws and civil monetary penalty laws, including the False Claims Act, which prohibits individuals or entities from, among other things, knowingly presenting, or causing to be presented, claims for payment to, or approval by, the federal government that are false, fictitious or fraudulent, or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the federal government. The False Claims Act also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the False Claims Act and to share in any monetary recovery. In addition, AKS violations implicate the False Claims Act. Conduct that results in a False Claims Act violation may also implicate various federal criminal statutes. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">The Criminal Health Care Fraud Statute, which imposes criminal and civil liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors, and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the AKS, a person or entity does not need to have actual knowledge or specific intent to violate </span><span style="color:#000000;">the Criminal Health Care Fraud Statute</span><span style="color:#000000;">. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The Stark Law, which is directed at &#8220;self-referral,&#8221; prohibits, with certain exceptions, referrals for certain DHS, including laboratory services, that are covered by Medicare and Medicaid by physicians who personally, or through a family member, have an investment or ownership interest in, or a compensation arrangement with, an entity performing the tests. The prohibition also extends to payment for any testing referred in violation of the Stark Law. Because the Stark Law is a strict liability statute, proof of specific intent to violate the law is not a required element of a violation. Any person who engages in a scheme to circumvent the Stark Law&#8217;s referral prohibition may be fined up to $100,000 for each such arrangement or scheme. In addition, any person who presents or causes to be presented a claim to Medicare or Medicaid in violation of the Stark Law is subject to civil monetary penalties of up to $15,000 per bill submission, an assessment of up to three times the amount claimed and possible exclusion from participation in federal governmental payor programs, and those claims are considered false claims for which the parties to the arrangement may be liable under the False Claims Act. Bills submitted in violation of the Stark Law may not be paid by Medicare or Medicaid, and any person collecting any amounts with respect to any such prohibited bill is obligated to refund such amounts. Many states have comparable laws that are not limited to Medicare and Medicaid referrals. The Stark Law also places an annual cap on the amount of non-monetary compensation, which consists of meal spend and educational items, that a company can spend on a physician in the aggregate. This annual cap requires careful tracking and coordination and if it is exceeded, as long as the amount exceeded is less than 50% of the total annual cap and is recouped from the physician within 180 calendar days or before the end of the calendar year, it is not a violation. This &#8220;return&#8221; option may only be used once every three years with respect to the same referring physician. We occasionally enter into financial relationships, usually compensation relationships, such as a consulting arrangement, with physicians who refer patients for testing. If these arrangements do not meet the Stark Law&#8217;s requirements, any claims submitted to Medicare or Medicaid could violate the law and put both the physician referral source and us at risk. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The administrative simplification provisions of HIPAA, as amended and supplemented by HITECH, impose, among other things, obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of protected health information (&#8220;PHI&#8221;) held by certain healthcare providers, health plans and healthcare clearinghouses, known as covered entities, and their respective business associates. Among other things, HITECH made certain aspects of HIPAA&#8217;s rules, notably the &#8220;HIPAA Security Rule,&#8221; directly applicable to business associates, independent contractors or agents of covered entities that create, receive, maintain or transmit PHI in connection with providing a function on behalf of, or a service to, a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates and gave state attorneys general new authority to file civil actions for damages or injunctions in federal court to enforce the federal HIPAA regulation and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. The HHS Office for Civil Rights (&#8220;OCR&#8221;) has increased its focus on compliance and continues to train state attorneys general for enforcement purposes. The OCR has recently increased both its efforts to audit HIPAA compliance and its level of enforcement, with one recent penalty exceeding $16&#160;million. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">GINA, which restricts employers and health insurance companies from requiring or using the results of genetic tests in specific contexts and does not provide a private right of action. A number of states have also adopted laws regarding genetic tests, some aligned with GINA and some with broader applicability, including granting broader rights to individuals and imposing strict obligations on organizations to safeguard genetic data and the results of any such testing. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The Physician Payments Sunshine Act created under the ACA, and its implementing regulations, which requires applicable manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the State Children&#8217;s Health Insurance Program, with certain exceptions, to annually report to HHS information related to certain payments or other transfers of value made or distributed to physicians and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. The Physician Payments Sunshine Act has been extended to payments and transfers of value to physician assistants, nurse practitioners and other mid-level healthcare providers, with reporting requirements going into effect in 2022 for payments and transfers of value made to these practitioners in 2021. In addition, certain state and local laws may impose additional transparency and healthcare compliance requirements on medical device manufacturers, as well as certain restrictions or limits on interactions with healthcare professionals. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">The FTCA, which the FTC interprets to require taking appropriate steps to secure consumers&#8217; personal information and considers the failures to do so to constitute unfair acts or practices in or affecting commerce in violation of Section&#160;5(a) of the FTCA. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Medical data is considered sensitive data that merits stronger safeguards, and the FTC&#8217;s guidance for appropriately securing consumers&#8217; personal information is consistent with what is required by the HIPAA Security Rule. Some states, most notably Massachusetts and Nevada, also have adopted laws requiring the implementation of security measures to protect personal information, and all 50 states and the District of Columbia, Puerto Rico and Guam, have adopted breach notification laws. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Analogous state laws and regulations, such as state anti-kickback, self-referral and false claims laws, which may apply to items or services reimbursed by any third-party payor, including commercial insurers, and in some cases even in self-pay scenarios. In addition, some state laws require life sciences companies to comply with the industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or to impose transparency requirements or restrictions on marketing activities. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Various state, federal and foreign laws and regulations govern our ability to communicate, prospect, advertise and market our products and services through email, phone, text messages, facsimile and online methods. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of the breadth of these laws and the narrowness of the exceptions and safe harbors available under them, it is possible that certain of our business activities could be subject to challenge under one or more of such laws. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of the ongoing interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Ensuring that business arrangements with third parties comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert management&#8217;s attention from our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our operations are found to be in violation of any of the health regulatory laws described above or any other laws that apply to us, we may be subject to penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from participation in government healthcare programs, injunctions, private<span style="font-style:italic;"> qui tam</span> actions brought by individual whistleblowers in the name of the government and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our results of operations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our collection, use and disclosure of personal information, including health and employee information, is subject to state, federal and foreign privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The privacy and security of personal information stored, maintained, received or transmitted, including electronically, is a major issue in the United States and abroad. While we strive to comply with all applicable privacy and security laws and regulations, including, in our case, our own posted privacy policies, legal standards for privacy, including but not limited to &#8220;unfairness&#8221; and &#8220;deception,&#8221; as enforced by the FTC and state attorneys general, these laws and regulations continue to evolve and any failure or perceived failure to comply may result in proceedings or actions against us by government entities or others, or could cause us to lose customers, which could have a material adverse effect on our business. Recently, there has been an increase in public awareness of privacy issues in the wake of revelations about the data-collection activities of various government agencies and in the number of private privacy-related lawsuits filed against companies (including a private right of action under the CCPA and other similar state laws, as described below). Concerns about our practices with regard to the collection, use, retention, disclosure or security of personal information or other privacy-related matters, even if unfounded and even if we are in compliance with applicable laws, could damage our reputation and harm our business. Additionally, we receive personal information, including PHI from third parties, and if such third parties breach their representations to us regarding their compliance with applicable privacy and security laws, we could be exposed to proceedings or actions by government agencies or others. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerous foreign, federal and state laws and regulations govern the collection, dissemination, use and confidentiality of personal information, including genetic, biometric and health information, including state privacy, data security and breach notification laws, federal and state consumer protection and employment laws, HIPAA, GINA, the GDPR and other foreign data protection laws. These laws and regulations are increasing in complexity and number, may change frequently and sometimes conflict. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The HIPAA privacy, security and breach notification regulations, including the expanded requirements under HITECH, establish comprehensive federal standards with respect to the uses and disclosures of PHI by health plans, healthcare providers, including laboratories, and healthcare clearinghouses, in addition to setting standards to protect the confidentiality, integrity and security of PHI. The regulations establish a complex regulatory framework on a variety of subjects, including: </span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the circumstances under which uses and disclosures of PHI are permitted or required without a specific authorization by the patient&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a patient&#8217;s rights to access, amend and receive an accounting of certain disclosures of PHI&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">requirements to notify individuals if there is a breach of their unsecured PHI&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the contents of notices that must be provided to patients regarding our privacy practices for PHI&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">administrative, technical and physical safeguards required of entities that use or receive PHI&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the safeguarding of PHI. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Penalties for violations of these laws vary. For instance, penalties for failure to comply with a requirement of HIPAA and HITECH vary significantly, and include civil monetary penalties of up to $58,490 per violation, which cap has been increased to account for inflation, not to exceed approximately $1.75&#160;million per calendar year, for each provision of HIPAA that is violated and, in certain circumstances, criminal penalties with fines up to $250,000 per violation and imprisonment. However, a single breach can result in findings of violations of multiple provisions, leading to possible penalties in excess of $1.75&#160;million for violations in a calendar year. Any person who knowingly obtains or discloses PHI in violation of HIPAA may face a criminal penalty of up to $50,000 and up to one year of imprisonment. The criminal penalties increase if the wrongful conduct involves false pretenses or the intent to sell, transfer or use identifiable health information for commercial advantage, personal gain or malicious harm. In addition, responding to government investigations or related third-party private rights of action regarding alleged violations of these and other laws and regulations, even if they ultimately result in no findings of violations or no penalties imposed, can consume our resources and impact our business and, if public, harm our reputation. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer networks are vulnerable to breach and unauthorized persons may in the future be able to exploit weaknesses in the security systems of our computer networks and gain access to PHI. Additionally, we share PHI with third-party contractors, and while they are contractually obligated under business associate agreements to safeguard and maintain the confidentiality of PHI, their indemnification of us would not insulate us from reputational harm. Unauthorized persons may be able to gain access to PHI stored in such third-party contractors&#8217; computer networks. Any wrongful use or disclosure of PHI by us or our third-party contractors, including disclosure due to data theft or unauthorized access to our or our third-party contractors&#8217; computer networks, could subject us to fines or penalties that could adversely affect our business and results of operations. Although HIPAA and the regulations promulgated thereunder do not provide for a private right of action, we could incur damages under state laws to private parties for the wrongful use or disclosure of confidential health information or other private personal information. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, various states, such as California, New York and Massachusetts, have implemented similar privacy laws and regulations, such as the California Confidentiality of Medical Information Act, that impose restrictive requirements regulating the use and disclosure of health information and other personal information. These laws and regulations are not necessarily preempted by HIPAA, but they have a wider scope and afford greater protection to individuals than HIPAA. Where state laws are more protective, we and our collaborators must comply with the stricter provisions where they apply. In addition to fines and penalties imposed upon violators, some of these state laws also afford private rights of action to individuals who believe their personal information has been misused. The interplay of federal and state laws may be subject to varying interpretations by courts and government agencies, creating complex compliance issues for us and our customers and potentially exposing us to additional expense, adverse publicity and liability. Further, as regulatory focus on privacy, security and data use issues continues to increase and laws and regulations concerning the protection of personal information expand and become more complex, these potential risks to our immune medicine platform and related products and services could intensify. Changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as PHI, along with increased customer demand for enhanced data security infrastructure, could greatly increase the cost of providing our products and services, decrease demand for our products and services, reduce our revenue and subject us to additional liabilities. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently operate in some and may eventually operate in additional countries outside of the United States whose laws may in some cases be more stringent than the requirements in the United States. For example, the EU has specific requirements relating to cross-border transfers of personal data to certain jurisdictions, including to the United States. In addition, some countries have stricter consumer notice or consent requirements relating to personal data collection, use or sharing, have more stringent requirements relating to organizations&#8217; privacy programs and provide stronger individual rights. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, international privacy and data security regulations may become more complex and result in greater penalties. For instance, the GDPR</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> governs </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the collection and use of personal data of data subjects in the EU and the EEA. The GDPR applies extra-territorially under certain circumstances and imposes stringent requirements on controllers and processors of personal data, including, for example, requirements to obtain consent or other legal bases from individuals to process their personal data, provide robust disclosures to individuals, accommodate a set of individual data rights, provide data security breach notifications within 72 hours after </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">becoming aware of</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the breach, limit retention of personal information and apply enhanced protections to health data and other special categories of personal data. The GDPR also applies to pseudonymized data, which is defined as &#8220;the processing of personal data in such a way that the data can no longer be attributed to a specific data subject without the use of additional information,&#8221; and imposes additional obligations when we contract with third-party processors in connection with the processing of any personal data. The GDPR provides that EU </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">m</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ember </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tates may make their own further laws and regulations limiting the processing of personal data, including genetic, biometric or health data, which could limit our ability to use and share personal data, could cause our costs to increase and could harm our financial condition. Failure to comply with the requirements of the GDPR and the applicable national data protection laws of the EU member states may result in fines of up to &#8364;20&#160;million or up to 4% of the total worldwide annual turnover of our preceding fiscal year, whichever is higher, and other administrative penalties. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compliance with the GDPR requires us to put </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in place </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and maintain </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">additional </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">policies, procedures and documentation that may not have been required under the preceding framework, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">which may result in other substantial expenditures. This may be onerous and adversely affect our business, financial condition, results of operations and the profitability of our platform of products and services. Failure to comply with the GDPR and other countries&#8217; privacy or data security-related laws, rules or regulations could result in material penalties imposed by regulators, affect our compliance with contracts entered into with our collaborators and other third-party payors, and have an adverse effect on our business and financial condition. Currently, the GDPR is only applicable to us as a processor, but as we continue to expand into the European market, the GDPR will have direct applicability to us as a controller. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-right:0.74%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The GDPR also imposes strict rules on the transfer of personal data out of the EU to the United States. These obligations may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other requirements or our practices. In addition, these rules are consistently under scrutiny. In July 2020, the Court of Justice of the European Union (&#8220;CJEU&#8221;) invalidated the EU-US Privacy Shield, effective immediately, one of the methods for transfers of personal data into the US.  The CJEU found that under US surveillance laws, the US government has access to personal data that does not provide Europeans with privacy protections equivalent with the level of protection required under EU law and required companies based outside of the EU/EEA to implement additional protective measures to safeguard data from the EU/EEA. Furthering these requirements, the European Commission published a revised set of Standard Contractual Clauses in June 2021, which replace the former Standard Contractual Clauses on all existing transfers by December 2022 and impose additional technical and organizational measures on companies. Despite these recent changes, there is continued uncertainty in this area given that EU supervisory authorities are increasingly fining companies based in the United States for data transfers. In addition, given the CJEU&#8217;s findings on US surveillance laws, a future case might deem transfers to the United States based on Standard Contractual Clauses invalid because they fail to meet that "essentially equivalent to that guaranteed within the EU" standard.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the GDPR, we continue to expand our business into several jurisdictions that have data privacy laws or begin to develop new data privacy laws. Organizations operating in Canada and covered by the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;), or equivalent Canadian provincial laws, must obtain an individual&#8217;s consent when they collect, use or disclose that individual&#8217;s personal information. Individuals have the right to access and challenge the accuracy of their personal information held by an organization, and personal information may only be used for the purposes for which it was collected. If an organization intends to use personal information for another purpose, it must again obtain that individual&#8217;s consent. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of the breadth of these data protection laws and the narrowness of their exceptions and safe harbors, it is possible that our business or data protection policies could be subject to challenge under one or more of such laws. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of heightened regulatory focus on data privacy and security issues. If our operations are found to be in violation of any of the data protection laws described above or any other laws that apply to us, we may be subject to penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from participation in government healthcare programs, injunctions, private<span style="font-style:italic;"> qui tam</span> actions brought by individual whistleblowers in the name of the government, class action litigation and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corrective action plan or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our results of operations. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the interpretation and application of consumer, health-related and data protection laws, especially with respect to genetic samples and data, in the United States, the EU and elsewhere, are</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> changing and are also</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> often uncertain, contradictory and in flux. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within the United States, an increasing number of states have been and continue to add privacy bills to their legislative calendars each year. While not all of these bills become law, they add significant uncertainty about additional obligations or potential penalties. There are parallel activities at the federal level, with proposed rulemaking related to the FTC Act and HIPAA underway, as well as the potential of a federal privacy law similar to the GDPR. There are similar trends at the international level, with potential new laws, as well as interpretation of existing laws (e.g., GDPR) that may impact Adaptive&#8217;s operations. These uncertainties are confounded by parallel changes in laws adjacent to privacy, such as those impacting machine learning and artificial intelligence or data use, and we may incur substantial expense or experience disruption as related to compliance with these laws, which would adversely affect our ability to conduct our business. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Security breaches, loss of data and other disruptions could compromise confidential, personal and sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of our business, we and our collaborators collect and store sensitive data, including PHI, personal information, credit card and other financial information, intellectual property and proprietary business information owned or controlled by ourselves or our customers, third-party payors, our collaborators, government entities, insurance companies and other parties. We manage and maintain our applications and data through a combination of on-site systems and cloud-based data centers. We utilize external security and infrastructure vendors to manage components of our data centers. We also transmit sensitive data, including patient data, telephonically, through our website and pursuant to arrangements with multiple third-party vendors and their subcontractors. These applications and data encompass a wide variety of critical business information, including research and development information, patient data, commercial information and financial information. We face a number of risks related to protecting this critical information, including loss-of-access risk, unauthorized access, use, disclosure or modification, and the risk of our inability to adequately monitor, audit and modify our respective control over our critical information. This risk extends to the data we entrust to the third-party vendors and subcontractors that help us manage this sensitive data or otherwise process it on our behalf. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The secure processing, storage, maintenance and transmission of this critical information are vital to our operations and business strategy, and we devote significant resources to protecting such information. Although we take reasonable measures to protect sensitive and proprietary data from unauthorized access, use or disclosure, no security measures can be perfect and our respective information technology and infrastructure may be vulnerable to attacks by hackers or viruses or breached due to employee error, malfeasance or other malicious or inadvertent disruptions. Any such breach or interruption could compromise our networks and the information stored there could be accessed by unauthorized parties, publicly disclosed, lost or stolen. Any such access, breach or other loss of information could result in legal claims or proceedings, liability under federal or state laws that protect the privacy of personal information, such as HIPAA or HITECH, and regulatory penalties. Notice of breaches may be required to be provided to affected individuals, the Secretary of HHS or other federal, state and foreign regulators, the media or state attorneys general. Such a notice could harm our reputation and ability to compete. Although we have implemented security measures and formal, dedicated enterprise security programs to prevent unauthorized access to patient and other personal data, such data is currently accessible through multiple channels and we may experience one or more data breaches. Unauthorized access, loss or dissemination could also disrupt our operations and damage our reputation, which could adversely affect our results of operations and financial condition. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">No TCR-based cellular therapies have been approved in this new potential category of medicines and may never be approved as a result of efforts by others or us. TCR-based cellular therapy drug discovery has substantial clinical development and regulatory risks due to the novel and unprecedented nature of this new category of immune medicines. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a potential new category of medicines, no TCR-based cellular therapies have been approved to date by the FDA or other regulatory agency. Successful discovery and development of TCR-based cellular therapies by us and our collaborators is highly uncertain and depends on numerous factors, many of which are beyond our and their control. We and our collaborators have made and will continue to make a series of business decisions and take calculated risks to advance our development efforts and pipeline of immune-driven therapeutic product candidates, including those related to TCR-based cellular therapies, delivery technology and manufacturing processes, which may be shown to be incorrect based on further work by us, our collaborators or others. Our cellular therapeutics product candidates that appear promising in the early phases of development may fail to advance, experience delays in the clinic, experience clinical holds or fail to reach the market for many reasons, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">discovery efforts identifying potential TCR-based cellular therapies may not be successful&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">nonclinical or preclinical study results may show potential TCR-based cellular therapies to be less effective than desired or to have harmful or problematic side effects&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials may fail to meet one or more endpoints, or results may show the TCR-based cellular therapies to be less effective than expected or to have unacceptable side effects or toxicities&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">adverse effects relating to any one of our therapeutic product candidates or adverse effects relating to our TruTCR process may lead to delays in or termination of one or more of our products or services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability of our translational models to reduce risk or predict outcomes in humans, given that each component of our therapeutic product candidates may have a dependent or independent effect on safety, tolerability and efficacy, and that such effects may, among other things, be species-dependent&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">manufacturing failures or insufficient supply of current good manufacturing practices (&#8220;cGMP&#8221;) materials for future clinical trials, or higher than expected cost, could delay or set back clinical trials or make TCR-based cellular therapies commercially unattractive&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our collaborators&#8217; improvements in the manufacturing processes for this new class of potential immune medicines may not be sufficient to satisfy the clinical or commercial demand of our jointly developed TCR-based cellular therapies or regulatory requirements for clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes that we or our collaborators make to optimize manufacturing, testing or formulating of cGMP materials could impact the safety, tolerability and efficacy of our therapeutic products in development&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">pricing or reimbursement issues or other factors that delay clinical trials or make any TCR-based cellular therapies uneconomical or noncompetitive with other immunotherapies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">failure to timely advance our or our collaborators&#8217; therapeutic products or receive the necessary regulatory clearances, authorizations or approvals or a delay in receiving such clearances, authorizations or approvals due to, among other reasons, slow or failure to complete enrollment in clinical trials, withdrawal by trial participants from trials, failure to achieve trial endpoints, additional time requirements for data analysis, data integrity issues, Biologics License Application or the equivalent application, discussions with the FDA or the European Medicines Agency, a regulatory request for additional nonclinical or clinical data, or safety formulation or manufacturing issues may lead to our inability to obtain sufficient funding&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the proprietary rights of others and their competing products and services that may prevent our TCR-based cellular therapies from being commercialized or threaten future commercialization activities. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to our Intellectual Property </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not be successful in obtaining or maintaining sufficient intellectual property protection for our products, services and technologies and uses thereof, and the scope of the intellectual property protection obtained may not be sufficiently broad. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As is the case with other companies engaged in the life sciences industry, our success depends in large part on our ability to obtain and maintain protection of the intellectual property we may own solely and jointly with others, or license from third parties, particularly patents, in the United States and other countries with respect to our products, services and technologies. We rely on patent protection in addition to trademark, copyright, trade secret and other intellectual property rights protection and contractual restrictions to protect our proprietary technologies, all of which provide limited protection and may not adequately protect our rights or enable us to gain or maintain any competitive advantage. If we fail to protect our intellectual property, third parties may be able to compete more effectively against us. In addition, we may incur substantial litigation costs in our attempts to recover or restrict use of our intellectual property. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent our intellectual property offers inadequate protection, or is found to be invalid or unenforceable, we would be exposed to a greater risk of direct competition. If our intellectual property does not provide adequate barriers to competition, our competitive position could be adversely affected, as could our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We apply for or in-license patents covering our products and technologies and uses thereof, as we deem appropriate. However, obtaining and enforcing patents is costly, time-consuming and complex, and we may fail to apply for patents on important products, services and technologies in a timely fashion or at all, or we may fail to apply for patents in potentially relevant jurisdictions. We may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. We may not have the right to control the preparation, filing and prosecution of patent applications or to maintain the rights to patents licensed from third parties. Consequently, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, we own or have rights to 471 active patents and patent applications filed in the United States, Europe and elsewhere. Of these, there are 51 pending patent applications and 420 granted patents. Our pending patent applications may not result in issued patents in a timely fashion or at all. Even if patents are granted, they may not provide a basis for intellectual property protection of commercially viable products or services, may not provide us with any competitive advantages, or may be challenged and invalidated by third parties. It is also possible that others will design around our current or future patented technologies. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some of our patents, licensed patents or patent applications may be challenged in the future, and we may not be successful in defending any such challenges. For example, we may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), or become involved in opposition, derivation, reexamination,</span><span style="font-style:italic;"> inter </span><span style="font-style:italic;">partes</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> review, post-grant review or interference proceedings challenging our patent rights. Any successful third-party challenge to our patents could result in patent claims being narrowed, or patents being invalidated or held unenforceable, in whole or in part, which could lead to increased competition to our business. Conversely, we may have to challenge the patents or patent applications of third parties. The outcome of patent litigation or other proceeding can be uncertain, and any attempt by us to enforce our patent rights against others or to challenge the patent rights of others may not be successful, or, if successful, may take substantial time and result in substantial cost, and may divert our efforts and attention from other aspects of our business. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future products or services. The patent positions of biotechnology companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. Inconsistent policies regarding the eligibility for patent protection and the breadth of patentable claims in such companies&#8217; patents has emerged to date in the United States or elsewhere. Courts frequently render opinions in the biotechnology field that may affect the patentability of certain inventions or discoveries, including opinions that may affect the patentability of methods and compositions of matter useful in relation to immunosequencing. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent position of companies engaged in the development and commercialization of clinical diagnostic tests, like our clonoSEQ diagnostic test and T-Detect products, are particularly uncertain. Various courts, including the U.S. Supreme Court, have rendered decisions that affect the eligibility and scope of patentability of certain inventions or discoveries relating to certain diagnostic tests and related technology. These decisions state, among other things, that a patent claim that recites an abstract idea, natural phenomenon or law of nature (for example, the relationship between particular immune receptors and cancer) may not be patentable. Precisely what constitutes a law of nature is uncertain, and it is possible that certain aspects of our clinical diagnostics would be considered natural laws. The evolving case law in the United States may adversely affect our ability to obtain patents or defend patents we have obtained or have licensed and may facilitate third-party challenges to any owned or licensed patents. The laws of some foreign countries do not protect intellectual property rights to the same extent or for the same subject matter as the laws of the United States, and we may encounter difficulties in protecting and defending such rights in foreign jurisdictions. The legal systems of many other countries do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology, which could make it difficult for us to stop the infringement of our patents in such countries. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not be able to protect our intellectual property rights throughout the world. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filing, prosecuting and defending patents on our products and services in all countries throughout the world would be prohibitively expensive. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States, and we may encounter difficulties in protecting and defending such rights in foreign jurisdictions. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of many other countries do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology, which could make it difficult for us to stop the infringement of our patents in such countries. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Changes in patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products and services. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in either the patent laws or in interpretations of patent laws in the United States or other countries or regions may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. In addition, a third party that files a patent application before us could be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant of the time from invention to filing of a patent application. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we or our licensors were the first to either file any patent application related to our products or services or invent any of the inventions claimed in our or our licensor&#8217;s patents or patent applications. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties may also submit prior art to the USPTO during patent prosecution to attack the validity of a patent and it is also possible in the United States and other countries for third parties to challenge granted patents through Patent Office proceedings such as, in the United States, post-grant review,<span style="font-style:italic;"> inter partes</span> review and derivation proceedings. In the United States, a lower evidentiary standard is imposed in USPTO proceedings compared to the evidentiary standard in U.S. federal courts necessary to invalidate a patent claim. As such, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. The uncertainties and costs surrounding the prosecution of our owned or in-licensed patent applications and the enforcement or defense of our owned or in-licensed issued patents could have a material adverse effect on our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recent U.S. Supreme Court rulings have also narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations, including with respect to naturally occurring biological molecules such as the immune cell receptors which are a focus of our immune medicine platform. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Issued patents covering our products and services could be found invalid or unenforceable if challenged. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability and some of our patents or patent applications, including licensed patents, may be challenged, in courts or patent offices in the United States and abroad, in opposition, derivation, reexamination,<span style="font-style:italic;"> inter partes</span> review, post-grant review or interference. Additionally, if we and our licensing partners initiate or become involved in legal proceedings against a third party to enforce a patent covering one of our products or technologies, the defendant could counterclaim that the patent covering our product is invalid or unenforceable. In patent litigation in the United States, counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including patent eligible subject matter, lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. In addition, the United States now awards patent priority to the first party to file a patent application, and others may submit patent claims covering our inventions prior to us. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. A successful third-party challenge to our patents could result in the unenforceability or invalidity of such patents, which could have a material adverse impact on our business. Furthermore, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not be aware of all third-party intellectual property rights potentially relating to our immune medicine platform, products and services. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO. The outcome of such proceedings is uncertain, and other patent applications may have priority over our patent applications. Such proceedings could also result in substantial costs to us and divert our management&#8217;s attention and resources. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We rely on licenses from third parties in relation to certain products and services and if we lose these licenses then we may be subjected to future litigation. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a party to license agreements that grant us rights to use certain intellectual property, including patents and patent applications, typically in certain specified fields of use. Some of those licensed rights could provide us with freedom to operate for aspects of our products and services. We may need to obtain additional licenses from others to advance our research, development and commercialization activities. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success may depend in part on the ability of our licensors to obtain, maintain and enforce patent protection for our licensed intellectual property. Our licensors may not successfully prosecute the patent applications we license. Even if patents issue in respect of these patent applications, our licensors may fail to maintain these patents, may determine not to pursue litigation against other companies that are infringing these patents or may pursue such litigation less aggressively than we would. Without protection for the intellectual property we license, other companies might be able to offer substantially identical products for sale, which could adversely affect our competitive business position and harm our business prospects. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the scope of rights granted under the license agreement and other interpretation-related issues&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">whether, and the extent to which, our products, services, technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our right to sublicense patent and other rights to third parties under collaborative development relationships&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our collaborators&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the priority of invention of patented technology. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we do not prevail in such disputes, we may lose any or all of our rights under such license agreements. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize any affected products or services, which could have a material adverse effect on our business, financial conditions, results of operations and prospects. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Absent the license agreements, we may infringe patents subject to those agreements, and if the license agreements are terminated, we may be subject to litigation by the licensor. Litigation could result in substantial costs to us and distract our management. If we do not prevail, we may be required to pay damages, including treble damages, attorneys&#8217; fees, costs and expenses and royalties or be enjoined from selling our products or services, which could adversely affect our ability to offer products or services, our ability to continue operations and our financial condition. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to patent protection, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants, collaborators, academic institutions, life sciences research partners and, when needed, our advisers as well as other third parties. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure. If we are required to assert our rights against such party, it could result in significant cost and distraction. Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be expensive and time-consuming, and the outcome would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems. Besides the possibility that these security measures could be breached, such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for our proprietary information. Our security measures may also not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain former employees have obtained employment with companies or academic institutions that could be considered competitive with us. This competition may be limited by contractual provisions which may or may not be enforceable by us in certain jurisdictions. In addition, we may not be aware of such competitive employment arrangements until after our trade secrets have been disclosed to potentially competitive companies. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We employ, and expect to employ in the future, individuals who were previously employed at universities or other companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties, or to claims that we have improperly used or obtained such trade secrets. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. A loss of key research personnel work product could hamper or prevent our ability to commercialize potential products and services, which could harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management and other employees. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not be able to protect and enforce our trademarks. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not yet registered certain of our trademarks in all of our potential markets, although we have registered Adaptive Biotechnologies, clonoSEQ, immunoSEQ, pairSEQ and TruTCR in the United States, the EU and a number of other countries and are seeking to register additional trademarks, including our new corporate logos, certain slogans, T-Detect and TruAB for our antibody development program. As we apply to register our unregistered trademarks in the United States and other countries, our applications may not be allowed for registration in a timely fashion or at all, and our registered trademarks may not be maintained or enforced. In addition, opposition or cancellation proceedings may be filed against our trademark applications and registrations, and our trademarks may not survive such proceedings. In certain countries outside of the United States, trademark registration is required to enforce trademark rights. If we do not secure registrations for our trademarks, we may encounter more difficulty in enforcing them against third parties than we otherwise would. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. Ownership disputes may arise, for example, from conflicting obligations of employees, consultants or others who are involved in developing our future products and services. Our co-founder, Dr.&#160;Harlan Robins, had dual employment with Fred Hutch and us until June of 2019, and accordingly has had obligations to assign his rights to inventions to either Fred Hutch or us depending on how and where the inventions were conceived, reduced to practice, developed or created. Disputes may arise in the future between Fred Hutch and us regarding ownership of intellectual property generated by Dr.&#160;Robins&#8217; work. Fred Hutch may claim to have ownership rights to our intellectual property. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Litigation may be necessary to defend against these and other claims by a third party challenging inventorship of our or our licensors&#8217; ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our product or services. Alternatively, we may need to obtain one or more additional licenses from the third party which will be time-consuming and expensive and could result in substantial costs and diversion of resources and could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we become involved in patent litigation or other proceedings related to a determination of rights, we could incur substantial costs and expenses, substantial liability for damages or be required to stop our development and commercialization efforts of our products and services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the life sciences, clinical diagnostics and drug discovery industries, including patent infringement lawsuits, declaratory judgment litigation and adversarial proceedings before the USPTO, including interferences, derivation proceedings,<span style="font-style:italic;"> ex parte</span> reexaminations, post-grant review and<span style="font-style:italic;"> inter partes</span> review, as well as corresponding proceedings in foreign courts and foreign patent offices. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently involved in appeals from Opposition Proceedings at the European Patent Office related to three of our patents: EP2364368, EP2387627, and EP3059337. We may, in the future, become involved with litigation or actions at the USPTO or foreign patent offices with various third parties. We expect that the number of such claims may increase as our industry expands, more patents are issued, the number of products or services increases and the level of competition in our industry increases. Any infringement claim, regardless of its validity, could harm our business by, among other things, resulting in time-consuming and costly litigation, diverting management&#8217;s time and attention from the development of our business, requiring the payment of monetary damages (including treble damages, attorneys&#8217; fees, costs and expenses) or royalty payments. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It may be necessary for us to pursue litigation or adversarial proceedings before the patent office in order to enforce our patent and proprietary rights or to determine the scope, coverage and validity of the proprietary rights of others. The outcome of any such litigation might not be favorable to us, and even if we were to prevail, such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results or financial condition. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As we move into new markets and expand our products or services offerings, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of slowing our entry into such markets or as a means to extract substantial license and royalty payments from us. In addition, future litigation may involve patent holding companies or other adverse patent owners who have no relevant product or service revenue and against whom our own patents may provide little or no deterrence or protection. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties may assert that we are employing their proprietary technology without authorization. Given that clinical diagnostics and drug discovery fields are intense and highly competitive areas, there may be third-party intellectual property rights that others believe could relate to our immune medicine platform, products and services. We have been approached on four occasions with an offer from a third-party patent owner or licensee to license rights to us under patents relating to immune medicine. We have been contacted by Invivoscribe, Inc. regarding U.S. Pat. No.&#160;7,785,783 on March&#160;24, 2012&#59; by Keygene NV regarding U.S. Pat. No.&#160;9,453,256 on October&#160;10, 2016&#59; by MorphoSys AG regarding EP Patent 2243030 and U.S. Pat. No.&#160;9,404,929 on October&#160;10, 2018&#59; and by DName-iT NV regarding EP Patent 2201143 and U.S. Pat. No.&#160;8,318,434 in December 2018. In each instance, we have declined to pursue licenses to the patents and the matters have not been pursued further. One or more of these or other third-party patent owners or licensees may pursue or threaten to pursue litigation against us to enforce one or more patents. It would be costly and time-consuming to defend such claims. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our current or future products, technologies and services may infringe. We cannot be certain that we have identified or addressed all potentially significant third-party patents in advance of an infringement claim being made against us. In addition, similar to what other companies in our industry have experienced, we expect our competitors and others may have patents or may in the future obtain patents and claim that making, having made, using, selling, offering to sell or importing our products or services infringes these patents. Defense of infringement and other claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. Parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Parties making claims against us may be able to obtain injunctive or other relief, which could block our ability to develop, commercialize and sell products or services and could result in the award of substantial damages against us, including treble damages, attorneys&#8217; fees, costs and expenses if we are found to have willfully infringed. In the event of a successful claim of infringement against us, we may be required to pay damages and ongoing royalties and obtain one or more licenses from third parties, or be prohibited from selling certain products or services. We may not be able to obtain these licenses on acceptable or commercially reasonable terms, if at all, or these licenses may be non-exclusive, which could result in our competitors gaining access to the same intellectual property. In addition, we could encounter delays in product or service introductions while we attempt to develop alternative products or services to avoid infringing third-party patents or proprietary rights. Defense of any lawsuit or failure to obtain any of these licenses could prevent us from commercializing products or services, and the prohibition of sale of any of our products or services could materially affect our business and our ability to gain market acceptance for our products or services. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, our agreements with some of our customers, suppliers or other entities with whom we do business require us to defend or indemnify these parties to the extent they become involved in infringement claims, including the types of claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results or financial condition. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Patent terms may be inadequate to protect our competitive position on our products and services for an adequate amount of time. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our products and services are obtained, once the patent life has expired, we may be open to competition from competitive products. Given the amount of time required for the development, testing and regulatory review of new products and services, patents protecting such products and services might expire before or shortly after such products and services are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to our Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The market price of our common stock is volatile and is likely to continue to fluctuate substantially. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The market price of our common stock has been and is likely to continue to be highly volatile and may fluctuate substantially due to many factors, many of which are beyond our control. These factors include: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the commencement or termination of our collaborations&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of achievement of specified milestones in the development of our products and services&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">introductions of new or expanded products or services or new pricing policies by us or by our competitors&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in the status of our regulatory clearances, authorizations, approvals or applications, or those jointly developed with our collaborators&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">where required, the results of clinical trials of our future products and services, those jointly developed with our collaborators or those of our competitors&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success of competitive products or technologies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements by us or our competitors of significant acquisitions, collaborators or divestitures&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in governmental regulations and regulatory or legal developments in the United States and other countries&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">developments or disputes concerning patent applications, issued patents or other proprietary rights&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the recruitment or departure of key personnel&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">variations in our financial results or those of companies that are perceived to be similar to us&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in the structure of healthcare payment systems&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">market conditions in the life sciences, clinical diagnostics or drug discovery industry&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">general economic, industry and market conditions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">sales of our securities, including sales by our directors, officers or significant shareholders&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">speculation about our business in the media or the investment community&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">other factors, including factors unrelated to our operating performance or the operating performance of our competitors. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In recent years, the stock markets generally have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of listed companies. If the market for stock in our industry or the stock market in general experiences uneven investor confidence, the market price of our common stock could decline for reasons unrelated to our business, operating results or financial condition. The market price of our common stock might also decline in reaction to events that affect other companies within, or outside, our industry even if these events do not directly affect us. Any decline in the market price of our common stock may impair our ability to raise capital through the sale of equity securities. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the past, securities class action litigation has often been instituted against companies following periods of volatility in their stock price. This type of litigation, if instituted against us, could result in substantial costs to us and divert our management&#8217;s attention and resources, which could seriously harm our business, financial condition, results of operations and prospects. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If securities analysts do not publish research or reports about our business, or we are the subject of negative publicity, the price of our stock could decline. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The trading market for our common stock depends, in part, on the research and reports that securities or industry analysts publish about us or our business. We do not control these analysts. If one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable evaluations of our company or our stock, the price of our stock could decline. If one or more of these analysts cease coverage of our company or fail to publish reports covering our company regularly, our stock may lose visibility in the market, which in turn could cause our stock price to decline. In addition, if we are the subject of negative publicity, whether from an analyst, academic, industry group or the general or financial press, our stock price may decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our operating results could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue and expenses that are not readily apparent from other sources. If our assumptions change or if actual circumstances differ from our assumptions, our operating results may be adversely affected and could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock and potentially impair our ability to raise capital through the sale of equity securities.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" />

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Substantial future sales or perceived potential sales of our common stock or other equity securities in the public market could cause the price of our common stock to decline significantly. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of substantial amounts of our common stock or other equity securities in the public market, particularly by our directors, executive officers and significant shareholders, including upon the expiration of any lock-up periods entered into in connection with offerings of our common stock or other equity securities, or the perception that these sales could occur, could materially and adversely affect the price of our common stock and impair our ability to raise capital through the sale of equity securities. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are subject to financial reporting and other requirements for which our accounting and other management systems and resources may not be adequately prepared. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-right:0.37%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 (&#8220;Section 404&#8221;), we are required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. Our compliance with Section 404 necessitates that we incur substantial accounting expense and expend significant management efforts. We will continue to dedicate internal resources, potentially engage outside consultants, and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented, and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also required to maintain disclosure controls and procedures. Disclosure controls and procedures means our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC. We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. We believe a control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and any design may not succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Provisions in our charter documents and Washington law could make an acquisition of our company more difficult and limit attempts by our shareholders to replace or remove our current management. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated articles of incorporation (&#8220;Articles of Incorporation&#8221;) and our amended and restated bylaws (&#8220;Bylaws&#8221;), as well as Washington law, contain provisions that may have the effect of deterring takeovers or delaying or preventing a change in control of us or changes in our management that a shareholder might deem to be in his or her best interest. Our Articles of Incorporation and Bylaws contain provisions that: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">authorize &#8220;blank check&#8221; preferred stock, which could be issued by our board of directors without shareholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">create a classified board of directors whose members serve staggered three-year terms, with one class being elected each year by our shareholders&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">specify that special meetings of our shareholders can be called only by our board of directors, the Chairperson of our board of directors, our chief executive officer or our president&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">provide that a director may only be removed from the board of directors for cause and then only by the affirmative vote of our shareholders&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even if less than a quorum&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">specify that only our board of directors may change the size of our board of directors&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">establish an advance notice procedure for shareholder proposals to be brought before an annual meeting of our shareholders, including proposed nominations of persons for election to our board of directors&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">specify that no shareholder is permitted to cumulate votes at any election of directors&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expressly authorize our board of directors to modify, alter or repeal our Bylaws&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">require supermajority votes of the holders of our common stock to amend specified provisions of our Articles of Incorporation and Bylaws. </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management or our board of directors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, because we are incorporated in the State of Washington, we are governed by the provisions of Chapter 23B.19 of the Washington Business Corporation Act (&#8220;WBCA&#8221;), which prohibits certain business combinations between us and certain significant shareholders unless specified conditions are met. These provisions may also have the effect of delaying or preventing a change in control of our company. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any provision of our Articles of Incorporation or Bylaws or Washington law that has the effect of delaying or deterring a change in control could limit the opportunity for our shareholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our Articles of Incorporation provide that the state courts located in King County, Washington and, to the extent enforceable, the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our shareholders, which could limit our shareholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Articles of Incorporation provide that, unless we consent in writing to the selection of an alternative forum, the state courts located in King County, Washington (or, if the state courts located within King County, Washington do not have jurisdiction, the federal district court for the Western District of Washington) shall be the sole and exclusive forum for commencing and maintaining any proceeding (1)&#160;asserting a claim based on a violation of a duty under the laws of the State of Washington by any of our current or former directors, officers or shareholders in such capacity, (2)&#160;commenced or maintained in the right of our corporation, (3)&#160;asserting a claim arising pursuant to any provision of the WBCA, our Articles of Incorporation or our Bylaws (as either may be amended from time to time) or (4)&#160;asserting a claim concerning our internal affairs that is not included in clauses (1)&#160;through (3)&#160;above, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants. These provisions would not apply to suits brought to enforce a duty or liability created by the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Articles of Incorporation provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), subject to applicable law. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to these provisions. Our exclusive forum provision will not relieve us of our duties to comply with the federal securities laws and the rules and regulations thereunder, and our shareholders will not be deemed to have waived our compliance with these laws, rules and regulations. These exclusive-forum provisions may limit a shareholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees or cause shareholders to incur additional costs to bring claims in the forums designated in our Articles of Incorporation. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a court were to find these exclusive-forum provisions in our Articles of Incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could harm our results of operations. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a jurisdiction other than those designated in the exclusive forum provision, and the provision may not be enforced by a court in that jurisdiction. It is unclear whether Washington courts would reach a similar conclusion under Washington law. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management and other employees. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Articles of Incorporation provide that we will indemnify our directors and officers to the fullest extent permitted by Washington law. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, as permitted by Section&#160;23B.08.510 through Section&#160;23B.08.570 of the WBCA, our Articles of Incorporation and our indemnification agreements that we have entered into with most of our directors and officers provide that: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Washington law. Washington law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to our best interests and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The rights conferred in our Articles of Incorporation are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not retroactively amend our Articles of Incorporation provisions to reduce our indemnification obligations to directors, officers, employees and agents. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently intend to retain all available funds and any future earnings to support operations and to finance the growth and development of our business, and do not anticipate paying any cash dividends on our common stock for the foreseeable future. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">Item 1B. Unresolved Staff Comments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable<span style="color:#000000;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_2_PROPERTIES">Item 2. Properties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our newly occupied corporate headquarters is located in Seattle, Washington, where we lease approximately 100,000 square feet. The lease expires in August 2033, subject to our option to twice extend the lease for five years. Additionally, in two separate Seattle, Washington locations, we lease approximately 65,500 square feet pursuant to a lease that expires October 2032, subject to two options to extend the lease for five years, and approximately 14,750 square feet, pursuant to a lease expiring in October 2029, subject to our ability to exercise an early termination right in 2022. All of our Seattle, Washington locations contain office and laboratory space.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, we executed a lease to rent approximately 27,000 square feet of a warehouse in Bothell, Washington. The lease expires in October 2031, subject to an early termination option in 2028 and an option to twice extend the lease for five years.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also lease approximately 33,300 square feet of laboratory and office space in South San Francisco, California, pursuant to an amended lease that expires March 2026, subject to our option to extend the lease for five years, and approximately 3,100 square feet of office space in New York City, New York, pursuant to a lease that expires November 2025, subject to our ability to exercise an early termination right in 2023.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may add new facilities or expand existing facilities as we add employees and scale our operations, and we believe suitable additional or substitute space will be available as needed.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_1_LEGAL_PROCEEDINGS">Item 3. Legal Proceedings</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may be subject to legal proceedings. We are not currently a party to or aware of any proceedings that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Item 4. Mine Safety Disclosures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable<span style="font-weight:bold;color:#000000;">.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_II">PART II</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Market Information for Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock began trading on The Nasdaq Global Select Market under the symbol &#8220;ADPT&#8221; on June 27, 2019. Prior to that date, there was no public trading market for our common stock.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Holders of Record</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of&#160;February 10, 2022, there were approximately&#160;100&#160;holders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of shareholders, we are unable to estimate the total number of shareholders represented by these record holders.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Dividend Policy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently intend to retain all available funds and any future earnings to fund the growth and development of our business. We do not intend to pay cash dividends to our shareholders in the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant. Our future ability to pay cash dividends on our common stock may also be limited by the terms of any future debt securities, preferred stock or credit facility.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Stock Performance Graph</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The graph below compares the cumulative total shareholder return on our common stock with the cumulative total return on the NASDAQ Composite Index and the NASDAQ Biotechnology Index. The graph assumes $100 was invested in our common stock at the market close on June 27, 2019, which was our initial trading day. Data for the NASDAQ Composite Index and the NASDAQ Biotechnology Index assume reinvestment of dividends. Our offering price of our common stock in our initial public offering, which had a closing stock price of $40.30 on June 27, 2019, was $20.00 per share. The stock price performance below is based upon historical data and is not necessarily indicative of, nor intended to forecast, future performance of our common stock. </p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:0.93%;text-indent:0%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g4bdklltl5z5000018.jpg" title="" alt="" style="width:568px;height:288px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This graph shall not be deemed to be &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the SEC for purposes of Section 18 of the Exchange Act or incorporated by reference into any filing of Adaptive Biotechnologies Corporation under the Securities Act or the Exchange Act.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_RESERVED">Item 6. [Reserved]</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes and the other financial information appearing elsewhere in this Annual Report on Form 10-K, as well as the other financial information we file with the SEC from time to time. Some of the information contained in this discussion and analysis or set forth elsewhere in this report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties relating to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">This section generally discusses 2021 and 2020 items and year-to-year comparisons between 2021 and 2020. Discussions of 2019 items and year-to-year comparisons between 2020 and 2019 may be found in Part II, Item 7 under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 24, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#8217;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient&#8217;s immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and services that we are tailoring to each individual patient. We have commercial products and services and a robust pipeline of clinical products and services that we are designing to diagnose, monitor and enable the treatment of diseases, such as cancer, autoimmune disorders and infectious diseases.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our immune medicine platform is the foundation for our expanding suite of products and services. The cornerstone of our platform and core immunosequencing product, immunoSEQ, serves as our underlying research and development engine and generates revenue from biopharmaceutical and academic customers. Our first clinical diagnostic product, clonoSEQ, is the first test authorized by the FDA for the detection and monitoring of MRD in patients with MM, ALL and CLL and is also available as a CLIA-validated LDT for patients with other lymphoid cancers. Leveraging our collaboration with Microsoft, we are creating the TCR-Antigen Map. We are using this map to develop research solutions by disease called immunoSEQ T-MAP and a diagnostic product for many diseases from a single blood test called T-Detect.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T-Detect COVID, for which we have received EUA, is designed to confirm past SARS-CoV-2 infection, the virus that causes COVID-19, and is also the first indication for the T-Detect product line. We expect to launch a second indication, T-Detect Lyme, during the 2022 Lyme season. In addition, we have confirmed signals in Crohn&#8217;s disease, celiac disease, and multiple sclerosis, as well as identified new signals in ulcerative colitis and rheumatoid arthritis.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our therapeutic product candidates, being developed under the Genentech Agreement, leverage our platform to identify specific receptors on immune cells to develop into cellular therapies in oncology. We also extended our platform to identify highly potent neutralizing antibodies against SARS-CoV-2 and we believe this differentiated approach may be leveraged across multiple disease states.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our life sciences research customers, we provide two categories of products and services using immunoSEQ. First, we provide immunosequencing services, the revenue from which we record as sequencing revenue. Second, we provide certain research customers professional support, for which we receive nonrefundable upfront or recurring payments. We may receive additional payments upon those customers achieving specified milestones. Revenue related to these activities are recorded as development revenue. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clinical diagnostics customers, we sell our clonoSEQ diagnostic test and T-Detect COVID test, which include our immunosequencing services and are thus recorded as sequencing revenue. In the future, we intend to sell other diagnostic products and services, including other indications for T-Detect, which we also expect to record as sequencing revenue. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our current drug discovery collaborator, Genentech, we screen, identify and characterize TCRs in support of our collaboration. We record revenue from this collaboration as development revenue. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Historically, we have sold immunoSEQ as a fee-for-service offering. These research offerings have comprised the majority of our revenue to date, although our business is pursuing broader opportunities. As we continue to expand the use of our clonoSEQ diagnostic tests, develop and commercialize </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T-Detect</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and develop and commercialize therapeutic product candidates with our drug discovery collaborator, we expect our mix of revenue to shift to clinical products and services, which we believe will become our largest sources of revenue.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are actively pursuing opportunities to deepen our relationships with current customers and initiate relationships with new customers. We have an experienced, specialty salesforce that is targeting department heads, laboratory directors, principal investigators, core facility directors, clinicians, payors, research scientists and pathologists at leading academic institutions, biopharmaceutical companies, research institutions and contract research organizations. As MRD assessment becomes standard practice for patient management across a range of blood cancers, we believe it will be essential for clinicians and patients to have access to a highly accurate, sensitive and standardized MRD assessment tool. We are focused on establishing and maintaining collaborative relationships with payors, developing health economic evidence and building billing and patient access infrastructure to expand reimbursement coverage for our clinical diagnostics. We continue to seek expanded coverage of our clonoSEQ diagnostic test and have successfully expanded coverage through contractual agreements or positive medical policies with Medicare and several of the largest national private health insurers in the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized revenue of $154.3 million and $98.4 million for the year ended December 31, 2021 and 2020, respectively. Net loss attributable to Adaptive Biotechnologies Corporation was $207.3 million and $146.2 million for the year ended December 31, 2021 and 2020, respectively. We have funded our operations to date principally from the sale of convertible preferred stock and common stock and, to a lesser extent, sequencing and development revenue. As of December 31, 2021 and 2020, we had cash, cash equivalents and marketable securities of $570.2 million and $806.8 million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Follow-On Offering</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, we completed an underwritten public offering of our common stock in which we issued and sold 7,200,000 shares of common stock at a public offering price of $40.00 per share. We received $271.8&#160;million in net proceeds, after deducting underwriting discounts and net offering expenses paid by us.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Components of Results of Operations </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Revenue </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive our revenue from two sources: (1)&#160;sequencing revenue and (2)&#160;development revenue. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Sequencing revenue.<span style="font-style:normal;"> Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. We bill medical institutions and commercial and government payors based on tests delivered to ordering physicians. Amounts paid for clonoSEQ diagnostic tests by medical institutions and commercial and government payors vary based on respective reimbursement rates and patient responsibilities, which may differ from our targeted list price. We recognize clinical revenue by evaluating customer payment history, contracted reimbursement rates, if applicable, and other adjustments to estimate the amount of revenue that is collectible.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clonoSEQ coverage under Medicare, we bill an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#8217;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test. Revenue recognition commences at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. Any unrecognized revenue from the initial billable test is recorded as deferred revenue and recognized either as we deliver our estimate of the remaining tests in a patient&#8217;s treatment cycle or when the likelihood becomes remote that a patient will receive additional testing. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our research customers, which include biopharmaceutical customers and academic institutions, delivery of the sequencing results may include some level of professional support and analysis. Terms with biopharmaceutical customers generally include non-refundable upfront payments, which we record as deferred revenue. For all research customers, we recognize revenue as we deliver sequencing results. From time to time, we offer discounts in order to gain rights and access to certain datasets. Revenue is recognized net of these discounts and costs associated with these services are reflected in cost of revenue. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Development revenue</span><span style="font-style:normal;">. Development revenue primarily represents regulatory or development support services</span><span style="font-style:normal;"> </span><span style="font-style:normal;">that we provide to biopharmaceutical customers who seek access to our platform to support their therapeutic development activities. We enter into collaboration and similar agreements with these customers. </span><span style="font-style:normal;">These agreements may include substantial non-refundable upfront payments, which we recognize as development revenue over time as we perform the respective services.</span><span style="font-style:normal;"> </span><span style="font-style:normal;">When the agreements include sequencing activities, we separately classify those activities as sequencing revenue. </span><span style="font-style:normal;">Additionally, we generate development revenue from the achievement of regulatory milestones.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect revenue to increase over the long term, particularly as the mix of revenue migrates to clinical diagnostics and drug discovery. The pace by which this mix migrates will be determined by the level of customer adoption and frequency of use of our products and services. Our revenue may fluctuate from period to period due to the uncertain nature of delivery of our products and services, the achievement of milestones by us or our customers, timing of expenses incurred, changes in estimates of total anticipated costs related to our Genentech Agreement and other events not within our control, such as the delivery of customer samples or customer decisions to no longer pursue their development initiatives.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to the ongoing uncertainties related to the COVID-19 pandemic, we may experience variability in revenue in the near term as our customers&#8217; abilities to procure samples for their research initiatives change, as customer initiatives evolve and as clinical testing is impacted by the pandemic.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition. As such, cost of revenue and related volume does not always trend in the same direction as revenue recognition and related volume. Additionally, costs to support our Genentech Agreement are a component of our research and development expenses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect cost of revenue to increase in absolute dollars as we grow our sequencing volume and make increased investments in laboratory automation and facilities, but the cost per sample to decrease over the long term due to the efficiencies we may gain as sequencing volume increases from improved utilization of our laboratory capacity, automation and other value engineering initiatives. <span style="color:#000000;">If our sample volume throughput is reduced as a result of the COVID-19 pandemic or otherwise, cost of revenue as a percentage of total revenue may be adversely impacted due to fixed overhead costs.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Research and Development Expenses<span style="color:#000000;"> </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. Research and development activities support further development and refinement of existing assays and products, discovery of new technologies and investments in our immune medicine platform. We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. We are currently conducting research and development activities for several products and services and we typically use our laboratory materials, personnel, facilities, information technology and other development resources across multiple development programs. Additionally, certain of these research and development activities benefit more than one of our product opportunities. We do not track research and development expenses by specific product candidates. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A component of our research and development expenses are costs supporting clinical and analytical validations to obtain regulatory approval for future clinical products and services. Additionally, the costs to support our Genentech Agreement are a component of our research and development expenses. Some of these activities have generated and may in the future generate development revenue. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our research and development expenses to continue to increase in absolute dollars as we innovate and expand the application of our platform. However, we expect research and development expenses to decrease as a percentage of revenue in the long term, although the percentage may fluctuate from period to period due to the timing and extent of our development and commercialization efforts.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Sales and Marketing Expenses </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs, such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our sales and marketing expenses to increase in absolute dollars as we expand our commercial sales, marketing and business development teams and increase marketing activities to drive awareness and adoption of our products and services. However, we expect sales and marketing expenses to decrease as a percentage of revenue in the long term, subject to fluctuations from period to period due to the timing and magnitude of these expenses.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">General and Administrative Expenses </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses consist primarily of personnel-related expenses (including salaries, benefits and share-based compensation) for our personnel in executive, legal, finance and accounting, human resources and other administrative functions, including third-party billing services. In addition, these expenses include insurance costs, external legal costs, accounting and tax service expenses, consulting fees and allocated facility costs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our general and administrative expenses to continue to increase in absolute dollars as we increase headcount. Though expected to increase in absolute dollars, we expect these expenses to decrease as a percentage of revenue in the long term as revenue increases.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<hr style="page-break-after:always" />
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Statements of Operations Data and Other Financial and Operating Data</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth our statements of operations data and other financial and operating data for the periods presented:</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="11" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Statements of Operations Data:</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,896</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,439</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,519</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,448</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,943</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,552</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,344</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,382</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85,071</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,301</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,530</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,274</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,343</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,072</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,705</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,465</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,358</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,453</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74,502</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,536</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,332</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of intangible assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,703</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,698</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">363,310</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">251,199</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163,462</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(208,966</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(152,817</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(78,391</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,668</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,590</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,785</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,298</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Net loss attributable to noncontrolling interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment to Series E-1 convertible preferred stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(964</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,570</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.48</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.11</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.01</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,354,915</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,216,468</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,165,315</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other Financial and Operating Data:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjusted EBITDA<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(151,743</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(119,584</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,476</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup> Adjusted EBITDA is a non-GAAP financial measure that we define as net loss attributable to Adaptive Biotechnologies Corporation adjusted for interest and other income, net, income tax (expense) benefit, depreciation and amortization and share-based compensation expenses. Please refer to &#8220;Adjusted EBITDA&#8221; below for a reconciliation between Adjusted EBITDA and net loss attributable to Adaptive Biotechnologies Corporation, the most directly comparable GAAP financial measure, and a discussion about the limitations of Adjusted EBITDA.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Comparison of the Years Ended December 31, 2021 and 2020</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Revenue</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percent of Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,896</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,439</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,457</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,448</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,943</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,505</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,344</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,382</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,962</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $37.5 million increase in sequencing revenue was primarily attributable to a $24.3 million increase in revenue generated from biopharmaceutical and academic customers, inclusive of a $2.9 million increase due to changes in estimates of total samples to be provided under certain of our MRD development agreements. Additionally, there was a $13.2 million increase in revenue generated from clinical customers, inclusive of a $1.9 million increase related to Medicare reimbursements resulting from our determination that the likelihood of additional testing for specific patients was remote and a change in our estimate of expected cumulative tests per patient for one of our covered indications.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research sequencing volume increased by 42% to 32,146 sequences delivered in the year ended December 31, 2021 from 22,663 sequences delivered in the year ended December 3</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2020. Clinical sequencing volume, excluding T-Detect COVID volume, increased by 48% to 22,516 clinical tests delivered in the year ended December 3</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021 from 15,186 clinical tests delivered in the year ended December 31, 2020.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $18.5 million increase in development revenue was primarily attributable to a $9.2 million increase in revenue generated from the Genentech Agreement and an $8.4 million increase in revenue recognized from MRD development agreements, inclusive of a $7.5 million increase in revenue recognized upon the achievement of certain regulatory milestones by us and our customers' therapeutics. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percent of Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,301</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,530</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,771</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $26.8 million increase in cost of revenue was primarily attributable to a $13.5 million increase in labor, overhead and facility costs and a $9.7 million increase in materials costs resulting from increased revenue sample volume. Additionally, there was a $1.6 million increase in sample collection costs and a $1.5 million increase in shipping costs. These increases were partially offset by a $0.9 million decrease related to higher usage of our production laboratory to process research and development samples versus revenue samples.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percent of Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,343</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,072</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,271</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents disaggregated research and development expenses by cost classification for the periods presented: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.38%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development materials and allocated production laboratory expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,625</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,561</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,064</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Personnel expenses</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,874</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,969</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,905</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocable facilities and information technology expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,363</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,277</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,086</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software and cloud services expenses</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,344</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,521</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(177</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and other expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,137</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,744</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,393</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,343</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,072</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,271</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $26.3 million increase in research and development expenses was primarily attributable to a $17.9 million increase in personnel costs and a $6.4 million increase in depreciation and other expenses, which included a $2.3 million increase in consultant costs.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Sales and Marketing</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percent of Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,465</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,358</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,107</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $34.1 million increase in sales and marketing expenses was primarily attributable to $23.7 million in additional personnel costs, $6.0 million in additional marketing expenses, a $2.2 million increase in travel and customer event related expenses and a $1.2 million increase in consultant costs. Our clonoSEQ and T-Detect marketing efforts were the largest drivers of the $6.0 million increase in marketing expenses.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">General and Administrative</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percent of Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74,502</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,536</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,966</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $25.0 million increase in general and administrative expenses was primarily attributable to a $13.3 million increase in personnel costs, as well as a $7.8 million increase in building, facility and depreciation related expenses. Additionally, there was a $2.3 million increase in consultant costs and a $2.2 million increase in computer and software expenses, which were partially offset by a $2.1 million decrease in legal, accounting and tax fees.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Interest and Other Income, Net</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except percentages)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income, net</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,668</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,590</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,922</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75)%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The $4.9 million decrease in interest and other income, net was primarily attributable to a $4.8 million decrease in net interest income and investment amortization resulting from reductions in interest rates and related yields of a smaller portfolio.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Adjusted EBITDA</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjusted EBITDA is a non-GAAP financial measure that we define as net loss attributable to Adaptive Biotechnologies Corporation adjusted for interest and other income, net, income tax (expense) benefit, depreciation and amortization and share-based compensation expenses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management uses Adjusted EBITDA to evaluate the financial performance of our business and the effectiveness of our business strategies. We present Adjusted EBITDA because we believe it is frequently used by analysts, investors and other interested parties to evaluate companies in our industry and it facilitates comparisons on a consistent basis across reporting periods. Further, we believe it is helpful in highlighting trends in our operating results because it excludes items that are not indicative of our core operating performance.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjusted EBITDA has limitations as an analytical tool and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. We may in the future incur expenses similar to the adjustments in the presentation of Adjusted EBITDA. In particular, we expect to incur meaningful share-based compensation expense in the future. Other limitations include that Adjusted EBITDA does not reflect:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">all expenditures or future requirements for capital expenditures or contractual commitments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">changes in our working capital needs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">income tax (expense) benefit, which may be a necessary element of our costs and ability to operate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the costs of replacing the assets being depreciated and amortized, which will often have to be replaced in the future&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the non-cash component of employee compensation expense&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the impact of earnings or charges resulting from matters we consider not to be reflective, on a recurring basis, of our ongoing operations.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, Adjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a reconciliation of net loss</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> attributable to Adaptive Biotechnologies Corporation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to Adjusted EBITDA for the periods presented (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,668</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,590</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,785</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,953</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,472</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,791</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation expense <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,251</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,761</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,124</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjusted EBITDA</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(151,743</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(119,584</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,476</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup> Represents share-based compensation expense related to option and restricted stock unit awards. See Note 13 of the accompanying notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for details on our share-based compensation expense.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity and Capital Resources</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have incurred losses since inception and have incurred negative cash flows from operations since inception through December&#160;31, 2018, and again in the years ended December 31, 2020 and 2021. As of December 31, 2021, we had an accumulated deficit of $718.9 million.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have funded our operations to date principally from the sale of convertible preferred stock and common stock and, to a lesser extent, sequencing and development revenue. As of December 31, 2021, we had cash, cash equivalents and marketable securities of $570.2 million.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe our existing cash, cash equivalents and marketable securities will be sufficient to fund our operating expenses and capital expenditure requirements through at least the next 12&#160;months. We may consider raising additional capital to expand our business, to pursue strategic investments, to take advantage of financing opportunities or for other reasons. If our available cash, cash equivalents and marketable securities balances and anticipated cash flows from operations are insufficient to satisfy our liquidity requirements, we may seek to sell additional equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing. The sale of equity and convertible debt securities may result in dilution to our shareholders and, in the case of preferred equity securities or convertible debt, those securities could provide for rights, preferences or privileges senior to those of our common stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on our operations. This additional capital may not be available on reasonable terms, or at all. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to utilize the existing cash, cash equivalents and marketable securities on hand primarily to fund our commercial and marketing activities associated with our clinical products and services, continued research and development initiatives for our pipeline candidates and drug discovery initiatives and ongoing investments in our immune medicine platform. We also expect to make capital expenditures in the near term related to the expansion of our laboratory space and expect to continue investing in laboratory equipment and operations to support our anticipated growth. Cash in excess of immediate requirements is invested in accordance with our investment policy, primarily with a view to capital preservation and liquidity. Currently, our funds are held in money market funds and marketable securities consisting of U.S. government debt securities and corporate bonds.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our contractual obligations as of December 31, 2021 include operating lease obligations of $149.5 million, reflecting the minimum commitments for our office and laboratory spaces in Seattle, Washington and South San Francisco, California, our warehouse lease in Bothell, Washington and our office lease in New York City, New York, as well as a commitment for server space in Seattle, Washington. See Note 10 of the accompanying notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for more information, including the timing of cash payments related to these lease obligations. Additionally, we have minimum commitments for laboratory material suppliers, which are generally fulfilled within one year, software and service license commitments, which are generally fulfilled within one to three years, purchase commitments for cloud data storage through our collaboration with Microsoft and royalty commitments. Furthermore, in connection with one of our lease agreements, we have an existing letter of credit of $2.1 million with one of our existing financial institutions.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we may experience variability in revenue in the near term, as long-term revenue from sales of our current and future products and services is expected to grow, we expect our accounts receivable and inventory balances to increase. Any increase in accounts receivable and inventory may not be completely offset by increases in accounts payable and accrued expenses, which could result in greater working capital requirements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<hr style="page-break-after:always" />
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cash Flows</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our uses and sources of cash for the years ended December 31, 2021 and 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.36%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(192,727</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(149,683</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,210</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(117,044</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,146</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293,587</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Operating Activities</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash used in operating activities during the year ended December 31, 2021 was $192.7 million, which was primarily attributable to a net loss of $207.3 million and a net change in operating assets and liabilities of $56.8 million, partially offset by noncash share-based compensation of $43.3 million, noncash depreciation and amortization of $21.2 million and noncash lease expense of $7.0 million. The net change in operating assets and liabilities was primarily due to a $57.7 million reduction in deferred revenue primarily related to revenue recognized from the Genentech Agreement, a $7.4 million increase in accounts receivable, net and a $5.2 million increase in inventory, which were partially offset by an $8.5 million increase in operating lease liabilities, a $3.9 million increase in accounts payable and accrued liabilities primarily related to our corporate bonus to be paid in 2022, and a $1.3 million decrease in prepaid expenses and other assets.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash used in operating activities during the year ended December 31, 2020 was $149.7 million, which was primarily attributable to a net loss of $146.2 million and a net change in our operating assets and liabilities of $40.8 million, partially offset by noncash share-based compensation of $24.8 million, noncash depreciation and amortization of $9.2 million and noncash lease expense of $3.3 million. The net change in our operating assets and liabilities was primarily due to a $43.4 million reduction in deferred revenue primarily related to revenue recognized from the Genentech Agreement, a $5.0 million increase in inventory, a $1.4 million increase in prepaid expenses and other current assets and a $0.9 million decrease in operating lease liabilities. These changes were partially offset by an increase in accounts payable and accrued liabilities of $7.5 million and a reduction in accounts receivable, net of $2.6 million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Investing Activities</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided by investing activities during the year ended December 31, 2021 was $181.2 million, which was primarily attributable to proceeds from maturities of marketable securities of $559.5 million, partially offset by purchases of marketable securities of $316.5 million and purchases of property and equipment of $61.7 million.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash used in investing activities during the year ended December 31, 2020 was $117.0 million, which was primarily attributable to purchases of marketable securities of $695.0 million and purchases of property and equipment of $18.8 million, partially offset by proceeds from sales and maturities of marketable securities of $596.7 million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Financing Activities</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided by financing activities during the year ended December 31, 2021 was $27.1 million, which was primarily attributable to proceeds from the exercise of stock options.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided by financing activities during the year ended December 31, 2020 was $293.6 million, which was primarily attributable to $271.8 million in proceeds, after deducting underwriting discounts and net offering expenses paid by us, received from our underwritten public offering completed in July 2020, as well as $21.7 million in proceeds from the exercise of stock options.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Net Operating Loss Carryforwards</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of our NOL carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986 (&#8220;Section 382&#8221;) and similar state provisions. The annual limitation may result in the expiration of NOL carryforwards and credits before utilization. If there should be an ownership change, our ability to utilize our NOL carryforwards and credits could be limited. We have completed a Section 382 analysis for changes in ownership through December 31, 2020 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of our federal NOLs. Under the TCJA, federal NOLs incurred in 2018 and future years may be carried forward indefinitely, but the deductibility of such federal NOLs is subject to an annual limitation. NOLs generated prior to 2018 are eligible to be carried forward up to 20 years. Based on the available objective evidence, management determined that it was more likely than not that the net deferred tax assets would not be realizable as of December 31, 2021. Accordingly, management applied a full valuation allowance against net deferred tax assets as of December 31, 2021.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p>
<hr style="page-break-after:always" />

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Critical Accounting Policies and Estimates</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We have prepared our consolidated financial statements in accordance with GAAP. Our preparation of these consolidated financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities and related disclosures at the date of the consolidated financial statements, as well as revenue and expense recorded during the reporting periods. We evaluate our estimates and judgments on an ongoing basis. We base our estimates on historical experience and or other relevant assumptions that we believe to be reasonable under the</span><span style="font-size:12pt;"> </span>circumstances. Estimates are used in several areas, including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#8217;s estimates.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While our significant accounting policies are described in more detail in Note 2 of the accompanying notes to our consolidated financial statements included elsewhere in this <span style="Background-color:#FFFFFF;">Annual Report on Form 10-K</span>, we believe the following accounting policies are critical to the judgments and estimates used in the preparation of our consolidated financial statements.</p>
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our development and sequencing revenue arrangements may include upfront payments for the performance of services in the future, which have both fixed and variable consideration.&#160;Non-refundable&#160;upfront fees and funding for related development services are generally considered fixed consideration, while milestone payments are identified as variable consideration.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the appropriate amount of revenue to recognize as we fulfill our obligations under these agreements, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts&#59; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract&#59; (3)&#160;measure the transaction price, including the constraint on variable consideration&#59; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices&#59; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standard Codification (&#8220;ASC&#8221;) Topic 606,<span style="font-style:italic;">&#160;Revenue from Contracts with Customers</span>. Our performance obligations include sequencing services and services associated with regulatory submission and approval processes. Significant management judgment is applied to determine (1)&#160;the measurement of the transaction price, including the constraint on variable consideration, (2)&#160;the allocation of the transaction price to the performance obligations and (3)&#160;the appropriate input or output based method to recognize revenue and the extent of progress to date.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We include the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, we&#160;re-evaluate&#160;the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjust our estimate of the overall transaction price.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To determine the allocation of the transaction price to the performance obligations, we apply the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell the services and estimate the price that a customer in that market would be willing to pay for those services.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To select the measure of progress, we consider the expectations of the performance period which may be based on customer-dependent estimates of samples or internal estimates of the performance period based on both the customer and our expected development timeframes. For our collaboration with Genentech, we estimate the extent of progress using a proportional performance model that uses an input method based on costs incurred relative to the total estimated costs of research and development efforts to pursue both the Shared Products and Personalized Product pathways. These estimates are based on our internal estimates and development timeframes, which are subject to revision based on the potential outcomes for both product pathways, decisions made by Genentech, regulatory feedback or other factors not currently known. We regularly review our expectations of the extent of progress, including whether any variable consideration is no longer constrained, and, if any changes in estimates are made, we recognize revenue using the cumulative&#160;catch-up&#160;method.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p>
<hr style="page-break-after:always" />
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Goodwill</span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1 and upon any occurrence of triggering events or substantive changes in circumstances that could indicate a potential impairment.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. We evaluate certain qualitative factors such as macroeconomic conditions, the market and industry in which we operate, cost factors, overall financial performance and other relevant entity-specific events to determine if there are any negative trends or events that could indicate impairment. Key assumptions in this analysis include anticipated demand for our products and services, including industry and regulatory changes, future revenue growth and cash flow trends. These assumptions are determined based on our historical performance and management&#8217;s forecasted results. Management&#8217;s estimates of forecasted results are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have not recognized any impairment of goodwill.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU">Item 7A. Quantitative and Qualitative Disclosures About Market Risk </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Interest Rate Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to market risk for changes in interest rates related primarily to our cash and cash equivalents and marketable securities. As of December 31, 2021 and 2020, we had cash and cash equivalents of $139.1 million and $123.4 million, respectively, held primarily in cash deposits and money market funds. As of December 31, 2021, we had short-term and long-term marketable securities of $431.1&#160;million, held in U.S. government debt securities and corporate bonds. As of December 31, 2020, we had short-term and long-term marketable securities of $683.4 million, held in U.S. government debt securities and corporate bonds. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of interest rates in the United States. As of December 31, 2021, a hypothetical 100 basis point increase in interest rates would have resulted in a $4.0 million decline of the fair value of our available-for-sale securities, as compared to a $4.3 million decline as of December 31, 2020. This estimate is based on a sensitivity model that measures market value changes when changes in interest rates occur. Such losses would only be realized if we sold the investments prior to maturity. We do not enter into investments for trading purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_8_FINANCIAL_STATEMENTS_AND_SUPPLEME">Item 8. Financial Statements and Supplementary Data</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Adaptive Biotechnologies Corporation</span></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Index to Consolidated Financial Statements</span></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of December 31, 2021 and 2020 and </span></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the Years Ended December 31, 2021, 2020 and 2019</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><span style="text-decoration:underline;">Report of Independent Registered Public Accounting Firm</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (PCAOB ID: <ix:nonNumeric id="F_000034" name="dei:AuditorFirmId" contextRef="C_0001478320_20210101_20211231">42</ix:nonNumeric>)</span></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#BALANCE_SHEETS"><span style="text-decoration:underline;">Consolidated Balance Sheets</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_OPERATIONS"><span style="text-decoration:underline;">Consolidated Statements of Operations</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_COMPREHENSIVE_LOSS"><span style="text-decoration:underline;">Consolidated Statements of Comprehensive Loss</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_CONVERTIBLE_PREFERRED_STOCK_S"><span style="text-decoration:underline;">Consolidated Statements of Convertible Preferred Stock and Shareholders&#8217; (Deficit) Equity</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_CASH_FLOWS"><span style="text-decoration:underline;">Consolidated Statements of Cash Flows</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_FINANCIAL_STATEMENTS_DECEMBER_3"><span style="text-decoration:underline;">Notes to Consolidated Financial Statements</span></a></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">Report of Independent Registered Public Accounting Firm<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Shareholders and the Board of Directors of Adaptive Biotechnologies Corporation</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-weight:bold;font-family:Times New Roman;text-transform:none;font-variant: normal;">Opinion on the Financial Statements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying consolidated balance sheets of Adaptive Biotechnologies Corporation (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and shareholders&#8217; (deficit) equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 15, 2022 expressed an unqualified opinion thereon.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-weight:bold;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis for Opinion</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-weight:bold;font-family:Times New Roman;text-transform:none;font-variant: normal;">Critical Audit Matters<span style="Background-color:#F4F4F4;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:86.67%;">
<tr>
<td style="width:26.67%;"></td>
<td style="width:60%;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Genentech Agreement</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-style:italic;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Description of the Matter</p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As more fully described in Note 3 of the financial statements, Genentech Agreement revenue is estimated to be recognized over a period of seven to eight years from the effective date. The non-refundable upfront consideration of $300.0 million is recognized using a proportional performance model through an input method based on costs incurred relative to the total estimated costs of research and development efforts. For the year ended December 31, 2021, total revenue recognized was $62.0 million and the related deferred revenue at December 31, 2021 totaled $150.1 million.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditing management&#8217;s estimate of the total expected research and development costs at completion is complex and requires judgment as a result of the uncertainties of the ultimate progression of the customized product paths, timing and path of development and commercialization decisions, which are controlled by Genentech.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-style:italic;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">How We Addressed the Matter in Our Audit</p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s process to evaluate the progress of the collaboration and the likely path of future development based on significant decisions made by Genentech communicated through the joint committees and any resulting impacts on the total costs of research and development efforts for the collaboration.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To test the estimate of total expected research and development costs, we performed audit procedures that included, among others, observing the quarterly meetings with accounting and the Company collaboration managers discussing the status of the collaboration and the future development for the customized product paths, investigating any changes to the development path. We reviewed supporting documentation to corroborate progress and status of the overall timeline, including meeting minutes from the joint committees.&#160;&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ <ix:nonNumeric id="F_000035" name="dei:AuditorName" contextRef="C_0001478320_20210101_20211231">Ernst &#38; Young LLP</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 2015</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000036" name="dei:AuditorLocation" contextRef="C_0001478320_20210101_20211231">Seattle, Washington</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 15, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="BALANCE_SHEETS">Consolidated Balance<span style="letter-spacing:-0.05pt;"> </span>Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in<span style="letter-spacing:0.05pt;"> </span>thousands,<span style="letter-spacing:-0.05pt;"> </span>except<span style="letter-spacing:-0.05pt;"> </span>share<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>per share<span style="letter-spacing:-0.05pt;"> </span>amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000037" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">139,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000038" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">123,436</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities (amortized cost of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000102" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">214,115</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000103" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">564,036</ix:nonFraction>, respectively)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">213,996</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">564,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,409</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,047</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="us-gaap:InventoryNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,263</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="us-gaap:InventoryNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,063</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,015</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,535</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:AssetsCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">402,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:AssetsCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">726,914</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">85,262</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">87,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">99,350</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities (amortized cost of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000104" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">218,163</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000105" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,429</ix:nonFraction>, respectively)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">217,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,138</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,138</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:Goodwill" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,972</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:Goodwill" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,972</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" scale="3">875</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" scale="3">598</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:Assets" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">923,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:Assets" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,116,414</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and shareholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,307</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation and benefits</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,642</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,055</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,529</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">80,460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">73,319</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">113,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">105,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, less current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">106,685</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">104,333</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, less current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">163,618</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:Liabilities" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">319,242</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000082" name="us-gaap:Liabilities" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">373,148</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 11)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000083">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000084">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock: $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000106" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001478320_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000107" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001478320_20201231" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000108" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000109" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001478320_20201231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2021 and 2020&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000110" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001478320_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000111" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001478320_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000112" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001478320_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000113" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001478320_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2021 and 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000085">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000086">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock: $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000114" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001478320_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000115" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001478320_20201231" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000116" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000117" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001478320_20201231" decimals="INF" format="ixt:numdotdecimal">340,000,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2021 and 2020&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000118" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000120" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal">141,393,865</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_000119" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001478320_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000121" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001478320_20201231" decimals="INF" format="ixt:numdotdecimal">137,646,896</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2021 and 2020, respectively</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000087" name="us-gaap:CommonStockValue" contextRef="C_0001478320_20211231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000088" name="us-gaap:CommonStockValue" contextRef="C_0001478320_20201231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000089" name="us-gaap:AdditionalPaidInCapital" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,324,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000090" name="us-gaap:AdditionalPaidInCapital" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,253,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive (loss) gain</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001478320_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,137</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001478320_20201231" decimals="-3" scale="3">893</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001478320_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">718,891</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000094" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001478320_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">511,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Adaptive Biotechnologies Corporation shareholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000095" name="us-gaap:StockholdersEquity" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">603,992</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000096" name="us-gaap:StockholdersEquity" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">743,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncontrolling interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000097" name="us-gaap:MinorityInterest" contextRef="C_0001478320_20211231" decimals="-3" scale="3">110</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shareholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">604,102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">743,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and shareholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">923,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,116,414</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>accompanying notes<span style="letter-spacing:-0.05pt;"> </span>are<span style="letter-spacing:-0.05pt;"> </span>an<span style="letter-spacing:-0.05pt;"> </span>integral<span style="letter-spacing:-0.05pt;"> </span>part<span style="letter-spacing:-0.1pt;"> </span>of<span style="letter-spacing:-0.05pt;"> </span>these<span style="letter-spacing:-0.05pt;"> consolidated </span>financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_OPERATIONS">Consolidated Statements of Operations</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in<span style="letter-spacing:0.05pt;"> </span>thousands,<span style="letter-spacing:-0.05pt;"> </span>except<span style="letter-spacing:-0.05pt;"> </span>share<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>per share<span style="letter-spacing:-0.05pt;"> </span>amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000122" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">78,896</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000123" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,439</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,519</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,448</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,943</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,552</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">154,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000129" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,382</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000130" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">85,071</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000131" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,301</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000132" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,530</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,274</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">142,343</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">116,072</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">70,705</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:SellingAndMarketingExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">95,465</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:SellingAndMarketingExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,358</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:SellingAndMarketingExpense" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,453</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">74,502</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,536</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,332</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of intangible assets</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,703</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,698</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:CostsAndExpenses" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">363,310</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="us-gaap:CostsAndExpenses" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,199</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:CostsAndExpenses" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">163,462</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">208,966</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">152,817</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">78,391</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income, net</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:InterestAndOtherIncome" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,668</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="us-gaap:InterestAndOtherIncome" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,590</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:InterestAndOtherIncome" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,785</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,298</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Net loss attributable to noncontrolling interest</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000159" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,279</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment to Series E-1 convertible preferred stock options</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000162" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,279</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000165" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">69,570</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000166" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20210101_20211231" decimals="2" sign="-">1.48</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000167" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20200101_20201231" decimals="2" sign="-">1.11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000168" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20190101_20191231" decimals="2" sign="-">1.01</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000169" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20210101_20211231" decimals="0" format="ixt:numdotdecimal">140,354,915</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000170" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20200101_20201231" decimals="0" format="ixt:numdotdecimal">131,216,468</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000171" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20190101_20191231" decimals="0" format="ixt:numdotdecimal">69,165,315</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>accompanying<span style="letter-spacing:-0.05pt;"> </span>notes are an integral<span style="letter-spacing:-0.05pt;"> </span>part of these consolidated financial<span style="letter-spacing:-0.1pt;"> </span>statements.</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:1.5pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_COMPREHENSIVE_LOSS">Consolidated Statements of Comprehensive<span style="letter-spacing:-0.05pt;"> </span>Loss</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in<span style="letter-spacing:0.05pt;"> </span>thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000173" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000174" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive (loss) income:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in unrealized gains and losses on investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,030</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001478320_20200101_20201231" decimals="-3" scale="3">222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000177" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000178" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">209,328</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000179" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,005</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000180" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">67,828</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Comprehensive loss attributable to noncontrolling interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">209,309</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,005</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">67,828</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>accompanying<span style="letter-spacing:-0.05pt;"> </span>notes are an integral<span style="letter-spacing:-0.05pt;"> </span>part of these consolidated financial<span style="letter-spacing:-0.1pt;"> </span>statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_CONVERTIBLE_PREFERRED_STOCK_S">Consolidated Statements of Convertible Preferred Stock<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Shareholders&#8217;<span style="letter-spacing:-0.05pt;"> (</span>Deficit) Equity</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in<span style="letter-spacing:0.05pt;"> </span>thousands,<span style="letter-spacing:-0.05pt;"> </span>except<span style="letter-spacing:-0.05pt;"> </span>share<span style="letter-spacing:-0.05pt;"> </span>amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible Preferred Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-In</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Noncontrolling</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shareholders&#8217;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Deficit)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Loss) Gain</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000185" name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231" decimals="INF" format="ixt:numdotdecimal">92,790,094</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">560,858</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000187" name="us-gaap:SharesOutstanding" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="INF" format="ixt:numdotdecimal">12,841,536</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000188" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000190" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231" decimals="-3" sign="-" scale="3">107</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">295,908</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000192" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">258,112</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from initial public offering, net of underwriters' discounts and commissions</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000193" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">17,250,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">320,848</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">320,850</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial public offering costs</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,986</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000198" name="adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,986</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of convertible preferred stock to common stock</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000199" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="INF" sign="-" format="ixt:numdotdecimal">93,039,737</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">561,931</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000201" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">93,039,737</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">561,922</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000204" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">561,931</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of convertible preferred stock warrant to common stock warrant</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of common stock warrants</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000207" name="adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">54,792</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000209" name="adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash upon exercise of stock options</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000210" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">2,043,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,413</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000212" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,413</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000213" name="adpt:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">249,643</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="-3" scale="3">109</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of restricted stock units</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000215" name="adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">8,310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in redemption value for vested Series E-1 convertible preferred stock options</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="adpt:TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="-3" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock option and restricted stock unit share-based compensation</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,124</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,124</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" scale="3">778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:ProfitLoss" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000225" name="us-gaap:SharesOutstanding" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal">125,238,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000226" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000227" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">935,834</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" scale="3">671</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">365,478</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000230" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">571,039</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon public offering, after deducting underwriters' discounts and net offering costs paid by us</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000231" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">7,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000233" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">271,838</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000234" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">271,839</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to accumulated deficit for adoption of guidance on accounting for leases</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000235" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" scale="3">93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000236" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_20191231" decimals="-3" scale="3">93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash upon exercise of stock options</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000238" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">5,204,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000240" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000241" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,539</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of restricted stock units</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000242" name="adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">4,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock option and restricted stock unit share-based compensation</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,761</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000244" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,761</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" scale="3">222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000246" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_20200101_20201231" decimals="-3" scale="3">222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="us-gaap:ProfitLoss" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000249" name="us-gaap:SharesOutstanding" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">137,646,896</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000250" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000251" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,253,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000252" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231" decimals="-3" scale="3">893</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000253" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">511,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000254" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">743,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of common stock warrant</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000255" name="adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">54,162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for cash upon exercise of stock options</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000256" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">3,674,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000257" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,484</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,484</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of restricted stock units</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000259" name="adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">18,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock option and restricted stock unit share-based compensation</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000260" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000261" name="adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital contributions for Digital Biotechnologies, Inc.</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000262" name="adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">300</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000263" name="adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231" decimals="-3" scale="3">129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000264" name="adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">429</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-right:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.42%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000265" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,030</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000266" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,030</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000267" name="us-gaap:ProfitLoss" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,279</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="us-gaap:ProfitLoss" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231" decimals="-3" sign="-" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000269" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-right:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.42%; border-left:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000270" name="us-gaap:SharesOutstanding" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="INF" format="ixt:numdotdecimal">141,393,865</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000271" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,324,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,137</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">718,891</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000275" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20211231" decimals="-3" scale="3">110</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">604,102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>accompanying notes<span style="letter-spacing:-0.05pt;"> </span>are<span style="letter-spacing:-0.05pt;"> </span>an<span style="letter-spacing:-0.05pt;"> </span>integral<span style="letter-spacing:-0.05pt;"> </span>part<span style="letter-spacing:-0.1pt;"> </span>of<span style="letter-spacing:-0.05pt;"> </span>these<span style="letter-spacing:-0.05pt;"> consolidated </span>financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_CASH_FLOWS">Consolidated Statements of Cash<span style="letter-spacing:-0.05pt;"> </span>Flows</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in<span style="letter-spacing:0.05pt;"> </span>thousands)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000277" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000279" name="us-gaap:ProfitLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:Depreciation" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:Depreciation" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,769</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:Depreciation" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncash lease expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000283" name="adpt:NoncashLeaseExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,028</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="adpt:NoncashLeaseExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="us-gaap:ShareBasedCompensation" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="us-gaap:ShareBasedCompensation" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,761</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000287" name="us-gaap:ShareBasedCompensation" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,124</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets amortization</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000290" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,698</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">7,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">773</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment of convertible preferred stock warrant</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">78</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">71</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">359</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000298" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,362</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000299" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,613</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,817</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,994</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,231</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,362</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000306" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,576</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,940</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,149</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="adpt:IncreaseDecreaseInDeferredRent" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">78</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets and liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000311" name="adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" scale="3">886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,727</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000314" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">43,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000315" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">266,927</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000316" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000317" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="C_0001478320_20200101_20201231" decimals="-3" scale="3">276</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000318" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">597</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000319" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">192,727</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">149,683</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000321" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">205,404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,746</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,803</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">316,544</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">694,965</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">884,217</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sales and maturities of marketable securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">559,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">596,724</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">413,720</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">181,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">117,044</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">481,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from exercise of stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,717</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,055</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from public offering of common stock, net of underwriting discounts and commissions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">272,160</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">320,850</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of public offering costs, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001478320_20200101_20201231" decimals="-3" scale="3">321</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,986</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock upon the exercise of a common stock warrant</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000341" name="adpt:ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from initial capital contributions for Digital Biotechnologies, Inc.</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:ProceedsFromContributedCapital" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">429</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,146</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">293,587</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000346" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">319,916</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net increase in cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000347" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,629</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000348" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000349" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,623</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash at beginning of year</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000350" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">125,574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000351" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,714</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000352" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">55,091</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash at end of year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000353" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">141,203</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">125,574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001478320_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,714</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Noncash investing and financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of equipment included in accounts payable and accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000356" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">682</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000357" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000358" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">773</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncash additions to property through lease financing arrangements</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000359" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derecognition of lease financing arrangements upon adoption of guidance on accounting for leases</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000360" name="adpt:DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of convertible preferred stock to common stock upon closing of initial public offering</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000361" name="adpt:ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">561,931</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000362" name="adpt:ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>accompanying<span style="letter-spacing:-0.05pt;"> </span>notes are an integral<span style="letter-spacing:-0.05pt;"> </span>part of these consolidated financial<span style="letter-spacing:-0.1pt;"> </span>statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="NOTES_TO_FINANCIAL_STATEMENTS_DECEMBER_3">Notes<span style="letter-spacing:-0.05pt;"> </span>to Consolidated Financial Statements</p><ix:nonNumeric id="F_000363" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Organization<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Description of Business</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies Corporation (&#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is a commercial-stage company advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#8217;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient&#8217;s immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and services that we are tailoring to each individual patient. We have commercial products and services and a robust pipeline of clinical products and services that we are designing to diagnose, monitor and enable the treatment of diseases, such as cancer, autoimmune disorders and infectious diseases.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in the State of Washington on September&#160;8, 2009 under the name Adaptive TCR Corporation. On December&#160;21, 2011, we changed our name to Adaptive Biotechnologies Corporation. We are headquartered in Seattle, Washington.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Digital Biotechnologies, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, we formed a subsidiary, Spin Technologies, Inc., to facilitate the development of a potential new early-stage sequencing technology that is ancillary to our core business. In February 2022, the subsidiary&#8217;s name was changed to Digital Biotechnologies, Inc. We have a <ix:nonFraction unitRef="U_xbrlipure" id="F_000431" name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231" decimals="2" scale="-2">70</ix:nonFraction>% ownership interest in Digital Biotechnologies, Inc. All intercompany transactions and balances between us and Digital Biotechnologies, Inc. have been eliminated in consolidation. The remaining interest, held by certain of our related parties and related family trusts, was reported as noncontrolling interest in our consolidated financial statements.</p></ix:nonNumeric><ix:nonNumeric id="F_000364" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000364_dcnt_13b55f1f-d660-469e-b36e-cdc4e49cae9a">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">Significant</span><span style="letter-spacing:0.05pt;color:#000000;"> </span><span style="color:#000000;">Accounting</span><span style="letter-spacing:-0.05pt;color:#000000;"> </span><span style="color:#000000;">Policies</span></p></td></tr></table></div><ix:nonNumeric id="F_000380" name="adpt:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Basis<span style="letter-spacing:-0.05pt;"> </span>of Presentation and<span style="letter-spacing:-0.05pt;"> Principles of Consolidation</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of Adaptive Biotechnologies Corporation, its wholly-owned subsidiary and Digital Biotechnologies, Inc. Other shareholders&#8217; interests in Digital Biotechnologies, Inc. are shown in the consolidated financial statements as noncontrolling interest. All intercompany transactions and balances have been eliminated upon consolidation.</p></ix:nonNumeric><ix:nonNumeric id="F_000381" name="us-gaap:UseOfEstimates" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. Estimates are used in several areas including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, share-based compensation, including the fair value of stock, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#8217;s estimates.</p></ix:nonNumeric><ix:nonNumeric id="F_000382" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are stated at fair value. Cash equivalents include only securities having an original maturity of three months or less at the time of purchase. We limit our credit risk associated with cash and cash equivalents by placing our investments with banks that we believe are highly creditworthy and with highly rated money market funds. Cash and cash equivalents primarily consist of bank deposits and investments in money market funds.</p></ix:nonNumeric><ix:nonNumeric id="F_000383" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are required to maintain certain balances under lease arrangements for some of our property and facility leases. We had restricted cash of <span>$<ix:nonFraction unitRef="U_iso4217USD" id="F_000432" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_0001478320_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000433" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_0001478320_20201231" decimals="-5" scale="6">2.1</ix:nonFraction></ix:nonFraction></span> million as of December 31, 2021 and 2020.</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_13b55f1f-d660-469e-b36e-cdc4e49cae9a" continuedAt="F_000364_dcnt_df4f7a00-27b2-4329-8157-3b50c4f51341">
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Investments in Marketable Securities</p><ix:nonNumeric id="F_000384" name="us-gaap:MarketableSecuritiesPolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities are classified as&#160;available-for-sale, consist of U.S. government debt securities and corporate bonds and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of shareholders&#8217; equity in accumulated other comprehensive gain (loss) until realized. Realized gains and losses on the sale of these securities are recognized in net income or loss. The cost of marketable securities sold is based on the specific identification method.</p></ix:nonNumeric><ix:nonNumeric id="F_000385" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations<span style="letter-spacing:-0.05pt;"> </span>of Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to a concentration of risk from a limited number of suppliers, or in certain cases, single suppliers for some of our laboratory instruments and materials. This risk is managed by targeting a quantity of surplus stock. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and marketable securities are financial instruments that potentially subject us to concentrations of credit risk. We invest in money market funds, U.S. government debt securities, U.S. government agency securities, commercial paper and corporate bonds with high-quality accredited financial institutions. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant customers are those that represent more than 10% of our total revenue or accounts receivable, net balances for the periods and as of each date presented, respectively. Revenue from these customers reflects their purchase of our products and services and our collaboration efforts with Genentech.</p><ix:nonNumeric id="F_000405" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounts Receivable, Net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000434" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231" decimals="3" scale="-2">13.9</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000435" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="3" scale="-2">19.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000436" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231" decimals="3" scale="-2">11.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000437" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="3" scale="-2">12.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Genentech, Inc. and Roche Group</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000438" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231" decimals="3" scale="-2">41.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000439" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="3" scale="-2">55.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000440" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231" decimals="3" scale="-2">42.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* less than 10%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000386" name="us-gaap:ReceivablesPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000386_cnt_1">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accounts Receivable</p></ix:nonNumeric><ix:continuation id="F_000386_cnt_1">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable consists of amounts due from customers for services performed. We review our accounts receivable for credit impairment and regularly analyze the status of significant past due receivables to determine if any will potentially be uncollectible to estimate the amount of allowance necessary to reduce accounts receivable to its estimated net realizable value.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, we had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000441" name="us-gaap:UnbilledReceivablesCurrent" contextRef="C_0001478320_20211231" decimals="-5" scale="6">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000442" name="us-gaap:UnbilledReceivablesCurrent" contextRef="C_0001478320_20201231" decimals="-5" scale="6">0.9</ix:nonFraction> million of unbilled receivables as of December&#160;31, 2021 and 2020, respectively. These contract assets are amounts that will become due for which we have an unconditional right to consideration.</p></ix:continuation><ix:nonNumeric id="F_000388" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Inventory</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory consists of laboratory materials and supplies used in lab analysis. We capitalize inventory when purchased and record expense upon order fulfillment for servicing revenue or utilization in our research and development laboratories. Inventory is valued at the lower of cost or market on a&#160;first-in,&#160;first-out&#160;basis. We periodically perform obsolescence assessments and write off any inventory that is no longer usable.</p></ix:nonNumeric><ix:nonNumeric id="F_000389" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000389_dcnt_15d26a8d-4835-4e78-b22b-426ba9f9627c">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consists of computer equipment, computer software, laboratory equipment, leasehold improvements and furniture and office equipment. Property and equipment are recorded at cost and depreciation is recognized using the straight-line method based on estimated useful life. Maintenance and repairs are charged to expense as incurred and costs of improvements are capitalized.</p><ix:nonNumeric id="F_000406" name="adpt:ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Useful lives assigned to property and equipment are as follows:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;">
<tr>
<td style="width:223.55pt;"></td>
<td style="width:7.85pt;"></td>
<td style="width:223.5pt;"></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000443" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231" format="ixt-sec:durwordsen">3 years</ix:nonNumeric> to <ix:nonNumeric id="F_000444" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231" format="ixt-sec:durwordsen">7 years</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000445" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">Shorter of estimated useful life or remaining lease term</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000446" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231" format="ixt-sec:durwordsen">3 years</ix:nonNumeric> to <ix:nonNumeric id="F_000447" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231" format="ixt-sec:durwordsen">5 years</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000448" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231" format="ixt-sec:durwordsen">3 years</ix:nonNumeric> to <ix:nonNumeric id="F_000449" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231" format="ixt-sec:durwordsen">10 years</ix:nonNumeric></p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_df4f7a00-27b2-4329-8157-3b50c4f51341" continuedAt="F_000364_dcnt_7abded37-518c-46e7-98e8-b8697fd1bf61"><ix:continuation id="F_000389_dcnt_15d26a8d-4835-4e78-b22b-426ba9f9627c">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We review long-lived assets for impairment whenever events or circumstances indicate the carrying amount of an asset group may not be recoverable. Gains and losses from asset disposals and impairment losses are classified within our consolidated statements of operations in accordance with the use of the asset.</p></ix:continuation><ix:nonNumeric id="F_000390" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1, or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we so determine, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have <ix:nonFraction unitRef="U_iso4217USD" id="F_000450" name="us-gaap:GoodwillImpairmentLoss" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction>t recognized any impairment of goodwill.</p></ix:nonNumeric><ix:nonNumeric id="F_000391" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date, which is regarded as their cost.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets may also result from the purchase of assets and intellectual property in a transaction that does not qualify as a business combination. Intangible assets are amortized over their estimated useful lives on a straight-line basis which approximates their usage pattern. Intangible assets are reviewed for impairment at least annually or if indicators of potential impairment exist. We have <ix:nonFraction unitRef="U_iso4217USD" id="F_000451" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction>t recognized any impairment losses on intangible assets.</p></ix:nonNumeric><ix:nonNumeric id="F_000392" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Leases</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determine if an arrangement contains a lease at inception. We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy, as well as server space. Operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the date the underlying asset becomes available for our use and are based on the present value of the future minimum lease payments over the lease term. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. As our leases generally do not provide an implicit interest rate, the present value of our future minimum lease payments is determined using our incremental borrowing rate. This rate is an estimate of the collateralized borrowing rate we would incur on our future lease payments over a similar term and is based on the information available to us at the lease commencement date, or as of January 1, 2020 for commenced leases that existed as of our adoption of <span style="Background-color:#FFFFFF;">Accounting Standards Update No. 2016-02, </span><span style="font-style:italic;Background-color:#FFFFFF;">Leases</span><span style="Background-color:#FFFFFF;"> (Topic 842) (&#8220;ASC 842&#8221;)</span>. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of our leases contain options to extend or terminate the lease&#59; lease terms are adjusted for these options only when it is reasonably certain we will exercise these options. Our lease agreements do not contain residual value guarantees or covenants.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have made a policy election regarding our real estate leases not to separate nonlease components from lease components, to the extent they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease expense. Our leases for laboratory, office and warehouse facilities typically include variable nonlease components, such as common-area maintenance costs. We have also elected not to record on our consolidated balance sheets a lease that has a lease term of twelve months or less and does not contain a purchase option that we are reasonably certain to exercise.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expense is recognized on a straight-line basis over the terms of the leases. Incentives granted under our facilities leases, including rent holidays, are recognized as adjustments to lease expense on a straight-line basis over the terms of the leases.  </p></ix:nonNumeric><ix:nonNumeric id="F_000393" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000393_dcnt_6e0a4d84-2361-45ae-98cc-f3d152b66dcb">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Financial Accounting Standards Board (&#8220;FASB&#8221;) has defined fair value as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The FASB established a fair value hierarchy that requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. The hierarchy defines three levels of inputs that may be used to measure fair value:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level 1: Quoted </span><span style="Background-color:#FFFFFF;color:#000000;">prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;">Level 2: Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_7abded37-518c-46e7-98e8-b8697fd1bf61" continuedAt="F_000364_dcnt_5c55e3e8-756f-4fa5-ad86-00cc9c4ee9c2"><ix:continuation id="F_000393_dcnt_6e0a4d84-2361-45ae-98cc-f3d152b66dcb">
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A financial instrument categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain cases, where there is limited activity or less transparency around inputs to valuation, financial instruments are classified as Level&#160;3 within the valuation hierarchy. </span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our financial instruments consist of Level&#160;1 and Level&#160;2 assets and have included Level&#160;3 liabilities in the past. The carrying amounts of certain financial instruments approximate fair value due to their short&#160;maturities. We did not have any nonfinancial assets or liabilities that were measured or disclosed at fair value on a recurring basis as of December&#160;31, 2021 and 2020.</p></ix:continuation><ix:nonNumeric id="F_000394" name="adpt:StockholdersEquityConvertiblePreferredStockPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Convertible Preferred Stock Warrant</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We had issued a freestanding warrant to a venture capital firm to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000452" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231" decimals="INF" format="ixt:numdotdecimal">56,875</ix:nonFraction> shares of Series&#160;C convertible preferred stock with an exercise price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000453" name="adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231" decimals="2">2.64</ix:nonFraction> in connection with a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000454" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231" decimals="-5" scale="6">5.0</ix:nonFraction>&#160;million credit facility entered into in 2014. Immediately prior to and in connection with the completion of our initial public offering, the convertible preferred stock warrant converted to a common stock warrant. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the conversion, the fair value of this warrant was classified as a&#160;non-current&#160;liability in the balance sheets, since the underlying convertible preferred stock had been classified as temporary equity instead of shareholders&#8217; deficit in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities. Upon certain change in control events that were outside of our control, including liquidation, sale or transfer of control, holders of the convertible preferred stock may have caused its redemption. Prior to conversion, the warrant was subject to remeasurement at each balance sheet date, with changes in estimated fair value recognized as a component of interest and other income, net on our statements of operations. During the year ended December 31, 2019, we recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000455" name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20190101_20191231" decimals="-5" scale="6">2.3</ix:nonFraction> million of expense related to the revaluation of the convertible preferred stock warrant liability in the interest and other income, net line item on our consolidated statements of operations. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the convertible preferred stock warrant converted to a common stock warrant immediately prior to and in connection with the completion of the initial public offering, the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000456" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20211231" decimals="-5" scale="6">2.6</ix:nonFraction> million financial liability was reclassified to the additional paid-in capital line item on our balance sheet, thereby concluding the need for revaluation.</p></ix:nonNumeric><ix:nonNumeric id="F_000395" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000395_dcnt_d787d1ba-bce7-4955-a416-cea14e77a970">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Revenue<span style="letter-spacing:-0.1pt;"> </span>Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize revenue in accordance with ASC Topic 606 (&#8220;ASC 606&#8221;), <span style="font-style:italic;">Revenue from Contracts with Customers</span>. Under ASC 606, for all revenue-generating contracts, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts&#59; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract&#59; (3)&#160;measure the transaction price, including the constraint on variable consideration&#59; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices&#59; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation. The following is a summary of the application of the respective model to each of our revenue classifications. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue is generated from immunosequencing (&#8220;sequencing&#8221;) products and services (&#8220;sequencing revenue&#8221;) and from regulatory or development support services leveraging our immune medicine platform (&#8220;development revenue&#8221;). When revenue generating contracts have elements of both sequencing revenue and development revenue, we classify revenue based on the nature of the performance obligation and the allocated transaction price. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sequencing Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. In these transactions, we have identified one performance obligation, the delivery of a clonoSEQ report, and we bill and receive payments from medical institutions and commercial and government third-party payors. As payment from the respective payors may vary based on the various reimbursement rates and patient responsibilities, we consider the transaction price to be variable and record an estimate of the transaction price, subject to the constraint for variable consideration, as revenue at the time of delivery. The estimate of transaction price is based on historical and expected reimbursement rates with the various payors, which are monitored in subsequent periods and adjusted as necessary based on actual collection experience. </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_5c55e3e8-756f-4fa5-ad86-00cc9c4ee9c2" continuedAt="F_000364_dcnt_8e73809e-9938-497f-b98a-e8fd01e73a6b"><ix:continuation id="F_000395_dcnt_d787d1ba-bce7-4955-a416-cea14e77a970">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clonoSEQ coverag</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under Medicare, we bill </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#8217;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test.&#160;Revenue </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recognition commences </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the number of tests </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we expect to deliver</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over a patient&#8217;s treatment cycle based on historical testing frequencies for patients by indication. These estimates are subject to change as we develop more information about utilization over time.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any unrecognized revenue from the initial billable test is recorded as deferred revenue and is recognized</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> either</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as we deliver </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our estimate of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the remaining tests in a patient&#8217;s treatment cycle</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or when </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the likelihood</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> becomes remote that a patient will receive additional testing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For research customers, contracts typically include an amount billed in advance of services (&#8220;upfront&#8221;) and subsequent billings as sample results are delivered to the customer. Upfront amounts received are recorded as deferred revenue, which we recognize as revenue upon satisfaction of performance obligations. We have identified <ix:nonFraction unitRef="U_adptPerformance_Obligation" id="F_000457" name="adpt:NumberOfRevenuePerformanceObligation" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction> typical performance obligations under the terms of our research service contracts: sequencing services and related data analysis. We recognize revenue for both identified performance obligations as sample results are delivered to the customer. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Development<span style="letter-spacing:-0.05pt;"> </span>Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive revenue by providing services through development agreements to biopharmaceutical customers who seek access to our immune medicine platform technologies. We generate revenues from the delivery of professional support activities pertaining to the use of immunoSEQ and our MRD product in the development of the respective customers&#8217; initiatives. The transaction price for these contracts may consist of a combination of non-refundable upfront fees, separately priced sequencing fees, progress-based milestones and regulatory milestones. The development agreements include single or multiple performance obligations, depending on the contract. For certain contracts, we perform services to support the biopharmaceutical customers&#8217; regulatory submissions as part of their registrational trials. These services may include regulatory support pertaining to our technology intended to be utilized as part of the submission, development of analytical plans for our sequencing data, participation on joint research committees and assistance in completing a regulatory submission. Generally, these services are not distinct within the context of the contract and they are accounted for as a single performance obligation. If agreements include sequencing activities, we separately classify those activities as sequencing revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When sequencing services are separately priced customer options, we assess if a material right exists and, if not, the customer option to purchase additional sequencing services is not considered part of the contract. Except for any non-refundable upfront fees, the other forms of compensation represent variable consideration. Variable consideration related to progress-based and regulatory milestones is estimated using the most likely amount method, where variable consideration is constrained until it is probable that a significant reversal of cumulative revenue recognized will not occur. Progress milestones, such as the first sample result delivered or final patient enrollment in a customer trial, are customer dependent and are included in the transaction price when the respective milestone is probable of occurring. Milestone payments that are not within our customers&#8217; control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. Determining whether regulatory milestone payments are probable is an area that requires significant judgment. In making this assessment, we evaluate scientific, clinical, regulatory and other risks, as well as the level of effort and investment required to achieve the respective milestone. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The primary method used to estimate standalone selling price for performance obligations is the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell our services and estimate the price that a customer in that market would be willing to pay for our services. We recognize revenue using either an input or output measure of progress that faithfully depicts performance on a contract, depending on the contract. The measure used is dependent on the nature of the service to be provided in each contract. Selecting the measure of progress and estimating progress to date requires significant judgment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).</p></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_8e73809e-9938-497f-b98a-e8fd01e73a6b" continuedAt="F_000364_dcnt_b354c71c-ddec-417a-8e0b-e575bfeee98c"><ix:nonNumeric id="F_000396" name="adpt:ContractBalancesPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contract Balances</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain circumstances, billing may occur prior to services being performed. Upfront payments are recorded as deferred revenue, contract liabilities. We classify deferred revenue as current for sequencing revenue, as we expect our performance obligations will be completed within the next twelve months&#59; however, we do not control the timing of customer provided samples. For development services, we assess the performance obligations and recognize deferred revenue as current or&#160;non-current&#160;based upon forecasted delivery times, which are customer coordinated. In certain circumstances, the customer project may be cancelled or terminated prior to the delivery of all related services covered by a customer&#8217;s upfront payment. In these circumstances, we recognize revenue when sufficient evidence is obtained that a reversal of revenue is not probable.</p></ix:nonNumeric><ix:nonNumeric id="F_000397" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Share-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation includes compensation expense for stock option and restricted stock unit grants to employees and&#160;non-employees.&#160;It represents the grant date fair value of the grants and is recognized over the requisite service period of the awards, usually the vesting period, on a straight-line basis, net of actual forfeitures. We estimate the grant date fair value of stock option grants using the Black-Scholes option-pricing model. </p></ix:nonNumeric><ix:nonNumeric id="F_000398" name="us-gaap:AdvertisingCostsPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Advertising </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Advertising costs are expensed as incurred. Advertising expenses were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000458" name="us-gaap:AdvertisingExpense" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">22.4</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000459" name="us-gaap:AdvertisingExpense" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">14.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000460" name="us-gaap:AdvertisingExpense" contextRef="C_0001478320_20190101_20191231" decimals="-5" scale="6">6.6</ix:nonFraction> million for the year ended December 31, 2021, 2020 and 2019, respectively.</p></ix:nonNumeric><ix:nonNumeric id="F_000399" name="us-gaap:CostOfSalesPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition.</p></ix:nonNumeric><ix:nonNumeric id="F_000400" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. <span style="Background-color:#FFFFFF;color:#000000;">We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. </span>Research and development costs are expensed as incurred. Upfront payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized, then are recognized as an expense as the goods are consumed or the related services are performed. <span style="Background-color:#FFFFFF;color:#000000;">Costs to support our Genentech Agreement are also a component of our research and development expenses.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000401" name="adpt:SalesAndMarketingExpensePolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sales and Marketing Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs.</p></ix:nonNumeric><ix:nonNumeric id="F_000402" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000402_dcnt_c3fc818b-eb85-48d1-a39d-5af31ba3a554">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are accounted for under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and the operating loss and tax credit carryforwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets and liabilities are measured at the consolidated balance sheet date using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in the period such tax rate changes are enacted. Our net deferred tax assets are fully offset by a valuation allowance, because of our history of losses.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000364_dcnt_b354c71c-ddec-417a-8e0b-e575bfeee98c"><ix:continuation id="F_000402_dcnt_c3fc818b-eb85-48d1-a39d-5af31ba3a554">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the effect of income tax positions only if those positions are more likely than not of being sustained upon examination.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></ix:continuation><ix:nonNumeric id="F_000403" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We calculate basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders by dividing net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, common stock warrants, stock options and nonvested restricted stock units are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect is anti-dilutive.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the closing of our initial public offering in July 2019 and the related conversion of our convertible preferred stock into common stock, we calculated our basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders in conformity with the&#160;two-class&#160;method required for companies with participating securities. We considered our convertible preferred stock to be participating securities. In the event a dividend had been declared or paid on common stock, holders of convertible preferred stock would have been entitled to a share of such dividend in proportion to the holders of common stock on an&#160;as-if&#160;converted basis. Under the&#160;two-class&#160;method, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is calculated by dividing the net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. Net loss attributable to Adaptive Biotechnologies Corporation common shareholders is determined by allocating undistributed earnings between common and preferred shareholders. The net loss attributable to Adaptive Biotechnologies Corporation common shareholders was not allocated to the convertible preferred stock under the&#160;two-class&#160;method, as the convertible preferred stock did not have a contractual obligation to share in our losses. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders was computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, convertible preferred stock, convertible preferred stock warrants, common stock warrants and stock options were considered common stock equivalents but were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect was anti-dilutive.</p></ix:nonNumeric><ix:nonNumeric id="F_000404" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segment Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have determined that our chief executive officer is the chief operating decision maker (&#8220;CODM&#8221;). The CODM regularly reviews operating results and other financial information presented on a consolidated basis. While revenue is reviewed at levels lower than the consolidated entity, resource allocation decisions are made by the CODM based on the results presented at the consolidated entity level, which is determined to be a single reporting unit. There are no segment managers who are held accountable by the CODM for operations, operating results or planning at levels or components below the consolidated entity. As such, the consolidated entity operates as <ix:nonFraction unitRef="U_adptSegment" id="F_000461" name="us-gaap:NumberOfOperatingSegments" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> operating segment and represents <ix:nonFraction unitRef="U_adptSegment" id="F_000462" name="us-gaap:NumberOfReportableSegments" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> reportable segment. We present disaggregated revenue from contracts with customers by type of service. See Note 3,&#160;Revenue.</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000365" name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000365_dcnt_fae1d42e-bff8-4e01-bd41-9ce0a6752721">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Revenue</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We disaggregate our revenue from contracts with customers by type of service, as we believe this best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. <ix:nonNumeric id="F_000407" name="us-gaap:DisaggregationOfRevenueTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000407_cnt_1">The following table presents our revenue disaggregated by type of products and services for the periods presented (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000407_cnt_1" continuedAt="F_000407_dcnt_e4d6dd5c-67ca-4770-aca4-1d1e58bb8c4d">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000463" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">78,896</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000464" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,439</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000465" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,519</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development support</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000466" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">65,448</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000467" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,443</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000468" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory milestones</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000469" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000470" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000471" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total development revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000472" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,448</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000473" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,943</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000474" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000475" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">154,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000476" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000477" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">85,071</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;">&#160;</p></ix:continuation></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000365_dcnt_fae1d42e-bff8-4e01-bd41-9ce0a6752721" continuedAt="F_000365_dcnt_14ccaff5-900b-4b84-9489-971cb99ac8e0"><ix:continuation id="F_000407_dcnt_e4d6dd5c-67ca-4770-aca4-1d1e58bb8c4d">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">MRD Development<span style="letter-spacing:-0.05pt;"> </span>Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into agreements with biopharmaceutical customers to further develop and commercialize our MRD product and the biopharmaceutical customers&#8217; therapeutics. Under each of the agreements, we received or will receive non-refundable upfront payments and could receive substantial additional payments upon reaching certain progress-based milestones or achieving certain regulatory milestones pertaining to the customers&#8217; therapeutics and our MRD product.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the contracts, we identify performance obligations, which may include: (1)&#160;obligations to provide services supporting the customer&#8217;s regulatory submission activities as they relate to our MRD product&#59; and (2)&#160;sequencing services related to customer-provided samples for their regulatory submissions. The transaction price allocated to the respective performance obligations is estimated using an adjusted market assessment approach for the regulatory support services and a standalone selling price for the estimated immunosequencing services. At contract inception, we fully constrain any consideration related to regulatory milestones, as the achievement of such milestones is subject to third-party regulatory approval and the customers&#8217; own submission decision-making. We recognize revenue related to the sequencing services as sequencing revenue over time using an output method based on the proportion of sample results delivered relative to the total amount of sample results expected to be delivered, when expected to be a faithful depiction of progress. We use the same method to recognize the regulatory support services. When an output method based on the proportion of sample results delivered is not expected to be a faithful depiction of progress, we utilize an input method using a cost-based model based on estimates of effort completed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000478" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231" decimals="-5" scale="6">3.2</ix:nonFraction> million in revenue during the year ended December 31, 2021 due to changes in estimates of total samples to be provided under certain of our MRD development agreements for which we had previously received upfront consideration, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000479" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231" decimals="-5" scale="6">0.3</ix:nonFraction> million was recognized as development revenue in the respective period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We earned $<ix:nonFraction unitRef="U_iso4217USD" id="F_000480" name="adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231" decimals="-5" scale="6">10.0</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000481" name="adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231" decimals="-5" scale="6">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000482" name="adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231" decimals="-5" scale="6">2.0</ix:nonFraction> million during the year ended December 31, 2021, 2020 and 2019, respectively, upon the achievement of certain regulatory milestones by us and our respective customers&#8217; therapeutics. We recognized these earnings as development revenue within the respective periods, as we determined that the amounts were consistent with our estimated standalone selling prices and the respective performance obligations were complete.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In total, we recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000483" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231" decimals="-5" scale="6">11.8</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231" decimals="-5" scale="6">3.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000485" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231" decimals="-5" scale="6">3.7</ix:nonFraction> million in development revenue related to our MRD development agreements during the year ended December 31, 2021, 2020 and 2019, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, in future periods we could receive up to an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000486" name="adpt:AdditionalMilestonePayment" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20211231" decimals="INF" scale="6">333.5</ix:nonFraction> million in milestone payments if certain regulatory approvals are obtained by our customers&#8217; therapeutics in connection with MRD data generated from our MRD product.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Genentech<span style="letter-spacing:-0.05pt;"> </span>Collaboration Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2018, we entered into a worldwide collaboration and license agreement with Genentech (&#8220;Genentech Agreement&#8221;) to leverage our capability to develop cellular therapies in oncology. Subsequent to receipt of regulatory approval in January 2019, we received a non-refundable, upfront payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000487" name="adpt:NonRefundableUpfrontPaymentsReceived" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190201_20190228" decimals="-5" scale="6">300.0</ix:nonFraction> million in February 2019 and may be eligible to receive more than $<ix:nonFraction unitRef="U_iso4217USD" id="F_000488" name="adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231" decimals="INF" scale="6">1.8</ix:nonFraction> billion over time, including payments of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000489" name="adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptRegulatoryMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231" decimals="INF" scale="6">75.0</ix:nonFraction> million upon the achievement of specified regulatory milestones, up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000490" name="adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptDevelopmentMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231" decimals="INF" scale="6">300.0</ix:nonFraction> million upon the achievement of specified development milestones and up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000491" name="adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptCommercialMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231" decimals="INF" format="ixt:numdotdecimal" scale="6">1,430.0</ix:nonFraction> million upon the achievement of specified commercial milestones. In addition, we are separately able to receive tiered royalties at a rate ranging from the mid-single digits to the mid-teens on aggregate worldwide net sales of products arising from the strategic collaboration, subject to certain reductions, with aggregate minimum floors. Under the agreement, we are pursuing two product development pathways for novel T cell immunotherapies in which Genentech intends to use TCRs screened by our immune medicine platform to engineer and manufacture cellular medicines: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">Shared Products. The shared products will use &#8220;off-the-shelf&#8221; TCRs identified against cancer antigens shared among patients (&#8220;Shared Products&#8221;). </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">Personalized Product. The personalized product will use patient-specific TCRs identified by real-time screening of TCRs against cancer antigens in each patient (&#8220;Personalized Product&#8221;). </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, we granted Genentech exclusive worldwide licenses to develop and commercialize TCR-based cellular therapies in the field of oncology, including licenses to existing shared antigen data packages. Additionally, Genentech has the right to determine which product candidates to further develop for commercialization purposes. We determined that this arrangement meets the criteria set forth in ASC Topic 808, <span style="font-style:italic;">Collaborative Arrangements</span> (&#8220;ASC 808&#8221;), because both parties are active participants in the activity and are exposed to significant risks and rewards depending on the activity&#8217;s commercial failure or success. Because ASC 808 does not provide guidance on how to account for the activities under a collaborative arrangement, we applied the guidance in ASC 606 to account for the activities related to the Genentech Agreement.<span style="color:#000000;"> </span></p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000365_dcnt_14ccaff5-900b-4b84-9489-971cb99ac8e0">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In applying ASC&#160;606, we identified the following performance obligations at the inception of the agreement: </span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">License to utilize on an exclusive basis all TCR-specific platform intellectual property to develop and commercialize any licensed products in the field of oncology. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">License to utilize all data and information within each shared antigen data package and any other know-how disclosed by us to Genentech in oncology. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">License to utilize all private antigen TCR product data in connection with research and development activities in the field of use. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">License to existing shared antigen data packages. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Research and development services for shared product development, including expansion of shared antigen data packages. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">6.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Research and development services for private product development. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.87%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">7.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Obligations to participate on various joint research, development and project committees. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined that none of the licenses, research and development services or obligations to participate on various committees were distinct within the context of the contract, given such rights and activities were highly interrelated and there was substantial additional research and development to further develop the licenses. We considered factors such as the stage of development of the respective existing antigen data packages, the subsequent development that would be required to both identify and submit a potential target for investigational new drug acceptance under both product pathways and the variability in research and development pathways given Genentech&#8217;s control of product commercialization. Specifically, under the agreement, Genentech is not required to pursue development or commercialization activities pertaining to both product pathways and may choose to proceed with one or the other, as opposed to both. Accordingly, we determined that all of the identified performance obligations were attributable to one general performance obligation, which is to further the development of our TCR-specific platform, including data packages, and continue to make our TCR identification process available to Genentech to pursue either product pathway.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Separately, we have a responsibility to Genentech to enter into a supply and manufacturing agreement for patient-specific TCRs as it pertains to any Personalized Product therapeutic. We determined this was an option right of Genentech should they pursue commercialization of a Personalized Product therapy. Because of the uncertainty resulting from the early stage of development, the novel approach of our collaboration with Genentech and our rights to future commercial milestones and royalty payments, we determined that this option right was not a material right that should be accounted for at inception. As such, we will account for the supply and manufacturing agreement when entered into between the parties. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined the initial transaction price shall be made up of only the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000492" name="adpt:NonRefundableUpfrontPaymentsReceived" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231" decimals="-5" scale="6">300.0</ix:nonFraction> million upfront, non-refundable payment, as all potential regulatory and development milestone payments were probable of significant revenue reversal given their achievement was highly dependent on factors outside our control. As a result, these payments were fully constrained and were not included in the transaction price as of December 31, 2021. We excluded the commercial milestones and potential royalties from the transaction price, as those items relate predominantly to the license rights granted to Genentech and will be assessed when and if such events occur. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As there are potential substantive developments necessary, which Genentech may be able to direct, we determined that we would apply a proportional performance model to recognize revenue for our performance obligation. We measure proportional performance using an input method based on costs incurred relative to the total estimated costs of research and development efforts to pursue both the Shared Products and Personalized Product pathways. When any of the potential regulatory and development milestones are no longer fully constrained and included in the transaction price, such amounts will be recognized using the cumulative catch-up method based on proportional performance at such time. We currently expect to recognize the revenue over a period of approximately <ix:nonNumeric id="F_000493" name="adpt:RevenueRecognitionExpectedPeriod" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231" format="ixt-sec:durwordsen" continuedAt="C_204cb18d-7556-4dc4-9c1c-23a4e7d95f9f">seven</ix:nonNumeric> to <ix:nonNumeric id="F_000494" name="adpt:RevenueRecognitionExpectedPeriod" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231" format="ixt-sec:durwordsen">eight<ix:continuation id="C_204cb18d-7556-4dc4-9c1c-23a4e7d95f9f"> years</ix:continuation></ix:nonNumeric> from the effective date. This estimate of the research and development period considers pursuit options of development activities supporting both the Shared Products and the Personalized Product, but may be reduced or increased based on the various activities as directed by the joint committees, decisions made by Genentech, regulatory feedback or other factors not currently known. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized revenue of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000495" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231" decimals="-5" scale="6">62.0</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000496" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20200101_20201231" decimals="-5" scale="6">52.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000497" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190101_20191231" decimals="-5" scale="6">35.1</ix:nonFraction> million during the year ended December 31, 2021, 2020 and 2019, respectively, related to the Genentech Agreement. Costs related to the Genentech Agreement are included in research and development expenses.</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000366" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Fair Value<span style="letter-spacing:-0.05pt;"> </span>Measurements</p></td></tr></table></div><ix:nonNumeric id="F_000408" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables set forth the fair value of financial assets as of December 31, 2021 and 2020 that were measured at fair value on a recurring basis (in thousands): </p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000498" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">131,946</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000499" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">131,946</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000500" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">391,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000501" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">391,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000502" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,996</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000503" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,996</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000504" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">131,946</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000505" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">431,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000506" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">563,087</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000507" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">103,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000508" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">103,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000509" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">671,777</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000510" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">671,777</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000511" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,581</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000512" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,581</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000513" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">103,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000514" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">683,358</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000515" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">786,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1 securities include highly liquid money market funds, for which we measure the fair value based on quoted prices in active markets for identical assets or liabilities. Level&#160;2 securities consist of U.S. government debt securities and corporate bonds, and are valued based on recent trades of securities in inactive markets or on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data.</p></ix:nonNumeric><ix:nonNumeric id="F_000367" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000367_dcnt_c6d64e26-086c-4a7e-b6b0-ee4510a12763">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Investments</p></td></tr></table></div><ix:nonNumeric id="F_000409" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available-for-sale investments consisted of the following as of December 31, 2021 and 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000516" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">186,752</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000522" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000524" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" scale="3">109</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000530" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">186,647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000517" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,363</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000525" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000531" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000518" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">214,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000523" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000526" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231" decimals="-3" scale="3">123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000532" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">213,996</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000519" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">205,472</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000527" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" scale="3">974</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000533" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">204,498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000520" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,691</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000528" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" scale="3">44</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000534" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000521" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">218,163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000529" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,018</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000535" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">217,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000536" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">552,539</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000541" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" scale="3">723</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000546" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000551" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">553,252</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000537" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000542" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231" decimals="-3" scale="3">86</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000547" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000552" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,581</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000538" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">564,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231" decimals="-3" scale="3">809</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000548" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231" decimals="-3" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000553" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">564,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000539" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,429</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000544" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" scale="3">98</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000549" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000554" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000540" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,429</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000545" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231" decimals="-3" scale="3">98</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000555" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All the U.S. government debt securities and corporate bonds designated as short-term marketable securities have an effective maturity date that is equal to or less than one year from the respective consolidated balance sheet date. Those that are designated as long-term marketable securities have an effective maturity date that is more than one year from the respective consolidated balance sheet date.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000367_dcnt_c6d64e26-086c-4a7e-b6b0-ee4510a12763">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest receivable is excluded from the amortized cost and estimated fair value of our marketable securities. Accrued interest receivable of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000556" name="us-gaap:InterestReceivableCurrent" contextRef="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231" decimals="-5" scale="6">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000557" name="us-gaap:InterestReceivableCurrent" contextRef="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231" decimals="-5" scale="6">2.5</ix:nonFraction> million were presented separately within the prepaid expenses and other current assets line item on our consolidated balance sheet as of December 31, 2021 and 2020, respectively.</p><ix:nonNumeric id="F_000410" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the gross unrealized holding losses and fair value for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of December&#160;31, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less Than 12 Months</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12 Months Or Greater</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000558" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">345,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000561" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,083</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000559" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000562" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231" decimals="-3" scale="3">58</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000560" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">377,900</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000563" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically review our available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security ratings or sector credit ratings and other relevant market data.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we did not intend, nor were we more likely than not to be required, to sell our available-for-sale investments before the recovery of their amortized cost basis, which may be maturity. Based on our assessment, we concluded all impairment as of December 31, 2021 to be due to factors other than credit loss, such as changes in interest rates. A credit allowance was not recognized and the impairment of our available-for-sale securities was recorded in other comprehensive loss.</p></ix:continuation><ix:nonNumeric id="F_000368" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Property and Equipment, Net</p></td></tr></table></div><ix:nonNumeric id="F_000411" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000564" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000565" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000566" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,988</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000567" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000568" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,579</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000569" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,717</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000570" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20211231" decimals="-3" scale="3">992</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000571" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20201231" decimals="-3" scale="3">860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000572" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,658</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000573" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,185</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000574" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">65,959</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000575" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,945</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, at cost</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000576" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">121,488</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000577" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">64,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000578" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000579" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000580" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">85,262</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000581" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000582" name="us-gaap:Depreciation" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">12.3</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000583" name="us-gaap:Depreciation" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">6.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000584" name="us-gaap:Depreciation" contextRef="C_0001478320_20190101_20191231" decimals="-5" scale="6">6.1</ix:nonFraction> million for the year ended December&#160;31, 2021, 2020 and 2019, respectively.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000369" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Goodwill<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Intangible Assets</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been <ix:nonFraction unitRef="U_iso4217USD" id="F_000585" name="us-gaap:Goodwill" contextRef="C_0001478320_20151231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> changes in the carrying amount of goodwill since its recognition in 2015. </p><ix:nonNumeric id="F_000412" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization as of December 31, 2021 and 2020 consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,638</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,362</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231" decimals="-3" scale="3">325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231" decimals="-3" scale="3">161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231" decimals="-3" scale="3">164</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,799</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,972</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,028</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231" decimals="-3" scale="3">325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231" decimals="-3" scale="3">128</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231" decimals="-3" scale="3">197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,100</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The developed technology was acquired in connection with our acquisition of Sequenta in 2015. The remaining balance of the acquired technology and the purchased intellectual property is expected to be amortized over the next <ix:nonNumeric id="F_000586" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20210101_20211231" format="ixt-sec:duryear">5.0</ix:nonNumeric> years. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000413" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, expected future amortization expense for intangible assets was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000605" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000608" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000609" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000610" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="C_0001478320_20211231" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000611" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000370" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8. </span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Accrued Liabilities</p></td></tr></table></div><ix:nonNumeric id="F_000414" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000612" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000613" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,219</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical and contract research organization costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000614" name="adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,646</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000615" name="adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,781</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Travel and entertainment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000616" name="us-gaap:AccruedEmployeeBenefitsCurrent" contextRef="C_0001478320_20211231" decimals="-3" scale="3">184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000617" name="us-gaap:AccruedEmployeeBenefitsCurrent" contextRef="C_0001478320_20201231" decimals="-3" scale="3">91</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000618" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_0001478320_20211231" decimals="-3" scale="3">391</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000619" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000620" name="adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent" contextRef="C_0001478320_20211231" decimals="-3" scale="3">615</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000621" name="adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,423</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000622" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000623" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000624" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000625" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accrued tax liabilities balance as of December 31, 2020 includes a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000626" name="adpt:AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" contextRef="C_0001478320_20201231" decimals="-5" scale="6">1.4</ix:nonFraction> million tax withholding liability related to unsettled option exercises as of December 31, 2020.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000371" name="adpt:DeferredRevenueTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000371_dcnt_f5a2cacf-fca3-4d68-b09e-bd6f241aebf1">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Deferred Revenue</p></td></tr></table></div><ix:nonNumeric id="F_000415" name="adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue by revenue classification as of December 31, 2021 and 2020 was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current deferred revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000627" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,915</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000628" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000629" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">58,545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000630" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">57,856</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000631" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">80,460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000632" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">73,319</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-current deferred revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000633" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231" decimals="-3" scale="3">174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000634" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231" decimals="-3" scale="3">724</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000635" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,576</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000636" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">162,894</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total non-current deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000637" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000638" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">163,618</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current and non-current deferred revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000639" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">179,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000640" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">236,937</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue from our Genentech Agreement represents $<ix:nonFraction unitRef="U_iso4217USD" id="F_000641" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231" decimals="-5" scale="6">56.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000643" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231" decimals="-5" scale="6">94.0</ix:nonFraction> million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2021 and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000642" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231" decimals="-5" scale="6">55.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000644" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231" decimals="-5" scale="6">157.0</ix:nonFraction> million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2020. In general, we expect that the current <span style="Background-color:#FFFFFF;">amounts</span> will be recognized as revenue within <ix:nonNumeric id="F_000645" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231" format="ixt-sec:durmonth">12</ix:nonNumeric> months and the non-current amounts will be recognized as revenue over a period of approximately <ix:nonNumeric id="F_000646" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMinimumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231" format="ixt-sec:durwordsen" continuedAt="C_791ea4cb-8be0-4d18-bff1-0ec3bd3331ff">five</ix:nonNumeric> to <ix:nonNumeric id="F_000647" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMaximumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231" format="ixt-sec:durwordsen">six<ix:continuation id="C_791ea4cb-8be0-4d18-bff1-0ec3bd3331ff"> years</ix:continuation></ix:nonNumeric> from December 31, 2021. This period of time represents an estimate of the research and development period to develop cellular therapies in oncology, which may be reduced or increased based on the various development activities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the year ended December 31, 2021, we recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000648" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231" decimals="-5" scale="6">3.6</ix:nonFraction> million in revenue as a result of changes in estimates of total samples to be provided under certain of our agreements and cancelled biopharmaceutical customer sequencing contracts for which we had received upfront consideration. Additionally, we recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000649" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_srtMajorCustomersAxis_adptSpecificPatientsMember_srtProductOrServiceAxis_adptMedicareRevenueMember_20210101_20211231" decimals="-5" scale="6">2.5</ix:nonFraction> million of sequencing revenue during the year ended December 31, 2021 related to Medicare reimbursements resulting from our determination that the likelihood of additional testing for specific patients was remote and a change in our estimate of expected cumulative tests per patient for one of our covered indications.</span></p><ix:nonNumeric id="F_000416" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in deferred revenue during the year ended December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000650" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">236,937</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions to deferred revenue during the period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000651" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue recognized during the period</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000652" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">95,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000653" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">179,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000371_dcnt_f5a2cacf-fca3-4d68-b09e-bd6f241aebf1">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000654" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001478320_20211230_20211231" decimals="-5" scale="6">75.7</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million was recognized</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as revenue</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that was included in the deferred revenue balance </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></ix:continuation><ix:nonNumeric id="F_000372" name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000372_dcnt_818c9545-693a-4d52-a655-9e049bf03c80">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Leases</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy in various locations, as well as server space. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In July 2011, we entered into a non-cancelable lease agreement with an, at the time, minority shareholder for office and laboratory space in Seattle, Washington. The lease terms were subsequently amended multiple times, most recently in August 2019, when we expanded the existing premises to approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000655" name="us-gaap:AreaOfLand" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190831" decimals="0" format="ixt:numdotdecimal">65,500</ix:nonFraction> square feet. </span><span style="Background-color:#FFFFFF;"><ix:nonNumeric id="F_000656" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831">Cash payment for rent of the expanded premises commenced <ix:nonNumeric id="F_000657" name="adpt:LesseeOperatingLeaseRentCommencementMonthAndYear" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831" format="ixt:datemonthyearen">January 2020</ix:nonNumeric>, four months after the landlord delivered the expanded premises to us for construction of certain tenant improvements, and the lease term for both the existing premises and the expanded premises ends October 2032, subject to our option to twice extend the lease for <ix:nonNumeric id="F_000659" name="adpt:LesseeOperatingLeaseExtendedTermOfContract" contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</ix:nonNumeric></span> <span style="Background-color:#FFFFFF;">The amended lease also requires us to pay additional amounts for operating and maintenance expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In August 2019, we entered into an agreement to rent approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000661" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20190831" decimals="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> square feet in what was a to-be-constructed, new headquarters building in Seattle, Washington. In connection with the lease, we entered into a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000662" name="us-gaap:LettersOfCreditOutstandingAmount" contextRef="C_0001478320_20190831" decimals="-5" scale="6">2.1</ix:nonFraction> million letter of credit with one of our existing financial institutions. Due to our </span>significant<span style="Background-color:#FFFFFF;"> involvement during the construction process of the leased building, we qualified as the deemed owner of the building under build-to-suit lease accounting guidance that proceeded ASC 842. The resulting asset and long-term financing obligation recorded on our balance sheet as of December 31, 2019 for the cost of the building was derecognized effective January 1, 2020 upon adoption of ASC 842. The lease commenced in <ix:nonNumeric id="F_000663" name="adpt:LeaseCommencementMonthAndYear" contextRef="C_0001478320_20190801_20190831" format="ixt:datemonthyearen">December 2020</ix:nonNumeric>, when the landlord delivered the premises to us for construction of certain tenant improvements. We occupied the new building in 2021, <ix:nonNumeric id="F_000664" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001478320_20190801_20190831">cash payment for rent began in <ix:nonNumeric id="F_000665" name="adpt:LesseeOperatingLeaseRentCommencementMonthAndYear" contextRef="C_0001478320_20190801_20190831" format="ixt:datemonthyearen">October 2021</ix:nonNumeric> and the lease term ends in <ix:nonNumeric id="F_000666" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_20190801_20190831" format="ixt:datemonthyearen">August 2033</ix:nonNumeric>, </ix:nonNumeric></span><span style="Background-color:#FFFFFF;color:#000000;">subject to our option to twice extend the lease for&#160;<ix:nonNumeric id="F_000668" name="adpt:LesseeOperatingLeaseExtendedTermOfContract" contextRef="C_0001478320_20190801_20190831" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.&#160;In connection with this lease, the landlord agreed to fund $<ix:nonFraction unitRef="U_iso4217USD" id="F_000669" name="us-gaap:LeaseholdImprovementsGross" contextRef="C_0001478320_20190831" decimals="-5" scale="6">20.0</ix:nonFraction>&#160;million in improvements, which was subsequently reduced to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000670" name="us-gaap:LeaseholdImprovementsGross" contextRef="C_0001478320_20211231" decimals="-5" scale="6">14.8</ix:nonFraction> million as a result of our change requests made during landlord construction of the building, net of an administration fee. As of December 31, 2021, we have incurred $<ix:nonFraction unitRef="U_iso4217USD" id="F_000674" name="adpt:TenantImprovementCostsIncurred" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">14.9</ix:nonFraction> million in certain tenant improvement costs, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000672" name="adpt:ProceedsFromLandlordReimbursements" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">10.9</ix:nonFraction> million has been reimbursed by the landlord. The remaining $<ix:nonFraction unitRef="U_iso4217USD" id="F_000676" name="adpt:TenantImprovementCostsReceivable" contextRef="C_0001478320_20211231" decimals="-5" scale="6">4.0</ix:nonFraction> million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2021 and will be reimbursed by the landlord. As of December 31, 2020, w</span><span style="Background-color:#FFFFFF;">e incurred $<ix:nonFraction unitRef="U_iso4217USD" id="F_000673" name="adpt:TenantImprovementCostsIncurred" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">5.2</ix:nonFraction> million in certain tenant improvement costs, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000671" name="adpt:ProceedsFromLandlordReimbursements" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">0.7</ix:nonFraction> million had been reimbursed by the landlord. The remaining $<ix:nonFraction unitRef="U_iso4217USD" id="F_000675" name="adpt:TenantImprovementCostsReceivable" contextRef="C_0001478320_20201231" decimals="-5" scale="6">4.5</ix:nonFraction> million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2020. </span><span style="Background-color:#FFFFFF;color:#000000;">The lease also requires us to pay additional amounts for operating and maintenance expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In October 2019, we entered into an agreement to lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000677" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20191031" decimals="0" format="ixt:numdotdecimal">14,750</ix:nonFraction> square feet in a separate Seattle, Washington location, pursuant to a lease expiring in October 2029, which is subject to our ability to exercise an early termination right after the third year. In connection with the lease, the landlord agreed to provide a tenant improvement allowance in the maximum amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000679" name="us-gaap:TenantImprovements" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20191031" decimals="INF" scale="6">0.7</ix:nonFraction> million. The lease also requires us to pay additional amounts for operating expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In April 2018, we entered into a lease agreement to lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000680" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20180430" decimals="0" format="ixt:numdotdecimal">13,400</ix:nonFraction> square feet in South San Francisco, California. <ix:nonNumeric id="F_000685" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001478320_20180401_20180430">The lease term is through <ix:nonNumeric id="F_000682" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_20180401_20180430" format="ixt:datemonthyearen">March 2026</ix:nonNumeric> and provides for one <span style="-sec-ix-hidden:F_000687">five-year</span> extension option.</ix:nonNumeric> We are responsible for our share of allocable operating expenses, tax expenses and utilities cost during the duration of the lease term. In connection with the lease, the landlord funded agreed-upon improvements. The landlord was solely responsible for the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000688" name="us-gaap:TenantImprovements" contextRef="C_0001478320_20180430" decimals="-5" scale="6">2.4</ix:nonFraction> million cost of such improvements. The lease agreement was amended in February 2020 to lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000689" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20200229" decimals="0" format="ixt:numdotdecimal">19,900</ix:nonFraction> additional square feet and provides for a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000690" name="adpt:TenantImprovementAllowanceAndCommenced" contextRef="C_0001478320_20200201_20200229" decimals="-5" scale="6">0.6</ix:nonFraction> million tenant improvement allowance.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In December 2019, we entered into an agreement to lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000691" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20191231" decimals="0" format="ixt:numdotdecimal">3,100</ix:nonFraction> square feet of office space in New York City, New York, pursuant to a lease that expires <ix:nonNumeric id="F_000692" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_20191201_20191231" format="ixt:datemonthyearen">November 2025</ix:nonNumeric>, subject to our ability to exercise an early termination right in 2023. The lease requires us to pay certain operating expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In March 2021, we executed a lease to rent approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000681" name="us-gaap:AreaOfLand" contextRef="C_0001478320_20210331" decimals="0" format="ixt:numdotdecimal">27,000</ix:nonFraction> square feet of a warehouse in Bothell, Washington, which we classified as an operating lease upon commencement during the year ended December 31, 2021. Rent obligations commenced in <ix:nonNumeric id="F_000684" name="adpt:LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" contextRef="C_0001478320_20210101_20211231" format="ixt:datemonthyearen">October 2021</ix:nonNumeric> and the lease expires <ix:nonNumeric id="F_000683" name="adpt:LeaseExpirationMonthAndYear" contextRef="C_0001478320_20210101_20211231" format="ixt:datemonthyearen">October 2031</ix:nonNumeric>, <ix:nonNumeric id="F_000701" name="adpt:LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" contextRef="C_0001478320_20210101_20211231">subject to an early termination option after the seventh year</ix:nonNumeric> and an <ix:nonNumeric id="F_000702" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" contextRef="C_0001478320_20210101_20211231">option to twice extend the lease for <ix:nonNumeric id="F_000704" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" contextRef="C_0001478320_20211231" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:nonNumeric>. The lease requires us to pay certain operating expenses. Furthermore, the landlord agreed to fund $<ix:nonFraction unitRef="U_iso4217USD" id="F_000703" name="adpt:LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" contextRef="C_0001478320_20211231" decimals="-5" scale="6">1.2</ix:nonFraction> million in improvements in connection with this lease.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021, we were not party to any finance leases. Our leases have remaining terms of <ix:nonNumeric id="F_000693" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20211231" format="ixt-sec:duryear">0.3</ix:nonNumeric> years to <ix:nonNumeric id="F_000694" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20211231" format="ixt-sec:duryear">11.7</ix:nonNumeric> years and include <ix:nonNumeric id="F_000695" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001478320_20210101_20211231">options to extend certain of the leases up to <ix:nonNumeric id="F_000697" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001478320_20211231" format="ixt-sec:duryear">10.0</ix:nonNumeric> years</ix:nonNumeric> and terminate certain of the leases after <ix:nonNumeric id="F_000698" name="adpt:LesseeOperatingLeaseTerminationPeriod" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">3.0</ix:nonNumeric> years. We adjust lease terms for these options only when it is reasonably certain we will exercise these options. As of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021, it was reasonably certain that we would exercise our option to terminate </span><ix:nonFraction unitRef="U_adptLease" id="F_000699" name="adpt:NumberOfOperatingLeaseTerminate" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="Background-color:#FFFFFF;"> of our leases after <ix:nonNumeric id="F_000700" name="adpt:LesseeOperatingLeaseTerminationPeriod" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">3.0 </ix:nonNumeric></span>years<span style="Background-color:#FFFFFF;">.</span></p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000372_dcnt_818c9545-693a-4d52-a655-9e049bf03c80"><ix:nonNumeric id="F_000417" name="us-gaap:LeaseCostTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Other information related to our operating leases as of </span>December <span style="Background-color:#FFFFFF;">31, 2021 and 2020 was as follows:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">10.55</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000706">11.33</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000707" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001478320_20211231" decimals="3" scale="-2">4.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000708" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001478320_20201231" decimals="3" scale="-2">4.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000418" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table reconciles our undiscounted operating lease cash flows to our operating lease liabilities as of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021 (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000709" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000710" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000711" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000712" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,098</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000713" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,330</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000714" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">81,188</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total undiscounted lease payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000715" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">149,456</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Imputed interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000716" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,410</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Tenant improvement receivables</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000717" name="adpt:LesseeOperatingLeaseLiabilityTenantImprovementReceivable" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,306</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000718" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">111,740</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000719" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,055</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, less current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000720" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">106,685</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Operating lease expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000721" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">12.4</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000722" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">5.5</ix:nonFraction> million for the year ended</span> December <span style="Background-color:#FFFFFF;">31, 2021 and 2020, respectively. Variable lease expense for operating leases was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000723" name="adpt:OperatingLeaseVariableLeaseExpense" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000724" name="adpt:OperatingLeaseVariableLeaseExpense" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">2.6</ix:nonFraction> million for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2021 and 2020, respectively.</span> <span style="Background-color:#FFFFFF;">Rent expense recognized under ASC 840, </span><span style="font-style:italic;Background-color:#FFFFFF;">Leases</span><span style="Background-color:#FFFFFF;">, inclusive of operating and maintenance costs, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000725" name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="C_0001478320_20190101_20191231" decimals="-5" scale="6">5.3</ix:nonFraction> million for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2019.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cash paid for amounts included in the measurement of lease liabilities was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000726" name="us-gaap:OperatingLeasePayments" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">8.3</ix:nonFraction> million and cash received for tenant improvement allowances was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000728" name="us-gaap:PaymentsForProceedsFromTenantAllowance" contextRef="C_0001478320_20210101_20211231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">11.5</ix:nonFraction> million during the year ended December 31, 2021. Cash paid for amounts included in the measurement of lease liabilities for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2020 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000727" name="us-gaap:OperatingLeasePayments" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">3.2</ix:nonFraction> million, net of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000729" name="us-gaap:PaymentsForProceedsFromTenantAllowance" contextRef="C_0001478320_20200101_20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">2.5</ix:nonFraction> million of cash received for tenant improvement allowances. For the year ended December 31, 2021, ROU assets obtained in exchange for operating lease liabilities was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000730" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">5.4</ix:nonFraction> million. For the year ended December 31, 2020, ROU assets obtained in exchange for operating lease liabilities was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000731" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">109.1</ix:nonFraction> million, inclusive of the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000732" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001478320_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20201231" decimals="-5" scale="6">33.0</ix:nonFraction> million recognized from the adoption of ASC 842.</span></p></ix:continuation><ix:nonNumeric id="F_000373" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000373_dcnt_d79bb0a2-eb2f-4c38-9e74-ffa19ce889ac">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Commitments and Contingencies</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Legal Proceedings </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to claims and assessments from time to time in the ordinary course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. We were not party to any material legal proceedings as of December 31, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Indemnification Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of business, we may provide indemnification of varying scope and terms to vendors, lessors, customers and other parties with respect to certain matters including, but not limited to, losses arising out of breach of our agreements with them or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with members of our board of directors and certain of our executive officers that will require us to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments that we could be required to make under these indemnification agreements is, in many cases, unlimited. We have not incurred any material costs as a result of such indemnifications and are not currently aware of any indemnification claims.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000373_dcnt_d79bb0a2-eb2f-4c38-9e74-ffa19ce889ac">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000374" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="color:#231F20;font-family:Times New Roman;letter-spacing:-0.05pt;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="color:#231F20;letter-spacing:-0.05pt;">Shareholders&#8217;</span><span style="color:#231F20;"> Equity</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock has no preferences or privileges and is not redeemable. <ix:nonNumeric id="F_000733" name="us-gaap:CommonStockVotingRights" contextRef="C_0001478320_20210101_20211231">Holders of our common stock are entitled to <ix:nonFraction unitRef="U_adptVote" id="F_000734" name="adpt:NumberOfCommonStockVotingRights" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> vote for each share of common stock held</ix:nonNumeric>. The holders of record of outstanding shares of common stock shall be entitled to receive, when, as and if declared, out of funds legally available, such cash and other dividends as may be declared from time to time.</p><ix:nonNumeric id="F_000419" name="adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we <span style="color:#231F20;">have reserved shares of common stock for the following:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issuable upon the exercise of outstanding common stock options and the vesting of outstanding common restricted stock units granted</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000735" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001478320_us-gaapAwardTypeAxis_adptCommonStockOptionsAndRestrictedStockUnitsGrantedMember_20211231" decimals="INF" format="ixt:numdotdecimal">13,990,175</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the 2019 Equity Incentive Plan</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000736" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">22,299,923</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the Employee Stock Purchase Plan</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000737" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231" decimals="INF" format="ixt:numdotdecimal">2,804,298</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares of common stock reserved for future issuance</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000738" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal">39,094,396</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our 2019 Equity Incentive Plan (&#8220;2019 Plan&#8221;) provides for annual increases in the number of shares that may be issued under the 2019 Plan on January 1, 2020 and on each subsequent January 1, thereafter, by a number of shares equal to the lesser of (a) <ix:nonFraction unitRef="U_xbrlipure" id="F_000739" name="adpt:PercentageOfAnnualIncreasesInNumberOfShares" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20200101" decimals="INF" scale="-2">5</ix:nonFraction>% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, our Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for annual increases in the number of shares available for issuance under our ESPP on January 1, 2020 and on each January 1, thereafter, by a number of shares equal to the smallest of (a) <ix:nonFraction unitRef="U_xbrlipure" id="F_000740" name="adpt:PercentageOfAnnualIncreasesInNumberOfShares" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20200101" decimals="2" scale="-2">1</ix:nonFraction>% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2021, our 2019 Plan reserve increased by <ix:nonFraction unitRef="U_xbrlishares" id="F_000741" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20210101" decimals="INF" format="ixt:numdotdecimal">6,882,344</ix:nonFraction> shares. Our board of directors determined not to increase the ESPP reserve in 2021. Furthermore, our board of directors determined not to increase the 2019 Plan and ESPP reserves in 2022.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Common<span style="letter-spacing:-0.05pt;"> </span>Stock<span style="letter-spacing:-0.05pt;"> </span>Warrant</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2014, we issued a warrant to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000742" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231" decimals="INF" format="ixt:numdotdecimal">56,875</ix:nonFraction> shares of Series C convertible preferred stock at an exercise price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000744" name="adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231" decimals="2">2.64</ix:nonFraction>. The warrant was exercisable for a period of <ix:nonNumeric id="F_000743" name="adpt:ClassOfWarrantOrRightsTerm" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20140101_20141231" format="ixt-sec:durwordsen">seven years</ix:nonNumeric> from the date of issuance. Immediately prior to and in connection with the completion of our initial public offering on July 1, 2019, this convertible preferred stock warrant was converted to a warrant to purchase the same number of shares of common stock. The warrant was exercised on February 25, 2021 through a cashless exercise, resulting in the issuance of <ix:nonFraction unitRef="U_xbrlishares" id="F_000745" name="adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">54,162</ix:nonFraction> shares of our common stock. The impact of this cashless exercise was immaterial to our consolidated financial statements. As of December 31, 2021, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_000746" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001478320_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> outstanding warrants to purchase common stock.</p></ix:nonNumeric><ix:nonNumeric id="F_000375" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000375_dcnt_877c37f2-8b7a-47e7-9c34-43c5af0d84fd">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Equity Incentive Plans</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Sequenta 2008 Stock Plan, as amended</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our acquisition of Sequenta in January 2015, we assumed Sequenta&#8217;s Equity Incentive Plan (&#8220;2008 Plan&#8221;), including all outstanding options and shares available for future issuance under the 2008 Plan, which, prior to the completion of our initial public offering, were all exercisable for Series E-1 convertible preferred stock. Upon completion of our initial public offering in July 2019, the outstanding options were exercisable for common stock. <ix:nonFraction unitRef="U_xbrlishares" id="F_000747" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> shares are available for future issuance under this plan and <ix:nonFraction unitRef="U_xbrlishares" id="F_000748" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" contextRef="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> equity awards are outstanding under this plan as of December 31, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Adaptive 2009 Equity Incentive Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We adopted an equity incentive plan in 2009 (&#8220;2009 Plan&#8221;) that provided for the issuance of incentive and nonqualified common stock options and other share-based awards for employees, directors and consultants. Under the 2009 Plan, the option exercise price for incentive and nonqualified stock options were not to be less than the fair market value of our common stock at the date of grant. Options granted under this plan expire no later than <ix:nonNumeric id="F_000749" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> from the grant date and vesting was established at the time of grant. Pursuant to the terms of the 2019 Plan, any shares subject to outstanding options originally granted under the 2009 Plan that terminate, expire or lapse for any reason without the delivery of shares to the holder thereof shall become available for issuance pursuant to awards granted under the 2019 Plan. While <ix:nonFraction unitRef="U_xbrlishares" id="F_000750" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> shares are available for future issuance under the 2009 Plan, it continues to govern outstanding equity awards granted thereunder.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000375_dcnt_877c37f2-8b7a-47e7-9c34-43c5af0d84fd" continuedAt="F_000375_dcnt_03b8c8b9-1ede-4e37-9b66-3a9a7515a499">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">2019 Equity Incentive Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2019 Plan became effective immediately prior to the closing of our initial public offering in July 2019. The 2019 Plan provides for the issuance of awards in the form of options and other share-based awards for employees, directors and consultants. Under the 2019 Plan, the option exercise price per share shall not be less than the fair market value of a share of stock on the effective date of grant, as defined by the 2019 Plan, unless explicitly qualified under the provisions of Section 409A or Section 424(a) of the Internal Revenue Code of 1986. Additionally, unless otherwise specified, options granted under this plan expire no later than <ix:nonNumeric id="F_000751" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> from the grant date and vesting is established at the time of grant. Except for certain option and restricted stock unit grants made to non-employee directors, stock options and restricted stock units granted under the 2019 Plan generally vest over a <span style="-sec-ix-hidden:F_000752">four-year</span> period, subject to continuous service through each applicable vesting date. As of December 31, 2021, we have authorized <ix:nonFraction unitRef="U_xbrlishares" id="F_000753" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">29,131,628</ix:nonFraction> shares of common stock for issuance under the 2019 Plan.</p><ix:nonNumeric id="F_000420" name="adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in shares available for grant during the year ended December 31, 2021 were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available for Grant</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000754" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">18,617,001</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019 Equity Incentive Plan reserve increase effective January 1, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000755" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">6,882,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000756" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">4,306,265</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units forfeited, cancelled or expired</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000757" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,106,843</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000758" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">22,299,923</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000421" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option activity under the 2009 Plan and 2019 Plan during the year ended December&#160;31, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Subject to</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000759" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001478320_20201231" decimals="INF" format="ixt:numdotdecimal">14,433,560</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000766" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001478320_20201231" decimals="2">12.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000760" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">3,052,025</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000767" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001478320_20210101_20211231" decimals="2">39.39</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited or cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000761" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">992,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000768" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_0001478320_20210101_20211231" decimals="2">25.90</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000762" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">40,116</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000769" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_0001478320_20210101_20211231" decimals="2">26.56</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000763" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">3,674,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000770" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001478320_20210101_20211231" decimals="2">7.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000764" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal">12,778,984</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000771" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001478320_20211231" decimals="2">19.72</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000773" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">156,105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and exercisable at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000765" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" contextRef="C_0001478320_20211231" decimals="INF" format="ixt:numdotdecimal">7,281,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000772" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" contextRef="C_0001478320_20211231" decimals="2">10.99</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000774" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">132,537</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average remaining contractual life for options outstanding as of December 31, 2021 was <ix:nonNumeric id="F_000775" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">7.0</ix:nonNumeric> years. The weighted-average remaining contractual life for vested and exercisable options as of December 31, 2021 was <ix:nonNumeric id="F_000776" name="adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">5.7</ix:nonNumeric> years. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant date fair value per share of options granted during the year ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000777" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_20210101_20211231" decimals="2">24.22</ix:nonFraction>, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000778" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_20200101_20201231" decimals="2">21.11</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000779" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_20190101_20191231" decimals="2">6.87</ix:nonFraction>, respectively. The total intrinsic value of options exercised during the year ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000780" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">156.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000781" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">190.4</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000782" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001478320_20190101_20191231" decimals="-5" scale="6">39.1</ix:nonFraction> million, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Of the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000783" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">26.7</ix:nonFraction> million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2021, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000785" name="adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">0.3</ix:nonFraction> million related to options exercised during the year ended December 31, 2020 but settled during the year ended December 31, 2021. Of the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000784" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">21.7</ix:nonFraction> million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2020, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000786" name="adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">0.5</ix:nonFraction> million related to options exercised during the year ended December 31, 2019 but settled during the year ended December 31, 2020.</p><ix:nonNumeric id="F_000422" name="us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock unit activity under the 2019 Plan during the year ended December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-weight:bold;;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">50,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000792" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="2">28.10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000788" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,254,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000793" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">37.98</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units forfeited or cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000789" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">74,299</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000794" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">43.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units vested</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000790" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">18,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000795" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">28.10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000791" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">1,211,191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000796" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="2">37.41</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000375_dcnt_03b8c8b9-1ede-4e37-9b66-3a9a7515a499">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant date fair value per share of restricted stock units granted during the year ended December 31, 2020 and 2019 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000797" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231" decimals="2">28.10</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000798" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20190101_20191231" decimals="2">41.63</ix:nonFraction>, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Grant Date Fair Value of Options and Restricted Stock Units Granted</p><ix:nonNumeric id="F_000423" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair values of options granted during the years ended December&#160;31, 2021, 2020 and 2019 were estimated using the Black-Scholes option-pricing model with the following assumptions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of common stock</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$30.86 - $66.50</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$17.68 - $55.23</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.80 - $47.81</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">5.27 - 6.08</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">5.27 - 6.08</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">5.27 - 6.08</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000811">0.5% - 1.4%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">0.4% - 1.7%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">1.4% - 2.5%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000817">67.1% - 70.0%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000818">70.5% - 73.3%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000819">64.3% - 72.9%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The determination of the grant date fair value of stock options using a Black-Scholes option-pricing model is affected by the fair value of our common stock, as well as assumptions regarding a number of variables that are complex, subjective and generally require significant judgment to determine. The valuation assumptions were determined as follows: </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair value of common stock&#8212;<span style="font-style:normal;">Prior to the closing of our initial public offering, the fair value of our common stock was determined with input from management using valuation methodologies which utilized certain assumptions, including probability weighting of events, volatility, time to liquidation, a risk-free interest rate and an assumption for a discount for lack of marketability (Level 3 inputs). In determining the fair value of our common stock, the methodologies, approaches and assumptions used to estimate the enterprise value were consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, </span>Valuation of Privately-Held-Company Equity Securities Issued as Compensation<span style="font-style:normal;">. For option grants made after the closing of our initial public offering, the fair value of each share of common stock is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.</span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expected term<span style="font-style:normal;">&#8212;The expected term of options granted to employees and non-employee directors is determined using the &#8220;simplified&#8221; method, as illustrated in ASC Topic 718, </span>Compensation&#8212;Stock Compensation<span style="font-style:normal;">, as we do not have sufficient exercise history to determine a better estimate of expected term. Under this approach, the expected term is </span><span style="color:#000000;font-style:normal;">based on the midpoint between the vesting date and the end of the contractual term of the option.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-free interest rate<span style="font-style:normal;">&#8212;We utilize a risk-free interest rate in the option valuation model based on U.S. Treasury zero-coupon issues with remaining terms similar to the expected terms of the options.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected volatility<span style="font-style:normal;">&#8212;As we do not have sufficient trading history for our common stock, the expected volatility is based on the historical volatility of our publicly traded industry peers utilizing a period of time consistent with our estimate of expected term.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected dividend yield<span style="font-style:normal;">&#8212;We do not anticipate paying any cash dividends in the foreseeable future and, therefore, use an expected dividend yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_000823" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001478320_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210101_20211231" decimals="2" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction> in the option valuation model.</span> </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The grant date fair value of restricted stock units granted <span style="color:#000000;">is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000424" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000424_cnt_1">The compensation costs related to stock options and restricted stock units for the years ended December 31, 2021, 2020 and 2019 are included on our consolidated statements of operations as follows (in thousands):</ix:nonNumeric> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p><ix:continuation id="F_000424_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000824" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,100</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000825" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231" decimals="-3" scale="3">817</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000826" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231" decimals="-3" scale="3">555</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000827" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,061</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000828" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,519</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000829" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,934</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000830" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000831" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000832" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,480</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000833" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000834" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,798</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000835" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,155</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000836" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000837" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,761</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000838" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001478320_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,124</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, unrecognized share-based compensation expense related to unvested stock options was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000839" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0001478320_20211231" decimals="-5" scale="6">96.8</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average period of <ix:nonNumeric id="F_000840" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">2.9</ix:nonNumeric> years. Additionally, as of December 31, 2021, unrecognized share-based compensation expense related to unvested restricted stock units was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000842" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="-5" scale="6">38.3</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average period of <ix:nonNumeric id="F_000841" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" format="ixt-sec:duryear">3.4</ix:nonNumeric> years.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p><ix:nonNumeric id="F_000376" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Microsoft Collaboration Agreement</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Summary of Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2017, we entered into a collaboration agreement with Microsoft (&#8220;Microsoft Agreement&#8221;) to computationally derive a comprehensive TCR antigen map for purposes of developing a universal diagnostic based on a single blood test.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contemporaneously with the Microsoft Agreement, we entered into a separate agreement to use Microsoft&#8217;s Azure cloud services at standard volume pricing with a minimum Azure purchase requirement of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000843" name="adpt:MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231" decimals="INF" scale="6">12.0</ix:nonFraction>&#160;million over the <span style="-sec-ix-hidden:F_000844">seven-year</span> term of the Microsoft Agreement, which we expect to meet in the ordinary course of business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, contemporaneously with entering into the Microsoft Agreement, Microsoft made a preferred stock investment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000845" name="us-gaap:PreferredStockValue" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_adptSeriesFOneConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171231" decimals="-5" scale="6">45.0</ix:nonFraction>&#160;million as a part of our&#160;Series&#160;F-1&#160;convertible preferred stock issuance.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Summary of Accounting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The terms of the Microsoft Agreement meet the criteria under ASC Topic 808,&#160;<span style="font-style:italic;">Collaborative Arrangements</span>&#160;(&#8220;ASC 808&#8221;), as both parties are active participants in the activity and are exposed to significant risks and rewards dependent on the commercial success of the activity.&#160;ASC 808 does not provide guidance on how to account for the activities under the collaboration and we determined that Microsoft did not meet the definition of a customer under ASC 606. Accordingly,&#160;we looked to other guidance to determine the accounting for the respective elements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined that the preferred stock issuance and commitment to use Microsoft&#8217;s Azure cloud services were made at terms consistent with market rates. All consideration received as part of the Series&#160;F-1&#160;convertible preferred stock issuance was accounted for as part of the Series&#160;F-1&#160;preferred stock issuance.&#160;Since the commitment to purchase Microsoft&#8217;s Azure cloud services was at market terms and we expect to meet the commitment in the ordinary course of business during the seven-year term, we record the expenses in the period in which the services are consumed. These costs are recorded in our consolidated statements of operations based on the underlying activities for which they support.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining elements of the agreement were highly interrelated, so we evaluated them in the aggregate to determine the appropriate accounting application. Specifically, we determined that the transfer of license rights between the parties, our commitment to provide data and immunomics, diagnostic and bioinformatics expertise to Microsoft and Microsoft&#8217;s commitment to provide machine learning software and related development services to us were highly interrelated because they were necessary for the parties to perform the activities under the Microsoft Agreement and, therefore, should be evaluated as one unit of account.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accounted for these collaboration activities by analogy to ASC Topic 845,&#160;<span style="font-style:italic;">Nonmonetary Transactions</span>, and determined that major uncertainties exist about the realizability of the value that would be assigned to an asset received from or provided to Microsoft under the collaboration and, therefore, fair value could not be reliably measured. As a result, we did not recognize any&#160;non-monetary&#160;assets or corresponding&#160;non-monetary&#160;income or expenses pertaining to the rights provided to us or to be received by us under the Microsoft Agreement.</p></ix:nonNumeric><ix:nonNumeric id="F_000377" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000377_dcnt_ab1e2f89-6a49-4440-81c3-a1222139380c">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5</span><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Income Taxes</p></td></tr></table></div><ix:nonNumeric id="F_000425" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of loss before provision for income taxes for the periods presented are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000846" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,314</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000847" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000848" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000849" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001478320_20210101_20211231" decimals="-3" scale="3">16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before provision for income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000850" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000851" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000852" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000377_dcnt_ab1e2f89-6a49-4440-81c3-a1222139380c" continuedAt="F_000377_dcnt_2ede91ee-b4c1-4cf3-a34f-6b4f46c3ce62">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. <ix:nonNumeric id="F_000426" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000426_cnt_1">The significant components of our deferred tax assets and liabilities as of the dates presented are as follows (in thousands):</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p><ix:continuation id="F_000426_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000853" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">200,363</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000854" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">105,433</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credit carryforward</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000855" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000856" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonqualifying stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000857" name="adpt:DeferredTaxAssetsNonQualifiedStockOptions" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,072</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000858" name="adpt:DeferredTaxAssetsNonQualifiedStockOptions" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,096</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000859" name="adpt:DeferredTaxAssetsOperatingLeaseLiabilities" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,401</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000860" name="adpt:DeferredTaxAssetsOperatingLeaseLiabilities" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,052</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000861" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,481</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000862" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">59,713</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000863" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,345</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000864" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,983</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000865" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">326,862</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000866" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">230,258</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000867" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">297,020</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000868" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">197,527</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets, net of valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000869" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,842</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000870" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,731</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tangible and intangible assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000871" name="adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000872" name="adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,760</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000873" name="adpt:DeferredTaxLiabilitiesRightOfUseAssets" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,532</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000874" name="adpt:DeferredTaxLiabilitiesRightOfUseAssets" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000875" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000876" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASC Topic 740, <span style="font-style:italic;">Income Taxes</span>, requires that the tax benefit of NOLs, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is &#8220;more likely than not.&#8221; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a valuation allowance. The valuation allowance increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000877" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">99.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000878" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">96.6</ix:nonFraction> million during the year ended December 31, 2021 and 2020, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal tax laws impose substantial restrictions on the utilization of NOL and credit carryforwards in the event of an ownership change, as defined in Section 382 of the Internal Revenue Code of 1986. Accordingly, our ability to utilize these carryforwards may be limited due to such ownership changes. We have completed a Section 382 analysis for changes in ownership through December 31, 2020 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of our federal NOLs. Under the TCJA federal income tax law, federal NOLs incurred in 2018 and future years may be carried forward indefinitely, but the deductibility of such federal NOLs is subject to an annual limitation. NOLs generated prior to 2018 are eligible to be carried forward up to <ix:nonNumeric id="F_000879" name="adpt:NetOperatingLossCarryforwardExpirationPeriod" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:duryear">20</ix:nonNumeric> years. As of December 31, 2021, we had U.S. federal NOLs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000880" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231" decimals="-5" scale="6">192.5</ix:nonFraction> million and U.S. federal tax credits of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000881" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231" decimals="-5" scale="6">33.6</ix:nonFraction> million that will begin to expire in <ix:nonNumeric id="F_000882" name="us-gaap:TaxCreditCarryforwardLimitationsOnUse" contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231"><ix:nonNumeric id="F_000883" name="adpt:OperatingLossCarryforwardsExpirationYear" contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">2028</ix:nonNumeric></ix:nonNumeric>. We also had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000884" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001478320_20211231" decimals="-5" scale="6">576.2</ix:nonFraction> million of NOLs as of December 31, 2021 that do not expire.</p><ix:nonNumeric id="F_000427" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effective tax rate of our provision for income taxes differs from the federal statutory rate for the periods presented as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statutory rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000885" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001478320_20210101_20211231" decimals="INF" scale="-2">21.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000886" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001478320_20200101_20201231" decimals="INF" scale="-2">21.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000887" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001478320_20190101_20191231" decimals="INF" scale="-2">21.0</ix:nonFraction>%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal tax benefit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000888" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001478320_20210101_20211231" decimals="INF" scale="-2">8.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000889" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001478320_20200101_20201231" decimals="INF" scale="-2">13.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000890" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001478320_20190101_20191231" decimals="INF" scale="-2">8.1</ix:nonFraction></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000891" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001478320_20210101_20211231" decimals="3" scale="-2">14.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000892" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001478320_20200101_20201231" decimals="3" scale="-2">25.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000893" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001478320_20190101_20191231" decimals="3" scale="-2">9.8</ix:nonFraction></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000894" name="adpt:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0001478320_20210101_20211231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction>)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000895" name="adpt:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0001478320_20200101_20201231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction>)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000896" name="adpt:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0001478320_20190101_20191231" decimals="3" sign="-" scale="-2">1.0</ix:nonFraction>)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credits</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000897" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001478320_20210101_20211231" decimals="3" scale="-2">4.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000898" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001478320_20200101_20201231" decimals="3" scale="-2">5.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000899" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001478320_20190101_20191231" decimals="3" scale="-2">6.1</ix:nonFraction></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000900" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001478320_20210101_20211231" decimals="3" sign="-" scale="-2">0.3</ix:nonFraction>)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000901" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001478320_20200101_20201231" decimals="3" scale="-2">0.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000902" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001478320_20190101_20191231" decimals="3" scale="-2">0.3</ix:nonFraction></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000903" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001478320_20210101_20211231" decimals="3" sign="-" scale="-2">47.7</ix:nonFraction>)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000904" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001478320_20200101_20201231" decimals="3" sign="-" scale="-2">66.1</ix:nonFraction>)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_000905" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001478320_20190101_20191231" decimals="3" sign="-" scale="-2">44.3</ix:nonFraction>)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000906" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001478320_20210101_20211231" decimals="3" scale="-2">0.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000907" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001478320_20200101_20201231" decimals="3" scale="-2">0.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000908" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001478320_20190101_20191231" decimals="3" scale="-2">0.0</ix:nonFraction>%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000377_dcnt_2ede91ee-b4c1-4cf3-a34f-6b4f46c3ce62">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for Global Intangible Low-Taxed Income as period costs when incurred. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize, in our consolidated financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. We had unrecognized tax benefits of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000909" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001478320_20211231" decimals="-5" scale="6">6.9</ix:nonFraction> million as of December 31, 2021. <ix:nonNumeric id="F_000428" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000428_cnt_1">A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the dates presented are as follows (in thousands):</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p><ix:continuation id="F_000428_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000910" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001478320_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,260</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000911" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">792</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000912" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001478320_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,052</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000913" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,437</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000914" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001478320_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,489</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000915" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,426</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000916" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001478320_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,915</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, 2020 and 2019, we recognized uncertain tax positions of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000917" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">3.4</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000918" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000919" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001478320_20190101_20191231" decimals="-5" scale="6">0.8</ix:nonFraction> million, respectively, related to a reduction of the research and development credit deferred tax asset. Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not expect a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our operating results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We had <ix:nonFraction unitRef="U_iso4217USD" id="F_000920" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001478320_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000921" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001478320_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> accrued interest or penalties related to uncertain tax positions as of December 31, 2021 and 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We file federal and certain state income tax returns, which provide varying statutes of limitations on assessments. However, because of NOL carryforwards, substantially all tax years since inception remain open to federal and state tax examination.</p></ix:continuation><ix:nonNumeric id="F_000378" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000378_dcnt_ce59d44c-8ac8-4b87-adff-a95e9f1c7c72">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Net Loss<span style="letter-spacing:-0.05pt;"> </span>Per Share<span style="letter-spacing:-0.05pt;"> </span>Attributable<span style="letter-spacing:0.05pt;"> </span>to Adaptive Biotechnologies Corporation Common <span style="letter-spacing:-0.05pt;">Shareholders</span></p></td></tr></table></div><ix:nonNumeric id="F_000429" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of the basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019 (in thousands, except share and per share amounts): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000922" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,279</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000923" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000924" name="us-gaap:NetIncomeLoss" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">68,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment to redemption value for Series E-1 convertible preferred stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000925" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="C_0001478320_20190101_20191231" decimals="-3" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000926" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">207,279</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000927" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">146,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000928" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001478320_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">69,570</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000929" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20210101_20211231" decimals="0" format="ixt:numdotdecimal">140,354,915</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000930" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20200101_20201231" decimals="0" format="ixt:numdotdecimal">131,216,468</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000931" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001478320_20190101_20191231" decimals="0" format="ixt:numdotdecimal">69,165,315</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000932" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20210101_20211231" decimals="2" sign="-">1.48</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000933" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20200101_20201231" decimals="2" sign="-">1.11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000934" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001478320_20190101_20191231" decimals="2" sign="-">1.01</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p>
<hr style="page-break-after:always" />
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive<span style="letter-spacing:-0.05pt;"> </span>Biotechnologies<span style="letter-spacing:-0.05pt;"> </span>Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.13%;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements (Continued)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:continuation id="F_000378_dcnt_ce59d44c-8ac8-4b87-adff-a95e9f1c7c72">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since we were in a loss position for all periods presented, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is the same as diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. <ix:nonNumeric id="F_000430" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000430_cnt_1">The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019, as they had an anti-dilutive effect:</ix:nonNumeric></p><ix:continuation id="F_000430_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock (on as if converted basis)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000935" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">46,104,469</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options issued and outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000936" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">13,097,374</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000937" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">16,125,548</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000938" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">17,183,546</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000939" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">693,173</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000940" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">38,125</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000941" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">4,952</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000942" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">8,570</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000943" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">56,875</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000944" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">55,961</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock warrant</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000945" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptConvertiblePreferredStockWarrantsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">28,204</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000946" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">13,799,117</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000947" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">16,220,548</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000948" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001478320_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">63,377,132</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p></ix:continuation></ix:continuation><ix:nonNumeric id="F_000379" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" contextRef="C_0001478320_20210101_20211231" escape="true" continuedAt="F_000379_dcnt_7de56071-cb61-4c51-a016-fa2a0f7eda91">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Retirement Plan</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain a salary deferral 401(k) plan (&#8220;401(k) Plan&#8221;) covering employees who have met certain eligibility requirements. Employees may defer up to <ix:nonFraction unitRef="U_xbrlipure" id="F_000949" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" contextRef="C_0001478320_20210101_20211231" decimals="2" scale="-2">100</ix:nonFraction>% of their compensation to the 401(k) Plan, subject to federal limits. We made $<ix:nonFraction unitRef="U_iso4217USD" id="F_000950" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001478320_20210101_20211231" decimals="-5" scale="6">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000951" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001478320_20200101_20201231" decimals="-5" scale="6">1.6</ix:nonFraction> million in discretionary contributions during the year ended December 31, 2021 and 2020, respectively, which are fully vested after <ix:nonNumeric id="F_000953" name="adpt:DefinedContributionPlanEmployeeServicePeriodForVesting" contextRef="C_0001478320_20210101_20211231" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_000954" name="adpt:DefinedContributionPlanEmployeeServicePeriodForVesting" contextRef="C_0001478320_20200101_20201231" format="ixt-sec:durwordsen">one year</ix:nonNumeric></ix:nonNumeric> of employee service. We did <ix:nonFraction unitRef="U_iso4217USD" id="F_000952" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001478320_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction>t make any discretionary contributions during the year ended December 31, 2019.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000379_dcnt_7de56071-cb61-4c51-a016-fa2a0f7eda91">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not<span style="color:#231F20;"> applicable</span>.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_9A_CONTROLS_PROCEDURES">Item 9A. Controls and Procedures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;;font-weight:normal;font-style:normal;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act as of December 31, 2021. Based on that evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective as of December 31, 2021. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Management&#8217;s Annual Report on Internal Control over Financial Reporting</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. Management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on that assessment, management has concluded that our internal control over financial reporting was effective as of December 31, 2021 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effectiveness of our internal control over financial reporting as of December 31, 2021 has been audited by an independent registered public accounting firm, as stated in their report, which is included below.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Changes in Internal Control</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was not any change in our internal control over financial reporting, as such term is defined in Rules&#160;13a-15(f) under the Exchange Act, during the three months ended December&#160;31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Registered Public Accounting Firm</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Shareholders and the Board of Directors of Adaptive Biotechnologies Corporation</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Opinion on Internal Control Over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited Adaptive Biotechnologies Corporation&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Adaptive Biotechnologies Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (the PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and shareholders&#8217; (deficit) equity and cash flows for each of the three years in the period ended December 31, 2021, and related notes and our report dated February 15, 2022 expressed an unqualified opinion thereon.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis for Opinion</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Definition and Inherent Limitations of Internal Control Over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company&#59; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company&#59; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ernst &#38; Young LLP</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seattle, Washington</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 15, 2022</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9B_OR_INFORMATION">Item 9B. Other Information </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9C">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not<span style="color:#231F20;"> applicable</span>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_III">PART III </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO">Item 10. Directors, Executive Officers and Corporate Governance </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 10 of Form 10-K will be included in our definitive proxy statement to be filed with the SEC in connection with the solicitation of proxies for our 2022 Annual Meeting of Shareholders (&#8220;2022 Proxy Statement&#8221;) and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_11_EXECUTIVE_COMPENSATION">Item 11. Executive Compensation </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 11 of Form 10-K will be included in our 2022 Proxy Statement and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 12 of Form 10-K, including with respect to our equity compensation plans, will be included in our 2022 Proxy Statement and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">Item 13. Certain Relationships and Related Transactions, and Director Independence </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 13 of Form 10-K will be included in our 2022 Proxy Statement and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC">Item 14. Principal Accounting Fees and Services </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="color:#000000;"> information required by this Item 14 of Form 10-K will be included in our 2022 Proxy Statement and is incorporated herein by reference.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART IV </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">Item 15. Exhibits, Financial Statement Schedules </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:1.06%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(a)</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>&#160;&#160;The following documents are filed as part of this <span style="Background-color:#FFFFFF;color:#000000;">Annual Report on Form 10-K</span>:</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.4%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>&#160;&#160; Financial Statements</p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Index to Consolidated Financial Statements in Part II, Item 8 of this <span style="Background-color:#FFFFFF;color:#000000;">Annual Report on Form 10-K</span>.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.4%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>&#160;&#160; Financial Statement Schedules</p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All financial statement schedules have been omitted since the required information was not applicable or was not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements or the accompanying notes.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.4%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>&#160;&#160; Exhibits</p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The exhibits listed in the following Index to Exhibits are filed, furnished or incorporated by reference as part of this <span style="Background-color:#FFFFFF;color:#000000;">Annual Report on Form 10-K</span>.</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Index to Exhibits</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:9.62%;">
<p style="line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:39.38%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:76.95pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:13.48%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="4" valign="bottom" style="width:37.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference</p></td>
</tr>
<tr>
<td valign="bottom" style="width:9.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:39.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Title</p></td>
<td valign="bottom" style="width:13.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed/Furnished</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">With This</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report</p></td>
<td valign="bottom" style="width:6.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:10.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:11.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="width:39.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519187427/d27753dex31.htm"><span style="text-decoration:underline;">Amended and Restated Articles of Incorporation</span></a></p></td>
<td valign="top" style="width:13.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:10.94%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="width:11.4%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7/1/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519187427/d27753dex32.htm"><span style="text-decoration:underline;">Amended and Restated Bylaws</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7/1/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex41.htm"><span style="text-decoration:underline;">Seventh Amended and Restated Investors' Rights Agreement among the Registrant and certain of its shareholders, dated May 30, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459020006830/adpt-ex43_880.htm"><span style="text-decoration:underline;">Description of Securities</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2020</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1&#8224;</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex101.htm"><span style="text-decoration:underline;">Strategic Collaboration and License Agreement between Genentech, Inc. and the Registrant, dated December 19, 2018</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2&#8224;</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex102.htm"><span style="text-decoration:underline;">Strategic Collaboration Agreement between Microsoft Corporation and the Registrant, dated December 11, 2017</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3&#8224;</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519174174/d706383dex103.htm"><span style="text-decoration:underline;">Master Terms &#38; Conditions of Sale between Illumina, Inc. and the Registrant, dated May 28, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/17/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex105.htm"><span style="text-decoration:underline;">Amended and Restated Side Letter Agreement among Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Long Fund Master Ltd. and the Registrant, dated May 8, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-bottom:8pt;line-height:10pt;margin-top:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex107.htm"><span style="text-decoration:underline;">Form of Amended and Restated Employment Agreement between the Registrant and certain of its executive officers</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex108.htm"><span style="text-decoration:underline;">Form of Amended and Restated Employment Agreement between the Registrant and each of Lance Baldo, MD and Francis T. Lo</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex109.htm"><span style="text-decoration:underline;">Form of Restated Non-Employee Director Change in Control Agreement between the Registrant and each of its non-employee directors</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex1011.htm"><span style="text-decoration:underline;">Executive Severance Agreement between the Registrant and Lance Baldo, MD, dated April 22, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:9.62%;">
<p style="line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:39.38%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:76.95pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:13.48%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="4" valign="bottom" style="width:37.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference</p></td>
</tr>
<tr>
<td valign="bottom" style="width:9.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:39.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Title</p></td>
<td valign="bottom" style="width:13.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed/Furnished</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">With This</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report</p></td>
<td valign="bottom" style="width:6.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:10.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:11.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459020038958/adpt-ex101_139.htm"><span style="text-decoration:underline;">Form of Executive Severance Agreement between the Registrant and certain of its executive officers</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/10/2020</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.10*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex1013.htm"><span style="text-decoration:underline;">Form of Indemnification Agreement between the Registrant and its directors and executive officers</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.13</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459021008124/adpt-ex1012_218.htm"><span style="text-decoration:underline;">Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/24/2021</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex1015.htm"><span style="text-decoration:underline;">Adaptive Biotechnologies Corporation 2009 Equity Incentive Plan and form of award agreement thereunder</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.15</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.13*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459019031827/adpt-ex1012_196.htm"><span style="text-decoration:underline;">Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan and form of award agreement thereunder</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/13/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.14*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519174174/d706383dex1017.htm"><span style="text-decoration:underline;">Adaptive Biotechnologies Corporation 2019 Employee Stock Purchase Plan</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.17</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/17/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.15*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459021008124/adpt-ex1016_340.htm"><span style="text-decoration:underline;">Form of Stock Option Agreement for Non-U.S Participants</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.16</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/24/2021</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.16*</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000156459021008124/adpt-ex1017_339.htm"><span style="text-decoration:underline;">Form of Restricted Stock Unit Agreement for Non-U.S Participants</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.17</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/24/2021</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.17</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519161447/d706383dex1018.htm"><span style="text-decoration:underline;">Lease Agreement between ARE-Seattle No. 11, LLC and Adaptive TCR Corporation, dated July 21, 2011, as amended by Amendment No. 1, dated August 26, 2011, Amendment No. 2, dated June 30, 2014, Amendment No. 3, dated November 5, 2015, Amendment No. 4, dated December 23, 2015, and Amendment No. 5, dated June 6, 2016</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-231838</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/30/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18&#8224;</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519215526/d777595dex101.htm"><span style="text-decoration:underline;">Sixth Amendment to Lease Agreement between Adaptive Biotechnologies Corporation and ARE-Seattle No. 11, LLC, dated August 2, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/7/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.19&#8224;</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1478320/000119312519215526/d777595dex102.htm"><span style="text-decoration:underline;">Lease Agreement between Adaptive Biotechnologies Corporation and ARE-Seattle No. 12, LLC, dated August 2, 2019</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:6.52%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:10.94%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-38957</p></td>
<td valign="top" style="width:8.66%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:11.4%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/7/2019</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.1</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex211_7.htm"><span style="text-decoration:underline;">List of Subsidiaries</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex231_14.htm"><span style="text-decoration:underline;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24.1</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">Power of Attorney (included on the signature page)</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.1</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex311_6.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer pursuant to Rule 13a&#8209;14(a) or Rule 15d&#8209;14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.2</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex312_8.htm"><span style="text-decoration:underline;">Certification of Principal Financial Officer pursuant to Rule 13a&#8209;14(a) or Rule 15d&#8209;14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:9.62%;">
<p style="line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:39.38%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:76.95pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:13.48%;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="4" valign="bottom" style="width:37.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference</p></td>
</tr>
<tr>
<td valign="bottom" style="width:9.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:2.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:39.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:12.96%;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Title</p></td>
<td valign="bottom" style="width:13.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed/Furnished</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">With This</p>
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:5.9pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report</p></td>
<td valign="bottom" style="width:6.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:10.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:8.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:11.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.1</span></p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex321_11.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.2</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex322_13.htm"><span style="text-decoration:underline;">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document<span style="Background-color:#FFFFFF;"> &#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:9.62%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:2.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:39.38%;">
<p style="margin-top:8pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.56%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (formatted in Inline XBRL and included in Exhibit 101)</p></td>
<td valign="top" style="width:13.48%;">
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
<td valign="top" style="width:6.52%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:10.94%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:8.66%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:11.4%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Management contract or compensation plan or arrangement.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Portions of this exhibit have been omitted pursuant to Item 601 of Regulation S-K promulgated under the Securities Act because the information is not material and would be competitively harmful if publicly disclosed.</p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_16_FORM_10K_SUMMARY">Item 16. Form 10-K Summary</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable<span style="font-weight:bold;color:#000000;">.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of <span style="color:#000000;">Section 13 or 15(d) of the Securities Exchange Act of 1934</span>, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Seattle, State of Washington, on February&#160;15, 2022.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td colspan="3" valign="top" style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies Corporation</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:11.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:88.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:11.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:&#160;&#160;&#160;&#160;</p></td>
<td valign="bottom" style="width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:86.12%;">
<p style="margin-bottom:1pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Robins</p></td>
</tr>
<tr>
<td valign="top" style="width:11.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:86.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Robins</p>
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">POWER OF ATTORNEY </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Chad Robins, his attorney-in-fact, with the power of substitution, for him in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the SEC, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:35.56%;white-space:nowrap;">
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:43.34%;white-space:nowrap;">
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:18.86%;white-space:nowrap;">
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Robins</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Robins</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer and Director</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Cohen</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Cohen</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal&#160;Financial Officer)</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Kyle Piskel</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kyle Piskel</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP, Principal Accounting Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Accounting Officer)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Kevin Conroy</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kevin Conroy</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michelle Griffin</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michelle Griffin</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Robert Hershberg</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Robert Hershberg, PhD, MD</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Peter Neupert</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Peter Neupert</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Katey Owen</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Katey Owen, PhD</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael Pellini</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Pellini, MD</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
<tr>
<td valign="middle" style="width:35.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:44.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:19.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:35.56%;">
<p style="text-align:center;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Leslie Trigg</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leslie Trigg</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;15, 2022</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>adpt-ex211_7.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex211_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 21.1</p>
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">List of Subsidiaries of Adaptive Biotechnologies Corporation</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Subsidiary</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Jurisdiction of Organization</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Digital Biotechnologies, Inc.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies B.V.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Netherlands</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>adpt-ex231_14.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex231_14.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Consent of Independent Registered Public Accounting Firm</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in the following Registration Statements:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Times New Roman;">Registration Statement (Form S-8 No. 333-232495) pertaining to the Sequenta Inc., 2008 Stock Plan, the Adaptive Biotechnologies Corporation 2009 Equity Incentive Plan, the Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan and the Adaptive Biotechnologies Corporation 2019 Employee Stock Purchase Plan&#160;and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Times New Roman;">Registration Statement (Form S-3ASR No. 333-239854) of Adaptive Biotechnologies Corporation; </font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our reports dated February 15, 2022, with respect to the consolidated financial statements of Adaptive Biotechnologies Corporation, and the effectiveness of internal control over financial reporting of Adaptive Biotechnologies Corporation, included in this Annual Report (Form 10-K) for the year ended December 31, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ernst &amp; Young LLP</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seattle, Washington</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 15, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>adpt-ex311_6.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex311_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-top:18pt;line-height:11pt;margin-bottom:0pt;margin-right:2.14%;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER <br />PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="text-align:center;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-top:6pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Chad Robins, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">I have reviewed this Annual Report on Form 10-K of Adaptive Biotechnologies Corporation;</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:11pt;margin-left:7.69%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.69%;margin-right:2.14%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.69%;margin-right:2.14%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:22pt;line-height:11pt;margin-bottom:0pt;margin-left:3.85%;color:#000000;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:52.99%;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99.14%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 15, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;letter-spacing:-0.05pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Robins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Robins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="margin-top:4pt;line-height:11pt;margin-bottom:0pt;margin-left:53.08%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>adpt-ex312_8.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex312_8.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-top:17pt;line-height:11pt;margin-bottom:0pt;margin-right:2.14%;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER <br />PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="text-align:center;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:6pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Chad Cohen, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:11pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">I have reviewed this Annual Report on Form 10-K of Adaptive Biotechnologies Corporation;</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.69%;margin-right:2.14%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.69%;margin-right:2.14%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.69%;margin-right:2.14%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></p></td>
<td valign="top" style="width:2.14%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99.14%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 15, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;letter-spacing:-0.05pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-top:22pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>adpt-ex321_11.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex321_11.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-top:17pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;margin-top:6pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of Adaptive Biotechnologies Corporation (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-top:12pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99.14%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 15, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;letter-spacing:-0.05pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Robins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Robins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:13pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>adpt-ex322_13.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex322_13.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-top:17pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2</p>
<p style="text-align:center;margin-top:6pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="text-align:center;margin-top:0pt;line-height:11pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:6pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of Adaptive Biotechnologies Corporation (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-top:12pt;line-height:12pt;margin-bottom:0pt;margin-left:3.85%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99.14%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 15, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;letter-spacing:-0.05pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:13pt;line-height:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g4bdklltl5z5000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000003.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" +Q!G(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEUL["]K3YK<ROZGIM%%%8F@4444 %%%% !1110 4444 %%%% !1110 4444
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M5M%6T5TM4GU77\W;8[*,I2CK_2"BBBN4U"BBB@ HHHH **** "BBB@ HHHH
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M\)_B]\-_^%1>/?!L-UX;7R1'I-M-):QQB$@QJOD,C*JX&%! P,8QQ7"?#O\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  1G@TFT#M2T4
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M33UNI[K^QWN+FW,I/EPOYLA3>J*&W! &$BG Z5[F#X=S7'2M&'+_ (M/PW_
MX</F> Q69O+Z4[U8IMJSTMO=VMIVO<_6BBOY_;3_ (+P?\%,[:]^TS?&[3;B
M/=G[+-X/TT1XSTRL ;';[V??O7KGPI_X.4_VI?#E]''\8/@EX-\46*1L'_LF
M2XTJZ=L<$REIXQ@]A#SZCK7HU>"\ZIQO'EEY)_YI+\3V7@JZ/VFHKP_]D/\
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MSKVSBY\O7D347+TNTO5G34445@=@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8ERMHS\BRWC.GA^+YXSV48TZCY9/2ZC=^]S*^NSDE=2MIT9^-M*JM(P1>K'
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M_ %_\D'_ !-+F'_0KA_X-?\ \@?N=_PN#X2_]%1\._\ @[@_^+H_X7!\)?\
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M)?\ HJ/AW_P=P?\ Q=?AC11_Q!_"_P#07+_P!?\ R0?\32YA_P!"N'_@U_\
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M:LFM*?A#AITU+ZV]5?X%_P#)'/6^E%F%*M*']F1T;7\5]'_@/W._X7!\)?\
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M?"7_ **CX=_\'<'_ ,71_P +@^$O_14?#O\ X.X/_BZ_#&BC_B#^%_Z"Y?\
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M O\ Y(/^)I<P_P"A7#_P:_\ Y _<[_A<'PE_Z*CX=_\ !W!_\71_PN#X2_\
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M_B#^%_Z"Y?\ @"_^2#_B:7,/^A7#_P &O_Y _<[_ (7!\)?^BH^'?_!W!_\
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MSC-,=3PE'+(<TW97JRM\[4V_N3/V&_X7!\)?^BH^'?\ P=P?_%T?\+@^$O\
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MPN#X2_\ 14?#O_@[@_\ BZ_#&BC_ (@_A?\ H+E_X O_ )(/^)I<P_Z%</\
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ML/\ :FF_]!"#_O\ +_C1_:FF_P#00@_[_+_C7CU% 'L/]J:;_P!!"#_O\O\
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M,=R4X-1:IN#BG?1T]$]^J^+OTLRO[.H<TI)M.7-?;7F^73I^I^0/["/[-_\
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M_P"#B#_Y'H_X<Y?LH?\ 0;\9?^#B#_Y'H_XBEPMWG_X#_P $/^)<?$;M1_\
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M+]E#_H-^,O\ P<0?_(]'_#G+]E#_ *#?C+_P<0?_ "/1_P 12X6[S_\  ?\
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M  3/_B7'Q&[4?_!G_P!J?E[17ZA?\.<OV4/^@WXR_P#!Q!_\CT?\.<OV4/\
MH-^,O_!Q!_\ (]'_ !%+A;O/_P !_P""'_$N/B-VH_\ @S_[4_+VBOU"_P"'
M.7[*'_0;\9?^#B#_ .1Z/^'.7[*'_0;\9?\ @X@_^1Z/^(I<+=Y_^ _\$/\
MB7'Q&[4?_!G_ -J?E[17ZA?\.<OV4/\ H-^,O_!Q!_\ (]'_  YR_90_Z#?C
M+_P<0?\ R/1_Q%+A;O/_ ,!_X(?\2X^(W:C_ .#/_M3\O:*_4+_ASE^RA_T&
M_&7_ (.(/_D>C_ASE^RA_P!!OQE_X.(/_D>C_B*7"W>?_@/_  0_XEQ\1NU'
M_P &?_:GY>T5^H7_  YR_90_Z#?C+_P<0?\ R/1_PYR_90_Z#?C+_P '$'_R
M/1_Q%+A;O/\ \!_X(?\ $N/B-VH_^#/_ +4_+VBOU"_X<Y?LH?\ 0;\9?^#B
M#_Y'H_X<Y?LH?]!OQE_X.(/_ )'H_P"(I<+=Y_\ @/\ P0_XEQ\1NU'_ ,&?
M_:GY>T5^H7_#G+]E#_H-^,O_  <0?_(]'_#G+]E#_H-^,O\ P<0?_(]'_$4N
M%N\__ ?^"'_$N/B-VH_^#/\ [4_+VBOU"_X<Y?LH?]!OQE_X.(/_ )'H_P"'
M.7[*'_0;\9?^#B#_ .1Z/^(I<+=Y_P#@/_!#_B7'Q&[4?_!G_P!J?E[17ZA?
M\.<OV4/^@WXR_P#!Q!_\CT?\.<OV4/\ H-^,O_!Q!_\ (]'_ !%+A;O/_P !
M_P""'_$N/B-VH_\ @S_[4_+VBOU"_P"'.7[*'_0;\9?^#B#_ .1Z/^'.7[*'
M_0;\9?\ @X@_^1Z/^(I<+=Y_^ _\$/\ B7'Q&[4?_!G_ -J?E[17ZA?\.<OV
M4/\ H-^,O_!Q!_\ (]'_  YR_90_Z#?C+_P<0?\ R/1_Q%+A;O/_ ,!_X(?\
M2X^(W:C_ .#/_M3\O:*_4+_ASE^RA_T&_&7_ (.(/_D>C_ASE^RA_P!!OQE_
MX.(/_D>C_B*7"W>?_@/_  0_XEQ\1NU'_P &?_:GY>T5^H7_  YR_90_Z#?C
M+_P<0?\ R/1_PYR_90_Z#?C+_P '$'_R/1_Q%+A;O/\ \!_X(?\ $N/B-VH_
M^#/_ +4_+VBOU"_X<Y?LH?\ 0;\9?^#B#_Y'H_X<Y?LH?]!OQE_X.(/_ )'H
M_P"(I<+=Y_\ @/\ P0_XEQ\1NU'_ ,&?_:GY>UZ)^S)_R/\ K'_9/?%7_IAO
MJ^_O^'.7[*'_ $&_&7_@X@_^1ZUO!7_!*C]FKP%JUQK.A:SXK::ZT>_TV07&
MJ0LHAN[66UE(Q /F$<S;3T#8)!'%<N.\3.&<1@ZE*'/>46E[O5KU/0R?Z/?B
M%@<VH8BHJ7+"<9.U36R:;^R?E/17ZA#_ ((Y?LHXYUOQE_X.(/\ Y'H_X<Y?
MLH?]!OQE_P"#B#_Y'KJ_XBEPMWG_ . _\$\__B7'Q&[4?_!G_P!J?E[17ZA?
M\.<OV4/^@WXR_P#!Q!_\CT?\.<OV4/\ H-^,O_!Q!_\ (]'_ !%+A;O/_P !
M_P""'_$N/B-VH_\ @S_[4_+VBOU"_P"'.7[*'_0;\9?^#B#_ .1Z/^'.7[*'
M_0;\9?\ @X@_^1Z/^(I<+=Y_^ _\$/\ B7'Q&[4?_!G_ -J?E[17ZA?\.<OV
M4/\ H-^,O_!Q!_\ (]'_  YR_90_Z#?C+_P<0?\ R/1_Q%+A;O/_ ,!_X(?\
M2X^(W:C_ .#/_M3\O:*_4+_ASE^RA_T&_&7_ (.(/_D>C_ASE^RA_P!!OQE_
MX.(/_D>C_B*7"W>?_@/_  0_XEQ\1NU'_P &?_:GY>UZE^RI\5='^$/B/Q;X
MBU'Q3<:/=W7P]U>QT.^LQ*)5U"6$"W"-$"T;;P,/P%(R6'6OO#_ASE^RA_T&
M_&7_ (.(/_D>C_ASE^RA_P!!OQE_X.(/_D>N7&>)'"..PTJ%1U.66C]U?JV=
MV5^ ?B=E&84\905'G@[J]1VO\DG]S/@WX6_M >,M2^/WP_\ &WQS^+&OZMIG
MAOQ59WDEUKFJ7-]]B@%Q$\SHK%V&5C!(09;8.#@5T'P=U3X1_LY^-9OCA_PO
M'1_$VM:/;73^&-!\.Z-J.)KV6&6*.2>2\MK=8XXV=9#MWEMF,>OVE_PYR_90
M_P"@WXR_\'$'_P CT?\ #G+]E#_H-^,O_!Q!_P#(]<>(XZX-K1E",JD(RCRR
MC&$4G&[;6S:OS-.S3UTL]3UL%X->*V#E"I.G0JU*<W4A.=6HY1G:"4KII/EY
M(N*DI*ZU36A\CW7[9MM\'M'\&?#?X.>#/!?B+3_!FF6]Q:Z]X@\,FYG75YBM
MS>36[S".2(+.1&IVJQ%NAR0%KS/X\^(/AO<_'C4/'OPAECN]"U&^AU:WL+BU
M:,6LLH6::S=2J@K'*9(QMRI15PQS7Z"?\.<OV4/^@WXR_P#!Q!_\CT?\.<OV
M4/\ H-^,O_!Q!_\ (]+"<<<$X*M[6E[3F::D^7XN9\S<M=[W:M9+FEIJ5F?@
M_P"+N;87ZOB/8.$90<$IO]VH1<%&&FD>7E34N9ODAKIK\;_$;6_V<=6^*'BC
MX[6'QGU34)/$FNQZCH_ANUTN>WN;*2>[6XG&H/)&T+0PJ'55@>5I6\LYC -=
M3KGQ]^%?CJ3Q9HNF_$SPUH+_ /"UM<US2]2\5_#B+6;74].OYHL,GFVEQ-;S
M((-VWRT#AT5F!3Y?I_\ X<Y?LH?]!OQE_P"#B#_Y'H_X<Y?LH?\ 0;\9?^#B
M#_Y'KFEQAP9.,%.K6?)I%N$'962M9QY7HNJ>[>]FO0AX6>*]*I5E2P^%@JK;
MFHU*JYFW*5^93YUK*_NR2]U*UN92^5M)^,OP.\1^(/%7BG7?&VA77B&;6K*+
M3-8^(O@N6XL;C2X;(6Q>'3]/B:WBN%V+L66+ CVKO#;V,7QI^._P@\0>&/BE
MI'A'QNMW_P ))H?@VUT58=!DL5N6L(42Y7R4016X0ID1@[!P(RP KZN_X<Y?
MLH?]!OQE_P"#B#_Y'H_X<Y?LH?\ 0;\9?^#B#_Y'J8\7<$QKQJ^TK>[RV7+&
MR4)0DDM+I7IK1.VKLE=6JIX8^+E7!SP[HX7WW4<I>TJ<TG4A5A)R;DTY<M:7
MO-.3:CS-V=_E_1?VC_ .KV7@/QD?BUHOA:X\(^&['3]4TNX^&%EJNL^?81*D
M,VGWDUDRYEV*P\Z:+R')QO %8?@?XA? _P 8:W\)?B+X[^+7_"+WGP^\JUUS
M1QX?N)9+J.#49KV*>T:W1HSO\_9()#$4*,R+)\JGZ\_X<Y?LH?\ 0;\9?^#B
M#_Y'H_X<Y?LH?]!OQE_X.(/_ )'H_P!;N"8Q:ISJQO?50A=)J2M?ENU:;^+F
M>BUWN/PO\7*E2,JU+#5+6NI5:KBVG3DI64THN]-:0Y(N[7+;E4?S1\<ZE9:Q
MXVUC5]-F\RWNM4N)K>3:1N1I&*G!P1D$=>:RZ_4+_ASE^RA_T&_&7_@X@_\
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MZ*C'G^*#^'HI)OKV1Z&5_1[\0L'BG4J*E;DJ1TJ=94Y17V>[5S\IZ*_4(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO9F ZG:VR,?,Y4[1@,1^M<"9?DN%R2MFF9.FX1=[R2:ARKK=;OFT6O2VK.7
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M%04><?M@_P#)J?Q&_P"Q*U+_ -)GKF_^"=/_ "99X#_[!T__ *535TG[8/\
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M]9/Y]/1)(****\H]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M45^*O_#8'[5?_1QOC;_PI;G_ .+H_P"&P/VJ_P#HXWQM_P"%+<__ !=?1?\
M$(<T_P"@F'W2_P CX7_B:'AS_H J_P#@4/\ ,_:JBOQ5_P"&P/VJ_P#HXWQM
M_P"%+<__ !='_#8'[5?_ $<;XV_\*6Y_^+H_XA#FG_03#[I?Y!_Q-#PY_P!
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M ,"A_F?M517XJ_\ #8'[5?\ T<;XV_\ "EN?_BZ/^&P/VJ_^CC?&W_A2W/\
M\71_Q"'-/^@F'W2_R#_B:'AS_H J_P#@4/\ ,_:JBOQ5_P"&P/VJ_P#HXWQM
M_P"%+<__ !='_#8'[5?_ $<;XV_\*6Y_^+H_XA#FG_03#[I?Y!_Q-#PY_P!
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M^-O_  I;G_XNC_AL#]JO_HXWQM_X4MS_ /%T?\0AS3_H)A]TO\@_XFAX<_Z
M*O\ X%#_ #/VJHK\5?\ AL#]JO\ Z.-\;?\ A2W/_P 71_PV!^U7_P!'&^-O
M_"EN?_BZ/^(0YI_T$P^Z7^0?\30\.?\ 0!5_\"A_F?M517XJ_P##8'[5?_1Q
MOC;_ ,*6Y_\ BZ/^&P/VJ_\ HXWQM_X4MS_\71_Q"'-/^@F'W2_R#_B:'AS_
M * *O_@4/\S]JJ*_%7_AL#]JO_HXWQM_X4MS_P#%T?\ #8'[5?\ T<;XV_\
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M^-O_  I;G_XNC_AL#]JO_HXWQM_X4MS_ /%T?\0AS3_H)A]TO\@_XFAX<_Z
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M_BZ/^&P/VJ_^CC?&W_A2W/\ \71_Q"'-/^@F'W2_R#_B:'AS_H J_P#@4/\
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M^@I?^ S_ /D0_P"()^*'_0ME_P"!TO\ Y,^(:*^WO^')GQ%_Z+IHO_@IF_\
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M;W_#DSXB_P#1=-%_\%,W_P 51_PY,^(O_1=-%_\ !3-_\51_K]PA_P!!2_\
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M:+_X*9O_ (JNS_7[A#_H*7_@,_\ Y$\S_B"?BA_T+9?^!TO_ ),^(:*^WO\
MAR9\1?\ HNFB_P#@IF_^*H_X<F?$7_HNFB_^"F;_ .*H_P!?N$/^@I?^ S_^
M1#_B"?BA_P!"V7_@=+_Y,^(:*^WO^')GQ%_Z+IHO_@IF_P#BJ/\ AR9\1?\
MHNFB_P#@IF_^*H_U^X0_Z"E_X#/_ .1#_B"?BA_T+9?^!TO_ ),^(:*^WO\
MAR9\1?\ HNFB_P#@IF_^*H_X<F?$7_HNFB_^"F;_ .*H_P!?N$/^@I?^ S_^
M1#_B"?BA_P!"V7_@=+_Y,^(:*^WO^')GQ%_Z+IHO_@IF_P#BJ/\ AR9\1?\
MHNFB_P#@IF_^*H_U^X0_Z"E_X#/_ .1#_B"?BA_T+9?^!TO_ ),^(:*^WO\
MAR9\1?\ HNFB_P#@IF_^*H_X<F?$7_HNFB_^"F;_ .*H_P!?N$/^@I?^ S_^
M1#_B"?BA_P!"V7_@=+_Y,^(:*^WO^')GQ%_Z+IHO_@IF_P#BJ/\ AR9\1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 <E\>O'>L_"_X)^+/B1X>M[::^T'P]=W
M]G%>(S1/)%$SJ'"LI*Y'."#CN*R/V4/BSXD^.G[/?AGXL>+K*QM]1UJUDENH
M=-C=(599I$&T.S,!A1U8\YIG[8/_ ":G\1O^Q*U+_P!)GKF_^"=/_)EG@/\
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M'M7[''_0Q:Y_X(9*/^'M7[''_0Q:Y_X(9*/]4^)O^@.I_P" /_(/^(F^'O\
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M0_\ !D?\SZ8HKYG_ .'M7[''_0Q:Y_X(9*/^'M7[''_0Q:Y_X(9*/]4^)O\
MH#J?^ /_ "#_ (B;X>_]#6A_X,C_ )GTQ17S/_P]J_8X_P"ABUS_ ,$,E'_#
MVK]CC_H8M<_\$,E'^J?$W_0'4_\  '_D'_$3?#W_ *&M#_P9'_,^F**^9_\
MA[5^QQ_T,6N?^"&2C_A[5^QQ_P!#%KG_ ((9*/\ 5/B;_H#J?^ /_(/^(F^'
MO_0UH?\ @R/^9],45\S_ /#VK]CC_H8M<_\ !#)1_P /:OV./^ABUS_P0R4?
MZI\3?] =3_P!_P"0?\1-\/?^AK0_\&1_S/IBBOF?_A[5^QQ_T,6N?^"&2C_A
M[5^QQ_T,6N?^"&2C_5/B;_H#J?\ @#_R#_B)OA[_ -#6A_X,C_F?3%%?,_\
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MK]CC_H8M<_\ !#)1_JGQ-_T!U/\ P!_Y!_Q$WP]_Z&M#_P &1_S/IBBOF?\
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M?]8_[)[XJ_\ 3#?5P9I_R+:W^&7Y,]KAS_DH,)_U\A_Z4CSNBBBN\\4****
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MSV;M-1]M:*Y8R<4N1KE]KY!X[T^STGQOK.E:=!Y=O:ZK<16\8)^1%E8*.>>
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MM#D2:1K'PUHVGVZ:/;1,V1#]DD1TF51\H>;S)<#ER>:_?C]@;]K:Y_X*#_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&T[5-8MXY98X;D3)#Y>$0LYWR1@%000X8$@YKT%&WH' ///(I?VAF'_/V?\
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M337]R/\ D<3-^S5^SG<S/<7/P!\$R22,6DDD\*V99F)R228^33?^&9/V;?\
MHWOP/_X2=G_\;KN**/[0S#_G[+_P)_YA_8>2O5X6G_X!'_(X?_AF3]FW_HWO
MP/\ ^$G9_P#QNC_AF3]FW_HWOP/_ .$G9_\ QNNXHH_M#,/^?TO_  )_YA_8
M>2?] M/_ , C_D</_P ,R?LV_P#1O?@?_P ).S_^-T?\,R?LV_\ 1O?@?_PD
M[/\ ^-UW%%']H9A_S^E_X$_\P_L/)/\ H%I_^ 1_R.'_ .&9/V;?^C>_ _\
MX2=G_P#&Z/\ AF3]FW_HWOP/_P"$G9__ !NNXHH_M#,/^?TO_ G_ )A_8>2?
M] M/_P  C_D</_PS)^S;_P!&]^!__"3L_P#XW1_PS)^S;_T;WX'_ /"3L_\
MXW7<44?VAF'_ #^E_P"!/_,/[#R3_H%I_P#@$?\ (X?_ (9D_9M_Z-[\#_\
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M ,P_L/)/^@6G_P" 1_R.'_X9D_9M_P"C>_ __A)V?_QNC_AF3]FW_HWOP/\
M^$G9_P#QNNXHH_M#,/\ G]+_ ,"?^8?V'DG_ $"T_P#P"/\ D</_ ,,R?LV_
M]&]^!_\ PD[/_P"-U/IW[/'P!TB=KK2/@=X/M9)+>6!Y+;PS:QLT4B-'(A*Q
MC*LC,K+T96(.0378T4GF&.DK.K+_ ,"?^81R7)H24HX:FFO[D?\ (X<?LQ_L
MV@?\F^>!_P#PD[/_ .-T?\,R?LV_]&]^!_\ PD[/_P"-UW%%/^T,P_Y_2_\
M G_F']AY)_T"T_\ P"/^1P__  S)^S;_ -&]^!__  D[/_XW1_PS)^S;_P!&
M]^!__"3L_P#XW7<44?VAF'_/Z7_@3_S#^P\D_P"@6G_X!'_(X?\ X9D_9M_Z
M-[\#_P#A)V?_ ,;H_P"&9/V;?^C>_ __ (2=G_\ &Z[BBC^T,P_Y_2_\"?\
MF']AY)_T"T__  "/^1P__#,G[-O_ $;WX'_\).S_ /C='_#,G[-O_1O?@?\
M\).S_P#C==Q11_:&8?\ /Z7_ ($_\P_L/)/^@6G_ . 1_P CA_\ AF3]FW_H
MWOP/_P"$G9__ !NC_AF3]FW_ *-[\#_^$G9__&Z[BBC^T,P_Y_2_\"?^8?V'
MDG_0+3_\ C_D</\ \,R?LV_]&]^!_P#PD[/_ .-T?\,R?LV_]&]^!_\ PD[/
M_P"-UW%%']H9A_S^E_X$_P#,/[#R3_H%I_\ @$?\CA_^&9/V;?\ HWOP/_X2
M=G_\;H_X9D_9M_Z-[\#_ /A)V?\ \;KN**/[0S#_ )_2_P# G_F']AY)_P!
MM/\ \ C_ )'#_P##,G[-O_1O?@?_ ,).S_\ C='_  S)^S;_ -&]^!__  D[
M/_XW7<44?VAF'_/Z7_@3_P P_L/)/^@6G_X!'_(X?_AF3]FW_HWOP/\ ^$G9
M_P#QNC_AF3]FW_HWOP/_ .$G9_\ QNNXHH_M#,/^?TO_  )_YA_8>2?] M/_
M , C_D</_P ,R?LV_P#1O?@?_P ).S_^-T?\,R?LV_\ 1O?@?_PD[/\ ^-UW
M%%']H9A_S^E_X$_\P_L/)/\ H%I_^ 1_R.'_ .&9/V;?^C>_ _\ X2=G_P#&
MZ/\ AF3]FW_HWOP/_P"$G9__ !NNXHH_M#,/^?TO_ G_ )A_8>2?] M/_P
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MC>_ _P#X2=G_ /&Z[BBC^T,P_P"?TO\ P)_YA_8>2?\ 0+3_ / (_P"1P_\
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M ,P_L/)/^@6G_P" 1_R.'_X9D_9M_P"C>_ __A)V?_QNC_AF3]FW_HWOP/\
M^$G9_P#QNNXHH_M#,/\ G]+_ ,"?^8?V'DG_ $"T_P#P"/\ D</_ ,,R?LV_
M]&]^!_\ PD[/_P"-T?\ #,G[-O\ T;WX'_\ "3L__C==Q11_:&8?\_I?^!/_
M ##^P\D_Z!:?_@$?\CA_^&9/V;?^C>_ _P#X2=G_ /&Z/^&9/V;?^C>_ _\
MX2=G_P#&Z[BBC^T,P_Y_2_\  G_F']AY)_T"T_\ P"/^1P__  S)^S;_ -&]
M^!__  D[/_XW1_PS)^S;_P!&]^!__"3L_P#XW7<44?VAF'_/Z7_@3_S#^P\D
M_P"@6G_X!'_(SO#?A#PIX.T1?#7A+PSI^EZ='N\NPTZRC@A7)R<(@"C)Z\<U
M+_PCV@?] .S_ / 5/\*N45RRE*<G*3NV>C3ITZ--0@DDM$DK)+LD4_\ A'M
M_P"@'9_^ J?X4?\ "/:!_P! .S_\!4_PJY14EE/_ (1[0/\ H!V?_@*G^%'_
M  CV@?\ 0#L__ 5/\*N44 4_^$>T#_H!V?\ X"I_A1_PCV@?] .S_P# 5/\
M"KE% %/_ (1[0/\ H!V?_@*G^%'_  CV@?\ 0#L__ 5/\*N44 4_^$>T#_H!
MV?\ X"I_A1_PCV@?] .S_P# 5/\ "KE% %/_ (1[0/\ H!V?_@*G^%'_  CV
M@?\ 0#L__ 5/\*N44 4_^$>T#_H!V?\ X"I_A1_PCV@?] .S_P# 5/\ "KE%
M $-IIVGV&XV-C##N^]Y407/Y5-110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P""JW_R!^@U%?GS_P /NO$W_1O%C_X4C_\ QBC_ (?=>)O^C>+'_P *1_\
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M_P",4?\ $-^,/^@=?^!P_P#D@_XCYX6?]!S_ /!5;_Y _0:BOSY_X?=>)O\
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M?]!S_P#!5;_Y _0:BOSY_P"'W7B;_HWBQ_\ "D?_ .,4?\/NO$W_ $;Q8_\
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MU[7]C6M?M?V>Y]_45^?/_#[KQ-_T;Q8_^%(__P 8H_X?=>)O^C>+'_PI'_\
MC%5_Q#?C#_H'7_@</_DB?^(^>%G_ $'/_P %5O\ Y _0:BOSY_X?=>)O^C>+
M'_PI'_\ C%6-(_X+2>.=?U6UT+1/V:;:ZO+VX2WL[6W\02-)-*[!510(,EB2
M !W)J7X<\7Q5W07_ ('#_P"2''QZ\+IR48XUMO9>QK?_ "L^_J*_/V[_ ."U
M_C"PNY;&^_9PLX9H9&CFBD\12!D8'!4CR."#4?\ P^Z\3?\ 1O%C_P"%(_\
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MOSY_X?=>)O\ HWBQ_P#"D?\ ^,4?\/NO$W_1O%C_ .%(_P#\8H_XAOQA_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'G'[8/_ ":G\1O^Q*U+_P!)GKF_^"=/_)EG@/\
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M;CXW_P#"8NO_ (BC^U<K_P"?\/\ P*/^8?ZM\1?] =7_ ,%S_P CSJBO1?\
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M *-Q\;_^$Q=?_$5K_:N5_P#/^'_@4?\ ,Y_]6^(O^@.K_P""Y_Y'G5%>B_\
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M_P"@.K_X+G_D>=45Z+_PR'^U5_T;CXW_ /"8NO\ XBC_ (9#_:J_Z-Q\;_\
MA,77_P 11_:N5_\ /^'_ (%'_,/]6^(O^@.K_P""Y_Y'G5%>B_\ #(?[57_1
MN/C?_P )BZ_^(H_X9#_:J_Z-Q\;_ /A,77_Q%']JY7_S_A_X%'_,/]6^(O\
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MK_X+G_D>=45Z+_PR'^U5_P!&X^-__"8NO_B*/^&0_P!JK_HW'QO_ .$Q=?\
MQ%']JY7_ ,_X?^!1_P P_P!6^(O^@.K_ ."Y_P"1YU17HO\ PR'^U5_T;CXW
M_P#"8NO_ (BC_AD/]JK_ *-Q\;_^$Q=?_$4?VKE?_/\ A_X%'_,/]6^(O^@.
MK_X+G_D>=45Z+_PR'^U5_P!&X^-__"8NO_B*/^&0_P!JK_HW'QO_ .$Q=?\
MQ%']JY7_ ,_X?^!1_P P_P!6^(O^@.K_ ."Y_P"1YU17HO\ PR'^U5_T;CXW
M_P#"8NO_ (BC_AD/]JK_ *-Q\;_^$Q=?_$4?VKE?_/\ A_X%'_,/]6^(O^@.
MK_X+G_D>=45Z+_PR'^U5_P!&X^-__"8NO_B*/^&0_P!JK_HW'QO_ .$Q=?\
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MIYAA@@B4)'%&@ "HJ@8'^%?B_$^?8#-,)3HT8-2B[NZMRZ-./^?33[O[NRC
MUL/4=64DXR6EG=.^J?\ EZF#15[_ (1?Q'_T ;S_ ,!V_P */^$7\1_] &\_
M\!V_PKXD]XHT5>_X1?Q'_P! &\_\!V_PH_X1?Q'_ - &\_\  =O\* *-%7O^
M$7\1_P#0!O/_  ';_"C_ (1?Q'_T ;S_ ,!V_P * *-%7O\ A%_$?_0!O/\
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M))*Q099F8DL3ZDT<K2N'-K8]5Q1BBBI&&*,444 &*,444 &*,444 &*,444
M&*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,"BB@ P*,
M444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444
M&*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*3:#U%+10
M;11BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1B
MBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q2;%SG%
M+10 ;11BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@
M   Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS*1R!TKDOVPAG]E/XC9'_,E:E_Z3/7-_\$Z?^3+/ ?\ V#I__2J:O8CE]%Y
M\==\ZJJ%M+6<'*^U[W7>UNA\M+/,5'C:&3\L?9O#RK7L^;F56,$KWMRVDW:U
M[VUMH>UT445XY]2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/VH?AW^RI\/&\<^.Y)+B:XD\C1]'M<>??SXSM7/"HH^9G/"C Y9D5OAO6_\
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M]J'_ *$'P#_X*[W_ .3*^1:*/]2>%?\ H$A]S_S#_B+GB5_T,ZOWK_(^NO\
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M  ^>_:A_Z$'P#_X*[W_Y,H_X?/?M0_\ 0@^ ?_!7>_\ R97R+11_J3PK_P!
MD/N?^8?\1<\2O^AG5^]?Y'UU_P /GOVH?^A!\ _^"N]_^3*/^'SW[4/_ $(/
M@'_P5WO_ ,F5\BT4?ZD\*_\ 0)#[G_F'_$7/$K_H9U?O7^1]=?\ #Y[]J'_H
M0? /_@KO?_DRC_A\]^U#_P!"#X!_\%=[_P#)E?(M%'^I/"O_ $"0^Y_YA_Q%
MSQ*_Z&=7[U_D?77_  ^>_:A_Z$'P#_X*[W_Y,H_X?/?M0_\ 0@^ ?_!7>_\
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M4WPUX8^$NCM\,?!]K\-KSQ%9^,O"]O?:EI^C_"O3-2;6KB=,WZ1:JU[#-9O
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M^G'UKMM/O[74[..^LI0\<BY5A_+ZUX[7H'PH>1M"G1C\JW1V^WRK0!U%%%%
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M_P ^J7_@,_\ Y8'_ !+'P'_T$XG_ ,#I?_*3\B_^'8/[<O\ T0__ ,N;3/\
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MN;3/_DFC_AV#^W+_ -$/_P#+FTS_ .2:_72BC_B+7$G_ #ZI?^ S_P#E@?\
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M ,2Q\!_]!.)_\#I?_*3\B_\ AV#^W+_T0_\ \N;3/_DFC_AV#^W+_P!$/_\
M+FTS_P"2:_72BC_B+7$G_/JE_P" S_\ E@?\2Q\!_P#03B?_  .E_P#*3\B_
M^'8/[<O_ $0__P N;3/_ ))H_P"'8/[<O_1#_P#RYM,_^2:_72BC_B+7$G_/
MJE_X#/\ ^6!_Q+'P'_T$XG_P.E_\I/R+_P"'8/[<O_1#_P#RYM,_^2:/^'8/
M[<O_ $0__P N;3/_ ))K]=**/^(M<2?\^J7_ (#/_P"6!_Q+'P'_ -!.)_\
M Z7_ ,I/R+_X=@_MR_\ 1#__ "YM,_\ DFC_ (=@_MR_]$/_ /+FTS_Y)K]=
M**/^(M<2?\^J7_@,_P#Y8'_$L? ?_03B?_ Z7_RD_(O_ (=@_MR_]$/_ /+F
MTS_Y)H_X=@_MR_\ 1#__ "YM,_\ DFOUTHH_XBUQ)_SZI?\ @,__ )8'_$L?
M ?\ T$XG_P #I?\ RD_(O_AV#^W+_P!$/_\ +FTS_P"2:/\ AV#^W+_T0_\
M\N;3/_DFOUTHH_XBUQ)_SZI?^ S_ /E@?\2Q\!_]!.)_\#I?_*3\B_\ AV#^
MW+_T0_\ \N;3/_DFC_AV#^W+_P!$/_\ +FTS_P"2:_72BC_B+7$G_/JE_P"
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M_03B?_ Z7_RD_(O_ (=@_MR_]$/_ /+FTS_Y)H_X=@_MR_\ 1#__ "YM,_\
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MO.E:Z=U>U%:?-'Y%C_@F%^W*1G_A1_\ Y<VF?_)-'_#L']N7_HA__ES:9_\
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MDT?\.P?VY?\ HA__ )<VF?\ R37ZZ44?\1:XD_Y]4O\ P&?_ ,L#_B6/@/\
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M_P#)B/\ ^*H_X5YXP_Z!'_DQ'_\ %5Z=10!YC_PKSQA_T"/_ "8C_P#BJ/\
MA7GC#_H$?^3$?_Q5>G44 >8_\*\\8?\ 0(_\F(__ (JC_A7GC#_H$?\ DQ'_
M /%5Z=10!YM9_#;Q1<7"Q75JENG\4DDRMC\%)YKOM$TBUT+38].LQ\J#YF/5
MF[DU;HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%^)'C.#X<_#O7OB
M%=6+W46@Z+=:C);1L%:5886D* GH2%QGWK:KA?VH/^3:?B)_V(NK?^D<M"W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK_\ 'J/^'T_P _Z);XP_[]VO_P >K\UZ*^L_XACPG_S[E_X&S\U_XF&\3/\
MG]3_ /!43]*/^'T_P _Z);XP_P"_=K_\>H_X?3_ #_HEOC#_ +]VO_QZOS7H
MH_XACPG_ ,^Y?^!L/^)AO$S_ )_4_P#P5$_2C_A]/\ /^B6^,/\ OW:__'J/
M^'T_P _Z);XP_P"_=K_\>K\UZ*/^(8\)_P#/N7_@;#_B8;Q,_P"?U/\ \%1/
MTH_X?3_ #_HEOC#_ +]VO_QZC_A]/\ /^B6^,/\ OW:__'J_->BC_B&/"?\
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M_'J/^'T_P _Z);XP_P"_=K_\>K\UZ*/^(8\)_P#/N7_@;#_B8;Q,_P"?U/\
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M\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\ HEOC#_OW:_\
MQZC_ (?3_ #_ *);XP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\
M!43]*/\ A]/\ /\ HEOC#_OW:_\ QZC_ (?3_ #_ *);XP_[]VO_ ,>K\UZ*
M/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\ HEOC#_OW:_\ QZC_
M (?3_ #_ *);XP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]
M*/\ A]/\ /\ HEOC#_OW:_\ QZC_ (?3_ #_ *);XP_[]VO_ ,>K\UZ*/^(8
M\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\ HEOC#_OW:_\ QZC_ (?3
M_ #_ *);XP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\
MA]/\ /\ HEOC#_OW:_\ QZC_ (?3_ #_ *);XP_[]VO_ ,>K\UZ*/^(8\)_\
M^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\ HEOC#_OW:_\ QZC_ (?3_ #_
M *);XP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\
M /\ HEOC#_OW:_\ QZC_ (?3_ #_ *);XP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^
M!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\ HEOC#_OW:_\ QZC_ (?3_ #_ *);
MXP_[]VO_ ,>K\UZ*/^(8\)_\^Y?^!L/^)AO$S_G]3_\ !43]*/\ A]/\ /\
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M?\2K_P#4X_\ +?\ ^[GX'T5^^&!Z48'I1_Q&+_J!_P#*O_W,/^)5_P#J<?\
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M*O\ ]3C_ ,M__NY^!]%?OA@>E&!Z4?\ $8O^H'_RK_\ <P_XE7_ZG'_EO_\
M=S\#Z*_?# ]*,#TH_P"(Q?\ 4#_Y5_\ N8?\2K_]3C_RW_\ NY^!]%?OA@>E
M&!Z4?\1B_P"H'_RK_P#<P_XE7_ZG'_EO_P#=S\#Z*_?# ]*,#TH_XC%_U _^
M5?\ [F'_ !*O_P!3C_RW_P#NY^!]%?OA@>E&!Z4?\1B_Z@?_ "K_ /<P_P")
M5_\ J<?^6_\ ]W/P/HK]\,#THP/2C_B,7_4#_P"5?_N8?\2K_P#4X_\ +?\
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MO"OA/7KU[NZ\.V/AR'6+>SED<N\=K+'=0>1&,X6%U<Q]-V %'[$;1_=H  Y
MKXS.^-)9ECWCL'2="K))2?.IQDELW%P6J6E[[=#]H\/_  \QW!>4_P!EXG&K
M$X=-R@G2=.4'+624E5E>+>MN7=MWULOG7]ES]E/X#_\ !/3]FJQ_95_9[L9/
MLL$LEQK&J76QKK4KR0*)KNY=5 >5PB(   D<:(,*BBNBKVC /448'I7Q56K4
MKU'4J.\F[MOJS]0C&-.*C%62/%Z*]HP/2C ]*S*/%Z*]HP/2C ]* /%Z*]HP
M/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C
M]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /
M%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /%Z*]HP/2C ]* /';'3
M=0U2;[/I]I),Y[(O3ZGM^->G>$/#W_"-Z.MB[AI68O,R]-Q[#V  %:F!Z44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YQ^V#_P F
MI_$;_L2M2_\ 29ZYO_@G3_R99X#_ .P=/_Z535TG[8/_ ":G\1O^Q*U+_P!)
MGKF_^"=/_)EG@/\ [!T__I5-7TT?^2-E_P!A$?\ TW(_/:G_ "=>G_V!3_\
M3],]KHHHKYD_0@HHHH **** "OG/]M_XS>-OAO\ %3X3^"]#^/L/PYT/Q5?:
MO%XC\0W%KI[I$D%JDD.7OHWCCS(=O;._')Q7T97SG^VY\)?B-XZ^*WPG\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=1QTMSJM"*E>U_A;6]M=CVNBBBO!/M HHHH **** "B@D 9)KSW6/VM/V7]
MOI--U;]H/P;#<0R-'-#_ ,)%;LT;J<,K!7.U@>"#@UO0PN*Q4FJ,'*W9-_D<
M>,S++\NBI8NM"FGLY24;^EVCT*BO,_\ AL[]DW_HXKP?_P"#R'_XJC_AL[]D
MW_HXKP?_ .#R'_XJNG^R,V_Z!Y_^ 2_R//\ ]:.&?^@VC_X-A_\ )'IE%>9_
M\-G?LF_]'%>#_P#P>0__ !5'_#9W[)O_ $<5X/\ _!Y#_P#%4?V1FW_0//\
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M_P# )?Y!_K1PS_T&T?\ P;#_ .2/3**\S_X;._9-_P"CBO!__@\A_P#BJ/\
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MWUF)I)YG8*B* <EBQ  [DT2RG-(QNZ$__ )?Y#CQ-PY4DHQQM)MZ)*I"[?\
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M (!+_(/]:.&?^@VC_P"#8?\ R1Z917F?_#9W[)O_ $<5X/\ _!Y#_P#%4?\
M#9W[)O\ T<5X/_\ !Y#_ /%4?V1FW_0//_P"7^0?ZT<,_P#0;1_\&P_^2/3*
M*\S_ .&SOV3?^CBO!_\ X/(?_BJ/^&SOV3?^CBO!_P#X/(?_ (JC^R,V_P"@
M>?\ X!+_ "#_ %HX9_Z#:/\ X-A_\D>F45YG_P -G?LF_P#1Q7@__P 'D/\
M\51_PV=^R;_T<5X/_P#!Y#_\51_9&;?] \__  "7^0?ZT<,_]!M'_P &P_\
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M(&?S(_.@"]16?_PEGAG_ *#MK_W^%'_"6>&?^@[:_P#?X4 :%%9__"6>&?\
MH.VO_?X4?\)9X9_Z#MK_ -_A0!H45G_\)9X9_P"@[:_]_A1_PEGAG_H.VO\
MW^% &A16?_PEGAG_ *#MK_W^%'_"6>&?^@[:_P#?X4 :%%9__"6>&?\ H.VO
M_?X4?\)9X9_Z#MK_ -_A0!H45G_\)9X9_P"@[:_]_A1_PEGAG_H.VO\ W^%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /./VP?\
MDU/XC?\ 8E:E_P"DSUS?_!.G_DRSP'_V#I__ $JFKI/VP?\ DU/XC?\ 8E:E
M_P"DSUS?_!.G_DRSP'_V#I__ $JFKZ:/_)&R_P"PB/\ Z;D?GM3_ ).O3_[
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M_#CX'?&/3?%.I_&?0=;L)-#URWN+C0[#4_\ 19)=+N8(5=;FSA8^9),J@H&
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M6(Y56,;O\S,I50:'A_X\?"BPU+Q!I\/Q%\/PCQ=\.?#=G!J6L>$Y=2M=+O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !])$8Y=\3^9T7;PO)S7H+B+B-_\QE7_ ,&3_P#DCQ?]0^!/^A5AO_!%+_Y
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M\D4?\.SOV(/^B&0_^#[4/_DBO=J*/]9.(O\ H,J_^#)_YA_J#P+_ -"K#?\
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M.SOV(/\ HAD/_@^U#_Y(KW:BFN(^(5HL95_\&3_S)EP'P-)W>58;_P $4O\
MY$\)_P"'9W[$'_1#(?\ P?:A_P#)%'_#L[]B#_HAD/\ X/M0_P#DBO=J*?\
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M"_\ 0JPW_@BE_P#('A/_  [._8@_Z(9#_P"#[4/_ )(H_P"'9W[$'_1#(?\
MP?:A_P#)%>[44?ZR<1?]!E7_ ,&3_P P_P!0>!?^A5AO_!%+_P"0/"?^'9W[
M$'_1#(?_  ?:A_\ )%'_  [._8@_Z(9#_P"#[4/_ )(KW:BC_63B+_H,J_\
M@R?^8?Z@\"_]"K#?^"*7_P @>$_\.SOV(/\ HAD/_@^U#_Y(H_X=G?L0?]$,
MA_\ !]J'_P D5[M11_K)Q%_T&5?_  9/_,/]0>!?^A5AO_!%+_Y \)_X=G?L
M0?\ 1#(?_!]J'_R11_P[._8@_P"B&0_^#[4/_DBO=J*/]9.(O^@RK_X,G_F'
M^H/ O_0JPW_@BE_\@>$_\.SOV(/^B&0_^#[4/_DBC_AV=^Q!_P!$,A_\'VH?
M_)%>[44?ZR<1?]!E7_P9/_,/]0>!?^A5AO\ P12_^0/"?^'9W[$'_1#(?_!]
MJ'_R15_PU_P3V_8^\(:A-JGASX.1VT\^GW5C+(-:OFW6]S ]O,F&G(^:*1US
MU&[(((!KV>BIEQ%Q!4BXRQ=5I[IU)V_,JGP+P31J*I3RO#J2=TU0I)IK9IJ.
MC/"1_P $S?V( ,?\*,A_\'VH?_)%'_#L[]B#_HAD/_@^U#_Y(KW:BJ_UDXB_
MZ#*O_@R?^9/^H/ O_0JPW_@BE_\ ('A/_#L[]B#_ *(9#_X/M0_^2*/^'9W[
M$'_1#(?_  ?:A_\ )%>[44?ZR<1?]!E7_P &3_S#_4'@7_H58;_P12_^0/"?
M^'9W[$'_ $0R'_P?:A_\D4?\.SOV(/\ HAD/_@^U#_Y(KW:BC_63B+_H,J_^
M#)_YA_J#P+_T*L-_X(I?_('A/_#L[]B#_HAD/_@^U#_Y(H_X=G?L0?\ 1#(?
M_!]J'_R17NU%'^LG$7_095_\&3_S#_4'@7_H58;_ ,$4O_D#PG_AV=^Q!_T0
MR'_P?:A_\D4?\.SOV(/^B&0_^#[4/_DBO=J*/]9.(O\ H,J_^#)_YA_J#P+_
M -"K#?\ @BE_\@>$_P##L[]B#_HAD/\ X/M0_P#DBC_AV=^Q!_T0R'_P?:A_
M\D5[M11_K)Q%_P!!E7_P9/\ S#_4'@7_ *%6&_\ !%+_ .0/"?\ AV=^Q!_T
M0R'_ ,'VH?\ R11_P[._8@_Z(9#_ .#[4/\ Y(KW:BC_ %DXB_Z#*O\ X,G_
M )A_J#P+_P!"K#?^"*7_ ,@>$_\ #L[]B#_HAD/_ (/M0_\ DBD/_!,W]A\\
M?\*-A_\ !]J'_P D5[O11_K)Q%_T&5?_  9/_,/]0>!?^A5AO_!%+_Y Y/X6
M?!+X=?!;0QX9^&^G:A8Z:G$.GS:]>74, R3B-)Y76($L20@&2<G-;^I^'M&U
MA574[%9MOW68G</;(YQ[5=HKR:U:MB*CJ59.4GNVVV_5O4^DPN$PN!P\:&&I
MQA"*LHQ2C%+LDDDEZ&-_PK_PA_T!Q_W^?_XJC_A7_A#_ * X_P"_S_\ Q5;-
M%9G08W_"O_"'_0''_?Y__BJ/^%?^$/\ H#C_ +_/_P#%5LT4 8W_  K_ ,(?
M] <?]_G_ /BJ/^%?^$/^@./^_P __P 56S10!C?\*_\ "'_0''_?Y_\ XJC_
M (5_X0_Z X_[_/\ _%5LT4 8W_"O_"'_ $!Q_P!_G_\ BJ/^%?\ A#_H#C_O
M\_\ \56S10!C?\*_\(?] <?]_G_^*H_X5_X0_P"@./\ O\__ ,56S10!C?\
M"O\ PA_T!Q_W^?\ ^*H_X5_X0_Z X_[_ #__ !5;-% &-_PK_P (?] <?]_G
M_P#BJ?%X'\+0))'%I6U9H]DG[Y^5R&QU]0*UJ* ,;_A7_A#_ * X_P"_S_\
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M !5'_"O_  A_T!Q_W^?_ .*K9HH QO\ A7_A#_H#C_O\_P#\51_PK_PA_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRJG!-J-G&,N>RT;DW>[U2M&_NFS_ ,+&^(/_ $/>L_\ @TE_^*H_X6-\0?\
MH>]9_P#!I+_\56-17WOU?#_R+[D?BWUW&?\ /R7WO_,V?^%C?$'_ *'O6?\
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MX@_]#WK/_@TE_P#BJQJ*/J^'_D7W(/KN,_Y^2^]_YFS_ ,+&^(/_ $/>L_\
M@TE_^*H_X6-\0?\ H>]9_P#!I+_\56-11]7P_P#(ON0?7<9_S\E][_S-G_A8
MWQ!_Z'O6?_!I+_\ %4?\+&^(/_0]ZS_X-)?_ (JL:BCZOA_Y%]R#Z[C/^?DO
MO?\ F;/_  L;X@_]#WK/_@TE_P#BJ/\ A8WQ!_Z'O6?_  :2_P#Q58U%'U?#
M_P B^Y!]=QG_ #\E][_S-G_A8WQ!_P"A[UG_ ,&DO_Q5'_"QOB#_ -#WK/\
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M?O#Q^^BK-J]I'_'EJ7_7B/\ T=%0!6^W7O\ S^2_]_#1]NO?^?R7_OX:BHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#SC]L'_DU/XC?]B5J7_I,]<W_ ,$Z?^3+/ ?_ &#I
M_P#TJFKI/VP?^34_B-_V)6I?^DSUS?\ P3I_Y,L\!_\ 8.G_ /2J:OIH_P#)
M&R_["(_^FY'Y[4_Y.O3_ .P*?_I^F>UT445\R?H04444 %%%% &#\2?AGX'^
M+W@Z^\ ?$;P]!JFDZA'MN;2?/.#D,K AD8'D,I!!&017R+XK_P""*'PNOM3:
MX\%?&G7--M6R?LVH:?%>,IST#JT7 ]P3[U]L5Y7^TC^UCX3_ &:-1\-:)K?P
MX\9>*-1\63746CZ7X+T>.^N7:W1))/W;2HQ^5MWRAN%8G %>WE/$6>9*G' U
MG!/5K1J_>S35_.USY'B;@3A#BZ49YQA(U915E+WHR2O>W-!QE:_2]M7IJSYG
M_P"'(GA[_HXJ\_\ "93_ .2*/^'(GA[_ *.*O/\ PF4_^2*^FO@-^UM\/OCS
MK][X'MO"WBKPGXHT^S%[<^$_'&@OIVH?8RX1;I8R65XBYV[E8X.-P&1GIO@;
M\8O#/Q^^$^B_&+P?8WUKIFNVS3V<&IQ(DZ*'9,.$=U!RIZ,>*]G_ (B!QBO^
M8I_^ P_^1/E/^('^%?\ T+E_X,K?_+#X_P#^'(GA[_HXJ\_\)E/_ )(H_P"'
M(GA[_HXJ\_\ "93_ .2*^[,BC(]:7_$0N,/^@I_^ P_^1'_Q WPK_P"A<O\
MP96_^6'PG_PY$\/?]'%7G_A,I_\ )%'_  Y$\/?]'%7G_A,I_P#)%?<FJZC!
MI&F7&JW*LT=K \LBI]XJJDD#/?BL3X1?$W0OC/\ #+0_BOX7M+NWTWQ!IL5[
M90W\:K,D;C(#A&90WKAB/<T_^(A<8?\ 04__  &'_P B'_$#?"O_ *%R_P#!
ME;_Y8?&W_#D3P]_T<5>?^$RG_P D4?\ #D3P]_T<5>?^$RG_ ,D5]V44O^(A
M<8?]!3_\!A_\B'_$#?"O_H7+_P &5O\ Y8?"?_#D3P]_T<5>?^$RG_R11_PY
M$\/?]'%7G_A,I_\ )%?=E%'_ !$+C#_H*?\ X##_ .1#_B!OA7_T+E_X,K?_
M "P^$_\ AR)X>_Z.*O/_  F4_P#DBC_AR)X>_P"CBKS_ ,)E/_DBONRBC_B(
M7&'_ $%/_P !A_\ (A_Q WPK_P"A<O\ P96_^6'PG_PY$\/?]'%7G_A,I_\
M)%'_  Y$\/?]'%7G_A,I_P#)%?=E%'_$0N,/^@I_^ P_^1#_ (@;X5_]"Y?^
M#*W_ ,L/A/\ X<B>'O\ HXJ\_P#"93_Y(H_X<B>'O^CBKS_PF4_^2*^[**/^
M(A<8?]!3_P# 8?\ R(?\0-\*_P#H7+_P96_^6'PG_P .1/#W_1Q5Y_X3*?\
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M*?\ R11_PY$\/?\ 1Q5Y_P"$RG_R17W911_Q$+C#_H*?_@,/_D0_X@;X5_\
M0N7_ (,K?_+#X3_X<B>'O^CBKS_PF4_^2*/^'(GA[_HXJ\_\)E/_ )(K[LHH
M_P"(A<8?]!3_ / 8?_(A_P 0-\*_^A<O_!E;_P"6'PG_ ,.1/#W_ $<5>?\
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MG_R14D'_  1.T>U?S+7]I+4(VQC='X;53^EQ7W115?\ $0>,/^@I_P#@$/\
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MZ#K?^ X_^*H_X5%#_P!!UO\ P''_ ,57944 <;_PJ*'_ *#K?^ X_P#BJ/\
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MC_XJC_A44/\ T'6_\!Q_\57944 <;_PJ*'_H.M_X#C_XJC_A44/_ $'6_P#
M<?\ Q5=E10!QO_"HH?\ H.M_X#C_ .*H_P"%10_]!UO_  ''_P 57944 <;_
M ,*BA_Z#K?\ @./_ (JC_A44/_0=;_P''_Q5=E10!QO_  J*'_H.M_X#C_XJ
MC_A44/\ T'6_\!Q_\57944 <;_PJ*'_H.M_X#C_XJC_A44/_ $'6_P# <?\
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M-TWX?^!]+^PZ/H]FEKIMGYSR>3"@PJ[I&9FP.Y)-*4DXC2U->BBBH*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH YGXT^ +CXJ_"/Q-\,[74ELY/$&AW6GI=R1;UA,L
M3)O*Y&<9SC(S67^S5\(+OX"? [P_\(KW7(]2DT2VDB:^C@,:R[I7DR%)./OX
MZGI7=45U?7<1]1>$O^[<E.UE\235[[[-Z7L>:\IP+SA9FX_OE3=)2N_@<E)J
MU[?$D[VOTO8****Y3T@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g4bdklltl5z5000011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000011.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0#!JH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **8[
M8^8#(52,C@EVP%0#HS XY/\ ^K/U+5+#2K*^U'5+ZSTO3=-MWNK_ %&]N%MK
M2QAA3?)+>7$[)##&J_>8N!GKVR :=%?D=^Q+_P %=/@C^W=^V1^U5^RO\%M/
MEU?2?V8M!T;5;WXEV]T9](\6W=_K0T&]M=+PHC\JROA,IE1F$GE\$C-?KC0
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MO7Z_GV_2C# \M\O7.?T]?UQ^-&MH-)OFW6B<=$[._P#7R%=6;>EO)Z_@/HI
M?R[?3_/%+3::=@332:U3V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M76W,].I_35/PF^B+.DJT?I'99'GDN:G[;"<KG:,FU*<-%RZ+56:75G]X3?\
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M_H-Z7_W_ )O_ ([1_P .+?VKO^@WI?\ W_F_^.T_]=N+O^B2Q/\ X#+R_O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%'\^P]3V'K^5(.@.0-RJ"""O)/!0GC)]#G\NH M%+@^A_*D8'&2=@&=QQSC
MU]MO7/3M0 44P,<X(Z\*1R",9#Y'0'[IS_%3Z "BBB@ HHHH *0$!TSG^(Y'
MW1A3DL>PYX]Z6D(R"#T(P?I0!_)E_P $5?V7_CQ\(?\ @L7_ ,%</BU\1_AW
MK7A7X>?%;3M$_P"$"\3ZA"R6'B1HO'#7C_89& #;+8F1E'&T!N<\?T8_MA?%
M?XA? O\ 9N^*OQ9^$G@";XH_$+P=H"ZGX9\"0JSS>)M1^V0VWV"%4PV\1RM/
MN'14)KZ76W@0DK#$K-C<R1HC,!T#LH#/C_:)&><4]HT?(=%8'.590R'ZHV5/
MY4 ?!?["OQC^*G[9/[&6B>/?VE_A!-\%O'?Q)L?&_A;QE\-+M7$FFZ6]SJ&@
MQEUF+,?[0TI_. ).1+Q\M?R:_"_X5?\ !5S_ (("_M ?'7P+^S=\!D_:A_8Q
M^-/C2_\ &?@?2;*:XF?PK<74\\MM!'I\;++I]W:PR"TNW5EANAAO++#=7]WJ
M11QA52.-%3.U4141<]<(HV@GN<9S2R112@+-%%,H.0LL:R*#ZJ'! /TQ0!_&
M!^RY^RI_P4;_ ."L/_!2;X$?M\?\%!?AQ9? K]G_ /9.E;5_A!\'Y56X.LZ^
MKI,\=[IMPK^7#>7:07.H2SEG=[6$*RKE6_M"P!PH 48"@# "@ * !P    !V
MINQ %54547(5$&Q!GKA%PO)YZ=SZTZ@ SV[U'+]W!S@D ]>G?/MZT_ SGO02
M #GH1@^X/:AJ4HR47RV:N^_7K?\ KH%[R48WB[*[Z[K_ #./\8:GK.C^%?$F
MJ^'=+77?$>G:#JESH>D>:L$.KZG;VTLFGZ>;AOEB:ZN!'"S$=&S[U_ Y^T7\
M _VM?'O[;.G?"WXJ^$=O[1_[1.G>(?BGX(\)7&L1W"7OA#2]1N+*3_B8E3#9
MIH@C-C%;.A+>2&&!7^@6%!_A]#T_NG@X['OG&?6OYT/VM!G_ (.._P#@FYG@
MK^QI\9C&PZE3XRUG>&Z=>G]*^]X#\1\?P!C<1CLHP6$Q.,KTX4)SQ=-R=."U
M7LW9J*;YI2MJUI?:WY_QOX<X'CN&%PN;YAB\+AL)4GB%'#SE%592BDX5-5=O
MEBHZ63=WY_SH_'W]CC]H7]E[3-$U3XW>%;3PE#X@OFLM&1=8MK^^OY,;V=[6
M%4D2VA) :Y&%1ODX-?,.PN7< L\+B.YEE<NHSQE)#EI$;.$!W,P.<_+7]SO[
M;7_!+K0?VX/B1IGCOQW\7/%FCZ9X<TG^R/"_A+3_ "O[,TI)2)-1G*,H,D]U
M<J)O,?<XP$!"\5_,A_P4_P#V&?"?["?CSX7^"O!_BO6O%=EXY\.ZQK=W<ZRB
MB>&YTN\AMDCC,2JACVR=&&<C@@=/VGC3Z5,<C\+\RS6E+#UN,O8JDJ5'#\F%
MP\JU;DB^=P7-*$90>K=W>VB.?Z*_T+*'B[])#A7@3.<3B,/P1CL76Q<JLL5>
MOBJ.#H_6'0<74NHU?925OY7ZH_-I-9:ULKO2X#+_ &9<7,5S=6!EE6VGNK96
MCBGE@WA)Y8@[>66!P,XQ7]#O_!!W]LF#P-XN\0_LO>--9-OX6\7RS^(? <FH
M3A8-,\0X#:E81>:>/[6)C\B)3M!A^5<U_.7UZJP?<&C0@8!'!8'J?4Y.,^E7
M-+U?5=!U"WUG1+^ZTG5[)UDL;ZPGEM[NWD0_)/!-$RR(ZGNK ^]?YRS^DGX@
MYG7K+BC%PSG+\PJ>TJ8-4J4)4JL6I0G3J\JLH1C&/Q6TV=C_ *3^+_V8'T?<
M=PE/!< 9#3X2XFP&"^K8'/J>(KR=6I""A)8BE*3@U.MS2DDG?H[NZ_T]K6:*
M;+1R12H_*.NUN,<+D,02.N!U!SQ5P_=P"IYST&2?S_STK^&+]F+_ (+'?M+_
M +/&@W?AK7'C^+&F&WMTT9?$UW)+<Z:T3%II!/N\Z3>K@,))&/  YS7Z>_!G
M_@X1\&S:;>?\+H^&&J6NM).5L(_"L\2VD\6T')^U*[&53GH=I'&*^XR#Q#R'
M/ZF&P7M_J>8XNK"E##3@DO:27-"'M?@<IJT;W6KMH?Y=^*'T'O'/PRAF^85\
M@>=Y#E4'6_M;+*T:D<1AZ4%*I66%J-5XJG%.56+YOA<H<ZM?^E[GK\N?P[]\
M>OX?A4J$[1T_(>OTKP']FGX]>'/VG?@GX%^.7@_3[_2_#7Q T^ZU#2['561]
M2M$M;^YTZ2.X:,*A)FM9"H4<+C/3->]H3M'0_ISSG/7Z]L5][4HU:-65&5"$
M*E*4H.*DG&#C-*:DEIS<R=K=+OM?^.U)R<4X5$G!3>\>5RL^24-.5QVL]5U)
MMW^ROY4A8]@/H /ZTG^?6FYSQANN,X]\=ZEJ22NXQ>FD5N[16WEZ^?K:YUM!
MOK=RM;X>E_Q[^FLF[_97\J-W^ROY4F,G(/W0<<C:Y[9P<C\QWQT-)SW ![XS
MC\,_TXHBFE9_TK";3LX_/Y6M_77<=GV4_A_ABC=_LK^5-HJFDMMGJ2G?7Y?*
MR';O]E?RHW?[*_E3:*0QV[_97\J-W^ROY4VB@!V[_97\J-W^ROY4VB@!V[_9
M7\J-W^ROY4VB@!V[_97\J-W^ROY4VB@!V[V7\J-W^ROY4VB@!V[_ &5_*C=_
MLK^5-HH =N]E_*C=_LK^5-HH =N_V5_*D8D@@*OY>])2$D#@<TUNM+Z[=P2O
MIWTWMOY]/7H,&[^/'Z<?3GCM_P#6S7\<?_!PV%F_:>^&$#.RAOAIJ,(.QF 2
M6]17B3"L"SY+D'//3CBO[&P=Y4,, DCN!SZG\N.M>&_$?]F_X*?%[6+?7_B-
M\/\ P_XLU.QA-M;7FL:?;W<\,'5HH7=&9$)P2!C/!Z\U][X9<6X7@?BBCQ!B
MZ$\9AZ.'Q=+ZK348W5>"@X\UXV6]W>^J[Z_G_B/PEBN-.&,5P[A,1#!U:N*P
MLEB9^_:-.K&HW\,KV_(_FR_8 _X+!_$O4O&/[,G[)Q^'GA]/#;#0/APNN[;C
M[>ECI=@UO'>J"XC%P5MTW*4'+,<5_5VN'^0])&W[0. 0 2#GD,V<G''IS7S1
MX9_8Y_9M\(>(=*\5^&OA5X6TG7-%N1>Z;?VFE6T5S9W48*I-;2I&'20!B,@Y
M.<DG-?3).UF.QGRH=0<#&W&-H['G/TZ]JSX]SOAC/LU6/X9RF624*D95,9AY
MOG=3%5:OM9S3<YZ23>K:6NAMP'D7$7#V5RR_/L[CG-3#N,<-5C&SHX>C2A2A
M34G&+?+R+W4W8_FV_;)_X+4?%7]FS]HSXB_!;0/ASX9UG3?!^IK96VH78N?.
M974'==F-PN3G' QGKFOF!O\ @X=^-S'_ )))X/P!&VUA=Y?<2&5,S?>P,H>0
M<U_2SXO_ &2OV=O'OB*_\6>,OA;X7U[Q#JLPFU#5+[2[::ZO)N@>XD,1,A
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M_P"M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% %6^O+73K.ZU"]N(+.SL;>:
M[NKRZD$5M:6]O$\T]S/(Q4)%#$CN[,0  22,9K^0S]IW_@[8_9_\!?%KQ9\)
M_P!ESX#>/OVC+CP1XBU+0M7\3Z-8:C>Z-J_]FS&VEU+0[?2XGOET_P"UI-;Q
MS7*KYAA9@%! K^@__@I]HWQ4\0_\$\_VQ]$^"/VX_%C4O@'X\M_ @TUV2^.N
MG2I3%]E965A+Y(E P02"1WK^>/\ X-'_ -G?]F[4OV O%GQ2N?!GA'Q/\>]1
M^,OC?P[\3-2US3]/U/Q-HL6F&P.FZ1<13K)<65I+NNY(&P%N'$C(6*24 >%'
M_@[N^)7?_@G9\5<_]BSXW_\ D6OT)_X)@_\ !P;XW_X*&_M8^'/V;=8_8^\<
M_!W3];\-^*->G\:^(-%\265A;CP]ICZ@EF9M3@2W62[9?*17(+$_(":_HN'P
M<^%)S_Q;7P:/3/A[3OU_T;FKVE?#KP)X=OX]4T#P5X<T;4H598K_ $S1K6RN
ME60;'C6YAAC=4<$"1=PWKQR#0!VV[<Z],!3@@C+ DCC'R[!TP.00#T%25"B!
M=BYP44OY9!!0N?F((X*DG R>GOQ4U !1110 4444 %%%% !1110 4444 %%%
M% !1111T:Z/>W7U%;5/9KMIV_K_@A_/M7\Y/[6B$?\''7_!-Q\\']C3XS@#T
M \9ZU_/!_2OZ-J_G-_:U_P"5C?\ X)M_]F:_&C_U,];IIVT26UMOE]]M+C>M
M[ZWMOKMVOMKJ?T6F-A)G('/) Y.!C'/'/<]Z_+__ (*;?L!:=^VO\+;>#2KN
MWTGXF>#'EU+P;K5Q$6621OFFT>\DC'G"PNOONL9!\U4/0$5^HQY<J.O)_6FL
M!ALJ6P#P.OX=C].]<&89=@\SP>(P&,HPJX;$QM5IRBFF[IJ23T4XM*2EO=)G
MU?!7&F?\ <391Q;PSC)9?G.2XFGB<'B*>CO#25.=FN:E5@Y4ZD+VE"<EVM_G
M$_'G]CC]HK]FF*74OBQ\/]2T7P[#K#Z+9^)A+'<:;J4SLRV[P^7ND@2Y56>,
MS$8 P3G%?,J&-2H!#94[)N<EARXYX 4G S@L3\N,5_I._'7X"_#O]HCP!K?P
MZ^(VA6NLZ!K=L8O+D0"6TF93Y5U:R;<PW,1.5D4AD/ ZD5_/%X\_X-XK:3Q!
MJ-SX ^,&HZ7X=NC+)8Z7?6%I=/INXL\4232?/*"?DR_*J.*_G+BGPCQ>%JRJ
M\.U:F84Y+F>&JS<?8)R;<8R=E+31.*5D^Q_ME]'[]I+P?G>62R_QEJTN&\XP
MDK4\9A</4J9=CZ7)'WFX1E.&(;D^:+C9R7NR::/Y? "W$A(E8@[< ?)V;(Y
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M;H$F@);F9TF\)>$PVG74=G$^?(C\16BO>W"L%)N-O7&:_I=^&W_!0/\ 9?\
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M?^'/$7Q6\*Z9KNES_9=3TNYU&);FVN'C281RQ[LJ?+D1^F,,,'GC^)?]F_\
M8]\=_M-?!OXB>./AW\1?#$?B/X>ZY!J^K^"/$%W:6%[>7ECF^TN\LI+F2*2>
M<);NX=-Z[D"L02,_+WB6[UKX@?\ "QOB1XX\;FT\<:/K.F6%_IES<S+J?BJ[
MO&;3I[ZR,9*A-/%FBS;F ,>W;GFOR+ 1X'XHX@R[(,RH9CP1.C@*>%IU<4J,
MXYC6I1595Y2E-Q4Y4G)S22O+E=TUK_0'%'@MXC<'<(YWQ;PCQ!E/B:LNQ4)Y
MO@,LAB'BLK=9PI*/L?8P<H.J^2$M5UCHKK^DK]H7_@L7IWA+]O;X=>&O"'B%
M-4_9W\'17&@?$"\M61[;4M9UJ(13ZS"\9(N;31XO*DMU^8F;S"H%? OQB_X+
M5?M#7GQZ\;ZY\--?$?P@3QC;77A+P_>1)YDWA_2)D$]K<2Q+E(M4$32%20P2
M4#UK\5&ADB\U&.+@'%[>38EC21@"@@)R9'(899NA)R>E;/ACPYK?B^>_M/#U
MA'J%QIVFWVL:A:M+!:J-+TR)I[V\#2M&'FBB4R-#&2[_ '55CQ7WN&SSPOX=
MJU,13X6Q6>Y+D6&EEN:9]-TIT*TJ>(4JV*C!3]^HI<RE-1TA[L;)'RD/HS>+
M_$^%RS#9GQUEG"W%_%<<-F^4\&5H8B.,5/%8>+PM!U8T'[&52%2#]G*27-)7
MU5S]U?#O_!:WXFVG[)'Q*\+ZCJEPO[0VI>,KT_#S63Y4EII7A/4KK[?(;O?E
MV>QCEFL[3 +;%C.1MK]QOV,_^"COP.^-'P+^&?B#QG\0-$\._$"[T_3_  _X
MCT36+N.'49?$=J(]/DN/*S^]&J3H+F' /$^T\\U_"*EQ;O&TR%8K%F5Q,T$;
MW;J^U-R ] /NA#C"\XS7NGB?PA=_ CXK>$+/5-<LO$&GZ#J'@'QQ<WOARY=[
M>?3[Q;#7WMK9\B&2YM;=C:WD:L3'=AD( %?$<4\0>'&9X"OFN3\/9OE^15:F
M(S&&?494IT7!15/V<</.<E3PTGR22BDTTK7UO^D\-_10\5LIS2'#&=\<9#C.
M.*5"A0I\)N%=8N4URSA3EBE12G6Y+KFE.[/]('[5&8HID<-%(D<J,@R#%( R
M2*>00P((P?ZFI/M$8P"V<\EAC&#WP<' Z<#WK^6;PO\ '']OS_@I1K$]W\"-
M:7X)? GPLT.FZ-KTC7$5YK+V:"$S07$)#W$P5?\ 2(7/DI)P.:L>(_B+_P %
M"O\ @FUXDT?QK\6?%9^-?P,U;5[*W\3ZE*;NZN]&MVD6&>XO99-[6,(W^9"8
M<(Q4+(037\WU.+\+""QM# YE5RN3?^W>RBZ3I*=O;\O.I*GJDY=.FMT_V!_1
MKSNEB(9!B>+.%Z?'2HROP8L54>;/$**G' N3IJBL9.";5*^]DY6]Y_U)&= 5
MSD*0#N/ &[[N?KZ_G2B>(XQ(OS#(.?\ //L:_G*_:&_X*6?&?]H[Q]X0_9X_
M8-LH+W7_ !1X9T[Q%XH\<W*-)9>']'U"-6E1W48B>T)VW+9%Q&Q01 @L:\_\
M1?LX_P#!5GX'Z.?BKX6^.T?Q UO1H3JVH^#;J6ZN8K^*$&>ZMM.AG;RFD"!U
MC28;2,CK6T^+Z$E.> R[&YKAZ3<:N*P:C*@G:+W<DW*";YHI:]'LWR4_H[YU
M@:6!H\7\1Y#P5G>945B,NX?SRK5IYEB*-5N&'G6A"#6&6(G%JGS-Z;VE>*_I
MS$PZY4CH<'D'L.IZ^O3WS3O- 7)Y(4N1TPH]R<$^PK\U/^"<O[<VF_ME?#*\
MFUVS7P]\4O!%ZVB_$#PS*IAN;34+5S;_ &Q8'59([6YGBD$:NHP5; V[2?K_
M ./7QI\(? /X4>+_ (J^,;Z.'0_">EW&H3\[?.N8XW-O8Q$D?O;R0"")#P6(
MSGM[F'S;"5\M6:J<7A73=9N]O9Q@KSC+71JTD[ZIK0_)\XX"XER7BV7!6+R[
M$2X@684<MC@J5-S=:OB)PCA_826M3ZRJE.5%I6E&2;47=+VEKA%(!W D @8R
M<'^(J.0H[DXZ4T729Y=1S@C(R.>#MX;D<YY ')Z<?Q$?&#_@HY^W)^T]\5O#
MF@_#'4=8\'6OCF^=OA[X3T 7%OJ3Z*]P8([V]DCV3O"J;9IFE^1%)*_* :T?
MVB_$7_!3C]CFX\)>)/B)\4M<O=)ULVS6^MV%Y?7ND6ET=CMI^JF=SY<L9),F
M[$3HI0-DU\%+Q/P+AC*^&RO'XO"X><*<J].,?8TG*7+S3F[/325G;IJKM']9
M83Z#7&3Q/#V49SQIPAD'$W$V"J8W*>&\;B:SS+%*G#GE3A%4TIM6<6X:*<9)
M7Y7?^VA9PXRI!7)#$\!><#G.#D\9' SUZX<)@3M&"1]X YP3T /0X'7^5?BO
M_P $N_\ @H[JO[3<.K_"+XQVL6E?&+P?IEOJ8E$+VL?B;P]<!5M]9BMI%0*&
M9D6-4 252).>M?M LEM@.60\*00<,>.KJ.A.<\=>IK[W*,TPN;X&EC\/4;HU
MG&S25Z;]U2IS3>DF^EWO=7Z_RIQ]X?<1>''$^8<*<38.>$S++:KA/V?[VEB8
M-VIUL/4:2G2K)-PEHUK&24HM*V7PN<$\9P!GZ_E]*;YR;6;(P",9*@$=VR2
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MZ"[M'G*'A2PQ@[L$#''0\@\^HI#(HVYS\P'UW'^''7H<[ONX[U_(U_P;9_\
M!03X]_%;XO?MO_L,?M??$/Q#X]^.'P-^(VJW_A/4O$<4T-Y+X+\+ZK-X0U:%
M!<?.R7>J1PZI 5ZVMPLBY1E8_P!;Y7S"-VWS I4$Y1$7[VWCJ5')/?&": )P
M223U5?OG&%7Y<G#'[V.,XSUR.*7+%=VQAR.-NXX/?"_KZ=Z_DB\%_ML?M-?M
MQ?\ !Q;JWP ^!'Q4O_#G[(_[&FAO??%G0+,3MHWC3Q!H,"Z/KVAWLT!-M-+?
M:WJ"&P5MRHMC,2=JDU^,'_!;3_@II_P4/^"O_!57]HCX;? #XT>*]"^&7P;\
M)Z)\3-2\)Z==W"Z?:^%M"N+6Y\0[DBEV^5-#/'#)\FP+(02N> #_ $>BY4 D
M=65>.HW9Y89R ,<Y QWIP8L"54DAB-N5R<8YZ\#GK[CUKY:_8H_:(TK]K+]D
MK]GS]I+1(EAL?C%\+_"_C'[&9%FDAN=1L(UO(9)$)(F%S%*71R'3(#X8&OQ.
M_P"#E[]OKXJ_LB?LO?!_X3_LZZ]JWA;]HG]IGXJZ;X?\#>)=%EV7&@Z-X5EM
M-2\2-.L3"X6+4[6\BL$F V*WFL21&< ']*V[#;6&UCG8"1\X Y/!^4=OFQS3
ML/D#8<8R3D<'T SD_45_+]_P;(?M5?M%?M1_L$_M)>-OVB?B%JWQ!\?^"/V@
M?B!X-T_7=8E:>YM-.T?P3X?ODL(9)&9Q:V^H7=R\0R&!+$C<23^'?_!/=?\
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M%7P6_;3UOX;:3^S_ /$;QNUM::I>W1MET0?$76_#FEZ;9*)OE%O!;1JG  1
MO % '^C3A^/D/.?3J#QGT!Z@TQG53@Y]"<<@^A'4#T/0\>M?QO:K_P $KO\
M@X&TJQN+_P /?\%$[;6-;M,75C:7][?Q65S<6[B1+2^9)<F*7:$8IGKC&*]^
M_P""(?\ P5>_:V^+7[4/QY_X)K_\%$]*TBP_:5^"^F7.N^&O%-I!;Z:OBO2=
M+N[6RN-.6WC(-S//:W$&LVES)^]FL<DY=6"@']4HRPR@+*>AZ9/IS_/I2?/P
M#&V3VX(![?,#C'OT'>OXE_\ @L_^T1^WGXB_X+3_ +-G[!'[*/[0NM?!C3/C
MGX4T2S@GMKB=-,T_5Y]&N]4N=2N8XY%W?)92*X"G_6+C.*]0O/\ @E3_ ,'
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M_:8^(7PH\1^%[UY[BP\$>$I_%<VEZ;J6DNQ,5O-I'DV\BJ^,6XG*[0 * /\
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M13L34V <W3*SF[(5VP1BN>\:>$?$WAO1?#GB37KQX;;X@Z9_;FCW#1*DNJ6
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ME/%GC/Q&T5YXI\5:M;Q23ZA=* KBT1@PM+0L=PMD=EW8;.>*^^W\-^'RC_\
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MN;3/@W^V8FF:#\0[+2[5K31X;F\:W\":C8ZC)&L<$ES>ZF=/\2%7)*(DUP0
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M=M.TOP+H^HR^'_A)\5OA%;W6F:';2-:Z;X6TQ;FPFU&\M[=,0VFFQVT3R7)
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MV/\ HNZ'?6^IZ9I&H6,T%W87^F6%W:WD#J\5U;SVL<L-Q&Z\,CKM9-ORLI#
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M;IX[,ZY;R3&_U,)YB#S+A717;!^X!D\X^#/^',G_  7-_P"DNGQ)_P# Q_\
MX]7Z1?\ !0O_ ()T_P#!37]IC]H:;XF?LL_\%-/'7[+/POE\*Z3HR?"SPY8)
M=Z=;ZW823M?ZN',B!IK])(1)\I*>2 #AVS\-_P##F;_@N-_TG#^+/_@DB_\
MCU 'Z<_\$R/V%_VR/V=_"GQN\(?MT_M2:[^UOI'Q3LFTC3;#Q4?/L](T.^M9
M-/UG2V5Y)-\6I64UQ#-&,AXY6W"OTC^ O[-GP)_96\%3?#SX ?#;PM\+? _]
MH3ZY<Z#X8LK?2=+:]E3;<WD\42QQ!_+!+NYP<*S'@U\$_P#!,W]CW]M?]D/3
MOBA+^VC^W%XD_:[7Q!]GN_#&H^+[9-/3P-96$8>_DCD,C*5F5&DE=F5(TSR%
M4X_$G]OS_@JK^U#_ ,%+?CSXK_X)=?\ !(:%K.VMM4?PY^T1^UD^I)8:-X4\
M,K*;#Q):Z!JK-&MGY#)<P-=VTDMQJ+*+*$0I<-*@!XQ_P60^,UO_ ,%>/^"E
M/['/_!.#]CN.W^(NG?LX?%[1_B=\>_BEI@:]\)^#[K0M1ADU#2;C6H ;7R[2
MQBELYL2LQU&2(0K)$2X_K[^+/[)'[-WQP\9?#+Q[\6_A-X3\<>,?@M(9_AAK
MVOZ7#?7W@YY#;R2/I-Q*C-"7EMH')')>)#UKX\_X)=_\$N/V<O\ @F%\&+;P
M/\.)++Q9\4_$L<.H_%?XRZ[/:7/BSQ[XHN4634+N6[FE:XAL6NC(;*S$A6&%
ME0%L$CTO_@I!_P %'/@7_P $U/V>-7^.?QHO?M=]*[:7\/\ P)8SHVO^//$\
ML>;32+"'/F_9_.*BZN5C=(1M7G?D 'H?[<W[:7P0_8(_9W\>?M"?'3Q5IOA_
M0/#VBW8T+2)+B(:SXR\0-:2)I?A[0]-9A+?7ES.\:E(D9(HR7D92463^?#_@
MUU^ 7QDNM/\ VU/^"AGQ:\*7'@BW_;B^)=CXA^'WAN^M'L+\^$-#U37;]-;6
MUD"O%9ZFVKQFT+*GFK:AU&""?GW]D7]A7]JG_@N'^T!X9_X*'?\ !5&9_ _[
M*'AW4!K/[,G[(#:I%;:?JFEQ2^=I.O>*-.2Y=8[1_P!W/=M=0>?KK;<M D<R
MR?V;^&=)\-^'=%TWPQX4M-'TKP_H-C;Z?I6D:*+6&PT[3;6)(;.VAM;8[(H8
MXXPH^50>HR: /Y;/^#L/P1J?A/\ 8[^ /[;7@2ZN='^*O[(?[1G@37_"/B&Q
M)CU"Q'BW4[6PD,DJ8<VT<MA \BEMN^16.,5_1_\ LU_%32/CE^SW\%OB]HU^
M=4TWXA?#GPEXD^W'"_:[R\T:U_M"60@D9&H+<@_,0S@DD<U^$_\ P=>^(]+T
M/_@C;\7H=093-KOQ/^$FC:9;,P\R:\NO$AVO IYD2V56FD8#Y$0GJ #^G/\
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M1110 5_.;^UK_P K&_\ P3;_ .S-?C1_ZF>MU_1E7\YO[6O_ "L;_P#!-O\
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MLEZ?C7^P[_P6/^"WP1_9U\%?#WXK3>,->\;Z0MP=6U,QRWQF:1_D43RLS.%
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M5SNI0BFGVB^56T3ZM'Z=;5W!<\[<X'7'J?Y=!SQUHVH3]['X\?U-?Q\_ ?\
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M^*_%>N^*O O@S4-+M]"TN)&G:PBWQ:79SW$42":>"PMI1"@D+".-3WK]N/\
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MCWNQ^T&(Z@;3<#\PC!R!BOW9HH BV-\NUMNP <\[\'JW?& !C\^M?SI_%O\
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M_B>^R9)X7U&91-#ICW+L\5J#P3EV8G(_5BF."0"H&58.,Y(!&>PY)]!Z\]J
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M9H/AK1]0UO6-1N[B*WM[+3=+M);VYFEGG=(X@D4#C>67<Q4$DD5_+%_P3/\
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MDG@<5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %?SF_M:_P#*QO\
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MBQ_9 ^ NIW'PB_X0[PW<6ESI^K(\$?B7;,=5*/J,SW"3(ZP$$MM!Y4C@#Z[
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MCI3J:ISDXP>_^-.JK-:.3D_YGN_6VEUL"DI+FBFD]4FK/^OZN%%%% PHHHH
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MEF)QV/S.OG&,GBL;"4,96G",TZ5:,:=11YHNS4;NZ::;/X3_ -FS]EG_ (*
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M3CSR@HRDER2C/IJM%IV7>^_??QW]H/\ Y(U\3O\ L2?$G_ILN:_BQ_X(N_\
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MWE9W=[WZ:ATY?LZ7CT>M]>KOUZ>1" <_*>H!//3U''^?ZM?<64$X .1CC+9
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M8[$&<W,<:1VL,C*MLV^1#EC7]B'@?]OS4[K_ ()QW7[1^K^$?%*_$WPIX?\
M^$+U'PX?#>IO=O\ $E;<:?ILB:<]N+J\TM[A[6YNKH1-&-\P)(4FOYN\>>$\
M!4XDR[.^'\3@*L<ZQ-#!XVE0K47&GBFXPH59*#M3A*'+&K)JT9P32=W;^B/
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M322:Z7/Y\XBXGXBSOC1YCBO[1POUK&RGAJ,*%>,'AJ+M2A"/+Y1YE?:]O/\
MOT_8P_:9\._M8?L[_#KXR^'YT,OB#1X;;Q#9L]OY]AXET]1::U'+;P2-]E@E
MOH9Y[!9A&\EFT3A<,#7U6I);KSP<8.,$8SD<'/;%?R/_ /!&_P#:$\2?!O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?=WFC^)M+CE=;?4K&[M89!NDB"27$+JIAE9HOF"[C_I$"( \' '3^\I[[3T
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M_B']G;XS^._@_P"*4NUO?!^MW5K87MY:R6LFN:")2-*URVAD^_#J$ ,B*K'
M4DGFO')&C!P[ -QM7<0Q0\^8BX^8\'#Y 7G(-?S]B:.,R;&UZ$I3I5J55PIS
MI\T:BQ%.27,GTM):).SW6Z9_LYEV9<,^(_!>!S.D\'G7#O$>6K$1H58PK4)X
M;$T%-1K)IQYE3G:HI+W;-.ST/[A/^"1'[>.H_M:?"#5] ^(MY#+\5?A<;6R\
M1W8188-8TF<>5I6KNS/@7UV4D^TH 0I0/GYL5[C^VU_P4G^!W[&.D6EIXEO)
M_$OCO5K:>XT3P;H;"[O7C"'R;K59$<?8-/FD!B2Y;<RE2=@P:_BY^!'A_P#;
M8T33=2\8?LU^$_C7::#XA'V+4_$?PXT>Z>TU?^SN8K:YG4;9!;%BT>!@;B=Q
M[^)_%#Q/\4_%GC749_C+J_B35?B!IV_2=87Q=,YU;3S NX:=/%( 8;I,C$0
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M;DEB9S<*U"G*59.,XQY8.-I-Q/[/QRJ8S@L021SWZG_/2BH!+N0XY5PLL9&
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MM=-N(]*6T=5$KPB/S(_-P-AS\WS<XQ7[Z;1Z?E_G\O2FF,'/+9.?FSSR>/\
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M??\ (%)/9W^\****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ/A'PSJMA?:;?^'](O+'4;.XL+VSGT^U>"ZM+F-HI[69#%AH9D9D=#P58BO
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M^OV"'P0_PQ_)'^<L_B?R_)!1115$A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4>_P#G\NM%% #)&"J6) "_,Q)"
MJ%7EF=CT11RQXP!G(K^4#_@I;_P<5_L;_L_?M"M^S[\#/V8;7]NC]I'PGJ-[
MI?B&^T'PSHFIV/@K5M/B#/IVFZ]-H>LZAX@N[90/M9T>>*'3RA\Z0'RS7[N?
M\%+_ (T>-OV=O^"?_P"U]\<?AS ]QX[^&/P,\;^*/"L4<?F2'5K/39%MC&FU
MMS(93(ORDAD!'(%?S\_\&M/[*WP/LO\ @G%XS_:TO_#WA7QW\??CEXO^)6J>
M-/B)J^GV.MZ]I"Z=:M);^&;2\OH[F?2Y;.ZN[J[OS"T,UU+=J9G94 (!Z+^S
MA_P7)UG]J'_@DI^UG^W'\</V5]&\36OP(^)&H^!=0^!VF0G4K#Q!I%A;:9=H
MFI0:C'.(9K'[>;?4'GA6&(PLPC517Z<?\$B/^"IG[*/_  4X^ D/B7]G?2]/
M^&/B3P&EMIGQ)_9_,>D:;JOPXN9H(_(N+6QTRVLK;4_"U\Q6#3M<L+2*UDN%
MEM6"S0-O_)G_ (---'TCQ!^Q?^V9HVNZ1IFO:/J/[;'Q0M[[1]8L;74=-O+2
M6STU6M[VQO8IK.YA;#%HY8GC;)!4XQ7R7\!_A?X2_8=_X.N;OX/_ +,^MZ5H
M'PN_:3^%/BWQ+\4OA?X86*'1/#UY%X1U;Q!:^'Y+./(LA8:SIL/B"UM%V1P?
M;'"IL9* /[@4!)5MV!N8A)#N<(. (BN %X!.X$\8YZFQ4:GYL$L, *J%>/7>
MIQD+@XY/48/-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\YO[6O
M_*QO_P $V_\ LS7XT?\ J9ZW7]&5?SF_M:_\K&__  3;_P"S-?C1_P"IGK=
M']&9ZGZG^=)2GJ?J?YTE !1110 4444 %%%% !1110 4444 %%%% !1112=[
M:;A=JW9M)O:R;U_KYD;Y[_=/&0.1_7_ZU0/&2 J /Y9#98_>!X([9X_*K6.#
MGG))Q^.?;^= &!@#'YTU:3Y6^WGZ?UT(C>G)J,KPG\,[W47IU3M^&F_6Y^>O
M[9G_  3>^ '[:5I:W?CS3+C0O&6EPF+2O&WAORK/Q#:)C_CV>Y*,L]L6X,<Z
M2$#/E[03G\Y?A_\ \&]_P(T+Q):ZIXV^(WC7Q1H]C=+<MHD=Q!;P:@L;AOLU
M\[0[Y+67 6:*-D<C=M(K^B,8YP.<\]>3^N!^@IC+UP,8S^G0\_\ U\5\WC.%
M,@Q^.AB\7E>&G.#YE4G&WM)JSYIJZ3=^LKWM?<_:N&/I#>,?!G#<^%N'>/L\
MR[(ZM.5&G@J.(YHX6E*ZJ1P=6<:E3#*?,]*+@MDN6USSCX=_"[P-\*_"&A^!
M? WAS2_#GA;0K%-.TW2M,MEA@MX(EV $+\TLDF6:260M(S$Y8\5_*W_P5V_X
M)D?%'3?BKXA_:2^!_A75?''AKQS?1W7C/PMX<M7O=?T36[D",ZIIVFQ(\M_8
MS+&BSI -]I@RN<$5_72J'!QC@Y!/KCZ=/7^M0LI9=ORD;60#:2P<C[Q/)VG/
M\O>HS[A?+>(,NEEF*B_JT$I8>I1IP53#SC[L5!V2<4FM-G&RO=76_@YX\\<>
M#/',N/.'<:L;C\5S4\SP^/JU:U+-*%:K"M46+FVZCJ.NO:*J^>46W)\UY1E_
MFM:1^SW\>]<U3^QM.^#/Q%O-4B?9+;#PQJ+&RPVWS;P&/,05L^<7_P!6 =W2
MOHS_ ()S>)?#_P +/VY_A+XA^(>LZ?X4T;PKJWBBQ\0ZMK%S%9Z=87$>F3VC
M1W5Q*52%DND: ABIWKMZU_?A<>$= ^S:A]@T;3;.\OH)H9KVVLX8+F1Y596+
M2HBRL=Q+,S,5]:_E4\;?\&]WQU\1^,O&7B"V^.GPTBT[Q)XJ\0^(+6QE\/>(
M)&M[?6=5NKZ""?DK)- MPL<K+\CR*S(,$5^08CPRQN18S+LPR:I4S;%T,7"=
M6E6ITZ=-0A*'+%OFO?2S>RTU/]+LE^GUPUXV\.\<<#>+WU7P^R3.LC^IX',<
M L3F.)GCJT94L54]DJ+A&,8M2IIQ2]YWD[(_H'7_ (*!?L>1VP,G[0GPM=EC
M!8)XKTP^=L7:$""<M\G7 Y.,>E?S*_M__P#!87XT_%'XA:]X$_9R\7WGP^^%
MWAW49].'B72)(CK/C&:W=XYKBWO-CQ1:*[#,.Q1(XVG>170:W_P;O?'C0]&U
M/6H_C%\,-0DTFQO+]+"W\+ZU]HO7MH9)EM+?((\ZXV^3$6&T.RGFOPFUO0[[
MPQX@U[PYJ,+6>J>&M3O=&U*TF0CR=1LIV@FC6)<&,!U*F)P&4_>Z57B#Q5QC
MAJ$,)BLNEDE+$RG#V^&J^U=2,'&]I0G+DW3WC?S1V_1"^C=]&7B3B[-<XR+C
M*/B=7R>E04\IS; 0PU#!3Q+G.GBJ>%JT:3Q$[4Y0Y^24:.WNN<3[0^$7_!2/
M]L;X-^*;+Q/I/QA\0^)[&*Z6>_\ #/B:?[;HFL,\BR7$%PK)YZ22HKK&\,B+
MO(8 !2*_LW_9#_;D^&G[2?[-VG_M ZAJUCX,TVU-SIOC2/7IXM-M/#_B#25C
MCUB-YKAE#VB3.#'>!A%(I!'(-?Y\##YB0AB./F0$N?M)^Z83RNU1]YCG9G/%
M=I%\1?'D7@N+X=6_BO6[7P8EY=ZA+X;L[ZXBTVYU&=E:>6Y2UD2"[$F 7AG6
M16P,@FOD.$/$3,.':N(^N3J9G0=.4*5.O5<IJNVN6:DW*\5KS6>J?1'])_2/
M^@GP)XNX+)\5P9A,LX(X@PN948X['X7"04<7E,5R8BE]7IJ$)UI6IRH5)NT'
M'^63B_\ 1*\'_M>?LU^/==M?#/@[XW?#GQ!X@O58V>DZ7XHTV\OKM8_OM;6T
M4I>54SEBJ\#WQ7T='-'*5:*571U!4H0RG=T(()&,]L]C7^7WI<]QH6H6NJZ#
M>7.AZK;S0W5MJ^E7$VFW5M*A#*UM=6KPW$6QTS/'O\N3(!&#7]G/_!%7]MGQ
ME^TI\+/$?P^^)M\=7\=_"EK.U'B"0L9]5\-W)^SZ==:@C$'^T@8V69P CHL;
M#+,Q/Z_P;XD0XIQ?]FXO#4\'BY.4Z3ISYE5I))\O=2BM;[=[;G^9WTH/H)YO
MX!\*T>-LJXA_UBR&%2AALR6(H0PV+PDL5-0HU8<CY)T_:*TEI*/Q:KW3]T"<
M -Z' )Z'/?L?YCM]'9Y&!P1UQQ[?YZ8J'861U+,NYL_-W  (./3OQT_.I(SD
M8R?E./PQC\>G^<5^IVBJ:2E[T9I2UUM=:?/7Y==T?YY\R7+34Y2FY223_P"?
M<%%W>FK=[+N24444QD<BDC(Z\#OGN<_T_+UINWY@,C(.<^G;VY]JE)QV)^@I
M>OK^1S^&<4$N<K\MM-EIZ/?U?X_?&5)/)[=<#\L4XJ1D9Z+CCOUZ9[C/_P!:
MG?YYIH))8<<=/\*-+Q3E)7=E;9^3\OU$_P#"T]%=+:]ET?GOW(BA)&#AL#[P
MRF0<KO'7CC'XY]:C>U@,FXPQ$L-S-L4 OTQTR0>2=W.*G3@D'_/)_.G$@G!'
MTXX)]O\ /M]:]I)35ISM-^S]UM6<5=W^:Z6M;Y-5:$*D%"4:5;V=I6G%2:>F
MNV^FE]?O*YCQOV *,8"*N &[87 XXYSTY[5^"7_!4#_@EQ\8_P!M'XS>%?B)
M\.O%/AG0=.T'PM)HT\&LQ.9GNVN$=GAV,H&5##Y@><]^:_?3: V[/7C'O_GJ
M/7FD8$#CA<CC_/J:]_AOBG-.$\SEG&3U_J^-ITWA_:3]Z,H2]G)IJZ3E>$4[
MO71.]SY[B+A3)^)\NGEV94O:82HU5]G91<)K5*#MI:[22[M[G\>WA[_@@%^T
MUI7B3PWJDWQ!\"26VC^)_#FM3IY<K&2UTG6++4+J)1O)$LJ6["-AA=Q&>:_K
MZBBEMX8(<;@EO;P, P96\J&.,MV;Y&!V\Y.[KS5Y<\G&1C'7&>??_/:G$#&=
MN/IV]/8_X5V<6\>9YQM6RZOGSH^WPRG3H>PH1HWC6<93E4<6^:3Y%9Z-/IJ<
M'"? ^2<'4<50RGZQ3CBO8SK2G4E-05)2Y8QV2MSR3VWVT/CG]O']GOQ-^T_^
MS)X[^#7A"_T_3-?\3K:BTO-45FLXS Y<^<%(^]G'4=\BOYHX_P#@WS_:@5%#
M?$+P'O*KN4QN54JH4K'M<8CXR 1N&3STK^R##\<]>/PZ@_S_ )=\5(?_ -7U
MKT.%_$GB/@S#U<'DE3"QI3K?6)>VP\:\E4GRQTD]HVBM'^IS\4>'F1<75Z&)
MS5XJI5C1C2@J=65)*$-6VK[N[^:[[_QPK_P;Y?M.D,3\0_ 0R&4$1R@ACG!.
M9#E ?O+U(&!TK^A?_@FS^RMXS_9 _9PL?A)X]U;2]7UZVUN]U"6]TA6%G+#/
MPJHI8L" .?FZG(K] !U.>Y]/Y].^34A7'0\^A(_3Z57$WB1Q)Q5ELLMS.O@I
M8=XJ&)O1PL825?3EO-2?N^5K$\+^'V0<+8R.+RJ.*]K["=&]6M*K&S5M$_5Z
M]WT1 F5*L0^V-BPZ_O%.!G'4,A^7!).,'IP/Y!?VA/\ @A[^T+?^.?CK\8SX
M]\&1Z!JWBCXB?$NW@$4OVN+2;F?4-?CLY 'YNA;KY+-C:)?F&!Q7]?Y#LP/8
M9_/VYY_SS6'XET&S\4>'M>\-ZB'%CX@T;4]#O6C($JVFK6-Q8W)AW?*)5AG=
MD+ KD#/H>#@SC?-^"L=4Q>73P\WC%1PN)6(PZKPE3I5O;-PO*-I2YK7N]+I/
MMU\9\&8'C+ TL+C*M:G6PO/B,/.A4=/EKU(PA%3MNOW<7R]KKS7^>_\ L _M
M*>%/V3?VCM ^-/B[1]3U[1=&LKS3I++2VB2Z:6021)- 64ABN<L6#9ZXK^WS
M]ES]L3P%^U#^S]+^T7H=C>>$O!D%_P")+2ZBUR:%;JS7PJQ%]=3S@)$(Y!G:
M"%!X Y-?G^O_  02_8T')O\ QY(&,CY.HVBR$N2[G8L&T*"25 4'@=:^/?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXB_%?P#<^*/%VL)%#=:G-XAU6!EMH%58K6TBBE$=I;(1N$$(5-Q8]2:\:?\
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M 4444 %%%% !2%00 1P#D=L$?3]?7O2T4;N[W:LWU:[7[>0=_-W?F[6_)6.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***3/)'I0!Y!\>O!_C'XA?!GXG^!?A[XDD\'>.?%G@W6]
M#\+>*H9GMY= UF_MFAL]3CFC#21O:R,) 5!)*XQS7\'&M_\ !IA_P43U[XG:
MS\8+O]M'PE;?$K6]2GOM1\<:5J?B'2M?U&6:>207FHW=C902S7HC9%DD#?.4
M4[OE!K^[G]HW0/&'BGX#_%_P[\/_ !7%X%\<:QX#\1V7A?QE/>KID'AC5WL)
MFMM:GU!PR645@Z"XDN7!6)4+MP#7^9I^S5!_P< _MM?';XI?"[]DS]L_XS_%
M'P9\+O&.H>$==^.5OXZFM?A8M];74JJ+;Q#)9M'/:X++$\43%=C955(H _5\
M?\&S/_!7E1@?\%,_$>!@#'Q(\?#@  =<]@*_2?\ X)/_ /!%#_@H3^Q+^V#X
M:^._[0O[;.M?&SX:Z5X6\6:-?^ KOQCXHUN&]U#6M,:TTV^EM-94VS&PG/FQ
MLC(R$EB&PN/R/^*O_!*__@Z<^&W@V]\5:5^V[XH^)<VGV+W5UX:\#_%NXO\
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M'B"7Q5H<^MZK?7FOQW*I'Y$=KJ.ZP:S())42%R>H!_99N#%L=B?YTM1Q]7X
M!((P/O C.XM_$6ZGTZ"I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6OU.DTZ=-IW7)&S[Z(_SVGI.2[.P44459 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PS_ ,%,O WQ-^)?
M_!/W]L#P!\&9+Z+XJ>+/@1XYTCP,VEO)'J+:[/I<Q@2S>(K(+B2-)8TV,&);
M /-?S]_\&EW[3O[.T?[!VI_LQ)KGA?P+^T-\.?BIXZO_ (D>#=6U&STWQ%KK
MW-Q9P+XEE:Z,<UT'>UN+9XG+M:R0O&JC<YK^N:50Z,C!65U9&#@E2KJRL& Y
M(*EEP/6OY$_^"I/_  ;I_L<^,/B!K7[5GPD_:AA_X)^^-M>UJ36?'&KMK#:/
MX,O;RY?S3?6%A87VEWMI/=7*O).OG2V\W)VC<RT ?U;Z[\1O 'A32+[Q%X@\
M<^$]$T+1K>YOM6U"]UW3H+6VMK>+S9999&N!Q&JEB/F)&=H)XK^)S_@F3\3-
M$_:;_P"#E[]NC]I;]F#5H(/V:/#7@34$^+'BK3)1;>&?&[+HUIH]AX@N"BQV
MQ6+Q#973[Y&W!;-KR3EBY^1]#_X(C?#OXYZYHW@/Q%_P< >#/BII]W?VL$O@
MW3?%&K"\U.W:79-901MXG,-Q+<(6BC-PDB!R&*L0*_K>_9U_X)'?LX?LA?L/
M_%S]DS]E"1/!]]\;/AYXD\'^(_C1JK+JGBC6]0\4Z#=:')KM_JVG&WN)UM([
MVXFTZVMIT2WE9=LAD7S* /P,U#XP?"S]HS_@[0^ NM_ 34--\::5\*O@WXST
M#XG>*_"ICOM'.M+X$\0P+]LU2T#07#6SWUC8;WD;]Z$B0L$&/[9U/RC\?YU^
M(W_!(C_@B#^S]_P2ATCQ'XB\-Z]J?Q5^//CW2;?2O'?Q3\001^;+:PW7VK[)
MH%O*LESIEI-,JS7!:=IIW9D9C'\I_;E 0.1WS_*@!U%%% !1110!%G$B,-I
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ML^">5X[+L[XERB.*J9K#]Y2P4%"%"*CK4E&UW\*OHO>?J?QM2JC@JY\TN2K
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M7C;;(C:E:*R-TVNIEW(WLP!SQBF'7M#!(.MZ.".N=2M .<8P?,P22<8ZYXH
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MO1+^>RECN(48^6;@P"ZMI&4>;;2)(I8-NKWK=UY.>Q(SMST/X\=L?A7\2_\
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MQ9K5_P"&-*\+Z'=:I?:_:Z9X<O;N33;!H]8_L'2X'M;>)(K99!%\SON^"/\
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MKX@^ KM;'Q#J^B:!\-A=NH<P:7\2]>LO!VL&//*R2:=JMQ&K*007STS7HO\
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MD?1[\65Y:F*-O]7%%<7FR%B@V"5<,H^[TK^FO]C+]AO]FW]@GX2V7P<_9L\
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M=)2GJ?J?YTE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB,RQ&$IUZV*E.K[:-.<I0GSPI3E+EC*ZLVK6V_B:_:=UW]GSQ]X$T^#]FO\
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M)-17-+UNM>VSUN?R%?\ !Y:6'_!/K]GK.!_QE9X:^8G"J?\ A$_$Q#,V<!<
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M><JVXAAAV+'V ^/_ !;X5_X)U?"?_@X@_8<^&_\ P3FM]$LOAAX+USPGX?\
M'UQH&L7.MZ+??$R76]1-XMCJ-X\B7)BTMM-BE:WFEBDG5V5E)"+_ $<^*_\
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MK2+?3;S$PR0\%U:7$+8^8-'M.,<?1?[3GP*\,?M-_L_?%WX!^,+>UFT3XJ>
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M3481%J'CWX0>$=4OE+%F:\AT]-.EF8L26:YFLGFD.>6E/3I7UVA^\IQN4_,
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M/Y].*_JUN/\ @W>^'K;6M_C5K=MC(*-IC/E?X5#>:N=H'7!QWYQ5;_B'?\"
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M?OG)"4(^^XKE5U!V;6^K7D_6S?F?Y!I^^H\B:YW&M-^ZXM6::2739(5?E&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *:Y.!C/7M^-.H/OVYHUZ;]/4", +PPR22>>>O;_ZPJC=01RQ31E P:&8
ML"/E3<C+B0='SP #_C5\$$%L<C(JNZ[EVNF5?#[B<9 .2K=?UX([5G*+J\U/
M^2FU'7?F5FF^MTO5^MVQ5'0G*LYRNJM/E:W:?*DF];K?T?X?Y\?_  4C^!6K
M_ #]KOXG^'KZR2RT7Q-J-UXR\+,@P+S3-3F>>[N-@&%(OY98E'M[YKX4R&VC
M&X-M+H>"J..C]AN![$XQ7])7_!P5\ /&+^/_ (<?M#Z587%_X5M?#DO@G6FM
MH7G&FW7VQ]0M[NY\M21;3*R0!N@;'6OYLB> 4W?/P"?]4F?O<]24;(P0, 8K
M^,^.,IEE?$.8T)4)8:C/&\].I)-0E2FH37)IW<K[MV>^Q_U*_0W\1Z7B+X%<
M%9C7QV'S#-<-E4<OSF-"I%5L%B,"O86J4U=J].$)*3Y;-]=Y?IY_P2+_ &BM
M$_9V_:_T*^\5W$-EX9^(FDS>!M5U&[D$4&B6;W O(+^0L0JQFXAB@WGG$E?W
M>Z+XATCQ!I5GK.B7UMJ>FWT"3VMY9S1SP3Q, 0\<J,588.?7U[9_S" "A,BL
MR2(PPP=DF1EY6:-UPRH" >#PX%?U'_\ !!#]KSQ/XIU'QO\ LR?$#7+_ ,0R
M:/I'_"6^!+F_F>:6TTB!DAU.TEE<DD?:98C;H>B CO7Z/X5<7JC4I\/5[)5J
MSEAZB5HZQC[MGWY6T]&FW?0_A/\ :/?1EJXO#XWQ\R*K%?4,/@\'Q)@'R^TQ
M-+VSHT,QCI%^UIJK"G4NVI4J2MJE?^H'>I&0<]?T[4%_NX[MC_ZU5T0D%O,W
ME2<R 8+$=4*]@O&T]_2K . @ZY]1S[8^F?QK^B%).I*T7R0LG=/=VV?6R?XZ
MVL?XJ.\7#W^=V;E",'S:VMU>R=[]KW6P^BBBF4%%%%#UT ",\&N6U7PCX5UJ
M[^UZQX=T?5+H(J&YU'3X+R40J. #*K$;" %QT]/7J:A8'>6'RE5 ^7EG!Y((
MXX''U!IJK.BXRA4G3:?V&U*?]VZ:>OYI&=2E1JQY:U&%5.W+&<%-*5])---.
MRON>+?$#3_A!\-_!WBCQ]XK\-^%=/T#PMHM]K6J7L^DV,<:VMC \IW$Q 99@
MD:J>KNHP37^?E^UA\=;K]I+X^>._BD;&#3-*U74[NR\-:;8Q+;6]AX?TZ9X=
M(A1$PL8"!I<@$OO'IBO[3_\ @IG\!OV@/VEO@M:?!OX):M9:#9^)-3CN?'6K
M7$WE-<Z1;-\VC( <^1=E@TP!P=BCH!7\Y4__  0L_:XMGDM8KC0IXHIC#%,L
MJ*)(UQB=1C[IY SU]^_]9?1^SKA/AZGF>=\3\0PHYAB:;P^!PF(K\_L\/3=Y
MMQG4M"563O>UVH+5V/Y3\>>'N)\_J9;D?#N1.I@Z-58FOBZ,/9KVK4'=RC#H
MEHK[WL]3\A? /C7Q%\-_&OA/X@^%KR6P\1^#M=L]8T744D9'2[L)5E$9?(:2
M)^4D#?*P]<8K[^\=?\%3?VI/%'B+QQJ-CXLNK#1O%WB_P;XQL=%CE=(]!U'P
MBUG-+%9.&R+35I;=_M<6 C)(1SSGYK_:B_9C\7_LH>/+3X;>/]5TF^\376C0
M:G<6>GS([:9:7!8)#>*A/E7#;<_-A@I!('6OFICO)3 7?A64-\K1Q@$QQ'W
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M&! !^P%Q_P ')?\ P2-BA>YB_:.MI1;C/E0Z7)F4J"RJ/W_#%AC]?2OY[/\
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M9ZW7]&5?SF_M:_\ *QO_ ,$V_P#LS7XT?^IGK= ']&9ZGZG^=)2GJ?J?YTE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %(3QZ9X'U-+2$9]>N>*:=FGV8
MFE)<KT3T;&.._//7]*<IRN/P_"EQD$>O4_3I0%V],\U'O1I^XOWEU]U^[TV!
MQCR\JNUI>^S:MT_KR. ^(7P^\'_$KPWJ'A/QOH>GZ_H.I1M'=:?J=O'/;SX&
M5(613LEB.)%88.0*_@8_X*/?L^Z%^S9^U=X\\!^%BD7AB[>+6]$L823]A@OU
M\Z>VE4GY(Q,^8P,?(!CM7^@_<*"CEONE2K'&2 1C/UYY/'&/2OXN?^"\'P7\
M3^#OVH=/^*[V-Q)X2\?:%:V\.JA)'M;34--5;;^SIWY6*6:)#<H20"N,C.*_
M*/%W+:>,X>^NK".K6PV(I*HZ<;U(TI)*35DW*#E97>FY_HQ^S:X^S'A_QNI<
M-UL\E@LDXARK'4JN7UJ]L'B,9AXTYX=PA)Q@L3*'M(^[[TH*T[\BM^'G'I^)
M]/\ /X5]?_L._M7WG[&OQTL?B[::,FL6TVDR^'-9MI",_P!B7MW#->2VW3]Z
MGEA@IS]T"OC[=DD?P]?,#*%52."3R"V< *.2:0A2&7JLBE""/E"G[Q"MR"W(
M8'W(&:_F; X^OEF,I8["N5.KAJM-P;O#V<?==V^FCMO\GU_WMX\X*R+Q(X3S
MCA/B"A',LGSJA/"8G#*S55>S3C-6;2]F[-/;F6EM&O\ 2B^ 7QR\%?M _"_P
MM\3_  3J$=YH_B?3(M01$=3-!.T:FYM+D!CB:W<['3JO&??VM&$A5AA@!D,!
MD_-V.#@<@<XX.:_SS_V=O^"A/[2W[,'AFR\%?#'Q/%#X5M-3NKZ/2+Q&FWS7
MTB27,4;G=Y<3[,!5( !X (S7]7W_  3)_P""D^D?MG^']1\->)[>W\/?%+PE
M!"VK:2C*HU:T;Y1J%FC-N9<@M, /ER.@K^K>%?$'*\YGA,O=64<Q^KP]K"I#
MDIU9\JYG2JW:F[INS2;6BUW_ .=7Z1?T*_$;P5EGG%%/!1S#@?"YA56$QN&J
MRK5\#@<16;POUV*@K<D9TZ-2:;LUS2M&[7Z\T5&')V@X^;/S#.W;CC!/?^O%
M,+E,!1D<\G.<>IP/Z=*_1DKJ]U:SDM=TK:_B?Q+I>SE%.S=G))Z;Z$]%1HY8
M]L8R#4E#5K>:37HPZ1>ZE&,EZ25U^ 5'D!SGV_I4E)M&<]Z5Y+X6EWNKW79=
MGU^0G%R7Q.-M=%O;I\QI;'3&<\CG&,]^V>F>]1'>P(.1G !)[\X]^.]6,=\?
MYZT4J<>2\7)SBVDKNS27GIUMIIMO8=HN'LY1NI+WGI=;;::?)GXM?M ?\$:?
MA#^T-\5_&/Q<\9>.?$[^(?&>KR7]X@ED=+2(QQHNGZ<KMB*RB1%PB#8"3C!S
M7YK?MR?\$L_V6OV-_@#XE^+&K>./$%_K,(72O!NCR2A)-7UZ\(BMXTA!+S1V
MN1+=LJXCB&6(W**_K)//S#=NW<GK^7IZ<>]?.?[0/[,'P?\ VE[3PY8?%WP_
M_P )%9>&;N[O-'M'EV06]U>0K!=7!C8B.1_(55&]6( RF#DU^J\+>*W$V38[
M**6*SG'_ -B994H3E@L/R.%3"TFFZ$(JG>TN7D=M>5NS5DU^3<4^$W"^=X3,
MJE'*L(LUS*+4L=.+3A6=^6I?FZ/6UWK;3=/_ #AXY2(XR2YD+[YX\<*6'6$X
M^X/NMGN"/I]A?L>_MA_$/]D;QQKGB;PG>W<VFZ]X/UGP[?:69I&MXI;V"?\
MLW4[>(L8A-8Z@\4_R('_ '=?JA_P60^%'[)'[,OAOPG\(?A#X+TW3OBKXND3
M6M3NT(-UH'ABUDS#/N!X>]O%: QXW>40^<&OY\44*H4.&56)0;P-A/+;23W/
M.#D?C7]]\-YUDWB=PQ+'X_+(T\NS%SI4\)CX1Y_8P48*:4K7C4E>496\UT/X
M.XARG-_#KBFI@,-F+EB\ E)8C!2DH<\W?V;<6W=1LG?76S/L7X,_MV_M"_"#
MQM'XTL/&&I:O,NC^,=%N+"_O9I+:6'QG-<ZAJ5Q%'(Y57&JS_;HV RDL:A2
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MC_9K^.7[.WB5WCT/XR_#;Q/X$OY$VDJNLZ?-# S;N-AN/*$G?83CG%?PW?\
M!)3_ (*]VO\ P1(/Q3_X)H?\%$? OC+PIH_P[^)_B"]^&7CVST^XEM?[.U6[
MA26%I+Q8K>XT40PP7=M<V\C>4)F5V)5Q0!_47\<O^"$'_!+[X\>"K?P5KO[,
MO@GPA#;X%MJW@NPAT76E/D"VB>6\MXQ*\JE$EC8$ .-V<M\O\_G_  1OT[XI
M?\$DO^"TOQL_X)*^(O$&N^-_@+\;?#>J^/?@3>ZI?S/:^';70K"_\16U_;VC
MR%8;K4-.MIM!NDB786L$E?\ >R9K]9?BQ_P<]?\ !*OX8>#X?%5A\4=0^(%[
M<1-]B\.>%K:&[U=YDB\Z-)U:3$*ER(VD'FA""0IQ7Y3?\$2M"^.G_!4O_@KC
M\:_^"Q/Q>\)>(?AY\(_A[H&K^"?V>]&U6RN(++48/$&GW?AQ-/MC>HDTL6F:
M+<3ZN]W&OER7EZP0_(K. ?V^QJRNX/7/S@<C=CAAGD C ..-W4U/5>,_-EB.
M2=N=V\G^,''&W=RN>W2K% !1110 4444 %%%(2!U- "T>_\ G\NM-W+Z_P Z
M7(SC//XT +11FB@ HHHH **** "OYS?VM?\ E8W_ .";?_9FOQH_]3/6Z_HR
MK^<W]K7_ )6-_P#@FW_V9K\:/_4SUN@#^C,]3]3_ #I*4]3]3_.DH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** (I%W8R"5'7IR#Q@CJ0.M>
M%_'K]GGX9?M%^![[P'\3?#]EKVD7H<(T\"/=6;E"@FLY64M#,%;:'4CCN*]W
M8$\#IWJ [D'S#.[(^7.1N^7C'?!.#T'<^G-B:-"O2G3Q-*%6C4<(5(S7,I0;
M2<+>=[^=]-3ORG-LSR7'X?-,JQF(P&.P6(A6PN*P\YTJU*LK<LZ<X--*.[NV
MFKIIJZ/X)/\ @J/^Q-H?[%7QJ\.^'_!WVV;P)XTT6YU?1!=!I?[.GL[@6LMF
MTPS'(79O, <[U"Y'%?F> 1@_W6()'()/<'D$>I!X'':O]"#]NK]AWP#^VQ\-
M9/"?B8G2O$>D,;CPOXE@5&N]+N?+; WXW202M_KHMQ#$YP3S7\GOQW_X([_M
M0_ SP=X[^(5\VAZWX.\$0W5Z'LVG_M&]T>&55%RD )B%PRE7=& PN<C K^9.
M/?#_ #+ 9IC\5E&#E7RFLXU:D()OV,>2$IPTL[1UEU]WJ];?[Y_0]^FQP7Q!
MP1D'"?B/Q/2P7'N$G3R:MB,SDHQSKVU94\#4HU6X4W7J\].C**O-U;^[:44?
ME(.S8ZL3D8Y3 ^Z>S'J#V^AKZ#_98_:%\7_LN?&[P;\6_"%PWFZ;J=G9Z]8^
M8RIK&A7MQ%!?V,Q)"XV,K1EL[2IY[U\\QECG=C(."!V(X(X^08(Q\N,]<=:5
M@6(P1P0>1P"#D'ODA@".."!QWK\QPF+JY=C\/BL+[2+P<X.-6-URM.+G!N^K
M6J5]OS_T(XRX7R;C[A3/>&,?'#XO 9[EU? \E>DZ]"4<30]R4HMOWH2FG&5]
M+)WV/]-GP!XKM?''@WP[XJLIHFMM=T;2]3C$<BM&GVVRANI51P2K"-IBA9>Z
MGV%=FTBGN".!D=3^7;G/ZU_ #\*/^"H/[67P?\/>%_#7AOQDESH?A*TBTW3[
M/51).ALH6)"W!.XN^PE >1L"@?=X_JL_X)J_\%$O#_[;?A*_TO4[:+0OB;X+
MM;67Q/HP;Y9H)!Y*:G;*?OPW<H90O)C'8=OZQX8X^R7B"6'RY5>3&U</":@W
M&[<81<TGOHU)JZU7F?\ -[X__0P\3O!3!YEQ1C*%'-^$:6-K4EF. ?\ N6'G
MB71PKQE-IN+G%TE*S:C*6W+[Q^J43-O=2N%4#ZY]QVXY']:GJM#]\G'.T8.2
M1M+$@-G^,9'T&!VJS7Z#K\M.7_#;3\#^-[Z)<CARI1M:U^56NO)VNM_4****
M "BBB@"-"6Y(]0,8[=2?<\= ?K37 W'<H/RY .""WN"./J.O>GA0G.?T_']>
M.O\ 6D<<[AR/?M[?3^?H.E3*4HPBH\LY02C-0>U[6LM7V;)2]^22_<U):+KI
MOOM^>FUS\UOCQ_P2R_9C_:-^)>M_%3XG:=KNM>*=>,(N)CJ<P@LH(8DC2TL(
MB3Y%L"@?RDPF_+8YKQA_^"&_[#I!W>&->Y]-3E&?;KWK]DADC(4 ^_<?AS^F
M.E-(<D\C'T_D>M?4X+C7BG!8:AA,+GN.HT*,53ITJ,W&%.*^S9)V:N_ZV^2Q
M7 ?"N88FMC<1DN%K5\3-SJU*\&ZDIV2>\NRVMNS\:A_P0P_8=QD>'/$ SSC^
MTY>,]NAJ%_\ @AG^P\K@?\(YX@YY4'5I5Y7GCD;B,9P<\?C7[. ../E_6HY<
M AV&XA3M7@?."&!#'D=".HSFNK_B('&$=9<09J[NRM5E\3Y5%KW=/>?_  +G
M+/PVX/E&W]A9='O:F[M65U\7VDW\GZ'\8W_!6_\ 90_9!_8[T+P1X(^$.G:D
MOQ?\5:@NKW7VB_-S#I7A6V&VZ6\AW9AGU%W1[3>JY6-RI/ K\-S(8OL\J%?/
M@DCFMI!O B>%Q)YD@&'VI(JM&3D$@$9YK^\O]H7_ ()5_LV?M-_$S4_BO\4O
M^$FU3Q3K%O:P.R:K-':6MI9*R6]I!"'*1K&C$*%P>.1Z_P Q/_!5#X#?LP_L
MR?$[0/A!\!(=0D\36&GF^^(%S>7_ -NCM8[G)T[2QDL(KB-5)F5L,H90P]?[
M!\$/%#!9GA,NX.Q$\?FV:8F->MF6-Q<95*-MW!RY$HTTI1I13DV[6U>I_(GC
M)X:8O)<9CN*L.L-EF5T?9T,OP6%DHU(U/=4:J2;ES;RD[:/LK'5?"_\ X+ _
M'KX=?L_>'_AD^I7FO^-- ^(=AKUMXNU2>22XN/"FGA%3PS-\Q#0RH!&"00$4
M9QS7[K?\$A?^"A&L_M:^$_'/@/XK:E WQ8\&:K<ZO:IF./\ M'PEJ5PYTYH5
M8JUQ<V$GF1W(C#F. 1,=J@U_%>1RO&WRFW!#C.WMNQU/?OV^H]R_9P_:"\?_
M +,/Q6TSXM?#B[$&MZ?9ZE:36TS-]FO;&_M_)N;>:('$C%/]7D':W( /3ZOC
M_P #.'<[R?,*>0X'"Y?F^*Q#QN&KM<D%64TYPK-*7+3J7DK1T49-QBWO\OP'
MXT\09#FF7ULYQ^)QV682C]3G0<F[TW"W.T_M*ZY9-;_%HD?T%_\ !5G_ (*C
M_$KX3_M!>'/A9^SQXCM[,_#>WOI_&%[$_FVM[X@U*#R&TNY*EDECL;5DN4Y(
M6YW X(X]&_X)A?\ !5;Q1^T+^T9XQ^&'QBFMM._X6!I6E:E\/$>=1!9:WH6E
M166M:;'YC"-5U06\VI(BX9IIMJC)K^5[Q?XHU?QUXN\3^,_$5Y/=ZSXIU>[U
MF]N97=V$NH74ERZ.7RP\GS1"J]1&H %3^!?&WB3X;^,_#'Q#\)73Z?XE\'ZY
M8:YI<MLWEL9-,N8IQ%NR"T=VL7ES@G!C=@>I%>=B? 3AY<!RRRE@J-3/J66>
M[F+:52.,:A5J2M=.495HI);.+Y?A:/0PWCEG_P#KK3S1XZO#(IYC&^!DG*'U
M?F<$WII%4W;RW6J/]-/<"(\C 8?+][;R"<DG[HX'4X'?'0*A&00.&X7 X[$G
M/IG/).*^,OV,_P!L;X;_ +7/PI\+^+/"FO6<OBU_#EE)XQ\-O(B:GH^L0I%;
M:H)K3C;9S7IE:VE"[3$R#(/%>R>'_P!H3X,>)_B)>?"KP]\0?#^K>/=.M;^[
MOO#=E>QM>VL>E7 L[V+R@PQ+;3MY<D"YD.-VW:I-?P/CLBS; X[&8'&9?BJ5
M;+H5/K5/V4U]64)J/M)MQTA.WNU'[DE:SDFC^\LLS_*L?E^#QV$S"A4H9A*F
M\-*52"E6E*,92I0BG[TUI>*NUK<]O_SQST."..^>W7VHI@;((P/]K! #G^\G
M]UU_B!QSZT^O+OR-1=]UIWV^1[*:DKKK^O0****;\E;\1A111SUQQ2 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2#I.F2F,G;.R+*;E&PT>4W8S7^<6?>&F>X7C?,N%<KPM;%RH5*N(P</=C[3
M2G^[J-S2U2M!ZW<XNRU/]$,B\3,@K<&9;Q!F>)CAHNG3H5:C4IMXN,(J:<87
M;TM)V7*[OJ?LJ'?"@@%QCS,=AD\#I\Q_#^5*I&" Q'L3DXZDJ>_&>W!]._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC_/3_
M .O0 4444 %%%% !1110 44OTS^6/ZFDH **7&>F??CI_G\,TG49'(/0_2@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%WA+0M5\)ZE'=V\UGXAU32)(S:Z@8F6);:>95,1D0L6B5COY)7BO&OB%X_\
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M6^NQ+N!. >/Z^E <?-D@;<Y_#K],4G !*G&!GC&>@ 'Y]NN>>M1DDLV5*_.
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M<=8<JE=;VTO9=;7\K].PES6UM?IK[K5]+/ORM-^I-GKP3CZ?7UI-W'0^WO\
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M;WB0Q7LMDK:5'I\MI<0&*>[U&6&WE><M$J2;L+UKXWM?V]?^#FG4(+6ZL_\
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MNE--=-MC1DEB5<X; _33H #@=O0<>@H 6B@'/3GZ4F1TR,T +12X/H?RI,T
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MV<*'/VGG/'(XYK]"O^"8'_!!SXT_L%?M6Z!^T1XV_;3^)?QKT/2/#?B70I/
MWB;4+FXTJZGUW3I+%+V2*69T\RS)\V,L,AAE<$4 ?TT*Q8J1C<0?,&-I5%.%
M^4GDECUY/ J:HHPH 95P'+?,3DL<GH23\O&0 <_A4M !1110 4444 (0#U]O
MIQTXZ<9I1QG'&22?Q_E^%%% "Y.<Y[8_R.F??K2#@@C@@8'L"<].G7OC-%%
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M^BF&09Z'D<9QGM_GIQ2[L@XSFINM=5IOY#2NHOI*UF]+\VVF_P K7'44@R
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MXA?MA^-=6^'?PX\::!H'BG1](.KQ67B2[OH!J5E$PCD%@L3KYDD3, R#/ )
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M85\.^%/%UM)/]IDM_$&B>$M)L]3CEN"3YLB744BN^?G9"1@$5_+'_P $??\
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M5I!+MEM[2WEMIK;5"X6..]5O+VKD5^4_C_\ X*K_ /!3S_@J'^U[\6_V:_\
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M/%>AZAH=M%X[\$>&+O6(-2TBQUB"*\;0[XK:2PM-&"7:XAV@($7^=<?L<_\
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M,IMWL9[626T(*?NHY2T15PI'C/\ P0E_9#T[]C'_ ()B?LW?#E+:"#Q-XO\
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MFOQH_P#4SUN@#^C,]3]3_.DI3U/U/\Z2@ HHHH **** "BBB@ HHHH ****
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MA\HP&&P6 7)A*-.-*$%9J,$E9)OM?MZWU/P7_:K_ ."+$O[5/QQ\9_&?Q?\
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M\4E+_P 57-K<S#[1)IZ7P\JT20GRH%54"KFOTQ+;?7GTJ/ /(7!SPW7IZ^E
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M7RG=UVR1SAD<.K)_1T^2JANV1S^!_P FFK@ @ \]/J>.>?I0!_.]_P %[_\
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MV=0U&SA\W6.H%R2T9)9C7[+GD8SCWJ,-M[$GU)P?ZXH _A2_8H_8!_X.7O\
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M.JS*7/\ :>NZO)8+<ZMJLF]EGOKG,L@ W-VK]<O^">FC_P#!P+8?M0^&9_\
M@H)X_P#@/X@_9E'AOQ7'XCT[X?\ A33])\0R^)Y-."^%FBNX;5+B.WM]1&^Y
M"3".2(LKHQP5_HC5F 'S$\?Y%-+?, S<=0N,D[1S@GH1G/O^% '\]7_!R]^T
MCJOP5_X)H^*OA;X"UF2W^-?[5_C+PU\!OA;X6L/-.K>+W\3:I:VOBW2-*"E
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MRK^<W]K7_E8W_P"";?\ V9K\:/\ U,];H _HS/4_4_SI*4]3]3_.DH ****
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M' P!WSGN3WR:** "BBB@!,#K@9^E+110 4N>"/7OW'T-)10 >W7ZT#CM110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!K G''?KZ?Y_I3< 8P V>?0^W?CBI**AQ_>0J1]V2NI_WE
MI;T_R2\V"WO+5*+5O-V_"WZ#<$# R<MSGWZ_Y/Y=JC*X8G.,#"=LN>Y/'O\
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M%NLEE++F-9MXVU]\ @]*_A_^"O[//A+_ ()K?\'1'@KX+?LP23>"/@I^UO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQQD9P7Q_?)&6'0>E35"C G/'+G^'#!MI+#!'"#D KC<>O%34 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "COT/\A^N/THJG?7UGIUM/?:E=6ME86J^9/=WL\=M:VR#K)-/*R1Q(.[R,
MJ#(YYH G=A\RCA^%'."2><!AGG'(KYF_:4^./[*GPQ\#ZU9_M1^.?A+I?@>Y
MT][C5/#GQ(OO#MW;ZK86ZEY2WAW5I)&U"-=I)0V<OHH.3FQ^T!J&K?$?]G+X
MUZ9\"_'&B'QYJ/@'Q%IGA/Q'I.MZ>]KH7B*ZLI(-/NYM1M;B2.Q>VED$HFD=
M&B"%Q]VOXN_@9_P;+:S\>M?T'XE_\%1O^"BZ_$K6M-UI[F7P'HOQ.LO%JWFC
M"X:?^R;SQ%K&KP3Z#/,A"7?]F+*L!_=1QA08P ?$/_!6G]H'_@WL^/FL>*M
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M2"6XAD:(7D44C1*)@ICDC=OV0P?E_P!KI^./\:_A2_X-L?@-X7_9=_X*X?\
M!4/]G?P7<7=UX6^#6IW7@'1+B^E:6[N+30M8>T\V9SDM<321R/)(3T& >:_N
MKW=>O')X_&@!Q&#BDJ)I-I  R2 ?08)[^GUZ5,H+ _+WQPRG'Y$B@!*_G-_:
MU_Y6-_\ @FW_ -F:_&C_ -3/6Z_HTV-Z?R_QK^<C]K9PO_!QS_P3:4XR?V-O
MC0.O.?\ A--:[#/KWQ[4 ?T;'J?J?YTE&[);&>O]310 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?[P//TI] !1110 4444 0LCM(K9^50<@]''9>.05/(:E6/869&?);(RWRG(
MY4''R]@>/QJ6B@!A0G>/-<;NI8E@>>RMD+GOM"C'&,\TA4\X)4@ QD$?(W1E
M _NMR<'('3@U)10 W8",EF)]"22!]3G].,G@"D,:,,$<>G7/7'7ISCI_+(+Z
M* &%695!<G')Y.[/KS\GMTP,\8YIV!P>^,$>G^?:EHH , =#G/)]B>U%%% !
M7\YO[6O_ "L;_P#!-O\ [,U^-'_J9ZW7]&5?SF_M:_\ *QO_ ,$V_P#LS7XT
M?^IGK= ']&9ZGZG^=)2GJ?J?YTE !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\M9+6)B.?EDGV(<C'&[<#G( P3^DG_!*_P#X.&Y?^"F7[1WA[X(Z'^S!X_\
M _AK6]!\2ZO-\2-0MVN/#5E-X>L)+P6$U]%OMQ/>NAMXE,F2_P!WUH _IE7)
M89.,_.#CA@ $(/;=GG*]JFJ*,DXR0,#>%7E64G;N&>0!D @=ZEH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OYS?VM?^5C?_@FW_V9K\:/_4SUNOZ,
MJ_G-_:U_Y6-_^";?_9FOQH_]3/6Z /Z,SU/U/\Z2E/4_4_SI* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBO\ 8)\"75U/K'CKQ8/%OB?PU9.S-?\ ]I7]AHWA*+[+&?WC07?VR:W&PX8
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M<CWQCUSR:GI@ !Q@[=WR^VT!3C'\&1@;O08I] !1110 4444 %%%% !1110
M4444 %%%% !1110 5_.;^UK_ ,K&_P#P3;_[,U^-'_J9ZW7]&5?SF_M:_P#*
MQO\ \$V_^S-?C1_ZF>MT ?T9GJ?J?YTE*>I^I_G24 %%%% !1110 4444#OO
MY_YI_H%%%% EH[ZO6_\ 7]=@HHHH **** "BD)P<?+D=1N'!/0'T)X_.@'/
MY88RIX(.<'KV![XY[4 +13=PSCIU/) .!WV]:7G:#@Y/0>OI@^XR>GH.IH 6
MBFE@,8R<D@8!SGL"O49[GM3N>/7^+GA>N<GIQQ]<\4 %%)D>^#T..H]_0],
M]>U!/!(YPP4YX^8XXR?J/Y4 +11WQT)^Z#P6(^]@=<+W/3]< Y&>Q/!]?\.>
M,?E0 449QR>G?C/Z4F> ?7G&<84XP3[\].M "T4A(4X)'0D@<E0/4#U_2D5@
MV?4 $@<X!&0>/7GZ=Z '44W<O(YSN ''# ]&SZ>I[4[MQC(SD9Q@]L>N>WZ9
MH **3/0'@X)(/&,#(^N>G'O2\@#/!/3)X/KD]O;UH **;N'&.A)7GCYEY88/
MH.<TI(VD@@D8. 1T/?/T[4 +102  >2I Y4;CD]L#GWS['BDR.F><XP.2!R<
MG'0<4 +1110 4444 %%%% !12CG/.,#/U]J1N-N.<]<=OKUH **** "BC_/^
M'_USVZT#GC!W>@&1_P!]#B@ HI,@XVD-N)VGH#C[W)Z$>E*#GGCGI@YX_#^5
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO^>U>)K^T1\%5&?^%C>%2G)3;K%F221R2/.QTZ8I!^T1\%3NQ\1_"X)&W/\
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M%[X7?M@V?Q>_X1G4VU;7? ]WJEO+#?Z4BEKD &X:21B-V%VXSC K]S/V-_\
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M !_#X1U;QI:W-WH,'EF1[BWM2=S;2RDDD;5QWP!7^;;^R;\"O%WPL_X*;?\
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MQY30]1M-(=+6\>UO]2LE-L%DL,1R3VEPVY'BV/O(8&OZ'OV0OVM?@M^V_P#
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M_&:>W<Q)K=GJ&DZ=;>'K2^E4+F"+3+W47E21MN;177+94_8?_!>OQ3/^V?\
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M<-4BN+(:A9:FC/IZW!93>P*9>)(MQ>-3\O &:]^_X)>_\$*_C%\+_P!JU?\
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MGXN_87\'-HMQ=VC?:M&\1Z%X6AU?3[J.WF02Q7JRV36L:E%</.0<9R/YT_\
M@V\T#XW_ +=/[>/PU^*'QWL;\?#_ /X)B?LXZ5\$_AWHFJVMU!'HOB<37NG:
M%K=O!>1((]6F@M;V:[:,&0>6I)VLA8 ]:_X*@^ -%^$__!PQ_P $6OA=X9L;
M?3?#/P\B_9Q\':#86RA4MK+P_P"(ELXXQ$H"(N55V(QN9W:NY_X.??"/COX@
M_P#!3/\ X);>!OACXR7X>_$7Q7XTT+0O _CKRQ(?"'B/4O%EA:Z3KOEMA9#I
M]])'=*I."R <<U=_X+)6-_/_ ,',/_!*.Z@T_4);.+Q7\$_/O8+"ZEM8@/&4
MQ<O=1Q-"I6++R*S@I'&TC (C,/5/^#@2SO9_^"RG_!&F:'3[RY@A^-/@(S3P
MV5S<6\:?\)_I)(FFBB=(L#<Y#L,(KS'"1LP )_VIO^"=7_!PS\$?@[XN^)OP
MG_X*3:M\=O$GA6TNM6G^'EAHPTK5=4TJSBEN;K^S)77Y[Y(D,L=NJL7QY:CH
M1^?W_!$C]DOX<?\ !6;X[Z1\<_V]/VKO%?QA_:$_9ZU*2]NOV:/&;'3;_P ,
M:_H7B*9HYKC2[HJVHV$<ENDMP8XY")DVN@5>/]$&3[[#G)(X8Y613U0IT*D'
M&3V[=,?P=_\ !=?]D+XI?\$K_P!N7X5?\%E/V*=#U&S\(:SXPTZ#]H/PCX7M
M9%TJUU2XN(H-1GO-.L L*Z/XKL=T$I>'RH]5?S&:)%)(!^U/_!T+;VUI_P $
M8OV@[2TMTMK2UO\ X<6UI!"BQP6UO!XLTN*&&.-?E6-(U5(U  15& ,"ONG_
M ((V?\HP?V,1M$9/P0\) !6)5<6$6<L.2>.I^F0,5^0__!<']IKP5^VQ_P &
M[_C?]HCX6KJ%QX?^)EI\,M7-@;"\6_TO68?$^F1:SHMQ9O"+B-K"_CN('=HP
MH15F8@,2/FC_ ()U?\'(O["G[-W[%'[.?P,^(&G?$NU\:_#3X:Z#X:\2P6W@
M[7)((;O3[6.*X:)_L!WKY@(R&QA0<'- ']7G[6>NZ-X=_9;_ &B=:UVYM=/T
MBP^#'Q$:]O;R18;6-9O"VJ6\>^60A5#SRQIEC]]T'<5_)7_P:A^-O^&<O^"6
MW[5?[2OQ.?4(O@SX>^)?B7Q%:3V$,VH70M/"43KXG^R6,*R2RW FN[/$<2%I
M"V>3BO-/V^/^"N7[3'_!8WX9:K^PW_P3=_9D^*4'@[XQZ[:>#/B%\;M?TG4=
M+T.W\,7=RD\T,=[-%:FQ26*$W%PV27CC*[@,8_J)_P""9W_!/SP#^P-^PI\,
M/V04MM-\30Z=H\^I_$R2^MHKO3/%?CGQ-%;W/BV[FM94:&:UN[R%8TA=739
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M?\$9?V4(KBVGM9XA\06>*Y@DMY5)\=:Z=SQRJD@5E/RR;2&4JRY4@T ?'_\
MP;M?M[R6G_!*/XO^$/CUJQTCXF?\$[+SQ[X/^(.G^()1;3:+HOA^WU6[\':5
M="5OE^R)I_\ 8TASY:W31Q?*V!7SA_P;5_#GQ)\5]+_X*&_\%AOB'I-J_BO]
MH?QO\4$^%M\[R7&L:3HOAS^VM6\46"-*-\-JVH)I%I;1(?+9+3Y<D$#\=/\
M@M=\./CS_P $^_\ @H+^U_\ L_? '2/$+?!K_@K!X7\.,J06]Y-9?\)?XL\4
MZ6?%\UH+2/RX38:[=2QLP97^S7$K86,.]?WN_L!_LB>&_P!D;]A;X(_LH6NE
MV6E'PY\*[/0/&W]GJN-1\6:YHJQ^+-5E( $MWJ%_<3RS2GJR@$\9H _SXO\
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M03^T'_!QF ?^",'[=+%C\WP\\/$9.W)'C_PH-@_O!>6Q@9YS0!_'9_P1&O\
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MN4E6/(XXK^J+_@\/CCD_X)L_#$2)E3\</ ZLJC.^-DVLF3V 8[1W).:^./\
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M]I#4-*M]0\/?!KP-:2ZIJ]U<WDB+;6&JO9I.VG3RHPFCC>,%HW1R0,BOB?\
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MO=;\*0:3<R'<;AYM.BBN8HI PGGAC8J20*\?^!__  7@\5?LD? 'X;_LE?\
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MC8':OZLD 4;1V)!]<^_O0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBC-
M'Q1_P47^"7BS]I3]A3]K+X"> ]0;2O&?Q3^"?C7PIX:OUG-LUOJM[ILCVQ6<
M%3&TC1^4IW*"7VDX-?S[?\&G7Q ^#G@+]B;X@_LR>(9?#7@']I/X7_'CQ_#\
M4?"/B&:PL/%.I6V^QBT_4F2\:.:>TB6WG1$1W2V<D(663?7].O[17@GQ?\2_
M@7\6?A]\/M>7PKXX\8>"-<T'PKXC,C1C1M:O[9X;/4/,0JZ^1*ZO\K X&,U_
M 7J7_!J]_P %-_"GC7Q1\9KC]N?X<>"O%7B*ZN9_$/C<:KJ7A^XU'[7,[?\
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MI7I-% $*H=ZR?Q+D'/RE2QYPN>2PXSZ\^E3444 %%%% !1110 4444 %%%%
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M?XF^+C<II]C<WGEQ22_#^3$WD(XB/E07#J7V_+'(P/R&O[1?%OPU^'OCK4-
MU;QKX,\/^*=7\)7CZAX;O-9TRWOKK0;N7"RW>DRS([02D*FYH=K,!@YQ5?QG
M\*/AG\27T6;Q_P"!_#'C-_#]PUWX=N/$.DVVH-HUQ,J*SZ<]Q&YMI'$:@M$5
M/RX8D#% &G\.0W_"O? ",98V_P"$*\*X4@HX9-#L=Z/D_?XPP(R#G-=@0S')
M(R/D()R002P^AP<'K_2FPP);I''&-D42)'#&N D<<:"-$11PJ*JA54= !4U
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ML:*HP%55 &,  4 ?P;Z5#^T5_P &Y_\ P4Z_:4^)5K\$?'WQP_8/_:TU._\
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M.37,^!OAWX$^&FDR>'_A[X1T+P;H\LYN_P"S/#NGVVG6,LS##7+V]LD:-*5
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M,022>Y]>OT_G45Q!'=6UU:W4,5S;7<$EM/;3(&AGMIXVCN(Y]V0\<D3-&R'
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MY<T44 )@?-VW'/';OQ^//-! )!/S%<XSV)&"1[G^=+10 @&,>P('XG-+110
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MVDK1RE)6>XE=I9&)- 'E'_!/7_@X!_9G_;<^,"?LU^,?"/B[]G3]HFZ!.C>
M_B)8SZ3'XFN."MCH<]]%;W5Q<S1AY(E",DJQML; .[]^N>_7O]:_A;_X.:_"
MWA:S_P""@7_!+^T_95TG3]+_ &V=2^($:VJ^!(K2RUYM"CUO1AI/]M6]@$D5
M_+.H+;2S;6:Q^T#(C):O[CM$%\ND:2NI;CJ TO35O]QR?MPLH!=$GU\\2%CS
MDY- &M129 (W-@,=JC;_ !<=3_D=:=R2<[,C ."1[\ \?7GM0 E?SF_M:_\
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MR/AZ]\21V]QIR20*OVB&Q,L95"@90^)B$R,YW<5_<-_P3E\6>-O''['OP?\
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MNHRW@\,CX:BWOYQ:+)+(85UC3-8MHY8E^5;BW=NA11_<SC(P?Q_S_C7\L?\
MP0P_X)#?M ? ']H#X]?\%)?V]KW3;S]K_P"/]WK<5CHFDD36GA#3?$\R3Z]J
M<LY^>2[UV%;.SEM#^ZM(+&)5+'+'^IT9P,\G R?4XY/XGF@#_/7_ .#K_P
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MY0J5=6 _O-^&^?\ A6OP\Z#/@7PD6)'.Q=!L"P!Z[CV]^?K^'G_!S=#IDO\
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MK\0]%TJ^FLF\8>&M*\%6MY+X<OI8CG[%?W@LQ=1D%6A@VXPQ%?I9_P %_/\
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M.S1O\[&@#]#/^"U7_!4[X2Z)_P %1/\ @FI\-? W[5>GZ3\*_@I\>+__ (;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F
M:DMXUO<KISQQ7[6EREA-.N^&+4'A=;*1H_XX%FV&=. R@BM.FLN<]02N PZC
M^>,>G5@>",4 ?Y_?_!0;_@J3_P '!G@QOVJ?V>_&'[*.F:S\(=(M_&W@G6/B
MUX8^&4B:3<^")%FM6\4Z=K,,YMX87TV9'%SN C<,WRD5^<__  2X_P""IO\
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MIY8=-MUE\P;2_DL^!0!]>J%8* '.06Q&H"D8.6;NX/W0/]H>M?B+_P %8/\
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M3C'FBXN+^%:V2OY_(Q=6741I&J#27B&M"PO%THW0WQ+J!@D^R^:AP#'YFSS
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M]II%]:>$$\.:9J'DBU@NBCVMYHEM.T>M3:FTH1_LJ6R1(S[F_JO^''_!-O\
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M0)N 2K8DY(Q7JO[07[._P<_:I^%/B?X(_'KP1I?Q#^&'B_[&GB+PIK,.^QU
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MA)K>B>#/#_P^L;C7TT#2?$VEO8^(KGQK-9JPT"?3/#M[J+RPSH<2)C?A1O\
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M^SAX;\#ZW P5L6>N_#_3K-BC$,-\)F\U' ^61$8<XK_,\?Q1\?O$OPY\)?\
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MH]1LXTCL$CVRI<_).'B#%F_OJV$N.0!N#G/S!F481LYXP1G';@^U? 7[3/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !11FCOSP.<GTX].] !11[$XQC!]3Z44 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<7G;O((&">,-P!D'@\Y[8_&FJQ;/RXQCJPR2<8&.V<]Z_BT_X+%_M _M)_\
M!-'_ (+-_L4_M/Z=\9_B#%^R;\>]3T;P5X]\!ZSXDU5OAEH5]?WT?A[Q8R>'
MS.='5K3P_<VWB!)F@\VTDAEGCVEV8_V;Z1JNE:YI6FZWI%[#J&BZYIUCJNC:
ME;,7M[_3M3M8KRPO;:7&7@N;2:*:)V RK@CKBD,TR7.0@R5(# $<$C."3QCW
M&:12Q<IGYU4,XQG;NY49'&3@X^E?RF_\'/?[:?Q8^%GP_P#V8/V)/V8_'_C#
MP+^TC^UA\4-&LX;GP-<ZC8^)(OAL-2?0K^_T_4M+>.]MI#K\EG%.\$L<D5I'
M=2[@H++XO_P<2ZI^T?\ L;?\$K_V#/AW\.OV@/B?X5^+$7QC^&_PV\=?$W1_
M&>LV?BSQ5J\_@J_&KW6MZU;7:76H03:VC7TD%Q.\3>7&N"H- ']B[;TY<A00
M6ZXZ'OSUQCI2[B0/F^]T!^4L#QQD=3V!ZU_(=_P:\_MD?'#QE=_M<?L4_M1_
M%'Q3\4/BW\$_&EGXD\(^(?&^L7VMZUK'@_54D_M"X%WJDTUX]C#>/8FR"LUN
MD$H7(8E1_3+^UQ\>-!_9A_9>^.O[0?BF18-%^%/PU\4^,;GS9%5Q<:;ILK6R
M1,W_ "UDNS (T3+%B%09- 'T6PEVJS [0P/H5''S,#Z#J,;B>E28DP" 2",Y
M '3'R\=<GTZCJ<5_G"_\$)OVDOV^_%__  6-^ FE_M(?'OXL^*_ ?[0GP*\=
M_M!>%_ GB3QKK6H^%)O!GC"2_D\)70T"XNFT^%[:+3IC:1" -:KA4&?G?Z\_
MX+D>*_VG_B?_ ,%YOV:/V,_A7^UK\:/V=O 'QD^%'PST_49/AKXJU33+72+S
M6M=\26]_K46CP7MK8W.I31V4 :20;V6)%+$%A0!_=^5FXP,Y!SRHQZ9SUS_L
MYQWIC%T^^-HXP>&))P, +GN0#Z=<XK^4J7_@W%_:IQ,D/_!;K]N-AND6%)=5
M8,W)\L3,NOL0<;3(%#<9"YXS\B_L>_M7?\%!?^"3/_!5WP5_P34_;@^,.K?M
M%?L__M"VQU#X.?%7Q=/+>^)Y$F%Q8:5KMG=O)/<A;C5[230M5TNY,=O!.C7,
M8+C( /[;@[$<')!(<<#9@X))/!&?2A=[?<R<?>R=N#^/7U!Z&F@LI9'C'[H%
MF*_=(9@4SQEB!C<IX/..U?SK?\'/?Q<^*GP-_P""8GB/QO\ !KX@>*_AGXOM
M_B)X6MHO$W@_6[W0]<CM;@W+7$,.H6,L-Q'#,%(:-7 P5^7B@#^BUR44;\CD
M@-R<D9].<8XW=.::S[%W8; &92!N*9]1R3GKD=OH<?P[_P#!K!^VS^TSJ?QR
M^-'[(_[7WQ/^('Q&\6_$;X1^!/VD/A+??$?Q%?ZYJ,'A"[LXHY8])N-6GEG%
MMJ$&JVEW]F@8I(8FF VJ0G]IWQ.\>Z)\*?AQXY^)OB:Y2PT'P#X5UWQ/JEU/
M(D48L]&TZXO"7DD*Q@,8A&IE(&YP#C&* .\7S&7<01\N[& <CK@$<$XYQ^!P
M:<C&3<54D!MN>!G@$D9QP,_C7^6=^R?^WO\ MT_&C_@KE^QQ\2/%W[0OQET?
MX7?M-?MJV.I:3\'W\:^(K?P.WPZ?Q@-+T^RAT5KU;&?P_?V(>/[&MNUB^?,1
M2XW5^]'_  <@^.OVB]1_X*#?\$Y?V:_@U^TE\5?V?]!_:#\3Z3X#\1:G\,_$
M>IZ+/;#Q)XEM=$DUF:TM+JUMM1N+&WNGDMX+EBC,O., T ?VD,LG!V,,\'!4
MD<\9PWX\>O.*0K( V<KA@/7CKNSZ>O>OY2I?^#<3]J;SI5C_ ."W7[<?V7<?
ML_F:FRW.W)&)"FOE58G(/EDC^'G%?EO^UA=?\%/O^#=W]H7]G7XS^*?VS?'O
M[7/[(WQ1\>V/P^\46GQ2U*YU/5(X3,E[KD%W97-Q=1V=U#H[2W6G7]NV\SP&
M [U8-& ?W]JQ;"J69AUY"\#/S\]5)XX)P2!UQ4P208XR",]1E3UP>>?3CC\*
M_GW_ .#@G]H#QIX:_P"",7Q-^/?P-\:>*?AYKGB72/A)XF\+>+O"VJW>A^(=
M-T;Q?J>BZ@D$.I:?+#<6KW.G7RPN89%W?,,\U^5'[$W_  1/_:[_ &L?V5O@
M?^T;J7_!9G]M7PIJ7Q<\"Z/XOO?#NG:W<7=AI)U:V2=K.UGN=<2:3R68IYDB
M;V&#QDB@#^UPK+P<'G'''&?KP,=#[_6FELLJ@'<"2PQPN,=3TSUQ_P#KK^$_
M]KO]GC_@LE_P0UTRQ_;(^%7[:?Q&_;3_ &?/ VL6@^+GA#XLW5SK.I6?A6:[
MCCGO;BTN;R[AMM.DC/D37T1:YM;F6-E 05_75^P/^V9\-?V_/V5OA3^U'\+K
MJW.A?$/1HI];T>&:2:7PGXSLHT3Q+X4OGD56%YHMZ_D..5=6C8MEL  ^RZ!R
M<+SC[W;'Y]>>*,_SQ^/I]?:N=U3Q?X5T35-)T36_$_AS1M;UZX^R:!I&K:YI
MNG:GK=R1E;?2=.NKB*[U.<\_N;2*:0X.%ZX .ASD;N,9QR5'3KCGM2]\ $G\
MA],G )^E>*7O[2/[/6FZ[)X8U'XY_"*R\06\[6MQH]U\0/"<%W!>(YBDLYX9
M-562WNTDS');RA)D<;&0.I6O9$N8Y8XY8G62.5$EA9&62":*1=\<L$R$I(KJ
M0T;ABK A@>: )QDDC'3[W^S_ (].U';/\&<;O3GTZUYUXX^+OPJ^&/V;_A8W
MQ(\#^ VO(6N;2U\6^*M%T"\O($<Q-<6MMJ5];7%U"LH:-Y88WC5_D+*W%2^!
MOBQ\,/B9%<W'PY^(O@CQTEBGF7H\(^*-&\0-;1%MBM=PZ;>W4UH"Q"AYTC5F
MP%R3B@#T'N,<[C@'!YX)ST[8YI"<9ZY!Q@#/3KTX_6L?6-?T;P[IMUKOB36=
M)\/:'81_:+S5];U&UTC2K&'(427FHWTL%I;(2ZC=--&I)Z]*\AT[]J#]F_6-
M4CT/2OCW\'[W5Y)A!%IUO\1/"KRSSNVU(8=NJ?Z1,[D+'%$9'D8A54EAD ]T
MW<D8YP"HR,N2,@ =N 3DX QSQ32S_+QM+8^0D;NI!..2=O!..WZ^!?M3_#>?
MXN?LZ_&CX8VWQ6U3X&7?CKP!KGA>#XR:'?VVEZQ\-Y=0MFAC\5Z;J%Y/:6UE
M>Z9O\ZWN9;B&-7"DR#.:^"M/O[K_ ()J_P#!+/Q[K3?M,#]ISQ;\$/@]X_\
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M11^!'Q]\*VL2^._V.M'^#OQSL+M8C)*?#VB:7IL.M66Y 952:XETVY^0XC>
ML00#CY&_X)T?'B__ ."V?_!83]G;]K&\SJ'PD_8G_8\\ ZUK^B2P%-.\)?M0
M^*K&:'7?[)A?<BVSW-M(1,!G]R%5>* .E\&_"3PS\"/^#IW]E;X*^#=.32/"
M7PO_ ."=/@[PAH&DQR%ET^VTCPWJZRQ[OXF:[-Q(W3<S\=%KY%_X+O\ Q_\
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M&_C#3=7FM[;2O$FN:GH^G:3K<=W:LT>RT>ZEECNHRY\OS0" YK]"T_X-,?\
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MX9_':VT6^DM+CQ/XO@\.:AI=M%J%O&C)-:6_AQ[#63+.&5;K2E4([,37HO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+28[J\UV.*-BULL-_:1>*9EDA>2-X@TR%0Z[1O85)HW_  9?>(O#J31^&_\
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MU_+O3SU/U/\ .D.>PS^E #-V1R#TYP.*;A0 3GD=L4]BW8?CU_2@#(7(Y %
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M:VT:C 2WMX=#6*)0,#"C8!P%%?U)!/<_AQ_C04SW/X\_X4 ?@5^RO_P;<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 444'/:@#X7_X*8_!'Q;^TC_P3^_:_P#@/X#<Q^,_BG\"
M_'/A7PT1<"U8ZI>Z9(]N$G) C=C"57G))"X.:_GQ_P"#4G]MK]G\_L67O[$W
MBKQ5X5^&W[0OP/\ B/XNCUWP)XAO[+P]J7BFQO[JWA37]-74)+8ZM>F[LY[?
M4X+<27D#PQ,X,;;D_JL^+GQ3\#?!+X8^._B_\3M:MO#?P^^''AG5/%GC#7+M
M-]OINA:3;O<WMQ(F&+CRU,87!W%PIP"37\7>K?\ !)[_ ()W_P#!?.P\;_\
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M%% !12'/MD\@>H_R#2C.,D?_ *Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT#_V3J-U<^;-#MCB&P(&;/9B/U*_X=>_\$WLE3^PU^RWG)'_ "1?P.?F^O\
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M[P[X*U*31;&]-YX1DCFT9(Y-:7Q7HUQ]GM!=M--]JTNYE4@2;(_ZNV@.""C
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M$?\ P=5_$CXZ?M#^*6\'_#C2_A%X7TJ^UI;>6Z:"\U/PMIPM$\B%6=T<Q.7
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M/K-],_@3X6CQ%X8BO_%/Q,CT\$PVVH6<45TXO,;OM5S;_P!T$]-^V3_P2_\
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MPIHGB1-#ADTCPIXE^*%_8V]CJ>M$)''/I7AJYUM;J[2&.-)8K8K"J+@U[Y\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBU=:Z-:$5J<*U.5.<$X5:4Z-2'1PG#E:G;=:M.V^MF^OP"G_  3$_8="*B?
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ME*797?2UM#T\)@L-@*4</@Z$,/0@K1ITXJ,%MLEM>U_6Y_%7_P 'CS?\4?\
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MU_QI\1[30CX?N/&NLZQJEU>0WNH63W-Y('TZPF@TNV:6YD86]NA)W%J^4?\
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M;P]::EJ\5G:0S?N3>^))-0-G'#;EIL:0"N2^*_J._P""0O\ P3IN_P#@EO\
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M_!-O_LS7XT?^IGK= ']&9ZGZG^=)2GJ?J?YTE !1110 4444 %%%% !1110
M4444 %%%% #/+'O_ )_"E" 9SN;TR>GL/:G44 ,\L Y&1DY^\,#O]/SIQ7=[
M8_SW(I:*  < #TI",X/I2T4 ,\L=>?\ /_ZZ?110 PQJP]!W]^>W/^-.5 I!
M7H. #Z^I_P XSWI:* #&"V#\[=SC:!['IG''6F;!M ]._P#C3Z* &;![_P"?
MPI]%% !1110 GOSTZ?\ UO6C#,,!MJG&3T;CGCO2T4 ,V+G&6/N>_OG'>@HA
MX?>1VQS_ $I]% "%<?QL0.!SSC'/N![<>U &TY&<^O7]*6B@",H,@\D=\<?=
M_7YB?QYI?+0#&,@<#/IV]J?10 S:!@!>/KC%.QSG)'MU'T'H3ZTM% !4+L=_
M(S&%Z#!;S<Y7IR !W]_3%34P@[B0 ,X^;OP/\CI0!^/M]_P2?T2]_P""N%Q_
MP5/;XFW UB;X9^'/AX?AL=/86\2:#HT6CK?KJ ?EKF."*1X2FU74E<;FW?KZ
MW[QU++D_*7 &"HYPZMGDC@%??VIQC;.[<6R,;>WU_I2A&^GX_P"% #]@/MCK
M[_J/TH*@\<CZ?E3J* (A$BD$ Y_P]>*DP#R1[4M% ##&I[''IGC\:/+3J!@]
M#Z4^B@"/RE!SSD^]*8T."0<CIC/7W]J?10 C*'(W$Y4?+V'TST_.D*[E7)(.
M2#CC(]#CZTZB@!H4*  .GY^O6G444  525W9^0EU';D$$?B><?IBD VY51\H
M.[ZLW/!'4#H3Z]:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]#_6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(;2*-F5IGNFD4XB8#^[^RLX]/MK2QMP?)L[6VLX@><0VL*6\?3'.R,&@#/\
M%7B;1/!V@ZUXI\2:A;Z/X>\-:;=:SK>JW<GEVEAI=E$9[ZZN'/ 2WA1I"3P
M":^'U_X*E?L!EL?\-.?#;"CY6&N0*CY."$Z E0/FZ8_6OMGQ;X6T+QMX<UWP
MCXJTNUUOPQXETJ\T;7=&OHC+9:II5_"UO?V-V@92T%U S1. 1E6."*^!H_\
M@D7_ ,$U@%W?L?\ PB VYC$FBSD)N.YMA^V??;.6_P!D@?0 Z/\ X>E?L"?]
M'.?#;_P>V_\ C7\['[<G_!3#]B#P/_P7-_8(_:+UWX^^#T^#?@C]E/XH^&/%
MGCBPN9M2TW1M<UKQ=JEQINGWJ64,\JS7$5Q"V!&6&2.@%?T$_P##HS_@FI_T
M:!\'O_!+<?\ R97X2_M&_L!_L8>#_P#@OG^P+\(=!_9L^%=M\+O&7[)WQ7\0
M>)O =QX>2Z\-ZWKVF>*=5L]/UF^TZ[EGBN[^RMXHQ!*^55XU#(XS0!^EO_$1
M_P#\$;" Q_;*\&@L,[3I>MAE'8,!IW''0$DXQGG-'_$1_P#\$:_^CRO!O_@L
MUW_Y7U]H+_P2S_X)R$N1^Q7^SH 6SG_A6^@ L3U)'V7CGIZCIBG_ /#K/_@G
M+_T99^SI_P"&WT#_ .1: /BS_B(__P""-?\ T>5X-_\ !9KO_P KZ/\ B(__
M ."-?_1Y7@W_ ,%FN_\ ROK[3_X=9_\ !.7_ *,L_9T_\-OH'_R+1_PZS_X)
MR_\ 1EG[.G_AM] _^1: /BS_ (B/_P#@C7_T>5X-_P#!9KO_ ,KZ/^(C_P#X
M(U_]'E>#?_!9KO\ \KZ^T_\ AUG_ ,$Y?^C+/V=/_#;Z!_\ (M'_  ZS_P""
M<O\ T99^SI_X;?0/_D6@#XL_XB/_ /@C7_T>5X-_\%FN_P#ROH_XB/\ _@C7
M_P!'E>#?_!9KO_ROK[3_ .'6?_!.7_HRS]G3_P -OH'_ ,BT?\.L_P#@G+_T
M99^SI_X;?0/_ )%H ^+/^(C_ /X(U_\ 1Y7@W_P6:[_\KZ/^(C__ ((U_P#1
MY7@W_P %FN__ "OK[3_X=9_\$Y?^C+/V=/\ PV^@?_(M'_#K/_@G+_T99^SI
M_P"&WT#_ .1: /BS_B(__P""-?\ T>5X-_\ !9KO_P KZ/\ B(__ ."-?_1Y
M7@W_ ,%FN_\ ROK[3_X=9_\ !.7_ *,L_9T_\-OH'_R+1_PZS_X)R_\ 1EG[
M.G_AM] _^1: /BP_\'('_!&SM^V3X-/M_9FN?_*^A?\ @X__ ."-S' _;(\%
MCW;3]:4<>[6 'X=Z^T7_ ."6?_!.3:<_L5_LZ'/&/^%;Z!R3QC_CT[U^#'_!
MQI^P=^Q?\&?^";S^-OA1^S!\&?AYXM/[2'[/.B)K_ACP/I.E:LND:QXX2VU;
M33=6D,<HL]0M=\%U;[C'+"=I7)! !^BG_$2!_P $;?\ H\CP;_X+M<_^5]*/
M^#D#_@C9W_;)\&C_ +AFN'_W'U]-_#/_ ()>?\$[+_X<?#V_N_V+?V>9[N]\
M#>$KNZN'^&VA.\MQ<:#82S22,\#.[O([,S.SLQ8EF8Y-=P/^"6?_  3D&0/V
M*OV=E[_-\-M &<^@^RF@#XM_XB/_ /@C7_T>5X-_\%FN_P#ROH_XB/\ _@C7
M_P!'E>#?_!9KO_ROK[3_ .'6?_!.7_HRS]G3_P -OH'_ ,BT?\.L_P#@G+_T
M99^SI_X;?0/_ )%H ^+/^(C_ /X(U_\ 1Y7@W_P6:[_\KZ/^(C__ ((U_P#1
MY7@W_P %FN__ "OK[3_X=9_\$Y?^C+/V=/\ PV^@?_(M'_#K/_@G+_T99^SI
M_P"&WT#_ .1: /BS_B(__P""-?\ T>5X-_\ !9KO_P KZ/\ B(__ ."-?_1Y
M7@W_ ,%FN_\ ROK[3_X=9_\ !.7_ *,L_9T_\-OH'_R+1_PZS_X)R_\ 1EG[
M.G_AM] _^1: /BS_ (B/_P#@C7_T>5X-_P#!9KO_ ,KZ/^(C_P#X(U_]'E>#
M?_!9KO\ \KZ^T_\ AUG_ ,$Y?^C+/V=/_#;Z!_\ (M'_  ZS_P""<O\ T99^
MSI_X;?0/_D6@#XL_XB/_ /@C7_T>5X-_\%FN_P#ROH_XB/\ _@C7_P!'E>#?
M_!9KO_ROK[3_ .'6?_!.7_HRS]G3_P -OH'_ ,BT?\.L_P#@G+_T99^SI_X;
M?0/_ )%H ^+/^(C_ /X(U_\ 1Y7@W_P6:[_\KZ0_\''_ /P1L. /VRO!W7_H
M&ZXOZG3\5]J?\.L_^"<O_1EG[.G_ (;?0/\ Y%KS?XR?\$PO^"=NE?"+XI:I
M9_L9?L\V]YIWP[\:7UG/#\.-#66&[M?#>I3VTL;QVZ2))'.B.C(RLK*&!!&:
M /G1O^#C[_@C<AP?VR/!AQCE=/UIQ_WTM@1G\:/^(C__ ((U_P#1Y7@W_P %
MFN__ "OK\[_^#<7]@S]C#XT?\$QO!GC;XM_LN_!CX@>,[KXL_%[3KOQ'XI\$
MZ3J^K7-AIWBB6+3;66]O(9)&M[*W)A@CR$CC&W&02?WC_P"'6?\ P3D_Z,L_
M9T_\-OH'_P BT ?%G_$1_P#\$:_^CRO!O_@LUW_Y7T?\1'__  1K_P"CRO!O
M_@LUW_Y7U]I_\.L_^"<O_1EG[.G_ (;?0/\ Y%H_X=9_\$Y?^C+/V=/_  V^
M@?\ R+0!\6?\1'__  1K_P"CRO!O_@LUW_Y7T?\ $1__ ,$:_P#H\KP;_P""
MS7?_ )7U]I_\.L_^"<O_ $99^SI_X;?0/_D6C_AUG_P3E_Z,L_9T_P##;Z!_
M\BT ?%G_ !$?_P#!&O\ Z/*\&_\ @LUW_P"5]'_$1_\ \$:_^CRO!O\ X+-=
M_P#E?7VG_P .L_\ @G+_ -&6?LZ?^&WT#_Y%H_X=9_\ !.7_ *,L_9T_\-OH
M'_R+0!\6?\1'_P#P1K_Z/*\&_P#@LUW_ .5]'_$1_P#\$:_^CRO!O_@LUW_Y
M7U]I_P##K/\ X)R_]&6?LZ?^&WT#_P"1:/\ AUG_ ,$Y?^C+/V=/_#;Z!_\
M(M 'Q9_Q$?\ _!&O_H\KP;_X+-=_^5]'_$1__P $:_\ H\KP;_X+-=_^5]?:
M?_#K/_@G+_T99^SI_P"&WT#_ .1:/^'6?_!.7_HRS]G3_P -OH'_ ,BT ?%G
M_$1__P $:_\ H\KP;_X+-=_^5],;_@X__P""-P.1^V1X-P>_]G:V.G_<-)X_
MKZ5]K?\ #K/_ ()R_P#1EG[.G_AM] _^1:A?_@EK_P $XE8[_P!BG]G4@ ,&
M_P"%;: P+] N/LN%..<_CVH ^,_^(C[_ ((VX!/[9/@P YZ:?K3-QZJ+#<OX
M@4G_ !$?_P#!&O\ Z/*\&_\ @LUW_P"5]?!_[-_[!?[%6L_\%SO^"C'PHU?]
MEKX*:A\.?!_P#_9@U;PGX.N_!.F2^'O#VJ:[X0BNM;U'2=,:,VEI=ZM,2]](
ML1\YV9P%8 U^X?\ PZS_ ."<O_1EG[.G_AM] _\ D6@#XL_XB/\ _@C7_P!'
ME>#?_!9KO_ROH_XB/_\ @C7_ -'E>#?_  6:[_\ *^OM/_AUG_P3E_Z,L_9T
M_P##;Z!_\BT?\.L_^"<O_1EG[.G_ (;?0/\ Y%H ^+/^(C__ ((U_P#1Y7@W
M_P %FN__ "OH_P"(C_\ X(U_]'E>#?\ P6:[_P#*^OM/_AUG_P $Y?\ HRS]
MG3_PV^@?_(M'_#K/_@G+_P!&6?LZ?^&WT#_Y%H ^+/\ B(__ ."-?_1Y7@W_
M ,%FN_\ ROH_XB/_ /@C7_T>5X-_\%FN_P#ROK[3_P"'6?\ P3E_Z,L_9T_\
M-OH'_P BT?\ #K/_ ()R_P#1EG[.G_AM] _^1: /BS_B(_\ ^"-?_1Y7@W_P
M6:[_ /*^C_B(_P#^"-?_ $>5X-_\%FN__*^OM/\ X=9_\$Y?^C+/V=/_  V^
M@?\ R+1_PZS_ ."<O_1EG[.G_AM] _\ D6@#XL_XB/\ _@C7_P!'E>#?_!9K
MO_ROH_XB/_\ @C7_ -'E>#?_  6:[_\ *^OM/_AUG_P3E_Z,L_9T_P##;Z!_
M\BT?\.L_^"<O_1EG[.G_ (;?0/\ Y%H ^+/^(C__ ((U_P#1Y7@W_P %FN__
M "OH_P"(C_\ X(U_]'E>#?\ P6:[_P#*^OM/_AUG_P $Y?\ HRS]G3_PV^@?
M_(M'_#K/_@G+_P!&6?LZ?^&WT#_Y%H ^+/\ B(^_X(W')'[97@S &>=/UE<_
M[H;3\L>O S31_P '('_!&WO^V3X._P#!;K?]-.%?GS_P5W_8,_8N^'7[4_\
MP2)T#P/^RY\%?"^A_$+]K+Q-H7CRQT?P5IFG67BO0;;P.MU#HFM16J1KJ%BM
MT?/2VD7'FMOW 5^[/_#K+_@G(&('[%7[.H[_ /)-M "\GL/LV 2>2 !ZY.:
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M^1: /BS_ (B/_P#@C7_T>5X-_P#!9KO_ ,KZ/^(C_P#X(U_]'E>#?_!9KO\
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M\.U+_P .L_\ @G+_ -&6?LZ?^&WT#_Y%H ^+/^(C_P#X(U_]'E>#?_!9KO\
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M /X(U_\ 1Y7@W_P6:[_\KZ^T_P#AUG_P3E_Z,L_9T_\ #;Z!_P#(M'_#K/\
MX)R_]&6?LZ?^&WT#_P"1: /BO_B(^_X(V'G_ (;)\%GZZ;K@_GIU+_Q$??\
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MG_PZS_X)R_\ 1EG[.G_AM] _^1:/^'6?_!.7_HRS]G3_ ,-OH'_R+0!\6?\
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M $99^SI_X;?0/_D6C_AUG_P3E_Z,L_9T_P##;Z!_\BT ?%G_ !$?_P#!&O\
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M^"S7?_E?1_Q$?_\ !&O_ */*\&_^"S7?_E?7VG_PZS_X)R_]&6?LZ?\ AM]
M_P#D6C_AUG_P3E_Z,L_9T_\ #;Z!_P#(M 'Q9_Q$?_\ !&O_ */*\&_^"S7?
M_E?1_P 1'_\ P1K_ .CRO!O_ (+-=_\ E?7VG_PZS_X)R_\ 1EG[.G_AM] _
M^1:/^'6?_!.7_HRS]G3_ ,-OH'_R+0!\6?\ $1__ ,$:_P#H\KP;_P""S7?_
M )7T?\1'_P#P1K_Z/*\&_P#@LUW_ .5]?:?_  ZS_P""<O\ T99^SI_X;?0/
M_D6C_AUG_P $Y?\ HRS]G3_PV^@?_(M 'Q9_Q$?_ /!&O_H\KP;_ ."S7?\
MY7TW_B(^_P""-QP/^&Q_!A4LR@MIVN!<8RQ!_LW[JC&!P"3BOM7_ (=9_P#!
M.7_HRS]G3_PV^@?_ "+7SO\ M8_\$T?^"?'AS]F#]H'7=#_8U_9^T_5M'^$7
MCV_TZ_M/A[HL%Q9:E#X=O9+>>UN(8(Y8KFWG2*:)T8;9$0$%<J0#] /V:_VF
M/@K^UM\*-#^-?P \;67Q"^&GB.2YBT?Q/IXF6VO9+61DN%59XH9%,3C:P*#!
MX]:][K\)/^#;.QM+#_@D'^S/':6L%JK_ /":O(L*A=SKXNU:)6D S\ZQ1QQC
MDX1%';)_=N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]3V'K7\[7_!T(H'_  2XVY/'[4W[,W7(&?\ A/UP#Z*,Y'K@#O7]$<N[8VT
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MC-?K!0 4444 %%%% !1110 4444 %%%% !110<X..O:@#^>7_@M5_P G?_\
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M."*;7_&_PZ\6^&-'%R?)A&JZUI%S8V@FE/RQVXFE0LQX4!B>M 'Y,_\ !MV
MO_!(7]F0 $<>-ST.,GQEK6=I/WA_M#@G-?NG7Y@?\$=?V4OBE^Q/^P!\%_V<
M?C+%ID7Q"\"?\)*NMIHU['J.G?\ $T\1:GJ=J;>[B_=R V]U$7V]'+#UK]/Z
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I"<#-+2'&.3MR0,^ASP>?2@!N
M\>_^?QI"2=Q!^>3'E\#&!@G)QC)YSSVKB?B)X^\+?"SP-XS^)/CW58-!\&>
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M#)=74J*L48R6 .X 'ZD@D)C<5;!0)CLV2">O/7\JDW<XY.%')&"2 ,U\(?\
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M_,#E4SP>P/7UXZU^.?\ P28_X+#?"7_@J%X;\=Z)9>&M7^%'Q\^$LXM/B?\
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MT&>_&.E+0 4444 %%%% !1110 4444 (QPI_SUXK^);_ (+#IX D_P"#CO\
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MG17+8&R6=%8 DX /[2**** "BBB@ HHHH **** "HION'&=PY X(QQN)!X.
M>/3K4M-89ZYQ@G 'WCC@$]AGJ.] 'X$?\%1?^"3W[0G_  4Q_:)^'.B>(?VF
M]>^%W[#NA>"[:W\?_"KPA-)9Z[XQ\7+?WD\TLLT4D:W.GW-G);VT]O<,(2L>
M"?F./R4_X(6_ CX:?LR_\%]_^"M7P#^#^ACPY\-OA=\/? 'A;PII(E:8VMC9
M_P#"//),SL 3->7DUQ>R_P!V6XD"\5_;$BL'0G&0#D_>+#!V_,?ND'J/3%?Q
M_P#_  2K&/\ @Y?_ ."V&.AT3P=G'_<M\>W3]/>@#]Y/^"F/_!.GP'_P4U_9
M^M?V=OB;\0O&/@+P9'XFL/%&J/X1,9EURXT[_CQL]3226-)+6VN=MW#N)9;A
M$< 8!KZ[^!OPF\"?LV?!/X>_!WP3;:?H?@?X4>"]&\,6LPBM=.MOL6@:9!:3
MZQJ&/+ACN;T6TE_?SNW^NED9G(''I6MZQH_AK2]4\0:]J5GI&A:'8W.IZMJE
M]<QVEC8V-I$TUS>7<\K+&D4*(S.[L %7 R2!7\<W[<__  4X_:4_X*U?&#Q/
M_P $X_\ @DE8ZL?AV;QO#GQ[_:TAM;B#PWI^FRO]FUFQ\/:OA(5BMD$\3W$+
MM)*07 "[0 #S?]C[4/#/[5W_  =+_M$_'[]E4H/@?\*_AE!X:^)_BOPW;_9_
M#/B3QEI>G6>A:_ ]S:JMG>W&KZXCW3'>[S/:&<Y/-?V]GJ?J:_-3_@F!_P $
MU/@Q_P $R_V>-)^#WPVLQJOC'4A!J_Q4^(]W!OUOQYXKGCWW][=7[CSWMHIW
M:.!7.=@#L-S$+^E5 !1110 4444 %%%% !1110!EZM%>S:=J,.GS?9[^?3[^
M*QN6 V6U[):S):3$GKY=PT;;1UQ[5_"[^WC_ ,$+_%G@3]BG]O#]N[]O_P"/
M?B#]I?\ :3\._"WXEZM\+].6[GB\%?#ZWNI]VB7UA9NY2/5+&S**R0Q^5NW*
MSC K^[1E##)&[!R020H'0L/5P.G^.*_(_P#X+O\ '_!(3]O(G[O_  H7Q6$)
M8[B#'#\[,.03DY'3'!H YW_@WS5G_P""-7[!'K_PIN#&.,*/$.N_+[!L9;'4
ML3UK^=S_ (.0OVE+/1?^"OG_  3I^&WQ$MM:USX2? 32]'_:&_X1/0]-N-1O
MO$GCC_A)+U['2+&WMXI3)<ZDOA_3K1OD^19(]Q"L,_T2?\&^)/\ PYJ_8&Y(
M/_"G(1W[^(M?QT^HKJ_%OQ-_X)D_&C_@HSH'P2\<Z/X'\3_MT?#3P[J+>&M/
M\3:*DFJ0Z':6":M<26<]VI@O5M;:07%F K[90WE@LK"@#\IM0_X.BM+\!:C8
MZE\;/^"?_P"T[\'/A5+K%EI]]\2_%?AJZMM#TG3[J=(QJ-R?LX"Q+;L+A0 %
M*C'7BOZ:?@Q\9?AQ^T+\,O!WQ@^$7BO3O&GP[\<Z/:ZUX<UW2YDFM[BVN$20
MK*R$B.>!F\BX@)W13*R$<5XQ^W;\-?AK\2_V._VE/#?Q1\,^']:\(0? _P")
MM_)'K6GV<L.ERZ3X+U>^LKZS\] +>?3YX$N+62)U82QHBG#;3_/1_P &>?BK
MQOK'_!/'XK:'X@OM4U#P-X-^/NM:1\*IM160PCPO/8I=72:>9./(_M)I6=(S
MMCD8K@8Q0!_6M1110 4444 %%%% !1110!S/B^VUN\\*>+-/\-70L?$=WX=U
MNW\.7KKN%GK=SI=U%I=XP;AX[6_>"<AL?<P!7\,'[?\ _P $,_%?PU_8+_X*
M _M\_M^_';7?VG/VIM"^#.MW7PV26XEM_"'P[-SXJT&*PU/2[/>R1ZE:V5R]
MJUO GV=PSN[A\"O[PROW<'K][(SD#)P6X*\C@#U]Z_'S_@O\#_PYH_X*$9()
M/P)N6^@_X2GPT<;>V,'ZGWH S/\ @WZ.?^"17[&K-N<?\*XM"P[L<G!.#R0>
M??OT%?A__P %^/!>N_L8_P#!4G]BK_@KMXFTO3/'_P "_AROA_PGXW\%3W<#
M:YI=QH<MRL6HZ!I4T@EN;VY2_,BO;PR#=#M=@017[A_\&_&T?\$B_P!C7G:/
M^%;V///5FP /KD>W.:_!3XO>%K#_ (*5_P#!SK>_LM?M0WNJ7OP _9O^#^H>
M,O!/PDEOYK;P]XC\2^&8[%X+^YLG98KU=4&H27-X C[TM (C@-D L_\ !67_
M (.#_P!B+]M3]B#Q'^RC^SG8:Q\1?BW^U%:V7@#2=+\6Z!<Z/I'@#5=6>$6^
MKW]_J%O!;/>6$[_Z++%( CJ[9Y!']*?_  2%_9O\7_LC?\$W?V3/V??'^HVF
MI>,O ?PRM(=?GT^Y2]TZ.]U;4+[6OLVG74;R)-901:A%'$RN1D$< 5\T?\%.
MO^"5_P"Q'\4?V(/C99)\&OAY\+-9^'/PT\3>+O 'Q \*:-I_A?5?"'B#P[I,
M][IVJ3:G:1123Q02VT9D%Q([/EF#;\ _/'_!KA^TE\5_VBO^"8VEQ?%GQ!<^
M+-3^#?Q6\7_!_P .>);Z2:XOM7\*^&X=.N=*N+F\F+27C)_:$D*W!=RRQ $D
MK0!_2%1110 4444 %%%% !112,3@XZ\?SH 7)'(&?TK\E?\ @G[_ ,$B_@!_
MP3W^,7[2/QU\!ZSK?CKXD?M(>--;\4Z]XC\56]L^H^'[;7-9NM;N?#^D7*M+
M,NG1WEVZC:RDPC8PP6%?K)EUSU..2.OX'\O\FOQB_P""K_\ P62^"7_!-GPD
MGA:QMI/BQ^U-XRL98/A;\$/"T3ZMXAO-3O5^SZ?<ZM;67F3V=@+J2.24R*&>
M(-A2O4 _,C_@[E^)?PGF_8D^''[/%]8Z7XL_:)^+_P 6O#=G\'_#%HMO=>+=
M,G6Z2*XU:TMXU:\MK2[=XM/$F%$TDH09(7/[?_"KX3_'_1?^"7OPG^#?@KQ+
M)X2_:-TO]EGX=>#-(\5:K$)Y/#?CFU\(Z39S7=Y'*<LVFRQS0R%CO)B!)W<5
M^*O_  2N_P""2OQU^/?QMA_X*K_\%8YKCQC^T-XGD7Q!\%/@;K):7PU\&?#]
MRZW6CRW.D2B2WBU..W\BYMK4J61]EQ*%<A3_ %@*PD()+'.0 R[02#PO;Y".
M<>ISUH _S@/^"TO_  1A_P"&)?\ @G%K_P"U=^T3\8?$?[1/[9_Q"_:!\ :?
MXF^(>KWLTVD>'=(UR74I;_1_#EO.[-%#</;QN\:*L48(6+*K7]TG_!-$Y_X)
M]_L<G!7/[/OPWX/)'_%/6?7WK\/O^#OL8_X)06.=V4_:.^%#X4[CQ_;F0&/\
M/S=.<\=A7[@_\$T/^4?7['..G_#/OPWQWX_X1ZTH ^X**** "BBB@ HHHH *
MAE!)4AB"K!AP" O(9>?[V>O48J:F%=Q^F.._K_GK0!^8_P#P4\_X)C_#;_@J
M'\*?!/PB^*OCWQ9X-\(^"?&EEXX?3O#8C>V\0WM@\9M[;5UDECS!$@E5"JNP
M,[G&>OWKX'\,>"/@G\,/#WA#0;?2/!_P_P#AKX5L=)ME5+;2]*TO1M"L$BDN
M),".WMX_+A:XGD."\KR2.2S$G<\6^+_#/@+PSK?C7QEK>G>'?"?AG3;O6=>U
M[5KF.ST[3=,L(FFNKJYN)2(U2-%X4G+L0J@L0*_C3_:Z_P""@/[57_!<GXJ^
M(/V"O^"8&GZ_X1_9FL/$AT'XZ?M8RVMU8:7J>A6<XBU6W\.:F55#;77[Z$"!
MG>50#@[@2 <-_P $D[:Q_:3_ .#CW_@H!^U9^S-!_9W[,'A2SUK0/%.LZ1 +
M/PQXU\1W^G0:#%+9+:A;*>6+7K&[U PQ[F0D7.,2;C^Q'_!<7_@HGXW^ G@G
MP=^Q'^R6H\5_MS?M=.?!'P^T;3B\][X&\+:RS:?JGCC5$MM]Q81V5O.QLYY1
M&$9/-)V$$?=?[%O[#WP7_P""6/[(-W\,/@5X4?5[WP=X1U3Q1XKUUK<OXE^)
MGC.QTR>^N+V_N-IGGFU"\C,5O'N.P.OR[V./XD_V-_\ @H)\=?@C^W5^TW^W
MC^UU^P5^TG\>_P!H+QOXGU7PW\(]7TWP/JTN@_"WX=6]Y+;6>G>'[>1/+M+E
M[5([222W_P!;&OGAP[# ![7K'_!/GP3_ ,$XO^"R/_!##X-Z*]QK7Q*\2_##
MQ3XX^.GCZ_E,^I^//BGK&M^*7U[5;^4EBQM+M9[.VDWN7MDB8GDU_H//@EQC
M:>!E@<,< YZ'HO'L?K7^:'^W9_P6$\5?&[_@KA_P3S_:TN_V./C?X(U/]GWP
M3KVE6'PC\1>'KVU\:?$%K_6=?O9-0\-:<P$U[;0R:@\#>7]S[.P8ED)/^@+^
MQ)^TWJ?[7_[-W@/]H'5?AAXL^#U_XQ&K&;X>^-[273?$6BQZ;J,]BO\ :%I.
M/-C-TL2W$1(&8I%.,4 ?6V0>0<CL?6BD4[E! P" <>GM^'2EH **** "BBB@
M HHHH ^2/VY?V3?"O[='[+GQ:_93\;>)-<\(^%/BYH<6A:WKWAX1MJEI;QW=
MMJ""".5XXYD>6SB$L;L%9>#G.*F_8K_9'^%O[#7[.'PX_9K^#UC!8^%/A]H4
M&G'5FM8;?4O$FI1*!?>(M:9%Q+J%ZX\RX9R0#GYNN?J:>6&!9YKIXK>VMX'N
M9KF6011PPPJ7FEEF<A((XHU9W=B%"*Q8@9-?R9?\%*O^"SWQ9_:%^)^M_P#!
M-O\ X)&:#J'Q0^/?BF\/@WXA?'/1;>6[\(_"ZRN7-IK,]MK"*;)+ZR@,G[\R
MD)M9TY^6@#XK_:SDT']J_P#X.JOV3+']E:TM=2UG]GJS\'^(OVBO'OA.<-I]
MQI7AF2YG\0:5K%Q9?Z+->:;:31:?<1W,I:Y:Z_C> @?W4EI5?[V5WMD8&6#%
MMBI_M#G)/0 =17XX_P#!(W_@D5\+_P#@F;\+[Z_OKV3XE_M1_$\QZ[\=/C=K
MA?4-8UK7-1W7&H:3H]W/F6#1[:YEF7<A#7A DEX4"OTA_:/^,VC_ +.OP#^,
MGQT\1123Z'\(_AUXJ\>:C%']Z6W\/Z5<WSQ)SD,_E!<]L]0: /Y&_P#@K]\4
M_'__  5N_P""GWP;_P"",7P4UZ\M/@C\-=8L_'G[76NZ)/(HFBT@V^I:IH-]
M<P@PK_9>F1@64,DJ>=>WK#&Y64_V%?"/X6^!O@A\-O GPB^&^@V?ASP-\._#
MNG>%?#6CV%O':VUMI^E6B6Z2B.!1&9;HJ]S<R'F6XFDD/S.:_D^_X-2/@;J7
MCOPK^UY_P4J^(<5[??$C]J7XQ^(](\/:KKL(EU'_ (0K2+XZI;W<%S+ODCCN
MI]0;3RT;?O(;((<JN#_8-&I3/# D\C>610 ,;/4$_EQ0!+1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<C))P<^_]?2I,9)/=N#[XZ?3\,4 -3A0 ,#L,<CDY!]><X]L=:=110 4444
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MRO\ \$[?V:O@3\7-+&C?$'X>>";71O$.FAA(+6\B&3&K+PW!RO(SZ\5^<O\
MP5J_X(\_&/X]_M">!?\ @H9^P-\38/@U^VE\,-%M](O+F=3#H_Q#\.Z=',UO
MI5\J 1RS&.1[>1)3BX+1J3N517]'S,V5P2>@8')SU!SGDX_K35&S 48Q@ #/
M !R ._4T ?Q5>.?V<?\ @XY_X*"^ Y?V6_V@-=\)_ 3X2>)+1=+^*/C:RGBC
MU'Q=H32>7?6$#0?O8OML <^6N3,'"<8R?ZCOV"/V*OA?_P $_/V7OAK^S'\)
M[??HG@?3$76-;F0"_P#$_B6X57U;7M08 -)<WDXP&?YO*2,<;2*^R_F;.[.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD%L^W/'XTM% "$9+'^\1^&*6BB@ HHHH **** "BBB@ HHHH **** "BBB@
M[''7MZ=>_P"&?QHHHH **** "BBB@ HHHH **** "BBB@ [\=/U]J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g4bdklltl5z5000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000005.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" +S!G(# 2(  A$! Q$!_\0
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M^)H_X5G\-_\ HGVA_P#@IA_^)K<HHYY]V'+'L8?_  K/X;_]$^T/_P %,/\
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M^)K<HHYY]V'+'L8?_"L_AO\ ]$^T/_P4P_\ Q-'_  K/X;_]$^T/_P %,/\
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M^)H_X5G\-_\ HGVA_P#@IA_^)K<HHYY]V'+'L8?_  K/X;_]$^T/_P %,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O-/VQ/'_B[X6?LR>,OB'X#U?[!K&DZ.
MT^GWGV>.7RI-RC.R165N">""*]+KS3]L3P#XN^*?[,GC+X>> M(^WZQJVCM!
M86?GQQ>;)O4XW2,JKP#R2!6V'Y?K$.;:ZO?:U^I%3F]F[=F>*?LY^)OC1\2]
M8\(ZC-_P5,\+:]=7R6FH:IX$L?".B_:YHPJS7%GNBF\U"$#HSA R8+8&,5:^
M*7[7/Q5_8[^*7BOP=\;VN_%VF^(;-M1^$-Q9Z6B37%SN6,Z/*((U!97DC(DP
MS;.26:18UH_ #P[\</A;>>%[2'_@E3X5TB_T^WMK&^\:6/C#1$NT78L,]U^[
MA\QBR[V90Y+9(R<Y-[XA_L@_$?\ ;&^(WB_QG^T+9W?A73])LWTKX2V%KJB3
M26,FY9#K$GV>0KYCNB#RRP.S*, 420^M+ZO]8?M>7DMTY+[Z6Y/Q\KG(O:>S
M7)?F\^:VW6_]7*OQV\=_MA_!3]E7P'=>(OC3]E^(/BKX@:?8:SJ2Z#82Q:;%
M=QS?Z)'$(O+=8MJ98DLSAL2;2 -+PW\3OVE_@+^UGX)_9[^+_P =]%^).G^/
M+&]E69/#\&EZCI#V\3R!VAMR5,+[<*S$EBLN-OE_-D_&WX,?M0_M,?LI^!?A
MW\7?A1YGB?1_B%I__"61QZU:+'J&G0QS1R7Z.DXP)$D7* K('W[4"[37MGP5
M_8W_ &:?V>-7F\1_"#X46>E:A-&8VOI+J>ZG5#U59+B21D![A2 >^:SJ5,/3
MHM347)\VD5&WD[[I+=6W*C&K*I=72TW;^>FS,7]B_P"+'Q ^+&G?$BX^('B#
M^T&T#XM:SHNDG[+%%Y%C!Y/E1?NU7=MWM\S98YY)XKG?BQ\8/C_\6/VC[[]E
MC]FGQ'I_A5?#6DV]]XT\<:AI@OI+.2<!X+6WMW_=L[(58ES@JS8V&/Y^3^"J
M?MG?LW:Q\0M!T+]C.3Q5I_B+XEZMK^GZJOQ!TRRW07#H(QY;LS#Y8PW.#\^"
M 1SL^+/A_P#M,_"KXX?\-;_!OX3PZ])XV\.6-O\ $;X<W&O00W%E=PP@)+;W
M1Q%+Y:CRB.=QW%0PD!BETZ<<1*2Y=5[NL6KZ;J^FE]]+[AS3=-+7?71WMY?A
MMT)=(^*O[2G[,?QR\)_"K]I+XB:=XZ\+^/;M[#1?&5OH*:9<V.I87R[::*',
M160D*F#N8DG("%3RGAKQ)^V7\;OB=\7CX-_;!M?!VD^ _%=S9:?IVH>"=/N8
M#"@9U\RX=5>- %PS$.0,MSC%=/I_@']H[]J[XY^#?B/\=?A+!\/_  9\/[QM
M4TOP_/K4=]?:MJ>!Y,TGE?)%'$5# $!@<CYQ)F/BU_X)GZ+\8_&'QH\2_&GP
M$UCJVO\ B2[G^'_B#^V&8112*Q28PP3;2H?:2LJ[B,C K:$L+&[J.*E97LHR
M5^;HMKVWMMZW):JOX;M7TNVNG???:YZE^R[^V'>_$;]C.Y_:7^+FF0V<VAVU
M^VK-8QE(KL6NX[X5=CRXPNW.#)D#' '.?L&?M"?M!^-?%VJ?##]J'4+>76]4
M\,V/C#PF;>SCB_XE%R=C1$1QH 8I#&N'R^YWY8*#6%JWP$_:-^*W[(7PV_96
M\1?"%/"=O+K%M:?$BXTW4=.2*#2[202&:(1.X,UPP20;48"59-X56!-[Q#^Q
M#\0?@M\6? /QV^#'Q)^(/Q U31=>CLM:T_QIXIM[KRM$FCD2X,+2B$!EW B/
M<<D@@96HE#!<M2-XIR;MUM;;7I=W^5@YJ_NNST2OYWWT\C%^(5G^WGX"_:'^
M'OP%_P"&\/M?_">Q:J_]K?\ "K]+C^P_8[;S\>5SYN_[OWEV]?FZ5V_Q'^*_
M[1ES\3/#/[%WP<\?Z=-XR3PNFJ^.OB/JFBQ!;.U#B+SH;-6\MIW<AO+.4 =!
MT+.G3_&/X3?$+Q5^V3\&_BMH'A[S]!\)V^OKKU]]JB7[*;FR\J'Y&<.^Y^/D
M5L=3@<UC_'KX1?&[P-^T5I_[7?[.OA2Q\37Y\.G0?%7@^[U!+.34+3SA*DL$
M\GR)(K!<[NJQ@ ,208C5I5.2_+?E;VBES7=KV2Z6T>FS97)*/-:^ZZMZ66WS
M[:F+?_$C]J/]D7XE^$=._:"^*^G_ !&\$^-=<AT3_A((_#L&E7VCZE-N\E3#
M"Q22!@A);EAAC\NU5DHW&K?M<?&S]JSXL_#CX:_M7CP/H?@631A8V3^![#4A
M(+NR,K9DE"NH#QL>2_W^,!0#8UGP?^TS^V9\1/!K_%SX*Q_#CP+X,\1V^OS6
MM_K4-]?ZS>PAQ$BB(?N8URP;=C<LF5).-N?X@_X)X^%?CU^TI\8_''Q[^'\W
M]G:Y#I2> =>M]9*R0N+!H;F58H9?O)(L.!.A4E> 5+9TC+#PNZCBI<NME&2O
MS*UE\-[7O;9:[W):J2LHWM?JVNCZ[VOWZF9X5_:8_:O^)_[)^N?%KP1XCTJZ
M\4?"_P ;7%KKBZ'9PSZ?XPT^T$;S>4SH6CW1N6#0E2P3Y0#(H3LE_:H\0_M,
M?&?P'\.?V5_&C6>B'2X_$OQ!UQ+&WN'M;)AB'2V$F]8KB1LAQ]]!M92P5P>S
M_88\ _$GX3?L_6/PG^*/P^L="U#PW>3V,,^ES0-;ZM;J^8[X"(DJT@;YO, D
M9E+,!NP,?]A+]GG6?@#8_$:'Q!\/[/0FUSXF:C=Z*+5H&\W1\1_9!^Y9MB+F
M;;&V"FYOE&[G.I4PJ]I:*O%OEVL[Z?.VZ[7L5&-5\NKUWWZ?Y[,]Z&0.:***
M\D[ HHHH **** "BBB@ HHHH **** /FGXX^(OVF/''[;%K^SS\&?VB/^$#T
MM?A>OB&>3_A$[/5/-N!J,ENPQ. RY4IT? \O[N6)K6^"_P =?C'X5^/>I?LG
M?M'WNEZIK2^'SK7A7Q9H]K]G35[(2-&PG@W$0SAE8[5^7"MV"L^=\9O#?[1?
M@K]MRV_:%^%'[/\ +XWTEOA:OA^98?$]EIYBN3J,EP3_ *0^XX0)T7!W]<@B
MK7P8^"_QL\?_ +1%]^UO^T3X3T[PSJ$/AEM"\*^#;'4%O9+&W,K.\T]PG[MY
M&+/MV9&R7!VE<5ZS]C]7][EMR].7FYOE[WK?2QR+G]II>]_.UOR^X\UB_;&^
M.]A_P3H\ _&_4O&L$?B#Q5XK;2/$'C.ZT-)H]%M&OKR(WQMX46-O+6&) "NU
MBPR"Q&?5?@QXZ^(_@'X?>+?C!\3/VK_#OQ:\%Z/HLE];ZMX?T&VM[J.:!'DG
M@_T64PX6-8\ Y=FE(/EA!OY?X(> OVE_V??V%O!OPUA_9XTOQ5K-E=WT7BSP
M?J6O6R,]E->74F(WR\$C%9(V(9B-N5VECA>?^!_[)_BKQM\5/B#XLU3X!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:]_([2BBBF=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7:QS4\T52,GR[66^NLDMK:;W/U^HKYM_X*_:SK'A[_@F+\;-;\/:O=6-[:^
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M #XI_P#DW_R1^P'_  WW^QW_ -%YT?\ [XF_^(H_X;[_ &._^B\Z/_WQ-_\
M$5^/]%'URIV0?\1:SO\ Y\4__)O_ )(_8#_AOO\ 8[_Z+SH__?$W_P 11_PW
MW^QW_P!%YT?_ +XF_P#B*_'^BCZY4[(/^(M9W_SXI_\ DW_R1^P'_#??['?_
M $7G1_\ OB;_ .(H_P"&^_V._P#HO.C_ /?$W_Q%?C_11]<J=D'_ !%K._\
MGQ3_ /)O_DC]@/\ AOO]CO\ Z+SH_P#WQ-_\11_PWW^QW_T7G1_^^)O_ (BO
MQ_HH^N5.R#_B+6=_\^*?_DW_ ,D?L!_PWW^QW_T7G1_^^)O_ (BKFM_MN?LJ
M>&[U-.UWXU:5;326=O=1QR++DPSPI/"_"=&BD1A[,*_'.N\_:-_Y*#I__8A^
M%?\ TP:?1]<J6O9&\?%7.I8657V%.ZE%?:ZJ3_F_NGZB?\-]_L=_]%YT?_OB
M;_XBC_AOO]CO_HO.C_\ ?$W_ ,17X_T4?7*G9&'_ !%K._\ GQ3_ /)O_DC]
M@/\ AOO]CO\ Z+SH_P#WQ-_\11_PWW^QW_T7G1_^^)O_ (BOQ_HH^N5.R#_B
M+6=_\^*?_DW_ ,D?L!_PWW^QW_T7G1_^^)O_ (BC_AOO]CO_ *+SH_\ WQ-_
M\17X_P!%'URIV0?\1:SO_GQ3_P#)O_DC]@/^&^_V._\ HO.C_P#?$W_Q%'_#
M??['?_1>='_[XF_^(K\?Z*/KE3L@_P"(M9W_ ,^*?_DW_P D?L!_PWW^QW_T
M7G1_^^)O_B*/^&^_V._^B\Z/_P!\3?\ Q%?C_11]<J=D'_$6L[_Y\4__ ";_
M .2/V _X;[_8[_Z+SH__ 'Q-_P#$4?\ #??['?\ T7G1_P#OB;_XBOQ_HH^N
M5.R#_B+6=_\ /BG_ .3?_)'[ ?\ #??['?\ T7G1_P#OB;_XBC_AOO\ 8[_Z
M+SH__?$W_P 17X_T4?7*G9!_Q%K._P#GQ3_\F_\ DC]@/^&^_P!CO_HO.C_]
M\3?_ !%'_#??['?_ $7G1_\ OB;_ .(K\?Z*/KE3L@_XBUG?_/BG_P"3?_)'
M[ ?\-]_L=_\ 1>='_P"^)O\ XBC_ (;[_8[_ .B\Z/\ ]\3?_$5^/]%'URIV
M0?\ $6L[_P"?%/\ \F_^2/V _P"&^_V._P#HO.C_ /?$W_Q%'_#??['?_1>=
M'_[XF_\ B*_'^BCZY4[(/^(M9W_SXI_^3?\ R1^P'_#??['?_1>='_[XF_\
MB*/^&^_V._\ HO.C_P#?$W_Q%?C_ $4?7*G9!_Q%K._^?%/_ ,F_^2/V _X;
M[_8[_P"B\Z/_ -\3?_$4?\-]_L=_]%YT?_OB;_XBOQ_HH^N5.R#_ (BUG?\
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M (3?PI_T&HOR/^%'_";^%/\ H-1?D?\ "O+** /4_P#A-_"G_0:B_(_X4?\
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M^Y2K:KV<)7::=W=--WUV3[]STRBBBOD3V@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M;)-%$K/+(JJHRS,> *\__:I_:*\(?LH?L_\ BCX_>-HFFL_#NG^;'9HY5KRX
M=A'!;JP5MIDE=$W8(7=N/ -?GWX*_93^)W[=JV?[1O\ P4/\>:UJW]K-]O\
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M_P#HK%Y_X3-]_P#&:/\ A[;^PG_T5B\_\)F^_P#C-?CM11_Q"?AO_GY5_P#
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M_!\7TG]NC01K!MOL[;?LAF,._?C;G>,;<Y[]*WJ/J=/S#_B%/#?\]7_P*/\
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MVSO^B=V/_A06G_QRC_AUK^V=_P!$[L?_  H+3_XY7ZM44?4Z7F'_ !"GAO\
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M?]_U_P :/^%<>+?^?!/^_P"O^->ET4 >:?\ "N/%O_/@G_?]?\:/^%<>+?\
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M%6P1D9!Y!]C65?> /!^H:C#JL_AZT\^&Z:XWQVZKYDA21"7P/GXE?ALC)SU
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MOO?==6<53+*WV)=([M[IWT>K2[6/C?Q)\1OVG?&G_!*_]K&S_:<_X*4_!O\
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M/!_P#\!Z/X<UG1[_ ,-33MX@UC28].@CMPQ9YE2X>UX./)C5Y6=D?RT02?\
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M9?\ +[Y?J?,R_P"2RA_V#R_].1/:****U/I@HHHH **** "OG+QCX'C\=_\
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M74OWI3A6*@E [/C!+ ?7E(% I:F4N8:5@HHHJ1A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1@9SBBB@ VCTJKKNA:'XHT6[\-^)M&M=1TZ_MWM[Z
MPOK=9H;B%QM:-T8%75@2"I!!!P:M44XRE&2:T:#?1GF?_#%?[&__ $:7\,__
M  @]._\ C-5]5_8>_8ZU'3I[%/V4_AK"TL3*LT?@73U9"1PP(AZCK7JE!YXK
MT8YQFT7=8B?_ ('+_,YI8/!RBTZ<?N1\<ZC^R/\ LUZ5?S:;>_LV^ UF@D*2
M+_PB%EU!_P"N72H?^&5_V8?^C<? ?_A'V7_QJOI#XN?#N;6H_P#A)-#M]UU$
MN+B%5^:91T(]6'ZCZ 'RL&OO<!GN,QV'4U6E?JN9Z/[_ +C\VS++7E^(<)1T
MZ.VZ_P ^YP?_  RO^S#_ -&X^ __  C[+_XU1_PRO^S#_P!&X^ __"/LO_C5
M=Y17;_:&8?\ /Z7_ ($_\SS_ &<.R.#_ .&5_P!F'_HW'P'_ .$?9?\ QJC_
M (97_9A_Z-Q\!_\ A'V7_P :KO**/[0S#_G]+_P)_P"8>SAV1P?_  RO^S#_
M -&X^ __  C[+_XU1_PRO^S#_P!&X^ __"/LO_C5=Y4EG9W>HW4=C86[332M
MMCC7J30\RQ\5=UI?^!/_ #!4XR=E'\#E_ 7[&/[,GBKQ/;Z<?V;? 9@5O,NO
M^*/LO]6#R/\ 5=^%_&OK-1@5S_P[\$0^#-'\F0A[N?#W4@]>RCV'ZG)[X'0U
M^?9YFU;-,0N:;E&.BNV]]WKWLON1^D9'EO\ 9^$]Y6E+5^79?+\VPHHHKQ#V
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \Z_:\_
MY-8^(G_8F:C_ .D[USG_  3R_P"3,_ O_8/F_P#2J:NC_:\_Y-8^(G_8F:C_
M .D[USG_  3R_P"3,_ O_8/F_P#2J:LO^7WR_4^9E_R64/\ L'E_Z<B>T444
M5J?3!1110 4444 %%>"_MQ?MNZ-^R3X>L].TK18=7\4:Q'(VFZ?-,5BMXUX^
MT3;?F*;B %&"^& 9=I-?&\W_  5O_:TEF::/_A&(59LK%'HK;4]AND)_,FL:
MF(ITY69\?G7'7#^1XQX6O*3FMU%7M?57=TKVZ:GZA45^7?\ P]L_:W_Y^/#?
M_@E_^SH_X>V?M;_\_'AO_P $O_V=9_6Z7F>1_P 12X8[5/\ P%?_ "1^HE%?
MEW_P]L_:W_Y^/#?_ ()?_LZ/^'MG[6__ #\>&_\ P2__ &='UNEYA_Q%+ACM
M4_\  5_\D?J)17Y=_P##VS]K?_GX\-_^"7_[.C_A[9^UO_S\>&__  2__9T?
M6Z7F'_$4N&.U3_P%?_)'ZB45^7?_  ]L_:W_ .?CPW_X)?\ [.C_ (>V?M;_
M //QX;_\$O\ ]G1];I>8?\12X8[5/_ 5_P#)'ZB45^7?_#VS]K?_ )^/#?\
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M3_P%?_)'ZB45^7?_  ]L_:W_ .?CPW_X)?\ [.C_ (>V?M;_ //QX;_\$O\
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M %Z/^%G^)_6W_P"_/_UZ /1J*\Y_X6?XG];?_OS_ /7H_P"%G^)_6W_[\_\
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M^O0!Z-17G/\ PL_Q/ZV__?G_ .O1_P +/\3^MO\ ]^?_ *] 'HU%><_\+/\
M$_K;_P#?G_Z]'_"S_$_K;_\ ?G_Z] 'HU%><_P#"S_$_K;_]^?\ Z]'_  L_
MQ/ZV_P#WY_\ KT >C45YS_PL_P 3^MO_ -^?_KT?\+/\3^MO_P!^?_KT >C4
M5YS_ ,+/\3^MO_WY_P#KT?\ "S_$_K;_ /?G_P"O0!Z-17G/_"S_ !/ZV_\
MWY_^O1_PL_Q/ZV__ 'Y_^O0!Z-17G/\ PL_Q/ZV__?G_ .O1_P +/\3^MO\
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MUKX?_%R'2;%?"-]IWQ\MM0M(=/%W?F*66"TL"LN9C=*T9E1BO!P""<SX-_\
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MXH6ZL-0MUEAE 8,-RL"#A@&'H0".0*\>D_X)M_L532M+)\$(-S-DA-:OU'X
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M_8G_ .B(1?\ @]U#_P"2*/J=3N@_XA-Q!_S^I??/_P"0/R2KO/VC?^2@Z?\
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M#K_W^?\ ^*KULWS:OG&+]O526B22[*[_ #;/U;!X2G@Z/LXN^M]3R^BO4/\
MA /"'_0'7_O\_P#\51_P@'A#_H#K_P!_G_\ BJ\LZCR^BO4/^$ \(?\ 0'7_
M +_/_P#%4?\ " >$/^@.O_?Y_P#XJ@#R^M3P;_R,EO\ \#_] :N\_P"$ \(?
M] =?^_S_ /Q526G@OPU87"W=II@21<[6\QSC(QZT >5T5ZA_P@'A#_H#K_W^
M?_XJC_A /"'_ $!U_P"_S_\ Q5 'E]%>H?\ " >$/^@.O_?Y_P#XJC_A /"'
M_0'7_O\ /_\ %4 >7T5ZA_P@'A#_ * Z_P#?Y_\ XJC_ (0#PA_T!U_[_/\
M_%4 >7T5ZA_P@'A#_H#K_P!_G_\ BJ/^$ \(?] =?^_S_P#Q5 'E]%>H?\(!
MX0_Z Z_]_G_^*H_X0#PA_P! =?\ O\__ ,50!Y?17J'_  @'A#_H#K_W^?\
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M#PA_T!U_[_/_ /%4 >7T5ZA_P@'A#_H#K_W^?_XJC_A /"'_ $!U_P"_S_\
MQ5 'E]%>H?\ " >$/^@.O_?Y_P#XJC_A /"'_0'7_O\ /_\ %4 >7T5ZA_P@
M'A#_ * Z_P#?Y_\ XJC_ (0#PA_T!U_[_/\ _%4 >7T5ZA_P@'A#_H#K_P!_
MG_\ BJ/^$ \(?] =?^_S_P#Q5 'E]%>H?\(!X0_Z Z_]_G_^*H_X0#PA_P!
M=?\ O\__ ,50!Y?17J'_  @'A#_H#K_W^?\ ^*H_X0#PA_T!U_[_ #__ !5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#97_Z.'\&_^%!!_P#%4?\ #7_[*_\ T</X-_\ "@@_^*HYX]P_M7*_^?\
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M_@4?\SOJ*\Y_X:__ &5_^CA_!O\ X4$'_P 51_PU_P#LK_\ 1P_@W_PH(/\
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M&O\ H.VO_?Y: -"BL_\ X2KPU_T';7_O\M'_  E7AK_H.VO_ '^6@#0HK/\
M^$J\-?\ 0=M?^_RT?\)5X:_Z#MK_ -_EH T**HQ^)O#LK[$URTW=A]H7G]:O
M4 %%%% !1110 4444 %%%?GW\7/VVOVU_P!H[_@JIXM_X)=?LE>-O"OPML/
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M]@^;_P!*IJR_Y??+]3YF7_)90_[!Y?\ IR)[11116I],%%%% !1110!^?_\
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MK_HB+_\ A0:=_P#)%'_#M/\ ;:_Z(B__ (4&G?\ R11[*I_*_N#_ %;XB_Z
MZO\ X+G_ )'A5%>Z_P##M/\ ;:_Z(B__ (4&G?\ R11_P[3_ &VO^B(O_P"%
M!IW_ ,D4>RJ?RO[@_P!6^(O^@.K_ ."Y_P"1X517NO\ P[3_ &VO^B(O_P"%
M!IW_ ,D4?\.T_P!MK_HB+_\ A0:=_P#)%'LJG\K^X/\ 5OB+_H#J_P#@N?\
MD>%45[K_ ,.T_P!MK_HB+_\ A0:=_P#)%'_#M/\ ;:_Z(B__ (4&G?\ R11[
M*I_*_N#_ %;XB_Z ZO\ X+G_ )'A5%>Z_P##M/\ ;:_Z(B__ (4&G?\ R11_
MP[3_ &VO^B(O_P"%!IW_ ,D4>RJ?RO[@_P!6^(O^@.K_ ."Y_P"1X517NO\
MP[3_ &VO^B(O_P"%!IW_ ,D4?\.T_P!MK_HB+_\ A0:=_P#)%'LJG\K^X/\
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M_P#T!S_W^3_XJC_A7_B__H#G_O\ )_\ %4 8U%;/_"O_ !?_ - <_P#?Y/\
MXJC_ (5_XO\ ^@.?^_R?_%4 8U%;/_"O_%__ $!S_P!_D_\ BJ/^%?\ B_\
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M*V?^%?\ B_\ Z Y_[_)_\51_PK_Q?_T!S_W^3_XJ@#&HK9_X5_XO_P"@.?\
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M - <_P#?Y/\ XJ@#&HK9_P"%?^+_ /H#G_O\G_Q5'_"O_%__ $!S_P!_D_\
MBJ ,:BMG_A7_ (O_ .@.?^_R?_%4?\*_\7_] <_]_D_^*H QJ*V?^%?^+_\
MH#G_ +_)_P#%4?\ "O\ Q?\ ] <_]_D_^*H QJ*V?^%?^+_^@.?^_P G_P 5
M1_PK_P 7_P#0'/\ W^3_ .*H QJ*V?\ A7_B_P#Z Y_[_)_\51_PK_Q?_P!
M<_\ ?Y/_ (J@#&HK9_X5_P"+_P#H#G_O\G_Q5'_"O_%__0'/_?Y/_BJ ,:N^
M^%FK75[I]QIUS(66U9?*9NRMGY?H-OZUS:?#SQ<[!3I>W/\ $TR8'ZUW'@_P
MPOAG3O(:4232-NFD7IGT'L/\XZ4 :U%%% !1110 4444 %?EWXRC\3_L _\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 55NM#TB^E:>\TR"5V:(LTD(8DQ/YD1Y_N/\R_W6Y&#5JB@"C<
M^&] O&F>[T6UD:XS]H:2W4F3(0'/'.1'&.>R+Z"HH_!?A**2.:/PSIZO%(SQ
MN+-,HS2)*Q!QP3)%$Y_VHT/501IT4 9-OX!\$6EJUA:^$=,C@D:(O#'8QJK>
M4L:QY &/E6&(+Z"- /NC$\OA;PW-9_V?)H-F8!/+,L)M4VB27?YCXQC<_F2;
MCU;S&SG<<WZ* ,_3O#.CZ=IL6EBSCF6.X:YW2PIEKAG:1YB  H=G9G) '+'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU/1Y-8UK5I'31]&BF\KS F/,EDDP=B+N4< LS,H QN9?C<_\%DOVG"QV^ _
M>.W_ !++W_Y+K>_X+-^!/%,/Q/\ "OQ.:*1]%N-"_LM)%#%(;J.:64ANRETE
M7'=O*;^[7Q;7GUZU2-1I.Q^ \;\7\1X3B"KA:%5TH0LDE;6Z3YF[:WZ=$O.[
M?UI_P^2_:=_Z$7P'_P""N]_^2Z/^'R7[3O\ T(O@/_P5WO\ \EU\ET5C[>MW
M/D?]=.*O^@N?X?Y'UI_P^2_:=_Z$7P'_ ."N]_\ DNC_ (?)?M._]"+X#_\
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M_P#"U_$7_/E9?]^W_P#BJ/\ A:_B+_GRLO\ OV__ ,57,44 =/\ \+7\1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTG2;]V"F">4RB3Y&95DD2-XXF8!W4YP>QI](K[@_U;X;_P"@.E_X+A_D8O\
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M0!B?\*[\(?\ 0+/_ ($/_P#%4?\ "N_"'_0+/_@0_P#\56W10!B?\*[\(?\
M0+/_ ($/_P#%4?\ "N_"'_0+/_@0_P#\56W10!B?\*[\(?\ 0+/_ ($/_P#%
M4^?P%X6N7$D^G%F"*F?.?[JJ% Z^@%;%% &)_P *[\(?] L_^!#_ /Q5'_"N
M_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!
M#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)
M_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_
M^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N
M_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!
M#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)
M_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_
M^!#_ /Q5'_"N_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N
M_"'_ $"S_P"!#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q5'_"N_"'_ $"S_P"!
M#_\ Q5;=% &)_P *[\(?] L_^!#_ /Q52V?@?PSI]RMW9Z>5D7.UO.<XR,=S
M6M10!B?\*[\(?] L_P#@0_\ \51_PKOPA_T"S_X$/_\ %5MT4 8G_"N_"'_0
M+/\ X$/_ /%4?\*[\(?] L_^!#__ !5;=% &)_PKOPA_T"S_ .!#_P#Q5'_"
MN_"'_0+/_@0__P 56W10!B?\*[\(?] L_P#@0_\ \51_PKOPA_T"S_X$/_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=JUY),[;[B&"^N0S0P3-RR%'*$MY31YKZ.HIJ4D*R/B;]I;X-?%7Q%J7C_X
M?!M/'5II_C[Q1!J%UI=UX01M-:XE:)KF\CU@2LD%H?+$DELZ^>TB%4"K(V?M
MA3D=:6BB4N8$K!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBB@D 9- !17SS^U-_P %1_V+OV1KFXT#XD?%>+4/$-ON#^%?#,/VZ^5U*@I(
M$(CMGPX8+/)&6 .W.*^.?'__  <NZ';ZE-:_"W]E"\O+/!^SWWB#Q2EO(?0M
M!#!(!]!*?KWK[+)_#[C+/J*K8/!R<'M*5H1:[IS<4UZ7/'QG$&3X&?)6K)/L
MKMKU23M\S]3**_'VP_X.5/CK'=QR:I^S5X3FMPW[Z*WU6YC=A[,=P!_X":]0
M^%O_  <I?"35KLV_QG_9L\0:%#T2Y\.:S!J>?=DE2V*CZ,Q_E7L8KPA\0,+3
MY_JG,E_+.#?W<UW\DSCI<79!5E;VMO527XVL?IE17EW[-_[:/[,/[6VE-J7P
M!^,&EZ])#&7NM+5F@OK90<%I+:8+*JYX#E=C'H37J(.1D5^>XO!XO 8B5#$T
MY0G'>,DXM>J=FCZ"C6HXBFITI*2>S3NOO04445SF@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !17"?M0?%C5?@/^SEXZ^-
M6B:7;WUYX3\*7VK6MG=,RQSR00/($8KR%)7!QS6%^PW^T)KW[5?[*?@W]H+Q
M-H%II=]XFL9I[BPL79H82EQ+$ I;YCQ&#SW-;_5ZWU;V]O=OR_.U_P BN67+
MS'K%%%%8$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M &[OV>_^"PO@NVDCL-)\01>$/BDEO"LAFTV42[9%C"KOE:TEU"+S)'PK168
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M0 4444 >,_\ !17_ ),)^,G_ &336O\ TCEKC?\ @CG_ ,HTOA3_ -@>Z_\
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M /8,_P"A'^)W_A/V7_R;1_Q$?_L&?]"/\3O_  G[+_Y-K\.:*/\ 4O)>TO\
MP+_@!]1H^9^XW_$1_P#L&?\ 0C_$[_PG[+_Y-H_XB/\ ]@S_ *$?XG?^$_9?
M_)M?AS11_J7DO:7_ (%_P ^HT?,_<;_B(_\ V#/^A'^)W_A/V7_R;1_Q$?\
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M_P#8,_Z$?XG?^$_9?_)M'_$1_P#L&?\ 0C_$[_PG[+_Y-K\.:*/]2\E[2_\
M O\ @!]1H^9^XW_$1_\ L&?]"/\ $[_PG[+_ .3:/^(C_P#8,_Z$?XG?^$_9
M?_)M?AS11_J7DO:7_@7_   ^HT?,_<;_ (B/_P!@S_H1_B=_X3]E_P#)M'_$
M1_\ L&?]"/\ $[_PG[+_ .3:_#FBC_4O)>TO_ O^ 'U&CYG[C?\ $1_^P9_T
M(_Q._P#"?LO_ )-H_P"(C_\ 8,_Z$?XG?^$_9?\ R;7X<T4?ZEY+VE_X%_P
M^HT?,_<;_B(__8,_Z$?XG?\ A/V7_P FT?\ $1_^P9_T(_Q._P#"?LO_ )-K
M\.:*/]2\E[2_\"_X ?4:/F?N-_Q$?_L&?]"/\3O_  G[+_Y-H_XB/_V#/^A'
M^)W_ (3]E_\ )M?AS11_J7DO:7_@7_ #ZC1\S]QO^(C_ /8,_P"A'^)W_A/V
M7_R;1_Q$?_L&?]"/\3O_  G[+_Y-K\.:*/\ 4O)>TO\ P+_@!]1H^9^XW_$1
M_P#L&?\ 0C_$[_PG[+_Y-H_XB/\ ]@S_ *$?XG?^$_9?_)M?AS11_J7DO:7_
M (%_P ^HT?,_<;_B(_\ V#/^A'^)W_A/V7_R;1_Q$?\ [!G_ $(_Q._\)^R_
M^3:_#FBC_4O)>TO_  +_ ( ?4:/F?N-_Q$?_ +!G_0C_ !._\)^R_P#DVC_B
M(_\ V#/^A'^)W_A/V7_R;7X<T4?ZEY+VE_X%_P  /J-'S/W&_P"(C_\ 8,_Z
M$?XG?^$_9?\ R;1_Q$?_ +!G_0C_ !._\)^R_P#DVOPYHH_U+R7M+_P+_@!]
M1H^9^XW_ !$?_L&?]"/\3O\ PG[+_P"3:/\ B(__ &#/^A'^)W_A/V7_ ,FU
M^'-%'^I>2]I?^!?\ /J-'S/WO^&?_!>+]C3XKV7BJ_\ #7A#X@QIX1\*S^(-
M4%YHMHA>UBFAA98]MVVZ3=.F =HP&Y& #RW_ !$@?L&?]"/\3O\ PG[+_P"3
M:_*W]B?_ )%SXY_]D+U/_P!..FUX77/3X0R>5:I%J5DU;7NK]B8X.CS-'[C?
M\1'_ .P9_P!"/\3O_"?LO_DVC_B(_P#V#/\ H1_B=_X3]E_\FU^'-%='^I>2
M]I?^!?\  *^HT?,_<;_B(_\ V#/^A'^)W_A/V7_R;7H'[-W_  6;^ G[6_Q"
M7X9? #X#?%;7M46 SW130]/B@M(0<&6:62_5(UR<#)RQ^506(!_GYK]!/AW\
M1OB-^RW_ ,&\'Q&^.W[)]_-IOC36/':V'B[Q3I)"W^CV;306^Y) -T96*1 C
M [HC>O(A1L,/-S/A?*\'1C[*+<IRC%7EHG+J[*]E^.QR8ZG0P>%E5LW8_:J^
M\4R:9I[:E?\ AO4(XDC#R[?*<QCW"R'IW(R!USBLO_A;_AC_ )];W_OTO_Q5
M?SA_\&_G[6_[7F@_\%-/ _PV\(?$GQ)KVA^.-0N;?QMX>U#5)+FVN[7[/+-)
M>.LI(66$Q^<)EQ(=K)N*R.C?O[K]M:6>O7UK88\F.[D6-54 * Q^4  8 Z#V
M'?K7Q^>9//)<4J,IJ5U=-:=UJM>QXN!QD<=1<TK6=CO_ /A;_AC_ )];W_OT
MO_Q5'_"W_#'_ #ZWO_?I?_BJ\UHKQ3M/2O\ A;_AC_GUO?\ OTO_ ,51_P +
M?\,?\^M[_P!^E_\ BJ\UHH ]*_X6_P"&/^?6]_[]+_\ %4?\+?\ #'_/K>_]
M^E_^*KS6B@#TK_A;_AC_ )];W_OTO_Q5'_"W_#'_ #ZWO_?I?_BJ\UHH ]*_
MX6_X8_Y];W_OTO\ \51_PM_PQ_SZWO\ WZ7_ .*KS6B@#TK_ (6_X8_Y];W_
M +]+_P#%4?\ "W_#'_/K>_\ ?I?_ (JO-:* /2O^%O\ AC_GUO?^_2__ !5'
M_"W_  Q_SZWO_?I?_BJ\UHH ]*_X6_X8_P"?6]_[]+_\51_PM_PQ_P ^M[_W
MZ7_XJO-:* /2O^%O^&/^?6]_[]+_ /%4?\+?\,?\^M[_ -^E_P#BJ\UHH ],
MB^+GA620)(EU&#_&\(P/R)/Z5T=E>VNHVJ7MC.LL4@RDB'@UXA7??!FXN'L[
MZU<GRHY(VC]F(;/\A0!VU%%% !1110 4444 %%%<#^T-^U'^S[^RCX*_X6%^
MT/\ %?2/"NE,S);R:C,3+=.!DQP0H&EG<#G9&K-CG&*NG3J59J$$VWLEJW\B
MHQE.2C%7;['?45XS^S#_ ,%!OV.?VR[F\T[]FWX[Z3XBOK&,RW6E&&>SO4B!
M ,HMKJ.*9HP64&0(5!903DBK'P%_;O\ V5?VF/B?XH^"WP<^*BZEXL\%R2)X
ME\/WFCWMA=6;1SF"3Y+N&,R!)1L<IN",R!L;USK+!XRFY*5.2Y?BNGI?:^FE
M_,TEA\1&]X-6WT>GKV/7J^+/VF/V/?VL_C=^U]KWBWX+?$R;X=Z%J7ANUTG5
M?&$,A%S)!^YDDAMEC*R%M\49+!X@0K+YG+(?=_VK/VZ/V6/V)-.T75?VF_BK
M'X9A\1330Z/_ ,2F\O'N6B5#)A+6&5@%$B98@#+J,Y(%?*-_^TS\<?$7_!P'
MH?[.=U\2]4'@'2O!$U_I_A=,6]OY\VE&1I9D55:9PW*^;N,>6"[<D'VLAEF.
M#=6O1BDG3GK.-TU%Q;Y;Z-II+6Z74Z\#3Q,>:I!67+)W:T=K7MT;O;T/I3]D
M#_@G/^RW^Q5;R:E\)_ RW/B2ZA,6I>,M;87&IW*DY91(0!"A.,QQ*BMM4L&8
M;J\O_;[_ ."=7QY^,/B^]_:*_8^_:H\0>#_B!)HYTV71-:U66?0]1LV&U[;R
MV63[.I#,^W9)$9 K!(V)E'J7QE_X*3_L7? 3XX6?[-GQ(^,OE^.]0^SBU\+Z
M-X=U'5;HO.?W,3+8V\VR5P598V(<JZ-MVLI.M^T]^WM^R%^QHEJO[27QTTGP
MW<WT0EM-,9)KJ]EB+%!*MK;)),8]RLOF;-N589X..>CB<[CC%B+2E.HM+Q<N
M>/56:=UZ;=+"ISS!8A5+-REM=7YEZ/=>A^7_ .P;_P $>OVQM2T7_A ?C#X2
M7P#;Z/J,\6HZAJTB7'F9?>/LR0N5N1M=3O#K']X;]RE:_4C]F[]C3X%_LO:?
MGX>>&C-JTD/EWGB'5&$UY,,Y(#8 B4\96,*#M7<&(S1^S+^W!^RA^V-IEQJ?
M[-WQOT?Q.UFNZ\L(?,M[VV3=M#R6LZI/&A/ =D"MV)JQ^TW^V9^S#^QQX;M?
M%/[2?QCTOPO;WSLNGPW0DFNKO:5#F&V@5YI0NY=Q1"%W+N(R*X<=1K9AFDJE
M2A:JW>RB[IO71.[/I,XXPXFSG"T\NJ2<*<8J/LXIKFLDO>ZRVO9Z+HCT[@45
M^7G_  6#_P""J_@_Q]^P)I_CS_@GO^U:!-J7Q M-&\2W7AV1[/5+>SDL[Z8(
MR3(EU:!Y+92LBB,N(W56*EP?T$^,/[1OP._9?^%</Q._:!^*&E^%]%2..-;S
M5+C#7$IC+>5%& 9)Y2JLPCC5G(5B!@&M:V5XJA1ISE%\TW)*-GS)QMNK=;Z(
M^7J8*O3IPDT[R;5K.^ENGS._HKPG]FC_ (*9?L,?M?\ BF3P/^S[^T-I6M:T
MBLT>CW-G=:?=3JJEF,,-Y%$\X5068QAMH!)Q7NU<E;#U\/4Y*L'%]FFG]S.>
MI3J49<LXM/LU8****Q,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ?_
M (*%_M*2_LF?L?>-OC7ILJKJUEI?V7P^K;<G4+AU@@?:W#B-Y!*R]2D35[17
MYK_\'*/Q*.C_  )^&_PCC$BMK_BJZU1F5L*4LK<1%3ZY:^4_5<]N/J^!LGIY
M]Q=@\#45XRFG)=XQ3G)?.,6CRL\QDL#E-:O%V:6GJ]%^+/Q]N+FZO;F2\O;B
M2:::1GFFD8LSL3DL2>22>YZTVBBO[]/P0*"<=:#TK]5O^"9'_!/SX?\ PM^&
M.C_';XG>&[35O&.OV,=]8B^MQ)'HUM(%DB6-'X$Y7:S2X#*6,:X 8R?.\3<2
MX/AC ?6*Z<FW:,5O)^O1+J_S;2.C#X>>(J<J/RTNO#^OV-BNJ7NA7D-K)_J[
MB6U=8V^C$8-5*_H8N[2UO[62ROK6.:&5"DL,T8974]00>"*_,_\ X*R?L">#
M_@_IL'[1OP1T"'3-'N+X6WB70[12L-I-(3Y5Q"@&V.)FS&R A59H]BX9MOR?
M#?B7A,[S".#Q%'V4IZ1?-S)OL]%9OIO=Z:'5B,OE1I\\7>VY\+T445^G'FG<
M_LS_ !W\3?LR?'[PG\>O"?F-=>&=8BNI+>.;RS=6_P!V>W+8.U986DB)P<!S
M7],?A/Q3H'CCPMIOC3PIJD=]I>L6$-[IM[#G9<6\J"2.1<@'#*P(SV-?RQGI
M7]"__!(#X@:C\2/^"<?POUK5IVDN++29]*)9LD1V5W-:Q#\(H8_PK^=_I 9/
M2E@<)FD5[T9.DWW4DY1OZ.,K?XF?H7 .,DJ]7"O9KF7JFD_ONON/I6BBBOY?
M/TX\F_;F_9(\%_MT_LH^-/V6?'6H-8VOBO2O*M-56W,K:;>QNLUK=B,.AD\J
M>.-S'O7S%5D+ ,37G7_!.K_@G#;_ /!-[]BR[_9B^%'Q1MK_ ,3WUUJ6HW7C
MR[\-E8Y]3N!LM[E['[2V4ABCMHS$)P)! 3N0R''T]175'&8J.%>&4O<<N:VE
MKK2__ V,G1I2K>U:]ZUK^1^>?[/O_!MS^PA\-_V=KSX6_'70(?B5XWU,Z@^H
M?$V^M9[*[\RX+"-X8!=2K&8E*$9=]TBLYQOVA^H_\$!O GC[_@G1X1_87^,_
M[05QK6O?#74M0O/AG\4M)\+K87NB?:93-Y#PM<S&>'S&^=!+'O6*$ QM$KU^
MA-%=DL\S:4^9UFWS<W31ZK3316;5E9-:-6,?J.#4;*"VM\O/OMN]3\Z?A=_P
M14_:WUCXN>!_''[9_P#P5G^(GQ(\/_#C78=5\->&=+M9=*:>Z@&(9[BY^U2,
M7*&2-SM:8I+(JSKO8G?_ &P_^"*'B#XF?M5W?[<G[#?[8/B#X$?$G6K-H/%D
MNDZ>;NPUSB,!GB6:+RRWEJT@;S8Y'CC?RUD#2/\ >]%+^VLR]LJBDE9-648J
M-GJTXI<KN]=5N'U'#<G+;K?=WNO.]_Q/SU\*_P#!"_QO/\ OC1X+^./_  4$
M\<^/OB%\:M%M=*U?QKKMK*VGZ=:V]PEQ$L>E_:RLKHPD59&F C20K$L*M*)>
MD\8_\$7F\6V7[']F?VD_L_\ PRC=PS[O^$/W?\)3Y<VFR8_X_!]AS_9^,_O\
M>=GG9AON:BD\ZS)RYN?JWM'K'D=E:R7+I;9;K74?U'"\MN7\7T=^_?4^-/VQ
M?^",OP5_:E_;5^%O[>/AGQ4/!?C?P%XQTC6/$<MIHJW,?BNWT^YAGA@G'FQ^
M5.!"(EN1O(C(5DD"1A."_:/_ ."*W[1/Q+_;Q\??MV?LX?\ !2S6/A%JWCZP
MT^QOM-T7P"+N2.WMK*SMO+:X.H1>8KO:++_JUP2!SMR?T(HJ:.<9C145&?PQ
M<5=1E[K:=M4]+I6OM:RT">#PU2]X[N^C:UVOHT?"/C?_ ())_M:_$3]G/PSX
M!\6?\%9_B+-\2O!?CJY\1^&/B98Z.;54$ULEM]EN+);LF94C^TJK"=0%O)E9
M'5F5I/V&O^"/?Q#^"'[7E]^WM^V9^V!J?QF^)QT(:3X?NGT-=-M=)@*-%(VQ
M9'\UC$=BA1$B>9.S+*\BNGW510\WQ[HRI\R2E=.T8IV>K2:2:3ZI60?4\/SJ
M5G=>;>VSWU?F%%%%>:=04444 %%%% !1110!XS_P45_Y,)^,G_9--:_](Y:X
MW_@CG_RC2^%/_8'NO_2ZYKLO^"BO_)A/QD_[)IK7_I'+7&_\$<_^4:7PI_[
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MHFCF1DD 7<IY53D!_P"MN?+_ )>+_P !C_D'UZOW_ _*G_B&6^.?_1SGA/\
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MRWQS_P"CG/"?_@GNO\:_8ZBC_6[/O^?B_P# 8_Y!]<Q'?\#\<?\ B&6^.?\
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MYSPG_P"">Z_QK]CJ*/\ 6[/O^?B_\!C_ )!]<Q'?\#\<?^(9;XY_]'.>$_\
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MUS/?:_+*T[>&YI<_:+7,OS_;FWMY\S $K+LCS$S23^(_\$3O@_\ "G_@I?\
MM(?&[]MC]L/P;HWC7Q"NM6?]F^'==7[;9Z<ETMS]ZVF#+)''%%%!!OW!%A?
MW*K#WGX#_P#!*S]KG_@GO^V5J'Q(_8.^)WA6\^#?B1XW\0?#OQQKE[!-&NYM
MT,4D=M.':$?-#<,1)AS%(' :22K\9_\ @F!^W!^RY^U/XI_:]_X)3_%[0;&/
MQU--=>,OASXJ^6VGG>02_N=RM%(IE>:1=Q@>W#,D;LDK()J8W#UJV(Y,0KUH
MQY)/W>5)W=-V7NZ:76CMOJ3+$4JE2KRUE>HERR>G*D[N+MM^3MYGE_\ P4/_
M &?OAI_P3W_X*C?LR_'7]D3PPOA";XA>+?[*\2>%_#-LD-G<0I=V%O,L5N/D
MC\^"^>(HJJ@:)'4!R6,?[/\ \)O O_!0S_@NQ\;M7_:NTRU\2Z;\+X9[+PMX
M/UAFFM#':W4=I"WD2,5:!<RS/%CRVFN]Y'S$-Z]^S-_P2X_;!^,/[7^A_MV_
M\%2?B]H>N:WX36*;P5X)\-(&M]/F21I8?-98TC18)#YBK'YK22;'>;]V4DT/
MVU_^"8G[5&C?MA_\/$?^":7Q4TGP[XZO;41>+O"VMN8K/6E$2QN!A&CD$JQQ
M;XI0@\R,3K(LH4AQS##12PSKKVOLG#VNMKN5U'FM>RCIS#6*HJU%U5S\CCSZ
MVO>Z5][6TN?/'_!QY^PA^R[\$?@UX)_:*^"/PKT/P7K$_BM?#^HZ=X7TZ*QL
M[^WDM;BX65[>)5C$L;6Y42*JEA,0Y;;'MY[]O3QC\0OCW_P6PC^%OB#]FBZ^
M-F@_"KPO8G0?A;:Z\+"&[6;3+6\EN)?,#JY$]TI=50>;';PHX9$;/HO[7_\
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MLK=U?KH^_ 8B-"HU/9GZZ5\T_P#!7'Q3H7A_]AGQ-IFKW"K/K5]IUCIL;?\
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M'_C GXR?]DTUK_TCDKC/^".1!_X)I?"G'_0'NO\ TNN:]B/_ "3[_P"OJ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+F98XXU+22.P 4#J237EGCOXQ7^JN^E^%I6M[4-AKI>))?I_='ZGVY%?*X/
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M*;?\%)O"W_!/CX>Z=-;>&UU_QAXE\Y?#FBR3&.%%CV^9<W# 9$:ET 08:0G
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MC[R_\!_X)^V]%?B1_P 1%G[=O_0D_#3_ ,$-[_\ )E'_ !$6?MV_]"3\-/\
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M)/PT_P#!#>__ "91_P 1%G[=O_0D_#3_ ,$-[_\ )E'_ ! _CG^6G_X'_P
M/]=LC[R_\!_X)^V]%?B1_P 1%G[=O_0D_#3_ ,$-[_\ )E'_ !$6?MV_]"3\
M-/\ P0WO_P F4?\ $#^.?Y:?_@?_   _UVR/O+_P'_@G[;T5^)'_ !$6?MV_
M]"3\-/\ P0WO_P F4?\ $19^W;_T)/PT_P#!#>__ "91_P 0/XY_EI_^!_\
M #_7;(^\O_ ?^"?MO17XD?\ $19^W;_T)/PT_P#!#>__ "91_P 1%G[=O_0D
M_#3_ ,$-[_\ )E'_ ! _CG^6G_X'_P  /]=LC[R_\!_X)^V]%?B1_P 1%G[=
MO_0D_#3_ ,$-[_\ )E=M\?\ _@O-^VA\+O'=AX:\.^$/A[);W7@GPSJ\C7>B
MW;,)]0T*QOYP"MV!L$MS(%&,A0H)8@DXR\%^-HXB-%QIWDFU[_2+BGT_O(M<
M99*Z;G>5DTOA[W\_)G[ T5^)'_$19^W;_P!"3\-/_!#>_P#R91_Q$6?MV_\
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M?\1%G[=O_0D_#3_P0WO_ ,F4?\1%G[=O_0D_#3_P0WO_ ,F4?\0/XY_EI_\
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MG^6G_P"!_P# #_7;(^\O_ ?^"?MO17XD?\1%G[=@Z^"OAI_X(;W_ .3*^Z=
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M3Q)_SPM/^_3?_%4?\+4\2?\ /"T_[]-_\50!Z'17GG_"U/$G_/"T_P"_3?\
MQ5'_  M3Q)_SPM/^_3?_ !5 'H=%>>?\+4\2?\\+3_OTW_Q5'_"U/$G_ #PM
M/^_3?_%4 >AT5YY_PM3Q)_SPM/\ OTW_ ,51_P +4\2?\\+3_OTW_P 50!Z'
M17GG_"U/$G_/"T_[]-_\51_PM3Q)_P \+3_OTW_Q5 'H=%</I?Q&UZ]2[:6&
MV_<6C2IMC/+!E'//3FJG_"U/$G_/"T_[]-_\50!Z'17GG_"U/$G_ #PM/^_3
M?_%4?\+4\2?\\+3_ +]-_P#%4 >AT5YY_P +4\2?\\+3_OTW_P 51_PM3Q)_
MSPM/^_3?_%4 >AT5YY_PM3Q)_P \+3_OTW_Q5'_"U/$G_/"T_P"_3?\ Q5 '
MH=%>>?\ "U/$G_/"T_[]-_\ %4?\+4\2?\\+3_OTW_Q5 'H=%>>?\+4\2?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M34.5-I)25HIQ:_NZ/R-?J=;VD)*25K7:O=I/;5ZI^>QZH.E%%%?-GJ!1110
M4444 >._\%#/^3$OC#_V3?6/_2.2N-_X) ?\HW/A7_V![K_TNN*[+_@H9_R8
ME\8?^R;ZQ_Z1R5QO_!(#_E&Y\*_^P/=?^EUQ7VT/^3<S_P"PN'_IF9XLO^2B
MC_UZ?_I<3Z4HHHKXD]H**** "BBB@#\@_P#@Y(^"WCF'XQ^!?VAX[22;PW=>
M&1X>DFCC8I:7L-Q<W(#GHIECN#M[G[/)Z5^9]?U,>,_!'@[XC>&KKP9\0/"F
MFZYH]\@2^TK5[&.YM[A00P#QR JPR >0<$ ]J^:Y?^"*7_!,>:9YW_9DC#.Q
M9@GB[6%49/8"\  ]@ *_H?@7QEROA_A^EEN94*C=+2,J:B[QNVKJ4HV:O;2]
M]]&?GN><'8K,,PEB<-.*YM6I75GY63O??H?S]T5_0'_PY._X)B_]&R+_ .%A
MK/\ \F4?\.3O^"8O_1LJ_P#A8ZS_ /)E?8_\1\X/_P"?%?\ \!I__+3Q_P#4
M/./^?E/[Y?\ R)_/Y17] 7_#D[_@F)_T;*O_ (6.L_\ R91_PY._X)B?]&RK
M_P"%CK/_ ,F4?\1\X/\ ^?%?_P !I_\ RT/]0\X_Y^4_OE_\B?S^T5_0'_PY
M._X)B_\ 1LJ_^%CK/_R91_PY-_X)B_\ 1LB_^%AK/_R91_Q'S@__ )\5_P#P
M&G_\M#_4/./^?E/[Y?\ R)_/Y17] ?\ PY._X)B]/^&95_\ "QUG_P"3*/\
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MUG_Y,H_XCYP?_P ^*_\ X#3_ /EH?ZAYQ_S\I_?+_P"1/Y_**_H#_P"')O\
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M_P $Q?\ HV1?_"PUG_Y,H_X<F_\ !,7_ *-D7_PL-9_^3*/^(^<'_P#/BO\
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M[71[G2_"MF;S4M/D2\NKA7>UA+2/DWC1.L:L89+:02;>*_2'_AR;_P $Q?\
MHV1?_"PUG_Y,KU7]G3]B[]G;]DV&ZLOV?O"6J>'[.\9GN-+_ .$NU2ZLVD;;
MNE%M<W,D2RD(H\P*'PH&<<5\#QSXG\.\2?5L1@H58UJ#G93A#DE&:BI)N-1M
M/W4TTGU36I[V2<,9AE_M*=>4'"=KV;NG&]FKQL]W=71\ _\ !N'^P9^TE^Q)
M^SC\3?B/^TYX9O/"TWQ*GTQ= \'ZJNR\M8K:*Z!N9HMQ,#RF["^4ZK*HMLN
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M'_DQ)_\ %4 >8T5Z=_PKSP?_ - C_P F)/\ XJC_ (5YX/\ ^@1_Y,2?_%4
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M:*]._P"%>>#_ /H$?^3$G_Q5'_"O/!__ $"/_)B3_P"*H \QHKT[_A7G@_\
MZ!'_ ),2?_%4?\*\\'_] C_R8D_^*H \QHKT[_A7G@__ *!'_DQ)_P#%4?\
M"O/!_P#T"/\ R8D_^*H \QHKT[_A7G@__H$?^3$G_P 51_PKSP?_ - C_P F
M)/\ XJ@#S&BO3O\ A7G@_P#Z!'_DQ)_\51_PKSP?_P! C_R8D_\ BJ /,:*]
M._X5YX/_ .@1_P"3$G_Q5'_"O/!__0(_\F)/_BJ /,:[OX3V%S!875_*A6.=
MU6/(Z[<Y/TYQ^!K5C\ >$8I%E31URIR-TKL/R)P:UHHTAC6*) JJ,*JC  ]*
M '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P# H?YGG_5Z/_/U?B? -%??W_#Q+_@F-_T8-8_^$+HO_P 51_P\2_X)C?\
M1@UC_P"$+HO_ ,51_K+G7_0KJ_\ @4/\P^KT?^?J_$^ :*^_O^'B7_!,;_HP
M:Q_\(71?_BJ/^'B7_!,;_HP:Q_\ "%T7_P"*H_UESK_H5U?_  *'^8?5Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+_,]@HKQ_P#X>#?L)_\ 1XOPS_\ "VLO_CM'_#P;]A/_ */%^&?_ (6UE_\
M':/[#SO_ *!:G_@$O\@^O8+_ )^Q_P# E_F>P45X_P#\/!OV$_\ H\7X9_\
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M6?\ X$+_ (T?\)1X<_Z#UG_X$+_C0!>HJC_PE'AS_H/6?_@0O^-'_"4>'/\
MH/6?_@0O^- %ZBJ/_"4>'/\ H/6?_@0O^-.@\0:%<RB"WUBVD=ONJDRDG]:
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MH_X2CPY_T'K/_P "%_QH O451_X2CPY_T'K/_P "%_QH_P"$H\.?]!ZS_P#
MA?\ &@"]15'_ (2CPY_T'K/_ ,"%_P :/^$H\.?]!ZS_ / A?\: +U%4?^$H
M\.?]!ZS_ / A?\:/^$H\.?\ 0>L__ A?\: +U%4X_$6@S!C%K-JVQ=S[9E.U
M?4\]*;_PE'AS_H/6?_@0O^- %ZBJ/_"4>'/^@]9_^!"_XT?\)1X<_P"@]9_^
M!"_XT 7J*H_\)1X<_P"@]9_^!"_XT?\ "4>'/^@]9_\ @0O^- %ZBJ/_  E'
MAS_H/6?_ ($+_C1_PE'AS_H/6?\ X$+_ (T 7J*H_P#"4>'/^@]9_P#@0O\
MC1_PE'AS_H/6?_@0O^- %ZBJ/_"4>'/^@]9_^!"_XT?\)1X<_P"@]9_^!"_X
MT 7J*H_\)1X<_P"@]9_^!"_XT?\ "4>'/^@]9_\ @0O^- %ZBJ/_  E'AS_H
M/6?_ ($+_C1_PE'AS_H/6?\ X$+_ (T 7J*H_P#"4>'/^@]9_P#@0O\ C1_P
ME'AS_H/6?_@0O^- %ZBJ/_"4>'/^@]9_^!"_XT?\)1X<_P"@]9_^!"_XT 7J
M*H_\)1X<_P"@]9_^!"_XT?\ "4>'/^@]9_\ @0O^- %ZBJ/_  E'AS_H/6?_
M ($+_C1_PE'AS_H/6?\ X$+_ (T 7J*H_P#"4>'/^@]9_P#@0O\ C1_PE'AS
M_H/6?_@0O^- %ZBJ*>)?#TC!$URT+-P +A>?UJ\#D9% !1110 4444 %%%%
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M  Y)_P""GG_1LO\ Y>FB_P#R97Z'_KIP?_T,:'_@ZG_\D?/?V-G'_0-4_P#
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M>?\ 1LO_ )>FB_\ R91_PY)_X*>?]&R_^7IHO_R91_KIP?\ ]#&A_P"#J?\
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M\\8?] C_ ,F(_P#XJC_A7GC#_H$?^3$?_P 50!BT5M?\*\\8?] C_P F(_\
MXJC_ (5YXP_Z!'_DQ'_\50!BT5M?\*\\8?\ 0(_\F(__ (JC_A7GC#_H$?\
MDQ'_ /%4 8M%;7_"O/&'_0(_\F(__BJ/^%>>,/\ H$?^3$?_ ,50!BT5M?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X[_P4,_Y,
M2^,/_9-]8_\ 2.2N-_X) ?\ *-SX5_\ 8'NO_2ZXKLO^"AG_ "8E\8?^R;ZQ
M_P"D<E<;_P $@/\ E&Y\*_\ L#W7_I=<5]M#_DW,_P#L+A_Z9F>++_DHH_\
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M-U':Z?I]CX;U26:YGD8(D4:+J!9W9B%"@$DD 5]W>)/^"D_P^_8F\.:#IO\
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M7_/E9?\ ?M__ (JC_A:_B+_GRLO^_;__ !5<Q10!T_\ PM?Q%_SY67_?M_\
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M )\K+_OV_P#\57,44 =/_P +7\1?\^5E_P!^W_\ BJ/^%K^(O^?*R_[]O_\
M%5S%% '3_P#"U_$7_/E9?]^W_P#BJ/\ A:_B+_GRLO\ OV__ ,57,44 =/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !K=HH PO^%<>$O^?!_^_P"W^-'_  KCPE_SX/\ ]_V_QK=HH PO^%<>$O\
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M_;_&C_A7'A+_ )\'_P"_[?XUNT4 87_"N/"7_/@__?\ ;_&C_A7'A+_GP?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!X[_P %#/\ DQ+XP_\ 9-]8_P#2.2N-_P""0'_*
M-SX5_P#8'NO_ $NN*[+_ (*&?\F)?&'_ +)OK'_I')7&_P#!(#_E&Y\*_P#L
M#W7_ *77%?;0_P"3<S_["X?^F9GBR_Y**/\ UZ?_ *7$^E****^)/:"BBB@
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M .!*?XT?\)!H/_0;L_\ P)3_ !KR.B@#US_A(-!_Z#=G_P"!*?XT?\)!H/\
MT&[/_P "4_QKR.B@#US_ (2#0?\ H-V?_@2G^-'_  D&@_\ 0;L__ E/\:\C
MHH ]<_X2#0?^@W9_^!*?XT?\)!H/_0;L_P#P)3_&O(Z* /7/^$@T'_H-V?\
MX$I_C1_PD&@_]!NS_P# E/\ &O(Z* /7/^$@T'_H-V?_ ($I_C1_PD&@_P#0
M;L__  )3_&O(Z* /7/\ A(-!_P"@W9_^!*?XT?\ "0:#_P!!NS_\"4_QKR.B
M@#US_A(-!_Z#=G_X$I_C1_PD&@_]!NS_ / E/\:\CHH ]<_X2#0?^@W9_P#@
M2G^-'_"0:#_T&[/_ ,"4_P :\CHH ]<_X2#0?^@W9_\ @2G^-.BUO1IY!%!J
MUJ['HJ3J2?UKR&M3P;_R,EO_ ,#_ /0&H ](_P"$@T'_ *#=G_X$I_C1_P )
M!H/_ $&[/_P)3_&O(Z* /7/^$@T'_H-V?_@2G^-'_"0:#_T&[/\ \"4_QKR.
MB@#US_A(-!_Z#=G_ .!*?XT?\)!H/_0;L_\ P)3_ !KR.B@#US_A(-!_Z#=G
M_P"!*?XT?\)!H/\ T&[/_P "4_QKR.B@#US_ (2#0?\ H-V?_@2G^-'_  D&
M@_\ 0;L__ E/\:\CHH ]<_X2#0?^@W9_^!*?XT?\)!H/_0;L_P#P)3_&O(Z*
M /7/^$@T'_H-V?\ X$I_C1_PD&@_]!NS_P# E/\ &O(Z* /7/^$@T'_H-V?_
M ($I_C1_PD&@_P#0;L__  )3_&O(Z* /7/\ A(-!_P"@W9_^!*?XT?\ "0:#
M_P!!NS_\"4_QKR.B@#US_A(-!_Z#=G_X$I_C1_PD&@_]!NS_ / E/\:\CHH
M]<_X2#0?^@W9_P#@2G^-'_"0:#_T&[/_ ,"4_P :\CHH ]<_X2#0?^@W9_\
M@2G^-'_"0:#_ -!NS_\  E/\:\CHH ]<_P"$@T'_ *#=G_X$I_C1_P )!H/_
M $&[/_P)3_&O(Z* /7DUO1I0QCU:U;:NYMMPIP/4\]*;_P )!H/_ $&[/_P)
M3_&O-- _U6H_]@Y__0TK.H ]<_X2#0?^@W9_^!*?XT?\)!H/_0;L_P#P)3_&
MO(Z* /7/^$@T'_H-V?\ X$I_C1_PD&@_]!NS_P# E/\ &O(Z* /7/^$@T'_H
M-V?_ ($I_C1_PD&@_P#0;L__  )3_&O(Z* /7/\ A(-!_P"@W9_^!*?XT?\
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MZ:PNY6D-JR^6S==K9P/PP?\ (H ZBBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#QW_@H9_P F)?&'_LF^L?\ I')7
M&_\ !(#_ )1N?"O_ + ]U_Z77%=E_P %#/\ DQ+XP_\ 9-]8_P#2.2N-_P""
M0'_*-SX5_P#8'NO_ $NN*^VA_P FYG_V%P_],S/%E_R44?\ KT__ $N)]*44
M45\2>T%%%% !1110!\0_\%CO^"9'BO\ ;A\.Z)\3_@H]BOCKPK:RVOV&]F6%
M=8L6/F" 2MPDB2;C'O*H?.DW,O!'Y>S?\$D/^"C<$K02?LJZ\61MK&.ZM67/
ML1,01[@XK^B#KP17*?$;XV?"OX2ZOX<T#XA^+H--O/%NM1Z5X=M7ADD>]NW(
M"Q@(K;1EE!=L("R@L"PS^I<+>+7$O"V5QR^C"G4IQOR\ZE>*;NTG&2NKMM73
M:[VLCY?-.$\MS3%/$3<HR>]FK/SU3U/P(_X=*_\ !1G_ *-3\0?]_K;_ ..T
M?\.E?^"C/_1J?B#_ +_6W_QVOZ(L#TJGJ>N:%HL]G;:QJ]K:R:A=?9M/CN;A
M8VN9]CR>5&&(WOLC=MHR=J,<8!Q])_Q'[BC_ *!J/W3_ /DSS?\ 4+*_^?L_
M_)?_ )$_GI_X=*_\%&?^C4_$'_?ZV_\ CM'_  Z5_P""C/\ T:GX@_[_ %M_
M\=K^B+ ]*Q= ^('A#Q1XGU[P;H>IF;4O#-U!;ZU;_9I%^SR30)/&-S*%?,4B
M-E"P&<'!! /^(_<4?] U'[I__)A_J%E?_/V?_DO_ ,B?S[_\.E?^"C/_ $:G
MX@_[_6W_ ,=H_P"'2O\ P49_Z-3\0?\ ?ZV_^.U_1%@>E&!Z4?\ $?N*/^@:
MC]T__DQ_ZA99_P _9_\ DO\ \B?SN_\ #I7_ (*,_P#1J?B#_O\ 6W_QVC_A
MTK_P49_Z-3\0?]_K;_X[7]$6!Z48'I1_Q'[BC_H&H_=/_P"3#_4++/\ G[/_
M ,E_^1/YW?\ ATK_ ,%&?^C4_$'_ '^MO_CM'_#I7_@HS_T:GX@_[_6W_P =
MK^B+ ]*,#TH_XC]Q1_T#4?NG_P#)A_J%EG_/V?\ Y+_\B?S[_#?_ ()J_P#!
M3[X3_$/0?BEX,_9;UR+6/#>LVNJ:7),UJZ+<02K+&64RX9=RC(/!'%?<W[2'
M_!&+]FC_ (*T^*;']J'X\> /B3\%_B7<:;;6_C+3;!K5H]0:&-8U<NT4L<S*
MB+''*K(QC1 \0( 'Z#?\+$\&?\+%'PG76%;Q!_8QU5M/2WD;R[/S1$)7<+L3
M+Y559@S;7*@A&(W,#TKY'BCQ*S;BB5*K5HPI5:=U&<.9/E=KQ=Y233:3U6CU
M36M_6RSAK"99&4(SE*,K74K-76S5DFF>%? ']D_X<?L@_L^:#^RY^S;X$O+'
MPOH*LS7%[,)+G4+AV+RW,[G!>21R68X51\JHJ(B(.B_X0CQ7_P! 67\Q_C7J
M=%?G52I4K5'.;NV[MO=L^AC&,(J,5HCRS_A"/%?_ $!9?S'^-'_"$>*_^@++
M^8_QKNOB#\0/"/PL\&ZA\0?'FK?8-'TN'S;Z\^SR2^4FX+G;&K,>2.@-7=9\
M0Z#X<AAN?$&MVEC'<WD-I;R7ERD2RW$KB.*)2Q&YW=E55'+,0 "34%'G'_"$
M>*_^@++^8_QH_P"$(\5_] 67\Q_C7J=% 'EG_"$>*_\ H"R_F/\ &C_A"/%?
M_0%E_,?XUZG03CM0!Y9_PA'BO_H"R_F/\:/^$(\5_P#0%E_,?XUZ3H>NZ)XG
MT:U\1>&M8M=0T^]A6:SOK&X6:&XC895T=2592.002"*SM(^(GA#7/&VL?#K3
MM3=M:T&&VFU.QEM98RD5PK&&1&=0LJ-L==T98!D920RD  X?_A"/%?\ T!9?
MS'^-'_"$>*_^@++^8_QKU.B@#RS_ (0CQ7_T!9?S'^-6M8\(>);F[62#29&4
M6L"D@C[RQ(".O8@UZ310!Y9_PA'BO_H"R_F/\:/^$(\5_P#0%E_,?XUZG10!
MY9_PA'BO_H"R_F/\:/\ A"/%?_0%E_,?XUZG10!Y9_PA'BO_ * LOYC_ !H_
MX0CQ7_T!9?S'^->IT4 >6?\ "$>*_P#H"R_F/\:/^$(\5_\ 0%E_,?XUZG10
M!Y9_PA'BO_H"R_F/\:/^$(\5_P#0%E_,?XUZG10!Y9_PA'BO_H"R_F/\:/\
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MBO\ Z LOYC_&C_A"/%?_ $!9?S'^->IT4 >6?\(1XK_Z LOYC_&C_A"/%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X[_P4,_Y,2^,/
M_9-]8_\ 2.2N-_X) ?\ *-SX5_\ 8'NO_2ZXKLO^"AG_ "8E\8?^R;ZQ_P"D
M<E<;_P $@/\ E&Y\*_\ L#W7_I=<5]M#_DW,_P#L+A_Z9F>++_DHH_\ 7I_^
MEQ/I2BBBOB3V@HHHH **** "OB7]I#P7\7/VP?C#X]'PT^&FG^)M!\*Z/-X-
MT'4KOQ>-/72M=WV]Y<W\2"&1I)(IDM8B T8/V9T).XX^VJ  .E5&7*)JY\H1
M_M73ZAK?P#^,_P 0O%]SX7\/ZC8^(-,\>?;+B2UTZWUR*&&/[/=9(C5EGM[O
MRO,[ E>M<3XNU_PQ\5OA=\//C1X_^,OBS3?#J_'[Q!;G78_$EYIZV6G33:LE
MK)(Q*M;A"EM"C/M\E)7C^5785]QO%'(-LB!AG.&%.VCI3YEV%RGQ7\>/BKK-
MIXP^)^H>+_VB/%_A/Q_X=OE7X0>!M!OG6VUF%[6(V#QV8A8:J;FZ,D<H82^5
M@I^["AC#\6O'OQGUCXB:YX4N_B9XB\.W%U\;_ >E7$6AZY(O]G0W>CV[7=O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &+\2/A]X4^+/@#6OACX[TTWFB^(-,FT_5K
M-9WB,UO*A21-\9#+E21E2".Q%4O@U\'OA]\ /AEI/P?^%6AMIOA_0X6BTRQ:
MZEG,2-(TA&^5F=OF=C\S'K73T5O]:Q/U;ZOSOV=^;EN^7FM;FMM>S:OO;0S]
MG3]I[3E7-:U[:VWM?M?H%%%%8&@4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g4bdklltl5z5000008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000008.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 4S")@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOZM^U#\,)X?%OABU\!ZCXRTFU\T(ET^GVC3O97+(0(9UQY;KE64G)Q7\Z_\
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M!_9,\7RR6UU#8P^)-(M9F*1Q);0&\F=$D(ZVZ-D@="37Y8?MI6MU^UG^U/\
MMD?&*^O)=3\/_"N"ZT[39-QDACDM9W2"*-\E4"J  !CISS1R2\OZ^0']=_\
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MB9\*?LDKN(_T37QMVY)VIIAZG*C< 1@\\5J?L@_\%W_V"/@1^S1\'OA%X\\
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M(;33[26T%U)^\<JK2!#A?F+'''45_/I^T7_P</\ PN\'>)=2\&?LU?"3Q/\
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M2/%_C^>ZGC\/S7?V>2PTN F-=04I(DI62[!MU&3D].<&O/O^"7/_  62T_\
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MEO;IP=EEI\.Y9)I6 'R+N"YY K^='XD?\')$-UXBO+/]FW]F/QC\6/#6GSM
M^K)97]S,0"5,CI8+B")FRT9EQG@,2,BOB3_@XA^-7C?XK_MA?#3]E72M:N[7
MPE8#0K4Z7!(4LI/$/B"ZCMQ=7<8(61DCF7[ZD)C(K^IG]BW]C+X*?LO_  %^
M'O@SPEX#\-2:RWA+19?$FNW.DV=S?:SJEW907=_+<3W$3.ZK/+)L!)  X)!
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M A$+^>+"Z9HFPVW>R!<$C=G E-RW5_\ AUU7;_AP/6?V8O\ @NO\=?CQ\=_
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M\56VG7.JRA5?4)K;2H8C+)L[L4R0.H//6OE_]A3_ (+B?L)?LW?LQ_#7X/\
MQ+\":UJ7C7PIIIM=<NXM#\.7<<EQE/+V272BXV%5RIE]_F(P!:C9-K5]-O\
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M!DU^_(_X./\ _@FT Q?X;>)$RRQR#_A&?"IYZ*"<A67G@J2,'MTI<C]?Z\[
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M]GGP5\<?#T,&GOXFM/\ B:Z5%,)_[(U*/F:Q=P6.U/E')R>2>AKY'_X*G?\
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MY3[Y@>0%8W(Z?G7!_M[Z]^QO+^R[\7K?XGZM\([C2CX1U9[6#3[OPW/J9OA
M_P!C-E'I\CW'VPS$;"@!)X/ K^<7_@V5B\4?\-"?'"?1UNF\ +HVJBY(#^09
M#>7/]C),W^K\WRC!M'4=#WIJ%UNU\O)?\'^EJ'[#_!C_ (+!:W\4O^"A'C/]
MB>;X1V.FVGA77+O2%\80WQ>6^^S(KF3[.9"%QDD\=?R'[M[54E!DC.#CYF.[
MU/.-OX#\*_B _8Y51_P7S^,&"?W?C?6"!AE*,\2[U.0-QSG!&5QC'O\ W D'
M+!>I+=..2"/\YI3T45VO^@'QC^W;^U!=?L??LY>,_CM9>&XO&$WA-80-&EE^
MSBYW$ ?."N3GJ?<&OF+_ ()V_P#!2'5OVY/V:?B/\>]1^'-MX-N/ ">(YX=!
M@O&N%O9=#T^[OHXWD+MM$WV<(_(^][55_P""WJ+_ ,.\OB\-HXCLQ],OEN?7
M@<]?0U^:O_!OR!_P[E_:)'3_ $?X@@=>AT+5,GCDG_:Y8=C5+X4^NBOVUM^6
M@'CVF_\ !S#\5=?U75M*\*_L?WGBN?2;Z\M+F'0FU'4Y8/L=Q)";B6.R=S$)
M FY?-QGG%='%_P '&/[14UQ#"O[!?C-#/);Q,3I/B E4EE6-W/RY.T$G!X&.
M:_/?_@A!^T9^SG^SE^T!^T'K?[1OC3POX.T;Q!;7-IH5QXGL3?6UY>P:C*9(
MX5^SW(C=4$@)\O+-M'R@EA_53X>_X*8_\$R/%.NZ9X=\/?&?X2:EKNMWT.FZ
M796_AHB:ZOYG$<5M$9-)13(SD ?.H!();%4_2^GRW2M_78#R']MS_@J3XA_9
M"_9$^#'[2K_"9-9UCXH0:0]]X.U">6PET.34E1GMG0M'.KPEONN<YX/(-?:/
M[#7[3LW[7_[.GA+XZWWAJ/PG/XHC?S]&CN/-ALDB())F9C@J#EF+952.<"OQ
M:_X.9/LP_9&^&_V:*&.V_P"$UTI[7R(E2!(9"C0I!$BC8C#!  P.<"O2?V+_
M (KW'P0_X(D7OQ)L;C['?^'_  +X@FTR7=M8WTD$J1*C Y\T?,R@G/RK67([
M7TZ?B!]!_MK?\%JOV;?V2?$&H?#G1H+WXJ?%6UW6X\.>&\7EO;W8R%MYY+<N
M[2;^&"D,#P?2OS\^'?\ P<C>3XDM+?\ :$_9B\6?"WP=J%RD%OXCDLM2AS"\
M@ N,WP\LH$^8X[<@]Z^5?^#?/]E_P9^TS\3OBY^U-\;--A\:ZUINJO=Z#;:Z
MHOX!>:C<&X>>Z2X\P$P^9\B$<8 '%?TU_M@?L0_!S]K'X*>(?A=K/A#PUIFH
MZC820^'-=M](L[6ZT6X4A4G@:*%/E3'"-P0.QI-6=@/=?@9\=OAK^T7\.=&^
M*'PJU^#Q)X6UR,/:3Q.C2*S ,UI<*I)BFA)PV[DD5Y=^V_\ M3Z'^QC^S?XZ
M^/6M6,>JGPO;QPZ1HT\RPKK&L7>?L.G*Q96+W.QVR#E-AKYG_P""8G_!/'Q#
M_P $^/!GBSP3>?%C4?'^A^(]0COM.TB[1$M?#Q"L&-BJDLJS'YG QZ#CI^,/
M_!S/\?=9U?5/@?\ LB>&+R21]?OK3Q/XCTJU9FFGO+^]BM- :2%"7,4:3RLN
M5YR^.XH2;T0'I/[+W_!R+_PNCX]_"[X2>/O@;9^ ] ^(7B"QT"3Q5'J;R#2Y
M=2<QV=W+'-,T9MG< %U& >YXK](_^"G_ /P4L^(O[!=]\+;;X>_ '7/C;:_$
M$:H]Y+H5GJ-ZNCK96ZSVSRM8AAY=YN 3/_ >:_FG_P""K7["0_8Q^!?["/QQ
M\*626'B?2O"7A_P[\2;FUMFBAD\2:;%;:EIEYF-0YN[HW3PR&3YM\)[$5_85
M^PS\9_"7[5W[)OP/^+DUEH>MWNJ^#=+LM9CO;.SU&?3=;T^V6SO+.3SHY#;W
M!$22R;MIS)R#G-5R/R_KY ?SK:Y_P<R_%KPTUO%XE_8WO_#4M\Q6RCUY]4TR
M2X&!O6"*YDC:1@"3@!LCM75>'_\ @XM_: U_5]!LHOV&/%WV+6-1T^T75H=*
MUZ>"&UO9HX_M<4BJ8WC2-]^02N!7G/\ P<N:+HVF?$_]DQ-+TC3-,6?7[D7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM^&0,$*@^*?C!@02 0ZG2PFWOM!."21SBI<I-W_!:+\ /U8_X+&_LV1^*/\
M@G/XS\ ?"7PO;:/I?PYM8=7TSPUHEH(+33]'L&>:>/3[1%5!&N'?9"N,LW&>
MOP/_ ,&S/QA\+WGP-^('P?GU.QL_&V@ZV-031[FX2"\NK>4,DC06LK(\K1$D
M2*BL4(.0 ./V:_80^!?[1WPU_9O?X9_ME^-M,^+WQ#O[B]CUC58M5O?$5A>:
M-=1& VC7.J003D$.P$;1[0<<GFOQN_:9_P""!'Q(TGXL:W\<?V _CK<_!CQ1
MK=Y/J$GAV\U&\T;3;*ZN)&FE%IJ>G1RW-O"\C$>2D)50>.12;;W _<K]M?\
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M?VH=5_:U_;Z_97^)>O61MO$4>O>#M#UJ0<+=3Z8@@FN!N.X.SH20XW'GBO\
M0Y_X5?I7B#X-V/PD\>6-IJ^F7'@+3/!^OVR();69XM&CL+J>R$@R1'(&>)R%
M;Y4;':OY/-'_ .#>7]I?X:?MG^&OBY\-/&'PIG^"/AKXEV_BVRL]=UG5H/%,
M>CK=/.UM%9P6$EHT\:L$C22=02,'CFGS)+7KY7^[Y=0.A_X.@GV^%/V2F4M(
M?L6OXSQN5ETP$CHOF*/<-U'>OU9_X)W?L(_LA^-_V)_V<O%WC']G3X:^(/$F
MN?#;1K[5];UCPO97&I:M/,9]][=SRVYDN)CC[^68XX;%>8_\%I/^"9G[0O\
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M7PJ\(ZA(QO=$\$Z%;777Y9OL,):,;@&!3!#9[U^?O_!;O#_\$\?B\Y90J?8
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M]JO]KWOB'3M2T>\1HGMGN-3@AN'15=E$+Q!5;!4\ U%[;/3?^M_Z^\#\=?\
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MH?1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#WBT>&]0NQ*WBJ;1M&:XL;9IK=$@FGACW&11A0-TA( !X-?@_P#\&\8^R?\
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M,TVS)6*UB2"/*^5A?DC&"">G/:M.9::I[>75?\/;R _SA/V//VG_ !%\'_\
M@I'X7^-\GA/5OA%IWQ$\>/%K/@Z]L=4TM;'2]>NT$]DD6KP6D\]OOD8F9X\L
M6)S7[R?\'.=]!JWP*^"&H6S+):ZI?K=VX4Y5[>]A2:(@KD'Y75AW(Q@8QGZ7
M_P""Q7_!(_XQ?MO>-OAA\3/V;M0^&_A3QEX/WQ:W/XKNKO11=)"JM87%J^EV
M4^^2*5=W[S;P 02:YK]N/_@F!^VM^UO^R#^S?\'9_$GPDD^*_P )K:VLO&&O
M:MKVL1:-JB6L,<,,]I-%827$MP(T1 98D& .>M.ZWNM%^=O^ !^5'_!1WP-K
MOPZ_9,_X)M?M->'ED0>"/#_APZEJ<2,D\4]C-9WJVN0!N\R&(J WS$\8QT=_
MP3"UR]_;6_;I^/\ ^T?XNL9+Y?#/P8\2/9-.I=K"]&B7J6SC=D+-]G+;<?,/
M:OW^_:5_X)T?$CXZ?\$U?!/[)4=]X,'Q8\%:%HL%GJ>I7%RGA:+6-/@,4TJW
MT5O)>+&5.Y)$MR[#AEP#7D'_  2"_P""57Q>_8/^&GQWL/C)J_@36_B'\5[*
M]TW2[GPA>WE]IMC:/HUSIULLUU>VMM-'%+)*CS[4..3@T77= ?BO_P &^0V?
M\%4_C0B[L+\+O'V _#",>)+4+N]6)QTST-?(/[4'P9D_:(_X+3^./@>?%&H>
M"#\3/V@IO#!\5:6D<VIZ(;TRL+^SB=EC>5/*&$D8##$]J_H$_P""6/\ P2/_
M &I?V,?VY/B1^T9\7-=^%>H?#_Q7X-\5Z#I5CX0UG5;_ ,0V][K.LP7UG]IM
M[VQM[=;=(4=9F29F1SM4,"37%2_\$:_VLV_X*R:;^VTFO_"+_A4-K\;T^(]S
MIQUO6/\ A-'T0"<>2+#^SOL$>H8D'EJMR4 # L.Z;M=W6RM^+_5?>!F6W_!L
MKH-Q?6R^,?VR?BEXN\.Q7'F76C7^F:>D=U&6!:%Y?/+G(!SW!/RY(K]U?V-?
MV'/@?^P[\.[OP)\&]$EM_P"TG,^N:[?LLFJZU(L1R\TW^L"JY+HF=H.!QCG[
M+=-Q+E=W)$0*@H&8DHP';;SEL<G/'%,VD*PP68(ZKQNSO4K\I/4 YR&QCH..
ML<\O+[OZ_K8#^([]CE6D_P""^WQBC1'<IXTU?:%W2NRB)3E@NXYZ*,<<5_;Z
M<ACPP^8X.TD?7@'CZXYK^.;XY?\ !$C_ (*5W_[8_P 7?VE/V>_BS\)OAZ/&
MGBR[UCPWJT7BS7M)\3VMC<1JJQ7,EGILGDR \F..1ESR":Z'_AVE_P ' Q)/
M_#;_ (<!S][_ (6KXR)/'3_D%=2?E]N*ER;W _8'_@M\77_@GG\8,@YVV0Z8
MZL #DX7!/'7OCJ#7YK?\&^Y_XUS_ +1 ?Y2(/B"K<$[6_L'4SL.,\G(^8<#J
M#Q7U$/V OV]OB!_P35\>?LR?'?XL^#?B-^T+XFUNZN;/Q1K7B?6M6\/_ -F/
M+OMK>[U.XLA?I+"GW42!DSWQ7H?_  2J_P"">/QV_8M_9'^+'P-^+FL>!M1\
M9^-[?Q7'I%YX1U&^O-&B;6=*O;*S_M&YN[6WN(B);F,OY<3@1AR#N !:DTK>
M=_QN!_-O_P $._V,_@1^V3\??C]X7^//AB7Q/I'ABVO+_2+5+J2U-M/<ZA*'
ME+Q@Y)SD'GL#@U_4CX6_X(C_ /!/GP7XET/Q9H/PKNK36/#VJ6VK:5-_;=TZ
MPWMK()(I3N&"5==S8..GX?'W_!&O_@E/^TO^P/\ &3XR>/OC=KWPTU71/']B
M]IH</@?6-5U&]BDDO'G5[Z*_L;2-4V''R,V&&[M7]%6 5P,;N1G&Y=P/)1#_
M  XZD>O'NU*3:UZK0#^9S_@YF@BMOV2OAM;6^1#:^-=+A@C)/RQ0;(D#/]YF
M5%PI/4C-;'[,_P --0^+/_!"37/!FE6\ESJMWX'UR]T^% S2RW=I&[H509^9
MEW#:."!ZY%?87_!9C]@KXV?M]? WPQ\.O@?JG@O2]>T7Q-:ZO<S^-]0O=.TU
MH(7!989+&WN96?&2%\O&>*^E_P#@G5^S'X\_9:_9+\$_ KXLR>&M8\2Z+;W-
MMK3>'9Y[S0KJ*Z!5H$DNH896B8$Y#Q L&;/%7NDNONNW7=/4#^>W_@V;^,WA
M3PCJ'QF_9Y\5ZK::-XXGO$N=+TZ_F2UGO9=/E-O<PQ1S,@DF5HW A7+L0 %.
M:_J&_:<^/WA3]F+X+^-OC+XRN+);#PEIDU[!87UU%:OK%RA&VPM [B661RP"
MI"KMC#;<&OPO_;._X(+7GC3XLZM^T)^QA\5C\#OB5J%P^HSZ.TDUAHQU:5C(
M\]GJ5HC7-B)')8B.,KO)(.<U\?7?_!#_ /X*H?M#7NG^&_VNOVPM)UGX=6MS
M&&M]/\6Z[XHNHK-"H/E6.IV=O;I.R#(D5F.X\XK.7Q/Y?D@/W9_8 _X*=_"O
M]OGPCX]\5^#?"'B3PHWPRB,GBJ35H%&F?):2WK1Z?>$ 3KY$3L>28\8;!XK^
M*#]IS]K/Q1\6O^"G/B/]HZ;P/J7QHL/AS\0U?PWX*L;/5]5CN/#'A>YDBTJR
MG32;>\N8;&(\R.(Q&I5<GO7]I_A_]@&\_9>_82\??LT?L:S:'9?$CQ-X9O-+
MM_&7C*XFLX[W6=2C$-_K&K7MI%-<X:-IA#"BNL8?:#MR:^/O^",__!)OXJ?L
M*>(?B]X^_:.NOAWXM^(7CQH;70K_ ,)W=WK45CI[EWU1;I]4L[=X/MLI1FCB
M#J<<GBB+L[V _#_]OS_@KM\5OV[/V=]3^!?BS]ASQ+X-MCJ>GZUI7B^WTCQ[
M/-X?GT<,8I[:*?14@2)D8+,)I1&(XUP>#7Z"_P#!LK^TA;:CX-^*O[,NO:IY
M>K:+?1>+_#5I=/Y4]TDC-'JT$-O(5D5[-8XGD5$ Y.X9&*_J>U+PKH.J:;J.
MDWNAZ&;;5+"[T^6#^R[3YX;J!X'B(\DJ5&_()().<8XK^8+]E'_@C+^V%^R9
M_P %$]0_:*\#>*OA1)\"I?&.N.EE+KFJKXON/!NNS&:ZM9--6R^PQ7\1DD2.
M$3F(*%P_) ?-I9*W;7Y]NX'CG_!S2P_X6?\ LE,QVA?$%P/4G*Q@$!<X&1@^
MG7I7]27[+[JO[.GP:!/WO 'AK'!_Y\+<_P!?Y]A7X\?\%E/^"8W[1?[?'C3X
M$^(/@AK/PYTG3?AOJLE[KZ^-M5U+3)YHI0H(L!I]E=B:3(QMEV+P #S7[6?!
MCP?JWP^^$WP\\#ZY)9S:SX4\+:1HVHRV$TCV;W=A9Q6\QMW=5>2(LCE"RJVW
M (!I<SLEVM^ '\<7_!Q;G_AMCX#,O.'\(#@ \_VWI^0<].^2:^V?^"\_PGU_
MQK_P3W^ _CK1K.>^M/!.FZ&NLFUA>6.RMKS3(?\ 2) JDK&KY1I&'EC8"3R*
M]4_X*U_\$G?VG?VXOVC/AA\5O@[KWPSTSPOX0ET$ZK#XNUC4K#49$TW4[6ZN
M3:PV5E<1RN8H7V+*Z*QPN<&OW6/P<\/^*O@C8?!?XG:+IGB?0[CP98^%?$%@
M\22V%RL>GK:7$MMYBY"J1YD,I4.CJI SBCF>GD!^0G_!O[^T-X,^*W[$GA_X
M=V>JV/\ PF?PROKG1=5T,W=O%J#VR,#;7T=H7%Q)$Z!OWBQE%/!(SBOTD_;Q
M^.W@/]G?]E7XS>/O'FOZ?HD$7@?6],T6SN[E8[K6M;U.QEM=-TRP@/[V>ZNY
MVVYB4I&JNS,"O/\ /C\4_P#@WR_:#^$/Q&U?XC_\$^_VEI?AU)J5S=W5MH6L
MZE>Z =/$TA>.Q.IZ9'/+=VT8)"F5 0O:N,M/^"$G_!1C]I;6M/L_VY_VP;;5
M_!>E7$%Q!;>'O$6L^,;J18V!DM$MM9MK2"U$BY47",TD9^90:.=_U\O\OS \
M(_X-K_A!K_BCX^_'K]H=[&:W\,>&/"/BC2;>\>-EMKK4?%\MY)+8VLN,23V<
M(#W )W ')[5S?_!)71=+\1_\%FOC?HFM6D6H:3K%G\9--U'3YD#V]Q93VUVC
MQ.K Y5E)WY /4CUK^OC]E[]DGX2_L@?!.Q^"7P7T%-+T:TTZXAO]0N3Y^IZ]
MK,]JT<VLZM>L!)<2SR,6(?\ U2G8O"BOQ4_8"_X)*?M0?LP_\%&O'O[6'Q%U
MWX7WGPR\2_\ "??8K'PYK.JW7B=!XECG73FN;.XL8;11'YBFY$<[%5!"Y &3
MGD!^1?[67P]\??\ !'+]NO6_B!X$TJ^/P,^+MMKGV6UA$BZ8]MK*2B\TXNN(
M0\#3R2(DF,*!CM7N/_!N9KUOXH_:^_:"\36<;Q6WB%-1UB&%^L<5_=2S("QX
M.P.% 4G(YK^DS_@I!^P[H/[=_P"SSKGPQG^Q:?XT@ADOO!&NZAE;?3=656\K
M[3*L;RK;2-C?M5B8\\9XK\OO^"-?_!)?]IS]@+XK^./&/QK\0_#/6-"UW2EL
M-*7P;JVI:A>;U;_7W,-[96R0*RY/[HOM<C@@9I-W=P/Z3 RLORG/S'].">>V
M:*0 #(R",X7( 0%OF]^0. <?SI:0!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #AT/^]'_ .AB
MB@=#_O1_^ABB@!O8?[J_^@BBCL/]U?\ T$44 %%%% !1110 4444 %%%)W X
MR0<#N<#/ [X[C]: %HSGI7"_$'XC^!_A;X>G\6?$'Q)IWA7PY:<7&JZM.+:W
M1SD@9.1VYYZ<8KYN3_@H#^QT^UHOCSX)8-M 8WS!5W#(<GR\%2#Z_C5*+>W]
M;?Y@?9=%?'0_X* _L<\@_'GP3D$J3]N;D@X)'[H\$]*7_AX!^QS_ -%Y\$_^
M![?_ !JE9K6W]?T_ZLP/L2BOCO\ X> ?L<_]%Y\$_P#@>W_QJC_AX!^QS_T7
MGP3_ .![?_&J0'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G
M_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5
M 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 '
MV)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P /
M /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8
MY_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_
M  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_
M^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\
M#P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^
MB\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G
M_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5
M 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 '
MV)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P /
M /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8
MY_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_
M  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_
M^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\
M#P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^
MB\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G
M_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5
M 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 '
MV)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P /
M /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8
MY_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_
M  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_
M^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\
M#P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^
MB\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G
M_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5
M 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 '
MV)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P /
M /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8
MY_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_
M  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_
M^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\
M#P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^
MB\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G
M_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5
M 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 '
MV)17QW_P\ _8Y_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P /
M /V.?^B\^"?_  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8
MY_Z+SX)_\#V_^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_
M  /;_P"-4?\ #P#]CG_HO/@G_P #V_\ C5 'V)17QW_P\ _8Y_Z+SX)_\#V_
M^-4?\/ /V.?^B\^"?_ ]O_C5 'V)17QW_P / /V.?^B\^"?_  /;_P"-4?\
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M/W72@#[$HKX[_P"'@'['/_1>?!/_ ('M_P#&J/\ AX!^QS_T7GP3_P"![?\
MQJ@#[$HKX[_X> ?L<_\ 1>?!/_@>W_QJC_AX!^QS_P!%Y\$_^![?_&J /L2B
MOCO_ (> ?L<_]%Y\$_\ @>W_ ,:H_P"'@'['/_1>?!/_ ('M_P#&J /L2BOC
MO_AX!^QS_P!%Y\$_^![?_&J/^'@'['/_ $7GP3_X'M_\:H ^Q**^._\ AX!^
MQS_T7GP3_P"![?\ QJC_ (> ?L<_]%Y\$_\ @>W_ ,:H ^Q**^._^'@'['/_
M $7GP3_X'M_\:H_X> ?L<_\ 1>?!/_@>W_QJ@#[$HKX[_P"'@'['/_1>?!/_
M ('M_P#&J/\ AX!^QS_T7GP3_P"![?\ QJ@#[$HKX[_X> ?L<_\ 1>?!/_@>
MW_QJC_AX!^QS_P!%Y\$_^![?_&J /L2BOCO_ (> ?L<_]%Y\$_\ @>W_ ,:H
M_P"'@'['/_1>?!/_ ('M_P#&J /L2BOCO_AX!^QS_P!%Y\$_^![?_&J/^'@'
M['/_ $7GP3_X'M_\:H ^Q**^._\ AX!^QS_T7GP3_P"![?\ QJC_ (> ?L<_
M]%Y\$_\ @>W_ ,:H ^Q**^._^'@'['/_ $7GP3_X'M_\:H_X> ?L<_\ 1>?!
M/_@>W_QJ@#[$HKX[_P"'@'['/_1>?!/_ ('M_P#&J/\ AX!^QS_T7GP3_P"!
M[?\ QJ@#[$HKX[_X> ?L<_\ 1>?!/_@>W_QJC_AX!^QS_P!%Y\$_^![?_&J
M/L2BOCO_ (> ?L<_]%Y\$_\ @>W_ ,:H_P"'@'['/_1>?!/_ ('M_P#&J /L
M2BOCO_AX!^QS_P!%Y\$_^![?_&J/^'@'['/_ $7GP3_X'M_\:H ^Q**^._\
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M^'@'['/_ $7GP3_X'M_\:H ^Q**^._\ AX!^QS_T7GP3_P"![?\ QJC_ (>
M?L<_]%Y\$_\ @>W_ ,:H ^Q**^._^'@'['/_ $7GP3_X'M_\:H_X> ?L<_\
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M/_1>?!/_ ('M_P#&J/\ AX!^QS_T7GP3_P"![?\ QJ@#[$HKX[_X> ?L<_\
M1>?!/_@>W_QJC_AX!^QS_P!%Y\$_^![?_&J /L2BOCO_ (> ?L<_]%Y\$_\
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M^![?_&J/^'@'['/_ $7GP3_X'M_\:H ^Q**^._\ AX!^QS_T7GP3_P"![?\
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M5_\ 0111V'^ZO_H(HH **** "BBB@ HHHH * .<\<!N".O!Z'M12CK^!_D:
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MDK_H@'PZ_P#!/_\ ;:^HZ* /ES_AB7]DK_H@'PZ_\$__ -MH_P"&)?V2O^B
M?#K_ ,$__P!MKZCHH ^7/^&)?V2O^B ?#K_P3_\ VVC_ (8E_9*_Z(!\.O\
MP3__ &VOJ.B@#Y<_X8E_9*_Z(!\.O_!/_P#;:/\ AB7]DK_H@'PZ_P#!/_\
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M\$__ -MH_P"&)?V2O^B ?#K_ ,$__P!MKZCHH ^7/^&)?V2O^B ?#K_P3_\
MVVC_ (8E_9*_Z(!\.O\ P3__ &VOJ.B@#Y<_X8E_9*_Z(!\.O_!/_P#;:/\
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MDK_H@'PZ_P#!/_\ ;:^HZ* /ES_AB7]DK_H@'PZ_\$__ -MH_P"&)?V2O^B
M?#K_ ,$__P!MKZCHH ^7/^&)?V2O^B ?#K_P3_\ VVC_ (8E_9*_Z(!\.O\
MP3__ &VOJ.B@#Y<_X8E_9*_Z(!\.O_!/_P#;:/\ AB7]DK_H@'PZ_P#!/_\
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M2=BA1QCTQ7["QC;D=5Y9>/NDG!(^O/T%?DU_P3;_ .2H?MFY_P"BTWWY[/\
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M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
M#$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_
MT0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_
M ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;
M7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?
M+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^
MR5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^
M'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__
M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
M#$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_
MT0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_
M ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;
M7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?
M+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^
MR5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^
M'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__
M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
M#$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_
MT0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_
M ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;
M7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?
M+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^
MR5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^
M'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__
M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
M#$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_
MT0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_
M ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;
M7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?
M+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^
MR5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^
M'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__
M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
M#$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_
MT0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_
M ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;
M7U'10!\N?\,2_LE?]$ ^'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?
M+G_#$O[)7_1 /AU_X)__ +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^
MR5_T0#X=?^"?_P"VT?\ #$O[)7_1 /AU_P""?_[;7U'10!\N?\,2_LE?]$ ^
M'7_@G_\ MM'_  Q+^R5_T0#X=?\ @G_^VU]1T4 ?+G_#$O[)7_1 /AU_X)__
M +;1_P ,2_LE?]$ ^'7_ ()__MM?4=% 'RY_PQ+^R5_T0#X=?^"?_P"VT?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 .'0_P"]'_Z&**!T/^]'_P"ABB@!O8?[J_\
MH(HH[#_=7_T$44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/QS^#>J:9K6O:;\3?!EYHWA]UBU_4%URQ^SZ7,96B5+N225!$ZRJR[!\X((
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MX'ZEJUU;:QK7ENOV^*[EO;HQW.F7J 036"H\AYP><U_4'$6D!D*E=Q+!3RC
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M,]4UWPOH&O\ _"!V5IXDU"WL/##Z9:2W%M*+19&67>\>UHF;.&+;P5P?//\
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M[Q9X:T'Q=>?$G5+7P3X#%U#;:C:>'K<J+6*R@9A)>1,H&648W$]B<?JQXO\
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MG>359K.X/VBUN((D\MPFYC@BOZ (V 4;2=IX+M_= VA,<]/6LVFG898HI!P
M/0#I2T@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!PZ'_>C_
M /0Q10.A_P!Z/_T,44 -[#_=7_T$44=A_NK_ .@BB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K2?,N.%]
M3@XQ@_>P<[??UQ7\R'_!PU\!]3N-*^"?[2?@W1;Q_$7A?61X4UO4]'M9;K4B
M;AP^@S3?9U,K"V993">B9)[<_P!.Y (((R/3L?KGMWK.U'2-+U:$VFJZ9IVK
M6H*.EOJEE;WUOYD?*O\ 9[F.2(2+_ ^P,O8^M1E9_P!>7^0'\L/_  0+^ /B
MWQA\2_B_^UC\5+36)=>15\.Z)=Z]:S)-J.HWD/D:I>[KA5E/DP06Z)("=NX<
MX%?U2*C"3=MQYA.,N&C3"@%R?0G@+G.?K5>QTC3-*A^S:3I6FZ5:%B[VNFV=
MO8PLS$;G\NTCBC,AQRQ'I[UIXXP H7!&W!X&W 'N<]^W7K3E*ZLNJ5_\@/BW
M]M[XQ_$?X)_!K5/%OP^^#4WQKEWF#5_"B)#*K6CC$DLUM/%*LT6"2P"Y"^AY
MK^8O]H'XZ_L"?M!?"'6K74_V//'?PW_:@N!/:VUEX/\ !VH6FF2:S*3M-]J8
MC:SD57/^KCB0>AQ7]H4D:R(8Y$6:-P59)55UY7:=Z-E'0C@J5.><=>.;_P"$
M+\(F7SV\(>%FN-V_[0= TGSB_9PYM-P;W))ZC/0U:JM*UNM_GI_E^@'\M/[)
MO_!/7X\?$/\ X)E_%SP#X\CUG2;[Q+?2^*/AAX/UB6=KFQN+" B$&"4EK5+J
M/YXU "EL;5R17CW[(G[4/P;_ &0_@QXC^"O[47[(6J^(OB[X2OM1C\,7K> )
M=6C\232N5MH]0O\ [._V.W\P*/.=B&4G! K^QA8%B18X4CB5-NQ8D$<*A/E"
MB)< +MXPH SCC K%O/"GAB_F>[N_"WAN\O'/-S>Z+IMS.<$'+S2V[2-GJ/FX
M(H=>5MNJVO?=?UZ=&!^4O_!/WQ1=_M,_"SXG:EK_ .RMI7[-^G^*=(O_  SI
M=Y:6<%A>>(["\MIK??%%'$DT=M:F2)QN)5@37XG?L@>-_B!_P1P_:R^-W@OX
MX?#OQAK?PX^(EX\,/B/PGHUUJT5_%97EU>Z)JFFK!&QN$Q>M%.%8#AN!BO[$
MKFR0:?/IUDL&GQFUN8K-[2&.W6TEDA=(9$BA58U$<C*X"*,E1UYK^>G7OBE_
MP5)_9Q^+.JZ9\0_@'HG[6?PU%QJ,?A^]TK1K.XU>;3Y9Y)=-F^W7EI.;-X8F
M6*YA+@2"/@52K<WQ6MV?YWZ?U:P'Y0?M5_M">,/VG_\ @H[\ _B1J_P\\1?#
M_P -7&M>&-/\ :=XBT^6PU;6?#D&IJ\.NRV4P$D1N=S!05R/J*^E?^"J>B:[
M>?\ !5+]G34;30]7O;.W\(>!UEU"TL+B6WB8:E:!A+)'&8]R $L"0 .<5[AX
M*_9@_;!_;I_;;\ _M-_'/X46_P "_A[\+Y=,_L'PM>Q^1=P6FDW"W%K9B"-(
MUF9W# R1KL.06!Z5_31=>'?#][=0WE[H6C7U[ B)!?7^DZ?=W<83&Q8[B:W>
MXC6,@%560;<#'2ASOU79*^RTT_!?<@/YN/\ @X%T?5]4^'/[-,6E:1J>IR17
MUH)?[/M)IVC4P1*6F\I',8P,'(&.?P]\_:UTS5;C_@CKH5A;:7?W-^G@O0HS
M806\LET-L#*R&!5,@)'WAC.23Z5^ZM[H.C:M'$NL:+H^KB EH!J.FVEZ(6/>
M 7<4PA&.@3&.G>I9M(TRXLQIUQI6FW.G$;&TZXL;66Q$:Y\M%M'B-N !CCR\
M5//9):-76S[+?_@/L!_-+^PU^SGXA_:'_P""1/CSX.6ME<Z9XHU&[UN_\.66
MIVTED9-3LVW6T,AF56C$@5E1F!!9@!UKXZ_8N_:&^%G[$_PS\;? G]KS]D[5
M/%7Q'\/:SK=WX3UI? DNMG79+J3-GI][J!MY!;6<3HH2=OE*,2A K^R2RTO3
MM*A6WTFPL],ME)86NG6EK8VX+=3Y=M%&F1QR!SDYK-OO"GAG49C<:AX9\.ZC
M.<?OK[1=-NI21_$\L]O)(QZXP1@\\TE5:NGL]]7;Y+OZ]^Q$E=I>NOW;ZJQ^
M.G[!?Q6U?X[_  U^-/C;4_V0='_9[T^S\(ZM:>'O%=GI\%A?>*H[RRN_,LH+
M2.))VA2!(]\F=N]E7;G.?A[_ (-Z='UG2?B;^V8VK:+JFCI/JMG)#)?V4]IY
MRCQ-KC*T1F11(2GS87C;M/0U_4!#8VUO MG;6=I;64:@+:06\,-O\PPX$$2+
M" 1_"4VD<'O5;3]"T32'FDTC1M)TR2Y*FYDT[3;.PDNB"2#<O:PQ&8*69L.6
MY)(Y)RN???6W7HK:?AVMMH)0\_P_X)_(%^U/H.O3_P#!;SX9:E!H&M7&G1^-
MO#+M>PV%R;)$6[LR96N%0Q+@?,P9N!S7T9_P<"_#'Q]>^*O@1\4M!\+ZOX@\
M+^&=9MY-:N=)M);I+)K.ZCGS<K$C'<JQD*.-Q S7]-LWAS0)[Q=3F\/Z)<ZI
M&RM'J4^EV$E^CKRLBW<D!N%9#@J1)N!'7-6K_3-/U.$V^I:?8:I;.=SVVH6D
M%Y#D9Y$5S')%EQU)4GGKZ"J>]?:VG7R>NUUIT-%HDNQ^'\W_  46UWQA^Q]I
M?C;X+?LV^*_BE9^&]'TOPOXM\.^)=':Q5CIVGQ6]W<Q:/?0227=F[1M_I"\#
M=D8P*_'W]I'XT?L"_M"?!O4["V_8Z\??#_\ :JN[>2&PM/!O@W4;/25\132*
M89;W4@CV=[;1?O,Q0QQD,5YXK^SRRT32=-@DL].TC1["RDXDM++3;2U@E4]5
M:&"*.%L'@[U(-9H\&>$5E%P/"/A87"MYBS#0-*$JR9)+++]DWB1N[YZYJO:V
MDVEO^N^G_! _'C_@A[\"_C9\&OV8;B'XP0ZMI1\0>(+K5O#NAZS<3O>:=I,C
MYCS;W!+VJ2H5V1\* #@"OVL10-S]F;  Z#T./?/UXIL,>U57B)$ 5(XU555!
M]V/:@"[4 XV@#GCO4N .!TS64FY.^VM[=MM%Z@%%%%( HHHH **** "BBB@
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MSCG&:HV.CZ9I<)@TO3-/TRW+#-MIMG:V$)51\HVVL42GG.0P(Y/UK34,,_,
M P(&.J[<;..P/2LYRYWJONOU0#AP  <@< ^H'?\ &BC\,>P[>U%0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 .'0_[T?_H8HH'0_P"]'_Z&
M** &]A_NK_Z"**.P_P!U?_0110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%-+@<<TTOZ?K_\ KH DHIH?.!SG]*1G].N<<CB@!]%-WKZTF\>] #Z*
M9O'O_G\:<#GD4 +12$@=3_.FEQVYH ?135;/UIU !1136;&,4 .HI@<=^*0O
MSQT_STH DHH!STHH **0G S_ )ZXJ/>?0>W% #9(@P)!*\=1SCKSCV[=^:<$
M*!</*BX&%W L?P;) ]@.]/5B02>WI[<TN0W/4^IZT ,968C<Q1@<#DD'';D[
M Q]0!TZT"-1@ ;>Y4G+YSZ]-N..,'-2=L=O3M10 45&7.<#L:4.._'\J 'T5
M'OY]NWK4E !112$@=>* %HIF\>_^?QI-_'O^G\Z )**8K9X/6GT %%(2!UXI
MH<'CF@!]%,+\\=.__P!:E#=R/E['_'GUH =13"Q'./EXY[_SH+^GZ_YZT /H
MI&.!FFAACD\_C0%I/;OVOH/HII8#/K3-Y]O\_C0--)Z[$M%,5\G!_#%/H$%%
M%% !36+#&.A(#>HSW'?(YX'K3JIW5Q%;H\UQ)'!%;H]U+-*VR&*&!6DED=\@
M(%1226(3 ):FDWH@/$?CY^T=\+OV:O"VG>+OBIK\.B:3K&OZ?X>TTR%?M$]]
MJ4PAB\A"09(X&(:<("P5AVK=\>?&?P%\-?A???&#Q=K":9X$T_1H-9EU23$8
MDM+J$7%NT<;D.9;A&'DJ.2QP,]*_!S51/_P5+_X*-KH\;3ZQ^RA^R9?)=32)
MO;0/%7CNTEVK$''[BZ'VE&2:,[VC5!P%YKH_^"@_C76_VP_VH/A7_P $Z_@U
M>.W@71;FP\1?'6[T4'[#IFCZ4\0AT"ZFA^2V,%O&OEQ,RAG)7!Z%\DNW]?U^
M0'[J?"[XJ>$_C!X$T#XB>!KX:CX7\16D=[I5XJ%!-;28Y93RKJ<JPXR0:]'7
M!+')R#C![ @&N(^'WP^\-_"_P3X9^'_A&P@T_P .^%=)L])TZV@CCB3RK2%(
MO,=4 4R2LGF.<<NQ-=PH('/7_/&:D!:*** "BBB@!" >M1LI.&4<GC<.&'8X
M*8'08Z_6I::6 X].P_SB@!%#("#+*QSC!(. >^1GZ=<_CFE"X!!_BSAB=S-G
MDC)SCU[<C ZTF_&=N03^'YX-*K _7_.?UHO>Z[?J H '2EI"P'6C(P"> :=U
M9+JKW^=@%HIN]:-R^O\ .D ZBFA@>E.H ***#T/;WH *R=:UG3]!TO4=:U6Y
MBM-+TFQNM3O[J=O+@M[6RB:6XE=S@8"#H3UK2=V'(D ^[@[>=ASO=5'5CD8!
MYR:_%K_@K9^T=XFLM"\$_L>?!F\>;XM_M ZG:Z'??86:2[T+PI=2^7J%Y=1P
MYDMXY8&.]B%"@#GD4XKF=@/TP^ G[1?PT_:1\*7GC+X6:N^KZ#I^M7VB7=P4
MVK#>:?(\=PC,,C!*.4.[E<'/>LWX5?M1?"/XT?$+XF_#7X?^($UGQ-\(]073
M_%T-N!]DBDE 7?;2J2LP21O(< DB16!Y!K\VOC7XH\(?\$I/^">^@_#CX>B&
MY^*'BK3XO"/A&WC"_P!L>(O'OB&!8[_6&BCS<W4]E<7+2(Q#;L*,G KW3_@E
MG^R&?V8_@!9^(?&*RWWQH^,K_P#"=_$W6;Q<Z@VHZRS7L>G;WS(EO;B9)#$S
M867C'I?)Y_A_P0/TUB<M@] 22!CMCCWJ>HT0J>>Q/XGO^'6G%@.#]>@__768
M#J*;O7UHW+Z_S_PH =13=Z_7_/O0&ST!_3_&@!U%)GV/Z?XTW>/<_P"?>@!]
M%(#D9I: "BBB@ HI"0.I_G3=X]Z 'U&T98AD)C(.,HQ!/U7@'^5*7';KZ]J0
M/SSCZXY_S]* 'D.4"AW0CJQ();'7..5^@Q^E! !Y&=R@$C@D^I+<G\.M(6 Y
M/4_YYI-X.!R>F,]J 'T5&7QP/?.:0.>_2@"6BHR_3'XY_IS3P0>E "T444 %
M%%,WCWH ?146]O:E+^GZT 244BDD9I&;''?]* '44T,.YY_&D+^G/KUH ?14
M6\^W^?QI=YS[9_''Y]: )**;O'O]/\\4!@>!F@!U%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9WY-])GPGSS'X3+,!G].KCL=6A1P]'K.=1J,4FDOM/S/Z_$1QG*.V#R,$9[
M@D8(P.<9_I3]ISN"-@=5VG)X/3C!/T)_6OPN\<_LV_\ !2CP/X2U_P 7S?MN
M+?1:'IUUJ!LCX9M,RK;Q,^-WFY!VKW(.>V:_'63]NC_@H3!<7%LW[0DCFWN)
M[?>=+@ D$,C)N7]Y^[R!E1R.W2OG^'^!>(.)56>28:6/=!QC44;6BVT]]-==
M=-5:VC/L>.O&+@CP[K8.EQ5F$<O^OPY\+S)KGCHW=/;>U[[>A_:YM)YV.OT
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MG_6_YG+Z6'@QIS<1T]^MENX]EIOVZ6]?[7&1L9",#D# &X?4]_\ /:G@, 0
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MW_!(;_@G/<ZIJK0:C\2=5TU[V1HTC%WXK^*GBR%F@0GB>6.UN9XS<E0YC"Y
M^;<-[_@DA^RQXB^%WPP\0?M%?%P&_P#CA^TE=GQOKL\\;/?Z+HFI7$EY8:.S
M2 R[81)&Q(.3"4!%?(_B:6Z_X*F_\%'+3PA9W4VJ_LD?L?ZC#J>KR6K.WASQ
M=X]MI0GD--M$%]&\\0MIK0;O*6$;N,$_N7\;?"'Q&\2?"C6/!_P2\4V7PY\8
MR065CX=\0&QBN+;0M/MR(V2UM&VQF3[,JQ1H-H4* *TNOR;LUY>?IZ_,#W0
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MGV_[:BO$/VB_A/\ \%)_V>_@E\2/C1J'[9B>(;3X=>&[SQ*^CQ>';2"2^6T
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M+KZ:6>MKG]RC*3C",.O13@''?@GDC&::$D^4J#_M## CT^\!D9_^MFOX;?\
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M 4444 %%%% #AT/^]'_Z&**!T/\ O1_^ABB@!O8?[J_^@BBCL/\ =7_T$44
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M_@I@@;]EOQ:,=X>ISG+/P?H.W3Z5^97_  1LY^*/Q(/]W1[$#'_75A7Z<_\
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MU7Q[K5[J@$FL:=X?027&DZ-$\QWQ3LK+%# A#?/W S7%?\$R_AKXI_:@^/\
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MOL[>NB/XC?\ @H/G_AKSXP_]A^3_ - CKXT8*,9;!V\8'XG&,"OLO_@H,/\
MC+WXP#U\02?JD5?&70],'&/P_P FOZBRCECEF$M=2C2A=V3O>UM^W]7/^;3Q
M;YEXC<6*4VV\WQDF[+K45EL^WRZ6&28W*0P[#],]/ISD].E?W$_L*C_C%SX3
M=\^%K3K]%_+J:_AYD^\O'0J,^WOVK^XK]A8X_9<^$HP#GPQ;]1Z*"/R/^>M?
M#>)3_P!BP5DF_:-2=DFVDM].M_P^[^VOV=B?^MO%J<FXQRS"U(Q=M&L0HMZ=
M=M+VZZGUT "2,8P3T]S].V*38<^P[]SW_P#K4Y?;T&?KSF@DX7ZK7XBO?J1;
M7+R7DUYI?+M^/W_Z]**:<7JM'YZM6U?ROZ:'YD_\%9P/^&0/&3'G%[I/3MF2
M3KQQT_4>M?QX1Y*+CIL7MU  P.E?V)_\%9^/V0O&8&?^0AI(/OB2?_ZU?QUQ
MDA5_W%'Z"OWGPZUR64M/][N]-X]%^-UV]3_%G]H&HP\6,LE%7G_8-*TWY58K
M9]=;7_)ZCERCL?48Z>WZY_#KUK]2/^"/Y'_#7EB-O/\ PCFH\]^8' 'ZU^6Y
M)/>OU(_X(^\_M=V;=_\ A'M2&?8Q,,<U]%Q0DLFS%K>4+I_W>573ZWZ+_AC^
M??HVRDO&K@-WLY9OAU-KJM&M-M[7VV/Z_@!_='Y48'H/RI:*_F<_Z)5LO1?D
M0S@>3)\H/RGC&*_BT_X*9*P_;%^(YS@F2WZC_9/'U]/;M7]I=Q_J9/\ =_J*
M_BU_X*9D_P##87Q(]1+;<]_N'_/-?HOAR_\ A5DGLXI6LGU3>_K\^Y_!/T_4
MWX88"SL_[6I/9;<MGKOV_K;X+"C:3_D8STJM/G;P/IG.,\8[]:GR=N/<_P!/
M\:C?HZ]O+W8]\@Y_I7[E53Y*T'9QG%I*VUTOU^[\O\:,M<?KV&E9_P"]4;+=
M652+>_4_ME_X)V#'[(OP=Z?\BTA'XW4X_EZ5]P[% S^.?7C'TQT[&OA[_@G7
M_P FB?![_L6E_P#2N>ON-N%QZ8_F*_EK-U_PIXJ2M:-:>GHTOUN?])OA2E/P
M]X4=Y)/),!=)M)J-&#E>W5W_ %(E/(X_#^7IWK\[?^"IJ_\ &'?Q)QG/D0MD
M<=9%]QG'^>]?HJI)D4=L+CVR#7YV?\%3,']CWXE@$X%K!R.O^N'^%='#K_X6
MLL=DHO&T9M+LYQ7;>_RU//\ &S7PJX^CHHRX;S)):-\L<-)I/F3VMOJ]>A_&
M:J[D5MV3A./<9X_^M3B"#C_/_P!>FQ']VI_W?ZU("223V4X]J_J'5<T862<F
M_>77F].M]7^9_P W-24E-[22E)KW8J[YK7=ENKI^NVA^D_\ P2<C!_;#\,$]
M1HFKG'K_ *../;CK^(]*_L9\K.>JC@X49)Q@X//0'CW]J_CI_P""31_XS"\,
MDD_\@35_Q_T<#^7^<U_8T/X3W Z_4<U^#>(R:SF%W_RY6BVN[?AIV[=C_:OZ
M ;_XU%BG)MR>=5.BLURS25UTT6WWZ&/KVBZ3XATN_P!%U_3+#5=)U2UGM+W3
M=3MXKRQNK.XA>*YADAE5EQ)"[J2/7C!VD?@;\2_ FO\ _!*'X\Z%\:OA$^IO
M^QG\5?$5KI?Q<^'PGEO=,\!ZQJEPL<7B73H7_P"09:Q><JEX\HD8,90U_00Z
MAE"XR >GIZX/:OGC]J7X1Z-\=/@%\3_AOJUI#?0ZQX5U06-M+'N,.J6]I-+8
MS#CETN5C(8<@U^>G]V'MN@>(=)\4:)I/B/P_?P:IH>NZ?:ZMI&H6[!X+JPO8
MEFMY8V4X(9'!QU'0\\5MJ2>V/ZU^9_\ P2C\>7_B?]DW1O"&O74MQXK^$7B3
M7OAYKT<Q+M#_ &)>FVLU!)R4^SH=H_A"G':OTP7DL%8%5)X(YYQMP?0 'M0
MZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*,PQZD4 ?DE_P1>U.SN?V2_$.EQ"*VU#0OCK\5[;4;/ 26TEEUQ&$DL/!5Y
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M(_X6E\1\\?\ $FLCSUP96K].O^"E[;OV7/%Y[;K7\/FD_P#K?YS7\+\=M?\
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M?]1.&_._Z&\[C8_S!<*26# [1GG)Z8QUSVK^=O\ :\\3:U_P4)_;.\%?L@>
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M>>#^'2IZ**S *8QYQ[$_^.FGU$1M)ZXP>?P[U:>ORC^<2*_\+T4G^9_EG?\
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M5_X);_L$:MX[\<21R?%KQGI\NO:K.RJVLZ[XR\0P&2RLG>3,LCP37"@K_"P
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MVI-IV@XXR3^8'^%0L0@YZ!6]SSC'3UK]TJOXOE^A_C+EJ;Q>&LFVL12>BO\
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MOXAT7Q!I]Q)K3QWNDZC;7P"RVT>QG%M+($W8^ZX# ]0*_% !WPP#MD;&)4@
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M5U?=7VUU2L?SB ,G\#'/'W>Y]<_Y]:D5&Z^7(<?[)P/Y?K7[N?\ #B+X?_\
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MWOKMY?(_B.I] #C.=2I4_MO"1]I4G4Y9+F<5.=[-\KU2>WGWW_"3D]4<_P#
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M;#'?S>./^VG?_/3!Z'PK_P $4-#\$ZY9^(_"?Q_\?:+KFGNTEGJ=I<%;B!W
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M<$8QCZ 5_/?B9X@8/C;B3 YU2INC2PKIRE"<;M\E2G45K.UTE9=W:UM3^T_
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M_P"'>_QE_P"CS_B__P"#"?\ ^2* /U5VMSP1Q_GV/TYJ!EEY(!(PW&,[N.,
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M#^AH16 &5/7I[<?_ %^]?E0?^">WQEX'_#9_Q>X 4?\ $RFP .!_RW[5*/\
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M!VFM--'=Q&X ,1-ND<>X;0V=PS7Y3#=OR_-JWY_J?K!Z1^TWXQ\-_P#!.?\
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M?$8:I/.L!5E1KT*CY8+6,*D9-?#O9;_F?J;^P_#*G[-/PN_=29;P[;,/,4H
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M%.G4I5IQ22G*,))N$7RJU_+\#]+/^"=<,@_9 ^#;M$ZLWAI2VY2H<BZG&4R
M<#U[X/6OMW:_/R=?;_Z]?D/X0_X)D?$'P'X?T_PMX0_:Y^*FB>'M*A^S:=I=
MK?3+!:P[S)Y<0$R@?,2>!TXZ5TW_  [W^,N[ _;-^+H.,\:C/]/^>]?D.-K4
M\7C<77A[JG-M7NDKN+Y=^E]NFNFQ_JQP=DU3(>&<DR2I./M,MRW"X:K5IZ<\
MJ,8P;VZV;[ZJQ^J1C; PK9/Z?RYK\Y_^"ID;C]COXD,8F=5MX,@*QZRJ.2.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML@;DW=R?IT_(!UZGG@^P'3'U[]/QHHHIIVZ+YH HHHI %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 .'0_[T?_ *&**!T/^]'_ .ABB@!O8?[J_P#H(HH[#_=7_P!!%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 44A. 30IR,XQ32N[+^OZN M
M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH 8Z_(P_V=QDDY50O8=,
MD9Q_D5\+?MQ^3XT\'> O@7]O:WE^,WCO0]&U=;5BE_'X6LKA-0U"[B3.YH5G
MMH(93TQ*,U]TNV05 +#@.I(7:N<LV3QC('X5\67WPJ\8>.?VO]-^*'B2TV>
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MDC@C^(9Y)SP?7VIP0E >-Q&"0!D<DD G/&?QQ0 HYE8_,5SP_P!XEB,E"1_
M.WI^=35&JD$<84#&WMGKNZY+>Y..O%24 %%%% !1110 4444 %%%% !1110!
M%*< 'Z_TKX&_9'F32?C/^V9X.)WRV_Q?L_$41 P9+:_T"QB8"+KM\U /,'!(
MQC/-??,H)'3/_P"L=Z^5OA3\%/$?@7]H3XZ?%"YNK4^&/B=#I4FG6J3*US%?
M67EK+(_=%,49 !_BXZT ?0/C&UBU#PGXELIX1<17.BZDDL$B@J%-G*%&PYP=
MQ!Q_%UKP;]CFZ^T?!#28/,21M.U_Q)8O$"-UJMOJDJ0QE>=N(^5' PV!TKZ8
MN4-Q;36V],W<,D)9AN0F12G3^,[2?E[?2OF?]E_X6>.OA3;?$[3/&+6C6&M^
M.[K6O"BV=RMRJ:3=+*[B8)Q!(TK*?)/(YS0!]34444 (S$<#DMD<<,!U+#Z>
MG?(KXE_::_8<^&'[5'Q&^"OQ#^)6J:_<Q_!3Q#'XCTGPA]J+^%-9O8I!)"=:
MTCB.Z<%1\TA("X&VOMHC((/<$>^#Z'L:C,2\D9!Q@<^G0<]>>N3W/- 'R=^U
MC^R7X'_:Z^&%I\)_&NN>)?#WA&TUC3=4FL_#5\=,@N[?3&C,.E7T$2@76GA8
MU6*V78B'DY'%?0'@;P/X=^'7@WPSX&\):=::3X<\+:19:/I5E90K#!';V<"0
MARB@#SIMGFSL>6D9F).:[!48')( QC;U4C^Z<DG'<]\TI5B,?PYX*X''I[8Y
M'T]ZI2:5OZ7X 2#H/H/Y4M-^Z!FDW'LI(]>?\*D!]%("#TYI: "BBB@ HHHH
M **** "E'MUZC\.:2D)P<^S >A) P,^I[#O0!6,SD,5 #*=I!Z$9Y&?0UX1\
M=?VA_ 7P$T"VU'Q7/+J.OZS.NF^$O!FCK]L\2^)M6E.+:TL;"',HA:5HTDF=
M0D:-N)(%=C\4=2\>:;X)U:Y^%FB6/B'QQ(JPZ+9:K=)8:9#<3OY;7M]/-\IA
ML@1,UJ"))L%4.2,>!_ ?]EZ'PCK$GQ8^,FKGXF_'O6@\EYXCU-3+I'A:*9RY
MTCP7I=T'@TZRM5(07(C-Q(T>4E7C(!YAX#^ 'Q+_ &AO%&E?&3]K,2:5INF7
MAO? /P#M+TS>'-#@$ADL=1\8Q1;8]4UIH]C^5)A;<_NW5NI_1"UM+:U@BM[6
MWAM+:W18+>VMXD@BABC&T)'#&!&D>,;0B@* !3D1O,!(. 0VYL[F.,9;)Y..
M/SJST]>N<>GKCZT ,V#U/^?PIRJ%&!G_ #T[4M% !1110 5ROC/P_8>+O#'B
M+POJ,0NK/6]'OM/N864/&R7-N\:Q.I'S%BP&!SMSCU'55"\6]XF^7,9+H6Z!
MP=N6QC)\OE<Y'MWH ^)OV)?&MI?^!O%'PHF+6_B+X*>+-0\-:GISQ-"L.D3S
M2SZ";97)+0+8J%+#Y=P&,9%?;PX&.I8EN.@'0#Z\U\O^&/@I>^#?VC_%WQ/T
M%8+?POX]\.QP>)+=9 LEWXBM65+2Y"C"8CMA(A.W=SUQ7T\,[1DKP<Y'(4J<
M!<CN: 'T4TMZ<GT'^32;QCW].?\ "@!]%("#TYI: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK_@H]^QOX,\1W7A;7/C5X7@UJTN#:WD,=S%(D4R-L8&1'*+\P]?Y&OJ3X?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT_5;Z7PAXIT2P@:Y;3992T"W%X8Y&?@+\CIC''!((I23V8' ?L3?$^V\*_\
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M!9[>4+GH<!NO7KVK*I-Q6G2U_O\ Z=NH'\G7_!*#]DWX5_M#?M _M@:U\8-
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M/C+X8G^&'P__ & I_AAXXUN./2KCX@ZA86ZZ?I4DF+>74K=0@$1 +S@AGY
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MC/2,$C.5_O=N/3@(*A% "1A=A\L@L5]-@P%&,Y/IBK "], X^F?QI<#T'Y4
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M/M%O>?NT18&AN%258P#DC[V.G[HL'<[R$D)^1=YS&JG[Q92"&(Z#/6K1 /4
MY]J4*%XQQQT]^31=]V!2,$,8'EP1(O.TK"@D)ZLW RJ[N@SSGM3BF_CE5[9;
M^,='V=%[G(Y]N:MD#TX[9%)@>@_*E<"J457!$<1;<@$A17(0$Y/*YW^ISWIH
MC0-YA1/E<&,)$%?<?O2-CJ!V!S_(5<P!T _*C /. ?P% $//*C=\JG:_48/+
M?[CMD@]>![5#Y* J8XH]_+!]JH5!X*NX'SYR?O#@<\5=QCH,?A1TZ"@"!5 4
MA QP2NUN5#=3USF//3BF>4HP%@A1F.Z0QJBL<8XR$!/J.]6J/?'- %7R]H//
M.?OA=K8[C(SOW<>_&?6FF&')+06[;NC^2C..!][*GT SNXJY10!49<J X9TY
M)PWS9!^52!@.!V/'ITXH$<1R7C1W0KN=H8R9<'*A6*DDKT+?A5K ]!^5&!Z#
M\J+@5T+JZY^< [VY"JN3T4 ?,57[J\#=^GY-_P#!-?\ 8Y^,W[+?C;]J[6_B
MPOAE],^,?QC\1^./!J:'J7]IN^AZE?W5U:-JL+Q1BRO#%.HFA!?:^X$FOULP
M/0?E1@>@_*G=]V!4"J 0(E01@/$L>U S=PVU1TZ >GYT%%PRLD<RME]DD:N%
M8X*@;A\Q3HHXXSTZU;X/8']:7&.@Q^%("D%5#A8U53@O'%&JHYZANF 1W3&#
MUI5BB#-((8EE;YF=8T4R=?E=@N01@=\GC.15RB@"@\>Y7$BJY8;1^[611&3]
MW:W"L#SNZCTIZIL&$54P 45%!0<#J!@9W=?8U;P/0?E1@#H!^5 %-H RA&CW
M;CN5I%24+)CYBRL#B-NR@^W?AZPH 5$810 -L:+&D@"Y/RJ!LRX'3/7BK5%
M#(UVHORA2>2H.<'W-/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH <.A_WH_P#T,44#
MH?\ >C_]#%% #>P_W5_]!%%'8?[J_P#H(HH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,XY]
M.3GT')_/&*P_$.MVGAS1=7U^_E6*PT?3+O59V<A2(;."2XE5B2 -R(=@ZDX
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MGS=/F[5S/BKQ3X=\(:)?^)/$VKV>BZ+IMM)=W=]J$R6T,<,:Y<[Y&4%QM8!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<_&3X;?%6QBN_!7BC3=4GD5);C2_M"V^KVV1N*SZ?*4GW1\APL90$<''%>J
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *0\*2>F0#_P ".*6F29PO]TL
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MHY& 1\JXP44G(CXXPH&![?C5B@ HHHH **** "F-&K,&(^8< CCCT/J*?10
MTHI()49'3V^GI^'UZU5N;:.>&2">*.>&4%)8YE62.9&&#'*K [T*\%2,5<I&
M&010!\<_$W]CSP!XPUFW\8>#+[4?A5X]MW,T.O\ A&9[&"8J<@7EI#LBFC)Q
MO5@0P)'I7FMI\7?VD_@!J<VE_&?P@WQ2^'<"9M/B'X-MF.N6EM&#B75M+3$4
MBA 6GF0M)P3R2:_0PHQ "G#+T9OFR&^^NWL/[OTYZU ]JLB2PS(EQ;2(T3P3
M*LB21N,$,C @ #C;R&R?:@#ROX4_'3X8_&S1(]=^&_BO3M;M_,>"YL2YM=7L
M+J(8EM[K3+H0WBO$V5<B$KD':S8Y]8,V"OS %CP&!"$+RQ9C@J1@X!]J^0/B
MC^QE\/?&EQ<>(O!%]JOPD^(#2?:;3Q?X(NGTJX^V(=ZF[MX,0SP2O@3Q,/G4
M8)YKRV?XR_M*?LX)96'QN\%R_&+P!')';'XD^ +$-KUA;Q817UKPY$=D@VJ'
MN;[S-['<VPYH _1G)/.,>W7Z<^_7\:*\K^&7QL^%_P 7[ 7OP_\ %VEZY)&B
M&\TM)EM]8TURFXP7VEW'E7<,D0RLA$31AE/SG(KU!I%7=NR IP21Q]1W(['C
M(/44 244P2*2,'@\!OX2?[H/7/X8SWI] 'SO\>OVH?@_^S1I_AS5?C!XD7PU
MIWBG55T?2;IT#Q2W;R1QYF)P8XXVDCWOR '!(/0>Y:-K%CK^EZ?K6D7=MJ&E
M:K96M_I]]:2I-!<V]V@EADA=&97!1E)YK\*O^"W?P_L?BI9_LK_#;4IY+.T\
M:_%";P^U[ Q26V:_6 1RQNI_Y9R)&Q3&#W(Q79_\$TOCCXP^$7C_ ,3?\$]_
MC]=LWQ ^&L/]H?##Q%>N8_\ A,O SJDEB(#*0D\UM V%,3/)*<KMR*V25EHM
MD]K@?J?X%^/GPX^)'Q)^*'PG\*ZP+WQI\'KRRL/'6FA<?V;<:A"L]H ^26\Q
M'5B,# XP>]+]I2S:_P#@1\4K1<EG\*:H4"\D%;64^F3@C^M?FA^P6 O_  4A
M_P""H_"^:?'?@\J>26C_ +)LCAO;=P.F.PXS7ZL?&" 77PO^($8 #R>%-9PA
M'R$_8IN#QUR.!CIVK/[2T_E\][ ?'NK_ +=_[.O[-WPU^#6F?%3Q9)H][KG@
M'0#IT4-M]HDG&G:=:V<^(T.[Y94()'.>O.:P_#W_  5G_8B\2:S9:''\5(M*
MGU&:.WM[S6+22PMO.F<)&AE=2 6) ]J_)*#0?#7Q?_:7_82TSQIH]AXFT"[\
M.^,+&\T[4H%F@F&GZY/;>6RL2"J[#@8X _+]EOC5_P $X_V2_B9\/O%'AP?"
M7PSH.H2Z-?OH^MZ18I9WVF7\5M)+;75M+'AU:.<*<\' .#P13E%W=EIY =%\
M>?$6B?\ "Q?V<O'>GZA9ZKH5YK+V-A?6<JS6]T-3"O;S031;@P8;2,G'7/.:
M^UFG\N.2:3Y(XXGFD9OX5CB\QS@9SA!^E?R[?LJ_$7Q/9?"G0_A-XMU:^U/4
M/@;^TS9>%K#5[RZDG0>'VNIEM!-,^2 D:!0#TX'U_IZO'1]&NI8G#B;2)V$B
MG@J=/D(<'N3P>1[U/++L_P"O^'_JS \$^"7[67P4_:$U?QAX?^&'BRTUS7?
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M6\'Z/9:/I5C"J*EK$J/-*  TT[ !I)G8%WE8EF)Y%=GY;A0,@MG)/W1[8'0
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M+"#:"?FV 87(!( X&:^N_P#@M^RQ_P#!-#]H1BR@#3=(50Q !W:M;!V&XX7
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M.\)_M*_M'?\ !2']ICX#?#KXJ:[X'\!7TZW'CO7+>[G>XTWP_%<D+9:-%O\
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MP2HU%8V3RU\(_%\*T;A@1_96JY8D$@L#WW<?C7Y6_LT_!'Q)\?O^"&'C/1/
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MWBEM[N6W-[<7=O;(BW.QAYH1W#R!OO8Y.":^@O\ @O$ZQ_LB^"R\BIN^.O@
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M;\?>+1\9?%?ASPIXQ\8ZO-=ZK-X+L+HE-6U>QP9&MFF!:43MLCC"XW#->4^
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MRF65#D$=:^R_^"X\B+^PCK&XH=GC3PDK1LXC5L7&6#%L!67(X'<X&<U^</\
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MN?MB_M5?!G]I@ZGX#\*?%CQFOB'P/X_U*QN(_#DUO!-<.EQ>:B$:&&&Y6ZD
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M8'%?>W_!"C4OBQJ'P0^)+>,K[Q3J/PZ@\:W-M\++WQA'=1ZK=:)!+,L$R+>
M3"!K80$ @+O)(SS2:5GI]RU^7]>0'[JT445B 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 X=#_O1_^ABB@=#_ +T?_H8HH ;V'^ZO_H(H
MH[#_ '5_]!%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %032PPQRS3NL<,$3RS2$X\N-%+-(_HB!
M2V?KZ4^0'.[)&WC X]OQKY]_:?\ &-WX)^"7CO5].9VU6?1Y]*TR*)@DS7>H
M(T$31DG+.K-E5 +$YQS2D^6-[7?*FX]K]+Z_?8+KW7?W&X\TNW,[/3JU_P
M\,_9>T6S\9_%WX\?'J207EQJ>M#P-X?N#A[?^Q=+D\YKFR?D!GN5:-]O) QQ
MTK[TB4^4JG()Y)] ?;Z=>>:^>?V6OAA;_"#X%^ O!JL]S>KI4>M:M?2L6GNM
M2UXMJUS)<,V6,D;W?V;D\>6, 9P/HE?NC_/>J<6G:\;:6O+=.VNB?5VWZ W%
M-^\[7T:6Z[[Z>@[Z=****5O.'_@7IY>?]70)P?VGK_=_X/\ 7W7****=GWC_
M .!>GEZ_=YCO#^?\/^#_ %;T"BBBBS[Q_P# O3RUW_#S%>'\_P"'IY_U9A11
M119]X_\ @7IY>OW>8[P_F_#T\_/^M HHHHL^\?\ P+T\O7[O,+P_F_#T\_Z^
MX****+/O'_P+T\O-^MA7A_/^'IY_U9A11119]X_^!>GEYO[O,+P_G_#_ (/]
M6] HHHHL^\?_  +T\O7[O,=X_P WX>GGY_UI<J,*RG<,'!R!G&?TJ2C /!P
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MR_%#XVSI;:;8^&=(W2Z'X+TT[+>+4/&.H(SPZ99V*;72VE837*Q[%96.:M_
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M#_5O0=X?S?AZ>?\ 7W!11119=W]W_!_JWH*\/Y_P]//^K,****++N_N_X/\
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M0%[IR9)2S')KU_\ #KUI,#T'Y4K2[/[F%U_?Z?9]//S_ *TO\B^-OV%/V/\
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M05[^N1=_L^?!?4?BU9_'6_\ AOX>N/C!I]DNGV/Q"EM6_P"$AM[-(C"MI:7
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M.?#>@?$SQU*\_C'QI8VK6VM>(G=0C3W\Q=@Y94120@W[0,#%>X48]OTH]_\
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MHEGH,/AN/2[!=!M[!=/MM'^S1RV":;%$+=+58)1(NP1D*%(/YUT5%/FEW?\
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M*.P_W5_]!%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"%&A^#_EMI?S_%B_XJ \$?]"/']/M/R_Z=_P##_,_NO_X6W\,/^A]\*_\
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MCL/_ $$O$O\ X4VL_P#R927T:>(-/^%*AWVC_<WUW?Z_>E^T"X'TMD./_P#
ME_=_Z=_\/\V?W7_\+;^&'_0^^%?_  <V7_QVC_A;?PP_Z'WPK_X.;+_X[7\*
M'_".P_\ 02\2_P#A3:S_ /)E+_PCL/\ T$O$O_A3:U_\FTU]&GB'3_A2H;+I
M';W?/9V_$?\ Q4"X(_Z$>/\ _ ^NFG\/?^NK/[KO^%M_##_H??"O_@YLO_CM
M'_"V_AA_T/OA7_P<V7_QVOX4/^$=A_Z"7B7_ ,*;6?\ Y,H_X1R'_H)^)?\
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MJ[^7X_>?\5 N"/\ H1X__P #_P /_3O^OF?W7_\ "V_AA_T/OA7_ ,'-E_\
M':/^%M_##_H??"O_ (.;+_X[7\*/_".P_P#02\2_^%-K7_R;2?\ ".P_]!+Q
M+_X4VL__ "91_P 2T\0Z?\*5#R^'7X;]?+\0_P"*@7!'_0CQ_2_O[;;_ +O_
M (?YL_NO_P"%M_##_H??"O\ X.;+_P".T?\ "V_AA_T/OA7_ ,'-E_\ ':_A
M0_X1R'_H)^)?_"FUG_Y,H_X1V'_H)>)?_"FUG_Y,I?\ $M/$&G_"E0];1MIR
M^?E^/WK_ (J!<$?]"+,+_P"/_#_<_P"'^;/[K_\ A;?PP_Z'WPK_ .#FR_\
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M[?K2_P"(;9G_ ,_Z?W^GG_7S8?\ %0?@?ID6._\  O\ #_T[]/OZ:6_T#O\
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MKWQ%\%>&;O[!XB\5Z#HMVR><D&HZC;VDQB]1%*ZNV.<X].^160GQK^$K ?\
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M )B:?2VO33R_J_WI?29X>_Z%M?=?:E_<_N[G^J%_PNGX2?\ 11?"7_@YLO\
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M^#FS_P#CO;_]5)_PNGX3_P#11?"'_@YL_P#X]7^5\?BI\4!M)^(7B_YAD?\
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M635JL:=+*,7*I*W+"G*[=FK^[R.]G9?CJ?ZF9^-/PE'_ #4;P@".QUJSZ?\
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MLO[ME\/I^/R_U0O^%T_"3_HHOA+_ ,'-E_\ 'J/^%T_"3_HHOA+_ ,'-E_\
M'J_RO?\ A:GQ*_Z*#XO_ /!_JG_R31_PM3XE?]%!\7_^#_5/_DFC_B#F=_\
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M?_#?)C_L_'?] .)_\)ZWEY>OW>8M%)M?U/\ WS1M?U/_ 'S1];P__052_P#
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MK\:/!&M:-9:(WC6/PEJ::E(MO;:)&K[;K5[^Y=E5;.W4AV9F"Y/7UY;XT_\
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M\2_!'QJ7PE8R:IXO\.>%M0M[G6=-MX5+2M;V]O,\LT4$>2S!2/EY.<U]Y_\
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M*3D^$\IN]7;#05WIJ[+R_,_G4_X<-C_HXOQ-_P!^5_\ BJ/^'#8_Z.+\3?\
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M_P!'%^)O^_*__%5_17@>@_*C ]!^5'^O?%7_ $.L;T_Y>R_N_P![R?W^H?\
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MGZ6/UG@S,,7X?X&66\(XBID&"G/VDL-E_P"YI2G:*;<8<L;M*VJ:Z[G\TGQ
M_P"#=_PI\4V@/CWXYZ[X@-M'Y<37ELCLJG!*J2W +_-C%>7C_@UW^!2\+\2K
MTDMG<;)"=I'*_>R/8C.,5_55@^B?E1\P(^5>>X'3BO9R:K5X>R_#Y5E$Y8#
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M\Q>*7@QFW&7$4LUP>+A2IRIQ2YTG>[NTO3SU/XH05 QN!]_\_P"?PI">?O\
M7T ^O-?VPC_@VI^!(Z_%+7OPL_\ [.C_ (AJO@7G_DJ>NX_Z\S_\6:^O_P"(
MP91_T#5$N]GIMK^%_FS\R?T:.('_ ,S"C?3H_+_@_@?Q/Y'7?^GOC^[^/THR
M/[_KV_\ L>_:O[8/^(:KX&?]%2US_P  O_LJ/^(:KX&?]%2US_P"_P#LJ?\
MQ%[)=-*G3['^'^YZ^M_-!_Q+1Q!_T,,-_P"3^7]SU_ _B?R/[_KV_P#L>_:@
MD#^/\A_]C7]L'_$-5\#/^BI:Y_X!?_94?\0U7P,_Z*EKG_@%_P#94?\ $7LE
MTTJ=/^7?^'^[_P /\T'_ !+1Q!_T,,-Y_%Y?W/7^MOXG\@?Q_P"<9_N_A]:,
MC&=_Z<],_P!W\/K7]L'_ !#5? S_ **EKG_@%_\ 94?\0U7P,_Z*EKG_ (!?
M_94?\1>R732IT_Y=_P"'^[_P_P T'_$M'$'_ $,,-Y_%Y?W/7\#^)\$'^/\
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M?(_B=)!499<GL>#U[CM_C4+E0C<D_*P; R1QZ'&<'\>@K^V8_P#!M3\"B?\
MDJ6N_C9\_H](?^#:CX%X./BCKF[^%OLA#*>Q4[C@Y]CQFI_XB_DMO@K/2UN5
M:W2^_?UVMN73^C5Q#&<7]?H:23VOK%W6Z_ _G/\ B9^U3\*O%7_!,;X)?LL:
M7=:PWQ3\"_%;6_&FO02V(BT=-$OKKS8)8[T2;GG=, P!.N[+'.!^??P\\?\
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M+*6'Q#X:BM7>--KEGMC<6VW<<"1>37]#!_X-I_@:X#?\+6UUFW[E9[,\,I(
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M56<JDY.-W)MIO[+>OE?SL?Q/[L]7 Z#A<=3]#^-&1G&_]..N/[OX_2O[8/\
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MABB@!O8?[J_^@BBCL/\ =7_T$44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110%D][^5O^'78****-]!I0337-I_
MP//R_+L%%%% M;^5OQ"BBBB[8!1110 4444 %%%% [OS_K_AE]P4444""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+FENMK+T].BL-:+ELFGNVE?I;3;Y/[Q, = /RI:**8;:+9:+T"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!PZ'_>C_\ 0Q10.A_WH_\ T,44 -[#_=7_ -!%%'8?[J_^
M@BB@ HHHH **** "BBB@ HHHH ***,T %%&:* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHIV?9_=_7=?> 4444@"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **,T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P".#_&CD?E_7R#G7G_7]?AZ'T5EO5?^^1_C1EO5?^^1_C7SK_PL/7O^>_\
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MY_U_7X>A]%9;U7_OD?XT9;U7_OD?XU\Z_P#"P]>_Y[_^.#_&C_A8>O?\]_\
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MZ_#T/HK+>J_]\C_&C+>J_P#?(_QKYU_X6'KW_/?_ ,<'^-'_  L/7O\ GO\
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M_KY!SKS_ *_K\/0^BLMZK_WR/\:,MZK_ -\C_&OG7_A8>O?\]_\ QP?XT?\
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M.#_&CD?E_7R#G7G_ %_7X>A]%9;U7_OD?XT9;U7_ +Y'^-?.O_"P]>_Y[_\
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MP&:3Y %1>58G@ 9)K^R>6..1=KHLBL"KAE5D9",;&4C:RGG*L",=NE9B>']
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M 3_LJ^&_VK/$FGWN@^$]?LYIXM+=3<7<,XN!;QPNT89"SR%0/PKY-^%?Q?\
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M%Y4*(L,,8P(XU4<,BKD @ <^_:OC_P#X* ?%O7?@;^QM\>_BCX8$O_"1^%?
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M " 6*D)R/[QXZ]\X[9YI%9VX R02#]1USS^O3G'>ORA_;+^/?QL^!.L_"/\
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MKZ]#P HHHH;3VV_X !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5CT /7%?U:_#3X:70G;QCXRW7VNWF)H89?G2TW?,@VMD=#STQCFOH,;WY8D
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M;%MYE^<D8J$!^E?B[]H[X"_#[7[GPOXZ^+/@[PMX@M! \^D:SJ(M+Z!+A#)
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MAM\_T1G4Z?/]!]5KB"&[AN;2Y3=:W=O/:7"X^_!<1-#,I]=\;LH^M6::ZNP
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M*[<BOK90V\D@\LQ]>N<?-T/U[T$NVEG?N3G.<'!X7D=.G3\.AI***!!1110
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M%UX4N28-2USPS"FHMH7G$(MY,T2AH%3(9I""!WKU70]W_#[?QB-C?\B)X?\
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M(I<I_P ]H/7_ (^(/_CE?S0G]G__ (*2%?\ 6^+/-?K_ ,546V8;G#@;<MZ
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M5AB5;;S$.#@!G..ISB@#^@AHI5Y=95&,YV,HQCKD\< <TT;"!G)&0,_Q989
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M!\01Z6]K?OG<;^V"B9-X)V2.=I_A !K:S5M7IZ>7EY ?W,HR[V FMRG4'[3
M,@^H\WAN@-6-H_YZV_\ X$V__P =K^.Y?V:O^"N"G:J?$- J@*O_  E3@ #&
M,94ELC'S=^U3']FW_@KCC_FHH'3(\5NWX8VTG&_VFEUM;R_/]0/["]H_YZV_
M_@3;_P#QVFMM4'][;DXR!]IM_P#X[7\>O_#-O_!7'^]\1O\ PJ7_ ,*1_P!F
MK_@KF<$/\12!UQXJ?C./]G_.*7)'N_P\OZ^[OH'].7[3O[4_PS_94\!3>.OB
M)=M(78P:5HEA+')?:K<;2RQQ%';RE8_+YA''O7Y)>#?^"\WP\U?Q@NE>+_@]
MJWASPS=726T>N0ZRM]=65O))L6ZN;=(T,F5(++D>6,DYQ7XD_M1?"C]L[P!I
M>BZC^TW#XMDTN61HM&GUG5)=3M8IG&&#G'EQ *=RE@#GOR!7QC)''Y>S)8+"
MRJV\-O\ ,ZE@,.6!.(^ISC%5)T8TW4JU8*%.W+4:5J4TDVFVK*VC<G96>_5Z
M1C)V=DG*5J/+JW/17=M;_B?Z*'@CQQX<^(GA/1/&OA.^BU+PYXALX+NPNEP[
MRQRJKQ[@#E)4W*'YR#Q]>6^)OPTM?&,(O;-O[/\ $-@OGVM[$/+:21/G2.1U
MQO)QP3G'2OC#_@E)IOBS2?V._ T7B[S//E>:72Q.6>2'2I&'V5B&^[O0KA<<
M5^E>TX"9PQ.%+<\KP<GV_P#U"OAN+^$,FX_RC%Y9F2PV+PM:G4>'Q-'V;J87
M%.*5/$4:T?>C*G)*7N-6:9[.4YWC\AS&GC*4:L)4$GB5.+]G6@VN>$XNW/&4
M;I)IV?GMX;\)/'&M:C>7?@SQ7I\\&MZ/$1]K:,JEU$GW'W=&) Y;@'KQBO<U
M=CR?N.<KCN4X].<_YQ5&&QM5OFU$6D"WY4PM<(@5G3D'<1R?;![],YJ^""0&
M&&5N% ['^+CL,_XGC-<WAWPOG/".04,AS3-O[9GA*DU1QCNYK!-MT*<I223E
M"+C"4KW>S;U->(LQP6<YA#,\#AH8"%>%WAJ;?).JU[]11G=13U[)7V[RT445
M]V?.A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !6QH'_(8T_\ Z^$_G6/6
MQX?S_;.GX_Y^$_G05'XH_P");^I]3CH/H/Y4M(.@^@_E2USFP4444 %%%% !
M1110 4444 .'0_[T?_H8HH'0_P"]'_Z&** &]A_NK_Z"**.P_P!U?_0110 4
M444 %%%% !1110 4AZ?B/YBEI#T_$?S% '#?$+_D7Y?^NBU\[#[Y^G^%?1/Q
M"_Y%^7_KHM?.P^^?I_A6L-OG^B,ZG3Y_H/I02.E)15F8A'&!CCID _ASTJ+Y
M\2+\VV; E'.) .@;U'L>,<8Q4U% '/W7ACPS>,)KOPMX9NIU.5FN?#^DSS@K
M@@^;+:-(3GN6//)K2M8(;./R[6W@LX\;/+M(8K:/;C&/+MUC0#'  '85>I,#
MT'Y4 1)D;0!\JY '9<\G&>!].]34G3H!2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'H<_Y]/UI:#T/?
M@\8ZXST^O;I@TU-1A4GJN1ZR7?336ROJMK_>@O*^JYHV>G:UK]M=[?D0$Y)]
MZCF(C5V:18E1-[LQQ%'$!EGW$D;L#H>G3'>FRNL<+32,(HX_FE9SCRP,?>/0
M8Z\?7IBOF;QSXVU;QSJR> O WFM;F1H]8U6$GRT3<!*JNOS<#=U. ,GH,5^5
M^)OB5E_!650I4Z,<TXES&:HY-E5.*>*GB'RN,W&'O*,+\TN:R:6Y]=POPO6S
MRK.MKA<NIQ4\=C)KDITZ/VO>=GS.UE;=[,9XY\;:MX^U=_A_\/W81N?)UG6
M&V^6?EE2-U[%-R2 'D'!]ODGXD?\$>_V3OB;JO\ PD^L1>*O"NNW2B369_!]
MS8VMOJE^YW2S2VUTK*OF/DOY**6Y/7)'Z->!_ >D^!=&BM[1?,O)\?:;T)NG
MD?@ON<_. #G))Z=^:[U'^ZS!4,6Z)=V CC^(AI.I&?O#/H.:^;\)N$\_PN*Q
MW&W&^9XB>>YS%36"E-PP^649J,J=&--R4.;EY8R:5[N7H_6XJS3+\53PW#_#
MN Y\!@?<I8NG#GKXJ<5^\G.23ERWNUS.UET/FG]F?]DOX+_LF:#=^'_@_H+Z
M;+JQ277?$&H_OM;U<Q\HMQ=+D*H;)$496)3_  5]/I-,.DDX SC?(Q8#GC(/
M/MCH*A!&U02Q923*&*\C/"IC)/MBI <Y_ \>A&1^/K7[Q!<\>>$HRCW4H^7G
MYW/SZ<)TY2C4BX2B[2C+1I^:>I-Y\^?];+CU\Q_Y9H\^?_GM+_W\?_&HN^/Q
MHJ4T]OZL2TUNM_\ A_U'-=7+#'F38_WW->3_ !8^#_@+XWZ/IWACXH:2_B3P
MQ8W\>J2:'<3W*65U=VSA[:2X6&1/,\LCA)"R$9#*<UZH"<9.#] ?\_I32RJ2
MQ?;N( /4=/XAV^O?/M6D-WY+7RV&H2E\*;]/Z\_ZLSF_"OA7PUX)TRVT;P?X
M=TGPUI-JBPVEIHNGVEA&L42A5$OV6&-I7VCYC*6).<YKH=I)R03\V[G)Y]?_
M *W2GK\KL"-HQG:.0,9 (&><^W SSBI< _=(/&<9&?IC)YJ6K1C+I+X7W_K_
M #)WOY.SZ?GZ]!N.".Q.2/4TXD_Y_IZ4E%/EEV_(=G>UM=[?=_FO0****D04
M444 ')X !/8$X!]B>V:_!#_@K[XHOO GQF_8_P#%UEX<U3Q?>^'O&=QJ]KX6
MT;8VH:RUK%'(NGV(VLOVFX93&B[3R>G6OWM89!&,YX SC)/09R,?F*_$W_@I
MK#=-^TW^PU/8PW+K:?$B$M/;1221Q<P_O)&P=N#E3N(7 H O7O\ P5&^.=W:
M36VB?\$]OV@[/6KB)H]'NM3M8YM/MKZ6,K!]N\BT#M:*Q5W$9#*N1D5D?LH_
ML_\ [0.DZE\??VP_C]HT7A_XG^.?"FIGP]X6LRSR:1"EG/Y),8&^(QQ$1M#)
M^\W GI7[DMJ%\0A%Y<Y*JV?-D4<KG*C=QDGGVZ>E9-]&MY;WEK-\RWMO<6T@
M;,@9+F%HI3(K9+DAR0!D ]>E 'XS?\$9]+TV;X:?&;QA=.DOBO5/BKKRZO*R
MJMX':YG;RY&<>:4&2 A.T=AWK]DK^"TO;*[L;V".]LKZVDBN+:[42V\]M.")
MXI(\%&AP?WBL"#UQ@5_/Q9ZY\7/^"8WQ^^(6I7WP]U_QO^SO\3=<EUXZIX?M
MS<MH5[=R,9WN(T1XHP@<OM&'POK7LOQ8_P""KGAKX@^%KWP/^ROX+\:?$'XE
M^)+1])MV.B7UA;>'KJ_C\AFN&EMT8_9M['S(SY?&[.<4&J;LN76R5^EOO^9^
MK&I>'_"7A?X8^+M*\':-H6C:3!X:U]XK+1;:UM+07$ME.99Y5LXT5YPQ)8R9
M<D\GM7\['["OQ$_X*)^%/A7XTLOV8?@Y\+/'/PT3XG>-+R?5_%^H7-GK!U5;
MZ5K^V6-)HPT:J$^S #+,<#DU^NW[)/P3\>?!C]EOQ3!\3M>U?7_'_C#1/$?B
M37HM2N[B_;1Y]4LYIWTBU^T/*$C@R$0+MQR*\C_X([I=P?LU>-XI8;FVE;XT
M>-W198V1\?;F*.5F 4,N<K@;7SQTH!N5G>/XVZ?U^1^;^I?M _M]?M_>(_%'
M[(_BRT^&/P0FAN;>V\8Z0HO-&UJ]@@N"LSVECJTGVO5(8T_>2M8C;+$5(R#Q
M_1#\!OA%I7P+^$G@7X1Z-<-<VO@S1;>P^VE<+=7ZHIOKM%Y8*TQD:))"2$(!
MR:_-C_@J)^S3KMY8Z!^V+\%B^F?&?X+W5K?ZH=.MY%NO%GA^SD66Y2ZDME#R
M_9$4O,K;C.A$9R@ K[L_9"_:+TC]ISX(>$?B3:!K+69+2*V\5:8\1BN;7Q!'
M L5Q$T;@%4D96F("@X;'7B@R/J+L.6)QRS?Q' Y'IGT_+BBCT)Y)'S-S@D>@
M[8Z&B@ HHHH ***!1>VKV6X?AY^?3\1K$!",9!X[D]/S[=!CVJE<Q17=NUM=
M6T5Y;RJR^1<PPW=O(F-K+-;W EA(()'S*>*T", D\ >O&<_7']*@./F55P<;
MBH)W,H.-P/0?@>?YZ4VH6E3;HNRENU[MUK9/T?1LTI.K"\^=N45&3ES--*RO
M;9==->YXKX8_9_\ A+X(\?7WQ/\ !OA&Q\'^+-3A^S:S<:$CV-MJ4);)>:RM
MV2R$A;^-8 WS<FO<//F9G(DE4#+<NXSNQQC.!G(SCMQ4.?W@7&/EP!G<"NW.
M>_(..M*I_B9E<G)YS@*.V.N1Q3>+J5IWDYU-%9W4KK3=]EYJQI5Q=:LH\U><
M[I-.4G)\NEKMMW3[7[=B3S+C_GK+_P!_&_\ BJ3?/_STD_[^-_\ %4N0.N?R
M/^%&1[_D?\*U5[/D?+)*^MNEK_/^NFO,IRB[RJ5)JZ3BM7TU^6GW^8HN900'
MFD&3C.YSSV4[3D XQN!!&:X3XC_#_P )_%;P?K/@+Q[I-MXB\+:[#Y.IZ=?I
MYT)CQ\K0*^6$J'E)$Q(I^964\UVRY+<YR>!P.6Z <\<]*7YLAMJ2!6QNW $,
M/F( [X((],YK*EBU2<JD*N)IU(O6<9)05K:WYK?EL=-#&U\+76)PU24(1LY3
MI-J4=F[MVU6G7[C\CK3_ ((M_L:6OB#_ (2 IXVN+87(ND\-W-Y;KH<4:N'6
MW(XNVC!"X!D+%/O9SS]/:+H-S^S+-9:/H-B3\+&*I:6-I$4@TV$,$5$4#'"X
M9V!Y()8GFOM-3YK,O23EWR5. O16!)3#<' Q_*LK5=-L=?LKBPU&W6XLYU9)
M4F0-Y6X$%XQT]QM'U.:_,/%[(.)..LIP.9Y-Q#BZ>?9!?%Y=^_:I3<+.5"I3
MC.2G%Q2B^=>=GH??9#Q]7J5*F"S^I',<NQBIPJ45)2J>SC)7JQ2?NN$5?IMO
M?0CT/6-/UVQMM3TNY2>RNHQ)%@@R*2H/EN <+M..O?\ "MGS,C(]<;3C/;TZ
M''K^=?(KQ:Y\#]?,L+3W_@G4KC)8;V^PI(2-PR"JJIQZ?A7U%HNLZ9KVG6NI
MV%RD]M<QJ?,0AMCD9V.%SANOI^M?/>%WBDN)WBN'^)(?V3Q?EE)4<7@<7"%*
M&*=-*/UG".5E-55&Z:^U+9G+Q-PO5RVC'.<FDL3DF,;E2J17//#W>M.K%7E&
M4&VNUK&RR@\]#CIG@9Z9Z^GUZTX!1]TYZ9_+_'/]*B4YY<\\=NI]_P#/Y5(N
M.<=\?Y__ %U^VI^UI4O<452C?WTN>^BNFKKTUNDNA\,DFI\RM.*34^D[\NGR
M70=1114D!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !^'\_P"E03Y*[<!E;@JPRI'.<CN/4=#T
M/6IZ/\] ?Y@T 8-IHFBZ;)<3Z9H.@Z7<7AW7MQIFCV.GW%ZW4F[GL[>&6X8G
MDM.SDGJ:NW5E9WT365]I]E?V3C$EEJ%K#?6<N1UDMKM)87/H60[?:M'Z$^^5
M7].#_2B@#E;#PAX1TB87.D>"O!>E72M\MYIGA70].O$4_-A;BSL89P W(P_W
MOFZ\UNNB.TBR()$D4AHYHUFAD5P-Z2I(K)(K@D%7#!@3D<U=P.?E!/J12CI@
M].X ']??% ',:=X8\+Z/=37FC>$_"^A7MPA2YO=#\/:3H]W<(S;V6>YTZTMY
M9E=_G=7<AG^8C.:Z4$D9/)*@$^W&![8XZ8Z4N!T(X^E'TZ=J ,.+0=$M]1GU
M6VT+1+;5IQMN-6M]'T^'5+E?[MQ?Q6ZW4PQP!+*XQTK:7/)/?C&!T/7CH/R&
M,<4ZB@!" 01ZX_,="/0CU&#4,MO#<0M;W4%O=6\@VR6UW!%<P2+D_+)%,KQN
M#DY#*0<\U/10!QX\"^ X)1/'\/\ P&LR/NCN$\&>'$N8Y,[O,2Y73A,KYYW!
MP03G.:Z3)P$2-414$:1HFQ(XQ@A$5=H101T4"KE% &(NA:*FHG6$T+1$UEE"
M-K::/IZZT\:@JL3ZN+?[>\0!($;3E .,5L*N,Y Y&/ZXZ\8/3&/:GT4 8.J^
M'?#>MRPS:YX:\.ZW-:L6M9M9T/3-4FMV)^]!+?6L\D1X&#&RXQ\N*UH(XX42
M&&&**&-=D<4421QQ(!@)&B*%1 !A5   X %3X!Z@?E1C'0 ?A0 M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA97/<UO44 *2<_,23T^;&?8<<8 Z8[5$\9;+#/R\DJ<.!C^#OGUJ2B@#,O\
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MLZC<::NY1E4G)3^TV^DK)62MI?S'44450PHHHH **** "BBB@ HHHH ****
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M2NHE4\J0H(X/:K]O9VUM MM:VZ6]K'&D5I90HD$4$$1PD44: +&D>,JH &W
M%6Z*?-+NQ&'K'AGP]XD@CM?$7A_1O$=I$1-'9ZY86^H6BR+RLD4%RCHLH. '
MP"",@YZ7K2QM[&"&VL[>"UL[9/W$5I$L<4" 82VBA 5!''P%4#&..V*O447;
MWNP$!R >>@ZC!_$#@'V'2EHHI %%%% ".Z0QO+*1&JC)D<C8J\G)+'  YSD
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M 4444 .'0_[T?_H8HH'0_P"]'_Z&** &]A_NK_Z"**.P_P!U?_0110 4444
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M!TQ_GUI<#K@9^E+6[E)M-O5*R?9+H+FE9QN[/=='ZA1114**C>RM=W?J3Y=
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M?O5?^_T/_P 11_PJ[0?^?O5?^_T/_P 11S+O_7]?UN'L_/\ #_@GA5%>Z_\
M"KM!_P"?O5?^_P!#_P#$4?\ "KM!_P"?O5?^_P!#_P#$4<R[_P!?U_6X>S\_
MP_X)X517NO\ PJ[0?^?O5?\ O]#_ /$4?\*NT'_G[U7_ +_0_P#Q%',N_P#7
M]?UN'L_/\/\ @GA5%>Z_\*NT'_G[U7_O]#_\11_PJ[0?^?O5?^_T/_Q%',N_
M]?U_6X>S\_P_X)X517NO_"KM!_Y^]5_[_0__ !%'_"KM!_Y^]5_[_0__ !%'
M,N_]?U_6X>S\_P /^">%45[K_P *NT'_ )^]5_[_ $/_ ,11_P *NT'_ )^]
M5_[_ $/_ ,11S+O_ %_7];A[/S_#_@GA5(Q.#C([9!"D?B0>O0CN#7NW_"KM
M!_Y^]5_[_0__ !%!^%VA=KO51_VUA/\ [)2YH73:4G'6/,FTF*5.3C93<6FK
M26]M-.OGY:['R1XT\ :3XW-D-7FNEBL)UD2"&79;SD'.V5/XP>_3CC'.*Z_3
M].M--LH].M(!;VD*+&D,*A2"@V@\#IW_ !]*^@S\*M#)S]MU3KG!D@//K]WU
MJ3_A5VA]?MFJ9/4^;#D_7Y:^;PW"G#F&SO$\0T\LPRSC%TXTZV-<+UG&,U-*
M$I7Y8I]$NG:YZM7-LRJX.EESQ=3ZE3?-[%MM<UDF]+:Z7MW]3P9$"XPQ9NCL
M>=P!RH_ =<?GP*EKW0?"[0O^?O5/PEA'_LII?^%7:#_S]ZK_ -_H?_B*^DYE
M=/F]4]4]$O6RW2OH]7>QYG)9II^]]J5M9]KZ]+:?\-;PJBO=?^%7:#_S]ZK_
M -_H?_B*/^%7:#_S]ZK_ -_H?_B*?,N_]?U_6XO9^?X?\$\*HKW7_A5V@_\
M/WJO_?Z'_P"(H_X5=H/_ #]ZK_W^A_\ B*.9=_Z_K^MP]GY_A_P3PJBO=?\
MA5V@_P#/WJO_ '^A_P#B*/\ A5V@_P#/WJO_ '^A_P#B*.9=_P"OZ_K</9^?
MX?\ !/"J*]U_X5=H/_/WJO\ W^A_^(H_X5=H/_/WJO\ W^A_^(HYEW_K^OZW
M#V?G^'_!/"J*]U_X5=H/_/WJO_?Z'_XBC_A5V@_\_>J_]_H?_B*.9=_Z_K^M
MP]GY_A_P3PJBO=?^%7:#_P _>J_]_H?_ (BC_A5V@_\ /WJO_?Z'_P"(HYEW
M_K^OZW#V?G^'_!/"J*]U_P"%7:#_ ,_>J_\ ?Z'_ .(H_P"%7:#_ ,_>J_\
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M?O5?^_T/_P 11_PJ[0?^?O5?^_T/_P 11S+O_7]?UN'L_/\ #_@GA5%>Z_\
M"KM!_P"?O5?^_P!#_P#$4?\ "KM!_P"?O5?^_P!#_P#$4<R[_P!?U_6X>S\_
MP_X)X517NO\ PJ[0?^?O5?\ O]#_ /$4?\*NT'_G[U7_ +_0_P#Q%',N_P#7
M]?UN'L_/\/\ @GA5%>Z_\*NT'_G[U7_O]#_\11_PJ[0?^?O5?^_T/_Q%',N_
M]?U_6X>S\_P_X)X517NO_"KM!_Y^]5_[_0__ !%'_"KM!_Y^]5_[_0__ !%'
M,N_]?U_6X>S\_P /^">%45[K_P *NT'_ )^]5_[_ $/_ ,11_P *NT'_ )^]
M5_[_ $/_ ,11S+O_ %_7];A[/S_#_@GA5%>Z_P#"KM!_Y^]5_P"_T/\ \11_
MPJ[0?^?O5?\ O]#_ /$4<R[_ -?U_6X>S\_P_P"">%45[K_PJ[0?^?O5?^_T
M/_Q%'_"KM!_Y^]5_[_0__$4<R[_U_7];A[/S_#_@GA5%>Z_\*NT'_G[U7_O]
M#_\ $4?\*NT'_G[U7_O]#_\ $4<R[_U_7];A[/S_  _X)X517NO_  J[0?\
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M (BCF7?^OZ_K</9^?X?\$\*HKW7_ (5=H/\ S]ZK_P!_H?\ XBC_ (5=H/\
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M!#;BO]\ *,?<95/SM[XSR>N>U>\CX5Z$  +[5!GMYL/MV$?7USUH'PLT(?\
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M_A5V@_\ /WJO_?Z'_P"(HYEW_K^OZW#V?G^'_!/"J*]U_P"%7:#_ ,_>J_\
M?Z'_ .(H_P"%7:#_ ,_>J_\ ?Z'_ .(HYEW_ *_K^MP]GY_A_P $\*HKW7_A
M5V@_\_>J_P#?Z'_XBC_A5V@_\_>J_P#?Z'_XBCF7?^OZ_K</9^?X?\$\*HKW
M7_A5V@_\_>J_]_H?_B*/^%7:#_S]ZK_W^A_^(HYEW_K^OZW#V?G^'_!/"J*]
MU_X5=H/_ #]ZK_W^A_\ B*/^%7:#_P _>J_]_H?_ (BCF7?^OZ_K</9^?X?\
M$\*HKW7_ (5=H/\ S]ZK_P!_H?\ XBC_ (5=H/\ S]ZK_P!_H?\ XBCF7?\
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M_=7_ -!%% !1110 4444 %%%% !1@9!(SBBB@!,#GJ<^[?X_SS2T44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !112X.,]J $HHHH **** "BBB@ HHHH **** "BB
MEP>#Z_TH 2B@<YQVZ^V:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HI0"<^U)0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12X(_'FDH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBBC7>V@!11G/YXHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHIK5VV\W^@!^'\__
M -5%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@<'.
M3C'-%% "DD__ *A_A2444 %%%% !1110 4444 %%%% #AT/^]'_Z&**!T/\
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M1C:"<<?[3 GG Z'KUIQ< ^ASPKC8%&<<L,Y/U]Z %HIB2*Y=5+94_.2 >O\
MSS/ *GL>HZ]Z-Q^49'\6=HSM Z<_QXZL<@#M0 ^BH1)@!5(8G..IR.<MN/\
M$>"J]/TIP?: #C>>-K=ASRWHQ'\)X&0,T 244P.K#/SJ,GY<#?D=SSC;^GTX
MH#JW][/0G&!UQ\H!P6_*@!]%1>:!G++N7ID?(P[9(S\W]:-RY*#>25+$9RY
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M=7'A;PM$\M[I]C<$+'*Y0.Q#98JQ&0!51CS/RZ@?J,DFXXY_S]*FK\P?@/\
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MM)!&%.6489R,]R2,$=./_KT .H)QUI@=3\^& YYX*@#MMSRW3)Y-&XG=MVD
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MP7$,U[KWC'X6:=XCCM75UL_$5A=36FI6DOWLS1X0R@\YFY'S5IZV\_73^ON
MZW6?^"EG[>?Q ^'9^.W[//[-^EZE\$?#6D6VH^)==\1PR)K?B4I"CZGJ'AO3
MBR,]FD@F$;J6 1!Q@&NI\/?\%4/V@_VH_"&@67[$WP.M_$GQ"T_1FU'XCW?C
M$M:^%_#=_$#'=:5'=/A9KMIHW6&($-N^3@"OTK_9AT;3-._89^%>E6MA;QZ>
MGP+B067D(ELRR:+/)*98\;"9&<L^\$DDGKG/YS_\$"=+L(/V=_C-JUO;0QW]
MW\??'MI<W"1*I:UMM7OC!!NQN>-,GRT!VJ3D"J_=ZVAULO.WY?<![M_P3U_X
M*#^-OVFO%OCGX)?';X?I\//C;\.II!K5A:1F.QO$C=DE>",LVV/:NZ-\G<F"
M:^2_&G_!6[X[Z!^U!\9?V;O"?PIT_P <>*/#^JKHWPRTS2[!UN)YG8I]J\07
M:NRQ6T)P7RBEE!R1UJ]^R=#&G_!8+]I4QH%_XDD[,00IES&V'D48RP[''' /
MOYW^Q=J7P\L_^"OW[5EIXE&GIXRN[R3_ (1.2\:*-RN'\TP&;.^8C[BQX<GI
MSP"U._P]%]_W@>O^#/\ @IU^U/\ !?XN^%/AK^W9\#=.\$:+X^U"VL/#WC/P
MLI.C6TE](L<$4]QO=3-&[(DB-R,GG(X^IOV^OVS_ !E^S5K_ .S-8> -$\,^
M(=+^,7C"UT?4[W6[-+V2WTZZN+=8Y]/D=AY4QCFSNP<,!Z&OG#_@NY=Z ?@I
M\'M!\VTE\>ZC\6?#4GAZ$&,:G):1:G:?:#:E2TJJ&'S$?*<'G@X\A_X*BQ75
MO;?\$X4OPRW:>*O#B7!DR&$@_LTE&!_B7=R3C/6E)4VE:-OR_#\ .Y^)4QNO
M^"Z7P6N)4;?<?L^6%P4CZ;Y;>5BFWN%8GC/(/M7T?^W%_P %*]9^!7Q6TG]F
MC]G[X=WGQ;_:&\26MK=0Z7"C3:1H4%X2()-2"<83K=%BOE+@L*^;_'X/_#\[
MX&'' _9YTH$^A-L^,_7%<-\!IM,TC_@NU^T-;>.3;0:MK'AS6;KP!_:H7=/9
MFSM?*%A-/\L1<^8+<1Y8L"$ )Q4<JTTW5^OEY^8'JG@[_@I5^U5\#OC-X)^$
M_P"WI\%-'\'VGQ,DM;?PQXQ\"">ZT6SDO658X+VZA656N8]V+B%M@BY/2OIO
M]N#_ (*0:=^S9K?AOX3_  J\&W?Q;^/'C>T@N/#7A;2XWE%I8W:+):ZCJ"(,
MB)C(F58C"DL?2O>?VP/C[^R[\!-/\%:K^TG9VVHRZ]X@BTWP;IZ:'#XEUK^U
MYBBB;3[-/])A125$DZ,%51D#(-?D+X/U[PM8?\%IDU+Q^D.F6GBGX;65Y\.3
MXE5+)?LE[;0RZ9' +L;$GVR1!(D(9'PG\-:)4[+W>FO57TN]_N [V\_X*1?M
M]_LZ:CH?B3]L7]G#0K'X4:_+:A]=\#B2>3P_;W4B -K,@9Q!-#&^7C('S*1G
M%?9_[;G[=]]\$/V/-#_:A^"L>D^)+/7M5T1;6+6HA<62Z3J*^9=+)$&0K<11
M@@#=G<0<XKO/^"HFK^#]'_8C^-L_C2>P,%UX<N+72!<M LQUB9'%K]C#EF>7
M.-HC^89!/WA7X?\ QTM-6C_X(;?"-=<9YYIO%^@B"&X#*\EC.\:1HX;EOD5P
MO0=P>10E3M\*6NJU>EN^G7?9W ^H(O\ @I#_ ,%%OB_\.HOBY^SM^S+HES\.
M]&TR.\UO4/$$+B_UQ8$$U_<^';!G1I;?8'*,I*J/7 K](?\ @GS^W!I_[;?P
MQU;Q3<^&Y_"'C7P=J1T#QEH4Q+0VNI0,4=X5.,+,X;]W@;,#DUZ9^R+IUEIO
M['GPML+&TBM;/_A5Z#R(XHPC$Z0X;*HJ@EN=V[.[&#UK\K?^")2^3\0_VT;:
M+$<"_$ZXV(!^[#&YG/SHN%!&2<X'ZUFU%7=EIK:[[_TNH'[G_$N\\:Z=X"\9
M:A\-;&SU/Q]!H-_+X/TW49-ECJ/B)(#]@M+X_P %HTVP,2?E1F;.17\A_P"S
M#XF_;TN?^"D/[1OB3P_\(_ACK_QXGUB.'XLZ1JTL,^B>%[&5+:.Z?P[=29P[
M6JJ=D>"7R,G+9_LQ1LE><D\;@F#P.<G/RD]CWK^?']A_/_#XS_@H9M(7-_;
MKDE61;:VPR+DX8G[Q).>?P(N.MNU^O\ E^5_R I?LDO<?\/?_P!HM[V&."^D
M\&V#7\-L!Y%MJ;:9;-?0?+@>5'=>:D9 P%"X]:]Z_:,_X*-?&4_'/4/V8_V,
M_A##\3/B7X?1'\2Z[K,<\/AC297VCR+J=T6-"#\P82'(^;IQ7B7[,LD4/_!8
M[]J*=FV0P>&YI)VVD9BCME=MQZ$J,D\ G! YK*OOVN?VI/C9^T-\7/"'_!/?
MX&_"^*+P-J!TKQOX_P#%HL-+U#5[I9/(:=;F7;.51U9$#,Q/!%79-[+5]O\
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MX99TK_AFB)K6XBLW21O'J>'%C0+JTMKNWQ036P,_F%?E1UQQQ7WGKG[:FO\
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MM&ZY!3!.:_5#]KC_ (*+>./ 7QGM?V8OV7/A=/\ %KXVW-I%/J\US;W!\.:
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MI>M1VOAFV\,$2V6I::T"3_:YGW-OD3=Y<@&U5*M@"OH;XV_%OPQ\"OA7XO\
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M7A$:EI%. 0.>#61^Q'^S'_P4 ^)G[.?@/Q)\#/\ @HAI?@_P%-:O':>$=/\
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MPQX%M/''ASQE;3/=:9':/=:]=W3J!:06$B." TF-R[&(!ZUX=^W!XST+7/\
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MV?MY_%7]G+PUKG[/_P#P4!TOX;^$$N+JW_X0*T\,)?S>&[H/^_@OW0>:]R2
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MV]_P32O85^SW9^*MQ']JC $X"K 50OC>^S)(+-A!T KF?^"B+V6E_P#!4O\
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MF67^+GFOVE,9)W9P>Q!/\L8SZG&?>CRVP06R&Z\G],#(_.J<Y7TC+II;T_\
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MIVR1V'3/3''':A3>RYK/KK;R_0=GV?W?UW1^$'B__@C1XC\->.O$/B7]D_\
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M3) &Y)XR$CS@9W=/F-?HQC;G: &' ?'/'3MZ\G^M.\LD#<02!_\ JX''/?\
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M[#C&> <KR<@@Y'/7_..E)L)# XPY^;'4_CCC\,9[U7/*][]M/ZU _%;XY?\
M!'_3=:^*FK?&C]EGXX>+OV:O&_B.=YO$UKH;W$_A6^EERYEM])LVC59Y2S-*
M\GF*I'R!<E1Z%^R?_P $L_#7P-^)TOQZ^,WQ.\0_M"_&T(L>E>*_%+SW%AX:
M*#:[:)874DAMKF3)(8*"GS;0*_6?81T. !M')''X=_?K[T%#D$#D#KP.3U..
M.?\ :(W>]+FEW _+_P#;5_X)F^ OVK/%FB?%_P '^+M<^"/Q[\/1106/Q(\)
M33V;:K:1\QP:[';21O>1P9PJ @MPLI88Q^+W_!1__@GQJ'[/'[-=K\:?B_\
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MT&,#MP,"E=]V (NT=*?112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^9]E?/WZ]L8Q^/3^OUH_>?YQ7QM_P\'_ &0_^BS>'/\ O_#WZ4?\/!_V0_\
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M^T57V53DY=/>Y^7ELK[WMZ'W!\O!VD9/!X 'OUQ^G/H::1CJ&S^&,U\-1_\
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M7_1:_"W_ ('K^&>>,]_3CUH_X>%?L=?]%K\+?C?J/Z_@?0<T?5,5_P ^JO\
MX#/R\O-!_K'D=U?.L#_X54/[M_\ EYY_*Q]M@./\@T?O/\XKXC_X>%?L<_\
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M6@X8CJ<=LC_'V_'Z5\2'_@HW^QB1_P ER\'?^#*T[G)_Y:>M!_X*-_L8D?\
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M^=LS][RL[]O(YQ[].:GC)#,#WQCVY/7^M $U%'_ZJ.O Y/6@ HHS1VSV]>U
M!11GI[]/?Z>M'].M !1D>H^O^>:BDW8!4X'U].?ZCFH1/!N\HSPB9@"L)E03
M%<\GRMP<@^NT@]J +?7_ !I,CU'YU""1C!XY[^G7BH9)X8E+RRQ1(.KS2)$@
MZXR\A51D\=>O% %W.>E''8@GT';ZU5CD5P&1PR'D-&X=&'JKKE6S[$T]E)4D
M'W')SU[X[^OO0!/FBJ:2)YGD^?#YV,^3YJ>=M_O&//F;>G.WW]ZMCH.<]L^I
M_P : %HHZ''<]!W-'MW]* "CCU&?3O3')"G'4=<=?_K9J/YN"0P/49SGCZ_G
M0!/135/RC\?YTZ@ HH]^PZT4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% #AT/\ O1_^ABB@=#_O1_\ H8HH ;V'^ZO_ *"**.P_W5_]!%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#*I()&>W
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M)\/C_MR0^_OVX^M?)7_!.T9^#&LG !/C#4SN Y[9_P#U]Z^_ #C!8GWZ&O\
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M\'/#VG1_$'*V5XUUJ6BVEU.FI:J[!RE_>RE)6<C(D93[_EG#-K?[./P5\/\
MPG_:H_8HT[QKX#TF+=%\9/AI ;R:;3X9$8>(]0U.U^='(19E;<<C)R.S@M$_
M._Z?I^@']*/B[XH> ? ?A-O'/B_Q3HFB^$EM1>'6[N^C%K)$Z[XOL4@)%QY@
M(VB/+-_+YR\&?M^?LK?$'Q3:^#O#WQ1TI]<U"40Z;;WAFLDO[DMB*WM&N(XX
MYS(?NA6.>V:_.C]ICXB?L=_$7]G#]G36]5USQYK'@J/4K"3P'\,O#,US<ZMX
MMNM-90ND:S:1L)+BW5\0R"1B& YKX&_;U^)=IXF^'/PV\4>#?V1M0^ 0\+>-
M/#XT+QMJ$']A:PL,=Y#''#%;1JC71DCY+NS-RVYFI0CU\[6]+._]?H!^MWQN
M\<>++'_@J+^S-X0L/$>IP>%-:^&WB2]U+08)V&F:G-'&?*N+B!6V,R@ H<'M
MCI7ZSR%HI"O#"0L1'GY<+\Q9L< 8X [8![5^&/B*_N=2_P""C?[!FK7KRSW-
MY^SW<7%_=R ,\US+HUNY:1C_ !2.26..I)-?N5(OG,>=A!=&4#+?,QSG)&0%
M&XG@ '\:EQUMOL_Z^8'Y1?\ !5?XU>)O#W@?X4_LZ_#;5[W1_B9^TQ\1M#\&
MV.KZ3*RZEX=\/07EM<ZMJ=MY9W1J;=GC\W@* 1GYJJ?\$JOBUXMO/#7Q@_9B
M^+^NW>K_ !9_9W\?:MHD]QJ\[3:OK?A"6ZD_L;6I#(V]ED3RX]XR.5YK\N_V
M@_VK_''C#_@I]<_%3P/\"?&/QX\!_LNV-QX$\.:9X2M9+JRA\4W2;K_5K\H6
M19H69XHN=R>6,' K)^%_[6'CWP=_P4U\-?M#?$CX&^-/V?\ P%\?(K3X<>)S
MXELI;6RU?7)"D>FW'G,Q0LDS1-(6!)&235+WHM=K;_U_PP']+7QA_:,^#OP#
MT^QO?BIXTTSPS_: /V&UN&#7]\ 1DVMO#ON)-G <A #D\U^3OQ7_ &J?#WQ9
M_;L_9+A^"WQ,DUGP7JKWL'B#2]+NI;:VFN S8CU*T8(XD X42)R!QD<BSX6\
M)^&OV@O^"LOQWT/XM6=OXK\.?!OX<^&KSX<>&M6;S=):;6(H9[O4K:R9C%=A
M-[ RA6"MC.0*\U_:!^!GPS^$O_!5/]D_6/AWI%EX:E\5V^H7.K:%I^V#3?M-
MOY@745M@=L;1)N8@!0/6GRQ[/;_+Y_\ #^@'["_&+]J[X!? 74(-+^)GC_3-
M"U6:)9UT="][J&U^?M#VD"22)$@S\Q7^+D'I6W\&_P!I+X-?'ZROK[X5^-],
M\3#3,R:C!;.!>V*XYBFM9-DT8(4_>3@?B*_&GQSX]_9Y\'_M7?%/6_"WPG\>
M_M=_%.]N8=.U@K;3:YX4\$ORATJU9@;:V/59%VL4(Y%>2_L&>*-2M?\ @I[\
M7K&S^&K?!RR\3>#I[V^^'D<S216$J6DKI<26VX1V\SD[B@7/3N*?)'^OS _:
M#7?V]/V7/#MGJ]WJWQ,TB)]$UJX\/:E8+(UQ?0:C9_ZZ(VL*/,"C _-M [9X
MKO\ 1?VG_@KXI^%VO?%_POXXTW7/!OAO3[BZU34+"3[1)IN(VQ'?6J SH^Y2
MNQX]R@=*_&C_ ():?LV_"'X@_%#]KCXH^-]&L?&'B*P^-?BGPY::%K!%]9:=
M9B]=OMD=A(Q3SI"Q1I=F-H !)XKN?@OX,\-?![_@IU^T%\!_ .C6]S\(OB!\
M)H/%WB?P)M-QX=T'6B^YI8K1F:*V-YDCRSM)WE=O0TN6-]GW_+^OG]P>R_\
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M //Q=?\ ?^3TS_>_#ZTVBC^RLK_Z!,'_ ."X_P!WR\E_28?ZPY[_ -#;,/\
MP?4\O[W]?-CO.G_Y^+K_ +_R>F?[WX?7BCSI_P#GXNO^_P#)W&?[WX?6FT4_
M[)RO_H$P?_@N/EY>2#_6'/?^AKF'_@ZIY?WOZ^;'>=/_ ,_%U_W_ ).XS_>_
M#ZTY9[C/%Q<\C/,\F/\ T/K4=*#@@XSBI>5Y;!.4,'A'*-K)4XWZ;*W;\O4'
MQ#GUM,US!^M:I_\ )?U\V.\ZY$D!-U<G]YU^T2\<C@C?UR>.O!Q7]27["GPW
M\$:W^SEX5U36?"^EZE?R.XDO;NW$D\XQR"22<=NO;KS7\M1V[X@ /]:#R,]2
M,=^HZ].Q-?UF?L!$C]F7P:HP2'D 8]1\@Q@CIC/IP17^2/[63&XSAOPKR3$<
M/8RMEE2ICH.L\&Y47JX7]Z#CTNTK[ONS_3;]G'B:F=<6<00S)O%J.%5EBFZJ
MT3V4V[7^[\SZ+_X5)\,\ CP1X> '3-DF1WP>GS=:4?";X:*,?\(/X?Y&?^/%
M,Y&><?A^72O10P9 2?FY;.<%L'&.F?QJ,NV3AFZ=C@C.><]"1R>G;Z5_SF1\
M1..93:AQ-GE6E&,FV\97TC9<]OWFB_"_SM_LY4X=R1TW)Y7@V[_NY0PL+N:C
M&SNDK]-UOHKW/.O^%5?#0G:/ WA]G4Y81V"!47^\?7'<<D].]*OPI^&IR1X)
MT$J,'(T^+GUXSG'ZU\]_M2_$[XU> +WP-'\)_"\GB.'5+Y(M:>.V\U8H6G1#
MO88V_(6SGZX[5Z9:>-/C"UE9S2_#BU$TMO"\H?4=AWLH+AD"':<YX[<=<9K]
M(]CXASX=RKB&KX@/ZGFU.IR86>?5:6+P_LW**56GJU\.EVM4>!%\./&8O!O(
M93Q.'FG4FL%!Q;=.%FG?[[>GIQOQ?\ ^"_#WB/\ 9NU/0?#FF:3?G]I;X=1?
M;;.V$$JVCM=F:/Y#\VX[>"<5_69"@6.!PP(D@MQL(PQ"P1[#GU!)///UK^0+
MXT^+/B;/J?P$^W^!+:S>W_:%\ W>G!+[?]LU&$W7V:Q)VC8)R3D^V<$5_1U'
M\6OVJ?+B'_"@=,QY$.V0>(=P.88\ GRAAB<DKT!..E?[/_0:K9G_ ,0?H?VS
MFTLZKRQL_9U)5Y8MPC=V3J35V^[>UK'\1>.\<''C&E'#X9X:*PJ]WV?L]=+>
MZK*ZU2VV>^Q]H*6P/EZYZ'^?'\\4[+?W?U%?&J_%G]JO;Q\ M*Q_V,/O_P!<
MZ=_PMG]JO_H@.D_^%#_]KK^TS\6/LC+?W?U%&6_N_J*^-_\ A;/[5?\ T0'2
M?_"A_P#M='_"V?VJ_P#H@.D_^%#_ /:Z /LC+?W?U%,9F&>V.W![5\=?\+9_
M:K_Z(#I/_A0__:Z8WQ9_:K/'_"@-+//;Q#_]J- 'V,DF]E3&<GJ1T_S_ (UG
MZFN-.U%N \6G794]>1#(0?T!]L5X'\-O'WQUU[Q1!I_C[X36?A#P^]K<2-K5
MMJPO9EO4 ^S6P@\M<K.2P:3/RXZ5] :G_P @[4T'SO\ V==#9C+,QAD  /?J
M!P.] 'Y,?\$M_&_B_P 9:Q^U3#XK\1:IKD6C?%[5K/2EOY6D73+-9'46]F&)
MVQ;  0.@%:W_  5T\9>+? OP$\$:IX0U_4- U&;XF>&+2>;2IWMKB:TGO[5)
M('D3:3#(APP)ZDX%>8?\$E]7LK;Q]^V+X1N+F*+Q%I_Q=U"^FTR1T6XCM+B=
M_+=8F(=E<D9(! R/QVO^"TFK62?!'X:^'!<Q/K.L?%7PHMCI@F0WDZIJ5HSM
M'"I:9E0\EPF" 1T'-\FMK_.WI?\ .WW@?>6K?M,_!KX/Z!\-=(^*7CFQ\.:U
MXB\':)>VW]HS@279;38&F=G?!D<R;V/4^F:K?#7]MS]FCXM>+T\">"_B7I-_
MXHD=XK72Y2]I+?/$2O\ HGVI(EN,@'B+=G./>OR&_;C^'6A_$O\ ;"_8*\%>
M+;9KK0[CPUHBZK9L7B69K>RA(CDC!!>(%=KJ?O=Q7:?\%//@U\.?A!XJ_9*\
M>?#'PSI?@OQ)8_%70]%^WZ#%_9LESITL\2R+.T)_?EU.&#@YR#ZT^3I?\.UO
M/S ^[-33P3HW[=E]XLO_ (Q:K'XBTOX/7\]W\&4N7?3$T6VC227Q.MB#C[1#
M$I?S ,XR03W^N_A7\6? ?QE\*Q^-/AMK]KXA\./>WVF#4+=Q(#?V4GEW5LYS
M\DD,@*NK<@]:_'2QA34/^"W-FE^&F&J?LA7%O=B0%T>&[LK:*1903M83+(V>
M.">]<-^SI\37_84^*?[?_P  _%%Q_9'A#PEH?B'X]_"FRN9-L;:;J\$LU]'I
MWF,/.C^TRP-&L?S \8&:.3S_  _X('[7>&_CY\+/%6N?$;P]HWBO3KG4/A1*
ML'CPR7$:6F@3%69H[JZ)$22JH)D!?(P!U(!\.L/^"@_[)6J^*#X/L_BQH[:H
MUX;%9V\V#37N@_E^1!J1C^SN7?*H ^"W.:_ GQEX=^(OP=_X)4WOQ:N9[^W^
M)'[7?QGTGQ1XMO\ SIK;4[KPIXJUR9+'3-1NCA[1&LHXA@_\LI$(&.OUAXE^
M"'Q.US]F^#X>:-^POX!T6SC\':?<Z5X^'BU(=3M;J72X98?$;:IY0<S&1Q=$
ME\(Q_,Y/[WX?+OW _;WXG?'+X9_!WP_IWBCXA>*-/\/^'M4EBCL=4N7C-I=&
MX1'A59P2IWJZLKY^;(YQ7F/@_P#;3_9Q\=P^)KOPU\1M.NM/\'VQN_$%]*K6
MUC86N,EQ/,B1RY(PK1&0D' '(K\+?VNO"_Q)M_\ @G#\!?!/QGU.RUCQ/:?$
M/0-$N+[2]9.JPW.F-J4,4,)U2/'GS0V^V)CU.TKFOT%_:?\ V-/"7B+]B[1?
M /PF?PM\-_%M]HOA*ZAU:<Q:2?$]REK:7!TK4KLL#.M]*5C=78[PQ(P230H=
MW=7Z ?5GA/\ X* _LG^-/%%KX1T3XKZ*=:O[A;2PCNA+:VMY</E8XK2[N(HX
MG:4D$;&Z^O6O>?B?\:/AG\&_#T?BCXD^,=)\,:/*/]'FO+A#]ORNX)9Q@F2Y
M<Y&TQH<Y K^=CQ#X]T+X5^'OAWX)_;&_8C'A:P\$7FD_9/B_\.8)!I<4UI/!
M!::M=ZA;;?DF<))('9@RL3G!KZ@_;0\>?LGZK\1OV>?&/B6/Q]\:=:3PO::E
M\/\ X)>$_M&HZ7J5LJ*T.J:SIT3*&.=I+R9#<YJN1>8'Z3?"W]MO]F?XR>*(
MO!O@;XE:3>^);F.62TT6\>33[V]0;<K:PW21>83U54+9'K7PSXE\=^,X?^"S
MO@_P!%XCU1/!5S\ #JT_A9KF0:4VI".3%X+;/E/*" 0_)4_6ORU_:M^(-SK_
M .TO^Q/XVT#]FN]_9SNW^)^F:>ET8AI.H>(],:Y"1VUU91>4#%$GRS*RD/P&
M8D9K]%_$LK'_ (+B> %9MSO^S/&9,G CS;R%G Q\A8[L*,Y(ZC.*EQ5MOLM_
M-6^7_#@?N4\8!9EX"?,0.A/7\QQ[9ZU^,?\ P5D^)GQ OM.^%/[-GP8\0:AH
MWQ+^+6ODFXT.=H]5TK2+!%N9+N5(F#QVKG*;FPI.?4U^S$T\4$<\DS*L4,<D
MLC9 78@)+R,3A0 .:_E%\4?M8_$6Y_X*0?$7X^>"/@%XU_: \+_#>UNOA[X:
MF\-VDMYI-A=Q,WVN2*Z4F+SE;='M !!7&>!13Z_+]0/UQ_X)9_'#Q3\1/@]X
MC^&'Q'U&XU'XD_ _Q)?^%==N+Z5SJE]!;SR1V]]<QMEG$@C'EL<A@X[5]@?&
M#]JWX"? 6^L],^*'Q TW0=4O$$\6E;FNK\J[ K)+9VZR211$9^9@!CZ5_._^
MRU^U/X]\&_\ !1R_\2^,/@YXL^ _@[]HBT:WNM \56;V<%]XC@+>5<6A=A&7
M;@;>IZ'FOLO]AWP)X/\ C_\ M9_M:^.?C!IMAXZUOP_XH/AW0--\1)]OCTK1
MT,J*(+&;<D1D3D%1PO0U3BG=M?UV T/AO^T1#\6O^"J<-O\ #_XA77B#X77O
MPK34+?3[.]=M+_M((N5-GG:DN3R'4$'O7Z:_%S]L?]G;X(:PGASXB?$/2=*U
M]D5Y-$MBU_J-N&R5>YMK1)C;M@9;>5V]^*_'WX4?"+P+\&_^"R7B71O -E;:
M#H][\+;O59M,M)=UIISRQ&2>6-"2+81K^\1.-@7I@5G:#\1?V;O!O[07QPU'
MX8?!'XD_M>?$'Q!XLN;#Q+XGU737U;PUX;U'S&2XTBPN)Q+;6=E'S&KQH3_N
MFJC23OOHK_BEY?FM_D!^X/PK_:+^$'QL\-ZMXJ^&?C+2?$^DZ"LK:R;2X!N]
M,$*L[FY@/[V E%8J'1<D>M>'WO\ P45_9&T[3%U2?XL:4\$FIWFD[;??<W$=
MWI\C17:RQ6T<K(L+HRF60*&VE<_+7XO?\$]]9U&U_;L_;@T&R\$S?"?P[K_P
MPU'6[CX="Y9[?1+Z.QGDS):[BMK*[$D[0"H(R*]J_P""+W[,?P1\6_ +XI^/
M_%WA71O&?B/Q#\7?B'H5R=7B&HKHVF6^J7!2VMXI21;O(99':4 -@#![4W2C
M%7;>ZZ7WLEI?ON_/TN'Z\^/?VF?AEIGP%\2?'/PWXNT[5_"=IHMU=:?K6FR?
M;+?^TOL[M;0RB$,Z$2 &2)U7:0P/?/QI_P $R?VX+/\ :6^'?BMO'7C.#4/'
M>G>(]9NY+:2)[2VTWP]!+*+5Q<NHA6+R$$C?/D9[5\?_ +*^CV7A+XO?\%"_
MV==+@&J?!OPSI%]K>A^&+]#>Z3H^J7<4A9+5)&9(E!<D*K#;V Q7SCX+U>?X
M5?\ !*CXF^+? .BV>D^+M5^*.K^&[G7-,M_LNH'2[G4YK=[1KZ/+Q6^QVCQG
M"@[NU3RKLON _>>?_@H)^R99^*!X.G^*^CQ:NMY_9CR[)6T[[:LGD^4U^J&U
M&9<(7\P8)^IKWKX@_&WX:_##P9!\0O&?B:PTOP==36J0:X\\9L)&O,?9\3HS
M*R2!ACJ .O&:_"CP3\)OB9KW[*VE^"-/_8=\#:EIOB+P:M]%\0[GQ5&-9DU"
M]L?,_P"$A_M%HC*)EGS<8\P*F#G)%>4_M!>$?BOX<_X)0Z?X(^,=YIMWJVG?
M%+2=,M)M'UG^VEM]#;4K>""UFOT(\R:&)C&1G(QGZ2X7>CM\O^"!^]/PO_:_
M^ ?QG\97?@+X;>.;3Q)XCL+9KNXMK.*5X/LJ*&:19VC6&95##;M=NOTKZ;7[
MH]?X@>QSR,=%[?*. .E?(/[)'P*^%'PY^$GPKUGPMX-T/2=>_P"$'TJ&76[6
MV U.]-S:1O.;VX/SRN[8)+GC'M7V!C:2!D\Y)(Y)^O?Z\5+C9;_A_7< HHHJ
M "BBB@ HHHH **** "BBB@ HHHH **** '#H?]Z/_P!#%% Z'_>C_P#0Q10
MWL/]U?\ T$44=A_NK_Z"** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!,\X[XS36D"@D<GL ,YZ]/P'\J?CV]OPJ%D4@L&
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M./\ AQY^R-_T&/B-_P"#L?\ Q%'_  X\_9&_Z#'Q&_\ !V/_ (BC_B:' ?\
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M/;@#Q?J+#,\*X#$ ;BS \]N.<>E?? N+4GF[MN@&/M,'?_@?;//Y5](^&_\
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MN<?4'_#-?W]_\0^_[!W ^P^+U]1_:,>?S$7^>*/^(?C]@_\ Y\O%W_@PC_\
MC5?Z#0\9\"WSRRRHI2@W*\OM.UE&R=K+J[V??4_B;_B5S'<\FL_PTHV?)%4&
MK6:M>]39^7S['\ >Y?7^?^%+N7U_G_A_];TK^_O_ (A^/V#_ /GR\7?^!\?_
M ,:H_P"(?C]@_P#Y\O%W_@?'_P#&J?\ Q&C!_P#0LJ=/^7K_ +M_^77^(7_$
MKV8?]#S#_P#@GT_Z>^GW^9_ )N7^\/U_P_\ U]LT;E]1^O\ A_GMDU_?W_Q#
M\?L'_P#/EXN_\#X__C5'_$/Q^P?_ ,^7B[_P/C_^-4?\1HP7_0LJ=/\ EZ_[
MM_\ EU_B_JP?\2O9A_T/,/\ ^"?3_I[Z??YG\ >Y?7^?^%&Y?7^?^%?W^?\
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M_8A_;<F\#0_ _7_VM;:]^#<*1:2LMIHUQ;>.6\,6RB*'2GUSS2YW6V(BY0$
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MM/FAN#=ZA"T$\EI,7VPV2*[B& +\HQ@U2\#_ /!/O]I?]G_QE\2;C]FOX_\
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M 4444 %%%% #AT/^]'_Z&**!T/\ O1_^ABB@!O8?[J_^@BBCL/\ =7_T$44
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MK/2U_)=^WY?>T;QV!^IQC_'\>OM33NXW<>AXX]>E2%2?XCP?\]._O^E!!XP
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MGO??IM^8@&!BEHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!I4'J/J.Q^M.QC@# SG&._K]:** "BBB@
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M5O\ /\/6P>D45YO_ ,+,T7_GG-^7_P!:C_A9FB_\\YOR_P#K4>S?=?U;_/\
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M_P \YOR_^M1_PLS1?^><WY?_ %J/9ONOZM_G^'K8/2**\W_X69HO_/.;\O\
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MF_+_ .M1_P +,T7_ )YS?E_]:CV;[K^K?Y_AZV#TBBO-_P#A9FB_\\YOR_\
MK4?\+,T7_GG-^7_UJ/9ONOZM_G^'K8/2**\W_P"%F:+_ ,\YOR_^M1_PLS1?
M^><WY?\ UJ/9ONOZM_G^'K8/2**\W_X69HO_ #SF_+_ZU'_"S-%_YYS?E_\
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M'I%%>;_\+,T7_GG-^7_UJ/\ A9FB_P#/.;\O_K4>S?=?U;_/\/6P>D45YO\
M\+,T7_GG-^7_ -:C_A9FB_\ /.;\O_K4>S?=?U;_ #_#UL'I%%>;_P#"S-%_
MYYS?E_\ 6H_X69HO_/.;\O\ ZU'LWW7]6_S_  ];%STBBO-_^%F:+_SSF_+_
M .M1_P +,T7_ )YS?E_]:E[.7E]Z\O\ /\'V ](HKS?_ (6;HO\ SSF_+_ZU
M'_"S-%_YYS?E_P#6H]G+R^]>7^?X/L!Z117F_P#PLS1?^><WY?\ UJ/^%FZ+
M_P \YOR_^M1[.7E]Z\O\_P 'V ](HKS?_A9FB_\ /.;\O_K4?\+,T7_GG-^7
M_P!:G[-]U_5O\_P];!Z117F__"S-%_YYS?E_]:C_ (69HO\ SSF_+_ZU'LWW
M7]6_S_#UL'I%%>;_ /"S-%_YYS?E_P#6H_X69HO_ #SF_+_ZU'LWW7]6_P _
MP];!Z117F_\ PLS1?^><WY?_ %J/^%F:+_SSF_+_ .M1[-]U_5O\_P /6P>D
M45YO_P +,T7_ )YS?E_]:C_A9FB_\\YOR_\ K4>S?=?U;_/\/6P>D45YO_PL
MS1?^><WY?_6H_P"%F:+_ ,\YOR_^M1[-]U_5O\_P];!Z117F_P#PLS1?^><W
MY?\ UJ/^%F:+_P \YOR_^M1[-]U_5O\ /\/6P>D45YO_ ,+,T7_GG-^7_P!:
MC_A9FB_\\YOR_P#K4>S?=?U;_/\ #UL'I%%>;_\ "S-%_P"><WY?_6H_X69H
MO_/.;\O_ *U'LWW7]6_S_#UL'I%%>;_\+,T7_GG-^7_UJ/\ A9FB_P#/.;\O
M_K4>S?=?U;_/\/6P>D45YO\ \+,T7_GG-^7_ -:C_A9FB_\ /.;\O_K4>S?=
M?U;_ #_#UL'I%%>;_P#"S-%_YYS?E_\ 6H_X69HO_/.;\O\ ZU'LWW7]6_S_
M  ];!Z117F__  LS1?\ GG-^7_UJ/^%F:+_SSF_+_P"M1[-]U_5O\_P];!Z1
M17F__"S-%_YYS?E_]:C_ (69HO\ SSF_+_ZU'LWW7]6_S_#UL'I%%>;_ /"S
M-%_YYS?E_P#6H_X69HO_ #SF_+_ZU'LWW7]6_P _P];!Z117F_\ PLS1?^><
MWY?_ %J/^%F:+_SSF_+_ .M1[-]U_5O\_P /6P>D45YO_P +,T7_ )YS?E_]
M:C_A9FB_\\YOR_\ K4>S?=?U;_/\/6P>D45YO_PLS1?^><WY?_6H_P"%F:+_
M ,\YOR_^M1[-]U_5O\_P];!Z117F_P#PLS1?^><WY?\ UJ/^%F:+_P \YOR_
M^M1[-]U_5O\ /\/6P>D4N#@GL.IKS<?$O1.X<?4]/PQVJU;>/](O;B"UA$A>
M>14';K^'/]*S [[!QG'!&?P_R:2A3E0RY / '?'O10 4444 %%%% !1110 4
M444 .'0_[T?_ *&**!T/^]'_ .ABB@!O8?[J_P#H(HH[#_=7_P!!%% !1110
M 4444 %%%% !03@?B.?;."/QS103QCW7^?\ ]>@#@_B(-WAZ0>DJ8]OI7SLH
M.[!YQ_+'3]<U]%_$+_D7Y?\ KHM?.JY#D9SQU_*M8;?/]$9S;T^?Z#\#T'Y4
M8'H/RI:*LB[\_P"O^&7W"8'H/RHP/0?E2TW<O(W*I'0.=F>_'6@+OS_K_AE]
MPN!Z#\J,#T'Y4W>N"<C './7G@>O;\Z!(IQS@G/#_+T&>.N: N_/^O\ AE]P
M[ ]!^5&!Z#\J%*MP&&?0')_ =Z6@+OS_ *_X9?<)@>@_*C ]!^5+10%WY_U_
MPR^X3 ]!^5&!Z#\J6B@+OS_K_AE]PF!Z#\J,#T'Y4M% 7?G_ %_PR^X3 ]!^
M5&!Z#\J6B@+OS_K_ (9?<)@>@_*C ]!^5+10%WY_U_PR^X3 ]!^5&!Z#\J6B
M@+OS_K_AE]PF!Z#\J,#T'Y4M% 7?G_7_  R^X3 ]!^5&!Z#\J6B@+OS_ *_X
M9?<)@>@_*C ]!^5+10%WY_U_PR^X3 ]!^5&!Z#\J6B@+OS_K_AE]PF!Z#\J,
M#T'Y4M% 7?G_ %_PR^X3 ]!^5&!Z#\J6B@+OS_K_ (9?<)@>@_*C ]!^5+10
M%WY_U_PR^X3 ]!^5&WCA03V^4=,_ATH) '/_ -?M4<DBK&6R0  6(ZJ@.7;'
MJ%SW'3\:SJU84J=6K6ER1P]-UI5'I%4FK.[V]SE;;W76URZ*G6E"'.Z;57DC
M%Q3]JI**7+I??1=G>[[F<'&$(XW#HPZ^F>?QZ]J;N7+9&#R ".,?PMSZ]??/
M2OFCQO\ M V_A_4Y]-\/V<5[):N8YKB5@4W#.<*3S@CD?AWKH_AO\9['QM,V
MEZA&NGZF4,HW,#&Y'4KR BD@[5R<#/.*_GG ?2D\(LQXQJ<$X?B'#+.:59X9
MJO-4\/.O&?(XQJ>[%.+5I:VT=]=#]&J^%W&-+**6;PRV?U*<.;GUE44=)\W)
MJVFGIIM;T/=%Z@,>N>0#@?7^?Z4[<,GA< <' .355;FWX#75LK<;PLJ'/]WG
M(_R:BN;R&&WGE22*=XHWDCC65%+,O(7.XY.!],^M?MN(XLX;PT:E;$9[E,X4
MJ3JSG3QF'<84U#VCBDJGO2Y5IH[Z=3XJCE.9U*GLZ6 Q3J<ZA*=6A647)M)+
MEY4M=%?2UR]G'/RG.>-O ^GT.<>E.50<]QZ]#_GGUKRC0?B]X2UFZ?3IKK^S
M-3@N&@FMKO 3<C;<K*2 P8]@.!7J45S#,NZ&2.5#]UX9$D0@G@[@>,CGI7C<
M/>(_!?$]-+).(\OS"%*M4A74:]&-6G)2:]E.+<9W6]X]K;&^8<,YWELX?7,#
MBH*I9JU&IR6T^TD[?>DEJ3X Q\N?PS^>>:3(_N'_ +YI0V[T]\'([]\#]!Q^
ME.YSTX]?_K5]I&49P3@TX/6+A+F7*[62EK?3KYGCU%*$W%QE"22NG>^RUU[V
M$P/0?E1@>@_*EHJEHK67K;4B[[O^O^&0F!Z#\J,#T'Y4M% 7?G_7_#+[A,#T
M'Y48'H/RI:* N_/^O^&7W"8'H/RHP/0?E2T4!=^?]?\ #+[A,#T'Y48'H/RI
M:* N_/\ K_AE]PF!Z#\J,#T'Y4M% 7?G_7_#+[A,#T'Y48'H/RI:* N_/^O^
M&7W"8'H/RHP/0?E2T4!=^?\ 7_#+[A,#T'Y48'H/RI:* N_/^O\ AE]PF!Z#
M\J,#T'Y4M% 7?G_7_#+[A,#T'Y48'H/RI:* N_/^O^&7W"8'H/RHP/0?E2T4
M!=^?]?\ #+[A,#T'Y48'H/RI:* N_/\ K_AE]PF!Z#\J,#T'Y4M% 7?G_7_#
M+[A,#T'Y4AVCD@?D*=1G'6@$VOZ_KL-;:!]T>G2D!4@\*#R.W_UJ:P(QDD]:
M,JN >2>< 9/;\:-;Q?NI*2<Y2ERJ,%\3N]&TME\^@)2<KIN[5OR7]=>PF .^
M<8XQU_'I2%AN''X?3U^M#;5R694&"3O*I@#.>&/8=,?I7GGB7XG>#O"^X7VI
MQ7%T 0EI9L)I=PX_>A2/*&3U)-?(<0^('!?#5%5LYXARW+J"JJ-2M5Q="Z=T
MN54^=RWZ6V>NA[67<.YUF4E_9^75L0VOL4ZCT]W5W7+T_*_9^C*03C:,GIQ]
M?\YH;@]%_*N9\.^(+?7=*AU/:MDDXWQP32J90C#*.1D$*PY_$&MUKJV!(>Z@
M'RAE/FH0VX9P,-QCI_A75@N->&L?A</BL+GV7/#5J<9T^;%8;WX2=XSDW/F7
M,FG\_0PQ.39OAL1*EB,+7I5*3M4@J-62UM\+46GK:]M-]B;=@=%^K<#KW/I0
M'3'!7)[$9R1_=/ZCUYKS/X@?$G2? UC'+*8;V]N%86]M'('3?@D>85)PN.><
M'G YKQ/0?VE[JZODCU[388M.FG6.![<!'0,P&2<$DKZGKBOR#BCZ3_A+P?Q-
M0X8S3B;!O'X^=*C#V$E6I49R<8+FG%2BM?.VNZ/M<H\*^,,\RRKFN RZ<J%*
M$I<\^>$FHP4W>$W>ZM_+MZ.WUXHS@E0 1T(&1]?<?U[TP;<C&3SCGIU_.JNF
MWUKJ-M!>VLA>VN8A+%*>05<;@#_M#D9]O>K>[)7/!SG&.@SQD].<?UK]]P6,
MPN88'"X[!UZ=;"XJC"K0JTTY+$1G&,U.^J2L[Z-+\C\]KTZN'DZ->+IXFE6G
M1KT[OW94WU[-6U?ROL28'H/RHP/0?E2T5N8W?G_7_#+[A,#T'Y48'H/RI:*
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MY4M% 7?G_7_#+[A,#T'Y48'H/RI:* N_/^O^&7W"8'H/RHP/0?E2T4!=^?\
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M7W"8'H/RHP/0?E2T4!=^?]?\,ON$P/0?E1@>@_*EHH"[\_Z_X9?<)@>@_*C
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MS7B[6M'\.>&M8UG7]7L]"TNSL;B6XU*_N([6WMU$;8+2R84;N@]OJ*P/B?\
M%'P)\'_!NL>/?'_B33M!T#1+.:\O'O;A(9YF5"1:V$;L//NGV[8X(P7.>F>*
M_GV\1^/?VB?^"M7Q$O?!/POCU?X:?LI>&K]$U[Q#,9K:3Q#;)(/,\IDV/=W$
MT:EEAC<K%N&]>"*\W-L/]?R[&Y;*MR+%X2M"-1:.DJD'&U_5]=?D=>%KQH8K
M"8J2]I'#5:<^6$4^;V<E*VO5[=?D]#[9M=<T?Q(]WKF@:I;ZOI=W?7+VM[;2
MK<0SJ'($B3*=KQ\C#<@\8QTKK?"/A_Q#XFU86?AWS8]0"$/<1,8Q&#_MKC
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MP]I^J7PM_$TXM5FN(1)LA+7@8 'Y03Z?GZA_P6;D\C]F'3;F.,RO;^*M-E$
M+9G*72,(\+DDL0%4<\FO"OA)_P %(OC'X8^&/@CP]9?LC_$_5[32/#NFV5EJ
M=EI=S/9ZE'!$%2:!A$1Y,@^8'T/YZQ<;+:__  0/%_VI/V>_&?\ P34\4?#3
MXW? [XT_$/6O">J>)+/2/$/ACQ;JEWJ$$\+2HMQ"L+32VA69#M20KO4YYK]+
M?VR_VY'_ &=_V;O"/C_P];6=[\3?BGINFVW@_1I\N(]3U>RBD^UI H+2>0\P
M:(,IB>12OM7P!\0M"_:__P""E7CCP)HOBOX57GP=^!_A77+75;U==^TVU[?>
M5(C3AXI-CB9U4!<*44\BL[_@IIH%KH'[67[#O@34&W^#M%;PAI]O#*!)8S2V
M6I6]M')-OS'EEC&4)^8G##%*3C96MOT]/^&_I >J_![_ ()E_$?]H+PYI_Q=
M_:V_:!^)DGB[QC;1ZVGAGPOK%W9Z9HEO>@7<%J\'VF."WNT@D0*D")$4&&&[
M('#_ !R_9;^/'_!.B_\ #_QY_9>^)_Q%^)G@JSU:RM/&OPS\037NOW4^F7EP
MB2R1VB/<Q$2"3RU$<?GK,P*X48']!UM%;PVUM%$%BM88(DB$0V0+&J@QCRX_
MD;Y0 O9%PH( IEZ^G);M/J"VAM+?$]P;ME6S4JV(GE:7$98,5>,N1L<#:<UF
M!\8?M&^-=0\8_L/>,_'IL-1\+ZEK7PV_M632[B.YTW4]$OKBR#O9S!A#<1R1
M,QP,!QCL:_*/]A;_ ()M?"[]H[]GSPY\4_&WQ3^,UIK^L76HI>0:7XGN4LH_
M)N-JF(3W8?!! V]1CFOV'_;:FCNOV5/C#<+=)>12>$+^2)HY5DC.8<IB120^
M!GYADCI7XR_L*_%W_@HUX6_9RT&S^!_[.G@OQU\.+6?59['Q#JNN26U[(1-N
MG46JR+N92H"X3>V<8R:"N67;\CV;X_\ _!)C0OAS\-?$GQ'^#7QX^+NF>+/!
M>DW7B"VCUCQ%>?99UTY?.<.T5WOP< ;1P?0C&?KW_@E?^T;XJ_:(_9V2?QO.
M^H^*O FH2>&=1UEB2=86UD:W65W8;I'&P%W8DGN<YK\K/%W[8'[='[7'C+4O
MV6]8T/P=\!=4U'S=+U]9;R[@FO("WERI;2:CY+2B5"1L@+(Y [=/W2_8V_9C
MT']E#X-:1\-]/NDO]5VK>^(M5C 4ZEJMS^\F=-HP4,C$A\DD'J:"=5H?6'3@
M=!THINX9Q@C)_+G%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBBDVE:[M=V7FP"BD# DCGC--WCWJTGII=/\EN)R2DH]6KV
M\M]>P^HW9055B5R>PSG/&#G]/_U4>8O&01D?EZYY]ZQ=4UB.T!CA GN6P%B7
MYF&>C?3GZY'2OSWQ#\3.'?#3)*F>Y[F%.C2E^[PV"YE/$XVJK<F'HTH^_*4V
MU%6LO4]#+LMQ&95HTJ<93LTY-+2*MJVWIMYJ]^VA+J5W!9QR"1AYCJ1%$IR2
MS A&Q_O8)_GGI^+'B+_@GO\ &K]J+]I?5/B'^U+XV&H_!CPUJ"S>"/!>D75S
M'97]I'*C0P26LSB&)_+ %S+(@+C<%)&*_9*PTF6YD%]J+$R,,QJ03L[@$-@
MC Z#Z5T^ 59"PVMM PO^K48SA<;7)Q_%V.,^GY1X/YSXH\?<0YCQQQ+260<'
MXRE[/A_(ZD+8MTG>V)Q$)1]WVL7%VN]CU\XHY;A,-'!T)*IC(/FJU8ZJ/PKV
M3:V::N[7U>^YS_A;PKX<\%:#IGA?PEH]EH.@:1;Q6NG:;81);P011(L:_+"%
M4N54%F&=[Y8Y)S71["/[H&<YQAO?YNOX$G/%*J*,8R0!QD ?0X' ^G04^OZ6
MY5%*]JK34:?-%+V:NG*5UK9_+;L?.\T90C%JRY6I6^-NVC36F]V]A,#.>]+G
M^OZ\444URQCS./-751>^M5R<RVNKVM?K]RU,X*4H<DZDW&EK34M.;9V\_3IU
MU0TA21D#/;G!Y]Q@T8Y;_:"Y_7_#^7I0025/H?\ "G57-)M\[3BV_<<8R?K=
M^7]=B,JT5RJ4'%ZM35[7:TO9WM^5^NH>G^ST]O7_ ":***F]^EDME:UEZ+1>
MB"S6ET]MMMD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%%"^X'?HK_@%%%%.\EHY7^_M_7W
MV!K1ZZZI;W C(YY&>G_UORIH"KD #YNH_P /3\,4ZBILX\K7+I4YWRJTGMI)
MOT^?</>Y5RN,7;71IO:]_-^?F^@>WIP*8Y[8QZG:,GT&1R?H?:GT4TM92<:;
M7/S24FW.2M&RBK6O=?<.*I\MN67-]N]K3^&W5WL[O]>T2HPY7=D=<DCV[GD<
M\_YQC:[X9T'Q3HFI>'/$^E66M:#J]O+:ZEIFI6\5Y:W$$J,C!HIE=-P!RK;0
M5/(Z"MT9[X_"CG(P0/P#?H>*4N2ZG3I1I)6;BM7*UOBZ:]=UIKU!3A3]V4:D
MXOX8PT2EI9RL]EOUTN?AK8_\$]/C/^RO^TSH?Q,_9$\6/I_PE\3ZM-<?$'P?
MJEU))IVEV%U*)+B&.U$C17*,2PBD\MI81@*1@"OVPTO4(;R!0'1KE43S$&0/
M,"CS=@;!V;]VW=R 1^&NZ+Y9'.XRE^.$*$#,.T8!0]SU_E7)7VDO;3?;=-S&
M<EW0;L>I Q_,]*_FCQ@SGQ,\/\]R_COAC"0SS@^E0=#B+AZE&52O2C.HI2QV
M&BHR;E"";LK'U&5T<JQU!X'&2A0Q=>WU?&25H1:2M!V6[T7;3S276@EB.<$#
MYEQ[]<_AQ4E<_I>L)<*T4X*7* 9#8W-SC^G3'H*W=ZX!YY[=_P##\B:_5_#G
MQ'X:\2<CHYKP_C85I1CR8S!3G;&8.M"RG2KTI>_%QG=6L]FEHCQ\QRW$9;6E
M2K0DHIVA4=N6JK*TXM;J2L_F/HIF\>YIX.0#_D=J_0+IQE-?#"_,]=+;Z;]M
MEYGGN+6K37_!U"BBBG%J7);_ )>.T-_>_P"&OU"S[;A1110(**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K9\/G&LZ>?^GF/^=8U;'A_G6=/'K<)_.AZZ=QQU:3V;5_2^I]3CH/H/Y4
MM(.@^@_E2USFX4444 %%%% !1110 4444 .'0_[T?_H8HH'0_P"]'_Z&** &
M]A_NK_Z"**.P_P!U?_0110 4444 %%%% !1110 4AZ?B/YBEI#T_$?S% '#?
M$+_D7Y?^NBU\[#[Y^G^%?1/Q"_Y%^7_KHM?.P^^?I_A6L-OG^B,ZG3Y_H/K-
MU&PBU&QU'3YQF&_T^_L)@!\WEZA:2V3,ON@N-V.X!'3-:5,<X .[;SWY'/J.
M_&<#UJS-7Z'Q3^RIXFU/PM<^,?V<O&\26GB;X9ZM=W/A!<^6GB#P->2O/HU[
M9;BOFW$$3,+T1;O*<J.,US__  4JT+7O%G['_P 3]#\,Z3?:[K=U:PO9Z=:P
M/=WERR2*[00Q1AF8H%^7 ZU[#\=O@5<_$B70O&_@76I/"7Q7\$7'VOP]X@C/
ME0ZA9QY>7P_K &/M%A>_<=9-P7C&*XOP9^U(VD3S>'/CSX:O/A[XKTO$1U22
MT>;PWKBK\K7EI<!)(XT?'F%=O ;%!7O_ -[\3\Y?@3_P4=\4?"GX)?#'X9ZK
M^R-\<-3U+P3X3LM"O+RTT&Z^SW=S;*PW0L0-OS/R"!E1ZXKE8O#O[0O_  4+
M_:4^&GC_ ,9_#/5?A5\'?A;J":O96^O6TEMJEW,CH1;RI,%(=E3;E,\FOV_L
MOC)\*]2LQ>6OCWPA/:N/-D=+BS0E&Y4O$\2LFTCD[<CTKSCQ5^U-\(O#L%Y#
MIFL)XPUN")OLND>%87O7O)CQ%!N@B55;</7@GO0/W_[W_#_U\OO/1?BAX_T+
MX4^ M7\3:K<"&STS33;:/&2!-<ZBL7E65FD>=\LC2B, (&89!QW/F'[*G@E_
M#'P^F\0ZE!)!X@^(NK7'BK5S<JPE OG>>VA<,-ZB-)%7##\NE>8>$?AS\0_V
M@O%^D?$SXT6<OASP5I$OVGPA\-I&)CNI%?=#>ZLG0W$:JK;7![5]U1I'"BI&
MBHL2B.-$ 54C0!51 . JC@ #H*"7?K?YW)^1U]2<]B3UQ]/PHH!R ?6B@044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110"OT"FE0?0'Z5&1E
MB/4G\/>F,VT=MJ]7)[#/] 365?&X3+L/7Q>.Q-+"X6E2DZTZTE"*@K2;4I-*
MZM>S:5EWL:051SBHTY59-I**3;U:U^7;_@CV(& 3P._<YZ_KQ[5S^H:N(&-M
M:*)+D\  <8'WCG'!7/\ GFJU]J4L\OV/3@97. 7_ .>>0=QSG&,C'.!U[U?T
M[28K1?-E_?7#X:5^I#'DJ.IX/0>U?Q9QCXF\8^,>;8GPZ\)9U\+D.'K_ %3/
M^.%&2I4H2DHU,/E\_P#EXU%24I*4=E:Y]=@\KPV3THYEFKA6K.T\+A$U=SLG
M%3777?IMT=ROIVCEF%[J/[VX?E4)R!GZCCM]/K72(FWG&W_97[O Q_GZ4;0$
MP@&..![?Y_SFI*_H3PP\*.&?#3):&"RK!O$9E4:EF6;U_?Q^/Q<E'VE:I6DG
M45W=I.4NR/$S7-:^:5?;UY6Y/=IX6%XTZ<-$K1V;7WA1117ZJY<SNDE>WPJR
MV[?GYW/'3BTG&_*]5S7O^/F%%%%(84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %(<]O?\^U+133BG>>D=I/LGI==;J^ENHI6
M:]Z+DM+Q3LWJNI7YYP2#SS_=[>G;\:R-4TF*\194S%<1@E94X+L/7OSWSU'T
MK=/S#CG'3TS_ "IAW\$CISQ_];_/?UKX+Q \..&?$O(L1D.?X*E7HTDJF#Q;
MBJ>)P=:W[JO0K6YU5A+56:=ST<!C\1E]6G4PTW2IJSE2?O*=K*UG_77;;E;'
M4Y+1Q;:D"&&%$AXR.V21W'7\*Z=&& RX96^ZV>2#\P]NG?VK/OK"WO599AB1
MAB-\=^WY$>_Y<5@07=WI$HMKQ3+;=$?L#GCU[$\]/0U_+&2\7<<?1VS[#<+\
M?U,9GWAQBZZIY1Q;*,ZU7+X.2C0PV8:R_=TX7BY.;^&]CZ7$83!\1T9XS .%
M+,J2O4PK5HU'9<TXKOIMKNSM-@/(.*?5:&XCE"O&VY&&<9Z9ZC YP,_YXJ9"
M,<?C_C7]H93G&7Y_@J.;Y77HXG!8R$*E&MAZJJ4:D'%-2BE\#L]4_P!#XZI3
MJTGRUH2A53<9J2L^:.CLK;=GUN/HHSG\\45Z9F%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 AS@X&3@X'J<=/QK.U74[+2=
M+O\ 5+Z01VFE6,U_>39P+:"UB=YF;.,LBJ0/?H<U?<X&XYV@Y./0=3GK69J.
MGVNJV%_IVH1)<V5_:R6]Y;2C<)[2X!5XFQC.58@^N30!_+G\<OVR=._;&^/N
MI?#7QU\2KGX5?LV>"]9EAOI+-;J&_P#%HL9BDT4CQQ_/%=8QL&593STK]5_@
M]^VE_P $_?@QX-T;X<_#?QA8:1I5HT-M%';6$T<U[=,43[1>S+;AY9)'.?G.
M%.>N:^IV_8I_9AF+2R?"+PO(\K&1Y#9Q%I'<[B[G .YB<M[U&O[%7[,%LZ2Q
M?"+PU#(CJZ.MG&I#(P9>0#T8 _A0!^77_!4G6['Q+\1_V-M<T:3[9IFK^.M!
MNK*X6)RL]K+,KHXVJ?+&"#EL9[XK]LO$/'PRUKG/_%"W0&?^P2N!WK#U_P"#
M'PP\4Q>&X_$'A'2=53P<\,_AOSH59M'-KCRA;9'!7:-I&,8]Z](>UMVLS920
MI-92V[6TEI("T;6DJ")XS_LB,$8]!0!^ ?\ P3?^'!^+7[.W[8WPW<30S^+?
M&'B[3+!G1HT74)!="SD^<+E!,RB1AT7D<TG[!/[9?A7]D7P-J7[)_P"T];W_
M ()\0?"_7=2LM UN>RN39ZQH\MS)-N#^44)WD21%6*LI7D&OW(\#_"[P'\,H
MM4MO OAZPT"#5[QM2OUL8PANKB9BTDQP!NF9F;+=<8ZBN>\>_L__  6^*%['
MJ/CWX=^'?$NJ(<F\N=-@-RD 7@7<WWI0>Q.3GUH _GH_:/\ VG]*_:=_;L_9
MAU+P'I^J/\./"FOQ:7H_B&]LIX8M<OY=22:XN[??&H,,+!H,CY>>O%?T^R?Z
MT\8&Q./3Y$XXS]>":\0B_9V^"MJ?#,MM\/?#=G)X,9G\,R6MC#&=/,TOGF2$
MJ =ZN,COGKZ5[0N>F2<@;">/E[=.G'&!0!^1_P#P6/+?\,U:*R+*Q3QEI.1$
MC.Y7[;&#\J@MQ]*_07]G":5/@-\)D5@BCP5H^Q0 C%#;)N+@IG<#P<\]:[/Q
MU\._!?Q)TM=#\<Z%9:_I,5Q'<+:WD8D5+B,[HY$W @$%<Y]174:1I%AHVG6.
ME:9;16EAIENMI9VT8VQP6R+M5$ ]%&./2@"^YD.]F);RUZ@ N<CH!@ CU.<^
MN*_+C_@J'^RSK_Q\^%&B^-/AO:22?%+X4:A%XC\.QPQC[1>0VI$IMXV!W9@>
M/S8E!Y<\5^II (QCZ<=*01X&%*Y88RP#KM(^9"C?+ALD$=.WK0!^-/[-G_!5
M/X2-X&T3PG^T"=9^'?Q(\*:?!HOB.WU73KI8+NZLD6V:X0O"2[321;V89'/T
M->._MF?MY?\ #3/AQ/V:OV/K/Q+XD\6^/+^SLM7\7:7;WMK::)IGGQF3;>)&
MJQ,"IF,FX;4'':OU_P#&'[,OP&^(&HR:OXK^%OAG4M3E8^=<MID$,TSD\R-(
MH^;.>A'ODUTGP^^!WPE^%CO)X!\!^'?#-PX*27%E80QWC#H09]N[IGD$<>]
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MG+%)6/C92YG\3DUHY/5M]6R8=!CIVHI!TQCIQ]<=Z6M!!1110 4444 %%%%
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MK_AUKC;74)M.G6SU+/V<$*EQURQZ'/OR1S_C76I(#LEX=&Y7/=3T_P"!>O\
M0]/U/PD\;,C\2<!*$Y/(>+<#>AG'#N8)4:]"O1M"K[.G*SG3J3NXS27,EM8\
M_-LGK8"=N95J3LZ6(IW<*D+)KF:^UMIU)Z*7D9.0=_S >@]AVZX_G25^URJ3
MDN>RC65K*VB6EG;M_P %,\%;V>ZM?I_7_!04444U>ROOU]>H!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %;'A_G6=/'K<)_.L>MCP^<:SIY_Z>$_G0[]!QOS*V]U;UOH?4XZ#Z#^5+
M2#H/H/Y4M<YN%%%% !1110 4444 %%%% #AT/^]'_P"ABB@=#_O1_P#H8HH
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M **** "CTZ\?YYHHH 0C/YY__72! IR,@]">Y'H?;VIU% " 8&*0J#US3J*
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M\_P_X)X-17O/_"M_#O\ SVN?S6C_ (5OX=_Y[7/YK1S^3_K^G_3T/9^?X?\
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M_3_IZ'L_/\/^">#45[S_ ,*W\._\]KG\UH_X5OX=_P">US^:T<_D_P"OZ?\
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M_3_IZ'L_/\/^">#45[S_ ,*W\._\]KG\UH_X5OX=_P">US^:T<_D_P"OZ?\
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MBBB@ HHHH **** '#H?]Z/\ ]#%% Z'_ 'H__0Q10 WL/]U?_0111V'^ZO\
MZ"** "BBB@ HHHH **** "BBB@ (!.2..PSQGL?KFF;?<?\ ?(I]% "8'H/R
MHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>
M@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10
MF!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M
M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?
ME2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C
M]!^5+1F@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'
MY48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P
M/0?E1@>@_*EI <XQW.!]?\]^GY4 &!Z#\J,#T'Y4M% "8'H/RHP/0?E2T47
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M0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH
M3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6
MB@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/
MRI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@
M>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^
M5&!Z#\J=CG'X^WY]/UIN?K^1_P * # ]!^5&!Z#\J6B@!,#T'Y48'H/RI:*
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M0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!/F[$*,<L3C'X=\XJ.6:"WVM+/;P;SRTSQ
MPE_]S>R\]^U<QXW\26_@WPCXG\77<;S0>&M!U36FB4%_-%C:23K$$ )+/(B
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M*X#3_B5\/]3\6W_@+3O&6B7?C+3H7N-0\+Q7\?\ ;EE"@!>66RYE55!!+$8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP7XX\-^)M!LS_IFKZ/J5O=:;;A>HDNT;RE9?XP2#S@X.,\)<?M0?LZVVM?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% ',>,=2\-:1X;UF^\8ZAINE>
M&4TV[BUK4-8FCM],AT^XB,%P+R><^2D+1R,&W@=1S7X)WG_!-;XN> ?$FO\
MQM_X)R?M-VOA?PUXON-1\0Q>$DO?[6\)7UU=N9I8=*,+O9(UQ*&'F?,4[GM7
M[??&OX8:7\:?A3X^^%.N,\6F>.?#FI:'+<HVUK62Z@98+E.AS#,L;Y!Z ]R*
M_G1_9[_:7_:<_P""6*ZS^S-\:O@)XW^+GPLT/Q!J5YX"^(?@ZSNKYFT2\N/-
MCMO-,<BXABVK%"Q9D(8UI%JUMG?[]5^/3\6!Z1=_MN_\%'/V.9]'U?\ :_\
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MV_X)N^((?C2VGC3$MS\-]+30DUWR!"TYWZ3YOE/=Y?!D/RD' '1)Z+T7]?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW1%T7QG8>&(I+_4=*N)IA->RFWA5S'*\X$R3N-HP,TWXC_MG?M1_\%!/BO\
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M$MO&7@-+>1M2N].:PM_M'EVBCSC<1HKY7:2C$9ZBE>^^]ETMT71; ;?[7/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:+K?5:6$W:,6DY<S2T7PWMJ[[)7U[>9AW/A[0[Z;[5>Z'I5U=D[C=SV%K+.
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MQCIJ!",8VKCIM^7\\ 9_'KWH,9(P=I'. 1E<GK\I&.:6G\T?Q\O+S0'Y _\
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M5,@[R76S>4(Z+NXYXY&=5CD '80. ,_D#G@@=P<@]:3/&W QG.-P(S].F/\
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MB32]2\$2R6XAM;W3HC+';W2RAVV).KE2@( ;!K](R,_W">V.OY^OMWIH0C.
M<]SW..1D]\?P]<?P]Z<7%--RCI\_S0<LNW]?T_ZLS\U_^":W['WB#]EWX9ZY
MK7Q0GAU'XW?%G6KGQ;\0K^-A)]DN;N4W,>CK+*3YKVLC,I>-MI 7' X_2P$9
M;)*8X) ..1G=SZ_=)&!GFF8P>0I.<_-@G) !()Y!([C^=/SA5  ./5L_@<]<
M\\= :)3BW\2\M_+R\_EKV8<LNWY&=>:79:BGD:A96E[ I#)#=0I<1%QRKX=6
M 8$9!['D^H@GTRPO(;:*[TZSNH('"6T,]K#/'$ZXVN@*,$,1&%(QC';'&QN)
M[#V 8#Z=/Z#_  I 6&?E !Z[6QGUQC&.>I')[]:5X_S1_'_(.678QY](L+IX
M7N-,M+J:R;-H\\$%Q)$ZGF2W=T<VQ)!/RE?SQ41T32FNOMZZ-I+:J?\ E]^P
MVQN%.!]ZX$8=I0%^5MY(YK=!(S\J@>Q )Y'4COGJ<G)QFC=M&W:H'H,=1ZXY
M)''/!H]W^:/X_P"0<LNS_K_A_P"K,H3P0W-N]O<1)<6TA$,D5VD<T-SGK%/&
MRL&C'HP(I+>RM[**.UL;>VM;6,_):6UNL$,!YY58%5<>G'ISWJT0IZXZ8]L-
MW^I_O=?>G_/@X[@9RV#CZ]>?Y@=\T1U5W[MUS)/=^G_!\NFHI)PE",OMOE4D
MFTGIN[;.^YC7VAZ5J-PLVH:1IFHS(-D<E[86MVR\[LH98G9.O'/7T(ITFB:/
M*D$,NE:>]K"P:VA>SMI([>=>=Z)Y9$9R/E*@8/ITK5Q]1@]1D>_7KSSW]:L?
MP],D@9  &>0?;)SSSUHVW37R]/\ /^K,2L^JT=NO^1D3Z7IUS+#->:;9W<UF
M0]K-<VT,TUN3QMMY"C&( 'Y<%<&O+?COKOQ3\)_"?QGXD^"GA32_'?Q0T?2W
MN_!W@_7KB>TTG7]3$D:&SN;FV>.:#Y"Y$H=55E&#BO:3NS]TY//4#GI_GWX[
M9J-L @C@XP<'G'!QU_/UYSFA:_\ !T[=_4'IY^B>GKIYI+S/P0_9F_9J_:__
M &F_VPM%_; _;R^'NA?#*W^$VGC3?A3\+]&U-=6LH=>QM77$<O(RQ1;G<R39
MDE9@68D9K][.=[<_*C.J-W(;C:?IR!]!3</G.[G^]_%CTSV7VSBG<DGN6QGO
MG'3 [<^E4ZL4HIWUT>B]VSM=[I+=KRZ6V$TTGM?OI]Y*K  9/\_6G;AZBHN,
M<J>/K^OIVQQ2Y7^Z?S/^>M9\\>52N[-V3L[>M^PN9<UMO.SMT[7[DFX>H_.C
M</4?G48VG^$_@2:7"_W6_7_&JTT::::3NOZ_KU"Z[_UI_FOO'[AZC\Z-P]1^
M=,PO]UOU_P :,+_=;]?\: NOZ^7^:^\?N'J/SHW#U'YTS"_W6_7_ !HPO]UO
MU_QH"Z_KY?YK[Q^X>H_.C</4?G3,+_=;]?\ &C"_W6_7_&@+K^OE_FOO'Y'J
M*6HB!C[K#\Z0!STS^>*=F_Z7I^I2U5TUZ==;6T\R;..M%1#).&YQ_GMUIZ[N
M<Y[?Y]Z2:=[-75KK6^MO+6U];;">EO/73IZ]AU%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 .'0_P"]'_Z&**!T/^]'_P"ABB@!O8?[J_\ H(HH[#_=7_T$
M44 %%%% !1110 4444 %%%% !1110 4QF/S8[ GMDXZ@ XR:?4##=(H^79NR
M^>. I8D'C!&#SF@#/U+6M-T;3KO5]8O[;3=)L+>2YO=0O98[>UMX8E+2&268
MHJ[0.YY) &2:^%9/VNO&_P 6;O6])_97^&%YX[M=#OY-)N_'OB03:'X&^W1E
ME?R;EA%=7T:$,1-:130MM)5B*Y+Q-)>?MJ?&?5_AYI>L7MI^SC\%]9MX_'ES
MILDENWQ#\=V[%Y/"K7R[6?2-+D_<ZI;Q[HYCM#=J^^[>S\)?#OPQY-K!H_A+
MPEH-F=L4$5O8:5I]A:H"2[91$1$&6=F+%BQR2: /AH>"/^"B6K;]1O/B;\'_
M  ],Y\R+1=.M-0O;)5<Y%M-=3V@E*H1M#("2V:T;3XF_MF_"**[N?BS\+_#7
MQ)\+6$9GDUSX8WES/K,4"#=)-=:9?K!^ZC7YRL*O(.@4G%<!XW_X*]?L.>!M
M=N-!U'XE#5;JVG>VGETBRNM2LXY('*LZ7-M#)&T8?<-V[&03T'/U3^S_ /M:
M_ O]I[3KN]^$/CG3?$LMI$3?Z<'6*]AC*D(7LI LI*]&S'QWQQ0!V'P;^/WP
M\^.?A\:WX(U7?=1N;;4=!O$>VU;3;R/(F@O-/G$=Q$86# NT00[?E8]:]HC<
MD'=@;>IZ#CC"@>IZ9Z@U^?W[2'P8U3P+J2?M+? NQDT_QWX4Q=>,O#&FDVVG
M^,M!0K)J'VNRBQ#)?00"2=9@-[8 YYKZY^%'Q#TOXK> O#OCS2@8H=;LX);F
MS8_/:7@C7[1;,.N^&7*,#SD>N: /3L' /8C(_+/]:2CG R<G&<<G /0?7V]J
M* "BBB@ HHHH **** "BBB@ HHHH **** &/]WZ'_P"M_6N:\1>*_#7A"S34
MO%6NZ7X=TZ2=+:._U>\AL;5[EP62W6>=XT\UP"57=EL&NFD!"CWQ_+_]5?EO
M_P %2M(M/$'@7]GWPWJL;S:1KW[0OA+3]5M5=E2ZLI+/4WD@E"$;D8HN03VK
MY?C3B>CP9PMG?$^(HRKT<EP%?'5*4':4XT8N<DGZ)_UJ=6"P\L5BJ6'C)0=6
M7*I-72?33KK8^\1\=?@T1_R5+P-D#)'_  D6EDX/TN2/R-.'QV^#)!/_  M'
MP.,?]3%IOX?\O _R/<5^43?LG? !2 / %D% 555)I@-H4 N1G@\]!WI#^RC\
M 0,?\(%;$$C.)9N#Z$[NN1_]:O\ )W'?M>?#7!XS$8-\'9G7Q&'Q%:E*<:CY
M/W$I0;MK;X7TMKWW_3J?A9CI4:4WC::E649)--?%RVT?K^)^KX^.OP7(!_X6
MEX&^G_"1:;_\DT?\+U^"_P#T5+P/_P"%%IA_E<GZ_P#U^*_*(?LG? %@"/ -
MD0?6YF!].1NXQTI?^&3?@#W\!68_W+J?/_H72N/_ (K#^&;LWPAFJ?5*MHF[
M:+WE^27?RK_B$V/T_P!MAMT3Z6]$?JY_PO;X+_\ 14O!'_A0Z;_\D?C_ /7X
MH_X7M\%_^BI>"/\ PH=-_P#DBORC_P"&3O@!_P!"';_^!4__ ,51_P ,G? #
M_H0[?_P*G_\ BJ?_ !6'\,O^B0S;_P '/_Y+3U#_ (A/C_\ H,C_ %\S]7/^
M%[?!?_HJ7@C_ ,*'3?\ Y(H_X7M\%_\ HJ7@C_PH=-_^2.__ .NORC_X9.^
M'_0AV_\ X%3_ /Q5'_#)WP _Z$.W_P# J?\ ^*H_XK#^&3_YI#-K_P#7Y_\
MR7_#A_Q"?'+5XR-KK]//_/S/U<_X7M\%_P#HJ7@C_P *'3?_ )([_P#ZZ:?C
MM\&",?\ "TO! _[F'33_ .W-?E+_ ,,G? #_ *$.W_\  J?_ .*I_P#PR;\
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M]H)P:M^&\PV6U5]$O7S_ *3/[E_^%X_!7_HJG@7_ ,*72O\ Y)H_X7C\%?\
MHJG@7_PI=*_^2:_AG/AG3>.)ST.!=W ]?]OM_6C_ (1K3?[EQ_X&7'_Q55_Q
M+/GO_0XP_3[/IY?K^;*_XJ"\&VTX;S%_]Q/3O;:_S/[F/^%Y?!7_ **KX%_\
M*72O_DFC_A>/P5_Z*KX%_P#"DTK_ .2:_AG'AK3?[MQ_X&7']6-)_P (UIN?
MNW'_ (&7'K_O8_3].*G_ (EFSQ_\SBAOV?EKV?X>EV3_ ,5 ^#?^B;S'=?\
M+S?X-=_3^KW_ +F?^%X_!;_HJO@7_P *32O_ )*H_P"%X_!7_HJO@7_PI-*_
M^2:_AF/AK3?[MQ_X&7/]''^>]*?#6F_W;C_P,N/Z,*:^C+G?_0XH:O\ ^1[[
M?EIH'_%0/@W3_C&\PTM_R\?]W;7SZ^7FS^YC_A>7P5_Z*KX%_P#"ETK_ .2:
M!\<?@M_T53P*<GC_ (J32A^'_'U_A7\,_P#PC6F_W+C_ ,#+C_XJD_X1O3NR
MW'O_ *9<?7^__G/84O\ B67/';_A7H]%HMKV\UI^5A?\5 ^#E:W#>.5_YZK4
M=5%O5O=]-'\M3^Y<_'+X+_\ 14_ O7''B72N!ZG-UG\.U,7XY_!<C(^*G@5L
M9Z>)-*[#<?\ EZ[#%?PU_P#".::HW;+@[>PO+G!QQC&_U)SS44GAO342; N(
MRJS'B\N.\>X;?G^F,?0USXOZ-N<X;#3Q#S6#6&HUZM2ZLFJ,'*R[OW?M:_@=
M6 ^GMP?C\7@<+#AO&QEB,32PJDZ[<?\ :,13HQ:5NCG^BTV_N6C^/7P4F4>5
M\5? CJ79=R>)-)8!AU!/VKJ/_K4C_'KX+0*SR?%;P(JIPS'Q+I(')!'6ZZX_
MK7\/W[.7@O0=>\ RW>JQW5U=#7]33>U[<\HEU,$4;G[*-O;@8/:NA^./@+PY
MI?PR\67]A;7-M=0Z?/-!.EU.S(Z(1Q^\X.><Y!!K_,C-/I)Y%E?B)B_#:>6U
M\3CZ6=K*I8F#M!U/;>QE4UU5VF]]'WZ?[+9#]'7-<W\-\!XBQS*CA<OQV1QS
MF&&FN><:-2C&O"G>RN^5\KO:^EMS^V2/X]_!1PK#XK^ 61QE6'BC1BO3/)%Y
MZ=L]C3S\>?@H1S\5O /(_P"AFTC\^;OGZ8'UK_(\USXH?$:VUC4+6'QKXCA@
M@NYEBBAU2\141'( _P!=QTQQG'2LP_%OXG#Y?^$Z\2?7^V+WUSP?,Z_E7]Y8
M/PPQ.-PE"O#%QA3Q%"E5]BU:454C&7+=+=7MTZ?+^',3XF8' XRMA*N$J3J8
M:O4H^UB_=ER2<>9*W5+5]+'^N;_POKX)*VP_%;P%O.3M7Q-I!? ]5%YGZ9QQ
M[U*WQV^"Z+O/Q3\"@<XQXDTO)P/^OKC_ #]*_P TS_@G1J&K_$'XA:A#XSUG
M5M>MH[*Y98KO4;J4KY8&W.Z4],Y&>_3TK]J1\-?""R%/[.G*LP*@W=PVU6)!
MZN /S^E?Q;XT>/.2^#?'%3@O'Y?BL9B:=.A4YH2]U^VDUZ)7CVWU\G_97@SX
M%YMXP<#TN-<#FL,)AY3K*5*2NK4XQE:2N[Z63OH?V$0_'[X)REU7XK^ F:,[
M74>)M(W1MQA6_P!+)W8/.1QQZU8'QV^# &/^%I^!2>N?^$ETLC'_ (%?I7^>
M_/HUM'\1/B59QSZC';67B>2"WC35;N)4C,,>U0 _ !SV^E;']BP@\WFK=^!J
MMV /;[_(^O3WK^J.#.&9\6\-93Q!AJBPD,WP]/$T\-4UDHU(Q=O+1_+YH_RT
M\:?IB9-X/>(O%?AYCN',1CL3P[F5; RQ=.M[*-=TE&[BDOM7T>E]KL_T"1\=
MO@L<Y^*7@;J/^9ETH$^__'U_GJ:7_A>WP6_Z*EX&_P#"ETH]_P#KY_\ U]>E
M?Y^O]BQ?\_FK9_["MV><\_Q=Z3^Q8N][JWX:K=^ONQKZ>/AIB].?&4X/K&6Z
M7GZK7N?E;_:)\,?]$?C8;>[+$2D]E=WY5?77;8_T"_\ A>WP6_Z*EX&_\*72
MCW_Z^?\ ]?7I1_PO;X+<_P#%TO W?_F9=*_^2>?PZ]J_S]/[%B_Y_=6QS_S%
M;O/_ *$10=%A[7NK=^NJW?X?Q?X_C3_XAIB;?[]2O?MZ6Z>O](/^*B?#'_1(
MXO\ \'2_R/\ 0+_X7M\%N?\ BZ7@;O\ \S+I7_R3S^'7M1_PO;X+?]%2\#?^
M%+I1[?\ 7S_^OIUK_/T.BP]KW5N_75;O_P"*_P ^_8_L6'_G]U;//35;O'3C
MJWK_ )-+_B&F)_Z#J73]/+K^'R%_Q43X8_Z)+&?^#GY>7K_5C_0+_P"%[?!;
M_HJ7@;_PI=)]/^OG_/3K1_PO;X+?]%2\#?\ A2Z5Z?\ 7S_GIUK_ #]/[%B[
MWNK?AJMW_5C_ )_*C^Q8?^?W5L?]A6[ST_WL=?;_  H_XAIB?^@ZEOVWV\OQ
M_P @7[1/AC_HD<9_X.?EY?UKY'^@7_PO;X+?]%2\#?\ A2Z4.W_7S_\ JZ=:
M/^%[?!;_ **EX&_\*72AV_Z^?_U=.M?Y^G]BP]KW5NW75;OTYZ,/\^G2C^Q8
M?^?W5L\==5N\=.>C>O\ D4_^(:8C7_;Z6R^_2_3U#_BHGPQ_T2.,_P#!S_K_
M (;TO_H%_P#"]O@MQ_Q=+P-V_P"9ETK_ .2>/QZ=Z:?CO\%._P 4_ OL#XDT
MK/U'^E=./\:_S]AHL/>]U;MTU6[_ !_B_P /PIIT6+G%WJ;,J2?>U:\R"4.#
MMW 8X]R>V.*SJ>&]:G3E*>-C**BVU!:RLK\NVE[6]7Y'1A?VAO#.(Q%&BN$L
M8G5JPI\WMW://*,>9W6ROK_D?Z :?'GX)S;_ "_BMX$)1S$2OB322-RX8C*W
M1' /Y4X?'7X+YQ_PM/P-_P"%'I?''M=?YS7\<7[ _P ,O!?C/X8^(]1\4:7/
MJ]_!XMO[:.XN+VY?9$F,+N9R>@& /3TK[I_X4'\*/^A53_P+G]/][\/_ *W-
M?Y>^*WTZN$O"GCKB'@7'\.8O$XCA_,)9=/$J=XRJ0LW-V>WO?+\_]?\ PR\(
M<T\1^!N'N-L#C:>$H9_@</CJ>&G%U)1A4M+EO>SMM\S^CD?'7X+*./BEX&_\
M*/2_I_S\D]?KZ^U+_P +T^"^21\5? O(!P/$6F'IQU^T?IC/?O7\Y(_9_P#A
M/P?^$73_ ,"[@?\ LQH/[/WPH/\ S+07T"W<_KG)^;D_IWK\X7[2C@:+N^&\
M6]7>U>7E?3?77IY'Z"OHR9[H_P"UZ">CUCWY;Z;?\-ZG]' ^.GP8'7XJ>!?Q
M\1:8/U^TX_\ UU2N?C]\#[96DN/BSX!A12H)E\2Z3'DO]U5+78!/XY./I7\Z
M;?L^_"8C'_"-'G@XN[@GKV&__/M7SG^T1\$/AG:6WPVM+70!'%J?Q#T6QOB+
MF=)+BTE=P\!(<$C'&,D]_K]IX?\ T^.#O$'BO*>%,)P_B:-;-,32P\)SGSI2
MG4CJW?STLNW1V?B\0_1[SC(<GQF;U,QI5OJ5)U94XK1PT^_71_<?U7_\-%_
M9<#_ (7#\/3N'R8\3Z1ACW +7F,\^P.?PK0'QU^##@$?%'P,01G</$>E8Y[9
M6YP2.OX\5_,S^T-^RC\"/#'P5\;:YH/@M['4[#089;.Z^VW(-O<![4B127!P
MVYL]>N>PK[>^'/[*_P !KSP!X)O+KP)9SSW?A;1+BXD:>8M+<2Z? \LS'=RS
MMGKSW^OZ+]*OZ7/#/T7,%PUC\_R7%YE#B*52CAU0FDZ7)>6ZM:RA;IUZ'Y+P
MUPGB>(JN)H0Q-*E+#14Y12^*\HJRMVO?=WU\C]CQ\=/@QC)^*7@8?]S)I?\
M\D_T^F:3_A>WP7_Z*EX(_P#"ATW_ .2/Q_\ K\5^4O\ PR?^S]_T3ZQ'TGF_
M^*IO_#)WP _Z$.W_ / J?_XJOXL7[8;PRT2X0S;_ ,'/RM]K3^ET/K/^(3X_
M_H,C^/;S:]/D?JW_ ,+V^"__ $5+P1_X4.F__)'X_P#UZ7_A>WP7_P"BI>"/
M_"ATW_Y(K\H_^&3O@!_T(=O_ .!4_P#\51_PR=\ /^A#M_\ P*G_ /BJ/^*P
M_AE_T2&;?^#GY?WM/7_@A_Q"?'_]!D?Z^9^KG_"]O@O_ -%2\#_^%#IO_P D
M=_\ ]>*7_A>OP7_Z*EX&_P#"BTS_ .2:_*+_ (9.^ '_ $(=O_X%3_\ Q5'_
M  R9\ ?^A!M_^_LO_P <I?\ %87PRE_S1^;/_N*_+^]_PX?\0GQ__09#YW\O
M/U_(_5T_'7X+]OBEX&_\*+3/_DG\*!\=/@P?^:I>!L_]C'IG_P DG^=?E(/V
M3?@!W\ 6Q[C]]+GZ<.?UIC?LH_L_C&/ %H.?XI9>1W_C_P \4?\ %83PRW7!
MV:M[I>U?EV;?ZZ^@O^(3X_6^-@K;[]D^K2Z_@?JRWQS^"Y8_\73\#<8S_P 5
M'I?IQ_R\\Y^M(?CI\%@NX_%'P.O;GQ%IO/\ Y,_0\>M?E1_PR?\  # /_" 6
M0],RS#GV^;OS_P#7I#^R=\ ,9_X5]9R+D$_Z7/P0V!QGL../?TJG^V \-XQK
M1GP=FB;E345*J[KF<5?6[TOVLM+Z7*?A5C81YGC(/:R^2=[VWW_X<_6K1/BK
M\,O$FIP:1X>\?>%-;U:Z!^SZ;IFM6%W>2A068I!%.\C  $G"GO\ AZ0&#<CE
M>F[L3Z<\Y[<BOYW/"OPN\%?"S_@H9^S-:^!=);0;?4K?6SJ,-O<RO#=#R;ED
M\U&;:2",+P<#D5_1"-VXL2 .00,MDMG!(_AX'6O],_ SQ<R[QN\/<GX_RK"5
M,#@LRUIX6J^:K34&HOF=[N[]Y7V^1^=9SE<\HQ]?!5)^TE1<4YK:7,D]/2^H
M^BBBOV'>4I:^\]$^EDEMTO:YY$7=7^\****!A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11119O:^FK .O!I
MF%(( ]CU_GUI6^Z:B&>@.,_Y%%[;64FK1<MD^C^0UNNFN_;S.2\2^/?!G@Y(
M'\6^)]%\-I<N([-M9U&UT\73_P!V%KJ6+>1C#8ST[]:YA/CM\%VR3\4O YP0
M<CQ%IA'U!%R<C/IFOR-_X*NZ#8^)_CC^Q9X<UJ*6[T76/'EQ;:Q8I<3107D&
M)2L<\2%1(O'0\<8QWK;/[)GP 61P/A_8HN<;5N9E4<8P!N.WV XYK^$/I2?3
MAX2^C!Q'E?#7$'#V)SC&9M@%F<*U"JU%4_:.E:W+=.\&FC[7AG@ROQ)@J^(I
MXR"5&?+JFOY7;9=/+3KY_JW_ ,+V^"V?^2H^",]_^*ATW^ESVI?^%Z_!?C/Q
M2\#C./\ F8=-[_\ ;Q^-?E"/V3O@%N.? 5HOL+J<,![\C/;\#3_^&3O@!_T(
M5M]#=W&#['YNA[U_+/\ Q6$\-(VY^#LTB^6+Y8U6HI246EJU9V:OIOJSZ7_B
M$^.=FL;"S2:LG;9=M/ZT/U;_ .%Z_!?_ **EX'_\*/3/_DG\?_KT?\+V^"__
M $5+P/\ ^%#IO_R1^/\ ]?BORD_X9/\ V?\ _HGUE_X%7'_Q5)_PR=\ /^A"
MME]ENI\#Z?-1_P 5AO#)6_XQ#-NW\9_I+_@"_P"(3X__ *#(?C?\;?U^'ZN?
M\+V^"_\ T5+P1_X4.F__ "11_P +V^"__14O!'_A0Z;_ /)%?E'_ ,,G? #_
M *$.W_\  J?_ .*H_P"&3O@!_P!"';_^!4__ ,51_P 5A_#+_HD,V_\ !S\O
M[VGK_P $?_$)\?\ ]!D?ZZ[_ -?G^KG_  O;X+_]%2\$?^%#IO\ \D=__P!=
M'_"]O@O_ -%2\$?^%#IO_P D=_\ ]=?E'_PR=\ /^A#M_P#P*G_^*H_X9.^
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M3)QXL\1CTSJ=V1TYZS=?3I2_\)IXT_Z&SQ#_ .#*Z[_]MO\ ]5'_ !!?,/\
MH.I].B?9]EYK]"_^)G,E_P"A17MIU]+]/+3_ (:W^J9_POGX)?\ 15? /;_F
M9M([GG_E[_\ U=Z0?'GX)$9_X6KX [=/$VD>N#_R]^G_ -?BO\K;_A,_&?\
MT-OB'M_S$KSN>?\ EX[=_P"E(/&GC/'_ "-GB'M_S$KOU_Z[_G[4?\08S#_H
M-ANNGI?IZ_\  Z3_ ,3/9)_T)Z_3_E_+R_N_UY]?]4H?'KX)''_%UO '3/\
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MH/X&6WEFY^+?@&W$I(C\[Q-I,>[!P0NZZ&XYXXX^G6HQ^T3\!N_Q@^'JMN
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MX_3_ &V#T6JVV]?^'/U<_P"%[?!?_HJ7@C_PH=-_^2*/^%[?!?\ Z*EX'_\
M"ATW_P"2._\ ^O%?E'_PR=\ /^A#M_\ P*G_ /BJ/^&3O@!_T(=O_P"!4_\
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M/]NGP5\"=$\%"7X8Z[8VEQ<:EY1,K6VTF_U5;CH$LEVNPZ#//)K]*2K'8_R
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M_?V/_&L?[)S:ZME6,Z?\PM;^[;['I]_9&BG"VM5?*JO[OGY_U?5F[_97\O\
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MW6GS^=_PUX#&VUIXFVG_ ##U6]XK\FWOVWOJF4]/T_ST_P#U493T'Y?YZ?\
MZLTNU?5?^^E_J3^G/O1M7U7_ +['^-/ZQ#_J'MI]N'EY^6GHB?J&*_Y]XGI?
M_9ZOE?\ 7S_1,IZ?I1E/3]/\_7_Z_%+M7U7_ +Z4?R(%&U?5?^^E_P <_K[]
M>:/K$=/]WZ7]^/EMKY?@@6 Q7_/O$[_] ]7R_P"#O;_)NY/3]!_GW_\ KTN4
M]/TI=J^J_P#?2G^9/^'MFC:OJO\ WTI_F2*:Q$/^H??_ )^1VT\_+RZ?)K+\
M4[?N\3KI_NU7^[_F_/\ $3*>@_+_ #U__7BFDIZ'\,4_:O\ L_\ ?8_^*I<
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MB35&!9@H\LW4V3CUS[__ %NJ^/S#_A4WC7&UE&EW W"1,',;9"_[0SQ[BO\
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M\P6"QFG^S8WI_P P]3^[Y>GW?>44F1ZC\Z7(]1^?^']*/:Q[T_P_S&L#C?\
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MTIWY^;XE**OTUA%Z=+;_ *GQ]];>OX6_S"BBB@ HHHH **** "BBB@ HHHH
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M%.25USK^)%)=?6RZ;]KG^-'U;$QE9TJD%&%^51DVX2MMIJ[>OKK<-B^G\_\
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MW^:#V%3^2ONO^74_+7Y6_!=A-B^G\_\ &C8OI_/_ !I?^VB?E[Y]/P^E&?\
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P ):/\ \K/Y[?\ APGX5_Z."^('_?\ B_\ C-'_  X3\+?]'!?$#_P(B_\
MC-?T);%]/Y_XT;%]/Y_XT?ZY<3?]#G'?^#ZG_P E_5_2Q_Q"K@#_ *)C*_\
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MPM.%+#X:A4=.E2IPTC&$8V25M/0_"[_AS1K/0?M3_$P?2[7_ .-4A_X(TZR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+\^X?ZG<,_\ 0FP'_A/3\O[OE^=]S^7H_P#!M)\*@<?\+;U[O_RS7L,_W/\
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M %ISO_H8UO\ P-^7GY?GW#_4[AG_ *$N _\ ">GY?W?+\6?R]_\ $-'\*O\
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M+^@_S^-'^M.=_P#0RK?^!_\ !_KYNY_J=PS_ -"7 ?\ A/3\O[OE^9_+T/\
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M [@ $#=U4DG  QSU]>* %HH/ X(SG'.=I;K@''I^N:0')P&4D?>'/''O@=:
M%S14;')VYP,G..?IC'7W]^E95EKFC:C<7=E8:O87EWI\WE7UK:W4,\]D^#^Z
MNHHG9X92,8615'% &S12 ]=QQ@8(ZD-VSCC'TYHW 9).X=,IC[W]WD]?\: %
MHI >0&&&;A5'+ XS\W;&.]+T&21][;QG&: $(!X(S7S)^U9\'7^,?PNU"QTB
MYETWQIX0N8O&/@;6(<B>VU[1!]J$$97#F*Z@BEMF4?>=E&#7TY5:7@YZMP-Q
M[<<8'3!&0XZ/WH ^?OV:/B_:_&3X5Z)X@CN87\0Z<'T/Q?IX?;=:7XATP_9K
MZUO$)\R.<.@9E<#[PQ7T*K+G*Y4Y^8$D\'COD?RZUY'X8^&_PY^%%WXR\3:#
M8V?AF/Q?JDWB/Q7<27:VNGS:I*09KT)(T=O;/*2&EP1O(R2:WT^)OPY/R+X_
M\(%RRX0^(-)#.6[9-V!],X_"@#T+.>E%9UI?6E[;0W=E=17EI<8:WNK.5+BV
MN%)(+0RQ,Z.%QRP8J1G!.,5;1N&R?NGYCRP/.!L(SG_:ST(QVH FHHR, YX[
MMGY5STW=\YX_*D)P3W &2 ,$<<$YP,&@!:*0LHX)VG;O)()4+Z9'4\C\* P8
M9!&"NX'G!!&?3MWH 6BD)Z ##')()&#CTYZ_6@G&<8)"[@ >_P#M>G% "T5E
MW^IV&E6TE[JFH6FFV,6Q7NKVYCMX8Y)#A5DEE=$4-_"2>35RUN(;J!)H)HYH
MY@'AE1@T4B,H975QD,CJ=R,I*D$'- %BBD)QR2-O3/(^;OUHSP,]2<<=,'IU
MYH 6B@\<>E% !1110 4444 &:*** "BBB@ HHHH **** "BBB@ HI#GL,^H[
MX]?H._U%8^L:WI.AVS7FLZG9:39*VQKS4+F&SM8V;A$DGG>.,22'Y47=\QZ4
M ;.:,]N_I7 0?$OX=32".'Q[X3D=V"1JNOZ9DN<9C(%UN9\D !<@Y!Z\5V4<
MZ2F-XI4ECF0212QNCQNG7>LBDJRLO*D'OSQ3::W7]?Y@7:*;N''5@WW,8SP/
MF+=NO0#J/SHW*" 6![$ $G?Z<9&/\*0#J*:64=QAL;"<@#UW\<?AWZT;QR<\
M+]XX)X/1EQG@_P!* '44F1U'S!AE6&,=.-P.#U].U .1U7<#R.1Q_LYZGM]:
M $8C!S^'U[5DZGJ-EI%C>:KJ5U%9Z?IUK/>W<\[A(HX+:,RNTDC$+&@53ELK
M]:U'YP$*E^"5.0V.N 2,=#GKS7$>/]+\+>(/">L:!XRN[>T\.:M;M8ZM]IO1
MIZ3VD_[J2W-V63RWDW[0@;+9& <T ?%G[-VFZU\:OB_XW_:8\53>=H5E/<^#
M?A39!,VHTRTD>&\U>VSQF651Y<R<N"3N(Z_H5%D+]<9 ]><^W?MZUR/@GPIX
M;\%>%=$\+^#[.*R\-Z/91VNCVT)#1PV2+^[(88\UG!+&<Y:0G<3GKUZM@ %3
MD]TY ('4]QGCWH ?11_GBD+!02<X Z]A[$=23VQWZT +1566;9&\TC+;Q1(9
M9I)W$<21J,EO,)"@ 9RSD =\ 5RUMX^\$WEREC:^,?#=Q?.^P6<&M6$UP&SC
M888KAI"Y.  %SGC%4HM[ =G15=&#R?*S9(W!7!!9<=5_GCZ5,2P )7U)QSQV
M  YW$#/I4ZK0!U%,\Q2 0#\WW2<=>X..?_U4NX$%A\RJ-W&<L".-H(Z\'.:
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MOZ_X=@%%%%')#NON?E_7_#L HHHHY(=U]S\OZ_X=@%%%%')#NON?E_7_  [
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MJ[UC2M/FLK;4=3L]/N-1E$&GP7EU#!->3X.8K:.1U:9\CA8PQZ\4 :]%,3/
M9@,L5))SD_PE/56ZC/Y4H;)Q@Y[#N>H/3CMQS0 ZBD)&1A6.>B\!OU/X_2C=
M]X?W<#J/F)/1?IGD\T +11GDC!P,#/8GOCZ&B@ HHHH **** "BBB@ HHHH
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MB-'\26MK\,?(OKLZ[J+K;6T=KITDD=VCO-M+OO0B-<;F. O.*^7K/5--M?\
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M/<^!=.^Q:TFI6$-KI-L^E0FVUBUG$*[;Y$Q*\X?S&ESU&*^&_P!ISX:7&E_
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M_P""I5W>Z9^PY\;;K3KRZT^ZCT1 EW92/!<1!YXE8I.I#QD(2?E/./:OR"^
M_P"P'^Q9XX^!GP^\;^-_VN]<T;Q5KWA"UU;6[-_B'9Q-INH/&[W"-;S:BDXF
MMS@^4T>XD *&K]=?^"K!W?L)?'5/E!;04B!;H!)<P(W'?*L1G(Q7Q-^S!_P2
M0_83^(_[-_PC\;^+O!>J3^)/%/@+3-4UJ_7QG=6\*ZC<PR&:Y6W$HCA$3?-Y
M8XP/F]MHJT4W=>:5][::^5ON^8'1_P#!'O5?'ECK/[47PTM_B#KGQ5^ OP[\
M<V^E_!OXC:Y<27DNKV[DC48K:XD+ 6MF-J1Q1DQ_>8'FOM;XG?\ !1']G7X6
M>--4\!3:KJ?BCQ+X>+)X@T[PC87>LOHK*NY_M_V*&9("2<D.V0>.#7YG?\$S
MG_X9^_;:_:C_ &._A]XGG\:_ /PUI4GB+2;PSK='POJ&UI9;1M0C+HS2(S6V
M2[8>/()Q70_!#XV/=^/?CAJ/[#G[*#>/=.OO'FHZ/X\^)GBZ_CGM=3UZTGDB
MU)3>W8W1V,,JRC[.%V$)SP*7(O/\/\@/U3^#'[8WP0^//@KQ7XZ^'OB1=1LO
M!,=Q<^)M-F1X=1TI+5&EF^V6LJI/$RQQM@,G7@9->1>$O^"EO[-OC[Q-HOAG
MP?JNK^(+O6M3DTI+C3M-N[BSTV]CE,,D6I7$<+0P*'!&)G3CGI7Y ?L4ZOXI
ME_:B_P""A*>(M&T'PO?WW@*]GU_POX3GC?PW8:HEO,0MI% ?(\YB-TIC&"V<
MX-?8W_!*WP;HF@?L3?%7Q-H&@Z;<>*]0\0?$'47O9[*&YOGOXDOS;A9G0R((
M2 T2QL,$9ZXI\J72^O7S:_K[P/LOXH_\%'?V;_A;XOU+P)?:[J?B/7]%B\[6
MK3PQIUWJRZ,C#>5OY+.&9(0B9+[F&T*<XKV_P!^U-\#_ (D_"F^^,_ASQQI3
M> ])M[B;5]1GNTB_LM[4'[1!=Q2%6@EC;"['4.3G K\S?^"-_A7P7XB^#WQC
M\4>(].TK6_B#KOQ/\76/C6^UJ"WNM5:P>YN%%A,UT#+;6:1DJJX"*@P#BOE_
M]N;_ (99\*?LP_%_P1^R]JM_I\0^/W@G3?C9;:=>7,NEZ>=2U,_VO:V\JXB@
MM)#M%PL)\KDAC1RQV_X?^OZWN!^E<'_!5C]E6:^AB?5_$$'A^ZU :;;^,9M$
MU"/PVUP9?)#C56MA!Y.[@N9 A!^]7V1\0/CW\*?AG\+&^,GBWQ?I5G\/FL[:
M[M==AN(9(=22\4FUCM'1F\^2<C:J1;G9LC&:\ \<?"GX&_\ ##VN>&)?#7A(
M?#>U^#,]W T4%C]GM[A- \]=2M[P+NCO&N<2K.LGF><NW/.VOYYO!VL:UXG_
M &7/^"7_ (1^)%Y>7WP?UC]J_P 5Z'XD_M:25M-U'PKI%XK>$8=3FE(5M/\
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M5V_[7>DZ;H7_  4Q_92UK0]/M--U>]T;4;:YN;*&.TEO(EB<Q1W#0*GF+&4
M4,K'M3Y%>VO7\+>7F!]^?'3]N/X#_ +Q-!X+\7Z_<:EXODC\X^&M!M9M7U>*
M$ DO)9V<<TB* ,G>J\9KG=,_:J_9X_:<^!_Q@GT#QG<V^@Z'X3URW\>VJ*UA
MXF\.6?V9ENKAK*01W,$L*9,;!.ISGH*^ /\ @G9I?A_QC^VG^V!XJ\>PVFL_
M$O3/%4UCI46O1I<7FFZ%NV1RV$=V&,44D9(_=1\C)R,9'L?QFTG]COPCJW[8
M^C?#-Q8?M":Y\&O$VH>/](TV=O[,6T:Q=A/]FA7[);7<A)) ^;V[T<B\_P
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M+PGX?U37KW3K-3)=7MIIUI+=3VT$8!,DLL4;(%]^]-;KU0'\Q'[(O[.WA?\
MX*&/\1?B]^TU^U!XQTGXGWGC[Q%HD/PLM?$:Z*W@_3M/O98+2VL]+N+JWE>,
MQ@'<B,KXW,5-?HY^RI^R/^T1^QW^T8NE>#?B3KWQ>_98\8Z0XO&\2:F-0OO!
MVJ6Z[4%NIFEV1L3PL197'SGISS_PU_9]_8+_ ."@_@U/V@?A=%>_"WQ_K\][
M]ON/"7B'_A'/$F@ZI;SM%=_VOI431[YI),R2,ZCS6(/&#CR/X=^(OB?^P_\
MMO?"#]G.Q^.>J_'[X;_&1-4M+O2]9O%U+6_!$L:2/;S7$L,LQBPR#:6XVY&>
M:V^_T:TZ?UO^0'ZD?'']MWX$_L_^)[;P5XJUN]U3QI=1BXC\,>';:YUC58;8
MY;SY[>SBF=!MY)E"@<5UGP _:S^#/[20UF#X<^(O.U?0O^0UH6I0/9ZO9D=3
M-9W213*J="0A7WQ7XH_LK2?M!^(?VNOVQ==\$^&OA;XG\>Z/X_GT:RN_B+J$
M4>O:;X<CDVV2Z+;74;N;&2-F$CP[0/[W>O4[SX2_'KP_^U)XA^+&I:K\)?A]
MXQ;X9^)(=4\!_#S5(9=3\0SBP9K>^N=.M8U D$C%D=@"#[BH4$TM7JK_ -:
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M*!?\% /@[\8_V<M3\(^!-=\2^'/$MUXG\,W6F2WVGWVBG6K%-5M$,NG7$\4
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M.< 4ZFKGH3DCC .0!VX[''7WYIU9R5FT 4444@"BBB@ HHHH **** "BBB@
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MZU\8:M^R[\)OV*_V8?VDY=8TSQ/\8O!?Q%\0:UXT\7>'88#+JT']L22RW?\
M9B*I<QV88LF%!&!CH:_5USL(#_+DLVU,,PP!\PVDX4CL>U5=0T^SU6RN=/U*
MV@OK&]MWM[NTNHDFMYXY%VM&\3@JT; D,I'.:KF\I?<M?7\ /YC-2\.?LXWG
M[(NH7GA[]KSQS'\/K_1;N\T+X"M?W U^QU*=)1:^%Y;0#[7Y2R,L3QE1%M.
MY.5'ZJ_\$F_AMK_PR_8Y\&Z;XATNZT:?5[Z_UBSTR\5DN[6PNY6:S^T*X# M
M;F(X89SGO7TM;?L>_LV6>K_VY!\)/"D>H+<I>(5TZ(0BX#[S)Y!'E9+Y883
M/TKZ.M+:"TB2VMX8[>VBCCAMX($6**&*,!4C2.,! BK@ !1T%$I)IZ_@!>7[
MH^G^?RIV>,8'Y<T@ "]>1VQU]Z*R \"_:8^!>D_M'_!CQE\&M>U6]T32/&5B
M;*^U/3US=6T6Y6\R)NJR!E7!_6OR>TS_ ((K7.C:7:Z+IG[9_P ?]-T2QMH]
M/L=+LM=G2UM;->(X+>%778C*2I501COQ7[ND ]0#V.<D$=QC..:;L4  #IP
M1D;3U'&#GT(P1S33:V; ^%OV/_V$_A/^QWHWBZ'PA=:CXB\3>/'V>,/&.O2O
M=:]JQVD".:YES((RSF3;D@,<\]!XGH/_  30_P"%=ZMX[/P=^/OC_P"''@OX
M@:Y>:_X@\%Z1(ZZ:=0U&=Y[^:VD0AXI9S*X9UW'GH*_5?:/EZ<#&,#!&,9YR
M=W'4D_C1M')Y4GG*X&3[@Y'3C^E/FEW_ "_R _,#X(_\$QOAI\"/&_Q)\9>%
M/&_B>]N?BAX7N?#_ (CAU:XDNVN);Q76?4C*^6:?=*Q&2=H],&OIW]EO]FGP
M]^R]\-+CX8:!J]]X@TB\U?4]7>[U)-[L^IR.]Q;,<<Q8=EP<\'FOJ$HK8R.1
MW_7^?)]>G'6EVC SU'.!P@;U"_SY]?I1S2[W^2 _,#Q#_P $WM*L?'7C/QM\
M%_C#XT^#,?Q&,Q\5:#X9F<Z5=W%SO6XN+>T7"03S*S!I5P>2<YKT7P!_P3S^
M W@GX'>,_@7J.FS>*-.^(-S/>^+]>U0^;K6KZK<GS!JDMTP+_:(91OA.28ST
M-??(4#IW&&R!Z?P\87MV/]2! ,;25P>@Q@C_ &B<DG/4\>V*:FUOK_7H!^2S
M?\$P+B?PDOPKU/\ :3^*%Y\'8W,0\!F]E\I],$@<:1/?AO,:R9 (WB;JG'2O
MJ'XD_L0_ WXA?L^Z%^S=-X?70/!'A.&QE\(3Z2/)OO#FKV&7M]3TZY3$BW;2
MDRR2*P9FSN)Z5]D]!QCJQ&1TSV^G ]_<4@50NW'RYR1SAB>N0<X/I@C'O1SO
MJ@/QW^(7_!)ZW^,'@_3/ GQ9_:+^)'C;0/#9ME\-66H7$GEZ?):;?L[W.'Q<
M211HB*TA.-N>#G'UQ\:?V*OAK\=/@WX%^$OBRZU&)_AO8Z9;^$?&-DYMM;TB
M]TFT@LX-0MIU*O'.P@0D X/XU]H!   /X<X)Y.3W/3.!@#/3 ^E!0,"&^8'&
M=PY./H>N>_IU%3S/N_O _+FT_P"";JZ]J_@V?XR?'KXA?%CPSX$N[:[T3PCK
M,\L&F/):,IMVOXXY/],,>Q2'DX+ -GI7Z;V=G#IMG:V%A"EK9:?##!:0)@JM
MK%&(XU(]%48 SZ$]!5_:-VX 9*[&SDY0#[HY&/U_I2;%P> O(P5ST&/E.<Y'
M X]J5V]P%0Y53G.0#D#&>/2G4?YXHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** #CN6&.<KT&"/O>WKTKY'_;3_ &3_  ]^VA\$;_X)^*_$.J>%],OM
M>T77!K&BN%O(;K1[DW4"Q=OF.".F3WKZW89'U!4YZ;6^]^/H>U(%4 #'"C&/
MX2.>H_O<\'/Y4 ?A4G_!%Z]DBBL;S]M#]H"[TI(8[)M+DUZXCMY=/A18DLF'
MF B$1)Y051C8  >*_0/X"?L0_!O]G[X'>*/@=X5L[B_T#QM%>Q>+-4OF9]4U
MM]0ADM[BXNIFS)-(/-?JW(/?-?:9'7'']T=@??.2??I2!0&) "Y !91\V1SQ
MG@<\\?3WJ^>7<#\HO"?_  30N? WAS4?AMX7_:-^)&D?!Z\N[F5_ 5I<R06M
ME;7<C-/96URGS00OG81GD9'K7:_ [_@FU\._@+X#^./PZ\*>,/$$_ACXV:=>
M6.JQ7[O-+I'V^%HI[JSE;!EFE+[V<G[^#FOTH"@8X'?<,##\]6&.3Z]O;/-&
MT;F<=6ZY^88XXQTP,=,?C2YY=_R ^>_V<O@+H7[.OP5\.?!'2+^Y\1:!X;LK
MNQCN]30&>_MKTOYT=QG<KJ5<KC!! [U\8W'_  30TKP[K7CNY^#GQN\<_"/P
MW\3+J]NO%/A?P]*W]GM-J;%KTV";E2T>8,0SIMZDBOU2VGIP-WWR!@^VWL/Z
MT! ,X)R<#)"\@= 1CTZX/M[T*3_JW^0'P#X>_P""=?[/&B?LU:G^S'-H#ZCX
M3UN_EUG5=8N#NUF]\3EWG/B)[O'FB_,[&4N&RW '3->,WG_!,2Z\3>$]!^%O
MCS]H_P")7B[X0^'I8D3P3=7,D,5Y86S[[;3]0O%9GNK>&,+$J.1\B@9/2OUE
M*CC&1@DC'8D8('LW .<\#K1@9SVSE5XVKQ].3GGFGSO^OE_P?O ^-/C7^Q)\
M&?C5\)/"'P>NM*;PSI'P]CM9_ .I:$?L-_X8OM/1([:^L)(L.)CY*O,P;YVR
M2.:^2?B!_P $I-.^,%EHMM\7?V@/B)XYF\,7&G3^&)K^=Q#I9TV2&2-2@8QR
MRNL>QI7&_:3E<FOU_9 RA3TW;B1P1SGY#_#SR1D@\XQ2[<@@XYZ$#!!!X/H3
MZ\<TN:7?\O\ (#XA_:!_8>^''[0?@GP!X=US4M5T#Q%\-+32[?PCXXT2X:UU
MS3I=+B2.*5)H\2'<R!GC9L,2<\<5Y?HO_!.ZWO\ QQX.\7_&;XT>.OC!!X"D
M@N?#/AW7KB1-,AN;7_CVN;B"-PMS-$0#O;.<<CD5^EY&[&>1@ @C(/&"<<=>
M<\_CQ2!0H4+D!#E0WS8Z<9X../7ZTFV]]0*T,:1110Q(L<44<<44:KM6..-0
MB(J]@J@ "K73;PS8.<YZ <DD=\=A2;5'(&.<]_\ &G=P>F,_7G@X[9QZ@T+?
M:X'RI^U/^R1\(_VO/ D/@OXI::\_]EWDFH^'?$5@&BUC0-1=/+^TV-RA66)P
M N=K8.T=#7YKV_\ P12T7%MIFK?M5_'+6/!<?#^$+S7[LZ3<6H)_T21?,+&
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MK]D_&'@WPS\1/#UQX8\6:19>(_#VI/#)+8ZA&L]M<Q#;+&^QLHSJ2&5SE1U
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M7/V!?#'C/XO7/QW^&OQ!\1_!GXCZM;):^(-4\+.4@UJ)8S&&O;50(VD .=S
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MI(,D?-MD>2,YCR"<MD QL>FT;N@SCH<TORZ=K/\ X('Y1:)_P3"F\(^'M<\
M?#_]H_XG>$OA/K\UVLO@6SN998++3KF3,MAIMPS^99V[(3'M085&P&ZBO7/&
M/_!.WX4>(/V<M#_9MT/4-5\+>%M"UZR\0OJEM,]SJ>I:E!.+F>:YDD)9VNI
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M1U1)7RRM)A<Y"KUX]R\_/[N_RZ@?$%O_ ,$P=-UN?P?I?Q7^.?C_ .)_P_\
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MW_7R\OZOZ ?E5>_\$T(O&=QX.L_C5\>_B#\5?!'@O4;/4=-\&ZW/(FFWAL9
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MU>1VE74I[AAYAN(YF:2-]P*G QP*^^=H)R>_!4#"%>W')!'J,?XFT=.H_B!
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M .,=..F,TFP9R0"3RY[D]L'L!Z<GW])N J_='^?:G444 %%%% !5>;*E7))
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M (!^!OAWXCV]MK^O>+/&/Q7M;NV\8^.=;N9+C6KL7B.':)I&81QJ7)5$5<8
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M6-1UOPGHFH:C=Z@\4<M[)?WTUE)+=RB7<-\KN<C.<FKB[J]NMON7HOZ^2 ^
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MCX6U;5IC<BY\5W6J7/FZU/<3+*DT-L',2R+E3@X%>[_>Z=%?I?K;OMZ[@/\
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M.G[,E[I[Z3X ^(4UE=V7C>TTM(ENH8IK?=;JEWL=8%N#P"-PW4_<_O>6B?\
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M6.VN;B6TM2S2LR(D2*J_* .@\Q_;V^%?A/XQ?'[]B7Q[>ZCXEMYOC#-X>O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^?39+LKK?[OEH!\D_#+]H+]GK]H#2/$/Q+_:?_:;^..C>/\ Q#J>I)X?\/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 1R $#+$<Y QW7H?8\U$%7!+DN<Y"GH,]< <#Z59HXZ$9&/\__ *J
M*KC/3.!@[=QQN'0XZ''!&:/WB_=?J<G///J <@'T/8U9VCT'Y48'H/RH @RQ
M4JS$@\GGO['J.>>._-&XJIY)&0>2>.>QZCU..2>:L=.@I#R.WXC/^?;WH \^
M^*'@^3Q]\/?&G@>*[73I/%>@:EI"WK ^5 ;^UD@6=POSL$WAV !R17SM^PW^
MS)?_ +(_P-T_X/ZCXDM_%%Q9ZSK6L'5+.$P1NFIW1F6,1,H'R [22,_6OLG'
M.<#(RJEB22IZ\_PGN,9YR:0(!D_>Q]P'@\_>#,.3G'4]>].[[L"KY9&5W'<.
M"')9_7?N.2 <\ <#'%2D2L!N8LH!!&XX(/!R.Y S@GD=>M3X!Y(!.,9QD_B3
MR?\ ZU+2N!7 ."J]^A;YF4#G )Y XZ=*15$9X&#G)Z?,3W;'WN#@9Z U9Z=!
M28'H/RH A4*,C&%))VC(&3WQG'K4])@>@_*EH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH K[-V>,^H[?B.AI2C2'YB,+@ 8 X4Y ./0_@:GZ=!10
M!'@KN;C+$YP.QXP/0<YP._-0;6&T1DC9G;CKSUS_ 'O?/.,^M6Z*+M[@5!O.
M0Y)! &TGY1CT7HOOCFG(-A+*2"1C/7CTY[>GIVJSCV_2CCGCD^WUSF@"N%>3
M())_=O$,GC#@CY@.O;GVY[5\"?LR?L;:I^S_ /'_ /:'^--YXLM=9M?C7JT-
M_9:+9PO'-IJ12!V29Y $<C:>5)(/%?H)P!QD'V&/3N#Q]<4S:,+NY(R?F&_:
M2/X2>?T]:=W:W0"N0&&23)D<%QDC(Z<YQ@\<=2,^E&"1AB,<9*\,2, $L,'@
M>]6< ]0#^%&!TQP.:0%9=Z;MK8W#!/?ZYQG/OUI0OW<9!!&"#ACVY;J<]\GG
MO5FC [ "@"- WS;@OS$$X Y([GU[YSUXIX &2!UY-+]/Y?\ US10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% #AT/^]'_Z&**!T/\ O1_^ABB@!O8?[J_^@BBCL/\ =7_T$44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M #AT/^]'_P"ABB@=#_O1_P#H8HH ;V'^ZO\ Z"**.P_W5_\ 0110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 .'
M0_[T?_H8HH'0_P"]'_Z&** &]A_NK_Z"**.P_P!U?_0110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 .'0_[T?_
M *&**!T/^]'_ .ABB@!O8?[J_P#H(HH[#_=7_P!!%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 X=#_O1_^ABB
M@=#_ +T?_H8HH ;V'^ZO_H(HH[#_ '5_]!%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M([XSP3^/% #J*.G!Z^E(<XX.">GO0 X<G'3KS_\ 6[TASC(&>?452D<H-S'
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M?;Z^E !11Z^W7V^OI1G].3[4 %%'I[\CW^E'3KQWH **.G6@'/3G/(QW'K0
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MT5Y<6\;LK3%>-P0';WQ5R(L3SZ\\=<C@_B>GK0!/11Z^W7V^OI1[]NN?;UH
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M+F76(-*>:#3-87S,NZ36D,2RN<CSL@$C%?='QB+?\*<^*RD@E?AUXT(ZC.-
MU$]0,YR.W(K\<O\ @G 9+?\ ;_\ V^K33 B^&_\ A(+)MMOM^S)J1G#3*@3@
M.>2Y ^]D>M?L?\8P#\(?BLS'Y/\ A7/C=3SC=GP_J.!GJ#Z$8Z\TERW5D[W6
M_JO,#^3?_@CMXOU']G3XZ?#R^U>[N7\#?M5-XT\--]HDD^P:5XC\/:SY-C,K
M9.)KB.,QC<02'/O7[P?\%2/BQJ_PZ_9MU/PCX4F>+QK\6;R/P;HOD@^9&FIY
MBG:,+^\($*OD]1G)Q7XO_"CX7W.J_P#!*OX8_'CPY'(/&G[._P <O$WCVP,
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M4+%P&!8(,]:_HZ!S)\V&*X50_P!Z1#C>1MR-H?&T=SS7\T?[8?[/>L_M+?\
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M[6&*_1S]@OXR^!_C'^S#\(]6\':YIVH3Z;X/TO2M7TZ"[B-[8:C8VRPSV]Q
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M7^ON^7X!_-9_P23_ &]1XL^.OQ;\ ^)O!?QFU.]^)OC?5-6TCQ1K-E-=>'/
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MZ^3!\H!S@8Q1RKMM;]-OZU Y7_@D5^W[IMS\+OC-X<\:>"/C#J^H^!K+Q/\
M%S5_&FK63S^';_2A>W+)X>L-6NR!_;L"C;)9F<*N#E0 <_N-^RQ^TEX4_:O^
M$6A?&+P3HNMZ!H/B&:\M8=.\0" :I;O8S&*7SOLTDL 1R/EV.6[GFOQJ_8("
MG_@F5^T\%,?$WQ,W/&J@B0G5''W1NR!@;3@8Q]:^M?\ @C/K>D+^P=X(O)-1
MLTMM&O\ Q-+J<C7,4:Z>8[V21Y+PLX2W^1&($FU=O?K0XI]+>G]6 ^C_ (!?
MMU_#O]H2[_:2M/"OA/Q;I#?LR>(]:\-^+6U=+$#7;G0K&[OKB;0/)N'S;RQV
M;QQFZ$+F1DRN 37Q[X=_X+>_LX>,V^']AX#^&7QH\<^(O&>JW&FZOH'A;PVN
MKW7@$I??8K6Y\7W5K)):6MK>D// R2NRQ(QD"G@_-?\ P2PU2SUJ[_X*OZOI
MMS'=Z?J/Q,^(%W9W$;"2.6WD\/:Z8I87CW1O&ZG.58@\;<BO>/\ @A)\//"G
MAK]A2/QOHOA_3D\:^+/'/Q'_ +:UM+:*34M1.F:K/'I=F]RR^8T%JK;8XF8+
M\S9!^44<L>W5+=]0/H_]JC_@J=^SK^RKK6C>"]:T[QA\1_B=K5E:ZE#\-/AQ
MI1UWQ79V]U"LV+R"(M'%)$K8DA#9!!&RNY_9$_X**_ /]L:;4]$\"OKWA#Q_
MHJAM7^''CVP_L7Q9:09^=GL9#R%.00GS9ZCFOQ+_ &,]0_:+F_:U_;&\8?#/
MX)?!'XL?$VP^*.HV$FK?%[Q7?Z-XJ\-Z?%*5AL_#5C%#.4LG0_O)[4*8]JX<
M L&^CKCX$_M4^,?VWO@[\<_%W@7]G3X"^)=#O)(_%&F_#SQU-<>(?'-G+CS(
M=1TJ[-M)?3;1N$BQ29^4LV<DYRBU=Z6_2_\ P0/Z"-1U);#3KR_DBEE&GVEW
M>S6L:[KFX2TB:0I;)_%*X38J?Q' QZ_S$_#[_@I';#_@JEX^U&^^&7Q]OO#7
MB32-$^&NC>#AHMU+<>%-3CO8;*Y\3:EI!79:^'KR8-.MVB@B-PQ=N<_T]%B6
MRZD,^UVW ;HF.%93_=&Y> ,AL\]<U^+'PE=!_P %I/VA5=(-Y^#?AKRRH#2'
MY;;))(R& Y('3!()/-5!)IW7>VG^'^KK5 ?'?P]_:]^$W[)/[>?[:?C?XF3:
M[>SZW)ID'A3P9X=L)]8\4^)M0=!+]ATO2X@S-<*N[^$*#G)R,']3_P!CG_@J
M-^SY^V/XIUOX<>'M*\;?"_XG:1&]X/AW\3-*_L7Q-?Z8/]9J=M;!V58HF 4V
M\K)<LI)2(H"1\.?L=?#;P/XK_P""JW[7OB[Q+X=TO7];\*"U7P]=:K9P79T>
MXDE\XWUEYR.(;EN52>,!E0[0<<U9^/WA?0/#7_!;3]EG5?#^E6FB7WBGPAJ4
MVOW&G01VS:S/;Q2Q(U\(@OF_NRP\Q\DG/UK1QAV=[76BL]5IOVN]OGH!]_?M
M@?\ !2C]GO\ 8VU"P\,^-)M?\=?$K5$BETSX6_#VQ76_&$T+CBX-E"Y$8FSN
MBAE(D8 [4/.*/[(G_!3+]GW]KO6[WP5H5GXM^&7Q,LE>[N/AE\3-+;0?%<EG
M@%;Q+:4A2A'S)$K;VYV*<$5^-7P4N_CO>_\ !2W]LGQ-\/\ X.?!SXN_$[1O
M$XL='_X71X@N]%U/PUHMNQ^Q7/A*WACG:5-@*M<QIYD*L?)*D[A])?$+X+_M
M;_$?]KKX _&SQK\-?V;O@;XY\$^(('U2Y\(^.;J\\0^/-)9PKV5WIU\L$^I&
M"(_Z.#%)CDDYR2G!::+5=/RMT_K6X']"R$NW(& 3SC:S^@4\8YR&^G:OYF?$
M?[2OPQ_9;_X*A?''XA?%#4=0BTX>$HK;1=%T>UEU+6O$.HLVY=/TNSA5Y9[A
MB0$11\Q8#(ZC^F*,L3'YN#*(QYF&P/-:,&81CUSR!T''0YQ_/3\._AQX(\<?
M\%D_B=?^+O#VF^(+CPWX5CU'0DU&UANX+"]6156ZAAF5HUN4*@K(/F7&0:SO
M#JG^B^X#[2_99_X*P_LZ_M0^/I_A9%H'C_X1?$,H9-$\,?%C1&T'5-=M%?/G
M:=!N,@1U^9!,%8@BKWA7Q-^S-+_P4Q^)?A;1OAWXOM/VG(?AAH5YXB^(<^I&
M3PEJ'A:2.$V>GVFG&[;RKBW4JDDGV)-Q#$2$XS\@_MW^&M"TW_@IQ^Q?K^G:
M5I^G:OJ4=\FJ:E9VT45W>+$#'!%=E IE7 503NQCDG!K3T5KRV_X+._M-3Z:
M&;5(OV6K*XTL#)F^VQ:-YEL8F7) 6<(8D!W;L<4URMZ+[_EY_P!?>!](_M/_
M /!77]G/]FGX@S_"BU\._$/XT_$72=[>)O"OPCT4:_?^&XX\^;+JBE@<1J&,
MZQ"0Q%2)%5JUOV=_^"L7[-_[3_QK\*_!#X5Z9XQU'Q!X@\)3^)[[4KVR@L+#
MPM?6R*=1\+ZW#-,M]%K-BYV3I% \(?@/VKY1_P""*7AWP)K6B?M%^.M>L-%U
M3X_:E\8O$D?C;5]9BM;SQ=:6WVFYCAM ;T&ZLM/GMV=IXXBL=PQW2\X%>=>&
MO!OPD\&?\%Y)+3X5V>A:0NH_!I=5\5Z7X;6T728O$=[:F6[N&ALSY-KJ-Y("
MUY$@#"0?O%4D"JY8[6_K[[_\,P/-/@[^V'\*_P!C_P#;8_X*">)OB&OB+Q!J
M.M>-+.T\)^"?!^F7.N>+?$]XK_O+?1]-@5I9/*"E6D8*JA@2V*_6#]CW_@IG
M\ _VRM6UWP;X6T[Q=\./B/HL5VUU\.OB38QZ-XCD@BB):46YD+*0,,8&*R@9
MRN>#\)?L%_#?P9XC_P""G_[=WCK7-%L=4\1^#O%CP>';N_LXYI=$-XRBXGM9
M)$;RYI%7"M&<H"2N"<UI_%#PGX;\._\ !97X7:MH.CV&C7FO^!K^;6+BPMHK
M7^UKMK5BL]VD05)9RQ^:Y?\ >L, GBBROMT[:;_=?] .4_8J^(</PG_:._X*
M+?$?4=%U;Q-;>$M:?5;O0]""2:O=VEK*995L8KETB$B*#P[H2.C#K7[*_LU_
MM,^ _P!I_P"$=C\8_ L.H:;H%VEV+S3=<-NFHZ7+8%UN+:^6VDD6*>(Q,6RY
M&%.3BOR>_P""=VD6/B#]K[_@H'H.IQHUAJ_B.[TJ^1OWC-%=3-#*!N!WG:Q*
MMV]J^8M#^.%S_P $^M+_ &U_V9[ZX>/Q!J%Q?:I\%K7 2&ZMO%4LUNPB8D;Y
MXS=DJ(\G(P:AJ\FEY?D@/W-_9J_;'\%_M1>(_BCH7@;PKXITZR^%7B&;PSJ7
MB36A8?V+JU]$7$LFCR6<\LLT:%2@:14(SR,@UL?M=?M5^&/V/OA;!\6/&/@_
MQ;XN\-+K6FZ-J@\)QV<UUHL6H3QVXUB_^VS0Q+86[2*961S(%SA6XKR#_@F?
M\$XO@K^REX%M+R!5\3^-(I/&7B>ZDC"7<^J:ZPOVCNG(#S%&G8*')VJ=O&*^
MD_VB_A#X>^//P/\ B=\)O%%I]KTKQEX3U;3BJX,L.H"WDFTZ6VSS'-'>QP'<
MG/RE<\FDHMMKL!TL7Q7\)-\+$^,3WR1^"9/!W_":Q7TD@79HHT]M1S-+G8)'
MC B7+;/.=%#=:^3? ?\ P4@^ 7B?]F";]K/Q<VM_"KX9KKFM:%IT'C2"VBUK
M69M(N?LT-YIEI9R3?:(-8<'^S@I+RJ"75>E?AQ%^UKXRO_\ @G/+^Q%=7K7G
M[1=S\8U_9>&FQNT-_!X';6!!%K,<083N;+3(6CG+J(\\[CNP/T7_ &LM'_9U
M_9,_9:_9P^ _CKX3?\+U\16EUX;\-_#+P.]W)86&O^.8 F=6UF2, &Q6]=I+
MCJP1@ #S3Y'Y?U\@,73_ /@O+^S@_B&SLO$?P9_:#\%^"]1U"*QL/B=XF\&/
MI_@NXAN)!';7]M?NRF2VN,AT*DNR_=#8(K[X_:*_;J^#?[.OP9\&?'G71JGB
MOX<^.-3TS3].U?PR+1DAM]4"&+4KW[9- $M( P,NQC,"K81N!7X^_P#!0O4?
MVW]8_9,UZT^*_P .?V:?@]\*;#2+#['X.TS5)=:UV&.VV"SATA-0A7[)?1*1
M&JV@_=R*QZDD^:_M2:=9^(/^"1/[(6DW^;K3]2\>>!;.[BD(=9K5M103PRLQ
M)8,A*E>5(.*OE3Z=ORTU_P @/OZ[_P""G_[-O[2&@?%WP%)\&OC?XB^%^E>#
MKK4M;\8C09-*\)>)M($,AGL]"UUI(4DD WJ'\X'<<AB,8^D?V;OCE^R]\+?V
M.-'^+GA:"_\ A#\!]%L;JYMK#Q=?_;-0M1&=Q@$AGN9+BXG;&Q4DD.]ANPN2
M)OCOX2\.^"O^">/B_P .>%-'L-"T/3_@W:_9K'3K>."%$DTB)I9&1%0%I79F
M9A\QW$YP:_-/P7\0_@=X$_X)>?!F#XV> YOBE'XC\51:;X$^']K<S6</B#Q/
M-<QII\%_.I7;8-,8UN(Y/OC*@;>2U"/]U:VUUWMKU[_FT![!=?\ !?#]FB#4
MXA=_!G]H&W^'US?+:#XKS>#'A\""'S #?-JKLJBU4 2J0=SH/D0]*S/^"R_Q
M+\%_%7_@GGX#^)G@;Q#:ZUX.\2_%[X7:WI>NV;,(&TY[YIY'E5?FA,$2-]I4
M@&,QMG&ZN)_:NNOVW]5_9!\=:+XG^#G[+W[/?P0MO!,OG>'6U#^U]3?3C!'+
M9C3K"^@2UM=<@C$=N%MR[EG9RQ;%?"/Q!E@OO^"$7PC2[E6ZLV_:"\/Z?=,D
MK%$T]];,-]$I)(B@2U:=C&ORI'R!UI\D5_*_G?\ ,#].M&_X+:?LM> )?!G@
M"_\ "/Q6U3P9I&E>'O#>J?&[3/#<C_"RTU6*RM[>[@_MV9X_.:TFXE\K<W/?
M'/J7_!5GQOX9^(O[ =UXX\$Z[9^(?"WB/4?#.J:)KFF3"2WOK*YN5>*1&0G
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M _3G]C3_ (* _ []MO1M:N_AL==\.^*/#!V>(_ GC"U2Q\3Z.'?RU^VVD;R
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MXL\4^--6@\<ZMJMS?7#7-MXIM([68V]LDOF_Z+N,(+.61CC'T)^R3\!OC1X
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MV_BWPJ9O[<TVX5-RO:K &F\V1RJQ^4K,>F,U]-8'H/RJ-XDDXD560G)26-9
M O\ $JL"I')QD'&,]:OF7\J_KY ?(W[#FF?$#2?V7/A=8_$W5?$&N^,(]+?^
MTM6\3RR2:YJ4"W4PL[V_>7]XMQ=6:PRM&W(#C([5TW[5_P"S_;?M0_!;Q/\
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M:#D%DVARH_@YY7'7'/6ID@C,GF#R]X(4OY:;XU QM60C<I;NN>/;G+V . 4
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MWK3F[NW;_@ ?S-_M\+^RA\0_VO9]'\1?$WXH?LA_&OP[IBQ+\5M/M)--\/\
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MO>F_MC_L/?#+]LCPYI-CXHO=4\(>,?#%U]L\*^//#LK0:SHDZ\H8I$V-*BN
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M=BYM+I(RMGJ5G)@F"[LI#YL$B?,ISBO9O+7.<#.<]*7:N0<#(]A0G;4#^?\
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M/_L]6/P#CUF2X@LO !\#G7C;)'++_H'V$:CY 8HK@'?Y8./>O>C$IZ<?@/\
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MLUU!>7>EW!(@NI;602VXF ^_;I(H+(>#W'- 'YO_ /!*?X(:SX/^'7Q#^/\
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MXOUWQ)^SG^U!\5/V?M-UZ^N-1N?#7A2\D338)KF1I)EMU$JA8PS'RT"X7)'
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MMOH<5K'-'JZ7!)8RW#,'B9,G:5'4"GZ3^R!8>'_VT/'?[9J>++R\U'Q1\/\
M3_!H\$I:((;==*B15N([D'?-<78B"" @)E\DYK[D\H>WY"EVX)*%EX502H*C
MIG;T[@ -_>XZ4 ?R6_$6P_9!^*W[1GQE\0> OVF/BS^P=\1[/Q)>6GC[PU>0
M3:!;>*M3@EDCN=7T\*WE26<[;F0H?F#<9!KH_P#@F5\'O -Q_P %,/%'C#X)
M^-?%GQ=^'7@+X5W$?C#XS^(X[A_^$L\?:F8OMEI#/. I1)3NCV$Y16X&,5^_
MWQ;_ &(/V7/C9XAF\6?$;X0^&=<UV7RQ<ZNMK';W=X4!P]S)%M+2QD_?;<6
M.>IKUKX2? _X4? W06\-?"CP1H?@[2IG$EPFD6D<$EZPS^^O)54//*O3>Y^@
MY-:1DWIKZ_Y@?.?P"_8[L_@3\?OV@/CI9^,+G79_CSK*:S>:!/9QQPZ#*K ^
M3!<!B]PI  ^<#'-)XP_8TTWQA^UOX._:J;QA<6M[X1T&;14\+?88Y+6]\^)H
M_/:<MO0IU 5<?A7W(8P?_K@&@1@=_P ABGRO^9_U\P/@'X&_LH>'?V6/B?\
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MUP,/'RBF10<,O':BF[1?JU^*_P @/S2_::_X)8-\9/C%?_&_X2_M#^/OV?\
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M)^)?[1FI>"KN.]\+:7XRO9);+3[B J8'.Z1PZ1A%_<%=K8QN%>L_M;_\$O\
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MQ42:;T_I_P!:?(!^,<>G'Y4445(!1110 4444 %%%% #AT/^]'_Z&**!T/\
MO1_^ABB@!O8?[J_^@BBCL/\ =7_T$44 %%%% !1110 4444 %%%% !43,<X'
M;TI9"!@G.!G..N.,X]_2O@K]O7]LFY_8P^'GASQG;>$G\:WWB/7XM!L](CW1
MR2W-QM,*1X^8NV\*/4_7% 'WH'(_^O1YC<]*_ ZX_P""LO[2>FV,FMZI^Q9X
MT31K:V6^NYX+>>21; )YKW*C81M\L';G.>O2OU _9-_:P\"?M>?"B'XE> (I
M[.Z#7.GZOX;U$"&_T+7+=&SI]\C8(S.H4-A>,Y]@#ZQWDE?J.AZ]*E)P"?2O
MCO\ 9G_:HLOCKXB^*?@#6]$D\'?$OX1>*[GP]K_A6Y/EW%UIV]O[.UVR#8+6
M%_$ID23!4*.&QR/L N,-CYFVDJOTX(;_ .L!0 >9[?K_ /6IAE.[&!]3V_E7
MX]?M6?\ !3/QU\"OVE;K]G/X=_ W4OBGK=IX.LO%\TFF&1KF.UNG=61H8_F/
ME;"2VW&,=LUXO+_P6!^+/@>2VUCXP?LD>./"?@A9X1JWB""SGD33;65PK74Y
M,9"1H,LS-@  \]ZKD;L^_P#7_! _?!7R>V/:D,G) V]3_GK7B7A7X]?"_P 5
M_!^R^.UCXGL+?X<W>B?VX^M74\<<-E;"$3/',2<-,@S&4W!BP(%?DSXF_P""
MQNJ>)O$6KV'[.7[./CGXK^&M&N)[67Q=#8SKI6HR02&-I=/E$9$D;$$@!B=I
M'TH<6E?3^K:?B!^Z?F$=<?Y_&E$F?_K=_:OS,_8^_P""DG@']IOQ)J7PN\5^
M&=4^$OQFT<H\O@GQ.IL[C4[=ER\^FK,$>3RV&"H#$]1QT\Y_;(_X*4^*_P!F
MK]H32OV>_ WP>O?BCXGU3PU8^(X8M.+&YD@O(S(8TB3+'R< ,<$'.>*4%S_#
MVOZV _7C>?04HD/(XYQ_DU^!FI?\%:?VD/#MK/JWB7]B[QK9:-IP^T:G-%;S
MRRQ6<9)FEB0(=[(@)XX7'-?J3^R1^UA\/?VPOA-I_P 4_AZ\MI +I].U_1+[
M"ZAH>I0?+<6-S'U6:-\KR!SP>>M\FF^OX>GK<#ZG+E<+QUZ_D?\ ZQIXE)(7
M@C/;_'\:YKQ!KUCX;T+5_$>JS+#IFC6%SJ5[<=1#;6D;2NFT$%I756Q@XZ>E
M>&?LQ_M+^%?VH_!6K>/?!%A=V>@:=X@OO#]N]Z09;JXT^:6.:<!<8C8Q$J#R
M 0/K$8/E7:_7U_K_ " ^G*4DGK4:[R,]00"KGY5![@@X)/IC\_52Z[MN<<#D
M\ 'H/]X$=,<TVFOR_)_U_5P=13#(H)#?)@X!/.X<_,,?=&<=?6G#<0#C''(Q
MG)]5Z?*.,GOG ]Y 6@G )]*:&!#$\ '@M\F>Q&&YZ_Q=,8XI%+2' R <C!4@
MK@9R2>"&Z*1BG9]G]WS ;O.1[=AQ2^9[?K_]:OA3X6?MD1_$;]JWXF_LT'PV
M+*7X?6"WO]N!\B\W$ 1%<\,,[C@=*^Z-C;E4#(/'F]$SZ 'DYZ @\GI2U6Z
M>DFXD>F?7W_IS4F:^#?@E^V2/B_^TI\7_P!G\>&1I3_"R1%;5M_F'40W4A03
MM+=1@<=#7V]J-XMAINHZAM++86%Y?>6?OO\ 9+:6<IMQDDE,<=LCKB@"^9#Z
M ?7_ "*D!R,U\+?L._M@+^V-X,\<^*X/#?\ PCP\&>.M=\%O;[MS7C:/=-;"
MY4$G9YH!;!Z<\8K[E7<FU&'[Q]S #H54#O\ PGZYQ0!+2$9&#0IW\KC&<8W
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MDY["@!::5!.>:%)<94CY>2W577'!3!R?3O\ TH)V_?P.3QW( SP,\<]<YX-
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ME(0#)^4!OD)/5F&3RH&,>YKY5U?]J3P=I'[5_A#]DQ;*\N/'/B;P/JOC^>[
M L[+1=.BD,8)/)EEDC9.#SQ@57(_+[_3I_6S ^KJ*:&#-M!Z9#''0CN1U5?<
M]>HI%+%B&PN<;=QXYYR#_&"/3H>":@!]%)S\V.@; 8@@ #J3D_-S@?+CUI<@
M$!CM+#Y2> 6[C;U^G.: "BF;P3@9R3@'&X _[0'(SSM'7BG;@!N;*KSRPP!M
M/S%FZ*#_  G'7K3L[7L M%,\Q<\<@@G).%_V07/&6/ )P.E*6"A=P(+<*!@E
MCUP /[HY/KCBD ZBHPX..0>3DC@%>F%R?OYQ\IZ\FGYY(Y 4%F8C"X[+G/##
MO]#TXH 6BD!S@>P)DQB+!!^ZQ^\V<# ]Z0-D@$'=@,1@C"]SSU[8'UHU>R =
M130=P&PCGY\XR @.,'!^\3G'L#QZ-,@7[P*G .&&  3A07^[NXSCN/2G9]G]
MP$E%-WC+ 9^4X*D88YZ%<GYE'4L..P[FE<[4#8W9(7CIR>N<].OT/!HL^W6W
MS_I@+13<DMM!^8_[+$#ODD8' X//#4YLKG(P!W/ /OGMQU![T@"BF>8N6QN.
MP#<0IPV[IM/3&>N<TK.%"EC@'[QZCM@+CJ3T [G\: '44UF*G.UL$@( -Q)8
MX!)& H)XP>1WI&?:0I'SC[R9P3G&"AZ87/SGG'M0 XG )J/S#[?Y_&F$LSA1
MCV.X8;(X"].A(W9[>E?D#^T=_P %/M8^&'[05_\ L\?"/X*Z]\6_%OAR'3[G
MQ?-IL;O!H\-_)&(Y'\M2458V).[J1VH _8(,Q[9QZ?Y-25R_@[5]0\0>%O#N
MNW^G/I-]K&C:?J5[I<N3+IUQ=VZ3264HX(>!F,9[94^U=.3@XP<L,H&^7IUW
M$\'GIC']: %H)P"?2F!B2?E^4 $Y^7:3T!))!SV/0=Z'8!BN1TY&">PW '.,
MX/ Y/?F@! ^0<\'''Y4!SP#T]><U\&?$O]LQ/A]^VO\ ![]D1?#)O9OBMX7U
M/Q&GB)G"C3_[-1Y&MBO\32*F%XX)K[PE!4LY.44GGCL"#GT*\\<;N@Y- $A?
MC&<X)Q]"2:89&'8$U\I?$?XY^/?!WQX^''PKTCX9:AX@\*>,K:2?6O'$&3::
M RR>6B2C'#.,-M)! ]Z^KS&1G&25'.1C)S@$>H_KR.*=GV>OE_7<",.XYVD_
MCG]*DWG (QG/^3^=-*L'"8(Y3G&5*D@,0PX4C(X.>:^(?@W^UY'\4OVIOCQ^
MS;_PCGV&7X,+9,^LJW.I"[7<,*>P_O#CG/-%FN@'W#NY ]0/S]*?G'6H,,'
M/!)W*I7(Q_SS+YV^81R/J*D#;N!@8'S;OKRHQU.,?0YI+73N!$\K X7'\_\
M/K3Q(<#(Y_*OE#]J']K#P)^R^GPYB\56MW?ZM\4O&FF^"O#.GVA#%KR^FAB:
MYG;HL4*2>8P/0#K7!_M#?MBQ_ KXX_ OX.'PX-4?XSWPLX=49P%TL A79^QW
M?\LQWR/3%7R2\@/NP/SSP*DIA5E;A6P!DYQ\P_V6'&?7C(^E.R2#@KN Y .<
M _=8\]".O0YY]:FS73MZ:^8"T4W=QNRNT]"""JX&278<<\X Y[=:=AB 1@ Y
MY;L!_%CJ01R ,>_%%GV?W %%-1PYVX(;GC(./0D=?<XZ \T@<,V 05!P6'W3
MV(#=%(/KFBS[/[OD ^BFY.#DJI7EL\A5ZC)!Y)'3IZC-+R0K*N589 ) 89/!
M(/4$<X'-%GV_IZ@*3CK4>\]A_7_"O /VH?C>G[.WP6\7_%B73/[7_P"$5MH[
MAM/Y N/,95&TY!(7=\V"2#SP*VO@!\5!\</A%X,^*,6G_P!F)XLTN'4A9@[A
M K@Y0<Y)^[@].<FBS[/[NX'M-%1[\X4,-S@A#U4L/?OD= .A!R:56+#[K*1@
MN"I)4>WJ3@GCH,9SS19]G]P#Z0G Z9]J:K!BV&! /.1M(!X48/4D@CTSD?0W
M#G) P,$$;6WD\  GH1WY]?:BS[/[@&[S^IZTY&W%OP^@KE_&/B?3O!/A?Q%X
MNUIFCTKPSI-_K>JR1C<8;'3[>2ZG('.YO*C8@"O)OV:/V@_"G[37PML/BUX)
MMKFW\,ZQJ6I66F&[_P!=<1:=/Y'VDJ!^[6;[R!AD@'FD!]"44T."< @KR?,'
MW0/[I'7=^/X4IR,8'4[2S$* W^Z>2/H<]:=GV?W +13"_NO0D\\'(^0!N@+-
MD8.?ZT[)4$NK9! .U<XR.,#G<,_+D8YHL^S_ "\OU 6BF!^&R5Z\,#P/9AU!
MSQ[=^!2;\;MW&-ONJ[O5QPQ] H!HL^S^X"2B@=<$KG!VX/!(/Z8[BF[ASC!V
MXW 'H>^6Z?CCCO2 =14;.00-HR><;QG(Y\LC^^>S?=/I3\\#((X!8<$J#[ @
MX'=NGM32;Z?T] %HIJL''&"<G.TAOE'<#C.>WI2Y.!\K9.> 0V,=,XZ]LJ.1
MZT6?9_< M!..M,#CC=\H;.TG^(CKCTY_A.3WI6)4Y/"\9 7<R>I8@XVD]&QC
M'7O2 9YI/ 'W>Q]^_P"-2@Y /K7S1^TM\9/&?P:\):3K_@GX?7WQ!U.^UVTT
MVXTK3U,\MM:7,RH]ZVP'"Q+\['@* <U[WX=U*YU?0='U6[M6L+G4M/M;RXLW
M&3933PI)+;28Y\R-F*%1C!4CZNS[/[@-P\C%0&$<8Y_R.N<YJ7YA]X$;B=OR
MD;5XQNYSG.2?:HVF53@?,2 0J\MC.,X'4$\=MHRS''%-1;Z?Y?>!(HPH&.G^
M-.IK.%(!(!*Y^\" W783P 2.AZ4@?.."NXC:""S'/<@8*@="3G/&.M'*_P"O
M.W^?2_4!6; ]Z9YA/IP2#3V /7C%>4?&/XP^ /@9X&UGXA?$;7+?0O#>BVLM
MS+<3LH>X>-"5MH$)!>:0X5 .I/ -2!ZGO)Y&./3I^/-/5LYS@5^"+_\ !8WX
M@^+[G4=9^#G[)WQ \7?#_3YY5B\23V5PG]J6L38-Y9*L0+1,HW+][(YS7W[^
MQQ^WE\,OVP--U2STBQU+P=\0?#+^3XI\#:_%]EU73'!VO,(7"NT 8'D+]WG-
M%FNENH'W>')8#C/T/2ICGOVXKXXT_P#:IL;3]J75OV:?&6AOX>U*;1(_$/@7
M7Y3ML?%MEG;-!;%NEU!RSC<WRX^7O7V$) " P(8#+ #(Z_PMT/4?4\<&@ :3
M:>F0/SS_ /6_I32=Z\J=IP?3]:^,_P!L[]M/X;?L8^!=/\5>,[:]\1>(O$FH
M+I/@[P1HH\S6_$-_+PGV6W :0Q1R,$D.TY.>E?FW)_P6%^+OA6*+Q+\1?V1/
MB!H'@ R127.KK8SBXLM.F._[9<1-$1&D<)$C$@#WHU>R _?  !@!R.,?_7J:
MO(?@M\9/!'Q\^&_A?XJ_#C41JGA3Q/9+=6THQYD$VT?:;*<\A+BQD/ES*>K>
MF:]=)^Z.C,,C/W2,9!Z\>F"<DT[/L_N_KN M%1A\OM'&."&4C)/1@W3;GMUQ
MGOBG$MP NXX)/15S[$D]!R<T6:W37R =129(V\9)Z+T9O<9)  '7/US@T@;E
M02/F+# !_A)!&[.T8QR>A[4@'44F<;-Q +G@=3CU&#R/_P!?2@'/*@L"2 %&
M><\$MG 'N1SVH 6BFEL=P>1CG"L.<X?IG'('/I0"3C@CJ3\I) '52!RK>F<Y
M]AU=GV?W .HI!Q][Y3\W!XX !!Y/3G!_G0-W.1@<-ZG;WR.N>N/;K2U[ !.!
MG&:9YGM^O_UJ\._:1^*/B?X._!?QS\1_!?@ZZ^('B/PO9V=SIOA.P#276LFX
MO[:UDBA5!N+QPRR3<=HR3QFO0? >NZEXJ\$^$?$^K:5-HFI>(?#FD:UJ&C3C
M$VD7>I64-U/I\P.#YEK+*8''4,AH [3MGM_C12'*(NX$$XRH&[H#GD>G4GH!
MUSQ30X(! SG"J0007/4=N!W/8XH ?10<CWSG;['LK<\G.<@8QQ49<ANG&S=@
MC# C[P;G@'L30!)148D#-A>1QSW!./EV]6)[$<>U/.0#W(/( R0#WQG)QT..
M1Z<&@!:*13D9P1R!@$'KC![=1SCL*:S[2<C !X).,_[.#T8]CT/I3L^S_JW^
M: ?32H/)S2YZD= 27_O(!V*]23ZCC@\4GF)P"<G!SV 8=02<XST7/?\ 0L^S
M^X!-@'(./<X^E-W[1T+8[]S^%2##AE&XD8R,8VD\CD]1].OM7P=_PV7%_P -
MF3_LFGPV!-%X>76UU[.2VX_ZLJ#CH0?7'.119WM9W] /O('(!]:*828Q\_08
M7Y5+?-G SSWX^G.>E*I)5F(P5'*]3D'I^/4#&1T-%G:]G;T 4G )J$2,3C;C
M\ZQ/%6N+X=\*^)?$?E^>N@>'M:UTQ]!+_9&G7%]Y!ST9S!M;T!/'>OS\^#/[
M<?B#XV_L1ZU^UCX*^&UUJ^OV=[XDL=+\ V4FZXU63P_JD>G-]G^\S/*':; Y
MPO:EJ]D!^D&\^WZ_XTY6SG..U?G%^T'^W1?_  !^&WP!\<:_X#E75OC/K'AC
M1-1\/W+F.X\.7WB!PDD<P)5LVK':0><CG-?H=83F>TL[UAA;VSMKH*%)V">%
M)""PXPA8;CC&#0!I44U3N.!M.,=&!+J?XD'H/?K3FPH7<<%CCIP2<X YX.<9
MSF@ HHY(. <@XZ9&1UYXR#SR.!QG/--R2'V\,#@*1R#G![C?CU7CD'IU !FV
MC_/YU"TI$8;JQ/0<=^,CTQS5?4Y9;:RO;E(C(]O:3SPQJ/,:2:*-G6+:O+%R
M  HYYKYF_9O^-GCKXS6GCBX\:_#?4/AV_A7Q1<Z'I4&H K)KVGPRF--6M@0,
M02* PZXSBG9]G]W<#ZH4D@$C!(SBEI@8[<A?EQPX((; Z*H^8DXP!GK2-(!W
M/\. 5.[+< %<Y!SVZXI 244F&.>,$$=1C*_Q$<]N<?A3=ZDKAE*L#L8<ACT
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MD\%^ Y?%EG<V.H^-?M=H\*^(F:]1);I;YGQ#*K2XM_+.\L:^J_V:?VK?#O\
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M8^%?BS3/A9_PLF8_VQ\3=<M);C3--1G540M&,)L/WR6&W))X%4?V6K?_ (*
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MU[X _'WPWX<NKCX@^ M1U[2K?X>^*[2SMK;4(M6O-%>-38-+ _FQWDBJZ?\
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M9BM?AOXAFT)?&OQ9T_0?$;Q!6%]ID\\2/:DR!OO;F [?A7Q3^WC\1IOV5/\
M@H3^S]^U5X^\+:]>_!<_#NP\+ZMXFTNU^TQ:==F&-'FNAL=+>*+[Q\S:[!3M
M!R*\!_;W_;H\"?M=?$_]D1/@IIVNZE\,_#WQAT6XU/QWJ=A+I^E:EJ=W=1;=
M/TLW"(;A[<Q!)&4L%))&*/Z_K^OT ^Z/VS?VN?V@?$_QS\%_L<?LH:UHGACQ
MU=>&+'Q7\0OB%X@N8;>UT>WDMXIC:KYNT-(,[C''@R-]W=@5X?-\>_VY?V"?
MB)\,]>_:1^+W@CXZ? SXB>+=.\(^*M1T"YADOO!]UJ4R10:B8 6E,:.Q4D8"
M[?FXKQK]O#X6>#/@G^VUH7Q^_:*^'_CWQC^SE\3?"&C:7>^+/A[J6L:3/X*U
MP6D<8_M.\TMXF2RB"B67SG42*P6++9K@O$ES_P $V?C=XW^'GPC_ &4_@]\4
M_P!I;Q%XJ\3Z;_:<^I^,_''_  A/A"VAECEGO]6N'N6,-Q9DY!DV E#@GL?+
MU ^VO^"B?[5'[4_@C]LK]G7X2_LQZY!+:_%?X<S7UKI%PN;:>^U.Y:*U\03_
M "EREC:R1W @7EMA)!!KR/XB?$K_ (*2?L&?$?X0^,?CI\5M ^+'PW^(/BVP
M\.ZQI5C;R6[:7+J4\0G WJ-WEB9]FWHRBO7OVD]/@T7_ (*\?L)Z%"D%BFF?
M!VZT^"W$GGBU33V:TCMX6D+3R"%(E1)GR64!G.2QKT'_ (+=2Q1_#KX"+,P1
M6^,.BE"2 0_VFV.03S\Q/0'GICM1S?#91>G6_3EOM_E^J8;G_!07]LWXW>&_
M&GP=_9R_99@L[7XG?&2QM=5;5-07S/['TB]5";E1@L'CW98C&X XX.*\[\#^
M%/\ @KK\ ?B=X"O?$_B#0_VB/A[X@U"VB\::992KIT^@65TX6XE#W8"N;-&+
M$(?X1@5Y?^W>GC']GG]I?]D[]M)?!^L^+OASX7\"Z)H'BV30K.:_N=(MY;:&
M66\DCCCE2-8X29#)* HQU]/8O%W_  6&T#XO>-/AK\,?V'O#NI?%OQ5XIU2R
M/C"\N],OX-,\'6%S(JWW]J3+%M2YM$9R1O$)=1@GC"5]-%Y_AZW??>_<#G?V
MA?VJ/VJOVC/VD/$'[-'[)OBOPU\*K'X:6EK_ ,+!\9^(KJ!8X-2N8C(UI%E@
M9O*8,K-&2%(Y'-9OPD_:9_:S_9%_:,^''P5_:U^(/A+XR> ?C-=KH7A3QGX7
MNH6DT?7IF46JS+N)6+S"1.6/( V8R:^)OC+\./A7^S5^VM\0O$7[;'@7XB3_
M  N^,,%EKFD_$?P/K6O:-H_AW4)HM][%K4^D21"6)924$4C%\#&WK7?_  PM
MOV#?CM^TW\)_#/[)7P-^(_QHB\+^)+77=6^*GBOQ=XPD\*>"H[1D=+_3OM-R
M\+W$1))@N3B4CA3UI@>P_M@?MA_M%^+OVX?$W[*7PU^.'A7]F_0_".FZ=)8>
M)/%\,D=GXJU&]5&$B7A*1Q0L)%1Y6?R1MW+@Y-?>?["</[9V@^+O%'A_X]_%
M3X?_ !P^&Z:>CZ#XQ\':A;WT]IJ@D+N)F@D<_9I4/E@$FO@+_@H%X^_8VU[]
MI#Q-\*/V\/@1J?@CPSI6F6O_  K']HWP\-4A?5HE@CW0ZQ>VR*EQ/'RMM;+*
M^UD!=5'->!_\$[M/MM._;Z\,:9^PMXY^*?CW]EC3O"VI#XE^(/&2W0\'N9D8
M64&DO-^[EG64F*+>3<K(,G" &@#^J/Q):ZIJ&A:M9:-<Q:?K-S8W,.CWK!ME
MK?RP,D%TP_N1RE'*]<#MD5_*O^S!\%OVP)/^"E7[0T4'QET*+Q'X+DTG6OBK
MJESI[SIXE\)&:.:VTJS!0F.9;;$6\X 8BOZQH]IE"DXVL-JG!.!PN>,YZ G\
M37X>_LG*;W_@J7^W]9!E62X\#^&[4(I7?F:&%%W<[EQG(X[4E)/8#R*^^./[
M??[=7QL^)/A7]ESQ=HOPC^$OPGUFZ\-7/BF^A>X;5]8L6:*:-A"I(W2(<*",
M9QBO1/V7OVHOVMO@E^U#:?LB_MBWNG>,Y?%^G7&H^"_'.GHT*SK$A=,*P5PI
M/!SD<Y],?/'[+_[6/AO_ ()G?&'X_?!']JO0=>\$>"_'?Q$UCX@>$OB9_9-]
M/H%X-0GEFCLFO5A9))OW@01I*?F()&,YZ'P1\3]0_P""BW_!1#X?_&3X3>"O
M$L'P,^#^C75K-X[UBRFTZRUV=(RP;39RD8G1V'"*SY! .>*J*3>NW_#6_7[E
M\@QU^,?_  4&_:/_ &K_ -H#]GWX&_$[3/!FB> ?$3RGQ!JUNURFGZ:[K]GL
M+985.Y2H<%FR<D9-?T!_!KPQX]\(?#+PIX;^)OBA?&'CC3M-BB\0^(U01)J=
MZ!^]GC7"[<GA0>H"@BOQX_X)RR0O^WU^W-@*'_X2"".3(7>JJX"C"Y*9 '48
M/7-?O(0C8RN5#!<'[WL3W[_TQ42E9I+;K??_ "_K[P_F;_X*7:I\6-(_X*G_
M ++5Q\#;6UO/BA?_  JUS2/"IOVQ:6DNHO-;3:K./^H>C?:,$9<+A>:L?$3X
MK?\ !2']@WXK?!CQ+\=?B=X<^+?PW^*'B_3O"^LZ5IUM-;?V9=ZG<Q"=<RC#
M&(2LT3+P649XKVS]IMX?^'WG[&<1,9E3X4^+7$<A4C9Y4H0JA.20V2#C@]^*
MZG_@MM)#'X-_9J620#=\=_#V6<JA#?:;3 0G&3[ YJM.6+[QN[O;X5KY:^MV
MOD'I?[1W[1WQ(\)?M]?LM?#CP_KCZ?\ #OX@^&KG6-?THPQ-)= DRJ&=U+#:
M@P2K =QTKYK\=?'O]N']M3]H_P")GPJ_9(\8Z+\+/AS\(;L:7K/BG4(GN&U'
M5X\B:+Y02I$B^7C(!)X[5K_M5^7/_P %)OV&;=I")KKX=M:)C!=&FAV*Q5_E
M(PP)(%>*?!K]HCPW_P $Q_VK_P!HCP;^T[H?B'PQX ^+7B6X\5>$OB3'IMS/
MH<YN&>9K629(_+E<Y$:+'(2&93@CJT]%[JV7?LO/R_J[ V?@/\?OV]? 7_!0
M;X;?LT_M(>-;?5]%GTR6?SK"$QVGB&V1E"7<@9%*AP-P;/4@Y[UY=<W7[5.H
M_P#!4#]LOP'^RP^F:-XB\3S:;%XD\;:LIDM?"VG1QY@"P@%YGFW'#1_=V@FI
M?!O[6N@?M>_\%<_@WXU\%:%K6F^!]%\-SZ9X;U;6K&2P?Q+:JR#[?9"6.,2V
MS\%"V[@@YR*^U/V.Y(C_ ,%6_P!O9$908DT/=AD:1,1?-N'+-^1Z<= *&[K9
M+TO_ %TZ(#SG]G'XX?ML?L[?MS>%OV4?VJO&VE?$C0OB=X4U#7O#GB?3HGAB
M@EM$WJJ^8,^;OW1N,Y&S'6OVMU'XW?!?0KZYTO5OBY\.=,U*PD:WN['4_&&A
M6=[:3HQ+B>WN+V.6.4?W)$4YQR37Y'?M7S1Q_P#!7#]C@$G<WP]\397]VQFR
M)5&(GY 7G>5&1D<CC'T3\2O^"/O["WQ6\;>)/B!XY^'6NZEXH\5ZA/JFM7\'
MC#7K6.ZO)W+-Y5M!=+%",]%C50.0,=:G=+Y/3_@_\.!^5W_!:7PA\:_%7QJ_
M9L\8>$/B=HD_PW\8>.-'TGX5V^F,MY'H_C!S:M_;[WD)DANK1LC*V[MQT.,"
MJG[>%G^T7\)O&W[!6C>(=8T_XG?M$:9>ZA:IK\:/#I>I:E?WQ&D3&)_FV:?&
M\:NIY^2O<?\ @KIX4\)_L\> OV(5T/1]3T_X2?!WXM::TTY-Q??V'H>GK;RR
MC4+P[Y5 BB+)-.P>0C8I)X-?]J+XW_#+]H?]J#_@G=\5/A9K\'B3P1XAU^9=
M,OTC:#S9[*Z^SSP/'<A)%,,P($@4;R 03GE[678#F/C;X[_X*A?L77G@OXY?
M%OXJ>'_'/@#7?%&EVWBGPAIMM(JZ)'JEU%%+;+(ZE7\KS@FU3U[5]6_\%)?V
MK_C;\+_"W[+&M_ NY6Q\0?&;6=*L#82J9()Y]>MX7ACGV XCMVG)^BX[$5Z!
M_P %I9$'[(-RYE1"/&OAI(Q( H\X:K9?Q-_L@X]<C'%?,_[>$D7V/_@F2,QJ
MLGC/P,V&8<J;*U.5.23R21C)Y_))W28'=:[\4?VNOV$_V>/B!\8_VD/B7I/Q
M2\;^+#9Z5\-?!UC;M#%I6L:QM6U@5& :XDM7D3S-H8#/(KP^S\"?\%D=9^'C
M?M!)\9/#=I<3:9_PF%G\-)+25KE=-\D7\=HC*GD^8UKA-A! QR*^Y?\ @K3\
M$?&GQ:_9EMM=^'FEW/B#Q;\+M<T?QGIN@V2/<2ZK:Z:8KBZ@,*AI9#Y:9 A5
MI&!'!Q7RQH/_  6W_9RTS]GVW\.ZEH?C*W^/5AX37PC_ ,*?31KMM<F\11V!
MTX-'$T(E^S+<@221!3(8CM5<L"'K^7_! R_B%_P4;^)OQ'_X)C^+_CMX9N%\
M#?&SP%XNTGP9XN%B4_T?5[74#:ZB;<."!'=!.58;@[$<* *_5^R\>^)Y/V,E
M^)AOY/\ A-)/@0/%W]I%1O76?^$6&H?:77_5%_M?SX QQS7\^NG_ ++?QNLO
M^"2'Q^UK5_ VK6OC3XG_ !%7XMQ>"Q8SR:S;:%)J4U^RFR2,SB:*!A(\0B$F
MW^'(KWS3?^"M/P+\0_L.V_P<^'^B>,_%7QY/P?N/!.J?#FST>Y^V>'+G3]"-
MAJ&J:S=M#Y%KI]M%')/(DA214&UL$,*7IT:T^[M;H!ZS\%O^"@?Q"\!?\$R;
MG]I+XD79\:?$B?7=:\/>'_/4#[;JMQ?2VNFQ.L8"_N"\>,@@A>.*\3DT?_@L
M-'\)[G]IMOBYX>:SN?#\GB^'X:BTD%W;:--9M>PPQG9M,L-L1\NW)P,8S7CG
MPG^#'CWXU?\ !%K38/A_I4VO>+O"'CB_\:1Z#8@W5QJ4NCZO]JO+6UBCWLS1
MI#)A2#YBC" DBOI>7_@LU^S]/^RG=_#X:#XR7X_V/@/_ (0>X^%+:+=#6X]9
MM](_LZ>\DB\G?;Z>LBM*?,C241C'0 U7-_=COK^'1NWW=_,#CO#/Q\^*?[0W
M_!)GXY^.OBSJTFK^*8-5O+9O-C*&!K>X7?:J,!L*R&,K_#GD9K@O@9X:_P""
MH'Q#_98\*_$WX1?$+P[\,_ O@WPI)+X7\%3P2RZAKUCI2/(\DDB+L5[E%)&[
M.!UK#_9ZO;J]_P""/?[0.H:I UI=W?BB_O9K4X06\T]]')/$,X96C+;75\$G
MJ/3]M_V+6A'[!G@$P[?)'PROV0KLP,Z?<9+ '!Y[X.1WS3<E&%U&-[VU5^VN
M_P#7F]0/C3X2_MM_%CXJ?\$W_BW\6=7E_L;XO_"RUU?0M5U.S"#.MZ66B>[A
M!78H=TSM(W ]0*^5/@7J/_!6+]K?X+>&?C-X ^*VC^"-"L]-DET+3-5M96U#
MQC+:O)FXE9$VAI60JH((/&<@U2_9L*2?\$TOVZPLBR(/'GC>1ECV@N_VR7Y>
M/NY( .,=*V_V$_\ @KE\!_@!^R1X+^'_ ,;=)\4>&?'O@W1I+;PUH=MI,\T7
MCV-YI_LDGAJ=8_*E:?<L7)DW.6"@D&ES7A=*/-IIY:=W_2OW ^H?V;_VZ/BS
M\8?V./VGY?'T-OX=_:%_9OTSQ1H.M7]N-J7FI:;9736^KHAPH831CHH .&'0
MY^LO^":7Q<\>_&K]BGX9_$OXB:S-KGB_6;'69]2U295$EP]K=2Q0X;:%8*@&
M!U/:OS;_ &)/@A\8O&W[,_[>OQM\0>"M1\+ZE^T['XQU3X=>#=3M9;?5[G1Y
M;"]FL'GM)8UGANKIF2/RVC5I'?* J0:\Q_X)\?\ !3CX)?LZ?LC67[.'Q%T+
MQI8?M _#J?6O#]K\,8M$O7UKQ/JU]<3BU.F0F#?;VT$S(DS7*J" TB;DJ+R_
MEANF^RT3[OR>G6_<#O?"OQ<_:7_:;_9N_P""AV@V_P 1_LFJ_#_Q7XOTOP]>
M7L&8K;PKIL5Z]YI<:PJ'D::SADA7)/WQGV[W_@A?X!^/VF? K1/&WB7X@6&I
M?!G4UU6'PUX*C@9+S3K^*X\NXEDDP(\/+\Z*/F RIY->'?\ !,2\U_QW^S]_
MP4:OI-(O;3Q-XGU7QQ=-X?V>9?Z??:AI.I.-/:"(%S?(T@B,87=O[9KZ<_X(
MD?M'_"W6_P!GS2OV:H-7NK7XQ?#Z]UZ7Q+X6OK*>WN[*.2^9R9A-&H25%'S!
MANSC&*IV6WX][+]?^'8'ZK?M,_%/4_@A\"_B/\3=&TM]:U3PKX?N[^PT]$<J
M)UC/E2W 0;MD;$,^/3TK^=?X(_&3]N_]I[0I?BEX#_;4^$WAW5KN^NYT^%6O
M7$>G7=F\5PWDZ68[F1)&;;B/<JD&OZ./V@]?\1^%O@]XYU[PWX&L_B5J6FZ/
M=22>"+U7FM_$%FD;&YM2B!VEE:/.U"K GH"<5_)3X_UG_@E'\1]"\1>-+^Q^
M)7[+_P"TK_Q,&N_AWX=354O;WQ6C.J66E6#*D,$<MRH()C4E6&W.>2#4DW)V
MUZ?TP/WS^.?[7GQ<_91_8QTCXD?%S3=#UGXYZN;;PMHEMI,Z/H.HZ_?8A@OH
MY%XDC3*3D@L"6^M?G]<6?_!6&U\ W/[1 _:0^&DEQ8:._C0_"@7]L+AM-^R_
MV@^CY+;&F^SD*BX)+G;UKPO4?@=^TY\<?^"5WAV^\1Z'XM\7ZG\//B"OBOPY
MX?UP7D/C'5OA[!/P'2?%XMTMJGFAH5\PAAY7:N2T?XT?\$CX?A06U_P[\>$^
M-=IHR:7<_!:3QAXW?Q)K/B-;412V$5JMR5$4]Z'C6()O6!D"IGI?NK5:OLUI
M\]@/UCO_ /@J'$O_  3AT_\ :UM-!AD^).K2'P-:^%(&$FWXC?:/[*DA(Y&U
M9\WB@KM*_*HZ5\JQZ=_P5^\'?#6?]I;6_B7X:\1Z7-X;?Q9??"Z.VDBN[+1+
MK3FO]\<A3RA=65L^X@@<J!W%9_C3]D;Q%XT_X)3:3/\ !'X%7?PE\5:)XXMO
MC;HWP;O-2U;5M7NX].O8Y)([R346>]74;JPC-TUH!DN64)O.#V6J_P#!9CX&
M^(_V7=6\ Z3X3\;R?M$CX=W'@S4OA)<Z)=IJ]CJL&CMI=_>W \K;'I<<PEG3
MS$1Q"H#X"DF;V^RONV^]]/ZZ@=7\,_VM_C9XI_X)4_$#]HFX\3SQ_$BSUC7E
MT[59$'VFUA@U*"&&V:,J0OD([(#CD9Y[U^E/[/7Q&\6^,/V-/"?Q(U_4?[0\
M87GPTGUNZU!QM:;4DL99HY&5,9VN@)&,]*_&O]FKPCXO^(7_  17^(^A:%I,
MM]XGO-2\7ZB=*MHS).TL&I175Q;1PVX:2210I6..,'D8Q4_P"_X*N?!/0?V-
M;3X%V?A_QKJO[0/A[P?JG@P_#6#1+D:I]MC@FMS?7,GD[;6RM^6=YPKA03GF
MH:A>[O=M:75K:7\_QV=]P/HW]F+]N;QYH/[''[0WQ_\ BSJ\GBC4OA[XO\0:
M?H,4R(L32I<O!IEKO #;-X5<9S@'(KYG\&7O_!4[X_\ @O\ X:"T/]H7X<?#
MRRU<3^(/"_PWN[R$7LVF<SVME*2X0+/ JK@KG+8ZUPG[*?PP\;_M _\ !+/]
MI3P5H6G2?\)IJ_CG5-<_L:/9,ZW=I>R7=SI"["6>X,9\L=3OSW%>(?!GXH?\
M$M/"WPJL] _:'\/?&KX>?'3P?8'1-:^'TGB_QO9W^NZM8JT!/AZS6ZCAC2_E
M7;#$$"KN_=TTHKX?GK?HK?J!^BEK_P %"_BG\2O^"=?QW^(S36GA7X[?!748
M_!_B2^TK#6+:I:W3P2W]HV#Q,(F9O[VX;0:\"^&@_P""NW[0O[/MA^T+I'QH
M\-^#=&A\*S:]HGA=K60WNO6FD6S22W4DJKB.>\6!W <[26)Y&:Y]_"7@C1O^
M"6'[5OC?P-\!-=^ OA?QMJL&IZ-:>*=6UC4-<\2Z>URZVVNWT>LN9XKF==K2
M)@*0V]>,&OV0_8Q,1_X)W?#=HMH3_A1^I$LH^5G.@W674,.O^Z,;@>],#YE_
M93_X**^(M?\ ^"?GC_\ :2^-%I;S>./A#)K?A[Q";7"1ZKK&FF2VL6:,@*KR
MW 19RB@L"S#UKY,^'<'_  5W_:;^'Z?M(^$?BMX>\#Z'KR7>M>"?AT;=FNKW
M3%<RV-N9@GE&"XC"QQF4%B&)).,CS7]CKX*>(/VB/^"7O[8'PU\&'S_$^I_%
M3Q7>Z1"K[OMMWIE]/=K8D1G'F7"V[1"/J6<<'.*]C_9G_P""OOP/^ G[-.B?
M"'XSZ%XL\"_'GX6:%/X2M?A[<Z)=I<>)-3TU3;6:Z/F ,\<SHB%]G.249@P
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MM+JWAD=U)Q'YSH220-N<'/17[:NZT[;)_P!=P/@GPW\<?V]_V_/$OC7Q_P#
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M-8U6QDM&ACU:5+U(I)9K]65S)@H5P0QY- 'ULGQB_P""@/[>'QB^*L/[+_Q
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M4_%/P=^P9XLU[X*PZ@?'EE\.-,.ER:1"]S?PVSZ?&EXUDD(:;ST@)=&B!:/
M)(QP ?F#KGAO_@JMKWAS6/B;XP_:@^%?P8U)8-2U=?A=JNKV:7%A%:1RW$>E
M27GF)#]J94 C7/S8&0<UZ%\&/V[OC7\4O^"7W[4'Q;U_6;.W^,GP.L-3T=?%
MVE%9;:^NK&_MUM[^'8-K$P)*I=,B0N&!/6O@3P#\<?\ @FQ9?!?2KKQ0OQ?^
M/G[4NK>'98=;\#27WBK5-4/C:\M"CI+I,SRPB*RU)\.5A8^2C+C&*B_8VUI;
MS_@D[_P4XT][!=$U+2-0O&U'P_.OD3Z$]W.LXTZY@D"-;R01J4\N95D4C&.U
M)_K'\T!]T_L;M_P4B_:/\,_#+]I+Q;\9](\*_"-]&>\N_!D5H\FJZ_I6F65S
MG45EV^6DVH2>7(0_.%([5Z5^R'^W!XMTGX!_M@?&GXTZRVO:?\&_'.NZ?H<4
M42"<VMI-+#9VFU57),QB#<?=W^M?8O\ P3X,/_#O7X(-"5\M_A 64+M$:R?V
M;<D,6'!/4DYZ]>E?C[^RY\'->_:#_8S_ ."@GPQ\)2B;Q1J_Q0\2R:1!&5V7
M%Q9WDEPMO(T?):=$=3M).=O>F!U_@O6?^"HG[3WAR7X\^%/C]\-OA;X<UQIM
M9\$^ -0O[;[=-H\CNVG1W&UU2.:2)%WAURA;GTKZZ_9V_P""@WC[Q+^S-\>[
MSXA:3!J?Q\_9PM[[3O$%OI++<VVNW<"2)#JMLT(*RP;D$CN@(4-DD=:_(;X%
M?$#_ ()H^ OAI;>!OVJO#/QK^&/QR\!6\VAZSX7_ .$K\9V2>);VP+PFX\/V
ML5Q'#%%<D Q+M6,@C;Q7Z._L-:5X0\._!3]HCX[_  )_9-UCPSH^M6UROAG0
M/'>LZ_J^N?%71HE<SW6H6VIO+L62!?,3[.F9BP5=Q.* /D[X)?&?]O/]J/0K
M_P"*WP]_;4^$GAK5&OYY+?X6^(+J/3M2M765_+TM8[J6,SD8\HO&I7=P:_HY
M_9\OOBK>_"GPC)\9WTN7XA+9A-?N-%='TRXD1 J312KE3]H(WG8>C=Z_DM\?
M:S_P2D^)&DZ_XTUBP^)/[,?[1T:Z@UY\-_"\.JQW5SXDA\QDATBR*1B&*:]7
M*@HKE6  -?M#_P $T_BOXX^#/[!.K_%?]JC6]?T?P+X1N=0UC1]:\76]S)XD
MMO!)NUBL+G5H)U,[N5EM_+4*2(VXQ@5G4^S\_P! /VC3.P$J$']T<*#GG&><
M\C/KU&:=_3CUZ\UY=\*OBQX)^-G@'0OB9\-]977?!WB:S6]T?54CDB2ZB8*?
M,$<P611SP&&,5Z<I.YN>R<?@>?2LP'T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_..Q^M(>>N#Z<#BA-K9@4(;***&*WBM8(;:&%;>.VBC5(8H%78L*1@!5C"#
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M#KQ3X1\/^,?#7@S2M%T[2=-\4:3::S;6SZ)9065E<K#>PS0BXCB@C"RH/,!
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M]'_Z&**!T/\ O1_^ABB@!O8?[J_^@BBCL/\ =7_T$44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 H.,^XQ2444 *>/?Z4E%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 O3^?\ GWI*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** %'/M]:2BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "C-%% !GM_GM_A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% #AT/^]'_P"ABB@=#_O1_P#H8HH ;V'^ZO\ Z"**
M.P_W5_\ 0110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 .'0_[T?_H8HH'0_P"]'_Z&** &]A_NK_Z"**<%; X_
MA7_T$4;&]/Y?XT -HIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0 VBG;
M&]/Y?XT;&]/Y?XT -HIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0 VBG
M;&]/Y?XT;&]/Y?XT -HIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0 VB
MG;&]/Y?XT;&]/Y?XT -HIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0 V
MBG;&]/Y?XT;&]/Y?XT -HIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0
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M:*=L;T_E_C1L;T_E_C0 VBG;&]/Y?XT;&]/Y?XT -HIVQO3^7^-&QO3^7^-
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MHIVQO3^7^-&QO3^7^- #:*=L;T_E_C1L;T_E_C0 VBG;&]/Y?XT;&]/Y?XT
M-HIVQO3^7^-&QO3^7^-  .A_WH__ $,44N"!R/XD_P#0Q10!)@>@_(48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
MHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/R
-HHH ,#T'Y4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g4bdklltl5z5000012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000012.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0.!)\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^O\ ]:@"2BD!STI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHS[$_09/X#O0 44F<^^,' Y8*>Y'8@\$9X]:4\=,GUP.1GI
MQ[T %%&><=\9]L=N?4YZ44 %%%% !1110 4444 %%%% !136Y!YQCGZ\=*KJ
M2S!>02>F,Y'=NV O&3SUH M9HK\P/VF/^"I7P,_9V_:J_9]_9 \MO'?Q;^.'
MB,Z->:=HFJ0!/ -F\<36FH:]M68[KJ1Y$2T)BE!C^8@DJ/T\0G?(AZ)T;UX'
M'_ULGH: 'T9J*618X9))66)(T,CO(<1JB]69^BXQSD<#FOP/_:T_X+\? /\
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M^^MNMV:1H5^12]A5J)2]^5.E4E!177F47M=)O9/J:PDSVZ$ \],],\=^U.+
M#/7G'X]Q]1S6$-:T:.<V+ZG9+<QQ[WMS<1+.D9Z2LC$'R3DA<\CBK2W]I. (
M9X9LG:(TF1]N!Q)A26'IR<>N:.>+G*$9P<HR:Y7)<TDK:I*[7FGJGIJRI8;$
MQLWAZ\(M*474I3BG%ZQE=I*TEJG>WF:1?C/?/3TI-Y/;GZ'I4"N&')![9XY
M&,]NOZT[S-F"!DM\HZG\\=A_4U2DI)N"DY0^*+5FTE=J/GZW[6,;2<HI1;YD
MW>\=+6OS)M=]+7\]B3>?;_/XTOF>WZ__ %JA9@O)S@8['\J<74X.< \J/_U<
M#U_2A/FBI1U4G:-]-=+WWM9O7_,E<W)&;BU&3M?3W=OBU>C\K]"8-DX(P>V>
M_P"E.J%?O#_/:IJ:O;5IOJX[7\A_<_-7M\@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *"< D]!UXSQWX[_2BCZ]/>@"NQ<85$R5)^3^+)!(9<\%#W[]LXZ?*/[5
MO[:7[//[%OP\U/X@_'OQ_H_A/2[6*62STE[J%M9UR=8F?[#ING._GS2RN=FT
M1LN&&1@UW?[4GC3Q9\-_V</C;X^\ VL=[XZ\&_#3Q9XC\)VLX9DGU_3M)N[G
M2X9!'EV5[F./*+EB. .<5_)#^Q5_P1G_ &EO^"BWB?PW^V!_P5&^*6K:[X=U
MR6'Q3H?P@L]1:XM(_M(%Y#:O:F62WTZT162)@L<=UY8Y7=0!^>/QV\+_ !-_
MX+O?M<P>+_V%_P!F6W^ OA'POJ*F]^/$-O-X=U/49Q,6;6+V^TE+.V65@&F"
MP.MZV<NW<_H'%_P;F?\ !3T16^[_ (*4:TA6*-6A3Q-X_P!\!5 -C2'4S'*$
MY 89) R#@BO["?@_\%?A9\"/!>G?#_X1>#-#\#>%-*@B@@L=$L+:T%R(T"![
MN:"-);N;: #-<%IB,\X)%>JJH)R<L<C<S <H.BXZ9!Y!^M 'X6?\$B_^":'[
M5?[ _BCXLZU^T5^U'>_M!Z?XZM-(@\/65YJWB2^'A^6RC*3R+_;UW<1QF?DM
MY 7DCM7[L^^<YZX&!GT'8CT/?UII1#E=H*MC=N^8Y'3 /!]\_4<TH 4 #)]<
M^OL.@'L,#VH 6BBB@ HHHH **** #&/Q.:0],9*]P1UR.@QC//M_^I:0@$=\
MCI_]?N.W(YXX- 'Y'_MI_P#!-CQ+^U5^VC^Q]^U1IOQ)T/PKI/[+^M7FJ:GX
M4U#3+^[U'Q.+A@ZKIUU;9MK8X.#]JZ] >*_5_4H9;_3[^WM9/(GNK&\M8)NG
MV>:XA9([HXP^(782$ [OE.WM6@JX"AB7^7:Y/!8#[N .A'7J,FD52%*L1(2"
M-Q&TGKM!VC'''(Y.,&@#\_/V$?V8/VAOV<?!GQ/\._M)?M#K^T;J'C3QYK_B
M#P[J1T^\LO\ A&O"^JW=S)I_AE5O?F<6-M/':M(F8Y!"#7Y4_M&?\$$/B'<?
M&SQC\;?V$/VP_%'[*^L?$V]FOO'_ (<DCU&ZT"ZNKB5GN9=,M='(5)75W9GF
M3*NV0V.:_I:*G&%8J0!S][IT7!R-N.,_>[T8P%*JI9<\MT^8G. !QUZ]>U '
MY$?\$V?^"3?@3]@>X\6_$/7_ (C^(?C?\?OB&_F^,OBAXGDEN+B=C]^'3C=&
M6Y@MS(SD)(XQ\HVD U2_X*2_\$D_!?[>NJ^%_BKX6^)7B+X$_M%?#R*-/"'Q
M/\-/+ J&([[>+5TMC'=7$$9V[EB?#<@J>#7["%1NRHV]LCK@\GCH>?7-+W!Q
MSR"<G&.V%Z9Z9H _FQ_9G_X(,>.]/^./@GX[_MX_M=>)/VM/$7PPOX]3^'OA
MEDU.T\*V-[:$&TO+W3M5<Q-<VX^8O#%^\?&XD\U_2&(HTC\F()Y,<2111* /
M*B0;!%L& $1551N' '&.*M;>.BYP<]0"Q/4$<K^'\J-H .T $@#. "3WW,!D
M^WZT ?CQ\7B?^'R_[*'_ &07XO@^G_(*@.,=.H_PK]BCU/U/\Z_'?XOJ?^'R
M_P"R@?7X"_& _EID*U^Q!ZGZG^= "4TY!SU'IW_#BG44?*_D%KZ=]/O(RA)R
M._/-!&T+CC&1^?)Z^^:DI",\$5*C)+]VX0_Q+_)/O^?JIC&TO)VO]Y 1G''W
M3G\??';V.0>N*0@$8PHYY.W_  YX[ =.?4YL  =!_GM0 !SCGKTSS^/O2E[2
M7)&?*VGS<T-4FNC77;M]_0E&T^>$I7Y;)?96SUU5[_UU/F?]J_X0ZA\;O@CX
MR^'NC&S36=7M0VF3748(AND^9)8W89ADYP)$(*]B,YK^> ?\$F_VFPTJ+::(
M[1R(L+_;HT\]4(R[%W!PWWN26W'(/05_5@1G&22Z\J2 ,,>O3G&..<^]>'?'
M[XY^"_V>_ 6H>._&MSY=G:(%@M(V_P!(OISD^5 I^8R#J0!C&#ZU\UGO#V79
ME..88^O5HRPUG*=*HZ<73A9KF^:2UWZ(_,?$#@;(>(:4,SS[,<;@\)EM)U)J
MCBIX>A&TE*3:C+=W:5E]^YA?LL?#O7/A#\%O!W@7Q7?6\NO:58B*\5+CSF21
M5/[B#>Q9P@Q]S*XSC&:^AG1)$*21^9'.K*5DP-ZE>5=2. 3P0>QQTXK^9G6_
M^"A%CXR_:[\%?$U==\2>'_A-I\$-M?Z3YTJVI9V0?:)[2)@),\[CY9(')/<?
MT*?#?XW?"_XM6L%WX!\8Z/KYEMXYWM;2ZAGN8%<*P,L(8R1-@X*NH(/'85MD
M><91F4)8;!UN;ZG>DFZSYIQ5EI=IMNSOU7W"X!X]X9SFA5R3(,QH1CDKH8+#
M^UK.>)Q,8)6JQYO>;:5]7U7H==I7@GPIX>&HG0_#FE:9)K/F-JG]GVD-NUU)
M*C))),857S&*LP+'D\DG.*_/7]I;]@[X"77P\^(?C71/!,5GXNBTV\U6WOK+
M?+++?X,\KM [,K!EW[]RGKN&,5^FX&X, =KG&2.N/?UX]O>JU];17L$EI/''
M+;S1/#<12+N2:-UV2(ZGAU968-NZY]*^@IQ]DJ,L/.KAVI>TA.G-TY0FK/FG
M.$E)]7?7I==#]KP.;8["XJ%65>K44I4_K2K3=2.)HQ24J<U44DTU[MM59Z6T
M/YDO^">/[$O@_P#:+L?C%?\ Q*@\2Z-;^'/$.D6/A6\M8((;2_M9X+A[]HGN
M(RLS6LT<<3>5PF\[BIP#[%^V_P#L!?";]G_]G_7/B#X5UCQ%)K$&I:?:6\-V
M]FMI(ETTF?,$2J<83/&<]Z_?+PUX4\.^#['^R_#.CV&BZ;YTEP;2Q@C@B>:8
MEI'9455RQYX')ZY[^,_M._ BR_:-^#_B+X8WFH?V5-J:>98:@(_-AM;R+FW>
M6-ARBG(8J,C)(-?08+'8;'<0Y7C\[Y\32PU?#NM*NY8BFH4E%3E%2<E\6^CE
M9]59FE?BWB'+L%G&%X:QM7*\+C(580PU%QIJ<*]N>FY03;C9+13=FEIT?\PG
M[.WA'X.>*_@U\6-<^(?BVTTWQSX?LK:X\%:5<WL5F][*-V[9%<.K7.["X2-6
M'7'49_0[]D;]@GX(?'_X1V'C?5O%VMW.M27$D.JV>ESV8AT]T+'RBIRX)_VB
M3T[<UXY-_P $7_BQYLHC\;Z 8XV\JWFD21BR(?E*!AN&[ _'MZ_K5^PA^RQK
M?[+/P^UKPUXBU:#5=1U?4?M4TUJ9/LZ1+CKO^4/Z@8./2O4\0^#^ ,US'$\1
M99B,-BJ^+AAZ<\ X13AJ[RBH[.';2_;73U^#_'/Q0R7A&EPA'-\SP4*>,EBX
MYC3Q,HM4O=]EAJ<G=J#DG)I)7?9*QXZ/^"2_P$Q@:_XP QN_UUH%4'@#)4G.
M>3GG\.*>?^"3/P$ P?$7C$=_]=:'V_NBOU(CD\T'8ZRXX8QNC#CD9 R0!D _
M[7YTK$@[<%7QD*P(S@9(#$;<_0U^7/A3A^G)K^S*"246TX.^KLGJKZO[KZI:
M'L_\1D\3Y22EQOG=Y;7QDG?Y[;+OL?EG_P .F_@+G:?$'C' [^;:#V],Y]CF
MD;_@DW\!04"^(/& 7KG?9$%P,!6^7/?.1FOU1B8%1N&'/\)P#Z=\#KZ&D8[O
MF7"DGG.#E><A>V\GD'T_*K7#61OD=/*\-3Y;MN46K)I:O5N^E^G??9Q\9/$]
MS37&V>-4KI-8R7NMK?:VO73R;/YO/VV?V(_!/[/-CX&U3P5>>(]2M?$'B"ST
M/4DO/(DAB:]N4C+Q^4H(95)VENA )[5XU^U+^S!9_"34_AOIO@6U\2Z[<>,=
M$%U<03VXN9!>M&CK'&((V+!BQ"@Y;%?U">)/"'AOQ=;6MGXET>QUBVMKB.[M
MH+^V@NEMYXR&6=!*K+YBL/E('&>*2Z\(^&-1DL)K[0M,N;G2B!I]S-:0RS6J
MKPH@D="\0  XC*X.,=!7S68< Y?BUBU3ITZ%3$RHJ$J*:C&E&4')VT7,W=O7
MI]_ZUPM]*7BW(Z'#;QU;'YK7RJ6.^O.OBY*&9*M*3PKQ'\WL)-+97BM;G\CG
MAGX1?M(>#]8M_$OAGX?^.-%UJTW?9[ZRT6_$J9P1Y9\CE2,'N.>.M1_%?4OV
MB);>V?XOOXW%G<3I+"?$4%U:VC7:GC8)U1&<#'RH,J.W>O[!HX(XU0!%S'G'
MIC  !^F,#T%?&_[9G[-%U^TGX(T_PYI=[!I5_9ZC%=&ZG3>BQ*0'V;?F5RO
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MTW3O!EU87?B1;6_O-.CN1!>0O/$T5O)$MTQ5&!6574KGC'2]\7?VX-!\7_M
M_"SXC:!J/BJ'PGX*M$@UC2[:]NK:*^E9E+O/91R+!<A!DDRH[$# Z'/!?M._
MLA>&_@KXF^#^B>'=3UC4;3XB/I\.IS7, :2SEN[V")YXQ"N%79(VW?@XQNQU
M#_C3^QMIG@/XY?"_X3^&M2U*[M/'UM;W%Q>W28DM69T%QY;Q83[C2,BL>,#/
M'%55J\:W4N1.U?#MQA4]RZA[DK:72^VDN]SP<KRWZ.U:ADKPCQK@\ISN>%5:
M&KPT*]-8R6(<Y<T<1&I94'/5PO[-M;_I9'_P57^ T4<$9MM:=2%)=;=LQOM.
M21MXSWZ=^:^"!^VWX??]K+_A;TNJ^+!\/ULH[4:6+V[^QEH@59UTWS!"2<\M
MY66]37VQ!_P2.^#C6D)?QCXJ6X>*+S"B6>TR;-Q)'7:6[]<<\<5^?$7[&>AK
M^UM_PH6YUC6!X>2".\365MAY_E2J2(LX\C(P-K9R><G/7W,QJ\>P=!8FG@WS
M8FDU.E+52DER<]HKW;7O^6Q^?\%4?HQXE\2++ZN?-TLHQDL7_:%.6F$BU[26
M#]I4E_M*?P*/+/5:ZZ?IE_P]:^ )X2#5@I"_.;5E<DX'S*%R#[X'3C@U7N/^
M"JWP)6WG9+36VE\B01*ML<NVQE4\KUR0>.WI6.?^"1?P5^5O^$Q\6NV[EO+L
MMV.,CICKTZ]>:KWW_!)'X.K977V;QCXJ^VQPR&"21;0(AV$C<!R>G;UZ\UZC
M_P"(B*-1I97R3BW!4Y1]JU9:IN"UZ*[?:VU_S^@_HI2JTHQGQBH3JQ3FZ55J
M-Y1^+]]>U][)ONKVM\8_LJ_MQ:#\*?B#\4M>\>ZGXEU31/&&K7.K:#%-=W=_
M]DCEO)95@A@G>5+8+"R@I&J*O( XK[V_X>M? )LXM]97GG_1)#G/0Y5<9/\
M.OSB_90_8M\-?'/XB?$_PMXGUK5M,TOP'J=UI=I+90J)[B2"[E@:8F8!2DD:
M _*,AR2.*_0#_AT;\%L CQCXMVX&#ML_Q[YSG/4?TKR\GGQ[+"T)QAE]G5FJ
M<L0_?B^:SYURMZ.Z3/M?$"'T7Z'$,X9E+B.6.CA,-*I'+*<_JC@Z,/9V]G4C
M'G<$G4LK\WQ:E'QG_P %1/@GK'A/Q'I>F?VY;ZG?Z/?VEA-';R1RI=7-M)%
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M9G@GE&&I3K1X9PDJ<,UHT>267RQ57V=2JJLI)XOF53VBLY\L8\S^%O\ 4_\
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M\(VEY+#H=SX;TV:[MM7T]F(ANEN$4K(\G<Q%D  (/-6_VSO^"D'@;X_?!_\
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M;AJ<)2A3J)-^U4(P5EJO@6^K6NR/ZE?@7X4\0\59OF&+R[*,7BL12PM=Y?\
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M[#:P'&!]/U6_X)[_ +*/Q&\(^/O%VN_$_P  II^EOH\5GI8UB".?-S+(WF/
MDBE064C>P'W?;KT,?[$7CAOB%^TGJE[X4T2?1_%.DW,?P^+31.4U.1'V;TV
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M:2NTL.TOK-U46B7OZ^\?SL1?\%"_VH[N]TZWQ./-OK6':F@WK;S+*J!"#"
MV<9)XSGZ_P!&_P ,M4U;7O 'A/6M?A:WUO4=%LKK4;5U*F*ZEA5Y/E/*'D-M
MQP3BK/\ P@/@=&5CX4T'AMRXTNS^5E(97QY/WE/*MQ@C [5UT*K&H1 H0*J
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MJ?YT )1110 4444 %%%%)WZ:?U\@&,N>1U]*5?NC\?YTZBF[2BDUL[W_ .
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M>*_V0O&0^$W[/_PW\4ZCX5T&_A>2RMKQ[&YF6W+.K*MU<7,,2S"3G$;]<8H
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1-M)X.#GG.:"@
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M !/\&:+X'/Q&U+6H;3P@;&+4_P"UVP8GMI5RFP#@ CICO]*S]&^,_P /M?\
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M/U-?UR@]1G.#CCG;C^'H.GX_6OY2_P#@W[_9'_;C^"/[0O[7OQJ_;-^&-UX
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MX.[!P#FO['#HND'II&FY[M]AMLDX[CRODQZ4#1M)'_,)TWN,FPMNG<?ZL?\
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M-5=Q9_[V>0>:^=Q' V$GF6"S"A[+#RP:IWA&-G55-1YM4OM6U?2^K;/RK&>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 )@>@_*D"@=L_44ZBB^EG%-/>]T^FS^_YA=I.UKOKJ+GZ?D/Z"
MFL-PQT^@I:*GE4;J-U%]WJM$M/N!=&[MK[GM_6S(O+QDCN>0.,Y]^>GO4BC
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M3BHR<%S4W.FY745)V5M91CU2M^59#5AE'$$Z,HU)4I:14(2[KOR_A;3\/ZL
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M-#^H!IV4A009%W*(0P!8$+N98SD[(^<-4^\MN8<A'QD]2& P/?'K[5^"5O\
MMS:?XU_X*%>%;KPU\3[RV^!TGA:VT&]TV>1;30W\0()!=7+M* "DI:,"3< V
M#C'-?N!X?\:>$_% F'AKQ'I&N"U.9UTV^@NVA5AE#)Y4CE5.?E)XX.">:]3
M9W@<S]L\-6A/V-:I1=IQ]^5-1O.$6TY1E?1I,^JX7XXR#BB>+658ZC6AA,;/
M!ZUH<]25)0_>4Z;?/.G+FTDH^IUA9C_];-+O(XQ^><TQ'XR>%)]>/3-.+ C<
M<!<\'![<?-SGZX_I7J*<;.W-=)N2Y7=;<OSET_&W7[64E=K16:UNM;V6GGY;
MV^X"Q)![BI5.1[]ZKAB1@XR#S@8'/.>_8C'X_A(K  \<_P _\,4[M2Y6FFW'
MEO\ :O:[7913N[]G8FS]_2RA:[];?YDM%1^8.X./S/Y#_&CS/;CMV_/K3BU)
MN*W71J2[:IM6ZC23T4HO[_\ (DHIA?C@=_IT_/UIXHV%KU5OZ\KH**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.O!X'J*** ,7Q!H>E>)
M='U3P_K]A;:MHNM6-QIFJ:;>1":RO].NT:&ZL;F%PR207,+,DJLIR&-?@Y^U
M1_P;Q?L2?'0ZCXB^%5MKW[.OQ)9)+C2?$?P^U&XTO3X+\R"1#<6UI)%*+=7/
M"0L" H4*:_?M_NY]>GN<XX]3]/I7S]\4OVI/V>/@K=1Z;\5/BYX*\&WUR51;
M'6M9LK>XC9ONB2%I?-CW9Z,HY)!H _DL\?\ [)__  7A_8-\(^)O#?PH^*2_
MM3_"*72;[1O[+U>2YU'5!H=Q;R0O%# _FWSRI _5V/S*.YX^=/\ @C1_P5(^
M'G_!.&/XJ_"+]LCP/XW^'/B?QUX[N]>NM3O-$NXM/TZYOIV:XA8RPJ5ACD8D
M%S]T?C7]Q-A\:_A3JG@6Y^)6E?$3PQ>^ K"S:\N_%5KJMI+I5E J^:7N)1*4
M4>6,@.1SVK\)/VAOVZ?^"&G[3OCJY^$'QFU7X9>)];N+J32Y/%']F6%JJWTC
M&W)?5K=$+LLIR'E=R6/)H _9']G#]L']GC]K7P]+XB^ /Q,\/^/K>TCAEU&U
MTJ]@EO=,$V"JWT".S6[@$?)(%;(/ ZU]/1]SP0?3O_4?0U^/_P#P3:_X)E_L
MO_L4^,_B?\8_V5O&4NO?#[XW6&ER0:1%?Q7VD::;9"WF:=);,T>)-PR&"RD=
M@:_8)<C(( ()&%! ]L9Y_/F@!U%%% !1110 4444 -89&"&(Y;:I'..._>OY
MA/\ @X'UB^^)OQ:_X)]_L>:C>3Q?#KXS_&ZQO?B!I<,OE1:U8Z3<Q26-K<@$
M%X$PXE1\J^\X'%?T]LX12XR67(Q[D]L_F?TK^7/_ (+Q6B>#OVQO^"7?QCUK
M-OX0T3XU1:7KNKR'99Z=))/&+=;B=L11>>9E WL-V#CI0!^MG[3W[!/[,?CW
M]B[XB? I?@MX!T[0-/\ A=?Q^'IM+\,Z19:MI.KZ3HKRZ;J-IJT-JE\;N.=/
M,:5[AM[$[P0L>WXK_P"#<CXF:[XW_P""=.D>%=<OI[T?!_XA^,_ACI4MQ-)-
M+#I6@ZO<P6MN9IR[OY>UCRW\1 PH%?KQ\=?B#X9\&_LZ?$OXCZKJEC;^'-/^
M%6NZL^IRW<*V$UI)H,KQM#.T@B9Y0X6(*<NQ7;FOQ8_X-H_#>H:/^P!X@\0S
MP.+7QY\<_B-XKT1KA2%N-.U'7+N2WFC/1E:.0%7^Z>HH _H;N+6VN+>6UN8(
M;FWGC*2V]Q''+#,A4AHYH9@\<L;J#N616SD\$5\2_M?>,_V>OV4?V?OB+\</
M&'PU^%,,'A30KV^L+:Z\$>%\ZGK!AD:QMH5;3MUQ-)<&/*#<SDGUY^VQYH)R
MO#(55'4[DR?FY[XSU'8U_,5_P7?\3ZO\;/C?^QS^PIX?EN;BV^)WQ&TG6O&%
MC:,X8:'I]U;2,\X3AH2R$,)<H5R#UH [[_@B=^R/J7B[4/''_!1;X[>$M$M/
MB=\<[^ZN_AI90Z'IVF0>%? TLKFP^P:=;VL$%G))$RXD6%9&P<-Q7Q9_P5A_
M:-^%7A7_ (+ _ "X^->E7?B'X<_ WP._B.;1H-$_MX:AK$F9H[9].:&>&Y2X
M;JCQN"<9%?UM?#WP5I?PX\#>#_ .B10VVE^$]#TS1;*WC41QE;&W2WVA4 11
ME&?:N.<MR#7YY6/Q9_8(^*O[<'B;X':[X!\+:E^T]X5TB*_GU#Q?X>M+J;4;
M%5.R+39=0CE2[1.B+'&1QR?4 ^)?V9?^"TG_  3B^/'Q3T#X97OP?TSX1>(-
M?U!=.\+ZAXX^%NB:#97VI[PEG!:WMSI%NL4DK >45<,IVA><5_0!<:GIFFZ>
MVJ7U_I^GZ-:6RW1U&>>.VL+:SD5622:YD98$B,93:=RJHV@'%?ST_P#!Q-\'
M_@;H?[!FJ^.;7PCX-\'?$_PYXT\)77P^USP[I&E:#XA_MB'5(F@MM,?3H;>X
MD,LOE*RQDL5R#P<#]+_@?\.+C]IK_@GC\'_AW\>&UF&Y^(WP6\.6OCW^S[VZ
MTW6A)+9Q;C'>0O'=0W#QK$2P?<.IH ^6/B'XJ\,^)_\ @LG^RE)X:\1Z'KT<
M/P'^+0G.DZC:WQA_XE<##S/L\DFW<I#+Z@^H-?M=NR21ZG^=?S2?"W]A7X+?
ML:_\%B_V:+'X23>,)8_$'P)^*SWH\4>(M0UYE6VTNW"^5)?W$S1[L?,%"YZ<
M@<_TKC=O.0>2<\?6@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
MG"G@D9]1D'V_#^M0. <GYN!QS@\<]?K5D@'J*3:.P_K^AX/TH \G^,W@2Q^(
MGPS\;>%+O1['5[O5O#.JVNF07]O%,(K^:UE2TD22128I!.4(>,JW&,\X/QU_
MP3C_ &<?&O[.7PK\3Z#X]L;.SUS6O%,VIQQQ;6*V6PQ01F9<.V% /S$J.]?H
MVR!LLZM\V!N&<95LKE0<XS_G%,Q@L<*#C:2<MD G(4'."1GH,Y]:].AG6,P^
M5XO*X592P6)KT<15@YSWA&+32[)I7MKIK:VG(\OH3QM'%JG14J4;/W(IRO9/
M[.MKZ?@<1XZ\.:!KGAK6DUO1],UI!H>JJHU*PM+UDWVLP(A:>*1X\ ?*(RIW
M#=U%?R9_LFP)8_MV:%9P11PP6_Q%U>VM5C 1$MHKJ<16R!0 FU!@$\C&WVK^
MOB^@CO+>YLIB@AO+::T^4'>(;B)HY2I QO*LP&3[G'4_C[^SI_P3>U+X4_M2
M^)_C#XHU2WU/PU!JVK:YX0@3YG2_U&ZDE@^U+U_T>%RA.,&3#=!FON>".),)
ME.5\28;%5Y1>/P,886DI2Y9SM+W>7;F=[;+H?.Y[E4L5CLOJ4H0@XUVY3A%<
MSC>+2;L]$KIW?7LV?L'J%W:V%M<WU[-%:VEM;_:;BXGD5(HHXUW.SLQ   !R
M<@8YKPR/]J#X RW362?%/PG]J1C&T#:G;;ED4E64GS>H8$8R>]=3\8_!VI>/
MOAEXR\(Z-?-I^J>(-&OK*TN=S )+<1,B %2&3!.T_=Z^V*_G)_X=$?M'B>5Q
MJNFAC/,ZW2WDQEE#2NZR.?,W!G##/IVZ5Y'"F0Y#FT:_]L9_1RBM3JP5-5%[
MLJ4KN3U5F]%WL_4[<WS+-,%5HPP67/%I1A&4[W5VEJ^RT:V^Y61_0[=_M&?!
M"RA>:Z^)7A>"-,$R-J=J5P0<#_6=3V'MQFM_P1\7OAK\2Y+F#P)XTT3Q//9(
M);J'3;R*:2",Y&]U5B>",<_G7\Y3_P#!)']IF972?6[*5",+YFISE5S_ !&-
MI<';CIM[\=S7W=_P3Z_89^,'[-/Q)\1>*O&VL6?]D:EI,5BEG:2-*MU(KL2S
M*[$*<'DXZ]Q7KYSPMPC@<%BJ^7<3T<?B:2O##*SC5:LU:T4FWW23N<>#S?,Z
MV*C2Q&5SI+2[5TMU>S>C>^_Z,_8N[N[6QL[B^O;B*VMK6"6>XN)6"10PQ(7D
MD>0G"HJ@G)(''6OD_P"*?[6GP8T'X8_$37-!^*'AJ;6M&\+:^=)2&]BDG37U
MT^Y73D2)9"[O]L$0  (SG&>_N7Q<\)WOCKX7^./"&EW3V&H>(O#VIZ5;7,;;
M&@FN;5XHW4J01\[ $KVR<XK^9'QI_P $M?VC/"'A+Q7XKU&[L+G3_#UEJ6M7
M<,5X[-=6&GP2W4LTJNY!D2*)IF!')R*\[@C(.'<XK2K9QF\<M<<12IPH>[?$
M:QM&+FI**E+W6[1LF[O5'9GN89AA(S^J8%U[8=\\F[NC[NZUT>E[]+?)?K#^
MP9^VMHGCSX%6^K?'3XG>'+;QW:7TYOX;VYCLKF&R)/D&;SV42!AAEV#(Z'DU
M^@?@CXT?"WXC7D^G^"?&VA^)+VWB\Z6VTV[BGE$1&=X5')('T!_K_)3^S-^Q
M/\7_ -J#PYJWBWP%]ELM TR]CTN[FNYFC^UWCP_:!Y85@DD:KC)Y"YQ[5^MG
M[!_[ WQI_9U^,DGCCQCJELNAP:?)!Y5K<,Z7LDH(,;1!L!4W<,5QVKZKC'A#
MA/+5F%?!\01680E>&4\T7R?NH2C'W;N+E=/E=Y:GAY)F^;XA8:EBL%4=&2UK
MV?/\?>ZNEL^FEM-G^V5U=V]E:SWES-%;VMO$\\TTSK''%#&"7=V8@*% R03D
M#K7YE?MR?MFZ!X ^$<]Y\'?B;X=N/&JZU9VHL;>YCN9IH1<HMVFV)V:/RTW;
MB1CC/T^Z/C-X2U?Q[\+_ !CX1T*\-EJVLZ/=V6GW2.8VBGGC*@%@0>,\D'MU
MK^5;]HK]@/XV?L^^%9/'/BZ>SU/0CJ126Z2XDFN8YKNXVIO$C,"TK,O(]*\+
MP_R#),TQU.6:9E3HXFGB$J&"K)<N)C9.5W).]H\TDERM.-^UO1XCS+,,)A_]
MBP<ZE-13E4N[QVLNNK;^=^Y^\?B#]L[PC#^RJ_C72_B%X<'Q'E\#QSQVGVZ!
M[L:]]G'F*L"OOW++DA<9S@=N)?\ @GM^U&OQY^$0;QKXLT^Z\>:5>36FKVTT
MT=O/@S.8'CCD82,I4C&.>_IC\&[O_@GS\>K'X-2_&*[%G'X:CT9->;3Q=2>8
MFGM'YBS%-P4$KRR@9-=O^Q9^Q/\ &CXXZ!)\2O!'C.?P#IMOJ+V8O;*XN8/[
M0%JV&D,:.OG%3N (#<U]_F7!'!=#)<TJ4\_PGMWF;_VJ/*XX)\R?U25HQ3=W
MRI-W7-:[>_SF#SW.98[ TI8&I:M0<MI):).^O:UUZ,_2[]O+]LSXG_ ']H#P
M5X5\ ZKI4GAW4_AY?:IJEC<$2Q+JKSSV\%P70D)+$J(ZHQW'@@9//RM:_P#!
M1CXK-^Q_XNU^X\<Z5#\8K?XFQ:3I%N3MU%O#)C$[31VV?-\K>S1+(4*[1R>U
M?&'[97[/OQ)^#'QATGPKXX\<7/C?6_$GAE_$%GK-W--(5T])9(/LN9G8P^7)
M&X*)M'&2.:^>XO@SXNN?A!J?QQBBB/A+1O$P\(:@7=3<IJ;0B<2*&X=3&0%/
M)R>#Z?3Y-P-PC6X9R2OB:V#Q'MJSC''PY:<L?*#J6I^\KVCKHGS>ZK:GC9AG
MV>?VIBHPHU*:CHJ<9OE:YHJVZNU:SNO7HS^MCX:_M;?!/6/AAX(U[Q#\4?#=
MOJVH^&]&;6C-J$$;KJYLH/[1CF4N&C=;KS 0<=@?2O8/!WQN^$OQ!U%M'\&^
M.] \0:E'$9A8Z??P33M&#G<JHY+<<@8SQ7\TG@G_ ()8?M%^,?!?ASQ/9W>F
M16/B*PMM8LK62Z=8A97\*W%I--$' 65HY%9AC\:^U/V,/^"=GQM^!7QOT7Q]
MXJU2TBT338G:Y%G=2DW4I)'E/#OY3GC*X_+C\NS[A+@O T<PQ.#XFI5\;2JU
M?8X*#@^62DU[)M13;@_=LG?1ZZ'U^69UG56IA*>)RJ5.DX1YZZOM[NK5[MV=
M];J]D?NO)+'%')))((HHT>1WF/E(BH-S%V? 4!03N.!Q^-?GC^VA^U[X9^'?
MP3\3:E\*OB+X<?XA66H6MG;VD-W#<7"$,1=QF)6+$I@*752 >XK[?^).@:AX
MM\!^,/#6EWAT_4M>T.]TVRODWC[+/<Q,D<R,,,I4G/7(Z5_*C^T/_P $]_CC
M\$/"&O\ Q)\7ZA:ZOH%IJSK<7;7<LEQ(MY,S)*8W=LE\=QU'/ X\GP\R+)<V
MS6G_ &WCJ>%]GBJ*H8*;C;&WL_8^\G?GLDTDGNET/2XES''83#3>"PLL0I4W
MSU8\R=*_*N;2U^5ZGW?^P=_P4,\6>/\ XH:]I/QZ\<Z7IVA2:7 NA&Z*VJ/>
MXQ,#)*53YCC!'H<\5ZG\6?VVO$,O[;7PP^&WPS\>:1??#+49-.L?$+6LBR6R
MWD\V+B!Y\M&79,<YP#[5^&O[/?[.7CO]I+QA=>$? +VHU#2K..]GFN)3 886
M&<HRE6S^->A:_P#LG?%3X8_M#>"_@SK.J)H_C7Q)=:?=Z9K%O,TB1B[E\N&X
M\U"9!*A7(^8-^?/['F_!'!M+-L=*&-PV&Q,LJFUEC<)1P]/1_6HQY>;W7HFI
M*"NU;4^!P>?9RLMHQ^JU*_-C(WQ#D^;XHWIMWT73O;Y']'/_  43^,'B+X3_
M ++?C7Q/\/\ 5[2Q\3SWFCZ1!<"0-*EEJ=T;>\DM]A#&00G*.GW#AB1S7X.?
M _X+_"GXL_LR_%OXA^//&NHV_P 2O#6J:G?Z9ILVMEQ?LMB;P/-:SRL\WGW)
M<94?*651QT]9_;#_ &//VB/A)\&K[QY\2OC#>^,O#.BZCIEFVDS7=PZ>;?3+
M!$QC>1DD"<;,J2&R>U?&7P;_ &7/BU\8/A;\0/BEX+F^S>%/ ,5X==9+R:W-
MZ]E9M?7$)AC=(Y0+0%F+*>FT^E?)8/PYX*SC@ZK0Q^9X/$TIYKR0S2'+34*D
M_916'3=TW4;48Q;OS25E>U^'C+"KB/,GA\QRRK4C1RV<?J4YOE7/3=JL>5ZJ
M.^JTMKV/"? N@KXP\6>%?#<UU!IT7B#4K339;ZYSY-JMW,D3/*>"JQ"0NQ8X
M&.,<5^TMQ_P3;^ WA'P-XM\077Q(3Q5K>B>')[ZSL-+OK-,7Z6YEWDEV:1-^
M2$RW&!ZU\$?LV_L+?&7]H_P?=_$#P%-IUEI-I>?8DEFN62XDN@GF8B&\-&5&
M/G&""0<U[UJO_!.S]JOX=>%?%GC#7/&,MAI>CZ/>7M_"FMWMQ]KMX(B6C:,W
M#*05!'<<D5^=X/P)\.L!Q)C/K?$."G*>(P\*6$J7T35.U&44K-RYKI7NE)/J
MS\LX5\)LNRS$9GF.8Y0\:L94O@O=M##4;*+TV=VI)^2UW;?@?[&7P4\-?'SX
MGZY\-O%GB/6M'TA8+R2U-A>R01-<0EUA-S;.ZVTRICYL1G//X=U^UC^Q?X _
M9_O/!MCI'Q-TK5[CQ9K8T[4$/E&31[-Y/+-W<JF42- Q)"A3P?7GPS]D;X:_
M$3XO?%^V\*?#GQ4_A/Q+=6=S(^KI*\1$"L5N!\K LSGG)Z<],@UZ9^U3^QY\
M;O@QXK\*V_CWQ"/&%UX^UD:1H-]=WL\YFNI)%C"@.[B-=S EN,=>IY^\S;P<
M\.:G$^&HU<1@L)*C@HNCEKORUUR:U4K6U5Y>33U6Y]$^!<CQF6SKQR&4YX>N
MZ2E+2DE=.R2=DWLFEN]#[G\3_'BU_8_^&/[-_P -_@I\7/#_ (B^U>(5NOB)
M-92+-;II=V8'VLI9V@CPS(5;;RC<#.*YC_@H3\2-&_:5^/G[-/PAT'Q9I.I>
M%-=?0+:[OK*1;B'2M8\3,;;4)[C8Q!,4*QD#@QG@]*^"_C?^Q?\ %KX$?\*[
M7Q@-.F/Q.NH].\/>1-YK"]<1.8)BS'8J"5" ,<'BLCXF?LY?$[X _%?X<>$-
M<O8K;Q9XJ31-4\-:C93-)+8R:E+Y=E*)=Q*RQ2*PVJ04QGZ^W1\-_#_$8'"Y
M?A\RP]=5,/F$(PO"4:UKJ2:C%.:PCBE!P:4>5J;;W^LK>WK97'A_$Y>J>7QA
MAJ<\-%S:='EAR1<W_/>[6K=DU:S/U7U/_@CGX2T?2M5U67XH)-%I6G7MQ J0
M","YAB>2-FD8G:V0%#9PO7IDU^7/[,OPI\&?%3X^W'PZ^)7B>ZL/#]JOB.*3
M6_MGEW:3Z*+B&TB%]=,5\B=H%QN9N#B,  "OU"\?_L=_MFZ-\*]<U^_^/UYJ
M6FZ7X5N]:O[ 7,Z37D,=B;J2T)$@.YXR8L^V:_'SX _!OQY\??B/:>!/ UT;
M3Q+?0WMU)<_:I;>3;;[VO7DF#JW&U]WS?-@Y]*^&X8\&>!,1D?$L:N/R^M1A
M4M/'.[C@N6G*\DVY.,&NSTCK=[GRV<^'O#4)8/#X/AY82>(DYSHJI.4:[2<8
MJ-[-2:?O==+7U.,^)7A_2_"_CKQ?X?T:Y^WZ;I&LW5KIUX6683VD4[QQ2L4R
MKR-&JDNF02<]*V]2\%>&K#X4:1XWMM;M)?$E_J\^G7?A_($R6RDF.9U!\Q0^
M,\8]_6O:?VF_V,_BG^S!IFBZUX]NK"ZLO$%V]M!<V]PTT_FQC>RR$,Q=S@'&
M2P'-?,-CX7UC4H='ELK?SUUO4X],T^V+NS/?3/Y<<FT')Y8$@#(_6O3X9\!>
M":_!->A[3+\<_K&(=+-UI+D4I-PDN6[OH[VZ6O>Y\#0\,<MP%+%8+%9>I5\3
M7J3PSLW*A*4U*,&I+5I;M?%YG[-?LX?L??LT>._@;INM>-_B'>Z5XBUBPFNK
MRVM]>2SAM'\HLL#6+RB*9<@9\V,YZ$]Q\=?!?]CGPI\=/C!\1/AQI?Q/T#PO
M:^&+V2'1+[4428:[:!SL9-A6-70==N,DY%>N:/\ \$LOVHKCPS9ZPNN);6]Q
MI::E'80ZO>1,(G@^T+$T:SA%)CP"I Z@8Q7A_P"S=^QQ\9_C%\1?%GA[PEKO
M_",:MX"U3[-XBU:"^E@GAN%=E5!)%(KRJ2.,D[OSKQ,%X.^&?]A9K&MFN"Q5
M;!4Z:^LKF:PLO?222BGNN6RLGR]-3[Z'A_E-?!9/A,TX9G4Y'&%3D?+]9BN7
M5>]'DT\EH^I_2=^QM^S19?LL_"EOAW:^)(O%,MUK5WKMQJ=NA6VDN+S87CMP
MQ8*1L'!)XP?2OG7_ (*'_#'X/_'[2/"G@GQ=\:?#7PY\2>#;V^UB*WU:>.9I
MX-0@6*>&YMD<,LC)$/(^7*L2>AY^IOV4O@_XU^"'PRB\'_$#QQ=>/-9&KW=]
M_:MT9));6"XV&*W5Y"[,L6S:O)'?UK\E?VN/^";'QU^,'Q_^)GQ.\-ZI;7?A
M[Q+?/JVDQWEVQEM8S;1H=/AC+[8HD,3.BA0=S'C-?)Y#POPQC<PGP]F>9TL+
MD=*FZ%'%6<(U(Q<?9QDY:Q4[MN_\NDG?7]AS;(L)'A!9'A,H<LK>%5#ZC&K+
MGCADDU%RO>Z:=U>Y^;?[.G[//PX^*OCSQGHOBSXQ>'OA_I/@;48)=*U+4<*/
M%,$&I20,^GLKK(CB*%9@P; 652<XK]]OVDOVK_!'PM_9IN)/A!\4_#VH^*_#
MNDZ1HFC2Q7D%U/<FRMH;5V\@.[%W6+>#C@Y'/4_S\_ K]CCXJ?'KQQXY\!^%
M8M/MM4^'$KIK\TTQB\F1KJ2RBC1\C=OFB9L ]J]%^/7_  3X^./P"\#7/COQ
M5)9ZAX=T^>-;V.UN'8Q2S@(DFQF*_*1G)!_Q_5J'A?X<Y3Q!3AA,WPV%Q+5#
MGP:E3Y*VB=."5FUS)J;>]FG>S/SSAC)X<+97F#R;):N$^L\OMIJ4WHI/DCJ]
M[WO))+YGV)HO["VK?MO>&?#GQ_U3XK:-I?B3Q+I@CUVSN+:2YFCNHG4%F*,!
M&63/RXX_#%?#FO?LV>%?A?\ $[XK?#GQ'XIM=8N/!GA*ZU'1=1T^5+:&]OTS
MB&0$@LOR_-$Q)/IBOMK]EO\ 87^//COX/Z#XS\%_'+5?".D^((9)X-$M9[E(
MHAN*<*KJJDYR=OX=,U^?_P 8_@!\3/!WQA\=>!KW76\2>(] TFXUW6-8DNIG
MN;W38RWFM,2^]L<X0GD>O)KR<G\)?#S'<79M5KXO"8JJZM2^&O+]S*249<SO
M)6LN5<L5KO=GC9UP'DF(G2SS$<.5GB\;-?6ZE2HYQJOW'*7*YR25M;):ZK6R
M/NG]D7]F#]FOXM?!*UUGQK\2-;T#Q%?R3V^HZ79>(5TZQ613A7DL3,BRQ C+
M+,A5B/7I\$_M9?!WP+\#_B9-X3\!>)8O%.BFPAO#J*O$[([@L8MT1,98'&_/
MS'DAJ] _9K_8C^.O[1'A2Y\5?#^^;2/#D-S)9O=C4;BUCGN8VQ)&L*2IDJ1A
MBHR,<]S7,:I^Q]\58?VB]-_9[\074)\5ZDD)349KN6[06LBEEF!DD9F "YP,
M_K58_P %O#;$3S_!X7-,"\1#!U6J-23;PCM%N:3BVN7F6J2T:;U:.7/O#_*L
MVR2GE]+AMX7VM)+#8V%IRNY_#%-I)_=W[L_1K]C_ /8)^#WQ-^!VB?$OQ5K_
M (CM]<UFUO[Z:#2M66SA'V>)I8H@B%7_ '9B!.X@9(SZUYY\#?V8_AG^U7\+
MO&_B/XD?%.^T_P >>#/&'B7PSIT^H:NEQ!9>$O#\S1:2TUK=R2,?,5'5I%"_
M,HVYR2/H#1?^";W[2W@KPA-I?AWX^W.EVVG:5=RVFF6GG1VT$GV:1Y8@ 0H6
M=5*<#@DX'-?F9^SA^R+\:_C_ *)\2M>^'?B.73K;PIJ6K:;JMHNHW5I_;.J6
MMY<Q78D2"5!*9)8Y)4W@JV\YSBOEN%?"C@B>08S!8W.L'*.'J86-2JY6Y8RK
M*$$Y-I<E72,$K>\F[N]CV,%P/E^6Y-EF4U.'ZM:?LI0Q$)SGRXSD@DYRBFU%
MQ5I26UNFNN3\&_V;/AW\6/BEXZ\#:G\8= \$:+X2O)(--UW4$)AUZ*WG,;R6
M)9PH;"[@>0#T]1_03^R;/^S'^SEX/M_A]X9^..E^);K4+E4F.I:W',C:@<1M
M'IEO+,3:H[G_ %:_*Q)X&0!_./\ !#]E#XM?'/XB>)OAYX62*S\1>$I9H=>D
MNI7@6T,4SPN=R%6+M(I*DDAR3N/-?;.B_P#!)+]HS3_$&C:I)JFEI%9:I9W4
MLL=W()HE@F1WD7]YAF<*2<=S7U.:>%7AMDF+=3"9YA<KQ?U1/ZM'X:EX)PFX
MI--U+;VUOH[G=P5PWA.'<56QN4\.0A5E5E3E4@Y*G"+FKQ26C<(OE;LV^Z1^
MCG[87_!.&V_:C\=67Q(T7QS!H%W+9Q6]QY]H]]#<6Q53&;?R>%W8!W$D>AKY
ML^$'[!/PL_9>^*T>L?$K]H#PPMU-IMS9IH#9TS4=EY#)$'6621=K .64*-P8
M*W:OW.\):==:!X8\/:5<R&>ZTK1M-T^\D7_EK/;6L44DO/!RR,21SSDU^)G[
M;?\ P3T^-WQU^-]WX_\ "&J6SZ+?6D21I=74BO:NH'W%5\(PQG(P>H%?D.1<
M#\*YIQ!.MF^+A@H6JNGC>9I.TXJ+46TE>.JVT/I<[\.>'/[1CQ)3R;ZUFU:I
M"I7:J5.2,G&SO%-)IMM;'SO^UO\ LW?LI>"_AOXG\6?#KXSZAX@\91W1NH?#
MUYXD74H;PS2;I0MF)-RL"Q*/@@8[C-?CI(H\IC(5;"]5(W2>9VD*\Y!' Z8!
MSUK]76_X)$_M'O+ODU/2Y !EII;II6D_NCYY&<_Y]<UXQ\>?^"=OQM^ 7P]O
M_B9XFETRY\/::RIJR6S!IXUYQ(%!)"D X)PIY&>U?18CP4X%QO$^6XC"\4X/
M%X;VU+FP3O)XF3B[TVY7L^JL_-6/Q'C3P=Q.?YYA,XI9;'!X'#NG+$8:G*4E
M4C3M[5OVC=KMK;H]+;#OA+^R3H/B7XX_ GX>:YXH)T/XF> -)\=ZC<Z6ZV]Y
M8+>+,SZ:)3]RY5D&'4 ')ZX%?OC\$_V>_P!G[]C+Q-JDEE\2=436?%5C'"UA
MXN\01RQO;P9=)+>"1EV$;N7/4#@^GY8_LQ_\$]?C-\2?!WPO^.MI\4I?#UQ>
MZ/I6H>$PK2/=6?AJ*7?:V9;/[M&C$B^7\O#=*^JOVVOV!_C+^T#\1O"?B?PC
MXJ,%CI?A/3]%U"22\F@;[=9VZI+<(J2*=TTF7+=6).34X3PWX+RGB*MAZ6;X
M2GA)XG%SCB$],%'FI)4=;Q;34E[T;R?5<I^F<"<"X7AC!YAFF"R*%3&3QD<1
M@YJ<X5:=&HHV@H-J,D[)W=V]WIO^GZ?'SX,RS-:1_$?PPTL>2Z#4K9=@0_-D
MF3!Q@\#.:_/3P;^VW-KO[:NL?#*3QOH+_#'[ ;?3)/-41S7X?!C2YWF(L3P"
M#]??X 3_ ()&_M'+NE7Q5!'*0Q>3^T[K>Y7E1_K\XD_BY/!YKY2\+_L7_%K5
M/VAKKX%PZG%I7B_3U%[<:PEU*B1VP8#S[>=7%QYP.3C?D]:_5<GX*X'E#-''
MB7#XZV"JM2M'FPW+"ZK3]U7>ZB[OX=$M3[7'9]GGM,-&>4SH2]K%THIW=1OD
MY^9W>T6GKIYG]B%I>VEXGG6ES#=0E05EMY4F7 _ZYDXYZ'/(QBN-\6_$WP'X
M&F@A\6^+-&T"XN5\R"#4KR&WDD4D X61U;D<\CN.]?*?['/[,WQ,_9YL=4M_
M'/Q/OO'*7T4*VMC<S3S"S* 97S;AV/*C.02 >*^9?V]_V&?BU^TK\2M(\5>"
M?$*66D6VEQVTUI/=2P^1<I@%T57"'=C'T%?E>!R?)JN?5,)B\YC3RYQFX8]1
MLERJ*BHK6W.^V_3J?65<=CZ6!^LTL"ZF+ER<U"^EERW6Z3?3I:Y^F%M\;/A1
M=HLMM\0/"\L;\!TU2V.3V7'FYYX_PXJE<?'WX-6]W]AG^(_AB*Z!13"=3MMV
MZ0A4 (EY)) &/6OY^HO^"2G[2\8(B\;)&!D>4FJ7<4>WU#+,%W'C'<Y]:K2?
M\$C?VD#+#*_C"WFD6:)VG?4;MYD6*5&"Y,I)V@$Y)/-?:3X.X&Y)2EQG"<HT
MN>E3BHISDHZ1E*R2<M%KYGD+.\X]K25;*)4U)QORW=MM=/Z[6Z_TSVUS#=V]
MO=6TB7$%Q&DT4T3!HI(W 97CD&5=2"""IJ]DY QQZUYM\)/"VI^"?AEX'\(Z
MU=&]U7PYX9T[2;Z\+LYNKBSB$;REG))+D9)/)]:](C)923V.,'@]OSK\GJTX
MTJM6G"3G"%2<82;OS04FHRO=[QL]&T?7TY2E"$I1<7*,6XO5JZ3M\O\ @CJ4
M^W/O245F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4<]N/>BC
M\,_Y]^/SH \@_:"^(<?PC^!_Q9^*$O$7P_\  /B;Q9@<;1HVF7-Z7SZYA)]J
M_B"_X)Q?\$N]1_X+3K\7/VT?VN?B_P"-F\-:_P"/]8TSP+H&DZE<I"VEO-)<
MV4B*TH2);:"6"/,8&3CT./[$?^"B&3^PC^UX.K?\,_\ Q,8;,9Q_PB^HD>PP
M005YX!]>?QA_X-F_B1\-?#'_  3&\#Z=XC^('@KP_J']N74LMEJWB71M-O8]
MT2;7-M=WD-P6.T\^7CC;GF@#\%?VW_V4OV@_V!_CQX/_ .">'PX^.7B[4_V=
M_P!J35M'M(%N]1O)M2TJVDOK>TNK*&9Y2RDPLP(&!SP,\5_0U?\ _!MS^P+<
M?LU_\(%;>$KV#XAKX2DNT^(371.KR^)/[.-P+J:3[^?M8#,=V1R<^GP-_P %
MKOB!X#U[_@IY_P $_M7T3QGX6U?3-,\3Z:VHZKIFNZ9>6&G@:E =UY<6UU)%
M % )8R,O(STYK^LM_C;\&#HFT?%KX;,[:,Z#'C+PY\Q-B?F(.H[@<CIU/"D<
MXH _FY_X-M_B=\0?#-Y^U3^Q?X_U^[\02?L\>-9K/0KC49Y;FZATF69TLUW.
MS$ 1*N #T]SBOZJD&!C.>>3DG<<#GGFOY$O^""U]9ZC_ ,%,_P#@J->Z=>6]
M]9S^)=(DM;JTN([J"[0R/MECGA=X'0C[I1V#=?>OZ[QC Q@^XSR>^??\^,<T
M +1110 4444 %%%% #&P5;Y<]>.G([U\.?M^_L3?#W]O?]GC6_@?X]DETN:3
M4++7/"/BFT5/[0\,^)M-8RZ??VTIQ)&JR',NPC("Y..*^YNQ'8]>U1!#[?Y]
M./\ #MZ< '\DTW_!![]OCQM8VOP7^*O_  4"\8^(?V;8&AL+CPMOD%S<Z' R
M"/3WD$Q>2-H%\J0-D%<9K^EWX"_ 'P%^S1\"?"'P'^%%E_8_A?P3X5_X1[1<
M+^_-V+9HSJ5PX4;[F:Z+W#L3D9 S@5[YY>T#9U X)Z]^_?=G!]>*01MCKSN+
M@=@WL.G8<9QZT ? 7[ _P _:5^ GA/XD:3^TI\<+WXXZSXB^(>O>)?"&K78>
M.70?#=_?7$VF^'(PS$F*QMGAM\C /EYQSQY#XW_X)]^(O'7_  4X\ _MP:WX
MJM[CP5X!\ 2^&-*\%2PB1HM7DE+_ -JJ_)$B_=VCGOT%?JWL=A\YR?7)RN#D
M;3CCW]>_:E",""#C P "<?7&.2?4T (%#C=EMLF6W%0K1L"<2*.,;NAQS@U^
M*/\ P46_X)*?\-7?$KP_^T9\"?BEJ_P#_:.\*60TVW\:Z$PCCU*UR6A6^VM&
MS[> 0Q/!.:_;, @<DG/7))'ICZ?_ *Z8T2G'&?FW$')#9&/F'.[ X&>E '\S
M7P9_X(C?M">-/BAX(\<_\% OVM/$O[1WA7X=Z[:Z_HOP_O69=%O=3TZ42:;)
M?0F1X)X$;$CJRDEU!/>OZ7+'3K'2[.UTW3K6*RLM/M(+.SM8%"PV]M#&L4,*
M*!A%CC5551Q@5,D6-P8$JR[0"<A1QP@_A]ZG'  'H >Y./4]3[>E 'XZ?&%?
M^-R_[)WJ/@)\7<D>VG1_ITK]C#U/U/\ .OQX^, '_#Y;]D\_]4$^,'Z:=$1_
M.OV'/4_4_P Z $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]XN\/^#YKN^7Q9XBU37]2FO"6E^T:E/+<R10G)_=1/,QC&?3 %?3ZH2<X7.
MF=H' Z ]_2@JS$YSR..<$#/]?S]JY*>,Q&&PM2A"MI6G3>)C>_-[.:E3^47;
M;R9I*A1G.-1I_NN>--K;]YHTGYWWOT?<^3O@K^R5X$^"?Q,^(7Q0\.7=[/K/
MQ N/.U.*Y.8HF>8RD1@=PS$ ]/I7UB/?I28(SUSC;SR.#D'ZYY_&GA6(SQ_C
M6N+QF*QM;VV*K2K5.2G!-[QA3BE&+]%K\_,6'PE'!T_8T4N7GE4:2^U-\S^>
MOE8"%' STXZ8Y_\ UTWGIZU( _J!_G'I1A^O!/T'\\"N24G"+:OI;1>;2-[)
MZ-73W(B,CGZC.<5Y!\=?@[H'QX^&OB+X8^)VN8=(\2V1@NIK9\21*NTB2+)&
M/7UZ@8KV0(2<M^7MZ8Z?YQ3,$E2,Y4Y7' QW7W7_ &>E7A\1B,%5C7P\G&>'
MKJI"6MU?7375I_+I9JYE4ITJT'3<?<>CNNUNZZ^=^O1(\X^$7PZTKX1_#+P5
M\,]#E>XT;P5H5KH.FSRG,LMI:!A&\I_OD,0?I7HRHNX<>OKZ4]4QQ@ #M@?Y
M%*=P. >O/0"G.I.K)U:CO4J2<ZG^-OF;\]6W<JG3C2A&G#X8)17HMNVVQ#(<
M$;1CTSU'2OF/3?V6? ^F?'C4/V@8+B]D\4W]A]BGMC)_H@3.?D4G 8^M?493
MN,9^G!_#H*9Y1]ASD#H ?8 ?XUI0QN+POM(X>;@J\'1J-6UC-6L[K;5_H34H
MX>JX3K1YI4[NGY-VOU_KYB1@.#\I11QM)RQ&!][/X>M.,:#+'/Z=^.E2*"!S
MC/J.I^IZFEK"[C).6LN7D;7W[_._R[[Z1?,K15HK;Y6=ONT3(!@=1D>G2E +
M$_G4I&1VSVR* H'..>] Q-HZ8_G_ )[4H '2EH.>U !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1]>G?Z=Z*#R"#G!ZXZ_A[T >.?'_X
M4VWQU^"/Q8^#-SJ<FAVOQ/\  GB+P1+JUO&)I-.B\1:=<:?+>+"Y"O-"LYD2
M,G!*@9&:_DTT3_@T;\/:#IUMIFD_MN?$C3K>W$:I!INCQV<$6Q!&66&&]5,D
MKD\<OSZU_9/*P0,Y$0"#?(\A 6%5 !D?/'RK\QYQ@'ZU_+#_ ,%'/^"\WQ&\
M-_&N^_8L_P"":_POO/CC^T1#?MH^O>([;1GU[2=!O6+1R6VGV:NEO>W$,I(E
MEDFC6VV%QEE((!\]WG_!HWX8OY8;F_\ VS_B+J-Y;N'MKR\T99KJW<'.^*66
M[+QGC@J<C@#UK0;_ (--K)5'_&='Q6V[60AM/?[C=2\GV[/MC'!(KRZS_9R_
MX.BOBE:GQEJ_QCTOP#<7X^UCPQ)XFATJ[LUD&]+,V:0R"T>+A&0.^T@J3CFL
MF+_@HY_P7$_X)8:YHVK_ +?GPDE^,G[/$NH1VFN^--(L/[3DLK=I$2:XM_$M
MMF6*XCCS(;9[<)*>2X% '[>?\$GO^",OAO\ X);>*OBSXMT?XTZ[\5KKXL6F
MD6EZ-;TR*TETYM+C95F\Y999+AY#]]I/H:_<)>Y/4DD\YY_I].0.W%?,'[)'
M[6/PB_;/^"OA/XY_!G5O[2\,^*+))'MK@C[=I-XRJ;G3=2CW%HYX'.SY@#QT
M&<5]0 8 P21USV_#V]* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** /QZ^,'_*97]D[_L@GQA_]-T-?L,>I^I_G7X\_&#_E,K^R=_V03XP_^FZ&
MOV&/4_4_SH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBBA:.]V]4[/5*UMNVR!:-/>VFO7U$^O7G_/Y4M%
M%5S/7;5W=EUT_P @[Z)7=]%8****BVEM>G7M;_(/\T_N#'.<<T@& !UI:*=E
MRN-E9[Z>@=&N[YGYO3_)!1_G']:**%[JY4DDK62Z6ZH=WW?RT"BBBDDUO*4O
M\3O;T[7%KW;\V%%%%4FT[@%%%%)7YN:[>M[/5+;9=-@3:VT79:#0N,X].G;/
MK3J**'K+FZV2^ZWSZ#O+^9[6_P"#Z^8 ,,YQ^!'^-%%%*T4FN6.KN].NFOKI
MN2E9<K;DO[SN^FS^7](****++2ZNUU>_3K\AK1)=MGUZ=?D'X4?Y]:**:TOH
MGS;WV#6Z=WIMKMM^?7_AK%%%%"TTLFNSV6VR^0+>^_KJEMLOD%%%%)J]KWT\
M[:=O338'JU+9JVVFUA,#T ]\ ?SI:**K2\=%[O\ P+W'=WOS/[]/^#\PHHHI
M=GJK;6$M+_KK]UPI/Y?3^N?Z4M%&NFK5GI_P1IM._P"?Z?UU8=P>X.0:***'
MK\[7MI>UG^B%W_O.[_#MZ(****;L_LI6VLK/IKIZ:=@6B:2WW_X';8:P+8'O
MS3J**2LG>ROIT[6_'0:=E%+[+NM_Q_$0C./8YZ?I2T44;?UY6_05M6^K=V%%
M%% "'D>GX9I1T_PZ444/6_GNN_F_/\RE)I6LON]-^]^H4444$A1110]4EM:2
MEI9:Q::O]WSZAV=D[=T%%%%'?6]Y<VO1Z;?<#U\K=M/RWN%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UNA_#J,CKW'<>H
M[TZD894CGIVZ_A[T ?%W_!0GXR:I\!OV+_VBOBGH;/'KOAKX8>)9-"N$X:VU
MJ72[J/3[H'^(13E&(X*[1SQS^*/_  ;/_LE>&-"_95F_;9\9V=KXF^./[1_B
M'5_$%UXKOH8[[4=)L/M3B[LK:256DM6GU![B4NCAMA"_=-?NU^VI\$W_ &B/
MV5OCI\'(2AOO'?P[\2:+IK,,*FJ3Z9/'I[^P2=EZ<EL\^G\XW_!NC^VSX=^%
MO@3QC_P3=_:!U6'P%\4O@=XIU72O"5GXCF738]9TB"]E@E2T:Y,9DDN;F,W4
M0#9>)P02#0!_6U&SD;B^Y00"X8D=E^49!^4\/G/)XKS/XR?"/P5\=?AQXJ^%
M7Q&T&S\1^$_%^E7VEZC87\,4ZH;B"2&&YC69'$<D+.&CD0*R')!P37H=I=V]
MY#YUI<6EY;.H:&:VN8I8GCZG8R,50+_&26Y!KY;_ &M_VP?@S^R%\(_&'Q7^
M)OC+1--7P[HM_<6&DM?6ZZCJE^()&LK6UMO-,DSM-L5MJ="<8- '\X/_  02
MN_$/[,'[<7[<?[ 3:A<:EX#\!>*KG6O!L9N"T6E0WLCSS11*<JH4;4 4 #&<
M5_7<A!!"CA3MSNW;L?Q$X'7TQ7\E_P#P;V_#WQW\=/CS^UI_P49\?:7=:/I_
MQH\5W5GX(M;J&6*632X))$2]8. 9(I8RKHR_*?UK^M 8)9@".<>W;D>GT/2@
M!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^/7Q@_Y3*_LG?]D$
M^,/_ *;H:_88]3]3_.OQY^,'_*97]D[_ +()\8?_ $W0U^PQZGZG^= "4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %&<<^G/Y449(Y R1R!ZXH BD)PRA?D!&5(^\S\%
M ._4MGUK\&/^"D/_  0O^#?[;?B^/XS?#?Q#=? GX]VZF67QEX5:?3O[8DC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0# Z $\MC.">YY)H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_'KXP?\ *97]D[_L@GQA_P#3=#7[#'J?J?YU^//Q@_Y3*_LG?]D$^,/_ *;H
M:_88]3]3_.@!**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!^1GQ@/_ !N6_9.'?_A0GQAX[_\ (-AK]ACU/U/\Z_'?XOG_ (W,_LG<<_\
M"@_C'G_P5PU^Q!ZGZG^= "4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>O-?AG_P;,:S=WO[!?C319997L_"/Q\^)?A_3$8L8K:TL]<O$CAMU;A(414
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MP;^SO^T!\*_&.K>']>\&>([M]&CO-+L[F6&SU>P%VD33+<QQ;R!E=C C).*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB'-\;/B)81SQVO@?X50#79;G48U8117-_#E8K<3 +/<0^<%4,0#P:_"[2/\
M@IU_P6K_ ."O-QK_ (<_84^&&@_ 'X:2WLND:EXP^U,]SHMO(QB$M_XAN##>
MZ=?&%M\P@A;8^0@& *_9_P""7_!*K_@EA\%?V=/&?CSX!^"?A_\ &+4V^'FM
MWVA_$'Q-J]GXWU<-_94S1WEE+/,9K.7?F3$B[U) XQ7S1_P;(1B#X9?M1VT(
M010_&7Q D<<<:P+'&M[*$@C5<[4C&%4 @  8Q0!]<_\ !'[_ ()4_&']@C4/
MBA\5OVA_VB-9^.OQI^-%IIW_  E44]Q<ZEI>B3V2_.MEJ=Z5N+Q69C]^)% '
MRDBOW83 &%Z#@'N?<^Y[T*NWW-.H **** "BBB@ HHHH :PRAQT).[W(SGWK
MB?'7@+P?\2_"&M>!/'_AC1?&7@SQ)93Z?KGAWQ!917^E:E92@++;W5I,&1@P
M.0^-RG!'-=Q10!^.?A'_ ((-_P#!+_P/\4K?XLZ/^SC93^(+349-6LM)UC4[
MO6/!-G=NZRJ;?PM=$Z<D5LX#VL03;"WW,9-?KFNE6,>E_P!B0VD-KI4=A_94
M6FVRB"TAL#;?9$M((XE"PP1VX$:1H-L:!5'3C9HH ^3_ -EG]B[X"?L8Z%XS
M\-? #PQJ'A?2?'7BW5?''B2'4-8NM9:^\2:U=37=]<1R79+6\,LT\C)%'\B!
M@%7 S7SW^T__ ,$B/V ?VP?%*>.OC5\"]*O/&(&;WQ'X:NYO"^K:NP;>QU6]
MTP)-J1&?OSG...]?II10!\U?LX?LF?L]_LE^"AX!_9Z^&.@?#O0<1R79TJU2
M/4M4=!M6XU75=OVJ^EV %C,Q8GEN2:I?M,?L<_LY_MA>#?\ A!OVAOA?X>\?
MZ.GF#3KR^LHH]<TB1O\ EIHFL*AN]-E?JTD#*6.3P<&OJ*B@#\U/V5_^"2G[
M!O[&OB<^-_@7\$=/T?QNBR"V\3:_>3>*-<TU93^^CTZ_U(-):*.WDL,C'%?I
M&N=P.#R?E8<#'3:Z]A_SSP,#!JQ10!^.WQ>_Y3*_LF?]D"^+_P#Z;(Z_8H]3
M]3_.OQY^,'_*97]D[_L@GQA_]-T-?L,>I^I_G0 E%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_LET\T<I:4[L.GOD<4 >)_\ !OG^WA^V=^UQIOQ;\(_M/Z1?WOAGX9VFE0^
MOB'>:5<6#>+[>5-KR1R3QK]H* (2<MG/O7],J9W'/4=3Q\W3DCC!/&1C(KC_
M  AX!\&> =+@T/P1X5T7PMI5LBI#8:'86EA!M084.+:.,$+@8!S[5V@.<Y*D
MY.=HQ@^A]QW- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X]?
M&#_E,K^R=_V03XP_^FZ&OV&/4_4_SK\>?C!_RF5_9._[()\8?_3=#7[#'J?J
M?YT )1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=:^(FGRQ:M<"1<7*K?73"YNB%QF&2)1%S@FOZHX^F1G!['J#WS_C0!)1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?CU\8/^4RO[)W_9!/C#_P"F
MZ&OV&/4_4_SK\>?C!_RF5_9._P"R"?&'_P!-T-?L,>I^I_G0 E%%% !1110
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M (<34?\ Y-H_X<P:/_T>W^U[_P"'$U'_ .3:_;.B@#\3/^',&C_]'M_M>_\
MAQ-1_P#DVC_AS!H__1[?[7O_ (<34?\ Y-K]LZ* /Q,_X<P:/_T>W^U[_P"'
M$U'_ .3:/^',&C_]'M_M>_\ AQ-1_P#DVOVSHH _$S_AS!H__1[?[7O_ (<3
M4?\ Y-H_X<P:/_T>W^U[_P"'$U'_ .3:_;.B@#\3/^',&C_]'M_M>_\ AQ-1
M_P#DVC_AS!H__1[?[7O_ (<34?\ Y-K]LZ* /Q,_X<P:/_T>W^U[_P"'$U'_
M .3:/^',&C_]'M_M>_\ AQ-1_P#DVOVSHH _$S_AS!H__1[?[7O_ (<34?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"?X^?!V^_L[QQX.NW,EM!+G#/9S$_O(R02C#@@=J /U@HHHH **** "BBB@
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MK)T#_D Z)_V!],_](8*UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCI^G:BL4D"ZA96U^MO.NRY@2\@CN([>6,?*)8?,*2KD[74@'@T ?D3\8"/\
MA\M^R<,\_P#"A/C#Z_\ 0-AK]ASU/U/\Z_'3XP9/_!9?]DWW^ GQ@.>QQID!
M./RK]BVZGZF@!**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0QH EHJ-79^%1N.I(X^GUIV_!*MPV,D'TSP1W_'ZT .HI%.[I^O%+0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.O\ P7(_Y,B'_99OA/\ ^I+#0!^NF@?\@'1/^P/IG_I#!6M63H'_ " =$_[
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M]D[_ +()\8?_ $W0U^PQZGZG^= "4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0
M?N2?]<W_ )44'[DG_7-_Y4 ?B?\ \$J_^3B/^"CW_9=M(_\ 3&U?MA7XG_\
M!*O_ ).(_P""CW_9=M(_],;5^V% 7"BBB@+C=O.<]\_CG/Y>U._STHHH 3'(
M/3&>,>M+110%W^H4444!<**7ZY]OK24 %%'\_P#]7_UZ<1QD<C STX/I0 VB
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\=?^"Y'
M_)D0_P"RS?"?_P!26&OV*K\=?^"Y'_)D0_[+-\)__4EAH _730/^0#HG_8'T
MS_TA@K6K)T#_ ) .B?\ 8'TS_P!(8*UJ "BBB@ HHHH **** "BBB@ HHHH
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MQ+*T,LUY+#$[PC*D%LL5^7)- '9+(W(8KD=1D97G W#J,]03QS3]_)!/S9
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M/&?Q?UMOAW\$?!+W3>&?AKHFF2/';75W<SXDU#6[Z K)=SR!V23A&XK]#O\
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M ()5_P#)Q'_!1[_LNVD?^F-J_:A\AG7("CYMP&6()&0.>"!T&<CGCM7XK_\
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M@O0;2:?Q#'\&H==T6SCA:2:XU'0[B'4$M8X-N]FDA@F 4#+.1@&OWV\5^%]
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M<^N_L5?\$>/V&?VIO^"6/P'?Q7\%/#^F_$3X@_!33[R7X@V4#6?B*W\22PW
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MG@7P%JEQO$^IZ)I$,%^ZORZ+<G=*J-T*A@,<?3Z#4$D# '.<C);W.X]/R]*
M.#\)?#/P-X(U3Q#K_A?PY9Z3JOBZ]_M#Q%=642QRZK?8(%Q=, &D;9_>^O4U
MW\7W0.1M).&'(!XV@\],CC/3UJ8<,6YR1Z_@#[X%)SC!Y.<DXZ^W]: "OQU_
MX+D?\F1#_LLWPG_]26&OV*K\=?\ @N1_R9$/^RS?"?\ ]26&@#]=- _Y .B?
M]@?3/_2&"M:LG0/^0#HG_8'TS_TA@K6H **** "BBB@ HHHH **** "BBB@
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M]D$^,/\ Z;H:_88]3]3_ #K\>?C!_P IE?V3O^R"?&'_ --T-?L,>I^I_G0
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MZ$@T 6:*** "BBB@ HHHH **** "OQU_X+D?\F1#_LLWPG_]26&OV*K\=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXK?&OX@D?\);\4/&LWGZK=('\Q[?3K?=)'IUOYI)6*!PH&%Q@5]1?'CQQ/\
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MG)  ^GO][;<<# !(R<9)4?P8Z8HP1ZCDXPQ&U>P4?GQ[]: /R]_:L_X)Q_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** &GGT12&&[K\_J17X5_\%ROVO_BC\!/A'\(_@-\
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M]?>D"X]_Z5^+G_#^S]@3_GM\=_\ PS/B+_Y(H_X?V?L"?\]OCO\ ^&9\1?\
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M /#,^(O_ )(H _:6BOQ:_P"']G[ G_/;X[_^&9\1?_)%'_#^S]@3_GM\=_\
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M09=$T56!##2-,R"I!!^Q0J02>I!4Y&..G7-:M !1110 4444 %%%% !1110
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M<$5^DT/AW08;W^T;?0]%M=2!8C4;;2+&&^9WP'8W0MQ,6D'WB6/3FM786+9
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M_1=OV3O_  F_%E'_  J__@NG_P!%V_9._P#";\65^X&!Z#\J,#T'Y4 ?A_\
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M\*O_ ."Z?_1=OV3O_";\65^X&!Z#\J,#T'Y4 ?A__P *O_X+I_\ 1=OV3O\
MPF_%E'_"K_\ @NG_ -%V_9._\)OQ97[@8'H/RHP/0?E0!^'_ /PJ_P#X+I_]
M%V_9._\ ";\64?\ "K_^"Z?_ $7;]D[_ ,)OQ97[@8'H/RHP/0?E0!^'_P#P
MJ_\ X+I_]%V_9._\)OQ91_PJ_P#X+I_]%V_9._\ ";\65^X&!Z#\J,#T'Y4
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M>@_*C ]!^5 'X?\ _"K_ /@NG_T7;]D[_P )OQ91_P *O_X+I_\ 1=OV3O\
MPF_%E?N!@>@_*C ]!^5 'X?_ /"K_P#@NG_T7;]D[_PF_%E'_"K_ /@NG_T7
M;]D[_P )OQ97[@8'H/RHP/0?E0!^'_\ PJ__ (+I_P#1=OV3O_";\64?\*O_
M ."Z?_1=OV3O_";\65^X&!Z#\J,#T'Y4 ?A__P *O_X+I_\ 1=OV3O\ PF_%
ME'_"K_\ @NG_ -%V_9._\)OQ97[@8'H/RHP/0?E0!^'_ /PJ_P#X+I_]%V_9
M._\ ";\64?\ "K_^"Z?_ $7;]D[_ ,)OQ97[@8'H/RHP/0?E0!^'_P#PJ_\
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MV3O_  F_%E?N!@>@_*C ]!^5 'X?_P#"K_\ @NG_ -%V_9._\)OQ91_PJ_\
MX+I_]%V_9._\)OQ97[@8'H/RHP/0?E0!^'__  J__@NG_P!%V_9._P#";\64
M?\*O_P""Z?\ T7;]D[_PF_%E?N!@>@_*C ]!^5 'X?\ _"K_ /@NG_T7;]D[
M_P )OQ91_P *O_X+I_\ 1=OV3O\ PF_%E?N!@>@_*C ]!^5 'X?_ /"K_P#@
MNG_T7;]D[_PF_%E'_"K_ /@NG_T7;]D[_P )OQ97[@8'H/RHP/0?E0!^'_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *1B0.!GGT-+2,V,?T]A_/I^M
M$0))QN(_.E[[2=RGY7!SR#P0!Z^E <Y8D<$\'U/I^%()&9@2-N".G'7\J;MI
M;=[^N@&+?^)M TC4-+TC5M8TZRU/67E@T6PN[B.*[U5H@#-'91,P:>2-2,A
M3STXS6XI.<8P!G.<Y'7@_3I7XW?M^W]_!^WA_P $U;:UOKNVM;OQ[XN6ZMH9
MY(X+I4LK4JMQ&C!)0AR5#@@$U^R#/Y3MD;MS,P'89)]?;%+77MT_4"6BHFD
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M?U]::)21]TJ,X 88<8[MZYZ]O2@"6B@'(!]:* "BBB@ HHHH **** "BBB@
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MZ^O/6G!BW\. ._K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI:1ACN%Y'&3T%6*@N$61-C\I)F-U*[D='X9)!_=8<$]N] '\I'_!4[_@L?\
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MT?P UWX;Z3H,G@73?VF=1\2M_P +"7PR8&T^"]DTJ2Y\^?4+6QQ%%-)&TSJ
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MZTMK*SA50HB@MHUACC7'RLJ(H&X=.]:51K'C.0,']/IZ#U QGOFI* "BBB@
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_"@ I3CMG\?_ *U-!STI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH @8L"=O')]?6FAV .2<@'\>,C'N>GK6;K&J:?HVG
M7NKZM>1:?IVG6\MY>7T[;+>T@A&^6:=OX8U49)QQ^-?F_P"&?V[9OB;^UAX6
M^"_@'35;X>W>D:Q?7OB:_L)8IM>GT^(M'<:')*4)TT2# N A$Q#+A>*X,;F6
M$P$J$,17L\145.-/LY*RT[-OKI?9.[/$S;/\NR5T8XVI-5<77IX?"TJ:NZE2
MHXQ7-V46_B??35'Z9!\XY// SQ[_ )?UI3N(!5@&/0Y[<#GV_P DU\@?M)?'
M/QMX+\0^"OA9\)=,TW5?BAX_>]^P?VPW_$LT6PLH3--JE\N1YD:C*K$2HD9-
MN[FO._AE\<?CIX/^+6A?"3]HBQ\,2R^,;.:?PMXM\,PFQLKN[MHVDGLI;0O)
ML=55B"7Y]JPGFV&I5_814G*ERPC4M^[<N7E4:DNBN]?.^^QS5>)\NHY@L"Z=
M?]U.-&O6Y7]6I5YJ/+&<]N?NK::ZZ6/O_P V3<%RV[OM4-G.1@KQCL._7GW<
M!)N#.I1@-A)^YMZ_ZOD9)/&#P>_K\E?M;_$?6?!?PXBD\)3:U+K&J:S9:?O\
M(+]MUN&VEEC$[VT,)=EG"DB,-@;]N2*V/V;?$%AJ>CZC;?\ "3_$C6=8@$;Z
MEI/Q-RGB#3&(!#-9M\T,4F?W0W,-HXZ<[4<=#ZU/"2TQ4Z2J2M?V:E)1:4.^
M_P#P#=9]AGF57*7!^V2A4A6_Y=7DDXK3K9K37KO9'U(-_M^/_P!;^M,)8'K^
M1_2H9+C:H9@\:]=V 1CON;(V_C7+Q>//"$NLP^&H]?TA]?G#-%I27L4UZT:#
MYW\F/>5VCDJ^WZGBNF52G2<8U)J=>;]S6]G9/?2UM^_ET/8]M3@Z<'6IQK5O
MAI3:YYZ=$]7Z>9U>><<D^W_UZ0$DC<&+ X!!Z<<9QZ9'^<UYO\7?%6H>"?AK
MXX\7Z2D;:AX=\-ZGJM@UPN^ W5G;O)%YT8(+P[P XR"RYP17Q3^P?^U-\3OC
MRWC'0/B[8:3IOB;1U@U;2)-%M38V]_X>OI'AM+J. R2>;&)$(-R&P[!EP"*Y
MZ^8X;"9AA<%4TKXN-TWLGL[O7M:*LVSQ\7Q#@,#FF$R>JJM/&X^/+2=O<7(]
M7?2W6UD[MI7Z'Z/O*^T9 &20 OWB,D'G^OUQQ3-Y^9?G(48.X^HXP<\C'7\Z
M_-O]LC]JWXE_!KQKX(\*_#&QT6\22>WN_'-WJMD;M=.TB\N!:6LD&)$\N:6X
MRH?).6Q5S]H/X]?'31_&'P8\#_".?PK9ZE\1M.AO-1N_$.FF]@A=K1)F^RIY
MT>WDEMI/"\<FN*MGN!H3J4:T9U)8:JH3]FK\\IVLEW>FMW;\SRL5QKD^&^MQ
M<:]6KEU:G0Q/+#F]K.H[0BM5S7EHW=+=J^MOT:4MM !YZ@9X'(//\_QI96DR
M,G/;MW__ %>U?F=XK\3_ +>OPST&]\:ZU>_"WQCHFB0M?ZIHVF:0=,U"XT^(
MAIFM;@W#[)A&"=A!Y&<C%:_Q?_:R\<0?L]^"?BE\,K+3-.\0^+=3TW2GM==M
M/MUM8W-Y((I$,?F1[U23<=X/"CD&E/.\)"I*$J=;#5J-.G4C3<;7I3J*VG-9
MWYMO4JMQEE]*[Q-+$X6=*A3Q4<.Z24JD)SC",;<^LFUL[/?S/T7>1NA#=>HZ
M>V,'T]<>_-2!F(/+#!!YX/T'<].?K7YNC5OV_-*T:'Q1->?"[Q39Q6J:I<>'
M[32FTR\OK3RO/D@M;WSY?+E:,'RF*MN8 8YKZ9_9Q^/>E_'OP-_PD-M9S:5K
M6E7]QH?B70IW_P!(TC6[)Q%=6[9&98A)RDA W+CBNZCF-#%8BGAW3J4G.'/3
M=5<BDXM3?+>]WI^=KI'5@.*<%F&*HX1X7%8"I4C[:DJU-TU5TUY=V_=7-;:W
M='T2 <$@'_/_ .KK^M+DXZG'IG^G6F;V0':-^,ECG"E^Z@DCZXP>0*P];\3Z
M#X=LY+_7=6T_1[2-=[W-_=16\"+W8M(RL0#G[JL>. 179*I&-JL\0E"/->$;
M<K5[*^NZ?<^CK5,-2<%5DJ4'*#A-M6:?+I*[ZROZ:/?0WLXZ$Y]/;W/7_/?F
MF[BAW'DG/';MU]_>O%OBA\?/A[\+/ 1\?:QK$=WI=U"S:)%IBR7ESKLQ7,<.
MFQHNZ=W/   4#G."!7@7[&?[3GB7]I+2_'GB'Q)I5OH5AH^OS6>AV/V8VM_!
MI<:.RMJ49=L71"AF7C'((SFN*IF>&HUZ.'JU?WN);^K1A\+A:_*[.VRW=^G0
M\7%\09?ALUI99+%7QN+7NPA9PIT5&]VT^57C'73O=GW0DC\@D ,,\X Z]L]?
MZ?C2,6P<-TZ\Y'Z]_3VK\V-9^/W[17Q<\>^,M _9XT[PIIOAKX?7;Z=?ZUXJ
MMS>G7-1B5B]I91!X_LY+(4W$L!D,<U[I^S)\?-6^+.BZ]IWCO2[3PSX[\&:K
M-H7B;3$G1+=KJ!F47EL)"NV";:S(NX\$5$,VPDJE.C-/DK3E3BVKP<H;I-6O
MT[;I:-J_)A>*\OQ>-]A1IU7&-26'IUJL;4J\X6YG"6S<;;6Z]3ZQS(1\I)'.
M]"V"V/NB'J1@9W=.<4HEZ;>57C.=YY'!R<$'U&,=*_//]L#]I#Q)X5TZX\+?
M"#4+;_A)=)NM'OO%VMPW4&W0-'N+ZWC:W#;SON;V)VQ&OS*HR2.<?=GAO4)-
M1T'1;R1EGEN],L9W9"':>5[:)I'79PREB6:0''/?FG0S&CBZM?#83W94[<VF
MVU_*ZV;^5^AZ6"SK!YACL3E]"O%U\(N>IR:Q3=KI/R6C^[8_(?\ X*"'/[?'
M_!,L_P#4_P#C#_TBM*_:,]3]3_.OQ<_X*";Q^WK_ ,$S"\;X7Q[XN7<BDC=]
MBM,YR OR]>#STX'-?M#G+/[,?YFO6FTXT_YE!*7GVZ>IZ^NEU\^_]6&O]TG*
M@#:3N'H3@^_/;Z9XKA?B+\1_"?PH\#^)?B'XZU:WTCPQX8TRYU/5-1N72)&B
M@B:06\6X_O)YMHBA1<LTC  9S7>'H!GG=PF/ODC&,]L=<XXK^:K]M_\ ;>_9
M_P#CE^V%I_[(/Q7_ &B_A?\  KX$_!R]M?$GQA_X3_Q)#H&I^/M4AF1[;PQI
ML$N%ELU9096DE2)QN#LJDFLQ%S_@G=_P4I^/7[7O_!1[XR^ _$45[X=^!>F>
M%6U/X;^&[NU:"2\T]9F2TU>97PP>ZC\N1"0,QMD=<5Z5_P %;OC_ /M?1_'[
M]G#]D[]B/QU!X0^*OQ,T_5O$.OWUSM^R:;I5C<B!+J\G;Y8;=E/S%\*"01FO
MA']E_P#:W_8C\-?\%D_B1K?A']H/X/6/PHU;X::+X2^'NKV?B&UA\-ZWJ<?D
MVUMHNBW:1B"ZU(L8XTB4@.V,2-D$_9W[;'_!+_\ :V_:M_;;G_:0^$G[4FF_
M!+P2_P -].\&Z)>:'9PZGXEMM-DMT:\DMBLRRVT6H.%N3*H4XSSUH G_ &/?
M@!_P6J\(?M"^ ?$/[2G[1/@SQQ\$-,OGD\::!I%W;W5UJ-N$E!2$P%U\P.5(
M!8'@^M?T+C^^/E63/!X(ST&SH"3]YL_RK^1^*R_;@_X(N_M)?LYQ?$?]J#5/
MVJOV</VD/'5E\./$EGXN62TU+PKJ^K2 1ZGI4<CS2>9')Y9CD5RKJY5ARP']
M;%K<)<0P3QCY9X()P>CHD\8E19$/W248;N3T/X %JBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH */H0" 6!(!QCT!P._J".U%!^Z3@, 1D'H5[GW
M([4 <#\4?%VH^!/A_P"+O%^D>'-3\7:GH6B7^HZ;X;TB 7.I:SJ%O;O+;V%O
M"S)\]W(JP@ _QY^O\N.M>(_^#@WXN67BS]I'PG)X7^#WA#P_-JVN>'O@IXAB
MBMM<N-#TII[A;75+3+AY9+&'<JF3DDDD5_6)+*D08RLD:*%(DG94C W#EI&P
MH! P%)//0U^>7[?G@+]N;XH> ]2\(_L??$#P#X&M=:\-W]AK\VOZ5'>ZWJ0N
MTDBGM-$U;SPFD&YMG: 7:Q2LK.<#D@@'CO[%W_!3*#X^?L!>,OVLO'WA:70_
M%OP;T3Q5;?$SPW "L$OB/P?!<PWOV/RR_P"ZOKRTDX3/E+(.>*_&SP#\8/\
M@NY^V5\.;[]MGX*^//AWX$^$]Q)XD\0^ /AG*+9!>>%_#XN+BTM]1MLD7,MQ
M;0[9I)&1I9/O@'('U!^P3^T9^S!\$?\ @G)^UK\/O'?PIUGPW>_LSGQ?HO[1
MW@O4;[^UKWQ?XBU:.[34=1@U0JGF6^N7C2-!)Y?[@7"X!K\Z_P!GO]@?_@L-
MXZ_9BU/Q3^RS\>]3_9^_9N^)]CK_ (L^&'[.>H>)4U#58? _BB*6]MM*CUAH
M%>S&MZ?,L5J@3$'FKC.* /Z6?^"6'[;&N_MV?LF^&/B[XRT&'PY\1-'UG5?
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MANT^.VD+;Z9H=A!8PHOG Y8Q(KR$XY:1G8YZ\XH _I:Z. ,#Y5X'3[@/\_\
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M (*#_P#)_'_!,K_L?O%__I':U^T)ZGZG^=?B[_P4&.?V^/\ @F4?^I]\7_\
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M[3_!NFR2!+K5;56!6*YA!9XW&W#@$D<U 'W;^S]_P4!_X*;_  C_ &@OAO\
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M">%?A7\,+NT@\"6U_:-;^(+VWN+D1I>ZP)41T2XA(N(8^NQERH[?IO\ '/\
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M!5L$Y!QD_2KM8^@ZI::WI&EZUI[LVGZMIMEJ.GY_Y]+R!)X<CL0CJ !VK8H
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M GGK_@[^VIX>\ _"'PEX2?X0?&FZ\2Z'H4&G+;+X0<V-SJ$*",(;LW *0NX
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MO-6_9JD\3Z)^T-\5/A7I'BVYLOB7J$^N:=IGCR+0D<:<-)O3Y5G9RW?^C_9
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M !1110 4444 %%%% !2$X&:6FLN['.,>U 'R+^W/\._C?\4OV7/BAX1_9O\
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M!4AL%-V"!S\QS@\\A1P!4@&/S_(=@![4 +1110 4444 %%%% !1110 4444
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MC7X._P##%W_!8_\ Z2'_  ]_\(#5_P#X[1_PQ=_P6/\ ^DA_P]_\(#5__CM
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M'_#%W_!8_P#Z2'_#W_P@-7_^.T ?O%L;T_E_C1L;T_E_C7X._P##%W_!8_\
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MZ?R_QK\'?^&+O^"Q_P#TD/\ A[_X0&K_ /QVC_AB[_@L?_TD/^'O_A :O_\
M': /WBV-Z?R_QHV-Z?R_QK\'?^&+O^"Q_P#TD/\ A[_X0&K_ /QVC_AB[_@L
M?_TD/^'O_A :O_\ ': /WBV-Z?R_QHV-Z?R_QK\'?^&+O^"Q_P#TD/\ A[_X
M0&K_ /QVC_AB[_@L?_TD/^'O_A :O_\ ': /WBV-Z?R_QHVGCCKP.GU_I7X.
M']BS_@L?V_X*'_#D#_LGVL__ !PTT?L6_P#!8XL1_P /$OAVA*$%U^'^KL5
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M\(#5_P#X[1_PQ=_P6/\ ^DA_P]_\(#5__CM '[Q;&]/Y?XT;&]/Y?XU^#O\
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M>:Q9@,%6&\N)&BC<$C+LNT]<4 ?L#_\ JHIBY)+,%W$#E3GCL&QQN'.3WI]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I0,D#CKW&1^7^<=:2D.,<G '?)'T
MR1SCUH _GO\ AQ;)XD_X+Q?%F_UUFEOO"_P<T^'0()2'%O;':K2VZ2?ZHX^^
M\6"PSG)KTCX^1)X<_P""T/[+NHZ! EO>>,?@GXIM_$\EM$HDO$L-4A@M);S
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M@E?+RL841J<<XP%&WV 7';GMUJ )J*** "BBB@ HHHH **** "BBB@ HHHH
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M[D^3J=]:Q"YE<>;+&]LBXBD)V@8Q@U^27QUU74O#/[/?_!1+P1X;AE@\+O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV]VP&LJM]X!N0Q!Z$@8&?H.GI2X&",#G/X9Q]WTZ<8Z9-+12 **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!?[>'P<TKXT? WQ!!J.EWB1Q:MHT\\;:SX?U(C$NGZI9(Q:%E?**X3;C!#4
M?8[.J]3^%()$/1OPYS58C=D =,A=S'<)>Z^Y]%)Q_*OP _X+-?\ !:G4?^"8
M?B/X1> ? 'PWTGXL^.OB!9:AX@UK1;R\NK9](\,V1>'[:JV >92;E#O:50BQ
M'<6 YH _H)W+Z_S_ ,*-R^O\_P#"OE+]C']J3P9^V;^S3\,/VB/ LD"Z9X]T
M"WN]2L(IFG_L778E6'6=,W9\QOLE^)(H_, 9XMC<C)K\>/VBO^"T_P 4?V/O
M^"@WA+]E;]HSX,:%X8^"/CR_LX/"?QDAU'4%:ZMKV80*\JRH+$S0S211S1[\
MH"QQQ0!_1IN7U_G_ (4;U]?YUC:5?6&L:;9ZQHU_#J.EZO;6VHZ5?6THGMKN
MRNHEFAECD4E6BDC8,C+G@]NWYN?\%2?^"D'@O_@F]\!I/B5J6GV_BOQ]K=W'
MI_@+P*9O*GUR^FD$2;TBS<F%965"T:G))'8T ?IYN7U_G2>8G9L^PK\__P!@
M7]I+XY?M$?LS:-^T%^TG\//#GP5F\0:?/XALM M;Z\F_L_PL(3<)J&M/?)&U
MO.+93*$CR#T/6OQ(_:B_X.:/"WAGXH>)_A)^QU^SWXH_:'U;PGJ$^CW_ (AM
M[+6)='N=1MIG@D:R.CV]Q)]D69"BR7 0NRMVP  ?U<AE*EL]#@^WY4F]/[W/
M;^M?QA>'O^#GS]H[P/?QZK^TI^P+XK\#^!A<V\%WJUE8>*HI+*V\P"XF62^L
M8[0N$!>-KAUC).&;%?U-?LC_ +7'P6_;9^"GAOX\_ _7O[;\(Z_'MN;>5HEU
M/0=1C59)](U2VA8B&^MF?E3]^,;_ +N* /J(R(HR6I58-TK\HOBE_P %"?$7
M[/W[=O@?]F/XY^"M(\-_!WXRZ9CX5_&%+RXCMY_%(E$;>&];$H%K;W<^0]N(
MW^8$#K7ZLP[0BD,)(\??&!^[8;DD4_Q*5QM8'IS0!-135)QAB"RDC(Z%?X3[
MG'>G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 (1G@BJ+V%E+,TLMA8RR$;6E>U@>8^A,KQLQV^A+5?IHX=AW(!'
MTQU_6@#^*'_@X-M;2W_X*D?\$Z$BM+:%&\3:)O2&"*)9#]L!_>JB!9!R1A@0
M1@=!BO[0=&TS2SI&DYTS3F*Z5IOS&RM^1]EA  _=_* !@#D 8&,"OXQ?^#A3
M_E*5_P $Y^G/B?1>._%X*_M'T; T?2SG@:5IJY]_LL./SH _$O\ X.*H8X?^
M"3W[0BQHJ*;KP>NU%"*H_MA0/+50!&0&ZJ.>O>M7_@W@4#_@DS^R]P/ETWQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR_#CX]#<N<R?#_4-P<?+A7W8*DJ=N "1C@5_0)\3OV1/V8OC1KR^*OBS\#?
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MQMXX7F  QON'1I).Y9CS0!Z4I))R-N<''89R>*=2DYQS_P !'\/_ .OKS24
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML/#/A^VEEFMM)TN'[/9VLD[;Y6MX1A8_,;DA0![<UU>U<?= (XXR!@=,^_\
MB:6B@!H1!_ OY=/I2A0,X'7KUI:* $  Z"EHHH *;L7T_G_C3J* $"@<@?SH
M8;N/?-+10 W8OI_.G8'3!V\?7U/_ -:BB@!<D_RIK#<,9(^GMSCGL>_M2T4
M<%IGPO\ A[HOB[4O'VE>#M!LO&NM1+;ZMXHBLD.LW<"8V0->L&E$7 ^165>O
M!ZUWF/DV= .>/7T^GIWZ4M% !DGJ%^H')^OX4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g4bdklltl5z5000013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000013.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" +: VP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBF^8N[;0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFN^P9Q0 ZBH_
M/7TH\\?W: )**9YW^S2>>,9VT 2-TZ5\R_M_?M6_%#]F3XA?L[^&?AY::5);
M_%+X]:;X.\3?VG:O(R:?/9WDS- 4D79+N@3#,&&"?ER<CZ91MPS7P]_P6*_Y
M+'^Q?_V=UH?_ *;=2H ^XJ*** "BD9MM)YHZ8H =12!P:7</6@ HHW#UI"P
MR#0 M%-\RCS/44 .HHW#UHW#UH **-P]:-P]: "BC</6C</6@ HHW#UHW#UH
M **-P]:-P]: "BC</6FLX'- #J*:) :-XH =13?,%'F+0 ZBF[Q0),GF@!U%
M%% !1110 4444 %%%% !111GM0 4444 %%&:* "BBB@ HHHH **** "BBB@
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MGX=?''P)\4/V.?!WQCTBS^(&H?#?4(9])M=01M0TJ.]M)88+MH5.]5W.&5B
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M .2*/["G_P"CFO''_?N7_P"2*/\ 4/'>?_@+#^V?$3_H13_\#B?K%_:NE_\
M00A_[^"C^U=+_P"@A#_W\%?DZ=#F_P"CFO''_?N7_P"2*0Z)/V_::\<?]^Y?
M_DBC_4/'>?\ X"P_MGQ$_P"A%/\ \#B?K'_:NE_]!"'_ +^"C^U=+_Z"$/\
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M?Z2=2^-VO:M9:M'*([I-4GC42)C<C R'C#+R>#D^E>H_ C_@JKX5\ ^$M!\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM[6,=$1$ 51^%?'/_!8K(^,?[%H_ZNXT/_TVZE7W%7P[_P %BO\ DL?[%_\
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M **** "BBB@ HHHH **** &O@'I364$<K4F,]11CVH C" #(6L/XCZ+:^(/
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MN%\Z_L+,U6G?V;5II6UB]UJ<%X8_;7_9UCT&TBU'XE6OVA;9!-NSG=M&:O\
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MW#UH **-P]:3<OK0 M%&X>M&1ZT %%&X>M&1C.: "BC(]:,T %%%% !1110
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MYI:* .-^,?PDT3XT>!+OX?\ B&:2.VNFC=I(OO(RL&!'Y5\U_&/_ ()\> ?
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M_2\7$2KC<*!/N;<C?+7Y(_%G]J+Q9XJU36[GPKX[UR".\\2-=V*_:G39;%&
M7 /')'%>R?L<_P#!0+P5\(?A7J'ACXO:UK>H:I<:A)+;S>6TVV,H HW$^H->
M)E?C-DN+S+ZG6I.FDK\\GIILOF13S+"U)631^A1N55L,10)B3D'CI7Y@^(/V
MT5U'6_!5[I_BS7%M]%DU ZTOF,/.$LVZ+O\ -A>/:CX3_MHGPKI?A:V\5>+-
M<N)-,\>/J6J-YCOYE@8R!'U^;G^'I6L?&7A^6-]@U97MS75C;Z[1YK71^H5!
M;!P&KYY\*?\ !2[]ECQ'8M=W7C23365]HAU"U96;WP,\5#XQ_P""FW[+?AQ(
MTL_%%UJC3 [O[/M&?9]<XQ7V\N..%8X?VWUN%K7^)7^XU]O2Y;\R/HHS@C&?
MQH$^1E3]:^'?V>/^"E'PB\ >";W1?B%?:Y=WT^NWEQ#)]G,NV&20F-<D\87M
MVH_9Q_X*4?"3X>^#=0T;XAWVN7=[/XAO;J"3[.TN+>23,:Y)XP.W:O&H^)W"
MM2I2BZ\5S)MZ[6MH_4F.)HW7O+;N?<7GX^7%.$C'M7Q#J_\ P4N^#US\?-*\
M<VMYKBZ#:^'YK6ZM?LK?-<-)N5MF>>.]>Q^'O^"CW[*.L:7%J,WQ"6R>1<M;
M74#+(GU%>A@/$#A7&U)P6*A'E=E=VNNY4<11EU1[WO:CS#W%>)?\/#/V3?\
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MP *:@[TJD$\"OH(QC%61=Q:***H HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\H_DC\[\*?\ DDU_U\J?^EL=1117BGZ2&,]11110 4444 %%%% !1C/4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 'D8K@?VG?A%IOQ\_9X\;?!?5K7SK?Q-X9O-/:'=MWM+"R
MJ,]OF(KOJ;*A<8% 'X\>/?CY\3?VE_\ @F]HG_!*"?X,>-+;XY7%YHN@ZU%=
M>&YDTS3[>RU&VDEOWNR/+: 0PC&TEB7''!K],_!?QLOKCXYZA^S=/\+O$%NO
MA_PW9WO_  ETULHTR\9Q@P1/G)D7N,<5Z4-+LDN?M@LHO./#2^6-Q'UQFI1
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M_@L5Q\8OV+1C_F[C0_\ TVZG0!]Q4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%?[U/U9^X9#_ ,B7#:W]R/Y+J.HHHK ]8**** "BBB@ HHHH **** "BBB@
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MIYGWDI5EX-.'%0VY 0'-2!L]:^(/GQU% (/2BF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!&#Q7R;_P5Z_Y-ZL_^PQ%_6OK(=*^3?^"O
M7_)O5G_V&(OZUZ>2_P#(SI^I\1XC?\D7B_\ #^J/>OV;/^2%^%_^P+;_ /H
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MJZ,I(8$$$$<$5\6_\%B?^2Q?L6G_ *NYT/\ ]-NI4 ?<5%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 A4'K2;%'>G4C9QQ0!'(% V@=Z^1O^
M"BNF:CX;^('@_P"*EIJ'DBU?[.NU<LK+)OW<\'@]#7UU-PN!]:XOXX_#RU^)
MWPXU3PU+HUK>7,EH_P!A^U1*PCFQ\K G[I]QS7L</XZ.6YM3K3^'9^CT?X,[
MLMQ,<+BXS>VS^98^$/Q.\-?%7P7:^*O"VI_:K=E\N20H5Q(HPP(/O^%=5YF!
MNXKXW^%/@[]NCX'^&O\ A"_!GA#2#9K,\JFZ_>,68\\AP,?A6IXT^,G[?'@#
MPQ=^+?$_A?P_#8V<8:XD%L3M&0.@D]37K8KAB-7&26$Q%-Q;]V\U=I[:=SNJ
MY3[2NU1J1:>VNI]:"1F'!J17^;::\:_9[_::T#QO\,=/\2?$;QCHMGJLRM]I
MMUN5B"X)Q\K,2./>O5=!\1Z)XFM1J7A_5K>]@8X$UM*'4GTR#7SF,P&+P-:5
M.K%KE=F[:77F>57P];#U'&2V-*BD#*3@&E)QUKD, HI-XSB@,"<4 +1110 4
M444 %%%% !1110 4444 %%%% !1110!&#Q7R;_P5Z_Y-ZL_^PQ%_6OK(=*^3
M?^"O7_)O5G_V&(OZUZ>2_P#(SI^I\1XC?\D7B_\ #^J/>OV;/^2%^%_^P+;_
M /H KO*X/]FS_DA?A?\ [ MO_P"@"N\KCQ7^]5/5GT.0_P#(EPW^"/Y(****
MP/6"BBB@ HHHH **** "BBB@ HHHH *#R,44$\4 <#^TO\5Y/@3^S_XR^,=I
MIWVN3PUX<O-0AM=IQ*\43,JG'8D#/I7YY_LV_P#!.3]L/]O7X"Z5^V%^T/\
M\%9OC)X?\8?$#18=6T#0_A;K4.F:!X>BD7?#;M;H&%]L!Y?=&6Z$GJ?T4_:
MU/P_HOP.\6:MXL\'7GB#2[?P_=OJ6AZ>J-/?0")O,B0.RJ69<@98<GJ*_-O]
MDK]@3XK?$G]G;2_%O_!/;_@KIX^^&/PB\7:;'=:=\.O$?A'3]7OO#JR#+V45
MRURK6FS.!&H)0]VH ^F/^"0?Q^_:,^*7@#XC?!C]J'QII_BOQ9\'?B+<^$KC
MQI86ZP?V]#'#%-%<R0J-L4FV4*P!()&<U]A5X?\ L)?L4?"#]AGX/3?"[X4:
MWJ6M3:AJDFI^)/%&N7HN-0UK4) /,N;B0#YG. !QP !SU/N% !1110 4444
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MOV+L?]'=:'_Z;=2K[BKX=_X+%?\ )8_V+_\ L[K0_P#TVZE0!]Q444%@.IH
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M2:DL27VLZI9,\\XCC6./<=PSA%51QT%<P_\ P1@_X)4A=R_L-^ _3_D&M_\
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M-O 7B6SUC2+]6:SU+3[@20S*&*DJPX.&4CZB@#Q+_A@[Q3_T?+\9O_!QI_\
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MGQ'B-_R1>+_P_JCWK]FS_DA?A?\ [ MO_P"@"N\K@_V;/^2%^%_^P+;_ /H
MKO 0>E<6*_WJIZL^AR'_ )$N&_P1_)!1116!ZP4444 %%%% !1110 4444 %
M%%% !39.E.ILIPG- 'Y.?\%'/V6_A5^SM^W+XN_;#U;_ (+"R_L_ZS\7;'3X
M+CPZNCP3M=0V-LL",NY][#*,V< 98C/%8'[$O_!*3QY\2-&\5?M"?L6_\%S_
M !!K5GXZ\0->>*-;T+PS:2+=Z@@V$R?O,JP'&"!Q7;?#>#X%?%/_ (.'_P!H
MKQ+^U-?>%[Q?AU\,_#.B>!;7Q9+;_9[2"[A6ZG,:3G:7WR2?-@D"0^U;W_!,
MCQ%^S)\"?^"G?[:7@WP#X]\)^'_",^H>"+_1K&WURWBL6N)M.O&NG@7>$R7Q
MNV],*#T% 'V!^PW^S?\ &_\ 9F^'>I>#_CC^U-K'Q9U*\U8W5OK>M:7':R6T
M)15\@+&Q! (+9]6->X5B^$/''@SQU9R:EX(\7Z7K%O')Y<EQI=]'<(KXSM+(
M2 <$<5M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7P[_P6*_Y+'^Q?_V=UH?_ *;=2K[BKX=_X+%?\EC_ &+_ /L[K0__ $VZ
ME0!]Q4C_ ':6D?[M 'SA_P $_O\ D=?C]_V6V^_](K.OI"OF_P#X)_?\CK\?
MO^RVWW_I%9U]($XZT %%,9QG -(9,C!- $A..M&:C5QC :@N0.E $E%)N'<T
MH.>E !1110 4444 %%%% !1110 444$@=: "BD5E;[II: "BBB@ HHHH *^6
M=5_Y3.Z7_P!FZR?^GEJ^IJ^6=5_Y3.Z7_P!FZR?^GEJ /J:BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YWXG>&-7\7^#K[
MPYH7B)]*N;N,(E]'$',8R-PVG@Y&1^-=%39(U;DBJISE3FIK=:E1DXR4ET/R
MS^('PN\=?"7XBZEX.N=-N&N+>.X6.18\^=;F-PS\=C'N/M^%=Y/K7[9J>/\
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MAW1M7V(Z93I7R_\ M@?!GXTZS\:-%^,OPHL(9I-(TU5#2,/W4B.[9(/4$/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444$XY- !12!EZ9I: "BDWKZT;UZ9H 6OAW_@L5_R6/\ 8O\
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M]G7XN>*K'X@:_P##Z.Q\2:;>17-KXDT&9K&^#(X?:TD6/,4XP58$$$BO7J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCX?_ +#_ ,+M2^'O@C7-4UJ^\1>*+[Q)XK\2:Y<>;>:OJEVP::XE;U(5% '
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MP$_X*=^%K6'4O#GCM1'):JL-O?:N6$:$# V,G!&*ZK_A"/\ @K+G_D=-)_\
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M+XF^"-KHK>"_&DFG)(T5Y86ZV_FM$>"LL>]&7.<.<&@##_8.MO&?P8_;5_:
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M27NR;.P&<<T4@8>M+7RQXP4444 %% ()X-% !12;E]:4$'H: "BBB@ HHHH
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MM5_Y3.Z7_P!FZR?^GEJ /J:BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT6G1J5/2OG<;CL1F&(=:L[MZ^7W=#RL1B*F(J.<WJQU%%%<IB%%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX=_X+%?\ )8_V+_\ L[K0
M_P#TVZE7W%7P[_P6*_Y+'^Q?_P!G=:'_ .FW4J /N*D?[M+2/]V@#YN_8#./
M&GQ^./\ FMM]_P"D5G7T1?726=G)>2@[8XR[;>O S7SS^P H?QI\?@?^BW7W
M_I%9U]&R0H\9C(R#QBFMP6^I\S/_ ,%._@Y%(P'@7Q-\K$?\>]OSSC_GM7&?
M$O\ X*4Z7XDTN_\ #OAOX57#6MU:F);N]U-89!D=XU1Q^3\U]8?\*S\ DY_X
M0?2?_!?%_P#$U!JOP@^'&L:=-IEWX*TWRYD*/Y=G&K8/H0,C\*^IPN8\+T9*
M4\')O3_EX[>MDOU/8HXK*:<DW1?_ (%_P#YA\ ?\%-=#TJRM]'\6?"R]AM[6
MU2-+C3]12=I"H ^XZQ@9Q_>-=0?^"GWP<QO_ .$'\3_^ ]O_ /'J]XLOA/\
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ML_Z1\2_^'&L?_B:/^&DOV[/^D?$O_AQK'_XFOHRB@#YS_P"&DOV[/^D?$O\
MX<:Q_P#B:/\ AI+]NS_I'Q+_ .'&L?\ XFOHRB@#YS_X:2_;L_Z1\2_^'&L?
M_B:/^&DOV[/^D?$O_AQK'_XFOHRB@#YS_P"&DOV[/^D?$O\ X<:Q_P#B:/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P BT?\ #D=?^DG_ .U1_P"'*A_^1: /N2BOAO\ X<CK_P!)/_VJ/_#E0_\
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M_P#D6@#[DHKX;_X<CK_TD_\ VJ/_  Y4/_R+1_PY'7_I)_\ M4?^'*A_^1:
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M *2?_M4?^'*A_P#D6@#[DHKX;_X<CK_TD_\ VJ/_  Y4/_R+1_PY'7_I)_\
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MQ?W_ ):!?.N) %#RMC+, ,DG@4 =-1110 4444 %%%% !1110 4444 %%%%
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M:]9_98_:E^#7[8/PIM?C)\#O$W]I:/<3R6\GFPF*:UGC.)(98V^9'4\%3T-
M'I-%%% !1110 4444 %%%% !1110 4444 %17:LT7R/M;^$BI:CN!NCQF@#\
M[?"W[7?[7O[*5SXZ_9I_;*_9J\>_%J\F\67Y^%?C#1=%BO;?Q!I<^Z2"&Y**
M$MGBWB(E@ 5QR2&KB_@O^S__ ,%(_P#@GO\ LC_!?Q_\+_#MUK4/AOQ[X@U;
MXL_!?17B+WND:Q/+)&D;,N6FL"Z,J(0K'/85]"?'[_@M)^RU^S[^T%XH_9IU
MOP+\2/$'B3P;]B_M[_A$O MUJ%O;FYMUN(098@5R4;Z@@CM7I?BG_@H5^SMX
M!_9+M?VS/B7J.J^&?"=Y'&+:UUS29+?4))I9/+BMQ;,/,,SN0%3&3F@#YA^'
M5CXY_;__ ."EWPE_;#\!_LVZU\/?!/PDTC6EU+7O%FC_ &"^\0W%[;-;+:)%
M@.4B+>;N;Y?3G%?HK; A>E?/?[''_!2C]F_]M'Q+JW@7X<_\)!H?B31[5;JZ
M\,^,-"ETV^-LQVB=(90&>/=\I8< U]#*03QZ4 .HHHH **** "BBB@ HHHH
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M5E[@]ZGH **** "BBB@ ILH)7BG4'I0!\S_\%%_V"-/_ &WO <=G??M >-/
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M]&4%>/6O2RG&XG'1DZL>1K[.MUZ]_D5&[/GWPSXW^-MQ^W+#X,\?/:V>D_\
M"$W5UI^FZ?<%TD'VJ-!*^1]_@_0&IO$&D>*OVC/C?XE\(Q?$+5-'\.^$H[>W
M1-&N/*DEO67>Y=NX *C'O6EK.FZFW[?NCZR-.F^QI\,[F-KKRCY8?[:AV;NF
M[';K67=^+K?]FGXZ^+M7\5Z%J']A>+8X]0L+S3[)[C==)'MEC(0$J2%3&>N:
M^1J1K4H3CB)R]DJLN9MN]K:+3I?L9;)W[G0_LXZU<?&7X97V@?$N%=6F\/\
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M ()U?'?P?X>\,_%;4O[6\5>&?&&DRSIINJ-&(YKRR,>-K2@!G#=7&>]?07[
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M&'P9HTWQ,M;%?'&@^.-)DGMWNK6+R8[J%HN0QC 4J>.,UZ[_ ,$Z_P!B6?\
M8D^$FN^'_$WCI_%'B[QQXVU+Q?X\\1M (EU#5[Z0/*Z1C[B@*B >BY[T ?0-
M%%% !1110 4444 %%%% !1110 4444 -F#,F%ZU\D_\ !83]C3X"?M/?L?>,
M?$WQH\)3:E=>$?".HWFB%-0EB2*;R6(+*C /R!PP(KZXKBOVCOA9<_''X"^+
MO@]9ZDMG+XF\/W6G1W3KN$)EC*;B.^,T ? 7Q0UW6/#7_!LFNLZ%J,UI=Q_
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M)/C+0[W65O/$5T8[#2K"W95>>0+\SG>Z@(/K7Y#_ +1WQ[^,&B?##X=_$O\
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M4>)/AU\0_!]WJNL>&_$VNS:G-X?N8" ER)IB65)<[<9QFOTBMQZ>M $M%%%
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M&Q]Y$A1DU'*ZLF,4]\[#BOS^_P""^_Q/_P""BOPZ_8X\>ZC^R7HG@RS\%Q^
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M.QM#H/\ P3\_:6L4=LLMG\"KF(-[D*1FKP_X.#_@0.G[#7[4G_AE;O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_**^ _^(A#X$_\ 1C7[4G_AE+O_ .*H_P"(A#X$_P#1C7[4G_AE+O\ ^*H
M^_*;-]RO@7_B(0^! Z_L-_M2?^&5N_\ XJ@_\'"/P&/!_8<_:C_\,K=__%4
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M^PM^U!''&H6../X)7:A5'0 !N!4G_$0A\"?^C&OVI/\ PREW_P#%4 ??E%?
M?_$0A\"?^C&OVI/_  REW_\ %4?\1"'P)_Z,:_:D_P##*7?_ ,50!]^45\!_
M\1"'P)_Z,:_:D_\ #*7?_P 51_Q$(? G_HQK]J3_ ,,I=_\ Q5 'WY17P'_Q
M$(? G_HQK]J3_P ,I=__ !5'_$0A\"?^C&OVI/\ PREW_P#%4 ??E%? ?_$0
MA\"?^C&OVI/_  REW_\ %4?\1"'P)_Z,:_:D_P##*7?_ ,50!]^45\!_\1"'
MP)_Z,:_:D_\ #*7?_P 51_Q$(? G_HQK]J3_ ,,I=_\ Q5 'WY17P'_Q$(?
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M %%%% !1110 4444 %%%% !1110 U^E-J2B@".BI,8Z"B@",@]<4$$=14E%
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M"? /XUO>1?!GXW^$/%SV&W[<OA?Q-:Z@;?=G;O\ (D;9G!QG&<<5'X@_:?\
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M[5')))KK*:BE3R:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO5)--^$/C#X:2>-;?P?#'+)!HEW;L5F-LFYMJN%W;$4<\ 5YI_P2I_X+$_\
M!/3]C/\ 92UCX)_M%_&W4-#\6:7\1O$UQ<:''X&UFZ<J]_*T862"T>(EAT^?
M'J17HW[*VH_M&?MG_M6_$K_@JU!\$=>\%>%-'^&-WX>^#.@^*='V:MK9"/-]
MM>VY*(\@78GS;@<<YH T-7_X+#_MZ^(OA5KW[8/P<_X)E_:O@MX;GN6-]XF\
M<?V?KNM6,+[6OK>T:WQ"F 3LD)9AT->W^#/^"KW@#QG\:?@9\.[#X8:A%X;^
M//@NXU;POXRDO#Y46H1?,=+:'R<E_+RYD+J .,'-?EAJ?QD_9:_:H_8,O(?V
MC_VH_CI\3/VCK_1;_P [X2Z7!K5G%8:A\Y>R^SPVT5M]GB R6=F& 1N)&*]G
MU_1Y_$/_  0 ^!W[6OP2TIM3\7?L[S6>NP6,,,D<RFUD,=]8NWRM&-G#XSPG
M0T ?;GQF_P""O'PZ^"_QY^,'PSUSX:377A7X)^ ;?Q!XV\96NM*Q%U<'$&G0
MVHA(>1B,,S2KL)7*D'(\W^%__!5K]O?5S\/_ (P_%#_@F7+:_"3XF:Q8V.CZ
MQX4\<1ZGJ^B1W3%8;F]MA"JO&?E9MC*(U+%B2 IX3]A;POXQTW_@E)\5OVV_
MC!^R]??$[Q5\<)[OQ7XE^&ZW7DW6H:?*0B6H:="-T=L"0 N6V# R17R/J'[2
M7[,/PLT;P7J?_!%?]J;XVK\5]6\1:;!#^SMJ6AZOJ&G7.YSY]I<-?0I#;10I
MNR\,I"A<[2 60 _2?X^ZZ_[+/_!6#X3^/M-98=#^.FE7GA77K:#+//JUI']I
MM9BF0J*(1(I<9).T8[U]KH>>17P=^W^NM^/OV\OV+?!MI;1S>)M)\6:IXD\0
M:3#(H>TL5TLP2S\G!19Y%3 )//3&37W?&V3@4 24444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g4bdklltl5z5000015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000015.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" ,2!? # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHH!!Z&@ HHH) ZF@ HH!!Z&B@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH)QUH **-P]:* "BBDW
M#UH 6B@$'I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% $=W=065M)=W,HCCC7+,W0"FVMU!=Q)<6\
MF]&7*MZTZY>%+=WN658U7+,_0"DMGADC22V*M&RY5DZ8]J ):*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBC(H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***,B@ HHHH **"<=: P/2@ HHHH ***
M* "BBB@ HHHH ***"VT9- !136E51DU\Q_M,_P#!7']D3]DSXM7GP6^+E[XB
MCUNQMH)[A=/T4S1!94#IA]PR=I&>.*[LNRO,<WQ'L,%2E4G:]HIMV6[LNFJ.
M?$8K#X.GSUIJ*O:[TU/IZBOB'_B(%_X)\ X.I^,/_":/_P 73A_P<"?\$^3T
MU/QA_P"$R?\ XNO>_P!1>,O^A?5_\ E_D</]O9+_ -!$?O1]N45Y_P#LR_M*
M_#/]K/X1V/QL^$DU\^AZA<3PV[:A:^3+NAD:-\IDX^93CGFN^+BOF<1AZV%K
MRHUHN,XMIIJS36C37=,].G4IUJ:G!W3U375#J:<!J-XK)\:^.?!_P[\-W7C'
MQYXGL='TFQ0/=ZAJ5RL,,()"C+,0 2Q  ZDD 9)K*,9U)*,%=O3N5*48J[9K
M%QV--#;AP?TKX7^+7_!?W]B3P%>W&E^"QX@\6S6]QY9FTVP\FWD7&=Z22D9'
M/H.E:_P3_P""[G[#?Q7U.RT#Q)KFK>$;Z\R"==L?]&B;LK3(2 3VXQZD5]/+
M@?BZGA/K,L#5Y+7ORN]N]M_P/*CGF42J^S]M&_J?:8[8%.JCH'B'0?$^CVWB
M+PYK%M?V%Y"LUI>6<RR13QL,JZ,I(92.002#7R+XW_X+J?L(_#_QCJO@7Q#J
M/BL7VCZA-9W@A\.EE$L;E&P=_(R#S7E9;DF<9O4E2P5"=24=6HQ;:6UVEMJ=
MF(QV#PD5*M444]FWN?9%%?$7_$0+_P $^?\ H)^,/_":/_Q==W^S9_P5Z_9
M_:L^+^F_!#X47OB)]<U2*>2U74-$,,16&%I7R^XX^5&QQR:]/$\&\68/#RKU
M\#5C"*NVX2226[;MH<U/.LIK5%"%:+;T23W9]145\^?M=_\ !3+]F3]B7QGI
MG@/XWW6N1ZAJVF?;[0:7I)N$,/F-'R=PP=R'BO4?V?OCKX$_:6^$.C?&[X9R
M73Z'KT4DE@U];^5*525XFW)DX^9&[]*\FME.98? T\;5HRC2GI&;349/R>SV
M9UPQF%J8B5",TYQW5]5ZG944!@:\M_:W_; ^#W[%/PWL_BI\;9]2CTF^UJ/2
MX&TNQ^T2?:'BEE4%<C"[87Y]<>M<^%PN(QV(C0P\'.<G912NV^R7<TK5J="F
MZE1VBMV]D>I45XY^Q_\ MS_ K]N#0-9\2? VXU62UT*\CMK_ /M33S;L)'3>
MNT9.1@5[&3CBC%X/%8#$2P^)@X3B[.+5FGYH*-:EB*:J4I)Q>S6P44WS!Z5\
M_P#[77_!3']F3]B7Q=IO@KXWW>N1WVK6+7=H-+TDW"F,-M.3N&#GM6F!R_'9
MGB%A\)3=2;VC%7;MY(G$8BAA:;J5I*,5U>B/H*BOB(_\' G_  3Y S_:?C#_
M ,)D_P#Q='_$0+_P3YS@ZGXP_P#":/\ \77T'^HO&7_0OJ_^ 2_R//\ [>R;
M_G_'[T?;M%>%_!7_ (*(?LZ_'SX">+/VD/A_=:P_AOP7:W4^M-=Z88YU2" S
MR;$W'<=@..1D\5E_LE_\%/OV7OVT_'5[\//@I>:[)J-AI_VRX&IZ0;=/*W!>
M&W')R1Q7DSR'.J<:TI8>:5%VJ>Z_<?:7;YG5',,#*4$JB]_X==_0^B**3<,9
MKY2^.?\ P68_8P_9Y^*^L?!GXBW_ (F76M#NO(OEL]!,L0? /RMO&1@^E8Y=
ME>99O5=+!495))7:BFVEWTZ&F(Q>&P<5*O-13TUT/JZBN3^-_P :/!7[/OPG
MUKXS_$*2Z71=!M?M&H-9V_FRA-RK\JY&3EAWKY./_!P)_P $^1UU/QA_X31_
M^+KIRWAW/<YIRJ8'#3JJ+LW&+:3[.QEB<RP&#DHUZBBWM=V/MVBOB+_B($_X
M)\_]!/QA_P"$R?\ XNO>?V/_ -NKX$_MPZ%K7B+X&7.JR6V@WD5MJ!U33S;L
M))%++M&3D8!K7,.%>),KPKQ&,PE2G!6O*46EKHM6NI&'S;+<545.C5C*3Z)Z
MGLE%?'_Q._X+A?L-_"/XD>(/A5XNU'Q2NK>&]:NM+U-;;P^9(Q<02M%(%;>-
MR[E.#W%87_$0+_P3YSC^T_&'/_4M'_XNNJGP3Q=6IQJ0P-5Q:334)6:>J:TZ
MHREGF3QDXNO&ZW5T?;M%>;_L[_M:_L^?M5>&?^$I^!OQ)L-:CC13=6L<FVYM
M20#MEB;#*<G&<8)!P3BO13,HZ5\[B,/B,)6=*O!QDMTTTUZIGHTZM.M34Z;3
M3ZH?17DW[7/[:7P1_8G\!:?\1OC??ZA%I^IZPNFVB:99_:)FF:*27.S<#M"Q
M-ENQ*CN*7]DO]M#X&?MJ>![WQ]\#M8O+BSTZ^-I?0ZA9F":&3:&&Y<G@@Y'/
M-=/]EYE_9_U_V,O8WMSV?+?M?:YG]<POUCV'.N>U[7UMZ'K%%-\P>E?+?[17
M_!87]CK]E[XO:M\$?BE?>)$US1O*^VK8:&9HAYD22KAMXS\KCMUIY;E.99Q7
M=' T959I7:BFW;O9=-4&)QF%P=-3KS45M=Z'U-17Q#_Q$"_\$^>VI>,#_P!R
MT?\ XNOHC]F?]M;]FW]KK19-7^!7Q'M=6EMX(Y;[3&4Q7=H'' DB;D>A(RN>
M,UW9APOQ%E-'VV,PE2G#O*+2^^QAA\TRW%5.2C5C)]DT>K45X?\ MC?\%!OV
M>OV%W\.I\=KG6(SXH%V=+_LG3#<9^S^3YF[YAM_U\>/7GTKQ+_B(%_X)\G_F
M)^,/_"9/_P 758'A/B;,\+'$X3!U*E.5[2C%M.SL[-+HTT37S;+,+5=.K6C&
M2W3>I]NT5\0_\1 O_!/G_H)>,/\ PF3_ /%U]):Y^UE\)/#W[,$/[76HSZ@/
M!\WAR#6TD6RS<_998UD0^5G[VUAE<\&L\=PUQ!ELJ<<7A9TW4=H\T6N9]E?=
MET<TR_$J3I58RY5=V>R[GIE%>$_L>?\ !1/]G/\ ;DU+7M*^!=UK4DWAV&WD
MU+^U=+-N LQD";?F.[_5MGTXKW5V"*6/:O-QN!QF6XF6'Q5-PFMXR5FKZZIG
M10Q%'%4E4I24HOJMA:*^2_A)_P %I?V*?C5\6=&^"W@B_P#$S:UKVIK86"W6
M@F.(S$D ,V\X''7%2?'/_@LW^Q=^SQ\5=8^#GQ%O_$RZUH=SY%\MGH)EB#8!
M^5MXR,'TKUEPGQ-+%+#+!U/:<O-R\CORWMS6MM?J<?\ :^5^S]I[:/+>U[Z7
M['UA17Q#_P 1 O\ P3XSC^T_%_\ X31_^+I?^(@7_@GSG']I^,/_  FC_P#%
MUV?ZB\9?]"^K_P" 2_R,_P"WLE_Z"(_>C[=HKPGXD?\ !1+]G3X5_LP^'?VN
M?%=SK2^#_%$EM'I<EOI9>X+3H[INCW?+Q&V>>.*UOV0OVXO@9^V[X8U;Q=\#
M[G5)+/1;];.^_M33_L["1D#C:,G(P>M>-4R7-J6#EBYT)*G&7*Y6?*I+3E;V
MO?H=D<=@YUE1C43DU=*^K7<]@/2H]RJ.35?6]?T3PYI5QK?B#5;>QL[:,R7-
MU>3+''$@ZLS,0%'N3BOC'XT?\%W_ -AGX7ZC>:'X9UC6/%U[9LJ[M#L2+:0D
M<A9I" <'@\=>F1S597D>;YY4=/ 4)U6M^5-V]7LOF&*Q^#P,>:O44?5GVN 0
M:?7PS\(?^"_'[$/Q!O[;2_&DNO>$9[B9E\S5-/\ -MXE"EMSR1$X!QCA3R17
MVAX*\>>#OB/X7L_&O@/Q)9ZOI.H0^;9ZAI]PLL4JYQD,#V(((Z@@@X((J\UR
M#.LCDHX_#SIWVYHM)^CV9.$S' XZ-Z%12]&:K%1]ZF;ESP>*\M_:E_;,_9Z_
M8]\+0^*OCIX[ATU;EF%AIT*^;=WC 9(BB'+8]3A0<#.2 ?E6Q_X.'OV,[GQ/
M)I5[X3\76VFIN,>J_P!GH^['3]T&W#/UKHRWA/B3.,.Z^"PLZD%U47;3>W?Y
M&>)S;+<'4Y*U51?:Y]_)[4ZO-?V</VM/@!^U7X37Q?\  [XBV.L0A%-U9QOL
MNK1BH.V6(_,A&<9QM)! )Q7I D4]#7BXC#XC"UG2KP<9+=--->J9V4ZM.M!3
MIM-/JAU%&<]**Q- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH CN88;BW:"XC5HV7#*PX(IMK##!$D-O&%1!M
M55Z 47UI!?6<EG=1;XY%VNOJ*2RMK:S@CM;1=L<:X5?2@">BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BB@G'- !130XZ5!J6KV.D:=<:
MKJ$WEV]M"TLTA_A11DG\!0O>=D%TM2S17RS\#?\ @L1^QC^T1\;=+^ ?PTUO
M7KC7-8NIX-/EN=&,5M*T44DI/F%N 5C;;QR2!WKZD$J'H:]#,,KS+*:JIXVC
M*G)I22DFFT]FK]-&<^'Q>%QD7*C-22=G9WU'45Y/^UW^V;\&/V)? .G?$GXW
MSZE'INJ:PNF6ITNQ^T2&=HI)1E<C VQ/SZX]:Z;X%?'CX:?M'?#'3?B[\*-=
M74-%U2,O;S8VNA!PR.O\+@\%3T-9RR_'1P,<8Z4O9-N*G9\K:W5]K^12Q.'=
M=T5)<Z5VKZV[V.RHIHD4C(-?,=K_ ,%<_P!D.\_:3D_93AOO$7_"61^*I?#S
M(=%/V?[9',T+#S-WW-ZGYL=*K Y7F&9\_P!4I2J<BYI<J;Y8K=NVR\R:^*PV
M%Y?:S4>9V5WN^R/IZBOFO]J?_@JS^RA^QW\3?^%2_&2\\01ZO]ACN]NFZ,9X
M_+?./F##GBO-?^(@7_@GQ_T$_&'_ (3)_P#BZ];"\'\58[#QKX?!59PDKJ2@
MVFGLT['+4SC*Z-1TYUHIK=-ZH^WJ*^(O^(@7_@GS_P!!/QA_X31_^+KVCP]_
MP41_9U\3?LF:A^VEIESK/_"$Z;(Z74DFEE;H%)Q <1;N?G8=^G-9XOA/B; J
M#Q&#J0YI*,;Q:O)[16FK?1%4<VRW$75.M%V5W9]%NSW6BO!/V/\ _@I!^S;^
MW!KVL^'/@;=:U)<Z#:Q7%_\ VII9MU"2,RKM.XY.5-5OVN?^"FW[,7[$_C33
M_ 7QNN]<CU#4]/\ MEJ-+TDW"&+>5Y.X8.0>*YX\/YY+,GEZP\_;K7DY7S6M
M?;?;4O\ M+ _5OK'M%R;<U]/O/H2BOB(?\' O_!/D\#4_&'_ (31_P#BZ[W]
MGG_@L%^P[^TKXZM_AMX*^(5YIVL7TR0:7:^(=/-H+Z5LXCB8DJ7.,!2022H&
M20*[,5P?Q5@Z,JU?!58QCJVX2LEYZ&-/.LIK5%"%:+;V5T?4%%-$R'I7)_&+
MX[?"3]G_ ,&2_$'XR^.]/\/Z3"X3[5J$VW>Y!(1%^\[$ G:H)P">@-?/TJ-6
MO45.G%RDW9)*[;[)'HSJ0IQ<I.R75G6,<-FC<&Z&O@/XA_\ !P[^QQX<U-;+
MP7X6\5>((P[)-<Q626ZKAB 5WME@>HZ5ZU^S9_P5]_8E_:4UZW\&>'?B')HN
MM731QVVF^)+;[*;B5O\ EG&Y)5CGY>HR<8SFOH\7P7Q9@<+]9KX*I&&]^5Z+
MN^J^9YM/.\IK5?90K1<O4^HU)(I:C29-N<U\_P#[77_!37]F+]B7QQIOP^^-
M]YKD>H:KI?\ :%H-+TDW"&'S'CY.X8.Y&X]*\3 9?CLTQ*P^$I2J3=[1BFV[
M:O1=CNQ&(P^%I.I6DHQ75['T)17Q"?\ @X%_X)\#_F)^,/\ PFC_ /%UWWP)
M_P""PW[!WQ^UY?"_A[XL-HNH27"PVMKXGM#9?:&;/W&8E>V.2.<"O8Q'!O%>
M#HNM6P-6,5NW"5E^!PT\ZRFM-0A7BV_-'U!17)_&/XQ>%_@C\*-;^,GBJSOK
MK1_#^GM?:@NE6XFF%NO+R*N1N"KESS]U21GH?"?V;O\ @KY^QK^U/\5K+X,_
M#+7M;CUS489'L8M6T@V\<Q1=Q16W'YMN2!W"GTKS<+D^:XW"U,3AZ,ITZ?Q2
M2;4>NKZ:=SJJXW"4:T:52:4I;)O5^A]144WSDQFOE#XU?\%HOV(?@1\5M8^#
M?B_7_$%UK&AWGV34!I.AM-$LX W1AMPRRD[3@=01S4Y=E.9YO5=+!495))7:
MBFVEW=N@\3C,+@XJ5>:BGHKNVI]8T5C^!O&=AX]\':;XVT[3KZTM]5LH[JWM
M]1M_)G1'4,H=,G:V",CJ*^;?VA/^"QG[&W[,GQAUGX&_$^^\2+KV@O"NH+8Z
M&9H@98(YUVON&?DE7/'!R*K+\GS3-<2\/@Z,JDTFW&*;:2=F[+HFT@KXS"X6
MFJE::C%[-NRU/JJBOB+_ (B!?^"?'_03\7_^$T?_ (NC_B(%_P""?/\ T$O&
M'_A,G_XNO:_U%XR_Z%]7_P  E_D<7]O9+_T$1^]'V[17@OB'_@H[^S?X9_9*
MTO\ ;4U.ZUK_ (0G6+H6]G)'I9-T7,\D',6[@;XF[],&K7['/_!03]GO]N@^
M(A\"KK6)/^$7^R?VI_:VFFWQ]H\[R]OS'=_J),^G'K7CU,CSBEA*F*G0FJ=.
M3A*7*[1DG9Q;Z--VL=4<?@Y5HTE47-)72OJUW7D>X44TR  FOE>P_P""Q?[&
M^I?'QOV;K6_\2?\ "3+XFDT$JVAGR/MB3&%AOW_=WJ?FQTYK+ Y7F6:<_P!4
MI2J<BYI<J;LN[MLO,TQ&,PN%Y?;34;NRN]V?55%>>_M.?M-_#']DGX2WGQI^
M+DM]'HEC<003MI]IYTH:601IA,C/S,,\\5\R?\1 O_!/G./[3\8?^$T?_BZ[
M,MX;X@SBBZV!PLZL4[-QBVK]KKJ8XG,\OP=3DKU8Q?9NQ]NT5\1'_@X%_P""
M?(ZZGXO_ /":/_Q=?1_P1_:W^$?[0/[/K?M,?#V;46\,+!>3,]Y9>5/MM6=9
M?W>3SF-L<\T\PX9XARFDJN,PM2G%NR<HM)M]->HL/FF7XJ3C1JQDTKZ.^AZ=
M17Q%_P 1 G_!/GK_ &GXO_\ ":/_ ,74^F?\%^?^">VHZE;Z<_B'Q1:K<3K&
M;FZ\.LL46XXWN0Y(4=2<$X[&N[_4?C!1YOJ%6W^"7^1A_;N3[>WC]Z/M:BN5
M^$7QL^%7QY\%V_Q#^#_CG3_$&CW#%([[3YMRAQC*,."C $':P!P0<<BNH616
MY%?,5*=2C4<*B::T:>C3[-'J1E&I%2B[I]1U%>#?M??\%'_V9?V(=8TGP]\<
M-:U2.^UJV>XL[72M--PXA5MI=N0 "V0.>QKT#]G;]H;X=?M0?"+2?C;\++BZ
MET/6O.^QM>6_E3#RYGB8,F3M.Y#WZ8/>NVKE694,!#&U*,E1F[1FT^5OLGL]
MF8QQF%J8AT(S3FM6KZH[FBFEP$+^E?&?BK_@O#^P7X.\4:EX0UG4O%@O-*U"
M:SNA'X=++YD3E&P=_(RIYK3+,ES;.JDH8"A*JXJ[48MV7G8G%8[!X**=>:C?
M:[L?9U%?$MI_P7^_X)[W5U%;'6_%D7FR*OFR^&V")DXR3OZ#O7U5\%?C[\'_
M -HGP1'\1?@KX]T_Q!H\DK1?:[&;/ER*<,CJ<,C#KM8 X(/0@G;,N'<^R>FI
MX[#3IIZ)RBTK^K1&&S+ 8R7+0JQD^R9V%%?-O[5'_!5;]E+]COXE+\*/C)>>
M((]6:QCNPNFZ.9X_+?./FW#GCI7FG_$0+_P3Y_Z"?C#_ ,)H_P#Q==6%X/XI
MQV'C7P^"J3A)74E!M-=T[&57.<JH5'"I6BFMTV?;M%?%_AS_ (+S_L$>*?$-
MAX8TO4O%GVK4KR*UMA)X<*J9)'"+D[^!DBO>?VM_VR_@S^Q3\/M/^)GQNFU*
M/2]2UA-,M3I=B;B3SVBDE&5R,#;$_/KCUKGQ'#/$&#Q5/"U\+4C4J?!%Q:<O
M1=32GFF7UJ4JL*L7&.[3T7J>KT5Y5^R9^V-\&OVTO MW\1/@I/J4FFV=\;28
MZG8_9W\P#/"Y.1@]:ZOXV?&+P=\ ?A5KGQD^(#W*Z+X>L6N]0:S@\R01@@':
MN1N//3->;6P.,P^,>$JTW&JGRN+7O7[6[G1#$4:E'VT9)QM>_2W<ZJBOG+]D
MW_@J3^RQ^VA\1+[X8?!6\UZ35-/T.75KA=4T<V\?V>.6&)L-N.6W3IQZ9]*\
M^\3_ /!>/]@KPCXFU#PGJ^I>+!>:7?36ET(_#I91)&Y1L'?R,@\UZ]/A/B:K
MBIX6&#J.I!)RBH.Z3V;5M+]#DEF^61I*JZT>5MI.^C:W/LZBOB'_ (B!O^"?
M'_04\7_^$V?_ (NIK+_@OS_P3^O[R&Q@U/Q=YDTJQQ[O#9^\3@?QUTRX&XQC
M%MX"KI_<E_D9?V]D[VKQ^]'VQ17@_P"U9_P49_9Q_8VT_P .ZG\9KG6HXO%%
MNTVE_P!FZ69R54*3N^8;>&%>@?LZ_M"?#W]J+X1:5\;?A;+>-H>L>;]C:_MO
M)E/ERM&V4R<?,A[UXM;*<SP^!CC*E&2I2=E-I\K:OHGM?1_<=T,9A:E=T8S3
MFE=J^MNYVS_6F[@.2:Q?B-\2_ 7PG\)7GCOXD>*['1='T^/?>:AJ$XCCC&<
M9/4DX  Y). ":^+/BQ_P<#_L5^"+Z32_ ]EXB\5R0W#1R36-B((64='1Y"-P
M/T!KIRGAW/,]DU@,/.I;=Q3:7J]D98O,L#@5>O44?)O4^[T.>0U.KXU^!?\
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MC*\/6]E4JQ4NU_S/OG-%<K\'_C7\*OCOX*M_'_P@\=:?X@T>X^5+W3I]ZJ^
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MX_X:A\"D#_F0_P#V]GK[\_X(XL!_P3:^&'_8/O/_ $X7->;Q7_R:#)O\<O\
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M1VL3.O; D4\YSVK\VOVNO%E_X#_X*)_$SQMI=O%-<:3\8-8O((I@=CO'J4K
M-@@XR.QKZ5U__@XM_:ZU?P_>:1IGPN\#Z;<7%G)%!J5K!=/):LRD"55DG*DJ
M?F 8$9'((K]1XBR_Q!QF"RR7#M5P@J,.>TDE>T;-I[JV^C/E\OQ&14:V)6/A
MS/F=M+OKLSP_]@KXB_$?]CK_ (**>'?#.E:C#-<+XX'A+Q###(?L]Y%+=BTD
MP67.%?$BG .4 . 2*_H4Y49 ^M?A/_P2<_8R^,7[6O[6FD?'WQKHNK?\(OH.
MO_V_K'BBXA*Q7^H1S"984D./,D:;#OMW8 YQN%?MA\;OBKH'P/\ A!XD^+GB
M>XCCL?#VCS7LS2L0K;$)5<@$C<V%S@XS7Y=XR5,-CN(\-0H-3Q"IQC5Y.LV]
M%IU\M]4?5<'QJT,MJU)IJG=N-^W5GX^_\%]_V@+KXU_M=:-^S_X1EDO+/P+8
MBU^RP1JWFZG=E'EVE26;"+;Q[6QM='P.3F3_ ((,?'K6/@9^V#K'[,WC>2:T
MA\70S6GV&9I#Y&JVFX[=H.T,46568C/[M1GFN(_X)8>!-5_;*_X*9V_Q;^(E
M\LMOH]_=>,M=FO;IE:2991]G16"X=_M$L+%6VAHXY#V *_\ !4OP)JW[&?\
MP4E_X7%\+DCMX;[4[7Q5H$D:KY)N%D#2QX1LE?,0[LXW;V'0U^F?5,O_ +-7
M 22Y_JW/S?\ 3Z_-;[[R]#YCVV(^M//6]/:6M_=V_+0_>!5 /)K\"O\ @L5I
MT.K?\%1?&FE7#LL=U>Z3%(R8R%:RM@<>^#[_ $]?W/\ @O\ %/PU\</A+X;^
M,?@XS?V7XGT6VU.R2Z"":..:-7"2!&95D7=M90Q 8$9.*_"[_@L?J/\ 8_\
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M".!IWD*KCS).K>YH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4X/< ]N/TK_X+=?L<0_M'?LLW?Q-\+Z4LOBCX?PR:E;NN%>>P4;KJ+)91\J
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M],\-ZS-;W.N3Q27!,R32MN:*.-,!G(&%&!CKUK\8_P#AZ;_P4=(_Y.%\3?\
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M;E<+'<)G=N8Y6-@H&  Q[UYO_P &]G[/FC^,OBYXN_:'\<PV\MGH>FG2=/\
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MS_P0$_8^^+GP(\&?$_Q'\3?B5;ZAXB\+V&I7L-GK&GK"DL\"2,J!K%F"@L0
M6)QU)ZU\X_\ !P6-G[<L0S_S*=G^/WJ\9\'_ /!2;]OWP7X5TWPCX1^._B&U
MTO2[&*TTVVAC&V*&- J*/EZ!0!7HX7*^*LT\/<JCDF+6'E&+YFY./,GLM$_,
MYZF(RW"Y_BOKM+VB;T5KV9^FGA;_ (-Y/V,_"'BC3O%6F_%'XG/<:7?PW<*3
M:UIQC9XW#J& L 2"0,X(..]97_!QY_R9IX/ _P"BF6W_ *;[ZODO]A'_ (**
M_MW?$O\ ;&^'/@'X@?&_7]0T75O%%O;ZI9W,8\N:%B=RGY>E?6?_  <=D?\
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M72;A(-0DM;>:,0R.I95/FHIY )XS7YT_\0TE_P#]'8Q_^$H?_DBOKW_@F?\
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MIW1__!;>?_&*V?VU+:R_:8_X)Y^-;OX1RKK=MXG\"2WWA^:'*+=QO#YL3C>
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MMIC,VW]X8\[<^V: +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^(M7^(>H_MD^*]+FMM'TBUGTOPJ\D;)]MNI!LGF3L\<:;XR>07<C.8V P?\
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M0"I/K75D_C?GTLZA]?4%AW+W[0]Y1?G=O0C%<$X*.!E[!R]HEI=Z7]+'%_\
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MHHKY$]@**** "BBB@ HHHH *;*,BG4?A0!&%7I3HU*+BG8'I1TX%'F 4444
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M@",C;_#[4$9J0@'J* H':F V-0.0*=110 4444 %%%% !1110 4444 %%%%
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M,]J< PZ4X@'K05!ZB@"+:N?NT_O@T[ '&*" >HI@1F--O_UZ%7!XJ0J#U%&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7!(QL^T6)8]QMZXP/U6! ^\U?*G_  5G_P"":.@?\%'_ (!VOAO1M6MO#_Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(YP*6B@!F">
MIKSK]KS_ )-0^)X_ZIYK7_I#-7I%<)^U!H6K^*/V;OB%X9\/Z?)=:AJ/@?5K
M6QM85R\TTEG*J(ON6( ^M:4=*L6^Z)J>]!^A\F_\&W/_ "A]^&)S_P OVO?^
MGJ]KY,_:R_8G\(_M\_\ !R!KWP-^)?B/4;/PG#\);+5?$UCIET\,FK6T,<"I
M:ET(POGR02G((_<],X(^VO\ @@O\&OBE\!/^"7?P_P#A9\9?!%]X=\1:=>:T
MU]I&I1[9H1)JMW(A(R?O(ZL/8BN%\%?L_P#QIT__ (.)O&'[1UY\.-2C\"WG
MP.CTNU\3M$/LLMX)+(F$-G[V$?C'\)KWZ>*^KYEBZM.6MIV>G\RV_0\V5+GP
MM*,EUC?[CS7_ (+U_LR? 7]D[_@C7KWPO_9U^&.G^$_#\GC[3;YM+TW?Y9N'
M?:\GSLQW$(@Z]A7Z+_L_-CX$>#<G_F5['_T0E>2?\%4OV-+W]O/]A_QE^SSX
M>EMX]<OK>.[\-R7D[1PK?0N'CWD \'YEYX!8$\"OB/\ 9M_X*U?\%"/A#\'M
M'_8J\;_\$ROB-KGQF\-Z;#H>G:PT3?V1?-% BQ75S<D;5) +OM8CC@Y) RIT
MZF89:H0:<XS;=VD[-+75^6I4I0PN*YI+1I)675/8ZS_@C"?^-J/[;_\ V-FF
M?^C+VO%?^"RG[8/[-_Q1_P""NOPE_9K_ &AOB=9Z%\,?@[>1Z]XXN+JUN+B.
M;4F59H[;RH;>1BVP0@C!1DE()%>E?\$1_P!G/]L3]C_XS?M4?%7]JOX8ZQ<:
MGJ<5KJ=O>:?;M*NO7,7VZ>:*RW,6D^9U1 3SE1GO6Y_P1V_X)F+\2='^)?[7
MO_!3;]EW0M:^(WQ*\;W-W'H_Q"\.PZB=+M =P$"71E"1EGV)P&5(57.W KTJ
MU3!X?,*N)G*ZC&,8\K5W)Q2NM]E?YG-&-:MAX4DM6VW=;).]F?//_!;/_@I/
M_P $_/CO:?";]IS]C/\ :9LM3^*7PA\80W6FV5KH.I6DEUITC(9HU>>U6/*O
M'$PW-POF!02W/[ _!7XU>%OVCOV:]!^//@FZ6;2_%?A6/4;5U1U&)(<E<. W
MRMD<@=*X/Q[_ ,$MO^">?C+P3JWA.U_8C^$6F3:EILUK'J5C\-=,BFM6="JR
MHR0JRLI(8$,#D=17SQ_P0E^'_P"U/^SO^SW\0OV,OVC/ACK.FV_@'Q)=IX'U
MS4+<+%JVFW!D($;;VW%9%<X  5)8P,\FO-Q%3!8K+8JC=.D_M-7<9=K6V?3S
M.BG#$4<2^;::Z7T:/SS_ .")/[(O[??[1GA+XI:Y^R#^WU<?!_3=/\;>1J^F
M0Z"+L7\Q5V67.X;<+\N*[C]O?]B']N/_ ()Y>/O _P#P4R_:T^/FF?M):3X(
MUZWM]0T?Q%:2VHL%ED58I(HO,9"2Y'*@894+!@.-+_@E%\0/^"AO_!,+P[\0
MO!=Y_P $QOB!XM7Q9XK_ +2AN[5HX%B10R ?,3G.<YKU7]K/Q3_P5-_X+%^%
MK/\ 8O'[!-]\'? >M:U9W/BKQSXLU 2R6\,#^:R)&A SN"X^]N^[A<[A]%B:
MV*CFLJEX>Q=KN\+\K5GJO>OOYGG4J=)X1)J7/T6MKW[;'ZH_!WXD^'/C'\,/
M#_Q8\(W*S:9XCT>WU"RD1MP,<L88#/&<9QGVKIJY;X*_"WPW\$/A3X=^$'A"
MV6+3/#>BV^G6:HNT%(HP@.,G&<9QD]:ZFO@:G+SOEVZ>A]%'FY5?<****DH*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "D89'2EHH C9'(P*$B8=14E% $;1N3Q0
M$8"I**+("(Q,QR:40G-244 1[&/:CRB.@J2B@!K(2N!4?E/D$U-10!&D14Y*
M]J4H>PI]% $:1L.-M'DD=*DHH ;&"!S3J** "BBB@ HHHH **** "BBB@ HH
MHH ***:T@7J#0 ZB@'(R*Q?%/Q&\"^"$9O%?BJRL66/>(9IAYCKG&50?,WX
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MD$TG@[7EO/LQ'VB/RW1H\],AP#C@\].*Z#S5[4 .HIOF+UIU !1110 4444
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MFZCASM5\<@9[9KG_ (@?&WP)\,M8L]&\67-S$U[&76:*V+QQ*#C<V.>OH":
M.NHK!\*?%#X?>.%7_A%?%UE>2,I86Z3;9@H."3&V' ^H%;@F0C//Y4 .HH#
M]** "BBB@ HHHH **** "BBB@ ILB%R,4ZB@"-48=10T;9R%J2B@!BHP'-,,
M+[LBIJ* (S$QYQ35A96P!WJ:B@!A5F&UA3-D@[5-11Y 1")LYVTHC8MN-244
M (H(I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFNX09
M-<[I_P 5_ VK^,&\":7KL5QJ20O))'#EE7:0""W3=[9SB@#<O]2L=+MI+W4K
MN*W@C&9)IY B+]2>!7F>O_M,:)=:HV@?#'P_>>)+\?\ /K&5B3IR6(Z=L],U
MZ1K6B:7XGTBXT36K43VMU$8IX6R RGW'(^H.0>E0^'_"7ASPI8KIOAS1K:RA
M7_EG;PA03W)QU)_.@"]9R2S6D<L\)C=HP7C/\)QR*YW6_A!\._$GB4>+M?\
M"]O>7RJJB2XRRX P 4)VD?4&NF P,44 5--T;3]'MDL-)T^WM;>//EV]O$(T
M7)SP%  JVPR,444 -6,JV=U.HHH **** &NA8Y!IK0!@5=58$$,K#@^U244
M9FD>#_#?AZYFO- T&SLI+A5%PUI;K'YFTDC.T#)^8\]>:7Q&==CT6\?PQ'#)
MJ"PM]C6X;$?F8XS[5I4UH\]Z /);;X^^+/!-P--^-/@*XL%!V?VMIZF2W<YQ
MN_V03C SFO6+2ZAO+6.ZMWW1R(&1O4$<4V>R@N4:*XC616ZJRY!J156- J*
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M7]VTBY4'U-)9"Z2&-;N16DVXD9%P"?6@">BBB@ HHHH **** "BBB@ HHHH
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M&:,T %%%% !11G/2C- !111F@ HHS10 4444 %%&:,T %%%% !1110 4444
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M<]*,T -\M.NV@1H#D+3J* "BBC- !111F@ HHHS0 449STHH **** "BBC-
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M^.&E^%[B2+6O%=K=&SL)50H#);-Y;F1=Q8#<%+ !E!5@:^6M/_;L\'?M_?\
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MK'P__@OL<?\ !(KXS_\ 8&L?_3G:5^<'[*4OQ)_X(3GX+_M<:(;_ ,1? /\
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M;2;E>]VTG:W2VQSX'%2Q,I-OKHK6LC4HHHKQ#T HHHH **** "BBB@ HHHH
M**** "BBB@ Z]11@#M110 8'3%1165E#=2WT-G$LTRJ)IEC :0+G:&/4XR<9
MZ9J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&^GDM
MK.2>*W:5E7*QQ]6]A3;&:2Y@CN)(6C9URT;]5XZ4Z^NH[*SDNY59EC7<P1<D
M_04EE<+=01W"*RJZY"NI!'X=J )Z*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH @N-,TV[N8;VZT^"2:WW&WFDA#-%GKM)&1G SCK4X51R%H
MHH ,#IBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;+TKYHO_P#@
MJO\ LF:/^WO+_P $X_$&NZMIOQ"5;<0R7]FD>G7$LUG'=Q01SF3)D>.50J[1
MN?Y1DD9^EY*_"7]M/]@2Y_X*(_\ !=K]I7X6>&O%\V@^*O#OPMT?Q'X+U!,^
M6NIV]GH21I)CYMC)-(F1RK,K8.W:?4RG"87%U:BQ$G%1BW=='=)-KMKJ<>,K
M5*,8NFKMNWX,_=B-N.E>5_MD?MB?!']ACX'ZA\?OCYK5U:Z'8S10+#86_G7-
MU-(V$BB0E0S'D\D# /-?,_\ P24_X*J6W[1OP0\4?#S]J^2W\)?%#X,VLD'Q
M$M]4NC&9K6V0A]2Q(=X7"'S"<X;G.&7/YX_MZ>+?C!_P6H\/?%C]M73=1U;1
M?V>?@?HL\/@33;N0Q?VWJNY%:Z,0'4JX8EB61-B@@NZUT8/)95,=[/$/EA%I
M-][[)=V^GEJ9XC&VP_-25Y-:+MWOZ'[1_LU_MB?"']J?]EK3?VO_ (:-JD/@
M_5+&]O(&U6S$5RD5K/-#*6C5F ^:!\88Y&/7%8W[*7_!0;]G;]LS]G[5?VE_
M@?JVI77AW19KR+4([ZP\FXB:V4NXV;B.4PR\\AAG!R!X#_P0GU?1M _X(<_#
MO7O$6DK?:?8Z!XCN+ZQ:-76XA35M19XRK?*P901@\'/-=K^Q5\?_ -G/]IS_
M ()FZU\7/V5?@):_#7P=>:3K\-GX5L]'L[%()8A,DLGDVG[H;W!;(Y.>>:PQ
M&#I4\15II-J-3E3OLKM:KJVD:0K3G3A*ZUC>W7H=Q^SA_P %)?V>/VIOV1?$
M7[:OPSA\0KX-\,QZG)J2:EIB0WFVQ@\^?9&)&4_)]W+#)ZXZU?\ A-_P4&_9
MU^+W[$2_\%!-'U/5--^'?]EZA?R7.KZ?Y=U%#9W4]M*6B1GY,D#A0"<@J>,\
M?GS_ ,$5/^5=GXR?]@_QQV_ZA(KZ!_X(0:SH'AW_ ((1^ /$/BK15U+2[#0_
M%ESJ6GO$LBW4":WJC21%7^5@R@K@\'//%;8S+\/A_:\MWRU%%:]&I/[]#.CB
M:E1P3ZQ;^>G^9]5_LB_M8?!_]MOX$Z-^T9\"M4O+GP[KAE2V_M"T,$T4D4C1
MR1NF3AE=2#@D<<$UZ<PQ@ 5\U_\ !-/]I7]F/X\?L0:3\>_V=_@Y8?"WX?\
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MG)%W_KN?104[LTZHU) J13D9KD.@**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HY  "!4E,?<>#0)['XE?\
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M ()+_M86^M>+/ .M>)/&EG?:S8Q^ [Z>2QL[%HBNI*BSV]N(BMN;DHB @%5
M.0!736G_  1._P""G'@WPW<_!CX7_P#!8WQ)8?#O$MI8Z1>Z*\M['8/D&,W
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M5YMFOLZT<5>$6E>[UNFO\S[?B;C%.0\8IL<94X-25\_YL],*:^=U.IK%>F:
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M76K\_0K?L_?M/? ']JOP1'\1OV>OBOH_BO2';#W&E70=H6W,NV1#AXSE&P&
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M_D0_URS+^2/W/_,_3G_AX)^R%_T5I?\ P27O_P 9H_X>"?LA?]%:7_P27O\
M\9K\QJ*/^(7Y+_S]J??'_P"1#_7+,OY(_<_\S].?^'@G[(7_ $5I?_!)>_\
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M7_P27O\ \9H_X>"?LA?]%:7_ ,$E[_\ &:_,:BC_ (A?DO\ S]J??'_Y$/\
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M^"2]_P#C-?F-11_Q"_)?^?M3[X__ "(?ZY9E_)'[G_F?IS_P\$_9"_Z*TO\
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MU_P3-U#]@#XS?M01S:C#IMQI'AGQSX4CG%S8:8_,<#?:&RWE@O$NTJ%AV(H
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M]'&5*-22?-3II.=[:).TK.ZOU[=3CC2K5<.II;2DVHVO9]KZ:'R7^WE\#O\
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MZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/LJ<VEK\K]GNOD<]3"X>I+FE'7^K%>QTVQT^TBL+"W6&"")8H885"K&BC"J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%?9G[6W_ "CY^&>3_P PW2?_ $B%?=<1?\C+*O\ '^B/F\MO]6QG^']3Q?\
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MJ-VWYE.3M9MK8^M/B=\ ?&7[1_[&W@7P1X(U#3;6ZM6L[V2359I(XS&MM,A
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MY/FF#Q5+"+G:I2O-1T6GP\UM^IY.#RW'8/$495]%SI<K>M[[V.#_ ."A&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6-0GNKJXD+SW%Q,SR2,>I9FR23ZDU%111&*C%)=!-MZL****H HHHH ****
M"BBB@ HHI,&@"6SM;K4+R+3["!I9YY5CAC7J[L< #W)K]4OV6/@M;_ KX+Z3
MX+6%?MAC^TZI-L ,EQ)R^2%!..%&<D!0,G%?%?\ P3E^"8^)OQJ'C#5;3S-+
M\+QBYDW*2KW+$B).O7@MZ'::_1Y1A<8K\5\2LY=;%0RZ#TA[TO\ $]E\E^9^
MA<(9?R4I8J2U>B].HQ1WI]%%?EI]L%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS,"BM_\ X5/\4O\ HFOB#_P3S_\ Q-'_  J?XI?]$U\0?^">?_XFNS^TLO\
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MX@_\$\__ ,11_:67_P#/V/WK_,/JN)_DE]S,&BM__A4_Q2_Z)KX@_P#!//\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK_S\1_\ ?5']HVO_ #\1_P#?5%I!ST>Z_ EQ%_<_2C$7]S]*B_M&U_Y^(_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M49H **** "BBB@ HHHS0 449HS0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !0:*1CQB@!&-?M=_P0+_9$E^#7[-LW[0_B
MW2VAU[XC,LUBLT+*]OI,1(@X901YS;IL@E7C: BORK_8>_9FU3]K?]I[PO\
M!6RCD^QWMZ)]<GBX,-C&0TS9[$K\@(!PS@X(K^D+POX;T;PEX<L?"OAO38;/
M3]-LX[6QM+>)4C@B10JHJJ %       %?SOX[<4^PP=+(Z,M9^_4MTBOAC\W
MK\D?H' ^5NK6EC)[1T7KU^XO1@GJ*D  Z4TC'W:=7\O(_4 HHHI@%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"%"/1:^O46BBBO".\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@_8+_P"C0OAY_P"$K;?_ !%'_#N#]@O_ *-"^'G_ (2MM_\ $4?\3 9/_P!
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M-YN'^2:-P_R37](?_#N#]@O_ *-"^'G_ (2MM_\ $4?\.X/V"_\ HT+X>?\
MA*VW_P 11_Q,!D__ $!5/_ HA_J!C/\ G]'[F?S>;A_DFC</\DU_2'_P[@_8
M+_Z-"^'G_A*VW_Q%'_#N#]@O_HT+X>?^$K;?_$4?\3 9/_T!5/\ P*(?Z@8S
M_G]'[F?S>;A_DFC</\DU_2'_ ,.X/V"_^C0OAY_X2MM_\11_P[@_8+_Z-"^'
MG_A*VW_Q%'_$P&3_ /0%4_\  HA_J!C/^?T?N9_-YN'^31D?Y-?T@7'_  3<
M_8*FA:(_LB_#]=RXW)X7ME(^A"\40?\ !-[]@J*-8A^R-\/V"KC+^%[9B?QV
M4_\ B8#)_P#H#J?^!1#_ %!QG_/Z/W,_F_W#_)-&X?Y)K^D/_AW!^P7_ -&A
M?#S_ ,)6V_\ B*/^'<'[!?\ T:%\//\ PE;;_P"(I?\ $P&3_P#0%4_\"B'^
MH&,_Y_1^YG\WFX?Y)HW#_)-?TA_\.X/V"_\ HT+X>?\ A*VW_P 11_P[@_8+
M_P"C0OAY_P"$K;?_ !%'_$P&3_\ 0%4_\"B'^H&,_P"?T?N9_-YN'^2:-P_R
M37](?_#N#]@O_HT+X>?^$K;?_$4?\.X/V"_^C0OAY_X2MM_\11_Q,!D__0%4
M_P# HA_J!C/^?T?N9_-YN'^2:-P_R37](?\ P[@_8+_Z-"^'G_A*VW_Q%'_#
MN#]@O_HT+X>?^$K;?_$4?\3 9/\ ] 53_P "B'^H&,_Y_1^YG\WFX?Y)HW#_
M "37](?_  [@_8+_ .C0OAY_X2MM_P#$4?\ #N#]@O\ Z-"^'G_A*VW_ ,11
M_P 3 9/_ - 53_P*(?Z@8S_G]'[F?S>;A_DFC</\DU_2'_P[@_8+_P"C0OAY
M_P"$K;?_ !%'_#N#]@O_ *-"^'G_ (2MM_\ $4?\3 9/_P! 53_P*(?Z@8S_
M )_1^YG\WFX?Y)HW#_)-?TA_\.X/V"_^C0OAY_X2MM_\11_P[@_8+_Z-"^'G
M_A*VW_Q%'_$P&3_] 53_ ,"B'^H&,_Y_1^YG\WFX?Y)HW#_)-?TA_P##N#]@
MO_HT+X>?^$K;?_$4?\.X?V"_^C0OAY_X2MM_\11_Q,!D_P#T!5/_  *(?Z@8
MS_G]'[F?S>;A_DFC</\ )-?TA_\ #N#]@O\ Z-"^'G_A*VW_ ,11_P .X/V"
M_P#HT+X>?^$K;?\ Q%'_ !,!D_\ T!5/_ HA_J!C/^?T?N9_-YN'^2:-P_R3
M7](?_#N#]@O_ *-"^'G_ (2MM_\ $4?\.X/V"_\ HT+X>?\ A*VW_P 11_Q,
M!D__ $!5/_ HA_J!C/\ G]'[F?S>;A_DFC<*_I#_ .'<'[!?_1H7P\_\)6V_
M^(H_X=P_L%]OV0OAY_X2MM_\11_Q,!E'_0'4_P# HA_J!C/^?T?N9_-WP>,?
M6OTC_P"#>O\ 9$@\=?$_6/VK/%VE)+8>%A]A\/?:(%96OI%R\J[E/,:'&000
M7'8U^D7_  [B_8,(P?V0OAY_X2MM_P#$5Z-\,?A%\,_@OX97P9\)O VE^'=)
M69IETW1[%+>$2-]YMJ #)QR:^6XR\:*/$/#]7+\'AYTY5-')R3]WJE;OMZ'I
MY/P94P.81Q%::DHZV2>_3?L= J-GK3DX:E"X[TH&!BOP(^_"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BAC@
M9KS']KS0/C=XH_9Q\5Z;^SCX\NO#OCB/2Y)_#>I6T$,A-S&-PB*3(ZD/C;C
MY(Y'6M*-/VU6,+I7:5WLK]7Y$SER0<K7L>G45_-+J'_!;;_@K!I.HS:5J/[6
M>J1W%M,\-Q$WA_2\HZG!!_T7J"#48_X+B_\ !5(G_D[K5/\ PG]+_P#D6OTZ
M/A-Q#.*E&K2L]?BE_P#(GS'^MF 6CA+[E_F?TO45_-%_P_%_X*I?]'<ZG_X3
M^E__ "+1_P /Q?\ @JE_T=SJ?_A/Z7_\BT?\0EXB_P"?M+[Y?_(B_P!;<O\
MY)?A_F?TNT5_-%_P_%_X*I?]'<ZG_P"$_I?_ ,BT?\/Q?^"J7_1W.I_^$_I?
M_P BT?\ $)>(O^?M+[Y?_(A_K;E_\DOP_P S^EVBOYHO^'XO_!5+_H[G4_\
MPG]+_P#D6C_A^+_P52_Z.YU/_P )_2__ )%H_P"(2\1?\_:7WR_^1#_6W+_Y
M)?A_F?TNT5_-%_P_%_X*I?\ 1W.I_P#A/Z7_ /(M'_#\7_@JE_T=SJ?_ (3^
ME_\ R+1_Q"7B+_G[2^^7_P B'^MN7_R2_#_,_I=HK^:+_A^+_P %4O\ H[G4
M_P#PG]+_ /D6C_A^+_P52_Z.YU/_ ,)_2_\ Y%H_XA+Q%_S]I??+_P"1#_6W
M+_Y)?A_F?TNT5_-%_P /Q?\ @JE_T=SJ?_A/Z7_\BT?\/Q?^"J7_ $=SJ?\
MX3^E_P#R+1_Q"7B+_G[2^^7_ ,B'^MN7_P DOP_S/Z7:*_FB_P"'XO\ P52_
MZ.YU/_PG]+_^1:/^'XO_  52_P"CN=3_ /"?TO\ ^1:/^(2\1?\ /VE]\O\
MY$/];<O_ ))?A_F?TNT5_-%_P_%_X*I?]'<ZG_X3^E__ "+1_P /Q?\ @JE_
MT=SJ?_A/Z7_\BT?\0EXB_P"?M+[Y?_(A_K;E_P#)+\/\S^EVBOYHO^'XO_!5
M+_H[G4__  G]+_\ D6C_ (?B_P#!5+_H[G4__"?TO_Y%H_XA+Q%_S]I??+_Y
M$/\ 6W+_ .27X?YG]+M%?S1?\/Q?^"J7_1W.I_\ A/Z7_P#(M'_#\7_@JE_T
M=SJ?_A/Z7_\ (M'_ !"7B+_G[2^^7_R(?ZVY?_)+\/\ ,_I7OH&NK.2V69HR
MZX\R/[R^XIME ;:&. S-)M7&]^K>]?S5?\/Q/^"J7_1W.I_^$_I?_P BT?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *:ZJ%)VTZFR?<-'F!_/+_P '!O[&$G[,O[:<WQ:\-:88O"_Q2675[-E!
MVPZBA47L.2QYWNDPP%4+.%4?(:^#1Q7]+W_!8W]BY/VUOV(_$'@_1=/\[Q3X
M9_XGWA%MR*S7<"-NAW.R*%EB:2/YF"@NKG)05_-#ATD*NN-O!]J_ISPYS[^V
M,BC2F[U*/NOTM[K^Y6]4S\QXBP/U/'N:7NSU7KU0ZBBBOT \$**** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^M>*M8T#0M,\%^'88V=[^_>W@*C:H)*( 6;'7  Y85I3CS7)E+EL?:W[9O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^"M/_!5WX-?M<_L/>*OA%^RGX6\1>)M/N;BQF\:>)[G19K:RT.TAO[1XLNX
M>66Y:WC51G 9R<87/ZQZKHFEZY92:9K6G6]Y;2\26]U"LB/]58$&J$'PX\!6
MNDW&A6G@G1X[&Z96NK./3(A#,P((+H%PQ! QD<8%.,XZ-K87*]C\TOV\V_XI
M/_@GFA'_ #.?A@?^0]+KZD_X*Y_LS?$S]I;]CZ^T?X+0QS>+O#>L6>O:!"S'
M=)+;2>8408*LY'W0PQFOI*[\)>&K\6:W_AZPF&G,K:>)K-&^RL,8,>1\A&!C
M&,8'I6B1D;:.?:W0:CHSX&^%W_!>W]DN#X?:;H7QITSQ=H/Q"M8(K/6?!O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4USVIU-;=NXH8'/_ !1^'/@[XP_#K7/A1\0M'74-#\2:
M3<:;J]D[%?.MYHS'(NY2"IVL<,""#R"" :_/1/\ @UR_8/9<_P#"YOB[^&MZ
M7S_Y3J_2MU!I!QQG\J]++\ZS;*HRCA*TJ:E:Z3M=HY<1@<'BY)U8*5NY^:W_
M !"X?L'_ /19OB]_X.M+_P#E=1_Q"X?L'_\ 19OB]_X.M+_^5U?I3G_:-&?]
MHUZ7^N'$_P#T%S^\YO[%RO\ Y](_-;_B%P_8/_Z+-\7O_!UI?_RNH_XA</V#
M_P#HLWQ>_P#!UI?_ ,KJ_2G/^T:,_P"T:/\ 7#B?_H+G]X?V+E?_ #Z1^:W_
M !"X?L'_ /19OB]_X.M+_P#E=1_Q"X?L'_\ 19OB]_X.M+_^5U?I3G_:-&?]
MHT?ZX<3_ /07/[P_L7*_^?2/S6_XA</V#_\ HLWQ>_\ !UI?_P KJ/\ B%P_
M8/\ ^BS?%[_P=:7_ /*ZOTIS_M&C/^T:/]<.)_\ H+G]X?V+E?\ SZ1^:W_$
M+A^P?_T6;XO?^#K2_P#Y74?\0N'[!_\ T6;XO?\ @ZTO_P"5U?I3G_:-&?\
M:-'^N'$__07/[P_L7*_^?2/S6_XA</V#_P#HLWQ>_P#!UI?_ ,KJ/^(7#]@_
M_HLWQ>_\'6E__*ZOTIS_ +1HS_M&C_7#B?\ Z"Y_>']BY7_SZ1^:W_$+A^P?
M_P!%F^+W_@ZTO_Y74?\ $+A^P?\ ]%F^+W_@ZTO_ .5U?I3G_:-&?]HT?ZX<
M3_\ 07/[P_L7*_\ GTC\UO\ B%P_8/\ ^BS?%[_P=:7_ /*ZC_B%P_8/_P"B
MS?%[_P '6E__ "NK]*<_[1HS_M&C_7#B?_H+G]XO[%RO_GTC\UO^(7#]@_\
MZ+-\7O\ P=:7_P#*ZC_B%P_8/_Z+-\7O_!UI?_RNK])+V*6XM)((+IH792%D
M4<K[TVR6:*".*:Z:5E4!I&ZL?6C_ %PXG_Z"Y_>/^Q<K_P"?2^X_-W_B%P_8
M/_Z+-\7O_!UI?_RNH_XA</V#_P#HLWQ>_P#!UI?_ ,KJ_2G/^T:,_P"T:/\
M7#B?_H+G]X?V+E?_ #Z1^:W_ !"X?L'_ /19OB]_X.M+_P#E=1_Q"X?L'_\
M19OB]_X.M+_^5U?I3G_:-&?]HT?ZX<3_ /07/[P_L7*_^?2/S6_XA</V#_\
MHLWQ>_\ !UI?_P KJ/\ B%P_8/\ ^BS?%[_P=:7_ /*ZOTIS_M&C/^T:/]<.
M)_\ H+G]X?V+E?\ SZ1^:W_$+A^P?_T6;XO?^#K2_P#Y74?\0N'[!_\ T6;X
MO?\ @ZTO_P"5U?I3G_:-&?\ :-'^N'$__07/[P_L7*_^?2/S6_XA</V#_P#H
MLWQ>_P#!UI?_ ,KJ/^(7#]@__HLWQ>_\'6E__*ZOTIS_ +1HS_M&C_7#B?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ,K\+_\ A6W'_P 8H_XB_OC5_P!&5>%__"MN/_C%?CIL%&P>]'^J>0_\^O\
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MVX_^,5^.FP>]&P>]'^J>1?\ /K_R9_YA_:N._G_ _8IO^#OWXU$?\F5>%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHMG:337%OX9NYIH#<PR1Y/E!DMX\3$?/'!&K,3%@;QE&4G?I?YF:7+'0]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_LK4E%&H##"AX/>D2!(UV(,+Z 5(0#UHHU 8(0#D&D>VCD_UBAL<C<O2I**
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M_<>UD^7U*,G4JQL]E^I,@4<CK3J:JD<YIU?!GT 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HR,XH/2FEM@RQH 4
MNH.,TN01FOG7_@HS_P %'?@E_P $Y?A!!X_^(\4VM>(M;NC9>"O VDR?\3#7
M[SCY(P%8I$N5\R8J53>B_,\D:/[)\(?&OB#XC_"[0/'OBGX=ZIX1U'6-*AN[
MSPSK3Q-=:;(Z!C!*8F9=RDXZY]0IRHT=&K&BJK5HMM)][;_<0JD)5.1/5'3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHP.3G[@HKJI8[&4:3I0FU%Z-7T?RV,98>C4FIRBKKJ-VL>2:=117*;!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[JSDMTN&A9T(61.J^XIMA#);01V\EP\S(N&DDZMQU- %BBBB@ HHHH ****
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M\6_V/$_;?\+6VL+X-?PO?:^L5Y9HE[]EM5E,@\L.5WXA? WX/'([9?\ P4R
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MXFMO#^J:IX]\.P3L0^K:WX57[-!QGY_L\TLG_?*-UKKO^#C4?\:GO'1'_/\
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M'XW_ !&_9H_92_8+NO'GC3X=_%#6M!U@KX@:VTVVTBSF\BWO9KEHCLGN)5F
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MSK_P2A\1:]\)]T,VDZUJ/B-;75-6LRQ22>WM?+(<*R.1\X!38V?FJ+_@A?\
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M_B"VLHK[P7XGD@+2Z+J:(#%.C*0ZC/RL%/*D\'I7JWQV_9V^"_[3?@A/AO\
M'OX<6'BC0X]0AOETW4U9HQ<19\N3Y2.5R<<]Z[2U@2VMEMH8]J1J%5<= !P*
MTCCI4\/2A3NI0E)W];?Y:F<L/SU)\VS27W'X._L??M"?M&?&+_@OQ^SK\-?V
MM_#RVGQ&^$OA3Q!X/\47T*J(]4>#2]<DBNEQP=\,L9+ *&8%@ #BOIK_ (*J
M_%#X>?!C_@N/^R1\3?BSXTTWP[X>TG0=:?4M:UBZ6"WMD:*Y0%Y&P%!=E49[
ML!7Z#:Y^R?\ LZZ_^T'I/[5VJ_!S1IOB-H=F]II?C#[.1>00O#+"R[@0&_=3
M2IE@3M;&< 8P_P!I#]@G]D#]K_6]-\2?M+? '0_&-]H]JUMIMSJT;LUO$S;F
M1=K#@MS7I2S;"5,9"JZ;C%4W!I=WS7:OT][;Y'+]3K1HRBG=\R:;\K;_ ''C
MO[0O_!=#_@FS\"_AS=>-=%_:3\/>.]352FE^%_ NI1ZA?7]P5^2(+&6$88\%
MW(4>N< \=_P11_9T_:&TV]^+7[?G[57A]M!\9?'[Q%;ZC;>$Y-^[1M)MQ,;6
M-A)EXW;[0_[LNP$:0_=;<H]W^#G_  2__P""?GP \5_\)K\(?V1_!VCZMY81
M;Y=+$S1X8,"OFE@K @$,,$8ZU[XJ]@*X:N*PM+#RHX:+]ZUW*U[+5)):+77N
M=5.C6E44ZK6FR1XQ_P %&P!_P3U^.Q _YH[XF_\ 37<5\<_\$I/VW?\ @E]\
M/?\ @G7\)?!/QB_:$^$6F>)].\)QPZUI^N:I8QW<$V]R5E60[@V".O-?HUXV
M\%>%_B-X,U;X>>-]$AU+1=>TV?3]8TZX!\NZM9HVCEB;'\+(S*?8U\VG_@B5
M_P $I\?\F/>"_P#P'F_^.56%Q6%C@Y4*_,KR4DXV[-:W)K4:TJRG3MM;4]$_
M9[_;*_8H^/&MS?#']E_]H#P'XFO[#3WOYM$\(ZQ;SO!;"5$>8QQ'Y4$DJ MC
M&YQW->%?\$+M"T73OV8_'NKZ?I=O#=:A\=/&#7UQ'$ ]P4U25$+D?>PH &>@
M&*]M_9S_ ."=W[%?[)/C2\^(G[./[.7A_P (ZW?:8^G7FI:3#());5I(Y&B.
MYC\I>*-NG5!7H/PI^"_PR^!WAZZ\)_"7P59Z%IUYJUUJEU:V2D+)=W$AEGF.
M2?F=R6/N:YZE:C&,X4;V=M[7TOO8TITZLI1E.VE]C\[_ -C#4I-$_P"#@?\
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M&.E8ULPHSHSIPBTFH)7U=H]7ZW^6Q<,+44U*3N_>O\^Q^4/@+'_$)=XF!_Z
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M6L7KHDM'UV^9OAZ-3ZBH/>W5=^ZZ'YC_ +)7[0WQ=_93_P""G7PZ_82^'?\
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M5K6:O>S[.[>JN$L-7CS*G;WDKWOVL?"?[1)/_$)+I>?^A&\)_P#J1Z?7/_\
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MGKX26?P<_9^\%Z;X9T/2(+@:'I-O$YM;5Y9))F^7=N*F61V(W G<<$5\H_\
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M ?B5XIUU_A=I_B+S5N++3G9&LY))1DRQB2.++(2&,4N,YYUO^"77_!4_X?\
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MV\(W'CG]I+X<^*+'QY\3DT30_P!G[PSX39KN/PY--L75S?M_I/GPQ?O)E*&
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MQ;\0+'XKVOB/5]2\/R&YM/#^GV\4J2M=7$ 9H2?,5]J@X6,LVW*;ON[X@_\
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M+G_!LU\<_ /P\T634M6O/$6L/:V,+*&E$46G2N!DXSLC<XZG& "2!7ZD6_\
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MB@ HHHH **** "BBB@ .<<4Q5Q_#WI]% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!%?-=+:2-91+)-M_=H[8!/N:;9
M&Y,2&[B59-O[Q5.0#3KV:>WM))[:W\Z15RL8;&X^E)92336\<UQ;&)F7+1EL
M[3Z4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 -*Y)RM.7..:** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH AOK@VMG)<K;R2F-<^7$N6;V%
M)97!N;>.<P21;UR8Y!AA[&EO[E+.SDNI59EC7<RQJ2Q^@I+*YCNH([B-6 D7
M<%=2"![@T 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 (_W:BCXE4#T;^8HHH FHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g4bdklltl5z5000016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000016.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .@"-T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHY]* "BBB@ HHHH **** "BBB@
MHHHH **** "BCGKCBB@ HHHH **.>N.** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***7!]#^5 "4444 %%%% !1110 4444 %%')Z"B@ HH
MHH **.>N.** "BCGTHH **** "BBB@ HHHH **** "BEP1U!'X4E !1110 4
M444 %%%% !12X(Z@_E24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5)'W_#^M1U)'W_#^M $=%%% !1110 4444 %%%% !1110 4444 %%%%
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MP+N'398])M[-C<WES!YDD05RD4FW:?ZVOA[X_P#!GQ6\%^%_B+\.O$NE^+_
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M\BO9_@'_ ,%1/V/OVF/B3I_PE^$?Q#/B#QOJEC>ZA9:8;*: 26NGJK74GF.
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M6D+<X&.N#N^7C';J#UQUKX*_:/\ ^"E/[)O[*?CU?AI\9_'Q\.>+7TVVU5+
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MG>*;ZH]*HH^G3_/UHKP_2]O/5GMZK??TL%%%% !1110 4444 %%%% !1110
M4444 %%%% !4D??\/ZU'4D??\/ZT 1T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?PV_\'>/B[QZ_BK]D_P "W,5Y!\+[:T\2^(K!
MXI)([/4_&-S')9WMM/$"(KJ2TTR*VG17RT>0R@9S7IG_  ;U?!3_ ()"_&']
MEG3/"'Q/\)?!+XE_M<W6I:MK?Q0\,_&:STC5?$&G10/Y5A)X+BUV(0VOA8V/
MDLT5C*SO?+=F6,!4)_H5_P""H_\ P3-^%_\ P4\^ L/PI\:ZO+X.\:^$]2N=
M?^&7Q%L[%;^Y\(:_<P16]VTUH7B^W:=J%M&EO=VQE4&,$J"W!_SY_P!IC_@A
M;_P4Y_97\37<$GP'\6_%;0;>UU'5$^(OP&N[W7=+B\.:?<S10W6O3Z=+IEUH
MNH7%O"+ZXT=O/\A'(#NH#, ?U(_\%CO^#?[P+^T9X#^%_C;_ ()V_"+X6?"S
MXJ>&-5FTOQ+I/ARXL_"/@3Q;X$O$GN3/-INEP&QO/$-MJAA%OJ__ !\+8![0
M[H]I'T7_ ,&^W["G[:W_  3]^'/QM^$O[45OX:B\'^)/%6F^+?AW#H?B.77%
MT>9+$6.IV%O \<:6%K=R,UX\:'#W'[SJQK^)KX!?\%7?^"F'[%NNZ1HOA7X]
M?%*STCP<%LK3X3?%6+4M8\#VZ1.&^QW.C:K;023X";&07TIV?+N[U_?)_P $
M9_\ @KAX:_X*A?";78O$^C6'@/\ : ^%SV%M\0?!5K>"2VUNVGBC6+QIX;MB
M3(GA^YN2MO/ 7D^QWL@MGD)P2 ?R ?\ !TG@?\%-_&'M\'?AV3CD\^&C@GO7
M]R7_  2*1_\ AVC^QN,?,?@GX3.,CC_1V![\=.F<U_#O_P '0IC3_@J%XI,^
MSR'^$GPT\\D980KX>"R!^GR;2?P.:\#^"O@;_@OO>_"GP+>?L]Z9^VY+\%9?
M#]G)\-G\$2EO"K>&B@^PGP^O 6R\O_4#H1SVH _NG_X+P*W_  ZO_:L]O!@8
MG(Z?:$YY_EU]J_DL_P"#4'/_  WGXUZX_P"%,:Q_Z)M*^$?VC_!7_!=?3?@Y
MXRO?VI[#]M"/X$Q:=')XZ/Q)S_PAL>GAAO;7#DCR-VW?ZD#%?>?_  :D;?\
MAOKQSLQL_P"%-ZYLQTV[;;;CVQC'M0!_HCGYF*]%)_AYW%1E@WJ"#C'MUK_,
M#_X+>?M(Z]_P4#_X*EZKX!^'ESIVO:)X*UK1OV;?@Q-ICNEKK=Y?:L#>S7P#
M,KWH\4W5_IKW)4/%;PJO(6O[^_\ @J'^UAI_[%G[#OQV^.USJ=SI&NZ7X5N/
M#7@.]MH]\R^/_%,,NE^$0JYSM359(YG?YOEB8$ 9(_@M_P"#=S]F:3]JG_@I
M+I_Q4^(=OIFI>&/@G;ZS\9_'TFJW-M;J?&_B*]GNO"UY +J96GN(_%;2W!2$
M2&),R/M0$@ ^)_A)K/QI_P""1O\ P4E^'][X]BL/#7Q)_9^\<^'K#XC6\<7]
MLV%OX'\86UF?%BV\#-%'?3W/A.[G>UD)_=3LK+R*_P!8#P5XMT'Q_P"#O"7C
MOPM<&Y\-^-O#>B>*M"G.V,W&D>(=.MM5TV214>14FDM;J(RQ!VV-NC)RM?PE
M?\'8'[*FD>'OC)\&OVO/"%IX?_L7XI:/<?#3X@_V3<6;W^I>-=&4WNG:UJ_D
MSR32JGAR*#3H9O*$1\DQ[RRD#]L_^#:#]KV;]I']@.T^&'B:_GOO'G[-6O2?
M#[5;J^N1+=ZCHEZLFK^'KJV@=S,;33[&5-+6<9B5XDA!4J P!\V?\'<HQ^Q)
M^SV NW_C)'3"P4X (\,ZD-Z^I7@#H0"17Q=_P:[?LA?LP_M*?!7]JC6_C_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#Y _;\4M^Q-^U/\J[O^%&_$)55AD _P#"/W9))_B!]".<>E?P.?\
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M9.HW5:G**J13Z.Q^VW_!4#_@AS\*_P!GKX%>(?V@/V8M2\6)IWP^MX-0\:^
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MW:8:#/\ $'6KH:/;W\S!FE:>]D>PMI&R52%1P *_L-_X-W_VH5^)/[.OB?\
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MSN)'R_ATK_0>CF654FA:.:"6-)8)8G#)+%( \<B%<@J4(*L"0P(()%?Y\?\
MP6]/_&RS]H?C@:3\/3QG_H4H>OMQC'TK\9^C6VN-\TYHS7_&*9I&VJ4;5<'S
M*5NB5UUUMTT/U_Z1L+\%Y4HRIS4N*LM<7)7U<:S3NT]5NNBUMOK_ ')_L?\
MS?LJ?LY@[P#\&/AR!SEOE\,:>1O;^$# !^O/ KZ.7/?ODGZD]/<>A[BOG3]C
M_C]E3]G/O_Q9?X=<_P#<KZ<?Q].G6OHPC((Y'O\ Y_S^M?@6:)?VEF,U91CF
M&*DDG;_E])+FO>ZM]UM'T?[GDK<,IRCVC;OEV$C=ZV?U>C=NUUKMT^[4_!O_
M (.+ #_P3]LPP# _'7X:$J?XL?VUP3_#W.>W%?!'_!LA'G7_ -K]L[2+;X7
MC@D*%ULXS_%@<=!TK[W_ .#BKC_@G[9YY(^.GPT]?^HS^=?!7_!L@3_PD/[8
M [&V^%P_--;!_&OZ)R>4E]&K/XPTY>*HN2DU::]MEB5D]?<Z]+,_GG.TO^)C
MLF53WJ4N'H15D^:+^KXA[QWBUO?JM#[:_:4_X('_  F_:/\ C[\4_CWK'QF\
M4Z%JWQ4\42>)M0T>UT.TGM-/G>TMK0V]O/)=*\BA+96,C(AR2,<9KXG_ &A?
M^"$_[)7[,'PF\6_&3XM?M.>)]!\(>%-/FN9!/H5@MSJNH-&PT[0](@6\::]U
M35;KR[6SAA1F,TH=RD:NZ_U;>*_$_ASP9X?UKQ7XOUK3_#OA?PUI]SJNN:UK
M-S'::;INGV<+33W=U<2D)'#"BDLQ.YL852< _P #/_!4?_@H+XL_X*%_'K3?
M!7POM=>OO@YX2\0R>&OA'X0L(9VU#Q_XDNI_[//B(:5$Q,UQJKKY6F),'46H
MMYU,>[B/"+._$_BK'8'*L+Q5B<MX7R*E0EF.+]A@_88/!4;<N%IU*N'E%UJD
M(2C3YY2Y$O:3V49;>*V0>&?"N"QF95N&J./XESRM-8'"K$8J5?$XJM9?6IPA
M7YE2I3?/**C[[]V'VG'\Z?A3\&O&?[1/Q:T3X/?!3PYJOB+Q!XSUV>R\,636
MQ>XM=$6Y+#6/$+@&/3+33=.*WNJR2.1 %E$9E9-I_MC_ &SO@G=_LZ?\$8?'
MGP:O]436M2\$_#'P]INI:A#$J03:B^N:9/?+;KWM8KB26&"4JK21(DK*K,5&
MQ_P2 _X)H6_[$WPP'Q!^)MCI][^T/\2M-LY_$;I&DX\#Z/*/M5KX2LKEES]J
MBWJ^J31B,_:6EM272/)]S_X+!%O^'=?[2&3\P\-:6<CI@Z_IN!Q[>F/IVKOX
M_P#$^GQSXB<'Y-EDH5<@R/B+*8T<6X\L\QQGUZA2JXKFTG['E3C32Y8RO*>L
M73.;@/PUGP;P'Q5G>8QE2SW..',?*O@V[T\!A?85JE.ARZP=7WHN5[N*M'XK
MI?QF_P#!,;]B7PM^W=\>->^#_B?Q9?\ @O3M#\"2^+H-4TBRBN[J>5-02R-J
MXD>-?+^<R%RP)/;U_?@_\&T_P8Z?\+^\: YX'_"/6*KS_M?;.6.,D^N>.E?S
M)_LD?M=_&C]C#XB:G\4/@3#H%QXOU?PVWAF^@U_PU=^)[)-(DNTO'D33[-DF
MBN#.BCS]^W9E3P37Z2_\1 W_  4CP1_9_P +E)PJM_PJ'7BN3S]WSQECT SQ
MZ@U^L>)&"\7ZO$4EP=Q'@,MR;ZG0E#"XG&X&C+VR<G6?L\11G4E=<EFYVTO9
M.]_R7P_Q7A11R)2XLX<S',LTEBJL7BL+AL76IJG>'*N>C6IP5M;KE7JU9'[0
M_ +_ (( ?";X"_&SX8_&O2_C;XMUG4OAEXKM/%%CI%UH=G'::A<V:2QK;7$J
M7;21QL)3E@I/'I3O^#CE5?\ 8M\(;LG?\7?"G+#C.9P,YX7C/XGU/'SW_P $
MI_\ @K1^V5^U_P#M:VGP:^-%GX(@\#S>"=<UZ2;0OAYJWAN_;4]/DA6WC34[
MN5X=BAV\V J&;@KTQ7T-_P ''((_8O\ "0/3_A;GA7'''WI_US7XAEM3C1^+
MW!>'XSS?#YGF5"I?#U:%;#5J=+#5(8B]-3PU*G"[G&3<6FTY1=TG9_M^.I<(
MQ\)^*ZW"&4XC*\OQ%.4ZT,13JTIU:\523J<E6<YZ4[1YE+R:W/PR_P""5O\
MP2^\"_\ !0/0?B;JWBSX@ZUX(D\ ZCIEK:P:1IL%Z+N*]^T%FDDFEAVE?)Z
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M6*XTX-Q5:KB:7#><XFA@:U64I-82&(J4^1R>MY2A&<?>Y8ZJ/*G)OUX@L>2
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M:XOXK4N1+<0QLZQ,V\X0,PXX:O8]#_Y FC?]@NQ_])XZU*_FSBCC[B[BN%+
M9_G6(S+"8+$U:V&HU:>'A&E4M[+FC[*C3>D-$FVDMC^B>$N!>%>%H_7LARFC
ME^+Q^!PT,77IU*TY58M0K-/VE2:5YW>B3\[:!^?XC%%%%?%Z]=7U9]N%%%%
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MQ>W/BRTGL--#_<^VH_E787(<PH6P5!K@?A3_ ,&O/_!3CXL^)T/[07C#P/\
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M^-G[._P\OM-TOQ=\1-".DZ3?ZPVS3K:X$BNK73 J1$PS\P.!CFOPV_X(D_\
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M;(R1_;;C>X\K8Z,<9K]:M,_X-.OVY-=OX;+Q3\;_ (9:9I;J9)+^\EU'Q#'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+]G#]CO]G/\ 9/T:ZTCX$_"[P]X);4(H(]9UFRL_,UO798$"BXU'4YC),[L
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M ^!-B/!/B/P_-=1?VS+IL,\TVE^(Q9DB;^S]2,\D,,X5D+VS X) /W!^V_\
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M#W\*0_TYQW'0U^J'_!O^W[3'P%^+/Q$^#/Q6^!OQG\$?#/XF:6GB?1M2\3>
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M_:X/A6[\8:'!XC_M'X81P:>='DO8DO?ML_\ 8B^3:F#>99-R[4R=PQ7[8_\
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M2C%:)L_D!_X-\/F_;Y\+8R6;X5^-,X4[0HT2+HV<<GJ<<].,5_>"XPK,Q"H
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M[\0& QMYF_QQHNJZU8VSIPWFB#4+>(KC+-T&>*_%#_@GG_P0=^+^I?$7PO\
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MTUK2M5TN\AO+66*\A60)OA)'FV\I>VGC.UHIHG1U5E(K\>?^"JO_  2'T/\
M;<(^+WPHU'3O!7[0&AZ<+*6:[A2+1?'NFV@:2WTG67B$8AU!F/EVNK7!=8\K
MY^46OYP=+^"?_!8_]@F[O?"WPRT'X[>%[?6)'M;JR^$L<GQ#\.NB$R*;<I;7
MUAI\+;_.1K2.!6E=L#=DU[N=PX=\<LGX=Q^'XCRS(>,\HP"P.98+.J_U;"8B
MC34$ITZTY-1IPES2IU(JI.?.X5%>*Y?G\FEGW@GF^>X+$Y!FF?\ "N;XV6-P
M&-RJ+KXK#5)2DTIT;VYY*<E4BVHI1BT][_T[_P#!73_@I7?_ +!_PU\,Z?\
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MD?RHDFU%PJ**BDN?5MJZ5W!JTF]4WY[H<;>]&2?-)Z1O;E5D]&G[L6TK==M
M+%5&XMC."P.[DD]B2V,\<@X'3UI%9U8\X7N.3@]%"@] 1@G'\7Z. &!QTY'^
M?QHP<Y_//]/ZT[7DY*\H)JUKII22Z6][5WL]O5"M*T(.24FN9K=-KETYM]?3
M5"Y;^\1]#_C06;YB6;Y1_#VR.XZ,>X]!G(HI#_\ J..E'NVY;W]E;F2YN;I;
M72[MYZC6C<KM7NKO6'39='\O+JR)2_/!#X&68_-W^\0<-G QW QFGEB3G)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4T.K*'7E20%/3)/89QR.ASCFG4 %%%!./?Z9_P _G0 44'C'?//';ZYQ^E%
M!1110 4444 %21]_P_K4=21]_P /ZT 1T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !12 _Y_P _E_\ 6Q2TW:*O)V3\F[>NUOQ^_02E%[.^MG;;
MI\+Z[];!12<X]?3M_.EI-I.R4WMKR^ZMMW?2ZV*2OLT[O37==_+KYNWS"BD.
M>,?C_GUI:+-;K?:VJMZV6O\ 6HM'LTWU75=]/ZN%%%% !1110 444ASVQFCO
MY)NR[*W^?X!K=:;O=NRZ=>^NVXM%)G Y_'&:6E?6W6R=GH[/K;MY^G<+/MII
M9K9W5]'9!1113 ****=I:72N^SNNGH+MI[K>C^[6WS"BDYSVQ^.?\/\ .*6C
M2VTEK]J-NVOWO^NM))OXHN^UGJ]%==-?GY:!1322.HX]1_GK3@<\U-X[)^\G
MJK-=$_ZU&XM>EKW\[I6M^(4444R0HHI,<D]S_P#6_P /U^E"<9.T7S:7?2UG
M;6]K=?N^8FTD^:Z>G*K/7;5/YV\WU%HHI#_4?C_G^5&^D=7[N^F]OT=REJTE
MK=7_ "O]UQ:*09]\8[]?Q^G]:6G9WV:W=VNB:^]N^BO_ ,!1]Y.UFURW2VUW
MLWV"BDS]?R_KTHSQD\?K_P#7_2DK^[=-)J_G?32W?_AQ.4;2:=U!VEH].S?E
MWUT%HHS2#..>M-*5TG&UTVW>ZC;H]/N':5F[:)V\WMK%=?O7W[+12=O\:4'/
M2E>'\\?^#Z>?1]1V?\LK]N6_;JGY_F%%%%&Z4DI->FJ]5?;N^BZ">CMK?1ZJ
MRUZ7[]+6^:"BBB@ HHHH ****._]7&E=I=_\KA11GCIG_/\ D_A^:=.23R<#
MTS^53*<8M?&[_P L;VU2[[/77RZW(4E9\WNN+M+K[VFB^\6BCV[^E'/?_/Z"
MG=.UFKN^CT2:MHWKKY6*>EW9M)K97;OL[=%WU"BD!ST[''_ZJ6A.Z3[_ #&U
M9V_K:X44452U_3S?;Y]!:]%<**;COT&W&/3/^<4ZDDWS*UG&VC>_IY>?RW$F
MG+E3OHG\V[6_X/R"BBBES)_!>36^C26W7RZ@W:2BE=Z7Z6O;U[[A11GI[]**
M$T]KZ:.ZM]W<=T]G=K?39]@HHHI@%%%% !1110 444475GKKT7< HHHIQC-I
M/E2NEHWW^73_ (8=F];?T@HHHI-2C;F6CZIWM\M-A!1111Z.Z[C?EKYA1110
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV\O^"!_:.<AL'^( CVZ_X4M(.I^O]!2UF 4444 %%%% !4D??\/ZU'4D??\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7AF>+R>EBL)0H5JN74LSHU,?#ZRX*-%X:*<GB%!QJ5:6DJ=*2FTXL^4R?C+
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M.F>5^H]^H8\?B*5>"<YXP 3Z#W_6OSO^)7[<9\%?\%!O@)^PW9^!YKR;XL^
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MYQQR<YP>!SQW]J-XR0>"#_%QG_=SU_"B_3J ZBCIV/3.<'I_GIZT9!Z')[@
MDCZ\<?C0%^O3N%%%(&!_F?;ZT;[:AT;TLMWV%HHHH#HGT>J\T%%%% !1110
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MGU[&OX!?^"P?_!.S_@K[\)O@YX,_;B_:?_;K^'/[3FK?LK^./#FM> [7X?\
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MWVC7T^M216EUJ$>O7,]G/=0OI$D=I;:?)!@)+&Y'Y._\%E/^":?QP_8?\'_
M;XM?M-?ML^*?VG/BS\8_C?:Z/<^&;G6=?B\%::+2P74;GQ-I?A?7+R1=-7S$
M:R-S:VL,*ATA#[R5H&NBT7]W?IU?]7\S]SO^#F#P+^T]\5?V"KC]ISX=_M%1
M> _V1-*^"'AS4?C3^R]/X?2[O_C!K'B[Q+HVL^']2_X2A8B=+.@V=[:6\ELL
MD:7+V;2<G:#](?\ !-/X._\ !0#]G;]@KQK\8_CG^VO:?'+P-KW[(&G^*_V=
M/ ]CX-30;KX(06_PV35?#-HVJ30K_;,^@6ZV=BKS"2-WM!@/'C*?\%UFW?\
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M:=H>KZ>-1T:^GCBU^?RM3GN= &FZ9 6>\BCTZ&2>W#- 8VK]B?BI\7?VB?\
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M3J\5!BQQ\7=2P6&,J=,M2I&?X3G*XY['I7]1E 3_ %?Y1/\ /N_X*%_LR?\
M!0I_^"YW[.WP^C_;JL!\:_C%KOQ)U[]E3XMCP0/)_9D\$7]MJ]YIW@RZT<P%
M/$CVVE^9IWVDI,DQG\V0@EL?I3_P6[_:R_;Y_8+\+?\ !,SX=^!_VIM:M_B#
MXHOO#?@SX^^/]!T'18+?XM:W8ZQX2TG7-<N--U.PNO[)M]7>ZU"40VODF!+L
MIG**1I?M_MG_ (.5_P#@ED 1QH/BC"J>2/\ A'-5+EP>0%(R,8R/PKQ__@[
M1XO'O_!.?4IHW%A;_%V"WGN<?N(I9_&WA!85F_B.XKPH/S-TZ&@TM?V2_NNQ
M_89JE]=0^"[_ %"&=EO8/"MW?I.?]8EY%HSW4=PG;*SA9#G*EN.@(K^=G_@@
MC^V)^TW^U5^PU^U#\3OV@_B]K_Q.^(/@CXO?&SP_X3\2ZQ::1:76AZ3X:EU>
M+1+*UATNQLK5H; V\1A-S!)*515FEF*M(W] OC;6=.\,_"?Q7X@UR_M-+TG0
MOAUJU_JE[?RQVUO:6UIX;GEFFNYIBJ0H@0Y)*\\<GBOY9/\ @V,D$_\ P3;_
M &R)T92ES\<OV@IXI%8,)(YY==ECE4CY3%)'+&\;="I!R1S01&+O?6_,E;U:
M_P SX!_8"^)W_!:[_@L=X'^,WP1T3]M+_A47PU^$WQ3\<2^)_CMJGAN.;Q9X
MS@U/6;[3-(^%$7_"/V]@$T7PQ%IR7EM<VK0WBR.3=3R?(H;X8_:"_P""S7_!
M-S]KSQ!_P2NT;XN6_P"U1\0_CKX9T>#X%>._$ME>WVE_#;2M9E>'Q!\5=.LI
M6FUF*X\/PW1:6UUJYO+"&73EN9(C"PK]8_\ @U(M+6/]A#X_7L=NGVN[_;<^
M/MM/<!$6>:*VU/3VA5Y  YCC\Z38A.$+L5 +'/-?%[Y?^#KK]E,C@-^Q=\6,
MD'J3H-X"#S].*!MVOLTNGIR_Y_@?G!^W+^S/_P %G?\ @D?X$/\ P44U'_@H
MM=?M"Q>&?%GA]OC'X96PO]+M+W2]1NHD^S7NEZO+<Z=?:;JE_P#\2B[32;.T
MN84G%RA0?=_HY_;D_P""IFG_ +'?_!,3PY^V[J.@:;J'Q&^(GPP\$ZQX"\"E
MI?[/U/Q]XQ\/:?JLNGQ9<S2V6C_:;N],6YIY[:S\D$O(37A'_!SX /\ @C1^
MTR0"?].^'OW>"<>++#&".YSW[U^4_P#P79M9;7_@C[_P2B\:WVF7-_X(^'?C
MGX ^+/B'%' \]NGA.S^'%J;];]4!7R)TWP,'^21Y-@R6 (/?2_VK>NEVOOT]
M-.XSX6_\$PO^"WW[?GP]\&?M=_%S_@I''\#O%?Q.TV#QKX(^%UKIFLW=EX6\
M*:NL6L^%(86\-W-A816UW8W%M<P6=W;7%]:Q.J7K2.6W?<'_  1Y_P""AO[8
M.A?M9_%[_@E)_P %'Y;?Q'\>_A;I+^+_ (:?&:[N[+3[SQ_X.:58[;3]1ME2
M"/5K_4[9AJOAV;3XUDCTF">.^-Q-Y;+_ $,?L]^)_"WC?X"?!3QAX$2"/P;X
ME^%G@;5_#,%FJK;P:)?>&]/N-.M(57Y83:6[I;F(@>2T;1, RD#^33XPPR_%
M'_@[ ^%[?#8QZ\?A5\./ 6I?$Z^T%_MT.EZ79^$=0TVYM]:GMC)%;-I=_<V]
MA=P3,KV]U*D4JJ[;:!;W73[.FUK?Y_A;R7S]>?M%?\%8OV\/^"F_[>'_  34
M^"O[7%]\-OA]IOQ0\:7L'C#6-%L&7X6?"CPI<PZ;<>$/#SZ5:6NK7/\ :LM_
M;Q.YO#?YP4N50/7]1_\ P3'_ &1?VE/V-O@+J'PO_::_:FU7]JKQ:WBG4KS0
M/$]S8S:;IWAWPBS)_9>CVL>HF;5)KV,M,VHSW-U<12N8O(V .*_GZ_X)"QPR
M?\'!G_!5ZX:)&F'C+XCK#*P!FCBDUS2G=5;&%CD."!G)P">]?V5?A03/I96T
MO:UM_P#AAJD,JL"2&&>A'Z'D?0\Y]J=1100%%%% !111^&?;I0#UT[Z?>%?/
MG[2OQ[\)_L]_"CQCXYU_7=(TW5K#P_JESX8TG4;^WMKS7M6M[<K;6VFVLCK+
M>2B5T9DB1R /FZXKZ '=N0%!9T[9(+?>/88/0XK^:75M&M_VP?VP_P!H+Q-\
M8IKCQ%X5^"GB6#P9X%\&O>.?#\4"%O(U"2UA< 7T1#;WC4?:-W[XOCC2E#GF
MH_T_+YG#F>/I9;A)XRI94Z$=4]/:2:5EYV[*[*'[,GP2T7XBZ!+^T/\ &>!/
MB+\2OBE?7GB.UU;7)7U"+2-%NKF8V<%I;SL\=O<B,>5/!L$*HJ&*-23G[AT+
MPYH'A>QDTWPYHVGZ#8>89C;:=;PP1.Y.3++Y2*&F?DN<[BO%7=,TS3M$L+32
M-(L(-,T[3X4@L["TC6*WM8D&%BCC4 )M&<C /.?7-WL00,=<=CGJ2,8_'G->
MU"G&,([773K_ ,#TV^\_!<SS.OF.*JU*N*K*,Y.<*=WRQC*W*M[6Y6M/^ -9
M4+LY $NQ5,S(K2B,?.(XB!E(CVC)SU/.>' D\[<<]A@=>N"<C/7UI>_/)Z_T
M_3I]*,Y]ZJ[V//C*<$H_%%O1O\].FO\ PV@>G&<G _R<4TGDK@@@'.>@ &22
M0>@')(_G6/XAT+3?$^CWV@:O%/)INIQ&*Z^RW4]C<#;\T;17=L\4\3!\<QNI
M/0Y'%?/FM_#WQS'XJ\&^$#KFN:O\&KIL:O#'<BWUFQNK)";/3-4OU9;IM EV
M),9HI1>O<A%=VA+ AT4<+"MS2E4Y=+VNNB7E9=4[^3/I6-X+I&$7ERQ,C0.4
MD!C9&1A(A(.[YAN7KW%?G_\ $[2-1_8R^(W@W]I;X(ZO?Z%8:KXWTO0_B'X*
MGNKAO#>L1:Y>)!,SV0DV[9(Y'FGD8>8LB(871=V?O?3])L-*MEM--B%I;HL?
MR/*\S-M^]DNS$DCJ2,GKFO!?CG\(-?\ CI&G@F^\0R>%?A[%LO;Z6P@@N-9U
MK4Q\T*PM<(T5K;6;</( DQ8@QL*RJPYUHOZ_K3R/6R',9Y9F%&2G:G%I5E?2
M=/35]Y:=KZN[MH?O'HFJ6^MZ/I.MVT@EM=6TZSU"!E(*".\@CG7RP.J8D !Y
MX&0>M;%?ST_ G]I;XK?L0?$_P)\'/CCXRD\<_LZ^-9?[%\'^,-3!;4?!=PA$
M=O;7MT^7>SA9E2Y$SG.Y3;A0#7] NG:A9:K9VNJ:9=V^HZ;?017-E?VDR7%M
M>6\ZAH);>:$F-D=3DGGTZBO'J0=.3COVT9^Y8+&X;'48UJ,U.$MG?572TMY>
M=M%:QHT445!TM6=@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %'^>E%,7YF8
M9. P+>AD/8$^AP>N/;M2?-]E>\E=)[.SBG%]KWTT>PU\[:77?5?CO8^,OVZ/
MVK;?]DOX':EXVTO3X_$OQ-\3:E9>!_@_X(2*2[O/%7Q"\0N;/1+-;&V87=Q8
M07!^T:C) I\B"/YR-PSYK^P3^QL_P(T'5OC3\8KV7X@_M=_&V.+Q-\8OB5K@
M^UWFFS:E_I5KX$\)[U_XDGA/P]$\=E;:=:+$7>*1[AFR /G6X\O]K7_@K*=,
MFO\ 3=>^$W[!_@BVU*31CO$UK\;O'\<T27TT?"22:%:Z?$\+.&\J1F9,9K]H
M5)"@MU.=QQQU)W>V[VZ<>M?69C)9-E&#RO#R4<7FV&I9CF^(IS?M?8UGS8++
MJFB]FJ-)+%5Z5E[2=>ES<T:<;_)Y?!YUF^,S.O%RPV58NMEN5T*D;T?:4E!8
MK'03TG*I*U.%37D5.:5I;-(&21EL_+M/R*I_B;GYF]SDYQ[4_."%Z@CK]*=]
M>?\ /XUXK\>OC[\*OV:_ASKOQ1^+WBG3?"WA?1;2>>,WMU%%>ZO>00O*FEZ/
M:.ZS7^HSE0D<%NLFT,))-L:LP^:P]#%8RO#"82C4K8BO.G"A3I4Y5*M>I4:C
M&E"G&\IR;:5HZ^]ON?2XG$8;!T)XC%5*=&C0A*=:M4J1A"A&"4G.=25HQ4-M
M;J[6^Q[52'&#G@'K].YYXZ=?:OQ-_P""7/\ P4X^(O[?WQ4^/>F:WX1\->%?
MA]X(>*]^'QTO[:VNW.CW%^(+2777N6:W-S<6CQS2B#"K*650% K]L.I/# CJ
MO!7:Q'.>0P)Y&.??&:]/B'A_-.&,UJ95F].%#'T*5&=>C"4:G)&M1A7A!U%>
M$6HS7-%?:O&[Z^3P_GN5\29=#,\IG4KX*I6JPIU)Q<'*=*HZ<IP5[\K<;Q?6
M+31YU\5_A3\/_C9\/_%'PN^)_AS3O%G@GQ7ID^F:MHVHVR3PF*9&2*ZLY)%9
M[;4;1F$]K>0,DMM,@=6X.?RD_8^\<>.?V+/VAKS_ ()V?&GQ+=>*_AYKUE>^
M*OV/?BEKLTBZOJGA2-_,O_A/KMS=EEU?Q!X8\V*'39[3_6V8<,"=FW]H<8_$
M\ =NO3TX/)K\MO\ @K+\,-2UC]FY?C]X(O5T/XL?LH>)]&^-G@CQ);V27>K0
MVGA^\B7Q)HED2CLL6KZ5/,)HS\DAMTW!L#'9PYB*5>?]AXZ4W@\UE[.C3@U*
M6&S22Y<!BJ4).T9.O[.CB%'^+AIS33<8VY>(<-5HRI9Y@X06+RR+E6J/W(8G
M+DKXS#UG%7E&G2YZU&3:Y:L%9ZL_4A=PSNQGCISQCHW^T._UQVIP&,GKD_\
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M$\6ZAJ^I:GIT]E!%/;V,U[#;6Z23K<-->QB-4B++E@N/S=_X)9^&_BS^S_\
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M'E=3AZK#+<)6P4\!3J8C,I8S!TIU,UJ8F26(EB>:I[:G6IU8Q@J,%&.COLL
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M^>>,H4:SC"K*25IR45[-NR;Y-=4V/'.T]Q@CZ]:6BBOB+WLNL5RR];)^7?\
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MFFXTI%DD99%<O(=\H:4;N'[5^I4/WTX_Y:1_^ABOE;]C3_D>?VR?^SE?$/\
MZ:=+J9_"_E^:*AM\_P!$?=9).YNV_:/T'_UZ***Q+"BBB@ HHHH *DC[_A_6
MHZDC[_A_6@".OPA_X.+?$/BG1?\ @G%=Z-X1U>\TNX^(O[0OP)^'6LM9320M
M?>'/%'B>6/6-(N#&5+6=]%:)'<PM^[=<AU(XK]WJ_"/_ (.*_#?BO6/^"<=U
MK?A"PFU"Y^'O[0OP+^).M"VB:9++P]X9\33/J^HS[0=EI9Q74;W$K#:BDLY
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M?M5?M ?$NX\'ZYX;M7:X\+^!?"L_@R[\1R:1;2W#.MOK%EJD#6]S::(?[!*
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MM<LSHMK/8FS\N\BC2.9A+YD;EAMVUX/X@_X)1_\ !PIX[TN\\+>-_P#@K/\
M"(^%=</D>(#X9\,^/=$UU[&;B=M)U.UL[>:QNR"PBD26-0P7G'3^N(KD[NXQ
M@_Q$?W0.A [$GC/YBY7 /^T0!C9'G^$]WSG)STR<>P%WIKMMY>GW'XC?\$RO
M^"(WP1_X)]>.-?\ CSXG^(/C3]I;]JKQA8)9:M\;?BE<_P!JZYH=E-9FVO\
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M*;5#>6VN(C2$V8(!1F3]POV?O@SX4_9[^"GPP^!?@>V^Q>%/A;X-T3P;HD(
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M\H(5@<_='/4*!R!R,],\]Z N_P ;_P!?KW/Y$?AQ_P $>O\ @NE^RSX.\0?
MC]D[_@J%\*M)_9]2YU.W\%:9\1_!OB'Q%XVTW0+TR)%'+J\NGWG]C70@90\?
MA^XBM;9@%M,(JU^F'_!)7_@CAX=_X)WZCX\^./Q0^)M_\>OVN_C-$8?B-\5+
MJ2]&FVEG<7"7^JZ#X<2\;[=<:9J&I10ZC/<:N&NA<11)%Y:*=_[?D<$+^N R
MCCA".H') ;C''%-"G)!((X&[D%AGD%1P"3SP.W/7D"[[_P!:?U_3/P=_88_X
M)1_&;]EK_@IK^VC^VUXQ^)_PW\2_#[]I77?$^K^$_!WAZQ\00>,- AUS4+2[
M@CU^YOX8]*F:VCMW24V$DBEF4H<9Q^\M-P "0#PW.?O/CH!V"'GCMZ>KJ ;;
MW"BBB@04444 %!Y'I10<]J:W7JAK=>IA^*!<_P#"->(!9EVOT\/ZQ]D\LD,;
M@Z=<"W*%>?,,NW9CU!ZXK^;S]@R6W_X0[XD1:WYD/Q-7XF>)9/'5K?<:SDZC
M)_9T]\/]<J"+_4L_(&.F<5_2O.\BV\KPC=+';3O"A&=\@1S$N/=L J>&]Z_E
ML^#GP\OO&_[1/[2?C"/Q_K/PZ^).C_%#5H->T?3+2UN+:\T^XG_=K<Z3>,B2
MQB-0#*$8V^<C;D9[,'9S::[M?U_2/EN+Z*KY/54GI1?MFKM*6JBH_>TS]*\$
M9!SN#,'R""S\99B1\S$8R1D=.IS5'5)KRVTS4;G3K-M1U"WM)IK+3U=8S>W"
M+E+82.0JF0Y )( Z4^Q@GM;*UM[FZ>^N((_*FO) %>XE!^:5HTRB;\Y&WCG'
M:K>,\9QGC/I[UZ2;:^_\S\/5_=36CE97[+M]R_IGCEE\;_ =YJ>B^&HKVZD\
M8:Q=-8P^&&T^[M]16YM$675G_P!(B16M--0EY+M,P2J/W3D]/8^A(XR"1\I#
M C)P002#D<^OK7FE_HK_ /"U/#WB)O#%C>P)HU[IY\3(D:ZAHESM8LDDAQ(+
M/4(R( (\DMD. #FO2@,9& .3PH  '; ';'0]2.O-,Z*O(HQ4(I::_@_7IMZ
M1N&T_=/4>N#D<]1@\\48PV\$@G ;J0Z@8VL"<$?7IVI:*#FLM]=?-K\F!'!
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M;V%=^1<:9WPU@L9E^7U,&\#CL32Q%;#XS"8?&1GB*,.2G4Y:\)J/+%R2<?\
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MO-:O]TTC.S-L2)#C9B@#ZX&<Y)!8@$X& ,CL>ISCG.,&EIJ?='!P#C<W5_\
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M7+ :;>F[@ABF<?9A)+M0),F#NY)Z=37\Q_[1'_!>_P".OB#]EKXM^&_VS_\
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M&=]=^,],TFWU/27OM.O98YK74+B'4T^SR0-YL"D$, P]D_X*4?\ !8CX<?\
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M*I"R6<;-!+N_>,NVOZ5O W@W0OAWX.\.>!O#%J+'0/"6CVNA:; !M$=K9Q!
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M<GY>N>.?X0>K?AUH ^[/ _BZV\8Z'!J4(5+E"8+^%2=T5TH_>AD^\5;!8<;
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M>+K_ %;V\Y4)T*>&Q4JT\:I_PL)AW3G7Q#4>63]C&HK.UVTS]E:*_#3X$?\
M!9&ZO_CMH?[.G[:?[-OC/]CWX@>,Y+>S\%S^)KN35O#FHZK=R!;+2]0UE;>&
MUL[K4C)#%IPC>X,US(L4@B0^8OV)_P % _V\=%_8)\"_#?QWX@\)-XKTGQS\
M1;'P+>,FH?8ET*VN;9KRXUN>412^;#:6Z-))&H VJ<$"O K<(<187,\'DT\
MIXS,TJF 5"O0Q%#'1EKSX7&4*M3"UEI9N%:2C)6>KL_=H\79!B<MQ&<_79TL
M'@9^SQWUBA7PM;"/W=,3AZ].G7I7D^M-77H[?H/28QDCOU_7_'_/6OP\^#O_
M  5G^,7QQ^-/@#0O ?[%7Q!NOV;OB1XPO/!?A?\ :(N[^:WTK4-1T^VN;B]N
M8-)EM!,U@%MI)+6[FDB@N(1OCDSM4\3=?\%S]!N?$OQG^%7@WX >+?'GQX\#
M?%:X^&/PU^%OABZGU#4/B.;,S1WGB&XNEM?*T+2K:XB$$DDY=!)(H+^OI?\
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M_-\'_";PG#-<:I<6KOY5MJ.LRV\4TFF:?>3K);6=R(IA+.DBN(U0,?AK3_\
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MJ>,IFWE()ANU+%X)T^9"1BM\X;)/.>2?7Z^OTI=H8HI?!Y/3"D!>BG)^<#
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MN\A67] =HY/'S=0/NG/J._Z=C2 ,.>C@C< ?D?(Z ]%13VIPS@9Y..>"/TH
M,=R22<9]./0=A[<TM%% !3,9)P>058,3]ULXV#/3(P<\XSTI](0,J2"06[#.
MT[2-Q]NGXT"[>OZ,_E"_X.>XK=+_ /X)?S)9VBRO^W+\,?/G-I;M-*O]NZ*I
MBGG\KSKB#8N/(E=X<;CY>7;/5_\ !U=9I/\ L;?LM^#(II--\.^.OVV_@]X0
M\4Z?8G['9ZMX>UTWUGJ5A?0P"..XMI(I2[1R*R[T5^J B'_@Z-\#?$B7X*_L
M:_'KP3\/_%'Q"T3]G7]J3PK\2?B%8>&M.GOVTCPOX>>WU=]3U)X%<V-E<SZ>
M-/\ MC1ND4UQ#E2&JG^UCJNB_P#!QQ_P2UO?'W[)%CXK\%?%KX$_$[1_B?X&
M\&>,8Y-)_M#XE>#;*ZD@\.RZA<6MO%>0-!-=3V-S% L4^HVUK" #*#0;?R/H
MEKY:)'](WP/^%G@;X-?!OX;?"WP!HNEZ1X,\)>"_#^@Z3I]A:6\5G)966EVU
MO')-%&BK<-<(#)+-*':61][Y8U_+O\(/ ?A7X _\'5WQ:\)?"W1V\-^%?BO^
MRA%\0O&N@:%&+?2+[QGXLABOM3UZ]T^#R[9"T]I&PE6(+ 2%C"[B#P_P?_X.
M1_'/[,_PI\/_ +/O[;7[$OQ[T/\ :Y\#^&]$\(^&/#HTFXM7^,M]96\>G6>I
M)FPG31)=0>&%GFNI)([Z0M-&D1?->Y?\$<OV8/VROVA/V]OCO_P5]_;7\ ^(
M?@AK/C?P_J/PK^"OP@\66YL_$UE\/[IHGA_M*P(5[*P\/P0I::-=2;O[6BO)
M9X@JQ-03&R3;?W-7UMY[K7[S^JL]3NQE%!4=6'J0<?-D 8].G45_(U^V;\/]
M!^./_!S_ /L9_#KXC3C6O!/@;]F1?BOX;\,:O*+C1K7QMX=UC5Y[2_CT^=7M
MOMMT%BAD#(WVE8T1P0F*_KF4%O0,?F.1D$],XR2I]5SSUK^6S_@M_P#L@?M/
M^!?VHOV:/^"L_P"Q3X(\2?%?XK_ B.S\&?%OX8:1)]NO-?\ AKI]Y-J-@FB:
M D8GN4O+J[OH=?E27$%HD$C#!Q0*F]?EUT['[??\%#_A5X'^,'[$7[3_ (#\
M;:'X>U;2+CX*?$.[TY=?L+>ZL=!U?3O#&H7&B:];*ZK]BN]$U""WOK2>!HVB
MEM@Q)0NK?R/?L,_%OQ7^SS_P;+?M4>*/!\\%SK-IKOB;P!)J)1V2;3?%$NF^
M$-6U&(QLKQ226-[/-'<*V5+!QSC'T)\;/^"]WQ=_X*$_ #X@_LJ_L0?L2_%K
M4?VA/B+X#\1^#?C6WB+2KJ]T#X*Z+J>GW.C^+Y)46UM&UC5)+2:]MM$EMYP+
M*]V/(LKPAZ^D_P#@BU^PIXS\6_\ !&3XQ?L@?'_X;:[\.M=\>W_Q!\,Z;IOQ
M,T"XL[NVU&;2$MO#GBR73I7$MS#9ZO#;:K X8;_*QR<T&BTB]HZQTWOK&_W6
MN_\ @Z_GI_P2._;^_;2_9"_8?^$'PS_9X_X(F?'3XY^%/[/OM0NOC]X+\0:5
M9VOQ>OKO4;J23Q'+<2Z7=W<[6T;1:2GF7!BCCL!MB21Y7?GOCSXO_P""E_[5
MO_!27]B?]M/PG_P1]_:+_9A\3_!'Q+9^&O&_B.2PLO$5EXG\/>)=;M;+5-9\
M33:=%I$?E:#H-S>Q+-=Q7,JVQ=B[JB(G=?L5?\%3?V@?^"%?@(_L!?\ !17]
MF7XD7_PV^$6LZQIGP5^/O@S3;RYTCQ!X.GO;O4#&R+;WLGB%[O4+F>_MKNS>
MU73H;DV$ZRM$K+]N_LB?\%!O^"G/_!3;_@H#\)?B=\$O@UX[_9M_X)W^#-!U
M@^,+SXD6H;0/B_I$]RWV/7-,N'MK9[[Q,UQY$%MIL MVTVPD>2<2-&[L!UOI
MVO>RZ/L]?T^1X5_P<O0VZ_MM?\$K&6VMRTWCN;S?]'@+7&?'/AE0+AC&6GC5
M4^5)BZ+EMJ@LV=K_ (.P_BGXATGX>?L8?L\:1X2A\0^#_B'\7K#X@:OX:TP+
MI]YXEUCP#J.FKI/A6WF@\N!(-?75+JQFAD1DD>:,XRB8L_\ !TAX#^)N@>-?
MV&/VMO#_ ,//$/C+X7?L^>,9+KXDZAH5C/J T&TD\3:-K$<FHPVR/+:V\UI8
MS+'>$,BSE(RN6KV;]N/PS:?\' 7_  2Q\)?M+?L;>%-2\.?%KX0?%G_A,_A?
MI/C?3+C3?%.L7'PQO8Y]<\&V$TR6\EK!XDO4TZXM9FC*W2V A!W39(2OL^5^
MO5VM_732Y#X*_P""N?\ P4=\"^"O#_@7P;_P;Q?M):%X*T'0K#1='\/Z3XAT
M2UT:VT>SLX;:UMH;+^PG22 P(@S.9I'4[Y9)G=W;YX_X(O\ @7]M_P /?\%7
M?VJ?C3X]_8)^-/[&?[._[5OAKQ-XQ\1Z#XQTB(^"?#OBO1;2W;P]I-AJUL\%
MGNNKA[V:&&VL((WEEF"JBX1=SX9_\'0^N?"#X=67PF_;$_8N^-_A_P#;"\*:
M59>&9?!VG:=<65I\3O%MFBV)O;&*33KD>&$U6:-9?)O9KHEV=U*K*JK^A_\
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M[?3?B-X:\2:/:V7Q&25IISXL,G]CS3W3:FTQ8/<7-RT<2K$NQ$$:?HY\'_\
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M_A%>R[RLMMX-\;:U=Z5K.GVSQD-%;O:32@%6!432<BOZ:?\ @JSX2\5>/O\
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M2:3XT\(VUQ--H]I;JEE=MK)NKB::[_MV%X88(KO[/+%(8 1Z!^S7\/OVL/\
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M/!&/DZL1S\R#HP&<'!&/I6?JL^HVVG74ND:?%JVHI%FUTZ:[2P2[D'W8FO9
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M:* 4[[)/T^7^7Y=M?G+_ (9S/_1=OC__ .%Y_P#<%'_#.9_Z+M\?_P#PO/\
M[@KZ-HH'=_R?AZ>7E^78^<O^&<S_ -%V^/\ _P"%Y_\ <%'_  SF?^B[?'__
M ,+S_P"X*^C:*!<_DOZM_E^7;7YR_P"&<V_Z+M\?_P#PO/\ [@I/^&=&_P"B
MZ_M ?^%X/_D&OHZB@:][7;IIIV_6WX'SD/V<W8@#XZ_'_DXY\>?X6!J=OV:G
MVY/QV^/S'<N%/CO(//4?Z#PP['GH/P^CK4%I2-N<*?IVK27D@8/7.<>G^)_E
M4S>C_+YHI1MK=Z?\-_E^!\T_LV^%9/!GQ'^-V@OXA\3>*1%)X0N!K7B[4?[6
MUR<RV-\QAGOO+BWP1<+!'L&Q2PR<U]B5X)\-HXU^+'Q?9  SV_@TN<=2+*^Q
MG^E>]UXU;^)*WE^2L_*_;_,]3#_PX_UV"BB@G'7UQ^)Z5D;&3K\I@T+6IER6
MCTF_D&#@Y2WD( /8\ @U^>@8R R/DM,1(V3R-QW[<\]SR>_I7Z%>(U!\.ZYS
MUTG4%^G^C2_K_C7YYJ-H4$]$"X/!X'7'_P!:@UAL_4?11106%%%% !1_(\'Z
M=Z** -SPRS1^)=!96(VZS8QD XRCS("N>V>_7.<8K]!3U/U-?GQX;Y\2:".[
M:WIY4>H$R$D>P')K]!G(!;)Q@\^V>GYT&=3I\_T"BBB@S"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!GN<
M_ABEI"<#H3]*F2LG-64TK*][--JZ=M5Y-!K=)*_7LU:SO?33NMGV$(#8SR.H
MQUR,\J>QKXY_; _8J^%/[8?A32K#QC_:?A+Q_P"#+U=;^%_Q;\(W)TGQSX \
M1P#=:WVEZM %GDLFE2+[=IDQ:VO8E\I]F2U?8^!QQTZ?Y]Z:1N#!AQ@C!'#?
MR'^>M=6"QN)R[$T,5@<34PN(IZPJ1U;YK*<&[.\)1?+.$DZ<XMQE%Q;./&8/
M#9CAJV$QN'AB*-1I5(OW;;>SJ1::DJD;MQJ1:J1EK%JR/Q3T7XZ?\%"/V(;R
M'P=^T3\*=8_:_P#@?IUQ]ET?]H/X16:S?$RP\/6EN'^W>/O 4;&2^U(LS0R7
M-O=IYH@$F2&:OH;X?_\ !6_]A'QQ8-<ZC\8X?AI?PRR6]WH'Q2T75?!VMV$T
M1(DBO;2ZMIHH2"" 3<%2> :_2/&0RE2R.I1HW&Z(C&"I0C!5E.#D$-T/6O+O
M%7P-^#GCF"X@\8?"[P'X@ANL&Z&H>%M'EEN"IW*))/LGGL0WS!O,YQ@\U[_]
MJY!F$H3S/*:F&Q/O?6,;DU6-&=:4FGSSP6)A/"PGO>.&>'IR_P"?=VV>%'+,
M\R_W,JS2.*HKD5'!9O3E*E1@DERQQ5%?69I.UO;.I**25]CYHU3_ (*;?L$:
M5 \LO[47PONV1 _V?3-4N=1NV5D#KLM[.TG?++T)VCH,@U\O>(/^"J'B3XO,
MOAO]A#]F+XK?'_Q!=ZE<Z-+X[\4:+<_#[X2^']T,D-OX@G\2ZDDQU:PM[SR9
M);:*W@::W#;9!GC]!_"G[)/[,G@FYDOO"GP)^&>C7<VXO/!X5TN20^8VYL_:
M;>< [CG ''; ''N^FZ5I>C0+9Z1IEAI5FJJ!;:996UA!D @$16L448"]  N>
M>N.*I8OA3!U83PN69EF;LYQAG.)IT*"J=)2I9?%5*O)\24L1"+DK24HW33PG
M%6,C.GC<RR[+'+E2J9/1G7K<FG/%RS!.,+VMS0AS*[U31^3GP&_X)Y>.O%_Q
M*TK]IO\ X*"?$.S^._QHTB&&?P+\.;"W:W^#7P9N9LS7B>'-!9GMM8U,W(CD
MBUBY4-%MPB-N./UO2/8-H"HBJJ)&% 6-%X"JHP H'    %+MR"3D[6R,@,23
MD9 '4KG@\\<T\#@>W09SCM@GOC->3F>;X_-Z\*F,J)TZ,%2PU"E&%'"8>G'E
M:I8?#TU&G2CHG+W>><KRJ3E-N1[&6Y7A,IH.&$I6J5I)XFO5DZV*KROK4KUY
MWE.3N^57Y8+W81C!*(U5V[OF)R=W)R03UY]/08XQ3Z*;SWZ G\1V[_ICM7E?
M&H>TDXU)MV4=ERZV?9:=>KZ'HI)<\8JU.'+WUD^5_P#!O^2'44450S\V?^"N
MOQ.\3_"+_@GK^T9XS\(M*FM1>%K?1D>$,9!9^(M2M=$U #;R ]E>SJY'W4+'
ML*YK_@CA\*/"'PJ_8%^"-KX8MM-^T>(=)NM?\0:S;)"][JFH:E=RW#"_O0OF
MW#V:NMI&DC$111!-N=Q/W!^T9\&M#_:!^!_Q.^#^OP6T]GX[\):OHT!NT\RW
MM=5ELYO['OI$ZLMCJ7V:[*Y!/DXSS7\SG[+7_!0+XO\ _!)?P?+^QQ^V=\"/
M&VI^'_!.J:M:?!KXI>&=-NI[+QO:7=Y-/#I898;G^T9;N]E!MK^/RDL+=TM9
MED,:E?U'A_"5\_X#S3(<HJ4GFU#B+!9K7P4L5A\+/%Y>L#4H<\7B:M*G6^K8
MAQ<J7-=*I[2,6TF?F&?XO"Y#QOEN=YO'$?V;B,EQ67X?%4L+5Q,,+C?K-*K[
M)JA3J5*3Q%)2_>-*-H<KDKGM/[7_ ,)O!W@'_@NS^P+XX\,Z=:Z=J_Q6CUO4
MO%26D<=O!<77AC2+_2K"Z>&)4199;>1S+)C?*Y\QB<UX-_P4T^)_Q!M?^"PW
MPCCTCX)^(OVFV^"?@CPUXL\"?!/0KZ&WGU/4=;L+B?4KL1W,<EO+#%<!+B2"
M2*3S)8D8J5!4U/"<W[9W[57_  54_8U_:Y^)'[/?Q#^'_P 'M3UG64\#Z/J&
MG27,?PZ\*Z5H^H6,VI^+;I%1-+/BFYFM[ZQ,RXO4D$L87&*^U_\ @J[^S!^T
M%X-_:&^"'_!17]E+P?/\0/B#\'[F"#XA>!+**>[U3Q/H=C$UO8?9K"!XY+RR
MM]-EO8KJ%6PL[0SMQ&17Z)@L52RCB3AK 9SC,NS/,)>'=?(\/[3'1AA:>9U9
MU88; 8C,<+6C+#NE&,\++%4J\)QDTXU(N7,?G6)PU3-L@S_'95ALQRW+8<:T
M,[K2H8*+Q%7+H1E*MBJ6!KT^3$<\IPJ_5ZE-J23YXJQF>-O^"CW[;WQ"\(:_
MX%\5?\$7/C=K7AKQ#H]WHFH:1J>L:7<V$UG>6LEL8S:G3=NR+<&586BD7:/+
M>-@K@_X(\?#3X^_!_P#8Q_:4^%OQU^"_C/X3Z9::_P"/_&?@S1OB#HRP7#VW
MBBTO;JZM[%+J6Y2:UTU(K:WM]B1I'M#1JK-FN.\0?\' L_C'PC/X"^"7[+'Q
M8U;]J74[.72K?X<W.G7%[%X8UZ1# ]W=.EG#'J\>G7!\Q[.W>)F(4,[*K _I
MG^POX=_:\U_]C*]L?VRM6-Y\9_&<'C*ZT^.Y"R:OHGAS7;1GT'2=>2)8U74K
M,NT,MMMWPHL<3$M7SV=/&9!P]/!XOAC(>%\-CL^RBLX4,ZQN9YE7J8&K.HL5
MAJ%;,L=1HT*,)N%>LXTI55."3J<J2^AR*&$SOB"GCZ/$F=\28K!9+F=-3KY)
MA<LP6'HXNE3I_5L54IX7#5*]2;BG1A^\C2?-\'.[_#W_  0">*Q_8C^,^KPV
MUO)>Z=^T1\;9[>5X(C=J8'@D2!I?+$JH, +$'V*I(4 ,V?RU_P"":W[4O[0/
MP0U/]IGX@?"G_@G[\1/VO/&7CCXY^-+3Q+\</"VJVT5UI]KIVMW;V'@.\GO;
M:YD0Z.'^TJ\1C)CFB1MRQ(%^J?\ @BA^U9HGP&\3^.?^">?QD^'?CCP?\5_%
M_P 8?BOXQTVYU?1+RTL);+4[P1PZ?J43P[;62ZMX5G@F:?9/'<(0#P1E>$_%
M?[2/_!$K]H7XX:7K'PA\=?&/]B?XK>*=0^(FD>(O"4?G6'@;4]>U![O6-8U*
M9()FM]6)8V<VEN'DGM+6WDC9"RL/K,0H3XA\2\JGEV79UCN(\1E.9Y-A,?FE
M7 T<VP&&JU*M54,;@L7AXNK%3A4CAJN(A&I+XJ;Y=/EL/*3R7P]S.CF.-RC!
M</TLYR_.<7@LKCBZV6X[%6C1]I@\5AJK<7)2O7A1FZ<8MPG&3TX#_@H=\:/V
M[/V[/A+I7@^/_@E!\?/ASX_\&^);'Q=X#^)EO/::UJWA?6;$ -+9V]O!:32-
M-&JI&7E*Q,$E50RU[U_P73TSQ!=_\$_/V*M(\;17T'BN\\5_#C3?%\.JC_B9
MP:[/\/K6WUY-2!)(OXK][E+U<D^>)$SGDV?%?_!5/]K;]O+QU\//AC_P3B^$
MGC7P3H3^*K2X\;?''QEI,L_AFRT >6MQ%J-G+;P/I\=M^\N'C=W;40GV6)HV
M8&O=_P#@NE\(_C-\3?V9/V;/#_A#P7XF^+?C+0/B_P"%[_QB_@709[LE[70!
M#JWB'^SXY&>PTJ>_\R5$=W$*R)"68C->=1Q6)RS/_#C*LQRG(N&:&79SCL?'
M+L#FN+Q^*PL<3"G&<\?B<5C<93H4JLJ:J4*4,0GK4DX)R/5J8&CF.2\=9CA<
MTSGB:IC\MP.#=?%Y91P.'KRHUJ<[X.A0H4)U:O(^6K4E2U4$N:77]B?V<= T
M[P[^SM\%=$TVVM(K#2OA3X+M[=8+:&&-7B\-V2?:41$54D?+,SJ [L[%V+$D
M_@__ ,$3/AKX7U;]K#_@I;\6K^PAN?&/A?X_WO@C1K^:*.6:ST?6WO-7OE@=
MT8P^;=6<+L8RCMR-^TL*_H'^#=E>:;\&?AKI^H6TUG?6/PY\+6EY97,1BN;6
MZ@T*TBFMYXCDQS0RJ8Y$/*.I%?CE_P $:_A=\3?AQ\5_^"E-_P#$+P!XJ\$V
MGC3]INUU[P?=^)=)FTV#Q1HG]GZLG]JZ))+Q?6&]XU\^+Y<R(.2>/@,LS"5'
MAWQ2Y<4J5?&U<JHT_P![#GQ=&>>RE724GS58ND[U.6_N>])I-,^XS'+G5SWP
MP4\*ZF'P:QU6:=!N&%K0R2G"FY24;491G%<O,XOG5E?IX7_P5<^&7@GXB_\
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MZXK]3/V./A_X/\)_L,?!7PQH'A[2M,T35?@+X=U+4]/L[*&*VO[SQ#X/@O\
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M/#^I7EW?R6=AJVJ(1%9W5TCHT,3@^8K@@\UX=^W!\+_VH/V)_P!O^+_@HO\
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M''0Y]7\*6VOZ3XCB-C=Q:7J,>IZ+,\UB$U$PRR);&1R9H4PLX"JP &:_"?\
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M %%%% !1110 4444 %'/;KVSZ]J*4'!'^<9XS^% '\]G[</B?_A?O[<GP^\
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MAQZ4=\]]NW\/3W^IY]Z $+N58?*%)V_>^?![GT/X<'IFA254*N6&2%RIR?\
M:)Z$>F1]>E+Z<#@8Z=OZ_C28'3\>I'^?I0 JDC.?E8<MD9+=LGI\HYR1T '-
M-R6PQ()8;,]%Q_>3.,'D\Y_"AB%&2-V.W))]A[GWXZYHW\J%8,S#)&-P4#M\
MO RQ(/?CB@#FM>\'>#_%36S>*O"/AGQ*]JKI9-XAT+2];> $EBL,VHVMP( Y
MR2B;<GD]:V[6UM-,M(+'3K2TT[3[6-8K6SM((;6SM(5^[#%:0)''#'DG:L:*
M@.,#%6?FSL&W=CYHUQE7P3EN2 K+C!ZGM3MO !4# Z'!Y(^;CGCTR2?I0!_,
M!_P4%^!G_!5/]CK]M[QE_P %#O\ @G])??'[X/\ Q"\*Z2WQ[_9HUWQ#<7T!
MO?#UE#H=K+X(\&M,UY>7CZ?&NH0C0/LDB:FWFW&Y0P/P#\:?BM_P6Y_X+A^"
M-<_9$A_9 NOV-_V<_$MUHL7QR\5?%+3M2\%^(M7\*M?P3R66C_V\[QZ]:0O'
M%?RZ5I21WSW=I S2,D0 _M^Z'<.#C;D>@QQ^@H.3P<D>AY'Y'CZ>G:@I2LMM
M;OY:'AG[-'P1T?\ 9M^ /PB^ N@WAOM*^%/@+PYX,CU9HEMY=6GT33H+*XU%
MX>=K:A/')<-R2-^"Q()/J&N^$?"7BL0CQ3X6\->)/LNX6W_"0:)IFLFVRV2(
M&U&VN GS<GR]N6.>:Z(    <#.,\]?KG_P"MVI>P&!@'(X'7^OXT$E*PL+'2
MK.'3]*L++2;"V3RX+&PMH+6QMD))"PVUHD4$*L68D)&!G'?.;O\ "8QNV#"D
M[3NP>=P/3'N03B@<=./P_GZ_C1VQSC&.IZ'M0 @;DLN2"NP8&Y=WJ<?AN[G\
M.%W.#U7<1R54D?0KG.X^O&>!BD(R .P.>..0,=L=J4?*,#@9S_GO0 F[+ G*
M@$\_\M&YZA><(<8/'0?B.4UGP-X'\0ZA'J>O>"?"6NZK$$\G4M9\.:/JE\$A
M*^6([V\LYKB,PX'EJLGRE1M QBNLQ_AGO@^_7N:#SP?4'\1Z>G3G'7OF@!J!
M%14C54CC58XT0*J(B *JJB *BJ  $  4  #BG4?YX&/Y44 %%%% !1110 44
M44 %%%% !1110 U@3C !Y^92#AD_B /9NFWU-4KFSM=0BEL;VTMK^TE(6:VO
MH8KNVD7<"!/:S(T;;2!@LI.0,GO5_P#H0?Q'0TF!Z?X_B>I_$T#3MTWTU/CO
M]IW]BGX,?M,>!-0\,:MX;TOPKXFC19?#7CCPSI]II6L:#J-N?-M9UFLXH3<6
M9FPM[$<RM -L3QG!'YEWG[#G_!1O0M/N?!/AWXU>$M7TC3+-AHOC68I9Z[.M
MG%BQTWRKD,85F"1P&>X5_*SYDA.#7[\8![=L?AZ?X^O>D**>W\_U]?QS50E*
M+O'1]=;:?\/I\SCQ."P>*C;%485(K:,XJ2O_ '5TD]=4T_/M_-:/BI^VCX!2
M3X>^,OV2O'WB[Q_I3PZ>/%GABPDO_!NH7H'EV]]=:A%&8KF)V"RWD\++"<N5
M S7T-\"?^"5\OQ0DUKXQ?MHW5]<_$+QEJ%K?1^!O#6JB+1=)T&%!Y&C:TT*$
MZ@S*RKY 93:Q!HI"9 2/W-)QCEO08+8_(<=O\BDVC.[')[\_Y_&MI5ZTU;FV
MTW7=?KZWOU.7 9+EV73J3PF&5-U7>\VI[V>B=[;KITT.)\ ?#OP3\+/"FF>"
M?A]X7TOPIX6TJ,066D:3;B"V1 .KGF229L9>29W?/&<8KMQTXR?<@@G''.>_
MKVI2,G=WZ=_Y=/TI22>M<YZHE%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110-.S3[,^9OB4<?'OX.'_J%>
M,/\ TV"O4:\O^)/_ "7OX-YZ?V7XPS_X+!7H\EU;Q$I+/$C=0OF*9,8Z,A.0
M?J/?M7L8!)TU:#>G9;:-+\WIZGC8R<:=5SE+DOI>6BU2_3U+-%9;ZUI:=;G/
M;B-CSUYQQ[<5'_;VE_\ /PWU\MO\\5VJE-]+>7W=_P /^'MPNOAXNTIQFW:7
M-?O;3I]WFC8HK&_M_2^\[?7RVI&\0:;_  S'CJ?+?G_/TI^PGY/Y^G_#?U8A
MXK#)7YU#SCOK;SO;T]#:HK!/B'3O^>K'_=C8'_QX8I/^$BT[^_+_ -\#_"E[
M&?9?>+Z[A?\ H)ET?5]G_7IZ&_16)_PD&G]F?_ODFE&OZ;_%,RGT*-^? I^Q
ME_7_  _K_3T/KF'_ )_ZT_S_  9M45C?V_I?_/=OPC;^N/YT?V_I?_/=OQC;
M^F:7LI7M_7G_ %\NI<<30DKJI%=-79].GS.CM?OM_N_U%:2\;?7!'_CP_P 3
M7-Z?JEC-*1%< @H3^\&T]1@@<<<'C/\ 6MJ*Y@E.R.;,@ ?;P01P3M^O7C]0
M:YJD))W::7;[O\^GS.J%:DTDII[*RUOJOOTU_$\[^&__ "5;XO?]>_@W_P!(
M[ZO>J\%^&_\ R5;XOG_IW\&8'L;*^Y__ %^M>]5Y-?\ B2_Q/_TF)[='2G&4
M/ALM?N[A2$9Z@XZ''& >I'N,<4M!R1Z#()/?(^Z ,\Y/4>E8E'@GQR\0WFG6
M6G:-83/;O?&26Z93MWVBJ4$9QSEW!!'0C-?+)SU(RV ./Y=QQZU].?'ZQ#V&
MAZ@L<GFQW,T%PZK\D<!B+)N.. TF<<GK]:^9 ,<"@TI]?Z_X/]>H4444&@44
M44 %&<!O<$?GZ>]%* 2>,9'(STR!]10 J,R2*\4IB9'2>&8<212QXY4CD=,\
M5]G?";Q%=>(O"<$M^S2W=C<-8S3'EI@0'20DY.0I&?H3TKXP(+%2%+')+8X"
M^^.G/XU]C_!G3S9>";:XP=^HSRW(1ARH4F+</7(!Q^':@SJ=/G^AZN,_E@ ?
M3C/XXI:, =.5XQZ<#!Q^-%!F%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ,5FEQNDSDDREF[FNF)9V()PQ^4-T"J>I5N T@P >?ITI=P.6(/R@D@9.1W
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M-NSGGL I"\_WLY.>/48%(3DE>V/O1@D$'@J3SSZ>E+_=_P!GI[9_SWH' ('
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M>_7'I_3M1=]_N>GJO\P*]U!#=PW%K=0QW%M<)LFMKF!)[>6(C:Z/"ZLDJ/\
MQHZLI[C%9&D>%O#7APS?\(_X;T#0C<@FX.CZ3IVEF=P<@3_8+>W,N"?^6F_G
MKU-;XX  S@=.I_7K3 %Z;3^(/MW]>.OZU2J2A%KVLH0>K@MI=WWO;3T)=&$Y
M*HZ,*DHV2<K7BD[^[?3K?4<I) /L.V/T[4M']?UHJ(V=W3<7'[=_CV5MU?[^
MVFI;]ZS<9PY=E]GIV_X;8****8@HHHH **** "BBB@ HHHH **** "BBB@ H
M(R",D>XX(^GO11ZT!>VO;4^3_P!J7]D'X4?M:>&;'1/B'97.GZYH$CW/A;QI
MH,@L?$WA^Y?AA;Z@@\Q[&4@&:W+;?O-%Y;DL?Q<_:?\ V;/V@OV(?"OA+XIV
M?[17B3QQ\/\ 2?%^EZ3K&DW&EO(FD^'KB6.(#4[A_.:ZBN0?LQ&5D9SE7]/Z
M4EX P21CC/I_,CV/]:Y+QQX)\*?$;PIK7@CQOH=GXB\+>(K-[#5M(OH1-;W$
M,H(*L3S%(AP\,Z%9(G 9&!'&M.M.-NW567E_E?U.3%8+#8VC*&(A1J\R:C.5
M*+<6VK-7C?3\;>I^4?AW7],\4:%I'B+1-0L]1TW5K&VO+:[TZ6.2%TFB229/
M*+,ZO"6*-"WS1[2&Y%;0.[A2BE06XY,Z$D98<A0IZY Y':OBS]KO]D>#]@>Y
M^'OQK^"7BCXA3_#RX\<IIOCOPM?W4^JZ#X1\.W6US/!%&"D%FT;-:Q>8-[2[
M%+L[BOJ/PU\0_ OC'3[+5O#'BO0M2M=4A2YL5M]0MVF,,BB3R9K42&>W:/(\
MY)!N5U*]17IT:L9P4I6YNO5Z=>ORV]#\7XBX<Q.4XJE-1J8C"59RE&I3B^6+
MOI%Q2T<;=5\[&;KUO\49-9N)_"^I^$+;1(+5/(M-<TN\O-0N[X*&"?:+::.)
M+5G 0';@ Y.17'? _2?%VEZ7XC;XAZ*NG^.;GQ+JFIWVH17<.HP:CIM[<>9I
M4&G7,0_=66GP9BCLVR]NK%9"3@U[B"K("K)(I42HV?E9S\N0PQ^Y.<H0>F*,
M*.,%<;2=KJY!]$ ZISAQC.>O'7H/%EB)>QG0A&,93]]SM:;DM%3E=)I23;>O
M0=TW+N;@AP&'WMW5@W7;GH.V>F,4?XY_S_G]*Y6U\9^%[K7IO"JZY8IXDM T
MAT>YE$.H2PXR\MM;NPDNH ,$S0@QJ?J*X/XR_'7P1\#M'M-4\5RW-UJ.L&:+
MP]X:TN)IM8UV]08CM[6)=VP;RH\UU* <$Y:I;@GK9/S7]>1G0P>)Q%2A2HT)
M_6VM+1]VS:L]/31WZ+Y]#\3_ (H>$OA3X0UOQ5XJU>ST]K*PNI;&QN+F*.\U
M>]$3K%:Z;"QW3R2,0H$:DJ1GOFNQ_P""27P'MO#GPIUSX_\ BSPO%#\0?BYX
MCUC5]"U_5XY9-?M? US<R2:?8F:[9Y+>)I3,66/8[QJJ,QCPI\7_ &.OV(+[
M]HKQ)J_[3?[6_A/4ULM9U-+_ .&'PGUFYNHM.T[38&9[;4M2TQW5K?<JQ-!
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MQ7/@+QAX M->U>[M+RVT 0W.OQ7&H7MU<:C=:9XE@U'3X[[2[B:2S\RS#1H
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M[4UUI^MKDL1J]GX3TZ#406.2Q%TDO)R3U/)H!Q7+=7^?_;K_ %_K0_K77Y0
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MZ9?:B]M9:G<,Y"PV]C//-.?]2C@U]T;V) 4!@1G<#QCMSWR.<C@ $_3^)?\
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M?7_$.I6>C:+I5C"/WU[J>J:C-;V6GVD.5\RXNIXHD!!9P*^8OC+^W=^Q_P#
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MRO"5<575&G[2;C32M&,%>4G.4HI66VNR9]MPGD?$_&>=93D&38*%;'9QC*.
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M>SK+\GP^9X_(L?FV05,#CL74H2^JP2JX?&UJE"-2E*FIQ?/2A/5:*VJ^C_\
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MV7]@C4[\1*\^G>-='U"W61491=622SP2,#E<"6-&;')&<\$U^1<,91#B3/\
M*\E]L\-_:684<!]85)3J4G4E&'/&#<>9>5TNQ^N<1YQ_J_DF8YO['V[RW!5<
M9*@Y.,:D::4N53LVFT[K1WV/TK^+?[;'[+'P,O-*T[XG?&OP-X=U'61;R6%@
M-9M=0O'M[O:;6[FMK"2>:WM+E6$D%S.B12QYD1B@+#WGP7X]\%?$?P_8^*_
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MV?A?QK;X,?AS2;;54AGM$LK<W$6IW,$,?]J3F"XGWM&",_\ :%_9KT_]K/\
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MBJ!A4 &-JKT"C@  =J4@\8..N>!W_(?I2T5@TI.[UM\NW;T/26Z>[6U]?+]
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MP_:%5AO 0$?+FOH>FC@C;\S"3YP3C:C'.['\6, KGOCVP ?Q!^ OV'W\1?\
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M_)]^:][-HVIMM/FM>_V;KEV]=/Q/ELAJ..(PR<&TY-<R6CO9*_\ 5K;>6O\
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M\\2J8Z\Y_P""V_[<WP-^.OBK]F_]GSX.>*['XAZGX)^/'A?Q5XZ\0^'FDN-
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M5[:KRL7PWC\4^"$IT53X>;68KF;E4@\I6!MAGR[>U=VY<G[O7>Z/Y>?^"?\
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M#6?&G@VWT;3]:U&RTRXU*6!YS-;V*WDT)N[A!-&QM;?S)560,(^<U=\7'/\
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M?76OZ[=0*\%MI\L<#V<2>:9VN)E#1JJDF]^W-^UW^S)JO[3_ (B_8V_X*,_
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M5*4^:37-?DE:Q^+?Q._X)U?\$@OVH/A/<_'O0O$O@OX3?\))X1'B.3Q#X/\
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MD\ ==I4$G![=0#ANY[8_"FM-M.@UIY^HZBD^8;SM.%/?CY>I88ZD>G3KSD4
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M_6@".BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HYSR<CZ<^PZXZ>]%%
M!1110 48SU&?PHHH *RM;T32/$FCZIX?\0Z98:YH>M6,^F:KI&J6L-YINHZ?
M=QM#=VEY9SH\-Q!/"[I)'(I#*Q''6M6B@#\Z9/\ @D7_ ,$Q);B:YE_83_9I
M>:>62>6;_A6>@B22:1S([L?L_+O(2[,,9)/![_>OAGPOX?\ !WAS1O"?A70]
M)\->&_#VGVNDZ'H&B6,&G:5I.F6,<<-G8V-I;(D,$$$42*JH@!VG/).>AHH
M3+G[S9]1C I?PHHH **** "CN#CI[444 '.2=QQZ ?IUZ?G1110 AW=F./3'
M _6EHHH **** "CGL<'UHHH .>QQ[XSBC]??U]Z** "BBB@ HHHH *.>U%%
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M45$Y.T )&2QWLQ"@!'.2S, <GK[+D8+@,0<8 SD_[B\8!^]G.3C-?S:^#_\
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M2Q>&C"=7 9A0>&QL*=6RC4=*3;</.+=GO:Z/5:***^9/J+I[-!1110,****
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M?&/]BM/#877@.T,('BC5+U4_XF-A9LKZ?)+#O=T9G3XF_92\._$?XS_L]?\
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M2QU"?X@6_D'_ (1[5-+$LCZ=I=UB359XML;QQA68 ]&_X*'?\%7/V@?^%/\
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M+R)%P"D%QD*J%1U<,=W/?GW;0?B[X0U=46XN7TF=OOPWPQ%G@@"[R(WQR?E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\,? 6PM]/_L:ZL=4CCU"RLY=;ELV3PZOD7(ABLKI)Y;-8_+G?> S?:G_  3
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MO[)^+TNDRVOASQ]I,UV;-+)=4(6UUKQ!#(KW\MU8QPP_V>\2&)G4M7Y=V_\
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MDC&3GOZ>E(%  5?E )) _BS_ 'LYSZT >6W/P0^$=YXC\!^+[WX=^$[GQ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA+]FO5-7OO%/AS5+:^EUK7TU&.58TT6>VQ:0F,R*9/MG& =E?J+158WC?/\
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ME]9HY@]L92K_ !1KIW=]FV^:Z;/Y>/%/[*__  6F_;KT9O@S^TYXN\$?L_\
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M*X9RG&9E_:M:C+ZW/ ULNQ,HRY8XS"5ERRI8E;SY;MPDFI0;NFG9K^6CX?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGB.Z'VKQ9X^\33YEU;Q;XNUV4->ZSK>KWTD]U<7%S*_E"7RH0J+R ?E#H?\
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MG VGC'' YQWH ^7?V1_VQ?@/^VU\*++XN_ /QA!XBT1;AM)\3^'KR-]-\7^
M?%%LO_$R\*>-?#]R(]2T/6]-E\R&6WO(46;RVD@>5%8K]2#_ #FOP"_;Q_90
M^)?[&/Q1\1?\%2?^"?EE;Z5XOTE;;4OVQ/V:;.W:'P/^TE\.+293KWBC3]'L
M$\FP^+6A6+R7>GZS:VXGU)8G\^3S5+-^Q/[-G[0OP\_:I^"'PY^/OPJU!=2\
M$?$GP_9ZYIP::"2^TN:92+W1M7C@DD6UU32;I9+._M7*S0S1X>-010![I11Z
M_4C\N_IS[$T4 % *YP<XY);/'3&#Z$=>,XZFBHB 7Z\X8%><8QU8=\D^A&.G
M(Y!KS_K\SXW_ &Y?VZ?@3_P3Y^!NL_'?X_:[<V/A^VF73/#OA_2XXY]?\:>(
M6C,\&@^'8962.6_DMTEFD\^2**.&.1RY("M_/)IG_!?_ /X*5_&S3=7^*7[*
M7_!)?Q!X[_9_TR0R)XM\=ZUXG\,>)Y+#RFNA=PZ,EFB:A')9KYT,^FI/;S@J
M8I&5UST'_!TY\+?BAJ?PT_9$^/VF>$]9^(_P._9_^.OASQ;\9O FCZ?<ZL5T
M:SU&WO;G6K[2K=)#<:9>Z=;3:%<YC=<7:+/L@9G'Z8?LA_\ !<S_ ():_M&>
M%OAUX?\  /[0?@'X6^*]8L+31M*^"/B]1X8\1>%A81I:6NB/!!:'P_96=O%%
M'%9*E_#$(45?*@ " *LFKJ[U^[[D_O\ U,'_ ()H_P#!;KX%_P#!07QIKOP(
MU_P/XX_9V_:A\(Z+!K&L?![XGZ9)H5SKMJJE-0U'P5_:"P:AJ%A;RD"-+^VA
MNKA,SVR30H[C]LPV -W"A1N9\J223C&T=<=<_ETK\K?B7_P3-_9A_:(_;C^!
MO_!2#POXQFTWXP?!N>&*ZU3P!JNF:KX>^(EOIMC+I^DV'BFXL+N2&:+3+.YF
MB1 92ZR*9%!4$\'_ ,%>/^"K>F?\$W/ W@+P_P""/ 5S\8?VG/CQJEWH'P/^
M%-J;EUU>\B>&"[U2^6S26Z,-A<75OY-M'$WVEMP)6..2@.6]FKOOMH].OIV6
MY^Q^X'(R P'S<9/.=I1>F3WSS6%XGUR/PQX;\0>(Y8FN8] T;4=7GMT/[R>+
M3;26[>*(DX6:18RBYQ\[+UYK^07Q=^U7_P '//[/G@'1OVN/BO\ "7X.?$?X
M/6_VOQ+XX_9N\+^!]$T_XF^"?"%JIN[V7Q-K&GO)J$<6G6*2R/-IGVN^?8I:
M $/7[Z?LB?MW_"K_ (*+?L):O^TC\+2^GQZEX0\9>'?''A:Y\UKSP-X_T71)
M/^$A\*ZB98H_-NM+DG@?S0IW131[OGW* 3B_79::_P"6Y+_P30_X*+^$/^"E
M/P?^(/Q>\%>!M?\ A]8> /C)XQ^#MYIGB&6WGN[J^\(2017&JQ?9GDC6VNVN
M%\I'(D0!A(JD5^C^<$C<H/\ %@YW'&%4 \+G@\8YK^57_@V&\9>%?AO_ ,$]
M_P!L'Q_XZURT\->#/!G[8?[1'BKQ7XCOO-6QT;P_HRVFH:KJUZ8$FE^SV5E;
M37$YCBDD6*/(0E0*\KTC_@J)_P %C?\ @J!\3_%]S_P2>^%WP[^#W[+/@WQ!
MKGAS1?V@_C7X8L_$6A?$*XT<;HYXXM559;675HF@N-+&EV]Q:FUNK4W,R7!D
M4 <K[;>G4_K[9@.!S@_, QW*P&><\A<=,=6'?LN[MN&2OF!FXX[@K]T;1_"3
MGO7\T/\ P3N_X*_?M4']K:R_X)S?\%1?@S8_";]I37=+OKWX8?$+1K2'2]!^
M*BZ<7N9[F/2X'.EZ?I=Q8Q_:-)NK&>5IY94M9HEF?Y/J/_@L1_P5PN/^"<NC
M?"_X8?"+X<-\:OVL?V@+R6T^$_PPB^VN'LI+PZ*OB&>*SAFDN?*UNXM;*"S;
M;"\K;[EDMP[T!ROMY]#]NPZD+@D@D@/@A2P/\1X*@^W'I7S;^UE^U?\ !W]B
MWX%>-OVA/CIKCZ!X"\$6;3W<UO%-=7>I7Y21K+1]-AC5B]_?R1^5;^;M@SS)
M(M?RN?$C]MO_ (.4_P!B_P"'>E?MB_M.?"[X/?$K]GO3(3XC^*?P=\+>"?#^
MC>-_AGX16\MXKF7Q7K&DSS7L4UK'<I"CZ3]L>6;:\RK'O8<U_P %Y?V\/BE^
MV!_P2\^ GQ3_ &;_ (6OXE_9*^.^B:CK?Q^^(+3P-=_!KQGHCV,&B^$=21WC
ME:YENI]5AE-O%*A^S*692< !1;VM]Z]>_P#6V[1_7A^SC\<O#O[3'P(^%'Q^
M\(Z9JVB^%OB_X+TCQUH.F:ZD$6KV&DZS!]IM(]26"22)+AHBK.D3NJ[@,YK;
M^-7Q,7X.?"#XC_%A] U;Q6GP]\'ZWXL;P[H-K-=ZSK@T:SDNSIFF65NDDUQ>
MW8C\JVABC>261@ I. ?P_P#^#>+XP_MJ?$;]DW1_!W[3'P!_X5-\(/AK\-_A
M3HW[,GCLS64I^+W@FYT>^>\\1>5;W,TL(A2'3@J7,<+,MP'53DX_H0* E3DC
M:!C!Y)'0DG.['8$$ 4"::/Y+9O\ @Z=TFWAGN;G_ ()T_MAVUI:M(T]W<_#+
MQ1!;0Q0R.)KF6:72$2*%(T,C/(415^9FV],?0?\ @["\ >*[>XO/"'[!_P"U
M#XPTZTN);*ZO/"7@_4_$MM;7T05IK.YNM%L;VWMKN(,#+:3R1W40*[XAD5_4
M-^T9))'^S_\ &I@P+K\+?'&&*(PR?#M^N=K*5S@G''!Y&" 1_.!_P:7,Y_8J
M_:A&[YO^&U?BLVXA<EGLM$R"3S@D  9(7/R@9-!:4>6]MK=7Y?Y]F?K+_P $
MQO\ @I%#_P %(? 7Q&\<6_P%^*OP$/P\\6V_A7^QOBKX=U3PY?:ZUSIZZ@-0
MTN'5+2SDN;2,/Y,LD2.B2!E+9&!\A?M_?\%__P!GO]D'XJWW[-?P>\ ^-OVL
M/VDK&$1:OX(^$VG7'B'1O!>KS,$M=.\77VDI<WL+O*5%T;*&9+$;X[N:&9'B
M'Z&?\%,OVFK;]D']AG]HSX]S3SVE]X6^'VLZ=X=OK9C%<:7XG\4VS^'/#VIP
MO& RRZ?K6HVEZC9SN@49 )-?B[_P:Y_LC>%?"W[',W[;WC2RM/%7[0/[4WBK
MQ/XBUKQUK-E#<^)=*T^UUF^T[4=.LM3F$EQ%;:YJ\%UK%V$=3+),%;Y,JP&F
MLFE96]7>SNV]?PZN_GY%J/\ P<3?MR_LYZKX>\3?MY?\$N/%?PB^"/B:%+VS
M\9_#K4/$?BO5[;2)I8XH]2U6*]METC1X8Q*C2C5+NT.3L7#%17]+G[*'[6'P
M._;3^#'A?X[?L_>-++QEX!\3PLB30YCU'1=5M_DU/0-;LW_?6>IZ;<A[:X#
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MB4_X.G-$C=&O/^"<?[:,=F'S/)%\+/%!E2W'WG57T=0&VY(9CM4<O@<UD?\
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M%A)"+4ZL]C-F56=!S0"3?WV/Z_=RDX9LA2N6Y3#,/E P.<]R1U/UI=Q&W?\
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MMOVPO@IHFE>+)=7'@?5-$MO$*LEG<>'_ !I!8ZA:W=Q'\Q67^S[U)%0YVR$
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M15)8"OZJOCQ_P50^-GPL_P""RO[/W_!.S2O!GA6X^&/Q5\)^#M<U[Q%=[O\
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M=?\ [(,T2Z)\2]!O(%G&IZ9%&[6MKK$MJXU1=*TR2[M$TG_2#+%*K1-\V?\
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MWIFHZ+K-K;ZII&KV-QIFHZ?<PI<6]]9:A"]O=6LT$@:.2&:%GC*."I!/'.*
M4];M_+ITO_P/S[_C]_P0X^-G[&_QT_8B\)>-/V/_ (0>%/@;86=P-!^+'PZT
M*WM?[9T?XAZ9:P1ZE+K>IJJ:EX@>^+">#6-1CC-P3/%&H%NP'YD_\% _^"1O
M[<6E?MN?$+]OC_@D]^T?H?@WXG_$RV;6/CU\,M8\6-8?VOJFD:?&NG16EO81
MW:ZM;ZL;1;:#0]5-C;QW3/)',S28JA^R3_P3>_;6_P""6'_!6'QSX@_9@\%R
M_$3_ ()[_M$:LD_C'2KC7#%>^ K+6[N::WNIS(@6^O\ P5J-Q?WX*01-?V5[
M#;,0L2UF_M3_ +)__!5+_@G=_P %%_C-^WY^P#X0'[3OP6_:)N='N_BC\"8K
MBZU'Q):0V#Q/=>%= T&XO!#81>9%+?:=XDM)$\FXNF26V;:4H'=7TWMI=/=V
MT;W_ $U\M?G+PO\ \%G_ /@HO^R=\3_@YX4_X+.?L.:/=^#]=\>V&G?#[XWW
MG@_2O"<W@B]4C3M4\3:';VW]M6NJR"S<2WMRTVFW9BA217PSHW]LGA_7=+\4
M:!H?B?0[I;[1?$>C:9KVCWJ?<N]+U>R@U#3[E?\ 9GM+B*5?9A7\7WQ]^$?_
M  5N_P""[WQ7^#WPX_: _9%O?V$OV//A=XVTWQGXPTOXCF.3Q[KDD7EVVJ1:
M;K/+ZO#J6GA[>&P@MK,6ESLO)&=8U5?[-O!_A?2_ _A'PKX*T-9$T7P?X;T/
MPMI"S,9)5TOP_IEKI-@LKGEY!:VD0=CRS MWH%+:.R>MTNFQ^?/_  54_;I^
M!O[ ?[*GB+XL?'+P?#\2=.\0WL/@WP?\,;BSM[V#X@>+;^.2YL] N$NK>ZA@
M@:*VDGEN3;SM&D9*Q,VT5^#/PS_;)_X.2?VI)O#UQ^SC^R3\(/V5O@_XKT>Q
MOOAQ??%GPK8:GX4\/>$9;6(Z$/[3$XO;JS;33 ]DPTR)VB"*+8$B.OU4_P""
M\_\ P3O^*_\ P44_9 T/P=\"]9TNS^+?P9^(NF?&3P3X>UEEM]/\9ZGH5E=6
MHT"34G#KI\[I=-=VCM%(MS<6T=H=OG G\K_A-^W-_P '#_B'X0^!_P!E'PI_
MP3FOOAO\9]%ALO!I_:H^)>E0Z5\)H/"VCVD>CV=X^@I<&.VU**QC2==8,TD5
MU<P1RFTCWL'!K5:6;ZI_=MZ=?D?-G_! ;1?C=X>_X+6_MU:)^TEX@\+^*OCW
MI7A;Q?:_%C7O!LWG>&;_ ,:+XCTG^U9-'?8A%LLI*K&4!1?I7VM_P1"M-%E_
MX*\?\%R+S7[31U^(=G^T$BZ9)#)'-<6VGW#N-<@TQI")S:/.MA]H\H>6&VJ^
M#MJA_P $C/\ @EM^W%^PW_P5 ^+_ ,8?VB+^+XL^%OC)\'K_ %;Q7\;K"Z$B
MZK\7O%.JV&K:SIUW;,B22I9M;3P'42$63Y (P#R?MN?L$?M+Z3^WGXO_ ."B
M?_!&'XJ_"?4/C7IM[=^$OVG_ ($R:U:C3KOQA;)"FKWOBG0X9VEU[4_$#S1'
M6-+N/L,Z2644T,F Q4*;^/S@M5ZWU[7OI??IJ?:'_!S39>$[W_@DQ\5?^$RF
M2*&W^(GPRN]".=I_X22+6)VT:VC;:S9DFWJP7:7&Y2=I(/F-]^WC\ OV"?\
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M!\0/A)XQUHVHSXBT'1[>:/P])=3S+<V=AK%P;1KF^LX;JXMYK6!UA.6(X_\
MX.!_V.OC_P#MK?LH_!CX:_L]>$E\9>+_  K^U7\(?B3K&GO=K9-:>$/"]U?2
MZSJ!=U8.]KYZ$Q\,XR 0>:S?^"Q?_!-#XU_MM_LH?!*\_9V\8ZKX+_:B_9PE
M\*^)O!5C_P )3>^'?#/B*#3;*QF\0^&]76U813W]U=:59)IMQ.&5 +B';_I.
M: 4G=+S_ .!_7;[C\5]0^+O_  <Q?\$Z-.N_"GQ5^%.E?MH_ CP?HT%]XQUZ
M+0+?XBZ=JGA.VA:.ZTZZ\8WTUIK4:R69$5^O]DRR0@JIA9HP!^ZO[%'_  4'
M^%/_  40_P""8_QC^*'PV^'EK\%M>\*^"?B/X+^(?PHT^*W6P\(>+=.T6Z%V
MNDS6MM91ZEH]SOQ;7KVL$LCQW,,D>8R6_,/3/^"D/_!PUJ_PF'[/TO\ P2[\
M06OQ\N)G\+G]I'6-"B@^#PL3']A:^G\*27,J2Q-$2[:H]VUM("97L2IVG]-?
M^"3/_!*KQ3^Q%^PG\3/@E\6?$NFZI\</VB+[Q[XO^*=WX=F$_AOPSKWC>"]D
M_L#0KQ41;ZPTFYNYW%\L<:R?:/+52L*E@IOJ][JUNJ]V_P#3/DG_ (-0"6_8
M%^-RGYL?MA?&0G+$*S'^R<D#^'<5&4'0@&OZ@F)*Y)VLW0C.< G*8[#/"^IY
MK^0/_@AKI'_!1/\ X)Z?%WQ[^P;\9/V%/B)>_ CQU\=?B9\1HOVI-)*MX*\-
MG7'4Z5&EPN1JVEZC!:66;@_9Y+.XDDV)*OFE?Z_F!5B0Q8A<E3RY"YP .QSR
M'_2@B?Q/Y?D?RM?\%+O^"0_[7GBK]M;4_P!OW_@EO^T9HGPU_:#\5:-867QK
M\!:WXJ?2H-7MO#FEQ66DWML^GQWEQ<K>P6T>G-X?U&*ST^2ZD^TO=*S''P=+
M_P %BO\ @J%^QCXG^'6F?\%BOV%]$\<_"R3QWHFF^!_BW=^#M(\,1^%]7LYT
MLKOQAH\MN-;@U;4[;3)I[EVN!IT\D8+I.&9@?L?]N_\ 9 _X*@?L<_\ !1KQ
MK_P4N_X)VZ2GQ\\'?%[P[H6D_%CX#R2W.HZK':Z.+>VOO#WA_P +S7:VT_\
M:Z02:K;>(+>2"33-3G4>2VW+?./[4/A3_@L/_P %U==^&W[/WQ/_ &*M4_8/
M_98\+^,=#\7_ !*NOBI)#+XEU[[!(\5V=#ULJTERDFFW-W FAP6\#-=&WN9)
MV$"J M=+V:MZ-=/EM^?8[#_@YV\9>'_B9X0_X)B^._"MTNJ>$O''QT^%'BCP
M_<N!&M_H_B#Q1X8O]/FDBY 2:QNXV>(Y7YMA! K^O/QY%%!\,O&=M&B)!#X
M\10QPHBQQ)#'X<NT6-(T"HL84!550%4 *H ''\V__!;+_@F=\>_CO\./^">7
MPN_93\&2>,?#O[,WQ!^%L.M27M\MO<V/@[P/JGAR'[9,SJ?-G&F:2]P^.2ZD
M=\U_2QXPT^[U/P3XHTFS0/?:GX3UO3+2(G!DO;S1KFUMXB_/WIG5<X..O;-
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M\$M#TW3/&'PG\6>)+6ST;X@?#>U-Q+IR:AI6T7!@W23Q:I:2(T/B"(VELUS
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M$L2R"/X'ZA)$&4,R3+X@T,"2,M]V0;B X(.TD?Q$'X'_ &8_V)OAO^W_ /\
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M9-=?AO=?=W?W(_H"HH_STQ^G:B@R"BBB@ HHHH **** "BBB@ HHHH ****
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M%_&]]=^,M>T/7@5$VK1>)+UUFM-0E;<L]WAQ<V>+3RT(WU^//_!3;P#\0/\
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M$6T \YVF621 /,(KQ+]DW0?^"$_B']I[X&6/P5'_  443XMV7Q%\.ZS\/O\
MA/G\=0^"!XGTN]CN-,?Q.]\?LC:2]P%%Y%/B*:+*MP2"$\R6[_!G]B$^M^'K
M69[:]\3^%;"[C&9;+4/$^@6%[![3V5WJ,-U Y'(2:)'(YVXP:L6M]INH;CIF
MK:/JP3'F-I&KZ;JRQYZ"5M.NKE8R>V\KGH.:_BI_:8\)_L0>-_\ @L3_ ,%$
M8/V_/&_Q;\)>!M.U_P -S^ Y_A=XJ\1:"J^)IM,L$U<:BVEO-;VVGI:;9+<2
M1PPAR2&SFOJ'_@D9I>AZ%_P46^*&F_L&Z_\ %7Q?^P)8^#HK/QKX@^*VJZGK
M=NNN^2+BR31=7U*1_MNMOJ1S*8,%+ C(VT#33VU/ZOJ*,YYY&<':R[2,C.3_
M 'MV=V[OZ<44#"BBB@ I",X!&1N3CUPP-+2,2!D=<C'YB@#]"?#UV+_0=)OE
M&5FT^$A?=8Q'Q]2A[=ZV,8X'^<\X_#I7(^ B?^$-\/9_Z!Z?^A/D5UU!SA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4D??\ #^M1
MU)'W_#^M $=?@A_P<>C5(/\ @G9IFN:;8W&H?\(E^U)^SQXFU!;>)YA::7I7
MBFY%W>713_5V]L)T,LS85-PR>:_>^OE/]N#X#W'[3/[(O[0GP%T^YM-/U;XD
M_#7Q)H&@ZEJ%I]LMM-UIK5KK2+\0@>89+:^MX7B>,B5'PR-0!] ^!+@7?@GP
M=<KC%QX3\-S@J=RD3:-9R@JP)#+AQ@Y.>N:ZEONDXR!R0.N ><>IQVK\M/\
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MK03<?D^I/U)/\\T'GJ2?J33=PVEATXX;Y203C.#V]Z4G&?R7/&X]P/?TZYH
M4<9QD9QGU..G/6C'.[OG.:;NZ=,G.!GYCCKD=L=\].]*6&W<.1C)P.WMZGV%
M #LG&,M^9S^><TW'Z\>M('4@\X(7=ST/^ZW1O?'0\4;LG !R I(QR%/?'7C_
M  H"X[)QC)QTZGI1VQ[8_#&,9Z]*;N'&,GYMK #E3VR.N#Z]!U^J@@]/Q'0@
M]P1_G(YH  H7.W*YQG!(Z=.A_P#U]Z7)]3^9_EG_ /5110%V XZ9';@D=/\
M/6C_ #_GTHHH"X>V2?J2?YYY]Z/Q8=N&8?R/%%% !W)R<G&3D]OQH&1TR,G)
M]R>I/KGO^=%%  !@@CJ,X]L]:0#;G;D9.3@GJ>_7C\*6B@ /.,Y..F2?\>?Q
MS1_^NBB@+BDD\$GGW/:D/S%2>=K;E]CZ_P">***  \]>>OZ]>E )'3(^E%%
M!Z')R.AR<\^^>?QS2Y.<YYQC/M_GOUI** $(!SGOUZ\XIQ)/!)I**  <# R!
MST)[]?QIKJ7!3! 8'?AR!M['K\K,._<"G4QE).0W;!!SAAZ-@YP.=N,>] 7/
MYXO^"I'_  2=_:@^./[3?@S_ (* ?L ?M):K\%/VJ/!'@B#X>:EX<OM2FL/!
M_CGPM83W%Q::;Y[F33M,:X:[FBUJ6ZLKE[VV$4<<L31@'X0^)'_!,G_@NY_P
M4M?0OA7_ ,%%OVA/A3\#_P!G#3;[0[OQAX,^!NN0Z_!\1H- N8[B!M4L[&*U
MN+?6G>/SXKY[C[)'<.S36[H-M?V&[%PP.[YB22",YXP.G 'Y^M.QGJQ7C V<
M#TZ'O@?G].0I2:MHG;[SR'X$_!;P+^SG\(/AU\#OACIO]C^ /AAX7L/"OAS3
MP/F6RLT)>XFQ]Z2[N9)[N<C ,\SMWKUY2< @MTQU(&![$_D>N,<TU5"+M4#:
M P4'/&>W4G!.<_IBG#@ =< #_/\ 2@3=_P#/KM;^O,0C.,Y...22>?<G-*,C
M !( Z#)QZ=/Z444"N]N@=#D=>>?KR:,?4_4D_P \T44 &3G.6_[Z./RSC]*3
M R3W)R2<DY/U^E+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4H]QG]*2EP3T]0,?6@#Y@_
M:4A-W+\";?DJOQV\%WSJ>F;-KW8Q_P!I/,.W'3FN6_9$C"7O[4Q P)OVKOB>
MP//W39>'B"/UY]S78_M#,RZI\#NQ?XO^'$VD_P 6;C&?KV^AKFOV3ROVK]I@
M)C_DZ+XDJ>.0PL]!SGU/ZXZUO_RX?JOS5_Q,8W^L?=^4?^"?78X 'I1116!L
M!SVZ]OK7D/QMG2/P<T9X>XO(D0CKN"J6Q^&<UZ]SV&?:OGKX_7X33]"TP9\V
M2ZDO7&>/*5#%M*]<AN2>E X[KU1\R44#CCTXHH-PHHHH >AVG=P%8;<N<*<<
M2)CJP93M.,86OYROB7\*_P!KO_@F=^VS\>/VN?V:_P!G^Y_:D_9Y_:A339/&
M_P )/ #+9>._!>OVDRR6VGZ)I[B60VIN]]_?:R,Q7*3_ &<1J4S7]&8'S*2
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MVOK?YD9;G>69S1G5RG,L%F*IJ,:E3"8BC6Y9.WQQA-\G-JXO2Z\]"6C/;O3
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M'M^?M@>?)OWN=RE&#YE[.R?-%I2<KVV;V^%K<[ES<JE'D:J:I2E\,&DX[/\
MX-^NA+13 20<# ]2>GIQS@$<_2A6W'&,8&3W.!W '4'L>F.]:7:G::]QQO%N
MU^;W5ROELK]M[^BN*\I4^:"7Q6EOJKK;FU^ZP[/L?\_TI:8'&,G.#SD?-SZ#
M'\N,4XG]?N\_>(ZX]<<9[>M1&4W\4=%R:R:BTK^]HMU:UGYE7BN7DOKM97YM
MMY2^&R5UTT%HS@<TQG"KGJ,@$@YP3_#D]6]%')R,4%EP>K8QN"\E21D!O[IZ
M?YS32=N9S2C9732][576BYETVU%HVXN/6SBF[J^VKLK[W5W:WF.W XY'Z?\
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M'X\U^*O_  <0?\H</VU_^R<1_P#IZTZ@4&G+71)I/S^'[M7<^F/^"1D<4/\
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M'C*[U0^*;ZPFU[[4-1U%]C?;@(DC6!,0_(?R3\3:!_P0V_X)1_MB?M _'/\
M:N_:.TKXM?M"_M(ZIKWB>^T/XN:38_&#_A7FFW.J/>W'A32M.T_2-;L]%"7;
M"TTJWU]X-0M;4"WA\FVRP Y5W;]%>_W-^FO4^YOV8_\ @XE_X)@?M5?$S0/A
M#X-^,%]X8\;>++Q=/\.0^.-!OO#NBZE>.C-'9MX@O5CTZRGN)%6"WCNI8?/F
M=(U;<0#^CG[8'[:O[//["7PRTKXR_M,^,Y_!'P_UKQQX;^'NF:W::%JWB!3X
ME\62SQ:+;2VNCP7-Q!;3?9YI+F_F5;2VBC:666-!D_P4_P#!8+_@H3_P3A_;
MCM_V<)OV./V=-0\&^/\ X:?M"?#(+\=?#7@C0_!/@4>&-0\5:;<:SX/U*WT"
MRL4N]?U"Z@TZ[THWT(N(;:*^5&9)5$?[V?\ !U*LNN?\$I?A/%-.\<_B#]I'
M]GBTFN8]H(EUJVU&UDF1>F0;DR* ,+@^O()QLEYGV=JW_!Q1_P $O]/_ &@#
M^S?IWQ7\2^+_ !H=530+>[\%>!_$'B?2M2\22VXO1H^BRZ9;32ZLWV5E<W-C
M'+!Y@DB&XQEC^C'['_[;'[.?[=_PXU;XK?LU>.9O&G@W0/&6N> ]:N+_ $75
M?#VJ:=XJ\/O''J5C>:3J]M::A"D,DBK#,T"P7!601,^QB/!OV!?V$?V<O@9^
MR=^S+X3@^$/PSU3Q?X.^'GA;57^(4_@GP^?&=UXHO='W7GB7_A)GT\ZPFI2K
M?W"EUO 8T;"  5^'W_!+/3&_X)S_ /!;7]M7_@GE<Z?J.D_"S]H_3=1^/O[/
M&G3ZEYNEZ5X?TZ6XU?4[R=KE]UQJ?B'4+_4H$$7[TO;JK [0H :MU_X/2_W[
M']$G[6O[>7[-/[$,WP;M/VB?%^I^%KKX]^.+CX<_"ZUTCPQKGB6X\2^,8;>V
MN7TPPZ+:W4EF?+O+;RI+KRHI))1&KEQBOL*SNX[ZTM+Z)95BO+6WNHA/$T$_
ME7$*S1B>!P)(90C@212 /&V489!K^27XOV,O_!2;_@XM^'7PK6'6=;^ 7_!.
M/P:?%_CJ.*\5])T'XW1+_:WA751:.YMY/[8N)(-%N)8T,QBM=CM\FT?UQ!BP
M#?WN1CI@^F>1[@\YS0#5K=WNNVPM%%%!(4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4<@$CJ.1[\CCZT44G?HKE17,[;:'R_^TW,;5_@1>="?V@/
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MCJ%]-J#ZGHM]K,2)JFB::\7V+3IK&26S6WV>6P&!7F7_  14\%>-?"'[0O\
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M?:ZU9_"73?$_BR;RK3QI%J%O<()?#XNTBO[D!6CBM'BBVJ !_4+^V[_P4P^
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M5Z7 D^**,,="4\716$J3A3A"3]GR8F+F^:-V_972Y5I=J_'_ /!6KX(?!O\
M8S_;#_8S^)/['_A_3/ OQJ\6^/;J\\5>$_!M^XN;V&QEL!I5W=Z3#/)=6EIK
M#7-["UN42QO_ +*0D+&,BOZ)_P!KG]N/X6_L2?!'0OBI\7A?ZAK'B"ST^S\*
M^ ]%"+XC\9^)[BPM9[G2--68-''+'+-F6>5?+M@RF3@XK^?W_@BQ^S=^R?\
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MHYK'/I83%Y7@\IS6OE:RZ4I9Q7H8.G.OA/9Q7+A:U1U8M1?M.76Z:B=5I/\
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M.V6T\)7QD</["&;RHPG4E2C*/OJ;;EHGUE_27_P4'_:?^#'[-VJ?LNV?Q?\
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M1VC6SK9 .;P20!;B,$;0:_1W]C_XV_#/XK_L@?"'X\^#_"-K\&/A5XI^'_\
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M_LQ*L65@P0C&X@ [\=CG[N1P6'/MBOB3QY_P39_8/^)OC=OB-XX_95^#.O\
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MV_X)-?\ !.*TUJ/78OV0?@L;R*X-RD,O@[3)=/$C-NQ]@DA:U,:G&V-HRAP
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M7FH+:JK3^7/JFAV=H#&K*64SJV"#C'-?0H_X)\?L*+C9^QU^S.,< _\ "EO
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M-WL7G1^6FMP:/;G7-DC-AU?6)KUD9224(()SD_TJ? C]AO\ 9'_9DUF\\2?
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MJ]OX@C^'\GPX\+S>%3K]G&8K77)M&FTZ2RGUB&-G5=3FB:]PQ_?9)-=GXN^
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MWMI%-'DR);Q_,0"3_2V"" 5! [9!!].G;T/J03WS7C'[/7P6\+?L\? [X6?
MWP386^E^%_ACX*T7PIIEA:R22P0O8VRM?/!-*!,T5QJ,ES<JS!7'FD;5& /:
M.<#/7 ![\B@).[O_ %LO^"%%%%!(4444 %%%% !1110 4444 %%%% !1110
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M[?4(;J1%M \B-;Q&Y5RPV@U_3L-[!<$?*1D$;@ !U /0^_Z=:<X9P0"%/&&
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M^'7B/X0WVE69\!Z%-?3S7GB>.+3+807<RQZ;++82PO+J5LURLT<+1NBG//\
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MN9HH8Y9!CEM\C9R2>>NQ10 =./3CBBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ****=]_/_ #3_ $ 0YZ@@;3DDC/'3@'OS7PE\4/!-
MI8?$GQ9X"OKJ;P]X'_:/T&].DZEHB1Z?+X=^*>G1^=J&O-J9(:W\0^)HC96V
MDR19N)9K>54Y0J?N[KTZ_P (SC)]/_K=Z\\^)WPX\.?%7PE>^$_$@GBADEAO
MM+U:PE-OJGAOQ'9;I-)\0:'>JIDM-6TJX(FM;A.(R"K!E8BKISY)7UZ;-K^O
MZ[F=6+J*S?X7ZK^F^FYQGP$^(%WXM\+2>&_$<$.F_$3P!<#PIXWT7[2]Q+%=
MZ:JV]GJL4DX2XO;'4K%+><WQC\J6\:YB5F,3&O=AZ[MP/<=...!QTQC_ .M7
MYI^)9]6\':_"_P 7=?U#X3?%#P]:V6C>%?VA=%LKFX\"?%31I;F2VT'1O&=A
M;1RC4]=M9E^T7GAF>..&)Y#J OBMT$3V^Q\:?&*/2HK67XD_"W6)F@R?%GE6
M.EL"R9%Q_P (T;EV &=WDF3=_">:ITN;X9+75Z_E9;/Y-+IJ"JV5N1W6FR?9
M=>WW;ZGN_P 6;\:=X!U^Y:>*TC6*".2YN)8[>"*.69$9Y)IG2*-0#\S.X5<Y
M) YK\YM+UCQ/\3-0NM"^$%O;MI^F[T\1_%+74-KX+\,['\EX8);H1Q:QK*G-
MU#;8.G3VZAQ=\U9\:>.O!GB,7%A\4/B=XF_:3U32-5_LJ]^&7PG\,W.@>&4&
MI*(85^(F@[XX-1T&%I%^T:FEXS01AYEB. *JZE9>./B%9Z=HOC/[!X"^'VCK
M]ATGX1_#V]6+2)K*QB^QVD6OZ];QPRZ]I$EDBNVDRQQ"WE^42';51C&FES.\
MOTNM-;/>]]$K!S3J^Y&,H*]W)>5NVG9^K[)G*Z)I/A7_ (2[2K?X5^(O&GBK
M3/"9U:P^('Q%\0:Q>7?AKQ_J]W<F?6-+\.Z3<!8!)IFI+LM[^$>5I-NO]FV#
MW%L3,WM9R<,226 (+*%8+_"A _N#@9YJK8VEGIUE::=IMK;V6G6-O':V5G:1
M+#;6]O"NR***-1PJJ  6+.>K,QYJT,G@ $\'GVZ_SK&=I23[?=K_ %Y6.FFG
M2C[-^_=?$]6K<NGW;^8F2 2%W'!POJ<<#\Z^S?!7AQ;?X9IIVTA]3TRXN[A&
MX/VBZ1BP.1G^%<9&?TKY&T33I-8UK2M,B;9)J%[!"BC/#!PYSZ#"D9-?H'!$
M(+9((]H$=JL*@ ##1Q;"<=#R/0>]2.>W]=T?G4X*R2J1M*33(1UQLE=,?^.T
MVKFH1^5J%_&!C9>W0_$SNQ_G5/!(/(0#YBYZ+CH3_P#JH&MEZ+\@H/RQM,Y$
M<**6DFE(CAC4#)>25RL<:*.2S,% Y)Q7E?QP^*6D_!?X4>-_B;KEQ;6=MX=T
M6:YL/MLABMKK6)T:+1[(, W%_?!(3D 8;J.WY,> ?AI^V7^V3X8L/BGX_P#C
MG??"[P+XNTR5=/\ !7A/=8_:M-.HF&]TW6K  -;F;3BZ6=^')G!4@ '-7"E*
MJU;I^>EOZ\SAS',\-EE#VV)J1C%S24&[2FNO+U=NW?S/VUM[FTNXOM%G?6%[
M;_,?M-E?6EY;X4D,?/MII(MJD$,=^%/#8-3=E/!5QE&!#*Z_WD925=?1E)!]
M:_)*P_X)S^(_#<=KH'P\_:E^)7@;PH]QY=SH<#3SP#3+AMU[ 7DF=D>X8LSS
M;LAFR *3]D+XU^+/@]\:/'O[+GQZ\2^(3!)J,T_P8\3_ !#+6USJ^FVCFWM]
M*T^Z8M%=C4T(NK'S70F),<$BJJX:<+2>RUO;TT[_ / _#ER_/\OS.M4H8::A
M*$(OV<G9R?N_"K[_ "/UNHI3QG*[0Q5"#]Y#CY9#CLPY)YV\<$&DK(]D****
M "BBB@ K8\/V3ZCKVCV4>=\VHVN,>D<JR-_XZIK'KN?AK$;CQWX<C.0$O'8D
M?[,+L/RQCMB@3V?HSW7X[:0+K0+'5H4)GTN\6$, >+>53YA;'10R#!.!D^]?
M* Z=_P >M??_ (NTHZYX<UO2S)L^VV,@0X^ZT2^8<'DC<8\ C_&O@'H2,$;6
M9<$8/RL5Y_*@SAO\OU04'.#CKVHH//'K0:FAI=RUCJ>GW8P#:WMM,,]B'4Y_
M#OSVK]"K:3SK:VF_Y[6\,OU\R-6S^.<U^<<AW@*!P>XY X Y_*OT \'7RZIX
M8T6\4@YT^"/@Y_U$8B_FI!]Z")K1/M^IT5%%%!D%%%% !1110 4444 %%%%
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M:"OC_@KI^T1YGS-&O]A6*Q*Q'R @:B2J!L$L 2.2/2M\?P+EV2RP,,WXKP6
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M#X4D9!-!5G9-:[W\OZ_3YG[-YZ]1ST_KGOGZ#'O17F7PC^(UE\4O!>G^*K6
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M+:ZURZ@\3W$<,>OI80-+/_95O(D1>Z"A&2570E<X_*[_ (*+?LW_ !"^&?\
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MSQ;I?C;Q'>>&WO=2NII8=2@\%ZK+!-9W%U)<-'-;.HN($0;6N(XQM.:^*O\
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MPE!X]\!>,_!-U(L,'C#PKKWAMYRO^I.LZ9=:>EP<\;K<SK*!UW)QT%?S(_\
M!);]I_2/V"_B=\;?^"=G[5?B+_A7L7A'QQ>:O\(?$?C#9HN@W&B:A-,TC3WM
MWLA*>*IVBU'3+KS!%(@"M@N&'1P[A<9FW 7%.79>O:8_!8_+LWQ.$H.^*QN5
MTTZ+]C2C[]:."JI8FM%*2BGSI<V_#Q!6P^5<><-9IF$_8X'&X/%Y3AZ]:\<-
MAL?+FJ?OJKM"E]8A-4J3;5YNSM9G]3R_*<@'Y?DW/\I+XRQSSD-][=@8'2LC
M3?#6@Z1>7>HZ7H6DV-]J=T]SJ%]9:;:P7E]<3L/.NKR\CB2>XDEP"[2R.< 9
MS@5Y;\4OVAO@I\%/ R_$CXE?$KP=X6\&S6#WVG:IJ&LV4<6MP);FZ@BT4F?_
M (F5Q=1[1;16^]I79 .O'XU?\$NOVH?VIOVU_P!K?]I;XY/XS\0#]BK2M1U#
MPS\+O!VNZ7]EL;B[$RKIUWHER84?[;IRPS?VVC2RAC<6V-N:^:P'#>;8O)\X
MSJ*6$RO+*5-UZV*E.A3Q=6I6C2A@L-=)5\2I24W23?+JVU+E3^JS#B3*<+F^
M3Y/)_7,RS&M*&'IX91K2P]*-+VLL97Y9-TJ'+'E]H_BTLFFS\O+_ ./7Q,_9
MW_X+8?M4_$+X1_L_>,/VD_% U'Q=HX^'7@FZCM=>CLKW3]+%WK4;2Q2J]O9J
MBF52AR),^AK[2^+_ /P7C_:/^$$5CHOQ%_X)T_$7X0>)_%JRVW@R;XA^*K:"
MTO=3D!CMY/LZ:<@NQ'*5:2V^TP,^ H/IR?[)K8_X.#?VIMN0GV#XA9'3_F&Z
M.3G'7)&=OKCT%?OO^V#^RMX _;#^!GC'X.^.+2T,FL6,DWACQ0]JD^H^$O%%
MNCR:-K5A.OEW2-97>QY88)H_.CS&W&,?K?$V;\+8;B+@ZGQ'P[2Q^#_U4X9C
MC,7'%XRGB%!X*$8RGAZ=6-&K3HV]I.ERJ=:GS0Y[\J/Q_AC*>)L5DG%F+R'B
M*I@<13XDSV6&P,<+1G1J<N)<IQIU96J4IUW[M.=W&E.TTE>1^.O_  3D_8W_
M &K?BK^U[J'_  4J_;2-CX9\4ZGX9O+3X8>!=#NDCAT_3_$.GC2YX[[24:?^
MS;1=*6&>WB-U,T]W(]RQ!<@?T9U_-!_P2 _:L^)7P%^,WCW_ ()@_M9ZU?R^
M-_AYJ.H)\'?$.LWTFH1ZEI-JSW)\/1:E<'S&MI=-:'6-/:>29FN+V33T<M&J
MC^E[/R[L$9) !&&)&<X!Y[9^E?!>)W]J?ZS2^OK!_4XX'!4\AEEM&5'+I9%"
MDGE[PD92F^14I?O(N<W3K>T@YNR/T/PS_LM\-QJ8'ZTL95QF+JYW#'S4\=#-
MYU7]<6):C&[]HG[*7*E*FHNR=TEHI 0>A!'M^H^HZ&EK\[/T(**** "BBB@
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M2D9WDGDOX- 6ROII9VW2-*91*[R,Q<M\Q).33LVF^Q#DKZJ]K];?/\.Y\/\
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MA_Z3-03)76G_  _D?:.<LQ'0[<?]\BEI!QGZ_P! *6@Q"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "D!!''(I:*/RZK[OQ73[]T&EO[R:
M<7V_%/\ '\A ,# SUS0>G3W_ "Y]#2T41M&R25E?ENMF[7?2_P K$\M]9-\W
M\RTUTM]R_2XT9)4XQN_A8=0.G!_6FG)RK$-C)(.2F!S@ =3C@=OQJ2BFG9M]
M6K76GH].PY:I12BHOXDU>^U[=KV(!%'R1$I'8E!U]L*&R/\ .:E&<X).  <;
ML@="!CV]Z=1_G_/YT<TFFIMRO=/5KMZV=DMK$JG3I_P:<*:V=HQ3<;IV;26N
M]GYC0.#@]<\YSU^F!_AS3A114<EXN,I3Y?LJ+Y;*ZTOJWM?5_+5E-:M[W7+[
MVNB=UM;6_P"'I<3'7L3WH&0,'DTM%5%1@N6-W'KS.[;Z:]+>7EL.RYHS=^:*
M:5G96=M+6?;^KZ%%%% &7K6DZ=KVDZEH>L6$&IZ1K%A>:9JNGW2A[6^TZ^MY
M+:\M+B,@EXKF"1X6 P<.>:_#_P :_P#! 3]C_P 1>+];\5>"/''QW^"MCK]T
M;J]\(_"KQU+X:\.EI26>(P0PM// =Q58[F>547Y%PN!7[J4GJ22!@<_3V_\
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MXX>+/#;I>>$G^-?B=O&=GX6OX6S;7VFPW,*!7M@"L%O.TUHO!\@D"OU4\=>
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MD^T_9 \3^+_BWX]^'%E\3[;XL1:WXS\6/KGC-/$=I>17MG:_VQ<PL5TFSDB
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MT_XK:I/\1OCEXST;R)_#FJ_&SQ,_BZ70-0MYEFAU*PE:*&9[R(HHA2Y::"(
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M5I^;D_#&09!4JU<GRO"X&I6LIU:<9SJRC%)1BZE6=2:BK?#"45M?8^'O ?[
MWP-^'/[5WC;]L;P]%XA_X6UX_BU:/Q!]HO4FT5AK4-M;WGV>S$0>-UCMH_+!
ME;!R>G3[>^8!6*A<C++WQSAAT''&0>>>?9_3IZY_'U^M%>7C\=C,TJ4:N88J
MMBJN'H4<+2J5)7E3PV'BH4*,=K0I07)#JEZ'HX'+L'ET*M+!X>GAZ5:M4Q-2
MG25H2Q%9\]:J[W?-4J7E+7K?<_/[]H3_ ()O_L\?M'?&SP'^T+XI@\1^&_BQ
M\/)=-FT#Q9X.U!-'OIY-(O%U'3Y=19(6%Z89PH(N-PEA40OOC&VOO:WBD@@M
MX7EGN9(;>&W-S<;6FNC%&BO=S;%14FD(+.0JJS%BJ@<"W_\ JHS_ (?AZ5IB
M\SS#'4L)A\9BZV)H9?1^KX&G5ES?5J#:;I4V]5#F5^79=$D3@\LP&7U,76P>
M&I8>KCJRKXN=--.O52Y54FKN/,DVKI1O=Z7;#\,>G3D>O&!D]:***X3O"BBB
M@ HHHH **** "BBB@ HHHH *DC[_ (?UJ.I(^_X?UH CHHHH **** "BBB@
MHHHH **** "BBB@ I1WSG/;']<^])2K]X<?_ *^P_/\ "@#%UC5%TZ'& ;AS
MA1D_+QD,,<^QS7GDUQ<7,A>:0O*Q)PQ. .>!SCIU]>35[5[A[J_F8\!&:,>Q
M4D%L?IQ].1S69CY2""6!X8'U/;IBMXJR_$!:***8!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQO;& OW<8R<YH%"Z3NK:GN/[+_@V'Q1\77\37HA6V^&FEO=Z+$&#SSZ]J_\
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MYX![[5#$^O'>KGPZU--4\&Z)<+G,-JFGN!U\VS B .>X&<X]:ZVYA6Y@GMY
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MCFX1O1HT*=6E3?MM?<]K*=J*^TH2=[1U_2?)PYVG"]N[$_W?\^]-5R<\<YX
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M$/%.B_M)_$>+P5XJUO7[_5K74_#&GR-&/MNA16+K:W%Y\YVQ7ZM%P.#7P9\
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M<MY6<HK3;1^?RN+D493CR-P<6W[S5_A]/, ,#'/XDD_F:6BBK?KS>??^ON[
MME9-*RLGNEV?F@HHHI#"BBB@ HHHH *0\@C@^QZ?C2T46YI0=[.#NGI\/NW3
MOWU\^JZB:]V>]FK-=Y:>\E^;\NNI$(\,#_#SQT ![8&.G;'/N!Q4O^?6DYST
MX]?_ *U+4Q45SN*=Y5&W>_9?U_P1MSO#F:=J=G;OIO\ +\ HHHJ@"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ J2/O\ A_6HZDC[_A_6@".BBB@ HHHH **** "BBB@
MHHHH **** "E'4?4?SI*4=1]1_.@#R>\_P"/NY_Z[R_^AFJU6;S_ (^[G_KO
M+_Z&:K5M#X5\_P V 44450!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444?SR#SSP.H
M_&@#SOXK>*+_ ,'^!-:US2Y8X-2AC6&SFDB69(YILA6,3_(^,$[37Y9:KK6L
M>(+^35M>U.ZU/4[S[]Q>3R.J(QX@M8>8[2WC;E(D(7D].E?H;^T[>?9_A5(
M?FN=>TZ/:/XHRS[@?51QQ].M?G&#A=I(YWY Z$'&>/IQ64]_D:PV^?Z(4+@!
MF7?N.7C5L$LO =#_  @#MP#CO73>$O&WBOP)>W%]X3UJ;2YYCOGM647EC=2$
M;3+/ITQ%N]T$^4R$Y"@8KF/PZ\'WIV-ZD'D*.A]^/K]/\*@LMZYXZUCX@^+/
M%.KZZD9U"UO+&U,\*B*.0?8(RY6!?EBW.2VQ/E&<YX%4JPM#6UN!J.JV4GF1
M:I>ERS'.R6S4VLJ_12C*1VQ6Z"'X'R@#AL8W'&.?H: "@<') P>"3P#WVDCG
MD9/IQS0,]ZJ7Y8:?J+(Q26/3KYX&''[_ .RRB/!_O9Z4 >?6EHGCS5=3O-2$
MK^%M%O9M)T[1I':)=6OK8@7MQJ*)\M[IKN4-I')\F V:]"L[.RTZT2RTZVM]
M.LXALAM[2%4@5">5  W =>F!C@>_,_#Z.YC\$^&#=@"[?28FO&'WWNFDE+M(
M?XG.!N8\]J[#H0>X& ?0'M]* #IQ@?@,#\A1110 ?I1\K!DVJT<JE0@P5W'[
MSOD9(;D''4?G110!YWK7AB/1(I/$O@R"WTO5=.\RZNM-M@;?1=:M%/G7ZW]L
M@P]^8A*]O<A2V\+&2 U=MI=_!JVFV.J6BM';7]M%=112C9+"LZ[]DB+D"0'(
M<9.P@ 5?V+*?*D *.C(Q/_/.3,;*?4'/(KA?AY)(="OH9"V;/Q+K]E$"<A;:
M"[VP*OH@7[J]A]: .VD3<I0,1E6&\9!!*E01_M#.<]B*Z?2?'7C;PYX&UKP+
MI.HZ9)HVLVLT-Y!=:;"ES<S7!#-YNJ+_ *2TC;,.V"5^7 P:YOL>P]O\]J#(
M %8@D*NY?]IFZL?]K Z_G0!FZ5?I?V<;^6\$\/\ HUU:R#Y[6XB&'A)YW ##
M*Q.2K GGBM*N<@,UMK&M6]K";DO96^H10*/GEO)682(N/XY% 'K[<UT$3R21
M1R/%Y!9 9(G'[Q7_ (E /*A3P5/UH ?1110 4<]NOY4#D[0"6/0 X/H#GV.,
M^U5+>YDN)[C-O+#:0E8;:Z="$O9(QB[:('&1;R_NG(ZF@#[&_9"G*:OXUMV<
M;GALI5C[2!8F!D/J4SC/;ZU]R].,Y]_7W_&OS/\ V=?$0\/_ !6TN"6=A#XE
MBET)(2,1^=,&EBDV]-Z+%A3U&?>OTPP02#V)'3'?T[5<-WZ&,_B?R_)!1116
MI(4444 ?-_[7WQ+\4?!S]FSXJ?$SP5<6UKXI\*:1;WND3WENEU:).UTL;>?!
M)\LBE3@ ]S7\RL?_  60_;6*1,_B/PD R[E7_A%-/W"1OO,%!*A3DXSC(P>O
M7^BK_@HE_P F5?'D=CX=L\C_ +?XZ_B#B)VD?WE4-_M #C/KB@#]5_\ A\?^
MVI_T,GA3_P )6P_^+II_X+'?MJ$C_BI/"G'_ %*UA_+=_6ORNIR_>'X_RH _
MHO\ ^"=__!1K]IC]H[]I?1OAC\2=8T&^\+7OAO7M4EM[#0[73[C[78)$;9Q<
M0DOL4NVZ/H_'2OZ&-H^<H?EW%"#P<J3G;WQSFOX^_P#@CP?^,U_#A[CP9XJP
M?3Y(.E?V#/\ >/\ UT<_CQS]: &4444 %%%% "'H?H?Y5ZM8?\>%E_U[1?RK
MRD]#]#_*O5K#_CPLO^O:+^53/X7\OS0%NBBBL0"BBB@ HHHH **** "BBB@
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M)CUN?_1)KSVO0/A;_P CWHG^]<?^BJ"C[>_C_P" _P!:=0>23CK10<X4444
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MB#1O%6I72^&_%/A_18I1IEK#IX#VKR*DTL=[8R!(M49HO.E4QBOC?Q/\ ?\
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M_P!DQ&28?#4*[CK.O"$>>%VK.R_X/1'X@_\ !#8!?BI_P4]QA5?]K:XV#'"
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M:VGBNY\<7<<AEU?1+2WM[2T;36TS2L:HUT^]+F(JJJN<G[X_X*7_ +>NG?\
M!.#]F75?VE=1^&%[\7+'2]:LM&;P?9>(8/#,\CWKI&MQ_:=S#<1Q&+S-Q5D.
M[;VS2O\ U_7JA\LNS_ _0,Y&TE2%./G;  )'?DXYX'K[4'.,X8X)5L#/S<G
M]1@<GH#Z]OYAO"G_  <#?M=^._!UG\1_!'_!$/\ :D\6^!-4TV75M-\8Z#XI
M@OM!U#3+>(SW%];7T6F>7):Q1JSF4'D*6XX%?7__  3\_P""UW@/_@H7X/\
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M(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !_@01V(/\
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MC!]<T^BA:7_O;^=MO/3IV':[3>\7>+[/NO,8$"A<%E"@C .%(/7(_/GM_/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<GQC\*>*K'PWX%M=3\62V;'PG+-=VDVW5;$V@6YE,PCD+C*?(N/T2_X)]_L
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M#;Y_H@-8,K6UWXDM+-W*W.EV)U51V,=T[6A'?!P#]>GTWJP$M /%=SJ'W?\
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M0M-\RO!^]&SOT_S,(3BI<M[MK9?+?LU?K8^&?V5&9?'/[6"(2L+?'CQ(PB&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]6L/^/"R_P"O:+^5>4GH?H?Y5ZM8?\>%E_U[1?RJ9_"_E^: MT445B 4444
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MHH ****+WV **** "BBB@ HHHHN 4444 %%%% !1110 4444 %%%% !1110
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M%% !1110 5)'W_#^M1U)'W_#^M $=%%% !1110 4444 %%%% !1110 4444
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M-=7+8_49Y_6JFA$7,/C34'YN9+F[LC)G,D<%G ##;OV)59<.V<^WIJ>  /\
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MT,2#GKZBGZ;/._BO>86>VNY]81KK_EFEO;"+[%GM\^7"G^+'L*".:7\K^_\
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MU?2\B'3K. $-,]NTA"@D GJ1DG**5_B3_!E1^)?U_7Z'[AVW_'Q!_P!=4_\
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M0Q(\DLTSB.**-%W/)([81$106=F*JJ@DD#-<'_PM;X6AB7^)7@%2K%"#XOT
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MN!_C4%S=6UE;S7=Y<06MK;1O-<7-U,EO;00QJ6DEGFD98XHXU!9W=@JJ"6(
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M5ZU^T':QP?&CQZB QQW%Y9S)A<(R-:HK$8QEF8DGKUYKRO2[H6.M^']28?\
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M1110 4444 3VO_'W9?\ 7[9_^E,5?HPOW4_W$_\ 017YSVO_ !]V7_7[9_\
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MG\&O'N_Q=;VDM_??#SQ1:GP_X[T^RA9%DN;S0+F1Y(XU,B[@LKR+GYD4"OR
M_P""(/[+WP\_:%\'_$O]O;X[^'="^)OQ<^*WQ<\52:+<>)].&HKX*;0;^:RO
MCHYO&EC1-1DE298PGEVZH410&X^]?B+_ ,$H_A_??MD_!;]K[X%^);/X$:UX
M \1-K/Q.\*>%M 3^R_BW; $)97[0W-M'IIFWN-0=8)DNBL!,:%"6^^SO)>!L
MEJYCPYB:V<0S_+J<J<\XYZ4LMJ9I3C&53!K 1I^W6'YI>QCB?:N2<>:4-V?
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M01+%%;@E OEJL2G"FJ/_  3\_:&^#_[,_P"UE_P5P^(OQO\ '^E^"/"47[1
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M&>$=93[7X9DUK7)9;N[\1W^F-B"[U73'LUCTVYF5C )7917L/_!<C]EGX8_
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MUJ=%Q;3]Z+A!J^C;9[OX4\4:#XW\-:!XO\+ZE;ZQX;\4:18:[H>JVCB2UO\
M2]3MX[NQNH7'59X)8Y%! 8!@&"G('E_PH_:/^"_QP\0_$GPI\+?'>C^+?$/P
MA\2OX1^(NE:;,7NO#'B! Y?3K]&5-LJ^6X8IO4$ 9YK\.O\ @FM^UQ%\*/\
M@E%\;?\ A96O:]%XV_8UA^('@3QUJ=[NN+W2M=N&OD\)VUF"0Q&E37-A:)'P
ML BP 54BOD3_ ()0V/C_ /9)_;3^',/QI\3W$P_X*$?!^Y^)&@. ;G_A)O'6
MH7<.JQ7^HR+M47ATT3F1V!,>0G1J^Q7AY*GA^,Y5ZM58G(ZLJ>448J%\?'#T
MUC\7/1R<HT<HG2Q<E'6/MHMM6<3Y*7'[EBN$J=##PJ4,WIJ6<55)WP,JU1X'
M#M>ZE:>90JX=N^\&DMF_Z@/B%^T;\&_A9\0OA?\ "CQSXXTOP_\ $/XS7UUI
MOPT\+W3L=3\4WUCY9NK:PA16!>'S$WF1D7!.UB5;'PM^SM\//V!/"G[<'[2?
MCOX/_$#7-6_:EUJ_URY^-_A6_P#&NJZMI>@W40@EU@6OANXB6QT=8%2(A;=V
M\L%L9R:^/OA)I3?MC_\ !:GXN?%:>"37?A5^Q3X9T[X?Z.EY=J8?#?QFD1A-
M?:9:E#C[9;)=R3-&P^:-=Q)%>+?\$][>WN_^"UW_  4.$T:-]J\2>,X;J,Q#
M]ZDHT]) \O!<2JSJT9Z+D$^G3A.%J>#RKB*$,?CL/C<#P;@<XS;#4JBA1KSQ
MN985T<!5A'F]I1AA:]"O)-INJE.W*DCSL;Q5/'9EPY-X'!5\-C^+L;E648BM
M3<ZN'CA,!)5L71EIR5I8F%6FG9WIQE%[-KS/P_\ \%%/@Q-_P63UGXL^+_VB
M;2X_9S\-?#CQ?X/\):MJ&LW#>"]'\1WP@TV?3=,MP@C2^NKV"2VD8QLS2(0"
M.<_17_!8S6M-F_:V_P""4_B./4VMM%E^/6@:N^IK?26-A)I<QL[Q+N\D26*%
MK;[,ZR_O_P!VJ$YX8BOF7P)^R/\ LS:[_P %PO'/P,U7X)?#Z\^$-K\-O%7B
M1/AO=:&'\+Q^((4M=0@UV&R:7:-0%])-=%]V%FE9PHR,>Q?\%X/AII7Q%^-W
M_!.CX.[YM'T/QI\4H/ 'GZ9(UK<:5I6HQVU@IL9$.ZW,%L%BAD0AH@@P>AK]
M!PE#AQ\><(T<)AL3@Z4N!:KS&4_8U:<*%;(L5)5Z5.,8\V)I0E4JUW)<LY\K
MA:TCXK'8G/ZG W%=;%8NAB*BXNH4L'K.G*5:CG.$@Z4IN_)0G)0A!*[45/FC
MJK_?7CK_ (+D?L ^!?BQ+\*KWQQXIUL0ZF^D:E\0_#OA>XU/X7:5J-O.;6ZM
M[[Q<L\=M&]G<*\<XCAEPT;%/,45^IGP^^(?@GXJ^#M"\??#GQ+I7C'P9XDMA
M?:%XCT.Y6[TW4;7S&C:2"9<9V2*R.KJC*P(*@C%? WQI_8!_9)\-?L>_%+X5
MZ/\  WX?VFB:'\,?$NI6%R-"M_MJ^)]*\-736OBB6[YNWUC[=$FH/=/.QEN3
M([J=QS\3_P#!NIXCUW4/V/?'7A/5-3N]2TSP!\6M1\.^'([J5IA9Z>=/BN9H
MH<_ZN.2X>27RQ\H=FQBORG,\DX3QW"V+SWAR&:X6OE68X++<?3S*K0KQS".+
MIS=+&4O90@\*U.D^?#MS2C.W,[19^GY=GG$^#XMP.0<0O 8BAF^5XG,L'/ 4
MYTE@:V&G"$L%5<VWB;QFVJON\THQLMTOZ!"X&W.?F.U?]IO0>^.?I7P]XV_X
M*0?L:?#[3_B7?>)?C9X8M)?A-J<^A>,=)6X9]8M?$$,<CKH%I8^6LEYJTYC,
M<%M$2))"%WKR1]P!0K[P2P)[M[]67Z\ ^G;K7\BG[#?[(7P^_:<_X*D_MF>(
M/BWH*>+?AQ\+/B)K^NV?A&]F_P"))JWCZ36V&FWFN:<5*:I:6>G-,\,,F%6Z
MCB9B5!4\/!N19-FU#/\ '9Y5Q6'P60Y7#,O9X!TY5L6_K%*BL+3=2T(.KS\J
MD](+FGKRV?=Q?G6=977R'+\BAA*V-SG&SP4JF,3C1PL5",_K,XKFE*-/6\(Z
MR;BKV>O[8?LN_P#!7S]BS]J_Q@GP_P#!'C#Q!X,\;WET+30_"_Q4T!_!.K>)
M)F#,HT*"\N)A>!T1GC+/#Y@QLW$@5^@_Q%^)7@+X1^#M:^(/Q,\5Z-X)\%>'
M;9KS6_$>OWD=CIFGVZ_QS3R$Y+' 2.)9))"0$1N<?@?_ ,%P_P!B_P"$ND?L
MTS?M1_"[P9HGP_\ BU\#-;\/^)5\1^%K1-)N=2\/:1<1R?V3>-9&#S8DFCME
MA==C+$9HV+*W'NWQT^%/P^_X*"_\$VOV??&O[3?QEF^#F@7'A7X=?%7Q=KD>
MJ1Z/X.OK^"WBGF@U[399HEOH9E\V&WB><B,3S$12%AM]7'<.<+XFAP]GF55L
MTP629OF=?*\=@:\8X_-,!6PJISE.@Z,8+%K$4JB=->RA*%31J:T/,PG$?$F$
MGG^39E1R[&9SEF I9C@,;&?U#+<92JN,7"NY\RP[HM^_+F::OJM&T\2?\%_/
M^"?OA[Q=_P (O%J_Q2\0V'VN*U/CKPY\/KS4? 061]ANV\1F[A@%G$/GEE\O
M*(0=I/%?IAX)_:H^ /Q'^#6K_'_P-\3/#?B7X3>'M.U#5->\7:==^?I^BP:1
M:K>:JFI'8)+6?3H'#W4;QG8 =I;K7XB>-/V\/^"(OPN^&,WP;TWP)X<^(7A"
MSL3I*^'?AY\*I/%>G:A=16YACNY[FR;[4D-S,OFM?,^%+F3!VXKP_P#X-\[?
MPU\0]'_;4^&5U9-K/P5U_6$DT_P)KD$@TG^P_$]]JL5UI]YI4I'DK=:8;>SN
MH"06BB$9/RDGW,VX%RJ/"^/XBP^1<39%')L7EU*K_;-2E4IYM1QE=TJCPR5*
ME+#5:$5&<DU6A^]C&[=[?/Y7QYF[XEP60U\YX>SF6;8+'UJ/]E1E3JY57PM&
M,Z<:]W)8FG5FW%2]V35.4N6/,KW_ -E#_@I%\$T_X*>_MD?$/XF?M(VUW\%?
M&>G^#O#'[/NHZYK4\_A>2V\V&2[TSPA%Y82WA^UR2N\:QAF=R=QSQ^O?C;P?
M^Q5X@_X*$? CXF>(_'>JV_[7\'PHUZ/X1^%+;Q5J%MHNO?#S4K::;5M4E\*I
M%_9^J2);2R217LTJRP#:5!*#'XW_ +%'['O[,'BG_@K#^W]\*/$/P,^'NK?#
M;X2IX'OOA?X+OM&6;0_ ]ZZVKSW7AVQ,FVSEN')=F#'#_= '%?4'QSL;2Q_X
M+^_L3VEG;QV]MI_[,WQ#L;&W0 +:V<&GZA'#!$F"8XXHU"*N?NKCH*]#.<MR
M3&YO4HY#4S7*WA/#C%9CB>:K1A'%4:&54L13PLHTDO=KWG'&.5XU9:PM%GGY
M'F><83)U6SKZAFL<3Q_@<!A93C4J2H5<3C52G7CS<JC*@FI89)^X[N2V3_:7
MX[?M&_!;]FCP=<>/?C;X_P! \!>'5=XK>ZUB]2";5+M8GD6RTRU^::ZNG"%$
M1%V%RJEUSFOSV^#?_!;_ /8)^,?C?_A!8?&OBKX<WUQ>QZ=H^K_%7PM<>#?#
MWB&]N+A;6S@T35;F>>*]-[*Z?9G"I&ZNK%U7FOQL_P""@O[1WP-UW_@K;?>&
MOVXK3Q-K_P"SC^S;X6T>S\+> O!WA/4_%L'BS6?$NEQ:X[^+-%TZ93/%:WL^
MZ.]<+^Y4VBL,@UUW[7?[>/\ P1C_ &E_@1XE^%T/PH^)WAKQ-;>%;G3/ACXJ
MT;]GK7-&UKP=J]G"LNC2Z3J5N1)8PR3P0V5Q._FE+.>9^&4-665^&>'_ ++R
M2KC<BXIS6MQ#@,/CWFF34X/+<DHXNHX4_:0E"I/'5:-)+$XBFI4;*2A&^C?5
MFGB5B7F6;QP6=\.Y90R/%UL&LJS1R>/SFKAX1G/V5566$A5G>A2?O^\MUN?U
M,?$[XL_#WX-_#GQ'\6_B3XFT_P ,?#OPEI8UKQ!XHO9=VFZ?I;211)>R30"4
M/ [SPA'B#AO,4C(Y'P#\>_\ @L)^PW^S_I/AK4=;^(]_X[OO%.B:5XGTWPU\
M+-'F\:>(XO#>MP_:-*US4-.LWB^Q:?>PAI(Y)Y5D"HQDBCP,_DUX0^,OC/XO
M_P#!N?\ &_5OB#=7^J:]X.\$>(?!8N=4@N4GDT+PWXITBTT**;[=&L\XM]/6
M.'?(&+,H)9NM?<7_  1Z_83^!O@W]C7X8_$;Q?\ #OPAXU^(WQ6\.3Z_J_B_
M7=*BU;69/#/B%0VG^&//O/-\K3]-M-UNEO"D:Q*[!-H.:\/_ %1X<R+)\SS3
MB6IF&,GEW%-3((8#+JE*@L;2C@H8N.(=:K&K[%*,E4LHS<O=I_S2/97%O$6>
MYO@,LX=A@\%#&<-4<[JXS'T9UOJE6>+GAI4E27(ZR<X.FK\BL^?6ZM^BG[*W
M[;'[/'[9OA2[\4_ GQU:>(/[+CM7\0>'KD"R\4>&3?+(UO#KNDL\CV<TBQN1
MY<DRC;@L&XK^?']O;]N+P/'_ ,%7/V=K5OCJZ? KX+:QHK_$S18M7FC\)^%_
M&6G7-P^H3:Q:(JJVI00O;B21]X3Y<!L5Z-^R]\&?"?[+7_!>/XE_"/X00/X8
M^&WC?X"ZS\1[SP;8R-'H=EJNL&VE6TLK$'9%9Z>Z.UA$V[R1-*$(4UXS^W9^
MSI\"Y?\ @LY^S?X'E^%/@Q_"/Q7BT'6/B;X>?3"=.\<:MJ=[>1WM]K\*R@7=
MQ<QQ11RN"FY8UR,CGZKA?(N%,LXRQL7#'X[*<9P1C,XRVG5=+ZQAH8G+9U*U
M*M)Q495Z,?:QH5HQC%OEE-+=_*\1<0<3YEPC@'&6$PN8X7B[#Y;F-2E&:IUY
M4<3%TJM&S]VG4E&/MJ+::5[/HOZI_AO\2O!/Q=\"^&OB9\.]?LO$_@?QAIYU
M;PYX@T]S)8ZIIYEDA%U;O@;HGEBD5#C)(KMGD5.7^5<%MYX0 +N)+'   Y).
M .Y%?'NO_M"_L4_L8VWA;X$^(OBC\(/@):Z!X=BN/!WPXU/7K/P\NG>%7NIX
MK>?3-,F):/36O!<JC*67S0ZUBZG^TC\$_P!K#X7?&[X9_LL?'GX=_$'XHW?P
MM\66>E6W@OQ5:75]HNJ:UHU_IVAZG<SVY=[&%=3DB"79&(G7< =N!^)QRRM5
MKJK3PV+IY97Q"5+%5Z,_9X?"SJQA&M7KQBJ4E24E[246HW32:W7[1+-L/1H2
MH5,7@ZN:T<.W/"4JT%6Q&*IT74E1H4)-U+U'"2@G#F2:T;W^>/V@?^"U'["O
M[/7C!_ VK>,O%'Q&U^RO+C3]?A^$GABX\;6_A>]M9FM[BV\07%M-;QV,L4J.
MC\RJ"I^:OLS]F?\ ;!_9[_:[\+W'BGX$?$+2O&,&F-;P^(-(AD$.O^&;JYC\
MV*TU[2I")K*<H0.#+%O/E^;ORH_D^_X)_P#[8'[*/["&E^._@#^W9^S)K>C?
M&33_ !#J6E>.OBC=^"9?&.I^,Y+F=UFFU8W4<:1VDKL]Q;W4=SFXMY?M)7YE
M _9C_@G%\#?V%)OVF/C'^U1^QQ\9],U&S^(_A+2--N_@=X7NH]+TWP+9&:.Z
MOI]9\.^?+(US>ZJ#=1ET4VS,D0F91BOU/BW@3(^'LMQB^H\14ZV'H8>IEO$7
M[G&Y#GLZDJ:FHO#P7U",X2G4I.I4;7(HSUG%2_-.%N-\[SO,L+[3'Y!4IXO$
M3I8OA_WL)G.2QIJ:ES.KKCJBE&*G""32DVF[2M^@GCO]O7]DGX9Z[\2/#'CC
MXU>$?#OB'X2Z1%K7CO2-1O3!>Z/9W 'V93$T8\^XNG*Q6\$)=WD=5QC)'S3^
MSO\ \%EOV'?VD?B'_P *O\+^-?$/@SQ;>7ZZ9X:M/B=X?D\&P>,[QR1'%X5N
M;JXFCU,3*K/$[&W21<;6+$*?R=\*?LF?#C]JO_@N%^TKIGQ:TM?$/@'X<^$O
M#GC>?PK<.?[&\3ZT@33[33_$5HN!J&F1>?\ ;A;2G8)H$R"17V-_P68_8<_9
M_D_8O^('QO\ !7@CP]\-OB7^SMHVG>.?"'BKPCI<>DZK):^';NWBM?#<EW9F
M)ETV:>:"?H7+6T8+A6?,5N%N \NQF1Y%C\5GE;-.(,JRK%K'8?V,,'E.*S.D
MIT(3HN$IXR%24H<UI4_9J:LY-2M<>)^.,9A,YSK"4LHP^69'F6/PSPU:,JF(
MS/#X"M&%><*R:6&<(<S@[3]I9I).R?[TW-W;6=K/>WEQ#:6=M$\]Q=7,J06\
M$$:&22>6:5ECCA1 7>1V5549)K\BOBU_P7$_8&^$WCE/ LGC;Q5\0KF.Y-GJ
MWB#X8>%;GQ=X5\/7,<IAN(==UJWF@BL&M75OM!*.J!20S5\*_MI_M<?%&X_X
M(>?!OXDQ:W>KXM^,-M\,?A;X_P#$(ED_M6XTK7H;FW\2ZE9RQ-')#J=Q!8^9
M"4;?O^0$[Z\;_9E_;Z_X(K_L\_!+0OA6GPC^)'B+4KKPQI^F?$3Q+JO[.^MZ
MKJ?CG5U@!U34=8U"=G>[::YDE FC*;HPK>]1D?ARX9=BLTS3)L]S]T\XQV24
M\MR!PIU,/5P'L_K&*QF(E3K*,&YQA0I1BW4;DW*RM&<\\1H_VG1RG+\XR?(7
M_9&"SB>/SJ$ZM.O3QRO1H8>A%1U7+)U9N:Y4K*_VOZ9/@=^T+\&OVDO!4/Q!
M^"7C_P /_$+PM+-]EEO] O4NFLKY41Y;"^@&V:UNX=X26.1  X94=]I->2_M
M5?MW?LS?L:Z1%??&_P"(%IH^L7UH][HW@O2U&J>,]>@C9E=M(T.)UEN2I5AA
MI(MV,)O.!7\[W_!+_P".?P83_@K!XY\(?L8P>,M"_9>^.7PZ\3>+]7\%>)?!
MVL>#]/\ "_BSPOIZWL5CX>TN_#V]MIZSO)(LD<@:9II$PVT =W^PI\)?!'_!
M0[_@I'^V!^T=^T#X?7Q]X:^$OB"/P]\)?"7B&Z-[X<T&[M+^XT>]^TZ'*#%.
MMH+%+[2WWJL-[++*P?A:C%^'N7Y/F.:8G-JN80R++,ER[.Y811IT\W<LVJSH
M8+*L2I-T\/B(UZ-:.(JI2Y(1C/EO+E6F#\0LPSG+,NH9/2P5;.\?G&*R98E.
M<\M:P$*53%YGATTI5\/[.M3E2IZ<\G*%TDF?K9^RI_P5S_8R_:^\6_\ " ?#
M_P 7Z_X0\<W#E=&\*?%'07\%ZYXA")YDCZ#9WMQ*;WRUQP7B9B0(ED;BNC^,
MW@/]C?5_V_?V9O&_Q)\;:OI?[7?A[P/XLLO@?X.M_%6H6&DZ[X7N)+M_$%Y?
M^%H8VT_6);5FG\NYNI4>#:H0'8IKR3]M7_@DS\)?VF-8^''C[X27NA_LY_&;
MX:>+].\56'Q&\*>%HI;O5XM.$36.D:M:6ES8K<Z?;SQ)<1#> 9<A@RDK7RG^
MU!8WUA_P6Z_X)C6.LWPUC6M,^ ?CFRU?7/(6W_M74K=;Z*]U%8LM]G^WW2O.
M;8,=B2;-QP#7'E^6\-9GCZM7A?&YQEB_U;XBQ..P&*G&KB,// 9=4K*E];I4
MZ=/$X3'PBX5(*,:D5)PFK6:Z\RS3B/*\#0I<3X3+,>_]9>'\'@\;0INGAZT,
M?C(477]@Y.=#%8.3YX2NXN2YDVM7\9_\%S?VKOAE\9?C'\!_V<_#_P 9XV^&
M7AGQ6?\ AH+2?#NJW5C-H-_!KT%E/_;%Q!Y<D,MMH[7C(HWK$ZB8 E0*^K=#
M_9&_X(S^%?V4-#UFT^,'C?\ X9W^)7[0G@GQ#HWC23XO^([A=9^,W@P/I'A_
M1K'6!;FY2T,GF0WFD*@M;R49D8$"OEO_ (+3?L_?!+PG^VM^QTWASX7^$=(?
MXP^)DN_BF+#31 ?'D]UXPL+.X;Q'MDQ=[[:::%W^1BDK(3R,?2'_  6]^"_P
MG^!/[&?[,_P[^#W@7P[\._ NG?M??"V^L_"GAJP2RT:WN]0U">XOIX+0%U$M
MW.6EF8'+2'=UK[>M6P57AGPRX?R;$9SEM+.88VOBJ=&O2A3KUJ6,J1G7Q*IP
M3JUXUZ<7A*CNJ="+4DYV9\$J>.AQ3XBY[G&'R?-:F38K+Z&#>(IU)5*%*K3P
M_LX89.\84E";]M&Z<JMI1?+=+^AF_P#$_@SP!X%/BG7=?L- \"^'- @O[OQ!
MK=Y';6-AHUG:IY5W>74I VK %)?EI"<@$\'\F?$G_!>K_@GSX=\?_P#""_\
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MLH?L53V^C?&'QO<W?C6ZMHKZW^'7@C3G\4>.I=/E?RQ?C0+61)$M@W+&25)
MGSB-E^:OG#_@E;_P3CTS]D'2/%_QI\7?%*3XT_&WXZV=EJ'B3QO;W:WF@?V$
M7_M2TMM&F!D.HW<UU<S3W>NAT%Y%(D0@5(ES^.OQ;^*'@W]A7_@K!^T5\7/V
MT/@%K?Q7\#?%1=%F^&'Q)G\.3:I9^';&RM(A=7_AS3)H[NVFS&!HUX$>W7-K
MYO&Y]WQV(RO)..N.LU^KPKYG+ 993E7PF72IY=C.*,WPO)1QM? _6(RHX>,K
M^UG%VJ5(TG.G"<IR/K<+FF><%\#95[6I0R]X_,>7#XK,(SQN&X=RRO+VF'HX
MU4DIU7&+<8K50YN64HN.G] /[*/_  5(_8__ &P]3M?#/PQ\=WNB^/+][C^S
M_AU\0-+D\)^-[^&TB::XN+71;F25I(8XD9R?.#E1E8S7Z'@@D#/7^7J:_FT^
M'FD?\$K?^"@?[3GP?^._P'^*<_P2^-'@S45NX_ ^BV\'PX\6^/KFPG74/](L
M#,RWB^1$;&Z2')N].9H?+PVX?TD@@N<>V1T ..?JQZX[#\Z_.^-<HRS)\QPU
M#+\'G>5RJX9U<9E>>4.7$Y?7BVO9PQ*A2ABZ,X*-2-6-.-G*4&[QM']%X-S?
M'YQ@*M?'9AD^905=TL)C\HJ7I8R'+%\]7#_%A:BDVO9RE)RC:5^LG9Y ]<_I
M2YI/K^'TXH(SCV/YU\7)N*[WE%Q:VY':]_QZ]NES["+YI))-+E:=_P"9?UJO
MP%J2/O\ A_6HZDC[_A_6GMU3\UL';T5_6RO^)'1110 4444 %%%% !1110 4
M444 %%%% !2CJ/J/YTE*.H^H_G0!Y/>?\?=S_P!=Y?\ T,U @4NH<E4+*&8
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MO]GLK&\_TD,FUF9LTUNO43OROHDM/-:+[]T?UF0>29HDF++ 6'FNO+*A)W$
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M@ [7U^7I_7_#&9%X]_X*(_M>_P#!5[]N/]B/X5_MK>.?V>?A9\(+?PC\1O\
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M\+^!_+BT2;3D()T+5+S33C@!H6\PJ1V(\WGBOU$_:A\/WVK_  R_M#3S%O\
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MGI@_RHH//'K0!-9E3>:<%[7EAGC_ *;QU^C*_=3_ '$_]!%?GEHT!N-8TJV
M_P!9?VHXZ_),C'^63^E?H<. H]%7_P!!%!G4Z?/] I#T88SE6&/J".G?Z4M%
M!F?!?BCPOJ.B>*;K1C$TTUW>O-8LL;%;B*]E)3#="0SX//.,<5]=> ?"<7A'
MP]!8LOF7LY6[U&91@F:0 B/=C.(E 7:3@')QWKJY=+L+B>VN[BUAGN[-F:VN
M9(T,L188;:V.FT  ?P]5P>:O_B?O;C[XZ ^W^<T%RE>UKB=R 057@>IW?-SZ
M[>E+1^ &3V_EZ8HH("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M72_$Z7]PUQ>Q:W8^'=/M]46[GE+2S72WJS">5B6DDW,Q.:]GC3(<EP^2\/\
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MDE*D\W4E"I4M=6P[:E)1NY/X3V,5PGB<1DG#^54\73HU,FQ^5XJ5247.-2&
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MW\^I]O2P:CEE'+I2Y5#!4\+.HM7^[H0HN73XE'RTML?R^?\ !O/\=/A/X/\
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MX0^-,^B6&BKXINYI?(N-#6!;.*XCU..+;?SVT<@$5I-&7# U[WXQ_P""4_\
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MIB$@5VD;(7!_LA'# # !.T]R">1G'09. #U/2OY+?^">GPV^&_QH_P""I?\
MP46^'/Q0\(Z%X[\'ZQIWB^VUCP[XAT];RTFC?QI;Q,R.ZK+:S-&2GVBTEAN
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MM)\>^%=3T6,R9\JWU&2W=])N),?,XL]26VN3@C<L14XSQ_-5_P $X_V\(?\
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MP64W":?I-G;Z;8F9AM=Y+.SCAMC*5^59!%G'#$BM&&TNKD$V]O-,%.&,4;N
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M>@ZGH4.C^ /">MRR$W/B;Q%K!LH3]QX+:QC9R,X+8(8CT[UQ,=A_:LEOHQ;
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MP! +?P9X>0+M+Z?;R$<#)G3=]/\ ZW-><_'FVW^'--O0,_9]12(L#T$^0?\
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M:<[6 (.3R2?3MT^M*0<9VYP<$EBN/7/(]J"AF[) 'OD$$'C'(]N^:7U)X .
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MI<6X*XJ+S\_N_P" ;7CY?A_71?@?$_Q<^,7AW]K7]MO]I;P/^W!_P5>^.O\
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MVV8KBRNXX;NTD4CD30QOU!%')+L/FTOZ?UZGY!?\$^((_C__ ,%Y_P#@H/\
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MBZ.+?(X9E\KS"2=P';%>+:AIUQJUUX<TFR!>\U#Q=X52)5R6*0:Y9S76%_B
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M@_5AHOBO7?'OB[2/#>L_:9[,:9K>I>$+:UTW4?M-LIGM3:7DD4OG0 R1;-Z
MFOBLPPV%H>%G'F%H1AAL-2\2J>'IQ:ERX?#0Q5*$$^6WNTH]MTK+:Q]KEF)Q
M57Q)X&Q>(YJ^(GP#B:]2U2FZE:O]7<FX\VKE4MJM7S23EU/Z=MKG^$KS\Q&>
MG RH..HX(['YAVK^+_\ X.%/@#\;_"'Q3A_:$\7_ !,BUSX%_$#Q/I'A?P#\
M,!K&NW4GA?Q%IGAAI-0U9]%NLZ#8_;$M9PMS8?Z0XD"S$;B*]/NO^"2?_!:Z
M87AB_;R5&FGN&@8?&+XCKLCD=O* Q8?+L0K]WH1QFNQ_X+Q^#O'7P^_X)\?L
M<^"OB7XA_P"$J^(/AKXB6^E>*_$/VVZU)=9U6W\&7J7=Z;R\5;J[:9@7$TZ"
M1B<GK7%X;X'+^%>/N$:^3\59)Q-4S3%O 8O"87!8F%3!T*U!S<Y5,;3C"G/G
MC"G&K1:G%IV=I2OMXBYACN*^!N)Z.;<,YUPQ3RRC3QN&Q>)Q5%TL=*GB(PY(
MQHV<XN'-)PJ*SO&2ORG;_P#!'W]E3]J7X6?"GX@_M*>,_CJ?$GP4\>_LT^,-
M.^&WPYM/$WB:ZNO!6OP_:=1BUE-,O#_8>F300VTD<5QIS"[C9DQB-A7S!_P0
M)^-?QH^(/[='Q*\/?$'XP?$WQ[H-I\'_ !'>V^A>,?&>M^(M(M[Z+Q;80QW\
M%CJ-S-;172Q.T4<T:[DB8QJVTFOW+_X)[WEI>_\ !*WP=);W%O<QGX*^/8P8
M60HWDZ/JD4ZJ%)#>5(/*E(SLD^0X;BOYZO\ @W7*G]OSXIXY*_!3Q,H&<%8Q
MXQTW:,'^8X[5ZE;%_P!MX#QTS#,<)@JF+PKP^&PM6GA*%/ZM&AF.(HPE2<8)
MQJ2IP2J5HVE5:YIN4FF_,A@8Y'C_  7P.5XO'0P6+Q'UK%4YXJK4]O.KA<-*
M49MR]^BY:JG+FC35^5)''?%[X]_MEQ?\%7_BG\*_@)\9/'$/BSQA\8_$/@3P
M!X=UGQ9JU]X'T"74BZ+=MX<GN3IBVUC9+<211^4%B=5=,,HK1_X*'?L]_MH_
M\$X+_P"#GQ7F_;,^+GQ!N_&-]-J.LS2^+=>.G:)XMTYX+Z^T\Z9-="TNO#5T
M\YM[2*53(8@ZLF$4"_X(0'_@X*@+")R/VGM8;E064?9[[ #-@97C!SGG\*_1
MW_@Y;./@;\%LL.?&.JX0@D-B&';D@'&,]^.>^*^]I9C' <:>%?#U'+<II99G
M_"& JYM"66X*=;'>TPF)CRU:TJ+DE&5)5(N#C)SE*4G*Z1\:\OKXO@_Q)SVM
MF>8RQ^2\48FCE-2..Q-*EA(+$TJDG3C[51DI>UE3<9WA&,5HGJ?,=K^SW_P4
M7_;^_9M\9?MQ^.?VG?&/PL:+PG-J_P 'OA9X)U?4?#>AZYX9T"V9[J]U-=*F
MB1VU;RII=.O2#=RSF07)"A"?I[_@WF_:S^-_QBL/CO\  OXL^*=3\:Z9\'[/
M0M9\/^)/$E_<ZKXFAGUK4;_3]1T>ZO[QY)KRRM&L2UM-*[.&9U(P!7Z'?L0X
M_P"'0/P7R F/V9+KL#P+75<X'0@_ETS7XR?\&VJ&7XV?MO)$?+>70_#:*>6>
M-F\5^)%!4]-H)RJ@]<?A\/F.84L]X$\4:&)RW*J%'AGB'"87(_JN P^'J9=A
MHYI2PG)"I1IPE44J2?,Y.4KRE';0^SR_ ULAXQ\-,5A,PS+$5^(\AKXK.%7Q
M=6M1Q^(GEM7%J3I5)N$6JG)&/(HIQ2D]6V<E^T?^U)^U;_P5 _;Z?]D']FGX
MH:K\(/A-X+UC6M-M=6\.:KJ6BWM];>&%(\5^)_$6I:5(EV]R&AN[+2])W/8X
MBCE;]Z[&N0_:7T7]N?\ X(L_&GX:_$VS_:-\?_'#X-^,[NWTZX'CG5]1UR'5
MDL'CO/$'A:ZT[4II-/T_5WLA-<6%]9*95MFC)8.,5\1?LB? 76?B5_P41^('
MP.U;X^>//V4_%^K>-/BLVF>._",T&F>)IKB/6=5U*+299;^XLTA_M:TEC$$,
MLJ/<B1!$KY&?UD_:N_X);? KPBWA;P3^V+_P5_\ C"\FHM<ZMX/\._%BTTG7
MEBG$1ANM5TZTEO;I;&1H=T1N)A"'CRJLPXK[+$RX:X8Q_#G#=>K@7PWC>&:%
M3,,AH<*8_-<TS58K"U'5S*EF>&PU9.K[?DJ7ISC[-<_ME:4;?&8'_6+B/!Y]
MG]*AF%3B'"\158X+.JW$N"RW+<M>'Q,8T\!4R[$5:;Y/8<]/WDY5)*+I[._]
M0GPE^(ND_%OX8^ OB;HFU=,\=>%-"\36\(D$OV0ZQIUO?26+R#AI;*29[:7_
M &XS7S9^WW^SUKW[2?[.OBOP1X<^+?C/X-WVFVU_XF?Q/X&OGL-5O(-(TJ]G
M?1;F:*6)FT_4 /*NT+;3&3P>E=_^Q]\*/#WP2_9N^%?PV\*>/;OXH>%_#_AR
M :#XZOK2"PG\0Z5=DW=C>_9+=FACB:VE00>4Q#1!6'6O8?B1M_X5QX_Z;&\#
M>+<C!R0-!OP>2,=^I^F*_D^.(CE7$WMLJ<I4,'F\G@)8NA%5?94\3R477P]>
M%N=4K<]*=.Z?-S13NE_54\//-.&)4,U2CB,7D_+CH8:NU25:>'4ZOLJU&2NE
M43M.$[-/^5G\@7_!##]E+Q-X_P#'?BGX^P?M!?$3P-X>_9]^*5O+XE^&^AZA
M+;>#_B9!#INJ&>?QA:K,D=ZD,4;RAWCF!/UX^EFUK]I__@L=^UI\;?!/P[_:
M"\3? #]DG]G3Q(GA>VUOX8W=WIOB#Q5?R"86FN6M^KVZZF-5%O,T]I=.UM9>
M1MB*AN>I_P"#?:RN=6^!_P"VKI5H"UQJ7C>\TZRCSEO-O-!UZW@CR>/];(BC
MGC/7 K?_ .#?#4+3P&O[7/[./BHPZ;\5?AO\6;J/7].O+B&/4M062YU&9S;0
M&3S[B+2EDCCN6C5TB,Z!BH.*_?\ BW-<1'/O$;B/EPE?.N':>28#)8UL'AZR
MPF&S&*^N8_V*I\E6MA4E%8BM&:I*IRS]Q<J_ >$<JPL\EX#R#VV)HY-Q#5S;
M$9QR8RM3^M5\'.*PN$C4C4C*E"LI3;IT)0<W%N_,[KQ;]I7X&?M?_P#!'2[\
M#?M3?"_]JSXG_M%_!J+Q9H/A7XJ^"OC#?W&J7$MIKMXMNBVEI%-<6EE:.J22
M3:K JWEKY2E67<"?;?\ @MC^U5XGTO\ 9P_8]^/OP,\?Z_HNF^+/%4?B:&;P
MEK^IZ-8^(+:XTW3'73-4:P>*6^T^"[GEBDAF5T)C?"DFOKC_ (+M_$7POX(_
M8!\<Z-KDEI-K7CGQ#X>\+>&](DF@74+K4-1NG@74;2UD<32PZ<[1M<3QH?)6
M12Q!89_&O_@HU\/_ !+\+_\ @EG_ ,$Q_A_XT@-MXDT"2PM-7M)MTCF2Y73[
MZ-&+\L/LUS"^'.,'!Z5Q\*SAQ)B?#SB#.\)@Z^:UN(\WRJO7>$P]"GFN!PV7
M1KT*F)PU.G"C5GAZ\I1]K&G&+YK/WTV>IQ%0GP__ *\\/Y#C,5A\LAD>5YC0
MA]8K8C^S,;7Q,J<XTJE2=3$4XXB"3<9U'RJ">B:9^L'[(_\ P3*^,&B>._A5
M^U/\:OVV_C=X[\6ZE8P>-?%/PJT[7+NU^%,USKEE%>Z/INGP-<K=S6&EP26P
MECN8 EQ()CM*%6;]QW8<EB44]6P2#G)5<?P]1R/7FN-^&J ?#;X=A0%">!?"
M0  &W']@6"X"@XX'"YX'TKLRH']X\?=P&Y)^^Q/WL#.0<[>H/K^&<19]F&=Y
MG]8S*M3J5(2JT8>RP^%PM.G1C5ERTXPP]*E"T=%&Z<TDHW=KG[5P]DF!R/*J
M=#+85**JRI8FJZM?$8F5:M*E2<Y.6(J59Q4I)MJ#C&^T4C^>#_@H?^TC\>_V
MEOVO?#O_  33_97^(<7PBM[32K7Q!^T3\6!>2Z5JOANPN(H]3L='TG4HY([B
MV^UZ6%FM9[1_.GU-H[6X46VXUXQ\;?\ @FE^TU^RGX&N/V@_V5?^"@OQL^,'
MQ0^%B3>+)/AS\2?&6GW6A>*-+T^!IM6MTT\:H]E?W$=FL\IMM1S"T$<ABW7
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MN?&G]I ?"[XL>%O -S/8^#M8\%QI9"^L=,\+0;+&T_M.)S%>);1D2ABH1%(
M_K:FGCN9&N(4,<-P?M$*,"KI#.!+$C@\ADC95*GE2"IZ5_.1J_[!7_!3G]N3
M]KO]FWXM?\%%-4^!'P_^"7[*_B\_%'X;^"_@;XCBUS7-7^(4+(T1UNY2VAW:
M9-Y4<=SO5@Z#;CC)_HUEF-Q--,4$;2RN[1JVY(V9BS*O P 2<#I5PW^7ZH0R
MBBBM0$/0_0_RKU:P_P"/"R_Z]HOY5Y2>A^A_E7JUA_QX67_7M%_*IG\+^7YH
M"W1116(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 9KY)^.5LR^+;6Y*;5FTV*$.>C-%
MN/'J1GG]*^MCT-?-O[0*J'\+N$^:1[\22=\(L>SGV+&@N#U^3_3_ "/G 9QR
M<GUZ_K2T@SW]_P"=+0:A1110 5V/P]MTN_''AJWE&8Y+_P"<8Z[(G<9_%17'
M5ZG\'--&H>.+.4G']F02WX]>/W./QWX]\T"D[)L^S"1A=H/93GL>G/T[5GZO
M9QW^EZAI\G,=W9W$+-C(P$.,]NO6M L2.1C)!(QD\'MT]::Z[TE0=XY1T[R*
M1S^73WZT&!^<; *TBKRJRS*/HDSH/_0:2M37+(Z=K6K6!ZVM_<)^!<O_ .S5
MET&Z=TGY!1110,*0G Z9]J6E'4?6@#Z:^ %MMLO$-R!S-=6B X[1PN",^F>M
M?0M>/_!"T2+P4+D<2WNH78;CM#(53'<X!('I7L%!C/XG_71!11102%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4GZ=#GU_
MR!2T4T[7[]'U7I<&DTU)735OR?Z" 8!^I[>O;\O\*80=N -I!R#UP1CGKR?0
M''Z5)14QC%7?*G)I+F>NBVLG=+Y6!MM[OEZQ6E_^WE[W3N<!\0?A?\._BQX?
MN?"/Q.\$>&_'OAF^*/=Z-XITFTUC3YGA.^$RVUW$ZLR2#<ASE">#7YQ>(?\
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MK%G<:2IBNM.U"VEL[N&0&9@#)!-(B, =N01@@5].?\.IO^">N<_\,N?#3/\
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MM=_;-UWQ%I$NEWGA[0?B0/AY8Z=?:!H,LHGL[ Z)%=M;WALI7N6\^217G\X
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M>)KC4$^)=W\2U^&;?#S3UT\37D<Z'1O[=6Z^TM%&9]QNO+#_ "!<8.:^A?\
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MZAI,<R72:7-<;V<VBW*+<"$87S5#\G 'TSC<688!P% /7;C],X';G@_7^?\
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M*A'5ZP245%J]G9+>US\S_P#@H)_P35^'O[=MCX0U^;Q3JWPH^,OPWE67X?\
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MS$US<B!M+GF2- UU$DSQ@X5&Q7Z=_M7?\$[O#7[2M]^R$VD^/+SX7Z+^R/\
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MH[X!Z"LS@\@Y4?>)X*_A6T=(K[P$HHHJ@"BBB@ HHHH **** "BBB@ HHHH
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MVH6^D_'3X4W-ZWE6M[J^I:>\[?NX;=IM-F%O+-(3MC661DAB+??=@HYKT_\
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M?D?_  %^7E_5_2S]S^1[+[7IY]+;^044447GK[\?_ 7_ )?Y_(/=_P"?<O\
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M_ O_ +8/PHHHIWG_ #Q_\!?EY?U^37)I[CW_ )MMO/7;;R"BBBE>>GOQ_P#
M7_E_D'N_\^Y?^!_\'R7W!^!_S^-%%%%YZ?O%_P" ^FFR^\/<_DE_X'UTM]KR
M7^3#\****$Y_\_%M_+M^&HO=T_=R_P# _P#@^2[$9!W;@HSCKWZ?6GC/7GD#
M(]P,#\J6D QP*24E)3]HIRY6FI*RZ?"DM-O5_>&EFN2*7-'X=Y*^\G;IU[K[
MV#/?OC ]./U[_E2T44=([:)+3?337]-7\A][VO?IMRI+E272VO8**** "BBB
M@ HHHH **** "BBB@ HHHH ****$W'5;O?;R[Z!\A,#!&.#C/OCI^5-(5<G'
M)(/4\D=_P_2GT4G&-FUNUHM=)/>7DUKJG>VPTWIJHKJK+5:77J]-==A!U+'J
MV,_AT'X>HQFEHHH4%&/*WS625^[TO*_EJ3=ROHHO1KK:R6EUWZ_\,%%%%,84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4D
M??\ #^M1U)'W_#^M $=%%% !1110 4444 %%%% !1110 4444 % P#GG@Y..
MN>V!W[=*** ,C5M+748E.0MTA+1/Q@\8VL?0@'@]Z\]N+2>UE9+B)U(SDX.Q
M_H3P?P[5ZS^7'J*9+##<C$\*2#_:_+O_ )!JXR:] /(J*]*;0]*)R+-/?+R?
MXT?V%I'_ #YK_P!]O_C3YWV_K^K_ -+4/-:*]*_L+2/^?-?^^W_QH_L+2/\
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M2/\ GS7_ +[?_&CG?;^OZO\ TM0\UHKTK^PM(_Y\U_[[?_&C^PM(_P"?-?\
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MYWV_K^K_ -+4/-:*]*_L+2/^?-?^^W_QH_L+2/\ GS7_ +[?_&CG?;^OZO\
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MHYWV_K^K_P!+4/-:*]*_L+2/^?-?^^W_ ,:/["TC_GS7_OM_\:.=]OZ_J_\
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MM74<GEL9(&<?ITH_'/OZ^_X]:*S **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH *DC[_A_6HZDC[_ (?UH CHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *DC[_A_6HZDC[_A_6@".BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI"
MP&,]2< =SZX'MU/I2]0.,@Y!_+G/I[^E " Y([=05?Y3_O@]QCMW]:,XSG.>
M?O#;@)P6 [AOJ,5^3?[:?_!8G]F']A_Q[?\ PG^(^C_$G4?B3;:9IVK6>DV'
MA.^M_#NK:=J4!FBETKQ7,&L+N2$;8;J.%':WF;9(5/7\QM7_ .#H'X5VMW-%
MHO[*GQ UFVC8".>7QYH5A(X&.'MY]+E>%NY#$[L<\T[/>VG]?YA?IU/ZG0V2
M?EQG[O/4#J5_O _AC\:6OR7_ .";/_!2KQG_ ,%%IO&GBG2?V:_$?P@^$?@M
MX]+'CGQ)XGT_78?%GB692[Z9X=^PV=HDL>E>6RZL5#?99)848YD%?K0*0!11
M10 4444 %%%% !7SU\?AFR\/,,E4N+@G']YE3 _//X5]##KW_#K7A/QXMV?P
MWIURH)6"]6,D=FD.!CIUPPST!%!4+7UT/E,'(Z?YS2T9HH-@HHHH LV3>7J&
MGR9QLO+5^G\2W,>"<]<8/'IFOT2@D\^""<$'S8(G.!QEESQZ#D\5^=5LI:ZL
MU 'S7EN!Z\RQ]?Z?C7Z'Z>"NGV0(_P"76W!SUW+& P^GI093WOW_ ,D6Z***
M"#A?B3<M:^#-;<8'F6QA.>ZR9!'X_P">*^%UP$0'CY0PSURW4?0#MVK[<^*\
M;/X'U7:,[?+<@=0JL<D_AT]Z^)0"54G&5QCW4J,?Y_R0VA\.GS]?ZU"BBB@H
M***1NASTZG\.: /L_P"#7/@'3SZ7=\/_ "-_]85ZE7FOPBA>'P)I:NNTR3W,
MBCU660LA_$5Z4*#&3O)V_K0****"0HHHH ****-]-O,&[)OL)GH5(;)[#.T<
M_>&>"._I30V\<=,_>4[LCISC[M&&. 3A=X.%."./FR?XOF]!7X=?M\?\%A/$
M7[ 7QKC^%OC?]F+Q)XW\.Z[I5GK7@GXBZ1XKTW0](\0PRH6U33K>SO;*X=KS
M0I&B@O3YPW-(A5:]C(<@S3B;'?V1DV&EC<P:<J="%2G3K55!Q<_9^TG",G!/
MFDN>_*G))V/%SS/\MX9P']KYOB'AL"G%3J.$IPIN2O'FY%)^];1N-K[V/W%R
M.,'&2-H;@X'! !^]GC!_(\TN>2#N7C@,O&>"/FSUY]J_F0\+?\'+?P=U"[\K
MQ;^SKXX\,VAE1&O8/%&EZSA&QOD\FVL8GS&,Y0%2> #GFOV"_8M_X*(?L_\
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M%.SM>VG]?YAJ]D%%%%(+].H4444 %%%% !1110 4444 %%%% !1110 4444
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M7M;62'P5H=T%ELYI= L7"76L:A8SDW%E?%)=(N#$C8DC<&OPC^ '[&G[>_\
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MB^5#./$.GQ&0Z+/<LI<:7JT09+JUC96N)X[<C.W:?TI)"C^0_P *:V05<@$
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MFX**B[12UG=-+XMHZZ:I];G[/&RLN=3<ES2;::L[:M;M>GK?J SWHHHI??\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&1\V2IP<87&[<>BD<]3SCI2EB!G'5B .3GC.=P^4^O!Z<=:"I.$5<;P<Y[#
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M;+<Q:=K^G!W^S:I;J^R[M@S+#)E0QZU\B?MU_P#!3;X*?\$_/'_[+_@/XO\
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MRT^XG6(:W/X@DO%TV2QCC/VCS8KB1GC!$:N^ ?Z(OA%^TQ\"?CM\#M%_:/\
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MS7XW> OAJ;OX4ZJT&V*]O-+\37L\%I]FL[L26EQ+-+%%YL+LA="I/T!\</\
M@X@_8;^&'P\^"/C3X:Z3\6?VH=<^-OA$^/=+^&O[/GA*;QIX\\'^%DG-C<ZC
MXVTN AM$\C6DGT<PSL)I;B%Y84:U*3,#Y9+I^OY'[U[N 3@#H>_/; '3)QD'
MD#F@MU.",'GC<",XW KQCMCD@D9XYK\?O^";?_!:']F'_@I9XO\ B)\-/A[X
M7^)GPA^+?PXLX-6U/X9?&+1;?P]XLOM FF%M)J]C9Q3S@1VUZWV.YMK@Q7T;
MAI#$8E+UZM_P43_X*L?LI?\ !-#PCIFJ_'/7]5UCQ]XFB\[P#\'/!%LFJ?$/
MQPJW<-E+_8UA(\5E&D$LX&[4+JW\YP$@65B!0*S[/[C]*MW)S\N"!AN#ANC9
MZ,/]W//'6G9X) ^Z1G/&<]ESCD>_%?S*>"O^#HK]CC4?'7@?PI\7OV>/VM?V
M</"WC?6[;1[?XI_&[X:2^%_ FE75\<6LUY?O,;BX@FD>,8T^&Z9$D\XQB$,X
M_9[]KK]MWX4_LB_LH^(?VO\ Q#8:W\2/A=H6A:5XAM5^'ALM1U/Q%I.M)'-I
MM]H?VRZMK.XM[F"6.:.1KE08W5LD4#<97_X;7\=_TOZK[-9E7/S#Y0<C!R#Z
M8^N #T.>.AII<#(;Y3@$ ]MV=H)Z;N,E1R1T&:_F=N_^#HC]D&^U#P3'\.?V
M<_VL/BWI7BC2?"LVM>*/ /P[CU;PSX%\1^)+D6D_@OQ7K27)L+;7O#[O&VKJ
MEP;6-9%,,TAS7]*6E7L>K:5INJ)%+!%J=C9ZC%;W"J)(%O;:*ZCCG.25EB$P
M1R,A75@I/% FFM&C3HI!T'T[<_K2T""BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBC- !13=PXYZYQP>W7G'_P"OM3CP0#P3G'OCKST_
MQ[47\K_?^@G=];"@$GCZ=<'Z\]0.X'-,4LP8@9QP,97+ _,/FP<@<Y'X&O"/
MV@?VF/@;^R]X(O?B#\<OB+H/@/P_9Q[HDU*Z3^UM3E?S%A@TG2(B^HWTLLD;
M1*T%N\*/_KY(EYK^/+]O3_@O_P#&C]H.6\^%?[)FF:M\'_AWJ5Q=Z.?%.Q[G
MXJ>.X;M%LULM.M[8R'0EE=&N=.GT>0ZG(MP(YBQ04U%O;I^/E_7W@W:W=Z']
M%W[>/_!7?]E[]A_3K[0K_7[?XG_&?[ \FB?"OP7>6VH7BW,K36\4^OZG%(]C
MI%O:7*(U_937":F+?>8K<,4)_CT_:&_;6_;S_P""KWQ*MOA[HNE>)-:T>]U2
M.+P_\#?A<FJ#PGITFH%+.!/%.H*-MQ9S,$=[SQ.[6,%QDQN @Q]._L(?\$+_
M -I#]K35;/XK_M(:CKWP:^$_B!YM;U#4]?)U#XK>.S<QL;.YL[;46:2T@NI8
MW34[C7%M[U(G#VZO(0I_LC_9;_8Z_9]_8[\#6G@7X#^ =*\+VJ6D5OJGB%H4
MNO%7B$H5:1]7UV=&U&Z62X4W*VSS_98'<F&),"JO'^7[_P"OT_,9^"/[ /\
MP;O^#/ LF@_$_P#;3U"P\=^);=+'4=*^#>AR2)X2\/S>2L\47B.]C=)-2U'3
M;H(K0Z?,VES",AMP.T_TZ>&/"WAGP7H&G^%_!^@Z1X7\-Z5"MOI>A:!IMII.
ME6$ )8QVUG910PQ;W8RRNJ!Y96>21F=W9MS'.-JXP-I R0!QAF/);OZ4M2WV
MT6FG]>?7</.VH$ C!SG &02#Q],9_&D*@G//I@\C;Z%>A/3YC\V><TM%(!
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M3)[9PPK]!0>3P<\ 'C')P?<8]N:^,_C-I::=XVGE7)&J6T=^QYQYK$Q.!VR
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M=,UB)EN+0Z^;3R%\2Z5)<Q)'=VFJ&;-M),$QD*?/?V)_VPOB)K_C/Q!^Q_\
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M\/@#P;<#!9+71-&A6:" ,4#WQ;:&K]JQM._:77MU!"<<_*< Y!)*XQC [G'
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M"K'[".@1:O\ M$?LP,9_'_@G1M-BDUSXA^$K/#RZL)/,2;4K[2]!2[T$6/\
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MU\?-0C^-/B?PQK/A_5+.TTB[MYXEU/2X-5^QG199K-KZT1HK:_D9U)**0I
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M\:!T5[;[49DEPI7<Z9!M7=NCB[=>WX];^G8_';]N+]MKPC\,?^#A3XI?%O\
M:(^"/C']IKP7^S'HLGPW^'WPM\+^$+GQO_9\U[H=CJFD>(GT&WM-0C670M6O
M9=2M;^2V^2X9BW%?2?[;'_!>G]F_]MC]G#XC_ ?XD?\ !-K]IC64\2>$-;TS
MP/J>L_!_Q0?^$/\ &$FGRQ>&=<L+E/#[7&GKI>HBUN9DM62.>WA,#@HV!Z[_
M ,%)_"7QE_X)-?\ !6WPQ_P5G\"_##Q/\8/V:?C'I%WX5^/^F>%K2[U+4?#^
MMZS9Q:)>7UQIMC;75Q(MGI5K#>^'7,8CFU)I(9Y(HU+5ZS\>_P#@ZE_9QUKX
M5Z]H/[%7P4^//CW]I;Q%;QZ/\-M!\8_"&\T[P]IVO:B?L\&IZN]E/J+SC3)9
M!+#I\\,$-[/&(;BXABW[@2VCI?16=]MKW[?CVZGP7X:^)?Q,\6?\&F_QW\)_
M$_2_%UGKGP@71?!=G=^.-*UK2M>U/1Q\1O#^JVLDL&O6UM>O%:?;'M;-MK(D
M$4,*MMC%?O[_ ,&\?P+^'/PB_P""8?P,UCPEX9T6S\2_$C3=6\2>./$\>GVZ
MZWXJO;C6+P6O]N:AY?VF^6QLREE;0S.T<4,05 N3GXX_X*2:Y^U_\2O^#<#X
MN>)?VQO#-G:_M.>,/ _A#5?&?A/P3X8>T^P27/Q!T*73+>'0=&6]F%RVF"WN
MKV)%<6SRRQR$+$QK]-/^"(5M=6?_  3 _96M[ZQO].ND\&SB:TU.PN].OH)#
MJ5UA9[.\A@N8'Z866)"5[<T";T:TO?OY+KIM^EM3\=_V7OAYX1^!_P#P=.?M
M8^"_AEHMEX2\+^*/V5_"7C#5-%TNWCM["XUKQC%;:_KUVL$85$-UJX6X^5?E
M8 UQG_!0[P[X?D_X.5_^";E@^BZ2;+5I].N]5L_[/M?LVJ3RZ%JYDFU"(Q^5
M>2R/M:1IU=FV@MO(->]?#C2M97_@ZQ_:-U<Z+JZ:/+^QM\+[:+6WTG4?['DG
MA\/V;301:JUL-.,J+(H,2W)<R"1%4O%*$^4?^"XOQ1TW]C'_ (+4_P#!/3]M
M/XK^'_%NH_!3P;I]UK.MW7@[P_>Z_J\5MX<TV]TN^%M;PB.U>^-U?0?9[*>[
MMY+B'>T9&W< J+U3O?W&O.__  [T/[1[6SM=/MX;+3[:WM+2T0PP6MO"EO!;
M0+]R&VBB58XXP.%CC 5>@7M7X5?\'%W[,=Q^T5_P3-^*.KZ!;01^,O@#K6@?
M'31M3CM5EU:'1_ =Y_:WB32M(GQYT#:S9Q1Q3F$[WC@Z'%?KC^SE^T#X _:F
M^"/PW^/_ ,+IM3E\!_$[P[9>)]!77+!M+UNTM;]-XM-6TQWD-EJ-J3Y=S!YL
M@A?($CCD^A^//"&@?$+P;XF\!>*-.AU;PYXP\/ZKX<UK3KL9BOM.U:SEM)[9
MP001(DA&2/ESD#B@RAI)/7=:>77\-S^4']O;]L6^_;%_X([_ /!.[X7^%=0@
M\ _%7_@I;XG^$/PFT>"&_:[&@)I,]K9^+8-8:)GF"26,$,E[%<["AG='7Y<!
M?^"*/C32O^";?BS_ (*L_L(^)+N^\0^'?V(K<_M!IXA<2+)K&D7?@Z&;5K72
MH)MJ&V>6P0VR+C#S1JP#%E'YR_\ !(?]ECXV0?\ !62']COXU>'-5U;X/_\
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M>>E.I.F,#OV'^<4G+EM>UK]4W:71Z:V6O1BE!5(N-VGNK.UTFK_IU_4^(/\
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MDL9S75N6=:SO."YG&;M*^AU?_!4;]G_5_C/_ ,$NOAAXX\%V5]/\4_@'\/\
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MS!;I'=9--F-FN(VWUX]?()<49AP:Z6.^J99E'AYD^(SBIA<4J>-J4Z6*S"^
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MNMIHVGWMM8?:8D")+B*1A.S9:5MK2?,!7RA_P4/_ &AO GA'_@L/:^)?CO\
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MOAW^T=X"T<:)\0)M9\-W<L7BJ[TK-JNLQWG[@2ZU>Q1AM3LS C?;/,D7(DP
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M'<=?:C/&>W7/M0#;8@X&,D^[')/U/\O:C&?7O_\ 6/X'D4OMWSC'OZ?6C/\
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M\_L_9\?*1A@,X=AM[X5&Z$+GG'TR.:YKQ)XZ\&>#_#NL>*_%'BSPWH'A;P_
M]SKGB+6=;T^QT?2(8@3+-J-]<3);V@3!_P!=(,;2#CFOYP?^#;S]N'XE_'OX
M2?'3]E7XT^,V^*'C_P#9'\8W.@:)\2TU*+6;7Q-\,[ZZO--\(XU5"\NK3QQZ
M9)<G4GFE,\=RB>8QCX_!_P#X(\?L&>+O^"HOQ=_:Z\"_M$_''XWI^RA\&?V@
M_B'XJM? >B>-M:BM/''CW5?'>OZ3?Z%KEW>7-PTOA^VT6TMUET@[[8JX\B&*
M1GE '*M;O;RTZ6_K^G_>Y\(/VC/@)^T%:ZGJ'P+^,GPW^+=CHDZ6^K7'P_\
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MJX!1YM&L;&&\B#+B62T6(+\X6OX9/^"3W[+?_!)#]OSX,>*/B1_P4._:9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A7QY@+^'=/GYQ#?;?
M^_@4<_E7RI7UU\<5)\'*^,A-2MAC_?8J#^&,U\C$8XSGW]?RXXH-X[+T$K0T
M<9UG2O;4M//_ )-1\50') ]3BIK2Y%E>VEYM+1VMS;SN?402K(>@&/NX].E
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MJ6(I<[5JV#=2I+DYE[6$G%[+F_689[G\@<=?7_\ 5_6G9KX&_9)_X*$_!O\
M:>M4\*:BUS\(?C]H>W3?'GP'^(>W0_&FA>((=\5[;:5:WOD/XATYFC^T6=]I
MB31O;3PE^=QK[S8D AC@8R2V <$\<C@,#P#TZ<5X>.P&-RS$5*>-PM2A5@TH
MPES04HW2]I&5_95J;WC5IRE"47[LFK7]S!8[ YE1C5P6(C7I2BISG"HW[):-
MQJ0FU.G4^)*$XJ2DG=:'Y._\%$/^";?B;]MWXK_LX?$C0OBSHWP\M?@5XFT?
M7[_2M3\/7.MS>(X]+\26NNO;VUQ!=6XLFFCMC;*[K*%=O,((&#^LBC: H]%^
M8#AL #!S][ID$8QBFEBH4 # Z[C\S'&=JG[I//)';/I2EL#)RH1=S$XPH^\5
M//3C);IUZ9K?%YKC\QP67Y=B:ZJ87*:5:AE].,*:]A#$U?;5HJ45SS4JK;;J
MN33TB[:&&"RG+<!C<QS+"TW3Q6:SI5\PJSJ5.6JZ$(PIRY9-PAR4UM323WDG
M=LD  Z#%?DQ_P4X^/OB*;0?#'[$OP'>75OVC/VH[R/PC#%I<DGG?#WX;7,BC
MQ?X\US4('QX?BMK#=%IMS=C;/+,=@^4&NL_:N_X*0>$?A?K$/P,_9PT:3]H_
M]JCQ4+BQ\-_#OP+-'JFE>$IR[6SZY\0M=M/.L= T[2YS&\UI>2174PR JJK9
MT?V&/V+_ !7\'M1\5?M&?M(>(8_B-^UO\7H8I/&GB0R";2O 6B.IDM? 7@\'
M/DZ;IZLL-Y/!A+R6)6CP@^;W<LP']@TZ.?9U2]C*E:KD^65DZ>(QN+A9T<5.
MEI.E@<-4Y:TISC%8B452I<ZG)KP\SQT\\JU,CRFO[2E4BZ6:YC1]_#X7"U+>
MUP\*J]VKBJ].3I15-R]BFY2<7&R^Q_V??@[X<_9^^#'PX^#'A62YGT/X=>%M
M,\-6EW?&&2_O6LX?](NK^:".)+B[FG>22:?9OD)W.S$EC['S_D?_ %_\^U1I
MR>5P>.5SMSR>O<^_TJ0=3UR/RY]/R&:^5KUJM?$5\172J5J]6=>K4=N:HZD^
M><[W5FYR<K>>ESZK#T:-"E0H8=6I82C3P\5)M\L*=.,:=V]9M1BE>[=^XM%%
M%9&Q\\?M4?#7XP?%SX(>,? 7P&^,=Q\ _BEK::</#?Q3M=-75I_#;6NHVUS>
M,E@Y N/MEE%-9E<_*)]_;-?SW_MB? '_ (*M?L??LY?$_P#:.UK_ (*E^*/&
MVF_#31K75;KPKI?@RTT>\U?[5J=EIHABU&>*ZBM75KP3EI8RK"-DZD9_J6.#
MP>Y_6ORI_P""V@!_X)B_M4\#_D3])Y^GBC1N".^/>ON^!>(<;@,WRS*:>%R?
M$X+'YM@88FGF.297F-2I"M7H4:E.&(QN$KUJ<7!VY:-2'+)N:M/4^ XZX>P>
M.RK,LTGB,WPV.P6 KU,-6P.;YA@:=.=*G*4)>QPN(IT9R3=[U(2YMG=)'YM?
MLQ_LQ_\ !5_]I_X&^!/C=I7_  55\4>$+#QYI(U*VT"Y\#V^H76F_,R>5<7R
M101SM\H??'$%VL,-G('[ :7XT\4?L#_L7:_XY_:Y^-US\<_$GPPTK7-?U[XA
MOIJ:5J7BKS)<Z1HUAI@<>9=H[+;JB;F*%YB"J,:PO^"4!S^P'^S]DY_XI=1C
MD9Q+P,<9 'Z5\*_\'&5S._[%WPXT2-KF*SU_]HSX;Z;J,\$LD<!L9Y+RWGL[
MH1,OF1W27+$1R$QDQ$NIP"/J,75K<6>(-'@[%T,JP66OB>MA*<,NR7*\NK4L
M-AJU1>S^L8/"T*]2*I1<+5:LFW:?O2BFOG</A:/"7 E3BO!5,SQN9KA^E5E/
M,,VS#'4IXC$1H+VGLL57K4H252?M+PC&WP:19\L_"[X7_P#!1W_@L-I/BGXO
M?$7XY:[^RY^R=XNOULO ?PL\/)/!>>+]"TR:18M90V;V^K:>\BLC/JSWK6NK
M$YMH52!\5/C!^Q%^W=_P2M^'6H?'W]DW]J7Q1\2_AQX,U*S\5_$OX2>+YM0U
M>TU?2K$EM3U&^N=4GO[F;38K<R>=:V4MM)'N#[L9(_HZ_9C\)Z/X#_9U^"O@
M[P_$L>D>'_AOX5T[38U.0L$.F0XY!YY9B#_$<UZ_K.B:1XBT34M!UW3;;5]$
MU>TFT_5--U&%)K.^L+E=D]O=6[@I+;RH2CQL"&'!X-<6)\1\9@LWK8.CDN0Q
MX7P>*JX;^PYY3@9TJV#I3]ERU\1+#_6JF*G2BI/%RJNI&JN:+2]U]6'\.L)B
M<ICBL3G&=U.)J^'I8J>;PS3&PJ4\56A&HW2H1K?5XX>$GR?5E#V;IWO&[3/S
M[^#?[:&G?M8?L ^(_P!I?X<S7?A+Q*/AAXFDU+3XI%-UX,\>Z-HLLUU:032Q
M^5*UM<F*ZM9"C*(IXHWW,K5^&/\ P3_\-?\ !4[_ (*"?"_QQ\5_#G_!2[QA
M\+[3PK\2M?\  +^']3\)V6N2S2:2EM<K?I=V]O;1I!)'=I"D021LPN2R@@'^
MD_XX^$/"7@?]EOXT^'_!?AK0O#&A6WPQ\9>3I.A:9::58A_[#N TA@L888GD
M90H:=U,S[1O<D"OY3O\ @DC_ ,%"?&'[(WP/^)?P\\._L9?M!?M(6VM?&?Q1
MXIG\9?":R@NO#NE7-Y!9VY\/7TDUI<%=2M$M1<2*' ,=PAVYQ7O\&8:KC>%N
M-\TX6RC*ZN.HYYD[P%+-\/D^,GA,NQ#Q$JU.G5SF'U=:*G&2C^]DDN52:DWX
M?&.(P^#X@X+R_B?-,RIX2KD^;?7ZN6XC-L+]9QE&C1]A4G#*F\0VY<SYN5QB
MV^;E3C%?HQ\1_P!A#_@LQX+\$^(?%7@__@I_XC^(VNZ%IMUJ=GX+M/"5EH5S
MK[VD+SM86M[<P742W4ZH4@1E!ED98U^9E!^P_P#@D+^W1X^_;.^"GB_3/C-H
MZ:+\:O@7XI_X5_X_NK9?*AUV^LX"IU(VQ&ZVU!'B:UU5#\KWPEDB1%(6OSE^
M(_\ P7G^-'Q:EU?X#_LR_L:_$WPE^T-J@N]%&G>/[FSOM2\-M=6DD+:A_8ND
MQ17MI?Z<)5O89KU'M(VB0S(RY%?>?_!(W]BWXQ_L=_ 3XK>-/C4;?4OCW\<=
M?U/XE>(M CN8[QM-U5K2Z:WTR]OK;;;3WNM792^NS JK:RW)A<;XW OB?+\R
MP_!F-CQSE>193Q!B,9EM7A99=@<JP.88JA.LX9C/$?V/3C0G@8T%!TJM5.\W
M))N7*D<-XS+JO&.$CP7C\\S')*&!QJXC_M#&9GB\#AJD:"G@8T/[4FZT,7*K
M?GA!1M%1;M&[/T]^)WQY^"_P9CT^3XM_%;P'\-DU=G32_P#A,/$VEZ!_:+1
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ML_\ "1:_I?A[1M/UCQ"0(VU_5;33[>VU+6S#DB/^U+Q)KW8,[#/M'%?S??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2/O\
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M?\5].;X-:CXAU/2XM5U:.#6+B\75"MG=B[M+>S;5GOV^S-'Y?GC8O[W^*_\
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MU#S&2XUFR"R21K_:8G?RG,1)4 4 ]59_DWIO9];KSM?3S/0_^"<OPC_X(0>
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M7D6J.\"6$DU]IMQ)IDERTRVI$:!1^N7C/_E;)^$N'*L?V!?%8^4_,0MG-N7
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M:M_:C_9"TWQE-)/JO@GX)>([;3='#S.9+BW-[-)'?W-B[LVVSNGDAB7A  *
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MTU@^!-2U"UOK'P1^SKHG_"%VH\F4O-I]_P"(-2M8M>:PD@,EOL@N ^V0L6#
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M+-$&!S]Z?\%^;RWM_B#_ ,$U;NZGBM[9/C]KL[W4TR0PV\*Z1HK&XD=R%\H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "I(^_X?UJ.I(^_X?UH CHHHH ****
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MWL/:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **.>PS^E9NIZA;:787.H7LR0
MVEK&\TTK,% C5<X&?O.3\JIU8_2@:3>Q\Y?'O4HI=2T/2@"9K.*2^E/K#=#R
ME3WYC.!_C7S]P,@'/S$GKZ#''L.*ZCQCXEN/%FOW>KRJ(XB1!91 ;3%9PD^2
MCD??8Y,A8_WL=JY?\^I/Y_Y_*@V6B2[(0G )Z8&<^GO2.2JA@6#  JR=?.W
MHQ^@((-.H//MG P.!QC' [C'6@9][^"-6MM:\+Z)?V[&1!:1V[L_WC<6JB&8
MYY/,BDBNISZGDG/^?ID?K7A'P'U=KG0]3TJ5U_XEMV#;0@ ?N)TWR$]2Q,O1
MCTZ# KW< !>.YR!W [@]^O-!@]WZL****!"$@8Y.6(  Z_4?3^>/:O%/CEJJ
MVGA6TTY482ZK?KL)_@^Q9E=F&<C>I !]\=:]K.,KD<9(..OS =/IC/6OD;XW
MZL][XHMM-69F@TRQ17BSPMW(Q\QN#U*%1CZ&@:W7JOS/&,C/N>?_ -=+110;
MAT[XW?*/8CDG\LU]@_!+48KKP5;V2MF?3KJY2X';%Q(TT/X[#^0'K7QZ>001
MT (^N><>AP,9]#7KWPB\:1>&M6FTN](CTK7+B$"9@,V]\J"*-WDXQ&P.PI]W
M)#&@B:;7I=L^PZ*8K9!Q\W .X?<YYX;H5 _B[DC&>M/SGD @'H",'\:#(***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHI-)[@%%%%"27?UW=NW0 HHHI@%%%% !1110 444F.OO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *DC[_ (?UJ.I(^_X?UH CHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0[#O;;P>HSDCTKZ#'0?04& M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5)'W_#^M1U)'W_  _K0!'1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^"/^4IWQZ_[-!^$7_JP?%%?HM7YT^"/^4IWQZ_[-!^$/_JP?%%?HM0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^=_A__E*K
M\0?^S(?!'_JX=:K]$*_._P /_P#*57X@_P#9D/@C_P!7#K5?HA0 4444 %%%
M% !1110 4444 %%%% !1110 5)'W_#^M1U)'W_#^M $=%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'YT^"/\ E*=\>O\ LT'X0_\
MJP?%%?HM7YT^"/\ E*=\>O\ LT'X0_\ JP?%%?HM0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^=_A__ )2J_$'_ +,A\$?^
MKAUJOT0K\[_#_P#RE5^(/_9D/@C_ -7#K5?HA0 4444 %%%% !1110 4444
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M_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !11QZK_P!]+_C1QZK_ -]+_C0
M44<>J_\ ?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !11QZK_P!]
M+_C1QZK_ -]+_C0 44<>J_\ ?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''JO\
MWTO^- !11QZK_P!]+_C1QZK_ -]+_C0 44<>J_\ ?2_XT<>J_P#?2_XT %%'
M'JO_ 'TO^-''JO\ WTO^- !11QZK_P!]+_C1QZK_ -]+_C0 44<>J_\ ?2_X
MT<>J_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !11QZK_P!]+_C1QZK_ -]+
M_C0 44<>J_\ ?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !11QZK
M_P!]+_C1QZK_ -]+_C0 44<>J_\ ?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''
MJO\ WTO^- !11QZK_P!]+_C1QZK_ -]+_C0 44<>J_\ ?2_XT<>J_P#?2_XT
M %%''JO_ 'TO^-''JO\ WTO^- !11QZK_P!]+_C1QZK_ -]+_C0 44<>J_\
M?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !11QZK_P!]+_C1QZK_
M -]+_C0 44<>J_\ ?2_XT<>J_P#?2_XT %%''JO_ 'TO^-''JO\ WTO^- !1
M3691G!7((ZN@X/?[Q_#/6E!!Z'/K@@X/U!(_6@!:*** /!/VGOVD?AK^R)\!
MOB7^TC\8I];MOAA\*-!7Q'XPNO#6CR^(=<ATXZA9Z8O]FZ-;O'-?3&YOK<O%
M'(I"%FSA37XB#_@Z?_X),A=[>*_CP@=-X\SX)ZPN5X^ZIU(<C/( R.]?8?\
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M.I_IB@^Q .1MST+=E/UH  Z?B3R2?4^_2@C(_$<]Q@]1Z$=CS]* /Q%_:?\
M^#@W_@G/^R!\=O'W[.'QH\1_%NP^)OPUN[*Q\46OA_X7:EK^CQW&H:=;:I"+
M'6(+Z*.\06MU$7=(T".60Y*FO"!_P=-_\$FPN\^*_CL$7G+?!360I4@ -N.I
M8*G(P2>OO7Z5?%__ ()0?\$Y?V@?B7XE^,'QF_9&^%/Q#^)OC&6WG\3^,_$%
MEJTNL:W+9VL5E;27KV^K6\#/%:P10#9"@*(H.:_@@T/]F?X 7?\ P7P?]F*X
M^$_AB7]GH_&6[\/GX3LEY_PC+:&EF'CTK8+G[7]ECD^=0+D.#_%B@#^RW]ES
M_@X._P""<O[8/Q]^'W[-7P8\2_%J]^)_Q,N-3MO"UIXA^%NI:!HTTND:9<:M
M=B]UB>^EBM%%I;R&,M&^^3;'@$U][_MC?MY_LO\ [!WP_F^(?[2GQ(T_PA92
M027&A^&;!4U7QOXJ$$D<$T'ACPU%-'>ZS-&\RM)Y9BCC4-NE!7!\W^#_ /P2
M>_X)Q_L]_$OPS\9?@U^R/\)OAQ\3/!+7L_ACQQH%IJL&L:$][926-[)9/<ZK
M<0)Y]C-+!,TD+CRG;H>:_A:^,,WC'_@LW_P73G^"_P 4-:UFQ^&FF_&#Q#\+
MK&UT::2\L?"/P^^&_P!N%Q=Z;!N:&SF\5'34@OKL@,UQ="1G H _?>X_X.UO
MV)H_%O\ 9MO\)OBW-X/6_2$^*I+%8;HV#/AKM=$,)F,R)\_V7[2SN1M# GC]
M[OV,OV^_V7_V^OA_>_$;]FCX@P>,-.TBZBL?$?AZ_@71O&?A.ZN/-:T'B/PU
M--)>Z:E['$\MI(^^*>-&9)"5<+\T:Q_P1 _X)A:C\*)_A-!^RA\.].T_^Q)M
M*L?$]K:WQ\5V&HO9FV3Q)'JAO=TFLQS[;UI&3R7GW8@1"$'Y1_\ !)[_ ((0
M?M4?\$\?VSO&/QXMOC[X2L_A FM^)/!<'P\>QO-:U3XH_"VZN%ET?7-3GM+N
MVL-"\36RQQI:&_MKJZLE#KC;*QH _7?]NO\ X+!_L9_\$YO&/A+P)^TOJ_Q&
MT_Q#XUTFXUG14\%?#^_\76365ON\PW-U9W4"VT@Q\J,ISQS7P=_Q%/?\$ET^
M]XN^._R8R&^"VL9.<\E?[2!..AXX_ U^)/\ P=N#_C*']F@;&8/X/DB?(.SR
M7U%$F4^BF-F#$] Q[BOWA_9L_P""7W_!%OQ5\ ?@UXA\7_LV_LPZIXLUGX<>
M&-3\07^IZS*-1N]5NM)@EU&ZO5/B.$K<2W)D:;,,85RP48 R ?2?['__  7*
M_P""=?[;/Q!A^%OP@^*VM:-X[U"&-]!T'XH>&9_ =SXEFDF\O[!X=_M"[F35
M-27[[6D;+)Y9&PLQ"']>SUZ8_#'Z=J_RWO\ @KC\)_V;?V7/^"D'@:R_X)A>
M(XK^>T?PQXJT;2O 6N1^)-,\"_&Z+Q&]OIWA#P9<6;32K:I;Q6EQ)I<D]RPN
M998I))54$_Z</PGO/$FH_"OX9:AXR6=/%]_\/?!=[XK6ZC\FY7Q)=>'--FUQ
M;B+ \J<:F]T)8\#9(&7 Q0!WS$@$@$\= NX\\# SZGD]A7Y%_M\_\%LOV'/^
M">NOS_#SXK^--2\5_&"/24U _#3X>V \1ZKI+7,<<VFQ^+KBVF\KPM_:44AN
M+3[:DDLENA;R@I5C]._\%%OVG(_V.OV+/V@OVB 774/ 7@34#H,T>T/:^(]<
M*:#H%X-V5;['JVHVEWM8$-Y.""#BOXE_^#?+_@G-X)_X*8_&WX^?M=_MC1'X
MN^&_ GBR*#6_#7B&^NKA?''Q5\4QGQ ]YXE\R4WEUX;LM-EF:UT^">&&"[6&
M.(1P I0!^V7PE_X.N_V"?&'B--%^)?@WXJ_"S3[J2WM['7O[%?Q39FXN)HX2
M^H16D=G)IUA"',T]^YE2&%'<K@5_2;\/OBC\/_BOX!T7XI?#7Q9HOC?P!XCT
MD:WH7B7PY?Q:EINIZ>T)G$MO/"Q7S$0$2V[;9$D'ENJLI%?A9_P4F_X(&?LD
M?M%?LS^,]&_9A^ 7@'X4_M':)8P7OPJU[PY=_P#",:?J6J1W-O&VA>+[J\DN
MK:;P[/8O<SRQ,L4QG@A E()0^M_\$:?^"<?[0W_!-7]G/XC_  D^-/Q\TSXM
M:!XE>U\5>#/!NC:7>6ME\)-1N=%O3XOT6RU&ZN;A=4MM2U&2WGBEME@MD:U/
MDQ!&!(!YCX^_X.9O^"6_PV\;^+OAYXI\4?&^W\0^"O$.H>&->^R_!O6+FRBU
M73)O)NDM[U;Y8YX XQ'.JA77E>M<>/\ @Z?_ ."3'/\ Q5OQVZ[1GX*ZO\V.
M1L_XF7S;NQ R>Y%?R=?L;^%OV5_&W_!9CXJ:'^VA#\.+OX!W7CSXHR:\GQ9U
M5=&\'2:A%=J=-2YO3<V*)<[MPMT>XC#DG<ZCD?UE']F?_@V0!V_V#_P3\&<H
M WQ-TM/NGD 'QAP!D\CK[T ?J+^P;_P4:_9J_P""CW@3Q5\2/V9-1\8ZKX9\
M&^)9/"6N2^,_"=UX1NH]7BB$SK:VEU/<-<PA&7]^K*#TQ7SE^SA_P7 _81_:
MJ_:I?]C?X1ZW\4;OXU"[\>:?]EU_X:ZCHGAE;GX<+=-XE!\037DD&V/[+-]C
M?R<7F%"%=U?47["WPI_8-^&?PUUA_P#@G_H?PATKX5>(/$EW<ZU=?!?5TUOP
MQJ/BB"*-;QKJ^AU+5(3J$43Q>8BSJ0&7<O(S_"A_P1)Y_P"#@J0]/^*F_:XY
M&,R?N=?&).,$+C@  C'6@#_2%SQRZCY0P(^7KP,CG()Y/J/SKP[]H_\ :%^'
M?[+'P7\>?'_XM3:S:_#OX;:4-8\47.@:7)K.K0V+7-O9K)9Z1"\<UZYGN8QL
M212$W-SLQ7N)1<,!D9[]_P ?7;_!@ #C@U^5G_!;8$?\$MOVO2IR5^'5O][D
M,!X@T@<CU.<GMF@#U/\ 8"_X*7_LO?\ !2SPK\1_&/[+^I^.-1T7X6>)-'\)
M^+)/&W@V\\(7*:OK>F/JU@-.@NKFY:]MVLXG,TZ%%CDQ&5R:_0 ,",=]Q!Q\
MQSZG^ZO7C\*_CK_X,]5'_#/_ .VT 6&?C?\ #G(!^4?\4'?9*C!P6ZMU]L8R
M?[%MN5"C@G&<8&  <LG?/U)Z_B #\]_V^/\ @IK^RU_P39\/^"_%'[3FI^.]
M.TOQ_>WVG^'V\$^#+SQA,]SIJ1/<K<VMI<0-:)MGC*.Q8.<CC&*^D_V:_P!H
MKX;_ +5WP3\!_M _"2?6KGX<?$;2(==\,W/B'2)="U>6PD=D#W^ES/++9R91
M@8'=FZ'O@?RG?\'?(V_!S]E\?>4>*?%P^N+;3\<]?][!^;C&,5^X/_!#A?\
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MI@?VGDCN!TQ]:^VOV+O^"TW[ /[>GCJX^&7P*^)^K6OQ"%HUUI?A#XC^')?
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M>AV7B#3-%\::++X>\3V%GJ4"W$$&OZ%/))-I6H")E+V4DCO%D9))K_/_ /\
M@B;^QY\1/^"KG_!0/XB_M_\ [3VE7?B'X6^ O'\OCG6)]49_[&\5_$K4)YKS
MPKX.TNSO/,.H^%-!M(7EU2VMW6'3[N&W@PK2K7^AJD21JJ1J$6-%CAC'$<<:
M#:BA1_=4*!]* !2VU6/(7))?Y"0>H8=<KP0.<@CBOA?]N[_@HO\ LQ?\$XO
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MB'Q/\<;?7? _B/6O"FO"#X,ZQ-9QZOH-_+I]^MK=C4%2ZA%S"X@G0!9H\,%
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M-?OVEM1_9]_;.^/?["'CZ_O[:P\?W7BI_">FW<JV.EZ7X\^&NHW\'B"_:WG
M;[7XJTZWMDL47$DY6W.648K^Q?\ X*$?M/:?^QS^QU\=_P!H2_O!97O@KP/J
ML7A:<P^?'#XSUFV?2O"3SQ?Q1QZ[=V;W"G.41AC)H ^6?V^/^"V?[#7_  3X
MURX\!_%'QO?>+OBW%;122_#7X?6:^(M5TB2YCCGLT\5W%O(8O#7VNV<3P_:U
M>5UP#$I8$?G%\*O^#KW]A'Q?XIMM#^(O@;XI_#+1[ZYBLX/$K:4?$-I;RSR+
M%'=:A!:QV<EGIZ[@]Q=;W6WCW2L'VE3^*'_!OU_P3F\)_P#!3CXY_'7]K_\
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M <K_ *\[?_)(_0VBOSR_X>=_LQ_\^WQ?_P##3^*/_C%'_#SO]F/_ )]OB_\
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M?P _Y]O&_P#X7OBG_P"6='_#!?P _P"?;QO_ .%[XI_^6=?9]% 'QA_PP7\
M/^?;QO\ ^%[XI_\ EG1_PP7\ /\ GV\;_P#A>^*?_EG7V?10!\8?\,%_ #_G
MV\;_ /A>^*?_ )9T?\,%_ #_ )]O&_\ X7OBG_Y9U]GT4 ?&'_#!?P _Y]O&
M_P#X7OBG_P"6='_#!?P _P"?;QO_ .%[XI_^6=?9]% 'QA_PP7\ /^?;QO\
M^%[XI_\ EG1_PP7\ /\ GV\;_P#A>^*?_EG7V?10!\8?\,%_ #_GV\;_ /A>
M^*?_ )9T?\,%_ #_ )]O&_\ X7OBG_Y9U]GT4 ?&'_#!?P _Y]O&_P#X7OBG
M_P"6='_#!?P _P"?;QO_ .%[XI_^6=?9]% 'QA_PP7\ /^?;QO\ ^%[XI_\
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M_P#A>^*?_EG7V?10!\8?\,%_ #_GV\;_ /A>^*?_ )9T?\,%_ #_ )]O&_\
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M#;1;WX;^+;>UUCQ[X \1>%-*N[B;Q+#+#;6M]J]C:P3W,L8\U8HW+LF7 VT
M>?\ [5/_  ;4?M+_ +-/[./QJ_: \3?MTZ/XYT#X2?#OQ!XZUKPA#I7Q A?Q
M)8:#:&[GTB*34->N;%'O5C\M#=P30&0KO4#D?5G_  9\2>?+^V1<@,J7%I\,
M9$C./W:NVM/L)0!"5WCH..>U?TZ?\%4=$U[Q1_P3B_;1\.^%M#U;Q+XBUC]G
M_P ?V6B^'M!L)]6UO5[^?2G6WL-,TRSCENKVZG;"0P01O)(W"J3BOYQ_^#2O
MX0?&+X6#]K/_ (6K\(_B9\+O[5T[X8C2O^%A>#-=\)#5GMUU<W8T_P#MBSM1
M=O;;D\]8-QB#KO W"@#\1_VD?V>?!?[5_P#P7W^,O[//Q"U/7M'\$_$[]H1M
M"UW5/#+6J:_:6EQ8Z:AFTU[R.:V6X4NVTSQM'P/EK^C/_B$)_P""=I)4?%?]
MI,$-@'_A(O"/#@<,67PF,].A(!;.1CBOY\_VS="_;)^ O_!9WX^_M0?!C]EG
MXP>/KKP=\;I/$_A&];X5>-]5\%Z^T-A8".2/4M)TYUO+!WB(\VRE968,%.X5
M^B9_X.#_ /@MZ69_^'<<R(68A!\&?C*=H.2 I;3]Y5?N@L=QQSDF@#^I+_@F
M?_P3$^!W_!+CX8^._A/\"O$?C_Q/H7Q!\;KX\UJ^^(%_IE_?PZO'I<&DB"R;
M2M.TR**T-O;J^R6%W,I)WD' _P \36OV9_$O[97_  68^+7[,O@GQY#\+_%'
MQ4_:.^,]AI7CVZAU.:'0KG1+K7M;FDDCT>>TU(FYBLFM(Q:W$3;Y5:1_+W5_
M9=_P1?\ ^"G'_!0/]N7XT?&/P/\ MB?LM2_ /P?X'^&NE>*O!^OR> O'?A%=
M=\27GB:+2+O2#>>*[6"SNO(TMY+S[/;,UPI7S&'EBOY[_P!B;X!_M :/_P '
M&FF?$36O@-\8]'^'A_:7^/&I-X^U/X=>)[+P='IMYI/BF.PU"7Q)/IZ:0MA?
M&6%+.[^T".X,D81V+#(!\ _\%1_^"57[3'_!,36?A['\8_B?KWQO^#/Q#G@M
M_P#A._#E_P"*K'1FU."XCDO_  =>VNO:C?6MAKM[9I<-H[WQ>"9E%QL,4;"O
M['/^#>CX0?\ !-K3_P!F&X^,G[$>GZ_?^.?$5T-&^,6M_%.[TW4_C+X7U@I'
M+_P@^N3Z;'!9P>'[>2.0Z'<V%M#!J]I']J,DS(1'^M/[<7[)/P[_ &Y/V:/B
M=^SA\1[2!M.\;Z'<KX?UDVT,U]X7\46B22:)XBTR2Y1UMKRTO,0F:+;(;*XN
MHD9#(&'\'W_!*_5?VT/^"0?_  40\7>#/B'\!/COK_P&U'Q3J/PM^-NN^#_A
M5X[\1>$;_3M*N&CT?XF^'3I6G31ZM-IRI#%8R0/(#:SW*Y*MB@#]6O\ @[-_
M:[70?A-\(/V,/#5_:MJOCW7XOB=X_CL[J:'4-(TSPD"?#%O=QQ2+YNFZ]->7
M_GV\JLLJVL;,&P /Q]_8\_X+7?L>_LQ_\$V_&G_!/SQ+^RC\7?&O_"T=%\=1
M_$WQMH_C;PE9:9JWB+QS:+:76J:397MH]_;6=@;>UEM8G<S1NCG=\PQZA\1?
M@+^T1_P5I_X+FV_B3Q[\!?C/;?LS7/Q3TK3;7Q=XI\ >)O ^E0_LZ> 7^TZ?
M>&[\0V%M9#5KEY%233F8SWBM(OEO@@_WH6O[*/[,%I;VD$?[.WP/86L-M912
M3?"OP.SM!:0QVT9=VT(DN(XER6R6(W$DDD@'^>S_ ,&T/[8FG_LW?M]M\*-4
MU:#2/A5^TYIDW@U!J,C-)!XITJ:YF^&^F1,Q$?VZZFO&L;F1 /.(<J"I K]H
MO^#OT+'^SI^QH"H.SXW^/L#DD#_A"+7=LSU/]T'MQVK\^/\ @OW_ ,$]?C%^
MS3^WM\+?VM?V)O@7XNDT;QI/I'C6U_X5!X%O?$5MX4^-7@V^^TW.H_\ ".^'
MM/EL_#^FRZ1%8R68:TMK6:^DG2)20:^M?^#@G4?C)^VQ_P $X_\ @FU\5? O
MP'^.&M^)_$OBOQ#K_C/P-#\.M>O/'?AF_B\%PZ'J4WBS0;#3VNM"^WZUI]W/
M;?:8+=98KB'8/F H _,?]C;_ ()H?\%I?CG^RU\,?B-^S9\8+OPY\"/&VA:E
M/X&\/+\5(?#RV^CMJ=]I]["FG&ZAET])[VVO.FQEDW29R:_6S_@G)_P;+>-O
MAU\?/"?[3'[>/Q6TSXF7WA&_M/%6C_##3+K5=:O=3\;V,\=UI^H>./%NI7=T
MNL:=I$RI/96]I*)3=6J,SK P4_MW_P $-?"OBSP3_P $L_V2_"_C?PSX@\&^
M*-+\':U'J_AKQ5I-WH>OZ7(_BS7I8X-2TJ_BAN[.4Q/%(J31(SQLDF"'S7ZS
MT 1LBR*PDB5HF4H\3QAHVC*&-P4QAU9"5*$;"N01UK_,N_X.'_V2?AM^SS_P
M4GOM/^&%JGAOP[^T GACQGJNB6<82#1O%WBW4+:V\2:KIZJHCABO[J\-ZEI"
MJI"R!%4+G/\ IHL!RQ.-Y.>3SMXRJ]V&0#@8ZD]*_@H_X.6_@;\=?B3_ ,%$
M?@GX@^&_P3^+7Q#\/V'AWX?K>:]X(\!>(?$VC6;V^MZ4\Z7&HZ58W-M%+"BN
M\B/(#'&KLP&": /Z_P#_ ()V?LO_  T_9%_8]^"?P<^&.EPV6DV/A'2O$.M:
MBJ%;SQ)XKUZQM]0USQ#J+$DR7FI7<K.ZC"11JB(B@'/VYTZ\5YO\'H+BT^$_
MPTMKRWFM+R#P+X7@N+2ZC:&[MYHM(M4EAFA<!XY(G!216 964JW(Q7I!Y&#G
MTH ^>/VK_C]X?_9=_9Q^,?Q\\2- ^G_#+P+XC\2PV$]];:<VLZI8:;<3:9HU
ME<79$1OM2NUCM[:(9:64J IYQ_E^?\$__P#@HK\/?V4?V]M4_;L^/OPW\;?'
M36K]OB!K.B>'=*UO2-.U&UUGQU-</9:EJMYK\%S!<3Z!:S6\-A)'M>.:WW(=
MNT5_6K_P=+?$/X[>)/V??A1^R?\  WX1?%#XF6WQ.\6MXM^)]_\ #_P+XI\1
M?V)I/@_[/?>%[9M3T2SGM(_[2U5KF*ZLYGW/#%$9%*FOK[_@AO\ \$V_A?\
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M?^"B&A-'9VL]T\0T?XFA)%@@DDE60GQ&S;75"IX88+9#=*_/?_@W.T.?PO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2@8Z #YMW0?>]?K110 [<WK_ "_PIA ;[P!YSDCD'V/5?PQ2T4 *"5&%P!Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4
MD??\/ZU'4D??\/ZT 1T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5)'W_#^M1U
*)'W_  _K0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g4bdklltl5z5000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000004.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" +S!G(# 2(  A$! Q$!_\0
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MI_T+&G_^ 4?^%'_"(^%/^A8T_P#\ H_\*T**.:7<+(S_ /A$?"G_ $+&G_\
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M_0L:?_X!1_X4?\(CX4_Z%C3_ /P"C_PK0HHYI=PLC/\ ^$1\*?\ 0L:?_P"
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M=PLC/_X1'PI_T+&G_P#@%'_A1_PB/A3_ *%C3_\ P"C_ ,*T**.:7<+(S_\
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M?_X!1_X4?\(CX4_Z%C3_ /P"C_PK0HHYI=PLC/\ ^$1\*?\ 0L:?_P" 4?\
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M'_"(^%/^A8T__P  H_\ "M"BCFEW"R,__A$?"G_0L:?_ . 4?^%'_"(^%/\
MH6-/_P# */\ PK0HHYI=PLC/_P"$1\*?]"QI_P#X!1_X4?\ "(^%/^A8T_\
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M_H6-/_\  */_  K0HHYI=PLC/_X1'PI_T+&G_P#@%'_A1_PB/A3_ *%C3_\
MP"C_ ,*T**.:7<+(S_\ A$?"G_0L:?\ ^ 4?^%'_  B/A3_H6-/_ / */_"M
M"BCFEW"R,_\ X1'PI_T+&G_^ 4?^%'_"(^%/^A8T_P#\ H_\*T**.:7<+(S_
M /A$?"G_ $+&G_\ @%'_ (4?\(CX4_Z%C3__  "C_P *T**.:7<+(S_^$1\*
M?]"QI_\ X!1_X4?\(CX4_P"A8T__ , H_P#"M"BCFEW"R,__ (1'PI_T+&G_
M /@%'_A16A11S2[A9!1114@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD]JCS6OF+MD\MR-R;E^5MI&1P>*O5"Q,X*/+NFW?NW_P$OQ'[.,KWZV7W?\
M!/GW0M+_ ."D_BGQ#I.D>-O$GPQ\,:18ZA#-K6K>'(+J\NM1A0[C#%%<#8BR
M8V,2590V5/&TX_[<G[$GQ&_:.\:Z/XS^$?CNR\.W%SHLGA_QK<75U.CWNCM<
M1SK%&(T8$AQ+E3L#APK-M&*^FJ*J.,J4ZJJ02379=^_?].@G1C*+C)MW*?A[
M0=)\*Z#8^&- L8[6PTVSCM;&UB7"PPQJ$1 .P"@ ?2KE%%<AL%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ ILLL<,;32NJJJDLS'  ]33J9<"5K>18&59"A"-(I90<<9&1D?B*
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MU Z5UM<=1151J.U]#6-^57"BBBI*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BD9U12[L%4#))[5B:A\2_ .
MF,R77BNSW+PRQ2^81^"YH W**Y=?C1\,V;:/$Z_\"MY1_P"RUJZ3XS\)ZZXB
MTCQ%9W$C=(XYQN_[YZ_I0!IT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%5=;US1?#6D77B#Q'J]KI]A90-/
M>7U[<+%#!&HRSN[$*J@<DD@ 5%X9\4^&?&NAV_B?P;XBL=6TV[4M:ZAIMVD\
M$R@D$I(A*L,@C@GD&GRRY;VT,_:T_:^SYES6O:^MMKVWM?2Y?HHHI&@4444
M%%%% !1110 &OFWP5\1?C/\ %B]\)^'4^,U]X?DU+2/&5Y>:AI^DZ?)YDEAK
M-O:6@D6>!U\M(I6#!-C-@$N#S7TD>1BN3U_X#_!#Q796NF>*?@YX5U*VL6G:
MQM]0\/6TT=NT[^9,45T(0R/\SXQN;DY-=%&I3IWYE^"?1K9^;3^1G4C*6S_J
MZ/G/0_VBOCY\6O%_@_2M"U3Q)Y.H>"=5O=0A^&L.ADWEQ::O]A6]1]:4J+:5
M!Y@16+#S8\;@&:K7Q5_:C^,7P5^)/Q.TG6=9EU#PCX>\.V%GI^N/I\+7&D:M
M/ISR6]S.(XE1H9YUV.S+L21X0 B,V/H+Q5\!_@?XZ6R7QO\ !OPKK TVU%MI
MPU7P];7'V6$=(H_,0[$&!\JX'%7[?X7_  UM--OM&M?A[H<=GJEC%9:E:QZ3
M"L=W;1Q^5'!*H7$D:Q_(J,"H7Y0 .*Z/K6%O_#5NUEW3W]-%I]Z,_95?YOZM
MV/%/"FM?'#Q-\1?A:)_C_JT&G^,/ LNO:II<>AZ9Y?G6J:7NC5S;&0)*;N9F
M^;()&PJ !7#^"/CW^T7\2;KP%I5MXI\87CZOX+UK4]4B\#V/A^.ZEFM]72UB
MD<ZH@A6)8GVE8R&+%#@C<:^L+;PEX6LI]/NK+PW80R:39-9Z7)%9HK6=NWE[
MH8B!^[C/E195< ^6F1\HQ7T/X=^ /#%S;7GAKP/H^GS6=G+:V<MCIL4+0022
MB62)"JC:C2 .RC 9@&()&:E8JBEK!?<O[W^:^X/8S_F?WOR_R?WGSWXV^/7Q
M@\+^/_%WPHT_XA6\>WQIX;\-:3XFUK3X&&D)=Z5]HFNW2*-$FE>5"J*VV,2S
MH,!!L.Q\<OBIXV_9J^$_B4:O^T1#KVK7VI6.F^&;N]\.P-J&BR70(>:>.R39
M<K'&DUTBBV0D0LI$N1CVK5/AM\.];AU:VUKP'HMY'X@\O^WH[K2XI%U'RU"I
MYX93YVU551OS@  8 JCX/^"'P<^'\-O!X'^%GA_25M+QKNU;3]'AB:*X:(Q-
M,"JY$AC9HR^<E"5S@XH^L8?2\-K75EK9+K:ZNUT[^H_9U-=>_?0\#L_CC\3/
MBQ^RWX5^+'@CXXWFCZS9^(M-\-^*!8Z+9,MW=3:K:V,MP\5U;LT#-%+]H2,*
MF!.FY>U2>,?CM\:O!OC?Q7\);;XD6[21^*/"_AW3?%6M:9!MTG[;8/+/>O'$
MB)+(\B;41ML8EFC'"94_1D_@CP9="Z6Z\):;)]NU"&^OO,L8V^T74/E^5.^1
M\\B>3#M<Y9?*CP1M7$.I_#?X>:W%JT.M>!-'O$UY8UUQ;K2XI!J*QKMC$^Y3
MYP4#"[\X' Q0L30N[P5M;:+2[3WMK:S^^PO95/YOS\_^ ?-?QX^-_P ?/@<G
MC[X9Z-\4IO$-WI_A'3]<T7Q9>:+9BXT:6;48K1K.Z6&);>7S%9I8B8XVVI*"
M'VAAVWP"_:,\;?%+]H/4OACXJM_[+O/#G@N$>*/#OV7"VFL"[=7EBD9=\D$L
M!ADB8,5,<BYP^X#TSP_\"/@GX5\,77@KPY\)/#=GI%_*LFH:;;Z+ L%TZD%6
ME3;B0@@8+ D;1CH*WHO#'AN'Q%)XPB\/V2ZM-9K:3:HMJGVA[=6+K"9,;B@9
MF8+G +$XR31+$8>5-QY->^B[=/D]/^#=QIU.:_-\OO\ Z_I%ZBBBN$W"BBB@
M KRCXTZK\0]1^-W@OX8^#/BA?^%[75O#NO7U[<Z;864[R36KZ>L.[[5!*-@^
MT2DA=I;(^88%>KUS_CGX3?"SXGFU/Q*^&N@>(OL0D%G_ &YH\%W]G#[=X3S4
M;;NV+G&,[1GH*THRC"I>2[]$^G9Z:$S3E&R/G33?CO\ '?XCZGX/T70]?\1W
MAFTOQ,-2NOAI:Z$O]K/INK6UC%?H=8+Q+;NCNQ6-]V^5<;D7-=+\7_C7\4/@
MIXEU[X5R>+6U35O$OA[35^%EYJ-G;122:G)-'IUPDGEJD<QCFEMKUP(P DTH
M50D8"^N>)_@7\$_&MCIVE^,O@_X7U:UT>W\C2;?5/#]M<1V46%'EPJZ$1KA%
M&U<#"CT%:"?#CX>Q-HK1>!='4^&XS'X=*Z9$/[*0QB,K;?+^X&P!,)@;0!TX
MKJ>(P_,O<5M=++O=:_<MMKF/LZEOB_JUCQWP!KWQI\6?M >*/#-]XT\>R:'X
M:\5V]C'=Z;:^'$TORDTNRN7BNO-B^W%Y9)7#- NT"9 K)M)6.R_:#^(FD_L9
MZA\:+[4;&ZUR/Q%J&GQZAJ4 CM;./^WYM/CN)EB"_NH(=LCXP2L+$G)+5ZKJ
M/P(^"&K^,E^(NJ_!SPK=>($NHKE=>N/#]L]XLT>WRY!.4,F]=J[6SE=HP1@4
MFD_ 7X&Z!JU]K^A_!KPK9WVIPS0ZE?6OAVVCFNXY3F5)75 TBN?O!B0W?-2Z
MV'E:\=N79)7MOUZ]_P "O9U%?7OU[[?<>+_$GXB?'/X"WMUX;G^-K>-&U;X9
MZYJ]O=W.AV4%SHM[86PD2\06Z+&UI([A!'*CLKB,>8X+"N-TWXV_M:ZC\*];
M\7^'?$'BJST^>P\/VVEZ_P#$3PG8V=U!K%UJ=O!-]F@A@B6XLS!/G?(F0V C
M$[MOTQX4^ 7P.\"6>I:?X+^#_AG2H-8MV@U:'3]#MXEO(2"#%*%0!X\,PV'*
MX)&,5T%]X8\-ZGHT?AW4O#]E<:?"T)BL9K5&A0Q.KQ$(1M&QD1EP/E*J1@@5
MI]:H1M[B>JNVDMGV6B[=N^Y/L9O[37S9\UO^TM^TOJW[0/P^\)Z_X"E\%Z'?
M2:SIVO6-];I))JNHVNF37#RV[L"?L22+%Y4JE3+E]PP,')@^+?[2&F_L6ZC^
MT#>>//&UOKDG@W2KO3[CQ+8>'&TZ>XNG@+W%I'8Q&8( 6 6YVG9,,H7!*?5&
MJ^$_"^NZG8ZUK7ARQO+S2VE.FWEU9I)+:&1#'(8W8$Q[D)5MI&Y20<CBN9TC
M]FC]G/0%NET+X!>"K(7UM]GO!9^%;./SX=ZOY;[8QN7>B-M.1N13U HCBL/I
M^[2M;I>]FV]^Z:778/95-?>[_DCR/P'\<OBO\;?C;?? ZX\6W7@G6-&\#E_$
MUGI^FV\S66K1W\2F:$W43B2WFMV5HR0RF.8'AU.WT+]CS6?'_B_]GWPW\0_B
M1\0;KQ!J7B32;;4I)+BPM;=;7S(5)A1;>*,% <D%@6YZXQ7H"^$_"Z>)F\:)
MX<L1K$EB+)]6%FGVIK8/O$)EQN,8<EMF=N3G&:FT/0M$\,:1;>'_  WI%KI]
MA9PK#9V-E;K%#!&HPJ(B@*J@<   "L:M:G.'+"*6W;SOKO9Z%PIRC*[=]RU1
M117*:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<7\1/C-H?@W=INF[;[4.0T*/\D/^^?7_9'/KCBJ'Q]^,MG\,/#=
MWY,^VZCL7N9IN#]G@56+/_O84X'X]N?@;]HS_@HU\)_AQ%<:/\,;R^\<:M8S
M3OXFM/ =LFJ7F@VMM,1=7%RNX0VH58YD#W+H@D:,D.N5(!]2^)/&_BCQ5.9=
M<UF:56/RPAML:^P4<?UKD]0\>^#-)T:Y\1ZSXHL;'3;.62*XU"_NE@@1HR1(
M/,<A?E*L"<X!4CL<>!:Q?_MF?&26VU[3)/"_PXTNUTRWD\C[6NN:U,\LL4OV
M,Y>WL[.XF01PAF-VF)"1MW 'EY_V$_AQX8\4>'O'_P ;/C]>>(M6\)P)=Z>W
MCJ.&]L]%L(+3%^BHJQ6L4C&19Q<F%''D(<,OG;P#Z.^%7QN^'OQG\,6OCGP%
MKT%UHNI3,FCWWG*OV\* 2\:9W!>>CA6XSMVE6;K@2IR*^1/&,_@7]FG]K[PC
MXJ^&TNEZMXC\5277ASXB6M@DB7'V+R)M0L[LZ=96KA1$WD6XNE"AUF1)"Y"M
M%]7>')]3NM#M;O6"OVB:%7D46K0[21G:8V9BI'0@L<'- '<^"_C#XK\)W*I<
M7DE_9]&M;B3./]UB"5QZ=*]G\&>.] \<Z=]MT>X_>+Q/;2<21'W'IZ$<'\Q7
MQ+^TW^TUX/\ V6O!-IXV\8>&]8U:.^O9[>WLM$6W\X^187>H3.3<S0QJJ6UE
M</RX+%55068"O2_A_P".YX(M.\=>%KF15NK:.XM_.B*[XG4,%=3@C((R#R/8
MB@#ZHHK*\&^++#QGX?@URQ^7S%Q+%N!,;CJI_P \C!K5H **** "BO#?B%_P
M4$^!7PT_;G\$_P#!/?Q#8^(&\>>/O#LNM:'-;:?&VGK;1I>NPEE,@97Q83\!
M&'*<\G#?V8?^"BW[,7[6GQJ^)G[.WPN\3W4/C3X4^([O2/%'A_6+=8)Y/L]R
M]M)=VP#-Y]MYR%-XPR$IO5/,CW]+P>*C3]HX.UE*]NC=D_2^GJ9^VI<W+S*]
M[?/>WW'NE%?,_AK_ (*M_LR>*H/VA+C3-+\5!?V:))T^(GFZ5$/-,1O WV/]
M\?._X\9L;O+ZIZG'@?@'_@YU_P""='Q(\::+X$\.>%/BE]LU[5;?3[&2?PK;
M+%YTTJQH6879PNYADX.!713RG,JO-R4I/EM?3:ZNOP=S*6,PL;7FM=OOM^9^
MBE%? OQQ_P"#CG]@7X ?&SQ9\ _&?A3XF76N>#=<N-)UAM(\+P3P>?#(48HQ
MNE)7*G!*@GTKV;PU_P %8?V-]5_8B@_X*">+_%^H^$?AY=7LUG;R>)M-,=_-
M<QW#V_D1VT+2O+(SQN55-QV*SG:JL553*\RIPC*5*5I-):;M[)>HXXS"RDTI
MK3?RL?2E%?GS\#O^#F/_ ()H_&?XE6/PXU:]\;>!%U2Z6WTOQ%X[T"&UTNYD
M9PBDSP7$WDH21F298XT'+LH!K)\4?\'1/_!-[PAXEOO"FL>%?BG]JT^^FM)O
M+\*6Q5I(W*-M)NQD9''%;?V%G'/R>PE??8S_ +0P7+?VB^\_1RBOC/PC_P %
MT?V,/&>E_!C5]*T+QU''\=O&UUX6\$K<Z#"K1WT%W9VCFZ'V@^5'YE]#AEWD
MJ'.!@ WOV]/^"WO["_\ P3U\>Q_"+XK:]KWB3QIY,4UYX1\"Z;'>WEA'(N^-
MK@RRPPQ,R$.(S)YA1D?9M=&;&.5YE*LJ2I2YG>RMV=G]ST?F:?6\,H.3FK*W
MXZK[T?7U%?.7["7_  52_8]_X*)^$=5\1?L[^,[QM2T&W$^O^%==L?LNJ:?&
M2P5VCW,DB';]^)Y$!(#,&.*9^SS_ ,%2/V;?VFOV,?&?[=?PYTSQ1'X)\"V^
MK3:U#J6EQ17S+IUF+N?RHEF96)C8;<N,MP<=:RG@,93E*,Z;3BTG=;-[+Y].
MY4<11DDU):W:^6_W'TA17R+XL_X+:?L-^!OV'?"O[?'BW7?$%EX5\<7UW9>$
M=!DTE6UK5+BVN9[>9([=)"BA6MY&,CR+& 8PSAI$1M;_ ()[?\%>OV3O^"E&
MLZWX2^!MCXPTCQ!X>M!=ZIX?\8>'?LL\5L75%E\R&2:WP68 )YOF'D[< D7+
M+<PA1E5E2DHQ;3=M$T[/[GH_,F.*P\IJ"DKM72/J2BBBN$Z HHHH **** /,
M?VUO^30OB;_V(NJ?^DSUR_\ P3._Y,8^'O\ V#;C_P!*YZZC]M7_ )-"^)O_
M &(NJ?\ I,]<O_P3._Y,8^'O_8-N/_2N>O17_(I?^-?^DL^#J?\ )SZ?_8'/
M_P!/TSW:BBBO./O HHHH **** "BOGO_ (*#_MR6'[&?P^LGT71X=4\5>(&E
MCT.QNF;R8EC"^9<3;<$HI= $!4N6X( 8C\U]<_X*5_MPZ_J,FI7/[0&J6[.>
M(;&UM[>-!GH%CC _$Y/J37L8')<7CJ7M(V4>E^OI9'Y1QIXP\+<%9E_9]>,Z
MM9).4::B^2ZNE)RE%7:::2OIJ[75_P!K**_$?_AXC^VS_P!'&>(/^_D?_P 1
M1_P\1_;9_P"CC/$'_?R/_P"(KM_U7QG\\?Q_R/CO^)D>$_\ H$K_ '4__DS]
MN**_$?\ X>(_ML_]'&>(/^_D?_Q%'_#Q']MG_HXSQ!_W\C_^(H_U7QG\\?Q_
MR#_B9'A/_H$K_=3_ /DS]N**_$?_ (>(_ML_]'&>(/\ OY'_ /$4?\/$?VV?
M^CC/$'_?R/\ ^(H_U7QG\\?Q_P @_P")D>$_^@2O]U/_ .3/VXHK\1_^'B/[
M;/\ T<9X@_[^1_\ Q%'_  \1_;9_Z.,\0?\ ?R/_ .(H_P!5\9_/'\?\@_XF
M1X3_ .@2O]U/_P"3/VXHK\1_^'B/[;/_ $<9X@_[^1__ !%'_#Q']MG_ *.,
M\0?]_(__ (BC_5?&?SQ_'_(/^)D>$_\ H$K_ '4__DS]N**_$?\ X>(_ML_]
M'&>(/^_D?_Q%'_#Q']MG_HXSQ!_W\C_^(H_U7QG\\?Q_R#_B9'A/_H$K_=3_
M /DS]N**_$?_ (>(_ML_]'&>(/\ OY'_ /$4?\/$?VV?^CC/$'_?R/\ ^(H_
MU7QG\\?Q_P @_P")D>$_^@2O]U/_ .3/VXHK\1_^'B/[;/\ T<9X@_[^1_\
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M $<9X@_[^1__ !%'_#Q']MG_ *.,\0?]_(__ (BC_5?&?SQ_'_(/^)D>$_\
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M\?Q_R./_ (F1X3_Z!*_W4_\ Y,_;BBOQ'_X>(_ML_P#1QGB#_OY'_P#$4?\
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M6\1_S\C][_R"7TA,AC=/+\3HG)^[#1)\K;]_9233>R:MN?LY17XV^/?VK/\
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MU7QG\\?Q_P @_P")D>$_^@2O]U/_ .3/VXHK\1_^'B/[;/\ T<9X@_[^1_\
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M/\*/^$U\5?\ 0;F_3_"@#U2BO*_^$U\5?]!N;]/\*/\ A-?%7_0;F_3_  H
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M'4;G6["U\&>*99]2T&%M8U1;#P_IT4KZ?\RFS7%OAY+HQND8;"HT)EY:)%8
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M\*=;.K^ M0_MB\MO[+O#-;3&7R[>9$G_ 'EG;MMF5U_=XQAF!Y?]K[_@F/\
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M_&Z/[9RO_GZOQ_R#_B$7B/\ ]"Z?WP_^2/AVBON+_AQ7\>/^BR^$?^_=U_\
M&Z/^'%?QX_Z++X1_[]W7_P ;H_MG*_\ GZOQ_P @_P"(1>(__0NG]\/_ )(^
M':*^XO\ AQ7\>/\ HLOA'_OW=?\ QNC_ (<5_'C_ *++X1_[]W7_ ,;H_MG*
M_P#GZOQ_R#_B$7B/_P!"Z?WP_P#DCX=HK[B_X<5_'C_HLOA'_OW=?_&Z/^'%
M?QX_Z++X1_[]W7_QNC^V<K_Y^K\?\@_XA%XC_P#0NG]\/_DCX=HK[B_X<5_'
MC_HLOA'_ +]W7_QNC_AQ7\>/^BR^$?\ OW=?_&Z/[9RO_GZOQ_R#_B$7B/\
M]"Z?WP_^2/AVO0OV1_\ DZ[X8_\ 90M%_P#2Z&OJ#_AQ7\>/^BR^$?\ OW=?
M_&ZZ?X)_\$9/C5\,/C+X1^)>J?%GPO<6OAWQ-8:G<6]O'<^9+'!<)*RKF,#<
M0A SQFLJV<9;*C)*HM4^_;T/0RCPH\0L/FV'JU,OFHQG!MWAHE)-OXNQ\'?$
M/_D?]<_[#%U_Z-:L>OO#Q/\ \$0/CGKGB34-;@^,/A-([R^FG1'CNMRAW+ '
M]WUYJC_PXK^/'_19?"/_ '[NO_C=7'.,LY5^]7X_Y')B/"3Q&GB)R67SLV^L
M._\ B/AVBON+_AQ7\>/^BR^$?^_=U_\ &Z/^'%?QX_Z++X1_[]W7_P ;JO[9
MRO\ Y^K\?\C+_B$7B/\ ]"Z?WP_^2/AVBON+_AQ7\>/^BR^$?^_=U_\ &Z/^
M'%?QX_Z++X1_[]W7_P ;H_MG*_\ GZOQ_P @_P"(1>(__0NG]\/_ )(^':*^
MXO\ AQ7\>/\ HLOA'_OW=?\ QNC_ (<5_'C_ *++X1_[]W7_ ,;H_MG*_P#G
MZOQ_R#_B$7B/_P!"Z?WP_P#DCX=HK[B_X<5_'C_HLOA'_OW=?_&Z/^'%?QX_
MZ++X1_[]W7_QNC^V<K_Y^K\?\@_XA%XC_P#0NG]\/_DCX=HK[B_X<5_'C_HL
MOA'_ +]W7_QNC_AQ7\>/^BR^$?\ OW=?_&Z/[9RO_GZOQ_R#_B$7B/\ ]"Z?
MWP_^2/AVBON+_AQ7\>/^BR^$?^_=U_\ &Z/^'%?QX_Z++X1_[]W7_P ;H_MG
M*_\ GZOQ_P @_P"(1>(__0NG]\/_ )(^':*^XO\ AQ7\>/\ HLOA'_OW=?\
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M[]W7_P ;H_MG*_\ GZOQ_P @_P"(1>(__0NG]\/_ )(^':*^XO\ AQ7\>/\
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MP_\ DCX=HK[B_P"'%?QX_P"BR^$?^_=U_P#&Z/\ AQ7\>/\ HLOA'_OW=?\
MQNC^V<K_ .?J_'_(/^(1>(__ $+I_?#_ .2/AVBON+_AQ7\>/^BR^$?^_=U_
M\;H_X<5_'C_HLOA'_OW=?_&Z/[9RO_GZOQ_R#_B$7B/_ -"Z?WP_^2/AVBON
M+_AQ7\>/^BR^$?\ OW=?_&Z/^'%?QX_Z++X1_P"_=U_\;H_MG*_^?J_'_(/^
M(1>(_P#T+I_?#_Y(P_@];C2?VZ_V>_#MEIJVFGV?@'09;&-"=KFYTZ2\N)>2
M>7NKBX8^Y(XQBOG'QIXD^!&L6EG:_"[X3>(M!U!=0C::\U?QI%J4;PX8%!&E
MC 58L4._>0 I&TYR/MRZ_P""2_[4;:'X032/CEX>TW7O!L5Q:Z7XDTZ^O8;@
M6;R&6*$%(PRM')+<XD#9*3*F (QGC5_X(6_'I&#+\9_"((Y!"77'_D.N*CF&
M6QGS2J]$NO1R=WWO>^OF?89QP+XA8K"K#8?+)<KG*;;5)V4Z=&*A%O6/(Z;C
M>/*FK=$CS"Z\,^-_%/\ P53U:#P!97,E]:?&:XNY+BWA9ULX8]4+27$N =L2
M+EF8\!<Y]*['P?%\&?!>B_$?XQGXU#X=1_$3XB75M\.M<A\,W5](NDZ?J"7L
MC0K P"JTQL5W-D?Z-(N#DX]6\0?\$Q?^"A/BS1[CP[XI_;GNM2T^\C,=U8ZA
MXHU::&9",%71\JP([$8KD[__ ((F_M,:KIECHNJ?M!>';FSTN)X],M+B:]>*
MT1Y#(ZQ*4Q&&=F<A0 68D\DFLOKF J1BI5DK)+2[VUZQMO;2VU^YZ$>$.-L%
M5JU,/E%2I*<ZM1>TE&*C*HE!JU.JI65-S]Y33<W!V7)K\\_MW^#_  IIGQTG
M^)_PTU&.^\)_$*W_ .$BT"^@C=4<S2.MU'M< HR723CRSRBE >M;/Q \2? G
M1_A'\(K;XH?"?Q%KU^WP]E:&\TCQI%IL:0_VYJH$9C>QG+,&#'?O (8#:,9/
MN.H?\$5OVH-6T/3_  QJO[1.@W6FZ1YW]DZ?<7%Z\%EYK;Y?*C*;8][ ,VT#
M<1DY-=)X6_X)=_\ !0#P-H-OX6\$_MOS:/I=H&%KINE^)=5M[>$%BQ"1QX5<
ML23@#))/>M?[0R_V,(>V3Y?.2NK-+5+?:YYL> >.I9IC,2LKG36(BM%&C449
M.4)R2A4G;EYE)1N[J-NMSY0\%Z-_PG'[,?Q:@^''AR[6WT[Q=H&L_P!ER70N
MKBUTV--5A:1F5$\T1FXA#R!% W;B%'3N?A/\)-5^)7[*_P -?@OK-M=:8WC#
MXUZCJ,-Q<0^7G1X-+LQ>7T9DP'CB02-D'!,9 R1BO9E_X)'?MK)X[D^*2?M<
MVJ^)I5"R>(AK&I?;W 01@&XQYA&Q57[WW0!T%)K?_!(W]M3Q+KTWBKQ'^UQ:
M:AJEQILFGSZE?:QJ4MQ)9N&5[=I&!8Q,'<&,G:0S CDU,\PP,KVK):WZNSY;
M=M==;_*W4VP? /&&'C'VN559V@Z35Z45*#K.JWI-\K<6X<JNHNTN9I<KXWXZ
MS? S]I'X5_$JQ^%OQSM/$VL:3J7_  F/A/0X_!\NF-I6EVMO'9W-FDLP E1;
M&.T;:@5F-@'(/./GSQM(-6_9%^'^J:HZF\TWQAX@TG3V\L!S8+%IUT$SC+*M
MQ=W+#L#.]?4'AW_@BE^TYX0U1=<\)_M#>']+OEBDB6\TZ>]@E"2(4==Z(#AD
M9E(S@JQ!X)K<^(?_  1Z_:!\<:#X8\(V?Q1\(Z?H_A7119:?8^=>2[YI)&FN
MKEB8@-\LSL< #;&L4>6\O<Q1QV6X=QC&M>*=]=U[K5M$O+IWN5FO!/'^=TZV
M(K94Z=:=/D:C*\9MUHU%)N=2<DTE).\K:045:]OSSHK[B_X<5_'C_HLOA'_O
MW=?_ !NC_AQ7\>/^BR^$?^_=U_\ &Z[_ .V<K_Y^K\?\CXG_ (A%XC_]"Z?W
MP_\ DCX=HK[B_P"'%?QX_P"BR^$?^_=U_P#&Z/\ AQ7\>/\ HLOA'_OW=?\
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M^E+I$6I+<:J'F9]025X1*+2&)(S,0"5'S,26^J?^"5^K?M"^(= \9:W\;_\
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M_P#@IK\)]4^&=G;V^M>*/#NNQ_$*.Q(5KG3HH$:TFN%7_INK*LC#+&-4R0@
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M\2N#^#L1'#YEB+56K\D8N4DN[LK1\KM-[I-'Z=T5^6?_  _,_:>_Z)CX#_\
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MYX=_\_:G_@N1^IE%?EG_ ,/S/VGO^B8^ _\ P!O?_DJC_A^9^T]_T3'P'_X
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MYX=_\_:G_@N1^IE%?EG_ ,/S/VGO^B8^ _\ P!O?_DJC_A^9^T]_T3'P'_X
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M[_Y^U/\ P7(_4RBORS_X?F?M/?\ 1,? ?_@#>_\ R51_P_,_:>_Z)CX#_P#
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M%G_WR_\ \51_PMC7O^?"S_[Y?_XJ@#T"BO/_ /A;&O?\^%G_ -\O_P#%4?\
M"V->_P"?"S_[Y?\ ^*H ] HKS_\ X6QKW_/A9_\ ?+__ !5'_"V->_Y\+/\
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MW_/A9_\ ?+__ !5'_"V->_Y\+/\ [Y?_ .*H ] HKS__ (6QKW_/A9_]\O\
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M )\+/_OE_P#XJ@#T"BO/_P#A;&O?\^%G_P!\O_\ %4?\+8U[_GPL_P#OE_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !5'US!_\_(_>O\ ,/\ 5/BK_H K_P#@JI_\B>-45[+_ ,.]?VU?^C<?$?\
MX#I_\51_P[U_;5_Z-Q\1_P#@.G_Q5'US!_\ /R/WK_,/]4^*O^@"O_X*J?\
MR)XU17LO_#O7]M7_ *-Q\1_^ Z?_ !5'_#O7]M7_ *-Q\1_^ Z?_ !5'US!_
M\_(_>O\ ,/\ 5/BK_H K_P#@JI_\B>-45[+_ ,.]?VU?^C<?$?\ X#I_\51_
MP[U_;5_Z-Q\1_P#@.G_Q5'US!_\ /R/WK_,/]4^*O^@"O_X*J?\ R)XU17LO
M_#O7]M7_ *-Q\1_^ Z?_ !5'_#O7]M7_ *-Q\1_^ Z?_ !5'US!_\_(_>O\
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MN/B/_P !T_\ BJ/^'>O[:O\ T;CXC_\  =/_ (JCZY@_^?D?O7^8?ZI\5?\
M0!7_ /!53_Y$\:HKV7_AWK^VK_T;CXC_ / =/_BJ/^'>O[:O_1N/B/\ \!T_
M^*H^N8/_ )^1^]?YA_JGQ5_T 5__  54_P#D3QJBO9?^'>O[:O\ T;CXC_\
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MT_\ BJ/KF#_Y^1^]?YA_JGQ5_P! %?\ \%5/_D3QJBO9?^'>O[:O_1N/B/\
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M (0SQ3_T!)OR%'_"&>*?^@)-^0H RZ*U/^$,\4_] 2;\A1_PAGBG_H"3?D*
M,NBM3_A#/%/_ $!)OR%'_"&>*?\ H"3?D* ,NBM3_A#/%/\ T!)OR%'_  AG
MBG_H"3?D* ,NBM3_ (0SQ3_T!)OR%'_"&>*?^@)-^0H RZ*U/^$,\4_] 2;\
MA1_PAGBG_H"3?D* ,NBM3_A#/%/_ $!)OR%'_"&>*?\ H"3?D* ,NBM3_A#/
M%/\ T!)OR%'_  AGBG_H"3?D* ,NBM3_ (0SQ3_T!)OR%'_"&>*?^@)-^0H
MRZ*U/^$,\4_] 2;\A1_PAGBG_H"3?D* ,NBM3_A#/%/_ $!)OR%'_"&>*?\
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M4 %%%% !1110 4444 %%%% !1110 4444 >8_MJ_\FA?$W_L1=4_])GKE_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9E4;F;%8U[\1?
MFGEENO%EB&5MK*EP'(/T7)H VJ*YN/XN?#B5MB^*[?/3YE=?YBM?2_$GA_6]
MPT?6[6ZV_>%O<*Q'UP>* +M%&:* "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_CE'_#1'[0'_ $7/QC_X4UW_ /'*/]5ZW_/U?<_\P_XF6RK_ *%\_P#P./\
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ME'_#1'[0'_1<_&/_ (4UW_\ '*/]5ZW_ #]7W/\ S#_B9;*O^A?/_P #C_\
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M?^!#?XT >O45Y#_;>L_]!:Z_\"&_QH_MO6?^@M=?^!#?XT >O45Y#_;>L_\
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M\"&_QH ]>HKR'^V]9_Z"UU_X$-_C1_;>L_\ 06NO_ AO\: /7J*\A_MO6?\
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M])NO$9@>:.&Y72KB-PR1AG 4ZC:L3C[KDC.UL?LQ\1_AG\-_C%X,O/AQ\7/
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M_P"3*/\ APK8_P#1TLW_ (18_P#DRC^WLJ_Y^?A+_(/^((^)W_0#_P"5:/\
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MTX->E>(/#^L:_$UF->%M;O\ >CAMOF8<<,V[D=>F.#@YK$_X5"G_ $,!_P#
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M_P#V5 '%45VO_"H5_P"A@/\ X"__ &5'_"H5_P"A@/\ X"__ &5 '%45VO\
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M"_\ V5'_  J%?^A@/_@+_P#94 <517:_\*A7_H8#_P" O_V5'_"H5_Z& _\
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M_9_N_.K9^]S]W'XT <'17:_\*A7_ *& _P#@+_\ 94?\*A7_ *& _P#@+_\
M94 <517:_P#"H5_Z& _^ O\ ]E1_PJ%?^A@/_@+_ /94 <517:_\*A7_ *&
M_P#@+_\ 94?\*A7_ *& _P#@+_\ 94 <517:_P#"H5_Z& _^ O\ ]E1_PJ%?
M^A@/_@+_ /94 <517:_\*A7_ *& _P#@+_\ 94?\*A7_ *& _P#@+_\ 94 <
M517:_P#"H5_Z& _^ O\ ]E1_PJ%?^A@/_@+_ /94 <517:_\*A7_ *& _P#@
M+_\ 94?\*A7_ *& _P#@+_\ 94 <517:_P#"H5_Z& _^ O\ ]E1_PJ%?^A@/
M_@+_ /94 <517:_\*A7_ *& _P#@+_\ 94?\*A7_ *& _P#@+_\ 94 <517:
M_P#"H5_Z& _^ O\ ]E1_PJ%?^A@/_@+_ /94 <517:_\*A7_ *& _P#@+_\
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MUQU(XGV,8.,FXMJVK36EKM-:VT3VO>Y8_P""VWQ[\7?#7_@JQ\+_ ((_$/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5([FSL=,!VV\J/>1SS1/)&!*S12HI9VD4@., 'Z5_ _PP_B'QM#?./\ 1].
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MA?\ A\7^VW_T-.@_^$]%1_P^+_;;_P"AIT'_ ,)Z*C_5O,.\?O?^0?\ $P_
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MBK_GXA_[\BC_ (67XJ_Y^(?^_(H ](HKS?\ X67XJ_Y^(?\ OR*/^%E^*O\
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M?BK_ )^(?^_(JSI_Q!\2W%M>22SQYAM0\?[D?>\Q%_DQH [^BO-_^%E^*O\
MGXA_[\BC_A9?BK_GXA_[\B@#TBBO-_\ A9?BK_GXA_[\BC_A9?BK_GXA_P"_
M(H ](HKS?_A9?BK_ )^(?^_(H_X67XJ_Y^(?^_(H ](HKS?_ (67XJ_Y^(?^
M_(H_X67XJ_Y^(?\ OR* /2**\W_X67XJ_P"?B'_OR*/^%E^*O^?B'_OR* /2
M**\W_P"%E^*O^?B'_OR*/^%E^*O^?B'_ +\B@#TBBO-_^%E^*O\ GXA_[\BC
M_A9?BK_GXA_[\B@#TBBO-_\ A9?BK_GXA_[\BC_A9?BK_GXA_P"_(H ](HKS
M?_A9?BK_ )^(?^_(H_X67XJ_Y^(?^_(H ](HKS?_ (67XJ_Y^(?^_(H_X67X
MJ_Y^(?\ OR* /2**\W_X67XJ_P"?B'_OR*/^%E^*O^?B'_OR* /2**\W_P"%
ME^*O^?B'_OR*/^%E^*O^?B'_ +\B@#TBBO-_^%E^*O\ GXA_[\BC_A9?BK_G
MXA_[\B@#TBBO-_\ A9?BK_GXA_[\BC_A9?BK_GXA_P"_(H ](HKS?_A9?BK_
M )^(?^_(H_X67XJ_Y^(?^_(H ](HKS?_ (67XJ_Y^(?^_(H_X67XJ_Y^(?\
MOR* /2**\]L/BEKL$ZM?00SQ_P 2A=K?@1_@:[K2M4M-8L(]1L7W1R+D9'(]
M0?<&@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&N6[;=KW=M%:^GY]C^N\IP$\)S3E*_-;2S7WII._R.1HK<_X5QXM_P"@>O\
MW_3_ !H_X5QXM_Z!Z_\ ?]/\:^3/9,.BMS_A7'BW_H'K_P!_T_QH_P"%<>+?
M^@>O_?\ 3_&@##HK<_X5QXM_Z!Z_]_T_QH_X5QXM_P"@>O\ W_3_ !H PZN>
M'/\ D8;'_K\B_P#0Q6A_PKCQ;_T#U_[_ *?XU:T;P#XHL]8M;NXL%6.*YC=V
M\Y> &!/>@#G;S_C\F_ZZ-_.HZZ"Y^'GBN2XDD33UPTA(_?IZ_6H_^%<>+?\
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M<>+?^@>O_?\ 3_&@##HK<_X5QXM_Z!Z_]_T_QH_X5QXM_P"@>O\ W_3_ !H
MPZ*W/^%<>+?^@>O_ '_3_&C_ (5QXM_Z!Z_]_P!/\: ,.BMS_A7'BW_H'K_W
M_3_&C_A7'BW_ *!Z_P#?]/\ &@##HK<_X5QXM_Z!Z_\ ?]/\:/\ A7'BW_H'
MK_W_ $_QH PZ*W/^%<>+?^@>O_?]/\:/^%<>+?\ H'K_ -_T_P : ,.BMS_A
M7'BW_H'K_P!_T_QH_P"%<>+?^@>O_?\ 3_&@##HK<_X5QXM_Z!Z_]_T_QH_X
M5QXM_P"@>O\ W_3_ !H PZ*W/^%<>+?^@>O_ '_3_&C_ (5QXM_Z!Z_]_P!/
M\: ,.M3P9_R--C_UV_I5C_A7'BW_ *!Z_P#?]/\ &KWAKP-XETW7K6^N[%5C
MCER[><IP/SH Y6BMS_A7'BW_ *!Z_P#?]/\ &C_A7'BW_H'K_P!_T_QH PZ*
MW/\ A7'BW_H'K_W_ $_QH_X5QXM_Z!Z_]_T_QH PZ*W/^%<>+?\ H'K_ -_T
M_P :/^%<>+?^@>O_ '_3_&@##HK<_P"%<>+?^@>O_?\ 3_&C_A7'BW_H'K_W
M_3_&@##HK<_X5QXM_P"@>O\ W_3_ !H_X5QXM_Z!Z_\ ?]/\: ,.BMS_ (5Q
MXM_Z!Z_]_P!/\:/^%<>+?^@>O_?]/\: ,.BMS_A7'BW_ *!Z_P#?]/\ &C_A
M7'BW_H'K_P!_T_QH PZ*W/\ A7'BW_H'K_W_ $_QH_X5QXM_Z!Z_]_T_QH P
MZ*W/^%<>+?\ H'K_ -_T_P :/^%<>+?^@>O_ '_3_&@##HK<_P"%<>+?^@>O
M_?\ 3_&C_A7'BW_H'K_W_3_&@##HK<_X5QXM_P"@>O\ W_3_ !H_X5QXM_Z!
MZ_\ ?]/\: ,.BMS_ (5QXM_Z!Z_]_P!/\:/^%<>+?^@>O_?]/\: ,.BMS_A7
M'BW_ *!Z_P#?]/\ &C_A7'BW_H'K_P!_T_QH PZ*W/\ A7'BW_H'K_W_ $_Q
MH_X5QXM_Z!Z_]_T_QH PZ*W/^%<>+?\ H'K_ -_T_P :/^%<>+?^@>O_ '_3
M_&@##HK<_P"%<>+?^@>O_?\ 3_&C_A7'BW_H'K_W_3_&@##J]I'_ !Y:E_UX
MC_T=%5[_ (5QXM_Z!Z_]_P!/\:M:?X#\3V]M?1RV*AIK4)'^^7EO-1O7T4T
M<S16Y_PKGQ;_ - ]?^_Z?XT?\*X\6_\ 0/7_ +_I_C0!AT5N?\*X\6_] ]?^
M_P"G^-'_  KCQ;_T#U_[_I_C0!AT5N?\*X\6_P#0/7_O^G^-'_"N/%O_ $#U
M_P"_Z?XT 8=%;G_"N/%O_0/7_O\ I_C1_P *X\6_] ]?^_Z?XT 8=%;G_"N/
M%O\ T#U_[_I_C1_PKCQ;_P! ]?\ O^G^- &'16Y_PKCQ;_T#U_[_ *?XT?\
M"N/%O_0/7_O^G^- &'16Y_PKCQ;_ - ]?^_Z?XT?\*X\6_\ 0/7_ +_I_C0!
MAT5N?\*X\6_] ]?^_P"G^-'_  KCQ;_T#U_[_I_C0!AT5N?\*X\6_P#0/7_O
M^G^-'_"N/%O_ $#U_P"_Z?XT 8=%;G_"N/%O_0/7_O\ I_C1_P *X\6_] ]?
M^_Z?XT 8=%;G_"N/%O\ T#U_[_I_C1_PKCQ;_P! ]?\ O^G^- &'16Y_PKCQ
M;_T#U_[_ *?XT?\ "N/%O_0/7_O^G^- &'16Y_PKCQ;_ - ]?^_Z?XT?\*X\
M6_\ 0/7_ +_I_C0!AT5N?\*X\6_] ]?^_P"G^-'_  KCQ;_T#U_[_I_C0!AT
M5N?\*X\6_P#0/7_O^G^-'_"N/%O_ $#U_P"_Z?XT 8=%;G_"N/%O_0/7_O\
MI_C1_P *X\6_] ]?^_Z?XT 8=>B?"W_D66_Z^F_D*Y^P^%_B&YEQ>M%;QY^9
MB^XX]@/\17=Z3I5IHMA'IUDI$<:_Q=6/<GW- %FBBB@ HHHH **** "BBB@
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M;+%937 9 ."28P.>QI\F@N8^H;R]L].M)=0U"ZCM[>"-I)III J1H!DLQ/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \Q_;5_Y-"^)O_8BZI_Z3/7+_ /!,
M[_DQCX>_]@VX_P#2N>NH_;5_Y-"^)O\ V(NJ?^DSUR__  3._P"3&/A[_P!@
MVX_]*YZ]%?\ (I?^-?\ I+/@ZG_)SZ?_ &!S_P#3],]VHHHKSC[P**** "BB
MB@ HKE?C'\:OAG\ O MS\1_BQXJ@TG2;9E3SI<L\TC?=BC106D<X.%4$X!/
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M;S_PK$_^1J/^'\V@?]&RWG_A6)_\C4?V'FG_ #[_ !C_ )A_Q&CPS_Z&"_\
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M_"W8?^@$W_@0/_B:/^%NP_\ 0";_ ,"!_P#$T =E17&_\+=A_P"@$W_@0/\
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M#_T F_\  @?_ !- '945QO\ PMV'_H!-_P"! _\ B:/^%NP_] )O_ @?_$T
M=E17&_\ "W8?^@$W_@0/_B:/^%NP_P#0";_P('_Q- '945QO_"W8?^@$W_@0
M/_B:/^%NP_\ 0";_ ,"!_P#$T =E17&_\+=A_P"@$W_@0/\ XFC_ (6[#_T
MF_\  @?_ !- '945QO\ PMV'_H!-_P"! _\ B:/^%NP_] )O_ @?_$T =E17
M&_\ "W8?^@$W_@0/_B:M:/\ $N+5]3ATQ=(:,S/MW^=G'Z4 =117&_\ "W8?
M^@$W_@0/_B:/^%NP_P#0";_P('_Q- '945QO_"W8?^@$W_@0/_B:/^%NP_\
M0";_ ,"!_P#$T =E17&_\+=A_P"@$W_@0/\ XFC_ (6[#_T F_\  @?_ !-
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M_P#$T =E17&_\+=A_P"@$W_@0/\ XFC_ (6[#_T F_\  @?_ !- '945QO\
MPMV'_H!-_P"! _\ B:/^%NP_] )O_ @?_$T =E17&_\ "W8?^@$W_@0/_B:/
M^%NP_P#0";_P('_Q- '945QO_"W8?^@$W_@0/_B:/^%NP_\ 0";_ ,"!_P#$
MT =E17&_\+=A_P"@$W_@0/\ XFC_ (6[#_T F_\  @?_ !- '945QO\ PMV'
M_H!-_P"! _\ B:/^%NP_] )O_ @?_$T =E17&_\ "W8?^@$W_@0/_B:FM?BA
M%=PW,PT9E^SP^9CS_O?.JXZ?[7Z4 =917&_\+=A_Z 3?^! _^)H_X6[#_P!
M)O\ P('_ ,30!V5%<;_PMV'_ * 3?^! _P#B:/\ A;L/_0";_P "!_\ $T =
ME17&_P#"W8?^@$W_ ($#_P")H_X6[#_T F_\"!_\30!V5%<;_P +=A_Z 3?^
M! _^)H_X6[#_ - )O_ @?_$T =E17&_\+=A_Z 3?^! _^)H_X6[#_P! )O\
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M.BI/L=Y_SZ2?]^S1]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\ OV:
M(Z*D^QWG_/I)_P!^S1]CO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_GTD_[
M]F@".BI/L=Y_SZ2?]^S1]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\
MOV: (Z*D^QWG_/I)_P!^S1]CO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_G
MTD_[]F@".BI/L=Y_SZ2?]^S1]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y]
M)/\ OV: (Z*D^QWG_/I)_P!^S1]CO/\ GTD_[]F@".KVD?\ 'EJ7_7B/_1T5
M5?L=Y_SZ2?\ ?LU>TFUNA9ZD#;2<V( ^0\_OHJ ,VBI/L=Y_SZ2?]^S1]CO/
M^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\ OV: (Z*D^QWG_/I)_P!^S1]C
MO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_GTD_[]F@".BI/L=Y_SZ2?]^S1
M]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\ OV: (Z*D^QWG_/I)_P!^
MS1]CO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_GTD_[]F@".BI/L=Y_SZ2?
M]^S1]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\ OV: (Z*D^QWG_/I)
M_P!^S1]CO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_GTD_[]F@".BI/L=Y_
MSZ2?]^S1]CO/^?23_OV: (Z*D^QWG_/I)_W[-'V.\_Y])/\ OV: (Z*D^QWG
M_/I)_P!^S1]CO/\ GTD_[]F@".BI/L=Y_P ^DG_?LT?8[S_GTD_[]F@".O1O
MAA+(_A<([EA'<.J ]AP<?F37"Z?X>UO5)A!9:9,Q;C<8R%'U)X%>E>%=#'A[
M1H].,F]^6E<="Q]/;M^% &E1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 >8_MJ_\FA?$W_L1=4_])GKE_P#@F=_R8Q\/?^P;<?\ I7/7
M4?MJ_P#)H7Q-_P"Q%U3_ -)GKE_^"9W_ "8Q\/?^P;<?^E<]>BO^12_\:_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'A/PO\&9O#:W']H+,+>=9[7RH,MMDD_=Q']YL .WG!.*\ET;X3?M?> _@_\
M"'X>-\/_ !9>>'='\(W$'BKP_P"!?&UIH^I1:J) T!ENC*K/;[<KM@E7EF9B
M0JHWVE@>E&!Z4N8.4^%?!G[)'[2UM\ ;C4[[X;26WBGP]^T=_P +"TSPA>>+
M$NFU:TC\H_9_M\CON=LOB:;YF*%G&6S7U!\&_B_\6?BEXGO1XF_9NUGP;H%O
MIZ&WU+Q)JEL+NZO-Y#0K:P-)B(+\WFLXR< *<DCTK ]*,>U#ES;@HV/G#XLZ
M5\=? '[<J_'SP!\ -4\::'<?">+P_(VEZS8VK0W8U.:X((N9D) 3;R 1\XYX
M.+OP8^%_QZ^*/[18_:K_ &CO"-GX271]!DTCP3X'MM66_ELA*X-Q>7$\>(S*
MX4*%3(V$!L,F6^@L8Z"C (P11S:!RGP[H?[.7CWP5^RC\,/"7Q&_9V\=76O>
M&+CQ#(=>^&WBZWM=<\,R75_*R>0!*%G6>*0;\.P14&Y3DXO^._V<?VP?B%\(
M?@_\3?B!;ZUK'C;P'J&JC7/#VD>,HM*U2ZLKPF*)TU" K$+F&%(MV"HE5I%+
M9)#?:>!Z48'I5>T8<I\9Z?\  /\ :,TGP'\2_B7\'/A=XP\,^/M2T^QTSP_>
M>,OBA'K&I:I9+.KW'^L:6"TD6,,D3-)(078C9P3=^ OP6^.-I^TMJ?Q)\5?!
M#Q1;^&E^%U_HMG!\0OB.NMWFIW;W%I+Y<I,\Z6T4@5T"H"O[MW?[Z(/K_'&,
M48'7%+G8<I\4?!_X"?'34-6O_A/X&\&?$/X;> =8\$ZMI/BO0?&?B:VU73](
MNY[;R[8:*RRM,52265VD)5'51D*V!6+\-_V1OC%<^'?"?P/^*_P'^(EY:Z3J
M5I:ZMJS_ !R;_A'XK6V9=M];6@D:3/R!H[?R4V$J-RX./O' ZXHQ[4_:,.4!
MTHHHK,H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\;_\!8UK2H5JW\.+EZ)O\CS<RSK)\GC&6/Q-.BI;.I.,+^G,U?Y'N=%?/_\
MP]*_8,_Z+_;_ /@AU'_Y'H_X>E?L&?\ 1?[?_P $.H__ "/6WU#'?\^I?^ O
M_(\G_7C@O_H9X?\ \'4__DCZ HKY_P#^'I7[!G_1?[?_ ,$.H_\ R/1_P]*_
M8,_Z+_;_ /@AU'_Y'H^H8[_GU+_P%_Y!_KQP7_T,\/\ ^#J?_P D?0%%?/\
M_P /2OV#/^B_V_\ X(=1_P#D>M;P3_P4._9"^)7B.'PA\/?BE=:WJEQDPZ?I
M?A75)Y6 &2VU+8G ')/0#DX%)X'&Q5W2E_X"_P#(TI<9<'UZBIT\QH2DW9)5
MJ;;;V22E=L]JHJ"?4;:WMOM<HEV8R<0.2![@#(_*L[_A/_"'_087_OR__P 3
M7*?2&Q16/_PG_A#_ *#"_P#?E_\ XFC_ (3_ ,(?]!A?^_+_ /Q- &Q16/\
M\)_X0_Z#"_\ ?E__ (FC_A/_  A_T&%_[\O_ /$T ;%%8_\ PG_A#_H,+_WY
M?_XFC_A/_"'_ $&%_P"_+_\ Q- &Q16/_P )_P"$/^@PO_?E_P#XFC_A/_"'
M_087_OR__P 30!L45C_\)_X0_P"@PO\ WY?_ .)H_P"$_P#"'_087_OR_P#\
M30!L45C_ /"?^$/^@PO_ 'Y?_P")H_X3_P (?]!A?^_+_P#Q- &Q16/_ ,)_
MX0_Z#"_]^7_^)H_X3_PA_P!!A?\ OR__ ,30!L45C_\ "?\ A#_H,+_WY?\
M^)H_X3_PA_T&%_[\O_\ $T ;%%8__"?^$/\ H,+_ -^7_P#B:/\ A/\ PA_T
M&%_[\O\ _$T ;%%8_P#PG_A#_H,+_P!^7_\ B:/^$_\ "'_087_OR_\ \30!
ML45C_P#"?^$/^@PO_?E__B:/^$_\(?\ 087_ +\O_P#$T ;%%8__  G_ (0_
MZ#"_]^7_ /B:=;^./"UW<1VMOJJM)(X2-?*?EB< =* -:BL=_'OA*-RCZNNY
M3@_N7_\ B:/^$_\ "'_087_OR_\ \30!L45C_P#"?^$/^@PO_?E__B:/^$_\
M(?\ 087_ +\O_P#$T ;%%8__  G_ (0_Z#"_]^7_ /B:/^$_\(?]!A?^_+__
M !- &Q16/_PG_A#_ *#"_P#?E_\ XFC_ (3_ ,(?]!A?^_+_ /Q- &Q16/\
M\)_X0_Z#"_\ ?E__ (FC_A/_  A_T&%_[\O_ /$T ;%%8_\ PG_A#_H,+_WY
M?_XFC_A/_"'_ $&%_P"_+_\ Q- &Q16/_P )_P"$/^@PO_?E_P#XFC_A/_"'
M_087_OR__P 30!L45C_\)_X0_P"@PO\ WY?_ .)H_P"$_P#"'_087_OR_P#\
M30!L45C_ /"?^$/^@PO_ 'Y?_P")H_X3_P (?]!A?^_+_P#Q- &Q16/_ ,)_
MX0_Z#"_]^7_^)H_X3_PA_P!!A?\ OR__ ,30!L45C_\ "?\ A#_H,+_WY?\
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MU0/)(V$7RGY/Y4 :E%8__"?^$/\ H,+_ -^7_P#B:/\ A/\ PA_T&%_[\O\
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M,+_WY?\ ^)H_X3_PA_T&%_[\O_\ $T ;%%8__"?^$/\ H,+_ -^7_P#B:/\
MA/\ PA_T&%_[\O\ _$T ;%%8_P#PG_A#_H,+_P!^7_\ B:/^$_\ "'_087_O
MR_\ \30!L45C_P#"?^$/^@PO_?E__B:/^$_\(?\ 087_ +\O_P#$T ;%%8__
M  G_ (0_Z#"_]^7_ /B:/^$_\(?]!A?^_+__ !- &Q16/_PG_A#_ *#"_P#?
ME_\ XFC_ (3_ ,(?]!A?^_+_ /Q- &Q16/\ \)_X0_Z#"_\ ?E__ (FC_A/_
M  A_T&%_[\O_ /$T ;%%8_\ PG_A#_H,+_WY?_XFC_A/_"'_ $&%_P"_+_\
MQ- &Q16/_P )_P"$/^@PO_?E_P#XFC_A/_"'_087_OR__P 30!L45C_\)_X0
M_P"@PO\ WY?_ .)H_P"$_P#"'_087_OR_P#\30!L45C_ /"?^$/^@PO_ 'Y?
M_P")H_X3_P (?]!A?^_+_P#Q- &Q16;8>+_#>I3BVL]6C:1N%5LKN]AN R:T
MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW_$_LC*8XZ,)?6+]+7W\_.VQS]%%%?)GL!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5<\.?\C#8_P#7Y%_Z&*IU<\.?\C#8_P#7
MY%_Z&* *]Y_Q^3?]=&_G4=27G_'Y-_UT;^=1T %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:
MG@S_ )&FQ_Z[?TK+K4\&?\C38_\ 78?RH RZ*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M][)=#OK/Q/!<-X@\VU:>X,$2XS]G*E'V-)@@EMF,5N?!'XQ2^)?#.D6/Q/\
MB#X!N/$^M76HC3;;P;K1FMKV*VF96$'FGS)'B0*)< A7#9V]!GRR1Z=SN/\
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M AD6:'1+565LJRVZ@@^O2KE% %$^&O#K$LVA69).23;K_A1_PC/AS_H V?\
MX#+_ (5>HH H_P#",^'/^@#9_P#@,O\ A1_PC/AS_H V?_@,O^%7J* */_",
M^'/^@#9_^ R_X4?\(SX<_P"@#9_^ R_X5>HH H_\(SX<_P"@#9_^ R_X4?\
M",^'/^@#9_\ @,O^%7J* */_  C/AS_H V?_ (#+_A1_PC/AS_H V?\ X#+_
M (5>HH H_P#",^'/^@#9_P#@,O\ A1_PC/AS_H V?_@,O^%7J* */_",^'/^
M@#9_^ R_X4?\(SX<_P"@#9_^ R_X5>HH H_\(SX<_P"@#9_^ R_X4?\ ",^'
M/^@#9_\ @,O^%7J* */_  C/AS_H V?_ (#+_A1_PC/AS_H V?\ X#+_ (5>
MHH H_P#",^'/^@#9_P#@,O\ A1_PC/AS_H V?_@,O^%7J* */_",^'/^@#9_
M^ R_X4?\(SX<_P"@#9_^ R_X5>HH H_\(SX<_P"@#9_^ R_X4?\ ",^'/^@#
M9_\ @,O^%7J* */_  C/AS_H V?_ (#+_A1_PC/AS_H V?\ X#+_ (5>HH H
M_P#",^'/^@#9_P#@,O\ A1_PC/AS_H V?_@,O^%7J* */_",^'/^@#9_^ R_
MX4?\(SX<_P"@#9_^ R_X5>HH H_\(SX<_P"@#9_^ R_X4?\ ",^'/^@#9_\
M@,O^%7J* */_  C/AS_H V?_ (#+_A3H?#^A6TJSV^CVL<B\JZ0*"/QQ5RB@
M"C_PC'AP?\P&S_\  9?\*/\ A&?#G_0!L_\ P&7_  J]10!1_P"$9\.?] &S
M_P# 9?\ "C_A&?#G_0!L_P#P&7_"KU% %'_A&?#G_0!L_P#P&7_"C_A&?#G_
M $ ;/_P&7_"KU% %'_A&?#G_ $ ;/_P&7_"C_A&?#G_0!L__  &7_"KU% %'
M_A&?#G_0!L__  &7_"C_ (1GPY_T ;/_ ,!E_P *O44 4?\ A&?#G_0!L_\
MP&7_  H_X1GPY_T ;/\ \!E_PJ]10!1_X1GPY_T ;/\ \!E_PH_X1GPY_P!
M&S_\!E_PJ]10!1_X1GPY_P! &S_\!E_PH_X1GPY_T ;/_P !E_PJ]10!1_X1
MGPY_T ;/_P !E_PH_P"$9\.?] &S_P# 9?\ "KU% %'_ (1GPY_T ;/_ ,!E
M_P */^$9\.?] &S_ / 9?\*O44 4?^$9\.?] &S_ / 9?\*/^$9\.?\ 0!L_
M_ 9?\*O44 4?^$9\.?\ 0!L__ 9?\*/^$9\.?] &S_\  9?\*O44 4?^$9\.
M?] &S_\  9?\*/\ A&?#G_0!L_\ P&7_  J]10!1_P"$9\.?] &S_P# 9?\
M"C_A&?#G_0!L_P#P&7_"KU% %'_A&?#G_0!L_P#P&7_"C_A&?#G_ $ ;/_P&
M7_"KU% %'_A&?#G_ $ ;/_P&7_"C_A&?#G_0!L__  &7_"KU% %'_A&?#G_0
M!L__  &7_"G)X=T"-66/1;51(NUPMNOS#(.#QSR ?PJY10!1_P"$9\.?] &S
M_P# 9?\ "C_A&?#G_0!L_P#P&7_"KU% %'_A&?#G_0!L_P#P&7_"C_A&?#G_
M $ ;/_P&7_"KU% %'_A&?#G_ $ ;/_P&7_"C_A&?#G_0!L__  &7_"KU% %'
M_A&?#G_0!L__  &7_"C_ (1GPY_T ;/_ ,!E_P *O44 4?\ A&?#G_0!L_\
MP&7_  H_X1GPY_T ;/\ \!E_PJ]10!1_X1GPY_T ;/\ \!E_PH_X1GPY_P!
M&S_\!E_PJ]10!1_X1GPY_P! &S_\!E_PH_X1GPY_T ;/_P !E_PJ]10!1_X1
MGPY_T ;/_P !E_PH_P"$9\.?] &S_P# 9?\ "KU% %'_ (1GPY_T ;/_ ,!E
M_P */^$9\.?] &S_ / 9?\*O44 4?^$9\.?] &S_ / 9?\*/^$9\.?\ 0!L_
M_ 9?\*O44 4?^$9\.?\ 0!L__ 9?\*/^$9\.?] &S_\  9?\*O44 4?^$9\.
M?] &S_\  9?\*/\ A&?#G_0!L_\ P&7_  J]10!1_P"$9\.?] &S_P# 9?\
M"C_A&?#G_0!L_P#P&7_"KU% %'_A&?#G_0!L_P#P&7_"C_A&?#G_ $ ;/_P&
M7_"KU% %'_A&?#G_ $ ;/_P&7_"C_A&?#G_0!L__  &7_"KU% %'_A&?#G_0
M!L__  &7_"C_ (1GPY_T ;/_ ,!E_P *O44 5;;0]%LY1/::3;12#H\<*@C]
M*M=.*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/;^*-'\*_!M?#]KX<9R\<^G7-](K7%Q*VZ0!/-V/&DA=%9%Q^H6T&C:/2A5
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M4 %%%% !1110 4444 %%%% !1110 4444 >8_MJ_\FA?$W_L1=4_])GKE_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!YC^VK_R:%\3?^Q%U3_TF>N7_
M ."9W_)C'P]_[!MQ_P"E<]=1^VK_ ,FA?$W_ +$75/\ TF>N7_X)G?\ )C'P
M]_[!MQ_Z5SUZ*_Y%+_QK_P!)9\'4_P"3GT_^P.?_ *?IGNU%%%><?>!1110
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MHW\ZCH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:Y^&OQO\57?P\M=!\3>%_%%G9_;9/"_C7P_+IM\UIN"BX1'RKQ[CMR&)!Z@
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MCJR?$[3(_B['\'3X>UK[9)X=;6!JW]FM_9XC6<0^3Y^<>?D[O+QG9R<9&2S
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M_P#B:ZFB@#EO^%3Z%_T$+O\ [Z7_ .)H_P"%3Z%_T$+O_OI?_B:ZFB@#EO\
MA4^A?]!"[_[Z7_XFC_A4^A?]!"[_ .^E_P#B:ZFB@#EO^%3Z%_T$+O\ [Z7_
M .)H_P"%3Z%_T$+O_OI?_B:ZFB@#EO\ A4^A?]!"[_[Z7_XFC_A4^A?]!"[_
M .^E_P#B:ZFB@#EO^%3Z%_T$+O\ [Z7_ .)H_P"%3Z%_T$+O_OI?_B:ZFB@#
MEO\ A4^A?]!"[_[Z7_XFC_A4^A?]!"[_ .^E_P#B:ZFB@#EO^%3Z%_T$+O\
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M_P *GT+_ *"%W_WTO_Q-=310!RW_  J?0O\ H(7?_?2__$T?\*GT+_H(7?\
MWTO_ ,374T4 <M_PJ?0O^@A=_P#?2_\ Q-'_  J?0O\ H(7?_?2__$UU-% '
M+?\ "I]"_P"@A=_]]+_\31_PJ?0O^@A=_P#?2_\ Q-=310!RW_"I]"_Z"%W_
M -]+_P#$T?\ "I]"_P"@A=_]]+_\374T4 <M_P *GT+_ *"%W_WTO_Q-'_"I
M]"_Z"%W_ -]+_P#$UU-% '+?\*GT+_H(7?\ WTO_ ,31_P *GT+_ *"%W_WT
MO_Q-=310!RW_  J?0O\ H(7?_?2__$T?\*GT+_H(7?\ WTO_ ,374T4 <M_P
MJ?0O^@A=_P#?2_\ Q-'_  J?0O\ H(7?_?2__$UU-% '+?\ "I]"_P"@A=_]
M]+_\31_PJ?0O^@A=_P#?2_\ Q-=310!RW_"I]"_Z"%W_ -]+_P#$T?\ "I]"
M_P"@A=_]]+_\374T4 <M_P *GT+_ *"%W_WTO_Q-'_"I]"_Z"%W_ -]+_P#$
MUU-% '+?\*GT+_H(7?\ WTO_ ,31_P *GT+_ *"%W_WTO_Q-=310!SMC\,/#
MEG.L\S3W&WD1S.-OY #/\JZ%$6-0B+A5& !VI:* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \Q_;5_P"30OB;_P!B+JG_ *3/7+_\
M$SO^3&/A[_V#;C_TKGKJ/VU?^30OB;_V(NJ?^DSUR_\ P3._Y,8^'O\ V#;C
M_P!*YZ]%?\BE_P"-?^DL^#J?\G/I_P#8'/\ ]/TSW:BBBO./O HHHH ****
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M"5W33,638S 1ME%))"ACFA2C_7H/E9RW_!3OXN:[\//V8K[P+X$T^\OO%'Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g4bdklltl5z5000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000007.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .V"%8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN6ES^[\L''?%2!^EH8,VT=""0>PQGAO0\=J5>=N>-V2/U_PK^<%?^#DC]GX
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MV!P>"_RD9S@$\@*?=<\&@!^>,X)Y'(P1[]\]>E)N_P!EORK\N?V]_P#@J/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\._\%+O^3$_VF_^
MR;WG_I=85]Q5\/?\%+O^3$_VF^W_ !;B\Y]/].L*<-WZK\X@?DM_P03^ _P5
M^)_[&NOZ]\0OACX,\::W;?&#Q98Q:KX@T2VU"_BLX8; PV0EG1F$5OOD,8
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M9<^&?#'B6W,/B.74[J4S6.J-;.6>SL=.AE,-F@?:8BH  KY(_P""Y[>*8O\
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M8\(2:+K&D3?$&TM-9M?"]HT,.IPRZQ>V]I)\EQ/?Z>KP2(@P26VJ!C'PY:?
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MD7S5)V_E=G;>[7]>E@/Z(OVOT5OV.OC7R0W_  J#6B IVERNB,5C+>C'C_\
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MJ/\ / ]*Z'XW#/P8^+V<<_##QX#GH?\ BE]4QD=,@9YZ\^U2MUZK\P/YU_\
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M^/\ J4L'P7^.%CH^N^"];D$DFG6NH:W%;-IFL01G MTU*YN4TZ6,%A&H,A7
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ME4?O+_"OPT ****S **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAKXL_&;XDZU\4M%\>6_Q179;Z=INEWMA/I8&HS7H%P]UA)2!*$)C[C/2KO\
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MW[</Q<7^TK?Q%?Z;\,_^$ITS3/#EG"+"Y-O;6D-S;Q1>8=70--:37;!64??
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M+_X-X?A?X?U:VUS]HOXP>)_B[+8745S::)IU_JEMH5ZJ.&:WU.#5Y;B26&0
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M8 ECK:03XN'81(D=^^"5N3R>21^4?_!=HY_;E_8Z'I#X7_\ 4[MS7W3\$?\
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MD5T7E_= &$B10D 10H&-J_+T "C  ^Z#C&.DE%).WJ Q-J[@5<DD9+<!2<X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP7/WF QNQP./4#OWIW/:EP?0_E1@^A_*@"/:<C#';DE@>[$=CC@>J_K3@,#
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M?^ 1_K^O-ARR_GE_X%+R\_+\/-GYI?\ #,'[>_\ T?IXD_\ !+HW_P CT?\
M#,'[>_\ T?IXD_\ !+HW_P CU^EN/<_I_A1CW/Z?X47I_P B_P# (_U_7FPY
M9?SR_P# I>7GY?AYL_-+_AF#]O?_ */T\2?^"71O_D>C_AF#]O?_ */T\2?^
M"71O_D>OTMQ[G]/\*,>Y_3_"B]/^1?\ @$?Z_KS8<LOYY?\ @4O+S\OP\V?F
ME_PS!^WO_P!'Z>)/_!+HW_R/1_PS!^WO_P!'Z>)/_!+HW_R/7Z6X]S^G^%&/
M<_I_A1>G_(O_  "/]?UYL.67\\O_  *7EY^7X>;/S2_X9@_;W_Z/T\2?^"71
MO_D>C_AF#]O?_H_3Q)_X)=&_^1Z_2W'N?T_PHQ[G]/\ "B]/^1?^ 1_K^O-A
MRR_GE_X%+R\_+\/-GYI?\,P?M[_]'Z>)/_!+HW_R/1_PS!^WO_T?IXD_\$NC
M?_(]?I;CW/Z?X48]S^G^%%Z?\B_\ C_7]>;#EE_/+_P*7EY^7X>;/S2_X9@_
M;W_Z/T\2?^"71O\ Y'H_X9@_;W_Z/T\2?^"71O\ Y'K]+<>Y_3_"C'N?T_PH
MO3_D7_@$?Z_KS8<LOYY?^!2\O/R_#S9^:7_#,'[>_P#T?IXD_P#!+HW_ ,CT
M?\,P?M[_ /1^GB3_ ,$NC?\ R/7Z6X]S^G^%&/<_I_A1>G_(O_ (_P!?UYL.
M67\\O_ I>7GY?AYL_-+_ (9@_;W_ .C]/$G_ ()=&_\ D>C_ (9@_;W_ .C]
M/$G_ ()=&_\ D>OTMQ[G]/\ "C'N?T_PHO3_ )%_X!'^OZ\V'++^>7_@4O+S
M\OP\V?FE_P ,P?M[_P#1^GB3_P $NC?_ "/1_P ,P?M[_P#1^GB3_P $NC?_
M "/7Z6X]S^G^%&/<_I_A1>G_ "+_ , C_7]>;#EE_/+_ ,"EY>?E^'FS\TO^
M&8/V]_\ H_3Q)_X)=&_^1Z/^&8/V]_\ H_3Q)_X)=&_^1Z_2W'N?T_PHQ[G]
M/\*+T_Y%_P" 1_K^O-ARR_GE_P"!2\O/R_#S9^:7_#,'[>__ $?IXD_\$NC?
M_(]'_#,'[>__ $?IXD_\$NC?_(]?I;CW/Z?X48]S^G^%%Z?\B_\  (_U_7FP
MY9?SR_\  I>7GY?AYL_-+_AF#]O?_H_3Q)_X)=&_^1Z/^&8/V]_^C]/$G_@E
MT;_Y'K]+<>Y_3_"C'N?T_P *+T_Y%_X!'^OZ\V'++^>7_@4O+S\OP\V?FE_P
MS!^WO_T?IXD_\$NC?_(]'_#,'[>__1^GB3_P2Z-_\CU^EN/<_I_A1CW/Z?X4
M7I_R+_P"/]?UYL.67\\O_ I>7GY?AYL_-+_AF#]O?_H_3Q)_X)=&_P#D>C_A
MF#]O?_H_3Q)_X)=&_P#D>OTMQ[G]/\*,>Y_3_"B]/^1?^ 1_K^O-ARR_GE_X
M%+R\_+\/-GYI?\,P?M[_ /1^GB3_ ,$NC?\ R/1_PS!^WO\ ]'Z>)/\ P2Z-
M_P#(]?I;CW/Z?X48]S^G^%%Z?\B_\ C_ %_7FPY9?SR_\"EY>?E^'FS\TO\
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M_2W'N?T_PHQ[G]/\*+T_Y%_X!'^OZ\V'++^>7_@4O+S\OP\V?FE_PS!^WO\
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M  2Z-_\ (]'_  S!^WO_ -'Z>)/_  2Z-_\ (]?I;CW/Z?X48]S^G^%%Z?\
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M-ARR_GE_X%+R\_+\/-GYI?\ #,'[>_\ T?IXD_\ !+HW_P CT?\ #,'[>_\
MT?IXD_\ !+HW_P CU^EN/<_I_A1CW/Z?X47I_P B_P# (_U_7FPY9?SR_P#
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MS^G^%&/<_I_A1>G_ "+_ , C_7]>;#EE_/+_ ,"EY>?E^'FS\TO^&8/V]_\
MH_3Q)_X)=&_^1Z/^&8/V]_\ H_3Q)_X)=&_^1Z_2W'N?T_PHQ[G]/\*+T_Y%
M_P" 1_K^O-ARR_GE_P"!2\O/R_#S9^:7_#,'[>__ $?IXD_\$NC?_(]'_#,'
M[>__ $?IXD_\$NC?_(]?I;CW/Z?X48]S^G^%%Z?\B_\  (_U_7FPY9?SR_\
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MCW/Z?X48]S^G^%%Z?\B_\ C_ %_7FPY9?SR_\"EY>?E^'FS\TO\ AF#]O?\
MZ/T\2?\ @ET;_P"1Z/\ AF#]O?\ Z/T\2?\ @ET;_P"1Z_2W'N?T_P *,>Y_
M3_"B]/\ D7_@$?Z_KS8<LOYY?^!2\O/R_#S9^:7_  S!^WO_ -'Z>)/_  2Z
M-_\ (]'_  S!^WO_ -'Z>)/_  2Z-_\ (]?I;CW/Z?X48]S^G^%%Z?\ (O\
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MPHQ[G]/\*+T_Y%_X!'^OZ\V'++^>7_@4O+S\OP\V?FE_PS!^WO\ ]'Z>)/\
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M?AYL_-+_ (9@_;W_ .C]/$G_ ()=&_\ D>C_ (9@_;W_ .C]/$G_ ()=&_\
MD>OTMQ[G]/\ "C'N?T_PHO3_ )%_X!'^OZ\V'++^>7_@4O+S\OP\V?FE_P ,
MP?M[_P#1^GB3_P $NC?_ "/1_P ,P?M[_P#1^GB3_P $NC?_ "/7Z6X]S^G^
M%&/<_I_A1>G_ "+_ , C_7]>;#EE_/+_ ,"EY>?E^'FS\TO^&8/V]_\ H_3Q
M)_X)=&_^1Z/^&8/V]_\ H_3Q)_X)=&_^1Z_2W'N?T_PHQ[G]/\*+T_Y%_P"
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M]/\ D7_@$?Z_KS8<LOYY?^!2\O/R_#S9^:7_  S!^WO_ -'Z>)/_  2Z-_\
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M_P#(]'_#,'[>_P#T?IXD_P#!+HW_ ,CU^EN/<_I_A1CW/Z?X47I_R+_P"/\
M7]>;#EE_/+_P*7EY^7X>;/S2_P"&8/V]_P#H_3Q)_P""71O_ )'H_P"&8/V]
M_P#H_3Q)_P""71O_ )'K]+<>Y_3_  HQ[G]/\*+T_P"1?^ 1_K^O-ARR_GE_
MX%+R\_+\/-GYI?\ #,'[>_\ T?IXD_\ !+HW_P CT?\ #,'[>_\ T?IXD_\
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MS^G^%%Z?\B_\ C_7]>;#EE_/+_P*7EY^7X>;/S2_X9@_;W_Z/T\2?^"71O\
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M]S^G^%%Z?\B_\ C_ %_7FPY9?SR_\"EY>?E^'FS\TO\ AF#]O?\ Z/T\2?\
M@ET;_P"1Z/\ AF#]O?\ Z/T\2?\ @ET;_P"1Z_2W'N?T_P *,>Y_3_"B]/\
MD7_@$?Z_KS8<LOYY?^!2\O/R_#S9^:7_  S!^WO_ -'Z>)/_  2Z-_\ (]'_
M  S!^WO_ -'Z>)/_  2Z-_\ (]?I;CW/Z?X48]S^G^%%Z?\ (O\ P"/]?UYL
M.67\\O\ P*7EY^7X>;/S2_X9@_;W_P"C]/$G_@ET;_Y'H_X9@_;W_P"C]/$G
M_@ET;_Y'K]+<>Y_3_"C'N?T_PHO3_D7_ (!'^OZ\V'++^>7_ (%+R\_+\/-G
MYI?\,P?M[_\ 1^GB3_P2Z-_\CT?\,P?M[_\ 1^GB3_P2Z-_\CU^EN/<_I_A1
MCW/Z?X47I_R+_P  C_7]>;#EE_/+_P "EY>?E^'FS\TO^&8/V]_^C]/$G_@E
MT;_Y'H_X9@_;W_Z/T\2?^"71O_D>OTMQ[G]/\*,>Y_3_  HO3_D7_@$?Z_KS
M8<LOYY?^!2\O/R_#S9^:7_#,'[>__1^GB3_P2Z-_\CT?\,P?M[_]'Z>)/_!+
MHW_R/7Z6X]S^G^%&/<_I_A1>G_(O_ (_U_7FPY9?SR_\"EY>?E^'FS\TO^&8
M/V]_^C]/$G_@ET;_ .1Z/^&8/V]_^C]/$G_@ET;_ .1Z_2W'N?T_PHQ[G]/\
M*+T_Y%_X!'^OZ\V'++^>7_@4O+S\OP\V?FE_PS!^WO\ ]'Z>)/\ P2Z-_P#(
M]'_#,'[>_P#T?IXD_P#!+HW_ ,CU^EN/<_I_A1CW/Z?X47I_R+_P"/\ 7]>;
M#EE_/+_P*7EY^7X>;/S2_P"&8/V]_P#H_3Q)_P""71O_ )'H_P"&8/V]_P#H
M_3Q)_P""71O_ )'K]+<>Y_3_  HQ[G]/\*+T_P"1?^ 1_K^O-ARR_GE_X%+R
M\_+\/-GYI?\ #,'[>_\ T?IXD_\ !+HW_P CT?\ #,'[>_\ T?IXD_\ !+HW
M_P CU^EN/<_I_A1CW/Z?X47I_P B_P# (_U_7FPY9?SR_P# I>7GY?AYL_-+
M_AF#]O?_ */T\2?^"71O_D>C_AF#]O?_ */T\2?^"71O_D>OTMQ[G]/\*,>Y
M_3_"B]/^1?\ @$?Z_KS8<LOYY?\ @4O+S\OP\V?FE_PS!^WO_P!'Z>)/_!+H
MW_R/1_PS!^WO_P!'Z>)/_!+HW_R/7Z6X]S^G^%&/<_I_A1>G_(O_  "/]?UY
ML.67\\O_  *7EY^7X>;/S2_X9@_;W_Z/T\2?^"71O_D>C_AF#]O?_H_3Q)_X
M)=&_^1Z_2W'N?T_PHQ[G]/\ "B]/^1?^ 1_K^O-ARR_GE_X%+R\_+\/-GYI?
M\,P?M[_]'Z>)/_!+HW_R/1_PS!^WO_T?IXD_\$NC?_(]?I;CW/Z?X48]S^G^
M%%Z?\B_\ C_7]>;#EE_/+_P*7EY^7X>;/S3_ .&8?V]U&_\ X;T\2,5(Q&-%
MT;,AZ8/^C]._X?6NT^&_[//[:FA>//#FL>+OVT/$/B[PQ8WJ2ZOX:ETC288-
M9A5@S6PFCMUD0%05;:5Z_2OOI1R<$AL?*PX(/7J.W8CWJUIX#7=LW/\ K=Q0
M_P"K!/!95!X/6I?)RR?(M-5HEV_4J'.I07-)JZ^T[;[;KLM_GV/1C[?Y]:2B
MBO.YK\VG]W[K?Y'LJZC'S2?W_P##!1112 *:_P!T_A_,4ZD8D X_SS2?ZK\R
MHIMZ.VA@^(?^/6/_ *Z_TKCJ['Q#_P >L?\ UU_I7'5VTO@7]=$>9B/C?J_T
M"BBBM;:-WVZ?=_F<[=K:7UM_P0HHHY_S_P#K_P *(6FF[VMW7IU^87=TK?/T
M"BBBIYE=KK^95M*36OM';MRO3>^X4444_P#@"84444TKNVPF[*]F_);A1113
M23=KZ=POIMV_%V"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%%-6ZNWR;').*3WNKV^X****5Q:V6E@HHHH **** "BBB@
M HHHII7W=K>7R ****'Y:^8FWT5_G8****0PHHHJHKF=MA-M;*^H4445-^G]
M=/\ ,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444*U[-V ****3=FENGI>WI_7R&DFGK9K
MIW"BBBF(**** "BBB@ HHHH&M6EW84444#DK6UN%%%%!(4444 %%%% :]@HH
MHH')./G^'7] HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444TKNU[ []
M%?\  ****3:3M?T\QI-]/Z_4****JRM>_P K??\ <(****D;\M?,****!!11
M10 4444 %%%% !1110 4444F[*X!1110G=7L 4444P"BBB@ HHHIORU\RK:7
MOKV^84444B0HHHH ****!ORU\PHHHH$%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU5_^&_ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=S7"G!DNH]LQ3ADW%3W-4J;DN=='9ZM=$UY=>O=="7))V?577WV^[S/L_P#
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MNFZ!I&GWL-[%J?A6"9ETS59)(<*)[A K/'U7/2G.'+KM_2V_74FG4YM.N_\
M7WGU;11169I<**** "BBB@+A1110%PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2E"[NV^6RNV];O6X4445QG>%%%% !1110 4444 %%%% !1110 4444 %%%%
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M:[^UUX-MK7PE\0[/X5ZYKC6_EKJECI7C72=.FFD589<+<6L5S$K;6^5\E2<
M5[?^WKA/V)_C_&'#I'\,+B./=@&15TI\0E5^41QK]WCC'K7Y,?L-?\H*OB2S
M %QX+^)?WR5'EO8WVU<# *K_  G!)_BQP:F,8>RB[*WMXZVUY>9:/NE?KLNG
M?6M[>E7CAO:<REAIS3;OND]$]FK?GW/#?V2_VW/^"Q7_  4(^$&E7W[-L_PQ
M\(7OA)?L_C3XQ^/='M++3O&FJW'S+8Z%HS[[1!IC?Z/(T!RQ;+XYJ?X2_P#!
M5#_@H?I7Q8^(?[!OQ0\ ^%_'O[:,6N0:+X,\3Z;:II'A#1%N;9I8M2UN.V/D
M+I[*OVA9WZ@JIZU]X?\ !OE;6UE_P2Z^#C6L,=O)<^,_'HE9%!>9WU=27=B,
MRD'[A?A!PN!7QW\,(H)?^#C+]H^21$:2#X;Z-)!)Y:DQ3)8Q(9$?&X3*,KE>
M<<9Q3O'VU6+C%6A))\J35G%+7M;1=K6U2)<:O)0E*<I.=:$)--V?-&U_EU_3
M0P_C7^UQ_P %F?\ @G_XK^&'CW]K;7O@Y\4O@QX_\9Z=X4U'0O!&FV5K<:*;
MZZ@2<76J6^V9#913$K)R)FC /)-?:_\ P4^_;@^./[/O_##>K?L_>)M,\.:%
M^T%\0=+TOQLNHZ';:T][H%_]FD6VM7N6#64@6=H_/CRW%<7_ ,'"#>9^R/\
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M"Z1X)56S@\XY-8G_  7R2/\ X7W_ ,$QPPW/_P +@O I*CS"#=PG;G^%6/&
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MP\4:+\1?#4@C9KJVLKB1+N^NL1C?Y=O"%,O& ,DBO@S]IO\ :"L?^"F>I_\
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M!>G7O!C('AT_2XKE)6E)AVA88@Q;&53Y<C[L^(O[#O\ P6XUWP'XMT3XE?\
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M=9:,6D;:VS&>RNV$T2RP#[K@KT&:_8/XO?&3P1\)?@EXT^._B#5(]-\!>'?
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MH7^S_P"*M=1/A9<>$/$7QV\*WEVZP6USXDOX+R6QM]/$NT9M&N([<Q0CJ"<
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MA?\ !/KP18:;J7@NRD/COXM>/]+;_A&-/UD*JO91R7*?9G@C)!MY$W><?E.
M*^6?C]^T5_P7!_8 \*Z;\=/VF?&'P5^+/P>M?$FD:1XBT?P;I.F6>JQ+J=PL
M05I82EPB.NXAT5@F" ?3T/QU^UY^VW^V9^V)\=/V<O\ @GG'X(^#.C? .\&D
M_$[XJ>(-(L/[8U3797\G[9.]O#YM[:/)S:^:96+J=W'7X5_X*F_L@?ML_#W]
MDS6OB[^V[^VN?BM=Q^*?#>EZ)\.O#\4>D:#J]Q/<C[-<M8IY#W360R9GAAD$
M0=6<J"N8IPC)T;^S6LKIZU&[)JROHK:J_6]E?4)U>6-36I=2ULY<NO*M7UNW
MY)-_?^GG_!9#XB:+\7O^"5&E_%#08G6P\<R>$==CBD!W6MQ?V]I<7%FX/2.&
M5WC63J0H(Y-?'?\ P44(/_!$O]CHJO5?"97VVSQ 8/?&,@GZ5Z1^W;,LO_!"
MSX2318VG3?!ZLJC$>1#;*1S@Y7& 5[YR>:\W_P""B@_XTE_L>G<  OA3#$CG
M,T/ID9[>F,'K6M-*,J+<O^8F4?-KWDO/LM-^J,JLXMUUK_NV'DG=WNU&3?JW
MK\M[:']%G[*1W?LO_L^GNWPK\, L>,YM>22.WO7HWQ&\<Z5\,/A_XV^(VO17
M=QHW@GP_?Z_>V=C$T]_)%8PEPEG"F7N9)9"BJ@&<$^G'F_[*>&_9=_9] SN/
MPJ\, @#G_CTQD9XH_:>^-GAG]G+X!_$_XU^+=*&N:#X"\+:CJ\V@/%%<+K4L
M" 1Z=)!<!XI4GE9-ZR*5VJ>N*\^4?WLFK_QWI_V]MZ=]]SUU*G&A36UZ$6WL
M[VC;7OT_#8_#?X<?M!?\%M_VY+7Q#\4/V88?A;\ ?A1_;]Y8^%-/^)6D6]QJ
M^J:3;S21VUVB:@GF@7$2I-))@&-W*#( KI/V=OV^OV[/@C^W3X)_8@_X*$+X
M*\5ZK\3-!EUKPKXZ\#VUI9:=;1A,P-Y=B[).)I"(F\T*5P3VKSCX 7O_  6=
M_;Y^&.B_'GX+_'#X9_LO_!KQY=W=[X(\-6&AVTDZ>&C=2P1K'!#;F&&7R5V[
MD56%PI(/&:^'-=^!7C;]G'_@LM^RAX+^+'QZU3X]_$K4- CU[Q)XCU299QH$
MEY)&IT.V@6206D:SDR1V\@C94*,%P03WPIPG.I#]WHW:,5^\TC%-MW2Y4]+<
MJUNT][^=4J3I0IU%3J-.44Y.3Y7>2M97=WUNDM#]3_\ @IA_P46_:9_9&_;)
M^#7PC^$BV7B/PC\1_#\MA9_#YM$M[J\U[QMJ,(71W;6RPNK*S2XVM,L8VL@^
M;@5X5^T)\>_^"[G[*7@?_AIGXJ:Y\%M:^#EC>V=_XD^&N@Z382Z[X?T*X=);
MBTO]34"XC-K;LT4EQN9ED4*<9JY_P4NMK>Z_X+%_L.+=Q++''?:1/$)!E#<1
M!3#P/ND'H5 YSSS7ZE_\%AOF_P""?7[3:#)\[PI=HUNV<'=<6^XDC/7^'/ &
M<XR:SERPEA8<JLXQE)\JNVU'?;7SZ]=V5%RJ3QLU5DN5OEIIZ65G?K]WGN[,
M_/#PM^U-_P %>?V^_"4?QD_8CT'X:? 'X+1VD!\.ZE\3;:#4=9^(LD-DDFH:
MCI=I>A@EHU\LUM;LF%?*GJ<U[O\ \$IO^"A?QB_:*\0?M'? C]K"'2;'XS?L
MS7$EQXP\1:5;1V.FW=DLOE3K!:1$Q 6R S$@?*I':OKS_@E!###_ ,$]/V3X
M;5$M[9/ -L(K>,?NT)NP70>A)+MD#')[FOPN_81BN9_^"B?_  6NM]/1TU*7
MPOXXMK&. L[2W4FG,('C!SND$F, 989&*3IQDZ]N6.J6F^_YNR7K?<$YI8=7
MG>LKO^ZU9[=-;VL]3Z$U+]O[_@HG^W3\;_B=\/O^":ND^#_ ?PP^$FM-H&L_
M%3XC:?!>Z;K.K0NT4R6PO,PK',Z_Z/Y8(<9)Q3;[]O7_ (*3_P#!/[XL_#/P
MY_P4?TKX??$OX-_%#7++PXWQ2^'D$.GVOA34-0G2VMI)4M (Y;OS9(\64@VM
M&6?MQZI_P;NZIH+?LA^-_"]K<VC^/M ^*?BD^.[.%HVU6&6XU(FREU&W'^DN
MNW)1I$;R@>"M-_X.,]3\-6?[$G@71-<$4OB+6/C;X57PI92%1J+7S3P+%J5O
M W[\PPRR(K,J&,,RY((H48+$PI.',O9VNEKK%2O>_JE;I9]+%OVCPTJWM+-3
M^%N^S4=$_P -#O\ _@K/^V[\>_V6M0_8\F_9Y\7Z/HFA_&[XL>%O#_BN>_T.
MSUX:QX7UN73Y/*LY+A@+*62UO#B>++*S#!XK]J]2<VVGW4T>1+#I"WRR9XCF
M^P13[SZAI6;"]!R!7\E__!533]>\/_ +_@DC:>,GG_MRR^)'PX@U-[]BK%WE
MT>:/S)'.X,D#(=SM\J+V&*_K%\57MEI'A/7=?U">.WT;2_"$FIW.H/(JVD-C
M;:/&[S_:&80O %5F+[SP"1QS6<X07LE&+O*=KZ*[]RW6SZVT>_F:4ZTW*;E*
MZ5.-E?;3MI]_D]W8_'O_ ()8_MC?M ?M2Z9^VO<_&CQ/I7B*7X+_ !2U_P +
M?#G^S-"M='&D:)9)>?9H+XVY/]H3KY41,TWS$*0>N:_-3]E?_@HY_P %:_VQ
M/$_QE^!GP.M/A_J7B[P5X\\0O%\:_$^C6ND>&/"GAC3=3N]/M?"=U:INM;W4
MV6%+@7,N9V7ZDU]!?\$']1L=:\,?\%&]:TRY2]T[6/C%XCO["ZA(:&ZMIX=1
M>%H&3*M'(I^5\\[@02*ZC_@WA@AC^%W[;MRD$?VF;]JS7XY)R@\]H@U\?(:4
M#?Y((_U>=I.3CDYT=Z<<1[D6TXI76BYU!:=M]D^F^AFG&J\/[[7-*K>S>KC9
M?I:[6ESSBR_;R_X*<?L1?M0?!WX1_P#!0E? 7Q,^&WQFUVUT'2/%W@#2;73K
M"WO-0EB@AM+:\LRIN=0M'E$MQ;N!B,9/6OE?_@KUX<_X* K^VQ^RM/J_C[X<
MW6EZ_P#%&_/[("6]C:K/X0U!Y+=TF\;8 -V@1H@6GR-JE,_*0/O7_@O2(O[<
M_P""=&YL%OVG+5DX!</YFGYC7^ZOKR,BJ?\ P6/);]L;_@E#)UW?%!D.T'"L
M&ML(JJ/F9CP2!CZ]:U@D_82Y8IRC)2]WM;;M?6]]7>S,I.<?K4$YM)TVG=W^
MS>^M[6M9=&?M+^S+I?[1.B_!3PIIO[6/B3PQXH^/43:B/'.N>"[:*#P[=PM<
M%M-^P00A8X#':X60( 0W7MCJ/C3\7_!/P#^$_CGXQ_$2^73?!O@/1+K6=2ES
M\THCB?[+:[S\P>YN!'#\O*[P:]:O=PNYD(92VYA%LVX!)[D#)<8;GCTXK\C/
M^"X-GJ=[_P $U?C[]BCN+FTATFRFU>.W1S+)8B\3?&8T!.!@X.".C"N**Y^2
M">]2W36UG:^MEKIU1WRFX4(U7=\M-[[WO;5VU:Z^A\%_"S]J/_@M#_P4 T[6
MOBS^R)_PJOX%_!.+7M0T_P *_P#"QM,M;S4->L+:1DMKNVEOP7DMYD7S%F7*
MMD#D"O:_V8_^"D7[3OPD_:KTK]BS_@I/H7AO2?'/BZWA'P[^*WAE%M/#OB;5
M+J)OLFEVL41^S2RW<P VJ<QXQQP*_0G_ ()AZYX0\2_L ?LLR^ )[*ZTO2OA
MCHNDZI;:1Y4C6&L6ZNMU:ZDL.<:A$V3-YG[WGYNO'Y#_ /!<?4O#NJ?MH?\
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MMIS*SM?62[ZV:ND=$U*$N7FD^:@Y7;>C4;I<V_36UKWMU/GG_@A!I?[<FE_
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M/ W[:?[-?['/QPTWPSX'\4WGC"VT3XH:GIVA6]_HGQ9T6^$CIJ?A^_D8#2C
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MD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'V+HQ^&Z^+71-/I;S^\^ /V\/V ?A]^W7\'=$\$^(]6N?"/Q'\"?8=4^'GQ
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M6S@<.FGZFL+"2:&(@-&N"N[[P(R*^*/&'_!+G]O[]IWPCK/P]_;(_;"A\8>
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MG?\ :.M-\7B+5HXYI/#_ (JMFB$?F36-MDR7]P%$%Q-.C)Y)^4 \U\Z^+_\
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MC2='TS38XMOV1X;* W9]W>[:9F!.<L2>^?1<MQB)6SG8)6^17;[S[1AL'/\
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M]5??OZ_3I0#@Y'!]?K1&M.,Y33LY:2M\OQ5D+V,'"G!JZIR<E_7S/P1^,?\
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M[N6M(QCVO^+N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-GC1VC?[\189,;_[2'Y3]*=42BXO7N_P+4N;7OJ[=WJ%%%%2,**** "BBB@
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M_P %=_V7_P!COX]Z7^T[\7O"'[6'PD^+'@.^\*>)]6TFPFM=2^&4MX\4W]J
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MA+&$@EOX1.+J.SLH<J1-:JJ*>7)S7]&[$%BQSMWY10<;0S;L%NG?@9K\K?\
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MDZB=V[O:,=^NR;NVD[[(Z(TE4Q56=2+C#D2LK))V3O;HEY6ZVMJ?SE?LJ_M
MZS_P30T/_@IG^R[XL\3&ST/X:_VWKOP.DNY?LTUSK/BQKA(]5L(I2':1Y)E:
M/RB=C1*<8XK]D?\ @BW^S]/\&_V-/#_CKQ79R2?%GX_:I>?$OQYK=RK"YUN/
M695O='FGWX9VCMY#M)X?/''-?EE_P5;_ &6? _QV_P""KW[+_@7P5</J?C;X
MA6NB:E\8_!5FWF6+>#/#,B7AU'45BW1@WT>Y9%EYQVK^JS1-#T?PMHNE>%=
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M^UP21W$8FU>^GA,BMN0"&3Y)5+ 9WC^6:_3DC.,_PY 'H#U^OXT#CIQG_/\
M^KT[5T>WJ+EM5JZ+X7;E>B\[I+7;[^IA5H4JLKNE"GIO33YKZ=]-;:F7HFA:
M1X7TG3?#_AW3;31=$T6VBL]-TK3[>*VL[>W1 D< BB58P0@"N0,R')?)-?&G
MQV_X)P_L8?M(^(;CQ7\7?@OH^L>([D".\U&QGDT::^;AA)-#8(D<[C&3)(2S
M8Y)S7V_CC;VSG'O_ #I02,>PP/8>E9QK54VY2W?V?OU[Z]-MF4\/0M2M%R<;
M<W-Y6ORVV_J^A\-_ K_@F_\ L8_LX^([7Q?\*_@UHNF>)+)G^P:KJ$\NKBS\
MT%0T$%^CI#*A4;)8U#QL RD'!/M_[0O[-WPB_:G^'W_"L/CGX;/BWP6-8M=8
M&G+>3V7EZI8,6L[A;BV(F=(68EE;*G//%>Z=P>XZ4#C ' &2!VR>IQTS[TU5
MDI-W?DNVW^7_   ]G!1E&,(Q4W[Z2T:Z:=[6WNKG@'[/'[,'P7_92\(:GX%^
M!GA<^$O#.K:C'J5]8&^N+]I[V-=@E26YW21@KGA<#'J2:\F^.W_!.[]DK]I/
MXCZ7\5?C)\-W\3>-M*MK.VT[5?[7OK%(;?3[A+NU4Q6S!'9+F-7)8DL!M;BO
MMCN6[D8)]1TQ^E)@8V]O3]:?M97C)2DFMVK7O^OG?=;B]C!T_8R5Z:UBMK-:
MKI\O2_H<M=>!/"6H^#?^%=ZOH.G:SX*&CC0YM"U.UAO;&72UA\B&W"7*.#)&
MAPMQM\Q#AE8-S7YTZ_\ \$:_^"=GB;4+G5=2^ EJUW*[SEH=:OXXG9FW-#'"
MI"1 'M& ",>U?J >3D]?\]NE!Y*D\E>GMGK4QJU8MOVLVF]M%_7_  XZE*G4
MC&$J<$H[..C=K6O?TULSY<^ '[%G[,7[,$UQ=_!3X7Z+X1U*]MQ;S:I(6U#4
MUAQRL-U=*TUH."N8'4G@]\U0_:7_ &(/V;?VNYM"N?CUX"_X2Z3PRCII!75+
MVR^R)(FQR/LY'F-("1N;YAGKG%?67<GN3DGWHZ$D=3U/K_2G[:IS.7.V[6C?
M?2UDW?;3I^(>PHMP2@HTU\<8_:=E9^M[W]=&<!X;^%W@3PG\-M/^$>DZ'&OP
MYTCPXGA2S\/73M>0'0?+, T^=Y@SRQM%E9#("3GIQ7P?)_P1_P#^"?9\61^-
M/^%&V0UNWU*/68WAUG4%M;2^CF$\3V]L#Y4;!L,D:J$  ! K]+Q\N2.,]?\
M)H'!R.O^?P^GIVJ54G=\ST>Z75[]^^U]1JG323M[\7:+LFE'MY/0^+OV@_\
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M"BBBM# **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"@]MNY3W;.0?P_STHHH 7Y3R0VX=#G@^IQ[TE%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR_JWI<HHHHO#^;\O+_@_UN6G_(_Z^7]6]+E%%%%X?S?EY?\ !_K<M/\ D?\
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M:'HM%%%<*=^;3\/./^=O0]9M6BE;X5^6WR"BBB@D*:02<8!R/ESSANN=O3
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M\_\ "?T[MT_Y=J/J\.\ON7E_D_N0_K%3^6/_ (%+RMT\NW;L>T?\-M?L;?\
M1TGP0_\ "XT[_&C_ (;:_8V_Z.D^"'_A<:=_C7B__#"W['__ $;]\//_  G]
M.[]?^7:C_AA;]C[_ *-^^'G_ (3^G?\ R-1]7AWE]R\O+R_!?)?6*G11Z=9=
ME?\ %?A]WM/_  VS^QO_ -'1_!'_ ,+C3OKZ^E'_  VS^QO_ -'1_!'_ ,+C
M3N_3O7BO_#"O['W_ $;]\.__  G]._\ D:C_ (86_8^_Z-^^'?\ X3^G=^O_
M "[4?5Z?>7X>7E_5E\CZQ5[1^^7]=%]Q[5_PVS^QO_T='\$?_"XT[MU[T?\
M#;/[&_\ T='\$?\ PN-._P :\5_X86_8^_Z-^^'?_A/Z=VZ?\NU'_#"O['W_
M $;]\.__  G]._\ D:CZO3[R_#R\OZLOD?6*O:/WR_KHON/:?^&VOV-O^CI/
M@A_X7&G?XT?\-M?L;?\ 1TGP0_\ "XT[_&O%_P#AA;]C[_HW[X>?^$_IW_R-
M1_PPM^Q__P!&_?#S_P )_3NW3_EVH^KT^\ON7EY>7X+Y'UBI_+'Y.2[6Z/:W
MY=CVC_AMK]C;_HZ3X(?^%QIW^-'_  VU^QM_T=)\$/\ PN-._P :\7_X86_8
M_P#^C?OAY_X3^G=^O_+M1_PPM^Q__P!&_P#P\_\ !!IW_P C4?5X=Y?<O+_)
M_<A_6)_RQZ=9>5_R[]NQ[1_PVU^QM_T=)\$/_"XT[_&C_AMK]C;_ *.D^"'_
M (7&G?XUXO\ \,+?L?\ _1OWP\_\)_3NW3_EVH_X86_8_P#^C?OAY_X3^G=^
MO_+M1]7AWE]R\O\ )_<A?6*G\L?OEOIZ=O/IV/:/^&VOV-O^CI/@A_X7&G?X
MTO\ PVS^QO\ ]'1_!'_PN-._QKQ;_AA;]C[_ *-^^'G_ (3^G?\ R-2?\,*_
ML??]&_?#O_PG]._^1J/J]/O+\/+R_JR^1]8J]H_?+^NB^X]J_P"&V?V-_P#H
MZ/X(_P#A<:=WZ=Z/^&V?V-_^CH_@C_X7&G=NO>O%?^&%OV/O^C?OAW_X3^G=
M^O\ R[4?\,+?L??]&_?#O_PG].[=/^7:CZO3[R_#R\OZLOD?6*O:/WR_KHON
M/:O^&V?V-_\ HZ/X(_\ A<:=_C2?\-M?L;?]'2?!#_PN-._QKQ;_ (85_8^_
MZ-^^'?\ X3^G?_(U+_PPM^Q]_P!&_?#S_P )_3O_ )&H^KT^\OP\O+^K+Y'U
MBIVC]\O+_)'M'_#;7[&W_1TGP0_\+C3O\:/^&VOV-O\ HZ3X(?\ A<:=_C7B
M_P#PPM^Q_P#]&_?#S_PG].[=/^7:C_AA;]C_ /Z-^^'G_A/Z=WZ_\NU'U>'>
M7W+R_P G]R#ZQ4_EC]\O+RTT7GT['M'_  VU^QM_T=)\$/\ PN-._P :/^&V
MOV-O^CI/@A_X7&G?XUXO_P ,+?L?_P#1O_P\_P#!!IW_ ,C4?\,+?L?_ /1O
MWP\_\)_3NW3_ )=J/J\.\ON7E_D_N0_K%3^6/_@4O*W3R[=NQ[1_PVU^QM_T
M=)\$/_"XT[_&C_AMK]C;_HZ3X(?^%QIW^->+_P##"W['_P#T;]\//_"?T[OU
M_P"7:C_AA;]C[_HW[X>?^$_IW_R-1]7AWE]R\O+R_!?)?6*G11Z=9=E?\5^'
MW>T_\-L_L;_]'1_!'_PN-._QH_X;9_8W_P"CH_@C_P"%QIW?IWKQ7_AA7]C[
M_HW[X=_^$_IW_P C4?\ #"W['W_1OWP[_P#"?T[OU_Y=J/J]/O+\/+R_JR^1
M]8J]H_?+^NB^X]J_X;9_8W_Z.C^"/_A<:=VZ]Z/^&V?V-_\ HZ/X(_\ A<:=
M]?7TKQ7_ (86_8^_Z-^^'?\ X3^G=NG_ "[4?\,*_L??]&_?#O\ \)_3O_D:
MCZO3[R_#R\OZLOD?6*O:/WR_KHON/:?^&VOV-O\ HZ3X(?\ A<:=_C1_PVU^
MQM_T=)\$/_"XT[_&O%_^&%OV/O\ HW[X>?\ A/Z=_P#(U'_#"W['_P#T;]\/
M/_"?T[MT_P"7:CZO3[R^Y>7EY?@OD?6*G\L?DY+M;H]K?EV/:/\ AMK]C;_H
MZ3X(?^%QIW^-'_#;7[&W_1TGP0_\+C3O\:\7_P"&%OV/_P#HW[X>?^$_IW?K
M_P NU'_#"W['_P#T;_\ #S_P0:=_\C4?5X=Y?<O+_)_<A_6)_P L>G67E?\
M+OV['M'_  VU^QM_T=)\$/\ PN-._P :/^&VOV-O^CI/@A_X7&G?XUXO_P ,
M+?L?_P#1OWP\_P#"?T[MT_Y=J/\ AA;]C_\ Z-^^'G_A/Z=WZ_\ +M1]7AWE
M]R\O\G]R%]8J?RQ^^7EY>7Y=CVC_ (;:_8V_Z.D^"'_A<:=_C2_\-L_L;_\
M1T?P1_\ "XT[_&O%O^&%OV/O^C?OAY_X3^G?_(U)_P ,*_L??]&_?#O_ ,)_
M3O\ Y&H^KT^\OP\O+^K+Y'UBKVC]\OZZ+[CVK_AMG]C?_HZ/X(_^%QIW?IWH
M_P"&V?V-_P#HZ/X(_P#A<:=VZ]Z\5_X86_8^_P"C?OAW_P"$_IW?K_R[4?\
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M "?W(?UBI_+'_P "EY6Z>7;MV/:/^&VOV-O^CI/@A_X7&G?XTO\ PVS^QO\
M]'2?!'_PN-.[=>]>+?\ #"W['_\ T;]\//\ PG].[]?^7:D_X86_8^_Z-^^'
M?_A/Z=VZ?\NU'U>'>7W+R\O+\%\E]8J=H].LO+_(]J_X;9_8W_Z.C^"/_A<:
M=_C1_P -L_L;_P#1T?P1_P#"XT[OT[UXK_PPK^Q]_P!&_?#O_P )_3O_ )&H
M_P"&%OV/O^C?OAW_ .$_IW?K_P NU'U>GWE^'EY?U9?(^L5>T?OE_71?<>U?
M\-L_L;_]'1_!'_PN-.[=>]'_  VS^QO_ -'2?!'_ ,+C3O\ &O%?^&%OV/O^
MC?OAW_X3^G=NG_+M1_PPK^Q]_P!&_?#O_P )_3O_ )&H^KT^\OP\O+^K+Y'U
MBKVC]\OZZ+[CVG_AMK]C;_HZ3X(?^%QIW^-'_#;7[&W_ $=)\$/_  N-._QK
MQ?\ X86_8_\ ^C?OAYZ_\B_IW_R-1_PPM^Q__P!&_?#S_P )_3NW3_EVH^KP
M[R^Y>7^3^Y!]8J?RQ^3DNUNCVM^78]H_X;:_8V_Z.D^"'_A<:=_C1_PVU^QM
M_P!'2?!#_P +C3O\:\7_ .&%OV/_ /HW[X>?^$_IW?K_ ,NU'_#"W['_ /T;
M_P##S_P0:=_\C4?5X=Y?<O+_ "?W(?UB?\L>G67E?\N_;L>T?\-M?L;?]'2?
M!#_PN-._QH_X;:_8V_Z.D^"'_A<:=_C7B_\ PPM^Q_\ ]&_?#S_PG].[=/\
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MOV/_ /HW_P"'G_@@T[_Y&H_X86_8_P#^C?OAY_X3^G=NG_+M1]7AWE]R\O\
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MR^Y>7^3^Y!]8J?RQ^^7E;ITMV['M'_#;7[&W_1TGP0_\+C3O\:/^&VOV-O\
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M )&H^KT^\ON7EY>7X+Y"Q%3M'==9;?TE]Q[1_P -M?L;?]'2?!#_ ,+C3O\
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MY=J/^&%?V/O^C?OAW_X3^G?_ "-1]7I]Y?AY>7]67R/K%7M'[Y?UT7W'M/\
MPVU^QM_T=)\$/_"XT[_&C_AMK]C;_HZ3X(?^%QIW^->+_P##"W['_P#T;_\
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M  N-._QKQ;_AA;]C[_HW[X=^G_(OZ=_\C4O_  PM^Q__ -&__#S_ ,$&G?\
MR-1]7I]Y?<O+R\OP7R%B*FGNQW[RVT_R[GM'_#;7[&W_ $=)\$/_  N-._QH
M_P"&VOV-O^CI/@A_X7&G?XUXO_PPM^Q__P!&_?#S_P )_3NW3_EVH_X86_8_
M_P"C?OAY_P"$_IW?K_R[4?5X=Y?<O+_)_<@^L5/Y8_?+R\M-%Y].Q[1_PVU^
MQM_T=)\$/_"XT[_&C_AMK]C;_HZ3X(?^%QIW^->+_P##"W['_P#T;_\ #S_P
M0:=_\C4?\,+?L?\ _1OWP\_\)_3NW3_EVH^KP[R^Y>7^7X(?UBI_+'_P*7E;
MIY=NW8]H_P"&VOV-O^CI/@A_X7&G?XTO_#;/[&__ $='\$?_  N-.[=>]>*_
M\,+?L??]&_?#O_PG].[]?^7:C_AA;]C[_HW[X=_^$_IW;I_R[4?5Z?>7X>7E
M_5E\E]8J]H_?+^NB^X]J_P"&V?V-_P#HZ/X(_P#A<:=_C1_PVS^QO_T='\$?
M_"XT[OT[UXK_ ,,*_L??]&_?#O\ \)_3O_D:C_AA;]C[_HW[X=_^$_IW?K_R
M[4?5Z?>7X>7E_5E\CZQ5[1^^7]=%]Q[5_P -L_L;_P#1T?P1_P#"XT[MU[TG
M_#;7[&W_ $=)\$/_  N-._QKQ;_AA;]C[_HW[X=_^$_IW;I_R[4?\,+?L??]
M&_?#OT_Y%_3O_D:CZO3[R_#R\OZLOD?6*O:/WR_KHON/:?\ AMK]C;_HZ3X(
M?^%QIW^-'_#;7[&W_1TGP0_\+C3O\:\7_P"&%OV/_P#HW_X>?^"#3O\ Y&H_
MX86_8_\ ^C?OAY_X3^G=NG_+M1]7AWE]R\O\G]R']8J?RQ_\"EY6Z>7;MV/:
M/^&VOV-O^CI/@A_X7&G?XT?\-M?L;?\ 1TGP0_\ "XT[_&O%_P#AA;]C_P#Z
M-^^'G_A/Z=WZ_P#+M1_PPM^Q_P#]&_\ P\_\$&G?_(U'U>'>7W+R_P G]R#Z
MQ/\ ECTZR\K_ )=^W8]H_P"&VOV-O^CI/@A_X7&G?XT?\-L_L;?]'2?!#_PN
M-.^GKZUXO_PPM^Q__P!&_?#S_P )_3NW3_EVI/\ AA;]C[_HW[X=_P#A/Z=W
MZ_\ +M1]7I]Y?<O+R_JR^2^L5.T?OEY>7E^1[5_PVS^QO_T='\$?_"XT[MU[
MT?\ #;/[&_\ T='\$?\ PN-._P :\5_X86_8^_Z-^^'?_A/Z=VZ?\NU'_#"O
M['W_ $;]\.__  G]._\ D:CZO3[R_#R\OZLOD?6*O:/WR_KHON/:O^&V?V-_
M^CH_@C_X7&G=^G>C_AMG]C?_ *.C^"/_ (7&G=NO>O%?^&%OV/O^C?OAW_X3
M^G=^O_+M1_PPM^Q]_P!&_?#O_P )_3NW3_EVH^KT^\OP\O+^K+Y'UBKVC]\O
MZZ+[CVG_ (;:_8V_Z.D^"'_A<:=_C1_PVU^QM_T=)\$/_"XT[_&O%O\ AA;]
MC[_HW[X=^G_(OZ=_\C4O_#"W['__ $;_ /#S_P $&G?_ "-1]7I]Y?<O+R\O
MP7R%B*G6,=^\MM/\N_;L>T?\-M?L;?\ 1TGP0_\ "XT[_&C_ (;:_8V_Z.D^
M"'_A<:=_C7B__#"W['__ $;]\//_  G].[=/^7:C_AA;]C__ *-^^'G_ (3^
MG=^O_+M1]7AWE]R\O\G]R#ZQ4_EC]\O+RTT7GT['M'_#;7[&W_1TGP0_\+C3
MO\:/^&VOV-O^CI/@A_X7&G?XUXO_ ,,+?L?_ /1O_P //_!!IW_R-1_PPM^Q
M_P#]&_?#S_PG].[=/^7:CZO#O+[EY?Y?@A_6*G\L?_ I>5NGEV[=CVC_ (;9
M_8V_Z.D^"'_A<:=]/7UI?^&V?V-_^CH_@C_X7&G=NO>O%?\ AA;]C[_HW[X=
M_P#A/Z=WZ_\ +M1_PPM^Q]_T;]\._P#PG].[=/\ EVH^KT^\OP\O+^K+Y+ZQ
M5[1^^7]=%]Q[5_PVS^QO_P!'1_!'_P +C3O\:/\ AMG]C?\ Z.C^"/\ X7&G
M=^G>O%?^&%?V/O\ HW[X=_\ A/Z=_P#(U'_#"W['W_1OWP[_ /"?T[OU_P"7
M:CZO3[R_#R\OZLOD?6*O:/WR_KHON/:O^&V?V-_^CI/@C_X7&G?XTG_#;7[&
MW_1TGP0_\+C3O\:\6_X86_8^_P"C?OAW_P"$_IW;I_R[4?\ #"W['W_1OWP[
M]/\ D7]._P#D:CZO3[R_#R\OZLOD?6*O:/WR_KHON/:?^&VOV-O^CI/@A_X7
M&G?XT?\ #;7[&W_1TGP0_P#"XT[_ !KQ?_AA;]C_ /Z-_P#AY_X(-._^1J/^
M&%OV/_\ HW[X>?\ A/Z=VZ?\NU'U>'>7W+R_R?W(?UBI_+'_ ,"EY6Z>7;MV
M/:/^&VOV-O\ HZ3X(?\ A<:=_C1_PVU^QM_T=)\$/_"XT[_&O%_^&%OV/_\
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M>?\ A/Z=VZ?\NU'U>'>7W+R_R?W(?UBI_+'_ ,"EY6Z>7;MV/:/^&VOV-O\
MHZ3X(?\ A<:=_C1_PVU^QM_T=)\$/_"XT[_&O%_^&%OV/_\ HW[X>?\ A/Z=
MWZ_\NU'_  PM^Q__ -&__#S_ ,$&G?\ R-1]7AWE]R\O\G]R#ZQ/^6/3K+RO
M^7?MV/:/^&VOV-O^CI/@A_X7&G?XTO\ PVS^QO\ ]'2?!'_PN-._QKQ;_AA;
M]C[_ *-^^'G_ (3^G?\ R-2?\,+?L??]&_?#O_PG].[]?^7:CZO3[R^Y>7E_
M5E\E]8J]H_?+^NB^X]J_X;9_8W_Z.C^"/_A<:=VZ]Z/^&V?V-_\ HZ/X(_\
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M2"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HH') [GI]?Y#\:!\P)'(5MI]F]/UH **** "BBB@ HHHH
M**** "BBB@ HHHH **!R,CGK^@R?TH'/(]_T(!_F*+-_G]W];!>R?R^6JU"B
MDR,D?W1D^V??I^'6EH **,\9[<_IU_*CL#ZD ?4]..O-'*XN[O;L[M??=BT:
MT?W7044N.2.X_P _0_A3<C^73WZ?G3L[7Z?U_F._337RUZ=1:*/\_P"3T/X4
M4@"BBB@ HHHH **** "BDR/TS^%+Z^PR?I3L^S^X HI 020#R.2._P#]?\*7
M_P"M^O\ G\.](+^OW!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444=R.XQG\?\ /X=Z=F]DW\AZ6\[WV_#]0HH/!QW'^?I12(3Y
M=[O7=JZZ;_C_ %8***.Q/91D_3^OX9H*"BD#!@"#G(R/IG'(ZCGCFEIV:W37
MR"X4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ')]X?C_(UH^'_P#D
M,6'_ %U7_P!"-9R?>'X_R-:/A_\ Y#%A_P!=5_\ 0C4S^%_+\T73_B4_\<?_
M $I'TK1117A/?Y+\D?1P^"/^&/Y(****104444 >?_$7_D%VG_7PW_H+5XO7
MM'Q%_P"07:?]?#?^@M7B]>MA/X?W'B9C_&7I'\T%21*'EC1B0K.JL1P=I(!P
M?7'3WJ.I;<?OX?>6/\]X_F>*[':<J:U5FKMK2RM]_73M<Y)64'IK)*W;11W/
MP'_:>_X*I?M!_!/]M/3_ -FWPGX/^&NH^!M1\8>'- ?5=9L+QO$J:?JNI6MG
M/)YR$1F:-)F>&11MW %C@5^^EQ$L,KP@EAMCDVC.&DDCC<C./[S$#''3/O\
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MQ#XA\(^,--M]7T34[>2-DF@GC1_+#(64R0L3%(,G#(W [=M7X@_LO?$S6O\
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M/ GP1LM3_9^DTO2K*XUZ.Y5YO+?Q1;Q8EO%\M5RDI'/4UK&%HV=FTWJF]/\
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M OA'P9/<7O@N?20?%NE>+]+N?[/OYI]9R&N-/O+I)9[:+8%6%EQQ7I/[4O\
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MI?$?PY\0WUAX^\7^)-&M;#0M0MKBZ']C6.C:?.2/M4=IN%U*C9,@R>37V?\
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M\;O^"QG[5_Q4\1^$KOP-XE\5>";4:_X3U G[5H6KZ6Z:=>Q'< 7CGG@DGMW
MQY+I@$8K^JP]3]3_ #I58N-K_AY_\,%&2G%R5[7MJNJ^?F)1116)L%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 .3[P_'^1K1\/_\ (8L/^NJ_^A&LY/O#
M\?Y&M'P__P ABP_ZZK_Z$:F?POY?FBZ?\2G_ (X_^E(^E:***\)[_)?DCZ.'
MP1_PQ_)!1112*"BBB@#S_P"(O_(+M/\ KX;_ -!:O%Z]H^(O_(+M/^OAO_06
MKQ>O6PG\/[CQ,Q_C+TC^:"IK?_CXA]I4/Y,#4-20D++$2< 21DGT 85VWC>%
MG9]=_*_Z['%--R@ME9;WM:T;_P#!/XOO^"E/AVS\6_\ !2N?PCJ&5TWQ1XO\
M-:+JCK_K?L6J:G:6<PA;J',<K;6'*G!%?M!/_P $)OV/5FV&Z\1D,D#MFZF+
M!GB1U3)^\48D9)R>OKG\QOVY_@E\7_$O_!3#1_%F@_#WQ+JOA:+XA>#+U]<M
M;&>33UM;?6[&29O/6,J/)16D8[^%&>E?UOW4JR3;T. 8H/W9'S*5MXAOZ<\\
M<YY'TKMJUW"$6KMI62[[?/77\=D>5AL/&=3$JHGRW5_O76_E\K>2/XB?^"F7
M[(?PR_8Z^-7PZ\$_"Z74)=)U]+'4;N3496GF2XAU6U4*C29*CJ,#':OZ,?V^
M P_X)._%#.3GX1>!P"<#/&F5^7?_  6T^$/Q2^(7[1GPDU/P)X'\1>+-,L=+
MB2^O]*L9KB"TD_M:UD(D:.-@NU%).>0!FOUB_;@\)>)/$G_!,#XB>#M"T>^U
M7Q1>?"OP=96VAVD3RZB]Y;#3Q/;"!5,GFQ%&9@%S\N#52J1FL(ZBY=4TEY\C
M>K[)[?EUFC2I4UC5"$IV7X)]-/Z\]#\U?^#?%YX]&_:!DME+7(T[26M%&23<
M"Y_=%4Z/\X&<]J^!_P!DU8[_ /X*QZR_BWY[H?&'Q?,B7CE6CUA-18V^Q'[A
MB1"BYX^[7Z:_\$&_AI\1_AC9?&A_'7@_6_"3W5KHPT]=:M)+47[Q709A$)43
M.W@C'IDUX-_P42_X)^?M#_"']HX_M;_LR:!J7B#2+W7;?Q7-;Z#"[ZOX:\4+
M(9KF[NHE!6X@O)N8U56!4G<#6Z5*6(J\LM':WK9?KM^6Z,8J=/#49PBTW)W@
MTT[77E\_N['[J_M_QZ5<?L<_M(Q^(BBZ<? VHLYF( W+<QE6+'GS-X&!Z'\*
M_ C_ (-X@A_:%_:#$'*O\*M&:$OPPB77&$8 _B!0*5)_G47QJ_:(_P""E_[7
M_P  /''A[QC\)K+X4?"WP/X6;4_B5XSA@NK>;Q1:VYC$MEJ<%ZD3"ZNW E8V
MZF(,Q'!Q5K_@WD3ROV@?V@I2KI:I\+='MXY<9C(CUIEV[O[W&>N,'\\W"U&L
MTW;1Z:[RANOZ^XN,I5,1AY2CRSCLFDKZ:+[[>?G=:_!'B.TMKS_@JIJ\-XK7
M$0_:PL9'#<'S4UNU,6 .J@_>&>GKW_K<_P""C@/_  QO^TBCJA"> M:( 4.%
MV+%M(0C"%1P"*_F&U3X"?&IO^"F^J^+T^&/BEO"TG[3L6KC65T^<V$FEG5K=
MQJ8G\K;Y$:#>6WA<+7]1G[?FC:MXF_9)_:#T7PW87&M:OK'@G6+2PTZUC:2[
MNYV$86*&-06<S$97 )/Y45)P56@N9WY5=-_W8Z^:T?;6]M"L+3E"EB745^:3
MY=+V[6TU5MNW=]?PT_X-ZMPU+XQ)DA#H]M)Y9'W"8EZ=R#G)/;WK^G2OYR_^
M"$'PI^)?PUU#XKGX@^#M<\*B^T>V2S;6+22U^T.L:?)&9(TW$$$8!/ZU_1I7
M'B[>V=G=63_S_+J=F!4XX=*>_/)_)VM^ 4445S'8%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY[BZL=.8V+K>V_[W]T2<@?ZSO7N_[5O_  ;X_L?:O\*/$MS^RSX,O?AW\5-
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MCXXZ)9RZ?9?$+1(=5^PS$N]O>[$^W0*S?-+%#<,Z1R-]^,!NYK\8O'G[$O\
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MR7JK7[:=Q1D[XB/+>5M?G;U>C=M-=&^I\G?L?QZY=>$_^"ONK?"X22>$Y_\
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MHWB;PW$/[(\-:R^H6%Y$YBL;F B[F\U%(^S(#%(Y&ZL3]KV*72O^"Y'[$/\
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MOB[XH>&+[2YO WA>$WT'@W2K%9@^HM>6R,N^9$&() FYCU/>OO?]KO\ 8/\
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MP<^('[,'[>7B[P!\3?@3?_#VU\(>";#PS#,-5TG4;>5DCU&X,Z^5_HT)26V
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M_8C^-?[*WQX^(GPY\27FO>#;/PU\*]1T];I+33HK)U$7]L'[YMQ$@1/+)<L
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MTFNX[P,+LS(2VUMQ.:]@^'?PK_X+Q:G\.OA]J'@K]J+X!_\ "&W7A+0[GPI
MGAW17>VT$V<9TJW>6/<))(;<)&<MN0KM(4C%?<?A?_@F#^SCX<_8KU#]BA-&
M!\(^((?[6U[7HHHTU;5/'<JN\GBSS4 "7 NV\XIO"' ZU\$_#O\ 8M_X*^?L
MV: ?A+\$?VH?A[K_ ,)]'N;I/!K^,1>W.MZ'IDKGRX3-F1G>%-JB,L8D/$0
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MU:3^S1\4_@1^TK\0/ 7BLW_P]N_!WPKN] CN5&GLUE-96QU0N 6MPC1'(._
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M7AB&/0$\]\]CG%73JQI/79O5Z^6WR77L1.E*IUU5K?/U;_I*Y_++\6?VA?\
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MQ;>@SG.:^\L%5@7&SS+:VG[L9);B".5LL>FW?@*>X%4HN"5J>CU6EV^VM_\
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MMP1KZW2?8K?Q!-^S/?&>]=#G@MV4X)[ ^E#CR3<9:I/UMHOU!2YE==0'&['
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M 2#J!G!QZCL?3K0TU=OR3?ST_$E2T>M]K==6U_P11L3;DDA@?)"YX/ PXY8
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M5*<UK%6]$QM)M>733RW_  $,I_=H96^2-4^7YE!1%0Y"\A21G!Y&>:C#<+R
M&=1\K#+G=T?/.T<8'OBLS7-0DTO0/$.NQQJ\FB^&]8U5+9/W8EETRQGO%1I.
M.)3$$8]@37YH_L4_M^^(?VJO@A^T'\6]4\ 6/A:_^"4WC&UL-)AO!<P:W_PC
M*R[))9<GR7GV9]1GVI.-2=Y:[Q6W]Y?/;^NR=54VES6;5K>6FGI_6A^H;EB"
MG),CE_*4@,,$ '.2?<8Q_*E#!P6('S8&.K;E& S'N1CC'!]Q7Y__ /!.G]L;
M7OVW?@KJGQ6U[PA:^#;O3?%.I:"-.@O!=!HM/N?(699OXO. #%.-G"^E??X
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MMGI/C"S^,-T-)^'OQJ\'V<5OHUWJ8D,4<8$0$(T])!MN9Y LJ,R[ 0<UZ/\
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M7TUNQCE_M&3_ $F%Q+M=D3Y1MV\5B_LS_M=_M&^'O^"D_P =_P!BW]IOQ?\
M\)1X8%I<^(O@AJW]C66E;EDFD:TT"VE@ ;4(;:VV*\[9<NG/)KP/]IB,#_@N
M-^S_ +@&_P"*5MPB[CEMT)*MP<#H>N,'BNO_ ."Q?A?Q+\"?CE^RW_P4)\ 6
MS7E_\,O'^G^!?%VG(OEQW^E:UJ44<U[=E0"]O;1W!4R3;L%>"!4)1>EK.VN]
M_P!%>WD)2G#6[:7GZ?K>W_#'UC_P5M_:N^(W[*W[.>B'X*>)(?"7QI^*GC;3
M/ WP]UEK"VU5[/4[BZB2XN/L%SN28M'(J?.-@P2#D5E?M._MM?$#]B7]E?X$
M2>+K(_&+]K'XOZ5H_A[0=#:!+%/$?C"[C U&Y>TM,FV:V>1'CCC4*3QGBOB'
MQ[K.D_\ !0O_ (*S?![PE#<RZ_\ !;]G?P'HWCKQ/HT$J3Z5:^,[RWM+RWNV
MV%H3/#=R*N\G/RXZY%>3_P#!='0OB7JO[8/[&,?A3QC:_#EM9UVVTCX<>/M1
M1Y-'\)>+LK"-5N$*F%%M76-Y&P%P.>:?+"]GY^>RO^/^>VEDZU64'**>C6[[
MN/SU\O/HM/>_^$>_X.$YM,3XRP^/OA1#X>:%=>/P#?3XSXG;38XS<RZ&\YC\
MT3&,%-V_>"A(&:^_?V&/VX[;]LWX(?$N7Q'X:E\"?&?X8Z1XN\+?%;P)=;XA
MINM6NC:C%)=:0) )IK)S&S-)(/\ 6G R*^%G_8,_X+G;Q,G_  5*\+2+*#+%
M?0:'<M%<03HS+=Q.MJ5:VEA)<,I,>PG''3T?_@G+^Q%\6?V8?'7[3OQ%^+G[
M2_PI_:!\2_$GP/XHC\1/\/;E9-1M-=32M0::\U^UAE:*VF(W(ZF*.7?G(S0H
M1CK%)Z:-=?3\-?R17--T]4]M7?35;OY]-SY1_P""35M\3YOV5_V[7^#7BI/!
M?Q.TSXB>/M:\*>(I;*'4'@N]*GOKR.U^QS@PW!U!D6W 89R<C%?HI_P2*_:Z
M^*'[6?[.>L7/QWU2WU;XY_#?QCK'A_QV;>T@L76""[\C3#<V-OA+<R)\Q&,-
M[5\I_P#! LQ-X(_:B61#+;S?&_Q4)4D"L'MVU*=982K9.UERH!'/TKQ[X,:G
M)_P3>_X*I_M*^ M7UJ./X._&OP+K_P 9WN+I_(L7U>"R:_MM)MVE*PA["8A9
M$C(9CP%[464ZO*NG+S=---M];>8Z4Y4Z47)-)MVL[::+S]==3[7^-7[47[1?
MB_\ X*=?"O\ 9'^ 'C&'PGX&\$Z(/%?[0\*:59ZJ==TF9C)#:QW%SEK#]PRH
MS0$/WK]C'V+(T:$,J$A&5BPVJ=N#GHQ/S$#@9.!7X._\$9?!&L_%76?VD/VZ
M_B#-)K7C'XR>/=9T7P)K$I/[OP)I5Y/:"R1VX\N-514VXX'>OW@VG:?)7<'.
M]?E*HG&"NX\8SSU[>G3&K'226ZM;IK9=?FSIA-NTG\/K>_R=KA7X[?\ !=S_
M )1Z>)7/RE/B+X1EDQAE2**X$A.6_B<J %'4MR*_8@$$LHY=<$KR,#)W,"?O
M #GC_"OQR_X+OB)?^">GB%G)-NWQ.\%_. <+B\4LLJCYL%>03A, YXHIQM).
M5O3^M]>@ZMW'F6UEZK4^+?@MXN_X+._M)_ _X?>,?V7-5^'?[/'PD\->$=)T
MKP[8>-;5+GQ!X_@TBRM[9[VUBNU8Q->/!Y<(7:")@>G)^[O^"<7[?/Q+^.'Q
M/\>?LG_M5^#/^$*_:5^$DD"ZP\ \O2_%M@TRP&]M\X"W\H(G>&#=&L+ @]J^
M]/V1+S2-6_9J^ ]]X2EM[O1$^'_AB.UETUXY;1;B#2[-+M8S!N@#QSJWFA?F
M#@EL'-?C5H-[I/B?_@O[I=QX*FMKR+PMX#:#Q_<:9*&2#4R45(]5:-B))@2J
M[ILD<#..*TDK.3LVDDTDMW;7[GO^!RQG*4;+=R>K>UVM5Z?CW/<?V.OVM/VA
M/BO_ ,%&?VLO@%X]\<Q:W\)_AC>2Q>"O#,>D6=HVC1*R;%.H1#[3=$9(*R\<
MX/K7H7_!9O\ ::^-W[)O['^C?%;]GWQ<G@CQ]??&/P7X2N=8ETVUU4/H.JSQ
MQW]G]ENP85%PK,/.7YX\\=*^,_\ @G[O/_!7[]N2)R$N7U&YEMH\@23PO(F]
MHXE&]U5>6;!5.K8KT3_@XOU.RL_V%/".@W4L=MJFH_'SP%J5AI\KA9KFQM+J
M*.ZN;=&P\L22$>9M# ''3%+DO4A:+:OK=>G_  _](TC5<:;4KWMYO=ZZZ?UL
MUN? /_!95OVPO&OP"_9C^*7B[XD^%=4^ /BC5?!;Z;X52R@M_$L/Q?OK?3YK
M?Q'=,B@_V6DDH+P*Q1 2=HR"?WD_X)R^%/VS/"7P1LH_VQ?B5X,^(^LZE;V%
MU\.KGP;!%%#HW@Y[.(Z=IFI*BJ&NH;<QI(YRQ8'GBOR=_P""NYQ_P3,_84W;
MN/BE\-A$<?>9K#1R 5 YR,$*W0=LXK^B#X/JR_"/X91R1D%/!OA]][C:I0Z;
M!A0/O8Z_S..:JI91WV;V5NZTUU\^ER<.I>TNW=-::W>R_P"#_5CJ/$EW+8>%
M_$.I6I\J\T[2-1N[=A\YCNH('> L&X9=X!P<J<8Z$U_+9^RW^WK_ ,%7/VM=
M>^-OP1^#6J^$M:\5>'?'^NP6?QB\7Z9!I.B?#_0M-OKBWM/#KQVB^3=2R1)'
M)YTP\[Y?0U_4=XR _P"$/\5[F5 _AS5Q"<9P!:OU(Z#TW<CM7X#_ /!OG:PK
MX:_;KNDMU6Z/[1-W"TQ $SIYUX64N>1$V/N@X(QQ2H1C[-N5OB?2^FBN^W]6
M*K-JI:-W?HFUYO\ ,Y+PY^VC_P %*_V)?VDOA?\ !O\ ;]U7P3\8/ _Q?UF#
M2M-^(OA.UCLM/T5[UXX+;3]--L@%W=I-(C-YP!\L ^M?HC_P4C_;ZNOV.?#W
M@3P9\-_!\WQ#^/OQEU"ST?X<^&FR+5;B]1&CN]2\G,R965/L^1L=^&(!S7QE
M_P %O%QX_P#V$G^3>GQQT-!_%QY]GDYZ!LCU[?6N1_;YGM-!_P""QO[&?B'Q
MPZ6_@.Y\%:%I^BW6H,JV2>)S86GE%&G_ -&6Y60@Y7#C ((K1*+M:UN5OX5N
MN71:^>QE*4U9/F5[;2[^??\ J^A?N-/_ .#@[PWH<GQEU?XB?"C7?#UI&VL7
M/P#M-.M1XN%FBF;^R%E"B3S4B#([!]WRDG.:_0/]AK]O"']LO]G7XB>.)="A
M\"?&#X5P>(/#WQ#\*EVEBT3Q7I>F7DT4EDDX$LZI/;[Y_,7RQ*I3<5XK]*;A
MY$ENKRZE,<$-I>W$UW(2(&@-I(3=_:&^00;,DNS^6000>]?S"_\ !*P-J_[3
MO_!2;Q5X0(C^&CV_C_3"ULK'2[GQ,+75V9T9/]&,[A6<2 EB#D'')++LON"S
M_FG_ .!/^NAYU^S/^V?_ ,%=_P!N/1O'WPX_9V\<>#-$\3_#KQ3X@N=8^-7C
M/1[:SLI+"VU"\L]/\%6MG&ALY9K=88V\X_OWR-V :]H_:?\ VZ_V]OV.?BI^
MRW\.?&_BBR^(OC7QQX:>Q\<>#O#^BV3V/C3QY?P>7I%M#= ":RM!>8,C08PC
M>U>W_P#!OS;6R?LP_'R[BAB6YG_::\;0ROL7SG"7%ZX2250'PI&0I.SH0 >:
M\=_X*86T%Y_P5/\ V&TN8H[J--;TF8(_/ES)-&5EQ_>4X(/&..])R4=$EKKV
MM_5A2IR:A)UI14I<D5O>5U_7]-/&^.WQ>_X+C_LS^&9?VI_B1XK^%^J_!FSO
M+34_$'P2\/V4%QK/A70KAUDGM=5O77[3'':0,8YI5+.LBC'6O1](_:4_X*O_
M /!03P?;_%+]B.S\ _LX?"2'3H+G1?$GQ 3[1J_Q&,%JIU-]*L[A6B$:WR36
MULRA2XV9ZU^CW_!5UO\ C!7]I0'<HD\':EALY#CS(?E8G.=P.>O0^E)_P2CC
M6V_X)\?LK6\2HD/_  B;,L$>%6)VNE## P!N))(QR23@FIYKZ6WT_P ^WYE2
MH3A4]FZLG447-1L]4DI;W^_\>M_EO_@E5^W=\;/VC/&GQM_9H_:6M=/7XZ_
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M4:]+/!HGAO1[W7M6EMXC/.EC80F>=HX55F>0JN%B123T ]?YZ- _:>_X*O\
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M!5,@>[TK2K6XN)]=L8IP)GM;C[*Z(V",N,5^>7AG]JS_ (*C?\%$?&OQ.O\
M]A'Q?\,/@)\'_AWXLO\ PA;ZSXXDL[F]UN\TR=H)G^S73&X%RSQ.SK%$8MA
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M(M_!*^\$_LR:I\=_&\4LWQ8_:5\3ZCX]\6ZW<'-QJFCWMR;C16RV'"^6.,
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M+?"O_"ROBA^TI;:6GP4\$W >!]2BUN)7-]=Q1 7"S69966)E7N"!7Q(_A_\
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M/A__ )#%A_UU7_T(UG)]X?C_ "-:/A__ )#%A_UU7_T(U,_A?R_-%T_XE/\
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M?B'X7\*:18:%X?T3X?ZO:6&DZ=!':VEI;K9LJF"*,!6E8 &1R 2>>U?RG?\
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M/^"=O[)?[3.N3>)OBK\.5/B2ZC%O<ZKX>N6T*ZOL<B34)+1-UW<C^%Y"2%)
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M'- U2VU[P=\1_#>MZ3INKVK)-:W;6BS^68<;AM-[$BK(C?,&# \BOE/XK?\
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ML-"LRO06UE;JFP<<#)88_2MJ]2T4NLHJ3?:6BU\[*QE@H2E5;>T'9+LM'O\
MY^74Z,9 [>H"] #R![XZ9I:,Y_AVX^4 >@X!_$8HKRSU5\4OE^04444%!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPL<CEB"!BOT*_:3_ ."=_P '/C]^R=H_[*>GR7G@O2_!5GIY^&OBB*>\EO\
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M>AP../0_Q?7O45:W,UNU+_@>G]>B%0I^SBUZ:^G3\CD_'?@SP_\ $CP3XM\
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MGK.3/:6+R,[SVY/[R4[Q@<5]^T5?UCFC:UGU77IUZ)WVU[&:H<DHN]US+O\
ME?JO4C(*_-\C/_"<<>7G"D\\$'MVQFOR\_;H_8L^(O[2_P"T!^R7\4O!VK:7
MIVA? OQO%XC\4VUZH>XOK:.:.4QVQ/()"$<'-?J/28'H/RK%2::=WNCJJJ[A
M'^M/U_X!\B_MQ_L;_#3]N3X1ZM\-?'!ET75K2]&L^!_&-FI.J^&-;MV\RTN%
MGB(E?3_."R3VL9!D(YZ5^6'A_P#8Q_X+">!O"4GP6\._M<>'-2\!"V;1=/\
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M<CD'GBI/V#?@=XE_9C_9,^"GP(\;W=M?>)_A[I5U9:K>Z<,6UQ<377GH5X(
M"\%N/ITKZS(!ZB@*!T'\Z%-JW]::$2IW=]-[J_=^A^5%E^Q!\3K3_@J'I_[:
MW]J:4OP\LO#%QHTVDG:=1:]DB"+.G.2BD!L#@UY=^U+_ ,$O?B)J/Q];]K/]
MB'XPW7P2^,.L2O+XXT22.1_#OC1RVY?-MHQY4)NC_P A!I03/V(K]J" >HI0
M,=!6GM?-].B_X?03HQ>KU??[OZ^X_G\US_@FY^W;^UUXG\*Z9^W1^T;9P_!G
MPMJEKJ^I?#WX>PW&F?\ "5S6DJSQJ]W:M'Y%PC(B+*[;?+W*1DBOM7]O#_@G
M'X._:W^ /@7X6^"=9/PZ\7?!JYTW4OA'XJ1'F&ESZ1%##:0:C&&9[A?]'CF)
M)YN29<FOTNI  .@ZT>U\W]R!T4U;1^J_X=GX W/['/\ P5_\?>$+/X0>-?VM
M/#WA/P(+.WT#4/&.B:=(WBO5=#5!;70N[B,>:9;JS_=R-P=H4 BO5/\ @FW_
M ,$S_B+^P1^T!\4-?D\86?C/X9^.]"CA.HR IK%QK4%LT37TAD)D"S3.'96)
M;&<DU^U=-VKZ?SH]MYO[E_7]=B?8+M'\3\J/V"?V(OB3^R_^T+^TI\5_&NLZ
M=J>B?&3Q%?ZKX>MK$!);2VN9KAU2[P#EPDO7LV#]?G?7?^"?/[:GPC_;,^*G
M[1_[*_Q8\*V?A/XW^(M(O_&^A>(=/+W=CHEMJ%O+J6G([?ZZ:2W2?RYEP!O
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MVM]:\*^&OVWOVC-(G^"/AJ]M+[6? /A.QD@3QL+1U,::@\>4\Z3:7=Y>-SG
M&*_H8(SP13/+]_T_^O6L:EE:[7]=.W?0RE3L]5O9?@EKV_/YGP#^UM_P3O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^OD.[?Y"!< *>0#NYZENH8GJ<'D \4N2>3R3U/J>YHHH%=H**** NV%%%%
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M ****:;6V@!1113YI=_R$U?=!1P>&&5/WEZ;AZ9^N#^%%%25=[#2,EFR=QP
MW=47&$'JO ZTH4 YY(R3C)ZD$<GOUXI:*:;6PA ,9P3@G)!).?3GVI:**6[O
MU74:;2LM%Y!1115<S[[^2%:W3?<****D HHHH!MMIO=;/L%%%% !1110 444
M4 %%%% !1110--K8****!7;"BBBC?< HHHH ****!));+^OZ04444#"BBB@
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M[773Y^AXF8?QEZ0_-!11174<<KIV?1)?@@HHHH$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY8_S?EY?U\U\U=_RO^K?Y_UK;]9Z*_)C_AX)^U-_T8%\2_\ P<VW_P C4?\
M#P3]J;_HP+XE_P#@YMO_ )&HY5_-^7E_7S7S+O\ E?\ 5O\ /^M;?K/17Y,?
M\/!/VIO^C OB7_X.;;_Y&H_X>"?M3?\ 1@7Q+_\ !S;?_(U'+'^;\O+^OFOF
M7?\ *_ZM_G_6MOUGHK\F/^'@G[4W_1@7Q+_\'-KVZ_\ +M1_P\$_:F_Z,"^)
M?_@YMO\ Y&HY%_-^7E_7S7S+O^5_U;_/^M;?K/17Y,?\/!/VIO\ HP+XE_\
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M_P!&!?$O_P '-M_\C4?\/!/VIO\ HP+XE_\ @YMO_D:CEC_-^7E_7S7S+O\
ME?\ 5O\ /^M;?K/17Y,?\/!/VIO^C OB7_X.;;_Y&H_X>"?M3?\ 1@7Q+_\
M!S;?_(U'+'^;\O+^OFOF7?\ *_ZM_G_6MOUGHK\F/^'@G[4W_1@7Q+_\'-M_
M\C4?\/!/VIO^C OB7_X.;7MU_P"7:CE7\WY>7]?-?,N_Y7_5O\_ZUM^L]%?D
MQ_P\$_:F_P"C OB7_P"#FV_^1J/^'@G[4W_1@7Q+_P#!S:]^G_+M1R+O_6G]
M?-?,N_Y7_5O\_P"M;?K/17Y,?\/!/VIO^C OB7_X.;7MU_Y=J/\ AX)^U-_T
M8%\2_P#P<VW_ ,C4<B_F_+R_KYKYEW_*_P"K?Y_UK;]9Z*_)C_AX)^U-_P!&
M!?$O_P '-KWZ?\NU'_#P3]J;_HP+XE_^#FV_^1J.6/\ -^7E_7S7S+O^5_U;
M_/\ K6WZST5^3'_#P3]J;_HP+XE_^#FV_P#D:C_AX)^U-_T8%\2__!S;?_(U
M'*OYOR\OZ^:^9=_RO^K?Y_UK;]9Z*_)C_AX)^U-_T8%\2_\ P<VW_P C4?\
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MYKYEW_*_ZM_G_6MOUGHK\F/^'@G[4W_1@7Q+_P#!S;?_ "-1_P /!/VIO^C
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M'*OYOR\OZ^:^9=_RO^K?Y_UK;]9Z*_)C_AX)^U-_T8%\2_\ P<VW_P C4?\
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MF_Z,"^)?_@YMO_D:CE7\WY>7]?-?,N_Y7_5O\_ZUM^L]%?DQ_P /!/VIO^C
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M_P '-KWZ?\NU'(N_]:?U\U\R[_E?]6_S_K6WZST5^3'_  \$_:F_Z,"^)?\
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MYKYEW_*_ZM_G_6MOUGHK\F/^'@G[4W_1@7Q+_P#!S;?_ "-1_P /!/VIO^C
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M_6MOUGHK\F/^'@G[4W_1@7Q+_P#!S;?_ "-1_P /!/VIO^C OB7_ .#FV_\
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M -\+_A1]JE]5_P"^%_PJO11S2[O^OZ_K4++LON+'VJ7U7_OA?\*/M,W]X?\
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M\+_A5>BGS2[O^OZ_K4++LON+'VJ7U7_OA?\ "C[5+ZK_ -\+_A5>BCFEW?\
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MO[P_[X3_ .)J"BB[[L++LON)_M,W]X?]\)_\3V__ %YH^TS?WA_WPG_Q/?\
M_5BH**+ONPLNR^XL?:IO5?\ OA/\*/M4OJO_ 'PO^%5Z*.9]V%EV7W=MBQ]J
ME]5_[X7_  H^U2^J_P#?"_X57HI\TN[_ *_K^M0LNR^XL?:I?5?^^%_PH^U2
M^J_]\+_A5>BCFEW?]?U_6H679?<6/M4WJO\ WPG^%)]IF_O#_OA/_B>__P"K
M%044KONPLNR^XG^TS?WA_P!\)_\ $T?:9O[P_P"^$_\ B>W_ .O-0447?=A9
M=E]Q/]IF_O#_ +X3_P")[_\ ZL4OVJ;U7_OA/\*KT47?=A9=E]Q8^U2^J_\
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M3OL)JW]7_(****:3?]?+]1/17>B84444W%K5K\A)I[?D_P"NJ"BBBI&%%%%
M!1110-IK^K_EZA1110(**** "BBBFDWLOT_,.J766J\T%%%%($[ZKO;YK_AP
MHHHIVL 4445-U_7R_P T.U@HHHIIWV%L%%%%%_Z^[_- %%%%.W7^ON#JEU?_
M  /\T%%%%2G?8;36C"BBBF(****5U_7R_P T/E?]-?Y^:^\****:][;7^K]?
M(35M_P#/MVOW04444 %%%%#TWTV_$ HHHHZ7Z=QI7"BBB@6P4444 %%%% TF
M]@HHHI77]?+_ #7WB"BBBBZ_KY?YK[QM-;_U_5PHHHH33V_K;_- DWJOS7]=
M4%%%%,?*_P"FO\_-?>%%%%!.P4444 %%%%*Z_KY?YK[P"BBBF 4444 %%%%
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M**"7IOII?Y!1111M^8)WT6NMOGV"BBB@;BUNOQ04444""BBB@ HHHH ****
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M!.5&T9.75?R#,,GV&::#GI7QO^U-\%OB-\7=5^ >I^!/C^_P0MO!GB31M?\
M%6E?;=/M!\1K!8+::7P\XO+B!YA<G<A%N'?+<@9%?7\^J:7!<PP7>IZ5IUS<
MMY=GI]]J%G9WEY(!AHK&UN)HY[S<0?\ CW21LC !-4U9:13LE>Z]+?-]-?O)
M4N9IW:OJEK;2U]=.N^GK8M45DS:_X;M9VL[GQ3X5@OE;C3KGQ)HT%\S'((-M
M)?),)$/RB,H&XQMS6KE0,[Q)#( XV,KQ.C8*RB1<AAG&-A(/':LFI;\K>MM+
M>7W/7;NK&RY7;WMU?9BT50O]9T;2'\K6/$'AW2;AU1X8M7UO3-,FDB?[KI%>
MW4,C!^[%=N/ND\TLNJZ)%]D,FOZ!$NHD_P!FM+KFEK_:TG=-,S=XOG0\!;7S
M>< \G%:?9?NJZ7EY;]GK]_J9JW-;F>NV[\^^O7\2]12G<&(8N3Q\SA06!'!^
M7C'I0,Y&,@YX(Z_A[U"VD^Z5_6\?\BG=5(]5'K^E]1*0'V(^M8'B;7;7PYX:
MU_7;F[TJQCTS2M0O8I-7O[?3H&N[>!WA$UQ>2Q0!I'&(XE?+XX!-?DA_P2,_
M:V^)?[4O@[]J#Q/\9_'.EZSX@T3XM>(?#O@O1C?:7;/8:)I=OJ"62Z5:),ES
M>0[88V\V.)U<KD$YK6G2_=3ELDU=^K26_?6VJ^9%6I%58K5MWLOEK]RU]#]D
M2I4 DKSZ.C'\0K$C\0*;7\\7_!(C]HWXQ?%?]K;]MSPO\5_B->Z_X2\#7UZO
MANTUJ>&UT[0(X];N+=52>XD6.)$B4 LY3&,G"BOZ";/6]"U-RFC>)/#FL3?,
M6CT?7M*U*Y5 .2T%G=32;3_>V8!&212E2E#?=I-)V3:=_/R?W"A5C/9.VU^B
M>F^UOB1J44 '(*@QJP&]1RL:_P 3.QX0'J3G"UD/XB\,17+6DOBOPI'?9\M+
M6;Q/H4=Q(3QL^S&^%P'!^7;L#$\8S6:YG:ZTUMY[7\^O=FK<;;ZJW,M=-%KI
MJOZZ&O2?Y'Z48R-B_O% WQ21D-!.""?DE!(9!G.]6*GLQH8YV*'$>X(61.03
MT^4MW_O9X(P11*;4>6VK:2TTZ?B[?T@A!-\SG=+I>[>W7Y]!:4 L<#'/J0H_
M-B /Q-5[J]L=/@^UWU]IFDVBDQ-+K%];:?;*_P#>%Q=30Q9/7&_.2,"OS>_X
M*N_%KQ)\-_V /C[\0OA#X[L-+\8^'=#T]M(USPSJECJDVE/+J4$<D_F65Q,L
M;,K% 9"H(-7&G*26R;Z:.^VVIG*K&+?5)VN]K]KV:_$_2K:2VWY<^N]0O_?9
M.W\<TA&"1QQZ$$?@1D'Z@U^9G@30/BE^TG_P3&^#MKIWQKO/A3\2_'7PS\.:
MGJ?QAN;BRM;ZTU(R2-=W,TU[-';*;Q<)@RAC@[1G-??/PMT+5?"/PS\">%_$
M'B0>,]6\-^$]*TK5O&$TT)B\27EI!LG\0RW43M 5NR?-:59&B''S]:'&47R\
MJNM=5K:]K[]] 4HR2E=I-VWZZ:?E]_H=S16+_P ))X6,_P!FC\7>$!<%M@M_
M^$IT)IA)D@CR1?F; .1MVE\C&*V01E6$OF.%R)$*O%<$\_NV4E60C[K@X/4$
MTKRM=03MV7I_G_3*]VZ3DU?7?IIKO_5W;I9:*S[S5M%TM%.KZ[X?T97RR1ZQ
MK>G:9*"1\KA;ZY@+*,?+M!!P>M6+:]LKZW:^TV^T_6+?[DL^D7]IJ-NI.-N9
MK.::(-)UQN'M23;UY5WM;5;?U]_D'-%65^R]7^3?S^XL45&\T4%O]HN+B&VM
MT3][/?3PVD46#PKW$SQP(H'.7=3@ ]^<J+Q-X3N)EMXO&'A"YG8K'&L'BK09
M9S*I!,:P1:@TC-VVA2Q].U3>6DG&U[>6UNCZ*_\ EN/W5M*ZTU_S_JQLT4_:
MV]0JI(SDE.<@]-QB9<AD8<J03GM6-<^(?"]I*8KWQ3X7TZY)^>ROO$FBVERF
MW@HT%Q>QRJ2>@*Y '8XII2>KC9)J][6OI9=-?ZZH%)/9I]='VMV^1K45%#-;
M7$/VBVN[:[@?E;JRN(;NSF'41I/ \D;CCDJQR?7K4=U?V-C!]JU#4-,TJWW%
M3)JNH6FFVZNN"2L][+#&S$CA0QP"*J[_ )5Z\H6B]>;WKZ+[O^#^)9HJC9:M
MH^J%_P"Q]<T36'0,7_LC6-,U5E;D9ECL+F=T4>I4*.-Q%7&8+\JH,Y"R%2Q5
MW;W/W6] ./7K4M2:NEY+332U_P QJ47)1;U73\OD.HI?D!4,N]6)PG(=INF\
M\=.BD?=ZD<UF7>MZ%I;&/5O$OAS29>?]'U#7M)TV3_9#Q7]W#*!GC*KZ\XJ5
M!OWI;*WDD[]VUV^_0=2<4TEU[)>6NFNG_ -*BJUM>6-Y&T^F7VGZG;!09;C3
M[^VU"TRV3M\^SEFC##C8F\$YX!Z5&FIZ4\TEG_;6E->PQ&XGTLZKIZ7\-OGB
MXN;$W O($'9Y(DCV?,6JN5Z:/6UO._;N3S+NOO+M%9T&O^';RX-M8^(_#5]?
M*-K66E>(='OKW /S#[)#>23;NQ CSGCK6DBN2%4 C(V;@=R!L;D<#YB_..!]
M*:O_ "I_*X/EZRL^U[?U_E\A**S+K7- TZ5HM2\3>&M,N^0MMJ'B'1[&=0,
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M'^H6DLL.H6/A#7KVRO$ !@FATF\G@GB_O;9%5T8=0 0:5VK>ZOB2VM;:_?\
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M3G+2%1@Y)JO9WFGZC&7TO4M.U1$ERTVDZA9ZC;1NO#1M/:331K(I&/+9@_\
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MAKS\S=\5)J+C[L?=>ZTTT[6>AWY8G'"QORM\TG[KNMEU[]PHHHKSST HHHH
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M7\^W_!N@Z_\ #*?Q,^]C_A9^L[2>BJM\>/U _P#U5_06^3#=KG<5M+M]P&[
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M'W;I;VB[W:WOY]]#EJ*^#IU?^7SFE)[:<Z6RV5G;;6V^A[5_P7#N+N+XD?\
M!,S[-?:A9)/\>_"XEBL;^[LHIT8Z>'CN$M9HA/&P^5HK@2+C^&O'_P#@OU9?
M%'6/VK/V ?#7P;\4:EX/^)'B/6]4T/P7K.GWUY;0:;K5[=^7!>W%K;S)%=&W
M3S"@GCE ..,"O6O^"Y# ?$K_ ()D;OE_XO[X6!7;MP0=.X]SUYIG_!7QBO\
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M@N?$FE)*8]6OI$&Z5Y%.YR26XK^L?QK\_@OQFH#2*WAC6592.9)?LDGW?QZ
M9]J_ '_@@)XK\+VOPP_:^\.W?B/1;;Q#=_'3QC#:Z#/?00:I.2FJD"VMG823
MMP<[ Q'T!-=-"<U0E9N-Y4T]KV;@GNFE=>6UC@Q*@\1>R:4)_P R]ZVG5;/[
MWWV/RJ_8C_9:\>?MG?MR?MG?"BU^+/BWX2?":WU[6-;^*+^";N32]>\5:;<Z
MS=0IHT&H(5\I4E8S;0ZL 1V%>O\ [:'[%C?\$=_B1^S/\<_V6OC9\8]1\/\
MC/XCZ?H7CC1?'7BR^UMKO2[6[A:ZLV^T3S0FUOD+1NOE*R@D9XS7U#_P0[)_
MX;@_X*"*V3Y6IZB#YG\,AUZY&2^>>.-I[]\BO2/^#C,EO@Y^S&/F7_B[J^80
M?D"BXA(P.V>?J/PKKE)2QGLI-.ER:Q5MW%/XM7NEUZOI:V,;1PBJQ7[YSU:N
M[QNDO=VU7D]M+=?8_P#@K-^V_P#$GP%\*?V>OA!\!]7L/ OQ4_;'?2K+3/'%
M[>P:9I_@O1]35%U*Y>^N66*R,2%S'=RLD4>"6(R*^5=*_P""*?[&^H:19^+_
M !W_ ,%$?%5]^T ^G1W=]XML?V@=%AT*#QBUL&:2.P&O;)+:+4"P8!,,@)V=
MCYQ_P6R^$^G:I\./^"=GQI^)'AC7O$7[//@K0/#7A[XS?\(Q+-;:M9Z#K<$(
M9;&]M\R6<\L;;A<KC9M)]Z]Q\%_\$<_^"'?C[X?Z5\3/#_Q \5_\(CJ>AQ^(
M!<3?'B<'2()K07LEOJ.X[H+NV5C!+$^7\Y"O)/.'-"-*FHN<?>G=QIJ=^66F
MKO96TON[;KKHHSE5J.2@THPY;S<=>5:Z-:]7VM:UM#V3_@CU^U?\1M7^(O[0
M?["7QN\?P_%CQG^SCJ7G>$?BI9:G;ZU9>*_",UQ]GL+)=1M&>*\:&-XW>=)'
M&X-EN,5^]D<,DDH@ !+R9#=2% ),7'8#CVZFOP#_ ."2OPF_X)IZ#\;OC=KG
M[!VC?&.;5?!%FOA3Q3XZ\9ZKJ&J^"]<2WO&5[+0KRZ7R+^\256D9XV+>4 QX
MK]_X)%AGCD&1$#N!4[9-Q!'/<(Y//<#BL<4H<]/V:E9N-[QZMJ]U^/3R\^K!
MJI*G5C)QYDI.-F^:]E9>=FC^7'XO:9\4?^"NW_!0GXF_LT0_%SQ+\,/V3?V?
M+)[+Q!9^";VZTK4O%.OJ7^W6=S<P21R+?+,C+:3-((D0$$$FO%?^"CW_  2P
M\2?L+_LB_$;Q+^R_\=?BMXC^#NKPV6G?&7X<_$OQ%<>(UN='%W%(FIZ=-.\Q
MB=;@JA4%6&!UZGWO]C;Q]X5_8F_X*R?M;?"#XYZM;>"+#XZWG_"8^!O%OB)?
M[.T34;J\\^:'3+;49P(6<[]C$-RY'K7U1_P7!_:]^!W@G]B3XA?"2W\<:%XH
M\>_&*WM-$\*Z#X;O(M7GB1+J"Y?4M1:W8_8;':I"S2?*6P!S75"\<3&G%+V+
M@O=Y='HM7)J^F^Z3?R1QS<7A7*:?UA32NG:ZNM+)KKY>AXE^V-.Z?\&\W@RX
ML[J\L2OPM\!JEU8W5S8W43K?W"H@FM9(;A,]-RNJG'.167_P4$^.GQB^"_\
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MIQNKIP47\4=%+E6UK6U[7V%HGJN22^"TG+GT5KIM\M[>5NFQ@?L]_LA>$O\
M@J!X4U+]J+]O_P#;;N?!LOC_ ,2:M>^#?@]X)^+VE>"AX.T1+@KIL:V<FJ6L
MUO;-"-T,$D#NC!]^,J3UWAW4I?\ @DO^VG^SM\//A/\ M3/\>_V5OVA]1D\'
MZGX3U?QS8^.;SP5>O*+:'6M4N+.\O&6XB.U[1A*H()XSD#YV_P""8W_!/O\
MX),_M>?!I/\ A=.I^._!_P"T?X3U74]"^(7A35/BA>>%)7GLKAH3?Z5HLNW;
M;S,-Q6(CR0 <$-D?3&K?L,_\$1/@'^U5\"O@SX-F^,?Q!^-OBSQ38WGAFV\'
M?$2_\7Z7X7O[*;-I>>*)(%>*PLMXW2F;"[>30FE.I&[Y8Q7NN&FEM>=17?\
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MM^,$'[4>IS7]QXHT5OB7<>"['1;\39MHA!?7=M:WCDG<\4+HX.4V9&:_3_\
MX)"?%WPC\%/^"0FH?%'Q[X?O_$W@KPWXP\;W7B71=(TIM9EN-%><M<HVF)EI
M[:&W91<C& @.1UKF?^& /^"/_P#P43\/:;^TI\-/$]O\)K_Q.LMU+IOAOQ9'
MX/\ [&OX03)/>^%HW1K"Y,C><QD*B3!(Q@X+JTU^\CJK.--2VC%6:LW'>^BV
MV%"-1M-1A-6LHRJ2C?WE;WKK5>OJK;??G_!/G]D+XU?L>I\3=/\ %O[4EA^T
M/^SW?V\^K?#*PG>ZU3Q-X433H'EDM;OQ TDMI>6YM8B2L,C$R#=[U^/9_M;_
M (*__M-_'6'X\?M36'[.W[+'P:UR;P-X/\!^'?'MAX(UCQE)87+0W&L,;S4+
M&634,(QFN5=XF 557KC2_P""4VK?%/X8?\% _P!J3]BWP/\ &CQ#^T%^SUX8
M\":G:Z7XGO+V34M#T>^U"SN(8)=,O2SP":U>1+"=8I'WNCD$@U\6_LA_L0_L
M#?$C]K/]IK]G3]O1_&/@?XL>'/B!K%YX U9_&]UX&T+Q#H]W?RS);6TI'DW5
MYLF!248,V2N015*'NR;<D^5--4^:2UOK'5W:^^SLM#13G=1Y8*3^Q[7W?LK6
M?G?OOY,^E?VEOV9_!/\ P2>\.>$_VI?V&/VU=8\;Z5X1\8^'K7X@_";Q'\7-
M+\<:EXOT;4+OR[Z.&TAU"[D:S,0!NB(5(! ##DU_4_\ ##XM>%?BC\+OA[\3
M[76-(TZP\?\ A31-?BBN+J*PC:^U&QAN;RS@%PZX%G-(T.[D?+ZG%?S-_M4?
M\$W_ /@A)^R-X7TSQ#\0-<^*WB+4]=U>PTG1/!W@OXI7WB;Q;J-Q?3+';^1I
M%MOFD@5MI=]IVKR?;]8?B?\ \$VOA?\ M&?"']GWP_X5^)?Q<^$/@7P!X&LS
MX2TO1?$=]9:K<:/K4$%_;+XCFB7?-J$$1CC=91OB8-&>E8R45#5RE)-KFE'E
M>G=6CZ\R6JO;0N'MG-2Y*=):/E]HYKH]&];;Z:VUUVM^BOC[QE'I/@+QYK/A
M2_TWQ'XIT3P;XBU?0=)T[4+:ZN;K4].TF[NK2/RH69W"SQ1G8J[I/F R2*_B
MQ_9!\!?LS?\ !2_Q+\1?$_\ P4._;#^*_P .?V@6\?Z[I^D_#32_&]WX#TWP
M]HD5[+!:!IYYH+2*)T1%CM9UCE0$NS= ?Z*?@)_P3@\'?L3^*=9^/]O\:?C3
M\3D\)^'-3N=0\*:_X@O]>M+S3;2TFN+@Q:5*NVZG,*. @Y<';CFOB\? +_@C
MK_P5WM=>^*UE#'\)OB+HVN:EH&NZ;8:HGPS\0SZC9SO%+JWB#P\/+EOGF?.R
M];;O*ACDY)FFXJ,MUII)6DDTTE96ETO=VLE=MK1E5KW3E[-[7BIM75M6M5KM
MHW>_='TY^PW_ ,$[_BK^R-\=IO%/P=_;+3XO?L?7>B/IQ^%7B?5I_&6N6NKR
M*JV>L1^);:XNK R6Q&Z',V>?F4YK\J_VJ/AS\<OC3_P6]^(WPB^#'Q%UGX;M
MXW\%Z7HOC;Q;9ZE?@^'O!4EH#J%UIUFDQM8;V4J\*RI K N#NXJO\"/ ^L_L
M(?\ !4OX(_L[?LU_M,^(_CO\*_&-E/;>,_AS%J\NKZ!X+TBX8[[W4S')+!+>
M6Z(ABN3)^Y/Y5ZOX_P#V@_A[^SG_ ,' WC#Q!\3-6M?#OAOQMX1TGP,NO:BP
M32]*N;RV$D-W?RMA+>$DI$)7^7<P&><UTP4YS=FFUAY3C>,4W:4-TEOKV7:R
MU9@W3C3AYXB,)>^VK-2LGKW3;U>RL:/[2O\ P13O?V2/A9XJ_::_8U_:-^.+
M_'/X:6Y\6ZS!XU\7ZCJ^F>+!IC&_U9+:U:Y>&WMI?(GEDC>(@PML!!.!]0^*
M/^"KFMZ/_P $@K;]LB*S@'Q=U*!/ADL,&$B/CAB=,NM>M%;(4V=P!=+N'&.>
M*^QO^"BG[;'P$^!G[)/Q9UF?XA>%O%FL>+_!^J>&_!?A?P]JEOJ.N>(=0\06
M,]I;I:V<#-*Z 7*.KKPVY0,U^$/Q,_8]^+T7_!O_ .%K"'PWJ$WB[1_&\GQC
ME\*F"2.^B\)ZY?27]S/=Q$;U-G:C>Z$9 -13UBG62<N9-.W*[::-<J[:NWSZ
MMUKQFE1NH)*^K:OWO?UVV?EOZK\'?^"57P _:@^&7A#XT_MK?\% ?$&J_&KQ
M_I%OXON;#PW\>-%\/Z=X?CUF&.^L]/NK#^VK=H[FS$JK<0M&A5E*GD$#V#]A
MCXK>/_V(OV](/V!_$WQXLOVD/@#\7-(.M? OQA'XIL/%FJ>%I[8&.32M4U*S
MN+M8TAB4@V\DQ=G0R E>:\9_8T_X):?\$6OVJ_V?_AY\4D\4>,;+Q7JGA^T_
MX3_0+OXU7&E:CH_BNV@5-;-UHLC"73[&6[266S1@$^SLNW@$#UC]D?\ 9J_X
M(^?"S]O[P_\ #?\ 99L_C/XW^.WPUEDU*;Q5!XKU#Q9\-_#\DT+V\LU]J@#6
M<\,*LR.0P"2@IUZJ\/WFK:M*R<;1CRO3EER^]HK6YG=OFVT4/VKE!)44KQO>
MK+F:=NB=KN_2UK6WWX7XX>*OC!_P51_X*2^/?V./"GQ1\7?##]FO]G^"YTGX
MF'PGJ$FGZCX@OE41G48Y[<QR*UV[M"@:3Y& 8BI_C7_P2%^-O["DW@/XX_\
M!-/XJ_&WX@>+="\6:3+X[^&OC3QO-J#^*-'%R/M=O%)?RSVT5@\>[[; 4+E
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MC'X(^ ?_  1VUSXJ?$KP_?\ BGP#X=^)_P 13XJT33=);7)[O1YKTQWAFTU
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MKMOT].W8EQIU,+6E5NZE._+9M.-MDEUOIK9VNOE]M_\ !+_;_P ,!_LONB@
M?"[P^ O/'[J3CKU&.OK].?LWQBN?!WB\CESX:UPHK?=+'3;H'(_'@5\8?\$O
M 5_X)_?LO@D,?^%7^'R6'0DI*3CZ$XZ]J^S_ !D2/!?C$@[6'AC7-K8R5/\
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M?\%/M?\ ^&7/^"K'[)G[8OC>PNQ\*=6T*U^'6JZ[%;/-INBRQHL%Q>W\H^2
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M?X.>%]4UG6M'\#:1;Z1:ZOK]W)?:MJ*6Z;!<W]U*\DDUPP +.S'+=>E?C?\
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M"/\ <WLW[2?_  596XU35+M1I_B<V\=WJ5]>1VS>9=\VD=S<2Q6NT=/(6(C
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MWB&ZUV[N[O6KU+:.SEFN9)U\J1)3+YB^6/W?(&:[[_@@W^U)\+O!WCC]JCX
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M40:<VJUFN65GRI<MG;2RUT5[O]2ZL%[*BZ"?M)).3<F^9NW,W[RMNEI\M;G
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MC.[\)_#;X1^$OB1IW@;5+W3-*EFMX]=9+G4;*6-[@(K7;N',DC*R+CD>^_\
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M;Q!V9G5BNT,P\C_X*Z? K_@F]^Q[\%?A7\$OV45TWQ#\8-9^)OA[7-5UIO%
M\;>(-*\(VVJVL>H6&KZNK,]K/<7!62VLIE61HT9@,8-;4=9)2;>C32@E%NR=
M^;E=O12WZ;F%9^ZG%:W6KF^:_,M$N:RZ[Q?>^Q^HW_!<_P 3W'C;]@W]EKQ?
M>HL5YXA^(O@35[V&(;8OMEW;:3-.X[_O)G>0X)'S'BO-?^"RX/\ PS'_ ,$V
MUR2#XY\(,5R/+W>38GIP>#P,'@=<UN?\%E+F*;_@FU^QE/%_JI?&/P\!R0,8
ML](7!_[Y(K"_X++M_P 8Q?\ !-M<<'QUX0^;NO[JSY]\X'X\=ZFE*-.6&?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'7Q4\4:OX;OM!\+>*O$\2H/ SW*J(=5TO2@TEK<266"(;9]L3CK@"OW"VC"
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M12^!/$4C:?,8I+[4=(M_LR(EXP8K,27G&?,[5\?^,_@7^RDW_!2']BKX#?\
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MW+J>MZM= <O=:I<+]J2)B2YMPY0RY;&17G'[6_\ P37_ &4/VS]0T?Q/\8?
M[1^.?#[AM)\:>&[V70M9#-A5:[N+)%ENY(L!U:5R01N!X%?>)PF\*H"C;YC
MYWD^G&3[]P0<^SL;C\N&SU."'5N,G#<;3T' ^M1[6?-I4J6>UK;))^MO+[UJ
M:*E1Y6E32BFKJ5T^FFKT\V?E1\$O^"-7[&'P6^(^B_%4>'_$/Q%\<>&)#-H%
M_P"/-<O/$5I939!2=;/4O-A+1$##<%>U?JMM11L11]F&V-8XD$2AP/DAAC7
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M+:4E*;5TKI1\KO;TNEOHMQNBG9.-/=/5O2W+Y;_?UMW?+^/O"&E?$?P-XQ\
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M?0'\>:<01COD9('51[@>M1=#>ET].7?RO;?[T)11QUSP> <$Y)[>Q]<]*/\
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M(_B21%D1B.Q*N"13:XF_>YND?<6OEMW/1>M2+7N^TCS6U6ED_P#+^KA1114
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MPQJGB'3['Q1J[RG*1V.DW$RW=Z"!@>3&W([5V/*Y8^8C1JWFASL4PH"7:5F
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MC/80:OHSZ=;:]'J^DR^%VC%U+X@M=2MQHS6) D:_&I[S;- L69'F$@18@6)
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M.D^']'MV\NYUC7=0M]+T^QY(/VB]NF2! _\ "690<?C7\>/[/WB3X+_L=_\
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M(>6,-N!'-?JVKF2*"4J8_.M[>9H2-I@DDACDEA9?X3%*SI_P'-'MV_3GK_\
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MEX6\&6.EI=O&EW]N0B*T6T7A)$R+O.\\#%?LM^R9_P $U/A-\*?C5X3^-'[
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MPE\%?AU?:K<:8VMZ'HUC_8,E^S[+U$D=8I3J/EE/M=SL\P,,AB1FOKCXP?\
M!+/XCW7_  3:TGX >'O%6I>.OC;H6H?\)UJ1U349[FTU'Q#+#LO=%TR:^FDE
MALX+?Y$5WPTZDC@BOS#_ &./VC/^"FO['6C:K^RS\*_V;O[<O=1UG4KJQC\3
M:-JH;2-9N#Y=W=6VL10C2Q!D+)$9)&#>Y I4J$:5-RA4IRJ6ORRLD_>]).UE
M=.SO9:]55:I4KU:2G3J0INCSS:W4K+IIH[M->>M[:_'-IX'^*OP]_P""D/PS
M\(_&WQ/9>-?BM:_%7PQ+XA\0:9<2W5M/<W<LLCVZRREG\VW.Y'1CMC/"X'3^
MC;_@O<TX_8E\(P[Y% ^(>F"0,QW*5TQ<@8)!R2QYXY]3BOP+\;_ /]KOX+?M
MJ^ ?B=\>/ WBWQ3XKO/&V@?$+Q3J_A_1K_6+'3TU"<W$NF)<V5M-%G3_ #O*
MV[P54'W(_J _X*>?L\>,/VKOV*[KP_\ #G3VOO&>EVFD^.M!T"8F.[U65]-M
MYI-,'F8$5RL3,623YE<%,;N*WQ,X2QV$GSV2BD[;;)7TT7K:]M3GPL)0P6+I
MN#<YM^RTO=.4=/DMEM??;3Y0_P"#=%S_ ,,C>.D3(0_''4S@9$9/V:/Y\#JS
MG&<@8.">E?A^<'_@LAJG+(6_:J</@\K(-7BPRKG&TG\,#\_K?_@DG\:?VS_V
M9?B!H/[+T'P"NH?A[XL^([:QX]U[7O#^L1:CH$T[PVMT-.U(P)IQMD"NY=G)
MVC*D9S7A<GPA^*T?_!7?4O$Z_#CQDWA?_AIM=3;Q(?#VJ'2)-,EU.*0W*7PM
M?LQMD!8^?YI7'._!IPE"GC,;.Z:G3M%R=W>T=7T6NWHEH$XU)X7!PL^:$VII
M*T;OEVW[=O,^J?\ @Y(NO$!^+7[.ME,;K_A&CX6\22QH2RV'VC^U46:20*?+
MDN0I8Q[QO ^[QQ7[P_\ !.6S\-V/[$/[.]KX1"MH8\(+-:-$54M=M.3<,WE<
M&43[Q\W.!BN#_P""G7[#EI^W)\&KGPWHMY9Z3\2O".H2ZIX(U>Z3=%,RY9M(
MED!W^1>.3D*=H)!;I7X$_"3]HW_@J9_P33\-O^SU/\ X_&>A6$[MX:?6-*U7
MQ'::9"[MM;3+K1X9HH[.:0BX$+R%EW?,...).+R^,>9*:J1:5^731;;]=7KH
M==-2HYBZK@Y1]G[RDN96MI:__ ?5G*?\' \6DV/[:'A2^\+O'#XR/PO\.W,Z
MZ<!]K_M)+EVL+AEB&?M@F5-C<S%@/Q]-_P""RUSKEY^RI_P3SN?$DDTFOW/P
MKM9-6EO-QN6U!]*LM[7(E_>"9V+;]WS;L[JZ?]F7_@GM^U?^VQ^T_I?[6_[9
MND?\(5X/75[3Q,FAW.3/KC6,Z76EZ3HMG,%EL=(MI8P9[>[0%HR5 SFO=O\
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M@N]*O+34;1) </']HM99H2PS@J')4YR!6B%9UGB9\"ZAEMF.!\OGQO#N)QT
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MJ:6XN()IE'FR-=2-.F)"5RU?5G_!'/P%J/BS3OVA/VV_$Z21ZE^U-\2=<O\
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MG;G'-9JJG64V^D8OS4>G3>^CWW\KZ/#R>'G3:3]Z36E]9<O7NK=/+R/Y]_\
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MGQ:T>V%RYL_!$NF::+VYF^RJ\L44\)GB\T)\I.6('-?2?PV_X)Q_\$ _BO\
M"&S^-GAKX>?"[_A WTH:GJ^HW'Q!OK670I;>!9=1M+^TGO$NQ<VC;A,D<)5G
MSL4 [1^Z5Y\-_!6L> %^%WB;0M/\3>"&T&#P_<:'K=O%>07&E6]JMF(KA9%:
M/S&@7[R ,K'*X.,?E'KG_!"#]@K6/$$^MZ?HOCKPGH]S=_:IO!/AWQ%>V7A*
M2-Y/,FADTM;Q(WCN,E908_F!QTK=UH3BE*4KK1<LFD[VMHGT?7RO:S:>3H5:
M=1UHJ+<E&#YH*5U=;7V>]VORM;A?^"4MK_P3,U;XN_&34?V OV?_ !EX+N/
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M@U:,KZR>[MJVUK9:ZZ]?S=T\/4Y_:-7DH0I_#;2*C=]?/KV]#\,O^"4A#?\
M!2C_ (*K1[O,(^)41/(#$"^AVB5%X&?7DD8SVKB/^"Y+"']L;_@E[(P6,O\
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MD6.AZ)H]AI&AZ=9KIMEHEI:6Z6$-B(Q$+?[+'&(7@V#&&5MP^]GFORR^+?\
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M%6J]+3XW:/+=2UB_=NU=/MUWTT(>&J*]K6O?WH_@]5YK?JS\"/\ @I[\!/\
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M(O OC#XV^.==^%:>-+B_G\12_#FXO=V@ZI?#4G>X@-R!-_H[;2BJ.!7ZS':
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M)NBP77P$T'66U;0[/P?<WUO'J.M75AI5U/8SA$DF@_TE>$&_ (R?Z0?VJ/\
M@F+^R1^V%XEM?''Q-\&3Z-X_LK<VLOCSP?,VB^(]0MQD+#<W5G);$^6#MW$[
MF/+,3S63^S+_ ,$KOV._V4_%:?$+P-X/O?%/Q LA]GT_QEX\NYO$&N:5$_S
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M&A0?\'$5B^X+_P 6PTTKAR5;;9$,)4)^7!.%P.:_3;_@L$NW_@FM^U^<!2/
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MY$^]U=^WZ@>1@\CCCZ=/RI" 3DC)(V_AZ4M%(84'D%3T.,CUQT_*BBFM?+U
M4$C)'&X;6]U]#ZTA^;@\CC].GY8HHH:MU3]-1)WZ->H@ !W #(XSB@@'&1G!
MR/PI:*0Q,#)..2<GZCO2^OOU]_KZT44VKRB[[=;ZW:7Y:_TF',_AL[?KH'48
M[=,4 8& , 4442UGS+:UOR"[VMI_6EOD%%%%( HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!R?>'X_R-6=,_X^K?\
MW_ZU63[P_'^1JSIG_'U;_P"__6A_#/\ PO\ -!'^)2_Q?Y'HM%%%>;'[7^)G
MLO:'^"/Y!1115""FO]T_A_,4ZD8X!X_/ZTGM\U^:+AO\OU1@^(?^/6/_ *Z_
MTKCJ['Q#_P >L?\ UU_I7'5VTO@7]=$>7B/C?J_T"BBBM# **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I%^^?JM+3U \P@@ AXBV/F(4GJ%&3@CKCK[]JC?=.S37KNBHM*23ZW
M2T/Y%_VOOV:K/]K'_@N79_";7KZ_L?!$^C:9JGCU--N9;2XU#PW;0J9; RQ/
M&YBGE18Y%!.59OE.<5^H/[:G_!'S]CSQ;^S/\0H/@]\+-"^$WQ+^'?A+4?%'
M@CQ_H#W%MJ^G7?A>RFU%W$Z%))Y;T6H$DD[,PD?<&!'/Y>_M>_M#S_LR?\%R
M)?BT=#OO$?AGP_X;TT_$6ST13=:E8>$7A6.XU"#3H0]Q-Y$C>;*%0856YK[M
M_:]_X+@_LIZK\!O'?@W]E3Q5=?&/X\_$?P]<^#_#?@6Q\/W[75H_BFWDTN^C
MODVOY,UK'=,@W)A)%SGBO0J\W^RVE]F%EKVCVVT=OP/)C:,J[M]KM\]+]+=M
M/NT^3_#O_!2/XW6/_!"O4_BQ_:+-\7M#\13? :Q\0S2R-?'0X;A]'_M5;C)D
M.IQ0*9$F9RV_!WYZ>?\ ['FO_P#!$7X8_!#PQ%\?O$6B_&'XY>)=-37OBAXZ
M\8:1KVIZE=:YJZ"YO-+:66UG4)ITDCVQ:'DL"X<@C'NEE_P2U^+$G_!$74_V
M>OWMM\9M1U=_CF=(?<US^\G?6#X66-1O&IR+F  +]X@$5@_L@?M\_P#!*NT^
M"O@[P9^V1\(_A]\#?COX TNW\(>+]$\2> ;@OJ4^@PI8KJHE,2&6XO?*\VZ?
M8WF3,6SR -+TES.TFU)J?(_)7>EG:]KV>[O:UV3S5?;-7IVY%NI/2T;;Z;=>
MGW(\7_98_:$^ ?[/O_!6#X=^"_V%/$^H^(OV6?VH+-M)\:^"(XM97PW\.=<0
MF4C1H;Y D,UP29!(XW*C!!(:]/UCP#)_P4]_X+%_$_X8_&V[O=5_9Y_92A^Q
M3_#=KNXATC6F_=KIMS/!$X6262X)^TNR,S)P&.*^G_V5/VF?@K^TO^VYH?@_
M]C/]D/P(OP$\ PG6/&'[0%_X5;29_,5BJ7GA.ZDC55F? C%JKF;:=^-HKYD^
M)7BGQ+_P2M_X*U>-_P!H?XEZ)JUY^R_^T_%=7&O>.=-L)[V+1)T5&@M+XQ(1
M$;)P99&=U#H-J\\UG'>3IJ\E#1.S=_*]]?G^ETE^[IN;BJ:K7GRJ5I74=&FD
MK;6[+I:Z/N3]MS_@BS\(?BGX*\*:U^Q?X?\ !_[-_P"T/X$\2:1JOA7QA#<7
M]CH[Z=:3K)=VFHMI^RYDDDC %OP2V3OS7PK^T?X)^)/[;G_!1_X&_L#?&[QS
M=3_#[X$_#7P]K_QCT?PQ=75MHWQ U2"R@>XN%+O'-<&X=&WBZ#_*WS#=7UU^
MU!_P74^!D?P[L](_8&UNU_:"_:+\2ZYI.E>&?"K^&]4NM)M8+R7RKFXU18U=
M@(%^88Z8^]BOC3]HC5/VBOV(?VV?@!_P4<^.'P]/B70OBUX%TGPY\>[SP!IU
MW_9?@NXN;:%EL4L&22XMGM(FS-<SE4S&P8Y/)359PYI13DK\J;O.]U;XKMJ*
MN]?U1I6]BZD'3<U23BYQ5N5JRW5EULOQTU/U=_:!_P""/G["/C+X#>-_!_A+
MX(Z+\.]<T#PIJFH^#O&_A]Y;?7]#UG1]/FN;.\AN49)9)KB6!4F\QSM+%XRI
M49_/+_@G'^T/XV^*?_!,+]L+X(?$S4;KQ%XN^ 7ASXB^&EUC4YI;J2;PNEI=
M6NE64]S.SS7$L$4?+2.Y.<'@ #ZQ^-G_  7;_8,A^#?C"Z^$/Q U#XI_$OQ#
MX7U32/#/PXT31;Y=:?5M:L9K.-)LJZ[K.:< @*?,:,JO+5\T?\$^?V:_'/P0
M_P""6O[67Q2^+.EW7A[XA?'7PQ\1?%]WI>I026MS:^&+JSNKO1I[JVE6.6VN
M"LA\V.50PVY[BE2UO[2_-S+XN9N_,D]]]/*U^^K;K\W_ "Y5E;W;6:Y6E;;^
MDOD>>?\ !##_ ()U? CXP?LGV/[0_P"T%X<A^+=[XP\0:WX=\%^&/$<DUQHW
M@/2]$N397D>D:>&:T@?56;SIW6)&+ 'J0U?,7A#]C7P!'_P6G^+/['WAEKOP
M_P#LNK+I/B[Q?\'M/U&\M-#\3:=-8^?+I5XMM+&6MS=E9 =I(5 @^4XK]HO^
M#?RYBE_X)>?!Z:"6*:+_ (3KQ\#)"0Z2XUA,J#SAFR.?X<?A7Q/\-[FV7_@X
MY^/EO]IA^TCP#HY\C>IF"FP!'RYR!D^G(Y'%%*<>>NF]%2FTM?LN-M]GK;1]
M>C)JT9J%"2CO6IJ7HXMN[LKJ_3RU[F'_ ,%K_P!A?]F']GOX&?"_XW? /X7Z
M/\)OB!X&^)?A^.'6_#4MQ9W=]I\5[:BWM9IHG#NJ/&&R6W/DJ^X?,>8_X+&?
MM1^(;CX2_L%_ +5O'&K^$/ GQITSPKK_ ,>?$FF7%W!J#>&5MXWFG:6S<74L
M?EB1KF %DF4X97K[C_X.#IH+7]BC2&N9H(DD^)6@YD+JL88ZE#^[RW0D<X]:
M^)?^"IW[/WBF]^!/_!//]L?PKX,U#XBZ+\"M(\$W?Q0\%Z=:/JCZ[X2$$;1P
M&TACE+6+JLJWSLI018+$"JPSIRP^'=2ZES34;OM%O7JEON^V^EIKPK1Q%=07
M[MT:3DK6VJ06FFK;[=+G30^+/^#=^V^'8^'']C^#YXH]$&E2^)#HGB%M9GU+
M[+Y;:\UXUJ9EO)[D"Z.U]JL<!5QSVW_!!OXWW4GCO]I;]E?PY\0-:^*7P3^'
M=]/XM^#?B[68;Y'MO#5S<R10Z/8R7J+(UI:;TB5'._*#C !KK='_ ."A_P#P
M0IU'P=9>(]>\,?#+0?%=SI*WU]X!E\ S)K%GKK6_F2Z&J[ 'F6YS;HRJ%)^;
M&.#]-_\ !*WXOR_M!R_%3XK>%_V4_#/[.7PF%]/X?^'VJVNAG2/$GC/3HY&>
M&^O\QQ&:TGC1)XRHV@R*I.>L2:=.>DM7O)WM)]KN[L^W3R-H*2G'9VM;E26B
M:M>RT^>Q^P0C$DEM$"Q+F/9Q_JV+<[NO+8_+&:_EP^,GAS3/^"E7_!:.']GS
MXGOJ.H?LY? /P?+K-QX&BOKFVTS5_$=C"9+J'5;6.1(;B*^F^Y(4D>,="M?U
M(*[12QR1[G?B1#P S)@LLOL,<=/QK^7S]IRXU3_@F9_P5GTG]LWQ#X:\1ZY^
MS1\;O"=SX=\3>(-*L9[V/PGK5U#Y6JZGJCP1LL45I+B2UC=D>9<[,UGA.7]Z
MKI+V<[=-;QM>VW7YW-\5=N@M6O:0;7_@/;UM\[GT+_P5"_X):_LT:7^Q_P#%
MGXI_L]?#C3?@U\3/A9X7O/$-CJ?A.XN;1O$NAVB>7=^%=5MXW2&\L9P^YUN%
MD)*$DODUXA\)4\W_ (-QO$4<Z0QNWPNO&FCBB01B7^UIS,HC(V!-X<  9W9]
M175?\%&?^"R?[+/Q$_8^^,7PY_98\3:C\9?&?CGP;?:/JL^C:%?Q:?X'T.YV
M"Y\1ZW<R(T44=L?W<@)0AFP2*V/V5OASX@^+?_!O]+X \-6[:EXBUWX4ZO-9
M06P\R>^GM;FZOIQ"BY:9BL;>7&@)9BJCDUK",O80NVX^T@U=N]E*%]]5UM?K
MJM-^:<XQJR<8KF>'G=I7ZZ?"[+HNU_,^X?\ @C!&D7_!.WX(+"BVR&Q?!"J(
ME!>7.5 ^7/\ %M'>OS&\4PVQ_P"#F/5IVCC\T?!#PD SQ+YI']B2;BD@&XJ<
M?*,]#5__ ();?\%9?V-/V?/V1_"?P4_:&\>:A\*?B9\.;V^TN^\+:SH6HR:E
M?P07$L4<L-HB+*'N2#M1D4C*]0:^;/V>OC=+^TC_ ,%YK/X])H.I^%_#GCSP
M%<:9X'MM>@DLM3U;PWX<MI+:SUO[!.([B"UU" K-;>8GSIR&8"G2HKZQ5<G[
MMI6?2S2M9ZJRUVZ[$UJLEAJ*47SMPO;>]];ZW3?9VTMJ?4__  3YL[>;_@N;
M_P %"5FMD,-Q\.'@O3Y<8:6"6^VNI=1N(=&*G&<YKSKXH?LH_LWS_P#!='X0
M_"5_A/X9;X:>*_A9J7B37?!K6P;3-1U^5)I7U6\CV 23-*3(<]6) 8'IZ3_P
M3QN+:7_@NG_P4#BBFCFFC\ <PI*@8_Z>,YC+%H\GCYP!WS7/?MG_ !X^&?[+
M/_!<?X)_&KX[ZZ? WPQTWX*W=MJ7BRYM)Y=,@GEBD2",R1C]_N?"E8=S)]_:
M1D4-<M>:B[Q6%A:SUTB[6\[W?KMJ*-_J]*Z2E]<EI).UN:%]5?R\NYYE_P %
M6/BE\.M>_;G^!/[$GQ:^(%S\&OV+OA/X6TKQ5XFTK0UO/[.U]+>)7M?"EW#8
MJ9Y+6Z5/LT7[MD0#/R]^O^)_BG_@WR\;_"GQ'\/_  S;^%O!6K2Z'>0>$?%^
MD:)XBM==\-Z]' [Z9K%K=QVJR/<174<?^ND=&W$8!.X4?^"C=GI7PU_;)_9U
M_P""HFD_#NP_:+_90^)W@C2O#?B2QDT6;6=/TWPSJENJ?\)7<6(CE*LL#&>P
M>0*8W!W'/ ^@O$__  41_P""&>G>!]0\1>$_!/P\\9>,(M*N+C1_AQIW@21-
M?O=3*9BTN0,K!7:=@A<J0 ",9Z+FA[.EHWJ_A_FYD_>2:U]=-T]=ZDI>W?\
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MTO\ LJ1^)=6\?_"_X(>)5O\ X,>/M86_.HZUX4UFZ(AC9[]039P6V$MHE;*
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MPOS^\K::^Y>_GWO\EQ/_  4+^)?_  2?O?@W%\4OV&]6L/AU^T_\,]6TC7_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2PXQL&.E7:*.9^[_ '=M7V2UU\OZTLXJ,>9N$).2:;FN;1_Y=/,^:KW]C/\
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MI:*R_(0#  YX]>2?4_B>?;I2T44@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!R?>'X_R-6=,_X^K?\ W_ZU63[P_'^1JSIG_'U;_P"__6A_#/\ PO\
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MKLA<[_EI?^!OO'[NO>W7J245']HL_P#H(:;_ .#&R[]/^6]'VBS_ .@AIO\
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M9_P^7]?)7.=Z>[2Z7]YK^7S]>WYDM%1_:+/_ *"&F_\ @QLNW7_EO1]HL_\
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M^@CIG_@QLO\ X_1]HL_^@CIG_@QLNW7_ );T<OG/IT_P^7E_5D'.[WY:-O\
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M;+MU_P"6]'+YSZ=/\/EY?U9!SN]^6C;_ !/^[Y_\-?U):*C^T6?_ $$--_\
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M;+OT_P"6_>A1\Y]/L_X?+^ODKG.]/=I=$_>:ZQ\_7^KDE%1_:+/_ *"&F_\
M@QLNW7_EO1]HL_\ H(:;_P"#&R_^/T^5=ZO_ ( NG+Y^7XKLA<\OY:7_ (&_
M[O\ P>G>_4DHJ/[19_\ 00TW_P &-EWZ?\MZ/M%G_P!!#3?_  8V7;K_ ,MZ
M.7;6KT^PO[OGY?BNR#G>GNTNGVWK\/\ P>W7S)**C^T6?_00TWT_Y"-E_P#'
MZ3[19?\ 01TS_P &-E_\?I<OG4Z?9_P_TO\ @(:F]/=I7NOM/^[IOZZ?Y,EH
MJ+[19_\ 01TS_P &-EVZ_P#+>C[19_\ 01TS_P &-EWZ?\MZ.7SGTZ?X?+R_
MJR#G>GNTM+7]Y]X^?K]]NY+147VBR_Z".F?^#&R_^/T?:+/_ *".F?\ @QLN
MW7_EO1R^<^G3_#Y>7]60<[O?EHV_Q/\ N^?_  U_4EHJ/[19_P#00TW_ ,&-
MEWZ?\MZ/M%G_ -!#3?\ P8V7;K_RWIJ.VM3I]E?W?/[O5=D+G>GNTNGVW_=\
M_7MY]22BH_M%G_T$--_\&-E_\?H^T6?_ $$--_\ !C9=^G_+>CE\ZO3["_N^
M?6WXKL@4Y:>[2Z?;?]V_7UZ]_,DHJ/[19_\ 00TW_P &-EVZ_P#+>C[19_\
M00TWT_Y"-E_\?HY?.I_X"E_+V;[?*Z\@4WI[M+_P-_W?3S_&_4DHJ+[19?\
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M<NVM7I]A?W?/R_%=D'.]/=I=/MO7X?\ @]NOF245']HL_P#H(:;Z?\A&R_\
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MV7_Q^C[19_\ 01TS_P &-EVZ_P#+>ER^<^G3_#Y>7]60^=WORT;?XG_=\_\
MAK^I+147VBS_ .@CIG_@QLN_3_EO1]HLO^@CIG_@QLO_ (_1R^<^G3_#Y>7]
M60*;VY:5_=^T_P"[Y]?QOZDM%1?:+/\ Z".F?^#&R[=?^6]+]HL_^@AIO_@Q
MLN_3_EO1R^=3IM'_  ^GR\[>3#G>GNTNGVGWCW?K^71DE%1_:+/_ *"&F_\
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M.F?^#&R[=?\ EO2Y?.?3I_A\O+^K(?.[WY:-O\3_ +OG_P -?U):*B^T6?\
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M%1_:+/\ Z"&F_P#@QLNW7_EO1]HL_P#H(:;_ .#&R_\ C]'+YU/G&VW+VO\
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MIO\ X,;+MU_Y;TGVBS_Z".F?^#&R[]/^6]'+YU/G&VW+VO\ UZ*XI/M2_P#
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M=ZO_ ( NG+Y^7XKL@YY?RTO_  -_W?\ @].]^I)14?VBS_Z"&F_^#&R[]/\
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MO_/R7W0_^1#V=/\ Y]Q_'_/R7W'Y8?\ #JO0/^CR/VL__"IL?\:/^'5>@?\
M1Y'[6?\ X5-C_C7ZGT4>UJ_\_)?=#_Y$/9T_^?<?Q_S\E]Q^6'_#JO0/^CR/
MVL__  J;'_&C_AU7H'_1Y'[6?_A4V/\ C7ZGT4>UJ_\ /R7W0_\ D?)?<'LZ
M?_/N/X_Y^2^X_+#_ (=5Z!_T>1^UG_X5-C_C1_PZKT#_ */(_:S_ /"IL?\
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M5>@?]'D?M9_^%38_XT?\.J] _P"CR/VL_P#PJ;'_ !K]3Z*/;5?^?DONC_\
M(A[.G_S[C^/^?DON/RP_X=5Z!_T>1^UG_P"%38_XT?\ #JO0/^CR/VL__"IL
M?\:_4^BCVM7_ )^2^Z'_ ,B'LZ?_ #[C^/\ GY+[C\L/^'5>@?\ 1Y'[6?\
MX5-C_C1_PZKT#_H\C]K/_P *FQ_QK]3Z*/:U?^?DONA_\CY(/9T_^?<?Q_S\
ME]Q^6'_#JO0/^CR/VL__  J;'_&C_AU7H'_1Y'[6?_A4V/\ C7ZGT4>UJ_\
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M3Z*/;5?^?DONC_\ (A[.G_S[C^/^?DON/RP_X=5Z!_T>1^UG_P"%38_XT?\
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M/^-?J?11[6K_ ,_)?=#_ .1\E]P>SI_\^X_C_GY+[C\L/^'5>@?]'D?M9_\
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MON#V=/\ Y]Q_'_/R7W'Y8?\ #JO0/^CR/VL__"IL?\:/^'5>@?\ 1Y'[6?\
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MJO0/^CR/VL__  J;'_&C_AU7H'_1Y'[6?_A4V/\ C7ZGT4>VJ_\ /R7W1_\
MD0]G3_Y]Q_'_ #\E]Q^6'_#JO0/^CR/VL_\ PJ;'_&C_ (=5Z!_T>1^UG_X5
M-C_C7ZGT4>VJ_P#/R7W1_P#D0]G3_P"?<?Q_S\E]Q^6'_#JO0/\ H\C]K/\
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M)?<?EA_PZKT#_H\C]K/_ ,*FQ_QH_P"'5>@?]'D?M9_^%38_XU^I]%'MJO\
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M_P#A4V/^-?J?11[:K_S\E]T?_D0]G3_Y]Q_'_/R7W'Y8?\.J] _Z/(_:S_\
M"IL?\:/^'5>@?]'D?M9_^%38_P"-?J?11[:K_P _)?='_P"1#V=/_GW'\?\
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M1[:K_P _)?='_P"1#V=/_GW'\?\ /R7W'Y8?\.J] _Z/(_:S_P#"IL?\:/\
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M/^-?J?11[6K_ ,_)?=#_ .1\E]P>SI_\^X_C_GY+[C\L/^'5>@?]'D?M9_\
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M110 4444 %%%% !1110 4444 %%%% >74****!72T;284444#"BBB@ HHHH
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M4 %%%% #D^\/Q_D:T?#_ /R&+#_KJO\ Z$:SD^\/Q_D:T?#_ /R&+#_KJO\
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MR"BC!( 3YR>0X_JG4 =SZ4G5<EE5E.UD!W'/'('J,YQW_$"LW[VBC)7MNO\
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MI+7^O/I87*UKS*5OLJUWMTM?Y?TRBE8JG7)"K\Q_A=BQ"X/8<C'KS3"3'G>
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MU#Q%_P %$/$FG_&Z]UF+P+HWBS3M)MRWFD6W@8W%L)GTR*4^6L C>4M<0#.
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MY/A!!XEN+'7[;3]=EGU'4_ D\TQBB,-N[VLM\L1BYW-@AL=./NK]IG_@JO\
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MXA:A\'/A=X(E^,/Q3TNXCM+W3XVG31+:]GSLLVN;%6N&G;##"J0,=J^4K/\
MX+F_%OP5KFFI^T1^R.OPU\*:BD;+J6E7.JW&I3[BI9K6.\A6W8+$0X#,).QX
M%?"7[5?PU_:'_8E_;QUW]HVQ^&#^-_#L?BK_ (2;PWK-_I5UKWAW6K>X:62>
MWU"&"WNC"EL)FCW7  #@,I"BOK'6/^"M7[''[5>G:!\-OVMOV=YM/TXW\=W-
MJ]A;6%OI>AWVU8[FZ1(HH]2-J &!@))"#INK3DCR4W&"?,[3?6.B[73;MWZ:
MZ,P]K6E[3VDG'D;4;;2VW?JMK6\^A^L_QP_;R^%?A#]CY?VHO"T6K>-O!OBJ
MRCT>SMO#<4U]JVD:IK2/ MIJ,-JDDMK>Z?)_Q]$*%C&TEABOY6/V//VO=)_9
MY_:ZUW]HWQMI'B[QO;:A:^)+6#3K>*]U?Q!;+K=R9;9)8@D]RD%LIVD;<)T.
M*_KI^!>@_LNI^S7XB'[+UAX2O_A%?:)KM[:VMG;KJ>E_VD]DQN;B6RU3[2;:
M_!Z_(KHXRFTG-?S9?\$G+&QO/^"E/BRUO].TR_T\V/Q#2.QU/3[+4+4LM^?+
M+6MS%+:HJ 8B_=@QJ.-O2JH*G!36K;N]5K=V]>J^3W08B52I]6E?XG;3;1QU
ML^_Z:]S^E*U_;2^%-K^RMHG[6OC=[_P9X)UW3;K4++0=31K3Q#>W$,A1--M+
M*Y5)I+Z9\%8F0$QDG( S7Y&:G_P7/^+/B"\U;6?@Y^R0_C'X8:3.%U'Q/J,^
MLP:C90Q2?OGE@M(6@8B!3(HC+#=P:YK_ (.!_%-S9P?!#X7Z?%#IOAZYAN?%
M+V.GPK8Z:E[#/]D1(;.U6*W4E"?DV;<Y)'<>9_LJ_P#!4O1?V?/@+X-^$FF?
ML;>-_$]II.EFWUSQ#I_@:?4;/Q5<S!DNKM[S^RIUNQ+&Y4/YCH!P#4TZ%.-)
MS4)2;JM:6LKO7?79-&\J\_;^SYU!1C'35MM)._S>OHC]G/V)?^"B_P 'OVU8
MM2T?0(+GP9\0M$A274/!NLYCNYXV'^DW.BQS;9+A+?[TI<!U';BN _:>_P""
MIWPK_99^.D7P*\8>$M>O;Z-+*6Y\0V\7_$N@M[Z,S>=.V?O1J#D<C) YQ7\[
M/[(WC;QM8_\ !13PM\6O"7PE\?\ @CPYX^^(DUJ=.F\)Z[8V6D:/XFNECN+:
M[<V,5K#!;H#\[;8D'((!./6?^"TMC#>_\%!;S3W>1K2;_A$[1B-O,4TT".C_
M -Z-D+*,$DJ<$FK5*FZSI^S:M3]I?W>G+?FO^'IMH8U:]:-&-55(M.:@TKZ*
MZU6BUT7X*^Q^B'QJ_P""WWB+PO+)KOP1_9MU+QS\,;:>*&Y\?^,EU/2=(E.0
M)_L<MO$89$4[Q$[85F"C=7=Z9_P7%^#NO?"O3M=T7X=^)-8^,VIWTNF6'PKT
M^UFO#+?QQADN9)8T>X729I2%AF S@Y.*^Q_VD?AUX'\/_P#!.CQKX0TCPGH-
MIH6G?!W1'M[*'3+)=L\FG6UW)+%*(1/YS3L9WEW>822"Q'%?A?\ \$$_ 'AC
MQ)\?_B?XMUC2;#5M9\#^&[670)M1M(+H6+7]Y);7#0I.CQ;C&@4%EWJ!E2#2
MM1Y'-6Y8NS>GE?O_ %O?4JH\1"K2I*K.]2*?2_35+Y+<^MOAK_P76U@?%.Q\
M ?M)? "U^#NEWVHVMA<ZSIU[J%SJ.E+>R!+>]U6TOD5(;)<@R2H&*C[M?K[^
MT[\=OAQ\&_V?-4^,GC'PQ8_$OX>I8VNJ1Z0]E!JUKK6GWT4<]K<?9;I)(9/,
MBEC=<J>" <=OYQ_^"^GA_0M-_:#^'^L6>E6>GZCKWAV-=6ELK6&W%VEDT8MR
MR0(L9,(Z$C)[DU^F'[9$L\__  2,T=I)6D+> ?#L9F<DD;-.L1&"?9   .PX
MXJ*E*'+3G%Z3:6FWV=5:W?\ X)5*O->VA-\SHKXO/;7R5MMO/<^N/V!OVI_A
M+^UE\//$?B_X-_#"S^&FBZ+XA?1KK2;30K#P^;N_^S^:;O[)I\444XV$1B:0
M;CC'T\6_;;_X*J?"W]D7Q!'\-M T"?XG?%DQ1RR:!9RNVCVDUQD16VHW5KON
M(KS=PT"@MD@8Z5\M?\$';U]*_92^.&JQX6YTGQ'K6JVMPO.)+'0I;B&-E]%D
MC5A@<GJ#BOS:_P""??AK1_VD/^"I&HZU\4[0>)(;O7_&_BYK#5#]I275].Q+
MIMP(Y2RB.SFC$B0LOE#ILQU(T87FY-\L(<UMMDGK?OK^HIUYR5.$+7JJUW=.
M[MMZ?>[O70^Z+;_@NC\7/!VJ:5<?';]DA? 'A+6#"]KK%A=ZO+?W-M*1_I%G
M%>1)"2%.XH[*W'"U^['P&^.'@#]HWX9^'OBI\--374O#GB&V\Y8G=#>Z=<+@
M36=_&I_<SH^["-@D#C(YK.^.7[-_P:_:/\,:?X/^+7@31O$.@:;J5KJ=I!;V
M%O;S&[L\B%$DM(XY4@.3YD:D1G^Z16K\&_@+\)_V>?#%SX+^$?@^'P3X=O[M
M;^]L+26=X);Q1L68I.[&*0*=I2(+&3RP)%85*E&I\"OUVTZ??KY:/YLZZ5&O
M3:YI77JO*^B\U_\ :]#UL\8]QFBC#+P2 3U3.2PX(E.. 3@#' HKCM:ZM;7I
M]QVRTMK?W5_6R"BBB@D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "D;<1A7*X=>5C +C'S*W."I'RGC!&?6E
MHH&M[6WT_%' R?!?X):QJXU+5_@G\*-8U&ZNX)+O4M3\">'[N_NI&D7S'N+B
M>R>28L268R,V23GOG^;;]BCX=_#K4_\ @MA^WQX7U7X=^!M4\*Z/JJ_V-X7U
M'PSI5WX?T@;+8E-+TB:W>RM%&6.R")!D].:_J0LFQ=VI_P"GB ?G*E?S/_L-
M<_\ !<W_ (*"#UU<?^B;:NNEMYV7I9?\.<=>*Y^6VCDEY[J^WW_\ _H!U7X7
M_"OPEX;\5ZKX0^%OP\\)ZHGAK6HQJ_AGPAHNB:I'%-:.)(X[RPM89_+< "1-
M^", ],5_+-_P2_\ VYOAA^QQH?[9MKXGT;Q/XV\>>.?VA)!X4^'O@C3'U?Q%
MJEM;W%Q%/JPMXXW*6%M)^[N9F*A2?2OZS?&94>#_ !>.3L\-ZL7/\1#6S81!
MW;/4X/H:_F]_X(#_  F\#ZQ\0?VX/B[K&AV&J^,="^,%_P"%_#FI:A9VM[_9
MFCZG<7$NHPI'=QRK#+)(,B1%5AU#4XM<ETKN[O\ )_/U)J)\U&-VE-VTMMLO
M)VM^?4^Y/V??^"QOP2^,?QDT[X#^.?A_X_\ @=X_U]A'X;MO'FE/I6E7\YY6
M(7$R)NN)1C:(V*[F SFOT3_:"_:(^$O[+_PXU;XJ?&#Q+!X>\.:1$6M(!)&^
MHZU=A"\5AHUNVZ6ZO;H@+$D:MDN,]<G\/_\ @N%H.@Z-\5/V'_B#I>BZ?IOB
MZV^+&@Z$=7TZRMK"6339=0LV>WG>UCB>?<7+;F+M@D XX'E7_!:WQKJ%U^V%
M^QYX O?!FK_$_P *^&=$T3QXOPVTZ1\>*-7?3K&1K?[,3Y-Q@H"RW$<B_.<#
M)S2]G"7*W>[3=EMIRWU[W:7Y]!^TE3BU>W++EU6KT5GZZV/JB+_@NO\ #?[%
M%XQG_9E_: M?A9)<.6\93>$[D>7:^84-S/$8?EB"GS!)MVA,G-?KY\(?CG\*
M_CI\,M+^,'PV\7Z9XA\!ZOI9U:;5;>Y7;ID<4)N;FUU($*;*\L%#1W,+*OSH
MP -?C-??\%*?C+?>'KGP;=?\$QO&)\*76D-H;Z$WA[1A;+IK6Y@$ 0:?L!9=
MI\S&\$9W;JX#_@D;\)OCPO@K]LOX)^-_AKXK^#7@#XMZAK&N?#NWU^&>%_#,
MFJVUUY>EZ9M2.)( \R(T=OMW*"<4>QAY_>+ZP^Z_\!/HOQI_P6U^$L7C/Q7X
M4^#7P4^+WQKM/!FHSZ5J_B[PAH$M]X>N;RT=H[A].NDCV3P0M&\;$-N+HW!S
MS]2?L9_\%(/@=^VIK'B3P9X0TWQ3X)^)OA*.*76_ WC>R;1]7D5SB273+1UC
MDN(HL[I&P5"U^'OP#^*/[=O_  217QI\%O&G['-C\5?@X?&VK>([#XBZ'H)U
M;Q1JD-[<RS>=8HEG<RFR,3@^5=[I1-OVX5VS^@7[&G[<O["7[3'QB\9_$KPW
M\#Y?@E^V'H/A/7+B"U\4V']A^)/$=CI]F9;N"#3X8;.U"A5'RW-N9B..I%-4
MUYZ:+7I]VGWLAUV^LON6GIJ_)^OH?4'[6O\ P5!^ O[*WC/3_A7_ &?XF^,'
MQ;U2,W$O@3X;6#ZYJFA(O^J77Q#'(+![A5+6X##@?-M/%>8_ O\ X+#_  0^
M*7Q3TGX/_$[P!\0/@!XO\1[%\,2_$G2Y-'T/4[MR(XK*._F01-=RMM\M-_)(
M'>OP[_8+_:F^('PU^/O[6OQIL?V6/$W[2OC7Q5\2=5M(_$EG:V.K-X+T[[9(
MHT+%];W4ELLR8$> A0 [,"O=_P!O;XZ_&[]M[X5:?X)3_@GK\0/"'CKPYXAT
MOQ#X/\?6FF6EK?Z-J%C=VTZ1F?3K.&\: >5R%<@Y((H=)235VK*^ZWV[>?\
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MC..M'*NW]?U_6HW5JOW;0M;?7R^[^M]S\-_@[\=/ '[2/_!>M/C!\-+J:_\
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MPLU.[LO$'AV]^R^*_ /B&$Z;XNT&4G8);W3G6.2.TD<;(V*YR.0!S7Y!?L<
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M3WU/4;3&^VL')-UOX4Q MUK^P"+]X?+D"-'Q$25#;DSP"L@V,#[@CVQ7X$?
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M?AF\NG::2[L+B^A8E)F+;DA*A$4,0J_* !Q7]6O[!^/^&4?V<24*2+X-T)6
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M6\DVE">WBA:>*20[V65G((P!BOGC_@IR#<?\$;_V;8"Y3[9IVAP;@0&02V\
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M^-/$^KW>GV-W=:IKNK>;->2W%U<PRS21A_F2,R% <\#I7YQ?M)?"#P+\,O\
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M?LU_\*O\9VL%C'>ZO-\3I;!O^$4N!OFDEA34"-F]1NDE8MG +$]37V1\=/\
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M!0BI7O<VA5E*33BDKI76N]M?S];>6OBW[77QD\$?L^_L]?$;XQ?$GPA;>//
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M=%=ZG:1)(UK9SL5CB9MK;SR .:^=?A;_ ,%GO@SXH^).@?##XO\ PM^)_P
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M=_.Z12YSS3@E%QA;1P;\U;E>GWZ^G7K$N:7-/F=XS44EUNXZ_=IIKYH]TO\
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M",2881DY7!'>OZ+?$OA;PQXST>3P_P"+?#VC>)M&GE,LVEZ[80ZA8/(PQO\
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MX*KK$EKJL>HZ)%<7OB3PG+(Z)>Z1J\T1B8BWV/,L1W;LIG=7Q_\ M_?M._\
M!,?XM_">;3?V8?AU:?\ "W]>N()4U?1_#-QH4GAV61EDGAE,K,-1:1RUN%A4
M;G^<#!%?U4?$'X3_  R^*MM;VOQ(\!^%_&8ME,=A-X@TBUU.ZLX6(+PPW,ZL
M\,9;+;1P<9Z8KR[1_P!CK]EC0KY=0TKX%?#^WNXG1X7?P_93(KHP82;6BPKJ
MPW*1SG!'I40KJFY*2]VUTUMM%)>;MMY>1=;!3FN:+U<;N*UUTZ6_K>VI^;__
M  1E^"WQ+\#_ +(/CQO&NGZEHZ?$2;6'\+>']4CFAGCCN8?W6HK#* 85U#(P
M,8 YQ7XA_LA_'?P5^Q?_ ,%!O''C;XXQZEX;\-V>K^-_#FI$64TUY:&\U"3R
M]0%@N)KB!\*5,?$@;(X!K^VN"..UMK:"UCALK:SC2UT^UM8E2*U@4;518TX5
M O"#&%["O"?&O[+W[//Q#UN3Q+XS^$'@?7=?F&V?4[O0;.6[NY <B2YF:,O(
M2<DLQR/RJ(8J$I/W7;NT]=K._P ]%;7;J:3P,U1PNM^62;2WU23NK:;7UW^9
M^+__  5.\!7G[=7[*7PL_:J_9[T34O%6GZ%-J,MQ8);R+J@\%V\[K)JL=GAI
MI9O.42?9%'F+'D]!7&_L0?\ !8WX _![]FRP^%/QSTRX\.>/?A5HDNF>%K:'
MP];W_P#PFC0"7[/:7<OV<MILS3D1O+=$E<G.<5_15X:\*>&O!^@6_A;PKH.G
M:'X:L(6M;?0K"WCMM,1)4VRQQVBKY1@D4G>H #$MQS7B&M?L@?LO^(]0EU?5
MO@=\/IK^>5Y)V3PY8QB>9SO::0B/'+DM@]6)/4\5*O"-+E492:G%MJ26OH[]
M'VVO?=A+"5'7E/GBM.L6^BM_2]=C\Q?^"?G_  4<_:E_;'^,FHZ%J'P>\*Z=
M\'[2XU>[E\7Z;X=LK&31].R&T?2WU(6P6]U%%R)Y(6#,QXK\N/\ @L==6T/_
M  41MUDG3>9/!1$3<L,2V^,_[3]1GD#K7]<O@SP'X*^'.C#P_P##[PMH7@_1
MPX=M/T+38-.@DE.,SRF%5\YS@'+ 8/2O/?&W[-WP+^)/B0>,_'/PP\+>)/%"
M^03K.JZ?;W>H%[3;]F99Y4+@Q;<ISP>!VJ88FE'$RDJ;2]CH[VC>ROTUOK?K
M?:_3.IAZD\&J?.K^V5_=:;C?5^271[6O\_)/VK61?V#_ (A2?+$T7P?T.0R&
M0 1HVC6H 4]&)SR!TSS7X6?\&^5S!+\5OCXD$B7##P]ICMM.20=2E)#*.2!U
M)]/09K^G_5_#.@>(/#UUX2US3+34O#-[:1Z=<:/=0))9SV$,:Q1VLT3901(B
MJJ@C;@ 5Y[\-?@+\&_@[>:AJ'PP^'?A[P7?:M&(K^YT+3X;*2\B5BZ)<20H"
MZACN*-QDGUJ%6I0HU*+5O:2YMMMM.GEI9W^\Z*V'J3Q6%K+EY:5-1?W)[7:^
M_P S^9[_ (.!;F"#XW?"19[A(DDT.?9DY 4.FY0>V<#()]?0U^C/[8L\2_\
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MVN-)ZWU=]+=O0[6K:>2OY/\ JWWA1113$%%%% !1110 4444 %%%% !1110
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M=UK55O3[F81H72WMLGIKM^/_  Q_-O\ M"^&?C;_ ,%0/VZO#/P/N/A_X[\
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M\$^*_%VG^&_C3J-YXEOO#>BWFKVOAVT>YB*76M36J.FG6K@<33E4P.M?O?\
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M_"MEK<^BG3_"<6JV%E#IEOJ:#[ JI;B:);A@7R%R23@UXS_P29\%_M1^"_\
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M7$,R/M?:NWDBN3^ GQ3_ &S/^"0%U\0?@#XL_9=\;_M(_ N7Q?JWB3X=Z_\
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M-%9K62OU?]?>;-MRCV2?]?D%%%%)[OU904444@"BBB@ HHHH **** "BBB@
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M;RZ#"TLK%4C$^HR11NS-\H /TZUI&FWK9V\C*56,5K*VU_O7Y[>OR9]L-G@
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MQB4EA(A"DNC]BPQ@ GM7A'[0W[1?PI_9A^$FM_&KXK^(HM%\$Z-!#-;W$?\
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M\-K3QW9'4M/\)>)9H;O6=.L&VM;W%W-; 1.MU&ZRQ%1@KWKT7X@>/O!WPO\
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M[/?Q_P# 7[3/PRTCXM?"^>[D\(:T98-/?4$5;IGA=UD$@&!U1@/PKYJ_:_\
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M$?@'X<7S>&OAMX/MM3GMK"W.IJ;N^U":)B4E=;C*JK[BIQ7S-_P46_9ULO\
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M3?'4>)B'63<QZ=:(4_<E4[2Y4GZKRWWV]1SY).-/DM[M[W=UI&WY:7^>M[?
MW[)OB'PY\-_^"CW@)/@#XFUVY^&E[\1GTW0KBXFGM6U[P]*)2;'5+5VP;>,L
MNU7&),!@>:_0O_@X.V?\)M\&KDB0A-%>]=$EDA16%MY@B5(W7.6R,GH/:OSU
M^$UQ\-]4_P""FO@6;X301:;\-%^*D=IX6B@D\RWCLK))+;SXIB%WQ3NBM&Y
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M%9\?NXCP@&  *^'_ (8?\IE_#P]/C5*?4\+>]C_6E3HN$L3I=.DGJN][Z/\
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M9)O[KQGX8\"WJ6_Q&^ \"EY?&EJS;OMEM(KK+&(XB8V,8R7 [U\:?'+]N_\
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M_P"W]_P21\<_$?X6^#?@AXD_:A_9I\6^);SQ/X'N/"AF-QX12^GDE%G'%;R
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M?]JGXI>!?VG_ (;? S0/V<_%OC7P)X]E:37OC+IT4Q\/>#&.YB][*K",8.
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M^<8_GGWQ7R9^V3^R1X0_;,^%D'PI\9ZWJWA_3(-;L==6]TJ4)="ZL7+1 ..
M')Y'3&,\BM:.)J\]*^Z;UV>_R[G/6PM-TJBHJU2ROH^MO\UTO=]S\ OV ?\
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M@!R%#=,YW +]=I'Z4@+!3R,8W9QWSC?CKQTQZ=A4O$593CJUR:7W[.R_R?\
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MZ^?H9.B:#I7A?1=&\.^'K*WL-#T'3+'2-'L;-?+@MK>PMHH-L<8"J(B8V<8
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MXX^G/&.<\4U<INVD@-T4\A/IGU]_PQ2T5+;>[&%%%%( HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** ')]X?C_(UH^'_^0Q8?]=5_]"-9R?>'
MX_R-:/A__D,6'_75?_0C4S^%_+\T73_B4_\ ''_TI'TK1117A/?Y+\D?1P^"
M/^&/Y(****104444 >?_ !%_Y!=I_P!?#?\ H+5XO7M'Q%_Y!=I_U\-_Z"U>
M+UZV$_A_<>)F/\9>D?S04445U'&]_DOR04444""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!R?>'
MX_R-:/A__D,6'_75?_0C6<GWA^/\C6CX?_Y#%A_UU7_T(U,_A?R_-%T_XE/_
M !Q_]*1]*T445X3W^2_)'T</@C_AC^2"BBBD4%%%%&G73Y!KT5V>?_$7_D%V
MG_7PW_H+5XO7M?Q%'_$JM./^6Y_] '^)KQ2O7P=G36ME=KSLG:_]?B>)F/\
M%3\H_@X_YA11177:/=_=Z?\ !_K?C?Z+\D%%%%%H]W]WI_P?ZW044446CW?W
M>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!
M1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[
MT_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HH
MHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>
MG_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@4444
M6CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_
M (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBB
MT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\
M'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446
MCW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_
M %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT
M>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?Z
MW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446C
MW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@
M44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O
M[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"
MBBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_
M=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@4
M4446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]
M/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"B
MBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_
M  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44
M446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X
M/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****
M+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!
M_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111
M:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/
M];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'
MN_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_
MK<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?
MW>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP****+1[O[O3_ (/]
M;@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_!_K<"BBBBT>[^
M[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!1111:/=_=Z?\'^MP
M****+1[O[O3_ (/];@44446CW?W>G_!_K<"BBBBT>[^[T_X/];@44446CW?W
M>G_!_K<"BBBBT>[^[T_X/];@44446CW?W>G_  ?ZW HHHHM'N_N]/^#_ %N!
M1111:/=_=Z?\'^MP****+1[O[O3_ (/];@44446CW?W>G_!_K<')]X?C_(UH
M^'_^0O8?]=5_]"-9R?>'X_RK2\/\:QIX/_/4?^A5G/FY96BVEU^Y]K?B:TTO
M:0][7F3V[-/?^O.Q]*44?_6HKPGO\E^2/H8_#'_"OR"BBBD4%&<=2 /KSGZ>
MGO11P.<9<_*/3\?UHTTOM=7^\'?IH^Y\U?M0_&[X;? OP3IWBGXH:_'X;T&X
MU)K&._F21X_M(B#;3Y<<A *XP=N*^ _^'E'[&?\ T5NP_P# 6\_^1:_5'X@^
M$_#'C#2K?3O%WAS0O$^GK<%DT_7M-M=3L(Y<8\_R;N*9/,/0$+GMTKQW_A0W
MP-QQ\'OAF/\ N3M _P#D"O4PE:E3@KVU;UU=E=?+S\WUT/$Q]*K.JFGIIL]O
MAUMM_P -<^$?^'E'[&7_ $5NQ_\  :[]3_TZ4?\ #RG]C+_HK=C_ . UW_\
M(E?=O_"AO@8/^:/?#3)[CP=H'X9_XE_;UZ>U+_PH?X%_]$?^&O\ X1N@].G_
M $#_ %[?CTXKJ=>FW>V_7[O/S\_/:QR_5J]M-=/+7;RZW_K6WPC_ ,/*?V,O
M^BMV/_@-=_\ R)1_P\I_8R_Z*W8_^ UW_P#(E?=O_"A_@9_T1[X:?^$;H/;K
M_P P_P#_ %]L&C_A0WP-_P"B/_#3_P ([0._3_F']CS_ #I>VI]OQ?EY_P!?
M)A]7K_GVZ)/K;T7H?"7_  \I_8R_Z*W8_P#@-=__ ")1_P /*?V,O^BMV/\
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M#_ O_HC_ ,-?_"-T'IT_Z!_KV_'IQ2?\*&^!O3_A3_PTST_Y$W0.W4_\@_\
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MZ!UZY_Y!_IQ_]>CVU/M^+\O/^ODP^KU_R[=?/R_KR^$_^'E/[&7_ $5NQ_\
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M'_P&N_\ Y$H_X>4_L9?]%;L?_ :[_P#D2ONW_A0WP-_Z(_\ #3_PC= [=?\
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M?_R)1_P\I_8R_P"BMV/_ (#7?_R)7W9_PH;X'?\ 1'_AG_X1N@]NO_,/[_\
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MO_Y$H_X>4_L9?]%;L?\ P&N__D2ONS_A0WP._P"B/_#/_P (W0>W7_F']_\
M]5'_  H;X'?]$?\ AGZ?\B;H'7KG_D'^G'_UZ/;4^WXOR\_Z^3#ZO7_+MU\_
M+^O+X3_X>4_L9?\ 16['_P !KO\ ^1*/^'E/[&7_ $5NQ_\  :[_ /D2ONS_
M (4-\#O^B/\ PS_\(W0>_3_F']O_ -=+_P *&^!O_1'_ (:?^$=H';K_ ,P_
MN>?Y4>VI]OQ?EY_U\F'U>O\ TEWM\^_]:?"7_#RG]C+_ **W8_\ @-=__(E'
M_#RG]C+_ **W8_\ @-=__(E?=W_"A_@9_P!$?^&O_A&Z!WZ?\P__ /5WS1_P
MH?X%_P#1'_AK_P"$;H/3I_T#_7M^/3BCVU/M^/IY^?\ 5F'U?$6Z=>WEY=?Z
MZV^$?^'E/[&7_16['_P&N_\ Y$H_X>4_L9?]%;L?_ :[_P#D2ON[_A0_P,_Z
M(_\ #7_PC= [=?\ F'__ *^V*/\ A0_P,_Z(_P##7_PC= []/^8?_P#J[YH]
MM3[?CZ>?G_5F/ZO7TVW\NRUV^6MOSM\(_P##RG]C+_HK=C_X#7?_ ,B4?\/*
M?V,O^BMV/_@-=_\ R)7W=_PH?X&?]$>^&O\ X1N@_3_H'^OX]^G%)_PH;X&]
MO@_\-/3_ )$[0.OK_P @_P#^L?8T>VI]OQ]//^ODQ?5Z_P"7;K\NGK_P/A+_
M (>4_L9?]%;L?_ :[_\ D2C_ (>4_L9?]%;L?_ :[_\ D2ONS_A0WP._Z(_\
M,_\ PC=![]/^8?V__71_PH;X'?\ 1'_AG_X1N@]NO_,/[_\ ZJ/;4^WXOR\_
MZ^3#ZO7[?EWM;S[_ -:?"?\ P\I_8R_Z*W8_^ UW_P#(E'_#RG]C+_HK=C_X
M#7?_ ,B5]V?\*&^!W_1'_AGZ?\B;H'7KG_D'^G'_ ->C_A0WP._Z(_\ #/\
M\(W0>_3_ )A_;_\ 71[:GV_%^7G_ %\F'U>O^?1=+=//^O+X3_X>4_L9?]%;
ML?\ P&N__D2C_AY3^QE_T5NQ_P# :[_^1*^[?^%#? W_ *(_\-/_  CM [=?
M^8?W//\ *E_X4/\  S_HC_PU_P#"-T#OT_YA_P#^KOFCVU/M^+\O/^ODP^KU
M]/\ @::>GR/A'_AY3^QE_P!%;L?_  &N_P#Y$H_X>4_L9?\ 16['_P !KO\
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M  H;X&]O@_\ #3T_Y$[0.OK_ ,@__P"L?8TG_"AO@=_T1_X9_P#A&Z#WZ?\
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M^KU]-M_+LM=OEK;\[?"/_#RG]C+_ **W8_\ @-=__(E'_#RG]C+_ **W8_\
M@-=__(E?=W_"A_@9_P!$>^&OK_R)N@_3_H'^OX]^G%)_PH;X'?\ 1'_AIZ?\
MB=H'U_Z!_IQZ?C1[:GV_'T\_Z^3%]7K_ )=NN_W'PE_P\I_8R_Z*W8_^ UW_
M /(E'_#RG]C+_HK=C_X#7?\ \B5]V?\ "AO@=_T1_P"&?_A&Z#WZ?\P_M_\
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M]6[V_P"#Z'PE_P /*?V,O^BMV/\ X#7?_P B4?\ #RG]C+_HK=C_ . UW_\
M(E?=W_"A_@9_T1_X:_\ A&Z!WZ?\P_\ _5WS1_PH?X%_]$?^&O\ X1N@].G_
M $#_ %[?CTXH]M3[?CZ>?G_5F'U?$6Z=>WEY=?ZZV^$?^'E/[&7_ $5NQ_\
M :[_ /D2C_AY3^QE_P!%;L?_  &N_P#Y$K[N_P"%#_ S_HC_ ,-?_"-T#MU_
MYA__ .OMBC_A0_P,_P"B/_#7_P (W0._3_F'_P#ZN^:/;4^WX^GGY_U9C^KU
M]-M_+LM=OEK;\[?"/_#RG]C+_HK=C_X#7?\ \B4?\/*?V,O^BMV/_@-=_P#R
M)7W;_P *'^!G;X/?#3U_Y$W0>@[?\@_OZ=?J*/\ A0WP._Z(_P##3T_Y$[0/
MK_T#_3CT_&CVU/M^+\O/^ODP^KU_R[=?\NI\)?\ #RG]C+_HK=C_ . UW_\
M(E'_  \I_8R_Z*W8_P#@-=__ ")7W9_PH;X'?]$?^&?_ (1N@]^G_,/[?_KH
M_P"%#? [_HC_ ,,__"-T'MU_YA_?_P#51[:GV_%^7G_7R8OJ]?M^7>UO/O\
MUI\)_P##RG]C+_HK=C_X#7?_ ,B4?\/*?V,O^BMV/_@-=_\ R)7W9_PH;X'?
M]$?^&?I_R)N@=>N?^0?Z<?\ UZ7_ (4-\#?^B/\ PT_\(W0._3_F']O_ -='
MMJ?;\7Y>?]?)A]7K_GVZ?Y]#X2_X>4_L9?\ 16['_P !KO\ ^1*/^'E/[&7_
M $5NQ_\  :[_ /D2ONW_ (4/\#/^B/?#3_PC=![?]P_N/\!ZTO\ PH?X&?\
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MA]7K_GVZ?Y]/ZM\)_P##RG]C+_HK=C_X#7?_ ,B4?\/*?V,O^BMV/_@-=_\
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M]?3;?R[+7;Y:V_.WPC_P\I_8R_Z*W8_^ UW_ /(E'_#RG]C+_HK=C_X#7?\
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MV,O^BMV/_@-=_P#R)7W=_P *'^!G_1'_ (:_^$;H'?I_S#^P_+H?6D_X4/\
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M=C_X#7?_ ,B4?\/*?V,O^BMV/_@-=_\ R)7W;_PH;X&_]$?^&G_A':!WZ?\
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M';K_ ,P__P#7VQ2?\*'^!G_1'OAI_P"$;H/?I_S#^P_+H?6CVU/M^/IY^?\
M5F'U>OY?AV3[?+I^=OA+_AY3^QE_T5NQ_P# :[_^1*/^'E/[&7_16['_ ,!K
MO_Y$K[M_X4-\#?\ HC_PT_\ "-T#MU_YA_?_ /52?\*&^!W_ $1_X9^G_(FZ
M!UZY_P"0?Z<?_7H]M3[?B_+S_KY,/J]?\NW7S\OZ\OA/_AY3^QE_T5NQ_P#
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M4XS4FW)KW;;7MJ]?-^M@HHHHM+M'_P "0G**JJG=NZ3<DM%=7MOKI]_0**5
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M?(****II+9W$FVM58****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** UZ*_P#7HPHI"0H)*L_HBXRY/;)_/BG;2' 4AF*[
M6VX*Q$?,5<G.7(...W3L TF_^ F^W^?X>@O>_E_'T\OZ^X2BD!R < ?3./PS
MS0V[&%ZG@],$=P2>@/J.:/Z_K^N@*_56_$6BD!1V/E#>0V%09"B0+R<MC(QG
M@=>.>E(I7>W#$^6-P ^2)<_*P/&6)&&&3CO1;Y>NPVTMKR?5*.JOW'44B[@
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M]?TA!1112_SM^"?Z@%%%%#=M1K5I=V%%%%/2V^O:WZBU[!1112OOY/\ 1/\
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M=GT3:[V]/Z^7F*Z6[04444)2;5XM>?;;_@_=YAS+NGY7"BB@>N!M!VN[#[G
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M?,TY)KFY=+:7V^5[[O8RIYC7ES5?8K22CTOK;9;V\]5=I7/ZBOC;HGC[Q/\
M"#XA:#\*]3N=%^).J:#<VW@_5K*9;:^TS5B"(KFWGD#)!*!SN8'C/UK\\/\
M@FU\#O\ @H%\(O%'Q0O_ -M3XJ>(OB/H>MZ/:6O@2VUK6K74QIFII?237%Q
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M>-/$.D,UKK;Z[JEU'9V_A[2]0B;SM/82SHT\T?,D;[&XKR3Q7_P1>_:^\)?
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M#0O$&BZY-"H:2+2=1M[V15[DK [$!>Y-:/<CC(X;) QCZ]??I@XK^0']K?\
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MM/&%WH5UX8\"QW+JK7OB+68C9);6R$@R7#0W+%%7D$9'(K\!=0_X)O:W8_\
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MC_\ $?X0_P#!-G2/#/A'X9?!359= \:_&#XAV,+6>MZY;R&*X@T<73;&@AD
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M (*<?\$X_BG\*KO]N^Y^'WQ2^ /Q1\06'A>\\2^!=,ALIO"VHZA<I;0SW#V
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M!));*T$INE8*JNZE36OU>]K-76ZOK;36U[_.WRU1C]92;NFU^7EL_P ^A_0
M.N#Q\@8D<@,?X>.OUZ>N*1@R@EE(4#Y\_>7/3*]2#Q@^]?@S^TG_ ,% OVJ/
MC1^U1J/[%?\ P3<T3P]?>+O UI<W/Q3^+/BR.*X\)Z'/%S-HYDGQ!!?V^"BI
MG=*PSVKRKXD?M$_\%>O^"?4'AOXR_M8'X;_'3]GQO$-AI/CZ'P9:6>GZYX<L
M+Z5(GU*YDMBTD>GV@D,S7; C]UM(YH^KM;R5][75VMW9/6^C?_#!]95MOG9V
M6RO\K[>:6O7])?\ @IW^V+XU_8?_ &;7^,_@+0M'U[64URQT?[#K4#36HBN)
ME5Y#&3DOM<[6[''TKP7]M7_@H[\3_P!F?]C3]GK]I3PMX7\.ZMXH^+UGX5EU
MK2]2@,NG69UU8FG6TC!RIAW[4P?7J.*\*_X+D_$3PI\6_P#@F=X5^*/@;48=
M6\)>.=4\.:[H%]"X>&YM+V2"1D5APS6\I:W8]2T6?>OF/_@K*O\ QJH_8=P.
M%L/AT2"V"I$=OSGNK-D'MCV-=$*:FHI+XI-._E"4K/YQV75'+4K2I\^LO=I4
MI;O>5:G#?76S?Z=+?TX_#WQ'=>,OA[\/O&-Y&D%WXN\&>'O$=W#;86W@OM7T
M^*[E@C(R$B#NR@'H./:NSV,V[ /RJ78L-BX!P<$\-@YZ?7I7X<?MN_M]?$/]
MDCX!?L=?";X%:)H^H_'?]H+P1X&T+P5?>(Y$M_#FA)_9=M;RWVH"8B!L2,Q4
MR$9_&O'?&]E_P< _"3P)=_%F7QI\'OBI%H=E;:WJ7PW\+Z%IEWK>J6I$4TMA
MHJV\A:YFE1FB41G(SY@S@UBZ"3=W%:N,;M*]FU9;:Z):7TM\^E8AW=XNRE9^
M6B>^RMYVZG]$P.0I'\0SZ_J.M%?.?[)WQB\8_'GX#^"/B1\1?AIXE^$/C_5-
M.BB\7^ _%-A+I]]I&M1!EN1;12DF6SD9?,BF'&'V_7Z,KGG#D=M_^&1TTY<Z
MOW=E^&O4!SMQSO\ ]5VWL#@K_LX]3G(YZ4<XY!#?PK@DL1U P.HY[=!GI32I
M?8@9599!(.>"!\H5'_O=RH]#7XI?MK_ME_MH7W[2OA7]CW]A'X>HGC&ZC:Z\
M<_%SQII?F^#-#W1C=907=QBV^2-O-%T.6D'E>]*,7)]EW_K^D*<U!7:;_K\_
MZ]?VR*,%+;6XP" IR"<<$>@]>E-((++@Y3E_8'&,?WLY[=.]?S1?M!_$/_@N
M/^Q7\.=4_:!^)/Q$^#GQ+^&_@F\LKCQAHFDZ3IEKJMQI4TP66"T"2>9@C<AG
M0$H"'K] OV@OVV?%MS_P3#G_ &Q?@M<P^'_&6I^#=-URS74K)=0M=)U5[9)-
M1MS;R,%N(892RQLQ <8(Z<;*@_<=U:3MH[JZLWMK\K7,HXE24DE:UFEW3:5_
M31V:ZZ/9L_5T(V2"-N",D]E(SNQW ]J0J1C ))/0C;A>S9/;M_\ JK^8']E;
M]HW_ (+._M]_!#PK\2/@GK/PL^'OAJQMCI]WXS\4Z79&3Q_K& 7O=/LIF_T*
MQMI,VTBQY4.03S7TO_P3O_;R_:LUO]K+XF_L)_MQ6OARY^+?@RR\[P]XL\*0
MPVVEZW('W26\4,!\N6V6V*RK=\!FS'VJYT%%.S5TKO75*R=[/O\ D]^I-/$.
M4DDF[M=-=;6MWU?]=?WFP>.G7!^88S['^(#.=PXKXW_;[_:+\4_LG_LO>/\
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MTLM+[Z[']*%!X&XX"YP3D$@GI\O7'J>U.8[F8XQEB<>F3FOR_P#^"H'_  4
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MX:O=-AMAHM[<KLE\2ZSJ)))L=')$\JR#:ZG!XXI_[2GQX_X+9?L$>&M%^/\
M\:_%?P@^)WPHM?$FE:/XP\,^&M'L4U*!=1N%2<I<Q'?%9Q1E\WF/W;*!W%:R
MPW+))[NUKVN[6;LM+VU;T=NNJ,GB^9*RO;=VT5['[C?MK?M9>&/V*_@3KOQP
M\5Z!J'BBUTZ>WTS3M!TR9;:XU#4[V1((%%R^8XXXGD661F&&52@Y.:]C^"'C
M^\^+'P;^&GQ0NK$:7=>/_"UEK\MA'\_V1;X-)% Q'!DC3:'D P3ST-?S;?\
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M/X#:G\/_  [H7B&;XK_$6W\&ZQ'KL!F2SLIITA-Q;8QLD ;=SD''0]:_4,@
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MWR[G5RN4+K3;]'_3"BBBJO?7N"V04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #D^\/Q_D:LZ9_Q]6_^_P#UJLGWA^/\C5G3
M/^/JW_W_ .M#^&?^%_F@C_$I?XO\CT6BBBO-C]K_ !,]E[0_P1_(****H04C
M$@''^>:6D;H<\>_XTGM\U^:+AO\ +]48/B'_ (]8_P#KK_2N.KL?$/\ QZQ_
M]=?Z5QU=M+X%_71'EXCXWZO] J6#_7P_]=8_;^,5%3XF"R1LW"JZ%CZ ,"?T
MJW%-TY;\LG?RV_X?UMYG.YM6C?XE)+3T_K_@7/X;O^"K'AZW\8?\%+M2\'74
MYM;7QAXN\+^%;N]M5$USIUKKVJ6>GS7MO')^[FF@CG,B1R?(SJ W!-?JDW_!
MM9^S[:RKC]I3XEA%,4A/_"*>'TE9F19-Q$>0"VX\*>!UP<@>*_MR_P#!/3]L
MSXL?\%$-%^-'PZ^#%YX@^&$/C_P5K<GBB+7-,M88M+TK7;*\U"[:UN'^T,(;
M>&23RP/,;&% .*_JKG=))A)$?E\J$(Q&&5U@B5RH(Y 8$#(]\GBO6K8M\D'"
M3YH1LTK6;O#>Z>J2:Z>>IY&%P,/;8B5:-XSNW:]_2RTMLGOY6NS\Z?V0?^"8
MO[,?[&^L1>,/ VDW7B?XBI8OIH\?>(@INX87_P!8;*Q -O;7DI)830[9$)(5
MN]?SU_\ !?\ TS4H_P!L7X=7=\+BUL]1^'MJ;+4IU8+# ^KQ1O<"7&Q&MV)G
M*JPD4+O"U_9&RYVG.XC)&[A5?KO4#C.?7OTK\[O^"BO_  3_ /"_[=_PMLM!
MDU&T\+?$GPI-)?>$?%EQ$72:1HRG]E:DT?[Y]-?J(D.!(<XXK.ABVZJG5=M%
M=[/=;.[WMMW??0VQ>!G++?9T7&RJ)\J2NTK:2^>_WK<_$GX;?\$=_P!J;QW\
M+/"OQ)\,_MH:_9>"M?\ #EKK]E):_$+Q%%IUCIDD)E+[HKT06T-LJMO12JQ;
M2"!7NG["G_!*?7?A)^TIX5^..G?M(^ ?B,_AVYNGUVPT?Q#!J&LZJLN3=7%P
MWGO>W,LW!GE8/N8?.W3'S78_LF?\%NO@_P"%+_\ 9Q^',^NZS\'+BWET1-9T
MK7M+@TB/2+W=!<16<%XS:C%:-#(Q9$8,%)"')%?J/_P2^_X)8:C^QKJNH?%G
MXM>,IO%OQ6U?3)+2RL+/5-5ETGPO:7T:F]M'M[NZDMYKN8Y$D@C;#?<*UTSQ
M*:J\DXR2DG'D5FH-+26KO-.Z<DTG\5NAQ4J$75HRG2J+EA%23ZV2UBK?#MIK
M975S^?7]O:SL]4_X*Q^-["ZB#VMU\2?!H$; .FQIH91N4Y4D,%!R#TK^YNP@
MMU\/:/:S1(UE_P (OH]M/$Y5(#:?V/:I*DI/RI"(CAB<+MSNP!BOY0?VJO\
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MJ&LVUEX7TS2!KVH>*#*@TV+2+>TCFFOI;G=L\N&(%PT;,S ?+FOR8_X*<_\
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MW?\ P+MGYA_M3:;>6_P6_P""'6GZS!*TDGBCP/)LNXR#!_Q,8&BCGAD ^7D
M*PP1BO[/?'1"^'O%RA5 7PSJ*;$4+&,:;T"#@(.R] .*_)W]O;_@FKXL_:L\
M??LA:_\ "[QMX+^&W@_]F'QMHOB&Z\-:S8WDCZMHFC2VSQZ;HOV/$4%PR6Y
M:;Y [9[XK];/$=O)K>E:U9Q$02:MI5WI\3R<I"UQ:FW620#DJK?,<=1[T8FM
M&<Z;AHHO6V_V>VG37S]"L/2G!5W*"M.G0BGI\4::6FGNZJ]OO=S\"_\ @WX
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M"?PQ_P $[/\ A@S]H/Q7HOC/]WXAC3QMX'CN].%D^IW/VC2[^Q^U,DL=]I^
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M?%UMX&\56NIVFM>%_$E^DLVFV&H6LHE#7<<)$[JVU0 G0YKGIR4:CDF[7O\
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MUY/AG?Q;EX8EKF;;DCDX)Z'K_/L/VQ/VP_VJ?BW^V_9?L)?L(OX+^'OC_1M
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M$ 455.M%48I22E?F]Y-JUEYQN_ZZCJTI.LY-:<J5E9).ZUUCKUT_0?\  /\
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MR]5:^]MS\MO@5;PW'_!QMXXD>*-WA^%GB<J7569<V"?,A(.UN.V#Q],_H_\
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M-%!4-_PO*R9,GDL+R$[?3#'@^@S7]#[,69F/5B3QT&>P] .@'85^87_!3/\
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M 3#,1+A5W,^UQZBO5O\ @W>6(^'/VNI8D7S;CXI7@EE;Y7<1:E)L5WZE1D@
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M(^#=*_9YUB75O$>D>(K6\N+[Q!&]\MTL>DR6A\J)EC78?/."V,<=<K_@I=\
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M7IY;,(.2NY*#DV]5'9:6M?M:PXR/AD)=$()*HY.XKV')$8.!@?Q=Z:/G:-B
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MBN_=/].O<)6G;FOH[KE=M?UZ"$MD!CC?]Z0=4=<A=R]<'MZY'0=5!;>'4-O
M =T;:2>S8YY''X4>OOU]_KZT4KIN3=US*SL]5Z%2G)J+YI>TBUJ]8\J>UO/U
M7KU';W<L7D9P"0I5BC%UYWDGKC_(]6_\"+D\LQYRW>CT]NGM]**3C#D45SZ=
MY-KIWU_K0F,YZN7)=](QLNGS[A1113;VT_X/_!(BFKW=[N_X(****104444
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MWMOIU]=^@5&KJTM%:^C2L[.-[]EIY[]!.F>/S'^>:2G$?WS%;H%SF6>.( Y
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M?EY[@"0>@(QW_P /ZT$YR.F?3M]/S_E0H)V!2J&0E0RNLI# <D;25=2. 0Q
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MQC]:>Z[<N);:3)P1;W$-SLR.BB&20$\9.XCVS35(9O+CW9VA]I7[S-][#'H
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M2G!6D( SP-SRL-@2,]7YPNWN&/0<XS2D*1DW%EM(VD)?6;,%'"L D[.6;Y2
M%)SQBJY.:,I)-7<6DW_+9Z=_T>[L#J04DN>.EMME=*]N_G?K?YLY[TA!/3..
MY';T_.EQM)&3\HW!B.>!U8-V([<CJ13MJ",%GMT64EH_M-W;VAE;TC6:5&8+
MU4 $,<@4DI3@I<KC[.2;NUK=K1=NOKVUN.4U"5N;G56*BFNEK:M/7K^K(@W;
M!QTR>Y_SS3Z_%3]HO]M/]HGX<?\ !5#X&_LK^%O%&D:?\%O'.B6]YXAT"XT&
MTN]2NKF9"TKP:RY^T0JQ'RK'E0,X-?ME<(L=U-' /+"O)'B8X1'5MJMN/&"N
M,DD*">U74IS@HZ)>V2FG?966C[Z]KZVWZ8TZZJ7VC[)\C[-Z.]^NVC>NI!VS
MV%'^>A_K3P@Y"S6C%!DPI>VLK!O4+%*\AW=,%>,^W,?R@8EC??D!@H.2#TC
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M@5)N/*FKR<U3=EVM>3ZM*^I]OYXSVI<TA\OS)"CJ@W'R!+)'%#L#$;6EF:-
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MW\ W_!:S_@FFNX[F\+:JJQ(0))6-_)A%!Y<_[*@MZ=:^9/\ @MG\+?A]K?\
MP4B_93U']H37/&7PZ^ ?C3PS!X'U/XA>#KV32-4TK7I9U%I:6.JY1;1_,D5K
MR3S $@^9@%KTZ7(XX-2N_P!U)V=K-I05^[TOIMLVKV/,FYPEBVKK][':^FK=
MM].OGION>OS_ /!)7]HWPGX3E^,_A#_@I1XFN?VM+59]>ETN_P#&FE3?"Z^U
M9E-Q+86UC+JY*BX=1%$)(A;*<]%()^M_^"?_ .W;XP_; _9)_:%TOXESV=G^
MT#^SW;^)/ ?Q'OM$D"VNHZK8VEQ%!K>G.F 3,('E>2%C$'(*-C!KQ=_^" _[
M%$?AI_&R_M2?M.?\(?#9G4IO%(^,)?0C9+&LIF&J^?\ 9=@4\L'X/RGFK'_!
M._X(?L!_#3X6?MG:I^Q!\9?B?\6OLNFZUH'Q-O\ QK)=W.FP:[;:==1 Z;J$
M]G:Q:J^4;==VS7*,3N\PYS40G!W3=_>5G[-P6ZT=T[7V:;NK[LKEJ*M&S<5[
M!WMB%)N_+:R5K[W=DUI;0_+[_@F[\#OVGO\ @I9X(^*WP\\4_M+?$WX3_ OX
M/?$#Q396VL^$=7NY_%FO>.WU#4'LX=0U&\NUD33([<1AH(IC&L8.U<@5]&?\
M%8KCXX?L5>"/^"<G@'X<_$7Q+XO^(7A_QE-X;35;[6=0B7QIKKA(M(;7/L]P
M6U&-IWBW17/G*6+C!%?2_P#P;?C;^S)^TXZHH$G[2WB':JCYI<O>9\UNI<#G
M.<=NM<9_P7@C'_"_O^"::E 4C_:)T-_FP3N^WV.7V\AB><#G!ZBKISC*HXV6
ME[72Z13OMOKY[:6ZY<DUAH2E*5G)+^)S;S276^W7Y-/KR?[1G_!.C]M2U_9\
M\8?MM>*OVT?B6G[4OA'1)/B=??#W2[MK/X8Z+HNGQ+?W7A^TL8IT,NIVML#&
MHFB\IW!#J>!6;^R+8_MM?\%G_@GI6O?%G]H77OV>?@9X2T^'0&L_A>!;^,?B
M-XM@MPD7B#4;YVA:"TMI1Y5W';2A=S,0,U_0'^W'N/[(W[4[G@'X)^-6&,"3
M_D"Y.Y>V>=N ,@\>M?F-_P &\RA?^"=O@-A^Z'_"2:RO)^96:_W;I#U(/J?7
M&:YXUF\&ZK5W'$<B=DVE[FVG2[^6_8WC0Y<;"DY.T\.JF[M>[WZ=-O)M/5'S
M;_P34^(_[2G[+W[>'Q,_X)T_&?XJWGQA^'^BZ2^J_#?7=8EDN[^U!D+)/<W]
MP\MU/*;=E1XWE9%ER5X K^E4'H"2%49PV,F0DY##G"G^# &>YK^;W0AN_P"#
M@K68UVG_ (H(N"_ 3A.1T'/49R>E?TA,1OD;D-EN3T8KG&.V._TJ:]J<Z:=U
MSJ+V:>MF]-WHK;?(O#1E.#EK:%>:UZV=O/?KHNG<_EH_X*?_ !:_:?\ !O\
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M_M>7OC6S_L[Q=-XXU!_$D,09475X[^6.]:%' /DS7*R2H''^K<#I7].;()9
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M^%7Q[L/V:?V0/@5XF_X0WQMKFEZO::9XV\6:S$\L<\VF37=S:OYI>,"U:%S
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M3^/GQ5TR/0O^$IGU'X/1WVSX9_8-%FG>646K7  DN4B8N?)R92O7-?T)?MA
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MMM\2KBZ^+GB7PH-OC;7]4>>5M.T[1[F1XDA'E961HY!@C@U^S?\ P1J"3?\
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M<I)5TE?]U+SVL[6W]+6OYL>-IKVF&;:NZL-?62UOUMO>P?M$?L,?MK_\$V_
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MU/D#_@H%XC_X*-_&'QE\)/@G^Q!X9USX<?"GQKI=AJOQ._:1N8[(:=HVDZI
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M^.?A#2KKQ3XW\(>/_&.DW_@W7XM-@?4M7L=$M9=6F:/SQ%,D220K)L95B!?
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M2 !6-24&O=:OIMA^6VL79O[OTN;4XU/K%+=)1C>]>,KW?1*SLKVT3]$FS]T
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MU5)%+R860 <5VW[0/[-'_!*__@IC^TS\1/AR?B#KGA/]JOX;+-;^-SX*EO/
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M\56L=S"JR;_(3;%$5:%@7!)-?0/[!?[27[3_ ,0?@'^VO^SE^UOI^HWWQ-^
M'@+QAI-AX_O-,N["Q\:Z,VFW4$$EE.\*6UVMNBQL9(Y)&)?D]:_7;]EKXJ^
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M_:Q^*/PH\ _#'5)O!OPTTGP'JEVVLZWK&DW,CW&M^)[JYNTDO(;R-E0B1Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX=0\&_%_0+?R_"/Q5\*W+Z;KNF&-3]D-\UN!+J-M9-B2WMV(",.^:^#O ?\
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M_9M75;^UTM+?#/;6,VL!B9XHI?*:0E0DJQLG.ZOZ!\'H. QPW5OD/)'.,XP
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MKVSLE=NVVS739VO^GD0L+23:5DF^;31>>FS;6]U>]]3\[_VX/^":WP*_;?\
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MQG/JKZ2-9CU.#3_+6;1Y+4LNQ+J)71I<_*&R,GBOSS^(G_!"M;B5="_9]_;
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M].^3ZYZ_2I]HY7<N:[>NJ]ZUK-VZJR\M+FGLHPM&#LH[6TMK>R^_S_ _/?\
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M ;BWD@+CUV^9G'?%?G+^Q)_P3Y7]C?XM_'WXHP_$W_A./^%ZZ[=:X^COH_\
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M5KFE^)HR9-]I<JDSHB@3XVY-?M >>.F>^,_H>#1P"I;,H!*LC$A67LV!T([
M?7BHA5E3ORWU[6^[5=?T-:E*%11N[\FUWMMJKZWM=;]7HV?@=\//^"%6BW?Q
M!TKQ5^UA^U7\5/VJ?"?A"YCN_ /@;Q;?7D&G>'DM'#V]K=F0LFH6T(55>*0*
M90O0=ON_]O/]@[3?VV/@U\-O@SIGC>#X4Z)\-/'7A?Q=I=W:Z*-0MYK3PTUL
M+;1(K-=JQ+)%;(GG#&S/<@9_0+) P ""WS ]T^O7(/Y]^M';J2>0. H R""
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M]\/3VR!;.XTFZ5=U@]MA2JQXSM'%?1@ VY^ZX^[@ XR>1GJ>/7]:"3[-R."
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M#X3G@N/!M]X^N;DZ7HALRDEJT^E7!:*X^RRQH\!/*LN?>OV\;YMH9V(4;,*
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MR+WQ+J'B)CON+C495^TW,;KDN3DYXK]9NG3('7&>#Z<]5"]>.M-V@ER69>Z
M<X8_>RW5@3_"1CFJ>(EU=K_X=M%9^[KY_@[$K"PDKN35GO=[Z:[V7R_1'Y_?
M&/\ 8W^,7Q-_:T^%'[1/AK]K7QW\.OAQ\/';_A)?@#HXN/\ A$O'R\E1J+H?
M*CR<')#=,'%?H&[;CO\ O#.U=@PH &,'IN)ZE^YS^"'/&, '&Y<< #^Z,8))
MYYI3][<#SG@ 8'3&_ X!(XQTQR.:CVU]-'LMEMIHM+V^_5[Z6+Y*</M/5)7U
M^]JZU2T=EHO.XE%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 Y/O#\?Y&K.F?\ 'U;_ .__ %JLGWA^/\C5G3/^/JW_ -_^M#^&?^%_
MF@C_ !*7^+_(]%HHHKS8_:_Q,]E[0_P1_(****H04U_NG\/YBG4C' /'Y_6D
M]OFOS1<-_E^J,'Q#_P >L?\ UU_I7'5V/B'_ (]8_P#KK_2N.KMI? OZZ(\O
M$?&_5_H%%%%:& 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^Z?K_GC_ /7FC^R=/_Y]T_7_ !K1HI\\_P":7WL7)#^2/_@*_P C._LG3_\
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M )]U_P _X?\ Z\T?V38?\^Z_Y_Q__5BM*BES2[O[PY(_RQ_\!7^1G?V3I_\
MS[K1_9.G_P#/NGZ_XUHT4^:7\TOO8<D/Y(_^ K_(SO[)T_\ Y]T_7_//_P"K
M%']DZ?\ \^Z?K_GC_P#7FM&BCGG_ #2^]AR0_DC_ . K_(SO[)T__GW3]?\
M&C^R=/\ ^?=:T:*.>7\TOO8<D/Y(_P#@*_R,W^R;#_GW7_/^'_Z\T?V38?\
M/NO^?\?_ -6*TJ*7-+N_O#DC_+'_ ,!7^1F_V38?\^ZT?V38?\^Z_P"?\/\
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MA_)'_P !7^1G?V3I_P#S[I^O^>?_ -6*/[)T_P#Y]T_7_/'_ .O-:-%'//\
MFE][#DA_)'_P%?Y&=_9.G_\ /NGZ_P"-)_9-A_S[K_GO6E11SR_FETZOIL')
M#^2/_@*_R,W^R;#_ )]U_P _X?\ Z\T?V38?\^Z_Y_Q__5BM*BES2[O[PY(_
MRQ_\!7^1F_V38?\ /NM']DV'_/NO^?\ #_\ 7FM*BCFEW?WAR1_EC_X"O\C-
M_LFP_P"?=?\ /^/_ .K%+_9.G_\ /NGZ_P">/_UYK1HI\\OYI?>^UOR#DC_+
M'_P%?Y&=_9.G_P#/NGZ_XT?V3I__ #[I^O\ GG_]6*T:*.>7\TOO8<D/Y(_^
M K_(SO[)T_\ Y]T_7_/'_P"O-']DZ?\ \^Z?K_C6C11S2_FE][#DA_)'_P !
M7^1F_P!DV'_/NO\ GO1_9-A_S[K_ )_P_P#UYK2HHYI/J_O8<D?Y8_\ @*_R
M,W^R;#_GW7_/^/\ ^K%']DV'_/NM:5%'-+N^G7L')'^6/_@*_P C-_LFP_Y]
MU_S_ (?_ *\T?V38?\^Z_P"?\?\ ]6*TJ*7-+N_O#DC_ "Q_\!7^1G?V3I__
M #[I^O\ GC_]>:/[)T__ )]T_7_&M&BGSR_FE][#DA_)'_P%?Y&=_9.G_P#/
MNGZ_YY__ %8H_LG3_P#GW3]?\\?_ *\UHT4<\_YI?>PY(?R1_P# 5_D9W]DZ
M?_S[I^O^-)_9-A_S[K6E11S2_F?3J^FWW!R0_DC_ . K_(S?[)L/^?=?\_X?
M_KS1_9-A_P ^Z_Y_Q_\ U8K2HI<TN[^\.2/\L?\ P%?Y&;_9-A_S[K1_9-A_
MS[K_ )_P_P#UYK2HHYI=W]X<D?Y8_P#@*_R,[^R=/_Y]U_S_ (__ *L4?V3I
M_P#S[I^O^>/_ ->:T:*?/+^:7WOM;\@Y(_RQ_P# 5_D9W]DZ?_S[I^O^-']D
MZ?\ \^Z?K_GG_P#5BM&BCGE_-+[V')#^2/\ X"O\C._LG3_^?=/U_P \?_KS
M1_9.G_\ /NGZ_P"-:-%'-+^:7WL.2'\D?_ 5_D9O]DV'_/NM']DV'_/NO^?\
M/_UYK2HHYI/J_O8<D?Y8_P#@*_R,W^R;#_GW7_/^/_ZL4?V38?\ /NM:5%'-
M+N^G7L')'^6/_@*_R,W^R;#_ )]U_P _X?\ Z\TO]DZ?_P ^Z_Y_Q_\ U8K1
MHI<TN[^\.2/\L?\ P%?Y&=_9.G_\^Z?K_GC_ /7FC^R=/_Y]T_7_ !K1HI\\
M_P":7WL.2'\D?_ 5_D9W]DZ?_P ^Z?K_ )Y__5BC^R=/_P"?=/U_SQ_^O-:-
M%'//^:7WL.2'\D?_  %?Y&=_9.G_ //NGZ_XTG]DV'_/NM:5%'-+^9].KZ;?
M<')#^2/_ ("O\C-_LFP_Y]U_S_A_^O-']DV'_/NO^?\ '_\ 5BM*BES2[O[P
MY(_RQ_\  5_D9O\ 9-A_S[K1_9-A_P ^Z_Y_P_\ UYK2HHYI=W]X<D?Y8_\
M@*_R,[^R=/\ ^?=?\_X__JQ1_9.G_P#/NGZ_YX__ %YK1HI\\OYI?>PY(_RQ
M_P# 5_D9W]DZ?_S[I^O^-']DZ?\ \^Z?K_GG_P#5BM&BCGE_-+[V')#^2/\
MX"O\C._LG3_^?=/U_P \?_KS1_9.G_\ /NGZ_P"-:-%'-+^:7WL.2/\ +'_P
M%?Y&;_9-A_S[K1_9-A_S[K_G_#_]>:TJ*.:3ZO[V')'^6/\ X"O\C-_LFP_Y
M]U_S_C_^K%']DV'_ #[K6E11S2[OIU[!R1_EC_X"O\C-_LFP_P"?=?\ /^'_
M .O-+_9.G_\ /NO^?\?_ -6*T:*.:7=_>^]_S#DC_+'_ ,!7^1G?V3I__/NG
MZ_YX_P#UYH_LG3_^?=/U_P :T:*.>?\ -+[V')#^2/\ X"O\C._LG3_^?=/U
M_P \_P#ZL4?V3I__ #[I^O\ GC_]>:T:*.>?\TOO8<D/Y(_^ K_(SO[)T_\
MY]T_7\J3^R;#_GW6M*BCFE_,^G5]-ON#DC_+'_P%?Y&;_9-A_P ^Z_Y_P_\
MUYH_LFP_Y]U_S_C_ /JQ6E12YI=W]X<D?Y8_^ K_ ",W^R;#_GW6C^R;#_GW
M7_/^'_Z\UI44<TN[^_N')'^6/_@*_P C._LG3_\ GW3]?\\__JQ1_9.G_P#/
MNGZ_YX__ %YK1HI\\OYI?>PY(_RQ_P# 5_D9W]DZ?_S[I^O^-']DZ?\ \^Z?
MK_GG_P#5BM&BCGE_-+[V')#^2/\ X"O\C._LG3_^?=/U_P \?_KS1_9.G_\
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M?=:TJ*.:7=].O;8.2/\ +'_P%?Y&;_9-A_S[K_G_  __ %YH_LFP_P"?=?\
M/^/_ .K%:5%+FEW?WAR1_EC_ . K_(S?[)L/^?=:7^R=/_Y]UK1HI\TN[^]A
MR1_EC_X"O\C._LG3_P#GW3]?\\__ *L4?V3I_P#S[I^O^>/_ ->:T:*.>7\T
MOO8<D?Y8_P#@*_R,[^R=/_Y]T_7_ !H_LG3_ /GW3]?\\_\ ZL5HT4<\OYI?
M>PY(?R1_\!7^1G?V3I__ #[I^O\ GC_]>:/[)T__ )]UK1HHYY?S2^]AR1_E
MC_X"O\C-_LFP_P"?=:/[)L/^?=?\_P"'_P"O-:5%+FEW?WAR1_EC_P" K_(S
M?[)L/^?=?\_X_P#ZL4?V38?\^ZUI44^:7=].O8.2/\L?_ 5_D9W]DZ?_ ,^Z
MT?V3I_\ S[I^O^>?_P!6*T:*.:7\TOO8<D/Y(_\ @*_R,[^R=/\ ^?=/U_SQ
M_P#KS1_9.G_\^Z?K_C6C11SS_FE][#DA_)'_ ,!7^1G?V3I__/NGZ_YY_P#U
M8H_LG3_^?=/U_P \?_KS6C11SS_FE][#DA_)'_P%?Y&=_9.G_P#/NM)_9-A_
MS[K6E11S2[OIU[!R1_EC_P" K_(S?[)L/^?=?\_X?_KS1_9-A_S[K_G_ !__
M %8K2HI<TN[^\.2/\L?_  %?Y&;_ &38?\^ZTO\ 9.G_ //NM:-%/FEW?WL.
M2/\ +'_P%?Y&=_9.G_\ /NGZ_P">?_U8H_LG3_\ GW3]?\\?_KS6C11SR_FE
M][#DA_)'_P !7^1G?V3I_P#S[I^O^-']DZ?_ ,^Z?K_GG_\ 5BM&BCGE_-+[
MV')#^2/_ ("O\C._LG3_ /GW3]?\\?\ Z\T?V3I__/NM:-%'-+^9_>_4.2/\
ML?\ P%?Y&;_9-A_S[K1_9-A_S[K_ )_P_P#UYK2HI<TN[^\.2/\ +'_P%?Y&
M;_9-A_S[K_G_ !__ %8H_LFP_P"?=:TJ*?-+N^G7L')'^6/_ ("O\C._LG3_
M /GW6C^R=/\ ^?=/U_SS_P#JQ6C11S2_FE][#DA_)'_P%?Y&=_9.G_\ /NGZ
M_P">/_UYH_LG3_\ GW3]?\:T:*.>?\TOO8<D/Y(_^ K_ ",[^R=/_P"?=/U_
MSS_^K%']DZ?_ ,^Z?K_GC_\ 7FM&BCGE_-+[V')#^2/_ ("O\C._LG3_ /GW
M6D_LFP_Y]UK2HHYI=WTZ]@Y(_P L?_ 5_D9O]DV'_/NO^?\ #_\ 7FC^R;#_
M )]U_P _X_\ ZL5I44N:7=_>')'^6/\ X"O\C-_LFP_Y]UI?[)T__GW3]?RK
M1HI\TN[^]AR1_EC_ . K_(SO[)T__GW3]?\ //\ ^K%']DZ?_P ^Z?K_ )X_
M_7FM&BCGE_-+[V')#^2/_@*_R,[^R=/_ .?=/U_QH_LG3_\ GW3]?\\__JQ6
MC11SR_FE][#DA_)'_P !7^1G?V3I_P#S[I^O^>/_ ->:3^R;#_GW7_/^/_ZL
M5I44<TOYG][]0Y(_RQ_\!7^1F_V38?\ /NM']DV'_/NO^?\ #_\ 7FM*BES2
M[O[PY(_RQ_\  5_D9O\ 9-A_S[K_ )_Q_P#U8H_LFP_Y]UK2HI\TN[Z=>P<D
M?Y8_^ K_ ",[^R=/_P"?=/U_*C^R=/\ ^?=/U_SS_P#JQ6C11S2_FE][Z;!R
M0_DC_P" K_(SO[)T_P#Y]T_7_/'_ .O-']DZ?_S[I^O^-:-%'//^:7WL.2'\
MD?\ P%?Y&=_9.G_\^Z?K_GG_ /5BC^R=/_Y]T_7_ #Q_^O-:-%'/+^:7WL.2
M'\D?_ 5_D9O]DV'_ #[K_G_'_P#5BC^R;#_GW6M*BCFEW?3KV#DC_+'_ ,!7
M^1F_V38?\^Z_Y_P__7FC^R;#_GW7_/\ C_\ JQ6E12YI=W]X<D?Y8_\ @*_R
M,[^R; ?\NZ_Y[TL>E6,3*\<(5E.5(/0^U:%%/GDKKFE9[ZL.2/\ +'_P%?Y!
M1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g4bdklltl5z5000018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000018.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .*!N\# 2(  A$! Q$!_\0
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M=XD\&Z7K&K:=/<7]U)J"S2I?WL"L+?4;JWBQ%#.D:[8HD4[5&2-QR237>?\
M"E/AY_T"+G_P:ZE_\DU)\%_^2=:'_P!==6_].]]7J= 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\Q^,G_)-_$?_ '"/_3]I
M=>G5YC\9/^2;^(_^X1_Z?M+H B^"_P#R3K0_^NNK?^G>^KU.O+/@O_R3K0_^
MNNK?^G>^KU.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KP#]HG]J3X"_LI>#$\=_'OXC:/X"T.ZN19:3!<Q
MWNJ>(/$-]YD$;V?AOPOHMKJ/B+7IK8W4$NH-I>FW-OI-G(=0U::QT^.6Z3V[
M6-6T_0-(U37=7NHK'2=%TZ^U;4[V9@D-GI^G6TMY>W4K' 6*WMH999&) "(2
M>E?Q^_LW?"WQ/_P6U_;C^)_QL^..L>(K+]F[X27ME-9^";:XN=/N/^$4U'4]
M27X=_"72[BVO[F'P_)K6GZ/?:]\3O$&A7<NIW%Q#J46C3:/>>(M%UOP^ ?I%
MJ7_!Q-^Q=9:O=V-G\-?VD=7TRUNY[:/6[+PE\.8(=0A@EDB2_L+'4_BG87PM
M+M$6XM4U*'3;\02J+RRL[A9+=/U!_9=_;=_9H_;&TK5]0^ GQ(L_$^H>'?)/
MB3PIJ6GZEX;\8Z"DZ0-%=WOAO7;6QO[C27>XCM8_$&E)J/AZ6_6;3X=5DOK:
MYMXMS2_V-/V1M&\)S>!-._9A^ 4/@^Z:*6^\/R?"/P)=Z=J5S!]C\J^U6*\T
M*<ZKJ*G3[!_[2U%KJ_:6RM)6N3);0NGAWP:_X)J_LX?L[_M/ZE^TW\$--U;X
M<WNN> =>\#ZW\,M%N8V^'4TNNZQHFKRZ_I.GW,<NH:#.IT:.WDT/3[\>&5 M
M)M,TC29;6<WP!]T>)_%'AOP5X>UGQ;XPU_1O"WA;P[IUUJ^O^(_$.I6>CZ'H
MNEV4;37>HZIJFH36]E865M$K237-S-'%&HRSBOQJ^*W_  7S_84^'6NRZ%X9
M/Q8^,9MKBZMKK7/AUX.TRW\-Q2VDODR"'4?'OB3P5=ZE',X9K.\TG3;_ $R[
MA1KB*_,+VSW'P_\ \%;OBC\3/VQOVV?@_P#\$R/@YKUYIF@PZOX7F^)XMLK8
MW?BS7]+B\:W&K:];3OI:Z[H7PF^%^WQM'IEEJ[PZAJ=]J=I]FD\1Z+I26G[4
M?L[?\$W/V.?V:_">C^'_  A\$O WB?7["Q2WU3XC_$/PSH?C3X@>(+R2WAAU
M&_N]>UO3[IM*BU)X1-+H?AR+1O#MNS%;32H 6W 'RK\%?^"Z_P"PA\7-:M?#
MVO:YX^^"6HWU[#865W\7/#.G6'ANXFN&(BDE\4>$-?\ &&D:)9K\JW.H^*9]
M L+5BS37*VZ?:#^Q=G>6FHVEK?Z?=6U]87MO#=V=[9SQ75I=VMQ&LL%S:W,#
M/#/;SQ,LD,T3O')&RNC,I!K\POVQ/^"3?[*/[3/P[\4V7A7X5^ _@[\7I+;5
MM5\(?$GX=^&=*\&R_P#"77(:[B?QMIWAVRLM/\7Z-J^H(D6NG5[*\UB*VN;V
M[T74=.U.0W3?!/\ P0)_:1\<W>F?&7]B?XJW-XOB/X%7%QXB\#Z5K%Q&^L^'
M_#Z>(9?#7Q"\&M"$WC3?!_C2XTJYMF:YNS;7/BV\T]'@L+738% /U>_;@_;T
M^$W[!?@[P5XQ^*OASQ[XHM_'GB2\\-:+IO@#3M"OM0CGT_3)-4O;V^;Q#XA\
M.64%E#$(( (KN>[EGNH_+M3#'<30G[$G[?GP._;R\*^+?$7PBA\5Z'J/@35;
M#3/%G@_QU9:-IWB;2X]8ANI]$U<0:%KOB&PN-%UD6&I0V-Y'?B0W>EZA;3VT
M#P*9?R3_ .#D3_DC/[-/_93O&/\ ZBMI7D/@%XO^"<'_  6@@\.E'T7X&?ME
M:+HT>EVT%QJDFE65S\6KVWDT>9]/AMDTZ*ZT'XY:/J?AVP!$]OX9\"^)9;IK
MVQMKN[@4 _JHKG?%_BWP[X"\)^)O'/B_5;70O"G@WP_K'BGQ-K5ZQ2STC0-
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MS_:6U#4;;Q./#ANGURZ^'FC7.F:?)X.LH-,F35I)?B1XBU>QT66TM(;F'7=
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M[GR]/-L@N(HX[B659DB^6?\ B(R_9"_Z(]^TC_X(?AA_\]&O$OCCH6A^)O\
M@X<^"^A^)-&TKQ!HM]X%LA>Z/K>G6FK:7>"W^!7Q&N[<76GW\-Q:7 @NH(+F
M'S87\JXABF3;)&C#^AS_ (4+\#/^B+_"?_PW7@__ .4] 'FO['_[6'@']M#X
M,V/QN^&^A^+?#OAN]\0:]X;&E^-K32+/78;[P_<1074DD6AZSKVGFVF$T4EN
M\>H-(58B6*)U(/U%6+X?\-^'?">FQZ-X6T#1?#6CPR2S1:5X?TJQT;38IKAS
M)/+'8Z=!;6J232$O*ZQ!I')9RS<UM4 (2 "20 !DD\  =22>@%?DA^T+_P %
ML?V&?@!XAU+P?%XI\6?&;Q7HNI_V3K6G?!G0;#Q!I6DW:VQN96E\8^(M;\*^
M#=5AMGV6-X?"^O>(;BSU)WL+FVBN+/44LO _^"[O[8OC#X'_  >\#_L]_"O4
M]2TGQ]^T)/K">(=6T5I%U?3OAKHIL['4='TV:SO(=1LM4\<ZUJUEH\$]O:W:
M7.A:;XKT[-O=7=I,/8/^"?7_  2,^ '[-?PL\,ZU\9OAUX+^,'[0&O0:3XF\
M6:]X[\.:3XJT?P'K CAOK+PI\/\ 1]:M[_3=*C\*3MY4_BN.W_X2/Q!K<=WJ
MS7NGZ3_8?AW00#'^#O\ P7F_82^*6OP^'?$=[\2_@I<WEYIUAI^K_%+PGIR^
M&+RYU.Y:UB$NN^!O$/C6+0[6TD\I]4U7Q3!H.B:=;3K=W&J"TM[Z>T_5KXD?
M%7PM\-/@]X]^-^HM<^(?!7P_^&OBGXJWS^%&T[5+S7/"WA3PO?>+KEO#3SZA
M8Z3J-SJ6DV#G1WFU6STZ\EFMC)J%O;2&Y3Y:_:"_X)J?L7?M'>&M<T;Q=\"_
M OA;Q!K%OB#XC_#3PUH/@3XAZ3J$-D+'3]4A\0Z'ID']L2:; D"6VF>*;77]
M!ECM[>"[TFX@ABC2A\</A/IOP(_X)@?'/X,:/J^I:_I7PO\ V(?C!X'T_6M7
M6%-2U.T\._!/Q-IL%Y=QVX%O#+-' &\B >3 NV&+Y$6@#O?V)_VTOAM^W7\*
M==^+GPN\.>./#&@^'O'^K?#F_P!.\?6.@V.KR:UI'A_PMXEGN[./P[XA\26<
MNER:?XNTR**::\MKLWD-]$]DD$5O<W7V#7X&_P#!NG_R9-\4?^SIO&W_ *J7
MX(5^^5 'P;\3/^"A/P?^%G[8GPR_8KUWPO\ $6]^)'Q1T_0=0T?Q)I.F^')?
M!&FCQ'+K\.FV^JWEYXGLM>64/X?G-TUEH%Y%"EU:M&\["X2'[6\3^(=.\(^&
MO$/BO6#,ND^&-#U;Q#JC6\1GN%T[1;"XU*]:"$%3-,+:VE,4093(^U,C.:_F
MA_;$_P"4^W[(?_8!^$O_ *7_ !&K^B+X]?\ )#/C/_V2?XB_^H?K% 'Y;_L_
M?\%SOV1_V@?B_P""O@W8>%?C%X UKX@ZS;>&_#6O^/=&\$6GAB7Q%J,@M]%T
M:^O-"\>:[?6=UKE\\.EZ6XTZ>WEU.ZM+6:6!9Q,/V@K^ /P-^SY?>+?^"7WB
M;]I[P6EQ8>/?V<?VP[U]1UW2[N]T_6+3P%XP\ _""P^W6-QIT1N6U'PWX]B\
M'ZEIER;BS&BV5[XBU*"[CE)CG_M?_8R_:'TW]JK]F+X._'6P\J.[\;>$[8^)
M[*!)XXM+\<:%//X>\<Z5"ES'#.;2Q\5Z5J\&GSO&JWNG+:7\#26UU#*X!].U
M^4'[8'_!8?\ 9@_8V^+EQ\$_&6@_$[QYXXTG2-,U7Q/#\.=*\*7NG^%I-;M(
M=2TG1]7NO$?B_P .2_VS=:/<V>LM:6EM<Q0:;J.G2RW(ENC#%^DOQ/\ B)X:
M^$7PW\>?%/QG=FQ\)_#KPAXA\:^(KI(Y9I8](\-:5=:M?"WMX(Y9[FZD@M7B
MM+6WBFN+JY>*WMXI9I$C;^)_5/AIKWQ>_83_ &[_ /@HK\4].,GC3XY_'7P7
MX=\ OJ"7=X^B: ?BKHNO^-9/#VIW]Q*\^@OJ5WH'@/1A%;6QT>R^'U_I%O*;
M.XDL[< _M,^"WQ7\.?'7X2?#CXR^$+;5K+PQ\3?!V@^--$L=>M[:TUNQT_7[
M"&_@LM6M[*\U&RBU&T$QM[Q;+4+ZS\^-S:WES 8YG^3O^'C'P;_X;N_X=^?\
M(C\3?^%M>7G_ (2O^R_"W_"NO-_X5#_PNK9_:'_"7?\ "3>7_P (I_H/F_\
M"+;O^$A_T/R?[-_XF]=3_P $X/\ DPS]DG_LA/P__P#3);U^'O\ SLR_Y_Z,
M!H _J8KYN_:R_:?\#?L>_!#Q)\>/B+H_BG7_  QX:U#P[IESI/@RTTJ\\075
MUXEURRT*R^RPZUJ^A:;Y4-Q?+<7;SZE"4MHI3"D\_EPR?2-?D'_P7/\ ^4<W
MQ3_['#X4?^K T.@#]'/@!\:O#'[1?P9^'?QO\&:?KFE>&/B3X>@\1Z/IOB2W
ML;77;*VFFGMFMM3@TS4-5L$N8I[:53]EU"ZA= CK)\Q5?F#_ (>,?!O_ (;N
M_P"'?G_"(_$W_A;7EY_X2O\ LOPM_P *Z\W_ (5#_P +JV?VA_PEW_"3>7_P
MBG^@^;_PBV[_ (2'_0_)_LW_ (F]+_P2Q_Y1[?LJ?]DQM_\ T\ZO7XR_\[,O
M^?\ HP&@#^IBBBB@#Q']HWX_^ OV7?@MX[^.OQ+DU >$/ .F07U]::/%:7&M
MZM>7^H6>CZ/HFB6U]>Z=9W&JZQJ^H66G64=U?6=LLMP)KJYM[:*::/Y>_88_
MX*5_ _\ ;YU#XC:1\+?#7Q%\(ZO\-+/PUJ6J6'Q$T_PO8R:MIOB6;6;6&\T(
M^&_%?B8W":7<Z/Y.L"^33Q;MJND?96O?M%R+/\[_ /@N+XUUSXO^,_V1_P#@
MGS\/]0N8?$_QR^)FA>+?&']G&\NI=*T%]5E\#^#;K6M%L3$VJ^&QJ.H^,?%N
MI+>7EM96#?#VVU.8 VT>H:;\YZKX5T/_ ()F?\%J?A8_A+2(/"GP#_:2\)^&
M/ ]I8Z7H0TW0],TWQQ;Z;X$O-)ANX6ATUY])^+WA#POX\\12P)%+8:-K4!N[
M+-W;WUV ?U5U^ -[_P '%?['EM>7=O;_  I_:+U"WM[F>""_MO#WPZBM[Z&*
M5XXKR"*]^)5K>1PW**LT4=W;6]RB.JSP0RAXU_?ZO+)_@9\$[J>:YN?@[\++
MBYN)9)[BXG^'WA*6>>>5S)+--+)I#22RRR,SR2.S.[L68DDF@#\2_P#B(R_9
M"_Z(]^TC_P""'X8?_/1KI?!G_!P9^R7XU\8>%/!ME\*/VA[&]\6^)="\,VE[
M?:!\.VL;.ZU[5+72K>ZO%L?B3>7K6MO+=I-<"SM+JZ,*.+>VGFV1-\$Z/X#\
M#'_@XRF\#GP9X4/@K^U-<'_"('P[I!\+X'[%FH:L!_PC_P!C_LG U4#4Q_HG
M&H#[;_Q\_O*_J(M/@A\%K"ZMKZQ^$'POL[VSN(;NSO+3P!X4M[JTNK>19K>Y
MMKB'24E@N()426&:)UDBD571E900 ?-O[<'[>_PH_8*\+^!/%?Q6\+?$/Q38
M?$#Q#J/AW2K?X>Z?X;U"[M+C2].34KNXU!?$GBCPQ"D)ADC2W6VFN'DEWB00
M*JN_K?[2_P"T?X8_9@^ GBS]H7Q7X6\:>+?"?@ZU\/7^K:+X'L-*U#Q,MAXA
MUS2-"2^2TU76-'T_[)IDNL07FK3/J2K:6$-U=?/'"Y'X>?\ !R)_R1G]FG_L
MIWC'_P!16TK]\_'OPV\/_&/X)^*_A-XKCDD\-?$GX:ZKX'UOR&,=S'IOB?PY
M-H]S<6DHYAO+6.[-S9SKAX+F**5"&0&@#A_V3_VG_A_^V%\$/#'QW^&MCXAT
MCPUXEO?$.FC1/%D&E6OB71]0\-Z[?Z%>VNKVVBZMKFFQ/<&RCU2Q^SZI<F72
M=0T^>=;:XEEM8/H^OY@_^"!?Q)USX4?%/]JW]A3QZ]G;^(O"'BG6O'&G6MHM
MS) /%?@?6;7X5_%:W2_G\E;B-WL? \NE0-8VEV]MI^K74H=%\JT_I\H _/[]
MM?\ X*,?!_\ 8;USX4^%_B!X,^*/Q \3?%]M>'AG0?A7HWAS7-3A70KS0-/5
M;^SUSQ3X<N7N==U#Q#!9^'K72X=2EO[BPU.*7[))#:K>>P?M<?M8_#_]C7X)
MW_QS^)FA^+]9\.V6L^'M &B>#[+2+[Q%/J7B.Y-O:QI%J^M:+I4<=JJ3SWDL
MNJJJQP,MN+F9XHW_  $CM1^WY_P7DN+M8[+6?A5^QV8(IIRFKV)"? B^D^SV
M_FA3#JMTW[27B>YFBA9K#1]7\(6EU(@U:V@D_MC[X_X+W_\ */S6_P#LK'PS
M_P#2S4Z /'/^(C+]D+_HCW[2/_@A^&'_ ,]&O</V;O\ @MS^S5^T[\;O 'P(
M\%_#3XXZ%XH^(NI7VEZ1JOBG1_ 5OH%G<6&BZGKDC:E-I'C_ %C48XY+?2YH
M8C;:;=-]HDA#JD1DEC^D/V$/@K\&]6_8I_9.U35?A+\,]3U/4OV>/A#?:CJ.
MH> _"U[?W]]=^!M$GNKR]O+G2I+BZNKF>1YKBXGDDFFE=Y)'9V)/V%HWP@^$
MOAS4[36O#WPN^'6@ZS8.\ECJVC>"?#6EZG9O)%)!(]I?V.F075N[P2RPNT,J
M%HI)(V)1V! /1:^1OVTOVS/AE^PS\)=,^+_Q4T;QAK^AZSXXT?X?Z7I/@>PT
MN_UN[U[6=(\0:]#\FM:OH>FP6<&E>&-7N;B>XU&+F&*"%)9YXXV^N:P_$/AC
MPWXNTYM'\5^'M#\3Z2TT5PVE^(=)L-:TYKB DPSM9:E;W-L9H2S&*4Q;XRQV
M,,F@#\%/^(C+]D+_ *(]^TC_ ."'X8?_ #T:/^(C+]D+_HCW[2/_ ((?AA_\
M]&OT _;O^"OP;TG]BG]K'5-*^$OPSTS4]-_9X^+U]IVHZ?X#\+65_87UIX&U
MN>UO+*\MM*CN+6ZMIXTFM[B"2.:&5$DC=74$?F[_ ,&_'PS^&_C/]C3XEZIX
MP^'W@CQ7J<'[3?C*P@U'Q+X4T'7;Z&QB^%?P8N(K**[U2PNKB.TCN+JZGCMD
MD$*37,\JH'FD9@#]"?V'/^"G/P2_;V\2^//"OPM\&?%#PGJ7P_T/2?$&IM\0
M-+\,6=K?6.K7]QIT:Z=/X;\5>),W%O<0J9HKU;/?',KVQG\NX$7V9\9?C=\)
M_P!GSP'J_P 3/C/XZT+X?^"M%C9[O6-;GD#7$XC>2+3='TRTBN=7\0:U=K&X
ML-"T*PU'6-0D4Q65C<2?+72^&/A[X!\$R7<W@SP/X0\(S:@D45_+X8\-:+H$
ME[' SO!'=OI5E:-<I"TLC1),76-I'* %V)_D_P#&?AKQ/_P6/_X*I>+OA_J^
MMZ[I_P"S#^S=+XCT.<Z==726EGX,\'ZY%H&K3^'Y8DO]"@\8_&;QU''/%JDP
ML=5E\!:?;S/_ &@W@"STZ@#]#O%O_!PS^Q-H&N7ND^'_  9\?_'.GV<HCB\3
MZ)X.\'Z5HFJ*T44@GTRV\5>/]"\2"%7DDMY!J^@:1.)H',<$MNT4[_4'[,__
M  6 _8B_:>UW1O!N@^/-6^&?C_Q!=+8Z)X)^,6DVWA"_U?4)[^#3-/TS2O$-
MCJFO>!=1UC6;RZM8M#T"V\6/X@U9[F.&TTI[M)[>'Z?^&G[$W[(_PA\-P>%?
M '[.?P?TC3([&QTZZN;KP)X?UW7M:@TZ*6&T?Q)XHU^QU/Q'XFNXUN+D_;->
MU34;IGNKIS*6N)2_Y$_\%8O^"4'P U;]G_Q_^T'^S[\/O"WP=^(_P=\+ZCXU
MU[0O!&F0>&/ GC/P'X9M[G5_%5M<^$]&M4T32/$.CZ+'J&LZ1K.C:;8/J+61
MT773<6L^GZAH0!^Y/QK^*_A_X%?"+XD?&7Q59:MJ/ASX8^#=?\:ZUI^@P6US
MK5]I_A_3Y]0GL]+@O;NPLGOKE8?)M_ME]9VJR.K7-S!"KRK^(_\ Q$9?LA?]
M$>_:1_\ !#\,/_GHU]/?\$?/VE]3_:Z_8DTRR^*!?Q9XN^%^K:G\%/'-]XE5
M-8/C?2M,T;2=0\/ZQK)U&?49=:FU+PEKNG:/X@O=8+W>N:YI.M:A>1R"]$DW
MZ(_\*%^!G_1%_A/_ .&Z\'__ "GH _%#_B(R_9"_Z(]^TC_X(?AA_P#/1KWW
M]E[_ (+6?LV_M6_'7P)\ ? _PW^-_A_Q5\09?$$.D:OXLT;P+!X>M9?#WA77
M/%MR-2FT3Q[K6IQ+<6.@75K;/;:7=#[;-;"X\BU,]U!^;?\ P0Y^&_P[\2?M
M+?MXZ7XB\ ^"]>TSP[JVCVGA_3M:\+:'JEAH5I_PGWQ"M_LNCV=]8SV^F6_V
M>SM(/)LHX(_)M;:+;L@B5?Z;="^$WPK\+:I;ZWX9^&?P^\.ZU:"9;75]"\&>
M'-(U2V6Y@DMKA;>_T_3;>[A$]M-+;S".51+!+)$^Z-V4@'H-?D9^TG_P6?\
MV5?V7_C_ *W^SWXW\/\ Q7US7_"EUX<L_%_BGPAH/AK4O"?AZY\06&GZO)#+
M)>^+=-US49-#TG5+.ZUB/2=%O9(YS<:9:I=:C:S6R_IQ\4?B)X<^$7PU\?\
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M,OV0<G'P>_:2(SP3H/PP!([9'_"TC@^V3CU-)_Q$9?LA?]$>_:1_\$/PP_\
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M9K>*[\;:?I%]I>H0WMY<QZM;:7I7Q@^%D6J>#-0N-.T:)M(U'2-2UWS9]?\
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MX9\0::9#>V;VMZLYTN\GB6UUS239ZSI<UUI][!.X!]1U\L_MS?\ )DW[8?\
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MXOAQ\2&L/#NO^1:VZ207\\'C&S^'UUF\C0:;I2:Y>07ENK7=O?\ YH?L-?\
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MQW-S'=+K>E:-+XUL9E^SM'IOBVRL[BUBN[6X+_LO0!_,+_P0?_Y.E_X*$_\
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MO$7C?QF+;2WM[_3?$$7Q5UJR^'$=WH(GU*74-'\,7EQ=Q6-CYFE_4'_#H?\
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MH7L?@HPV%H]EIVG1?#KXQ:;=^%=,U+4+6_GTSP!;:VIF676+N] !_3[\>O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-C9Z>SO')!:>$]$\<W>BQ1"U(86D=_%#([O;LR1CSW_INHH _#/]D#_@AO\
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MKTZO,?C)_P DW\1_]PC_ -/VET 1?!?_ ))UH?\ UUU;_P!.]]7J=>6?!?\
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MM,TV^U"+2-)CAEU759+*UEN4TW3(KB:VMY-0OFC%K9QSW%O"]S+&LLT2%I%
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MVNC_ /"%IX:3Q)>^&3I<EV=9&N#7#>6,DXB70FL/LSH?M_F[HE^G* "BBB@
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M*.S\.^(O$ELWAW6VCU73M.O9KNWN)=4\/:Y;/9I%:V]S=@'W!17S'\6?VJO
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M-"?QWX1TCQ0VC+JAL]..I+I9U4V2WYT^Q-X(!<&SM3)Y">JT %%%% !1110
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M  :^!_@?X26?A+_A/? ?PN^/9\9:Q\>_BQX1MM.?6[C4Y[7P#X@L_!?PZO\
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M4-;D\,VEEI] 'U7\,O$'[0FG_!?6]8_:)T+X6:3\7_#=EXFFNC\)=3\2:O\
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MC#P5J.A>'[GQ#K!1]+\/_P!K7'BNWO&OM3DLX8](\*:QK,]PNE^'-3NM/ /
M/^"I/BS]O;PM^PA\8O"/[3?@CX#^._!GC^V^%5N_Q+_9TE\<:-'\*_%6F?%C
MP%XDDTSQUX8^(-Q?W.L^#]:DT:70/#_C71;VPN4\07VCV&L>&[5=6AGM_P!1
M/B#^TWX<_9(_89^'WQBUW0[_ ,7ZE9_##X3^'/ O@'2)FM]:^(7Q"\2^&-&T
M_P )^#=*ECL]2GAFU2^+2WMU:Z7JUWI^CVFI:C;:3JDUFEA<?)G_  6_^.GP
MHT?]A+XE?".?QMHEU\2?B[+X '@/P=I-W'J^NZO8^$/B7X-\?>)->DL--:YG
MT_PWI/AOPMJMQ=>(+Y+?25NA9Z>+LWE[;POYK_P5'\%:QKW_  3G_9,\>VMK
MXJN_"OP0\=_LV?%+XE_\(-<RV/C+3/A]9^ =0\-:QK_A6]BDB-EKVCWGB73'
ML=0>6VBTHSR:Q/>VEOITSD ]^\3?%/\ X*W?#[X9ZA\??$_PP_9"U_1O#VDZ
MAXZ\5_LU^%YOBL/BYIO@FQT^?6;OPYI'Q$AU;7_"&O?$S1K"/[-J,.E^'-0T
M'5;^VOAX8CU:6?2].G]J^)'[3WQ5^*?["-M^UE^PWI7ACQ7XHO\ PA!\1]'\
M#^/O#VK>*;G6M%T1[ZW\?^ ;?3/!/B;3KL_$70+NPU;3K:RTS4-7CU#Q'X>N
M?#-K;37&JVU_9^1:!^QQ^ROX^\!6WCW0?VT_VJO$GPYUW26O4\2P?MQ>/KOP
MS=:3/&8[D7E[)X@:QCC0,]KJ%K>,CVTHFM+V**9)8E^B/!&J_LN_L'?L2VOB
M3P)XIMY_V:/A5X/U[QAX8U^'Q9:>,/\ A)[3Q5X@U3Q1:VWASQ&UV+#Q!J/C
M3Q7XD;3O"\-G<I:7^HZOI]C9LD<B$ 'S9X^_X*B:!X@_91^"'Q0_9IT/3?'W
M[07[4FN67PW^#'P>U:::2;2OB9#=6VG^/SXTLK6?3M5_X13X77$KS:WJ]N;'
M3M2@O/#5Z-4TW0/$<&NP?J;X0@\56WA7PW;^.=0T75O&D.AZ7'XLU/PWI=WH
MGAZ_\1)90C6;O0]'U#5-;OM,TF?4!<2:?97FKZG=6UH8HKB^N95>5OY1_@CX
M"\<?L2_&+X*_\%1/CA\+M$\/_!O]IWQY\3?^$R^'=EX>NM1OOV/;#X[:V;KP
M%\0=-NC?W<=DFO>'4AMM9OH=,T#4=&\):QJ'@*30X=>US3O#UK_3A\<OVAOA
M%^SC\+-0^-/Q=\5#P]\-M,FT."Y\16&DZUXG1G\27]KINC-;6/A?3]8U"[AO
M;J\MPEQ;6LENL3^?)*L7ST >U454L+ZUU2PLM3L)A<6.HVEM?6<X61!/:7<*
M7%O,$E5)$$D,B.%D1'7=AU5@0+= 'XM_\$H?^2Y_\%6?^S]/BC_ZF'CFLC_@
MO!J_]@?LV_LW:[_9^H:K_8O[;OP>U;^R]*@^U:IJ7]F^ _C!>?8--MMR_:-0
MO/)^SV<&Y?-N)(X]PW9K7_X)0_\ )<_^"K/_ &?I\4?_ %,/'-'_  7 _P"2
M&?LI?]GZ? S_ -0_XLT =-\=/VC?^"F/PG^%NN_M3CX+?LWV7PB\'V\?C#Q+
M^SUJ^N>.KWX^:=\+H88KG5=5USQ_9W-E\/=*\;:39RS:AKOA[2=!\1:;X?L;
M*Y^QZCXNU"$Z;/\ :WBK]K[X4>#OV1%_;.UJ748/A;/\*?#WQ4L;(I:1>(;^
M#Q;INFW/AGPI;P7-U!8CQ1K.KZQIGAFTMI[Z*S&MWD<4MW';A[A<S]O_ /Y,
M;_:]_P"S;OC+_P"H#KM?D_\ 'CP%XG^('_!OSX$LO"=C/J5_X:^ 7P0\>ZC8
M6QC$DGACP3K'AKQ!XLO6,LT$?D:#X<L]3\1W8)DD:UT>9+>&6Y:%" ?6NF_$
MK_@KCXT^'T7QP\,_"O\ 9#\+Z;J>F6?B_P -_LS^*KWXH:C\6M1\*R:=%J0\
M.ZO\2X]5\.^"M)^(^LQ-)!I$%UX>T_P_I=U<:;'XDEL9;?5;9?L;]CG]J#P]
M^V#^S]X+^.6@^'M2\'3Z\VK:/XH\%:O<P7NI>#O&7AG4[G1/$F@3WD$=N+VV
MAO[1KS1[^>RTN^U#0KW2[_4=&T2_N;G2++X4^"'[+_[+7QN^$?@_XK> OVS?
MVO=6\*Z]X;TS4Y+FW_;6^(L!T.X>PAFU#1M=LQKJ-H&KZ).9;+5M(OH[6YTN
MZMYK>>&(QXK[D_8\^#OP$^"7P=_X1;]F_P 5R^-OAQJ/C3QEX@?Q-)X^7XD_
MVCXMGU9])\7@>)XKFZMI9[36]&N;+4;2W=?L^K6^H-=J=1EO)) #+_;_ /\
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MPMK&O64_AV]FD\/ZI8W%CY6H7EO;ZK;17VE:OID/T3X'_:?^ 7C[X-:;\>]
M^*O@7_A55YX97Q3=>*KOQ'I=AIN@Z?#9_:M2MO$37L]M+H&J:$5FLM<TC5H;
M+4](U"UN=/U"SMKR"6!/ST_X) Z-JFM^'OVP_P!H9=,U?2/ /[3?[8'Q8^*/
MPEAU6WDT\:Q\/;W6;N?2_%%GI4\<5S8V^IW.HWFF W<5O/<?V"KI;BT6UN+D
M ^/_ /@C5I7[9=QX%^+]UX)\8_LZZ7\.+;]MOQ^OQAT?Q-X,^(.L^,-5\00Z
M/\+Y/B#)\/\ 7=,\4Z+I&F:5?:$UI:^%%U[0[RZLM4CN+S5/M%M+'9Q?II^T
MG^UG\7M-^/7AG]CO]D;P+X"\=?M$Z[\/K_XK^+/$7Q9UG6M'^$_P@^'5MJ,>
MB6&O>+(?#,$OB?Q%?:WKEQ:Z9::)X==;ZQ.H:5?WD4EC?AX?F#_@C%JVB>%/
MAU^V5X&US7=%L/$WAS]OKXU1:IIESJ$%I<Q+?:3\//#VFSBWO6MKH0ZGK&AZ
MII]@9;>)[FZM);98_M"/$O@7QD^$G@+3_P#@L/\ $Q?C_P#&GXO_  2\(_M*
M_ _P%JGP8\7> _BUK?P0T'7/%OA&V\%_#_4/AE>^,--OK5-:UB6Z\/WVNZ7X
M?&H64:W_ (ALH9M*N=4UOP_<WH!]N+^U7^U9^S1\;/A'\-OVV?#OP3\0_#+]
MH3QI8?#'X7?&[X 6OC?1HO#WQ.U>.T70/"/Q*\$^--1UV[MK?Q-J$UU::5K^
MA:I-86%O:?VCJ_EVPU'^R?0?VM/VP?B5X ^,GPL_9)_9?\ >&/B1^TY\7=!U
M?QE'-\0;[6].^%GPF^'FD_VC WCWXC7'AR"36[G3[_4=*U'3=,TS3;BPGN;F
MS:W6\.J:AX>TC7?.]6_8-_9"TKQW\';SXD_M&_'+Q;XDT3XH>%O%?PC\(_%[
M]K/Q)XJM=7^)?AJXEU?P^?#OA;Q/K$SZQK<26=ZWD:1"VH/IHU*/<MHUU7DG
MQ/\ %>@_ 7_@M1\-O'_Q5U6T\(^!?C[^R!J'P@^'OB_6KJWT_P .W7Q$T7XA
MVFN7GA>ZU.ZFCM[&]:VMM*BMS<M##=:EXK\.Z=;R2WNHI%0!]I?!GQ)^WGX?
M^*]OX(_:3\%_ ?QQ\,_$>DZM>:#\9O@)<>+_  U)X0UK2+.RN8_#OQ$^'_CW
M4=:OI$\2O-J<7A_7O"^KW>GV;:3'#K8@O-:L[:#\NO!?Q ^/GAK_ (*P?\%(
M/!O[.'PKT/QW\2?'N@? D67B[XB:KJ6A?!;X7V_A[X5:!+_;_P 3M1T&WO/%
M&H1:C=ZK:6.@>%/"EJ^O>(KF._:.ZTO3=,U/5K+]T[WXU_"FQ^(_A?X12^//
M#LWQ-\96&K:MH'@FQOX]1\07&C:'93W^IZW=V%A]IDTK1H(K=X8]5U7[%875
M\T6G6D\]]+';M^7_ .R'_P I9O\ @J3_ -@3]F3_ -5K84 >@_";]K7]IOP!
M^V-X9_8V_;(\+_"*XU+XN^"_$OC7X%_&#X)6_C72?#/BB;PG93:IK?@O7?#7
MBRYU^XT_6K+2-(\1ZK=ZB=<L;6S^RZ'IT5IJLGB.SO8I_P!KG]M[XQ_ +]KG
MX!_L]?#+X3V/Q?/QO^&WC;4-"\)VA?2?$=Y\0M+N[A-#EOO%UWK":3X8^'^D
M:;8ZAK?C75'\-:_J%CH]A=WEK 1&P3S?]KS_ )2S?\$MO^P)^TW_ .JUOZS/
MVF/^4TW_  3;_P"R3_M%?^JP^*] &UXX_:S_ &Z/V3?BU^S^O[7/A+]F_P 7
M? 7]H#Q_HWPANO%'P$3Q[I/B#X2?$SQ7<L?#5IJLGQ U^5/%?ADV$.H7<^H6
M6@V-U?66BZW>.N@7EAI&B^+OKO\ ;3_:\A_91\(>!4\/>!+[XM?&;XR^.=-^
M&7P4^$^F:K:Z+<>,/%^IM&K3:AJUVDT>D^'M(%Q:?VKJ9MY8X+G4=+M;B2R@
MO9-1L_BK_@N!_P D,_92_P"S]/@9_P"H?\6:3_@IOJ:_"/\ :M_X)I?M0>+K
M::+X-_"_XL_$/P+\1O%"^6+'P5<_%K2?"^C>'/$&NS3LD%GH-HNFZUJFJ7\D
MBFWM=%DB@6XO;FRMI0#HOB?\8?\ @K-^SM\,=1^/OQ(\%_L4?%OP9X"T'6_&
M/Q<^%?PKG^,'@WQII/A/1H'O;W4/!WC3QAJ>N:#?/H>D1W.O>)GU+0[B2UL]
M-OK#0-.\37$]K=Q]=^VS\9/!_P"T+_P26^,WQL\ R7;>$OB5\"+7Q1I,&HK:
MIJFFB]U72%OM$UB.QN[^RAUO0-2CO-$UJ"SOKVU@U2PNX;>\N8D2=_IK]JK]
MIWX)_"#]F'XE_%GQ)XX\'ZKX8NOAYXB_X16WL/$6B:@OQ#U36?#]['X>\.^%
MFANY[?7+CQ)<306]L;0W%JMI++J-R\>FVUS<1_E?9_"3QK\$O^#?GQ'X#^(6
MG7.B^+1\$_%WBW4=#O8[NWO=#MOB%\5-1\>:+I.HV-_:V5[I>L6>A>(]-37M
M)NK9)]+UTZE8R%V@,C 'V[X$_:4\#?LC_P#!+#]G7X\?$&*]O=#\'_LG?LXI
M::)I>S^U?$GB#5_AGX*TK0/#VG-(&CAFU/4[NWBFO)E:WTVQ6[U.Z4VUG-7)
M0>-/^"O^M>!C\7--^'?[&>C/<6T7BG2?V:M6F^*EU\2[CPS)80ZFO@[5/B<V
MOZ/X*L/BA<))/I$+OHUMX.M-66SN-2OK>U-]:P?%O[:W@_Q/K/\ P1F_82^(
M/AO0I_$T/[/WA[]BWXX^*-"M8KB2?4/"?ASX+CPSJHWV]K?-9VEI-XPLM0U;
M4I;*YM=+T:TU'4;N+[-;2LO[=:/^TS\ ->^$@^.NE_%_X?77PF&AW'B"?QO'
MXIT<Z+9V-E$\FH0WUP+LBSU3398IK'4=&N FJV.J0S:7<VD>H1O;@ \&_9\_
M;U^&WQM_9'\6?M6:KHFM^ [3X4:1X[/QM\ 7\;ZAXD^'GBSX8:.VM>-/"[1K
M!9SZC.M@+;4=",UCIM_?Z?JFF#4=+TC5'O-,LOCS3?VB?^"K7Q<_9QN_VL_A
M7X!_9(\%>#];\(W?Q'^'OP.\5P_$[QO\4=6\ VFFRZG:W5YXRT?7O#/A.]\3
M>)K.WDU7PWI,.C:);3Z9?:/:ZK+I&KM>V\?C/[)\,NC?\$Y/^"E/[1/C#X;Z
MKJ_PU_:+\=?M8_'#P5\/-6EU'P]/XG^$GB/PI/965U<-IZQ:KX=LM96'58SK
M&G.EW#HNG6^OZ1,(3I]W)XW\!OB-XTNOV/\ X>?L[V/_  5H_8=\"_#_ ,3_
M  ;TCP_?ZQXET^UT+X]?"O2?$F@(-<^'NDRZQ\6?"%@)O",-Y=^%M&\0:[I7
MAWQ9':PQW5O#HFHV]@;4 ^VM _;"_;'UW_@F)XI_;;T"[_9\\;^/4\/V_P 2
MO#FA:%X'\>Z;X7TKP-X7U)-(^+?A_P 2Z;J'CR74KWQ1X,N=)\93_P!K:9K]
MMI=U!H(2.QW2"63])/AY^T/X$\=?LT^%OVH9[R/0/A_KGPBL_B_J\^ISVT/_
M  C.BCPP/$FOVFK7 N)+.&Y\-B*_L-39;N6VBNK"X"7,D2B5JO[/?P1^$GPH
M_9N^'WP+^&LMAXH^$FB>!6\-:?J"W.E:I:^,M-UE+RX\0Z_?WFBQ0Z-J5UXQ
MU+5-7UO6;G3X8K*\O]5O98HDCD"C^:.;QWXY^$OP(^-W_!&#0M1U1_C#K'[7
M>@? _P"$^H_9C<WT7[-7QIUC_A9-YXXUD:9:M!>6/]C)>77CE+>'3AI>A_$L
M3L+:VTRZEB /Z /^">7QY^,O[3W[,^@?'KXT>'O#7A+4OB1XG\7:OX&\,^&M
M&UO25T?X:66KOH?A=-7FU[5M3N=?U349=*U/6H?$MK;Z'INLZ)J>C7%CHD$(
M%W>^*?\ !:G_ )1F?M*_]T;_ /5__"JOT>\ >!_#OPR\"^#?ASX0L4TSPKX#
M\+:!X/\ #FGQYVV>B>&]+M=(TRWW'+.T=G9PJ\CEGD<-([,[,Q_.'_@M3_RC
M,_:5_P"Z-_\ J_\ X54 >H_%SXS^+/V=_P#@G'-\:_ UKH=[XM^'7[.OP_\
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MP-S/P=_;>\;>&OVK?CY^R9^V.?AA\//$?AK3=0^+?[/_ (YT.?4/#GAKXH?
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MU(1Z_:VEOX5_P0P_Y1S?"S_L</BO_P"K URLK]AS_E)I_P %9?\ L-_LT_\
MJ%>+* .I7]K3]K;]IWX\_&+X:?L0^'O@3X?^%/[.GBN\^'/Q*^-/Q_L?B'K4
M?C#XF6<%PNH^%_AQX:\&7OATBU\+ZM8W&FZ]J&IW]W#?6-WIWB'2[N"UN--L
MM=^2_A_XV^,WC+_@MC\'8?C[\,M+^&7Q-\'_ +&OB3PAK</A?6[CQ%\/_&D5
MMXF^).MV?CWX<:M?VUEJ\OA#6X->%E'9:Y:0:SHNNZ3KNAWYN9--%Y<^M?\
M!(_QIX7^&GBS]NW]F#QWX@M]"^-7A;]L3XL_$RZ\/^*I'T;Q#XD\ >)[3PIH
MNC^-=+CU;R)M>T:\F\/_ -JRZEI\E]!#8>)O#FJSRI9>*-%NM1X^S^,GPV^-
M/_!=?X>:C\+O%.G^--&^'W[)WBWX5^(]?T-VO?#Z^.M"UWQWXIUS0]+UR$-I
MFM2Z+IGC;P_%JLVE7-W;V.I7%QI<\B7MG<PQ@'[Y5^3G_!6'7]9\<> O@?\
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M]7J=>6?!?_DG6A_]==6_].]]7J= !1110 4444 %%%% !1110 4444 %%%%
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MK?#VW\>E+C^W(O!;:C-JS>'5<3BV^P'4KB>\VFW,OFR$^;MPH_$_PWXS\)_
MG]LO]L3QA^W_ / [XD>+-8\?>.5M?V?_ (T2_!+Q/\;OA78?LZ:5<7DG@3X;
M^%)O#7A[Q4/"&LP1RQ:IXNTO3M&M_P"U/$/VC4/$$_\ :4<5WJ7[^T4 ?@9\
M./!'A;XZ_P#!1GX#?'7]CO\ 9V\4_ 7X-?"7PU\2KOX^?&&]^$6J_ #PO\='
M\?://#X:\-:'X7U'1/#5[X_U*VUTRZGKFJZEHD4T*W4>J:G<"?2O"QU']\Z*
M* ///BI\)_AS\;_ VK_#7XL>$=*\<^!->DTV76/#.M).^G7\FCZG9ZSICSK;
MS6\Q-GJEA9WL6R5<36Z;MRY4]U9VEMI]I:V%E"EM9V5M!:6EO$,1P6UM$L,$
M,8YPD42(B#/"J!5FB@#S+PW\&OA?X0^(OC_XM>&O!>D:/\2/BE%H,'Q!\76B
M7 U7Q5#X8L4TS0$U1GG>!AI=A&EM;>3!"1&HWESDD\2?!KX7^+_B+X ^+7B7
MP7I&L?$CX6Q:]!\/O%UVEP=5\*P^)[%],U]-+9)T@4:I82/;7/G03$QL=A0X
M(]-HH X'XD_"OX:_&/PO<^"OBOX"\(_$;PE=S0W,_AWQGH&F>(M)-W;,6MKV
M.SU2VN8H+ZU<E[6]@$=U;.2\$T;<U\_?#K]@#]BSX3^(M-\7> /V9_A)H7BC
M1;Z'4]%\0-X5M-7U?1=2MF5[74=&OM<_M.XTF_M9$66UO-/>VN;:4>;!)'(2
MQ^OZ* "O,O%GP:^%_CGQW\.OB;XM\%Z1KOCWX2S:[/\ #CQ1>I<'4O",WB6U
MMK+7GTIHIXXE.IVMI;07/GQ3 I"H0(<D^FT4 5;ZQLM4LKS3=2M+:_T[4;6X
ML;^PO(([FSO;*[A>WNK2[MIE>&XMKF"22&>"5'CEB=HW5E8@^'?#;]EW]G[X
M.^!O&GPT^%_PK\,>!O GQ#DU67QGX:\/0W=CI^NOK>CIH&IM<[;HSP_:='C2
MP"V<ULL$*C[,(7^>O>Z* ."^&/PO^'WP8\#Z'\-?A7X2T;P-X$\-I>IH?AC0
M+;[+I>G#4M1O-8U!X8RSNTM]JFH7NH7<\LDDUQ=W4\\KO)(Q)\3OA=\/?C1X
M(UOX;?%3PCHWCKP)XC6R76_#&OVWVK3-0_LW4+35M/>6,,DB36.IV-G?VD\,
MD<UO=6T,T4BN@-=[10!X1X]_9@_9Y^*7@3PS\,_B1\'/ /CCP1X+TNPT7P?H
M?BCP_9ZR/"VG:9ID6CV$/A[4;Y)M6T>6WTN&*R6[T^^M[QX$"R7#G)-#X,?L
MF?LT?L[W5YJ'P3^"'PZ^'&K:A;M97VN^'?#EE#XBNK%Y1.UA/XBN$N-<DT]I
M@LAL&U VF^.)O)S%'M^AJ* /!/CE^R[^S[^TM%X:A^._PH\*?$Y/!TFK2^%S
MXDM9Y9=#;7ETY-:&GSVMQ:SPQZF-'THWL/F&*=M.LGD0O;Q,OF'@?_@GC^P]
M\.=;LO$?A']EOX-V.NZ9>V>I:7JM_P"#[#Q%>:3J6GSI=6&I:3+XD75CI>HV
M-U%%=6=]8"WN[:YBBN(9DFC1U^RJ* .2\=^!?"7Q.\'>(OA_X\T.T\2^#?%F
MF3Z-XCT"_:=;+5]*NL"YL+O[--!,UM<*H2:-)4$L9:-]T;LIM>#_  AX9\ >
M%?#O@?P7HEAX;\)>$M&T[P]X;T#2X?(T_1]%TFUBLM.TZSBRQ2"UM88XH]S,
MY"[G=G+,>CHH \G^,OP*^$'[0WA*'P)\;/A[X;^)/A*VUFS\16FB>)K(W=M9
M:[I]O>V=GJ]C(CPW-EJ,-EJ6I6(NK2>&9K'4+ZR=FM;RXBD[KQ#X6\->+O#N
MJ^$/%GA[1?%'A37=-GT?6_#7B/3++7-!UG2;F+R+G3=6TG5(;JQU*QN(28Y[
M6\@FAF0E9$8$UO44 ?$%K_P35_8'L];_ +?A_9,^"3WWF>9Y%UX,L+[1-V%&
M/^$:OA<>'/+PH_=?V5Y62S;-SN6^??B-_P $P+;0OCI:?M'?L8?&;Q)^R7XZ
MU37="O\ XH> _"EE'=?!?XI:9IT][_:,.J^!;:2RT_2]5U*UU&YW2RVNO>&H
M+Y/[8T_PEIWB:\O_ !)/^L-% !7E?Q:^!OP<^/.@VWACXS_#'P1\3]"LKO\
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M+>0:K! \/Z/44 ,BBCACCAAC2&&%$BBBB18XXHXU")'&B *B(H"HB@*J@
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MM&(Y-XSGY'_X=L_L$_V]_P ))_PR7\#_ .T/-\[[/_P@^F?V#OQC'_"*[/\
MA%_*Q_RP_L?R,_-Y>[FOMRB@#X[_ &\= ^..J?L:_''PU^RVEU8?&"Y\$VNE
M^";;P]/'I&K1Z4-9T:'Q9I_A2XB,!T[Q#-X!7Q'8^%)+"2TO+76Y--.F7-G>
MI;3Q?G%\*?CW_P $Y/#'P \%_"+Q/^QG\1+7Q!X;\%Z3HNJ? SQG^Q#XS\8^
M.]5\0Z/;PW=[#?WMU\/]6\.^(-<U;7K>?6UUO6/$D$UYJ$O]L:G+IUZTJP_O
M#10!^5__  24^"_Q-^#_ ,"?B9<^._!FN_"?PO\ %+X]?$#XI?!GX(^);BY?
M7OA%\)_$_P#9K^&_"^L:7=,\GAC5"T%U<W?AIB+BR)2^U2*UUS4]5L[?R+X7
M?#E_V@?^"QGQQ_:%U#P#/I'@?]E#X5^'?@WX.\3ZAHNJ6,7CGXHZW#JT.L>)
MM.NK[3;.QU*;PKIFJ>/?!=Y)9W&I^19P>%-0CN8X[^U2']K:* "N!^*'PM^'
MWQI\"Z[\,_BIX4TKQOX"\3#3EU[POK<<LNF:F-(U>PU[3/M"0RPRYLM8TO3]
M1MV25&2YM(7!^7![ZB@#SWQ1\*?AWXU^&U[\'_%7A/2];^&>H^'[/PK>^#KQ
M9SI-SX>T^.VAL]*D6.:.X-K;QV=JB 3A\0IN<\YZ3PKX7\/^!_"_AOP7X2TF
MTT'PKX0T'1_"_AG0[!#'8:+X?\/Z?;Z3HVDV4;,[)::=IMI;6=LC,Q6&%%+$
MC)WJ* /,/A%\%_A9\!?!Z> /@[X)T7X?^#(M2O\ 6(_#N@1S0Z='J6J.DFH7
M:1SS3LDER\49=5<1C: B*.*\8\8_L&?L9?$'QW=?$SQK^S/\'O$WC:_NC>ZI
MK.K>#-+N5UJ^9"DE[KVEF(:-KU[*#F>[UC3[ZXG=4DFD>2.-E^MJ* /,_"?P
M:^%W@3QOX]^)'@_P3HGA[QQ\4(O"\'C[Q%ID$D%YXF@\%:6^B^%(;Y/--JD6
MA:5(]A81VL%ND=N=K!L CAOC/^R;^S3^T1=66H?&WX(_#KXCZMIMLMC8:[XB
M\.6<WB*SL$F-PNGV_B*W2WUR+3Q.SS"P34!9^9+,WDYFEW_0M% 'A'P;_9?_
M &=_V>FOY?@C\%_AU\,KS5K.#3]6U3PGX8TW3=;U:PM9!+;V6J:ZD+:QJ-K%
M,!<+!>WT\7VC_2"IF)D/4?"SX+_"SX):9KVC_"OP5H_@NQ\5>*-3\:^)UTM+
MB2Z\1>+=:6W35?$6MZC?3W>HZKJ]\EK;K<7M]=3S.L*+N &*]/HH \J\)_ [
MX2^!/B%X^^*W@[P'H/AKXA?%+^SS\0_$^D02V=YXODTO?]@N=:ABF%C=7EL9
M)F6]-JMVSW%R\DSO<W#2>J,H92K*&5@596 *LI&""#P01P0>".#2T4 ?(=C^
MP'^Q7IOCX?$^Q_9A^#5OXW354UZ'6$\%:48;77([N/4(M9LM&>)M"LM6AOXH
M[Z#4;33(;R"\!NHIDG9G;W?X=_"7X;_";P[J7A+X<>$-)\(^&]8UW7O$VI:/
MI*3)9W>N^)[AKO7]2D2::9A<:I<LTMSL98]Q.Q$'%>BT4 >;?";X/_#/X%>"
M=/\ AS\(_!VD^ _ ^EW.HWFG^&]$6X33K2ZU:\EU#49HEN9[B4/=WL\MQ+F4
M@R2,5 !Q4?A/X-?"_P #>._B+\3?"7@O2-"\>_%J;0I_B/XHLDN!J7BZ;PU:
MW-EH+ZJTL\D3'3+6[N8+;R(H0$F8.'."/3:* /FOXQ_L=?LM_M!Z]8>*OC/\
M"?AQ\0_%&FVT%C;>)->\/6SZ\VGVKRRVNF7>L6OV;4-1TNUDN+B2VTS4+BZL
M+=[BX>&W1IYB_7:#^SO\#O"OB3P)XN\+_"WP=X:U_P"&/A/4O OP_O/#VD0Z
M)#X1\(ZQ)YNJ:#HNG:9]ETRTL+Z7,MPBV9>24M(7WL6/LU% !7E_PN^"WPK^
M"MIXGL?A9X(T;P5;>-?%FJ>.O%BZ1'/YGB#Q?K26Z:IX@U2XNI[FXNM0O4M8
M!+(\NW]V-B*6;=ZA10!C>(_#NA>+_#VN^$_%.D:?X@\,^*-&U3P[XCT'5[2&
M^TG6]"UNQGTW5](U.QN%>"\T_4M/N;BRO;6='AN+::6&161V!X?P!\%/A/\
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M %%%% !1110 4444 %>8_&3_ ))OXC_[A'_I^TNO3J\Q^,G_ "3?Q'_W"/\
MT_:70!%\%_\ DG6A_P#775O_ $[WU>IUY9\%_P#DG6A_]==6_P#3O?5ZG0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  B4?C/3?"&DVO@'5;?Q7INBZ<([G1+^_P!1T&76+IFMKBWL$7SZ_53]IO\
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MY/C?\;OV$_#Z_"32H+/5?B/IOPH^/UIX_P#BO\+_  S,J/J?B#5_#4O@31M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KS'XR?\DW\1_\ <(_]/VEUZ=7F/QD_
MY)OXC_[A'_I^TN@"+X+_ /).M#_ZZZM_Z=[ZO4Z\L^"__).M#_ZZZM_Z=[ZO
M4Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Q7_X+C0PW/P&
M_98M[B*.>WG_ &\/@?#/!-&LL,T,O@WXM)+%+$X9)(Y$9DDC=2KJ2K @D5^A
M?[1?P*_9D\<_!?XB:3\<? GPV@^&MOX4U_4_$>O:SH>@:6OA*QLM)O)+GQ9I
M^OO#9S^'-4T*V\Z^LM=LK^PN]/EC\R*[BRQ.M^TM^RW\&_VMO VB_#SXVZ%J
MNN^&_#OC+2_'^B)HWB77O"FH:=XKT;3-;T;3]4@U/P]?Z?>%H-.\1:O ()99
M+;?<K<B(75M:SP_.=]_P2W_9/\0+:VGCJW^-7Q-T*UO[+5/^$3^)/[1OQQ\8
M>$KJ_P!-N$NK&?4?#NJ>.Y--U(6\J?\ 'O?0W%I+&\D-Q!+%(Z$ _/+]DCQ'
MXY\2_P#! GXOW'C:^U#5(M+^ _[4GASP7?ZI=75[=OX'\/V'C'2]'L%NKN>>
M5M/T"\M]4\-:+:JT=KI6BZ-IVCV,$-EI]O&N;^TEH/B'7_\ @WQ^',?AZQU#
M46TKX,_L[Z]K-KIL-S<S#P]I'BOPA=:K>SVUJDCR:?I$:IK.IS2K]FT^PT^X
MU6Z>*"PDFC_>7Q1\'?ASXL^$&N_ :\\,V&E_"G7_  #?_#&X\(>&8QX8TW3_
M  /J&B2>''T#0HM$%DNA6=KHTAL=/CTM;9=/A2);01") %\ ?"'P!\-OA/X;
M^"/AS0HI/AKX5\(V_@33?#FNR2>(+>;PK;V)TT:3JKZN;I]7MYK%FMKL:@;C
M[7$[I<>8';( _P"%'C?P7XY^$_@'Q]X)U?3-0\"^(/!'A_7M!U:RD@BTW^P[
MG1K6YMW.TK%8K:6Q\JZM9?*?3Y(9;:XCAD@D1/RM_P""420^+OBO_P %(/CI
MX,F8_!7XL_M7:E#\,Q:PHV@:]>>$Y?$TOC+XA^'=2BF>#5=-\=7/B?1KH7%K
M']EC;3?*6YFN5NK>S]UD_P""2W[$:Q^)=+TKP)X^\,>#/&6IWFK^*_AGX0^.
M/QF\*_#37;W4"GVPWG@S0_'-CI,=K*D-M!'864=K8V=G9V5A86UK8VEO;Q_?
MG@CP-X.^&OA30_ OP_\ #.B>#O!WAJR33M!\->'=.MM+T?2K)&9_(L[*TCCA
MC#RR23S/M,EQ<2RW$[R3RR2, ?DQ_P $>MMKI_[?>C321#4M,_X*#_'C[;:K
M(KR0+)!X:M8I&VDCRIKC3[V.*0$K(UM+M)V&O$/C+X \6ZU_P6FFTIOCUXZ_
M9TE^*7['-G9?"[QIX.MO!\^H>+[W0?&6DW&M?#33&\?>'?$>AS.XT/Q!XNO[
M#2[-=:B.F6,XEBM-0GCO/TEUG_@GG^RYK'QGU_X\P^%/%OAOQ_XQ\0Z'XK\<
M_P#"%?%'XD^#?"WCO7_#LT-SIFH>+_!OAOQ1IWAK6?\ 2H?MFHVLVFK9:S?7
M.I:AJ]M?7VKZM<WWJW[0O[*?[/\ ^U1H6E:!\=OAKHWC>/P]<R7GA?6FGU+0
M_%WA.[GN-/N[J;PKXS\.WND^*O#POKC2=+DU2WTK5[6TU<:=91:K;WL%M%&H
M!\=^/?\ @G+K7Q-O?AG<?&O]MO\ :%^(^A?#/XL>"?BKX8\/>)M-^"VF:8WC
MGPI=SQ:#(]QHOPXTF]DDN(]4O]*6V%RZSKJ3A('N1;M'Y-\4M3L/A]_P6]^
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MKP)XX\,W_A#Q!I6G75QI#S:!J-J;.YLK.[TYX+C3\VQ\J*2S>*2!0/*9"!@
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M%F@_'GXVZ'\,M1NKV87%T)?!^E>/;33X;>2=8I%M;3[/;VX@MX;6."W@BA4
M^$?V*+_P7=?LL_\ !7OXX>*]*\0>(/V:?BE\</VN?%>BZ9H,4ND3^-?A7_PC
M7B&7Q%?>"-3N);))%U_0]57P[9:M!)!9Z?J^C7$#7J76GWL=G7_8YUO_ (*&
MR_L.?"GX1_"CQK^Q;JNF>+?A;I5M\-OC)K?Q.\0KXZ^%?A+Q1I,5[-H/BCX:
MV'A'4M)U[XA?#&"^U;0=,:*__LFSO-(T:/Q5I&N2Z9KL>J_K!^U'I7BCX0_L
M5?&70_V8/ NGV?B3P9\'/$.E?"_P-X3\)Z=J=IIZ0Z8]HMMX?\%BRN=-UBYT
M_39;R]T[07TO4HM7OX(K2;2]6:Z>QNOQI_9TG_X(4Z3^ROX!B^(T?P1?Q5H'
M@#3D^)T?Q0T'6(?CBWCBWL8[SQQ;WFEQ6T_C.^U6+Q&^I6NG6?@PZIIJVT=O
MI?A6:ZTJ"S4@'[%_L^_LW:)^R1^QAH_P T'7)_%%OX$^''C/^T?$L]O]C/B#
MQ#XA&O\ B?Q)JUO8"XO!IVGWFNZSJ#Z5IOVR\?3],^QVDM[>S0R7<WXJ?"SP
MSXL\6_\ !N)XMTKP7/-;:Q:>&_B3XGO)(+RYL7;PGX*_:9U3QEX]@::T5I7A
MNO V@^([6XLW'V;4;>:73[UEL[F=A]U_\$BO!?C2'X&_M 6FL6'Q$T?]F[QE
M\<_'Y_91\*?$NY\1#Q+I'[/5Y;IIWAL:;%XFO+O7M(\,WND?88](LYI8HY=1
MM=:UZT2==:.IZA^D/P%_9_\ AA^S7\)M ^"7PHT6YTGX=^&GUY]+TC5=4U#Q
M#,G_  DNMZEX@U=;G4-8GN[R[CN=3U:^D$=Q*Z1PRBW11"BJ #\VOV2O@#\1
M/B]^S-\"_B#\-O\ @HS^T;;^#]=^%_@S^SM'T+1/V?+BP\*SZ=H5EIFJ>"B%
M^&VL/:WO@O5+.\\+:EI]QJFH7>G7^DW%E=WES<023/\ 5_[-/[&?PR_9S^&/
MQU^'>I^.-;^-&@?'3Q_X[\=_&"^^*">$Y(M9U;X@:#I^A>.=,U:T\/Z1HND1
MZ9K5C:O)J=A<6P3_ (F%U&J0VLB0KR<W_!+K]CRWUK7M7\'^$/'OPJMO%-\N
MH^)/"_P<^,_Q:^%?@C6+I85M2TG@WP1XQT;P]81/:+]E-MHUAIMLD+R"&*)Y
M'<_0'@G]DW]GGX=_ C5/V9O"'PSTK2O@AKFEZ]H^M^!VU'7K^'6++Q/&\>OM
MJ>MZCJUWXDO+W4DD(EU*;6&U"';#]ENH/L]OY0!^2WQQ^%7[0W_!)7X3^(/C
M=^R]\?W\?_LN>!=?T:[\0?LG?M"11:U'X?T;QCXNT_1[N#X0_%&WFM=?TPVM
M_JVG6^B^#IH+2RABN=?\3ZE<^-_%$PTS5_W0\'>(X_&'A'PKXMALKG3HO%'A
MS0_$46GWFW[781ZWIEKJ:65UM 7[3:K<B"?: OFHV!BO@W2/^"5?[%NG7'A:
M/4_ 7C'QQX9\$7$-UX/^'/Q*^+WQ5^(OPP\/2VMG+I]H+/X>^,/%^K^%Y[>T
ML9YK6WLM2TZ^LD@D:,V[*%V_HHJA5"JH55 554 *J@8  '  '  X X% 'XH?
M\%,)/^%#_M9_\$_/VX==TZ>;X4_"KQOXP^%/Q=UVU@N[I_!^D?%+2&T/P]XG
MU&"V@G":'I:ZIXKNKVY/ER&]ATS2K9+N_P!8L;>OV?TO6-)US2K'7=%U33]7
MT34[.'4=-U?3+RWOM,O]/N(A-;WUG?VTDMK<VDT+++%<0RO#)&0ZN5.:H>*_
M"?A?QWX;UKP=XU\/:+XL\)^(]/N-*U_PWXBTVTUC1-9TVZ79<6.I:9?Q3VEY
M;2K]Z*>)UR%8 ,JD?GU#_P $FOV*[32M1\*Z?X2^*.E?#S5Y[R?5/A;I'[0G
MQVTKX;WQU&;[1?13^%M/^(5O:_9[J8*\L".D1\N,!56-0 #YF_X+0>)]!\??
ML5>$/B-X)US2OB#\+OA?^UA\--6^,2^%-4L/$&D:KX5\,W_BWP1XE\+7T5O<
MOH>NRV?C[6?#FEW^A:M=1V$.M6R)>O#>V"*O[)Z;XY\%ZMX)LOB/I7BGP_>_
M#Z_\-0^,+'QG:ZK92>&+CPG/IRZM#XBAUE9O[/.BOI;"_&H>>+46G[\R",$C
MFM!^"?P?\,?"X_!'P_\ #+P-I/P@?1M3\/S?#6S\,Z3%X+NM'UM[J76[&^\/
M_93IU_'K<]]>W6M/>03S:M>WMY>ZC)<W=U/-)\2Q_P#!)+]B&+3I_#,7@;XA
M1_#NYU8:W<_">/XZ_&I/A;<:BM_#JBRS^"E\=C2Y474K>"]$$BM")H(<)Y<:
M1J ?-?\ P2H@?6?V</VX_BUHUK<VGPR^-O[47[2?Q"^$AGM'L8=5\$7&GV^F
M6VN6=I.(KJU@EO+&ZT-[6\M+2YMKKP]<PR0C:,>M_P#!$157_@FS\"2JJI?5
M_B\SD  NP^,/CI S$?>8(BKDY.U57HH _3G3?!'A/0_!EK\//#^@:7X<\%:?
MX>'A32_#7AZRM]%TC2/#T=@=,@TK2;'3XX+;3;.UL2+>UAM(XH[=%41JNT5P
MGP!^ GPT_9E^%7ASX,?"'2;W0_ /A6;6Y]&TW4-7U'7;N"7Q#KNH^(]4,NIZ
MK<7-]<";5=5O9D$TS"&.188PL4:* #\F_P!L7QEX5\!?\%B_^";OB3QIX@TK
MPOH"?#SXT:))K.M7<5AIL6J^+/"/Q#\)^'+.:[G9889-7\1ZWI.CVC2ND;7E
M_;H[HK%AZ;_P7"\2Z#:?L!^-_ D\@O/&OQ9\<?"GPA\,O#EG'-?:[XE\46GQ
M&\,^*+FST/2[..>\O[A?#^A:LI6&%E,MQ:VJL;R]LH+CRO\ ;2\">#?B=_P5
MW_X)]^ /B#X:TCQAX+\5?!;]H[2O$/AK7K.*_P!*U6PE^&/Q5<P75M,"I,<L
M<5Q;S(4N+2ZA@N[66&Y@BE3[I^&G_!.+]DWX6_$+PM\4-'\$>)O$OC'P%;&R
M^'=]\2_B?\2?BA9_#RU^41Q>#-(\>>*=>TO17M0D7V"[CM)+[36B233[JUE+
MNX!\/_MZK!\,?VLO^"0GQ(^)*16/PW\$>./'?P]\3^);]4N= \-^/?&7A3P'
MIG@\ZG//_H]@+O5M'N=2BUB79%86OAN^U>YGMHM+64?J/^U1\0_A[\+_ -FW
MXV>.OB??Z5:^!-+^&?BV/64U2:T2UUI-6T6[TFP\-6T=W(D&H:EXKU"_M/#V
MC:6I:75]3U.STZWCEFNHT;M/B]\'/AA\?/A_KWPM^,/@O1_'O@/Q+ (-6\/Z
MRDXC9D):WOM/O[*>TU71=8L)#Y^F:YHM]I^LZ5=*EUIM_:W*)*OQMH?_  2K
M_8NTJ;PO%JO@/QCX^\-^"+J&\\'?#[XG_%WXI_$7X9>');6VGLK-++X=^+?%
MNJ>$;FUL["XEL;>RU72=0LUM6\MH'/S4 ?G9X-\$^)/ 7_!N[J>C^*(3:W^J
M? _QGXVL;4E6$7AOXA_%O5O'?A6974D,-3\-^(M+UC!"M$=1,# F(LW[ _L+
MJ%_8E_8\"J%'_#+7[/S8  &YOA/X29C@=V8EF/4L23R37KGQ=^$G@?XX_#'Q
M?\'_ (AZ;/J/@3QQHYT'Q#IEA?W>CSW&F&:"?R+>_P!.EM[NR(DMH=LEK+&Z
MJNU2 2*W/A]X&\.?##P%X(^&G@ZSET_PA\//"'AKP-X5L)[NYOY['PWX2T:R
MT#0[.:^O99KR]EMM,T^UADN[N:6YN70S3RR2N[$ _(SP-\5/VH_VX?VJ?VKO
MAOX,_:(N?V5O@W^RE\0?^%7KX4\"> O!.N?&7XBZDQU33I/&?B'7?B!;>*+?
MP]X7NM8\+ZMJ/@V]T'0[.VU[P]J<5A=V;ZCID^KR^&?L=:--X;_X+7?M&^&[
MWXY^(/VA-5\/_L<2:3K7CSQ0?"AURUU:W^('P,:[\*WR^"])T3P_%/X>,B6T
MMO;Z=!<VLLDEMJ.Z_BN&K]//BQ_P3U_9<^,/Q6OOCAX@\(^*?#7Q6UK2+;0/
M$WC7X8_$SXB?"W5O%FC6JV\45CXF;P'XET&#5B;>SL;2>^GA&IW=EIVE6=W?
M3VVD:7%9[7P/_8._96_9M^(J?%'X'_"O3_AWXJ7X71?!^231-2U@V-[X.36]
M)\02R:O9WM]=+KGBB]U/0M)EU+QGK;ZAXIU*.RBAOM5G3<& /BVUVV'_  77
MU'[7)%"=:_X)\)_9BM(N^[:+XM6/F1QKG)E5-)U"8QD!O)MI)<;,&LS_ (+@
M?\D,_92_[/T^!G_J'_%FOO?]H']BO]GW]ICQ3X)\>_$WPUK\7Q"^'5GJ>F^#
M?B#X%\<^,OASXTT;2]8R=0TM=?\ !6MZ)=WEA(9+DV\&H&[_ +-_M#5UTQK)
M=;UA;ZQ\0_V-?@+\4OA7\*_@SXS\.Z[JO@3X,^+_  IX[\!VLGC/Q6^L6?BG
MP98:SINBZKJWB2?5I]>\1S_9]?U9M0_MW4-0_M*YNVNKWSITCD0 _/[_ (*1
MWVG>!OVW?^"5?Q<\=JEE\*?#7Q9^*O@W6_$VH1I+H/ASQEX_T;P9:>!VU22?
M_1]--WJ&ES:G'JTFR+3;;PW?:K<SVT6E+,/TF_:H^(?P]^%_[-OQL\=?$^_T
MJU\":7\,_%L>LIJDUHEKK2:MHMWI-AX:MH[N1(-0U+Q7J%_:>'M&TM2TNKZG
MJ=GIUO'+-=1HW:?%[X.?##X^?#_7OA;\8?!>C^/? ?B6 0:MX?UE)Q&S(2UO
M?:??V4]IJNBZQ82'S],US1;[3]9TJZ5+K3;^UN425?C;0_\ @E7^Q=I4WA>+
M5? ?C'Q]X;\$74-YX.^'WQ/^+OQ3^(OPR\.2VMM/96:67P[\6^+=4\(W-K9V
M%Q+8V]EJNDZA9K:MY;0.?FH _.SP;X)\2> O^#=W4]'\40FUO]4^!_C/QM8V
MI*L(O#?Q#^+>K>._"LRNI(8:GX;\1:7K&"%:(ZB8&!,19OV"_89_Y,F_8\_[
M-9_9]_\ 52^$:];^+OPD\#_''X8^+_@_\0]-GU'P)XXT<Z#XATRPO[O1Y[C3
M#-!/Y%O?Z=+;W=D1);0[9+66-U5=JD D5N?#[P-X<^&'@+P1\-/!UG+I_A#X
M>>$/#7@;PK83W=S?SV/AOPEHUEH&AV<U]>RS7E[+;:9I]K#)=W<TMS<NAFGE
MDE=V(!^1?_!!%F/_  3[T($DA/BO\3%4$DA5-]IS;5!^Z-S,V!@;F8]2:_:.
MO"/V<_V;?A-^RG\-H/A-\%M$O_#_ ((M]:U;Q!#INHZYJOB&XCU+6Y(I-0D_
MM'6;J\OFCD:"/9$\[)$ 0@&37N] !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>8_&3_DF_B/_N$?^G[2Z].KS'XR?\DW\1_]
MPC_T_:70!%\%_P#DG6A_]==6_P#3O?5ZG7EGP7_Y)UH?_775O_3O?5ZG0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>8_&3_DF_B/_ +A'_I^T
MNO3J\Q^,G_)-_$?_ '"/_3]I= $7P7_Y)UH?_775O_3O?5ZG7EGP7_Y)UH?_
M %UU;_T[WU>IT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F/Q
MD_Y)OXC_ .X1_P"G[2Z].KS'XR?\DW\1_P#<(_\ 3]I= $7P7_Y)UH?_ %UU
M;_T[WU>IUY9\%_\ DG6A_P#775O_ $[WU>IT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7F/QD_P"2;^(_^X1_Z?M+KTZO,?C)_P DW\1_]PC_
M -/VET 1?!?_ ))UH?\ UUU;_P!.]]7J=>6?!?\ Y)UH?_775O\ T[WU>IT
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M^)-%U&\2]M8KCQ%X0UO3]'U[08]9O='UA]*FN])MM/U6.RNI]&GO+*(34_\
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M\.,[+8P^&QI9TO;HRV!H ^F_VBO^"A'['G[*>N6WA7XX?&O0O#'BZZBCN/\
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MTS_P$3_Y44?\(G\:/^B@Z9_X")_\J* /<Z*\,_X1/XT?]%!TS_P$3_Y44?\
M")_&C_HH.F?^ B?_ "HH ]SHKPS_ (1/XT?]%!TS_P !$_\ E11_PB?QH_Z*
M#IG_ (")_P#*B@#W.BO#/^$3^-'_ $4'3/\ P$3_ .5%'_")_&C_ **#IG_@
M(G_RHH ]SHKPS_A$_C1_T4'3/_ 1/_E11_PB?QH_Z*#IG_@(G_RHH ]SHKPS
M_A$_C1_T4'3/_ 1/_E11_P (G\:/^B@Z9_X")_\ *B@#W.BO#/\ A$_C1_T4
M'3/_  $3_P"5%'_")_&C_HH.F?\ @(G_ ,J* /<Z*\,_X1/XT?\ 10=,_P#
M1/\ Y44?\(G\:/\ HH.F?^ B?_*B@#W.BO#/^$3^-'_10=,_\!$_^5%'_")_
M&C_HH.F?^ B?_*B@#W.BO#/^$3^-'_10=,_\!$_^5%'_  B?QH_Z*#IG_@(G
M_P J* /<Z*\,_P"$3^-'_10=,_\  1/_ )44?\(G\:/^B@Z9_P" B?\ RHH
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MH ]SHKPS_A$_C1_T4'3/_ 1/_E11_P (G\:/^B@Z9_X")_\ *B@#W.BO#/\
MA$_C1_T4'3/_  $3_P"5%'_")_&C_HH.F?\ @(G_ ,J* /<Z*\,_X1/XT?\
M10=,_P# 1/\ Y44?\(G\:/\ HH.F?^ B?_*B@#W.BO#/^$3^-'_10=,_\!$_
M^5%'_")_&C_HH.F?^ B?_*B@#W.BO#/^$3^-'_10=,_\!$_^5%'_  B?QH_Z
M*#IG_@(G_P J* /<Z*\,_P"$3^-'_10=,_\  1/_ )44?\(G\:/^B@Z9_P"
MB?\ RHH ]SHKPS_A$_C1_P!%!TS_ ,!$_P#E11_PB?QH_P"B@Z9_X")_\J*
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M%!TS_P !$_\ E11_PB?QH_Z*#IG_ (")_P#*B@#W.BO#/^$3^-'_ $4'3/\
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M^B@Z9_X")_\ *B@#W.BO#/\ A$_C1_T4'3/_  $3_P"5%'_")_&C_HH.F?\
M@(G_ ,J* /<Z*\,_X1/XT?\ 10=,_P# 1/\ Y44?\(G\:/\ HH.F?^ B?_*B
M@#W.BO#/^$3^-'_10=,_\!$_^5%'_")_&C_HH.F?^ B?_*B@#W.BO#/^$3^-
M'_10=,_\!$_^5%'_  B?QH_Z*#IG_@(G_P J* /<Z*\,_P"$3^-'_10=,_\
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M  $3_P"5%'_")_&C_HH.F?\ @(G_ ,J* /<Z*\,_X1/XT?\ 10=,_P# 1/\
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M2'\2P::VC0^(6TVS;7(='>X-V^E1:L83?QZ:]TS7+6*7 M6N"9C$9"6K7HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *\Q^,G_)-_$?_<(_]/VEUZ=7
MF/QD_P"2;^(_^X1_Z?M+H B^"_\ R3K0_P#KKJW_ *=[ZO4Z\L^"_P#R3K0_
M^NNK?^G>^KU.@ KQ?]H7X^?#W]F'X/\ B_XX_%6YU2S\!^"!H7]N3Z+IDNL:
MHK>(_$VC>$M+2TTV%XY+EI=9U[3XY<.HA@:6X<B.%S77_$_Q_HGPH^&OQ#^*
M7B7S_P#A'/AKX&\6^/\ Q!]FBDFN?[$\':!J'B+5?L\,4<LLL_V#3I_*CCBD
MD>3:J1NQ"G^<GP;\$OV[_P#@L?\  W6?BO\ $?\ :I\,? []G3XG^*-5'@GX
M$>%OA]#XMLH-*\">+&TZV3Q#?17O@W5[V2R\3>');V&[U?Q#KT]]?VO]I0V6
MAV$UAI-D ?TQ:;?PZIIUAJ=NDR6^HV5K?0)<1-!<)#=P1W$2SPM\T,RI(HEB
M;YHW#(>15VOA;]C#X3?MH?!P_$#PI^U)\?\ P?\ M#>#HX/"1^$/BG3O#2^&
M/&VF>1%K5OXLTOQ796NC6=K/9%4\.SZ/=3ZYXFU.25M3^T7UM"(+:O,_VH/A
MW_P4;^-_QBO? GP&^,G@K]EC]G30_#>C2W/Q0BT"Q\:_%/Q[XIU2"\EU>PTC
M29Y)#H^B:!_H5J9UO_!>I?:]]W:ZGK]O<&TTH _36BOYR$^-?[?'_!.W]LO]
MFSX+_M'_ !ZMOVJ?@)^T]XGM_!&@Z]J'A?3](\6:7J]]K>A>&KF_M6\U=5T?
M4?#7B#QAX6O+^TO?$?BO0M6\*7MW#8VEIKGV>32OU"_X*._MD/\ L2?LVZK\
M3="T>R\2_$OQ/X@TKX=_"7PUJ,.H7&G:IXY\017MU%=:I!I:&]GTW0=$TO6-
M=FLHY[#^VKK3[+PW'JNF7>MVM[$ ?>M%?@/I?[)7_!9CQ/\ #Z#XN:Y^W];^
M#/C7?:-<^(H/@1!X&\,3^"](U&XCGO=/\&ZIXCTZWD\*#4H8IX].U&2#P3XA
MT2PU-3!:ZWKMA:6^MS?9G_!,7]M#QA^UQ\!?%.J?&;2--\+?&KX+>.]>^&WQ
M;L[&Q;1-,DOM(C6^L->72YKZ_;2))=/DETS7;9KE+=?$>@Z[=6%IIVE3V-A;
M 'Z645_.I\-_BI_P4%_X*G_$#XK^-_V>?CY:_LA_L>^ ?%NJ^!?AYXHTCPE;
M>(/&?Q*U/2Y+.ZCU.YM+\Z+XC$USI,^GZWK9DU?PSHOAR/7M*\*:;IWBW5;'
MQ5JUIZ/\!OV@?VT?V2?VXOA_^Q5^V1\2=)^/OPY^.N@:I=_!?XUIX;MM"\0Q
MZ]IMD\MKI>ISVC6F^%KG2+_1=:T;5(O$NLQ:OXA\*ZO9^*$TF:[LY@#]Y***
M* "BBB@ HKB?&GCW1_ L5A-J]MJ5PNHR7$4 TZ&UF96MUB9S*+F\M H(E79L
M+DD-D+@9X#_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6
ME?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_
M ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+
MJC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_
MX:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@
M_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9
M_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\
M0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/
M$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_
M . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@
M%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5
M_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\
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M_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\
M0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/
M$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_
M . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@
M%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5
M_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\
MRZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ
M/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_A
MH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\
M&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_
M $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P!
MSQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3
M_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\
MX!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6
ME?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_
M ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+
MJ@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH
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M $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P!
MSQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3
M_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\
MX!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6
ME?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_
M ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+
MJC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_
MX:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@
M_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9
M_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\
M0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/
M$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_
M . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@
M%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5
M_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\
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M_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\
M0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/
M$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_
M . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@
M%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5
M_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\
MRZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ
M/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_A
MH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\
M&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_
M $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P!
MSQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3
M_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\
MX!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6
ME?\ RZH ]UHKPK_AH/P9_P! SQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_
M ,NJ /=:*\*_X:#\&?\ 0,\3_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+
MJ@#W6BO"O^&@_!G_ $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH
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M $#/$_\ X!:5_P#+JC_AH/P9_P! SQ/_ . 6E?\ RZH ]UHKPK_AH/P9_P!
MSQ/_ . 6E?\ RZH_X:#\&?\ 0,\3_P#@%I7_ ,NJ /=:*\*_X:#\&?\ 0,\3
M_P#@%I7_ ,NJ/^&@_!G_ $#/$_\ X!:5_P#+J@#W6BO"O^&@_!G_ $#/$_\
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M6.L^']"U?1KO4;&*>RGMKFWOY_T>=UC1I)&5$16=W<A41%!9F9F("JH!+,2
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M6W_?B+_XBK-% %;['9_\^EM_WXB_^(H^QV?_ #Z6W_?B+_XBK-% %;['9_\
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M*/L=G_SZ6W_?B+_XBK-% %;['9_\^EM_WXB_^(H^QV?_ #Z6W_?B+_XBK-%
M%;['9_\ /I;?]^(O_B*/L=G_ ,^EM_WXB_\ B*LT4 5OL=G_ ,^EM_WXB_\
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M^(H^QV?_ #Z6W_?B+_XBK-% %;['9_\ /I;?]^(O_B*/L=G_ ,^EM_WXB_\
MB*LT4 5OL=G_ ,^EM_WXB_\ B*/L=G_SZ6W_ 'XB_P#B*LT4 5OL=G_SZ6W_
M 'XB_P#B*/L=G_SZ6W_?B+_XBK-% %;['9_\^EM_WXB_^(H^QV?_ #Z6W_?B
M+_XBK-% %;['9_\ /I;?]^(O_B*/L=G_ ,^EM_WXB_\ B*LT4 5OL=G_ ,^E
MM_WXB_\ B*/L=G_SZ6W_ 'XB_P#B*LT4 5OL=G_SZ6W_ 'XB_P#B*/L=G_SZ
M6W_?B+_XBK-% %;['9_\^EM_WXB_^(H^QV?_ #Z6W_?B+_XBK-% %;['9_\
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M ![K1\K=I?@_PYJ_B.^C69BD<D]OI%I=R6\+,K_OYUCA4([,X5&(_KY^#O\
MP2#_ &+_ (5?9KS6?!NL_%_7;<E_[3^*.LMJ=AYCXW*OA71(-"\+3VX^[%%J
MVDZK+&OWKF23]X?T@\+>$/"?@?1[3P[X*\+^'O"&@6$4<%EH?A?1=-T#2+.&
M%%BBBM=-TJVM+."..-5CC2*%51%"J  !73AN <QQ4_;YMF482D[S4'4Q=>7=
M3K57",9;ZKVR];Z>/G/TKN$,BP_]F\ \'5J]"BG"A/%1PN0952M9*>'P&!AB
M:]6ERJ*4)K+Y]^512E_(Y\'O^",7[87Q'-I>^-+#PE\&-$EE'G2^--<BU3Q$
M;3:#]HLO#7A,:T3,7.P6>N:IX>F^21G,:^5YWZK?!W_@AQ^S9X-^R7_Q:\7^
M./C'JD4:"YTV.=/ '@Z:;<'=QINA3W7BD[2!''_Q6:Q-&9#+;LSIY/[7T5]9
M@>#<AP5F\*\947V\;/VR>V]%*&':NNM)NVEV?@7$WTCO%3B3VE.&>4^'L).Z
M^J\.8=9?)+6S685)XG-8R2=G[/'TXO?D3M;D_"/@3P9X!\-:-X-\%^%]#\,^
M%O#UE'IVBZ%H^G6UGIVG6<99A#;P1QA1ND>2::1MTL\\DMQ.\DTLDC=']CL_
M^?2V_P"_$7_Q%6:*^IC%1BHQBHQBE&,8I*,8I6226B26B2T2T1^&U:M6M4J5
MJU2=:M6G.K5JU92J5*M2I)SG4J3DW*<YR;E.<FY2DVVVW<K?8[/_ )]+;_OQ
M%_\ $4?8[/\ Y]+;_OQ%_P#$59HID%;['9_\^EM_WXB_^(H^QV?_ #Z6W_?B
M+_XBK-% %;['9_\ /I;?]^(O_B*/L=G_ ,^EM_WXB_\ B*LT4 (
M!@ #@  <  =!2T44 %%%% !7F/QD_P"2;^(_^X1_Z?M+KTZO,?C)_P DW\1_
M]PC_ -/VET 1?!?_ ))UH?\ UUU;_P!.]]7J=>6?!?\ Y)UH?_775O\ T[WU
M>IT %?(7B+]EN?Q+^VSX"_:VU#QG8S:/\/O@5K?PET3X:S>$K>6ZM_$FO>*[
MS7;_ ,>0^,_[36X4R:5-:Z''H4NC31VAM);^SU&"34+R%_KVB@ JA/I6EW4I
MFN=-L+B9@ TL]G;S2L% 509)(V8A5  R>  !Q5^B@#*_L+1/^@-I7_@NM/\
MXS6K110!7%G:"Y-X+6W%V5V&Z$$?VDI@+M,^WS2NT!=I;& !C JQ110!!<6M
MM>1^5=VT%U$&#B.XACGCW@$!MDJLNX D!L9 )P>34RJ%4*JA54!550 JJ!@
M <  < #@#@4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%?.?QC_:Y_9K^ ,5Q_PMGXR>"?"NH6T;R-X<_M,:UXOD
M5&*$P^#] CU3Q/,ID!C\Q-*,2R J\B[6(_)SXS?\%WOA;H37.F_ OX3>)_']
MW'*T*>(_'-];^"O#Q7RV9;VQTNQ77O$&IP^;Y:?9M13PO<%?-<NFQ!+Y..SS
M*<MNL9CZ%*:WI1E[6O\ ^":2G55^[@EY[GWO"_A?Q_QE[.7#W"V:XW#5/AQ]
M6@L#EC6E[9ECY8; R:3NX0KRJ6VB[H_>^O)/BE\>_@K\$K$:A\6OBEX'^'\,
MB,]M!XE\0Z=I^I7X56<KI>CO,=6U678CL(=-LKJ8JK$(0#7\@7QD_P""JW[:
MOQD2YLY?B?\ \*TT.ZC:*30OA%8-X+C =@7*>(OM>I^.!N4"-HSXK:$Q[E\K
M][*9/SUU/5-3UK4+O5M9U&^U;5;^9[F^U+4[NXO]0O;B3EY[N\NI);BYF<_?
MEFD=V[L:^-QWB)AH7CEV!JUWLJN*DJ-/U5*G[2<UY.=)G]'<+_1!SG$>SK\7
M\3X++:>DI8#(Z%3,<5*+^Q/&XN.$PV'J+6[IX;'T]DF[W7]5?QE_X+E?LY^#
MUNK#X.^#?&OQBU5(=UKJMW#_ ,*]\&R2NSHJF\URUNO%SO!M$TL+^#;6*5'B
MBBOED:9K;\G/C/\ \%B_VQ_BDUU9>%O$.@?!CP_.TJ)8_#O1XSK;VK@K&EWX
ML\1-K.L1W<8.3>^'SX<WO\RP1KA!\\?!K_@GO^V!\=&M;CP9\$_%6G:%<R1C
M_A*O'$"> _#JV\BJ_P!NMKOQ2VFW.LVBJPW/X>L]8E)RD<+NKJOZR_!O_@@M
M(Z6U_P#M ?&XPEHU-SX8^$6F*\D<C,2P3QKXPL6B)1 %9!X&=3(S%;@I&IF\
MCZUQQG_\"&(PN'GUHQ_LZARO=QKU)1KU8]&HU:MU=6>I^@?V%]&+PG=\QQ&4
MYWF^'T<,QKRXMS/VD5[L:F68.G5RS!5KISC4K8#!\K:E[1+DM_/?XK\9>,/'
MFL2^(?''BKQ)XSU^=%BGUSQ7KFJ>(M8FB1Y)$CEU/5[J\O9$6265U1YRJO+(
MP 9V)YNO[A/AS_P32_8C^&FEOING? /P?XIEG*-=ZK\1H)OB#JEQ(B(GF))X
MIEU&TTT,$!>#1;/3+1G+O]GW.Y;N+W]@W]C&_P#+,_[,?P73RM^W[%X%T33<
M[]N?,&GVUJ)L;1L,N_R\MLV[WW6O#S-*BYZN88/VLM9K_:*FKWO4=.+D^[Y=
M_O,)?2ZX'PL_JV X3XA> HI4\/)+*L)^[C%)*.$IXJI3HP3NHP59VC9VBVX+
M^$.M_1_%GBGP['-#X?\ $NOZ%#<NLMQ%H^L:CID<\B*5229+*Y@65T4E5=PS
M*I(! K^X_P#X=^_L4_\ 1LWPE_\ "8MO_BJ/^'?O[%/_ $;-\)?_  F+;_XJ
MB/AYF<7S1S'!Q:V<5B$_O4+F=3Z7G!=:#IUN$.(*M-V;A4EE52#L[J\98EQ=
MFDU=:/4_B)_X6=\2?^BA>./_  K->_\ D^C_ (6=\2?^BA>./_"LU[_Y/K^W
M;_AW[^Q3_P!&S?"7_P )BV_^*K+O_P#@G+^P]J,B2W'[-GPYC:-/+46%GJ.E
MQE=Q;+Q:9J-I%(^2?WDB-)MPN[: !;X!SCIFN&;\YXI?^V/\C"/TKO#UOW^!
MLYC'JXT,CF_+W7B8)_\ @2MYG\3O_"SOB3_T4+QQ_P"%9KW_ ,GUK6/QL^,V
MF0FWTWXM_$[3[=I&E:"Q\>^*K2$RL%5I#%;ZK&AD9416<KN(503A1C^S[_AV
MK^PO_P!&X>!__ CQ'_\ +RC_ (=J_L+_ /1N'@?_ ,"/$?\ \O*%P%G:U6:8
M9/RJXM?^XBY_2J\,ZBY9\$9Y.-[\L\!D$E=;.SQ[5S^,W_A?OQV_Z+5\6O\
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M0WE])WP:FK2X*XBDKWM+ASA5J_>SS]ZG\D/_  U)^TU_T<7\=O\ P[OQ _\
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M=7F/QD_Y)OXC_P"X1_Z?M+H B^"__).M#_ZZZM_Z=[ZO4Z\L^"__ "3K0_\
MKKJW_IWOJ]3H \R^-?A#Q#\0?@U\6_ 7A'7/^$8\5^-_AEX]\(>&/$NQI/\
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MLK7^CZK8B-I=.GD?Q[_@IA/I_P 9_P#@IE_P2S^ 7A&^MKWQS\.OB)J?Q?\
M&FGEKB-=*\%MXH^'WC65GNX[6XMQJLWAGX(^-;VUT[)N$"Z5/?K96&JV5Y*
M?T#4444 %%%% '"^-_!DWC&'3XHM>OM"-A)<2%[%68W'GK$H63;<6^!'Y65R
M6Y<\#OYY_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_
M  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.
MO_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\
MY95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@
M7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@
MZ_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^
M65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S
M_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^
MI?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM
M% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O
M/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#W
MZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\
M"D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z_
M_P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#E
ME7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?
M\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K
M_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y9
M4?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^
MB@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE
M_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4
M >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_
MZ*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J
M7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *
M1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__
M 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65
M>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_P
MI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_
M /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1
M_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*
M#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_
M .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!
MX%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_H
MH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?
M_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&
M\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\
M?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[
M[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D
M;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\
M]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_
M  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.
MO_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\
MY95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@
M7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@
MZ_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^
M65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S
M_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^
MI?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM
M% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O
M/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#W
MZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\
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M\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\
M?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[
M[10!X%_PI&\_Z*#K_P#WZE_^65'_  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D
M;S_HH.O_ /?J7_Y94?\ "D;S_HH.O_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\
M]^I?_EE1_P *1O/^B@Z__P!^I?\ Y95[[10!X%_PI&\_Z*#K_P#WZE_^65'_
M  I&\_Z*#K__ 'ZE_P#EE7OM% '@7_"D;S_HH.O_ /?J7_Y94?\ "D;S_HH.
MO_\ ?J7_ .65>^T4 >!?\*1O/^B@Z_\ ]^I?_EE1_P *1O/^B@Z__P!^I?\
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MFX.H:YJUTL2:CK-S96>GV=G^@U% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%(2 "20  22>  .223P !U- "T5
MP^L_$[X;>'!N\0_$+P/H2Y1<ZSXLT'2QF17=!F^OX!ETCD9!U94=AD*2/#M5
M_;D_8WT<9N_VH/@9-RH_XE7Q*\*ZZ<NK,.-$U+4#@!#N.,(Q57*LZ!L*F*PU
M'^-B*%+_ *^5J<-M_BDNZ/5P>19WF*;R_)LUQR5KO!Y?B\4ES7Y;NA1G\5G;
MO9V/JFBOSLU__@J]^P/X>F-M-\>;;5+@+&_EZ!X%^)6M0[) Q##4+#P?+I99
M=N)(1?&XC++OB .1XQXC_P""VW[%FB1E],3XO>,'W1*(?#O@2QM7(D#EGW>+
M?$OA>()"559?WF\F1/)28!RG!4S[)*5^?-LO36ZCBJ,Y*W3EA.4K^5KGU6#\
M*O$O'N'U;@+BUJI;DJ5LAS'"TI)[25;%8>C2Y7_-S\O6Y^O5%?@]K/\ P7K^
M!T"G_A'_ ('?%?4VRF!K.I^$-"4@AO,RUEJ7B(@JP0( IWAF+&,J%?P[5?\
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MO_"C]GOXX_'*_CT_X1_"KQQX]9[AK62^T#0+Z?0K&98S(RZMXDEBA\/Z,H4
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MQSFW>0Q&:-5279O4!6 K0H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO#9)4A]%\ M.R[492%_X2+6]>3#LPD;<K$.BA"D9>-_#M5_X*E_M[ZR"+O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS'XR?\ )-_$
M?_<(_P#3]I=>G5YC\9/^2;^(_P#N$?\ I^TN@"+X+_\ ).M#_P"NNK?^G>^K
MU.O+/@O_ ,DZT/\ ZZZM_P"G>^KU.@#S?XR>.KOX7_"'XJ_$NPT6\\27WP\^
M&_CGQS9>'=.ADN=0U^[\)>&-4U^WT6QMXB)9[S59M/2QM88R))9YT1"&85_.
M-^R7_P $_M/_ ."JGP1L/VL?VPOVH/CYXN\4^._&/C<Z9X(\">)?"^B>$?AQ
M;Z#X@O/#D>BZ?HGB7PUXZT_3&N(M.;5;>UT73O#4$.D:KIL<EI=SK/JNI_T^
MS0Q7$,MO<11SP3QO#/!,BRPS0RJ4DBEC<,DD<B,R.CJ5=258$$BOQ#\2?\$J
M/B_\ /%_B?XE_P#!-?\ :CU_]GV;Q!<WFL:G\!_'5NWBWX+ZQJDKZ?)#;6JW
M-OJ\>BVBI8O:17>L>$O&>N65I=&QTK7-)TU6M' /L[]BK]AZ3]BJ3QYH7A_]
MH+XP_%CX8^(](\#Z=X+\ _%;51K4?PPG\)R>*EU.7PM=V<]CH=GI_B.RUS1;
M2?2]'\):!]G_ .$:MI+N\U>.2PM]&9^U'X7_ &V?BY\1O#OP<^ _BCPS\ O@
M'?\ A*UUCXM_M&I-%K?Q>FO]0UC7;&X^''P>\,%C:Z#K-KI.CZ==ZOXVUR.&
M.WMO&=G>^&-2MM9\)W>E:]X+^PI^WK\:OB?\=OB;^QC^U_\ "W0?AK^TK\*?
M#_\ PDZ:OX.N;R3PA\0O#L=[91SZC8:=<OJ4>E2+I>N^%]8TZ^M/$6IV/B:T
MU+4KB+3?#$FD/I<WZWT ?AI_P0^T(^%?"O[;GA7^V=<\1#PU^V;\0]"&O>)K
M\ZIXCUPZ1INE:<=9\0:EY<(U#7-4%JM[J]_Y,/VR^EFG,:;PB_?_ .W[^U.O
M[''[*_Q+^-]G966J>*M+M++P]\/])U%6DT_4/'GBB[32?#S:C;QW=C/>:3I$
MDTWB+6[*UO;2\O-%T;4+:SN8+F6*9/A__@C5_P Y ?\ L^SXM?\ MI7F7_!Q
M%?2V'[)7P4N1!;W<-M^T_P"%;Z2QOHC<:=>2V?PT^*DD4%];;D$]O(K30RQ%
MU,D$L\890Y- '+?#G_@CCXT_:L\ :'\5O^"BG[3G[0GBKXP^-$_X2]O!'@[Q
M;X9LO#'PT@UR"*XM/#:V7B/P?XKT.'6+2UD7^V;/P7I'A;POHMY--X>T2#5-
M/TJ+7]7_ %[_ &9?@)%^R#\']<\"ZE\9_B?\7_#.BZYKWB_2_$OQ>U:WUWQ+
MX3\*_P!C:4K^%(=4M;:T6ZT32)=(U'5[3-K!Y,VL7L$$$-K%;PI^:6O_ /!.
MS_@IG\18].\<>-?^"K7C/PI\1K6%-4'@KX8^"=>\-_"ZTULF"\.BM/X6\>>
MK/Q!X?M[R%+..]U_X:74USIXD:ZT1_M=W9R\M^R-^UA^TE\?/V-O^"C_ ,$/
MC)J]AXH_:<_96\'_ !F^'R>,])L]&TT>(K[5/!7Q/TGPG]MFCMM,\+WVJZ1X
MQ\#>(],BUE-+T:RO]!@\/7.N6<VJ'5M9U4 \1^ _[-GC_P#X+/GXH?M-?M/?
M&;XR^ ?V=]0\>ZUX0^ WP/\ AQKNF:#IUOX<\,74,D6N:E::WIGB_P *W%S;
MW$UOI>J:M_8=UK>N>*M)UN9M1T[1M,T"Q7K?AIX>^*/_  2J_P""@?[/_P"S
MI%\;O''Q-_8\_:MTZ3P7X(\/_%#75U2_\!^,=*$&CZ/8Z,D:6FCZ9J<'BG5?
M"VF)<>&=+\.Z5XC\/^,H=)U+0KO5_#&B:G!]J_\ !#Z2V?\ X)N?!)8-GFPZ
M[\7([W8FUA<GXL^,I4\UMH\Q_L<MIA\MB/RX]WR;5^9/^"PRO/\ ME?\$?+6
MU*M?2?M*:DL<:2(DP:?XJ?LQ1VK$EE,:O,DBQ2.RIO20AAL<@ _H$HHHH **
M** .)\:>*=8\,16$FD>$]2\5-=R7"3QZ<;H-9+"L3(\OV;3=1.)C(RIO6(9C
M;!?D+P'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,
M4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +
M7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T
M2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__
M 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J_
M_,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>Z
MT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5
M_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?
MQG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(
M/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\
M?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\
MS%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\
M"U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_
M]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/
M_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJ
MO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7
MNM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >
M%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +
M7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T
M2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__
M 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J_
M_,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_
M  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&
M?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\
M3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]
M:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,
M5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM%
M'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\
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M/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\
M?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\
MS%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K1
M0!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_
M  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&
M?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\
M3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]
M:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,
M4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +
M7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T
M2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__
M 'UJO_S,5[K10!X5_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J_
M_,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>Z
MT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5
M_P +7\9_]$@\3_\ ?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?
MQG_T2#Q/_P!]:K_\S%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(
M/$__ 'UJO_S,4?\ "U_&?_1(/$__ 'UJO_S,5[K10!X5_P +7\9_]$@\3_\
M?6J__,Q1_P +7\9_]$@\3_\ ?6J__,Q7NM% 'A7_  M?QG_T2#Q/_P!]:K_\
MS%'_  M?QG_T2#Q/_P!]:K_\S%>ZT4 >%?\ "U_&?_1(/$__ 'UJO_S,4?\
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MS#.*R;=*.)K/ZKAN;>.#P5)4\'@X/=PPM"E%N[:;;;\*_P"%K^,_^B0>)_\
MOK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6BNX^8/"O\ A:_C/_HD'B?_ +ZU
M7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H
M_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6O
MXS_Z)!XG_P"^M5_^9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD
M'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\
MOK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^
M9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UH
MH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_
M (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=:* /"O\ A:_C
M/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>
M)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^
MM5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF
M*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%
MK^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z
M)!XG_P"^M5_^9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_
M +ZU7_YF*Z_5_C%\(] O9--UWXI?#G1-1B ,MAJ_C?PSIM[&"6 ,EK>:G#.@
M)5@"T8!*L!R#5D?%3X8'&/B/X".<8QXP\/'.>F,:CSGM7"LSRV4ZE)9A@74I
M/EJTUBZ#G2D[V52"J<T'H]))/1]B/:4[M<\+K=<T;KUU.'_X6OXS_P"B0>)_
M^^M5_P#F8H_X6OXS_P"B0>)_^^M5_P#F8KU!?&?@]F"KXK\-,S$*JKKNEEF8
MG   NLDD\ #DG@5JKJ^E.RHFIZ>[NP5$6]MF9F8X5542$LS$@  $DG YKJC6
MI3^"K3EM\,XRWVV;WZ%<R[K[T>-?\+7\9_\ 1(/$_P#WUJO_ ,S%'_"U_&?_
M $2#Q/\ ]]:K_P#,Q7NM%:#/"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD
M'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\
MOK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^
M9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UH
MH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_
M (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=:* /"O\ A:_C
M/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>
M)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^
MM5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF
M*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%
MK^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z
M)!XG_P"^M5_^9BO=:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_
M +ZU7_YF*]UHH \*_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?
M_F8KW6B@#PK_ (6OXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=
M:* /"O\ A:_C/_HD'B?_ +ZU7_YF*/\ A:_C/_HD'B?_ +ZU7_YF*]UHH \*
M_P"%K^,_^B0>)_\ OK5?_F8H_P"%K^,_^B0>)_\ OK5?_F8KW6B@#PK_ (6O
MXS_Z)!XG_P"^M5_^9BC_ (6OXS_Z)!XG_P"^M5_^9BO=:* *UG/)<VEK<2P/
M:RW%M!-);2;O,MY)8E=X'W)&V^%F,;;HT;<IRBGY19HHH **** "O,?C)_R3
M?Q'_ -PC_P!/VEUZ=7F/QD_Y)OXC_P"X1_Z?M+H B^"__).M#_ZZZM_Z=[ZO
M4Z\L^"__ "3K0_\ KKJW_IWOJ]3H \K^.,'Q6N?@[\3(?@9>:58?&-_!>O\
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MH<'Y;.\5+!2^N9U4@]&IYI6IPCAV])1> PF$KTW>/UFI%Z^0_!_X!?!GX!:
MOAKX._#CPOX"TPQQ)=-HFG(NJZJT,<<:3Z[KUR;C7=?N]D4:M>:SJ-]=,$7=
M*=HQZ]117VE.G3HPC2HTX4J<%:%.G",(17:,(I1BO))(_F[%XS&9AB:V,Q^*
MQ.-QF(FZE?%8NO5Q.)KU'O.M7K2G5J3?64Y2D^X44459S!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Y'X
MS^/?P9^'WG)XN^)7A/2KJW4O-IB:I#J>M(JYY_L/2?M^L-DJRJ%L6+LI5-S
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MV5T=5='0AD=& 965E)#*P(*L"0000<4Z@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P +NCJKHZ:_I+(Z, RLK+=D,K @JP)!!!!Q3O\ A-?!W_0V^&?_  ?:7_\
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M5^V:BUSK$>2 6+>'B%5@5WMN1?E<YXYX/X?YUG'$>4X.K"_-AGBZ=;&*V_\
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ME+_\30!Z=_;>C?\ 06TS_P #[7_X[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\
M/MJ?_@RE_P#B:/\ A1G@'_GVU/\ \&4O_P 30!Z=_;>C?]!;3/\ P/M?_CM'
M]MZ-_P!!;3/_  /M?_CM>8_\*,\ _P#/MJ?_ (,I?_B:/^%&> ?^?;4__!E+
M_P#$T >G?VWHW_06TS_P/M?_ ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/M
MJ?\ X,I?_B:/^%&> ?\ GVU/_P &4O\ \30!Z=_;>C?]!;3/_ ^U_P#CM']M
MZ-_T%M,_\#[7_P".UYC_ ,*,\ _\^VI_^#*7_P")H_X49X!_Y]M3_P#!E+_\
M30!Z=_;>C?\ 06TS_P #[7_X[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?
M_@RE_P#B:/\ A1G@'_GVU/\ \&4O_P 30!Z=_;>C?]!;3/\ P/M?_CM']MZ-
M_P!!;3/_  /M?_CM>8_\*,\ _P#/MJ?_ (,I?_B:/^%&> ?^?;4__!E+_P#$
MT >G?VWHW_06TS_P/M?_ ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\
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M_P".UYC_ ,*,\ _\^VI_^#*7_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\
M06TS_P #[7_X[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\
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M/M?_ ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\ X,I?_B:/^%&> ?\
MGVU/_P &4O\ \30!Z=_;>C?]!;3/_ ^U_P#CM']MZ-_T%M,_\#[7_P".UYC_
M ,*,\ _\^VI_^#*7_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\ 06TS_P #
M[7_X[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\ A1G@'_GV
MU/\ \&4O_P 30!Z=_;>C?]!;3/\ P/M?_CM']MZ-_P!!;3/_  /M?_CM>8_\
M*,\ _P#/MJ?_ (,I?_B:/^%&> ?^?;4__!E+_P#$T >G?VWHW_06TS_P/M?_
M ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\ X,I?_B:/^%&> ?\ GVU/
M_P &4O\ \30!Z=_;>C?]!;3/_ ^U_P#CM']MZ-_T%M,_\#[7_P".UYC_ ,*,
M\ _\^VI_^#*7_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\ 06TS_P #[7_X
M[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\ A1G@'_GVU/\
M\&4O_P 30!Z=_;>C?]!;3/\ P/M?_CM']MZ-_P!!;3/_  /M?_CM>8_\*,\
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M?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\ X,I?_B:/^%&> ?\ GVU/_P &4O\
M\30!Z=_;>C?]!;3/_ ^U_P#CM']MZ-_T%M,_\#[7_P".UYC_ ,*,\ _\^VI_
M^#*7_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\ 06TS_P #[7_X[1_;>C?]
M!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\ A1G@'_GVU/\ \&4O_P 3
M0!Z=_;>C?]!;3/\ P/M?_CM']MZ-_P!!;3/_  /M?_CM>8_\*,\ _P#/MJ?_
M (,I?_B:/^%&> ?^?;4__!E+_P#$T >G?VWHW_06TS_P/M?_ ([1_;>C?]!;
M3/\ P/M?_CM>8_\ "C/ /_/MJ?\ X,I?_B:/^%&> ?\ GVU/_P &4O\ \30!
MZ=_;>C?]!;3/_ ^U_P#CM']MZ-_T%M,_\#[7_P".UYC_ ,*,\ _\^VI_^#*7
M_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\ 06TS_P #[7_X[1_;>C?]!;3/
M_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\ A1G@'_GVU/\ \&4O_P 30!Z=
M_;>C?]!;3/\ P/M?_CM']MZ-_P!!;3/_  /M?_CM>8_\*,\ _P#/MJ?_ (,I
M?_B:/^%&> ?^?;4__!E+_P#$T >G?VWHW_06TS_P/M?_ ([1_;>C?]!;3/\
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MY0I:YNK9$N;J0J K27$TLC* &8@"NT_MO1O^@MIG_@?:_P#QVO,?^%&> ?\
MGVU/_P &4O\ \31_PHSP#_S[:G_X,I?_ (FOT6AAZ&%I0H8:A1P]"FK0HT*4
M*-*"[0ITXQA%>22.U)15HI12V25DODM#T[^V]&_Z"VF?^!]K_P#':/[;T;_H
M+:9_X'VO_P =KS'_ (49X!_Y]M3_ /!E+_\ $T?\*,\ _P#/MJ?_ (,I?_B:
MV&>G?VWHW_06TS_P/M?_ ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\
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M_P".UYC_ ,*,\ _\^VI_^#*7_P")H_X49X!_Y]M3_P#!E+_\30!Z=_;>C?\
M06TS_P #[7_X[1_;>C?]!;3/_ ^U_P#CM>8_\*,\ _\ /MJ?_@RE_P#B:/\
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M/M?_ ([1_;>C?]!;3/\ P/M?_CM>8_\ "C/ /_/MJ?\ X,I?_B:/^%&> ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDIXZO[7&5-&_CKRW?=W]:EA</0M[*C"+7VN6\_\ P.5Y/YL****^G-PHHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7F/QD_P"2;^(_^X1_Z?M+KTZO,?C)_P DW\1_]PC_ -/VET 1?!?_ ))U
MH?\ UUU;_P!.]]7J=>6?!?\ Y)UH?_775O\ T[WU>IT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?[7:E&@O+-O&%IK>E:1=Q2QI/%+H^DV*Q3J)HXUE <?9'_#LWXH?]%!\!?\
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MDI<^7YO7ZWJ<,93>-ND5A\OI<U[]5)Z:=0]OG2^S5?\ W+T_TI_U\CZPM?\
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M HHHH **** "BBB@ HHHH *1@&!5@&5@596&0P(P00>""."#P12T4 ?SY_\
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M.-#-HVHX?%SM3I9A*/NJE53LJ..;5N6RIXB6D%"JXTI_KY1117X.?KH4444
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M\,?^!=M_\UU 'NM%>%?V_P#'O_H2?#'_ (%VW_S74?V_\>_^A)\,?^!=M_\
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M_P *C0__ ).K^ *BOZ57T=Z-O>XMJM]UDD(K[GFLOS/PQ^-E3IPW!+SS9O\
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M ,-[?L:?]''_  L_\*.'_P"(K,O_ /@H;^Q5ISI'<?M%> )&D4NIL)]3U1
M=N'ETS3;R.)\]$E='(^8*5(-?QBVO@7QO?6T%Y9>#O%5Y:7423VUU:^'M7N+
M:XAD4-'-!/%:/%+%(I#))&S(RD%20:G_ .%=_$#_ *$7QC_X3&M__(-9+P'X
M3C*T^)<ST;4HJIEL))K2VM"5FGNG$V_XB[Q'**<,@P>J34N3'RBT[:JTU=-;
M6?5?/^R3_AX]^Q%_T<-X._\  +Q-_P#*&D/_  4?_8B )/[0W@_@9XL?$Y/'
MH!H))/L 2>U?QS6?PN^)NH3K:V'PZ\=WURX9DMK/PCX@N9W"*6<K##I[R,$4
M%F(4A5!)P!6Q_P *,^-O_1'?BG_X;[Q;_P#*BE+P-X*@[2XGS*+M>TL7E,7;
MO9X79Z_TM1>+'%4E>/#V#DKVNL/F+5]--*V^J^]=S^I3XC?\%@/V,_"/AJZU
M7P7XM\1?%?Q N8['PKX=\%^,/#<TTS#]W+?:QXZ\/^&],LK!6P+B>VDU.^C7
M+0:7=, A_"W]IS_@IQ^TE^T=]NT*WUK_ (5/\.;KS8?^$*\ WMY:7&HV<@"F
M#Q3XKS!K.OADW1W%I -(T*Z1OWNAEU#U\HZ-^SE^T%XAU*UTC1?@?\6]1U&]
ME2&WM;?X=^+"S,[JF^1VTE8K>!"P::YN)(K:WCW2SRQQ*SC]/?@=_P $</C3
MJS:?X@^.%HOAW3=T%R?!&@:]X<N]>NHP4D-KK.MIJLFGZ0L@#13PZ7_:ET8G
M8)>Z=<J&3TJ'#WA-X;0_M/&8REF&-3<\)+,<1A\VS"ZM98+ 82C2H1DI6MBI
M852HR:YL53BS@JYUXC\<R6 PN&J8'"M*.)^I4*^6X/E>[Q6,Q-6I6:<6[X>%
M=JK!.V'J-'Y$^!_ /C;XF>(['PA\/?"FO^,_$^I,%L]#\-Z7>:MJ$B>9'&]P
M\%G%*T%G TJ-=WUQY5G9QGSKJ>&(,X_;O]F;_@BIXIUO^SO%'[3_ (J_X1#3
M6\FZ_P"%:>"+NSU'Q/.O[J7[+XA\6;+O0]&Y$D%U9Z##K\TT+[H-;TVY7Y?U
MU^#WPDUSX ^'$\*_"'X%_#GP3I16(7DFF&WDU;6)88UC2ZU[7KSQA<ZUKMX$
M4*+K5K^\F5<(CK&%0>N_V_\ 'O\ Z$GPQ_X%VW_S75^=\5^.>=9G[7"<-4/[
M$P<KQ^N5>2OFM6+TO%^]A\%S)ZJDJ]:#M*GBHL^UX=\),JP'L\1GM7^UL4K2
M^K0YJ67TY:.S7NUL59K>HZ5*:=IX=F[\(?@9\(_@+X:3PG\(O 7A_P #Z,!#
M]J&DVF=2U>:",0QWFOZY=O<ZUX@OQ&JI]OUK4+Z[V )YP154>L5X5_;_ ,>_
M^A)\,?\ @7;?_-=1_;_Q[_Z$GPQ_X%VW_P UU?AN(Q&(Q=:IB<57K8G$5I.=
M:OB*DZU:K-[SJ5:DI3G)]92DV^Y^M4:-'#TH4,/2IT*-**A3HT:<:5*G%;1A
M3@HPA%=%%)+L>ZT5X5_;_P >_P#H2?#'_@7;?_-=1_;_ ,>_^A)\,?\ @7;?
M_-=6)H>ZT5X5_;_Q[_Z$GPQ_X%VW_P UU']O_'O_ *$GPQ_X%VW_ ,UU 'NM
M%>%?V_\ 'O\ Z$GPQ_X%VW_S74?V_P#'O_H2?#'_ (%VW_S74 >ZT5X5_;_Q
M[_Z$GPQ_X%VW_P UU']O_'O_ *$GPQ_X%VW_ ,UU 'NM%>%?V_\ 'O\ Z$GP
MQ_X%VW_S74?V_P#'O_H2?#'_ (%VW_S74 >ZT5X5_;_Q[_Z$GPQ_X%VW_P U
MU']O_'O_ *$GPQ_X%VW_ ,UU 'NM%>%?V_\ 'O\ Z$GPQ_X%VW_S74?V_P#'
MO_H2?#'_ (%VW_S74 >ZT5X5_;_Q[_Z$GPQ_X%VW_P UU']O_'O_ *$GPQ_X
M%VW_ ,UU 'NM%>%?V_\ 'O\ Z$GPQ_X%VW_S74?V_P#'O_H2?#'_ (%VW_S7
M4 ?$O_!0#_@F]X6_:BT^]^)'PVBTWPE\>=/LQ_IC;;/0_B-;VD6+?2?%)C7R
M[;6HXU%OI'BD1F9(Q%INM?:M-BL9M'_E)\3^&/&/PR\8:GX7\4Z3K/@[QMX0
MU8VNHZ9?1SZ;K.BZM8R)-$ZLI22*1&$-W8WMM(8IX7M[VRGD@EAF;^Y#^W_C
MW_T)/AC_ ,"[;_YKJ^#/VT_V)O%/[7VCP:M?>!?#'A3XKZ#9M;^'O'>EW-A;
MW&H6<?F20^&_%9/B*[_M/0C/(\EI,UO+J.A3RS7&F.;>YU'3]1_<O#/Q8K</
MNCD/$=2IB<AERTL+BI)U:^4I^ZH-:SKY>D[2HI2J8:.M!2@O8/\ )N//#JGG
M2J9ODD(8?.(WJ5\/&U.EF-M>:^D:.-T]VJVH5GI6:D_:KPS_ ()U_P#!4FU\
M<?V#\"OVE=;AL?&K"VTCP-\4]3F2"Q\82 >3::#XSNY"D5CXJE C@TW7IF6T
M\2S$6NH26_B"2WEU_P#=NOX$_BI\*/B#\$_'&L_#KXG>&;_PIXMT.4)>:;?*
MCI-!)N^S:CIM[;O+9:II5ZBF2RU/3Y[BRND!,4S%'5?U^_8:_P""J7COPC:>
M'?@G\:=4TG6=$1K;1_!WQ*\5/<->Z)'A(+#1/&.K/JMA%-HD0"6]EXCOF:XT
MI=D6L7$NEC[=I?O>(_A11KT9\5<$TZ>(PM>G]<Q>58-QJTYTIQ]I]=R?V=XU
M*4XOVD\'3;T?-@TXN.'CY' _B+5I58\/<5RG0Q-&?U;#YABE*G452#Y/JN9<
M]I0JQDN2.)G:[M'$VDG6G_3=17@L/B7XZW,,5Q;^#O"=Q;W$4<T$\-]:2PS0
MRH'BEBEC\7LDD4B,KQR(S(Z,&4D$&I?[?^/?_0D^&/\ P+MO_FNK^;S]P/=:
M*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_C
MW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/
M_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YK
MJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/
M?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P
M+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FN
MH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_
MM_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)
M/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV
M_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?
M^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D
M^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_
M )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]U
MHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]
M_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_
M ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#F
MNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_
M $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_
M  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ
M /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK
M^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0
MD^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[
M;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M
M_P"/?_0D^&/_  +MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/
MAC_P+MO_ )KJ /=:*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +M
MO_FNH ]UHKPK^W_CW_T)/AC_ ,"[;_YKJ/[?^/?_ $)/AC_P+MO_ )KJ /=:
M*\*_M_X]_P#0D^&/_ NV_P#FNH_M_P"/?_0D^&/_  +MO_FNH ]UHJM9M<O:
M6KWL:0WCVT#7<49S'%<M$IGC0AY0424NJD22 J!AW^\;- !1110 5YC\9/\
MDF_B/_N$?^G[2Z].KS'XR?\ )-_$?_<(_P#3]I= $7P7_P"2=:'_ -==6_\
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MM)I>@VFG@'[-4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ"2BHX/#I14=(J*5/1))6MMT/*O^%$_!#_HC?PJ_\-YX1_\ E/1_PHGX(?\
M1&_A5_X;SPC_ /*>O5:*YOK^._Z#,7_X45O_ )/R7W'3]5PW_0/0_P#!-/\
M^1//+#X1?"?2A*-+^&'P\TT3E#,+#P5X;LQ,8]WEF46^F1^84WOLWYV[VVXW
M'.A_PKCX>_\ 0A^#/_"7T/\ ^0:[.BLWBL3)WEB*\F]VZM1M]-W*Y:HT8JT:
M5-);)4XI=]DN^IQG_"N/A[_T(?@S_P )?0__ )!K:'AWP^  -"T8    :79
M #@  08  Z"MFBHE6K2MS5:DK;<TY.WI=^12A!;0BO2*6WHC'_X1[0/^@'H_
M_@LLO_C%6K72]-L7:2RTZQLY'78[VMI;V[LF0VQFAC1F7< =I)&0#C(%7J*E
MSFU9RDUV;=OZT7W#Y4MHK[E_71!1114C"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D/]K_\
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M[MG:S&J?80ELOKM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@A^Q_P#LX_L[PPGX5?"OPYHNL11F-_%NH02>(/&=QO.Z7?XIUR2_UBWBF?\
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M8WE6P4I-N:LG*>'DW6I)2?[RG%U3ZVHHHK\K/T$**** "BBB@ HHHH ****
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MZL(U*4X5*<TI0J4Y*<)Q>JE&46XR36J:;3.I--)IIIZIK5/T844458PHHHH
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M2O=:CJ5V\DDCS7=[?7MPSO([EI9[FZNIW+,[,6DFFF<EB6=V))-?S=QI](G
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MO_A:_P /?^AFM/\ P'U#_P"1* /0Z*\\_P"%K_#W_H9K3_P'U#_Y$H_X6O\
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M13MI.O2J<-4XQK)?%.D^2K>_LZ;3<O[<J*_B3_X>G_M\_P#1PVL?^$7\,O\
MYB:/^'I_[?/_ $<-K'_A%_#+_P"8FOFO^(AY-_T"9G_X*PO_ ,V'M_\ $H?B
M+_T/N"__  NSS_Z'O7^GI_;917\2?_#T_P#;Y_Z.&UC_ ,(OX9?_ #$TUO\
M@J=^WPZLI_:'UH!E*DKX-^&B, 1@[73P6KHW/#*RLIY4@@&C_B(>3?\ 0)F?
M_@K"_P#S8'_$H?B+_P!#[@O_ ,+L\_\ H?\ 7^GI_;=17\.__#R_]NK_ *..
M\:?^ 7A;_P"9^C_AY?\ MU?]''>-/_ +PM_\S]3_ ,1$RG_H#S'_ , PW_S2
M:?\ $H/'_P#T47!__A3G7_SE/[B**_AW_P"'E_[=7_1QWC3_ , O"W_S/T?\
M/+_VZO\ HX[QI_X!>%O_ )GZ/^(B93_T!YC_ . 8;_YI#_B4'C__ **+@_\
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M[*RMU::XF=54!0S+_)5^W!^W!X[_ &Q/'8N+@7GAGX3^&;RX_P"%?_#_ .T
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M *&:T_\  ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:T_\
M ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:T_\  ?4/_D2@
M#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:T_\  ?4/_D2@#T.BO//^
M%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:T_\  ?4/_D2@#T.BO//^%K_#W_H9
MK3_P'U#_ .1*/^%K_#W_ *&:T_\  ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_
M .1*/^%K_#W_ *&:T_\  ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K
M_#W_ *&:T_\  ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:
MT_\  ?4/_D2@#T.BO//^%K_#W_H9K3_P'U#_ .1*/^%K_#W_ *&:T_\  ?4/
M_D2@#K];T31_$NCZGX>\0Z5I^N:%K5C<Z9J^CZK:07^FZGIU[$T%W97UG<I)
M;W-K<0N\4T,T;QNC%64@U_+=_P %#O\ @F3J_P  Y-8^,GP.LM0\0?!6266^
M\0>'%\_4-<^%PE8O)(\A,MUJW@F)B1#J\IDO]"A*0:Y)<P1'6IOZ8O\ A:_P
M]_Z&:T_\!]0_^1*BF^*/PWN89;>X\0Z?<6]Q%)#/!-9WLL,T,J%)8I8GLF22
M*1&9)(W5E=&*L""17V/!G&V;\%9BL9E\_:X2LX1S#+:LFL-C:47UT?L<1!.7
ML,3"+G2;:E&I2E4I5/F>)^%<MXIP+PN-A[/$4U)X/'4XIU\)4E;6-VO:49M)
M5J$FHU(JZ<*D85(?Q%?L]_M%?%#]F7XAZ?\ $;X7:VVG:A 8[?6=&NO-G\/>
M*]'\P/<:'XCTU98EO;&<;O*E1X;[3K@K?:7=V=]%%<)_8'^R%^V1\,/VO_ G
M_"0^#YUT7QCHL5M%XZ^'FH74<FM^%[Z9<+<0L%A.K^'+Z17.DZ_;0)!<A6M;
MR&PU6WO-/M_PY_X*$?L >!]!GU?XT_LMS6USX>FDFU'QG\(]-MKM)/#F0TUW
MKG@6![:,2>'P0TU[X7C+3:)N>30T?10NFZ-^2WPG^+7Q ^"'CO1/B1\,O$=[
MX8\6:#/YEK?6C9ANK9ROVO2]4LWW6VJ:1J$:^3J&FWD<MK=18#IO2-T_H_.\
M@X7\8\BCGF15Z>$SW#TU3C6J14*]*M&/-_9N<TJ?-*5-_P#+C$1YW3357#RK
M4?:4:GX?E6<\0>&.;O*<WI5,3D]:;G[.#<J4Z<I6>.RRI/EBJBT=;#RY5-WI
MUHTJKA5C_?317\S4W_!=#XRF.U6V^"7PSCE2VB2]DN-7\47"W-XJXFN+:.*Y
MM/LEO(WS1VLCWDD0^5KN7K7/:M_P7'_:0F,']A?"OX(Z<%$GVH:MI_CS6C,3
MY?D^0;/QQH'V81XE\P2"Z\W?'M,/EMYOXO#P4\0)R2EEV#I)W]Z>9X)Q5MK^
MSJU)>]LK1>^ME=K]1GXJ<&1BW''XFHU:T89?C%)W:V]I2IQTO=WDM$[7=D_Z
MAJ*_E6N_^"W'[6MPJ"'P;\!+ J26:T\(>.W:0$8"O]N^)MXH"]1Y:HV3R2,"
MLB[_ ."TW[8-S&J0Z;\&]/8.',UIX*UQY&4*P,3"_P#&-[#L8L')6)9-R+B0
M*75^J/@;QV[7IY5&_P#-F*T]>6C+\+F#\6N$%M4S!^F!E^M1']8%%?R27G_!
M9']M"Y@:&'4_AMITC%2+JS\!P/.@4@E574-2OK8AQ\K;[=F )V,C88<Y?_\
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M8Z?*A+7R_$_OUJC=:GIMBRI?:A8V;NNY$NKN"W9U!P659I$+*#QD C/'6O\
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MW]GB,Z9<36S0W$MA=6WB#6;.\M&F\BYLM2O+9T\JYG63SS_@E'^VA\-/V1?
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M"MI?_?N3_P".4?\ "L_ 7_0K:7_W[D_^.5W5% '"_P#"L_ 7_0K:7_W[D_\
MCE'_  K/P%_T*VE_]^Y/_CE=U10!PO\ PK/P%_T*VE_]^Y/_ (Y1_P *S\!?
M]"MI?_?N3_XY7=44 <+_ ,*S\!?]"MI?_?N3_P".4?\ "L_ 7_0K:7_W[D_^
M.5W5% '"_P#"L_ 7_0K:7_W[D_\ CE'_  K/P%_T*VE_]^Y/_CE=U10!PO\
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M^%]E4DHO50FYPU:<6FT_XG_C+_P3Y_:W^![W,_BGX0>(-=T&WEV+XK^'\?\
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M^Y/_ (Y1_P *S\!?]"MI?_?N3_XY7=44 <+_ ,*S\!?]"MI?_?N3_P".4?\
M"L_ 7_0K:7_W[D_^.5W5% '"_P#"L_ 7_0K:7_W[D_\ CE'_  K/P%_T*VE_
M]^Y/_CE=U10!PO\ PK/P%_T*VE_]^Y/_ (Y1_P *S\!?]"MI?_?N3_XY7=44
M <+_ ,*S\!?]"MI?_?N3_P".4?\ "L_ 7_0K:7_W[D_^.5W5% '"_P#"L_ 7
M_0K:7_W[D_\ CE'_  K/P%_T*VE_]^Y/_CE=U10!PO\ PK/P%_T*VE_]^Y/_
M (Y1_P *S\!?]"MI?_?N3_XY7=44 <+_ ,*S\!?]"MI?_?N3_P".4?\ "L_
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M;GSP)_.6T$GG9EW>82Q^LHT2)$BB1(XXT6...-0B1H@"HB(H"JBJ JJH 4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\Q^,G_ "3?Q'_W"/\
MT_:77IU>8_&3_DF_B/\ [A'_ *?M+H B^"__ "3K0_\ KKJW_IWOJ]3KRSX+
M_P#).M#_ .NNK?\ IWOJ]3H **** "BBOG[]H#]JG]GG]EG0;/Q'\??BMX6^
M'%EJB7LFB6.JW%Q>^)/$2Z8UFFI'PSX2T:VU+Q1XC&G/J.GKJ+:+I%\FG_;[
M,WK6ZW,+. ?0-%?AM_P3R_X*G?"WXV?$?X]^ OBY^T5I4WB7Q?\ M-^.;?\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\5_V_O\
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MM[M2,Z<-6BBBOD#Z0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS^@XQC",8QBHQBE&,8I1C&*5E&*5DDDK))62T04445(PHHHH **** "BBB@
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M -/VET 1?!?_ ))UH?\ UUU;_P!.]]7J=>6?!?\ Y)UH?_775O\ T[WU>IT
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MU>72I+W3-+LK&8Q6L=SJO]OW5MK5GH=SX;UD \6\)^-/^"-$?[%</BN#P_\
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M/&@_]]/_ /,Q7OU% '@/_"+?';_H>-!_[Z?_ .9BC_A%OCM_T/&@_P#?3_\
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M#QH/_?3_ /S,5[]10!X#_P (M\=O^AXT'_OI_P#YF*/^$6^.W_0\:#_WT_\
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MQH/_ 'T__P S%>_44 > _P#"+?';_H>-!_[Z?_YF*/\ A%OCM_T/&@_]]/\
M_,Q7OU% '@/_  BWQV_Z'C0?^^G_ /F8H_X1;X[?]#QH/_?3_P#S,5[]10!X
M#_PBWQV_Z'C0?^^G_P#F8H_X1;X[?]#QH/\ WT__ ,S%>_44 > _\(M\=O\
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M^+=K_P %X[Y%<7W[+EK<.6&QK7XS36:JN.0ZS?"V^+L3R&#Q@#C:>M=]IO\
MP78^'<IM?[7_ &??&EB'B4WITWQKH>JFWF,.YX[47.C:/]LB6?$:S2FQ=H?W
MY@1Q]G/#5\(O$2BKRX<J26O\+,<HK/17^&ECYR]+QU>BN==+Q(X*JNT<\IQ>
MG\7!YC26OG5P<(OSLW;=V/UF_P"$6^.W_0\:#_WT_P#\S%'_  BWQV_Z'C0?
M^^G_ /F8K\Q[/_@N7^S^ZN;_ .$7QBMG# 1K9KX*OE9<<EWF\4:>48'@*J2
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M_P#?3_\ S,4?\(M\=O\ H>-!_P"^G_\ F8KWZBI&> _\(M\=O^AXT'_OI_\
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M?^^G_P#F8H_X1;X[?]#QH/\ WT__ ,S%>_44 > _\(M\=O\ H>-!_P"^G_\
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M\:#_ -]/_P#,Q7OU% '@/_"+?';_ *'C0?\ OI__ )F*/^$6^.W_ $/&@_\
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M!_[Z?_YF*/\ A%OCM_T/&@_]]/\ _,Q7OU%> >P> _\ "+?';_H>-!_[Z?\
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M?\DW\1_]PC_T_:77IU>8_&3_ ))OXC_[A'_I^TN@"+X+_P#).M#_ .NNK?\
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M4Q 1D;!BO/[K]CG]DJ\5%F_9D^ :!&+ VOPD\"6+$D8^=['0K=Y%]%=F4'D
M'FOI"BN^EFN:4-*&98^BM-*6,Q%/967P5%LM%V6B.2I@,#6:=;!82JU>SJ8:
MC-J^KMS0>[U?<^2+[]@O]C74/M'G_LW_  JC^U(T<GV'PU;Z9M5X_*)M_P"S
M6M/LD@7E9;3R94D_>HZR_/7":M_P3'_86UE84O/V?]%A$#.R'2?%GQ$T%F,@
M4,)GT/QAISW*@*-B7#2K&=QC"EV)^\J*[J7%'$U!IT>(L]HM;.EF^84VM+:.
M&(36FGIH<E3(,BK)QK9+E-6+W53+<'-/5/52HM/5)^J1^;EW_P $E?V%+GS_
M "?A-J^G^:K"/[)\2OB0_P!E++@-!]O\4WNYD/S+]I^T*6X=77Y:Y.__ .".
M7[%EX(A;Z)\0]*\LN7-AX^OI#/NV[1+_ &I::D (]IV>2(2=[>87PFS]3Z*[
MH<=\:T[./%?$+M_/FV-J]+:JI6G?Y]==]3DEPEPM/?AW)%?^7+,'#M_)1C;;
MIYK9L_'+4?\ @B)^RC=RW4UEXY^/.EF9F:WM8?%/@2ZL;,G[J(EY\-IK^:)?
M2?47F.>9ZY2\_P""&GP"?R_[/^+_ ,8+4#=YOVP>"[[?G;L\LP>&M.\K;AMV
MX3;\K@IM._\ ;BBO0AXF\>T[*/$^8NRLN=T*O2VKJ49MOS=W?6]]3BEP'P?-
MMO(,"KN_NQJ06]]%"I%)7Z))):;:'X*:E_P0F\"2QW8T?]H?Q;8ROYGV!]2\
M!:/JL=MEOW7VN.U\1:,U[L7B3R9=/\QOF7RA\M<+=_\ !!W44*?8?VH;*X!#
M>8;OX.3V10\;0@A^)]_Y@(SN+&/;@8#9)7^B6BNZEXO>(E)6CQ%.2O?][EV4
M57LE\53+Y36VRDE>[W;9R5/#;@JJ[RR2$6O^?>-S*DM[_#3QD8OM=J]M%8_F
MPOO^"%'Q(C2X.F?M >"+N1686BWW@[7M.29/,PK7#V^J:H;5C%\[)''=A9/W
M8=E_>UPVJ_\ !#C]I.%X1H?Q3^!^HQLC&=]5U+Q[HSQ."-BPQV?@37EG1ER6
M=Y;<J0%$;@[A_4117=2\:O$"FTYYGA*Z5]*N5X!)Z6U]A0HO1ZJS6N]UH<E3
MPLX,FFHY?B*+=O>IYAC6U9]/;5JL==G=/3:SU/Y1;O\ X(J?M?6R3/#K7P5U
M!HFPD=IXS\2(]P-X3?";_P #V4:KM/FXN)(&V C;YF(SRM__ ,$=OVU;-T2W
M\/> -45U+-)8>/\ 3(TB(.-CC4X=.D+D?,#%'(F#RX;*U_7)17=#QUXYC\7]
MC5/*>7S73;]WBJ;\_5]M#DEX1\)2V69P\XXU/_TNA,_C9OO^"5G[>5CY['X%
MM=0PRM&LUC\1_A-<_:%$GEI-!;)XZ%\T4G$BB2TCE2,[IXHBKA>9N_\ @FO^
MW%92+%-^SWXI=F02 VFL>#M0C"EF7#2V'B2YB1\J<QNZR!=K%0K*3_:917?#
MZ0'%ZMSY7PY+_#ALS@W_ .96:OO>RMV2..7@UPT_AQ^>1\GB,!);]/\ A-3V
MTU;^9_#YJ7[#'[8FE6UQ=W7[-GQ@EBMF59$TWP7JVLW+%YD@'V>RT>"^O+M0
M[AF:U@F5(0]PY6"-Y%\CUSX'_&KPPI;Q)\'_ (H^'E7&YM<^'_BS257)D R;
M_2;<#)AE SU,4F/N-C^]^BO1P_TA,YC_ +UP]EE;7_F'Q6*PVEEI^\6+UO=W
MVLTK:-OBK>"^52_@9SF%/3_E]1PU?6[U]Q8?2UE;>]W?6R_SSZ4,5(92592"
MK D$$'(((Y!!Y!'(-?Z!VM>$?"GB1)(_$/ACP]KT<R-'-'K6BZ;JB2H\1@=)
M%OK:=71H"865@0T1,9!0XKQ'7OV//V4O$TDT^L_LX_!2XN;EF>XO8/AMX3T^
M_N)'9&:2>_TW2[2\EE)C4>9).T@7<H8*[AO?PWTAL!/_ 'SAC&4%_P!0V9T<
M5ZZ5<)@^GGKMIN>/7\%<7&WU;B##U7?_ )?X"KA_FG3Q6)=_DO4_BUT3X\_'
M+PT$'ASXS?%?P^(SNC&B?$3Q?I0C/FB?*?8-8@V'S@)LK@^:!)]\9KVWPY_P
M4"_;0\+11Q:9^T;\2;I8A&%/B/5+?QA*?+,I7S)O%MIK<TQ/FMYAFD<R@1"4
MN(81'_3AXB_X)>_L+^))C<W/P*L-,N2,"3P[XO\ B!X>A53*\S :=I/BJUTK
M+-(R[S8F1(@D,;I%%$B>(>)/^"+W['NMIC2;OXM^#I 0ROH/C33;U6*Q2($E
MC\5>&?$9:)W=)I5B>"4M"BQ3PQM(K]2\7?#',DH9EPYB5=WG]=R/*<923[WA
MB:\Y+S]BGY&'_$-N/L"W+ Y]1=E:/U;-\SPU5K32TJ%.$?3VK6FY^-7AO_@K
MG^W#H*A-0^(GAOQ<BG"#Q)\//!T;*@B$2QF7PSI7AN:4*1YWF3RRSO*299I(
MSY=>W^'O^"X'[3-C-CQ)\.?@MX@L]I^6QTGQGH.H&0R1$$WG_"9ZM9>4L*S(
M(QI0D,LL<IG*0M#-]=>(O^"%?PKN8Y1X3^/'Q!T64I(('\1>&?#GBB..0H@B
M:6+39_"#3(D@D:1$F@:5&1%DA:-I)/$=;_X(3>.[=9/^$<_:'\):JP8^4-;\
M!:QX?5U\T &1K#Q%XF,;&#,A55E E AW%"9P?V[X"9G?VV"RG"2GHX?V'F.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;;>K;;U;;U;>Y]HDDDDDDE9)*R26R26R04444AA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN;D&#7Y;;1-=GCOWTJ\:PN+76M"\3:%JHT3PF(+?PKJ.D?\ "24 >.?L\?\
M!.G]O;]DGXB67B3X7_MM^$OB)X(\<_&BQ^)'[0/@/QW\,F\/Q>.X?$.K6$?Q
M(UZRU7[1\0-2B\9ZAH<#SV$UA?>&$NM4MK-+S4(K594F_4O]JK]HSP=^R?\
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M]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I_P#X!6W_ ,:H_LG2O^@9I_\
MX!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B
M_LG2O^@9I_\ X!6W_P :H_LG2O\ H&:?_P" 5M_\:H \=_X: \%_\^'B3_P!
MT[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_ *!FG_\ @%;?_&J/[)TK_H&:
M?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]'_#0'@O_ )\/$G_@#IW_ ,MZ
M]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M_P#&J /'?^&@/!?_ #X>)/\
MP!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I_P#X!6W_ ,:H_LG2
MO^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X
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M=_X: \%_\^'B3_P!T[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_ *!FG_\
M@%;?_&J/[)TK_H&:?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]'_#0'@O_
M )\/$G_@#IW_ ,MZ]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M_P#&J /'
M?^&@/!?_ #X>)/\ P!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I
M_P#X!6W_ ,:H_LG2O^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1
M_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\ X!6W_P :H_LG2O\ H&:?_P"
M5M_\:H \=_X: \%_\^'B3_P!T[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_
M *!FG_\ @%;?_&J/[)TK_H&:?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]
M'_#0'@O_ )\/$G_@#IW_ ,MZ]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M
M_P#&J /'?^&@/!?_ #X>)/\ P!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_
MLG2O^@9I_P#X!6W_ ,:H_LG2O^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\
M '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\ X!6W_P :H_LG2O\
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M_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\
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M .6]'_#0'@O_ )\/$G_@#IW_ ,MZ]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\
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MK_H&:?\ ^ 5M_P#&J /'?^&@/!?_ #X>)/\ P!T[_P"6]'_#0'@O_GP\2?\
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M]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I_P#X!6W_ ,:H_LG2O^@9I_\
MX!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B
M_LG2O^@9I_\ X!6W_P :H_LG2O\ H&:?_P" 5M_\:H \=_X: \%_\^'B3_P!
MT[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_ *!FG_\ @%;?_&J/[)TK_H&:
M?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]'_#0'@O_ )\/$G_@#IW_ ,MZ
M]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M_P#&J /'?^&@/!?_ #X>)/\
MP!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I_P#X!6W_ ,:H_LG2
MO^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X
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M=_X: \%_\^'B3_P!T[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_ *!FG_\
M@%;?_&J/[)TK_H&:?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]'_#0'@O_
M )\/$G_@#IW_ ,MZ]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M_P#&J /'
M?^&@/!?_ #X>)/\ P!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_LG2O^@9I
M_P#X!6W_ ,:H_LG2O^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\  '3O_EO1
M_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\ X!6W_P :H_LG2O\ H&:?_P"
M5M_\:H \=_X: \%_\^'B3_P!T[_Y;T?\- >"_P#GP\2?^ .G?_+>O8O[)TK_
M *!FG_\ @%;?_&J/[)TK_H&:?_X!6W_QJ@#QW_AH#P7_ ,^'B3_P!T[_ .6]
M'_#0'@O_ )\/$G_@#IW_ ,MZ]B_LG2O^@9I__@%;?_&J/[)TK_H&:?\ ^ 5M
M_P#&J /'?^&@/!?_ #X>)/\ P!T[_P"6]'_#0'@O_GP\2?\ @#IW_P MZ]B_
MLG2O^@9I_P#X!6W_ ,:H_LG2O^@9I_\ X!6W_P :H \=_P"&@/!?_/AXD_\
M '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\ X!6W_P :H_LG2O\
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M_P"&@/!?_/AXD_\  '3O_EO1_P - >"_^?#Q)_X Z=_\MZ]B_LG2O^@9I_\
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M'BS4-.TP0_VEJ@TRV9[72-/-S)%;+?:M>M;:;:27,L5M'<74<EQ)'"KN,_\
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M\)_L\? 7X.ZP/%.D?LVV_C+PS\7M4^-7Q2M[*\M=#\:_$7Q'HT4FB67P_P#
MZ:B;SPIX)2.+4+_QA;3:UXA34+"S\-RVX!^H'A;Q3X<\;^&M \8^$-;TWQ)X
M5\4Z1I^O^'/$&CW<5]I6M:+JUK%>Z;J>GWD#/%<VEY:313P2QL5>-P>O%;U?
MEM_P3 T:Q^&VG_M=?L]^#=;DU_X._L_?M9^/?!/PBD^VKJD'A7P_K6B^'/&V
MO?#:+56DN+S4+CP+XP\1ZY9:K/JMW>:O_:][?#4+CS\PP_J30 4444 %%%%
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MA+J>I>*)YU /U[HHHH **** "BBB@ HHHH **** "BBB@ HI"0 22  ,DG@
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MN[J^3XI^%-(CENM4@N;G4=4EL=,U'^WK_4VA\.^./B2 =#_P3&\(VWP:U_\
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ME>37&H:OK.JW=[JVKZE<W.HZG>75[<33OZ/110 4444 %%%% !1110 4444
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M3[SQ'J*^"+*XWQZ_<-9:W:6NDG6=2N?'D,&I:3KWL/[1_P"SAXS^,-[\*/\
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MU7PAX9UV'8^&_P#P4N\??LVZ=:_!;_@I'\)OB7X1^-.@7T?A/PQ\6OAO\/\
M4_&WPO\ VDY_,6V\.ZEX)N?#%G'#;^.O%$ 66\\,VEA:V#WJ3W4EGX*O;Q_
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M$?B/6)UU+QA\0/&.HK%_;WCKQUKWE0RZ[XIUV6&-KNZ:."SL;."QT31+'2]
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M$W@JWN]0T'Q+IVC%+#PC:_V!X:MTEBTX74_Z7T %%%% !1110 4444 %%%%
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M;3QUK7PS@TR;RM1N/#4D&M3> +07-YI$[26FN>)].L8;G5[;W?\ :"C^$?\
MP4O_ &*?CY\,OV>_BKX*^(7_  D^A1:=I.J:#KR/8Z9\0O"FJZ-X]\&:3XG\
MN-M1T*UU#7] T5;U[RP$G]D7,]Y!;7<0"/M?L"?ME^'?VJ/AD^@:[''X0_:+
M^#BP^ OVA?A/?0'2]9\)>/?#COX?UW4+'2)[N\N?^$5U36]-OSIDPNKUM,G6
M?0-3NCJFGSF4 N^-8_@7_P %/?V*?'.B?#OQ7I7B/P1\8/!VI:9H&OSVDLEW
MX'^(&F"/4?#=WK^A?:+/4=/USP5XMM='U/4=#FN+.:\M[;R$N7TS4XKJ=?\
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ME\:265CK-MX'LM \(1JSV6NZYXH_1:BB@ HHHH **** "BBB@ HHHH ****
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M@U;1;K7="N;>XN+>;2M1M2LOF+)'']/4 %%%% !1110 4444 %%%% !1110
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M,W@WOIVI0C5]*@U6V%QI&HW.GZUI:7*:QHNMZ;IOS!_P33^/$W@72C_P3O\
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M=/6YO;71;)+W7+N\\4ZM8-9R^+]?N+[5Y+#1[.[BT2T_0:BB@ HHHH ****
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MWJ>F6]G9^(/$.E6=N]UXD\016=K)J&JZA,EZ+[4K:]UG5 #@OV0_V";KP?\
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M^*GPDU6RNDT_7O!T%M,+A?B5\-YKJZO]#_L2*#Q5J=H;:+0-1DN=(_X1/QB
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M],OTD?89+N"2&XB?R'^M: "BBB@ HHHH **** "BBB@ HHHH ***_.KXB?\
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MUL8;)O#]EXJ_MB?PWIMGI]O'I6E2PBXNM0O[R\EC /KA5"J%50JJ JJH 55
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MW^H16\:7E[!8>?=?88;JX62>*S^U7/V9)%A\^;9YC7J "BBB@ HHHH ****
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MQCU;18_%?B#PUH^MW5IH>E3OH-H ?H3Y<?F";RT\X(8A+L7S!&6#&,/C=L+
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M0GNM3U6_GN+_ %&[NKR>:=_0*** "BBB@ HHHH **** "BBB@ HHHH ****
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M)M3.NZSX4\%R"RM6T'PQJ'B"2XUN^M]UWJ>I7<EK;ZGJMYINBZ!8Z5]CT44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F/QD_
MY)OXC_[A'_I^TNO3J\Q^,G_)-_$?_<(_]/VET 1?!?\ Y)UH?_775O\ T[WU
M>IUY9\%_^2=:'_UUU;_T[WU>IT %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7F/QD_Y)OXC_P"X1_Z?M+KTZO,?C)_R3?Q'_P!PC_T_:70!%\%_
M^2=:'_UUU;_T[WU>IUY9\%_^2=:'_P!==6_].]]7J= !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5YC\9/^2;^(_P#N$?\ I^TNO3J\Q^,G_)-_
M$?\ W"/_ $_:70!%\%_^2=:'_P!==6_].]]7J=>6?!?_ ))UH?\ UUU;_P!.
M]]7J= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YC\9/\ DF_B
M/_N$?^G[2Z].KS'XR?\ )-_$?_<(_P#3]I= $7P7_P"2=:'_ -==6_\ 3O?5
MZG7EGP7_ .2=:'_UUU;_ -.]]7J= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17B/[27QR\
M-_LU? ?XJ?';Q6L,^D?#3P?J?B%=.GOXM+_M[655++PSX6M]0GCFBM;_ ,6>
M);O2/#6FRM!.?[0U6V5+>=V6)_&OV)_VL]9_:I\(_$A_'7PHU'X&?%GX/?$[
M5_AA\2?A9JNOV_B6YT74;/3]-U?2=7LM9M]/TI=2T37=.U,'3M173X;2^GL+
M^;2KC4M(-AJM\ ?:=%%?F]^UC\=/BK\./VU_^"</PJ\&>*Y-%\ ?'+Q)^T-8
M?%/P\NE:'>Q^*[7P7X,\$ZEX7BEU#4=,N]7TK^R;_6-0N4;0]0TQKIYPE^;N
M&*&., _2&BBB@ HHHH **\B^$/QU^&'QV@^(=S\,/$$OB&'X5_%/Q;\%_'#R
MZ-K>C?V3\1? Z:9)XET.-=;T_3GU**P35]/*:MIJW>D7GGD6=].8I0F!X#^)
MOQ4\2_&_XV_#OQ1\$M4\%_#/X>P^!W^&WQAN?$5M?Z?\7)O$.BG4/$\-CH"Z
M;:W&B'PEJ7_$ID=K_5$O&1IW:S,D4# 'OE%%% !1110 45\"_M%_M7?&KX<_
MM#_#C]G+X%_ #PW\9O%WCSX7^*?BC/=^)OB['\+;'1](\*Z_8Z#>0"2?P7XI
MCOI))M1LWCVS02DRE1;F..29<;X-_MO^/=4_:*TS]E3]I_\ 9TU']G/XM^,O
M"VO>-/A1J6G?$70OBG\-OBGHGAE&GUVRT#Q5INE^';NR\5Z98V^IZI=>&;C2
M+BZM=%T>XU75)]*74-$M=2 /T3HKP.V^)OQ4F_:5U#X1R?!'5(/@U9_":#QM
M!^T$WB*W_LF\\>R^(X-+/PUB\+MIJ7!NDT>2?6WU:+5YO*6U\B73ECN([A??
M* "BBO+OA[\9?AY\4M=^)WASP1K<NK:O\'O&TGP[^(-M)I6K:<NB^+H=+L-9
METN*?4[*T@U5$T[4[&?[?I4E[I[&;RDNFFCEC0 ]1HHHH ***^&/^"B'Q<^(
M?P4_9V@\;?##Q'+X6\4/\8?@=X9;58M.TC4W.A^+/BEX9\/^(;#[+K>GZE8[
M=1T>_N[-IQ;?:;=9C+:307"I*H!]ST444 %%%% !117PQ\3OBY\0] _;Z_9;
M^#FD>(Y;/X;?$'X/_'WQ-XP\,KIVD31:SKG@X^$?^$;OWU*XT^76;-M,_M*]
MV0:?J-I;7/GG[9#<;(]@!]ST444 %%%<9\1_$'B3PG\//'GBGP=X0G^('B[P
MUX,\4:_X5\!6NHQZ/<^-_$>C:'?:CH?A&WU::VO8=+G\2:G;6NC1:C+9W<=C
M)>K<O;3K$8G .SHKS'X,>,/&GQ ^%?@3QI\1?AW>_"7QQXD\/6>J>)OAOJ.J
M0ZU?>#]4N-WG:/<ZI!;627DD*A)-[6=I,JRB*XM;>X26)/3J "BBB@ HK%\2
M>)- \'>'M=\6^*]9TWP[X8\,:/J7B#Q%K^L7<.GZ3HFAZ/9S:AJNK:G?7+QV
M]G8:?8V\]W=W,[I%!!%))(P52:_,CPS^WG^TK\=['4O'O[)7["^N?%+X(6Z:
MD?"WQ*^*GQJ\+? B^^*LNDWU]9S/\/?!FL^&_$NJ#1-3%G&^@^)/%-SH5M=M
M>>1JEEHMS8WD"@'ZHT5XO\!OC!<?&SP&?%FI?#;Q_P#"+Q%INOZYX3\5?#SX
ME:9;:=XF\.^(?#UW]EO8UFT^ZOM*UO0M1A>VU?PWXDT>\N-,U_0K^PU.U:,3
MM#%[10 4444 %%%% !1110 4444 %%<IX\\;^&OAGX&\9_$?QIJ#:3X.^'_A
M3Q%XW\6:JEG>ZB^F>&O"FCWFO:[J"Z?IMO=ZC?-9:7875RMGI]I=7MR8Q#:V
M\T[QQM!\._'_ (6^*O@+P;\3/ VH/J_@SQ_X9T3QAX5U62ROM-DU'P_XAT^W
MU32+Y]/U.WM-1LFNK&Z@F-K?6MM=P%_*N((I59% .RHKY^_9F^*'Q8^+_P *
M['QI\:/@9JG[._CFXUO7M.N?AKJ_B6T\67=II^F7[VNG:L-8M--TA)8=5@4S
M1(^G6S *98O.M9;>XE^@: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM+Z)HWB/1XII;2V^UWTVGYNX+  _32BFNZQHTDC*B(K.[N0J(B@LS,S$!54
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MXAN[C5)+C1M'M=0U1[[PGHD7B9-,M-#&J(+U=,AM+NYCC>X]H^'?C_PM\5?
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M?'/X;Z'?ZXHB@G\?6NC:+X;\5>"-&CU*6TT=-9U#1[F.]U*X>&VM#"EI<:@
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MG,MP\LTGZ&T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7F/QD_Y)OXC_[A'_I^TNO3J\Q^,G_)-_$?_<(_]/VET 1?!?\ Y)UH
M?_775O\ T[WU>IUY9\%_^2=:'_UUU;_T[WU>IT %%%% !1110 4444 %%%%
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M5_\ "YMO_F?H_P"(E^#W_1+4_P#Q%\G_ /EG]6]+G^HOB=_T4E3_ ,2#-?\
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M^'VCW'AWX>^"]$O]6MK+4-9OM-T6X9=<UJ:SMH[F5+*RMUNQITFLZL ? O\
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M.W#7>H6FK^&0#M;#QMXS;_@L9K?P[;Q=XG;X?I_P3KA\8)X%.O:J?!R>+O\
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M?_0WE_X=<=_\@'_$;?HW_P#1 4/_ ! ^&O\ Y<?ST_\ #R_]NK_HX[QI_P"
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MM\$?'FD_M\?%G]H.\M=.7X<>+_V<?AO\,]&NTU*&359/%/ACQIXCUS589]*
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M<+'-%-N$<E '@W[/G[*'Q3_:Y^!'A']I'X^?MB_M5>'?BE\=_"&G_$+0=&^
MGQ?U;X3?"_X1:'XG^UZYX.T?P3X)T*U2WNKBQ\/ZCHL.NWWBBZUW4=0NK(1R
M:A+=1W&KZCA_"O\ :Y_:4?\ 8)_;YEUGQ%8>+?VB_P!B'Q9\??@S:?%6#1M.
MLSXL7X5Z:&M/BG?^';V.^T-->TFS_M?59=*GAU'3-1?0+%]1@U!]0OH9N_\
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MQO,-2\5?$CQ9!K27FF^&=-U?5F\)>'?!EAH^GPZ1/J#S75I^E/[#G[/GQ&^
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MMX&T33U\/Z'X@T[X%:CX9L9=;^(UIX;@LTC/B;QC9>%[C7X#J.K6E]9&6PO
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MC7AH4&MZG+K.J(?$GB;6O%VJM=:E,D<EP9=:U_498LHBPP/%;HH2):]HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O,?C)_P DW\1_]PC_ -/VEUZ=7F/QD_Y)
MOXC_ .X1_P"G[2Z /.OAI\3_  =X;\&Z7H^K:C/;W]K)J#31)87LZJ+C4;JX
MBQ+# \;;HI48[6."=IP017>?\+K^'G_07N?_  5:E_\ (U=T/"_AH  >'="
M P -(T\  = !]GX I?\ A&/#?_0O:'_X*;#_ .1Z .$_X77\//\ H+W/_@JU
M+_Y&H_X77\//^@O<_P#@JU+_ .1J[O\ X1CPW_T+VA_^"FP_^1Z/^$8\-_\
M0O:'_P""FP_^1Z .$_X77\//^@O<_P#@JU+_ .1J/^%U_#S_ *"]S_X*M2_^
M1J[O_A&/#?\ T+VA_P#@IL/_ )'H_P"$8\-_]"]H?_@IL/\ Y'H X3_A=?P\
M_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN_P#A&/#?_0O:'_X*;#_Y
M'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z"]S_ ."K4O\ Y&H_X77\//\
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M%U_#S_H+W/\ X*M2_P#D:N[_ .$8\-_]"]H?_@IL/_D>C_A&/#?_ $+VA_\
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M[_X1CPW_ -"]H?\ X*;#_P"1Z/\ A&/#?_0O:'_X*;#_ .1Z .$_X77\//\
MH+W/_@JU+_Y&H_X77\//^@O<_P#@JU+_ .1J[O\ X1CPW_T+VA_^"FP_^1Z/
M^$8\-_\ 0O:'_P""FP_^1Z .$_X77\//^@O<_P#@JU+_ .1J/^%U_#S_ *"]
MS_X*M2_^1J[O_A&/#?\ T+VA_P#@IL/_ )'H_P"$8\-_]"]H?_@IL/\ Y'H
MX3_A=?P\_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN_P#A&/#?_0O:
M'_X*;#_Y'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z"]S_ ."K4O\ Y&H_
MX77\//\ H+W/_@JU+_Y&KN_^$8\-_P#0O:'_ ."FP_\ D>C_ (1CPW_T+VA_
M^"FP_P#D>@#A/^%U_#S_ *"]S_X*M2_^1J/^%U_#S_H+W/\ X*M2_P#D:N[_
M .$8\-_]"]H?_@IL/_D>C_A&/#?_ $+VA_\ @IL/_D>@#A/^%U_#S_H+W/\
MX*M2_P#D:C_A=?P\_P"@O<_^"K4O_D:N[_X1CPW_ -"]H?\ X*;#_P"1Z/\
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M *"]S_X*M2_^1J[O_A&/#?\ T+VA_P#@IL/_ )'H_P"$8\-_]"]H?_@IL/\
MY'H X3_A=?P\_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN_P#A&/#?
M_0O:'_X*;#_Y'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z"]S_ ."K4O\
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M1Z .$_X77\//^@O<_P#@JU+_ .1J/^%U_#S_ *"]S_X*M2_^1J[O_A&/#?\
MT+VA_P#@IL/_ )'H_P"$8\-_]"]H?_@IL/\ Y'H X3_A=?P\_P"@O<_^"K4O
M_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN_P#A&/#?_0O:'_X*;#_Y'H_X1CPW_P!"
M]H?_ (*;#_Y'H X3_A=?P\_Z"]S_ ."K4O\ Y&H_X77\//\ H+W/_@JU+_Y&
MKN_^$8\-_P#0O:'_ ."FP_\ D>C_ (1CPW_T+VA_^"FP_P#D>@#A/^%U_#S_
M *"]S_X*M2_^1J/^%U_#S_H+W/\ X*M2_P#D:N[_ .$8\-_]"]H?_@IL/_D>
MC_A&/#?_ $+VA_\ @IL/_D>@#A/^%U_#S_H+W/\ X*M2_P#D:C_A=?P\_P"@
MO<_^"K4O_D:N[_X1CPW_ -"]H?\ X*;#_P"1Z/\ A&/#?_0O:'_X*;#_ .1Z
M .$_X77\//\ H+W/_@JU+_Y&H_X77\//^@O<_P#@JU+_ .1J[O\ X1CPW_T+
MVA_^"FP_^1Z/^$8\-_\ 0O:'_P""FP_^1Z .$_X77\//^@O<_P#@JU+_ .1J
M/^%U_#S_ *"]S_X*M2_^1J[O_A&/#?\ T+VA_P#@IL/_ )'H_P"$8\-_]"]H
M?_@IL/\ Y'H X3_A=?P\_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN
M_P#A&/#?_0O:'_X*;#_Y'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z"]S_
M ."K4O\ Y&H_X77\//\ H+W/_@JU+_Y&KN_^$8\-_P#0O:'_ ."FP_\ D>C_
M (1CPW_T+VA_^"FP_P#D>@#A/^%U_#S_ *"]S_X*M2_^1J/^%U_#S_H+W/\
MX*M2_P#D:N[_ .$8\-_]"]H?_@IL/_D>C_A&/#?_ $+VA_\ @IL/_D>@#A/^
M%U_#S_H+W/\ X*M2_P#D:C_A=?P\_P"@O<_^"K4O_D:N[_X1CPW_ -"]H?\
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M]"]H?_@IL/\ Y'H X3_A=?P\_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\
MY&KN_P#A&/#?_0O:'_X*;#_Y'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z
M"]S_ ."K4O\ Y&H_X77\//\ H+W/_@JU+_Y&KN_^$8\-_P#0O:'_ ."FP_\
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M*;#_ .1Z .$_X77\//\ H+W/_@JU+_Y&H_X77\//^@O<_P#@JU+_ .1J[O\
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M+_Y&H_X77\//^@O<_P#@JU+_ .1J[O\ X1CPW_T+VA_^"FP_^1Z/^$8\-_\
M0O:'_P""FP_^1Z .$_X77\//^@O<_P#@JU+_ .1J/^%U_#S_ *"]S_X*M2_^
M1J[O_A&/#?\ T+VA_P#@IL/_ )'H_P"$8\-_]"]H?_@IL/\ Y'H X3_A=?P\
M_P"@O<_^"K4O_D:C_A=?P\_Z"]S_ ."K4O\ Y&KN_P#A&/#?_0O:'_X*;#_Y
M'H_X1CPW_P!"]H?_ (*;#_Y'H X3_A=?P\_Z"]S_ ."K4O\ Y&H_X77\//\
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M%U_#S_H+W/\ X*M2_P#D:N[_ .$8\-_]"]H?_@IL/_D>C_A&/#?_ $+VA_\
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+ ."FP_\ D>@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g4bdklltl5z5000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" *D J0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHH) ZT %%)N&,@T;UQG- "T4%@.IHR/6@ HII< XQ2JP;I0 M%&
M:;O':@!U%&1C--,J 9H =12!U(SF@,"<"@!:*0L <4;AC)H 6BF^:N<4>8*
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M>OIT.J\+>+O#_C'3CJWAO4DNK?S"ADCSPP'(Y[\BM&2YB@C:::1415W,S'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MIKOMIIDQ_%^E $F0.IH/IFH9)MHW$5X;^T;^WW\'?@)#)HEK>_\ "0>)FS':
MZ#I3B20RD#8LC#(C!+#U)YP"1BI<E'5G)C,=A<!2]I7DHK^MCW)I"K;0>HH4
MEUY-?(/@WPG^WS^U-XMTWX@_$'QM)\-?"MI>I=6>AZ3))%<74:NQ"R[&5W#+
MA6\QE4C#+'R:^O+>+9&%/&*<9<VIAE^/EF$935.48Z6<M.9=[;KYG)^)_"'B
M_P 4:S);S^(1;Z7_  1P_?/'0_YYSTK6\,>!]!\*H5TNU^=UQ),YRS>V>U;!
M4-P12KGN*WEB*DJ?)T\OU.B.$HQJ^T:O)]]?N$$:GIQS2G"KC/6J^H:M8:59
MR7VHWT-O;QC,DTT@55'N3P*\(^+W_!2']G7X77DWAW2=8N/$^L1_+'IN@P^<
M6DWE"AD^X&!!)7.<= <C.+:CN1C,QP.7QOB*BCY/?[MSU[3E&C^.+JQ"_NM0
MA\^/V=>&Y^F*Z)CA2?:OD/P7^T#^V_\ %SQIH_CJ;X Z3X9\&V=[$]Y/J[2M
M<BW8?O'0[TWY4\ 1'#8R2,FOKA)5<#!X.*J4O:6E\ON_X!S95F%/'1FZ<9))
MZ735T^USPC]HK_@H9\#_ -G?7[CP1K#7^J:[!;EFL--A!2.0KE(WD8@*6XZ!
ML9Y':D_9D_:A^.'Q\^(%]:>(?V>-0\*^&;6S^6^UC?'.;G/W-KJN\=>B\$<G
MM7L;?#KP&GB:X\;+X-TL:Q<0K%<:L+&,7,L:]$:3&XJ.P)P*J>%5BTSQ1K&B
MB-(UDF6[A5>KJXPQ_P"^E_#/IBIC!RC+78YWA\V_M"-2I7M3N[1BNG9MFOK^
MDR:SI,NFI?2VOFJ!YT/WEYYQ_+\:YB#X)Z SF?5-0O+QOX6DDP179G)/!-)E
M\8%:T\16HQ:@['K5<+0KRO45S%L_ASX.LG26+1(=R?Q,-V?SK8M;>WM(?L]K
M"L<:\*J* !^ J3:QX!IK,T>%%9U*DYO5M_,TIT:5+X(I?('7S&PS=*PK6P:'
MQ_=W3'B;38]OX,16V9P&KG]0N)A\1K%(W_=OITN_T.&&*5.4'=>5B:SMRM]&
MCH0/ESFD\L??ILMW!:0---(L:*,LS' 4>I-51XN\,$ ?\)!9_P#@0O\ C7/4
MQ%&C)*<DGTNT=$83DKI,O8^4KFL/P';>1H.2/OW4S?FQJ\?%GAG'_(?L_P#P
M(7_&JO@R[MKGP]%+:SQR+N<;HV!&=Y]*NABL/5@X0DG\T]C&I2DJT9--63-@
MKQQQ6!K=@+SQMHS"3_CW2XF9?7Y57_V;]*W?-<8)%8+P2/\ $M+Q/]7%I)5C
MGH6DX'_CIK>FXIOF:V9%?51TZHWEB53G8/RIUQ!%<0M!<*K1NI5U89!% EW,
M .U.WD\D_I648QCK%&_J<OJ/PB\%7S!ETYH<+C$,A /X5FR_"?4],"S^'_&E
MU%)&W'F'*A?3 .*[@N2#DT8!X85UQQV)C[O-?R>OYG#/+\+*[Y;-]M/R,7P1
M8^*+"REB\3:BMTWF?N74<[?<_P"<5?UW6;+0-*N-:U2;RK>UA:6>3!.U5&3T
MJV$P<H*KZR]O!ITTUXJ-&L3&19,;2N.<URUO:5KN-DW^9U4HQHQ2N[+\CA_!
MWQ'\"^-O&,VJZ?XDM6*PI!9V\S>7(S'YFV@X)_#/2N^B^=<]LYKR^R_9M^''
MBWP]#J=[I,VG75TWG%M/GV>6I)(0+@H!C'\.?>O0O!GA*U\%^&K7PS9ZC=W4
M-JI6.6]FWR;<D@9P.!G &,   <"O-PM3.'7=+&1C:.THMZ^J>QU3IX%4E+#M
MZZM-=_-&DBEN.E-9#U6N=\2?$FR\*:X-,U33;I8&13]K5<KSFM+2/%>A:[;K
M-IFIQR9'W=WS*<9P1U!KV)4:L8*36G?H<4<10E4<%+5="S?Z3IVJ0-::C9I-
M&W\,BY__ %4S2=#TO0[466EV:P0[MVR,<9]:M)(#SGZ9IP/]XU'-)1Y;Z?@6
MJ=-RYTM>_4RO$_BG3O"MB-3U%)6C\P)^Y3<0<$\\^U/T+Q3HWB2+[1I5\LH'
MWDSAE^HJ]/;6]S"T,T*M&RD,C*"K#N,5R=U\*=-CUF+6O#M]-I\BRAY$M\[6
M&<D 9!&>GI[5K26'<&I-I]]T<]5XF%12@DX]5U.THJ!YVMT:24X55R6/:LWP
MOX[\)^-;=KSPCXHT[5(8Y-DDEA>),J-Z$H3@\&L^635T=EU>US9HIIDYP*%;
ML:FX#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI'.!UIC
MEP,[Z %F8J !5?[0V_9GOC!K$\=^-+KPS!#;Z?ILEW<73%8453C(ZD_X=ZS?
M!_@WQ"^K+XN\6ZG(UUY>V.VC;"HI[''&/;UY/-;1H_NO:2=ET[LY)XG]^J4(
MW?7HDO4K_M$?#SQU\5OA?>>#/AW\0Y/"^I7$D>W5H82[)&&^=, J?F&1UKS?
M]EO]CGX1? 35)K:\T1-7\31_OG\0:E&)))E8J=T>[[F&4=.0>_)KZ  / QP*
MQO&6EW=Q%#K6D'%]8,9+=>TJ_P 49]F''UQTK.G&$I:]>O9G)BLMPM3%1Q<H
MWE'OM;R6R?F;,:+L^YCZ5($('%9^B:Y;ZSIT-_:,5\Q?F1NJ-W4^X[U;9W Y
M;!/0>E*2:E9H].,HRC>)3\1>)_#_ (0TB?Q!XHUVST[3[5=US>7UPL4<2YZL
MS$!1SW-<W\(/V@OA#\>K&_OOA+XTM]9CTRX6&^\J&2,QLPRO$BJ2#SAAE3@X
M)P:\*\>?\$_O'7QV^*.I>*OV@?CQJ&M^'X;QY?#OA^S7R8XHSDJK@#:A7.PL
MH+NHY<&O=/@7X ^'?PV\#1>&OAUX.L=#MX9,7EK:0X+3J!&SR-]Z1R$4%W)8
M@#).*2C*4>;H>/A\5F=?'<LZ2A35]W>4GY6T7XG(_M,?LEZ;^T]?:7'XD^(^
MO:;I>GY^T:/IDZQPWF6!)DR,DX&W_P"OS6Q\&_V2O@#\"[18/ ?P^LX[@%6;
M4+Q/.N&968J?,?)!&XXQCCZ5Z4H4+NV4Y60?-BIM[U['7_9>!^M/$."<WU>K
M^5]BK?:?:WMC)I\J?NY(F1PO'!&#67\/;Z:YT);*[*M<:?,UI<%<GYHSCJ>N
M5VG/O6X0=W%>._M$?M"^&_V5G/C7Q)I6HZA!KDD=O9V.GQ^9)+>*I^5>@7,8
MSSU*UM%KV<D_4>,K4<#%8BH[1CH_1['LS8QU]JYO7#%I/C+2]3:156Z62UD^
M7)<D;D'L 1^M?-?A']JG]N3XX^*=/G^%W[.5GHOAW[4IO+SQ1)(IG@\P!B#\
MNQ@N> LA] >A^EO'L<Q\./>QLRR6KI./+7<WRG) _#-31]Z=NFWWF%#,:.8T
M93HJ5E9IM-7]+DNJ^/?"FBRF#4=<MU=6VM&AWL&QW"YQ^.*PKCXV:3)-]DT7
M1KN\E+X55CV[AZC&2?RS6O;^!_!^JW/]OW&AQRRW0\Q_.)93D?W22OZ5N6FG
MV%A;+;65M'%&OW4C0*!^ KI4L'3T<7)^;LO/;4VY<PK:J48KR5WY'.>$O%GB
MW7M2D_M+PT;.S\LF-YLJY;(XP<$\9Y QQ72,X<Y-.*KC"BEQQ@@8Q7-4:E*\
M59'51IRIT^64G)]W8\K\3? GQOXM\23ZAJOQ5O(].DN&DM[.U4JT2D\*#NQ@
M?2I_"GPSL_A7XNL;H>)=2U)]09X/]-DW!!MSQ^5>G%0XR8ZP?%\$!U/2+Z5]
MODZACV^9"*\G!Y#EN'QOUA)\^KNVWK;U.S&9AC*N%]GS))66B2TNNQ?\0:'8
M>)=%N="U.)FM[J%HI@K8)4C'45PJ?LJ?"0C*V%Y_X&-7HZJNW -.4<<"M,5E
MN!QLE+$4U)K:Z'1Q6(H1:IS:OV/,;S]ESX206LD_V"\^52?^/QJZ+X.^&-&\
M+^"+:VT2%DBF9I6\R0MEB3ZUT6LY_LJXR/\ EB_\C67\-3_Q16G\_P#+N/YF
MJPN3Y;@XNI0I*,MKI&5;'8RM55.I-M;V9>\1:%;>(M%N=$N)YHUNH2C202%7
M7/<$=#7CL7[/%U=:WJ6E6?Q%UI&M88O(GDD+!F;)P<8SCV/?FO<G9=N#7.^$
M[Z2]UG6VD"_N]1\M<>@10#4XS)\#F47*O&]E;=K=^15/,,1A9QA3E;F?;LK]
M2;P)HFK>&O#5KH^NZVVHW,*D27C+M+Y8D=>F!@?A6=\3=<^)NC6UK<?#OPW:
MZFS.PNH;B8(RC&5(RP&.N><].V<=68E&-JC\J:R[%P%YJIX/FPGL(3<>B:W5
MO6Y4:W[[GDE+NGM^!X_)^TCX[\*+Y/Q ^$UU;LLFV2YM]RQ8]B00WX-6YH'[
M4?PJUL;+O5)K!]P 6ZMC\WOE-P ^I%=+JUNM_P",]+L)K'S([=)9_,Y^1A\H
M/ZU;U;X>>!-9O3J.K^$=-NKAMN9Y[)&<XZ?,1GBO*CEN?X3E]GB5-=IQZ7[J
MW3R.F.,R[$73HN+6EXR_1IFM#(LG/M6#\19V;1H]'1MK:E=1VRMMR/F/.?\
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MXN:#\<OVA-1D\&^'(=0^U6'A6P9HBT[1@ RQDG8K9.?,;?G@JO%?8R<KN/\
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MP.<_3<!]*T/#OQ:\-:XBV]Q=&SN&X\JYX4MW ;IUX&<$^E=8ZJ3M*\5A^(_
MGAGQ+N:_T]1*W_+Q'\K]/7O^.:[56P]2-JD;>:_5;'G2P^+H^]1G==I?HS:A
M8NBL6[5G>(=:BT73)M0)7>JXC7</F<G 7DCJ:A\+>'&\+:4-,34I;B.-F,9E
M'W0>BCV_S[54OKNVU7Q0L4URL=IIC*TC,V \[#Y5Z]AS^(K",(^TNMMSHG4D
MJ2O\3_K<N>&M&_L_2%MK]!)+-NDNF9?ONWWNO7_"KFC:)HWAW3(](\/Z1:V5
MK""(;6S@6../)).%4 #DD\=ZM*$9 ZA:&V@&IE*4K^9M",8Q2730^*_VE_\
M@JQXJ_8M_:PG^%7[2WP.N;'X<ZU! W@WQUI>^7S"$ N6F7D.$D= R)MDC7G9
M+O0GZ@^ _C'P5\3/A]8_$_P)XNL==L?$4*WT.I6,PDC=6'W1W&WE2IY!4@@$
M$"CX]^'/@?\ :'LM0\$?$GPQ9ZWX5$;V]UIFH0B2*ZE_O8/]S@JPPRN RD$
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M_P#9L_8O\:2>.]-_:2_:&^,]]XD\41[IK.SLYV6SM-V[Y,G!< -PH"*.1M;
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M_P!6NS5(_P#GI;]WQW9>H]B16M:G1IM4H3YO/I?LN_J98B$:,_:1=^_I_P
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MC&!]<X[5PM(0>E<53*,#4BTHVOV.RGG.8TI*7/>W?4]KTSXF^#-48+#K"(W
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M4E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1129;=TH
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M%W36CNNQI6C&5/V"6ZZ]%W/SA_8U_:6^-G_!,/XO0?L<?\% +9Y?"VI2+;>
M_B4\CRPV\0.([=I6ZVQ_ASAX#\K9C"B'].K.\M=1@CN[*X6:*6,/')&P974C
M(((X(([UPG[2?[-'PH_:L^%FH?";XO>'([[3;R,^5)@"6TE_AFB?JCJ>A'TZ
M9KS+_@G9^SK^TQ^RMX0USX/_ !H^*=CXK\+:7J 3X?W:[VO(K''W)RP 7'0*
M"V,<$ A1[&;XS 9U1>.5J=?13C]F?3FCT3_FCMU78C#T:F%G[+>'1]5Y/_,^
MC) =H/'N*^+_ /@J)^Q3>?$)]/\ VJ_V6KV\T+XX>#RMSHEUH:CSM9BCZP2I
M]V0A-P4L&#*6B8.K@#Z[\1^(7M95T71;?S]1G7,47:-?^>C>BC]3P*9X7\))
MI>^_O[MKF^FYGN)!_P".KZ+[5YF68RME>)6)@_\ MU[275276+V:*Q$?K'[J
M*]7V]/,^7_\ @E__ ,% O!W[;7AF_A\:Z?\ V1\4M!_=^)M#E1E15#;1+:JQ
MW+%GAD;+HY(8L-KM]=1KYO.:^2?VC_\ @F[J^L?M1>&_VQ/V3?'%MX%\:1ZM
M&/&;&W+6NLV3$"9GB7AIMN1S@/\ Q$$!A];6@*QX/K6^=2RVO7CB,%I&:NX/
M>#ZQ3ZQ_EZVT8\'&I3@X3W3W[^?KW*NO>'['Q#ITFF:C LD<@P<_P^X]Q5+P
MCX:?PEI0TF34I+I49MAD4#:I_A'M]2?;'2MVLWQ(-6&DWO\ 8+1+??97^QFX
M0M&)=OR;@""5W8S@@X[UY/M)>SY>F]CHC1IRK*5M=KEQ;A0< _A226_GC.!A
MAWKY&_X)T_MV>/OC1KOB']G3]J:RM=#^*'A:\9)K%XA;OJ$(R6=(\;?D&WE"
M0R,K@;3N/U[!GRQFLJ=2-2/-%_UV/2S++L1EF*>'KI75GIJFFKII]4UL<;I/
M@K6?#/C1KS0#%'I5PN;B$M]UO0#&>O3MU'I79F0+QBFM%WW57NM3L;:XBMKB
MZC62;/DQM( SXZX'?'?TK>I4J5I)OIH>72HTL-%I:)NY:W\9Q3JB5MW+"I:S
M-O0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CEN#&VT+
M4E<O\3O%2>&M&9(&S>70\NUC7[V>[8]OYX]:NG3E5J*,>IG6JQHTW.70U-+\
M5Z7K5[<6&G3[Y+.3;<+CI[^XK0$G\5<[\.?"<?AK0HS)G[3/^\N6;KN/;\*Z
M&,*HP1T_6BLJ<:C4-43AY5)T5*HK,4EL8%<3\1+3Q#XEUFU\'V,$D=E(OFW=
MQT4J#TS_ $]Q5GXA_'CX0?"?Q/X8\&_$;XAZ3HNI^,M6_LSPO9:A=".34KO8
M6\J,'N?E4$X!DDBC!+RQJW5^4K[7W_>YIT9SP\E.WI?\PQ&']O3Y&[)[^:*^
MF:39Z3I\6FV*;888PD:]< 5;,C#M2 *.]8_C'Q%'X7\/S:NZAF4;8UY^9CTZ
M"HCS5)6W;_,J4HT:=[:+]"X_B/2O[5706O(_M<B[E@W?,1@G^0-6O+!.,\&N
M.^%_A>ZM6D\7>( S:A?'=MD7F)3V^IX]/2NT;*+G%76C&G/EB[_E<RPM2I6I
M^TFK7V7ET*>L:/9:I826.H1^9'(OS*?YCW]^U>;?&KXQZM^S7\)O$'Q&\3:!
MJ'B*UT739+BSCTFU,MS<.!\D)50>22!NQ@#)/2NR^*7Q3\ _!GX?:M\3_BAX
MDATG0M%LVN=3U"96988UZG:@9G/HJ@L3P 34/PZ^(/P[^.GPXTWXC?#S6X=:
M\-Z]9^?IM]'&ZK<0DD9VN PY!&" 1Z55&7*N:<;PO_5F:5*/O*HM'^#\F?G_
M /\ !/O]AGXT_M=?'!?^"F'_  4',T^H7C+/X \%W496.TM02UN[1-_J8(PV
MZ*'[SLS32$LY,GZ2JA48S7+I]L^'0S!%-=:1CYHURTEJ?4?WD]1_#]*Z.RU.
M#4;6.]L9$DAD7<DB'.16^.Q%3$U%-_#M%+9+L7]8=:5I*S[=O0F<[AMS7Q+_
M ,%4OB1^VIH.H:3^SU^PQ\,==75_B!8RC6/&VGJ%BTZ,.$98I,_Z//M.6F."
MB,"GSX>/Z0^'O[7W[.GQ6^-?B;]GCX=_$NTU;QAX/C+^(]+M+:=EL]KHC S^
M7Y+.KNJ,BNS(VY6"LK >D;?-.<5GAZL\'74YP3ZV>S[?+J:<O+)-K5=SYE_X
M)I?\$^?A/^Q!\*OM.EW$.O>-M>C5_%GBR2,^9-+G<;:+=\T<*-V.&=OG?^%4
M^GH]NS:*YW6=,O= O6\1Z!&S[N;ZS7I,/[P_VQ^O>M72-=L=8L(]1TZ3?'(N
M5..1[$=CUX]:G$U*F(DZTFW?^K&*K2G4Y9_%^:\B[NV\YKFOB3<Z'!HRW&K7
MS6\T,RR6,D:[G65>A [CU'3'X4SQ[\1[#PBBVRQK<7DBY6%7^X/[S>W\Z\CU
M?6M2UV];4=2NFE=VSUX'T]..*]'+<KK8F2G+2/XOT/#S?.*.%BZ4-9?@O4U/
M%'Q"\1>*XUM[J<0P!0&AA)"N?5N>?IT'ZU@>7MP0>G^<T[MC-87Q)^)_P[^#
MO@V\^(?Q5\;Z7X=T+3PIO-6UF^2WMXMS!5!=R!EF(55ZLQ  )(%?8T,/3H14
M*:L?"UL16Q-3FF[LW"0.32\9YKYD_9"_X* ^)OVU?BMJE[\)_P!G[6K?X065
MD\-C\1M>=+1M0U)).4@MBQ>2%D/#@?*1A]K'8/IH%MV"*WE&479F7*X[CJ**
M*!!02/6C--);^$=Z3#7H+D]10"34^F:1JVM2^3I.FS7## ;RXRP3/]XCA?J>
M*Z32?@SXNOMLE]Y-HNXAQ))N8#UPO'ZUR5L=A</_ !)I'50P.-Q'\.FW\CDR
MQ%&\DX KT[3_ (#::J*VJZW-(X;YA"H52/QR?UK8LOA#X'LY_._LUI?]F:1F
M7\C7GU,^P<=KO\/S/6I<-YA-:I+U=_R/&5DSU% /J:]VB\ >#;>02Q>&[967
M[K>75P:!I 3":9;_ /?I?\*Y)\1P6U-_>=E/A:J_BJ+Y7/&_'A(&B^^@V_\
M[-6#O_&O>+/2GG,W]LZ?9_).RVGEIG]R/N@YZ'KD#BIKKPCX:U&'RKO1+=T/
M8PBL</GBP]-0<-O/YFU?AV6(J.:G:_=?(\"#9'3\*-QQTKW&X^&/@:>(Q'08
M4RN-T8VD?C61?_!#PE.B_9);BW*\EHY=V?SS7;#B+"RW37XG%4X9QD=8R3_
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MI$"[?)7HQ+3$$+&P_13X8^%/ /@;P%I?@KX8:)9:;H.E6:6^EV&GIMB@C7@
M#U]2>222222:VH](T^TFGN[:QACFNF4W$J1 -*0H4%C_ !84 <] *Q=1\.7V
MEW;:YX1E"2=9K!CB&X]?]UL=&]>M>A5Q4<11A1BN516U]WU;\W^1-6I4C9KX
M5T-YXT/&/O?>%?*O_!27XG?M/_!?X>Z7X._8X^'5[JWB+XA:H^C0ZA!#NM]
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M/\TC. X0K7#A,+[>M:II%:M]DO\ /IYET.6L[IZ%O_@G5X%^,W[?7[3VM?\
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MEQJ6DVVH7=A):23VZ226LV-\+%02C8XR#P<=Q5@JN,A:^$_V;/\ @I)^VO\
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M/!ZAB.2?]D?I7@8?$8BA5C4P[Y7%IIIV::ZW/K)0IJ/[U\S?]:&=\,_">B_
M+X0^&_AI)XAN+Z+P[H=GI<-]>-NN+P01+$)&')9VVY/7DU<*>)?&+9NI)--T
MW_GFC8GD]\_PC]>*X?\ :4\0_$'X&_ OQ%\8?AWX)_X3;Q5I5GY]O8W4A4%0
M?G**N3M4%W$:_,WW0>A$W[&7[4OA?]K[X&:7\7?#\2V\UPIBU33LDFTND.'3
M) R,\@]"#U-85,1#VSUO-ZMOK?>QWPRS&5L#];:M234='JG:ZOY/H=5\1?@U
MX ^)OPQU7X2>)]"BFT;6+)[:[MU)7(9<;LCG<..<YKY?_P""7_AS]HG]GSQO
MX\_9+^)^A:M=>%_#-\)_!_B2\SY+6SL0(8R1RN!N SP2PP!@5]G>6N,T!06Y
M4?E7/*FIU%.^J.["YE4P^75<$XIPG9I/[,D])1\[:/NGJ" LO)_&L7XB^!O"
M_P 3?!&K?#WQII<=[I>L:?+9W]K)G;)%(A5AD8(R">001V(K:W#.Y6^[6/K?
MB_2=*E%F!/=7;_<L[./?(?4^W&3R1T.*TC!SEHKGG>W^K34[V:U7?Y'PO_P3
M,\;^.OV4_P!H/Q/_ ,$X/BPUQ<16DT^I^"=0D)836>=Q_B(164;@HX5_,'.<
MU]R7GC.T69M-T*!KZZ7&Z.!OD3..6?H!SG\#7.W/P@T'QMXRLOB?XS\+:;;Z
MQ8VKV]G=6\"FZBA?&^(W&-VTXY52 >*[;3-%TS2;06>F6:0QK_#&H&?>IHTH
MX>GR-WMLO+M?K8[LZS)9UC%B*</9N45SOO+K)+I??7K<PH/">JZU)]I\7ZEY
MB[MPT^WRL0]F/5OY<5NVR65NR65L(X\+A(X\# 'MZ<BK&T#D#)KA_B;%>^'M
M=T_QY9,Q6W(ANH^P4DX/"G&<LI)[[<<UU4^;%5%"]NWKV^>QXM:2PM'GM>V_
MIW.XV[03BO,?VLOV9_!O[6WP5U+X,>-;R2SBOMLEKJ%O&&DLYT.4E4'K@CD9
M&02.]>D6%Y'?VT=Y;R[HY%#(W/(-2LH8L:Y904H\LO2QZ&%Q5;"U8UZ$K233
M371]SEO@E\-U^#_PNT'X91^([S6%T/3H[1-2U!AYTRH, MCCIQCL !76;B3P
M:SM1U[3-'>&/4;M(FGD\N%6_C;T_^O[U>B??R*KEY8I]":E9UJTI2=Y-W?JR
M4;@V":=30I+*PIU!(4444 %%%% !1110 4444 %%%% !39=W 'K3J;*2,$4
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M^"[_ (ROOVNX-+VV'@FR/P9;Q L:0JH6/S&AZ(\@=KOYI-SCL1A<<O\ MO\
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MCTW3H-BKU/\ $Y]2>YK30?)TKX',<QJ8VIVBME^K/T'*<KAE].[UD]WV\D(
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M&1YUM(5*.P*E3P<@?F?$5' 4\PE]4?N]>REV1]-EM6O/#KVN_3S1W2JK_+7
M_$_X8KJ;2>(/#\.+C[UQ"G_+7_:'^U_.N]7*C(I<KC%>/A\36PM93AO^9T8K
M"T<91=.HM/R/G$HR':Z_,.H(Z&O)OVDOV9/@7\4_ACXV/B3X"^']?U36]!G6
MZ8:7"EYJ$D<1,*&X51)N#(@5MV5P,=*^IOBE\-%U!)?$>@0!;A5+74"_\M0.
MK#_:]N_UZ^9 9Y)S7W> S".+IJ<'9]5V9^<X_ 5<NQ'++Y=F?D9^SG^U+\.O
M^"1O[+.K^+_C5<:AX@^/WQ(@BOH?!^I7\LUUIUE&&BTZVO9I#F&..,O)M(W_
M #%0-I0U['^RM^U'^W]\'OVF_A_X3_;C\6>'_$'A_P"/&EBY\,PZ#- W]A7H
MC,B0((V^:)H]K-("Z9;AN!GZ[7]B3]E ?$?QE\6Y_@9H5QX@\?::VG^+;ZZM
MO.%_:LNV2(HY*()!CS-BKYA52^X@&O)_V;O^"//[)7[,WQLM_CIX6O/%NO:E
MI4<L?A;3_%NM)>V?AV-W9@MFODJZ[0S*ID>1@"3DL2Q]EUJ,HMM:O?3\NR1S
M^TIN]^O]?(^K\ CI0'=&#HS*RG*E3R*!QQ0<XXKEW5C!-Q=T>D>"M3O?B);B
MRUK6ML5HJK-9PG:UR,#YV/7&<<#WSUKNM/LK/3[9+.RMECC5<)&JXQ7A7A;Q
M!=^&-;@U2U+85MLR*<"2//*G@_\ ZZ]TTK4+/5[2/4K"<21RIN1A7PN;866%
MK7C\+V\C[_(\93QE%J7QKJ]V27]K:WEF]E=P+)%*I62-URK*>H([BOSHLYC_
M ,$KO^"@TMA+ ;/X3?%J9%MV#A8--O2X&<$A41&?#'LC*3@)BOT<PIY)KPO_
M (*&_LR^'/VK?V<=4^&=_K-CINK!UN_#NHWV\I!>1YV@B,ABKKOC/#8W[@K,
MJBO#K49U$G3^):K_ "^9]]D&98? UY4,7_ JKEG?IVDO.+U^]'N4$BW$0E0[
ME;D-FJ&O>)-*T-%6\N?WC [((UW22=>BCGL?:O*OV4])_:(@_9S\(^%OC)J-
MO'XBL=)2WUC5XYI)GN N5C;,G+RF(1F21CAI#(5!&#7J&B^$](T)FGAC::XD
M_P!9=7#%Y6/N3_3 KHC&,8WF]>Q\_B5..(E3I--)M<W1I=5_2/A&3XN?&/\
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MHW_HEJ_I:QQFOYI?^#GX$_\ !5K6A_U)>C?^B6KZ[@G_ )'7_;K_ $/'SO\
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M*R])LX;5KH0:C-<>9=-(WG2[_+8]47T [#MFM)7!%-_$R(?"AU%%%!84444
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M'AQ+E>AKZOV^/-8*R%;;2XRR-M_ULNW'()X4'\ZV8K>"TC6W@B6.-,+&D:@
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M^N9KQ_\ X)R_\H^_@7_V1WPQ_P"FFVJO<?'O]JN:)D_X81UH94C_ )'[1_\
MX]72?L<?#GQ3\'/V2_A?\(/'%M%#K7A7X=:)H^L103"2-+JVL(8)55APP#HV
M&'!'-?)-<L=3VE)2J778]*HHI"P!Q4&@M&>>E-:7;U6O$_VL_P#@HC^R!^Q)
MHQU3]HSXU:5HEPT1DMM%67SK^Y &<) F7.1TR #@X-53IU*TN6";?9$RJ0IQ
MO)V/:7DVG +4F\8PKU^/7[1/_!V[\&/#UW-I?[-/[-NM>)_)U#9_:7B74ETZ
MVN;7:W[R-4620,6V_*ZKQNYX /R_XS_X.NO^"@^I^);J_P# 7PT^&^CZ7(^;
M73[_ $FZO981CHTPN(M_UV#TKW\/PKG>(BG[/E]6D>?/-L#![W/Z$]"GT.47
MG]B;?EOY!=[4(_?<;CSU/3D<5H*V#C.*_G'/_!U5_P %-\G'AKX5_P#A*W7_
M ,F5ZE\'?^#N3X]Z/;Z?I_QS_9<\-ZY)]L4:IJGA_5IK)C;EQN\NWD60;PN<
M!I "<9(%;UN$<[IW:@GZ-&-/.,'9)MKY'[U?,W(-25^>_P"RI_P<H_\ !.;]
MHF[M_#WC'Q+JGPYU>YN&CAM?%UN! 1D!#]HB+1@N3PI.1CG%??&@>*?#_BK1
M[?Q#X7UJTU+3[N,26M]8W"S0S(>C*ZDJP]P:^?Q&#Q6#ERUH./JCTZ5>E6C>
M#3-"BHQ.#T6G>9SC;7.:@_2OQ+_X/$C\_P"SS]?%G\M'K]M&;*YQWK\R_P#@
MXD_X)E_M7?\ !1UOA"?V7_#>DZA_PAW]O_VY_:FM16?E_:O[.\G;O^_G[-+G
M'3 SU%>OD.(HX;-J52I*T4]7\CAS*G.I@Y1BKL_G+SD@_P"U_2OZ?O@E_P H
M@/V6/^OKX3?^G;2*_(4_\&R/_!5X8_XMQX3_ /"TMO2OVO\ #?[-_P <_ '_
M  31^#/P)M/!=OJOC;X=)X$FU;0[?5H8TF?2+ZPN+J..=R(\[;>3:2<$X]:^
MGXNS+ XZ-'V%12LW>QY.4X>M1J2<XM'UJW2O#OV /^2,>)O^RW?$;_U,M9J7
M_AH+]J@G!_82UKI_T/VC_P#QZKW[$_@'XA?#OX*7FG_%+PNNBZQJ_P 0/%NO
MRZ2M]'=?9(=3\0ZAJ$$;21$HSB&YCW;20&R.U?#I<M.2?D>_=2G&W0]@'2B@
M'/(HK$U"BBB@!KKQD5SOQ'\,GQ'X7F@C4&:-?,AXZD=OQKHV7=2.&*D''2JH
MU)4:BG'=.YC6HQKTG"6S5CYO.5.U@<K]X'M0!6U\1-!'A[Q;<VT,>V*0^;#Q
MQL;L/H<C\*QAG.:_1</6]M14UU29^5XBC+#UG3?1L6@G':B@C-=)B,)]:]-^
M'>H^+O$>@1V>FZE:6T=KB-YF1GEX[8/ X^M>9LN>,<?6NZ^!FKFUUJXT>0L1
M<0[X_0%>OXX(_*O'SJFY81S2^'7_ #/:R*LJ>.4&[*6G;T.U@^'^F/)YVM7E
MQJ,G/_'U(2HYSC:,#@^U<Y^TO\$=&^.7[/WBSX,7-M:PKK^A7%M:RR6OF);W
M!0^3/L!&3'($D'(Y0<BO05<'G;^%,?YS\WY5\1.4ZFC9^D85_4ZT:M)6::=^
MMUJ?&?\ P1%^,-QXS_90D^$OB ^3K'@'6I].N+*19!-%;NQEC,N_HV\S)M&-
MHB ('?[.3GYEKX2_9$\+^+/V>_\ @J;\7?AI+HNN1>&?'$3:YI=U<6!>WN+I
MR)Y'\X* H5Y+F-5SZ Y."?N2[UC2M-0?;]0BAR,_O) IQZUS87F=))KR^X^@
MXJCAHYO.O2:Y:BC/?1<R3:^3N?-G_!4K]H+XW?LO_ S3_C+\&M<LK;^S_$5O
M%K-K>6*S?;()#CRP6^YR.6'..E>_?##QSI_Q$^'NB>.M*OK:ZMM7TV&ZAN+.
M421,'0-E6!(*^]>;?M?^$K#]H[]G;Q5\&?"]]))>:_I,D5C-%:ET$PPRJ3P!
MDKC.>,Y[52_8H\$?'?X1_LP>#/A7\2/#^G)J^B:6+.X:&Y/EQQH<1+WW,$QN
M(X+9(XK:-&LJSOLTM^Z.&I6RVIP_"4+>VA-IVW<6KK[FOQ/<S+N&XG\:Y#6_
MCY\(O#GQ;T3X#ZOXZLX?%WB&RGO-)T'):>6"($O(=H(1<*^TN5W^7)MW;'VZ
M$>@>,]1$;ZIXICAVL?,CT^VP&'U;//X5\+_\%6?"\'P%_:,^ W[5VG6VHS)I
M?B?^S/$&I+?M]HFB\Q)H+;J!M*_;N !D.0V1C!B.6C3Y[WLUMZ_H3P_@8YOC
MUA9MQO&5GIK)1;2U[M6/T(Y^\E4O$NFIJ>AW>GR E9K=E^7KTZ5:A8F!2#]Y
M0:>YRN/:J@W%IGEU(<U-Q?70Y/X,W[7/A<6,\A,MI<,C*PQL]!78,K%" U<S
MX(\'ZAX7U34));N.2WNIO,A4*=P.3G-=002,"NC%.,L1*4>ISX&-2&&C&>ZT
M.+^+.K:SX>M]/UO3[IECBO )HE;'F=POT^4_G760E70.G\2UE^._"S^*_#LF
MDQ/&LI96ADDSA6!Z\>V1^-7="L+C3-'M=.NI1(]O;I&T@_B( !-$Y4Y8>/=-
MW)IQJQQDK_"TK>I=3(^7%.IJ9/S9IU<YV!1110 4444 %%%% !01D8HI&;:,
MT ,F4$5P?@B.;5?BGKNKR%5^SK]GVC_> 4_E&?Q-=U([;,XKF/ASX5U+P]/J
M6H:Q*K7%Y=9W*W!49(/L<L:Z:,E3HU.[22^\XL33E5KTDEHFV_N.JC!!P36'
M\2]5;1_!]Y?1NRMY>Q'3@JS< _K6VC'/2LCQWX>E\5>'Y-&@N5B:1E;S&7(X
M8&LJ+BJT7/:ZN;XB,Y4)*&]M!?A_]K/A.Q.H.S3&W!9G.2?3]*UG3,F*KZ3;
M"QL8K)6SY$:ID]\#&:EED96R*FI)2J.7=E48RC249;I)'G7QM_98^$7[0/C#
MP?XT^(^DW%Q?>!=874]!:&\>)4N%9&!8*1O :-#@\?+CH2#Z2BB./:!FN*\$
M_'WX3_$3Q[X@^&/@SQE:ZAKWA9D3Q!IL.[?9LY(4-D 9.UNA/2NR:;D<>U8Q
MY;MQU.S$5,5RPI56[17NI]$]=%YWN5=7NC965Q>(F62-F_$#BOAG_@B-IFK>
M-O#OQ2_:9U:"T@_X3KQY/-'9PABUNP+32)N(^[FX&.>=O/:ONR6*.96#@LK#
M#*?Y5F^#/AYX(^'>C#PWX#\)Z;HNG*S.MAI-C';PAB>2$C4*"?I4RI\]2,K[
M7_$[,+F4</EE?"J.M7EU[*+O;YNWW&IL&W!'%?'G_!:N75;?]CJ30?!VGWDF
MH:UXDLK)8-.T^21KE78YB.Q3]X[0 <%C@#)XK['VC9CTJ%X8Y/\ 6+N^M54B
MY4W"]KJQAE>,CEN84L5RJ3@T[>GWGFWP-^".D_#GX,^&/ _AV]U;34TO1;6W
M5?M3%@(XPNU@V<$8YX'\ZZM]/^(%@6DM-<L[Q2W$=Y;F,A?]Y.I_"N@6+YN3
MGVH<#'%=$:LEIOZGGXB/UBM.L[IMMO7JSSWXH^)?$/\ PC<FD:OX;^R+/,J+
M/'>+(KXRQP.&'3N/7IT/G ]0*[GX[7RRZU8Z:%YAMVDW>N]NG_CGZUPYYK[3
M)*:C@5)*W-JS\[SVI*>8-7NHV0<YHHHKV#QAIR3Q5G1=,EUG5K728<AKB94W
M*N=N3C=CV_"J[>PKK?@QI7V[Q?\ ;9(VVVENSJRGHQ^49_ M7'C:WU?"SJ=D
M=> H_6,9"GW:/7M.MK>RLX[.TC58XE"(JC@ # 'Y5-38AA-OI3J_.WJ?JD4H
MJR"BBB@84'D8HH- #&7C:3UI@B"L#NJ4+ZG-(8QZU+6MP(]N[@F@0@'.[BI/
M+&<YH,>>K4 -901M#411[.].$2B@X7H*!A)($QD=:YWXJ?%CX<_!3P!JGQ5^
M+'C&PT#P[HEFUSJFKZE<".&WC'4DGOT 499B0 "2!2?%?XJ> /@K\.=8^+'Q
M5\4V>B>'= L9+S5M4OI-D=O"@R6/J>@ &2Q( !) K^9[_@LG_P %DOB)_P %
M)OB&W@7P-->:'\)=#O"VAZ&S;)-5E7@7MV!U8]4C.0@.3ECD>UDN2XC.L1RP
MTBMWT7_!.''8ZG@Z=WJWLCZ6_P""H?\ P<[?$KXBZQJGP:_X)YW$GAKPS#-+
M;3?$6XMR-2U>,Q,A:UCD4&QCW,65R//.R-LPDM'7Y,^-O'/C7XF>)KKQI\0O
M%FH:UJU_,\MYJ&IW;333.S%B2S$GEF)_&LS;[TAX/ K]ARW)\%EM+DHP5^_5
M^K_I'QN(Q>(Q$KR8@! ZTY3Q2=SB@L1TKT4<W-<=31@=:7<<\4@ [53$^PGE
M@<@_C7T7^Q#_ ,%4OVT_V O$%O>? WXL73:&MPCWWA'6V:ZTN[0/&60PL?W9
M98Q'OB*.JLVUE)S7SKG/WJ"3CK7/BL+A\93<*T4T^_\ 7Y&E.K4I2O!V]#^I
M+_@EM_P6P_9G_P""DFA6OA*.ZA\'_%"&&234O 6H7)9IHXSS/9S%56XC*D,4
M&)8\,&4JHD?[0#DM\PK^++P%X\\9_"WQKI?Q$^'?B:\T77-%O([K2=4L)C'-
M:S(<JZD=/IT(X.02*_I)_P"")/\ P6H\'_\ !0[P7%\%_C!=6FD?%_0[#?>6
M8PD6O6Z##7EL/[P',D0Y7[PRN2/RKB3AEY=>OA]:?5=8_P# /JLMS/ZQ^[K?
M%T?<_08[F3;NQ0JXZT1MO8?)4A3T-?(>\>V1B')X-(( #PW?-2J@0Y%&PYSN
MI 1O#N(RW3GI3EC"H%7H*DQSF@@GH: &ITZTZA1M&**8!1110 4-THH;[M '
MG'QUT-'L[77XD^:*0PR[5Y*L,@D^@(/XM7FF,<YKW3Q]I UCPC?V05G;[.7C
M56Y+*=P'Y@5X6#Q@"OL,AK>TPOLW]E_@SX'B3#^SQGM%]I+[]AU%%%?0'SH5
MH^$M9B\/^);/5I_]7%-^\]E(P3[X!)_"LZFMQR#6=:G&I2<'L]#2C4E2JQG'
M=.Y[8OCM;UE'A_P[J%]OCW1S+;^5$?8M)MQ^5#3?$#5F4BRL=-C*'/F2&>1&
MYYXPOIW-:F@W*ZOHUKJ 38LUNDNSTRN<5<"JJYSG-?F\I1A)J,;>NO\ P#]2
MITY5(J4I/6VVF_X_B<[#X+U&[DCN-?\ %-U/(L921;<"%&4^R\_K5FP\">&M
M/D26#2XW:,_+)-\[#\3FO(O^"C/[7NM?L/\ [,>H?'OP_P"#;77KFSU.SM5T
MZ\NFAC832A"Q903QG/3FO7_AWXH3QSX#T;QIY<:_VMI=O=[(9-RKYD:O@'N!
MG&:M^W5'VFT6[?-?\.;?58\JE)7-2*TA@C"0JL8'\*KC%<QX0^,_PE^(GBSQ
M!X&\"?$C1=8UCPK=);>)-+TW48YIM-F;=A)D4DQL=KCG'*,.JL!UBJ O6OSC
M^!LOACX-?\'!_P 3?!3+)I=KXZ\!--I=K\XCU'4&2QO99!V)"Q7K;NV' QDB
MKPV'6(A4N]8QNO.UM#:G!23\NQ^CD8(0?XUR'Q?^!?PK^/&AVGAOXL>#+/6[
M*PU2'4+."\CW"*XCSM<>^&93ZAF!X)KKHQT/K5?4;R2RL9KJ*V,K11,ZQJW+
M$#I^-<G+S:6"-:I1E[2,K-:W6Y,D:Q(JKV&*?M]#6/X'\4?\)?H*:L]L(6\Q
MDDC!R 16P^#\@X%7*,J<G%[HRIU(U(J<>NHU6 ?&!^=2!\D#%<3\0;[5='\5
MZ'>6=^ZQ37/E/ K':V2 21WX;O7:1,6.153IRA",F]_T,Z=>-2I."5G%_F.F
M8*G-4]+UK3=<A:[TN\CFC61D+QMD9!QC_/;FK4VYDP>.:X7X/1FPOM<T5)6:
M&UOML(;V9AGZ\#\JJ%&-2C*=_AM^+)K5I4\1"G;25_P.\0MNYIU-4G.W':G5
MB=(4444 %%%% !1110 4U_NYIU-?[N* *]]=V]I;M=74BI'&NYI&. H'<U3\
M-^)?#_BO1K?Q%X5U>UU"PNHP]K>6<RR1RJ>A5E."/H:\L_X* ^/Y/AG^QO\
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M "U/H.&Z2GF%WT3?WZ'4Q_=IU-C^[3J^,/T **** "BBB@ HHHH ***#GM0
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M)SDYKMQ6"QE/.*]6>%]M&5K-VWLC&CB*,L+"/M>1J]]^YZ-_P7]^&VB_&O\
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MHD=O,:3YH]QSA3C@#MZ5H[1_=HP/2CFEW%[./8RYM):>U@M3JEXGDNC>9'*
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MJ;BN:]W;;8SR[!8K,H5I027LXN>K6J5KI>9]L>9'_>Q4<]S;01%YKA8U]68
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MW0*O)CT_:WL<,?ZUW3':/F/YUP_A^!)/C'K,KQ[C';J4]LJ@IX7EY9M_RO\
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M.:E(;73];M9I-N?+CN%8X^@-+$2Q%:LZM3=ZLZ?K%.M+XE<^5_\ @I#^U_\
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M%K2)WL[%<RW$TT\=O!$,\#?-+&I8\*#D\"O6IL^7TK\R_P!LO_@LO\#O /\
MP48\5?\ !,/]M#X/Z/)\(M4T'3]/OO$US(TQ6[O+:.XWW4;?*MMB9(_E!>-H
M_,+,&VQ]6!PLL5B.6,7)+5I;M+>QCB*RI4[MVOHO7H?AS^WI^WU\>/\ @H9\
M;[SXS?&K6SL5FBT'0+9V^R:3:[N(8E/4_P!YR,N>3V \A\*>*?$W@3Q/I_C3
MP9KMUIFKZ3>1W>F:E8W#136TZ,&21&4@JRD9!'2OM'_@L)_P1Z\7?\$^O&J?
M%?X22S>)?@SXFF\WP[X@A?SSII?YEM+AQG<,?ZN7HZ]?F!S\I?L]_L^?%_\
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M!.]W<F1MW44ZFI@#&:=7,(**** "BBB@ HHHH *&&X8(HHH C,1(X.*^,_\
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MCOQ%=ZMK6L7DEUJFIWTQDFN9G;+.['DDDU_7C_P3D7'_  3[^!;?]4=\,_\
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MKA555  'L *DO_!?A#5_$-IXIU/PS8W&I6"LMCJ$UHC36X/4(Y&Y0?8UI>6
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MMX4&M"-+C5M&D F\H."\1SU5URI'\^17R'\7/^"4/@[]D[;\;_V1_P!L>'X
MZ9;^$CH7C;4O$#)-87T;@6\5S(\LT2QSEY!AB3^],90*Q.[]"NO!/>O#?VHO
M^"=?[*?[9'CS1?'_ .T-X%NM=NM#TF?3[.U&M7-O;M'(ZN'9(G7YT8-M8$9$
MC!PX"!/K:-:459O3J?+0J2YMSXC_ &9_^"E'[&W_  3Z^$W@_P#98_91\+>+
M_C!'J'B:"UU[QA:VITVQGU6[*JZPO=* 9/D&V$[$V 'S3\S5^I5M*T]K',]N
M\32(K-%)C<F1]TX)&1[$BORG_9&\$Z/\)_V@?%7B?XY_%K4&^!?[)NJ:A9^
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M[1GTJA83ZC,)O[0M%AVW#+#M?=OCXPQ]"?2M!?NBF[\VI,/X:"BBB@H****
M&R\IBN1^-_B[QYX!^%>L^+?A;\+;SQKXBM+7_B3^&+'4+>U>^N&8*JF:YD2.
M.,$[G8DL$5BJNVU&Z]L8YIN0!BE?EE?<-U8\<_9)^"/Q4^%VAZQXW_:!^)\G
MB;QYXPNH[[Q(UK(ZZ7II5"L=CI\38\NWB4E0S?/(<N^"<#9^!/Q*U'X]_#37
M=3\2:9#:^3XT\4>'?+L6=<V^GZS>Z=')DDD.T=NK,0>&8XP, >BR8 Y[US?P
MK^%OAOX1^';[PWX6ENGM[[Q)JVMS?;) S"XU'4)[^< A1\@FN)-HQD+M!)()
M-RGS7?6Y/+9JQY+^RMX3_::^ /C&\_9Q^(T%[XT^'ME9_:/ ?Q(N-0A:\M+<
M-M&DZBCN)9I4&/+N45PZ#$A5AEOH*+:><4UPIYQVKF_&OQ$TCPC T*R":[VC
M9;JW//<^@JHTZF(J*,%J8U*E'"TW*<M%U9K>)/$>F^&;%M1U.YV(H^5>-SGT
M [D_YQ7B_C'QGJGC'43=7C>7"IQ!;J?E0?U/O5?Q!XDU7Q/J+:EJDY9NB1Y^
M6-?051Z]J^PRW*H83]Y/67Y>A\+FV=5,;+V=/2'Y^H'D=*^8_P#@I)\5OVH+
M/PC8?LX_L@_"K4M4\8?$&SO(8_%$F8=-T.WBCS*TEQ]U;AP=L:'&?F;G;BL_
M_@LC^UW\2_V-OV-+GQ]\(I8;?Q!KWB"VT&PU6;!_LSSHYI&N55@59U6$JN[(
M!<,0=NTVOV7OV /@%_P3M_X2C]H^[^)?BKQ!XBOO#KMXV\5>*M6%PUZ(]LTT
MP4C<"SQE@&=VYV[FZU]!3BJ<54?R7?U/'C'3F?R/FW_@F9\-/V'_ -J_]DS4
M/V /CK\)9M/^(G@G4+FY\:>&_$=PXU1+YF\J74[60D.JDLJ,$_U;% P(:-VW
M/@)_P20_:1TCXT:+\-_VCOCG;^+/@+\,]1;4/ /AR8?O-1D<YBCNX0H0"$@D
M\L&8Y4+O(7W3QK^RE^S1_P %"+?X?_ML_"WQ!KG@_P 3QS6.K:#X_P##<7V+
M4KJQ# /;3*X(=9(-\0+AMH8 ATW1M]28P:TJ8B2ORMZZM=GY#G4ML-CAAMXE
M@BC6-$4!55<!0!C 'TK3\*>&[WQ7J\>F6J-@\S2*O^K7U/\ 2L](WE;RT7YC
MZ#IZFO;/A_X/L?"FDK'!+YDMQAYI.H8XZ#VQ7S^:X_ZG1M'XGL>CDV72QV(]
M[X5O_P  J>']9/@^.'POXAMEM8XUV6M_D"*; [_W&(['J0V.G/4(^<8/YTS4
MK&RU&S:TU"TCFB;AHY$#*:YSR==\%'=:K-J&F#DQLV9;91_=_OKC\1BOC9.-
M:\MG_6I]]3C+#VA:ZZ/JC:\1^(_#_ABQ_M+Q-K=I86_F*AN+VX6*,,QPJ[F(
M&22 /4G JY$RR)D!:^3?$>HZG^VY^T)#X9T6:8> ?"-QYMQ?PYVW4V.OS<9)
M!1>"0NYN00!]86=O%;P)#"H544*JJ.  .!7CX/'2QDJCC'W4[)]VM[>5^I[F
M89?'+X4U*5YR5VNR>R?G;5KH9.K>#+2>[_M?2)VLKW.?/AZ.?]I>C?C7,?$3
MXOW?PB\!ZIXJ\<Z4#]@M6>WGM=QCNI.B1\ F-F8@9(*C.<X%=_(P4<C'K7RE
M\9M2N/VO/VBK#X%:%=3+X9\.3-/X@N(C@22+P<'.#UV#C(+,1D"JS+,)87#\
MB7-.3Y8KK=_HB<ERFGBL9[23Y:<%S3[67ZO9>9Z#^Q,/BGK/@G4OB;\3-=N9
MG\4:A]MT^QFSM@A^Z&4'[JN-NT#C:JD$YKVX,Q&ZN7C\'7'A18H_ <\=K:PK
MM&E2+BWVCH$ _P!7] ,>U7-*\86U]<_V;J%M)8WG>&YXW'_9/0]NGJ*Z<'A)
M8;"QAS<S2U;WN<N.QT,5CIS4>1-Z);6Z?@;3OA\,Q^E2)#&PWLH)]:^8_&'C
MSQ7^T%^U/IWPT\ >)M1L_#_A28S:Y=Z?=/$)ID;E&*CG!&S!)!RW QFOIZ ;
M8E!/:L,'BX8R4^1>[%VOT;6]O3N=6.P$\!&GSR]Z4>:W5)[7]5K]PH11T%<Y
MXX\;0>$-/68PB:XFD\NWA\P+N/<GV _F.F:Z3K7$W7A[6-?^)PU+4H&73]-5
M?LI;.UWQGCGJ"3D_[(!KU</&E*3=39*_J^B/%Q<JT8)4EJVEZ=W]QU=E+-+;
MQRS1^6[1@O'NSL..1GO]:F8$]Z0!0=IIM]<V]K;274S8CC0LQ] *P^*6QT)\
ML=S#U?QLNE^)+/PS%:-<3W3?-MD \M?4_@/:MY??FN%^&]M/XI\4WOCN]5A'
MN,5FO^SZ]/3\N:] P/2NC$4X4Y*"WMKZ_P# .;!U:E:FYRV;T]!L8PM.HHKG
M.L**** "BBB@ HHHH **** "BBB@ HHHH *9*,T^FR$C^'-# YOQWXOG\'K9
M7BV/G6TD^RZ;GY%]1CO_ (5T%C-%<VRS1,&5E!5LYW ]#6=XKT./Q)HD^CRK
MCSD^1L?=8=#53X9V.OZ5X;&E>(4"R6\S1P\Y_=CI^'7'MBM[4I8=26DD_O7_
M  #DC*M'&.+NXM7]&NAT6 1C%?"G[7W[3'QZ_8U_X*0^ ?&/C;QMJ%S\%_B!
MIZ:'<:;Y;M:Z5?AB/-.R!@')='7#&1U64$JB"ONO(/0UX7_P4&_9#\.?MI?L
MVZY\(]3AB74A']K\.WS1KNMKV,$H0Q!*JWW&QC*L1G%=^25L'2Q\8XN-Z<[Q
MEI=I2TYEV<=UZ%XJ-25&]-V:U7G;I\SVR"59H5EBD5E9<JRG@BFS11W%N\%S
M K+(I5T900R^A]:^-?\ @CC^UEK/Q=^"UW^SW\7M1\GXA_#&Z;2=6L+IRMQ/
M:QG;%/M;YB!_JV;CYES@ KGZTUCQ;::=-]@LHVNKY\B.WBY(/'+'^$>YKGQ^
M75\NQT\/+5Q>CZ-='Z-:H5/%4JE%3O:_WW['YP6^H_\ #H?_ (*=7-GJ=K'9
M_!GX[31FVN/.BB@T:^$@!=F8(L4<$DQ#C=@03JY+-&$K]$VU_6_%A:#PK'Y%
MGNVR:E,F-X]8AW/7DX%>1_MN?L5P?MP?L^ZM\,/'6J+:ZLV+WPK.C,(=+U)%
M813-MYD&UV1\@_)(^T!L$=Y^RC\-/B3\'?V>/"OPM^+_ ([C\2>(-!T_['?Z
MY"I5;D*[>6>0#\L6Q22,G;DY)R?8S;'8/,,'1Q,G_M$4H3W]Y17NSOWM:+[V
M3ZG%AZ595)15U!ZKOZ>2OJ=AI?A;2](B<K#Y\TPQ<7%Q\SR=>I/U/'3FOS?\
M;C4/^".G[?D?Q LUF3X'_&+4"FJPB\C8:9J3-EY2KA=D<9?=PQ'ELPS\BI7Z
M:$@C&:\V_:O_ &;O 7[6/P)U[X(?$0>38ZK;YM]06)&DL9E.Z.>/>#AE/T)4
ML,C)-<N29I#!XJ4,3>5&JN6:\NC7]Z+U7I;J=-?#QY4Z>DHZJWY>CZGH=A>6
MNH6::A9SK)#-&'C9#E64C((/<$&LO6O%$EK=G1='LFO-0D^ZBGY(L]&D/8?J
M<<5\D?\ !*/1?VS_  7\(]:_9M^.OAQ;'1O NI+I_@[Q9,Q:35=/W2C;&,G*
M1A4V/Q\DBKM^3)^Q=!\/Z;X?@-IIMMY:LVZ1V.6=NY)/)KDQ^#IY;C)T>=3L
M]&GHUT?W6TW6PJ5:KBH)Q3CW;_3_ #/S>_;E_9^^*/\ P3V_:+L?^"E_[/.G
M+=:'>7W_ !=_0;!5C$PEF!>Z$1XVR9R[ Y24"3@,[+]^_ /X[_#3]I'X6:3\
M8_A+KZZCHFL6XEMYMI62-NC12*>4=3\K*>A'<8-;WC/P?X<\?>&+[P7XRT2W
MU+2M4M7MK^QO(@\<\3 AE8'J"*^(?V1_V9?VK?V$?VW[_P""OPL\/76L?L^^
M*%FU&&XOKL./#\WEL0B$G=N+@(5QAE8/D$'=[-3%T<^RNU>25>A'W6[)3@OL
MOO*/V>ZTW2,X4)8*M[EW&3UMT??T?4^\L@^V:AU"QM=1MFLKR%98Y%*LCKP?
M:I80%+'UZ;JQ/%7BF:PG72-"LC=:C+]V-3\L*G^-SV%?+TXRE)*)W594XTWS
M;'E?C_P@_A#6_LT9W6\P+V^6&0/0]^/7O6& ,U[9:>!K.[TR9/$!6\NKM?\
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M2,<'FN2^#_P-\#_!N/5#X3MIM^K:@]U=37$FYBS?P@XX4=A7,? 'X[ZU\0_
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M/[??_#M+Q;^T9XJ\*_ _QTM[X@\(Z#X?N!;_ -I.X/FZ?YJ@R!0OFA@QVLJ
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MJ^W4'@^_AG[37QK\1^/-=_X9H^ W^E:U?+Y>M:C$Y6*QA/WE9QTX/S>@XY)
MKV_QYX-?QGX<NM(MM7FT^]:%UL]2ML>9:N1@.O\ AT-<-^S=\(?!WP5TRX\,
M1Q,VO2,9=4U*YYDO><[PQ_A]NQY->?F5#$XRU&GI!_$[ZI=EZ]^A]#E.(P>6
MWKUO?FK<D6M+]Y>2[=6:?[.G[.WA+]GWP<-$T6,7.H7&V35M4D7#W4N.PS\J
M#G:N3CU)+,>VUW0K'6++[-=C:RG=%+&VUXV'1E/8C_.:N1E4Y8G&.*Q?B)X\
M\-_#GPA>>-?$UYY-G80F25MN2>P '<DX 'J:VHT\/E^'M#W8Q7W'+7GB<UQ3
M=1N<YOYMO^M#E?'_ ,;+/X">%9]<^*SR301MBRN+"$,]VW:/;D!9._4+COP2
M>P\"^,M*\>>$;'QEHOF+9ZE;K/;_ &B$HX4CH0>A_P \U\Q?"[P]XO\ VW?B
M.WQ4^)VF36W@G2YF70](+D1SN#C)_OD8^9NF?E'0U]$"XF^'*I97?F3:/PL%
MP%R;4=E;'\(['\/2L<OQ-?-*DJR25/:.FLN[].QU9I@\+D]"%"3<JJNYN^D>
MT?5=7?R.M5@W(J.:1(PTDCKM RQ;M1;7%O+$LT4FY6^967D$>OO5+Q)H \3:
M-/H[7+0K.H#21]1R#C\<8^AKT(KWDI'E2E+V;E!7TT.6\/\ B/6_&GC234M)
MO)(=)LU\O8S?ZT^N/?\ ' 'OBNZ7Y4''6L[0?#=OX>TN'2[*,;85P6[NW=C[
MDUH@E1AFK;$3ISG[BLEHO^"886C4ITVZCO)N[[:]%Z TD:MP:Y;3_'-WK'CR
M7P]I5HLUE;QD75QMV[)/8YY7^'&,D\YP.8OB9XMFTRV70M$/F:C>?)'''RRJ
M>"?;VK1\!^#(_">AK:C#7$GSW$FWEF]/H.@JXTXQP_M*F[V7Z_(SE6G5Q2I4
M]%'63_0VP!G[M34U8\<TZN5'<%%%%, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ JO/"T@;RWVMSAO3WJQ361B>#2!ZJQP/A3Q)JWASQ-
M-X/\8WLDC3/NL;B1MV[)Z;O?M[Y'H*[Y5#*":QO%'@;2?%@B;4=RR0R*T<\)
MVNH!!(S[_IUK8#I&H13TK>M4IU+2BK/KVOY'+AJ=:G>,G=='U^?H,>V5HRC8
MVG((]17G>IV=_P###Q-_;FFQ-_8MU(/M,2<B(_3M[?B/05Z09,C&*IZAI]MJ
M-G)9W<7F1R*59:*%;V<K25XO1H,5A_;133M):K^NP6&HVFIVJWEA.LD<B[E9
M#P:FEFC$3$MC Y8UQG@[0]=\":U>6EQ+NT0PM-'<2. (SGT[''7MWZ\5:@35
M_'EWOF$EMHH.54@J]V/4^BG]:JI1@JCM+W>_]=3.EBJDJ:4X^]LU^OH?.'_!
M03]@K3_VW+*T^*7PBO(_"WQ&\'KYGA/QM#NBDO'1BPM)&7DP;LE9#DQN24RK
M2+)Z-_P3^^)O[0WQ%^!,%O\ M.?!.[\%^+-#N&TZ]66)8X=4\OC[7"@)*JW?
M^$G)4E2,>X16L5O"L$"*J1C"JJ]!3\"--Q'M796S>M6R]8.:347>+>\>Z3ZI
M]GL]K%4\)&%;VU]6M?,='22#><<<]<BL>'QQX>E\0S>&7N6CNHF  D7:KDC.
M >_]>V:VAM/*UYDJ<H_$K'1"I3JI\KO;<X:[^'&J>'/$JZ]X'N4BCFD'VJS?
MA=I/./\ 9]NQZ8' [-6 XQSU)Q3I"   <DUY=^U;XF^.5K\&?$>D_LK6%C>_
M$(:?YFBQZDP$$1WKN+9XWF/?L4\%]NXA<FNF'M,=6A3DUT5WHDN[?9=^QA&G
M1P<9.'5WMY^2\SK_ !#?W?B741X8T2?9$C9U.Z7^!?\ GF#_ 'C[<@>E5+NQ
ML_&$[^";6UC_ +#MD"ZAY:_+.PZ0#T7NQ&2>G&<U\B_L2?\ !3:#XBZQ#^QM
M^T+X5F\"?&+3YY++6(-218[>]F7DR1,6_P!;(IWJ@RK#YD9E*BOMS1=&L]&T
MZ'3K,%8XUQSU;W^IKMS# XK*:WLJJL]XM.Z:_F36C3Z-'-1E'%.]_7_+_,\&
M^%G_  3-_9C^"O[4DW[5_P (-*U#PWJ=QIDEG-X9TF:&'1CO4*TJVXBW1N0!
MPCJF1G;DDGZ O]1LM*LY+_4KN."&",O--*X544#)8D\  =ZF "#EJX3]I+X
M>$OVGO@KKWP-\<:AJ%KI?B"V6*ZFTN[,,RA9%D&&'494!E/#+E3P37%5Q5;'
MXB,L74;V5WJU%?G;S.^-.-&%H+]-3M[:\M[N!;FTN$DBD4/'+&VY64C(((Z@
MBN>UEF\5^(X_#4#*UC:[9M488^9NL<6>>XR>G'0]C^>$.F?\%-/^"4&IV>@>
M&[>^^.7PG:7[/8:?9VLDNIV .X1Q*BAY%  '*AD]0@VU^CG@?1QIOAV":6-E
MN+I1<7GF##-*X!;/N.GX5WYAED,K2JTJL:D)7Y7%ZZ6O>+UBUV?RN<D*SQDO
M9N+5OBO^1K!-C?*.E<[X\L[/5XK7P\;6*2XO)MJ,T8/E(!\\G4$8!P.>IKHI
M)@%,A;CO[5A^%@^L7]UXMN5*K-^ZL%8$;8%_BQ_M'+?3;7E4>:+YUI;\S:NH
MU(^SM>_Y')>)/@B;:*2^\/ZI\JJ6,-U@9X[,/ZC\:X:YTC5+.WCN[S3YHXYH
M]\4C1G:RX!R#Z<U['X[FEOK2'PO:3>7-J<WE%O2/&7/I]WC\:VDL+*6V6T:V
M1HU4*L90;0!VQ7L8;.L50IIU/>O^7J>#B.'\+B*DO8^[9+TOZ>2_,^>MW;'_
M ->A6W'BO9-;^$7A/52[PVK6LC?QP' ZYSBN+\3?"6[T.:W2QU6.8W=QY4$<
MB[6Z9KVL+G6#K:.Z?F>%BLAQV'U237E_D<C16GJ/@KQ=I3 7OA^X (SNCCWC
M\UR!^-99)':O4IUZ-6-X23]&>34HUJ+M.+7KH+12;O:DWYZ"MKW,AU(.M!)S
MB@<4!UN;_COKH_\ V ;;_P!FK!K=\=$DZ,1_T ;?_P!FK"SQFN+ ?[K'Y_F=
MF._WJ7R_)!129.,XI-Y)X%=IQCJ*;O\ ;VJ:SL-1U%F2PT^:<K]X0Q,V/R!K
M.52G%-M[%1ISD[15R)L8YI&^49KH- ^&_B?Q"OGV\,<4:R%&>20<,#@C SR/
M0XKK-)^!>GQ+YFKZK),>0T<(VJ?ZUY^(S7!T7;FN_+4]+#Y-CL39J%EYZ'FB
M*TQV1HS'T5<FMVT^&?C"ZT^749--:".&-G(D^^^.RKUR>W0<5Z'\.-(TBR@N
MM+CL8?M5E<M'-)MRQ'523[@UU+Q IL(X88;CM7C8G/JBGRTHV]==#WL'PW2E
M34ZTKM]%T]3C?"?PL\&_V5'?RQ-?-<0@^9-C"Y'\('0^^20>AK2\ W<]M:3^
M%;]LW&ER"(-@#S8>L;^V5XZDC'-'A)FTJ]OO"TDF[[/)YEL-IXA?D=NQR*/%
M"?V+J=KXMMU8JO\ H]^JJ3F$G(/3^%N>W4UY%:I6Q$I1G)N^U_P_ ]RA1HX:
MG&=.*5M)6[=?QU.FA&$Q3JR]7\5>'?"VD2:WXAUJUL;&$!IKN\N%BB0$@ EF
M( Y(ZGO6A'.)4WIWKC/0C.$M$]CC?C-\>_A7\!O#S^)_B;XJ@T^W5E6.,Y>6
M5F. $C7+-T)X' !/:OC_ ,1^*?VE_P#@H9J-Q<^"=!O/!7PSA7R=2NR1]JU.
M'=OQP/G.W;^[4E%).YF!%?1WQ(_8A^"_Q;^-D?QJ^(EO>:I<16:01Z5<W!-H
M"N0&V?0CY>F1GKFO6[+2K'3+&/3=.MH[>WA0)#!#&%1$ P% '  '&*(WYO+\
MSYO&9;F&;5I4\1/DHIZ*+UE_B?;R1PG[._P,^&?P"^&MMX3^%]DPM9OWUS?7
M#*T][*0,R2L  S'&.@ &   !7?36T=Q T<\2LK*0ZMT(KG=/<^$O$1T2=S]@
MOF+V,C9VQ2=X?3GJO3/(&:Z-IHU?83][WJI1]GI';=>A[6#IT:.'5**45'2W
M3^F<MIVJP?#^X?0=>OU2Q$;S6-],V%1!RT;D\#:.1CC;Z8KQCPQ^V]K?QQ_:
M#T[X9?LW^#HM:\/V,SMXL\2WRND4<0R!Y#*0,[AP6#!N@&/F'J7[27P!LOVB
M_AI)\-]0\6ZEH]O-=1S7$VFE=TZ*#^Z;<.4)()'J!VR*@_9T^%?P\^!_AR7X
M;>"?#D>G/9RA[J0$L]V3TE9CRV1QZ#H*<KU/>7S_ ,SR\13S)XZ%&G)1HK5O
MJ_[ODCT;R6'S9K%\7>$O[?CCOK.Z^S:A;-NM;I>JM_=/JI[_ /ZP=PR8/*]Z
MK:KK%AH]FU]J%RL,:?>9N_M[FE3E/FO#<]NI&G*G[^QG>%O$#:O%)IVI6_V?
M4+5MMW;-V]&7U4]0:\S^-O[._C/X]?$C3(/%7C"&'P'I^V:;1;/>D]W,.SG&
M"IZ9!!49  )W#NK&YB\?V/\ PDFCPR65U:W#)9W#+GS4&#@^J'D$<X(-;7A[
M74U59+6ZA^SWMOQ=6['[O^T/53V-9YA@J>*AR5%UU5_S[KR-,KS&M@Y*I2:O
M9VE;77JNS7<L:)H>E>'-*M]#T.QBM;.UB6.WM[>,*D:J,  #@#%33QQR@I)@
MKZ'O3]V_K^HKRO\ :A_:(TWX)>&UTK2$:^\4:JOE:'I<$9DD9V.T2%5R=H;
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M^K/>S+,\/]76!P"Y:,;-M[S?\TOT73U$ &,8^E2+]VC8M*!@8%>VCY\****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ IKC(S3J38OI0 QXHMO*CUK.T[PSH6DZA/J.G:>D,UT<S2+GYOP
MZ?E6FR@C)%,D7Y,_RHYI1T6ER7",Y)OH-D;RUWEONUS%_=W/C359=!MW9=-M
M_EO94./.;_GF#Z>N.>U>;?M]_L^_&7]H[X#3>%O@%\:-2\%>+-,OXM3T>]L;
MQH8;R:(-MMKAE!81,3G</NNJ,0P4J?G7]B'_ (*;>)/ 'C6Q_8>_X*%^$I_!
MGQ)MIEM=-UZXCA6PUC=@P[I$8H)7SM5US'(1C<'.T^U@<IK8S+YXG#-3G"]X
M?:2_FMU7>U[;O0X\152JJG/1/KT?D?>UI:00VZVL<*K&J!0NW& .@^E<7\-_
MV:_@/\'?&VO_ !'^%_PQTK0M8\4>7_;UUID)B%WY98J2@.P'+L254$EB3D\U
MVUE-',@FBE$BL R,IR"#W'M4[!0>!7CJM6IQE'F:3WU=GUU[ZG9RQTLMC'U;
MQ?I.AZG!I>HWGE27*DQLRG;QZGM6G!*LH$BONSSD=#6?XJ\+:+XFM/LFK6RL
M%YC=3AD/J#6-X+\.^*O"FIR:?=:Q'=Z;Y>8=V=ZMGICL,=><=,8YK3EHRHWB
M[2[=_0Y74Q%/$6DKQ?5=/4ZPYQTKF?BQ\)_AO\;O ]]\-?BQX-L=>T34H3'>
M:?J$(9&!&,@]4<=5=2&4X*D$9KIHWPN2::RACN(K&G4E3J*<'9K9[6.J48RC
M:2N?#OPY_P""2OB[]EK]IK2_BM^QE^T3J'A7P?=7YF\6>"=6\R[M[F,ELQQJ
M"%?Y3M0R?/&!G>W(/W#&2HYI0J$9Q4=Q(MNC2.^U5Y8_A7;CLRQF:3C/$RYI
M)6O97?:[W;\W=F5&C3PZ:@K*][=# \<W4M^UOX2LI2LE^Y\YDX*0C[Q_'I^-
M;]K9V]I:K;VT*JL:A551@ #M7C-]X*^++ZW=?%7X8:\K?;;AB-+NY,^;$" -
MI;CYL'@[2H[U>T+]IBYT:^70OB]X5NM#N-HQ="%C$X^;YMN-P'& 1O!.>0 :
M^4J<14<+B/JV,ING9Z2:O%^?,M/O/1HY;*M!UZ,E.ZV6Z2\O\CN/& 76;RR\
M(!N+F3S;H?\ 3%#D@_4X%=$(HDBPB_=7@>E<OX!UC3?&%Y?>,=-NHIX9)O(M
M7C?.(U]1DX)/Z5U1QGI7O>TIU*:Y)75MUJG?L>?3ISC4<IJS\_+8\I\3_LS:
M9-J5QXA\#>*;[1;Z=I&<Q2MM9FYVY!#!=W7DU2%_^TYX GS>V-KXFM?,QNCP
MLA^7V PH/J,U[&8XV'*_\!JOK%[!I>E3:A+M40QELL<#@5\Y4X;P[J>TPLY4
MI-W]UZ-^:>AZT<TJJ'[Y*:7=;)=GO^)P/P>\<ZA\0?$VI:IK/AJZT^:WM885
M6>/Y%Y;>%8@9^;K^%>@7]]9:;!]IO[J.&,''F2R!5_,UF^ [![+P];^=$RR3
M9FD4MG#,<G^=+\0O!.C_ ! \.2>&]:,JPRL&W0OM96'((_\ KY%>M[/&X;"N
M+E[6I%:-^[=K;;8X:;P]6HI)<D9.[6]K^NY5D+ZIX^MSY4<D-CIS21S*>5DD
M8#]50UT=N<@D5X?H?P!U^'4;ZY\"_$S5M)6"X-NS3KYC3!1UW*4&,YXP<5[)
MHD%]9:7#9ZA?FXN(X42:XV;?-8#!?';/7&348/%YAB).&*H<CBEK=-/TL5*C
MAZ<>>E4YN;79I_<7G..]<Y8VLI^(.HWN?D^QPIC/?)-4_BQXT\;>#+*TO/"'
M@N76=\^VZ6$L6C7']U03SZX(&.>HKSBS^/'CO0KS4M;O_@QJBQS3*TS2R2JL
M&%'RY,..^>U88GB++\OJ2I5>9.W\K:U\TK&D<LQ.*C"I32>O==/*]SW(!>YK
MF_& 4>+O#X_Z>I?_ $77$1?M=^#"@-QX5UQ7V_,J0Q$ _4R#/Y"NQU.\37-8
M\,ZM DBQS;YE6488 Q @'WYKJRO-,OS"HUAY\UKWTVOZHY\QP>)PM->TCRZH
MZP<':*0 ,/F%<MXA^*6A^'=7DTBYL[Z26+'F&&$%1E=P&21GBG^&/B;I/BO4
M_P"RK&POHI/++[IXU"X';(8\_A7I?5ZW)S\NG<YOKF&]HJ:EJ2^+[N33]8T2
M5/\ EIJ'E'Z,C"G>-S<PG2[VU'^JUB 2,?X4?*'_ -"Q]2*=XV%G%;V6HW7_
M "[ZE"5;TRV/ZUY[\4/B)\4]1O[OP3X:^%-\RK=*D&IX<H^&!#@[0J\CJ6(%
M<&.S/#Y71IU:R;3;6B;?W(UHX.MC*E2G!J]D]7:Q[ C#H#4@(->,-JG[6OB"
M>.TAT'2=%49W7/F1LOT/SR'\A70?#7P9\8M.\32>(/B/X_ANHOLYCCT^S)\M
MB2/G.54*1[#)SU['Q\/GL\7B(PI8>=F]9-62\W<]*6!5.FY2J1OV3NW]QW>O
M:QI.@:5-J^N:C!:6MNN^:XN90B1KZEB0!7S=KO\ P46_9:^&>LZG'%XV_M2*
M\G\Z$:/;O-B0* X<D#&6Z=NM?0/CGP;X<^(GA._\$^,-+COM-U*W:"[M9>CH
M?Z]P1R#S7FGA_P#9?^ GP8U71;[P5\,]'M%;.G7,S6 EFG5P"F]VRS$/&N23
MDYZU])#GE%J-M3Y;-EFW-%X1QBENW=V^2.W^"OQ-B^,/PRTGXE6N@WFFQ:M;
M^=%9:@NV6)=Q'(]\9'J"*YG]K?X"P_M"_"67P7)XHU+23#<+="32Y=IG5596
MAD&1O1E9A@G&=IYQ@^F6T,<,2VT$:K&B@*JJ  /08]*6<)(/*=<AN/K4KS.^
MIAHXC!RH5M;JSZ7/$/@+^PC^R_\ "ZWL_$WAWP(NI7W$T.I:Y(+F2,Y##:"!
M&"I'#!0P/>O</(1!M2,#Z5S_ ()D:P>^\+RR\6=QFWS@?NF^88'H,D5T.%D7
MAJJ=.-.5DO,SR_"8/"T%&C!1[V75;G-Z/LT#Q5=:$J[(;U?M5K_=#='4=NO/
MK6SJUC;ZO83:9=*K1S1E6%>._M5?M=_!+X SV]KXD\2^=XBLY$GM]#TVW\ZZ
MD1B 5/\ #$&5L@NRY ^7)P*\;B^,G_!0+]L.*.Q^$GP]C^&_AF[ACD?Q!JDK
M"9XW0L&CD9 TBL,%6BC&#C+@'-%2>TEO^IY>(SS"X2M+"Q3J3Z1BKOT?1?,^
MJ/ GC+39Y9O ]WK=JVL:7\LUG]H7SC&,;9-F<X((YQCFM3Q1I^IZMH\UAIFI
MM9S28VS+]>GM^%>0_LP?L/>#/V=]?F^(-YXLU3Q%XLOK5X-0UK4)BJLCE&=4
MC!( +(#\Q9AS\V.*]S$:MM.WH*?M)>TYK6U/2P*Q57!VQ,.5[6O>RZ:]['-^
M%OAKX?\ #++=O +FZZM<3<X;CD#MSWZ\]:Z?&T;<4T#'.VD8E4+FBI4J5I<T
M[L[*5&GAZ?+322'. 8\GUKF-90^%==7Q+$O^CW6V*_&.%[+)]<\$^E4/$?Q3
MEFNET#P+:?;KUSM,G\"'/;^]T/.0!QR>:W]*L]2NO#J6/BLI+<2PE;H+C!S]
M,=O3OZ]:U]G.C%2GHGTZV[V.?VU+%2<*>KCUZ7[7/&?VM?V7_BE^U)KND^&8
M/BQ'H?@2&#S=6T^TA8W-Y<Y?!8Y"M&!LPI( ;<Q#$+CT[X/_  6^&_P0\*P^
M#OAMX9M]/M45?.DCC'FW+ 8\R1\9=CZG\,#BKGA*ZN-+OI?!6JOF2W7?8R?\
M];;.!D_WE/!X';&>370@#.0*YY4^65^O3T,<-@,&\3+&<O[R6C;=VO)=OEN.
M79']Q:@U'4;73;1[V\G6&&-2SR,>!4S[3P7KG_&/@]O%<EK#=:K)':0R;[BW
M0?ZWTYZC\C[8/-73492]]V1W592C3?LU=]$0>%_B!/XMUR6WTK2I&L(E^:\=
ML?-Z8_R:Z4 D99,57T?2M/T>R73]-M5BAC^ZJ_S/O5U%!'/Y4ZDJ<I>XK(,/
M&M&G^]=W_6@Q0<=<5)&?EP33MHQC% 4#H*S-@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH &!(Q3"">]/HQ[5+5P(I555.5_#UKQC]L;]AWX%_MK?#RZ\&_%7PQ"-0^RL
MFD>)+>W47NFR<E6C?J5W=8R=K9/0X(]LZ]11@>E=&&Q.(P==5J,G&2V:T9,Z
M<:D>62NCX<_8.^%'_!0W]D7XYK^RK\0;J#QM\%['3[B;0/&UY-_I5DA&8K7E
MBV5<%?+(*J&RK;0J#[;C9LY+9J:0XXQ6-XQ?Q1#I/F^$XX6NED4F.3^),\@<
M@9_IG'.*Z,=C)YIBU6G&,9-6=E9-_P S6UWUM8QC%86B[7=KON_0UVVOP12#
MT"UR7A/XG:?JS+I6M(]GJ2G9)#(I56;H=N??L?UQFNJCX7)/_P!>N.I1E1=I
M+_@E4:]&O'F@[_IY,@U$7PLIETQD6?RF$._[H;'&?;->36'QT\<?#W4/[#^,
MWAJ58R^(=4LX_D?[WX'ITSG&3C%>Q;MW&*JZOI6F:W:R:?JUC'<0R*5>*9-R
ME2,$8/M7BYE@L9B)1JX:LZ<HWLMXOR:/0PM;#T[QK0YD_DUYIE3PWXP\.^+[
M'^T/#>KPW4/\31R<CZCJ/Q%4/&US+J3V_@VQD_?:@_\ I##GR[<??)^OW1GK
MD]Q7#^*OV<?[%OF\4_"GQ1)H5U'EGB:0^01G)Z9*CV(*X&,"NL^%MCKUWI*^
M*?%ERDVIW,"1&:-<+L4=5&!@,<L<8!R.!6F4XK,JDI1QM'E<%I).\9/RZ^>I
MCCZ.'Y8JC4NI/5/=);WZ'5VMM!9VL5K;1[8XT"HOH ,5SWQ-LM+U7P[_ &3?
M:=;W$UY*MO:K/&&P[?+N&1P0N>:Z".]LWF^RK>1^8OWH]XW?E6#!L\1>.9+E
MH_\ 1]%7RXWV_>G< M@@X.U0!@C(+?0UZ2CA\1?VEI+K>S.6K*I1BE3NFVDO
MZ]"/X?\ PN\*?#B2X?PW#,C7FWSM\A(^4=AV]?QK6\2:U/H6E/JD6G2W31L!
MY,*Y8\X_3K6QM7TIKJ"I^6L\-A\/A(J-.*45T-ZLZM:[<M7U.0TCXN^%+TM%
M?326<V[#+<+T.>F:M^-[C[386NCP.6_M&Z2/<J[EV9RV?; J_J_A3P_K(W:C
MH]O*>S-&,C\:S8HTU'QZL<46V'2;/&Z.085Y. I7_=!/X_GZ'^SN7/!-6UL]
M4>;RXGEY*K3N[)K1^=_D=##&L86.(!54;54=A2:E<):V;W+D[8T+-CT S7*?
M%#4_BQID=H_PPT*SORS/]L6\8#:!C;CYTZ\^O3\_/]9_:%\>:9HDFF^-OAA>
MZ?)/"T0OH<[6D_V4=>G_  (GZU\WBL]P.!Q7LL3S17\W*^7[TCVZ>7XBOA^>
ME9^5U?[F>I?#M"OA:WN&E:3[06GW/U^=BV/UK>"*Q^6O,O"W[2_PJNK*UL+O
M49]/N,K";>[M6&P_=^9ERH'N2,=\5Z5 Y8;L5W8?,L%F-YX>:EKTZ>IS_5*^
M$@HU8M:=>H' )YS6!X"FGO[*^GNEW%M4F&=O4 @#]!6S=7MO%YB"5#*J$^7N
M&>F>E9?P]NA>>%+:^,04SM))M],NQQ79&5.5*2T=V<\^98B+6FC-?[+;*>(E
M]OEK-U..-_%.FAQ]V&=E_):U#CTK)O95/C+3[?/_ "ZS'_T&E1I4Z;;@DM'L
M56EHK]T:^Q3R8U]/K1Y$8.549^E/'RKR:0-ZFDY+J7RQ,+XB6;W?AM@C*OEW
M,4A^@<&MQ  , YK&^()*^#[\H/F6$E<5=TN\A32+>>XG"[H$+,S8[#FM*DHQ
MHIR?5[_(PA_O$M-;(N%5QP*5F3IM%16]S;W8\VWG1USC<C!A]*H^-?%FA^!/
M">I>-?$]W]GTW2;&6\O[@1L_EPQH7=MJ@DX4$X )/:LH\LHW6QO.2IIN3M8T
ML$G[E8_C^RENO"MVT#.LD*B:+RQ\Q9#N 'UQBOF7Q#_P5C^&4TL]A\*/A-XL
M\37?G"+3Y([-8+:[<D  /N:1<^\1/M67J'[0G_!2SXPQWR?"W]F*T\*V+QK"
MLFO2?Z5"Y7F16N&B20#KQ"P'0YJHU(QFFCYNMQ)EE2FX4>:H^T(M_C:WXGU[
MI%VVH6$-]C:LT*N!Z C-<K\9?CU\*?@-HL.N?%3Q?;Z7%=,ZV<<F6DN&5=Q5
M%')XQD] 2,D9%8?[)^D?&?P[\,6T#X[^)K#5=>L]2F1KC3E C6'Y2B\1Q\\G
MG;W'/IU_C_X6_#OXJ:?!I7Q%\$:9KEO;3^=;PZI9I,L3[2-X#@X."1QZU<OB
M;1Z=.OB<3E\:E'W9M)I2Z>J7^9\SZ#_P4$NOBS\8])TW]GWX,:YK%E=WT-GJ
MNK7-J8X8X2X+R$@':R+EL,>17UQ$28\@?A5/0O#N@^';*/3]#T>VLX8U"I';
MPJB@ 8 P/05?&T' %0^:6C)RW"8S"QD\15YW)WVLEZ'':U\#_A'XA\?1?$[7
M_A[I=YKT$*1PZE=6HD= K!E(SP&4\AL;AV(JUX(5])DN_!\TF?L$FZS+=3;O
MRO7K@Y7TX%=)C)X ^M<[XM5-$UBR\79PL;_9KS'>)^A. 2<-@CIU-:T]4X/J
M;RH4:$_:P5N[MJT][_F=$JY7(%.+!5)-9/B;Q OAS1)M:^SR3^6H\N)&^\2<
M#GL,XR?Y]*Y$Z5\2_B!SJMS_ &1I[,?W"CYV7)X(X)_' [@=JTHX?VBYIM12
MZO\ 1;L=;%*G)0A%RD^B_5[&]KWQ.\.:)=+8QW#75PTBJ8[9=V,D<9]<'@>V
M*Z239/ 8Y$4JRX96'45A^&/ /A[PPNZQM/,E;[UQ-\SMT_(<=L"M[(QD"LZS
MHII4[Z;M]2\/]8M>K;79+I\^IGZ/X>T70XFBTK3HX-S98HO)Y[GK5YD&.WO2
M^9D<BE<_N_E'-9\TI/FD[F\8Q@K15C#\8Z3<W=G'JFFLL=]8OYMLY[\89?HP
MXKP/]H+_ (*"^'/!A@^&_P &-+D\3>.M44166FV8$D=K,25Q*0?O#!)7MCD@
M9K<_:_\ !7[6?Q4U/1/AI\#-;M/#WAO4=[>)/%"7Q6[MMO(B"#:VQAC'EDLS
M?*QB0$OO?LO_ +''PH_9HTDIX=LFU#6+E5.HZ]?*&FG<#G;_ ,\UR20H]>2Q
MY)*4G%1_$^=QDLTQ6-E0PB=..TIM?^D+OYO0Y_\ 8Z^%'[1VAZCJWQB_:*^(
MEU<:IXHC#R>%5?-KIH!'E[1DA&"Y7:G&&^8LPS7OG&-V*EPO3%* !T%)1M&Q
M[."P<,#AU2BV_-N[;ZLCP .33HL]Q3L ]J,8Z"F=84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 -D'0U'U]:FHQCH* ,76/"6@ZW=0WFH::LDL+ I
M)@@C!_45H 8[58?K@&HI1Q@BB4Y-6;T7X$QA",KI;[F1:^,_"U[KUQX:MM<M
MVO[5L36OF8=<C/ [\>F<=ZUHR2!FO/\ XE_L_P#A[QU>-XCL+B73=8X*WUN3
MAB!P7&?I\PP>!DG&*Y6T^)'QC^#4JZ=\3/#\NL:7&VU-6M_FD"]CNZ,< \,%
M;U-?,ULZQ66XAPQM*U-O2<=5_P!O=4>I3P-/$4[T)WEUB]'\NC/2_&TLNH7%
MOX4M&8/?-FX9<_+"OWN??I^-;UO#':VZ6\,0544!5]!7&_"KQ9H7Q"?4/&.E
MWBRR23"(1?Q6\8^ZIX')Y;O[&NTW)CE_SKZ.GB*&(H1E2ES1>MUL_P"MCR51
MK4ZLO:*SVL^EOZN><>/?V?[;Q#KLWC7PIK]UI6LR.',T<A*.PQU'4#C\:O?!
M_P /_%3PZ]YI_CZ[LKBW9R]O<0?ZV60LQ9GX Y&.O3&*[U64#Y2*5@W>O*IY
M/A*..^M4FXMZM)OE?JMCOEC:TZ'LI6:Z-K5>CW#>BC+,!3?/A=?DE4_C5?5M
M-MM6T^?2[V-FAN(6BF4,02K#!&1R.#7D=Q^S=XQ\(W'V[X4_$R^M.5)M;Y_E
M<C^\4&UAZ!D/UYJLQQN.P=I4:'M(];.S7R>XL/1H5KQG4Y7TNG;[UL>P,6";
MO2L'X?;KVUNO$;@YU*\>2-BNUO*4[4!_ 9_&O+]9^)?Q\\$:)<:7XZ\#1WT$
MENT*ZE9OL;)R-Q*!ESZ*%4\5Z1\(?&&D>,/"4=SI&FWUK#9M]EV:@JK(=B+\
MWRD@\$<^H-/+\]P>.;HI2C/^62:T7X&>*R^O2J*H[."ZIIZO;SVN=4=@XWUS
MOC3_ $J[TO2A!'(DU\KS*>H5 6S^8K:N[RPM7CCGNDC:1L(K. 6/MZUANL=]
M\0HQY;#^S]/9U;/RL7;&/R!KTZ+HSJ-:.RV./$<_*DNK19N? G@^]F:XNO"V
MGR2-)O>1[-"S-GJ3CFM549!@5(I[@T)A^IK.G1HT6W&-K[V1T2G*=E)W/,?B
MC\$+#6]8O?B$GBO4M-F%J3<?8V^^$7 QSQP.E6OA'\([[P4]OKP\<ZE>6]Q9
MKFQN&W1@L <CGC'M77>.YX(/"6H+/)A9+5D!SU)X _45H:9#'8V$-E ?DAB5
M%SZ 5PQR/*Z=3ZQ"#4^:][NU^]KV-'F&+D_8N2Y.6VR[][7) CE>*\R\4?"W
MXR:KXMFUW1/B<MK"S$6L)ML^4AQ\OZ5ZB"W45(I!'!K3'9?1Q\5"<FK?RMK\
M@H5Y8>7-%)^J3_,\A7X5_M"-_P UHZ?].W_UJW?A]X'^+/A_Q!]N\8_$3^U+
M/R"OV7R=N'R,-GZ9_.O0::<]!BN'#Y!A<+656,YW7>;:^:N=%3,*U2FXM1U[
M12_0S_$$0GT*\B/\5K(,^GRGFO(]&_9R?Q1H5O?7GQ-UMH;F%6:WDERO^[UK
MV:^A2YLY+<MQ)&RDCW%9?@9((?"MG:QR[O)CV=?0D5Z&.RG YE17UF-[/35K
M3Y.QQT,9BL+B/W3M=>6_0J_#WX>:)\-]%_L#0/.\EIS,[32;B6( _H*VM2L+
M'5=-GTO5;&&ZM[B)H[BWGC#QRHPP58'@@@X(/45,IC)R#3F< 9XK;#T:>%HQ
MI4E:,5HNPJDY5YN4W=O?S,OP[X2\->$K'^R_#'ARQTZVW%OL]C:I%'N/?:H
MS6@ZA4''?M3O,7'6AMAXQUK>_F9QITZ<;15CG=/<:7X[N[0+'&M];K,N/O.Z
M_*Q_+%=$K#.2W2O)_P!HS]HKX0_L_:IHNM?$7QA%I\DDK@6\=NTLTT1&"0B@
MMM!QSBO'-4_X*>:SXXO5T;]F[]FSQ1XHN&28M-=1^3'L4@+(@C60NI.<@[".
M.YXNI4AIKK8\2KG>7Y?5E2JS]Z^D4KO6W1>I]>#;U+\]O>HIY%7+[N%4DD5\
MJ?#OP[_P4P^+'CS1_&GQ+\8:'X(\/V>H6\]WH.GVZ,]U"HRZ[?WC_,"5*O*
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M!IU%%C8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"*-TC#;<?6A63=C/3K61XLG\60V<;>%+:WEF\S]XMP< )@\]1SG%8,=_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4UD#]:=10 SRO>E,?]VG44 -
M$?S9-#+N.<TZBE9 -\KUH1 HZ4ZBF!&T&YMQ-'DM_>J2B@7*AHC*C --\@GJ
M14E% QAA&, TAA]#4E%*R ;L/'.*,/V-.HI@-*DCM0J8&2.:=10 U4(.33AD
M'FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g4bdklltl5z5000010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000010.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" );!G$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BC(HH ***,T %%<;XX^)VN>$_'GA_PAI_@'4-1M]8E9+C4[928K,
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MD?\ ?7\Z '44WS8_^>B_G1YD?]]?SH =13?,C_OK^='F1_WU_.@!U%-\R/\
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MV'-?-7_!,SQM\/?"?Q4^-7PN^*6JV>G_ !@N?BOJE[K<6K2+'>:IIKR?Z!+
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M9OT/]G3QP?%6E:Y\7+GXA2ZM:1YALK*PMSOB<C[C&21(]K8;)P0._@8? 8O
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MN0/4UW8?#X?"4E3HQ48KHM$?(YQG6;<08YXS,:\ZU5I)RFW*325DKOLEL:6
M>U(5%8&C>/M-U+P;I_C34?\ B7PW]O#(L-Q(C-&T@&$+1LRDY./E)&>A-8.N
M_M+_  0\+?#J;XJ^*_B9I>DZ):Z6FHW5UJTWV5H+9PVUWBEVR)NVL &4$E2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>IT >M?'_P#9K^!_[47A*U\#_'OX>V?B/2[#5(]1L[6[=U\BZC5E2561E96
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M_P ^GXGT_G'6@'-0P7*7"++$ZR(ZAE93D,".H/I4V,=*^?/M HH)/84G^]0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44''0T# X% !1110
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MT77?"FO>*9KK7[62YM!J'CW6%CM88U!E>4+<DG:65=H.2QQD#FN9^&?QLO\
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M_P#R1]6>>O7:W_?-'VA/[K?]\U\IW/QQ_;N@B4'Q?\#5N&N9H5@DCNAO*,X
M#?;CEB%&5QE<]QS3K/X\_MIZA]KCL_B)\#?.MBO[HQW)X8J%+D7YV99@O(P>
MU'U6/_/V/WO_ "#ZU4_Y]2_\E_\ DCZJ\]?[K?\ ?-'GK_=;_OFOE&7X[_MU
MP7ZV<GBOX(JK>8QD9;D,(U"'?M^W9XW-D=MHYYX=;?'?]N&83&;QS\"H5AD*
MK,PNF63"%Q]V^)!*@$#'9CT )/JL?^?D?O?^0?6JG_/J7_DO_P D?5GVA/[K
M?]\T>>O]UO\ OFOEE_C9^V_]J:UL?B1\!KMA&K+'##>AWW%@.#>="%!!Z'<
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M+/\ ^.5\OC]I+_@CL3_R;)'_ .([:E_\KZ#^TG_P1V"Y_P"&8X__ !'74_\
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MPPPX.1ZUEZA^WG\.]1\;VW@_6[#P+_;%CJ5XEBNJ^+&A:"ZMI4M9MCRV>U)
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MT77;*2VNK=]DT4BX*G^H]#T(KT[]GW]HBX\ SQ>$O&%TTFBR-MAN&Y:R)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%;XJ_#Y2/^7?6?\ T7!7NE>%?M/JQ^*OP_ ;!^SZT!_WQ!7=EO\ O3_PS_\
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M48;@*, D*,"O1K&Q^&=OX=U&V@^ VO:>NH:Y;0W$,UR\<EZOE3YE0*"S80R
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M3\;>'?'UGH/V:ZU7XAG2IK:2RMIH9$,7V27.3("&W 8[5O?\+Q_X*B_]&#^
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M)9PW485X/.D$I61 QVL7VMMZ@XKIH/V(/V6K1[=['X.Z=;BT;S%CADE5)I<
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M75K.8VD@8"$#YI(DE:5<2NR_.[ D'Z'))/%.'3I02?/?C'_@F]\#?'/AO0]
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M;_D3+0_],A_*O!?VM? EE\-?AC\/O!UEJ-Q>"W\37$LUY=8\RXFE66:65@H
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MW;R?^%U:C_\ *.@#Q']HO_@HWX[_ &A/ W@/PY^S3X/^,'PZL?&WQ9T[P_\
M\+2;PO8K:_9?MDMO/Y+3O*,NT3*I:+MVKV _L._M(A<C_@JE\8/_  5>'_\
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M6W%N,7:+LW9M7L]KWMI?P\14S27LX4*6UVU-Z2:;5G-7M9:J\6I76UFUPO\
MP2^TSXQ?#']L35OACH7Q!U*\\-Q:KNTK5OB=>*MU<6=S&7,=O!;S N7R6190
M617!8 FOUP\">%-*\$>%;+PCH8F^QZ?"(+87$S2/M'JS<GZFO/?V</V;]#^$
MWA&W&N7]EX@U5G21=::Q3>L:($AC1\;F5(PJJQY( KU>(*!\M?$5XT_;WCK9
M6OZ?E?3;LCZ#!_6*&%E1DURRG*=EY[7T3=DWOLW*VC,#XL'_ (MSK7_8/D_E
M5S4=,N-7T%],M]1FLVGM=B75N1OBRN-RY!&1]#5/XLC/PYUK_L'R?RK=L?\
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MXO\ P\\#+XEUCPSX?N-2L]"DN#"+PPH79-P!(^4,>!SC'&:_G,_:V_X+C?\
M!03]K;[5HNI?%:3P?X>N-RGP_P"#-UFK(?X9)@?-D_%@/:OZ;KVVM[RTDM+N
M%9(I8RDD;C(92,$'VQ7\JG_!47]E"?\ 8Q_;D\=?!2WLFAT==3;4O#65^5M.
MN?WL(7U"9,9]XS0!X#<33W=P]W=SM+-(VZ261BS.?4D\DTVC(KI/A;\'/BQ\
M</$\/@SX._#G6O$VJ3,!'8Z+ITEP_P".P':/<X% '-D#'-?MC_P:P?M>'6?
M_C+]C'Q/JNZ;19O[?\+QR/S]FE(2YC7/99-CX_Z:-7@7[)?_  ;'_M5?%8VO
MB+]I[QKI_P .=)DVO)IEOMOM4=?[NU6\J(_[SL1_=-?JE^PU_P $E/V,/V K
M^/Q;\&_ ]U>>*_LK6\_B_7KQKB]:-@-ZH!B.)6QR$4$]R<4 ?50.>:*:DD>
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M@(.U8U[# /0?7'[/WCWXLZ_-X#BT?X>7L\D?B"Y_LK5/%5W]BCN+?[+="$L
MLDY/E\Y,8)P,D9S58;!1C*O.E2]G=OGDX\BG+D?O)M^\O3O>Q.,QRE&G"<^:
MW+9)\SBN9:-+X?F?=#M^[YQ7)ZU\;O@UX8U630_$?Q7\-:?>P$">SO-<MXI8
MR?56<$?B*Q6^&GQ6\36L@^)'QBN(89$Q)IO@^Q&GH1T*F=S)<?\  HWC;/0C
MI7R[\/\ 0/A+>_#OP4?$FD?"VXU233=.G>?Q#XAG@U"=I FYWVON:8L"P8EM
M[L6.UBQ/E+#T8T74<^:S2M'S3>[7E;;YG5]8Q$JRIJ/+=-W?DTMEZ]_D?67_
M  T;^SYNR/CCX0ZX_P"1DM>O_?RE_P"&C?V?C_S6[PCZ?\C):_\ Q=?.UEX<
M^%L%RL0T/X+JDUQ<;)?[8N"T\JR(L@92_+;8CN;+%64C# L3)_PC_P *()X[
MC0+/X07ES:J]I#(=5N8&C4XX)6:0[E81DKR21G<IZQ;"]I?>O\C:V*[Q^Y_Y
MGT(?VCOV?0>?CAX1_'Q):_\ Q=!_:,_9_!S_ ,+O\)?^%);?_'*^>[WPK\$C
M:#P]+#\)8[6YNKBYFL9M2N&#"220/*O^D#+%VVLO"D\[AP%?<V7@72A=W&SX
M.7%O,R><MWKUU"L@!BC(=FDD RCJF<$?O%R,$@G+ANTOO7^0?[5WC]S_ ,SZ
M#'[1G[/V,GXW>$?_  I+7_XN@_M&_L_8W#XV^$<?]C):_P#QROG2^\*?!5]1
M_M2.'X3R7F9)%\S5KI2UQMC5&.+@CED16."1@$;B,,S3?#/PLM[R:ZTK1?@Z
MXN)I/MLAUZ[DV2&%G.%+D%@?F_@X9G^4]2V%[2^]!_M7>/W/_,^C!^T?^SXS
M;5^.'@\_]S):_P#QRB/]HW]G^614A^-_A%F=MJJOB2U)8^GW^OM7S_JNF_"^
M]NUCU&T^#;1R+%]LVW4\<D2[Y2=N)/F =@5SMR>/EVC$5AI'P5T75+?5]*LO
M@V&FU2-;N?\ MN4"*9EB>+:OF,KR,4"X)0[0I&[YD*Y<+VE]Z"V*[Q^Y_P"9
MV'[?L\5SH?@>X@E61'\2,R.K9!'D-R,5ZY\%_P#D3+0_],U_E7RS\1)()/V:
MOAI]CD@:WC\;:M%:_9&S"D*7=VD:1\G$:HJJ@R0%50.E?4_P7)_X0NS_ .N0
M_E6=>G[&M*FG>S:^YFE&HZE&,VK72?WHZR,GS'X_BKYS_9 S_P -B?M28_Z*
M!H/_ *C6G5]&1???_>KYS_9!R?VQ/VH_^R@:#_ZC6G5D:'TA\U .>E'4<4$D
M"@!#D#BC=ZFOG[]H7]L+XP_#C]H?3?V;_@;^RU<_$/5[KP<_B.^N%\76NEQV
MEN+K[,J_OP?,8MD\=!4>B>.?&_B3X::E\6_'_BG4O"/C:QN)HSX)CU>.XM]/
MF5R(;-HD&VZ,B[3Y@&7\S*$87 !]#9]J0G;Q5;3K^.YB6.26/[0L:F:%7&Z,
MD=".U6B,T %-E7?$R?WEQ3NG6B@#Y&^$W[!W[:7P+\#P?##X5?\ !11=/\/6
M%Y>2Z78W7PGL+B2!)[J6X*&1ILOAI2-QZX[=*Z,_LT_\%%0<#_@I7:_^&;T[
M_P"/5]+<TF30!\UC]FC_ (**'G_AY5:_^&<T[_X]0?V:O^"B@//_  4LM?\
MPS>G?_'J^E >.*,$CF@#YK_X9K_X**'C_AY5:_\ AF]._P#CU+_PS5_P44[_
M /!2JU_\,YIW_P >KZ4H.>U 'AWPD^!_[9W@_P"(-CXA^+'[;MOXPT&W\S[=
MX>C^&MEIYN=T;*G[^*0LFUBK< YVX/!KU'XE/\/H/!]W-\3H]/;1HX6:Z74H
MP\94*<_*0=QQG@ FM_)/2L3XA>*/!7A+PK=:U\0KRV@TJ.-A=&\CWHR[22NW
M!W9 /RX.: .9_9VN-/NM"\0W&CO&UJWBZ_-N8ON[-RXQ[8Q7H )[UY[^SI>6
M]WX7UK4H5\N&Z\7:E);[HS'F/SR$(![%0.U>@&>+',JX_P!Z@!91D<"N4O?@
M?\'=1\8:A\0-1^%GAZXU[5M/73]4UF;1X6NKJU"LH@DE*[GCVNR[22,,1TKJ
MA<0YQYJ_]]4OVB G'G+_ -]55.I6HR;IR<;JSL[76]G;=72=NZ#1[D6FV-II
MME'8V-LL,,*!(8HU"JB@8  '0 58[]*89X1_RV7_ +ZI/M$/_/5?SJ0,#XL9
M_P"%=:U_V#Y/Y5O6)_T*'_KDO\JY;XYZD;#X.>)K^V>,R0:+<21[N1N"$C-=
M-:31+91*95_U:_Q>PH G!'K2U&)[<#_6K_WT*//B_P">R_\ ?0H >32BF">#
M_GLO_?5)Y\(Z2K_WT* )*YWQK_R'O#6?^@RW_I/-6^;B''^M7_OH5S?C&X67
MQ=X5M%D7;)JD[-_P&TF(_6@#IZ*** "L?QWXPT'P#X0U+QKXFO5M]/TNRDNK
MR9C]V-%+'\>.!W-:[=*^<_\ @ICX.^-/CG]G27P[\(M(DO(6OEE\06]LY\^2
MU0%MJ+_&-^TL.N%Z'FML/3C6KQ@W9-[G#F>*J8++ZM>G!RE&+:2W;Z?\'R/!
MOAU_P4O\$_%_6[[P-^U'X/MK;1;Z]D.CZQ8Q'?IR%OD63J>!C+K^(-=5\2_@
M5J/A33X_&G@[4H]>\,W2"6UU:Q82!4/3?MX_$<?2OS\GADMY6MYXFCD1MKI(
MNTJ1U!'8UZ[^R_\ MG?%+]F74C8Z5.NK>&[J3_B8>';YLPN#PS1YSY;D=QP>
MX-?75LMY%S8;[NC].S_ _$,#Q5]9E[+-;OM42]Z/^)+XHW^:Z7V/:&*[<BOH
MK]E#XUZPOA77M!\2W$MY%H.FM?6;/EG$:@[H\GL,#'IFO O$7Q ^'GQ2U,^.
M_A?I,UAI.HQK(MC-&%,,V,2+@<8#9QCCTKO_ -G5C'I/CIV!VCPC,"?J< 5Y
MN)@IT/>5G^6I]7E-:6'S!.C.ZUU6S5FT_3JKG%^-O'?B7XA^()O$/BC4GN)I
M&.Q2QVQ+G[JCL!5+2-$U7Q#J,>D:)8375S,VV.&%"S,:IX ''I4WCC]O3PM\
M O!2_#_X#>%8Y/%TL.W6_$>H0Y6UD/58P?OD?@H/K71[.II"E&[_  7FSSIX
MC"QE*MC*O*MV]Y2?9=W^"1Z;JWAKX*_LMZ%'XZ_:8\20RZ@T?F:?X4M)!)-,
MWH5!^;ZG"CN37=?L.?MNZ1^U%?>(/#3^%+?0;C1Y$ETRPAEW>98L-H)X WJP
MYP ,.N.]?E_XO\:^+/B!XBN/%7C;Q#=:IJ-V^Z>\O)"SL?Z#T P!7JG[ >J_
M$K0_VH?#>J_#7P_=:DWVG[/J\-NA*BSD^64N>BA1ALGNHK7$97%X23J2O.U[
M[)6Z)>9R97QA5CG5&GAJ?+1<K..\I7TNWO=;V5ET/UX3!' I23G&*;"21\U/
MKY _;@JEK6F6VLZ;=:5>)NANK=HI%]F&#5VFNFZB[6J%**E&S/A'Q)HMSX8\
M07WAV]7$EE=/"W'7!QG\N:["PE/C#]GR\TTC?=>%=46XA[D6TW#?@&YK4_:Y
M\'GP_P#$_P#MR&-EAU:V63/;S%^5A^6T_C6+^S]JMI'XW?PGJCXL_$5A-IUQ
MN/&YU^0]?[PQ^-?>2K>WP,:\=6K2^[=?FC\@CA_J>;U,'+12;A]_POY/E?R.
M+LKZ?3;V'4+0[9K>998F Z,IR/UK[G\'>(K3Q3X7T_Q#:,/+O+2.9>>F0"1^
M!KX:U;3+K1-6N=&O5VS6MP\4RGJ&4X/\J^G/V0O$EQJWPP;2KA&_XEEZ\4;D
M<,C?.!^!)_2N'/Z,:F&C5CT?X,]C@W$2HXZ>'E]I?BO^ SURBD7.T9I:^1/T
M@**** "BBB@!I;'6O,?VQO%W_"&?LT^,-:CDVR-H[V\3?[4N(Q_Z%7I[?=KS
M3]J;X'ZC^T+\(;[X:Z7XB72YKJ:*5+B2$R(Q1MVU@"#@^HZ>]=> E1CCJ3JN
MT5)-O?2ZN>;G$<54RJO##J\W"2BN[::6Y^2A '45]I_LN:;_ ,(9^PCJ6L$;
M)O$OB)E7_:12J?R1J\3^*O[ G[2OPJ,EU-X(;6K&/G[=H3&X&/4I@./^^<5]
M*^+=#F^'/[,'PW^'-S;-;W T_P"U7L#H5992NX@YZ'<YS7Z?G6.PN,P]&%":
MDI33T?2*;_.Q^!\*Y/F&5XS%5<72E!PIM+F36LVHZ/9Z-['G1R?E(KZ^_9CT
M;^Q?@WI*E<-<QO</[[W)'Z8KY#56F=88QEG8*H]SQ7W1X+TJ/0?"VFZ,@Q]E
ML(HO^^5 KY'B"I;#PAW=_N7_  3]&X*H\V,J5>RM][_X!K=13'*G&:4R*#RP
MJL-2LKIMMM>Q2;6(8)(&P1U''I7R9^D'S=^WS_P4A^''[%BZ?X5O+==0\2ZQ
M:RS:?IX?Y45,8:3'.#SC'I7#_LU?\%F/V=OB-\.CXB^-^OV_A'4UOIHEMY$=
MEFB0@"08!(SNQ@\\5XU_P6J\%?#_ %[XC1R^&?@1K&M>-6\/K]H\26MTT<5E
M$21$4!^5WR""!SBOS'\<ZB_P2U?0? OQJ\)W]JUK?0W5];M*%DN[4MN9,G*G
M(W=>]>!B,;BZ>+DJ;NE9-=%?57ZW/U?)^'>',9P_3>)3A4DG)2NE*5M++5KE
MN^W34_1G_@JA_P %$OVL?A+\>/#?A#P1XJT_1_AKXNTV.\\,:]IWS3:HC)AP
MQ/*@%NG&>.:^;?V>OC5\?_'7[3%GX.^"/Q7FTWQ=>:;?*M]J5XY@D0(6)(.<
MO@$@=<UK?\%-O%VM?M3>"_#][I>@:3;>"?"\=O<^%;RQA8S:9;&#88,*<NA;
M:<]%QGM7&_L%?%/P#\%_'.C?$M/AM_:FN6=J\=KJ4UTR/*\GR;]F3@;"V 1S
MUKDQ$Z=3$0K3FU%I-;]>UCV^'8XJ.1U\!A,/"52[BW[KNHK[3;V>BOLVWT.H
M_8K_ &TOVTKWX[3Z3HWQ7U_QAKW]MBWDTNXD+1W)C9@PV'HN-W/'J:_<GP==
MZY?>%]/OO$NGK9ZA-:QO?6JMD12E067/?!K\0/%_PO\ $_PM_:$A_:$_8YGU
MBVOIG\ZXFOVC;['/(Y,@Q@;D^8CFOMSX@?\ !9_PK^SMJ/@KP+\4? >HZU<Z
MKX?\[5]:L%"9NDPK(D6#R3SU'%>IA5+"RG.K)V=NMTOU/C^()X?/HX;#Y?2C
M[2*DG:/+)OS?PM::6;U3L?>V[G=D4!\]Z_'_ /;P_P""RWQ=\:)X5N?V?O[>
M\&:=+.XU"X"Q-]I;<-@)(.T8'3OFOMK_ ();_MC:U^U3\'[D>/;_ '^(M%N/
M*N?-0+++#_#(RC Y]A6U',L/6KJG#6^SZ,\O,."\XRS*Y8W$)+E:YHZ\T4]F
M^EMNO7UM]4#&.*CGA692C*I4C# CK3E*D8S3ACL*] ^1/)_BQ\*_V?O"6D7O
MQ)\6>![=A;KN>.W9D$[DX5=JD#)/'ZFOG?QQ^T#XT\5VC>']#2'P_HH&U-+T
M=?+4KZ,PP6]^@]J]J_;KUS[+\/M+T-'.Z\U3>P ZK&A_JRU\N#&<+7M8&GS4
ME.>NNE^A^?\ $&*='&.A02BK*]E9MO75K41BJAF=QZEC_.N%\;?'SP1X1,EI
M:3G4KQ>/(M2"BGT9^@_#)_IT'_!1OPYI?PFT?P/X)\.W5Q'>:GH\E_KDGVAL
MS%B@52,XV@[\#'US7S'X1T67Q-XJTOPY I:34-0AMD4<Y+N%_K7N82C3K455
M>Q^?9QCL1@<:\'32YE:[WU:3LO2Y^M7[-'P)\#:+\/=!\=:KX:CFUK4M+@NY
MY+S]Y]G>1 VU 1@8SC.,\=:]C4*J]*IZ)91:3I5II-O%MCM;>.*-0.@50H'Z
M5?Z"OC:M256HY,_=\'A:>#P\:<$E9*]N]@XZXH.>U HYK,Z@HHYILIQ&QS0
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MP 5"C[V<AL]>M=7]H<U['CKAGDE'F[=WI^!X5X!^"FMZOKZZ.(HHYMS;FGE
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M>0')MY^DUJ^,;XWZJ?T/<&O:R_.*V%M"I[T?Q7I_D?!\2\#X/-[U\+:G6_\
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MXQZ5X:\57VH3PZ7)Y%Y'?2"-9]Q:3SAD\A=Z@\X., <8KH)?V@M=T/XDV]I
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M^,O-"Y5/])1.K E,''S8P>><>2Z5\5_B/9_$#5+>"XURS-BD\JZQ=:E-*K;
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MZ/IU;/A?PM\2_P!G"">&/2_B[\*_W-Y>1M'9_#>*(A1<'Y!^ZZ!E)+# EP&
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M)!@FN+J6)A'A=BM&Z,%P, @8&,5]1?!?_D3+3'_/(?RKR3_@H$@CT?P2 /\
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MP[8Z;%)\ ]/>2.QLTA5F_MFY&2% R>*M_P#!)(#_ (8#\$Y_Y_-:_P#3Q>T
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M=IK,7[2FDWE]<6L5S^TAXC22YL[IH)8P;/3_ )ED4@HP[,#D5QWBE?%FB_\
M!.;XG>-= ^/_ (UA\2PZMK4.G^))?%4MQ=:=]EUJYMK9HO,8J L:("I!63;\
MP;FO,OV*='_X*9^)(/CWX?TK0O@'>6]Y\>->B\36FJ#5Y(9;QK6Q$R1C@FW*
M[0-PW?>SVKT;2_V5OV^-$\":G\-]+_9W_9#M=%UD@ZKH-IHNK+IMX0Q8&6+
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M-_"Y!SL/(%?-7B=F%W%Q_#7V7\74\,W?@JZT.6:&SNKZW-Y"LJ^7O= "=QZ
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M\+_#H8<_V+; ^W[L5\%-TK[W^&$;+\-=!C<<KH]L#G_KFM<^9_PX^IZG"?\
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MZ'Q-9?"3P1:",MIK3,J@,TLS'><=2.F:Z*WM;>R@6VM8$CC5<*B+@"OII/\
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M=_LO96T.7_6#+\XC]7P\H2>'<82Y4D[\R?O/[3\SZQN.8&Q_=-?"G@3XB?\
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M&#S1[.G_ ,_H_P#D_P#\@+VU3_GS+_R3_P"3.!3XEW=Q9+%+JVK%K=3Y\?\
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M'MO)\I1*TVV&/?DD,)LA5&VN=_9@_:V_:*^(/Q:\,0_$'XF^&G_MJ:\C\8^
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MAT8=.U7-"L_#MI:_9O#=M9PV_F,S)8JBINS\QPG&<]>]7!!#:IMB"QJ.<*H
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M%+QUX?R/*:V7Y)75?%33CS0=X4[Z.3DM)272,6]?BML_688Q'$L:# 48%/H
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MU\:&''@Z;_P?7_\ \=H^T?&H<#P=-_X/;_\ ^.U]NCP7H(_Y<(_^^:/^$,T
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M_P#0/C_[YH>-Q4DTYOM]XU@\*FGRK0^;/^&LOVKNI^&'AO\ [\W/_P =I/\
MAK']JXGCX8>&_P#OQ<__ !VOI3_A"]!SG[!'_P!\T?\ "&:#WL(_^^:Y3I/F
MW_AK#]JX#_DF'AO_ +\7/_QVFK^UC^U<.#\,/#?_ (#W/_QVOI3_ (0S0?\
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ME=5MUA\O[2C,@5_M8?R^IQ@XK85O^"NB$_\ ) 7W?WEUA=OTP3G\<5##8?\
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M1S^56K32]4>T>5]'O(I/^6<+6IRW!!!(.!P3CD\]:N?\+0U;_H7[/_P8R_\
MQBC_ (6;JW7_ (1VR_\ !A+_ /&*KFQ#Z+[T*-/"+:3[?"_\C.MM%U&^;R;_
M $34((NK.;?+'G( "D]_7L/>D&F:\D_EIX?OFPWS3?9\*??KG\,5H#XG:MU'
MA^S_ /!A+_\ &*</BCJZ\'P_9_\ @QE_^,4<V([+[Q>SPO\ -+_P%_Y',^*?
M FMW%XDNF:9>S)Y:JS&UVD$=3@D?IFG7_@+5/^$?@MK6QO'N$;,D?V1L'GC!
M/U/Y^W/1_P#"SM5Q_P B]9_3^T)O_C%'_"T-6_Z%ZS_\&$O_ ,8JO;8JR5EI
MYHS>%P#E)WEK_=?^1S6B^ =532+R&^T^\BEFCQ'']E)YW*>2"1_"/7]*9X8\
M!ZW;:HMSJFE7T42_>*VNXD9[ $_KC&<]L5T__"S]6[^';/\ \&$O_P 8IP^*
M.J'Y1X?L_P#P8R__ "/3]MBM;):^:#ZK@$XN\M/[K_R-"W\2:S:6JV#>$[^2
M15"+,L($;<?>(W;A],&J^C7E[X9@:UC\.ZE>1R-YFZ&U"LK;0",,PXR,CG@<
M=A5<_$_5NO\ PCUG_P"#"7_XQ1_PL_5?^A>L_P#P82__ !BN?V=2UN7\?^"=
MOM:=T^=Z;>Z_\C4\+K?W&OZEK%UITUL+F"W54FCVD%?,R/<X()^N.U%^,7GB
M3 _YA47_ *!-67_PM'5^G_".V?\ X,)?_C%-L/$HU*VU[4M5:UM7FT\)'&MP
MS9VI)W=$Y^;H,UG.G4CS2:MHEOZ&E.I2<HPBVW=O5-;I^7F>%_L!9.@QC;V_
MI7U@.E?*7[ 2,NA1Y_NU]6K]T5S'>%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4UHPW4TZB@"/R$]:%@1!A34E% #?)3&*<!CBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG!'<'!'<5UJL#T-<LHRC*S5F=<91E&ZU0M%%%(84444 %%%% !1110 4444
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MJQ;[*2?ZGM]%1P7"3#<C9S4F:Y3K"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **1F"C)-8WB_Q[X4\!:'<^)O&'B*QTO3K*(RWE_J%TD,,* <L
MSN0J@>I-"]YV0-V5V;5%?&7Q(_X+V?\ !,'X:ZS)H>I?M+V>I30R^7*=!TVY
MOD#9P?GBC*D#U!(KL_V?/^"N_P#P3]_:9UZ/PI\+/VD]!FU:=PEOI>I2-8W$
M['H$2X5-Y]ER:[)9?CJ=/GE2DEWY7_D<<<PP,JG)&K%OMS*_YGTU14-K>Q72
M^9'("O:IJXSL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#R91RR"Y^@-%?G[_Q$@_L)_P#0B?$K_P $5G_\F4?\1(/["?\ T(?Q*_\
M!%9__)E'+(+GZ!45^?O_ !$@_L)_]"%\2_\ P16?_P F4O\ Q$@?L)GC_A!/
MB5_X(;/_ .3*.607/N?QQXRT?P1X?NO$>NW\5M:6=N\]S<3.%6.-5+,Q)Z
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M2O\ P16?_P F4O\ Q$@_L)_]"'\2O_!%9_\ R91RR"Y^@-%?G]_Q$@_L)_\
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MHY9!<_0&BOS]_P"(D+]A/_H1/B5_X(K/_P"3*/\ B)!_83_Z$/XE?^"*S_\
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MPG_T(GQ*_P#!%9__ "91_P 1(/["?_0A_$K_ ,$5G_\ )E'+(+GZ!45^?O\
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M]AP?F%'"8J="H[<]K/S5[+YW/CN,<MJXS!PK4U=T[W7D[7^ZQ\!GBOT8_:>
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M[UX_%68T\+E[HW]^>B7E?5_I\SV>$\MJXK,8UVO<AK?SMHOU/GBT_P"#;/\
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MK]KJ*?/(.5'XI?\ $-A^U_C_ )+3\._^_P#>_P#R/2?\0V'[7_\ T6CX>?\
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M;:&\^I6<!BU.SMX_FN[<$E6&.KID\=U..H KZ7A?,J>!S#EJNT9JU^SOI?\
M+YGS'%66U,=EZE25Y0=[=U;6WYGYV_L<_L5_'']NSXGW7P@^ %GI=QK=GI$V
MI26^J:DML'MXV56V%@=S9=?E'KVK[,_X(Y?\%&_VS]-_:/\  '_!.OQ?9V_B
M;X;WEQ/X8U;P+J'A^ -96K&4SN76,29C)<OYA8;=P('!'PE^SU^T)\8?V3/C
M)I/QN^"OB>;1/$N@W#&WF\L%6!&UX98VX=&!*LAZCWP1]FZU_P '#O[0,?\
M;'C'X8_LK?!OP;\0/$%JT.L_$;0?"O\ Q,YMW60,['+=_P!X7&><=*^ZS3#X
MO%*5-4XS@U[K;LXRLU?6]_)K4^#RO$X/".-1U)0DG[R2NI1T=M+6ZW3T/F__
M (*;_!SX;?L__M\_%+X/?"!$C\.:)XIEBTRUC<LMJK(LC6X)YQ&[-&/]RN7_
M &0_V;/'7[5OQTTOX._#VZM+6^NEDG:\U#>(((XUR6<HK-@DJHP#RPK@]6U;
MQ9\0_%MSK>KWUYJ^MZUJ#S75Q*S2W%Y<RN69CW9F8D_4U^RG_!!W_@G;XA^%
M4$OQ?^(>D&+7-:CC'V>6/YK*W!R(L_WB<,V.F .U<^=8Z.6Y/[.<KS<>5=V[
M6;_K]3?(\#/,\Z56$;0C+F?9*]TCG_#O_!MS^UW?:5#<I\:?A[\R X,U]_\
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MK_VO_P#HM/P\_P# B^_^1Z_:ZBO+YY'J<J/Q1'_!M?\ M??]%I^'G_@1??\
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M:_\ :]'_ #6KX>?]_P"^_P#D>OVMHHYY!RH_%$_\&V'[7V./C3\//^_][_\
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M^!PM2C6K5:BUG)O_ +=22BCY_,,53K4:-*E\,(V_[>;O)@Q ')]Z_3?]D?\
MX(%_M6?&'X6Z3XVT_P")/@O2EU*QBNO[/U.6[$\&]0WEN%@(W+G!P2,@U\T_
M\$S/V$/&'[5'QDTKQ%K.BS)X3TN^CGN)I83LOY$<$0KZKD?,>F!CJ>/Z7OV?
M/ $7@?P39Z8(E4QPJ/N^U?&<8YE2J5(86F[\KO+UV2_._P C[7@S+:M&G/%5
M%;F5H^F[?Y6/R3'_  ;7?M?_ /1:OAY_W^O?_C%+_P 0V'[7XX_X73\//_ B
M]_\ C%?M;[8HP!T%?$<\C[KE1^*/_$-A^U_G/_"Z?AY_W_O?_D>@?\&U_P"U
M_C'_  NGX=_]_P"]_P#D>OVNHZ]11SR#E1^*/_$-A^U^#_R6KX>?]_[[_P",
M4'_@VP_; SQ\:OAY_P!_[W_Y'K]KJ*.>0<J/Q1'_  ;7_M?_ ,7QJ^'?_?\
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MBMF"RM[<8BB4?05+7GU*M2M-SJ2;;ZO4]"G3IT8*%-))=%H@HHHK,T"BBB@
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MT:5:')4BI+LU=?B?S_ZW_P &^5W'JV-/\2:]% '_ -5^[;C/3)3->\_LG_\
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M:,*%7' JU'%'$-L:XIU=)](%%%% !1110 4444 %%%% !1110 4444 %%%%
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M&'@_7;74]+U*W6>PU"QF$D-Q$PRKHRY#*1T(H T:*3<OK2YH **** "BBB@
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M_#1=/D^('C;2]&75M0CL=,.I7B0_:KE_N0Q[B-SGLHY- &_130ZD9S3MP]:
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M^&-3F\033PZ'%8ZQ%(U_)"NZ58<-^\*#EL9P.M=YO3^]0 ZBFAUQ]ZEW#N:
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M5]#U.WO+6X3?;W5K,LD<B]F5E)!'N*LT %%%% !1110 4444 %%%% !1110
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MHW_@H]^UO\1OBUXT_9?^,7@KPAX?^%?CB3P[IOA/Q%HR2+K302E)9;F[<[H
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M\/O^"87[*G@/]E;5OV0F\+7FK>&O$%P]WKEYJMX7OKN\)4BY,J@;9%*KMV@
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M73X9.6B=X_\ 7L7R3(V#T    I2:L)7/=****@84444 %%%% !1110 4444
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M%I_'6G:+IMW#)+;LNQ8+:X9E<$%(P6 (89QD'-4G%*X%[X>_M4_MH_"?X_\
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MOIO@>ULIHT^SM-&D)4%HG$>Q'=3F4J6;DU]&>+/^"47P6\7?#SXR?#>]\?\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH *0H&Y-+10  8X%%%% !1110
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M::["[_;\_9EL?A5X#^-$_C2Z7P_\2M8ATOPC=?V7,6NKF5V1%9-NZ,%E/+
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M#W1?'7P.NM'T.3Q#;I&TMRRQPIY[(2J3,48["=P15)KQZP^'7[:'B?\ 91^
MO[)MS^Q#X]T^;X5_%*SN_$GB"ZM4-O+%]NEE#PJI+2(JRL7D V+L')W"GRQ
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M 4444 %%%% !1110 4444 %)M'7%+10 @4#FEHHH **** $* TM%% !1110
M4444 %%%% ";1Z4M%% !1110 4444 %!HHSCK0!^?_[:7_!53XB_L=?\%*/#
M?P6\5K8R_"V\\.V-QXB9=/S=6+7,TT7VOS0<A$81$J1@C<!R17J7PB_;5\7:
M_P#MZ_'#X1^._%VBP_#KX>^$=+UG2[_R4C\B*:UBGFFDGS\Z8=F!Z 5P/QS_
M &--6_:-_P""I7BK_A97PQU*X^'/B3]GIM!F\1_8S]FCOOM\<B(DIX$Z;1(H
M[%<U\U_LV?\ !.+]MBWT[]IKX&?$#1-46_U;X?V>@>#_ !9J"[+/6ULID^SQ
M1S'C8\$,<9R?E#?-T-:>Z+4_0']GO_@IK^QY^T]\0S\+?A+\2YKC6I())]/M
M]0TFXM!J,4>=[VS2HHF  ).TYP"<<'%N#_@HI^RO=? #Q)^T[!XWNF\'^$]>
MDT;7-0_LF;?#>(T:L@CV[F&9H_F (Y]C7PO^PS^S#\<->_:!^# ^(W[/_P :
M--E^%NDNFHZYXUURTM=(TF18O+,%C$EJSW,,N!\@D! ()8@%CQGBKX-?MJ>"
M/V*/C3^P9I'[%?C?6-0UGXF76O6GBFQ@C;3Y[!IK<J8CNW32-Y (1 3AR3C:
M11RQN&I]CV?_  5C\&:G_P %%+/]C^VT[R_#]QH<*V^L?V;<O<76KW#0-##C
M:%B@$4C$R$$$D?,,8/6>'/\ @KU^PEXI\77G@S3/BS<"ZT^&^EU.:XT.YCM[
M)+16:9I9&3:O"-MYRV,#D@'QC1O 'QR^#/\ P5.\&_%Z;]G;Q1KGAGQ+\'M*
M\+SZUI%D)(='N]\ EDNB3^[6(1,6[X(QGG&)^R%\ /VG_@Q_P3M^.H\&? N2
MR^)VJ>/-8N_#-AX@T6(S7MJPMPDB),-LHV>>8PWRLXQ@YP5:(SZ6_9__ ."H
M/[(7[3GQ"C^%/PL\>:A_;EY8R7FDVNK:#<68U"% 2SP-*@$H !;@] 3V-?-G
MP1_X*1?M'?$+]G?X?_$CQE\6O"6@ZIK_ .T ?"=XUYX;F=-1T\,@%K"L"OY4
MS!CB5MJCN17F7[*7P6_:CU7]NKX$_''QU\$OC1_9^CZ'?:=XHU[Q_#&8K2\:
MPG0I;6\  LK(/*BIE5#9/78QK+^'/[('[4NG?LM?!SPKJ'P"\40ZEHW[6*:[
MJUE)I;B2TTSS(_\ 3)%_AAX/S=.*=H@?;'Q/_P""Q?["GP;\8ZMX$^(7Q UF
MQU#1-2FL+Y3X5O&C$\;%657$>U^0>02"*TOC7_P5;_8O^ ?C(^ ?'OQ"U!M3
MAT^WO-2ATKP_<W8TV&9%>-KAHT(A)5E.&.0",U\8_'K6?VJ/C+^WG+\6OVA?
M^">?Q0\8?#WP#J$R?#_P?H&EJMG=3I)A;^Y9QB8OM#@8QC8/N@[H_P!LOPI^
MW5\<_BK\4-%U?]GKXKQZ+XF\)V;> ='\#V]I9Z?(&M5DDCUBX $D[QL67R2V
M2Z[ N"IHY8@?2?Q+_P""O?PV\,?ML?#_ /9V\,&'4/"?B;18;W4?$T%A<3O)
M)=Q;[&.!47!1@\3-)\P7)!VD&NK^!'[;5G:77QV\7_M!?'KPM-X9^&_C::PA
MDL=)N+5M'MU>15MIS)&OVB<E54&+?N;@9R*^6_AO\,/VC?@C\;/V3?C5=_LK
M^-M;L?#OP?3POXDLM/TO_2-)OB9(F-PK8,:H'#[C@%0<=*P?B3^P)^U/\6OA
MG^TKIOA_X6WT%]<?M!1^+/#FE:Q"8(_$]A"UWNCA+$*ZL)E89(#;0,@D4<L0
M/O#]FS_@I)^R5^U;XCN_!OPD^(4[ZQ9V+7G]DZOI,]C<3VPZS1+,H\Q.^5SQ
MS7%K_P %H?\ @GTUY8VK?&.Z1;W4FL7NG\/78ALY@Y0"XD\O;%D@D9/*\].:
M\?\ !/A+]H7]LG]OKX?_ +25_P#LD>(OA+X=^&?A"]LM2D\31QPW&JW,T4D:
MVL*I@R1(6X;   /3(4^1G]CC]H6/_@BGXN^$"_L^>(/^$WO_ (J2:E!H']CM
M]NFA^W1[9PF-Q'E X;^Z/2E:('ZRV\R3PK-'(K*RY5EZ$=C3ZS?!T%Q:^$]+
MM;N)HYH]/A25''*L$&0??-:50 4444 %%%% !1110 4444 %%%% !1110 44
M44 (% .0*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]*-JGM2T4 )L&,8HV+TQ2T4 (44\$4FQ?2G44 -V+Z4NQ<YQ2T4 %&!Z444
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MD HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;H_92TWX,:;^T!+\9=-D\*ZS>?8])U"TAFGDO+K+ V\<$:-,TH*MF,)N&TY
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MDAL#-_JA<SQQM%;%AR!*Z$@YZ5Z_!/%<PK<02*\<BAD=6R&!Z$'TI .HHHH
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M)/:ORZ_93^'7_!/OPM^SQX1T3]H7]@3XK7GCBTTF-?$=U'\,_$#K)= G)!C
M0]N@ K]7J, =JI2 ^"_V\/ GQJ/C'P]\8?V4/ >M2+\:O :> _$T8TN:.;2(
MIF22TU"YC*[H3#%)<QOOP5RH." *J_'G3O&GP#_:)T'X5>$K#Q9X(\%:/\*[
M+2]%\8_#GX7KK6K:Y)'*0^G/=>1+]E5 JN RA69V8GBOOX@'@TTHIZT<P'YH
M_L<_"GXN:+H_[.FF^)/A;XLT^XT#XR^,YM:CUK1I$FLHI;6Y\J6X94$:JY<
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M$G[.OPX^(_P;^%GB"/Q1XKM?%/P^\367]DS)/86U_K%U-9:A*A4,L<+,[[F
M&V13D#!KTCQE\'OB3\ /"O[2?ACX._ :3Q':V7A_P3IWANPU/PVU]:WT%M81
MQ33Q0LNV]>':9"@SEU&1GBOT$TS6=&UN-Y]'U2VNDCD*2/;3K(%8=5.TG!'I
M5@JAJN8#\OK33?BK\1/VF=%\<VNH?%KQQIW_  I_Q?I4GB3Q3\-SH]G%>2V
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MT?-BJWA#X8?%6Y\ Z/N^%WB2.2+]@V^T*2.;0;E634QA!989 ?/)4XB^\1C
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M87'DKO@C1>$56R HX &!TKN***D HHHH **** "BBB@ HHHH **** "BBB@
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M2ZD\*^(8=;T1DN7C\F]B5U20[2-X =OE;(.>E=0!C@4 %%%% !1110 4444
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M444 %>-_\%!=2^(NB_L6_$[6OAAJEG8ZI9^"=2G^U7@D_=P);2-*8S&P*S;
MVQLX#[201Q7LE<C\?/AC+\:_@;XQ^#L.L+IS>*O"]_I"Z@T'FBV-Q;O#YFS*
M[MN_.,C.,9% 'PS^RYXS_:K^!L?PU_9%_9O^&'PHM[KQ'\,X?&FM:U>KJ$4
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M /X)VGQ?^*EA\+?'V@7:Z/X@_8QT#1]0DDM654=YYE906&!(F0V#R" <4:6
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M\8I60'Z2 YHIJ$8XIU2 4444 %%%% !1110 4444 %%%% !1110 4=.@HHH
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M_!0[X&S? #PK=PSZ?X!\1V6H7<WAFXTY8!]A CL#YT2;WB.[*KN5-W!^:CE
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MQZAKVGI))+_H=T+A-WS(79D3S C$9 Y/%>&_LG:OHG[.D_P,^.'[2/A'5(?
MMK\)]8T+2]6F\/W-[%H>J_VQ/(5DCCC=X3+;!$5]O(3;G%'*!^@VL?M/?L\>
M'?A9:_&[6OC-X;M_"-]M^P^('U2/[+<,<@*C@_.W!^49/!XX-11?M6_LV3_"
M>3XZ0_&_PRW@^*;R9/$*ZM']E27./*+9X?/&S[WM7P+\8[&/4IOA!^T7\./A
MAKWP?^%>F^-/$T_]H0>#1JS6DUV5^S:W+ITL1,$=RPD*Y0M%O5A@L*QCX+\
MZU\+O'_QHU7Q5\8=4T#4OBYH&I67Q*TCX?VEA#I^HVL$B/K<.FA=\UH-T<<Q
M: %W52 3N(.4#]*OA)\<?A!\>?#S>+/@W\1M)\2:?',89KK2;Q95BDQG8^.4
M;'." <5U5?'O_!+OQIXP\8^,OBA>:A%H_B;1_P"TK!K'XM:;X!D\.R^*IO((
MD6>W<#S)(>%,J@*=WN*^PJD HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7-_)X4\<+<:KX4,2%UBU.TF2-MS8VGR@=IZ\<TM0/K^&&.")8HHU557"JHP
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MM^S[X(_9I^&D/PU\$7-_=Q_;)[W4M6U>Z\Z\U.]G<O-=7$F!OD=CR<
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M@1(%VA<#& !VIU% #5A1>%7 ZX%'EKT IU% #1#&.BT>6N<XIU%  !BBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH :T4; AESFCRT]*=10 T0QJ-
MJK@>U<+XP^ '@_QG\;O!_P >=4N[Z/5_!-KJ,&E0PRJ()%O(UCE,BE<D@*,8
M(P>N:[RB@!ODIG=MYH\F/.[9R.].HH :8T/5:&BC9=K+D>AIU% #?*3&-H_*
M@11A=NS@<4ZB@!JHJ !5QCI3J** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.CW7B'Q%JMO8V%C;O/>WMY,L<4$2#<TCNQ 50 222 !7.>%?CU\$?'7BVZ\
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MHHNF:?''Y4=E"J[=FWRQC;_=^E+)IMC+N\VSB?<03NC!SBCF _,"R/[*4/[
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%&:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BC-% !1110 4444 %%%% !1110 4444 %%%% !1110
M4449H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #C=1S
MVHQSFCG- "$GH*49Q03[4=*  9[BBCGN**  Y["CGUHHH .:"<=J.]% "$D4
MF[U-./K7S3_P46N_VI/AE\(/%7[1/P+_ &F!X5L?"/A&:\?PO)X+LK]+^XB+
MN7-Q/EXPRE5V@$#;GDDT ?2@;/ -..>@KY=LOCOX[_8W^$FD_%C]K?X\:Y\2
MH_&E[I]CX<TWP_\ #ZUM[BWO;B%Y%@2.V8-.9& 09Z-M[$D=UX0_;B^%WBOP
M!XX^(%SX3\5:+'\.]/CO/%&E:YHXM[VW5[07001>8<N(R,C(YXSWI\K ]G'R
M]Z3S >]?)G[<O[7GQKTCPYX%\/\ [&XAD\4>)-#NO&-Q#?:>D[+H-G:B>2)D
M8$)).\D4*MU#%L$$ UE_M=?MH>(7\!_ ;QS\'?VB]-^''AWXI:L_]K>+]3TF
MUO8[.U_LZ2Y166YPBGS5"'E3DX]J?*!]CEN,@T>8G]ZOEC]@_P#:3^)/Q5^+
MGCKX5:M\=M"^+7AOPWI^GW.G_$?0=$CL$^U3F42:?(L+-#(Z*BN&CZ"0!N:/
MB_XG_:J^)/[==Y^SG\&?VDH_ &BZ7\,[;Q!(P\&66J-<7#WKP$$W&"HVA3PW
M;IWI6 ^I]XZ@TH.>17QQ+^UO\:_AQX>^(_P8^/WQ,L[+Q=\/-:\/&W\=>&_"
M\<RZOINI7,20NUC+)LCE)WPR%6VKNWJ,C%>G7G_!07X0V?Q0O/AM!X*\;7EG
MI?B=/#NJ>,K'PV9M'L]58JHMI)5<R AF56<1F-2>6%%F![T2<<"@9[UX'=_\
M%%/@;:>/_P#A$5T'Q=/HR>*?^$:N/'MOX?9M"AU;?Y?V1KG=NR)?W9<(8P_R
MEP:@L_\ @I'\![WQ5!IR:!XOC\-W7B0^'[/XB2>'ROA^?4O,,7V=;G=NP908
MQ*4$1<8#FBS ^@^<T$GL*\9M_P!N7X+W/PIT_P"+,4.LM!J7C8>$K?1_[/']
MH#5OM9M3;M%OP"K*SL=W$:EO:L:/_@HY\"9/&*Z,NA>+/^$=?Q,?#T?Q$_L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 URP^Z*K_:]3_Z!)_[_ "U:HH J_;-2_P"@.W_?
M]:/MFI?] =O^_P"M6J* *;7VJ _+HC-_V\+2?;]6_P"@$W_@0E7:* *7V_5O
M^@$W_@0E'V_5O^@$W_@0E7:* *1O]6'_ # 6_P# A*/M^K?] )O_  (2KM%
M&>VHZX#\OAUO_ I*/[1UW_H7&_\  I*T** ,_P#M'7?^A<;_ ,"DH_M'7._A
MUO\ P*2M"B@#/&HZY_T+K?\ @4E!U'7!T\.M_P"!25H44 9IU37P<#PPW_@4
ME']JZ_V\,-_X%)6E10!F_P!JZ_\ ]"PW_@4E']JZ]_T*[_\ @4E:5% &;_:N
MO_\ 0L/_ .!24?VKK_\ T+#?^!25I44 9?\ ;'B/_H47_P# V.C^U_$?_0I-
M_P"!L=:E% &4=8\2 <>$6_\  V.E_MCQ'_T*3?\ @;'6I10!E_VOXC_Z%)O_
M  -CIO\ ;'B7'_(HO_X&1_XUK44 8YUSQ/V\%2?^!T7^-']N>*<_\B3)_P"!
M\5;%% &.=<\3]O!4G_@=%_C1_;GBCMX*D_\  Z+_ !K8HH Q_P"V_%'_ $)D
MG_@='_C0=<\4CIX*D/\ V_1?XUL44 8O]O>+/^A%D_\ !A%1_;WBS_H19/\
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M0?I0*#GM0 4&D.=O I: #M12<]Z7D# H "<#.*\L_;5^%WBSXZ_LG_$+X.^
M(K=]:\1>%[JPTU;R8Q1&:1"%W/@[1GJ<&O4^<<5'(TP/R1YH \'^.WP"\?\
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MY_X55C_\50?B;\<3T_9IO/\ PJK'_P"*KT.B@#SP?$SXY=_V:;S_ ,*JQ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/ "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g4bdklltl5z5000014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000014.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" %P!G,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHR/6@
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M1XB\/^(+=;O0=<L[Z)L[9+.Z213@X."I/>BS N449HH **** "BBB@ HHHH
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M3EN['YSQ?LB_\%YOVD]L'Q[_ &^?#/PM\.ZK']KGTOX?:>'U+2I=F5M@]O#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45\[?MM_\%1_V0_V#;%K+XN^.FU#Q.T0DL_!/AQ5NM4E4M&-S
MIN5+9-L@<-.\8=4?R_,9=M?+5K?_ /!:W_@J'"M_I=Q#^RY\*[]HVBD5Y3XB
MO8=X.]& CNMRO#D$?8$DBG',RDDZ1IR:N]$2Y+9'V9^TI_P4 _8W_9$S;_M!
M?M :#H=^#'_Q(XYFO-2VR!BDAL[99)Q&=A_>% @. 6&1GY%E_P""X?QY_:7N
MF\/_ /!-O_@G?XV\;"X46L7B[Q9']FTZPU#+'RYUMR\(CV!&#27D!)8@@8!;
MU;]EK_@A=^P'^S=''J^O_#@_$?Q!M8W&L?$ )?1;F10X2SVBV"[E+*7CDE0N
M1YIXK["M;6VLK:.SL[>.&&&,)%%&H544# 4 <  =J+TX[*XO?EOH?G7!\%_^
M#AG]IF2._P#B3^TA\/\ X(Z%JS?9]6\.^&K6*YU#380^&F@>..=C(P&X!=07
M@@$IR X?\$#O&'Q4A&C?MC?\%-OC!\2M'@<RV.F_;)+=8)L8W_Z;<7RYQQPB
MG'>OT6HH]K+II\@]G'J?GWX6_P"#:W_@GKX?N//U;Q%\2-<7=GR=4\26R+]/
M]&M(FQ^-=I%_P;_?\$O([1K9_@EJKR'_ )>&\9:CO'3TF"_IW^F/M"BCVM3N
M/V<.Q\!^+_\ @VZ_X)U>)79]&N/B!X?#-G;H_B:)P/;_ $JWFK%3_@WOT7X2
MQM=?L9?M_P#Q@^&5_=)Y>J7:ZDLXNHP<JA%B;%L \_,S#/85^BU%'MJG</9P
M['YSS?LC_P#!>G]FP-#\!?V]O#/Q3\.Z1']JM]*^(%@$U/5Y-F6M6>XAG=06
M&U2;]!W+1Y-1'_@K]^WK^RK.+?\ X*-_\$T]<TW2;=O.U;QQ\.7:XT^S@=2(
M5P9)[9Y#(%5@U]&0&SMR K?H[1^%'M$_B2?X"Y>S/G3]EC_@JW^PG^U_)9Z-
M\+?CE86?B"\$*IX3\3#^SM1,T@.((TEPEU(-IR+=Y0..>1GZ+S7S/^U7_P $
MA_V"_P!KJ.ZU'QU\%;30?$%U+--)XL\%JFF:@TTLBO+-*44PW4C%3E[B.4C>
MY7:6)KYGD_9I_P""PO\ P3 LEU']E/XNQ_'[X6Z2F?\ A7OB6%CJMC9I$W[J
MV5G,FR*&&....UF.Z23Y;,C-/EIR^%V]?\PYI1W1^F%%?)?[%7_!8S]EK]KG
M6U^%7B2:Z^&OQ+AN&L[WP%XT802O=J\<;P6T[!4N'\US&(6$=P3&Y\@*I-?6
ME1*,HNS*4E+8****D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC'\,/@!\-]6^+OQE\:V/A_PYHEJ9]2U2_D(5%Z!54 M)(QPJ1H&>1V545F8
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M5E('FXS!U\#6=.JK'=A<71QE)5*3NCI:***Y3J"BBB@ HHHH **** "BBB@
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MO\#_  #+//#8W<062Y;S[Q6^5DA4@;>N<\^F07YZ5] "@ HHHH *^7?V]/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M [R+!)O7?YY+W!:23,VU]@^M***SE*4G=EI*.B"BBBI&%%%% !1110 4444
M%%%% !1110!\[_MP_P#!,#]D[]O;1I)?BUX)_L_Q1';B+3_'&@;;?4[8!E(5
MVP4N8\+LV3*X57?R_+9MX^1]#_:F_;Z_X(R^(;#X9_MT66H?%_X(7-U/;^'_
M (J:2KS:IIV7!BBN#*Y.<'_CWG8G#L(+B5+<Q5^H%4?$OAGPYXS\/7WA'QAX
M?L=6TG4K62VU+3-2M4GM[J%U*O%)&X*NC*2"K @@X-:1J:6EJB7'JMS'^#_Q
MC^&'Q^^&^D_%WX-^-;+Q!X<UNU$^FZI82$K(O0JRD!HY%8%7C<*\;JRNJLI
MZ:ORZ^.'[''[0O\ P1E\=7G[:'_!/*YU+Q-\)O.:?XG?!W4;Z286UCU:XB<[
MG:.)>EQAI[8*&D^T0&X"_>O[)'[8/P+_ &V?A%9_&/X$>*?MMC-B/4-.NE$=
M[I5SC+6US$"?+D7V)1AAD9U(8DH65XZH(RZ/<]0HHHK,H**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML1;RXYLXC7?%< P@SJ_[%5^'XW!UL!B94*JLTS]2PN)I8NBJM-W3"BBBN4Z
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *X_X_?'?X:?LS?!_7OCE\7M=73_  _X>LC<7LV 7D.0J11J2-\L
MCE8T7(W,ZCC-=9>7EII]I)?W]U'!!#&TDTTSA4C4#)8D\  <DGI7Y8JFO?\
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M>K:I>,=D,8]  6=F)"JB@N[,JJ&9@#^:O@#P%\:/^"^7QKM?C=\;]*UCP?\
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MQQI_@FSNM+MKC2]>^.GB<6<Y>0DLITC2UNI@40*2D\]J^Y]I4%34WBCX%?\
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MR2?6FT45]D>06=)U>^T2^6_T^;;(O!]&']TCN*]K^#_Q&&DZWI?C6S=TCCF
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M,+R/49(1I&C[3(T,S1J2JRQ)++, 2XM864Q2+<I7V7^RW^S3\,OV0_@3X?\
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M/_"?PI\ :Y\4/'NK?8-#\.:/<ZIK%]Y+R?9[6")I99-D:L[[41CM4%CC !)
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MYI5/>M+O^:/4CI>):HHHK(L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M'WUZ?:7I;7U2/W@HKG?A#\2_#_QH^%'ACXP^$XYUTOQ7X>LM8TU+I LJV]S
MDT8< D!@KC(R<'-=%7]2'X(%%%% !1110 4444 %%%% !1110 4444 %%%%
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MKIF@:)JVA:QX7:6'Q)X3\4". WT,C1@-"8Y'5RG#!@=VV1719(A*1X/$'$6
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M:KJ)NKCK)+L"C/H  ./UJU67X.UF77O#=KJ,Y_>LI6;IRRG!/&,9QG';-:E
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MN7D3*AO*N7W2P-M4A<%HP6W&-^E>O?LX?';P1^V/_P %Z%^+?PREN&TOP_\
M O$B7-N8I89"T0DBD'S#<CWNPD':2H*EAAF^%Z^A_P#@@/I6HW?_  4Y^)GB
M*WMF:QM?A:]K<7 ^ZDLEWI91#[D0RG_@!KY?B#!X:GA_;0BE*]M-+W7_  #^
MHOH_\6\19AG5;*,77E4H1I.I%3;DXR4X1M&3U46I.\=KI-6UO^S-%%%?%G]9
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
MG+_P72M_(_:(_9#\0W!VV]G\7 DTQ^ZFZ[TQN?PC;\C7IOQ7T]XM4M]25?W<
MT.P\?Q*>_P"!'Y5YM_P<P(VG_L5^!_%MA"5O]-^+E@UM>1YWP Z=J+'!'W07
MCC_%5KW;Q)H<'B31Y+!B Q^:"3^ZPZ'Z=OH:^WX4Q'L4[[)_G<^'XKI_OJ<N
MZ?X6_P SP7XK?#3P[\8/ -_\.O%;W2V&H>7YS6<H20;)5D4@D$?>0=0:^/?C
M9^S[XB^);Z1?>%?AWH?A'Q/,OV.Q^&UC<1&ZDLHQ,S7\TVY%Y='7<Z*& 4>8
MSE5/W1>6=UI]U)97L#1RQMAT;M_G]:Y7QG\*_#/B^YN]?2'^S]?FT6;3+3Q%
M9KMN[*)PW,3_ ,)5F+ C!&3@C)KWN(>'<-GE*[5W9)VLFTG=6E9M-7ERJ_*W
M*\D[*WN>'GB)F'!.(M3FU&[E&_-*,92CRRYH*2BXSM#VC2=11@E2E!RE?\S9
MOAC\38+1=0F^'6N+;M8S7J7']E3>6]M%M\R<-MP8TWIN<':-RY(R*]H^!WP#
MO?AQJUYKOQ*\#:5K?BRUL5N=&^&.L21B;5+217W7$9+%#(@24^64E8>2X,:N
MT3K]-Q?LY:]:7>@6=K\7]1AT71/ T_AMK*#3XEN)5E0*UPEQR8F!CMV4!3M-
MNO)#,#N_#3X"^#?A[IOA^2^0ZYKGA[3'L;/Q)JL8>[$3LS%%;^%!O9$7)*1D
MH"06W?$93X>SPN-52:>EK.3BTG97:2YKM-MPYERWA[T6I(_;N*OI!4<RR:>&
MHRC[]TXTU54I)N=HRG+V;A%QC&-7V;Y[5;TIQE!WD^ ?PI\-_"+X=P:'X=\,
M3:.U_)_:&HZ;<:E]K:VNI47?#YO1Q&%6,,.&$88Y)+'UCX8:<]WXC^W?-MM8
MF8D=-S#: ?P+'\*YV"":YF6WMXF>1VPJJ.2:]0\'^&H_#6E+ ^UKB3YKB11W
M_N_0?XGC-?I56-#+\#'#TDDDK))):>B27W):G\JYAF&+S?,*F-Q4G*=23E)M
MN3N_.3<G;97;=EN:U36CZ86DM-=T:VU+3;NWDMM4TV\A66&\M9$*2PR(P*NC
M(S*58$'/(-0T5XTH\T;,QA.5.:E'=:GD_P#P37\8WW[(GQ^\5?\ !+KXAZT\
MNF6OF^)_@CJE],@;4]"N9'E>VR5C,DR-YDA"QG+I>GB.),_=%?#_ .V%^S]X
MX_:!^'&B^(?@AJW]F_%SX9ZH==^%>I?:%C$DVY'N=/?S T+"98U9!*H0R1JC
MNL<D@/O/["_[9O@7]MGX)6WQ%\/0MINO:>XL/&7AFY4I/H^I(O[V(J>3&QRT
M;_Q+PP5UD1/.XMP,LPI?VU26K:C72Z5.E2W2-9*]]E54X_RW^XX?QT'36%;\
MX>G6/K#;_ XON>ST445\"?3!3+BX@M+>2ZNITCBC0O))(P544#)))Z "GU\Z
M_M.>+_C'XYOKCP#X/^'/B*/1;>8I=7,.DSG^T&4]054CRLC(P?FX8]@/FN*N
M)*/"^52Q3IRJ3>D(13;E+SLG9+=M[+:[LGZ659;+-,4J2DHK=MM*R_5]E^AQ
M7[47QHT7XK>);?3_  WI\;6.DF1(=192)+DMC<1Z)\HQGD]>,X'EN[VKTWPS
M\#%\'>'+OXO?M!K)HGA71[?[3<VLC;;J\.0$A"Y#1[F(7G:Q+!5 W;U^?/B+
M^UY>_$+XHW'BF3P;9Z;H9ACM;#2[&!$>VMXQM0EE $C[< YP  JKM"BOY(S_
M "/B3.E4SS-+0KUI)QI./+*4$K<UM.6*248<VL[-]+O]LR+#TZD/JF7QYJ=)
M:ROIS;\J?63NV[:1T[I'7ZEIUKJUF]C>1Y1_3J#ZCWKS_7O#FH:!/LN%WQ,V
M(YU7Y6_P/M7I^I:3K.B3K::[HMY83M"LOV>_M)()0K#()1U##CU -5+FW@O(
M6M[J!9(V^\K+D&OB*&(Q&7UG3J1:L[.+T:?H]F>OA\4Z>JU3/*Z*ZS6?ASR9
M]#G]_L\WX]&_(8/YUSM]HNK:9G[=I\L:J<;ROR_F.*]^CBL/77NOY=3U:=>E
M4^%E6BBBN@V"BK5CHNK:E@V6GR2*>C[<+^9X_6NAT;X=$,L^MSY[^3">O3JW
MY\#\ZYZV*H4/B?RZF-2O3I[LQ-!\-W^OS[8%V0JV))V7Y5]O<^U>@:=86NE6
M:65G'MCC'?J?<^]3:;IS%H=+TJQ+,[".&WMXR2S$\  #DDGZDFM-%UOP)XIB
M;5-#\J^TVZ222QU.U)4L"&"NC#E2,?4'CL:\/$5ZN,:E).-)-)NUTK]^[M=I
M7Z/S9Y&)Q<JLN5;VNE??^OP/G+X+:]INN_\ !?;X+G3)_,6U\&ZI;R.OW2XT
M[6R<'N!NQ]0:_8RORW^"3_#O]HC_ (.#K;Q]X"\+_P!BR^!/A7-J7B"UC^5)
M=2GB:"60=B&358R2 -S L1N+5^I%?WAPG@Z&7\+X*A0J>T@J<>65FN:+]Z,K
M/5733MTV/Y^SJLL1F]>IRN-Y.Z=FTU9-76CLTPHHHKZ \T**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K\Z?^"YMPWPK^/W[)O[5>O2-9^%? _Q
M6\KQ1JT4>YH8I9["XV[5^9\P65X< 'H1U(S^BU?&_P#P7E^!;_&W_@FQXPN]
M.T6ZOM3\$WEGXGTV*UD"^6+>3RKJ5P2-R)93W;D?[.1D@"M*3_>(F?PL^R!T
MHKRO]A[X[#]IG]D'X<_'.;6+6^O?$/A*SFUJXLXRL0U)8Q%>HJG.W9<I,F,G
M&W&37JE9O1V*"BBB@ KBOV@OA[;?$GX6ZAHSS10W%LOVRQGF8*L<L8)Y)8 !
MEW(6)PH<M@XKM:Y/XL?#&?XJZ5;^'9_%UYING>;NU"WLHUW7:\;5+'[H&"<8
M()(R.!7C<1866-R/$8=4?;<\''DYE'FYM/B>D;7O?=6NDW9/LR^K[#'4ZG/R
M<K3O9NUM=EOVML^NA^?WCG1)=7TU;BT1FFMR2L:_Q*>H^O -<)7TM\$/V<OB
MY\?= OOBQJD5CX3T.]C4>"]!N+(M--;C.V::5=K8<$'S&5FD)+*L<8C#<C\2
MOV8/'GAR::Y\1^"+^U\N,R27]G'YT&W)^9G3*CH3@D-CKU%?QQB.%^(^'\+&
MIB,/.5"2O&I&+<;>?6*>ZYE%M:I6V_H'!Y[ET<1+"2JQYXNS2>SZKLVGH^6Z
M3NKGB]*JL[!$4LS'  [UU]E\)+W4KN/3].U&2XN)FVPPPV19W;T #9)^E>P?
M"#]B/Q[KUXEYJ.CRZ-;<A[_6(\2KR 0D'#9[@L%!&?F[5SY;A<?G554LMH3K
M2>GNQ=E_BD[1BO-M)';C<[RW+Z3G6J)>NGW+=_*YRW[,7PPT[Q3\0M(\%:Y?
MVL+ZA,UQ=6\UTJ230Q+O>*,%E9VV\'9DJ&+?=4FOT!KY)?\ 8JA\3?$5O 'B
MJ_O=)OM*MVU;PGXWT+$,_P DL:[&X^;:SH^W<'C9<JVV3+?57A^RU/3-"LM.
MUK6FU*\M[6..ZU!X%B:ZD50&E*)A4+'+;5&!G XK^B_"/)<1DV6XCZS1<:TY
M^^W9.\=%"W:-W*,DY*2G=-;'X[QMC\/F6(I5:57FT^&STOKS)[.ZLFG9IQM9
M[ERBBBOUT^'# SFBBB@#Q7XN_!'QA\0M2\=R:;#'%'J.DV\6FM(RYN9HS;3;
M!D@ $P%"S$ %@><''I7PFTV^T;X6>&M(U.U:"YM?#]G#<0R#YHY%@164^X((
MKH**]#$9EB,3A8X>=N6+37RBH_BDOF<.'R^CA\1*M&]Y7O\ .3E^#;"BBBO/
M.X**** "BBB@#C?C7X<^*7BWPY'H'PRU#1+1II,WUQK4'G (""JI&T;HV3U+
M#C P,G(^??&_@SQGX&UA=*\>7FGW&H2VZS-/I=ND,+H25&$1$5<;<'"C)&><
MY/UI7EO[4'@J/5/#4/C6W,:S:80EQNX,D+L !GN5<C Z89N_7Z?A[-)8?$0P
MTDE&3>MO>N]KO>U[*VQ\WQ!EJQ&&E7BVY1UM?2RWTVVNSX4^,_BRW^'>C>*O
M'>IV<DT.B6E[J,T$?#21Q(\I SW(7CZUZ;_P;F_"Z]\ ?\$W;/Q9=:C%,GCC
MQIJNMVT<><VZ1M'IVQLCJ6T]GXR,.O?('SE_P5R\3'X;_LO:QK%C?S6]QXHN
M+?186A7.7<[Y%/HKVT,ZG_$BOTK_ &)/@@_[-W[(GPW^!]UH]K8WWAWP?8V^
MM6]C(7B.HF)7O'5C][?<M,^>,EN@Z5ZO&V-C6E0I1^S&[]7NOP1R<)T'&C4J
MOJ[?=_P[/4J***^#/KPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /SB_P"#D+0;?PO\#/A-^TWH]E,_B+P%\4H(]+F$A\N*
M&>"2XDWKTYFT^TPQ''('WC7?6]Q!=P)=6LRR1R*&CDC8,K*>001U!%>I_P#!
M6WX077QQ_P""</Q:\#Z?<&.XM_"[:S;[8#(TC:=+'J'E*HYW2?9C&,=WKY+_
M ."??Q&A^*'[&WP_\0):>1)::#'I4\7VCS6WV1-H7)P,%Q")-I&0) ,GJ='K
M13[,C:HSV2MSX=321>+K9$<J)%D5P/XAL)Q^8!_"L.ND^&&F27?B#^T<'R[2
M,DMQ]Y@5 _+<?PK,L],TVPU"ZNHY5\9Z]I]HLF)K;2%8*WJV[S  W0?=/ '7
MI7LVGB!;"%;5Y&C$*^6TCLS,N."2Q+$X[DY/?FL_P/I#:+X8M;.5-LC)YDP*
MX(9N<'W ('X5K4 %>*?MJ_#VSUSP1;^/(IX8;O1Y-CB614\^&0@%1D99E;#*
MN0,&3J2!7M=>/_M9>!;F\\$:A\14MM8\076C6H;1?"=G&6@N;IF5$+I&OF2#
M<P+!6#%00I7.:^0X\R^>;<*8G"1I*HYQTN[*+6JG>S?N-7LDW)JUM6>UP]5]
MCG%&?-RZI>M]+=$KWM=M);GQ#\0/#\GF_P!O6J[E*@7"CJ,=&^F./;'O7*U]
M:>'OV(_C#<?#&#Q!XQ\3:?-XNNI);G4-'CMXX8(E<;E@5XAY?F*<@[56++;5
M.U-[^0^/_P!F_P 6>%)9IM?\(ZEI*QR!'N&MR]MN//#C*'T^5L5_)^8<.<1\
M,P4<QPTU3M=32;C;?WFK\K2WB[-=M+G[EEW$65XF3HPK1DXNVCWMII>S:[-*
MS1Y34UA8W.I7:65I'NDD.![>Y]J[;PQ\"]>\674T'ARWU#5C;;3=1:;ISR-$
M&SMW;=VW.#C(YP?2O>OA7^P7XE^Q33>+;J+1/W;".%&6XGDDVX5G*G:J;L$@
M$D\C"YS3RK)\\X@ER97AIU+_ &K<L%ZSE:*V>E[NUEJ=&9<195EM-NK42?;K
M]V_X!^P9\/M&N_%UUKXU>W>3PU;K&EI'<J9A-.K#S'0,652F_&X ,6^4G80/
MK*OFWX$?LBR:)\1#\5K_ %35O"_B;1;T6-VNBM$MCK=F$0[I$:,A_,4A69=N
M3&KD"8-(?I(9 P:_IOPPRF63\*4Z,Z3A.4I2DY?%*3=FY+>+5N1KM%6;O<_$
M^+L51QF;.K2J\ZLEMMW2>JDFWS)^>J5@HHHK]#/EPHHHH \;^)O[#?P:^+WC
MR;XD^.]2\0W>J2,IBD_M;$=NBG*1QIMPB*<X ZDDG)))^2?'>AWUG8:GH.IV
M[0W5HTB7$38+))&W*_FN*_1HU\>_M5:;X0D^+>I7G@:XDN9%A$OB!+>W'DVD
M^Y8R=R]R2F_(XD?!8LQ5?Y[\;N'<%1R_#YKAHQC4C-J2T3GS)._>3BXWTV3D
MWHF?I/!>>8ZKBGA:\Y2C&*Y;ZJ-GLNB3O]Z2/EFBMKQ9X7FT:Z:ZM(BUHS95
MEY\O/\)_'I_C6+7XG2JPK4U.+T9^RTZD:D>:(4Z&&6XF6WA3<\C!57U)[4VN
MH\%^&)XTD\3:C:R&*TM9;D1K"SL(XXV=Y2H!.U45FZ= 3P!DJM4]G'17;T2Z
MM]$D36J1HTW)GT9^RQ\"/#7Q935]4\8V]X;.Q,4-J;=]BR2-N+_-CDJ G'_3
M09[5]-> O FC_#G0%\,Z!<7CVD<A:%+RY,IBSCY5)Z+GG'J3ZUQ'['>M_#7Q
M#\"-)U7X8ZL+RWFRVJ,ZA9H[X@&6.51]UURJ@<Y0(064ACZC7]6>'/".6\/\
M/X:M[.#Q$H7E45FWSOFY>9;J.D>WNW/YWXFS3&8K,JU&;DH1E91>EN72]NC>
MK^85'>WEKIUG-J%_<+#!!&TDTTC85$ R6)[ "I*^;?\ @KW\9;7X'?\ !.#X
MK^)YHX9)M5\,2>'[.WDN!&TDFI,+$LG=FC2=YMHY(B;L"1^C17-)(^;;LKG@
M/_!NM!JGQ!^"'Q:_:M\:V3+XH^)7Q;O+C6+Q+?RH;I4ACN-T2X^Z+B]O!P2
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MBBB@ HHHH **** /D;_@NC\.I_B+_P $P_B-'IWAYM1OM$73]7LU3[UNL%_
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MNPS2@!]X&QYE#GRY6%Q'Z-^S?_P52^&_BW6K[X'?M<Z&WPC^+/AV';KWAKQ
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MBB@ HJGX@UF#P]H=UKMS$SQV=NTLBQXW%5&2!GO5?2O%^D:W>6]KI4WG+<6
MNUD' $9(QGN"<].U &I7$_'WX>ZQ\4/ 7_"'Z*\<<EQJ$#232'Y8HPV6?'?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^;?\
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M[O\ =!H[:XF$I,@E=(GCDWD.9[:<E5!45]A5^9O_  4$\#^+?^"7?[=.B_\
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MU.+D_)-_D>;F6<93DM%5<PQ$*,6[)U)Q@F][)R:3=E>RU/SF_P""EWA;X4?
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M[J4%\_7_ (!$?>]X****R+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO)=W4JQQQ(7DD;HJ@9)/X4^L_P 062ZM;QZ/+_JKB4?:!S\T8Y*Y'3. /QH
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M=23^&<4J<F[2C%M2?T.6YW4PONRO*"W3UE%=XMZRBNL7>26J;V7Z2T5Q_P
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M/ACXYN.+6_L2S""+S6^]"?NQ,Q)B(-N^WRU5/JCXBQ2Q^+KEG1@KK&T9/<;
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M(ZY:O0J "FSPK<0/;N6"R*58QR%6&1V(P0?<'(IU,N)XK6WDN9WVQQH6=CV
M&2: /'/$NE>)/#6O77A[4_%#ZM9\36<MY,TEQ;[C]PL3QP!D=#\K *369JFK
M6EA$^HZO?*BEB6DE;EFZ_4D_F:LZUJ\EW<7.MZG-RVZ69N2%'7W. .GL*\C\
M3>([SQ)J#7=RY$:Y$$/:-?\ $]SW^@  !V%Y\5M#A9EM+.XFVMC<0%4CU'.?
MS KXA\33>)_^"W/[7L/[,7PUUUM/^!'PUNH=3\>>)+%3(VL7(+(L,,H^7+_O
M8H2#MVK/<'S@D48Y_P"//Q0^+/[?_P :H_\ @GS^Q'J"S07:L/B-XT@W&UL;
M$$+-&95_Y9#.U]IS*S+"I(9PWZH?LD_LH?!_]B[X'Z5\"/@KH*VNFV"^;?7L
MB@W.JWC*HEO+EQ_K)GVC)Z*JI&@5$1%V7[J-WOT\O,S?OZ=#O/#/AKP]X+\-
MZ?X/\(Z):Z;I.DV,5GIFFV,*QPVMO$@2.*-%P%144*% P  !5ZBBL30****
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M]Y2?Q2?F_N2LEHD%%%%<)],%%%% !1110 4444 %%%% !1110 4444 %%%%
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ML70!'F2L.B+DA(A\J G&69V;V>BBLFW)W9HM-$%%%%( HHHH **** "BBB@
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MUK-TH.&(!/DP)N810!B(U8DL\CR2OU_[*/[)/P-_8N^$&G_!?X#^$DT_3K1
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M;LY.+GRIWO+D47S**]Z2TT3U6Z\S\,?$7XSZ-H&I>#?CUX/T_0M?\5>+%M_
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M"BBBLR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X[_;6_P"",7[.O[4?
MBA?C3\*-9O/A'\4K?4%O[7QQX-@\L37?GB8W%Q;QO%YD^3(PN(Y(IO,96=Y
M@2O#K3]M_P#X*L?\$PX8=$_X*$_ @?%GX<V?E1-\5O \OF7%I#^X4R3OL0-M
M\P1J+N*U>:7<?/D W5^FM%:*II:6J)<>JT/!_P!E7_@I=^Q5^V3#9V?P5^.&
MER:Y=J /"6LR?8=663R?->-;:;#3^6N=SP>;$"C8<@$U[Q7R?^U#_P $4O\
M@GS^U-=3:]K7PC;P?KUPRF;7_ $R:;-)B1G8O!L>UD=V=M\KPM*PQ\_ QX;;
M?\$_O^"RW['-MC]CC_@H!9_$3P[9VJRKX/\ B3;,)66W!$&GVIN/M*1H8\)E
M)[-,XSM #!\M.6SMZ_YBYI+='Z02(DB-'(H967#*PZBOYX:_0C_AZ7_P55^
M>-&_:R_X)*:UK$R_Z3>:[\-;N>:QM;/^)F\A+^/S%4%L-<QYQR%'-?EK#^TS
M\.'U.33K^UU;3_+D96:^LA\A!Z,$9F!]L=:^EX<JTL.ZBJ22ORVU]?\ ,_G+
MZ0/#F?<0T\OGEN&G6]E[;GY4VUS>RMHM7?E=K)['H5%<;'\?_A'*VQ?%Z_\
M K*=?YI5H?&CX6E-X\:6G_CV?RQ7U2Q6%>TX_>C^7ZG!W%U'2>75UZT:B_\
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MQ0EEB;%?J[^S%_P0-_8%_9^GM?$GC;PC>_$SQ!#LEDO_ !Q,LUF)O**2[+%
ML#1LS,P2X$[*=N')7=7V=HVBZ/X<TBU\/^'])MK&PL;>.WL;&S@6*&WA10J1
MHB@*BJH "@  # K"MF4I:01]-D?A1D>6R53&-UYKH](?^ J]_P#MYM>1^?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K'\;_  ^\!?$S0)/"GQ(\$:/X@TN9@TNF
MZYIL5W;NPZ$QRJRDCZ5L44 >0M_P3\_8,<[F_8E^$>3R3_PK;2^?_(%4)_\
M@FQ_P3ZN-2_M63]BSX8B4.K;8_!=FL>1C'[L1A,<<C;@\YSDU[;15<TNXN6/
M8\A_X=]?L%?]&2?"+_PVVE__ !BNZ^&WP:^$'P9TV;1O@_\ "GPWX4L[F17N
M+7PWH=O8QRL!@,RP(H8@< D<5TE%+FD.R#\****0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 9OBOP?X2\>:!<>%/'
M'A;3=:TN[7;=:;JUC'<6\PSG#QR JPSZBO-9/^"?W[!LKM))^Q-\(V9FRS-\
M-]+R3Z_ZBO7**?,UL!XEJ7_!-?\ X)]ZK<BZNOV+/ABK*NT"V\%V<*]?[L<:
MJ3[XS5__ (=]?L%9S_PQ)\(O_#;:7_\ &*]>HI\TNXN6/8Y/X9_ 7X&?!5)H
M_@Y\%_"?A);E0MPOAGP[:V E Z!O(1=WXUUG3H***D84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !17C?BC_@HM_P $^?!'B74?!?C3]NOX-Z/K&CWTUEJVDZI\
M3M)M[FRN8G*2P3127 :.1'5E9& 96!! (JC_ ,//O^":G_20WX&_^':T;_Y)
MH ]RHJGX=\1^'O&'A^Q\6>$M=L]4TK5+..[TW4M.NDGM[NWD4/'+%(A*R(RD
M,K*2""""15R@ HHHH **** "BBB@ HHHH **** "BBB@ HHJCXG\3^&O!/AK
M4/&?C/Q#8Z1H^D6,U[JVK:I=I;VUE;1(7EGEE<A8XT169G8A54$D@"@"]17(
M_!WX_P#P(_:(T"Y\5_L__&OPCXZTNSO#:7FI>#O$EKJ=O!<!%<PO);2.JOM=
M&VD@X93C!%==0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4457U?5])\
M/Z3=:]KVJ6]C8V-N]Q>WMY,L<-O"BEGD=V(555026)  !)H L45X;_P\^_X)
MJ?\ 20WX&_\ AVM&_P#DFC_AY]_P34_Z2&_ W_P[6C?_ "30![E17#?!?]I_
M]FK]I#^TO^&=_P!H;P-X]_L7R?[8_P"$+\6V>J?8?.W^5YWV:5_*W^5)MW8W
M>6^,[3CN: "BBN=^*7Q@^$OP-\(2_$'XV?%'P[X/T&":.*;7/%.MP:?9QR.=
MJ(TT[H@9CP 3DG@4 =%17QA;?\'"_P#P1PNO%R^"8OVVM)%XUUY FD\,ZNEG
MNSC/VMK,6X3/\?F;,<YQS7UG\-_B=\-OC)X+L_B/\(OB%H?BKP[J7F?V?KWA
MO5H;ZRNMDC1OY<\+-&^UT=#M)PRL#R"* -RBBB@ HJKKNNZ)X7T2\\3>)M8M
M=.TW3K62ZU#4+ZX6&"U@C4N\LCN0J(J@L6)  !).*X?X.?M;?LJ?M%:M>:#^
MS[^TU\/?'5]I]N+C4++P;XTL=4FMH2VT22);2NR*6XW$ 9XH ]"HKS77OVS/
MV0/"WQ8C^ GB?]JSX:Z;XZEU"VL(_!=_XZT^'5GNKC9]GMQ:/,)C++YD>Q-N
MY_,7:#N&?2J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"'_"7?;/^$=W:!J%]]K^R^1Y_P#QYV\NS;]IA^_MSOXSAL?S(_##]IWX<?\
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MC<J[:?!J5P7O-0"/$DGV6TB#W%V4,T6\0QN45PS;5YK\^?\ @CA_P28\(?\
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MVO\ P4!U!M?$A9;Z3X;QBS9>R>0+\N#T&_S3Z[>U<]_P0\_X):_\%AOV#?\
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MHM?TE4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+3+>RL;+]MU(+.SM(5CB@B3Q@%2-$4 *JJ  H   P*_?+_@NU^S'\-?VIO\
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M^U:XLC@$)<KI\$_V9RK*P278Q4A@"#FE^-G_  6-_P"":7[/7@;P9\3/B?\
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MW)BU2\DB"P063 PV[1%/W<MPK_:7&(CZ%_P>??\ -MO_ './_N$K]G_@_P#
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M<,JHTS16Z(AD*HBEB,D(HS@"NJH **** "BBB@ HHHH **** "BBB@ HHHH
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MP3\3/"=_X"^)'@[2_$&A:K;F#5-%US3X[NTO(CUCEAE5DD4_W6!% 'X82_\
M!Y?\13\/FTV']@715\5?V3Y:ZTWQ#E.GB^\O'G_8OL0D,/F?-Y'VG=M^7SL_
M/6/_ ,$5OVV?^"T_[>'_  4[N?VD].NI];^'VN7BV'Q0;5;:6U\*:+I$#>:E
ME8XW!+R%;C_1XT+SNT^^X9HY+B<?K\/^"4O_  3'&H?VG_P[X^#/F;L[?^%:
MZ9Y?_?OR=GZ5[?X6\*^&/ WAK3_!?@GPY8Z/H^DV45GI6DZ79I;VUE;1($CA
MBBC 6.-% 544 *    * /YKO^"T_[#WQ(_X)L?\ !4&^_;3\9?!6Q^)'PA^(
M7Q"N?$ENNNP>=I][<7LDES?Z)>,(\6TVY[DP-AB8ECE0N\4RQM^,'_!6K_@C
MQ-\)(4^ W_!$/P?;^.KS3Y%NF\5WR/I>D76/D=/( EU! >JL+0GUK^E+Q7X3
M\+>//#.H>"O''AK3]9T;5K.2SU72=5LTN+6]MY%*20RQ2 I)&RDJRL"""000
M:\Q\$?\ !/K]@KX9^+;#Q]\-_P!B+X0^']=TNX$^EZUH?PUTNTN[.4=)(IHH
M%>-A_>4@T ?-/[,WAKX#R?\ !$/QE\:/@A^R/'\&&^(7P9US5O$?A(:*]BWV
MY=,N(&G5'9F>WD\OS;>1CF2WDA<A2Y _.?\ X,YO^3KOB]_V3VU_]+DK^@+7
M="T3Q1HEYX9\3:-:ZCINH6LEKJ&GWUNLT%S!(I1XI$<%71E)4J0002",&N'^
M#G[)/[*G[.VK7FO?L_?LR_#WP+?:A;BWO[WP;X+L=+FN80VX1R/;1(SJ&YVD
MD9YH _GW_;L_Y6P]#_[. ^'/_H&BU_257FNN_L9_L?\ BGXL1_'KQ-^RE\-=
M2\=1:A;7\?C2_P# NGS:LEU;[/(N!=O"9A+%Y<>Q]VY/+7:1M&/2J "BBB@
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MWEI<VMUX,TSPW:V^DS07.[[1$]HD8A9)=[[U*X?>VX')K$^'_P"QI^R!\)M
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M?#OX?_%CP???#SXI^!='\3>']4C6/4M#\0:9%>6=V@8,%EAF5DD 958!@1D
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MJ5FC.TT=I<#]Y&DX60#.TS1&*YG^@*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *_FQ_P"#N/\ Y2?>'_\ LCVE?^G#4J_I.KS7XN?L9?L??M >*(_&_P >
M/V4?AKXVUJ*S6TBUCQ=X%T_4KI+=69EA$MQ"[A SN0N< NQ Y- '5Z3X?T'Q
M9\+K7PMXIT2SU+2]2T%+74M-U"V6:WNH)( DD4D;@JZ,I*LK @@D$$&J/P)^
M!/PB_9E^$FA_ GX#^!++PUX3\-VGV;1]%L-WEP(79V)9R7D=W9Y'D=F=W=G9
MF9B3U<$$-K EM;0K''&H6..-<*J@8  ["G4 ?RH?\[*W_=\O_NY5]]?\'EMK
M\56\#_ >]L$U0^!TU;74U9K=9OL:ZLT5F;07!!\KSC M[Y&X;PHN]O!>OU?_
M .&$/V'O^%E?\+G_ .&-?A3_ ,)A_;G]M?\ "6?\*[TS^T_[3\[S_MOVKR/-
M^T>=^\\[=OW_ #9SS7=_$;X:?#GXP>#+[X<?%OP!HOBCP[J2HNI:#XBTJ&^L
MKL(ZR()()E9'"NBL-P.&52.0#0!_-5??\% _^"9J_P#!,6Q_9'_9(_X)<V^M
M?'>Z^'[6?B_Q]XH\ Z?J#V+)ITDNMZW:WGFW%\S(D5Q-%D01VJ$S91+80O\
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MM2'29XWCNK6"%K*!8Y)D;RS,Q<I&TFQ5D*2Q4/\ @GE_RMI>(/\ LN7Q0_\
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MLK6T2&0*6) ;(!)QUKOJ** "BBB@ HHHH **** "BBO-_P!H/]L+]EG]D_\
MLC_AI;X_>%? W]O?:/[%_P"$FUB*T^W>1Y?G>7O(W;/.BW8Z>8OK0!Z114=I
M>6VH6D5_93K+#-&LD,J-E74C((/H17YU?LI_\'#GP_\ VI?^"H5]_P $X=+_
M &9=8TB#^VM<TK1/&UQX@5WNKC3(9YI#/8-;QM;1NEK<;3YLCAO+#(-[&, _
M1FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBO-/VR?VB/^&2?V5O'W[3
M/_"'_P#"0?\ "#^%[K6/[$_M#[+]M\E"WE>=Y<GEYZ;MC8]#0!Z717X:_P#$
M9]_UC<_\S%_]YZ/^(S[_ *QN?^9B_P#O/0!^Y5%>&_\ !-G]M#_AX5^Q7X+_
M &P/^%;?\(C_ ,)=_:/_ !3O]L?VA]D^RZE=67^O\F'S-WV;S/\ 5KMW[><;
MC[E0 4444 %%%% !117F_P"T'^V%^RS^R?\ V1_PTM\?O"O@7^W_ +1_8O\
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M?J+6J:FMO$[M;L[1,]M(&1HW62+S(G5E= RE0 >Z45\-?\$8/^"SY_X*\?\
M"R?^,;?^%>_\*]_L?_F</[6^W_;_ +=_TYV_E;/L?^WN\S^';\WW+0 4444
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M2YU"$?;_ (=:A<6-UIUIN_>M]GO))TO90O*KYMLI(P67.1^PWB_]MSX5WG[
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M>>_\5:E>>"X8;72?&.H$Q_:[GRF(G%^T>V1@[7#21VTLC2C8$K]3: "BBB@
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M,O$UM>>&M>\4:7/?PZ!K=U%&(K.RM;0I-?7+K+$VP2*D5Q%;,%DG@0P? /\
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M 7PB\>_&#XR?'CQEX'L=3\4>!+#0;3PCJ5[$)#I2Z@=2^U20JV0DS+:11^:
M'6-I4#!99 WD_P#P=M^!O!G@W_@IOX?U#PEX4TW2Y_$'PATW4]<FT^R2%M0O
M3J>J0FYF*@>;*8H(8R[98K$@SA1@ _H0_:G_ &H?@W^QI\!O$/[2'QZ\2-I?
MACPW:K+>S10&6:5W=8XH(HQR\LDCHBC@9;)*J"P_$SX[?\'B_P ;[OXCQC]F
M;]DKPKI_A&UU"19/^$ZOKF\U+4[42_NY!]EDABL96B'S)_I2H[</(%RW2?\
M!VG\7/B5K_[,?[+>@7FM2?V1XJAU37_$%G#;JL,^I066FK;RDXRI1+^]"J"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBT?0-.^T1P_:KVYTRXA@B\R5EC3=(ZKN=E49R2 ": /YD?\ @DE_P3T_:_\
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MB&.6/ @>.60&'_@Y4_X)8_MX_M__ !_^''C;]DCX$_\ "6:7H/@^XL=6NO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g4bdklltl5z5000009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000009.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *=",H# 2(  A$! Q$!_\0
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MO1QZG\O_ *]%_P"OZ]5]X7C_ #+\?+R\_P Q**7CU/Y?_7HX]3^7_P!>B_\
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MU/Y?_7HX]3^7_P!>B_\ 7]>J^\+KNNG?K;R\_P Q**7CU/Y?_7HX]_R_/O\
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M>'-'^;\'_E_5O2Z44O'J?R_^O1QZG\O_ *]%_P"OZ]5]X7C_ #+IWZV\O/\
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MY?Y(_47_ (?2?\%+_P#HXBV_\-UX,_\ D"C_ (?2?\%+_P#HXBV_\-UX,_\
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M_P!'$6W_ (;KP9_\@4?\/I/^"E__ $<1;?\ ANO!G_R!7Y=#)Z#/TYH]N_\
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MMO\ PW7@S_Y H_X?2?\ !2__ *.(MO\ PW7@S_Y K\NO\<?CZ?6@D#J0/3)
MS],]?PI?5<'TPL;_ /7JGY?U_3L+-,QTMC,1TM^\EY6_)'ZB_P##Z3_@I?\
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M -!F(_\ !DO+_)'ZB_\ #Z3_ (*7_P#1Q%M_X;KP9_\ (%'_  ^D_P""E_\
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MS_Y K\NJ*/JF$_Z!5_X)I^7]?T[']J9C_P!!F(_\&2\O\D?J+_P^D_X*7_\
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MQ_:F8_\ 09B/_!DO+_)'ZB_\/I/^"E__ $<1;?\ ANO!G_R!1_P^D_X*7_\
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M $ZI^7]?T[']J9C_ -!F(_\ !DO+_)'ZB_\ #Z3_ (*7_P#1Q%M_X;KP9_\
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M_P#D"C_A])_P4O\ ^CB+;_PW7@S_ .0*_+K_ !Q^(ZCZT=,^W7V^M)83"/\
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M[=?:C-+ZKA'MA8_^"J?EU_K\&']J9C_T&8C_ ,&2\O\ )'ZB_P##Z3_@I?\
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MQ%M_X;KP9_\ (%?ET>,9XSP,]^_'X4>OMU]L],^F:?U3"?\ 0(O_  33\O\
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M .CB+;_PW7@S_P"0*/\ A])_P4O_ .CB+;_PW7@S_P"0*_+JBG]4PG_0*O\
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M_P#1Q%M_X;KP9_\ (%'_  ^D_P""E_\ T<1;?^&Z\&?_ "!7Y=44?5,)_P!
MJZ?\N:?E_7Z;V/[4S'_H,Q'_ (,EY?Y(_47_ (?2?\%+_P#HXBV_\-UX,_\
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MP4O_ .CB+;_PW7@S_P"0*/\ A])_P4O_ .CB+;_PW7@S_P"0*_+JBCZIA/\
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M1J+#1PL:]50J2@W)P33;C9M.3NUYI'Y+G_@W5_;GQC_A/?@ PZ#_ (G'BD,
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MXLJ_U)? _P#R)/@O_L5O#W_IILJ\#.]L'UTJ?/6)]MPGMB_^X?\ Z2C^$_\
MX+D_\I!/'O\ V -'_P#1$&?UK\A*_7K_ (+D?\I!/'O_ & =(_\ 1,%?D+7K
M8/\ W6A_UZA\O=1\WF__ ",<3_U\84445TGFA1110 4444 %%%% "X.!P.>$
M(;DL/XW0X5@OW=N<'J3FOU2_9/\ ^"/G[47[97P8T3X\_"KQ5\*-,\'^(=3U
MS2+2T\8:EK=IK2W.@7[Z;?O/;:?IUU:I ]U$YM]LWF;0&91D$_E7@?-D Y&
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M=G[S6JTOWMHS@?\ B'5_;EY*^/O@(5/&/[;\4'(YP0QT?*X'7'7/2N%^)/\
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MC6;2_P!3?P5;P/I$VN>7>W!LQ?QR"T@=2JVID$Q";>M?='_$.I^W,I4CQ]\
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M\02ZGX-U%XI_-FTC4M!D18KC1IU>2$6+.%5#'\Q\L;OTZ_X*(_\ !5G]E?\
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MO=/\D?1<6?!AO\4_R@<K1117T1\2%%%% !1110 4444 %%%% !1110 4444
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M;KQQ\#M.FN889C9S:OXBDN;3S$#FWG:+2WA%Q"3Y;^3(\98-AR,5\,_M@_\
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M;*">PO\ 4_[)CM;<6-I<7,5_'>Y%Q#/%&88P5?:XVU^CQ_X-UOVYN#_PGWP
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M_I\_X)>_"/\ :1^#OP>U7]KC]O;]J7XG:G#J_A6?Q!I/P_\ 'WC&>;P?\._
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M-8\8>*(I=-U#1)[F1LPZEHVF&/5HD2)V0NCAAUK^C3PU\:?@]_P49\'?MD?
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M92+(ZNT?G:I-&K;]V-T;<FOA'_@IK_P69U;]K;PE?_ 3X :'K'P\^"%U??\
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M^'S6CQQ.)ACR]S_+7\B&H.LVJ:S(CYBGU[7ID;.?M*RZQ?20LLO1D:-EEC<
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M,BI'-_9Z3B#S8XXT?9E$4'%?E'P5.[C!+#?R?-4XWQXP?EQ@ YZ _7[_ /\
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M>(Q!RP"EB #FORFL]#U/Q7J.G>%-(MS>:OXIU"R\.:/;1QLWGZOK$\>GV5M
MB_,X>>>-"@QL8[MPY-?VS>+/B7_P2X_X+!_"SPG:_$OQUIW@CQY8ZC;Z;I5E
MJ/B'3_ /Q9\.ZP\$%Q?Z1X>NM261]5T6>>Y>W6YM[::VN7C=D2&3EL?P'_P3
MM_X)/_L#_$72/C#XM^+<=UXB\/Z;=:QX6T?XN?%#0M:M(;K30]P=8T#0TMK&
M:]UR)H?+M!$TSO.(XXX3(5K2AF$</1E0G0G]8C2]C'W'R=%JN^SOU?J95LD^
MLXNIBJ>*H+!XBI[:<O:J-2,=&[W\[Z-=+'=_\%)KS3?@[_P1KU?X:^/M2L=
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M^CX?E"GB<9)RC#_8)).Z5VU%J[=M;[?U;^-&"-IM'"(>7LY$5@<$EXV"D-T
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M2P>3X:6'J0YE6Y90GRR3CI]G1I:6OIVN?V$_\%&_B+^V)X'_ &;T^+_[!?\
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M+.2TCDP7M([6ZBMX)$)1FA8 DJ<?W7?MM?MCVG[#W[)G@SXS7?PR7XK0?9O
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M !1110 4444 %?JM_P $2O\ E)?\!O\ L!_$_P#]0^XK\J:_5;_@B5_RDO\
M@-_V _B?_P"H?<5R8[_=*_\ @_5'?E?^_P"$_P"O]+_TN)_?T>@_WA_Z"]%!
MZ#_>'_H+T5\6NOI^J/U;K\J7Y1"BBBI6R]%^1H]WZO\ ,4=1]1_.@]3]3_.@
M=1]1_.@]3]3_ #IB$[#_ '5_]!%%'8?[J_\ H(HH **** "E']#_ "I* >?;
M!R>@';))X[].O>B_Z?CH'1^:M^*/Y#O^#EW_ )*S^R;_ -B%\0__ $\Z57\T
M%?U,_P#!Q?\ "WXI?$+XI?LM7/P[^&?C_P ?V^F>"/'T.IS^#/"6L^(X=.EG
MU?3&@BO[C2[:XBM)955FBBF*O*H+("%-?SG']FG]ICM^SC\<S[_\*Q\5#_W'
M5]=EM6DL%",IQ4TMG)*W[Q-WN^Q^;9]AZ\LQK5(TISC)4[.,7+:G!;)=SQ>B
MO:?^&:?VE_\ HW+XY_\ AL?%?_RNH_X9I_:7_P"C<OCG_P"&Q\5__*ZNWVU'
M_G[#_P "1Y"PF)=O]GJZV^P^MO+S1XM17M/_  S3^TO_ -&Y?'/_ ,-CXK_^
M5U'_  S3^TO_ -&Y?'/_ ,-CXK_^5U'MJ/\ S]A_X$@^J8G_ )\5?_ 'Y>7F
MCQ:BO:?^&:?VE_\ HW+XY_\ AL?%?_RNH_X9I_:7_P"C<OCG_P"&Q\5__*ZC
MVU'_ )^P_P# D'U3$_\ /BK_ . /R\O-'BU%>T_\,T_M+_\ 1N7QS_\ #8^*
M_P#Y74?\,T_M+_\ 1N7QS_\ #8^*_P#Y74>VH_\ /V'_ ($@^J8G_GQ5_P#
M'Y>7FCQ:BO:?^&:?VE_^C<OCG_X;'Q7_ /*ZC_AFG]I?_HW+XY_^&Q\5_P#R
MNH]M1_Y^P_\  D'U3$_\^*O_ ( _+R\T>+45[3_PS3^TO_T;E\<__#8^*_\
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M^_3;>YX?-:VUP09[:"<J,*9H8Y"HZX!=6(&>PJ90%544!44!550 J@< *HP
M .@ Q7M7_#-/[2__ $;E\<__  V/BO\ ^5U'_#-/[2__ $;E\<__  V/BO\
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MK_B?.YMAJ\L?B)0HU)1E.ZE&+:=[=?FD>+45[3_PS3^TO_T;E\<__#8^*_\
MY74?\,T_M+_]&Y?'/_PV/BO_ .5U=/MJ/_/V'_@2/.^J8G_GQ5_\ ?EY>:/%
MJ*]I_P"&:?VE_P#HW+XY_P#AL?%?_P KJ/\ AFG]I?\ Z-R^.?\ X;'Q7_\
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M<OCG_P"&P\5^W_4.]J)3P_O?OX34VM-K))::]W_5Q_5\9&7/"C6<DU*-XO\
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MBE+XJD%>R=I+5>?GZ!'"XI*25"M=I2C-Q?,I+ELNCM:UOE\O$(8(+<$6\,,
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M\()7=M4M=_0^@XHHU:L*'LX2GRRG=13>ZAV/G"BO:?\ AFG]I?\ Z-R^.?\
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M=?[DNMO+S1XM59[.TDD\V2UMGE)#&1X(FD++T.]E+9'8YR.U>Y?\,T_M+_\
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M?Y:_J>)2PPSKLFBCF7.=DL:R+D=#AP1G\.*2&""W!$$,4*L076*-(@Q' +!
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M!#HZ*R,">0RL""#WR*]K_P"&:?VE_P#HW+XY_P#AL?%?_P KJ/\ AFG]I?\
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M[MDL:2)N_O;7!&??&:]N_P"&:?VE_P#HW+XY_P#AL/%?_P KJ/\ AFG]I?\
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M'!7'!SD8X.>N1T.>^>M>T_\ #-/[2_\ T;E\<_\ PV/BO_Y74?\ #-/[2_\
MT;E\<_\ PV/BO_Y74Z=7#TY.TX.+A97DK\UM;K;YW^14L-BZEG*E7TLDE!].
M7EW5NIX=%:6L#^9!:V\+X(WQ0QQM@]1N10<'ZU8_P(_ ]1]#W'0U[1_PS3^T
MOSG]G+XYX_[)CXK_ /E=2_\ #-/[2_\ T;E\<_\ PV/BO_Y74E6HJDH*<$[M
MNTE;WK7[?=UM][6'Q<FW4H59.246^1WBE;EMWWO^9X;'9V<+^;%:VT4G/[R.
M")'YZ_.JAN>_//>K! 8$, 0P(8$9# \%3D<@]P>"*]J_X9I_:7_Z-R^.>?\
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M%)'0[7!!(]<9';BFPV]O;9^SP109Z^5&D>?KL S7M_\ PS3^TO\ ]&Y?'/\
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M/JF)_P"?%7_P!^7EYH\6HKVG_AFG]I?_ *-R^.?_ (;'Q7_\KJ/^&:?VE_\
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M+R]='^K"[[Q_KY^O]/1VYO7^7^%&YO7^7^%-HH]W_GXON7EY>O\ 387?>/\
M7S]?Z>CMS>O\O\*-S>O\O\*;12T_Y^K[EY>7K^'F%WWC_7S]?Z>CMS>O\O\
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M\O\ "FT4_=_Y^+[EY>7K_387?>/]?/U_IZ.W-Z_R_P *-S>O\O\ "FT4:?\
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MU_IZ.W-Z_P O\*-S>O\ +_"FT4:?\_%OV7EY:]?\M6%WWC_7S]?Z>CMS>O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH 4=1]1_.@]3]3_ #H'4?4?SH/4_4_S
MH 3L/]U?_0111V'^ZO\ Z"** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 HZCZC^=!ZGZG^
M= ZCZC^=!ZGZG^= "=A_NK_Z"**.P_W5_P#0110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
MU]J0YXQZ\_2F\[ASQUQ[=.G&?:I=E=V=W*,);ZQDNC0XWOTLDY+;=<N_E]PH
MX&"<Y./KGH/?/_UJ=ANX/3I@_C[?YZUS/BZ+4+CPGXIMM+\TZK-X<UN'21:M
MLN3J4VF726'V=SCR[C[2T8B;</+E*G([?Y_\W['O_!P(]S?F/3?VQS%/J^J2
M0'_A=$*LML^HW3V;$#Q&!'$;8Q;$4\(5! Q7TO#^04,[6)4LYR_)XX1TX?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 HZCZC^=!ZGZG^= ZCZC^=
M!ZGZG^= "=A_NK_Z"**.P_W5_P#0110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110%[;Z+O:_X"*<C/^?3
M^E8-]XDT;3M5TW0[[4[2TU?63<G2=/FD5;G4!:(LER+2,G,RP(P>1N"JGVK?
MKS37]/\ A[<_$#P2_B$::WCE(-;?P/%=,?[0:&WMHI-?DTT='6.U,+W1/\&,
M>W#CJU6C&A[&5/GG7HTI>T]V*C.24[:>]4LTH+N_-G7AZ5&I.?MO:>S5.I4C
M[%<\G*$4XMK3EIIJ]1W]V-V>E!@?3C@@9//O[T9SG'N/QKSOQ'\6?AWX1\11
M^%?$OB[1=&UZ71;WQ$FG7]PMK,=%TY&DO=0^?Y/)MT1BYW%S@A%8\5XWH7[:
M'[.FOZ^GA^R\?64,T]U!9V>H7UM>66D:A<W4BQVT-GJ,]O'!(UQ(RK%N9%<L
MH#8P:\W%<5\/8+$_4\7G674L5[>>%]A[9>TC7Y8-4JD5=TZD5)-\[C:,D[H[
M,/P]GN-HU<3A<IS"O0I4(8MU:6%JSIK#.<DJW.H^_3<HSBN6]^27\KM]4#/<
MYI>?\_Y_I7A7Q3_:,^$GP?DM;/QIXJM;;5+^W:\M-&LEEU#59K-7"-<K:6<<
MS+ 'X\R0HK=5R,&NB^&/QF^''Q@TZ[U+P!XELM;337ABU*TB9XK_ $Z6XC$D
M$5]93I%/"TD?SH2A0@'Y\@U='B3(JV9/)*.;X"MFE."J_4H5U[9QLG*]DXV4
M>S<NZN1/)<YAEL,XJY;C*>73FZ*QCP\OJZDK))3^'FDVHJ3]UMJ,6Y71ZEGW
M[_RY(_*D5LEO;C^?/^?2N/\ $'C_ ,'>$[Y-,\0:_IVE7\VD:AX@2UO)Q"_]
MBZ4\<>I:GR-HM;-Y8DF?)*F1 %.:\,TG]LS]GG6?$0\-VWCVTBNGE2"VOKNU
MO;32;V:5BD4=IJ%Q;QP2-(P*IDH">A-+,.*>'\KQ%'"9EF^!P&*J5/9PPU>M
M:<ZDHIQ@[)\EXVDG)I/1Z7N&#R'/,QH5\1EV58_'8>C15:=;#8>I-4Z*<5.<
MFHZWEM:\NRLFSZES30221]>WY?7/X5X7\2/VD/@W\*95MO%_C&QMM5DMHKR'
M1;)9=0U:>UGSY4ZVMG'-MC<<HTC)D'< 1S6[\-/C?\,OB[;W,W@/Q18:S/91
MQRZAIZ%X=2L!*<1"[LYXXIHRQX!"LN>,TZ7$V05<PI952SC 5,=4A*2PT,0I
M5:C5I<L;:<R2;LFY63NBY9#G$,$LTGE>80RY3C#ZW+#5(T%4<8M<T[6Y)*2L
MW:$I?"VW8]8)P/6D+8'/!P>.OT.?\]?:N-N/B%X/L_&5E\/KO7;"#QEJ6FR:
MO8>'WE_XF-UID3F.2\CBQS"LBLA;.<CIWKL"5X8D^BY_B.,\=>1WSWKU*6+P
M^(566'Q%*;H2=.HK\WL)1UFJMMIQM>SLTK'F3H5:7)&M3J159*K"=G%3BY6C
M[.Z5X.S2E%V;BUT=G@Y''\J7/7-<KH/C7POXHTN^UKP_K%IJNEZ9>:EI]_>6
MC^9#:WNCS/!J=O*Q VR64L;I..=K*1]?(/$'[57P'\-:':^(;[X@Z-/9ZA/J
M-KIT-A-+?7U_-I$XMM2CM;2VBDG)M)R(Y6D1%#_=8YKS<?Q#D674:6(S#-L)
MA*$Z3Q$:E6LJ4:E"/*I58;N<(2E%6BGK))N]D=^$RC-<;5>'P66XO$5G5A0Y
M*=&I5E[>HG*E2DHQER2J1A.24K-J,I6M&37T1S].G;G_ "?THYSVQCIW^O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.P_W5_\ 0111V'^ZO_H(HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLW.4:4>2";WY8J]EV738DHHY  )R0,$]_P#@7^UZT5N9!1110 4444 %%%%
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M]4['P7"/".+X;S+/\=7KTL12SG%1KTU34E*@HRJ2Y9\WNR;51?"^CN?RY_\
M!TVRK\ ?V4=[JA_X7/XK&20HS_PAHZ$X[<UM?\&M+J_[+_[2Y1E8?\+\L_ND
M$#_BCM/ZXZ'O_G%?OQ^T-^RC^SG^UEHWA[PU^T;\)_"WQ;T7PGJD^M>&]-\4
M0WDMMHVJW=J+.YOK8V=W:L+B:U_<.7+*8^BU/^SQ^RM^SU^RGX=U[PI^SO\
M"GPQ\)?#OB?6%\0:_I/A6.[CM=4UE+9+--1N#=W5T[3BUC2#*LJA% VYYIKB
MK#/@B7"*H5)8CZ_'&^V]I!4W%5/:2IRC\;;7NWY5%23>SUI\+8I<>1XLEB*2
MPJP4L(Z7)+VJE.@J//&5N2*NDVFV[=-TO&_^"E7P1U;]HG]A3]I;X0Z!<_9=
M7\5?#N_ELY6RQ,GA^YMO$;1( "3)<1Z2T$2@9:25!WK^#/\ X),_MN^&/V _
MVN[;XK_$C0-5OO _B#PKJGPT\??8+.27Q!X7TN;4(KV36;72CY<]]>VMW8P1
M2V"&*1TD<AA@U_I7NBLOEO&)4<,K(VTJZL"&5U8%64J<,&!5E)!&"17Y%_M3
M?\$1OV"/VIO$;>,M=^'U]\,_%^HZQ<:UXD\1_"?4(_#5YXIO+MQ)-_;T;V][
M8NC.&(6TM;499CSFNO@OBK*,IR[-,BS[#5:F4YEK6GADG4H5.2,'RQ;CTC#D
MJ+X)^\T^G'QGPEFV;9IE6?9'B:5+,\K<52IUY6A6IQ:E'5*UN9RYXR^*"2B[
ML_"O_@KA_P %H_A/^VA^S[>?L[_L>Z%\2M<T[49;?Q?\7/'6K^'KGPW;^&?!
MN@RR?;-&NM(F-Q)<Z?K!N(&NM4:YBBL6AC!C8ONK$_X->)(6_:"_:%$;Q/CP
M3H>"F-WE[SLW$$[N.C=Q7]-?P=_X)B?L-?!'X9^+OA5X.^ 7@U_#OQ'\,6O@
M_P")]SJ]I+J&M?$32+:((4\3:D9EF/VG DN&TTV"2.$8IE01Z3^S[^PU^R/^
MRGK&LZ_^SM\"?!GPFUKQ#9P66M:AX6@U"&ZU*RM?]1:S?;+V[5DC' "JI'4D
MUV5N,,AH\,9KPOD>68NEA\764J>-Q->%6M52G&7-724%#X$HQIIJUKI/F.7#
M<'<08CBC*^*,ZS/"5:V"IRC5PF'I2HTJ3E2=-0H*3GS17->4I2O*5VKJS?UJ
M.H^H_G7^9Y_P6HEB7_@IO^V,&DC4CQCHN074$9\*:/C()S7^EZ!C^$#UP>%Y
MR%+9 +<<D=/3%?!?Q3_X)@?L ?&_Q[XH^)_Q8_9;^&GCGXA>,[N&\\6>*]:M
MM6?5==O8+>*SAGO3!J<$3%+:&*%6CC1=B*"#W\+@CBJAPOC\7C:^'J8E5LOK
MX)TX2C!P=:I2J*HY3:325/9:W>VC/;XXX6Q/%>7X/!X>O##O"YC1QSG.+E&:
MHPE#V5HZQYN?XMM'MU^DOV<B#^SU\!V!X_X4S\,1CW_X0O13GT__ %UY%^WA
M^R5X4_;7_9D^)/P(\2K%;W_B+1IY_!VN_(EYX=\6V6VZT?4+&Z96-FTUS$EC
M=SJ"5L;FX&#FOJW0-$TKPSH>C>'-"L8=,T3P_I=AHFC:;;AA;Z?I6E6T=CIU
ME '+.(+6T@B@A#,S>6B[F)R3J.,@#C)^ZIZ,?0^N!DCW&.]?,TL76PV.AC\+
M5G2K4L2L30FOL-352+TM=W2WNG&ZU3/J98"ABLL>!QM*-2G4PL<+B(;*4>2,
M)1M=K?5.UT]='J?YC7P]\<?M@_\ !(O]K.[U-]#U3X=?$[P;=2>'?%.B:]IU
MS+X-^)G@J/4$>ZA2?Y+75=!UR.(7FCZE#-#(MR+>\3"Q%#^Y_C/_ (.G-5U'
MPIK]GX$_90E\,^-;W298/#WB37OB+I6N:'I.L.@2&^U#1;;3K6?4;6!BSK:)
M<1$G:&8J&#?U0_'/]F7X ?M+>'_^$3^/7PD\&?%'0!<V]]'9>)]+6:<7-J)%
M@DCOK=K;4HXX1,ZK"MV(F!!=&VJ!\@_\.</^"895U/[&7PD*L"LH:VUH+D<;
M?^0OD9!.&!!Q7Z9CN->%\\EAL9Q)PW4K9K2A3A4Q6"Q$:5+%<EN9U:;<&TVM
M%/G482E!RE%L_+\%P/Q5D*Q&$X9XDIT<KJU)RAA<90E.>%Y[+]U)*2YO>M>'
M+\,6XWM;^%+]G;]F_P#:/_X*P?M;:SY,-_J6K?$#QO%XO^-?Q5FL+J^\+^"-
M+O[F.XO[B9;DF!H[JWA^R:7HEK*JD.^SR]I)_M1_X*@?"_PA\$/^"2_Q)^$O
M@32K'0O!WP]^'^A>&="TRPA^S6-G9Z<JHWV>)F?8MQ<&>Y9=YVR3MSZ?IO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN4-1TO3=6M);'5M/LM3LYE"S6NH6L-Y:RA6W+YMM<))!+M/*[XVP1D8->/\
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M -H7X(?#7XNZ'K6FKH]_'XT\*:3JNH-IB7+7<=C;:U);#6=/MTN&>14L+^V
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M7L.!R 1WY(X.T_W3CN*6D48& " "1R!D\]3CKGU//K2T#L^S^[^NZ^\****
ML^S^[^NZ^\**** L^S^[^NZ^\**** L^S^[^NZ^\***/\_Y]/QH%KV_K^F@H
MINY>>1QV[_@.I_#-.HZI=7LNKTOIWTU]!)IJZ=UW_KJ%%%%%QW"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHI"0,9(&<=>.O SZ9]\47UMULW;K9;O
MY!_G;Y]O46BCU]CBBG9[V=O0 HHHI %%%% !1110 4444 %%%% !1110 4A
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M+26M[:VWMT]0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** %'4?4?SH/4_4_P Z!U'U'\Z#
MU/U/\Z $[#_=7_T$44=A_NK_ .@BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D(!XQW_P FEYX_7_ZU-9L8]<C\L^_%&DDHN2?M(R<7'2RM%:-;/\;W
MWV!M*-1OWMXM?S64==M4D_2QA>)O$^A>#M#U+Q)XEU.VT?1-(MI+S4-1NI!'
M#:P1*6=V)ZL0"$C7=)*W[N-68A3^>]__ ,%*_AA_:-]:^&/ 'Q$\9:;93&./
M7/#^F1W-A=(1D2JJYDA#KR(YU28J<E>,BG_P4<2]UC3/@CX#&I7EEHOCGXFV
MVA:ZEI,\:7%K/% L;7$2G9<_997$\,<N5$HSG&:^X? 7PD^'_P /_#]AX?\
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M*?E_U#^OK;S/SM/_  4H\)YY^#'QA_\ !'GZX]>/\*#_ ,%*/"8Z_!CXP_\
M@D_/Z\=:_1+_ (1GP]_T!=-_\!(?_B:/^$9\/?\ 0%TW_P !(?\ XFC_ %4\
M6-/^-@9=_P"&E>7][U^X7]N>&VG_ !A&:_\ B15/[O\ U#_U;S/SM_X>4>$\
M9_X4Q\8<?]@/_/&._P"% _X*4>$^WP8^,/\ X)!_GIW_  K]$O\ A&?#W_0%
MTW_P$A_^)H_X1GP]_P! 73?_  $A_P#B:/\ 53Q8_P"C@9=T_P"95Z?W_7]-
MQ_VYX;?]$3FO3_FHI^7_ %#^OK;S/SM'_!2CPGGCX,?&'_P1X^F?3C_"D_X>
M4>$@?^2,?&'M_P P3\OQK]$_^$9\/?\ 0%TW_P !(?\ XFC_ (1GP]_T!=-_
M\!(?_B:/]5/%C_HX&7=/^95_A_O^OKKW#^W?#;_HB,U_\2*?E?\ YA_7[O,_
M.T_\%*/"8Q_Q9CXP^W_$C_+\>O':C_AY1X3Q_P D8^,/;_F"#\/\]NM?HE_P
MC/A[_H"Z;_X"0_\ Q-'_  C/A[_H"Z;_ . D/_Q-'^JGBQ_T<#+NG_,JO;;^
M_P"OW7MJ']N>&VG_ !A&:]/^:BGY?]0^O7[O,_.T?\%*/"9''P8^,/\ X)/R
M_7\NM(/^"E'A+M\&/C#_ ."3W_EFOT3_ .$9\/?] 73?_ 2'_P")H_X1GP]_
MT!=-_P# 2'_XFC_53Q8_Z.!EVZ?_ "*O\._O^O;:P+//#;_HB,U_\2*?E_U#
M_P!6\S\[?^'E'A/./^%,?&'/_8$]_P#'O^-!_P""E'A,#GX,?&'_ ,$GY_K^
M?6OT2_X1GP]_T!=-_P# 2'_XFC_A&?#W_0%TW_P$A_\ B:/]5/%C_HX&7=/^
M95_A_O\ KZZ]P_MSPVT_XPC-?_$BGY?]0_K]WF?G;_P\H\)X_P"2,?&'O_S!
M!^/^>_6@?\%*/"9S_P 68^,/O_Q(_P _QZ<=Z_1+_A&?#W_0%TW_ ,!(?_B:
M/^$9\/?] 73?_ 2'_P")H_U4\6-/^-@9=_X:O3?W_7\>X?VYX;?]$3FO3_FH
MI^7_ %#^OK;S/SL_X>4>$B?^2,?&'O\ \P3\_P :4_\ !2CPGGGX,?&'_P $
M>?KCUX_PK]$O^$9\/?\ 0%TW_P !(?\ XFC_ (1GP]_T!=-_\!(?_B:/]5/%
MC3_C8&7?^&K7I_>]?6P?VYX;?]$1FO\ XD4_+_J'_JWF?G:?^"E'A,=?@Q\8
M?_!(/3]>._X4?\/*/">,_P#"F/C#C_L!_P">,=_PK]$O^$9\/?\ 0%TW_P !
M(?\ XFC_ (1GP]_T!=-_\!(?_B:/]5/%C_HX&7;)?\BKTZ<_K]VFX?VYX;?]
M$1FO3_FHI^7_ %#^OK;S/SM'_!2CPF>GP8^,/;_F"?E^G^'>@?\ !2CPGGCX
M,?&'_P $>/IGTX_PK]$O^$9\/?\ 0%TW_P !(?\ XFC_ (1GP]_T!=-_\!(?
M_B:/]5/%C3_C/\NZ?\RK_#_?]?Q[A_;OAM_T1&:]/^:BGY7_ .8?U^[S/SM/
M_!2CPF,?\68^,/M_Q(_R_'KQVH/_  4H\)C'_%F/C#[?\2/\OQZ\=J_1+_A&
M?#W_ $!=-_\  2'_ .)H_P"$9\/?] 73?_ 2'_XFC_53Q8_Z.!EW3_F5>G]_
MU\M/,/[<\-O^B)S7_P 2*?E_U#^OW>9^=H_X*4>$\<?!CXP_AH?Y?K^76@?\
M%*/"9''P8^,/_@D_+]?RZU^B7_",^'O^@+IO_@)#_P#$T?\ ",^'O^@+IO\
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MKZV\S\[1_P %*/"9S_Q9CXP^_P#Q(_S_ !Z<=Z3_ (>4>$LX_P"%,?&'J?\
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M_P"@+IO_ ("0_P#Q-'_",^'O^@+IO_@)#_\ $T?ZJ>+'_1P,NZ?\RK_#_?\
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M/K0?^"E'A/'/P8^,/XZ'^?Z_GUK]$O\ A&?#W_0%TW_P$A_^)H_X1GP]_P!
M73?_  $A_P#B:/\ 53Q8_P"B_P NZ?\ ,J_P_P!_U_'N']N^&VG_ !A&:_\
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M_H3/"W_@BTW_ .1Z/^$!\"_]"9X6_P#!%IO_ ,CT_K_"6G_"+C__  X_X?\
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M/VR/_#?6WI_U\>O'_P!?B@?\'(OP/_Z,X_;([?\ -/K;_P"2/P_P/%?T(?\
M" ^!?^A,\+?^"+3?_D>C_A ? O\ T)GA;_P1:;_\CT_K_"7_ $)<?T_YF/\
MAU_A>7E^(_J?$W_0[P?_ (0KR_N_U\M?Y[_^(D7X'_\ 1G'[9'_AOK;T_P"O
MC_/L>*/^(D7X'_\ 1G'[9';_ )I];?C_ ,O';\/?%?T(?\(#X%_Z$SPM_P""
M+3?_ )'H_P"$!\"_]"9X6_\ !%IO_P CTOK_  E_T)<?TM_PH]N7_IUMH'U/
MB;_H=X/_ ,(5Y?W3^>__ (B1?@?_ -&<?MD=O^:?6WX_\O';\/?% _X.1?@?
M_P!&<?MD?^&^MOQ_Y>.PY_G@<U_0A_P@/@7_ *$SPM_X(M-_^1Z/^$!\"_\
M0F>%O_!%IO\ \CT?7^$^F2X[I_S,7TM_TZ\D+ZGQ/_T.\'_X0K_(_GO_ .(D
M7X'_ /1G'[9'_AOK;U_Z[_C_ /6YH_XB1?@?G_DSC]LC_P -];>O_7QZ<_\
MUN:_H0_X0'P+_P!"9X6_\$6F_P#R/1_P@/@7_H3/"W_@BTW_ .1Z/K_"6G_"
M+C]_^ACT5O\ IUY!]3XF_P"AW@__  A7^1_/>?\ @Y%^!_\ T9Q^V1_X;ZV_
M^2/Q_ED<T'_@Y%^!_P#T9Q^V1_X;ZV_#_EX[CG^61S7]"'_" ^!?^A,\+?\
M@BTW_P"1Z/\ A ? O_0F>%O_  1:;_\ (]'U_A+_ *$F/Z?\S#M;;]UY?U=C
M^I\3:?\ "W@]7;_<EY?W?Z^6O\]__$2+\#_^C./VR.__ #3ZV_#_ )>._P"/
MMFC_ (B1?@?_ -&<?MD=_P#FGUM^'_+QW_'VS7]"'_" ^!?^A,\+?^"+3?\
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M([?\T^MO_DC\/\#Q1_Q$B_ __HSC]LC_ ,-];?\ R1Z\?X'BOZ$/^$!\"_\
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M^\?F;X]^&_#O[4G_  7J\3^%?B_IC>*/!WP6^$%GX@\&^#[^[EO?#::]X7B
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M1_Q$:VO_ $8K^TM_X1^K_C_RX=N]?I#]MN?^>G_CD?\ \11]MN?^>G_CD?\
M\11_JC@?^?TO_)O+_@?AVU/^(D8K_H&73[+\OZ?_  6?F]_Q$:VO_1BO[2P_
M[D_5_P#Y [#GZ4?\1&MK_P!&*?M+?^$?J_\ \@>G/TK](?MMS_ST_P#'(_\
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M^Y/U?_Y ['CZU^D/VVY_YZ?^.1__ !%'VVY_YZ?^.1__ !%'^J.!_P"?TO\
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M4?\ 1(_VPO\ PP&N_P#R97[$?9=-_P"@-H?_ ()-(_\ D&C[+IO_ $!M#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "CJ/J/YT'J?J?YT#J/
MJ/YT'J?J?YT )V'^ZO\ Z"**.P_W5_\ 0110 4444 %%%% !1110 4444 %%
M%% !7XX?\%[O^47W[1?_ &"+'_TK2OV/K\<?^"]@S_P2_P#VB@?^@19?^E25
MMA_XU/\ Q?HS.L[4Y/T_-'M?[")_XP@_9#_[-\^'?Z:817U77RK^PB,?L/\
M[(?_ &;Y\.__ $UY_K7U52KI.J[IZ/\ RV*I:4[?S*+7W(****ARUTT731>7
M^15FM'N%%%%',_Z2_P O)?< 4444<S_I+_+R7W %%%%',_Z2_P O)?< 44AS
MQC@[@<GD!1]XD=3@5D^(O$7ASPAX?U?Q=XM\0:/X5\*Z!83:GKOB;Q%?0:5X
M?TC2[=6>XU'4-0N72&UMX(U9Y78G:J,3@9HYG_27^7DON UZ*^+5_P""D_\
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M_P#;1]9?]?8?FC\U_P#@H"?^)]^RZ/3XVZ9^HM:_2* _)_P)OT.*_-S_ (*
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M_P (:_<31>'K?X8Z/I&A^//$'@NW@MY(#$_B>]U35K>]N8G2[G6[V&;$400
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MTZO?010I<S6]C;6UK&[(93%$IE>1]SL ?MK^RW^V!_P3@_X)]?\ !(OX5?M
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M_P#L@VN?RMZ_8NOUSAW_ )%=#^OLP/P'CO\ Y'L_^O2_]M"BBBO</C HHHH
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MKG&5PRO-,9@X598CV/*U4JN*ERR49JUG9RBFE./22VV"BBBN_P CS+A1110
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M?CE_P7K_ .48'[17_8(LO_2I*_8VOQR_X+U_\HP/VBO^P19?^E25MA_XU/\
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M7?B1XAM]#\0:KXLUF\U&TV#^R+*.6QM&4_8K:!F+#^Z?]C_]FCP-^QY^S/\
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MD\N)'(+A5R  ?4(Y^F,[ARN<D  ]"21VY]J.ZC'7KV*CIDKUP3P.GK7YF?\
M!,?_ (*>_"C_ (*??#KXK^._AKX'\5?#*\^#WQ>\1_"+Q1X-\=:GH%YXD74O
M#T%E+)K\%MH=Y=1Q:-?R73VUG+<!)/M-I=QR*KQL*Y[]H[_@J=X+_9\_;_\
MV:?^"=EA\$_B/\4_B]^TGX5N_&>E:]X1U;PS9>'?!?AW3[W6(=3OO$JZS>P:
MBWV#3="U36I8[.&4FS@0+^\FA5@#W7X+_P#!13]DW]H']J/XU?L;?"WXA7FO
M?'_]GO25UKXJ^$I?#.O:?::!I[7NF:?YD.O7EE#HVIR+=:QIJ20:?>7$T2W4
M;R(JD&OMW/08&XG 7(SC/5NZC'//TZU^/G[)_P#P4(_9D^/7_!2#]L']C;X:
M_LXS> OCA^SUX7M-:^)/QM/ASP+IMK\2]/GUC1=-BLHM:T6*/Q=J&+G4[:Z5
M-?=H";5V0M)#\OP'^UK_ ,'(>F^!OVAOB)^RI^P[^QO\:/VS?B?\)_$J>&O'
M_B_PKH][_P *ST'5]+%XOB[PS>W5E"=7M]?T.YLY]/2>\6VTVYOK>:*&2Y.
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M*O\ L<M(_P#2._K](/\ @G-_R87^R'_V0'X;_P#J.6-?85_^2(RK_LH,Q_\
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M4_4_SH'4?4?SH/4_4_SH 3L/]U?_ $$44=A_NK_Z"** "BBB@ HHHH ****
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M-K^=WJ?:%%?&'_#?G[,?_10=/_*?_P"-=O\ ]='_  WY^S'_ -%!T_\ *?\
M^-=O_P!='_$3^ /^BJRG_P *I^7]SS0_]0.-_P#HE\X_\)*O_P C_7R9]GT5
M\8?\-^?LQ_\ 10=/_*?_ .-4?\-^?LQ_]%!T_P#*?_XU1_Q$_@#_ **K*?\
MPJGY?W/-"_U XW_Z)?-__"2KY?W?Z^3/L^BOC#_AOS]F/_HH.G_E/_\ &OQ_
M^MQ1_P -^?LQ_P#10=._*?\ ^-?C_P#6H_XB?P!_T564_P#A5/R_N>:'_J!Q
MO_T2^<?^$E7_ .1_KY,^SZ*^,/\ AOS]F/\ Z*#I_P"4_P#\:I/^&_/V8_\
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M?17QA_PWY^S'_P!%!T_\I_\ XU^/_P!;BC_AOS]F/_HH.G_E/_\ &J/^(G\
M?]%5E'3_ )BI_P!W^YY_F/\ U XV_P"B7SC_ ,)*OE_=\S[/HKXP_P"&_/V8
M_P#HH.G_ )3_ /QJC_AOS]F/_HH.G_E/_P#&N_\ ^JC_ (B?P!_T564=/^8J
M?E_<\U^(?Z@<;?\ 1+YQT_YA*OE_=\_ZU/L^BOC#_AOS]F/_ **#IWY3_P#Q
MKO\ _JQ1_P -^?LQ_P#10=/_ "G_ /C5'_$3^ /^BJRG_P *I^7]SS0O]0.-
M_P#HE\W_ /"2KY?W?Z^3/L^BOB__ (;\_9C_ .B@Z?\ E/\ _&OP_P#KTO\
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M_P"RY^$__3%J]?TS_$G_ ))Q\0?^Q'\6?^F*_K^9C_@V6_X\/V_/^RY^$_\
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MT^W:3Q#X7U"S32M1L'O+T7OAE_,AC+QN #B_V7-%F_X)G_\ !RE^T9\#9H?
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M"^*?A/XUU!C?01R70P-)\.^'H[V_T#1[;2GNK77--_LZYU""SOK.1F /4?\
M@KGX$\):-_P<.?\ !![Q[I7AO3=-\6>.O%/Q"LO%WB2UM4@U'Q'%X132K;P]
M;ZI=(@:\.BVFIW5M:>8[-;V]SY2A4<9Z;3_^5PC7/^T9</\ Z6:/7PKH'[$7
M_!;#X_\ _!8C_@FW_P %%OVROA;,/ K_ !%U7Q'K?PL\$:O97GAK]BSP%I5K
M<:?IOA+Q1!=:E$LNL:]'>6M_JFL:)!J=QK5U9O/J4PFBC6/]=++]DC]I*/\
MX.;]6_;)D^$GB5?V8+C]@N/X76_QCWZ6?"\GCU9]+=O#)3[?_:RZ@##-C.G"
MW(3(N.=M 'R%:3S2?\'B4.^1GQ^P)K$!W'.((M&O/+C'^RA5,#L /2HO^"X4
M.I_L"?\ !5#_ ()N_P#!5OPGJ:Z5X?\ %'B-/V6/CY?7?AQ;OPUX4^&VK7B0
MZQXIUK5(+=_L.HZCH7B[5;"PN;UHFDFTV&&W=I %K3_X*1?LW_\ !1W]F#_@
ML_X#_P""JG[$7[(MK^VCX?\ $?[.MW\#=<^&VF^+U\-:OX6UI(;BWU37?$%Q
M=-"MK8WEI?V;:$;,W*7$]KJ$=U';JJ25^J__  6D^ &@_M>_\$B_VE/#?Q8L
MM3\%W>C?!8?'F;2K:Y"W.@>/?A?H8\?Z?H=]<1,1<VMEK>GG3KXJ2MQ'&_)0
M\@'Y4?M17=I_P51_X+^_LT_LQZ1-JOCW]EK_ ()W^#-'_:,^,5C8M#H^G^%/
MC;JEN?%'PQ\0V^JQM%J>IP:PEU\/XQ:*)+5H(KII0-ZU_7,22<GO]?3CK7\J
M/_!K)\!OB'K'[.7Q-_X*)_M Q6>M?'/]L?5=$TW1?'D%P!/K7P3^%^CZ3X(\
M,:5=Z7"J6EE<V&N^&-5A+QKYDT,%OO)*%F_JL&>_7ZD_7DX/6@!:*** "BBB
M@ HHHH ****J&_\ V]+_ -(B'V'_ -?(_E$_ _\ X../^4<?BK_L<M(_]([^
MOT@_X)S?\F%_LA_]D!^&_P#ZCEC7YO\ _!QQ_P HX_%7_8Y:1_Z1W]?I!_P3
MF_Y,+_9#_P"R _#?_P!1RQK["O\ \D1E7_909C_ZAT#XVC_R7F9?]D_@_P#U
M.9]H4445\;'^'#_M[_TH^S>__;GZP"BBB@04444 %%%% !1110 4444 %*.H
M^H_G24J_>'U_S_\ 6JU\#]?\@?PK_%^L3^2/3_\ E8&_:#_[(-KG\K>OV+K\
M<M.S_P 1 _[0 ^;YO@-KC$8&Y5Q;_AM]"3DY%?L;^!'L>H^M?K/#O_(KH+M^
ML8_Y'X%QY_R/9>=)?^VK] HHHKW#XP**** "BBB@ I<GWI** "C-%% ?IL'7
MJ*,G\NE%% [M[W84444T[.XXOWDO+;RM^0',@=#P2 KYX B_AW X#B3)7 S@
M?>[5^,'QV%G:?\%O_P#@G?IMI#:V,<'P#_:#6QTV!(K>WAMSX4CDD$-K%CRT
M,C/+((E.6=F;!)K]GSD@ DD Y&>=O? ST4]QT/>N4O? 7@;4?&&A_$+4?!WA
MN_\ B!X8LKW3O#7CB[TNWF\4^'].U2$0ZE8:/K#@W5C::A!B&\@A8+/&-CY%
M<>*H.OIUYHROZ2BVOP_&_0]'+,<L+.<W=ITJ].VJ_B494UY63DF_)/T.KR.!
MC(QN5E;Y@V<&,*,?*/O;A\V,!CVI>N!2<=< 'H"!@J.X4]0#W ZTN?YUU25X
M0BM'%):^2[_UV6AY4TW345O[7GW\U;O_ %V @CK_ )Y(_I24I.?U_F3_ %I*
M9;;;N%%%% +=>J_,=_%_P+^M?D3_ ,%OO^3"_&O_ &-7A'_T[QU^NQ/+>HY]
M@ 3D^YXZ8K\B?^"WI'_#!?C494D>*?"!PI)^4ZNH#D] "V!@XY_*N?%_[IB?
M^O,OT/9X<=\XP7_8527W-'],O[//_)!/@1_V1SX:?^H3HM>OUY!^SS_R03X$
M?]D<^&G_ *A.BUZ_7XBOBE_U\7Y']*?97_;OYH****DM[_)?D@HHHH$%%%%
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M?NZFKM\'IOKYA[2E_P _/P_X/FOO/VPHK\3_ /B(*_X)P?\ 0P_%?_PA#_\
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M/FOO/VPHK\3_ /B(*_X)P?\ 0P_%?_PA#_\ )Q_K2?\ $05_P3@_Z&'XK_\
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M(?\ Y.']*/J]7_GW4].3T\_-![2E_P _/P_X/FOO/VPHK\3_ /B(*_X)P?\
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M8&@E?36RBETZ6.W_ %AS[KG6:-K9O'XEO_TX>$?\,Q_ +_HDO@3_ ,)^S_\
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M\)^S_P#B:/\ AF/X!?\ 1)? G_A/V?\ \37N]%'^I7"/_1.91_X14NEO[O\
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M&.:=10 GS9+;B3C 7.%/'/T.3P>>W2E'"D*6!R#[#U&/3&>?7!(XHHH 0J.
M.%'(&!U]2.[ $X;/IQUIN&8Y=CQE0 <HPR"'9.A<=N>.N:?10 TJ?EPS' ;D
MG^(D'G^]]3V XH VG R <$L#@C&?E"]-HR3CWYYIU% #%4CC.T!B5 R2Q;JQ
M;((STP,X]Z0JQ&"=P/4=,G^\W][ _AZ$\YYQ4E% #2N5"EMXZ'<,K@<@A2>N
M0,=,4H##.'()(Y(X.!Z C!/0X)SU/-+10 $L=IZ#!W+G.YB,<GN /\XII!8%
M69MK8SC[P YX/JQY)[<8S3J* &@,.02.,;<GGKR6QG/3MV_+^<7_ (*R_L,?
M\%B?VX_B)>?L[_!+]ISX0?#3_@G?\61X1A^+4PT^?0OCOX=TN/5)_P#A-/#F
ME:CI^GW+^+/#NH:8EK(-,N]3TV'46EFL;Y9+0&-OZ/** /)/@-\%O G[.GP:
M^&_P/^&>@:/X<\%?#+PCI/A;0]+T+2[?1M.4:=:+'=WT.G6N8;6;5K\W.J7@
M1G+7EW/*[R.[.?6E!  .2<#.>3GOSWYI:* "BBB@ HHHH **** "BBBJAO\
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M=_Q#:_\ !-3_ *!_Q]_\/'>?_*>C_B&T_P"":G_0/^/O_AX[S_Y3T?ZXT_\
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M=?\ B;3?R^S9I_\ Q#:?\$U/^@?\??\ P\=Y_P#*>@?\&VG_  34_P"?'X^
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M^C,O@O\ ^".Y_P#EA7Z+44>VJ?\ /RK_ .#&')3_ .?:^Z/_ ,CY+[C\Z?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y7\5?C?\
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MZ12/ZFZ***^1BM)OLU;YI'U_1?X8_P#I*"BBBD 4444 %%%% !1110 4444
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MQ6$K>UJ<U;#R?\)_!!-J[A/IZ;;;G^IXH(QDXSG"D'.%P <D\GUXI]?RY_\
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M;V\L+O\ :0^']M>:;=75C>6[ZH@>"\M)7MKFV=<'$R31O$%_OK@$D5I^'/\
M@I%^PSXIU&WTG2_VEOA<FH7<D,%I;7_B.TL1<SS2!(H(GN&5&N7<X2,N&9L!
M1DU_&K_P3G_9M^%'[4W_  4:UGX-_%S05UCP/J9^.&OW=A;[+:634= O[RZT
MZ3SPK,!',[,>#G.*_:O]M_\ X(-?LN:!\"_B3\4O@1?^(/ASXW^&W@W5O&%E
M:7ETFI>%]3M/#5I-JVK6]Y9QVJ7R:E>:?;3PZ?>P72BVNC$YC*Y9>JIAL+1E
M"G.<W5DHN'+%27OVM[SLKZ.Z5K)]SR\+F698FE6Q-*C1E1I2JPDI2<6Y4K2?
M+&^JY;V?76VJL?TJ03V]W;P7MK/#/:W,<<]O=03)+'/!*BR0SP31EHY(YHRI
M1D+!D((/-6Z_G"_X-X_VNM9^*_P>\:_LY>-==U;7/$GPB@L_$OA!]2:YO)+3
MX;ZU<1VT-E-J5T\LUW=0:W-<!5DD=D@D4+A%4#^CK<?08P2&R,>F/8@X![=<
M=JX<11EAZTH3]V4;)^C2:?W6ZZ;;),]W XJGCL+2Q$7;VJ;BNMTK-/OK>WE;
M9W2^=?CA^UI^SS^SCJ7AW2?C9\4/#GP^U+Q1:7=_H%IKEVMM+J5E8S)!>3PA
MA\\,,TB)*W1691WKQ#_AZ+^P1EL_M*?#D'H?^)M'\V.PXR3SR><#K7\_/_!S
M4J'XK_LLR&WBGG3X:_$9H"Z*Q60:UI[( 6!P&<*,="W%>U?LW_L-_P#!'#Q=
M^S_\'/$_Q1^(7PET[XB^(?ASX5U7QQ8WWQ/\-:9?6GBB]TR"XUB"[T^YNDGL
M;N&[DE@F@DC5D:/I@9/9##4/80KS]I^\;TIPYE??6R?]>6AXU3,L9]?KX6C&
MA&%"$7*5>HJ5U+E:<7+26^O:V]S]Z/@]^VU^RM\>_&)^'GP>^,?A+QUXP;3;
MW61H6CWRW%VVE6!3[9<*H_Y8VQECW/V+#.>QJ7[<'[*^D?%K_A1&H_&7PCI_
MQ9_X2:W\'-X-N-1CAU7_ (26[V?9M(*/@"ZF#*(P2,C&37R/^Q%^QE_P3<^$
MOQ<O?BE^R-XB\$^)_B'HWAN]\.:E)X2\<:/XIETW0]>: S+>VNESS-:I<&W0
MQR3!=Q'&:_D<_P""G.D:CJ'_  4>_:YNM$MY!JFD?$K4M=2\L)'M[^PAT>PT
MRYDU*"ZMBEU;W$!VGS8I%E0$[6&3F*&$AB:TZ5.ZY:?->I[CTW3OMI=I=>_0
MUQV8XO"X*E4<:3K5:T:?N3YX<NFJ:T[^2^::_P!$7!YC&/=2.0%&[ ;GJ02&
MZ9-?/WP@_:J_9_\ CSXJ\7^"/A+\2O#WC3Q5X$25_%^CZ1<B>[T7[/J4VCR?
M;0/]7MU&&2T8=/,4\YKXK_X)"?MO6O[9'[,'A]?$5_:K\7OA7!%X,^(6GRZA
M;RZGJJZ?#'#I7B^+3QB[MM)U6V:.UBGN0[2WEG=%I,N ?R&_X("000_MU_\
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MO^+?QJ^&'P(\)R>.?BQXOTOP7X3BN(;)M8UF<6]G'<R@F-2[=VP2/:N8\/\
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MM"6OB2V\*O\ #Z+3M&N-+/A*&RLIEU6*<SQH+@WGFVJADSC[,6Z,#7Z/XQP
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M8D^G;FO-]<\/Z_X7U2XT/Q1H6K^&]<L]OVW1M=L+C3-4LMZ[D^UV5VD<UN'
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MO[W9-7^Y'U_1?X8_^DH**** "BBB@ HHHH *"<#O^ R:*0YP<9_#&?PSQF@
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M>!@Y;IM &2W/7&.E !Z9X^O'7IG/3/;.,]J0D ,>R\'ZGH!ZD]L5\._LS?\
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MM&V1#!SG .>>W Q7V .@XQ[5\??&_P#Y3D_M _\ 9)+O_P!!@K[!K^I/#/\
MY)JE_P!?7_Z1%G\-^.__ "6;\L-%?^DA1117Z&?B@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4445,OA?R_,4O@DK:NUM/,.V1U[@]&
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M9^QM_P!&H_ #_P -MH?_ ,:H_P"&+/V-O^C4?@!_X;;0_P#XU1SX+_GSB?\
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M!1111< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.G_US_4T447 /P_R.GY4444?+??S **** "BBB@#B_B3_P DX^(/_8C^+/\
MTQ7]?S,?\&RW_'A^WY_V7/PG_P"F+5Z_IG^)/_)./B#_ -B/XL_],5_7\S'_
M  ;+?\>'[?G_ &7/PG_Z8M7KZ_*_^21XG_["<F_]/U#Y#-O^2IX:_P"O69?^
MD4C^INBBBOD$])Z;M:]M$?7]%_AC_P"DH**** "BBB@ HHHH *,XY]/7/X44
M=>.F?P_6@#\EO^"X7[7VM?L/_P#!,K]I;XX^&K>\E\4-X9@^&WAF]TV^GTZ^
MT'Q%\3IO^$/TGQ-97L#)-%<^'[W5(=5MF1PPFMEP1UKXH_X-BOV-OAQ\!O\
M@F_\+_C^?"0C_:!_:B77_B/\6_'GB*V@OO&.I277B/4K+2]*AURX6748M#NM
M/TZQUM[%;@6\^IWUU>S1M<.)!]/?\'!?[,?BK]K/_@D[^U'\-?!FH6>GZYX<
MT#3_ (O(+V&XF_M"R^$-ZOCO4-)M8;.*>XEU#4[71Y+33XTB+RW4D48&6 /%
M?\&XO[1GA#X__P#!*#]FNSTOQ=HGB#Q[\)O#^I?#CXIZ!ISNFI>"?$FD^(-7
M_LW2-:LI$CEMKNZ\._V9J*,%,3BY*JY9)0@!^BG[=G[$'P,_X*&?LX^-_P!F
MWX^Z!;:EX5\6VF_2?$,5G9R^)O /B2W*R:;XK\(W]Q&TFEZS8RH4:6&6'[98
M2W-A<,UO<2+7Y$_'_P 8_&[_ (-X?^"6GPCLO@SIOB;]N[P;\%_B9!H?Q5\<
M_&;5Y]$\0^ ?@CXDU#4KB'5;:/0)IXVLO!TTFB>$/#NG;WMH[.:TWJ0FP_MY
M^U!^T'X"_93_ &??BW^T-\2]:TGP]X1^%O@K7/%-U<Z[=-96-[J-C8S?V)HT
MD\<<K^?K^K_8M)M1'&\GGWL9"A<L/SF^$7QJ^$__  78_P""37Q \0GX6>-?
M"?@C]HCX=^-_ EYX,\421Z5?7'C#PPTD4,FAZE:32F[T&/QMI5I+I.I'R6O+
M:!-\:[FH _2GX6?'CP7\6_V?/!/[2GA@WO\ PKOQY\+-,^+VBR7D:PZA_P (
MMJ_AR/Q-:B:)]B+.VG2*R[B!GDL <U_'9^V'_P %<?VU_P#@HA_P1_\ ^"AW
MQ@^$W[%'@X_LF:WJ/Q!^">A_$#_A.KP^-](^$.B)=V_C[XI^+- N)[>T34_#
M=LVC7,&E:;YL<K7ER3%,+;8WR/\ ";_@H;\4?@;_ ,&]O[4_[$?Q'OOB)%^U
MM\'?VAKO]@$:M_;A2X\#7_Q%UJ\'@VWTO6;.<WR:#X4T3P[K'ALK:A98!Y4$
M*G<%;]X?VB/V0[3]A?\ X-D/VB/V;FT[PY9^*O!/[#_BR3XE:AX65_[+\3?$
MO5-#M+GQAXH\^2..6[NM9U#]]/=2H'EVIDD*#0!\P_\ !O9^VU^UO\-OV!_A
M_%^U9^RUX=^!G_!/?]G_ /9NU#QIX._;!E\5/J-SXW\-^'I]1O;C5+_PE:W=
M]>6T7E)<AY8]/@;=#Y2PM@N>"T[_ (*I_P#!<7_@J0?%GQ&_X)8?LS>"_@G^
MRY\/O&GBH^#?C%\6[:VO=;_:"T[0K/3VM/"D6D^(@]EIMU>-*UVNJZ!&MBGV
MZWL9]2^UVUW!!8L8O'C?\&?NBMX'=[6XC_9*DN/$C'*>;X'2^O\ _A)%4G'[
MN6SPKM]W8'/3)K]I?^" EYI=U_P1O_X)_P#]D30W,%M\#K*VN%MIX9S:W\7B
M'76OK2Y\IV$=W'<2.TD,F)D+ NF6R0#YF_X):_\ !:KXF?M,?M*_$C]@3]OG
M]G=/V0OVW_A[;1ZMH/@BWU"YU;PS\2O#D.A:=JFI76B:A)+=1OKMM;37&OW$
M>GW%SH3:+-"+6]-_:WEI'\-_L7>(/$?A3_@XD_X+L^+/!GA]?%?C#PM^RKI/
MB+PGX5:62&/Q-XGT6'P1?Z'X>EEB_>QC6M4@M]/:2+YX_/+I\X!KT3]J6ZT"
M7_@ZZ_X)X1:==Z,^IP?L?_%*'7H=.N;-]0@U)M'^*<]M;:U%;R-/%?MIAM[B
M&*\5+A]+>WE1#;&*0TO^";Y(_P"#G'_@LD3QM^"/P]('10HU;X=D%@.QX/0\
MMN/.* /U*_X(S_\ !4&Z_P""HG[/'C;QUXW^'6G?![X[_!GXG>(?A;\<?A7H
M]WJNH:7X.\2:?J.I#1+:UU#54%W//>:/9I-J4+%Q9ZBMS;!V$:FOGS]I'_@K
M5^T_H_\ P4U\5?\ !.;]C?\ 9C^'GQR\2_"SX!+\=/B;K7C+QU?^'M2NH;ZS
MTV;2O#?@NWTUC82:D+K6](M-0_MB2!()+H[2"A%?FG\#?%L7_!'W_@O)^U]\
M%==B\3>%OV:/V[OA?XT_:/\ @EI^KW-K)X?\=?&_P[HC^._&]Y'J+W'G:?':
M3:?XW\/PK-%&/-O+-8PRD9^B_P#@V8\!W_QN\/\ [9'_  5-\>Z-I;^)_P!M
MO]HOQG>_#1M72;5O'?PY^&_ACQ'KME>>!U\27\?VI/#-U?S:=]@TZSE-D]KH
MMC(PRJD@'XY?\$6OVIO^"H'A_P#X*>?\%!KGP9_P3^\.^)-7^-W[4>BR?MGZ
M=<>.%T]/V5[VZ\2>)&U&QTZX;55'B,68N-4:&.)=1DN6T]<^6K-(O]'?P3_X
M+#_$SXI?\%JOC%_P2RU7X->!=&^'GPP\ >*_&%K\6+7Q%KLOC'4I_#5EI-Q'
M:W>BS1C18()YK^:.:2*3S(5M@RY,GR_&7_!!,L?^"J?_  7SX;RS^U3&<\X#
M?\)-XSP/3./4Y('H#7R!^RES_P '<O[8^,'_ (L7\7DSMR%/]G:*<<@$8((.
M <T ?5?QQ_X+-?\ !0_]MK]IOXX?LA_\$8/V?/"WBOPG\&=3T+PIX\_;1\>3
MQ7'A?PSXH;5=3BU6?1-%OW&B:UX=F&GOIED#%>ZZ)[34;N?3[:S:REG]>_8!
M_P""N?[=?AK]MWP%_P $PO\ @JS^SIH'P[^-_C?X?:GX@^%'QV\!ZC:R>'OB
M]_8-UXA-WXCUK1H+LZ=X?TO68M).E:+'I$$5PFLV_D7]E ES#._*_P#!I9+H
MX_8>_:9CMIM+.M?\-R?&V;4H;>XLY-8%@8/#D>FRWUI'(VH0Z>T@NQ837<4=
MO-(FH"V=VBN O[9_M#?'3_@GQ\&_VA/@9IO[2/B7X,^&/VF_B)/#X6^ I\8^
M'UU3XGZN=1U7['#I_A'4;71]1U/3M/N-5E,(E:YL=/%T9 \P=9, 'W<201EB
M2&"\@A02=HZ<L<8]5SU/I^$O_!Q+^VGKG[(/_!.KQMHWP\O=9T_XX?M0:YIG
M[.GP4?1[.ROY9?%/C29/[:LKM+UA!'#J?@^'7M-BG7YH+J^MGR-F*_=S@DAP
MWRC()Y*#&TDX^ZV.F.I.?>OX0?\ @LII'[5O_!6;_@LU\-/V*OV)-1\+Z?JG
M[ /@S3?BQXDU7XAZ\MW\(HO&]U>Z)XETSQCJ>E6=MJT=UJ>BOJVF>%&@-A<7
M7VXRV<JJ"\= 'B7[1/[$&J_\$*_"O_!%C]O[X=>&K;PY)\,]1TCX?_M?^$M5
MU34]/\6>+O'OQNM/^$CU^V\5WFD(]C<>$O!$*>(=.MHKNY=8;RSTU1'^^&/[
M^M&^('A'Q)X$T_XFZ%K]AJW@35_"J>--.\0V$JS:=?>&)M-&K1:O;W"Y5[=[
M$^?&X8ADY)QS7\=/[9W[ W_!S+^UO^S7\4_@=^T5^T1^P#X\^%'B7PY=WWB'
M1='\$+I?B)SH"G6(9?#&JV?PVMKG2]>!LFM[.\MYH' N9K<R)%/(:F_X)1?M
MG?&C]J'_ (-^/VM?V=O#DFMC]KS]C3X3^,O@O'H<6E'1=6TSP_%8:A!\.[*-
M2R75UJ5KX;T76+#5)IHTF6>V$;$[D4 &_K7_  5Z_P""LG_!4[XM>/O W_!&
M/X+>&/ '[.GPF\1WND:G^UM\6=,M;_3O&6KZ1:322>'K;3-<CETZ*+6I[?&D
MG2K*YOHX7E;5+BR+6S'Z"_8>_P""W'[:_P 1O%7[2W[#'[47[(>D>#O^"FWP
M-^"'B7X@_!GX51ZM>6'AS]I35/"^B7-QY,NJ)OTGP_%KL\4-S!>V%]_9,MA)
M(;>9+N.6UB[G_@TIET5O^"0/A,:0)ENT^/?QF_X203N'E'B<WFB?VG*X!)6"
M11;F!3_RSV[1C%?LAJOQA_86T_\ ;BT;X0ZCKOPBA_;_ -8^$MQJ^@:(^@*_
MQFN/A'&FK7CF#Q&FD-+#X<QIVJW']G2ZQ$&$$\BVK JS '\*_P#P;C?M%_\
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M; 9AERI5J.!S[$82O_:-"K4]E/ZG4PM.C:M0M&K*E-3YJ<I-.+BHS]4\8?\
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MG[)NHU*C.[2LO>N]K::>M[>>II]8PZC[55J4EI>2J1Y5JNJ;5[M:[M]=3WS
M_P YY^OK^M+_ )Z?A_+BOSF\/_\ !6W_ ()U>)=5L]%T[]J7X>QZCJ-_::;I
M\-[+J5LMW>WTR6]M!'*UAY,9DFD1-]Q)#$FX-(ZJ"1^B5O<VUW!%=6EQ%=6U
MS"D]O<6\L<UM/#(JO'-#-$SQRQ2(P:.2-F212&4D$4ZM*<8KVE"=)WND[]+7
MWM=VZZ]+ZNPJ=>E7O&&)A4>FD&KW=M[7\[;;/?6TXR.G3L ,8_R>:.^>_3/?
M'I2*RM\RG*D?+ZG(ZX[#.,=Z6DW=WWT3O\E^I=W*_,M;V];6L_G_ ,$3 &<
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M7M(ZO5I/T]T_J;7/0]CCV_#';TI:**Y+6LKMZ+5[[7-MON7XJX4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 444A]?3G]"/ZT._P#7:^HGHM-7=)1ZO76W3;NPR.3G[O7V_P ^
MU?R,_MV'_CHL_8Q/'$7PLSGMFUU?'&1G\#7]<3' SC!.-IQNRV#P!QEN3@\Y
MZU^"_P"TU_P3?_:!^+7_  5M_9V_;8\+W'@[_A3GPO3P0/$D&H:T(/$S-H$%
M^E^]CI?D,;DYN8C WG+D!^!CGQL]H5<5A\%3I1YDL?@ZTK7NH4JJE4?71+6^
MEM.Y^E^%F<Y9E&=YWB,SQ4,#1K\(\2X"DZ[LJF+QN7JCAZ$;:\U:I[D?.VQ^
MR/QT^"_@#]H7X7>-/@[\4-$77O!?CK1[W1-5L]PBN(4NHGBCO]/NMK/8ZC9N
M_G6EW$I>"1%89R<_*7_!/#_@G/\ !?\ X)T_">[^'WPV:X\2^*-?U.^U;QS\
M2M;AC3Q#XGEFO))=,L&V-*=.T71[,6UM::?%-)$;F.>]8[[DHGZ%$Y)/O4+%
M06+ #@Y<<$*.,$YYZ\^BUZ'U3#5,0L4Z%/V]*$Z<:MO?<)6<XM[I-[VUM?HV
MG\52SS-:.45\BHX_%4LJQE:GB\1E\*U2.&KXG#^Y3J5*2E:3@FWV;C!M-P@X
M_P :/_!<4@_\%D?^">0'_/A\,<'LP/Q=Z_Y[5_9J<!R3U+H![_*.*_G@_P""
ME7_!,;]HK]K'_@H-^R=^T]\+[KP7'\./@M:^#+;QA#KVO+I^L2G0?'W_  DM
M^VF6+02&ZSIN%APZF2X!3@\C^AMGW,IYQD-P!N5<=6[CG'KZ?3SLMP]6.-S:
M<X<E/$8BA4I/6THQP_+.2;W2GI?J_O/O^.,ZRK,^$O"_ X'%0K8O)<AS+"YK
M1C*\L+BJV9NO3ISOHI3I-5%%;1^X_FE_9 X_X.)/V]/;]G+P<#U'(UO3,CG'
M2OZ(?B>N/AK\1CDY;P%XO.>N,>'M0QM'TY)[D8/:ORJ^ G["WQK^&W_!6G]J
M']M3Q%-X9D^#OQ?^$/A_P1X3@LM6%SXE36=.U"SN[J34-*$*FUMC%;R;9?.?
M<S#@9K]9?&>EW.O>"O&&A6/EB]UKPMK^C6(9ML7VK4]+N[.U,C8^1/-G3>>=
MBAB<T\JHU:.#Q*K149SQ>,K)/;DJU'*F]==59K_-'+X@9OEV:\0\.8K 8JGB
ML/AN&.$<!B*M-ODIXK+\OP]#%T))V=Z,X2A*]TFK[:G\A7_!NQ^RQ^S9^T'\
M*?V@]6^-OP,^&7Q2U+0OB5]FTC4O&_A:QUV]T^VEO=6::WAEO4D$<,C(CE50
M$[ ,[2P/9?MQ?!?QI_P14_:R\)?M[?LB>'+VQ_95^)VOZ?X>_:-^$.FZ:+[P
M=X>:]ECB=["VBC+^';;44&?#DMNJVV@307SAMER5K]+_ /@BI_P3[^._[ ?P
M^^,GACXYS^$[C4O'?C-->T5_"FL#6(A8I/J$C?;9A!#Y4X6YC*Q[3T89R#7[
M ?$KX<>#OB]X \7?#+Q_H=EXB\%^-= U#P]K^D7\"7-O?Z?J4#V]P&AD!&Y0
MV^&1-LB2*&C9& ->7EV3/^R*$)TUAL=AW4Q'MJ5.G&O[:,W*G&4G%R<9)I2U
M3<6^Q]WQ5XH<OB=Q#C:>85N)."<WC#+\=EE3&8FI@,9D^(PN$IXF.$HRG[*A
MB</*E*IAJM.FG3K0NM)R9C_!3XP_#_X_?"SP3\8OA?XATWQ/X*\>Z#9:[HFL
M:9=)>V[1W,*O-:R2C#)/93F2UG@E1)4DB;<HR*_%C_@X*_:0\6?#K]F'P5^S
M=\*+S5(/BY^UUX\L/A;X;E\/ZRFG:O:VC2V\]W87L2DSOI/BV*23P_*7"02+
M-)%DL0!9_P""6?\ P3^_;"_X)W?'#XP_#._\5>&/'G[$WC'5]:U[P)YGB-H?
M$/A/5)W%U975KX0>.0V1U"-X]&OXH;LPP06,=R%)<UO^-/\ @G/\<_V@/^"M
M7AK]L/\ :"A^%^M_LW? _P ,S^'_ (*>$(S)?:YJ4X0ZIHVO:_II=8;37O#G
MBB>?4K'5"6<PI!"4\M0I[<16QN,RE4%@L1AZ^*JT\)B%.UJ,:DE&OB*<TVW#
MENZ<KZ76E]7\MDN%X1X<X]J9G'.L)FN09+AL3Q#DTJD)<^98O#T7B<GR;$T)
M*\,5];]G3Q5.:Y7[.4I.-.HXKY7^"_\ P0H_:U^''PK\#>$_!'_!57]HGX-:
M'8>'=/N5^&G@WP_I=EX=\&ZKJ%O%?:OHVGQ1ZHOG0V6I37$#3S*))GC,C ;\
M#XO_ ."EG_!'O]I#X'_ _5/VS_&'[<WQ4_:S\<_LV+HOB?PSX=^(_AN&6[M[
M.Q\1Z??QP:1=V%Y=78MTU<6]Y>V"H(9+=)9'?:K8_M*R26 *C/S;O[O'S-C^
M+/.3VYS7,^,O"^D^-_"GB3P;KR&71_%N@:QX<U-!Y;.;'6]/N--NWM_,62-9
MTM[EY('9&\N14;!QBIQ'#66K"U*$*=:FJ=&,</)8O%SY)PM[.?LYUG!RA)*4
M59+32VENG+/'#CBAGM'-,9B<LQ%&>*D\THQR#(<-7Q>!KU'+&8:6-P^6PQ:C
MBL/.=&I4C5=649/VDI:\WR[^P'^T_I'[87[)OP=^.VFZE#JFH^)?"]K9^+KB
MV@%I;Q>.=&@AL/%]I!; MY4%OK"7"P*.-F N<9/V4IR/I@=<Y & 3Z$\Y%?B
M9_P2._8<_:3_ ."?NI?M"_![QU?:1X@_9O\ $7Q!N_$WP$O8O&:ZMJ_A31%>
M>*/2+O0S9Q-;W.N)*-4U6[$Q'VR$*5.<C]M%&!TVYY*XZ'OSDY)_#Z5Z^ ==
MX.@\1&U?V<8U+WO>"BN;75\[7-KWW=KOX#C##91A>),UAD.,HX_)ZM?ZUEV(
MPZ:I*ABHPQ"P[B]8SPCJ2PLHR47>BY6BI)"T445UGS(4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 <7\2?^2<?$'_ +$?Q9_Z8K^OYF/^#9;_ (\/V_/^RY^$_P#TQ:O7
M],_Q)_Y)Q\0?^Q'\6?\ IBOZ_F8_X-EO^/#]OS_LN?A/_P!,6KU]?E?_ "2/
M$_\ V$Y-_P"GZA\AFW_)4\-?]>LR_P#2*1_4W1117R,7I/UC^2/K^B_PQ_\
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MD73^'Y^O7_,^BUZZOK;^NFP4444 %%%% !1110 4444 %%%% !1110 4444
M*.H^H_G0>I^I_G0.H^H_G0>I^I_G0 G8?[J_^@BBCL/]U?\ T$44 %%%% !1
M110 4444 %%%% !1110 5^.7_!>O_E&!^T5_V"++_P!*DK]C:_'+_@O7_P H
MP/VBO^P19?\ I4E;8?\ C4_\1E7_ (4_3]4>V?L)?\F/_LA?]F^?#O\ ]-0K
MZIKY6_82_P"3'_V0O^S?/AW_ .FH5]4TJ_\ %GZ_HBX?!'_#'\D%%%%9&D_B
M?R_)!11102%&,\<?CT_S_6E[>^>G]:='&\TD<,:[Y)9$BC7GYGD8(J\?WF(&
M>V<T ?@M_P '&G[6-K^SA_P3E\:_#;1M7T]/B;^UOK&D? 'PMH,.MM8^,8M
M\43[==\=>%[2UVWUX?#TEM!97!M&#)/?PH6!;(_*+_@A]HWQ'_X)-?\ !3'X
MJ_\ !*;XZ?$6+QMH/[0_P2\$_'GX1^+;S77M/#6CZBUG>:LVGVVC:BTDJ>*?
M&8,NE3VEO*K%M)@=E+S_ #?-/_!6/_@HK\+O%W_!=?X)W'C+0O%/Q<_9P_X)
MO&*>3POX&\%7.N:I>_&>>>TO/&O@_7Q+!=6MQI*:QIUM%!=20K'&+9U5W+-M
M^<_^"PG_  63^%?[47Q6_8U_:W_9H^!'Q-^%7QF_9&^(K>*)M4^(?@J]M-,\
M6Z,=2TV_TK2=9UBSMK60:3X?;3S'!97DSQ&WO+F.)0CLE '^@G\=/C-X$_9P
M^#_Q&^.7Q3GU73OAY\*?#&I>+?&EUH^F2ZSJ]EHVDQ/-?R:?I,+)/?7$<:EH
M[2-P[G"@BOQD\;_\',G_  1_\!:!\._$FJ?'+QSKEM\2_#;^*='TSP9\,-7\
M2:_X;L4O);'^S?B%H]M<I)X1\1221?:8=&O))+B6QDANUQ'(,>Y_MW?''P?^
MTO\ \$3?VA/VAOA[JL6M^$OB[^R-KWC32M8B@EMH;J]O?#Q37/)MY?WD,5MK
M45_;QQ/DJL0PQ7!KY@_X-P_V/_V:/ __  2M_9S^+>F_!OP#JGQ%^/.E:UXJ
M^)WBKQ1X5T3Q/J>M:AI7B/5-%L(X9==LM0^QVUO8VD,:P6PACRNXH6)) /T_
M_9D_X*,?LC?M=?LW>,?VM_@-\0+GQE\&?AMI/B;7/B(CZ5+:>._"$'A'2;G7
MM7L=<\%&634K#5)=&M);_2]-9F?4(WB\I\R 5_'3^PU_P7)_9H@_X+:_M-_M
M*_%WXN?&KQ)\#/CO\.=-^!_[.R7GA#7]1GLM6USQ;X9AT;2KKP=;W0@\.6*2
M_:S_ &I+!++$TA5I"COC],O^"1?P1\#?L[?\'!7_  5\_9[^&5E)I7P@T_X9
M>&?$MMX"DE:7PNNI^+M1\*Z[JSMH<S/IDBO/K>H6J*UJ52QN'LT"VNV$>4_\
M$MO!'@>^_P"#CK_@IMH][X$\$SZ)H_P7OKW1]$G\(^'Y='T6[MO$OA&2"]T7
M2Y=.:QTJXA=<"YL(+>50TB[]KL" ?L_X"?\ 8/A_X+6_'RU\+ZM\4Y?^"C(_
M9FT7_A9^AW]OJ ^#UO\ "".R\.RV=UH5\['3&\0FRO-#-RL:B9G\Q, H[/W'
M[=G_  6,_P""?O\ P3@\3Z!X'_:A^+E_9^/O$6GQZI!X!^'7AVX\?>+]'TR[
M0S6.I^*=%TN9)M L-2B5Y-+N+ML72+A0'*@_F'\-=>;PW_P=2?MR^)V@6Z?0
M/^">>FZZ8&5O*N?[)\.^"+X0G)/[J9;=8^<[E.17S;_P;O\ PV^%_P"V;^T]
M_P %*?\ @H-\:OA[X4\>_$K6_CMJ6A_#*X\;VJ>*[CX=^'-1U+4O[9T6STW7
M3>Z=!92VZ:99:;'):%K2UT]8[,PH30!^J7A'_@XF_P""4OCGP3X2\=>%_C-X
MRU"'QI\2+#X6:9X1?X>ZDGC^R\3ZI+'#IUWK?A(W/VW2?#%_+*%LM>E=[>;R
MYAM#1L!^IOQ^_:,^"W[+?P7\2?M"?'OQ[HWPX^$OA;3++4]1\2ZW<1PO=2:M
M;I<Z-HNCV;.LVJ^(M9#B'2]'M\S7%R&A#*:_D?\ ^#D[]D#X+?#G]I#_ ()U
M_M._"[X?>!_ 'B[Q?\;-,\$?%2;PKIMOX?NO'"6^M:.WA"Y?0],6VTJ7_A'X
M(+^WDN;6PBG*7B>=(YC4UYI_P7Y^,WB/QU_P5/\ V,/V8OB'\!?BU^UM^SI\
M)?@+X$^.MQ^RY\%1J7_"3?$?7=4AG.M'Q%96%IJ O_#L$'AVQ2^?[#)<65E)
M?)#/;I<S>8 ?L]\,O^#G3_@CS\5_'7A[X?Z7\;?B#X.U#Q%=BPL_$GQ)^%FL
M>#/!5C*06$^O>)+ZYDM=)MI-NV.XG4IO*H<.ZJ?UA_:H_:]^!7[&G[.?B/\
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M^'=#U)S*ESX>O_$.E7$=HGB'2IH7M]6TL R:?-M29OF4G[=_8B_X*#_LE_\
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M/M^8^GKZT?./_@4?\P$HZ@T[:?\ )'T]?7BC:?\ )'^--6?56>C]Y>7GOM^
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MC[UO/?OY:M#, '('//\ X]UXZ<_RXZ4'KP.>H/H>?\^G/2G;3W ZC'(_#O\
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M_)./B#_V(_BS_P!,5_7\S'_!LM_QX?M^?]ES\)_^F+5Z_IG^)/\ R3CX@_\
M8C^+/_3%?U_,Q_P;+?\ 'A^WY_V7/PG_ .F+5Z^ORO\ Y)'B?_L)R;_T_4/D
M,V_Y*GAK_KUF7_I%(_J;HHHKY&*TF^S5OFD?7]%_AC_Z2@HHHI %%%% !111
M0 4444 %%%% !UH[Y[GN1FBB@! H'0=<_KUI?\]*** "BBB@ H_^N/SZT44
M*"1C';@?EC^7K2>WKUXHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^/\ _P!DEO/_ $"*OL$=!]!_*OC_ .-W/_!<KX_#YMS?"6[VX4E"=D.1OY'
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M_P &%%%%0OU?YLIN^VNB_)!1113$%%%% !1110 4444 %%%% !1110 4444
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M3=.-DW%-K:^Z6]OPNWJ0\GC[>I6CB\1#VLN><(MJ+?2UFMEMH?A+_P $C_\
M@E-XG_8OU3Q1\;_COKUEK'QT\8Z9/H%MHND:@NL:9X6T2ZNEN]2^U:Y)YAUW
M6=4O8(;H:C&8F@A+V[&0R-L^:?V]OV)/VF/BO_P5D^%7Q]\"?#JYUKX3Z#9_
M"9-4\3Q7"HEN_A_^T/[75X2I;-GYT?.[YM_0=OZ;RI;[QR..,=3WR>H&.F,$
M=R: '&?G(4MD ?PJ.@&?_'LGFH6+J.LZTK<SCR-;)1TT2CLE;;6]W=O<WEEE
M!X>CAH-PIT:\,1=^]*I4A>W-JKMWU>FVB2/Y[/\ @NY^R+^T%^U/I'[,%O\
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M!C&4;D/A[^R__P %9O\ @J7_ ,% OV8OVJ/^"E7P2\*?L>_ _P#8HN[?QO\
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MM8[749+59-2GL;&.R 1%@RI+5_8/)*]U'%!<.+FUM^88+P,\4+>L2D%5QU!
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M%11_-$W_  3/_P""WQ_YRM^">IX_X03Q%D9Z_P#+#'';\.!2#_@F9_P6]/\
MSE;\$_\ A">(_P"EOBOZ7@..!@XP<YR#W!]_?UI5&WCMVZ^G>E_J_ECC"2CC
M$I/WG]>Q<9=-?X^NMMMC!>+_ !:JGNX+A32*NWP=PY:[:NE'^S[/O)NW7J?S
M0_\ #LS_ (+??])6_!/_ (0?B3_Y'H_X=F?\%OO^DK?@G_P@_$G_ ,CU_3!1
M2_U?RK^;'?\ A=C?_F@O_B,7&'_0%PI_XAG#7E_U+_+\7W/YG_\ AV9_P6^_
MZ2M^"?\ P@_$G_R/1_P[,_X+??\ 25OP3_X0?B3_ .1Z_I@HH_U?RK^?'?\
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M8>,/^@+A32S_ .2-X:\O^I?OW^9_,_\ \.S/^"WW_25OP3_X0?B3_P"1Z/\
MAV9_P6^_Z2M^"?\ P@_$G_R/7],%%+_5_*OYL=_X78W_ .:!?\1BXP_Z N%/
M_$,X:\O^I?Y?B^Y_,_\ \.S/^"WW_25OP3_X0?B3_P"1Z/\ AV9_P6^_Z2M^
M"?\ P@_$G_R/7],%%'^K^5?S8[_POQO_ ,T!_P 1CXO_ .@+A3_Q#.&M=O\
MJ7Z^;\V?S/\ _#LS_@M]_P!)6_!/_A!^)/\ Y'H_X=F?\%OO^DK?@G_P@_$G
M_P CU_3!11_J_E6W-CO_  OQO_R\%XQ<8:?[%PITWX,X:\M_^$_RU]6?S/\
M_#LS_@M]_P!)6_!/_A!^)/\ Y'H_X=F?\%OO^DK?@G_P@_$G_P CU_3!13_U
M?RK?FQW_ (7XWI;_ *B/ZN'_ !&+C#_H"X4_\0SAKI;_ *E_6WYG\S__  [,
M_P""WW_25OP3_P"$'XD_^1Z/^'9G_!;[_I*WX)_\(/Q)_P#(]?TP44O]7\J_
MFQW_ (78W_Y>'_$8N+_^@+A3_P 0SAKR_P"I?Y?B^Y_,_P#\.S/^"WW_ $E;
M\$_^$'XD_P#D>C_AV9_P6^_Z2M^"?_"#\2?_ "/7],%%'^K^5?S8[_POQO\
M\T?F'_$8N+_^@+A3_P 0SAKRW_X3_+\6?S/_ /#LS_@M]_TE;\$_^$'XD_\
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M_P!D!^&__J.6-?F__P '''_*./Q5_P!CEI'_ *1W]?I!_P $YO\ DPO]D/\
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M_?!H^QW7_/O+_P!\&NW_ .(<+X??]'W?M??^#_2/_B*/^(<+X??]'W?M??\
M@_TC_P"(H_XB_E?_ $ XGHM'Z;:^7Y=V'_$N>;?]#FG]R\O+K^OH<1]CNO\
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M4_4_SH'4?4?SH/4_4_SH 3L/]U?_ $$44=A_NK_Z"** "BBB@ HHHH ****
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MK#N_Z^?]?)GZ&]\_ASR/R/%';'/XY/\ .OSR_P"'M7_!-#_H\KX3?]_]9_\
ME91_P]J_X)H?]'E?";_O_K/_ ,K*/85?^?-;_P  ]//U[_YGM8=W_7S_ *^3
M/T-HK\\O^'M7_!-#_H\KX3?]_P#6?_E91_P]J_X)H?\ 1Y7PF_[_ .L__*RE
M["K_ ,^:W_@"\O/K?\5\SVL.[_KY_P!?)GZ&T5^>7_#VK_@FA_T>5\)O^_\
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MT/KW[6O['W[//[2?B?P]IGA3Q#\9/AMI7C;5O#6BW-S>:3I%[J#SI)8V5W>
M74T$?D@I), Y).[M7UEM;C@_-D$\80X."!RQYXY&!CGBOXL?VY_C'\5_@/\
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MOV@?V]/^"XW[>OQ9_8Z_8E^/GBC]D']@S]C[73X5^,W[1O@-[^S^)_CGXCZ
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M^OU\,ZQ=JMS+IWP_U;Q9X@BU:UU&QCN-/CU>UAAO=(U"YAN@R;8'D /ZB_\
M@L9_P4>'_!+S]BGQG^TCIWA&T\<^.9=5TGP7\-/#.J37-KX?O_&6N7!^SC7+
MRT5KN*TMM,M]2OHXH%:2ZN;2*V "2.P^+?\ @CGXZ_X+<?$_Q3X:^,O_  4'
MUGX5:K^S1\>?@W>_$KX?^'/"WAS1_#WC3X8ZYJ>J:1?>#M#UX:=IUC/<6>L^
M%M0N;VV:ZGU"4QPV\LLZ22%#^)__  =7_"3Q7\8/V3?V9/V^=.^/_P 3-)^'
M?Q.;X0Z?9_LN7$C/\.=(U;QKX9_X2*'QQ&4O463Q1IZ7#VK-<Z>Y"A1;31*9
MQ)]D^&OB3\4?^""7_!(Z;]H;6?VE/C1^VM\4/VKK/X%^&?V:_!_Q6C$OA'X.
M>/\ Q)X)UBZT?PW8OJ6O7_V3P;%;S/-?'_0;:6ZT/3+6.R1+B2<@']A85^XZ
M]L'"^X(^]GK@\]N.\,\ODP2S^7))Y,,TWDPH9)I!"A8QHG),SD;8T'WF(7J:
M_B0\+?\ !+/_ (*??';X->(/VBOC5_P6_P#&7P9_;*\?_P!K?$&Q_9_\$_%O
M3;?X(>&-?O?)U3PSX1U&32?'%K8Z';QD+9ZMI>B^'[[2;!E%OONT-TX^JOV.
MOVB?VI?^"Q'[)'[5?_!/SX[_ !\\<?LF?MU?L;_$CP]HOQ?^/_[/3:3-8>*=
M"L9=:BT;^PM1T+5[2TG3Q-_8^H0>*'TV\C#P"TO+5FDG*  _9#_@EC_P48M_
M^"F7PI^-OQIT3X<W?P\\$^ /VD?B%\$?!%IJ<[3>(-=T/P-8>'IO^$@\1PAI
M+/3M9N[K6)DGTRQN)X+6%+<-(99&K].OND;CV.,@@LQX"XQP%ZY';D\5_!5_
MP;'_ /!.OXF?%7X.?'KXV)^W+^T'X(\!0?%3]H_]GK5O@=X,U.[TKPSJNOZC
MX<TG2#\9_P"T5UE5T_Q_:W&I6VJ6-_;:3)>Q7FGQ9OTB&R7]4/\ @VV_:P^,
M_B[2_P!LO]AG]JSXE_$KQ]^TE^R/\=/$,<$GQ8N)]6\8VWP:U>:TT_PC=:OK
MMR\DVI7-WJ$%]=()FW+8W=F5PAY /ZA</D8!ZC/3:1CD9Z@\'!]3BF[N"54O
M@\ <'TP<\?+U.WG K^5WXT_%KXT?MI_\'$GPO_9A^#/Q-^,7@[]G_P#87^%$
M7BW]K;PMX3\=ZCX*\->*_$6NK<Z[X/GO+#3)R/$=D=0U[P=INH6UU%MDMDGM
M]R++,*_JC?E>>^-K9VA 2 N .AQ@GCGI[T ?RK_MY_\ !;C_ (*)?!W_ (*<
M_$+_ ()T_L/_ +#/@3]JCQ%X0^'G@KX@V1NO&&HZ#XINM,\1>%M.\0:S<W$4
M]]IFB16.CSZ@+57^U><T2"1P22:Y/_AY_P#\'+__ $@^\'_^';TO_P";2OSS
M_;+_ &Z/AI_P3W_X.C?C3\>_BMX(^*?Q \-0_LT_#+PTNA_"#PW'XI\5"^U7
MX?\ AQ[:X.ES7-HKV,(@)N7$\9Y5 ZEMP_4P_P#!V5^Q%_T:W^WQ_P"&(M?_
M )JJ /T]_P""7_[2W_!2+]HS2/BG=_\ !0K]BK2/V.]2\-ZCH5O\.M/TKQ7;
M>*#XRLKR&Z?6;J8VVK:LEF-/EBMXE#3HT@GW!!BOU8R?FR I/RJI.<$<ECC)
MQ@C@_P#Z_P :(/VF+G_@L%_P2X_:*\;_ +'-Q\:/V;_&_BS1/B3\./AKK_Q(
ML[_X6>/?"_Q!\+Z9I][:^((9M'OKZZMM&D?4($MM0L+T^<RW4+-!-!)L\K_X
M-R/VQ/'?[7'_  3@\()\8-8N==^+_P  _&_C#X#^.O$.O>*I_$OC'QG<^";B
MUGB\<>(Y=1F?6EFU1=6:RBN=1C59VTR18Y99(IMH!^]66)X4E3T..#@?-D]%
M0GIDAJ< Q!;!(V]!C<&R<X_A( XZ_AFOY-_V4?VJ_P!H']M?_@M3^WK\;? O
MQ/\ B?XP_9._X)[?"S4OA]\)O@E\*-0O9OAC^TIXWO=$\06]W9ZA;WT]CHMS
MX\TC7KZY6TG,<\YO-.T6)I[:S64R>6_"?_@GW_P6M_X*BZUX_P#V@OVXOVVO
MVA_^":]AIFOZGX8^#GP'^#=G8^'+\> +?5+[4]/UGQOI?AKQ?I>DMK"6UY!8
M2ZO=7M_?7JV*RE;9'DC0 _L8RPY,9P.6Z@;>!QW+#.3CCM7X]?"K_@I+\0_'
M_P#P66_:0_X)GZA\.O"MA\.O@G^SWX2^,NC?$:UU+4I/%FM:GXAA\%R3Z1J&
MFR*-,@L(&\4W:130-YY-C 7XF:OQ1_X)^?'K]N;_ ()L?\%=/"G_  2]_:+_
M &F=0_;?_9__ &JM%\0^)_@C\5_%7BNV\5^.O"^I>&M(N]0O;S5;]=5UG4]%
MC4^'=8T6_P#"M]>M;M<W5OJ=MA8X6?Z1_9L'_'6!^WSSD']A?X7DYZY,'PG^
M7W7'/U"B@#^J([P Q7!.<J 2 "?E+-VP.H'/3BA0Y'?AB<E1DC^Z0.@/8CGO
MFOY//^")_P"T'\=_BC_P5E_X*_?#_P")'QE^)'CWP'\.?C'XCTSX?>"_%GBK
M4]:\-^"]-A\5ZI';VWA?2+V5[;28([<Q6L=O9I%$EO!$-A??(_._\')O[0WQ
M[^"G[5'_  2?T+X._&GXF_"O1/B%\6O$^F>.])\!>+M4\-V'C#3X-;\#!+3Q
M';:?*D>K6\$,]S;117BRQ)#>W05 [+(@!_7*-[9'"L%^8#+ 'O@]\=AU[&EV
MR#J 2"0 H/S*<#+$C (ZX7KZ5_/)_P %3=7_ ."N'QS^,/P2_8L_8'\->)_@
MK\#/B-X.@E_:0_;8?3=%NK'P[HWB%(+>71_ NKRWJ>(=#\9Z':6-[>->Z5;0
M333ZK8Q"\2-9!7Y"?\% ?^";W_!2;_@E]\#[C]LCX"_\%E/V@_CCXX^"5S:>
M--9^$_QX\7C3]"\0>&-.DC&J2Z=X<UGQKK5GXT-D',MQH=S8-)=VZDQ+D2O"
M ?UB?\%"/VT_"'_!/?\ 9)^*_P"UGXY\*>(O&OAWX8:?I\DWAOPNELVIWNHZ
MWJ=IHFD(\MW-;V]OI_\ :=_9C4+IY<V]J[NBR.%0^)>&?VS/VDOC-_P3)T?]
MLS]GG]GC2_'W[0'CGX<6_CCX<_ 2;7IK#3->O+S4OL]MI,NO7;VKP_Z )+B:
M9I(U%Q"\2,5Z_P \O_!:3XA>+O\ @I7_ ,&ZGP2_;RA^(WB_X0C2]%T'X@_$
M'X5>'04\+?%[4M7UVS\ WFD>+88+NW1-*TK7],G\5:% T5[;02SB+R]Z03IY
M5^SI^S)^T+^Q?_P0/^/_ .V!X<_;U_:&\877Q4_9;\.W/PX^'<NL7NBZ'^S_
M 'D?BJVE?4OAQJB:M=W=AJ<L$CV,LEG:6,!M" %+LP !_7U^Q#\3_P!I?XP_
MLS^ ?B%^U[\$;+]G3X^ZXNJ-XS^$NG:O'KUKX7-OJ5S;Z6HU**ZOHYC?:?%!
M>2A+J<0O.8A(VS-?6F)-HR/FX.%!.XX&5Y' !/#'!/YU_'=^SM_P5V^(W[%G
M_!NQ^SQ^U#X]UKQ5\?OVH_C#JWB'X6_!AO'VK:CXEU+QE\5-=\4:Q%H2>(]7
MO'N+ZZM-#TFSO+ZWAG:9KUM.MM.D?;<LXP?AI_P1C_X+%_M,? P?M0?''_@K
M?^T-\$OVL_BCIT_Q(T[X$^"-7U?3_@]X2O-7C@UGPIX6UB+3M>TR#098H98[
M?Q#HFF^&[NPTJZ#Z=OO8XYGH _LOR<C (R< .-N=O4C'.6/'/'7%*%=@<?*3
MZ@Y3Z=FSZYQ[U_-!_P $6_\ @IA^TW^T=8?MK_L6?MRZKX,?]K[]BO5O$OA2
M_P#%/A,PZ5<>/]&L;/7-/?5[/2X+6TB>3PO?:7:QSZ_"@DU4ZA:7MPBRLS/^
M%W_!'OX1_P#!9G_@K1\&/'/A;Q;_ ,%!_C7^S_\ L:_#[XQ^.I=)^-6B:E<Z
M]\>_'?Q%MW2&7P1IWBN?6M-UF?P1X:C>TNK_ $Z;4K*SL;F\CCLX98I_LQ /
M]"WYPJEL*S9&T#@8/+$GG..QXIV3N/RLR@<8(R>,ACZ;N=HZ9'O7\BG_  32
M^)_[>7[ 7_!8+Q'_ ,$@/VEOV@=4_;#^#'Q:^%7B?]HGX/\ QB^(NLZCJ/Q2
M\-Z-I.E7[PQZK-?2ZA<0_P!L7/AN\TV^\+OJM[IVELB:KIEU(E\\*>)?M1_'
M']JG_@J-_P %AOVC?^"=6F_MYS_\$Y_@+^Q9:V]UI>K_  X\0GPY\2OC%K^L
M^']'N[BZ_M&77/#4>L)IZZFK3:#<:HMGI=E$-2MTGNIV6( _M7)8%25<*5)(
M(&$QT+-GJ0.G09]:522@)QDENASQGY?TYK^4O]C#]G/_ (*_?\$_?^"A'PV^
M%"?M"?%+_@H+_P $W_C)HNI^*O'OQN\=_P!F>*O$'@?7+?2-0TK2=.76]5\1
MZKJ&A*==ATV\DM?#]Y?Z9>Z4UU/*T=PI2OZM  ,@$'IDJ !T'0CK_3I50^+_
M +>?_I,?G_7J#?NV_O)_BOZN_1=3\$/^#CC_ )1Q^*O^QRTC_P!([^OT@_X)
MS?\ )A?[(?\ V0'X;_\ J.6-?F__ ,'''_*./Q5_V.6D?^D=_7Z0?\$YO^3"
M_P!D/_L@/PW_ /4<L:^PK_\ )$95_P!E!F/_ *AT#XVC_P EYF7_ &3^#_\
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M O\ T =?_P#"HU/\?XO\^]'_ !+GQA_T,<HZ/_>)>7_3GS_JX?\ $Z/AE_T
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M1115-W_#\%8;_1?D@HHHI""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:T\:7\WC;X:V'C6^O;^[U2ZAM[JRU*ZOK;R=-ELXXW2%%)W-O#8-?3__  <
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M0O$'PE2*."Y\0ZS:1S2P6&J:-?\ ^C7S1%TOX=]^PA;?"/JW_@GSH^F^'_\
M@WE\-Z9H]HMA8P?L,_&R>"V3[JM>>!_'-[<R@>LUS<23..I>1SU8FOX_/^#2
M#1=3\2_$S_@I/X;T*SFO]>\1?L'^-="T?3K<%[K4]6U7439:=96BC!\^XNIH
MH(U!!9V !!- 'VA\6_\ @ME_P5V_X*I?M_\ C_\ 8R_X)23^$_ _PL\->+;^
M#0?%ME91_:8O#'@2_GTG4/B?XW^)7DS7.C^!_$]]):O!I=KI5UM-[IUJOVB2
M0>5S'[</_!>/_@O;_P $X/''PH_9._:'\.? 30/BSI EFU[XPVO@F/QKX5^-
M'AK6[_2(_#-UX=EG&C6MI=>&;)KJPUV\@A6\U.^N5N;VWMY8T,_GO_!G[\6_
MAI^S[^VQ^TM^S3\;--T7X?\ QS\8^'+C0/#&I^++N#2=;;6_!6N0V?BCX76'
MVEE$FL2W$<FKR6&\/*-'G*;Y(D1NQ_X/(OCM\)_B#^UC^Q3\(?!GBO2=?^(/
MP=TCQ+>_$C2M*DM[MO#L7CKQ!X,N_#%O?7ENS@W-U;:3>RM:,^ZU &Y$>5Q0
M!_H$? KQ?K?Q!^"WPI\<^(W@?7_%W@+PQXBUEK2 6MH^HZII-K>7C6]HI98(
MC-,S)&&;RU.T$]:]7KP']E/_ )-E^ ?_ &2?P/\ ^H_8U[]0 4444 %%%% !
M1110 4444 %%%% !1110 4444 >&_M.?\FZ?&_\ [)CXP_\ 3)>5^#/_  ;%
M_P#)IG[0W_9U'C;_ --EC7[S?M.?\FZ?&_\ [)CXP_\ 3)>5^#/_  ;%_P#)
MIG[0W_9U'C;_ --EC7S^*_Y*++?^P'%_^ETS]9R7_DSW&7_94\/_ /IFL?TL
M4445[ZV7HOR/R;HO\,?_ $E!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M XOXD_\ )./B#_V(_BS_ -,5_7\S'_!LM_QX?M^?]ES\)_\ IBU>OZ9_B3_R
M3CX@_P#8C^+/_3%?U_,Q_P &RW_'A^WY_P!ES\)_^F+5Z^ORO_DDN)_^PG)_
M_3]0^0S;_DJ>&O\ KUF7_I%(_J;K^83_ (.\/^4-OC+_ +.#^!7_ *>=6K^G
MNOBK]OO]@KX$_P#!2+]GN^_9D_:,_P"$S'PUU+Q;X8\:7#> _$,?AG7_ .V?
M"4]S<:4%U2;3]3B%IONI?M,#6C^:-F'C90P^1CM/UC^2/K^B_P ,?_24?R=_
M\%/_ /E4._9M_P"P9^RW_P"K"GK^SC]G8C_A07P'^4Y_X4U\,CE0%5!_PA.B
M]5   )R H& >W%?$_P 9_P#@DU^RC\=_V O!7_!-KQRWQ+_X9S\!0^"+?03I
M'C*.R\>X\ :K)J^@_;_%$VE7<=TS7<KB]+Z</M,> #$P##]%O"'AK3O!/A3P
MMX+T7[1_9/@_P[HOA;2/MTWVF];3/#^F6VE6+W-QM7S[DVEI'Y\NU?-EW/A=
MV @/Y%O^#4K'_"7_ /!7!N W_#='Q!S(?X<ZIJ)_+C<>>U?V%XZ+@C'[P-_"
MYZ\YYYZ=Z_/;]AG_ ()H?LV_\$\M1^/.I?L]MX_%S^T;\2M3^*OQ%'CGQ7'X
MFB_X2G59I[B[_L**/3=._L^P+W$@2VD-U*H*A[A]HQ^A/<XX*@_>;YMF,X;@
M[1D?EB@#^:'_ (.?_P!EK5/B1^Q'X8_:[^'^FZ1;_%;]A/XD>&/CC%KY%S:^
M*+GX>Z=J45MXC\'Z#JEC'+>0C4-4O-%U"YB&(O*T^:1_E#H_YT7GQ,B_X+=_
M\%G?^":-M>^'?#]A\%_V8OV2/!W[9/C72<R^,/#^M>*/B9:Z!JU_\+O$:@#2
M[/5='U."R@LC>[[P16FHDP+M<G^TKQMX-\._$?P5XJ\ ^*["'5/#7C3P_J_A
MKQ!ITD4<J76DZY93V%Y&J3I+&'$-PSVTS(WE3+',JY05^=7_  3;_P""1O[)
M7_!*ZQ^*FG_LP)\2)E^,-[X8O/%MQ\3?%]KXSOH&\)6^K6VDP:+=)HVES:=:
M"/6;LWEN'E2[=;9W.;:/: 4_^"VZI'_P2'_X*(1JH6./]E7XH*B*/DC5-"D"
M1IC PBA1C&!VXK^?;XV03S_\&>'P/$,33>5^SC\-YY=H+&.&/Q)K#22G /RH
M" <\ 'DU_7+^TM\ / 7[5GP ^+G[-OQ5&NGX<_&GP1K?P^\9GPUJ*Z/KQT#7
MK?[-J']DZ@UO=+879B;$=PUO.$.=T39Q7S]IW_!.K]F[3_V!K3_@F[-IWBK5
MOV;;'X3W?P=M(M3UY;CQO#X:O%O?+OX?$JV,2IXALY[Z6XL-3CT]!:SQQ.MO
MM380#\G/V/\ 4+&Y_P"#7/1(;:]M+FXMO^";GQA^TPP74$TUN6\+>/B!/'&[
MO"WJLBJP/# ,"*^C?^#;5L?\$6OV'LG&?!_C8 8SNS\3O&F.?X3G'3K^-8'[
M"'_!!3X&?L/> OVIOA+8_''XV_$OX5_M0?#+5?@Q?^#O$_BF9+7P/\/=6AUF
MUNHO" _?V^D^(9;36[J*35;:U1?,6&5;;$82OU)_8[_9-^%?[#?[.?PV_9:^
M"+^)G^&7PILM5L/"X\8ZLOB#Q$]KK.N:EX@NDO\ 5UM;%+HC4-5NA$Z6D*10
M>5"B!8P2 ?S"?\&Z'Q?\+_L\?MB_\%:?V&_CE9ZQ\*OV@?%7[7WQ!_:*\.>'
M?&D-CHMAK?PZU?5GL](;3]2N;U?M&KZA::G8Z[9Z>D;K<:%="^BD#)-%7H__
M  =H?'KX=S?L2_#']E?0M=\(>*/C9^T1\;?!V@^#_!4&J0:AXCT_2!+<P7GC
M"VTVR%S.MC8ZG)I^D-.PC9IM46.$28EV?H]_P49_X(,_L3_\%&_B%#\=/&R^
M/_A-^T+8Z&FBVGQ8^$GB>3POJ&IO:&!=)N?%UI!;LVOW.D16T5IIUPMW97%I
M:J(TE*KM/DO[!W_!N9^QG^QQ\7=._:.\?^(/B#^U3^T!H,=POAKQG\;];;Q)
MHWA.[DNK:XMM=T'P]?+<K;^)+2.%K*SU6>[G2VM+J\CM[6.2?S5 /UI_8B^$
M/B7X _L>_LR?!'QG<1W7B_X5? _X<^!?$5S'(9%FUGPYX9T_3M2PYR6'VB%R
MQSR1CGK7Y)?\%L?^"F_[1W_!,GXO?L'?$O0]&23]B3QC\3-3\-?MA^*$\!P^
M*=4TG2)+[0%\/V&@ZR][;2>'M5U+3Y/$5Q;&.*4W)L_D82(D<G]"7/U]Z\4_
M:!_9W^"O[4_PO\0_!C]H'X<>'?BG\,_$R)_:GA/Q/9)?V,MS#'+':ZA;H^#:
MZA8>?++9WD3++!,0ZL.<@'*0Z]^RI^V#\%K#5I;SX1?'#X)?%7PWIVMV_P#:
M[>'=?\-^)] U.-+FSGN;>]\S!*X5UN8XYHI%DA=4=9%K^*#XS?!;X8?LI_\
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MT^+[K6O@UX@UZ36_"FKWOC,R2:K)=,@LH7CM9)C)IGG6DDUH BB9E3G\S?\
M@Y3^/'[&?[>WPM_99_8@^"/C7P!\=?VH/BI^T_X?\(?#_4? 'BFV\1:C\!1<
MZSIVA>.O&7BO0M,>2=]$N[".\\/WYF:#[(8+FX!Q:R%0#ZR_X-D_A!XI\7_!
MS]IG_@I#\6(+?7?B7^WC\=_&OC/P5XZUJZ?6/']I\#M'UAM)T/P1K.K3@2C3
MM,UC1IGLK!288UMK9H_W<4-?U +ELA!^+ X(Y (D[$# /OQCI7B/[,WP,\+?
MLT?L_P#P?^ _@W2=%T;1/A?\/_#'A,6OA^Q73M)N-4TO2K6'7-5MK-2WDG6M
M96^U:<,S.T]Y([L6))]R8X&><9 .TX89.!C@YYX/M0!_'+I5YI-C_P '>WQD
MFUF[T6RLD_9)\!AI];N=+M+4%O 'A9C'')JCI"]RP+&)83]J)&(!O K^N,^*
M/AGD_P#%1> NI_YB_AW_ .2*_%_]M[_@WD_8"_;]_:5\3_M5_'&_^/UA\6/%
MFA^&=!U6;X=_%%?"FB#3O">C6N@Z8EC8#P]?S6[FQLX?MFV]9)Y]TWE*SG/R
MY_Q"4?\ !+7_ *&K]L/_ ,2$F_\ F4H _I=TK4_#>L1W$&A:EH.JVR+Y=[;Z
M/?:?=QPI.&!$\=C+(@\] PQ(%WA3C.TU_!W\4_VA;/\ X(1?\%:?^"JNCVM[
MX(\(^%/VR_V5==_:&_9^O[JRN]/\*^%/BOI(\33?#SX<6>CI"=*U'4O$GB)]
M7M+N"!X6)?39)RL<B&OZG?\ @G/_ ,$COV6/^"7D_P 5)_V;-5^,VIO\88O"
MT7BQ?BQ\1KCQW!&OA!M8?2O[$A?3=-@TN9SKEZ+V9(I)KQ4M4ED\NUA18O\
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MPN\4ZIK&K>%[Q7E@L;6..[6#5;&VFN((-5%Q#'<W"Q>:W[E?LU_\K8'[?/\
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MM$\;ZI=+]NU"?P_'XC\3W'B;3+>SFCN]=:>6SM[+3H-Z9>0K+_4+_P %,_\
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MPHK6R54.=1TKE&)1L7<?)7&,XQ[Y]J^K23@_0_RKY2_;1_Y(9KG_ &$-(_\
M2E*^2X\C;A'B"/QQGE.+=JOO\LG2>L=K/3??S9^D^#2Y/$[@=1<VYY_ELKSE
MSN/[^&D=%RK5:+30_P!!_P#9YX^ ?P)/;_A3GPT_]0G1:]?KR#]GG_D@GP(_
M[(Y\-/\ U"=%KU^O\T$_?F^\E'\%K^!_MXG[J^7XV04445"=_O?X.Q3T_#\5
M<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?Q_\)QX*M?"WAKX>ZEX3O+*YT_7+;Q']L%S?Z_K)OFN!9&Q@M8HX&,LX8LV
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M).3U'L/0#L/SS2T4 +ZC PW4=N1@GV)'7%?EW^SA_P $:O\ @G7^RG\>]?\
MVFO@Y^SSX;T?XSZUJNO:Q9^,=1DNM7N_#%WXI6]3Q$WAJ&\F>WTXZLFH7:3N
M8II8UE/V>2$\U^H=% !^&/I1V(]>M%% !CK_ +0P?\^W_P"O-%%% !^F>N/X
MOK].U(54G<47/![CH<CH?7K2T4 !&<>W3U!S]X>_;TQVI-O/)+=P">%/J!QS
M^GM2T4 (1[D=QCMTS_WUW_&C:N<[1].P]0!Z$\_7ICI2T4 -*@YZC=@G''(Z
M-TX8>O?OFE(SU)(YR,\-['&.!VYI:* &[0 0.,L6SWW'^+GH1V]*=WW8!.T+
MD\\ Y_,]S110 T*![@G)![GJ">_';G%*5!QGJ.A[CG./_P!8Z4M% ";1SUYS
MSGGDY_\ K#VXI?4=C@8],>AZ\]\DT44 -*@@@YYS^1ZCZ'WS044C&,#L!T [
MCZ'OGGWIU% !Q\W'WACOP!T ^G;]:",X[8YP.Y]^_P"&0/:BB@ (![#Z <#Z
M>F:0  <?GW/UI:*J&_\ V\__ $B(?8?_ %\C^43\#_\ @XX_Y1Q^*O\ L<M(
M_P#2._K](/\ @G-_R87^R'_V0'X;_P#J.6-?F_\ \'''_*./Q5_V.6D?^D=_
M7Z0?\$YO^3"_V0_^R _#?_U'+&OL*_\ R1&5?]E!F/\ ZAT#XVC_ ,EYF7_9
M/X/_ -3F?:%%%%?&Q_AP_P"WO_2C[-[_ /;GZP"BBB@04444 %%%% !1110
M4444 %*.H^H_G24HZCZC^=$?M_+_ -M$NOK^B/X0?V]?^4Q?QXS_ -"-#_Z*
M'L:S*T_V]>?^"Q?QX_[$:'V_Y9#UK,K^^/ K_DBJ7_7[_P!M/\GOI=?\G4K?
M]@-'_P!)@%%%%?M!_+(4444 'Z44=\_Y[_XT4K-<TN2FUHM?XDMOA=_=MZ.X
MUS\E6W+S+E=.[25M%-23^*^EMO+8^4_C[^VI\ OV9-:TKP_\7M6\2Z9J6M69
MO]-71/#%_KL4MNN,^=):D"!SGA6YX/IFOGX?\%<OV(0C,WB_Q^" "$/P[U=6
MR<\;3(&(']X CGK7Z,7V@>']5D$VK>'M UB54*I+K.B:7JTT0/\ RRBDO[6X
M:.,Y^ZC <#.:_%/]I30/#\/_  54_9_TVW\.^';739_ ?AQ[G2[30]+M]+GD
M:6Y#-/IT=JMG,[8^=Y('9N.>!7Y1QUG''?#T<'C\OS+(G@<;F^!RREAJ^4UI
MXC#?7)<BJU,0L7&-7V?*VU&G!M.RV/Z,\)<A\)N,O;Y1G7#7%;SG+.'<US[,
M<QPG$V%HX'%_V5!598?#X'^RYU*#KPG&FG+$5$I1<VFGRK[M^"7_  4%_9B_
M:%^(.F?"_P"&&O\ B_4/&&L6FH7UC:ZQX-U'1;!K;3+?[3=M)J-RQAC*Q@E
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MV'^ZO_H(HH[#_=7_ -!%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_B$5;_HO_#C_ ,2O"^7_ $Y]/Z>O]@&X>H_.C</4?G7\?^[_ (.A?^?S2?\
MP4_"_P#^.?YZ]:-W_!T+_P _FD?^"GX7_P#QS_/7K3_UA7_0JSC_ ,(*GE_>
M_JZ^9_Q"*M_T7_AQ_P")7A?+_ISZ?T]?[ -P]1^=&X>H_.OX_P#=_P '0O\
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M_-)_\%/PP_\ CG^>G2C_ %A7_0JSG?\ Z )^6OQ?\'5?,_XA%6_Z+_PXZ?\
M-5X7R_Z=>GK\]?[ =P]1^=&X>H_.OX_]W_!T+_S^:3_X*?A?_P#'*-W_  ="
M_P#/YI'_ (*?A?\ _'/_ -7:C_6%?]"K./\ P@J>7][S_%?,_P"(15O^B_\
M#C_Q*\+_ '?^G7]>=]?[ -P]1^=&X>H_.OX_]W_!T+_S^:3_ ."GX7__ !S_
M /5VI-W_  ="_P#/YI/_ (*?AA_\<_\ U=J7^L*T_P"$G.?_  @GY?WO/I?=
M?,_XA%6_Z+_PX_\ $KPOE_TY]/Z>O]@.X>H_.C</4?G7\?\ N_X.A?\ G\TG
M_P %/PO_ /CE&[_@Z%_Y_-(_\%/PO_\ CG^>O6C_ %A7_0ISG_P@GY?WO/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBJAO_ -O2
M_P#2(A]A_P#7R/Y1/P/_ .#CC_E''XJ_['+2/_2._K](/^"<W_)A?[(?_9 ?
MAO\ ^HY8U^;_ /P<<?\ *./Q5_V.6D?^D=_7Z0?\$YO^3"_V0_\ L@/PW_\
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MDY[8QMQP?KZ\< 'IU%/HH>MD^FWE;T$US*S\O_)=ON_K43'0GDCH>AQS@#T
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M/_A#BO*__+KIK_3#^ULH_P"AE@>G_,9ANMO[_G_6MOO:BO@G_AZ-_P $]_\
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M/_A#BO*__+KI_EW#^ULH_P"AE@>G_,9ANMO[_G_6MOO:BO@G_AZ-_P $]_\
MH[+X2_\ @WNO_D*C_AZ-_P $]_\ H[+X2_\ @WNO_D*E_8^:_P#0LS'_ ,(<
M5Y?].O7[O,?]K93_ -#+!?\ A9AO+^_Y_P!:V^]J*^"?^'HW_!/?_H[+X2_^
M#>Z_^0J/^'HW_!/?_H[+X2_^#>Z_^0J/['S7_H69C_X0XKR_Z=>OW>8?VME/
M_0QP73_F,P_E_?\ /^M;?>U%?!/_  ]&_P"">_\ T=E\)?\ P;W7_P A4?\
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M_P#A#BO+_IU_6G?1?VOE'_0RP/3_ )C,-Y?W_/\ K6WWM17P3_P]&_X)[_\
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M_81TG_TI3']?U]*^K#R" ,GI@9)R>F1_GIZU\J?MH\_ O7 .?^)CI"Y'J;M
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M_P"@BBCL/]U?_0110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M2O'76UOBNM%?;79Z#BN:]GJNFOE_F%%%%.^MN]VO-::K[T):W\G8**** "BB
MB@ HHS2 YS['%';SO^%O\^@6D]HW7>Z_+?;MZ"T4G<=?Z?CWI:.ORONMG;I>
M_7L.S6ZMV\]NVJM?J%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^G;M7[XT4?ZT\1_]#K,?_"FI_F'^JW#_ /T*<)_X#+R\_P"K+Y?@=_Q#;?\
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MTX_7K1_Q#;?\$S_^@'\:O_#MZMZ_]>7IQ^M?OC11_K3Q'_T.LQ_\*:G^8_\
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M3Q'_ -#K,?/_ &FIO]XO]5N'_P#H4X3=?9GTM_>]?PTW/P-/_!MM_P $S_\
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M_'0/^)*N/?\ HHL@_P#!6-_^0.#V/_<8_P# 31L?^XX[_=/?/MBN]_X<H_\
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MFYIX=N6B^)\]WK^&_D_^)*>.W;_C(>'X<B2AR4<9JURVE.\-7IKIZ6.#V/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPMHGA;P_IUB?]"M]-T?3H+*V%H6PSVY6+?$Y&7#;B 37?5ZQN%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "CJ/J/YT'J?J?YT#J/J/YT'
MJ?J?YT )V'^ZO_H(HH[#_=7_ -!%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ?;]+]%_5]NA1110+_MWJOM=/=O^O;TTT****!Z?R_\ DWIY>O\ P/LE%%%
M=O=6_P#/Z:_#Y_G\BBBC- :?R_\ DWIY?U^1^'^?PHHSZ4?Y]:->:R4WIUBD
MGMUNORZ^1.]G>*76*=WTV=O._7?[BBBBC5:-)/R=PO?9->3"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X+
MXH^!;;XH?#3XC?#6]U*YTBR^(W@+Q?X$O-5M(4GN-+M?%_A_4-!FU*UMYBL,
MUU8Q:@\\$,K".62-%D(0DU\>?\$QOV!/#'_!,O\ 9 \#?LA^#_B-X@^*V@^!
M]?\ &^O6OC/Q/HVG:!K%])XV\4:CXFN;2;2]*N+JSAAT^;4&M+9TG=Y88E>4
M[R:^R/B;XVL_AK\./B%\2=1MKF]T[X>>"/%GCF\LK4;KF[LO"6@W^NW=G I.
M'GN(+"2&$$@;W3\/DG_@FY^W=X(_X*2?LF>"/VM/AYX6UWP9X7\;ZUXPT.UT
M#Q&(AJEM<^"_$=_X:OI9# SQ-#<W>GRS6S(S!H&C;)S0!]W4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 *.H^H_G0>I^I
M_G0.H^H_G0>I^I_G0 G8?[J_^@BBCL/]U?\ T$44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 444TDC/;I@X)R3].F.IZY]J?F]%>VO1Z;]MP6M_*U_*_
M]=!6) . 3].3SQT[_3O566YMH=OG7=M;N58 7,D4)9?10[J1P<%MI%?(/[:?
MQ_USX%?#?2QX.M&O_'_CS65\,>#8%M6NT;4F57F41*RYNS _^A+GYK@H,'&*
M^-;7]AG]I7XM:-HOB_XI?M$:WI'BC4;3[;-H$UO<W_\ 8$=RQ>'3S<VUQ:1M
M,D;)YT)B)MY-T!9BG/P&?<8X[ YEB,GR+(,5Q!F&$P]'$8JE[2.%P5.->35.
M/UN<*D76LKNGR74=;Z-+PL=FM6GBJF"P>6U\=B:-.%2I4558>C3527NP]K/W
M7-I<UHIOE?DTOV%&I:;@?\3"P' X^VVW'M_K:7^TM-_Z"-A_X&6W_P =K\?O
M^'9/Q. Q_P -*:KGH?\ B4ZAC_TY9_\ KT?\.R?B;_T<IJW_ (*M1_\ EI7C
M+C/CQ*"7AS*"G:4_^%RA[OPK1?5M4[=/U.2&:\06M+AQWNE_R,\/VCO[J77Y
MW=]T?L#_ &EIO_01L/\ P,MO_CM']I:;_P!!&P_\#+;_ ..U^/W_  [(^)O_
M $<IJW_@JU#\/^8I_GVH_P"'9'Q-_P"CE-6_\%6H?A_S%/\ /M3_ -<>.]/^
M-?3_ /#S0UV_ZAOZON/^U,_T_P",=ET_YF6'_N_W/^'_ .WD?L#_ &EIO_01
ML/\ P,MO_CM']I:;_P!!&P_\#+;_ ..U^/W_  [(^)O_ $<IJW_@JU#_ .6E
M'_#LCXF_]'*:M_X*M0_^6E+_ %QX[_Z-]/\ \/-#R_ZAOZOZ LTS[3_C'I?^
M'+#_ -W^YK?]?,_8'^TM-_Z"-A_X&6W_ ,=H_M+3?^@C8?\ @9;?_':_'[_A
MV1\3?^CE-6_\%6H?_+3U_P />C_AV1\3/^CE-6_\%6H?_+/U_P ]Z?\ KCQW
M_P!&^G_X>:'EK_NW^>XO[4S_ /Z)V73_ )F>'_N_W/Z^:/V!_M+3?^@C8?\
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M1\3?^CE-6_\ !5J'_P M*/\ AV1\3?\ HY35O_!5J'_RTI_ZX\=_]&_GLO\
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MD?$W_HY35?\ P5:C^'_,4_S[4O\ 7'CO3_C7T_\ P\T-=O\ J&_JZ&LTS_\
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M_P =K\?O^'9'Q-_Z.4U;_P %6H?_ "TH_P"'9'Q-_P"CE-6_\%6H?C_S%/\
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MESI2NG=+X7?[^S[KH%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHYQ_G_\
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M2ZL^6RM='TEU>7*DK2:=ENUHWIU"BBBJ **** "BBB@ HHHH **** "BBB@
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M]=/W,_XB=OV6N/\ BRGQ.[?\O^G_ (8_T'\J7_B)V_9:_P"B*?$_M_R_Z?\
MA_RY?E7X9_V-HA_Y@>B_^"FP'\K>C^QM$_Z >B?^"G3_ /Y'H_X@5'_H>T>G
M_,/4_N_]//Z\[ZK_ (J08?IX8XOI_P SRATY?^H3^Z?N6/\ @YV_9:Q_R13X
MG=NE_I^.O_7CZ]/>@?\ !SM^RU_T13XG?A?Z?Z_]>/K^M?AI_8VB?] /1?\
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MO]W^NG[E_P#$3M^RUQ_Q93XG=O\ E_T_\,?Z#^5+_P 1._[+/3_A2GQ/Z_\
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M !1110 4444 %.Q\N>^['Z4VG?P?\"_I2O[U3_'_ .VQ*VO;3W8_^VGYE?\
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MO,T/QAX4:\N+K4E\-:NC/8Q1:G,][#J>G7\;.\)A:OYUOV]_^#NG]D7]I?\
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M .#=_P#;^^#6KVG[;GQ7_:+\)7_AZS\>>%HOB!X]\9^+?#_BSPE=7LN@>-/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !3OX/^!?TIM._@_X%_2E]JI_C_\ ;8E=_P##'_VT_,K_ (*(?\C#^RG_
M -EUTK_T&UK],HONQ?0?^A&OS-_X*(?\C#^RG_V772O_ $&UK],HONQ?0?\
MH1KX;A[_ )*SB[_N0_\ 4=GCX/\ Y&6;?XL)_P"HZ''J?J?YTE*>I^I_G25]
MX_@I_P"%?DCUEL_\3_\ 28!1114@%%%% !1110 4444 %%%% !1110 4444
M (W*.Y/'OCFO\V/]O/P=X2^('_!VY\"/!/CSPSH/C/P9XH^-'P-T;Q)X5\3Z
M9:ZWX>U[2[M=36XT[5]*O(YK/4+*8;?-MKF*2"3 $B,H(K_29;.Y<'D?,!U/
M'/ /&> ,D],CC)K\H/'?_!%O]A7XD_MV>$O^"C/B7PM\0I?VF_!?B7POXQT3
M6++XB:Q9>$HM;\(^9_8TUUX1C0Z?<01^8WVBW9]DXV[\=P#Z$/\ P32_X)Z
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M>)0S.'"_WXX([\?PC.>/7/7YNO- !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <+\3_ /DG/CC_ +%?6/\ TCDK\_/^"6(Q\*/B.!_T5?7O_2>&
MOT#^)_\ R3GQQ_V*^L?^D<E?GW_P2QS_ ,*G^(^>O_"U]>_])X:_,,Z_Y.;P
MG_V(L=_Z>1\UBO\ DJ<K_P"Q9CO_ $N']?,_3ZBBBOT\^EZ+_#'_ -)04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %*.H^H_G24HZCZC^=-=?1_D'1_]N_\
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MH?RH 2BEP?0_E2$, 3M)P,X Y/TH!NVO8X7XG_\ ).?''_8KZQ_Z1R5^??\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %*.H^H_G24HZCZC^=-=?1_D'1_]N_\ I<3^"?\ X*)?\I?OCO\
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M?2O<?0_S%?-7[6'_ "1S6?\ K^T__P!*UKY_BS_DG\V_[%]?_P!-H_9/ /\
MY//X;_\ 9391_P"GX'^BO^SS_P D$^!'_9'/AI_ZA.BUZ_7D'[//_)!/@1_V
M1SX:?^H3HM>OU_"*^*7_ %\7Y'_16_U7YH****A;?-_FRGO\E^2"BBBF(***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUMX2^&W[4T^G>#M.-TNC:?+I[O\ V;:2W#RQ6\DEV+B6XEV-AG67RU;(1$7
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MFOK?\N/^&=/V^_\ H[.3_P %</\ \CT?\,Z_M^#!_P"&LG/(X.F0X]_^7?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_+;_ #VSBD_X2;PU_P!#)X?_ /!Q8?\ Q_\ S^E?N]_Q#$?LG_\ 1:_BW_X
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MU'\Z#U/U/\Z!U'U'\Z#U/U/\Z $[#_=7_P!!%%'8?[J_^@BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHO+^[_X"O\ ,.:?\R_\!_X(44447[J+_P"W?-/]!-R>[OVTT6VMNNVG8;D
MG@[L?ACKT_\ U<TJ\#@$?7K2T4HJU[I.^VEK;?JK@M))QT7VE_-+O?\ 0***
M*?X!*[=UHNUOZ_(****$ 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "CJ/J/YT'J?J?YT#J/J/Y
)T'J?J?YT ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g4bdklltl5z5000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +>!UH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!QOQ-TG^TO",LZ+F:R83K_N]&'Y'/X5B?"W7XH?#FI6MR
M^%L,W ]HR"3CZ$'_ +ZKTF>&.YMY()5W1R(4=3W!&#7S=>I=^'M3U/35<J3N
MMI#_ 'DW _KM%,#I_ 5I+XD\?2:K<C*PLUW)GIO)^4?F<_\  :Z/XQ73)INE
MV@)VRS/(1Z[0!_[/6G\+-(_L_P +?;'7$U\_F=.=@X4?S/XUE?&.W9K#2KH
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M[NPM-4@1G%KN28*,X4X(;Z C]:?X7^)6BQ>'K:VU29[>ZM8EB(\MG$@48!!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R1K+&T
M;C*."K#U!K&TCPCH6A7C7>FV/D3LAC+>:[?*2#C#,1V%;=% %#5-%T[6[<0:
ME:1W$8^[N'*_0CD?A6?:>"O#EC#-%;Z7$JS(T;L69FVL,$!B<C(]#6_10!EZ
M-X<TGP^LPTNT^SB8@R?O'?.,X^\3ZFHM5\)Z%K<OFZAIL4LO>0$HQ^I4@G\:
MV:* ,C2?"^B:&_F:=IT4,F,>9RSX]-S$FC6?"^C>()(I-4L_/>(%4/FNN >O
MW2*UZ* (K>WBM+6*V@79#"@C1<DX4# '/M63I_A#0M*U(ZC96/E71W?O/.=O
MO=>"Q%;=% &=JVA:9KL"PZG9QW"H<J6R&7Z,,$?G56S\(Z%I]C=65K8+'!=I
MLG42.2X]"2<]SWK;HH RM&\-Z3X>\_\ LNT^S^?M\S]X[[MN<?>)]34.G^$-
M"TK4CJ-E8^5='=^\\YV^]UX+$5MT4 9>L^'=*\0)"FJ6OGK"28QYC+C/7[I'
MI5RQLK?3K*&SM(_+MX5VHFXG ^IYJQ10!@:CX*\.:K<&XN]*B:5CEG1FC+'U
M.TC/XU=TK0-*T-&73;&*WW##,HRS#W8\G\ZTJ* *U_IUGJEJUK?6T=Q"QR4D
M7(SZ^Q]ZR=/\%>'-+N!/::7$LHY5W9I"I]1N)P?I6_10!BZ/X3T30;I[G3++
MR)G3RV;S7;*Y!Q\Q/<"MJBB@#*U?PUH^NE3J5A'.RC ?)5@/3<I!Q45MX1T&
MST^XL;?38D@N%V2@,Q9QUP6SN_6MJB@#*TKPWI.B6]Q;Z?:F&&X_UJ>:[ \8
M_B)QP>U1:/X3T30;I[G3++R)G3RV;S7;*Y!Q\Q/<"MJN=U?QGI>DZO;:26:>
M_FFCB,2?\L]Y&"Q[<'..3_.@"_K/A_2_$$<4>J6OGI$2R#S&7!/7[I%6["QM
MM,L8K*SC\NWA&U$W$X'U/-9_B?7?^$<T*;4_LWVCRV5?+W[,Y('7!]?2J_A#
MQ-_PE>DRWWV/[+Y<YAV>;OSA5.<X'][]* &W'@3PQ<W?VJ72(?-)R=K,JD_[
MH('Z4^\\$^'+^6&2XTQ"88Q'&$D>,*H)(&%('4G\ZWZ* "F21QS1/%*BR1N"
MK(PR&!Z@CN*?10!SMOX%\,VM\EY#I2).C;U/F.0IZ@@9P/RJ=O"&A/K7]L-8
MYO\ S!+YOG/]X=#C=C]*VZ*  @$8(R#7.3^ O"]Q=?:9-(B\PG<0CNJY_P!T
M$#]*Z.B@##U'P?H&JI;I=Z:C);)LA5':,(OIA2*U?L=L;(63PK);!!'Y<OS@
MJ!C!W9S^-3T4 <R?A[X5,_G?V1'NSG'FOM_[YW8_2N@M;6WLK=+>UACAA086
M.-0H'X"IJ* ,2Q\(:%INJ?VG:6/EWA+'S/.<\MUX+8[^E6-8\/Z7K\446J6@
MN%B8LGSLI!/7E2#6G10!1L=(L--TP:;:VX%F 0(G8R#!Y(^8GCGI6/)\/O"L
MLYF;2(PQ.<+(ZK_WR&Q^E=-10!7LK&TTZV6VLK>*WA7HD:@#Z_6J>K^'-(UX
M*-3L8YR@PKDE6 ]-P(./;-:E% &!'X*\.1:?-8II<2P38$F&;<P!W %\[L9
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MF>,UTUIH6G6NAII(M86M!&$9"@P_')/N>N:\=\!0K;?$R&!"2D3SHI/H$84
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MI6-XC^(:>'?$2:7)IWF1D(S3F?;M#=3MVGI]:X32T_L#XMK:6)*PB\,(7/\
M W\/X9_2D^**E_'#(O5H8P/UH [+3?BC#JOB&'3+;29FBGE$<<WFC=C^\4QP
M.IZ]!7H%9.E^&M(T>.#[)I]JDT*;1.(E\P\8)+=>>>]:U( HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]J]J P /3U-+10!F>(M'37M N]-9@IF3Y&/\+ Y4_F!7D>BZ[K7PXN;FRO\
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M>;Q-K4;QG>TL:2+M:1VS\V.P&>/P[5C?$K_DH"?]<X:]NHIW ****0!1110
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MN5\'?\A#Q-_V%9/Y"@ _X23Q%_T)US_X&1T?\))XB_Z$ZY_\#(ZZJB@#E?\
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MJB@#E?\ A)/$7_0G7/\ X&1T?\))XB_Z$ZY_\#(ZZJB@#E?^$D\1?]"=<_\
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MKJJ* .5_X23Q%_T)US_X&1T?\))XB_Z$ZY_\#(ZZJB@#E?\ A)/$7_0G7/\
MX&1T?\))XB_Z$ZY_\#(ZZJB@#E?^$D\1?]"=<_\ @9'1_P ))XB_Z$ZY_P#
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MB@ HHHH *Y7P=_R$/$W_ &%9/Y"NJKE?!W_(0\3?]A63^0H ZJBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE?$G_(W^%/\ KO/_
M .BZZJN5\2?\C?X4_P"N\_\ Z+H ZJBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HK \5^)6\-6EK+'8_;)+F<0)'YOE
M\D'O@^E9\_BO7["(W&H^#[B*U09=X+Q)F4>NT#I0!U]%4-(UBQUW3TO;"820
ML<'C!4]P1V-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBJNIWO\ 9NDWE]Y?F?9H'FV9QNVJ3C/;I0!:HK-T
M#5O[=T*UU/R/(\]2WE[MVW!(ZX&>GI6E0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<KXD_P"1O\*?]=Y__1==57*^)/\ D;_"G_7>?_T70!U5%%%
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MNMU/PUH^L2B6_L8Y9!_&"48_4J03^-6-.TFPTFV:WL;5(8F.6 YW=N2>3^-
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M N[RW\4WUM?Z>=/^WH+F*'SEE!=>'(([G@X]JZ*UTBPL;DW%M;+%(8EARI.
MB] !T%23Z?:W5W;74T6Z>V+&%PQ&W(P>AYR/6@#G/#2/(OB=(SB1M1G"_7'%
M3^![FW;PI;0HRK);!DGC)Y1MQSGT]:V[/3[6P:X:VB\LW$IFE^8G<YZGD\?A
M6??>$M"U&[:ZNM.1YF.6969-Q]2%(S0!F>)+^6]U#2[+3+5=2VL;R2-)E565
M#A?F/&-Q_P#':SX)M1^VZ[I]QIS:?-J=H\]O")A+F0*5;!7N>#CVKK[31]/L
M+@SVMLL4AB6'*DX"#H .@J6?3[6ZN[:ZFBW3VQ8PN&(VY&#T/.1ZT <WHCR:
MGX/T^+2-62PFMHU6X/DK*00,$%6Z<\YK&EU*ZOO"VBZGJ4WGQP:JK7#[ !M#
M$ D 8P/ZUU=]X1T'4;IKFZTY&F8Y9E=DW'U.TC)K0BTRQAT_[!':0K:$$&'8
M-I!ZY% $IN[81QR&XB"2D+&V\8<GH >^:XJ2XU'5-5UBXM=".HVDJFP23[6D
M6U%SNP&ZY8DY]A6_:>#] L;M;JWTY%F4[E8NS;3Z@$X!K3L+"VTRS2TLXO+@
M3)5=Q/4Y/)Y/)H RO"%[+=:!'#<@K=6;&UG4]0R<?RQ6]5:VT^UM+FYN((MD
MMTP>8[B0Q QG&<#\*LT %%%% !1110 5RO@[_D(>)O\ L*R?R%=57*^#O^0A
MXF_["LG\A0!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M *+H ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "D) &2< =32USWCB>6#PC>M$2I;8C,.RLP!_0X_&@"3_A,_#QO/LHU2+S-
MVW.UMN?][&W]:M:IX@TK12BZA>)"SC*K@LQ'K@ G'O5B#3K&+3H[*.WB:U50
M%0J"I'J?7ZU@^&(X[G6]?OIE#7:WK0*S#E(U&% ] ?Z4 6Y/&GAZ*WBN&U)?
M*E)"%8W;D8R" ,@_,.OK2V7C'0=1O([2UO\ S)Y3A%\F09/7J5Q6S'!%"7,4
M2(9&WOM4#<WJ?4\5P^C3RVWPIN)H"1(L<VTCJ/F(S0!OS^,O#UM=FVEU.(2J
M<':K,H/^\!C]:TK[4[/3K!KZZG6.V4 ^8 6!STQC.>O:J>@Z=90>&K.WBAB:
M"2!&8%01(2 23ZYK%\4:II5OK.EZ=J,RQ64(-S*FPL"1\L:X4'OD_A0!UL$\
M=S;QSPN'BD4.C#N",@UBS^-/#MM<&"34X_,!P=B,P'X@$?K7+1:PO_"O-8MM
M/N#(+*3R8I0""87<8.#R."P_"NBN7?P]HD,>DZ)'>V*PEYF$ZQ@  ')!!W9&
M30!MOJ5E'IXU![J);0J'$Q;Y2#TK+@\9^'KE96BU)3Y2%V!C<' ZX!&3^%8U
MQ/#K%_X3BDMD@L+A9+C[.,;-RKE5Z8./IWKLS!"TD<C0QF2/[C%1E>W![4 <
M_P#\)]X9_P"@G_Y D_\ B:NW?B?1K&UM[FYODCCN$$D7RL693T.T#./PK/C_
M .2F3?\ 8*'_ *,%-\/1I=>)]?O9U#745P((RW5(P.,>F: -S3=6L=8MS<6%
MRL\8.TD @@^X/(HL=7L-2GN8;.X662U?9, "-IY]1ST/(JMKEY!H6B7^H1QQ
MQR;2V54 O(>%SZ\XKC]"U31;'7M)CTV]$S3P&UNOW;KE\[E?Y@,DL2/QH [3
M5/$&E:*5&H7J0LPRJX+,1ZX )Q3M+UO3=:C=].NEG"8W@ @KG.,@@'L:Y[P\
M'D?7M6%J+O5EO9(EC9PK!5P%0$_=&/Y5'/KUQ/IGB0-I*Z=J-I;KYC)*LC-N
M!()8 =!SWZT ;$_C+P];79MI=3B$JG!VJS*#_O 8_6FW/C7P]:7#V\VHA9$.
M& B=A^87!JQH.G64'AJSMXH8F@D@1F!4$2$@$D^N:SO'*JGAN-54*JW,(  P
M -U &E8^)M'U&UN+FVOD:"VQYKNK(%ST^\!Z57M_&?AZZNEMH=20RLVU04=0
M3G'4C%4_%,:WFN^']/N>;*>:1I4)X=E4%0?Q-.UG6+C3;N"WN/#T4FG&XCAA
MN#.F,GH0F"1CG\J -G5-:TW1HEDU"[2 ,<*""6;Z 9)HTO6=/UF%I=/NEG5#
MAL @K]0<$5BZ7&EWXZUN>Y4--:+#%;AN=B%<DCZGO[UM:C<6VD:?>ZD8HU9(
MR[L% +D?=!/?DX_&@!(M<TV>YO;>.Z#2V0)N%VM\@'7MST[9K+_X3[PS_P!!
M/_R!)_\ $URVD:QH]EJ.B3VU\);R7=#?_NW7<9#NW9(Q\K_I73:A_P E"T?_
M *]9J -&7Q-HT&F0ZC+?(EK/GRF*ME\'!PN-WZ5+IVO:7JT$LUE>1RQPC,A(
M*[!SR0V,#@_E6/91QWGQ"U62Y4.]G!"ML'&=H898C\>_O1XW1(]%^15C^UW,
M,-Q*H 8QY[GT_P : +D/C+P_<7BVL6IQM,S;5&Q@"?\ >QC]:@/CWPR"0=2Y
M'_3"3_XFMQ;&T2UCMA;1>1%C9&4!5<=,"L#Q+_R,7AK_ *^G_P#010!H?\)3
MHO\ 9@U(WZ+:EBBNRL"Q'4!2,G\!4NE:_I>M;_[/NUF,?++M*D?@0#608X[W
MXC.MTH<6=BKVZ,. 2W+#W[5T,WV:T6:^DC12D9,DNT;MH&>OIQ0!$FKV$FK2
M:6EPIO8TWO%@\#COC'<<9HU+5K#2(!-?W20(>%W=6^@')_"O.+?7](A-CJRW
M8.JF]::Y3RV_U<GRLN<8^5=O?L:Z>TBCO_'VJRW*+,]E#"+1&Y #+DL/?/?W
MH V-+\2Z/K,S0V%ZLLH&XH593CUPP'K3=2\4:+I%QY%]?I'-C)0*SD?7:#C\
M:H:?K5S<>)(['4=!2RNC;M*DOVA)6VYQC(' S[TSP)%'+H;Z@ZAKRZGD:=R/
MFSN(P3Z<#CWH MW'C3P]:^5YNI+B5-Z%8W8$9(Z@'N#^52:?XLT/5+AH+.^#
MR*AD8-&Z *.IRP J;688K?PQJ<<,21H+28A44 9*DG@>]<QJ3L/AMI$.\I%<
M"WBF8'&$/7^5 &]#XR\/W%XMK%J<;3,VU1L8 G_>QC]:T-2U>PT>&.:_N!#'
M(X125)R?P%2K8VB6L=L+:+R(L;(R@*KCI@5QGB/5-$N/$DUEJ]V(K>UM6C0>
M6S_O9!R?E!Z+C\30!W+R)%&TDCJD:C<S,< #U)K!'C?PV9_)&J1[LXR4<+_W
MUC'ZUS<NI_VQX2T&WDES!+?1V=VX)&X+V/ID &MOQ%JDVA6;H/#D-SI$2*"Y
MG15&3C'EX)ZF@#>U#4[+2K4W-]<I!%T#-W/H .2?I68GC/P]):RW*:DICBQO
M_=OD9.!\N,X]\53G2.]^(D$-RH:*VL/.MT;IO+X+8]<?RKIO(B\_S_*3SMNW
MS-HW8],^E '/_P#"?>&?^@G_ .0)/_B:O:EXFT;2)1%?7Z12$ [ K,PSZA02
M/QK.T'_D;_%'^_;_ /H!JCX4\Z/PS+K%M8B^U:YF<S*9 C$[\8W'H .<4 =1
MINK6.KVQN+"Y2>('!(R,'KR#R*SG\9^'8[HVS:I%Y@."0K%<_P"]C;^M86H:
MW+=>#_$$J::NGW<,H@F6-PY))4,20!G@D=ZZRQTVQAT>&RCMX6M?+ V% 5?C
MJ1WS0!)J.IV>DV;7=],(H%(!;:3R>G R:IZAXGT?2UMVO+P1K<)YD1$;MN7U
MX!]:Q/%&K:2GB"PL-5G"6<$;7$JE68.Q&U!A0>GS'\JL>#=1AN_#D]K%/YRV
M3O"CX(+1]4.#TXX_"@"_8>+]"U.]CL[.^\RXDSL3R7&< D\E<= :VZYSP'_R
M)6G?23_T8U='0 4444 %%%% !7*^#O\ D(>)O^PK)_(5U5<EX/EC6_\ $N9%
M&=5D(R?84P.MHJ/SX?\ GJG_ 'T*//A_YZI_WT*+,5T245'Y\/\ SU3_ +Z%
M'VB'_GM'_P!]"D.Y)14?GP_\]4_[Z%'GP_\ /5/^^A0!)14?GP_\]4_[Z%'G
MP_\ /5/^^A0!)14?GPCK+'_WT*//A_YZI_WT* NB2BH_/A_YZI_WT*//A_YZ
MI_WT*=F*Z)**C\^'_GJG_?0H\^'_ )ZI_P!]"BS"Z)**C\^'_GJG_?0H\^$]
M)8_^^A2'<DHJ/SX?^>J?]]"CSX?^>J?]]"@"2BH_/A_YZI_WT*//A_YZI_WT
M* )**C-Q".LT8_X$*//A_P">J?\ ?0HL*Z&W5G;7T!@N[:&XA)R8YD#J3]#3
MXHHX(4AAC2.)%"HB* J@=  .@I//A_YZI_WT*//A_P">J?\ ?0IV871)14?G
MP_\ /5/^^A1Y\/\ SU3_ +Z%%F%T245'Y\/_ #U3_OH4>?#_ ,]4_P"^A2&2
M45'Y\/\ SU3_ +Z%'GP_\]4_[Z% $E%1^?#_ ,]4_P"^A1Y\/_/5/^^A0!)1
M4?GP_P#/6/\ [Z%'GP_\]4_[Z%%A71)14?GP_P#/5/\ OH4>?#_SU3_OH4[,
M+HDHJ/SX?^>J?]]"CSX?^>J?]]"BS"Z)**C^T0CK-'_WT*//A_YZI_WT*0R2
MBH_/A_YZI_WT*//A_P">J?\ ?0H DHJ/SX?^>J?]]"CSX?\ GJG_ 'T* )**
MC^T0YQYT>?\ >%'GP_\ /5/^^A19BNB2BH_/A_YZI_WT*//A_P">J?\ ?0IV
M871)14?GP_\ /5/^^A1Y\/\ SU3_ +Z%%F%T245']HA_YZQ_]]"CSX?^>J?]
M]"D,DHJ/SX?^>J?]]"CSX?\ GJG_ 'T* )**C\^'_GJG_?0H\^'_ )ZI_P!]
M"@"2BH3=VP.#<1 ^[BD^V6O_ #\P_P#?8H"Y/14/VNV/2XA_[[%*+F ])H_^
M^Q0!+14?VB$_\MH_^^A1Y\/_ #U3_OH4 245'Y\/_/5/^^A1Y\/_ #U3_OH4
M 1WEA9ZA$(KVT@N8U.X)-&' /K@]ZKV^@Z/:2B6VTFQAD'1X[9%(_$"K9N8%
M^]/&/JXI/M=M_P _$/\ WV* )J*A^UVW_/Q#_P!]BE%S >DT9^CB@"6BH_/A
M_P">J?\ ?0H\^'_GJG_?0H DHJ/SX?\ GJG_ 'T*//A_YZI_WT* )**C\^$#
M)EC_ .^A3?MEM_S\0_\ ?8H FHJ'[7;?\_$/_?8H^UVQZ7$7_?8HL%R:BH_/
MA_YZI_WT*//A_P">J?\ ?0H DHJ/SX?^>J?]]"CSX?\ GJG_ 'T* )**C\^'
M_GJG_?0H\^'_ )ZI_P!]"@"2BH_M$/\ SVC_ .^A1]HA_P">T?\ WT*!71)1
M4?VB'_GM'_WT*/M$/_/:/_OH4!=$E%1_:(?^>T?_ 'T*//A_YZQ_]]"@9)14
M?GP_\]4_[Z%'GP_\]4_[Z% $E%1^?#_SU3_OH4>?#_SU3_OH4 254N=+T^]F
MCFN["UGEC^X\L*LR_0D<5-]I@SCSH_\ OH4?:8/^>T?_ 'V*!71+147VF#_G
MM'_WV*/M,'_/:/\ [[% 71+147VF#_GM'_WT*47$!Z31G_@0H'<DHJ/[1#_S
MVC_[Z%'VB#_GM'_WT* )**C^T0?\]H_^^A1]H@_Y[1_]]"@"2BHOM$'_ #VC
M_P"^A1]H@_Y[1_\ ?0H"Y+14?VB'_GM'_P!]"C[1#_SVC_[Z% KHDHJ/[1#_
M ,]8_P#OH4?:(?\ GM'_ -]"@=T245'Y\/\ SU3_ +Z%'GP_\]4_[Z% $E<K
MXD_Y&_PI_P!=Y_\ T773>?#_ ,]4_P"^A7+^(I$?Q?X4VNK8GGZ'/_+.@#K*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KWUE
M!J-C-9W*;H9E*L,U8HH Y>'PQJT,2VJ>*+H6*_*L8@42!?3S.M6+[PW.VIR:
MCI.JRZ;<38\\"(2))@<':>,^]=!10!0TJPN;"WD6[U":^FD?>TD@"@<#A5'
M''3WJ#1="CTK01I4LHN8_G#L4VA@Q)(QD^N.M:U% '+1>%=3LXOLECXEN8+
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M\P>AH\P>AK0_M:W_ .@?'^8_PH_M:W_Z!\?YC_"I-#/\P>AI5;>X4#DFK_\
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M_,?X54U'6(%ML?84^8XQD?X5,JLDKV*IT83DHJ7X'+^8/0TOF#T-:']K6_\
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MM69@H89)P*ZNSACL[=8D7H/F/]X^M0Z?J5O)>QYT^/"_-U';\/7%;W]K6_\
MT#X_S'^%<N*EJHG7A$W%R9G^8/0T>8/0UH?VM;_] ^/\Q_A1_:UO_P! ^/\
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MV@\?\M9/_0#5S^UK?_H'Q_F/\*CLKN.Z\:^']ENL.V67.T]?D/M0!ZO1110
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MB-)^'9<=2/X?I[5,MAK<X&O-O&>E76EW>G36OB+75_M#45ADC^VD*BN22$
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MG\ZK5;TS_D)V_P#OBNN7PLY(KWD=G1117EGJ!1110 5A^)'(BMT_O,3^6/\
M&MRN?\2_>MOHW]*UH?Q$95_X;,+/N:,GU-)17HGG'9Z:@33;<>J _GS5NH++
M_CQM_P#KFO\ *IZ\N7Q,]6.R"BBBI&%17+^5;2R?W4)_(5+5:_\ ^0?<_P#7
M-OY4XZM"ELSB\GU-&?<TE%>H>6;7AU,W<KG^%,?F?_K5TE<_X;QON?7"_P!:
MZ"N"O_$9WT/@04445B;!1110 E0Y/J:G[5!6E,\_';Q#)]3^=&3ZG\Z**T.
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M*PJ* -S[1#_SV3_OH5'YL?\ ST7\ZQZE4Y45I#<X,<O=3-+S8_[Z_G1YL?\
M?7\ZSJ*U/.N:/FQ_WU_.E$L>1\Z_G6;12L"E9W-;[1#_ ,]4_P"^A2_:(?\
MGJG_ 'T*PCUHKG/?3NC=^T0_\]4_[Z%'VB'_ )ZI_P!]"L*B@9N_:(?^>J?]
M]"F//$1Q*A_X$*Q:5?O"JCN8UU>FT:WFQ_WU_.CS8_[Z_G6=16YXMS1\V/\
MOK^='FQ_WU_.LZB@+FHDT0SF1!_P(4_[1#_SU3_OH5C/]VHZQFM3U\)*])&[
M]HA_YZI_WT*/M$/_ #U3_OH5A45!TF[]HA_YZI_WT*DTB1'\;:#L=6Q+)G!S
M_ :YZM+PO_R/&B_]='_] -,#V^BBBD 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1_2?^?&+\J /)O[/B_O/^8_PI/[/B_O/^8_PKUEO#ND,,&QC_#(_K0/#VD@
M"QBX]<UWQQEE[VYY4\N;DW%Z'DW]GQ?WG_,?X4?V?%_>?\Q_A7K7_"/Z3_SX
MQ?E1_P (_I/_ #XQ?E5?7(]F3_9T^Z/)?[/B_O/^8_PH_L^+^\_YC_"O6O\
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MH_X1_2?^?&+\J?UR/9A_9T^Z/)?[/B_O/^8_PH_LZ(C&Y_S'^%>M?\(_I/\
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MI?\ A'=(_P"?"'\J/:(GZC/NCR/['&>"S?G3O[-A(X:3\Q_A7K7_  CND?\
M/A#^5(?#FD''^@QC'H2/ZU,I)G3AZ,Z5T]CR;^S(?[\GYBC^S(?[\GYBO6_^
M$?TG_GQB_*C_ (1_2?\ GQB_*H.H\D_LR'^_)^8JSH=JEOXWT+86.Z63.?\
M<->I?\(_I/\ SXQ?E7.ZSIUG8^,/"QM;=(B\\P;;W_=T =I1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'5-2_LNW2;[%>W>Y
M]NRTB\QAP3DC(XXJ]10!S%MXV@NY6C@T76G*2>7(1:@A&[AL-P137\<01W$<
M#Z'KBS2Y,<;6@#/CK@;LG%.\(?\ 'SXA_P"PK-_2C5_^1\\.?[ES_P"@4 69
M_%EG;6MM)+:7ZW-SGR[+R/WY )&2N>!QZ\U8T[Q#::A'<LT-S9M:J&F2\B\L
MHIS@GVX-9NG;3\0]:\['FBWA$&?[F/FQ_P "Q3_'F?\ A%Y,[O)\Z/SMO]S<
M,_TH 3_A-[%@9(=.U6>U!Q]JCM28OKG.?TK3O]?T_3M-AOII&,<X7R5127DW
M#( %4->O=6TW3OMNCKIC6$$&]A,'W$#ILV\8QBJ!N/MGB_P[<784++8-+$/X
M?-(!.,^U &QIGB2#4KW[&UCJ%G.4+JMW;^7N ZXY-/E\16,/B"+16\S[3(NX
M, -BD@D*3GJ0/2M21UBC:1V"H@+,3V KS&74VN=+NK]=(U8WTEV+Z&Z%J3$H
M0_(-V?N[!^IH ZN^\9P:?.T4^CZP!YODI)]F&V1LX&TEN<XX]:G/BRSAT]KN
M\M+^S_>"*.&X@VR2L?[JYYJAXHNH[[2= NHCF.;4;9U^A!-2ZEM/Q!T<7&/+
M%M*8-W3S.^/?% %_3/$D&I7OV-K'4+.<H75;NW\O<!UQR:JR^,[$3RQV=EJ.
MH+$=KRV=OYB _7(K0\1&8>&]2-OGS?LS[<=?NGI67IOVX>$=*/AT:?CR5,GV
MK?C./FQM[[LYH U%U_3SHG]KO*T5H,Y,B$,"#MQCKG(Q5.R\6VMY=P0-8:E;
M"<XAEN+8JCGM@Y/6N?N=5DUO1O#%]J"1I#-J&)P@(3(9@N<D\<=S7?T 9.K>
M(K'1;JTM[KS-URVU2@!"#(&YN>!DBJ^K^*H=&GF2?2]4DBB +7$5N#%R!_$2
M/7'UKFM0OXM2U'7/,TK4[R.2/[%;RVEMYB(%Y)SGKOY_ 5?O]2;5/A?<7,F?
M/$(CF!ZAU8 Y_+/XTP-6W\66DEK/=75EJ%A;PH',MW!L5L] N"<FBR\6VMY=
MP0-8:E;"<XAEN+8JCGM@Y/6L[Q!M-KX86?\ X]#=0^;G[N=ORY]NM=A2 R=6
M\16.BW5I;W7F;KEMJE "$&0-S<\#)%7;_4+73+.2[O)EBA3JQ_D!W-<+J%_%
MJ6HZYYFE:G>1R1_8K>6TMO,1 O).<]=_/X"GW&I#5+3PG/?']S]J,=T).GG*
M,#<#[@GGUI@;D?C.S=XR^FZK#!(P5;F6U(C.>ASGI^%7]7\06>CO%%*LT]S-
M_J[>WCWR,/7'I6;XAU77M'N%N(DTUM.::.)0X<S?-@'/('7/Z4FG;3\0]:\[
M'FBWA$&?[F/FQ_P+%(#5TG7(-7::-+:[MIH-IDBNHO+8 YP<?@:BMO$EC=ZO
M>:9"LQN+12S?*,/C&0O/)!.*MZMJ":5I-U?/@B&,L >Y[#\3@5P$&H?V;%HM
MRVE:K;S6DI^UW,]KLC=93\^6S_>(QF@#HW\<01W$<#Z'KBS2Y,<;6@#/CK@;
MLG%/N/&<5K!Y\^AZY'$%W,S6@ 09QR2W%)J__(^>'/\ <N?_ $"KGB__ )%+
M4_\ KB: &6GBRUN()KB>QU"QMHHO-,]W!L1AQ@*03DG/ %,M/%]I=7,,1T_4
MX(YW"13SVQ6-R>F#GO69K^W_ (1_PT)\?8S<VWVC/3;M[^U=I0!AZAXJL;&^
M:RB@O+ZZ09DALX?,9![]!5G3-<M=3MYY52>V^SG$R74?EM'QGG]?RK \)FZ/
MAW4#8_9CJYO)/.-SG&_=_%MYZ9Q[U3U35M5OO"?B.WO4MA<V;I$3:A@I4D;O
MO'/3/I0!L'QQI^&E2RU.2S4D&\2U)A^N<Y_2M76=9MM#T_[;<K(Z;@BI$ 68
MGT!(]S^%6+ 0#3K86V/(\I?+QTVXXKF-=U1/^$KMH6T^]OH+&(R2):0>;B1Q
MA=PS@87)_&@#6O/$D5K;VMQ%IVHWL-Q$)5>T@\P*/]KG@U7TSQ?;:H\9BTW4
MXK=PQ^U30 0J%!))<,1V(^M5O!]YOTB^TYHKB%K*1E2*X3;(L399-P]<9'X5
MCQ&4?!D^5G=Y;9Q_=\XY_3-,#=/CC3\-*EEJ<EFI(-XEJ3#]<YS^E:&J^(K'
M2)8H)!-/=2C*6UM'OD8>N*NV @&G6PML>1Y2^7CIMQQ7.:+G_A*?$WW/[1W)
MY7F_W-OR^^W.,X]J0&KI7B&WU6YDM1:7MI<(N\Q7</EDKQR.OJ*J3^,;&.YF
MBM[/4+Y8&VRRVEOO1".N3FJD&K:\VH:EI5^ECY\=@T\368?[QX RQ_I5[P5Y
M'_"(Z?Y&W!0E\?W\G=GWS0!H2:Q:1Z&=7+-]E$7F_=PQ'I@]^U4QXGMY-&AU
M.VL=0NHY7,?E00AY$(SG<N>.GKW%4/&%^JS:;IQMKFZ62;SYX;:/>[1ISC'H
M6Q^1J+POJ2GQ!JEF+2[LXK@_;(8KN+RVR>'P/3.#^= %FT\:07T_DP:-K)*R
M^5(WV48C;N&PW&.]2W/C"QANYK>WM-0OC =LSVEOO2,^A.153PUY@7Q.8L^9
M_:,^S'KCBK/@7R?^$0LC#C)W&3UW[CG/O_\ 6H TVUJS70VU@L_V41>9]W#?
M3![YXI^DZI;ZQIT=[;!UC<D;9  RD'!!'8UA>,+]5FTW3C;7-TLDWGSPVT>]
MVC3G&/0MC\C698ZD^[Q)9V]I>69N+>2\MHKJ+RWWE2'P/3."/QH VYO&-BMS
M+#9V>HZB86VR/96_F*I],Y%7X=>L)M&;56D:&U3.\RH5*D'&"/7-9&B"]'@S
M2_\ A'OL'F%!YOVG=MSCYON\YW5D7NK3ZUX=T6[U%(4A;552Y$8(3:"1SDGB
MF!T%IXOM+JYAB.GZG!'.X2*>>V*QN3TP<]ZMZSXBLM"DM4NQ*3<-M'EJ#M&0
M"S9(P.16M7 :EJ$&H:UK ETO4[V$0_8(I+2V\Q4(Y<YS][=C\A2 [^BL7PIJ
M+:EX=MI)<BXB'DS*PP0Z\'/OT/XUM4 %%%% !1110 5RO@[_ )"'B;_L*R?R
M%=57*^#O^0AXF_["LG\A0!U5%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445YKJ,7CG1=3N;VW=[FWDD9]D1\U ">!L/(P/
M0?C0!Z517GNF_$^$L(M6L7A<'#20\C/NIY'YFNST[6=-U9-]C>13<9*JWS#Z
MJ>10!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y#QWXAO_#\
M-BU@T:F9G#[TW=,8_G0!U]%0V<C364$KXW/&K''J14U !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKF?%/C*T\/QM!'MGU CY8@>$]V]/IU/ZUC>*?'GER'3-!/G73'8TZ#< ?1/4
M^_\ /L>%O ?ER#4]>'G7+'>L#G< ?5SW/M_/L 9>B^%M2\67O]KZ]+(ML_*J
M>&D'8*/X5_R/6O3K:V@L[=+>VB2*&,85$& !4M% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<KXD_P"1O\*?]=Y__1==57*^)/\ D;_"G_7>
M?_T70!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP-"&RL?"FD7LL#2BVC#3>7)(6"X'W5SR.E8?AZVN="UJW^V2,3K,!EEW?PW
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M15ADU"R5D>"5MHFC(/R@] >3C/'/M27%IK7BW2KS3=8TB'2K:6(A6^U">3S
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MTW6-8N[RV*O:P7=X&C# CID  XSCD5J>*=+U77-*T$QV?^E0WL,]S'YBCRP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM;^)KK6H;ZT.?-5[58F'!QMV^^.M4S=ZSK^IWD.E7T>G65E*86G, E>60?>
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M-)GSTO88I@>H=20<_EG\:U_$ZS6.JZ3KL=O)/#9M(EPD:[F".,;@/;FNGHH
MYZ'QKHUT6%I)-.$C:21UA8+&%4M\Q(&.F!UYK$T_P]K>JZ'),VMK;Q:GNGEM
MC9HX^?\ VB<],?2N\HH \\M+Z[B.DZ^UM+<"TB?3[](AN>,J?O8[]B:C#Z!J
M/BW2[O08Y);E[II;N15DP 03D[N!SGI7H]% '%VVIP^$M8U2#5A+%:WETUU!
M<B,LC;ARIP,Y&*Z72M7MM9MY+BT6;R5?8KR1E1)P#E<\XYJ_10!Q'ARQ?4_A
MD]E&<23+,J?[V\X_6I].\:Z;::;!::@MQ;ZA!&L3VQ@8LS 8XP,8./6NPHH
MXVX2_P#$/B<OI]\VGC38%7>]NLA$D@RPVDX!  !K-NM)OUDUCP_<78NY]1@6
M\@E\L1!Y$8;EP. 3@5Z)10!YWK.L^']9TOR]7M9XM9@A9(K=TD#+(1CC;P1D
M#K4Y@NM+T[POK!M)Y%L83'<Q*A+HCKC./:N]HH P]/\ %FE:M>QVNGO-<.X)
M9EA8+'@$_,2!CICOS5-6"?$J=F("C2023V_>"NHHH X;3-,U?6XKW5K?6190
MZE(Q\DVB2EHQE5R6/H.E4K?[;;VVGSK"]U/X=NI;:XCC'S-$PP&4?[M>C44
M>::O<>'M9U2SN='BFEU:2\B>;"2Y5!P<@_*,<=/2MR[O!X9\6WNH7T<HT[4(
MXQ]H1"PC=!MPV.1Q77T4 <=K%_'XKT>4Z(DL\EC+'<HS1E$E()^5<\D]>WI6
M/XEU3PYKUC)(]O<#75B$44#QR!T.<XP/E/4UZ310!QNI>?HVHZ-KDEO+);16
MGV:Z"+EH@0"&Q]>M6YO'.DO:74MB\MQY$#2&01,J ] "6 Y)('XUT]% '!#P
MGKC^&/LYUSY7C\\VOV-<^8?GQOSG.[O4VI:D-7TSPG?#[TNHP[QZ,,AOU!KM
MZ* .5\0M)I/B+3]>,$DUG'$]O<F-=QC!Y#8],U,?&VD307,ED\MPL$#2M((6
M5!CH"2!R3@?C7244 <%#X5UVZ\--$VN*J72&=[4V:'+M\^"^<YSW[4VUU66"
M[L/%#V\LUK/9_9;SREW-#(K<L1Z$C_/%=_10!YUIZZ'=>.-+N/#L4CJ#,]Y*
M%DV@E#C.[IR3T]16A8:M;^$M0U.QU82P6\]T]S;7'ELRN&QQD \C%=K10!G6
M.JP:QILUS;),(0656EC*[QC.Y<\XY_0URVEZ=+JWPF2R@YE>-R@SC)64L!^.
M,5W5% '*6WCO2UM4BN5NH]050KV8MV,F['('&/U%0-!J.O>)[Z[T[4_L"6"B
MT5S;K+N8_,_4\$' _"NRHH \YGTS4(X]6T$SBZO Z:G;/Y8C$IR-XVC@<]AW
MIOB/5_#NNZ=(US;7":XD/EQ6[QR!T?KC ^4\D]:](HH XJ]2XTAO#NM/;320
MVMJ(+J-$R\8*#G'L>M;6G>*M+U>]6UT]YK@E2S2+"P1,>I(%;=% '+02+%\0
MM3D=@J)IZ,Q/8 UG:7I&LZU8W6I1ZT+.'5'=W@-FDF4^Z 6)S]T"NZHH \ZM
M9+R"'2]0\B2YET.66RO(HQE]F,!@/85%?S>']6U_2[K1(II=2?4(I+E@DGRH
M#SD'@=NGH:]*HH **** "BBB@ HHHH *Y7P=_P A#Q-_V%9/Y"NJKE?!W_(0
M\3?]A63^0H ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:N4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?B%<ZII^G6U_IUY+
MJ/Y<RH>N>A_,8_&O+M0UG4=56-;Z[DG$9)0.>F>M>Z:UIRZMHUW8MC]]&0I/
M9NJG\\5\_NC1R,CJ5920P/8TT!N6GB;Q%++!:6^IW&YV6.-01U/ %>WV\;0V
MT43R-(Z(%9VZL0.I^M>0_#G2_MWB073KF*S3S#Z;CPO]3^%>Q4, HHHI %%%
M% !1110 4444 %%%% !1110 4455U+4(-+TZ>]N6Q%"NX^_H![D\4 4-3\3:
M?I.K6>G7+[9+GG=GB,= 6^IXK5GN(;6W>>>18XHQN9V. !7S]JFI3ZMJ4]]<
MG,DK9QGA1V ]@.*U[*XU?Q;/8Z'+?A88QA?,.!@=S_>8#I_^LT[ ;NN^+=0\
M37G]C^'XY1"_RLZ\-*._^ZO^3Z5U'A;P7:: BW$^VXU CF3'RQ^R_P"/7Z5J
M:%X?L?#]GY%I'\[?ZR5OO.??V]JU:0!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7*^)/^1O\*?\ 7>?_ -%UU5<K
MXD_Y&_PI_P!=Y_\ T70!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7E7QEC;=H\N/EQ,I/O\G_ ->O5:P_%?AJ#Q1I!LY7\J5&
MWPR@9VMCOZ@]Z )/"<JR^$-'9#D"SB7\0H!_45P?QED7&CQY^;]\Q'H/DJI9
M^'/B+X;#6NDRA[<DD>7+$R?@).GX"I+7X?>(_$.K)>^*+K8@QO7S TA&?NJ%
M^51_CTI@=).AC^#@4C'_ !+%/YJ#6%\&HU_XG$N/F_<J#Z#Y_P#ZWY5W?B/3
MI;OPG?:=80AI'MS%#&"%'L,G@5S?PS\.:MX?BU(:I:?9S,8S'^\5\XW9^Z3Z
MB@#FOC"!_;FGG')MB,_\"-=+XW_Y)7'_ -<K?^:U3^)/A;6M?U2RFTRS\^..
M$JY\U%P=V?XB*W/%.BZAJ/@!-,M+?S+P1P@Q[U'*XSR3CMZT <KX,$A^$OB(
M1YW;Y^GIY*9_2F_!L1?:M7)QYP2(+Z[<MG]=M=1\/-!OM%\-75CJUJ(I);EW
M\LNKAD*(/X21V-<G=^ ?$OA[6VO?"TOF1DGR\2*KJI_A8/PP_//I0!H_&,Q?
MV;I:G'F^<Y7UVX&?UQ4]A_R1!_\ KUE_]&-7'>,]$UZVL;;5O$5Z)KR>3REB
M!!$:@$]N!SV'%>C>"[*/4?AE:64V?+N()8F(Z@%W% '._!HCR]9&><PG'_?=
M9GQ@93XCLE!&X6@)'I\[46G@OQQX:U21M%9&5QM,\<D>UESQE7[_ ('':H];
M^'OBR[EBO)C_ &C>S F=A,H$?3:OS$9X]!@4 :/Q+\S_ (1+P[C/E[1N^OEK
MC^M.\,:?XZG\-V4FD:YI\-@5/E1N@++R<@_NSSG/<UVNJ>&HM=\)0:3>9BE2
M*/:XY,<BKC/OW'XUP%KX:^(?AQ);+2)0]JY)S%+&5^H$F"I^E &CI/@#Q);>
M+;?7+Z^T^1Q/YLYC9@S9^]@; .<GTKT^N \#^"]6T>^;4=7U"3>=VVVCF8J2
MW5G['Z<\\UW]( HHHH P/&W_ ")6K?\ 7N:XOX-F'R]7''GYB^NWYOZ_TKO/
M%-E<:CX7U&SM(_,N)H2J)N R?J>*\PT;P%XPTN%M1L7%CJ$;[1$94/F)CU!*
MGGLW%,#7^,GD_9-)SCSM\FWUVX7/ZXK1LO$5KX;^&6E7&HP_:&EC"10<?/R2
M,YZ #'-<]'X%\6>)=8CN?$TWE1+@,S2(S;?1%3@?I^-=CXS\'?V_H%M9V#)#
M+9?ZA&X0KC&WVZ#\J ,73-9\9ZS8(^A:+INFZ<^3$[_[QR0,^IZ[>>:Y/X=B
M0?$2(2L&D'G;F'0G:<FMC2O#OQ$@M?['2Y^PZ?R"YEC;:">=I&7'K@8_"IM
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M /HN@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8QG)QN)S\I/3Z=: .?\ !O@[_A-?MFJZO?7&P2["R,-[O@$DD@X !':M;3_
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MCBKV^@ HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>7>.9GUWQA8Z);MD1$(2.S/@L?P
M7'ZUZ5>W<5A8SW<QQ'"A=OH!7G/P]M)=6\0W^OW0R59MI_Z:/UQ]!Q^(I@=Q
M>>&M%U"W2&[TVWE5%"*Q3#  8 ##G]:U%4(BHHPJC %+12 **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N5\
M'?\ (0\3?]A63^0KJJY7P=_R$/$W_85D_D* .JHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0D $DX
M Y)H 6BO/=5US4;R]=K>>:&W!Q&L;[>/4X[U0^WZM_S_ -W_ -_V_P :ZUA)
M-7;//EF%-.R5SU&BO+OM^K?\_P#=_P#?]O\ &C[?JW_/_=_]_P!O\:?U27<7
M]HP['J-%>7?;]6_Y_P"[_P"_[?XT?;]6_P"?^[_[_M_C1]4EW#^T8=CU&BO*
MWU;4HVVMJ%T#_P!=V_QIO]M:A_T$;O\ [_-_C7-4AR2M<[:53VD>:UCU:BO*
M?[:U#_H(W?\ W^;_ !H_MK4/^@C=_P#?YO\ &H-#U:BO*?[:U#_H(W?_ '^;
M_&C^VM0_Z"-W_P!_F_QH ]6HKPK5O$NM-<&&WU.]C1."5N&!)_.L[^WO$/\
MT&=1_P# M_\ &NB.&E)7.>6)C%V/H:BOGR+6O$4LJ1C6=1!8XS]K?C]:ZB#5
M-0@B5#JM](0.6>X<DG\ZBI2]GNRZ=7VFR/6Z*\I_MK4/^@C=_P#?YO\ &C^V
MM0_Z"-W_ -_F_P :R-3U:BO*?[:U#_H(W?\ W^;_ !H_MK4/^@C=_P#?YO\
M&@#U:BO*AJNJ.#LO[L_]MF_QI/[0UC_G_N__  (;_&K4&T<M7%1IRY3U:BO*
M?[0UC_G_ +O_ ,"&_P :/[0UC_G_ +O_ ,"&_P :?LV9_7H]CU:BO*?[0UC_
M )_[O_P(;_&E74=5WX;4;L=S^_;_ !H]FP^O1['JM%>=Z?K][8W2R2W$T\.?
MWD<CELCVST->A(ZR(KH0RL 01W%3*+1T4:T:JT'4445)L%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!4I\R]A)XPC@?F#_ $J)K0Z<'*U6W<ZZBBBL3U@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N5\2?\
MC?X4_P"N\_\ Z+KJJY7Q)_R-_A3_ *[S_P#HN@#JJ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "H+R[M["SEN[J58H(5+.[= *F)
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MZAXABT^\:V:!W*@'(([BM>-_,B1P,;E!Q13Q%*I.4(.[CN$J4X14I+1G*_\
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M\('LHQ^E '9^$="&@Z#% Z@7,O[R<_[1[?@./SK>HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
ME?!W_(0\3?\ 85D_D*ZJN5\'?\A#Q-_V%9/Y"@#JJ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/@KPN- T[SKA1]ON!F0_W!V0?U]_I74T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<KX._Y
M"'B;_L*R?R%=57*^#O\ D(>)O^PK)_(4 =51110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-W_R)2_]<H__ $(5R%=?=_\ (E+_ -<H_P#T(5R%<.;_ !T_\"_4Z,#\,_\
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M9CZ?_P E2UC_ *\8OZ5U]<AI_P#R5+6/^O&+^E=?7M'GA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R_B
MWQA;^'X&MX"LNHNORQ]1&#_$W^'>@!/&/BV/0+3[/;,KZA*OR+U\L?WC_05D
M>!O"D@D&O:J&>YD)>%).2,_QM[GM^?TK>$/"5QJ-Y_;VN[G+MYD<4HYD/]YA
MZ>@_IU])I@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE?!W_(0\3?]A63^0KJJY7P=
M_P A#Q-_V%9/Y"@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9^K_ #-F+_D49_\ KZ_H*QJV8O\ D49_^OK^@K&IXO:G_A7YL*.\O4ZCP?\
M\OO_  #_ -FKJ*Y?P?\ \OO_  #_ -FKJ*^LR?\ W*'S_-GB8[_>)?+\C@+[
M_D89O^OC^M=_7 7W_(PS?]?']:[^N7)OXE;_ !?YF^/^&GZ?Y'.>+O\ CUMO
M]\_RJQX5_P"00?\ KJW\A5?Q=_QZVW^^?Y58\*_\@@_]=6_D*(?\C>7I^B"7
M^XKU,'Q+_P AN;_=7^0KM+7_ (](?^N:_P JXOQ+_P AN;_=7^0KM+7_ (](
M?^N:_P J,L_WS$>OZL,7_ I>GZ(Y+Q;_ ,A6+_K@/_0FK!K>\6_\A6+_ *X#
M_P!":L&OG\R_WNIZGI83^!$Z]_\ D2A_UR'_ *%5KPU_R!(O]YOYU5?_ )$H
M?]<A_P"A5:\-?\@2+_>;^=?1X?\ WNG_ ->U^9Y=7^!+_&8^G_\ )4M8_P"O
M&+^E=?7(:?\ \E2UC_KQB_I77U[1YX4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 455U#4K/2[5KF]N$AB'=CU/H!W
M/L*\WU7Q7J_BRZ.EZ#;RQV[<,PX=QZL?X5_SGM0!M>*_'D=@6L-(*SWI.UI0
M-RQGV_O-^G\JK>%? \C3C5]?#27#MYB02')SUW/ZGV_/TK6\+>"+300MS<[;
MG4,??Q\L?^Z/Z_RKJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y7P=_R$/$
MW_85D_D*ZJN5\'?\A#Q-_P!A63^0H ZJBBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KE?$G_(W^%/^N\__HNNJKE?$G_(W^%/^N\_
M_HN@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "N0\1ZE=:OJ/_  B^
MBR%)G&;^Z7I;1'M_O'_/J+OBC7YM/$.F:6HFUF]^6WC[1CO(WH!_GH:M^'-
MA\/Z;Y"N9KF5O,N;AOO2R'J3[>G_ .N@"YIFFVND:=#8V<8C@A7"CN?4GU)Z
MU;HHH **** "BBB@#E?AO_R(.F?]M?\ T:]7/%O_ ""HO^NX_P#06JG\-_\
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M8U/%[4_\*_-A1WEZG4>#_P#E]_X!_P"S5U%<OX/_ .7W_@'_ +-745]9D_\
MN4/G^;/$QW^\2^7Y' 7W_(PS?]?']:[^N OO^1AF_P"OC^M=_7+DW\2M_B_S
M-\?\-/T_R.<\7?\ 'K;?[Y_E5CPK_P @@_\ 75OY"J_B[_CUMO\ ?/\ *K'A
M7_D$'_KJW\A1#_D;R]/T02_W%>I@^)?^0W-_NK_(5VEK_P >D/\ US7^5<7X
ME_Y#<W^ZO\A7:6O_ !Z0_P#7-?Y499_OF(]?U88O^!2]/T1R7BW_ )"L7_7
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ME?\ A#KO_H:]<_[_ (_PH_X0Z[_Z&O7/^_X_PKJJ* .5_P"$.N_^AKUS_O\
MC_"C_A#KO_H:]<_[_C_"NJHH Y7_ (0Z[_Z&O7/^_P"/\*/^$.N_^AKUS_O^
M/\*ZJB@#E?\ A#KO_H:]<_[_ (_PH_X0Z[_Z&O7/^_X_PKJJ* .5_P"$.N_^
MAKUS_O\ C_"C_A#KO_H:]<_[_C_"NJHH Y7_ (0Z[_Z&O7/^_P"/\*/^$.N_
M^AKUS_O^/\*ZJB@#E?\ A#KO_H:]<_[_ (_PH_X0Z[_Z&O7/^_X_PKJJ* .5
M_P"$.N_^AKUS_O\ C_"C_A#KO_H:]<_[_C_"NJHH Y7_ (0Z[_Z&O7/^_P"/
M\*/^$.N_^AKUS_O^/\*ZJB@#E?\ A#KO_H:]<_[_ (_PH_X0Z[_Z&O7/^_X_
MPKJJ* .5_P"$.N_^AKUS_O\ C_"C_A#KO_H:]<_[_C_"NJHH Y7_ (0Z[_Z&
MO7/^_P"/\*/^$.N_^AKUS_O^/\*ZJB@#E?\ A#KO_H:]<_[_ (_PH_X0Z[_Z
M&O7/^_X_PKJJ* .5_P"$.N_^AKUS_O\ C_"C_A#KO_H:]<_[_C_"NJHH Y7_
M (0Z[_Z&O7/^_P"/\*/^$.N_^AKUS_O^/\*ZJB@#E?\ A#KO_H:]<_[_ (_P
MH_X0Z[_Z&O7/^_X_PKJJ* .5_P"$.N_^AKUS_O\ C_"C_A#KO_H:]<_[_C_"
MNJHH Y7_ (0Z[_Z&O7/^_P"/\*/^$.N_^AKUS_O^/\*ZJB@#E?\ A#KO_H:]
M<_[_ (_PH_X0Z[_Z&O7/^_X_PKJJ* .5_P"$.N_^AKUS_O\ C_"C_A#KO_H:
M]<_[_C_"NJHH Y7_ (0Z[_Z&O7/^_P"/\*=:^#?)U:SU"YUO4[U[1F:-+B0,
MH)&#VKJ** "BBB@ HHHH **** "BBB@ HHHH *YG6O$=VNJ#0]!MDNM4*[I7
MD)$5LOJY'?V__5717$PM[:6=AD1H7(^@S7,^ +7;X<&I2_->:E(]S._<DL<#
MZ =O<T -7PWXBG'F7?BZX68\[;>W147VQWJG?:OXF\(6\D^IK'K6GA3BYB01
M21MVWJ.-N<#(]?PKL_M$7VAH"X$BH'()[$D9_2AEAO+4JZK+!,F"&'#*1_A2
M4DQM-'.^$M'DBB?7-1E2YU34%#O*IRL<9Y5$/IC'3^E=,V0I*@%L< G KE?
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MOA?'N\W5K]Y6/)2 8!/NQY/Y"NSTW0],TA-MC910G&"X&6/U8\UH44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ' ?%3_D&:?\ ]=F_E78Z-_R ]/\ ^O:/_P!!%<=\5/\
MD&:?_P!=F_E78Z-_R ]/_P"O:/\ ]!% %ZBBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNK_ E_C,?3_^2I:Q_P!>,7]*Z^N0T_\ Y*EK'_7C%_2NOKVCSPHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#@/BI_R#-/_ .NS?RKL=&_Y >G_ /7M'_Z"*X[XJ?\ (,T__KLW
M\J['1O\ D!Z?_P!>T?\ Z"* +U%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'8V&O^5;1DE4^QQMC)R>3D]35@ZUXM'_ #,?_DC%_A7T57%X2M!TY2T?D_\
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M )2XO\: +VMZ)/J=S'+%+&@5-I#9]:S/^$2N_P#GX@_7_"I?[!\6_P#0Z?\
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M?_H(H O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &!XEN[NWC2"((8+Q'@+
M-QM<@[0#[YQSZ=JOZ+??VAI4$SMF8+LFXP0XX.1V]?QJ34[.'4-/EM9V"K(,
M!C_">QK(MM2_LH/"=,N95+DO<6Q$HE;H6;'W22.E<,G*E7<Y/W6OZ_KS.V*C
M5H*$5[R?]?UY$GBJ]:WL4MXWVO.2&Q_='7\^/UKC57<P%7]:OEU#4WFC8F(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<!\5/^09I_\ UV;^5=CHW_(#T_\ Z]H__017'?%3_D&:?_UV;^5=CHW_ " ]
M/_Z]H_\ T$4 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD_PH_P"%>^(O^@U'_P!_9/\ "@#TVBO,O^%>^(O^@U'_ -_9/\*/^%>^(O\
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M_P"@U'_W]D_PH ]-HKS+_A7OB+_H-1_]_9/\*/\ A7OB+_H-1_\ ?V3_  H
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MOB+_ *#4?_?V3_"@#TVBO,O^%>^(O^@U'_W]D_PH_P"%>^(O^@U'_P!_9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !69XBTEM<T&ZTQ9A"9P%\PKNVX8'IW
MZ5IT4 <9I'PQ\/Z;M>XC>_F'.9S\N?\ =''YYKL(88K>)8H(DBC485$4*!]
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MR>S#_'I^->=D9!![UX>/H\E6ZV9PUH6?J40:#TI'4QN5/;H:3-<%CEN1DX-
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M]>9Z<JL)4%"VJ?\ 7]>1+11172<P4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA548  P *;YT1E\L2)YF,[=PS^5?24:<:,%!'HPC960^BBBM1A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!DZKJUQILB 6MO)&^=K/>+$>,9X8>_8FJ</BC=;W4DMK&)(
ME!CAAN%E,AY_N],<>O&?2MJ>PL[I]]Q:02N!C=)&&/ZTL%E:6K%K>UAA8C!,
M<87C\*Y94Z[FVIV7R_R_4ZHU*"A9PN_G_G^AR%MIDNKW\JS2AKA2S7<RY*QM
MC"QJ,\XQS],9K.O]-N=.F$=P@&[[K*<AOI70^'M4>>Z6U-M#"&CD:78A!,P?
M!SSS\I4_6NCEACGB:.5%=&&"K#(KBIX2G7I<T7K_ %_7J1F%*]756?\ 7]>A
MY9)"DO48/K51[=TYQD>HKM]0\)G)DL'&.3Y4AZ>P/^/YUSEQ;S6LS0SQLDB]
M0:X:N'J4G[R/)G2:W,:BM!X4?J,'U%0M9G^%OP-8F+@RI@4;14QMI1_#GZ&F
M%&7JI'U%!-F,VBDVBG447$)M%&!3Q&[=$;GVJ06TI[ ?4T#LR&BK:V@_B8_A
M4RQH@^50/>@I095CM6;E_E'ZU;2-8QA15RRT^YU"4I;1EL?>8\!?J:GMK9;*
M^,M]&&AM)Q'<H5)V@CY']U)_IZU:IMV;V?4Z\/A)U7:"'Z5HEQJ9#C]W;AL,
MY[_2NULK"WT^ 0VZ;1W8]6/J34RO$KB%60,%!" C(7L<>E/KWL/AH45IJ^YO
M&FH!5>ZLH;T0B= ZQ2"0*>F0#C^=6**Z7%25F:*3B[HKV5G#86PM[==L2DE5
MSG&23_6K%%%$8J*LM@E)R=WN%%%%,04444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 85EH)
MM;YKT2-YPN97";L(4<XQWZ#GMS^=;M%%9TZ4:2M$TJ595'>05'+#%.FR:))%
M]'4$5)6-K.N2Z9@1V3/G@2RR+&F?0$]3[<45:D*<>:>P4Z4JLN6.YGZOX=L;
M6RN+R.9X1&I;:QROL!GGD\=>]8B:1?2S211P%Y(E0R*#C86&0.>_TK9MI+OQ
M% MO+(6A$XEEE6';$R#_ )9KGEN<<GW]!FSHE_;VI,-S<(;N\N968H24W@@;
M<G\,#W'J*\J5.E5FFERQ?]?JOQ-9X""@U]I=OZ\G^!RLUI<VPS/;RQ \ NA
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M?7\_T9Z.&<(0G-O6VGY?JB/4O#=S,4\G[)<Q1QB.-+A61D4#  9#\WX\5?\
M#ME-9VLB7-O-%+NZR3"1<=@N#P/K^9[;-%7#"4X5/:1W_KYF<\74G3]G+;^O
MD%%%%=1S!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g4bdklltl5z5000017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# L$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BLSQ!JE
MQHVBSW]MIL^HS1%<6T'WWRP''TSG\*XG_A9VN?\ 1/=:_/\ ^QH"YZ317FW_
M  L[7/\ HGNM?G_]C1_PL[7/^B>ZU^?_ -C3LQ71Z317FW_"SM<_Z)[K7Y__
M &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU
M^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871Z317
MFW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?
M_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGN
MM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT
M5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?
MG_\ 8T?\+.US_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)
M[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I
M-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K
M7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^
MB>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871
MZ317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>
MZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\+.US
M_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%
MT>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_H
MGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM
M<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19
MA='I-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871Z317FW_"SM<_
MZ)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL
M[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T
M6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7
M/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.US_HGNM?G_\ 8T?\
M+.US_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'_"SM<_Z)[K7Y_P#V
M-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\ ]C19A='I-%>;?\+.
MUS_HGNM?G_\ 8T?\+.US_HGNM?G_ /8T6871Z317FW_"SM<_Z)[K7Y__ &-'
M_"SM<_Z)[K7Y_P#V-%F%T>DT5YM_PL[7/^B>ZU^?_P!C1_PL[7/^B>ZU^?\
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M^.+=#&Q$ASC&X# .?4]Q7%_#[QO<:SX@U#0[C58]72*(7%MJ"VQMRZY 963
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M52X\0:KIJVD46T6NGQ$B=N?F=G7*XX.%.#CMWZJBBP784444Q!1110 4444
M%%%% !1165XCU^U\,:'/JU['-);PE0RPJ"QW,%& 2!U/K0!E>./"!\6:?;&V
MO&LM2L9/.M+@9^5O0XY )"\CD8!YZ5R__"!>,_$&H60\7^(;2XTZUE$PBM4P
MS,,<<(@Z9Y.<=AS4T?QR\+O(JM::J@8@%VACPON<.3^0KT:UNH+ZTAN[:198
M)D$D;KT92,@U.C*U1Y)9PZZ_QA\4RZ!<64=U'$FZ.]1C%(I"=2IR".H(^E:$
MWPQU)_!&IV!OK6;6]4NUNKJ=RRQY#9P"%)[L>G?M7I$6G6,%[->PV5O'=S#$
MLZ1*'D'^TP&3T'6K-'*',<'=^!;F]\:Z!JUQ]BEL-/L/LUQ#(26=MK@%1MP1
MEE/)'2J47PTNV\-ZQX9N+V'^RI+G[1I<BEFEMSG.U@0 1VX/<GOQVPUC/B Z
M3_9NH\1>9]L\C_1_]W?G[WMBM.G9!=G(:%I_CA;^U;7-7TU+&VB"M#81%FN6
MQC+LZ_+Z_+C/H*Z^BBF)L****!!1110 4444 %%%<WXN\;:;X,BM9-1@NY5N
M694^SHK8VXSG<P]: W-37K&75/#NIZ? R+-=6DL",Y(4,R%1G&>,FO--,\'?
M%#1M+BTW3_$>DP6D0(2,+G;DDGDPD]2>]:^F_&7P[JFJ6>GP66J+-=3I C/%
M&%#,P49PYXR:UO%/Q'\/^$KI;2]DGGNR 6@M4#,@(X+9( ^F<\@XQ4Z/4I76
MAS-Q\*K]/!.GZ-:7UO)>)J(O[J69F5"Q3:0N 2>W7&<$\=*Z6'PK?1_%"X\3
M&6W^Q268@$89O,W?+SC&,<>M7?"OC71O&%O(^F2R++%S+;S+MD0$D \$@@X[
M$^^*Z*FD@;?4\]L?AW<.GC.WU*XM_L^O7!F@:$EFB^=W4L"!R"RG /8\UC:M
MX \<ZSX5L]!NM4T;[-8L@AV>8&E500"[;>JC   YR<G(&?6ZR-<\1V>@-81W
M*32S7]PMO!# H+,Q[\D<#C)]Z+(%)F&OA&_'Q(U+Q%YUM]CNK#[,B;F\P-A!
MDC;C'RGO6;I?@+5;+X6ZAX8EN+,WMP[,DBNWEC)4\G;GMZ5Z+61XE\16?A;1
M9-4OHYY($=4*P*"V2<#J0/UHL@NSSGQ'I*>'(_!LC:W8Z?K^GQ"")KE)#;3@
M8# N%^4#=WQPW;K2>#7NM1^,6H7TU_::@ZZ</.N+'FW1CLPB')R!Z]3@^^.U
M@U_P]XK\&RZW<V*SZ; ))7AO($<J8P<_*21G'3GO6)H'Q"\*KX?U:_T?1+FT
ML]/:)[F*&UBC+>82H8!6P<;><]O6EI<=W8]$HJ.WN(KNVBN8'$D,R"2-QT92
M,@_E4E40%%%% !1110!Y#I/@7XC^'TN8=&U[2;:WGG:9D(+Y8\9^:(]@*V+C
MP;XJU2Z\*7FKZC87-WI-Y)-<R*2N]"\94( @!.$/4#M7HU%+E*YF>>>//AU/
MXL\0:=J%K<0PQ*H@OE=F4R1!PPVX')^]UQT7FM7QAX2N=9ETO4M&N(+75=*D
MW6_G*?*=3C*-CD#CL/4=\CKJ*+(5V<_X=M/%$=Q=77B/4[.7S,"&SL8L11 8
MRVYAO)/H3@>^>-?4;&'4],NK"X&8;F)HG&.S#%8/B[QWI/@LVBZC'=2O=;BB
MVRJQ 7&2<L,#G^=='!-'<V\<\+AXI5#HPZ,I&0:/(-=S@?AM\/[SP?-?76IW
M%O<7,RK%$T#,P2,<D?,!U./RI_\ P@^I_P!M>,KSS[3R];LW@MAO;*,4V@O\
MO SZ9KOZ*+(.9G):+X1FMOAJOA:_GC$K6\L+RP991O9B",@$XW#TKC[SX=^-
M;[P;;^&Y=2T5;2SD#0[!)NE&6/SMMXQG@ <]SQSZ[119#YF<7KNA>*KB9%T^
MZT6^TUX5233M7MMT4;KMPRE5W-D@GYCQGOQBSX#\(R>$M+N8[B>*2ZNYS/*M
MNNV*,]E0'G _#Z<5U=%%A7TL<AJWA6^O_B/HOB**6W%G8PM'*C,WF$D/T&,?
MQ#J16+?_  TG/Q-M/$VG2VL=IYRW%S"Y8-O_ (BH"D'/7DCDFO2:*+(.9GG4
M7@_Q7X>O]53PKJ6EQ:=J,WG_ .F(QDMG).=@ *GC'WO0<=2;OBOP;J^L0:!=
MV>J0RZQH\OFB:[CV1SL2I)(0?+R@X Z<9[UN7?BJQL_%]CX:DBN#>WL+31NJ
MKY8 #DY.<Y^0]CVK'\2_%#PYX8U#[!</<75TO^MCM$#>5[,6(&?8$GUQ2T'J
M5-'\(>(T^(2^)]9O=.FW6IB>.U#KY9Q@*H(Y7ODG//2LRP^'OB33O#6O>&X[
MK2I-.OF>6WE9I!,)"4 W_+@+M0Y R<GKBNV\,>+-)\6V#76ES,WED++%(NUX
MB>@(_J"1P>>#6Y3L@NSA]5\$7FI_#"T\,_:XHKRWAB&\$F-V3L>,[3ZX]#BL
MJ#P-XGEUWP[J=]<:)''I+",6EDCQH(^[ D<N<GC ' ]37IM9&I>([/3-:TO2
M9$FEO-19A$D*@[0HRS-DC"@?7H?2BR!-G'Q> -52T\;Q&XLMVO3F2U(=L("[
MM\_R\<,.F:SM=^'/B?4]&\/:7%=Z6UIID"^;!-)($EE!.3\JY*[<#L>3TKUB
ML#Q9XNL/!VG0WVH0W,L4LPA46ZJS X)YW,..#2:0*3.7UWPEXO\ %7AF32M4
MGT*T,,D<MHM@)0A*A@5?<.%P1C /(Z4EIX*\2MXOT+7=0N-%5-/1H#:62/''
M''M(&S(Y/S'@X P,5U'_  F&F?\ "&?\)3B?^S_*\S;M'F?>V[<9QG/'6LFT
M^*&B7?AZ77%MM02RANDM92\:90L!\Q 8_*,CIS[4:#NS/M/!'B#3=1\3Q6MS
MIDFEZV)V)E,@F1G1]HX&W 9\'KP,^U(OPWO'^'ND:.]]#!K.E3/<6US%EXPY
MD9@#D X.5YQP1WZ'T96#*&4@J1D$=Z6G9"YF<+8^$]?U/Q38Z[XKO-/8Z<I%
MI:Z>K["QZNQ?G/3@>@Z8(+/#W@G4M)\/>)]/N)[1IM5>9H#&[%5WH5&[*C')
M[9KO:*+"NSG_  1H5UX:\'V&D7DD,EQ;^9O:$DH=TC,,$@'HP[5T%%%,1+;?
M\?"_C_*M"L^V_P"/A?Q_E6A6<]S:GL%%%%0617/_ ![M^'\ZSZT+G_CW;\/Y
MUGUI#8QJ;A1115D!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7#_%W_DFVI?[\/\ Z,6NXK#\7>'?^$J\-7.C_:OLOGE#YOE[]NU@W3(]
M/6D]AK<\@U+Q'XQET#3?#6L6>D:9IVIVT<-O>SABI0 ;265F"D_+U7C.3@<C
M9\2WE[X=O/#?@FUN-7^RQ60EN7T=/]*F/S#"=P,H2?8]\5WNM>#;37/!D7A^
MZD&8(42&Y\OE'1<!P,_F,]"1FLJ?X?7<UEH\J^(9(M<TE3'!J26P):/IM="Q
MW<$C.>YSG-39E71SVD^*/$>B^&/$SW5MK!M[*,2:9<:Q;E9OF;&')X<@D'K^
MF ,?7H?$&E?#.P\11^+-8>ZOVC>X1KDA%#Y9?+QRF. 0#@_@!7HB^&I+#PSK
M*:WJ.J>()+N)VG5."5P?EABSM4^PZD#V%>.WTL&L>%K'0=*\0ZEJLXN0MEI,
MECY30+\^2[#(? Z?-\H)X Z#&M3T:#5[Z/XNFV>]NGLTT@3&W\UBA;:#G;G&
M??%9.EKKWBSPIJGC!_$VI65W$TLEK:6TNVW01C<%9/XL],_GGI7;P>#1%XX7
MQ(;T,!9"U-MY7H ,[L^W3%9$GPSN($O=/TGQ-=:?H5\Y:?3UMU<X/WE20G*@
MCCH>.N:=F*Z.7U7Q3KNNV/P^N;34I].NM1GEAG:!B$=EDC3<R=&'4X((Y(K<
MT*34=!^+4OAXZSJ.HV$]CYP%_-YK(W7(/;OT X/.<"MR_P#A_:SW/A<V5U]D
MMM E+I"8]YE!9#@MD8.4ZX/6KA\)9^("^*OMWW;7[/\ 9O*_7=G],46871TM
M%%%40%%%% !1110 5Y7\8GNH[_PF]C&LMVM\3!&Y^5GRFT'D<$X[BO5*Y'QQ
MX)D\8C3C#JK:=+8R-(DB0[VR<8(.Y<$;>M)[#B[,S]$U;XESZU:Q:SX>TVWT
MYGQ/+%("RK@\C]Z>^.QK.^&D<5QXQ\8WETJOJ:7S1AG^^D>YN!Z#@#\!5BR^
M'/B.UO[>XE^(6JSQQ2J[0L),2 $$J?WIX/3I5WQ)\-H]6UIM:T?6+O1-2E&V
M>6VSB0?0,I!.!GG!QTSS2U*NCH;73O#]AK.J:C:PVD>HLH:^D0@NJD9&X?P@
MXSVW8SS26_BO1[G3)M26>>.QBB$QN)[2:)&0]"I=1NSV"Y)R/6N:TOX>Z;X:
MTG6+K4M3O;V\O;>2.[OPA,JQMG=L7YCGU/S'BN9U'#:=J-IX?N[G4/#=I;64
MS,9FG6-DE4LH)SC$8#%!PN.@HO85DSUC3=6LM7ADELI6<12&*17C:-XW'4,K
M ,#R.H[UPFM%K[XZ:!:R\P6=B\Z*?[YWC/Z+^5;'@YQ>>(?%6IV\BS6%S=Q+
M!,A!20I$%8J1P1GC(]*S?%\!TKXC^%?$9!^SNQTZ=NR[PP3/MEV_*A[ MS*@
MM]5\1?%+Q)I3>(]5LM/MT1A%:7!5NBX"DY"C.<X'/XUS6KZQJ5S\._$^B:G>
M/>RZ/J<=NES)RSKYC#D]3RA///-;@T^23XE^(+ZS\03:5>NJB+RK43X7"@K(
MA[DC"CN0"#RNZ^_@G3/^$+NM"_M&]2ZN[A9[R_FM"[&8'(0J&^\>P!.<]3N7
M.?/'N=2PU;^5G(BYDTC1M3\'1,5EUB2P:V &2?.1?-/_ (Z!^-:O@'3X-GQ(
MT[8/(&80O7 'G@5TUUX9TRY\5Z'KDEU<Q'2H$@DA^QGYI$SL4D'Y6R>  P.!
MS\RYISV=MX0T?QQK:7LLLFI@OY,EOY9MY6+A4)W'<<R]NPST(--2BWN3*A5C
M&[B;?PGO)+SX=:=YART)DB!]@YQ^F!^%=K7.^!-%?0/!6F:?,I6=8O,E4]0[
MDL0?IG'X5T5:+8YGN%%%%,04444 %%%% !113)5D:%UB<)(5(5RNX*>QQW^E
M 'AVOZWX>UGXC:]_;VH?9[2ULGT^S)B=\2\AF&T'&"7^O%;'A'4+WQ+\';W3
M[&]G@U73%,<4EO*R.0OSI@CG!&4_"NI\-?#;1M%TZ2#4K>SUBZEF:5[JZLU+
M'../FW8''KW-3Z#X(B\.^+-2U;3[I(K&^0*=/2W"JC#&"&!]=W&W^*ILRVT<
M:GBF^\8-X*TK3[^Y@FG7[1J<D$S(^V/Y6!(QPQ5_S6LO4/$>L>(->\0-'+XK
M7['*UO81:)%F&,J6 ,V#DY(!]>O.,"N_\*?#NT\*^(M3U:&Z\T7>5AA\K;Y"
M%MQ7.3GL.@Z5#?\ @"^75]2OO#WB6?1EU,9NX5MUE#.<Y922"A.2<CG).".
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ML.O7JMNM;S6)YK9Q]V2/Y5W*>X)4X^E9>H0-HGQFT_4V!^SZQ9O:%\\"5<$
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M=SC)*@@#/KBK^L:Q8:!I4VIZG/Y%G!M\R38S;=S!1PH)ZD=J?.Q<B(/+NO\
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M7_/HW_?:_P"-'EW7_/HW_?:_XUJT4<[#D1E>7=?\^C?]]K_C1Y=U_P ^C?\
M?:_XUJT4<[#D1E>7=?\ /HW_ 'VO^-'EW7_/HW_?:_XUJT4<[#D1GVR7 N%+
MV[(O.264]O8UH444F[E));!1112&%%%5=26\?2[I-.:);UHF$#2DA%<CY2<
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MC<,<9 !&X 8Z9(/%N'X21R^ [[1]0U 2ZM?W O9KU4^5)_11QE1EAV)W$\<
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M-I"L*%SDD*,9/O5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2F93YZ#[)*1_=9@3TVG .1LYRM<IX-L/C'X'T,Z3IGA+3);<S--NN;B-FR0
M>5G QQZ4 8=A$4_9J\0RI=K);S:DC06WFAVMT\V,;7_NDXSC X(/\5=C??!_
MPA<?"W^T[73WM=3&E+=BY6XD;,@C#G*LQ7!/!X[\527X9^+&^&GBM;JU@;7M
M>O(;G[!!(BI$%EW'YB0H/+< G@#DG@2O;?&C5?#B>%I-"TG3;&2V6S>\\]=R
MQA=IR1*_4#!PA//&* /1/A=K-WK_ ,-=$U&^E:6Y>)HY)'.6<H[)N)[D[<DU
MU]9'A?0(/"WAC3]$MY#)':1!/,(QO;.6;';))..V:UZ "BBB@ HHHH ****
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M!\+^$=-T9I%DDMHL2.OW2[$LV/;+'%;E !1110 4444 %%%% !1110 4444
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MYX7\.:Q#JD+7UW<0'="+N566-NS *JY([9R/QP:H?'C_ ))['_U_1?\ H+T
M9>IZW\1?"&D#^U]7T[4+[5I8[33O*C \AVSN<CRUS@8QG(R>01P>@T#7M?TG
MXAR>$/$.I)JOVBT^UVEX+98&]"I5>,?*_/7CWXH_%V-X-'\-:N49K73M1AEN
M"HSM4XY_,8^I%1PW5MXE^/EK?Z3<17=GINDE9KB"0/'N8O@!AP3^\''L?2@"
MF?BK>:[\1M#T_0_.@T*6=HGFD@ ^V$=2-PR ..F#SSV V/$>O^(]0^)$?A+1
MM5BT6*.S-T]T]LLS2GT ?C'T]&Z]*H^,[>&U^*_@&WMX8X88MZ1QQJ%5%&,
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M##$H2..-0JHHZ  < 5#;:986=S<7-K8VT%Q<G=/+%$JM*>>6(&6/)Z^M6J*
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M;WL][!96T5W. )ITB59),=-S 9/XU:HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *K:A;O=Z9=6T94/-"\:EN@)! S5FB@#G/#'A.ST
M72-+6ZL+"35K2U2![R.$%R5&.'(#8K6U#1],U9$34M.M+U4^Z+F!9 OTW U=
MHH K/IUC)!!"]E;M%;NLD,9B4K$R_=91C@CL1TI\EI;374-U+;PO<0!A#*R
MO'NX;:>HS@9QUQ4U% &;/X>T2ZNI+JXT?3YKB52DDLELC.ZGJ"2,D>U3_P!E
MZ?OD?[#:[I(1;N?)7+1#HAXY7D\=*MT4 59--L)=/73Y+*V>R555;9HE,8"X
MV@+C&!@8],"N7U[0=?O-7DN(;?P[JEJ<-;+JUN=]HV.=I53N!//.#VS7944
M8OA703X<T)+*2X^T7#2///,%VAY'8LQ [#)P/I6U110 4444 %%%% !1110
M4444 %%%% !1110 4444 (<XXQGWIN9/1?SI]% #,R>B_G1F3T7\ZX+Q#\8_
M"OAW5)-.D:[O9XB5E^QQJRQL.JDLR@GZ9QT/-=1X;\3Z5XLTI=1TFX\V+.UU
M9=KQM@$JP]1GZ>A- &KF3T7\Z,R>B_G3Z* &9D]%_.C,GHOYU7U/4[+1M-GU
M'4+A;>TMUWR2-G"CZ#DGL .2:73;^'5=*L]1MPP@NX$GCWC!VLH89'K@T 3Y
MD]%_.C,GHOYT^B@!F9/1?SHS)Z+^=8?A'Q=8>--'?4].AN8H4F:$K<*JMN !
M_A8C'S#O6_0 S,GHOYT9D]%_.GT4 ,S)Z+^=&9/1?SI]% #,R>B_G1F3T7\Z
M?10 S,GHOYT9D]%_.GT4 ,S)Z+^=&9/1?SI]% #,R>B_G1F3T7\Z?10 S,GH
MOYT9D]%_.GUY[XB^,7A[PSKUUH][9ZI)<6Q4.T,490Y4-P2X/0^E '?YD]%_
M.C,GHOYUR/A+XEZ!XRDN8=/^U0W,"&0P7,85F08RRX)!&2!US7-?\- >%/\
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M .,4?;_&'_0OZ3_X-G_^,5T=% '.?;_&'_0OZ3_X-G_^,4?;_&'_ $+^D_\
M@V?_ .,5T=% '.?;_&'_ $+^D_\ @V?_ .,4?;_&'_0OZ3_X-G_^,5T=% '.
M?;_&'_0OZ3_X-G_^,4?;_&'_ $+^D_\ @V?_ .,5T=% '.?;_&'_ $+^D_\
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MZ3_X-G_^,5T=% '.?;_&'_0OZ3_X-G_^,4?;_&'_ $+^D_\ @V?_ .,5T=%
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M .,4?;_&'_0OZ3_X-G_^,5T=% '.?;_&'_0OZ3_X-G_^,4?;_&'_ $+^D_\
M@V?_ .,5T=% '.?;_&'_ $+^D_\ @V?_ .,4?;_&'_0OZ3_X-G_^,5T=% '.
M?;_&'_0OZ3_X-G_^,4?;_&'_ $+^D_\ @V?_ .,5T=% '.?;_&'_ $+^D_\
M@V?_ .,4?;_&'_0OZ3_X-G_^,5T=% '.?;_&'_0OZ3_X-G_^,4?;_&'_ $+^
MD_\ @V?_ .,5T=% '.?;_&'_ $+^D_\ @V?_ .,4?;_&'_0OZ3_X-G_^,5T=
M% &-I]WXCEO$34-(TZWMB#NDAU!I6''&%,2YY]Q6S110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g4bdklltl5z5000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4bdklltl5z5000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +\!)X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKG_"
M/B:'Q+I7F_*MW"=EQ&.S=B/8_P"([52A)Q<ELB'.*DHO=_H=!1114EA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&M._0^BPN8X?%?PY:]GN7:***YCM"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#DM
M6^(FB:-JD^GW279FA(#;(P1R >.?>J?_  MCP[_<OO\ OR/_ (JO-?'_ /R/
M.J?]=%_] 6NTTOX5:5?:197DE_>*\\"2L%VX!90>./>O8>%PM.E&=2^J/%CB
ML75JSA2MHS=M?B?X:N90C33V^3C=+$<?IFNNAFBN8$F@D22)QN1T.0P]0:\2
M\9?#]_#-DM_;79N;4N$<.NUD)Z'W%;GPBUB=IKS1Y'+0K'Y\0)^YR P'L<@_
M_KK.O@Z3H^VH.Z1K0QE95O8UU9LZ[7?'>D>'M1^PWJW)FV!_W<8(P?Q'I6YI
MFH0ZMIMO?VP<0SKO3>,''O7C7Q5_Y'(_]>T?]:](\*W]GIW@/2I[VZAMXA !
MOE<*,Y/'-9UL+".'A4CNS2ABISQ$Z<MHG445EV'B31=3F\FRU.UFE/2,2#<?
MH#R:U*X91E%VDK'?&49*\7<**K7NHV6FP^=?7<-M&3@-*X4'\ZRU\9>&WDV#
M6K//O)@?F>*<:<Y*Z38I5(1=I-(W:*9#-%<1++#(DD;#*NC @_0BH;S4;'3E
M5KZ]M[57.%,\JH&^F34I-NR*;25V6:*H'6]*%@U]_:5H;16VF99E*9],@XS[
M4RR\0:1J,4LEIJ5M*L2EY")!\BCJ3GH/>J]G.U[$^TA>US2HJC:ZWI5]/Y%G
MJ=E<2D9$<-PKMCZ U6N_%.@V-P;>YU:UCF!PR>8"5/OCI^-"IS;LD[@ZD$KM
MJQKT5%;W,%W L]M-'-"XRLD;!E/T(K+F\6>'[>X-O+K%FL@."/-!P?<]!24)
M2=DARG&*NV;-%,AFBN(EEAD22-QE71@01[$4YF"J68@*!DDGI4E"T5B3>,/#
MD#E)-9L]P."%D#?RJ]8:OINJ FPOK>YV]1%(&(^H'2K=.:5VF0JL).R:N7:*
M**@L*YK7?'>AZ!,UO<3M-<K]Z&W7<R_4] ?;.:O>*=1DTGPOJ%["<2QPG8?1
MCP#^!.:\.\*:$/%/B);.XNFB#*TLDG5VQUQGN<_SKOP>%A4C*K5?NH\_&8N=
M.<:5)>\ST1?B_I&_#:=>A/4;"?RS74:#XMT?Q&"MA<_OE&6@E&UP/7'?\,US
M\WPFT![<I%/>QR8^60R!N?<8Y_2O+6L-7\/^(76WCF^UV4WRR1(2#@]?H1^A
MKHCAL)B$U2;37<YIXG%X>2=9)I]CZ.HJ"RN/MEA;W)0IYT2R;3U7(!Q3+[4;
M+38A+?7<%M&>C2N%S],]:\GE=[=3V.96YNA:HK(L_%.@W\PAMM6M'E)PJ>8
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MC6"-3D*>/4DUY&.Q2KSLME_5SV<!A70A=K5[_P"0LDJ0H7D8*H[FH?[1L_\
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M/LXQ^?2M"WN8+J(2V\T<L9Z-&P8?I5RISBKR5B(5J<W:$D_F2T445!H%%%%
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M_D<C_P!>T?\ 6IO#?@C4?%^F0WE]J+6]E$ODVR[-Y(!P<#( &>_<YJ'XJ_\
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M0KE/AB,^.+4^D<A_\=-=7\8O^0?I?_75_P"0J*L4LPC;JO\ ,NE)O+IWZ/\
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MQ:3LMW<Z#Q+\,KC0])?4+6^%VD(S,ABV$#^\.3GZ5T/PN\4W&H1S:-?2M+)
MGF0.QR2G0J3WQD8^OM63<Z=\3[RUEMKA9)(9D*.AEM_F4C!'6I? O@[Q%HGB
MJWO+ZP\FV".KOYT;8RIQP&)ZXHJR4\/*-:<926JLT%*+AB8RHPE&+T=TRO\
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M<I_N_,A_ _T-<7JOA'5M*#.\'GP#_EK#\P ]QU%>MQ1M&NTN6';-.:1%8!F
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MI>GZH^>XC_W>/K^C/5=&_P"0'I__ %[1_P#H(JW+&LT3Q.,JZE6'L:J:-_R
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MKL]<^(=SXFL7T;1-+G$ETNQV8[FV]P /YGM7I>H:%I6K,&O]/M[AP,!Y(P6
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M<$#/0U=FABN(7AGC26)QM='4,K#T(/6M<3BE6K1J);6_,QPN$E1HRIMWO?\
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MMU>[ &"YR./;ITK2C<2(''0_I7AU)SJ/FF[GIQP[OR?#'LNOJP12D:J6+$
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MEJ=Q<]LG^F*ZKP1X=ETR&2_O$*7$R[4C/5$Z\^YXX]JZ&TT;3;!]]K8P1/\
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MR%:QQM"BFZ$+-]V<\\KQ6)<5BJB<5V1(BA$5%&%48%+117E'OA1110 4444
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MC*([B(IM8J&ZN >#[&@#H:*YOP7KMUK>D2_V@$6_M9FAG"# /<''N#^E9_Q
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M%NU.#QCJS<Q6\::? ?\ =96?_P >-;GC*POCH6E:EIUM)+J.FRQR)&D99B"
M&7 Y],_2J]SHUY;_  EFLA;RRW\T0EEC1"7:1W#$8'.1G]* -2_U?^P_AU'?
M@XD2QC6+_?90%_4Y_"N&BU?PJOPS;0FU,&]>(RG]Q)_KL[@,[<=<+FM_6=.O
M=9F\)Z(UC<_8HDCGO)&A;8-JX"$XQGAACW%=;_PB_A__ * 6F?\ @)'_ (4
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M< <>G_UZT+G3K?4;62PNE8QJP88;!QV_J*LVR);[K9$5$7E HP,4Z;Y)$E[
M[6^A_P#KTTNC'&#Y/WCOW*EEI=CI<ZK:VT<89<!@,MD>YYJ[.I:!P.H&1]1S
M27 /E;QU0[A^'_UJD!# $=#1M9FD8I)Q6P(P=%8=",U%<\0%O[I#?D:+?B,I
M_<8K_A3Y5W0NOJI%&TA[Q'U">+M?="/U%/B;="C>J@TR3_CXA/\ O#]*%O8'
MM<FJ%_\ CZB_W6_I4U0M_P ?<?\ N-_2E$);"W)Q;2?[I%2*,*!Z"HKG_4X_
MO,H_45-1T#[1%<,5MY".N,"I$78BJ.PQ44_S&)/[SC/X<U-0]@6Y#<?,$C_O
ML ?IU-2[1NW8&?7%1#Y[LGM&N/Q-34/:P+=LRO$5K?7FBS1:;?FQNN"LP&>A
MZ>V:YS0]4\8V6KP:7KNF"ZAD.!?0C@#'5L<?F ?K792?O)TC[+\[?T_S[5-6
M\*RA3<)13O\ >OF*UY73&NX1&<] ,TV!"D>6^^QW-]:P_%&BW/B"T6UL]1FL
M9H&$JR1D@%NP./SKF+;QEKGA6X2Q\7V;20$[8[^$9!^N.#^A]C5TL,ZL/W;O
M+MU^7<ES2EKL;OBGP3I.NH;@H;74,_)<0C#%NVX=_P"?O6OH&GW>F:-#:7UZ
M;RY3.Z<C!;GCZX&!GVJ:QO+;58UO;69)K;&(W0Y!/<_TJ[6=2M4Y%2D]%^!4
M8J_,@ILA0(3)C:!DYJ!HY(7+PY8$Y*&G#_2'#'_5*>/]H_X"LK=0YGM;4JWM
M]#IEA/JE[N6*%-VU5R57Z>II^DZQ8ZY8)>V$XEA;KZJ?0CL:M3F/R6$JAU8;
M2A&=V>V*Y'2_!,VA^*%U'2[P6VGR@_:;+D@GG 7VS^7XUO"-*=-\SM+IV?D+
M5.R.Q90RE6&0>HJL"UJ^TY:)CP?2K5(Y4(2^-HZYK!/H5*-]>H9&W=D8QG-<
M[XG\-6_BW3C#(!%)&";>XQ\RM_\ $GN*VCB4;Y/DA'13QN^OM[59JX3E2DIQ
M>J$US:/8P?"$>N0:&MOKP7[3"YC1P^XN@Q@D^O6JGC#PT-7M3=VJ#[=$.@_Y
M:KZ?7T_*NG?=L;9C=CC-,@F\U<$8=?O"KC7G&K[:.C\MC'$8>G7INC4U3_K[
MSPD@@D$8(ZBDKNO'7ASRG;5[1/D8_P"D(!T/][\>]<+7U.'KQKTU.)^?XS"S
MPM5TI_\ #H*O:1JD^CZE%>0'E3AESPZ]P:HT5K**DG&6S,(3E"2G%V:/=+&]
MAU&RBN[=MT4J[A[>Q]Q5BO-/ NO?8KS^S;A_W%PW[LD_=?T_'^>*]+KY+%X=
MT*CCTZ'Z%E^,CBZ"J+?KZA1117,=P4444 %%%% !1110 4444 (2%4LQ  &2
M3VK ?QOX>21D-_D@XRL3D?F!6CK4L,&B7LMQ$9H4A8O&&V[ACD9[5Y>->\*Y
M_P"1:?\ \"FK:G3YE<\S'XR="24915^]_P!$=\/&V@'I>G_OR_\ A3QXRT(]
M+P_]^G_PK@EU[POV\./_ .!35,NN^&>WA]A_V\M1*E);(XHYK/K4A]TO\CN1
MXOT0]+L_]^G_ ,*</%>C'I='_OTW^%<4NN>'.V@L/^WEJF76?#YZ:(P_[>&K
MFESHWCF+?VX_^3?Y'8CQ1I!Z7)_[]M_A3AXDTH]+D_\ ?MO\*Y)=8T+MHS#_
M +;M4RZMHAZ:2W_?]JYY5:BZK\3>.,;^U'\3J1XATP_\O!_[]M_A3TUW3G8*
M)^3ZHP_I7,+JFC'II;?]_FJ1=2TGMIK#_MLU8RQ-1?:C^)O'$7ZK\3M 01D'
M(-%063(]C"T:;$*#:N<X%3UZ$7=7.I.Z"BBBF,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!" >HS00#U'2EHH *0 #. .>
MM+10 A (P1D4$ C! -+10 4F!G..?6EHH * ,# HHH C>"&0YDB1B.A90:?M
M'' XZ<=*6BE9#NQ,#.<#/K2T44Q"  =!UH9%==KJ&4]B,TM%%@&1Q1Q#$<:H
M/11BGT44)6V"]R*6V@N,>=!')CIO0'^=/2-(D"1HJ*.@48%.HH :R(XPZJP]
MQFF_9X?^>,?_ 'R*DHH 8(8E(*Q(".A"BGT44 0RVEM.<S6\4A'=T!_G4B(D
M:!(T5%'0*,"G44 86M^&8=5O+?4;:X:QU.W8>7=1KDE>ZL.-P-;M%% !163K
MGB72O#L*R:E="-G^Y&HW._T _GTKGK'XJ^&[RY$,AN[0$X$EQ$-N?JI./J>*
M .WHI%97171@RL,A@<@BN3UGXC>'M%NFMGFENIT.'2V0-M/H22!^1H ZVBN9
MT+Q[H/B"=;>WN'AN6^[#<+M9OH<D$^V<U?U/Q%::3JVGZ?=13AK]]D4JJ/+#
M>A.<@\CMWH UZ**R'\16B^)DT!8IY+MH?.9T5=D:\_>.<YZ= >HH UZ*Q]*\
M1V>KZ1<ZG;QSK#;LZNLB@,2@R<8)'ZURW_"X/#__ #YZG_WZC_\ BZ /0:*Y
MSP_XXT3Q)-]GLYGCN<9$$Z[6(]N2#^!KHZ "BBB@ HHHH @O;R#3K&>\N7"0
MPH7=O8?UKYQU[6;C7]9N-0N"09&^1,\(@Z*/H*[[XK^)"TD>@6S_ "KB2Z([
MGJJ_U_*O+Z^@RS#<D/:RW?Y'SN:8GGG[*.R_/_@!1117J'DDMM;S7=S%;6\;
M232L$1%ZDGH*^@_"7AR#POHBV_RFX<;[F7^\WI]!T'_UZY#X6>%Q%"=?NX_W
MC@I:AAT7H7_'H/;/K7I,T9E4*&P,\UX.98KGG[*+T6Y]!EN%]G#VTEJ]AT<@
ME3< <9QS3Z15"J%48 X ID\HBCSU8\ 5Y5KO0]>]E=DE9ECHUEHIF;3;2.)9
MGWRJO5CZY_ITJ[!$44LYR[<FIJ=[:(2NUV*UUJ%K96$M[<3+';Q*6=V[?_7]
MJY'PGX@UOQ1KMSJ"QB#P_&#'$CJ-TC>N?7U[=JI^)-&UGQ9XK&F2026FA6VV
M224''V@X['N><>W)]*[JPAM[:TCM;6)88H5"+$!C:*U:C"'=O\"KVT>Y8(#*
M01D'J#4*DP,$<YC/"L>WL:R?%/BBS\+Z6;FX^>=\B" 'F1OZ =S67X)L]>G6
MZU?7[F3-\ 8[,YVQ+V./X?I^?-1&#Y.9[ XZ7.L: /+O<Y Z+VJ6H%8PL(W.
M5/",?Y&N8\7>-8M"*Z=I\?VS6)OEC@49V9Z%L?H*2C*3LA12>QU4L9< J<.O
M*FN$U3POKGBW795U:]%MH<+_ +NW@;YI/K[^Y_ 5T'A&TURUTIGU^\\^[FD\
MS9Q^Z!_AR/Z<"MF52C^<@R0,.H_B'^-7&3@VE]X/W7=#+"PMM,L(;*TC\NWA
M7:BYS@4Z/]S)Y)^Z>4_J*F5@RAE.01D&FRQ^8F <,.5/H:SOKJ#UU0R<$!95
M'S1G/U'>I"%EC(ZJPI(I/,3)&&'##T-,A_=LT)_AY7Z4=/0G2_J+ Q:+:WWE
M^5J2WX0QGK&=OX=OTH/[JY#=%D&#]1_]:F/(L-V,_P :@'ZYX_K3M?85[;CQ
M\MVP[.N?Q''^%357N/-\R)HUSMS5BD^C*B]6B&U_U 7^Z2OY&DN'5'AR0#NS
M^&*6"W6 M@DY]:>\22$%USCI3NN:Y-I<ENH^JY=?MRKD9V$?CQ5BF>3'YOF;
M?F]:E-=2I)O8CN&&Z)<C)<'%3U$\$<DBNPY&*EH=K(%>[N0GYKM1_<0G\_\
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MP4444 %%%% !1110 4444 5-4DN(=*NI+2$37"Q,8XRN0S8X&.]<"-;\9?\
M0LV__@(W_P 57H=W US9S0+,\+2(5$L9PR$CJ/<5YY)X8\>+*PCU[>@/RL;E
MQD?3%;T>6SO;YGG8V-1M.'-\K?J.&M>,/^A:M_\ P%;_ .*IXUKQ?_T+EO\
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MJ%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBUC2;:_A4JDR9VMU4]"/P(-6PB!-@4;<8QCBHI9[2PBC$LL-O&6"(&8*"3T
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MMO"7_0)_\F9?_BJZNB@#,TGP]I&AJ1IMA%;EAAG )8CT+')/YUIT44 %%%%
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M8XPI;<1WI]+9Z#M=:A1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M^D?R"BBBN4](**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1110 4444 %%%% !1110 444AH 6BFT4 .HI!UH- "T4VB@!U%-HH =13:*
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MF_YKN<1Q\?WGX'Y5RGBW5[_0;_2KII!)ILDI2Y4J/\],D?2NFTO[7_95K]O
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M?%%L"<+,&B/XCC]0*]<KYG-*?+B+]S[G(:WM,&H_RMK]?U"BBBO./:"BBB@
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M];WL]NKW%MGRG.<K3DFXV0L/4C3JJI-7MK\^GXB6-L=,L+>SCC#10QA%*\'
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M110 4444 %%%% !1110 4444 %(:6D- "54U+4;;2--N-0O)/+MK=#)(V,X
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MR^W7-[F0OYD[9(X VCT''ZULT5#J3:Y6QJ$4[H****@H**** "BBB@ HHHH
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M-KG[/*Z M%GKM/:EU#2[+5[7[+J-I#=6Y8-Y<RAER.AQ1[2[3[#/(UT;0_\
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M%W!1D\ # I]AJUIJ-A!>0N5CF0.H<8.#ZU1\86MS>^%+ZVLXFEFD50J+U/S
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M5Z)\-A_H5^WK(H_0UPYE_NTOE^9ZN1K_ &Z'S_)G<4445\N?>!1110 4444
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MGG_XXKBA1A6P\7:W-.WR-Y3E"H^MHEVW^)6N:I=2OI'AMKFSB/S8W,^.V2.
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M"I*',VVC1RG.HXIVT&>#/%T7BS3I9?)\BY@8+-&&R.>A!]#@_E72UY/\&?\
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MNAQ,7@>YC^(1\2&\B,)D9_)VG=RA7KT[TSQQX$N?$FH6^HZ?>1P7448C(DR
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M5.S<#JD;?0D4]H8G^\BD^N*9Y&/N2R+[9R/UIW06:&R77D1/+-$R(BEF8$$
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M44,'4GY6^_3]3B:***^J/SH*]E\+P^1X8T],8S$'_P"^OF_K7C:J68*HR2<
M5[K:P"VLX8!TBC5!^ Q7CYQ+W(Q\SZ7AN%ZLY]DE]_\ PQ-1117@'UP4444
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M5 L4F#CY1UY[513XA:?/;Q_8[*]NKR5W5+.% TF%.TL><*N>A-=:D20Q+'&
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M5,SQQ+\Q"CM4;M),I6-"JG^)CC\A5+R)EV;)Z*CA1HX@K-N/K4E0RUL%%%%
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MAI=V'B2SU:'5Q.T4BRSFX4[I&S\WYCUS5[QQX$N?$FH6^HZ?>1P7448C(DR
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M[-;E">$/K^/.*\#M;F6SNX;J!RDT+AT8=B#D5]%Z/KD6L:%:ZG H*R@>8O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!CKGM201M''AVR2<_2IMI<J^MB6BHHITF+!"?EJ6AIK<:::N@HHHI#"BBB@
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M8>JTEI:PV5LD$"!8U''O[GWJ&_N+>SB%Q/*(B#A6QDGVQWK*G%03E4>KW?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)X^M"LE8S;I8:.G_  6=7<*7MW"KN<#*#..>W-<MINB7FIZF=1UYSYD1S%;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA/XNVM\J6/B1$@F/RBZ4?NW_ -X?PGWZ?2O&Q>"J*SBW**Z=4=E.NGH]&>J
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MNQ?$WB5[&9[.TB GB =[B4[4B&.N3QWZGBO&]>\7O)-(MA</-.W^LO6SG/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0@H*R"BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD=K96\<%O&,+'&N *L445Y;;;NSJ"BBBD 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVWVB['_+S<89P?\ 9[+^ S[UU-%%>9.I*;O)W9U**BK(****@84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 56O=/LM2A\F^M(+F+^Y-&''ZU9HIIM.Z X34_A'X7O]S013V,A
MYS!+D9^C9_3%<=J7P1U&,EM-U6VG7^[.AC/YC<#^E>V45U4\;7AM*_J92H4W
MT/FJ_P#AOXLT_)?2)9E'\5NPDS^"G/Z5SEU87EBVV[M)[=LXQ+&4/ZU]<4A
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAEA9A_K)",<>P!//KCWKW%E5T*LH96&""."*9!!%;0)!!$D4,:A41% 50.P
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M;0N^H4445YYT!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV=<?K[5V]M=6][ L]M,DL3=&0Y%?-7AG"O> = P _6NOTW5KW2Y_-LYVC/\
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M%%%%8&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+F/^[-&&'ZT*M!77+[KZ JD5=6T9XCXR^(D_C:"+0="TZY$<S@NK &64@\*
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MM[:"TA$5M#'#&.B1J% _ 5+6,W%N\59&<FF]%8****@D**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLS:HID3.T2-(FQR 64'.#Z9[T^I$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !6;J=C<SW=E>6C1>=:LWR2DA65A@\C)!'TK
M2HIIV!.QFC3'%IJ</F+F\=V4X^[N4#^E9TOAZ6*Y%Q!!I]TSPQQR)=Q]&08W
M*P!/([8[#FNCHIJ30TV9]OI[0ZB+K,:K]E6'RXUP 02>/;FL:#PS=1M$CO:8
MBNA<&Z\O,\^&+88D<=<9!/3M74T4*;0<S.0L[/4KVTUBSMIX8[:YOKA'D<'S
M(@3AMHZ'OC.,9[U=G\/O%J$UQ:VVGW*3A R7D>3&54+E2 <C '![]^:Z+ '0
M44W-W'S,QWT^_M]1-U8M:[98$BDCD4@(5SAEQU'/W3CIUJO;:)>Z?%IC03PS
MSVB212&4%1(KL"2,9P?E''3K7044N9BYF83:+=1,EQ:W$8NHKJ69 ZG8ZOU0
MXY'8Y'<5+>6NI7MFD4]II<^[/F1REBJGL0<<_D*V**.9A<JZ;:/8:9;6DDS3
M-#&$,C=6Q5JBBI>H@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>26
<FILENAME>adpt-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-13T23:36:31.8843983+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:adpt="http://www.adaptivebiotech.com/20211231" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.adaptivebiotech.com/20211231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.adaptivebiotech.com/20211231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="Role_StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100040 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity" id="Role_StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity">
        <link:definition>100050 - Statement - Consolidated Statements of Convertible Preferred Stock and Shareholders&apos; (Deficit) Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness" id="Role_DisclosureOrganizationAndDescriptionOfBusiness">
        <link:definition>100070 - Disclosure - Organization and Description of Business</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies" id="Role_DisclosureSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue" id="Role_DisclosureRevenue">
        <link:definition>100090 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments" id="Role_DisclosureInvestments">
        <link:definition>100110 - Disclosure - Investments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet" id="Role_DisclosurePropertyAndEquipmentNet">
        <link:definition>100120 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets" id="Role_DisclosureGoodwillAndIntangibleAssets">
        <link:definition>100130 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities" id="Role_DisclosureAccruedLiabilities">
        <link:definition>100140 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue" id="Role_DisclosureDeferredRevenue">
        <link:definition>100150 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>100160 - Disclosure - Leases</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100170 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity" id="Role_DisclosureShareholdersEquity">
        <link:definition>100180 - Disclosure - Shareholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans" id="Role_DisclosureEquityIncentivePlans">
        <link:definition>100190 - Disclosure - Equity Incentive Plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement" id="Role_DisclosureMicrosoftCollaborationAgreement">
        <link:definition>100200 - Disclosure - Microsoft Collaboration Agreement</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100210 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders" id="Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders">
        <link:definition>100220 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan" id="Role_DisclosureRetirementPlan">
        <link:definition>100230 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies" id="Role_DisclosureSignificantAccountingPoliciesPolicies">
        <link:definition>100240 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables" id="Role_DisclosureSignificantAccountingPoliciesTables">
        <link:definition>100250 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables" id="Role_DisclosureRevenueTables">
        <link:definition>100260 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100270 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables" id="Role_DisclosureInvestmentsTables">
        <link:definition>100280 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" id="Role_DisclosurePropertyAndEquipmentNetTables">
        <link:definition>100290 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" id="Role_DisclosureGoodwillAndIntangibleAssetsTables">
        <link:definition>100300 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables" id="Role_DisclosureAccruedLiabilitiesTables">
        <link:definition>100310 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables" id="Role_DisclosureDeferredRevenueTables">
        <link:definition>100320 - Disclosure - Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>100330 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables" id="Role_DisclosureShareholdersEquityTables">
        <link:definition>100340 - Disclosure - Shareholders&apos; Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables" id="Role_DisclosureEquityIncentivePlansTables">
        <link:definition>100350 - Disclosure - Equity Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100360 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables" id="Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables">
        <link:definition>100370 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails" id="Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails">
        <link:definition>100380 - Disclosure - Organization and Description of Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails" id="Role_DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails">
        <link:definition>100400 - Disclosure - Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails" id="Role_DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails">
        <link:definition>100410 - Disclosure - Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails" id="Role_DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails">
        <link:definition>100420 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" id="Role_DisclosureRevenueAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Revenue - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100440 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" id="Role_DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails">
        <link:definition>100450 - Disclosure - Investments - Schedule of Available-for-sale Investments (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" id="Role_DisclosureInvestmentsAdditionalInformationDetails">
        <link:definition>100460 - Disclosure - Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails" id="Role_DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails">
        <link:definition>100470 - Disclosure - Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" id="Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
        <link:definition>100480 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" id="Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails">
        <link:definition>100490 - Disclosure - Property and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" id="Role_DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" id="Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails">
        <link:definition>100510 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails" id="Role_DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails">
        <link:definition>100520 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" id="Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails">
        <link:definition>100530 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails" id="Role_DisclosureAccruedLiabilitiesAdditionalInformationDetails">
        <link:definition>100540 - Disclosure - Accrued Liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" id="Role_DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails">
        <link:definition>100550 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails" id="Role_DisclosureDeferredRevenueAdditionalInformationDetails">
        <link:definition>100560 - Disclosure - Deferred Revenue - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1" id="Role_DisclosureDeferredRevenueAdditionalInformationDetails1">
        <link:definition>100570 - Disclosure - Deferred Revenue - Additional Information (Details1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1Default" id="Role_DisclosureDeferredRevenueAdditionalInformationDetails1Default">
        <link:definition>100570 - Disclosure - Deferred Revenue - Additional Information (Details1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails" id="Role_DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails">
        <link:definition>100580 - Disclosure - Deferred Revenue - Schedule of Changes in Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="Role_DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100590 - Disclosure - Leases- Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails" id="Role_DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails">
        <link:definition>100600 - Disclosure - Leases- Summary of Other Information Related to Operating Lease (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails" id="Role_DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails">
        <link:definition>100610 - Disclosure - Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2" id="Role_DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2">
        <link:definition>100620 - Disclosure - Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails" id="Role_DisclosureShareholdersEquityAdditionalInformationDetails">
        <link:definition>100630 - Disclosure - Shareholders&apos; Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails" id="Role_DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails">
        <link:definition>100640 - Disclosure - Shareholders&apos; Equity - Summary of Reserved Shares of Common Stock (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails" id="Role_DisclosureEquityIncentivePlansAdditionalInformationDetails">
        <link:definition>100650 - Disclosure - Equity Incentive Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails" id="Role_DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails">
        <link:definition>100660 - Disclosure - Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails" id="Role_DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails">
        <link:definition>100670 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails" id="Role_DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails">
        <link:definition>100680 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails" id="Role_DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails">
        <link:definition>100690 - Disclosure - Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails" id="Role_DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails">
        <link:definition>100700 - Disclosure - Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails" id="Role_DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails">
        <link:definition>100710 - Disclosure - Microsoft Collaboration Agreement - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails" id="Role_DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails">
        <link:definition>100720 - Disclosure - Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>100730 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100740 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail" id="Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail">
        <link:definition>100750 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail">
        <link:definition>100760 - Disclosure - Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" id="Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails">
        <link:definition>100770 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails">
        <link:definition>100780 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails" id="Role_DisclosureRetirementPlanAdditionalInformationDetails">
        <link:definition>100790 - Disclosure - Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" name="LesseeOperatingLeaseLiabilityTenantImprovementReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_SequencingRevenueMember" name="SequencingRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_DevelopmentRevenueMember" name="DevelopmentRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" name="AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" name="AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" name="StockIssuedDuringPeriodValueCommonStockWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" name="StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" name="StockIssuedDuringPeriodSharesRestrictedStockAwardVested" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" name="ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" name="TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" name="AdjustmentsToAdditionalPaidInCapitalCapitalContributions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_NoncashLeaseExpense" name="NoncashLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_IncreaseDecreaseInDeferredRent" name="IncreaseDecreaseInDeferredRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" name="ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" name="DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" name="ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" name="ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_DeferredRevenueTextBlock" name="DeferredRevenueTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" name="StockholdersEquityConvertiblePreferredStockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ContractBalancesPolicyTextBlock" name="ContractBalancesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_SalesAndMarketingExpensePolicyTextBlock" name="SalesAndMarketingExpensePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" name="ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" name="ScheduleOfReservedSharesOfCommonStockTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" name="ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_DigitalBiotechnologiesIncMember" name="DigitalBiotechnologiesIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_SignificantAccountingPoliciesLineItems" name="SignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_SignificantAccountingPoliciesTable" name="SignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_SeriesCConvertiblePreferredStockMember" name="SeriesCConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_CustomerAMember" name="CustomerAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_CustomerBMember" name="CustomerBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_GenentechIncAndRocheGroupMember" name="GenentechIncAndRocheGroupMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ComputerEquipmentAndSoftwareMember" name="ComputerEquipmentAndSoftwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_FurnitureAndOfficeEquipmentMember" name="FurnitureAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" name="ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="adpt_NumberOfRevenuePerformanceObligation" name="NumberOfRevenuePerformanceObligation" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_DevelopmentSupportRevenueMember" name="DevelopmentSupportRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_DevelopmentRevenueRegulatoryMilestonesMember" name="DevelopmentRevenueRegulatoryMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_MRDDevelopmentAgreementsMember" name="MRDDevelopmentAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_GenentechCollaborationAgreementMember" name="GenentechCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_RegulatoryMilestonesMember" name="RegulatoryMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_DevelopmentMilestonesMember" name="DevelopmentMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_CommercialMilestonesMember" name="CommercialMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" name="ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_AdditionalMilestonePayment" name="AdditionalMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_NonRefundableUpfrontPaymentsReceived" name="NonRefundableUpfrontPaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" name="RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_RevenueRecognitionExpectedPeriod" name="RevenueRecognitionExpectedPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" name="AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" name="AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ComputerSoftwareMember" name="ComputerSoftwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" name="AccruedClinicalAndContractResearchOrganizationCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" name="AccruedPurchaseOfPropertyAndEquipmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" name="AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_ContractWithCustomerLiabilityCurrentAbstract" name="ContractWithCustomerLiabilityCurrentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" name="ContractWithCustomerLiabilityNonCurrentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_GenentechIncMember" name="GenentechIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_MedicareRevenueMember" name="MedicareRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_SpecificPatientsMember" name="SpecificPatientsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_LeaseExpirationMonthAndYear" name="LeaseExpirationMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" name="LesseeOperatingLeaseRentCommencementMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_LesseeOperatingLeaseExtendedTermOfContract" name="LesseeOperatingLeaseExtendedTermOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_LeaseCommencementMonthAndYear" name="LeaseCommencementMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ProceedsFromLandlordReimbursements" name="ProceedsFromLandlordReimbursements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_TenantImprovementCostsIncurred" name="TenantImprovementCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_TenantImprovementCostsReceivable" name="TenantImprovementCostsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_LesseeOperatingLeaseTerminationPeriod" name="LesseeOperatingLeaseTerminationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_NumberOfOperatingLeaseTerminate" name="NumberOfOperatingLeaseTerminate" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_TenantImprovementAllowanceAndCommenced" name="TenantImprovementAllowanceAndCommenced" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" name="LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" name="LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" name="LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_OperatingLeaseVariableLeaseExpense" name="OperatingLeaseVariableLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_NumberOfCommonStockVotingRights" name="NumberOfCommonStockVotingRights" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" name="TwoThousandAndNineteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" name="CommonStockOptionsAndRestrictedStockUnitsGrantedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_PercentageOfAnnualIncreasesInNumberOfShares" name="PercentageOfAnnualIncreasesInNumberOfShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ClassOfWarrantOrRightsTerm" name="ClassOfWarrantOrRightsTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="adpt_SequentaTwoThousandAndEightStockPlanMember" name="SequentaTwoThousandAndEightStockPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_TwoThousandAndNineEquityIncentivePlanMember" name="TwoThousandAndNineEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_NonEmployeeDirectorsMember" name="NonEmployeeDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" name="ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" name="MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" name="MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_CollaborationArrangementDisclosureAbstract" name="CollaborationArrangementDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_MicrosoftCollaborationAgreementMember" name="MicrosoftCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_SeriesFOneConvertiblePreferredStockMember" name="SeriesFOneConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_DeferredTaxAssetsNonQualifiedStockOptions" name="DeferredTaxAssetsNonQualifiedStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" name="DeferredTaxAssetsOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" name="DeferredTaxLiabilitiesTangibleAndIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_DeferredTaxLiabilitiesRightOfUseAssets" name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="adpt_IncomeTaxesLineItems" name="IncomeTaxesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_IncomeTaxesTable" name="IncomeTaxesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_NetOperatingLossCarryforwardExpirationPeriod" name="NetOperatingLossCarryforwardExpirationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" name="EffectiveIncomeTaxRateReconciliationPermanentItems" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="adpt_UnvestedRestrictedStockUnitsMember" name="UnvestedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_CommonStockWarrantsMember" name="CommonStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_ConvertiblePreferredStockWarrantsMember" name="ConvertiblePreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" name="DefinedContributionPlanEmployeeServicePeriodForVesting" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>27
<FILENAME>adpt-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-13T23:36:31.8843983+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="adpt-20211231.xsd#TemplateLink" roleURI="http://www.adaptivebiotech.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:type="locator" xlink:label="us-gaap_MinorityInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquity" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_MinorityInterest" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10270.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10280.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10290.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="10300.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10310.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ProfitLoss" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_InterestAndOtherIncome" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10130.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ProfitLoss" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInDeferredRent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NoncashLeaseExpense" xlink:type="locator" xlink:label="adpt_NoncashLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:type="locator" xlink:label="us-gaap_ProceedsFromContributedCapital" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" xlink:type="locator" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromContributedCapital" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="adpt_NoncashLeaseExpense" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10180.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10210.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="10220.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10230.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="adpt_IncreaseDecreaseInDeferredRent" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="10270.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" order="10280.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" xlink:type="locator" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" xlink:type="locator" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsNonQualifiedStockOptions" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="adpt_DeferredTaxLiabilitiesRightOfUseAssets" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="adpt_DeferredTaxAssetsNonQualifiedStockOptions" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10120.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>28
<FILENAME>adpt-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-13T23:36:31.8843983+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="adpt-20211231.xsd#TemplateLink" roleURI="http://www.adaptivebiotech.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10140.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_2" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestAndOtherIncome" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11530.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_2" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="11780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" order="11990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" order="12390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" order="12590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" order="12650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="12790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="12990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="13010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" order="13190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" order="13390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" order="13430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" order="13590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" order="13790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="13990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="14190.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="11970.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DigitalBiotechnologiesIncMember" xlink:type="locator" xlink:label="adpt_DigitalBiotechnologiesIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="srt_OwnershipAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="adpt_DigitalBiotechnologiesIncMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfRevenuePerformanceObligation" xlink:type="locator" xlink:label="adpt_NumberOfRevenuePerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:type="locator" xlink:label="us-gaap_UnbilledReceivablesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashNoncurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesCConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesCConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesTable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_SignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="adpt_SeriesCConvertiblePreferredStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnbilledReceivablesCurrent" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_NumberOfRevenuePerformanceObligation" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdvertisingExpense" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="10930.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncAndRocheGroupMember" xlink:type="locator" xlink:label="adpt_GenentechIncAndRocheGroupMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerBMember" xlink:type="locator" xlink:label="adpt_CustomerBMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerAMember" xlink:type="locator" xlink:label="adpt_CustomerAMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesTable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_SignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_CustomerAMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_CustomerBMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncAndRocheGroupMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_2" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10440.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_FurnitureAndOfficeEquipmentMember" xlink:type="locator" xlink:label="adpt_FurnitureAndOfficeEquipmentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerEquipmentAndSoftwareMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="adpt_LaboratoryEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_LaboratoryEquipmentMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_ComputerEquipmentAndSoftwareMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_FurnitureAndOfficeEquipmentMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10460.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueRegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentSupportRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentSupportRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentSupportRevenueMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueRegulatoryMilestonesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenueAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionExpectedPeriod" xlink:type="locator" xlink:label="adpt_RevenueRecognitionExpectedPeriod" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" xlink:type="locator" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonRefundableUpfrontPaymentsReceived" xlink:type="locator" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdditionalMilestonePayment" xlink:type="locator" xlink:label="adpt_AdditionalMilestonePayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommercialMilestonesMember" xlink:type="locator" xlink:label="adpt_CommercialMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_RegulatoryMilestonesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_GenentechCollaborationAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MRDDevelopmentAgreementsMember" xlink:type="locator" xlink:label="adpt_MRDDevelopmentAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_MRDDevelopmentAgreementsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_GenentechCollaborationAgreementMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain_2" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_RegulatoryMilestonesMember" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_DevelopmentMilestonesMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_CommercialMilestonesMember" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_AdditionalMilestonePayment" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_NonRefundableUpfrontPaymentsReceived" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_RevenueRecognitionExpectedPeriod" order="11610.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10740.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11210.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_InterestReceivableCurrent" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="10440.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerSoftwareMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_FurnitureAndOfficeEquipmentMember" xlink:type="locator" xlink:label="adpt_FurnitureAndOfficeEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="adpt_LaboratoryEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_LaboratoryEquipmentMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_FurnitureAndOfficeEquipmentMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_ComputerSoftwareMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10560.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems" xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10170.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10360.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityCurrentAbstract" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="10600.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SpecificPatientsMember" xlink:type="locator" xlink:label="adpt_SpecificPatientsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MedicareRevenueMember" xlink:type="locator" xlink:label="adpt_MedicareRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_MedicareRevenueMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_SpecificPatientsMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueAdditionalInformationDetails1" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10230.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1Default" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueAdditionalInformationDetails1Default" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1Default">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncMember" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLeaseVariableLeaseExpense" xlink:type="locator" xlink:label="adpt_OperatingLeaseVariableLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfOperatingLeaseTerminate" xlink:type="locator" xlink:label="adpt_NumberOfOperatingLeaseTerminate" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseTerminationPeriod" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementAllowanceAndCommenced" xlink:type="locator" xlink:label="adpt_TenantImprovementAllowanceAndCommenced" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:type="locator" xlink:label="us-gaap_TenantImprovements" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsReceivable" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsReceivable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsIncurred" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsIncurred" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromLandlordReimbursements" xlink:type="locator" xlink:label="adpt_ProceedsFromLandlordReimbursements" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:type="locator" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseExpirationMonthAndYear" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseExtendedTermOfContract" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA" xlink:type="locator" xlink:label="stpr_WA" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_WA" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_2" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfLand" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseExtendedTermOfContract" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LeaseExpirationMonthAndYear" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LettersOfCreditOutstandingAmount" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LeaseCommencementMonthAndYear" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseholdImprovementsGross" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_ProceedsFromLandlordReimbursements" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementCostsIncurred" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementCostsReceivable" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_TenantImprovements" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementAllowanceAndCommenced" order="11930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="12230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="12630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseTerminationPeriod" order="12730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_NumberOfOperatingLeaseTerminate" order="12830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" order="13030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" order="13130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" order="13230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" order="13330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="13460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_OperatingLeaseVariableLeaseExpense" order="13520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="13580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="13640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance" order="13700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="13760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="13820.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquityAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightsTerm" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightsTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_PercentageOfAnnualIncreasesInNumberOfShares" xlink:type="locator" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfCommonStockVotingRights" xlink:type="locator" xlink:label="adpt_NumberOfCommonStockVotingRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesCConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesCConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="adpt_SeriesCConvertiblePreferredStockMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_NumberOfCommonStockVotingRights" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_PercentageOfAnnualIncreasesInNumberOfShares" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_ClassOfWarrantOrRightsTerm" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" order="10880.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" xlink:type="locator" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10280.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" xlink:type="locator" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonEmployeeDirectorsMember" xlink:type="locator" xlink:label="adpt_NonEmployeeDirectorsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequentaTwoThousandAndEightStockPlanMember" xlink:type="locator" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_SequentaTwoThousandAndEightStockPlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineEquityIncentivePlanMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="adpt_NonEmployeeDirectorsMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_2" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="11720.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11050.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10720.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesFOneConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MicrosoftCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_MicrosoftCollaborationAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_MicrosoftCollaborationAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="adpt_SeriesFOneConvertiblePreferredStockMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_PreferredStockValue" order="10310.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLossCarryforwardsExpirationYear" xlink:type="locator" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardLimitationsOnUse" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NetOperatingLossCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesTable" xlink:type="locator" xlink:label="adpt_IncomeTaxesTable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesLineItems" xlink:type="locator" xlink:label="adpt_IncomeTaxesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_IncomeTaxesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="adpt_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_NetOperatingLossCarryforwardExpirationPeriod" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLimitationsOnUse" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_OperatingLossCarryforwardsExpirationYear" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10540.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConvertiblePreferredStockWarrantsMember" xlink:type="locator" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockWarrantsMember" xlink:type="locator" xlink:label="adpt_CommonStockWarrantsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="adpt_UnvestedRestrictedStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_UnvestedRestrictedStockUnitsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_CommonStockWarrantsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_ConvertiblePreferredStockWarrantsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>29
<FILENAME>adpt-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-13T23:36:31.8843983+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease liability tenant improvement receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" xlink:to="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm Id</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term marketable securities (amortized cost of $214,115 and $564,036, respectively)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Noncurrent [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term marketable securities (amortized cost of $218,163 and $118,429, respectively)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and shareholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Noncurrent [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 11)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock: $0.0001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020; no shares issued and outstanding at December 31, 2021 and 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock: $0.0001 par value, 340,000,000 shares authorized at December 31, 2021 and 2020; 141,393,865 and 137,646,896 shares issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive (loss) gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Adaptive Biotechnologies Corporation shareholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:type="locator" xlink:label="us-gaap_MinorityInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MinorityInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MinorityInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minority Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total shareholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Including Portion Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and shareholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost of short-term marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Amortized Cost Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost of long-term marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Amortized Cost Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Or Service [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Products And Services [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_SequencingRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sequencing revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SequencingRevenueMember" xlink:to="adpt_SequencingRevenueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SequencingRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sequencing Revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SequencingRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sequencing Revenue [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DevelopmentRevenueMember" xlink:to="adpt_DevelopmentRevenueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Revenue [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Excluding Assessed Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and marketing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling And Marketing Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Intangible Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest And Other Income</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Add: Net loss attributable to noncontrolling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to Adaptive Biotechnologies Corporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fair value adjustment to Series E-1 convertible preferred stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Accretion To Redemption Value Adjustment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Available To Common Stockholders Basic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in unrealized gains and losses on investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Add: Comprehensive loss attributable to noncontrolling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss attributable to Adaptive Biotechnologies Corporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital, initial public offering costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital conversion of convertible preferred stock warrant to common stock warrant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" />
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period, value, common stock warrants exercised.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" xlink:to="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" />
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period, shares, common stock warrants exercised.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:to="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, stock issued during period, shares, new issues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" />
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares restricted stock award vested.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" xlink:to="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:label xml:lang="en-US" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in redemption value for vested convertible preferred stock options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:to="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity value change in redemption value for vested convertible preferred stock options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:to="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid In capital share based compensation stock option and restricted stock unit requisite service period recognition value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital capital contributions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid In Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive (Loss) Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restatement [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restatement [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period, Accounting Standards Update, Adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revision Of Prior Period Accounting Standards Update Adjustment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Convertible preferred stock, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Carrying Amount Attributable To Parent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Convertible preferred stock, Beginning Balance, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from initial public offering/ issuance of common stock upon public offering, net of underwriters&apos; discounts and commissions and net offering costs paid by us</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from initial public offering, net of underwriters&apos; discounts and commissions, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update Extensible List</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update Extensible List</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial public offering costs</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Initial Public Offering Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock warrant to common stock warrant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrant To Common Stock Warrant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of common stock warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Common Stock Warrants Exercised</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of common stock warrants, Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Common Stock Warrants Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for cash upon exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for cash upon exercise of stock options, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Value New Issues</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value, Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Award Vested</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in redemption value for vested Series E-1 convertible preferred stock options</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Redemption Value For Vested Convertible Preferred Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in redemption value for vested Series E-1 convertible preferred stock options</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Value Change In Redemption Value For Vested Convertible Preferred Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock option and restricted stock unit share-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Share Based Compensation Stock Option And Restricted Stock Unit Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capital contributions for Digital Biotechnologies, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Capital Contributions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Convertible preferred stock, Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Convertible preferred stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NoncashLeaseExpense" xlink:type="locator" xlink:label="adpt_NoncashLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="adpt_NoncashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash lease expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NoncashLeaseExpense" xlink:to="adpt_NoncashLeaseExpense_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInDeferredRent" />
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in deferred rent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_IncreaseDecreaseInDeferredRent" xlink:to="adpt_IncreaseDecreaseInDeferredRent_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in operating lease right-of-use assets and liabilities .</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:to="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" xlink:type="locator" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" />
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock upon exercise of common stock warrant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" xlink:to="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" xlink:type="locator" xlink:label="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" />
    <link:label xml:lang="en-US" xlink:label="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognition of lease financing arrangements upon adoption of guidance on accounting for lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" xlink:to="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:type="locator" xlink:label="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" />
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible preferred stock to common stock upon closing of initial public offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:to="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" xlink:type="locator" xlink:label="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" />
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" xlink:to="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NoncashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncash lease expense</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NoncashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Lease Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intangible assets amortization</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Investment amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value adjustment of convertible preferred stock warrant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustment Of Warrants</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Inventories</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable And Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Deferred Rent</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets and liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Right Of Use Assets And Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract With Customer Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Capital Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Marketable Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales and maturities of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Marketable Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from public offering of common stock, net of underwriting discounts and commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of public offering costs, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon the exercise of a common stock warrant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock Upon Exercise Of Common Stock Warrant</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:type="locator" xlink:label="us-gaap_ProceedsFromContributedCapital" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromContributedCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from initial capital contributions for Digital Biotechnologies, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributedCapital" xlink:to="us-gaap_ProceedsFromContributedCapital_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromContributedCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Contributed Capital</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Payments For Other Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash at beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncash investing and financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of equipment included in accounts payable and accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred But Not Yet Paid</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncash additions to property through lease financing arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Or Part Noncash Acquisition Fixed Assets Acquired1</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognition of lease financing arrangements upon adoption of guidance on accounting for leases</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Derecognition Of Lease Financing Arrangements Upon Adoption Of Guidance On Accounting For Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock upon closing of initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Convertible Preferred Stock To Common Stock Upon Closing Of Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Convertible Preferred Stock Warrant To Common Stock Warrant Upon Closing Of Initial Public Offering</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Description of Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Description And Basis Of Presentation [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Debt And Equity Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill and Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payables And Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable And Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredRevenueTextBlock" xlink:type="locator" xlink:label="adpt_DeferredRevenueTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredRevenueTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DeferredRevenueTextBlock" xlink:to="adpt_DeferredRevenueTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredRevenueTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredRevenueTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders&apos; Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Microsoft Collaboration Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Retirement Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" xlink:type="locator" xlink:label="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Basis of presentation and principles of consolidation policy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" xlink:to="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Presentation And Principles Of Consolidation Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivables Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Goodwill Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Intangible Assets Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Leases Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments Policy</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" xlink:type="locator" xlink:label="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stockholders equity convertible preferred stock policy text block.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" xlink:to="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock Warrant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Convertible Preferred Stock Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Policy [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractBalancesPolicyTextBlock" xlink:type="locator" xlink:label="adpt_ContractBalancesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractBalancesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract balances.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ContractBalancesPolicyTextBlock" xlink:to="adpt_ContractBalancesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractBalancesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract Balances</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ContractBalancesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract Balances Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Option And Incentive Plans Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advertising</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Advertising Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SalesAndMarketingExpensePolicyTextBlock" xlink:type="locator" xlink:label="adpt_SalesAndMarketingExpensePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_SalesAndMarketingExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales and marketing expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SalesAndMarketingExpensePolicyTextBlock" xlink:to="adpt_SalesAndMarketingExpensePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SalesAndMarketingExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SalesAndMarketingExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales And Marketing Expense Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="locator" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Concentrations of Risk Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedules Of Concentration Of Risk By Risk Factor [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of estimated useful lives of property plant and equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Useful Lives Assigned to Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Estimated Useful Lives Of Property Plant And Equipment Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revenue Disaggregated by Type of Products and Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-sale Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Unrealized Loss Position Fair Value Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Intangible Assets Subject to Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Finite Lived Intangible Assets Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Amortization Expense for Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of deferred revenue by revenue classification.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" xlink:to="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Revenue by Revenue Classification</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Revenue By Revenue Classification Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Changes in Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset And Liability Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Information Related to Operating Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciles Undiscounted Operating Lease Cash Flows</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Maturity Table [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of reserved shares of common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" xlink:to="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reserved Shares of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Reserved Shares Of Common Stock Table [Text Block]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of share-based compensation, shares available for grant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" xlink:to="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Changes in Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Shares Available For Grant Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity Under 2008 Plan 2009 Plan and 2019 Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Unit Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Unvested Restricted Stock Units Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Grant Date Fair Values of Options Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Compensation Costs Related to Stock Options and RSUs Included on Statements of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Loss Before Provision for Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Change in Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Income Tax Contingencies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Subsidiary Or Equity Method Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Subsidiary Or Equity Method Investee [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DigitalBiotechnologiesIncMember" xlink:type="locator" xlink:label="adpt_DigitalBiotechnologiesIncMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_DigitalBiotechnologiesIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Digital Biotechnologies, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DigitalBiotechnologiesIncMember" xlink:to="adpt_DigitalBiotechnologiesIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DigitalBiotechnologiesIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Digital Biotechnologies, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DigitalBiotechnologiesIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Digital Biotechnologies Inc [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership interest percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minority Interest Ownership Percentage By Parent</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant accounting policies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_SignificantAccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant accounting policies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="adpt_SignificantAccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesCConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesCConvertiblePreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesCConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SeriesCConvertiblePreferredStockMember" xlink:to="adpt_SeriesCConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesCConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesCConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series C Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted cash</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Major Customer [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerAMember" xlink:type="locator" xlink:label="adpt_CustomerAMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer A.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CustomerAMember" xlink:to="adpt_CustomerAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer A</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer A [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerBMember" xlink:type="locator" xlink:label="adpt_CustomerBMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer B.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CustomerBMember" xlink:to="adpt_CustomerBMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer B</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_CustomerBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer B [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncAndRocheGroupMember" xlink:type="locator" xlink:label="adpt_GenentechIncAndRocheGroupMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncAndRocheGroupMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Genentech, Inc. and Roche Group.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_GenentechIncAndRocheGroupMember" xlink:to="adpt_GenentechIncAndRocheGroupMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncAndRocheGroupMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Genentech, Inc. and Roche Group</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncAndRocheGroupMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Genentech Inc And Roche Group [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Benchmark [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Revenue Net [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration risk, percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Percentage1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:type="locator" xlink:label="us-gaap_UnbilledReceivablesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unbilled receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledReceivablesCurrent" xlink:to="us-gaap_UnbilledReceivablesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unbilled Receivables Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="adpt_LaboratoryEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LaboratoryEquipmentMember" xlink:to="adpt_LaboratoryEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerEquipmentAndSoftwareMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Computer equipment and software.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ComputerEquipmentAndSoftwareMember" xlink:to="adpt_ComputerEquipmentAndSoftwareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment and Software</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment And Software [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_FurnitureAndOfficeEquipmentMember" xlink:type="locator" xlink:label="adpt_FurnitureAndOfficeEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_FurnitureAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Furniture and office equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_FurnitureAndOfficeEquipmentMember" xlink:to="adpt_FurnitureAndOfficeEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_FurnitureAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Office Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_FurnitureAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Office Equipment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Estimated Useful Lives</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill Impairment Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment losses on intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Intangible Assets Finitelived</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right, weighted average exercise price of warrants or rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:to="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued to purchase stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average exercise price of warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Current Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value adjustment of warrants</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfRevenuePerformanceObligation" xlink:type="locator" xlink:label="adpt_NumberOfRevenuePerformanceObligation" />
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfRevenuePerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of revenue performance obligation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NumberOfRevenuePerformanceObligation" xlink:to="adpt_NumberOfRevenuePerformanceObligation_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfRevenuePerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of revenue performance obligations</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfRevenuePerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Revenue Performance Obligation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdvertisingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Advertising expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdvertisingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Advertising Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Reportable Segments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Table]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentSupportRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentSupportRevenueMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentSupportRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development support revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DevelopmentSupportRevenueMember" xlink:to="adpt_DevelopmentSupportRevenueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentSupportRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Support Revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentSupportRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Support Revenue [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueRegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development revenue regulatory milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DevelopmentRevenueRegulatoryMilestonesMember" xlink:to="adpt_DevelopmentRevenueRegulatoryMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Revenue Regulatory Milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Revenue Regulatory Milestones [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MRDDevelopmentAgreementsMember" xlink:type="locator" xlink:label="adpt_MRDDevelopmentAgreementsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_MRDDevelopmentAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">MRD development agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_MRDDevelopmentAgreementsMember" xlink:to="adpt_MRDDevelopmentAgreementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_MRDDevelopmentAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MRD Development Agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MRDDevelopmentAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M R D Development Agreements [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_GenentechCollaborationAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Genentech collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_GenentechCollaborationAgreementMember" xlink:to="adpt_GenentechCollaborationAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Genentech Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Genentech Collaboration Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration by Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_RegulatoryMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_RegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_RegulatoryMilestonesMember" xlink:to="adpt_RegulatoryMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_RegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory Milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_RegulatoryMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestones [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DevelopmentMilestonesMember" xlink:to="adpt_DevelopmentMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DevelopmentMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Milestones [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommercialMilestonesMember" xlink:type="locator" xlink:label="adpt_CommercialMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommercialMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CommercialMilestonesMember" xlink:to="adpt_CommercialMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommercialMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_CommercialMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Milestones [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue from collaboration agreement</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability milestone method revenue recognized.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" xlink:to="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone revenue recognized</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Milestone Method Revenue Recognized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdditionalMilestonePayment" xlink:type="locator" xlink:label="adpt_AdditionalMilestonePayment" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdditionalMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AdditionalMilestonePayment" xlink:to="adpt_AdditionalMilestonePayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_AdditionalMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional milestone payment receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AdditionalMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Milestone Payment</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonRefundableUpfrontPaymentsReceived" xlink:type="locator" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived" />
    <link:label xml:lang="en-US" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-refundable upfront payments received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NonRefundableUpfrontPaymentsReceived" xlink:to="adpt_NonRefundableUpfrontPaymentsReceived_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" xlink:type="locator" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" />
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition milestone method expected milestone receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" xlink:to="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-refundable upfront payments received</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Refundable Upfront Payments Received</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected revenue through milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Milestone Method Expected Milestone Receivable</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionExpectedPeriod" xlink:type="locator" xlink:label="adpt_RevenueRecognitionExpectedPeriod" />
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionExpectedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition expected period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_RevenueRecognitionExpectedPeriod" xlink:to="adpt_RevenueRecognitionExpectedPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionExpectedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognition expected period</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_RevenueRecognitionExpectedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Expected Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total financial assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities Available For Sale [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateBondSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateBondSecuritiesMember" xlink:to="us-gaap_CorporateBondSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Security Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Information By Category Of Debt Security [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt securities current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt securities noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Term Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Noncurrent [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-Sale Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivableCurrent" xlink:to="us-gaap_InterestReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less than 12 months, Fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less than 12 months, Unrealized loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">12 months or greater, Fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">12 months or greater, Unrealized loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerSoftwareMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Computer software.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ComputerSoftwareMember" xlink:to="adpt_ComputerSoftwareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Software</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ComputerSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Software [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, at cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Goodwill [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Goodwill [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchased Intellectual Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Intellectual Property [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems" xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization period of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Asset Useful Life</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquired Developed Technology</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Carrying Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Accumulated Amortization</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Carrying Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense After Year Five</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" xlink:type="locator" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" />
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical and contract research organization costs, current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" xlink:to="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" xlink:type="locator" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" />
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued purchase of property and equipment current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" xlink:to="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical and contract research organization costs</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical And Contract Research Organization Costs Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Travel and entertainment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Employee Benefits Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Income Taxes Current</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Purchase Of Property And Equipment Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued liabilities</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" xlink:type="locator" xlink:label="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" />
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued tax withholding liability related to unsettled option exercises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" xlink:to="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued tax withholding liability related to unsettled option exercises</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Tax Withholding Liability Related To Unsettled Option Exercises</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability current abstract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:to="adpt_ContractWithCustomerLiabilityCurrentAbstract_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability non current abstract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:to="adpt_ContractWithCustomerLiabilityNonCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total current deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Non Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total non-current deferred revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current and non-current deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Genentech Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_GenentechIncMember" xlink:to="adpt_GenentechIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Genentech, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_GenentechIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Genentech Inc [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MedicareRevenueMember" xlink:type="locator" xlink:label="adpt_MedicareRevenueMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_MedicareRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Medicare revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_MedicareRevenueMember" xlink:to="adpt_MedicareRevenueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_MedicareRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medicare</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MedicareRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Medicare Revenue [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SpecificPatientsMember" xlink:type="locator" xlink:label="adpt_SpecificPatientsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_SpecificPatientsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Specific patients.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SpecificPatientsMember" xlink:to="adpt_SpecificPatientsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SpecificPatientsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Specific Patients</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SpecificPatientsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Specific Patients [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Current deferred revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, expected to be recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Deferred revenue balance at December 31, 2020</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions to deferred revenue during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue recognized during the period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Deferred revenue balance at December 31, 2021</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseExpirationMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LeaseExpirationMonthAndYear" xlink:to="adpt_LeaseExpirationMonthAndYear_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease rent commencement month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" xlink:to="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseExtendedTermOfContract" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating lease, extended term of contract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseExtendedTermOfContract" xlink:to="adpt_LesseeOperatingLeaseExtendedTermOfContract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Lease Description [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA" xlink:type="locator" xlink:label="stpr_WA" />
    <link:label xml:lang="en-US" xlink:label="stpr_WA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Seattle, Washington</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_WA" xlink:to="stpr_WA_lbl" />
    <link:label xml:lang="en-US" xlink:label="stpr_WA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">WASHINGTON</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments For New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Adoption [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASC 842</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201602 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Lease Description [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AreaOfLand_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of square feet</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AreaOfLand_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Land</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease, option to extend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Option To Extend</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease, rent commencement month and year</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Rent Commencement Month And Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, Operating Lease, Existence of Option to Extend [true false]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Existence Of Option To Extend</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease, extended term of contract</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Extended Term Of Contract</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration month and year</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Month And Year</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseCommencementMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LeaseCommencementMonthAndYear" xlink:to="adpt_LeaseCommencementMonthAndYear_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromLandlordReimbursements" xlink:type="locator" xlink:label="adpt_ProceedsFromLandlordReimbursements" />
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromLandlordReimbursements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from landlord reimbursements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ProceedsFromLandlordReimbursements" xlink:to="adpt_ProceedsFromLandlordReimbursements_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsIncurred" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsIncurred" />
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tenant improvement costs incurred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TenantImprovementCostsIncurred" xlink:to="adpt_TenantImprovementCostsIncurred_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsReceivable" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsReceivable" />
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tenant improvement costs receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TenantImprovementCostsReceivable" xlink:to="adpt_TenantImprovementCostsReceivable_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:type="locator" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LettersOfCreditOutstandingAmount" xlink:to="us-gaap_LettersOfCreditOutstandingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Letters Of Credit Outstanding Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commenced moth and year</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LeaseCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Month And Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Landlord contribution for leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromLandlordReimbursements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from landlord reimbursements</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromLandlordReimbursements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Landlord Reimbursements</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tenant improvement costs incurred</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Improvement Costs Incurred</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tenant improvement costs receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementCostsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Improvement Costs Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:type="locator" xlink:label="us-gaap_TenantImprovements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TenantImprovements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tenant improvement allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TenantImprovements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Improvements</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseTerminationPeriod" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease termination period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseTerminationPeriod" xlink:to="adpt_LesseeOperatingLeaseTerminationPeriod_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfOperatingLeaseTerminate" xlink:type="locator" xlink:label="adpt_NumberOfOperatingLeaseTerminate" />
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfOperatingLeaseTerminate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of operating lease terminate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NumberOfOperatingLeaseTerminate" xlink:to="adpt_NumberOfOperatingLeaseTerminate_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementAllowanceAndCommenced" xlink:type="locator" xlink:label="adpt_TenantImprovementAllowanceAndCommenced" />
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementAllowanceAndCommenced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tenant improvement allowance and commenced.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TenantImprovementAllowanceAndCommenced" xlink:to="adpt_TenantImprovementAllowanceAndCommenced_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease rent obligations commencement month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" xlink:to="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating lease, lease not yet commenced termination option description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease lease not yet commenced tenant improvement receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent obligations, commencement date</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Rent Obligations Commencement Month And Year</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementAllowanceAndCommenced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tenant improvement allowance and commenced</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TenantImprovementAllowanceAndCommenced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Improvement Allowance And Commenced</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Remaining Lease Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease termination period</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Termination Period</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfOperatingLeaseTerminate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating lease terminate</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfOperatingLeaseTerminate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Lease Terminate</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease not yet commenced, termination option description</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Lease Not Yet Commenced Termination Option Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease not yet commenced, option to extend description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Lease Not Yet Commenced Option To Extend</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease not yet commenced landlord agreed to fund for improvements</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Lease Not Yet Commenced Tenant Improvement Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease not yet commenced, option to extend term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Lease Not Yet Commenced Renewal Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Weighted Average Discount Rate Percent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total undiscounted lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Imputed interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tenant improvement receivables</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Tenant Improvement Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Current portion</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLeaseVariableLeaseExpense" xlink:type="locator" xlink:label="adpt_OperatingLeaseVariableLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLeaseVariableLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease variable lease expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_OperatingLeaseVariableLeaseExpense" xlink:to="adpt_OperatingLeaseVariableLeaseExpense_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLeaseVariableLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease variable lease expense</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLeaseVariableLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Variable Lease Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Rent Expense Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in measurement of lease liabilities, net of tenant improvement allowances received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash received for tenant improvement allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Proceeds From Tenant Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ROU assets obtained in exchange for operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Asset Obtained In Exchange For Operating Lease Liability</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfCommonStockVotingRights" xlink:type="locator" xlink:label="adpt_NumberOfCommonStockVotingRights" />
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfCommonStockVotingRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of common stock voting rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NumberOfCommonStockVotingRights" xlink:to="adpt_NumberOfCommonStockVotingRights_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and nineteen equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Nineteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock voting rights description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfCommonStockVotingRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of vote for each share</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NumberOfCommonStockVotingRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Common Stock Voting Rights</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" xlink:type="locator" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock options and restricted stock units granted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" xlink:to="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of Outstanding Common Stock Options and Vesting of Outstanding Common Restricted Stock Units Granted</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Options And Restricted Stock Units Granted [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Grant</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total shares of common stock reserved for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_PercentageOfAnnualIncreasesInNumberOfShares" xlink:type="locator" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares" />
    <link:label xml:lang="en-US" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of annual increases in number of shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_PercentageOfAnnualIncreasesInNumberOfShares" xlink:to="adpt_PercentageOfAnnualIncreasesInNumberOfShares_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of annual increases in number of shares</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Annual Increases In Number Of Shares</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in share reserve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightsTerm" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightsTerm" />
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightsTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or rights, term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ClassOfWarrantOrRightsTerm" xlink:to="adpt_ClassOfWarrantOrRightsTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrant issued to purchase stock</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightsTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercisable term</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ClassOfWarrantOrRightsTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Rights Term</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issued during period, common stock</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award outstanding number.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequentaTwoThousandAndEightStockPlanMember" xlink:type="locator" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sequenta two thousand and eight stock plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SequentaTwoThousandAndEightStockPlanMember" xlink:to="adpt_SequentaTwoThousandAndEightStockPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sequenta 2008 Stock Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sequenta Two Thousand And Eight Stock Plan [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and nine equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_TwoThousandAndNineEquityIncentivePlanMember" xlink:to="adpt_TwoThousandAndNineEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2009 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Nine Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonEmployeeDirectorsMember" xlink:type="locator" xlink:label="adpt_NonEmployeeDirectorsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_NonEmployeeDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-employee directors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NonEmployeeDirectorsMember" xlink:to="adpt_NonEmployeeDirectorsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_NonEmployeeDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Employee Directors</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NonEmployeeDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Employee Directors [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Valuation Model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique Option Pricing Model [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares available for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity awards outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award increase reserve shares available for grant,</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment awards granted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment awards forfeited, canceled or expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Shares Available for Grant, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available for Grant, 2019 Equity Incentive Plan reserve increase</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Increase Reserve Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Available for Grant, Options and restricted stock units granted</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Awards Granted</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available for Grant, Options and restricted stock units forfeited, cancelled or expired</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Awards Forfeited Canceled Or Expired</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Shares Available for Grant, Outstanding, Ending Balance</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options vested and exercisable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Shares Subject to Outstanding Options, Options outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Subject to Outstanding Options, Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Subject to Outstanding Options, Options forfeited or cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Subject to Outstanding Options, Options expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Subject to Outstanding Options, Options exercised</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Shares Subject to Outstanding Options, Options outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Subject to Outstanding Options, Options vested and exercisable</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options vested and exercisable weighted average exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Exercise Price per Share, Options outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share, Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share, Options forfeited or cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share, Options expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share, Options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Exercise Price per Share, Options outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share, Options vested and exercisable</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options vested and exercisable intrinsic value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Option outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Options vested and exercisable</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" />
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award vested and exercisable options outstanding weighted average remaining contractual term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining contractual life options outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining contractual life vested and exercisable options outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Vested And Exercisable Options Outstanding Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" xlink:type="locator" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" />
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from settlement of stock option exercised in prior periods.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" xlink:to="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from settlement of stock option exercised in prior periods</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Settlement Of Stock Option Exercised In Prior Periods</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Restricted Stock Units Outstanding, Nonvested Outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units Outstanding, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted Stock Units Outstanding, Forfeited or cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted Stock Units Outstanding, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Restricted Stock Units Outstanding, Nonvested Outstanding, Ending Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Forfeited or cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Ending Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling And Marketing Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total share-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized share-based compensation expense related to unvested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized share-based compensation expense related to unvested stock options, weighted-average period for recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized share-based compensation expense related to unvested RSUs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" />
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum service consumption requirement amount under license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" xlink:to="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" />
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum service consumption requirement term under license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" xlink:to="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CollaborationArrangementDisclosureAbstract" xlink:type="locator" xlink:label="adpt_CollaborationArrangementDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="adpt_CollaborationArrangementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration Arrangement Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CollaborationArrangementDisclosureAbstract" xlink:to="adpt_CollaborationArrangementDisclosureAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CollaborationArrangementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Arrangement Disclosure [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Fair Value Off Balance Sheet Risks [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Off Balance Sheet Risks [Table]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MicrosoftCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_MicrosoftCollaborationAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_MicrosoftCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Microsoft collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_MicrosoftCollaborationAgreementMember" xlink:to="adpt_MicrosoftCollaborationAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_MicrosoftCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Microsoft Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MicrosoftCollaborationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Microsoft Collaboration Agreement [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesFOneConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series F one convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_SeriesFOneConvertiblePreferredStockMember" xlink:to="adpt_SeriesFOneConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series F-1 Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series F One Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum service consumption requirement amount</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Service Consumption Requirement Amount Under License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum service consumption requirement term</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Service Consumption Requirement Term Under License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">preferred stock investment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Domestic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Foreign</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total loss before provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsNonQualifiedStockOptions" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, non qualified stock options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DeferredTaxAssetsNonQualifiedStockOptions" xlink:to="adpt_DeferredTaxAssetsNonQualifiedStockOptions_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="adpt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities, tangible and intangible assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" xlink:to="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right of use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="adpt_DeferredTaxLiabilitiesRightOfUseAssets_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards General Business</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonqualifying stock options</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Non Qualified Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Lease Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Deferred Income</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred tax assets, net of valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Net [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tangible and intangible assets</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Tangible And Intangible Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">ROU assets</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Right Of Use Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesLineItems" xlink:type="locator" xlink:label="adpt_IncomeTaxesLineItems" />
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_IncomeTaxesLineItems_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesTable" xlink:type="locator" xlink:label="adpt_IncomeTaxesTable" />
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_IncomeTaxesTable" xlink:to="adpt_IncomeTaxesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Country [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NetOperatingLossCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Operating Loss Carryforward Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_NetOperatingLossCarryforwardExpirationPeriod" xlink:to="adpt_NetOperatingLossCarryforwardExpirationPeriod_lbl" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLossCarryforwardsExpirationYear" xlink:type="locator" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear" />
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Loss Carryforwards, Expiration Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_OperatingLossCarryforwardsExpirationYear" xlink:to="adpt_OperatingLossCarryforwardsExpirationYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity period for NOLs carryovers</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforward Expiration Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal NOLs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardLimitationsOnUse" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards expiration year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:to="us-gaap_TaxCreditCarryforwardLimitationsOnUse_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Limitations On Use</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOLs expiration year</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Expiration Year</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:label xml:lang="en-US" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation Permanent Items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:to="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax, net of federal tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation State And Local Income Taxes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Permanent Items</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Tax Credits</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Other Adjustments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Continuing Operations</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Uncertain tax positions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest or penalties related to uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss attributable to Adaptive Biotechnologies Corporation</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Fair value adjustment to redemption value for Series E-1 convertible preferred stock options</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="adpt_UnvestedRestrictedStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_UnvestedRestrictedStockUnitsMember" xlink:to="adpt_UnvestedRestrictedStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonvested Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Units [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockWarrantsMember" xlink:type="locator" xlink:label="adpt_CommonStockWarrantsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock warrants member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_CommonStockWarrantsMember" xlink:to="adpt_CommonStockWarrantsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_CommonStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrants [Member]</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConvertiblePreferredStockWarrantsMember" xlink:type="locator" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember" />
    <link:label xml:lang="en-US" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock warrants member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_ConvertiblePreferredStockWarrantsMember" xlink:to="adpt_ConvertiblePreferredStockWarrantsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock Warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Warrants [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" xlink:type="locator" xlink:label="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" />
    <link:label xml:lang="en-US" xlink:label="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined contribution plan employee service period for vesting.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" xlink:to="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees maximum annual contribution of their compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Maximum Annual Contributions Per Employee Percent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employer discretionary contribution amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee service period for vesting</link:label>
    <link:label xml:lang="en-US" xlink:label="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employee Service Period For Vesting</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>30
<FILENAME>adpt-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-13T23:36:31.8853976+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 83f9d20f95644b1c8764edc14d02d31a -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/role/TemplateLink" xlink:href="adpt-20211231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="adpt-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:type="locator" xlink:label="us-gaap_MinorityInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_Liabilities" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_MinorityInterest" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestAndOtherIncome" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_ProfitLoss" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" xlink:type="locator" xlink:label="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" xlink:type="locator" xlink:label="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts" order="11980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant" order="12380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised" order="12580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" order="12640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="12780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="12980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="13000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested" order="13180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" order="13380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions" order="13420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue" order="13580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions" order="13780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="13980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="14180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_li0l2" order="14380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_li0l2" order="14400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_li0l2" order="14420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="14440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="adpt-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" xlink:type="locator" xlink:label="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:type="locator" xlink:label="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" xlink:type="locator" xlink:label="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:type="locator" xlink:label="us-gaap_ProceedsFromContributedCapital" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" xlink:type="locator" xlink:label="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="adpt_IncreaseDecreaseInDeferredRent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NoncashLeaseExpense" xlink:type="locator" xlink:label="adpt_NoncashLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="adpt_NoncashLeaseExpense" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="adpt_IncreaseDecreaseInDeferredRent" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="12270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant" order="12330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromContributedCapital" order="12390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="12450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="12870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="12930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness" xlink:href="adpt-20211231.xsd#Role_DisclosureOrganizationAndDescriptionOfBusiness" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenue" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="adpt-20211231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNet" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities" xlink:href="adpt-20211231.xsd#Role_DisclosureAccruedLiabilities" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenue" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredRevenueTextBlock" xlink:type="locator" xlink:label="adpt_DeferredRevenueTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="adpt_DeferredRevenueTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases" xlink:href="adpt-20211231.xsd#Role_DisclosureLeases" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="adpt-20211231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlans" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement" xlink:href="adpt-20211231.xsd#Role_DisclosureMicrosoftCollaborationAgreement" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders" xlink:href="adpt-20211231.xsd#Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan" xlink:href="adpt-20211231.xsd#Role_DisclosureRetirementPlan" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SalesAndMarketingExpensePolicyTextBlock" xlink:type="locator" xlink:label="adpt_SalesAndMarketingExpensePolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractBalancesPolicyTextBlock" xlink:type="locator" xlink:label="adpt_ContractBalancesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" xlink:type="locator" xlink:label="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" xlink:type="locator" xlink:label="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_ContractBalancesPolicyTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_SalesAndMarketingExpensePolicyTextBlock" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="locator" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenueTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="adpt-20211231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables" xlink:href="adpt-20211231.xsd#Role_DisclosureAccruedLiabilitiesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquityTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" xlink:type="locator" xlink:label="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables" xlink:href="adpt-20211231.xsd#Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DigitalBiotechnologiesIncMember" xlink:type="locator" xlink:label="adpt_DigitalBiotechnologiesIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="srt_OwnershipAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="adpt_DigitalBiotechnologiesIncMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfRevenuePerformanceObligation" xlink:type="locator" xlink:label="adpt_NumberOfRevenuePerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:type="locator" xlink:label="us-gaap_UnbilledReceivablesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashNoncurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesCConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesCConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_SignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="adpt_SeriesCConvertiblePreferredStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="adpt_SignificantAccountingPoliciesLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnbilledReceivablesCurrent" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="adpt_NumberOfRevenuePerformanceObligation" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdvertisingExpense" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncAndRocheGroupMember" xlink:type="locator" xlink:label="adpt_GenentechIncAndRocheGroupMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerBMember" xlink:type="locator" xlink:label="adpt_CustomerBMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CustomerAMember" xlink:type="locator" xlink:label="adpt_CustomerAMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="adpt_SignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="adpt_SignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_CustomerAMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_CustomerBMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncAndRocheGroupMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesTable" xlink:to="adpt_SignificantAccountingPoliciesLineItems" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_FurnitureAndOfficeEquipmentMember" xlink:type="locator" xlink:label="adpt_FurnitureAndOfficeEquipmentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerEquipmentAndSoftwareMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="adpt_LaboratoryEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_LaboratoryEquipmentMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_ComputerEquipmentAndSoftwareMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_FurnitureAndOfficeEquipmentMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueRegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueRegulatoryMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentSupportRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentSupportRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentSupportRevenueMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueRegulatoryMilestonesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureRevenueAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionExpectedPeriod" xlink:type="locator" xlink:label="adpt_RevenueRecognitionExpectedPeriod" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" xlink:type="locator" xlink:label="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonRefundableUpfrontPaymentsReceived" xlink:type="locator" xlink:label="adpt_NonRefundableUpfrontPaymentsReceived" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AdditionalMilestonePayment" xlink:type="locator" xlink:label="adpt_AdditionalMilestonePayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommercialMilestonesMember" xlink:type="locator" xlink:label="adpt_CommercialMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentMilestonesMember" xlink:type="locator" xlink:label="adpt_DevelopmentMilestonesMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_RegulatoryMilestonesMember" xlink:type="locator" xlink:label="adpt_RegulatoryMilestonesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_GenentechCollaborationAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MRDDevelopmentAgreementsMember" xlink:type="locator" xlink:label="adpt_MRDDevelopmentAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_MRDDevelopmentAgreementsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_GenentechCollaborationAgreementMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_RegulatoryMilestonesMember" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_DevelopmentMilestonesMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="adpt_CommercialMilestonesMember" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_AdditionalMilestonePayment" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_NonRefundableUpfrontPaymentsReceived" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_RevenueRecognitionExpectedPeriod" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" xlink:type="locator" xlink:label="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" order="10060.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_InterestReceivableCurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ComputerSoftwareMember" xlink:type="locator" xlink:label="adpt_ComputerSoftwareMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_FurnitureAndOfficeEquipmentMember" xlink:type="locator" xlink:label="adpt_FurnitureAndOfficeEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="adpt_LaboratoryEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_LaboratoryEquipmentMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_FurnitureAndOfficeEquipmentMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="adpt_ComputerSoftwareMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems" xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_GoodwillLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" xlink:type="locator" xlink:label="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" xlink:type="locator" xlink:label="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureAccruedLiabilitiesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" xlink:type="locator" xlink:label="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:type="locator" xlink:label="adpt_ContractWithCustomerLiabilityCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityCurrentAbstract" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_ContractWithCustomerLiabilityCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_ContractWithCustomerLiabilityNonCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SpecificPatientsMember" xlink:type="locator" xlink:label="adpt_SpecificPatientsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MedicareRevenueMember" xlink:type="locator" xlink:label="adpt_MedicareRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequencingRevenueMember" xlink:type="locator" xlink:label="adpt_SequencingRevenueMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DevelopmentRevenueMember" xlink:type="locator" xlink:label="adpt_DevelopmentRevenueMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_DevelopmentRevenueMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_SequencingRevenueMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="adpt_MedicareRevenueMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_SpecificPatientsMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueAdditionalInformationDetails1" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_GenentechIncMember" xlink:type="locator" xlink:label="adpt_GenentechIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="adpt_GenentechIncMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiability" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiability_li0l2" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLeaseVariableLeaseExpense" xlink:type="locator" xlink:label="adpt_OperatingLeaseVariableLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfOperatingLeaseTerminate" xlink:type="locator" xlink:label="adpt_NumberOfOperatingLeaseTerminate" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseTerminationPeriod" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseTerminationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementAllowanceAndCommenced" xlink:type="locator" xlink:label="adpt_TenantImprovementAllowanceAndCommenced" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:type="locator" xlink:label="us-gaap_TenantImprovements" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsReceivable" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsReceivable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TenantImprovementCostsIncurred" xlink:type="locator" xlink:label="adpt_TenantImprovementCostsIncurred" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromLandlordReimbursements" xlink:type="locator" xlink:label="adpt_ProceedsFromLandlordReimbursements" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:type="locator" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="adpt_LeaseExpirationMonthAndYear" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseExtendedTermOfContract" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseExtendedTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA" xlink:type="locator" xlink:label="stpr_WA" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_WA" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfLand" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseRentCommencementMonthAndYear" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseExtendedTermOfContract" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LeaseExpirationMonthAndYear" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LettersOfCreditOutstandingAmount" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LeaseCommencementMonthAndYear" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseholdImprovementsGross" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_ProceedsFromLandlordReimbursements" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementCostsIncurred" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementCostsReceivable" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_TenantImprovements" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_TenantImprovementAllowanceAndCommenced" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="12620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseTerminationPeriod" order="12720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_NumberOfOperatingLeaseTerminate" order="12820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription" order="13020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" order="13120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable" order="13220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" order="13320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="13450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="adpt_OperatingLeaseVariableLeaseExpense" order="13510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="13570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="13630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance" order="13690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="13750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="13810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" xlink:type="locator" xlink:label="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_LesseeDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquityAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" xlink:type="locator" xlink:label="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ClassOfWarrantOrRightsTerm" xlink:type="locator" xlink:label="adpt_ClassOfWarrantOrRightsTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_PercentageOfAnnualIncreasesInNumberOfShares" xlink:type="locator" xlink:label="adpt_PercentageOfAnnualIncreasesInNumberOfShares" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NumberOfCommonStockVotingRights" xlink:type="locator" xlink:label="adpt_NumberOfCommonStockVotingRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesCConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesCConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="adpt_SeriesCConvertiblePreferredStockMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_NumberOfCommonStockVotingRights" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_PercentageOfAnnualIncreasesInNumberOfShares" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_ClassOfWarrantOrRightsTerm" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" xlink:type="locator" xlink:label="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember_li0l2" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_PlanNameAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" xlink:type="locator" xlink:label="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NonEmployeeDirectorsMember" xlink:type="locator" xlink:label="adpt_NonEmployeeDirectorsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineEquityIncentivePlanMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SequentaTwoThousandAndEightStockPlanMember" xlink:type="locator" xlink:label="adpt_SequentaTwoThousandAndEightStockPlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_SequentaTwoThousandAndEightStockPlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineEquityIncentivePlanMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="adpt_NonEmployeeDirectorsMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" xlink:type="locator" xlink:label="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="adpt_TwoThousandAndNineteenEquityIncentivePlanMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" xlink:type="locator" xlink:label="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_SeriesFOneConvertiblePreferredStockMember" xlink:type="locator" xlink:label="adpt_SeriesFOneConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_MicrosoftCollaborationAgreementMember" xlink:type="locator" xlink:label="adpt_MicrosoftCollaborationAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CollaborationArrangementDisclosureAbstract" xlink:type="locator" xlink:label="adpt_CollaborationArrangementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_CollaborationArrangementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="adpt_MicrosoftCollaborationAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="adpt_SeriesFOneConvertiblePreferredStockMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_PreferredStockValue" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" xlink:type="locator" xlink:label="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DeferredTaxAssetsNonQualifiedStockOptions" xlink:type="locator" xlink:label="adpt_DeferredTaxAssetsNonQualifiedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="adpt_DeferredTaxAssetsNonQualifiedStockOptions" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="adpt_DeferredTaxAssetsOperatingLeaseLiabilities" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="adpt_DeferredTaxLiabilitiesRightOfUseAssets" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_OperatingLossCarryforwardsExpirationYear" xlink:type="locator" xlink:label="adpt_OperatingLossCarryforwardsExpirationYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardLimitationsOnUse" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_NetOperatingLossCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="adpt_NetOperatingLossCarryforwardExpirationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesLineItems" xlink:type="locator" xlink:label="adpt_IncomeTaxesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_IncomeTaxesTable" xlink:type="locator" xlink:label="adpt_IncomeTaxesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="adpt_IncomeTaxesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesTable" xlink:to="adpt_IncomeTaxesLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_NetOperatingLossCarryforwardExpirationPeriod" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLimitationsOnUse" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="adpt_OperatingLossCarryforwardsExpirationYear" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adpt_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="adpt_EffectiveIncomeTaxRateReconciliationPermanentItems" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail" xlink:href="adpt-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_li0l2" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_ConvertiblePreferredStockWarrantsMember" xlink:type="locator" xlink:label="adpt_ConvertiblePreferredStockWarrantsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_CommonStockWarrantsMember" xlink:type="locator" xlink:label="adpt_CommonStockWarrantsMember" />
    <link:loc xlink:href="adpt-20211231.xsd#adpt_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="adpt_UnvestedRestrictedStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_UnvestedRestrictedStockUnitsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_CommonStockWarrantsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="adpt_ConvertiblePreferredStockWarrantsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails" xlink:href="adpt-20211231.xsd#Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails">
    <link:loc xlink:href="adpt-20211231.xsd#adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" xlink:type="locator" xlink:label="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="adpt_DefinedContributionPlanEmployeeServicePeriodForVesting" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205140232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 10, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADPT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADAPTIVE BIOTECHNOLOGIES CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001478320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,951,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,583,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0907024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1165 Eastlake Avenue East<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Seattle<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">659-0067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated herein by reference from the registrant&#8217;s definitive proxy statement relating to the Annual Meeting of Shareholders to be held in 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Seattle, Washington<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207485224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 139,065,000<span></span>
</td>
<td class="nump">$ 123,436,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities (amortized cost of $214,115 and $564,036, respectively)</a></td>
<td class="nump">213,996,000<span></span>
</td>
<td class="nump">564,833,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">17,409,000<span></span>
</td>
<td class="nump">10,047,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">19,263,000<span></span>
</td>
<td class="nump">14,063,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13,015,000<span></span>
</td>
<td class="nump">14,535,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">402,748,000<span></span>
</td>
<td class="nump">726,914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">85,262,000<span></span>
</td>
<td class="nump">39,692,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">87,678,000<span></span>
</td>
<td class="nump">99,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term marketable securities (amortized cost of $218,163 and $118,429, respectively)</a></td>
<td class="nump">217,145,000<span></span>
</td>
<td class="nump">118,525,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">2,138,000<span></span>
</td>
<td class="nump">2,138,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">8,526,000<span></span>
</td>
<td class="nump">10,225,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">118,972,000<span></span>
</td>
<td class="nump">118,972,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">875,000<span></span>
</td>
<td class="nump">598,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">923,344,000<span></span>
</td>
<td class="nump">1,116,414,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,307,000<span></span>
</td>
<td class="nump">3,237,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">9,343,000<span></span>
</td>
<td class="nump">13,162,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">15,642,000<span></span>
</td>
<td class="nump">11,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">5,055,000<span></span>
</td>
<td class="nump">3,529,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of deferred revenue</a></td>
<td class="nump">80,460,000<span></span>
</td>
<td class="nump">73,319,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">113,807,000<span></span>
</td>
<td class="nump">105,197,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, less current portion</a></td>
<td class="nump">106,685,000<span></span>
</td>
<td class="nump">104,333,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, less current portion</a></td>
<td class="nump">98,750,000<span></span>
</td>
<td class="nump">163,618,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">319,242,000<span></span>
</td>
<td class="nump">373,148,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $0.0001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020; no shares issued and outstanding at December 31, 2021 and 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.0001 par value, 340,000,000 shares authorized at December 31, 2021 and 2020; 141,393,865 and 137,646,896 shares issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,324,006,000<span></span>
</td>
<td class="nump">1,253,971,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) gain</a></td>
<td class="num">(1,137,000)<span></span>
</td>
<td class="nump">893,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(718,891,000)<span></span>
</td>
<td class="num">(511,612,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Adaptive Biotechnologies Corporation shareholders&#8217; equity</a></td>
<td class="nump">603,992,000<span></span>
</td>
<td class="nump">743,266,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">604,102,000<span></span>
</td>
<td class="nump">743,266,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 923,344,000<span></span>
</td>
<td class="nump">$ 1,116,414,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205114536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized cost of short-term marketable securities</a></td>
<td class="nump">$ 214,115<span></span>
</td>
<td class="nump">$ 564,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent', window );">Amortized cost of long-term marketable securities</a></td>
<td class="nump">$ 218,163<span></span>
</td>
<td class="nump">$ 118,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized</a></td>
<td class="nump">340,000,000<span></span>
</td>
<td class="nump">340,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued</a></td>
<td class="nump">141,393,865<span></span>
</td>
<td class="nump">137,646,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding</a></td>
<td class="nump">141,393,865<span></span>
</td>
<td class="nump">137,646,896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205197160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154,344<span></span>
</td>
<td class="nump">$ 98,382<span></span>
</td>
<td class="nump">$ 85,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">49,301<span></span>
</td>
<td class="nump">22,530<span></span>
</td>
<td class="nump">22,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">142,343<span></span>
</td>
<td class="nump">116,072<span></span>
</td>
<td class="nump">70,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">95,465<span></span>
</td>
<td class="nump">61,358<span></span>
</td>
<td class="nump">38,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">74,502<span></span>
</td>
<td class="nump">49,536<span></span>
</td>
<td class="nump">30,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">363,310<span></span>
</td>
<td class="nump">251,199<span></span>
</td>
<td class="nump">163,462<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(208,966)<span></span>
</td>
<td class="num">(152,817)<span></span>
</td>
<td class="num">(78,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">1,668<span></span>
</td>
<td class="nump">6,590<span></span>
</td>
<td class="nump">9,785<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(207,298)<span></span>
</td>
<td class="num">(146,227)<span></span>
</td>
<td class="num">(68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Add: Net loss attributable to noncontrolling interest</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Adaptive Biotechnologies Corporation</a></td>
<td class="num">(207,279)<span></span>
</td>
<td class="num">(146,227)<span></span>
</td>
<td class="num">(68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Fair value adjustment to Series E-1 convertible preferred stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders</a></td>
<td class="num">$ (207,279)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (69,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</a></td>
<td class="num">$ (1.48)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (1.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</a></td>
<td class="nump">140,354,915<span></span>
</td>
<td class="nump">131,216,468<span></span>
</td>
<td class="nump">69,165,315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember', window );">Sequencing Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 78,896<span></span>
</td>
<td class="nump">$ 41,439<span></span>
</td>
<td class="nump">$ 43,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 75,448<span></span>
</td>
<td class="nump">$ 56,943<span></span>
</td>
<td class="nump">$ 41,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_SequencingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207734536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (207,298)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gains and losses on investments</a></td>
<td class="num">(2,030)<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">778<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(209,328)<span></span>
</td>
<td class="num">(146,005)<span></span>
</td>
<td class="num">(67,828)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Add: Comprehensive loss attributable to noncontrolling interest</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Adaptive Biotechnologies Corporation</a></td>
<td class="num">$ (209,309)<span></span>
</td>
<td class="num">$ (146,005)<span></span>
</td>
<td class="num">$ (67,828)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206497496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Shareholders' (Deficit) Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Revision of Prior Period, Accounting Standards Update, Adjustment</div></th>
<th class="th"><div>Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Gain</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Revision of Prior Period, Accounting Standards Update, Adjustment</div>
</th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="num">$ (258,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 37,902<span></span>
</td>
<td class="num">$ (107)<span></span>
</td>
<td class="num">$ (295,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,841,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, Beginning Balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 560,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, Beginning Balance, Shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,790,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from initial public offering/ issuance of common stock upon public offering, net of underwriters' discounts and commissions and net offering costs paid by us</a></td>
<td class="nump">320,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">320,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds from initial public offering, net of underwriters' discounts and commissions, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts', window );">Initial public offering costs</a></td>
<td class="num">(4,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock</a></td>
<td class="nump">561,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (561,931)<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">561,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,039,737)<span></span>
</td>
<td class="nump">93,039,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant', window );">Conversion of convertible preferred stock warrant to common stock warrant</a></td>
<td class="nump">2,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised', window );">Issuance of common stock upon exercise of common stock warrants</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised', window );">Issuance of common stock upon exercise of common stock warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options</a></td>
<td class="nump">4,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,043,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions', window );">Change in redemption value for vested Series E-1 convertible preferred stock options</a></td>
<td class="num">(964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions', window );">Change in redemption value for vested Series E-1 convertible preferred stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue', window );">Common stock option and restricted stock unit share-based compensation</a></td>
<td class="nump">13,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(68,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">571,039<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">935,834<span></span>
</td>
<td class="nump">671<span></span>
</td>
<td class="num">(365,478)<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,238,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from initial public offering/ issuance of common stock upon public offering, net of underwriters' discounts and commissions and net offering costs paid by us</a></td>
<td class="nump">$ 271,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">271,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds from initial public offering, net of underwriters' discounts and commissions, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update Extensible List</a></td>
<td class="text">ASC 842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options</a></td>
<td class="nump">$ 21,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">21,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,204,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue', window );">Common stock option and restricted stock unit share-based compensation</a></td>
<td class="nump">24,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(146,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">743,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">1,253,971<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="num">(511,612)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,646,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised', window );">Issuance of common stock upon exercise of common stock warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options</a></td>
<td class="nump">$ 26,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock for cash upon exercise of stock options, Shares</a></td>
<td class="nump">3,674,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,674,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue', window );">Common stock option and restricted stock unit share-based compensation</a></td>
<td class="nump">$ 43,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions', window );">Capital contributions for Digital Biotechnologies, Inc.</a></td>
<td class="nump">429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2,030)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,030)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(207,298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 604,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1,324,006<span></span>
</td>
<td class="num">$ (1,137)<span></span>
</td>
<td class="num">$ (718,891)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,393,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital capital contributions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital conversion of convertible preferred stock warrant to common stock warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital, initial public offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid In capital share based compensation stock option and restricted stock unit requisite service period recognition value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in redemption value for vested convertible preferred stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, shares, common stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares restricted stock award vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, value, common stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, stock issued during period, shares, new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity value change in redemption value for vested convertible preferred stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206350568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (207,298)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">12,254<span></span>
</td>
<td class="nump">6,769<span></span>
</td>
<td class="nump">6,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NoncashLeaseExpense', window );">Noncash lease expense</a></td>
<td class="nump">7,028<span></span>
</td>
<td class="nump">3,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">43,251<span></span>
</td>
<td class="nump">24,761<span></span>
</td>
<td class="nump">13,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible assets amortization</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Investment amortization</a></td>
<td class="nump">7,233<span></span>
</td>
<td class="nump">773<span></span>
</td>
<td class="num">(4,463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of convertible preferred stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(78)<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(7,362)<span></span>
</td>
<td class="nump">2,613<span></span>
</td>
<td class="num">(7,817)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(5,200)<span></span>
</td>
<td class="num">(4,994)<span></span>
</td>
<td class="num">(1,231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,286<span></span>
</td>
<td class="num">(1,362)<span></span>
</td>
<td class="num">(8,576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">3,940<span></span>
</td>
<td class="nump">7,495<span></span>
</td>
<td class="nump">6,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities', window );">Operating lease right-of-use assets and liabilities</a></td>
<td class="nump">8,522<span></span>
</td>
<td class="num">(886)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(57,727)<span></span>
</td>
<td class="num">(43,389)<span></span>
</td>
<td class="nump">266,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(275)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="num">(597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(192,727)<span></span>
</td>
<td class="num">(149,683)<span></span>
</td>
<td class="nump">205,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(61,746)<span></span>
</td>
<td class="num">(18,803)<span></span>
</td>
<td class="num">(11,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(316,544)<span></span>
</td>
<td class="num">(694,965)<span></span>
</td>
<td class="num">(884,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of marketable securities</a></td>
<td class="nump">559,500<span></span>
</td>
<td class="nump">596,724<span></span>
</td>
<td class="nump">413,720<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">181,210<span></span>
</td>
<td class="num">(117,044)<span></span>
</td>
<td class="num">(481,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">26,717<span></span>
</td>
<td class="nump">21,748<span></span>
</td>
<td class="nump">4,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering of common stock, net of underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,160<span></span>
</td>
<td class="nump">320,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of public offering costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(321)<span></span>
</td>
<td class="num">(4,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant', window );">Proceeds from issuance of common stock upon the exercise of a common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Proceeds from initial capital contributions for Digital Biotechnologies, Inc.</a></td>
<td class="nump">429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">27,146<span></span>
</td>
<td class="nump">293,587<span></span>
</td>
<td class="nump">319,916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">15,629<span></span>
</td>
<td class="nump">26,860<span></span>
</td>
<td class="nump">43,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">125,574<span></span>
</td>
<td class="nump">98,714<span></span>
</td>
<td class="nump">55,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">141,203<span></span>
</td>
<td class="nump">125,574<span></span>
</td>
<td class="nump">98,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">$ 682<span></span>
</td>
<td class="nump">4,679<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Noncash additions to property through lease financing arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease', window );">Derecognition of lease financing arrangements upon adoption of guidance on accounting for leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering', window );">Conversion of convertible preferred stock to common stock upon closing of initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering', window );">Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible preferred stock to common stock upon closing of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognition of lease financing arrangements upon adoption of guidance on accounting for lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating lease right-of-use assets and liabilities .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock upon exercise of common stock warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205111352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Organization and Description of Business</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Organization<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Description of Business</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies Corporation (&#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is a commercial-stage company advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#8217;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient&#8217;s immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and services that we are tailoring to each individual patient. We have commercial products and services and a robust pipeline of clinical products and services that we are designing to diagnose, monitor and enable the treatment of diseases, such as cancer, autoimmune disorders and infectious diseases.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in the State of Washington on September&#160;8, 2009 under the name Adaptive TCR Corporation. On December&#160;21, 2011, we changed our name to Adaptive Biotechnologies Corporation. We are headquartered in Seattle, Washington.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Digital Biotechnologies, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, we formed a subsidiary, Spin Technologies, Inc., to facilitate the development of a potential new early-stage sequencing technology that is ancillary to our core business. In February 2022, the subsidiary&#8217;s name was changed to Digital Biotechnologies, Inc. We have a 70% ownership interest in Digital Biotechnologies, Inc. All intercompany transactions and balances between us and Digital Biotechnologies, Inc. have been eliminated in consolidation. The remaining interest, held by certain of our related parties and related family trusts, was reported as noncontrolling interest in our consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207891240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">Significant</span><span style="letter-spacing:0.05pt;color:#000000;"> </span><span style="color:#000000;">Accounting</span><span style="letter-spacing:-0.05pt;color:#000000;"> </span><span style="color:#000000;">Policies</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Basis<span style="letter-spacing:-0.05pt;"> </span>of Presentation and<span style="letter-spacing:-0.05pt;"> Principles of Consolidation</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of Adaptive Biotechnologies Corporation, its wholly-owned subsidiary and Digital Biotechnologies, Inc. Other shareholders&#8217; interests in Digital Biotechnologies, Inc. are shown in the consolidated financial statements as noncontrolling interest. All intercompany transactions and balances have been eliminated upon consolidation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. Estimates are used in several areas including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, share-based compensation, including the fair value of stock, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#8217;s estimates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are stated at fair value. Cash equivalents include only securities having an original maturity of three months or less at the time of purchase. We limit our credit risk associated with cash and cash equivalents by placing our investments with banks that we believe are highly creditworthy and with highly rated money market funds. Cash and cash equivalents primarily consist of bank deposits and investments in money market funds.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are required to maintain certain balances under lease arrangements for some of our property and facility leases. We had restricted cash of <span>$2.1</span> million as of December 31, 2021 and 2020.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Investments in Marketable Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities are classified as&#160;available-for-sale, consist of U.S. government debt securities and corporate bonds and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of shareholders&#8217; equity in accumulated other comprehensive gain (loss) until realized. Realized gains and losses on the sale of these securities are recognized in net income or loss. The cost of marketable securities sold is based on the specific identification method.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations<span style="letter-spacing:-0.05pt;"> </span>of Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to a concentration of risk from a limited number of suppliers, or in certain cases, single suppliers for some of our laboratory instruments and materials. This risk is managed by targeting a quantity of surplus stock. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and marketable securities are financial instruments that potentially subject us to concentrations of credit risk. We invest in money market funds, U.S. government debt securities, U.S. government agency securities, commercial paper and corporate bonds with high-quality accredited financial institutions. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant customers are those that represent more than 10% of our total revenue or accounts receivable, net balances for the periods and as of each date presented, respectively. Revenue from these customers reflects their purchase of our products and services and our collaboration efforts with Genentech.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounts Receivable, Net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.9%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Genentech, Inc. and Roche Group</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* less than 10%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accounts Receivable</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable consists of amounts due from customers for services performed. We review our accounts receivable for credit impairment and regularly analyze the status of significant past due receivables to determine if any will potentially be uncollectible to estimate the amount of allowance necessary to reduce accounts receivable to its estimated net realizable value.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, we had $0.2 million and $0.9 million of unbilled receivables as of December&#160;31, 2021 and 2020, respectively. These contract assets are amounts that will become due for which we have an unconditional right to consideration.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Inventory</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory consists of laboratory materials and supplies used in lab analysis. We capitalize inventory when purchased and record expense upon order fulfillment for servicing revenue or utilization in our research and development laboratories. Inventory is valued at the lower of cost or market on a&#160;first-in,&#160;first-out&#160;basis. We periodically perform obsolescence assessments and write off any inventory that is no longer usable.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consists of computer equipment, computer software, laboratory equipment, leasehold improvements and furniture and office equipment. Property and equipment are recorded at cost and depreciation is recognized using the straight-line method based on estimated useful life. Maintenance and repairs are charged to expense as incurred and costs of improvements are capitalized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Useful lives assigned to property and equipment are as follows:</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;">
<tr>
<td style="width:223.55pt;"/>
<td style="width:7.85pt;"/>
<td style="width:223.5pt;"/>
</tr>
<tr>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 7 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shorter of estimated useful life or remaining lease term</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 5 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 10 years</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We review long-lived assets for impairment whenever events or circumstances indicate the carrying amount of an asset group may not be recoverable. Gains and losses from asset disposals and impairment losses are classified within our consolidated statements of operations in accordance with the use of the asset.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1, or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we so determine, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have not recognized any impairment of goodwill.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date, which is regarded as their cost.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets may also result from the purchase of assets and intellectual property in a transaction that does not qualify as a business combination. Intangible assets are amortized over their estimated useful lives on a straight-line basis which approximates their usage pattern. Intangible assets are reviewed for impairment at least annually or if indicators of potential impairment exist. We have not recognized any impairment losses on intangible assets.</p>
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Leases</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determine if an arrangement contains a lease at inception. We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy, as well as server space. Operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the date the underlying asset becomes available for our use and are based on the present value of the future minimum lease payments over the lease term. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. As our leases generally do not provide an implicit interest rate, the present value of our future minimum lease payments is determined using our incremental borrowing rate. This rate is an estimate of the collateralized borrowing rate we would incur on our future lease payments over a similar term and is based on the information available to us at the lease commencement date, or as of January 1, 2020 for commenced leases that existed as of our adoption of <span style="Background-color:#FFFFFF;">Accounting Standards Update No. 2016-02, </span><span style="font-style:italic;Background-color:#FFFFFF;">Leases</span><span style="Background-color:#FFFFFF;"> (Topic 842) (&#8220;ASC 842&#8221;)</span>. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of our leases contain options to extend or terminate the lease; lease terms are adjusted for these options only when it is reasonably certain we will exercise these options. Our lease agreements do not contain residual value guarantees or covenants.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have made a policy election regarding our real estate leases not to separate nonlease components from lease components, to the extent they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease expense. Our leases for laboratory, office and warehouse facilities typically include variable nonlease components, such as common-area maintenance costs. We have also elected not to record on our consolidated balance sheets a lease that has a lease term of twelve months or less and does not contain a purchase option that we are reasonably certain to exercise.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expense is recognized on a straight-line basis over the terms of the leases. Incentives granted under our facilities leases, including rent holidays, are recognized as adjustments to lease expense on a straight-line basis over the terms of the leases.  </p>
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Financial Accounting Standards Board (&#8220;FASB&#8221;) has defined fair value as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The FASB established a fair value hierarchy that requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. The hierarchy defines three levels of inputs that may be used to measure fair value:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level 1: Quoted </span><span style="Background-color:#FFFFFF;color:#000000;">prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;">Level 2: Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A financial instrument categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain cases, where there is limited activity or less transparency around inputs to valuation, financial instruments are classified as Level&#160;3 within the valuation hierarchy. </span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our financial instruments consist of Level&#160;1 and Level&#160;2 assets and have included Level&#160;3 liabilities in the past. The carrying amounts of certain financial instruments approximate fair value due to their short&#160;maturities. We did not have any nonfinancial assets or liabilities that were measured or disclosed at fair value on a recurring basis as of December&#160;31, 2021 and 2020.</p>
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Convertible Preferred Stock Warrant</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We had issued a freestanding warrant to a venture capital firm to purchase 56,875 shares of Series&#160;C convertible preferred stock with an exercise price of $2.64 in connection with a $5.0&#160;million credit facility entered into in 2014. Immediately prior to and in connection with the completion of our initial public offering, the convertible preferred stock warrant converted to a common stock warrant. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the conversion, the fair value of this warrant was classified as a&#160;non-current&#160;liability in the balance sheets, since the underlying convertible preferred stock had been classified as temporary equity instead of shareholders&#8217; deficit in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities. Upon certain change in control events that were outside of our control, including liquidation, sale or transfer of control, holders of the convertible preferred stock may have caused its redemption. Prior to conversion, the warrant was subject to remeasurement at each balance sheet date, with changes in estimated fair value recognized as a component of interest and other income, net on our statements of operations. During the year ended December 31, 2019, we recognized $2.3 million of expense related to the revaluation of the convertible preferred stock warrant liability in the interest and other income, net line item on our consolidated statements of operations. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the convertible preferred stock warrant converted to a common stock warrant immediately prior to and in connection with the completion of the initial public offering, the $2.6 million financial liability was reclassified to the additional paid-in capital line item on our balance sheet, thereby concluding the need for revaluation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Revenue<span style="letter-spacing:-0.1pt;"> </span>Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize revenue in accordance with ASC Topic 606 (&#8220;ASC 606&#8221;), <span style="font-style:italic;">Revenue from Contracts with Customers</span>. Under ASC 606, for all revenue-generating contracts, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation. The following is a summary of the application of the respective model to each of our revenue classifications. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue is generated from immunosequencing (&#8220;sequencing&#8221;) products and services (&#8220;sequencing revenue&#8221;) and from regulatory or development support services leveraging our immune medicine platform (&#8220;development revenue&#8221;). When revenue generating contracts have elements of both sequencing revenue and development revenue, we classify revenue based on the nature of the performance obligation and the allocated transaction price. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sequencing Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. In these transactions, we have identified one performance obligation, the delivery of a clonoSEQ report, and we bill and receive payments from medical institutions and commercial and government third-party payors. As payment from the respective payors may vary based on the various reimbursement rates and patient responsibilities, we consider the transaction price to be variable and record an estimate of the transaction price, subject to the constraint for variable consideration, as revenue at the time of delivery. The estimate of transaction price is based on historical and expected reimbursement rates with the various payors, which are monitored in subsequent periods and adjusted as necessary based on actual collection experience. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clonoSEQ coverag</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under Medicare, we bill </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#8217;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test.&#160;Revenue </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recognition commences </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the number of tests </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we expect to deliver</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over a patient&#8217;s treatment cycle based on historical testing frequencies for patients by indication. These estimates are subject to change as we develop more information about utilization over time.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any unrecognized revenue from the initial billable test is recorded as deferred revenue and is recognized</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> either</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as we deliver </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our estimate of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the remaining tests in a patient&#8217;s treatment cycle</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or when </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the likelihood</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> becomes remote that a patient will receive additional testing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For research customers, contracts typically include an amount billed in advance of services (&#8220;upfront&#8221;) and subsequent billings as sample results are delivered to the customer. Upfront amounts received are recorded as deferred revenue, which we recognize as revenue upon satisfaction of performance obligations. We have identified two typical performance obligations under the terms of our research service contracts: sequencing services and related data analysis. We recognize revenue for both identified performance obligations as sample results are delivered to the customer. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Development<span style="letter-spacing:-0.05pt;"> </span>Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive revenue by providing services through development agreements to biopharmaceutical customers who seek access to our immune medicine platform technologies. We generate revenues from the delivery of professional support activities pertaining to the use of immunoSEQ and our MRD product in the development of the respective customers&#8217; initiatives. The transaction price for these contracts may consist of a combination of non-refundable upfront fees, separately priced sequencing fees, progress-based milestones and regulatory milestones. The development agreements include single or multiple performance obligations, depending on the contract. For certain contracts, we perform services to support the biopharmaceutical customers&#8217; regulatory submissions as part of their registrational trials. These services may include regulatory support pertaining to our technology intended to be utilized as part of the submission, development of analytical plans for our sequencing data, participation on joint research committees and assistance in completing a regulatory submission. Generally, these services are not distinct within the context of the contract and they are accounted for as a single performance obligation. If agreements include sequencing activities, we separately classify those activities as sequencing revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When sequencing services are separately priced customer options, we assess if a material right exists and, if not, the customer option to purchase additional sequencing services is not considered part of the contract. Except for any non-refundable upfront fees, the other forms of compensation represent variable consideration. Variable consideration related to progress-based and regulatory milestones is estimated using the most likely amount method, where variable consideration is constrained until it is probable that a significant reversal of cumulative revenue recognized will not occur. Progress milestones, such as the first sample result delivered or final patient enrollment in a customer trial, are customer dependent and are included in the transaction price when the respective milestone is probable of occurring. Milestone payments that are not within our customers&#8217; control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. Determining whether regulatory milestone payments are probable is an area that requires significant judgment. In making this assessment, we evaluate scientific, clinical, regulatory and other risks, as well as the level of effort and investment required to achieve the respective milestone. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The primary method used to estimate standalone selling price for performance obligations is the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell our services and estimate the price that a customer in that market would be willing to pay for our services. We recognize revenue using either an input or output measure of progress that faithfully depicts performance on a contract, depending on the contract. The measure used is dependent on the nature of the service to be provided in each contract. Selecting the measure of progress and estimating progress to date requires significant judgment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contract Balances</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain circumstances, billing may occur prior to services being performed. Upfront payments are recorded as deferred revenue, contract liabilities. We classify deferred revenue as current for sequencing revenue, as we expect our performance obligations will be completed within the next twelve months; however, we do not control the timing of customer provided samples. For development services, we assess the performance obligations and recognize deferred revenue as current or&#160;non-current&#160;based upon forecasted delivery times, which are customer coordinated. In certain circumstances, the customer project may be cancelled or terminated prior to the delivery of all related services covered by a customer&#8217;s upfront payment. In these circumstances, we recognize revenue when sufficient evidence is obtained that a reversal of revenue is not probable.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Share-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation includes compensation expense for stock option and restricted stock unit grants to employees and&#160;non-employees.&#160;It represents the grant date fair value of the grants and is recognized over the requisite service period of the awards, usually the vesting period, on a straight-line basis, net of actual forfeitures. We estimate the grant date fair value of stock option grants using the Black-Scholes option-pricing model. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Advertising </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Advertising costs are expensed as incurred. Advertising expenses were $22.4 million, $14.5 million and $6.6 million for the year ended December 31, 2021, 2020 and 2019, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. <span style="Background-color:#FFFFFF;color:#000000;">We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. </span>Research and development costs are expensed as incurred. Upfront payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized, then are recognized as an expense as the goods are consumed or the related services are performed. <span style="Background-color:#FFFFFF;color:#000000;">Costs to support our Genentech Agreement are also a component of our research and development expenses.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sales and Marketing Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are accounted for under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and the operating loss and tax credit carryforwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets and liabilities are measured at the consolidated balance sheet date using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in the period such tax rate changes are enacted. Our net deferred tax assets are fully offset by a valuation allowance, because of our history of losses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the effect of income tax positions only if those positions are more likely than not of being sustained upon examination.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We calculate basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders by dividing net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, common stock warrants, stock options and nonvested restricted stock units are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect is anti-dilutive.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the closing of our initial public offering in July 2019 and the related conversion of our convertible preferred stock into common stock, we calculated our basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders in conformity with the&#160;two-class&#160;method required for companies with participating securities. We considered our convertible preferred stock to be participating securities. In the event a dividend had been declared or paid on common stock, holders of convertible preferred stock would have been entitled to a share of such dividend in proportion to the holders of common stock on an&#160;as-if&#160;converted basis. Under the&#160;two-class&#160;method, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is calculated by dividing the net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. Net loss attributable to Adaptive Biotechnologies Corporation common shareholders is determined by allocating undistributed earnings between common and preferred shareholders. The net loss attributable to Adaptive Biotechnologies Corporation common shareholders was not allocated to the convertible preferred stock under the&#160;two-class&#160;method, as the convertible preferred stock did not have a contractual obligation to share in our losses. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders was computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, convertible preferred stock, convertible preferred stock warrants, common stock warrants and stock options were considered common stock equivalents but were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect was anti-dilutive.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segment Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have determined that our chief executive officer is the chief operating decision maker (&#8220;CODM&#8221;). The CODM regularly reviews operating results and other financial information presented on a consolidated basis. While revenue is reviewed at levels lower than the consolidated entity, resource allocation decisions are made by the CODM based on the results presented at the consolidated entity level, which is determined to be a single reporting unit. There are no segment managers who are held accountable by the CODM for operations, operating results or planning at levels or components below the consolidated entity. As such, the consolidated entity operates as one operating segment and represents one reportable segment. We present disaggregated revenue from contracts with customers by type of service. See Note 3,&#160;Revenue.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209860824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Revenue</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We disaggregate our revenue from contracts with customers by type of service, as we believe this best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following table presents our revenue disaggregated by type of products and services for the periods presented (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,896</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,519</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development support</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,448</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,443</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory milestones</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total development revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,448</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,943</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85,071</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">MRD Development<span style="letter-spacing:-0.05pt;"> </span>Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into agreements with biopharmaceutical customers to further develop and commercialize our MRD product and the biopharmaceutical customers&#8217; therapeutics. Under each of the agreements, we received or will receive non-refundable upfront payments and could receive substantial additional payments upon reaching certain progress-based milestones or achieving certain regulatory milestones pertaining to the customers&#8217; therapeutics and our MRD product.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the contracts, we identify performance obligations, which may include: (1)&#160;obligations to provide services supporting the customer&#8217;s regulatory submission activities as they relate to our MRD product; and (2)&#160;sequencing services related to customer-provided samples for their regulatory submissions. The transaction price allocated to the respective performance obligations is estimated using an adjusted market assessment approach for the regulatory support services and a standalone selling price for the estimated immunosequencing services. At contract inception, we fully constrain any consideration related to regulatory milestones, as the achievement of such milestones is subject to third-party regulatory approval and the customers&#8217; own submission decision-making. We recognize revenue related to the sequencing services as sequencing revenue over time using an output method based on the proportion of sample results delivered relative to the total amount of sample results expected to be delivered, when expected to be a faithful depiction of progress. We use the same method to recognize the regulatory support services. When an output method based on the proportion of sample results delivered is not expected to be a faithful depiction of progress, we utilize an input method using a cost-based model based on estimates of effort completed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized $3.2 million in revenue during the year ended December 31, 2021 due to changes in estimates of total samples to be provided under certain of our MRD development agreements for which we had previously received upfront consideration, of which $0.3 million was recognized as development revenue in the respective period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We earned $10.0 million, $2.5 million and $2.0 million during the year ended December 31, 2021, 2020 and 2019, respectively, upon the achievement of certain regulatory milestones by us and our respective customers&#8217; therapeutics. We recognized these earnings as development revenue within the respective periods, as we determined that the amounts were consistent with our estimated standalone selling prices and the respective performance obligations were complete.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In total, we recognized $11.8&#160;million, $3.4&#160;million and $3.7 million in development revenue related to our MRD development agreements during the year ended December 31, 2021, 2020 and 2019, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, in future periods we could receive up to an additional $333.5 million in milestone payments if certain regulatory approvals are obtained by our customers&#8217; therapeutics in connection with MRD data generated from our MRD product.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Genentech<span style="letter-spacing:-0.05pt;"> </span>Collaboration Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2018, we entered into a worldwide collaboration and license agreement with Genentech (&#8220;Genentech Agreement&#8221;) to leverage our capability to develop cellular therapies in oncology. Subsequent to receipt of regulatory approval in January 2019, we received a non-refundable, upfront payment of $300.0 million in February 2019 and may be eligible to receive more than $1.8 billion over time, including payments of up to $75.0 million upon the achievement of specified regulatory milestones, up to $300.0 million upon the achievement of specified development milestones and up to $1,430.0 million upon the achievement of specified commercial milestones. In addition, we are separately able to receive tiered royalties at a rate ranging from the mid-single digits to the mid-teens on aggregate worldwide net sales of products arising from the strategic collaboration, subject to certain reductions, with aggregate minimum floors. Under the agreement, we are pursuing two product development pathways for novel T cell immunotherapies in which Genentech intends to use TCRs screened by our immune medicine platform to engineer and manufacture cellular medicines: </p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;">Shared Products. The shared products will use &#8220;off-the-shelf&#8221; TCRs identified against cancer antigens shared among patients (&#8220;Shared Products&#8221;). </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;">Personalized Product. The personalized product will use patient-specific TCRs identified by real-time screening of TCRs against cancer antigens in each patient (&#8220;Personalized Product&#8221;). </span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, we granted Genentech exclusive worldwide licenses to develop and commercialize TCR-based cellular therapies in the field of oncology, including licenses to existing shared antigen data packages. Additionally, Genentech has the right to determine which product candidates to further develop for commercialization purposes. We determined that this arrangement meets the criteria set forth in ASC Topic 808, <span style="font-style:italic;">Collaborative Arrangements</span> (&#8220;ASC 808&#8221;), because both parties are active participants in the activity and are exposed to significant risks and rewards depending on the activity&#8217;s commercial failure or success. Because ASC 808 does not provide guidance on how to account for the activities under a collaborative arrangement, we applied the guidance in ASC 606 to account for the activities related to the Genentech Agreement.<span style="color:#000000;"> </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In applying ASC&#160;606, we identified the following performance obligations at the inception of the agreement: </span></p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">License to utilize on an exclusive basis all TCR-specific platform intellectual property to develop and commercialize any licensed products in the field of oncology. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">License to utilize all data and information within each shared antigen data package and any other know-how disclosed by us to Genentech in oncology. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">License to utilize all private antigen TCR product data in connection with research and development activities in the field of use. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">License to existing shared antigen data packages. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Research and development services for shared product development, including expansion of shared antigen data packages. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">6.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Research and development services for private product development. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">7.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Obligations to participate on various joint research, development and project committees. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined that none of the licenses, research and development services or obligations to participate on various committees were distinct within the context of the contract, given such rights and activities were highly interrelated and there was substantial additional research and development to further develop the licenses. We considered factors such as the stage of development of the respective existing antigen data packages, the subsequent development that would be required to both identify and submit a potential target for investigational new drug acceptance under both product pathways and the variability in research and development pathways given Genentech&#8217;s control of product commercialization. Specifically, under the agreement, Genentech is not required to pursue development or commercialization activities pertaining to both product pathways and may choose to proceed with one or the other, as opposed to both. Accordingly, we determined that all of the identified performance obligations were attributable to one general performance obligation, which is to further the development of our TCR-specific platform, including data packages, and continue to make our TCR identification process available to Genentech to pursue either product pathway.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Separately, we have a responsibility to Genentech to enter into a supply and manufacturing agreement for patient-specific TCRs as it pertains to any Personalized Product therapeutic. We determined this was an option right of Genentech should they pursue commercialization of a Personalized Product therapy. Because of the uncertainty resulting from the early stage of development, the novel approach of our collaboration with Genentech and our rights to future commercial milestones and royalty payments, we determined that this option right was not a material right that should be accounted for at inception. As such, we will account for the supply and manufacturing agreement when entered into between the parties. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined the initial transaction price shall be made up of only the $300.0 million upfront, non-refundable payment, as all potential regulatory and development milestone payments were probable of significant revenue reversal given their achievement was highly dependent on factors outside our control. As a result, these payments were fully constrained and were not included in the transaction price as of December 31, 2021. We excluded the commercial milestones and potential royalties from the transaction price, as those items relate predominantly to the license rights granted to Genentech and will be assessed when and if such events occur. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As there are potential substantive developments necessary, which Genentech may be able to direct, we determined that we would apply a proportional performance model to recognize revenue for our performance obligation. We measure proportional performance using an input method based on costs incurred relative to the total estimated costs of research and development efforts to pursue both the Shared Products and Personalized Product pathways. When any of the potential regulatory and development milestones are no longer fully constrained and included in the transaction price, such amounts will be recognized using the cumulative catch-up method based on proportional performance at such time. We currently expect to recognize the revenue over a period of approximately seven to eight years from the effective date. This estimate of the research and development period considers pursuit options of development activities supporting both the Shared Products and the Personalized Product, but may be reduced or increased based on the various activities as directed by the joint committees, decisions made by Genentech, regulatory feedback or other factors not currently known. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized revenue of $62.0 million, $52.8 million and $35.1 million during the year ended December 31, 2021, 2020 and 2019, respectively, related to the Genentech Agreement. Costs related to the Genentech Agreement are included in research and development expenses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209716344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Fair Value<span style="letter-spacing:-0.05pt;"> </span>Measurements</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables set forth the fair value of financial assets as of December 31, 2021 and 2020 that were measured at fair value on a recurring basis (in thousands): </p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">563,087</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">671,777</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">671,777</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">683,358</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1 securities include highly liquid money market funds, for which we measure the fair value based on quoted prices in active markets for identical assets or liabilities. Level&#160;2 securities consist of U.S. government debt securities and corporate bonds, and are valued based on recent trades of securities in inactive markets or on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209721384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Investments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available-for-sale investments consisted of the following as of December 31, 2021 and 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,752</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(109</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,363</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,349</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">214,115</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(123</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">213,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,472</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(974</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">204,498</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,691</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">218,163</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">217,145</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">552,539</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">723</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">553,252</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">564,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">564,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,429</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,525</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,429</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,525</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All the U.S. government debt securities and corporate bonds designated as short-term marketable securities have an effective maturity date that is equal to or less than one year from the respective consolidated balance sheet date. Those that are designated as long-term marketable securities have an effective maturity date that is more than one year from the respective consolidated balance sheet date.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest receivable is excluded from the amortized cost and estimated fair value of our marketable securities. Accrued interest receivable of $1.4 million and $2.5 million were presented separately within the prepaid expenses and other current assets line item on our consolidated balance sheet as of December 31, 2021 and 2020, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the gross unrealized holding losses and fair value for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of December&#160;31, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less Than 12 Months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12 Months Or Greater</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">345,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,083</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,886</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377,900</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically review our available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security ratings or sector credit ratings and other relevant market data.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we did not intend, nor were we more likely than not to be required, to sell our available-for-sale investments before the recovery of their amortized cost basis, which may be maturity. Based on our assessment, we concluded all impairment as of December 31, 2021 to be due to factors other than credit loss, such as changes in interest rates. A credit allowance was not recognized and the impairment of our available-for-sale securities was recorded in other comprehensive loss.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209847512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Property and Equipment, Net</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,767</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,988</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,600</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,579</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,717</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">992</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,658</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,185</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,959</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,945</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, at cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,488</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,226</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85,262</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $12.3 million, $6.8&#160;million and $6.1 million for the year ended December&#160;31, 2021, 2020 and 2019, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209691960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Goodwill<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Intangible Assets</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been no changes in the carrying amount of goodwill since its recognition in 2015. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization as of December 31, 2021 and 2020 consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,638</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,362</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,799</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,526</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,972</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,028</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(128</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,100</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,225</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The developed technology was acquired in connection with our acquisition of Sequenta in 2015. The remaining balance of the acquired technology and the purchased intellectual property is expected to be amortized over the next 5.0 years. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, expected future amortization expense for intangible assets was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,526</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209678312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8. </span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Accrued Liabilities</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,687</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical and contract research organization costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,781</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Travel and entertainment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">615</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,423</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,820</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,881</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,162</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accrued tax liabilities balance as of December 31, 2020 includes a $1.4 million tax withholding liability related to unsettled option exercises as of December 31, 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209796456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DeferredRevenueTextBlock', window );">Deferred Revenue</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Deferred Revenue</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue by revenue classification as of December 31, 2021 and 2020 was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,915</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,545</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,319</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">724</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,576</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,894</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total non-current deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163,618</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current and non-current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,210</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,937</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue from our Genentech Agreement represents $56.1 million and $94.0 million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2021 and $55.1 million and $157.0 million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2020. In general, we expect that the current <span style="Background-color:#FFFFFF;">amounts</span> will be recognized as revenue within 12 months and the non-current amounts will be recognized as revenue over a period of approximately five to six years from December 31, 2021. This period of time represents an estimate of the research and development period to develop cellular therapies in oncology, which may be reduced or increased based on the various development activities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the year ended December 31, 2021, we recognized $3.6 million in revenue as a result of changes in estimates of total samples to be provided under certain of our agreements and cancelled biopharmaceutical customer sequencing contracts for which we had received upfront consideration. Additionally, we recognized $2.5 million of sequencing revenue during the year ended December 31, 2021 related to Medicare reimbursements resulting from our determination that the likelihood of additional testing for specific patients was remote and a change in our estimate of expected cumulative tests per patient for one of our covered indications.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in deferred revenue during the year ended December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,937</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions to deferred revenue during the period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,062</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue recognized during the period</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(95,789</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,210</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$75.7</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million was recognized</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as revenue</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that was included in the deferred revenue balance </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DeferredRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DeferredRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207922536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Leases</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy in various locations, as well as server space. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In July 2011, we entered into a non-cancelable lease agreement with an, at the time, minority shareholder for office and laboratory space in Seattle, Washington. The lease terms were subsequently amended multiple times, most recently in August 2019, when we expanded the existing premises to approximately 65,500 square feet. </span><span style="Background-color:#FFFFFF;">Cash payment for rent of the expanded premises commenced January 2020, four months after the landlord delivered the expanded premises to us for construction of certain tenant improvements, and the lease term for both the existing premises and the expanded premises ends October 2032, subject to our option to twice extend the lease for five years.</span> <span style="Background-color:#FFFFFF;">The amended lease also requires us to pay additional amounts for operating and maintenance expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In August 2019, we entered into an agreement to rent approximately 100,000 square feet in what was a to-be-constructed, new headquarters building in Seattle, Washington. In connection with the lease, we entered into a $2.1 million letter of credit with one of our existing financial institutions. Due to our </span>significant<span style="Background-color:#FFFFFF;"> involvement during the construction process of the leased building, we qualified as the deemed owner of the building under build-to-suit lease accounting guidance that proceeded ASC 842. The resulting asset and long-term financing obligation recorded on our balance sheet as of December 31, 2019 for the cost of the building was derecognized effective January 1, 2020 upon adoption of ASC 842. The lease commenced in December 2020, when the landlord delivered the premises to us for construction of certain tenant improvements. We occupied the new building in 2021, cash payment for rent began in October 2021 and the lease term ends in August 2033, </span><span style="Background-color:#FFFFFF;color:#000000;">subject to our option to twice extend the lease for&#160;five years.&#160;In connection with this lease, the landlord agreed to fund $20.0&#160;million in improvements, which was subsequently reduced to $14.8 million as a result of our change requests made during landlord construction of the building, net of an administration fee. As of December 31, 2021, we have incurred $14.9 million in certain tenant improvement costs, of which $10.9 million has been reimbursed by the landlord. The remaining $4.0 million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2021 and will be reimbursed by the landlord. As of December 31, 2020, w</span><span style="Background-color:#FFFFFF;">e incurred $5.2 million in certain tenant improvement costs, of which $0.7 million had been reimbursed by the landlord. The remaining $4.5 million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2020. </span><span style="Background-color:#FFFFFF;color:#000000;">The lease also requires us to pay additional amounts for operating and maintenance expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In October 2019, we entered into an agreement to lease approximately 14,750 square feet in a separate Seattle, Washington location, pursuant to a lease expiring in October 2029, which is subject to our ability to exercise an early termination right after the third year. In connection with the lease, the landlord agreed to provide a tenant improvement allowance in the maximum amount of $0.7 million. The lease also requires us to pay additional amounts for operating expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In April 2018, we entered into a lease agreement to lease approximately 13,400 square feet in South San Francisco, California. The lease term is through March 2026 and provides for one <span style="-sec-ix-hidden:F_000687">five-year</span> extension option. We are responsible for our share of allocable operating expenses, tax expenses and utilities cost during the duration of the lease term. In connection with the lease, the landlord funded agreed-upon improvements. The landlord was solely responsible for the $2.4 million cost of such improvements. The lease agreement was amended in February 2020 to lease approximately 19,900 additional square feet and provides for a $0.6 million tenant improvement allowance.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In December 2019, we entered into an agreement to lease approximately 3,100 square feet of office space in New York City, New York, pursuant to a lease that expires November 2025, subject to our ability to exercise an early termination right in 2023. The lease requires us to pay certain operating expenses.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In March 2021, we executed a lease to rent approximately 27,000 square feet of a warehouse in Bothell, Washington, which we classified as an operating lease upon commencement during the year ended December 31, 2021. Rent obligations commenced in October 2021 and the lease expires October 2031, subject to an early termination option after the seventh year and an option to twice extend the lease for five years. The lease requires us to pay certain operating expenses. Furthermore, the landlord agreed to fund $1.2 million in improvements in connection with this lease.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021, we were not party to any finance leases. Our leases have remaining terms of 0.3 years to 11.7 years and include options to extend certain of the leases up to 10.0 years and terminate certain of the leases after 3.0 years. We adjust lease terms for these options only when it is reasonably certain we will exercise these options. As of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021, it was reasonably certain that we would exercise our option to terminate </span>two<span style="Background-color:#FFFFFF;"> of our leases after 3.0 </span>years<span style="Background-color:#FFFFFF;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Other information related to our operating leases as of </span>December <span style="Background-color:#FFFFFF;">31, 2021 and 2020 was as follows:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">10.55</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000706">11.33</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table reconciles our undiscounted operating lease cash flows to our operating lease liabilities as of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021 (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,184</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,964</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,098</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,330</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,188</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total undiscounted lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,456</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Imputed interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,410</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Tenant improvement receivables</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,306</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,055</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, less current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,685</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Operating lease expense was $12.4 million and $5.5 million for the year ended</span> December <span style="Background-color:#FFFFFF;">31, 2021 and 2020, respectively. Variable lease expense for operating leases was $3.5 million and $2.6 million for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2021 and 2020, respectively.</span> <span style="Background-color:#FFFFFF;">Rent expense recognized under ASC 840, </span><span style="font-style:italic;Background-color:#FFFFFF;">Leases</span><span style="Background-color:#FFFFFF;">, inclusive of operating and maintenance costs, was $5.3 million for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2019.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cash paid for amounts included in the measurement of lease liabilities was $8.3 million and cash received for tenant improvement allowances was $11.5 million during the year ended December 31, 2021. Cash paid for amounts included in the measurement of lease liabilities for the year ended </span>December<span style="Background-color:#FFFFFF;"> 31, 2020 was $3.2 million, net of $2.5 million of cash received for tenant improvement allowances. For the year ended December 31, 2021, ROU assets obtained in exchange for operating lease liabilities was $5.4 million. For the year ended December 31, 2020, ROU assets obtained in exchange for operating lease liabilities was $109.1 million, inclusive of the $33.0 million recognized from the adoption of ASC 842.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209828632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Commitments and Contingencies</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Legal Proceedings </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to claims and assessments from time to time in the ordinary course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. We were not party to any material legal proceedings as of December 31, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Indemnification Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of business, we may provide indemnification of varying scope and terms to vendors, lessors, customers and other parties with respect to certain matters including, but not limited to, losses arising out of breach of our agreements with them or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with members of our board of directors and certain of our executive officers that will require us to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments that we could be required to make under these indemnification agreements is, in many cases, unlimited. We have not incurred any material costs as a result of such indemnifications and are not currently aware of any indemnification claims.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209874152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="color:#231F20;font-family:Times New Roman;letter-spacing:-0.05pt;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="color:#231F20;letter-spacing:-0.05pt;">Shareholders&#8217;</span><span style="color:#231F20;"> Equity</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock has no preferences or privileges and is not redeemable. Holders of our common stock are entitled to one vote for each share of common stock held. The holders of record of outstanding shares of common stock shall be entitled to receive, when, as and if declared, out of funds legally available, such cash and other dividends as may be declared from time to time.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we <span style="color:#231F20;">have reserved shares of common stock for the following:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issuable upon the exercise of outstanding common stock options and the vesting of outstanding common restricted stock units granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,990,175</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the 2019 Equity Incentive Plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,299,923</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,804,298</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares of common stock reserved for future issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,094,396</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our 2019 Equity Incentive Plan (&#8220;2019 Plan&#8221;) provides for annual increases in the number of shares that may be issued under the 2019 Plan on January 1, 2020 and on each subsequent January 1, thereafter, by a number of shares equal to the lesser of (a) 5% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, our Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for annual increases in the number of shares available for issuance under our ESPP on January 1, 2020 and on each January 1, thereafter, by a number of shares equal to the smallest of (a) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2021, our 2019 Plan reserve increased by 6,882,344 shares. Our board of directors determined not to increase the ESPP reserve in 2021. Furthermore, our board of directors determined not to increase the 2019 Plan and ESPP reserves in 2022.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Common<span style="letter-spacing:-0.05pt;"> </span>Stock<span style="letter-spacing:-0.05pt;"> </span>Warrant</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2014, we issued a warrant to purchase 56,875 shares of Series C convertible preferred stock at an exercise price of $2.64. The warrant was exercisable for a period of seven years from the date of issuance. Immediately prior to and in connection with the completion of our initial public offering on July 1, 2019, this convertible preferred stock warrant was converted to a warrant to purchase the same number of shares of common stock. The warrant was exercised on February 25, 2021 through a cashless exercise, resulting in the issuance of 54,162 shares of our common stock. The impact of this cashless exercise was immaterial to our consolidated financial statements. As of December 31, 2021, there were no outstanding warrants to purchase common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207883992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plans</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Equity Incentive Plans</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Sequenta 2008 Stock Plan, as amended</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our acquisition of Sequenta in January 2015, we assumed Sequenta&#8217;s Equity Incentive Plan (&#8220;2008 Plan&#8221;), including all outstanding options and shares available for future issuance under the 2008 Plan, which, prior to the completion of our initial public offering, were all exercisable for Series E-1 convertible preferred stock. Upon completion of our initial public offering in July 2019, the outstanding options were exercisable for common stock. No shares are available for future issuance under this plan and no equity awards are outstanding under this plan as of December 31, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Adaptive 2009 Equity Incentive Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We adopted an equity incentive plan in 2009 (&#8220;2009 Plan&#8221;) that provided for the issuance of incentive and nonqualified common stock options and other share-based awards for employees, directors and consultants. Under the 2009 Plan, the option exercise price for incentive and nonqualified stock options were not to be less than the fair market value of our common stock at the date of grant. Options granted under this plan expire no later than ten years from the grant date and vesting was established at the time of grant. Pursuant to the terms of the 2019 Plan, any shares subject to outstanding options originally granted under the 2009 Plan that terminate, expire or lapse for any reason without the delivery of shares to the holder thereof shall become available for issuance pursuant to awards granted under the 2019 Plan. While no shares are available for future issuance under the 2009 Plan, it continues to govern outstanding equity awards granted thereunder.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">2019 Equity Incentive Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2019 Plan became effective immediately prior to the closing of our initial public offering in July 2019. The 2019 Plan provides for the issuance of awards in the form of options and other share-based awards for employees, directors and consultants. Under the 2019 Plan, the option exercise price per share shall not be less than the fair market value of a share of stock on the effective date of grant, as defined by the 2019 Plan, unless explicitly qualified under the provisions of Section 409A or Section 424(a) of the Internal Revenue Code of 1986. Additionally, unless otherwise specified, options granted under this plan expire no later than ten years from the grant date and vesting is established at the time of grant. Except for certain option and restricted stock unit grants made to non-employee directors, stock options and restricted stock units granted under the 2019 Plan generally vest over a <span style="-sec-ix-hidden:F_000752">four-year</span> period, subject to continuous service through each applicable vesting date. As of December 31, 2021, we have authorized 29,131,628 shares of common stock for issuance under the 2019 Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in shares available for grant during the year ended December 31, 2021 were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available for Grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,617,001</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019 Equity Incentive Plan reserve increase effective January 1, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,882,344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,306,265</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units forfeited, cancelled or expired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,106,843</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,299,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option activity under the 2009 Plan and 2019 Plan during the year ended December&#160;31, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Subject to</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,433,560</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,052,025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.39</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited or cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(992,428</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.90</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,116</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.56</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,674,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,778,984</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.72</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,105</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and exercisable at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,281,600</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.99</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132,537</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average remaining contractual life for options outstanding as of December 31, 2021 was 7.0 years. The weighted-average remaining contractual life for vested and exercisable options as of December 31, 2021 was 5.7 years. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant date fair value per share of options granted during the year ended December&#160;31, 2021, 2020 and 2019 was $24.22, $21.11 and $6.87, respectively. The total intrinsic value of options exercised during the year ended December&#160;31, 2021, 2020 and 2019 was $156.5&#160;million, $190.4 million and $39.1 million, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Of the $26.7 million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2021, $0.3 million related to options exercised during the year ended December 31, 2020 but settled during the year ended December 31, 2021. Of the $21.7 million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2020, $0.5 million related to options exercised during the year ended December 31, 2019 but settled during the year ended December 31, 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock unit activity under the 2019 Plan during the year ended December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-weight:bold;;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,254,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.98</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units forfeited or cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(74,299</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units vested</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,211,191</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.41</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant date fair value per share of restricted stock units granted during the year ended December 31, 2020 and 2019 was $28.10 and $41.63, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Grant Date Fair Value of Options and Restricted Stock Units Granted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair values of options granted during the years ended December&#160;31, 2021, 2020 and 2019 were estimated using the Black-Scholes option-pricing model with the following assumptions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$30.86 - $66.50</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$17.68 - $55.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.80 - $47.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000811">0.5% - 1.4%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">0.4% - 1.7%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">1.4% - 2.5%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000817">67.1% - 70.0%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000818">70.5% - 73.3%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000819">64.3% - 72.9%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The determination of the grant date fair value of stock options using a Black-Scholes option-pricing model is affected by the fair value of our common stock, as well as assumptions regarding a number of variables that are complex, subjective and generally require significant judgment to determine. The valuation assumptions were determined as follows: </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair value of common stock&#8212;<span style="font-style:normal;">Prior to the closing of our initial public offering, the fair value of our common stock was determined with input from management using valuation methodologies which utilized certain assumptions, including probability weighting of events, volatility, time to liquidation, a risk-free interest rate and an assumption for a discount for lack of marketability (Level 3 inputs). In determining the fair value of our common stock, the methodologies, approaches and assumptions used to estimate the enterprise value were consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, </span>Valuation of Privately-Held-Company Equity Securities Issued as Compensation<span style="font-style:normal;">. For option grants made after the closing of our initial public offering, the fair value of each share of common stock is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.</span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expected term<span style="font-style:normal;">&#8212;The expected term of options granted to employees and non-employee directors is determined using the &#8220;simplified&#8221; method, as illustrated in ASC Topic 718, </span>Compensation&#8212;Stock Compensation<span style="font-style:normal;">, as we do not have sufficient exercise history to determine a better estimate of expected term. Under this approach, the expected term is </span><span style="color:#000000;font-style:normal;">based on the midpoint between the vesting date and the end of the contractual term of the option.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-free interest rate<span style="font-style:normal;">&#8212;We utilize a risk-free interest rate in the option valuation model based on U.S. Treasury zero-coupon issues with remaining terms similar to the expected terms of the options.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected volatility<span style="font-style:normal;">&#8212;As we do not have sufficient trading history for our common stock, the expected volatility is based on the historical volatility of our publicly traded industry peers utilizing a period of time consistent with our estimate of expected term.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected dividend yield<span style="font-style:normal;">&#8212;We do not anticipate paying any cash dividends in the foreseeable future and, therefore, use an expected dividend yield of zero in the option valuation model.</span> </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The grant date fair value of restricted stock units granted <span style="color:#000000;">is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation costs related to stock options and restricted stock units for the years ended December 31, 2021, 2020 and 2019 are included on our consolidated statements of operations as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,100</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">817</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,061</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,519</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,934</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,627</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,480</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,778</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,798</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,155</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,251</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,761</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,124</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, unrecognized share-based compensation expense related to unvested stock options was $96.8 million, which is expected to be recognized over a remaining weighted-average period of 2.9 years. Additionally, as of December 31, 2021, unrecognized share-based compensation expense related to unvested restricted stock units was $38.3 million, which is expected to be recognized over a remaining weighted-average period of 3.4 years.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207918296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Microsoft Collaboration Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Microsoft Collaboration Agreement</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Microsoft Collaboration Agreement</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Summary of Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2017, we entered into a collaboration agreement with Microsoft (&#8220;Microsoft Agreement&#8221;) to computationally derive a comprehensive TCR antigen map for purposes of developing a universal diagnostic based on a single blood test.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contemporaneously with the Microsoft Agreement, we entered into a separate agreement to use Microsoft&#8217;s Azure cloud services at standard volume pricing with a minimum Azure purchase requirement of $12.0&#160;million over the <span style="-sec-ix-hidden:F_000844">seven-year</span> term of the Microsoft Agreement, which we expect to meet in the ordinary course of business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, contemporaneously with entering into the Microsoft Agreement, Microsoft made a preferred stock investment of $45.0&#160;million as a part of our&#160;Series&#160;F-1&#160;convertible preferred stock issuance.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Summary of Accounting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The terms of the Microsoft Agreement meet the criteria under ASC Topic 808,&#160;<span style="font-style:italic;">Collaborative Arrangements</span>&#160;(&#8220;ASC 808&#8221;), as both parties are active participants in the activity and are exposed to significant risks and rewards dependent on the commercial success of the activity.&#160;ASC 808 does not provide guidance on how to account for the activities under the collaboration and we determined that Microsoft did not meet the definition of a customer under ASC 606. Accordingly,&#160;we looked to other guidance to determine the accounting for the respective elements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determined that the preferred stock issuance and commitment to use Microsoft&#8217;s Azure cloud services were made at terms consistent with market rates. All consideration received as part of the Series&#160;F-1&#160;convertible preferred stock issuance was accounted for as part of the Series&#160;F-1&#160;preferred stock issuance.&#160;Since the commitment to purchase Microsoft&#8217;s Azure cloud services was at market terms and we expect to meet the commitment in the ordinary course of business during the seven-year term, we record the expenses in the period in which the services are consumed. These costs are recorded in our consolidated statements of operations based on the underlying activities for which they support.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining elements of the agreement were highly interrelated, so we evaluated them in the aggregate to determine the appropriate accounting application. Specifically, we determined that the transfer of license rights between the parties, our commitment to provide data and immunomics, diagnostic and bioinformatics expertise to Microsoft and Microsoft&#8217;s commitment to provide machine learning software and related development services to us were highly interrelated because they were necessary for the parties to perform the activities under the Microsoft Agreement and, therefore, should be evaluated as one unit of account.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accounted for these collaboration activities by analogy to ASC Topic 845,&#160;<span style="font-style:italic;">Nonmonetary Transactions</span>, and determined that major uncertainties exist about the realizability of the value that would be assigned to an asset received from or provided to Microsoft under the collaboration and, therefore, fair value could not be reliably measured. As a result, we did not recognize any&#160;non-monetary&#160;assets or corresponding&#160;non-monetary&#160;income or expenses pertaining to the rights provided to us or to be received by us under the Microsoft Agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209829752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5</span><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Income Taxes</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of loss before provision for income taxes for the periods presented are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before provision for income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,298</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of our deferred tax assets and liabilities as of the dates presented are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200,363</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,433</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credit carryforward</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonqualifying stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,072</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,096</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,401</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,052</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,481</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,713</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,983</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230,258</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(297,020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(197,527</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets, net of valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,731</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tangible and intangible assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,310</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,760</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,532</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,971</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASC Topic 740, <span style="font-style:italic;">Income Taxes</span>, requires that the tax benefit of NOLs, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is &#8220;more likely than not.&#8221; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a valuation allowance. The valuation allowance increased by $99.5 million and $96.6 million during the year ended December 31, 2021 and 2020, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal tax laws impose substantial restrictions on the utilization of NOL and credit carryforwards in the event of an ownership change, as defined in Section 382 of the Internal Revenue Code of 1986. Accordingly, our ability to utilize these carryforwards may be limited due to such ownership changes. We have completed a Section 382 analysis for changes in ownership through December 31, 2020 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of our federal NOLs. Under the TCJA federal income tax law, federal NOLs incurred in 2018 and future years may be carried forward indefinitely, but the deductibility of such federal NOLs is subject to an annual limitation. NOLs generated prior to 2018 are eligible to be carried forward up to 20 years. As of December 31, 2021, we had U.S. federal NOLs of $192.5 million and U.S. federal tax credits of $33.6 million that will begin to expire in 2028. We also had $576.2 million of NOLs as of December 31, 2021 that do not expire.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effective tax rate of our provision for income taxes differs from the federal statutory rate for the periods presented as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.0)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47.7)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66.1)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44.3)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for Global Intangible Low-Taxed Income as period costs when incurred. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize, in our consolidated financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. We had unrecognized tax benefits of $6.9 million as of December 31, 2021. A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the dates presented are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,260</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">792</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,052</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,437</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,489</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,426</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,915</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, 2020 and 2019, we recognized uncertain tax positions of $3.4 million, $1.4 million and $0.8 million, respectively, related to a reduction of the research and development credit deferred tax asset. Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not expect a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our operating results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We had no accrued interest or penalties related to uncertain tax positions as of December 31, 2021 and 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We file federal and certain state income tax returns, which provide varying statutes of limitations on assessments. However, because of NOL carryforwards, substantially all tax years since inception remain open to federal and state tax examination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209829752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Net Loss<span style="letter-spacing:-0.05pt;"> </span>Per Share<span style="letter-spacing:-0.05pt;"> </span>Attributable<span style="letter-spacing:0.05pt;"> </span>to Adaptive Biotechnologies Corporation Common <span style="letter-spacing:-0.05pt;">Shareholders</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of the basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019 (in thousands, except share and per share amounts): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment to redemption value for Series E-1 convertible preferred stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(964</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,570</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,354,915</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,216,468</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,165,315</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.48</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.01</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since we were in a loss position for all periods presented, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is the same as diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019, as they had an anti-dilutive effect:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock (on as if converted basis)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,104,469</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options issued and outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,097,374</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,125,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,183,546</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested restricted stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">693,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,125</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,952</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,570</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,875</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,961</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock warrant</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,204</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,799,117</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,220,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,377,132</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209700856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation And Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Retirement Plan</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Retirement Plan</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain a salary deferral 401(k) plan (&#8220;401(k) Plan&#8221;) covering employees who have met certain eligibility requirements. Employees may defer up to 100% of their compensation to the 401(k) Plan, subject to federal limits. We made $2.5 million and $1.6 million in discretionary contributions during the year ended December 31, 2021 and 2020, respectively, which are fully vested after one year of employee service. We did not make any discretionary contributions during the year ended December 31, 2019.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206298616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Basis<span style="letter-spacing:-0.05pt;"> </span>of Presentation and<span style="letter-spacing:-0.05pt;"> Principles of Consolidation</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of Adaptive Biotechnologies Corporation, its wholly-owned subsidiary and Digital Biotechnologies, Inc. Other shareholders&#8217; interests in Digital Biotechnologies, Inc. are shown in the consolidated financial statements as noncontrolling interest. All intercompany transactions and balances have been eliminated upon consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. Estimates are used in several areas including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, share-based compensation, including the fair value of stock, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#8217;s estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are stated at fair value. Cash equivalents include only securities having an original maturity of three months or less at the time of purchase. We limit our credit risk associated with cash and cash equivalents by placing our investments with banks that we believe are highly creditworthy and with highly rated money market funds. Cash and cash equivalents primarily consist of bank deposits and investments in money market funds.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are required to maintain certain balances under lease arrangements for some of our property and facility leases. We had restricted cash of <span>$2.1</span> million as of December 31, 2021 and 2020.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments in Marketable Securities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities are classified as&#160;available-for-sale, consist of U.S. government debt securities and corporate bonds and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of shareholders&#8217; equity in accumulated other comprehensive gain (loss) until realized. Realized gains and losses on the sale of these securities are recognized in net income or loss. The cost of marketable securities sold is based on the specific identification method.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Risk</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations<span style="letter-spacing:-0.05pt;"> </span>of Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to a concentration of risk from a limited number of suppliers, or in certain cases, single suppliers for some of our laboratory instruments and materials. This risk is managed by targeting a quantity of surplus stock. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and marketable securities are financial instruments that potentially subject us to concentrations of credit risk. We invest in money market funds, U.S. government debt securities, U.S. government agency securities, commercial paper and corporate bonds with high-quality accredited financial institutions. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant customers are those that represent more than 10% of our total revenue or accounts receivable, net balances for the periods and as of each date presented, respectively. Revenue from these customers reflects their purchase of our products and services and our collaboration efforts with Genentech.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounts Receivable, Net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.9%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Genentech, Inc. and Roche Group</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* less than 10%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accounts Receivable</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable consists of amounts due from customers for services performed. We review our accounts receivable for credit impairment and regularly analyze the status of significant past due receivables to determine if any will potentially be uncollectible to estimate the amount of allowance necessary to reduce accounts receivable to its estimated net realizable value.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, we had $0.2 million and $0.9 million of unbilled receivables as of December&#160;31, 2021 and 2020, respectively. These contract assets are amounts that will become due for which we have an unconditional right to consideration.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Inventory</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory consists of laboratory materials and supplies used in lab analysis. We capitalize inventory when purchased and record expense upon order fulfillment for servicing revenue or utilization in our research and development laboratories. Inventory is valued at the lower of cost or market on a&#160;first-in,&#160;first-out&#160;basis. We periodically perform obsolescence assessments and write off any inventory that is no longer usable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consists of computer equipment, computer software, laboratory equipment, leasehold improvements and furniture and office equipment. Property and equipment are recorded at cost and depreciation is recognized using the straight-line method based on estimated useful life. Maintenance and repairs are charged to expense as incurred and costs of improvements are capitalized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Useful lives assigned to property and equipment are as follows:</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;">
<tr>
<td style="width:223.55pt;"/>
<td style="width:7.85pt;"/>
<td style="width:223.5pt;"/>
</tr>
<tr>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 7 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shorter of estimated useful life or remaining lease term</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 5 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 10 years</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We review long-lived assets for impairment whenever events or circumstances indicate the carrying amount of an asset group may not be recoverable. Gains and losses from asset disposals and impairment losses are classified within our consolidated statements of operations in accordance with the use of the asset.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1, or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we so determine, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have not recognized any impairment of goodwill.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date, which is regarded as their cost.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets may also result from the purchase of assets and intellectual property in a transaction that does not qualify as a business combination. Intangible assets are amortized over their estimated useful lives on a straight-line basis which approximates their usage pattern. Intangible assets are reviewed for impairment at least annually or if indicators of potential impairment exist. We have not recognized any impairment losses on intangible assets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Leases</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We determine if an arrangement contains a lease at inception. We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy, as well as server space. Operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the date the underlying asset becomes available for our use and are based on the present value of the future minimum lease payments over the lease term. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. As our leases generally do not provide an implicit interest rate, the present value of our future minimum lease payments is determined using our incremental borrowing rate. This rate is an estimate of the collateralized borrowing rate we would incur on our future lease payments over a similar term and is based on the information available to us at the lease commencement date, or as of January 1, 2020 for commenced leases that existed as of our adoption of <span style="Background-color:#FFFFFF;">Accounting Standards Update No. 2016-02, </span><span style="font-style:italic;Background-color:#FFFFFF;">Leases</span><span style="Background-color:#FFFFFF;"> (Topic 842) (&#8220;ASC 842&#8221;)</span>. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of our leases contain options to extend or terminate the lease; lease terms are adjusted for these options only when it is reasonably certain we will exercise these options. Our lease agreements do not contain residual value guarantees or covenants.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have made a policy election regarding our real estate leases not to separate nonlease components from lease components, to the extent they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease expense. Our leases for laboratory, office and warehouse facilities typically include variable nonlease components, such as common-area maintenance costs. We have also elected not to record on our consolidated balance sheets a lease that has a lease term of twelve months or less and does not contain a purchase option that we are reasonably certain to exercise.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expense is recognized on a straight-line basis over the terms of the leases. Incentives granted under our facilities leases, including rent holidays, are recognized as adjustments to lease expense on a straight-line basis over the terms of the leases.  </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Financial Accounting Standards Board (&#8220;FASB&#8221;) has defined fair value as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The FASB established a fair value hierarchy that requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. The hierarchy defines three levels of inputs that may be used to measure fair value:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level 1: Quoted </span><span style="Background-color:#FFFFFF;color:#000000;">prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;">Level 2: Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.87%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:2.27%;white-space:nowrap" valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A financial instrument categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain cases, where there is limited activity or less transparency around inputs to valuation, financial instruments are classified as Level&#160;3 within the valuation hierarchy. </span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our financial instruments consist of Level&#160;1 and Level&#160;2 assets and have included Level&#160;3 liabilities in the past. The carrying amounts of certain financial instruments approximate fair value due to their short&#160;maturities. We did not have any nonfinancial assets or liabilities that were measured or disclosed at fair value on a recurring basis as of December&#160;31, 2021 and 2020.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock', window );">Convertible Preferred Stock Warrant</a></td>
<td class="text">
<p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Convertible Preferred Stock Warrant</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We had issued a freestanding warrant to a venture capital firm to purchase 56,875 shares of Series&#160;C convertible preferred stock with an exercise price of $2.64 in connection with a $5.0&#160;million credit facility entered into in 2014. Immediately prior to and in connection with the completion of our initial public offering, the convertible preferred stock warrant converted to a common stock warrant. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the conversion, the fair value of this warrant was classified as a&#160;non-current&#160;liability in the balance sheets, since the underlying convertible preferred stock had been classified as temporary equity instead of shareholders&#8217; deficit in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities. Upon certain change in control events that were outside of our control, including liquidation, sale or transfer of control, holders of the convertible preferred stock may have caused its redemption. Prior to conversion, the warrant was subject to remeasurement at each balance sheet date, with changes in estimated fair value recognized as a component of interest and other income, net on our statements of operations. During the year ended December 31, 2019, we recognized $2.3 million of expense related to the revaluation of the convertible preferred stock warrant liability in the interest and other income, net line item on our consolidated statements of operations. </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the convertible preferred stock warrant converted to a common stock warrant immediately prior to and in connection with the completion of the initial public offering, the $2.6 million financial liability was reclassified to the additional paid-in capital line item on our balance sheet, thereby concluding the need for revaluation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Revenue<span style="letter-spacing:-0.1pt;"> </span>Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize revenue in accordance with ASC Topic 606 (&#8220;ASC 606&#8221;), <span style="font-style:italic;">Revenue from Contracts with Customers</span>. Under ASC 606, for all revenue-generating contracts, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation. The following is a summary of the application of the respective model to each of our revenue classifications. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue is generated from immunosequencing (&#8220;sequencing&#8221;) products and services (&#8220;sequencing revenue&#8221;) and from regulatory or development support services leveraging our immune medicine platform (&#8220;development revenue&#8221;). When revenue generating contracts have elements of both sequencing revenue and development revenue, we classify revenue based on the nature of the performance obligation and the allocated transaction price. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sequencing Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. In these transactions, we have identified one performance obligation, the delivery of a clonoSEQ report, and we bill and receive payments from medical institutions and commercial and government third-party payors. As payment from the respective payors may vary based on the various reimbursement rates and patient responsibilities, we consider the transaction price to be variable and record an estimate of the transaction price, subject to the constraint for variable consideration, as revenue at the time of delivery. The estimate of transaction price is based on historical and expected reimbursement rates with the various payors, which are monitored in subsequent periods and adjusted as necessary based on actual collection experience. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For our clonoSEQ coverag</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under Medicare, we bill </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#8217;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test.&#160;Revenue </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recognition commences </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the number of tests </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we expect to deliver</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over a patient&#8217;s treatment cycle based on historical testing frequencies for patients by indication. These estimates are subject to change as we develop more information about utilization over time.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any unrecognized revenue from the initial billable test is recorded as deferred revenue and is recognized</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> either</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as we deliver </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our estimate of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the remaining tests in a patient&#8217;s treatment cycle</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or when </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the likelihood</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> becomes remote that a patient will receive additional testing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For research customers, contracts typically include an amount billed in advance of services (&#8220;upfront&#8221;) and subsequent billings as sample results are delivered to the customer. Upfront amounts received are recorded as deferred revenue, which we recognize as revenue upon satisfaction of performance obligations. We have identified two typical performance obligations under the terms of our research service contracts: sequencing services and related data analysis. We recognize revenue for both identified performance obligations as sample results are delivered to the customer. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Development<span style="letter-spacing:-0.05pt;"> </span>Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive revenue by providing services through development agreements to biopharmaceutical customers who seek access to our immune medicine platform technologies. We generate revenues from the delivery of professional support activities pertaining to the use of immunoSEQ and our MRD product in the development of the respective customers&#8217; initiatives. The transaction price for these contracts may consist of a combination of non-refundable upfront fees, separately priced sequencing fees, progress-based milestones and regulatory milestones. The development agreements include single or multiple performance obligations, depending on the contract. For certain contracts, we perform services to support the biopharmaceutical customers&#8217; regulatory submissions as part of their registrational trials. These services may include regulatory support pertaining to our technology intended to be utilized as part of the submission, development of analytical plans for our sequencing data, participation on joint research committees and assistance in completing a regulatory submission. Generally, these services are not distinct within the context of the contract and they are accounted for as a single performance obligation. If agreements include sequencing activities, we separately classify those activities as sequencing revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When sequencing services are separately priced customer options, we assess if a material right exists and, if not, the customer option to purchase additional sequencing services is not considered part of the contract. Except for any non-refundable upfront fees, the other forms of compensation represent variable consideration. Variable consideration related to progress-based and regulatory milestones is estimated using the most likely amount method, where variable consideration is constrained until it is probable that a significant reversal of cumulative revenue recognized will not occur. Progress milestones, such as the first sample result delivered or final patient enrollment in a customer trial, are customer dependent and are included in the transaction price when the respective milestone is probable of occurring. Milestone payments that are not within our customers&#8217; control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. Determining whether regulatory milestone payments are probable is an area that requires significant judgment. In making this assessment, we evaluate scientific, clinical, regulatory and other risks, as well as the level of effort and investment required to achieve the respective milestone. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The primary method used to estimate standalone selling price for performance obligations is the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell our services and estimate the price that a customer in that market would be willing to pay for our services. We recognize revenue using either an input or output measure of progress that faithfully depicts performance on a contract, depending on the contract. The measure used is dependent on the nature of the service to be provided in each contract. Selecting the measure of progress and estimating progress to date requires significant judgment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractBalancesPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contract Balances</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain circumstances, billing may occur prior to services being performed. Upfront payments are recorded as deferred revenue, contract liabilities. We classify deferred revenue as current for sequencing revenue, as we expect our performance obligations will be completed within the next twelve months; however, we do not control the timing of customer provided samples. For development services, we assess the performance obligations and recognize deferred revenue as current or&#160;non-current&#160;based upon forecasted delivery times, which are customer coordinated. In certain circumstances, the customer project may be cancelled or terminated prior to the delivery of all related services covered by a customer&#8217;s upfront payment. In these circumstances, we recognize revenue when sufficient evidence is obtained that a reversal of revenue is not probable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Share-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation includes compensation expense for stock option and restricted stock unit grants to employees and&#160;non-employees.&#160;It represents the grant date fair value of the grants and is recognized over the requisite service period of the awards, usually the vesting period, on a straight-line basis, net of actual forfeitures. We estimate the grant date fair value of stock option grants using the Black-Scholes option-pricing model. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Advertising </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Advertising costs are expensed as incurred. Advertising expenses were $22.4 million, $14.5 million and $6.6 million for the year ended December 31, 2021, 2020 and 2019, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. <span style="Background-color:#FFFFFF;color:#000000;">We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. </span>Research and development costs are expensed as incurred. Upfront payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized, then are recognized as an expense as the goods are consumed or the related services are performed. <span style="Background-color:#FFFFFF;color:#000000;">Costs to support our Genentech Agreement are also a component of our research and development expenses.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SalesAndMarketingExpensePolicyTextBlock', window );">Sales and Marketing Expenses</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sales and Marketing Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are accounted for under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and the operating loss and tax credit carryforwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets and liabilities are measured at the consolidated balance sheet date using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in the period such tax rate changes are enacted. Our net deferred tax assets are fully offset by a valuation allowance, because of our history of losses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the effect of income tax positions only if those positions are more likely than not of being sustained upon examination.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We calculate basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders by dividing net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, common stock warrants, stock options and nonvested restricted stock units are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect is anti-dilutive.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the closing of our initial public offering in July 2019 and the related conversion of our convertible preferred stock into common stock, we calculated our basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders in conformity with the&#160;two-class&#160;method required for companies with participating securities. We considered our convertible preferred stock to be participating securities. In the event a dividend had been declared or paid on common stock, holders of convertible preferred stock would have been entitled to a share of such dividend in proportion to the holders of common stock on an&#160;as-if&#160;converted basis. Under the&#160;two-class&#160;method, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is calculated by dividing the net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. Net loss attributable to Adaptive Biotechnologies Corporation common shareholders is determined by allocating undistributed earnings between common and preferred shareholders. The net loss attributable to Adaptive Biotechnologies Corporation common shareholders was not allocated to the convertible preferred stock under the&#160;two-class&#160;method, as the convertible preferred stock did not have a contractual obligation to share in our losses. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders was computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, convertible preferred stock, convertible preferred stock warrants, common stock warrants and stock options were considered common stock equivalents but were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect was anti-dilutive.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segment Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have determined that our chief executive officer is the chief operating decision maker (&#8220;CODM&#8221;). The CODM regularly reviews operating results and other financial information presented on a consolidated basis. While revenue is reviewed at levels lower than the consolidated entity, resource allocation decisions are made by the CODM based on the results presented at the consolidated entity level, which is determined to be a single reporting unit. There are no segment managers who are held accountable by the CODM for operations, operating results or planning at levels or components below the consolidated entity. As such, the consolidated entity operates as one operating segment and represents one reportable segment. We present disaggregated revenue from contracts with customers by type of service. See Note 3,&#160;Revenue.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation and principles of consolidation policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ContractBalancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ContractBalancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_SalesAndMarketingExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales and marketing expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_SalesAndMarketingExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders equity convertible preferred stock policy text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207914680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Concentrations of Risk Percentage</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounts Receivable, Net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.9%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Genentech, Inc. and Roche Group</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* less than 10%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock', window );">Summary of Useful Lives Assigned to Property and Equipment</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Useful lives assigned to property and equipment are as follows:</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;">
<tr>
<td style="width:223.55pt;"/>
<td style="width:7.85pt;"/>
<td style="width:223.5pt;"/>
</tr>
<tr>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 7 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shorter of estimated useful life or remaining lease term</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 5 years</p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td valign="bottom">
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years to 10 years</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of estimated useful lives of property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209850088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue Disaggregated by Type of Products and Services</a></td>
<td class="text">The following table presents our revenue disaggregated by type of products and services for the periods presented (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,896</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,519</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development support</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,448</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,443</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory milestones</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total development revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,448</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,943</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85,071</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209696520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables set forth the fair value of financial assets as of December 31, 2021 and 2020 that were measured at fair value on a recurring basis (in thousands): </p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,946</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">563,087</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">671,777</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">671,777</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financial assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,283</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">683,358</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006210755320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Investments</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available-for-sale investments consisted of the following as of December 31, 2021 and 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,752</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(109</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,363</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,349</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">214,115</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(123</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">213,996</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,472</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(974</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">204,498</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,691</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">218,163</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">217,145</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">552,539</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">723</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">553,252</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,581</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total short-term marketable securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">564,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">564,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,429</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,525</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term marketable securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,429</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,525</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the gross unrealized holding losses and fair value for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of December&#160;31, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less Than 12 Months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12 Months Or Greater</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">345,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,083</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,886</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377,900</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209655256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,767</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,988</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,600</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and office equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,579</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,717</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">992</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,658</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,185</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,959</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,945</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, at cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,488</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,226</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85,262</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209789976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Intangible Assets Subject to Amortization</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization as of December 31, 2021 and 2020 consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,638</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,362</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,799</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,526</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,972</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,028</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchased intellectual property</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(128</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,100</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,225</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense for Intangible Assets</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, expected future amortization expense for intangible assets was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,526</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209695688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities as of December 31, 2021 and 2020 consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,687</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical and contract research organization costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,781</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Travel and entertainment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">615</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,423</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,820</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,881</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,162</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006210758104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock', window );">Schedule of Deferred Revenue by Revenue Classification</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue by revenue classification as of December 31, 2021 and 2020 was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,915</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,545</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,319</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sequencing</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">724</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,576</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,894</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total non-current deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163,618</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current and non-current deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,210</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,937</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Deferred Revenue</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in deferred revenue during the year ended December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,937</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions to deferred revenue during the period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,062</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue recognized during the period</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(95,789</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue balance at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,210</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of deferred revenue by revenue classification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006210767256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Other Information Related to Operating Lease</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Other information related to our operating leases as of </span>December <span style="Background-color:#FFFFFF;">31, 2021 and 2020 was as follows:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">10.55</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000706">11.33</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Reconciles Undiscounted Operating Lease Cash Flows</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table reconciles our undiscounted operating lease cash flows to our operating lease liabilities as of </span>December<span style="Background-color:#FFFFFF;"> 31, 2021 (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,184</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,964</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,098</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,330</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,188</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total undiscounted lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,456</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Imputed interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,410</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Tenant improvement receivables</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,306</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,055</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, less current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,685</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209694088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock', window );">Summary of Reserved Shares of Common Stock</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we <span style="color:#231F20;">have reserved shares of common stock for the following:</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issuable upon the exercise of outstanding common stock options and the vesting of outstanding common restricted stock units granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,990,175</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the 2019 Equity Incentive Plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,299,923</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future grant under the Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,804,298</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares of common stock reserved for future issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,094,396</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of reserved shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209906984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock', window );">Summary of Changes in Shares Available for Grant</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in shares available for grant during the year ended December 31, 2021 were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available for Grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,617,001</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019 Equity Incentive Plan reserve increase effective January 1, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,882,344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,306,265</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock units forfeited, cancelled or expired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,106,843</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for grant at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,299,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity Under 2008 Plan 2009 Plan and 2019 Plan</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock option activity under the 2009 Plan and 2019 Plan during the year ended December&#160;31, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Subject to</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,433,560</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,052,025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.39</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited or cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(992,428</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.90</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,116</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.56</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,674,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,778,984</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.72</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,105</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and exercisable at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,281,600</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.99</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132,537</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock', window );">Summary of Restricted Stock Unit Activity</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock unit activity under the 2019 Plan during the year ended December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-weight:bold;;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,254,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.98</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units forfeited or cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(74,299</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units vested</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested outstanding restricted stock units at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,211,191</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.41</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Estimated Grant Date Fair Values of Options Granted</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair values of options granted during the years ended December&#160;31, 2021, 2020 and 2019 were estimated using the Black-Scholes option-pricing model with the following assumptions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$30.86 - $66.50</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$17.68 - $55.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.80 - $47.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">5.27 - 6.08</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000811">0.5% - 1.4%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">0.4% - 1.7%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">1.4% - 2.5%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000817">67.1% - 70.0%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000818">70.5% - 73.3%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000819">64.3% - 72.9%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Compensation Costs Related to Stock Options and RSUs Included on Statements of Operations</a></td>
<td class="text">The compensation costs related to stock options and restricted stock units for the years ended December 31, 2021, 2020 and 2019 are included on our consolidated statements of operations as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,100</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">817</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,061</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,519</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,934</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,627</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,480</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,778</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,798</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,155</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,251</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,761</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,124</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation, shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in restricted stock units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006210739160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Loss Before Provision for Income Taxes</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of loss before provision for income taxes for the periods presented are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before provision for income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,298</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The significant components of our deferred tax assets and liabilities as of the dates presented are as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200,363</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,433</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credit carryforward</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonqualifying stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,072</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,096</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,401</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,052</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,481</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,713</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,983</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230,258</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(297,020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(197,527</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets, net of valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,731</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tangible and intangible assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,310</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,760</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,532</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,971</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effective tax rate of our provision for income taxes differs from the federal statutory rate for the periods presented as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.0)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47.7)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66.1)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44.3)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Change in Unrecognized Tax Benefits</a></td>
<td class="text">A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the dates presented are as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,260</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">792</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,052</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,437</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,489</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions in 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,426</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,915</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209755928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of the basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019 (in thousands, except share and per share amounts): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment to redemption value for Series E-1 convertible preferred stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(964</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(207,279</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(146,227</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,570</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,354,915</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,216,468</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,165,315</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.48</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.01</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share</a></td>
<td class="text">The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019, as they had an anti-dilutive effect:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock (on as if converted basis)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,104,469</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options issued and outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,097,374</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,125,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,183,546</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested restricted stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">693,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,125</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,952</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,570</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,875</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,961</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock warrant</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,204</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,799,117</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,220,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,377,132</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209804968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Description of Business - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=adpt_DigitalBiotechnologiesIncMember', window );">Digital Biotechnologies, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary Or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership interest percentage</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=adpt_DigitalBiotechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=adpt_DigitalBiotechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200708488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Performance_Obligation </div>
<div>Segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 2,138,000<span></span>
</td>
<td class="nump">$ 2,138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment losses on intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase stock | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,266,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expenses</a></td>
<td class="nump">$ 22,400,000<span></span>
</td>
<td class="nump">$ 14,500,000<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember', window );">Sequencing Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NumberOfRevenuePerformanceObligation', window );">Number of revenue performance obligations | Performance_Obligation</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights', window );">Weighted-average exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, weighted average exercise price of warrants or rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NumberOfRevenuePerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of revenue performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NumberOfRevenuePerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_SequencingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205020536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_CustomerAMember', window );">Customer A | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_CustomerAMember', window );">Customer A | Accounts Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_CustomerBMember', window );">Customer B | Accounts Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.30%<span></span>
</td>
<td class="nump">12.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_GenentechIncAndRocheGroupMember', window );">Genentech, Inc. and Roche Group | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">41.90%<span></span>
</td>
<td class="nump">55.80%<span></span>
</td>
<td class="nump">42.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_GenentechIncAndRocheGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_GenentechIncAndRocheGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207840872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember', window );">Laboratory Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember', window );">Laboratory Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">Shorter of estimated useful life or remaining lease term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205028248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154,344<span></span>
</td>
<td class="nump">$ 98,382<span></span>
</td>
<td class="nump">$ 85,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember', window );">Sequencing Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">78,896<span></span>
</td>
<td class="nump">41,439<span></span>
</td>
<td class="nump">43,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentSupportRevenueMember', window );">Development Support Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">65,448<span></span>
</td>
<td class="nump">54,443<span></span>
</td>
<td class="nump">39,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueRegulatoryMilestonesMember', window );">Development Revenue Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 75,448<span></span>
</td>
<td class="nump">$ 56,943<span></span>
</td>
<td class="nump">$ 41,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_SequencingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentSupportRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentSupportRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206247544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,344,000<span></span>
</td>
<td class="nump">$ 98,382,000<span></span>
</td>
<td class="nump">$ 85,071,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 75,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,789,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,448,000<span></span>
</td>
<td class="nump">56,943,000<span></span>
</td>
<td class="nump">41,552,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_MRDDevelopmentAgreementsMember', window );">MRD Development Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized', window );">Milestone revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_MRDDevelopmentAgreementsMember', window );">MRD Development Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AdditionalMilestonePayment', window );">Additional milestone payment receivable</a></td>
<td class="nump">333,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_MRDDevelopmentAgreementsMember', window );">MRD Development Agreements | Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="nump">$ 52,800,000<span></span>
</td>
<td class="nump">$ 35,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NonRefundableUpfrontPaymentsReceived', window );">Non-refundable upfront payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionExpectedPeriod', window );">Revenue recognition expected period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement | Maximum | Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable', window );">Expected revenue through milestone payments</a></td>
<td class="nump">75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement | Maximum | Development Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable', window );">Expected revenue through milestone payments</a></td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement | Maximum | Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable', window );">Expected revenue through milestone payments</a></td>
<td class="nump">1,430,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,430,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember', window );">Genentech Collaboration Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable', window );">Expected revenue through milestone payments</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_RevenueRecognitionExpectedPeriod', window );">Revenue recognition expected period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AdditionalMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AdditionalMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability milestone method revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NonRefundableUpfrontPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-refundable upfront payments received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NonRefundableUpfrontPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_RevenueRecognitionExpectedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition expected period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_RevenueRecognitionExpectedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition milestone method expected milestone receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=adpt_MRDDevelopmentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=adpt_MRDDevelopmentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=adpt_GenentechCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=adpt_RegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=adpt_RegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=adpt_DevelopmentMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=adpt_DevelopmentMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=adpt_CommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=adpt_CommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207783208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 563,087<span></span>
</td>
<td class="nump">$ 786,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">131,946<span></span>
</td>
<td class="nump">103,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">431,141<span></span>
</td>
<td class="nump">683,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">131,946<span></span>
</td>
<td class="nump">103,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">131,946<span></span>
</td>
<td class="nump">103,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">391,145<span></span>
</td>
<td class="nump">671,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Debt Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">391,145<span></span>
</td>
<td class="nump">671,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">39,996<span></span>
</td>
<td class="nump">11,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate Bonds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 39,996<span></span>
</td>
<td class="nump">$ 11,581<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206254248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Available-for-sale Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember', window );">Short-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 214,115<span></span>
</td>
<td class="nump">$ 564,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(123)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">213,996<span></span>
</td>
<td class="nump">564,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember', window );">Long-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">218,163<span></span>
</td>
<td class="nump">118,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1,018)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">217,145<span></span>
</td>
<td class="nump">118,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Debt Securities | Short-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">186,752<span></span>
</td>
<td class="nump">552,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(109)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">186,647<span></span>
</td>
<td class="nump">553,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Debt Securities | Long-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">205,472<span></span>
</td>
<td class="nump">118,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(974)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">204,498<span></span>
</td>
<td class="nump">118,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds | Short-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">27,363<span></span>
</td>
<td class="nump">11,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">27,349<span></span>
</td>
<td class="nump">$ 11,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds | Long-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 12,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006211583560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Accrued interest receivable</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200692680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair value</a></td>
<td class="nump">$ 377,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized loss</a></td>
<td class="num">(1,141)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair value</a></td>
<td class="nump">345,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized loss</a></td>
<td class="num">(1,083)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair value</a></td>
<td class="nump">32,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized loss</a></td>
<td class="num">$ (58)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207754632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">$ 121,488<span></span>
</td>
<td class="nump">$ 64,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(36,226)<span></span>
</td>
<td class="num">(24,382)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">85,262<span></span>
</td>
<td class="nump">39,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">36,312<span></span>
</td>
<td class="nump">27,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">6,988<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">2,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerSoftwareMember', window );">Computer Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">5,658<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="nump">$ 65,959<span></span>
</td>
<td class="nump">$ 21,945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=adpt_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006211460456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 12,254<span></span>
</td>
<td class="nump">$ 6,769<span></span>
</td>
<td class="nump">$ 6,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206394280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 118,972,000<span></span>
</td>
<td class="nump">$ 118,972,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Purchased Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006204942136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 20,325<span></span>
</td>
<td class="nump">$ 20,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(11,799)<span></span>
</td>
<td class="num">(10,100)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">8,526<span></span>
</td>
<td class="nump">10,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Acquired Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(11,638)<span></span>
</td>
<td class="num">(9,972)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">8,362<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Purchased Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207837384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 8,526<span></span>
</td>
<td class="nump">$ 10,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206233864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">$ 3,687<span></span>
</td>
<td class="nump">$ 3,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent', window );">Clinical and contract research organization costs</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Travel and entertainment</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Tax liabilities</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent', window );">Purchases of property and equipment</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">4,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,820<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 9,343<span></span>
</td>
<td class="nump">$ 13,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical and contract research organization costs, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued purchase of property and equipment current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006209874152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises', window );">Accrued tax withholding liability related to unsettled option exercises</a></td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued tax withholding liability related to unsettled option exercises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206308360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityCurrentAbstract', window );"><strong>Current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total current deferred revenue</a></td>
<td class="nump">$ 80,460<span></span>
</td>
<td class="nump">$ 73,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityNonCurrentAbstract', window );"><strong>Non-current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total non-current deferred revenue</a></td>
<td class="nump">98,750<span></span>
</td>
<td class="nump">163,618<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Total current and non-current deferred revenue</a></td>
<td class="nump">179,210<span></span>
</td>
<td class="nump">236,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember', window );">Sequencing Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityCurrentAbstract', window );"><strong>Current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total current deferred revenue</a></td>
<td class="nump">21,915<span></span>
</td>
<td class="nump">15,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityNonCurrentAbstract', window );"><strong>Non-current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total non-current deferred revenue</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityCurrentAbstract', window );"><strong>Current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total current deferred revenue</a></td>
<td class="nump">58,545<span></span>
</td>
<td class="nump">57,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ContractWithCustomerLiabilityNonCurrentAbstract', window );"><strong>Non-current deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total non-current deferred revenue</a></td>
<td class="nump">$ 98,576<span></span>
</td>
<td class="nump">$ 162,894<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ContractWithCustomerLiabilityCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability current abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ContractWithCustomerLiabilityCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ContractWithCustomerLiabilityNonCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability non current abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ContractWithCustomerLiabilityNonCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_SequencingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205439496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current deferred revenue</a></td>
<td class="nump">$ 80,460<span></span>
</td>
<td class="nump">$ 80,460<span></span>
</td>
<td class="nump">$ 73,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, less current portion</a></td>
<td class="nump">98,750<span></span>
</td>
<td class="nump">98,750<span></span>
</td>
<td class="nump">163,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">75,700<span></span>
</td>
<td class="num">(95,789)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current deferred revenue</a></td>
<td class="nump">58,545<span></span>
</td>
<td class="nump">58,545<span></span>
</td>
<td class="nump">57,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, less current portion</a></td>
<td class="nump">98,576<span></span>
</td>
<td class="nump">98,576<span></span>
</td>
<td class="nump">162,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember', window );">Development Revenue | Genentech, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current deferred revenue</a></td>
<td class="nump">56,100<span></span>
</td>
<td class="nump">56,100<span></span>
</td>
<td class="nump">55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, less current portion</a></td>
<td class="nump">94,000<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="nump">157,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember', window );">Sequencing Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current deferred revenue</a></td>
<td class="nump">21,915<span></span>
</td>
<td class="nump">21,915<span></span>
</td>
<td class="nump">15,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, less current portion</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">$ 724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=adpt_MedicareRevenueMember', window );">Medicare | Specific Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_GenentechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_GenentechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_SequencingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_SequencingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=adpt_MedicareRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=adpt_MedicareRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_SpecificPatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_SpecificPatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206298600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue - Additional Information (Details1) - Genentech, Inc. - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue, expected to be recognized</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_GenentechIncMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue, expected to be recognized</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=adpt_GenentechIncMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue, expected to be recognized</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=adpt_GenentechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=adpt_GenentechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006204916600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Schedule of Changes in Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue balance at December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 236,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Additions to deferred revenue during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized during the period</a></td>
<td class="nump">$ 75,700<span></span>
</td>
<td class="num">(95,789)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue balance at December 31, 2021</a></td>
<td class="nump">$ 179,210<span></span>
</td>
<td class="nump">$ 179,210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006201092088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases- Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Lease</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Number of square feet | ft&#178;</a></td>
<td class="nump">19,900<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">14,750<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lessee, operating lease, option to extend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">cash payment for rent began in October 2021 and the lease term ends in August 2033, <span></span>
</td>
<td class="text">The lease term is through March 2026 and provides for one five-year extension option.<span></span>
</td>
<td class="text">options to extend certain of the leases up to 10.0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseRentCommencementMonthAndYear', window );">Lessee, operating lease, rent commencement month and year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Lessee, Operating Lease, Existence of Option to Extend [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseExtendedTermOfContract', window );">Lessee, operating lease, extended term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LeaseExpirationMonthAndYear', window );">Lease expiration month and year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025-11<span></span>
</td>
<td class="text">2029-10<span></span>
</td>
<td class="text">2033-08<span></span>
</td>
<td class="text">2026-03<span></span>
</td>
<td class="text">2031-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LeaseCommencementMonthAndYear', window );">Lease commenced moth and year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020-12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Landlord contribution for leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ProceedsFromLandlordReimbursements', window );">Proceeds from landlord reimbursements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_TenantImprovementCostsIncurred', window );">Tenant improvement costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_TenantImprovementCostsReceivable', window );">Tenant improvement costs receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear', window );">Rent obligations, commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_TenantImprovementAllowanceAndCommenced', window );">Tenant improvement allowance and commenced</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseTerminationPeriod', window );">Operating lease termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NumberOfOperatingLeaseTerminate', window );">Number of operating lease terminate | Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription', window );">Lease not yet commenced, termination option description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">subject to an early termination option after the seventh year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend', window );">Lease not yet commenced, option to extend description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">option to twice extend the lease for five years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable', window );">Lease not yet commenced landlord agreed to fund for improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1', window );">Lease not yet commenced, option to extend term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_OperatingLeaseVariableLeaseExpense', window );">Operating lease variable lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in measurement of lease liabilities, net of tenant improvement allowances received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromTenantAllowance', window );">Cash received for tenant improvement allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="nump">109,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,678,000<span></span>
</td>
<td class="nump">99,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating lease remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating lease remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WA', window );">Seattle, Washington</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Number of square feet | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lessee, operating lease, option to extend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cash payment for rent of the expanded premises commenced January 2020, four months after the landlord delivered the expanded premises to us for construction of certain tenant improvements, and the lease term for both the existing premises and the expanded premises ends October 2032, subject to our option to twice extend the lease for five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseRentCommencementMonthAndYear', window );">Lessee, operating lease, rent commencement month and year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020-01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Lessee, Operating Lease, Existence of Option to Extend [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseExtendedTermOfContract', window );">Lessee, operating lease, extended term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LeaseExpirationMonthAndYear', window );">Lease expiration month and year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2032-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LeaseCommencementMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease commencement month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LeaseCommencementMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LeaseExpirationMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease expiration month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LeaseExpirationMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseExtendedTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating lease, extended term of contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseExtendedTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease lease not yet commenced tenant improvement receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating lease, lease not yet commenced termination option description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseRentCommencementMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease rent commencement month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseRentCommencementMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease rent obligations commencement month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease termination period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NumberOfOperatingLeaseTerminate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating lease terminate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NumberOfOperatingLeaseTerminate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_OperatingLeaseVariableLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease variable lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_OperatingLeaseVariableLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ProceedsFromLandlordReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from landlord reimbursements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ProceedsFromLandlordReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_TenantImprovementAllowanceAndCommenced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant improvement allowance and commenced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_TenantImprovementAllowanceAndCommenced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_TenantImprovementCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant improvement costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_TenantImprovementCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_TenantImprovementCostsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant improvement costs receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_TenantImprovementCostsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease that has not yet commenced. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromTenantAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromTenantAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205501848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases- Summary of Other Information Related to Operating Lease (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">10 years 6 months 18 days<span></span>
</td>
<td class="text">11 years 3 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205423816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 14,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">13,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">13,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">14,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">12,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">81,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">149,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Imputed interest rate</a></td>
<td class="num">(32,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable', window );">Tenant improvement receivables</a></td>
<td class="num">(5,306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">111,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(5,055)<span></span>
</td>
<td class="num">$ (3,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, less current portion</a></td>
<td class="nump">$ 106,685<span></span>
</td>
<td class="nump">$ 104,333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease liability tenant improvement receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200595352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Vote </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holders of our common stock are entitled to one vote for each share of common stock held<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NumberOfCommonStockVotingRights', window );">Number of vote for each share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued to purchase stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued to purchase stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ClassOfWarrantOrRightsTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights', window );">Weighted-average exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised', window );">Stock issued during period, common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,162<span></span>
</td>
<td class="nump">54,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_PercentageOfAnnualIncreasesInNumberOfShares', window );">Percentage of annual increases in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in share reserve</a></td>
<td class="nump">6,882,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_PercentageOfAnnualIncreasesInNumberOfShares', window );">Percentage of annual increases in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, weighted average exercise price of warrants or rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ClassOfWarrantOrRightsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights, term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ClassOfWarrantOrRightsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NumberOfCommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NumberOfCommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_PercentageOfAnnualIncreasesInNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of annual increases in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_PercentageOfAnnualIncreasesInNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, shares, common stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=adpt_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207505016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Summary of Reserved Shares of Common Stock (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuance</a></td>
<td class="nump">39,094,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember', window );">Exercise of Outstanding Common Stock Options and Vesting of Outstanding Common Restricted Stock Units Granted</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuance</a></td>
<td class="nump">13,990,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Grant | 2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuance</a></td>
<td class="nump">22,299,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Grant | Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuance</a></td>
<td class="nump">2,804,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200951752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life options outstanding</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted-average remaining contractual life vested and exercisable options outstanding</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 24.22<span></span>
</td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="nump">$ 6.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 156,500<span></span>
</td>
<td class="nump">$ 190,400<span></span>
</td>
<td class="nump">$ 39,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">26,717<span></span>
</td>
<td class="nump">21,748<span></span>
</td>
<td class="nump">$ 4,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods', window );">Proceeds from settlement of stock option exercised in prior periods</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense related to unvested stock options</a></td>
<td class="nump">$ 96,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense related to unvested stock options, weighted-average period for recognition</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Option Valuation Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense related to unvested stock options, weighted-average period for recognition</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation expense related to unvested RSUs</a></td>
<td class="nump">$ 38,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_SequentaTwoThousandAndEightStockPlanMember', window );">Sequenta 2008 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber', window );">Equity awards outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineEquityIncentivePlanMember', window );">2009 Equity Incentive Plan | Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineEquityIncentivePlanMember', window );">2009 Equity Incentive Plan | Grant | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="nump">22,299,923<span></span>
</td>
<td class="nump">18,617,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan | Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="nump">29,131,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan | Grant | Non Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan | Grant | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 37.98<span></span>
</td>
<td class="nump">$ 28.10<span></span>
</td>
<td class="nump">$ 41.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from settlement of stock option exercised in prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award outstanding number.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award vested and exercisable options outstanding weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_SequentaTwoThousandAndEightStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_SequentaTwoThousandAndEightStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=adpt_NonEmployeeDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=adpt_NonEmployeeDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006307544728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details) - 2019 Equity Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant, Outstanding, Beginning Balance</a></td>
<td class="nump">18,617,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant', window );">Shares Available for Grant, 2019 Equity Incentive Plan reserve increase</a></td>
<td class="nump">6,882,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted', window );">Shares Available for Grant, Options and restricted stock units granted</a></td>
<td class="num">(4,306,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired', window );">Shares Available for Grant, Options and restricted stock units forfeited, cancelled or expired</a></td>
<td class="nump">1,106,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant, Outstanding, Ending Balance</a></td>
<td class="nump">22,299,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award increase reserve shares available for grant,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment awards forfeited, canceled or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment awards granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206442296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Subject to Outstanding Options, Options outstanding, Beginning Balance | shares</a></td>
<td class="nump">14,433,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Subject to Outstanding Options, Options granted | shares</a></td>
<td class="nump">3,052,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares Subject to Outstanding Options, Options forfeited or cancelled | shares</a></td>
<td class="num">(992,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares Subject to Outstanding Options, Options expired | shares</a></td>
<td class="num">(40,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares Subject to Outstanding Options, Options exercised | shares</a></td>
<td class="num">(3,674,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Subject to Outstanding Options, Options outstanding, Ending Balance | shares</a></td>
<td class="nump">12,778,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable', window );">Shares Subject to Outstanding Options, Options vested and exercisable | shares</a></td>
<td class="nump">7,281,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options outstanding, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 12.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options granted | $ / shares</a></td>
<td class="nump">39.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options forfeited or cancelled | $ / shares</a></td>
<td class="nump">25.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options expired | $ / shares</a></td>
<td class="nump">26.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options exercised | $ / shares</a></td>
<td class="nump">7.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options outstanding, Ending Balance | $ / shares</a></td>
<td class="nump">19.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Options vested and exercisable | $ / shares</a></td>
<td class="nump">$ 10.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Option outstanding | $</a></td>
<td class="nump">$ 156,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue', window );">Aggregate Intrinsic Value, Options vested and exercisable | $</a></td>
<td class="nump">$ 132,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested and exercisable intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested and exercisable weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006201081880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 24.22<span></span>
</td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="nump">$ 6.87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | 2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Units Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units Outstanding, Nonvested Outstanding, Beginning Balance</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted Stock Units Outstanding, Granted</a></td>
<td class="nump">1,254,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted Stock Units Outstanding, Forfeited or cancelled</a></td>
<td class="num">(74,299)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted Stock Units Outstanding, Vested</a></td>
<td class="num">(18,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units Outstanding, Nonvested Outstanding, Ending Balance</a></td>
<td class="nump">1,211,191<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Beginning Balance</a></td>
<td class="nump">$ 28.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">37.98<span></span>
</td>
<td class="nump">$ 28.10<span></span>
</td>
<td class="nump">$ 41.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Forfeited or cancelled</a></td>
<td class="nump">43.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Vested</a></td>
<td class="nump">28.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Ending Balance</a></td>
<td class="nump">$ 37.41<span></span>
</td>
<td class="nump">$ 28.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=adpt_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200458600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">67.10%<span></span>
</td>
<td class="nump">70.50%<span></span>
</td>
<td class="nump">64.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">73.30%<span></span>
</td>
<td class="nump">72.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of common stock</a></td>
<td class="nump">$ 30.86<span></span>
</td>
<td class="nump">$ 17.68<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 3 months 7 days<span></span>
</td>
<td class="text">5 years 3 months 7 days<span></span>
</td>
<td class="text">5 years 3 months 7 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of common stock</a></td>
<td class="nump">$ 66.50<span></span>
</td>
<td class="nump">$ 55.23<span></span>
</td>
<td class="nump">$ 47.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207821576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 43,251<span></span>
</td>
<td class="nump">$ 24,761<span></span>
</td>
<td class="nump">$ 13,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">817<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">14,061<span></span>
</td>
<td class="nump">8,519<span></span>
</td>
<td class="nump">3,934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">12,312<span></span>
</td>
<td class="nump">6,627<span></span>
</td>
<td class="nump">3,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 14,778<span></span>
</td>
<td class="nump">$ 8,798<span></span>
</td>
<td class="nump">$ 5,155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006206508488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Microsoft Collaboration Agreement - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">preferred stock investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_MicrosoftCollaborationAgreementMember', window );">Microsoft Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement', window );">Minimum service consumption requirement amount</a></td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement', window );">Minimum service consumption requirement term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=adpt_MicrosoftCollaborationAgreementMember', window );">Microsoft Collaboration Agreement | Series F-1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">preferred stock investment</a></td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum service consumption requirement amount under license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum service consumption requirement term under license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=adpt_MicrosoftCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=adpt_MicrosoftCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=adpt_SeriesFOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=adpt_SeriesFOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205189864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (207,314)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before provision for income taxes</a></td>
<td class="num">$ (207,298)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (68,606)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205086792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 200,363<span></span>
</td>
<td class="nump">$ 105,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness', window );">Tax credit carryforward</a></td>
<td class="nump">31,200<span></span>
</td>
<td class="nump">18,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DeferredTaxAssetsNonQualifiedStockOptions', window );">Nonqualifying stock options</a></td>
<td class="nump">18,072<span></span>
</td>
<td class="nump">12,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">30,401<span></span>
</td>
<td class="nump">31,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">42,481<span></span>
</td>
<td class="nump">59,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">4,345<span></span>
</td>
<td class="nump">2,983<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">326,862<span></span>
</td>
<td class="nump">230,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">(297,020)<span></span>
</td>
<td class="num">(197,527)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="nump">29,842<span></span>
</td>
<td class="nump">32,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets', window );">Tangible and intangible assets</a></td>
<td class="num">(7,310)<span></span>
</td>
<td class="num">(5,760)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DeferredTaxLiabilitiesRightOfUseAssets', window );">ROU assets</a></td>
<td class="num">(22,532)<span></span>
</td>
<td class="num">(26,971)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DeferredTaxAssetsNonQualifiedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, non qualified stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DeferredTaxAssetsNonQualifiedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, tangible and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible general business tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205439224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 99,500,000<span></span>
</td>
<td class="nump">$ 96,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_NetOperatingLossCarryforwardExpirationPeriod', window );">Maturity period for NOLs carryovers</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal NOLs</a></td>
<td class="nump">$ 576,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">6,915,000<span></span>
</td>
<td class="nump">3,489,000<span></span>
</td>
<td class="nump">$ 2,052,000<span></span>
</td>
<td class="nump">$ 1,260,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Uncertain tax positions</a></td>
<td class="nump">3,426,000<span></span>
</td>
<td class="nump">1,437,000<span></span>
</td>
<td class="nump">$ 792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest or penalties related to uncertain tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal NOLs</a></td>
<td class="nump">192,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">U.S. federal tax credits</a></td>
<td class="nump">$ 33,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_OperatingLossCarryforwardsExpirationYear', window );">NOLs expiration year</a></td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_NetOperatingLossCarryforwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Loss Carryforward Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_NetOperatingLossCarryforwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Expiration Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the limitation related to use of the tax credit carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006200456504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax, net of federal tax benefit</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">13.80%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">14.10%<span></span>
</td>
<td class="nump">25.20%<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_EffectiveIncomeTaxRateReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Credits</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(47.70%)<span></span>
</td>
<td class="num">(66.10%)<span></span>
</td>
<td class="num">(44.30%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_EffectiveIncomeTaxRateReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Permanent Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_EffectiveIncomeTaxRateReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205175512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance</a></td>
<td class="nump">$ 3,489<span></span>
</td>
<td class="nump">$ 2,052<span></span>
</td>
<td class="nump">$ 1,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions</a></td>
<td class="nump">3,426<span></span>
</td>
<td class="nump">1,437<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance</a></td>
<td class="nump">$ 6,915<span></span>
</td>
<td class="nump">$ 3,489<span></span>
</td>
<td class="nump">$ 2,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205029448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Adaptive Biotechnologies Corporation</a></td>
<td class="num">$ (207,279)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (68,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Fair value adjustment to redemption value for Series E-1 convertible preferred stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to Adaptive Biotechnologies Corporation common shareholders</a></td>
<td class="num">$ (207,279)<span></span>
</td>
<td class="num">$ (146,227)<span></span>
</td>
<td class="num">$ (69,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</a></td>
<td class="nump">140,354,915<span></span>
</td>
<td class="nump">131,216,468<span></span>
</td>
<td class="nump">69,165,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted</a></td>
<td class="num">$ (1.48)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (1.01)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006205213720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">13,799,117<span></span>
</td>
<td class="nump">16,220,548<span></span>
</td>
<td class="nump">63,377,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,104,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">13,097,374<span></span>
</td>
<td class="nump">16,125,548<span></span>
</td>
<td class="nump">17,183,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_UnvestedRestrictedStockUnitsMember', window );">Nonvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">693,173<span></span>
</td>
<td class="nump">38,125<span></span>
</td>
<td class="nump">4,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">8,570<span></span>
</td>
<td class="nump">56,875<span></span>
</td>
<td class="nump">55,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_ConvertiblePreferredStockWarrantsMember', window );">Convertible Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_UnvestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_UnvestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_ConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adpt_ConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140006207866120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation And Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Employees maximum annual contribution of their compensation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer discretionary contribution amount</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_adpt_DefinedContributionPlanEmployeeServicePeriodForVesting', window );">Employee service period for vesting</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adpt_DefinedContributionPlanEmployeeServicePeriodForVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan employee service period for vesting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adpt_DefinedContributionPlanEmployeeServicePeriodForVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adpt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>adpt-10k_20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:adpt="http://www.adaptivebiotech.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2021"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="adpt-20211231.xsd" xlink:type="simple"/>
    <context id="C_0001478320_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001478320_20220210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2022-02-10</instant>
        </period>
    </context>
    <context id="C_0001478320_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">adpt:DigitalBiotechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncAndRocheGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentSupportRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MRDDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190201_20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptRegulatoryMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:RegulatoryMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptDevelopmentMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:DevelopmentMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptCommercialMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">adpt:CommercialMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:GenentechCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">adpt:AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adpt:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:SequencingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:DevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMinimumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMaximumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:GenentechIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtMajorCustomersAxis_adptSpecificPatientsMember_srtProductOrServiceAxis_adptMedicareRevenueMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">adpt:SpecificPatientsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">adpt:MedicareRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20211230_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2021-12-30</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtStatementGeographicalAxis_stprWA_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20191001_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="C_0001478320_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001478320_20180401_20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_0001478320_20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="C_0001478320_20200201_20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="C_0001478320_20191201_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_adptCommonStockOptionsAndRestrictedStockUnitsGrantedMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">adpt:CommonStockOptionsAndRestrictedStockUnitsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20140101_20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">adpt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:SequentaTwoThousandAndEightStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtTitleOfIndividualAxis_adptNonEmployeeDirectorsMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">adpt:NonEmployeeDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">adpt:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MicrosoftCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapStatementClassOfStockAxis_adptSeriesFOneConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">adpt:SeriesFOneConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">adpt:MicrosoftCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptConvertiblePreferredStockWarrantsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">adpt:ConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_adptPerformance_Obligation">
        <measure>adpt:Performance_Obligation</measure>
    </unit>
    <unit id="U_adptSegment">
        <measure>adpt:Segment</measure>
    </unit>
    <unit id="U_utrsqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_adptLease">
        <measure>adpt:Lease</measure>
    </unit>
    <unit id="U_adptVote">
        <measure>adpt:Vote</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001478320_20210101_20211231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001478320_20210101_20211231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001478320_20210101_20211231" id="F_000007">0001478320</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001478320_20210101_20211231" id="F_000009">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831"
      id="F_000658">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <adpt:LeaseExpirationMonthAndYear
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831"
      id="F_000660">2032-10</adpt:LeaseExpirationMonthAndYear>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend contextRef="C_0001478320_20190801_20190831" id="F_000667">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <adpt:LeaseExpirationMonthAndYear contextRef="C_0001478320_20191001_20191031" id="F_000678">2029-10</adpt:LeaseExpirationMonthAndYear>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend contextRef="C_0001478320_20180401_20180430" id="F_000686">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend contextRef="C_0001478320_20210101_20211231" id="F_000696">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <adpt:LesseeOperatingLeaseExtendedTermOfContract contextRef="C_0001478320_20180401_20180430" id="F_000687">P5Y</adpt:LesseeOperatingLeaseExtendedTermOfContract>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001478320_srtTitleOfIndividualAxis_adptNonEmployeeDirectorsMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000752">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <adpt:MinimumServiceConsumptionRequirementTermUnderLicenseAgreement
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231"
      id="F_000844">P7Y</adpt:MinimumServiceConsumptionRequirementTermUnderLicenseAgreement>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001478320_20211231"
      id="F_000083"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001478320_20201231"
      id="F_000084"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001478320_20211231"
      id="F_000085"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001478320_20201231"
      id="F_000086"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:AccountingStandardsUpdateExtensibleList contextRef="C_0001478320_20200101_20201231" id="F_000237">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001478320_20211231" id="F_000705">P10Y6M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001478320_20201231" id="F_000706">P11Y3M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231"
      id="F_000805">P5Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_000806">P5Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231"
      id="F_000807">P5Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000811"
      unitRef="U_xbrlipure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000812"
      unitRef="U_xbrlipure">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000813"
      unitRef="U_xbrlipure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000817"
      unitRef="U_xbrlipure">0.671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000818"
      unitRef="U_xbrlipure">0.705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000819"
      unitRef="U_xbrlipure">0.643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20210101_20211231"
      decimals="2"
      id="F_000799"
      unitRef="U_iso4217USD_xbrlishares">30.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20200101_20201231"
      decimals="2"
      id="F_000800"
      unitRef="U_iso4217USD_xbrlishares">17.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20190101_20191231"
      decimals="2"
      id="F_000801"
      unitRef="U_iso4217USD_xbrlishares">7.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231"
      decimals="2"
      id="F_000802"
      unitRef="U_iso4217USD_xbrlishares">66.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231"
      decimals="2"
      id="F_000803"
      unitRef="U_iso4217USD_xbrlishares">55.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231"
      decimals="2"
      id="F_000804"
      unitRef="U_iso4217USD_xbrlishares">47.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20210101_20211231"
      id="F_000808">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_000809">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20190101_20191231"
      id="F_000810">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000814"
      unitRef="U_xbrlipure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000815"
      unitRef="U_xbrlipure">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000816"
      unitRef="U_xbrlipure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000820"
      unitRef="U_xbrlipure">0.700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000821"
      unitRef="U_xbrlipure">0.733</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000822"
      unitRef="U_xbrlipure">0.729</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <dei:DocumentType contextRef="C_0001478320_20210101_20211231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0001478320_20210101_20211231" id="F_000029">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_0001478320_20210101_20211231" id="F_000002">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001478320_20210101_20211231" id="F_000003">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0001478320_20210101_20211231" id="F_000030">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001478320_20210101_20211231" id="F_000021">001-38957</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001478320_20210101_20211231" id="F_000006">ADAPTIVE BIOTECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001478320_20210101_20211231" id="F_000031">WA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001478320_20210101_20211231" id="F_000022">27-0907024</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001478320_20210101_20211231" id="F_000023">1165 Eastlake Avenue East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001478320_20210101_20211231" id="F_000024">Seattle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001478320_20210101_20211231" id="F_000025">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001478320_20210101_20211231" id="F_000026">98109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001478320_20210101_20211231" id="F_000027">(206)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001478320_20210101_20211231" id="F_000028">659-0067</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001478320_20210101_20211231" id="F_000015">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001478320_20210101_20211231" id="F_000005">ADPT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001478320_20210101_20211231" id="F_000016">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0001478320_20210101_20211231" id="F_000011">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="C_0001478320_20210101_20211231" id="F_000008">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="C_0001478320_20210101_20211231" id="F_000018">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001478320_20210101_20211231" id="F_000020">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0001478320_20210101_20211231" id="F_000010">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001478320_20210101_20211231" id="F_000013">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001478320_20210101_20211231" id="F_000014">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0001478320_20210101_20211231" id="F_000032">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0001478320_20210101_20211231" id="F_000019">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0001478320_20210630"
      decimals="0"
      id="F_000012"
      unitRef="U_iso4217USD">3951000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001478320_20220210"
      decimals="INF"
      id="F_000017"
      unitRef="U_xbrlishares">141583720</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000033">The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated herein by reference from the registrant&#x2019;s definitive proxy statement relating to the Annual Meeting of Shareholders to be held in 2022.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="C_0001478320_20210101_20211231" id="F_000034">42</dei:AuditorFirmId>
    <dei:AuditorName contextRef="C_0001478320_20210101_20211231" id="F_000035">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="C_0001478320_20210101_20211231" id="F_000036">Seattle, Washington</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000037"
      unitRef="U_iso4217USD">139065000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000038"
      unitRef="U_iso4217USD">123436000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000102"
      unitRef="U_iso4217USD">214115000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000103"
      unitRef="U_iso4217USD">564036000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">213996000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">564833000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">17409000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">10047000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">19263000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">14063000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">13015000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">14535000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">402748000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">726914000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">85262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">39692000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">87678000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">99350000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000104"
      unitRef="U_iso4217USD">218163000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000105"
      unitRef="U_iso4217USD">118429000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">217145000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">118525000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">2138000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">2138000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">8526000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">10225000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">118972000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">118972000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">875000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">598000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">923344000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">1116414000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">3307000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">3237000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">9343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000068"
      unitRef="U_iso4217USD">13162000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000069"
      unitRef="U_iso4217USD">15642000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">11950000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">5055000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">3529000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">80460000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">73319000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">113807000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000076"
      unitRef="U_iso4217USD">105197000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000077"
      unitRef="U_iso4217USD">106685000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000078"
      unitRef="U_iso4217USD">104333000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000079"
      unitRef="U_iso4217USD">98750000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">163618000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">319242000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000082"
      unitRef="U_iso4217USD">373148000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000106"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000107"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000108"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000109"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000110"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000111"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000112"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000113"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000114"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000115"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000116"
      unitRef="U_xbrlishares">340000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000117"
      unitRef="U_xbrlishares">340000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000118"
      unitRef="U_xbrlishares">141393865</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000120"
      unitRef="U_xbrlishares">141393865</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000119"
      unitRef="U_xbrlishares">137646896</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000121"
      unitRef="U_xbrlishares">137646896</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000087"
      unitRef="U_iso4217USD">14000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000088"
      unitRef="U_iso4217USD">14000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000089"
      unitRef="U_iso4217USD">1324006000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000090"
      unitRef="U_iso4217USD">1253971000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">-1137000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">893000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">-718891000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000094"
      unitRef="U_iso4217USD">-511612000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000095"
      unitRef="U_iso4217USD">603992000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000096"
      unitRef="U_iso4217USD">743266000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000097"
      unitRef="U_iso4217USD">110000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">604102000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">743266000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">923344000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">1116414000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231"
      decimals="-3"
      id="F_000122"
      unitRef="U_iso4217USD">78896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000123"
      unitRef="U_iso4217USD">41439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">43519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">75448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">56943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">41552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">154344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000129"
      unitRef="U_iso4217USD">98382000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000130"
      unitRef="U_iso4217USD">85071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000131"
      unitRef="U_iso4217USD">49301000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000132"
      unitRef="U_iso4217USD">22530000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">22274000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">142343000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">116072000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">70705000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">95465000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">61358000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">38453000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">74502000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">49536000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">30332000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">1699000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">1703000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">1698000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">363310000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">251199000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">163462000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">-208966000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">-152817000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">-78391000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">1668000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">6590000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">9785000</us-gaap:InterestAndOtherIncome>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">-207298000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">-146227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">-68606000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">-19000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000159"
      unitRef="U_iso4217USD">-207279000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">-146227000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">-68606000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000162"
      unitRef="U_iso4217USD">964000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">-207279000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">-146227000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000165"
      unitRef="U_iso4217USD">-69570000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000166"
      unitRef="U_iso4217USD_xbrlishares">-1.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20200101_20201231"
      decimals="2"
      id="F_000167"
      unitRef="U_iso4217USD_xbrlishares">-1.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20190101_20191231"
      decimals="2"
      id="F_000168"
      unitRef="U_iso4217USD_xbrlishares">-1.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20210101_20211231"
      decimals="0"
      id="F_000169"
      unitRef="U_xbrlishares">140354915</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20200101_20201231"
      decimals="0"
      id="F_000170"
      unitRef="U_xbrlishares">131216468</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20190101_20191231"
      decimals="0"
      id="F_000171"
      unitRef="U_xbrlishares">69165315</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">-207298000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000173"
      unitRef="U_iso4217USD">-146227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000174"
      unitRef="U_iso4217USD">-68606000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">-2030000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">222000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000177"
      unitRef="U_iso4217USD">778000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000178"
      unitRef="U_iso4217USD">-209328000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000179"
      unitRef="U_iso4217USD">-146005000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000180"
      unitRef="U_iso4217USD">-67828000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">-19000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">-209309000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">-146005000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">-67828000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231"
      decimals="INF"
      id="F_000185"
      unitRef="U_xbrlishares">92790094</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20181231"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">560858000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="INF"
      id="F_000187"
      unitRef="U_xbrlishares">12841536</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="-3"
      id="F_000188"
      unitRef="U_iso4217USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">37902000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231"
      decimals="-3"
      id="F_000190"
      unitRef="U_iso4217USD">-107000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">-295908000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20181231"
      decimals="-3"
      id="F_000192"
      unitRef="U_iso4217USD">-258112000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000193"
      unitRef="U_xbrlishares">17250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">320848000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">320850000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">-4986000</adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts>
    <adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000198"
      unitRef="U_iso4217USD">-4986000</adpt:AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="INF"
      id="F_000199"
      unitRef="U_xbrlishares">-93039737</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">-561931000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000201"
      unitRef="U_xbrlishares">93039737</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">9000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">561922000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000204"
      unitRef="U_iso4217USD">561931000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">2602000</adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant>
    <adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">2602000</adpt:AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant>
    <adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000207"
      unitRef="U_xbrlishares">54792</adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised>
    <adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">9000</adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised>
    <adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000209"
      unitRef="U_iso4217USD">9000</adpt:StockIssuedDuringPeriodValueCommonStockWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000210"
      unitRef="U_xbrlishares">2043767</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">4413000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000212"
      unitRef="U_iso4217USD">4413000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <adpt:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="INF"
      id="F_000213"
      unitRef="U_xbrlishares">249643</adpt:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">109000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000215"
      unitRef="U_xbrlishares">8310</adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested>
    <adpt:TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">964000</adpt:TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions>
    <adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">-964000</adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions>
    <adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">-964000</adpt:ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">13124000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">13124000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">778000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">778000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">-68606000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">-68606000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000225"
      unitRef="U_xbrlishares">125238142</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000226"
      unitRef="U_iso4217USD">12000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000227"
      unitRef="U_iso4217USD">935834000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">671000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">-365478000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20191231"
      decimals="-3"
      id="F_000230"
      unitRef="U_iso4217USD">571039000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000231"
      unitRef="U_xbrlishares">7200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000233"
      unitRef="U_iso4217USD">271838000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000234"
      unitRef="U_iso4217USD">271839000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000235"
      unitRef="U_iso4217USD">93000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_srtRestatementAxis_srtRevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_20191231"
      decimals="-3"
      id="F_000236"
      unitRef="U_iso4217USD">93000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000238"
      unitRef="U_xbrlishares">5204254</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000240"
      unitRef="U_iso4217USD">21538000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000241"
      unitRef="U_iso4217USD">21539000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000242"
      unitRef="U_xbrlishares">4500</adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">24761000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000244"
      unitRef="U_iso4217USD">24761000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">222000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000246"
      unitRef="U_iso4217USD">222000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">-146227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">-146227000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000249"
      unitRef="U_xbrlishares">137646896</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000250"
      unitRef="U_iso4217USD">14000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000251"
      unitRef="U_iso4217USD">1253971000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231"
      decimals="-3"
      id="F_000252"
      unitRef="U_iso4217USD">893000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000253"
      unitRef="U_iso4217USD">-511612000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000254"
      unitRef="U_iso4217USD">743266000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000255"
      unitRef="U_xbrlishares">54162</adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000256"
      unitRef="U_xbrlishares">3674057</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000257"
      unitRef="U_iso4217USD">26484000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000258"
      unitRef="U_iso4217USD">26484000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000259"
      unitRef="U_xbrlishares">18750</adpt:StockIssuedDuringPeriodSharesRestrictedStockAwardVested>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000260"
      unitRef="U_iso4217USD">43251000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000261"
      unitRef="U_iso4217USD">43251000</adpt:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue>
    <adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000262"
      unitRef="U_iso4217USD">300000</adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions>
    <adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231"
      decimals="-3"
      id="F_000263"
      unitRef="U_iso4217USD">129000</adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions>
    <adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000264"
      unitRef="U_iso4217USD">429000</adpt:AdjustmentsToAdditionalPaidInCapitalCapitalContributions>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000265"
      unitRef="U_iso4217USD">-2030000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000266"
      unitRef="U_iso4217USD">-2030000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231"
      decimals="-3"
      id="F_000267"
      unitRef="U_iso4217USD">-207279000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20210101_20211231"
      decimals="-3"
      id="F_000268"
      unitRef="U_iso4217USD">-19000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000269"
      unitRef="U_iso4217USD">-207298000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="INF"
      id="F_000270"
      unitRef="U_xbrlishares">141393865</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="-3"
      id="F_000271"
      unitRef="U_iso4217USD">14000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">1324006000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">-1137000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">-718891000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20211231"
      decimals="-3"
      id="F_000275"
      unitRef="U_iso4217USD">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">604102000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000277"
      unitRef="U_iso4217USD">-207298000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">-146227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000279"
      unitRef="U_iso4217USD">-68606000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">12254000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">6769000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">6093000</us-gaap:Depreciation>
    <adpt:NoncashLeaseExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000283"
      unitRef="U_iso4217USD">7028000</adpt:NoncashLeaseExpense>
    <adpt:NoncashLeaseExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">3266000</adpt:NoncashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">43251000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">24761000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000287"
      unitRef="U_iso4217USD">13124000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">1699000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">1703000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000290"
      unitRef="U_iso4217USD">1698000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">-7233000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">-773000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">4463000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">2266000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">78000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000296"
      unitRef="U_iso4217USD">-71000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000297"
      unitRef="U_iso4217USD">-359000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000298"
      unitRef="U_iso4217USD">7362000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000299"
      unitRef="U_iso4217USD">-2613000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000300"
      unitRef="U_iso4217USD">7817000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000301"
      unitRef="U_iso4217USD">5200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">4994000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">1231000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">-1286000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">1362000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000306"
      unitRef="U_iso4217USD">8576000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">3940000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">7495000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">6149000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <adpt:IncreaseDecreaseInDeferredRent
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">78000</adpt:IncreaseDecreaseInDeferredRent>
    <adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000311"
      unitRef="U_iso4217USD">8522000</adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">-886000</adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">-57727000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000314"
      unitRef="U_iso4217USD">-43389000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000315"
      unitRef="U_iso4217USD">266927000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000316"
      unitRef="U_iso4217USD">275000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000317"
      unitRef="U_iso4217USD">276000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000318"
      unitRef="U_iso4217USD">597000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000319"
      unitRef="U_iso4217USD">-192727000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">-149683000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000321"
      unitRef="U_iso4217USD">205404000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">61746000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">18803000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">11200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000325"
      unitRef="U_iso4217USD">316544000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">694965000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">884217000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">559500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000329"
      unitRef="U_iso4217USD">596724000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">413720000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">181210000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">-117044000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">-481697000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">26717000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000335"
      unitRef="U_iso4217USD">21748000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">4055000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">272160000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">320850000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">321000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">4986000</us-gaap:PaymentsOfStockIssuanceCosts>
    <adpt:ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000341"
      unitRef="U_iso4217USD">9000</adpt:ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">429000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000343"
      unitRef="U_iso4217USD">-12000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000344"
      unitRef="U_iso4217USD">27146000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000345"
      unitRef="U_iso4217USD">293587000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000346"
      unitRef="U_iso4217USD">319916000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000347"
      unitRef="U_iso4217USD">15629000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000348"
      unitRef="U_iso4217USD">26860000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000349"
      unitRef="U_iso4217USD">43623000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000350"
      unitRef="U_iso4217USD">125574000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20191231"
      decimals="-3"
      id="F_000351"
      unitRef="U_iso4217USD">98714000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20181231"
      decimals="-3"
      id="F_000352"
      unitRef="U_iso4217USD">55091000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000353"
      unitRef="U_iso4217USD">141203000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000354"
      unitRef="U_iso4217USD">125574000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001478320_20191231"
      decimals="-3"
      id="F_000355"
      unitRef="U_iso4217USD">98714000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000356"
      unitRef="U_iso4217USD">682000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000357"
      unitRef="U_iso4217USD">4679000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000358"
      unitRef="U_iso4217USD">773000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000359"
      unitRef="U_iso4217USD">36607000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <adpt:DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000360"
      unitRef="U_iso4217USD">36607000</adpt:DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease>
    <adpt:ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000361"
      unitRef="U_iso4217USD">561931000</adpt:ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering>
    <adpt:ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000362"
      unitRef="U_iso4217USD">2602000</adpt:ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000363">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Organization&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Description of Business&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Adaptive Biotechnologies Corporation (&#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) is a commercial-stage company advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#x2019;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient&#x2019;s immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and services that we are tailoring to each individual patient. We have commercial products and services and a robust pipeline of clinical products and services that we are designing to diagnose, monitor and enable the treatment of diseases, such as cancer, autoimmune disorders and infectious diseases.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We were incorporated in the State of Washington on September&#160;8, 2009 under the name Adaptive TCR Corporation. On December&#160;21, 2011, we changed our name to Adaptive Biotechnologies Corporation. We are headquartered in Seattle, Washington.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Digital Biotechnologies, Inc.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2021, we formed a subsidiary, Spin Technologies, Inc., to facilitate the development of a potential new early-stage sequencing technology that is ancillary to our core business. In February 2022, the subsidiary&#x2019;s name was changed to Digital Biotechnologies, Inc. We have a 70% ownership interest in Digital Biotechnologies, Inc. All intercompany transactions and balances between us and Digital Biotechnologies, Inc. have been eliminated in consolidation. The remaining interest, held by certain of our related parties and related family trusts, was reported as noncontrolling interest in our consolidated financial statements.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231"
      decimals="2"
      id="F_000431"
      unitRef="U_xbrlipure">0.70</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000364">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="color:#000000;"&gt;Significant&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Accounting&lt;/span&gt;&lt;span style="letter-spacing:-0.05pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Policies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of Presentation and&lt;span style="letter-spacing:-0.05pt;"&gt; Principles of Consolidation&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements include the accounts of Adaptive Biotechnologies Corporation, its wholly-owned subsidiary and Digital Biotechnologies, Inc. Other shareholders&#x2019; interests in Digital Biotechnologies, Inc. are shown in the consolidated financial statements as noncontrolling interest. All intercompany transactions and balances have been eliminated upon consolidation.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. Estimates are used in several areas including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, share-based compensation, including the fair value of stock, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#x2019;s estimates.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents are stated at fair value. Cash equivalents include only securities having an original maturity of three months or less at the time of purchase. We limit our credit risk associated with cash and cash equivalents by placing our investments with banks that we believe are highly creditworthy and with highly rated money market funds. Cash and cash equivalents primarily consist of bank deposits and investments in money market funds.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Restricted Cash&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are required to maintain certain balances under lease arrangements for some of our property and facility leases. We had restricted cash of &lt;span&gt;$2.1&lt;/span&gt; million as of December 31, 2021 and 2020.&lt;/p&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Investments in Marketable Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities are classified as&#160;available-for-sale, consist of U.S. government debt securities and corporate bonds and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of shareholders&#x2019; equity in accumulated other comprehensive gain (loss) until realized. Realized gains and losses on the sale of these securities are recognized in net income or loss. The cost of marketable securities sold is based on the specific identification method.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Concentrations&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of Risk&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to a concentration of risk from a limited number of suppliers, or in certain cases, single suppliers for some of our laboratory instruments and materials. This risk is managed by targeting a quantity of surplus stock. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash, cash equivalents and marketable securities are financial instruments that potentially subject us to concentrations of credit risk. We invest in money market funds, U.S. government debt securities, U.S. government agency securities, commercial paper and corporate bonds with high-quality accredited financial institutions. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant customers are those that represent more than 10% of our total revenue or accounts receivable, net balances for the periods and as of each date presented, respectively. Revenue from these customers reflects their purchase of our products and services and our collaboration efforts with Genentech.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts Receivable, Net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.9%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer B&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Genentech, Inc. and Roche Group&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;* less than 10%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accounts Receivable&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable consists of amounts due from customers for services performed. We review our accounts receivable for credit impairment and regularly analyze the status of significant past due receivables to determine if any will potentially be uncollectible to estimate the amount of allowance necessary to reduce accounts receivable to its estimated net realizable value.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additionally, we had $0.2 million and $0.9 million of unbilled receivables as of December&#160;31, 2021 and 2020, respectively. These contract assets are amounts that will become due for which we have an unconditional right to consideration.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Inventory&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventory consists of laboratory materials and supplies used in lab analysis. We capitalize inventory when purchased and record expense upon order fulfillment for servicing revenue or utilization in our research and development laboratories. Inventory is valued at the lower of cost or market on a&#160;first-in,&#160;first-out&#160;basis. We periodically perform obsolescence assessments and write off any inventory that is no longer usable.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consists of computer equipment, computer software, laboratory equipment, leasehold improvements and furniture and office equipment. Property and equipment are recorded at cost and depreciation is recognized using the straight-line method based on estimated useful life. Maintenance and repairs are charged to expense as incurred and costs of improvements are capitalized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Useful lives assigned to property and equipment are as follows:&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;"&gt;
&lt;tr&gt;
&lt;td style="width:223.55pt;"/&gt;
&lt;td style="width:7.85pt;"/&gt;
&lt;td style="width:223.5pt;"/&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 7 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shorter of estimated useful life or remaining lease term&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 10 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We review long-lived assets for impairment whenever events or circumstances indicate the carrying amount of an asset group may not be recoverable. Gains and losses from asset disposals and impairment losses are classified within our consolidated statements of operations in accordance with the use of the asset.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1, or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we so determine, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have not recognized any impairment of goodwill.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Intangible Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date, which is regarded as their cost.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets may also result from the purchase of assets and intellectual property in a transaction that does not qualify as a business combination. Intangible assets are amortized over their estimated useful lives on a straight-line basis which approximates their usage pattern. Intangible assets are reviewed for impairment at least annually or if indicators of potential impairment exist. We have not recognized any impairment losses on intangible assets.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We determine if an arrangement contains a lease at inception. We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy, as well as server space. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized at the date the underlying asset becomes available for our use and are based on the present value of the future minimum lease payments over the lease term. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. As our leases generally do not provide an implicit interest rate, the present value of our future minimum lease payments is determined using our incremental borrowing rate. This rate is an estimate of the collateralized borrowing rate we would incur on our future lease payments over a similar term and is based on the information available to us at the lease commencement date, or as of January 1, 2020 for commenced leases that existed as of our adoption of &lt;span style="Background-color:#FFFFFF;"&gt;Accounting Standards Update No. 2016-02, &lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Leases&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt; (Topic 842) (&#x201c;ASC 842&#x201d;)&lt;/span&gt;. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certain of our leases contain options to extend or terminate the lease; lease terms are adjusted for these options only when it is reasonably certain we will exercise these options. Our lease agreements do not contain residual value guarantees or covenants.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have made a policy election regarding our real estate leases not to separate nonlease components from lease components, to the extent they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease expense. Our leases for laboratory, office and warehouse facilities typically include variable nonlease components, such as common-area maintenance costs. We have also elected not to record on our consolidated balance sheets a lease that has a lease term of twelve months or less and does not contain a purchase option that we are reasonably certain to exercise.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expense is recognized on a straight-line basis over the terms of the leases. Incentives granted under our facilities leases, including rent holidays, are recognized as adjustments to lease expense on a straight-line basis over the terms of the leases.  &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) has defined fair value as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The FASB established a fair value hierarchy that requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. The hierarchy defines three levels of inputs that may be used to measure fair value:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level 1: Quoted &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Level 2: Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A financial instrument categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In certain cases, where there is limited activity or less transparency around inputs to valuation, financial instruments are classified as Level&#160;3 within the valuation hierarchy. &lt;/span&gt;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our financial instruments consist of Level&#160;1 and Level&#160;2 assets and have included Level&#160;3 liabilities in the past. The carrying amounts of certain financial instruments approximate fair value due to their short&#160;maturities. We did not have any nonfinancial assets or liabilities that were measured or disclosed at fair value on a recurring basis as of December&#160;31, 2021 and 2020.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Convertible Preferred Stock Warrant&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We had issued a freestanding warrant to a venture capital firm to purchase 56,875 shares of Series&#160;C convertible preferred stock with an exercise price of $2.64 in connection with a $5.0&#160;million credit facility entered into in 2014. Immediately prior to and in connection with the completion of our initial public offering, the convertible preferred stock warrant converted to a common stock warrant. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the conversion, the fair value of this warrant was classified as a&#160;non-current&#160;liability in the balance sheets, since the underlying convertible preferred stock had been classified as temporary equity instead of shareholders&#x2019; deficit in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities. Upon certain change in control events that were outside of our control, including liquidation, sale or transfer of control, holders of the convertible preferred stock may have caused its redemption. Prior to conversion, the warrant was subject to remeasurement at each balance sheet date, with changes in estimated fair value recognized as a component of interest and other income, net on our statements of operations. During the year ended December 31, 2019, we recognized $2.3 million of expense related to the revaluation of the convertible preferred stock warrant liability in the interest and other income, net line item on our consolidated statements of operations. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;When the convertible preferred stock warrant converted to a common stock warrant immediately prior to and in connection with the completion of the initial public offering, the $2.6 million financial liability was reclassified to the additional paid-in capital line item on our balance sheet, thereby concluding the need for revaluation.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Revenue&lt;span style="letter-spacing:-0.1pt;"&gt; &lt;/span&gt;Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize revenue in accordance with ASC Topic 606 (&#x201c;ASC 606&#x201d;), &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;. Under ASC 606, for all revenue-generating contracts, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation. The following is a summary of the application of the respective model to each of our revenue classifications. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Overview&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our revenue is generated from immunosequencing (&#x201c;sequencing&#x201d;) products and services (&#x201c;sequencing revenue&#x201d;) and from regulatory or development support services leveraging our immune medicine platform (&#x201c;development revenue&#x201d;). When revenue generating contracts have elements of both sequencing revenue and development revenue, we classify revenue based on the nature of the performance obligation and the allocated transaction price. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Sequencing Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. In these transactions, we have identified one performance obligation, the delivery of a clonoSEQ report, and we bill and receive payments from medical institutions and commercial and government third-party payors. As payment from the respective payors may vary based on the various reimbursement rates and patient responsibilities, we consider the transaction price to be variable and record an estimate of the transaction price, subject to the constraint for variable consideration, as revenue at the time of delivery. The estimate of transaction price is based on historical and expected reimbursement rates with the various payors, which are monitored in subsequent periods and adjusted as necessary based on actual collection experience. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For our clonoSEQ coverag&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;e&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; under Medicare, we bill &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#x2019;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test.&#160;Revenue &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;recognition commences &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We estimate the number of tests &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we expect to deliver&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; over a patient&#x2019;s treatment cycle based on historical testing frequencies for patients by indication. These estimates are subject to change as we develop more information about utilization over time.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Any unrecognized revenue from the initial billable test is recorded as deferred revenue and is recognized&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; either&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as we deliver &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our estimate of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the remaining tests in a patient&#x2019;s treatment cycle&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; or when &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the likelihood&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; becomes remote that a patient will receive additional testing&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For research customers, contracts typically include an amount billed in advance of services (&#x201c;upfront&#x201d;) and subsequent billings as sample results are delivered to the customer. Upfront amounts received are recorded as deferred revenue, which we recognize as revenue upon satisfaction of performance obligations. We have identified two typical performance obligations under the terms of our research service contracts: sequencing services and related data analysis. We recognize revenue for both identified performance obligations as sample results are delivered to the customer. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We derive revenue by providing services through development agreements to biopharmaceutical customers who seek access to our immune medicine platform technologies. We generate revenues from the delivery of professional support activities pertaining to the use of immunoSEQ and our MRD product in the development of the respective customers&#x2019; initiatives. The transaction price for these contracts may consist of a combination of non-refundable upfront fees, separately priced sequencing fees, progress-based milestones and regulatory milestones. The development agreements include single or multiple performance obligations, depending on the contract. For certain contracts, we perform services to support the biopharmaceutical customers&#x2019; regulatory submissions as part of their registrational trials. These services may include regulatory support pertaining to our technology intended to be utilized as part of the submission, development of analytical plans for our sequencing data, participation on joint research committees and assistance in completing a regulatory submission. Generally, these services are not distinct within the context of the contract and they are accounted for as a single performance obligation. If agreements include sequencing activities, we separately classify those activities as sequencing revenue.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;When sequencing services are separately priced customer options, we assess if a material right exists and, if not, the customer option to purchase additional sequencing services is not considered part of the contract. Except for any non-refundable upfront fees, the other forms of compensation represent variable consideration. Variable consideration related to progress-based and regulatory milestones is estimated using the most likely amount method, where variable consideration is constrained until it is probable that a significant reversal of cumulative revenue recognized will not occur. Progress milestones, such as the first sample result delivered or final patient enrollment in a customer trial, are customer dependent and are included in the transaction price when the respective milestone is probable of occurring. Milestone payments that are not within our customers&#x2019; control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. Determining whether regulatory milestone payments are probable is an area that requires significant judgment. In making this assessment, we evaluate scientific, clinical, regulatory and other risks, as well as the level of effort and investment required to achieve the respective milestone. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The primary method used to estimate standalone selling price for performance obligations is the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell our services and estimate the price that a customer in that market would be willing to pay for our services. We recognize revenue using either an input or output measure of progress that faithfully depicts performance on a contract, depending on the contract. The measure used is dependent on the nature of the service to be provided in each contract. Selecting the measure of progress and estimating progress to date requires significant judgment.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contract Balances&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In certain circumstances, billing may occur prior to services being performed. Upfront payments are recorded as deferred revenue, contract liabilities. We classify deferred revenue as current for sequencing revenue, as we expect our performance obligations will be completed within the next twelve months; however, we do not control the timing of customer provided samples. For development services, we assess the performance obligations and recognize deferred revenue as current or&#160;non-current&#160;based upon forecasted delivery times, which are customer coordinated. In certain circumstances, the customer project may be cancelled or terminated prior to the delivery of all related services covered by a customer&#x2019;s upfront payment. In these circumstances, we recognize revenue when sufficient evidence is obtained that a reversal of revenue is not probable.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Share-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Share-based compensation includes compensation expense for stock option and restricted stock unit grants to employees and&#160;non-employees.&#160;It represents the grant date fair value of the grants and is recognized over the requisite service period of the awards, usually the vesting period, on a straight-line basis, net of actual forfeitures. We estimate the grant date fair value of stock option grants using the Black-Scholes option-pricing model. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Advertising &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Advertising costs are expensed as incurred. Advertising expenses were $22.4 million, $14.5 million and $6.6 million for the year ended December 31, 2021, 2020 and 2019, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Cost of Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Research and Development Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. &lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. &lt;/span&gt;Research and development costs are expensed as incurred. Upfront payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized, then are recognized as an expense as the goods are consumed or the related services are performed. &lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Costs to support our Genentech Agreement are also a component of our research and development expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Sales and Marketing Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income taxes are accounted for under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and the operating loss and tax credit carryforwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets and liabilities are measured at the consolidated balance sheet date using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in the period such tax rate changes are enacted. Our net deferred tax assets are fully offset by a valuation allowance, because of our history of losses.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the effect of income tax positions only if those positions are more likely than not of being sustained upon examination.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We calculate basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders by dividing net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, common stock warrants, stock options and nonvested restricted stock units are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect is anti-dilutive.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the closing of our initial public offering in July 2019 and the related conversion of our convertible preferred stock into common stock, we calculated our basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders in conformity with the&#160;two-class&#160;method required for companies with participating securities. We considered our convertible preferred stock to be participating securities. In the event a dividend had been declared or paid on common stock, holders of convertible preferred stock would have been entitled to a share of such dividend in proportion to the holders of common stock on an&#160;as-if&#160;converted basis. Under the&#160;two-class&#160;method, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is calculated by dividing the net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. Net loss attributable to Adaptive Biotechnologies Corporation common shareholders is determined by allocating undistributed earnings between common and preferred shareholders. The net loss attributable to Adaptive Biotechnologies Corporation common shareholders was not allocated to the convertible preferred stock under the&#160;two-class&#160;method, as the convertible preferred stock did not have a contractual obligation to share in our losses. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders was computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, convertible preferred stock, convertible preferred stock warrants, common stock warrants and stock options were considered common stock equivalents but were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect was anti-dilutive.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Segment Information&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have determined that our chief executive officer is the chief operating decision maker (&#x201c;CODM&#x201d;). The CODM regularly reviews operating results and other financial information presented on a consolidated basis. While revenue is reviewed at levels lower than the consolidated entity, resource allocation decisions are made by the CODM based on the results presented at the consolidated entity level, which is determined to be a single reporting unit. There are no segment managers who are held accountable by the CODM for operations, operating results or planning at levels or components below the consolidated entity. As such, the consolidated entity operates as one operating segment and represents one reportable segment. We present disaggregated revenue from contracts with customers by type of service. See Note 3,&#160;Revenue.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <adpt:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000380">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of Presentation and&lt;span style="letter-spacing:-0.05pt;"&gt; Principles of Consolidation&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements include the accounts of Adaptive Biotechnologies Corporation, its wholly-owned subsidiary and Digital Biotechnologies, Inc. Other shareholders&#x2019; interests in Digital Biotechnologies, Inc. are shown in the consolidated financial statements as noncontrolling interest. All intercompany transactions and balances have been eliminated upon consolidation.&lt;/p&gt;</adpt:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_0001478320_20210101_20211231" id="F_000381">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. Estimates are used in several areas including, but not limited to, estimates of progress to date for certain performance obligations and the transaction price for certain contracts with customers, share-based compensation, including the fair value of stock, the provision for income taxes, including related reserves, and goodwill, among others. These estimates generally involve complex issues and require judgments, involve the analysis of historical results and prediction of future trends, can require extended periods of time to resolve and are subject to change from period to period. Actual results may differ materially from management&#x2019;s estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000382">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents are stated at fair value. Cash equivalents include only securities having an original maturity of three months or less at the time of purchase. We limit our credit risk associated with cash and cash equivalents by placing our investments with banks that we believe are highly creditworthy and with highly rated money market funds. Cash and cash equivalents primarily consist of bank deposits and investments in money market funds.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="C_0001478320_20210101_20211231" id="F_000383">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Restricted Cash&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are required to maintain certain balances under lease arrangements for some of our property and facility leases. We had restricted cash of &lt;span&gt;$2.1&lt;/span&gt; million as of December 31, 2021 and 2020.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000432"
      unitRef="U_iso4217USD">2100000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-5"
      id="F_000433"
      unitRef="U_iso4217USD">2100000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:MarketableSecuritiesPolicy contextRef="C_0001478320_20210101_20211231" id="F_000384">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities are classified as&#160;available-for-sale, consist of U.S. government debt securities and corporate bonds and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of shareholders&#x2019; equity in accumulated other comprehensive gain (loss) until realized. Realized gains and losses on the sale of these securities are recognized in net income or loss. The cost of marketable securities sold is based on the specific identification method.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001478320_20210101_20211231" id="F_000385">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Concentrations&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of Risk&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to a concentration of risk from a limited number of suppliers, or in certain cases, single suppliers for some of our laboratory instruments and materials. This risk is managed by targeting a quantity of surplus stock. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash, cash equivalents and marketable securities are financial instruments that potentially subject us to concentrations of credit risk. We invest in money market funds, U.S. government debt securities, U.S. government agency securities, commercial paper and corporate bonds with high-quality accredited financial institutions. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant customers are those that represent more than 10% of our total revenue or accounts receivable, net balances for the periods and as of each date presented, respectively. Revenue from these customers reflects their purchase of our products and services and our collaboration efforts with Genentech.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts Receivable, Net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.9%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer B&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Genentech, Inc. and Roche Group&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;* less than 10%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000405">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For each significant customer, revenue as a percentage of total revenue for the periods presented and accounts receivable, net as a percentage of total accounts receivable, net as of the dates presented were as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts Receivable, Net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="4" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.9%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Customer B&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Genentech, Inc. and Roche Group&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;*&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;* less than 10%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231"
      decimals="3"
      id="F_000434"
      unitRef="U_xbrlipure">0.139</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="3"
      id="F_000435"
      unitRef="U_xbrlipure">0.191</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231"
      decimals="3"
      id="F_000436"
      unitRef="U_xbrlipure">0.113</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptCustomerBMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="3"
      id="F_000437"
      unitRef="U_xbrlipure">0.122</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231"
      decimals="3"
      id="F_000438"
      unitRef="U_xbrlipure">0.419</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="3"
      id="F_000439"
      unitRef="U_xbrlipure">0.558</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncAndRocheGroupMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231"
      decimals="3"
      id="F_000440"
      unitRef="U_xbrlipure">0.421</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000386">
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accounts Receivable&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable consists of amounts due from customers for services performed. We review our accounts receivable for credit impairment and regularly analyze the status of significant past due receivables to determine if any will potentially be uncollectible to estimate the amount of allowance necessary to reduce accounts receivable to its estimated net realizable value.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additionally, we had $0.2 million and $0.9 million of unbilled receivables as of December&#160;31, 2021 and 2020, respectively. These contract assets are amounts that will become due for which we have an unconditional right to consideration.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000441"
      unitRef="U_iso4217USD">200000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-5"
      id="F_000442"
      unitRef="U_iso4217USD">900000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000388">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Inventory&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventory consists of laboratory materials and supplies used in lab analysis. We capitalize inventory when purchased and record expense upon order fulfillment for servicing revenue or utilization in our research and development laboratories. Inventory is valued at the lower of cost or market on a&#160;first-in,&#160;first-out&#160;basis. We periodically perform obsolescence assessments and write off any inventory that is no longer usable.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000389">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consists of computer equipment, computer software, laboratory equipment, leasehold improvements and furniture and office equipment. Property and equipment are recorded at cost and depreciation is recognized using the straight-line method based on estimated useful life. Maintenance and repairs are charged to expense as incurred and costs of improvements are capitalized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Useful lives assigned to property and equipment are as follows:&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;"&gt;
&lt;tr&gt;
&lt;td style="width:223.55pt;"/&gt;
&lt;td style="width:7.85pt;"/&gt;
&lt;td style="width:223.5pt;"/&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 7 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shorter of estimated useful life or remaining lease term&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 10 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We review long-lived assets for impairment whenever events or circumstances indicate the carrying amount of an asset group may not be recoverable. Gains and losses from asset disposals and impairment losses are classified within our consolidated statements of operations in accordance with the use of the asset.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <adpt:ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000406">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Useful lives assigned to property and equipment are as follows:&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:454.9pt;;"&gt;
&lt;tr&gt;
&lt;td style="width:223.55pt;"/&gt;
&lt;td style="width:7.85pt;"/&gt;
&lt;td style="width:223.5pt;"/&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 7 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shorter of estimated useful life or remaining lease term&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="text-align:right;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.5pt;;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3 years to 10 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</adpt:ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231"
      id="F_000443">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231"
      id="F_000444">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231"
      id="F_000445">Shorter of estimated useful life or remaining lease term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231"
      id="F_000446">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerEquipmentAndSoftwareMember_20210101_20211231"
      id="F_000447">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231"
      id="F_000448">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20210101_20211231"
      id="F_000449">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="C_0001478320_20210101_20211231" id="F_000390">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill represents the excess of the purchase price over the net amount of identifiable assets acquired and liabilities assumed in a business combination measured at fair value. We assess goodwill for impairment annually on October&#160;1, or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. We evaluate goodwill for impairment by first assessing qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we so determine, or if we choose to bypass the qualitative assessment, we perform a quantitative goodwill impairment test. Goodwill impairment exists when the estimated fair value of our one reporting unit is less than its carrying value. If impairment exists, the carrying value of the goodwill is reduced to fair value through an impairment charge recorded in our consolidated statements of operations. To date, we have not recognized any impairment of goodwill.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000450"
      unitRef="U_iso4217USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="C_0001478320_20210101_20211231" id="F_000391">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Intangible Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date, which is regarded as their cost.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets may also result from the purchase of assets and intellectual property in a transaction that does not qualify as a business combination. Intangible assets are amortized over their estimated useful lives on a straight-line basis which approximates their usage pattern. Intangible assets are reviewed for impairment at least annually or if indicators of potential impairment exist. We have not recognized any impairment losses on intangible assets.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000451"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000392">
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We determine if an arrangement contains a lease at inception. We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy, as well as server space. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized at the date the underlying asset becomes available for our use and are based on the present value of the future minimum lease payments over the lease term. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. As our leases generally do not provide an implicit interest rate, the present value of our future minimum lease payments is determined using our incremental borrowing rate. This rate is an estimate of the collateralized borrowing rate we would incur on our future lease payments over a similar term and is based on the information available to us at the lease commencement date, or as of January 1, 2020 for commenced leases that existed as of our adoption of &lt;span style="Background-color:#FFFFFF;"&gt;Accounting Standards Update No. 2016-02, &lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Leases&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt; (Topic 842) (&#x201c;ASC 842&#x201d;)&lt;/span&gt;. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certain of our leases contain options to extend or terminate the lease; lease terms are adjusted for these options only when it is reasonably certain we will exercise these options. Our lease agreements do not contain residual value guarantees or covenants.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have made a policy election regarding our real estate leases not to separate nonlease components from lease components, to the extent they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease expense. Our leases for laboratory, office and warehouse facilities typically include variable nonlease components, such as common-area maintenance costs. We have also elected not to record on our consolidated balance sheets a lease that has a lease term of twelve months or less and does not contain a purchase option that we are reasonably certain to exercise.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expense is recognized on a straight-line basis over the terms of the leases. Incentives granted under our facilities leases, including rent holidays, are recognized as adjustments to lease expense on a straight-line basis over the terms of the leases.  &lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="C_0001478320_20210101_20211231" id="F_000393">
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) has defined fair value as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The FASB established a fair value hierarchy that requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. The hierarchy defines three levels of inputs that may be used to measure fair value:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level 1: Quoted &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Level 2: Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A financial instrument categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In certain cases, where there is limited activity or less transparency around inputs to valuation, financial instruments are classified as Level&#160;3 within the valuation hierarchy. &lt;/span&gt;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our financial instruments consist of Level&#160;1 and Level&#160;2 assets and have included Level&#160;3 liabilities in the past. The carrying amounts of certain financial instruments approximate fair value due to their short&#160;maturities. We did not have any nonfinancial assets or liabilities that were measured or disclosed at fair value on a recurring basis as of December&#160;31, 2021 and 2020.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <adpt:StockholdersEquityConvertiblePreferredStockPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000394">
&lt;p style="Background-color:#FFFFFF;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Convertible Preferred Stock Warrant&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We had issued a freestanding warrant to a venture capital firm to purchase 56,875 shares of Series&#160;C convertible preferred stock with an exercise price of $2.64 in connection with a $5.0&#160;million credit facility entered into in 2014. Immediately prior to and in connection with the completion of our initial public offering, the convertible preferred stock warrant converted to a common stock warrant. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the conversion, the fair value of this warrant was classified as a&#160;non-current&#160;liability in the balance sheets, since the underlying convertible preferred stock had been classified as temporary equity instead of shareholders&#x2019; deficit in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities. Upon certain change in control events that were outside of our control, including liquidation, sale or transfer of control, holders of the convertible preferred stock may have caused its redemption. Prior to conversion, the warrant was subject to remeasurement at each balance sheet date, with changes in estimated fair value recognized as a component of interest and other income, net on our statements of operations. During the year ended December 31, 2019, we recognized $2.3 million of expense related to the revaluation of the convertible preferred stock warrant liability in the interest and other income, net line item on our consolidated statements of operations. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;When the convertible preferred stock warrant converted to a common stock warrant immediately prior to and in connection with the completion of the initial public offering, the $2.6 million financial liability was reclassified to the additional paid-in capital line item on our balance sheet, thereby concluding the need for revaluation.&lt;/p&gt;</adpt:StockholdersEquityConvertiblePreferredStockPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231"
      decimals="INF"
      id="F_000452"
      unitRef="U_xbrlishares">56875</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231"
      decimals="2"
      id="F_000453"
      unitRef="U_iso4217USD_xbrlishares">2.64</adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231"
      decimals="-5"
      id="F_000454"
      unitRef="U_iso4217USD">5000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20190101_20191231"
      decimals="-5"
      id="F_000455"
      unitRef="U_iso4217USD">2300000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20211231"
      decimals="-5"
      id="F_000456"
      unitRef="U_iso4217USD">2600000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000395">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Revenue&lt;span style="letter-spacing:-0.1pt;"&gt; &lt;/span&gt;Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize revenue in accordance with ASC Topic 606 (&#x201c;ASC 606&#x201d;), &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;. Under ASC 606, for all revenue-generating contracts, we perform the following steps to determine the amount of revenue to be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) we satisfy each performance obligation. The following is a summary of the application of the respective model to each of our revenue classifications. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Overview&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our revenue is generated from immunosequencing (&#x201c;sequencing&#x201d;) products and services (&#x201c;sequencing revenue&#x201d;) and from regulatory or development support services leveraging our immune medicine platform (&#x201c;development revenue&#x201d;). When revenue generating contracts have elements of both sequencing revenue and development revenue, we classify revenue based on the nature of the performance obligation and the allocated transaction price. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Sequencing Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing revenue reflects the amounts generated from providing testing services through clonoSEQ to clinical and research customers, from providing our T-Detect COVID test to clinical customers and from providing sequencing services through immunoSEQ to research customers.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For clinical customers, we primarily derive revenue from providing our clonoSEQ report to ordering physicians. In these transactions, we have identified one performance obligation, the delivery of a clonoSEQ report, and we bill and receive payments from medical institutions and commercial and government third-party payors. As payment from the respective payors may vary based on the various reimbursement rates and patient responsibilities, we consider the transaction price to be variable and record an estimate of the transaction price, subject to the constraint for variable consideration, as revenue at the time of delivery. The estimate of transaction price is based on historical and expected reimbursement rates with the various payors, which are monitored in subsequent periods and adjusted as necessary based on actual collection experience. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For our clonoSEQ coverag&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;e&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; under Medicare, we bill &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;an episode of treatment when we deliver the first eligible test results. This billing contemplates all necessary tests required during a patient&#x2019;s treatment cycle, which is currently estimated at approximately four tests per patient, including the initial sequence identification test.&#160;Revenue &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;recognition commences &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at the time the initial billable test result is delivered and is based upon cumulative tests delivered to date. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We estimate the number of tests &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we expect to deliver&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; over a patient&#x2019;s treatment cycle based on historical testing frequencies for patients by indication. These estimates are subject to change as we develop more information about utilization over time.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Any unrecognized revenue from the initial billable test is recorded as deferred revenue and is recognized&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; either&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as we deliver &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our estimate of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the remaining tests in a patient&#x2019;s treatment cycle&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; or when &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the likelihood&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; becomes remote that a patient will receive additional testing&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For research customers, contracts typically include an amount billed in advance of services (&#x201c;upfront&#x201d;) and subsequent billings as sample results are delivered to the customer. Upfront amounts received are recorded as deferred revenue, which we recognize as revenue upon satisfaction of performance obligations. We have identified two typical performance obligations under the terms of our research service contracts: sequencing services and related data analysis. We recognize revenue for both identified performance obligations as sample results are delivered to the customer. In periods where our sample estimates are reduced or a customer project is cancelled and, in either case, we have remaining related deferred revenue, we recognize revenue using a cumulative catch-up approach based on the proportion of samples delivered to date relative to the remaining samples expected to be delivered.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We derive revenue by providing services through development agreements to biopharmaceutical customers who seek access to our immune medicine platform technologies. We generate revenues from the delivery of professional support activities pertaining to the use of immunoSEQ and our MRD product in the development of the respective customers&#x2019; initiatives. The transaction price for these contracts may consist of a combination of non-refundable upfront fees, separately priced sequencing fees, progress-based milestones and regulatory milestones. The development agreements include single or multiple performance obligations, depending on the contract. For certain contracts, we perform services to support the biopharmaceutical customers&#x2019; regulatory submissions as part of their registrational trials. These services may include regulatory support pertaining to our technology intended to be utilized as part of the submission, development of analytical plans for our sequencing data, participation on joint research committees and assistance in completing a regulatory submission. Generally, these services are not distinct within the context of the contract and they are accounted for as a single performance obligation. If agreements include sequencing activities, we separately classify those activities as sequencing revenue.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;When sequencing services are separately priced customer options, we assess if a material right exists and, if not, the customer option to purchase additional sequencing services is not considered part of the contract. Except for any non-refundable upfront fees, the other forms of compensation represent variable consideration. Variable consideration related to progress-based and regulatory milestones is estimated using the most likely amount method, where variable consideration is constrained until it is probable that a significant reversal of cumulative revenue recognized will not occur. Progress milestones, such as the first sample result delivered or final patient enrollment in a customer trial, are customer dependent and are included in the transaction price when the respective milestone is probable of occurring. Milestone payments that are not within our customers&#x2019; control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. Determining whether regulatory milestone payments are probable is an area that requires significant judgment. In making this assessment, we evaluate scientific, clinical, regulatory and other risks, as well as the level of effort and investment required to achieve the respective milestone. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The primary method used to estimate standalone selling price for performance obligations is the adjusted market assessment approach. Using this approach, we evaluate the market in which we sell our services and estimate the price that a customer in that market would be willing to pay for our services. We recognize revenue using either an input or output measure of progress that faithfully depicts performance on a contract, depending on the contract. The measure used is dependent on the nature of the service to be provided in each contract. Selecting the measure of progress and estimating progress to date requires significant judgment.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, we executed an intellectual property license agreement that includes variable consideration related to sales-based royalties. Any consideration related to such royalties will be recognized as development revenue at the later of when (i) the related sales occur or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied (or partially satisfied).&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <adpt:NumberOfRevenuePerformanceObligation
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231"
      decimals="INF"
      id="F_000457"
      unitRef="U_adptPerformance_Obligation">2</adpt:NumberOfRevenuePerformanceObligation>
    <adpt:ContractBalancesPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000396">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contract Balances&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In certain circumstances, billing may occur prior to services being performed. Upfront payments are recorded as deferred revenue, contract liabilities. We classify deferred revenue as current for sequencing revenue, as we expect our performance obligations will be completed within the next twelve months; however, we do not control the timing of customer provided samples. For development services, we assess the performance obligations and recognize deferred revenue as current or&#160;non-current&#160;based upon forecasted delivery times, which are customer coordinated. In certain circumstances, the customer project may be cancelled or terminated prior to the delivery of all related services covered by a customer&#x2019;s upfront payment. In these circumstances, we recognize revenue when sufficient evidence is obtained that a reversal of revenue is not probable.&lt;/p&gt;</adpt:ContractBalancesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="C_0001478320_20210101_20211231" id="F_000397">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Share-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Share-based compensation includes compensation expense for stock option and restricted stock unit grants to employees and&#160;non-employees.&#160;It represents the grant date fair value of the grants and is recognized over the requisite service period of the awards, usually the vesting period, on a straight-line basis, net of actual forfeitures. We estimate the grant date fair value of stock option grants using the Black-Scholes option-pricing model. &lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000398">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Advertising &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Advertising costs are expensed as incurred. Advertising expenses were $22.4 million, $14.5 million and $6.6 million for the year ended December 31, 2021, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000458"
      unitRef="U_iso4217USD">22400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000459"
      unitRef="U_iso4217USD">14500000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-5"
      id="F_000460"
      unitRef="U_iso4217USD">6600000</us-gaap:AdvertisingExpense>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000399">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Cost of Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue includes the cost of materials, personnel-related expenses (including salaries, benefits and share-based compensation), shipping and handling expenses, equipment costs and allocated facility costs associated with processing samples and professional support for our sequencing revenue activities. Allocated facility costs include depreciation of laboratory equipment, as well as allocated facility occupancy and information technology costs. Costs associated with processing samples are recorded as expense, regardless of the timing of revenue recognition.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_0001478320_20210101_20211231" id="F_000400">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Research and Development Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses consist of laboratory materials costs, personnel-related expenses, equipment costs, allocated facility costs, information technology expenses and contract service expenses. &lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;We also include in research and development expenses the costs associated with software development of applications to support future commercial opportunities, as well as development activities to support laboratory scaling and workflow. &lt;/span&gt;Research and development costs are expensed as incurred. Upfront payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized, then are recognized as an expense as the goods are consumed or the related services are performed. &lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;Costs to support our Genentech Agreement are also a component of our research and development expenses.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <adpt:SalesAndMarketingExpensePolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000401">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Sales and Marketing Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales and marketing expenses consist primarily of personnel-related expenses for commercial sales, product and account management, marketing, reimbursement, medical education and business development personnel that support commercialization of our platform products. In addition, these expenses include external costs such as advertising expenses, customer education and promotional expenses, market analysis expenses, conference fees, travel expenses and allocated facility costs.&lt;/p&gt;</adpt:SalesAndMarketingExpensePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000402">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income taxes are accounted for under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and the operating loss and tax credit carryforwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets and liabilities are measured at the consolidated balance sheet date using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in the period such tax rate changes are enacted. Our net deferred tax assets are fully offset by a valuation allowance, because of our history of losses.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the effect of income tax positions only if those positions are more likely than not of being sustained upon examination.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000403">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We calculate basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders by dividing net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, common stock warrants, stock options and nonvested restricted stock units are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect is anti-dilutive.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the closing of our initial public offering in July 2019 and the related conversion of our convertible preferred stock into common stock, we calculated our basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders in conformity with the&#160;two-class&#160;method required for companies with participating securities. We considered our convertible preferred stock to be participating securities. In the event a dividend had been declared or paid on common stock, holders of convertible preferred stock would have been entitled to a share of such dividend in proportion to the holders of common stock on an&#160;as-if&#160;converted basis. Under the&#160;two-class&#160;method, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is calculated by dividing the net loss attributable to Adaptive Biotechnologies Corporation common shareholders by the weighted-average number of shares of common stock outstanding for the period. Net loss attributable to Adaptive Biotechnologies Corporation common shareholders is determined by allocating undistributed earnings between common and preferred shareholders. The net loss attributable to Adaptive Biotechnologies Corporation common shareholders was not allocated to the convertible preferred stock under the&#160;two-class&#160;method, as the convertible preferred stock did not have a contractual obligation to share in our losses. The diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders was computed by giving effect to all potential dilutive common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, convertible preferred stock, convertible preferred stock warrants, common stock warrants and stock options were considered common stock equivalents but were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as their effect was anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000404">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Segment Information&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have determined that our chief executive officer is the chief operating decision maker (&#x201c;CODM&#x201d;). The CODM regularly reviews operating results and other financial information presented on a consolidated basis. While revenue is reviewed at levels lower than the consolidated entity, resource allocation decisions are made by the CODM based on the results presented at the consolidated entity level, which is determined to be a single reporting unit. There are no segment managers who are held accountable by the CODM for operations, operating results or planning at levels or components below the consolidated entity. As such, the consolidated entity operates as one operating segment and represents one reportable segment. We present disaggregated revenue from contracts with customers by type of service. See Note 3,&#160;Revenue.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000461"
      unitRef="U_adptSegment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000462"
      unitRef="U_adptSegment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000365">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We disaggregate our revenue from contracts with customers by type of service, as we believe this best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following table presents our revenue disaggregated by type of products and services for the periods presented (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,896&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,519&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development support&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,448&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,443&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Regulatory milestones&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total development revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,448&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,943&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;85,071&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;MRD Development&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Agreements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have entered into agreements with biopharmaceutical customers to further develop and commercialize our MRD product and the biopharmaceutical customers&#x2019; therapeutics. Under each of the agreements, we received or will receive non-refundable upfront payments and could receive substantial additional payments upon reaching certain progress-based milestones or achieving certain regulatory milestones pertaining to the customers&#x2019; therapeutics and our MRD product.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the contracts, we identify performance obligations, which may include: (1)&#160;obligations to provide services supporting the customer&#x2019;s regulatory submission activities as they relate to our MRD product; and (2)&#160;sequencing services related to customer-provided samples for their regulatory submissions. The transaction price allocated to the respective performance obligations is estimated using an adjusted market assessment approach for the regulatory support services and a standalone selling price for the estimated immunosequencing services. At contract inception, we fully constrain any consideration related to regulatory milestones, as the achievement of such milestones is subject to third-party regulatory approval and the customers&#x2019; own submission decision-making. We recognize revenue related to the sequencing services as sequencing revenue over time using an output method based on the proportion of sample results delivered relative to the total amount of sample results expected to be delivered, when expected to be a faithful depiction of progress. We use the same method to recognize the regulatory support services. When an output method based on the proportion of sample results delivered is not expected to be a faithful depiction of progress, we utilize an input method using a cost-based model based on estimates of effort completed.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognized $3.2 million in revenue during the year ended December 31, 2021 due to changes in estimates of total samples to be provided under certain of our MRD development agreements for which we had previously received upfront consideration, of which $0.3 million was recognized as development revenue in the respective period.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We earned $10.0 million, $2.5 million and $2.0 million during the year ended December 31, 2021, 2020 and 2019, respectively, upon the achievement of certain regulatory milestones by us and our respective customers&#x2019; therapeutics. We recognized these earnings as development revenue within the respective periods, as we determined that the amounts were consistent with our estimated standalone selling prices and the respective performance obligations were complete.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In total, we recognized $11.8&#160;million, $3.4&#160;million and $3.7 million in development revenue related to our MRD development agreements during the year ended December 31, 2021, 2020 and 2019, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, in future periods we could receive up to an additional $333.5 million in milestone payments if certain regulatory approvals are obtained by our customers&#x2019; therapeutics in connection with MRD data generated from our MRD product.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Genentech&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Collaboration Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2018, we entered into a worldwide collaboration and license agreement with Genentech (&#x201c;Genentech Agreement&#x201d;) to leverage our capability to develop cellular therapies in oncology. Subsequent to receipt of regulatory approval in January 2019, we received a non-refundable, upfront payment of $300.0 million in February 2019 and may be eligible to receive more than $1.8 billion over time, including payments of up to $75.0 million upon the achievement of specified regulatory milestones, up to $300.0 million upon the achievement of specified development milestones and up to $1,430.0 million upon the achievement of specified commercial milestones. In addition, we are separately able to receive tiered royalties at a rate ranging from the mid-single digits to the mid-teens on aggregate worldwide net sales of products arising from the strategic collaboration, subject to certain reductions, with aggregate minimum floors. Under the agreement, we are pursuing two product development pathways for novel T cell immunotherapies in which Genentech intends to use TCRs screened by our immune medicine platform to engineer and manufacture cellular medicines: &lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;"&gt;Shared Products. The shared products will use &#x201c;off-the-shelf&#x201d; TCRs identified against cancer antigens shared among patients (&#x201c;Shared Products&#x201d;). &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;"&gt;Personalized Product. The personalized product will use patient-specific TCRs identified by real-time screening of TCRs against cancer antigens in each patient (&#x201c;Personalized Product&#x201d;). &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the agreement, we granted Genentech exclusive worldwide licenses to develop and commercialize TCR-based cellular therapies in the field of oncology, including licenses to existing shared antigen data packages. Additionally, Genentech has the right to determine which product candidates to further develop for commercialization purposes. We determined that this arrangement meets the criteria set forth in ASC Topic 808, &lt;span style="font-style:italic;"&gt;Collaborative Arrangements&lt;/span&gt; (&#x201c;ASC 808&#x201d;), because both parties are active participants in the activity and are exposed to significant risks and rewards depending on the activity&#x2019;s commercial failure or success. Because ASC 808 does not provide guidance on how to account for the activities under a collaborative arrangement, we applied the guidance in ASC 606 to account for the activities related to the Genentech Agreement.&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In applying ASC&#160;606, we identified the following performance obligations at the inception of the agreement: &lt;/span&gt;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;1.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;License to utilize on an exclusive basis all TCR-specific platform intellectual property to develop and commercialize any licensed products in the field of oncology. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;2.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;License to utilize all data and information within each shared antigen data package and any other know-how disclosed by us to Genentech in oncology. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;3.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;License to utilize all private antigen TCR product data in connection with research and development activities in the field of use. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;4.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;License to existing shared antigen data packages. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;5.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Research and development services for shared product development, including expansion of shared antigen data packages. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;6.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Research and development services for private product development. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:7.87%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:2.27%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;7.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Obligations to participate on various joint research, development and project committees. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We determined that none of the licenses, research and development services or obligations to participate on various committees were distinct within the context of the contract, given such rights and activities were highly interrelated and there was substantial additional research and development to further develop the licenses. We considered factors such as the stage of development of the respective existing antigen data packages, the subsequent development that would be required to both identify and submit a potential target for investigational new drug acceptance under both product pathways and the variability in research and development pathways given Genentech&#x2019;s control of product commercialization. Specifically, under the agreement, Genentech is not required to pursue development or commercialization activities pertaining to both product pathways and may choose to proceed with one or the other, as opposed to both. Accordingly, we determined that all of the identified performance obligations were attributable to one general performance obligation, which is to further the development of our TCR-specific platform, including data packages, and continue to make our TCR identification process available to Genentech to pursue either product pathway.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Separately, we have a responsibility to Genentech to enter into a supply and manufacturing agreement for patient-specific TCRs as it pertains to any Personalized Product therapeutic. We determined this was an option right of Genentech should they pursue commercialization of a Personalized Product therapy. Because of the uncertainty resulting from the early stage of development, the novel approach of our collaboration with Genentech and our rights to future commercial milestones and royalty payments, we determined that this option right was not a material right that should be accounted for at inception. As such, we will account for the supply and manufacturing agreement when entered into between the parties. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We determined the initial transaction price shall be made up of only the $300.0 million upfront, non-refundable payment, as all potential regulatory and development milestone payments were probable of significant revenue reversal given their achievement was highly dependent on factors outside our control. As a result, these payments were fully constrained and were not included in the transaction price as of December 31, 2021. We excluded the commercial milestones and potential royalties from the transaction price, as those items relate predominantly to the license rights granted to Genentech and will be assessed when and if such events occur. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As there are potential substantive developments necessary, which Genentech may be able to direct, we determined that we would apply a proportional performance model to recognize revenue for our performance obligation. We measure proportional performance using an input method based on costs incurred relative to the total estimated costs of research and development efforts to pursue both the Shared Products and Personalized Product pathways. When any of the potential regulatory and development milestones are no longer fully constrained and included in the transaction price, such amounts will be recognized using the cumulative catch-up method based on proportional performance at such time. We currently expect to recognize the revenue over a period of approximately seven to eight years from the effective date. This estimate of the research and development period considers pursuit options of development activities supporting both the Shared Products and the Personalized Product, but may be reduced or increased based on the various activities as directed by the joint committees, decisions made by Genentech, regulatory feedback or other factors not currently known. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognized revenue of $62.0 million, $52.8 million and $35.1 million during the year ended December 31, 2021, 2020 and 2019, respectively, related to the Genentech Agreement. Costs related to the Genentech Agreement are included in research and development expenses.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000407">The following table presents our revenue disaggregated by type of products and services for the periods presented (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,896&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,519&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development support&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,448&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,443&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Regulatory milestones&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total development revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,448&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,943&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;85,071&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;font-weight:bold;font-style:italic;;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231"
      decimals="-3"
      id="F_000463"
      unitRef="U_iso4217USD">78896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000464"
      unitRef="U_iso4217USD">41439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000465"
      unitRef="U_iso4217USD">43519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20210101_20211231"
      decimals="-3"
      id="F_000466"
      unitRef="U_iso4217USD">65448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000467"
      unitRef="U_iso4217USD">54443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000468"
      unitRef="U_iso4217USD">39552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20210101_20211231"
      decimals="-3"
      id="F_000469"
      unitRef="U_iso4217USD">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20200101_20201231"
      decimals="-3"
      id="F_000470"
      unitRef="U_iso4217USD">2500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueRegulatoryMilestonesMember_20190101_20191231"
      decimals="-3"
      id="F_000471"
      unitRef="U_iso4217USD">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20210101_20211231"
      decimals="-3"
      id="F_000472"
      unitRef="U_iso4217USD">75448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000473"
      unitRef="U_iso4217USD">56943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000474"
      unitRef="U_iso4217USD">41552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000475"
      unitRef="U_iso4217USD">154344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000476"
      unitRef="U_iso4217USD">98382000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000477"
      unitRef="U_iso4217USD">85071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231"
      decimals="-5"
      id="F_000478"
      unitRef="U_iso4217USD">3200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231"
      decimals="-5"
      id="F_000479"
      unitRef="U_iso4217USD">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231"
      decimals="-5"
      id="F_000480"
      unitRef="U_iso4217USD">10000000.0</adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized>
    <adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231"
      decimals="-5"
      id="F_000481"
      unitRef="U_iso4217USD">2500000</adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized>
    <adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231"
      decimals="-5"
      id="F_000482"
      unitRef="U_iso4217USD">2000000.0</adpt:ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231"
      decimals="-5"
      id="F_000483"
      unitRef="U_iso4217USD">11800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20200101_20201231"
      decimals="-5"
      id="F_000484"
      unitRef="U_iso4217USD">3400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20190101_20191231"
      decimals="-5"
      id="F_000485"
      unitRef="U_iso4217USD">3700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <adpt:AdditionalMilestonePayment
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20211231"
      decimals="INF"
      id="F_000486"
      unitRef="U_iso4217USD">333500000</adpt:AdditionalMilestonePayment>
    <adpt:NonRefundableUpfrontPaymentsReceived
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190201_20190228"
      decimals="-5"
      id="F_000487"
      unitRef="U_iso4217USD">300000000.0</adpt:NonRefundableUpfrontPaymentsReceived>
    <adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231"
      decimals="INF"
      id="F_000488"
      unitRef="U_iso4217USD">1800000</adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable>
    <adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptRegulatoryMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231"
      decimals="INF"
      id="F_000489"
      unitRef="U_iso4217USD">75000000.0</adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable>
    <adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptDevelopmentMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231"
      decimals="INF"
      id="F_000490"
      unitRef="U_iso4217USD">300000000.0</adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable>
    <adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapContingentConsiderationByTypeAxis_adptCommercialMilestonesMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20211231"
      decimals="INF"
      id="F_000491"
      unitRef="U_iso4217USD">1430000000.0</adpt:RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable>
    <adpt:NonRefundableUpfrontPaymentsReceived
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231"
      decimals="-5"
      id="F_000492"
      unitRef="U_iso4217USD">300000000.0</adpt:NonRefundableUpfrontPaymentsReceived>
    <adpt:RevenueRecognitionExpectedPeriod
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231"
      id="F_000493">P7Y</adpt:RevenueRecognitionExpectedPeriod>
    <adpt:RevenueRecognitionExpectedPeriod
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231"
      id="F_000494">P8Y</adpt:RevenueRecognitionExpectedPeriod>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20210101_20211231"
      decimals="-5"
      id="F_000495"
      unitRef="U_iso4217USD">62000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000496"
      unitRef="U_iso4217USD">52800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptGenentechCollaborationAgreementMember_20190101_20191231"
      decimals="-5"
      id="F_000497"
      unitRef="U_iso4217USD">35100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000366">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Fair Value&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Measurements&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following tables set forth the fair value of financial assets as of December 31, 2021 and 2020 that were measured at fair value on a recurring basis (in thousands): &lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;431,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;563,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;671,777&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;671,777&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;683,358&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&#160;1 securities include highly liquid money market funds, for which we measure the fair value based on quoted prices in active markets for identical assets or liabilities. Level&#160;2 securities consist of U.S. government debt securities and corporate bonds, and are valued based on recent trades of securities in inactive markets or on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000408">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following tables set forth the fair value of financial assets as of December 31, 2021 and 2020 that were measured at fair value on a recurring basis (in thousands): &lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,946&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;431,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;563,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;671,777&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;671,777&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financial assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,283&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;683,358&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000498"
      unitRef="U_iso4217USD">131946000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000499"
      unitRef="U_iso4217USD">131946000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000500"
      unitRef="U_iso4217USD">391145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000501"
      unitRef="U_iso4217USD">391145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000502"
      unitRef="U_iso4217USD">39996000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000503"
      unitRef="U_iso4217USD">39996000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000504"
      unitRef="U_iso4217USD">131946000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000505"
      unitRef="U_iso4217USD">431141000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000506"
      unitRef="U_iso4217USD">563087000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000507"
      unitRef="U_iso4217USD">103283000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000508"
      unitRef="U_iso4217USD">103283000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000509"
      unitRef="U_iso4217USD">671777000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000510"
      unitRef="U_iso4217USD">671777000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000511"
      unitRef="U_iso4217USD">11581000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000512"
      unitRef="U_iso4217USD">11581000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000513"
      unitRef="U_iso4217USD">103283000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000514"
      unitRef="U_iso4217USD">683358000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000515"
      unitRef="U_iso4217USD">786641000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000367">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Investments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Available-for-sale investments consisted of the following as of December 31, 2021 and 2020 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;186,752&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(109&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;186,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,363&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,349&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;214,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(123&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;213,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;205,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(974&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;204,498&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,691&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(44&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;218,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;217,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;552,539&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;723&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;553,252&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;86&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;564,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;809&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;564,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,429&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,429&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;All the U.S. government debt securities and corporate bonds designated as short-term marketable securities have an effective maturity date that is equal to or less than one year from the respective consolidated balance sheet date. Those that are designated as long-term marketable securities have an effective maturity date that is more than one year from the respective consolidated balance sheet date.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued interest receivable is excluded from the amortized cost and estimated fair value of our marketable securities. Accrued interest receivable of $1.4 million and $2.5 million were presented separately within the prepaid expenses and other current assets line item on our consolidated balance sheet as of December 31, 2021 and 2020, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the gross unrealized holding losses and fair value for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of December&#160;31, 2021 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less Than 12 Months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;12 Months Or Greater&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;345,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,083&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;377,900&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We periodically review our available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security ratings or sector credit ratings and other relevant market data.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, we did not intend, nor were we more likely than not to be required, to sell our available-for-sale investments before the recovery of their amortized cost basis, which may be maturity. Based on our assessment, we concluded all impairment as of December 31, 2021 to be due to factors other than credit loss, such as changes in interest rates. A credit allowance was not recognized and the impairment of our available-for-sale securities was recorded in other comprehensive loss.&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000409">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Available-for-sale investments consisted of the following as of December 31, 2021 and 2020 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;186,752&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(109&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;186,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,363&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,349&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;214,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(123&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;213,996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;205,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(974&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;204,498&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,691&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(44&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;218,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;217,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;552,539&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;723&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;553,252&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;86&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total short-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;564,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;809&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;564,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,429&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total long-term marketable securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,429&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000516"
      unitRef="U_iso4217USD">186752000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000522"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000524"
      unitRef="U_iso4217USD">109000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000530"
      unitRef="U_iso4217USD">186647000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000517"
      unitRef="U_iso4217USD">27363000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000525"
      unitRef="U_iso4217USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000531"
      unitRef="U_iso4217USD">27349000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231"
      decimals="-3"
      id="F_000518"
      unitRef="U_iso4217USD">214115000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231"
      decimals="-3"
      id="F_000523"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231"
      decimals="-3"
      id="F_000526"
      unitRef="U_iso4217USD">123000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231"
      decimals="-3"
      id="F_000532"
      unitRef="U_iso4217USD">213996000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000519"
      unitRef="U_iso4217USD">205472000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000527"
      unitRef="U_iso4217USD">974000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000533"
      unitRef="U_iso4217USD">204498000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000520"
      unitRef="U_iso4217USD">12691000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000528"
      unitRef="U_iso4217USD">44000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000534"
      unitRef="U_iso4217USD">12647000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231"
      decimals="-3"
      id="F_000521"
      unitRef="U_iso4217USD">218163000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231"
      decimals="-3"
      id="F_000529"
      unitRef="U_iso4217USD">1018000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20211231"
      decimals="-3"
      id="F_000535"
      unitRef="U_iso4217USD">217145000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000536"
      unitRef="U_iso4217USD">552539000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000541"
      unitRef="U_iso4217USD">723000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000546"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000551"
      unitRef="U_iso4217USD">553252000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000537"
      unitRef="U_iso4217USD">11497000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000542"
      unitRef="U_iso4217USD">86000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000547"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000552"
      unitRef="U_iso4217USD">11581000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231"
      decimals="-3"
      id="F_000538"
      unitRef="U_iso4217USD">564036000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231"
      decimals="-3"
      id="F_000543"
      unitRef="U_iso4217USD">809000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231"
      decimals="-3"
      id="F_000548"
      unitRef="U_iso4217USD">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20201231"
      decimals="-3"
      id="F_000553"
      unitRef="U_iso4217USD">564833000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000539"
      unitRef="U_iso4217USD">118429000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000544"
      unitRef="U_iso4217USD">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000549"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000554"
      unitRef="U_iso4217USD">118525000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231"
      decimals="-3"
      id="F_000540"
      unitRef="U_iso4217USD">118429000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231"
      decimals="-3"
      id="F_000545"
      unitRef="U_iso4217USD">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231"
      decimals="-3"
      id="F_000550"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember_20201231"
      decimals="-3"
      id="F_000555"
      unitRef="U_iso4217USD">118525000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231"
      decimals="-5"
      id="F_000556"
      unitRef="U_iso4217USD">1400000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231"
      decimals="-5"
      id="F_000557"
      unitRef="U_iso4217USD">2500000</us-gaap:InterestReceivableCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000410">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the gross unrealized holding losses and fair value for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of December&#160;31, 2021 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less Than 12 Months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;12 Months Or Greater&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;345,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,083&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;377,900&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000558"
      unitRef="U_iso4217USD">345014000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000561"
      unitRef="U_iso4217USD">1083000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000559"
      unitRef="U_iso4217USD">32886000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001478320_us-gaapInvestmentTypeAxis_us-gaapCorporateBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000562"
      unitRef="U_iso4217USD">58000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000560"
      unitRef="U_iso4217USD">377900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000563"
      unitRef="U_iso4217USD">1141000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000368">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Property and Equipment, Net&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,988&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,579&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,717&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;992&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,658&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,959&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,945&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, at cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;121,488&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(36,226&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(24,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;85,262&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation expense was $12.3 million, $6.8&#160;million and $6.1 million for the year ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000411">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,988&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,579&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,717&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;992&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,658&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,959&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,945&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, at cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;121,488&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(36,226&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(24,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;85,262&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20211231"
      decimals="-3"
      id="F_000564"
      unitRef="U_iso4217USD">36312000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20201231"
      decimals="-3"
      id="F_000565"
      unitRef="U_iso4217USD">27767000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231"
      decimals="-3"
      id="F_000566"
      unitRef="U_iso4217USD">6988000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231"
      decimals="-3"
      id="F_000567"
      unitRef="U_iso4217USD">3600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20211231"
      decimals="-3"
      id="F_000568"
      unitRef="U_iso4217USD">5579000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptFurnitureAndOfficeEquipmentMember_20201231"
      decimals="-3"
      id="F_000569"
      unitRef="U_iso4217USD">2717000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20211231"
      decimals="-3"
      id="F_000570"
      unitRef="U_iso4217USD">992000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptComputerSoftwareMember_20201231"
      decimals="-3"
      id="F_000571"
      unitRef="U_iso4217USD">860000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231"
      decimals="-3"
      id="F_000572"
      unitRef="U_iso4217USD">5658000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231"
      decimals="-3"
      id="F_000573"
      unitRef="U_iso4217USD">7185000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231"
      decimals="-3"
      id="F_000574"
      unitRef="U_iso4217USD">65959000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231"
      decimals="-3"
      id="F_000575"
      unitRef="U_iso4217USD">21945000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000576"
      unitRef="U_iso4217USD">121488000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000577"
      unitRef="U_iso4217USD">64074000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000578"
      unitRef="U_iso4217USD">36226000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000579"
      unitRef="U_iso4217USD">24382000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000580"
      unitRef="U_iso4217USD">85262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000581"
      unitRef="U_iso4217USD">39692000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000582"
      unitRef="U_iso4217USD">12300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000583"
      unitRef="U_iso4217USD">6800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001478320_20190101_20191231"
      decimals="-5"
      id="F_000584"
      unitRef="U_iso4217USD">6100000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000369">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;7&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Goodwill&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Intangible Assets&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There have been no changes in the carrying amount of goodwill since its recognition in 2015. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets subject to amortization as of December 31, 2021 and 2020 consisted of the following (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquired developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,638&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,362&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchased intellectual property&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;164&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,799&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,526&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquired developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9,972&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,028&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchased intellectual property&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10,100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The developed technology was acquired in connection with our acquisition of Sequenta in 2015. The remaining balance of the acquired technology and the purchased intellectual property is expected to be amortized over the next 5.0 years. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, expected future amortization expense for intangible assets was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future amortization expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,526&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="C_0001478320_20151231"
      decimals="INF"
      id="F_000585"
      unitRef="U_iso4217USD">0</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000412">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets subject to amortization as of December 31, 2021 and 2020 consisted of the following (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquired developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,638&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,362&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchased intellectual property&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;164&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,799&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,526&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquired developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9,972&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,028&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchased intellectual property&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10,100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">20000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">11638000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20211231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">8362000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">325000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">161000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20211231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">164000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">20325000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">11799000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">8526000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">20000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">9972000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20201231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">10028000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">325000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">128000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20201231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">197000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">20325000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">10100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">10225000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_0001478320_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapIntellectualPropertyMember_20210101_20211231"
      id="F_000586">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000413">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, expected future amortization expense for intangible assets was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future amortization expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,526&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000605"
      unitRef="U_iso4217USD">1699000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000606"
      unitRef="U_iso4217USD">1699000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000607"
      unitRef="U_iso4217USD">1703000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000608"
      unitRef="U_iso4217USD">1699000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000609"
      unitRef="U_iso4217USD">1699000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000610"
      unitRef="U_iso4217USD">27000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000611"
      unitRef="U_iso4217USD">8526000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000370">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;8. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Accrued Liabilities&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued liabilities as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,687&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Clinical and contract research organization costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,781&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Travel and entertainment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchases of property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;615&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,423&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,162&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accrued tax liabilities balance as of December 31, 2020 includes a $1.4 million tax withholding liability related to unsettled option exercises as of December 31, 2020.&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000414">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued liabilities as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,687&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Clinical and contract research organization costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,781&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Travel and entertainment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;391&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchases of property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;615&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,423&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,162&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000612"
      unitRef="U_iso4217USD">3687000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000613"
      unitRef="U_iso4217USD">3219000</us-gaap:AccruedProfessionalFeesCurrent>
    <adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000614"
      unitRef="U_iso4217USD">1646000</adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent>
    <adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000615"
      unitRef="U_iso4217USD">1781000</adpt:AccruedClinicalAndContractResearchOrganizationCostsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000616"
      unitRef="U_iso4217USD">184000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000617"
      unitRef="U_iso4217USD">91000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000618"
      unitRef="U_iso4217USD">391000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000619"
      unitRef="U_iso4217USD">1767000</us-gaap:AccruedIncomeTaxesCurrent>
    <adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000620"
      unitRef="U_iso4217USD">615000</adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent>
    <adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000621"
      unitRef="U_iso4217USD">4423000</adpt:AccruedPurchaseOfPropertyAndEquipmentCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000622"
      unitRef="U_iso4217USD">2820000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000623"
      unitRef="U_iso4217USD">1881000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000624"
      unitRef="U_iso4217USD">9343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000625"
      unitRef="U_iso4217USD">13162000</us-gaap:AccruedLiabilitiesCurrent>
    <adpt:AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises
      contextRef="C_0001478320_20201231"
      decimals="-5"
      id="F_000626"
      unitRef="U_iso4217USD">1400000</adpt:AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises>
    <adpt:DeferredRevenueTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000371">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Deferred Revenue&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue by revenue classification as of December 31, 2021 and 2020 was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,545&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80,460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;73,319&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;724&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,576&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;162,894&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;163,618&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current and non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;236,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue from our Genentech Agreement represents $56.1 million and $94.0 million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2021 and $55.1 million and $157.0 million of the current and non-current development deferred revenue balances, respectively, as of December 31, 2020. In general, we expect that the current &lt;span style="Background-color:#FFFFFF;"&gt;amounts&lt;/span&gt; will be recognized as revenue within 12 months and the non-current amounts will be recognized as revenue over a period of approximately five to six years from December 31, 2021. This period of time represents an estimate of the research and development period to develop cellular therapies in oncology, which may be reduced or increased based on the various development activities.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;During the year ended December 31, 2021, we recognized $3.6 million in revenue as a result of changes in estimates of total samples to be provided under certain of our agreements and cancelled biopharmaceutical customer sequencing contracts for which we had received upfront consideration. Additionally, we recognized $2.5 million of sequencing revenue during the year ended December 31, 2021 related to Medicare reimbursements resulting from our determination that the likelihood of additional testing for specific patients was remote and a change in our estimate of expected cumulative tests per patient for one of our covered indications.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Changes in deferred revenue during the year ended December 31, 2021 were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;236,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions to deferred revenue during the period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,062&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue recognized during the period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(95,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$75.7&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million was recognized&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as revenue&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; that was included in the deferred revenue balance &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</adpt:DeferredRevenueTextBlock>
    <adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000415">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue by revenue classification as of December 31, 2021 and 2020 was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,545&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80,460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;73,319&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sequencing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;724&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,576&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;162,894&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;163,618&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current and non-current deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;236,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231"
      decimals="-3"
      id="F_000627"
      unitRef="U_iso4217USD">21915000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231"
      decimals="-3"
      id="F_000628"
      unitRef="U_iso4217USD">15463000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231"
      decimals="-3"
      id="F_000629"
      unitRef="U_iso4217USD">58545000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231"
      decimals="-3"
      id="F_000630"
      unitRef="U_iso4217USD">57856000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000631"
      unitRef="U_iso4217USD">80460000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000632"
      unitRef="U_iso4217USD">73319000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20211231"
      decimals="-3"
      id="F_000633"
      unitRef="U_iso4217USD">174000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20201231"
      decimals="-3"
      id="F_000634"
      unitRef="U_iso4217USD">724000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231"
      decimals="-3"
      id="F_000635"
      unitRef="U_iso4217USD">98576000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231"
      decimals="-3"
      id="F_000636"
      unitRef="U_iso4217USD">162894000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000637"
      unitRef="U_iso4217USD">98750000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000638"
      unitRef="U_iso4217USD">163618000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000639"
      unitRef="U_iso4217USD">179210000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000640"
      unitRef="U_iso4217USD">236937000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231"
      decimals="-5"
      id="F_000641"
      unitRef="U_iso4217USD">56100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20211231"
      decimals="-5"
      id="F_000643"
      unitRef="U_iso4217USD">94000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231"
      decimals="-5"
      id="F_000642"
      unitRef="U_iso4217USD">55100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231"
      decimals="-5"
      id="F_000644"
      unitRef="U_iso4217USD">157000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231"
      id="F_000645">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMinimumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231"
      id="F_000646">P5Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtRangeAxis_srtMaximumMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231"
      id="F_000647">P6Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_srtProductOrServiceAxis_adptSequencingRevenueMember_20210101_20211231"
      decimals="-5"
      id="F_000648"
      unitRef="U_iso4217USD">3600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_srtMajorCustomersAxis_adptSpecificPatientsMember_srtProductOrServiceAxis_adptMedicareRevenueMember_20210101_20211231"
      decimals="-5"
      id="F_000649"
      unitRef="U_iso4217USD">2500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000416">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Changes in deferred revenue during the year ended December 31, 2021 were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;236,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions to deferred revenue during the period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,062&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue recognized during the period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(95,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000650"
      unitRef="U_iso4217USD">236937000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000651"
      unitRef="U_iso4217USD">38062000</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000652"
      unitRef="U_iso4217USD">-95789000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000653"
      unitRef="U_iso4217USD">179210000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001478320_20211230_20211231"
      decimals="-5"
      id="F_000654"
      unitRef="U_iso4217USD">75700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000372">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Leases&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;We have operating lease agreements for the laboratory, office and warehouse facilities that we occupy in various locations, as well as server space. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In July 2011, we entered into a non-cancelable lease agreement with an, at the time, minority shareholder for office and laboratory space in Seattle, Washington. The lease terms were subsequently amended multiple times, most recently in August 2019, when we expanded the existing premises to approximately 65,500 square feet. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Cash payment for rent of the expanded premises commenced January 2020, four months after the landlord delivered the expanded premises to us for construction of certain tenant improvements, and the lease term for both the existing premises and the expanded premises ends October 2032, subject to our option to twice extend the lease for five years.&lt;/span&gt; &lt;span style="Background-color:#FFFFFF;"&gt;The amended lease also requires us to pay additional amounts for operating and maintenance expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In August 2019, we entered into an agreement to rent approximately 100,000 square feet in what was a to-be-constructed, new headquarters building in Seattle, Washington. In connection with the lease, we entered into a $2.1 million letter of credit with one of our existing financial institutions. Due to our &lt;/span&gt;significant&lt;span style="Background-color:#FFFFFF;"&gt; involvement during the construction process of the leased building, we qualified as the deemed owner of the building under build-to-suit lease accounting guidance that proceeded ASC 842. The resulting asset and long-term financing obligation recorded on our balance sheet as of December 31, 2019 for the cost of the building was derecognized effective January 1, 2020 upon adoption of ASC 842. The lease commenced in December 2020, when the landlord delivered the premises to us for construction of certain tenant improvements. We occupied the new building in 2021, cash payment for rent began in October 2021 and the lease term ends in August 2033, &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;subject to our option to twice extend the lease for&#160;five years.&#160;In connection with this lease, the landlord agreed to fund $20.0&#160;million in improvements, which was subsequently reduced to $14.8 million as a result of our change requests made during landlord construction of the building, net of an administration fee. As of December 31, 2021, we have incurred $14.9 million in certain tenant improvement costs, of which $10.9 million has been reimbursed by the landlord. The remaining $4.0 million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2021 and will be reimbursed by the landlord. As of December 31, 2020, w&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;e incurred $5.2 million in certain tenant improvement costs, of which $0.7 million had been reimbursed by the landlord. The remaining $4.5 million is presented as a reduction in the cash flows used to measure our ROU asset and lease liabilities on our consolidated balance sheet as of December 31, 2020. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;The lease also requires us to pay additional amounts for operating and maintenance expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In October 2019, we entered into an agreement to lease approximately 14,750 square feet in a separate Seattle, Washington location, pursuant to a lease expiring in October 2029, which is subject to our ability to exercise an early termination right after the third year. In connection with the lease, the landlord agreed to provide a tenant improvement allowance in the maximum amount of $0.7 million. The lease also requires us to pay additional amounts for operating expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In April 2018, we entered into a lease agreement to lease approximately 13,400 square feet in South San Francisco, California. The lease term is through March 2026 and provides for one &lt;span style="-sec-ix-hidden:F_000687"&gt;five-year&lt;/span&gt; extension option. We are responsible for our share of allocable operating expenses, tax expenses and utilities cost during the duration of the lease term. In connection with the lease, the landlord funded agreed-upon improvements. The landlord was solely responsible for the $2.4 million cost of such improvements. The lease agreement was amended in February 2020 to lease approximately 19,900 additional square feet and provides for a $0.6 million tenant improvement allowance.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In December 2019, we entered into an agreement to lease approximately 3,100 square feet of office space in New York City, New York, pursuant to a lease that expires November 2025, subject to our ability to exercise an early termination right in 2023. The lease requires us to pay certain operating expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In March 2021, we executed a lease to rent approximately 27,000 square feet of a warehouse in Bothell, Washington, which we classified as an operating lease upon commencement during the year ended December 31, 2021. Rent obligations commenced in October 2021 and the lease expires October 2031, subject to an early termination option after the seventh year and an option to twice extend the lease for five years. The lease requires us to pay certain operating expenses. Furthermore, the landlord agreed to fund $1.2 million in improvements in connection with this lease.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;As of &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2021, we were not party to any finance leases. Our leases have remaining terms of 0.3 years to 11.7 years and include options to extend certain of the leases up to 10.0 years and terminate certain of the leases after 3.0 years. We adjust lease terms for these options only when it is reasonably certain we will exercise these options. As of &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2021, it was reasonably certain that we would exercise our option to terminate &lt;/span&gt;two&lt;span style="Background-color:#FFFFFF;"&gt; of our leases after 3.0 &lt;/span&gt;years&lt;span style="Background-color:#FFFFFF;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Other information related to our operating leases as of &lt;/span&gt;December &lt;span style="Background-color:#FFFFFF;"&gt;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000705"&gt;10.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000706"&gt;11.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The following table reconciles our undiscounted operating lease cash flows to our operating lease liabilities as of &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,964&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,098&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,330&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,188&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total undiscounted lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;149,456&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Imputed interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32,410&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Tenant improvement receivables&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,306&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,055&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, less current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,685&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Operating lease expense was $12.4 million and $5.5 million for the year ended&lt;/span&gt; December &lt;span style="Background-color:#FFFFFF;"&gt;31, 2021 and 2020, respectively. Variable lease expense for operating leases was $3.5 million and $2.6 million for the year ended &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2021 and 2020, respectively.&lt;/span&gt; &lt;span style="Background-color:#FFFFFF;"&gt;Rent expense recognized under ASC 840, &lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Leases&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;, inclusive of operating and maintenance costs, was $5.3 million for the year ended &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2019.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Cash paid for amounts included in the measurement of lease liabilities was $8.3 million and cash received for tenant improvement allowances was $11.5 million during the year ended December 31, 2021. Cash paid for amounts included in the measurement of lease liabilities for the year ended &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2020 was $3.2 million, net of $2.5 million of cash received for tenant improvement allowances. For the year ended December 31, 2021, ROU assets obtained in exchange for operating lease liabilities was $5.4 million. For the year ended December 31, 2020, ROU assets obtained in exchange for operating lease liabilities was $109.1 million, inclusive of the $33.0 million recognized from the adoption of ASC 842.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190831"
      decimals="0"
      id="F_000655"
      unitRef="U_utrsqft">65500</us-gaap:AreaOfLand>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831"
      id="F_000656">Cash payment for rent of the expanded premises commenced January 2020, four months after the landlord delivered the expanded premises to us for construction of certain tenant improvements, and the lease term for both the existing premises and the expanded premises ends October 2032, subject to our option to twice extend the lease for five years.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <adpt:LesseeOperatingLeaseRentCommencementMonthAndYear
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831"
      id="F_000657">2020-01</adpt:LesseeOperatingLeaseRentCommencementMonthAndYear>
    <adpt:LesseeOperatingLeaseExtendedTermOfContract
      contextRef="C_0001478320_srtStatementGeographicalAxis_stprWA_20190801_20190831"
      id="F_000659">P5Y</adpt:LesseeOperatingLeaseExtendedTermOfContract>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20190831"
      decimals="0"
      id="F_000661"
      unitRef="U_utrsqft">100000</us-gaap:AreaOfLand>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="C_0001478320_20190831"
      decimals="-5"
      id="F_000662"
      unitRef="U_iso4217USD">2100000</us-gaap:LettersOfCreditOutstandingAmount>
    <adpt:LeaseCommencementMonthAndYear contextRef="C_0001478320_20190801_20190831" id="F_000663">2020-12</adpt:LeaseCommencementMonthAndYear>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="C_0001478320_20190801_20190831" id="F_000664">cash payment for rent began in October 2021 and the lease term ends in August 2033, </us-gaap:LesseeOperatingLeaseOptionToExtend>
    <adpt:LesseeOperatingLeaseRentCommencementMonthAndYear contextRef="C_0001478320_20190801_20190831" id="F_000665">2021-10</adpt:LesseeOperatingLeaseRentCommencementMonthAndYear>
    <adpt:LeaseExpirationMonthAndYear contextRef="C_0001478320_20190801_20190831" id="F_000666">2033-08</adpt:LeaseExpirationMonthAndYear>
    <adpt:LesseeOperatingLeaseExtendedTermOfContract contextRef="C_0001478320_20190801_20190831" id="F_000668">P5Y</adpt:LesseeOperatingLeaseExtendedTermOfContract>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="C_0001478320_20190831"
      decimals="-5"
      id="F_000669"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000670"
      unitRef="U_iso4217USD">14800000</us-gaap:LeaseholdImprovementsGross>
    <adpt:TenantImprovementCostsIncurred
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000674"
      unitRef="U_iso4217USD">14900000</adpt:TenantImprovementCostsIncurred>
    <adpt:ProceedsFromLandlordReimbursements
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000672"
      unitRef="U_iso4217USD">10900000</adpt:ProceedsFromLandlordReimbursements>
    <adpt:TenantImprovementCostsReceivable
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000676"
      unitRef="U_iso4217USD">4000000.0</adpt:TenantImprovementCostsReceivable>
    <adpt:TenantImprovementCostsIncurred
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000673"
      unitRef="U_iso4217USD">5200000</adpt:TenantImprovementCostsIncurred>
    <adpt:ProceedsFromLandlordReimbursements
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000671"
      unitRef="U_iso4217USD">700000</adpt:ProceedsFromLandlordReimbursements>
    <adpt:TenantImprovementCostsReceivable
      contextRef="C_0001478320_20201231"
      decimals="-5"
      id="F_000675"
      unitRef="U_iso4217USD">4500000</adpt:TenantImprovementCostsReceivable>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20191031"
      decimals="0"
      id="F_000677"
      unitRef="U_utrsqft">14750</us-gaap:AreaOfLand>
    <us-gaap:TenantImprovements
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20191031"
      decimals="INF"
      id="F_000679"
      unitRef="U_iso4217USD">700000</us-gaap:TenantImprovements>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20180430"
      decimals="0"
      id="F_000680"
      unitRef="U_utrsqft">13400</us-gaap:AreaOfLand>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="C_0001478320_20180401_20180430" id="F_000685">The lease term is through March 2026 and provides for one five-year extension option.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <adpt:LeaseExpirationMonthAndYear contextRef="C_0001478320_20180401_20180430" id="F_000682">2026-03</adpt:LeaseExpirationMonthAndYear>
    <us-gaap:TenantImprovements
      contextRef="C_0001478320_20180430"
      decimals="-5"
      id="F_000688"
      unitRef="U_iso4217USD">2400000</us-gaap:TenantImprovements>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20200229"
      decimals="0"
      id="F_000689"
      unitRef="U_utrsqft">19900</us-gaap:AreaOfLand>
    <adpt:TenantImprovementAllowanceAndCommenced
      contextRef="C_0001478320_20200201_20200229"
      decimals="-5"
      id="F_000690"
      unitRef="U_iso4217USD">600000</adpt:TenantImprovementAllowanceAndCommenced>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20191231"
      decimals="0"
      id="F_000691"
      unitRef="U_utrsqft">3100</us-gaap:AreaOfLand>
    <adpt:LeaseExpirationMonthAndYear contextRef="C_0001478320_20191201_20191231" id="F_000692">2025-11</adpt:LeaseExpirationMonthAndYear>
    <us-gaap:AreaOfLand
      contextRef="C_0001478320_20210331"
      decimals="0"
      id="F_000681"
      unitRef="U_utrsqft">27000</us-gaap:AreaOfLand>
    <adpt:LesseeOperatingLeaseRentObligationsCommencementMonthAndYear contextRef="C_0001478320_20210101_20211231" id="F_000684">2021-10</adpt:LesseeOperatingLeaseRentObligationsCommencementMonthAndYear>
    <adpt:LeaseExpirationMonthAndYear contextRef="C_0001478320_20210101_20211231" id="F_000683">2031-10</adpt:LeaseExpirationMonthAndYear>
    <adpt:LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription contextRef="C_0001478320_20210101_20211231" id="F_000701">subject to an early termination option after the seventh year</adpt:LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend contextRef="C_0001478320_20210101_20211231" id="F_000702">option to twice extend the lease for five years</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1 contextRef="C_0001478320_20211231" id="F_000704">P5Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1>
    <adpt:LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000703"
      unitRef="U_iso4217USD">1200000</adpt:LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_0001478320_srtRangeAxis_srtMinimumMember_20211231"
      id="F_000693">P0Y3M18D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_20211231"
      id="F_000694">P11Y8M12D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="C_0001478320_20210101_20211231" id="F_000695">options to extend certain of the leases up to 10.0 years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="C_0001478320_20211231" id="F_000697">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <adpt:LesseeOperatingLeaseTerminationPeriod contextRef="C_0001478320_20210101_20211231" id="F_000698">P3Y</adpt:LesseeOperatingLeaseTerminationPeriod>
    <adpt:NumberOfOperatingLeaseTerminate
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000699"
      unitRef="U_adptLease">2</adpt:NumberOfOperatingLeaseTerminate>
    <adpt:LesseeOperatingLeaseTerminationPeriod contextRef="C_0001478320_20210101_20211231" id="F_000700">P3Y</adpt:LesseeOperatingLeaseTerminationPeriod>
    <us-gaap:LeaseCostTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000417">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Other information related to our operating leases as of &lt;/span&gt;December &lt;span style="Background-color:#FFFFFF;"&gt;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000705"&gt;10.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000706"&gt;11.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001478320_20211231"
      decimals="3"
      id="F_000707"
      unitRef="U_xbrlipure">0.046</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001478320_20201231"
      decimals="3"
      id="F_000708"
      unitRef="U_xbrlipure">0.046</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000418">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The following table reconciles our undiscounted operating lease cash flows to our operating lease liabilities as of &lt;/span&gt;December&lt;span style="Background-color:#FFFFFF;"&gt; 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,964&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,098&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,330&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,188&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total undiscounted lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;149,456&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Imputed interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32,410&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Tenant improvement receivables&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,306&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,055&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, less current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,685&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000709"
      unitRef="U_iso4217USD">14184000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000710"
      unitRef="U_iso4217USD">13964000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000711"
      unitRef="U_iso4217USD">13692000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000712"
      unitRef="U_iso4217USD">14098000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000713"
      unitRef="U_iso4217USD">12330000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000714"
      unitRef="U_iso4217USD">81188000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000715"
      unitRef="U_iso4217USD">149456000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000716"
      unitRef="U_iso4217USD">32410000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <adpt:LesseeOperatingLeaseLiabilityTenantImprovementReceivable
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000717"
      unitRef="U_iso4217USD">5306000</adpt:LesseeOperatingLeaseLiabilityTenantImprovementReceivable>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000718"
      unitRef="U_iso4217USD">111740000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000719"
      unitRef="U_iso4217USD">5055000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000720"
      unitRef="U_iso4217USD">106685000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000721"
      unitRef="U_iso4217USD">12400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000722"
      unitRef="U_iso4217USD">5500000</us-gaap:OperatingLeaseExpense>
    <adpt:OperatingLeaseVariableLeaseExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000723"
      unitRef="U_iso4217USD">3500000</adpt:OperatingLeaseVariableLeaseExpense>
    <adpt:OperatingLeaseVariableLeaseExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000724"
      unitRef="U_iso4217USD">2600000</adpt:OperatingLeaseVariableLeaseExpense>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="C_0001478320_20190101_20191231"
      decimals="-5"
      id="F_000725"
      unitRef="U_iso4217USD">5300000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000726"
      unitRef="U_iso4217USD">8300000</us-gaap:OperatingLeasePayments>
    <us-gaap:PaymentsForProceedsFromTenantAllowance
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000728"
      unitRef="U_iso4217USD">-11500000</us-gaap:PaymentsForProceedsFromTenantAllowance>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000727"
      unitRef="U_iso4217USD">3200000</us-gaap:OperatingLeasePayments>
    <us-gaap:PaymentsForProceedsFromTenantAllowance
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000729"
      unitRef="U_iso4217USD">-2500000</us-gaap:PaymentsForProceedsFromTenantAllowance>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000730"
      unitRef="U_iso4217USD">5400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000731"
      unitRef="U_iso4217USD">109100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001478320_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20201231"
      decimals="-5"
      id="F_000732"
      unitRef="U_iso4217USD">33000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000373">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Commitments and Contingencies&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Legal Proceedings &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to claims and assessments from time to time in the ordinary course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. We were not party to any material legal proceedings as of December 31, 2021.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Indemnification Agreements &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the ordinary course of business, we may provide indemnification of varying scope and terms to vendors, lessors, customers and other parties with respect to certain matters including, but not limited to, losses arising out of breach of our agreements with them or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with members of our board of directors and certain of our executive officers that will require us to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments that we could be required to make under these indemnification agreements is, in many cases, unlimited. We have not incurred any material costs as a result of such indemnifications and are not currently aware of any indemnification claims.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000374">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;letter-spacing:-0.05pt;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="color:#231F20;letter-spacing:-0.05pt;"&gt;Shareholders&#x2019;&lt;/span&gt;&lt;span style="color:#231F20;"&gt; Equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our common stock has no preferences or privileges and is not redeemable. Holders of our common stock are entitled to one vote for each share of common stock held. The holders of record of outstanding shares of common stock shall be entitled to receive, when, as and if declared, out of funds legally available, such cash and other dividends as may be declared from time to time.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, we &lt;span style="color:#231F20;"&gt;have reserved shares of common stock for the following:&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares issuable upon the exercise of outstanding common stock options and the vesting of outstanding common restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,990,175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future grant under the 2019 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,299,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future grant under the Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,804,298&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares of common stock reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,094,396&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our 2019 Equity Incentive Plan (&#x201c;2019 Plan&#x201d;) provides for annual increases in the number of shares that may be issued under the 2019 Plan on January 1, 2020 and on each subsequent January 1, thereafter, by a number of shares equal to the lesser of (a) 5% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furthermore, our Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) provides for annual increases in the number of shares available for issuance under our ESPP on January 1, 2020 and on each January 1, thereafter, by a number of shares equal to the smallest of (a) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by our board of directors.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective January 1, 2021, our 2019 Plan reserve increased by 6,882,344 shares. Our board of directors determined not to increase the ESPP reserve in 2021. Furthermore, our board of directors determined not to increase the 2019 Plan and ESPP reserves in 2022.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Common&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Stock&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Warrant&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2014, we issued a warrant to purchase 56,875 shares of Series C convertible preferred stock at an exercise price of $2.64. The warrant was exercisable for a period of seven years from the date of issuance. Immediately prior to and in connection with the completion of our initial public offering on July 1, 2019, this convertible preferred stock warrant was converted to a warrant to purchase the same number of shares of common stock. The warrant was exercised on February 25, 2021 through a cashless exercise, resulting in the issuance of 54,162 shares of our common stock. The impact of this cashless exercise was immaterial to our consolidated financial statements. As of December 31, 2021, there were no outstanding warrants to purchase common stock.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockVotingRights contextRef="C_0001478320_20210101_20211231" id="F_000733">Holders of our common stock are entitled to one vote for each share of common stock held</us-gaap:CommonStockVotingRights>
    <adpt:NumberOfCommonStockVotingRights
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000734"
      unitRef="U_adptVote">1</adpt:NumberOfCommonStockVotingRights>
    <adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000419">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, we &lt;span style="color:#231F20;"&gt;have reserved shares of common stock for the following:&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares issuable upon the exercise of outstanding common stock options and the vesting of outstanding common restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,990,175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future grant under the 2019 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,299,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future grant under the Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,804,298&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares of common stock reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,094,396&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001478320_us-gaapAwardTypeAxis_adptCommonStockOptionsAndRestrictedStockUnitsGrantedMember_20211231"
      decimals="INF"
      id="F_000735"
      unitRef="U_xbrlishares">13990175</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000736"
      unitRef="U_xbrlishares">22299923</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231"
      decimals="INF"
      id="F_000737"
      unitRef="U_xbrlishares">2804298</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000738"
      unitRef="U_xbrlishares">39094396</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <adpt:PercentageOfAnnualIncreasesInNumberOfShares
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20200101"
      decimals="INF"
      id="F_000739"
      unitRef="U_xbrlipure">0.05</adpt:PercentageOfAnnualIncreasesInNumberOfShares>
    <adpt:PercentageOfAnnualIncreasesInNumberOfShares
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20200101"
      decimals="2"
      id="F_000740"
      unitRef="U_xbrlipure">0.01</adpt:PercentageOfAnnualIncreasesInNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20210101"
      decimals="INF"
      id="F_000741"
      unitRef="U_xbrlishares">6882344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231"
      decimals="INF"
      id="F_000742"
      unitRef="U_xbrlishares">56875</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20141231"
      decimals="2"
      id="F_000744"
      unitRef="U_iso4217USD_xbrlishares">2.64</adpt:ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights>
    <adpt:ClassOfWarrantOrRightsTerm
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_adptSeriesCConvertiblePreferredStockMember_20140101_20141231"
      id="F_000743">P7Y</adpt:ClassOfWarrantOrRightsTerm>
    <adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised
      contextRef="C_0001478320_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000745"
      unitRef="U_xbrlishares">54162</adpt:StockIssuedDuringPeriodSharesCommonStockWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000746"
      unitRef="U_xbrlishares">0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000375">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Equity Incentive Plans&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Sequenta 2008 Stock Plan, as amended&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with our acquisition of Sequenta in January 2015, we assumed Sequenta&#x2019;s Equity Incentive Plan (&#x201c;2008 Plan&#x201d;), including all outstanding options and shares available for future issuance under the 2008 Plan, which, prior to the completion of our initial public offering, were all exercisable for Series E-1 convertible preferred stock. Upon completion of our initial public offering in July 2019, the outstanding options were exercisable for common stock. No shares are available for future issuance under this plan and no equity awards are outstanding under this plan as of December 31, 2021.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Adaptive 2009 Equity Incentive Plan&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We adopted an equity incentive plan in 2009 (&#x201c;2009 Plan&#x201d;) that provided for the issuance of incentive and nonqualified common stock options and other share-based awards for employees, directors and consultants. Under the 2009 Plan, the option exercise price for incentive and nonqualified stock options were not to be less than the fair market value of our common stock at the date of grant. Options granted under this plan expire no later than ten years from the grant date and vesting was established at the time of grant. Pursuant to the terms of the 2019 Plan, any shares subject to outstanding options originally granted under the 2009 Plan that terminate, expire or lapse for any reason without the delivery of shares to the holder thereof shall become available for issuance pursuant to awards granted under the 2019 Plan. While no shares are available for future issuance under the 2009 Plan, it continues to govern outstanding equity awards granted thereunder.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;2019 Equity Incentive Plan&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The 2019 Plan became effective immediately prior to the closing of our initial public offering in July 2019. The 2019 Plan provides for the issuance of awards in the form of options and other share-based awards for employees, directors and consultants. Under the 2019 Plan, the option exercise price per share shall not be less than the fair market value of a share of stock on the effective date of grant, as defined by the 2019 Plan, unless explicitly qualified under the provisions of Section 409A or Section 424(a) of the Internal Revenue Code of 1986. Additionally, unless otherwise specified, options granted under this plan expire no later than ten years from the grant date and vesting is established at the time of grant. Except for certain option and restricted stock unit grants made to non-employee directors, stock options and restricted stock units granted under the 2019 Plan generally vest over a &lt;span style="-sec-ix-hidden:F_000752"&gt;four-year&lt;/span&gt; period, subject to continuous service through each applicable vesting date. As of December 31, 2021, we have authorized 29,131,628 shares of common stock for issuance under the 2019 Plan.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Changes in shares available for grant during the year ended December 31, 2021 were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Available for Grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for grant at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,617,001&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019 Equity Incentive Plan reserve increase effective January 1, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,882,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options and restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,306,265&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options and restricted stock units forfeited, cancelled or expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,106,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for grant at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,299,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock option activity under the 2009 Plan and 2019 Plan during the year ended December&#160;31, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Subject to&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate Intrinsic Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,433,560&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,052,025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39.39&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited or cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(992,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.90&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,116&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,674,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,778,984&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.72&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested and exercisable at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,281,600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.99&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;132,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted-average remaining contractual life for options outstanding as of December 31, 2021 was 7.0 years. The weighted-average remaining contractual life for vested and exercisable options as of December 31, 2021 was 5.7 years. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted-average grant date fair value per share of options granted during the year ended December&#160;31, 2021, 2020 and 2019 was $24.22, $21.11 and $6.87, respectively. The total intrinsic value of options exercised during the year ended December&#160;31, 2021, 2020 and 2019 was $156.5&#160;million, $190.4 million and $39.1 million, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Of the $26.7 million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2021, $0.3 million related to options exercised during the year ended December 31, 2020 but settled during the year ended December 31, 2021. Of the $21.7 million proceeds from exercise of stock options included on our consolidated statements of cash flows for the year ended December 31, 2020, $0.5 million related to options exercised during the year ended December 31, 2019 but settled during the year ended December 31, 2020.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock unit activity under the 2019 Plan during the year ended December 31, 2021 was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-weight:bold;;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested outstanding restricted stock units at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,254,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units forfeited or cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(74,299&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested outstanding restricted stock units at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,211,191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted-average grant date fair value per share of restricted stock units granted during the year ended December 31, 2020 and 2019 was $28.10 and $41.63, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Grant Date Fair Value of Options and Restricted Stock Units Granted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The estimated grant date fair values of options granted during the years ended December&#160;31, 2021, 2020 and 2019 were estimated using the Black-Scholes option-pricing model with the following assumptions: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$30.86 - $66.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$17.68 - $55.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$7.80 - $47.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000805"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000807"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000811"&gt;0.5% - 1.4%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000812"&gt;0.4% - 1.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000813"&gt;1.4% - 2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000817"&gt;67.1% - 70.0%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000818"&gt;70.5% - 73.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000819"&gt;64.3% - 72.9%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The determination of the grant date fair value of stock options using a Black-Scholes option-pricing model is affected by the fair value of our common stock, as well as assumptions regarding a number of variables that are complex, subjective and generally require significant judgment to determine. The valuation assumptions were determined as follows: &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Fair value of common stock&#x2014;&lt;span style="font-style:normal;"&gt;Prior to the closing of our initial public offering, the fair value of our common stock was determined with input from management using valuation methodologies which utilized certain assumptions, including probability weighting of events, volatility, time to liquidation, a risk-free interest rate and an assumption for a discount for lack of marketability (Level 3 inputs). In determining the fair value of our common stock, the methodologies, approaches and assumptions used to estimate the enterprise value were consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, &lt;/span&gt;Valuation of Privately-Held-Company Equity Securities Issued as Compensation&lt;span style="font-style:normal;"&gt;. For option grants made after the closing of our initial public offering, the fair value of each share of common stock is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.&lt;/span&gt;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Expected term&lt;span style="font-style:normal;"&gt;&#x2014;The expected term of options granted to employees and non-employee directors is determined using the &#x201c;simplified&#x201d; method, as illustrated in ASC Topic 718, &lt;/span&gt;Compensation&#x2014;Stock Compensation&lt;span style="font-style:normal;"&gt;, as we do not have sufficient exercise history to determine a better estimate of expected term. Under this approach, the expected term is &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;based on the midpoint between the vesting date and the end of the contractual term of the option.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;span style="font-style:normal;"&gt;&#x2014;We utilize a risk-free interest rate in the option valuation model based on U.S. Treasury zero-coupon issues with remaining terms similar to the expected terms of the options.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;span style="font-style:normal;"&gt;&#x2014;As we do not have sufficient trading history for our common stock, the expected volatility is based on the historical volatility of our publicly traded industry peers utilizing a period of time consistent with our estimate of expected term.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;span style="font-style:normal;"&gt;&#x2014;We do not anticipate paying any cash dividends in the foreseeable future and, therefore, use an expected dividend yield of zero in the option valuation model.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The grant date fair value of restricted stock units granted &lt;span style="color:#000000;"&gt;is based on the closing price of our common stock on the date of grant, or other relevant determination date, as reported on The Nasdaq Global Select Market.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The compensation costs related to stock options and restricted stock units for the years ended December 31, 2021, 2020 and 2019 are included on our consolidated statements of operations as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;817&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,061&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,519&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,934&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales and marketing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,480&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,798&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,155&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total share-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,761&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,124&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, unrecognized share-based compensation expense related to unvested stock options was $96.8 million, which is expected to be recognized over a remaining weighted-average period of 2.9 years. Additionally, as of December 31, 2021, unrecognized share-based compensation expense related to unvested restricted stock units was $38.3 million, which is expected to be recognized over a remaining weighted-average period of 3.4 years.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231"
      decimals="INF"
      id="F_000747"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptSequentaTwoThousandAndEightStockPlanMember_20211231"
      decimals="INF"
      id="F_000748"
      unitRef="U_xbrlishares">0</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20210101_20211231"
      id="F_000749">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000750"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001478320_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000751">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000753"
      unitRef="U_xbrlishares">29131628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000420">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Changes in shares available for grant during the year ended December 31, 2021 were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Available for Grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for grant at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,617,001&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019 Equity Incentive Plan reserve increase effective January 1, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,882,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options and restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,306,265&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options and restricted stock units forfeited, cancelled or expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,106,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for grant at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,299,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="INF"
      id="F_000754"
      unitRef="U_xbrlishares">18617001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000755"
      unitRef="U_xbrlishares">6882344</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000756"
      unitRef="U_xbrlishares">4306265</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000757"
      unitRef="U_xbrlishares">1106843</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000758"
      unitRef="U_xbrlishares">22299923</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000421">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock option activity under the 2009 Plan and 2019 Plan during the year ended December&#160;31, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Subject to&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate Intrinsic Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,433,560&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,052,025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39.39&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited or cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(992,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.90&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,116&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,674,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,778,984&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.72&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested and exercisable at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,281,600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.99&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;132,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000759"
      unitRef="U_xbrlishares">14433560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001478320_20201231"
      decimals="2"
      id="F_000766"
      unitRef="U_iso4217USD_xbrlishares">12.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000760"
      unitRef="U_xbrlishares">3052025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000767"
      unitRef="U_iso4217USD_xbrlishares">39.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000761"
      unitRef="U_xbrlishares">992428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000768"
      unitRef="U_iso4217USD_xbrlishares">25.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000762"
      unitRef="U_xbrlishares">40116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000769"
      unitRef="U_iso4217USD_xbrlishares">26.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000763"
      unitRef="U_xbrlishares">3674057</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000770"
      unitRef="U_iso4217USD_xbrlishares">7.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000764"
      unitRef="U_xbrlishares">12778984</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001478320_20211231"
      decimals="2"
      id="F_000771"
      unitRef="U_iso4217USD_xbrlishares">19.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000773"
      unitRef="U_iso4217USD">156105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000765"
      unitRef="U_xbrlishares">7281600</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice
      contextRef="C_0001478320_20211231"
      decimals="2"
      id="F_000772"
      unitRef="U_iso4217USD_xbrlishares">10.99</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000774"
      unitRef="U_iso4217USD">132537000</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001478320_20210101_20211231" id="F_000775">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="C_0001478320_20210101_20211231" id="F_000776">P5Y8M12D</adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000777"
      unitRef="U_iso4217USD_xbrlishares">24.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_20200101_20201231"
      decimals="2"
      id="F_000778"
      unitRef="U_iso4217USD_xbrlishares">21.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_20190101_20191231"
      decimals="2"
      id="F_000779"
      unitRef="U_iso4217USD_xbrlishares">6.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000780"
      unitRef="U_iso4217USD">156500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000781"
      unitRef="U_iso4217USD">190400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001478320_20190101_20191231"
      decimals="-5"
      id="F_000782"
      unitRef="U_iso4217USD">39100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000783"
      unitRef="U_iso4217USD">26700000</us-gaap:ProceedsFromStockOptionsExercised>
    <adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000785"
      unitRef="U_iso4217USD">300000</adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000784"
      unitRef="U_iso4217USD">21700000</us-gaap:ProceedsFromStockOptionsExercised>
    <adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000786"
      unitRef="U_iso4217USD">500000</adpt:ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods>
    <us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000422">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock unit activity under the 2019 Plan during the year ended December 31, 2021 was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-weight:bold;;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested outstanding restricted stock units at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,254,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.98&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units forfeited or cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(74,299&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested outstanding restricted stock units at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,211,191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="INF"
      id="F_000787"
      unitRef="U_xbrlishares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="2"
      id="F_000792"
      unitRef="U_iso4217USD_xbrlishares">28.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000788"
      unitRef="U_xbrlishares">1254240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000793"
      unitRef="U_iso4217USD_xbrlishares">37.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000789"
      unitRef="U_xbrlishares">74299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000794"
      unitRef="U_iso4217USD_xbrlishares">43.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000790"
      unitRef="U_xbrlishares">18750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000795"
      unitRef="U_iso4217USD_xbrlishares">28.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000791"
      unitRef="U_xbrlishares">1211191</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="2"
      id="F_000796"
      unitRef="U_iso4217USD_xbrlishares">37.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231"
      decimals="2"
      id="F_000797"
      unitRef="U_iso4217USD_xbrlishares">28.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20190101_20191231"
      decimals="2"
      id="F_000798"
      unitRef="U_iso4217USD_xbrlishares">41.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000423">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The estimated grant date fair values of options granted during the years ended December&#160;31, 2021, 2020 and 2019 were estimated using the Black-Scholes option-pricing model with the following assumptions: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$30.86 - $66.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$17.68 - $55.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$7.80 - $47.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000805"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000807"&gt;5.27 - 6.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000811"&gt;0.5% - 1.4%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000812"&gt;0.4% - 1.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000813"&gt;1.4% - 2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000817"&gt;67.1% - 70.0%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000818"&gt;70.5% - 73.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000819"&gt;64.3% - 72.9%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001478320_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210101_20211231"
      decimals="2"
      id="F_000823"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000424">The compensation costs related to stock options and restricted stock units for the years ended December 31, 2021, 2020 and 2019 are included on our consolidated statements of operations as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;817&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,061&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,519&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,934&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales and marketing&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,480&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,798&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,155&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total share-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,761&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,124&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231"
      decimals="-3"
      id="F_000824"
      unitRef="U_iso4217USD">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231"
      decimals="-3"
      id="F_000825"
      unitRef="U_iso4217USD">817000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231"
      decimals="-3"
      id="F_000826"
      unitRef="U_iso4217USD">555000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_000827"
      unitRef="U_iso4217USD">14061000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000828"
      unitRef="U_iso4217USD">8519000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_000829"
      unitRef="U_iso4217USD">3934000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_000830"
      unitRef="U_iso4217USD">12312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000831"
      unitRef="U_iso4217USD">6627000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_000832"
      unitRef="U_iso4217USD">3480000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_000833"
      unitRef="U_iso4217USD">14778000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000834"
      unitRef="U_iso4217USD">8798000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_000835"
      unitRef="U_iso4217USD">5155000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000836"
      unitRef="U_iso4217USD">43251000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000837"
      unitRef="U_iso4217USD">24761000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000838"
      unitRef="U_iso4217USD">13124000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000839"
      unitRef="U_iso4217USD">96800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="C_0001478320_20210101_20211231" id="F_000840">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="-5"
      id="F_000842"
      unitRef="U_iso4217USD">38300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      id="F_000841">P3Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000376">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Microsoft Collaboration Agreement&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Summary of Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2017, we entered into a collaboration agreement with Microsoft (&#x201c;Microsoft Agreement&#x201d;) to computationally derive a comprehensive TCR antigen map for purposes of developing a universal diagnostic based on a single blood test.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contemporaneously with the Microsoft Agreement, we entered into a separate agreement to use Microsoft&#x2019;s Azure cloud services at standard volume pricing with a minimum Azure purchase requirement of $12.0&#160;million over the &lt;span style="-sec-ix-hidden:F_000844"&gt;seven-year&lt;/span&gt; term of the Microsoft Agreement, which we expect to meet in the ordinary course of business.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, contemporaneously with entering into the Microsoft Agreement, Microsoft made a preferred stock investment of $45.0&#160;million as a part of our&#160;Series&#160;F-1&#160;convertible preferred stock issuance.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Summary of Accounting&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The terms of the Microsoft Agreement meet the criteria under ASC Topic 808,&#160;&lt;span style="font-style:italic;"&gt;Collaborative Arrangements&lt;/span&gt;&#160;(&#x201c;ASC 808&#x201d;), as both parties are active participants in the activity and are exposed to significant risks and rewards dependent on the commercial success of the activity.&#160;ASC 808 does not provide guidance on how to account for the activities under the collaboration and we determined that Microsoft did not meet the definition of a customer under ASC 606. Accordingly,&#160;we looked to other guidance to determine the accounting for the respective elements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We determined that the preferred stock issuance and commitment to use Microsoft&#x2019;s Azure cloud services were made at terms consistent with market rates. All consideration received as part of the Series&#160;F-1&#160;convertible preferred stock issuance was accounted for as part of the Series&#160;F-1&#160;preferred stock issuance.&#160;Since the commitment to purchase Microsoft&#x2019;s Azure cloud services was at market terms and we expect to meet the commitment in the ordinary course of business during the seven-year term, we record the expenses in the period in which the services are consumed. These costs are recorded in our consolidated statements of operations based on the underlying activities for which they support.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The remaining elements of the agreement were highly interrelated, so we evaluated them in the aggregate to determine the appropriate accounting application. Specifically, we determined that the transfer of license rights between the parties, our commitment to provide data and immunomics, diagnostic and bioinformatics expertise to Microsoft and Microsoft&#x2019;s commitment to provide machine learning software and related development services to us were highly interrelated because they were necessary for the parties to perform the activities under the Microsoft Agreement and, therefore, should be evaluated as one unit of account.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We accounted for these collaboration activities by analogy to ASC Topic 845,&#160;&lt;span style="font-style:italic;"&gt;Nonmonetary Transactions&lt;/span&gt;, and determined that major uncertainties exist about the realizability of the value that would be assigned to an asset received from or provided to Microsoft under the collaboration and, therefore, fair value could not be reliably measured. As a result, we did not recognize any&#160;non-monetary&#160;assets or corresponding&#160;non-monetary&#160;income or expenses pertaining to the rights provided to us or to be received by us under the Microsoft Agreement.&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <adpt:MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement
      contextRef="C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231"
      decimals="INF"
      id="F_000843"
      unitRef="U_iso4217USD">12000000.0</adpt:MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement>
    <us-gaap:PreferredStockValue
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_adptSeriesFOneConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171231"
      decimals="-5"
      id="F_000845"
      unitRef="U_iso4217USD">45000000.0</us-gaap:PreferredStockValue>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000377">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;5&lt;/span&gt;&lt;span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Income Taxes&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of loss before provision for income taxes for the periods presented are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total loss before provision for income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,298&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of our deferred tax assets and liabilities as of the dates presented are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200,363&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credit carryforward&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonqualifying stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,096&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred rent&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,401&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,052&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,713&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,345&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,258&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(297,020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(197,527&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets, net of valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,731&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tangible and intangible assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ROU assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,532&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ASC Topic 740, &lt;span style="font-style:italic;"&gt;Income Taxes&lt;/span&gt;, requires that the tax benefit of NOLs, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is &#x201c;more likely than not.&#x201d; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a valuation allowance. The valuation allowance increased by $99.5 million and $96.6 million during the year ended December 31, 2021 and 2020, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal tax laws impose substantial restrictions on the utilization of NOL and credit carryforwards in the event of an ownership change, as defined in Section 382 of the Internal Revenue Code of 1986. Accordingly, our ability to utilize these carryforwards may be limited due to such ownership changes. We have completed a Section 382 analysis for changes in ownership through December 31, 2020 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of our federal NOLs. Under the TCJA federal income tax law, federal NOLs incurred in 2018 and future years may be carried forward indefinitely, but the deductibility of such federal NOLs is subject to an annual limitation. NOLs generated prior to 2018 are eligible to be carried forward up to 20 years. As of December 31, 2021, we had U.S. federal NOLs of $192.5 million and U.S. federal tax credits of $33.6 million that will begin to expire in 2028. We also had $576.2 million of NOLs as of December 31, 2021 that do not expire.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The effective tax rate of our provision for income taxes differs from the federal statutory rate for the periods presented as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.1&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.8&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.0)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.1&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47.7)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(44.3)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We account for Global Intangible Low-Taxed Income as period costs when incurred. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize, in our consolidated financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. We had unrecognized tax benefits of $6.9 million as of December 31, 2021. A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the dates presented are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,260&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;792&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,052&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,437&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,489&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, 2020 and 2019, we recognized uncertain tax positions of $3.4 million, $1.4 million and $0.8 million, respectively, related to a reduction of the research and development credit deferred tax asset. Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not expect a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our operating results.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We had no accrued interest or penalties related to uncertain tax positions as of December 31, 2021 and 2020.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We file federal and certain state income tax returns, which provide varying statutes of limitations on assessments. However, because of NOL carryforwards, substantially all tax years since inception remain open to federal and state tax examination.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000425">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of loss before provision for income taxes for the periods presented are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total loss before provision for income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,298&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000846"
      unitRef="U_iso4217USD">-207314000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000847"
      unitRef="U_iso4217USD">-146227000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000848"
      unitRef="U_iso4217USD">-68606000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000849"
      unitRef="U_iso4217USD">16000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000850"
      unitRef="U_iso4217USD">-207298000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000851"
      unitRef="U_iso4217USD">-146227000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000852"
      unitRef="U_iso4217USD">-68606000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000426">The significant components of our deferred tax assets and liabilities as of the dates presented are as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200,363&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credit carryforward&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonqualifying stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,096&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred rent&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,401&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,052&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,713&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,345&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,258&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(297,020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(197,527&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets, net of valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,731&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tangible and intangible assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ROU assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,532&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000853"
      unitRef="U_iso4217USD">200363000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000854"
      unitRef="U_iso4217USD">105433000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000855"
      unitRef="U_iso4217USD">31200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000856"
      unitRef="U_iso4217USD">18981000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness>
    <adpt:DeferredTaxAssetsNonQualifiedStockOptions
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000857"
      unitRef="U_iso4217USD">18072000</adpt:DeferredTaxAssetsNonQualifiedStockOptions>
    <adpt:DeferredTaxAssetsNonQualifiedStockOptions
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000858"
      unitRef="U_iso4217USD">12096000</adpt:DeferredTaxAssetsNonQualifiedStockOptions>
    <adpt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000859"
      unitRef="U_iso4217USD">30401000</adpt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <adpt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000860"
      unitRef="U_iso4217USD">31052000</adpt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000861"
      unitRef="U_iso4217USD">42481000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000862"
      unitRef="U_iso4217USD">59713000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000863"
      unitRef="U_iso4217USD">4345000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000864"
      unitRef="U_iso4217USD">2983000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000865"
      unitRef="U_iso4217USD">326862000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000866"
      unitRef="U_iso4217USD">230258000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000867"
      unitRef="U_iso4217USD">297020000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000868"
      unitRef="U_iso4217USD">197527000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000869"
      unitRef="U_iso4217USD">29842000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000870"
      unitRef="U_iso4217USD">32731000</us-gaap:DeferredTaxAssetsNet>
    <adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000871"
      unitRef="U_iso4217USD">7310000</adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets>
    <adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000872"
      unitRef="U_iso4217USD">5760000</adpt:DeferredTaxLiabilitiesTangibleAndIntangibleAssets>
    <adpt:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000873"
      unitRef="U_iso4217USD">22532000</adpt:DeferredTaxLiabilitiesRightOfUseAssets>
    <adpt:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000874"
      unitRef="U_iso4217USD">26971000</adpt:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000875"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000876"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000877"
      unitRef="U_iso4217USD">99500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000878"
      unitRef="U_iso4217USD">96600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <adpt:NetOperatingLossCarryforwardExpirationPeriod contextRef="C_0001478320_20210101_20211231" id="F_000879">P20Y</adpt:NetOperatingLossCarryforwardExpirationPeriod>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231"
      decimals="-5"
      id="F_000880"
      unitRef="U_iso4217USD">192500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231"
      decimals="-5"
      id="F_000881"
      unitRef="U_iso4217USD">33600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardLimitationsOnUse
      contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231"
      id="F_000882">2028</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
    <adpt:OperatingLossCarryforwardsExpirationYear
      contextRef="C_0001478320_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231"
      id="F_000883">2028</adpt:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000884"
      unitRef="U_iso4217USD">576200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000427">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The effective tax rate of our provision for income taxes differs from the federal statutory rate for the periods presented as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.1&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.8&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.0)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.1&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47.7)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66.1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(44.3)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000885"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001478320_20200101_20201231"
      decimals="INF"
      id="F_000886"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001478320_20190101_20191231"
      decimals="INF"
      id="F_000887"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000888"
      unitRef="U_xbrlipure">0.083</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001478320_20200101_20201231"
      decimals="INF"
      id="F_000889"
      unitRef="U_xbrlipure">0.138</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001478320_20190101_20191231"
      decimals="INF"
      id="F_000890"
      unitRef="U_xbrlipure">0.081</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000891"
      unitRef="U_xbrlipure">0.141</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000892"
      unitRef="U_xbrlipure">0.252</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000893"
      unitRef="U_xbrlipure">0.098</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <adpt:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000894"
      unitRef="U_xbrlipure">-0.001</adpt:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <adpt:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000895"
      unitRef="U_xbrlipure">-0.001</adpt:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <adpt:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000896"
      unitRef="U_xbrlipure">-0.010</adpt:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000897"
      unitRef="U_xbrlipure">0.047</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000898"
      unitRef="U_xbrlipure">0.057</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000899"
      unitRef="U_xbrlipure">0.061</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000900"
      unitRef="U_xbrlipure">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000901"
      unitRef="U_xbrlipure">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000902"
      unitRef="U_xbrlipure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000903"
      unitRef="U_xbrlipure">-0.477</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000904"
      unitRef="U_xbrlipure">-0.661</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000905"
      unitRef="U_xbrlipure">-0.443</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001478320_20210101_20211231"
      decimals="3"
      id="F_000906"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001478320_20200101_20201231"
      decimals="3"
      id="F_000907"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001478320_20190101_20191231"
      decimals="3"
      id="F_000908"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001478320_20211231"
      decimals="-5"
      id="F_000909"
      unitRef="U_iso4217USD">6900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000428">A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the dates presented are as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,260&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;792&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,052&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,437&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,489&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions in 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"&gt;&#160;&lt;/p&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001478320_20181231"
      decimals="-3"
      id="F_000910"
      unitRef="U_iso4217USD">1260000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000911"
      unitRef="U_iso4217USD">792000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001478320_20191231"
      decimals="-3"
      id="F_000912"
      unitRef="U_iso4217USD">2052000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000913"
      unitRef="U_iso4217USD">1437000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001478320_20201231"
      decimals="-3"
      id="F_000914"
      unitRef="U_iso4217USD">3489000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000915"
      unitRef="U_iso4217USD">3426000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001478320_20211231"
      decimals="-3"
      id="F_000916"
      unitRef="U_iso4217USD">6915000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000917"
      unitRef="U_iso4217USD">3400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000918"
      unitRef="U_iso4217USD">1400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001478320_20190101_20191231"
      decimals="-5"
      id="F_000919"
      unitRef="U_iso4217USD">800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001478320_20211231"
      decimals="INF"
      id="F_000920"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001478320_20201231"
      decimals="INF"
      id="F_000921"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000378">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;6&lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;color:#231F20;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Net Loss&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Per Share&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Attributable&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to Adaptive Biotechnologies Corporation Common &lt;span style="letter-spacing:-0.05pt;"&gt;Shareholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the computation of the basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019 (in thousands, except share and per share amounts): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss attributable to Adaptive Biotechnologies Corporation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,279&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value adjustment to redemption value for Series E-1 convertible preferred stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(964&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,279&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,570&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;140,354,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,216,468&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,165,315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.48&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.01&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Since we were in a loss position for all periods presented, basic net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders is the same as diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019, as they had an anti-dilutive effect:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible preferred stock (on as if converted basis)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,104,469&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options issued and outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,097,374&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,125,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,183,546&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;693,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,125&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,952&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock warrants&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,570&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,961&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible preferred stock warrant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,799,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,220,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;63,377,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000429">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the computation of the basic and diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019 (in thousands, except share and per share amounts): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss attributable to Adaptive Biotechnologies Corporation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,279&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(68,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value adjustment to redemption value for Series E-1 convertible preferred stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(964&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(207,279&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(146,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,570&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;140,354,915&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;131,216,468&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,165,315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.48&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.01&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000922"
      unitRef="U_iso4217USD">-207279000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000923"
      unitRef="U_iso4217USD">-146227000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000924"
      unitRef="U_iso4217USD">-68606000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000925"
      unitRef="U_iso4217USD">964000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20210101_20211231"
      decimals="-3"
      id="F_000926"
      unitRef="U_iso4217USD">-207279000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20200101_20201231"
      decimals="-3"
      id="F_000927"
      unitRef="U_iso4217USD">-146227000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001478320_20190101_20191231"
      decimals="-3"
      id="F_000928"
      unitRef="U_iso4217USD">-69570000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20210101_20211231"
      decimals="0"
      id="F_000929"
      unitRef="U_xbrlishares">140354915</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20200101_20201231"
      decimals="0"
      id="F_000930"
      unitRef="U_xbrlishares">131216468</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001478320_20190101_20191231"
      decimals="0"
      id="F_000931"
      unitRef="U_xbrlishares">69165315</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000932"
      unitRef="U_iso4217USD_xbrlishares">-1.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20200101_20201231"
      decimals="2"
      id="F_000933"
      unitRef="U_iso4217USD_xbrlishares">-1.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001478320_20190101_20191231"
      decimals="2"
      id="F_000934"
      unitRef="U_iso4217USD_xbrlishares">-1.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000430">The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders for the years ended December 31, 2021, 2020 and 2019, as they had an anti-dilutive effect:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible preferred stock (on as if converted basis)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,104,469&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options issued and outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,097,374&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,125,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,183,546&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;693,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,125&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,952&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock warrants&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,570&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,961&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible preferred stock warrant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,799,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,220,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;63,377,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20190101_20191231"
      decimals="INF"
      id="F_000935"
      unitRef="U_xbrlishares">46104469</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_000936"
      unitRef="U_xbrlishares">13097374</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000937"
      unitRef="U_xbrlishares">16125548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_000938"
      unitRef="U_xbrlishares">17183546</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_000939"
      unitRef="U_xbrlishares">693173</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_000940"
      unitRef="U_xbrlishares">38125</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptUnvestedRestrictedStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000941"
      unitRef="U_xbrlishares">4952</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20210101_20211231"
      decimals="INF"
      id="F_000942"
      unitRef="U_xbrlishares">8570</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20200101_20201231"
      decimals="INF"
      id="F_000943"
      unitRef="U_xbrlishares">56875</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptCommonStockWarrantsMember_20190101_20191231"
      decimals="INF"
      id="F_000944"
      unitRef="U_xbrlishares">55961</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_adptConvertiblePreferredStockWarrantsMember_20190101_20191231"
      decimals="INF"
      id="F_000945"
      unitRef="U_xbrlishares">28204</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_20210101_20211231"
      decimals="INF"
      id="F_000946"
      unitRef="U_xbrlishares">13799117</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_20200101_20201231"
      decimals="INF"
      id="F_000947"
      unitRef="U_xbrlishares">16220548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001478320_20190101_20191231"
      decimals="INF"
      id="F_000948"
      unitRef="U_xbrlishares">63377132</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="C_0001478320_20210101_20211231" id="F_000379">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;7&lt;/span&gt;&lt;span style="font-weight:bold;color:#231F20;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#231F20;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Retirement Plan&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#231F20;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We maintain a salary deferral 401(k) plan (&#x201c;401(k) Plan&#x201d;) covering employees who have met certain eligibility requirements. Employees may defer up to 100% of their compensation to the 401(k) Plan, subject to federal limits. We made $2.5 million and $1.6 million in discretionary contributions during the year ended December 31, 2021 and 2020, respectively, which are fully vested after one year of employee service. We did not make any discretionary contributions during the year ended December 31, 2019.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="C_0001478320_20210101_20211231"
      decimals="2"
      id="F_000949"
      unitRef="U_xbrlipure">1</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001478320_20210101_20211231"
      decimals="-5"
      id="F_000950"
      unitRef="U_iso4217USD">2500000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001478320_20200101_20201231"
      decimals="-5"
      id="F_000951"
      unitRef="U_iso4217USD">1600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <adpt:DefinedContributionPlanEmployeeServicePeriodForVesting contextRef="C_0001478320_20210101_20211231" id="F_000953">P1Y</adpt:DefinedContributionPlanEmployeeServicePeriodForVesting>
    <adpt:DefinedContributionPlanEmployeeServicePeriodForVesting contextRef="C_0001478320_20200101_20201231" id="F_000954">P1Y</adpt:DefinedContributionPlanEmployeeServicePeriodForVesting>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001478320_20190101_20191231"
      decimals="INF"
      id="F_000952"
      unitRef="U_iso4217USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MR5/Q;K_?(4&NM$C+8"!(XZSXRY[+AM@)&#E[ F@90%\%N/M*\,H [W7 8$]
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M>,?7W4.(Q]"A$CIS"A;\3#[QET9F7,IQ'+<_''G4P<AH348/(?LJDCS3L-:
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M.@U[% D\+A) 7V[;;=.?Q.\.V$!IPI[W'TT>)7G;:&M_)"NA4#[AH1:X -V
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M )_OE+(O$W=T:8ZJB_\!4$L#!!0    ( .Z#3U0$ZT.YG04  -\5   8
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M"+0SP/];A4IV Q>@OV?-_P502P,$%     @ [H-/5#22'(N4"   :RP  !@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6S=6FMSV[82_2L836>:S%@1\>"K
M8WLFMN1')K?7$S?M9YJ"+#04H9*0G?S[ B0MBGA)=N)[._4'2Q1W%[N+!<[!
MDL>/O/I2+RD5X.NJ*.N3T5*(]2^329TOZ2JKW_$U+>6=!:]6F9"7U?VD7E<T
MFS=*JV*"@B":K#)6CDZ/F]]NJM-COA$%*^E-!>K-:I55W\YHP1]/1G#T],,G
M=K\4ZH?)Z?$ZNZ>W5'Q>WU3R:K*U,F<K6M:,EZ"BBY/1>_C+!Q(IA4;B=T8?
MZYWO0(5RQ_D7=7$]/QD%RB-:T%PH$YG\>*#GM"B4)>G'7YW1T79,I;C[_<GZ
M11.\#.8NJ^DY+_Y@<[$\&24C,*>+;%.(3_SQBG8!A<I>SHNZ^0\>.]E@!/)-
M+?BJ4Y8>K%C9?F9?NT3L*$#L4$"= M(4HLBA@#L%K"F@Q*% .@5RJ$MAIQ#J
M(\0.A:A3B#0%0AP*<:<0ZR.XTIIT"HFFX)R'M%-(]1%<+L'@:>:"IH+:*6_J
M99J)[/2XXH^@4O+2GOK2%%VC+\N$E6I]W(I*WF523YR>\[+F!9MG@L[!K9 ?
MLOA%#?@"R%L/M!+LKJ#@1E8MK:I&AN=?0%;*;\NLHDM>S&E5_PS>3.F"Y4R\
M!;._-DQ\ V/P^78*WOST%OP$6 E^6_)-+=7JXXF0?JO1)WGGXUGK(W+X^!L7
M66%1._>K?:(/K%G&,I:;BO$*W%#Y,3\"[_.<;TK!RGL5<CG/JGD-/J]5$N3-
M^9\R\2H+EB&G_B$]*;,8F^TSMEI)[UW:%W[M]_,Y4SM05H";C,W!=0G.LS6S
M9_)RCZT\WZPV15,C_Q5+6LG:6,GM>*GVR0<*WGSD=?T67,KMV&+\ZG#C70U9
MC%P_V\AK3/\'OQ>_\C+GI:AX42CCUZ6@%:TU0Q.Y0K?+%&V7*6HL$X?E,WK/
MRE(9/<N*K,PIR(0,-'\',#P"*(");5FU-L/&I@+*A],Q"A,(T?'D8;<.33DX
ME+@P)7"<!IJ=2\MX,(B'0E<VI](P#9*MW"!#>)LA_+P,';4;5'U(IF:M[6@W
M R@A,,21W2NR]8IXO=K=$-;;#:%62_H(O&A2I\3(7Q@%2>A(7[AU-/R!CCXG
MM]/0R&V*9/$$*;&['&U=CKPNWU0\IU0NW47%5Q)BY'8G-[OUYJY@N5ST,@3I
M\02PNMXTR97[0-YNJ4U88+.67S7Q(U!*3BHE-Z6$M<>*B0;<YJQNMHRZ 3YE
M15J5>TM[W:JT!N3-6HJMU99[]PULK' 7&1G!2$YAH"W+R)AI;<%=V T11RW$
MV\3&WY_8YV;JJ61LJR\V5U^,PD#^V0-)MH$DWD"N[:ZW<V2;F,1P9$S2)-*R
MOD]JX&NZ]34]8 $^ 5;N7HY \$$=V^)(#0_#"*98V]6GJ;D5V^1FIERJI<0^
M($+VG,"@9Z?!ZV3%4V[3;LS!!*8XP&F,-;":640-R6%H.\0;_J#0'K.JRDJA
MA_CTNY500\-O%.EX?;%/:AA9SU6@GZQ<>W=<^I56.:O-NUTX]@,",N=!#\8G
M,HRDYQ303RJ^,Q+?G@=-RA&2.'4EOR<<T,\XG"XO) /.LWII^M[>YVMU7+!G
MGQB^$@*Q/@%[I(8!]<0$^IG)]P;DG023FZ" X#ARK>Z>FT _.=GU^E:BCN1*
MLS'T+G-W/ <:Z )6I&R1L0H\9,6&6C= DUG P+58>M8 _;3A'Q.R=^\WN08B
M:41<9=I3#>CG&K_+@Y[B%M)W=>:K6"ZV7FXD#['7GTDE$@P=K ?V5 +NX1++
MK+RGJNLB,T5738[:U#09?Y#^J;;$LU)LW1=,V!_+7&H'OGU2PP-Q3PW0'FKP
MOPERVKDQ8#].[WOT1_O0?V<G:T=O&+.U=D"MZGFL^L -IU[3LLZ4BO70;X(Z
MQ!!ILW*Q5VP8V$ZCP@_^;7\H'_2'6"FO*7A3J#:1U6<3N^,X&7I\N4=HZ&\/
M\<@/\;_*4XSRR^J6B='C*(D"[4!PM5]NZ%P/YL@/YK-R[FD/I%:?310.8R@I
MZ]#G<V3V$5(-T6<6&;UW=&$9+\5A@HD^>Z9<%$,]D:;0&$>2%VFU<.WW?ICM
MGFD@/],89MO5X[!E?89,(@%1B' "B8/1H9Y*H']KGP-9.A@Q3/1:G%GDC :D
MV>IH3+G6?\]:T#^LV8%,!A*CP-WL0#T%07X*XNEK@]E7H39CA7T?F=Z2[F9K
MC_7;<Y"H:G8WLWN"@OP$Y34.*<CL4B 8FK5FBAFU9A(69<G5H.X9"_8SEM<\
MR6"S41'*HPP*'8".>Z:"_4SE1<06F^R"A*X*QSVYP'YR\7JL"9OD I$XTDMC
MK]@PL)V'%WX6\B+6A$W:@9#^3&:/T-#?GIA@/S'QL29L 7%((H3T)T$'" [=
MZY$</P?)-01'@=5K$\%C@E&D<;U9)S?8/W1N;;$EV0!.=;YS:1%,=!9V91$:
MAQ!&T#6+/;/ ?F9Q$.&QIFN&33R&.(Y(E*0.UHM[2,:'-Q)^<-<-F^ ;$ABY
M,ME#+][SI.$5 *T;<@!H$4F,8C-["$.Q84@]1N/7Q6C/-)QA$V%Q%),@U/OO
M!P@.G\OV8$S\8/PB6",FRL(D#AVX1GJ,)?^O;D W\&X1R5TMU'&-6/!Z(#8,
MK =LL@>PVU=.0/-:!+O;M-TZ54%3=M_<.6-<T'Q9\H+?,RJKYKK,WUDC,:&7
M(/TA@$4(!]ISU0_$\KX#<K0_20_AY!4@G%@Z!RC FL>7>\6&/N^\G?!R&"<6
M=$9!C%+M+'[E$HQ3/>\VO'?EO<=Z\CU8#ZVAF1@>!03JS\=F%CD#ZVTR&)%
M;Q)=6@3'$.I/'*]L8O*@FZ10SZ9E8%?KF/24@/P(2F#+ZHQ8* &!.,5)%&IN
M379>6%2OX?XGJ^Z9W!@*NI"ZP;M81E6U;[:V%X*OFW<8[[@0?-5\7=),GL65
M@+R_X'(7Z2[4:Y';]XM/_P902P,$%     @ [H-/5'_B\[>)"   #20  !@
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M9,,0G%J:DE/*MA0UC]J1FKUJ/Y<V;'\^=":>1?M+M%?R19A(BY[?(@DX]U/
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M#@S %;F)"Y>Y#TN2N)@Y#B&3)I/P;OK'F'-[5A+@#)Q:4],%NX>L$ [PS1K
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M>392(=_!\TORK=Q["Y]PBY9';BD*O #?EQYUZ%]X@^T/H8M_ %!+ P04
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MK33X088N^0 ..%JWQ[0"FXZ[$TQ422D1RUXY'N4@"-<G.%@FA^]G?)YX/#[
M+Q7G\;H4U4T<&A6BS1W),$TE;-EARC?A%)N?:!4_@A]>D]!@SRN[.N#HC_GZ
M"#RXC?ENULO!AT-6!9^(S4Y*(>7_F&YK'QLY$B ?-9V5\Z?3+4!_6D,0YODC
M1^<>$O[2D"O/<RXJ3"O/8K?7J-D 73+6138^<E=3W+X:[)32?Q1J?&>G/W)P
M8.7YB'\E.'!2>CZK0.3EXPQQ'>DYUZ?7='SXB61P6%SMK8-'U1%"/=N!0.]<
M%[JXC&18A4^U;2 WE;BIP76'I^Q.N/S:MAES,B>7AJ][)!^3>:^IJ%#ZD8#'
M5;7_^-V;Q3.Q=,<XI=/[<]NHPU8Y D1]DCN:]2 :_S*0P( +'+2DV8.Q=RII
M[SK9=,/]A2E*I4#:F+_43A5( +9Q_QDD?_R%'J;$77/.P5/+$X5$DQJ^Y$MZ
MJV1.BA@XGUVDO:X),7T(/9J=.#G:"SWW[I8]!9%BCGU\;2LLT22D>I-/:D@6
M+>A.^N?N[([B'%%"WSCQH%+5KUL 408]&<# 5VMBB9@2V6C"5-S5<J[$N0^0
ML$7"A7N_Q-+ @WV8_1,41")<1 X&=2'Q['\)E?'3'P[F^,0JF#3BA\@!BZBB
MX7G@).9MS16M9M3K<.(1!4I+!A<5]\>C=I=+.#GI0DK;A*>)?[B#^O+N@Z^/
MF]M## 3!UG':2LA6ZPC,W/MGJ?I=_J^KZT_B_LZ;B5TP:2Y(6'5D,7!<^6.M
M 7[X_Z<A@,T^L 1N'">D2:?$,)X5<B?[Q1$6UEMK[Y::D>:S4O@<K-8J'^1V
M])U)$\E'PO!)NS:4PE^_>OXR=C."UG$EBU\3D$,INV2D](-=6LF5'$81@8]?
MB[!*@M31E7KPM:]<FFD*1V#FO9V7(T>]LW-TY"_+N3^<!B"4%*&YT;,_*@M6
M1PN'I:E<YQ6."JEM2<F7-":\<SUEB.%*.GK2S6%[(9\^H9C1VSHM-"([0O9;
MHG%:]\Q?OW)5B-4QY:5@<P0_M%;/)K:EX?A:S55'$8MJ(^FI;')6\HD%<F<>
M#(G9213(K/H!A3H-T=BJ].1VR\'%TW_U\ (MOG@;CVHD?96O5HC3]^Z@*>;4
MQ_,8,_MMVN0!/L+A@N2X/@P-S?.ISY/>3S[_2H.M^".W$,&$=OD2;+B:V7=T
MK^3SL?%Q^0COR[Q=X=#3RBWIU0?SSQ_?DZ),^Z-OMOPQV473$^3\<^V((EL\
M0/>7#0&L?V""\'7A;_\'4$L#!!0    ( .Z#3U2--.[0V@\  &@N   9
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M_A7/42/ ^*'87A(0U@,K^+!^H.Y,6>PH.\Q1 LJ5";D"";@$L&J79.Z>D^&
M'XCYQ>S5\,N[N)2?S%_]2"(MH7$K-[ZZR&4C5W#VR!;P*%8B.< ,P=D@!NV=
MJZG!E-E KY^1XG-,;T-T4[IA\Q_+.+#S'[+N)'[S&$G+#7E48&3'%091O5S.
M$@='!']6*]M39.E0U@W_CNBWT52H1+Z I,I8"KR TB69T"J0Z5.0+*3K;+X1
M13C6(_#R_C8Y^YS?(]3KM>8D9#27"\0.;_)M:JEY)HZ4FPZ>(M79?XSF4&,F
M)-GQ1%-C'9&=.(5,$NA&D)-'4D7EP3F7V<O25R%P(((6XT^](6&R11 KE2ZN
M*'4HJ6NQT:V+&1H]:!5@3;G#T- 9S*!&HN]DZ0/ZT-BPVAT<0$EVJS8Z/[2;
M+,V,!Z= 1$+%1A8TG(M(H*NNHEX-]V*&4K WNEXT36==QSYR9_H"/557(]OM
M3NY]ZE #;:7XPI85"HH#V_+YP6"Y\ =PN2PGRBF_?/B$-#H'#XG38C*49A8:
MN34X NPHPM F11I08-[;1MU1?XG\;6_:<9M[.6'O</=J\GDK2:4?@YA]2>?\
MC[WLN3M / 5O8];K*USERFU5N0Y^QO,;"F:"G-Q \@Z)$44_8JK5&])Z((Z0
MR[8'')'M14=VQ$]T8M.>X8_PV!08.$!^C"[WB^]R#4^B=GK6PTE7P2;R$WY7
ME-3)\HHK%"]W4C4PR"O/78<R4"I# _W^(F-\]K=)4$;)B#OIT##D-C JBC(#
M1-03G)8C4QS,)<0(ESKST[82[A"R]W%'3Z=## C&E!<'KY]ZR?08]83\B"N^
MH$LO#!\=&YE_1:BA2KF/XI0^#K?8AB+7TF3 LQU2LF 347F0=:$+SNU'>F=D
M8^DE?=B$C38HW'T&>9KK:?(DY*R\DZR4:CTSN=58JR7\7TND6S)(\>[S!_'%
MH&82#S-$[P^#IX$.W@V$'+O2IBGW)!;:=3>[2UM(VB>Q29OW7&X84M*^M7""
MC9>3^73R7R$S(&<1*C?.&1*(0-UT6^"?E-_COG<9Y&]*F@)UU*I#@:GL84IP
MBB+J: 0@).[A''RFD\4HH\020X4.T+6?H,4T*]K3,]#R[1RPPOY4?*W-[HHZ
M]H5V>6F<M^6.,9-ZUX2OY5F^D,L_4EB(YT)T@Z<G'D820^JJ2XLSB*^#Y'KH
MUQW+""YI.KDY8./[K&IR2T.1,P<>=/X/O7BZ+K5K]=1(/TJDA.'9D^^^]^0H
MQ)&CIY/[Z>2_C[JCTB+GU@W/=6KQB%"/(EO\9C37,?[$[%"R-5^,XSQ!5+=(
M*<9MOJ9*(=A0=&+9>9WU%\$]CKNXXWP.Y_NZKF UYFU:CE+'4#VUD8_80,S$
M!I9:^_X>N\/0JQR PR2W>%3NV6)M+.A"N8FGU%4XTX$_>\T1?YH*B"496QI4
MZ/A1E6<TN&^<MV')IG3#!9,:N(?U**HR3VHH+@Z8)/WMN$1<$<W?.VU#5\N0
M?X[=>1YZ41^3TM'&4.E.<FBEW7AG#LD]4@GOE8E'M8*[L!V8RLG-LA/V[2&F
M'(';YW.QMB>=Q^*)\\HSXNTW>OWV;JAO\#,"3)FDN*>Q#$57<-H^@G9CJ6GB
MX7SS+Q43)ZSJ4$%C03/!V^$\Y;PTJ/C*M\9XWX4EN<*9OF%"!N<990_-G1?3
M-.R: U%D!WEN++D@NMI(7X:\<4!3$D.?[:C(MK5ZU;6Q;B%&?+%>GMD8!SCZ
M(,.@,X] 3<GW:!A-?>D1LGW\!.>U;UI6\JN*A/H[Y2%M(0$ZB/91ZC+R/^AV
MT*72S.*13@"5OFS+?+ORD1J_9(=DQ4.]?T"36Q&Q$4&-Z7)_5#VPX?;=!W;N
MHXDT- SK"^!QOHVS%V-)<-IG.7784 2Y,^J&^^S')XG0P,"XV[)+X/E7D,HI
MI+%#/G<^1/9>Y9)*@X"R=*+O6^L']28,'=(9<WK>A_ERKQ]+!<P<]G2.NC=]
M5]1[?D:@K]C&RG5>[FOO?=^T&#4=%N.!_$BFY!RDH"ZF)<(A^Z;U0: T*H!1
M=EQTD*IE,N'BSAZY?SZ1RZJPN!^??0> _)0E;8"M5+M#J>6G'!1@Q\(XI</:
M^_23:2-R%O "WBM9< N1,U#P0=M.FB_<:,J.1]Q!FNRH. OL8TC:W:K/]&:&
M#A)[(0!@Q50IH=*;FHW\H"/["%B"MH\-?L*:=FY(62'B%ZJA-BSYH+H/PJ9K
M*2X'?'$<8>W( -LLM,L/V3J:3H8,@A\1,L+XNHB9ZLA8=[RSZZ<23V&WSV[.
MH3>1:]]#Z@WLY,0P#:40@]JLBE-K&L,4!M" 4,M];"O%5FFPI5@['W@\OK#V
M:/&C9 I9?OI64!.9TQM2$W4#\[RS+%>?97$#J.>_S[<>#T(%K$R1'Y=VGYTT
M>$*_,GKW E$Z;T<-F"R,35)ZBTKF?T>AS,_B#N:-_6M1E,$"(N.1C]56*>DZ
MJ\Z3[R>U!S/!?O1'0T&J;2"I\\/887;BEW//^$S>Y,>'+HEWG($0L:/.$&\=
M]>\Q3>D'J_OHX?^86?NQ06U$:5#EVS,&]$V[R4+2'$=, 7_)F,<+V4_HJRZ(
M$'E!OKV".SN6^5E=D2.GDZB!Y?-WT@K;B!\(CXVED]&\#(,9#IT4QIY8;13T
M%#LJY L<,V@ZE-BMXG?;V! D3;.^;).7.9*"X$RF[,^,M88+3=8VQ"]W7& D
MJ6KR$LVS**'?QY"2B15AVELEMXC]RU!0J54L[H,9?*SW#M_"\58<WL;#*E^U
M#C5AUK]6X7R$PKK>)60I$-=(H%=('KGRY"0O.GSRSX,RJ=]1'P](>TVNQ>7=
MXF T?+L8AHAA;'@[G?_)P^&CMT)&YE%3\8'-_]LKV>Y2NSKO+H!K+E?'WE*]
M3M[^13S:\#O.5'G!#OV+P/VO_6O4[_S;P\-R_P[V+Z@D*:TMU1I;9]/[VPL?
M:.*7UC3\+C%PV)J*/VX5M&UI 9ZO#5Q/^$(']"^7O_TW4$L#!!0    ( .Z#
M3U01/-GDM@,  "H)   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;*U6
MVV[C-A!]]U<0VJ+H H)UM:VDMH%<&K1  P2;W>U#T0=*&EE$*-(A*7OS]QU2
MLGRKLP5:( AO,V?.'',XFF^E>M$U@"'?&B[TPJN-65\'@2YJ:*@>RS4(/*FD
M:JC!I5H%>JV ELZIX4$<AM.@H4QXR[G;>U++N6P-9P*>%-%MTU#U=@M<;A=>
MY.TV/K%5;>Q&L)ROZ0J>P7Q9/RE<!0-*R1H0FDE!%%0+[R:ZODVMO3/XRF"K
M#^;$9I)+^6(7OY4++[2$@$-A+ +%80-WP+D%0AJO/:8WA+2.A_,=^H/+'7/)
MJ88[R?]@I:D77N:1$BK:<O-);G^%/I^)Q2LDU^X_V7:V2>J1HM5&-KTS,FB8
MZ$;ZK=?AP"$++SC$O4/L>'>!',M[:NARKN26*&N-:';B4G7>2(X)^Z,\&X6G
M#/W,\H$R1;Y2W@)Y!*I;!:BXT?/ (+@U"8H>Z+8#BB\ 13%YE,+4FOPB2BB/
M 0)D-5"+=]1NXW<1[Z$8DR3R21S&T3MXR9!JXO"2[Z=ZSW3!I<U6DS]O<FT4
MWHZ_WHF1#C%2%R/][W*^#Y2.1P=8GVL@E>1804RLB*$Y1^(:2Q:KTM3$V&-K
MO7'6LB(5$U04C')"-=II'.PV2@I-#FJ0E5!1VDF(&-20+2@@34>\)+AQB(HE
MA&58M$I9$E@*3).?F$!/V6K$T1^O1V<!1K_#!CC9C7$_)J//TE ^>CCA.<([
M!&]XP=6+S:Y%U-$/HPC1KM(ISG[\D,51_//1;'?Z9?P\)BNY 26LZ%B;N4&1
MD# S#/3@D5Q%?I1.SM9W4JVEH@9(+FW<_;E_=34]73K^9SH?D4T3"QP=D9U,
M$S_,9F="A?^/4&'BQUER2:C^]-\*-9U%_FPV.UM?$BJ*_$D6G2XO"S60G6:)
MGTRR([*S;.I/T^'^'/ C3!2\+8'4^.+R-\+9:\M*TIP)XMOR(-N:%37>[-V]
M/JT6^Z:7]G:_MM+@;*U8X8+T':.'U Z,E2@8*_9UA7N<T9QQ1VU,^E_OD&XA
ML85I8^OO.\J[:BR.U?7=)D7>CFZYYXNU:#'P[2K!5?>11/AWPA^I[K/L=>J3
MM<ZL89QBA@)?P]:]6BZR1+FPB;.58!4FC@&96+=X6()"]))42C86&WDKF3OF
M2/*-R%R#VMBG:A>LQ 8U_J='-CCH7PVHE>O25KA6F*Z5#;O#A\!-U__VYMU7
MQ"-5*TR!<*C0-1S/)AY176?N%D:N73?,I<'>ZJ8U?LR L@9X7DG4IU_8 ,/G
MT?)O4$L#!!0    ( .Z#3U19''N#; 8  "P1   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;,U868_;-A!^UZ\@W$61 (IMR9*/='>!W5P-D*!!-L=#
MT0=:HBTBE.B0M+WNK^\WE"QK+V_0YJ$/R5)#SCWS#>G3K3;?;"&$8]>EJNQ9
MKW!N]7PPL%DA2F[[>B4J["RT*;G#IUD.[,H(GGNF4@WBX7 \*+FL>N>GGO;!
MG)_JM5.R$A\,L^NRY&9W*93>GO6BWI[P42X+1X3!^>F*+\65<)]7'PR^!JV4
M7):BLE)7S(C%6>\B>GZ9T'E_X(L46]M9,_)DKO4W^GB;G_6&9)!0(G,D@>//
M1KP02I$@F/&]D=EK51)C=[V7_MK[#E_FW(H76GV5N2O.>M,>R\6"KY7[J+>_
MB\:?E.1E6EG_/]O69]-ACV5KZW39,,."4E;U7W[=Q*'#,'V((6X88F]WK<A;
M^9([?GYJ])89.@UIM/"N>FX8)RM*RI4SV)7@<^=OJXVP#E%V]G3@()#(@ZQA
MOJR9XP>8HYB]UY4K+'M5Y2*_*6  2UISXKTYE_%1B2]%UF>C*&3Q,(Z.R!NU
M[HV\O-'C[K&78N[8196S5]_7TNW8E<C61CHI+/OS8FZ=087\=41GTNI,O,[D
MWX7T.'/:#[HV7VRX5'RNQ#/TWS/+E6"RLYUI=(=U(F=ZP5PAV$(KM)FLEHQ;
MHB&>HIP+T\:4<00 BR%[(BNPZ+4%Q3Y]'MPY&ER4VCCY-Z2_T-8%GRMTO?+?
M;]#MW>]WVMK@E742;8+/UUP:]H6KM0BN"LAXYH0I4;7FFW#D#+-MZ(//_:L^
M6^J-,!7YA(Y"ECK[)T$T'8>3-,8JP;\GT7 6/&W(XV02O-!FI0WTLKF&)T$\
M"4?C4?#K+],XBG_#^03'B9C,@D_:<<7L8S:=!'&4A%&4MCKCD=<91Z-P-AL'
M[W2U_&].Q<,T3";DU-Y0J)E-DEK-, F3V?2.:U$<CF?1P;6$CA,18:A=4X\8
M1BY,PPCQN:$X"H?1M/%P$D9)>J<:AO^7:DC3.$Q',ZPF\:BN!V]XFH["&%5R
M)V810CD)IN/@24S1BL)T&OUX(:3C)!R.QEA-A[.Z%&IUH$]'HY]0"1$2DL0D
M&QD_J:VLJ6F<_G!:CTNY4,K#PR/6>'#(;@809ZQ<5CZ3P)3'0L8*OA&0P\1B
M(?S$Q3E'FSN6DU!7<,>D9>+[&HXYS;1A2EA+&Q73E6 [P0U;&%UZDXVPJT80
MH9U6,O>VS+GB50;5_NI"M#[[5&C;:.!&W++\D1C^L.%H _$SC+W(,K/&GJQ@
M%! =S)F0&V\6Q><Z4VL,U8-PWC9@A@;TN1)MDRVHR3;49 3[>FWN]_*X6G">
M1/T$]PRE_)4)*D[B?MH2MF!AN/Q9% ]D6+'B5"EJAUN+*_Q \?LK+F'<-6Z.
MMJDJC1V#"XTQ5'?<6H'Q1<./22=*A-+;?"1HC\VSL!-\M:-:Z$[#.@Z-Y=:;
MN32 *;8^P%:A54YG%>B-U9VH8O[>&+V2PM-E)S:VTE;2;3/T[*1&B6KI"C^?
M<9D%6RXW,J?:OUU[<R$J+Y;"X&2UQFR^(_6!*-P>YN^HHSY1D;9WM.!P6_O#
ML#>P&P40=,#Y-H(?V7H<U49)BIF2-,-E6H_/P\39KVZC]2@.IP35*4VC_:']
MWQH+^=TKT4W-DTDX&PYKS5$2/:#Y*\I!&*ESF7&% C9B0V\(JL*C&@BRJ'P1
M7RJ)S(A< A=*E+RA6/39E2Y%>Q_#G5*;YJ*6HWMRGV'/3[5VX /=-[QG$]>.
M2%"U+616-*+:6@0\'"#S'FC ,T5:%$N.!%D/1;FO'PLOE>\M2":^QJT=E2N5
M)MX;9D>(O!1Z:?@*R@E)><@RJ%K6WN^9&/(&'RR=!\T=HK'?.#0^](H-ATLU
M*A$$<F#1_=4< F=8#@2IM/,X5>4AUJ:&'^QY"%;R&P&/CP$=A&5S0F!<[F%%
M6%N*N?= 1KN]/!>+&M2)/Z.RWC4)1,COCVV=EY+O2.E^4/39)1Z(^1[-ZC23
M"N\1TM! .@JNF_F'FKKV*$?"L=I74AU/[W43;8*($*]JV -)^T3)J@/QR#E!
M_YZ#$RQZ;-V"@X)';B\K[^4>N#H&-A/E>%^0*!)C\KK(&\37)5"WH%<\((Y,
M[=_WQ!IT7K"E,$O_3J>V65>N?LRVU/:G@(OZ!7PX7O^.\)Z;I:RH0Q9@'?8G
M:8^9^FU>?SB]\N_AN79X7?ME(3B:DPY@?Z&UVW^0@O8'DO-_ %!+ P04
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M3(HL9^\H>\NRR9QR2B=S[]F@#_KOLE)F5Y.\R&E/\TDZR]A'JMQ1$?\,B/A
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M+T*,+MN[7IWRLJ:[K+DY;5M8/_CD]3WP?L;PH1>=0PD<)YV//.7E/]8NUT)
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MLL+=>4<EDQM1*%D6K!++9R<7P>,7,:W7"SY*<:,&UXPT693E9[KY.7MVXI-
M(A=I310X_EV+ER+/B1#$^&)IGG0L:>/PNJ7^6NL.719<B9=E_DEF]?K9R>R$
M96+)F[Q^5][\0UA])D0O+7.E_[(;LS8)3UC:J+K<V,V08",+\Y]_M788;)CY
M!S:$=D.HY3:,M)0_\9H_?UJ5-ZRBU:!&%UI5O1O"R8*<<E57>"JQKW[^ZDLC
MZUOV<Y&*@NS#+G->J*?G-6C3BO/4TGEAZ(0'Z 0A^Z4LZK5BKXI,9+L$SB%4
M)UG82O8BO)?B3R+U6!2X+/3#X!YZ4:=II.E%A^A)E>:E:BK!WB[9RW*#N%9<
MA\8[D?-:9/A1U8I=K7DER-,9N^2W"$#\]I^+A:HKA-!_[Y$D[B2)M23Q#]O\
M?CH!BYCGC%-C5^)+@Q\XS.?/V%5=II_U$Y=QQ3BT@I>PB:5E4=@,N9'UFI5-
MA50!327UC^6R)R4+]D]>-$A>4 TF+KL1H(9\!JEVT=__-@N#Y GB8$PN=DK/
M0_^)EHI^T??!DT<NJ*=YD\EBQ7B>0XY:U;S0]^661('81<84>0>7UUSF?)$+
M!F!BRZ8FOTK(PL&/-="N8O5:L(X/A%W+=.VR;26QHR[UXQ1AD(M64=)=%M";
MYVS;+'*9XM>EJ" #Z0H.))GX*JI4JH[Y%19 HE=G 1GS6E2UI$? 2&RM8!I%
MQO?8AVU9',]0&[O)M:7GKA9VS"1:JGV)P&0#!I;OKV5G--+@*,-)Q;;D+K)X
M43)A?,EO>)49,D-9[FQ2I!OR5VP6>-#FL,<N,K[5H0"OS \$R">(F$$[V UW
MEK'LUF@&,(VF, BF^4XP01A>PP/EM:0P)TW)@)V:$*\G:70LOC0\ETN)Y4/S
M[<1>"2*5,>:9 0AK$6(@X-CR5@CELDQ62*FR,KL0% HU@@-'$ 3#R)S;R-3.
MU7Q:5U+XR-3XZ!Y)=T74L5"4-07W0K!<*$6&*#3])9<5"D?U&87^FN>-:.-O
M1UM8C19G@$-ZOJH@M<?>6@;Z%FSW'2Z^;J5FS0A'*\M4%.Q6<!AA694;35;O
M-\1)E6NA:HJ?&P0,+A&4$H4L:X6H4?P'0EPV%7FO;E,7C#8ZT(PQ@]:8O+AM
MXUTUB__!$;1C+'?*2JYD@92^O:/9P#TFEH@;UM;";;6%9W*^5<9'Q!0]D;(H
M"F[&CB*'WP"7$-/*9*5?E[GE5 GS$,BR$'#&?HIV0;L=&,#&W9C8UA >^[26
MN7;*=V?_3G#*FB(8CFJ,]*L2&A4[!MV%AU8HK9LFZ1FQQA/^_5!J,@&*$Q-
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M]%#6#<+8N1B?:-(+,M2O$FTQ=7W?XC ,B:8]N^]]84#GWOG4F_7S/=-:2C6
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M))W6+U'H_>B=A$'FA]G,.[43&J=^&&;=))WZ:9#B^!7CBMPQT2*_XF^L'UA
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M=#(U+GAM;-4]:9/;1G;?YU>@%&]*WN)00^JP)1]5HY'M:,NRM!K+JE0J'YI
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MJK%BS:SY^]'8-&A7<?)B?#42F8GN3;B(0*C)?U&<DXM#][TQ;"1I8 <-D?G
M.5#!@:HJ)1?H@T2=2%"4Q4=KB)Q/S!]ZZX20$*>%B=6STM9T_\1ZZR.'8H9P
M-029.'7 (H@'50>N&C)1;C@";DYL/++Y!2MF#]!^E"0O+P3&.A#ZWC0@049!
M8,L#N?A$_C=D",6*@,2/&!@H'S&SIZY[CW<EBW,KAX3XOCN%;Y)C0KG*8KK:
MA&S"83:9?!$K$I_5>Y/:;^[M)==^3U;#LYW$,N)\%SGP;$%I,HQR$7;/Q*"8
M$<'B;4ZSJ6R4,",_T%N^,S4FR6.C# R:1)(\<S;D/,LT;??'3LT(00_*%(\S
M3UZ?[$NQ@?-R?8X+WL>4SO+BJ[>OW]%?BZ\^CQGD%.:./=*5"'&E"UEPF!W,
M6<V1)<D1C"@A1L=&:8R J-SHI&(T\MQ1!5)> )?A=NU. -N;HTAPM;2"83]/
MX'3^5"@>-/O-#C )*C!T*XS[LX_3<7OPJ9-==B:C:X8#K.R:X^*Z)<7KX?HY
MX$^BC'0A?^LHH4 \SJ$C])@N:TZ>,+F%HHVL)'ZB2A$"%WD):P<;7SA&.>S9
M,+9PS6EL@4#QE*W>)>?9TXH. (@!D@0VI# (;*7)&[QFAT02 G:^OBG'?& E
MR;WNZTBQ;!P2BO&B(RB'[A+$H-L!P51TERRV3S)VKN"28=)3GKK /&A]<<+H
MU6#&@H3;WPQ(/G Y.6AWP;%1>3[3JR&F(XEG-6=!L=6LW&N"+:KSO 81EX'J
MJI-W>^*+G\HY++YX<GZQG"4B7.[_7.Y=FGSY:/FYY\;+ZRO\P'/DE63A-,G&
M;XK<24HMR"JEO@8/Q9>JS$AO?!7QA&BD[->6CB(""!6D+$:%(63^L3GGZ[J.
M/B>(5XDJWW[$]!3EBZ(50/"T55_4"4DK[$"R+D/MRT2[@2L F]5:=B^   KX
M9QV$*#,>:"+@@F/B"Z[91%#JQ2 ODB6>7G!%%GL94MP%G$])@G/=XO6>?CK#
MU]B_:\ADWMJCY!,_(NO^-+ 0UQ)6K SI.?J7A%6R;EP%8X$5>X"\D#P6X8\5
MQ"<IA^->0H(JZOPF R>?)76+1@59,;NR.,<2/"[\D& 12<5P"R1$K=0."&HE
MKEH.&-B2^4NH=#RH24+3UD0?((.C% %%=M,O,\+0F!IA2C\F,NWVP5@[:!U+
MCVB)29A>Y\R"/MS5#;6-6F!>PS ?B=33:I:70;YOB)0SJ9,A,1=NB)_O5OH!
M>6T):4<L\SM1K[5PJ^2MRRZU_%%PIXRN4/6VF*Y5^QZM^5]4ZWSOL\TO0Z)]
MT"+[TZM2B4?X9E#T/B_A/UZR?G]Y_=R+5:2]S*Y)]\4>B0_H<-DAAW"8KDAU
MK:S7W<29/LP&?X.I2YXI^0]KTE]J-!U9VQ2H0!I>=::UXWNNIX=#4,P%+?$,
M*V[!I@?>]E4%)*9-$[;S:Y/7(IF,O%,\#N "0X$@ET5  C8.]R(5R]M+Y,CK
M12Z>0621'%WE#G@WPV1$0-/6@8X'WCMJG8!48N,!N7*#JL? 2W&2/I2@7KE"
M Y6$D2OV+<H?4#2HCE1W<Y$KV2PG[[9%[VW64GP"O/HX\H6G"'#R7==2Q9AC
MIH;#V;P.'0-=R)44)2/\C)AHT6=G1#]/OCK[$1=(%L^2O[<E\CG=J$0T*>3"
M")>P+H7ZL'!6#-'H\C ]=++J\EGRNG=0+K"BF(KL+7L& ?Y;!Q3*8HGU-+CM
M[.0%5WB@.TI,#H3V.L?%(HSA,]&EH-XV2'18HU*5I+.XNB=Z2$@12,TPD.T*
M0X<2,6 K'RP+KQ"V]FYH>_@L>3= (1Y.3"-RR1S  TLT#'!1*D1T4"<IBO!:
ME.T6<Z ;!AL',+D<K#Q*,&R_*2M-)4K<'-?A>*:CLGRE7&_Q4KI24X9UPT3L
M:=CG\*8!CK@=%=9ID1<S8T/_BX$\J1+SJ%&%3#(&I E5+)D*1&_F$5Z&8\Q&
M2J_ZI9)RA[<@@PVCX36CPDKE$+Q(X:G8LR4[1HRCS.\<^[<JF0V&-W[N)U@X
MIRBH&SEB"-/$^,<D/M^*PRXD($@MLG92$)LYMJLDNX]IFR)L,4AI:OA4-N0!
MX EI1CE-"K"]4&&9&0E-MA5N*V"8C-&$HN7%=-'Q55F 3<(%'V\J"TH28;W&
MVK[D/056AO/"?WI5+36FW@?29J '4.Z0_760AZAN$E,<;4AL8@9A1RE,M38?
M/YE]^<5CKHXEK%UCVTR=7"$->D#V'A J7>3\%ED XC))>HAJG9\\DC:G0KP:
M?CKY[/'\PM>>2+F.KZ*V% >@4";&-="]? 1,#7YKYC@^"UN@V5!*Q+.W ?OL
MV!6B+BQ' #@LLF]!^:?H<-B*NG&DA6G\B()&>8;5J!'/HOL,IL8%MK!J32)C
M2,1B]%,6/Z"OTBVS1A8Y)Z<*XXRQ681K=5T0*F1->W&JJ6,AW5#+77?;QNZP
M#E-2U0U7O5J3C55.HPG"X9M>VM.T#8@"GZYI'7^GL4'=-PU]G;'5%H=G*>B>
M@<=]4@<[3]Y1DZ"*>S9OM<NIS#6S%R1)"<(<(T]"%/)<[+7D[K=6^@UG4K!=
M!>.7>_OX'<%$U 8WBFPTPDCTI8;K?:BR*[,[":EZLCDEF9@^HCIHQ%% %89P
ML(*S0Q.:=*!VE)#6',Q[G;AEW7IY'Y@+[7-<F,[EF.(?C^><7H06/BP82&RO
MW!)Y_"GEI") 0'X\C O4U"_4_C'AL<H&C7J'BU!\]OCIEE.2_PE6PVXP'C!^
M^/>:;_P'29C$_2E!R">=$(0HM3W6@X(.Z$)"A%L*,D/NP?BJ0_(8S\GZ8E73
MPUV'3F=LF*VH;B[N,RRL>*/1%4_JZ] ^LYCN=-&2Z[=,;6-MXW=<Y7U$MKZP
M;D <8@R40Z-/+IYT(J/P;W7A9]UZ\*MNM^:5+Y%]?8.U?/9 IJ/?5$/MQ-[X
M/E +.)@U%3M0X9]N&S[RP8/A8O+^"[I=2*\4LAO7V%*=$QIJ4>&@N"EAV9QZ
M8S<^/(]PHIV787VBQ1:YAG+^NGV\V,G^PF2*!,& J#_!'LE>FP<>70&+)_TS
M]2H>Y7,23D+T1_]P)V9?&+*OM%QFL$G7]^AB\6_*8NRT6W<.AI<'2XGAN@]I
MW!K@#?B3Z^<\"S$4RGWXK[\ K2X 6[HHK[_[.RD?(''VZ(LL%(%&+<(GB^+-
M_7S^PC:HE:Y>__+R!>W362IJPRAZ4$47T .,25<@ZP/#C0O];;ABQ+<T@H)&
MXZ.*F:I[ (\ KOC W2CFA-_OM\<:"-(4% >5=$ \QB 44FCE$Q'$V/VSC,TL
MIL0K:@0RI_MSI A;/[7X0")S(8O$G;^6:F0[#3!2T^B[:[BQVK?B@,%99><8
M+3OB8B4B\;+6=4-M0:CIEL?(?+E!F[!#\1B!QUA>9=UNU58U&R,5]\%C$S6<
MF7FHWJ,;&V(T!^OKN)/AEG7NO?<Q_JC.>2!!UWM]%MM*.J( 0\E2".W7[523
M4\K9"X)N#[#>&3O.'0!ZL,?9O*B_7.<:I-S]WL>9U]F*6,:^%HY@> 'L 0?K
MR7R!=L4,U'0[CS0'AL,Y?&N!A\AP<8@V*6!MK9^0P$S5X0JNJMPD.OW@%=%=
MQ1)1:#2Q>U>7F:##FL87>^)#@CKV@*AN#3[@0@F2%M+F+GE87%)E-YC'.5,3
M;!-U2= X$]_2*R,BC-*;[X0/H*3'-(\+<,2K OD0S&&,C(7H!I8!43<8[85-
M:K+ZZ30$M:9$E-G3)DNN2'OKA;:W.'PNMMMO'J^)N# G>.(,-V%4LOG=4)IT
MKR+S,NSA81DFP46&<5-*:)?D5PY6")5K"/GZ)'=]"Y('*5^5CU1=TJ2@=>E1
M2DWQ4IA#WM#IT(?AX0E4'Z+*FDL:.WGS%?85Q-T-G#@")(/8*XY SY&WT5$0
MXW<@&34MWLK4CH_-AV[6S3KR)118P64TKT2%6*C@;G1<S^W8IL89\3"HGM-M
M2RR;E\H46+-L)-/C%TNDV)>U2F2WZS6Q%!C2_\&@ZN=C,6?$=<#22(0'P)0/
MAX-Z!F6[!USST;P5&4DTD0,4PJL-^C!A0$=ENU1-$EZ@Q)  +>QM(I_9ZO8G
M]&]O%IJ0@D$?J03B+YR)4J^-GPTR,HTEI)8CPZ YE(JXT2DN8<:,3V]V6G($
MC^$JG@U:4:PP97P/)B4ZK45]?P79D6SB"-S103.?>B,O"Z^@.!1/ 0->HLOE
M6@F+:46_ !ILQ/LHN1$:(B\X(24;A<$PU!^LL<!,'@G]RQ[" U<,F5B,@E1*
MM^?MGM4#QUDZ)5TE50HS.?"I!J0N ^)N; A<*(CZCC<.V/CQ2\R3%Y%'0K5[
M':,61XI$)O6)'1U[,U'9"N[AROW6P 6GMFU.C/7#%FM+[ ?T8F40T:2?%H\3
M(Q)33T2AK(-HC>U? 'R-->PD@-1+E,2,X^[/1L5B&>=-@WN@[<ZOWKY0'U:#
M.O'9O9CUQJT_;9B5AC*?:AW8SAL>I=1TNAS9.H[R-*939@P?8!P7O#7@;)XB
M)?)I;2G/&>J.:8<L9F=^1*=!R6RFG0-B:<K"<[EWNL,W#/[(U:O$EMX$S,\#
M%^/LNS&6GV$+E^6L0NGC671\\<-.ITMU"O<#39;^CBF&/4Z >B71Z4 Y[!R1
M"HD@]&/D4AW*QXVK9:P!JC(_EX$';<C^>%-Z^L[*#%.7V-C\$[(^4H"0(I?,
MG6Q8L"*)0(F@G)V2'XE@/B?P35'[<M'HQE%6ST)% Y-0D?Q:.G:D1"6#Z>@:
MJBJ3L6^.&U4X"L@1/Y)C@_B;4_]_Q0W"31=%FB#/'!H#:1/G+LDF_]A$<5;I
M\^6H!I>12>>R5I+0'!8FM&'BHM:)(>H,2 GR@,@J8AD?DN'Y#I'@H*KATZ")
MA(H&%69E!WC1JR"I :3]I?4(ZZ9]4Z\T*$N7">LFY/QFUM&%OJ8K2KQ%%M@0
M8,[7AY&GBGHY(K? AM]]Q )M*=\Y3@L=?)-CW'@AOI=4)[Z%3K 13WF>_#+X
M>1R</Y%:HZ(*#QCW#*AC135#TJ,DAB4WA6H^?Q@T,A+4VZ=:-9S1PR6? -**
M;7DVB..B J20JC94>A I_ZKKN/U.'8'HC<*58*%Z1=VP/*POG"F4KP2GMV,R
M1?9!R:G_W)OGML!9FB0TR ?PM$-"C>OH_&<LE[6SD_M4I 1 F+:OP[S'$.E"
M#WL'3VA\II)1GR>O_#,^%-6IJ8E;)4_EN$^:*6(B6B"[Z@;D]<PO%5-[!,S*
MLCC8XE TO5MA?5U$S7RI1'\AU>"4$)<FN"$Z#&?"]_VF7!%.Y:/=HK"8=G3.
M(%FZ._.!29C*#SJ-;+ZSKTZ=! EF/H0YZZ D3*IT]8?^ $U?)<-374X&M"7Q
MN#/!UNB%SV5^*49,C]IWK=5BWDFEH@*3(Z)JRQ&:8!"-.0I.@M,:D-*2)(\5
M;U)CCW7 FGS8Q1G)!%X 2[754T-H1(E&KD\GO!&5.T;<Y JMCZ,U?2'D00)0
M*,+,,=+1O/R(_\1R2YW]0JJ7Z-T&_]*RN\YPSRU7L#1;K W#6#6XADW=16?!
M,Z](R$^:83^'JD>9*5%'TF$P2:&^)%LTTI1!@H/2R6'M:ZY+5\D\<)8(Z4P;
M)P-,;^&;.^6(EPNFB(\V;7FNT$B_6PZ'*N(J?2DC8\E8CVF.2'EAWE\U5U4>
M32ZE;\5QXAV4;/YA'7)RDEL?R"WYC@XC3?XDG^^[SX5E>0."B*4QDM5])]^/
M))H 'F:16B;(80A5K[UWN"-5#E,U2,A,^8\XY($1@?L4M*MTLIA^_OED6C8,
MD5O<.OV-[<GG,EAK,"G[B6MTR@'CENZ9#S6C5\"(]0EU+TQ8XT0SB#2ZU%$7
MTU$E;R=WRBC?1PG%?AS1QZAE<,NI)2L:0>.T- QL1 HK(8I?8+/8I"_0GN^T
M)WR5;,L#&D/$;%%W"];32)B:!-"Z$Z!AT2&A#'8*.PE@06AL0(^3;^T3/BQE
MI_!#U:ZA4"H*A6,;6VIJCOY(R '#OYV,BC]#6I;8<&-HL/0XT72L>0U,28UU
M"$[%_4I9(*M>]H\"L<+@2G*4<>&"WJ"N? 2X[=)?E)<\ 70PO$6BI6ZQV89M
M3;RV@G-6Y:IADUDT96P11Q4&TK^WNFV2SC+,(%M.3P^[IL'3S^GBKB(W9(C]
MIY<:;GH=6S^Y'IEX'31%YU.M0"*.I*(<\>8D7:[37OD[&AM '3/<R :,41[5
M8T>*]9_ '493"9DOZ$69_=TKS)95^\D&WQI#ZK;&L4BJXV7*M)9V'["59 :&
M0NL+U&\D_,]/SD8;<*3L:ZV91$#'VM+,F+J?6AH]1P>!<J#@_#W/3?KA_#K=
MEJ3UZ*ESM.-(7I? 0Y.=/LLP^VLY/;_K,J.J+-QXD-SN_'82_\T]MV,M<O/.
MLW[4/=4G?K9<SA]I =8L^6SQ:/ZX.[?M25R@):64TS83=7]RQ3.6V75&MDTA
M,8S"6DY/L+J2F;22Y1Q$Y">MD.B_0SF5,"3;O#H"5P:JS9!F:RQ^R\]5G'JT
MW@_Y6A!FIJ(HTLH6=JV3K<<&WW^.,_'=?L_SP]$@*K(\OK)99RZ7!'XB"\K7
M-,N7)T/"08JF,K]%4P \>WX@)#X0*O2ZT >]Z#<WAO?6J%IG%%=W/ETT&RSR
M-@=.0PWZAGHDR.T,.=<H7"H-EE=W/OF)&24XGDDG;!Z-(@H&R$ETYK8*P668
MJ[2<'H[T-IZ %V=?OI.K'Z3Q/[EF\G9L[IXGYBC-,#A9D+ ^Q0X]DIV-TNML
M[&H]-%QN),:M*AK]EJ<TQ<,)N#OZEA,J@_>)1L>6]<+J.$@Q-;YEW+,,M^!'
M]5 E?8&*F81 1.6=3$D((D>K1>BN4Y.K3,"?S5KGY4$I/7H#V=5/>4TNO2]*
M07+$RTF=]>3D18_5*?(.8WB6TR-TKHT*&Q[ZCJ>9I.P_OEP2OMSY+WOT' KV
M.*4^)LS]# .^4/)D9S[K%PT:CGX98Q8VGG7KKF:^B@[3SJ%"T\_ B6_ 0\7V
ML=YR@,:7F<AL9DV-:ETMF>H:[->\BS^9,@EVY5<%%6@A/6FXU Q8#+/@B'3A
MAQUWI:04PL,:?=-?/XF6*0OPK\@/D/Q 93"^V&'T,3$Q29%AS,UR>LS-2QYU
M_S/^6LP@!?Z!83?QFLG+Z.=H!O)4H>PBE+K+?'R0U>)]PLNC/YG4;6Y7PTQ_
M.09>1%*7&C&L^ )G8=4V.M>#'$/ZB1?^7CN<M79QZN>5!MOX*!'E1]6,_L03
M94Y]3!C!7''+I!8J1_-R2@GST6&X:8MVAK.2-S&GWG:A0AUN+%9PU')-+NC0
MR.-L ,W:7,#YGY,"B?##"W>]H7B>8 ^U_>Z9R"&QA>&=80.NUHR!015$1X&O
MI4V7J$V"+#PGTT>M91:];[2*+UY]ALXQ-2) D2!L\<VD#)5_W0L'C-T! =*D
M::(VJ7":KA^IG:+L,Y(,TD=]+Q%!RECA!E;T"@?AJ+CY&67[FN8F86#CID\K
M:)93?Y2*4"XA))W <[9.@N]-A(-U](-3"?UL39CZXM:"\_ Y%],.3$'T6:8:
M9*ND$/?D_)N='X<V)?+"D(GE]#B(GP 5/R)3O0')0Z&(Y/)$+-SEIP,QI+'3
M8(:TI U*T/\U:'B8=9[2KZI0#"'EGBK<;J^_6]B3B7?:3GNDXNU6R%)2#N7W
M^4>N3HUY]).E-CLW5!\=%]&&%MI.!Q>V'FIK;O?'$J1:Q^6M3G7_9Z'&U3H@
MFN*+&T<_CB4\A,(AGF?/$#G^C;5PCO@72L;/U!_#Q<EHDL!';8L4#8O1XGT+
MH->V]JVQ2C)D+0WUPF&:/8HB^<@:!K+L2$1.NO1#>GGT:/@C?='O4GZ4K+JO
M8HO HP:!?_[MS<*\2+DQRDXW[EPOZK3_&  13WFB QJE_=]:D($8'O**7TWO
MT) :]<R.=C)2TW:,4N[U4.;/I/T/)0!Y./\*DN__T"91XJ$\I_R+IKQ]SEQ\
MC+TIG#9E1/585)J3QJ,-(F*Z#3V2:!U=[:7,IKTA/Y&EF*7(D_1J9]AY*:8
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M=(F']A[]UFLG+1DS>*W$9U[8:AG, RBP9(VP#VKW)W9Z)@XO5\+X+^RZM5$
M>6.LJKMD8E!SV8[L2]>'GTE(NH3$\VX+>98WS++50JL=:+>:T)SAI?IL(L>E
MVY1'JRG**<^N;AG7\(F)!N$.F6DT4L>M@7=/+!-HWB]"2U7<VC#O$-<M8G(&
M,4[@3DE;&?A#%E@< X1$K^>8[#FNDS<1;S ?01H/(8F2^ V\M-><>KSTQYIO
MN,F%<K(-_'V5&:OIF/SS1HUQ7V/L:XS/U'AL#SFH$FZY9#+G3,"5,4B]9;*
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M")"')P#Q'A [W7T@I_*&&;:<*[FCRGHCFS5<J@Z-XKBPBW)O%'[EB#/+&ZA
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M5CNN21O12'"I.FL,3K9$RI/5>"K1SJ[_!$S)\(MGL:G!3):!15 Z"O(]P/4
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MEP$S?8_W >K&]]5!(W6IGU;T+(!Q";1?:/H+0^!:=7QHTG]02P,$%     @
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MI4.GYZ $UJ3,U()O/T.=4,?PQ3R3]A=MZ[.^@^)2*I[78!U!3EGU3^YK(0X
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MA[^RH?BA.#^MN-*GL>)RKP_,5)@ W;_E7#TWS)&L/H+/_@!02P,$%     @
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M+PS4]VO&Y/-#<7M9WU;/?@)02P,$%     @ [H-/5)/C[>A) @  _@0  !D
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MJJ83N :H]PEC\GF@VYJVC5W\!U!+ P04    " #N@T]4_C(&4EP"  #"!0
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M329:542[:&1S U],CT;Y3+JVWUF-NPQQ-OFB5%XQS@F5.;F6ELH56W @,V/
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MN>?<XW#LQ4FJ'[H$,.AGQ85>!J4Q]5T8ZJ*$BNI;68.P;_925=38H3J$NE9
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M    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;+65WV_:,!#'_Y53GC:)-C^
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M[IX@QTD2M3N=9N*X)H[?OJ]K>^0::&LMHE$\-73.=(W3)]@(;C2LK.7K/*Z
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M0ZNH8 _3'MSDTEK8<6<[+4C[XW=VTE"F-""!1!^:V+GON^_.9Y\'&ZD>]!+
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MZ+\3($R ?K_B7+W=F 'J/RBS'U!+ P04    " #N@T]4+,KNHF\#   3#0
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M5OI. V$ >K_@7&TF)D!_2R9_ %!+ P04    " #N@T]4/!Y]H(\#  #4"@
M&0   'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6S%5MN.VS80_96!D(<$V%U=
M+,MV8!OP98,62()%W&T>BC[0UMAB5R)5DK+3O^^0DA7;T1I&T:(O-DF=.>0Y
MP\N,#U*]Z S1P+<B%WKB9<:4[WU?;S(LF'Z0)0KZLI6J8(:Z:N?K4B%+75"1
M^U$0)'[!N/"F8S?VI*9C69F<"WQ2H*NB8.JO.>;R,/%"[SCPA>\R8P?\Z;AD
M.URA>2Z?%/7\EB7E!0K-I0"%VXDW"]\OAQ;O +]R/.B3-E@E:RE?;.?G=.(%
M=D&8X\98!D9_>UQ@GELB6L:?#:?73FD#3]M']@]..VE9,XT+F7_EJ<DFWM"#
M%+>LRLT7>?@)&SU]R[>1N7:_<&BP@0>;2AM9-,&T@H*+^I]]:WPX"0B35P*B
M)B"Z#(A?">@U ;U; ^(F(';.U%*<#TMFV'2LY &411.;;3@S733)Y\*F?644
M?>449Z:?:6=]E%K#$RI894PAS(Q1?%T9MLX1C(19RDJ;')AS:7"3"9G+'4<-
M"ZE*J9C+WT(6!?TYADSF*2H-]W:T)"*'D%LP&9$PS3? 1 I+GE<&4[AA"5WL
M;Y=H&,_U.YKG>;6$MV_>P1OP05N0!B[@67"C[VB0VK]DLM(TJQ[[AFRSXOU-
M8]&\MBAZQ:(P@D]2F$S#HT@Q/2?PR>_6].AH^CRZRKC$S0/TPCN(@BCL6-#B
M]O"@(WQY<W@XNJ*FUVZAGN/KO<+WR)3@8G>:O]]F:VT4G>G?K_#'+7_L^.,K
M6S2W^X/]@XW9E>YZNKZ;SEZ+^^E]% RB 9FQ/\U"!RZ,DR@:G..6';ADF 1)
M"SN3W6]E]Z_*_L"X@CW+*P26_D$W 5VVQLI6F&)1NC-5?Z;+'U:HK/+'^Q V
M4NQ1&6Y=HJ=@BXHB@&Z2S0M(%]=U");U:I)3%:,D[M:0M!J2_RYU),2=>GUR
MZKO2F=R8S@Y<9SH[<,FH/PBZK1BT5@RN6O'5O4"8WC-*#CVHQWNJTI0<[L32
M54GG",31M)+.DT/]:_;=V3>RN7[3^OKM<G3PPU8(XZ#7CT=A_\+3#F0OC,(D
M3H87KOZ(3$9ATN^=4)[Y.FQ]'=ZVQ?XWM^KU#<_VU4-\H7_1B0K#"Y<Z44%X
M89%_\MX7J':N;M(DH1*F?H7:T;8TF[F*Y&)\3B5;76%]IZGKO4],[;C0D..6
M*(.' 9T'5==0=<?(TE45:VFH1G'-C,I.5!9 W[>2O&XZ=H*VD)W^#5!+ P04
M    " #N@T]47^T<9-$#  #.#@  &0   'AL+W=O<FMS:&5E=',O<VAE970W
M."YX;6S-5\F.VS@0_17"IQE@TA*U*[ ->.G,!$@R1C<R?0ARH"7:(IHB'9*R
M.W\_)*V6O,B"#S[X8DETU5/5>ZRB:KCCXE46&"OP5E(F1X-"J<U'QY%9@4LD
M'_@&,_W/BHL2*?THUH[<"(QRZU12QW/=R"D188/QT*XMQ'C(*T4)PPL!9%66
M2/R>8LIWHP$<O"\\D76AS((S'F[0&C]C]7VS$/K):5!R4F(F"6= X-5H,($?
MYS U#M;B/X)W\N >F%26G+^:A\_Y:.":B##%F3(02%^V>(8I-4@ZCE\UZ*!Y
MIW$\O']'_V23U\DLD<0S3E](KHK1(!F '*]01=43W_V#ZX1"@Y=Q*NTOV-6V
M[@!DE52\K)UU!"5A^RMZJXDX<(#1!0>O=O!.'8(+#G[MX%_K$-0.@65FGXKE
M88X4&@\%WP%AK#6:N;%D6F^=/F%&]V<E]+]$^ZGQ-[VUOG IP0(+\%P@@<%$
M*4&6E4)+BH'B8)*CC1$'3 E7."L8IWQ-L 0S+C9<(*O?C)>EOEB$@M,<"PD^
M@!=+.\X_3+98Z&W4F"F>O8+'7Q79(HJ9DF"']9L?WS):Y3@'GP0OP0S1K*)[
M>+X"<T(K#04Z(OYCCA4B5/ZI7RG-BAPZ2I-C4G2RFHCIG@CO A'0 U\Y4X4$
MCTR'< S@:%8;:KUW:J=>+^(<9P_ AW\!S_5@1T"SZ]W=#O?YU>XP[<G&;S:*
M;_'\"W@3IDAN)# [X1EGE2#*;((3S7BYT3O':O;O"CPBP0A;'VKUXXL&!I\5
M+N7/GK"")JS AA5<$Y9LPNK2?P\462#3#K=CZ,=I"F$\=+:'NG081I[GAD%R
M;#@_-XQ\/XZA[S6&1TF%35)A;U(SSG2]*&(*<*'[(!9"$VR+IH>RJ$&/[DG)
MN DKOI&2\_B,]R"";A!$:3?O21-"TAO"WP(QU9-*VN"D]\0P=-MF[]ZJ6FJD
MXW)QT]B/@Y-RZ;*,H!>>UTN790P3/PRB;N'@P3$&>S/[9DI&FO/A25\$R=1[
MQ8#OC"C91Y_7OL2[*UW;W@S]F^GJGS>MU(>Q?ZKJN9V?:%5/)3TW"]+P0O^#
M;5>'_6W]Z#OA!0E3F+T:MJT5AG>E8=N5870S#:,STI,P=D\5/+<*HR0^4[##
M+$PC>$'"MIW#_G[><XA=I6C;M&%R5XJVIP!,;W6BU4B'(GB)YP8G(C@''_HE
M%FL[,$F0\8JI_8=IL]H,91,[BIRL3\VP9@>(%F8_Z7U%8DV8!!2O-*3[$.MR
M$OOA:?^@^,:.$TNN]'!B;PL]<&)A#/3_*ZZGA/K!O* 98<?_ U!+ P04
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( .Z#3U2H%Z]@JP4  "4T   /
M>&PO=V]R:V)O;VLN>&ULQ9MM;]LV$(#_"N$OZX!MMO7:!DF +%F[ &D3)%F^
M#K1$VT0ETB.II,FO[TF:UY,C'_;EXD^.7B(_.I'W'"GZ^,FZKPMKOXIO=67\
MR60=PN9H.O7%6M72_V8WRL"1I76U#+#I5E._<4J6?JU4J*MI-)METUIJ,SD]
MWE[KQDWQA@VJ"-H:V-GN>-#JR?\XWFZ*1^WU0E<Z/)],NK\K-1&U-KK6+ZH\
MF<PFPJ_MTY_6Z1=K@JSN"F>KZF0R[P\\*!=T\6KW70MY+Q>^VQ/DXE8"R,DD
MF\$%E]KYT)W175\"XZ."D_NM)MB/N@K*7<B@/CG;;+19M9>!NYBBV^CBL/WL
M@WCD_D\8[7*I"W5ABZ96)O1Q=*IJ 8U?ZXV?""-K=3+9GB*D*<4?)D"0Q*7I
M+P7GMG<*7WU9]G<= !?%T!UI.. NRPZ<#_(<MFVE2_CV4OPN*VD*);K@>@08
M$8#1P0#%NQN)(&,",GY#R+L6HOT'+^Q27&^40Y ) 9D<#/+<UAL$F1*0Z0$A
MS2."S C(['"0TJ\19$Y YKR0UVXEC7[I#G0IZ$+YPNE-MVV7"/(] ?F>%_).
MKXR&<R6DR;.BL VD2;,2-Q#=0BN<@CX0D!]X(6_5HS*-P@E[1F7L&2_.1ZF=
M>)!5H\1G)7WC^M:'\4BA,!OETCPJ'UXA40J9,SL$2AG(PJ#?SL3_-'K3_L,O
MXHL*&)$2R)S9()^L+9]T576(EU IF55+(,Z\'ZIX3AEDSJP0Z**N@9QWI657
M]0V[Z)SRQIQ9'!=JJ9P#MI'>2JEBSNR**^BBPRA13I@S2P%$7^N^<W8M#4S6
M)EQE=K+MG'+"G%L*:^G4VE:E<OZGKK^&9\Q&J6#.[(*>!GIH >?!N$/<0$4Z
M*)4I-43,:OBL81SE[3+ @ZTJN;"NU__9RBFP!,:D%!&Q*Z*PM1+W\MN@T47D
M,(/9$> "<66]%S?*B:X%BK,0G%XT,/RL!J&C/!$Q>^)6!=T+OVMY&(L20\0L
M!K*.^SO"F)0D(F9)T)@QQJ2<$3$[XU^%B7?W;=/S/V,NRAX1LSWV5)Y;3HQ)
M^2-B]@>J0$=#2/DC8O8'48JVK'@Z@Q))S"P2NAP5&),22<PLDI%Z=.R)QY18
M8F:Q[!:FHX#DW!6S4OH*=12+4DK,K921*G 4DA)*S"R4\7)P%),22LPL%%QP
MC<)15HF9K4)67H/:(::L$C-;A9Q/&V)2@HF9!4.7. F>BJ8$DS +AL9,,28E
MF(19,#1FAC$IQR3,CMFJY5=Q!U<K&S"U7?XGG N,29DF81^\;#'/RE*WAV6%
M7HEA3/(]";-Y]I6Y$-VFKG&-EE#N29C=@\O<X8,_>Y2ZPIB4>Q)V]V#,5P\>
M8U(62I@MM#^:GQS("6-2%DJ8+42-'P ;8U(62@XXS(%&@-\U4A9*#SG,&3@]
MI2R4,EN(QL33%BEEH9390C0F+CU2RD(ILX7&!HVHQV-,RD+IV[]KP?D38Y+O
MZ]_XO<M.\L28E(529@N-8&(584S*0BFSA4C,84*B+)0R6XA\Z$-,RD(ILX7Z
MF8T]U:;!;3.C+)0Q6VB+V567[KE;-136,!A^52%EE(4R9@N-8-ZJPII"5Y":
M_L*8E(4R9@N-SAO]: ,8D[)0QFRA/9C;X&),RD(9LX7V3'!MXXDQ*0MEAYF'
MV\838Y+KQI@M1&(.\F9&62ACMA"-B>O-C+)0QFPA&A/7FQEEH>QME@SH<4P\
MU953%LH/N79@T#9SRD+Y&ZX=V*DU=U:QYI2%<F8+$9AM\80Q*0OES!;:P=PM
ME# F9:&<V4)$--L2!&-2%LK99^3VM\WU8+%&3EDH9[80_<(%I_><7+]\T/="
M.+WGE(5R9@OMK,C9[448D[)0WEEHVIWL3X]+M=1&E5_@*SSL+V15W#C1?G1+
MX*(D;9?!+9NJ.H=]U^;*RG+[*Y?M+W1.OP-02P,$%     @ [H-/5+M)TM]B
M @  M"X  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W:2VZC0!2%
MX:U8+""X[JN<5IQ13S)M90/(*3\4VR"@U<GNVW(&]D$]Z$G$&:$"<?E'GU#!
MTZ]R;,9#>Q[VAVY8?)R.YV%=[<>Q^U'7PV9?3LWPT';E?+FR;?M3,UZ6_:[N
MFLU[LRNU+)=1]_<SJN>G^YF+U\^N_,_$=KL];,K/=O/[5,[C/P;7?]K^?=B7
M,E:+UZ;?E7%=U1_'V^FAOA[2PV5RM7AY6U?]RUNJZKF#!()D_B"%()T_R"#(
MY@]R"/+Y@P*"8OZ@#$%Y_J 5!*WF#WJ$H,?Y@](295P2)$VP)M Z(=>)P.N$
M8"<"L1.2G0C,3HAV(E [(=N)P.V$<"<"N1/2G0CL3HAW(M!;4&\AT%M0;R'0
M6R8OVP1Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'HKZJT$
M>BOJK01Z*^JM!'KK9+.$0&]%O95 ;T6]E4!O1;V50&]%O95 ;T6]E4!O1;V5
M0&]#O8U ;T.]C4!O0[V-0&]#O8U ;YML=A/H;:BW$>AMJ+<1Z&VHMQ'H;:BW
M$>AMJ+<1Z.VHMQ/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMDX^5!'H[ZNT$>COJ
M[01Z.^KM!'H[ZNT$>@?J'01Z!^H=!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>L?D
M9Q,"O0/U#@*] _4. KT#]0X"O3/JG0GTSJAW)M [H]Z90.^,>F<"O3/JG0GT
MSJAW)M [H]Z90.\\^5F00.^,>F<"O3/JG;]3[V'\/);AUO.UAN>OOI/J\7)O
MN3W^NOPZB3BOKCC7]Q7#\U]02P,$%     @ [H-/5-TG:PL8 @  A2T  !,
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M_2?'S\]Z<-WXDL_F?U]?_P902P$"% ,4    " #N@T]4!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M .Z#3U0IJ0( [0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( .Z#3U297)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ [H-/5.Y"
MN5'@!@  K1L  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( .Z#3U240KG?+0<  %,>   8
M  " @2(/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #N
M@T]4'&E,FBL#  "V"@  &               @(&%%@  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ [H-/5 3K0[F=!0  WQ4  !@
M         ("!YAD  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( .Z#3U2*Z7J32@,  ',)   8              " @;D?  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #N@T]4-)(<BY0(  !K+
M&               @($Y(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ [H-/5'_B\[>)"   #20  !@              ("! RP  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .Z#3U1"@OMAM@4
M !0-   8              " @<(T  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " #N@T]4QJO/?*PE  !I>   &               @(&N
M.@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ [H-/5(TT
M[M#:#P  :"X  !D              ("!D&   'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " #N@T]4$3S9Y+8#   J"0  &0
M    @(&A<   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M .Z#3U19''N#; 8  "P1   9              " @8YT  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ [H-/5)D0]$HP P  Z@8  !D
M             ("!,7L  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " #N@T]4D8,9!;D#   4"0  &0              @(&8?@  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .Z#3U23ZA-T!0,
M (<&   9              " @8B"  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ [H-/5-F4*.^S!   ]0L  !D              ("!
MQ(4  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #N@T]4
M9+I>*D\*  "Y'@  &0              @(&NB@  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( .Z#3U3@T[5KF@0  (L*   9
M      " @325  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ [H-/5!EL=W^X!0  #P\  !D              ("!!9H  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #N@T]4&,93XZD-  ! *@
M&0              @('TGP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( .Z#3U3$1Z69GP4  *4-   9              " @=2M  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ [H-/5*(KVP[V
M"   S14  !D              ("!JK,  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " #N@T]4Y(+X\YD$  #D#   &0
M@('7O   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .Z#
M3U05^P%V_P(  ($&   9              " @:?!  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ [H-/5+FO$DM>)P  /84  !D
M         ("!W<0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " #N@T]4 &FN$7\#  #Z!P  &0              @(%R[   >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( .Z#3U3\;K@$Z (  !<&
M   9              " @2CP  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ [H-/5 [!6A,< P  E <  !D              ("!1_,
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #N@T]4GZRM
M[U($  "Q"P  &0              @(&:]@  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( .Z#3U3*>T5&_P(  %(&   9
M  " @2/[  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M[H-/5')Z>W]D P  C@@  !D              ("!6?X  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " #N@T]49T.0+<L"  #8!0  &0
M            @('T 0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( .Z#3U3FP(AU.P,  !((   9              " @?8$ 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ [H-/5#G<#]!I P
MR0<  !D              ("!: @! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " #N@T]4>;8[!LP"   M!@  &0              @($(
M# $ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( .Z#3U0$
M]2QHCP8  )01   9              " @0L/ 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ [H-/5!9<B\I+!0  O@T  !D
M     ("!T14! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .Z#3U3#3#4720,  "$.   9              "
M@4@J 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ [H-/
M5/EB:8-< P  % P  !D              ("!R"T! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " #N@T]4_Y=18N,$  "Y&0  &0
M        @(%;,0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( .Z#3U20' #AE@,  (X/   9              " @74V 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ [H-/5+FJ(RZC!   N18
M !D              ("!0CH! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " #N@T]4D^/MZ$D"  #^!   &0              @($</P$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( .Z#3U0W2\IH
MTP(  +@(   9              " @9Q! 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ [H-/5 M4)>&2 P  T@X  !D
M ("!ID0! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #N
M@T]4_C(&4EP"  #"!0  &0              @(%O2 $ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( .Z#3U3=9B$PB (  .P&   9
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M970U-2YX;6Q02P$"% ,4    " #N@T]4J?K)#O\"  !>"P  &0
M    @(%J60$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M .Z#3U3:$'Q[M ,  ,(/   9              " @:!< 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ [H-/5 *(Y'1N @  +@<  !D
M             ("!BV ! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " #N@T]4=C#T@XD"  "<!@  &0              @($P8P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( .Z#3U3633J2]P@
M *(J   9              " @?!E 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ [H-/5';HB8=# @  K04  !D              ("!
M'F\! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #N@T]4
M-]).QC\#   <"@  &0              @(&8<0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( .Z#3U0\J> Q) 0  &,/   9
M      " @0YU 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ [H-/5&+$6WG0 @  G0@  !D              ("!:7D! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " #N@T]4MFDU\2,&  "^'0
M&0              @(%P? $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( .Z#3U381H8CZP(  ,<'   9              " @<J" 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ [H-/5#30<1@J
M!   X@\  !D              ("![(4! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " #N@T]4Q( 4F+L#  "X#@  &0
M@(%-B@$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( .Z#
M3U2'_)>JQ0,  !T/   9              " @3^. 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ [H-/5*011"&G P  :PT  !D
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M=#<T+GAM;%!+ 0(4 Q0    ( .Z#3U0LRNZB;P,  !,-   9
M  " @02D 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @
M[H-/5%UW9*>D @  ,0<  !D              ("!JJ<! 'AL+W=O<FMS:&5E
M=',O<VAE970W-BYX;6Q02P$"% ,4    " #N@T]4/!Y]H(\#  #4"@  &0
M            @(&%J@$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4
M Q0    ( .Z#3U1?[1QDT0,  ,X.   9              " @4NN 0!X;"]W
M;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ [H-/5-K\D@^W @
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M2P$"% ,4    " #N@T]4NTG2WV("  "T+@  &@              @ %*OP$
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #N@T]4W2=K
M"Q@"  "%+0  $P              @ 'DP0$ 6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     5P!7 -@7   MQ $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>221</ContextCount>
  <ElementCount>486</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>72</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Convertible Preferred Stock and Shareholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Shareholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Organization and Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness</Role>
      <ShortName>Organization and Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Equity Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans</Role>
      <ShortName>Equity Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Microsoft Collaboration Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement</Role>
      <ShortName>Microsoft Collaboration Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders</Role>
      <ShortName>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Equity Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables</Role>
      <ShortName>Equity Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Organization and Description of Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails</Role>
      <ShortName>Organization and Description of Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails</Role>
      <ShortName>Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails</Role>
      <ShortName>Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Revenue - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails</Role>
      <ShortName>Revenue - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Investments - Schedule of Available-for-sale Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Available-for-sale Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities - Schedule of Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Accrued Liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails</Role>
      <ShortName>Accrued Liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails</Role>
      <ShortName>Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Deferred Revenue - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails</Role>
      <ShortName>Deferred Revenue - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Deferred Revenue - Additional Information (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1</Role>
      <ShortName>Deferred Revenue - Additional Information (Details1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Deferred Revenue - Schedule of Changes in Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails</Role>
      <ShortName>Deferred Revenue - Schedule of Changes in Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Leases- Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases- Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Leases- Summary of Other Information Related to Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails</Role>
      <ShortName>Leases- Summary of Other Information Related to Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails</Role>
      <ShortName>Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Shareholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Shareholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Shareholders' Equity - Summary of Reserved Shares of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails</Role>
      <ShortName>Shareholders' Equity - Summary of Reserved Shares of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Equity Incentive Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails</Role>
      <ShortName>Equity Incentive Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails</Role>
      <ShortName>Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Microsoft Collaboration Agreement - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails</Role>
      <ShortName>Microsoft Collaboration Agreement - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>100740 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>100750 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>100760 - Disclosure - Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>100770 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>100780 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="adpt-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>100790 - Disclosure - Retirement Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails</Role>
      <ShortName>Retirement Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="adpt-10k_20211231.htm">adpt-10k_20211231.htm</File>
    <File>adpt-20211231.xsd</File>
    <File>adpt-20211231_cal.xml</File>
    <File>adpt-20211231_def.xml</File>
    <File>adpt-20211231_lab.xml</File>
    <File>adpt-20211231_pre.xml</File>
    <File>adpt-ex211_7.htm</File>
    <File>adpt-ex231_14.htm</File>
    <File>adpt-ex311_6.htm</File>
    <File>adpt-ex312_8.htm</File>
    <File>adpt-ex321_11.htm</File>
    <File>adpt-ex322_13.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g4bdklltl5z5000001.jpg</File>
    <File>g4bdklltl5z5000002.jpg</File>
    <File>g4bdklltl5z5000003.jpg</File>
    <File>g4bdklltl5z5000004.jpg</File>
    <File>g4bdklltl5z5000005.jpg</File>
    <File>g4bdklltl5z5000006.jpg</File>
    <File>g4bdklltl5z5000007.jpg</File>
    <File>g4bdklltl5z5000008.jpg</File>
    <File>g4bdklltl5z5000009.jpg</File>
    <File>g4bdklltl5z5000010.jpg</File>
    <File>g4bdklltl5z5000011.jpg</File>
    <File>g4bdklltl5z5000012.jpg</File>
    <File>g4bdklltl5z5000013.jpg</File>
    <File>g4bdklltl5z5000014.jpg</File>
    <File>g4bdklltl5z5000015.jpg</File>
    <File>g4bdklltl5z5000016.jpg</File>
    <File>g4bdklltl5z5000017.jpg</File>
    <File>g4bdklltl5z5000018.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="795">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "adpt-10k_20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "contextCount": 221,
   "dts": {
    "calculationLink": {
     "local": [
      "adpt-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "adpt-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "adpt-10k_20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adpt-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adpt-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "adpt-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 608,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 36,
    "http://www.adaptivebiotech.com/20211231": 4,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 44
   },
   "keyCustom": 73,
   "keyStandard": 413,
   "memberCustom": 33,
   "memberStandard": 37,
   "nsprefix": "adpt",
   "nsuri": "http://www.adaptivebiotech.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Revenue",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Fair Value Measurements",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Investments",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Property and Equipment, Net",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Accrued Liabilities",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:DeferredRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Deferred Revenue",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:DeferredRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Leases",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Commitments and Contingencies",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Shareholders' Equity",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Equity Incentive Plans",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans",
     "shortName": "Equity Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Microsoft Collaboration Agreement",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement",
     "shortName": "Microsoft Collaboration Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Income Taxes",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders",
     "shortName": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Retirement Plan",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan",
     "shortName": "Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Revenue (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Investments (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Deferred Revenue (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Leases (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Equity Incentive Plans (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables",
     "shortName": "Equity Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables",
     "shortName": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Organization and Description of Business - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails",
     "shortName": "Organization and Description of Business - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtOwnershipAxis_adptDigitalBiotechnologiesIncMember_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Statements of Operations",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails",
     "shortName": "Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtMajorCustomersAxis_adptCustomerAMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails",
     "shortName": "Significant Accounting Policies - Summary of Useful Lives Assigned to Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_adptLaboratoryEquipmentMember_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
     "shortName": "Revenue - Schedule of Revenue Disaggregated by Type of Products and Services (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtProductOrServiceAxis_adptDevelopmentSupportRevenueMember_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Revenue - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
     "shortName": "Revenue - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapTypeOfArrangementAxis_adptMRDDevelopmentAgreementsMember_20210101_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Investments - Schedule of Available-for-sale Investments (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
     "shortName": "Investments - Schedule of Available-for-sale Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapInformationByCategoryOfDebtSecurityAxis_adptAvailableForSaleSecuritiesDebtSecuritiesCurrentMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Investments - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
     "shortName": "Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails",
     "shortName": "Investments - Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
     "shortName": "Property and Equipment, Net - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Property and Equipment, Net - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails",
     "shortName": "Property and Equipment, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
     "shortName": "Goodwill and Intangible Assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20151231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails",
     "shortName": "Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities - Schedule of Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "adpt:AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Accrued Liabilities - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails",
     "shortName": "Accrued Liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "adpt:AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
     "shortName": "Deferred Revenue - Schedule of Deferred Revenue by Revenue Classification (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Deferred Revenue - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
     "shortName": "Deferred Revenue - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_srtProductOrServiceAxis_adptDevelopmentRevenueMember_20201231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Deferred Revenue - Additional Information (Details1)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
     "shortName": "Deferred Revenue - Additional Information (Details1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_srtMajorCustomersAxis_adptGenentechIncMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock",
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Deferred Revenue - Schedule of Changes in Deferred Revenue (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails",
     "shortName": "Deferred Revenue - Schedule of Changes in Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "adpt:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Convertible Preferred Stock and Shareholders' (Deficit) Equity",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity",
     "shortName": "Consolidated Statements of Convertible Preferred Stock and Shareholders' (Deficit) Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20200229",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfLand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_utrsqft",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Leases- Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases- Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20200229",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfLand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_utrsqft",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Leases- Summary of Other Information Related to Operating Lease (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails",
     "shortName": "Leases- Summary of Other Information Related to Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails",
     "shortName": "Leases- Summary of Reconciles Undiscounted Operating Lease Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Shareholders' Equity - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
     "shortName": "Shareholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Shareholders' Equity - Summary of Reserved Shares of Common Stock (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails",
     "shortName": "Shareholders' Equity - Summary of Reserved Shares of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfReservedSharesOfCommonStockTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Equity Incentive Plans - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
     "shortName": "Equity Incentive Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
     "shortName": "Equity Incentive Plans - Summary of Changes in Shares Available for Grant (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "adpt:ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231",
      "decimals": "INF",
      "lang": null,
      "name": "adpt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails",
     "shortName": "Equity Incentive Plans - Summary of Stock Option Activity Under 2009 Plan and 2019 Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
     "shortName": "Equity Incentive Plans - Summary of Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_adptTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
     "shortName": "Equity Incentive Plans - Summary of Estimated Grant Date Fair Values of Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "adpt:NoncashLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails",
     "shortName": "Equity incentive Plans - Summary of Compensation Costs Related to Stock Options and RSUS Included on Statements of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "adpt:MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Microsoft Collaboration Agreement - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
     "shortName": "Microsoft Collaboration Agreement - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_us-gaapTypeOfArrangementAxis_adptMicrosoftCollaborationAgreementMember_20171201_20171231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "adpt:MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Components of Loss Before Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100740 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100750 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail",
     "shortName": "Income Taxes - Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100760 - Disclosure - Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Taxes - Schedule of Change In Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100770 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
     "shortName": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100780 - Disclosure - Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100790 - Disclosure - Retirement Plan - Additional Information (Details)",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails",
     "shortName": "Retirement Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Organization and Description of Business",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness",
     "shortName": "Organization and Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Significant Accounting Policies",
     "role": "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "adpt-10k_20211231.htm",
      "contextRef": "C_0001478320_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 72,
   "tag": {
    "adpt_AccruedClinicalAndContractResearchOrganizationCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued clinical and contract research organization costs, current.",
        "label": "Accrued Clinical And Contract Research Organization Costs Current",
        "terseLabel": "Clinical and contract research organization costs"
       }
      }
     },
     "localname": "AccruedClinicalAndContractResearchOrganizationCostsCurrent",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AccruedPurchaseOfPropertyAndEquipmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued purchase of property and equipment current.",
        "label": "Accrued Purchase Of Property And Equipment Current",
        "terseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "AccruedPurchaseOfPropertyAndEquipmentCurrent",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued tax withholding liability related to unsettled option exercises.",
        "label": "Accrued Tax Withholding Liability Related To Unsettled Option Exercises",
        "terseLabel": "Accrued tax withholding liability related to unsettled option exercises"
       }
      }
     },
     "localname": "AccruedTaxWithholdingLiabilityRelatedToUnsettledOptionExercises",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AdditionalMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional milestone payment.",
        "label": "Additional Milestone Payment",
        "terseLabel": "Additional milestone payment receivable"
       }
      }
     },
     "localname": "AdditionalMilestonePayment",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AdjustmentsToAdditionalPaidInCapitalCapitalContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital capital contributions.",
        "label": "Adjustments To Additional Paid In Capital Capital Contributions",
        "terseLabel": "Capital contributions for Digital Biotechnologies, Inc."
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalCapitalContributions",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital conversion of convertible preferred stock warrant to common stock warrant.",
        "label": "Adjustments To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrant To Common Stock Warrant",
        "terseLabel": "Conversion of convertible preferred stock warrant to common stock warrant"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantToCommonStockWarrant",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital, initial public offering costs.",
        "label": "Adjustments To Additional Paid In Capital Initial Public Offering Costs",
        "terseLabel": "Initial public offering costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalInitialPublicOfferingCosts",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid In capital share based compensation stock option and restricted stock unit requisite service period recognition value.",
        "label": "Adjustments To Additional Paid In Capital Share Based Compensation Stock Option And Restricted Stock Unit Requisite Service Period Recognition Value",
        "terseLabel": "Common stock option and restricted stock unit share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionAndRestrictedStockUnitRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_AvailableForSaleSecuritiesDebtSecuritiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt securities current.",
        "label": "Available For Sale Securities Debt Securities Current [Member]",
        "terseLabel": "Short-Term Marketable Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrentMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt securities noncurrent.",
        "label": "Available For Sale Securities Debt Securities Noncurrent [Member]",
        "terseLabel": "Long-Term Marketable Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrentMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation and principles of consolidation policy.",
        "label": "Basis Of Presentation And Principles Of Consolidation Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in redemption value for vested convertible preferred stock options.",
        "label": "Change In Redemption Value For Vested Convertible Preferred Stock Options",
        "terseLabel": "Change in redemption value for vested Series E-1 convertible preferred stock options"
       }
      }
     },
     "localname": "ChangeInRedemptionValueForVestedConvertiblePreferredStockOptions",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right, weighted average exercise price of warrants or rights",
        "label": "Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights",
        "terseLabel": "Weighted-average exercise price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "adpt_ClassOfWarrantOrRightsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or rights, term.",
        "label": "Class Of Warrant Or Rights Term",
        "terseLabel": "Warrant exercisable term"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsTerm",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_CollaborationArrangementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement Disclosure [Abstract]",
        "label": "Collaboration Arrangement Disclosure [Abstract]"
       }
      }
     },
     "localname": "CollaborationArrangementDisclosureAbstract",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "xbrltype": "stringItemType"
    },
    "adpt_CommercialMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial milestones.",
        "label": "Commercial Milestones [Member]",
        "terseLabel": "Commercial Milestones"
       }
      }
     },
     "localname": "CommercialMilestonesMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_CommonStockOptionsAndRestrictedStockUnitsGrantedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock options and restricted stock units granted.",
        "label": "Common Stock Options And Restricted Stock Units Granted [Member]",
        "terseLabel": "Exercise of Outstanding Common Stock Options and Vesting of Outstanding Common Restricted Stock Units Granted"
       }
      }
     },
     "localname": "CommonStockOptionsAndRestrictedStockUnitsGrantedMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrants member.",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment and software.",
        "label": "Computer Equipment And Software [Member]",
        "terseLabel": "Computer Equipment and Software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_ComputerSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer software.",
        "label": "Computer Software [Member]",
        "terseLabel": "Computer Software"
       }
      }
     },
     "localname": "ComputerSoftwareMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_ContractBalancesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract balances.",
        "label": "Contract Balances Policy [Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "ContractBalancesPolicyTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ContractWithCustomerLiabilityCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability current abstract.",
        "label": "Contract With Customer Liability Current [Abstract]",
        "terseLabel": "Current deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrentAbstract",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability milestone method revenue recognized.",
        "label": "Contract With Customer Liability Milestone Method Revenue Recognized",
        "terseLabel": "Milestone revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityMilestoneMethodRevenueRecognized",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ContractWithCustomerLiabilityNonCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability non current abstract.",
        "label": "Contract With Customer Liability Non Current [Abstract]",
        "terseLabel": "Non-current deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNonCurrentAbstract",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of convertible preferred stock to common stock upon closing of initial public offering.",
        "label": "Conversion Of Convertible Preferred Stock To Common Stock Upon Closing Of Initial Public Offering",
        "terseLabel": "Conversion of convertible preferred stock to common stock upon closing of initial public offering"
       }
      }
     },
     "localname": "ConversionOfConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering.",
        "label": "Conversion Of Convertible Preferred Stock Warrant To Common Stock Warrant Upon Closing Of Initial Public Offering",
        "terseLabel": "Conversion of convertible preferred stock warrant to common stock warrant upon closing of initial public offering"
       }
      }
     },
     "localname": "ConversionOfConvertiblePreferredStockWarrantToCommonStockWarrantUponClosingOfInitialPublicOffering",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock warrants member.",
        "label": "Convertible Preferred Stock Warrants [Member]",
        "terseLabel": "Convertible Preferred Stock Warrants"
       }
      }
     },
     "localname": "ConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A.",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer B.",
        "label": "Customer B [Member]",
        "terseLabel": "Customer B"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_DeferredRevenueTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue.",
        "label": "Deferred Revenue [Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenueTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_DeferredTaxAssetsNonQualifiedStockOptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, non qualified stock options.",
        "label": "Deferred Tax Assets Non Qualified Stock Options",
        "terseLabel": "Nonqualifying stock options"
       }
      }
     },
     "localname": "DeferredTaxAssetsNonQualifiedStockOptions",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10100.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets",
        "negatedLabel": "ROU assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_DeferredTaxLiabilitiesTangibleAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, tangible and intangible assets.",
        "label": "Deferred Tax Liabilities Tangible And Intangible Assets",
        "negatedLabel": "Tangible and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesTangibleAndIntangibleAssets",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_DefinedContributionPlanEmployeeServicePeriodForVesting": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan employee service period for vesting.",
        "label": "Defined Contribution Plan Employee Service Period For Vesting",
        "terseLabel": "Employee service period for vesting"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployeeServicePeriodForVesting",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognition of lease financing arrangements upon adoption of guidance on accounting for lease.",
        "label": "Derecognition Of Lease Financing Arrangements Upon Adoption Of Guidance On Accounting For Lease",
        "terseLabel": "Derecognition of lease financing arrangements upon adoption of guidance on accounting for leases"
       }
      }
     },
     "localname": "DerecognitionOfLeaseFinancingArrangementsUponAdoptionOfGuidanceOnAccountingForLease",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_DevelopmentMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development milestones.",
        "label": "Development Milestones [Member]",
        "terseLabel": "Development Milestones"
       }
      }
     },
     "localname": "DevelopmentMilestonesMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_DevelopmentRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development revenue.",
        "label": "Development Revenue [Member]",
        "terseLabel": "Development Revenue"
       }
      }
     },
     "localname": "DevelopmentRevenueMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_DevelopmentRevenueRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development revenue regulatory milestones.",
        "label": "Development Revenue Regulatory Milestones [Member]",
        "terseLabel": "Development Revenue Regulatory Milestones"
       }
      }
     },
     "localname": "DevelopmentRevenueRegulatoryMilestonesMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_DevelopmentSupportRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development support revenue.",
        "label": "Development Support Revenue [Member]",
        "terseLabel": "Development Support Revenue"
       }
      }
     },
     "localname": "DevelopmentSupportRevenueMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_DigitalBiotechnologiesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Digital Biotechnologies, Inc.",
        "label": "Digital Biotechnologies Inc [Member]",
        "terseLabel": "Digital Biotechnologies, Inc."
       }
      }
     },
     "localname": "DigitalBiotechnologiesIncMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_EffectiveIncomeTaxRateReconciliationPermanentItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Permanent Items",
        "label": "Effective Income Tax Rate Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentItems",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "adpt_FurnitureAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and office equipment.",
        "label": "Furniture And Office Equipment [Member]",
        "terseLabel": "Furniture and Office Equipment"
       }
      }
     },
     "localname": "FurnitureAndOfficeEquipmentMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_GenentechCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genentech collaboration agreement.",
        "label": "Genentech Collaboration Agreement [Member]",
        "terseLabel": "Genentech Collaboration Agreement"
       }
      }
     },
     "localname": "GenentechCollaborationAgreementMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_GenentechIncAndRocheGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genentech, Inc. and Roche Group.",
        "label": "Genentech Inc And Roche Group [Member]",
        "terseLabel": "Genentech, Inc. and Roche Group"
       }
      }
     },
     "localname": "GenentechIncAndRocheGroupMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_GenentechIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genentech Inc.",
        "label": "Genentech Inc [Member]",
        "terseLabel": "Genentech, Inc."
       }
      }
     },
     "localname": "GenentechIncMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes.",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes.",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10250.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in deferred rent.",
        "label": "Increase Decrease In Deferred Rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10260.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in operating lease right-of-use assets and liabilities .",
        "label": "Increase Decrease In Operating Lease Right Of Use Assets And Liabilities",
        "terseLabel": "Operating lease right-of-use assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_LeaseCommencementMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease commencement month and year.",
        "label": "Lease Commencement Month And Year",
        "terseLabel": "Lease commenced moth and year"
       }
      }
     },
     "localname": "LeaseCommencementMonthAndYear",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "adpt_LeaseExpirationMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration month and year.",
        "label": "Lease Expiration Month And Year",
        "terseLabel": "Lease expiration month and year"
       }
      }
     },
     "localname": "LeaseExpirationMonthAndYear",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "adpt_LesseeOperatingLeaseExtendedTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating lease, extended term of contract.",
        "label": "Lessee Operating Lease Extended Term Of Contract",
        "terseLabel": "Lessee, operating lease, extended term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExtendedTermOfContract",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease lease not yet commenced tenant improvement receivable.",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Tenant Improvement Receivable",
        "terseLabel": "Lease not yet commenced landlord agreed to fund for improvements"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTenantImprovementReceivable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating lease, lease not yet commenced termination option description.",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Termination Option Description",
        "terseLabel": "Lease not yet commenced, termination option description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTerminationOptionDescription",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_LesseeOperatingLeaseLiabilityTenantImprovementReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2": {
       "order": 10020.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease liability tenant improvement receivable.",
        "label": "Lessee Operating Lease Liability Tenant Improvement Receivable",
        "negatedLabel": "Tenant improvement receivables"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityTenantImprovementReceivable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_LesseeOperatingLeaseRentCommencementMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease rent commencement month and year.",
        "label": "Lessee Operating Lease Rent Commencement Month And Year",
        "terseLabel": "Lessee, operating lease, rent commencement month and year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRentCommencementMonthAndYear",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "adpt_LesseeOperatingLeaseRentObligationsCommencementMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease rent obligations commencement month and year.",
        "label": "Lessee Operating Lease Rent Obligations Commencement Month And Year",
        "terseLabel": "Rent obligations, commencement date"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRentObligationsCommencementMonthAndYear",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "adpt_LesseeOperatingLeaseTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease termination period.",
        "label": "Lessee Operating Lease Termination Period",
        "terseLabel": "Operating lease termination period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriod",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_MRDDevelopmentAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRD development agreements.",
        "label": "M R D Development Agreements [Member]",
        "terseLabel": "MRD Development Agreements"
       }
      }
     },
     "localname": "MRDDevelopmentAgreementsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_MedicareRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare revenue.",
        "label": "Medicare Revenue [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareRevenueMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_MicrosoftCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Microsoft collaboration agreement.",
        "label": "Microsoft Collaboration Agreement [Member]",
        "terseLabel": "Microsoft Collaboration Agreement"
       }
      }
     },
     "localname": "MicrosoftCollaborationAgreementMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum service consumption requirement amount under license agreement.",
        "label": "Minimum Service Consumption Requirement Amount Under License Agreement",
        "terseLabel": "Minimum service consumption requirement amount"
       }
      }
     },
     "localname": "MinimumServiceConsumptionRequirementAmountUnderLicenseAgreement",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_MinimumServiceConsumptionRequirementTermUnderLicenseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum service consumption requirement term under license agreement.",
        "label": "Minimum Service Consumption Requirement Term Under License Agreement",
        "terseLabel": "Minimum service consumption requirement term"
       }
      }
     },
     "localname": "MinimumServiceConsumptionRequirementTermUnderLicenseAgreement",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_NetOperatingLossCarryforwardExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryforward Expiration Period",
        "label": "Net Operating Loss Carryforward Expiration Period",
        "terseLabel": "Maturity period for NOLs carryovers"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardExpirationPeriod",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_NonEmployeeDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-employee directors.",
        "label": "Non Employee Directors [Member]",
        "terseLabel": "Non Employee Directors"
       }
      }
     },
     "localname": "NonEmployeeDirectorsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_NonRefundableUpfrontPaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-refundable upfront payments received.",
        "label": "Non Refundable Upfront Payments Received",
        "terseLabel": "Non-refundable upfront payments received"
       }
      }
     },
     "localname": "NonRefundableUpfrontPaymentsReceived",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash lease expense.",
        "label": "Noncash Lease Expense",
        "terseLabel": "Noncash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_NumberOfCommonStockVotingRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock voting rights.",
        "label": "Number Of Common Stock Voting Rights",
        "terseLabel": "Number of vote for each share"
       }
      }
     },
     "localname": "NumberOfCommonStockVotingRights",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "adpt_NumberOfOperatingLeaseTerminate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating lease terminate.",
        "label": "Number Of Operating Lease Terminate",
        "terseLabel": "Number of operating lease terminate"
       }
      }
     },
     "localname": "NumberOfOperatingLeaseTerminate",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "adpt_NumberOfRevenuePerformanceObligation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of revenue performance obligation.",
        "label": "Number Of Revenue Performance Obligation",
        "terseLabel": "Number of revenue performance obligations"
       }
      }
     },
     "localname": "NumberOfRevenuePerformanceObligation",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "adpt_OperatingLeaseVariableLeaseExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease variable lease expense.",
        "label": "Operating Lease Variable Lease Expense",
        "terseLabel": "Operating lease variable lease expense"
       }
      }
     },
     "localname": "OperatingLeaseVariableLeaseExpense",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Expiration Year",
        "label": "Operating Loss Carryforwards Expiration Year",
        "terseLabel": "NOLs expiration year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "adpt_PercentageOfAnnualIncreasesInNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of annual increases in number of shares.",
        "label": "Percentage Of Annual Increases In Number Of Shares",
        "terseLabel": "Percentage of annual increases in number of shares"
       }
      }
     },
     "localname": "PercentageOfAnnualIncreasesInNumberOfShares",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "adpt_ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock upon exercise of common stock warrant.",
        "label": "Proceeds From Issuance Of Common Stock Upon Exercise Of Common Stock Warrant",
        "terseLabel": "Proceeds from issuance of common stock upon the exercise of a common stock warrant"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockUponExerciseOfCommonStockWarrant",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ProceedsFromLandlordReimbursements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from landlord reimbursements.",
        "label": "Proceeds From Landlord Reimbursements",
        "terseLabel": "Proceeds from landlord reimbursements"
       }
      }
     },
     "localname": "ProceedsFromLandlordReimbursements",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from settlement of stock option exercised in prior periods.",
        "label": "Proceeds From Settlement Of Stock Option Exercised In Prior Periods",
        "terseLabel": "Proceeds from settlement of stock option exercised in prior periods"
       }
      }
     },
     "localname": "ProceedsFromSettlementOfStockOptionExercisedInPriorPeriods",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_RegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestones.",
        "label": "Regulatory Milestones [Member]",
        "terseLabel": "Regulatory Milestones"
       }
      }
     },
     "localname": "RegulatoryMilestonesMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_RevenueRecognitionExpectedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition expected period.",
        "label": "Revenue Recognition Expected Period",
        "terseLabel": "Revenue recognition expected period"
       }
      }
     },
     "localname": "RevenueRecognitionExpectedPeriod",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition milestone method expected milestone receivable.",
        "label": "Revenue Recognition Milestone Method Expected Milestone Receivable",
        "terseLabel": "Expected revenue through milestone payments"
       }
      }
     },
     "localname": "RevenueRecognitionMilestoneMethodExpectedMilestoneReceivable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_SalesAndMarketingExpensePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales and marketing expenses.",
        "label": "Sales And Marketing Expense Policy [Text Block]",
        "terseLabel": "Sales and Marketing Expenses"
       }
      }
     },
     "localname": "SalesAndMarketingExpensePolicyTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of deferred revenue by revenue classification.",
        "label": "Schedule Of Deferred Revenue By Revenue Classification Table [Text Block]",
        "terseLabel": "Schedule of Deferred Revenue by Revenue Classification"
       }
      }
     },
     "localname": "ScheduleOfDeferredRevenueByRevenueClassificationTableTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of estimated useful lives of property plant and equipment.",
        "label": "Schedule Of Estimated Useful Lives Of Property Plant And Equipment Table [Text Block]",
        "terseLabel": "Summary of Useful Lives Assigned to Property and Equipment"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ScheduleOfReservedSharesOfCommonStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of reserved shares of common stock.",
        "label": "Schedule Of Reserved Shares Of Common Stock Table [Text Block]",
        "terseLabel": "Summary of Reserved Shares of Common Stock"
       }
      }
     },
     "localname": "ScheduleOfReservedSharesOfCommonStockTableTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation, shares available for grant.",
        "label": "Schedule Of Share Based Compensation Shares Available For Grant Table [Text Block]",
        "terseLabel": "Summary of Changes in Shares Available for Grant"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAvailableForGrantTableTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_SequencingRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sequencing revenue.",
        "label": "Sequencing Revenue [Member]",
        "terseLabel": "Sequencing Revenue"
       }
      }
     },
     "localname": "SequencingRevenueMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_SequentaTwoThousandAndEightStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sequenta two thousand and eight stock plan.",
        "label": "Sequenta Two Thousand And Eight Stock Plan [Member]",
        "terseLabel": "Sequenta 2008 Stock Plan"
       }
      }
     },
     "localname": "SequentaTwoThousandAndEightStockPlanMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_SeriesCConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C convertible preferred stock.",
        "label": "Series C Convertible Preferred Stock [Member]",
        "terseLabel": "Series C Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesCConvertiblePreferredStockMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_SeriesFOneConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series F one convertible preferred stock.",
        "label": "Series F One Convertible Preferred Stock [Member]",
        "terseLabel": "Series F-1 Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesFOneConvertiblePreferredStockMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award increase reserve shares available for grant,",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Increase Reserve Shares Available For Grant",
        "terseLabel": "Shares Available for Grant, 2019 Equity Incentive Plan reserve increase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseReserveSharesAvailableForGrant",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options vested and exercisable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable",
        "terseLabel": "Shares Subject to Outstanding Options, Options vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options vested and exercisable intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options vested and exercisable weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price per Share, Options vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award outstanding number.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Outstanding Number",
        "terseLabel": "Equity awards outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award vested and exercisable options outstanding weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Vested And Exercisable Options Outstanding Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life vested and exercisable options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExercisableOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment awards forfeited, canceled or expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Awards Forfeited Canceled Or Expired",
        "terseLabel": "Shares Available for Grant, Options and restricted stock units forfeited, cancelled or expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeitedCanceledOrExpired",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment awards granted.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Awards Granted",
        "negatedLabel": "Shares Available for Grant, Options and restricted stock units granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardsGranted",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant accounting policies.",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant accounting policies.",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "adpt_SpecificPatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific patients.",
        "label": "Specific Patients [Member]",
        "terseLabel": "Specific Patients"
       }
      }
     },
     "localname": "SpecificPatientsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_StockIssuedDuringPeriodSharesCommonStockWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period, shares, common stock warrants exercised.",
        "label": "Stock Issued During Period Shares Common Stock Warrants Exercised",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrants, Shares",
        "verboseLabel": "Stock issued during period, common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesCommonStockWarrantsExercised",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_StockIssuedDuringPeriodSharesRestrictedStockAwardVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares restricted stock award vested.",
        "label": "Stock Issued During Period Shares Restricted Stock Award Vested",
        "terseLabel": "Vesting of restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardVested",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_StockIssuedDuringPeriodValueCommonStockWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period, value, common stock warrants exercised.",
        "label": "Stock Issued During Period Value Common Stock Warrants Exercised",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueCommonStockWarrantsExercised",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_StockholdersEquityConvertiblePreferredStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders equity convertible preferred stock policy text block.",
        "label": "Stockholders Equity Convertible Preferred Stock Policy [Text Block]",
        "terseLabel": "Convertible Preferred Stock Warrant"
       }
      }
     },
     "localname": "StockholdersEquityConvertiblePreferredStockPolicyTextBlock",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "adpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, stock issued during period, shares, new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value, Shares"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "adpt_TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity value change in redemption value for vested convertible preferred stock options.",
        "label": "Temporary Equity Value Change In Redemption Value For Vested Convertible Preferred Stock Options",
        "terseLabel": "Change in redemption value for vested Series E-1 convertible preferred stock options"
       }
      }
     },
     "localname": "TemporaryEquityValueChangeInRedemptionValueForVestedConvertiblePreferredStockOptions",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_TenantImprovementAllowanceAndCommenced": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement allowance and commenced.",
        "label": "Tenant Improvement Allowance And Commenced",
        "terseLabel": "Tenant improvement allowance and commenced"
       }
      }
     },
     "localname": "TenantImprovementAllowanceAndCommenced",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_TenantImprovementCostsIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement costs incurred.",
        "label": "Tenant Improvement Costs Incurred",
        "terseLabel": "Tenant improvement costs incurred"
       }
      }
     },
     "localname": "TenantImprovementCostsIncurred",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_TenantImprovementCostsReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement costs receivable.",
        "label": "Tenant Improvement Costs Receivable",
        "verboseLabel": "Tenant improvement costs receivable"
       }
      }
     },
     "localname": "TenantImprovementCostsReceivable",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "adpt_TwoThousandAndNineEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and nine equity incentive plan.",
        "label": "Two Thousand And Nine Equity Incentive Plan [Member]",
        "terseLabel": "2009 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineEquityIncentivePlanMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_TwoThousandAndNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and nineteen equity incentive plan.",
        "label": "Two Thousand And Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineteenEquityIncentivePlanMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "adpt_UnvestedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested restricted stock units.",
        "label": "Unvested Restricted Stock Units [Member]",
        "terseLabel": "Nonvested Restricted Stock Units"
       }
      }
     },
     "localname": "UnvestedRestrictedStockUnitsMember",
     "nsuri": "http://www.adaptivebiotech.com/20211231",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r185",
      "r319",
      "r325",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major Customers [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r264",
      "r275",
      "r343",
      "r344",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r575",
      "r579",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r264",
      "r275",
      "r343",
      "r344",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r575",
      "r579",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r185",
      "r319",
      "r325",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Of Major Customer [Domain]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r182",
      "r319",
      "r323",
      "r533",
      "r574",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r182",
      "r319",
      "r323",
      "r533",
      "r574",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products And Services [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r264",
      "r275",
      "r334",
      "r343",
      "r344",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r575",
      "r579",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r264",
      "r275",
      "r334",
      "r343",
      "r344",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r575",
      "r579",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r117",
      "r118",
      "r119",
      "r120",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r141",
      "r212",
      "r213",
      "r386",
      "r419",
      "r456",
      "r460",
      "r461",
      "r462",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement [Axis]",
        "terseLabel": "Revision of Prior Period"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r117",
      "r118",
      "r119",
      "r120",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r141",
      "r212",
      "r213",
      "r386",
      "r419",
      "r456",
      "r460",
      "r461",
      "r462",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement [Domain]",
        "terseLabel": "Revision of Prior Period"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r3",
      "r113",
      "r114",
      "r120",
      "r127",
      "r212",
      "r213",
      "r386",
      "r419",
      "r456",
      "r462",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision Of Prior Period Accounting Standards Update Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Accounting Standards Update, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r183",
      "r184",
      "r319",
      "r324",
      "r577",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r183",
      "r184",
      "r319",
      "r324",
      "r577",
      "r610",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r186",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WASHINGTON",
        "terseLabel": "Seattle, Washington"
       }
      }
     },
     "localname": "WA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update201602 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r194",
      "r195",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r252",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r418",
      "r419",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r515",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update Extensible List",
        "terseLabel": "Accounting Standards Update Extensible List"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable And Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r27",
      "r187",
      "r188"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10290.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Net Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Investment amortization"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r45"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits Current",
        "terseLabel": "Travel and entertainment"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r22",
      "r544",
      "r561"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes Current",
        "terseLabel": "Tax liabilities"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r45"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r242"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r59",
      "r60",
      "r61",
      "r562",
      "r587",
      "r591"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) gain"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r69",
      "r70",
      "r71",
      "r110",
      "r111",
      "r112",
      "r444",
      "r582",
      "r583",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Gain"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r386",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid In Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r383",
      "r384",
      "r385",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r127",
      "r194",
      "r195",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r252",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r416",
      "r417",
      "r418",
      "r419",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r515",
      "r535",
      "r536",
      "r537",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments For New Accounting Pronouncements [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Costs Policy [Text Block]",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "verboseLabel": "Advertising expenses"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r347",
      "r375",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r91",
      "r228",
      "r234"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10130.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization Of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Intangible assets amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Antidilutive securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area Of Land",
        "terseLabel": "Number of square feet"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r104",
      "r165",
      "r174",
      "r180",
      "r207",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r438",
      "r445",
      "r480",
      "r517",
      "r519",
      "r543",
      "r560"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r56",
      "r104",
      "r207",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r438",
      "r445",
      "r480",
      "r517",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Fair Value Disclosure",
        "terseLabel": "Total financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Noncurrent [Abstract]",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r201"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r199",
      "r214"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Amortized Cost Basis",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r196",
      "r200",
      "r214",
      "r547"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r198",
      "r214"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10280.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Available For Sale Securities Debt Securities Current",
        "terseLabel": "Short-term marketable securities (amortized cost of $214,115 and $564,036, respectively)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r198",
      "r214"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10220.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Available For Sale Securities Debt Securities Noncurrent",
        "terseLabel": "Long-term marketable securities (amortized cost of $218,163 and $118,429, respectively)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r348",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r6",
      "r109",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description And Basis Of Presentation [Text Block]",
        "terseLabel": "Organization and Description of Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r95",
      "r96",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred But Not Yet Paid",
        "terseLabel": "Purchases of equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r36",
      "r93"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10270.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash And Cash Equivalents Policy [Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r18",
      "r94",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r88",
      "r93",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r489"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]",
        "terseLabel": "Noncash investing and financing activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r102",
      "r104",
      "r130",
      "r131",
      "r132",
      "r135",
      "r137",
      "r145",
      "r146",
      "r147",
      "r207",
      "r253",
      "r257",
      "r258",
      "r259",
      "r262",
      "r263",
      "r273",
      "r274",
      "r278",
      "r282",
      "r480",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Warrants issued to purchase stock",
        "verboseLabel": "Warrant issued to purchase stock"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r429",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Microsoft Collaboration Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r250",
      "r548",
      "r567"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r251",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Total shares of common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock: $0.0001 par value, 340,000,000 shares authorized at December 31, 2021 and 2020; 141,393,865 and 137,646,896 shares issued and outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock Voting Rights",
        "terseLabel": "Common stock voting rights description"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r332",
      "r333",
      "r345",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation And Employee Benefit Plans [Text Block]",
        "terseLabel": "Retirement Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation And Retirement Disclosure [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r66",
      "r67",
      "r76",
      "r553",
      "r572"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss attributable to Adaptive Biotechnologies Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r64",
      "r66",
      "r75",
      "r436",
      "r437",
      "r449",
      "r552",
      "r571"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest",
        "negatedLabel": "Add: Comprehensive loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r64",
      "r66",
      "r74",
      "r435",
      "r449",
      "r551",
      "r570"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r185",
      "r477",
      "r478",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r185",
      "r477",
      "r478",
      "r593",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk By Benchmark [Axis]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r185",
      "r477",
      "r478",
      "r593",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk By Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r150",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r155",
      "r156",
      "r185",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage1",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r185",
      "r477",
      "r478",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration By Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract With Customer Asset And Liability Table [Text Block]",
        "terseLabel": "Schedule of Changes in Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r298",
      "r299",
      "r320"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract With Customer Liability",
        "periodEndLabel": "Deferred revenue balance at December 31, 2021",
        "periodStartLabel": "Deferred revenue balance at December 31, 2020",
        "totalLabel": "Total current and non-current deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r298",
      "r299",
      "r320"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_ContractWithCustomerLiability",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract With Customer Liability Current",
        "positiveTerseLabel": "Current deferred revenue",
        "terseLabel": "Current portion of deferred revenue",
        "verboseLabel": "Total current deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination",
        "terseLabel": "Additions to deferred revenue during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r298",
      "r299",
      "r320"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_ContractWithCustomerLiability",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract With Customer Liability Noncurrent",
        "terseLabel": "Deferred revenue, less current portion",
        "verboseLabel": "Total non-current deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract With Customer Liability Revenue Recognized",
        "terseLabel": "Revenue recognized",
        "verboseLabel": "Revenue recognized during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfChangesInDeferredRevenueDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r335",
      "r342",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r79",
      "r533"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10090.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost Of Sales [Member]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost Of Sales Policy [Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10080.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs And Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r154",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r199",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities Available For Sale Amortized Cost Current",
        "terseLabel": "Amortized cost of short-term marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent": {
     "auth_ref": [
      "r199",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities Available For Sale Amortized Cost Noncurrent",
        "terseLabel": "Amortized cost of long-term marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r204",
      "r216",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer",
        "terseLabel": "12 months or greater, Fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r204",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss",
        "negatedLabel": "12 months or greater, Unrealized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r204",
      "r216",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months",
        "terseLabel": "Less than 12 months, Fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r204",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss",
        "negatedLabel": "Less than 12 months, Unrealized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale [Table]",
        "terseLabel": "Debt Securities Available For Sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r203",
      "r215",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Unrealized Loss Position Fair Value Table [Text Block]",
        "terseLabel": "Schedule of Gross Unrealized Holding Losses and Fair Value for Investments in Unrealized Loss Position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10110.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Net",
        "totalLabel": "Deferred tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Net [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10120.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness": {
     "auth_ref": [
      "r412",
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible general business tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards General Business",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10090.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Less: Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r396",
      "r409"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities",
        "totalLabel": "Net deferred taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities Net [Abstract]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan Employer Discretionary Contribution Amount",
        "terseLabel": "Employer discretionary contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan Maximum Annual Contributions Per Employee Percent",
        "terseLabel": "Employees maximum annual contribution of their compensation"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r91",
      "r240"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Acquired Developed Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation Of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r319",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueScheduleOfDeferredRevenueByRevenueClassificationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue Table [Text Block]",
        "terseLabel": "Schedule of Revenue Disaggregated by Type of Products and Services"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Equity Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Country [Member]",
        "terseLabel": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r138",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Continuing Operations",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r107",
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate",
        "terseLabel": "Statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation Other Adjustments",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation State And Local Income Taxes",
        "terseLabel": "State tax, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r397",
      "r422"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation Tax Credits",
        "terseLabel": "Credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateOfProvisionForIncomeTaxesDiffersFromFederalStatutoryRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Unrecognized share-based compensation expense related to unvested stock options, weighted-average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
        "terseLabel": "Unrecognized share-based compensation expense related to unvested RSUs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized share-based compensation expense related to unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Grant",
        "verboseLabel": "Grant"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r69",
      "r70",
      "r71",
      "r110",
      "r111",
      "r112",
      "r114",
      "r123",
      "r126",
      "r144",
      "r211",
      "r289",
      "r296",
      "r383",
      "r384",
      "r385",
      "r418",
      "r419",
      "r460",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r582",
      "r583",
      "r584",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r91",
      "r269"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment Of Warrants",
        "terseLabel": "Fair value adjustment of convertible preferred stock warrant",
        "verboseLabel": "Fair value adjustment of warrants"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r463",
      "r464",
      "r465",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r463",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Fair Value By Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r464",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r463",
      "r464",
      "r467",
      "r468",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r265",
      "r335",
      "r336",
      "r341",
      "r342",
      "r464",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r335",
      "r336",
      "r341",
      "r342",
      "r464",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r464",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Inputs Level3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value Of Financial Instruments Policy",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease Weighted Average Discount Rate Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite Lived Intangible Asset Useful Life",
        "terseLabel": "Amortization period of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r229",
      "r230",
      "r233",
      "r236",
      "r534",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite Lived Intangible Assets By Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r233",
      "r538"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r229",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r233",
      "r534"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10240.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseForIntangibleAssetsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10120.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r221",
      "r223",
      "r519",
      "r542"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10250.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill And Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill And Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill And Intangible Assets Goodwill Policy",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill And Intangible Assets Intangible Assets Policy",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r91",
      "r222",
      "r224",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill Impairment Loss",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r91",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment Of Intangible Assets Finitelived",
        "terseLabel": "Impairment losses on intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r106",
      "r421"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r539",
      "r549",
      "r554",
      "r573"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "totalLabel": "Total loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r106",
      "r421"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfLossBeforeProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r244",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r398",
      "r405",
      "r411",
      "r420",
      "r423",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r394",
      "r395",
      "r405",
      "r406",
      "r410",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10240.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase Decrease In Accounts Payable And Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase Decrease In Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r90",
      "r530"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10270.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase Decrease In Contract With Customer Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase Decrease In Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10280.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase Decrease In Other Operating Capital Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10230.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Information By Category Of Debt Security [Axis]",
        "terseLabel": "Debt Security Category"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Purchased Intellectual Property"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10060.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest And Other Income",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable Current",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r53",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10300.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r54",
      "r100",
      "r143",
      "r218",
      "r219",
      "r220",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory Policy [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Debt And Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r206",
      "r540",
      "r557",
      "r609",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease Cost Table [Text Block]",
        "terseLabel": "Summary of Other Information Related to Operating Lease"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r13",
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements Gross",
        "terseLabel": "Landlord contribution for leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "localname": "LesseeDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee Lease Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee Lease Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee Leases Policy [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease.",
        "label": "Lessee Operating Lease Existence Of Option To Extend",
        "terseLabel": "Lessee, Operating Lease, Existence of Option to Extend [true false]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease that has not yet commenced. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Option To Extend",
        "terseLabel": "Lease not yet commenced, option to extend description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Renewal Term1",
        "terseLabel": "Lease not yet commenced, option to extend term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee Operating Lease Liability Maturity Table [Text Block]",
        "terseLabel": "Summary of Reconciles Undiscounted Operating Lease Cash Flows"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Lease Liability Payments Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10080.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10070.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2": {
       "order": 10010.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee Operating Lease Liability Undiscounted Excess Amount",
        "negatedLabel": "Imputed interest rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee Operating Lease Option To Extend",
        "terseLabel": "Lessee, operating lease, option to extend"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Remaining Lease Term",
        "terseLabel": "Operating lease remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Operating lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters Of Credit Outstanding Amount",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r104",
      "r175",
      "r207",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r439",
      "r445",
      "r446",
      "r480",
      "r517",
      "r518"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r104",
      "r207",
      "r480",
      "r519",
      "r546",
      "r565"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "Liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r46",
      "r104",
      "r207",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r439",
      "r445",
      "r446",
      "r480",
      "r517",
      "r518",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line Of Credit Facility Current Borrowing Capacity",
        "terseLabel": "Line of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities Policy",
        "terseLabel": "Investments in Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r52",
      "r104",
      "r207",
      "r253",
      "r257",
      "r258",
      "r259",
      "r262",
      "r263",
      "r480",
      "r545",
      "r564"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Minority Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Minority Interest Ownership Percentage By Parent",
        "terseLabel": "Ownership interest percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r89",
      "r92"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r62",
      "r65",
      "r71",
      "r73",
      "r92",
      "r104",
      "r113",
      "r117",
      "r118",
      "r120",
      "r121",
      "r125",
      "r126",
      "r133",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r207",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r462",
      "r480",
      "r550",
      "r569"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10010.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "totalLabel": "Net loss attributable to Adaptive Biotechnologies Corporation",
        "verboseLabel": "Net loss attributable to Adaptive Biotechnologies Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r65",
      "r71",
      "r125",
      "r126",
      "r441",
      "r448"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income Loss Attributable To Noncontrolling Interest",
        "negatedLabel": "Add: Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r117",
      "r118",
      "r120",
      "r121",
      "r128",
      "r129",
      "r134",
      "r137",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income Loss Available To Common Stockholders Basic",
        "totalLabel": "Net loss attributable to Adaptive Biotechnologies Corporation common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r95",
      "r96",
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired1",
        "terseLabel": "Noncash additions to property through lease financing arrangements"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r296",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number Of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r165",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10050.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails2": {
       "order": 10030.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "negatedLabel": "Less: Current portion",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Operating lease liabilities, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfReconcilesUndiscountedOperatingLeaseCashFlowsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r501",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease Payments",
        "terseLabel": "Cash paid for amounts included in measurement of lease liabilities, net of tenant improvement allowances received"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r498"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r509",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases Rent Expense Net",
        "terseLabel": "Rent expenses"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "U.S. federal NOLs"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r45"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10260.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r63",
      "r66",
      "r435",
      "r436",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10040.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax",
        "terseLabel": "Change in unrealized gains and losses on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income Expense",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables And Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromTenantAllowance": {
     "auth_ref": [
      "r81",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy.",
        "label": "Payments For Proceeds From Tenant Allowance",
        "negatedLabel": "Cash received for tenant improvement allowances"
       }
      }
     },
     "localname": "PaymentsForProceedsFromTenantAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments Of Stock Issuance Costs",
        "negatedLabel": "Payment of public offering costs, net"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments To Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r348",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred stock issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Preferred stock outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock: $0.0001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020; no shares issued and outstanding at December 31, 2021 and 2020",
        "verboseLabel": "preferred stock investment"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10310.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromContributedCapital": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
        "label": "Proceeds From Contributed Capital",
        "terseLabel": "Proceeds from initial capital contributions for Digital Biotechnologies, Inc."
       }
      }
     },
     "localname": "ProceedsFromContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "terseLabel": "Proceeds from public offering of common stock, net of underwriting discounts and commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r85",
      "r86"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds From Payments For Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds From Sale And Maturity Of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r84",
      "r378"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r62",
      "r65",
      "r71",
      "r87",
      "r104",
      "r113",
      "r125",
      "r126",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r207",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r435",
      "r440",
      "r442",
      "r448",
      "r449",
      "r462",
      "r480",
      "r554"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10030.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10030.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r245",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property Plant And Equipment Estimated Useful Lives",
        "terseLabel": "Property and equipment, useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r241"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r243",
      "r519",
      "r558",
      "r566"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r37",
      "r243",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r19",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r19",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Property and equipment, useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r189",
      "r191",
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivables Policy [Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r392",
      "r532",
      "r628"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10100.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research And Development Expense Policy",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r12",
      "r21",
      "r98",
      "r611"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10230.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash Noncurrent",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r296",
      "r386",
      "r519",
      "r563",
      "r586",
      "r591"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r110",
      "r111",
      "r112",
      "r114",
      "r123",
      "r126",
      "r211",
      "r383",
      "r384",
      "r385",
      "r418",
      "r419",
      "r460",
      "r582",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From Contract With Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r163",
      "r164",
      "r172",
      "r177",
      "r178",
      "r182",
      "r183",
      "r185",
      "r318",
      "r319",
      "r533"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10070.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Contract With Customer Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenue from collaboration agreement"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueDisaggregatedByTypeOfProductsAndServicesDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r101",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue From Contract With Customer Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r322",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue From Contract With Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1",
        "terseLabel": "Deferred revenue, expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureDeferredRevenueAdditionalInformationDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r508",
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability",
        "terseLabel": "ROU assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r155",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Sales Revenue Net [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationsOfRiskPercentageDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule Of Accrued Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Weighted-Average Common Stock Equivalents were Excluded From Calculation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Available For Sale Securities [Line Items]",
        "terseLabel": "Schedule of Available-for-Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule Of Available For Sale Securities Reconciliation Table [Text Block]",
        "terseLabel": "Schedule of Available-for-sale Investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Schedule of Reconciliation of Effective Tax Rate of Provision for Income Taxes Differs from Federal Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r347",
      "r374",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Summary of Compensation Costs Related to Stock Options and RSUs Included on Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]",
        "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule Of Fair Value Off Balance Sheet Risks [Table]",
        "terseLabel": "Schedule Of Fair Value Off Balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r229",
      "r232",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule Of Finite Lived Intangible Assets [Table]",
        "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r229",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule Of Finite Lived Intangible Assets Table [Text Block]",
        "terseLabel": "Summary of Intangible Assets Subject to Amortization"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule Of Goodwill [Table]",
        "terseLabel": "Schedule Of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]",
        "terseLabel": "Schedule of Components of Loss Before Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfUsefulLivesAssignedToPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r348",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r354",
      "r365",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Option Activity Under 2008 Plan 2009 Plan and 2019 Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Summary of Estimated Grant Date Fair Values of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r48",
      "r102",
      "r145",
      "r146",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r282",
      "r287",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule Of Subsidiary Or Equity Method Investee [Table]",
        "terseLabel": "Schedule Of Subsidiary Or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in restricted stock units (RSUs).",
        "label": "Schedule Of Unvested Restricted Stock Units Roll Forward Table [Text Block]",
        "terseLabel": "Summary of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block]",
        "terseLabel": "Schedule of Future Amortization Expense for Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r153",
      "r155",
      "r156",
      "r157",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules Of Concentration Of Risk By Risk Factor [Text Block]",
        "terseLabel": "Schedule of Concentrations of Risk Percentage"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10110.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling And Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling And Marketing Expense [Member]",
        "terseLabel": "Sales and Marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10160.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period",
        "negatedLabel": "Restricted Stock Units Outstanding, Forfeited or cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Forfeited or cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "terseLabel": "Restricted Stock Units Outstanding, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
        "periodEndLabel": "Restricted Stock Units Outstanding, Nonvested Outstanding, Ending Balance",
        "periodStartLabel": "Restricted Stock Units Outstanding, Nonvested Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward",
        "terseLabel": "Restricted Stock Units Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Ending Balance",
        "periodStartLabel": "Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Restricted Stock Units Outstanding, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfCompensationCostsRelatedToStockOptionsAndRSUSIncludedOnStatementsOfOperationsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized",
        "terseLabel": "Increase in share reserve"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "periodEndLabel": "Shares Available for Grant, Outstanding, Ending Balance",
        "periodStartLabel": "Shares Available for Grant, Outstanding, Beginning Balance",
        "terseLabel": "Shares available for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfChangesInSharesAvailableForGrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period",
        "negatedLabel": "Shares Subject to Outstanding Options, Options expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period",
        "negatedLabel": "Shares Subject to Outstanding Options, Options forfeited or cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price per Share, Options forfeited or cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Shares Subject to Outstanding Options, Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Option outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r356",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Shares Subject to Outstanding Options, Options outstanding, Ending Balance",
        "periodStartLabel": "Shares Subject to Outstanding Options, Options outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price per Share, Options outstanding, Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price per Share, Options outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r346",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price per Share, Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price per Share, Options expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price per Share, Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r348",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share Based Compensation Option And Incentive Plans Policy",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Option expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r371",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfEstimatedGrantDateFairValuesOfOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Weighted-average remaining contractual life options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r99",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r102",
      "r104",
      "r130",
      "r131",
      "r132",
      "r135",
      "r137",
      "r145",
      "r146",
      "r147",
      "r207",
      "r253",
      "r257",
      "r258",
      "r259",
      "r262",
      "r263",
      "r273",
      "r274",
      "r278",
      "r282",
      "r289",
      "r480",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Statement Class Of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersWeightedAverageCommonStockEquivalentsWereExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r51",
      "r69",
      "r70",
      "r71",
      "r110",
      "r111",
      "r112",
      "r114",
      "r123",
      "r126",
      "r144",
      "r211",
      "r289",
      "r296",
      "r383",
      "r384",
      "r385",
      "r418",
      "r419",
      "r460",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r582",
      "r583",
      "r584",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r144",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r266",
      "r289",
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r289",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "terseLabel": "Proceeds from initial public offering, net of underwriters' discounts and commissions, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r289",
      "r296",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Shares Subject to Outstanding Options, Options exercised",
        "terseLabel": "Issuance of common stock for cash upon exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansSummaryOfStockOptionActivityUnder2009PlanAnd2019PlanDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r51",
      "r289",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period Value Conversion Of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r289",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Proceeds from initial public offering/ issuance of common stock upon public offering, net of underwriters' discounts and commissions and net offering costs paid by us"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r51",
      "r289",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Issuance of common stock for cash upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r104",
      "r190",
      "r207",
      "r480",
      "r519"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "totalLabel": "Total Adaptive Biotechnologies Corporation shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r70",
      "r104",
      "r110",
      "r111",
      "r112",
      "r114",
      "r123",
      "r207",
      "r211",
      "r296",
      "r383",
      "r384",
      "r385",
      "r418",
      "r419",
      "r433",
      "r434",
      "r447",
      "r460",
      "r480",
      "r490",
      "r491",
      "r495",
      "r583",
      "r584",
      "r645"
     ],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary Or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary Or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureShareholdersEquitySummaryOfReservedSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r400",
      "r404",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary Of Income Tax Contingencies [Text Block]",
        "terseLabel": "Schedule of Change in Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward Amount",
        "terseLabel": "U.S. federal tax credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the limitation related to use of the tax credit carryforward.",
        "label": "Tax Credit Carryforward Limitations On Use",
        "terseLabel": "Tax credit carryforwards expiration year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10020.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity Accretion To Redemption Value Adjustment",
        "negatedLabel": "Fair value adjustment to Series E-1 convertible preferred stock options",
        "negatedTerseLabel": "Fair value adjustment to redemption value for Series E-1 convertible preferred stock options"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r253",
      "r257",
      "r258",
      "r259",
      "r262",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Carrying Amount Attributable To Parent",
        "periodEndLabel": "Convertible preferred stock, Ending Balance",
        "periodStartLabel": "Convertible preferred stock, Beginning Balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Outstanding",
        "periodEndLabel": "Convertible preferred stock, Ending Balance, Shares",
        "periodStartLabel": "Convertible preferred stock, Beginning Balance, Shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of Series E-1 convertible preferred stock for cash upon exercise of Series E-1 convertible preferred stock options at fair value"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndShareholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TenantImprovements": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.",
        "label": "Tenant Improvements",
        "terseLabel": "Tenant improvement allowance"
       }
      }
     },
     "localname": "TenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r127",
      "r194",
      "r195",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r252",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r416",
      "r417",
      "r418",
      "r419",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r515",
      "r535",
      "r536",
      "r537",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type Of Adoption [Member]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureMicrosoftCollaborationAgreementAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r108",
      "r335",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "U S Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. Government Debt Securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfAvailableForSaleInvestmentsDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureInvestmentsScheduleOfGrossUnrealizedHoldingLossesAndFairValueForInvestmentsInUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables Current",
        "terseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r393",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued",
        "terseLabel": "Accrued interest or penalties related to uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions",
        "terseLabel": "Additions",
        "verboseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r148",
      "r149",
      "r151",
      "r152",
      "r158",
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating price of option.",
        "label": "Valuation Technique Option Pricing Model [Member]",
        "terseLabel": "Option Valuation Model"
       }
      }
     },
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted",
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/DisclosureNetLossPerShareAttributableToAdaptiveBiotechnologiesCorporationCommonShareholdersComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://www.adaptivebiotech.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r629": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r630": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r631": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r632": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r633": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r634": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r635": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r636": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r637": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r638": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r639": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r640": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0001564590-22-005228-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-005228-xbrl.zip
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M;\XA05K,_,'0E<7L#A@]YHC=@$T+'$C\B(QF&=?6V%ZK^>?>1>O@9,W5S:'
M\ZZN*5?7^G/[HGVXWNH.YF%'HF[PL#0<9*7AF>D$A,^=4#+T$'0WD&5<PC\@
M&V_P^5SE#2(A(I;(H%W8[?ZZFYT[BF)N-DM6C]OL',D7<K-@*[2DJK[J9O/X
M+SFCIW' -/9[T&H]FZZ7!X,;)_Q^!LI#%_8>@!IX VQ,[&\M[=JPF>5,3#?\
M96L;[/I&L[F[MOS)W__SZ;K/NO\,@L_O?^>9]C^G;A5B_UF<G]M_Z[GVG\\#
MGFO_D@?\[KOP&!<LB.>B@+W]UC-!8,['5!0(/$ #^\_& PX+"H&'J&!O9_L)
M6C@'1HC["#5P[!\^'SBXO1U^A0NCL.MQ#T!&G:,?T9^J8/>,6I &L?;6Y^UF
MXV#O^2%VT&R6&&*+J0P@UMIO[!V\!,2>3^UX=8@MH4J V'[CH/D2 'L^/>7E
M 6;^6(,H]_8:NR\"L>?3;%X?8DN)<G>WT7X!QG_0G'-IE0=BRXER!ZARN;J4
M8QWFZT5O;AT^0%R?K_?^7-_'D2_R"[?7.;/_$7MMY0OKHNUUWNI_<*^K*[S/
M1^@K&WU\>T\S^I_-Z,MWZ;WY_A\R^EO[S[3_?"_?6^__0:.__4P&7_OY]/4U
M#+YGH(#]YOJ:4CX$7M;M]P0(/&3T;Z^O^>1#X&4=?X^'P$-4L-\^S(4 ?:DE
MFB% *)*&J0VA !+F0QZ%E+0([S8HY_((,P5_V0J=R=3%#$;Z;AS@TBAQ3B7-
M_0AM^;,96(&/V6\K9UZND?RY:D[GYY\_IO>3P"&S<0Z+T(^#!!2$%4?B( @Q
M'LKPH/ODC8S2T\1W\DO'QJ^'#@L,6A3+39(\[OZ6SDW+WBS?]#'G5>)-4]*H
M,Z\/(S,@C?JS#"<V6_(AR6_I>QA/9N-WB!2U]"_IQ>@OEM\)(*8 B_1'4$T%
M?M.;F# 3"PX^BPN.X KY2/E3ZCWXS#5.;P^S7PI_:#QW.!)'ME??3IXM?GGR
M >CV7OX)"!RA2Y[O".@4RG4$O$#EF8Y@*7J6A*>DT#/%'UX.-LWRP:;YG+#)
MY9U+J)ARY;*,'1]RR0LQ?+G#M3EOFO#G'J>]ZH1Y_L3QEKWL02:3?MO\$^6O
M^G[79TQ@;%\'OAU;T54@,NQ4_EN/_1UCRI8WNF%WS(O98C_+:V.G$O)LA)IG
M&L@V+.''U'4L1^3H&;8SP20EK &$#1_E[7CK,R4;+MCSSQ]S'YP]J?1R2JVR
M/#?&9+U5%<8\.\8TU\:89H$Q9L[G5V',<V-,ZW!=C($[WAIC3@!FKC]%&+P?
ML;1HTY5<>C+.;*Q@*A#.E%$R+<&9S15-Q<&9PLJF K",S23& M#59F*LB.FH
MHN%CUPS#JR%5%.G5@:+.'VMYTF5'">,[*!N_4_&L19O?^IR4K"W=_NNPP,2+
MUCIX%0]C%CEX:2<&_7R/JO=2"#*9^-[&H43>EG6TR&RZ0H1IQ[8=C+6:[K7I
MV%WOV)PZD>F^'Z18"H *0:8=RXHGL0M7VE?1F 5X5<#&".T[UO4L?\+>$;*L
M"HP*<:8W+#(=C]FG9H!5K>'[P9+\G6\H2KS=>18?-D_6R-[:BMITU:R41M^3
MU+EW@U$%T.M*B5U/<"EL$&X5W+=02LQZG+*X04A57*UQX_!I+:OUW:!8P<S7
MC<.Z?!U^PY'J[;VJAX4SYAY6PS<<*0J@?1<;0=:23YN.+,422X5&G"6*\H9C
M24&\JJ^#$B5*G"@TN>1I9&^>]+/IJEDI<I2>4YU[/QA5 +VN%-B%;5!8*&$J
MFZ'<L#L'P7XUO(;G![Q]T,*^R!W[KSBDQMOISNZ5GO#\>L(*R\!\V\R9;GWF
M7S[E5#=4@7D1 B@C]E9H4P0;^AU)Z&(9TZ60UL\B6-\/BA4E4K41^)1OH6XX
M!KUYS.!Y&UN\DI&YX4A1 -NRV BREKZSZ<A2+#6GT(BS1&79<"PI1LR@@"B1
MJW64M^=".=2/4C1?>%:5Y=U@5 %TEXW#KDO?P^<$ONL"[Y9=E]\A<BT#1(5;
M+Z]+OQM$*YA2O7%8MU@1?S<H5AC?X2;@4[X6O^$8]/:^P]=I&/R\BOB&(T4!
M].]B(\A:^LZF(TNQU)Q"(\X2E67#L:0@OL/BH<2#=OF&(\;;F^,OA1[9V1HT
M7"B]GG33>[Q /O")<S7"(+JZ]U@0CIUITKG3&:$8_^+X$;/&GN_Z(X>%P*)+
MC&V8^Y7:J6S8N7ROY<:L9<=^8?[E!\=Q&('<#4)U]O*;3CK[]1BH#[83T!0K
M',GV9?:%>=9X8@:I?@4]TV6AZ'QZR:('']*?35G*MA*OG[MT$^J&$0?GP2X0
M,0/X!Q!O#?[ZT-$E+#;W\%YT(?+X-3MS.0*\OLNBL"72+T;#(AL6,,%BSITY
M<-D+D'&)\_:*3L:+SN^]4W)A$Q<?IN0O1:;D\GK15Z+D+Q4E%XZ2BQI&*#DE
M;[A,KBBY>)1</IG\E:%WBEGCKF=U//O&![S_&OCQM*@6\Z8*Z <.HK*@BT+C
MY9/6Y:/Q#17=%8V7A,8K.5YYOBL:WV@:+[(G_,;T1DSVN[AP/&<23](D>!WX
M\*)H=NV:7@1HAM%FFM.GD2*BX[DY\&DL^4Q=L0F:M,2J%< @R'(A()Y.!]2(
M0YX8[\N1.K-*1UV,V^:/"K?+AMOZF56XG4U_6@5[Q:7GS S9V'?M[F0:^'>4
M-K11^?PKH;"\> DT*BQ[&>T L]/BB 7J=[BVYP^C>S/8J-*EU5GIPQ"I](6R
MZ@L5MA<%VRL-XN5Y^UD<>$X4!PRNN1H.'8N]<RWY08!4G+VLG+W"]6+@>L77
M'U\8@^?6@S>Q\/CXX3%Y.V7%X0?J8PA[5P/#ZR"8UKUVISA55.LA2WDC+67%
MFE($&IX?T\HK6LN&8*]0O8=[OF;!T \FIF>QVZN!ZXPH;+>@G(^ E'^'?.5J
M]7V91?0XJ):]55RRWFN6Z::@:MFQ%5T%<.AWH#XEU83LCKD^:5*]>#KUJ1\]
M!E8W0=%$)2YOY[*Z</G>*XWON3"HW.E/I<*@ F?Z/ &#2JSRE0V#"JO>K8A!
M GPW;(3=3/Q@=N&X+(Q ^]F(4.3JZ/0@("KY]B*X]1Z$71%QJ^22;Q7<>A=B
ML("X55B9*,Q]])9?#3M!@/YKBGM*!+NX.=% VQD%;/.R<G)W+_!J^?XK"?A(
M+I4.:U7H]R+H]Q)<M<+[Y^>@Y57X2LE!BZKG/1V32JS>E1&3"JO5K91+\B2A
M6Z%761-$WJH+ZF)T4P6"Q[[K\LH-@)>"O\[=VH*[-=OM@TU#OY7 \#9,KKTN
MDX,[V@>OS>3RDD.?CG6;R>N> ]D>R?)>/__S+?JO/BQ_C^%N!R[R(O@KA//G
M9Y#)Y%SBSJM0O @HKA5]+S].L:Q'NR4K#>,5R$U3 "MZVPAZ6W*B%<&]/<'A
MX"$66([I5O2V$?2V^$ K<GMK"WK#@R4%M: +&[IX-0NZPKI-,:7+B=?KN;\K
MO'YKO*[*)E]8#]CLB'-1]8#2!I[7B-!L<ORYH'A5V#"T@.F9Z02_FV[,OLPZ
M8<BB8]<,4[,/+\!&G%V8P7<6G<6>G;'_M=O5G[_"D9N!-9Z=HW='?Y:ZI.M-
MXRBDWUL+'WC!Z^+P),X"]G?,/&N6^S3M0FSR'P<!V,(;X&!8 19)0[)5H/%\
M#H>%:),L*!]Q7F0)2U O!T#SR+?9KHGG(_&*(M\?16XZ\G_K??7O6.#QM"(X
M18>%)VP0]?"@G,C)>KR?+O':%7UM)GVMBDK%DH'MB@T\C0U45%M1[>83R+$?
M3-&H9I5PK,CL$62V%'\JB5A^@J_H\]W2Y^:00N7$?)]447D07Y9 *K7NO1+(
M>U.F*GQ^97S>'-39U !L:?-8RL&:JP#L^B3>+">)5Q3Y_BARTY%_$P.P%7V5
M.93S3BRDC6$#%=565+OY!+(Q =B*S$H7X*DD8@D(OJ+/=TN?FT,*E1/S?5)%
MY4$L>P"V(I!B$LA[4Z8J?"Y] /954:?KT0A(WB_I&/2OD1_,KH::%C93M=:=
M.]-QS8'+SOR@9[HL4=/22MLQ@(^IVFOUHCL61@@BU61K7=]7F?,"YK?_EH[;
M%4]=%)<_ZMPW.V^A &2C+*8OOF>_&UI9NNN*0-X1@90;PROT*AQZ7?J>56DN
M[U)SR1Y]13PO3SR5_E(Z_:4BDV<GDW+C>85D142R%_2_E-8M^!ZTF+?5_]^;
MV_)!_64C::74^DM%(,_K?RDQAE?H53CT>EG_2XEQ=?,UES?7^3>/>,J-\A62
M/17)OIBNZ5FL-V8L.O<MW@]<XYW7 9N:CGWZ8PK09V''LZ^B,0N$#*,TS4WP
MQ2T"0\)#5P?$9GLBGA=A2LM[2HTPKRS&JKC8R^IE)><H5>SG^7PG)4>%Z\"'
M1T6S:V"N$7#,T[]CAP:?9F9NGO/9):#NJ2LV "E6V+W091?NOT*/!]&CM"I'
M&='C536-5=!#29;)-(Y8\.[81R)D<@%0\8^'$62S&4C1$*1P' 0Y[%D<>$X4
M!PRMNN'0L=B[8R0D:!Z$0\5/5D:7S68K!4670G(7R7I[_C"Z-P/VKEA*_N8K
M/K(<,=X!\R@(8A2.8RB%%582Q!8ZHKL>W#@*6+@)KK(UM=;%4*AXR(JHLMG,
MI)"H4E2N<L[,D(U]U^Y.IH%_QRO?WQM360*$BJ>LABCO@Z44"5%>AZ/ P>Z^
MS=$^ 3:MW5?MNN* S<O.G3MF=SUXS\@9N(R'_[_,+LR__&"NJ1U<QUR765%L
MNA(!-:;;A/]7:NZ[!D@2XEH,E->A+<"1(#HQ(\;9<!/_OWJT^BU]#_/LY(X4
MSLE?"H-S)]@&":!J]YDU]GS7'\UNG-%X(Z3]H_#M 8!LMN1_?J;UKG#GK7E5
MB=!F!;Y36N5Q(_C.Z[:H>VZ^\[YPIT!\YW70)@PBV*<=6]%5T&/!G6,EWO(>
M[^7G>*,;("DO+G,<!?9YE+=1X1M?L-4-%3:///32L8*2'/K;4[H0F;B?C2?U
M17M]A[2^[-@WC=@+<^RO1NU<QXG#R)^P(%2'_I5YL&Q0C;N>)8Z[8@U/PI$5
M7SQ_'N*U\R>RN;SHY9&R8ER;@I0%Y)3"3A0'<<,F)EB9WNB:!51)[5GL:N Z
M(ZIFQ,)%*V)VWYG )5?#'GP;#DV*E_>DOYM>!GMM<W]X:;GJ\^&1>F$TFS)[
ML7W_O&>PI5[_/WY^F3<T;!^?\SDY[)\_ONR;%$ _SD/TO8F2&],;<6+#.P'(
MDWA2T71%TYM(TRL>KR*)K<]TVCI15 IH#M<P?U1<H^(:%==(<0V=*-X=U^C!
M.0#E6-=P %J^WC+3]8+9CF4&;-Z94MJLI*54GP^BYS%>EUC-N6"N\IRTO$/"
ML^8;(MQ3 8M@:KX58&//X5#]=AM'0?CW,,H <,(GG7V&7X_P9_DP^7WJ#?BT
ME7D1</B(,F._,G\4F-,Q(#J?S!A&T^"/#N:4'C8/RL=#%FX,1 WL[.B/SFL+
MF-9AO7GP*@)FQ4,E"5&=[G.Q9WZ^Z[#G+$:\&'M^JT,N/K44@!(V%^E:S5+
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MV=<B+SK9PX=YQ?PZ#XJ!K>E=O"IZ+DQ-2*&=$*=<XJR;DW#=7]'?EHM'>V7
MHZ*PO0(B4FLOCW^="HFT=H[+G)\799MT\?;!/KSL]$XZ_S*H;M2XH(E=QOGY
M\0HNQN?-^'M>F[U9-H-]E#'8=3$XIQ.!NH+>*4W*E!507<_&N" S!C/#&C-
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M"-C/@DF(/_O41\3R)U,SX'0!OS@>Z "C6<TPW0C .1H#>0-!NNZR@Y9XQ%]
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M?.YV=B_))I*5\YWP37&8*5+/TE6Y67TWHSX[B*Q,4CV@Y C%V\CU!]3_S<8
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MG%<K\\!Z-FV-2]DXD/74?/PN555/R,7_W4.'#\B!BYL3<E;HG0M:![5DZ?I
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M-^!4\,P>695*[12>?:T#.C]-%@1B@5I0C!SBZ+  KA0FO#P59:'(12HRJR!
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M&!O"<WT&BOY*",QWJTU81=E(56M6;UER2<9&NY6.T0BZ06'0+:TM> !CVW6
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M. 4*#B.$<7P?@D>32C!<$DHCC3(9D2NB3;V+3<NL7UXW&W<\Z/UP )'\BZ.
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M)< !XJI8@)#6=>NF7TPJNDO5H,?3=,DU@<>T"C5]\DZ;YZTX&. J5;K8]<+
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MZM;9'R=Y6T=%R=) YU..=4NZDZ%541>KC:ZNF"[+K) H9'=$K-XWIIFX)UU
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M>WP0RNKC+"\O.6BEQFIDXUDA#]F$@7;<JG1:,8.YJLR+9?^UCCID"S3,"4*
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M8[@R2P9*B23*SH,@"P(7M6']B C#X_#/2D1J.=:#(G>M!E/]-"=SLYFO8I[
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M,JE1;;U 'U+N &_*(CE%VZ?O&'V*BO-W.4EQ+MN#7RR(&@QJA49S(0_E*F/
M8"DL*5I:>1P_ <1;GN ?<,NZ81[_"4!&-YQ?=:N"^VM97CW[-2[%2_0D(&B_
MI:UKYVN+Z9HM*P;^:*O:Y1>"K9/)M $TXM)%,FZS?,HUN0&RWG>9GSO&V9F&
M=>O4 M/%IW'3697.$:-D+1>+K&F4: C7UP!%%BEY#U8T;H7)> I)LY*3[=Q9
MZPO</4NXD"\O<WY1U'XY[6QH9ANJ,$J,.&= ?XS,.U6L7^Z$_W<KU+7/GK\4
M_-^4QLV=[T)U\-Q*C]^[FE:0Y,]/TO-S1]L?GK__J=;.A[M1A\N'DD;Y7__Q
M\+[T1] @1HG]*WGW_N6SYZ/D:0X(7^V?H"/0<&4\)O%!:6Q?93-I@_A +DG!
MG=5:$LUB,4_;8@(>= #] H  @_E'<ES3&4C>I=QQV1D#__J4SC&MOU;3=3Y?
M7R>CK@V+S,N@=(]8+FV8U(#C/%O67MWXK>,&*_\$.KBR_=Q.$)I=EVWN07+F
M&7<9R<DRY&-H"G$]N1%KGDWICB7C+*W#,QDP >][Y;AOBIZE+3KO9+Q2J/[\
MWRV&<CR]R&K /YV0<IMDN=#[%5DI6-2(H-IY9;BNVM-\S,I)RU?)-U"!?IN;
MM2,8"%' AH\UJ>BE?,VDY)U[3-&&JH<MW7J6<\9U>@GLD LC8=+[$8&)G935
MDBG&,3TYUR]I_3\E=TZ>O[R;U%R=3S-\\N#OY*P&D,B?N7/L/61.30]9:+N!
MK%3T*VZ]+HP\W@ELIZ4U^6DY>)16+JV\[E\"M1M]YS0$>1;O90='4YL,>($%
M%12/L%:4T[/GKQ.ZE,+-A+64#K3HR$E4XI?"KU['&ME/GK65P5G0$0"[]=*C
M/0EFY65R2C*JH6,RIWVGU:O0TQ0)1C[2QMO.C0?TVY_0ZT8#2_Z98JGKW$GC
M/)_4M"APJ(P7JS_:TW<OWR0_956.^Y)X82Z@)'DY$1 1G%AM\,!0:CN65AKK
MZ4XSG#F6Z+Q>H>E&6NYSQZR>S,U'YU0P$#",F2,]X?:L[9 O'2^QXL?0[=>.
MDDE5DMGWO_$-W):OV+GW]8T .N3@V@N4-4]=X689"KQNG_XGH<6:/FB]27_Z
M8YU^@(/EKS19H[\$FZ33MCOF<((4P)&Y$)N>[@Y *$RPI5'73FVM0=$[/;NI
M81C(\_?BMP+W"$"$(\-K14^/HB'5\[)J!%<VC&.D#,&<-8.\;;)*6M)L>DQM
M.V76*[ *2H<A[P/N%?1?Q/4E2+0HWHB<*Z77Q-,8I$+42"A7SP3<&.>+&1A5
MLE<.F\" ('4#S JTOB8I]S\%W>;A>23+Q^H1.^J4QDMF)\I5[ $\F,T2W')<
M9P9:@%?6F'*1&9=\J^D#?8B:$-H0QN*6AU"GET(B5J3M.3J-Z;$%9Q)55'I3
MXE401,?6QZ4";^1]3(\BYW(W]GC'PJI82B<RJ3.T*V][]CN266@(_?,@Y+Z%
MO/%F9(P@]U__<>_QC\F96BZW4?*0YP&M#70/W\/7 :U" :Y9;@R&P]A7!B<G
MH,]B9,;,Q+'7L.FY^\FIXHT(RF@6N1-\H>G!"U!"PBRDBU_Q^^LR;Q6C)MCQ
MD27Y%OI44*_-EAQ=:6F*T<#?V*N0+UB,@>]&"O6%XY9_.=]JE7YPP9X/3]2;
M(+A<(<33H(,W'9/YD3QC,#(V6&D!@C QBA9NW(9GH2X4>FSU-7'<B$S9<4G7
M.++L1\FS=/6V /=SGMO]C^R/#JV9=P9H6WAMZ2BYCZ-DG M6G5_F"3NBJFEF
M+N6-),]TMH<P_Q1H,NA:]=\70CF!%FI:QM>4 [.OPQ-3G)Z(9F,&9*(-^OF]
MH5<N\XR;0<NP?30JH%#Q(4*S49BYR- %W%O&=I#V=T&+J94(!ZMP,L_<+'G^
M28-GR5N0WH LTS\T79"FJM-IJ448,]YRMC2M8_[V-3)[OYU1J [O'?BYBD+2
M@W#U 2HD+MDN<& [\,5'H_L':&1O11V%@_#V@CVBZ'6!H,C.\$OM;2X*'")_
M[$';ZU:1<_XJJQL&U_7/$B) ."K_:J?G>F_4,X6N):=F64=Q4'N4]X%(]Y,C
MR-A@ HYHF/\7RE4N5D-6=58DJ\4KR-/&.[;,Q<"M"=:1L,M:T>!%2 @Z9J6&
M27/K+L5I9K229(Q6YXZ%T2S"5N$&?3A7>S,2S(K>Z]=F&:V-#ZLYQM@:,VJ>
M<Q);:W"U:D!(NH_2RV*,K0SC:.16"E*CL"PC(#0*W$T&PQH:%:ZC '=R@!\4
MM9"@(RMQ[D;BN@,$6#/?A<*YJ64>O-L!H<YS: L#QX:12]+6RT3HKSC*MZ!1
MDH:H!=1\VDZZW. TV+(64T RS'[=E.<[*$U8G#$[%T?;@#.> >XNJ'SAT-41
M^( 4OKT'1WAO7B[ SD[7PGA&C;DC@DV) $,W/X\$X$P1 ']C,!ZX9_-5K51@
MM-2"8= =/_DS3!&R/FK:KHJ$2UID^@Y;.#"H56IT1P_3"",]L(1L%:1MV:=I
MC"(-#T?D462!B;"BPUP6Y8)1W<B.<Y-YP62HO/<U0(3H6FI0#GKA2(YZR;I2
M3U$QJ^C,5JW2OC*A_"6#'0F%F;?YZ,N>/6Z^&E?DU& .C/Q@OH^0S;'1Q?6-
M(#:%_F58$8EGZLK)YNMIX 4W='&/-7."M=A^ 148[ZM)WZ^/7K2%LE@VYBTO
MX+&!NM1_#-3H6RJ9P ?@9[/C"$UDR1@6D!Q"Y&PE5Q*C!J.R=PL!L\]>;%@<
MG\RX(=S,^\D[0-NG(H&Z-//''5J-M/J6Y P1 X-%7"/.YOI/8:&(XMC"J32[
M<D'8F^8S(&DX55.""T3R]),D 3F"10[WN:&Y53Y>%;"8,'R%@!(H]:X7OY'I
MP%[8W?XKP:!W,77_Y*MQ$-THL7/=&JZ_0/SU:' ^3ZG3I]+AC$8@.O5!DS_
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M)*63-IHEQ*'>XPCE&AD=RV9Q!M=E9WQ'H9&&8BL"@*YH:TT1K7O=K0*'FG6
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M!\8-)M1&%D=N]E<#T^AR(=$57)>!T)JC2^\7#5S(VFZ*CJ9?8IH>58S8DP5
MBKYKX4F;\(PP)WXL8A,H]<#>KH2=2$<@M$'+)AWBM!&&==@'Y[DAMI=)0.&9
M,KKSBYK>@B6)UCN[9^'(-[HN=Y7TCV/?QU8AR$&'4>>0&J3=F=#-$[ #8D72
M0V*V3.U<T)FBM79%<_P'9[0:8O?V%J.U3N,#AB3M6<:,#?H2S^;Y%I\?F:-$
MWWQK8\[4;9;(1*=8W15#\\C O2@U>EL;1@5E6)NZ!N,V/)05\S(V7AV,A)R
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M30B1#B-.1(M))_/K%9JC!_('!>H=H%JTT@AV2B+@%M9]9^#(ZI^Y^+V/EC4
MJ7!KK7OG/B@@DH\7^[.7H%#<VC/KY[/O:L75N6=;V=^SY]%DQSU[J,4]>YYX
M2.[9@VWOV?-@AFV!UHA0LAUHD7E>07%MT!B (-.07Y.J,V)9E$%"1,I6DF%H
M3JA'?,A<P9U?]VIDIU:]O..DKNM1R!D4V/-0>G(;AB='$WNX) =9ZTWM2N_
MA5U7WI3%K290S2%D'\M"PM#"\F7( Y4M.SZ+A=EL?K98,.'ZM*X70";NK_5=
M+^MV0V3+"^!YN?I[?'D1P/OH T>S@)L6*/G/-=64^T"M/9 CYJ!T87 4=6?P
M\%8%*YMYOS%(<+ETPUDC:/-!$I.]N:&Y*=GSM'H)7+,N:G8$(AHM^Y!N+2Y[
MO<FL.\[:ZXELSYXWVP;NW;-E6%5Y$/8U!:QUZ]\-_?YX'(,^9J5$&[OTZ;S2
M!VFT?7O'^MV8MY^,.KC!XZB#P3ZI"8Z]7WH+2#A0U-\OV+#QBG3$Z%Z=]G03
M?!BB'0D P\V#0I\-EC<D?;V_,9_=&F"7\KV@]:3\%V$PV$/W3QM[P57_ R>R
M80X0,V:5!8$X'G(4:VN&.W]W)^L];Q.^=*WS.$GT3T7QQY_+4 =RWT7-$NIV
MS"S['*!J$T/13 Y5HH+#R%*HINZ/>@'*418T@?1T[,\983J(_.808M_J./$W
MWR3Z^YU-40LX\#>UR6(8_9:KORJV'7$  ,+Z1<AA6G278DCBMLN>J"N/O[LP
MG!/B.%IG&!N+[5U6Q48B V]DW# 'D5LS1SN[Q.5GSYXA_Z+S!3G&*+=KG?-;
M]@TSM0P?V'QPT5_#*<>(.-L@T""L79[H/6.::.#LF[GT/5O60$71?.NG#Q]\
M].9/4+H&6YGQPY>RH*,]2,N,"6AU:_.R^M\?"[U4IZ#5=O5M4UA"5]R$&"7C
M1M@Y!H.#:^+>3XNKID=E!4 ,(<*E"2@&#4;@RUKH%=NN7UAQS1NQO_OZ&SS2
M6;?;%NWQE]LGYC19.X0;I-+C0[QN1"-2<,P]I$<R\7N@JUD$@[WW:I=193FV
M89;,W2S-4:+;P\$RVGD?_DF^%7T>^V71FAY 43$;%GC1PF-:%G?+U[O8317;
M"[0+(RT'HS=YRG_-WLO>9X07:Q9G;XIBRRMO\_D;@J]DZI3R7ZTHJOP:%UK<
M%&@HUXF%ID!YC)_@'[JRU6O08^6Y"NHQTUITMN_#Z6R4%\/Q3T"N#?=7-, /
MCW67\QFD>O\S5LE4(^Z3"/9+@$5I8H+)!+-<82"7OGX*K.NXGME@I**)^##O
M]L4,A[Y%"2"=D9BOT,J1(^$#=@U8F+1!-I2H(JD&$3X)96-ILC0KW<[%"U5X
M4:KA.;$Q%?<-2W;DA_^"HP7Y>*L!#[+.YXHDIM 2$+,,Y?^B0<O?H<04P91-
M>VNMW43FS[90)[[1PQMWXAL]\8W^;B]UXAN]YWRCL=<LM,;!V0DID'^\>ID%
MC JJX#;U6QK&#.J6)S.,[AP%5\<*).(XU',:\9#L@.,B5V221OV<F/=)?NU-
MQX@L.O/1-/<W+,@"%F3@Z3EKH00JO8847JQ)A\D&G7D>5A'?]41P?93'YF1P
M3@;G9'#NH<'Q>'08F:N%$;V[*J_*SI/7&G^RH2>=6.@K1L5( O,GC8,UP=_R
M=U;AJ)?+,][/:TKZ 8]7VR)T$L)T&8,<,+KL&17@6SY^,@)'*<HG(W R B<C
M< ^-0'VU-H==T9R#"U^8:\\,HK4GL0">IBP'DZV+(N]6JO7;0B=%4=YK0A<I
M:H,1W!;=G069'IA$Y,361 I2UM"1\4*-S/[,B]ZR-YR$W#N]EN)45-;<I/UV
M?+:])]MAS$",')]#/M< '>+\_4S,D68 G^;ENM>W91"WLXI[9/8^E.H;4I[N
MMR0D]0#W(A2B05/(;5[MI7HG 0:'Y>+6J#U0#,Z2<K$Y#_/RIEP#VSA?*_@*
M/@Q,D/5:=YNE9N^$4+G1#RGRK,&9!Y_#YI" %-*W6]0\-(G,GHI9N^J[!2!A
MHA\4R$>:8MFW"OW#6J;7K6(!34'4K8CE%8,V-(&\^/:B3;D>*Y$!2]?K';!1
MBR:_S4FB,KBN7RVX2;8P:3U=/@'T$W:/'&_I_(5/<Y@J4(!1$<WOJ^/'9;#:
MW)/O,ZW/.('-1&Z>_.>A+3-W/_OR"?^>N9MMO)S%ID;1AB4SP [)#9&) 1\.
M>I'7RS/44V)5U1-0[ZR"HY)\4W9-J(/'CH;9MZ;,'ZNV?EPV-J#D$B_O^-@E
M_CQ6Q2,X[<Q>!YO];8XJ[L,O P;Q7\\(R3DHA/.Y)QD]M7@X4&BQ:!D?S:L7
MLU/YXGZZ0Z= XA1(G *)>QA('-ZAU&*,O_6D;6T\[&6BFM_G?JK084*<94E>
MWPQ+$:Z:*GRWB0$I;]STPBF%35$81VFPF>..5S2(:']%F+E56Z([-<*-9*_K
MGO%A@XUX9J"#ZIP;)U_4VV[8;YQ"\WD!I=VU7;%I!V [GB@[GYTR9$=Y/$^&
M[6383H;M@S%LES'*4J(YJ/WWMVL#6]'5 2$A1$2P'\![U*9A3898\3\/AF4T
M4:IV@Z# $TV@"2I:7R&?-M4G.NH_N"D;X.JAE78=[2B@,V /K\'=O"F4LTUS
M)I[^: J,U@Q21IV;\PAW1>;%B2Z'JT9[$JI=>D^[=-]J1)QT9(<I\L&E!H&O
MYRB3]*(%RJUG/Y,<V;2#\;ZV]T,9)O_T)PZ3GWR.>Z8Y3S['R><X^1R_V.?X
M*5M^][[^EA[)#^6U. 75O/C9T?7 *2$G+, 7@D6WX87W"6M_LJ4\KCS^<Z:K
M5;L^^@PTL \_SRRU3Y@I);1FB2<IMRV;?%, I#_[M7/O"0A4DGQ_Z<EW]^LX
M2RP;B7I#\,<4"RRT_7C=Y7O]-.NYHV*B??/E4&!D]^.B/,"RC, O$O^*RUP:
M/1I!C%JF4PS""V#I"38C<C)VJT40W)<DY+"Y:+GH;J95OJ)1M+^PZH#*:K'U
M"DD6W%!XU+8@RH5)^#+Y4^IS$K\N3HGG-IR&GT -:\]K<)P399QS<;"[<FV^
M9PFRH@&J'%-2*&:756]P\45G4"')VHIOS6=>ULT &B\?E,J^/^*Z'YF3GR:S
M8HQ(4L&6-?C& >R.'P?,\<F1JB2H3\#:CN0<79B"DI &> HZM@B841UR1!P$
MI+ P\!80_A0[FT&D'1P(UPJ\FN&:>X-YQLB(,:ZT6FB)2,R.:["*_&=O+ :1
M N>X]^-"V^MM38;O#V;#9Q<)!&D+TLR:@U,A9PL I[PQ6C!$R^M46!6M31&K
M S@T0G887SGC0+]L.)[+05>B8D3RQFW?: _ETA#?"+B0C,%%EL>$,[-P>A[\
M,=!FQG$]=O(HONPV+QO[:V;,+I;2P.=71;[N5N>SB[MDC9HLIC&P8'$51472
M))IN5)C4MXYAX5C9@;G&XO3T#@[<)I=.KBK?OHQF@G@B(A%GR?7MXN?Z1(9R
M*3O5.5IK,I'A^/?6.J)4G0'Z-4M/H:-T-C9=$68?-&4OCP<PPV&'31;Q,8A+
MR>%O3TJ4S=3*AK4)H'GY -14?(V2!I78'")(0%72M8_OQG:10?F_-+Q/)%$*
M/J(88T?PE4M>EP:>>07[N$SA50UQD*\0F0= T>N$34NR*Y&*53D']&^BW75&
M'68V:*?$19#EN"EV/H&ZM>G2@I#(W6T]VQ6Y9H=4./=VSRG"PDG,K+]LC!CB
MO$.RTGT%5)J^FA?I3>59!Y8F09H_(%Y[FI9FG Y%'-49YOS@BZP/W&4=WJ]X
MJX.JQZY>1VRC%-'AV0#5P]IV2+&B2U"&NG,C,H^IWLX@Q&VOK>_K\N*%^H7T
M(BZ9:E/MJ7YR RZ<C[_XB_U8BG?A\NSN\N6WKZ*WS!M>\P#S?-*%!'H-GANP
MY5#7!325W#E1_7: _D=3I@[?&R6 FV[O'EKR*:4KY<_2YGI<E*H.,UO7%6E3
M_/UI-YKKO#+G#U@/X;"(AXKOEFVB2TOP4!0]5>6WKU(I5TMEUY5/IM+(Y50<
MNTS>2?LN'5DW?L4B/MSTFZBT+@9[9?R$X<C;RN$@.E2W!Q98FF.7=&YOP&55
M!\_\*V+G(%9.-7PJ"4/LZI'<:*RMA6CW4];Y;6;4.!')O56 6$9N :&A6)B5
M07OCZ/+[3S-N#CV7 \/#V5J=(+9X_I@3EKF#%>0M[WJWV!UL4F "Y.^36!0]
M2_(=1--PDI,'SOTD*KH8F*1331J(W[T## NG6P!JVHV9T11F4KT#8X#1CSX&
MA&?PF;ZF#V1'R[!+T$_= JG6_!W=@HP4"->.=*47\WC]-1AP7I71V<Y 8D]^
M6J)Z#WTFAI6\!5=*SJ\&Z\D2PZ5OTX!QD>R(W^3<HBD1E]9X S3DY:8D5XLX
M]S1@'BH81'YPAS5EM!O^O0O@G%J:62C]GCE-HV9C[95MYTW)"'L\FKI7=CEF
MC?#*N#GL7$;W8YUNA$M$X#/MSNKEF05F>Z$$".M$=F/X0"E.)-T8Y8JW!,O)
M^'K_!_R0H;:7#_Q,"PYS$V]+&(FXF_@I:25 \:LS.HN)CT8%Y(AH8(G,Y:O?
M/'ZMK%">.4F]>3=YYG%G[W:5P@$56S/D*\,K,UD99'<LKJE#'N:D XED$%!V
M_,A]%=L:/XWE.ECZ]SF&'DVK'Y(WN[5\.9N]7-6+8O:LU9]>%%75[M8W8L_S
M9)/XHGB)NI$_'/L!((8QHA-F C4)1IUG)R+52'?(?:B2QX,"KH"&.KX^>"3L
M0!"/4%P0961=[@ANF3R&ZFN&F4/'%#@V2W=>( G@LE.9'EV!)+80RI[)G(EK
MW3KZ93++KW [[I(-GCF:8V* \9#>XB+MBE,QJ>^T=[=CEQK9KLEL Y32$G47
M<Q& ).20!4DX.,I ,$JG8SUP3N$!#[-?,U4EH@.S<=8Z!977Z$ D-S-.'6.9
MA^4ESCRF2Q99&#Y1&MZ;VMHN1@\V>*AL_U$H_,Q*V->GDC >%W,R1)Y)>5##
M[$PZC&LUGSFH"+PUWJ9\MJ*8VN%+A=&>WXXRX[=/,"?QR>- !/V:(% ?'C*C
M ZG!QJY*P)%!6D"6^Q:E _C&Z8 7X,>;PH-S#&PY IOBKXLM;YG^@Y+)^*.Z
M\HKH*^[\$) U8)I$M,<XSC3P%JR)QX;)46\\2[Y3.]8[<TICB#,^!I0R@,$:
MOI[7@PI7#@:VZ'&5HJ6@GRJ0@6>.#6C IQQ6A 9A'A/J?)W&-*/4D'<7$4[?
M4@G($24ISC 1SV"$:BDAZ!EAT_FSZ'!F7]G2A]D99.YN\G*M23\"N<+1XJR^
MPH2K%L#R 5=R&0#2UKO-=E67B\% 3>))I0B-P$-TN&"86-4"9EB))P<-H06
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MG5.-FHJ^G,6VPV0]_B!V(?3E<[I,LP7),(MM)]F#5GES!="[V,G(VE7\TR#
MV.]'B^V\AMV;X1!LBB[3&2GQMU'>>$<O)G'4$N:#G7Y9I[8#860"E,3E55'U
M8JP.D\7^E*A2"L=I6I9=,C'M8V7IRX9YI*I ]DIT]9HE\RKNZQVW0$2^UHQI
MW83,GI-=#A]>W_"*AQ&;Q;!(DW,8-&$HD8UW7[]10.RHH&HB,8EJ/+O:G>'_
M 5^IZF4A)Q @?450"&F5<N_F+T)1"#H!SS=N.T)URTKXS/_HN49!OFQKZM0L
MUIB,)O5.B(?BK5RBU<Q O4FP]"P_>%CWM>,\7M)(1!#*9$>3B'O</;7"TEI3
M L(I[;N8+?NN#RD.[7N-W?9I<B>'>7[CYEGG=HJ]E YSI4R30AV2+RM-R;J=
MBD@M(I_-X@S+L5,;E:K*"*JL?:.%(JYXJ=%-"1E%Y,MHWMMK','NFHNE+F(T
M! FN&1%';@'*L"ZNUO6M@==(_-QT;AG9(69V?^?NX]0[!K6,G::;')\J=LD@
M&;N4]:6EIZLGD3)JF/$V;KGL50(.+@7M*;][J6UK$C,>NV<((3]XA$S>F">J
M3(V&1A/_HZH<RRU.@M3L^]J)GA#QF? FN_=ZK(VY&*R.Y-<YM!KE6W/E\E 8
M3XIZ2H&?-6G*.6*DGU&WSKV![6KP)^M.)*OV'6Y2T-MV6[C"Q@VNV$3X1:98
M/<0-&SN2FF_);4S5467E9SZ =B#BV_MRJUKJG2M%A1(<>$4V:UTKNH>N?6+N
MG8R]<2QK0! -:*+E(CH2S2YT'!M%.9VSI?@OE6'L#U/ZYFA[#%#0]]D_VGS(
MW)1WC\20VW=^K&>]I/G@6@J^.,%K_-Z*,+H+?G "0F W^#,*:C;,,\I3M%0Z
M,9<IEN>F9 >Z?,=TR)DK#L^&PZ<I;(PB:)=EL:ZKG:4CV#](!""4;423JOL&
M!Z.Y]EK<\+0[1OWXP=4!'$&0#AX31YVS/WADW#YSFZ[H0_65H;0QB$&3/%+R
MUQ%%3/R(+G;G33XXE([BZ^OSW/*_R>L[[E>(_A0Q;*%GGHABAM 0+J#OLRQQ
M)U/=2^(^LD'@)JP6NW(K=[]W24538?%NBR8 @+^E#[H8455HWYKIIX!U(1;&
M\<(5CL+<+GHMJL6PLF9(W-%,7:^@8'$#U["98728B;1Z=>++LF[C57>[:GRJ
M 48K]2 BTEJWA?W!3'/V+<.#,#).,]BPA9A] UR/$#*.LB+#%<G&?AX<@ !H
M;4MJ*3R+T=Y(/!9+U")W QZ\(3"L7L!+WD, Z%?P^_;;7WTY0CS<FUDIJNO\
M.F)G)N?8>6+,;U\0FP79+?7@H^MN)3)OE4O;-IIBVW=6N"#:R@>"L1&0AT+'
MIW@<U!X>H9@GH"7*$+(-\05273?,N:HZLX'12WQ *Q.>GHR>S*&L8_&6$;'F
M_V:YB/]FZ]3"^C?T3[)4IE"<B\*?89#R4Y'O_%BE9W4,Z;\7!95#!]H5NN=I
MHLA8))O&N3/56VGP>CBQV ZJ I,Z9!36JB<9L WB@[Y[9?%5Q45B,FPN:V6^
M(R>X"/FYG:$)2C1-J9BR?)U-_L:R7N%O=CG9BB7&[SI'*4KBLHB_<* ;:2$Z
ME_U2  J.0>)(P$;[B-4>^YEG5D94](@;PJ3^&_?T0P@LQ\%RB-BB(F 77PC8
MZF#>H#_>56BP2*V-,5R['\.],]PW@>%0ZC[V^GX2__7[T)6)USCK\HW7M_81
M"?:6)C<^6U<KH^XG'JP\SJBB5VZ]'.<H$IN;(TLXR!:+BA.G"79)21NX'(8T
M,W$!61 =W5,_SY91%V[44I'>-M CJ5)*/6, F*PTF\Q-E]U%*EX6N SH][[]
M]=B'\#.E1Q8PB\P>O'LK_C'<"A9P,:"C.4?U%C6'T1:HTH81H;PU/&9N/<P=
MP_>D$41I6(SX+(^7AF[ $&J^-A<UG\I.I]$KN@MK@O'?YIIHA@XFZ!J"Y_/9
MCRN=I+#UF<YJ6*UH,2EA4'F>BDEA $2\H;&YXH 8Z*@8K%6R)]+ )H?7+%YW
M'. >[DXVVZY[A]N-Z8=0;(.N^^/#A]D7#S[&C?[XZ./LLP>?JW>.68=$MFS<
M;$]SM <D+AV.V\";UX? .-=LB-"@!I[;>KY_@ZB2#+)M+4Z+MRJQYRHI*R13
M1&,SHL^?""Y])*8T"83N=XF9^GU58)FL(1=T+&4P>QL*&@A\+($5DG1,[+(:
M@=[BX?(>MUD93,YXAT7*\N&>:*JNK),M7]?7==^.M=?^0<E]JH]ELXEQJ]B4
MK >?=U&4MAAK32;:+9:3S96OPKFZT]8<]UX]KV;/YUTMRG+8(JWQX:N0"_B^
M+<X>BY?$T/-%Y&JCY7HANJ/&BC[?EH#L12&4_AX6\G6@<H,J>>&8EX2]J2.T
M68"\>?A%:&UX]?V+%\]?ODXQR)B"-?G18YQ\R,M1JER?K*U54+2;=T^PYRP\
MWM0]G_S]93)V9GB="9,>6$_6ZS,7E+3TXXYY6!>%=-/D]+A^R[YO/L4*1B6;
MR,I[YBIBI<:E#-1NYS,\<6P!'C=!*H8<\BM;&UM58)-&QX31-6>=[(:?.5LJ
M[UGRG?/9I:*-)K]C'(T*E]I@-BT4CI?M(,SM8-#1BTZ#BO/L50S&UU:[3A8R
M'.,1I G;(?>;5+:=%KF3O+A(G8HVAZ'QC]A@P7ZP ]LPM=CJQ4YM5);"ABHB
M>>BBY958D S'"4U+"SM.D6INXNWY</IK+ZTU<;KC0#M.'GI(V..KW3FR=5KI
M9"?.L'=?AP>XIIXQ0V^-#H"X1;5F<]&M:,08<<,8C*:"'ULU=E5N@ZS;X_C0
MPSQDOIKZ2MQ$^<+\V%7I4U<(("GHM]K<'[&>?W%WGG> 7NKE1>LZ7D ZQ6H^
M]--T'M8<,V+CW\I>(OFB^3=@Y]XZ""X-;MFTG8J2S_?*ZVSK1H=#S3,B3\06
MX/4#+,K4Y='2/M#?9.<Y5)2'3R8+Q!PS\Y$^8Q-GHN+$=^LC5:MB'5%.+.]!
M9Y)]Z_9(EMN=N OKYFK\<W;D\-43DS)%86I)$60D*UFM9:\4DR%UOL[C*(X^
M+-_=:P_>&Y[BEW@?8UIG7VK:UBDC2VWP5V#2H.+\ATAC^V. 6L$;>/'='XX0
M3'I;^>GAEU^:8:><7H'-JME-1;XB/2+8M^ET5]I^63:;X?8$!S>+PP]<R88^
M&LP,FQ(K!"R,$U7C.2BE)L=\RR+.C"%]* -XTO;D0N6>W[!MTN(3O(3-NEN%
M*,J6UC)LKKTTAK4U0KDP6C:X9"#)9&U6,04#$D#:^*25"2=N2(E0<%E9LV(3
M$V,'ML%QQ>/9B[8@AG;)MLE=/LK_I-9-!Q&8KR^VLZNZ?N/I;\7?<CXNPJ7;
M$4(S&T_04BL P_ZF(!;)T_!K'UW9/<%QT8Z!-1 %@%L2Z"P*L<$A3PX*K-,U
M=-Z,#ZX\_.6I//P[QYTZ2A*CSC@0IZU:8+-D$)Z<.P:+0T0/ZW)#2Q+PY]1
MF5KPJNL$D *^.9X(UG)LFF(SG!G50V:0-'WG3V3FZGSV0VR^"Q'NWK-K^80-
MA^&CP]XJN+5TN'019A4_JG2;S/Q7 V[TS'+D2O$^+J)YN4S) ;Q),1MI31L@
M3 %A_VK/#&]%0JX'H7J'D5V6.Q70!%?Z6[_VF=T'#Q]FX[6!888&:WWFV'/3
M<(SE^:^)]:Y1^J:TG/,UP9:2-N[07ITO;F15T8,]:&EOBMN\B1F;8;:7$$1R
MV_4N\*0'IOJ^<KW9)+/,:6&*16;[F+:L6F5#XM6^D9W_:WC=8'6]]A$<!=JV
M9;X>SLL/R [&:Q[Y+<K6R$7'L8!RE955 M8W=25$18"J&A1/EI:EE#\S[[J/
MHI+>R7RZE.H:W;&>U,/Q81MQ8$^C^"8N7.720)P57"[IBTR+SLGPX_!BZ!JV
M%*OF-%S.SN]@6/EW*3=9]L_NV5-EJ/H2LU0G*F'T4_T4H+X4%PBQ8TCNY%L1
MLF?/8K+%L_I/D4A8[<52QF$7YEZ>Q@#GGJV*!!3W[(E2Z 1+F]GR<T_@,Z*M
MCWO5BUII/% +_O(!!8-OJS9<>PG8'+Q(JJM9;J  Q-W4:6+'VF""GD>4 WQ:
M'20I@4,S!"E@GF&3;P?02BYVR>?F]<)!Z= /=&XC#8MZWFL\-&H#'W9(F8LM
M,N;^\0%XIB'^"530NL@7UHY:ZBNJ3A1A_?BS3_[R\/R!^>D2M%I^*J+U\6[V
MR4</'F02_EM_%'LE;HH/A@*F,EZ'BT6N,(C%VVT>N!W"2+!6B2VMN&(]+/8@
M)4+Y_=^UB.><?ZSH))W0'M?+YU)+UGETFZOXJT42C_'Z.C !8U?F76)W!K<-
MN5$D+VW<%/F_1+3PP7]*G-DN%, 8V;(!N?0RGD8*M:.ITD3Y&&59F:X=M\"I
M(=-I!6 $$.EN.%BM<TJ9FGTF\+35RI>','"DD$CH0SG/?\Q3U,R:O2!OLOQE
M]M*3D"^2!.MQGR(H\OB"KS#M$=[RF]36=B( ^,W^I*@12\OWK=U.<[7,;23\
M9"&=E<Q;,PD1[FYM\QMB-'=PK38Z-<5JA)['Z'NG2>($+< '\C+3QY[QAGH4
M1\\2J41Q\@R+%7E#XCK,*2<4!=M\1Y&^VAUJWQ2W4\?[BD-SGD71J:&))R14
M0\YG<K<$AF5BP((\=^,!*XO0+/<>=BF,5:F!X50M @'.Z%@COJ8J@3[D6TEB
M :ML9.\U>K6M6TV7CEJ>AG,4L^',E5JO"?".\/B9UF33BF]'"@797AU)"O6
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M>>H0GW_*FO&-+YI=KH DS+TP$6^9#@#0+P@5ND"?%B#/X/#"Y <EIF\T==G
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MS!A*7+ZAJ_1=/7O5-T"85I83_:WWPGWW*LZJIAP>=35[7,P5=_#1Y^"S>O1
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ML1ZAD_$Y&9^3\;F'QH>16*+8JT*4>TW^A+94:DE#]\Z P:^5Y^1#5G$T^X.
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MP3A>HEY+SK0F0B>YR&1JE>./IHF.5GWL)<QFB.=]]""Y\2A03XG^29#\0M%
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M1^:$X$JRV>$WW,&P*R T[Q#[&'?&B.'ALHI)PTRLQOO/F(_*?Q"""'&7CG&
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M'0<_.SEWY6+9M269'&4C' \KB%,HO?26T,XD@4?TW^&N>!G(M,665H1^@H9
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MC4:2[XO?7-D[KX:O__+ZRL;T6]Y"$5">JM2M(]="U@(_X/SYE0W]&B522!=
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MN/&,]"W],W#:.68(N'^BNKE1#$8 R7K$WTT"WANA ]?'P#:DVKPZ@Y_)"YY
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M=7U)<%ZY3>_3%F*2=R4XQJ/8R:K<X_E\'$=UD[RQ'K,_F^5Q&IU,7:-BDGV
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M3HG,PVTE<AM%2KW%P9L43&_@K44@R87#'@_:BP(>,6+%\>]H1A[:SMP>;Y0
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M <TN"]E?SY1YNKK[N;KM>X;J^3YJ(OM3P*'^WC>M_S(-_D\G'&BDHW%,S"M
M+[ORL:H]DZ$+T)B*=Q$8.N(&?D"()9#,$[@+(*32MH.XXBXT^PO:F%%%9*]R
M$6DQ#Y+U+*P\-0PF*$&W;G9]. _<3MXE4+/CE2LBM "/8QF!,23@Y_-*1N'0
M%12/81DB6T3;[\)J,7#3B;,&+]"$U)F1L)KG)L>PWDE06;9KM%4ABUWA/<]
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MMCV<W]9V3M >^5-;\<Q@CZ-/7J"63X_.@8_<$B>2;K%&D[UC29ONBY7]3*2
MT"HP<++',M3CXL_/^G[QOD0^4,_L_$0>*@ Z,HYCC%0(9#<Z4-O%FI11SUBD
MBA;&AE-3!OAFA7[4'4WS+S !8D[UPV>>ST8-V=G8^6KHL'ASC;7(!+54+/:
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MX!9 .%&I:WD0)BH_*S@OVVF:KR&6MDI7<<FB&F=],,O=5Z/YV,JHUD&3+9.
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MF<IAMUS:(^63=*KCDV=DK6V2% 6?CP2D+BV76$H,O>M)CK+:Y&Q.-U_SB$*
M[F[HV8@(/^AY8Z3VHAWKT#C*A)#C]8T&O^\$9&H[M#MNKT?OA9C"-,;F:!Y:
M1X<H?A:/,;>"<(7VC@R?LA#GR0T9P\5HY0/N*.^XP%W$[9PC+;5MLU)*U883
M5E8?)XT>8=ITL_85NR:C<NH/CV]=JOU !O1^Z/H(BC &TL*:3L+UYU%V7-3Q
MZ8_%=36ESE6,5C:?(+5]M,  C(,A+18/&C$+L"LG>ADU;2=?9L@ENEW-N\__
MG1?FNZO7##VS>O7-?[QYK<$=4L6??W\C.!+8=9_#Y"+"#;JZK0_@*99U A>5
M/@[:+F8M0[5WS$!K**DS-\J<H@-:E-RVKW?5K3[#HNA:*8%3Y.IR9@'>^-B,
MOS R@:4Z"D;G4'O_R)U:.&YP3Z1:$$6N]:WDF=-<:(ENSDT9%+GVD/\8#$\6
MP0&DKVT S8Y/KGDV;N[IQ"5!/!_V&U\N6YI_?_>M"ZEI@L&AS$17DC[OY5GD
MM96[<4T';":4.^HM- T2Q.*]N+OLY.V"C9VI23;SR[8$"L0D9%*UFV&/N&P(
M:' E@@9*T!4A>"[R\Q5&*";3T(G/L('%)PF7X(J>D!?J-/,X'G6:1RE%R[F.
M2HQ3GUFMLGK%T#%G%/^,!RR@CVG](Q?YL$7#Q@GO3I$(6>SYD]UAUQHVDN$G
MG'LT*QZ#<#_=EI$,B>V))XU)M@#*O6)?3_8[5TU0S>T!NNBLA8E[+FT4\V5H
M%YZ]_>R?D+U]YM;(21SH7W04;V=O!5=<T(4#6*Q&$*>E*6Q5;EH2Z/7'TAEG
M6!(3ZPLIN(#&QVI#?26NY(:(P5+A#XC/FL@)V'AL#\S@X5VO_E*Z#KCD?7A0
M*"],82>@ B)%8/A5T>B/I+XJY-S2WVX$3]4ULA556[JZ+Q9%W5Q9319Q*_"B
MD;/>Y?O2]^:%^B5GP*#V,,U,L5KT\,:D2G9E^('/_EN_,LMLCV.L7<5M<Z -
M94!!W:+,&K;@97YK,8CO:8+?U+MC9NU;KG-?>D":9'[IWNAL:7"A&(UL^2L-
MKT2+1IM'9$TGDWY+7M^02\X#\[0$#Q1P"M&<L\F#@DWK1&2 @/.[*ZA5>?(L
MO^4N'QOVOG$]#-UP@"7C]"19O&1%-WM-0_HQDK*,[=%Z-_ Y.H^+LMRG-JP$
M')*3/9<=QBE4T:.AB?08Y059L0+$*,98U5E*-"9WOWBM22UW5/'[J>$JR68V
M*F@MN.M.XBA-GWNW.S7;.I()C8;*"AB;U7H(YB;#</K^^2 W.BR/#Y?=:=3&
MOEEUL;<^('LU>T:OK).NM\H7(0^0*&]B?."A%%^%AB8M:\%.Q/;04>FZI(1_
MWQ35]LC/-,A/7XHH]9UR"VPN*OH$UY.M&M<K(^VE(?7"V(LA:^\,^1C1XCJ'
M-#YQ-G[$< Q<62MM4W0FQ F*X4GVTN>LSC>SG7_.6>].>:.F'Q(9E*36LO L
MN[3H"-V+<&*P@!5C$CS%6,1HR+$IK6-HFB[@&BB43P(.]G+C,U],^B[&=Y7)
M94KI0Z,I,WJ]ALWT@H]BTS#/(;VE+M45]YYPH"\]M.)<S% Y:\VQ&M9%QU2G
MASA&45!9CH)M7M>OOGWMH>#6NZ8I%,-.@#G9,W/PQ%J@BPWQC^_11(ZG.JP/
M %_PU[%3H\ -#R#O]$E1)-_Q\#1W0<\]<23&X(!\/!@SR*F.HBD5$W:C62U]
M&HN]5$^?#+-P!S?.%0,\7Z^^;!Y*!518?;/I&U0_O'SQZ6^C&*BZ;H '^T#2
MN"4')BK\HB&%PD]%VB:TN80?N@X3)Y__L<5@T0'0?VTAU&PCJ[R.>Y=#3*7\
M2<(D$S6QG1HS-SN270Q%&S9L!WD%L;MS,I/;[6W>%>BB[@63C=;J=Q''EIL/
MM#+A,*QIHCRQH>NL#:WVYAYG#3K&3?%:*U!;  0$T:JT.L?DK;3.[O=5WY=:
M%=>P[3/4HXQ\GM1"6#\ZA^X%5)[+>JIM>)%% 5D5(Z"A^\>742'C_8A3,Q0+
M%C?M@2/$ 6G%B[LI^KRKDS$CHI-GA2['>&;H-<[0G@I$NX2OL$B\>@8W2A^\
M9O.Q:6UW7W&L@7?PM0/9^#8O8K^T<NL&_+#7WWX90!ND_> GK@0IB[0=HX'\
M83< M YJ<I'G(&U<Z[)_X-HLU''9WL]41WLU]JM_P^+>5V2GJ_N:-._R>L>J
M+\N194])D.F^SYMC:K^I)S,2@EBOK__ZCH6PX,>;-VZ;:/Z7PX]5<1"4XE;A
MRV%K\1D-IB:R@,QCG$7(5OIR+#"#/R$5JYNT96-  34.G(Q*C'/NP776=8QR
M3[(>&C]+R@UBD<,\7,'3K%FH':..>(H5BR7ZARS67] XW8:P9^8% ^[G*:O4
M,G\^7KIF]3\O)E2Z6#)#;''IT.*^S?D _!@"_;#3L<1NN^#/@;>K<%/E)&1O
MU>1L]G/B1_2,VL(1J0F[;H!7I;G5X6N??/;IBT_>_^8W+K7)MS!9$_[YXV*@
MP(VZ#U+ F]_LPKW]ZB;8,+ E,^ZTD11MA-UQ(!/<P6=EV#[1_!\W?Z=+?K/I
MK;] & SX7FK+#Y<UC"LWW!:MA[8HI:Q' 0223*X5[)P.Z9M&\[4KYY/"IY+!
M/]^',A7W+'RG)$-3;9T1)M<XI7SB2+UQ )EJG:1PZ?=79GH'>QLB-.-I3$,1
M,5*2OR\-$4YQ+ T)-@:AYI_M3@5@//8XB4%4CIIU+]IE1/5('L-S/HQM395Z
MVH-E'4XFYR"#8!'U/CU\<N+.G;;XC'#N1J4!6LD9JV;LB['$X"QQT)F$FF?V
M:94]Y6,ISON+ $X^E(++*,FVT ^A^5L'@S.K@^;:0[=)$>8X[#@';1?X*$;Y
M2-W9LI+P53PE9T"98VK2*3J 8.P$U8<,$F"=<AR1L3(33X(^I%$#_@P6S@GO
M3Y+1VY8QV_@U\D4+&:8F_@1:CN.@P;T?N]_ZX !PECYZXD([$W#.*<U<;>HH
M_JI-4_V1"S5^CC$O0I&O?Q4QGC)_G H+VA9F6(-KKKYE0%*8;#OK@DXZHS^Z
MU.OOEL;97[H .93L;9T]3"8GYP%"^+*M;INV&;@&!AWB6<!*E<I7"]=QTSUN
MD]C'SF(.V-AJMN$501B%"MN@ %$U-?)5.9DA94EZOU&TFV\EAB]6HD%0CU,3
M JS!,3+D^YC9*KJ+Y";DSD\5W%KHWVCRT-#*S1U+=:Z^-Q'O>&A[6*O^6AM
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MT9S_Q\]:S#-=!>=O85%NM)=$7C@EY.")_'=-ZL.\D<GK<7#(2/[=GYV)=^(
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MO;MR!I)@D;T7?((6V;O(WD7V/D/9RW#QW)_FLH[H66O1#-G=#?VJ8,[4#^I
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MC&S)VL/K\-<8.H5&>=<,G#= >!D^2_#K8].T GA4K<T4FQ(ZB<C-:4A3<A'
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MSIW&3^BQNT;:^1\$\T@I7UU3NP?[G41/8U0D16&KSU*N) ?%AN2Y97$.N7*
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ME!J#B9D7.JW(4@5Z,\:K1BPH,H4XW!QA4!MZP[0@2VU_Z9KBN]A!FF[ B2-
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M^//?_MJ>VS<]4'.;=E<@<KL2)NE5/[0U[$++"@I../9G2W8"?4$*,G@G4/D
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MM&B@9ZB!TLHQY:?7EH!N@/SF2N=N8  <M%<IM,]MTTSKSA0S,R"";?[ZU=N
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M8MP@Z^*W^KE7(\K/-D=M0/L>%6F'(POZ3/X*0-&V]-B@\PNFRN&0<FP:C/7
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MJ[KN]11.VY[%Z#!B7R#I^ J+E QR !?\V=B'7EQ=5N;":\Q@1U/D()RIA(:
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MR6&,E-A>"!K>R;V->F: 'G[8'9;1=>1U-I7'OMDT:VW;PQ]E"'W/&5E4@*@
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MUJJRH/"0:FZE&=[73*M5IQT;'B!<>QT$(8M2V7 +A7]JQ=&8FZ>!_VK;1D,
M]E[8=]J$!G7?#"UK=#=D>;.YH8UC?\MH\QU0%"M3.6\WK-N1CU9*?XT=JPO0
M4AL<#,SHS?6CXHIV%,X^>EU)0CW.-<LY?OK4_#@(WEH2-T']L"2S%5;6XP72
M68(A#]003B$DSNQ:ZUAHIP6=-\;IK,?6:+U@%,[M<P?>DLOVE.8U8:'"BWS
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M4HC^ HN,"U++<&2X_OJNL^ZD)T9Y3IM#9<5$@;4I[/I+8O9#*+_'7@9>''"
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MKMJ%#?E>J/*:AN-H^NL/KX.M#*J4:CKJB^D C^!>"9RFS9>4=B0PID[L@ON
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MQ-SENTC,Z :<,1>9$%A;:=D@?!#/_I#EH9[QU?U=C4ZW[OL:=(Z4SK^K/"Z
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MI=#SUA"C,&G<#\969)0WE)$J+4B$$@0ZO#N%,YH2;JR:P6$A5&Z'T7=-(IN
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MLL1&6V<9,)6B[AH@+_AY,8$RZ8Q23*46^+-CG5UU\J>AM19L^!W@K 2+@8
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MN5[*Y&:2N%7$-0B-H?:4+-H&DO*,&);>M50VS-7L*U(6UT +9V7+EG2U%C[
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M+IJI^!F]Z)\=#1L*13IH!6J@MV3QP@9P!5\?D 9$5FXL*\\&)U\*([&/HE+
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M@&:2%:6>0!U\=SPX[/SX]/;BV#  'H6%PE>2:JKH4>,UNYID:5$E)1P$OWJ
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MZ':=1"M=)QXU3>YC==FVSWS/&E4%X<\WBIP<AD=#:=\6R23:8/MGOF=\+]K
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MMJTD[;^"\B2S=A6D$+S33E*ER/*,WG4LK:4DM9]<$'$H8@P"# #*UO[Z]UP
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MM)X:B#V,6#]8_*0^6[JH%,82J66OH_W=FU3"_.X;O(.!!!X_55ON6MDIJC"
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MHJK%I/I::ZXNRV1;@WGYHOS8#T8SU:I!1#>$TR$D6"3TCYF3?@/A-$==*+S
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M.#:?'6FM<^&7_:.CV-3?,]/G!H>+U(0Q 6DT9RX5P8]%+SZZRPJF8ECN\8G
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MB[LCU@48+;V_QP9WAQK."0_J]+8#G$P'"W!R'; $)Y^,DW.=^8Y8O=#HZ,8
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M"FI4 _*8^%<.G##Q[R G*[D62[)$,#*95])4'BJ9O]MHZ8/!_MP>G*U4W 2
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M-<[@CR[_%!RR9'?0,!J&_,?6_3-Z>K/3T/G#["U #J-1::.!O3,)&* ,%%
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M)!4$;$$"!B@#!13 %F +*C"05!"P!0D8H P44 !;@"VHP$!20< 6)&" ,E!
M 6Q1X)2G><A3'IS-U,D(8)KX40%(5Y#?<1WE-[LZ,X0R/C$_M!\<IDU]-F*^
MSZP7:\LWO$!4?*Z9H38R;5] /&.82UX:[D7[C$JC  ^H2(E!*],IYYY-IIYO
M^L\J)65MN0%_#?FG8(M,ETO'#(*;D;QNMKP@,;NWL=7=7[%!>Z!WV_MSHF!'
M*FU'$%8@ 0.4@0(*(-4"887V8EAA,UJ5408RK)IM8F<TT,:.FF 2-1GH85!.
MI-##@"Q0,&P44( OA+[M5& @J2#8.9.  <I  06P!=B""@PD%01L00(&* ,%
M%, 68 LJ,)!4$+ %"1B@#!10 %N +:C 0%)!P!8D8( R4$ !; &VH (#204!
M6Y"  <I  06P!=B""@PD%01L00(&* ,%%, 68 LJ,&"H]TD!^),%(7]Q45#M
M\W_Z]C!,2J=%S02F=I>'+] GHM(H@+716HP*#"05!'L\$C! &2B@ +8 6U"!
M@:2"H.*UG$BAXI4L4#!L%%  \Q=IJ=7)M-1:VT/K<Q(H4\T[OIF^)>)H5.=V
M]_66T4 W4F(R2M1Z8!-- @8H P440*781%.!@:2"@"U(P !EH( "V )L004&
MD@H"MB ! Y2! @I@"[ %%1A(*@C8@@0,4 8**( MP!948""I(& +$C! &2B@
M +8 6U"!@:2"@"U(P !EH( "V )L004&3&@^*0"78]-]9)KM:CZSV$3.3E8C
MD^4DYB>9Y;CEZ&4,6RX-Q:"M0:51 -&C[P<5&$@J"+:%)&" ,E!  6Q18(IP
M-U-&M#!"6,X*5B[VM?LY<;#EKS]XOJHA6CG_]T:YT[1&# ^Z;8P8)B:U1.T)
M"J[+B10*KLD"!<-& 04X2MA64X&!I()@6TT"!B@#!13 %F +*C"05!"P!0D8
MH P44 !;@"VHP$!20< 6)&" ,E!  6P!MJ " TD% 5N0@ '*0 $%L,6OK[?/
M\.AE,CR.F,VQKF/L9Q::MLNL*]-W.=;!QHD<4@3/D-%!6TS?D , 1$H"AIKI
M 5$40*38=E&!@:2"@"U(P !EH( "V*+(MJM_K&T7]DS5D+',G@E3I8^Z]FJ
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MP7:8! Q0!@HH@"W %E1@(*D@*,PN)U(HS"8+% P;!13 _&!^*C"05!#L$TG
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M77[I(&ERM7S0X[Q,8- B,\@1IHBT*0(ODX !RD !!? R=G%48""I(& +$C!
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MVCZ% 77*A+X/'/X(=\13!K</M;7:5QQJ,TPT#34:#)@L^Y?*!0;,'0"S>VC
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MBP3>AR0,9/5UO=EH]H@2UM]_QNM^L1T'?&H[F,/7<)M$Q%O^/MKV@<%VUWO
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M1YJO*G/_GH%W>XDXPQ:/6SI-DRLN9SZ^R_$Q>!#RQ+*]1)K/)=M]8J[?N:;
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M/,YYR+!GFG"9JO@<[KT\X6<N& MZYH\0J1ZC\2S,V\O(D%JSQP=HF"9:^XI
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M50$JD _%7E]6V42!=4+K$D:HT;!K2/.@OXX)DC:!HM!*/)U H-*B! @L$HK
M6'^E\'8J[A*GT<Q/8QG$;5BGS2;<0]661*^(1*O ($]7%,DJJ[IU32"&LA3O
MTU@.G"QJ!.5[\B@4;6EEF&9YA*;V%)Y4+P ^!LZ\=$FQN!IL3+04A+*@5!VX
M3MMNP )::BE3@Z_N)2F]S:E+0:&V)4]NR.+U24CU\,!: &691 +VT#=@TEK-
M'[2R)6%"X7=*2*'"9FET #0!DC5"!P'A+(N&H+X6DU0R&X<WI#)Y2N)DB:L:
MACMF6$C^(/PY@JQ\$ID/U?&<+5TY )0X _=!AT$+T945E?6RU,]7E@/-E!C#
M,G6(\Y\"O0?8B#76>9K=9@4=[YR)<%-=_Y(KPNT83?W;.?[O!]L!6W7<*IBC
MB^('D GB?KQ$)FN9?)%?-\L*;<F9*@G@HFQE<B2E;)5LKKSONE^HE*Y+R;;\
M0=048*.8^W[X&+]>923VTH"\T'&LVN!VK<F4ZWB-+1UOGE&?^4(S0[H@M96Q
M(;3EM^1U:^9./3< ,ELV->2(43@SYH"UNKOR8U_47Q)_J@QQ&1XR_+24$; 2
M=/'_\0H XOBSI#KM)QF5UXJ^C-(<G6W*K6 %.CHGUBM0UP0%:L/>G15H(;^A
M':4O!4?IDTA,&RNV4IU>8JR8&:S:_#B/BW;D#.030Y(YC##:IT,*+\4CQJP"
M7_]/V)'UGDI2RVWUG5;-!+6[2'4RT<-C==IHO()A.K2L(?AR=(I]NM/@$_MT
M%\B(E<!SU;ABW-EV,D&SW3))HW;B&JL<J]SIL!+KW%GES.<3J]S9L!*/_#!)
MY5BC6*-.FY7L-YX&G];'"]LFQ N'K'ZGZ$-R=O@YD<3B&,8JBVX^?&A^N#F
MKLG(XLL=^=7<A-K[K,U75:_6]:[:<3#2'R@M90SIG^?<'8SLTKD[WAF-+\Z'
M__[!.!XL$_VSY@'K@AE\8%TX/@]8%\S@P];3^RNM_Y5VY7QJ?VO]N/[?['^%
MD?;-XFQFO_[D6LWH5P^J/.?M_*T(G DV-])OU75WMB]B57S^221/WN3K?":*
MO]>/KUR:'1FPYL3@3NGL@%:G<54]/< XH6?C8P8?+L[X,! ?GP>&ZL(+E9HQ
M&]:S84 FZ4E.G+6&;.TB/3W1Y<@NDNXLRAN+#N EM9NZL;XR,G#!2[I:.C/0
M,$VX-(/TP_/CU0?+#5U,O/JM<5EQCE<?L1CA@D#WOXUC >\,S. #J\+16<"J
M8 8?6!6.S@)6!3/X<'&JL'54HO]B48FW)D<E%L?]K8Q*M!J=O44EV/P<U/R8
M6+EZ03S9VA0-V!1M%2!M-]HG8(HN+$#*5;U'9D V0E@?W!NX\"1G(JQ_ H%G
MYF40.'3*514FPO'PX'"<J2HHZG7@DI:2DII:XK7Q-J';6E+B99P.\#;!##ZP
M+7K*%EVQ+=IYG]#K-89LBXS3 ;9%9O!A6UO4;;(MVKGTO;O\(%C#=(!MD1E\
MN#A;M',BDU7!O$S"P7AR<9D$ ]6"H]K'FGI[L8'M_[; C8NS<P'-R_1P(-N4
M$A<F.TO[>9*=I9VE_7+(SM+.TGXY9&=I9VF_(+)?? C!"#9L.,J .7'V"G%T
M+JB0VL]TJ#Q\BF?,ZV39IW0J(L_9CABE=]_\>/O%9_Z]]&>>"NT,*\TC>65T
M_#GT/6?^%9;PU@^=;VL2H4OJJD3LV#,,:T>ID+_T@E2XUTG^Z#^=(/FS51:/
MMZND=2VIABM(59P07&"UEX"J.-LH\!92L>1TWU4L452A;&R)*<LH4WC=?O[V
M!7H4"=!M]+KKQ679R^]1-S(J1!D54 AB+X;/PK%E3^77;BJL<11.+4?GT"VX
MMQ6+Z,%S8,$S$>&SA-NP_A!PLP</WB!,(\M>\@#\I1,)UTLL;SJS/?A=D%#Y
M<"3N4]^._#G\9?OS?PLKF0B@K)VDM)P8+*<W]AQX"6MFQPFM*[]S;"6AY8I$
M1%,O$)8'ZP_FUJ/G^]8L3. AGNW#O4?"2@,06U\XB8<+@E^)./&F=B(?*-^:
MWM_WPT<[<(05P%/BV([F>#4L/H7/EKT<?.O!)_I^+OPP@>]!DO]-WX/Y3T4#
M1>V$I0: !94!J5FS'H4UL5WK;VOJ.[PX[+9;@]_OWI4*/%J+5NWW8 3,$F[!
MNMVD$8XK?\*J+19#U'M9-43_U2_-)?T;%A#.QV6BW.VP]O:^UEXI*EM<>[6^
M-5L[2&BJ'EM2 YNTI7)ZI86DHA?&Y];@)_$,=>!!^/.&]74B8M+^!)\#]X@%
M"+(=B<P*)!,[D>HT$@Y8 6D60)O!G7 F4A >X/* ]"O00F)1HA0U@TR+*V1A
M2R.SMT4#NP8$*W72'X,'(&\8S?<'@:NTLC5\4BT!S3;V:S:#NBU4,B/%:5N6
M[#5**.3;HQ!D!C]&FPH_\F,2XSB=S7P/%IC&H %>@%=*Z(#?$A0!:XFV "5>
M=N_'B0BL61HY$QM_)Y''"2/7$M]G(@ M2&>H77B.@C5._3&(/&%4CGG@6"/,
M8:477&>EB8<&7GH( 2$?*)>PX1%T>Q<N]<,9W21[&UAXP\K?V(LE.,""$H(A
M@!YX/KR_$P+4P5.PW@S0!(V6U.FQ%\7(O%KQSS!-Y)\C6U,!X-D+7<!-A#^%
MU58XBD,P%HY >$-MCV-<GZ3L8P0;!'BVA-"<=&0"8*5!",L+[F%]:8PVI[&=
M/ULI,_X<A;"N9/[9!X&X#MSW?Z4>D>O WNW5GRXY<3VWW;>';KT[[/3J73$8
MUD?M]JC>;?=']M7XJM\>."=K&S1MB;$984_;4)3>2>AW*ED-0*A9"M8B_[J6
M?Q:'X^01L*U6-"Z%"WT!IF$"G$ 7-0H?1*X:XS0"[R!%7(2_0$7  \Y_VK!6
M+ V!5%H9J>&DU-(VS.!S3QD/<B9#<'/_#9>E,=H9Z0-'-A*O[J-G.Q7))'2M
M$9DO^%7N;8(A!(-E^=Y8-*S?; ]T)2#_51HY]+8EIH/MB^[A!^C[*J,'7H,7
M..BS2)N(*R1*EDD0%:VJ*Q5_A:)WF]G&%<MM7]\Y$_"<?7$[?J]7_#LM^%?P
M0>+;\4HK\!5MS"'Q_01$_G?-V@?R\' O)/DW6RUP-N[3< \3OU;ZCK$.#$31
M9D0>%?2/5TV@J/"Q] Z!+?M;19#H[Q+)7MMI$KY1!PWA3LJ>Q>*U_L<;2]4)
M];J-*XP$O2H5,*D[J6/IVYU&#Z-5KXHQLM(E@\9P_05TC](5ZSJ!5UKQYE(1
M6!OG:G?IP<>4BE^7F*_U$<>-RAE7Z\2S"?)$7'3?/&H>F4$K;6.WL[$3I(WD
M6*QO<_AB@TM&'078\^ %WC2=EKL05CZBT(V ICH7J^R*U<V92 ,;?"H/B!(+
MY[6;1H]@&V(1O/JE8\W!#8X774.T6ZLI4SGD8,^4L;\;0)G!<LIL.M%@.R0S
MWHPM];?.UI#ML")S[5AEWO9*55KF]:W1VRTT4UV:B=''@A2M5,]?[B9AE,@]
M]E(7&C?=D9B"&XU^..T)+(PNL\[2F.3*!DL&9=36BI7W%)2WDEDTR G1 I9]
M#]?>*>EZ06^D,B[+(&]D_R3JL5N2Z\V'M;$>MG"G8.$J:2.#+%PF7W#-+4G7
M,;9;FT?C7][ [9U"K>;&!NXP!4+;!!+[%-9:4S%429^N,#KEH]8IEM+>)&MQ
MQ.JY5JNE8I:32+_1S+X7]5$D[&]U>PPO]-KV'^TY["%^?N+%,6Q>G\C%M5KK
MS-O2 K=&Z^J')TN75"442."']O9UA[L78]@S3.'_'1NG-0%\D<!;UU5 ]W6]
MV6C*"*GU]Y_QNE_>>B'.O0A@R?>>B+?[\4T8S4*9Q%_,(JT4N8T)W3&5T)^
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M>E@S+PY=Y=\(.\D.8L(U*U](QC;IT!+X0([.IKV+'. >JXFO^(9Z"R^F& Y
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MCME:N(,+F)K$.BF.7R0"G#%,U]KW0*E[O$'NO 4BL6+;E[DVY>+CAL*+2P_
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MZY$Y8L@!+WR(!C9LHO/\D2OXD_W,4V.\.%\]:BD*?\4&TCN&NNS<9D'E1/J
M>)U$W/\;&Z'!BES/%PN-"C7@???\9-//C3:8ZG.:1,X*W395/&K3I"JS2*3?
M$^^DM\!G_A-:7M3:'\LADH$EN#D^S $;1*Q=;,^*YQ  VXJR#3BY1VS3*H@)
M?W* (4TOO,?" +8.>%ZG*#80A1:1791T6(C[MW*.BYIP\4X/.XXW^:*@;W+;
MG:JC  YP[533B7S52D^YC;*C1*U,6-0L(G61+BHMTL?$6TBP+(&*RF-2_)8=
MT;/[-+"%E;%R71$>A8\8#-XIFN(ZO"@$%\H3 7AW77>=U*#@0WO*M0%Z&4U
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M009)\85,@=:0BDR!IC(,1I>>8=!PN'HT)5N@%:(A2V$\#0K?,2C<;J:U-(T
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MCG'9*$&K,CA>,N^"C $IDS'(#B [@.P L@,Z90>4-P,.!@4DSQ61*L.C6Z;
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M";O4+0]-O9 I[E)Q0Z]8Y_>4?:^%;_ZKO!$^V3;"/T6/_C-Y<C1"Z+#5_4[
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M;3GL:B46IVF%.]^GTWL:6#A%1Q/M=^':9JSC@2T^#LK;$56/Z=K4U\@/OP"
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M-O6#@%D:C4[ 3,!,P%P=F$?EICXT%?,8#"?J?#@E8*[$96?'@BCD\5.@P^G
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M 9C^:1,;%#?S RZZ,;;@GW0/;'+4$&E B9X"7!/]5C&8;8>V[N'WP&6SP*L
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M'3D6X_QMT&G^A;AT'*:U9H$AG Q:(LLW,5FB7-7OS AY?"5FI!JR9695!6L
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M((VLX0**[+2&5!39:2RRD^N(O\/6B51K<R&<_GA,(9Q6<)D$(9Q]!I#IACB
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M5^KRZL]SL_4?0#N/*7ZX^"\S B5P%</6K0=!6;2W?%]06H CK 8_P_\W<K=
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M%'K]U4G35: ](@1?>_>M6F8,%H7<M7EO6M^,0=(?%Z_;3\#9BU884A"'!(>
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M]%KK@6*:[C&M3C%-/[W1[ON>UYP/=O CW_:%8#;&:1&$S.>AT"\I1FO_O:N
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M.IHHXN2CDQYJ(**S M$I%_=(=!Z%XX N@>=\2\+L5I+SI5S9*-%9!-V,5==
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MY#62D^('',=["]@[2?*]* #,#MZ?KW4>9K&XQH[=Q+O&JP*$&LHYCT+OXX;
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MB0-;T%F)MG#.,^3)!XWX,"0LTXIC',HW$"HR].68'3A2HCFIYAVU6J&NYV'
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MA"IN"7 /%P;"N&LQX5KRGUUT4#GMV>I$]\4GH)F"B_HB0,"R&*RO4&1M#_<
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M_%T)27]<7-Q/<*LC\>*G]>U^ED[1=%I"@#P!JD-ERARS3Y;H"3E]5*L=P._
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MQ\)E8;!+9)2KQ85;2<UBC;:2:"N)MI)H*XG.8<S'03J'L30 EIX!!G9T$(,
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MW6,8"_!FP<A=,E %I4') T_%R7CK8@.=I6O*TAZF,F\12=]3,[<7="D]T,8
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M"+20\_G^.J,S<M%,-.)'0@/L3**V&(LX$"\<9&4<Y.BE+#= K]2GT_FB@%$
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MAJ0X#%9):M_V2V*5NQU^%P;#1@DI[)J[-O"M0I:K,(!'TV"7R\T0^ZZ_U?P
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MT[5Z1_KVJ=J,A*Q>=-@^84H!=>T5BL()M>4/XC^/8$]__#]02P,$%     @
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M<A4=_8?[GPF+!&\8@B  +T=7?NB$KN\$1_,-TO]W=!VZ;XXF07!T1S_#1W<
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ML&^*VI?]KDJK[-Y'6':U[G;@PKJDXGY6?;AU>ALUI[&=J-K1)S<[VN$I\Z?
M9M^;#84>.N3%[WPUIGS$, DVN.7M>VM'U0E:&YIACXQ8=YSR!+&:#+&ZH!P3
MC6T'9I^2,>DQ)#FCO3G$6R:;LI"\#:\H]2J)TWU)6'1H=2F)LWU)F)]&W+NS
MCB-C*I?7>_.SC_FSR7AD4*S9X/:+*4\NO0Z? ([2-,;\]:')D^,'U/2X@FCN
M!,5?DDL7;3F*00F@LDB49$/NL,&LZ&V;6B@IDINFFH3/'7:VF9BX;KRF=7/
M^X(@)A<3!)R UG_<D+^=@P5$0+ ];$<#&BV<+T0Q*A7.SH F"&<-4419FT(<
M)0=?AW(HH2W7EIMS+Y)#G![AXDU!Y0?H%<^T5S!3$20=+<99M +H?N6$]V!-
MO1[HY7K]2$P(>F1,B5'F1U1_ ,P*V*[#2P>%Q"K#4[*AEL2, 'BV*!XTPBD9
M/3(Q"K$U$\JR80IO2IR_9"R]S!:%32*<$<--4FWF\#FD;7\ZR!PN)S1F#G>U
M(#=;@=;*;S;)W\ER$@?'0VV0L!0JD"(KXKIB_VLU74&WC;0=:T&\SRD/.27
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MESY%C)EY;^P;O'[;,WW")(8Q+N?TY/0K^8T5GJ$;&"X!*CB2Z*]U9[6V9L0
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MD18-J7\G<X1NR*^0K9.+D8?E+D;I#=ED#>,PZA];[3ARST,#Y -\-0OIB$\
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M_C2H2XKVKUF\?2K -^$?J8CX?=,4)@E\!5=Q&J1A'"3@7KSI";A.PV_!*DG
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M,\M YIC8#]MW,"^R."SXS&B% TKT9_R9K: ]1-]%R.[G-W' %BF@62D0-_B
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MUE(8P*5AW7]!)4_5U<ZW8<:2[2"[2$TRC$D+>E875&MP,V8U@>-TL[8_$/(
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MTWK=V(JW'[XK@1B2UZ&_Z'"OZD1B)F<Y1S1'E1V=W<7Y;^<9C.*"_*2VBSQ
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MC(I:Y$U[@RBQ<^J"(A\%DN0"<J6%]*XE&6]-[V.-ZZ\2],63U;^)51QU@=&
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M-X\A28;0L'?7B=;EAUGI@7C$O$>;XDN0*>0$29/2O;,S2MK-)2G.MAK>Z.V
MG'/V8:Q3P \I*M-SK(Z;,\&L-I 0H 1;"_>P)GJII/=]5K7WL>;]5X<LC8M#
M!C'U]683AU!W+BM!2=.>1BD[<?V2*S4D1/GZ-<N5QPZI:=)OG.INWP2),;4Y
M#Y[HE9+VVZPZWL;6S%BJ"L8=:5:I4K>E]H!>R862@(-#"^+3I+E[D("/>#:%
M-3QN'E,4N3C6,NI4AA<:Y49*J4Y8CX7RDQ^+CAXQT)VS<FA>V^/QV-&I$$_T
MVK3*"2/DQSB-=X>=FF6V'M(LO50G8M\Z.?GYK;%;PZA7"=YH,VDH<EJK#%XT
MK++YD&Y!L!>G5LG(>V"5G1I&O4KP1IM)0Y&S[;/VG@?=Z'0:D:'FX.SJQEVM
MS>$TC!O?>HHHP"ES[GACJXO(5-#)G#K.V3:D5P^?<[@Y)#?Q1BF[38J< ]0J
M\@X]CNPAE#L\)^! >8(D?O8E550%3!EO:VMU <#)^!OC"0A3;]SM$J_W=D$!
M(Z$0;%16'*^;L ,DNQC]CS.J0BWCEOV:7A2L,JY:<J^<=A!@-U[[ :'H2YPD
MU[M]$&=TEH!R)??LHZ /6#=%^PY7T0=H [:<JQ\N-H(+DM.6GQAP[Q L0 T'
MPF1J%ZC8KS?7:<%3'&F&8WX5IW$!2>B-5'Q"FJ0^0)(LG'I-@M&".4 IZ2XG
M4D,#*H(?7J0*+=+4[T)@3(X07&] Q95E]>:@QM<XQ2;!YK#>_!)D&1X!U]E=
MO'TJ?H'DOS!:/<,LV,++%YB%<0YOLSB$Y7=S_F7Y/G-6>.DF?ICS=I/%0^0B
MH]L7Q@V@#&2$W0GXPJ4# 1,/0"X?V!,!:P_EY5,SN[5UDT*VX1ONA6?K-GB7
MM)\.9$]SO;F'X2&+"](.*""7#<]>=1S*&BN#6\MFK.T/?((#B//\@/VF0&"/
MZ3T%V&7R\3Y.D]T\MV0=R#(4"[<$/G:R@(J'3<Z%M$RF;  3B/RI$@DPF<@=
MI])ZQ ,CL711HT[#33C_-^/CRE>D@5'S$$(!+A408@$J5^T9*1-Q=!,@3K&&
MSC,8Q<55$,9)7+SR"^IG*,O0ESC=G@=[_)?B56484:-KD)BNP,?!Y0%RUH'-
M.Z3\P88+X,>PH 4M,E'MDF!,:@AB3V2L@> MBC2 DCL0[*VTQ+O"R[$_!\D!
MKJ*_'?*"K09%-'#1%X\P!,^$(PA*EG*1V4W@P4O.( WC(+F)@T>B<SQXEEJY
MB/,P02173"7F2)/4MU-)%@Z2?P5CD%2<_8@SJD@B374N!+6D#5B-*:!N2-F"
MBJ_IEHN8&/-:R[<PVZ!LA[G#]6,2;]G&@.R>BAPQS4T3&>).=D7X5!W'NXP7
MI-Y7O $JF?MPU4$)3J2L6>^AJX<]6=PL+"RF>\&D\6YX\B&*I-=X@HKIY.72
M(]K=.<>3GLN7/4QSI4&XZVF#LMQ'U%Q,CFI<\-J5LO%D;!W  HUKR3^])\<*
MY_2GMG+A[FL<4 +2 /L>;NEE8Q5C'R"BK_M>HB[#*Q+,0,ZX^6'_XR@A:<5Y
MB\C1>%#R 8+17-YQ!_<H*T@Y-!/WZ*)BCL8Q5;?S#\%->(@G0X0$5!T^TJ<\
M?V'IF#65B,SE)G@-%VRW&603M7+NJ%Q'<YB./B9#=.T[2Y-;?6+K58%,*="0
MBA)]!B@QQD9N$^("DTL0372\/^R)9W(&BJ451NEHKE]'Z#K9=:CQ!#EC*M:Q
M/FPTR$*&5%3H,SR-8%7#AG,$4OWAO'F;9/1%K%5.J?'@I._@]I#0<F8?XP3F
M!4JA0@$Q#:+F=C7*Q'D,$'M862D"V)4R>!81Y''N" ^2JEX,IGV!0_A9Q1]4
M E@-(Q.]:$=,&7S'V6[6]DR<;G3NU8[3LC[!NW%WIW9@IG?CVX5::13'I^,W
MMB[33H/8^+1<"BPWSD4J!Z\W*Y(8L*756E1KS_<0T >EDZ"+RGI)PNJTQL\0
MU-C1&WKUW]?%$\Q \12DH/&0'WXU#""2TJN78'&WH:6ML;/4$9FGFGQ-@GR5
M1I]0&E2?/."?\B"D!Y0:+8=521L<]ZBQ^A_'ZSVOTS0'9(C%PJ 7QX UWO2N
M;),[J+.WMI;]>'=1F]ZN\."K6OY:BHSFVF:8K),5*F8)HMJ$/RB9^K DE80+
M*>C/8V@:5: P+O6%6,71?&4YQ;MP)_\([D#?BUASZ@\PQ?1@^%0;$U!:,E+T
M;4EJFG8D1=V)IY><05AG77F\#PZO!B525ZK_L-6C0(59@V_E1.;!8,(W2R1?
M:LZ^NR3Q HN ?\KC"#+)]%JP21 SZO$Z3-Q)&U[.$C1X@L=7O]K 2T*(E+7I
M/5S)"%+S]E[K40*12+WSF@0QZW!5Q"?T+N]=JP._<==JJ])[K,9<B_F5I7YK
M%LY7'9RF3GQV>N?K.:G"J:BC,] I3SP=G6Y.=)9IZ=QR/#/"1B*$B[R'R=,<
M_/)5&80Z4AA<92Q,FZ#@*!MALN0#!QY[CG8[4H<A2+0==HB$?A^Q'I*N>KUQ
M=IYYJP0Z2%)EGB+1ZN0F8+#IJ:Y?(1F07L)/%:;V/!OB"AL(F7=G05C\$A=/
MYP?,#/.^? F30X1GXZ2.'?Y?]!"\N+@@*)(RB*'V[9V:QZ7C]Q-7QZL9TD=8
M/*&HS 8+T3:-_R%7JM(&%VV?,N#J*  RB< 7+!((N4QE<87:@@/LJ%BUY$TA
MF!_QTH;5('LX+=="FGV!!/K'L-N(S[._;&TS@[H!$04(6<J2%;4E$V#BU-)!
MQ_7A;A.Q5WM:D5&7LMF6E3PG%TMZ-:N><H-1 UMDIMEEX2CKN@:>VC-%6451
M3(;/VKSR-G@EHZKT_&.(A.;0T4_2R<RA8E>;(^P90Q]F!!(@(4G->0I(/9 -
MH4&B&XR?R?5&\S';]4LE1^]3#;V<D7&=*)3>P<TAC8A&/N^QS:0%)YW?454I
M+"3DB.D6&Y(@[J9.%$K?9"5G<&"LA4'EW*+\F/HKP8F4-3M<V+KWV*H^Y!&=
MMJ:SI-I+6,"H_/BN]%&%@RT3)MH'+OI,'1V.-:9P=#/B:-$*N5"UOU1!T0<C
MMF(PR!I&WL>K1G$2R6!EH3;:9.^7E*\&*HZ LQ0#80[NK+W:_'Y=AU0P*[<=
MBJ<,';9/QY,;*P>P<[]Z>43;6*G04':T\5"JIOK+G<3\3G?<$NQN818C^6G1
M."%KXT^3\&1C3#FD["E?/P>1'O3Z!XHN97J-U,!N3A=,+J*%B]<:B AE +@=
M>2-'!:O+DMVT9](JC6J%?3_"@%3RC=9XG P/64:.I.AEJDS\>A;D<:Y<&,HB
M4X/RR;:$<% 6NZJGS%M9D6MD]8K+0CZP)C,*+I*X;%;*"*B0?M6ILF]PR!FF
M7XUQ)?/8E>.0=?;*Q25C^U4&_WZ :?BJ>IU!BIP%2^@G[^"@K^($2E:>^;\$
M>EV>/:;&!2!U[(UGKZ 3LIDN-)2:Z-*#^I4&*7(6<.LG__OT, GTNCQL3(T+
M0.K8PWK<2_5>@T,'R\OQ5KVHAAP]N\"UZ;M8 (KYQB.9;_CK7;W0C;A7MPJ7
M -.@@^6UJ>-<-UYK@SF=ZM*&=@93PS81*].,)E$'Q\B$/J ,/'.>7E2ZIWQ=
MBO(6@<[I70V*N2=U;.G7L0BEJ[K/*7K,84;WGZ_3_:$@FU4IZ1_';_96*C.8
M"5J7P=I2W9I,OR=W=F52_5L[EF'Z6LVG=^.G>Z.'[>O490546-"4]BB@S32-
M_HA2^/HQR'Z#Q=4AC32JT?51T+>';HH.%J"$#V", .7D1TP8P03):<I/_2=]
MJI]MFOOY_@-ZAEG*ZEWA-6T,\POX6%2MN]5]0IZF/DJR/.S[S>=O[[\%%7-
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MQM7NPAA9OCHSBRZ@RGS:XG#,)U)48'LO:KO_]4DHOR,053+ZZA?:5C7D('H
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MTG<JZAD543+=WIN8/E,6UQK7SSRY4R''^^7D1>4R]0SM<*-)5!JMYB;JW7-
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MNDM9[5D9>I)O6SU>9&59@6-&#\S&J;\[H<KN1KJF#LVU/% [#AJ TQU7P#0
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MQF.&^N+-CX^E@!SLF!X@HHJT@P=M0?$&X\S#\F$F,80L.&L&>.&C9TFK39F
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MG4U(_-A44>EL&G*'IXY2!]-1<81X*6J9WFZ&ZWXF[&1%K$\ >XK#2*Y#A>0
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M?#/X#'WK1!J^9FG>#%8SW2X*8=W/_,^@^ZCACM)!F<JUY0:_6Q[Q;%OD[_1
M9@]Q7+N^Y1-[FM@OU'FSU1@NL:SI%\XDRHC,X)#;<1" Q7-AA:YDUQNM//6J
M5$;/S+5D!U$6,U;8%(7R@,J)Z$EQ*AM?JGUW/3$MD\HXJ-I%N:V3>&R#G9UT
M*%$Y % \L%ZP;OQU'(6WQ"]S+I[05DFFLXF<J9G(6><3.54SD=-N)I*7]=D/
M_\-% 1@^RXUX38(@8;V3O=@<<D+!%TVFY*6HJ?PB6).P%+I$+]$CD5BI4!/=
MEC6$M$SF^?$+?D6!GZ0;D=8>I-E>LWGQT]0RQ:]P0=I\M8(_470-=U*)"951
MZ$*%%^A.JBR???P2HH!> JF8(_<<@-YSTZ@7_7SJ6:% !G_[/.@62(R#!C)H
MGTAW*B3#OX%2K*37V=2N@Z35D"*=>$!.]\8KXJ7!%BPG=S3W"N%R!(6#Z@6)
M7?^DWH*JIM.Y(XYKFKB591Q*'8/ZXU:T'E5292@E$"(2NPC#*I4SE"(($75>
M@^&A03*4"@A=1W[?EC6];H+_3E"NLA3>?TQO9JCM%HOKK^NFU[MT@36_KV<H
M530ZT:_Q( [E03==NK+2]VQZ&92D=[_.P"N/5;#7PP:B&H5B0T6X%H6W3'^?
MKU44SPY1'(CR4HGB^2&*HSYJKH_49%9D:_+S0':VTDR8?$^,^I0?AK79"</\
MJ50\^.7+>30X'SO(R[SQ7U$8)?E_V0MYDU?+]8@0N,;!H^7E?TDNT[+A*+W*
MG92=BY9$PCTVV+UL]Y8FE$_(35-/KN0>.[M,3&P[7I%"4.1\"7 (5]T 61XI
M-+F%OUV@.0Z08,MC10/V&IPO8%)I!6=OP#Z L\)!1%B;XC"B*E<A#@6TM4RY
M7$ QY@XM"X[Y"A*6ZZO/*7C 5B*6$A+N["L_0*OSF;8ZF:G(3!1MPUFT1,'3
MTO*?T(HX#8/-S6H-UA;1CU,PE]R("$L4LK+ &__*"GPP?L,I2(\%6%PHG,WS
M6E4X-:=%)K2 F'O-Y&*3,K29S7.K*YS4PTU2;W+K!28=LQ0DMQ83&I-;56W(
M[4$@K1*V1^1ONIW$)\=#K8-IB1^IPZ_U--[=M3CVM(%X_UT><IK7@V[VB>]<
M_16#9,IQ)Y'8)D*U<Z>&! 18<"E9"$EYKXA>^8=$C@FN/M9#R:FJ$(BE"!7+
M;X;8YP$A5JD9&^8SG(XX'N!88_XQ\,Q.)Y66=)QW@EWQ9VZVGNB]"VNY<K)X
MIMDBH'W7 6[F0&$+8;8XZ=]"'+KEV%J8;5](BG9!IRT+&9N-IIR3'#=Q_K,^
MKNJ[_>#(\H8"+6]\*</[D]D=8#O#>R_8R3I/JL/[<X*W3[INI;]K(N+EX776
M\\_,%F$YRT#A:_:"5/N::B+_JKTR-RQL$N"&]?M+#6$QKVLID3$>KGJR]P$"
M YUV;/3!,)_X#K7A4\2W)2*B<1H1JEJF>6%YEF^CQR5"< 6QDX,A'!VNHM+9
M-$2#3^4TQA#4&((ZGA"4V44WDK?W\L,]E 8)M2*R!JVA-4/@T(Q83K$/I1."
M9D?;Z>B=J+PK5UP?M(9$^U*GL>>$^0_LD3= $C\\G-^LH 50SGU_X^_Z;>YQ
MZ"JY7VMBK*]7]+:GW[T)G[R4%.,X+.;T].PK_,8RG 6WV%^@(.<O)+^FSOAO
MS$@/[D.B<^@.O:. ZQ:%(0E/;IGO;._5,G*$8':'WN@85#_9,=%^3+0?$^U'
M+^?HY1R]G'USG50GVIOMWVPCT=YL#Z>V1'O#_9PM)]J;[=;4[20V6V\T=A*K
MOG\.I5ZD9\ ?N$W:2+0W-*=0M?LO@_Y\/ (:@2\_ A^T'($.PESW 5ZC(-JD
M-Z\U,4GN4,06IN@7Y )7*H;J52BJT83T)"0FX]][EA_M<2F6@EA%1T\O*78T
M+Q&LM>VF";FP$:C \IVT[H/^O)1CD6FK&U-3^FG)^#0ZJF2]4TK=3D<J+,!#
M3<NT;I$5HB7VG)O5.H!;,?5]B3N5*\EH"FKX813$-MGZ-V3S+T "2\4TJNA(
M-?Z:XM4Z!D/G$<^C[V"$"';V*OM<BI?K./#=B/1#]9W9?.[:*-MZ@FQQ4-*T
M\ D\$O.H)2$%,=A0Q"N"@XTLM!44NI5UQ#LDGEO/1:[;B5UL9&)07.0TQZ_+
MP1:-3/'3[';M9*)2',0ZOXWR3[C0JUBW:,RW;?;K#,)' PL>\*&TSA(1GCP8
MYJ7_4 (M(IH5UUL#0PFQ",)6:]<-)9@BL]TX[/JAO&8G U_9;6TH;]!)']6J
M:_=07I.3!*_2^\+B9F;KB%;LO-N" +SA;\().#IY$$Q]M$-IDR:'GCK7/FO:
MI:X.KI]1<L7[E,:.&'KJKW('?;GZ$UY5V&ZGP0C'$$SMO U/7CR(I9GGOQL=
M=KUQV.TN#/.#*"]C?D7!"^Z^D/D+QLYWU_, GQL8TE^X8).E#R.J$T,-1^F5
M*)*=BXXS?NWZ;H1N84K[O#V':!Y[M^Y<*.; 1T^+^-K"+L(^^T8KBX<6CP"O
MMYHS#D@3!\]#=A1;WE9BRE2QE5/1,HWRG1I^M?Z)@ZEGA>&=M9*(EPJ3[GK"
M%QO&EV@,58BLYECJ]H@T")WND= J%@H41L5[N (B@Y-PYP:9'!"%T=2]=1Q*
M%5_=6<"2!WDH)7TR0I,/TV)-,)3"/UGMB_DLB*&$HP6.=X&Y.)3H<[F978#/
M<%YGXH*%[T*G-3C:+Z?'8[Q:6>1!H<-_>/DG2*<GG/?\*_>&-!K^6-PD<I/L
M^%(E6!131ZGK.V(NQ)4'6]$42ZEW/6WA8I=Z6EU/2<K;Q$=O=$")1()>D0?C
M.D\@(GWLX<7FP5TL9:IW:DEUO>5&CYHA'K4*WAHXV>JICGZW(_6[U2_M\.H8
MN ]1<^^<V14-W7GGS'8K*?#.U9HD0W$^Z?)T&EX)T9KT+/*'&IXA+'0WY$-Q
M8%G"+2!8Z@%IXU'D?F8$MX#J;E;PN9E9P56>4R8V8UH3EMM:Z4M!]!&+/2-?
MN9=:!1M'XZUN--G1:ZW4:WV(_60.JN0?R JNX0-5[NO:87H(1/L8]'_Z.!9R
MM,J.T-/I/\'X+2]_.D1? ?B.6YX^&:"'D[\#K?CT'7FO2/R!F*8CC;[<H_+E
M-EUNYC3[Q>@[H6:@,^G"\%5W/QSQS2NOH26$:40X,8^&TJ*]"X"I^<T -CL@
MI!G@O3L>0WG4=+(H[SKL3M6KM#XX[":V'<3 L&N]N!YM-9_K7'_P;W+>N$9C
M],K5)C<335W$]T;/WK/FOU!4$-%R4Z*OQ"N921TEJ6Z\*;W[.+"75EC2!5^
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M5"1E!A!4(!4JJ6@"."(^Z=E\"AO/C69Q%$:PX""D)BL<BS4NK*<E#S;<I]R
M2DIYJ,MH*%,;5ZD7D&A.0"%UYS;2$F4D.[,ZKM[<,"(;EEBC*B\;%825ZO76
ME'GG)_F0+;4K)+8LBJ8U"9 UFQ,E),)^_BN-Z-\F <?LVG@K4ZE92TH/[K9-
M9#:L_2,1XE;@A,]K!RZ;9R0!]XR_J$R0H!YK%_B=S2=.$BD3GTOQ]WK6Q?EG
M'$9;/_L=^LYP!:O-AS\F$HB[+DV2\# K3'M=FSO \M<=ID)D_[C KS^%T3I(
MF")_H@PEK,#?_O@VX6)B^ZNM8?*(%N0T?4%X$5CKI6M;GECE:P6!]IB.0%[O
MCRJRL!4$.E33PF6PE60T3B3W7KQ$KETYC<ZS:&JGASD78RAUK3P;&]>>0=,S
MW_AD&*X5L$,H<JU74#BG)X=2U"IPSL::ULJ:5C/EL6P5YUCA:WZ%KZ ,D;R8
M#Z5B5<X1@NN<.*R@TFQ%5ND"P\)N.]:FT\S'@B7/;JTO=RA]BGG]X[C8A\]@
M,O-BT@ FGDA-BQV)CQ4^R5 >0U)Y^<VQ(BD9U!U*8V<5>[(L"X U=#:[QX8X
MAA7I'@RT49<<'.&Z#![VC/)HKQSL. ZU\?,0K[8U>ZX\.2^#[=,0;Q7ENXTG
M/Y-A9_9%5A2[NMS;#+?/HX2KQRV?4<V04R[D>E;D+R'FBE+DMX"=JJ_E/^JM
MUJA<(@-U]*A4G]^2(IH,OU'^\=QPBVJFMA">Z6C*9P*$N7*Z#+N/(W9U,K&@
MO#*#[Y<1OCQ\M16T&7"?1N#J]IUX]?06W?-!IF$)2T2>POL,4D,S*=K?L!5-
M'3)P1PTNNU]W>X%D@(Y6^3Z@)8UC,L0^C#&[_/GFZ1B48??S&!>IW&T'_: 8
M<J-+HA(YU@\L@^SC&$_:@XRW(QR#4%TL^',"H4\:\R/GB$%LU$HP0_:748M4
MGN>#;I09<I\TZ)#.FJP^QJN5%6S@8APM49!K,/J /')NGO N3$WZKS8<JX>M
M665GI*-"[!INXR!<Z;C?$-G=R)F\ C<+6E=%POD/P.,]"FPDUN=#E'('_1OW
MV#ITT@JU/Q2G/=8 ZJT!%%^A%IOL]U Q\J$H>K!;[.K>1Q5)&MK[MNNA\-EW
M4CR(7RZ_]:96N+P&NS94HBB;C-AG=2DU+_U:)+.C[W"2'B*F)SF(=: :,SZF
MRF8T[<-T%,Q#93?;+<W6^A1S#=!=<^(M>_D##A=6^%69QG)2 W0_^:W_XS*6
M:"_!0[-74YS,06N3))QK4 ]MS'=O@%Y-OLUY]WG*.!;JG"5.NW=3?H*16UOF
ME'C_)OT=MS9E0KI7$[X#(_CI._)>$4TME.C>)S/&Z#/HHF^0S$JQ>^\02M?4
MHIF=>-;M873 -- 4#,8A1!_5PY@8&0S%(83)6D"16J<,Q2$D#ZA%<>]NPZ <
M58SXM9@U<5&O6W!D><:A5^Y$85"JDXQ]3LVH!K.A.XZ!J4Y 'B^8M=Y8!I=Z
M(7BLQ[C.!<_::J@3?<9NL7PH1FN+H0Z"F8]+0)34V0,S5W_%,#&%#RS+$>]5
MB%)P"C*!HL<(VW_>A&&,G,LX((WJ:-46'9E6M&*?_LHW*PA B817;RBPW5#@
M8:D&(TB%OJ:>%8:S>4IN%M LNKW4@>T8]X%+^@!MATY_F?]1*B5CJ9MER/OB
M7BT)+8Z_0@:V57&/",0@['78(Y;G(>=B([-*RH;2 @@]$Q>@#4CQ,TF 3W57
M0%)JB>%VL6&_DMXN)M^MP-G.A(F'Y'A-XF@)"N-OON.JA0VY=^22]!XX34#<
M]V,B_NR )G#<^-DRTK&XM[\0S49/K>:$W.^8:'Q!*5-+1\]IE9]%+0F=XH8.
M?ROS"E() =WHB[\-5/"QU(9^!,T-0G**?5!MD0OWQ_NMT2G(F1 Y+0 G]A41
M>-@'L<#_\$D- 3V*8_N P!X3PB\NU1#2LQ)@>^,-0I*;O?!S/:M@>2@5#W?6
M"O[X!!HSA.L?L=&%]Q,/-3W3BE]"UW&M8)-C27ACE1,9G^T:G^T28JR59[O*
M7E?^CI^6. XMWYGXSAUH_0@A/Y&.8"^":(1+_;UG";S8)T=7RU$G Q)A(RZM
M]K_4RJZH,-K]3H\0M9?(B3/)=[&AQJ3P*U^59#3:23(Y.OM?=NZM+9D*YH1[
M*.]X\6Q=7':X3'^^JU(4%: RE.>Z:C0*EE6#0WG4B_/0C8]Z[>$P/NHU/NHU
M/NHEI;@KKNA#><"KWM6!Q1PT+%W$[&[Q JXO7..J8Y"9*;EE3V>U9W;WA'XT
M%S4N3S>N=<NS%U?,/IC580TL&(EAJ)E]-FM1JXBL,8S&&TH>J>+@*7N%QNQS
M6!U\+MY1NS%RAI39Q4FU2/'E1#"XS'8\\<$EE.S"H#-;@G&?R583HC*T/XYH
MJ\G5RQ!5WV"R9X_^\!W^JD1/AI7915T-D!+-YV6OG(V:IU'Z-P-2>>UFT3GN
M10%$KA]9B()7E *U8^BHJH>0&*OGY1$B,]*<M3FUUFZTU?];]JYQ<!U',!5R
M0)*^T_SQ= GB!N?9COD[8_Y.BZR.2:EC4FJ[FRIY3*GAULH3^<-S3[PS(Z8B
M6R3'-&1"+019#>HQ M,]2EW;S[Y+WG:V2)L!01T@2[X?M61AF=."_L\33!YF
M(Z]0VAE?"W2, 4%YLO?AF%@Z)I:.B:7*(DA[IVLHF:7%TDC$.RTE:8>2H-JJ
MGL0-+87!9+NVO @<!B9+"C0[$-TYU-MK28L9NCV+TK25AVE>?G?[>9BFI_RV
MD(=Y:KCN45?>9&YBM'1YD^%)O*V5-YV96:C14O+@F=E2729YD#<DV$;_SS[U
M&"PX;*'"+H.RY'L52!>>A-:( NQ<UT;%]Y8[DK$>DN0<<CD)GT@+U?R_3W$8
MW>'H'XCTO,4+GZ3<,4K)1_2AU*>EY:=7<ZF(A7XF]89U5,\OR0(">93^B/R>
MT .HNCD[;KCSKJ=>H+S+4#\B8F6.CVO+#7ZWO)@\PQVO$IZOWM:(N.XNW5?7
M 9%,'B%5&AYKSHQ<I\4 VP@YX348((\HBCS*3&I[).N59>C=^/?$5D@.C$#C
MQ09#Z$E+R3.8VZ="O6\%B/5[]^_Q&\*2T-6@Q_S&CP+7#UV;;DDM!T"(GWY#
MN[6[PBB(J>MU7\O3<$ VP[U$9/J/EW#4,Y&@!7_U3,OUHI3E__=$5?E.NH/(
MG3/E?!9'801W===?E+W7/<4^#>K&EB?4;+DO[.H[$"_UDWTI.=OB$SL3WOJZ
MV>NW)-HM >NH;;1HL^BN0<O.9U;5('2#43MNOP\V6*AN0'\Y85C+<3T<5*^F
MR<F)9(NWKRT*ANSW&=H[^Z^6ZQ$-!]=O:BET(7\.>>@WA(<>X3;!NM7<^)S8
MB)2W)V0O??>O.+5^2/D=[/*OV$&>>*:Q"-6.IBF><EM.HZ,IB.;/EE'0PGY1
M.M;#X[/XWJHA)/>4!/:WKKA+-T VC!X*9JM7D6BM7_.3&Y$@WPUHI%?7 6OX
MFQLM'Y!'5SE<NNLG?.5'<)_DW^U29/5-4*0Y=<G'PRMT._Z.Z;WN-3_ =NY&
ME#6-I4##* 7B%NEMB'-I45[Z2!#8;7YD[8YT1?QD] !(,"U"<JRS/NHZZUQB
MF+34:%+\UG10+2"QS!W:V2+CDUK A/4P"@]<8J%,:5W3D3I/G5,$57'I7M/-
M,L!"/T6'>GQO8GQOHA*7TD:W_);$4(KOA'/8>?+73:^S:5.B518ZFUOTU76A
ML^&E*IT7?@ZRND6==*A\ZL>\RC.)IW[.S:S<EGS<YMQ,<2;Y\-&YV1*GM3I$
MPY_':$U2EX3V3'^FI3XD6H9/7037]*;T3:+EF"/$S]K,&WZB-9FY-5D>K'>U
MX7"W>1$NRP?:E:*?C 6W)J.J$JD#N?G); NH-H&N$JWR[#^&W^C1DC[(*K)-
MLX7X;/9&5I@'K/()F]+D:+8NRE];,7A=E*?YLV70T,?#F&5HH<9DNQ"GI@=U
M^R6G"HNBLK4X-?O-O)ZM17E!'UL0L\/S/9-230I7V9*9Z7CIHWY77/2=+:'I
MKY#W2PRJ[Y3 %G*TM34NI%#+D6R-SD>;0WR-.-KE9 ";'IM2KY":M%YBL(_^
M%XVRA[_?5[9 AD;(VET@39WNLD7Z.%Z >K1()4T?V6J-3K4>K1:C5-8<-5NX
M7S0883WI:IP]?CM=DF4#*[7$9Z^NT['LD+WO?BP\L5[4\1YQDQV^QRI5=V@*
M8?@Y<DDA&.F&[B%G%E"//E_GLQ8'UXQ#^NZ4ADEG(^F=(1SO ,$/TT[X#4Z"
M'C[ZT1C@B 5*WR$\M)QZT;7+Q.XR8WE_-;-C>?]8WC^6]X_E_;U,'1S+^ZM0
M&<O[=^(;\G5.AM?X'T]V[YAETL_LWM//JM=E37WNCY$51&:NCAY/ 2NJ-ULE
M]FEMF!>KC><3/R?H^VA!;-@1?T'7*:OY'A-P^J-*#IY]/U>>PI8HE"M_]\CT
M+3J7RP>8V/#/\)O//F!"#C[Y33!<ST#;DC^V$*B3'_UX8G82<]3[+D@2I2Y*
M\A5_3TT;*_UVIQ]F1W?W-%T%$YH?H"E?W;UDXVW6'ZF [7;;53-V;)NP*<R:
M6>*+PG?>EKPL'UL;VHHY.Q:XMZ6.?01<D+=^0%XSJ_26$Q-[VG>ZQ+]=1ONQ
M&'5[K+):I[NM+\)6/X V5GWVR+[KU(8[OHW&_SYC:X/KM;W(%?DF#&/D7,9!
M5C*?^&X:OWDN0_TH=DR!9M.Y9PJ'/PK@:@V$7EDK1P+JKN;_$N!03S)AU?!'
M 5R_!/^853: K#+UFX:EKB@/<_4P,M^_)2D4?VQ1E*=+]"KVV+_EX%#J+)?%
M]%A]_Y:G>D$4MC,9S()(W+%8[%U=JM!@\&[KOL]:[;>DQ_<3(HQ8EA9]5VQ!
M1AW>V1FI=K.RQP"4]V48;5_500?V\H#93<OZ=YX:AN6RA?O%[,SB'IXO^;7Z
M9';2:R_72BC9@ZW4:%[TTKPX,,S5=U0?#7/5B8&LZ_IH9'1VJDI;H1K>[?L(
M3D_ITIQIT$)]*\$H>+MK6RC00LD%_VC'4V+!,:=>!X)K6W-G;0DYNG)KB!TK
MY+=?.=[2$TZ$G$#O]#ZLDC#31[Y(.0?$D:R0&,='OCS"[P_T886$F3[R13)7
M$PUH:<!>]$"T$*K'MDH[K)NR8!K3_D29,M(^ZP?2^SP=.<19$XQ^H5S UI$#
MO6MR] /E?9Z.'.)CD,SF@-Q?<^2(K(W;L8/SV,%Y<!V<"SR_X</C,_^NX234
MC[-?&OM/.F+"-&'3RV^V=L;7 AUC0'#/[GTXMAWG&'0L$#.^0&QL.]ZKGL9[
M4FHH?<>+I;J2;+DJC364]N6MVAN8V[8:NYZW_##!F;&02C],<&JV,FKM88)3
MPU];/IJ'"<X,EY7JW& J5D#28\A6R^SD^HY\Q'I7]J#315L5LKVJ]C-Y:?>#
M5FQEQ_>UCW5-"\*]K#S7]#X#)B_L?K8$6U5UNG5<U8ZUZT&QF_HB[=X5NQVM
MJ2N6J\?*MPV_0O8-^'[NC7SEL7(OZS#MZ/YN"^$D>5;L;+:?;M"[0JRXA6V)
MT?-E[)80KDACA?:C56'LKA"O)F6E_B?#?-;O*HS<%;G$'F(4SN9YM8R<%HK,
M&PQ_/%7G,I/L11IAV4',V)^$8;S*6C\A$KF_=%]=!Q!^@&EJR3#F9Z8?N9DR
M\_@=>T#&@RU&9O+5>G-7\:IS=$NX,@9FU^\CS%NNC@_F!S?\\SI I*D+ A$=
M]6$O5_)D",0=[^-*GO1!_%(_G1>18_F$@M6I,*@M<='OG=KCO@UF=F<X]/CW
MHL:K&)8PB'*0P-_VX8 ?_9'*9/YZG8*/VF,ND6:"S.U^U!IS#V3YQ%C;^:1=
MQGC+</8^&,MO. 8=RV_&\INQ_$9'YNZ>=#*][*98>N,"Y6%ZA4R9@L6%.M[T
M I8Z-';-,58KH-SWW@LTCJ]6X-3,0]K3!*K&.0\*WX,;V'*UY(5A#Y69W<V]
M9P=)V.DXYN_W>YVV_O<V$O+'=6HC&-5&DOVX4FU$9X?RK-D1K=1NE@++?]?P
M)%;?TI'RJ%)_6.H;>\+YMV$G@-7C\R/0\&('.3/_$5A/+E DGP:E3Y"UD*_4
M)G_'D]#4"@I:NG]YU,6,G.)S3 ZD'PJYZWDICO%"9?%"85B^(!\VFP?[<>*L
MP&(A_G2RJ=/%$>\!R$E0SYHC#X@N@)>O5O GBN#/TO.JIZ6K5R,"1;\$/B[1
M*_+PFFP=Z5EQD=,R,2(K9_-'RT.A^#0*/M;"-,AOO$*9[+XE3,(Y%^\:64.H
MR\F(-H.L)#/&IL?8]!B;'F/3/8L45<HLTR/6(O*_'K.A]7_D,P%PI:UB>NQ;
M&BLN\W0HL7)A].JO+$-IY2@,'><M=FSI.*9I&."YYW74:<VNZ,#]_M6%=0CQ
M/)IB#RXQ./'"3A8!HMA.',=-9G?CSW&P2F2(E"-=P4B]<HDWF8^6UUBVFY$Z
MX85+: H_EWJS)XT*/Z+@U;71%/O;B-<#^BMV XH6R9AYAC4*;N%7X.!E,/*P
MK&*4UF8V6>'8C]J?6^4X6MPK64QS-I]?6)[EV^AQB5!$<CI"=FYRQT$JSM!H
M&*EE!MQ=%%[/? +]*PHB%]3Z[OD0?&Y*@*(>3[1GA2%8.F1@<4]NT==ZO)Y;
MZS;/@:CSMH*(I%"HU N".X63FI['DG(F+^G_#LJ-_>0)_A1:-HWABD<SA$EK
MF3!YJ6(VS_$FNK=*"&@."51*S 9>?QZZ4D=H=Z\S])AT%W'*"Y/L[,HC._E"
M-SO/Z@S/DRYP%G#M.1Z*F[Q:#N(&8GPH+G-9U8G%S("A>-6;GN<*FV\H3R#5
MV\ZXVL(?BB.]XFZ$Q:]SPW.?RYW01K=\]GZ.V5M3A<<%J_(Q,=#--H9T@U[A
MM&20FUV\H0CR2M<V*]94'E('C?""NP_U)!'A)^L-A4PZDZ 7]I,D_%L<AA<(
M, 3=A5_=$'BZQD'N,[G C_)Q>Q4&4C<[?0FOA*5K.&$@<"+7CUU_P>HO$E9S
M[%V]18$%I\.%*\N&GBFXO=CP)0 !#"ZVI9KB";,ML:$Q<UAH!K#JR%U(Y$C+
MC=)7&,"&AF5R[99Q8,-H! )&EO-1<I'I7 _S3/(@75)RU8;B6VL?TTPB,$C-
MKLIN'U)^9<3N^^I-=!Q97B^-RLMT&O#C21@BZO*\=:T74G[N*C4CQ4;JO^'(
M.1\MU3*,E1P'0E4P)12D8H+%Q!Y(>Z39_#E$"5S<\4!><@IY?;+\!7$,PI*"
M?-C^107;E93UE%85\G6'(JGJJ7IBNB>5@ DL2,XC]WTWK!,O1Z*#/0]_)QZ4
M1C,I(M?-Q+X$H+@;S26ET W[],VB1NRG%+IA?_N#1)DUFL<^J::2-T4G,>+\
MQ2VRP$(54V3")+M9!&+IIC]+\]9)$5'PBHCU,+'M(+:\#-X'SL13E:.I64HP
ML?\OT';G;NJY31N+R*]D.<7.%G(*?W>CJ14$FWGR9EJ8%N9<Q*'KHX:RCG.$
MCF1A=K! (.\PV$Q 5I#MS(YH:!<5T!G=7!WY#ZJ7A3D S/9C<6WR*M2JCBD+
M=&IH@G;,('+*]Z$$CGGQ%#4/&'YF>U)5[$=18Y$%XD>!6;XW*RXA#$"SVQDW
MWIS[-T[6!WK4,M6J.G$Y,+Q&+5*)5^IA8GBIUQH'L:!CQJO(N]A&\^_/"7@^
M6I!. ,; 1]W,#"_U6J!/FTW^LE866V ML0>C!FIB-@56"&_TB8&I3N;U_M@V
M@O,P!LE:@ ](]-5C6!=F9K!ID(#=IEXH;-,B2+6O*16=MU]Y]@-DXX7O_DUW
MY@7RT=PE#SNE+-XCX(ULU$1LTG0A>B%FH/!X4AL-H\5E7,YA0*ZNX0,*8X_<
M9&GV51P0&9$\?D78QZ'+'>11/6*7\"B8KV3<K=P/>_6V=I.,N'\@B[^%!3]!
M/4T=BERDM^[*3415./.?Q7K^<Q+L;G))V5;C*6W):)F(FEB@?.BOY'" *5)*
MD^WF1)AP'Q QHEK@/[R![]\RITM2OG[CBV\N<=I22Y4S!FY%^DQ5?*PG6IRF
MP$_)W(.->"^=$@)ZX\.3.%I28UOV88 B&AU-0>XY@$,*3;<Q=ZN>D@_'# '-
M3J>2=3"]ZT[UOCVHO#@\*(.K_2D6-95(#;/I?(5FP;4:T/3N.+7GKL*T,;V;
M=+U)B)M8J*8_PLT%G\1EAB72F-D.1VC;\67 C>>SVCW!D!J&E!='ZM WU6+S
MD^/!3-!9R3 ;AA5?N<]*7= ,)3,S)56@)!R88(E$RK5F4:^BXX65(P;61EY1
MGQ[X*"PS?P"\?-OU7,K";'XUGR.;D(;?(\^.S^9EO8I<^,V -DJX1@Y)*B=]
M).,(!_19^23 *A]QULUA7Z/7VG#0X1',6,ZX(PP4]=D0<1"*4-7B^"QF:'?]
MMM=&Q>79RH?N#6 TTWCB_#,.(]H[634JA_1[,_7,=%<^Z3QEJ9@$SR!@MZPL
MT@)/+/ F0[HW2W:'B5:(;=K_-ZUW*7Y?C+R(J7I914?O#6RT%35I= ,0>#D5
MIAJ@\G%Z \4DVE?6.[^L&I':X<:084=YZDI6S_2 1XO8ELN*H71P;P%440W%
M7+EFNB5ET@ED#"33@P<M;MF\K6RZQ[=%& _O60S,43<)@BETE6_15VP>SL7N
M(^8B5J^&>E9(E&MAGVZR$N>Z.D^OT$#]=]CR3>>X*TO^\-P3[VRL'QIV_=!X
M^V]-.]6'TT^4UZ:OZ0Z&>V\0':E.5QY>/S&[KXD:>+?*H,77!9*M>>4[75M*
M=R@B>4&P::C;8A)%@?L21R3/]@E/4HH7"44?>WCAHG"*@W7Z7N<4KU;8IY\N
ML0=PA<3G$4=I;/?""EU[XCN7KA='R*D<[)"47+GW$<VH5[;?,>"F):AA!3Y(
MU(RW/<Z% A9UI+28(]\0Z;^!G,DK7  7Z"XFM0.S.>5H%D=A9/D.<-E@GK(C
M:)D^;#7V'LKD%?;1SBXC71#374;Y$YFW,&D]%=-H10YEL+GZ*R8%.#88"]3Q
MAQ^0@Y+7&.D3@<Q[)3)I*?+Z5UIZ'77%3O=D@\P-H9Q&YY98[?1P*?PMW@AZ
MD@LJ Y+4L6-0JBOBV>VS]-0G\U]ZT_'([C;;7O>I_9P(B+**GV&I_&9UQ$>\
MUES4VN3:A,OHWO[,G6TB15\MCT3NOJ$ 7;W97@Q7*NI'L3P[]M)[2_%]I2<W
M4TW3,_N:VC:(.HS)B1^Y#N$"YOZ([#B@#0-W&,Y?Q@^$DG#'&T4#:K&T&_)Z
M*])J1_V86B":8A]V/TUBVGU*7KQ73RTI/1/RK# $0X0,+-ZOI^AK+6S3'#UB
MNN<Y$&W64T%$*C>^=$6_64%@@7#DWR1B]"2YS>2W-'^E%*0X>H;IAA%Y# ),
M/]>.TMD^^ZXP:SRD]'@OP!; &X1RCXB(BXH*(ATJACMKA<1%1CVM8]!U%YMB
M J(BJ%4V]$CB+/VEX5RX6YRU-?+HS=1[BU>]?J;W5FOYQ&%-4FDH'=YT:)C:
M-<OKU:&TB^.V5C"7A=5B)57/7+ BP'%;V<R#;78ACS!X%;<GAIG9FDP",\X;
M\5 J]=JW!2J<)+N:_,Q<D&N=3;C:)<9VH]D%3Q7.1"S@^!Q*[6?O#?G;@B:Q
M9T-420UB(.I6X[#+I9EMRQY0Y 94WMY[EJ_P?2MQPKT*Z JP+^-]OT1SV+P.
MJ8.D@6)23 [C9#<C%+RZ-DJ*)JYQ\#MIL^TON#WRLN3U/+Q1R5Q UB!)(K."
M3?Z7Q./!34?J$HZOUIN[BE<3WX\M+_^/1$1M%Q+^: LFRBH93E/XE_6IF/@.
M.Y'-"MB$R':N(F5 P(I7N\74UUZ9(^U@S2UMVDB+-0CF1HJMS319 3,N_1?R
M/R]6B/[/_P=02P,$%     @ [X-/5'2>=29G @  #0H  !    !A9'!T+65X
M,C$Q7S<N:'1MY59;3]LP%'Y'VG\PD=C3$C=<!$U#I=&BC8D5Q+I->YJ<V$V.
MY-B6<V@HOWYVDK+!0!N:-*;Q4N?<SW?.ESKIYO1L,O]R?DS>SM^?DO./1Z<G
M$Q*$E'[>F5 ZG4\[PVXTB,G<,E4#@E9,4GH\"TA0(IJ$TJ9IHF8GTK:@\PM:
M8B5WJ=2Z%A%''HQ?;*1>UYZ"<7\BH!3N@7&#H;C:CN.O^Y%S<B:ZMJ5T[;T9
MAF3VADRT6@J+PI+E7C2(MJ/] 0E#[Y!IOG+G1FI(C2LI#@,45Q@R"85*+!0E
MCBIF"U!AIA%UE0S,C0:U:<4V A07"I/!UFBA%8:-\+%)IB7O% M6@5PE<ZA$
M36:B(1>Z8JJSU7 MDCAVJ3K1-Y(H;2LFN^3H![AP"J=5HO-:,@O,522]8S ^
MOBHA R3;<12GU(SO!Y6[-H6]@^K@WT65>OTM'%SDVC)/I^32]6<EN.A@? HU
M$KT@'RZS&CBX1*XG)[_FS" L!3D"C2(OE9:Z\+:)MJ9/E%)?9=Q-C<.2M+,Z
M#*188.!4R#(I2*:M*W<8# *2"REKPW)0Q8UL&.=KN>^WBPAS+24SM4C6#R/2
M ,<R&0ZC@^'6J"UA_0]?1W;VW6$TW/-V1V[^&W;:9>E3+7L4;J4!^9$.OZ1T
M+WKXK7R;#5[Q9'RX6>_*;^O[7/Y+L.\N+=0<<L]1S^4S6S %USUGS1.M_1'
M^Z'U@/YH%E,H )F\^QJ_(B<JC_XR%YYH D*RAEGQW#;_X#_X4?3I>6Q^)K!T
M%QU3O/YI^;2]G)S.W5N/0GS?#?\ O&#\4F6U&77%^X^FE/8?9]\ 4$L#!!0
M   ( .^#3U2P*%,G+@0  ),7   1    861P="UE>#(S,5\Q-"YH=&WM6&U/
M&T<0_AZI_V%R45"0N#<;6C@;)##01B$4@2N43]7>[=A>96_WLK>V<7]]9^_.
MU"28FI FA<0?[F5W7I^9G;EQ]_GA[[W^N[,C^*W_]@3._C@X>=T#SP_#RW8O
M# _[A_7&9A#%T#=,E<(*K9@,PZ-3#[R1M442AM/I-)BV VV&8?\\'-E<;H92
MZQ(#;KFW]].SKENK[LBXNUMA)=(#XX7U\:K5CO^,-P.BHKUPOMD-Y^3/?1].
M?X6>5A,T%@U,MH(H: 6_1.#[CB#5?$;W9]T"2CN3N.M9O+(^DV*H$B.&(]O)
MF1D*Y:?:6ITG47&]8G51O58<0G%4-HE>=@9:67^*CC=)M>2=3$MMDA=1]:NW
M!RP7<I;T18XEG.(4SG7.5+U7BK\PB6,27+\ZLQ*E3<YDK<HZ/ >T0*L*:ZH)
M,X*1?F@(O;VCJY%(A856.XB[8;%WNXL9&8WF\WR\RXE%_\F8-9661>=)F_'M
M(TY97I)%H ?PFFPKL#(0SG$H2G(+.9R-4RDRV,\R/596J"$<"Y-_U; L"<)]
M53P,X296#7(/ OT2(6MPMQKL"$&H3)M"&^8J'J0S,#@@]%7FMBJ*@9923QW\
M=6P:T@O++.8DJ4QJ=+B80!6(74_BP'JT9%DJ$5)M.)I=+_(@0RG+@F4D[?J]
M8)S/W^< URP^X29946(R?^C 5' [2N*(4*TT&'?A,&DT4P"\N9":M!UL;[WL
M3$?"HN]4.]BFAA7>DBQRMO][#JT4F)MA7SE,$BWEL=_@](^Z)F5Z9&=JQ,>I
MLIBJU%SXH\'EMI1?<CH> J&WUW6D<\]6/UD<L^9XU H/6/9^:*@D<;]QA(VM
M_E9.O8K7NZ$CWUL>^">7Z3<BN20>M\:.6!NP%B7<M/YVFKN[Q.V5$5X=DY]P
MX6_#J0Z@W6[[K79K<V=K'0KZP&-"N:K:%.(+_# F'D;=, LVH!5%VR1)9^_A
M3#*U4='L<U98,4$X$-IB-E)D^%"0+;V%&DZ<.W#T82SLS,DBF8[CWD+B)4*
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M=#$%58ES(]V0T%1!"-/4]D(7G=Z=>=I2;"71(EL>24[(_/H]1W)(R 5"<TO
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MP@K6%';+9:_V]+QN?M-LPX;P-3SX)U-:AKR/Z13=>587?O.6QCI [PG3H&&
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M'X;'/$;]/1KK]8M@^+W' %.3EEQ 7\8**H#%](AKNT2'7"RT]>")HMGB?CY
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MR!U]KQB="A1((6A@R .-F Z1#BEJ"#'$''5H+)5&LH\:!,>:75%TQ*2F02C
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M!J?3P)%]#O*J/R<,B%^7,M?QRGM4=9IS5B]%<;10ZNU4 G' 69P8"_-2U3W
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ME:OJXVE+9) ^K$\[G^+7H>^L<QW[R 7YF $H3/)YC7L*)PG],%I)R/H,\L/
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MPV"PAZ(HA;GN*AK?*4%)4<4J)Y#PF0NRY/RS1P';0B^<5<5O-<ZYR?ZN,?U
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M2DWX.G\'R5U)!]V;E93Y%-&06B/CUOK>Y?+7..+6]HZ@KP('\Q$.3^I270=
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M8+\B=''@]U")#8%K8P^*=.+!(SC73SI,@W3B_2QN2X(2-Q<<QZMA+^&3S>3
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MOHS+=VC#0GI<$5?F-^U4 HN1.DFZ[XJ;FO=<T\ ?9'FFQ:Q#A?R9/FK(U=7
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MH1>^"]8,D*/DQ_Y-:@B[54FFHQ+ZK\D8,W]9$OHKLOSN]Z7WS)7C\H==R#/
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MI9?47[6W%:H"&E9;D"67ECSR_FD+E /:D7?M#(![1(J"N4&BS*7IWU,E?,X
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M$ BWQUC.>7-VDN(_\AOHOZ;L]F).9ERQ23)B"\2#S3&32#2,(KGZ]Y%2N+J
M1TK-^MQI,M:#)C)<:RN(VK :[A68*9<-.@Z;R-A LR[_'$-BV\N6.D/OD65U
ME%*Y7!\#6W>SZXT#NOU#%%$34.OFYA205'#EBBC=D+E'B]\F&!35)S;<_/T(
M+;3D=T038G'6]\?N2'KPI)>6VT64FHW>RSD#M,JF]V+4Z4?*"6KALT"#(/;M
MGFPAMH(*R*TRE13_U&9'/:^1A</B@LHN^I&W5S?_;X$U9:RMC4)<(">C_S^
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M$?03][^XO\2:$O%5]QXB7:?"K-2&P\B7)]=].W.COGX\C,\_7>R5>F8-R/;
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MAZ]I]G$C3IEZ>=X'Z^,(KXYU,'/.LC)G@ KS07%US6TF'/C1%Z<JM#I3YAE
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MWPG:A3V!C$HMHM5BW>HO$$4,W3LON)$^?WE;"H:SI,H/.:?Q=BW)PEQG)8>
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MXT;'M3>\LG(+?(?ER1(S+G$EF[1P,SHDP5JP:*.HFM:\WI+0BXYXF=/"P%O
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M=1M;,6H.@>DK0D<H1YA..'TM#GXW\4CBGR];A?T,+!VA.%4QQR-.=BXJ0"I
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M/_>;VV:;2D9+S-A6WV_'-%16K&V:A[?>%+4*6CU=HN-LYEDQP,ZLXS@L&BL
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MJR-I=9Y7.E^F:EK:KC.NVJ4J[$*#U$Z+^EZJ.-J6@J73D]N0#7!8P/EOT5M
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MBPSQB2I;;I:B/Y%S*J%=_J I,,N^G "2]0=+9EJQD;$2*'356M''^RBP8_/
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M<0VY>2ZF!U:/JH8;"LJEWO@W_\QR#$0+WOG'=Y'(O!Q,/PW/@Q+4=_HB1::
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M8F]#T6,DL6;X%PDH^N[]V),Y\/32[7I;JGS4:SS(9]33MY1"JYK=B8H8HL&
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M=F<ENP\6!;D(CD"9)&:%S8=L+VV8_3V"WB!$(HTR>2X[$17K;%[C9V7;O^0
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MMK.VAF[^'/PZ&N+1SQ?DJYHDK!Z+KZ<\W7RCY5HB*4:'-KX*_/6$=B3LV3U
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MA*+:-80 N=<X\M#QU1'7":RA")M<$RKB#R*,$-]$K/HT*GE'Q)P#[#J\R;^
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M?Z.$I"6[>[=+N6E >6V7>"=*+/M7U<S3G-FC4P3?Z!RY%$?T>M8%^<CWDZB
M[IS<=7RP1')SZL])%!@,ID.!W2%7=9=B[YMKF0/NGN%O"\!\*"/.=<QRH&]^
M]NCRK/M)5B,</TTN::0E7@WMYQ,G%X0*6,_;N=JS57V<'^SPD6@?->9MO,:
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M>EMX6?(#L,(XLDR"%+)<W#ZBIEI*"'=X$^S!*U/ DQUV03]>,>4M9]2=#T^
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M<V<67EV4^:RI]MGLH"-X7"9#2YQ1_&4)1F&DLL'0(W=JQOSOH&5<3%&][VG
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M)4%#"2JYQ.U4'2<_!89]OIU.@SSFB.LJ9(S+.+I\TLF\]GBLY'4UMT+5F(1
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MZ+H3[6YQ;,/]9;?""ZM-=;+7ZG\'DGB],%K1P'-#O*4E8E6N3^])X./" %2
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MO&^A::$.YU>CH\] )(AZ'>Y UHGFY'\H2N@G,Q1M-]XIT/8010<2+M99ZI?
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M04UUN@<*=C?J+&K66@JF<[@F+LR^PFV">CMOL0T$-BD1X.4]!XX&P85F*Q<
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M"<Q$(-56KK3(_U+S7DD(^HP:^U1=(B=Z)%B[&$;=VR]9SJ3[K/N##N#*_"_
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M1@H3O)"PWOLMOWL#C,/US$<JIQQBHW2/W1H6//J4)4FJ>/C7([><&8)%N61
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MD_KQIP?RI<^/^B5-&(?4H*Z:4V*5JE<ID+4K'M<6/I\1T;+O15 A_J#N[P>
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M@^/\0Y\;P+!X'\?ST_6J]<3D3+W0QUONB8/"AC,?.KDU9=5<0G=(VS-&MFX
M-O (UEJ?J*+=);KVC_"O:4"&PFAV"NX(_6-0P2>5M%K;+Y:-9L4]C)O\2/'#
M3!L?7E.A]SJ?B%^I*H]6[2]7NOU>F7Q>CY]K!I>R_R9*THR1[Y8%G.72;?-D
M6?TG#P[^-R*R9297F9XJ^+?Q<R):0TSJY_*%-_Y%CJ4<E94\7/?9B4]I?MZ3
MU8_:^^3$HT+W[)NFAE$K[?)[J_O].^#&!-":(JGYWC0+0_VTP"QALDH<GAYE
M&HN1Q>YD^I9_[&.S;[D!K%KLWP!6#IG-);_N"W*.>\>3+)DD1;*YF3KL').Q
MW%/MX4NIQ25@(<L3I85![S'XIIXT1A<-XZ7-[T(VS;E,1,B[8%T+41.9;KN&
M*#(7/EVP*DK_!@#V5BG6(M*BU#SA]O>.&<4WB8[A7?B;(KK;(P3H/R])N-)[
M'G6V!\)"8'%@$R1S>9,)\I&^TBW@") 14]H-I>WBGI"SR5_DKU9]\54);X"%
M-!6&]6TT7S&@);FD0X?:XK.?13[[8J=F.AJPX'P#*(=P:I=KEK7FU,P.Y[>7
M9KNO+<T0YKID]A?%,07MWOD@$2E/,0^J>"2SR@<IO--YQPV  J^'V5MT)"@T
M5S<@'(3 [L27,[;\W>DXHH3X5N'H0_UDBN1H _+%EA)_!:IXV3V]C)B VHR-
MD%*;-L/9\5_[^?9-$G7F$+?%:)$_=R6'(Z;74[36]$]=).8,QK?&#FWL(U>?
M1-N1O>)%WK'UD!)?]V6M\8T-8G<_.XQ0?"Q4+JWC H9M>"BV?'"QVJ:GF(:6
MH1CC.V;U/@:^.ZVIL>!NJ#SY:-#BH)MRTN1S-86J%+;,:.4C7CG;FS.!4S9(
M3\!9WOVMF#I*1K\,O07K:6DWPJ5ACSL8.'O2UN!$*L%W4M$DNP;@JFH/2:JP
M-(5H&BV:'=;[059Y?LA.[?D=!I?3,@F7,S-H>$FOSS/\$@\;1D7AY_C \3R+
M=!./FBC!B*O6(BR;3PBNEE.TO]Q4D T'RU=XJUBN!7NVB=T U)K'3G[=\>"8
M[C_FV:6YY4RPKJ\XY!<PE]IJ>C>KW,DG=1>"*+=J0@5C280W*@G#XS.3-4=5
M/CV*;*#QG.VA7&-9@7@Y%45>]5*E#-AM/X4S^X8F3#V,(X[K/&%_I$8B("D>
MI*_]W5(O.O#S:ZM+Z% 6@YB)>QR\-6&4I]]'QU<.M0KI("4'&[;BOF3S3=3.
M1!1+LMJ VRC=A(>9'J: 5E@[90_ORK>UR'D6FYO,&U4XNS)Z6582LV<+H\U\
MX[?"*1XXD<K],!(PNC6LXT=T2O.KX USW!>)#ZR)="FT"I^ 9!YR%5E:9:_)
MM:#GS757LV=B_I&"6G\;!35-G)O/Z_IN2YOS_6G1QB#6N$I79^H6'J]ZS';^
M42KCFE/080IJSP_X*C"A%_V*B6&<.6T4U?W:PVFI?Q8?'N%OM3%(#2O1.I:+
M"*$AC,3= ,1S"Z]E0T]+?5?.PPC\N- N5E<LI$L+K:[(!I\)RFH(BI4(2<?O
MC3@6RM_CBZ+X;N56EV(XY&NV.7M1FD4C2C+)TU#''*@D-#*,O?,ZF.2('6]0
M37895 @]DF<\\PBE_FAP/@U[[%T?N4ECCT@TA5^U@F;@O]0SI 4&W#F<\R#N
M1B'WWCW%E&>5>1P<V<Q,CR281\KR_-[4 T[9!,J+@[22JE!OZ*,[5Q6]T-X;
M[:_AR*4H*#<RF/:*Z.5Q2VKF'[18QC=K "&\OHZ/E!FH 5.?=+9J0C1\RVU
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M*1(ZBF\4BU$Z+B._TM*YY3'NJ%E4H1QO'!JD0-.\HJO>.;<*/3YYV=K<FS:
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MHNJ^7*I636OK/ RM['_<?G_.'OSP66NZKTLO;%;YT_Z:%:5 L3 $AAQT)XT
M@^O;)__ HU_&R6&0+?T9R.&HXQ-@)EU2:E@M,J^ZMJ%>3CS5/(R6&0K0NI"+
M?W^N%'[>G/C9/*;C&L63>-B@ND1_6KD$*O>K2%K#,6<M&Q>X%3 %/*Z$A_O<
M !&),Y"-\!-:GCT$-K0VD,WL6C+8U^'YD+K(H+-7SL?C]';LG>Z7$/8P$[)-
MQ4_.=1/3?'^N:*_!SB(%!K6VC'40?DHN BWKH73/-D0R=@?\L^&I(P*\$&DX
M#IJ&>2+\ET,<8!0*#V)7A;Z?M+,B7+#QT+E$^H8X( +XBFWIYFSY[9D1@M(V
M=LO3A>@\_)"C)RJ%1FK5-ZR1^C&4?$QDNH5L1!/?J2$.^(%P%;&;8/Y=7H'1
M@E>%\JV<T&UX 4V]MDSBPWEV7UO(E-SD$=-E^=6BN(US@Q\/FY D'ZI^4WU#
MZ[??3=]%<QS;*,/)U-9 5BF,83>#-B#2\J96X2I'1'*"Z3=J#0*^.5H)I5P8
M+?94L<HCD;)T,#?N28*"H873W(+ZW-<L!JR5Z%DYR63ONM:HE\S\V5<Y6]E_
M&QAYG]F\MF$1?;F-7/MH5;2NRRT0*?PQ]G/;%)C+6&[&YK<NK<_G\%*O Z+"
M;56*$]D/J#Y_U$LDZ\<KUUL26LY&D\6$WAGT9Q=_Q(!U@I7"%V971I?MC\W"
M,33%+7Z^*!X<[*!T+P']35=5R9OY;LO*S]]#+N$##W4O'-I&&1)JI''_-@!,
MJ41&USOS@,2VS]Z\D%,8<)Z"X!2V1Y="T_RS\D@2?6U0__HGZ74CW4--",F.
M"(,2-T8E3+ 7ZT1:%*GE KA!0*O%&XHW7%)P"IJD0+#+A'0Y OL_(2^;J':T
M;&Y+3S%3LH7?G*]EOT0;NQ&L1 =ZU'-RV'.\N2@_SFF(?JRB57_05>H?ST_/
MP^9/W+X^J"V;;I;3.UMN@-$A=__MZ;X)9&D7789Z/EV/>!64+S1\A:FU*P@9
MR29^]CM*Q,LYP?OH+^O_4MO1[9!3Z0WQ=3X)BQA'54C_E"1[^LL(M_N$F>D&
ML2H11MTDK57VJ/YX$*(Y<0FJL((Y.%;Z%'G;S87TY7RX +##W#M;"5E/G+20
M,G]WQGBF1:]=^]XQC\%=Y*)V_[+BAK/D4+ EP;N\^5!TVI1NL\<O];:E&]:/
M0"NYUQ 7ZW60KZF-@6?#>Z_;/KS[E_L(X7H4>$5OG-S-?8]?CJCH_.P'LHJH
M2\4I=Q+=MJECQ.42%P4;?=OC8P,9*H-87F,K>X'7C6(I%8CE?,[8;#\E_#G/
MLU?7.JL.8=*NS'L&?%4Q43OWE)N7S*HA.-L<2*?.2P0FR:^QS[)1E(F#]G!(
M/,Z69%0_N/QV9]X#40IZRN2FUK-]KU3L.(L.;1:=]3-T^&P\;O ,R%?.NGO,
M@S_T'YH\:G-<M0%5N>SL..V5-[V_$ZO,[6?@VB[;1/0\??);9)##P[[V\0,O
MU^Q6_J\?[&Y%RC>F)02I,KIYU:SI'7,^:(S]MH9JMMZ2JP1-B?XG8!A@E885
MAQ-KF0%X *4]GV;T9'AUG.E?!KF5JFIX:DAY--?.M.)OO/^$X_GZM)E,"!97
M^2'ZHSSZH3%3V;G!H_HD8W5(%[O-%YEHGI@&]!^U%C_NTJX/6RA49&B8+F8I
MPAZ.$I'Q9FO,ST)#S>+_1LM5+V? )M#Z=XUI3/,T)L'8@Y3#W&#5\SQQV2S[
M,TBW, EY]:$G/E%= _H@!W!6E'3@!I#E[WQJ0$,$XY:HJ6BQ(E1H>6',%I'8
M+]]?*"*50GSP%A4  % "6$'HT>F5Q^!M1_H<RZM9FKG54;A5A)?5AML"5SQU
MIO<GASC\>M;7*N4DU1D_,MP>M%'/A</]5#9<W,K24Q@ROB:=#?DU3GM*M@WV
M^AR/!;4"/7F3[*DG\ID9@\Q=K_L-(!:%<_NQI$=V:_4R+N_5@\>@5""KB.["
M7:R R].J\,Y/# G,FLO&#?QU_N):V5UC-I;%2LUI[UL<D.VX-BN<IR2>^$UD
M<^^&#<[Z6GBG1V9FY9,E2/CJUW],$V;@FYQK55Y%"FLMWCQB^\9!W(9)/TD%
MS9+Z:9F38,4V6\DQ8XO%:1:Q"WB;_H0S28/W7/?K'PR9LP!6J9V+ Z( 3[@V
M:%T^M"+NQMAA@RD*CZ47;4W:18$QM!Z-__38^!H2U"IIN[XQ4=Z-'&- VT-C
M-SLFK:M)IJ+A5MPW>,M7]*.$K13L;0PN)U*7]=[-)X[<X";8AY/_>93=W)$;
M"$<%2H0N+D[/<)/<#4UUW?@&Z%=NT33_ -Y=^N#MPEK9-6>X!7_=<SL6V10&
MY%\AC^-V+[11OD::O=W-#^0?Z=O!SSEYIQ\@>XI_EZU^SKF;Z<TTEP _0 $R
M6#QD^_3FAC^0RO!$<VC'7KIF%''9B/_)#<^:'-V!'X@;*E#;;(EH2<?9IBL:
M_V1:CD5U"Z \4ZW<D-.G_350,R;,%\$-0W&WN(+U>F:1W)G:?R:X-&%W%KD/
M_@-L4;N-/J>9.C0)Q8F-W>YI?$]*2@KPU8W_^7>RU?IPQ^?."-RB5)]EK,HU
M]?ZL_YNYOB6-S31OS FR@MHC?6YTX/3T ?S-.7^(C-L(4!2%@"IT3VV/W6=7
MIBK]H]C/!MT6@%G3P.9BD=)D9$\8I1NPP,N=62PZS6&WB%(<PMQ-/5Q9AJ(1
M6YK$\190=>"_/T,\TJ.3-&GT8=$B4IFWSPG5]=5=LL;,Z6:TPM2Y'<UN6L":
M^VG_H;IK;H&UIBVWY_B^PRGGD1G_\H=8.9&EOJ8FV!<'Q@L!$&;%%OQ>@RB
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M K6U5M=/<Z:MG! G,1V4 Q%W-Q'"5H%?/'(I>_0,J!S,XA)FS@M7=7N:A],
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M4#KNP._6I("A=EMQ:T.LAO7V1MX9G-WD]O9?7_<!'\V<%*?055 PPZZ<DZZ
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M9"<9H\@7#W-U=,B9$D0 NC9!W-O5)]:ICP?Y9?GE9148$JQN8M2]B1_ O4O
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M[2@3VJ;X/2<*Y(YT(?/QV&T4$@(A;T>>T05)DS$6Y);M]YI2G:77^+Z[(<,
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MEG/8?YT2YRWSJC-)\+ ?<\SJP ":Z@)_@R5_H[=/2$:]Y">,:\:3+V]')(_
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M3NXZ.MT>A;%)W>W%K)*C)%LXC4!!]HZ23\OR#,I(L%/9R/ 0&VMI.8=X5!A
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M7!3U!HZ:7?\*\JS,V @(F[W510?;^UIDS<WM$3'-O&:9=N_'>M3+6DZV53Y
M[-9Q\B=P/4ZY,N,K3?8W4T7M_ *=QBG>;D@[)]CG!\7OY,>7%8-:/"MBP0NT
MG[Q*EDEWS.:16+4[P'&+NP/LNZSY4RK=-U\/+O'Q]E,2HT\&6%(@_HX\_$]<
M>B>C6X]N9RPVFUOW*>TP !?0N2#S$*V7!T7G3 NIKUWK"CJ?]*M01+I*YVAJ
M 3.I"]&+U,FRP];ND9MA>]U;557-'E^5SD;VV"R=%7Q(P;YN\OH7CG5;UD</
M<XL,.<F&_::HUO/KZBQ"3W /I@66O3[>M$(L-[-&3EF\>^OH[KU\$;Q+@G6@
M(4S[6X !Y+,PL%F4MLL%H6<Y1Q*\WU_R<]:4*4#_PP)!I*O$)Q=->U&?O4:Y
MH50+?M8^D#55\,WT+,4(OH[2(9+J9HK,HE EP6X* S@\1@ +UP0U&RO%&(/(
MU9Y*1#'[!][\U*M$6&BAIT:YX=:#1>(-D"7:-3X(Q6G180#UGJ1NEF3&]F;Z
MYTP, .R#MKC12T\>N_KQ-O%T!C5BP]!U2Z49/&?HAX0D#5[XL&7_MKR-S8:R
M ?XC'G4U"RZ?<IPFU52@';4X(=T9(W= #$ 9OIHX_'W=S-X"-0?7Q0 B!&#(
M<(CR)5/+<0HJYK'L @909W43[Q72N@9:Q?\?0IO=K-+E>"^TSD]NYVFW:@YK
M!L(1%N>HX4&<&B6DPMD]K3: %-G^2Y'*_U]1L"\:M&O(O7EK<?VRZHMOK CM
MMVX1.*LENQ")IU=,EZK1K5X/J;31:T,,( >.PCZ&K'?-L*M]!E.GSU:][F=M
MR)^9U<PO;)=VE^0O5=!T<B[0A8>Y)\Z(2]O OW@.T)T_/0A.!,8*)9GFG 0K
M+W*CR_:OI>K";S.,[L$(M2^N8V8EKR78H7$UE8,75KC%1D#$3G$2+A!X\%BR
M'I_PCT<YS:XA?Y7W*\@N4<*!#P9 AXW":=KT<$GXT#D[TY>_.%);K*05R7-I
M=W70^/2P@KPB[<5:=HU,Q;%S\S8K"@/(J-&Y;"*[K+_P_'%7JXCJEH*3;;>N
MV,L7JJ@PDFO%@_NBO==J@Y2VXRR@0EQ'O0^DCC6,^FT@5&^FM]A_%)YM 8B"
M9YXTP,*?H+=5:L9+Z./FD!_B18-D"GJQ)](" #/2\%F(%?C$8-X\.^1AB#BM
M&\QM2-GQ3\\$G$PC<GZJM1W2SCN#Z[NZJ&**B*#>RGMJ0JLF-=WYB4%WY0)Y
MB0&XX\R> J&DG4AWUP@W[LG*IVLA]2.%ZW4(Z-*WY%4%=[:#S$JB=/AXF< G
M1^[^C?B@PK&E97J:ET,-2@KH,PS S'!;W#Q[V2M,*48M^M3Q(S@![I\;)CT_
MGT:KQID7U^62*-%JZ, U<J]HK*.>19%I_NO4>?D;HAXAM<EP:2O;0.Y5J0)L
M>/GD9;$.?KSZ]V?S>_![HL#1_DE4,YGS[VQBY<3R K?/+[OZ5#H#,PI\:$_@
MO1S]<7WF4R -4$%^A,^F5RQ^0D'+]7,C;04.)8)%[%/:9%]_NXYMVP6^V0TM
M.D(NKQ^;59KJRU+0/6(-@Y3E<,%E?(,[N$8]0?&G\"<&(YFT&QID?YP3.0X<
M<\N&1#E'2->?0*WGIDG7)(=)GJ'J((:'@NG6G<:51BVBJ];A:52?M)$$DQ1S
M9:]J2'SBP 0XOU*K#0*@ S/BLOE>GJ/&=F\>\O4^_6*U<(M_QAF- 81TYGC/
MHD?^]31N^3JRV82<R/M:KBL^&F'+:OC2\[O$*^B?491"OA=T<@1N_$SXY/17
M9]8U[4R>U>Z2Q'@-+0$UKN,Q73/>*?J&F&=S6%Z65G8NRWROCOG/W2(J[) Q
MORE=E5B/-\_K7&7:XWKLX/"8PHKG11[I0,>EP]$POI,8]*=FVH2+GHI+@SPW
MZ^0>6YF-W.EP<MF^&UCWETGNZ1.N\>P0,36\IQ]]D3K<9FO643EV=10>W36W
MJH\<K:,%.;Q&R%WV#4N8/TO*D?KW>V0F"5V(B7(&AZTMAUG%<G86R."?-BM+
MH7["QIO$*&]-U(;%FMC'?;V?Z(R>0-INM:<Z=;/+-;GQ2.B!(8FVV="V7]D-
MX2BW?-#:V.H.H8$UE_I@_>M0'/WHAG4RY(RTKZ\CW&#@LS>_K//+@;[M0$.U
M*$7!W!I?0OBK5-!''\Y0LP@:RC>2&J1%R;UIYI20#(CR(7?9A^;:Z+4Y[43R
M)_\.<.4H6MT;KRI\5<8V^15-ZFK(EEW!Y0 U%5;_I+C_/HB7F4]-/P-4JJ(Q
M0I[(GU6+)I[843$\]R#89(:^>P-T^QM07?@RAJ?7+:,$,J(<9:E(_"ZS*9HO
MIQ#NK4H_V$4P2;<C^;O&B##]3G;0V^NKN6\#50!--6)-_X:<RZ=B#WRAO5P!
M]K#) %<JK8Q0*.4-'[BW*-7--\$:MY?WVU&X/M1N2_RCWTU&,Y@YZC1H^1>_
M]0[M(N[SQ'A,+1\IE+W'P=!($,@^K,2(7"]]QS!1)UM%I$EB3E%W76M_!MG2
M.P6%&W5Z\IG<_5B0G\#ZCAL%]9U.(_)O7'J[]HDN03:'?3-PPY]#0E:Y;M)]
M/I4]B5V4Q%H\;@?R:$CG9/B[2]:.B[[QPK<Y%L>2)P!-U\=B-=S"K^W2"LKB
M0<=F)[CL%,\YP=:NC% AGL,=0#]+]H0'IZIA-R]7WCF=W\HZ571FL*82@W(4
M!3R-S/&#Y"[-5@/P"3@E.J1H;\[R%_#*\Y2[&7YT/DN#LD#?9!OW%T?_8!_^
MD>)3[+\88&,F'N# U8*,*65NSK"D@S6+"'$K4,F\\<1:;>C-,[FH&)[8:F0Z
M5)_O&RZA/2YL+RR,H"B)7/$;FHZO"82[CVV:OIGXW;Y&SB37]9EQB-9L[<X;
M99]:#D($PN_@LBHUM!+%&[ KHV#D6G/';SAOZ:$MR[4A[>/4U;M0'B6'2S,@
M@E[WHFEZHD;%OGOD*/>%U)%83)=UD89)/#0>?"D^J]2AK+%(<Q59!MV3UB7'
M^DQ<$[;Z?+G.RWKLVT"7>"(&\.4$^%YWT\]*4=3MDS_^!)N.#E@^>^^?894N
M^(^=N0]6T*3.B!]>RW/W2"I<.-6Z]L<&G4T[GC7JZ,3%)>[K[$$DQV\8JQ,*
M_%:HT[K6BP$L*"#URIF/_68VO/TRCOO1%BCEY5/F$[.6"K2]Z;8I99D1R#??
MZ]72'$NB7BV]CCQHR?":8[T+]?H&;2/_2C@-!M^XOQ%7ZL#_=S8PA'YY!74D
M!NRQ8QOB KB)Y]@>3&K99F)KJ&9_H983A@(\_G<O=?PITD\#\"N5[ @-L!\_
M;G;JRB"I1>5."[TF+JPA[V>Y8I?7_$OQ0TMZ*]V(\+]LY6M'Z4^JEH<R5&F%
M-O]\**$38($\+#MKMEE;Q !@:V+VS ZEU>2,8S\WT('V=;SPD?"81#B>A=9W
M?%X)?,EL*.?N2 (.DK'=\,.X'R-\/J$KAC:=M6S[I@%IB=_1S"@]$5U:/CMK
MP2GXIQ1]%. \(721VBA+L]X1+4*ROC4E&"6TYVL@(>2M'1!&NS+$?WUK83#M
M0>E-G['V,:XD(HCTK<C5;<Y)64MF5/2!H_,Q[Y/<HAED2'ZRXU7$W_&GKJ1N
M[OWE.))[DO'5F^&%OG[1H,Y&^=PE[FFA%IF%G%=GCEUA1>Y]*,#VPHSY=F 7
M= P6 $M7?&KU(O>EO#3U/FVW#^P*%.I<%MB58=J' 2PY89^/K,I4Z^:D9C 4
MJ:C&FP7FV7L[^E(JV;M0[92H5SN0/:%6()%P16./]<!6532[X^T#MQNP:7WA
MN]"IJ4N!;+ >Z?EAHHB>R/ X2 HH^JJBB25/3-=]M:Q6#E>K$[<(D=^I55^O
M6UT-2EPHU^M_BS9+</(&T2+A(NA]5XZ,J.*RXMRYI7Z".O $)'$;OKY4LD=:
M 9[SZ#Z 7W^2-[Y=<<]OF0I8U1AVU=YL=D?)R.MUJ)72X$'^ J,,R'I)1A!
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MN[M[8\WP?];[W'?DSIJY:S[4U[/..K)K[_I5[<)SS)7"4G[#^8I(*K)H3WS
M9 IZ3U;G6C,)#7U8B)<E [MB*R-_,);DGKCZ(FVU?7G.WWPXS"NH%9$,9ZQ
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M&KZZGRDK+4<1J%HNO'*;S#1*I]E%\:/3!OOP6Q+KG^J]0XE8^ED5D_;YPJO
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M:(Z)[0P\6'=9[W[L]1$;!'.FE1I3YV(^>QLH&,Y8(7X>4T3:.OH=FG=<4OF
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MQ#3LF,1B>*7W5FOC3$+XE:210]SGS.RL/,)A!,N7MI%:V6IXC//-07_E:6W
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ME+-\I>XWVJU;_7[[V(^ IU2JJ%AOF<XP;D@^GYGXT4#>@,7=F< E)<,#T[E
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MU) ^:+_\:XZB?7.FS#W92O7VV/&3BFW)XZG,;&OL(MU>78$G9YFH\_Q(LD=
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M= 1YV[J^C7!)>N4+#G0DB+R)B]Z>1@L\.*^H[9J[* H]#ZT\4.8Z'2 1[GU
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M7L?."DF_>76CY'GH/:W2[Z*]/P<KJ6ND:#$(_XB>H36!C%+^F5:,+\LL8GI
M7!3.S<M:VI*W,8>.&6MB^]VPN&SY6%@*F5R*=@9)L<JG.U]\G<A+\BKEOIQE
MIXY#PO6OOY7#QG67WHN"LYHO[_]6PS/E!J^ *8K5V#3VR?99ZO<*.R)[RGI-
M7QKB5Q<\'2.KS_^I,O+S<X9%6VY?U@:6#  +LSI,])-MX]C$30?.2WZ^S,;Q
M-];@=7<TTBWH%FIK'.'#HL!A\AJ7XRXW65FG]QTQ[;X5J;MJ\,KOD9@W^X-[
MPD!"67E6R='> IZ?K3 ZDM^LWC6$.ULT=GQ5K_ABQABC(H-[<PN*1&IQ[J9%
M7CK[7D/M?&5-KZ/!RX.EC/1O+A2.127%LE??JS$- HWT($9A6N$,E<8W-=[,
M<NR5.?6A?J>@YR*U2^T=$W-"S)]M<XBCZ9YWBAN*K\*TEF6F"$ZW,)(DDDB!
MC%GKTY$QO>U@(&+_0@$B..*2Y/UMTC<4R?Q[>%%FHK&EDVN/WU%5-:&SX];S
MS4YN^ FPZ+]<D?]_.#9%J78P#8[_=*AM(>%7)\9.#J+F][)(=%<737CQ[K"R
M"!82KDFURIIZVD,TY?/I>/L2,S0S1U%G<4O;@?_O(+BF' OO'Q<6*/4(7A^$
M'Z0B*+.T5E\C(46ZM_U3WTM*4\9N7HQEV AJ(08KM:_5;<LET2<6=/M;E'X?
MR=$)^?FEJB[@+\]H]06CWNUZB0Y%/#1>!6:TH YP:ZYNH?T@>T,9OH]!GUL<
M0 :/@/[+*@&7W0&-XOT[R(]^^%#D!^=P1T# \V<4SWE&KN%:D]Q*K^XD%8(9
M%3E+,CZ_Z/8]B?'Q(\HKV,/;TS5HOPA=).LGI;_&=?#]5<DS#JW5].(SG=J2
M.\V022)<>GYRMPLFB\JWR6\CU8@CA5RT^#[GV=&.MVN.%@.NB:T"/TLT7 HM
MW_4UPB>2WNN0))H1\5--3E<>Z";5-U1VIG)$U5FH75LJQ72;&D3S*8RR#PGI
MO5PPI7/GAX4S#[-0W/TRY+*E69,KF.#1<=<;N@H7$.UHIJ+\"2]2UOY^Q&I2
M9S#Q"*!)5YDEMP]W>65$:!U5--1=.I_W ^M&:>_Z5BLZQ7C.+]/>GK5+?YC0
M)DKHPN=E0VAUQ23QTU3!5BJ.:JRV;WLZWCK\3.YC K9'(@.?GQE'!NJ/1*Q<
MNU#B&R+?\ '),R><S=YN:HTX0\5',)LKPDE\9JY,,7,HSN/E)3T=HR8H!WR'
M\3)6,FC.O0,WW6)KY.J^J[9(CD'4I52_#G$LTKK:G\VUG6FT3;5AK^FX,H=9
M(+B9=\4\$Q*>B(04"KG1AI]_+I!;C;8:8*0)5I/A%YZ<RMWMY53>O7@0E8C8
M\CH,&9>690GZ6,I%ZSO^X)<4 &)MQ6I* ?0^)S-/O\N[MTYN6-(C41;_NNJ+
MV4['$6([.XB6 5VW-RK0*[5/<LHE](1RO6026#9C<7*2P1#<KJ?#KW-<G:?+
M>&"R+1CL:'B?FQON\J-*PD\W.3AMP;JPXB_YS__X7[?W6L>AV2[PF?(??<+)
MS0UPY*=C)+XHL:Z#UQ)8E^76!4LU@]A#PW[==_86)G/0F/(;.Q6-P5,E<[1(
MGADC'*JWZ 5<CI!"[]PG'L+J,Z&J)@D>U,'D'E\4Z$RD?ZU$BY.+%PY&$BL0
MWTP7HX[/B_+*0_]^4LZ5I,&/_@VAMF;^6/?]+H1&)#)T9)](PRS>XVGZ/Q?R
M?QFL0F);(GGM2_5\XXH^?C0VLNIW+<F\T0M'E%H[,PS/NG.8<5ZGJ)HWHK-0
M?VVU_,<E[QV2RHSCNWBC,=H79%UR<M6L'AT>E3;"\>C0%TEZ%^'-']1]&AK*
MK]4K=]GG-9BA\3I)MFSQ$6" O:>$L"%,:6DPJBQC!K?D[DYY:V VI6Q&<4#[
M"!\XV&%UUQU36SH<R<0W*?-+A?CS!L-8$]V%5KVFIKM($9M-M<C$A71X+HUZ
M8&$>427H%HL@)^8/%B].?E;B+'7 !G4\=RPCUG=_!U]IX[V M3N5&,5Z&>E8
MC#3#;HM&V(J"GM5*C!"M2MZ'>"AWAMJXG[F@'5YD^B1*JOX/.-)528O\PSQ@
M@_M0"*=)#'A<D55[_O"!7-1Z2\OZ?6J-P>VW7?ER<^[<!N];G.^K2LWM4TOM
M**GCM1'"H%@6JZ=E[(K>M^KL/$+@M]_>F^BZS7V3@5 6Z)<S<(?EGSQ+F9;/
M)6[Z)KX^LWYQFU8:E9_XIO,;M^F;^>)S(V^+ P<HWGG4>%=I=UL%33H%]#>D
M:(VYM;#-FHDPC@AQH46"T5(UN?@RW&JE=]4T/'M7H7)E%$/3@E]%[OPIK"<?
MJ?X(*(4?0A]FM!\!\I<;T?PI7ZV*10A-,@TS:D,NOUQG$?+;B-D4K3X"GIW,
MM-%7#%^YS,K>;8)NXG33((%M<M8.M?-M;C714=L084N:=L'P7D^8-;,.N<8U
M!!O3S]IH:CE'0?%=_%P08KA542SZJ<.RRJ>MBG%ISWB?D>W&YZ<],E=_,WK<
M?RUI\?]F8-C59N_./;2IV'STK.ZABOMD(G#>OV]S4%_^QFW7'HSE\#OP95PQ
MP(^(E4C9R7&SXWNQM$+:7!"1 @BQ.E[GW2Z__J!9)R/!=54]YBOW\QZ\#;S6
M[F!Y+1Q1/M(ZD]F$+J/L\ 2CQ6%&;EJI3P%?K<[ZT)>9177T51<39K0T$[(K
M %?5T#Y;> GS)".+O(EMSC#[;G_AK#X& -DO.A;9&\V]AJT_'QTND647H9@3
MV\F%5?8<X1U%;==/'%*P)%K;CFADK6-Q&""J-$MZ59(RS+>G\V9ZI@.MH9\0
M["_.DC7XQ7H.F?O3UY9#82RL]D?<I.I@)V 2C1##5S)\Q,H#&-)%B>\:\WJ$
MMNZXC/A7=XH8>/Z=KQQPS.P.A%7EFMV<!I]\5XK8SME)G)(V*4@D*&+ZO&,C
M\,$JW%ZU[H)J&Z-P3[\!K*X!=V, PJRGYNK>Z4];I=16[*P)#.%6*O>=EEW\
M\1CZ[7B=_,OP#1Y2ZQ' T_9S/:M5[APE4WM/N;87I=@04H9;"]::E5W^E8BS
M O%^!$P;&('4\PX8VT'=K9ZW>%N(<I2LR2E!+W]UZW5ZS2/@8M?X]-)O_W [
MWBOA"/AYBGLN#^T&P2G5C_HJYMUR.RU8.V:WIV8I%?=2L(P126SV+@^&/-[1
ME;J-/%&@4_F6%.:TD '1;28L8]IP/11A-#^]3R'P-Z7%(C;#WY7ZFM^<- YJ
M:6&P3CN$EN^6^7[YF,:[;G4WN+Q(6UWRFZN_'_AG>4_;C7*1Z*=-%@'"1Z08
M8GO]^<=BS<3NHB1[%2JSML>UX_4TR&@<!;^4LS67Y1@F"[SNY0I<<#;0+);Y
M>%F7N7Y=:72&-,G?.*!U &0#/F***TA+<Y$]'UM=]O?%=-:W-DCG,^.!^(K^
MK?TC5WU'G8&I@[*G#VL.>4L9X?A/BW^B/<TS6EIXBR)&:=Y>%;6>TFNTS0S0
M:!_<U]^-2&PC[A!C?9M2KQWY#ZT#KU+H'@%8IFA(R.TD#W:K-BV1=]P0Y^\G
M7\]V@2PY[@2 "QXL?SG'=WC/5;0#;W#WI"<PM:<S4HC[;LYSAZ2PVW5$",-S
M\!AV,-!!448'\00;Q6@Q,+H*WKEJB_!*)W,,,5;_@5^WD^'O)M:5#[)S2X!D
M,*%OC&AV*^@Z@0]2/MM,.-9-L_H_!AK!..[:8[5D3Z2<6(K)E<4+S+$*M,W>
MA<^'/KV2T$ 1UE4=WGP/D-.5>_,)8T'=(DK-#$I.NG7O,2P*C/=8KO4)N85
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M2/QN1ZH?<\D(U7BMN4<B//^%449M7PYS3TT?NOB57#^(,DH> P/3)LVE 'C
MVRIV1E:8?UG+I.#\K,!$+K;AF!B#S!2ZJ[7'Z<LV!2ZW-;]1("^ZOYN\IM:F
MUDZ,?YO#O8)<@LLO*;X+/C'1)]/[#)GEH8EDH BH95_M9!O&_ATZXX^'HD!
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M<K>O4%O#')<*=X&-=*MW@WR^RQ+."GTH!C!CD!%7[K&<!2O;+ ,>5(@<B[8
MPQE_1&XQ1U7+>#,$H;D75CFTD;'$3V.&N!-\CS" %89NV T,V-_WNQ0HU,A6
MF:DZK]SL)4ZU[Q? 2R!YS,;(F\C$&$FDJO<DTD2;F5B&$:^\'#=VG]"+N3F
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M+4#*M==#B;,;7]<OA/ZN)Q0K^')]@K5==L)*CM=GNSCO&2K>.USIS] EK[.
MR^O>7IQ$--_/-AA/:^Z9.3V@R3B@]WI^CJ&JWNUJ3NNZFO-JBKE&4%8ZUDC
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M/]5]NV=[VM3%0*VUA\.L/#G0(X#L:'(A-T%V!7%#NN([&) O(/)<Q+^A9GX
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MP4 T4;A/ 5W]"I^?HH"^@[^A_Y([YA30:3@S!:1+52"M?!20!!BG\BV6Q+1
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M6!SD2!0!)-C+S\$!=N)IJF3TP0G5@HD"%! J)Z/&>IWOWYOQ3W'IM%CPVJ.
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MP5BUWDW%:=]>5$W$I1M'\I8C-46+%9<T]\]_+ Z__2E8K^P*UT2HE9I$X/=
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MY(%?T.0V.OI);]EJSR*44 H!5S^?,1=[*T#7E_^B^\O:>7W<NZT6TU[TJYU
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M5D[3TV,F#?2"3J6B+]-IM0@Q>)_1FIX@Z>Q\JBODC\#D[V9A!OP1HLCN4AC
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M,A=O?#/Y_*&89$+];I74>\N@-Q3-"9[>:3KG>-HQ;Z D..*[H54VA4K].R&
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M:F@1!,$M A8X7<S'07E@.77A6E#)EK+']4NTT?J5I?6C%:&(80$,2,/2MS&
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M)'5;JH^<4"R@?^GA KOG>9-]RQ6S_ON'P%,?Z?*4L'%< -H!48C=3HD5NF?
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M(.LN"6Y ^O1^%P.(90$OP"#)\E%?D@$P02=;#3[@*%[L"VT,X"R< <BY'F<
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MK?I.L&]L0T\VH$&3NYX\[3?_[C7<6Z;AQ#RUS2]R8L#GF#\\Q>69"8=_Y6
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M*>CQ++3]R0[-IFJU=_T2F+H!&[D2F<P.AVLGQ<J/KFLK/;&>UE=:8.4)<V]
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M@X=YRJA[.ND D+C-O-/= -G@TZ(#3(P$*59=+FP=\MMQ:7RJ1'TZD!Z&1]!
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MV(<S%WSG6<ES=K%N6V0*<YB6;3V64Q(36&<$N@BRVLCW[H4X&1Z@<)*\)A$
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M;,-X!F@L!_J^8[4D9:#:S]#S%]?T(LXF#B:-QYZD7B<@-[6(EL:0\]1[0[K
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M>:GA<O.[A:2 /\$"'97.R1AT7M:?9VXSUSQ_8R>*.N@*(W!F*(I40.[!QUN
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M/7.CM!DWZ6_8D*KU:M3BQ)KDA=I[T\@9I00?QP$#TW;CUK04N\W-"G<EO5_
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MG"]=_BE:\2W?Y<:NZUSB/[^UJE%[O6#/:)^P'O&FB\#6^7@&@(WJL/#)QIZ
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M)K6#13(#\!;1UD5 T9AL*$>+Q([K9CL?&?G?Y.H_$Z*0// ;N4B_\;<!_C;
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M.D*/?HG>@BG57U4G"N/F6S#1($Y,I<8U0K;E1<R_J.^V4M.D4M8*59A\J,,
M?!Q<Q^Q-H1/33 ,2:$68J40&\+E[%?MI<7=[59L"<42+#RC7($ZV6823YAIW
M3HR;71WBCVV1B FVOR]<>C+A 7!:9Z%IC@Q9(=];RK&,;[VM6@U;<QKR+8Q2
M%^QO&-QM*MA?Y-'K5=G4L3Y"&J=N$;C"P;ST'RC"TPWJ568 84O\0@G!I^$\
M2]Q4IZ':LT^CLI:VBUR\CKV^F6^;*CC3\R:1(&3IA4C,J/'QHAYM(B72TN!"
MB 8,I(Q9G4(Q(AHR[[U;\9VM%15I?(/E"_*>PDF%'M(?*F\4S+A+9.D\$UHU
M2CA4=_<%92]%AMZ,+6E;N3;5B62!=R+VE:$.+&Z7G$Z.? M_.&3Z+:5"<,W>
M(=F_!NN6N,*KOJ_^5&W*M#:5FX?.[D6Y#+-%D[>(VB2#/D4-O5RL\(3%4K=%
M_^E[Z"KYNJSDR5'\^8=>3\V'LQ[:/Z"$2:R5YJ,1U<FHTIO)$29/X5WME/:R
M\CEG[70=)X<MD5O^Y/)O.X7EE74N=?)C1INVN)"5>298\&<Z1(7^%7V C*0\
M7,#LA2LL5%>&>ZZ_NI@=;K\A7_A1:'9\YJ;5IZ!CF2EM%RY\_Q$AXQ^RQ$46
M'Z+R^I$2R>44-]AU6B#$N9+L-HT4).LVRL"PQ]""[:ROEU5)?<W\[#.5FN%V
M1CFB*88@R>:>6LN)4(H2B<E_7GK16Z#EJ$8:UQ2V#3DRUK2+"8&=W=. \U,W
MLVGX^<B8F]4D=E39\!<JZ&\3ECT3Q6+(]P0[S #H[!,487C#<Z%XY$H. :)/
MJ$WNE!GPY*JPLK&QEJ7U.T?D2"1TLL4<NQ<P,RV1W,F3>L_=[&)QCN %G?86
M%6'-#JM1'14YKP@]M1R/SV;A*N_QO3H2VX,=HP5UHJ1+N>'218F7[OR;.\S0
M_[H[S'LWUND<'W#8(Y;P'Y/<1)>N_$#=.H+3R,@WRUGG4-=YGS>'F^6;67?7
MQ.*)HO U>"^V%-2X/EJ$&T<=1DL[]I;)*:*RE_B?LE85HUC9Q1\<^,Z^SXSO
M?O^3 V1M*-/G1ZFFE0,2$8U84>HE+R;*.&W?K[RX.@NYJW^&B[(P/XKND_Y^
MQH/@GFEA57C1LU2;N!V.YB8^5X^0F_.Q!KG=K#'L-3!\E1^GIY.7EY=56)!1
MBL4)R:TIDMVA;<C=TV@F;\5X0:FNR-].U$%74XOH\*(V*K(+@N?V9B; U44:
M@4DXD2&/BKY@<"T(,<A""5F;3IM $*LAO_V_XBEF9Q?SBRN_LF'2[Q_5"!AD
M1QPW^O?(1OY5="#]A$ H _BI@,)RT6^0GX=3(N@BIL1I>H3B*\3ZQ! #$,[X
MW03%@=D!47G_PI1#-?$0&D?V-A.YQX)%T]%,0!G"1_5F .F=.!!EVY,!M"[\
MP11]A,GCYI?^PM;_M/U/V_^!MM=QD+29Q:J0;,ND&1R:#*!WP9E9SW_S]6K$
M2P1!2S\*>@A\CJR-M\DA.C1N\Z-%B2K!V>YN;J+=2:>?6$GDYR76CU\]HM3J
M+#O2:BE[[F;Z )A6QW5-FI#1?!KL$I)GI)@<Z;!_ I=NJ(>)*"9X-4-V0%O=
ME$/6B(7!?%]*4S,#(%SGBO:=#U/A=.6*!//<6%?,>L<]73W^8?PSV[:_3RZ$
M@,<@03_-84P'P-<PY FK9Y&E\? M.&3FZ0,-":*0=UB[W6:I6[XZ,TA_7V1S
M_S4JG7\FQI^V_VG[/]IVYQ',5!IJPQ=[&+'R@'G@LM-V]V_UK\&,(.GL;,2(
M*8<V+ ?,:@@NXVV_T7UE@'\)/]BCH-'.*W/,^NM^GS7G0R9N;[LYS[>FU^AY
MKB[XB5S 04./@4\TX.7N21V[6G!!9U)(4GF,7"V^&?[WV%[  /[J=PW$_S#'
M_X.2KHE\R549-59$\B.LODVN2/9'!7@(/K:]^KRJJN]C[9>$6!^_O(A@\$ST
MV?"=MM8T"3)WOH7Y*%6!K(>79[MC?54U>=.4^-'BC=OA8[S<F9'[S(JO87P
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M.#F$ ;#ZTM[#W-^3;1M5$;PP\>P%.E^/YEN4[;R-+MI1PK&PT"PQ 'OZ>QO
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M6J5<4$$ ^M9LSEQ2>!4_^L#L@5'4R*;VK6?S<[R?B>WW%J4QGM:9M[?G)AE
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M?6_V7^+_VQF;MJ$SB,T-B"\#4-I ;>F'8Q;V8.@'F7[YFJ;R]YU"^V]G.,,
M[I+SZ %R3)R1BZ*&3=\U+6%"ESIFV';50-S,V8L(9C+_=L+_&1-&0,2WBS:Y
M_E3@3P7^5. W"M@$49BEHGT(=I8!E 2E,X!%#Y6>WYW1> S>!?E<M.J%4QQ5
M8]* <*H.@0M:VE?6+>QHZALT\T/AZXGH#2DOMY3T3Q*4@ZUHI8,+[;(Q(UO6
M2"-)G(UT=BHN\S3GP_@;JA,R(PIV>=OZ*/ )IGP&4(@8?K#, +3*;8=JO<=(
M++12%9#@TFX0<H6(ESF!NOLE5I!_XDG'PP=<DVMR2G3198H3 ^CY\FL+898^
MIB(%XI&-3XLFM=>A<^X/ONB'9X:EF!T<P^QX@IG]2<,IG 0E>Q7]6F&B-8V'
M4-GTZ4Q:]9N)O.5$R,X.J Z1%+*;W0+]R<+LE?ON,AF3OE!Z7<+O16;\P=1?
M3Y&(R/VUV]QE/B:?,=:G7R?FRHT@<).8BB*:,/+7GL.B$#*34OYF EP5R.RN
M,92AG3\U^%.#/S7X0PUNI]#9==*]$5:T:@V00*AXL'ZIMO\S.U9BWND$[I%O
M7Y_44]N_A6N?R&#U*'H!F9IB )%0(;04$\89H26\G?$K0R:#Z,.U@3J$K##)
MH23.MRFD1W;A9O4XO<:O"I9HAU'O.VR33(C[$$265FPH"DV&M(!88*Q$R<*"
M=*A\5RKZQFCSDYXOIOLR/$]'5['$).FS#HV 0)BI9&P)A,J7UU3MUNPVNDEZ
M0#1] ?//MB@(7*KP:NVEGV\52>](P54'G+T7I:PYI%AV:CKMP%RB1J6J6=7H
M$_?9;0M7A>VZHM(1!J## &Y[2VH+:H?DS9!3+]U4J<O+35W\?C;5RE;XV?E1
MHOM(7;+C)9<=)AK='P&[1_Z!%:%+45FC\1O+N#%O3<_.3S,*I%WXY\H[5_B_
MO2NN)>BX?V%)VI?N0#,K&A:]+>?G?Q//H37!^ZRZ=>3[W;-MBV:_-EK2IEQ$
M-$#0 M8P.1J2?K@"R9]YKBO/*4Y'8MNK3W;UJ+Y&<VW0%?4[#Y0GQXR]CO@:
M3&%X7S" XSJ8]1BH>)H]KY)&AW?XV=F("DJ-G/58'B3CS#'?1*O3CET3&>?"
M^QG *Z46R$_6E U>1*,@'K6[1V_GX,;A)H7_CT- 9WHY!'>(J$]C.44- A&"
MO;/I 7'PJP'G%@KTR=<TC)@II8,YH4T]D2;# -Y+8%^_/U0M9T0_TLW+ 'X<
M=?O*I"L'',(1"^QJ,])[_W=+62+%,  QBP2:-Y(FRJ?WKR>3G4S!0;B;'.&Q
MBSQR.H_XSUS>2>F*G-Y@VWA_Z.!_.S/_ETCY"0UJ1AV:0M4\F?)[(O>FF.R/
M3QFY"D;-%,(=3]T#J!=1]:8?'@G)HU]DMF6-%;NDUE02SRXANIV JG_P#7JV
M1/J_MX376OO?70>\4+3#BR$6T211;$;TV_X0REX4'97E5\YK8..^_>*OXK0%
M%S5A6Q1]1/L2_+L&XIME,V;7*9OO.=>U!0NY[PS D0%$>Z%*0QK;R+4P<5IQ
MYF)U9KIWF'CUH]FRSV_MPBT3!VP1*AD*!;/O @JG:VW9XLD-E/N(1C0Y".^V
MAZQ?[UBDS6PN00F32D/E)_(.X%]I%;KD!_<C)KMFWW:ZC D>WCL/S#XVU:XT
M@$I#5BF4ZXYH08)^M IRN ZK2XX1K<,$FNH36VI+]1#N7"ENO)1TXY<RIL_"
MV"6Y=2_FV;%9XK!C*71N/1Z\+;P/P@EMV,UN),LKE#O[JQD*O1***A^&V/F9
M']2LFG&??74/>%!USXL5%BN@K/_^4U$"G1/1H.-"]2)"KY =B'(XT82@:>+#
M;K;@+7D(GC\I/R3UU%;XG)PI]M%WL#'GEX03[OW(3RQ=1R.BIV]3]O$:&)[Y
MC_QP\CZ2\.C_POOHSRBE_A.\9/.?9?R7KXC'8<N+ZO6C(;PP!&$=CZS7Y_-V
MTQV$L?ODW,(0XJYIO.XDY7D&"C]@356@?WRJ;;$M))-]SS>-166]!;2/*DT,
M8TH/A^F0$<S*!\_.I+VP)\P6#'RY&R^I$WOMN$2IS)T7^U?'#\7N\TE8D:><
M)0_9T%YI.+CC_78$6J#\M?*J[VP1^99EBOL3^%-'X6]CT]_NF"A.OGP?&Q>Y
M)BZUXKP*;C*J5/6-?Z-VI'A?>O*9CAL7V-@FLQ;U4Z[ZZ/.!2K4CV!H9P OT
M?OID'[V'4&G8J^ 95GJJL[RL=Z[4G:LS->'UF7&!6;;S&L:@<$1Q5%$KBI]J
MPJS+RQ91'J!0M$!/V9AQJ3PIY<+*PV3CQ)=[7DMX)RK<?G[D":=?"^^S&[#L
M;U 6!G ?*TQFPP<C\2C0"$S$1:U)/2JJ[16=Q\)LR>);BJ!MU9?$EZ=GM4:G
M+._QO'YRD7;Q/*_!]8^S7R3OI8?+:OVCL^I_\[A'-2#[9< LR.Z%L#-$OH%^
M(42H<M)/2GM^DLG#Z+O2+1QRTO?8&V2U_(0R"$I3\\$(!V:!%X(TK+-!L=:.
MR2**?!]W4T,WJ\NB3DP:<.MTIH6?;_%\8TRYF=8]@M6=G/030=QIJ/5MW5!T
M2L=U#<672X%T/S:&2W]2_T\_V?SG^'/\.?X<?X[_Q4/+SJ JA2_*CRA0G^QC
M5TVT"[5SR<]Y(A+XTRH9&$VO^D)7@)V/KU ,7]WLFS.%SLE!=8E2(5MU3=J#
MJZX5-)S;DWSM(;9PH$93\#\!R^746NCR! 800%7\Y-W7DAQKONAKG)I@$303
MWG(_6.7TVM673P"I #U3LC^1K0'+IR%J2]R+HU>)968L&90.8Z_FYYT+EKUQ
MB(72H2U>;GJZRJ<@:VCQ&2@?1R_>@GNNRG=U>G9U^CVS]+/.]+/8%;YKH*GS
MV4"3%_AS_-\?/-'E3;"KY+%T[SL52>FK:+3@(6Z,%SL#>+0-;B*V&)'[B,;4
M2R)I/#^L(D;$08]0=.^,PX&T='42VU!VN'#>W2^64E61MXBE;>SN5?$W]@4L
M73Y==:GRT!8O2S$>)$3.:#$J&YTL5<YM.WEDS!::'@TI\!%H!(TBZE%\&D:?
M8!HU?5M<A\A9K4N;G82VL )ZIY^/'6=38R5!:_A<P_$[#0F27@'#Y[L_SJ'=
M:&60^X@@!&_:-"F1D!G5&D14:E1=S7_D2X\Y^VIR8K2QB]7KYMFY+.,[GV4I
M8.LQ'4.61=_U55U"1!,#*--*HBA..*NIB9WN+S/MI[?=S^YZ6E&\4]QV++4Y
M\L2FVHT&U,$\#GZY*C5?#<-VGOS/-7(R'245!U2(&.I1/Q-"99L7.8H"=1;2
MS/.>;H:?#&XS[<]OSCGT-OOVYYJ(]G =B;-[2MN$@6&WTA/U;1#;0]N\+*-D
MT+17&%7IR8G![!3#4G$QJU[[Z]N'?"#7VGKKD(UHQ1^U=ED*V1\FUFU88RJY
M>!">(;:[8B-%2<M&C6(* U2!?(7BCSJ;_B/I;C6R#I+Z9-)[KBSI? ; X1W;
MU)+,AZ[)BIO]EC0Z85#-!YX:#/H7:&L:2Q_'5K %0.ZMC[BU0,NEFM^I+M_I
MHZJX<"-UBV/X_9:3LFX<?\&1RME[H\KU^7O[AK'P=EH8QA41P@ J!5;</]*'
M05QEP@7@SCME:.>Z_1MK,@J/7>7MWLH<C\F0V'/+LO\U>_2-X4\3X0MF5M>:
M_&T3QC'RNS9#E>,.JSD4J /"=Z@R9HW7M!U3JD;ELVV$E!51>9"M"(*!M1QN
M?V;F(OQP[];82*V2>ZZV9$O'XMLN]4]OCALK"#SZ>G[IF8T<'D)6G(_(QSBL
M[Z?WP??_8K%4<Z)#8*W>U-CZ$:=D!A""C\4W-1%'G=1(SS2]/$5+-06O%ZL=
M^M;!?^%N*DO<@ CJ;([AG3N#YV9],]?-:YPHXH*V9WK"X]XN+6M7^B-[.N1P
MW<,A=(Z;$.=+$!MR!%&<=(8<1$#ALD*FU+MY*UOT^4>_C4J.\_==1?(J%51_
M+.&+U0&T[$].U!MJBRGE(!J^Z7[J]"&:XARH/->F!<+H[(YJ^H>+B4X<VM'"
MGE$OO^+/NI*FA1,XY,>UYZT;V%L<19#*\3I&=[>BBO)=O$KJ5A%RV*\)R$;I
MG MN,W1:Q>8P32<=+4?+14Q5(DHKZQ6'E1H@A#O08#1_/_BXMW:;F&S(U>*R
MXFI+X13ST<D-<]9&8Y<BGA$=GE,7)/CLK7@FJ39_V5J G\S' /;Q$Z!4GC;\
M\P3WK"4;, %V$1-2:ZPRXVR_'3LQ8=F479W*Y\.9\0KVKE?#/:@ST(H!C"32
M+2EJI#K_SF>.Z(3^OF4SO[&42KI>Y:2_HB;LUQX+YYGG3Z;R,__>AW&7D/.(
M$/T4BP'/ H/',!7<)?#&^<)RM6..,_M>C/ :O.L^U;M7X\:3AQ9S\%,,H &*
MWD_EIWVA"\!;0'P:\I\<U4!\M=SW"Q^A3_M]&?T^.+?AE^BR8F^UWW#]\9V;
MY]0ZC\GREN9FOIW.,S0^L;]OSKD[ 5_I9_6T^4>VE*"NL5N;6^TN/GR'0C]X
MC:D9'UF) ;#VT=(^DA>)-I/^M^>6[T3H$]:#E7?B%<K]LBX\O%J?*^$>$C/C
M%G_U16>UW)-!",$$<< &/@@"&("=(MDH.1D+\R8[NTUS0LSH \B.W@=OOR_-
MKVR<ZNK]S)_I)0.\91,QS$Z8EC,@?0YTWR[O6\GK7(/.?ID-S6#?N."<C5]!
M;R[GRLU;8LG2^B',2W0JTP1!T.LC#.Z4ZQ:QH'BY>!&/I$8&CW_70,FYKF*E
M)B>BG=.8OK1!-%C0 42#02UGOA.6\^=8-R<YHRF!Q7-]_](VN^2W(Q? >OVN
MB>8?8"ZG >DEXX#]JD_-X>>4K1W8.MY8^K\IZJ _1PR\>"#=D2VE6ND\5X#X
MMEL83N9J9  $&V1(FB13AANYFW[P+&B%6*"925;#[_&VF&Z2+[SJJO#0K9A.
ML]L@Y3* +,6.NZC7FUUFM"3(5 D6A'B$B; Y0N";IQZ]-IT=Y 'BAUX!4:6$
M!D,\E&N$?;1P7A)9/48=HU<FONPY,,_W8\.JXVQJ)H=TQ;MQDYQ3@[L+@ZT(
MZ\9-B<RZY)ZM'9"O@2;?[+LK_\6_^B:SL&7"*ID9HD*KWM(?D6H00KQ""^=S
M32OR:)\H_O+%.$:Y\V&]<VS(>I5MA<K]LOCGCU\-8Q-]&<"J-47?.VMGB]./
M%$PL:$;*M9>1DQ=MM6S?'@C'V8)6/@$ <&Q/7>U^[= V U*E@;[S%D1X&BET
M'O%RT^$M1<:T@#>UW\(@JM=1==W'/*O7Q-1B<A%.,("^!!%Z0&5L- '(,0:
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MQ;NV8YC;K9?$'9FG=0[4)R2.+O?!J7*TI"/M^T8\X5X:G7G->\VG]Z\EEC*
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M&H[YKCC^&EXP96+5!LWOUH4*],J8%UB057=,&KT9?]AHV8-'X2@L^9A^+02
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MX8>P&8I8WL/.H_W$DS&M=Y-T# SJ<PYK*=)[L27(KZ0UO$D3-X>;VDP(59R
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M]V#TDWY-@%%?#&EN_)-3H>F,,?S;[&M#\/7.[#]95+^%DT_0.>@=LQE;V%>
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M,/"C:NW1$42$@F3R&R%1-U'7J1+SDMY7!5W4\K4F^I%V*CN*3\^8Q-/Y"EG
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M:IQW;>*1QN#7.D:7S,E%IF4);[%6GWROMNJ;9L8O;GB];9,0K0FJ;477O>W
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M,(^1*F=7;PC'OO3_H5]5Y>ZN("&A4H-ABAH^9@''>?&T^=_R6%C.(=9W5;*
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MR;(N#89]^&1.PR^>9E,/&XR:\#Q@+H0NZD:G7-I^#/H)'!)HPT&O5F?F^S;
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M7&E][$.BT%'57<;[<<*I'K/\EK.JP@2$(/[J&']P.UZL&#_$U9C2,ZI#$7M
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MB!]5O2WT4D.UN<F*?LWDN7DFD06$*(9];)Q89P$3R974;D9>PTW"ZMBJ);A
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MQPZ@B\;D3 ^A5_/O*#C7XLIGTW4GQR/GMJKGJU^-5.^L%I(P+$!?;&1^*#2
M_<P"0;1,EC9B5$(]L&,THGQ\&'*&Q+GD0B9]3P4M._2,<A.T& V9]TS7G,:[
M)(V%LIT^B-[KNK.KW)GYE!R^.55"D%*[ALW^FOOS<H1] 8YSWG,X[?'G62HZ
MFZD;?(W:P2A$WH+$(@0IQ<V]$),1K?H$ 0*$9VSIF47 8?7)EC5&T5R.;X^
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MTQZN?.(G6BV"JGC%RU3#+\'KXK@L/G"#%*X<XI_!L;1_?7QET%?I0UF((]F
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MM2C$$:>EC":QQE0/\DJM7-H[KJBTGKKDT[.WQ"$G)Q2E6F50WC\*-_40-UG
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MMD67IAUD HE^EYYH_9UT7XNDI(RG>?%'!57IRN657AK,EE/I@'!X6\(H)YG
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M>CKRO UB-\6,5.0=E7=FS9Z(":U6SKZ?%!A1\';K]@-3HDJS@<60W1$3S1G
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M%=S4^/CP^($^MLN.MQ<6HJ>_2SQK/*D#;CA2" 5B:YV4'_D&Q8MJ1W,CKC1
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MH@1770^UM_"+#] Y'%]>>Q@QTT$MWGKSK*[E\O%NQ UZ+$V5=+E+NU<>P_U
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MXM&4F]6@#%='8%1:\:[W&DX@>R8$[/;182: GTYCG,"RHKX_V7DZ(P7<-[
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M^2@7TYA>K>X/R>UKN^V^QFM?>"*X;% G^;4=:)F!1771.'7(;R6?4-CJ?);
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M^(B2_?"YFU\OAT?LB((V'1OP5-D?WC&"X+73.;"13#:2\]S )+;-0E O+IO
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MP$$H/)[+E:,3<+L)Z"/0J1PDZ('[-5O)O\T& ?Z2QAF&-"[_OZ4QWFAZ!U=
M!\B0PVE%^"7J@2$ZH/D1'2#>1 ?\Q@Z?=K8JAHIRDJ[.14 %,/H;[X?6.N0]
M%54\HDL//G\6X1)P_^J$6:AH\I"I.?\U]9PG<Q>@^0?N3-[[C,^71_+K*LR4
M)%[8X3Q,@EO4J#Z-S>XYC?6U S%]8\=K);-09%%'X-_D&(F9]J_ 6Z5CNLR/
MP)=0?AVS4L: -IS_4DZPT0+<9@.1CO^*O9Z#5_[A^]Q9PO.%EM@9:+VU?B'C
MT@^O_<1SK/&9!6-%B/S-KX&_^:7%S!]]_I'[&+E@X.S+N[(!+OG)";X5]4N7
MOG;ZVHS<.BSUU[9L!F^IPX=3#P[0#OTZ!\CVR1\]_E%[Z*">0\^[?Y$3? Q6
M5Q)&-,(L3V&1GW]=_V-/TJ8]=Z$##@(9\*ZX5IKI!(T7_1+T\R0<?_K/N/&/
M'O\0/7AAHA =VT=#M4][Z0"L[?&KO.6RA[@^B<7(?,(<6+[YW[\MY+]T.TD9
M,6NP(IZ+UB^JCJ<#PK?KHE=7-UC1S2XN'JR)!CFNPC(R,2F.-P'"25:@SZ@P
M30/,P(1V<R,_P3\D,,_=PE])?C266J>C+.<E>>K"N4/"QP-%.%S^Y>P4G_P[
M5*\8W!I. CE$&U('UZR:F>JX!I_Z2WT<!Q8<(H_EC(,=)OW:NJ<XP? ;MM(Q
M>3J@#-:)6D-X&3V9^>$MZC @?FERJLK/SG=Z\(JH,18\,=Z1 +5 D0;QP/E-
MDI'5>#$FO/VD>LK+VLQWA8%<;^;2LK;N)9Y-.&*\+,W^\<-KK)1&&_B+=S34
M;0YQ>)FF3MHK\$A'AL'.?(=T;)F//(EX,:/RY0(UZHCC?5NKFSYJKPJF;VY.
M!YGSV@WQQJOA W"$/(C2/",+,'(IF)B&N'2>N K_2-):U=,-$S&_8HWDVO74
M>EID+*9\/TU\2_5%+SM"&.2"XJ18DCCFO9_#!!('6D_2)+ZXVJQW&NKJVR7W
MADFZMKZ5!D*>"!,<0G447*IQCS(ODV2@WH3\)B#?0"2LAPXXHDI$4HQH##F@
M'E9:@<88<NCU(A?7Y?>,U9=9,<#K$Q+WQCRQ $MF0[ 9Y$!"VM!3Z>M)\YSA
M@O[%@1+]4^NG7^PO*&D?ZNLYK2=M%&@LZO%SY6R!P=&OI QBRJ_*ES:;U'@:
M "ID(F+C1M,B7!<,'4OUFSODJ5(BZ9K^8_/R7<,NY@^;;8FVZGMK8KQ7"L5=
MUD+51-Q<LV[_.%3$8ZJCW_([+]WZH_W1_FA_M#_:_YHF<2#I"C/OUL":,1W
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M/.5V5[71\;/%L5=?+>[)/=N+$J]TVES6$T\EG.<U.^O0?7,7\?;44)))G4'
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M*?@<R)DAD J2KTX0<,7!:!),XJ,P>7\<W (]1LV+,T2G1'L)CT233";@FYY
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M*3-7_;5SSZ5RLLK=K"C9$^>R_I,VY2#Y&+2%TH82:5V(TMW81I7E+Y]6QFS
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M&W0;?B4]> T3FW/1IS>A8VSK2\'FZ*NB.BO9DP=LZZ@/!U!+\W1 DQ--%^&
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M!7[8.WK>WH?78?&>!,T:V%\GSW1EF**6KY"1_V'RF'7&AL;3](;?[*[8,R*
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MHW:4.,W]R=U:R]FQH:4!(/[Q$NXT68'"15+!("9E,?$M#9S-3]MHLF#.%?6
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MM7SGJ'16/5//?]KQ'I0"1C3,<'R=WZSVTKC4MLU]H.J9"=&!!1NR)TBU0(;
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MEK^?M@WU (PE0.PL /BKC+_*^+]1AK4[A05 7,UT%ZPB92 XJ%R+A C.LQ_
M2-=JED?XI@SD<RQQ<S9 5SD'[KPQ\=YI>3^0D^,\QX&F:ISZ@]VJ9RX/&A7.
M+X:'W4*5AY^Y&%7JX1L3;4*:!U%2N*HV="B2PN,\V\<"#IO7FC.VK=U2>_%W
MDMQ_ (U?ZI.85V*P0QQTSS\VQ^&47\QPQ%_Y_\K_)\M_=GHX)XA VU7! KY^
MH*?KP<LS?@#W?BA_*!#2 :MM<2H8K2I!1TW\1W)+P"*28ZCP^\Y3WF,-46>.
MS[R2--#;K1_X7/]&?[7;."V@UD."]$Q;;M1/2<.E0?G:H\3Y6%FT?L9-Q657
M* A=]^3&1<N&B$5K]XP]4WW3K73-,,I:P)8BZ6IB;SN)%XMA/JJ4G=3=1V[I
M3>P:&1&U38GONMXP\2+,(NKPL'+1>QY[IXPM&>M]09(K)AK"V(%#+]8". Q/
MG7AE[,%GJE;JVNR?VG\_5>:5_H!XL+[?.&.O.2_8PF5.7QQ:"PU1J&W$ K3W
MHN;;0<JIC?_5&R?735RW3@1K.BC2#'(!"R":_BU0Q8DZPD)-.\348 '\>G^5
M\C\H!9'&,.C.L9I-"^I;%HB0<[__O?J1=XN9:_H/&0%_,?YQPH^Y?U6]!7LR
MS$)_A<'PKU+^L:5D4*SKSN5U==T#N]77)N8;<F/(;+E)^JT\_B]3?9?N$TJ'
M.FZV;HKY_^OC]>\^EW*Q?A0)TG@-<>O:I>>AD$X;5N-Y_>[G\2\J7A]Q]KC?
MR/G"R/8DK_^6A5-F"<;Y%G?=*WCMBB="'Z4*%4M?<+<P,)"/HEVF+ Q;-X0J
M)M.T*.DUC@IN_">PE<(4L:R58NZ$-$:HZ*6K7L^<^;O&L@M%OO@_2+ I>7_]
M<OKROL!C)_&J8MW7<5PPK8')Q 4F2,4P"WR((;&E;F"-$F7WF*FW8?EIA13*
M.XW6@[V EY9JLH%AG#8VN@017\G.N$FKIZMCH*&1X*HAY!#&U[[8@>":YU7D
M\G[+^5CUC5+W8ZR<?"[N.=2@ES.Q3(UC/H:VKKDN<RI5;L6ZDTNG[$Q'.<[&
M*_..U9 .]7A[2G&$G7HO++PE\UUUY( HY03$R0;;X-ZT%;JPZ2T*6_5YM A6
MYX&!3[="%L7W17WQ#:6=PKW;-XE?NZ0LZ.VG?Q<QC> N-WCOS4B,-8HO>=T6
M%ICNS)EKW'3K8'R>%\C7Z3BK] $3'>SU!*=HT[^W7W2L':,SV-N[^J)H>H#I
M25>&I>#%0-*-)DO!&F*O2%=MM:Z$9ZRIF?"3ZUFG]0S:WKY7S^K^&OF$PU&R
M_T/ E/ZNH&_:(A#F$T(X)XT%.'G29(D-YCU>LUC1D4M/ZQ.YK#FOWVP*H(9O
M:$"U73HHDPJLF#[^M!FMD.O?%U(N7?LY7:Y'Q'*@U'UB:-F^[[/90+R11/T#
MGY"ZCDI%,W/86*^"*A>H F$KXDC:7HT9'TGC^8NCFYMD]H@>Q<O/>.U'1JK.
MTVXA9V#;55O; 5X:#[  VA+."TJG&#+7=<#YS7*RSA$3D/:6:$G8RIZ ,>)7
M2"/S#)Y&%M#XD@4$MT&-R(7:^B&:!)X%X"W_(^>1:1O/<<.N#NOW*/(JZLLH
MA,&4P7T!5T690I$6P=Q&!IGB"VT>90&C'> K!JQB]7Q0Y&VK7:(K;:MBY)N-
M4=-=>TE,N_/+-UX]?NZ15]].L#H@/BKFI]9O/:813!PN)N;" 'S*W"\-(H0\
MBA^JR+1)K,2E*JW.C>XF&C-41DRY&AQWM#,<2+>L1&=53N:%+9A5%KNW]1_:
MS?Y 7Z<SY@Y[:_?X#NO:@R\..:KM5]UCIJ;DEB&?X:!4H;)H)MI\[O$Y!PWY
M#P(KZ?E,K@[+0^-A*Q*3B/=(VH%EZFT* J][@,'%O(,39?!3V.LFK1V#&R$=
M,B)PQD.RO'.Q[[*=C#M/DI'PT<CL%/2R^[?9H./B<BB:AB?U#L7S#NCJB4?G
M"M;-W]'=1;-F 1R;"E%U^'4,%$7]Z=Z"59UG"R$>>[TU&^8$--[PC.P3/O>$
M]M5Z2C^G:NAN%YH_6U>K%[N+7.YXH#17P-I1&5]+;7K=?&7]'3:'>POQVKNY
M XL8&8WK(XX,>U8[V(\4QC5&F),0@7/:7B^^/-VKU7""ANM9<K,_+[EI\]P'
MO_?"O!_4Y3?6X1L_>B^B^H30,X27]+T'<?+3S3<'^^S3;XK[=DPQO?L6EGH'
M]KJA0=UN5,(03:I[II%NB>5GWK]"',XEODFL\/,>107KJG:J$D/$-T4KV\&$
MR:OVLFI TQF50-Z#L<KF'R*;>1[87[VP%BPNP';/ @L8CH54'^,K*-9V5_S!
MNGRSG+:A0.1&76X&.[F6)C$,UGANH6GH1TW.76ACR"?U379EJ6SDE@T;X.%Z
M^)K+25)F UE65PC+0U,AF]1JB'/!?Z-KQ7G:YI4DR\H^8Y7@'-3V?LW7Y2W;
M-[_^K)RRONY"H(7Y^N*/):&75.7:'ZD]BC;/D2NSO#7KZVDO3+K6'?2*0_9*
MO%O:0*%C40?M)L0=P@:)H4B#J#&/+N+B"Z)\P=#*:27+1J;8;A8PF2T'14!"
M6"3-DFQ2XT7C&FZI54)@#(\$.<>*"=:L*HC<2CDVKC@BQ&.A(F[$)KF4;0N>
M;_DRJRM47*W*?*0KHA2 / FU>V[&K[_, GK<;Q8[]T;D1'_SZ]-#JWC,;''>
M?FYA2M6KTZU$R^RYLUO6]C,)%>A]4Q<7$L6W=U0*E3"IW634=FV_D6GB74*Q
M]$P<Y3)Q^(6C(/.-3Q EJS(ZG28XXW4<NU>LO??P0E61;UY-'+K<4M0TM[P/
M8W\A1>H[LWC-\^8H%@'/_*M@-1IT'0HB%&>_=1\F\&!-*>E4XAWLY9%C5)N!
MR6N#: <%T&UG6OFU1B^V]1]S/8M<>F*/12(FQVN)7SRILK0CHUSF(6@.HA,+
M"*P4[,[48 :?(<_7,M4;O@_Y;_=4=#EG;?KA8_J&"[R(#9WS>##/?*:6;C5)
M7?6=%2:SU^BJV1\84%TI-TRJ]E&+?VLUPN%P_.&<S-LO30FI!U]G$<[MWT95
MVZ5H*'ZZ6^$BQ5M>\M&5Q*G>P=GH+96%![T;C"<']MKU?IHMFZ8A'P]MTI7'
M:L*-"H#U\7L[Y.Q^.D^M5-JP9Q"1.SV?%C-JHB6\=V;IYHLB8E'(W,43^Y6\
M+_-Z N]*L7CQ"9)U-AO$389S1^-JAW(%&7PG&E8U9E&4VF-M2P:TA%>NVVCV
M33<3#D,]B\WJJOOM#3(_95..W0G9S)GP,8D7=4%W*Y:=)DW7QIA VU"WASBT
M-88'MC>/&[W ..G?;1#>T_OZHD_@2>U[<G=G8P\(2Y4O0V($6#&.3+* K;#Z
MW<,"@M(-86O%-=19^):K<FW'O8J$5PWJ;O&MU_R+LGR;VR[GFFP,N==Y[+VW
MH^G$[+R]IPGRK@AL:6C;DO T#973E,0,$E<6VQ%*W.S94N*]ZV6W;4V#J4?T
M]CPP6'ENKLRQ:TO5A3Z!\1MN$P2:S(/4S,L@^4RS^O019LD,Z/R*!9 ,)P,@
M :G42]&-(BN&ZF6.1X6CNWW)BVIT2PIR&%G5<M]Q<R'-F>(]W'B/<8I4)IP2
MVU(+29!GLY8>\1H$2ERXZ]*K)I?YX;F,G-"=VVZ)M!@Z/ZX1*<PXINU$":<>
MISF/-#NX.Q4Y6-<-LK7/SQWEN2_I>(6<?\7"3/" \##G))[/,L;Z8+L_W303
MTK7'&J5[.'@4*ON=Z3CIM/?MS:R<6T5#R2M#\,(ACJL7WPGWU$D:D81F;+>'
M.%_J'L" =02^F8)I=&@BHG7984(C2G]#5]'T]O7#Z[;EE[V]<6[AZ/>&=9?T
M/;7@G#>@+^B"X)ED%K!1E@;/P@WM9'!VEI33&T!"A"YRH/(+(X1WE92T[G[0
M._D952#Y6=44T2-X':']KFA&/45%!IFAR3[C2=^-.4&"<LE/:XAYQ-I;*C65
M.R,ENQDJZ33Q&C'4B>L-#27%QXYZ\]<,ET;MV__Y%6,#,QCEU-+C:5-.0<Y0
MZ*H8^>K5A.]&8ET9R1C<9H^OH3W"R0LU*W=WMZ7Z'2I:GQ2XJ:3+Z^YJA9U5
M0%1,K^F1&/4HJ]-A7F[T4I0$^E47]6%4U.G"WHI><W?'5RLS_DF3^MNMFQ.3
M_CV@R=IYE)7]2O=15-,E_)H?]!!-DIV1ZDU"_QS09&0MH(DSXW%< Y(NM=H(
M1;X_X\G@98,LWY)S?@YHXH5V1ZQHJ+" -_^V-9WRRZWIZ'_?FD;!'3+\%7]W
M\&#P*/(.Z(*9E7Q:Z^LH+"X>Y3)Z/C;N3?^9_MOC*4^<2K1N$O+?3Z*?+#&/
M8UJJQ;?2(D@9.9NP>N073[-=EM_QTHT[9YS>%I=8' $H[SC?O&-_>%5/)V/L
M+3@<AB8?]WOA-T2]<%\E]Q+'R.RYDQ>HZ\F SNWUQ&2:8,.9G& :+M;^B<7+
M@;T2<JZ*E#+7*:N(^(J"BN4V0N+X,[&PCRH<YZ^VAXUUOG*P7;'5&L(%+RSK
M@WH@^>L\34J)*0JK=]*YS)]VS?XM20Y.<OHIZ1:>8?@)5IH$?A9 %@$9!;"=
MWZ$]"N%.T+^Q@'>$EF_\S'5@;31Q^#%A\4H&K! ?Y/^T6?$[277881:P0D&S
M@'7I+*#I"//()]3X-U0EFA'*@-K0K4C&02V((YP%&'P@TFRF48PGAHR#&C^G
MO(-3W'Y*^1$.ZC=@8.ZV5G4%BO0$)AM<8LXL(%H&)D_28/5^<*)'$$[C_EM:
MR$HU"U@8(4)LYBP@-G@U^!G8\@'$$E?X5A@IQ"04[9HG@T\0BH@$R6^ZP!5E
M_&\3\,^0+$!7'AX'JG#;7,"7?HT,1OIR$PN(1!$^R*_"G#Q8"E;-OZ[Z=Q/_
MPO-_!T_.*68>ZFL6;$90C;'L+.!E;#2ZL!':_!16O/7:8*VR$B0@TL("I$[G
MW$<-/P3)9D/(J=;I2D5FHL#WJ2'CW/9S3R'>+#N=HJ(;D;9]AO=*@9F[FZ-O
M:*CWYRH8:4=3VN]]PZ<[6.2X-'CA9K4&S;C!IJ&Y,D9$:M5*7NV''>2RR_.*
M8>B!!52B_]_3+/D<2&(<QML2!B_0W"C(S@E*'D<N?"<,*4%'(5 F9P(![?BI
M$2P@]0*:H:!&@(ZG_E[2C\4@I\1A>P@ER_P.K_?FX]_#H-NPDGE/)!]'KZKK
MLX":6MNU;4O4[R2-Z%X%&;0<%G"[G05\2_X+SU]X_G1X9DNM^T'RU?09![H>
M6'U(#6:V2+*ETA=BE5UZ'7[C%(%[]OK-!*6:HDL+5NU?39HR GT+[Q7@HS%M
MF@V9YZ)Z#TD-RB\&_[9:6(TDH,[/]_1138.FFJ@X<NPK$EVKP;GD,]QZQ4[%
MS%Z#OE)+=V]O21/9S:D?.9&<F[SJL8@=-$)MN='2%0-.?B>[@(1'I*U&!JYR
M1B4=[B@?U<^W3M@E4HUJA8/0L[+=CW9(N_64I8OV9#2T^/I<Q\*J8A,)JB84
MQ,T8T0\P3&EXNAGFTD)-.]:8<-R!K7KU]4QY85BO?)+'I7"O?=HO9I0>3>6]
M+&JZS7EG^91_43I)A\OV:4O'[(4GP0,#7E*"$VQG3X$TZT1XU4XRA(X;L8!Z
MZQ';(,WLB_<3I5*,FHIZ)>.&\46UK0\$PM+$(L=4K=/!FG(RR%R/^G[>')+#
M_RHO3^Y_]8H%^^,VQP06P+D J^=%V !_'XI:NV/>$8."[B!7]DO_M*OMI._O
MRY!O@?NT50)6PY(L8&0MJH(?S%%6-X!?ZPB,4X!?!/_D$#E'&UXS]/",Q]$L
M("P5XA^';:T)'EA7\JYM?O^KHKEJQ[Z:90A5PVM8<IJS]:M#PR!7;Z@ MXKG
M4^$'YD,'/WS=<6O^G"4\#7^!YK9V0]CB_(^0+'^-!E@0D6\G_@#)\-=HV#ZZ
MY)C]"A+R1]DD(?:G5&C]2D#@7VC^,)HRXCVJX#X;!_2'0*>$3J=WT\4'469>
M-)%.?)4X3YA^C*K/AV<1G\L0[YZ)=(6I!JF%27*^WO<Z%4 8 S[_P \#XFCZ
M)5P[;@<3SP(NM6S'M8I+OM$@?HEU566J7=CLZ;G')VQP1V+8!9_^*MZ78G>+
M^I'W< *X.A'"K+P"LB"'L5W%OD/[\BBW_SJ?RZ3PI^^3VK%:'E^-Q#(M4F6W
M9"P_)"@(G#WU1=B^ASA<J;NCRP?\HH<),"]P"T=NI8T;=_B46!^X>;S),R"@
MO3E1;OXZM_<QBGJ@\X@Y8FJ_HXVK0&[_EX&JOB@7AR,2K^8X'QKFYG1A+EF]
MI]D)]8M^R[)+.V;L9F2PS\*58U[<PU?6[I-QTP7<S7K^UZ<_QHJ#&\['.XBZ
M3]%[NQP*Y[!+%-1:Y ,=-R-D6.4FNT&&"N5%XL@M1+TX7X?TG:P7I\Z6I2**
M/>RCGDH>  X(LT\@:%*"LS<I\M1PLG1H)2P:_RLWB'R5 E-MD^)*48/]C>*I
MHAG,> 9W\J''^HJ'L9DG/EJ$[MX](1XS0B";3J13BAG;FZAX6BK)P>TC>8Z0
M/E$J-M*0S3MN>8Q'5'BX8*^;EW"C^3Z>V@M+EV)<G9^IA:\RG@V*[T\X^&'.
MTN/Y3E(S4:&#4#KP*"K*3B5N9]8)KJ<G I6"W%_MR2^PKRC+\.R=H,^5(/#=
M(SH"M2:-J_38A_1[9YQ8 #(;*A^BPH/S\2&8GX.SFHPRZ;#8BZ8H5+7ZK2(_
M64.YE]UQ(Y]1VL0K:)HDNH8%1)C[C!)OSSL/#_&]\VT^+R&?-J1^<*_(>O=^
MRD(#Y[,=#;;AUF/.]6  D0_:A"E"K\>>(3O,!;\^7%;9@@FX$AJET3!E;'SO
M+ENJ<M16Q"8BCJ.J&1M'/P_S8ST6< ZU"1.D% 3RE;-?I"C334O!0IN^B:+X
M>R)GJL[>798T'+MV,O/B$^.\RL_[P+02Z8@#4?P"7#TF?!L*3$;"T(/^]FEI
M7Z/M4>^\'FOKO)UO6D%-OV/$I51", 4/A0U3XD1U)D@.:@/7=/$(;/)[KNYS
M0S)V74=#<D1X+MMZYZSR=[* JF3(F;#DCUI8PDE7J5H/#9$I2C0I#::0&A[:
M5OKSS0K:)A!'!&PR<\-RO*<8OJ9%H+QQ]*(\;(K?.<*HG5H$QZ<8YK==<HC$
M7]>%IV'B&'RBT'V11A:PV4%P;8EA7OQ$G+"&;>GUP2O!G;!!T]))(P"),4QN
ML'J7[BY7)"]L33TC<"TUG_;>4Y^(5X_RO?'@PY3;L6#F:I F8_2')@:N-9&Y
MMF'IP3"@V5.<J(?(0_C*+=B#^)I$T<JW1!%<N#AAX^L:J^\N7\_M8&\2?6[H
MH3DN'<\(;KC2)/J8/(#,/.ML&/NZX/E(UYN$T=3*,@8^;QACD'A933@=HR.8
MZ0.5):[M"2T<7'WXBTBW_]GS#]TTXB0GHQJ0O4JC@O<9.LG8LQW:"%A/LTU%
M3C0A@]S='Z1G3'&[>?HH?&[RW9"QA2>S+472[0G7L8]?-LL/N+W#2>":Q57?
MT@)>86V8A,J##C1VQ^ZH#13):RY7I^)Q:5^3CXVY7;;E-!,\[Q>Z<Z/%IM/3
MIWA4XFGA(RR@5Y14@T%2KQ32&IU>8=H;H9T=N]H9/CZDD&1-7(R;1[?R.^I4
M@W!VYXV4;:%\ DT[>TVD[_MXAJ/R"'5(-H=I4%0M9P?&I"%1H9#<D)R.B6IH
MFNW2*#YOOGMJ\*;-67&;ZZ<P _:<1B<2Y5]VH2[0&);D<3/R>'BE,BW?@F(0
MG0UZ7,9I:_ 8WG)ZN>V(D!/'U[1<J[:G5D$JH@\/'?#/&@9[ AJ['0^T0;MP
MGU'(;-Q.1\PETIRV2GHMZ8MJENX'4NKWYO9JT8.)I),EAKY]XE2Y.Y6N&75V
MB7ZHV;T4YZJA?$&\-G^VV[4I@H"VRL@D5BRY_WC1FW[7N.+V=<\=%?3\=JH*
M[FLJ#$)$2LV/-+I[CWJ&XGAHJ2,MP1J5VB4=$N3Y:FXMJZ I-YO(M(Z/O8^N
M#6[+J$7UC.[1'>ZKVC%N4D_(D[HSDM.;;L!\L8=R_&'CB]Z:[D$1>_Y]4X)4
MRH#^9?_O'N\P3N4))]U15=?4A^=IP<.6W952<!7[*-8Q+(!#^K8[0X6*>C-'
M1\6I?26X#)5[MO12\MG$'7W%OG!2N,VY=-69*3@>W'L</S.O>W0L=Z0 GL9H
MHV[M<R0$[V2O;\_<[)S3G6R!S_8W,7N*(C=DOW^;MN%UAKSOJ@ Z@LBIAN9K
M)N?7(H6Q,#?@"#?<;3>A/$4V]=U1(R'=XI*7F<EO0+4LF-WPS1\O04;.J(Q2
MAIE<)/-&8N^EZ8;$S>1^ 9[)2IY<<EI1C.>UHG/:]\JO?G_OS;OB51SWEDUY
M/7W5NNV0X$$YE>DPR1&>,=V];:C+A%Z!1A(+"$VA!5->=)L\:*$^*"<GOJ5P
M(K?6["13H[?S:/I=?2?Y8'O4K3<*W;K7&A259QK=$!>8>)P*AC#B&Z*["W,>
M#-F/&:_%"5(V5N0$5>X\7)3!?)G7I]!N7]S#LRMRMB=F2^[KC&#'=1L2<H+0
M^800B)=F/W(ICH0(;6M\C:$WQ.>$+#+M'+9H3BPX&O+*^1E<.>-GH-.C<">T
MVH)=Q[<:?P_'3Q,F=YO0G.#IIFOBH,XWYC!H-';&T6S&T>T)@9869>#L5-6T
M ]C']BBUE=<9U@NG+_[CG!O^WW^$6, V!AL)&9:XL4M7%,,"CN*MVM0&--W$
MK!K.5SO?U9>;CMGU:)C\X8AL]89MW+B;U719>'4]2CR[]S"X"6H9Y,FG#9#3
M/"2CCWZ>6PJ9\:D0X7MWN^"Q]9E<9)GMD2L*O&)];HMWPU85\*&Y/3ND#?9%
MV*GDQQQ\,=+;:Q+38!EEFNWR7LMEKD [LTFZYE*H9IS5@\]V*-,3IGYJ$S@O
M5Q%?!G\<-3$4AX25H',N33X=+7\D ]->-R@=]GVD"S6B3JG+V/GPI9S0T2^2
M6,H.368X70CW#L7- LZ#=ZCH395BS5Z8)JU!M_C.D3NZ&;=V6NZIO5-#?OTZ
M5<MR.V^=@*=-2JE*MD+#I2_Z >G&VUV&GM3$QU7LR7^6+FM\NBS/,P:M?^MX
M7G\X>VR'S^[^],)O[H(7HHQN=2]P4L ^_&@<S/-[EDG:Z&V52K3!1L/"NPON
MKTVE)N>%7GVT.*K\G3@@*7, B+[-(>[) C8:PDOH4YHWE8VLEAU*2E!OL:<%
MCHCZWF(W*'VXHO[P[LG!,X&[RK-Z3NF=?/>A:M_FKSAAQC7:"B6<^HC";*QC
M 0]T442*0.'5,MU._V&%_7>/A<ET; C:9QL2P7]20%I8&N5#(@;VQ/$:"R=*
M.39M2<3/FO7JGLJSSW:^=</<'O/,LL[FC)CL\/#;UVHY+DO6<ZM]\RZK;%28
M-]S-QCHPD_7G[^"VA^>P8W3=*<<>?MB4_+(^47O%FFF5]^#\_=$M'UIVQZ^@
MDKYVC=<2@BIU:64C=/0ZK HY8:PPTU&W[Z:H4+&Z\KI+*)]MSF,W=IV\=FQ'
M]\3RC#,+V'"3[%Q;[4[AHB;1I4/5LC+V$(.<5@KH@I] +/AML@'HU0NY>(<7
MFXEZOO])'!=YJ^,K?9DEBP?YT7.K+*#O\XV)4HF%S2?J1E^C0=T01OTG?TMT
M:WU%845:^8VB-PJ6#7<D'JCUODPZ"[#KL;M&\Y-9 $6(. 5;6'(L8%DEGRY-
MAQD-@V]E-(68_-$R##6R'^Q 0*=8P-PY9C23!=1"' Q*&[IU3*8>^8N<^Z#W
M,-N#]>0&"/->;'KUZ-HG.89H!8V-SH-5I=F^GESH&>K!.(HF6'V:XML1VQUW
M=.#,T0]^6Z*:=S];B'E-W(I5@&0I1P5:>-Q<1)M+I>=FV><(RWCD\57KM\#V
ML]9?(1E,H*)\36M5 S[?(OKI\MOL61?FX][W397C@U<O69"S7\B9+9_),/$C
MML_!3(0HJDO^HR%3*$/_%?UQB(,-*>BXR2B"&7T+9I['OF9K0!SK6(!,_YK3
MQ]F;.4S%DIRB8,;3)RS@RQG4XL<6 ?1W2T.H L54E/Z\=O&RT>R_JQ-^]*G.
M@@HNTY(NGPKCP4^?N@3BI^:FSNVP:$A5F/FH=XHMRJB*_YLR6*U'/&?SW(5
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MR6_-0D71<W$G%C7Y]UC==]YSJ2LCMYT%U'13!!DKMN!0\=_,GIP1I97O>2R
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MR,@@]PWA&Z,1FBH[")4>)Q]Z=?>F_ #+OL!BD^"/T%"_A-4UNWU=X(_0\#_
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MW2M&*[>!08['U"*FN?N6)FJ&ZVZ=CXH_1]CFH&M]5T7_8Y6I&LXM!DC%%QA
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MBH#?HMK(?*PDQ1,$Z%Y6"] P)4!H7)E[L>&/_,4=&'VD)I[Z2$GGYLM=3"P
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MLNOK.^ /0PR#(69/XHSL[@!]>^B9R>PW#ZI..#*^"_RQT1.WQ(E^ZZWM_0Z
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M?1V9,./N=)5TRC.KVF7JJR@<O$I7_@"NG9Z<_3GM7:%?-A%SVP\HL8Z*DD7
MKBY/IC-"7)7%QG?FWLGZ@_L7X"?'\X+IB(!ES Y\87 MBX=OE=CFG)3F)-Y[
MM#XW:'JB+*5<QD*T[TNU/CW\-ZN'D[VMWL(N;_49BHD4]D7'86-);?8=TO[R
MXC4]=WZ*F]AKP= G'I+G>-^85CHS059HULDRWAJM.(^/W[JI64R>!/DKKP8M
M^FE%EUF-(W76(7R[0[M,;^2??JA]N8T3<<D,(SSV^R^50&*O#T:FQ\5E7G1>
M:[#-=ML9VF22O\BC]VG2<]$QGFN"49RW]^[OOVJK0=J[/'Y0.67&$*CPRAU/
MK/((! 0V.:IG41^'-^I?^$&"="A ==^I*15TO.X @FM_Z>:9ZE8>..$NV"KZ
M187W1!MB^X(&Y)[MV^1T/#H1$ 8/U4E]5UZ=8I J^GP8G^,HT+%S-QT\TO*\
M 8JSIZM6Y>#D_6.'X,<AV[/8!_*4[JPT':(;DEXZ[Y7NA7-F_:_2".=#44'V
M;?\D9'9#$7@\6N&J;7\8HZLAY:93T$U&5TRR-+IB0+1]SCP1P=PW=,"$U4,^
MKL5>WDCT(ZG\KI%?U<<,L2B*1QXLGX-1PZXL DCOW%TT0\8=@!' WE^U%E=:
MS"EY%4:4M^DE/S:D]29W@*D,+SP,LJB:BZ,WPE]%22D1PR@,1"):'UA>AX9L
M_YK(CUM?WW6K.TJ1LYFNBA%PY.^^Q]\*MG;(1>IU,WSV.'T0Q9;"9"_1?JM4
MXD!X!_P6='9W]UP?_$,?-J @%SK$(9$23GSM3E,!OP-4?8U^MW+^BKXU'>\B
M9SD0B;T.>"M)]=-25WYI*SG,98=.D*1RU!K"S]?W1($ ')H/O)ZQKXYD[$JZ
M#OU<;I#]2HFZ.)J[:@#53IGGZY6ZX_=TI.[-3AT^7^6"8,0U)8F1-#?<I7%B
M;@ZI-G\B8J:T%3[!-])UH:!Y'8O4@G[=B5W>I>@)H/CPH3 72X8=P)(9SOQ_
ME/)H6A]9/1-7#-L(_TWV\%$ME9)(E=E@JSKDFO#,3KVS43M@-=+A1F"V[_20
M(/XR8N'+F^AF-?'4=3_>7#+J]WVR<S,OLZYCCC/_<E5-2:KD(X,Z=.=WJZK;
M+"IOCTS,YM_K8<>.+DEQ8L<A]?+^V&B+'R9E@[[;]RR%.YAM>G[;)+<AZYA_
MEOD3N52]OP![-N79UK0\>.D<)8O7&!T$/66\ VK!-Z\K6L&P?F78C<.M)44Y
M0G=@16V\6D)""=7DH2LOMZB&1]OPM]I>..S,**CVS0*_\E;P T5F'2<Q]A5@
MVB$B$[&;!YM5AL5-?RU]9&>RNI7PK,_0(ULY%J0]KR9SV2%$O('ZGU&-B=T!
MS/KZR-!U)B_1A!+-0>9JF;/7<XMSUYE]A/NN#B&Z3(;@;W.]0NYC<@8< A4\
M[1:QDYD?N!(06S6]H:VLW24E\MEQ[XX^<N0*;'S:WH.R&QB6(T3DDF6^O9.<
M6%&GD//ODE4PCE)7DPK+LN"'!V'*C-'K4^@U@T[5;(3/OU$CB0=GWYC((B6I
MG-=)S!FO:BR-*R+8Z#9QW7C\/I(]5V^5()WN]UAY!3=+2J08*\NVV8JY]VM1
MJ&,6)";&RI*1J-/C7NJ$('Q74YMY(TTP[9,'=>,1TSP20UG#:):0LF?&%FM?
M*2 =G^,6GZK?5+.4W $BD&@'KP]N8-+M.(?0-\45;(]2J#BR>IRNX@W=5]7)
M.M?5R7W#=S?O5W19)&K^TL,!H,_0KBLHX0]^8"/@D_;[@(NK^PUMG\$G@H:P
MV11,83'ASXC@^.UE$1H<V9-,]8)I*W:#YYWIAT !Y2/OF1]M94L=\'@EK434
M?O<[YM-^>9#DS2K92 G*Y Z(L4^^ PPRKPB+?NX*6AN!JE-*QYJ33$;,L"$%
M0XPG?=" K!<HT"H)^QOXF5=&,=6B5+\#-TY$ #4E]'-$>I"^T5<A(?AE>-ZO
MX*557$.V;<CC;4S9XY:!C;B(ST>Z"@UKZ]1Y?US6^_*GL^AAQ4E04)QOHP[M
M^K"3SXOU%&'\7-. \+P'/02:/3"J5.":K3XZ[%HULC?8OD;LPY*G=>&O_I:0
ML0E.20M0H%?XX7XR,CR2P[]&7D;YWK/V,\K'T*P\P5BDWMH2E^9DYIO&FE->
M[G*H,\>W3GL:I54F%G4G_;IP;D@;,M;3C,HN;AWQ\<UN$_;UK"J\K:O1,*5
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M9%Z?AMX!,IAE1CJO<Z @+ _0_>C!&RBISTJU_4WK@N)I 3)^G1#IWL6_ZU!
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M @?[P31'+[NN*L!T!BN2A"C2.M#8JZ?CK,L(0%NT,H;=6UN&9K!!OBV-OO'
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ME(#U#-([$6.#$2@8S:T5.L?W/:^"BZ=H29XY:'#5RVG;_5(]L8GA(DRWICI
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MXIPPO>75OAA1LB)(=>54A,<P%$RP(]<XPLZKP*R=)$,^C\]_>\/ZP8GH]GD
MC,'O5#YA;+YM?GU1!*_N]@.'FY'13V0>.,EL_9<Y4T)[E:J*36X3/I,R)B]H
M/N$/-<M5_ , %<]3?(G7;<>?;66U="AXH>D1/Q]<,Z2\K^:4*JU\,/%^E(-'
M_^G^[FH)"7&,>]C#U9@T'X-*E/P26?=\M[<L3'OS-D^7$B8?'T+#.*]FG1Z\
M=80I6R2%3Y(KYML5]-$?;[%>S?5PT+NQE\B>TO06S7Y?<$O6KB117MBRUYDA
M<WUZI26W 6!T"AC4;,4R<R]M5<+>M%23!\+2"JT9H.U3MWM'\,149%!18]$M
M;@FP[?&R";$9ZATR#"9]-.3!FYE]CT]XA*XT+[ .F;?B%[(+9GOU>>*^<GU]
M+?'DN4DQH)6FR(4CI"[ 7LH#XV*CTST8&,P^4ZXB,ZJ^W[F(]7AC+\5!6=<-
MK&J(KGT'TM HU7L,<WBZBA71#CLA0_?E9Q/A=[5TQ&XYQ,EG#5WLC:MQ6Z5J
M,5P:F@K-7@XY%4X^"Y:K2:#+F[DI?46!1__FNCS%>4EKN4SG(F%OS\W($&<[
M1J;_-D3$DR[</);BHGPKTII?X0#66<H.U>V[,51*VW.Q>TC6D$(K_/()G6!+
M!H9;$*I[AL(RA:BAJF^R:8+ J]H9&HEO.$T-XUQLDWX9,PNZ5AZ!<V<9Y1($
M!DKK4I$7PKY=;\B??VFJ.G"IS:+P3,2NX-*I3I!-XA,D75D7=0P=G7!*KD<
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MFT$ SZRVK-,.> AT+UCD(M69YQ5W::3HHX9#-RW^X;*_5+,]_8C_0A5>/X0
MLG:*_O;S)FK1OW2#\]\L.?0HL?88JO)ZYY&,";AWYBN?%]J\[Q=F>8)Q(G!M
M<4OIXL6UB)U8+Z],P\",([1JXV;7YL9JLG 9FT62J2YP^>D@5[%_OW0IP$A]
M^AI;J)--2)@)MFRM_I+HGG^.1[HAQ.CBM<"><Z//I2FV2S7D5@6."B_I2U$4
M^ <46R5R-P\6MU(*%4-FE:=$$3,QX?Y -^C)SHZ\Z0I2$AHB1R<10'^:ZCO#
M1Q)Q4X5Z&OWVDG<="66"I.:OU+ 'MKV5B+YNCO79'.0M6]PE8'6TH2OX\7X
ML!M:X<#5U4^V=!9X5V3O4LP5 #\@O;&6NU*M&"LAO]QVCOPN+F:$YC?TPEAP
M9[IP4\CY S5Y174H:=)=6BDC-?P'M 1*I=8D'>1Y\78E6QXNV5P=IG?XN?+:
M6F*..FM>>J[""5$F6T5<^0Z',(-#)7'"A?VYL%\/K2CAS.B1TH^O'*.T?@MO
M\:'%OYQB(_[<?%#&&V8CMMC-FG/T^L.MNX&S1HM' JR@>YNE^M>B6<^HX[*D
M/5]__ICX;H<4 -Y*8+A(*0 V3;FFU&F\&'4A-O>"[Q/_D!%E8<<EN_!8,[6
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M(%B7))LPH6/\IHH*R<H^7D( :84(P/N>R 5XHPB\\#2,4Y] 6?G' 0(84D,
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MPF*[/L^6L\-OCU+0%T\6?VCC;S57F%;8ICF8]Z_9%T-<264?M"@+YBJN;#
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M>?+%NF*)#3Q"@BZWDYJA]6GM=Q-V6E]+56.F(\.TF<$/1H(S9=*/ II'/>M
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M,KR++".#AHE5\#,>3Q,^U]1Q21% FO)1^&2KI992L18?OWI,%5.WFMBV45
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MR<6^OG'U;$KD_M&)F<8[O2_6MT,N# ASD1]BH?5+)[!HX2;O",Y4KVC,$0E
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ML\\YH%DR^^(;?IA1#.TO<E6L(,P'9I)3T;M$64JO:1N8%R6;&ZQ_^2C_;[C
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M^.;0_X_6%N29O]2**J#1@I#^N'?:>SQP\!2SZ^NZ:MJ2*!*&=Z.)*O&BKKG
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M5E#YU"ZBSE1'"OO@'L[X8U2Y/5D[ZZN:4XM0M*BC&Q%[%3Z[])$WXHI0?R7
M!IS*&*#6<$JILT+B_)ZST-U^80.K1)COV%O&E#"(?D"OY_1Y:,TC+),HW)O*
MGN_$V=3D=++ U/Z95WN +]AZ7@XAEQ3KF@P8M 01!J'+=F\*N%FD=_!_G-;C
MK%AB%39N)U-XKQ.=2'S$29K/3C.G-+.9MGU0VR>T7] ?RCXSB-S806#Z#_U9
M9FH";*+*,"M+B1FSH?F;%2E75QCB%X=L4WQ?WU-;T0.V4E/IFW:3(.(%779%
MYZ:(KD"?;S-2Q&Q^1W:HE"=GN.K50[D<J!V[/GPZZFL%LKNY@2+2RZA+.5*:
MXOW.G-BD6V6-9QKDQY9Z3WG7.XSJ/+4,DPYF9JA9CES 1SL:70?%1WT2-K:;
M]<+I^#*C>[N94&MX,7%ZW_,@Z:L$XZ8E3MP::W ]:XC[-7SC CW</KK8V>\?
MA-<#HD=J3U.TE.QEM]H.TB.S>:W(DN_3\9#[+S%N=S@;G ',5B;IRP;LBCDV
MX+VC')7/ $]NO:JMG38+*2T\^D!- 8GRX=*(8O'C<"2NX7;"V;XK[KA?8JW2
M%*HVY-K/^VQHDR%*LDRO&VR[2']]/GFI! .]HKVYSS0L03JNWY4F]H0AGB9C
MV$\877XTB*4UU18;!>IW=7V9KZ/7_*JGVL%&J_]Q#3-3*!<)<M+@"Y:.E5:S
M<]#+FBK6"*\7\_M%F[=M!1K)=,\!<]\FI!>7-I;LN]/L*K^K83%K;1-'A+J"
M[5T7[6IM/ZA<O6V&W]N/Q:@Y=O9D]'EYU,;.RQ"BE8[C*^.C>/E&;056(DL)
M.5;ND5VTWXL7*JIV[US=478>A4KZY8U;26M4;"4?=AQ*6G%/X(I OCX2Q-K
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MV)4($\3[#F3LZCTZ4.,C\P(#4A;4'[@V3,-D+Y9H+K=,=PKRTV_);#5$H=Q
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M4%/5J.LJF<WFWE%Q\6*=M(B<D,G'4D;N?L9D G%6#L4O6EH"*$BZ+L0S!E[
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M T^>LKF\TE402*FOS&57(B^OY24-3@Q%#Z/W;G)DNXC).ZK#D*9Y3LG5J',
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M-A %"A <0,0Q4#W/\71" FX_8Z'%TK.RL1Z@2:_#QCK*@ .>V_C/B_)06-Z
MB"#C=M"'M!K5JRJ7P4[,1 1^X24\ ?,*84\M3&C#Y1AI/-[[6CH-(<T#\G!
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M^JDD=0K+N(45'RW6^;6D\/4AYD62&MSG"]@7 QG<X JQ>##/.]7$T)^4PQ)
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MN"Y;?.V"$LG/(I24K(GPA9X[F*>^4!5]4*L.-9V8^VF=5[,'>>0W'93C D]
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M8/XX#.HI/K5O2&OFL//L/2V[1#0QADN<^.P$?G((]1<-/!"_:5#3Q^/?G9#
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MNNV%KY-+K153RDN[^^!UV0<&VKMV(?"<9)*U M">5LB. (A6P;W *D*:>MS
MF**=-8C$=/Z)4"](+?AH;4D^5?Z-L]NT%%=.^RN/ZY[!@#,5_&Y-6HO]L;L
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M,OPC3(FX5^=2QC&0,>@Q#C1VA>:^]MPA<*B16L*]I*RLPB]O9_]#$ZS]T 2
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M/XND ^W%49P,_'#<CZ\,K!<^=Z&_C1U\@_40WX8H1+ _'/*?U9O/%8/YM.N
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M@L&NFJ"+8E8Y)_.ZM;EU?I%&@8Z3A5])4>,TO,]FV79?+6?S"=51L=3^1RS
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MY][W^NO)':N(G=>Q[=\%HSR;L !#4'I>N</I!6DLX#RNH4.EYTTQ@<1H5TQ
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MY  XX**H5NGGD(2.CM+ H*J+C5+N#-(J 5]8J6H<EG0W-XOY5DBF6O7"-2?
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M9+D"(O9H>,*4IG:%I^6W^QL:\ID+IA)=23^M!F0^9VC<O.-N-P_>4&&"CDP
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MOP@-(RF6[?TZPYEAYZV&C9)!ZRMRSE?1UMJ0GNAI.]8D-ZP)?$+/P5S-#J4
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MX.',!A.4T*Q.++>J_F,9%<R=_C"@U&LD(GUZ^3#T>VG=^:>%/MD<RO&R)2O
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M.>) DQ^&!WP,Y]K4/+8R/?5[SU UCQJ:^N.20KQ++7W9DRWAIMG%]4"5J=*
MU;8PUCNMK ZT8$]9.5YI!7FHX+N*DD)^?SLO1!5MOL0$?2S_O&,UU31W:J(-
M%0,3:A5Q]B'Y[COS#E4\B:B+\BJ.X9O F"1XS;V.2"]W4X#Q&R;OM8191<.N
MC-<FX7]DWAT)D3U_B@DJ5$=ZJW]ZG4I4U-@V/D',RYH.74/VTYXR;D,)^( #
M QB.@]& 9J V5UGA2>8;DOB0>LY]@X,*]Y<_<2O I5_FQ5-N],<;B )DNP&4
M\*95B9[0JD;S #(KX+>'X1$!Y*NA#BO3_CE1#R#97$4ZR^)"(7&OGYVY[+:I
M-5+)ZH1;6,+;V9/_YKT_<+6&(<:I9920(A M5B$[%MF:$_VIP(IZ(U;A^9=M
MA7/S,?,7E[FC;JCL.-GWHQW0*!/H90A?>%/',%P*,!,!RCN]U9#\1NP99J<;
M/I;S*)(J7U=*1)?+Q[Z:);:< _H[U"[):9"&9/YJ8#_*=DY ?>:YC?77?0]<
MP23_M!YWWB)*5_*YY#)>>?*'LY??Q3^W#LBZ*_SXTZ?W=TU H/.63-"Q5;@7
M$U34G;9#QC!!RF/3&@P*:YOT)F [O]?;&,5[AIU$60ZGQ/9#1O9A\^$->GUZ
MV:03SH?'[7.?[\G[?P;^]JE=C"'T$,X?U!,F=LJ9(,Z5__QK\V$U'<TP0/S$
M8X2ZNQDC&+(H(X\TR#A>H'6=M)!_LN,O#F=_)3C@A/.#WT/:XYE.7VVM]]L,
MRW?+&3Q55!X 0SD!1!$'N0 ,\0/-II$L5AMR3T?)H!6GU*?*(U4[>B-K'G+_
MJ&GXWC8*.&-&.PZ>T]PH+;,@JW;:U\ U ,*K*Q+D!-226:DOU..("P.7T)VQ
M:IG$Q2G2\:-3^>?%Q=R%:Q/V>R.'):L3L#&A"5_?3Y7O1:9GS((]3QZDSUXR
MTG+0#E>J#1-N4G@9V"<P%&FWS?+4W)P^4)XZO"SCI[,$$)HK,-$; 4=R3B_T
M)IZL15E'BRTZA.]Z;>%N"FGG^'[.5-#*U ZL%HEG;_(38O"PHN&11R3-!-0<
M/H;E]5):M-H2%#VTR[TU!JIJ'BL^&>C+WN*/940F@$*X6M_3$[&$Y%DI@(<L
MAI_';$B2!9&I4+%=ZM+8$]NWZ%,D1D&P/)[2E.)D71JQQ_E:U72(>,3E:#OA
MV[3>?B8U9PWPFW@,=6WE\C[<S"(%S_GG$=V4:4JV$$[23&5U]=\J;.+U9QI&
M/:ZPG[."04%6SN%HNT]C;DN>;49GT6#-J_S?=F4(+FS3Q9^RT*5WD8 L]"=[
M\IFR_T7V,'VP(] ET2/-$=]WX##3\A@IN#OZ._(9+1_9WJ&DO*%#!6L=^_1U
MI?MMTMV[<H;5_5HR9S^GO7WSZO.[#!-1NODR1).4O&PO!18+]PSREG*5\9VV
M$>CW/*K_L/%LI_%1);DIT8,KK%6\R#I?]@"*P<LQKYDP>W88HNH-%<QL,Q#8
M3'49V^VG'@04-[7J?2"JJ'U5F"K GO\C\3#:=^<6LKT1)C4<JKF1PGMFSD1.
M%^3VKA?7)FL@6!#OG&$!<] </62"$EP0BP@<&!/6+C1E0\"\@#M\ ;8NCQG=
M.H2\+PUWZ+07JW#[Y#-Q.#-06W4?FQ.@W2&A7GIF_^;"?7$%N\ ?#'U6^X.0
MGH,2/K-G@ &J5WB_9>/(!D31I[$@)TZI)=6\Y/?["8T;C*I@WN^BA=)17ZXL
M9G5FWRZ.=4XD:3($Y@#8'-T>YTC_P#@7CB*NUXM;.TY[Y88PROS>.W_6]\",
M$7XO?,NXYPY2+;YDR7XI9 TVA(EI%IV#)2(DAHW$"2\%>SL+)4@;62T)61]6
M7O7Z>7KZ!4A<_>>ER2!(_-7?IB"+TRDE8FBL;0MD"W@,?8T%SC1=95F0(WGT
M/(]L+Y>77+F+465%& SF]*K X*FNRO2N9\$[YJM%LN'H5:*F!/#/50F(!FGX
MY)EVQ2ZI!YQQUJ\0X^'&E[CSETYCCV$)[[$D,Y0$ @>5>X2XL R6UK9*')I>
M]B[2* @L61V%;9K9[7QHJG+?GO0C%'$MD=%)3!!1%OI2,0UXY#Z?:O6R!F""
M2M/^JLSHB(968 >S$ ((>:2-<C=#Y!=R[AQI&HT$4"NE'%BN-8[)B1S$D)VS
MX>]6$-RN 5 @^D9K$<$TA=Q:!@]9+H]B[&HHZS,"A:B^*5)7K_@9HU]L([+)
M/S"4R_!S8 B, N.=?%37+HNUS/G@'D%S=F#;&%C+I6_08Y /"\(HQO0"(T.2
M61?CHM5SJ>R4L+)!Z'/DZ \?8?PO]^V_4OF9CHP5BY3]5!O<B8HIO)_4[_5]
M1E:+-,<.C'&4E8R/R)*%>IV4B=SMZ.DBXA.IM%X\;WBYC50T/DG]"5[ [+.7
MV X]7FW]_25?<=R';S$6]V4BJDW;*A^_QT;E/C&7(EHF(;JJ(CYNWA]=K^ 3
M=+9P:H[)LYI5_QJ;$9A+DZ,W8 E)<EST=_# "#**$DWNI D"I9_QT1C'.)V_
M"/&QI1_? ]0WGI3&1#E=6I3.O<RX$A/$AL[;9"7.'#S)EF[583;WL8@*=_P#
M-XBZ.X+KK#8FU#%^6;U6M)##C90$'>-I[@:'+WY><] NG-[%#3P9WJ4^W0[
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M"S#6_@724P10NP)H=$=@N@8/N?MWX"[23!I*LO(#I*]_F75/K+53>?WJW:"
MXT$&Y@*P+Y(+K_EL'$+Z#UX1(<AZ#/@P=5BR]%\S,^LOC/7O?2!9783YSM@<
M])<_2GI[+[O/O27M3DS'&Q$93)P^^;G'>2ZHS]62:^-><#3A$1.F)BSK<;W#
M6^O'8*FW<WQD#V:_L2@U:WQ^_[6+15WZJ;"-PU,WBGC;#VYWY*E>?,V>32;J
M0EI'=6VQ(4VW1J<K7.NW\?DWBY>NY)O;%=DYV-G99\Y:3SJ&1P6^^<ZVY_K'
M6V2[.=X/-27'Z /T::F4DU.PU ZP* NL%8/J_#VBM8;17Y=[>"9F9*:AMF.Y
M?U#[?/V -/&K:2 OS)'*3U_G"#8Q3\- '%F?^8]--%<7P- KT@<Y;Q_;+)Q^
M3[N%PA:@C+HFVK!M+WU.(I+JS)5[?GNG7<E[4(5LMT&CU_!<<54]/]-5VZO
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M\<VU?:SV@[*;R_/>-]&RF2?)M5;*H5&&4/+.'0S6;"+EF-["JY>R[,VV+59
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M8*9=>>H[E&7&#1.XN4K\R:A\+P.!#S7Z36K=A],>FS[:A'S"5Z-6K6C;#$G
MV%0!,+LQSG*8!XMZ"'G-JR9ON5:\0]MTXY0>R>CD30]H]$(/9+OZ$A[\>"<L
M_1M'Z&,' REQRVI_PH4/#QU>&88,Y94W:9S?XQ%:Q>Z@MT>WSY5>T0T8M+!?
MK<_%5N%?_QG.8O8-''PD'#9M^%7 \K^*YQR:#*8?]:.4(0H\9Y[C$""-I52^
M>93$G]SA6*2?W^HO6D]\B<NP<.E[=@%56R;4\+ZRZLWR._#JPV!K]FU.7NK#
ML^%2G+-G7)M +F]M>\02";FG(4-+G&R-J3*[I(_IMW_^'&V.Z$8KS#:O;6^
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MUBU!!Q%P\^HZ=%6O3V'[L^=M.Y0S2?T-:5>D[04?8I(H#$OF-72S!&X?\(9
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M@^.<C&P'.$"(9XT6W8&7Y'9E][)&?/C'I9U4'CF? ^6#^&_L&/1,LD[@VCZ
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MB]'4N5[0/?PP92D3UE'L7V_F"%5,(#^!J$2HM^4%8)>M.R!<ICHAU'0-?YQ
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MID:PQ)?F_5/7*F=CU=K04DBG;"^\U(#;Z"W,!.K4H+^V7JQY6XT L*?USCX
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MB(E38_)3J(KJJ R?P<3SL&&5GW5\,M<['>A<?)2/_P3C4H0A:M$04M%]1D"
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MR(XFO7P-)3;,LLC]&["C51>>+=""<:_+(OZ64@SOAZ>KGRYYG,CR9W'-\FW
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MUF 0I-1WO02*B^C>H&?^(;MH[0,2MY:#]P&M:8/OBI^]"I/(*;IG&=,PICQ
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M&3+2@_/MVB*+I1V7IR2C!J\]Y!%8/'HK(KZA;1N;@Y[) AU#R2+_59VWLV=
MY^"A&D!9QDL!M/!*@L?4Z2JF4TQ0;&RNN3NBW/LN&*8J=[[/Z/&FLP!7M:<J
MN"K00O7?^@[#B&_GK-T!N-_<WN9]?5TO^!F^[M]-%9+Y%ZZ_7M-8%; C!D=/
MZK:?<.P(/6]?6*$LZW+*KN90B.Z8])?Y-_G:]::C5IR=COSBS=%_<9>I$M9
M!]FB?/-4V*G4+.XW>\!^(99(Y2RPA1 U3;W/W4!8!HQ/,T+'&4M- 760^*FQ
M%N?3E4SG6.^]D/5NOK,UO^N=>XW'K[P =,I'L1]QWV4%U5DGQ4[#R[&,&;=G
M2K5N#N*/_JZ.#<[U"(@^7O!FIKO ?B'XPO!5$_ZIY$L"6O(4?E8VMYLGTHX1
MR 1Q9V'*<I^#1./EJZC@B*=UC(C9Z%)'.W3%Q/C*F,Z[MPH-B??UOAPXI/%1
M^VEN]A+S$.T11)#P7&VBM4,'$J%IYT\Y@ 13J^L+ENMPU7(R\UZ*YJ]FFEKS
M4LO;GCY'TDYL5U_)C46><U.\\%,Y3<M;97D(2M#$_HF3QER3.6DF[#QA6I]7
MAIO0[^]38RA0R/!<!);#-_L%BC^-C_NY0_<=P$WR4WN./=L8NS6T1/A6UXTA
M^%_>D%!,D93;!_S'!97P< D"KI,E"IQ3(RN6>!K=IZ+?(0W+&!T<Q[\- T^*
MH4GAOZ3/_W?Y54[B-:509@;[*C4KC%;302C?"44_QTX8V=8TA)ATU(ASI"NA
M]IAGL5^6@X;';%/=#CBK;57'37NK]RGOQ7,EIHSJ#00=(+BJJ+5EG<:9P\61
M3@UHL7L#QPO @C]O$47Z&$=,Y2VF7$T*[VYXSCWI,O.'=Y//YZ6DF*=<[%)H
MV ?(A3U>H$E&:?O[=UD8OP3;:JSO#*PUX.DH?'U5W/]B[\WCH5S___%ID21I
MD]U4DB2T*%FGS9:8M!!BDDH2RKZ,F5(H2T(XV:9(D\0DRV2=[.24&%$CQAB2
M99BQC)O9?O?4.:>%<][GG/?G_?Y^?M_OZ?&X__'@OJ[KM3Q?S^?KNKJOL5W#
M)3O.%B=CR@"BDYEOP])+VPT/3=5A-7</*RE7>8F9%N_$-YJJD,AMA#WIYP:\
M0O"CSC;XK#>;TL+V_66%=%O&Z-K:,X_.V)=N;5JXE865+0DXYGGE5#_KB<2F
M^@_N.V)TM6XY98NQ=L^P3=P:[_6TQ&>J4W8Z=M8V,AS';1FR:.I]1/"I,R/T
M7H&G+YZZ;9F$5I;X<HMR/"C7S6%L&6.&3*.4^M,!K7L%2:4VV8>W[FU0J!,4
MC+ZMJSSA6(-^"KTUR?]P3MTU'L150@?^4+^;(#)P^!V<PH-$>VEV0D3>N,IK
MROK)Q:5T\__;!CY*AW]G*HSA0VORZ'%112P$PEX.MG54A1TOT'9,5(@\P7@^
MMLS,MRG#W^YM0 /ZC8Z#RY8D1%1G6K'.C<,QD=J9NW)UIH9>]LFN>MM!-$TI
MU@'?JCJ\E]!]ERQ1VJ( I<< YBF[J U*_GTR!\B[T*113(Y>'.CR<[@$UA)4
MTTJ9R]V-XM,&"^:Y01J778V2'+FD_;8)V(0?)O0@.I29AQEU+]0$ARQ0<@S1
ML +3-4Q9F\-+7.)%M'SBC7H_+!9TA@@U."3+A919,LT W2PVA)-2+H&480A,
MEF.?^$KONV9<3LBO>Y]S)F33&QW[/1+:QNQ<VNM!C\,QWBYX90[.E%E85HIS
M>*P^?7E%2J*EI;$3X,3Q*IHX@PA<M(VPA4K<7<$<\1L=130AV"O7:H(3CP#S
M^HBMPZGTNL+PF(Z[5UO3213!M7)W=W*$Y 7N:,]O+'4].;GW+5K.4*X 4$5W
MWX45-%6,=ICT"-*46*JH-\4:(6QI!JYN!A:FIP0@K%I.Q3BI2]L:"&<;[GNV
M?6S,9+Y1](=K)5N$),4DSL5)Y2:]K7'+\L^V9H\,$U2<:QI7A2;+C]2:-GCF
M!2=.$N" 0Q_TO517)Z@=*.C(V/H;CL\ +ZI D*/IV/Z/';BD_&2ZT72]K('A
M!=845_@E@8&#2XU4+63HQ:Z7<?S90X'P<W3JWH6Q)?C=3!*@"/)9_B&3*E%
M"5\MVA%ZF&$0Y].-$0?G^8:FH[DB8G"K[85+6TY;^78Y= DOO[0-8<S7(H2S
M;JM1[PEY<D5T[4JMM[>"<RZ0RE+3$C. X_@0Y7,1^0X^+X6$KD9081C]@T_C
M%045E'97Q=[%EB45!]BJSTQ-PF-2-N=64-=21U^79DB[G7O[A#34/ &;A^Y.
MGSF7AP:GQ;^[V]?6RLXXP]JI?!V]MYAP8Y_.&U]W(?9/V9,E945[.7=WJ582
MEMIO7F2F_ D=2J:;C )*35%($8J:I*\X5WA'3V.3(!"UE[@3NO2#4[$LNS <
M^\I%6E^@1!\:G]8I=&7]U?Q: ^7)J2I$KL\UMCYK*7"4N0WH=W;J*5M3]^(V
M #]97GA,5&Q8(%7DZ*&[QWYZ&'($5[;(=M[^B/8^MR#0_O$8NGG3^V=D*\"+
MM8W; 0+;$G>N4X+!4T;@=1\?KAA1T:&PRM DR/J#M?QIQ8@(:AC6=G.<G_,^
MH;8DD_CM%NX="&T_*X4/4?9*^Y+BE-HN;+4;?I!]=G5G[$'62/&DI30+BJ[8
M7J[ %N.4T\IUV0Z@24)]%9FW@$Y[BDDDM!HE\CS8LD>?>3WW>I -<*!G4%M[
MD_L#TPN/P_S</1#-)<M/Y+[NG-87E-Z_:WC- /EJ(CN;_[E^T(/;=319LK[7
M:A&2H$X;/P9TL@XA]Z^LZW$+*Z9[E10^Q7#.13TTZ+VA8K3E23W*_AHB$S@Y
MKT%FV\+8( CU3?>M!QXGXQ0E"UX=V6[9TF:;^%YM8-!?PK<8&?]P8##V>I)K
MIXV[RRBQT52TWY")86A<9_.W)R8XT05J$@@GDOYULM#(Q)#(_B.I$A<IK2/K
MQVA4/ZRRE+&7_):M9T*<E@1/YT9UXJ)(#^- '+N*D?0BK+*U.?%I%V$9$JYZ
MWP>]>:]C;V&2TJV.G^\\UGPN>/%R_]1=R#F"$L$5!FR8;*+A6*< <6K43>0I
MDGC5Z%*VGIM(XYI8]S:]=42VH6,Q]4!;_O1IN?.[-'J4$TB&/V4^I9LB&508
MH !EKY:FIL0'T]VH=32"3R:W20_:JM*3*+NFYB);OP<G\KYQS,E_:%^72W7"
M&G*17U_C.NE<VQ5WCEF6$Z=LRKN&CA"/E<:V.W>8^@U4'CQ1VXW9GJ#0]NI!
M0CK--<'PHV65VWS?J6HH_0"<Y%R3NB*(#L"/ )T!/1V7S[?HN'4'*A^M?7)$
M C Y&K<TO??4WO4$K"B@@+^!E._A0=X),]U:4= GHO<JNAL#-)^XG(OL)4YN
M"MO '*^30R:%Q'J6FXBP;':.ZLWC_(1:BMS)P=SG_(3<2=$^@5K.@U2J>5 "
M]^^#K'V;C;,_@<.6*J#]5%K#%+WM2WR;K-DV+83N&$0A;+BH!R-1QQ)$M1$!
M;0H\ C?BMA[PH0KKMUY$*L@.:1]*W%M\2J]9**Y:W&A!;=BCW?-O'CM^BB)^
M[K&FDO5KDM? (.'GRNN;*1>:D]>#L'MR\."@*JE$.ZNK<^=NL%8HYV0^!!*X
M2[;QOY-)5PQQ4\E!K?W$W=D\&>G:]BJ>>C2//MC941+^TWT]?X-'DG=E7""]
ML:D[8(Y5;O1Q[K+EP-O[;(.H8;T-C-"JI [,O O^X9(ZG;O&:DRSLY.?R9F^
M#%JY>,Q2QB$[$,<215=L'"8XCH;AR?G]-'$&W)*3!G.R:5!-,F&8%4.'[=;@
MRR6>Y^:&[&E0/[CUZ5;YQA?RT4W\@\U@/4NT%J?%/O8UZ6F_HN.3A5S#R="3
M:Y0&$#VW@H83-':9K[0\V!JO(VD/N9$6W322,!)68)$4GJ%1(&EXUUK%I--F
M]&$Q>S)W6\:1([ZA:_HG?R*<:PM3Z2P@.N)30W/XEQEX$80!!%>(!V$=/^D[
M8J,<*#=$N87#[E]VK[F.D_7XD/GII\]"3DN9/(Q=EEMW5]KUV"D9)!FTFC-]
M)(GJ!BB@*\B"%Y:G#\@ITQUOZ.AN;Y!ZMM\QFU/^6G.%!)('.6<2?.IY_1F(
M98,<_S(38VX'-)]\34>?PO^0?VYL72(JDI*4A0C16_,F7<HN%A8.$<(ZEV\*
M\"CDW+_A$NT(U79WGDS_/+]=0 +3B!./DF0O8%AD.64#URK6>%1<1F/OF%AI
M=)JJGR.[OMU\OW4563#62K/8]\*E</?81RD=):1MY)R&DL+8\OI/D0I'Q2R\
MUE.7'7CR),;;C/DI(:Z81,*\MAS.8NT9@M%-142Y2QQ9JD!>=6W3?L"9@\]A
M+XL90>29>CP!<G-6ZEI4*AEY1_?>M89M2HE<F>P0QHD&5Z7";2*RI3F1.C J
M3NQ]@V(-)HJ4T5]-D'/VV5S9;Q-E%>?FZ8<EAWC?ZMJ?GPK5N?P*9?7Y2RMG
M,0O8WN +<*A&K@#]>-4@:A<0[)QV 2'!%CO7=3;<=T?5=@5*JY=8N.<ILF'1
M&2N_N@O<+'5344-Z87B&K^4>O!0JF,*1$Q$W>+9OB=5[)V9(UTN)8Y>B*\8$
M%@1E69\^DZRT\ZS2HY=.3H3- VT-&L2 %=<?]FFE3F0L,7V$5@[SF1[%3H0/
MQZP/V7RIKF^93J$@)[OS:*H@&FG^!I-TF;MEZ5K=2O^K1+T"!F*X@M[.+*);
MWN)N'B3D.];HBM:AEK479'5$A9#,$AR6KOHD=2#V8%M\>Y1DYY;HZN80M9B#
MJ7ZX_%:QXT?ZZF623SDJWAO>%D9)+$B= N%T.H6>]#B9YFK9Z*:BDX!(L#^?
M%A84%+;IWOS_1Q[5RO\#@PHJ=D&CQG8Z'N)!HK+0H!^R+69?Q@*M@M$)KQ:B
M;YJP$;W^*JO-[2ZBVH&[PV7WN8NY>_57'U^LA)N"4]@U6M&WYE''9UH"D.T?
MPT-X$+6W$M_?M@(%$;_N"7JR?<92UC:_7(#C:9AP R!G<>9'1-=W7[OM?^K6
MWJ:+<AZD,&53UT1DX2">ALWA/M2^4/9Q*J*]Y-.349SE_;'0NM%W/DQK#G;4
MOHVKSE9H1IKGO+?AQ.WTW9!@7)JZJ'[C2$_#$9OA91H?U"/K['8@M  ;[F(J
MB%(C=.^,17D/D MS62=7&EZ62+(L3UVUOK!WOJ2>\;&GDEVP>.>)7I ?5MT6
MO*>+(D0NN)7LR.9!9LJT+0WQCXI<+'+"*=Y]_FK:#PHZ1@?M+8(W/RO)6.+O
M9JKG/$ V=<E,2#MO;1@\D:)1Q94ENJC;KM(O#&LR;<EG^68_H=&:YQM"PA1.
M5"R>7[1@NTQ"PTX&MLX-4!0=MF<9 2'4&K0X2OC33-V-D3VWQLUS4TVEG#]2
MKL?N/W539F1;[(;K>0XQ'@@W:F197G( #Z)UV*CNZ0NF7%RR\W'3(A,?)HH3
M,$1TN0L7W=>:+:XH[>'A9\TN[)@I#ZU"SR=T)_$@N5'#U!YMA#A;&=B9-I"Z
MX9DC:U'6([AJSA;VFV/JRQ'I#[;?-W]VHE7GX@(EP84L-$V8I8%<S\GD0M&5
M3X%^2EX/62#R=/L)*?<N^-F^P?BEUJ\IKBHW[K:L.6UEL]FC26PDI6)$Z_#N
M%S+S8@0OIF)E=XR:'H^)]4&9%)+YGWC235Y]5J)RVU'4C(E!L5-76]=@_Q54
M$S1/L +]WJ12"G,5M<CW)&!2I568+I<1>,HM1XT4\*[]5)Q"4>>&4SF^)Y?Z
MQS@WE&NC*[0)9W D>(]> L.2JECEP]"(S,]RUG;1/LYM+\\U<IE@72\I."J6
MM]#;Y*>W#:=-YA4\QQ5JQX\8"$W*;ILY<LK!S0W>ABF(HRHH;<1?:"<,]0>V
M]3"W>G(BX@:R3Q?F6>=@U$QF9 K:K^HH/ (TN&)=N'L#I*:@D%OJFODJ9FW2
M'9*>!:'U(1\47N[>;A J?!G_\_X0"Y%7*,\A'H1N0  4'6\6"*=8'@&$+K2[
ME[RVEKW W9UR%Z^^K?+!ACURS5<6UQ6@[LF9P1'C'1F",0_&++&%_JVUV2<*
M.4](;B[BH'1>IG4GLS7"?O.E@]J[/W5F.Y.)-COZFJY <QV':UA;32_[T(]2
M4.$4V8/,#S:O'AO9'&YMDW%_VFFK;'I^M_)/LL;=4Z\.<S)XD-.B[_',DJ1]
M1<!DMQI@\H#^4LM)P,ND0^W9AINY]2Q-.0<C(>FDCY)#R99MM@TC9L93Z?<W
M>.G"<1-8VF,/38]"VGERH,J93B81VR-7&7[IX!+U]CH)#O:LXU  N=W@DIPT
M8-L-%V+O(G)7#&C).-/[C>@]OD>:JMK-VF_+"C9N%='S^6E'H[1^W.UZ(<V!
M&B14D;V"!^$*,9%6T$@8Q>"]B"OY2)15)*7-2Z @O_R6O0[<[:)HG/2BJ@T7
M[D,@RY4G2I%%\A&@239>K:@?XJ)%L=@+<4=\D$V&Q;9V'!8MT""3:*P=P/ .
M?^9DB(]] Y0PKX$5U)_;P(,4&-[04>QQB^1!1$7#)MT6^)XC5]J)IWC9=*PA
MEL(N-FQ9H^!2;Q7V3&E\@\#SNK) TVZT ("F-%W3T>U6$SJ!/LL_[&-:>)-"
MVWG6SZ[N$+X^1%X[963K.U7W.KVXMQ,0;T%Y!L=IZR+=YZ-FQQ74T[6?&W9'
M=A2&D5S2K6VX$(-DITRS)6][N7KQDV3$.)'P$I./&X:S=J':"?1(C3K"/+4(
M3$6F=_'J-.[0(>=U_GM3#A7JGTDYP8S=W23'K:"'4D2OH.:SM=_HB;&5F]?1
MVZ^6JJS./>]_Z!!1(=]GNQ]QI/BV7TO#ANO)Y?ZISD1WM,Z""<FZ\70=!_S#
MS2E^SVM7(ENI3(3APTYQQ NEYG0SLP?VK/?((X'>!%O1)+13U'OE;AC-AQ(E
M L! >+P.K=42O5Y05+J7,K0WT ,K+'NDASR<=ZCI7 76\IIRX;Y]_9=Z+W<A
MQ0!%>C_3C[[L+KV*HG>]2XYN$+4E0>M<$C,SIWK'J[%Z.Z>&Z%;0_G5C>H\7
M:04&^M/]^PMD/49*X,4S1X[;%J'J]#LF6%>/1IS$KBY[DN@3H*(RB/)C'__\
M>=]*M!32_A' J@.UV3!.QR3K9%E7KI?+H\X3-F2[@UUG\$=('2Y7&N13^L)2
M>OMNKB]3JT:+P\Y$ 8IU55$"P*J:U"W-J&5L6 LE$;;P?.*#,8T..5EB8%C+
MZ8@S :&'H[/B!.[N[2FOT)GLOP*;]P8EUHV0!:D7X0HTOR\D.H/M!YR]AS1\
M2@=QWZGY7OM*QS4:$I!&H9O-UR 0R=V<S?>M"CG9?0)TA6*+]OXL2W;J0X1E
MY$ZEPU,7FJCN;:HTA(O_>?0:.^UP_KVOX?P]ME%%8"_%.0LN@MP'7'4)]&QP
M6V<3*0@ON5H@BSCL>[BCHZSSP1&7I8,9)[PVM$\=I8@N==(3I&-"2L72JYO/
M=ZU\X\E98'9<8D7'B8XG3B]V+UB75V</ %,54>]-F)<XJ1M*,=V82KBP[Z(1
MKD!^:7E+MG"7J9ODAVCA\-@M;Q[I8)3>I$9&(_9<#3(:K'*:6I#[RO,TXT+Q
M]=,/TB4RG&P*2LH3D3,C]M<J2C7RDYP[S+ :V]^Z#V -T::",E,+"K?5K[TD
MVJ.T:8',$N6@A@UI96YCY61MV:D #I:AQT*R1GO_YO^VDX4VTF/0,9 'HZ,3
M&6D8]1SRCK;-NP:>(?K?8>MIZ<6V\8.D:1?<I'O8IDQ+T@PJP!F O;"VR09+
M25K8YHF23C50ON>D61K[6!!<,7H4_=7''L0,DMXS.PI*7[J_1:L=Q[L0N@F8
M/6EAF\S(Y_30H0FXB?>JF^'4Y"W<F@)+N$W9! ^B++#:_+@G=Q.)Q"J;F!A"
M#W;C9!_TLAH#4+!V_DU*BJX)TQTS(\HO!P;.%A=RVF/8S( /F]+"+L=&M,;?
M5+&TF)AH&>1![B)?:U6V$WLL38[CJ8 +_SR,5OYTZIC93-=+DMW4IYW*MIR'
MV<^>=3@/$?M0:7*&^UY0KU;HS' )!QD$TJH7<KL +-VCEKL(<*$F1864:[<_
MH2"6 F,-%L9(W8"%68K)T?5[T-LL&ST=\H/@BKAGS1]2>R&!+S1E/+O'6[+N
MCBLR+>$Q$^/<NPDJ5 7%41.3C)8.9,GDV, TG+4$7:&>0S@'NYFZG7.?NY-]
MXFVY'NH-=V>>[7:$E+.0I)YTBSR,0;LO^_I-]L^^8;Z69\YC^^0(6;MW:TJ?
MH&EO2SC_QM[*>.*D7^EDW>K0&.-!LQ[_,UQH8X;2!JKB[GIH%.+U8R^9Q$""
MB0V\BFC;$ P[QVG<P%7()J=S9-_<,=<_D.3*4<&G8GK/Q]R*MH"C$@>(,YQ]
M89L>_-LGGOYY_O!9$#LJ6C<ME?<07?>6P.+?N3&+\(M2, #B8Q"L.H.K-J:[
M)FP3;A?,F7V(:?<&),SHM6"J75_=QL+2N9Z#SAPB@-YF3!M')*I*LPG'['U#
MN;H.8!(26IX/#G]_S6(+(#[9+&<G3T7A)I9L2LO?^J?W+D1=2NY,7>R%5K$G
MTL(@B#MC^UUEE_GJ8>4F[OQG[Z'\Y_GO/_]3=W_:W*?JPE*THD/V0IMN<<MV
MT-IB+9M++A1,QZTA-B.XLJ 0K7N_[D7%N!_[.2A$15>L8!H9-8BH+5S*'(V@
M,G+T2I34[Q.PJ>&O2G!W^T]K)D]&N1PA3 >O-K?&+HKK<RMIY(I.$G8<Y2*&
M1KAEGF"@IE#8Y(0$-G3(G<@UY" )6?XGP4)3"DL:&^-!KG%<K='U/ @N8=+-
M! 1 \=!QE!V"CLYNA$]#)\>XV0-@54NC<]T:^>\M<N)!Y+GEB+=EJN;ZJ^V@
MKZ;]T!5<O JL%]W>.(//>+DI+;QJFJ"F!L#:^K#LJ)EIM,5$D?YJ<U^T1A\H
MK01G/N3S(-$\"$)ML"L!+$YJHA_9I81N'L0F'C,&&^KCV+3T@;7LGQG_,^-_
M9OS/C/^9\3\S_F?&_\SXGQG_,^/_S(Q'YJ#U#^8+[>Z78;1>;LH<WOPZJ:;S
MJ<ZJC8M\FU [:* P??01Q8EK><\A@YP_2\I@5YQ&&Z-XL*!D^CQ_Q^FD$CD)
M7O4:UN^VO\W%6LF&@H@G@])TTP:E!RLO7W'7.SD>,I12MA4RQ%T]J-U/P/F;
MVMK,?'!ZQQB-@*U!B;,WO,FG.?00JF%"R-W-HZ-VM8WF#&_<HG"G .2C#;N8
MS^#5XYOM?]Y_.]0+.<"#B.2QI-'-+<@5/$@EU8P'D6(B2!K=_ -)$79B+>IJ
M879+WK#='CC-A'>]>S=4>!BQW]FWV<_%8\D'P[6WCDJ\L]VC[3N D #_0!A5
M1\4.<^CC/(@01QNT6E9KU1'L9B>\"M3$FN3\V'6D R9?5]N6N22Y,.I](+(8
M2T;O)Z$IA6@'](P6+&CW) ]RG<R? NRWG\& DTYDJIT*#[)4A07E09H);!T>
MI&)1"@]2WXJA5Q)RISC24U4$MN+$*-<@FXN#EQ+&$&IJ@XU]#;3!G-L#;;:Q
M/(C:<R8&<,&\Z^#>BNT.Y8I+^:!2/O$@(21.).'3@-YB-.4R%AWIBV=OQ0\'
M\B &'/KHYS40$-/>&>#OK>%$\2"?R.5R: H,ZPT:3;4UT [CAY*S0[Q-J#\1
MEI(^YFY;BG&K9T8!+KAOA@&:00,7?#'P\E\-S$ #]F[\S^1$LBC]W%4S/BC"
M&,V0/S8:')L'X1MPH90/&+CFD[X^"1]*"0V<>O0)S%@=ULH/,3;:D4N#TCL0
MN7B.K&*%*%M5?921SI5V9N[B0=(? .MXD.#:%.[.'O!%E>1<'H1OGR;0/B.=
ML#Y2U%Q#OZ5T(=S!U%*<6A=X&CM6-QH_X^\]/O!NUFI:^'>;<6MYD E/]$(T
M_3FQO+P\KH?\S3B(:7&^(QZ 1A/C1!% F\GR(*#1T&,[H9;8+D1H0L+DV3&]
MW*-I460UM3'$51J"W@'+)7!DH150<"DC'.WF+S$)^KJ9_24H:>UEOKBY?)/.
ME;!AZH'+1@&@N:YS4SJP[!+S2?_ /L#/#VV!D!\2"S <39AL#JPK0'\_<T)M
M[!PV(_\84;]XG_"K\V>M(Q\%(DJ,[FP'J*.K7%"UY E/S$+8Y_%*$?S9PC[/
MUN_K;+]&-A*,[$JTV6@[U_;13*EVXXB=G1TB2/3),>X)SMC8&%&_G_A7/0_Z
MJXF]W(G,COPMOG[-3SP<M-\@?52MR \=R[K-S3TZ[<"#7#5YV:E3XCT<8,C>
MU3[LPH,8&M/W\R#"D=KL\[,3AO#C2W]PRI=E\E,UT$ZV;TH-_%>!3&C;[&D.
MYF4<#R(&!'819[E[9F;&?-8/1XF?8P#W70R &//HJX.^1)K/T _I.5-CU\SJ
MXW@B+O\8:YT!LV.-GY\(?I*P^#E"YN>(*^9S>LX>>J9,;XRM4TK(4HN>#"M+
MGVJ<^51.Y0,:P<%M1@L>!/T,7K,MZ5P#SC28X# ZHS$:B@'@ [_OGPG6+V$P
M#3V1R<Z=UE1M^\3$]\U.S?_+@09,'YNYXFI6"?AL,OK8&/=)N6';9B:(,D-I
MK*@+8)2\YT2"(/Z)NQ@T_F6LST!7%+\DD+FWHKJC^(.ZE@W5H']S"QIT2^<,
M#])8 .6O[K<AOBPNBSBJ5M78./,,=$L6"88DY(2/Z&9QI1WYWQ9/3P?D?\$
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M9,.<P_ZNU\'"]9O7RU/+9_'*N;70D;D/C<PZX_9_#V4Y]L<=7<*<F/^K).7
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M,R(O*I1UGI2<^2#I?1&RM#^1>V=8X;;MNYSAZT575(^;S;NK2TAUGD[BA&Q
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M#??U9)\^C5DH-/8!NMDJ^JH3I*\L;S]663U[G$!UR0:V9MQ C2?&A@5,.^'
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M%_(\.^9=)#3&EWN"/#:YY!+]0L2)_" MDJ"L<VPJ2^D/FO$K>ZMW=(0K:,-
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M9D%T39_0?X+*\+4^_KL^DP+OW]/+ZK;&W_4>=334+=.=JBO1U(P,WGZ$*7:
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MI/OJ.8W7AHX  USAQ0D][22KM,/SS/ZP!Y$M]SW>?#/L,FE<V@DBS&ES^<V
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M_F%!)['4QDS-O&Y?U3R2J!"JM&6>SBEK@CX*4MZ>LAL:W38*3PFX153D-E&
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M-1Z(UD0(&9)HEY#]/7H%I3S/VNY?>E+'9J^.K]$YDHYW"OLA28-']?8QTB3
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MHH)V2-T&G(!MUYG'@:I9?S>?U.B79[3C896K=#WJAP8E1C=-+$7CE:^\V%+
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MN9*6[&Q6Q>#FT/"B"S(7,E@_=+6K$9G##A/67TP#DK,GF<]^G6.0ZVUO,MW
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M9:0LON:<]1Y .TS(SOQ.X(-XM@&&+2W.$*-OMT#$N).NBK3M5E0,3I]003K
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M0_JD-W6H RSI)63EV@KT(Z+OS3*C $A'Q7QG:W[UBOC,ZLT$)9@:N?-+% Z
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M]T5>[G.<T>__6./8,#0WQ!7@6JI7YOD.WX[.S(96L=>6-BM3I+C"KP,"_X$
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M(TD.Y"W^.O3<W]K)/S+VO!6I%_TM+SDQ[CVBI9$BS&_K^.MZ6NF?Z-]P%MV
M*SS,<F,K<3X@3L!#.2^X9HNNAP:XFI)A,^!]S.G(<<X%DEUX_9B4=6QAIM9*
M8M;3@8]6U6\0KN@[UM#SU$5.Z.%/VF!'3!1A*PK!$>?? \3_&_9R$^26F@0Z
MB%-$3#D!_VT9D:93:HIACC?IQ3&45'"I976:UE1P^I_5VKHJP:A?MM6N8[^1
MUT>R';"[4<G<@E^[(9SOQLDQ99Z_O;3O6!T-ZNO]+B0X5(@0]<;3;,7'KS!R
MF%VT3]/J[",R,P&Q<$<R/MJ)3%>/A0N0O\S?13F\&+FWJNK\4L5+_3'0Z]#G
M5TQ7W^VOAS6]!D6N7PWM[SCL/'ZL>7S\ZOZ.@SK7A-X#W@>..NB?+!A?7FCX
M0=K:SATH(N/-^UP<0Y!,_X6->)Y9_[:B,.=8$E.P*J.^IDWZ_&NQ\C_W=%Z+
MH9^,)&L")X6;5]2?=J::/A=%7I<W$=8*EEM1LJE_]R2:H:'EXBHER @I'GLG
M]^:M2+D7%%T:+C>-N\JIPKN3]B'&]P#\:UQQYOSZA@5,QP)/ 4IY_T7Y]YO:
M!,A>,!BX$5HKD*9R&!H8,^$XWX:XQXQD@'DAY0_<E'8-WT0ZP!T&B:G3$-G%
M791)OE;YO#![W]HG+YO>OY1Z.C=EE366O=T[?RUP';^_(C&^/"' 66V[DM"P
MN;R;TW6WV-4NYLXG.W-&=E4WRWL=$2&++-<;\P'27$@ICE/B!:/,)SV-CC18
M"4O3HRJ=^0%Z 3_>>O_5Q X>AKN7]B9*!]%J":0Y@<8U526F^/R%B,\&TJTZ
M5+Q9G][_U8.$(YM,0>0"927.ZPJ4-*RX%:>&FC;H"'B-11)!A^&1H>L/SA!>
MU'?$M5LIS:4,0U36]K>L>2;,X#V!HZCIXF8(\U0\58#ER(QVHO& 0\M: DZ.
MVTKC9A3O=#ACL_V']$??_'?U(3D)T.JI;SVV7F?M8DSD(@G%06HWGMZQ>[!T
M5WL2T[WI[?)C#U#0L80Q>;G:*UT6FMR8\7S?D@4)@JE$Z/ ,-6R4=VW1R9_/
M#C)GFJV4^PV@\M_F[D<\3!)MY6@R(@4/GU7(#9UV7,W\^R$R2_$HE5 )U^*9
M@SPGH_X:RQ/Q"W&":43> T@L3LG28W93,DJ\G.)^ %G&)N@+"U3@HKD#<#N/
MOZF=K-?V;&#N678# 3<>P>$F+$##M)T2L[CKD-2[4*TE> [OFJ(./.<Q_IOV
MIG.!@GRN>I7_C2/+&/2V9L%=O-Z(CV\_[E\QW95[1.__30T9^S'5K1\WL6BP
M_EUW4T8G4J$NQWQC_Z^([9G%=14N+R/>2GT-*@UHPXS%SRRT@N.XQ_\4#M6K
M?((K_-EL"LZ*<$W[>&G6QZK$_?#1D+OKC()/[SCJG%BN,"^3^W R$1+PP_2&
M>=07&*I1/IBQ6\C(J%XD(/SH/8F@\VM=!X/F0Q?DC-!SMT_;.384H9G><_B/
M.XJT8OOQ]AL7.,.KA/3E!APU=[%XFM!2/LN3<Y.YEL=)%>TT=92\:.FO/<"3
M&/^<^#.Z ZE7.E6'4^,"YI!-+?+E5"$4[;OIQ3!E&+?/IOMWU],["UI;F JV
M%DN(_6  2?[JA*>6!)4P70-B:V/SWIQ,Y>,Y@_!AO<MI+[L[NI:^1]@Q00PI
M)I:RQCS-8['4TLCOS"<!L6%<T6%3XW>G37F22Q?&4!VF3KX!;CZ.E06>35(J
M3HDPN!UD [&]CMZ,1( 2;-"_YFY\2CJ<6/Z%,5S)#<"@)N Y]#6NL,T,VGX&
ME(CW C/5+:EJ,M&FCTM\'>6+6\7W%>&@%:KT,QFF/T+4J[*C9GYK/D9K9SR*
M:GKQH/E?US;:'<CHE6F9%AU1Q.24'&VA52>&:TX_FDMNH^\!8J@?AJ K_IC"
MN$&B(:*;M%C[:D/%,^$:<2#N397OI+D*3WS&2#_\2R00'D+/Y0KO 5@7[S'U
M+C*_AE_ S" !\(LU=7_.+U9F/PG+M;9(OXM]D;-^X319/%O)]UP'5[B/!>7^
M 4F;*S%+N >%Z>,M4QI,"*WN#I9^,HU&:')]=F])^7A9_N/* E;?8T.+E O:
MT;]V+@*U# S7EX><G7;'75'#<</7N^7O:ZHA)O77-M:BP%/6FO\%^*'U90T2
MHRP&!W<UY"YE=#94)2P=&R@PV'=6H+27R 1S#QJQ')@F##/.NTK2ZRE-&B*7
MOG]]B3%N08N/WO(UQ%0L[P$.N];$VS;45N4['9=&=_2NNY\RDMZ.T;4,$"A,
MTMT#?!IS(HXY_Q 2#O ]\O3B\Q?)I9;RZPCWEV!\&QZ[L.)+(8UG,"+I@DV3
MD#O<=D)LJU-V3&6O@X*23]NOK!+S@S\KLJ!X+X^=E\_O),S9;>>N%<_5$(Q^
M-VGZ%G$V5PB>_6P"#1P#(E>3*M1?UFN5=- #*#*-I'AEHP&_$-E@J,&UH<^$
M8- A'UI'"/3DNU%1_I_.QCMJ!VDB'NZIJ3S<F&?.3Y=I[F-J=E!U:'N MCV
M5#$3/R,N#COH"Y&$<>D#A80MH^/>2IF?PJ7.[G<[*/OB)]\4#D?+_M_^:0T-
M%7T>%$L,HUK1JOI:II0''])P.=->Z-4GP]3S)I&!;K[\EQ]VMX]TRGYRSQC
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M[A@G3S_?\M8?N"#G)\&I_&^H\=O"82W_@1\JWA_MZCXZCDG!OQT)M)[R7Z9
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M =%>0;E]M^0W<"?,QA?]/7]P_%HM =E"\^0*)27@*T#L(P*A,2!:U<G3$E
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MZX*&8G]%(/*. >",M.;$+315%VI)P9:NGUUPM>@0%9I"!!8/:4W?L[DN:/@
M">KZ[G]?ZANJ'V)!+J;G, 08OYP;X_2U*FBFOY8GO7_AFJF>HG>Z@9GV\J>A
M/?Y/3$Y;<=U,S3^7XX"&A*;3M]!NJ.M=7^XM@^?,V].J$725GT</>06E4,<
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MR_BWW7B*HD5289P-QDF]E-0G<F<M@,[3M"A\@=$X2QBIS 7!]7>P_%LF^+I
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MOEQ]FK=>*!?>[3X]HK (HL@%]=/.L9%IXL> @=>13P=Q20/TZ_U^&'H6"E<
M:I#J#L2L8,GOZ1]1_MCG(''&%6,<=92'4GG[MW>TM91?U!V7UG"L[UBVXXP>
MV*>68\B?S14_\PV.*[0NHBCRT 1/W_V>P>!-Z?KT>B=3KDM+EM;4>11LJE2#
MWFD##@B6+5OD^5B_WV02CY,ES)$_ =D+Q!0QV"-JW):F?1[O.K;)$&(RK)JS
MMU=])!R-!2 2 ^(A3H5"] HX[LL_I72L",UT NA.$(5>HO 0*SLD%=J)<^\K
M*&UX%66:;3.D_Q7:UB@<-L[Y\XF76?&?[X>1*PU 7.;OZ5G8;!'Q7K2KV>W0
MEB;OQHF?597^,UZ]6Z_=#K=[3B&O"?.WO/KR*5O:GLD:*;):O99B?>WRE&'F
M2T[1J\<[?V_F+AW5E,\SJQ8><K';/CM0,QJBI)[W?F_MW'D3]EGIK*+"FD&L
M)S82VWB$6(_B.V4K."\)\=!K<YM",G.YQ;[A3_HK0R5XYW^T"Z16&B^]H5W
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MO:]!UA[AX-L)G*D!OH3SL68]TUD'%8*(=ATN9'8*86E)+3(*\CQ?,64Y?_L
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M@.SC83\$X[ ]P</!9!NQ&R5#<:':[PZ]3[#GDQ%JE&FJ/V.FJ%X%K[$X.NW
M.+LY/RO7[3W?095*,52-W+5&I=P9"^LY%? !5(\I+>AMJW]VQNW<*[/6;PB^
M?[VI6O^UKWD$QWUJ#W!/1MOO+H7T_>GY=5AP/58T<UI&/WBL.6]TIHZ\3&^!
M^ZBD'P/. A^*T$X133ND3C;$SH/$H?]-A$9?@=YZ6M.:=J:]T(+C?B%#YV]@
M_>Z,$TO%+K?OCBF) ,$']EL7?;A9U021Q40;8ORHA%\XF#+C-YSH.$J1NT)$
M]F Q;/T@CG9]Z$4TS>53I,>]!F),6]O;X=29@IZ[BICBLT%GS6]C[N"[]E>%
M]H T8=;>YG]Z?@]5$MPTQO[#3K<KD*Q?-.3=_<*BX'>.+*PB(G?R*8_\2^3)
M+=G]89@[O-,&[ADXLXM#;&'F$2^/ 8W6^/<AI*$>T=&>4<[U*+FXJNX_/C]'
MG_I[M"=:!W/6YH'VGUB]KE7@]'S<OLQ<IW)=2V:T?J3GRXKXST9>7WI94,HS
M'?I+QJ:C8W/#[XT.I [E:AAU&-[TIER+_>^,LADJ1]]AO[W=A80BVJ5U,\YB
MJ*QU0JFEH\_%EH<"3O8?3)"*;K ]V$/$T+^C_% S&60=)#V^_7*D7*^A]5;_
M@I)"9S-/7P%?*-BB83J$,YS\BNOF#>^Z7-(#=?<S:T'@#CBN4B^/<19-/17W
MTRE0_\+.LI6JQWQ0-)$[FOL]8IP'8XKC1-4GT@2N44[W"7V?"K5^(2E&&DW8
MFM2?)F@< [A]O_UU9/JGTR5E,8!D?*EF9FTX!.FU.AR8 W]_=]6JSO[ =SPO
M?%I+HJ5]LVXM!KV(2C$4(D9T@GBA 4W-R'&:7"F%'2YF%*V(:HJ;(YA'S^I;
MR,3@LX8"7I@M4UC'<1F42VQ]B!D5\FN*U")/NE0]3RJHYUR['(G1Q-;5IFPI
M.7ZG81S*%1@<+%F@J.;"A?ZY*?IL)_ZMSB8H5?(:O:[5CH1AG TALI+=&E'9
M!'(LZ:!'0@V'3&_5"[S ^-5,[$W#-S1T.MX]7%!P ?M>S+IJZ!D0#)IPZ%!Y
MSI"BG"<ZS&=T\7#.*!4FX8K.K,VXIGV_RQD!]TR(GGI#7WWUUURU"09+^%9Q
MIC=Z)I2 N8_&3LR\-7>8="J=Q3?L;4>IO S#*W2Y24VUVB L]$7E$O:B9Z/M
ML^=D]-<]W,\6AJ<+V7N_^C+_R%AVCQ5]N/8+Z$N@7/UW^UO8C=170N4&QL&]
M02\,V4D2*^]+**,+5N^#R1FB,S,_2=V7VLH^!I2*AMY=]7<_':F-P *3W71_
MM8O0M$C8'B"_LQB!)U*EVQGQL@&BJ3UV+P92YJ*^.U,5DI!L%'1Z.+/2Q&@Y
MN!=N &37CV!64F8UC4N+U 6E%-69]D@E@FH=.B A/5&-!3@QO)IQ@E[UO3OC
MV[FSI:CZ<;R][/>T.U7#7]4&L\0>WBL1J=^W;ZM!NRAI-![5D@260Q>]HPWL
M4\+:<UVVD?<0E&"J)S,],'.:9\9,.>Y@:Y4YW8E)&@_)^A9E'*:T!WPIR9_.
MH3%N@7HCJA=M_38C=XA/X"HIRXU*-6>@4>(H+Q1%WK0#RPJ]24FZ".O'BJJ_
M"ZV$2$*X^Q1\],&?917*''MKKM(K/CFMW-SH";JA+73(1[T+&P6)H+RM,0[D
MZW7T8J"O"W:&9R&];0&L0+=RNB3UZ!<^;>LZOJ'VT>4Z\TL7+3-$=43\'Z*W
M5FGG$#C#4A*(#*REI,QS25I&+&AMD2K7I/CU-0*]SX)KE3SB8FXZ/I /D:BN
M9W'2N7!#UN-\==/#*2;=.T%@&L?VJT\UO\$!"?,>W]\Q7*+7&QJLH6I7MS D
MET7ERDJ,CS!#G#@[BXC?]O;*U2LZC^T\!@ANF?-Q9L44AXOSQ8]K'.*)*>05
MRD>B#.-L:2D,C6K,2)+JP?)#W34FVGE^;:L/Q7"[FAPQS##=A5)Q<[\"(FL^
MOF7_\>,\6JX->H+Z$#;.R\ 6<?[K+7H,J-/J_J:5HM(NOP$3F63H.#D!"X*+
M^^?[[5%-K<9S]@J/3[:8";-F('Z!B" @UY](*;(S_5VH<'UFX F*S,)H-X+'
M+PACG *J75=SQ+@,ZW[@N\TO,EEHTG=#+T\B^/Y"3FO683@>0BC9H=V::9JQ
M:7'8F,&CX-9V,:G6;)06!D<;U2X2;$59)Z;T@=@9K#1]-$X4F0@3I23TR>_'
M@.ZHGE=ZKN;ZH<"K^;GB0\W?[U6O3[4C_Y$-IM<8MTM#W2G="]AI'G(M,:V\
MFS!CW>E/<C06?G\J(P."YU8)5.\-^S,JZ&E](?5=E]8/<Z&C:N*/8\!M=+LH
M37N")A4"^1P9OML)$X*(+EK<G1*XV7SIC1=$<N+I5?>LZS]XCP%5)PM#0*/8
MOFK3&R0VFK@PD07;*>#T=V-&JBL$LM#2)JN8 HX6^I*79VE4O>/18A,KW]13
M_FRZ6!#=BF^KAH<YA3E7'P-J2D>>W.&)GJ56KS=2J[=C!*@Z#/0QH-ZTAX=R
M]:#/>CJBMQ#(F*1(X+"G-G)'$VF"ZGD68>.$K7E?XVZ_H92*GR+ATQ=F% ;:
M51ESH,8BO /5A+)*?OBOO!9Q1D984[SUL]NO4@@+"O!&GV#0C3X]O*:U#O0Y
M&/QR3M.+CE/860IQ U.OGV6"\C@L8Y)WA@7-3Y,E.??QO@TT=-6,23LO HR6
MR]AT>\TL0H*3ZAQA=*3^!?571B1)E1FV!ZB)^J82Q_W*-+X Q)O9DT%(J8?V
M%QSQ.[,O=>1RQZ>-0UUG2R'[!'133GW>NDK;,>#UX;_-("U2($W0M O.">.B
M"=";MF@2B]^9-+=DHU"0,HL+\A@+TSL&-+@DU8/?\2K**UYC[ ;?[4EUV*\D
M6C/,D%T!YOVQ4/U/138^38O?%K.PJ>@E!YIP'Z%["EN[VLT%?! )1"(,E7V4
MYLV4)6PW]$K;&L#O(<6/9*^Z#W@;=XH_1KDRSD" IV#\\U:_<99LER+_+@S#
M'O$H9 *+G$=JK8ITV[(/]AV. ;&($'_58X#?<D1#]:P;%<I8@A8Q7_\_ *,#
M6_]0CI7!&W-+[L_3VXP"@TTBDU/PD0YH0AZ+!UL%Q*(.J6^W&:P482)V7CEA
M1IZ21.*6N4#"3R#(%<"Z#P7.,B)Z'TY+WPL^+[T+0C+QZ10;^22]Q-"]B')3
M T!Z\6CU793'MQO='U=J@;C7NHD)&AG_E(A_MG/ECD5+Z'6KS6R<:WRLE6<U
M 1OC?.7GR^T:L)05TB?7TV+-*G37)K2B;=QAABZ\O_ZP8GO!.ZQ<N2!BV1<&
MC]U5V3*BAL/&@V'C(8QN.!*4L%<)3,UQMMA@G"0UOCGW?SC[TG"HO_#O:9$B
MA%"VJ6P)J9 LF39;0@@AIK*;F(0,QDQEWW\1BC(54EDFZ\@R8Y<D68>9&#.2
M+,.,97R9Q3/^U_/FN:[GS?.\F!<SUWS/.=_[/N=S/I^SW#>IMVNTCJ\%NV4.
MJ>1FL\G^-Q/"C8+[PB/A=#OFTC1/6'D;5*77G:[/ZV=R9/',8(9NGGN13=B_
M!]=HB_,IO!<W'G%ZI1]7SL/^H,GOA3%2Z%9_@B=<#"$BN]"=%Q[['N-\/N1I
M1& 1Z<A?/*X100[=%5B%_'0^\\(I6,.@BQQ/% S7S+9C&\Q?.3;^NYNMH/^T
MX!^ZF;C^><;6RAS_R8^]L!5P]<7FO2/-GAHX5"YAKH+X@(:>>DMAW-Q)-<T*
MXQ*,11CF4VGSB-*V@E.#]+(:=&R(OW2F KI#?Z'NMW6I)SV'H:'_NDOUV^V,
MZS,H0V ;Q!.NY1-\6WMN">\8QQ2PHFG'%LCZK?/UE@)C/;OY9WF1'U'%RUUU
MA9E%![D61MC?./!P?J+3FT>4'N#3,X%Q;G;LK\TV#?IIB_$OK<JW5;A3L\O8
MRV3, R+=G',X6(IPGT+R/_)4$C"RF\1^/Q>/":A;7'$K,59\[7C]3%K%*&%"
M5>=%G?5"12.2@%5Z"=QCAP![.M%?Z!AZ/JU':\U=M;L57@YD7$]ZFBPF:0Y7
M$I&>=-[U\O=OTYDK$8'+J<09P79(&H'ABB7GC.!-4'UYR^T[-VBF\CTFP0<1
M.MTYEBK+J6NEZNG$VJ]?KSY4;4S\7#?QL2SDJ-)SJL/M !DH ZZ=.#5$]WEU
MGZD7USGLU/@JKLSUQ;+AEXS9XYY'#38O_4G/Y@JCVEPI\4AK-ACU,WQ2L+%V
M.!0&C_<X4AD^=%ZO1K;V0\%S"NDKCCL(-=?N-9F2)U#^?K"KLD^VCM"*-,F'
M-'WDK>;I9"6<LBVUX<IQ.(MH(P((I<)Y .P,JS= %)@N-24%1#"CVAMT#662
M0Q$*%)MA[]1SII_G5@WNCV[%6@3=4F]+NI+,=>5B" $9&1XF.Q29-TRIAB<W
M!>A!GA%$UDHM.3)3&T-:@>C*"I\&BYFPX?O;(,NFTZDM$1,ZT#-(JV;&>C]'
M)I<JY%?EVEL^#EPRI>4\NY6#QND6D8L7-,ZZ[%7;!3T(VC0S#.+U3*/YG)]%
MW=R?%NH.^;2Y)[I*IWX5@XH<_JH/&R+WSI#1@/( ZN=C@N&0VUS#.GLKW-B7
ME<1O51+O-UJ,+V]0)[@O\0>X633%E%)$I)'V7LX9PM"Q^/X;(]J>XVK)VK4O
M!<D%(BHOW8UO(-]?"#+\RPG>.0HBT,)-T"V%D 2G^S-,I#A0P%RZQ!]>CKS(
MR'XAE'>Q>6T!0[<VTY,YO^ O?+<I0O/2[Q WJ*@6M7X;%),0)E-PH1@&CYL\
MGGG@I<9^,-O$>--%[6#P<&KZR)85OW#$;MNQ/=.IWB$$*Y%#?\J"O!+.G8_H
MGS=RP"C;_QV<\^A9VA@+<,A'?B*CDXK_51#*;<V91/H 8X&ZL6A[C^T#I'=%
M&!M]0AA2[@QQ]+VN_@XPI/<U7=9U.T<QKB=DW\(TLQZZ91%7$JC=&82I1G3-
M9(PGVQQYFFG>M@V*PPCKE2W@CP ZM)3]9M4TL%B2HM6%4/*KPQ/ZK-3]7Y*4
M2=29:9 0$T-6%.$/KRF^;*KT[GS[>#"T7Q:P6>T\^!3?KYBB,)D_*U=E E6*
MJ>]EX_>KY?&RT;Z]='UG0(41?HM1V!GV[@Y"J;W;,LOZ)(O^0/.M_2A]W_UT
ME>=N,U?V>RL/-AG<I_NJ7]>P7ES$KV.C(Y,\@BSK7I\H)D1IH" )UF+M\+&K
M/"$%MBMJ ,JPTX)/:7=9B#TQ/DY%[UZ0YAT#K+BY0MS\K@:I>K?F !&/2]I>
MSVA_-G]]N'$M] +V7S"R]E3%D7<]H/5S?Z8JZ13\66@_N+7<@4^N.3*SM!MX
MZ:]#2W=K 4BT_T=\@2<BZW9\=^#*#<:;#^O*2OVKHBNH=?35VS]_O^DX=/OY
M!I.[&,F^7XT5D3%;LR)BL9L!H?>^>JUG5=6E03#0WA7(<S% @_*,$/22\  >
MNPH#2S:)0.(Y5M,IN]BG_7]=%:]G7!O'67@Q[<CL7[E>-\@KR,I!@B-*ZW_X
M!IPC6<TR9/PM9$,1&6T8A6T03!N,R*X1BV<I2IA6#X3]\WVF4CTT[>;H8LS>
MZY=B\5G6;%J9N).LTFL(7"NV*']8 ,SX$EKD*/<J);IBK!)*ZP%K&T<]KK#E
M";NR(O7I,#Y]6",VA>^=I7(@ASAZ$K6_.M/2W\F.2==C?G1HR)O_S4X_5RC2
M&9!_:RK/^F.G7RW^C7/)C[^X9=]EHY YK-76&J^\DN /YS/E70#9X@LP]!9Y
M#;"D0H0\2&Z(>,J48U^J!)"\?%T\_VF1>?"Y35K$O4V%5S'/SNV+Y'[EUS[%
M'Y()!'I:"4"F]G>*"6/;^TE*5,?UGV^F;?<^/R7WK:S83W6TIN.5D_E3E=2N
M/]20[Q(&V)%KS[5=26SK__H^W"&;AI=,N@8'L"2N80^S!D^.LWP3=?:EQ4:9
M"\H[K]:RS\Q[R#/U.3*>K,91$WFKD@D@ )QP_G%#>N$[34^+? =<;#?RX']B
MU2DO_SJ[Q0F&6-7C^OIL3[T9BFN@!$T\(%";1=Q>W)'W_O%[$#<SS$N8/MM^
M0G/3;P.;'[-JK"9_^L($47FUX&P,])L81PK2PI_PA+7)OE/R!2H @<'[2^D@
M2/EL@^*MTH41L06@KP6TXR4]M#IA]H P_9Q@_RR42(X3G3'/217&'J\*26LW
M,+(ZZ(DMD>)LHEOO="2P>OD&"CS>+LX,,@ ?(<>$[9)+VDRX .DM^&KO5!I$
M-ID(T^LPLU''UZTN /C)A&J..;=B9]-?C;#8>4^&/TU1]O-^\6G;<D:3U>D$
M!N$20U/1[$V97.-3@9H4V(-GMM4NU;L>]1X).Q9,5%2 %:);6_-^OL8<I2/#
M&5E7&34Y_C1'0#RLI! VZ%_^0#OKNLL/J-^J5VRLL[+%D;@NV'?(5).K;;H>
MA*S&.IK25G"A"G#_#%UP+<^-1:DM/-3E@1GGF_4VW0*A]F9..#_:B[3*[P<"
M6U+S6'Q(O*<-G';HE1K!<:3TVW*?6^_V<*&X_=/7"KR8FJP2?_NEZXOS@V9.
MUUK'E+I-*Q*',A!8+8D!K9PZKDQ(;D$XV]I](Y!2OH7'!^)G)\!?!.FS_FQ7
MY$7F%O+Z+R4@A%D]5;,5E]M)V=4VV$R/E;U.(.F]>.8M6=[\+ZDIUE&Y&B1-
M,#&G[RP^7^3B34YP+!G=B\(PJNT3Z$&>'&S5CXF\ 607W_G(M!__<5]=H)G;
M(#;Y4(IZ0_%KQ2SO )LMQ;'C9I@8\(;!-=AN-"F&"J$+T\"'$>>FG8!7'Q"[
M:0;&-X+6;FX0G0M.#(V:U=:Q[2_=M9B<U#MWUW =>Q0(8X;PA/@47N#8%Z9S
MA]BX3"=%#.V-?C(Z>6Z4HT,5D[S];Y0Q;U@_&)2J'S*?DR/],=/#[8_NRN'
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M[2[AAK-X0 _%5%60B?XSET_9IA[K0UND[T>_%M/+5#_@(?.@LBQY]]J1@SJ
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ME;9ZA\/!\[!@GRHI)=C^5"JC\%DS MM/&-N8]BGG_YNRLYL#8P4PX_$Y!9)
M8 F009-IZVW\*JW2Q 0GXH>UL&77.HZ**V=+7)B>J!TZ;GK+O\U-?]6V=VN3
M^],QH$O\!=T_T#=ZL1$RUPA^3]C/AVL2F,7'@&=OD7: W114OKN(]YVPJ^9L
M$6*Z7;K!-/LW"9=^,$J<[)C%/7%8_\CIY(>"-N\)7G7>W]_$JQ]]SCKOM*=Q
M?_%/2ZW_@G^%]F"["< )2JO&\E[>C[R2;K1<IR9%&N(/E9PWN<@,PCT,"?[L
MMX%3G39]4">OG7.A!83=3;CWXO'MS8=]LMBKQZ\H:1786'HT,^^L_F$5+#4\
M7MA8GL5Y?L#H5_V-##$J#UJ?X1&F?G,LN;4[F@2B4(,AF9MQD]#W;87\352!
M\4\N$05:3)]2)2O/J8CB[LS<AQ_/; 9WM4V]2K>9J%WIS]@Y70EH+',D\0MM
M! G" _0AY$7N6Q.AA2UZ_!N:2Q.XY"6!NO\+_HVT_ZQAJ.W#H,#W/N)F-PN_
MU0<9E!'&;G47H5M#^5-;H$;7 R:0Z_S+$RJJ,DG5FWPO_[W$VO_+RC<MB[UN
M?TYEO 1I;"RSLID;+>@X\'[.Y>EE4N:"Z0!*[!]1.HEFM V2'!-QL*YK;'C9
M[JV<HVJ &E*ZOK_#HM.PSG#T5W+4.H?0;^YYU)IBDT?V1?7_10:S@W;V6VNV
M0>/=4]VM!"FD%@/+T<0F@VN*ZW(P L:2#Q4%A]^/TISUB<'7!-KZ?%Q<[GM[
M3#V%2D#X_IVB6ED;H,[J=T!B<3SYVQ"JTC8H3D Q_PA39^Z_MJ"_ R:_/%=S
M;B4AJSHWEJY2C@(8GM#7LCYF!NL#]UF3,_L"\MH01W(*+?.;[(_99:+^VW_#
M"27+^% EY^7ZX['SV?>7_??&ZGKVBF>W['F+;?3EQJ"GOE99:<;PA/*IYBZ>
MCV&=OX)BP\\/EIZM3\H91A=:B6M>5RAPDQ =L,V\R&[&A,%*N:S:-XNU9D%A
M<LWL(*X1ZHWV,!O#.L/%\0U.=F ] CY]7E!4^,J =%(2&L32C#685JTR ?<#
MU:!?!N#3]1A;\P[LAV_,-YG?"+JQ3UOW$70)4QGFD,H,^J2M+1V2 MX2Z(SF
MR[&]#&X23YW7:YA!#Y[.2";4)+112((=%$GC7;0PXA\@_''FI#]IQ9]8=0>Z
M4#=P_1?95ONL86+A?R;AHK6K.([X#&%:>"=LY(L<64QGW/[]O]T"6\ )G^@V
MW_6OT_45T/1_E!75H!#_YD$K](+'-N@5EE]I#C#TGO>3#[\W*.E0V; Q_(CW
M3N@JD_-$=#7O_E9Y7_G2/\WWIXI*\G[L"CIC*-X90A#$G^3[/ @=1-CCCZXA
M+,XQ85/85FS,I'K.TG0;0:QVIII K*AA6X[?FN'T%NN<2AR[\?&R9\U=KW T
MP]Q6$ D!^*[?.P_@IL#)1,/ A"?(>[3^(WZ*:@TC073-P'?5!+R&<D]$E/)C
MUDK'I5/])Z:>]D7<Y]>I1@CD=S3:>I/U_R!<E2PTUMG,#2."N#)[DS?>5&^6
M%8&K;(JW*A=;/)Z(N^QW^=_MI3[](XU;/1-KUEK8.A+,^Y^>>M>$1"U]96YS
MTV-";)@PYC!M2V^<MG;H)H@0'FR#GN+P^T<Y(C/F;SE.0S0H< U_XFS6=\RB
MUE\9L]NK#W>_G];;,BE^N%O^XY1\UO.%+!Y:EF/\/U>7)BBUMDEH?[ 4KQ-<
M5Q(?6JY$0\?67!O658BRS;%<#HMXGD 2K7#F*JKF[%;8#;IZ_BRT'F-P<_)6
MRD!PM7#C.[DGI/.O9R]&R<Y^VI=3%UWN^R%]88;[X+%]7N9\K:M;Z673"Z4'
M*_0/?PN'-MC>%?00O,.-=("]'OO_2\/V__9Y%$T%MD%*KB;@;=!_G0G<,"AW
M_^C_[<?A?BI:NT_&%GBQ#>H&<]7!UP=,I:@7>58KY@/M4QF Y^:Q]\GJAP_;
MF8(B^/T,NBE 0A/;T?^T/+0]!O[/T'GEL3SP;\2K#&9N$5KW\/B1(H?OG]W?
M/8L8U6,/UIPU3I% X]1OIO"&1$4,7T@4B0\?,A^6)UZK>*U8ZLZ:3S?W/:H!
M\^/49-#0D&W043[6%$$KL9W0M!C68VX)P0=227:%X? *(T@T#7."AA:V4CQ>
M.WR_CBS5;AIV_*;\UT.?1'\+ ;X\(74V7^RVGL=+(=7@1Y"[ 4S(1X[;2)B5
MNO%%:KE,QW\+LAK^]E^C+WF8>A\/-+2X?^JXQ)F3"+5D7L).INHQ2=9M;DGM
M4YI8"E3T;A.QP^S >MKNN1HW]K=$ZM)LK?4&#K(V>+6QQ&"*LT#- )3$%@6H
MUM<5[+NI783@8+CAC<IY$]6FIKJ[:0UZ]?%>)ZD_][RC5GJ\+P4'N\\3W4,G
M7"A+?,:OTX.P["_X28F<Q\S.$HMK-F-X!^Z%,%47> <ZF>5-#[=>%RA8*]V&
M)A0ZZC2EE$1G7OXH;%"BDAPQ1F*_%!\D[%@H'UI#C(-X9Y"^KW857(QZ:2Q#
M,Z+;MGN<&)E^NK0O0:"K_,*SE7^JD$>^89;*RJ=.WW[M"Q[#=H*%_RD*<U^C
MC@/0MCS3^#@J5Y+*P_K?*YK[90[S]P^J>_#Y;O(9J>*[NYY_VUL0Y;RRLYP3
M#?A.@5.A-=U=:!#2@O$70\,(!?#$1N\V#]7N+WQULZXY)+XVNUU7W_-8V3=]
M;9"B .Q*N4&TOW_5 OHB)5!WQ<QQ[GM*FTK$]8WY;5#.!,]]S7=.AB,-9LT"
M2F6\OA".. ";+I?L\C@!9)_.^'RGY^WOSH^D.5GW5$)@G&_CTPFE@H>3;FUC
M?N3C7Z5V3K=T<M,Y[GQBMW<3X!'K,OT+U+E%NB+7>R\-U0K T%JZ'T&#VH(O
M06>@9D<S;P2B]JOIL2CQD*ET]!?G6*2=3/(:(3ZO9BN[EN/,& LP.=% &.BH
M[/N[M_[+*^,<W$'0B@6I-[ME'^%&*!=B,_C@04V:=!O9<K#FVXF:H;7>"SFD
MT=')O>/R3I7'A/[[S'A^C!2M\888J[2?<HVK7UU+KJ-$#I,N1-86&_2YVH9N
M#/9$N&NWAP!\QO$L> %<C6XED/2[((*00'"\Q^%13;6<A?;S^CS#0=2 : PM
MRG)R5*;>TD.[<NR.<J!R>.9]);E]\O<)-]#^4!*&=\"1(4A336/,MA$J-]K0
M:9+S9Z[ :_L%R6X*I]M6YDW310RETR.DMR)<'>UFP$W!R=P;W+>0J3>$*BA=
MI\*:!D\FB-X",N?/PD,^ Y$S-1JEBX^4AY5KK(GA2H#'%0O[2WKM2'E^2V_Q
M.J![C:U+$(16RD'59J)N4BP+RG@Q/X2(L:E[L__$G_%)M5SE?Y?\GO[5%VI_
M6^(@*1;N#%/QFN#4V)HMST07$.T.Z@YEIF6SL<OFA ^DX@83CYUM/<ZN&F!G
M-IL9T.;M0RKA&)JNY^8\(%4 M-!5KVQ+%1/I&NU($GN3]Y?T6_!Y<,[>T 6/
M _S_0[EU)B((-ZIT"=L8>9-IDS^E+0DXW!P.:S9<[B#:^3<\+O?5C8_Z5K!%
M+8P79ML;U]/E-ZO.7U+$#-Q-E\%ECEKY*5=GRM2=MY5M;LHQ-:Y[AK#MG7FP
M>0,:BNT=).B;J*-;52#W,"D\90+3/-GD",4UP#6M=]*CFTH/F+Y6%?4J'UEM
M[A^ =UT.^5KYJZ!YX8A3N^$YA]0A^XF)?^6S&\T-"F(BR8[OJ1=*OF>O#?GZ
MXK=@,Y5,F0X(H#F;>)=;=@+086BW;,$[E_>ZP\Y[* [\Q,B2%V3KWNDRV\,C
M_%'A,;XP.0OJ$XUCUM]M3!'Z''DQW54/Y/ZFIIKSX3*N!E\+6E]?']UP-@RP
M-%:UZP)<?CQX*-@#.-/#%Y=WA@+W!=I[XC[T$.<D$'[0</I:8.$H\NICY-6/
M<V^?D==*\VLD;O]^K-,1OBM;7I; OLEKAU83Z2F0A"74A7\-HU6\(Y8G!KM>
ME=_YMQ!4I9TS&4+^=*Y1NS=GG57NZ91Z:B!;SZ\>]9QBF[D-BKFO(+3N-USB
M&&+=!T6E$^E$..;5*CCQ,)8C(3U\Z!)TG$=4JACBO@9ZYF+('T(F">?XD#7)
M5YA2F$[J-N@F[ X;7?CIS^-IA2AYXIIU&!N"U&T&9,"+].!['[7;@"8]<*SD
M#=ZO%P':[[O%G][3;XDH5T]+=-DOTHAQ78&.1[%$N*\)GA-778;Q^_UDEU(B
M:!?LB0X\XFA%F+>?DG52C<V^P4,'_[,UWBA<.)0F2Z#DVWZGN[!6",[U(P<:
MAGU+EMZ^"P\\O]2(72A996^#!/=.\V13IB+4]O .S^_Z9\L:1H#O, 'B?'@G
MO]-NY7;W \KF,4TB;UWZ(VC"Z#@/66)H*2S47RTG6KP$GZ>!<-#2ZIA_)ZTG
M\"H1Y(-_SY^VIC"4:B@]9AHLAEB83DA8[_/M,)'YM0VBR@^<#DU[-&N)B[&4
M.;'0DW/D<%'59@OX(OZN*&FKM*5 Z)>)+$*?S\XXZGOK4'*,Q\_A[_X]SM6I
M'5[XX';0_/!J_81N_875.T'PMF+G.$/=>VAJ;[ZM2;DK%Q6U<=C/DG96JFP;
M%*7HMDQ>QCELQO-?X"2*"!7!"\Z#)?$"2%\BL26OH#DZ,.SM!.()VO>V_P8I
M1/S3>,#0'5U__PM9QY3K[T9,2ZWGTEWXTODU1 0/^8<11OM:2UH! ^^:G+9L
M\'F!]0T-7YF.(W_LR.B[T*Z?N:-7!B:*+?1/*@5?L-=8HJ1A&%;8,1S?XTG8
M)N@T)3[W#"+A5KT.Q1T!L\N]6E=?[YG3V/AL8+>E<:IEGME?,P//3G^.$+^I
MOKQN=#4F27<;)(V\ ,#4.,J1-JPO(\97/UM5G,>8T$S[FIR#Z;B77B__F/T6
MM,FV*39,+II<J5[^D+M4YQIXS^%=4D9UFH'*$:M7&BKD53;>_&\"1R;7;<38
MDJV,ZO4X3M2U1.J5PE F#<-A(OLB8@?GG)U-Y.)=M)1?@(X.$TX)]FP8IIOT
M\YMRIU5KEB-9T?7]<(1:XU"3;2#\,!KE4ESEE29S5#GKUT'%D?5N^E7V"8X4
MM[+I+)4@B P;6 \,-V7$XR")-2=KWMA''R\<#@KL+*KJT:M7O?WCR+6T>*DO
ME_K"";MY!_BR\0U>80XMC)>Y[7$; 3$K\'^PB-4N&JZXGW-Y=1/G(/ \)91D
M)ECN>PK7UGHU7#G7L30C.A*UK^8?$?&*^.+%^VG_!VM5Y&B3!1ZZ1X8C":&I
M/>.)HUO-D.[E2'.F]!OJ16F#)C0UO]S*);2VKG;D-+Q(W-4Z6..$V>U/ CV;
MMO(^A#*Q1%G]9Y  POA"MZ+\+SVKP*A6BCA'OWS., @;T*-73G;5Y+DDR,4/
M14F<^I:VNN^@V F\ ["SE/"*FX@Z!Q"<F/VI>/ \# L+QZ(_FR15_/XW*@G]
M;9 943 Z;HS[FG?%';-\-BABBKL'G+(-\H&,>5)Q,7C%!8^S@R9R",EKN#SP
M@7%$S"VML!#YN[^M#NK\:*PH>5$Q?#7M9TMX:<=HFG-\]L53]G:-:36UC5 /
M+EKGU&%?R_M*JMPW9IOPNG+X?.TJ)!VS'QG,=%[,92RPVKBY>M_@;T<X;B$R
M"6M/?>CRKB;O/$O[]#C5)ULSC9JU,H^!_F2>A0Y"..(I+$0SH,$^Y09@.YR"
M28A"6M\";.74,:>OC&]HHVL1MT'FO?5/4-1U[&P6K0@ESVW863;8&*4(K+DE
M-NE/+R<ZK4:4RQ<$%7\8O^.6YN#4D.;L7:,OW:/:H563*IX)8P<PT'&AE-V
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MM\\6RNEZDP1]Y16-?UM7SIVU(EGB?</J\@,WQD8/OUV6\YB NA.P@.>*%>^
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M#7L;Y"[B.I0[ /W%0X9J VI8SF$'UB/& [0PVEN;Y-1&H095%KE<#GF'J#@
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M*R9\5O,TJ,NCT5.UA,J-LHQ[9O79CU@G;L!.N?A#1-; 8?QVZO3'-:G-;/[
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M-L),]$HU/3')EPX)_+8 Q1]V_$R"#VAAR6Z;&^LZK+.;?%;4OP9Y14E',RS
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M[TL^7G75Z38>,X=B0@R#C7L(\C3">]E3[TPL^"@W-S,4B/)V+*8;0&$5S8$
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MKBF]27V;17;@@&S0\R/7PMH"96:LV!*\#,.PQ3?@!R?8 XI= SCN(\J?-7)
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MR_!;./T&W=^%F-_Q\5^4[%6$:Y\#2AD%"#R_V.<O]G(Z_][67P#AUC K]>M
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M3P-OUF/PIB--F)_M@L37S@LU6HQRY>DR:T5_T$[%#G) F4 <" S_*O=1 AR
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MFT.TI^*ZL49YUGN.[M2&=+M<ID7M$"BG](0_2BLIX8!<HNZICY]B'JKR9/L
M)(K!Y?!4A@6"IW6G"+A^K7*!^YZI#U3=^A!;O"\T%Q[HEYE>VQ-E\Z+#[B8L
M-YJA(S"G&;*)5S+*$CX&I6T7J< ]P %=[64UL2K4!J8!<@ J6D=1J=I\,K8M
MY5A^=&7-1'*.+.;QE0V'#9Z!-%7:(E)W)A:'( =KY%S&B]T.)1N</B?6>EA[
M;I0PAM8APGVJ2%$;PM5Q??#=&AAB(/.0O3OZ0<844S>!T+7K\(&BPH5JZ9%G
MU]<<$=_<K-T;<6CO(7.H^<<E.NGF]S/M'UVU7Z?KT+3C;O"Z ,DM) 4]R]FY
MIG%2+?*0GGM2-/X1QF=NMH,#BKEY>K?IJY01Q(&8U2]O*$FE20:CC2*?\4=9
M]GO!1=4;7UI>&*.^!\^%Z,T02IMY'M8ZNNPUN&HU9'Q]X&6R:(UN9H_YOBD+
M-8C8!F7-W9"R!MW\20[H0WQ@50X%'( 89"C$!#)EO523^-RO,W42NKM.]_9F
ME2!\9[+35(Z_>K:P(<'1#6;%U_ 2VC&6.YTZA<;(/-YK?]GR2=Z[?/>,OI"P
MU5?#;YX>4![,]I+IS"W"?31X!"9D-VMBL@'9+8KXA(V]Z2/WKI/[\HLH4@'7
M9:V/VV?*J1Y+-B-TO1"(-E=Y,#D0.*PLP+?#X<.-HPYK+V"*L_*QC/,A0_%I
M=C=65**\;%X>-PV+.D,UK -+I7Y4XO=XI4U*1,9VD&<90)_IKD2Y/N>9G.H0
M'/]HJ;LH\_1+9OLMB-#Y28?K$QGL1A^D58JYC"][Q* HY\WM'9)[(O0]]@KZ
MA=Z^^,P%_1%-DUFH:%CO?8C[Y IV$TY(G=^=CM>FX/QS+#;Z@"LDA%OW*IAG
M'(1A;"\_<LC*>[*-/[B649ITJ^OAJE<ISV+U^)PSDN>S.J<8J,0]ARN@*%P$
M@8[3#6MN6K7#L2IAN>_R]0*],)D!!$WJ7C#S/$6 NI,5YPT?L+AF[U9QA ,J
M*Q(P:L/ 7XMEG&;W*QVRT&]Q" \P719VFHZM,+QH[JY?H12=)>H@RX2D=Y7M
M8=%&[I3VGWIRZ%-Z9E_8Z3H98ZJY!3$3;U+,4%S-KB5D&#8QZ,4,. >TQEG"
M7"( 2$HB')#(*8/;DD-7('FC(S.:5G23F9V,)=X[6/E(!)'?VXYVSY[A0"/V
MD5-O^QYP1Y7DYI\Y8%Z]*AO;@M#-3O,XQ'CYPO1HI6*8H4PG$H:ZA9L^AZ9)
MC=Q"X&!3]W"Y_,D4=!E2(/5M2Z%C[UJ'>EZ'^0SAB[OSL=CEA;#K%,D'2=">
M5X<.SF4^:0KT#G)/+LC-MV72.RT43U68V.^B%T!],L9F60)CU,#%6NHI5J*\
M/B&;ZD%#4/ :V? E UM6-UF8ZY$VQO0O]X=@)F0[03F"#>^LY&;M%>9@AX??
M#4F8L)P5[KZ+B</5GDU\7&&\2<I*V*#2:0?^8-)&ZH!J@VK3P2IQ+[UE*BL^
M2"J_[O1!EHD8!:GH;Z09SM#69\!A_;J;QX<:IL.RC[G/1B\/WI,R/!":8Y>1
MB+=7ZJ0OXJ*<9%W,$)D]12%FNX_GNH=-[M\9>DS5I[?(#=PG6I5Q5:<?O/9"
MO2S:VZ /SE=*W!G' 3UPUH&_U^=A;39OB1D>/9O2ZU[IR7\P.E8C,Q=K#Y&C
M71.G:(_'QRF0&^%XBB9&^1':(A72;8U@+7_FJU#GGC)$]A;K)Y%VES<=ZP,+
M6L(6VB*T9/,;$"D7&U:4.VG6B?F''S/6W!J.7X[O1S(%20/HBJE05Q1F"0T[
M$&)4>=/=JE\S.7ETF4%E]Y%2E3&K@*:6P<BA[?Z;JA+J+L(*+#*)J4PEJ)&2
ML9H:@D:HFDPSS)-"J(=F+/KO"$NH4,3Q Q$V'"+.WN=M3JOE@%:L;%3?Z8X_
M3[D6-;TP<"Y6RL]> 82C;&VJJ"@-XML6F6=O@ ]5OX.[CL84\9RQQ9^C_#_2
MSCLJZ3?\^_1M6+G-E0M+T\Q9KC23IC,U=TXJ<R IE5L1LE++16IJ:DGE3$5R
M(&[<5F;F5DQ13,V!@"F2#'_TG.>?Y_GS>?[@',[AW-Q\KONZWM?[]1G<PHFA
M4=XZDH+^WL-U4PSZZY;\_@;E68N9MX4 UNCWS/%==>I(J0?2!5^1,K)6E1<6
M X7E%E]WKF_[U(JBR'@7EZX^$,U5'89A]*7_4SA:5U]KH[#1V.4_4I =<?HX
MH&S?C5,(OUO?K]Z+0%Y"=HE&.5J"HA#RFJ6N2\WP 5>-NM:\L>:_&,U"\,27
M@*+. UKN9X,)%TRJE(ZV'-,8/NOT7)NNFW6YP$X")?6\15._O2:YIT L;ZO:
M35.3;?]^(**!]I^')NN&75"<H>1OH0>!YQZQ1+TK1M@,%?L46)1!-L\(;_S9
M- @H4VW"5:=9PK":E9IW_Q;QS%?0.D929)^CYEA_CX#53XK&6OKG 8/OW#['
M)'6,]LWA;0^_/R;-J4HWZT;K=J:[#E,UEO(DL[72"OPN*XJ<?]^H&FR!9VYM
M<W-B]YW6R\NO3Z[BX#>1ZM/O_9)*M2H*NV(4\DUK"R^7I]S_,7UKQ-7E ?M)
MD\_/9(;??-;UQKM&-Z^?7(UV_!)R%&I\HKE:%F=!'MMB-(V0D>3QH(%>SD4^
MKS]%5D+[C,A9O[8>6!=/Q.K)OY>/+9S&,,*]]@ 5NU(!E?TVL$NCN90ME&AD
MB$OC\S<>*^[<]+)!&0&8YL'BG[5B7=C/#[\_=#^1B]<Q7_COEI/:V=/'Q<20
M\8]_=K_D<TR"6*ZC,?_V<=^WH5K)Y31Y6.\!P ]6U660QR(=AEH^LKWF^2']
M!S>#X8[O/1H1\;Y)T*WT>WRI[Z-I9I&8 '_\6],AWS H\OY\^,^I08F?PM^M
M>BXVMYP3)4'/]D:]5R7N 8;W 'IH[$^T1D'-,&NM:G!Y9'CA=_F1BH!-Z[ #
MWHH_[C76Q4ZD:^&*ZXAW'[GI'XX?@NK,T8*S3QHK0.K=E^+*K6@0A#*M%_,P
M0QDW8G*Y"/QM]=G&?_P7OI2*J=XXP"ZS#\)!(:68B>7ZM][=;4Z8;Y22UGH6
M'HS(^3'T(;\5$.%G(6&HV_)-5.GY/> YLQ-*0,H% .AYB@S9Q(T<)-IR8N'J
M!R:V*W-UW%1BHDJ3/ +GS0'N>1CDHY&.G]+$GGIMLQ\PL'E;3JC%^8J0PR(T
M/'N&" ;E7/[2<V75M6:,L8U$E(9_=3U.#.&,N[ 9F4_7HTHF>.:8+0I<0/9@
M4]L$.<544W7FB#/]U:P4L_;C[UF%6-=@CJ[MD[\+U@$/>NH/ ."3Y^77=O[+
MLC .>1"KR2S: SA K N.>E"QWTZ_GX0E SY7"=U"]INV(K7_Y$%"+]W(J.K6
M&-0H]L%;T,X-?YUVEC _E?M*V#TU.L(L1_ZZ#\]<:>IU'F[QFC?R3TVZZB_U
M8DM-U4\SP2Q.^UO/)*=G.OU[%"9*6MG[7JJ >BI%XYGRV;C!7*7JHR*J%_ '
MB!''T@*L[ (84Z6M!'GO N^[09I$[[:86/*0FPV6"0DJ;,GL,95.ZBC:='3.
M[(X^=^O%C[>,%Z$P>&)^BLG=JR>%W,S4S63SH679Y-E5(F/RY<G&D8W;S769
M T"5*<JL1=&UM2;#8..\$N*3'>?=[?#P"3MP^\E7Z-Z)'-N\J+:UZE,2+JN,
MKYT&#:/8]5#6K1F)C3#HFHW!5&X</Y (._5$9%DID/HSLMW$V:,UIBO< U1G
M8CW?"AJXZ6-CUVU\/=E*5O8 **#EN56*;.BCWN.R2@*7BR47I3:(X^/$C2;.
M2L0GHI4U:6:KV3VTYF\@*^^5<WCKR$*MEYG7E9[0SG,[U++)GM(FGYU'@I>7
M/4":MK9T ^E0U>++ON6_F]ZK6DSHV3Q\>==I"/?6T"DR[N(]#]G<J?_2BAZ?
M7HR&-% %8[<+\:0_VD-.*F-USZN&.X-@U^K'Y"U0UFB73\E.^; 3FG43#1Y3
M;](0MSPBSF]5N$H9,)Z/S-A!?05NM^ C<D3=W:^]?S3L:?> WG-8<>'<N8_!
MN@6)&M@@4$747RSAL^U-I]7O*V6GW:81_L5MT9#6/!5 9ARJ.QZ8JXBH$W%:
M>(*<.I$XY_02N?_?$[4=E^&QE4PEAC9S9@&=Z'T:93NA!^;WG@TH4![2UH0M
MU+3<4O9M2%H==KM]]_AE8HV<W#T!UQYD-8IRE:YJPW-9^EZ(X8)S=-_2%URM
MR(AVL(C)U9+5 M4V?%U0A,OP<^[WU.Y:]0%\N,-Y0XOU_\YDGQ$J3][Q&+/L
M\5)?4W>#3Y.L@WW/?-6U7UEO+?1^83CM^Q>-ZQ9Y8":HYO!.S!5M;@9Z[J*,
M4'1=1+/%9!E/Z'L BB9+(E*=G-B#E8>TJ3'?DM=0(C.! K"MT=%*<DS%:\H[
M8Z=C^?TQ7A?EE9+<WJ6<NW;\A9$^!5E#:B>\0!YI4X%#Z/XH4, "/;]K5J\%
MBA**=-X6-%XTE5,ERKC@-BE:OI$BYJSLF%>76C_K%5OV$#E!R[/]S7@;T_G>
M2K^J%H(L=*<Y&@T;<JM>0RC$1 5G=K?)0ZVCY(.U#[467<05E?)]:6BT[GW"
MYZ)\>"DT)+,O,+O/<1AW1PDB\SVY7!%<8 -T&=FV;P>UA/B$@+*3SM^=7*9]
M#9U.\O(@O*UKK=SUX'&1BF-E8R/.LTE3'JL.0=J$$]?&-U.[X^+2$'[.;+R.
M,F=?$7:9RN5795UB^S)UZ7T,PQ]<*2;+F9:0OJ M'^#BK?[4I@,_KN$_IC&7
M-^ZL(9TK.F4G+RM_'<%2*2XYHK$U7[Z")&*+5W;L(4!B-H@XHCLY_45O#S"5
ML$!9?U:KJX,_O>^G<.%;H].]NY!8&.9-J"M;:NY,B.>P]?J,ARO]U%^DMVM9
M24NUV0>(MWA<VE+>TO6DF>-V TM6/2[*MH^&):2-5"JF9B&[*;Y;K=:V8Z*G
M^FV*5B6C4^N"6_2"+A:-F-6H26]./=T#5+M)+HJOSQ#FLLO>IUT.4U8#JMUA
MS3Q.>_K^?L&;@JRWL94![CYG5GD](W'+_]6A7EP5)/K>L!I%W##G9KT'Y]O^
MV;S6>I>-,182? Z+:6*L!@S=)/Z<]C;+D72MCZ#5[A-G&&8WQ6<>XH/$Y*NI
M/)=8-PPI.-,4V*270RU1J2X<J-""#\C(^]@$^4B;[ '\8DLI7T'/#STV(.5+
M+Q6T9K=YL:+V .B?C3EA.Q^V);Q7=_MM$ZQ;7>U']/(MXF9B*TC$E?K+R&<7
MQWY^ZLSP?X)1I%*=P1Y#2D]F-[QB+B>,4X&^HZKC6PVAK%Z3DVZSUJ'U$W<&
M9U@F-8;NK_\$+P1I5S5!AHG:.DT;N/"_C.VQV*4LB?R'V,@0NY>78\@H 3<K
MEOMY?6&1 $:$D*=_Z(/!*+FT([Q.<"4K3+'*7#_*2L?34OR'5=N]B(<6-1U:
MB/FT6VX++Z-KSCJF?QEP7&IMO,OZC1WY8+=%VH@H+6W+&F.$KTS8_GK%TTAK
MVY$[QP*)V?E%/7VY6MB/DY 'WVP?.'A,S=FT&CR>NKB;%)107+2:GOD!&FU0
M^ZDVZ\=VK*&S:'DL90_@T_BF AGYYK314M9;2E#,J5WM$Z5\=6-8Z%3.Z?(<
M][2L4HIQ6D41Y(.;Y 7_,7UK3;TO#Y9_)0#K!X\.*BG\9]Z8V[!?SAF*078U
MP6?-"LDP@4E/F@+)D2Z)\GET=>&.P8YAM=7QAK,9KT//F#TZ\[Y\7+UP?,(5
MOX*=;Q3#G[.R<ZUIJ\?MKD YQ+Q7#DH]YS2&K/"B !E5?+;:AU<69E-*>2H!
MB_8I;U.ZI'L#,>/O2R!#Q\-L'*V'WZ<W-([I7Y _9]@G]'SB3WME]QX@]*41
MGX1:,R$,-@;!-&,N2&VH>T/ L/XV LWUT8R$0[_#,.Y:=BSPUM#VZW10E%9J
M^63@"SD?0/W]8-6IIUUZK^5$U&H"C9UTKT/"*B&2^&%?S/W@;6M^Z_X&QL)]
MEY!!^6]S83,"MD<65''J*Q\FOD1IKXTQ?K08+%-'\(./*!(9W).T82]95;KK
M,Q_"S7=N V2OX]J&.N=3W/.'SC^<\MJGO)"G/W-W\/)06.S=#9;=R.WJ81Q_
M<PS&??=[;T?5G>J" $.OGP-RI[R=KKSWS#C<ZR1#N+MK>0%6GP^KRN<*#'Q7
M#X)!->$MN+]:LR6-!WR4CO^Z><@U0GKK9S%!0N 63V<7^MBB:XQ:9B;+,1+(
MB*/[]Z)E?A-G"45P.)TOT018J,]]"]-')^A]W,!0*'6\\O"HZ#=/$W]YXU-#
M2$9\ G1-.)%T '&*Z<$H9Z+H,#?.>X^> C[ZJ9J>0K8(*QQ]DNG%G [5(#=
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MS]$1E@@(W^*^TAMN;4)<;.,<<7@43JDGY,R)VU\_$?__M>](X/?</0#090]
MW0.X5_Y?M_O6@1*0\\B\PWL L1PFX?.6^^D/+9,<+%UW*N8J6_3?O>CE(@Z&
M5PLN[@%DW*&<$2;RK"7E#SA/2Y9-<+H3F<B]Z+,'J"(,-ZRN_Q]_I1$^S)3:
M'E+P5EI 8+>.%DSN 8H\>!]%$K;TR\[$P)A,_*"=J0;O%_14("6T79'9I(EY
M$G^%U;FQ1WAH-!*L?97YF+?VSR)C+.E@MD2$ ZVM]7".!5V[&RG\.Z\(TF]=
MNIH7GU7\_<CGGR?34=5+=2WFI<QE[I%]/#J7K1W-4&\P%5]M:GGD5FEWQ@V*
M%,85BN0I-FY6A<F?^UGOL;PIFZT^CF:%RN\!:*X-@*^B])".60>?,IGO;R+V
MKR*3 2^-)[9XAW;0FY.L1R7N,&+&EH;J(DN8K;1I.Z1(I,*NLO##BY7A'PU*
M"Y4.:NJNVL?)V2_OW'LXWA9/%G<^HXGU/;\Y< &VH9PY@F%M;9L&ILJ.]3C5
M,EX5O34LQ[?ZUXRO<JV7$/P\\QAEXO4.?IDYP=)E+G1%W)R)1/;,'JJ9"(UY
MKNPVL8YOJD(_E+,Q\2B,*G3EUSGP"OYT &DY:\R\3-9&H:MMDVGH+@50"_-.
MS()PPJQT32L]*"55@!A6-E0YT&Z9*2@@UM/J=V+BL$<!E"E&1Z:9Q& ](OG;
M%0R;6M^VB04F=NW:5'WXOI.G.XAU-R@L_GSO0GO"DJZ<_=:EAOU)W ;07 52
MFJL$5_QW+I!] IEH/%X\OT:2A11(TK[C*@*&6^N+H<5 H<GO2_S/VZ ^:M]L
M5.E*$A<#J^LXF1V;ENZ",;*KA45>)+<@9'/SG2>808T.*\T0+Z?PV6GB=, Z
M9A&F_98KCN@!TZQ1DZCK]/@<2A;=8SZG#R6SENF5[#$P#*TOD!U:\F.!IN9K
M&_,BV=> WZ ?EY35@U1T"T! D'\JDL>"<<BY8J20%LAO4"PPDZTSRM6!$/T3
M@Z_5NKTPN5 V\QE3^D7D 3;PY-$G1E?9#5@":"Z'] F]KL[S?5*CID:($:"H
M7QN]*H?<:N8%OM9*'V083T$8AXR&=SP^O6[VO!II37V5FK9_^8W_/%HH$,0?
MILT\ ^KZW"8\O3(.%@@EI1D?2IT/'U%T^M2 'X'=2U*C?(77F#_2N4Y\6[L/
M79CB>YP\?[[QZX.GP=]U'CVTFZES@I4'?[>&YGY_F#.Z;/7@F9)*HR=5'W+=
M4'FZ)IJX O8 0O_EQA[@'L^N ?D0RA!>>;%URYD?=GK1Q_6/:[6XE:Y.5 ^\
MF^0DA^KL >Y.GW:I_RG\O=(605N+V]EAB_9SCU!HKEUH8<01!#'<5)&^QG:B
MJR86HV\.;81)YW<:;'K:Z%?T0.^*6R^^?E+S=AI?_;G]RZ8=\_SN^)TYZE/7
MA[T'P,$M]7X@8YL+%HNN2%H#N*FU3W_7DJ>7*?32)\N<!)[+HPI>)5..@D5*
MGMS/OX1RBL-%;F1LN'D3/13A0\;:W^=2*B.#^XZ/8>Q]7T>6D792+8D[+EOU
ML]F;QA_M/]0:#R^C6FU X0ZPW-/-Q3&SNYN42:X7AD<HPL\G?MW:L0(%1DW(
M3HLNN^!^I?88+>"9P+4*[E%7(/N.-D5/Z%>&72+QAX L%/]%X3"H75Q P?1^
M'M>4'5.![0(RU6$O<(.2?9STDBG$:$54;%CX#1'B2DC@>#%._05Z7V7ZU?-O
MV(_5]#D\O][A"0H<?,H5Y*1P3T)D>'5B1+:!DF?1>X##?0EU&* 3?A2VH:D?
MYJ"O*Z[AI4$^7+RD>/(_XS\I#ZU"=C$?8]'1$V.LMT'-KMM_^0_/"Y@:V]:$
MG=">V78905"#[+X-,@TM+PTA V[4OFP#OC;/UBCBK>QGN5\T.T_6GQ])[+AA
MA/0:3V1!<^^,J9V#0FNNNX?>+]B]R!O/#:F\9:/A&MZD@??5#\,'O);X<[\H
MW?Q^7/,T0XHK.)'258SX,?YK8^K]S][OYV^4Y)QA5Z0=NG1@Y]<.-HYG+GWW
M<X_^*3SH)T 0,[E]X^VE[^P>%*-)&#&E/VW[ Y/TYM6=_OC"SWEM&%#^F&%C
M_'6I^':OKP\_NGL/#Y2&STV3!D=&L%N-_VOS:S6D'W(RL2^'((:0 4<2NF=-
M6H;!-Y*=Z9A%W%;TK;9GFJ-Y5KWE/_)S8+.PV4N 8#(!A#C#&ZAI>C0 A#OT
MD66!F"3@7./AKG/) ^X[7N,(&6:I$U]WA."I[MJ5O)NUV;^!Z^HQX9OWDF8E
MM,1%[*RX3TR5H#*)"? C"^AC ?4):\ZT/4!\6)"'+2[RV[!UC+_?/7S"^>C^
M5I;0,PZ4&<C);A&=MYN>9I#IA@D$7@DER5"RD\N\F 6[XPLN=#GBO67[9/O\
M]5FIZN;T)^X:EJ_OXCN(XOM^^ QV&H^D5%A]R'0(A-<M?"-G#1._%%%QT]XN
M%^A_WEN%GC8.,GN86-/RJ_!X#,;HXNQ@#%?FW[[>CG;L8]_7NKD2$WN .\FM
M%ZY/:)S(Z^N9%:?ALL:SYJ=O439IT/H!#8PJX\FWN(BB=W+!$BP6#=6SNY.R
M!YA+^1/H?9+0,$H-0HBL&@B6S7X=F?'4,)"*N5?@>NK7_3OGNM_L6P$GH6FN
MX 1@-7)]81Z9@*P=7&\\E!M##M):6NN>U:6+!9YE)GNP@!GCA>9C\&NO_?Q>
MQKZ_[_E?>81_*Z*;.[ATC%>RKFV;'@B$5&#OO;[=>I;@[&5/.NK&+D-_S%TG
M^]C^P#"Y0C<OG%]V/@EKP[FAL_&@9P%[QK/V7=9;&^W2K*:P%:0N&<4TV /P
M.7,^3&[K1(;(T1ZDCM"6B83R,UQ7PMSTIM!'UC5V\Y6.^7:I$K/QP??L71\Z
M=C6AA3U DE#YL+#1-Q.#T1O!%20B;KUY4$U0AP\CUIJFPJ@_3W](^C-XZ7]O
M7_C__%(3$K=LOW1VR7*,(1?[Y[-27(J06H#T47.O<JHB[&]@ZR5>#A]6 G++
MCP4^P"/1_=LR[H93",+X\I\)5G0&FN:.9:I,V<OL 7KD*R3\E+*,GQ4N*;^Y
MIW!AUZ<8>577UR]+Z>:#=:OJH^_\<V0;_>1=,Z?EH7\)O,[8MD9EF7)G@9_L
M*%GD6"7[_+D]0-?4="="=SQ(4[G%ZTR0%?/^.0V?18MA>^44B\-)M[:P,\BC
MB!][ $";(A-J1T?'M^E$[G>B+7V$2)8>W/(^50/3,IKS0)V9HWX3\S@$"DA-
M\"%.K0S>'UVTNJAG.15U/71K=9WQ^]'(*Q\C\&XM=9D)'.QC2SV/8[DC.S1R
MP7'TQBN-+@<V6B_UP00\%^3N*40[(N?F/-#/S\(].4]/,IW+2+>8&VM>!:3.
M)[)K_1Y^XUIA^PZ$D*:) S(_,4T7K-*_9@B4WGCH64I96  )_SO+!9HK0U?G
MM),>-W'?+K3J,D+I)D!1=MB"L-"WIK2G4-B!_A!DJ:"+V _-7TJ_;FU*$R1^
M\H8AN(H0( ^S X!,U3U -\?%R#9^#B3U!3-K+N[GD? )-_;,=NG$MV?FBNF)
MGH=4XSP<DK*L'G 7,C<SDL"QL\E!#*,*6RL)ORV<Q>G?W E-*NQ/K+&\2R,O
MI?</FP3-NR%4F;6,*N:?,NY8=-KSME/)/3^8>/NGG2[>*MG]% 8QM@TE\2U&
ML;Y1W5]4[7%9H^-X,Y"I J+,TQTMF/M9SFQ#3IG^?C(HB5 M9\R.3FL,C?!B
M)MH.*S5X'1UQ>/G8OV#E0YSW;0,*HN4VMTYX6HGA5\^\ *,WP/UHHK0;IB*H
M;LW0 L7:*/?0X?AIB,HT\G68\'E9'RCJ[#W9R).$ MCDL7E4,B&0U\E!-&<T
MD:^+*%E1PH0R,F#'W-CZUM-&&ANXQM#XYNS#Z\Z]WNJ#FHAO*^EJ#RK6'&T]
MAQ!3,\C^5K&=QL+%JKR+6ZU?*E^=<71RK"N,SIM=RS+%3'MX?(QC 1$]!![(
MS-5P)>E8BC\+#(<Q6_\]H:!&K\=#:/WSU#BX9=@[@\S2%2D_U?B"([?_X_=5
MO/2@)P>=7QS OL<THJ.YAV%TZ!RZ!_44)&D20[=F@.@325N\'(U<ZP")A'W9
MKN@7M/-JL<!(JC9D^!LZ7"/?VK#/UG<^$X7%@.:>@G"&73&@J2MK#!]F)EF>
M;WZY%_S$VY!^*(ML)Q!9LBLOL[K)W]]K,%@Z[?D*.J5I?Y0DW7&V]O3M0Q:;
M6*:6(45T3AOEPXCB)"(.KV83Q-LT(W,6S)^Q_1$%(KEA,4'"-D.P#\>F9OL#
MO"]XO#CI\C+8R,FV[^2KJ$6]XF*]&<ZTF_O.DG55'OC[=':Y T.M[(M+B_Y2
M9O,CR]]5]7:E@TZH$[Q:I:VVZ=-!%%662#^MK[N)$-]BOF"CWE5ZB5 ]"L-\
M&/'H=I5,R1&;=K>1BSCGUA>N##8P,DHYRD"F\ECA,FR_&UR)CN^E@!FYG/=P
M<Y9Y)+@=S[W00I>?2,4=H(TM51>MH(E^LX):_*_9#?QG>A]779+#7H'_X1Y=
M*^E_AY@$TVQL)%<\;0HG(Z7L"LY%6$K,Y*^$UYK]6M; '@O[?1UI"09: WGT
M(^-T5A8AS"QJEML(,Y7IZ"LY='FKXJVS<(69Y,V<,_DU8][J7GIMNX&45?^C
M9\#>KT:6GOF>,6Y6.Q53$;#.JF\*W ;G@&E72$15LBME'TO*0[O'RYW:K7"6
M&4.^Z-AEWHW?_+L3G?K,D%_PF<.%._GK#[7:!QO3+%4SP;4"1=?/!\V"I[3Z
M[Z5N]C,@C;?Y!B936VZ'@ ?Q;-EW/*<B4$K7I?IP)1&U=05)%?!(SJ4]P+;K
MEN1?G9FJ"(FZYMCVX':67@NR9B81'/T+PZ6SFD]]SVZ5\B;.[L(^3IGGW3IO
M&&%X:(G57/S!/0R))+$=$0/ FM(>X#20>Q3("F&K_F@['8F>-^^(9$-"RMA^
M8RW "*U<,E ",NQUH.8'!J9T+V"<'S7KZWG[3=X.:=J1P4<79HNRVF>/<ZI!
M]\!$O@4;:D(+<($DY ZWH/FGL.TBR$=,KOI4S/YU=/N8Y[9@+9OEH)5Y]]/5
M>*7C587<(XFLFW #IA$/^PPX36V2<+N)+>KA+KIYKVLZT]![?-'ZHG%0X/#:
M8,-(,,[-[6Y<@1C!W_(P2>D@G_XVB"TUP4ACWBGC]J5S!PKVT;V?+MBE (^;
M1,Q;PXY&^G09OS+N+2+XM,ZHSTY/2T5*+GK&9A7M'U"DR#Z 5H4$8LZ#9^ ?
MJSQ*ZEAYM7^CY?1&+[YYX]2*V8Z(\ #;%*R9U?\MX!'VP>_,CQ#Z4^Z1%=89
M]BT:A3*3BDWCGF:?'L>:I<?&EMS=W(4>IZZ[K6\HONJ#7:B[;GW_MI&#L F)
M+2<80[:V>TSZ!&:?S*NJ*([,6.Y&"E:&0EL-'=IJ[HUB0VUD^(]O"%;2<%^G
M9[Z(K]?"!)RR!2P'0;Q9X4PHDL:;U94E 3<=*S ;JP,#V8JQSBI7Q>N;LN9'
MBEMJ,G2_ME9.OW_P($*-W QB:O/"F,QC_@-+BW% 483@&RP?]R+<Y&>LA=+H
MO8(GY4/!^=9<[_&$BO6/CO5K ]3%57=&JHW-E_,C15LCLX&NT#^;;=D7CU*Y
MAT]\8+LRPR!TU85!"H@'!MW@NH&=9Y3MY?'[)M!8GWE98=$]@+_YPY(.3@[L
MH>3:K?QU^F> MVB#LJL7;WZ>6T&H00@']@!0[<0] )#M7\;<)#%LZ*8X'[X7
M81#!@9_UQG>_;UY1@<WB6ILN2<YXY29E6.JS&.ND21TY'V3\UN9O6ZM2QJDJ
MJ8CF_8/8B]"_'WDZ8LTT^T,61+$E".WURISF'K"HB>/[2?S-4X2TW<,3\FY9
MDP?E/4JCOQBZ\*.SO]<96.J](><UK:-C5K>G-#GHVAR]X/SB4Q71.,F10#OS
M&$W-Z5:V!P/*R8##> &OH"?VPHB.C"+F/%VI"\BWA95;59!AVM%VYNM;8^=_
MOQ^ZK]J00+*OS3CR+E5B["2T*.=;1.X+N=NN3Y =O#RYBWU!JE;MMINDMLL8
M]@K+P6]RLK6YYR-A#C3;G(56,QL?;QHZ-:'P-M[ T?OKO:C;!N8/8'I5D?\1
MKO&:2#P0V"8+UV<^I(<PKC&+R4'J\]0>NWBTV/;OH"T[B6]YFAO-)1<Y'88,
MZU#G$M39U'BSHW_>N+Y&=O <,:_-/0.*(+2X?>C:OL<F]J7,KMXV<>;T//9X
M9-6?*UG:=;%*=FB'D77RR+1#?-[^\J@W_4'IIY]O! X+V6/L_^WX$+X""VB>
MP5"725>S/[0)O07_A2^]*B"&%-=,N4T'!;4EXI =#S:TR,QTW@)_8^DSWM_+
M9,?0&K+595G-ITO-C",C-\3& Y[1/_UU5X\[N<"$]O&.BN "%@]#$6L9^V@3
M'03Q0&]A9CKY(LSI!UNJ<F5G(OL'I&F,0LHY2.G!M'R1&,+;Z;PK,+IT?N&_
M5BB7_V4[W(JWZO>"_R+)7.8MB6G\ ?D+J)")/'^V!#V)9W,LD'-9'IMGZ1;G
MZA&WKR]P1KX+GO&LNKE4R_E)JL -(P))P[ZC-F:%R=#LT-&PX*%@P^TA')%(
M:3/LIC(5^1)Q6  4?2P8% A&[:(IUD61P:P>I1[CG%3]?7-4IG7E^KW1;<&\
M:U*BZ-KDYZ46+U/4IC>##J#^73ZT01 +C)IY;QZPO9C_V+F[M%L&OSY?Q9SN
MS(MXCDLXUU^Q!^C4AB(5<B3?+4,M@JD8G^>UP.W@0Q&N5.&4R?KXA4]FBPK2
M]/2S_H+?7WP4_!PK?5M.Z(C1-G81RCV"HB7:,W=XH2[E-",D(%H\D.+K02<9
MRH3:&[EF4\V;QK +]2Z>?Q[=O55H_RUE.DJEYKW1>*$K4?EGX(_%.H<Z96+&
M\,0T%NTQ??^:DFTQ\"XQI6S\T5CSU[/)*6\96]--7@\(/BBF:ND+PAQF5I0.
MHZ2R?."QS(&2E8+S]/K6(!JI0V$?77_C\:S4<&55;A"F<-,W06K805'PPP&M
M?5V@:!J(:,?P94ZQCB,[+B'OP)XT#?909>#6S.-1="7;T39^[TB4]ZB6OM?)
M[\3%B5O#N"/DAEL;UW)DCU@7Z@013E/ E81_O1(Z[SNX'@/L$):.G.B:/<RL
MY8%:F^(0W&9>6&15)Z )@\-@OB3QOW[7J*Y<]I7?N@[^+J6@I$V-%_RWW#'D
M4>YY9(<=\C;J&8$??KDDL@;VE'NQQDYZS5CC151126G%3]P I@V-% VH*M!S
MP-]58GU\=$2_SL>>?,8AG'%&K1CJMED:=@HZNV;+*@XZ&V3.;UO*)CSR',RM
M8[C4#Q%9$1NH5?8=GWBSC1,IBX/?S-IOU0);_\@)^"==."1_^*_E7#7#NZ0Z
M#'DL$GHIH:/%'/M[5[K1.K26.S%ZLDXJ1U;413K;P;!9[H[9H]B_F.>_W+*T
M3H9FJS]S4TH7SI5)6)3Y[[QO\&'%!07<\A=]*:QKK.84 FVZ7&S[$/[QHWM_
M53,X%CA+4/I%FH8Q[M!4*6&L"Y']\]K=7LB>63G:GVLF-W91<=M&H4$0[=#3
MWC$>R'HSNN%4"4+K[D^)"<6GX.\@MD@S]PB+]K2W0)&9P[)>16@S\_T7P%,3
MY-(7)D;S\OQV]%,#A&?;%TU[!QWKGRQWYSE8^8QABRXWN:;;+BMGDPF52!DV
MEY^>]WA8/=+'S<7!* -<8[F#5'CL3R0 D'./"]1IK=@N82*K"X]0&@IJN1I!
M'^G5(?[6)5T^]-%(K?RE)N;MLTP\WX7]HEL')FR.#-S,RD]=M+F(]9LK6"D.
M6\2E"5@][?;^4LR#EG,[F%+G6A8I%O45.XEBN-.7*6]9CQ!3I*.:" TF?EZU
M$QH;<VN<>YKP)/C7\#95 H(W'AA5*[Q<=@*LYN"B&R14N4\^/GH/0'G/DC1D
MBY+(YNN#]$&&.W.*CK*G[0%2N$HKNU)I>F#YR!J6![15:WQ#LJD65F>GIS+^
ME]]L;5']M+)_RL0HB':U!CG? )I[ES1EZE):]G0)*9#HW7A<NR!R 4(EG6Q5
MX@KIGFH30GSS60(SFRN61!"7/I#%="[XH\O8ZE4.#KTQ:GHKCZ 203\=F;B8
MXHF*%:B/K/GA\A[$WT&7*JIL4>L,SMLN2'-BDB>5E:1ZGHJ@]\'5. 5M(G"^
ML743?KHCHR_V3/\->@]E7<8//=<*='3RLEJD5KG=K3E[(D3^9V6Z^9-;*4E_
M7?\)I1JW=S<AW9^\!Y#GB>,UN',LZY+I6_F9G>3[R !Y2?FCPM*X3WX9%_9A
M[V<0-2]]NGU,X/';MZ@WR([[;<=6B*5=/#GP[T6_4)">:+G.,F&J7Z)-)+;I
M(CO/:HP3<05/,1V'?:M;\=^R0_IE@Z744_,M=[ /:6"VZ"#W<,0"-7'7M7M0
MF'V)SG,[Q@6)P.<'NTD*JGP63Z"78TZU%39L/-F8NM6A89?SYR56^4^BGI)5
M7O*;V)69WKRW?WU+JA@NPZSFX*;?A4;.9;_>#:<8P0SEHUR:]+&NQ'%<W<5,
M[N%MEBO;;(Q[DOL#^2FGEPKLHOOT(FO3BI<CS<G%V:4PC%LDME/7,[:@\TN8
MK%DD5D9ZUC!JV%SVJ6]##X)A+I!AI0@0V[QGZ"#^WPW/\/VHX!("@!?X#,(1
MPEQ>M' O-96XO"Y?"/?)=Z9=SV,Z]I@:TPLJR@+;^"?$9NE9ZW7J_<6;VE0Q
M9\CQA;NS-P4BL22F\BW_M,OI(A?B'.MMND4''Z3976PG5_><#AEA!+H$&[9$
MUV/#F%N;?U8[RC-*7<X]7+*R-8#E,5R\PP.XG@AM"%H<.5=%HMU$OR#47@-)
MF5C3NA@V'+1&07^W).)(:],P3EM\;15,&8\PU+&42X;7*FD6#2B^$!&YK-+B
MRCUZD=<A/M%5U[59)]EF=.UU GV"C'_.%5JE34%(QQ%R;&NZ1-_S\65SJ8<6
M>05O]:AG7XS/E4L<O'4[;#66RC"@[\0C[\*8ZJJ4(-K3A0),T%RR<!H>37O-
ME.UI.PE>IQRS;VKYLY1XHW[4_S_)$(*/R,]&!=RV.5N*C]'*E)]#3V:2I3JM
MD7(!WJ?IU%[U&)MCG4W""=238\LOQ%;Y<T9QDG@?AJQ\^94!U:\>@!"OFRT/
MSY:*MR8_V8D*C=;TS&O+W\A$*C\<Z)GW+$&/BP\WA3<U#7^I:O-.?(&8'&E"
M=K3,"C34-K54J]/P[8$Y+H:N!H;VQJ2?9Q3SQBV"CUTT5"]_$Y+NAJ3=M$M#
M2[?]N[@#W /<:T8GY%%?F)PT<9M#Q1-!:8@3 7_Z3W&3YZ?S#V?>3%J=;^E/
M])B<P@\LP4Y%2 U $).41=[0EC8AL7/UII),<1V L$X^Z_&^X%QA=,X/UW$9
M*D6;98CXCJ398J>$P$1\AY2"+M-N83 >*0S71<IQ99!BO_."*./Y<BX3QN4^
M_=4W/5]7 >6/.*;G#=A4J*N,N=41W4N*J[!C6,T8F1B]*I+>R17'<4J;_YF@
M9BWJ]8E9\\6)=A#SU"#[&('QDG8HGPZ<(['%^<G];"AA2 /F.ZX_F+0)R78I
MT&FLL_1-9>LCD8+?ZNOQZ[\K *^,3Q;PWP=/@Q)$X/<YCT%W8')04!VR9T:*
M\9BNVFG#[SQN8KCPUGAXZ6>@C-Z#;Z'J@I -+K0_[D$]?=#D6N6GC'U&$G]3
MZ2#N818OI=KIB0DFE^D3<SD47H7P:6VCA>W( Q>Z94#=3HU#+::;1(-"0/WP
MA[SS% <5-=':XQE2'&)BF+,IKRD?^#M!"" 1^[A'(*R'<!FZ02M9^'E]F^0H
MVWI^,$'A_/BO L8>P'W$Y/Q$A&C'P>["L%\1-]V4?P1]E[ST%"?XI6>F5+:B
M]* 4W?RZEC,.$Q0#OA-04)%A/5?WIG'+I2EH<W;69:4ZCG61^]G[W\7J=Y&.
M#IPR L_!3P<O=]0P>2*:AZ,^10A'JI(967/OYRBB6D=7JC%O\HHKQQD#AV<$
MQ"YMI  1YXJV9^5'B_]A!9>(K,5W#3[; ^!TV3&<+$) K)D=WRKBV!@[Q&<A
M?_"@=\L'HCS4J:&VI<6WX3DEQDRL3+% ]Z5I.&^T#[+#E*<BF2#<<D?1'B!^
MY".3VK$'J$,^V_:RN\*,G[=Q),<OQY^*6J^2.88L#JBA3,-T!7ON*GT!R(E,
M 6\$DCX-LD6/S0$ISC3UN<&G?LP^.M\"+-G$T2=J/A_&![]&H"-RYF-8:K60
M*/(+1=>DSO[(&;5\?GSF%8AM4?!?'XF-!D@Q;MF>AU[Y7D[.C.QR-XBE:>IX
M1OZ8YNV-ECKOB.K=4SS  3+WL3RYHTB)-@GV>9IYMS;3$53]+'L/ &-VT65M
MZ1<+XBK N?DZQ!Z3C*XSU_5S#]R]WJ5CVLBNYY2!YK+0-#O8U--Y_Q>F:FQC
MWH$_9E^CD7I:Q?KLVVBQO.KI?0UW"XHE6ZM;:CGT;%V\X)(74-R:*WF^X/J]
MU%\WG5+25X$T>T&P/><=<JX$+ BZBTHF'&^Y2E-B! Z;G BNSA=\!!:^Q=QT
M<KYFG4S[(H[_ZAP4WR\Q];9T?UX$18G%C^R0!]T&/D&+<<_,K)Z#6S)1Y<RK
M+D,MVN^8^61^)GG9GGZHV/]BVUL,A'@\7.>U:L9QXJ*ETU%AQ;-"A@]+(38E
MF8%ZF<G!$TOAF6TYP71JD(/XF\R,0+451&":ED&L&,0-'Q15MQ9K5T+P%2:2
M%JBIR+GD66WFLN; 'B")J\V\VM5VEE:?CIDVX/A\^3$7$-1BJ43QR]XEGM2Z
M%7_JM8#KKXEU398RHG,/0+L)3"2"TP@!@]/XA0- G$*I/J<O2<^%F?-PKEE>
MDFV3'_!,:B)\')]F^9-^Y??<HL$]/X(=+Y%>HJ7@2C1'[I$C97![.C61RK:9
MPPKR@&['^]10:*H:+C=8S_4-[JO!ZUP(Y3W>5TI)^K"0N?L2<OXQ: [%F]@>
M) PAU)5VV1V;9JL0Z,;]85KY\P1)\[D]P#J4>?F<7<Q\P(Q,YZ_/LR''C[[0
ML>@5XJ^P06P:5YP?<2">=0D<Z(OY73]Y,]5LQ/[96&7AF8Q4SB(L>LUY;16#
M)_&2 #W%O^"Z'HT^%KH'D.2.9@/K0.L[2)@IAO:U,Z)IS,1F_MK(NZA[N&;Z
M?DO-XL5&W/.,3Y^[/QO&3"Q,<<=YB4/@CB#E[S#I+,=;B.^DFKX.S"/8_DA0
M.T*>3DE\HH\Z;GGGT8^?4 &8/O_Q>Z,Z*7Z-KI&O#SI[-PSS!CL&DL2YTCSB
MX%&OW22^?0\@8W*5=1DQZ"U-4RF%%C,+-ADVUE>'J#C^"\]OY]QHU: =P7A?
M^_3V;OI.D]&!IV!)[F=DM?"Z(%V)4<LI(?C;30^Q?>:0R0IRS+A*[\C]+DC9
MF4C9*W0A5 12XTM0D)J"S=C2ESA+,X$I]9?7'1*;57YF+MKHV^59>ZS)>Q%9
MZ^MU>HYO1Z-N%W'[<#N(K^.(""HATS2+4TSP0Q[@-175%J-Y$#&'(<W!A:%D
M5[Q%Z:A$#$*1K4(']@QH]\GD)&\%7:'VMZ7)6H3Q-\I\Z][7=%)"462_D W2
M<0\@8*H9Z4I&=5(3"<<H8:E*MI]XL!FO9X,X7:7UX5,J%B<K'0S3F),2:I ,
ML?BQ\0O>5BK!'N". 6D\3&6>4%U/G8_5[0:)\)K'[,G1[1GO+LLA$_DY0I+K
MK H]N/!A[+D^V"^(Y/12QL&@8A*$V(*&C0-?\-+(!AO/4S'_3N#43A=7@IE#
M#YD7CH/OFX/JSFMJ7Z?+;V=7/"Q<NWD9>;]-*>\4R>#] ;/S,[ZRY-M#!5DI
MKYST'[W*A.;9+T9'N*"PY]PKIJ_,4]Z,-JH-NYN" Y::+LJ.3Z]@<!-01!*3
MU6N_8OH??:EVWIICV(U0&S*1)6N"+P^'4JX05Y?6'$?J\ILK+-AE;F\[!\7]
M[U:MF-X^9X$E]S$NTZ36>95Y4)NNW0T^Q@OU5<)]4-(>0 @9($GG-I>N@ 3U
M"+(S3&$;&N.%Q/HG]T,%4>_JDE2O74\;#TMS.M!L> GY ?T83;,5YD-T<]7&
M$:!I-H0Y0C<R49T?L%V^22LAD/DYT<-_;.KJ\LAS/<56S<&E.H6/G^;P!1MA
MD_O:M9E*6+;$[(0W$^,K@#S2=O(W<:GX';0I**$,+<"^:EKH?Z%'"T,6%A;6
M\EC._5.S74\](_WK5VX)N5!S/,_2W5)OV,4EQWJ&^,6KOL[7I74DIS;&^TR0
MEX<+SIU2&$$(C35B"?(.[ +W#/<S2;Z$;M=!FM8TU4;T340KK?3-N[[8AK!]
MJ]Q7-\]@"JJ!+X*JM"H%LKN#$W7]T;FVT$TLHXP90N]?L&-+[I -.[6? D7#
MT F4!>3!E6CMU!8/_X_@I_/4@Y8!0N_#2MV*>L=EIZQ:U,]<JN1_VIR$I2FU
M[PZNG^!%V)JIQ+J &$#6#3[G7F"KTU-?,69UF2&26"WLNTAMBP:?MAW'LU\T
MQ&8]/IQ(^O6%E?G7M8+7B1E/F3$L(][O;Y_5H?-U#[A/=+7)TO'/0M'[M5K+
M/MEH6S6VU(M=C4"JW]&<5RZZXOHW0N?XLO[(0:.!J9)Q!<?4!?&98L%AC[6I
M\)JQUX:V>O/+SU-.4>LK1RL+6D=@KC75A2P>^72(4Y'W4/$%9WCU[ ,F&BXD
MLT.8D&"X1V7' EAJU;@ME]Q1<I8PED$<J_*6C8' 7RQF&#Y_RG__P+&X;>$D
MT%Q%WBQ/.0\\J>?4G*Q]#/<:?6>78"T@;8%*DWY[;LV[SN6SH_^#@\,;<CX%
MZNLPYNE22C7MV)S_>B;=WPU-EHIO<:N,)'3LEB:PI>:1PH'9NVF-9/FKW9*Z
M1(]BS!N!X:9]C]*J6@P6]^LSK])U&1>9K5)LV3W //0PW+#,ADP!]F["?7(Z
M2XXHM25W1B]NY>SHSG2;;1N$%\:\/PX8=1Q7&[?LS]6C?*64I#ZJ(C;#=_'N
M]#RGX'<9;9B*G59.^-1?V"J!#SF7!0:  H43O$68(RPH3R3AE\O9@71N.HS,
MRA<69$<.P4&ED8B+?M+4RBU6A3"E(CQMZ9M5Q4-^LW@WJX++^R=!=U!)LR#.
M<P+, G0;>0P>6<,I,@6P/8>%<#3M7E%F25=/7FE\:?TA(SV,HT-M0_.M8>E7
M3V'*/5,_/A_QAO8B?>R8ITK9HE!&!0?-58 [V(E']O;W1)<F4D#SH!]:7'U/
MB'L:BMP<(*%?&_;A<Z>7::]'7;:'WNUCZ^O-D0>$;W'2]P!^6*;2<N?@-*MK
M#\!+?]]\4 K7D$FAC;OIJ[4X\R5M"TO"#6GLS"N,S8'8<L!X2-?16J67[<KO
M2KW+:9PE3(75E]XAE/I(MF<;(VE\*0*6'R0."EP\D"6.E9VM;,P+__VVBCH\
MCL.3XIGS9&P*D.8,9*IIHY ^J*.\IAO1)3R%92"?+%LR7\-5RRQ+5TT5VYQ%
MWYH94;X]4O=JKCLM8Y?^^.X99"J29@%.)7PJFMW/7. ET BS@HXG\R6':DM"
MSC&I\]A4$YC!.^[IH9[/+*\6!W#_Q3H7805J??O-QDO_-5[4 =U#B]]"=(-H
M[H/$Z4ZP@M9ZR[%"Q+#NP$>V*3WGN;*'/-_-D1/I6I@-5X<WF!:QF2]-TC[^
M?W.O+!> [H)@=DRU')[5G$R>E\>C0BU-C.A]Y$.XRA5CPP13R4A8-R-]+?I7
M=!'7FC3=+Y+.;C";DA/O>A*^5?;HE5R4!L[5Q26BMC9\)'C-:^!V9LF,73+Q
MT2SEE/CP-&YWJE6[X@:[@%,91A);1=+<P4S50\55?64!,KT510$1;2JTF?I2
M>+9D]/;84^N*6YY37<;NGIK%"U^.MGQJN-V6-0^F>0Y.7ITWC$="8,\(DG5[
M "FV57XW",?7VWKA*GTI)P0[H!7_SFW6#@I1GA6HA81##"TRJLU?*!'G;QG*
M14OU#<I%YI!=V9)\W"/%]/T]7 %DHO<)>EIF*72BX&CF39E732<#75+#@@0F
M5B7\<S^\/*YTU 3_];:0^HHV4SNWKQL\"4Y#SK_74^2S1=951NX!3+/&['O&
MNPPR;#.74-=QF11_WS9TW"LI?1,G+Y*FQ6GOE8HR]NS&Q/B,%AS+$[TKG 13
M&6X[\A/R*0((EZ?W]=C$6-'->SC"W:Y-B6EPGX^!T:N#,1K'^@_BV(9G!R3*
M9L.)U( ?\%SX/<Z_2SCZG!I3-;@,YS7A+FDJ<<X4@WS'OL,I,P'.8:1NT&,K
M^RA$VQR)5Y([]?2O'8LLK]6ZUR_?3MW("/$J9<N9I[-4X*>)9AY]LQ("?>7[
MY-]W+F_DR!U:AR[8,=7!"2VN- YH[A6Z_O /JCXL 7DPE' (* >^O']0(5WY
MQZ5QE?F;8K.1Z9_#>P_<*\"]<2_[]'-C,^=",*F?OY>!]PJ=)3)DETJWXP\&
M7'=8'&KSAO053)!L#)M<M[TI9<B.5JYL_GPW6E23 "$0]Q$"(2WZ?,\5)ZI,
MH&4H?G,RZ1.&-$6RD+H:F-PY!)O^9(T_[:J_"^750#V:@<-Q<ON>$NYSA&^.
MF)Z&@^BG=A+T-&$NA*?VHW#H'$LU= 1^-2HLN/P)-.LP /E&9:9[$_K[-0A*
MFNJDSLN!9($+H"XJ\[HO[17B9/8"5TQ=ZL3W7,Z'4)?+BO>:SF75!3P7EBO"
MWI_X3J+9HJ>IWCQ?^"023!;NED8<\H*?84;,"TNLFHK1)IY3P[;'A%.#]?XN
M7F^KJ1$M](!L=LC\O&YP2Y[UR.;16)8YW8KK6>_N89/-M?[RMF[!TJUW=\HC
MMXVX2_#. Q9._FV[$Q^F]+3YSLWS(,_M[9*O^^I'4:KAZ>4ELNFH]>:6%&'/
M$(K%NW=K+=6+';]0-NA.OAT>*[Q9YDC92Z\5!Y)*<B,\:8C=K1Q2&"\XOW$C
MF[6L-TAL-_<186XF_LX<;-K^QK-@3BD\D%_H^!Z #"N/4]AH!YA^('QH;E[C
ME_BC?X$E:*SR]\ $_@&Q3\V^<[JELGP#E.IZZM+@_B1N&&AN)INOG51?*+J$
M[+T9.7;MTI:JRUC-'B#1!.%'\-P#W$=/_C'GU,#EY[4/K0'%3$)HP\)\:X9Y
MWV10<3CKMY(;[)EV12CT"V73+][X@\&AA72/L4"'^H]@%Y+ORH@MR^-]_Q5N
M;[%U#!VQD=S$9M2.[K9->_P(XW]67S>Q9=U?*?9R>C4\X_OEXX(" 8O%084?
MG@XN@[\A*7P?X7Z\A2E"=IBS_5G2D5<7)'&T4D8@4VK^#W)!=-YHHU)?^[CI
M$G<$ETV>+'I1T:-S=NK[\/-"5(("^@.XELH6 _'4#<#5XBTM#D4Y1L?V["C(
MY'D\AX/(8,E5J=WK(Y\4^?/5G)3Z"N(:^I;!^:!:9!H<R!+G60(H"")\E!TZ
M/M$1K=TGJ&)IPK<@Z*=TY_VJ>U6U<HZ]N^ 5KT^7#]QIP;^I'\L\.@.ULCJ;
M_$KFXRGYD]D;7XD>'D$EJ[V1B8Z<G#PM=-VKV(J(J8;9@=^56*QU?3]8YA^G
M$60)=X+,Y_MZ!YDJR&Y2"D$$;E\<63_$CJ%1R<*IRZ.\!J\X)!DP^S?#>N7>
MD_,EJ('4NP%9KW1^E<UXK_'DX3P'BS -'&3I</N\#TQL$::H9!!%MF1%!M^+
ME PDXNIS'])&+#?O&L=GHS%6=/?V&C_[!],YWZ_6G!.";@DS-GC1S8(+<UX@
MCJ'D,!OQ]*=DE58DM(1MRG2<MQ/Q&*A@-MLW99S_\25JW\L51DI:B3K^JES-
MN=YWF>#'))I+*S^/4Z7:#+A=(!R(XDN;Z&T38@K2,SN:A.+H?)V[IH4/#Q7/
M\7_LQ&>5K85_+IFJ'+?9M/KZX;JBG//'@8;R]*P/K5./*EI][FVYKF%#G_>4
M.3@KB%GBC2&E*@NRF+"(>DP8;,1Q)6:0>;)T'5H<,('0HJ'9XH[=]>@Z#8-C
MI*G(F@7&XZ'\SN&UH6Y_-UGSH(=TOTWLSX//^8*_ZX*MD!V:2)ZD*/R[::O&
MGZ))2U[@2SY!)_1H3TTR)]H'%LZ:1!B:ZO[0U,,X7(@-G>EA?9R_%J^$S[(4
M/K:_L3;]USEDQW'D7*)J>P;;!D4V?$YJ)TP)8DH^(4R^T_F=$K\'M'1>U6S?
M#W7/$FQ95])?)=%LA!.!G\PR::J,2CIU_=0'N,,(6R\/]H)]@NP50U8IC"DC
MKNUD$U7>O8B81^$>:VV1>7:E[Y?R1XTZ5<G6'>=B6%(&ROG#CL,FKF@D?&E]
M. ]S&;&A\PI<YU1N50C[NE-/4-TA\:AU#M6"[% C!(D=.0"_QIS^SJ>Z+E/%
M'Y,Y&C>-N\O+WXL(9?8UICE/,X!,S,)@O"0^,_+/#3JJ1WFX9,0I?T!GX(+R
M[F*]!&.@]#TT?J$\?% 62#,GF[/%\AG#5/1S@DR47%CU6'-(&BDU DVS0*<@
M#C/Y>%\7/F%Z!FY%X_!4"KY_GL1#/5&[I#H;0\N@1S&M"M 1^?E\FTONY &E
M"U6/CFK<SI8^],+*H'(#*_-ID5568<K"3;][5U1^TQ*RKK*]7=!DFD/X6_@'
MQ3C!2>49QNGI=AF^U#9CQ"Q(6I53&G:^JJK%_(YJ]Q1;PK\$ZC8CQR_(6<3A
MV$\<W,B/*PR.EOOS"/DJF&:[!YB26NA;1T$6"/S,$4;.,"$ ^<0=-]G*]/.%
MME[M41!+TO%)ZEWSRK ,TN<':=\.BYM)*0Q_F,2FPYBJ,+;H'\8>X(<>DF@]
M[YH\Q_2*(D>BG:SM^"-[3%1A[\ G:_5JF7>-CK$,EE2"J$LZ8@]'WD09LL5D
M>PCBIA*\<%]!0H"3K$[D\>T] %&) :5I/0[>0A\G>5E_A!C[E?B&B:PT)>MV
M'<'9,]S>ITY:GM3+3[M<GAEBHW;AM'I/SZG88XLU7KC:B*&_Z5:6YT.NFP8/
MS!#"ON BAJ>5FVYQBQ.$[MUIO!$WHQ,N<5YV\-'9C*B%R8EY,(7 4N*.$.H-
M*38^\Z@DI)0VP9\Z>>S*#\D[Y4QD;SCB^!@<3,YYEJM9DF>='"6B,=WRQ/=P
M8?:<'R$<,^9.EGX1YG([ Q!Y71.OA)H]+8=_-X!4(1R_OT[@F<,SJ![@U 3C
M(W.&C'H&.H10"#C;-3?XGWMD ?CP2H%JP>'G3QVK<W-/0*B66I/WO\;2U M>
M^?TBG?-LPO='!!G4;ZQ]B' 9@8:-/WQV[&&07MT2-,;#]1<EIBJU6:EO#Q"$
MFMS/4.'$<Z4""5($/^KT,ED!39^^@C>>>*8G.Y@,64 Q+3<J@]]K%[H35XAO
M.V_-_&R;DUDU=&C>Y#O..<=YSSW'[%J L45TP<SFA?P7P-Z"D\SK1=YKN_'Q
MW8P(0RF7Z)3PI06*P:# VL.35W,+5&V^>:1!YP:G_S#L>-IGB>P (7T'DPT(
M0@1R"Y-.OVKQ/\1=^S_37_Q?I50JY7Y?0DBHW)++*A\DL53(==U<9B&Y,UNE
MDGL(Y;;*_;K"R&US%T*N8V(;(9>QA7FSB^_Z_@/?'[\_[(<]'MO>9\_S>CU?
MS^?[O,YY7^)_024BO;@0(M*HW/HA9)+YY3SY<^LGF0_;H+KO^[!#TZ>"(73O
M03>5?N,C3G]_2$KL@A"5W\LXDL][PU97M+I<TJOB)Y_:*I0ZET]@*]\%;*NG
MC!$O?N9LI(ZX\:LK*9?/5'LWC4Y:X8OS'[;O@NYC 46S8M9C5 ]8@*O '8=4
MIW>I:F=;7JV!'&9+4V#B9,\:*?X7UM1\I9$"/Z-?'Z.F7:;ZK1=$I_^9^K/&
MVMPV MU6\ V8#O6^/1/4P-"D3 VT#<^B!;'1FJLZTGT7VB<XI:9OK((5*S3N
MU4(WNM9U>Y758)4P^@U[GC/B8W'>*;2X)5(U7C;7M8FY8T(2$VS-KV#2RU'W
M#6B[H,BW["M;^RQ8>G"+%PWOU@85_VOS6\^>Z$*9WI<T#C5EZ]I-..!M<VL2
M[7.74NIULG4D;KV[\RX/HX7?LE_^/%F [?.>)<O) _&\<@7[WW)SA9.T 8US
MU00"61JH ;RT5D@N]WCI<K:&KY374<V=,%Q?@ZEB6'EV:Q.N<4 E[JI63:,>
M]S"<-]2B,<@#\'CFK""/<MQYTES<T(*>QNWI(<[ZMF&BY4Y]8T@M97@YKWUI
M&)J&*Y^O=\5O!YUX>7%!=(U0.1!KJ,\ZPL/LX2[("_(:)A78(,@//)PM>$\B
M\#RB%(+Z6#L"=F?$+9GBV%;4;R?Q^<WWDTE5B7H@"G&,0'?&D+8HF.?H>X18
MF, *VX.Z)H8T!:H*NCX#EFVN,B/WQS0DG+[5?QOUS9AZ4_75"9VA_UO:I7_T
MMW^>\IF0C',%Q*IT92V_6().Q>3&!FT\72KP'"[?;C7?X.]$]:QWLHMO04U0
M_79$+>]O$B9W04?X69KU*B"D!AT0& #7IR0TF5W:X>BS]#K5,/PAC0G. ,)9
MI7S+4E;WCTQBUW.8!+I%<P_/8FVMX \=05/M 62:["%5U8L[P@E-I2N[($DA
M0_%9H6-C<A)$W9H+=W9!'LY_^;$%:AEA,W/*]2F6N!1'IQU6PKA^A*F:P[?R
M+4?-3K(_))8,G+9GBXI!QM&MF&KE9XDKJ0SB[$Y(["PV-I Q WT5AB1FZ*;=
MMAU1GX2..!H8?-04$/J3F1KC_T*-2/#! NK!\1!/\HL=0G,3F&D+=+,NA$!F
M'N_X/)^%Q(#%V$9%%@^IG,.(?*GXZ1R&PV5\2 U<H-V:\^QY?!?DWU8:/.HB
M/?&U\2'NB%C&0@Q;[^.4!<LBI()RI=QU? +J?P(_<B7U8?W^WPMQB>F%?DD[
ML:Q -H*3LD&>")[I&.C<!4D@-1@:SY"B,]>T731M,!8C%7,,69YU]"TP3G2/
M[$O>48L6LOK)'O2V5XZ3*U0YDYR2M]"'(-WR1EXB=2L'^@)ZYGSR2M?UBK^O
M;L)=F/9D;YWPQ8ELS15Y"B$2<XCP2#/26 PPFLW6ZL <.XO4>O@TYP++^=S$
M$JG\]^$MXM/M9&'$V2IA;K1:Z,_9Q\^D=EH,KU#K)!6@0D#$W%-0O Y"SS_E
M>?79O*^&]R]W#RRP9] M8+0'1(C[$T:_7GZ;"DY 6LT*[@DQX'&%*/)*.6#@
M,H35J%X3<8+[+9WVQ/>&<_%&NO.G#%_9S*U(N&K!K$+,N0=3*;Z'@)2V::5(
M9@[GH\XAMEX):>GM. R8O15N0$5<^'&R+G[DT$Q$@Z,NJ^<)XE!G%EZYNZ2F
M;V(7E%835JKNTE^OE<PRW/$MH2V,TP< -<$NWSB>U.-Q'62BBWNH@P5A7V\$
M'A%$9KE30,H,YVA^K U+(C!AMFTKV90U5I7<&]AN?%O>X</=Y/VAM5T0X.3H
M6@LTZE)A!WI\8)8G>)K,F3GT]8FEM#2N,J./-AV-7?HZ@_A#4_?X%E)N9V$F
M+Z3PD4\XLL.?4$MD^JZD\NCC'><M!(X%3[DXLL%$MI''YR6N1LZ8>>7/S:@$
MV5,"!IEQH0@MC<FZWP\.R\,%KZIMH9FO.+4$#\C$&J4K&J6'( @WBL\<5;#X
M63C"UL_WY)ZL:APQA!<955D5PG75CL0!#>F/;SFKG#K:_JV'IF?W\Z6^5)6E
MZYU?U=9K5CK!4SYKG]VU%\3UBX?#=,M_;%0MEFS@2PM6V%\XQ;L@7TU2+A/-
M(S@$6W?$^!1@K?F*@".WQYOU4D4&$>),XNW%/X^L+LQVM7*/UPQ.]31@3WUX
M=U:Q]GUH'Y)#60,4/'BY)=Y*$FS7) ER#ZO/0$^P(XC5F;+HFXQCKQAK9D,!
M+I"[(V4S]<>S57'?M_)31\IEV]T>;.<J>QYH=.(>=F&8=\'H-S& ,IHG#B<U
M.R![#6_3,:VNXD#ZZ0]8MJ&WQ::1ZUI+L-ZR#%?)\ON#^,^5R40]L2WY<[')
MA_K"%YHQ@*(]^P3_+*$5?(AM3R<FL&&G/Y3^D8I8K=8TUG,FN?ZISW4T/UV(
M0+O).VB3SU!^V$H_W;XGZB[+GR_1K6]F;<7Z<MM[RB@@:()&O&J;;]NA8N$4
MEO+N5 U!K=Z[E.:3OAHFSA:.Y4U_._0UA.=5O;" <G [-BX#UH410$+HX&BD
M)?WAS$NILDN;8Z4%W?E39@$0FJ6#>XP3PL#9N.ULXD*QP1?_6^B6QJQQ%+&(
M? X6*U6UU^^=^TC!W)-+&TN78G)9!]@'>--@'Z+&C %V07G<]C2R*-N4H4Q9
M:\.(.@"Q75*UT6N-5^B+LYD6#;4AVDU7;5D:^:?JSCCJ49_/5/!^NU 74G,
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MJTEX27?+4KB=;N#M 9WM7CH_\P.CD'U">(;8-3!AR7R#L6- 6IR:>!(_DF6
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MRSWXB:[%[ ;4Z0AJ!AL.O&*0EMLS4+6?P >!]9N,X*A&=?2CE3$B2J7QE:,
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MV&I^EA&4V0WZ]L5;UOLVZ-NOXN]KTY?E]_R:<A2S?QWH#R+VK'RF^L0O;*Q
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M:(^,ZITHEQW4;%A-"?D%OL]?&4+T#D72\Y;[.^'4J^@-*S(,;QO'E#-]'U:
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M61"3/9@F#>UG*J&H66125]XAMF?AOU\;0OW%2A.K%"[XQ5M-(7;G]%QI?/@
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M$HX LR5[2M2[-!EJ*WX_1?=275G^=/^Y*+H1@5U)T<G::UL-<P)A>^!R[AH
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M_FO:R]YSFQ&4"9HY1:%<2@895)<-J=O;:7'XTRSTL2@K56=\LEUA> 6%G5K
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M)];P\:LDQB+C ^I%$3=N=8,=C\:L&T5&@8C8,\[3"!WM@?I^&/X<S"AM,5)
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M"EL$IW^-&P[[(+_U=3:89)&WN WWU&;MX_Y'/ =T\H1'V0\Y1LS--KS8(N5
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M.'[HX3#=]?Y>OBUQ*PWUTM;43&)I>SD4 7@:W7G;_+SDI];/4OOR'O>LDJJ
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MK@DHD#H12Q5L5S],!8)SQ-49P$X#$L"F$\ ?1!BX:?)Z-=C4;]VYM[30YL?
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M&=$REE&++]"U+LB]W5"==@=Z?W?;[1ZK+O6M4&[</_&J,^!($&:^<#^3IC^
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M('1AN&M0LWOM0TVN"7U_]TL@\<9K]/@/!YC1XE!%\9*1QZ6%_8V(!%\-86I
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M(S#PC4U:5<YX5;XM,7?8*%)BPF:MPKJCY7*PE9^M7VW5%G-F,P1]>0]$,[\
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MH/AOCW&M'D+;&)R:9JM6A7::>:F==\AV:,B?UV]S!XT]72^I)K\E;N+CP)*
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MUX>YIM@'#RJ_G+ZN\2?J]96OX/J[Y8..>;KN;OCE#%O?>/C2MFOQ+9A-D/N
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MVLE1<?7C?6V=4L+L=AUSI(<6\5@ HP[X0G)"BF+(0.K>YFB%6/_2!U:.,*7
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M61Z]!N.C1I&S*8)CY?HBGE74B%;$V0:G?T.1K88@>4JZN:(#BK8[-MA$368
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M].<&0+Z&;#$U;')E>=*S#EQ<6_)L>YC)Q; RVWG5KBT#EO?#N:@3I[[0*3
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M@?HVYTR#3SE(M<[::M>&,*.8TTB2K8LD!4S-))7,"VV,LC(]-W,0)$X/)#"
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MF;> OO\*J&YY9V4%IWU/HX;H7IO7<+6]*^O3E;TWCNU$A9 0/?\Q1GN+OPV
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M;L[-.V;VAHAO_?$'ZA7= H\7I;XN\D_ERD\QK].]J0XD>?-!?T0<7'E(E[^
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M4(OKY/E&%\P30QCS+N>=\1XN 4^W$XE#"7%B#*$?@$2F ^>#&MF<@7VFF.@
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M,_[&\FR+UX20C&7EWYJ#>SIZH9_1'9ZH\\@;#*DN35Y^V=$1\9N00S[H>BU
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MV7\&_%=G#FK&\&E[]Z?I4'T0E&@D1A#((BU_=,;B8C/FDA:??+6\68%,Q^N
MM195<1@/EX81SBE>M8O2R1SF"J"ZF^\0*ZL:LAG$KBR!B@55\5I*XO7AMQ;D
M_-Q9;:L7ISQ>9(8\G.B#_36@>LH+T@62;VJR3^P\-)>.>B/D'2=V0'&/C>RA
MB$A('AI0[>L220RFT*W XW]Z"I0'ZPGB0.V,1N,,10)IW?BIL6 79'] L>:!
M4J(XXL2)AP+:6MSYZVZ*$IM\S_$S/%[QZ0N@^ XL""S:$'%:'3.Y1MI6 +3D
MKW[,=)MFDNLPEW XGI7YV'G%^'K0U;<!*:,_Y@-^%N?AYY8_KA;]GMK6?97[
M%_.FIN*K2VD+8LJ&6+0E,=0R!?<-^8OD)<]^OF?\*'UTAP7[=98D.AESI%&K
M3]8#NI%_=XXIT@HU9"S"C/Y=XXIV37V&KL,LV[+<@;A93/0C9 154R"4W'TN
M-*13NO:;3J*(F$7E5&)RV/+#DRH(]WI7OU-I,CXO)Z/J6)YLF:\!912D&0>W
M:8GZ6I=Z!$CLDR;$7U _: _V'GK/.)#RKBPR=OGB.0)?SFVWQTDUAXZ<3]B
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M0$D?.0,IB4'2Z+<MI*))SUP\YIBW.52_B_E<D]L(N$$_</R:*+O%E6\T-%M
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MII1<*;17-"8#T*BU__VN)L! (WN<ZSI9($)B?NKJYC>LF+W:(?C;F<R*1)&
M!%!VK-K_#[JX/SP!,NPR^SI3A;C22%GI:(XO_LUF^2IM' $?C5<,H\)5$2:X
M@"_ Z(%ZC\\T=_ZINN\[Q@S\*XJ.]OQ:I^.:5GL$_Z. :?"YD<KM/^:?U!7=
M,MLRE!G713N,IRCBHQL))9AQ^S^E#OY%CJNDUP7]$PVSOPI-[=^4@-\@,YEF
M!,CY<"^$@F"!#OQA%O.7:/.[QXQ V8I>?3Z)(0+IYA?:PZ&^- 5_[.2V BE,
MIR0-YX@=R,C:$0N]ND*:E30\E/2OA^<W/OHR^8=TD_2YF&OM[5YYXK>"STP\
M\D_TS?X&0#UH9=/,4Z](J.EY&),%FG\I!,]3DF;&N-XL\MRS7W?D.8,%ZJET
MTSH"TTOHP"1>@$E=N22C^'#\U!:?ZOLBE5I[%]CP*3+:;O6I2UX$>!3)>7B&
M8!$J']+':).Q]>1-'7<<GVF=BQ%/+![*>(_'/!"JTSXE[418^7=%IQ^EYB$L
M=PV_J?JIC\X"&<;!)5H-\?U4!_9*5%[8Q#C7I& ?A(MJ/3N +4?=V6Z_>R@&
MO8 M$SPAJ'2N=?'M/L6CM[/[U&/N[-B/>2\ZDH)P0):EJT%8(*TPFAFRWQC@
ML0K")+8<NK2^$TDH0XY*6\M:X[BH#F,T))30[7,C"-'AUSB!+ZF:P=K,5#$%
MS9XAFX80[4CJN8^S\TMA.@943^M;P'*/:0 (^HUMF$>649I>!R-W/8X-LA!)
M0O?&TO4E3FSM/6OD9>JRZ"O6A*E[OG2)!>),_P 9G8$X0N@'G9"58;^W"L39
ME(G0G0IC@?;+VADPX573+!!$=!$<!::,E; QPX07@,!]EUI%7VETG!\%S]T
MYZ*8/(J00>B+.<-)!Q:HL0;^@04:\H_N%FI T6EA@ROK0:0@_6V^[ PAK4F
M*.[HA5&;?MP.WG@TJ;.-!4*%TYZS0-5+LOGJ\9"E17 5G1[=C;B +'LYQ[6L
M%M;9R )MB@5/)S$%37]U"PL4@D W:>6EK^Y6BP5ZS/5W[/[EZNZ!G0V=[&@!
M=N)*1P+CJN%[]*.88RQ04C7C%0M$>?%FY6TW/YA#&(-S^YGC9V>@'I"E;0L
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MI8H@XT!NF?V+ERPRN&]=N:JI>8._@<?F;(=-T\8)=R+.\;V_PG1L?U@PW7,
M>;>79SHA;("+CWI &5Q1:/W84W!P5/:Z@B N:9@%JLH967<#UN!SN,"V@U&N
MQ'/4=VKRY0Q4FH:?5=<(<KF0V5=TE@5*=QK*'Y2IHV_NTAC,4*?<'IF249+K
M"]#:9(JU>CN2P*YOCQ9?M,8/&1N>W]GD@-^%SX#T;=0$"0Q&A+II#+)]B&+N
M.,XO,,A],:H3[Q]6%/Q,[+DL*7@G*:%MOZ]_0-")C[/>:W:?N)/RN&NS4$7O
MC,JH\+GU3PL/AO1(OO=G!RQ!ES-LRCMERXB[[#7D"RG.@_:X [''"T,7JG1;
MMTU&U4\EJFX=$M.P+5!]$NJ0)&1'T+.^.=8AZEF"SYBG-QHDQKSBL%3LTRZ;
M["KFC/-2KY[4?X&KP\XO_JE'L4.K_Y$_QQ_" NU[R+4\AE_>_NIW/GN!>L>$
MQLB@IB58H%#(LI%&9&*0Y+O5Q]U)]TK!E*J9XYK<1N(KCVYG@<SEAV=X2=\_
M_[;82(?D3RN !V5/,Z\=O'#HZO_C[$H<F?[__SJ%(G?.5:YR5H1<2T*2A'*S
M"CD6J]S,%N4.H2A"Y:K$"K-R;+E#$F*9[%+D&.^1>6>'[SZ_/^'W![S?>SW?
MS\?S<;S?>[_>Z2JI9X7^>(@EMB<V.CL_"_@+D;0WV79:/0/6"=E9N'0BP3W
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M*(5S.I1RL!6P7C2B2$UPH8RLU)96H+((^:OK=4?,T;BJX!]'LJL>/UZ5MU]
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M+N\Q!*\UXD1D[ 8CPF^HYE2Z7B:5%>O&)Y(3E])\"0V<PK)BHN;BGT0KCI?
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MY$UN'1^39%*)M;?'#1MB ZLSAY=]G1YA@JD/T+M!@>3M:@=#6#4,&TZ(BKB
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M!+DR-7!JNX^U?CH\]%RM6H"R(\%^VRZ/!!5QE+LR9Y?W))XKF\!>S730EE)
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MQ_X@WRW&VJWALA!BBY??%9X"XH3+4FFI4LQ*0'$;CXL@EV^$N7^^?]%0KG=
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MA;H1%]\AJ_9'ZPIXU6.>?94RR,%9K+$D23!>ENX0] I-Y$6-"/]B>L^?J;M
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MP#BMX5:"=)156VX')Q[5?*D36^P3ND$6Z#'257P=P. []KSH.,5^@VO>!R&
MSPPB&2L; D^#B 9HA)3),#QI=PF\>/&EFI]#I;KUH45A?E&N E;/-PH_QWL>
MS.(](&>^^.\/G#MHDOQ!>N [IA&Z#_,-_(RC0&29TO[TO2I A0QYY5L?:[WI
MFRYG1%FL7EP2M)*U/VJ@-;O,@\?","W<#GI$$L8%&' :UZT?L?112=UZW8.3
M0EW);<EV@@)65<4>M7CQ;7[>UQ7]O]O>WFM3QN730GT*/_C\S:@8>5Y<9YOB
MI/UNE4C<M";U$TJ:TNIT$1IG^:Y=&/7?#YZ\.2D\L3G+J:) JM(>HTSI3@PX
M0*?UMSY0&DM != V' <>6=EGW3_JTG\X_5CO/5L3_^/GO@O^MX6+,H@Y_X(G
M[(TX<US.<NVOA*'[S=D/JM%W.I,E^ \MIZ_7U.BQA(*+':_"FO9 /;,A5T]_
MS$[T,6(0_'91U=!79$!)I3WMF3ZB+07.X2NCMS%N ._>^>06YB14^JTEY8YF
MAB,H-P*/XRL3S1W>WEE]>DO_KLEYHS%B0_C).NACK.@>R+\?4.09:X<\-E)C
MYZ 03 N60$[';DV"D=P25Y&-.I4YE(98)2BF^A7?2[R% &>=2'BTS9Y5"H(9
M[H%NKD^Y?$_,F+@PTI5-4$OZ0KM-N\ 4;LL?_AXX__A\BU:I?_O9SE$UX0?&
M?2)I]%W;[I*,B*!=W3_D7]T7'^7F,T;*=*I><[!+7JQV9&(/HY5K$ 16(*"E
MDH3G72)40)?K:#GM-L@BFR_T]O,FN*4:N^"DIT.KZG]2]1#N>=^JASZ1 F)J
MC_CM>@Z5J5<V" AI=/ [^(A?R'5^_^5/0.D))V3\M#2XLW*^ONX-5M_MS+L#
M<Y<MU"ZN/SL@8_!E$<-?EGK8/_)YD-Y"AD&^UMK5TKIBQ:HJ7-E:5 3:<5N[
M4+10F0M3CW8PSMI00RBEU$66#DZ"<NFJ4C>^4?6M+^?46 A$^'=9W).WOZV+
MEZ23WZ\I&ZC*>/BLRMEG?"WVE]W$Y31:,261,8PR;M=,46# 0"ZOZRDWOL*F
MN^)TUO@^-GFH9Q<7 CFF&ZN9)G4U+_DJQ]<*! Z6G9*_HQ>HRAA01!98VB0'
M70DJO^B^^O#OPUWIX)_NS_%!@S$GVE!]#XRV82\9FTN]M\]4%FNN[8X[1)'+
M:LYG2=@,YT8$G2J+F(QBXC:@;R"Q6-IM+,F*0HY!&3"AJ&O<UJ!1M^B8CGX^
M'[LI_D$48OJW"OS@#V7LT06&_7;.?Y-OTT6?J&WS,(P$Y%4%.'RO*6#B!TON
M:_GH 8((P1?&LU0?EMCH0V,83%HY.Y^?!;0+6?F!V/<^CFO9:HA5]<KQF\0Y
M@] ).0>+7LPU$YM&D=+__DR=E'B$!(%W/>\D?PO%8/I>;I]_<4<W_/EQ)1':
M4>7[#HU5K!VQJS5G2KIQ:^6COG2V1-^LH=J;8ETE[S;;\8*JE2B7M=N8"V0Q
MM!QG!$JSAI*\J/TKUC1>RD^R'!J$BDS01(53]D!@IX+ZU2Q4>871Z_?CDA[9
MXF9"6BYG5IY7M\3D8KLPM)M04A>C:[",(\35-E\Q'>!Q<@?^Q+ _91BOA++\
M(EZ=JYPY%]"0WQ>9I&ASTBP,5*0BY[=K&.UPW#U#.=U")D<][EER-$@/W'_1
M4,1.B=!0F^8_=NP[[+B6OW/7V@/>[_A$8:CTI0:.+; '@H]-%HVP_FQ#8B$T
M.UPL1!S^;S@Q\4'F5%PR^=@CK P@#1>U?KN@JS]5]<GWR*4B1N&&@X.9QX7L
M#=65G'NV:6^H! >"1X_!BBK%O$5&R*5[YNJP?Z/<M'>(C.JF7V2>$;*T-*PC
M6/"Q89#RJ+U9B]E!D>>FD7>U+ /[%6]J!VD=G'J,N&&/?9VQ\#N3M6MZ(EPR
MP>+^.IJ5)51W]MR7/5"DWN;L8$AX%G&<V(.Q:4V\.;6]R($/.OMCH'N@+^ G
M^./(, X_FQD)C+G0-),JP;Q+$:QC?]$J(]I6O= VXB#[_7ZX^8A*LA-<8R![
M79+>[P8_R^*A%W5I_N;E\.LQS9T +,,1R*-#6Z&5Y Z/^D&6&X4D4+<)%ES(
M+9QY'>!UJRF.]PDU3FONKC+-K?]GA/V6N2*7?EH4<N+4#MO2G\I]:^K?3KW.
M8\4@5:90G.+N_#ZU(_8 (ONXEAD/['2HN/1,C_DMLB\LA7;(&CJ;*Z^,!/AM
M;S55#:X%.+!6.;]<#@*QQ5Q6](5Z8B$^G/WT%'+TRF9)> A$?/RO?07@9Q7N
M&KJNH^ZJ<.'+S]?1C8&4Z,.[$2HK>90T65\RS0'Q&]>IKQMC>.LSH&M*$]NJ
M;J!.JEYIK*/-)05YAEKHJ#LJ^CE9RD0?M3O(L656YVBI">W_WBKEUG;YX9^=
M5SL?%9/C#9\?TO]5<ZS@6I+JF9^6#T >:J#I3-G36]];=%R&<FWV0+C -69_
MEE./;=$M'?-LK<5)BZI"DF5Y?LXH49*XFN!*+1-H=Y$8;H5]!(K,\;^J[-+-
MC+H^.;U4N9E\]J_-LZY!0K+F>#_#'2BF@H%3647+YV8T=:\#QC0K*KJ"GM=H
M^+JP:OC1OD\]G[P_N]JNSS"O'+JP+^Z0ZNY]=CV4RU)$!88+;>P)5PY T3VY
M72N7HJ@&DU=[VG/M8H.U=:>$U]T@X_5IX],>NK]@FKOMP;$'/O*@YKD1O9[]
M"JT)V-\ VI@.G.%<5R[8>$.(O$[ZL1_30Z="WU' ?.WM#DC43V:>J!,A^U?@
M/GX*_V!*4U*#U=20'^<2]*=M<8VC>-,+>ZNUGJA0?%H?$X+[3S7R=ESK^$&[
M[.[L[&Q*S*S#Y8.A \52 M7:IHS.BSA]H(W29$*%MF(2,.#*DI8B7XX&#?-,
M6^A?N;HC]2/:/4D&-P;W7SB=?45XG.)5)/;W3O/Q4VVLP@1E6&-0>[Y91)I;
M8@3HT."!UB(U)[;KMDM=RT+N[/7UD>41DDO:4$WZB))W056]%<V)L5['PJ([
MX57@%1EN=S_3P,\('MAGT"_0=FS2=BXB16?2'@;$TM;,_5Y;>R "B=Z]<P5J
M\[I\T89I4ZP"; 0=09+XEZ_!?,6&/L\(8A>A,$QUY'PS@0<MCYRQ'&*I3 LI
MF->/LIP*VZ)0WR:G_':=8^LG=IQ(&**[K<6-(Y.J3)WX&TU/KMGT+4DJM:-$
M3^>#OAMX= 7")+<^"I"RPG)6CDH=;@ZY46H5]'D"M<@K"+M&"?(KM/?#!:85
ML<[U;,'7,/"P8A8%T^+6*$0'=Y&EH*[J?BT8,,J'NB2@;MXBD=O4%SN]M&(&
M ;=Z#<Z_9CK>4?#XZA>BIIQZ7_I2LLQS8\YCCH*)(ED %>YU4,OY[@1*<UC]
M;57U+?7A;:'IX03_0:6>5U?>OF\W"IJ1W2Q?T?",=>I.SWIY3%GFC.5B=\&]
MNO[ R$>?1)]_O^^O-VOTJRFBHL:3L;;0ZW6Z;GTI1&[7IR@2L2T]]/YMP6N"
M+@N\])4UB6DYA_' B*#LV,E0?_ 3C"A+A@K>;TT7Z,@_F=3V#>@R:1B2GMJ-
M_!B@ZE@9O: 0&5MS3\[%</[!I9(,X #3Y]]NU'7XP3N<'P0IS'U< D3N+1 >
M'O41>: +*CQ=6U<]HAVN(>FSL1CVQ5@Q2.J(Z:G_@@^Z=TXD<O*FJ [?S]>\
M% VXI<S'@YRR)WU.HS**79L:GH2V!-%GU H>C\N-'82H/^L[K/=N+'0DW"=T
M:ZAHZZ]F25<DH0[MM5Y&6X.Q*SGJF)8[4,]^H@HC'K"D0@608>VY/%OST8]*
MK,_/,2T!#.752=6 C\C,.]%*E4,A&*B04MD/AP=6]Q(YG\9S4*7C'H>NR3?%
M#>4_96YW7 HLE[N"4 B'9<R@P7EO=LH)70V%]C+?#5[*7[]\XUV#N^:U,/DW
MH[:*?\0B_XYA;;]MU&P-3EL;VU7G1#B5)]F2/X="^0@4RE^E6G8R2_6@\/WZ
M'"KA:7;?90OO5>FE;4&P+>*BF=:PX%QCVO3\OWKG1'8N6A:0H,QW0G_;4[TZ
MTA(B,$^UG[&TZ.!F,R<RWV+$[5U_WK8P_1?9C#7(:IEU<5W*2UUAF::H?VDL
M"( #'4K= RU74,C"J%,TW@3.22"11)V/J1+(@[3F1OKJQU;G^*'20J*TSW3;
MC1Z4*7R.?>$^MH1][#[\J#\>*EQ)2G_H$>Y*@?#^GG(\_T2];+(\UD.H-Z_U
MN44V7_J@K6')Z:L++S(^P @!VMMN>#;Y9ZOH'[5KD\3K&0T1JDUA+MB0_BX<
MH%2S3*"/0I((4H3 -"+6]"NMI@.>FO.?ND#S][<_IJ,.7U>N:;)K9BJN_W>4
M;\5"N-;SDE\<%W=LD1)=1N+L*BX'%CH2$@V/4;&"WGA%X(G;P^D\.'Q \U&9
M9ON1J-J<AH' 59O[PP'-/WR.JUW8Y6=3L_*]M*Y/N3\5M)#P.84DNLFJO6*N
M+/0'PW+# V\JY;W*ULQ05#FI>)<2D75IH[DTJBB]X,'ZC;CJP#!RA6/3L3U0
M_%> ZS1X[K$3\:HLWTPNUZP8,'5_VC.>L%^'&!?_U=>W4(AO=[2I=2JIB;M5
MY[BJ#1:T 3G$/%"=C^4VO9,SIF(.CX_A\(W32S@2-D-FJ7A-<7L_RD"Y#*PB
M[^[=J-<_1-A?V)\R)O*M,5?XG:\^_WUF_'(1_TN01]1%5O^2%_,J[<J 3 +K
MN3%(;#)S\A;BHN*?*+W-#\1P#/R!6>SG8<PD^0,I< \$M=;GG.=&5T7"?7+B
M'NA %2&14!6V<EH/EH:MO%XA_@'W=PI9%V\RF+WL[-2C^!GDM/[D?K;AH7UF
MIF@TI\_("/C#/,!]WXS@(Z3: ?FVW0%.<!%G%QN=-==(F"'P+XPAILD"WL2\
MY2<A33<Y%Z4GWZ=JX;V3#D@:8F&+%A5ZGNE)V1!]'O[463>,[*$#&6V;O==S
M<IXW_^I2U78/N"/5^9->F[VH12(6V_X9C]H#C6T5=2O$W4VX!-$:9.SL:"Y@
M>\F=X#AXE3WKF!NC#7C"M.7TP04#C0Q0^P&R+P(51ENZ4BD1L1I;K/6UCGFI
M)DLMY=-=B8V3=9</^KU0R+0&_N7R/\-N@/KU"V)CR-^ZEF_1[1E1=&P"KK22
M24XPTJ^QOJ3M9Z)]?YTQ.#?WXRC?\>0?&AN<K[?-&BECF_&R*X'!OGVI[><>
M&'YQE_KN.N3+0%"+W?'UKR0OM:>^KJZO=6Y/_R$).;\E:;3)YH(E&P/;O?=E
M&\A/,B47O=JQ87J@6UV,V$5[(%<PF"4TVABA@TE#\__2SHOH[ZK_7(HK0Y*M
M3$(B/02??3K.&< &?+X;,"ZN6[,?SP/\VWVU97_= WGU@[SA^]':F!8H6@-U
M&<!24J3)+43[9$,)KV"56$U[JYAE1X_>V0$G;7L#,=M5+[OVQB]+\,$+O-\_
MK*Z%GK'_<^O'#HP6-R,;=6;15^*)H,VDE;1(+(\MJG%KW[.=G*DB8CAT<<J%
M\/B/2?8HPF.>V#4#91V+F2:L%%,#K&:*5E29=Y$5[1&F71UL&?@ 6@XE7-_@
MHPT]O)";FA<NE,(*?2WVJ.=[KG=98>JUAI3^00)7E[V"BJ#UT%SQ"$$KH7N@
M1Z$>\$3IK9P.1.+N:C%O1X""=:.\P*_CPSI27HFKZZS+ >7WSMT]/?$MX* \
M4H<-T\8I6QV5HF<X)<A%5/;\$BZ(>!,Q\@)?M][X(JNW7GDDT5/R/OCX.ZGF
MXY1=-]$9U4F'E5W<TD]TZT0&>6H,MKY.+KIM&T+\+["O#PE1#;3=26\Z]!]E
MDQ@YY#U3K-DP!-&L91SXVJ5MY^>@NH49F_(G!:6Y8[=V>$1M+%?9#L:FHC=!
M[Q-/_6_/OA_;\3.L%&\ PS$1AVR-8#85'/[_CVY!8UD$;6<H]=8>2!:S61"E
M:BIJ_W1[1_,'Q!P<#9U.FXU./%5PP\94=!^7V$0PLQ)<X(,+[8'>5B&;(LW;
MX3L\1,Q8&^:ONHNF2_4Q /.0Z@GM=$EG_;(Q%1M^V+-ISWQNXQ) -Y_A;5V+
MGI*OI]MW0*7_<L #R^^U&A9U190FZ&\G57Z7OAJ-K+["\W7_UZY"%(G6P^&'
M,H^B/$:=VO9 PG@#;_W\SVFR5N)%"(T8 2M5,8OVW>1TL^7>]<?@H3(?Z8 E
M+X3":=MDNV_58\RQ^1K<#ZS_!23HX=^+>Z M?JHAG-8S/9\V5UU+[XHVU*4F
ME=QAO=8+R=/HOY$]J-5CC%#Z>?1%\DRHZ)/:[3+<$:"D#2TZ@&V75QK3GI0P
MMIA)WRIAUJI7MJ>Z"\GVAJDE''XR')V10VR.YN-] SZ$L@/<Z/RKU+9FO"&M
M/[%\.<"T8R0_H=0!/M&Q+U #]3K\SPLSIS\;ATEKUF8%+@E$-E?4"Y%V36\_
M^B-9/38.C\+;+^PH!R#=6O*/T&Q?#:%.3 > 6QDJ"<=_;?98:U\3_6,W2S25
MR+^=UVS9@)!D+*2=>(&1@.&,WT1ZX6JJPHN2C+18)VD\] $4@B[3BCXVXCB)
MR&US&M-F&KRHSF$[_WP^<==<N4N!AUYS@*#SKI@% X+? 7XP^L>*&3AX 2\Z
MS/I:A(S;N%E5,XC(16R!>68SU8Z::]YYY7X21E'^>/MSG_V(RV@5*QMGC>FI
M$_XH34>3LVXY%JSXU=84LJ%ES-(C("BLITR,PM%G?X)Z$>*F#F(2IG2 K],!
M6LWO7&Z/J8<(^.V!JA3=%0GCC.RAQMW4'X?MQ!NZ\V7RWW0UXTCFC+OLCX'*
M%8 J'6%!M]UJT*]^K7W>1_K-'S/SW\N(/ T-8/:EV[T/N*LX-P=UA'LULW$7
M,=93F%L2'Q3,6/F<J_YHW F775]>O;$;299EG_:5<C&X$^C5^$K]7L63U34-
MSRRWFLJJ%"O#FF-Z(EVR%@)6"D>>-6;PH%1G]D# Z?[ET[0&^.LV>1U@Y_WX
MDGC'J/?FI-&20_74T^BOD[\-GQL=;B%VB5T5*G=V(6MJ-,6?>7&RKJGA[UIY
M@U_D'LB>7#,E:A_-.LK^9+2/,\ XY@OEP2LLR)]-G S[X9NJ%G(IYD2!=$ ;
MNZ2;5P^CB>#%PB[3XSO \1#PGZH:>E=*H\&T51(YMT\]^%;E4.\@!@VN[)5Z
M<.G)3)/7F:#DNH"-BFH"+>QHV55?^J>"ZKD-.+9X\N917L<=[(S*2@[S++J?
M&)I5C'($&J:Y!M-2WB8VE9K=I^/7L*37Z5IG97#:,23:]&"7'ES#N#O36:4%
M0?2BZ*[(?30JH\&I1BDS CI_5M)CLW%'KB$RK,],<XA?!#=TLQ5:N!JS&U5N
M%Q$>@6E+U'EWVDRC]P+N<\W6COS?PX8AK--^?49*+ ? C^;6MFVD"KR;D8.T
M$.6^&51U%H<+ADG8O%7K=W4?5-QVW[=]W%YET6^F7QC38@>E8#D:8\N&.N\X
MOZ0?$3\6&I <34+>+XH_^*'M)>C>\*;TPL#\A^X6"]ECN5=?%)6L^S2%59/'
M+F?=,2;!6D*W.'CSO]?MLXYG&+=(=<MZ(2'M]LRFI=<P&:1&@.,E?K $@';V
M^;@.K<BY/42ZH?48$RR6<=W3YX?@U?#()_VRQ^PKA<+,Z<IY;CC [?;7L4JG
M31^U$.?S<S(DF:QSU6L:U,F"9Y67L>?"CA9)[2><-M1B"G(Z=J$K446LT'\7
M$V#24RC?&GIR[A:AK0X5Z?7P;77]%#) KU*4X.,XL9,!J=CAP=NLSTK[@J<<
M\:9A[JO8F8%C=CYFKPE=&K=SG-TXD=AR<_P^.?-+01?GR8:YIS7+W\=JX'"!
M 67'$USF%E?GKD031\]EA]:&\Q><JM7S.G-([Z\U2I=^C,/OP!1&G1[KBFT,
MII--OXYE_;Q)7,@.7@I=.FYPF1F:O^X4%)Q>.[/QZ?8LY7,A74<F9*00>+1^
M)BB1/12Q7@S_(Q&P!RJ+@ 0-N#C3<#->K8B4W;-C'#'DF@D]-9=66C<4J!"Y
MY!$BF!9>Q"<]-V4(>55H:I-?-81LZ\+S 5%> <7 ?(>TRM-*9AV^!Q%2OBA>
M'U+5,:H;_F#"V5K4M/O/4]>:F:\%"_VO NN=6"M+O\=(INN65<S*[%T?Q$C8
M8LAC2LR:Y9L0'!]]?@7*O,0Z3S-GJ:7)H.QIY>F4C_WI)5V?G. R$_O;?SN1
MK@]."1[@O(5>&X/0H(Q1=M8>R,>@V!\OR'(98,&BCIV/BEY7&4#,N1^_6%E!
M>)3_=_\#_-7J2+OT0@V_*L_,-=Q6D*WWE+5E9!\;@@"@(VG%3_JOG@9Y[-PY
M8JS B[O59Q!E<'/4IM+K?$YCY1BND'!;U,84]']^AKK%#\0I[H>.@L _V^7Y
M4\=GR"/#E'?K#=6'$KWX@XR/=#IG?1W^;C;<>=:")6T?>J"K\2%];!K:AI%"
M@J<)22R'CPOY^D#FO\)'AP!?'P@3[FC@A!JX\I9ZQ)ZG4U17"J?"?K<'"H!&
MP[\1DCBR2 @U:PIWJ($.<ZCXA5+.%E'\ODU\,4 B=874'A4U_!0F;#Q[G_ &
M08IGS#<1N%3_ALNEQV;9KXW4G C+V\)ET[]1(N=CRE$W11:/\8P:BL9!U(BR
M(-TNQ9<479VI?^=)C<[>0>Z!.B$T&#3-Y3AM"D<C71^I6N'MDNZ/1<&.<"9I
MV7FNGXP?AOE]UF@_M"J#E.H^4W+ALDW&N2%!0Z^&/9 1%FL[3S!)K#[1L@/O
M[QE:VUEYQW98]L:;S4X[J61<>?;MM!'SKN?SY_HT55I/)YSF##_PUU[7D1!/
M<.LG0CH)0NJ*"1+4[-=%5=AX7.7W=XD71LMFZBHWQ)MY? 0+NY?A33]PP[CQ
M',9+ ,YT9"D.&)UGG1JV)L=5I5W2.-Z0?K)N0"/ ?->V_+TD*RTP3%6/6/8E
MO5-5U_3C8%/FMVT,;GT9<;TI []*(EN1>NC+_>_V]5_EZW)DH8!)+MIF >HT
M A5-H&&GO5K6$LB5Y 1#I0>C\J>QT[=/+ET?V!+M8^II#,J\]'ATO.0%)BOK
MR>S]AK7Q8 Y_#0W&R 32(2VXHTAP%[9BOB-I*3CD+5*5&E5"O NDGNI<R&Y=
MF*EY;'D4U::W$?SU_/",=>>:<X/39TVBN34" UW< REL22@*=3^X'2@EQ?L[
MS81,J$+1F=:<H3V0P![(';=O 7X4KS[A>P0)=Z1??S4MHU#8J9A>E6>38>"1
M^9,GX_SZF8QSG0_A_\UX3\B$\IUX$";H_CCRD/\;KT36?]P%P?ZQ']WI<JB^
M]KEZ(T3>4"X\6/')0X2?GWKC]M%JI-%MB_85J>9+OCYM^=8&DT[]3LMG*AZF
MC)&W(56[9D4!90O2=C4>V"]+^E'Y)1ZUKO@?&(3<")YR4?!^EM9:[J]^.&(/
MY(P6)')7DC]:!O!K,X(,<J0X/Z%R1GI(:&N^^"_M21@5&OUH08$VG=]F61E-
M7VDD.5RCM2@&J1H&WI8DU< &^W]O,WX!YY@!2.'Y3@(?8C4@1$AZ;5G^#,VS
M] I:@=9$"TCS^T0,/+HZN:[X_FSRA"#U]8>;]E8?AD+Q<'7].R_M"A6;/MA7
MAFVZN"1AH%I+GU77&QCON;VO8O&SWQ@I6]/LVUP.<?T0#]T+]AA6!NA.IQ"(
MJY76.^>,P\X7T"O[#H0_!MT[KO98>H/P%$)SQ$1/&0(Y;UEG@ ::$S5G^4<Y
M\'%.51/L"Q']8!6E>:OIY4KBB$:R'=W,(?%M:$##][OSI;6W'0W*7R_LLDGE
M'6>&R0U%&JEC2T4YY=ABIFI+GTEZS//'XH:/I*A8T8 @6LN1E%SK3B6EI\_^
MR_C+3A*\MS_2_BGZ%[D2WHH=CY]6KJ&74 G/W@^@CGTP%AS=%MD#%4SXW9HX
MY6?@K*.@^'W,_7.Q<XM)'"*;H(:"<!?Q$$V\K-1'/_L=$\+Y-04!W,(B#/L3
MQR*">Z=?6^L'=(>,*Z3V]UX0>;>1ZZK<B^WH$BW6K<>3_M8XA]0:FI[Z6[IE
M%5GB,TB,ZO?ZNBO!U$,3L3P$WS1QEBW-O+6AZ>;&74"'ZM<O@!Q4!3)4O:M4
M^?*G_MP+V9=8D%XK%YRX.Q8MX:.ANW__QI_D>W%N&T>$HTIV4-P)D ;PG4M4
M DO4B0J+4U.FV[W^A#*G:Z9HJZI#Q<?J.9F&8Q$IGR^[R[CE4\D\J)\;/]:P
MX[#?3@PV$,Y$>D..ZL . [KM&,&M_MBI<P1::!-E#R3F['1W<1"/51RP_MS%
M\.>I\'GG;ALR$00^&7^5J#CFIUKXAP1;R+Q>O^WH-#*^,*KZB]F9"-@S\.R&
M1@CS)+*!$O]XC2,/8*GQ27A]H!PLX.VH&8LH4R_?U-2WF)&>*I+KF\N$&9\*
M$RF_?*LWJ@M"W*]"?.%T;:!UHYULX-#XK'S@NWW\Z=K3I'_9 "I>W U9V Y'
M1\@PKX??=LYCAQ*<&]0YU&5[B2/Q=[RRE1[&BWS_*QMQ]J86, SE$/KP9]@5
MT,"UIY"O*O&-EXI9QM4CAK>H6,F)JJ(8O!S2G0]E0[6W$WFU?'S?1*OB"?#J
M[[C-.8+1+'<\EY&Z;7-R,.Z2]&&:H$[1C+-YFNAK"65\ORH;PO/,B6MY 0I'
M_DNOR;V66G? 6Z],P7J-!.\((/=&,,Z%O"\,Q%?O+*.7!^!83.4\2U1WFK"\
MPCP+W&+4_6))42$I>R!>EI-\3K!X":6DP<E!.PIJ=S^[)F<IF'#&7;A,\L28
M3V_4$]IK*C0>?1ZE0X-V0/FEP/&-P=.]!NWB-A;=V^(F-ZJ=LK_5JC[WK+0C
M:>V+;GY^;O@1*6S,*2J[C8C39!W>O*I*P<5":FJB\>?1(W I@J?F890A7;L:
M>J#R]!9.G.4=N:1%>>51%6>55':&.($I4/K3>+;[KL'Z#8I]E_PI[B!,H[23
M.O(5:=LMA/'XF?B5 ^^03G<:![8@,L#17RE\Y:6>D9&Q*;G$N_J],N6#XZVK
MG:=NS^(:!A;\ E4<5"_I.B-&PC$N99":-[,BR=&')_/JMIM5(%?75353,7Q;
MT*1M^/Y'6$D?(K8C0-?T=7M$5^Q*@5MD@<^Y(YU6OT3/J"7%I5AY(7R!,(;W
MOPM6*&EV01&0-EVFV2RO3X-T0N*-CA'H22QQ^FUY^^1&TZ(%QMR<Q:-GU[P'
M?YQ)^?HE=CB3K /8TR0X_+R1TUC@C&XGE@A"]V"D=):PS^0E*VE/ %<O\35)
MI(T[R3>D%_Z(QVW(/BS?U@TV6<SBO_TZ!M]35L6I@M-:2^Q?=<WF[084UFP2
M)C#WP]U^+ Q82BH*ZQTH*EHR164R;=#C7._ #22:L;DJ[80D8F%'WEIBP*-Y
M6E&T_P<_[%%DCMUPF6N#M?#@Z*5!TV!_3Z9V1:.GPOEO,;DL(H3FC.!;P(D7
MST!_-S!2:; GTA;$^2XB_@WY-T,_\DW>S<43GAGJWSJ8@P(':MYLZLAW6UET
MD-ZYC&#:&M#QJY-B5'V5E0.TM4[X/AS!&QM?7T9(1?$@*$L$*8<\>:IR+H?8
M/7'7NBCA@+X3^=,)Q<2[VK"V3[AN:P6.0 W-J\/EZ%!(&@C=MP>2Y)Q CBY&
MV<G!IW-B[SO#G&C=/F'J_AHASO\-\I6)($ ;E&>QF3V&J<*.A1<8-2_SW+,V
MF6N[D#KM47\P>@0@T1HX B%,;22Y#2N"8(53TN198G1<6Y+%:B!>$HF?F$02
M7'+#T?T(UX)QI\YO/\*T_]PP.^%E^V#63:?%9P]$<X;%5KN<H_7'XT]S?D)D
M\()(MPYB(3[G ^L*O5'5CRO(-HNO/'3Y^<VI]8?PJ(.SU6J*L%-BT?7W%=:$
MI7EVV.G[IZW,,DB?QQ#JW,CO4K00OZ+'=$2ILC.XJG!-%&6?UAZTX*(RJOY(
M_2(RS+IV>-6(''XV>I_A#6,M<_%U 0,>D%MZ)SIC,.1P2(K6E=$5P3@AOZM#
M6TDJKT*OJ6VIWEDM:_S]?9_['0_;=,G]N.=F9N!F>$W\2A4-P;@&>-&&J"JI
M>'$8O:>5+!+2)#S4.F.A?_MYL\XK6_^0V(#K>M/K7Z@>WG5=)F^DM\&I7!6/
M:5D;QU+L7M/)5'PI7I:67_;N[UB]>-)Z==&GR44B2J+:17;H[<W"U9NG/SR5
MO-UYE?6!5PR5\0*A%#:&QZ:LL!\I73=<RRH)6*C /-F<7UI;LEKB8/JGX='K
MF)9P%I^KUQZ(3Z.,*<49B("U&9]$ )EA'A4FJ3](!VZZ^]V@@C6W25:K[K)!
MP?#2?#'V)PX?LHTB"JWLS)QQUN6(2=&6\T_BZ;+K!38^Z<9\N=36/W(MG%_Q
MA[1\#[_"QOZ'-%R/02_BJVMN74=[>9)5KV\CJCCFOQZIW;=.OW=:;7^@&I]=
M*^7(@W ]*6@L6O0'UTY^T5RJM^W)_'L@-RQ1@KH60ZVMBQ[JY$A4C'_P_6^R
M.RGI)B,C,#%D_Y5]";;^%Z3Q/]GQ_XJ.PWFA 0019&9+OARM)@$M@;I&NY%F
M,X:71L[[.[*D0[=25B^3Y%N5!:/%C4] +DIV^/\EA%T?&YRLBFIX977DA;?B
MZ!K"8I>CCUI#.-.Z5E)H?AV0RLYBIN*"?>X'E-/ BN-JI-^SYW<.BQSXZG!Y
MRE*H69V4Z-6&)6E1NCI@:?D7V;DHS;#/D&=[(/#[6FR[W49KDJM4M=1SDS-I
M9[=F,C/.K<"Y4[I?@9<C\(<NQXB^'OO@YEW7Z%(;5[V=FH?1$1'!-N@VU3E,
MBS?43_BF;@#4H?VU>;?M]7/)4<O[^BXK5V49I:A^*LMB+ORI,9USE1Z,@.[L
M9F-5V!$5NX:WGH._<&Y7[6S35#G\(M.8%'@5K ,Z?N V8$W= \62CZ'%'>[Z
MUMB[* ^K!98:FA9TSCKY2KN'MKBGJGZ_?==,]F@BY8+J&,8?0QQKQGSU:@GP
MFH&F:J>8=]B,3Q$77.1I9BG!/!^;9H3NKWLD7H*:Y\YONSST$:44?[^DFI.U
M<6H[DK2^&E+<\9_U'JB_?T"GBF%4]+YQ:5HBK1Q_!J5&TVPG]?/YX@]BNUP@
M7^C[D5K.V7HZ.' 7&G]_W/>FV<& A](!ZI7[-H0-QC[(%RU9ULAT$69&_W["
M>SQ2$ILGB^-/.+"4 -<9;*)TZNN04A\.SZ_RJJ5>C4X+:B,A;D"*.#7Y9T?<
M<O^*G>%^8QV SH5BGF' E/H/+/K;X.-M,^8=L&.^V3>GEHQX:*B'Y$5Y$8M5
MCVJ^4M]0FK6G1SIUX@2/._^,:H</__G<.4>_@)>%=F\0O?55(RL?L]GHC>V3
MB2Q/((S[M:WL[$8X!2>/C.F4%Z//MZY)(X7GNJYG3E\@>(_AM>G"%<4__CCX
M.)H6EOJIWM6NM3QW+#R\AUH'$^(B>C!:G)#&4J%@$_= %;J=N"<17LE;%[6;
M%+KDC1*X?F?[YH[=1G>&\<'$U ZT<W-*LW31?S[P30X!E[7!V"1]8\&WV*BT
MB:NJ?_J)F8Q60)5Y@J56#530;SF;%/@)^$&>;D9=&JE"B,/AYK(,.\>[3DGB
M]7%WB"K$YAR0>SK\9>:_1I3=JPZP@_U68.3"A,(]%S5%JM+%;_J\0_6OG/S8
M\RAT3G,*M?*\,3.Q?[Q_YP[[\_H>J)E @31(:'7X^(2%GY.WS:H<"]IO,?5<
M\^7W<ZQK;RGV/S$5NBLAM!Q&=0V0$T)+C;J*1(L"WV \0.FBC;EDC$/*K,.)
M2N*^]'T)S2I%\B/F#!]VF=$QSCAV?Q6,.Q9\JZN'<AG2?:]*O(G/119SA8L"
M A<>^D2)[!#"3AQ6Y!?;.>.W'LPY+!?L6HBTXO ?^.PK$;H;^*H />!8M<4I
M#E9[X/";V*;$RG3N-\A*O>B6XM#3_9NB$6;WY>/(VD>RT2AI*$C)V;C36<;*
M?'YA#O/?LP:&6="5ISQ\VVV"8G;+=]ZX>QV8PM^.870!EI_00U\YW^EM5&/Z
M_0#QJ$>-N;:MR!"U +<-9_O;ZSQU+]_!)U_]X'T_%H?B^W>7$[!BO&*_1=VB
MP2G0ECV0+,!L,3K4D$UJQU2*E?TIPS[VUWC_HD4M]->$)A;S0,4^S:,QN5WS
MI82GT)T!0@#B:7T12U2:S%!-HHR^ W<DL-2CJ!<YFA<'C=JS+WSA*_PZ]57(
MON\5+*?2^DO8P2#/+ .]!J,F%&?)B-,@=B;QZ-.I(3_3 9^:S;0!1;V9H:(=
M5G''XT5,'OHBZCJW>8,H?L"43J)*-&N*H=2 QQPEFK:5./;3PDVG11N@Z\X;
MR->_N6:O?=/"Q'J'3AMK/_L>S].0NU$&_4< _3"Z5_PF-(GP+;X+\X0C2Y=_
M%_#1"=CH9+1H&T2^_I$Q18J(RE5Y_GU=X7!Z\I/K%I1A)A3:QCELUJ3I8>N@
M36JP\G.*@L)O;=\X>PF\48@[2R=S^0PBA!?SA4L;NE*C=*\"(85_3U/U&LVU
M!PI+=U&C)6'^U3L>D]J+5ZX^SMX0/DPER*A#*0W_\M&_6JV""7"^0RI5$O#2
MI+O_P]EW!C75A6%&19$BO0E"+!25IM)$2CX;"(A1$! 0HB)2(D0%)$A(%*27
M* @H+2I-1(C42(W4H(A(#3T% 2F!!"1<2&'CSNS,SL[^V?UQ_]RY9^XYYWW?
MYWV>4PTQS.KJ4EE(K&?/W:-C'P^[-2;[RE]NM'S\2-+(5C*]L&R*_?>/B3-.
M72WCFO,VR*(:^H[3<<ENQVJZ\)'=580//Q\R<)U$ \C=7N"X5@MN_,@T);YY
M-TJ7&1M/5]O/C 0JN"$?H*!^(_$+E3?GI49VL+_HWY]L?'/ARV;+IM5)6-$A
MXPRS2KGE9/(+8/])ZMU8_@'PG.OIU4EWJ!WF<GU0L?J,=\A'PK=UNY5MT-,P
MR78*%B=B*07WE&%2L.8P[_?(;-+6>[^\?4QN_YXA(\[<78>,%\GM%]6H/VX<
M?_GK]\/O_$%PC6*;Y*@D;13(9D7"QV'B-_W'T*DJ]A<SECP79.("TM-;G#Q^
MG';CW_J7""FU3E,E I12$("?B"4(=;4*7+7<;)@8(#H/S669,I0UE;&1?>^E
MXWPZC[PH32/UP+PQ+;?XAO8<*TS+B493EO,TK3>^6>Y;.>HJLQ7R#.5?"HX+
M7JF O0M;/O42JW=1_,\Y[M>'C,%YZZRH>=^_%,0 YA<]I(!?G=;\8M-5F[@(
ML\)<5%,CZZ#L_XV0 \6V:QK]YM"W\UGL-/6W.CU%"\,OI]S?##X ?T\W!:G9
M^Y.I/[&""K\# JBX6(Q$HPD3S[X/4#CG_J"E!>^:P.XL_-/@T3N_#@W^;=HS
M1G&J2G M*W2]@C-W*/B)Q:81Y+>D.;+H*>(>3"!6;+&>TG8ZQ'Y7NZ5\L['G
M,:8FL1H^9O L=BUR^D'"U3ZSYV)-MNL[JW+UIZY0>LHR-URX)EWSR?#6 \/$
MX\-L8D0OX0/^!W%L@"^*8YYG.[,8V%8[R;T <9K449KMW=C(%&[;VTPIF5?H
MEYQH?J=C\^!%U]R.=P\J+^9\V=D81=/G*OQ;!Y#<K(%$T#([5I[A%(CW[+9!
MBI.D(B#H)I#O>[O/R,(A=)5Q/W6M*U+)S6<3]4U])';E.N=8,)&_$P)7JR4(
M,/HI^EL?3!4]AJEUB8+<@49[J@)-TY+B<(&\H<29NQ8#-]IHW=WN?CJRURZD
MAWS3TPN2JT=)F;YY'O!&6N1\#VKWM#Z@Y].V3\[3GR+Q;[]V"G%_L]J-#G$R
M1!:E=?<7X']Z2CZ+?C$#[BKT>30#69BN/N*F>/!9@B7>O7N93RR>]UE/L,1@
MUGF0\QNB"=S((0RU"E?5P-5F0MHE8]5VLS8Z(?+ K%V7%W"-"G=N8D%CYS[O
MK\/>1-[),KOX6\?A1T5!\HN"%_!WO#0BM1PB#/$')P9QQ8?Y2LAM$!L#O-7-
MF[-G$ML+KS<.BV*ZQ;QOT'QG[DL](\^-V<ZF%9[6[L9 %WNV06Y:SC+8^K]-
MN5/9^O:PWG+2PHS<J$GG4O0CI[B#CZPHC0\IPD=4@P#R7"\C0N!'^X';'"7N
M.2"(JA_'EV!)E")8RFU7B026\YM0^)[<=XEBCH]T\;J:.\.S$\N*CLJ WQ1\
M!0UVFO^D%'Y_56:/*EM@$"?0SZ_!7E,J,5RY5C+[,T!4;.4=87L /<SI_QK[
MC73AMD#A]"5G<FM]64JNTDN-J!^$^$Q&5ZA[R2.D*5M@?U\(H -M@47!Y(RP
M4=N@?7P%E#6OR!Q.RWX60"_%1$OQ*KO/UMT:J:UKO%3^SL#**>.Z^/X;4A<=
MBBB9W[=!)9;]X_S'$ ^_'<*%:"?T#PK3F1B)JY9LYX C^09 *$N2_0C(+K_0
MCX2U8>3N_ZY!R'R/U87?#NYS;TT54AFV^FYZ2/C'0]@U-%G@0"V8D:JOP^A3
M0$4)]&%X^80N]KFY:L$S_3B4TP?9;9!:O?=G36NT2^#(2"WMV?4_WT*([^L\
M^XWK0_GUVR /R;*C^)9Q(J"7G/+&-R3"G2W**S;$BY,X\US[D'N[GY]!=B)F
MDD:%8Z1BPR3.@H*B8"6X*A+C-C.4_08X(DQ:B=W::J-&5S?5#\<4\[$AM'G#
M/[^S5GL=)*Q?&AZ3RVGN.P3+-(O6O\L5*#P%Z3*YE6(*FM1?=UW"%%29:<69
M01YWA(38')@&O^A!9=*QXXY4G*!+_<LDV2;#RS6[ 1(=(CZ.)-A7Q.\8L'H9
M!GX3N/9]#W4\*+?LV^(\+#=K&\15M*9Y4.+7)[6H*TL=K('IN9B_NE9SME]8
M&\\^W?B39N-UI.-1X[C=AF;*1>F,J1:['=4)7*!/8,;>G>@A(M-#,A*FV QV
M\\^Z]^8AT^O*KQ /,<^J\ !$&_K0@.X-?S1XT"M=OGWX\CG3L;=I7\N\[.RF
MR)M_!U:&MD$ODQ8MC$-+9\N\U:8P&7'\Q$8GC@?J*!/#D*<11S$W8%+;H-9N
ME@5N["^Y9D#/^U='G5"4WMO/AM<^.YE2CG/8)=QPCBM*$T!PSJ-.\EXW7@PJ
MT6_O3;PZ :4"NH==#6<31HC9&NTI)A&_.\^2#MQKA-)AC'QF?@N8H!6)\=;U
MHLXL%[/T.]V"0[>L.X3.7,@8NYBO+2M4IF[_X>FYZ?N/4AJ?N+1B:O<U8Z@$
MV&>A_<ZWWRV\#(L2K=BWFB_EGFK3+=7(T,RL=,-;#_=B+$1"FLAX;I,=PL@'
MX3036MA+L3J7?/CSX0LO2)HG*]X$9<#P:H-CP)'S N+Q#("Z\;X84480-P$/
M.D4821\;7G-D$I/6[19-N9!I"^/!,'Q8X5C[[A\G*P/'*G__?N+R"U)-9 A3
M$:,P*B')TH1K]7*\;4JFVB_3GI"E'=X#OWJ;'_U^U-Y@;\;:M;2-!P:J'RE(
MM?3L*Q#1=<^,@37^I^#.CX$!XU2WT97E&D3N-HCV*;Q&G@:K0G22>.^;Q9!:
MT_\Q]1J88P.DQ]8. UP-NNN[AN'@Q3UCPQN*0>X[9,L& RO;K]_"/_D+BU.S
M9(:V;H/V(!/IDEBC!I@D &G-"N@L+8.'II3"?1 !*EV7DUQ!IUZM3N]^IO,U
MY%-_P*C$O$;HN.?<[8MH^7^"MH_YN$:#06E=&1E@QP,U-"6?+RFD3K3R9]_@
M9+<I$66CQL^GQB"Y0AU*G5U+)W;\U%[<!HV4\D4=F5YL,MG<CIJ\JVWJ*.#.
M.M]:(9;K2"M.<>QBB8Y%3^JP(BMB;UA/.27E:5M?@=,0Z-XM?O5@M',N;S$,
M7K2(+_R[A$[H@^$@M2Y<N32JRY+'1R"\94JC@LP_PKW.NK%F"(EN%L,R/-6_
MU KIYRR4ZK^:62W9U:D>LOGUX+WFZTPP5W$7S;*")=R*W@5T<,Z@O'@Y-%91
M84"!KZ4VD BR5UB\VI!Q.N!65Z2X8:].F,=HTHE[TX;3MH4UF7/ (@\=I'-1
M#X=[SU@;)\+!M9"YK3Z8"7J 4H-IP8ZJT+Q[.WH3\S1JJWX)/50]_/WGA8QM
M4'NHXK'FG^1+R3>SL9"#AA6Q*0>6'PG#OOL1J4UJPA6552S-)HXR^A=?%0@)
M5;]L>7A!X7N]T&.'+R(?&K*=Q.Y=R[AF<$FJV*K@PY +.<*Y=E-__I!MT]'"
M[K+^IFJR#P_S%?+D S[+G5T/[))<FE-DN(9/\_3(U$];2L/YK*,O[WII92C-
MV_A7AE52-G^[[TW3N;&9_=AEY@>.Z0$3]219XJF](W@VEH5_]CZ]7<VT?TG4
M3_&Q[Q*D.J!O:7*F]B[L]"F#?07BL]C;AH*"X1JA:WPB;=ZYJ/\AI6QLJ1$[
M^5U[9ALT:L:N R"<NUP(!HS2&!;A]];!)661[@[:DG$H[9*+[>PG'?EWW(-4
M9BZD6B4 &DA\E*4^IL774A80HV.2+.6YVH T"\Y^,=2X&[D5FF $C<E8U,LN
M6I"JLG[HH]-\X8]FS/6[1QY?.;T_?Q0"X0I9_"\-5QG\9G]G&!>^6LJ^+8C0
M:JX2+]]2>WX;M,O\&G/E?\Z@13P>G$"ZMU!D#W(L-N+5S]EU%%>D3%QZMV?E
MY'G-A[_(H?].#[+E2_,[\XR9 O#JL6NQ/ 4TL1#M;D\6AC'[^.!./:.NZF^.
MQAN/7J26CT>M?ESZ'A)X)N_;IH"@'F*X9/*%B%T\%7P.Q \SEDW+7,JG822
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MTHE#-0,^J3,'!]YCWUO[!:(BA94.T+'/ZQ/X;1"F&_0 UV@H.'8 O9\_4F\
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M6"3CHOMO1GF-7U*G]^C$8E$&46VQXBA!9AM$S94+S*%J 2<M.5)5EYEX+*+
M^ZW:,]Q:CI[-E^>N+JX3%](I@8E[-D5L'HB<$_KYRQ(%C305&W7W@0OQQ'SD
MRJIK(S+3F826"-0'GZ!7#96#&B'J5IK^FGE"_WD?<TQH4?.Q-_%C3:W+ >:L
MBZT$Y@TB>;Z+=QJ(HBN*T+9!*:M)?@BQ\/0;U=I_\6HIA==,\.D/K"4%) (
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M/]:1E(+DA/P?3W-SSZ/T^.O9H0,)2=L@,6,H#1&+.LE-X8D"UUVJ29PP.N*
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MI,3[;=&S\BF^/?G19PXBAWJ4F,DU52?4/%KI_'T>UXT>6UH/XGXB>"+(']'
M<;V%-U0IH.8#\D)=71_^%$>M/V]?\3B9W#53Z9IO[J)NDW'LCTU-S^:(^]H?
M-&0;Y$T CL]RI.3-^OA9'1R+KI)IAX\:762A*@)S38 :="@Z'^YC>,D^[]9%
MST_Y);KO+K*[HKWMV-$E\@^"KVZZ9S,"*C$P[-I(3=%H$IE@\_BQ I$C5=0\
M=@E:B^-(-JQ?&_(<K"$^X\?R_=^'^U>W00<GSI6%X5Q+/G>#$Y9NQ@[E9Y@Z
MNYRW>6*BS\/P5)#'@#"6/*TK 2\<_J[-Y096++17'"%Z*QS5^6-XV$CQI,/-
M-#&33)/AW O']YO2KRLH"'/N<NL)U&R(C"[Z*:4*FD3P6I*#A^/68[DO-5:Y
M%@..K$LIG_RP!Q879'J_9=*7:6_]2I[T\#"^RP=??@&[K! DT"U7H-2\R>.
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M0"SVR_=L5&;:]KGXL+3&]/45LN78*^M,[G-3;3X]4V0?X3P ]M:^M61 V!J
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MOE(!I4;7Z_[&V U!?0@)&RA%"P=#&]^-ZZ-=PMD?+Q81'PV?O"LT+2*^:VY
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M39()"GKR=2;XYTS0 P03=-[]H_ /J4?.ZS%A@F0B[V+ZAR'Y<?1=96#:YC*
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M+>^2K-5ODVK!6,/L11,*'AVW"->R2;TI>9X)<B,[S>5-.3 8NJ,B(.<PALO
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MG?+)PV+38V?@$ CY<I$U?.8%S-Y<;][+_66AT>+&,/J4X$(W2[WELM>@_"/
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MZS/0,E.I D\6:/[W/L_SC>[#*"*NP\EB2P379;C/ST])C\D!R^<]T&_VU$4
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M(;9;4V&9VR><8ZM$G-==$6?9LWV ;W3!3F-U#H8K!J"GH1T:,6*^ P#I+W2
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M>QVE')"]%@5QU>!('@6]UASS?UE"6+N4T<(%,[M,(3Z_<POXT?\IH".+MYX
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MS[!IRA%K+=3#2V\=WL&K] _W$M9!$7;%L5LS&XU$1Q*)S#UF?R$LT7F<%M
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M/M) =8?\A[P!L?TV#YH%;+>R&D7<=W[ICR>QI]'_2?(IS*<TB3AQ84U/9L"
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MQ"?N0.K*[PK:^_C\HX9GO]L&0BV04V@LFO;J(_>7 NA?K\(#D3@=(DH<X5Z
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MMUL(G2#32R!"CYW0BNAN@>Z\M5^T&;O;T/,\_OFJA+QO74IAF8_+_4J#E/%
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M'ZNL7!?M5GU7=R)0RG\@<S2\%!;N,>&GQ]B KX.+WIAQU];QZ62$U7GH39[
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M>K(*.YB%:&F>ALAQ]<C]:V($GO>%K-^SM?T*RYZNN 655X[[#BALIK+EM^N
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MO9QAN?7-U%&8( 7NY<QN3M^4["BT+(C/"?]==PI<T06?B5IT?J-PXJ%-.#\
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MWK?")F*5M8<-7,XC%G";JUJVZ;Y+XY:-^'I'(O?T(G<:*!8$_772%*9M"Z2
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M2DYJPT\%<M#TAO*MVEHP_(M]Z"'J%S>\&7!F&E+SX;V71EB&#FA/XHT7Z(7
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M7S?-ZID'?(*1FY'WVF^^1C;?')@C?!D,?'Q1=!-;8[6O/!]S^=ALO:=+>LL
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MW%3.N!EZT/3?W_BH9IM<Z[ZY<P&CX0:'\IN&5(FJ,W4O@F'1-&9@ZF)O_D'
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MXEJ?0L GY.2=-@P'KHR*5K=V.3K+P-9;M.+#[:0FD+Z_3FY0%W=]?)&/"[+
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MKL*D ]X9<5%QG78",<_&%%=C\]?..^9PU4YR/>J6^%!!/&^B6J9Z4V5&;:H
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M(->]]#/H@4EXZT)\/Z9!L80'6"I:CY!HP)OUCUL=X;QW<'-FC<I"1$]4O$A
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MI MGS46F3UI!Z$X@54SIU[_*KJ9YH\EP<])LLOTB\#S5J]WP%VD\BT>X_1B
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MYX-9T;IAND+>(B<V!F35V]5?;(VJH9N$NO *9]GG(HT(AT]!KRZH:+X]!N0
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MW#%>>6D[C#UIL9#&T^.F>R2>EAZW/-U;6N%P2#+E-$!A@;G_SA;=PAYV1(]
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MO45-*NL5IOH2VD1KN29?YS6;DID+HY5;IW< =[(F"M-%3C]<4S[ST];L<0G
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M&.6IDFIU]8+_U)D6E]SHI:X*_:?II2/T$.3+OG$2U+UTX@H]RN=K!=H7@YM
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MY_1(/<C.CO2IOKT=C-VHZQ?3TE+#YXZ$+I.A[=Q]S"[NH8*#PAV.HWB.#)^
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MGCRVM7_SN7.!_VS_G3.K[.F,VCP0\&+_72MSES=GS[5\$]E3$!$J2TI^+([
MYUN@E;-2E-,'2>J92T1R_:)?K+TGY&DNI &7-5?=0 B)\OW.!-&C.$?#H*Q\
MWJL0Y)AP*W$"U:HA.M[VWLDS(AY5I#Y1DG!E!R#QTPU;F61A6:;QML1OB5N^
M)K^YN0-X1A9U9:LP()3^5IM1<#N(@6Z\]"DLH"8+HUUBXZQ/-' -9[FBJHHF
M75;S ;IH^\?VM1?\?^W7W8I6Z!_Z-JL4>SM@:&]BZ[O+-G0A3F$LRJ2K7+PP
M/13?Y%&X/N^.1LYCWG]>''/JZ^O5P*]]>S?E]MD0LZYZL%]6X8V_*.+(5HA
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MVL%$#BN'7<AYS$YKWJZ.Z(JF,2L^A$ +YPBAO]*=$L]_FI"FZJ3XV_-EJ?B
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MH4.%TT+?;+8?<EX??HZT$ALE5"-R>JJ7SN+2+9.<B!Q@RQ_,(/TCEI=P-R%
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M81\FOG3+SC]LOM-P@KD_4"P' #@V^QB>Y* 85[DI]H:,?/K2!*7A,?O5Z%8
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M4D&S/"WJ]R.3Z/5 3_4R Y*"J2H_K4:_2=)?P;<8:DAPG0X0( YYR33MZ84
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M&L5T779J),7;\M0<U<"Y9>23^]BVCRQF_%G+:,5EVYD;;E<TC6S?RCJ_QA4
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M$\V-V,@.!'Q<+8P?WQ&H6?GF@X=U?G!/B_ @VY>&?"_OXIO?3WRYMOB,$Z.
M(>"5!#;Q----4-FT]D,7A%H#<P+3#W<!3X[TT3'H#$@P8@9#<E8\Q?P&J4$_
M1[KC!9C# V2>=>/INM"3]6I7\+#JHV_.5M=F#X9TL#^[;6Q-3/J[A"00+:=E
MOJS3.,-^V83?/)>ZP&IVD3[0>;R_#SR-T<'X8I+G!*F\ (N7U%&;B>L7]A0Y
MJ5(.";=QE^1'11\5__SK,"[5\%TQY9BUGHVXS88O_3I R.R3%S\+=\&.8K:O
M5N*/A%G=);*@0D**VA)^JXOSCX[9*^F^!5SQ"&"&NX@+B%_(XRUV!$L)Q& 3
M\)\"1?X56?NZ\5HOB=M#6EC3ZT@W&\RM3\M:=16 SO>I/RG*%,_@U%'74=<^
M0-K3QX"%HH"/&2 ?#<\PQQ9T:VFZ8<[+UWSC\W/SWGMMEZ]&&!7I?&_Z7#9-
ML'TWIG'YD]Z6*2R[3Q+S_JDXJ$6<@TW$*JUA6%86EW^L^8O0[UP1E]S(^+OQ
M(DO%-H%/31:,LHP?AK$(FAVSU(=]6]Y4!+A(2B .*:DK!;] @K8/6$+"W-LE
MI1I(^W29A-M9ERM,75<E!KN]Q#\4.]ZT]6'[L/<;$X;T'4Z/L-P8ITG!_:GH
M"N<NS\"2,"WK+S]>Y^L+Y1TL,9KMI^SLL_3#2W<D?BHX[+M+R%%7_SU58[:K
M06OS-E)IGO#PB5W*SQ;O"L_I%B2_='-ZN.; 0#"RHFB+^WBXPD?QZ*UOJ;T?
M,_=AN#Z!#2Q%E5&V*S #IH23;+ 0 0/.8N:Y?\E6F2/4B=Q(O:'[Z&LH1]K/
MO\:RLED1I_Y"F#Q%0(BEQY&$(@0OR3VI9CC!F@GU/0$KN%K7V.1UMXZ+\[>Q
MS<WE,76)CW]DF4>*J0RDNW#/\)17=^B0 ET'&?YA9=J)N)DK5J2YX.!TRU!,
M8DFX[Z&2@/CRN>9TJB:K43H!WWF2[;\Q]Z;Q4+[1__A(66/LLDYE*WL199M6
M2SY("V6;"B&&*"%C)F0/15&*J:QEF2QC"3-VLF;?S58DAIDP[LSB-[[?_]/_
MZ_5[^'LPS^:>N>[KG/,^[_>YKW/N8SD#"R'V8_],>-Z+]QPF9M@;1"=77*J>
MY!S 8]Y 'G#MJ ,E8FA[]D3 **A]_BC1,IPBD-#&>'G?2-_E#\0OZGS7>=[+
MR7\-E*I^W2PA^E381>UYYUGN;B6T<CV/!MB1T,JSP.7);A-\$G9B9'73M!13
MI1^GHJ?=&Y8O+2JTI/'>)X=S;1=T.U)A?:J4\8>=N?5;V1\JR@JA&64K;?;W
M9VV'W$=>B+O;H562$>"9%T[&<4$U9A5@;# ^L.N0!SG?/63#T/:T](3U4#L[
M+B9&"L_/W[0K;ZHJ&30K(>K'/'G4TRFJ5,/)9HE!K??.KA%H+E1_CI T\^(?
M-&\H)+;6@Z=VE .YCS.2[S")G?MNX+?]P%4GH^NOA?Z][_"&&<&!<'ZJXUZ-
M)WR4@607<=0Y@QQ%]CL2O9GPE'4KC 377'? UZ,=)W_6'58YY[F_R"KGQD&G
M0YG!FN&G,?WK@+&>G9T"1\B9#K&Z AK!'0QOZ]]G08IUK4J-V0DQV9;CJS=_
M;*<.!DY;V6:Z11F)*(-G/KI>>><4Z6M8_^'HTD#6CNVGVN]\CUFC^I<&^40N
MQS:CM_#_>'9T=D'BZBR7'VL!@4VA3%D W6XA9]#U+0]3,N4O(^YR]M _/*Y1
M.-"-MRV4DK;%W&""D03(_EU0X%!"'9?G.$288SE)AU(Z+&1PFJ>4C);'7ORR
M^!?]\X!GB DRM)6SL+.]&J2WVDA_0B CRVEIE,L6XN-Y$R(6Z^T/_]P#N%;V
M-')<_FO>/7NP(^ 8CT9L"V9)EB/R.J430ON!5M08GEAN GTS^J)K#?XI)_)K
MB''R/\(?%N%8:TVH$OC)?5E7[-^_,!JJL 39SCK$M6FK/TH*3_RH;,!.6@2L
M/(MFPIW=&D=DN\0(LEG,U9X*+^:9%W%=-F:AK(2UA?&K5[R>$RF+GHUC&ZGX
MIRPMX"D[[8852W:(PB?()J1NQ?#)73;H:!S[*=)]IE7.S5-Y%S0GR*\M^UEG
M-,U:A;7X:M/1';/#0T^GSC*ON".["=79SSFFM\(#]0[9D4X]$Y&_A1S4#1/C
M'Q3ZN?1YFP^W5]EYS(T%Z]"@V4R&'Y!.7W<$'L*)L^D@C<2EA',Q] H9ACO8
MH1&79ORB$2X9]5[EK\4V]@;WL@4NP+8WX?1$\A-7NT?ULI8FHX=@%V Y>%I0
M#X2V!IM1?;0+L@)B^#T2SH^?#/^)9C3<F1K7B[/XIL68(&0]#6>\XWJ?/NO&
MY):[ZV4:9A4506[8?+?29_OFD?I8Z)G;3*6.%^^2/*O"3@CN"X09RRU)#W?N
MG8O@#%]SNR#$:44:7##+HI\P<4@4O)YU(W6.U6!Z3H,_.LU_@[#7EF:)'$15
M9U-YF.=64#5!J69Z1*I"A\RD48YT=]*JW1;VUZK\\R)K$JQZ+G'^BK7@W[\#
M-8@/69!QAP0\L0A*^R]=:N6;3P+"G(XFJ1=6K(3]6/[F_AH?GYCSA^,CW@D7
MS[2Y=-+@!?_@!PG!@!M0V^6_\UHH]Z=_(;,/.4*99,BT,.,B<()Y&=_F-1&:
MGBSF!XXB4L]'!*C]^#GV6HZ:*VQETJ2&6WF_%-MSBI&^>HII/\"$<0;S)("5
M*%()2P.:K(*"6J91!N*_'SV<<>_>:4W16RG>U],>:-'].:)>3'WV2YP".^>8
M9^TNZ-GDY4C8435K"3DAP^/[K?/OZK>"#HH^T!I!<>V;O W9#R4FR>(E @(M
MNE&D7= ^( 9^TGWV)L%F_V>)?%ZT(:+_PWM6Z:T04Y@].A%RCC/#!1,,5R/:
MT/D^TI8L8[;)Q9VN[A.4]CR%SE_-S5,]KA$_ZW2IZIQ#QP^"^4?P4 LEK@_U
M+#@DZ7"CU]=A.J43+8Q0*G$KD.&H9/1=3=!O>BK\G #6_N#PAE)W>!OS&D4D
M0*=1K>B:H8[U%#36N&O ""*_XA+X9?N)2.VW3QR>B)(YA82\95VSEO\L?'J>
M!3_EEV:?XDQ!*L&M0S/=Q.)$I*R_A1AMXFW)'R.)"Z2!QP3K:NRWX4"I.!NB
M[T>'UR?:C/>+=F4Z/>:=1_(A'@/^S$NL,\.X8PC-22)=(P[;TS[C()EO7=9B
MX.*FF7$W1^+!;(.J<S9R=A>$M4A@'N(,<$R K?*;W5_0PK/=HB_S'4ZV?>NJ
M#$-_7>[M?)TRM_JXYXQ=/,YG[]@8JM4,P=5&^P&:3XJ99 3=TY'.22";GS>E
MFEHW7K2%@<7*#DU]R>BMAKQMZ?Y *:: 68I#].U;XUL.T;N@*HUX/=676\P5
M!TD@_3+VGE]Q$[XY>?2LWY'S;IWR#EJZSN]QILD201?Y"SA]!%J('DLW/1TE
MC),(9Q+AZ*>;X$2/PY4_5.G7G[SK,6P(U3@Q/=^G.&IX;WH.Y&[)LQ:.&8$"
MQW=!+*EJLMZJ;!2M=I:TWJ+TD +'=(A_,?_Y33HO_\DWDVG7,L:0ULUX9?=%
MHB24INS_KYA[:^7(M@N,$X L4X 53"O,N!F.ODS+3F"9TM47)Z8_Q3M(^%6Z
MWG?Q7O2\LKCV>][LI)P%G);7X<R09AYD^="RJ>Y,=188:#B5E5"^\ <G,K**
M?;,>L+HEMSD?Y%#K:MIWQNSW3Z/M_1<SOC?Z];^/?3_^OT_D-LHK4*W]>)DF
MPPEZ>#;#&$\;J^MWZC6/V+([:1L=W7P[>=%ZQA*4^51!!1OJ =DKMJ)\15#.
M/P(^L>/-W!DZGHZC5%FGA,N3Q3$*KM/YZ=1@ZR^>X2/&A!>7B<[ON;[:EZ.;
M6H1P8&=*VHX8#ISPF5R[U#):!B_#_3"RBGOO:G7HU4'*08'N%?8%9!]'@I;)
M&8+Q+:&$PX.+N-'&W_[?/;BDO9_M.P&#(R_+W_8_^^M6^S"Y=.LG=7*$4/04
M:8.<A]!<H.+(;IPI<(+8 6CQ)Q8"I?D [%I#SM\U?ZU<N:V5%-.(V^'R%^].
M=/W.+6LX((*<_^UQ9G0=I[0,$\<6U=(8V6&D4@>)/]NRUPH>^#&J;J4TN#76
MCEMG/AB24_3*X9S"$\F54K!:3,O%*RJ7@O@/7+\B#25'%-.^\$D'3Y_=A[?B
MTH):5(U5,E(8U7H&*05<:Y/'=J5_1EC]>*0#=6RL?$W.B5(VUX34S"1=3Y)6
M_+X!BE@>-73?3&.PLK>BLGM$,#,^'%%90(NVU.G,X6'G<93#$R@)*8]FIP/6
MT][MKYZ:LPWLSW-_@YU;?1:+;6U5,G%^PY+?JY8@M#22B#]V0??!T[N@+MB!
M,NSQ_%C[L31TA)B-ZLOKIWIA)7K[CJOUPXST+SU&T\[N/0<+BL??,S=@Q- 3
MXAX%22$L@:0O;@NN]W.:7QF/^,G_9V_1]4/XU:.-0J>[W9D9#P>0+U"MUM"[
ML!AT3?=J._W>I!L0^6$6&#I'\ZBL"#?N<)*/PJ9]+%IY8E=0YW15.ZOR2'B2
MI8VGYX;6P27?@K7QG,N,R;6M>4PO,:J4UDV!M!.>[X)$ I#'62?H.NG)9@JE
M?MOR>;DE4Y<S8CSK#,S+IT2[%D(UQ3_=532^Z_^/ 41PDQ&?7TXW-328>1IQ
M#K#U)ND=/$=Y-[3?AO)H+&5(NM^Y:'!DT5H>IG/5<J9CE1+F K1S1+ZR"UAV
MWN1=4!JA*B@Q5"O5]KR[I#L=$J>]IN:3;H?_D?-'R?=LP6NQN2XIJD-][VEI
MX#C]&BFA YP,P>*I_$&TA4'R1H>R&!V6BKA'GG:;4W_W86%N87ZNRY.]R/0=
M#<EK>C+R$[E'TS?7Z,9)? G$>9_.K.2<5_*PA+6F<[X?6V5_7/":?$#U-KWL
M9BE=)SH 2R/0[-<!+8MJ9@@B!"BD(5=([L4Q=X&P"%1 SGO9U$>AXMX1:C@O
MIY<=E[*@!B#1<(PA%Q]LD0M&,&SZJCGW=D! W2T)EBMPC0CWN3BALZYK4$)8
M=MH)^.'J'JLBJ/3)ZZ9BR'6]TX<G%QU8"@L"[#J4'R%;;@QQH3[S^YW/<T^M
M%4/R8\>2$XIRGW(&5 X:?]S_AA \=-[U.7,+.E'F6 /O45P*#'G"\SZ4H;CU
M_^!H-RBT'4-:7SX+>86FN<#><02WZ)ERK56)F>G?>/5_AB[503RPK$E4JRJ*
MF G9CP]<GT[I@HHAX&2H='A0MU%.7F&![Y.\U)(AD;C7'9$9@_[OQ%8.=*G.
M+FKQ_ET[/8"Z!:$YZDT3NO%8Y]5R.IA8W!Z9R]?7R='$)NM8K'2$A<F8N-DI
M\ V,=Y89]!<7W5 )Y#-U[ML%T:S 4PX4GU5I)M0?=A!G] <G/-YDA2)K-;L(
MFH$C(TK\[HZ$:;_+X<S,.)AY!1XYL_^O7^?T')BRX@"8<MD"H#Y)72\">!F3
M %<]2>(.3:TX 6A''1U<X0<W=ST&*DD[3/#(>]<2FPJXS=2^6M)[YVU/>AB,
MQI^,NKT+2EPX"MBI9R&5_"&\V%("'^YY9?F+X:)A]_(1@<R?SRZ"L^X>.O8G
MQ%CHGS-'B)M]][>/HH@?(8)P*$G8A"^:3FC=2#*3)N=Z+]:,K)6IJZUMP@-=
M?8O>?GJ;>*)7/.=PH57O7/@D2W*; 6$WXW@X/1 %J!=^AK\3)61F]\'?0WJR
MS +LKZPTB4UAELM>FX2['*^!NZ]KWPE_9*TF '^F?"<Z[-FUIO$-:M& .=.4
M\Q1IB&JM1U4/M0:E*QNQ2X\" [3N-K1$.<)<)O[1:99S@<L?QH[G_,J3C+D^
M/ZGO1UMU>HNF;^F//.M2D&8[H0$-Z*HQ]AI'+HS$"[I<PDT7QK84'-F)H/)U
MZ+^#C_CP6>!8-.T"!-"&K-)+PO.8Q" J/^T=Z1E.N^$U=AJA1D%+^3V\GY42
M:3[^2C9>Z9@@<FC)VUA11<+YU!K7FE0]X+0"?Q"UCO1"__P'H)C"MU^"1[38
M5K .]\->4/5A<O9Q8U2K+QX$=8(2*_'57LACW$!]" RU0 01>O#\990H_,[X
MYI"(;U:,L!W4ZJM/3O@F\^*-<_(D@I?6\^K@/#SO7LL1]!!"+X)F3.9O_;=E
MJ@!5\#69&I.T:JBWUM,M_W4PPU"FJLJL7%S5NJ3L2NP+$(7ASQ#C\@0KQ"GV
M.P()3<VFP W(VQVFS)2IK50G':?M#B?9G%-CEKR^DR8%8O;G1%LLAZG\BGG^
M]$;&6^X"]R.L1Y#:_BA%U&UH6AV4S\RQ?,&AQ(8T.V"Y83D:4%&AZE<HDY.7
MJUAG1&MZ;I7QXO65\)]7X<TM[%XV=A?DOPM*V 55:K3,1U+ Z>K8^KSOY#JN
MR(_W;KBY'LI<5ERKP=Y0#S"TU4Y5-[(DB=6=HH7N@JA'2"A "\:2C&0D0@\T
M:9#-A:^--4'*_)R^/:Y-@<Q@V6=DUB)=!5N5 ^X??G0^0@=KI2']SY5+^O:K
M<]><Q!E>4!W]Q*[G_K\[U)5FGT5++-_4DUA1UL9_JQ6-]P]6QOC[*S5A#GFG
M>:F]>ATXA5G>8-QCO[600W['\[-.T7Q(CU,9T(._9?S@.OU/S1?+'R^GE%*M
M#@L6?CN2VD4.L3\C1=%Z$E2\Q7XR_8%CC2+.0E-Q8,"*OD)): $GNF#1\0A7
MRFF*_/XG'9^+RSF%I,_>,4R[D_]Y7F^:VP4UQB7ZG6G1D&:7_'E2FTMBJV^X
MCV.%=0RL1U:7FG&XYOIX8:G:&)7CN6M+CY)49@0/#O)0)_!YD%D,1T"6!$U#
M26&X=!X\G4!6&VK!)!O7!95[3+D$IE]JI N*','598DO+NN$'A<Y7>>DZ'4/
M=Q0%J RQ9++)ZMF0=GP*K#;MV2[HH'>,G='?KKYNCL9X(?H_D:K3HNA03^FF
MES6P%<>"?S9MBYC<,.9DX2[(>!LV!H4:YCJA9J$<X:0P,B%AV*8,0'%DG\GG
M98?Y*E\R@22LZ9 ;OKT=_27SFS%2U6/?]9^^JCC:@VL,W'0!@783$R\#,SVZ
M"VK3D-3T.: R#K=R(%^UC&3L.&]R;V4_@?O%*RRYO8*>G_/,>-Q/M!A2=^6K
M55 9XMP$_*ZLD=-J=#%VY*X";D#A\BV71W=4A^.<NR^S=D'L!BZ;>@G%:E#W
M^BS -#VJ U$DB 3'M#N(?O]H$^5-U@FZ44M7*,K]?"XTY BV]FO.?/7!@.'X
M[,47<5'YZE]V8$%7H.HH8KZ'.AV\RL_]$=%T"C3FXTUU^GI;Z0&K))=#A9E7
MAC-ZS_XZ'W^[6C+M R?4>/4MK8CIPEVN"V<65@-++"OF_ #B*@AV!_I?9CW.
M'NQ_)Q0?+&/3?ILWSPXYA&KUAA(SH4K0(#F<J#^,9RLH?L<AT4RV4$2E\V3X
MV@[3/CX\8_J.C;;JZ.K:S_<Q'U]9EWPYPV_F/.RAN(<1K/.T=);$Y$UV"@(:
M2?R-/+;B<2AK9-W9=;: UCS8>"*U*$)O@D!-%0P->C.[+F3B^*CN-D*$NZT\
M :A6 XX9J+]0#4@^]+,N.]7@"N2;QKID9EZ</6@3TSL$' U:=:3),GX ;*:M
M+T09H:&7M(GFG\<N9@8=^#GA[W/JU_SPR9X?L4T]X?UO3'&.WS&_9SF">Y&V
M#6PPY3C=$$G./H3K>!-_2?ADEP-Y:42W2:V$X.&KCPJ\-=?JQVA,:72-?#J[
MZ)R;)5GM-UV?P[($N"&^?V]Z10/B(#T[U>P:384RV184/ZFL.[:V%H0Q.T-!
M2RYGY[S.G^O3*0NK<EUVS55)<PLPVV=O\K<AZ]M.5-\'R&<"-HPE5LP0'MX%
M^1"2D4=I/G%K7"*<WH83FPAE2W:DEWYG^)M?L,=&O@O[)ODJE>1C%W_R07]?
ME[4T%X!8"E%,!]8UNLY0%V$ZOS-G\2,9O3_<]BQN#*$6'++A?HFT7.[37),U
MLT"JNU@;1N]2C3<*=>\.B%CD.IP$%XA54$0NOD@9?C<3IULQ!F@5U42=8%P[
MV500IP+477$:O7>Z_F_9O5$9A:1>=-:"I?AITI30GK?&>*):]5AJW"U8 >Z0
MYT5'.XJ[(1)-J/NR'9SC&</:Y<\>%*3"BV;:GG+("V3+%[W6/G\L_1Y6U$4^
MH@99$%%&W&1C&Z/ $4ZA_"VM@8@A+MVV/'^"[[>^8W2UTEATGG4/ER;1'B3>
MV6LZ!XRL;C@<Q)]NY7>K.AP2'/M<#/D&,PJ;RN<(BC"O<X;0M*LH:>0$SG22
M([W TIL(1<G\D<DR$:TN=0LOOS-IMEY9QC"8ZO1NWI^R)%VO*BK[^,"M/?VY
MMP'X^^FSUQB%0!0=3>0TTBK:VSP.F9P>H[(\R^YG/:E)*?[SP/TR_$Y-97U<
M=+RZ@/(E]?]$97/"G.W9$$I0!S@/1:S"?UUH\*&-$AVHHS2(=91I%PS,@A C
MA^11GE:_YMZL/EH1[L'J?#V@*U62_/@G56=,GF4W@KJOY,S LG%X;U32DZV7
MM72I)]NQ->;WS[7-.Q0=CO&/KE\3'7SV@A*\E+PW;Q*XL>.<:"$RQ5*E_THM
MPA2YA0O_1T/B Q+5L&_)P_E?O^7U6)^\&,(7_CXNZ+6"4ND_,ZY'$1=@,S!2
M,15-PJ2@1<SNT(I0,1;R0'80>5;+/.S6^ ?Z?T],YLVH<.GW,A(NAO32_:FJ
MN>=4^-/\-E2Q*[]0C;_&1!,XHC%1."EVQEM;:V0GAF(6Z.2N+V&B]R9_SMAQ
M >^$(N82OJ:O)E!04VA&"#WL.<K'(1YWF*[>0)NUQ(UO-7NV,9SEL\K-NJ*V
MZQ[V!7K5OZ&L_WI#B>^,2&?)9'($WS+/[XTHVH1&NP2U*L%("YD:[>&ACR8G
MNY]D?2R^8+B=<D]G,.\1T[8H4T3XK?$S2)@<9@ F@&H]AB(V6?#0)E*)ZP>0
M4WG"M.YX,W.OG,=)G_P(DF;NTO&YG@(6-PK?"Q;"8PR_SY3H&RLR2I:<:O&3
M^;"GD-'N:.A=U+0M"9VTN2['L@ .T%;:+(Z/N.^"JK?F)=M=HN*+O1</B$Y,
M^NVS.W2;[['^]T/=+IP[>.*BD0H%NOKEBBQTYDN!WO7^S]^OQ80X7!$<FFA&
MD= LR7R.<.M'Q$6:90,E:-:@_=O0LYIT";]LG.JH"I!+7EX<,W2-C,OX.Z^2
M_9]UT<G.!D3#(2V)D_[+!$"[F"4QQ$"SFUD7:!?< 14R.'[';1<DNCFJW/"0
MX@Z[-KJF-H;L3=;XZB^LE7_<(&;VY]1UL?:<?O \X=G1<[1,TE7J;13)%9"S
M]AH4H V^;7 3?VUV^^=!Y=.G6%ZHUM8\S6&</F>&&U,X"8#?$4N73=QDIHJV
M7ZL;54^CKZY7G'+U9#B)95N$'+G;VW"\YGVPQR]^EL0Z1WB=[YW_ATZF'W!U
M]F)M5>WHD9I:()\"^K'\^$=AC=,+OI'QB_JN)6F&/3Q2QS!<RG3; 3AR$<7+
MT9GA#..Q#AWQP#3]<>^C,</?'K=T:QJ57$T'2,WUCL%/Z+BS!D>70#OC"SJZ
M_HVPB^6SW+"T,VMA=[!SS90BB-!HF%"32HEUU_9%FGT</'3RU[M5_:SG@3S1
M_XE-K\/0>)IK$Y0EV4W>R+KRF0%J29T.&12#FP52-,QX\R(P$S_>EX T/U\7
MQ_1^_GI'W%)?^CPE.AEPX A!F4:(L^PRJ#<X$;H?=V@>B'2@)R1[#*\&FMD]
M-*]XD6<#)T? /^5<TGEQ5B"$1R/3+L1BI10W;[+ W$$^16G :-9@0'6]56^6
MPK@-I-)YNRU4Z0[QK(=WR.5A[4_XBC_]"9-AN" 8'Y'MD3I/0V-"TEJL,WA?
MV!] .!:RU'Z@B#F[H+I%-&V=L0 $HJ60RLLS_<&S ^'WX*;7:4UUE[D26':9
M[X8O1OE03P3UWK];K]M%/CAO,;F8Z\V.P1DA6PC50\^1LJQ'8TW29>'9'O2)
M2K+IK29A5"2J2%AX(G&VVV!A=J:G[NGQC>M'SD5C_P=2G6& NGDV2TJ+N/"6
M/R8AP1":KBS88)M^ "AU\ZFJRNN]4[4+NC2A6WXGA[*:<30ZL-7+/TS[SYE2
M^UW0TC8*IE=OD0'\JT!8T"&K_'1(!TSXG=TN*.YA&0L\'F1V^)N)JI%@P= G
M_/2'9 5$5VH@-*3WK;"F249P#H>+%?/0Z0TBH3L]&5H3F$M/(:'B<"I^,\K1
MWA9O\C1'=+:\1G4U)A'59EJ&(=H2/:E?K84R!*YEMK+SV+'X.]!9 M%G-9B.
M9S@ &^2AN 6-D:8+)#C,'K"-^A3^SG4<UCXY@\UWM2U8^%YRLV4BQ] SX$<*
M2K_@^:J4S-)?7A*$)5;'$6(S+?[D'1[G\".0@!UM8J/C"'&\HDF/0I#RR_B3
MA?;S3[R-]WU4>%+ +?[,4/]I2MG&I5+379#3Y-ZHC!VT Z#AL&I68(KL0PF"
MHP9(2F<(3P[J7G$A?>5S'+0,'O0GKP/:2ZN=NR!! DL2W:7,!SB3?M=$F9*^
MS/KOH!(V4^X$P>'Y?O1%$KP\_X; 2^^S:88M??M.8WKQP.,$EJ)4R0T4?!<D
M<L*+"$Y&GOAWZ/F#@<)X+U[ FC?- /8#O*I#TV,D GY,8U1;-;L*X5^$@-&W
M-NMJOS%*V9A(LI+IU>%U\4^1/O5CQ'C2\(WIBWIB-P*DS7@=(P,V"3N$'68+
MB\M=8OTL#,)-KP."%$RLY/V)QWDFM+JDBJ#B'VN!GC%<75+'GHX1E/,(.-!7
MILF!T7E&\%R!#D^?V6B!5NJUI(NQ N@L1G7%:[7FH@120Z"$%COL^K=[UMK:
ME/.C/0F>;]4O>J7_.JD_IT5K9[SA9EM>A.6PA>;*+DB!BPZ0M!"6/-T)&ZG[
M"7$B"A5:X)<5)JOM]?KV6(!*1OBGNY:2?2V*0C1;&' $PI+R9&30+3(AU.],
MMYLK"P='BIYV^W\*1]^B>_?-JH!/S@B<2G'UI2I['4!,U9V4?&UV;2G[!:0)
M6@VA#A'!LTR&#8"FHTCK"6:V)+AZ]T6Z3\*I8UL]PR=*IW^/?(]4SM7,G92A
MA-_(_-BCY/\OB;LU43A>%@388MHC)TR<NR )RG) >H%OUF2=R0UNNHB,<IFT
M;<[N>O(^Q,VU@&[2:C9,4KYRW5BH_PEDI8Y(6,VE,1E![+<01B"@4]A=Z.OD
M(3%N:"N(F47LI&%*IKX'[A15A\@B1N?<+/ZI'WEO%3W8"NLU;D<#1\)8TK-$
MY^<(.'GHZ2Y(&2?.,L#1TTI+[4K< ?]NCV,CF%,B)]=O-H[!M==S"#9R8N5M
MC8>U8]RG5*\NHB8_P8H7^;?TH<3WA*_35XH9+L!%Z8UZ"/^RYX>UJP=_I9W[
M#EHB2/<@YY0/T%#MT"E>"B:&)4AJUFO+DQK&R?MSA4S"9J3OJN&L0-X,V3)^
M9$'-^J/3R[><LR?[':X-$:U8IK8<T8/'8YD/PF_;U&N^!HHIAQMY^GPX:K<H
M1<-Y9P:0)0@1=NHN*#!Q%W0'FK8+ NV"_-)3E)6 MW0T6?U=B1]'FBY"2-R"
MAUG6)I-[K3UE9UYOE85E?4VZ)6C] 6D9/)*1"4-3'D!?K0.JQ2S)JS#@F&0X
MQQ"@DKEV@='B.X4U6"I.+^:5KO?/E;?4AX_]N\WJB-$'J^,1'%E4*Q:R?Q,L
M[<=1 3KI!#)_5R3<@BS\;&3K#7SUZ)N6%<U.K=F>I5[=]UT\5RVN:LU B<EX
MVG]!,P8<P2V-CFFDR0H*?"J8#%!';97YQD.5K/.[G$/FA9FVCLKZ#U2T^?^R
M.>UP7CRJN-#9K.GI3S-!(DH$84++3F@2)BE9*&FT6\A5UHT:IAI-2ZO4U=2>
M4SP^?(YR9NUA#^87C"-:>  ASCQ\ !+6E7=:^P'R!MS4DK?6TAZ9"V!6;M0%
M=UV'*SRFP8!;KA6_!H-_/%_$"Z*(=3":'6%&DB-TA(1Y:N+0 O=ID;]$:(=*
MA!??H!NS-%PJ/A9?.E51Z5/<>D];M1+[+6)>%?NB-T/SRSZAS,RKLY'1.]Y,
M<7&N5(YCGJYXX$J"Q?=F#MD:#IEM]"Q/X%-0@"8^%HN:CN4(T0L1+O30POFZ
MV"9',N$@-UZ#Y@7K&D=6,0'4]?-SBB4YQP^_? [*%MR0[C[%QG$&H:);NZ!G
M:)"%.$N??O$;@J-"@\;4P,#^5_UTU+IR=;9>'3U>\#7/*^U"@.M+E:,69V9S
M_G5SA'BX&6P5./$_S-X'$HM4O:2;2H8+YE':E,U&I5UO_EAWUQ?[":Z9,?5$
MZ+9:?^_RM2M_NK--@G8X""&<@4@B01E0N3G*ND!:%_>5]RB$HXK<.\,@.S?*
MKMKX'8^;ZS9O>OY=\[+TZQ?//:59>V=R!E"*3<>#B4%QNZ!]AE$P>SP];K%L
M)^]C\:VY2Y'!<%_JSVXINFM-5:O!?[V?CM]PR[!P<^8-XBYS;[8%%K$_9ZD-
M6M5-?5OHQ\7EN:]UL8YT))[D6C\\RR_OD>WWT$?NNNJ:C4U@G*4-YA/>VP$P
M)L!J@.("5@B['F<XQ[I+CW_]^=P7-'AZWNW^D\"/J(,QC_S9'FR5IBRUU^=.
M''I<:W+MJE\=88?3?/8?DUS7+N)/\F$IL#\NXX[6H!W&L*G7;,<'RL="K+2O
MS!_W?=Y#>2"QO_>%0*OTWTF61"1'4(WFP]AD9R."*.LRX?F=2!D@VKO\_C?=
M:-0G0I_R.W]M84Z<-N/ A%RENHP[\1?,["5L#,R2ZF.<HV]3O9E'5F#5VZW\
MM/2$K>^!CPI&)#O"9.7#$JB&5(N32?O,7TG:*AR]+?*"3;0/\>_EZHHTPE=\
M5_J4%I$/3VNG.)43YUT[7.J2];"E-BS)R(B2Y>]^IOF:W]6VL&6XAZ"PI^_.
M\?J9H\V:\)@5.B_  J)HS%8N%[$/FOT#3D#7KK>- >G$*#V/^*X%IK.QCH_(
M\^W[.0XIAC]?JR8S!.+5LGC?W%P3^5N"V;0%(K\ %YQI#L^P#B#<&X[@V",E
MD^WVJ\M\!*;9LK%,L(V_HI:OR]PATAV%+U%MA4]BM/[Z<(2VN;;\ELT1$J=-
MGL<#0<;Q9J?HHZW;UM]D\)BW\$VV@U5V4LV\"V-&+C#KV-.!:M5 >G4MO_3X
M_TCD>[!94\8%X/AG%IC]A9LY$Y#'N-H[H2(#%?^M+C9TWO4FO@9;'^#V>WOY
MLXNK0 #U51#6-T5BK:5$6F=^GK7*O^+?4TDJT*RLN/?RS=-]FEN;JK<KY7J4
M&CI1>4$L&5-&2C8%PY)*OY+9[F*?3Y<\#^A%W/FX/".3"D=]$?%0T$I<#Q6^
MJ?.H)]!'BU&2M^"3?)3.ZGQZ%(\')\L'/0]U2+ P'+& V-X!IV(V1:Y.MFW<
M_VOF)':_SJC*"JXS1B_]+G77Z=KB!Y]S/[P.[H),431;!T E@2K"U$..(XW8
M^2@_M@]7!]T;CZ\K\14#7*_C)O4\)T(;9U-*W^I.7JN*DU!-([V\=2LQX#9/
MK,MQ56Y(V:!@&AO@@:!T&,T%F@)51-U+A3&\QU"WH>*^>?)-M-SL^(#0_<.(
MJ(?JV<IH'Z4RV8D??9\$GGVN'H /.JN]_7;P,=<!X#"J]&< 2M'K@$QW>S1^
MJQYM<O2=J4CY2."/<;6[/+9(/.0SK?HPL-<L,.7(6@.&*KZI(V/]_*JORX5.
MPQ"MPZ/ELN(]0M\/[5,.VQ=!>1P%<#S,N&QTOP_[ZU[IZ  DEE'/SD5<HZ6W
M<P-WD9Z*3L1L1EUP'J^9#[&S<(W5+?4*@!O^TQYZ7]8O\&;MP?&BG(GO4"A^
MY]\6+VEH=N1[$)38!-G_\;%O,NL*[</I/EZA\C:H.=^/J270TO,-CW/,B'!F
M%X3F  ..HZD'R.RC,_Z1X&0<#UTD*WN_ CF>#)9>SJ+-P(SFCO]=.'[3XO'G
M05%_1A CAHLK#GO3,V3V^DK1(M  =ZU;P"U_&J%M9BVZ="4'OE#]!9/HQ1EZ
M7KY<5>TJ@WV]G7%'8C Z8>%H[5X_-91F TF#U$VFXA3"F43US[0EFPD6])-Q
M0I,]Y\S8EI+.NB'0%_5F)BJF]_=_1S=@2;>$2.=C'=X-P$N71S=XZ58DV;:.
M410Q'E:S"^HR94,YFN!DB%Q-\SE,CGFF7;%52=]#10&@_VNWJ77OM(J&2@YS
MDB, [V9)\#-F3./!24B-E_4T09IHSH.'H]"PO&>2(WC+ICW([  ^0(DO9XQ7
M(4016&L"N;PH^Z/NQXH_DV&/.3+-XV68I::Q>\P F:%PJ;(5J9/L-XUE*'VY
MTUP#Q=SGAMLIJ"]L6H.Q?V]FVCU8TDY=>]\N*'&O;T3NCX5L(VVB$!5%FCHZ
MR=+S*;@EXK*V-B+\YFU@^5S_T;BVL]>+;KZTP0] 7T_@WT#Z'%@2L1Q!J@9+
M2H'LTXD1Z*;G=T+Y'*(-]T]T%9+>^?LWA*I$E$:EKU9U!Q\]ELK[UMBJ\>/@
M&<QO!=(D2\&*EO ?72T/2X_DDNTX>JS#USR%Q,U<IXF15M?>!PN.];6O?XKC
MYBO>MO)+_^;Z\J4A0,V!RLUJ^SE .3VVBZ"XA8DW*4JG#!UT7391]=@_CK6S
M9"RLZ3A3,8R",>URB4/RXMC]VKL@"YY.U"4ML9E](B4\IU4S,UIJURTUSG1%
M;)8L96=OL9$63Q$\3">6/BVH%0]H8+I0"1:@8=*PV7%2^K.9SOCLXEG++Q*G
MR\_+J!Z;^RL]KUH0J(,N1ZIS-Q/#!6M:F86Q2=?Z(;HA9>#2O>=?&U#9X8>^
M:_!JH/N@PWBJ(ZVO RVW"_))3T$+FZD$%[L Z5T<\!C7F>;N_VTR<3.># Y(
MPA2F*E]\BFYR5*J>FOQK3'O($4CAQM=K-AI^2@$<@ZZ!M>'CLTP*-MSNRRS(
M K'D\I,*GPO>%HB8/9ZQAAF6IG9X/R1\_ QOWN)EWK&XO_KO9NS[%PVST7.W
M\R+#,)0ZCNBKNZ&PZ5;9MP=-VB,0L4^=SWC^7;+@-*]$<I2*=T'\O DID%I"
MO%%Y9T'5:2[M/)!Q,[\^=3'&4O[62?XDKTOST5G=]OXKZ8"6!DNBF%'#_M8$
M9AKYH<&L6[0%!VF$/FV\/"%]"Z*X8E)8S,BKU8:3&YLK&ZJK&C(6CP?F9YW?
M$)BY,NTM=_39ZAH_&M5J]PH-'-9H_ZL?_)$E]P", MZTG5AN7=FDG"+O/?34
M ]30JQ',&\BN&?[.H.=Y('2'AT'S)-96*_7L?4F7?UE?3U@3-6,50'_.*9E.
M_H%2W_Z/7Y#H&QQ!/Q)LJJ]E!Q-S!&CXN(P&Z^B=TO&_@L/2,FU)*5CTM;\5
MQ-JL=<]B&73]=ZW!T=%9//$5M$JO$S:%9OSW@R/ @N%I1<44$5.7L:#"!EHJ
M=2$_WU#V9%"J9PY#V*^?Z!/RIHVF/\<505O_>,8Y Q":[?HTF'&93@+2:==:
M#("PSJLNYBD$F\\.C_#W7DGY9IPYZ_Y!0O1,E]9>XW+,M"+7<V[@P'<X6]OQ
M\9>C1D*UHAKU3=Y[FOLS<YVZ1,&$GU!S?HLK70;OO1[_%CV ,D3MS4!7]:$Z
M,)V0<Q#P+L@7'^^RW;8"WA?N0K'.XPQUS Q^]L/T:&..Y#G"X?Z>YCB*A/[9
MT6,Z3_TO;CI'F4,K<G96^;DJL;4#)8 =DN%THZN'.@8T1Q;)A!9QW[[2B./?
M3,,U:K YQID0S?BH/S:_^=TFE_$L<1A7PE@8(MM00H_61?V-PBR.T(S>&X*E
M?G]^D!I9N#";6^A=J[-T)U[@Q<<4U3NEFY)=$%Z$'-V5B&$=3T_.D<DEF_->
MH97CHDNGW4"T@N]W:_^ZNYQP.NH: <I8".!7Y4VS@?1GIZ*(,?A:6(N#W$K>
MX;WG.YQQWI8=]<9(M3[?'$;C%\![E9QA%5KGWWQT87EM1*?S1N&5*47>F&,(
M#/F?*1=P1T=A5Z#W4<1/,-I5?#PW89CSM^1D/]_\S7+^#'0[Y;3!P,N3M*)&
MGZ)6>1O=$AWI/G4)AQ?]XEXJ EW5R!-[!5*$%I0E">O"UQ9':X=B#OKAC@*A
M)?CH:QU&%(?Q(W312J7!E_GS_;'^8)4KLV:JU U$&7N"#R^/E.9>C8?4)'2!
MDYXX=Z0#QZ!4B&S'J=% >.#ZHRBPTQC"<F9F]K^JJ.@MN). ;AFU0$C&*5FG
MOWC_;>??VRSI6 8ONV 7=!\U74UR6&UG'EU &-&@[7CA^>Y=D& @FLR^=F7$
M$S_RJ/18^::2Q0C!KKH^S2N&#,5:;P1HK_5'G/Z\K5/<@6V>KYD,,I=A,WE8
M7'78:K0+@A,2"97=76 EY/"3L%5Z.><'4HN>6[A5/E$I\X[L1ZV)\G1K>N<X
MH4O$_=A<F1J@DAK>*I]1>'*^\^EO_R".D ]7ARXQ5NCH:(X>D,"X2P>WS >U
M3(C<WMD%,7Q2KD[>C-:3^6/8U#!1TV<:GG>F[8O^D:D#?P0UF'OYUY?3Z<>4
M0G[W  %JY%*PT'VD^>BEQ<\4.,RRUK9/Q-6M,><_M\[0T/T/ORLU5ZLU!?X^
M9%G $SOTD/F8TRL?1 UBGF#9 !K%MWSEG1.;; N@+)5OV/GW^BXS_F)Z;WT,
MYMIY<H[)/TH[GLMS1SR -_I:__;H3MT_I#98;:^-?.^>J1"F)$*-OM_E51B7
M4\4]JC=3(?M['LM8[%VQO9$\YA9R,V*B1]XBTO,#YM<NB"/$1<+C;P%8!D_0
M(<#L,[0#02?4V2<H66IMRW($&K@0PV!7H(AH!EZ<=9P^ZPYXEP):G9![^!%/
MFD7UE_O76DMG7\I_#SZPE5MU3N%2[I#,HG;P\WM-_(P%[HK.[8WFKW%F2>FU
MPK :3YO.T2J&2$6Q9(CHGYVX],13N4Z$CHP+13:XGZXNLS?M[M]\GAAK7SA$
MZ/89TMT%C:^S46\@(\B7F:14K=CNA #[J,'WL1#8"#YN?6IH[X@[#3\; R5I
M ,FH^0=' WH4/HF>89QBCT^Y]/GGWYJR33>9O8RMRO0YW*?TJ64JL#'LL_?*
M7^+6:<QB+.,)=WEGD>,P83RQQ)A0:YQTBKM;D@C-^O&F6X@L^<#*+W- R>R*
MJT5;JK?YL\?/?@4_.$CQ@^BNU9 TJJ,,>?].<D3WT0(;N7E+2(6V1(E;R(W0
M2]@*)J5+3=L/ZU<WHMNWZ5&?AC5X[[QC*[W^I%-_[*"S'Q^^>A<TW<@%_&=(
M4Y8(X$/7:LG!H<N6+0[3[D4;HN]^B_=[Q"1\=>V.\ M6M.\2I :JY!A(?4GK
M?4J,E_L[-/N0H01 F8]81\>0LJP;HRJV'^P(<4W.OHFGT,+WWQS1+:MXO*XO
M63/D_U*Q5\B8#__^$(J8@*)=ATV/K#&YA*ARG?K:LRA\'YF4JQ.*DO;'2:/[
M1!H4IY>=LHU(T<2G[2IS.<T9XQK^[M%;DRS%E\RS@&3;+JBJXB5-UQQEWP@D
M4-;%+ADBE>KJTZ(L^_ZK%!KZ['Y!X42=51Y4P^N=H,9A\5B8)K(?=6!K/0Y"
M.Y>>NK.>"/>NS"8GH,E:D<*),\<]JVO25VOK(@4@C0UR+ZTAI^64_$=1/KL@
MP+B1#$NS4%V&RJ*('U"00*3F2DX4RSG,0_H'UG3^ZI"C_J#NB&EJY)4TK1Y2
MSJ5]_H\2"UX:[+,/AC40:J&KG66(.^RT)CC3F"6#I4W&!VZ!A3M)>,&;?S)L
M/4EL"^&;(UKA%:K89!M/\2]1O\EWI^^I:+QAY,'262#H>SQPU&$53TR?H7 $
ML4P'Q!%ZWML#] F65_N%QI=6;^^467E&ZN1V')@\QD$$?R Y#$9@NB&'$'>
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MO5D-P4=Y!L+I1BGT0]]&KI)55PO)N.Z&CF<-HQ6&IRM.\WO=':ZJJA8ZM?_
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MK$,YT<BK0]^<$EY,7 VT07?GB'(IS[PD\KEMBD=4?P(VJUTO]SH!I>G.H9A
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M?/P@;B=?5,![*<Z6MR'Z%_.W&ID"(#(]D:HO0<3T/GD?FAK#^4'>P*Y:=\F
MYLLR?.7VAL6UC@2U1OGU^*% _87=X?YA19F3B 5I\ECJYKH)S_/,PUW2<]X9
MW6'XC<E%J__?,>T_H_P?P>%+=E\>KO>!0R_U9$1E=B]LN4[2)7@?8^%&\@2'
MLCT]JI/=7;&?SYXBS[\AM3U[#=HR *N /*^+-1D#1\J]/37M^W$&,2(_L:)8
M?"*D8;T'-\'A"OX@88BC:5IV(F!7YZ#K4OZAF?>*V=0.[L&.UY.O:Z;X)DZ+
MQ>AFE*'0SR-B5:3S1T)^=H0*- R9=<W[^IR5>%);\,K!TQSK3U??+*==HA_
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M@R1LK^H]#^T$RG(GE,_P*$%$LSMB&&([NKEWMR[]%'*\3 J]]MW@O3C0]]F
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MFT\+U\PWE',FC' /.16%RTXA>I#<:+4M7(2C)9S?BQ;%15CBQ)PZ(?>!VH[
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MO6?0VC>V11Z^]9?T+P?ZH$:0N< TEWI4>XKE$O!-RVE**+T]]X48?UU4)9=
MCWW8R\>8D+PIB4=OY["FI8:<WQ%%WL75OP1T_R)+_UI/FUWQZ]%(^?D1;0$<
MO-^4F(#@NM<R:-/9Q%)Y<2>M?,W6;DB/]4,89S7'41SKR&?%;'KH,4 <G R:
M1"WPSW?-DR^C$^@2=!2$E9Q"Z%P02*PKFZ@3/@:<=7!:,[N4(NA2Y\EG>-$(
MA/]BKXDOY5YG84*KK;H(M[%Y@[ZQ4L]"'<AK1.:%04P/: J.RDVMB0DE8?DV
M?AOZX$XJ!DAFQVG=6-<V'/MN4>.F<B6E10WZ,!>24N(I7IU5O);[B#>L.L_-
M\Z%4[W)C79*X?S@@#=(J"BU>.RJ6]:E8RPTM>U:<%6]36]_V4A@V)V?'TYMW
MY+[T5FG;]HL78KWI*(*)NAA]E?:=+A@=0OO<HK&@.#5  B PD/-F :ZG5E+V
MT6S=BQL%5U9G>G;658R#?,]C94U,LYA%_K!P!;D0[-.FO''5.43O!0S^):&L
ML\%9^CLY\"C8GOZRJ&-TYBG*I#6!-+>T2:SPE.NX)K[+VJ^L;;?74!8.O3FB
M(2IA,+R7D/$ZSWSTV;/SOE<?8$?8\O:E687@OUS(EQ_#\5,?9\AN*%CMM=\M
MYI_7)M)\<-N =9)9=,@#WH5;#5:=DH&=RH?BTX=RB5>F)'3'=ROGUNPG[-HF
MUNF1-$KL(9 2#&VW"E'$YI TQMI$J!ID8R++M%/S<!5K=]H9[S90R\B>"U /
M8:*0V[.%4TO=^[5^*\+]H0C(UVRQ]>7^-O7,=YQ::P(LHMP2_-JF/VZ.7;JI
MX$62I(P/[P>A^(<UHE>])R%@ZK]E["_H&!C;,6 Q/Q@]^8G.XQ1>Y5.E^W@I
M;7-#%&S1RE-;_'VRJJI8WE/HT1!_[RE_84U[6A4M'OHXC):#?.+"2A4G/ARM
MHSVZ_/+@E7AC7<(6"C^ZN&QPJL-4V%285R@I2\_XU@=S%\.R#"J2YX'>""7M
M%Y(L59WSQ1[:+@]16#MH<B[R"*>#B%Y2)>.(B8,A=*GCE2^&%U^S2::T\!4R
M_6V1H'.M#M?-*J+ B,IUK'Y)J5R.>,]!?1"VY"=]M!&5\_?S89Z1_AI:"\V0
MY]C57/,4^.171(%"?W?#U^QSMN?JZP,K4^!_IPUY.Q9[F&P-YB<^E#W55D\>
M.E)_7;2FJ'3IR:CJ@"Q0-\1*J2Y!^JUL]+R2EBZNK,"[]!BPG',89_JL)6W9
MFW1G6&W:A2R_G:RFM<?U2%XI!'9>V4OEOJ-\T==LLN/MX5>]00<6N]-GY[&8
M!<44Z"-+LHP[L@[\N@WH&/V85M@25#[O=8 -/F\UL>#@8XW9/,H,"RUT3&I*
MS9++<,9V+'RX_?1:.WPC'<2]>NY@\$O[(IZ#RZK/4TU0M9(-/@6[,#/W]<1"
MC>",_0W+V^/3LRH68X^>JLGKHVP:AA9]8CQ/S0@W?TM:U^)Y$(NUT#J1"E7<
ML%2T@@VZ,##0!_EB7J@-'&[9#OJN2.4[PG2WG41&G?9QZ(9<)#P*]]HP;_GQ
M(Z7:/7P+C\KR]CRM@RC0^"B16FC&X&7>A+]?D(0[?I,4BFQGSIKK0U7A4">%
M'H=*+BF^![7@1[SM0B\<?OZX!KF'5;ZJ#;UK'Y88+"J5G&L1^VG-UV0F&'^E
MISLOF5>R+N$2NGII2'.OI)E ?UWNV!Y1OAJI_BGLV53"^L'MVJ8?K]R_[50K
MB*<_3=)GFUPJ?4HJM*RG9V..5EEQ:50!-\NQ$-!DYO1:4\A64:""*N[W?0?3
M@$OMG \N"6:]O[SLQI]"D0IG[=979(2THO'"K+1)FPN/<_CI+A?7X3^(;.&-
MUR=DWSSU*;@9YZGO\T/DK?>!\H'):)T.M'8]TKF@PH$;TE<^-3UOOY)ZTTZI
MM[EQZ<]/(=%U;W/]D0ZLCHZPK*SPY02)VN]U"1-8Y<CWB[$2+^]F]+]8YCS/
M?[- JG^V)/1(JNS0DT%FO1F,Y"ZMU(7DBR#.;Z)PVPEM# 7P,@LW?][;?BZ>
M,U=T4]OZ5^HQ8-4^NYCX2LY\XO=KB66^HR./;O0T="$MB2X;/MT!:D!M\E1X
MYAHVSZUA%9,0:'9+.#DNJN3= N4FL-3X9(92K/53WV6/>Y)*7$/0TDD&-YE4
M&*3JBQ#VSL=3T>4&19Y$IYQUE0#1IIDSW!8XRNY\*_@. 9-8%\;G-2?V.\2T
M]F-;2;'GP=!'3J4'"N+OZ*ZQ<1: RGOI6<8#K54;)8=153IPV#6Z$D-&%,Y_
MQ[QJ"?FG_T;:9"']<VSD-P0,Z1%A"QY5@8K!]6ZK'M!1YYZK%7Y.?F<<C,DQ
MN]+M=Z7W=V7L&)\+UA_[8+)2<.I%4N/*N[CYK8PAK1ZOE-2T4D__]ZJM*I:C
M\@.<TY[UH?5GLJQV4NIK;I;E+U^5R-BO4N-4V04PGV#1KIYYMO1-3U9KH&"]
M;6/_FJ8_@%7<'U@N>@PX?YFJM*D39?6_O^'/_V$7<^)_;W&,_;\[&+"0_JO)
M3-&W8T (=(_G?W0P^9^7C5DL2G6$#H,? ZJ?2W[.!6F*K.P5>^QMY =J?F0=
M-I]K0^2A6@'Z24^(VW3H>7^MY3LGADU,1"UW2W-$?_S[A2UZHN#:J;,V#VJ2
M[S"7E[**DHL5T:)@]"U >A(3^M9EP.>W^9S'@,+&\@/8=7PW0-TD_L1U6935
MD/9NFN_L8=G)RP+ *PHL OYR4)8^YDGNO?U'UZ4;RAI4?W"A;=8C?S,+/7@U
MTRTHPFW**OI#AQETA]4"P3;VD*GAAW7@(1INWKB4+#)64#,]^F^[L56.UL]-
M3X-4*O0*((9?C![3'#F6^6\7O7@([OFY_YZ$.36*#AMBS/9]52'0/@9PUIJ7
MU5GF4_M2+B#F; >5.(H\!MAG:@3J.Z.H$?L?6:UNRQEK'H:O('<_(LLVZ(PA
MK1:[Q>8^=4VU!*<P>>HUD]KB5TNSF?41@RO35+HJEVIA,^_P;;N^=JJ2Y<?K
M_WQE_JA3<-6$:UUE)JQW)7;#XDN8'8]#T6" I+^A;UJ(W$A][Z.$4YY2[^;%
MQ>]:FS[B V279D2*ZQHOK>!%"<TD+T)] 6X[*9>J?2GCJ_<1-!$Q>L$%81E3
M<?O"F]X;U],U!1/RQ>7X$[UFB2L]4*9H-;)+##&^&]OA67AR=.^IVH<04R7!
M])%UG@#?X9YEK>Q%P8@K6G+^*B-(5C4K,)5?D<ZAWJ3KHU]#N0SIR^D+47W=
MB@#RAV^-.%6>":"\^43*=,]5:2VZ*W+J;Q.8?!F<$H*<!I(^DNT8(+E!5@O'
M+SB=^]O9Y2+JNW<'TEGZ],BFZ\)OA=+$Y?JK#CUMCK?[A?H<Q5[NF#7LTR#7
M(.O1"N2*17"RV,G?^A?#SY.]] 6(_,5A3?=PGZZK(=[_R=RI+KO2F?S6>QAS
MLJ:O5[-]DXVE,2UQ'MBB04"VZPN1H8O";*K' &ZRG>GWD>"-IQ*IDCM5%TQ:
M4'>9;J?71J0&#-2HS5P6#\)0B;EOS_WWR^B3XF)UPC*:CT4*-;@%0S5E8G^[
MP2=*&&Y+L^BDXI[S&(B+#\B*+)V,?QZU[+&& :=ZWE@X WVC^2A,Q2-=.2C-
M>2:9&Y%'+/AQD@XJY+KR#>RR"YMX,[?1L'[B.>LM^QL_0XHD (5,92'N397S
M*P_/)?GN%P4>'0.TKVDG/7T8:5,.^)P$-)B>>\[1-U%7 +X^LB_J?>]'TJC9
MR#/?.AU*Q?1 W-Q$_Z5LG%U0[//X3WK>IK.)%Z_I;W'/A8ILAUB-IQHQK5Q"
MGD,N5,$08:^_(A1/TE$P%C\QOS=0!'>9]Z?YF)>Y9JVG.W*L#R-?_AGS_VL6
M_B<VE73AQG.M99NDOZ',>YT+TG@!PBCI':%D);GMG-=VY:HVI"[FL]/,6>RW
M.<\=W3"V7\I7;VD9-&>UHR,'R?<H5M$2Y&'B:9Q?ITLB7=S<HVN>;?_4*-6)
MJQ'DGF1ZS8DT4B%[U52XUY_]HN'#"!:D>IL:N:@#1+AE299NBR<L+:XFK. 2
MDQ#D%HE%X?".8\"S\#>HM@NQ;LB)\Y=W@T+TLKH'3)(-?#N2\SD.+,E2L,T$
MZ!/P\W.0"\2D@1ABT9+L,: CC*CQH,5QG:M\0PY3LS8]KRS5VOA!4DG%]?&2
M6$[?"AG:SKPW(2T?_YO71!"?JK<>F7*F8J4&_'J;'%)VCCE^?Q5,"WG/_3FO
M->;I3!L23;W,-&83!L=0*;^%]9AHX)[GHH:78M+6Z*JS2S/' %@D P2>+S_)
M_J]33638F2OHP;-+<\]!5HC'K]PO*7,K)U\'WUL _;GE&+JQ@7T+UEW:2(6B
M1YZ+&61RB/Y._6HB58/1_ .)!Y6<!$0(S7SDU90\2I^!=59=>*BE9WGX-R-<
M4Z3P/=J+ 5!"T?YZN[G75I"W -E)R<C;$"UZ_F@[:PE _C^;V6TTTABCX3]'
M(I4HKAW]/IEI+2/YY%V>2!CMWQP,N%=@/6^19?JM3YGV[CJ@&PZIGF'Y% \B
M:F6" 6YY+5$T,/HL"VML[G_Z7?_OWI?_?\+U_Z)W@-IKE%C;7.+$<U&K[UE]
M@A#E$SO&C@D'/9HB8\H#M>KOBN\OW8R0S#7BZ>8USO:4#.VX<J7B2:@X@!W-
M?ZA!/ ;0.6*+5L5T8 LYFY\(N_=II?I*#N:2YW]!SJ::P=C#O0B ="Y+IWCU
MMF<*00' #S^%C2PES_H]^;/:AA>E@'_3GG02;CY^NR,H GL6"_LT75CPY6%9
MG)N67J*O3IPQZ[O1??C?TZ0&6C%XX0N2\YFN: 7U)C&M,^WE</CB2N.PKL["
M )MOB"B';'@7VJ-J[IMQ;H#PEV\Z]8T]X>+1^N!_QZM?N)"&9Q87_!DZLI#2
M>Y+X3OI7ZWB:U9I+3'JX1W>T<7S1^\?A0K8=$R[-^?:( DS41HC'[B@2E^^Z
M=) HPI6/%D>K? D.NAQXJTI&M<34S%B@!%$_W3Q?AZQ+AS<S"8ND!QQQ0C.&
M+E]>.'&WD-WG(W$M/AX&)<!Q;^FS(,(=1R+E6E\#AJ(O5PC>*'-< ;E8R%11
M0J#MU^^D@Y\*71-T*U#F%?8B@"<>KI25Z2>TUBTTB*E)[ORX+COG%^*#K]X8
MW=[8V3VZ'ZZ)B#:X)88SG?76P4[KN>R]H\&SG@'?U:0"6$,MRZ=1EAOF,N(
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M3X1?GR[3I=CAUNG__"W.$#B=@5WW.7D9'K<4''(87(?"SD([00P0O_WZPC'
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MK6[I5UM@0[9KIFP1EX>S[!N2+X19VTXHF>KLM<TB;8ZX=F86GE_3ZKT2R+H
MU,3/EYT]*YYOM'Q"Z>>R&-B@;X^?[IO.R+YV<(/&ARN*75P&!]8MMV\: /\T
M2V3L_NE\^)8; )\ DZ7*\'Z,:L/.J&F%WE"!8#B0/OP]6C5CT>+#QWD3C+:C
M]ONQGA]A\M7=J7:G!3+%0V=AF10\'"K4\:&-&;C?XL.?T-DS.!9S-_^N'P1?
M@G$N0R\T%DFC'DV<9GU]U!VAL?5LO,'LR69&*_RSWR]Z_]@9Z/BW@_9C  <$
M^(E:2?3_UXG0AA^T$_W-X],Q(,D>O<&HBU#+D32R.X@LDT,#R2/I?.>@U-"V
MH"RH,AU91M/3?TO[[/.3ES]5!Q 8%;"=<>@^*IKT,.N"/U/OHS"Q@>?7Q>B?
MD8+"I&N,27W8?(1L4+WP_-"!SA,E_[Q0'SH?R*8I&L%@7$]<IC9([>2HI0\A
MZ%0DH@O)KZM:_T@6RFV_=M6SO*%XL2SB0NBCDM=ZVE%W1JQFU>M&EYN/ <[7
M8K*(4%S92PB#Q!)=ND'"<R6)B=0+)4[KF-NWY#*$PPL^U==S]TL6>G(4!^2G
M!P:\2Z(:,T;B'PV>:-.+=B'7,.P-(B\R.WC:MS3]@G+@,&=/#D=+N \950A@
M+2:M'>['7W;ZTBBXSL6X[=1Y<B(.A-TEI9*#_AW?0G8H[Z.]:"I)?-6FYGW^
M69KTY-[ @^R%M9%!;FLA(0'WV,F(O/</,0RJ<DJ"7"+]$QX/8D<^=)GJY@6^
MFA=T'='E]_ IC1M9A9Q]6-]40.NR76A%A"75UN0:WG-\G'K^"X_OFF+$'&;4
M'%S]R?M@U$FUK5G,F!#8LTOG^!<G+!CH4U'[H;^[)!?:^SH9A&*B>E.R!T7'
MF5B8=_5UG2 ^+Q@8X*/K(WN6LXH;G9]+?X-+:3M,R;J1=DG-O,W:3<Q9L^,8
M$ )@$A!<<Y&AHY#?_1+![MM3!^WS[%3-O"U$ZWF=V:C[[\[.>,U)_6C0$#@X
M0,Z_=>SO%7JM?!%@HD9MHH;36L%^?J>H7N2\13/+U!O"HJ>[L=U5+]2;HJVZ
M_;P:E&E),T8@X'+[GXHAU@%T2>2#)W:I@X^OA-O+#.4>?)T>/E1(G2MH@A6$
MQ^)R6,D>+P9J\AW>RS4EN#E,657(^^(^+R-L*;?68FC S15>GG[DJ#=H#3U1
M4%>3GNQ_%7"2-RKT)_-&+ET8O+C$D,DL$G3%NG;?%8J^U/*.O^ZOM-NA?QFY
M'Y<";;_&^6Z+C-=2P%U%NB;CY4(/$U>69?1;*X=AK"O!GV>^;9G9_GGR%>$3
M.D(+J3D,UL]VYK+]4F&#TU;._--GF>.IT?^YSEZ=1+/<,BER=W5X"S38R9@L
M/ 8D6NR==1V^?PSX:4FV6TALA\?^PQJ79#!7BRR1>YHT9JZD:_BPH68-U7DN
MD/;>+.'.R(? J"6XQ;5>.(-T)X 9P\MUAY%]-=G!^[)3!!UWH>LKR-&Z:+H$
MEZZ>I8>,89_GY6YXJ.GF-MRYE_ZB?_>V?E#VPNYMOL#.1VLWZH16:27:2<K)
MV2G> C':.GAW"%IP4NQEHB@_4BP@S8NCWN[ X^1SRU\F?0 1[N=!Z>'\Y"ZP
MNR)9)AL ;I 4%(EN$ZCMZV'UC*1_;C.GP57]R)?G-[,(XQ#)=5C=(=&^OL2O
M%%56'>_W[)%W-E:JWV3.P])1T=&FT_4+;L.FTRI1S2L=83=SY%(V\#<H@!N:
M[3]A\V8H*'*#/6>A(NJ9Q87Y W\+68?YT,/0D0-P\4ZR8$JU\1/F_97]M>LI
MS<S'@.AZ:!:4JY/.H4&!++@M(7Z%7I:<O*FA'GC_D44K\K8- ]*]Z1PG5-)2
M<\ O,PWTD"ME2R[7&C5T_3-;X\GI*9BR =\#,. 8\+J>\'AHX%7%3KM^U(/9
MTHS#.5+8#OC'8SO63RB(,+),Y(@/6]SI40:_%A..WT<ONO2B-F.)&#J',,6>
M:M!"AKI1+,$O'R-&"_>K5X:KML:R? 6-=CAW46*=HZ!R&*$72K!1/-(WN?]2
M"$QX\^ +02DESOF'GC'R-N9UZD" UF,/ WZJ63V.WC]JKAU,;0![+J1J+6Z!
M^]Q@_A,J&U/!Z[?R*KTO]\L[7<JNQ[?F?* 8&83:'(K8L+O&(I:7)+S=/4:3
M^4:1(BO31"A=B)7.\7B,/O,69/6?4B8.G;8T. P:>0]U!Y-E_ ]AI.575R1$
MH!TJ3Z^?%&&FC$RQQJ+T?E0+#UC<\O*R-H,X^%3#OS=C"*UM]8C6@DN+V_UG
M4DP=OEJW;.V/.SC(1SK -PF\&O+"\1D][$O30M2FT6]+@LGY1PDGF3'YW##+
M#9<>%Y3?-#.=@X>@@6M(HI^;@PQKG!]'O]C.[?$Q5VT4=R@S+V[ZW&\T(NB:
M9C.-Z<VC<VA1H.X>2R5]/W5/7SX\&;)("1.;@E>4= @-7;Q:=2OQAZ:,9,N(
M5S]^(P0^!]7[>PRX!6(+C [54$01I>045$[9WE42C%)?&^(>\9Z-A)/UD3.O
MC?HZU'4"J$W'@#30V]X90$K&[X6E4H@;+(>1?<_ABPR^601MV&EY&!WR(='6
MYLG[=GP!-7(YK!LR'"U EF#@Y"5R'P'=@>1]!O71W'L?;55F6%Z:2S^/"$68
M^M_3[53<5E_^R*A5"\R.0JD&J0,R5H7*^JA"VV&=/?N&4KB#0D%U# Q 'OP)
MN>2FI*G/-UBQM.XJ8U3B?'/?>E@]MPD94W](/V2;V1=<"$7KH7Y'CF0^;F=Z
MS4HI7MD1L5OB^ \IESB ^FKR6YA8D@TW^ZPMP3L8Y.&& :073+"16X#,O M"
M#2R^N=HY?]&9[1B@">?1K*SV]1X:]@E<*_-]XZ2Q#BE?SG2<Q>%&[LP7DL:1
M,*J&Y=1(57JH$LHJ3CD*WRLDMO>UJH</=,WD*'ACNH):>3A!J]!E_U=Y:!_:
M>#9 _&K :3$P3W?1H#?3*&NB3]5ROI/*I9L#BCY(YP6[Y2\,>F*$7/@H# ")
M5IO\E#AGTGG2?<=%,JA= C.MO\6:J"+7_Z)&T&07A2U_$ S!XS%-#78Q#6#Q
M);A(BS9A0S7!JEMKY.<3M=6HR'!/60;[\%1HRWVPX0V;*9+1[+BZ,6S!A(*P
M+R<_R>6US"P'XSFO2HQN,[V#T>N]R3X,&$V%S,_2M69ZK\Y+3[HQ3[\]_+F4
M'^!B0>^#(BRI9U5(%>3O?H1:%"G7CWU&_T-0>8'5WBM%MXMSZD'G1.D4IN<L
M@>%"N*8 7?D\5YGQ*MN7%<-QF7E3]H-TX=E"(#=-*EH&YXAA3G>?HBI-E6I_
ME;'NP*)S/2\7CQQ4S\WBW8XH3*W Y:?M>^ LB )PZC2=PST"W" '(M]^L$*D
MX4&$?YX"'^D[0*F7Y(X!9'ST,&4G;(SVR6==F>?]'B" #'/%HTL,:YI\?"=]
MRGPCAHSGC@'[^_">2__1&.*/D;Y1P<X:&M2+];XW5O(5/V". >-S2(8H\P1A
MX70.($4WVI$(ZOC!^$*&:ABP> R0!R-R3!H0NZ?CTR5,V987F--C(NT@+MEN
M*MIM Z=-S:MF]S&&6Z1YNS&RKS91.$%7<Z#B;[Y5<BJ0U;;8TZ@X@PSSD=_9
M=0!-DGIZ0M]M\J?&'$%AMSSM?G;4AS'U(RU6MDCXC4$H%X/EG1)AU*%8GGCB
MQ&KD,>!C)UH/&:YUM)0ZAOI7/B'SJU_G"2U;#_2=;?O%J6+7#@][=2'YF%9Z
MB8=C1F9%H-'I#_T8+-9[8YH.7%9MRRX\W3=:VIB>/S-C'=K\-\-4^G')MC<<
M:4#)XCA\S#'#$Y_,(O;QB'XW#T2I.CQ/A[8Q41F6B$NGAI+-%A630J'U24_?
MAE=:TG\GFN9TAN988RO>X29W6SXN/QMB74I.IIRG_X-COIU_4M>@,?08\,+^
M%_,JZ[:_TL_U(!=%;>5/UL%7J/X^ZOM8S'H3/722_JI_5T0_(+;SR7WVJ.AS
MBD#.>^<;K/Z6607=Z#=UJJL^!D10]&IV4[[&=.0'D4-$USC:V-FZ2$LBE)5\
MNR5IJC(K]>PHG*IQ%NS"2&'T8M>/)>1(&Y160A=FI([),>#)OP<]$F1X.7V*
MN8N''.,F?2N^,_N;[H#$J:']S"-2'W.=9T*'KN%3JR([[%!Q$9LAO'XYXQ:V
MV7EH<'JL4WN(X*B7Y;;[=<AY@"G;M2RY>RQ[N,C<.:QV-0-CZ60#_O0[;:<@
ML7SHND@4T,7-K"X6W.36NT#0/@84:H?\12:4,W#0I8%\*@TE',<N?#+[7?-+
MB8I3=.<(6J3-,> _](AG=.G?6QD8J($2 VF#W3H2\H=$>,LI;/6;ZJ]3YLN,
M?2;*=J>/[,DR_?-'HQ;[YVVMH$V%*=U.DN-Y;>F'LBJ4MP^GP,T!4^%+H9I#
M*B]75=!Z:S?Z7_#FQ:Z?%5DBKE[?*)R5)>_1<L">:>3+?G@MHM]MLH,KY18X
MP7=?1Z?R4_E <:?_NS<W[3HOO.7\IKD$M_2B^5E.Y= Y<A;5<QP(:/SK11CO
MAA)@(A*4I*OT!*LV%@] A4;W3 D_9_(IBQ]I24;+=O\)&>>\+2&D?2O4;GX6
M>]0Z5VDNMK+9PH5CY0I/S!X?TG03YH2<*+B7&/*H,(NWV?MSF 6]0EX5['$
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M;!/JU*O$VIV?&\]%5I@O0]&8_-P&QN2R[X'9J&>^-AX#DDI/1*UP&$/7-NY
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MZ +B2LP1X\*0]CMRRR*$]QO2Y%'"LW7]A!5PYM^,]O$R,NK+<BZ]A8=&6FW
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MXA9!H+D\D#*^C@$;!/(RL8<(JB[^X7NXIHH0IQ;S8H\CYS D.L:F%;E\@!R
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M.KT.+D64=^-2;Z1V,K/DF$O2+K\^L6>]CV?*R;HF&[EEZ_F=Q19F\N[U"&^
MPO7QX_06V64U "S0=]_CV>&ONHO]VR2$'-0-YI-.Z6\]MS,*\!TM<E<>FQ][
M?"RS03T%5Q<'V/ *!3+ 9$%%H?O?00+C,<N/;UL7Z^9??)FM,*#^Z$K3F;O=
M=^65@G*/BI_$'$>">Y'W!ZWV W#QT#YT6+/\759(P$\;K+I62UJ8T'\%)2%
M_P WI02@D7%%KI>XW1F'SLX><9(=&?()J$WEBQ!=V+^SA+!?;O$?O(T6##;E
MNITJ,?[T/CTM>$]>R=NJBFI&Y'SAA-%P[:VG7H4_(MFO%R$:;[E0P*<N4@1&
M^ 9EU$1P6 \O=>^X,!3"C10U_X\HP%4IKI?FM323LR4$A5(7T&3Y6,'YWR<5
M#$UK=CB-;CMR:-9;MN_WH+__6B=D+T(D JQG[N%A#\0/MIX\^#5*U]:_J@,X
MK%\U$[]P<F<:U -L<K0XI.[^9)WC%'-@SDQ*7(3HQ5#1R6\RHK9.GA-4T4_T
M9,E/H_O'\M:E1$.UDR1Y4WUXL*V92P\J.J2DPS T>LKJJU#K5[>UM!GTX.S!
MZ]^W/312NVNEL,ISJ7,'&HWKM3V'T#ZA?"^!:W;7I/JC205MND['EL2+YP;.
M@_US=\[JX%_+"M8F?1+DS0TFSV\+MGZ99[-I]L>%G-MC^ZV#93\R[F5DA?J[
M.?#1#4BQ(/2F,!F3B:@.!1LX\3*/Z,TW'3JU>4=\D?41= ;C]TNJ1>12X<K)
M4K7X%I5]6FDT?JBKB:NNRG&YB]\:1U(<H;JODV6U592#X[DUCN/(#L$*IN8+
MK"F;!!OTNFRUVTB*[7I+JAV:=@.ITZGOPA6U<\K*=(Z;17:C)EH *;2@C[0;
M?]5 AVN&6\H2JMTU-5"4M!K_4&@IN4DQQ!Y3F.54)(A^(10+JU',GKG4[W-)
M[[/\L,5-?C7*W[[C7CE8.1_$C/O3X".Y9U#WN@8.??'L\>_C$4AKGACG4LI9
MX1MS^7T;KZHG:%EM1NK>.-/N3+8S]C&KTV0#D)(%<S5(A-A<W%9"W9N__](.
M_'-L<V#GCA1NB;(,)!$^@=[FUV<\&L,:([OBBO.'#_<10M<O?''[^75O7G/*
MSN6-=[9IXHUY9ZY_RW1([)B(+Y%T:>K-VU":5J3BN%20U<M3(6R,WO"U.3XL
MZ^!O?WK8\3\=@3L_2\<FWK8[]K#<V:-B:3J(0W6Q4FSD?>">%^?(3KZ_T$K=
M=1$G+EXXCVFI:MW_5'".53^=CI?V>W#DJ[IP/_^@*FL)\V>8P+0;>]+5U->-
M&T#MRI:\&J;V<$Y&8BKQC([IK?J0O@V*V./J^BL!8X+MS8VN<2._V")$FPBA
MA X//48)#%2;:M=+,Z"'[.=>LPM*"Z(^P*2 Z$GSRPU&/X=DDO,NUG[^\<RW
M<?]BZ_'C)B-CDV[[WT;?!FRCU6K7_3:]T6'DMB[+Z]!5OZF>F0^.1?)?:S[H
M3(,.-5,AMM%]WT #51RK'>^-FCCIT."83GRSQ*;,8FHPS$E4/%>$2*/2W $J
M,!4*"_;J$A@HUSPMC]Q=ZYL[\.+^&CV,QB:.RG6YQ;_+8.KO&E'.6("BJSTY
ME7W0J:P%B*9\.'>\&KNMRG56);O.' <DD212\:UHQ%'G/6%YUKK'-YQ$E[<N
M,S>&?U^BW'+A-!=@!F<AJ2_U=6DF_LJH4U75U9D^.UH^G;SQY9.N]*8,^Z=W
MY918F"?FVV$PVQ=ESJQ*U$/N*&R34ACMF.#S/<Z:'#M^B6Y0)EE;:1)C,A"2
MLZILXI('Q[6C"''SE]=$?!-%'/J%D5Q*IK0N)5\<"-.V_/+EZ:^BV>HSJ9;>
MP>]_IN[*U+]WP]X U2<M*4]LK/5@24E.;M,\4A);N-"W+>-FQ?627_)F),8(
MHZ"RH@)JY^F&2;T$#SV@W+PQ$+?%[6=A_+/HW*4!CQK?OOGVR\C#X"GJQ7\/
M(X/&7#R-,K:($&55"[_>"Q_8)=)U?7GTQX>/ .%:)V84<@^I#GU[<.6_(!<1
MXA9VAQ^AJHH1/([IKYJH+=".&]NLKXC<'N586[7_H\_NZ^_;\[[_C7IG<>Y4
MN-9PG%A )#%1G4D02,- P0UX<Y-RF[3+]'+^X7=[0RJK)J64YSLEIC-AO:2Z
MU]7]G))IE\I4+S!#0Y(^_,.8*$7PM'8K-L&YRUUP#>P.4D^L=2C"Q*YE<G@Q
M_#.[[NK=;U>P>'KD6"H#D]Q]=]K:]>N[RJHS4.0L;!H!EV)7 V=G:LA0Q%A'
M-PMU7J Z8:;>B-O5&:7Z>F!_;OKK6><(3\)ZG0]#K<K/;';]U[;NPM0NY;A@
MB13<M9?;_F/0;F[."3"+"/ZGM<PEL@@Q8#.IWH:2LYQ$;8,ZZX^#7E<J/Y\4
MQD_,9\5V6:EBV$E%&EM;",]3TQN/MQ.E_MWTE_3*DD%@ ;EV^I*5BV3X(,_Q
M H<JK@LJQ=AN7A& -BOO?_X2?Q#!4%(;AF<J0CR!^?DH 8[K@S!'1 J\18@\
M"D@2(1[ )I"[[S[**:3*= >9RT'9^6V\'+Y'^NBPE\E7&N*>&3\BE-@A!8:2
MV] \,ZDG8Z#.2W@OOH60Y!+KQ8-"@4%H:]?'C<"DEZ'1'K:<XJ.PK7-&OSR>
MN2OZ.[\<LQD86/LCJ-KG^T,ZL3K K6IX,'*M;!45 S=&*W,*#I'$*& %X2Q"
M/(P[?L-)LN6;<S+S^.S7>Q^U037/66#\#1PZL8=&&32W4W_:9!-;-C_LWVB3
MDK-"OAV$Z8=M'!(T=!E7;\7+S:N8@<DLF1:<)@M7ITLIGG>-D?;P_'$_+ERA
M:ON)PSGI-:8K-N/PYNAQ\::Q73<A8Z94"VH'Z-5:O:')X^_@3.X9E^SHGU<>
MAEV_^-%@BBE!7Q6&F$;&XJ706G[=8>$7!]CV'B9"JN44]CX+FW!HQI;_9,?N
M+)MR(C&]CE,!K?!T+RSD)44]B3WIL&8Y*IXGUB/U]Z;%E8V.[%D&/,:8.IPC
M$E2O:O,4%Q@ K8L(N#C+'/J$& <Z<+WPD,3"0R(&H4TFU[KYI^ZB5E\#/"[Q
M>\FO@S\.[^]0(T9K=W0O5DU1J $W[];UO*5Z.-C@!L-)Q]A'6&I\Y9F=+[96
M-"0[2H<__O1ZRU1ZPV)0BBV )S#VS*%NXE-F4U-9D9,'. T;+H45.VV16#A)
MR[DW0^J:H4.2*ZRL!:J1L*Q>^[9;."<=0"DDESWU696GW)I:)7Y?BL$PL6L+
M(_R342@4G%V3 >YA+UL@#19>H";SZ=1M[*U:BZ++=:OQ.91P-<S-E^G55I+J
M:M3A.VCI"?!VI7G!H4-:9PY:&%('?EP,J4KGAB-EVX;U,0DW)_:>=9V8FL[S
M" ]A5(H0C\@T0*!X=C<:/.B4@-<-QVWKRSZEDW'2-[ =.4Q3+]#!_"W[G(!X
MT#,5IYD[(O&=AX?J &WLO]F68#A?7G 2Q-+PL0194YOQ (<6XT'0QYFU+4,[
M-1KK__Z:1,;ULV<WJWV)2:*II0129A-A833'Z4Y:8(=,)J%I#4GCARU7Q,K4
MAJ\;C-97-+8I]&J)$/H\H6R'==BEBXF,CD,&&95]MJ4C-3RE_>E.WY>+KGPH
MIRM9?QA;\7 ([1IT'=%'.7+,CXK=B3YJM+J$MP8QT";W-$+_:4[N($$WZC#5
M_;.+QH?/Y$?7+$V9=T)B+<\GLC!@:%7;K4"^3Y2'PI+P#4J$0*Y"P3_^N:-D
MEMBDW*-@X@:0PJD$"XF@6XOSQ=GJ47QTM.;@W*YC25987=,670-QKT3F4?U#
M$SIAM\YD^V7XZ7LK&@S&EP7<7*VVC9BOZ%H++-^?T'RMJ)7?>^BW#N[3!8]!
MES+?)>('V/Z]\';*9?WN;Z^M&93DGN)V73NCDM3 GLWMWT?Z1 +U7B^R2 S\
M=#P&+#!'(E]*39?Y#3YN%%,]LG%:^03%KH*W$34^@!DP(VA/>EQMOW'-XT+L
MI;2!<;9:ZA#!=>U?U)Q>DH1^RH3%SH^KD[%*47K?6+=V5>;N^\H4S"@$VT0>
M<O4_5WAHW^UEM9!#.73U+M+Y27.C!OKEPU&5#Y7\'#D&6.*7>T-\;@#69F2)
MB]]ZQP!UD')PQNAQT4GC+BNSNK>^Z@.#F#XZ#,V$PST%FPUFKKQQ+%K'2OVZ
MBZ*@%H1)P#"=I?#U>UGZY!C454ILF8>'X +86S3D!B;:&EMJOPUS*CRW=(/P
M8_];F;/7AY7NV^/]A%*DWE5*/XWC2S6U8*F3L^.?O &!UV-SAKF'6!YC+X"/
M8_M^[2\I6 L)TO_YYDKB=NO%-F/J-%D  RFGB(5JP<".;CR?5+ZS3=FR-6V.
MP"0>UC>"*-B))7'?$KT_(RVW$3HRMU/)7P.VOFK6YYXWQ':L^(T1YG"?(BP9
MAC3D5C@PCXL0U]";<)2QS6\=6$'D"&_BPZACA;XWXR_T1)TL/JU<F5_T:UI,
MIZ7KW _:X:JG=_SG,. !ZD(1<N$/4\H*&BI/1#_.19&?F 9__%&R?V'PT8>W
MTR7YJ8TO=6YK/C)5,2+^EAH@G.XCC><1*O]GGJPO2>YC>I0TN*,8_5J@U[W;
MP,"UM-C[6/&8IM' (:V8-$?Q:;(1<9"()XG7VK+BFXZ&^30!TOI+C^3^-_;>
M*ZK)MFL7#8(405 $ 2E!40$1$ 'I!$6Z$$$%(4!04)H0.J$E M*;@( B19I1
M$:)T::%7(?30(81>$VH@(2S>[UMK[7_M\8^]QUHG>Q_\!W.,G#SCR5WFO*[K
M?N:\)ZN[8/L^-F(JI]9AR-U5D._<CV\ @#_[1SD4*6CF/?"!SB7Z YF]/<)(
M_JAGAF?" $8\C<:R0LIQSS[UNY6&$\"7N-/ ")S["B.+MK?=_^=RYTQ2@"(]
M:/S2;'8@UB1ETM\<=4"_BW%1WMW=6T;D6?T,9R%&'#]]-R\4S/]5.7$<\PXZ
MWF@''8<2]%5=SY$''RMYWVKQ*WH/H(L$IG$?*RA0+Q$(XKS "EAK?P>6^NB5
M<#PE^$_S&9:.6;._Z0?4"WD-UC='O($7UDX 5ZC.WYW]R_^FI8?G>2HY;KK:
M7:^-;2U-%57L9?3<@$*; C5U1+)N%3RC.CQ9.5[ZNK]64KF*O!4DILK:&_BF
M$QX@W>6^^\O[[J3IS2)[$YQ[T3D9O65,8N4T36?'A)7^/?-NAXT_\'$0QPF@
M.-_TS>F _[SC%HY-OG8P&QM[065W#I-WRGM#& -OS2;$9$EW+AV_]C^@C(FJ
MK8#PC=GGFAE/E5_-'$W[KMT*U9P>R<:N_B)TO'[5^NI"N?C3V!?/]/7:*$[#
MV>,[_H7 5CAT[+CM8Z#VE?R=GV?-C=$/\A9"1NY\YY,G;KW"+"*^TIJ)7=FE
MX*:M*;U4XD8IAXP^H$!'Y.NFA[(GV0QWU4Z0BZ99CM A.]-8<DC QG'YB(A:
M&8H5]=F EZ'4I,6HXSYNX.<]HO34L^.CX%AV]XDUR"F_8""3NWA/Z;L]U9K^
M^PD@*G;Z&#0 2D%HQ;?<-KI9[K#C,?1=/* +:X8$D8/ >[!W=YTR0,U^VF +
MXY0W&*DFO%/ON;X/WYZ@#,MS9])J*J8XAN_I,8N^Z)7I$Z )[$#? XGF'?/
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M%]5H,AY,&SFD4%8J<IPSY+ 3)#U^YV<>&8PI#XPAY<UB6I%,SH\#[Y(A%(O
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M.MV%-:K/#5W#5K[I3US);CGU]R4]+0XK*H85LOE+DKM.W6?S)J-G?( G+2#
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M[2J%1(9<D]%*$K?N<7R3WQ?HT#_THY Z>U527.\ZSTF/HHUWP!MG"X0N-9\
MKI1#+EY8N9C:QII!U\?H]^SWJM[7J0VOSV#DVN!CPV(7R%+YUH)+S1O1C1%D
M*>(RW+<5.]A4KT*<_J[\UE.RUB(S3_F"8E,85E2 PY\"NC_\ N?E(@JI9("L
M77D57\"A^G&KB%#UP'WY)Z"Q':1_>+!?1QR'%^[[D+,+.IG]7O9)H=^,GC&7
M=M$TY)>ZZ\%WGP%1WD_[.U[7]H=X"?]LKQ_D!&9<WN<QGR^KN)PX(2.*DXE=
M8HKWR\=U6J]()@^ZXGY-P!"=@6E[QR)3?H1@7+&1.SF!5N^(9#\!6*OX"/1K
M"<+(7I2H<D)GR7;_[MKV%6W/=A%!HOM&XD3]+27]TFO%>E??-@ML&B?C8M'6
M3MK+8.'@M\UDWXM9*DNH)>@EQ$QVN6LR11#1JWZ/C)+;Q\YU_LSO0P =ML^F
M&AJT5O]\/6'@78;]["F8L5DZF6^SJ/;#?[#^^]C-S%UK4VJT8:'3;C\P+;L2
M%^M] IA [_\A^U+HJ6)U66L-"-8AEUHKBL;:99/J44V75W(NQV$!JEH?7.,,
MM#+_'K ]?BM1^\]7?ZH1C(VL@)>F7NK>=WX"(V"BG//)KCO@OO;4:2!1OJ31
MWCO QX4T_[F,K9*S$KM3:A-? R2"T6&I)X#?L/4\DL1^SW$.K!77BHE5=MEJ
M!5Y934^Z;9;N730'_N:(X*GT^PA*4T7SW^>E"]%-=#ET\P.3;R0T8;@1?2<
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M&2R>5]K?\V73>?:>]TJ]$A:>9\]-RPQP^69NI-#L:W_7$O*H:HVK_[*>&N.
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MNM:8A)V=:3AFPB,^SV'YS)>K?6.+=C=8&R\Y/7FQER@85_56;ON.D%=JFY+
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M>XA8V=\<_ %PO52 C4)SFVI/G'6&Y1+D^J1XJEEOL:V/JO["8/,(I4<@5@F
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M?IY=/(0382#8N[WY@2S@&HSMQ4-XXHH@=_S!BY\-KBE_%/!5$P64<SZ.A8J
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M/'3QKM R!*R6"*VJ= &0IU[,+PS>]ID-4A/90C3(F7<:A<3H@X(UJ8*NY(=
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M;6[D2IOT?$')ZF?Y?+__QLK%U:@BH&5QES )[X45/SF]EI4'.>&.O-MOJD^
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MBS7QA-6D3\I,MF)F(-[JM_W/0,TPE=A:#?;+?W"5MN=X,AZ]I;ZQ^O[!H.M
M^_#_/#?G_[_^>['_KQG(S&^.0)$P&H_M.=[_JV&"Q?\<7?3_JD._5F:T@<%O
MJ:(QL4\P_NU'A5+CH=%(NGUJC\6DQA_G^8'K)VKCK%/L4V1Y!Y)N;5T%G6R8
MBWE7&',\9#)VBF9(%R;M$:H_+[M0)?*[7:+'ZZ:1"EN'@0GJ7BG)^4.M34D$
M.<4;;16+N^:@Z)F-^',R6"(*E_F2E-;E(&,T[A]P_W?E5=?D2@?"HY?'5^!J
MEXOQWY\@NEK)(Y&%(6,7GGUB/V=1-KOE-P85#3?LZ82R$(L>UPV8M3>D%&^2
M4=X+Q[B?-YH&RX/8W+ZSIFR_OML.+KM:6$@[ FG]IWL$%Z?TJ?_;=&E1)3&"
MU?^F0X5C/O4*D/66JD(LW4BCFOE]<O=]I'5!NM>0+P]:^>'=@Z)7P7X!82\\
M*!/6!YXWLQ?:Y2K&N"ZG/\,(C0]P#4J-*XP_EV>]9)BCLMHKQN_#/-PA@;@+
M^)/\KKK9="(U)D)[.P7G^QX\W=*UP>P&JMW\2QP38+UKSO"*<NVFK[R^?YYP
M'9;:O6;0<YI^? [;PC0VB=]+1E47]:"/ YD;.*6>[>4;:QM]I_ OP6G& DIS
MA'I.L;O*?]PD"W2=[@2Q]ERXE_U\T'$,KEH'#%,N(4<?W7!"?H/RP800HK<-
M+*&J"&B<[VYF(<<BK:K8PQI;HPG\;;%WFDJ4C4T%T:39&TRAO==GLQ%G@3'B
M).Y'MG<% .XS#*@2'I*75&S*-#D_G1IWNZ7N[K['*]VANLMO:MXY5@2Z];&%
ML:GH&W_9$#\,.0=^^T+::H$/!R6OOCBQG2B/_KLY OW?#O@6:']@#H-\#:M2
M %Z2\KO@G'O&DKYXU>%%>7S[ PA/>#2!(+,W,KW+Q9&+'Y;?^5;]U.+57]LQ
MZ8H9!7WILU$A?TGP C315NQ['=&F:TSDHU=:#UK2&#1I6<Z-826W>_FI9G3F
M#'G9G#/7+P:/:ROE!%W(Y%!2"6<1UM\UI'Q;C3#'QW7>X@?K@^YL?-265RNO
M+6&WLK^3DACD^3_8>\^H)J.H73 "BD@)(E6J5)7>I!,1I8B(B(+42),F721
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MH:]@VI^YN2\B>!RL@<<4(?LPN7F_N' 26TMD"]B"#D#&><<)\(TA6 UQ&T"
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MLL7+S; BNN3N\4"1[WBA??8S8NRMPBER,,US5#9D ]B&RCT4' J"[_QK00%
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M<[P&O=TV?S/)ED6[^!0W;0-\[$IR%F"NVM2MRC/(BGA/:43T82["39P)1;J
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MZKF]1-B)$1LK-!Q=:7^X&\_V,UO)4:@JXCS'YSBWTXSE95;9PF\T01;9:A(
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M_^%Q IP_B/BUQC!@(T??5%TT<RDCP%!3OFU-P:9@\6X\(>R7[UNCEZ@?VBI
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M/<!!UH>M=D $FB D:>LG(\JV=W%X?:(8MMK/YE<O[5WSJW6</#HIBEC5W2%
M,JEU1P#VEW07T"'?A-LW3U*4B;KWFPE#K^"/%QLUNJFMN=1=:]B7\8'OH2@A
MOUVIJ, K4"MR'GZ5PAE(\B<<M/R@&!($.WWA.L T+HLQ!'J.HCWVXK!&Z_Y8
M1Z"#5AKZRIAI8#N?UXI"V5N^,$O?H8$3T&G"< G^ H@\)?DJ@D0'.,E*K*:H
MPQK# _/OF!<=4S*^.J/[:4U:286!O_.==8>B]6T>"9F;\VK:-;S7W/,]7D[]
MKO5>"3M6.EVW'V+ '%H5TZ+%($5QQ(&Y59*40L$=4P\]IO[:\=\P+-5EU-+\
M.?![1D]\YHK)NXLM+:@BM/;&/&18&PRLF@&/\\&L%-U:PO$& +GG (\K<\Z?
M=A=?JWF0ELI'HV^*[88X""8MG-?6@-,2Z/(N-/GG [50!@#2KF[R1GJO-[Y.
M6W!\['Z"<5H^RP2K397>">BJ=!2_1]2I91EP Z">T$B" #FXH8C:AE=H^>CN
MGI $F;GM "V)>]E;31.>IHH2&6X,0WT%"=VCWQM7)M80=96VU)V_M+N8FZ=3
MP$Z=FK2HL1.'J:7?"O\&D\#9U7HK9^S%R?)8K34@HSCU@Z0WY[EWZHQ$GUS\
MT)9V(5]R;?W4O?HGH(03$"L*<0WN=YRC:4Q41LL"^DLU:R>@5RI=9B:DNA^5
MB?H7XGPLZY;!CI%U:H,>?TL6AV(PBQ^HHH#L%SCT^--I&;432[T!U(44:@W%
M(01L@'QSV\<UO;19"9+W"0V2-'&0OJ2W[;YM%G7(5C#E#F'[@%1]_-$33IOO
MCN B3.S'3VFS#RLO*"N_&A4.E)N=[W[!AA](4U[X*\';,WA]QCQ8.N^F*C(Z
M]\SQ9Z3;"0C[E_0-4%Y*BL\5)ZBTQWESSMD :=M=1RZYO*YS:5HW6M+-O']$
MGX#,%0?U"P-SY0!O8BJ5(8OL0#D[JBE/;.Q$JP*^1*2%K8;Y2)-AJ-;:.<,.
MF4=]JY$BE\8*0X8HE^P,3D!+OP7KP.FB(4FOMQ_C^[S *]]EJ]ET ^A8K^]0
M.,\]P1\70QPN2;V.@CMZ)LF54VH+N=N^JF%3\](ERFR>%FPY'TC.;_1/K=#G
M(UOO(5UEX^>O NT$#9+ <6Z3OFPD!4I$7-VA>. ^/.D.R/\SEK-R=1K,J/PQ
MY4%'0EG46B<\@^R(;%5%*U%_(BOS.O->"S*A(;#N;CE4A-<GH&1)\.*\4:AC
MN6O5)G4$4VU88/^<-/H>^]U/'R7>[$*]H%L$I)(<CBN1SS#86@C8'2T#>!:Z
M35ZF[W@T6KK:F'6K[@GG^1S'.@NDS!,GLN'[L,=7=2\.O(00'@@"URTV1_"8
M7QLX_4@T(ZR 8DA<Z(3$'*31WASV%&],;ST*_>E;L]_]9OD10V&<IH+ABCSO
M!Z?(5GA30R=\W'R@<'=N8W=N7?"?2K&8CO<O6A+\?$L0@GN(3Y+F]]ZJ$*<V
MGH/DW17JT76*D?9X:>NE\C>:AOC&4+8] &I(][%A'%XIS-3.^Q+-XJ<JD(.0
M^:<KSSWV'^IG6IY/GP V9YTTQE,V#>[YZ/+M"[%,T_RKVRX2:7&![2;3&CA4
MG#;KG6"X6]$?ORRNL8\><1MTR98N#;6)FHW];!'  X-2LP.2]28996("""'T
M8?Y4AK]$"[QL]'Y2W FH5G_+[2M%BUA>Z(_\:@UXW"6&EF<5 G='YGZR&M-
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M!D7,.[N>R#\_Z]RS&*C*,X#X=W1BNH]=8$;T0 C&&+:U_T;;>X UU:WKHE%
MI$:EUXB@H)0H@B M5A 1L8+4J(B B!'I$!(;(%U!0$6(4D2E1*2WA(Z(&'HH
MD@:(](02)J2=\/][[;/V6N?>N\^Y]SX/DX>,F<PQQE?>[WU')G/(EMY)WU"9
M>AKH;*-U^<>;E1%'[\L=/LJ:G+M)BB9"W]9?NIM=7)H1[L[:7/ETXO9:[ .\
MR$JKB)&DMONH'G^O("Z4)?$AST\N6O?>KBZ$6K=:I<-0]^E=A>>&E# A=_W<
M,EGZW '5HYLKA%F8,KU4QI4G#"C5(HD&VQZ2M29H_5'W<8>[1&=B4(?VL=;$
M4'**6TP!NM$=?4L+YMG&N 2D7X#LQ#1UYD";MO4MM"?<9"A-=]X:A.89G @L
M<Z23O=U<MZ_[=:SG,%6!D^,$(50#O#R_%?MLQ) 0N0I)W,F71TZWD\*ECOLA
MLG_5MPZDSK?H"X6(]_SX>/7A44OC+MV[V \-SIR7T,45-*".;76U.5M7U6>H
M'0%KQ2*"O>8%F4NYBU^:]6^D/L;@#AZW*)]0;&^L)8R N2)*><B3#&@B^R+B
M,]N43LHKE+_1GS]<9&:%2/E\A#V64_KQ2OIN?[=/+.BOXSR0Y&V@ CG4D&3#
M"$DMK=KOG=@WO9QXG'"2</:/A;@\D;L]?=P_58"[0^76:R.]GM?NS2\R7UVP
M\1WK *W*YX4;?7;"UO0X"'3RX_,M_$OR++PD/0ZEZ0W947<3>9RA1,75Y@S]
MV?_912\C=ZQ9:JSQ2,96W- ]U5/7^M^)VUP/YU3RJ4@D,%484L"\SPA^A-L]
MDYZ..P2(T: [O%#J7.(K/CT_[O&A[.M(1.F/O73?HN$6+-M,V2&7'S!J'@GX
M&X3(T_L<O-5>PQ]^9WSH>8[QL\FJ6]4T!*KY2AC,P"3!KD-&G,=_H26NU_<A
MS5DW0U3-3<^&7WFA.U_G\=E.%N./%HF_FWC*"(PH#[7PWN@)6/S<D[^.;G0M
M;& 1N"))12$$YDM.,0_D QXI=2$:AF.W3./4ZH! .OFLT6'TC?JGNUX5>Y27
MZ4Z8T<M,W8X9:1\4+D+-SX;:*EW3^JFH KT8T1K[L,MG?\-H\I$762:JKVDX
MS4W^Q-Y:RLG$W\)&HL031^?><#_E:L8AW9;>2770['8(U?<[7;)TK$Q5]_NF
M,9YH-VK2"9ZS]=2-]PY+4XDZ:-$!_=DNK!$LG_O6V=Z)64GHLT5W#&]A)W#;
MR5M11MQ?$$68-SEZH[(=(@? J'*/4&HS#BDCTTX)/X(54U=_YNC85PRN[3NN
M<W#TJU3)MEYCXVFX&_<77LG,AK4O))SB,&=(@25X-CKEQSIT,CS;H#(NWX@F
M%@_/"[6D1_N+J"BW=@CZ_CSL*L?>>>3:!)#/0L@/WU-![7,QB?1 U!>X/(D4
MEK=W2;0RK\8>Y<^U%0GI,X.RK) RG#S<[A!)'HCFT&CC^T:XQ55QL,UGI7>N
M4CNC45ETD3/'?G],H<OW)Y9>$/2U?F60R8%1HG^23(!0NAV%\.0V4$J'<46]
M/6F0! O%I[,.BK=S:!EQ]::M#FG#5=5].>6I%>U3-?KO&@0/*A-_91T=U(51
M<C%T6T^@]C-0>;D[<'%K2/B5=&<$F&R-<"_V,3EEX3(=LAM!:CRL%W1P=_14
M-3;+0BN$S ][*CX21G^+- 7\*#S0,Y)Y__P-!)AMU*M3?,_,1B__@%Z7Z=6^
M[/A.1 SX)5E;F?+6'].]&#6R[?4[=*,^3AWNC1<)(#S:0#\S$Z9)A$$$O2>'
M#2;J*[UW^93L42_LS5$+<?17&"]I,1K0OH.'I:_^ C_&4Y+)6Y#F=']FV" /
M=)?CW*ZJE083^9.E>Q@X-7/9XFE3(^9;REPD^QWAOKH@1>H%"1=,%TY"0EA!
M=T@Z )[EP!VSAPFN>!++Z[4;>2"1.</A%9_Y?4V]?YH](@)\1X,W3KS0\=+7
M "VTHA+XC @%P;<2@+V5B5RE:RZ?70#\>49;AH^&;G*ZG4;*J)" ^F&[75J7
MPKX0G-CMG"B#14 S_4D 018IP:GG*GEE;0&(%,PNGRS/.#/_#[^&O-\L/-?+
MF)/*6WX?F7^MZFKT#XG:2B>_L-J"%7;YX,:C5?B< ^M*Y=P8RROD)/-<&2>O
M##_B3G%H[;Q:#H32E").8\OMQ( /'NZ>V:2R_*?I@O<? %/*#DG>;CL !LL&
MW7@>[0L;3CD-%- 0VY!Z_6S/?7FT@@(EUB/_#R->!T==3N;_8;F(&=2E3E@N
M,:/:_8@D'LAC-&FHF0:?[Z'BA;G?X%\7$HH!4VIJB]N!?I0%06B@.#-WIN+L
MM8K(!ST164LGSCC+)JP=N59UGB,WIZ9OQT>1> Z>!^K=XZU.Q#Y4N+R/6%&^
M?DT2GE*5)O;0/W'_LBY\SZ@O#T28\@@F#1[SY1*Y, :$+67##* ;S:W2IV@>
M\X18E#;PP6>[Q?Z0WB6?@@0!J]<R]Q;V5;UX_:@R)B8^#;3EQ5MB>S!>" ?R
MRMJ%@/S!T*^,FB8E#E;88.,^F5V^/W+U9\%$T>CT["VE[X<RWHZ^5)=77FZ-
MV-SR  <<+012K %-/BO?,<L#J89H4K$Q7.+XHN0T,]FM8U_TGMQ@*27C1_Z[
MLG'SU9HI)!PZKHVO54[: 9>;:5#V;I*LQ0&3$V=1BBH65*2G1<67+<R]O4T&
MGTM=]\/A&:G2M(%RI[FYM-H[*T0$H+1E%3%'9'F$I#,S^)D=@0RK86S#^GY$
MG@)<W_F$2:S%K&0\EG.J*'O4.^I:GBK_U0!W\>Y6V* ??//.$@O\+6@2#U0I
MUVB#V8$\QWE?YTW%1CG=JRWT)LET![B>#5G,KXOR%B"YGM^[O%6;\G1E7![+
M1W+/ K#$)EDSY],NK&J('44H?8Y#790)<79-.=5#['J\=K4WF61?V8_8_7HG
MU7M'SLM[6]P[L Z;6SGXIC/U^B;LA2T.$L]?UV815MHZ%R\%@Q<E9U^04HG:
M8?O&ZBT@R\.H=TC^A 27&95MB\/IS#4@@R6*M $>?61;TO=A*$7.;22Y0<.8
MR>KZTLJ^/<N^ QH/V@\?4^[X)</6CN[^ $SQ?7&#4X@R";D$C3/A@9IXH.%\
MBGT%5S4<*MJU-^]GN7_-&8K7I)7EX?.,LQ[WMVSQ'R)F_W%S);+E*ELKLFD&
MX82'8:U)Z=7'G\RG60ZY0$U?X3.2\^[G!F)5.;$HHQ ;KD@UZR9W +X-[?WD
M$P!NPLB:W<:IT6%)J]I*S]A'#>ND7$Q<W.ZH*<K?J';^!/*X':B=&2VXTSG-
M=8557,$.6KD>X4X79M[A?(6Y0T9J3V^N-?A@D:Z<EVS'K158Z+-%CYHZ>DE@
M9Y=XLNDN7V::I[JFAG+LNC\3P_F(IQ:B??#/T*53,3#O+BCS.B! 3YZ8WFAE
M$Q<]/@&C%^(?98CLF+R2?)4)21%<I40\"N9;Y! CO7UQ%$K%SW%8<A_2Q]&1
M06NG<8?8I]-/^G!VZ4(Z.7,XU8%;(J('%BU<8DFWL%7RQ*WXPTA/>A\SE/,&
M3WF'5[R+O@>/3%?=#=@P/!U2'(%@AJRO!6WV3._34H^1A7FYCO*$(?S;O1ZW
MCJ<*QSXW,#O)L&E$?W&(-Y-B2#&].%4&/%"2FUR_(0=VEH%IFK_LDG*YOJJD
M-LLX:V&X6![D+GY^RT^8*+<0*4#KA"N':#9Q]4NVFMI)>]6@2I3/#@\S:[VF
M/(1+$C!*EE?&4^ _L*U=P5P1[P\AE0UP,!]?H,-K3?@RSQ8[Z=D@BU-N2I4U
MU3UEQN+?G)98%Q)U7UC?"]7>9^'1H%F$/H>7+$O)YGONS;'>W=UNA),E\7^8
M\S6Z:G7/XJ:[WXH_.QIG,?!V_D,&.^L9^ F>DH\O#XY!>Z"'%UR=&^[GXG>P
M@PN' 9MFL-$>I80+<5?K14U"+YV+#&UZKKV\U@"AVY!'8-< OWQD:#WG$]O?
MEW7BCN+A$+Q=TORR4;0OXD-E^-"*T5=]Z9!8V4K]@_)CR9;:,S! A]P(461?
MXKP-L)-'6O3>*Y]WIQK%KI#E25X5?O6M78-)'WZU!@9<C]P2JF)65'O56GF'
M<:%=%)Y^#3.T,<J\UU=G38/($G*1)^B+D0Y6.,#9S]V/7WP\VO">MWU/9Q:_
MO6"KX?^+$EIU:4=*V;B,CX>'S^P:#V2_M") Y4NQO='MA%A5 3M "]:"2-AH
M*RH&GE -"T=P!?EN8S:&;TVBWI;FM/M*E=Z-]4XS&BGH862E4LAB=1<IA-$L
M%>=QS#R"A9PF;R]>S81?>M($%S'P1;GNK3N:Z_1S]H:?WZ1^U3)-[/<I2V."
MTS2:\GK0;3?G,UN='YP6924EU;UFQQGHL_W;7N3;*CD3//P_Y?8-CYY7WN:H
MX'YE^XSD;[%I%Z,Y)3[ "Q)[D!(?D;*<*@M%+[(XSHQM,6CH:WIMD!V1_VN:
M&39?5/0C!F'F\!6;;O[C6VU=U9,<X1-? X4>,87G#%G7?B&W<; KB\,*,*],
M=68Z8,38UN2#W0JT?>=@$>Q#G[9P8[)=;=6VG5@X(=?A3D!E63&P)SG9."BZ
MT9X=2C])A;<FN#<HNA7DK#M-KI;_ZCU](^^#Q;!,O.1,C)^&<_NKG/NW?]J&
MI\]%1[ @R N<TL( V+  TZ5OT4R(/KVW=H!K^LO996C(\4[%A+2K"@EV(/!5
MO)/\T'I"0H/ FV' 4><!NO$^2J/M=N)ER%.$@G*5KGH9,CGS8@-%V5U=(<]C
M.*(!.<:ZQOU)5L)37CGQ$6XQ"2:.,@\AMKFI#""=<__@#O74G?YH%Y!N^]&M
M6:4OVRSW[O.S$UKR*B :_A2>D@>I%(ZS$&%+ ,?SD1:#.G7J-!XH<03U0CGK
M(,Y4I^Y0_IW[QZ"KASD=[Y<][G,LI8.++W/%OOW!ET(>'3Y0O!AKH=!L\_"*
M7IYWEI+HT,I//\QYI!A7-(^.<&8XS*VS-)#NE?2@]PSA1KB$ 4'2;APK,?W<
M.GAOV^-!9J^+]<0)1<NDCE^M%^U^',D2,=A<GX:8=-'MF!$5]*=<BSXTY;,L
M@=&FM&V0T@]IE1.PJAU4?T:2T"TT"CV+>\!YR^BXE[JJV8P&]@NWV3V#TVT1
M"3@8?7PT)&D<W1B7@1$B W$GP:%";2^+?6\R8C\+:.11X<;4,Y>.T^HJB']5
M7#APV9.FS!6A5S&NXE[\-FH^4I)IYAE8G'OVPW=SY?TO7!>^Q+<4^': WA*[
MX:7XA PJ84Z-X3E.;,(/==K0LQ(*9DK-8&+[K+G#XPB!T5J=C1],_6,>GN$.
MNW)/&UDG/I%V#')F<O'%[U A7 )&W$*,VX,'EV'DR9O?FIK94K$C_BY]<O:N
M1JX,\9&(K$Q:J$;R\?R\C.]?I"LR;H*-WXL.M2NCS\"_5$2S+ %W"BJ#FC3B
MZ4KG@>+8'MGP7R/>JKIT#MOI91@/%.W. ST/7'CO)]6A4!]P8$YF5.GAE P@
M5/B'/U5+NQ%3ZDZ@M##D$=H3'7MA6JYOAB38C5@T $LUTS+V)EOKW UX]7Z7
MVWKZW5VR[E*VR]?]X.'H1E%#:)QB=",X1G=<>U%Z!B;YCE'45=G429:W"E0M
M",P^KM,I^*WRX;G=/C>V@![6=JB;]7H[3J_IHN#$YY":LHNG;_[_OJO-_],A
M(]C;+/Z@R[3P?J-4I\'3\<X$Z=(SW&>/;#QGI^V>*R]T*(4TC(\RL)C-Q5?Y
M,4"3DIZX&G$TL]QQ)72E2%_KE497\$?UXU*6UITFI1Y7MK9,*?>F3";,!W_/
M2/)9P>$C'L^.!:\I)1G4^IN:FY3S0" Z83C\="D#TTI.@JCF/G=SN1/633>*
M7I!4);/D;%)^^F1H3FP+3_4B(S3$_7IQ*S%V+S\_$)G '(O 98;^QH5RTG#R
MSNS=@!P%NJW O&MF^N*L4_E*H5-XD8V;;H%+Q_VN-'W+-?3M"<9D_):WX&R'
MA:1ETJ?6?)^V$:>E,5.?[ C7RC\2K4:+IG#+M%G<1ICD1D!V['[GGQ! +C\=
MLQH@TLC)QZZA^3H*'OA=*SL3$\(#4=RRW/#!KQ;!4VP8_X3]BJA6=IP%@P=J
MJ#<K)].79:AL?HSE8U9O\XTJ&S'. ST*"PWCD-SK8!GTE>5E;MD_?: >M7CP
M[W8NCI(=JU6Z"&&+]75V;0PY1"]S5;/0 Z\NGI9V7$OB"DU/_N9NOAG##^HG
M'.=NK>Q8'58[#[1U96F55=?.'YD1=7IJBN/]($?T>["XLO*CMYXKG[0:S)1!
M85./3F/6T'2H'11>VR5*YR*:^P@;)>Q5U#!Y!YHZAJGTK9R_I+LWB8II7XPB
MJ=$7X^9TM]B8>]*VQ7A,>1\FF;!?N!I\;=L3?#2EPK]]&$8_BWZ2CA(!Q#XC
M;S+,_#OXDQS1;-FH;$FXXSSTK;ZT=U6[8Z+7 )A 9)W1G1\Q$GAO;"X406!$
M4S0;L2-RS4S2#F"4/MZ,WL4V]4!+%MS(#<D:6-!]UZ\[9.801-6(NN81_[%3
MY!CRQI,ML2M=4J=[ W2U;7L,M+5]C4[WS%'ZRHHLNLQJ;924KJ6)A=MXK8]*
M[VPK>6A-]>__G7R>68>FZ[T)==N(I++)?$_8S-RQ>GYV00>DH!'QVVR!:49)
M:LO+%14^ZQ3T7]SSSY;E@6K_<>;F/;%YE&H6"CV8_L]GT/8K-;^CEV%L8>[V
M_^*C0R0( 4 W<HO^_&L H/\C *I/2U_T),$V@PP[]EN.[VD('5T0)OY<68 -
MS)+-H^NOILJ>\M+;\_A4:E#=):$W"CDWOH6,.3J;K2JO%)2AI O_,8@ '/?$
MYL#YEV4K,*9:\$.CU,KXNO,H-4#/UYD*:=5Z?T,XL4XD>%]<J%;[CCL'3]<,
M,KOQ&]_.@:J$;.)_U[V!Q$/*B'-4E59L.U[8FA%-'7N25@%@Z0N$X&=S!I0A
M,A:PU.US^7HZ1A-G_;)"H<(OEJ.DOCLVS^QBIW+<@=R/5Q_%#+@9?=..MA:P
M[*DX$S%CV=LNC1[MAC/7^#DT^X6HS8)OI@/B9"=7BGT7<&94GHB# ]XTSF%X
MN0>\;*C=I+'0NQ>M4O$^_]REF9]>&^>B]LA$=4T0B^5$SQS]AHWCZJ):\1+<
MW63->#/P)Q^T &K_\'>H+CN<WOOG3Z61PY:G,8BB:[M]32_U3;P4>BU4=N_/
MC^QC][5_3@"C+%L403'U0RICN<&*EM]\*^$&/!XN5N1FZS1T:JL.28,>MEY9
ML.>CA#\J25GX]_.VP\F]=O,G)[77@^ 3K?DV[ '\Y=])@+;9,YP)YYG"*TTV
MW >45_+D]6YA[(=MQUC# H.U9&"_T=PG&O895Y(.G=>F*T+G"".FS*#T\XR@
MF.#\]^5X!CHZH.IZ=3_;T-\,;4AQ#O3W]MSM$1QTS.J[\!#3FZ7')1Y!R3(,
MN_*?6.QW"9%RL$4TQWS\UCN3M8/8/>%2_MA6?)#(7+I^](7*U;9##88K3991
MP[[#8KNCY]H.U@[ON;7TXVYF^O61QC6/,PJK?:_W%L26IRY&&.!M\<YA4=C3
MM4'$T]C7['5THQ+*(']^)\L.1<(H6J;NBX0EKF*$R7<4E;OB,J%72DJCK?N+
MQK:+UR+F[EW;NJTIB$5<),;J]%VD$Y[=G;I.)WD[T'=8/E =Z(_/JE/E0\[L
M.KH).TR@V#5*^+1F:0!6],HF+HAHH>;*UZ0*,ZJJ%<F]B!UNH;UVS,P31U+'
MDQ$65JEUN7$Z$UEVJNTA!7OSY@0%?H_^>/9*YWC(Z_N?WB:CZE;:G2)#S^OF
MOIOT(3M/?R_RF:VHZ'=P8W$MJXN*TB-4\>KKNG1H*W@K4I?S$;WYC4MTO %8
M,,2]@;L;^/1A#(AN29^]D>]XTBAV=7^V=_[]QF.V[[;6N<=RBH!1/GMVYCQ#
MJ0!2+4Z#,8S%!O1.LV,;]N\E$ZB8K3/=P),K];@W@]?F9<_<[7P9^>'6)?^L
M!N6)T*0&]!"6>0.8]&38G &6Z;!&N%0@?!O2;H#6Y\'PB.RS\T 4O#:$'-"2
MG5&_5_B3$"7NT7'__C'(V1 X5R23!0*TG4J);"AK/W)OCV&1Q:GD]@NE/5.A
M[SRN4X<]:Y/5R]NM=]F=/[!HA#HS5E3>P^HP"H>?+DXGVI9KVT*S9S9&SR<1
M-_K9H9RW*.F0[#[F(<;:O-BXKO:%/D-R+%HY@ =ZYA28V0_UT7"#I%R\Z+%T
MYOTXYU?U!%ID58:C#(3124CSG@6[+B9VN\;<Q$3RR.6W*8G6('^WPRS[$'^;
M%.9M("7/^5KC#>\<(&C_RJBS<T!Y1:F/::?='NUK[E<39*P$[O! AS?7,AS)
M#@",S@U?U+>LIJ=E"C4&J=Z:T?UAMZ6!]57M>LN#8Z"P-[BU'EWN!+N6W>IM
M,&)=^P=;X 2?PGYHGT2P=_DW<I6!.-9A5&^6,,,VLN(3%2N## #RLV=EC<ZF
M.(\YD4@&^AJQQQ5<J>GO?[U[O'T;'L(#W5D$KN%+$NK);*G9MI,7B!8R0,%X
M>C,Y!E-*2( :&=B'Z>;'X(B?@##/!ST-NK3;E>7EDBW2XL;J,*)PL]T3'DB<
M*SY=4Q%'QS9L&#TJ\T4XU#'VY7MGM^H?1Q??D;R%PV>)>*3B!OS4H#J/'E>W
M28L[F#)\F(& '&.Z;C\/)(:A)D7B-+HH7;:!&!%;FJE1UOCQ_I>/*],N->L<
MMOQVT=FG-EMFK/2HH=G8U;>NA0,9OJ.VT,K56T>*L,-E@1$C \C,GAD+Z115
M*7J)^&A25, NRRW?N%T51]L1:%3J)%P9[P4#L86ZYP/M9%P)'WUJZHH\J+!M
MWCLY^!:<QD">?!31KD]MW\WXN8_+5=?&+SD?O:3]#74$U?<"@-B7 .9T:',G
MX^3XW6G?#T. YYDQO6A*O<%<9=P%1N*[>/IT6M#^\MX1>RF7PG"9U,0[Y ;"
ML!MT>\@;%FVM+<(+:0_,T[9)N83$+FFFG*"[G!<Q$7Z\LCY,Z;M[_?90[[JO
M69+JZG/1KN' \-D/Y"3R\GI!>R%>D@<RY&A.HHWI5@U),>@RN6>%%MJH@?-W
M5VS$5@=0JDCQLN?%<=G.3Z:<2$"YNUJ@A(N>POOT9XYG=PQUH9XXCCJ-.K?Z
M> K5E^?A6KX^%KRF%JLA?W'[L8(ED)S7Q<K\?45[DJV1AR80PL)8K1U+H.D4
MXM*G^]N,E0/&\WOC]#9YUNH2I);=F6]G!X/-'O?*C@UR)8_Q0,(;E>_<_KD,
M_V<KEL_;S,WX%&W;?VE>!/_^)SJGM[CP-Q6 \IO_>G>1WF:-#T8'LR$SI,=_
MEUQN88LFZ.TX_\=XK;T<Y<8E8RK6XO#N,"7DUMJJWK(\P)0AW-K<3-Y9!X_P
MV3N1I5@1X&"D<_.6K)^.[V^S)<2Q+4K6"MA^V'(#89H\[>;!@%'!S9!XKD(U
MW:$U2=!+%4;/&]:UB*&)J?GGE^ZX^KK-_E2*\M;$HL="NJ;X6NYV-Q/6:"BZ
MD0=ZB-K.[85#4!+< 7(E#S3WY#V7P#7J16FU4W5M#8N"'>FY2W<4+=,1M5U+
M]_3&XS6S9KDED&U&ZW9WN D:>U\5WP=!](Z>BV21YA]:G5]=#FZT&UICPCF9
MT'L(E# 23!=N=N[\<GI@*FJE(FKI>HCI[9IDVK7VXG:7I#L;\'C&DRR*I_R<
MW3F6GV7FIDD%H9#???7U9NQ%CMJ6!C@2W)MY6GJNEC]F\"KB. G2!82%\DGU
M_?^549MBM;([:UGXO[RALDGA-D\_XG,FCS$.>9,H"?W-ZS"K>43!0$&4S%+P
M? I]"?(,)L ^?>"X3@WY8?%=G!K@-9JTPA=R;I8X&Y]+V^AZ#_>K"0M/;L-]
M*>P<#8&Z5W^MB36-L_EVJ^R-B/ K#>ON]@-?DVJ>&OTP-Z'TWA-QN^1S+].U
MCH.B]$4XV?^>=/"S*^:!)BO=?W)%0\;M@"1Z90-7OP^1W;]GT,!4N*HJLE(-
M_UBZ$I>0 9N]7A-[[9;*2<OA13<L'$,N<4LFBZQBXO&E+T=RB4R\)-L[HBCD
MB@M.3ZXI2SUS5?[5,91'611W*3S@_MGD5\)]BP/B0R0'A?6'"[F3HFL+%N7[
MR3Z+ V@X/<S[HW>707&_K[=A9U=X !$?T<$GI3?_OW@*\H%OA]N4)VLT28O=
MP6LJ;3[/&<$/ZQ08X-,UW6:!U B!UAKS)3.YH+"V#$18PKV0D,;7"N-'&\24
M]N_.\JG.;9A]]'8J/\Q[F,P%061"W+DB8ZP=@$W+Q1!L,[K4JEG7J.70^7NT
M_FU/[6=,DUDC'LN>R;JCU=O=U<VKNR+"?3X,37_9^R'=V\/=0_39>&E)>=3W
M7U80)?'[![2&#I6Y*RSVVW=!(N&F\Z-T%OZ8F0!M<8Y !X_/'71"W@*L*62(
MT\@7G]O$LI#<-,V98U7Q[8>AGSP-\^EQS'#@$!ULG7X",*03FS"2 <._RM)J
M)%_+?*U5+5ZN?&U6K3R_?&Q.>$_]U]A$[V T<95S1S@V)(F) @[1",]PJD U
M#1'MM*V H=ETR$!5A9'9^BG"TS;J<G14[TV*92'YR%BT@&IJ-_(B<)D^.PY_
MO(J/XH%DD&IY(>,-6;NO2;G2*\H%7+S3IY5T2G0GCG?C.B[ Q*L.V)6'N4IG
M((@;'!"M#D9)$@&LFD;L'K*/OO-^@WZRHFLBH6Y#GSA24O$Z?SJH9+MN84[%
M*QNE1NEK"6K74<??;K"[C-A2RTS=6D8N?F<QS!,2M0S0IBYR^R/"62)"9.;C
MH^CRFL+L7RI\]/HXRB7D#_=?V'8>X^[YP;'9XX8/PL/;4]'*V]M#_+[S246)
MC^Z)&E>N7)6_&"\>7-!B=$!IT@5)26A9#2(@);=#>O/;CS+;J6>N>:K6A0<N
M<M!.#I4M<VO.L]-3Q(\:OZKM!^ORAJ?S,THMO(!:UF[N#XSJXHU^U$'D+CHT
MJ7S[Z ZR3XV^M;';%G<=J'@\>?[HT?:P%40D1LA"FBW3>[F9!Q(U$Z*2!;QZ
M7LB7T+D8B6Q!$.,PJ+=ZKC;7O-ZG_T_1E;'Z/TODGVM.\&4TW?I2DOU@D6\@
M7U441R\GL-21^MW<S9WJS\+N(220EG0^%3"3PT[[C9*\N6H]6>.V^$JY,<'2
MEA=RLQ5G-,A)Z88L=SJ"Z<+)0GN^#^;W[DP5?LQ5*9\M2]<'T-:)8J_KFFS2
MJU,_O-%OGQI*K'9)3%W<.>T48*1/.G[#'1%\'Y2U(&8:4IROXF?8XE?8F^3Y
M *9Z!P"AS/W)E4LTC,G<XI!TSAB'A*&?=V@A[:03XPU\"&"@\D2?F74VR;)[
MS+LFL]!H<#EWYNJ 6N:UW4-GQ+?[UBL9+@?S;3$$8YH#5VEE#$(S87B-VAYE
MYBC34KG3)TCQ@-C+K* Q]9NA^^+\54,2@J126R-"DQ"]\>'!A/-<O--1S!)^
M=N(J<8T'HH,W*Z)-M]>E,V\TSV3)[CDLM4<^1Z0ANF.T) <TKA3TQ;@5^8E&
M'K)CFC&(\=$M$%D4 2-1GJ2H^R,8,YJNJ"CVK;AG+2YETEI9*2YAZ-".]N+S
M/K/89E)\>.!LJ^UDCT&M,U=X=2WRK]X@ &R@'CI5L]B,V JD- ;#)0WQ(EY$
MU-9^@]4^A)D^\V)S7N?UA[O+TT9V*I;=K0<U=G0<G8Y[AY0"KE(Q45WT\&:N
M</=*4F2E241;"O3QO*^B^=Z5T8:FF>%W>L[?,L*U$]:/:EID59^&AI>R7KFB
MT3S0EK]J="_7A@)Y3!:SD V1P,DA3>@6CZC0:#O?3T,$JNN>L:(R\M<[C [9
M'+GGKAW._:];R!9G2U0.0)_B!7"[D-OH84@+X#C%5J A2U(N.'BJN4:F<GAE
MJA;WO--?Z]'(,;?ICN1+/Q[X$'D@R7KOS<W>SO;.<7_+P<G3S(B_B %T"9J
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MAN<'M)Z]>GCHK9ZE;7C8QXN)5>9^@,#ZS<S+WA9)"RI_!_]?X3@)D^&*L76
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MCD.OXMVE-V)28U97IO*GCNW\]F-+^U[+4-7<*9#_:-(T/!-6812CB[S(\*2
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MB((@59'YZB::XO\,S12AZK1%*):T,S MBYV8GIS:6Q:O:$B"5.EE*;A9H'@
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M'JY!=*N^6+<.M=D+*-W3@G8X X?TVY4 TFX3YQY5S:#_\#/P<.*O5KZ=R=&
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MJ43Z)?0QL9\_WPV4PZG1('"O^1_,=PUUET'ZGS6%K<X+Y.-UVZ/_J3W8D0"
MOS2=-E99SY_D[?R'G)A!FD7J W_X_8^?%7,SQR"B%EV!H>+8 ]G.MG(1_70Y
M"Z"3/3DT.376F-&[*SI$6JU^=G5VJ'8G/F4^2C'N_70OW@&@'HE-7)#LC(E0
MX]$*RN:9.!_3>J=<&L'C-Z^Z^N+VO3O]^]8N+);Q'@WB-R=HR;CXG'^F_9H7
M^/Q)Y\&17/?Y,<@\?+[JP,F)$F.;M,)$2,:$E!K0EV+.9,Y7@V4=%$/W?3@
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M1:#]6!!@*\>U.2="[0T@0BM.U O*@(CL%]UQ83/&']!D3+K"G $J,P/3?V\
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M^!+X3] A72<QNE[00R0\ BY>0D]+_ [> !C48='3)<321:C] ],ON@P)+4*
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M>0,AJMN4M9Y&6IE=0W(&E&IWX;KAR:_.A45[=.7VG3F@??&"0],KJ;!A@S8
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MY'BRWU[22C*")A%J\'R4Q&]?2GI=X1M01.$O?AY7*6P5H1K_C4/4_NIE[6F
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MQ46!WI]AO[G,390]=$3,I?BD9Z)$WYS12&JB5;'3B*N%Q0Z>]@3CRKF?"B!
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M$9Q!5LF1^S=(U' RM ?)E#(5B>9G ![9C*0Q@_Y?)J89O#$&EL52;KG?VC6
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M,@!?\E#/K$74D$C@+DP2NT'I_;*+;J,^P590.9OH>T@P6%6;\*)J7U03&:/
MLY%,/2?DP[Y+?&FHB+ZW"7(PF3Y1I2*_09_$_SS8Z!<()F;06FRV^W]17<+_
M5.X_3=7?EUH@%<RAC2]G2"((%@:@^*]P3B*DZ0 &0)7Y7#@#L#$*S&+*27G[
M;^6DF?8D;@*2@$C(W&C5#NK?P?44,Y7T:#Q*&3DAA2Q6HI\X49?V6H^T Z;0
M27\+3>]GCL)?"_.ODS8B<L)$-=R88F E]RDU"P4R )V/5!:-_TX;>'^7D YJ
MBPGY\$\M.E"CVL-)9>66;08AZ?[1H)LL.W._1H4R%W1VF(XQYR33#,G5@\"G
M&(!!NM=&!?6<[%&.3TA\-C##H9C("I-"!JHP +8V: _F%W[Q>&JC?^G$+ET8
M-E#+F>71ZH/$U]AL]'B0C?="M)ERA<^[$0_#AO>D0\HGZ.62A4369GZQ&VK$
M4G\&8//W=#>SUX)B#1NLT^D->;3*.:!U_@_:)!/HE<J_L!Y"T_I3"_^T*7^B
M^2>:_Z-H[L088+;K<]0VJ!JO6D$4MIVOU*NX[VZJ\Z!6.29[@]VP7JI;B96C
M=_E&1YQ8WSN-@?9APX.L;]6).K__C&A?Q_75O^^;&RK!@_9U#[^R* XWGE/@
M4-QAN/OWO5O_]5ZL\/QI\*O<'!#X&+4%\ AS%#,#2QTWI8=0H#WXM;NA^!$J
M!=<+_GD[F5XE$[BLL4-!AL+9ZY!9\@7]\Q1.RI$ -HFLHJY_M6'@UY7'V]"J
MUO^IE:E<)]^N$52D%<>6L^T",.U^J\HE#[(]4X=JDP.H)1>U):J9./NY7'2+
M[;FH+#@7FR,VP]X!$)]I$\^*\U>Z8>OU3K6;5I><9[WH@R2NV;B>Z<I_Z=U:
M>7AD37$/ZV=T2* 1,;6U:C5;^ONBDK]5Q VMFA-]^XV?-5_M ZA<S1;/R/B,
M;E!_0-P.53_9-)F;H</UK 7O\F/J0BDM9U%+R4\)Z79FA@& ]AJ&ESIH;=1U
MXK(6:]:V@<B=XFJ'&QKRI>6<])!2NI>4XBJ;8A#HPD4_(61KW76R,[%)V 6%
M?_&&T!K2_NVI74<L];SF7B36QKI50XZJ 3@Q>"MC.9;'9.$)U@9;"SD8)%HC
M.YT6?RBUY$S]7:EI47[3>OQBT^'G317.@F?$L<[H-_FAA;QV.WZT\:K-P;9W
M>! O*UH\+8C]["");CJK@Y=M^M0^>!&YE(JD%("GW /5A!1BJ&$#F[*MZ,-)
MJ*4,[?&5-GZ#0K4[#\=K-W]L?STAC.PC,0#@AHSBV#0G\#9NAVZZK[CL\4BP
M;IMX?V7#)EJ.*?@6 I%)11DKWNG:'VN9'%EWT==?1K)$7;ZX[7SFOF?6?0\_
MQK7J[O"F9=YK7<:+><YP*LD3EQJIG_8_:[LU78,^)J@NI'.=_5F4?E]9:237
M=DW_F'-QQ&T'>$ Q3VGYEC]\Q&."-VP8REX_N<I*85F!8->[ R>F(,-<355A
MSM0K]F=C/",RTUB\N(N'#3J@':P9;2P**^:02*I<B524O.7[&A_ L^.S)^YE
M= OL=X7D#]9J'".^:"I1S-0OT6HF2ZV_0V_ZF88/VJBAQSJ2%?K7-CZD9I^9
M:%>@PV8\228L!:T'1;\=U9D[Q$VA::2;>QUWVT:_P^5E8((HKT*YC6[]TP8&
M;;?V'ZJ]E[<7)BJ61I8,7$KKJGW6]Q0O<A]KLYYX]18EJF)\05L'1ZX+P>0^
M<!RFAV=K/QC8E);FJ__"974:SZ*BK$(%)TE_H4*(:_440??#TF&#)5O3QQY\
M+S\\P;5>(H][$C)>?>'[.6TIR_>9TA;7O4:*RU8VUM6/X)Y_M,Q0'XJ62A*^
M63V3:-J=BVJLHNLO;_/<'4GDNQ!)[0F7_H(5NGC ;YLO/\Q8^>[E>C&/G5T*
MKC/C*'D'7KBH!-4X4_M"L_^>Z0EOHZ8ZO2H$,<?RP"BK(:;8_S[5A>Q8?"K&
MW"DC]I4 $4297VH-\"A=+W)6<>]D-]JLJBVBPV0Q7];?:X@\*E$\G^-Q0UUR
M0WDXYYNX;VGJIP!X7JJC?S?/+)A0C1! ?O5A $3*@#]?,P"_O;&CH2(7GKX;
M3W&L]G.UKX!Z+8P(RT^]UC!-G>RO6R\4.)-'V?(Q&]UT?34?'52KEI%>EWC(
MYG/D1N2D/>MWCOGA&C2=%]:4U0"U5A%S/RV-<LHXX \TGU'W(FXWF2/"3Q%J
MI[Z5O9[H#'&,>B_7>MA>T':C7WTPX6.1G?X[CH0WJ>75)(PA2JUDCJ]$=2I0
MXV3MPSFR?IFD=&/<NX1WI8E]"S18>]#AV-VZJ#E)IW=<I7NOC"N+S!-R)E]J
M\]VUY9#+>/W3VS5B%*%XI>9G"BP%S#=7/$19]Q0?EM:2<NF\:M-Z#"#@@1.N
M1'_6X/<="G2;>NLEQQD?P'7P_!1@!^&B=,)DXM%B$+G80S"C'*HO7V"L(#:9
M9I*8*]F>%Q=SC13A\W'9ERH];6C0XENU@SBA\/!^076#GN2&%L@\.CEF._9'
MEP_UC<\:38<!L,[@%4J.V?*@+KP)OH5GIVH*@9"RL'EC:-SH5MHM\^M:YX/Z
MJEP-3$9I)Q=R[<YWE]F)CR&;:@-^^I3_I#/K?]>5<&S4GG@Z+N)MB8/$B@]\
M"[,YNQ@N4%Z+DS&=KG!<7-"(*D:Y ?EVLX7:0:H^;?,WXWA216=-SUF 9:V;
M.7($GXP&2=WW.]S6Y1;_E6.GA&L:&+FL(43F;<ZX].VQE5J3O]?8KMXI 7'?
M^.UCWI/5(M06YR>-]^4&"*_TCT99&IZMN4",0$E[I&L=K+-0TYJHG']0F20@
MV7#_DZ!3;ECCI,2M%AN!&+7\JVE^J>,@KH!\C$W91)F[30_@QZ$OHB+SKA!_
M-Y\OPG>.^ T;\H>_BX&4@-GHCM2 74_ZU[KS1*'!PFSRB!$A+RGYXG7[G(4C
M+[7V29\Z"KGX:O1+UV.7F2/(@ZWP->!0")V-*]<Q1:@GD8B_7=&_&< =:;Y$
MN'RG3$PL6\\M9+V[U,5%17P0<[\[D'UZ&2V=_TH[I?7;VWA?RTN6[TP@5LX!
M(_W%50O4BB;@=0;@"#D\@ABH9,*K_I%;W/B2&[FYX)ZTE/NL\T!"W OO7NFU
MDE3$Q[ >#<O=>>5-UFA.( V10-GA1[IP#KV^R@"T^"7L>T)_-J%FL\;UV6W'
M'IVK1A=(WK)G #()]O1:H)!&'28W4'KRO$QMDLZK!1?[30=SBO4PC0%XO2L6
M^)!0=_VU6YYN?!^6U\"]+'N0,K98MP8K=HO=UO8@K2U%?G..J=H;\OW347E<
M/T9_!_R3]L,V:DP(>//'1*<WLL<A?&N:EL('ID(=AP0+2KVNJJV>^<Q2@JQ]
M,O$:M8?H^ (NUB5J%]#)KI@TQH7SQ@@](7=/!<#6S6>LP'.***_Y.<Q43-'V
MT3W2R5_XC-W:E](\<]F;'K,(DZ^\HBE%3@8(9F1A%#54$./61WHO20OY3,Y'
MDK!''8>#^MK?^088]:,>%.0ET98??;'<7WOY\DV5-2Q/ 2&5S@8B>+1NO1SQ
MG3U/!\)O'#7<9EDQ=\J)M%EY7B9ZU2-!2G<A@SV LW%<S@^Y]=3=R3B?QZ^A
M#U5>GK&>"U^OB]Y:6MHH7."94NO),!"6["PPM:SK*;.\!@K54RJ5JGA C>LW
MX*>(XAPZ)HFQ7X5W:Y7G/T_G1 8+N)Z"G--86&F@@8_@,GPUIRN:8,)O-=B)
MV+":JUV*.R=.1A[O"0'ZW),R"ELUF1,%^V[$:%I.2AYTZTT6Y/"=G*J-$17"
MFI/5K:UB.G.RHS-5U=?&HG0_&UAX2=2B$#BP7><GIPJU3 A_XOU[$8T]*<D5
M^1(]:27)M?Q:U6T;F&Z-"(D2>[M\=3N989@]'$:A]BS=.4-4P_@Y#2:9F?^T
M,E?^B1_=*WB7^@9EE1-/?4+*XS!D>]*JC3!&GD922-.FW&M Z?CU#X /HF0]
M94'HGNFU""0[7;C1GI@?K:XR]:JAW@!B$GSH$,L9U4]RP+'Z-L$^+\FK,CTK
MA<L4$BT(HK,GX4%EZZE[%]/JZF2Y; >DC!+OM*O=>7O%NF?>ERW-&3"S9=,*
M<@>W9LO;\AZ\?>KNI)>E6]*^(YPW[%5X=N:)<#K;=8)X_2.KAJD[)8%!Q>]0
MGZ[D2\9<3XA]W(Y,CV01G!=2FZY9FE2B<H.;K&54>VJ)^2TG(:&9#M1:EB9O
MLSR]-Z4W-@+<BTY @1(]>]2)W6Y%7ORF1I"Q7:B#1DK)[LK\#P16YP=^NM9%
MN+CY<.B'#]D<$/LKC?F#C@7*>5-:5SKTP0[+E?'.8HA"Z=6;'97&>P2W0&JW
MBH.5;VK4T!.)[VFU8+MI9J \=4_<$E!N^%D(8#J6MJ?5%VMY/Q=<4;%<'?FS
MO>>&?0Q)O$=MQ@4XX[9@<<[T<.DLW*MVU]M*#68S#YYF\T5AS]#S[$OZ9B/-
MV-#R_@]W_19F4C4P=]U:1^=W,=,/ZQD 6P:@/D9AG96JE+_\N2GFF5SLFN-8
MD)\K-O<:V%5VR(<5?#3AJ#P#(.RZ1L>]W<*6 <T;&0 LF;0R.(YXR!ML+5F.
MIV?/=XPA\DU,[6@3)LL@JN IY0:1@#3/-A"X1[+MT6B>HN7YY<FCT)"7K)8^
M6'UJ 2T',YFM<?BK.G +^<1_].1$A.MS32\WEVN*-S_B_4_9[,Z"+RPM1"?N
M/)_"CE1LQ1.VGXL2>7#-[!#+LEW]4:L?N/7LA>UCK.QGWC6]Y\,]E$(I67)L
MML$N/'743I>\:B[9XSPN%T:A5JQXH36W2M@I N3,%G70"ZP;G[+M8KH*EOUI
MEZPFE['1]:3S:=D!5H%FV_$K-I1HJ,Z^ K,]/EP5%6A86[Y_K%S#\(7+8$L&
M0/8-!1I!926C'8C94^AP^BES+4'V@A&MK>]X@,Y^@M;%D4E/MF9F3NG#LP*(
M;9]14O?<Q)=SNCJN-9F&G99IJ#3O3%%MM(#S.J\%J0$[[] U8Z9&1X3BYN2>
MRE4B3GM*MX(Y+YU#R?J.J>F/!<0AF/F=8U$J)-]E6_U!,5QMNZ)S@YFJO0S^
M-_G@?2)(+X\EI@Z9#Q(H7,4+#(#BGL^11[,%YT,&/Q;:-%&75'TW/T/F+P\N
M[EI94EX?^ 8 Z+7JD=H<O41^:(3L& ^RCXT.23O]_1[B__4>7V'4,_K]I)<D
MJLX&]YZF0*8OBD7 *#_*-M[OSB_0>4B09MD=WED&H.0%3(VS#H&:,F]R1?V(
M7/3<H8?\R(KX="$KPN0Q@L"WV[S!  3BT?X ?0GE_?Z/D35R::2&A:7!>)%'
M5]A1U<&^(([+"QFE@-*;[H(B.S$FCR^W?0#12Q%\6_\]*;Z,C#3^BG@3D(8?
MN61E=?[A6"WZW>9*7A5IU*!,V#:MK"RK9.V'5H>B6YKG%_P/AR.O67UW3%@S
M./3PPMD@4-77U:'O[_C+9V.T?F[FM,]G*2-]*8,H_JP4R[Z@=+(<K:K%?:C2
MZ)5T343EK4BW.$/6.G@'5GZT.NS][;3^B\V]35/O$^:-O>PO%71(*:7=7ZW,
M&8RUV) 6#F.1:9GC>\=GKNR?*&ZU'K#_Q#O(\)TKP\,_4U_;I%U^X-$U4JHL
M&]QM"9K7-SC7>HVC24R_<_?#28)E?&O+;!4%-W\C"?JV0';H?%1M/P.0W2D(
M^=P<&5AQ(YCSE8I(4,\FJ2X^=XD!$*BY7(5[=CH#VU .!?[P=L*>'#O88WRU
M1CKC@#NG-4AZ42T(J%]>&CU\^+!":5G4O0CQLB?EU_8<,9&X+7_7=GXT ,E"
MQ(6JM/55*-!'HVX3)MCMY NNGVT9S)5Z%=FC-). U](_?M.Y,\X,#O\15!X4
M;V<I'=IX-^.L@L>/IE2N@PJJMWV_E16H% L.[)B/GY]O@G'4<2[2%?U<% XD
M7^OK%].3.A$0$KW(RR]:!ZJ&%NOL7EH87<'-:K4W^G$\8F79%ZUJSXI;@!F<
MD[M6*"BGPRV(6!2[!7QV,_LQDC+P\%CT =;\'?$=W&(:/TF)@!'MN/#9:5Z6
M/MS6%QP5:(!T,!APD.Y0C#/":*'Q7H1$.87*LJ=EPTLZ[X:<)K*KK;#)D.7>
MN^ZLS\X MQHP&2 DUIR5>0,\=R^9^"1F$_WV!_I]3*]]P\R$[)&^IT#=GNS9
M($0_KK8BZ-GMRA$K]=0*E]U\FUD?VFO/55U<#O_";OX2W:\$VH+:,_GUTNOS
M1:XNFU971G7@SJZN8J]?IG%)L$C5:CSX0EJ!.1P]V #L23EVI8>IH C!37R%
MPMP#E!:0C?A=W8R3,ZZ)]9R6I FEV1&2$9$8GZY6[;%B;X_3*G!K4:O^O%SL
M)T,RLYI([B)G-\$^M3U3.)B):H8:.4@M%MU_?A*>I-W XN_&17'A,QFNK;A"
MYIJT8C]APDZCXM<ZWX[J'A+=]RIE+/.[_%<Y,1^TXS"(F!:;-+.ETN-+VL?F
M-C,3F)]_(^8+D>YAW;8WZ&3-^4F^WN+D6:1U:V\D<N3#\=3BE?,HI6J)EJ'A
MSL3 YXE^>HH9[\;7AH,N1:^NZ=C/CV;:VSODU[\TSZK/WBM2M)X&V#M3+=?#
MJM*^ZE?X/./*O@M@.7#S&!:2J\NA:E-RN7Z2$JV,];]Q)#Y:KUTC?Q"#S#1,
MN)_-ZG*[11K],4Y_(C%2:)".\372DN#'5I@U'"8!(N.I2T:'M$34*@'+ %?7
MU0\+L0O7P_A9Y]W:#W)*?WL,V?/A2WM;V:54;T!6R,@'\4=7.:: ]W7Q8B$K
M6N)YZ8\ELD5'/4<OGP.( XZJ[$-9JW!/7]!A=55CYC -I%5=/C[ZN2")/:5&
MD;2^0XB;PFSY12]P8C9\+1([,?RG/&KN!D-V]Q%Q.'43O=*)>Z4#*#>);)4>
M5?L8H^4@VL--"A<#L+2UF2.2%7T1*B)H=WO>063OK>U.>[8Q^<L4F^&__L^E
M;CR 74UO)C(&N;%P(Y:% 'WDPN=^1="+!4?=SAV)\XCMT<&G()3K)P,"=@>D
M6UIV\C 'CNN/;S>=*2DW"UCJ#QJ:S3A#UIQ$<1]*-?J4NN(>=^WKJ&'DH78!
MHQDO/I"&=5B-6C/XT]X&8.I4NBUMK- NL,Y&6&^D]K*UWB0]"+ZT?L=BWZS.
M?7E4H1?V=)KI'>6;:C$W/=*"@\")_KZ6V&-AZ3MIKG"5\];CWA ZL)OJ[=>@
M#DKO=V^9RLJ5 >5*;F"]W@TLH5W5LB<G#E(/?E,0,MS0)4*&2:]E%&MKNRY\
M&NX)F1V."FGO618>6F@%B2 Z4QZL@Z?.5!V*EF=!L&22YJGXQ4;Y,!'Y8 T;
MK&%X!GF;?HM]-(P*1D,:J^R;51)R1MV.Z=T)5!\K62UE^GCL_#H#P*9L<IC7
M,$^X.* S14&ZI]_10,.LJ':@%.K:-@LAV]6"Z6&2#,!:-)(DV <<\KC!.D<4
MJ@=A?#+ :ZCB("O=R^#IRPP ",[;S!^9M5.8SU<68%(!5UO(1W1^)2&G3Q 2
M3!(^;DIH]SG<&G,HU!_VP>P )6*&/*Z+HHY;RMJ=8CWB[U8A%"1/AI["NP[U
MX35[;0=J0'Z*: ];):OZ>E%5-)5X4^.!LGADQ@2LG!C6=A\S9KD;G>8QL7/2
MH)H076FJLL6_6G]7B7I0D'Z_+!LUQ[V$'GNWEGA][),K?,B:1OI$^M 01<A^
MZG9)NC?_Z9:IE&8*S\Y(U'Y$N4-@RD*%R;JIY]BMSBW79=JUT54'/C'VN990
MD:)*8S;)1?\T#Y@CO8=7U>GD_KD45VZX]G*[0D[T.SR;]G'Y8,X/:QD!T%Y6
MR/L[7<&-S2JLGJU]1T>CW;WW:GLTJ*BL1.S@I\%-A6.G*1 ALJBG:O$GOXJM
MEW:G*DV=FY]EMW57B)Y"GJ1FM[H>_3Q_JO,1/X9SYF77>E?5.]31NSMGU#T)
M42T=98>E\[6L7=@XG0>PF02?AA+!]@TG6^).^L,'OJ]4_1Z<S7L9D?0N,GZH
M?>'$A)4:4+=UY&N%\D1I^,X=0_^W:VN;6/U71QY)=R"$J7H?B.7IQ_6#)ZQ*
MA:U6,R9$"\4[^O8K.Q'\5/9YH4VNUMQ=OXS]0%I8LZ(*M>S(\L^\NC$OWMQ;
M*'B#N[#_:7^!=EU$[LF7U0E2_8EXY5H3Z ?*>8_X^^[JE@2^%)/<Y=0MC[?]
MIO?.8OSXQ>(C4VL'ML=G$HQ&7EXAD2C,*(>45?>Q8T5%>T$<OE1<6N'U??W,
MJIY6V;LJ^&V,V.[.__)*3E[B6*EUE6R-M^OLV_K/:C$8851,7T@<PFR!C@3Z
M7]23\A6D(7LDBQ3W#K7=]1C-"!?$"]$>)DZ63*UP]750)@PHKIA7[AU&+DIE
M S,54 <8<;QGY/F'Z"N3QR+G\_G ALJD)1B8WG_BI!F& &NE<P^LA5;!J\0&
MS5T,Q>4?Y_'=CWIDJ?98Z6[&#MJ$F!Q)BCG@<'PQI?3['K8&IZ)].!,&X(B1
M+.QU>20^DTH/(F!"R[ O5-=].UN#X4CVX2[#^-RT92W-W?<V+D*ZPQ!^EU$V
MJL4+ZOVV1VO';*D*]9<R7[MY?O"45KUI6,YU+E._R,ZL#M2Z>L(HH=+RS7B2
MCSW.B,  L+<(RJ5W/I\U86WR+=IOR7%F_!+1M\)<,$+YCEX  W <&FE5LHI4
M]O]Y(N5)7YN;0=)FA)Y/^V)[VET0+8HC9>>NN5^>U4WAM?K<QB^V!^:*Z$*]
M5WJF<<D!6B=&'&@MGG264BEW^#IZ^1KN7O3)>_Q6':D(NYXK"^.8(&QXZ:&X
M8XJAV:-E-? C5_'ZI>G947(?S/0F[:WJWD3KF ^$262;1HOIVD1Y%\EIGWK.
M*@)XQA,@'(RIDJ:=(L?S-U5ZLRR^;)C[VC@U*"\0/ICN=,WABEF"R,C,TT6K
M%A6ULXEC,1O)IRA''AD:M/(MX_E??>O^:/\<;;(G\;Z-A'FZ7N75=,>T7N=&
MV<0R^(C-NBM="#)9;H-Z?C+[J&&],]\1#CW@>15@/C>RJ2"09V3:L( 9Z&)H
M,=8[5%7HDI'3T=OS#]5N/8GV]\8NX5(>VE$0P*DUV"E97O(8,^]]:&;NE"T
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MD(L5\V%E71K\[ H@MS)#6][^&LB!UP4_IG=NO6"WY@VFW4D0^GAMZO9^=26
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M-*1)0L\*KJOM',  E6C6VS!Z@8H$J3E^,XDA57BV8:HKWD;;UJ1#X\8_4G7
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M,%.R2Q$PUA"#.3FF.H*$D1UQ$&[C_#(<\PUG/H&AUX#*L;A@MH6[DO.)W*F
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MX=X,] G$"\L9KY@? U[MV0]R7VT>"L$/C.14*KOX5/837[S+,$-+DTB<'/3
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M<;MWKTG)X5V*G=,O\K[ '=D+XI-4WBN ?,[)%2#N"QBW 1/G/H5=0T4BPQ7
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M_Y\/MHDO55[>&$ ,Q^'XN'<G*I8,_P#KA#O>7]CTPH+/].LOOD^4KYL@'OA
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M=)*;!D(B<W7K<2XHP@#X+NRCQ2WB* SS%AS%3GJ9C[2EAG5\PI&MEN](QJW
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MM#@'X:#KC^BQ=&B_ F3#$1PYP+@"WLNRMEM7@-%51YF^BT[WN+\:\C\=-J\
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M9IP$GJ1WP-^FJ<N,( (J418U//I'.62 0,E-7X?[ UZ<1:"^9GF+>[OS83H
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M1WL<A4*CB=?:B^&^9, ;FUPR8'"NC R 4I33DLB_/[)F0P; T:<S:C#8(AE
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MQ)/@,:9Q'1 ^@W,Q-,HS\Y<9-AE(XIT8%BOOTC+8_13TRY7EZY=&*TUHTWZ
M@XMWHZ\-3^V$[6D.FV90+M[J\W'S6&C.<U62KMZ_8YK'_R?]&?Y%S'_A^ O'
M7SC^PO$7CK]P_-?!P2KEI%;1[+HW:<!4B A?B$: .B&DZG62%-[W"V3"]+<\
M]_.9O@:ME9A?S[ORMX<#^D8ZR !)=N8P+]HYM3(T1<\U"$&7]TV[(6?;PIM$
M()P,J$@GL;I1U!JH 7Y&I*BW=W"@>J],J%"_XX=U\QOFV^<?C+H8,H'GBD07
MUTI-O![,,Z1B2A%)&ZMXXA,+BV>W?07O,[,/,)==K\_CZ-)RLFIP#14.LT+=
M=_N.0FFR-C<QGQA9:0+3OM]<<.OV"&0B55M<H VY0&II/L&06'?FL64^JBMS
M6T5H"2#1X&^A''3_I!0Z/PG%9^RVVWV#< E=HWO389)WG^;#R]\%K/2J295Q
M#N<;8BQ5BGR:IGJ?%#@?BH_!3:8'FF<*Y'^.(C+-)C#BZ-]E.0SYX:T]JF2
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M9VMP@8MGE$J2E2,5(%C+:RU^138ER_-PD"5N2T:/*HZ#1?K$C,,8")0*>C,
M50:DQ3SU/(X>N A@.3D]C6RE)LSJ;"G)+?1G)6;"<<QQC JW-'J5D+F8NY>,
M5#/-?9$GQ*"8>\MN9OX_:2^26'N[L4I::M1>AD7P%01&FPPX;X8U;+T5[S</
M(')CD5W0&^I\**N3.<%A53Z&E%^?5T1-4^TO$\88;CP.*3"YG*-O'/L>6,ZW
MUQH**[(.'*T^J2;(DP%M]WQ@TY>6*QJQ@J0;Z!8&G' T486VL5B]A%\NK278
M1?1'??@W^XS;K;<%%B)CSG@L%/D^BE+3\?.%VJ?UH',BAXR=BIX*?_F\_]A
M]^3B8B3;3, "];$V\,S9_R."ER'_NWV$P;"V$8*#QG'GX#B?NI>Z7 N<-/F<
M";RI,]"HJQ(]IS(9G*=X8E*Q[2&+Y-H'WPJ=F*^J2"'P!U_$L2$O!]UKP*E%
M1]\Z0*G$B[7?2_GIJQLG+>>:<.?*145%FJ4P]3P9A@5?_DB2II*5_"J8-E3
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M6^.A-S=SZ,;5>6>=:*F 457L<ZX/C@>>TB477W+CMO",\UT*4YM4-P!9^@9
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M8\KG 9%-JOWOLP-U^\\-M'><T8C\9FR^<Q?GSZD<I1S<!=7M@KH#=;,F$AT
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M1,:=V0HBK XPHX(KO/:>.%@&[4Y!0?]L17=?%<HJYB%-2<Y43YGY0+F_0&O
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M*FS?:5/:DOGR-AX8:D:3$W=!(+F#%FOR2+-[0:FB6.:S^4]=2M%_S04O<I]
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MD7EWBO:J[_![<>66I+"_PRT/%@M*RO4_3W!CX%NHHK>;,=P97B;?R!;^4\[
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M'[XR@4_X\M/8O;B26;%R4S^M2PEW1%5NLL?<:IKD;L*U\9(EQ2 EYE%ZSWS
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M*X2;MK%@1#(W>0;/$9Y+L-" 3[9S26Z\8_0L%Z._*5N,P\VP%E\908_;S]0
M]P)O/<!</(C&I(GPD@7X5BRCV(:@; =S4Z* :?#^H!SMZ2#2D*X!LQQS__UD
M_M_X(3=Y#,Y%WH-</[<",Z+?GH/$2^#BG)/:W&6K!I0;SNT&XEW:O*@V+D>\
M[EU&XE47YF*QXKM_&"!$BRI,B %FC\Z8L/(?8\6M"KS9I[/^$MIRA(_KJ,'E
MTEA)OV_.?<A-UPAA_*@U?:6ZDWM72KFV9Q]1N48V;GN9=*73(-C\GI"F9/?R
M<T4^<H<\+:RN>&<R +,W9=6/J-Q8:R'G4ZOH7H4P+7I-KDWT%W>^H+O?QB4)
MH]LRVW^%;2WJ'GOXF=7/C7D(=\X-H+I5P+-(L,SD%0[@>3 '4!/0'D"_MH;U
MY@ .Q#349:T0+N&?E[M=(][I'Q ]^XB]*LO/B_GX_0YQ&/4[=(_WW %9^?F<
M3X[\BH"8J<>RC#!J7C@QH%DTA:G(D(9ITAT8:A%HJAO=QD/@N2[P<(3F;7)'
MYT^*U(;FCEL )*V?V.[<U/J@KBD\]6M8_RURP]8MZ ^KM23P&H1\&C?;,'.N
MAE(QN>I4UT7M:WP]>NU)8"Y-_5!_/_0LH"T4*TY3.&AWOFL?[*.7P#!";=/$
M\8&XHO=" !Z_(;+;CQ!Y?9K:6,4!:/YJQ3S&??,MV[5B< 5.BV:#&<.2:374
M9,A4HZ/GP4^ TI7TXP(4:,*#-!,_9SV%YR/J?N_\-4Q_G/N8[;%HZI0%D^-"
MT<;G)N(8S(#B1<UCY9IZ,BZMY@C6)6ZU1EE^]/>#@3U#^012_JX,+K\U_5,7
M&Z_^A9*=Q?HF5D(YL=@9&(3T&H C+M]%_9TRVLMF;)N&+L^@=3->&OS1S<Q$
MC(1N[]NHFID&NJ%^H29-V())G^!#()-_G0L<CSFRL_$$+04S\Q-&RJL-Y!"Z
M:W\\,7\ZLS(S<>FUML+2K:*@EK]-=A11IMB_1Z,DMN7NP/^ JS;:(8D@53>0
M2P!__91;RYS?:4K8;OA$!LHT@51N:77KC<LG;!3[Z3YX+E_8%O94;8M9"'+;
M-*0Y]]?RT$&[*:(BI6MY,*M0=57*Q>M^0P.CDHT(8;")BVS?O=I=88H,6Q!5
M CO/2F<+P'_C.(#C:Y_JZ7HEWM*5[F=B-!9G1SX-KC?L5#%.UO4>M?YIH38F
M:9JCNA/>%@6A*B?H"A_H)=KF+M4]2//LRJ@XC?82+KJLZ&]_^9Y&0?L/823%
MY9X1R*_]<-"PB/6ZB+:(UC+D%G6]>S'%+M+T,;%@=4#VWJ=?UZ%"B. 9/-G8
MG[W(;02[B'>;-:10KDPR9I4U'?;!"().5+&R)1#+49;U7WL7?++VY_EM3<Q,
M'/TE_L;Q*"VQH*4#?OTA!T"V+$W)K/-#Q\(5X-.8HWJ89_H%:MCGVTD?+G<Y
MOK=%\L==,48.'5[RN]!Q0O/'UC.A#H3YFJ"LQ\#"H3?;ROM2U[SK>=R^B-3N
MB0W)!M&O'1^"9$ 3,M%9-=V:JS3P)E@3<0=#5Y;+7].<+WV9'N'5M4DO;6XR
MN.5D2U[/]=->B?)0D _Q<5KOXU\HG]VX;W\K'5<<@>W"T)4N@<[0*XI@/JPL
MD#$71"$4=%)>*O.V[\=B'%7D*_:G[=EQ9^/G/SW5WWFR-2)+)QRDE,,"HP]#
M-CMU5H+04:;5+?SE,J7*V\W=S)7LQ1A%C2R7(0X@S?8CFP.HW8V,+%WANM96
M%%VQ+Z$5GP(^Q#;+[VST[01IDLLR$-(K.6=MIR$.%+/MGS.CX:**0C+VP4>4
M^0Y:]_N&4].X>("X,2WIXX7P 41%31?F&+N? SC<<$T*I.*F2=)>SGK>#)#Y
M22J^'1[Y5ECA@UOT)P<<]7'76- KGB7CQTM&-*S[[I>S8SVGLLEV1@"J@!3P
M5Z9I/3C+W86UBK5WWHW",U'$A"X$^<+MIC,1]U9OT_,8U^BK\Q)=9S2_>PW!
M/.8MFQK(U2BY['GOOHP7]W5<IMPMBXZE/+-Z+AOL"V0+^<Z&_^$ O-!C(7,U
M+TOF* )41(>;8FM4X_KX"3=+U:M\=D-Y'ZZE+-K,(^&D)K@Y5IPE1?*WO'6<
M$&:T04*Y0P@=, S#CMV-/XCP53=H=H9V&%;9%,.EZ=5@*7KP55#H<\+(H.Z+
MF'R%S!<',I]J/6DYMKOC]/H&VH6ZO=:V,+ZKC9A%YFCC=/N46V> K%+VZ0@$
M-0JGIMOH3)B[A_?9OSFN^7V^KKZL;/CZ75G]LX-U%_WG<C>;DQ-\6"_IX@QC
MKK+ZT'2,2\0"(*F'-GET]]$.DJ;RG9<%OIDZDY4266^VOX.C(X-J\]2:2VPF
M *OK4:&OC6/BT?DN^>N5O3*^0O?L(*F^!UVZ?J9O'976",D)]IGO='P*Z%Z"
M]*&^AJ >B9P) 6U0Y-!>-(0;;@9N!./AIO4.?97ZB/4%=I[B-5=*DBER@6E2
M("^J@/\N :B/)/^NWGL^4ZB4=E5V4%'F:MQO%9G>ZX#.]8>L+YC9-#B0CJ)<
MWB DK&U1HKED5('J<'-K\\7!974T$_2\$8O%4Z/Z5X^O$I4RM ,N3)&(J#$6
M^K0)T4@VU&@5OQ1!_;KP5'"%1W:;6-C<K(P_AM.9?#]*M=W D<7H' !##]&B
M4@F.1XL_8IO !_ 2#;8,*Z;#0"M:V$?^='3ZYR6=0Y'A8<8QO>7%8ZJO?GTZ
MW]*\L19'/?P!$8"@^VG2[4A7RR."W439AQ$_IM2;MSY9WYS3H$5*\D1>KS?G
MQ5CJEQSH$D &F\O'F1GG9#,&/_P.F3;GSM&E+*6(]-B[AA57JAV**45D,LV:
MHGG.$(/,M;M_&LV]3@O+)R^&/-7*$0Z$BC7PSR$2W84HP#8.0&KYC\^,%,4R
M,^2K#S7ML\&[@-"CYHPC]KU$A6!R]=3WV',E>UK/KXW;J)+05SQFLGIRSFEA
ME4O-(CLW\DVC_J:%A8\VPP%<&],B!=*$@3-OD+'-J,F >=$V]+.H#R._4^D:
M%V-"0[Z.NYOHUH6A=:^_*/Z\F?U1[.RKMG!WU6T4]3PK'G24W3W#@X.IS^&&
M33V^1PSW::),;\][6U!+YXU*[/,6PK5MZBSC(5HM3D8'9QIPD^\/=&HU=]%S
M/H3@2QN5,ZP4#J'M1+=7\;@F[UH0RAPL"CJ+:)%=2)A_T$C1I-JS/IO>91A-
M1Y1X^S><GR-IN_2B1-^_?*D#^3HV:?C2V:W]9ZI42Z>4[PP'X(&@G[:* S]
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MRSJW:AO[M28G:WB+WN'G45=!&YH0VVW1JS#<SM^F+4I<"YY\&2\#.\,J*N4
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MYX.!X'O0)^!*@Q8SDUFO))@)Z]T<2G2LS6^V$7))R*\HPMG%.D-%4[?V5WK
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M@*6*B!!N1VO[WR<?VJ5<Z/W/V3$LON%--E<)A\^N(?P]@=N&O7N(WVZBZQP
M K>! )>UGNNZ?EXYS1 +JC4EE/(=HV!^8A=4"1!ZA-5: @=@\;X-06,#\[?R
MN$X^CMV-V+[=P-5,B+FOY4PXFHR&(G8I#KT!(3%PY\BQVW\=.("+2 &V^, F
M-ZY2 @9:CN"NA]4&N%^5$$"/ /_7E&@:6W[:&SPW!RR7-P=*P?1PV=C#;*N]
MZ[?A=ZIN'>SA '")234T1&FCTM;OK_A-@V:SC+=U$@PP?C.&%F/ .%/CD78L
M)FHP)3A1I\6D7(M.:%(E2"%FN0Q1KJD \R#W'A;E_:L1T0\&YA,GCG( _-R\
M#M]GWB//\U]4?/!7LSXE\#P+H7DYN+>"7]XK<[2ZN.9"V,WJXI\3HU4S&=!(
M^_[RR,M:*;YQKQ?7"]3<E,_85!:+DS0FHY6:KJ(?'BIK-K.BQ1LR8QK/]#[!
ME5S>M#0D[B%R\&+.B)9+& _&TLV528) @K-:.1(B!3QS=J96 4DCY+R>MF(?
M5&8H>(]N1(,[@2+?O6M,UL4=0Y!E?'RE#IT\>[B7LEU\)#?)^7.K8E+!QNX3
M:=\6\P@]?;_QML'X7*L!-0SPK/N,H>N5@F"&A=.XX\+BT QQ<;&\B5;SB2;0
MVS)A"1&(%<"XPK/WI+TE5V3 \3I082ONZ2NRDD[;$PCH.-XZ53_CXKK9G'8)
MAU=V!U:WBX!DRL988T(?9;+%-.1)D3,*U[>]O9&XS2Y,*GRP-!Q687/A,JVZ
M/K+X,3Y&]/2MMQ=<J\X.-JYA(N74[Z_7^7J0VHWZ \V5\_VSLU.7MW,# [L4
MWBP)U-R09[]CKL[5(^@JM+6 T,>C^E!IF&;0R<_U#1*O?L>"[RW]YI'U4D:R
M^'T0;<U<L/QKET)Q;;F2'HS%?4]P<N%A2R8AKH;981*"#BL[10-Y-R:V5T;R
M[?(F;S8HGSI%"S4SEC2]>1)=_>E"X^6HB;RS>F<O7L7KGIPGC;@R; (/]-NT
M*$O.1LDW[!"_>@=S "CH'#>>(BA=A;@6$D:[ $Z6ETTF3;49^K[-/&3\5*J)
MJAV$W"9DE7$!),1*J8<](M> N8AF?]M^>)?HGI5]PJCS,N7UO0GO2<>A"N=I
MO1A1/O$/GA'&@[G(OA^/SY[?['_CO%WX2]UYQ?[U\&?:GSP,GKJQ8;RSP*V,
MVEP:FBA. 3)--:E&7&H6JFBMY0!^/$UG<F&*:_X'KN?P+NBV,U.=CB]@8UYN
MF]Z(@1RI=/SF6U-_JK&A\1!BU#21O1X:6X5C=MA#N5X%8HKO=<\ 3;*(NQVG
M1XDIM>LF;#V*)M-4E6K,I0+<7$ GRVJ'"?DTCZ)'.*V%<H%7VHJGRV/B(PEF
M+,.=W)6WI;LT+F!YT)F96:([*$4.X-.H  =PL  1SF '[%E-FALNXY=M$SK!
MK4U*_TN$',"35;I7C@Y^".7,Q3"T#,<ZCA&"&ZR 2V=C!'1C'+@2&O2-*Q1U
M-C>WSK/+%L*=^G^ Z3<N,FHX@,P<A"K0+Y; C/L/5I@'_PLNA!M<12L^F=NN
M4*5 .V_$_YP5,1M%V,+^V_>_3,L!:.K1GLZ;HB!TY^9)R&[B)Q9^8Q?SDQ'
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MB[&=JOT1CRY<<_)W_*94Z3(CE.^4EU-WBZ'".F#6TK6=KZ)TCBA7,03"Y',
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M>W#_UK6I9I /P,I2"/_)?@"<19!U'4=WP_TJHB[(WIHQY@KGP8Y5O#.F*CE
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MMSX_'.TG%4WJ$(N='2&!33J9-]$KHWC7Q;5!@97@S7!N!8BD^+E^@5;P9+N
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M-,N^ZJASF"AB9](2B76A0B,2O'\;P7GPE*RS(=> >E,X+B=9"+:6:<Z2I'L
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M2=H&DQ,HGD\3%3W,!SJO(5OS25+35W[DO<X^++"\KTW5L2UYER?Z3%GRM<X
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M>DL(V3C[3!]IN;;B>%@^;Y?"'7.!! W5Q^@;RG705D0V94>5.D:#5<;N]Q%
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M)F%61TV54-Q>2;&?6>X8FLHOZSY6[#\3\"[]*]+FVP2(1Y#VS,!0Q0PM06C
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M0A1=1BHR]V;FZJ5A;+JSE]*)\1^M55KO>^Y=N1LVL+=ZP\9W8CEP2WG"3(S
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M:TU"![]VQ.>+-53VOA0W")[[T:^P]XI)SVZEJ%1U^4HW2D%&/9GW JD 4?@
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M;03 ZL29AC95]'3;_N,E-49Z<Q0(3< ;9*Y2F*=*!<'ON-UCG#&G?BUHVFC
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M$#H(E0RJ**]-B_-XII B=WG:X(TX=SD"@C(R.!0ZP0**1JTK=8:W!2D##L^
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M%D3,0;1PQ5'F@PB?A^8VBT-<)^ 5+=H;M!WJ>F8H9B3WMY7SW4;T<["3OMQ
MLK5YJV3V/ISM#^]07";P3Y0GF QO?PI<=F'3&U$[MG\7T)24HU.JA6;QPA5-
MQKHY<#HRQ%'[T3JP/G<#WE184:9CTHAM!*409=IIVF!V%UP)>VK7M2:"Z[XA
MM]:!GD@2]>U<GN.HR];],IB)MM_@2\%SZDQ?O"K  I1F)G48A ?]F6L%L04_
M_I/@4\ZP9@'D@TD6H)-(!K,](R9;&[]Z)#NYG)$N9+0\:\H4XSUO\7R%[VGA
M[!Y<3BX_+=10?03[#?M>D6IVWZ0XD^*;;V1C6VQY0W?UN8')8A:3B1BB=U.6
M=,1M&1E/'5JE(.,NLTVCJ<>T$=^#KF18I'UNZ-75+:;F5 :LS8S>E*JJNMNJ
MK?3YS.E[F<HN7B&/.$>04F&:;)L,9:2'J>*0G!04\[C"B_%\=LB@7W;&>9["
MVF+NUW]A#J%'*[^D'SA@*ZI\3UXTX<TF8OA'TFW'KY;'CKVAC\;Q2#_F//2*
MDW/!,G@)_,-HH+7Y$_BI S?SH[/BDGJ)T.5BD. IKPOSJ>;FP1,XF$=I-3"K
M_BI>2\@C&^8^T"RK<D/O:GOWXO1*Q;RM!WGI0_ZP<T(]2B\O_;JW8HH>#4D=
M:J/EDID/LL#]+@3Q:E@#FU'"-@O_9>;NXI&_7*^9!VH("'FI6%S<K]]W9%)D
M[G5"0:E68.&XJF;G'JX(%-9PSX4[&Y)ZE7(\NRBMM$NP9@4=GV*ZRPC0571,
M&U]51!+%2;YTX=,3OQ+O4<)]O6;/R6S3/?>- @XU/YPM5ICEI!]?PD%SR5&M
MR%.PA[!Q<>M?!Y0"]SFR=?9\8U7,0V[?.%%(R]CG0QU_7M!;+]N);  O[:ZU
M")9 IUGI(&&#B*P=&/@"4(^IPT1I;;>OCD?,0%!9"NW4@(3<L+,NZMDBV<WS
M7X?06:_MS6.+(:<> RQ+GK2[,R> 95X--.MVTFL5A9.W@FXU"K')L1GY^8^&
M"H^J(<]/#XQ%NL?>(%Y]KW@\N<F[#4M=I<(VB24"NN7Q#&")$#L99@$B.=87
M>K:T,,LP2 ;WQ GF"4%-.M"#=#M,7N^(AR033?..WM];J'IX&OQJV@(BWM/9
M*8!7G8=5;]-/Q,,F1-GAZ)!.Z"Q<:(+"846JMW(%'G6A"97UX6$<4Y/ZNJC(
M!=<L18&UW>_?:!5*1C/LUYYPZ$:!U@SVG?9)0M.I [WTQAF]VY0EFGR8#F6'
M=!CIPDX?FCQUE(\DY!+'KU1)GPX7V[Y<'2^G;E6QGS-5M^++2^?Q?4>,%QJY
MJQ@O8)Y=]8>YFQBPK<JJ!HKZ08.\3U7IJNW5\?:M)[O%HDS"_;[+!]K?%9O?
M!0C (9WK7VD*&YDC\:;SA#V;PIP[*GY(!12]B=[#R('-P ?"S!AP/5XZ)\4/
M-UJO_(&N0=[W\E/69;M(3Q.\M:-:D)>\G9O$JV[Y4B>U<S9W.=1\QAM?,=[!
M'I0HX[>;BD$1U.R&PA^V(5Y9N?+).#DQG+UIG;"S066D3&A;4*8F2(LG]8'W
M190FHBCLL]%W>.\;P]PG\'6*]0<T$H'CQ*N_1-[&3G#B"IY5)$0 3P'=5DZT
M8?<NERX[#WD^#%/SI-L6NVX=O](_BG7O=9R??-41W\W[0E(R%F-/3F4>0.(.
M-$J&R5!Z:*KT*VBF(&5I-O6YIPZ?5Z/8(-QA *)B+W$59RR;]7AZUO?;P2^Z
M(%[JR%TK## +R,$O% \[51HXSPAKHFM2V,/>GD[&>Z9N$'Z6NQT9+5H1GOV%
M+#@+B=OH.V9WZUPLF:(G=VH0IK38:CIX]QY-M;T3$/QMM;(Q>;.=!5CVP<FP
M !.8%FR5#*45Y,C-KN[ '8J?S\SJ9VVG2:S$.;7AXQL7K%]\Z6ZS?G5!N0_X
M/D/W 'MH->'AAB$HE@OA*2-+Y1S?H3*4T+9&>4HPC@7@H@ =(BZ2SWW-<3_U
M(*%TZB+F*-%OJH7\:<V^6,:T\NVQ2'X4[SI\69LF8T23H/.#HD(B2UQP<)[%
MD(5<'(B7DB-SYJ#'J:I\G7)3]63Y'1Y#ASTV=P&]D_Z(BF^7)>)![^F-65*S
MO(8 ^DY>!CAJAK-)M-IH^=ZO)UTCPTY.\Y(/ISYFBH?ID0VB7H0IXCG+3C"2
MEJN/F:K6H;A3?I;G*+VR!Z@-:ME&+,(_<W8@=],O0F*0Y5$=4\!90AOW<:*:
M&O X;NA1F@)=&9=!"[JBM/B9&(H:*YU8\&SODB ,89;*3T,@!28)G2(%1&;P
M1T)XZB0GGM $I$A*MH,BL961Y300W80RQMWF:=K6>**^W[]'H&+G?8UZR#.Y
M/6MVU\ /U:Z6XOAWTW/Y54V;?C%XY#AX"T9.;<M(&$.PN5J4CB2)AG.)]JHW
M*W2=%B<UCZAF28<;6LF1T?Z2MYV]C=7F(_9/9-HN)R0B"4"\^1J; (*8#4*_
M39=1ND@@Y@$,'L2NBH 2'3=D1S<Z\J@L4R),'B-+OW$?8=>EUA",DZK8:1P(
M26U/4?EBVY?J]>5Q(:\^'AZ!G$EA 78AW8''Z <H<7CP&!;/2&TMT6[#\H?!
M\I8:!<C[$JF]<(A<:8&OH V:UW%OULX)Z6(O3;QXK.W&>A%Q)#WY^4(63'1<
M%C&3TKN(/1/VP\NZ7:R<RY,KUE!)*WU=]"EV%Y,7VI?-UT@"M7 ?O$6YW&I+
M77B/,UW1ZS9.UZPLL0.I,<GC;A+G[-/T7&[<UMBYF)OM]&M&;1VQ/$8[$10X
M VI%O$@_5XS3[N.G&U :%5PH<>1]-)\A58^E4<<#SZK[#N<=UW1=01WDO=@A
M,X^,@)',$"^RN4B0-OAC-N5C2O]@RC&RPSR+/+2J,F9[PH5GR>=>%[HK]<FJ
MFWY4><;W9&YOP#N9BA#;Y< WBK%D-JM=&MQ_T7-,7"C<:,'-S[2.B40L70<*
MJJR.NFP-D5:?_-3;'Q2X559539&PJ,C@_S#@ A-T:Q3TJS*3GG X7G3]SF3,
M:5"JI+#'T*\C.)IU[Y 1RS&S?6,Q37I*25=3#<CR23A3Y E*M.:F1YSA8LN"
M3$Q*6O;%Y6TY40%MZRJ?)>J+H_+>RDE)V<'O"O6P^J#LB]ZP(V&*/C/(W12K
M%EMUBVFS688@".V%.*Z;LVBO<5+R//"YL:7^AEC=ZGK"3YH+LC2<^!Y 2/>7
M/#?\=B^/A>7?.BB%(^HR<P-&Y<]Y\I<]C?=M_>E!S]S?3YD$\%C\?_-1R;ZX
M.H'6!:)([V*?<D-K\E&GJ0&HS?Q\C^E%]<9$TVE[_T;J3=VYRL3DZ>@1'SM_
M6F>:8I_3Y.8675J_4T"X+F%],S_GV8?ER8T!W\J JKK:2B8TM"S#TT!3T[Z1
MIK!6#?^FQ?$$0^S#7SO[91OFP'3:H'H)#CEOHF;CW<98 *6->1AAFYEG1PU$
MV[  PK"2T"]/WL[</J[EOT%%H[[IW1<.32!_>(8BGT!/%*#IT4'\_$6QUIKI
MYKXIU1FU=LLI6TMKU1Z#1 &5%:];^AH3GL(3R*Q4<VH, \@ =^>^]NM5"H$*
M0QO<3:3R<P8D,2E$L.GFV@Z]/1CLU:"R@D#8$G]<V2_$2T!RD!A20;IJW(4$
M=B8,M_.Y'KP0%T,T39DXNX[<>3[OX8@P^IS&48K>$&)GXBQ X ;/2@S;4O5V
M\D9UV8GEK$G?SAF&/9,;/R>RO6ZZR@(\%H)]V8%M,LZS (U !2:R@!(ZN P&
M$9@J#W_[9@%6.ED &V8C"W#&@SY(8^C4(TO8\0.+[&$!$$1FZ"#[6C25!7!*
MO4N% <FY?_IVU.V$,.V9P(1$R#0SF!V+2$!$QHF$+:!"#W)G._>T?_/&.*=H
MB7S[!A.&-VS^">QK=+,#NZ1P[U173?'6LP#%CK<:A/(P-\*WUM:8E8(US@!G
MH'X?AHI[M5>W>[WO&OSRZ(.LS[<W):MW<*^MOBZEY\'I]3Z%(U_2S50VW""#
M4]O$?A/%RN4AM+G\]GQE_0JZ]T?L\0+ [L8\/V:X7V8"5&KQJZ;TA? GJ\25
M[U=# N@AL$S+A/5HM\H'JYIVMEXC=A\2)^:)Q4-5\PHOVV4*Y*_6=(/, CV<
M&C-BS_CU&L_%$M;XB1L+3[;-E90W]1KA5A/3[ Q92TKUP*T:)_/)R>\5*^B
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M]AT.7K'E#/=#K>4+K'X_I5TI9:R2*AL^!3DYA05G=T]\MK%354BJOD& KK
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M9E90TX5Z=H4[3_ZG\+%_XOOOC8_O[SNF4Z_3GPAW\Q;'GP-"QM\("+\(-YA
MT6OZ(XQ>_X)1,SA\Z==QR9RC?S=TP/^/J^;_]J[[)[[_KOAJ-"0_+WI\1[4U
MG*CQV=0%<@44VTP#!Q6\3E<^N^H4S,OIA8P"#I9S-#9W^#0+T(%=>>_-K97F
M.)J$R:O_=DU8XR]'Z@ISTP98@!]WHP&0.\Q%]I58M/:?IP?_]7*'OH;H"\*$
MACCY.\^)#MU?3Q)O_N"(H+Q0#PK1)TH[3Q#!VN>U/P>CUE @C.H&N$UAAX_=
MHM(8L%;IY=>99,Q:R9WJO@U#/P@(_@/XYP6F[I3H,GFV8A&4^]N_)MRE+^AR
MSIN:3=;'=><].A+@@A1V/80$+C$%PEMF_KS*9158>J"S20B/R>9$0'J?B&7Z
M/?5KI3?L"UI*W[W:]^MQ+K#W\N]K9SS%WOPN_4+PIL#\=_]6CL&N0 (#UJI0
M<^WW^^W._R[N]T4URX&+CNRF@DD]/T_\"^B_2/HUU9_[J[SB.A\4AJ$KT9[]
M6F?C9Q?GYSRN6V<B9U,GS_V^_";'LQ<+WV0!N!IG?P$P9)<7N?Z7 A,,FM77
M;;1  Z-,#@#\6 #,BD67V*?[91<!)\4_OM,,0!4Z; L#3_66W+0LL"EQ\S7B
M-AM)-LJ[<>[3SZUM37N(_PA&/CK+[9+0SXP;P>)\/(R/B=$.M>!P/I?0Q@5O
MGV?B<:VY1QK3".2E\8ROOF/\.H_WXT5;)JF;VWTF.[D=+$#%8634IN8&EGNL
M/?1L\=N%FN0G9JV:+4F]^^>@PDNY% @Y&]6!5DLM-*R%?KC>K7Y!\:NPR=IN
MJ=,K#IE<Z]',X*9P*1VQ;T$=!7MF*5%<Y>DWL@4^KEN3UA$":QH=!74\N.'\
MDHI S.4-]T8^GSC9G!0(5Q7,,E/SZV:R@;#D]ZYBMX(/&?;]VP:+'")?YSB>
M;#)A^=K>7;/>G)R N>$;7ZMG5(?+J@5;NJ. 4P1Q>GKTPAJ_)R%9(CHP6CU1
M8\3:\EO]\UY\TI.-OA+HQ M<KV"K8?Y#P] WO3Q%6N59.@^$.WB&='.C30H:
MY&]\B*?ZZTG'6Z4-%2T3;RN:%V@]*[!Y?I_OW*!I:K+<(]M!C(*+$+U $P_A
M(&YHHO(UK86V11JX=P@C];GZE(99N0?$#6(ILEQ50_[4@9)2T@E?M<E/>8^;
M$VYK\"Y:.+0J_8R\.G]YVTG@^)73V4=F@CH)^4&3NCC@7K*N2IFY>,_Z?LL2
M2]XACX$X.U]+CS%SN8Y ^VG=DB^-=UHUI^TUPOTXHI\6/2@Q+#A;03/6#B>>
M+=(#H'K@K<#LX+Q.YBP+T.AVV6MCN[ES%<NQ(01]\],/G0!F5H;GW1=HUE"9
MV8QY]C55IC(QI1J-2,,/63Z;=+A_0*(T:[4,X[3U5T:9GU.96E(IMEK']H97
M_]T\YC\3F*5P;B+GG-20B[#KGG$FLK35WE7T4<BCO+U7=<[KQ&,9[AZ[%1-!
M=DK%CX,E,W<E39!S[=MI15*2FB8.'R^ 3]0-5%2!]1Z_R2S-J+.AIVYB/K_E
M:/2)5\20B5=O>@E!14'@DL.5OK>2]QW0[OX Z UR'GV$(CH%X\ OIX^0&F?#
MB]I]'NTZX/:@Q2WP"#"$)^'\O4T)3*</]PLAOE;K&P\)+WPG:Y]^S+6L=' \
M5/#HZPV]0#FJO4MI5&6J]T__-&.8R_SPE\.(+^:YZ*GA*=\-.F*,JO3*7"TV
M.S,<UNOJQ6U +TXCK;Z0VYR2%@:YCTG@P[S-I-,N7>C6%-@C<P1VU,._M.3)
MF9_O1,_?UW,_.A'I?6'2N8!B:W,H+LA#]'DK[O/7+0?2<%''HYTO-R'0XX&Q
M<Y,[J4IN= :7HJ8:)++-)$7\D%.RB?GPZ<+AQ!'L(0NW)8\)LZUS4T\&H"5-
M2Y/4Z\**S0[9;2X2L$?,7$SZ.O"%Z/%'<(Z;*-D/@A,3S^] /(6>H*$'1.Y8
M>M<0,D6\-1$G^F%NH<7%<PE.Z#LQYNG^\9S5NX0Y+@A([DEL+"B563MRG@JB
MF#;3S2Y'*IN?:ZZ'ZCTJ;!TUMLDW]/5YNI!IG5.Y7E67N^*;<)#2JM,CO5##
M5>O[WN1XJL[.[+G<O>I!9M.+V)[JW&I,M/)3:X#1I7U&F$F8TT9SM;B #CX[
M"Z95_ %KMZC6[S3>Z32^<$;6,EO?5O Q<.6(87C#XO1R<A^G9H<6%SD)G0FS
M8VSOC6U9X!>2U^9TRGHH+QTKW5]LIBE[Q87_NSDU[]-JKND:4!=A7BIB'A=4
M&Y1^H\"P01L98(UU^FYON];8]B\&;K.@_C_-]?X)['\:L RC=_1]4D-6];E=
MDBXF2M"!LZL>]_*RXP>&D:@K"B%F!L/7H]88'S:6/$_"YXL.Z&3S_<I9YZX+
MGJ9_Y+E=\9834J7;W*5;\W&]-X7<YZ.==_VBP$(:Y>JP]=<N7?-]BF Y2O56
MO*/Z]92>5JT01]GC;^_7?A5\_S8B<6!NYK20EP A.WE'_253F23Z+.B:FD),
M>700_UUI*8N\^9#R:+?O':>^&N2/C6WWT_1X9K(E\-)EN4FWIUPM%OPR*OAJ
M<U:^+5=6)O^<#PBW_[J/7T8+V5,'Z2PHO=IU.A2/5)GAK8.!YIW421.XWF1\
M>\J(@1G0ICJA-V5L5,SLZ&S^LQ-/OS;UA45$;P[XN&OR!4QI!1=1Z9,A?D[P
M Y3BIDR_-[-^];DOE!;?<CURMN*VO/G1^OZ^-[! FTR"@'Z=6U !^CUA85(.
M/A=$I7"U*K2'7OV!$ A%0'R:M4O2ZP*Q)2\U#O=Z<Q.(.^@G>[Z@^#MG EB
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M1G54W"Z/K9MRFW6;=)V;P^<NU=)+NMA=/[+1>5+8_F:&39H%+%1Z[UP@/X?
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M'G:TX</3-PK@I\3C/Z\UY.F*WLC-[&X/?L=\5-SO?M=Q^-PWI1_4=SW\UKO
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MN7'I/9=R7'8\/%+":9D$-B77.+,ZS1XXH:=^[5$,A=+L%)9@A)S#[QD_85/
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M 0;(]EN/E(<\PVUW[DR[!"UO-@_TZ&2(Z0^:G$_TOF-PCR=0AD0=0-F%Q$@
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M/FF%+$!3PA_G_4!WXQ,O5MW#YC(A91[T+LW V>8</NT-ADY11E1P-KK$<DY
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M_\8;H1YR '1.G!QTB7!BZ-Z.!OG5WACM UVUD&1[?,(Z&5Y)R:]ZU?1Z+"-
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MOEEA%:X#XO=)^7@WO.9+5V3;B=N,7Y1W^Y $U'X%R*,_>^(,DCY(885N/ST
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M.AT]XIM-/BZ+36*M!ED5'N7.5A5>C+9G:M6VO,'SOARQ7]N(G_QG771*, <
M#M0*EP_C#GOX%5L!H=*T6_1"G;8,/F\I^XQM*Z --5!J944<H\]6F(1W:D5W
MW0Q ^6%G%]^>X.M_;BXZ3I>G[:18L[/@MDMD^.1Z,GVU8XZGF##>>8;/CRW
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M1XOQ$H9*1##]+*T9+:U<]V8[.+F?4/\ZT&*GWR"H+IW:/'BF?$J9RNVTU*N
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MDM7- %?992L?T1)KQ4?\C ?S^(@8:_8&/N*4' ':;,-'M)_C(X1S& +0_1,
MN!T'3UC$1^R)971#<<)#<+U"098V?_$1#VVP,'Q]Y"/0FLO^_SDN:BP\0I*/
M>%DPB@4/!U"A,PNPS,1WH=C7%^XB6?OA@4;/\Q'@!22CDXI _3*IYB.:8.K"
M?HT:?PM)HSCYFG!MI-#YB$Z@-18\%>'71U/PQ)-)($CJ([%=J)OYB%_%(0HP
M<Y+3X2.23_ 1W*DB6G7S/74X[);- M"DG!8?,=>#L>4C6A4C$##H[J3R$1MA
M6\;A>1B=! 3PR[B"CR"D ,P ^.#;1FD"/"L:W%M?6J1=%PFYPC9>2(1M' 2T
MIP9""5-./%L?.)X4'/LR1G"&CS#9F45\H3!GJ/R&6J'8]-&Q&S=.O7LMQ4"%
MC;.P^^&M[-TL-.\[E^TP40UJN,]"%]V;[)W-Q']8)XQ$;ZAU;_3/3>,L>*UI
M1$A\!SQ\XC'R?09_)$]=MHYV"W2]DD$YL?]&S85KKV5B.OPP>0V 6>1>X*;@
M9IY"R'<GZ>0[*RCE=@-5!;'E^![+P?#MWMZ6SF^JEZLSHG",0YH*K7;M)$FK
MUL'##3(.9U6IB525VSA6#G)N!^.0Q^EC$<YL0"M?\X@O.^_,#>4&QYMUG[_^
MP+9JOR3(&VU/<XJP8Z",2>"!,!<4"O8/=X9CSHY>,P#_8!#G3C"63+Y$:*Y8
M*5Y@++-6C^-N?[@>G'A*8(]:])?$G+4E]$F@)8I]C@3:">!M*FVB9K?,;E^C
MRC4^==(<Q4K:CCEU'^IP];S08MNA_ 6GX)M:HZ]30*O.*%ZNWS#ZW9VHI_WG
M>(SKV7CNIU=KWSAEJ7;EUI>]<]<PR*^4];29(X]G1%D;1I@7^.+6PO@(HY?1
M3,HHB;=';>,2'V$GGP%"?=Q5UAZ0AI]=8^33(:4"%W#$29C^BX4<X"/&3M(@
MT?P9(M>)CD,WD"AX@C8[FE<@NRL#3 E]D$YHCTQO")ZAD$WF@?%+[ZM??CXV
MU[![1<G'NW[0QW/&*QSYM88]Q7"'XC.B$GTI;6%_+1N6U:ZN@+<4V7,,)R1'
M&2/HFGB2*9'NFTA87-PBB)<V5.'TP.F%8=O!Z=7%!8C?V *4A2LBS-?Z&4UJ
M#YY,U2:4C'V5C;L:?L!:E?Y124B^IWF8K%AD.%.MS,L#=V _'=.5;.U?-NC>
M$]OT%5?I+5[DDJ_47K% S2K"5.N]0YO!96K;_=)'B>ZG\N]\4[E0;*IRWC=/
M4.]PU9RG:>F>N8)5=U:X)!%_S[8X!',D9+NI\%^I3-7D)M$^/]5&AL*FH'WQ
MV: _^]@/.&_[&/+'8.%W/\,2SE]<1'@ ?C1VK/"!FW;L0X.%"C&1^.69$/,A
M;\S%E]^\;;6E,<?B!8OD'H2I,T:R$D3OH.86:63DR Q/=Q6_@KL';NT)(3S0
MD#_TXIGR^?=OJK<]_5HX/+'UFL>I-W8$-Q541C%DZLM'D!T>A(@\6AH1;;]^
M\8>U@@+1H>E[Z?;LMSEGM0VSWZ0/$@'50>0/$JB&O$=E78@0@B'S4!J,">=%
M$E&;";]>AT@RF(<RX .'"#$!C,]/ 3I!"M8_W8DA? 2 7:*4*C$ZLHA<Z,Q4
MJ#^1P"5]"L 7H<UNSQEJWK(8FC.W2L\!%(=>,&=6[MVY18U9VI'>AS[=$,%'
MY)/FT9 DMAG-5<Z%D:8EXRSLDTS46 BX!\:TXE$TJ!2 ARSP8]EL=RM:',DD
M*OB.(3 TQ[L).]#3"IH@0EN< .8%-/,(9X&W\QC/B%24,<,I)XP_KY?QTO51
M!U;%R U5A$_0)&HL-&)]T))_#9KWS\2-ZQ.G_)X8DB;&5%#G?P"C;L1EU_6G
M%7_/PM7!_HO*D"<LN+)XNC"DQ=T@(<'/AWT&8(D*R6=<AY'\)%L'BJLG!O(1
M:CIL;2J9V\!'U.#8+K]]QX;A>;N5"@R>KV"WTA@.4#P^"F#D]Q(XL#==QTIU
MUJJ1;&E_GBR0RRIJO>RSZHUB:-"XQPH;$VJHO)V'X>+(D5_#7+Z)9/YEM(,,
MJ=>W6@+=1-YPY=+,Q"1IWA62S/BW(7][4)#X.Y &V_W@ ,6GG$7&@I'  T 8
M!N3''H0?'^ BT(V%E%,@T883Y3_"^8A"ITB  /GWPR@>YT:2(XRY8$U?#JXL
M7<;82X+G1:+32EM#)@#ZZV^!YWSL5R.U@*,V\TZ@W^_:9]/4X$N,"R@3+.[Y
M#NS\ULZF,YP2L/&YFV^[%\5IE;7"_LLH:]T#:L.7IU?X:KA\=&Y63?6.;X<Z
MX5OVTCF+L0;MW;>%'G:](3[J3F3.RV" 0G66-ND1]SA=][864T0[^N(M[>EO
MM>6W$F3?U!&"YSS9<A=%BJH%:<P0V2.Z/C+2U]2UWKZV7@_4S3:[/(FT6CWH
MD16AYB9D&"'^S#R-Z="46# 0K!BGE;XA]B^;P5HL5*D AK&/;GS?R71LBB]N
M58>35?" Z/>9,E0I($)]GW&/)1?>I#$\_6[8V7D'8&<U%^[?=?!;L[@WINOX
MRNB5E;)8&O9NO5X!J,%TXSVH[*G\IA^Q9*SO;/TI\:$YLGZ4GOUSER?XL<<H
M.53"8?R06JO'1"53EWMIL*L@+KI"SL9KULW.^<*@3R02@YNM,F$%]O@#.QCR
M?Q U\AYT,P=D_9]>+:RA[]4^W%&O--*UD+98-\AU]%^[CJ51F\VWMXX3[EZ2
M=;L8DF>F0C9("IT:,GQL (:R#YNC]M0+P%SA1=89D%-'GXI:QB\:4(P.1YA5
M?=<6NACA.:Y[Y=Z\6_SA0,NV\Z?]X&KM3/S3-SO@32O39_P.!QC39RI2UJZM
M4@R0FO@)],A%E+"Z[H^#VQGM'>),<:4+*T<OG[N@(.TW?+1OCES4S?87&[\A
M*)!0>K_D?K'^TUO+A]<N$H*<DGTGSP[;]K'>034$1F/C-I7;\&5MKO\YAQ;S
MV,PP/._B/I7MNV!;3?2Y]ZN.U([:&/59?=Q*35$ :H17)@I>P5HDMJ+9BQ+0
MF/W@E0G-T-V>4II77N,6OW"N-A6?ON7'?"KKLUDXBX4?3&)06H3VV\Q.=;W?
M^'SXQ_&^:\;3HR*D*71[HU;(4C);A[A'5PV9,?[N:6; K_.3]QLH<_F4EPY8
MK^5%8,!%F"V9%=+<Q/I $<ALW1:;.J-DFUQ;J=MAGUS7F&[-1?:?1B$;MW4Y
M.\ .?Y9WPMD\KN+QUVHI>S["4C%(1$_6=\9>$.; "%=( A=E,8-C6P24P\0H
M"ET Y()<[0I U.C@):)1GEQE1MS/>R-:?=[CYQ-:Y?L0*(3L"M>>N')DWU)H
M2?#HK>HK(CZ$CUS6*GXZ47CL&=-GAYN!<<RKMT]Z&"RF%J-/._GQF?:A;O-%
M3AY8P2R:BDL),1Q7V\,.31S[9'9"K+4F[;;PNX"9\,.4@%3O\>0UAZ]3D64D
MUC:D7*.0+!TNY[58SK. YS8$& =R"S/6>:0/S".W_$8,0Y@RP@R00BD </B5
M(^@E3HD[U%+MGKT$.D^AWEU;""_!["VEXNOV<D/8'H_(.&EKD3=NM2Z8$A?Z
MA,]*'(/($V7W>\UWBRH9I@US+BQ3O+"L]1HRQW!<K^($1D$O%N!R8&J\/ 43
M<Y][<!UL[V7H / UP4A,9\P,$DCD-0DU#J_O'0EL]X9IQ@M1XZ]7Y\)+@F=>
M#T/(=@CU&,6.>9H%$&P;UL(<B_"L:$A9L17).C,.@UH  5[T)PGK?+6&CWA4
M,.K-1RQI3*'!%-(8I1+):&@4 K[:,G0@\=IS<S"51D&-.9X@;^<C$<]A1X*S
M/4R:XV&>P\/.7@3HJ_8D0VW'^@!:"<Q]4BRA_86*4'1Q ,^@%D+N!]I/LUVA
MN"/NT$Z,BPNA[S\,C43-T$'6S&\SJ;#\V &_K9HVM3XIO>@RO+QM9B_6C4Q3
M8TJ">1?7[^_^,R>1]\![B<R;#5R!RP5J?.\UX)=^.J]ZJ)O)1^Q#5]C$H'XE
M=0"C](D)GN=/X#GZ_S%^Z@F 0N(C2HHNK^L!B=]ZP <N<R^&H$: YZQ/X7"!
M:ZV#J_9SE MU+'J>R-)4[[]LE0N$;:7GP;8FV<"V*J!7N(YJ!$O6L@C[%4X8
M^*J0P$<TDV#Q%,,B<-=+S K[*!%T5A,(XB.>_2XWN2CY'%@4$)JM^0AQ4&A6
M)$[K#<^<ZV"-ZB"0^F^^76WHJPOH@T."A&,ETI(9<+&F?:3P4['B2!]>8YM)
M=/4=*=J/W/[Q]\5C#;<")I1HKH=?57V3*"\GJ ZZ?%_&F)M)KL0P/BN(FL6/
M';D6>*L%IU,=A#7(DW</+&\DP,[8&Q'*5CP.5]_QZJAMYNJ[&P_TGOGQX9I&
M]>D[(A/62#F,$!W)J #7726?092GH.G:H"^F"=9?]9(T5(R1PK>(<P6D$FKS
M^-#:S7E5-6_T=8L$U4F_L UW#0U5YG'LOX#MJ%\7;$ A')FWT KK]1X@HU$E
M4O^#94NN_KC\9B)C4DWLX1C8<BF J1R<\/I43\_ W$($ ;4,JR*UK?XVHFR9
MV ]# H^+[K_ C=YA3X=XM']+O6K;.]$P.U?]"4HT)Z+O=>FRUZ-VF$4H L$4
MRLS,',P0A<BCC1;(/1%"'P4%VBY?G2*B*S!/29AE\"=VG6JC!"%16%4UU47Q
M$>_WBLSR&,_YB$\5DE^._H!J.CDUJ*(P< S3F[CE4=U8O6/?2-_$1*0.Q277
M_)?*K\[<7WQ$Y2_%O.^&')]"*F.DB'7'2#]"2@ZC'"+)9$H\1:$K8!U,.5^&
M046(5-DGT\9)=Z^:*F_+:*O],U1M]8*E\UT;6@JV -#W6C,"#RD@&8_E0W3K
M/BCBKQ+ -8?/0(5YLTA,4#IU1^G1@ VREW%MAA(=[$?/>BT?63BW-IVY<X8H
MU6D($=9_LYA,BZXW'J\O>G L&Q67YZC5UMO:XH_3M\TY,ST,LLKGO@ZPZTU8
MX9\U9''26=\^>=ASTQ3MSX]7W"$O4,Q7D7T J(5N<H-#^J"5P9I''C*PR;^*
MO2/DXFJP)H!KJ1 DHJ-W;D"*1P@;2_\P,"]PS1UPS-ZM#QDX+&FNF6"Z4!L-
MU!D.'8.3T:/5[[[-:DFYO:]=\_IX?'7#W)DDBSMWAK(,P^AO\=6-LE 7'[$!
M;[!A-*L;O_$2R9#ZH,+R4=S>T$>6OJHX@6Y-N1_OJ\*6J#-<M5[\E'\KRO23
MY [7)3!#\IG)PP+;1+F_,JTS#D[45KYYX9T3ADQF4+:-A\27';JOKE5LN6./
MGJE:_&)\>;4G-3@R MO/9))'.S0P2B%2P(_. CYBT8;%O9'R'UT +)&/P+?_
M+<$A$I5E\\:\-Y3 ?NT#:@0WB7!WP9#'4 8@9<(CR;D81O?I#R;KS[XE=5$]
M;:8"C-Y#^XU04+0">V7)D_P34_H[Q?^CJ3$%_/=.P__G+@/P=7_6.G+QY@R!
MT?4F \#;8L[EX$IPZ\#,1\#(C(+$]7WXB /!\$SC<'G"_S9PO3P]^G.=T((O
M_\?VR3.&('1?!EA;@R]7%O;/G@>,+O22^20)&B>H+?S=T8 G,Z$#:BCT1YXS
M"H:"E;^SK(($68"'D7)&PDC.:Y<M)%Y"F#M\ 3@Z.C5ZQ8J]@=HD0?S 8]5P
M[]"7"W5F\]90":Y-$M&X\707<P!."P-X_CWW&=V!S0,EX05SZ(P;U!G\<\*X
M&&VY\?CVH84!HU)50A2WG"H+":6CF '@C@Y-^ SYC"DB6+^$*]T/:]R+JC2F
M>=/,$$[4HQZVDO2%.8-.@WW(1R".B8#[)$S(&I_T5CAU<#FDY*/*@YN$W:$]
MR]F/GMAPG<!=_;+N;VE8X&S1VA4#G01/LPBYS$,35J9G2VHG?1V^+UBNE/=R
MG8K&[(^+3H9\-'S3:#&R0@78_LLEI]DEC.ZVS.R]YK'UD6-6/O:U@K-<[V>E
M%YU'SHI+7'MB>N)C$\*B)9>/B,W?LN/C1)CWK$V1 ;WZ#T(.:3NHRG!H(;$/
MN\_V>(XZ'ZR0B3Q+==1/.+ZJ4:]CTEES?>E<EL>^!#5!@23TUZW#'][MVVDL
M<#1YH%F!'2+GR=-D:+9_JNM8$/'#H+K>IAW3/=)].>0R/K-4>\M+3L[\/&\B
MLM&<?NFS@T$>$KW9%M-[WLDN<]"IT]!0[17W\$O"U1';],:EKT;I%EZ]*S4_
M38?1"]L/OXQZ\#_U]/_/ODRS!KFWFO09'D]MMPKT+T.1'H[SF0_=G^N2..(N
M0Y<L2DR[KW-13[[/%-:M+.FI[6:O-N?N/(-L;U3\&G$\0U7AO9?[N4IR.YF/
M")*H33_ZTW5' FOA>\U]]AS#N=RF74T@>Y>?@6FAZ/(FI^P$[@V" C!:4KL#
M&P?I0NVYLM]?IB^8?C<(]?5Z<[&@[:MQZ):#*K+,_>?^8'YA=JB/5)%FGS$V
M7+]CA.Q_29>QGW0[UW%L"ZVZ?Z<>?DRD0)$<>[\Q0=8\C4'9=6=%4;?C1O_F
M9RV5VTM-[582TTJ[ Q:V9!I18D(T"+NOE(PKT?:E22].9T(.7ADV1_4YT-^
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M&O(_KF,=*BD3R/\&\=C_#LEJ[#>H&#3KS TJ6P\>[-1_[2BO,/^9KIJW!R6
MQ3^L^()BO?Q=7S#1L&B(ZP!^NI)1N$'/Q93U$(KPM@81!\K<KW*\B_?S4C"(
MBB1ZTW%4A' H.5+$_K,F9.5ILD((<7N$/Q4_.MM98U]DK9$6/'^V(D^JLS3
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M' 1.NBE>A</EQ[Q2DH08&U)C=:*N^*)MK.Z0U:&-KKA&T%]A^'3P<ABEO\Z
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MBM\]P<%D ?])3[N@2A]E)H\/D::5RP*.,E'=S8QS17!L>>$H!>O,!LDH@$+
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M**SP.@M(R2>8;#H3-WU1799_F8LF]  E%O"\=1 ,8M*7MC:1"?1C 7]DFK*
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M;BQSH\>T*J#:9G99'M?X;?%8>MZ$HL8E=_.'L;,=!=.<$GZO\?-5E;2G;UA
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MLT7=ND,E)R'9T3I?S,;U6I@#BX ='IM1;9N\*[2NU%4$B9+-=.M@ 3..MBR
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MC8--V-_PC:@82.)=7XW2MEL&0=Z)!=<;/^:0C!IOXCP[HQP//3YA5YCP"7V
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MMDC^.59AJE/JOM17J"3\!S%7$^\5>]P+-R]WX2VE%=\&J3-JVP,]APH@<'I
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M'"P:BZ[KCT^E?S]9N5HZ5%%J_/8"9X!J)=I[)_M$P!^UT)-OA4CC*Z74!-H
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M6H^]!D46?NT)_V@6.,Y[=%O:K-7WWF/=(TY_D)YII7P*G/R"BD"%PTF[6@*
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M;@CMLAQ3&DW*X?"W9*V./J+6:BGDEL?G*5GS!A+7Q!?V2TJ;&H(OSN!/F0L
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MHD;H>DB:ZJ^@<HS4-.>7A^+0@S%_C0^-K3$V&QC!1=K4Y8KZ&11?CCY/H'>
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MD("78*E1,)+P2!/ F[0F/;/(%?:L0 I__M*:TR I](B75'6]QY1EX7NU*)-
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M<TE@D'O'W]!AR4&3Z=+(<(L&P&Q6V,NW>BGGUM;?>.N@WUU#E[\>.Z[;SB?
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M'>YE?+F'UZ060EW<AF"TR6T>2D%\ <T^3ZX3+5T+38-*<$X@RV?MTU!J JZ
M7<O-\]6_4B[?.E$=G:P<&-UG#7K@'TBH8X&9O(!>NX<B^U,=$W9D6>H&9S2
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M?"N+TT[D#_KT \N'BXLD#![/RQ#TF&<%;-\@I *F-^/5H<?[B';0>A"^PG/
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M* 75HQZ+8"'Q'L=0D<5%#H;/TF?Z*??JQ?B,GCTO>?+->_U:XC&I(!%]#K\
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M+;P$SW59A'1$>EAC=X72O./F"-*&C17UZ^0NT;0Y'3S")#Y\694_=;M$53K
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M;HCX6LRYO2%CO>>MP_3,H&"W&.?YR8=]OB,USI^&]&@"]'):R &<,70(JM?
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MT5GY,_WE; C/L0 [>LB&MI0X&<PJ?JOD2J?O@R\L;+Y:4N0 W>=JT:$283\
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M>*TO\E<69>V,G.268N@5K@AS^D&1_%.CEL#OIRXH$CL8\TV/I]7:SPU*6#Z
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M''6N8(-8_U_/'\580?]/"L'E[O^KZ;@ V-C99/W&08.[2%"NIRNF3V58+&9
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MT3EAI9\CV1P[4SW?GO*#%TDG[B1EV;=HG&+"3W29L+,Q_AAQY'<4[?K[+AW
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MASBB0(6WCTR\&E!!&1A=,W703S,?4GHA$H$OV]4K</L/Z9 +^M13D]EUG&5
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M<V/"2;33A%I+2RK[\'RA*:9^IZ[>]W$PM449T,C$KL_\762H *D":?K@_6Y
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MV(,_(R$/*M5R([2S#_'FF,QLCK/7V*A72LK<#!?1I^(]+K&3D:J6U9:ZL6I
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M/?0Z9$R44 V-F_J[R!$)(=>(N"'4 9GJ)8[R^*I!IACK/UI_1NK[:3>BAW>
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MF4_8R3C43LK:]DG][K_T_+[]%ZVMQJ"]#J.X6H<.F^GW@PQ%>MWS(*0H2G"
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M)@@%;P,UO\5H_?L,\NS2J3GS'\GY].H0D\D-"^9=SB"WA%S5VW=W!*.\A%#
M'&3Q-611DELF61HXD?M62 FM\_OMOYRQWL/.MNV,I-PFIUM>T?+8A>#_4]E@
M6F';%0EW"#'P_<U!7&.YC^B'V-=L1PDXO.4TQ'IH$O+AS,QO^^O5C,P*BX\(
M[>;40#7?4H7[_D#X'PM9IC%F%BINJLP=RE&#P<2\XV,/:O *J,=;MP!LI,G%
MDJ>CKF"B9"NNV(U7YU?:;?$;MTX?ZZY7N]<TC27',.8TZZNKP %F"&8,)\\Z
M)#+F8.0F2,\K\"<: ,\[Y18\QM0]A,V-/F9"\AK*=R$<P1"F_I*;X+\;* F1
MIF+>FI8 H<,J6<^^>LC_GIY-B&?QE;) DT]O7_]Z<N%//_MIWYX/^ILMC/51
MQ'\J^_ZW=E\3K<B\S#H[W'J6,]-ZA([O)LBAK]0@);G$FN]2R,PI7 IVRE%,
MO%U@Z+#'SIOR4NI2T\V%WD>NA!ANR\?M0A0)]W#$5$IO(M:]S*);196=Q[)!
M,7 2K5"_N8-&,J8RG^^KV'5_"LDR]5@1E*Q(,\RMI=U-8"NQ(SDG0>@\=+43
M2+4'@AN*?2676\5&-LL0UR+75$/OEDS-'->;^7$.OV@^W'B@?4QX4?E8%@W&
M?(P^P<YA^0!5E%EVT6(2*XQ^L^OADD)(#!IFT+)6]K[]D=K#VHH/%Q6KSOL(
MM2I^%>R7?0@)M.P?O+4+$8/]WIJ-V/;DEO0<B "RYAU84J6, V  ?=P_E4LS
M"98!?9*E?L+7:1?"4C4447Y?%!IXO\J7Y%/-U(!)G(@=3.HG7U+,WH0J_/,E
M</(+8^QSD_/8_144F. /Q^4ZHX=@RL#\$Z?D7R_U=;-2&,0>Z^!+#=D:O /1
MYB&U$/E?S1L<03_ J@U;7<>2PC,$0%VZ^0ACI=W-"/2<MRV?GIJU*O[MG^F4
ML;!YX'T^DKFD2+,MWS+OL>1+V*[B"(IS4_Q-T Y0;7N!1K/?;"*E0'PG5FQ=
M.P@6C^ +<GVP"[F>WI4G6Y=M. 9[$N:H_%>])>'$$G#LJ96*QV#_PU>9B7:5
M?\>?[D(NB^$)Y%B5L_3['XHYPR210_2\*CH?A:\3%R?V'FU -Z]1RSH<!M^*
M/.7>'/SPWDNI,Q:*E.#-'BU&XKQ#UV6,!/H8O;=+ZYN0&UT0A31K;0F3[3S!
M;G)M/BP 2>@Y(+=P.[)8D7-CBH;0P;8;H5V9AN ,PPFX3V#JHARL *.H]Q>1
MY>"-*3.=TB(P>]9>^X8(!@NR&K*/=AZ7==!JO:2&5RQ=@QYX]SZBG#;E6!UV
M57)IP$MCB)SZ1@=U3Z^]M+$%CT>LK&UC>%@3V'8UKL&UI0ZF$&18O%3D/M;]
ML76,!DBZ-5Z=*N5G>-,5%=A&=&W^/F]-5Z9]V87$NXYQL7_\]<M;&K,X0XLY
MD@J!7 VO,FK'QAG7=6)%43>IV-ZS(9VC+77Q"Z#%6^B!:6_)<\$_=B'>5P6C
M+\O?ME3S' HP20 [&4K-D\=-Q;APN Q#PQ1%@DE=>;J9T[275YMZWZAE2^!:
M'&5.?#7<A82$V,GMY'#XR\B$: 303P)>^2C8Q 3!XE0.3];L0D";O\XU54UT
MZ:_XL$>+[1];VOR^W)5_Z/YB[Z,_G]ODK"U"?N:UXM)XUV'3%HP14);I 5Y
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M=W#PUO5/4\V1AX>[U:Y,I1V8WBM>V82;EN0(:G$39$_.S6$3P9VM:!/LNY*
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M/P=!G^PJLSV<=15T!AC=000Y:Z$4'9%7.I?N^:\ER%]^&7[F^D8"O%*3)37
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M<FY. \!WG)7RV^(HIIAL5_Y.N*UDGI^T<N!%UZUX::<:@A<6U))=)3%M6'X
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MUV^JE_@,L5LJ0 U_/"TC^?#EL=9?!X^X7?Z&T>8*D1YF#PL!PNF)C/@)EG,
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M.(=Z,B%PW.?$P2_\RGX,"7814X3YWK:U\XE)F]!"FNS4YP^+)[U^S8:+7<L
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M#)V)55/S/"<T^M[O;[$WV;VXKN[ORLYHL.AY^;V+<F05;$]IGMLYC"F'FRP
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M/ ^F%O>4L\D_GJFYA(*%?P=_PV3,4:[!!1AH0(%^CB$TCCOZUS$PA2)3+='
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M339$/:)+*NAW6=W4^N80:]7BOMY9U?$5J=Q/[<L8.!H>:?%$V*AM";)T**<
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M.6+4J\D2<B.IGY?ESW=/PD&PZN71YWNA#!(PQY[O<<-(&/5B%TS"#(0:@HA
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M?R4":\#=H.V#<#[M9VA<T="]GOSG>9@*2"ZF$<L02X#Z09^Y<  _B;#466U
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M1N@<+^I?4'C6#Z;E-,8[SQ^]QX=T6HH?#(6FYDYU4<V\^)5X19_)W5;\=9;
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M:U+J7J/KM-9: [ZM5?$7MBA8!FD'WQ_4)SJ01:FK=!+TP1:@4137I3Y"M)5
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M@XHP;ED=8VXW$2*#SZ'<P8\(XD909@!RPNT<NTQGW54;KWR IMN_H.%G_RS
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M155V9)2[J*$NS-UK%TIL"AO#V>/<L;-X1LHXTAAQC9V.\TNMGX:< J!74)*
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M)L."!DFM<G6":_1UJ4]6+[9/Z)QX[1W0Y/?4(]QQ;%7BRP%8F^(^>&TJ1V"
MZ83\BE0%)NFCC'L E1(DRK*8XBAYUZ^UR: 1AF'[M[,H*JK2.X>ETR@J7F'G
M#[&Z)G<K:3!*RP8*_N\H, $X,9V)U%Q#-0ZT]&N+EU?T97 YBZ2CQ?'<@-A3
M/V<?Y+[J7KVOV_G#3S'80A/B<NA<)<'MV?_4%JW]5X6DQ[1+_P[@1]JLHA7U
M<G2!L'=K$! -E1;PIGYR,-XK2,5JMZ8V3R/%*3VJ/=U]DT_Q7B/O.T")_HPC
MZ,J$(:X!%%H?2;N_4[7738JFGJT+KZ!GU_$.JTE_@UD'^)5?.GI'O/SV?Y6#
M^JHUL:Y,$<XDJA$3C_/&I$/KMZB19 UMZ37( 1IU*ST<*^UX).VTIN;=0B>I
M5_DB0IH6<MM;L[; 45;N,!DUN_WRU%R7UAKY1OD!O.NUI9#X!"$]E= S?NE%
M?72@CR-(H ?U/H 3,?W0 Q$!Y]0OM[]H;6TL/?ATT!3D-''62"3V1.><&R;,
M.1I5$-?+I;P#HO_2X!8%I@1?9P0 :64L-4"+N"6^I@RF]?D^'+.^@(MZ_>/B
MQ:$C(+PD5A;]&55TZ"K108:YWX\@KXL%3D7V6T%G>:\UC7<= R))>(9R3<0]
MVYFFL/L',WWK L$/:0ABV+24^D80,Q  <P1&H/U8+C*\_XHP)1J;6M%36K%P
MT_ZZU4C[U5+-IO:V0A=#OWUUU-+-L*77]]3=OWSWS_.U_8ZB1.Q0]W.1R!7(
MIY]>[VVK2/P3&T.:^4!K2FD1G=%]UBFLRFLSH5V3_LI":]%SR-X=Y)%N^$-T
M-6)'J3(N"GP^=D-IH/X5^RL(;\#?A%1BQ>9S!.WHB914=*-M:M=I&FJCCV;?
M*U&.2^RP(-?<'K-"*YB"Q==ZU>X73@H,>Y9L'#SP54"7&7.^0?5)O%]RNJ4X
MY-F;*T$G;5]H_3L9.XO+?X34Y7R9;:'R,R\/<P=J3B?T8P6 '3,@L=*9I0=$
M"7,C+APEJ)WH7O3@*3M7.8\^MP;UR;HY=$='"\>3-G+?FOF%J8U[Q;[$Y&5<
M8+]#^6REHIH[L1MI3!/639K7X(C& %)HLL/I%7RTUX$&FUWEM4Q;AA_S\\H9
MB#AS65[@6?!_A\\Z.:,'L7.CC$V 0G>Q8N>S(LI9IX%C-(SKLSY+LK7SE"5E
M.J)=H%1AZ*S@EH.HY(L3[A=^F4=A4Z%>X#2,L-$_M+<'H&319)10TV@B3D!7
ME!>>WX/D+1HHC+QP$9V%G/:F81\]Q=H=:W-91IB>:OS0\NO+K\&N*G8QRI<@
MPHVDTQQM1"S[.<H7*KKN)D=S2.<<74>)&0G1(03K-LSE*9NZ$)VM-[N?P$7G
MDW*ECUGX&$TNNA=/-C$B7:DQ/K%M?W=YNA%\$SAO'! 3U <]A!Q_V!:![Q<5
M@LM<?Y_:[^QXOX&NC&XSW0]80CQ#WQW>7/0RWA\[P+P"94F^(A,&,>( C$1(
M1Z@SS[..T-827\ ;^O^6EV21GTP<'G\M5E LJ<+;9AJG0=Y*XJJ::E23*$MJ
MJQLLUF%,<O7J@T@J\TQ6=T@NJ#0SE5^1_623EB)"^,J<_)>?G.J)0YK?*9D6
MQK*\V)@E]EN((1HX*9H-.?Y3PMMYD<'58ZQC^W?2_CP7W -=32N9&ZC OQD^
M)!-P!K1?SOR+P'(Q:MZZ:P=% _TM8EQB5T)],:G@YD9P/1J/24>* #,O@8PK
M =?Z^KMD.A(8ANHV^W8+-[KUC9Y\WY+KD5J915.EF"C67783RB=H)I&HE^&_
M$4[E[3_U'E[EE%S\J?NO<7W*S.%;GXL<RNCR7EFOQ4;!FIS/&+$N"3B:(UA$
M:W "C&ES_;!#$!G?-K6VR,1-EL?^@1I"NKS1B8F:\D[!G</SP3_G7@\9-2C;
M5K$,V'4(72:8ZU%KJ#_N,,*2-H5#T;@DYT3*=#_R]#>=W2 2[=:&[_ZLA>HZ
MU<?CF^>6+0440@:CQ3K_.'.-D=IR"5(%F#!-D+.8>GYJ *V/$<VN-[(M9UVE
M\>-G'GQE\5!J(.IQIN3^3-W.3#?W_0HQ;S]80,^YJQSH,J.W]*#GCJ, S=-I
MI'985K$NKE_)BK1922:(P)_7'/=SU2;YRV?UY\%O>S^.0@<S/@YW(%J-IEOA
M>$HRFB6ESEABYU?_JXTENMZ"XD/=QRI:T^UA0/M;G^G"O^8MU5?>/VH,.+WU
MR<5)$J\8LBM\\KFGR'VSRQIU[$K(180Q^RF4V( 10)Y N.,Z:/BXB-$9,K/W
M-O)$WA>?\%5=MOGRLD* T=7#3Q4-*\/C"LT,2_@,RFN+PZFK05U$'\Y7<),M
MU96^Q7@R"?4<G?$81,H# :*]\Q+_[8&2\^D2_1+X@^U3_YU5(^OF)-"L+S!N
MF7:&"M&+,21^ZC&F&_(CIK&B#Q=/:-+N!Q]DP6C@@1IS8]4^R!D:BSYRX>F[
MSY>N'C1_8/;PB&51MLTWF B7@#OTV,;A6E+[N3"#:]I)A!SYP3H 4"M6D>HT
M:/\6W[H\!UWN/1S")Z'YM_-+KIK)5$RD7%/!SKN\C\]VL0[ !<+[U$'H["L2
M!,U40T@ 6?0\42&_J;;E,KI]?Y<F/9,C10LJ."I9C*<V-)YW.VFGDKU!X95=
MOZ0\P[S,@K.;$1Y,./P3PY[]G'6W @B=VC))_SOM,/DJBFIT7O:&^E.CCL+"
M_V3ZQ&5:RI%XSF<NO\'3F"1D41GK(?TS^##RB*FJ A4YJYX]7Z22\!90-T[1
MQWY"I829[X%H3J)I=8V]3O;=N2?Y/XF ,@O4O0SC9=4BC*.+V=,1L@9VA/?$
MWYR8J8B+B#W0):@HCEB%:G88V(KGZ !0F@<)EJ$SFHRAU3^ SH$E(CY9!NJ,
MZ,I-V@F9GWDF2CB6\B,/+F7!<&[ALNHX;ZB,D5Q8%6<,<Q#G34B:76RF#$H[
M'Z@*"'GK,QOPJS9""'ZO8"D[YM:Q H7,O&J-"NY#E:SK@"U)X=_]$V+L-RBO
M2. I$P)_7+\.%6]\JTVX0S/;_5@8TZ[_U+\ZIYFAI19P^@?BQS392%Y[@_X2
M$0F ^5GB<^2@0; "\"7H49O62GJXM7&$*0DJZGUYS>!T ,M4X[[;U(DG@WRM
M:<UY,5-TNY#.A0SK-A>7(#\>I@S3 SF%:4SMWYIMX<@V,$SI>JD(L;> @UG&
M3:",+M1_#L\GK_ #],FS]PZ_D(0Y;?>8*Z9R(*HH!>J-FX,RC@#?:*-]T$;"
MOXO^6,&  ]T#UDRKOLB=3NU+OTZ)&Q_R]$FMWCLR9D?-9/6'93?#?J=2,VAS
M),+&;VZV.$1'#8K.3G>70J:[0*Q8&B'U="U$!1"RFVZL0J5V:30V-#=/')W$
MZCAD62=:\>[6+5Q]M[H'4F[-67XQ]J]^./T9!=6+YD4.P_BZCB._.83 WWVZ
M/<%RK0+&!V_ #7N:&?D#ZHQ\R\C0CRW-&UT^Z?>JU'PE#Y7<]O$)8.S&[P11
M4YG6G(E_]^W,BS*@;+1NK%YOVTOO$"!U4%F_*_-SX87\Y+-Q9;:/Y5675Y8"
MFWYA!T0S"30[[(P#&=L-2\+(<HZL<DY],_*AM"N$4&*EI6VI5B=KI8Z-U5(*
MHA0$AL%Z=R*Q5L .><2*(\#DSEDHE9%/GTYLFK<BZG&SO#,\S(GNEN&G2VU)
MWO+_II)*/?V68]8A!AHS[C-7,U-I)OLM[X'F;+E9.8+IQOF*J>]Z3G.QGHH(
M2EV0 ]+*?XQ2F-2+Y%&SR0B+ULO^X3.>R4;3\9:_^?Q[2D(&S<Y KR.BF*8(
M!RZ?)U:@#G+XG8%T%UBJ\C' *0CKZZQXUZQZ-N-R]8.<MCRE#.74A18H\0U,
MF8M=XI/0!QJP%,Z19Y=A\BRG\3_<+&?B"//)'Q4WKCQW@#GW1(20C+!GPEGF
MSQ@WN2LYB3-*:') =VAAW5@R4)$-(^TJ^#.K)N9_SA$S*3I1M2EX*_A+)O[S
M[(8DE?]H!S]CA]UF),!T1=BR<R6(;Y[7KL$.L8SIJ68?)EB1E=^M*E:="RLB
M(Z3GH59Z!U-(U,\F:O<U)?/,3W!PV/4_O)OH.3U&*_L%PI8^VH.JPV^4U7B7
MRM(GIU,T$0YT(;+,H]-W6YJ^41=;TCU\NP*_CAW:/(M/5(V=_RY%^HV(8;>B
MW#&/,(>V_VUZV4G@XO8A((T\;]@+.341+O3$LXL6.U5^SNS 2_?]Y6=?U=TP
MWT?=_8"59W= I.'GB1AJ4QD"R7[9!09V!J$-1?V$@]ZSKEL9$.4UY\%\:$)3
MCX^B!]/FMQ7\J>9+P6-%7R+$-?9G:!43.RS#N,)A!IBGH%+_I\P&-)$@N0?R
M"1*#5_7_#6*4_,5DLD+V0 =MD[3*"@V\<).URDN9>M*>BW(7]ETGEN(_38@V
MXX@O44T65%LB>DZ#$0%8,<^NYUCYT6&DS]-3;6:]R[,Q5)NEETUTOCW0R=#"
M"_46P2IN+G?5#OL-<8XBKOT[A(3LP8AQ#@-X2L5  "\9WX=Z!-%Z3]NL*W><
M&PZ<O=/VF"[0O? JLO!X[+/H<^G_-(1MHAGWP0YD;[3DR?WI/AC^P$9 J[\4
MWF1M7#QF"'>^/#YTY&J!N-?P?9Z2Q3JL";?SO)4D2J1KG^9G,1>*2/KU/!Y1
MQC./'%OH66.>E3>&=B.T&;/5*;9!4,LNLC)EA24IPQ@!YDDX>802NP1W_XDF
M%:F.\*QKFG2Y.2'SF8,?T[XET&J7T$.9+U15B-,GDCNVNCE<VR6TL7B YT0-
M@@20:,I^"5$&$J\W9PP6WW]<56'[PLE5WR7-=#ZNUO];QN%4P'Q_%(JZ4'J6
M78KR0<T8,L9@_.N0TT 8";7O9S%_AN?7ZF5<ZYC64G.*4Y!:MO[2U2E]RYSA
M$X)GI\>_=_R[ZSSE*T0;/D["]H&_Q_2U%0W@I. 5-^LA9SK:Q[6)XT9*=\..
MUNPP7G^2GFAM- \UIPM$R*IG'HO5<4.EUA!BMWZ(1#*2V>^@OMC9\XP<.O_&
M-^9Q -L'$ZQ&RCL[[X%Z>^B81[4O'(D3M??.Z;YV<G_PZ\FY!O.K-PP4IX)Z
M;6>]& WL7)3W:"IX/\H/]@@B#@P3P9G3?F5P^T&D3%ORZV_;JT_-WGUN3W/L
MZ+VRA%81?C*,3>LZQ]('')BZR%G"X0XSIC]<AJRV!Q+J.M-SO]8'*L82K?&;
MO8 FS5_V;ED8J+%];7FX\-CCQV)7!VAG6VHBN=Q4"^=.R"8T$GI1ASC#,%ZD
M*LL[HY>CUC0=$91>JD&/S%2C522\:O0,QXUWC8?2.ONOY+FWZC_.EMQ^P_^>
M\QW<#*;*D+?F4OL)]45]L&QE*?:S/]"#JVWAA<IJ=,0Y"R]RC?FV75(:_)J%
MI*;:S2@G5FY+*'%Q>@'UO@3:_#"1O"4)1U$( [:I>R!%B,*;4O0+ -\SF]SY
MAU'\(J<]K5A D5U\$^+(5PP(<03W4[:^S[FQ7QM9TUXQ:(!8):#:=_'V4[\]
MD"">D46C31Z)=3Z68/QU7:9YJ#+$"%'35/^1Z<0383<"![,DVFV;QW%!V$,^
MF/<MV<B3P [#<;Q#JU(T#:E"SYL7Y6]]*NMD\KJ#T%X8\?C)RP7KCT/G@N/D
M09RW+$N_=[[RTC7W7]T9J%C7NZ!WYN=.M<+]&M;[<R;A?<S<CW8?M[NIN;"/
MN(T>F@NCFRLC;S%-S?@'706UQ8#3UNK.0-6[.ZM;%^%%O>;>R\UCU3V7/9X&
MU$G_CI--Y]2]FKTO:'/A_6P%'S&XE6+P4X!EC53F#'\,0A$K42W;.?>=3AN)
MDMJOISL@'Z1(NO[8O..EFCWQ./^[Z-$N@,*,Y<S#%"!J@ /C#OUA!@U-TNZ-
M?;#>YP YV96\J> PI>GTLOC"X4K5\$?!+S*]9+%7V$4X7^W9.6(1U=2'>93S
MO:4M,G.)CGP>\A;0QE^,UM&XV)\\+MASYZ21XF(8YC\$G:G-F8)PF4R"%^(N
MP*99,*J^1FSQP;7Q*#%=]"-E<> I.S\6$@_7%5@J-CS>Z>BD]FPGGL_GY.XC
M-0^#GP@Q.O0Z]^$,5,\5")CE"5@3L>(]M/-$3E:$GU[V=L;)QG6MA^&9[P,N
MA.:F??L>G#Z:<\F _.ZD7BV!-L5&+OTZ% '@N1%ZX-]Q?-\]T"PO(Q90H!O^
M1WN01@2+&57TRS>UWWF#>=..G=G0*I0R?/PVV*D^U-P:=0EUH.,LA7 0<8Y6
MD<(Y#I0A[E*R#*W3M0\#6=>O%#__">XLU>VE#I-,UO8E:- I'(%/:MK,6.2/
M[X)@COA!U?PCD>^JXEX)Y3T%1<@:A\$ZDE0]- H.R?!OQ4@0<'\&KI0_R)NK
MV=D#::]OB2X'<01=WR$<QZ#$RCU0_22^>\[%931=AKLXFT94>]^PZWQ\3K_\
M[6+][@MT33F+D2E6))2\7(VX M1P)W>$G8C40,C2M?&PM 5%H(5&(*=F_-D2
M6K]X^WF ;@OC_D)%V.'G82?Z9).JOYVC.9G#L?[L-PM@('9EPTOL[%-[DFW&
M'8LC-RY$W4@ZE;28,Z-"222DKZ&(S6.FX$34@_*\2WJ(2!K#Z6.9,./9?WSJ
M<I#NY2H;QRYZ>_L<R7G7;_UAE\DJJC&2JD17[86U3&\TT2A]?RFK_ZISJ "^
M*X[3?UX=LC[V5>UCV?.)][.)?%4\/\*QQ:P(KJ AL9N@WGN@-(P@SA,M^Q,G
M!%%D'6F7=VL@/[^L_B' P@%]U+OK^K7<H[OP(;Y2P]LXJL/2*'?2Q]DI ;.7
MC[<!#Z?2,F7,BY72!V!+JH<$5!S2$?+LET9ZW)2*9U?M@;S1!SCC;>!'B+-$
MT0RW8Q_H#DE=:O@W/T;+O@3*+?LY';_*:KVS:)ZAF)1R7U^URM9LLZ8(^6GT
MT]]V7B\B%+\U-]T-HUT/2B$TV%*/4%QB86:8_PI1%WLEE"H>!>0^/O8C/O=:
M*F^P_[;*2F=4Q,@TU?XM5^)>YTI<'LXGT3?>"T?I1K/^;FKTYNHW5C AGV_X
M)_MZ>:)* _#"X/E9@4J$ M/Y)[AIBR4U2B1D(:3*_)R#XO_ A$??P(-N3U5[
MOD>)SU:I,&-S"O7[FT=[+L]]4%DYVC7!SEY\Q/W.[3U0D*?Y]7O6H@_EY*_T
MPRZ0/NDM1H=\%51HF]&VV@.Y7E0Q6F&$ "2F/_(+H44O&7<?/%LU..O0GR5$
MCDS6%8[I*U4??PF_E^!R9>%=E_OH,UQXX/G<!B4_1HL=,$^#7>YJ'=L.RL"(
MA(]<ZS5O::^;8-TM<UJ8M<FT2J-N:GL4&ECLJ)D9X-6F%R.I,!TN3>FY _6(
ML_Q!$$58%[#GY.J/V3W"Y,@\7S(WMU#-C)6@:W .,IE"B-OTEC2("GR%--5>
M"7\U$)WT]TT3BC]3=]UQ$ZL>.K+D8A)>=_G\-X];O#EGIRK"NVQMN=*+B'1
M]?@@CM"Q S!YW(-16;@I^6$:M \E"Z=8C"&EYE8S6W)_<LZ$^1+FMJ($\A2J
MS(<^SK6'?*7L>X=<D$8UPGJ#%) ]SGJ/(K*@Y$BJV!NW->E*["!:I*C2UV&G
MWT="%K,\4S%(KZI<6<2&_",2</M>5 ,^#G=/ZNN?6.X@+/_=*%D\;F,]L,-0
M3JVHZ:C/NDS;*KB4?G189T/Y\H63ZHDPQDN 0/O$2&6_A1*?$Z0@TGXT>'Z/
M\I'I9==S;%5OHYF-VJY1(U&E(4O)OC,J5R6#5 [;1,4X/>1] LQ1<, IF0W7
M*"(N&R;-.05'X2&@:81=^1R\HE<^H#&]32VZ?,+.RK_^8@%*XXM DZW;Y'80
M2[*(@07F:+A>0OU@"^WTDC_"A/[,::Q:..F=9T+4]CK<37;ENXAJB\_PW].&
M8F[QW @JS^7?2 Q=OGG9R(_T.O/J/K2^;S.LG["1B+Z3&0([SUD0-V- @>-7
M/_O6PT>[1U+N?GRF85]@H/;+4G9XY9?E_''^B%J6';L6=Q<Z0R'S<\6^*=DM
MGVXUR-&\$.W0!^-WG&L\Z^,\6-<4X'[379YLY9!K-%(6-WJT S+:C:$Y*7F1
M*,BOEO3\OH=%$CX8VA,GED[>V.U65[UA&?JLZJDHB(<SZ<+A2_BC74M<1S2R
MQ.@5 ]B9PCE7(*K\!Y X@!-J&@$/1@<F>J)#3E?YO7E2>_K%F;<^GA!GSX.W
M7KM;\$O]&DSD3K2%7=(X.L,@]+45IE(T4.C;RA(P+LWNQ5C+4YN&.\R4XL<3
M+20N'V.>^Q&OEKO_G&SVY)WW1]9W43V\VF09EF00.:@?!1R'9G ,X0]("&%Z
M0[?;Z3&$')ETSYX-=FB:$*Y]&="7P!=I8G!;(;%.\<0^G,-&1PPY"NIQ#'@2
MM+@'2AJSC><=(,R:F6]/H4C2\JFSKJA)&29L-.XL7I?UEPN4]83!=6U +15/
M]7.@7:CQH]BF[8'$',@_W(2DSP]7SWG?\+6'U3]3R_QR//V N-'E(\<)I"$L
M8AQ%K('N8YDR1>98B@#J)7QT *9LV\-$\ZUA1/S_Q&":X:$KME^S4LK>^>D%
MB.;Z5<R9*>8/Y4GF7@_P/]Q;5&'>R&QW>:'<0'/A"/+3A;A0]]\SS*P5V6R&
M7M&?MCWOU[< _LV5%VLM,F.SJW47!_=QB!WP(95D2CK=0 <%:.J@!#91/LU
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MM6V6]5_*RRQ;%=&,.W$$K+]'S36E,%_:2_+'XH]+)6JC[.)]9J!'3O+I:'U
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M<+4+@-PJ,&RKBS]GZU>:<SW=)XXJ!F Z2X3HJU*-<T8T=+*92\#;GX3(MS-
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M2J?G2_B2YU5BW5"G,_TL,(X50N@'21%"=?-Z:D@=@BO^4?*/9X6N3,=4!W*
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M1H%.DLR_>88:?QKZ"DJ[!DE$-?KL,%7FC/:?&BARN(VT'[DWC4JSX( QG&[
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MP,Q\H2XDH8K_5)<&PX$O\E-'%8\J'E4\JGA4\?!2#.QFLO^_"0!02P,$%
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MKE,/GN=4;!>6/4_<??EZ"S.WB-R0*.FS:U\\^VN.W?HAS_[IV+_\ZH:P;MH
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MZX?FG N+4J"ER8P6-'IX)M(Z0CN)'6(<8>N$C+N/UBS5S OFYE/IR$Z71"]
M'S^8@2(:LO<@R=?I.?Z6Q-+!SEI^U#8*S]E6N9D$J3TT@:$FV^$D[Q?'BLO;
MLFR+3X1S%@:V?#(=9T!^ TN66!J/,'!^^\@ %3(EM'Z0F1:,M=D27*4B?QC&
MOJ?AW/GKY&LQ/09]N(&.IJ2MCD]LK*.J3R6)Y^UGOB=^)$';K(_'/&75=^"[
M6"E=(N-7Y$D_X<. _!#TM#Z3$#.>J >5F5GW_&%6^Z83!-&+X^!QUAVJ?H)P
MTP]_U3"@]-E,6 3PF)]A[W1ECQ':R!KI5W[^!HT%U'T'<5BL@P5;=*)G.@>/
MM-6G0YO7.W[%0M*Q#(CHZE^-/VH=+YUGCRV$(['/UUN^$%(=Z(7A(A6?_?Z'
ML]'$!:3=!B,&5OLMQS44?"SK&[L)0,=&R[+69(J^BU06F#XN$>[E/<)E!)7C
M,O@7_L/KHL_<*Q'X?40U,]7L<GR",#.GB6HF8,>TVJ\E!)@H$@!+0[!-J3(@
M@Y\YQI16^_UXOI9X+6< "# D(.O@,O^(H2,# OL^U5,.=M,'6@Q(QM(4:-,3
M-IV36T@KP3@[(W$,2$?!#^>&O- :!7?!#<!UOC"U^!0#(NVX4C@]]X/-8W!$
M26FECNO)U/PUU>9GJRDK%I\QU+QJ1,NBHQZRSUE4 4&N@O#R *F)4=R"X?<5
MC^RIRB'H)+<,<LT#EH5;F/GPX^WVXD+WO8##=%,F!-W8')^#<4'_^P@PA6QX
M]WT(DO,C3ZUYT-("3+>2*VL8D%[Q?XP5$H#-=S=R/-T(A6[&3(#)!E69  ,R
MT:2J@&^>+ZP'M8KU/V N Q5=]47_53 "2K0 M;P.SFTK%XPZ/702"'HHH1GS
MSVD^:R>,H97%Q>"_3Y'%GXTR^&\FFUMYKT$&1+Z 9N OG6R'K]ORQ%H@[A%J
M'8?YZ(MV4OL57YB#9M\ [>]ED-F=>*33 J&Y'G7V.U/SA=*RA+X,5E_%"&Z.
M!I(M] L/N?(A:-J.WSTU3-6O^[8DT4M X2;(@!B;,"!84.3\BG[O,2#5W]TA
ML*2ZD:F59_>5[ZL>^Z69H(IBAAM7+%?6,B KTU]:*XO<>_<"68[6@>_/%P$K
M1 ]\Y-:Y%SRR#'UC;5.75214 FN)&ORI#IG)@ 0+32S.K'W5PCR_TL+XSJ/<
M/93HQ<+O&? ( ^ X$@6W"9J%*:E1QJ/2+X$)_5OF=$U4$E0(EO4'TSKR.V7R
MYK]1)O_C1(L=_QMCQ!9+Z%@3*,26^_^F\TQ1_C-*FD)$,S"RUQB0A#L%JM[0
M'65[P YD)=083T>!U7\857$2CUCHKB(_H]P=9(_"[WY!PM^60P8]I*#/M@H3
M4V\^#]?SA7(ZKOOVAY>+]_/?K>NRCX8>L#MZ)92EZ I*S)BZ I;Y**I^DG:1
M 7FSR6T-56F;@@(OUF>S5K&<XG5ZB-&4&XV-BCX:(-F>E5TRU^*NJH(6BLAX
M/)1LRF/B"FKUP_7U\JDE> +&C7J"M+NF)O8F=L!<>\RBVZ$DL6W'5D\8PEKE
M=0[3JXL<_$P$@>V[:3R40H %+)(M!PG^EL/ERHWDVP4A=3"28(ZM+1--HIE)
MZ59'Q[K#I3MGR**CV_G$%ZY;YL0>QR[(UJ 6Q2E/D_H%.IH!0Q=4*H*&4P&5
MM/#$/>BL"XD)>#HOT53O:)@F'I8E;R#A,(PI]3OLZ/5\CJ0@QAD<LJ>U6C\"
M<]SRE+ZTB4%!8VJ\(@6=C/IK6(:K_VI9!&;/_MW/K=;^SGW8UV9@_$T\$OY-
M+#?2'OS73K+DCW>27 %_HYP_]'7ZAZVYP1I '88.^M%EW=\QM_]=PU/4Y[TH
MQ]^R%Y5)MT9-<D,_N]5'][3^V=0!_R=0R/@;H<#S&0I?2NBGG?T_P.G_RI8J
MY8O^T/KFVM#CG\+8K]?X:S^U6_V[PY3];?^ _-L.Y4[C_9]Y3O%_R\L_!0IW
M?672RG <T\?UY;D9W>DBZ/J6*!@X- ;(+0)E_V T4&C(?!9\X#1Q^GNFB?7E
MU>3.3X-4(?4%K2^+?<&!2LP8@/KU%/[=SR"RO7E'EU<_#Q1)=%7@T3>B&Z.F
M_X.#%6 SC\-5T7DQ23U>77^U)?A2OSS8F%IX!YIN7<\&<62#P((,I9==[K'X
MGU@2I<M^+S*SV6'D"S,,B'[:WP"!#H?565\^4 I+P)EC9O.385GX?U]F?6<5
M6NJ?N)=<E%*QK"I+*,02^G_5UW[U+,(<U5CO8PX:%OO+AG^9N%E/'H]HO?!E
MN:''@+C! M3FA%;L_JUO?^>4"A941A"8] M3R?1V504&!/IU-O]^'3"U0!B8
MFH']2U%\>7!W,=6:P'_'<^Z\E=7W+L=H0 !46;4T*:@CKOU:++[=QKZ]%>,2
M'PCM>/YS&>\$9V8:_<2Z01(=WTSAX^;9MK*>:1;PBM #PQ/_#9Y3R.]+?6[/
M/=BFI*?+7&Y3L'_;3/\KI"7FWW_>+ZM1S(@6!@\+[/4%/G,6AOH[?*H[O_(]
MLHL!V1LH_&J]A:#6%X#+B^7<QH",@\I)'#PU \+Z,_,YE@$Q_G?IA*8I?"8K
M_AZ04[*<YT3]'+&#?[U]EX[@,;ZJ6JZ=/3-3_[G^R?CRT% 7U=B9VC'S?4]U
M42OKYP?O/0.,?JW*\#0HC1_,65@AU6X_'-FO:V[N0GX#/%F_^WV)LT*;R:*K
ML/DRZ4/*0R"?W$J;H_L&LH)!8%]GJ_8)7+24FOB>=2PL=0-9[)G:;3)3EL!Q
M%=13E#+*J&*E,@6U[@%KI#$@65>_+?Y8D&L^W[^.5IJI\U7V6/]OM97Z T_,
M2SSF.KLC0/KGF N. IB_O(CQ4S)"2Q@K4#R"AJ7-GB#\38K)<@<[$P$_!@J4
MBBF@(9\!P7S=I3538<<&9AXGH#J_DO1?MZ@E''U$M?;0!U^#?WL/(N[;5@ID
MGA_I>=D!8,I8 4$\S!?^64M)HD#H2P"!\&^3G^MG+6SRW<32,K)G1(5U=:%N
M2 NDF*O+S:F.OW[J]!/-@("U"9H-4,O[MU$'9_6Y_ 5B%3D"OCZ"^4Y"F?G<
M8+2NDJ>2VOYI=XLA@,>*@5WU",@SO9KHY44SL_Y W?F?>+_G_X<[M<W?=FK
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MY.O_*_/OGX-@@=P/B6% K)LXP4[#;0R\Q#$Q( _$*E!D"6\_!D1/P1@P-V%
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M0$A;@U"2NL_VK(I%[!-Q2;O7[M*0Q:["] MJ-G5:H( <!V]@9?*"'=[JA7=
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M^&LN!TUH7KQ:OK0>N#?SI+X\,S_G6ME8Q0]PK.QA.D\G,LZ-'_"DG!Y>Z.!
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MILI*M83F]!M*D<KR=TAW;J=\GS^B]!?Q#3(U+"NO!!T M); )<8;RK,_H@Y
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M*,U\CFK^-*L6]6[#\7S@HDN=YZC-(Q>*ZX@[D'XUE(.$H *.TKC5_VQ8(V0
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M:=;'+)KD0@\&0"<N4V3/JV3H.,_4D]8#Y3PU/E\11[@,@N_8-02[W.3TT@D
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M'\.[HBI275\CS&=XO%SHW(TG[3!/>&L&>B:UM)D2!G1J83&F 4ZY9F5N'^H
M];/IL090<I^B9])I@$\?,&@GEA"'=LV+GT;)K 2V72_2E9ENEFT>ZD6H]O"O
M?BA3SL^EID>(U4-W+>R\M>+K@&*>R$S5#RR-FI>@SB0]0E9O\&V\4]OT4<CY
MT9]WAFB %F-\G)!N+9-ZGA=W25E9;L/[>9=SPE[-0I_44_7#A1AP?6N7"$SX
M@P22N2 /C ^"_36E&/EI0,,RMZ^(4@B0\J3$8_2* L)T'T\^.1XJ(C?#!S.
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M?&$WLA_NU$EZ*=,JN 9D=*L[)!4QGV5AU8 3$I9R=IY^&%P7K7[%E'U8G5C
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M>;,NM2[3P(;SC.G#>W)#+&Z-7*R,%AZJ*C84O5=M:* G*XP-'@NR3-&/E5Q
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M1:J&>8/W=ZTFUW*O-ZG@GH(XYD@: @(-US:8W@QTJO9*&V?D,MX>LU+K?(?
MC^O4@//03I=95G<(_"]GJ>Q]K:P)<-*M;5,$O239!G"MX0ZO0$QW,92WFL+D
M4T2)=D\X7NI" )F_C!P5@)OF''.O&]AAXBTP5W)7_*'GX*\68MXQ/_-POJFT
M7\%0LE5-( [7<[J#7_X.@9ING^.,=?]B[XE<LC*K]%/S33G2K1(R.GCJPRMY
M^0#G^C>9R1]G+YZ5@RUGQ0:SE)W4W>/> ,L;<%DSQX<#F<R?%YNTE1@RHCX-
MC^@V2OD_KZGSKAN17W9\D1W=+<# JZ\H/MS2R109WF7\*_8*KVWICA$&9"N
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M->Q5=M3=>R!(>T'^\ZJA/NJI\;C9G@ #9-V^^?C>%&:C*>2A=_RU4V"M/J@
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MUZ;Y%&DA<FO=5@>PKKU .*^^4U=2D[6A36C!TTYXR5DD87T*1*@GTR-PM#?
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MF"AX42D4F(Y_ $MEJV&7N3N4905NS!Z,W,8JTE<FWM;#!.*\ ]557:Z[""]
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M+>)HA&J7:#^Q>CI2]#'CL4=B&;I]V\N-T:?RB\M:?,Z%,2SJ<_$^%M+;Q5A
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MZA*A8BYQ+M^X>N@8;84/>RSUR6U)U*3D:.QF,?XH!QP/Y!L3C(0/IB=Z>IE
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M /M%>P?8Y\0RJ_9W:F6/#Y213=N,BA&N7#5XDFOQM!C=90A+&_(7@14'!-9
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M/S_\)#'WB3+6P#^L(5#QXTBP- 0ZL[5DZ'@!-N](42X@;\LHB(JX^J6Y+EP
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MP4C^\VXO>%.(^A43@YEM G ?6B!%32%*&5T^+$C&B M1(S'V9/)[(>K;/2;
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M;Z2JS .CH:H:'"PASE@EP2T 9]@-\'+$@9:^QO7YL9J?L6JLK 5/378Z_2B
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MXU?:,;-Q,,4"0W],FW8#BM""N^AP(8H7Y] SM)@__C=+'/D(/*</G\=QCU_
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M8M#[GG4+:-@%_8+<9$7'0FKC"(FE_'WDD!I9(/LTXJF'AY @?>MDI3.?,G
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M&"A1A2EASH%\&URA1X.YNI@#N<B!)&'I(2NP+2MCIH'7?QO!7TZF&SB9ZVQ
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MG,E[[N-=^]&/[BKX"6_;YUO'1!&(JO6&<!'H_??BDFFS"9[7,M4\AQ/0#3C
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MM=A@GBL51+L$>KP;6]"@" $982&O6^0, 7ZV,-V?>IUF2ZE9*F+XS?=/C(8
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M_</P8G4-ZU"JYS5O0_<\]T4O!]O%C_#@/\'*\OU?W,?Y]XL= $Q.\^^BKW4
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M>E+T/*_.W4;G54#&[F^/+NJ7]LCZ-S5-,V=CW7\^-)U\J+WY^[>;[+;;D]C
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ME<^$QY=5S*O 8UE5=>@5CL%0A:#!IODUK[V8XXFM4W:SYO)HO^2@Y6=Y"TG
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M2T&L@.=P[)-G2R1UP!?4M3'W29,*ML208?R4C")$;4;%Z5\)9,F(7ZVK;?Q
MM*R;J#$6[)G,.BNTA*P9G#228)S_K+-0\FBR#]]N_JCK>R\ZN[+:;_*];X/U
MWFO*I9X&XV@C+6[^K4HS"\<B?)5+>NWZ-,0/XEZVYTQBMI*ORS%F!^LY<(2M
MC;4R9XYV8&)<I 'WZ457VXH^/_(AX*EC7I'+O$Y?MP^JZ-*)B$9ZQ>BI%JT/
M5;UJ>9?-PA[C'> ,&Q @,+["*RE?&M8ZLLMF<L)@/WZFS(X.[1>53+6M-_VN
M-.MQ*Z>XU-&TY.]R]8;S=0O9%[6>(RV7QARTE8U.7^OW,;<PG?!2SU O^EMP
MM.,<7TI*XLP0F[U&^MX/ZL,33$L/M9Y](5;V?AE)"YJNCMA5-WO:W$?YTH%K
M>Q+6?Z7=2C ]%JBCO=1TAEL.=Z-$P0]SQ!E7VBF2N&/4WCB84&Z_=P-T&GUI
M;4<I-IG2^LCT8/AF<)O[B5K>8+*2,.5[3=R?F]*0\[ZYMJF7;[QPZSERHO/<
MI&$)QQ19Y#:<_/&6M'1JL-C->*L(DVLZ.3$ZW[@S7H;.9T=BB!;3OI]G2#+X
MI@JT-"[OR>.'YV2)".\7??8U$H+U4L&K<U 98_VP^%\AHU^)4#@FZ<<\;;3M
M&,.*2E[DFR:(XZR]&H.;<= "T^*J3Z--1T0(&,?%3(O(GZ8%&R)263]O!YE_
MJ.4[G:><T-7S5LGW9+'7MV2GD;I/LZ':H:_>%^T-T59^]N<M]VNUQ,JUL[B/
MX\M>$\A7:^L([ZEL0GO2EZ;S !E4WTYN'&\'=F"%VMN.&)?ZC(<PV[,Q:-]0
M:F. N;6_%%:=;E^:_\QAMEH3G:%CFR2<;!UY\;SH'S7P7[VV7[>=-*=4SGQI
MF\([=9<E/WQHM"<V(&L:]SG$O3Q!.<4V==\_4L3;SF*'R8K17L89;)9R:F.E
M!LJMQW0T8CBC?\J\Q(^CBH]A^_VJNL#%-W$].JIAN;S:S5&5:;(4<(4&BZP@
M20#BK77P6(Y:F?W$G(-%[9NIME#7(+= 8<2N$GG5'JE.J<A37<][CYPX$2-O
M8TDU@',KX6Z8"**X7])CXJ$F':S>%Z*$/U#QJ@(#\4SV%"CS%/(JO)2O+R#X
M8J2&_"__G\[/7+V#"W>3PW^6=M%/>M)2ZLIM;YKJ%*0$.DCJ]E7(STCZI-0]
M2DY.&>@T*ZE<))D%&+S^#N]5Y'C(:,8?F)%8GD]RV.BFSRRBV3KX[C[ 88;U
M!&BD$B(>8@?,_N)4-&(<-JR<,LTCI1(NZXE]+*\_47H[YXC\RM7;[^/*?7IP
M(+R'_H<N#X2QG7%J7^?9BX'S$T;:GEESCSJM7@P.CY_Q<D._6:YKG$PY71S3
M8E6,NOMWT+-W;*AX;Z>.%THA@TPT#QCB'I[]*J$5E;/W.\+@ER_1*9ZP-D\G
MA",9-X@_JNFCB1642"0_P2-I!^XBD_<1'1I8B$5>3K%&7_LW<?WQ)+)7>!)5
MU;<1D#;=HX1ZLG??#83H+)BJ/)%C*ZS; UK9OO3EMJ1]G%.#_NR.P=7SN"N!
MIWO>378(],C;! 1\<)HR$95[\/VV6->$9<'!KE+B)^^\FWEZ%>\;YQM+"W.J
MJW,*B78M;]G6#B_2TI.+9:W?S67:UCLL49P1N,];D/,S\_.; ]O3_*+^T<CG
M&^"@>Z&W^_E@TZW+^_V6Q].I"\&)>014X2QCJKO846UR<;43@][UJ#(JY4@R
M2DCGI^D!TQJMQ'?[8&]LUL^./C3T1_F(#E=^4[K0V-;PL0>M?UJYP?>*UG5F
M]^'HYKSDL_>>F[C)"UF4*K6KC-_(5@S)7QX8G1H-F">9S2TH^\_:-MR)B3 N
M?.:Y'C UNE(U<6&M@BY79/'Y@"LGQV,YAWN&(OLBMHMR.JL8IE'\=3ZQY5Q'
ML(/Y)"54!*Q,!9-=G&['B9&1\@T0QXI W"&/3F'G+D K-;8@[V*5G*>XMBYY
MAY.#,Q MX[$G!3[\)[<C=OP'8PP;XB)67OO#+#E_+R"&MB"Z$(O_WD@[ +9$
MXCT]^7IG['_R(4O#IQM;X RSY?&3HB!/%HY3SX\7"@B'#>9DV2Z$XL\3FH.W
M(+\E8!6VW*>JY-5BE0=P9O$6)+JKG#O$A=\*L5TXUKL 9Q];VF_' TDP=)_$
M>![OA+'$'8[<,T*#3WL0Z=W\;\P/,]YU NLR2$IP  @'"G.1M_JCT<-I)./Y
MF8E_ZME#8J1;1.JGU?TGWWQ"-W;YQ 9X+IM[#[,6%JN>&!Z^*7!E WZ$0"2M
M5IY\$[_)T!7)>HC5WX)DK;Y6@_Y"AOQ;X36Q<X +;-E)@O+ESY".7/3KZ:SJ
M(KXM2.D-YTG['^/.+L@I1[L?8RVJHPX1OV91KFCT_O0@C?NOTDZ^2;".N[84
MFY?C]9)AW*H!X5SKO\_4:,%( I@. ZFG/+H)T9'17HQ^-\O:3,W;-:1ZE;70
MS<HT_IQV?,_I_1\/"Z3!NYHV"/^,D8;\4HG&\"\F+5J$+W9X_IP+FFV'^57A
MZ4R\"YY,>';#8@\"@20AOL>ZFOUOE+UY.)3OWS<^K1(20M:I$!*RKYE*$F*R
MEVTJR3+90B;&3)M]*T+9I@@A3?;=V-<DQCIBK,D^8QD7L_W&Y_E^[^>^G^?^
MW<?Q_'$=S'7-=<ZYO)?7ZSS/]_L\SB?2]UAJ5)00G>8;=+)BJ"KAA[%7;\6,
MX \W ?E1^A_$&3MP)ZO4]XP5K>Y9GZ99GTY:&W_G53)W8V"FYB!*R![ MZ3
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M6U0S-_ $5S'<T0]/0*9FH./X<<H3DL]E0PE[O+)6AS$C B7]34^8=D-+R_L
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MFMK]D&=%2.ODGE:RH>OTJI"7EZJI!A723'Q$U7?XV[Y&5MWU<AB_B7K"!$$
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MW8GZU*]VEZ;AFO^[/O-#R,RI8@Q5O,^J.E(R@8,CFNS-/]%\8_TPEV1G3+<
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M]NK9&RH=X'CH)MT].'@A;SO/4*17TJ>]=B[Y>I3:PI]GI\]AP9,/C@:[JAX
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M.)(7$]3B'<H$57BO7F950I95B5=(#R!X&BI.,QYFZ'C8@5ODXD4(>5%K>F*
MG_E@N>)JAD"?Z8CI6L:1=Q6+N7?=B[O<[ 9&H'=6?LB8@E#Y"$/&B?.L8BR
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M>P:,P24/8$GX62:HF0F*AG$U2"&YR= 6&&A)>O9$?,'?("8HLNP3V?46[E>
MO +>/HS+D HVPWL5;07#+A_M7$E5/5YP"H2:17KNYX9GT?4$'"@ P_'720D8
M9[%:WB5Q>9+3B]D>1< &QKVM*&;OKFT;L9*-P_L3>7^SZ)%A-B+&OAM'$!8=
M7[MX_G?BV^?018V58*H'HQ=2B6T>U5-$]8!Y'^N=0UBNWA[SV$/$C &ES4%)
M Y'R99C3;D^*,5<&O6;.P^WAR?*2%_K29;&1N*EX#,D4,A9,<:,_USL"'$,J
MD<"MII:S'2W$$ZS1JIX%"R%,;HX$] D[(&__\L2"3>H;ACP5O.7E5;E$+%-:
M",@@_^'BCH<1?P6\)VUGN6DB'Z8QP V4'DOOX>A'Z-#B<81$(XQ4Q9!%6#;9
MR4<FZX Y3)TU8FC@J86R]%HGPQ,OW'T/7NN!I$<>[/PF>;OQT'8/)7<_BS=Z
M*HD)*B:V>_,A#P&UY,1VX;Y6V%%='R!+,53\P*#>.2!0?S"].T5/'$<^D>0K
MEH4(-TX5K!PJ^\Z9BARW>+3[#E.)?J (R$!6]@]?XP'\"I!F]"2]\P:SCN K
M]2;@4X"W=9GGH0X&7[*[9%2S-P]@/$]@@FZ6#8G+AF7XROK7G>QV;K1C*.*<
MF2!"7P>1Y-V.(2]/&:ZRH-'AIEJ [((F/_%$,D9J7$/E X[5!:G!ES^<'=0U
MG,4(_\T\,Q 0,?O2/"![='&GYFGVJ42'MOSHM+?\> 8)W23.8%%9,;3;.N$5
M)8:>@[[G?7(9)4+/9LC\M?..:%!&@LDG/CR;@INH#HNO+=^I)=F^EHKJ[H'A
MMR:NKF%L< /R+OBMY"JC&:HTX<,QMJT')YYU:JUE@^ALFSM9,3Q-3! DY7_/
M!1Z)A@)[%4P0-@*]]6!D,X]5_58FZ-TXNND6;L5K!++EE 'K=\FCA=BC1UHA
M>TKP7?S^OB-TMR?+B\ H&G#,GJ+9M]\04C%Z>P:2JK5 NXF.1*_F;6L9G+(5
M(<[A)/WK&28;^[OE3OYW(-/\1E PYB]T*U>P':'9_:5#,I'1=YOMB5N0Y.3
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MD6-]8<(&DJ/U0E=$2I3!/$6 -^!&=1Z&%'&(5:Q+90MX,Y4@#92SL(@<YKK
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MW: F[.F4PAZ/S6==O3L>.XX<YLO5A"]N1G">&:20\ .Q?@5N6^S=!>I1X,?
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M7@0+SA]56NNZ_I#MRN.;&_,\GTMD[* [']9^J+-B;;$&GYXR]9UYB]E9*0C
MC,3$.B:H_Q%>MDQ19TR*;X<NE<:D9<$?'@]3]?CC->-8270Z)+-*2[+#8"IA
MU[[FP&_MTZ3EP\71ES/<8NQ+;W14SJ3,G?IQJ\/A8].7]?O0;$!BY;*PD\^
M0,TE(R+SP[LX8J"(CM[$TZ>'986%Z 04A^:(5!QXN_[=$5=4[)_R6OQ$(J@$
M=7Y[ @UIBJC7YR^K?JW (A8H7 G*BH%IC5S&2X88T)X?M'UJL0?VR4!<0IH8
M6/O]%/:_4)P8<+@CN*)XD*2.9U>B?6*@F987CC73]*SYYT'^L!%FSX+^BS:/
M-,(A>KIBL.8;?"J6UBTCS)X?N7=[VV?Y(W=O%#>YD%-'6@T4?Z0%UV46/B^\
MD3<VYW?*>Z[FYF.OHK#"DA=>W1OO>)NX>3L73.>D9'37)DVZDOH^+%RVT?^F
M=ISZ0P_W5>"8IW!3=X-!/M906"EIMT\8'GK(3XUFN\FI2B;RT\YJ#583/4@?
M28@*7A ',X2[J%V;T,I4>7[V^.4R&<22EYS"(6K8/"&YENO$!QD< <$C!6V^
M24F$/7%-UHL>Y!763#XY_QN'N?F$*)$JH7TP[4S9RMLW#/>DH/)N^PB;;^^\
M8_'27VM"6G&%]'V)2S?G&A:'[*UR];P8FOA+C@)NAUW7\Q.GAVJ(>T9;M>^G
MCCECEJ$J<8C-N$N(0?VSDV^Z/^4Z7?&67JY[3'</,^_IMX]O6D=VV)SRL53W
M.7P:B@!Y':17 R*5\2LD^.@@"[EM@QAUC+X1 ]9"MB.J;&Z"&<>19R0&9()X
M*H51'+E9,1"7=@@!XR?34-61?H((F']Z^,J>="Q>.'9BC6.Q/R22.4]#UJ>(
M ;UIQ(IT'ZH:A#'[;G?=B]7!<U:.8N!W!C_B/3H+L7.8IQKF"*RE3%YN$W-6
MCX85J%T!:/Q,!0/9$$A&]S'Z??YP"I9_8M[B>;6D!="@! >'Z!D14/T.9 ;+
M=O(#-?BIS1_-P9G84*B%#LY_6T(AC9TB O@ZJ/I@*-3JR.B'*,P_(S1ZT6HE
M5CVE80&1\QQD)Y;](@8:)4GS;SD@4#PB;/K7YQ)G4QHGF$AU&"HY@_F-;)!P
M(]1$A>='S2=B >7#;U"E&[6./D4J4X+8'FG0Q&%(@O2?I*N%F0W_1>#_>(N_
MD7)<#.S22,-<*"0E160VB>;@^>96*Z!&G#S$+HM)$5G/'UOWWSH6U;OY5]T'
M88V2GA&(ZK<@@C1T;<LU<-#C%L3>7\H<ZF!,38&<0,H6,?!02UL,5$;@"'-Q
MT\(R,3!^#U4;$;B*@<<B7J88D-94%P,WGF$0*!:E@(-,BAZFPMH]8N#K"W0Q
M\V]ZK<+#OWF3$,<,6'CPC_K'/AT;P)4%V3:Z;3TBCCMI:J!A[O7?\&6QMP4]
M-66!!9C-[LQ+H@F,F_\B(OZ_&I[TK@/9W/&.- ?,SSQ<FF WC^[_C#@84IF=
ME[KAFB'VMT::(_E_ UR80R'_3.) +FY.]1L>=B 0YH(&1*Y_U_>0&-@RI_47
MAR*]^^_ZTT].?0M5]M'@%"NLB7V4>! #>*E='7H?<WU''/P +\,<E(P%>:Q=
M=>CCMY"$\-O/; K^5UZ8EQBP!^,B<VH!7Q)54L.B@]((&M[T;X@LHE2B.C:5
MA+D%'")BTHC9]=F_$#<8C1^OR)OB)R;4=HBP4^E_/17KOWG/6L4 _(($>S O
M=M8*<%<E1?5JJ:!!;^U;Z<%O-?+>,))>4U^7LMS2P'?,>J;%9O R>E=K13Y+
M ,D;J7YX8U%&T]N[9\9'<3I"Q07/6B_"SF]>S*+1ESZXM'8[/SG.[MBQB[*L
M#9+[IQJ4AK66PDF\&8Y1&BM$LM9*@9_^PEIC$B\'1]FWJ_7UG0[<\S:ZYGMH
M]JX/&G%TK]U][S]*?MR.E=9)0DUDD39!L+B4*!F,K#6_>_OK1!9.TFJ6<Z=_
M7'-^UE*D)^4PSW-LO= \)+[J@KL:S;6@!5V'@,7,5&$E:L"KV)_@_\2GCY*>
MTS<FD^250E"W2@G\/BS#5)I$=O7'*)Y#[:]^WGR;%_3LUT.WTJ*??6]=/_R%
ML<3%;L07]Z*?E8Z/<?6B'PL)-\BX?XP_&W?MW/B62H?*QN?KC51;,DS;,^L/
M$:V5'PLZ D3J>+V]PJR3^,V2ZR]-Z'%;CQF; JV5EOQ4>"@5%M3[LW"E&+JD
M6)<L9+E7BGR6<TF+89]JNQ.N[S?87 UT,3CN:W(\..*V'_( 7O31;^7IDN6D
MN()/'4$Y#QB=Z$UH:5$@JX\I37UDK7C8!*KD'5$7J7R-C--]\H?EJ_\+KP4V
M!Z?QGZ-:1<3)AT'X@\B@)1%#CSEPX&\K1R[@?S#0R'_R^.K=RC6J7[9D^)V3
M.J2J4/YYR7O-K>T/K/'M=ZDK*;+\$50J5BB'-CN/HOHPG:=0H6)%*'T;WNM8
M':9T30UW->C. ;.V FG=*-:JKR]O*9_6_E$K\0YDU^!Y]HRYU0%0_]R &+C6
M,5*M],2[E59IEM,WDW$#V4#4-M\1T8$6HCD-[R'8'T(4?-"K]UFPU1N\<!_M
M_WD#\P$0BT?<PW-\:U*[?E#F$>P/'P0+FQ,.*!%+%DD3\Q3(?_@ :2!C'^FG
M[XI"'M.R,#+T HB'E74KOV8@=,S#UWP3N=&O8XZ'U9?PN@[1<C/L=P@K:6LP
M)X^9WXAMS!R,Q3J$*"$=-2(Q%!WFZLFS0JPQ60Q.3)#.G7= K44N=763/Z@8
M[BOGGS2[1YK:C0E?+L(^I8:5E!?24 TL&2_LQO*,#HCB?D PYNF9!=32@W8C
M2LR!,1*B*@;>FV']@0X6J-[/0HZ>7T'$E(E*%8B!W0<@!/]%#/"Q>%6-\?87
M]6*GH-@1"8XCU8H1)XH0$9:]HO"SDFO!KPAS%D\8'D5B?L(^&C;]C[R8H+@<
MC)?9D7:FNV[:B-&_SPKQCRI&RZ;G)JWQ3MEB /3&^*M%W6WGZ:Q&L[]]FYT!
ML5+\C_Q#<_.UB=S\EE]?J$GAGAB0[  1'S'0T?<7EOZ$=G["TKS50_^%U5E_
M-#JSX< MYA_?SISFQ%GEN:!4S*_*:4C4#?H$8;C/G40/F,#_4:'SQL7_A+;(
M[2=TJ"2$EC)]@;H+^CEXTG\.PX/3<:Q) 0.5@;YJW!(#-[&4\Y7"S,S[&3^8
M@?_H6J0!AO.?]HGGV?/C2.8O]B42R\UX9F8=.?OZ<9S%JS?/#6B.3 _'::TN
M.2(HH ;X!@YE^(E*)-=:77=LF9J80!H^,B0Q*92A_OM6,AU9B+6/T&JP>$IP
MJ5MS:_56B#S8\O6XLZ_>L%'DA:O7FT+?++71J[L.V5L8L$DR(>J5<R:7*9H/
MO=Q5>,R8K$<M@?:2UKF1E7;-HRNW7^_J[.K1/M?SF,#3X[?>\'GT^-6M ?V
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MVQ+$^XYTO8&DG@H16#8#J:8AQ[4LQ"S !I&,10L 2+WW^IK<S]4]F.%X14E
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MY+'N4A2KU;&#]ZU*63>QPC]1T^56JA=K%CH"<G;(-X.,2\1^'.L<%\=!,OD
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M>'L8JQ^"P_'ZU>,U(WC]X YG2)5]D7-V]7,(7E\@2E0]DVEB 151\@T-(*'
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M/1T\31E+,S7LD]/)I2V#YAV\G1CRQ2[7\]_>"NHX;)ES'YOK$CD4I^9Z>$T
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M<!;,9B9 DQV':W[(N+F^+>!Y[(N:P=#A4C%YG5<B^DL^WB$+]5P.T>N<J6&
MT(HP#A"\EN5#G;XFNZ6%Z(Z3=G50*FKWR<,PRV&(O)J.U"VM1P%5U[.W)%H6
M%7=$A ^992]!?B+7S1R\78A0.MR2[F'7GSBYFV,)UNS &D+OP560'M0B 9;8
M<#?,,G,[YN+"$#^"+L@;6N)=?O4BGZ[5,Q/6=_L;UU#$*ZU:;$?9>?=ZPS+;
MM&9=M=O/EX<O-WGL+Q_)G3!T3[1Y=7:&[?_T\JLSVU<=?_9>3+'MVMTMEMIO
MO?MSC!,\K5(4VZ_B*G9D).E0H^J.$>Q$+-+]H_3S*W<\Q.YTL$$ETV*?3DG
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MI?$A+4I!%M?$!^X$!@3"O^%L%[7\V7?!F@^01@EUPXO<*(5TC>6_G@"B;[-
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MF#2[F@:UD>#_;_K:(X><(J#I!2059OO/__S4?& P$T&?B(LDSEU.*H56%8M
MME9\X)3_-!3S=<(FZ#$QA_UCL_HDDB:;"&V&A^Z%ADIYP:2/B$E5+>CJ7@1+
M\$GMQ@M0*QD<D3O#!T(3*%Q?(H)(_838"(X,:F*X8JX(;A%,.2*!2,%.Y.\[
M"^&=!J-P&:WOQP<.L4%6P.-! J=T<4IM\A<^ $5^\N8##U(1'&(/5'V!%_K]
M%''?S>_&X$ RMQE:4.Q1.(746,..;3)%L7R-ZREL'7,;/K#,-H[&!W:C9J>-
MV;1&< XS7  /WBRBQ@Z?G9MI%^$<1?*!-)^YWV?,Y^">H;ML,;RE%Y'T/=U\
M(+:%EYD%1_FA.KCE4B6R)K%(L*[ $,ZT+6]=*2RE-B1B,0K$_4')."Y<XY*J
M$..),O")U3C4XL,/,WS@B0?QJ8A 2Q2KT8D,G3\A6!??"T) ?<83(M_[K0C\
MSJOH.,H?7?8W,8BP&."BRR@4]+T?OP"G')Z0 T6.>A!AV'12H6&N 9?T4>V+
M'<5_M:,+L4O*UT)36;A,:#*ACU=)F1UMP,*6^8L9+&$TO?F*IJ=\H#_'<IP/
M7(/M:^Z9*$,(@K;,==L4.?CL;^94EH+6([T=*96A0P'<1P.L0.L[,7R BA()
MDI?N[D734; ,,EIQK/LG1#C!)=.=D"U6XX\ZUT$K[S#TB).*3U/KH.VV<2BN
M)'/R:\ B&?%)!&B5CPAT$O?N+)[G17MUCZM;V,('7H^%3\+]\3NUWAD$D[A.
MT=!A<^76M$=]3A$5K5KDVPO%4]T.3_XS7"W\AJOC EREL\!W1[D<JV\L\L7U
MBRXHGB>-R-8B@PLG'P_R@2.4]@\)+CBXT=@T1Z0/"L)4DS@^](\&Z8-O@Q1'
M6)R&=97[&SD=@,DIE4C]#<MP*QJ1)(N>7\NS%V)F@7BN8P$<5NHJR 6P#(X[
M/H"18PIQS&!Z>103 2VW QE=R#_3XM=8L1/$2@0?4%7X R6!,ZVX;T-G+0RM
M)QCDV BZZ^$^/G!P_!-R49(ZS_)F(7.JA_])%#="9W'#?7'?"_%]P.+)D+.&
M/@QD/_8$\M\4.I9_Q8B_A2HD>R$ ;$.B>14?D,7JTVSYS')8[P0$.H*#HR_,
M(D]_GUK2OS<P%_LG^Y')W)!LY&_$B(;I <DM@JUH\.248V,@^(J8.@ZKN)<,
MD^[._L*O&J)1BP]@>J_@D<:'XGX-UG^8=-,%V%7_G1-A[**X'$OH!:,/QR#@
MB3SA)P%VT!G!NZR/5<A(,K2[D\A; _<'O9W]X^Q_VH=U A]VW?D[\0*S$8K5
M288#IWFMKP Y8R-N&B0^,)(JR"O3BV 9#_V.=_6?)OF_RBDC?TYBCWY-FH&_
M)4U-F*W^X7#\#B%X NO+$_1_! YROC$6UH="PK W?Z"@X,0R2_F [H)#F;>1
M@.>^$Q@6&IXG>/W78Q&+_%(>S(%?4R<4@ASR$NA9RM7L/@UK"HN1 N]SC@";
M>*2QZ3+.DC_D+L1WF:V3MB"@%^??Z47P4@1N<2']+\S=N5,/%B/$$#>K\X7G
M>L%CFDEP^32',H-U_%(@?$TL_TF! /Y%'&2#?P PO!/ABAZ/^S8@M7K'2D6^
M%@BCWE\"\E\N$)!_F"[K16,L/&4,*%CER^N .W),VIYM-[.A6?L:'(H.^909
M==B ?NAKA#&X.D#^J3KHYP-PZ3E\U?#37T[Y:RP@6#N,Z^% T%+.$>%<'T-$
MV*,D,UA-<2J3U(G/$Y.(R239V9+H7_:2YGN^1DA*D,\[.C/0V'CJ(INXEYW.
MW" YZ;RT&[7LY=%$CD&]UYX$:,?NY\- _^9SH>\#[61TF9O&20A2I_804:+2
MF*.")1,+D>'%F$C<6@A)8=WUOX"_P=U'K1AWR;VH:2YO8OVBS(SJ9?"I,OJM
M\?*WR.WX]TNNH=.)A6J-!DCF-9;E(W]V5Y^>C-6%!OP-[QN#)\/OY=0C0T3N
M[[YW;^^IK>O+->X>,G':Q@E&OO+QTF\_)]EQ/(K:,W1",_;Q]6PKS2=G1PY9
MAIF<>;[;5-->4>_8J>P&_*="O%ISAYPX7;MGZ0PW^ +'G^P58^KCDG7GGM+S
M!=?+!MOR?/Q\THT_/)SE5BED*6Y+/:07.#S:*<KFO.A5-@CFI,XDZEJ5^YE1
M_3@<P_%'<!OT\K^Z+L1_ZY;^$,3Q ?L=_L,POL:AHF33SO%GWA@W@_*Y=C\*
M^VR+N8K)DECN'*G\R6#HI,52V?X@+:%NN1)P2P]YW,V^B^U+9D/WFB\F6VA!
M[HA>7L R44_>(!=&&7=!W\L8T8<F<4&25Z/&23Z@S*E"$D;MN]VMRZ='(; C
M42$];EIM&,+B"!87:)RF13Z FR59N'2AF]0JV%!B9D=*YSQF%BI:I?#U:,3B
ME/90++*2>)\/(&G=&K:_G=BLEY\2U,VMC=*&9B!P>&Z\6^.K%()OS91<*"(F
MH/WF>6IF27[H=B*)6_Z;D'5<YF:&0,AW(&XVMM*J$+)9" 31K16+>1J<R85I
M,I<P3!3GKC%4X"JS4NCOQB(.H2*1(OHN_0=R&SQ*O2X,-_1)MU7J^RA,]+;L
M3$9)171=%]EVUO?ZH7>//@<+;C5G\Z[ U<)5)Z@!)T(\IXW=3F)<1B[QCVA,
M&O#OH]4]][<U8]!08F,..\1Q'UO08]$_NE"Z$(XFYA,DW8:ALF7/D$:7*KEU
MN,K+.NR%T=&;<_H,BT7C_8^\ 5FAX?%YIK:^I0NH4CW-VDI&!>HNL@,">GZU
M*G+X^?"O]I@?I8A.J@TF]O) L]:AE$[**'3&:#,8 ")GV7/37T^B04&I.IG.
M7,+4'$3,]+(89Q?RP+R=EM^X\%>3DN='F\7!M] T:IQM$U)L.TG "];4.Y4F
M\ P._E-_[HN3<"PPE1;[C3=Q[\H-.+]["3<XR7).VH.L%*%!VIGM\E,4XCPO
MT!69!.5!X+55BC<_+G&Q,FF4E_[Y<XE>OZ],]H%S5W6.OOS)\^6;BTRA1YN0
MMCN3"UP=DOB W7R/:?,GS1"D-'A_3"$M+&^2?&F50EKTE?^I"QW_IY^&W-?[
M2N0)VQFA1>UFI$5YD(]>[TT.T556!NU^M!GVG!2;;:&0YY#JR/['88D.O+N7
M#SNQ)C/7EX:][_8XX3/ZNF;I!K>YXHV?CX:IIKRU\"()Z8>FBB /H)- NJ7(
MXB:D$Y*SL\L&NN:.SMH=\A&ZQ@?V:]*#]=->%$;[W3%3LW%[0.BIVCE=6,4E
MC/E_5&[2:,ZO[EBI>C&18UB*CJVBW"^#8Y2@O\ 'YEOVC05M3M5=X%98HKTS
MNJZ7.=$GWW)&2AWL(5K76*=JU2 !:7%BO)/XGB)87VV6#Y#ANN0*40V)(C;'
M]J$7=;\\QCL"NZ2,R>LATH5X%*0F:S&JVX6,QNK!G<=2F/."X9)@$NX+U9I(
MY.G9,YCM<%HFS,Q#)? Q'3XP"N?,E^A$')XRU(C93IXDJ$W-\7Z,4DC'02E-
M^$]8!ZP;8U:LLB+DQ2(Z;1:&62*2IY>(@NN+BN$A(F)W=U-^*M>7W-3V]Z:"
M#L*_63HG-",8D<A=MAC !LVC^LS@ @C]>;OH"\.(F8S,2>2H0/Y!>$CI>9G*
MJA#6-#Y1L,I0&RPA?$0"/E+-!RSMFOB ?%QB(F%N3B&S9OQ:W"FK(W#394&!
M?N16\@SYP%Z] #7NVA"*R/SIM*A3Z]O6LRQ)@N.8L,6 <3+[HBI<*MT1J)\:
M:21J-<P'\)='F8B%8&XG;4@YP ?MH><"_J[*'.>K)HZE\;"1.@5/KZ/V?S7-
M5T5"H, <P7S@S!8CT:\30<#O@H"?X?)-X#G%24X9*+!*,];@8UY)BN8"K1I'
MAT?"D_XL>P#HUSDE,'0LR/9EAR0.#H\N+#[[*@$?V"IJ:;039/OMQ#G!!1 \
MH.'9TL3C3%I)(N_W\5#/N'F=Y.E.WU]%4$./G_U>ZHNJGTLA'SRN%AYM55!0
MO$-PGIT[)D2V&\I5'5PP1P\^'J:(_F1B*,6:4CQNVD2U/Z>[9WH_\=R=GW+.
M[9F-P<>B-B=Q(9CG;5.(*PVW'8IZBJ2ZCH=:[2[^V>P"L,3@AR6A5X3V1?&6
MLQXA!WI8PS*HL/E0TCXH8H?;[#BT\L)N>O* R9AQ@[V_L($J%<[$^C9#DK0H
M!O+:= 8?>%Z(ZG.9U+$WNI"G,M!;5E3<]<OB0V?U@8=IEC;@)]:+O61KD]HQ
MZ_&2E([D'A[R2, VX9Z;@9=V&>R&4_JX1<:I2<E, MDQQ*.[TRS'T$[9'F'B
M$W Y(V]'2L+DA;X4V$Y/_]=?K_@/MA_4W^_"5CV17_*,??.FK C"5#B@T?87
M#YK\G2*:O*0<,L$SM6[47&-P1?7S.YS4U&0>>]E"D7U_B9N)/3ZCNJF*;,%&
M*$'MZ!*_B7&.F/_6SD9*D7R<:J5<)J7GC5.:2P)C;\Y C,=!Y>&8C77,# JE
MX:+DVC:&_#T/V=UR^?.D@:QL/B"D!;VQ[KK'*[E'OS,0GI=9XZ5B+?4XOO7E
MF/A3T,_[HH=*5Q!*(_C5RI,9%C=-"&](+!7A4OE& DN)&,F5IDD2IO0EZ'@J
M\YIL*+7,0\I<1VWBL?R1LB@MQ\UR)^XV;*?]O)[R)N;4K=T.ZWDQCV_^\/C"
MHV7'EW"441>5KH@Z3PQO4UBR+=XSWD23/;S,'VVHT"1KF*5YFC:IXZA(]K+J
M[C7=$UW]?O)MDYF;(ZN[D9@Y=;P?+TI]88M;Y:@=+7UTY>;S2AF>EB];:_NL
M8[1-,Y6>EFJ5]Z0WN14[+JC /<![2D$'^#DJV(*+F>/._;_VOCNLB77==ZQ8
M4%04I,:&@(BH(%VRU(6("!$1D!H5D28B @(*&04!J5$04!"B(,0&64B)TB)=
M0$! "45*0N\))0PIDSO1M?9:NYVSSGW.W?L\S[E_S,/,,)GW>_O[^^8KP[!M
M(/JD"%=ZDJ/L!)\@5DY7(Y[>9 (.UK3.D2K0$W:B))9L)&+OR2*#K !37F0:
M:O'." 52_ 55UU-: V\[!8[<,N #JU_Y@ZV]F-%QZ"3O^=9 =/\Y.E)!T*['
MC"?"S]"%N"&PT@2AC!90%GR?0\N@QQ$2&2B&%UDP /1G,SIH3V6#1)Z_3\TH
M-A1L[Y3'3!P61>"G.JII8C&=(_4S@E=EPP7+5J#YP ,$8-_;@F++-B/!?O\\
M6K!/!9JD@Z1A^O.M'FQUS2:NWNE1#_9=> Q]O>8/_)5_YP\MX"\=WG&#ET 9
M09J$Q&X5-BA8S@>=B% G(-1YP!R6N[D=G#DLS]J'(."?#HLCC;% <2_BH3L(
MVGXV*4N876?&H<PM<*>[D!L1]R]01MK[M<%/4V$F6'8(/#W?NJ#ZG<8[/A"I
MR-0A<RE(:T/1G\$]6"B\BV7-!](4F>@?M\.X[W'FD!,O^H\2QD^XB\*W;\K#
M:Q"<"1NDP]O."N1-Y%9\@:=YNG#Q]*OOA-E^#I&"_K8Z&2UP3)1#G#K'!X)3
M*(YOP-K-4$I7!DR(H<SWC[?VW$$,7 =7CYW3UY/'B;-!$L^/#>=#+@A9\+.(
M/F(@Q@BO.UO BR/@W+)FD&&.@-EJP0(_HK\)^ZLN9728.#>/1B0-(I(N3> #
M(7\A[,3]^2^RYHJTSE+AXD 0>_.'B8'-2&MZLV#".!^PURL)'&>T(GH=YX6E
M(;DSLV(QD+ 9=' .@\\+.+XB-$-^YK=E'9IV X]9#'W)ZV7?8H_/?N4#52?V
M]\Y=\4Q!#_D>RZ",B7->\)#L>.\O_/;"V#FN#U)LH.Q+Y[X;'A7-=-23]^4#
MB3PTLXDM,OQ#QW]K8:A9 <MFY\&4$A1SZ3,B=U\S'RAW)0CV'23-<*:1\+!E
M6P78G%,-TOZ@9)7O2G[_0\F4[]J, 3^#VO^17VT /_T0]QWXQASEK^P-(>W
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M%>]<"%TC-4@JM9$7-J^>.@+2ERV[)O.3YH@_O92SO>%9BJ.F</.19O;D&I_
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MCT7/OV[S.Z3-?^N%\VQ\4P"N] E,R9!>J!D?;1IGF_WNV*8_'!M1A6S2:.L
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MR;#:))L238<%][MYXX2&;-N^58;9AD,ZK+N;S<7$J%:E5#/_J^ 6)BV3"%E
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M^/$Z8&IJA>CT4<ZRXJKU6U 4"&4XB16DVU?#.>+OHSK2VTI,8'AALG)/V35
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M,;>D6]O\B3I%M]B#;>(JDWY\L3"OT*N$!\?D'6^9D6M3':\L@5=""=101R)
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M/E&+1O)O5K,8I+EJ*+$&/UZ"ZS;L^I<6RJDPWKNJD:E;KKTO#5[AS\[&S[C
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MHY1U<R$.>JYZ/1R][?$MI.W*HIOP5[H0]YZQA4#-R0Q=*51".N[<'S@O%U+
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MGG%\;R43F-5A^LAJY#XSZG"^'V>+,=FG0Q6!!7LYZ.5,;I?!^MM'EVI[*0#
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MTJ@(HO";NDTA3=^1WWJK[IQJS*M]_O<GOO+.*TXDMSMQ7XT;8R8.VZ>_;5(
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M#1%_,5LK+2*':]^@ !XWT1OX>KRX%N>0<>&$4^=4 +=(@=F#AY>I+]ODD(?
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MZH-J-%#Y=CML7&'G,T$$M><\5:5;_]GI;>A8H^H@Q=_2?V29? C;_5WU*_T
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M]H#,+D ]DH)]JU)VX=;>T-A6ESQQP)PL;"O,YR;)_J*3>H&96 KK? .SHZ$
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MU/7UD=+V DENXXT;\:_D^>V_'!@S);<E:_@)[[)TX=*7X7_F9RNQA)SSG&?
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MEW.?GYRB"NE5$RTQ.\HDMTVA&HZ3+VIRU)MUPVYR 6R6LFT\_@')$@JA$)K
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M].^?>+D%.6_A2)AN1IXV:IG"93I.&\?OW0XQ>R):_2VCLWQY7?BV][C-/E,
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MR>/=/[NR7C+%?(&LQ#X+6@G"%)AWX1\IIF<.[%-W\*CLP8S=P2:>P;'NLT;
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M$CO)4S!S+/+Y;?),:/YSX4)A/\\A@5KD3V#T6D6PL7Y]3<T!JTACN!879X4
MVC?52^; .\2T=\'S6XG^@R$CK+&KOU4MF75K)#<;'RM^K1CIR"/*W8DR:<OU
M7W4WSP]JVAAS6L^!Z!P;$@T+B8G_C6NH$J=QS=(%/6<UH^GOK!ML9N^TY7ED
M*D0?"1XM:3!12HYZ@(Z2UL?)1$4F:B@MJLC]UT:I;MH3(3WY2ZVZ86JQ-8=T
MK>DDO2_4*^YA67+CTLV:BZ1Z^[$]^?X2^4\S,7\KY"#6"0 >E_W =\99Y.>4
MU!IW%B+<B/*#2NN@"':[EW+CGV-IN*N;^R/6)C>U>Y;3-"W6L;D@EK 8)^TV
M%9])7%Z<000DCC5U;>*>G;=AL6I>]<JJ=I_1M$-2XT["Z XEDI*I(;MQ#A#0
M8-F L\FE;ZPYD^2<XP6!_@KS/YY3!8., YF-[Z#ET OQ\S?VT+9Q;!:PO_#J
MN&AS$*8&\GDP/7?K<1=-XGB%TM6()W/H%PG_0<+$/>L00:G\H,F'F_U+9D P
M46Q=S? [2&Q0[%5R=?[>D\.J2<ST_MS@;%SJ.<"=R41OJ85%T_@<$.?,<]>V
MVQ\*WTE:LN(<$S(G**3G7IT]+MEXWX84\PZQ"B.]=Z8S(,X&N2'VI[#M@',
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M'$-[>HCUS/VQ2ALC.VOJ_*XZ7G1J;7KHX4IZX%+LSBX-$&?U3BZ0:YS:#01
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M]94,CW.I=<L6#5.9J-8!9@BB(XOC[(#?)Y<2F5H#M(#C6UY^X"L6'1>/@XU
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MG/ :.GP(KJQH0LJ[V:BVV<9ZY'J5!NBZ8]YXF0/8:A(YXH#8X@[7QA>@OM,
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MKV")61=;_]R9#5>7_WKQ15_N5  \TX-\YQ^D,T[]DO_<\>0+71?T%E_]W9O
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M#?I9- <>U2TA^=V"<O[,='N=ZR@-+<6/E3TJ$%L5S$>X\Z(*-V'<6G? D?O
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M?<B7'UF?W2>H*NX^U@9JJ1N\N7+R%"(3D+&J0@-@V6IG?Z'X(=XK\;JIIDL
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MB>35B2+!Q";5<:KPPO#"09K0_V8&?*^@.B]\<@$(+\,2R2W'.><L;M:;+V^
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M!JJ%,XZG35UWDG":"O3V>^KWSHQ=33@&\,ISYK:<[56O(4I'E& B.F.#^IT
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MM3)X&,-,VZHN !@/HB;T):%DV90$P?&I)XHQ6%IUH..OS6\CE;T<,]XFDYK
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MC6C-FU':2U>U^I5I:S<:*:-KW6@UL+/?D'(NIYZ/VE5KD=!KY_G*)EBUE0M
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MMI(KW5U=*<#'E>_KGF4O8Y.ZX+?VH!1%-%0&BOGE^:TB@2OZ^IR%MVIZ>-]
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MI]")6":_3>- 7&6Y]EK<'W]FMM(6;3.5QIH<D_-1]E1_]>_SG$77I[+O-K@
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MO(#4>*-S](%PB+C>U;J8\(&1LN%4T.+[6;< 2,. 5BI!!!KS^#L+E/BT^5+
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M["Y#(&$7M%F@V,\W4$JI\+#7 "FE %G<Y+[0OOG@!D<3"X3L #IV^["^^?T
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M,FC*;*]DMEQOAI$R"*[8#5F\-)"6W:,3>B@N9I?0],2F#E]5:E\O"^0<Q@S
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M%QS[/'/3C@Q^9-\SMJWEW53U7OTQ,D44\JM)[;7,<^FE6CGTGGG\;:A&C,]
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M(D%PZ385S*CD-6/@!)IT986K>W9:D^#TJ;20=I'>Y5T!Q8750<87!3.>?:F
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M1_0Y,F-M,V4DWZ<!#.^3]Q*UYFR>73,B'(!V>D_P4JI(Q^>Z5L:N4UX!<;G
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MTF)U1H97T'8>]J\"U/$0-IH R2\5I6M^'-N\]<CS>ENBJ5(3=?[NGQ\LYWA
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M*J0I]>J/</,OB%3G>?OX#AJ>V 95YL<=@'=JO??\P-0:#,HE<YKS(">D**M
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MS"VU^H5__IZ*.?J14PHCET%4N!:H$6\A0):QV<4]P /;54C :.EXNYYL]W;
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M^D^YLPN9UXAW<_5K1'+&)4Y_QYD!;JQ3J#&(8AU2B:[$O-Y.=TQ8Y(E$S'X
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ME;(+ZJ5)4RIX16\_X@,!I=GTWA_I1W;0_SX?85'YR#2=:>;6D7TZWXY/H%7
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M5HZ\?/3?GFZ?Z!A$UC/JF*6<Y^VG69XDU*==4.,N* T' 2YN6M,G2NJBJQ&
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MO'#],EQ,F"IG J7(GN$+5+CH=>:=FG8G2487W)!E+KZ:^X&%!KR@_82'^#.
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MY*'[5"$?Z\)>(C:V41U[D<X>^C(-]6Q(:G_'7?2P*::G?/EW32*$;F>E?F5
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M3.8IM/-4*9W08YM9+#FYI9HV:YU15&FN^.6X]>_3=O>NJBA'G.<]0(!K92;
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M_V]OX?_OM8YSVTWLTKV4[<A$0R W)>(A2_F'OT2$I'Y^&OP8JBST/<1&)%>
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MUD_'QSB?7%K<CZZY=6V47,O\E-ISM)&WSCX^MAW[;#GQ<2K:I;R]H4&M!B]
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MG=Y3WJ (.J4_T?)I#@?6AR,TJ9FL97"VNWQ%X,TS<&J8"*I#HUXQ'B:@ZIN
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M$X#OO&-2"*1(E"9_8A=7-**V,I+ELQ+S0'$3!@>7%'O%C" "SS2&]EW-],B
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MCQYQRE5_$]]-J;$-AJ<9.J'V5Z-[)1GF>;X\MM5M2]A9_>[1,/LK8MA\39/
M+H2](^"!JRAD?5IB-9"*%//,LC%;'RZ RHE3GE.86.K]L6(S6C#):OUC"NJ;
M@Z*A5VC*ZC\(RBZ*S4S&E;=?*FM[ +_&\I%4S6/Q.\?%$0-C#9+%J B]3QL4
M[C6<4J]*WFZ>TGTM1P;>^YQ)=&:QM01V&N>\)QVDN.TU:43FH>Q<588WI[I
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M@_/!/&PG ^PUMS!"7?LLFZ&BO]3'TUQ*'>M%_9SMWYW#?.8$'GV)@[N;[UO
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MJ:>*@O&!8VB9G"-60&E#@[E!M=C9,"X%(I[1O#]5008JPX/Z-!1BJYJWF\B
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M(=,-T6ZUGBQV21JGA2/[@G$!G9W;^TV]]P]-F.^IA^;Q6Q9O]Q&=RB_PB%@
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M)19,9#A>9!5.C0N7O","LZGJ=?,JKY=1$]*R$E\RZQWX_C+.^U]4_QK%H&\
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MG4A?JYLE&5CX_MOX251!:]]K\G6AS0A/LKL^!.I9RX]C,/DE?92JU3,F6PK
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M7!CS].TE4@[(*MW/?9+7U*^W]<4!HEPYCA5UOP:XU>=.^[6.%5Q\_(:\19"
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M/5M$)%'1'H;!.-:"[MX,XEN_!GQ,U-44<G.80'E/) DB[D'L^2US[S?BL^O
MS<C_.O*KH]8ZVS 6J.G$U2OS@8&[#!KC)U_XEXZFWE5HT-N\MQ=Y^""58I T
M=[.#A4C9T%K+\S-]@=PEW:,,^( &]&!/!S_9.,J-?6YI<^WU6-B>15 4T(_3
M3*C+TN.IXJEL@<AJ@E2/[;,J/L>_#M:Q$>SO^+TO=9T':(NB+8=GQQ<[N-\=
M.E;[>R''9[HL#T6Z]8L25EX=TH4-]#+DZ8T4\'\.- TTSN%)GJ=>DJ!W'DP'
MMEC^',_R4S\N(!H<GO<P1* :$; ")L6E#&R[A>@B? O-.A8\EW\4*WL\[5+Q
MX5U8YI1A-;3FPP5A#'K9GTRT"ZQYW,6EJ&.>UGB0RAMG5K_$6%E9J-VTZ'6<
M$:PY%\.7T\KTT-Z@T!6XO 9<)2/M1#XNUX)Z8FDBEJC''W7P)BU"LJ;P>J/P
MBIVWH996((E\1W8[F>1(@0=.PZ1Q64>@^28"^2)Z&?L+[9[G/J_(A"'K<<,B
M2''SFA]D/=[%%CS1ZGFGDP>I": WUW;R-790_R$0AFV TL4LO5 61RGVF.9P
M%<3FA\4']*0QCV>E7J5LNDIQLMGIJ1NG5?F<IY"<G*";F%!J=OP$6L\1EO!C
M,A.NJGX.@V_'6LW<$::!OF*&TVRZ4'_IU+)+=7ZH?Y"2"3W>R!E^$^DZ2J7B
M4XH+6MWJLWHX?0"8F3&^#3$5SB<_9N)*,-(TL=G(>R2BD@ 95@2BUU!.B>TJ
ME<ZYK.B$)I0'[7:QIE0;F_0L@JN6/-VQ%7HFDOGE+]6RA/M\LAAX/ O>+0-?
M*4S1"F'\?:GV@J,W=-]U2>!HU<U5!^B1SBG-K;QG_Y;_O/FU$E8.,<WQUX-
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M'L5_/5I;+4 W<YKIP#LY!-,'A1HK&DJ.DP9;\^499_HMNY<^HTL)JY%4OI*
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M_-[(<X%,=/=M"UT/_GF\H.1*:#W?%XDLT^P%ZHE2MA'2ZRM/#1D+5+[:U\G
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M2%4#-<P3WQU4#KA9'A^[Q>#EJ/ZVB] NX-D4_*14^KWUG7OO<N9U/*3CXO[
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MA23"5D^X+DY[8IY&="_7)[:\IU-SGKU=5VFU\+X HV?KJ_V08OUW<!=0RL=
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MKUYPI!R.>!P$- 2.3"59*5ZR'^=%4PZ+)V3NBQ3X^ XK_Q/$OKEHUB[B^14
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M<X=$#RT5%9(3], &5D:" LFB3((\8V+.KWV/OEB_;?J==$H/'3D#U+)U@^9
MV#^)1!4LM.U*$_;4[7* E'1L&5W]=C+Z1?VENHJMIGOW(HX,\]]K"5%FZ/Z.
MT5UG?!H8]^!.NWD7O*1C>=AW"14 Q'PX ]3=6^U"SG&](#.4JFU-1T(?6 WX
MY\[PMUBMM8N,X4XTMHB,@TE6/PO0*^4ZI9R@S[M^P8I\/8/C7%\,^O?*-90G
MI%COEIC% YW6AMU^Q66(^'TH<&D1K!P?M>%&Z *_ B_Z ".5,GC(=KI<X6C"
MQ+V/@P0YHMS&V*"/3CFKE_8K9P7Z">%^DY0X/*^YXIQ>#W4$+?)YF.&Z-O?A
M.FQ$1^2"Q&_%%6NQJJ2W\DDI*0ET/S"KLE--SZ9#\S5;=WON=R@*I;Q+?!R$
M_*MDJ="B+;ZLL3=WRI=)E=X=FO@=9]7>/WP\3[1I:#L4&S6^.U&^>N]E8Z33
M)48M$7GM2QA/,?\^I?4PD;'^(K4G;XPF$F!W%1=4G))=6X0UVN1==TKG3J\*
MZ10HW=>7CH./)KNVL<SF'R=//)?'>U],>D<-&]).OO(,/_.;:NV[0PXH9$P3
MB%\*Y_MQ!H"G H45ZSQ??5MJMEK:F5[Q%QA/3D!FJMW*T)E;)*TMO^!^O_#;
M.:G/=^3HV%0HFB)UKL[L?Z=M>8FF\460\*?MN]3I K?ZT<59ZR!IL:2@7_T<
M? [1E2VIV+?\7RO2#<T!^?]<T7^&!H>>O*&X]FNSHW%!?&DW4K%REME%6\+W
ME+T1R;:CEF-QN&FQ%#,]RQ'P,]\BP^PUQ28AB#'INY[B^0.6"'$(YB37Q->J
M@J@<*(SD.?:F#^\PWT01$M;P![NH$=Y)\MXYR'AW&MX*(L9BD=TVDJ179+6O
M(SAQ8.^?/=LSP(<0O;IQ+_ZQ]-')ITC:Q,'$H8X9_[W0<SI_LE8;# 6O[NX7
M?NX<$4]!?%'=A9P!VK7X0%"$13?%L8=;*?OE7IR@7332[*IRLG&5>;:&I6F)
M;DKZBP!KQYN_Y_7G9I<V0,DX7MJ?BE'W>QW-XWB9XZ2N2<X;=&&QEA+,<4@.
M3?KA-SJ'5J^!X2=,9$$^RLU [=J$$6V"4$SMO.+'NVC]J:*Z"($WO.ZTN6G\
MEQHD%MB4! [5C8CS))/3>I33SI6BQ'8I*TAW5_LMA,7W7W=1L.M+*KHEZZ+\
MEE9BKS ?I*,1 @=S^C3G .:1@F9_#EZ$5@2Z<4WQ8K&WYH@7',$)70!634>>
M 3QWPM-1M*I&.!M05W, *JX6Q%994!!_*.[[+3;W:I-A]PJLMF'PVA5E?W#5
M"O@98U>[YP=X4)*#Y 5E8J2](3MMZ]._.J,EALR33<7KE5^\_XS\] ?_\Q?K
MUZK[HR9NZ(_L&GI=MB Z1UDJV:=5(#7U)E0H1+QUI!-%OE=$864B!9U^ACD]
M(J#Q#1];?0/PL8D?H<)39IM9SY=N#V<B045:A:EMZ=OR-O%<1]_]OH>G_1 "
M3F1$AFH4D6NZLQ0^[D>F>XI:CXL=A- DR>MX>K_4C0W[H:UNK[G1+JT_GI0"
M'C$\#Z0MRU<^_'IVKJ:M+[N60ER[3A%E\R#N&27_;O8.?(-U#/5=*PL6TLJ"
M05V#/!YVE1"G*.6Z'HLI2)^NV8]OY=5KVP27)U2]!ZV!:7 F7A?[\/<R"4Z2
M7,KD!9/G^@I,,44BK^]KN@[UQ9!>A)9ZIPG\&=,U<PI#13;:RG5B837D2CC;
M+*98!**<*J(T6>(JN")?> P.\RY%@3X!W;S)]S,V=TYX(2F/",@^E9&;%NOM
M_&/#R,(S@-U?9^.Z$&\E[+S -QQ/=61\PU/C",-K01V$D2@4P0(T@\(A$BCB
MA(UN951\/E$R-B#6ADTK<J=KQ_U21D.RP(NCL;"*M-M+&-G/BCP75$T3MZ;/
M:4$7@6UK" ^F)X_WMBM,JXKZ8CWI:A4K:O,7,J1DQP8% @5NO]IEY6'B.>;[
MC<(Q;8:<&(9RD*=Q*N?LAI8JM61%ING9$PI7]<PEN^'<IZG#C=Y5ZV\"7]HK
MQ0MIRV,<6++-)B%AG>K<ODZZMHH+.QSI1'$QF3(1DWN<Y@P_M0U;2PVM^]=%
M##YL9_0VHP9\1S@@&5VSDR)D,=35>.QZ'5X_NV3<L,_/OT]B?:B"JR;#M@7Q
M5_[F]\Y0.MJ3SQ=,M,24MK6\X.3BM%V=##X)B^=NZB_5#>-3DC?5[9)VML!P
MON_U5<1YDS/ >RC9S((\X(L/021(0_C1*6Z!ZB+O\H@H4JN_.XVF=)<!:#[-
M='[S8:%Y]#/N&.K3=@GJ#)!@"(R@WIM^[<U%\2(?8<1U_H2]6GT\3M'V:W8\
M6(P9NO_>_%OR9&P?0@1]E]CBHO03F7S.S?8D) 9K%JY<E.WH:M<P-0X*6]/B
MH/<K8<!BZGPSJIO#"JY56*TKEO50A.A69GF!;!FOBK24BO0++&R7C4H,'IN6
M">9D!U4(IL>KL2;N7XQHD.&V#]]U5KFB;H.NX=O&-\BI0;VA WP-?)N', (#
MQB_TT6E>.Y]-Z-,)*A]$FHF%)[ W*S1X:SEF1_;D&?+;A)T_-V*N>EWZL_/C
MF!$_'YJ[*,W6_:[O U< \:W9BH/./.$)QJL%H5=<T^VEXVRL!16N@IF4 TI?
M1-7EFB87_QV9;7JD?\-+O*RH+FOB9#-%J6/ULXCBX!6)2&&3(IURO&:=<O6W
MC4?Z#XIS!;'W*I-UC4]81JTSXB@!6*8H*$\[T3FA52,? NH.?OFDV#UX9=.4
MT_.S?X3,XN!35_BL&@0) ,]_(:D',*)JH[H$:7)YI<<?A'7N!?'B$X-C.+SL
M8F+A;!=C>WK5S<34.>L<"@HS"NA$UVN7C5_C:IZW7)0#<21TV3GA"O.B>PR^
M+8#G=/)Q<Z,;]NO]HBN:ITU !T!<-RF!K*GS_MSL/Z"?8Z[E(V3>TH#[VU#G
MX:IG&4 Q^95'5.A&W'*QE250QKY #A#7W*Z[!8?HHX*!M1T6TC1"*0FXF*,W
M=A&%ZS@?Q58U.0DMY1FWB6\%!7E!G:(M?QOXF;XX?FXNC63C^] SZ1/ JLP>
M8U+PHR&M1%^_?_B<-**#-+3^7(.:JNBSWQ]@"O7]! K=_]/N, GT!,X^T9@,
M4&,Q.?W:SFKN=BQW.IQ1NC9M*S%NUSI^P*!DR5"F4LS3W>U[Z<?H -?5_G7C
M75%5>2:VN#==6%_V]&3/%WF&Y=_R-[/S]*5]02VF<KU_V,48[<6<1")OR:3$
M\01_SR\22'&3\(M)T2XK>%,9!M2 T+R#N2%FQW'>T7<(R.[_V"V/2=4.IQL1
M&/[TEZJV??&Z8:FSKY6Y]0_?\.QK#\*NAHQFN-Y&#K:FT0CQ?H7R)]3)$6;B
MQ)^-]?PJBRH1MZ??7]71\X1:QDA,-[=/@VSHN^U]/O=[U;/=T&71EUY)_:LO
M]ZJ@,'[<3WO]B]4W2Y'BMK>-\0X?5WXPT?='NG2'C8UZ[:E[O0EM]'#@3?TA
MQZ""5-B<?J#ON1IBE9;@X%3?_-RKOM%DP2[;X58\J?H]'?OM*>N4Z<7D^LJU
M_+2MD/8<A&V4EFI04U"&@H)X9>6*E[O$]HAQG>7RJRU6ODPXJ_8]OPOX2\YW
MWIT4Q<6=8L=2I3H$N _9@=B8G!!@,BI]P*9?#UC'EYV\M;B&,M@WTK5/^(WG
MBWRDZIN"GDH"OY&F3Z:[?<"NN%\09CAMO%(3K)&_,[NX>;#\7=QD,DM/R--C
M:3Z03T-0"TD>6VT(+K/(W_PRMR6ZU1!V3'\:L%@!WX B"*?_Q%P)B8/6.J6,
MSNZ<AIT!;AN"G&&M][_%7/F?F3-C920^D3[R[^4F-G\:U8D5<-CGT&(L0OJX
MN;D+>_C'<9^#-=BP2UO6&Z\AC\VIEJ+"^6TA5H'QV4,S_6&2ZQHR,^:8-^H]
MG^:X<EQ$51U7(R;[28(R$Y+'5_LT(O=Z;FV8^'=%\.:)/KH,NG'\AD?4I= _
M)9NT?P;8"#%Z_U8J$<D3#(MP*9LRK*Z(UA;$"YGJ^:O5&K9E/)W6+^+OP#BR
M-[SKUO1WGT/9ZYU4!6J[DN ;0TM_M$BW8K[>'-WOD+XV:N<6Q)]"+4M(4W;-
M\GE7H8EPJ$>G>(G;F=,I#; _IOVI]M/Z3V7*B&&C *-_=@C4MLWUD?V[\ DO
M]?!IWE/@",M6Z=#C W=AOST%X8%T/=> P<V"V37'E?JD+CMAS6_F;FSZ(@81
M(JX%HCICM0$ZA_5E6O5%P&*R5K=R103I"PQ[>G<7;5#3^+VM!@&J@TA42-B[
M%-5E,IJ[.&DZO%9E?27:0>6C]BU7CW2-L K%J_.%TI*]L9*LO:Q=3RK^+O'4
MU*'B;"+9#/)G' TD2$ORJP+9X>#'D)0>SL (56 E!&'FRC\6JE*P[*Z<G70G
M_6G5N"=\>PL?_?+'!J.^Z0._S7]^.[5?)K.<0U'UTQ28RW*,_!F AGJ+G-&C
MG!BWC6MO;JB?4)4)*)K%@\R2=P(VJVM?&9LO?)A/B?--LFT'@X 5X7TXZ9TM
M)<R:82+I0_$$\@#2F;\5DWIO@+VVO.ETNN(8?NU5(_AR3*?8<+H%HZ.K(B;-
MS=C$>+[F=78N+#8_>%XW;__*LM;8U_NC:UFATGU^G*(JC@ZWLST=HUEO^WYZ
MA*M]_.DWJ0\H X?/H/%;ME*$0WQ#-U,,5(*<A(%=(*?/VTQ36=;GH!'X9Q7R
MK?)9]47VI[D\=;6Y(W-9M#6L^+OOW/TJ+B;CVM+5"LQHA 3@9#2[P.$E M!R
MUU>6F+I^3M/\Q[/7-'4BS$?@4EEQJ6VG*7K::D;Z:VU,[A)P^@(AH\N&J<5=
MY27"V D>X5W7>]LNV8[YS<M.8ZI1I(@S0+(,493:@V0^ ZQ5KZ-BF<AW=R@(
M5!1LD^'?Y<BRJ!- %ZD6S'1/U3@O/5$2>,C0= ;@I(J> 3"Q:*K,<C?\6"$!
MN(]!'YOAK8.S<-O7]OIZSP K.EK'!ONZL6> C_['!NU)V')IF*J@,-]B*,P7
MFGKL\!_]Z7N^2\!NOI]\JV)4H5W*)P,-UJ<1-PW^8U>(_]\UWC/ ZNZ&QDW
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MS8P:A8#P4'S)X<OMFU&SHJ.N(S%Q_G&7-0837S0$)7LFA/:G\-K*?>W3Y'U
M<)_5\[^ HPDWDPEWAY#:'L!$$(<*N_(GX=Z=KPVD%B0E 5,?;9 YC+N8HD$
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M<ASSITN8D[PC='+)-BPU6"K,CM2?232>GN9_5XG5YYO/319:?'<6P$?S8TS
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MIR_;G\)H!M4XS:40)1BGOAW:@<)"Z+G.S/FX;UCA0:W@&DC@(I)KVJ@:8E'
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M%Y,;T)W-7I= HA\Y!SRTG;+58_WER2M!P^_VVK)(D,)EG>%'H-.)C[T&R4'
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MXP\2T5*_UL (AV5<#4:'E)\@:]S<,.?2S:FX^/?7'AO".]S#Q>E7VJK2#6M
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MUV\XL"OVG[MRK/PV([SLFFZ@GMA,-&EL"[)H^Q.PB'P?5X"*8PW^JA38<W_
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M+B7C@]8(BB7A4%6N/M1^P:&G#%<]/#E1IODX>F-,)ZZH&DZ^=8W!=>&3:VC
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M#D*ASDA^X9=0\+"8%=@U\*SY%-:!B^N>BZ-WVY 4&=Q54GDPF%$DRT>VR5B
ML5)F#8)J0%7^ZQB+JD%2M9)?BO@Y8)TF55C\\EY-U<$B#'&"N/"[EWPU@;6%
M<*=&X?M$0J[8?);$&SL&C"^>UI,N&)G-N.DTM%S%_%+Y!MRKEL:F3LX0SAM@
MN@1#&X%G0['/"''!-#@+0_3-K 4N>HC%RI"+P-/:; *GWTE]R'*]\O/YVAO8
MZ9%JWIJ;0*5/[VCARTQ[FY>J?D-8&UR!/<:YP\?'U)K_=RVL.H3J^=\&0XL=
M2J4UAPB1Z#N/V/Q.=R/QE]M<Q');N:@0N<:P(WPP$T5D__LWK5Y"7:X&7KNO
MO+.$ LS%="^ELNKJ/B8 Q^%S?[Z[Z_FB0./BW>7=<@/K.1N6RJGK:;85404:
M=%GFS,7C8>:Q'M.RV@'RPGC99N"H82^L+K4KC@SBBG._!#JW\];7XKYA!#1G
MO'-HMCUT6>,=\M39\Q<24/F-E]$!3NQL:73JKWK<3V3V;'3$ICUN--#O<4.:
M5AW)KP#OSZJ."W$9E_9X%US5I>H6K*[HF^LKB!9Z>"-5-JRR?'C0[,-TLW":
MBX@(%E7_Y>8:$ONY.6C/\O&-]F,@VBIGGG1=<DOE+@WS[9']8*2CWYA:X^#C
M\LU-;C>6R.BWIH,KK2]0IQ&=Y<UOMDW"6879F,(A=4XESA4)D:]]3,%&]6#3
MXTGBYR7%2XA.W]1R6$0*7_?-C],Q\GJ,,?F9!6)!AK7KL2DNPG/0CQ*Z[%J\
M^P\UF9^-C*MPAPL>IW'4T%.29J(5T=1*;"BN?1YT/S9^K-6X B(QO3SU  V*
MD@:2.T>^4Y4.K\I?T $KZ-[[^,7W6SI=!S@Z1-D9A\5 \8Q(;"/&]TNK[O+=
M-LDNA''JMSH= O6JP<3&I&U[0^VDR]+=L@R!!SZ6(@:RB0\Y!K@I\]EG!F U
MJ?N;F"*L<AO&$GDW-B,(O/IU1:$]JT(_8-1RAU9GD\-6(SI%(0GF8_;^/$MK
M04_7RP:OMJR_]\_JX[OJR>KXBY8N59O- 0-J\+QNI:D7*F_PH+Z]8@N3.JK6
M+_##IBV%)SRXA*M<DP$R$IV47](_UX\X%C/3T#.MXYA*'+T"J'T=&0VX9_'@
M4]_>40_*1XETP?8;+S-WC4O_/\O]VY_LT[YME9+P9@/69C!  3R3';;C:6^K
M[#)=Z8U/2,1;5QZ1K<&6%_"7:PZ(6F\P3@RT'U2^K9"2Y)5#,1MCH=TZP7BP
M6!4\0<GDIN4BW2//]KPZ0L5P\P$6/[7^&B/YH"*J1$N-[6^2_.:IV6#F6T3K
M20O8HG[+M^HG*,:H1&C$4M(@,S-!7R8_O=9DD<^U%.E/4+XF"9V:5P#[89EC
MH[IVS.D7<@U<FR/:U" ^6[G9-[(J^MN'(XY91@DMKB17-(^I_:N%F5D5>0PR
MG,B)$^@!W6LU+$4X6M.CER+<JW8NZHY*S1';#;\ITC<#'QNPW"'S</LW2+(!
M&Q9;[0W(.CE+]0VL%)/F %UZ:*9O[!>TS.0V71H%)(TFV*1?/$IZT2@+J&$@
ML7S?3L#]-U)0@U"D\@1"'H4-PCQ'N/2'Z<47;@6TE]',@TQGZH*>4$+?3\77
MQ+'O\#"12+8,63=5U0W+'7<CI-WH.N#2?EJ!#&DC#72Z?=12A+S<??JIR7.+
MMLHZGYF-W\"GA_F4)1OB'-'+OL;-,(,BRJYH#B%'^5?:*@CK\:-U72L!WXJ#
MN ,'U,QU)<-[XFR6Q:,X;\"L=+J($N/A!86ZR73GG!^_[S>])I:N,0])N=3M
M"VFCHM<AOKA-]"[6!WUSLP?Y[:)IM%74KF3;7,?ICC%L_-3LI4RUR#M\&6]4
MA-U\(J@;O@>[EO(I(0_X[@H080@1QOFZY.UP,NE:[QI7U\]L3O*FZC>US?)'
M_LW\NK>@T6X)^+K*O4^:O@YS!N($&_MA\TS=G)QHWYZD\9-A\J>PYDF5SEQ]
M2 HB;!)3JH&(J9L-7W>Y<YYRQ.!YMV$+K565]$]):[E51JC\-[IOJF-$FI.Q
M]I=,7:KT366O5B-ZPM*A3U .%8$$8MV_(6]"+E?5?>(V&_GCQ7L&QPVCMJI:
MPD(U-7TEX=31H]U9<+<M-Q@5/)J#!H&I_#Q[SIJY.JX  &O<D/K$FN"2<(MW
MW<2!*RE@&M/-?=RYF%63R6/'4\4I['LM,1Z75R 3ZEF,I_U3VS EJKOV_F"=
M6R&L>6!=2_E;ZIW1B%M2MFQB)+=@6;J:/8VF6/-KO#>-MOA@LDO&^5(OPN#(
M7B*_L1-P/&>)K^Q,2[HYT!L ZD/&JO#CD,5^"F<] 1IQRZ=H_?!RB'S^FP\R
MWZCR'+'_PER+7I5DI+TSY/T47<W;:#FS.GL%N'<<>5KM5VI6X 1JS2T>+U);
MB,H,VFK,BPQ3K,N1GM>Z7J+N!]Y26PX':?(,N"^0IF[$&[EC_M5&:SC*K>SH
M4/X15/ Z6 7M&DLG;A2Q2IU&9KA'$A9SB-2TF+_3^W#\(\=;6=6DCN.+W83R
M]:_=OT +1_)Q/+QV\=,M0')HIY>*M-^\Z;0X_M&EG//20_1FQ"_9YJF45"E?
MA=ZP.DU9)M/JOLKXY_=DQ@<?Y\E7;9:"8EA[D QU7)''..?NQ!UKKH:Q?1<I
M_NJ[OT#=>6_Z'>@3YWLY^;)M[F6C:AK.S6JSIG:1-%< %^ WX%VBK%_9*O0S
M7G&Y@O4*T'?Q= RBBLKX\)Z3\4^=S>5D(/W3+HN4&YJ$L?E_CD>LRQV8 U_6
MZHMI?W,CGABO&7Y.,:AI78ZB::UOM&&<Y/@%,KCRT063GX.F4 DU.[J*GS@+
M43Q-=V;+T;+A20LTI\VF:M)$2.\YF2:Y?X_2SHU,YDTC-!#[@ W(+O@\L,/#
M+Z-#-A=N,9[_0DEW.6.%9TI*5),E>V3C!J2+U)5"0C#RJ411?5!4J5.#N73,
M4E6QE:9ST=S\@*<G;V5U/U6KX+B62#3R8;EV?K;&:+"K)&BS$VV*W<*570+Q
MKAAXWQ4@G/566*Y3NU)M-A6X,R7&GR8\9O(H(H$@FB3<*_(1Z-,"B-'K_.2\
M514-0K^!(1I7F;IA#-<U:A\O_\LQ6VS\P,M%S7SLP/MND/8@6TRNH2M2;";-
MU.YM>#\'\\S6'U"4OUVG7J5$[$._68UZ/E8OJ._7:/F@I"M "SPW84I]:68;
MK]M[!:CMCUWN9WZ#GN;A[T17NM8@CM_LC616^QNY/U*RIJVT_JC6=3F69VQF
M?&;T!^R)A:]LXAG5S&=4N'$1R_U[R6B'GBL FP,Z;#(EX"S2R^)]\UAN>Z1&
M[!M;/[OXHJ>K3@L:?>0//@DXEL)J9_",$ZH8\EY>G.2E)H[\-4YYY<O4KU'[
M26D6AKIYEV"/SU+SH\^&[(C5=^&>#7)G1QJZP>3$ 23:0#P266,:YM)Z']W=
M87VKL;ZYJ27CS<S!<M;IHOG*@8!90=.?YW*/:_VKGX/>VFI_,BO[J\(/X<#E
M5>%Y)J#.2 :G&7-L#,:AWUJD<?I4W8RW=4))M: &::$+]>:W^VHM5>+XH6#Z
MV0-2=M-%M+59&D;_ECL3IQAW+'6EX1V/@I257S<UZK5'3#M?MVQX\[$Z6DE-
M3#E!R",7R#M5Z'%%7=EDF]:<-E;4PMZ/S4 L]G/)+ZT]]5KM],Y39)X0%H6"
MIQU+[V1\L?$Z\0&.L0YBD:_JZF!U*8I1%L6YZ8_RW 9X#7^FR//8\THH2#0_
MYI7XKDF>:# I<M+"MJCY.DO$BZ R[3P_7Y)E%\ZFXX?0^6;_GEM(DZY6\GX8
MJ?P!,"<0C!.LZHF;RR-2I%T*X=TF\?(TD7B=50L@3O.4;-+\Q4#M>.N\A7.K
M^*%?0PCSV7>5+?FJ$1H$.?%N*@:Z"NS29X9(CD,8"OU40,R.%7E6SM.FAO53
M#5E!S7<GZQ?\$G86_XG,(3XWNGF"&MVXPC(-^YE%&.U3EQ^CA]R]'QGVV J8
MCQ<Q+N^_6UF<"/$8FY/=22.Z^E7W+T@N.]S;M)1-MUVUX$BU?2*U5?IDP[C@
M6I5>ZP(L*@X6"3*1T[*UIN97 %-H[>8^#1J)34:_:U?"V9?/.S4KQ[95X)SV
M#=2=HQ3;Z(B!C^R:PIC/WZ,ZQ"KR[3E=ZKX]3*%J;MOUM=8+I)-L5*99[?\8
MS(#7N48,#+"/RIHHIGV*(CSCC/>'!S@+3 ).M;@][P'M=K!8"(VPWJ1-\@AD
M'J]>6$.8<?1%U4,_7$SG\87'E.^,N7@6;:>'Y]T;(,D>09B-JT#;>4B:>%BX
M-_)Z8DGZT.+WE0HQ)<_<NJ<Z)\'9DMV3"=$)3J.;1=*"3667F3$[>_[MG)B-
M^S%RT$MS)RD,?8&UM-N,>\EE/9S"H]&;96*]UMG,T^+Y2+R>IK(F.;?GC)(/
M'I;\;);EA/SHA)@S DOF8K@6H0-*!U%>0=+[^0##6$6JMQ2(!?G]DE;#:09]
MZS^IW=Q3[\;/[Z9O%%P!0B-4>'.'>" /1QMBB_8]$\A?=9-S/"7WU6NO/WB%
MUH^K9GYC5[)>)V3C9!CC"@53NVH=U>U-^AA8J./AG(TQD/L1O7 *=JLW*X],
MO?ATQUT>(9XXREQH[SJ##"\0*!HPZ'CW)9]^L.(IOO_CQ4:K+/8CKL0?TX+B
MZJJ*,@_+#S ^ZQ&_Y:C"_^=WQ%F\N6[Q\Q&TAI[6<\#;4)QW%1R.>W2(I]?O
M!?Z^SCRWE]$SH7NM)K![&S,)ZY4%\9S3R@\1CVI*GV1MO.3< 6Q&XBBK(B2C
M#Q6+NL]].!DD!:SK;VKK"I;6"0B.C.]SFFX6!=&T_</E" ]X0$]#V61UQ(P$
MIY)6*M?OC'WY)2R05S>-;30Y<5B",D,=@5]@I$J&Z.XN+EHE5>K$<H@51A -
M"Q5= V>?F0N%/7C[A3D/_.39$/^]!M.$VU7!$>'V-&T:_AV+"1X>FD6JT91V
M[<XX7USH"APA2;S3NPK_AF2#*(SA;&#O022.1*%QB'S1L"_O=\V;P[T+O@&"
M:JW.,7RMP^WW^+Q)*)3N$+.@J!]7@/K>HGW'RR=^^CT!T1AU#%-G QHGNZ+Q
M8U\ (7)*$&)H-',PH\FV/IB6>]\4WZ<R/5'BTA%YR?D$O02[:^]GJ:X]^80E
MELZ]>_/D\:FQ9NH*YHDQ>C!7#Q.]-:#^I\!_D,:8#QR)N@+0S=!O-&4J_!*1
ML?I6_S*A[8U'$)1*]5)H(D)""X[@G]!?CD[9(K#EYKW5H2I:[U\B5[$@&<PY
MO"'/!BO0 OV0=>%,W]\D.NS2G26Q'OD>@G>AJ6KGU\@[M+E=!/(:IWYY"T(U
MW4[O=]B30U,_;(I-0Q\D^I?[V1DTCY_>C7JD)+Y"$9:9*E.C<0W69>_U2L4S
MSO.H,DL?;>Z=7P%NG1,GH&S!9/@'N&[/_SF,>[C0$J*+\U\&LRXY#I7BON76
M)/:8OV1-1/0-^='_4!FMEN2LC-G/L;]^@<&!:_091(2K51/*($]RNKNR^:JV
MD%C2?OSCL[VL9!'@LAI>2HZ<%(B.=L0W_A80./Y)LSJ/S?A]!0AI@7:VF<]T
M'R)8#[')4["/R-D$*.T'(@LN9CGNWOQ"_6'X/OB@M?AM=N#WLVU?]QL+RI4%
M&VRJ4DZU]PH0P'T@U@%W!4")(W)0P*XX!,]R#&())[QR&.J5P[CE64W](!S+
MA7PS6/Q&4SIFP7.^P2?!3O03LVDO$FT.O^WGV8=$:T/G<S0Q&EEVQ7,6>!),
M=OV'QOB\@O"\0C-_+&M!V7=(V9"\<?;2ZPB3<U62F.#WT,X2&+V8-Q#' _OL
M"O%=N?VQ#G8;\A87AHKA/#1MC9Q>ZE?[G:@3)-')_R?^8:2XS,[[;\:?5>Q0
M[S\!BVP[&&S+98Y>=+OUDR6O-2S'G_0II!,%@H4@WCCX%8!L\EJ;R7B6/,A3
M7-2*3LZ</G;Q=XT^A9_$F6D[#$T,\U]Y<P589IJ@&V$;6 _I"@2SFP^YKS_0
M>()\^%;PY;5AQ_ Z.%]/]YL%1;&MPNZ^4ME&,ACG $C"@O93VN??.#I];)\B
MXD- S(!$T! 3GJ/J4LB94YX0I\(8/'<%H"H?KNKEFJ-9L8Y829/>EY ASEP!
MOM@93'[\U?!D@.OP9DIH^=?3\D)6EEO8![[W2 @?FA#_J-\<B";,O@6@5H$[
M ZC+["F\-[2S"U2GWY<3"VH4Q]\_)E+878KZ=5N@KP Q^*#5?>"*0*^N6E<[
M=Z+FY$<O+@F_ R7E4GT'*8]^%_&P9=B,'5U-F1:]8^?WQ\0O,%1V3@/P"]0)
MA!.HZJA"K!^*B=99'(8^WE61:)FT,@^TTNE0>-?L&RMVR)[5NW3Y?+(*\#WD
M=6BC@#1^\3I)D^/Y_*_=F>K:TW*#D5"T"?RK@E5[R?(UY1B\1,UT6)3-_@L?
M.YE[6%.#$8M<Z.%6H:UAU,5:/AR&\A_^R/P$@5X!R,60Q#%K=D(+U%9\SA#K
MBYO"D'<H!!==*CE?J*=OJSR8W.O+ W[QNHQ:F_26='1+ #E)S#IZ:DQ(UE7P
M'+RW=;X0OC;K=52Y<'AB)_YKU@<1P C$GC(?$@7Q/+!I%6J_V45KZ:5:]^O\
M&]91/29=\4&Q;N7,NO;&^I)[&T)61$\2% -%F^\Z*Q[BY(J(%$Q%.]^CLL2(
M;!D<>A2/QZP<4\],&9O#6KCA \I)M:H/?W>:*-E)[\#0+S2;KO<+NE:$.Q"5
MQX76JPCN&NH.IL.=7=,H*BXT6+?NC_Y>%)AF4=<=^G.[X?$[OK;%ON2*P0HR
M;0IGNG+9!W=(+CJO57 G>":8A_#].M3208S28!+0HCG$%#=4@@M$0;O-O"YS
M>,PGE-16YPOK64<2V44:Z8:*^/[P]I4;CE#>5M0-?@3M+,B6(N2Z$N6@G1K!
M3,&CT/NM-IC[EC@[%[1VC_I*EOFE8=S+26]RC%?ZY]I8K)G*H+5<18*1;D'T
MTP8_TFTP[M&7>.(2$&T-FKV+)9\(&_+3Q.JC&ZHO3? .C2W\F]T7^TG3*8T*
MC%E\[>:+ISI/R(3O+);<!N<,W7AIF@WM; K^K^.?'@S55-UUIY.F%QCA]K05
MDH)VAMVS^7Q+CL0FAIZD W '@#\C%*BP!8^#&J%X=BCF$LN'ANV;8L11J2'Z
MX:VZ*P05*U++J91^??T[?H9Z4U1AE5F.'E^_!1S1_S4V(OD1HL]50 ?MK ?5
MZY;S![$1[Z1A0B9,Z^P\"_0]H2M:^[9MUB[6!^+UB5*T_TC/ _6"#ZCE\7DX
M^*437H7P"8C:AB-(L5&XK%]^43W!]!-*]U>!=^"%?B:#%H1WBWXYG<U6R>6C
M\^KLY6//=X8ED[NJ#$'U"D5X#M_+AYWV(NE,'>#8);YIWHCW:;ES.-LCQ2R#
M3:+9W+Q20_:;^'6 V''F=\9/*M>N&"(#[7QV!?B(G%LEWK''F!)O7T?+31+<
M5R0S7BT_2T\_]+I@': $WK2U3GC%X;26OU6N/&21$C7L&CSS*1.\M#1UW_?U
M_@O:&PTQHM:1S!&-6WH9JZ%0YC)"T_@:U*.)I]W%&A!*H& :G#"R%XX3Z=\7
M0"?V0 %XJJ*@9JXOUO<PTN6(X+)2*VL_1R6!HCDVMK7(+?-9O_?V[>EX@7C1
MJ9[X?@& +)9P_Y8NBC+%]@4Y6T/FJMN(Y.B)LCH 2@U%^Z;VYL0MW<1%75+B
MQ%&@'A@SCO0U+LQE)8OUA9)P^=*V?L7.C,)B<G8RV"W%\/GQ,.\Q[VM&\HV@
M3R%=,!T@:I8&4;LBT >?+5L1[P#'!?/-0-0NU8.'N)B5=%%Q7^$K?PK^S+S]
M/7TH)MXJZ^C).YMM8^/LH)SX]VE/=1+D,7?PAVN'FJUE@\ZS$2D>N#$%JF$\
M55/? Z<_X@J6'1[MAL9J/I-X,ARHN;?J 41E@M">P'[DW.ZE-K$?A<33W^]H
M@-*U2LU@1&0N4GL)YDNBMCJB0B^%= D97HBIUK]IM/F83-?W9*1G><2[#)<F
M.;,31(JY2PV(;?5,8O>2//3V,"HGS%<K5!K> V5JQ(+"]QX(?/;TY%E0TONY
M=Q1[RSUNU9-(E8'[=6FN?FU;KYEV2N(8%U,PMU_#ICXA!^^[0@7NXN2?\=:9
M5^8QAT7I3'%'6BCN?KN_SU@2P"I D:1U3VQ4_K]972''3A<Y^_Z7UW[3*0%%
M):MP3?%,*0E@V%89TS P;.1871*30E5$*QO*Y=D2E-HIO4O\4%2J)<K?6YZL
M -)H$^OKCH[#WT_HF[F&_J'U0-=] ?T012N@)CJB9Y%U<$G:Z'G=^(DXQ1N+
MKV,:]_Q-!E]84B8$CI+#877DW?H(3>S9?S=^KP".H-F<;E ]N <6PGD[]#E&
M,^KD>'D?;,PHH[6L3^7HNS(XW858IJ/UF8C9>/Q+;_6Z"%S8 /%LFI=Z6F"/
M>&BG0;M$1G@<8Q1_P0J0C_I)6K1OKB,3<)%G&Q2/9( Y[X.Q#Z]WRH<ZB<=F
M<^%H,0+8Z,F/$,E5$)5 MWZ8#Q<8X[(0S(TNC'<6JP #8E_..3IENZPF=_7-
M\<,,@A]#.Q'?\?<FXML%KQ4E#7.B"3M#M-7W!#,W81:S8L.*%G;X)7Y'I!!<
MPGJ<A8653'HW[,D>UC[Z2<-,B(<ZPG&"XG@Z(/'.#'J(2-%]Z0KQYZH#=H@C
MN#3KP6'6\E,<Z6>Z(>N'(G5L^Q*R5P#=$"WO#,8Q;S:7UVOQ7R7[?!K()T!H
M/X'>*T#D=<:^ KR#S;&>+<OV<-%#Y*=:U2Y?+FVE%Q8M!QGLZC2W3" [ MJZ
M+!9T'45>HOG&^X%):R7"GTBXXZY)@,T58"X*NWYM^+_03GWB?6BG(<SY"A"6
MPD4.>P\/53"NP@N!*:T4.TN<W=[TBQ4MERG>?F??%&\W)<U\FK&HFC@0M$OO
MP;A 4P_MW-*%89\1(F,]<Q"#$/137K^[9F1OCS]IC&4W#0->X:2OH><!<0)&
M3Z3!B^$2Q?'TNZLJR>(]P @B+:9B\8MYX]?UV#&\_J\Y9_X1&>>N)Q_%&1EM
MNA6>=++/7 .F.M=K>G7SVB]#_95<T,C5U$C8ARQ][ @AK+Z*=IN3 ;,17V%A
MJ56,,V=+\RDW9/MT]AN9(7? 5SNY&!,UQ-HUZR"2,]>_%S(/?7<M<W'F*I$>
MV/73?0:,?\ J*$"\(=]?#WEPO<,J.B("XG@-T+X2_IP@[YF;+ZH70%C:I^MV
MHXK'1C)*9YT"[&9W?$:ZUYK#K-5C^N4\\JH 7'D@@(JLGS V'B> [E[M[\ZH
M;T?K]X)N?<B60N^MSWC.[OJX+U;4#5+<=7==7X[W>S#6Q$'PY5D7U F-/_Y^
MBP1E$_%/0\720W'FV.):3W7XEREGQ-N=: ?3:\XC6/&Q51XCNP(-]2HC!%S(
M5>Q[!;&]":%BTX\,3+O13_F:A7&)NZ-X@59#^(*M%A>%/C@Z&N^;Z5MB:&YI
MR6;>JW Y':*H='7E R\6M.JXF>'_90J%#,=U?5)(G:HK\TUAD596N/69,_!K
MI?@#+9O(!VE\\>;J1ZLQJB)K0L7LF9X@!3]%+)R0"(&N$M26'4* 'Z!AG *X
MJ#Q=T88\%(&GSUQZH\U>M#:Y*=)%A2W/C3<Z(;K @^T&["L(T;*<NB]Z:0OM
MO"8.C$ [F@A@';@'^05)C0]$F1T&/XRCP169A,SKX5QRMQT#5\J@E-N%!XH<
M0%-8@Y_+\I^&&%XSOO=4XVU1Q+LZ_W-$=MJUT\;-@D&$:JC=%8 )KX]SP:RB
ME(@L?R:50#21KC-&F/WZC;*;E=7%N%##\ ^'7*^]'WF4)T@9#K%8A,5KC),0
MYF[99=[3N-7)9:+QL>S&@L=MENW)DZI,E<?!,[ :Y-X5H,0Q7;8O)PYZE\CL
MA,B0<$R'1N%!^8Y,J2_9**-N+DZZ_N,2>@50O9A9MH+C&317D%TY.-F['5<
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MYFP*L=KM83]!.G8H(U12,AA.R3Z8139\$AD,.OF?320O;#]-26'54I4E2Z)
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M-6+U'K%FGJ:9)DJF8#B S@ZA.9RA6)M-6\WZHTRKX_U==T;*S'(7XAC7F,I
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ML#V-,.Z<E@6"C.UH^I6Y@1QG=2V)2K%THA[JEJO-,81"I$N(@0SAKZQ10W2
M8UPOV^_J1%\;U!._5E2-?3K"6-3^7'GN?0].U^^DT$XO_\EN\]%4!P=?VQ$[
MA^(+F\.Z)G8O&]0/9.###Y EN )AQDQ1YZ+TW5Q5RNH%8FC$?95P7[O=8*-^
M7KL;!K.R6Y7;S&;V^]36#M62,83B 2!X; )6"'T;*XGHZCD4>GJH4D-L!7=^
M;=';R]#U&?\=<J[!Q;O)\/80]]+SVZO?,( \O(M9APQ%^L>6 -+>,F:+3FS&
M/"O0?^DT;BBQZ2G[H_)/+DTTU%<V9]VGS(:KT05=6_1" S@6G.S#]4VM:NLA
MF 5A>'[F#*DJX0PWO]K'G+L"3W!;9[U93E]ZP TNN5'+]$66EZRGQ(A,A,Y)
MC<T[,BQ/4ZMC(2%.55/2+98FH83Q+W\K] PA>-+>X+)&^2@SX30^5%D[%,F=
M[\VVMC&;H9;^>D%Y'2)/'DJS/.ENFBIAE13ON?5K0#CI9SDX I:K*?OG8>"@
MBYLOFBCN_)+@F48-0=3TN%9M%9'!SO2\%O5/FRBI'PS(KSRA0KG?'RBA=<_T
M/C2$N14IF1R*JGCQ5CNE3;%)3 51;8!>RET@E_32C;34CIG.61;N7$IZ,.]J
M40B\N?DC)*06(%]*^53UO*?7QPBC_ /RYECK$:A6G0#AD*A!1%Y3^L]";6S;
M(SUL@!\R9+3"/U9U[CDS5>8%292DK(4O:%_7GT8_OQJT2#3(C!]LN@Y<)C$B
M=@_K#* =T99<8AIGP8%9>N/K<+TOS7;Y)DOJ63NSZQQT'W(/;_=(\3(;WV?#
M2W4W2#;"GG]^VLJ^:RSX$;B^N.-A@U,%SO5V5,T<4##TW-I<AA)CN F:8"@#
M2$#8$!L<@^RU?S59ZY_4Q9>PN,]=^^_@4;AW=)+//-\#ITA-&H,QS^ =JT3[
M#TNNPT H5D1&)Y:3=D&C3?2'D"0K8X<:YC@V4[&O>)#IAE1^LU"2"U_)!@OK
M7@ZB#M>,U ZJR&=8?JD><R0,S*=8G/=R2SV.;36;,%:S;P@+"?Z02OP:8L"+
MI[Z_TTRJCU'SAH6M9Z?/#>N"NI]OF3B_?%E@KKE&8H1UY$+X5J,F/-D[O$G?
M<(OB*J5BUO%"E##//X]_CAH,7'_?MN89@5M46YWA9CO?!53@IMT?BD(KB,NO
MEU7=0FX-#"US[:_8MNZ/P0E^EA,H#F=4WZ.E+HZ=F5ABW<&V7*CD]L^,;OMW
M\]??SP0^F.\D7:,,"+&^@8,R^3HB&WWGV8Q6EKYF-U;0)("!0L0:<;A=,IH8
M&:.\[3>&-"*\-E![>#<ZJ.Y8R!;/+&'GMJ^4JR$+J^X9IX,E9C.^T_[[.(05
M".*N6 5OI5QD]\GN?]VXD/H\+#8=T6T(3C \%E,C_)2F+L[*]B! R(7SHN-5
M9&'_V]^BWXEM'S&B0"2GEN^SG(2H"+^\?OM7@0XE\D96RA<T*\Y_J$V5L LD
MIVT-9V<'+$^X>W+P@D6_Y64.E':FY$RI7;B5Z@H0)S[,+=I9;9?2+%'S*%W@
M%KE_JL,5LT6ERB'-@,M$,'C>LR3ISCCM@M*CA]B/UJ44G52>*]>T'?W"BJ11
M).S0%<&]MER_8F?&($J>Q%I$-03V;@*;54"S3>N8X1F;=XO7BWZA>.)O'CAJ
M59L>"U#9L5?SS>$E/5"DTG(Z/,'?9L< 6-?N PZ9@(=O7_:L&MJRQ>Q=D+S(
M'3IX%T#CPYX8G"6\O:9EXF9:(^<$9(5"KNI)X<*)+4>@_9RNX:W$.R](RRH.
M8I^+;:V&JC3F(BE#UN;7?Q6%-UZ>>] @O'T;P/2^Y8Y,&%Y'C."&^:^V2=7Z
M3W5/(J)Z8I\UZD+,OS7O1$:\'SD"O3FDJ0(U 5Q%1J0UW*[%QT73"*]0E5C4
MFEK;2C(BK7Z&.'Q28ELF-G6R8KCC")3F2JGQ,D"STZP/Q.+^,Q'7#V:Y&;\8
MY1NZ:GQN[GZI1*JY76B-CL3I(Y!)$8G:7MEM$TO3<8C) %[-JK ?\'(;47IO
MU$&>TN1#[/M(DRG"KVR+_+>4QQ/LN$UD3MR6J&K3_<.X-XC4^AXZO?501J4\
ML9]4M_KA2UF^WJOU3BU;VU?$E9^2324^](L$U5GU7E%#JTR">J5$IY]+FXO-
MC(5Z@72K9E+9NLZ-"K-.QX.YYH-[;UP]>_^N;BS58+:%/R'-QY;K $%BL.I-
MI[%K8ESU*9\,,P>"!*+ X9-$.>WKZO?G8D-\QIUJD&( C!Q&.,#!1-R#CD!?
MJQ)I\.6*B+NC-,UW@:Z:*X8"(_*-WB9%RJ/M'6OU+^K=RKU$02J=V+9C)<[\
M1R IK?=7.KX&%VZ(!.NJ_;S_K6_XIPUC\(OJFCB'D9;Y)0Z$T<X4>_:9E[5K
M):XD$HK/=UPQVFSU=4HCU>S"S6(YK:TWKV2+!9O'KC7K>QRL,6$R(4TG5CG;
M(@6O5)"F_>SP*XX09M"3]O!OZ7A*Q/H-0?[5IP]L0U>=K&:M(,,9-/X2!KM)
M@223F5X2#[9M")(<#F1T6FKFNB='D [,BM2&T6<78U>>\>1'N 6<$&H_<2<,
M%D4S8@IZ>U0O2GVDQ<HWB#1@-;H/YW&9E]YPY!-)SX\R\-LZN'^-UTXN/CCU
M&D+G>\?VH64U:#.M79IPG/?GVP@E3&3HAMI8@[OHK=-?,UGN6X N6CP\BR!@
M$YT6?>>57_I.1^'/9M_\7*$2..'?>4MA;R[/VMIP)T?&\=?+&TP6=K?_\XSL
ME@2\KQ+PUL'J#I!5BD^_=E=A@R07/>TR9F;4S+HQ=QE56T11?EL@WV1E(RS,
M!8UA2X/ZV4@A68$C$!&2T+365<5#,R79=!Z!$H6?!QZT2?V -R!RS--O]O2/
M;FX1W ;C1G4JI94$L[YK;J)K_7JJ4H] 0@S1 $C-$:@+/;.&.P*QH_T65%V9
MSGN&<)PSFZA3MG<=!]DH1%-+MU_-S7=?^MOL[2TKJRAQ#+:@Q! D[8]7:"XE
M_(E.R36/"H%8-T2^2$=/FMF'O;TM*K)6H<[@V>%\=FI1_,=;12$6JLK(E3_X
MGKET_8/UY#^[GS$<.3;LL6GN]M\#B#*)/7=^O/)*Z-;1Z;,OE=MIKI^8:UJJ
MR)D.E1]UNDB$^N)$$SAOJWE*$TAV'7B@5]1V/%O([N.[:HW[HSDU)8F.JP^>
M"415_"Y7_XME1M(/PLX8A=5PUU$U4%,PSOW&6NC,K#A&"*&WYOQE_$\WFLUJ
M-23N[FY1YBYC\E96<5UB\SW?SA?)M )274*G%812!\21(;W0KSFX!3C>4KLI
M/R&F30+A9S8AZV3AE-DY=;/@]^JB*#)I^[W5=7Z62^9U7Q2II0VDR9B@58Y@
M?O,G _Q=LL^G.\1:[+@JTWE-]A5N;-V+O:G]#*E6YX (NR;SQ"* \NXYZ[$C
MT*V.=AG)')#4?738=P.;KCLBGS><E<I%+90&?_6R<7Z--VR32C]I+354X:Y?
MHD/5JW$,K-4--*+^R'R$Z9!P(PS))WOR2^;>12 ]X1:\,-'$_ZI%;D1L>A?K
MM<UJK%VXBB05ZUID7VJJ"9R< _+H)1%+,WN]BR?&\'1FBWD'PE2^K&WG?^E1
M,$0/EN[()JO]GH(QE_\R)%O'[@7<9K^D-")R:/8$\FH56ZH*R&-[6WTH6?1L
MFFHYS>A'Q&6.7C'#_"/0*;^,/ZW>0QM#OX/F+'Q\Z.^OX\RVZ37WN/H0!V6U
MJ=HL,3!_##L .\O?I7=N]-1MC6;+:AD0NIS:0NO=[-6IX."2MQX=>3]6NWE9
M[]+?%TK!Q'KS4VP!H7P9ZG"C9HRE=TN!XO);89X5P* RVS:Y.*G#1\XUVPL&
M<1)-"M]P*WBUZ>UG5U)COJBV]C/%]F?RSV0]A,V34 FU-[=ZQP<O>)_W(26_
M(HV3GA=97TJO#HU3N/\T<J)97@X5/!P3 07D;+:,RS><#EL/.JBZ\#K]OIT=
M7\9HJU3$Q$#N.90$2+1/!P3V<H PV-6H'#J^4#8E2E.6%[WXT8.2S7/J.\ET
M:?=M45T=4<./V6V>$BZX\2*Q\+VMQ7P=.9&Q=*_DF\EIGU_=<G-QL]+X]=C]
MFW9<L5V$WPO?S')=JODXXH;[6.ED\.[B]F;C=X1X^Z(H$(3?X4;P=QS>'Z6I
M$905EJ[_J!U_&/%UK,+AL];&SM[%FZ@]B8*U"I04N@.A1--&D_S:\RY7=5WV
MZ\4(17AX;RRU'W[,"(B*A,2%KYC-X2*=KL[*GYB?%6$Z%>0B:_]4SVDGA;-4
MM!=;[./IGV=8UJ=27.R\H2S"VPG?/OOM8D]8<_^E<@%YF8?S?JV&HL33+5"<
MC@'%@2S2_]IU##?$@^M_M3'^,GC/)M?:?2S$WGH#S=$4K-DMH6N<J!/-_[RS
MPD! [6*<R/!T63)/AJR##^M;G]^F6?H>J@END+[AK0M4+YHL/84A;$JHT*=<
M ]8_(\VF_N@'@9,\SZ=T3?&Y  4646NY0J/L.?WI(KANQ\M%44._3U6:4GCH
M[VA&) L*C>S9C,]XAN9KD:'J,7X4G*4*%1-:T<98;4^)B;KHF,OYZVEG@YS'
M-YTN/2YS]/7?&IK?/HZMC"<EQ'UA040:G^&QWM8:]V%["DI<26\U)9@9R!/N
M>,E*28[XA+^XZ^2A-ZOM8J(U("7=_S55ZM0*]_[!]!+OKH$W472*,+M?'463
MVY^=J#F]G_DRT.%NZ9!=JJ^)>;2\]?R+&Z=_F*L.WS<46=-AO_.\",=3$O^]
MK$?GO%WG5?#,986Q!Y2 /H>).CLKC_7RJ6B$XRQ.Q<4&LCMV_M0LJ[GM<PYM
ME+I].7]!+EM)P]]!QXM9:EN_RE#(7=8'_ 7EL6/U.LN?^T'W?J])I,?N[6S#
MTF^8]S\-Z+]E_\;M 4W+>B$[[W F$#5L;7'0]['0W.3B8]EQ)XW6D+KMFLFU
M7<$C$%MV-H1D4S6SJ0,A9Q6(_4WJ+&7"O T.IZYU7QBTDJGVIVKQ"#1MO&S3
MJ:Q..4?/"E9ER"/$1G?G\-I=KPI&8?P!['H6X/@M_+<D0E"U=,N#7FF->X4=
M5\U^!>7^.T7V;_X@0X#Y=#!D!TSQZ.XE(693("5%0N.4H41))E#$OX^/'JBX
MT=EY8..FZQ@@?:LNDV/F69QSIO7B*E8B^ B$'X<_>>A(<G5F3*-KZ](JWMIV
M^ ;YEM?5U:6J'9=)GA395WYQK>S&,_?S$I'E8Q\7+NL)1F\NP5I>,KB-_XU
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MRH2([[#J*U[56$+Y[TO_F;Z*0;)\!NWJKESX:[UCF=V-&D5WF&/QR>@:/YI
M+!':"4LK4)Y"6OW;7MZQ.6".A))5VZMQ317[67%3E((WOJ5SM?5]^@&SK],W
M%M>++RGT*'_?9>S8,PT\PW2!.9(9P:=O4<-'(!8&"S(,2"/.B<.>MIT=H]GX
M$0>%9N>#I*0GMI"7D.J:B\4"+WLEK- LK1/?S6'ANSHK85<@UQE]$'$4]RRC
M'UL3D;_6#3D^YVY,4B=$M.+L@#=FYM)Y$-;UB^[7I>NF[X1G7Y#I O4[_)94
MIQV!T!W]S,7:8Y_58[YJ)T)O#\\L]XC)=U?-BE/*6T88$O,(X_:#E*K%=2F>
MUG'IZ-+?W-DAU[1SA)\[S_6*/^^0,I6Y+??(#(H?KWI"R:90'D+KH=MJOD%^
M(?7UCE\"?P97!"^+I.L4,49/'S]_ZYK(Z2(6S<,+5$%TQTGL;9OIFNX\[6XT
M&(#8 1AR\XWC3D ^6=XVQQ.;3;>>KN,(UB(-!_E$G<8L#/)&&G];?6)XCXY!
MXY.:T$E0?"JTIHK&O]>+%F)BPFDR5V4AP2;-$$HV[7)[_1EI'["\V1R=;^I&
M6LJEI(3K>>":,G(>5IS/^E#G7GD]:JV]"M"R)Y2T'X'2H!R&EYQ13 E;MY:B
MVB8"3)F2T[#Q2-.*;L.$JK8,Z-L\DS+,K/72S 'G\7Y!D:T3("--NH&!I>/U
M[RRGVDEN]R6%WW6FGO\%(KYU6'Z0/7#)[)CX_9NQU1FRK&L&CVZRD2U(6E9+
M)$15]^VP+/I;PW,X;1[46GSX_*7#$-":9-1P&*P:0PI=>8+ND#H"!8[5Q'Y
MH SB0%[[ Q%_PP[J[SRW"<L[9.M$DV[ 8MO S$QY#3"+/-J'6,4SCW0CRS_5
MW#GA@7#T/\-H?]H+^Q+?242HG(B'Z_+QF'BSO!Q2@UFAYI:^RL>B0S)F2HC@
MK3XRQ&6\UH:==NUICZ23PP@AW>/JA-+OS'6A65U)GOSOQY3P^_OOP"M[. PK
M$DX>8W!N C ")($!&4>:$]/D":9QR."@XH"GYBK%8P80\EVJTY0*WZFO4^SP
M(F.TS/78[URI[\J8:64. ^0;:.)KU/N,GB4.0VE$#J'AJ3)#[9>49"U3'_0$
ML^"6^#0EA6'5Y,I\4(IC6_.8W+@2Q14V(.[IUB?AZ>XV>^D(I+!V^(.> ;T#
M/X[JA7[%=!Z!9N0[&]01#80C4!>$?0EA.(KFF>N2G>UY@8Y\'!G!6NR76_'3
M[<5CC4N=W<LON,7/)E;U8&?5&5S)]#A#59K1E*$L[3P9C,N8P7B0(P;W=U*"
M#84W1CL^!!X([[7B"C5V:MV,?.!MCL<GE;\+/[F"!R%92-&$)1J/.L&4)NB&
M[]U*H)YG]*'.,F7^YO5Q//DRM@>2L'AI/ )[#*DQ&?[+S39IGQK?U)3^RXA3
MMN6I,:?E2(>B[$N3BNY E ;)E,:OS^!^33[(8&C"/ $W@O#V8Y+CW'52!@[&
MVTV!<IL3,8+=A&T+VUHK5YL_9N]&(M+.!#1PR7ZZDB?9&]Z"OHXAV4  6;:M
M,";PSWQI:@/D\.MUL*2\[<(ZLE,W6K"/7DH<O)VC>N:IRW]I'XUTS_1QM52*
MQJJA,1Q !1-T4NF?T-[8I*6&R03F&];_$1SR])LN[/&ZJE- D MPC.HR8Q%1
MX@Z$];3)C64'A\P^=CFCR)I3'!C: 3>XH)U%B>&W]%$J;H>:8/&-1Z &S-88
MR8?!GD"U5E[KKCH>N*@ E)*&'4GR75"N=3$&IFP#=8$LGRB3IO0N?K0G:FU7
MB%=C2CA8Y*EDLFS$0A;M'M,$6V0XD$M59S)FV1+$4 \)":A G4.PJLZRN)'2
M2P2_+J8).P3E"^E$^/C/6TD5J*P\+EI5NOFBHRH#"J\"Y(] --Y>BC#]!4,-
M>05#*9[ !E:E%YP'?,N!,(HSZ6')\BG:C7",4. #U]X2*[^/ 9%YSYWF9)ZH
MC KK@\Z:GT!?6R+!,5LO(O 00$:^TX;)41"DN.30&W*.#1F>VF**A_&Z\(EW
M07C3:D<"FBI2-TZ;R]4J].@*7()<J-Y-!M'^G55B]@T*1R ?,' >O#6,5YWC
MIRS2FUNBR&X]BZJ/;6# 2]*;;BB_4H6!/L$M):4/XS ")[2,C_X>TO_T*JJ_
MGBCB-5U-85D^ @D!3@SV"1*&P7V&GF#X;SNJ;L4?"]5X*8XI WEFYD/<_<6Z
MAQK>+R$M<]S&K8C3&]H9TNZO:^O'O+,J5K,OR#OY^LI*'X%,#?^-2K''>@U@
M$UVGDE#BM!M 'RFGW5 &Z[;M1X#%U:T/)^SX9-IK[C][63=O5Y$_XI=JNO)2
MX+JM1;#HP=P1"-#:H9PD[60<@>YF)$&.UQZ!>&@"9.C6U/( 1'(]+_T%E+*P
MD[H3OI8<'8WF]5SL$]B!S,H$^/HNK<+GJATXGR"9L6%SWQ!RM68R\HF8\7W%
M3TKA@U#*[H@JO*JRF'?.U<UUD.!2&2*?E6CF79_D:G['^_CY 1Y^S2%TQV*;
M JDWA4GN;S UOQL)EZ/-R-PIVMLG"T_520HQ%AD]=_]MZ3"_(=?](1/G.[M!
MU5YAZQ/1I)] =YA"\;G8FC6:P Z>D43"4&(:)F30K$%A"$R[I^*/$JI**4&5
M;V'6U#>RS*7GM-S(MSIC_NNR+Y[)/ZAW8/F[0P0#VG \6PK4:X<+U>6I""R0
M[7%MITC8;@(YVIILW2#[*+LE+R] L?C<"YYO38CM6EPBFT/ZW:Z8;A#J'5(:
M\'V'#&:F1!1-$; @1@=%+[ 0;;9>X&U.P8KG.2Y_K6PF82V_I!/>W7;H\]+L
M])#O1T<+W+ODX/1WRH,Q!1&&,K-(WF^[F>DSRQRG)BA_"/3>&S2SBSQ=6UZN
MGZ+*XTE3)O_&ACTF0GCF7K?G5F@^]AZPR)MTYAZNV9"3^<NNR2B <;6P^Y"Z
M",-/VL1_3?'-KV/!+>*$*M: !ONX=+<4,->Z4-[ESZ/OLV%:%M'7 AX6R,J_
M=5IAZV%&_2QTJYJ\R524!#!P 9):9Q7:=@;PWNG,BQM^(E-3ASX5]"@CEIEN
MX0/4[=%R>IG-PH(EPUC=1DR+>!UD5?COXNL[P&.F\8:3Z-O@$^N469O4.IL9
M[X.NV?=N1Z#_+(@FQ85S089GFE"LFQ7V3@V(N4G36[(%-KO_SA*QT1.P^#1T
M[4X[1I F3/]F* 9$WZ#7H7B1IN2':<OYZCV,BQ,&,H_+_&&S)F!PBKANR)97
ME-*H>&*E=)(HK6N53<'!Z5 Q\7OP,IMB?JJNY+&;= =!2#CG[> 5,=HY>B,4
MO[@S'489 ;)"R97B,'[D:6#PT[SF9./R<%QDVH>!2NL-]<CH$F/ENN9 N8Z
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M5:J\!.G/Y (51 (>G101[(-T.JS/IY=]]>=98(<^.G#U+7A-V5LP$]XVO/.
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MPL_Z2^MHA+YYI5?T!8V_RHNLZ<[CR)B>J-[%15T2.)9Q#F&,*SA&7DL(QPH
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M+.W&='^7W11OQOOT<]VA+(K[1=$D-)\D]:L 9&\5XX/]!_<![QKBA?-;+4J
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M;!]Q9M:(!V>*Z9PTJZ<WC\[B4R,XZV95BE5@FP1G&O\F;SV(OG6'[[9^-R>
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M 6Z?]0^NI]J)%B]]2I?=6M[QK VN]?\ #]S<]_@3@(7C/N#)0[1]9Y0X.11
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M6=Z31S>O &,:N?_H:Z#90D0QC*5=APQ@J;UFYC;\L_BMW/6_M_G3L0#4DS.
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M;MILGL_0G25&#(7(J&/D\**YQN.+#N5OPFKI!>9'M8[:-?-Y;>XC_#,)KZ\
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M."]IO%U0G'2=<ZYHWT7[(KS+*CO[VUU"_.BURR[XM]J5T[%1"AY_.=O"ISP
M5-*BKKXQ"OC$+%EKH6!AD"CA!5_\6QOL6_T?)^\?W/>3!C0$7P&*AFMDO2^N
M  I6B2@E(NF80>[_K*ML_PNC+'G]9X!/PSH_ DZY\W37FAFSBPW$V>.?X[CP
MW1#Z$* ]U)GYRT]I-,^B>>NS<%=Y<QTU"9-Y3DU4"S3 1I^L/.C]@>HQ]<'
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M]7I\7[9JW<Z[!"V"_COP!J]483H6KKG1E.IQ72"JK_#M>UML27P-JSSY>_5
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M=L&XBKCO7E^Z,"Y:VL43PD:_C3:TQE]7[I*'JX^GP;)]*C=2<&Y<,/@6O2@
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M4F:G..S HOE7NPC&X&(.4:UM?.V]A7JMK4U#M&DM96TJ/]VK6GM:F/>TR-,
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MJ0_'"D!+_H<\070@2V$:5<534WO?[\,@";:O:M'[Q<,@SK_*>9$MIV;W[+^
M X-J0M.F:4'/PE."(GRZ_@:#W:M^^4#9*.^E@72#1B.^,&_7XL3PR4 T9(:[
M^U2UKS121?K28CDP.Q"49NRZ#&78F'2Y?YRRL)FBGM(#DOSBH1PNI@YV]5#!
MC:6BC*11/)ZTI1=I/""(W3-0X^%1S;?\&1HRG2'!AOPS'ZM5CEPJ. .QD]D
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M>"\ [(SB\=2/KN+,*H(G6WYK'?<[3U+(Y)92\:R4=%1L2A$5J+N0N!"&"SH
M&9!T)=S'RE6EK"7OZT?M5N2O:=WLYV@)N'5R;K[\%GB#S*EFI^D<V4':P-2)
M=82C<%Q)%0BN*OB,*24O7S&J:'W[/N"W1-E9%P\J\ZQ2/;]I/+SA2K!0)N8V
MY(!FS 9];BVLS'1=S#N][#BO<H0GR#Z^RUV;/%;<'Y._T5IG:W_F4^O,O/&X
MPOOZO_W&*3E64?A)\S_WJI]_Y#!Q++PYFO!'OR;K?+HZ14G%U"*LJ?D^+;(;
M17: L:#)_3$=BU9(SZCSRJCW-M23>OW-_*BIE1#*#^M5JWFNUE7U<^5[A7=3
M$_L@$1PSACD,)CMUA1"3I]GL 1]U]"<OK=4V98!8%)TJB,T8;PFUR\^_6=)N
MY083&1\LE"0:/]607GR,TNIZ8&T<-*3PROC%!G3X2%__3(6)@/E3N?WOC^Y]
M<7?'L1N](*;E;/=J#" __@> VZ=^PCFDFWE-BOAYH?S*=U\_J.87N7(GR+M7
M=RD70NBE6=D^V43Z1%#0B1<RJE.9O[MMD]0%KIW,U\]0VD!6V-I1[RRUIH\L
M-C4D#9F@\BLC:?>1 _.G?FO[ADX2Q5[F-TSL]%M:'_-#F!<ZS]W@7531[/.'
MG6E/E4A[,2W_3$+"3+XU5"S*6(.N!$2$Z+[#8=X@!2FZA;Y^DV*Z3KK-#TON
M.V.+->];\+8,$H29RA=$S$%O^51862;J,6H:0A CQ1!=G/$+7<F2GI)<<8'A
M<FL41WCJYK\CI8[7.R]QO.I>7S(7NL 3:7CT<KLBYHXV+ (LB<*];>,#2BEI
MA. $A&H9_#T!&K&K'GT X@ML%0U;K1*"CH]H,\=3U!QK?1_%]4*5EDT#G_2@
M-/R57DGK92SI:!I6Q<LJQ9;=1H\_C]OQ&LV ^MK>,"B8Q5OP#]C9F#=\5"JS
M!(\@=(CV0D]"@@P7M/ E=W_(WWS>X[9JAVK...>M&6"=7;?FF>Y+L0RL-1X#
M:ED)UO,#T&LKY@E'/"1&5/^7)G,H3R!S'5^54'DZ17(8J+)7D=EZL_3.W**,
M5R)5IQX^D_C73^$)YL9A=0C@K%7'0L1"+3H)@<+!WK0)LS"2U"U)TTCM.3;G
M45B]%H'753?9LB5UY'A!NI.3V0^=?O&..Q>>W4!QZ.G9-Q6.+^4'!VAC$TES
M [ND[E0)I52?;ZXA>>;_99W?7/9S#A8?$I&N"# TN>2GIF *,K2^-20KMOET
M]M>]*J5G^TEF2B(TA;9$0YU8--]$IIY )'.HZT[A.^N/)X*\ED24+XZ57?K6
MGWTN2/C33G-\?=VW?<E_-RB* AYURL.%\<5)W?9Y)PI#,S)NR2@KG0A<*<@)
MO*U>XV\W:LJXCQ _?/-X%4VV4A>#3_89R\5!L>".9PN '7;$^8VS]83.G)WY
M[60"W!>N.>78_[SL_".C#M5+M,[_=9"_B9RQQ]0O;-#E*9OEC6@)!'>P44R2
MD^,IYUP[@YA49YGGW&:O#$6MS\<_>?\;"??/[1.AJY'>'HW[>T[#&F_>);PB
M_KS@F8''I16?S05 29WDC**=8HXPQ2D]XV,I</[N"G T\K1C[9?&--/F= 7)
MM,^Y&]CK(SIK9]DSDV54AHBP_'D;TVBM53+=VW9 *2XDD_?YE7MW7]^3Y4RL
M\+8]O4@4W?S<]F3';@V'D=W.Z [1H_YQ*&^Z""TA?"J\.X+8E3_CA.AW>CLZ
M;^ZJ7*7UKYJUIGKFC!BTQK3];(4A_^<.&"6X;P\ZG<=C<QX64-0#VM[:+7O_
MX!;Z@8!"9JSN ,;KV<M,<=G) Q#['N.+H3+- 7&4K/?FX\13_FXCO2ZR(WRR
MJR*$VWMX3?)Y86YOH;_'UU^93ND_J/\MG166>+$HS49_CNHP0?E(85C.BYI%
M@2;A6KZACL!]?I&+NRSU;:%S\% LKF7O[VE$M[?]&]@=QA_'RWY'JEBJ_$H/
M.2JIM+%,<W5T!)H<?!%:E/@;\7C&8'Z02OC[ZRVI%'7M]7I;R+HZS%KJ_!>L
MX"-_;)N0!EGU 4(QI-Y;)$OXP6KY8*&(Z-I8L8Z(H7QBP99)3GU#9>!FQ0OT
MO'O;1=M>>"&/L(_- <BN.B@/*IGUI_CXC8+/9=-5GJ-[%77E5-.]FVA_J^='
MY"]AK<B1*_HG@FYP&A:<BE3A7;-/B5Y\L"//]>IB*3>'Q*4-$"C5? -$M\)#
M?Y"T24HOZF#-#<N[Z0J%QWZH*-_061F?1,9T+I!MJM& $IJ4DG( TN8B@/:(
M)F@)H]M&ZQ0#)N_1)V"RN7FZQ@ETW4+OLWPE[@PR_J+LXM'P9T8<2)8$.F[/
M,'7^T!Z?Y&8C<_?A_<<R?R^!W*I_@):+73. K ,0YTN6?&-NS@E>!-<-]5[E
M+U'&__K"EM>"Y#J:8KJ33TG#\W=M):-X6SS(\82L&&V,""#?UR8[UG*IRDNR
ML%SO;K];B5,_>WG>HUK3\P_IW]W?%*1\9Y/G"Z"[L&8O19^DVY.=J=]8DDE%
M=1CIJ)0*M6-X6MP_PXGM338#YX>]LC2 MJTNPLCLS>XN(3A2ZOCL4<.9Z.?3
M?E94(B%9&([JD)6E<"70[4NG5_(DR)6)J"J?ICEZ&4?>^T*OAIJY^?G[_:?N
MF5601LQE_HN(F,"\3@9TT9>!7$H?E<6 5VW(&5?N^D8?L* 3,-0!/;&+![\O
M\':%I'6'5I;B>]C+3%6;5P4\]_R.&&3^B94RE0//=PRQ^[I#5,A(ZH6K>S9Y
M&Z'_3M -#D"149A'48P&#.X=5,I0[R/@#3Z)L 2L'B!5Z1<T^Q?;WI<!#X[3
MKP1(+3]3Q^M,W.'?]Z1Q'KL(SI+,Z*/+./CM@C<8P;AL+/?,5O4[0[TB3HN[
MANA'4;4^61D?IR2BD4^7, 4LC*!E#NP2H-,>'=G\I,QLXT)*?K>KU'B@>KPH
M]D931SZTLB3+SE[W;<\Q!V*<BV: <,118D#P  AY']71 &YXR/B"PF5!CZ<Y
MC)UNIBRTNREU#(EBWUD,P6#XEAGX;<)*IJ8?YK?O.''[\OF44@DG^CAK99E,
M.?A[:CVC$/5@ 5 0ZW2>V@H:2D0+[D#?H,2T2WC*L6K)#X.$L\].\$CW>805
M_*AP[5&(\MV[(DMP?%F5@\(E&RO#@#,>=%$:=97%]#" :DI&=T+B60EL.MT>
ML"_D''C55V@:3!CB_2%9+?#S-/G4&"E?%->V?DOZY>5_*LQC[_"T+4!9B2[R
MGKIRZ''@HZ30 ]#+%HY*%P0/(UO'F2; $349K4V+CU<UWKZ];Z\7JIA8W"'T
M4Z-^EY,M\\Q+HS0F7S+@@8>].JQ&>0RA1#;)Y<S 0Z(A$B@/_F.>V4%?9G@;
MT!]Y[2;.?I2YK"J "!C+@^OLN]&XG5CAC'V6-2O+%CITD*HZ1?F^9!_F"2/:
M*;A*>].;4?$9!V^P9,L5\2_ZF67'&6,+T\&)14\N:W+,B)P;U*+)'X"X@GU1
M@(+H9_O<A3IT._V+G74?"8NMQ<?,?S]A(/"]ZB4&5X8"(:Y5'AZ%PN!R40WJ
MG20]ARRB_8;S)[HL92\ZB"2%FC$TPAM9;&#(&3[VQG?%:T:2,HKFS!B/^![?
MUZ\ H2YCR"X8;.\D5?^P#0QR9.'DHY;F.@HDOD5+J5.=P^*A7L9G4P(ZUC4X
M)K!_YG+!S8$G?H]S"]\\D1->/,F+DF'R,#(4&<DH7!&*?!GS^A^I(2?/L)F1
M;:A!1+]IBD:#]1MC6SR(_((^(W/0FUT#3<W14O^=+\Y^XO6.]#[ /^(?E/:<
M.>QD2A?9IKYED2#/_'X XJT<2C \3L3PP6VH7<#68R6[AG%#Y0^K5)42!Q]*
M[X"@3BXS]O-L>#;Q:=S>E<YH.2DTV7; >,B<I7=I+$26[F2'/N&PVF3?0>*^
M_:4Q FEA(061@!=-3!S+RKG!8Y8B9\AA'9HPS,5Z@.OYW,R4-Y1\D[:^_J:\
MO!SSU$AP;?/OTO5H[,3$?/@YKTWWW"\IUWCNMHPVOZW^G/4(I,.X <"H;8QT
M GDRQA;CA7ZY?MZ)+U'Z\P%(%"%L%E33:+<@,&%WX]&"LN9I3>GHRU=$Z!4L
M&>%=I49;O(I9?VDAQ,K/)Q? &ZDED5VAV;U;4B@/'_*TE_U:C3)/JKEOL)RI
MM:31.VO>\(\?#ET>"Z1P,[BOCA61,=W'-M7KPO7_KA(IO:W17YMJX[QN5LVT
M3[==%?&/6N.\W,[UAY\NW4^[3.=@E!V ?*" $FICFZ:YYB36B\**=1V Q%MT
MRJ$^$%[W6HIAMFZR/\%%'[X3,QX8X"\S,2JU+EA@8RY39_?\YFP9B4G1_JY6
MOC-W;N*OZ;?FQM$ZFL'['-S<7)=GK.%72/"O%)>I+](IT#34ETGZR2WF<=+A
M]1C*#D;$F(.N9 ^D^[8->!$.0"(+<_"T>R-7[$S?F[ZW#<L:K721&1[RIK1-
M^K^][;-+['?IR'KV*.328,AW'/F;T4W"2P@7!O?G41?SV!;-)I63+[[XZ)7!
M7[.Z4QU[\ERKP.1?*]JI/CVZ4#\11C]I2@5^ZTBI\\'YJ>6 3 %R$"4.JR0X
M[#2K2JJZ:,\%WVWZBKC"61RJ3JJ4R[26O5[]H/BB_#^6'X_,Z#P =>5BO*LC
M#T!R%1I)_$>O/)M-R+OGT0@=Q/ Q59 _]Z!UC71)"]HE(+*KWXT_X0#T9"@:
M*08P\KVUG.J:LJB0B"H=BRW!E2:=;C,_U<IZYTOYIXCN+M27F*,O(64P0!E"
MLG&CR2$[#D!U*-(IOJJBU7\QKXU%UQOSV)J^9;@UCB%<RE>K8'BIB]/?>8WF
M/QI]B^#ZUWGYLL-+U&#-%M493?6G!--/QO3DG?V]:R1&*";9TLP!+FH*4.93
MX6SN4>H,Q/="1>NBOT!KS40)V(EP&9(:/O9+LZ+=?L0 LH4YBVD(1)/O+4PE
M,X_UT(2 T'T(_BRC#N%.GF=E0J]& [T22<NO#37(6$+O=/'7N*-_M;)J\OXN
MSD: ,]DNS5\Q6J9+R^";(5RH#DN6:<4P3XS&&R6_1IZE\Y,'\WJN"KA]1)B0
ME]X_E?(#;<LWF+@S3QYSU;@L>]BT'K:FJV^: ,%E2%:6!HFBBU91]451)="%
M6;/J#@\WCU+//;W@Y\TGY:/GQ0LR/9X+*X3%@H2@H[J']^$Y&6_R?P>:H:F?
M@;.IB6(6IJK$ :%'%^OBGR'F$37D>Z^"E=<"VID/631M8;@]F7KCK" USTMA
MYPWX"#13/]21VQK]4K55C>.K+(N\0G-4SF7 %U-'-H/,!2)//6A_=:3J6_T6
MH*/'/&Y @,4$9[J* \%$*RZ@\3[YJZ12/(XR^0;V9+B^K!]$;6IRN.\JY9@]
MOW0]Y4.&D^9G>R[M(_LL!\]UG;FP4(,BY9.3<4,;=VFJZTX>)#::N?<!2$K;
MH.(LH-BQZ_;IJF_ESF\?][*9/OE9BY+9V9ZE^!#)>?$'/K%3)I5NS*@V/;H!
M!=5I!<BA8YEBB,N)GRA#+R$/H7R 3<_$B!7UG2K]RB>XA7GM&#$3E[;T/>NN
M6>7^_O1Q<7;[OWTLBPL_ $4YLWZ_8+E/-+R+>9Q&"Z5+DE\SSU-@\=T'H-I&
MD@[!Y=S$$A5,DE" <EOYE,QU4JYY$<Z>N**0^;Q\(C1G7>#.^[N8.BAPKJF*
M;I!&'1(2/ Y($2)/W3GR/4XURDSZ(_8"/R3$JA"$O,5R2/FJC<QC0V1ZDC^%
M2/PNG1?3(SH'01>%K$.'87V82##?83G6U]"3QOQT.W);%LL%L,&W.K&3,;L,
ME7OU<7C7P;5!=WYN_:PXN+OR>4V3_M/ZB[IZ;/0]5$=^@BE=X#V>I0#OF$;T
M8-O[#U(15M[/X.TKYD8<*#-C0PHJ!L&!PX@!HSW8ULQ(/.P$/,QA<I<1</=K
MTL+M4>TYX\Z0S4JURL?NB:(7.Q1@[&\_&S_I :'$6'F#%[H;+4)7!UC&SR'
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MR*C<")?Z[JNP&AI,O5NC\5Y]HZ@N875IM'_?^%=#D?K9GM>>5-(9_[?\74/
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M2N1GT2UOB>@7H!?)8V=Z0X8:+A8&B<OQW0\8VUDV9J!N@I@Z$%P<FGPY&6M
M/=Q3>0D,41,8'X-0W/!(?%57A7S?/_5V7G[+UJ:Q@E$Y2E%IJ.^?QKJ66+E1
MV:Y;J=./'&0Z;RMHU,@=;3LLVM!^^-H5Y069<:8>6LT+Y##DF%2G/R!$]0;>
MXU BB!N^S_]N\IJ?1Q@0<[6Z&ZNGNDX8V@O*& _"\;,_F@BV?$O:YQ9&,DT,
M<EX:&;/$5.Y6H8B#Q%1!_QOFVF:I*<<B:U@OY# +#5>)(CO^-;87D3NGF4/0
M.MEDBEB?:7=PEFXB(\8=53AOAH4WQMW5_F1P*;U[WG7_Q)%S('/FZYUF1U7M
M7-GI,8GRNG6I2WP$$5=N.#Y+:4LZ_8Q1P'90A>"+5#'Y!'!H*.-W\M]0EL*P
M<@<.*FM6?5=4AV4;+\!RL^QG1@R5:,YTH<GS]58Q2/5OP5]\;4PLNK\VD1G,
MPJ,ZW8K<K^-M1BN)@N:P,)@HF\G19!39HQT] R/TT06Y6=E@K1A)-T\(ANVS
M!73*Z8J^,,LQ]:T==2$I<=]R0PC!R.DON7YZ3$?J(F+.K41,H>YQIANT9CDE
M@3B?S]M8K326 UZ/ S&%,8^2I[B8?(<G/) (KA$,"U%,5QUVA;>+(->:4/1B
M$?9N;@0P?Q]!QL3(OD?OTP'(]@ 4F_CGOZ]P-;5[9F\O3(/.V":9&_=06.YC
M[@#$)87JN*K]_O Z)[6?46)\$F'(R*%;E7HM$]R'.HTT+=FZ0Z,CV;XUC^(;
MZ^.X?<V5K-FFH6:J'J<0BX%2SK2[/&9<2NC06WFAVQ,OC549D:B'6X=WMJU@
MTWV=X%IH.TEA!@CHNAM;G_@(?])[7HTBO!)?"D]S3+GL6+7E*-RLI<$M*&=P
MSWYZ.BO/OUG@ Y-S SQV\9\;>2DOW[//U>NV6=\?TF5P;S%=%HQG!V+(7<SC
M[\C_7$S63:VDF=-ZQH)I#C6V--=T0U,\2>6&?N)G08'*ISV4;Y'^2V;V%W]\
M)C._H\D!R5VPF%6:%D*648(\!L3C;!NCH1U,;LI>7-WS!0$<^08S9^)%(HH@
M'&W1;^34=3O=%':FKMNYZ>Q54-78$*!F2A>R(*+IPD\6J,+QN,H*O,M9Y, !
MJ%[T'26Y3Y40]L-7<KE+U]_K(>%WM]D!R',L>,KLD_()-04^!R+7GM7-ALQ^
MBY$-EX@P2\V?XU0TL>'512CZQ>V0H6+A(_O<+'=\6/3R#AS"/(ZB0>#)G?K%
M;\X A10,T;AR7@O8H\C;70E0C]59GT*3G P5PS?_N;R_/WNU]]%?:+6>_96E
M%V[[QRDL9YS/TMUCC+@#D,_6&TB]!UT 1;2/,N3"8Y)JUD.W>B"1:,'KC?.B
MHPB+S]Y@O]1P,9/C9S)+?<^GW9^=J=CP#)QX]Z'QUZE[J ?_H5!#+)1IA>6Z
M\@]-^<!/U%4'Y)/I(OG,$_:4?+Q:-6NB*,9'!*\_S9 N/7&:8MO8.10YL>V9
MR=2:\*U\E"<5[F/Y^HJ;V'\EP[H?)2W\>5MJ>L1==O]5L![,8:WUDA>$?!<S
MO8!/BB3[=!/Q8GW)TRFC-HP\PRN\W1/Z/(KS$Q-C -1!-TRI\4N3A8J=V,0Z
M-3X$/_^QI8^75C>UXD 9ED9/4HIYDN*$_RT?@"I82O)T 83!K<^YM0LAQ%J!
M79KN-."]=\68^RM%TK/'T%0T[NFD9=C7%K-,#,PGLX;#B6BPV"]*(T%+P=6F
M=$'.+:H8BS)7YF]HC5XTXD&;,3!.NP;7(]PN(ZJ+KZW(?1E#*L*W.K97'FGK
M[J=HQZL4)[L1?\'[?RZT//+9RXF17F2B&*%76Y*W4&'[#W8_\+/<(W#JL(<,
MC*B^P8KS[$1*XT8RS71NQ:Y-A5)43^$TB$_FL=+Y4U$42U0]YZ)XR=KY];4S
M8P*_1D[>=7M4]K?D$==R,EWP&O-X(8MO*!9U#Y%CDL5=1E(LG\)E>(/& 1")
M]O&(8"+IM,6+;Y3PS>0RYSFO?[K%16N:3O&)6M9U+[UJ[SLY#_H6YV&A>LJG
MRZ%3?)Q\F_Z]8?\.0$Z>)P(BAN[FY;9]HY>P[;>QQG_&\N@:*,^AZ4CFB74:
M"CF-$B@@-]/E&)\01@&%<(Z=;\M9CEH_" ,&=LDT:^SUOSAN'Y^S*1^#MQ7@
MO>.V+V %&%PSFFR)%CD\[@1Q@P+VJ!.;@15@8G%7LO0*6J!-:%WRG6B;76G!
M]X=?:WQO'EO\6AL-=_>ZTRFU1[Y,DD*T,Z=$'FFD)&^3+L_M/;^X3*=L709'
M+I OPP!%TVX8H"2VT4?AG"$R&)G--#/Z,R#K,[R?T-#\,$RM$%;BM$HR:HS2
M"@F0#A@*ELF8FW$U6_ED7K"0L#BV0'8" _+?68M,7('P(S40(I3QR0[TC $U
M-&47%0D6+%<[,XK_]E6H+X0SIM+%2?A;W._*ATEF57A5?X\O/9+_%:8X[\$?
MI_;E$-M"_2<R7T(2()+( 30Y*+DG.::IJKU*F#F,J:V,QT.$5WSQO#X]H6I9
M:AF$B]K*OCU1XV.N"O7UDNB9HD:.Q28>I=RYO0OJV8S#U.3PF+&&(1=+/QH9
MV6*XJN@6R\_  :A75F5BH9>5-R!0Y69# 02HQ)K=;[5"A;.;)-_B#OVFF=/5
M7C??E];Z:Q<P\W.G.Y30R&^E]TZ"(,O9H#>5X[P91\2D$]S'%I5=7W(N!Q-\
M !)KKD_P1^I3W$SNPQ<IS$-6S'NF#9&SJ*\\&'EMI[TS!T];\,O"D[#+G?^N
M9V?\F/$52=</9V;!:UUN5G]L3.?$'H=N6-]_P):00ZR$<[W4!S^#5[W"X I0
M7_HB4+B/"S56W<G3?;W0%?V&BJ(?Y?1+%)=OSBZF'0LG=^#8[<ZF/U$$MC/Y
MSFNQ3QL51:&Z8TT:&R!#*R:W,^T,X@ZC"8/+69#$/!F*^.N9Q@+J?7_A-Y<O
M^SY:<ZCK_UK7&MIE^Q]W<U :IX^#PS4Y?K%?%=M57),87!:T-KG;:MJ *LA
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MHI\(E@*I%*VBPL^+$CXFS^3'XJI5F7<_&4[[L<+$I[O\^I/*UIN+1;OICFK
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M9\!)[.XO;64N 2D<LGV9AMHB5\X,B[^QYK'EO#AX8R-:29+X@5PN%77=ZQ0
MH,BL(\[)"@U@R&LQ#;^B^!9+^]CM"%^1^LB;PU)]5Y)])O3>B@6G,.T\;(:C
MCWK ."=6@G0NB=VC3RT]&HHJ@]5Q(?#0[BB^PC*\;&\A>T_NLYG#:7G#$=<
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MJU\J#5SU%/!\TNZ/PN:2T,\S9'ZA?Z!4_CI[WDVR\3][5?A_3Y[[TH;'JGG
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M/,C&S@$"B@,%LKS55D -=.WE+G.'U^(7"!HF0';#D_H5;MX^XHD*<N"(X11
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MWF_9""EY7?'WA)H5<A)1^PELOQ%B]O'L<DO]]^I,4^Y>L3X!_H@M=&K NM,
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MMRPOV=7G@Z:,S?Z% 1DKM1SE6\$EB?S;YP>O3K#<]35^]ASZ_>/M-4DQ%[C
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MUF''FWVJ8_E[\?&((:8P4,6#Y_23**,,3DUF]P3IV$.(!WJZKJM=N0E TT[
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M]5W^@QIIPYXT$2O_VKKY[*W>Y]A-ICF$M7H9EN#E+.JQ-G-]QI]!50A"&A_
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M6;8;=M=@1/@TG&"9BE0&8T):HOG&"T=675RW0J1O_][3$ADV?K[XJ%+2K#Y
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M!,IM%N\5EK%L[^U46-=SYF-8C9%[VI,MJ]#430C'3@LPV2V1DZ(OA="C6%1
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M%J61V8J" Z]^K4XZA'C 09TF BRY_;PGYACL$?0IG"EE72P%P:[EKM'.,(Q
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M58K3VE"%"(4O$[1S[%E!IW[YR?A>5JAZF'RU*X*8EIQYM1H*0IG(2Z#8K68
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M<6S@X!9-$HPJG/%$<H$^!XI@3I>,Y,CJ6[.H\(_U:/Y7VL4F1Y1R1+DUQWY
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M52;* L5>%66ISS6I<:OQ4ZZ#V]4!'0Q5?P+K 9[21R3!^/XV'4!)E1MII/(
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MG,T"82Q60CC9>!V'4\Z=AE$#YPP;BGJ>YY#1@$'_U8E:C" S))[#5M48W7:
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M84 4(:NYAFF1"CVM0IA.W*_J7MF<MUU!HW_B5"Z\#$PW<N(6&9/B6UH,@ V
MZ:?&%H8WM&E,CM=^^1#T&#Q]A9K]<_?W_[;_R9I@: +Y/T@NU4T8&_1I6Z+>
MNS%#S0"C@<L385:6[N8CY;\^\#EU-Q^_[G$@W6Q$P/ "4/,J\E9TC;6!R<]G
MM<IN'U;LJARG'7V?Q+P0ONL6YQS@>Z- /,/!6!)P(Z]UB&XV$1$GCFZ&0"@*
M\;Z/L!3)V@\K.EGU^[OC Z)A23:;PA-AC>+T@4>IZ2'0H CPXB2#5W]D]ZTM
M@^OH]M:U7)M1;>49*_5$QOFPOG45C\;X/G1=,UA1Z%9'\I?*-+8AW4R8FL@K
M!0$<NAWO=*^LC#E*78:0TY_]1XSBHZS+WK:7."]J]=SU^'DGLX%4F:\QJ9^O
M=9OP=N8P/AI:DR<)>TF!$AR.E-@H+0C?ZOR9IO2USM#DJF)G_#T %5*WB;F>
MY>ZEZOCE B75AMVRK1B8)& CC>564O] 3S5#"H+[S5YL<C=H8?F\)O;?)@8)
M+CE-K)QM2")9O>**,0-=R(\]&Z&7,MTB9SL]MB#77$*>4^@ QRJ=-7;+Y[ ]
MX4GXE0':O,P9J"?C->P/ZQ_^/R5+>RA!273HPM&SL/KU!+> ]Z@Q2+7KYMOR
MX"%;;N=:)B? <OW)5@[W*>>O/B&WQ(B5=9^M_FV5R[*H<7_ ?'?8RPOAYN7Q
MZ!&;W426GSG<!\'%^?[%O "?*8]&XI,8Q4RF41^+8#^G:FY3]6O=]^_;6S_P
M-T=WE;T^!XIQ-]PB3E"'EGCL!2=/692+IUF+7=#_EMJ>!$(;8:N7Z?PGT0M%
M$/)5,.X,L78SY=.?0Y 0TH"FA[0@0[JQ/"Y>>W;5[21GR#%OV(K.C6'1_B#)
M)I\E?)?;I6]>\Z<**I3_K3'#U5'%*7@K*[I=GPEMN@ P!4.H[U9.$4P1!Z*Z
MK'12".6F&[)??JD]RIHZ/?$A3N>+H<_%@*9B"-[^)8.'+D\VCBX/AK?C>9N5
MCBPR>\@ZS'3D68*5D;+=A:L_-<8_$Y(>OLUG]W3X_OE:>FS\@CWURD'VL=>P
M:1KAQF.0#X+3B\6!=<=GSF<&@\K[R;'=1W- M_?.:Q\4H@2 ^@4/^IDFJBTP
M?922R*<55LGA'%Q_B]R][9D/KJ;(?<BYLY\Y,,AC?)6B2M!PJ?X2727E^OTD
M*H,Y)BR:?,W'GG%BD"85_&*2],3N6_W&"9K9:BD)DL3MKS'NEHSSK!"R)+=T
M5?OJGIYQPL^=O(F'>C6FO8U8!,^H'T?R Z9D7,BF,02I3;9]J:;V4VY@'QQ;
M0^..N^D@D:1R0_D)+TN;3*KR:)7T1=F,O /\VN14*!?HWX>C_(:O)H]AP..M
MJ(802P3P3NML\N; $)ZR7//=,<[05[9*)0 VM$R7:"*TG&G'D"T0O "L/50>
M0Y@3,CTH8)QQ^",JF.!U,CG[8Z? Q"?R)2\/W[1.Q.EK?FEF\>\6]=9@$T<X
MD?Q<X2A5BF[)G,4'7J$<G97'@>Q>_7W4")1+W2:#8'UNS?&76UU]T_CUC 1E
MK9#KY[H%%G&G=37>B)Q1 1G?.7B+72"5PZD^!_G(X^04ZO!!IO'Y*=2(,3L9
M'/LW7$V=U],^2%^]BZ;L*ODS.. N^>_(C*5X:?C])Z.7/[.3\=WIH1! FF.]
MD&9&1Q\T8;VQ@,KDAA=Y8HV@4TUIK_BK_@(#WBT+JIGX"P'/XZY\F)VW=M-Q
MKZEM(&^T?#!P?)._/JAF^]_S0Y EE O%B52E8-J9["D4VZ4>/0^>I#L7(.6!
M(!^?<"+TY)2+-\Z%>D]P].;&FTVID,+&^K?N]DEQ2E)2.SG[R=S!Y0_C.:5C
M)B;F-?AU['[*U9PW*V21BC]?];ZD[>Y=D!N(Q032WIH)WA X!+$O,ZW#!NME
M&V>'94.&4SJIX(-R;8-#D,#@YV"=GN6[W\@^$Z6?C;'&[YY]42[*7,HO#0KQ
M'/A!A!]/%G_ JGN3"2=4F"IO05HQC^UTGE;F"8ENAV(?J\>'=O?V^MSN_*;;
ME1(G*3^B_EE+_42PTYC36.!%0:OZ&+FZ=*LFK>3=J;HUZ0L\"&EL0PI?L$=G
MJ\KHEA;TS!\G8^R[V8X1%Z^<N:2ZPD?ZT/DK EU/U67&6OV3X9EDW?;A:#1W
M]QA2'_!?V&+-[;)K;"!3XXI71@?8_2I^7DX7S\?H&*3ZFT"&]C9,:>JH>0C9
MIA*025D_(/<S3C013Z@R+J &OW@REWJWA)AYM7,?/;S8!7?0U$-U<GW',9CO
MXVN7SIG-[B#Z:);UM+%&_2$H*A']:#@>RF9H1$C![5$%@6@B!B?6R1!F=$\P
M))D.A#?K8!<B&O[2T5N]2*[GOWNC>(>6VUIPL<*NK\8]9HOHQU8BTB3I_WQ$
MS%@*/6=]_=H[E9=5=/*249FDG-AU$IG#CL))\2TF(PB_WQ$?-SA_KVU*X?)"
MX]@)O(M95E&^G&G.J5U/+8@1T&PPH)-!O0.,D"O;T.2;8-SM7LP);?5(*!CJ
M;<L_"\=P&@NN_NQ[%/;!4]0H)4'-LF'4]<ZTRHERY^D9'L$<ML>TILLDYMQ_
M".5M>D"VIZ[6_-(*-[=,/P117U!TIZ7'G_BJ=+7Z#-6>TFD-E<XZ_I3_*Z6!
M;-%>N2[GXV,W]^1]7?S\N/EB>#IGH<79Z)%"7&I/F6C72):92=0+H8_'_>>Y
M :\%]=A3L!DDE.P;N3 5:#6MOJNH):$S8^UJ1IG.MVIJ]WU5?7US?6! ,TO!
M,![$X((N).!K[>GZ> :7-0V.&D#73'94OLHQ?X7U2L$I6/QLYJYT_!-4[>G7
M5P)@'+,F5IVQTN]R.IS#;<0BGU4(+4TY6MPW;@8<W\$IZ/:%_(L3'T<"34=@
M"RE=BN]^,=K]M.I"#%G=:D7W[D<-S*66855Z(\+0]YVVVB%1#"6*7$J2H2UY
MN-UI,O'O"J&QBB)97+"RLUJW]WS=2>R5^CSK!9>K(99!B%MZWF,)A*#.)K28
M;E<8F@WP,9;JXY[I)_&/;F )T@VU.=)L6<NW[PA)WDD[UWVV)O>:XO=N$ I\
M5*/\$%2U64^S1;<;5C)DZ<9CN\[X1/Q7W:1GF&0L]YA%4OZ&NE93K@7RDFZF
M\(6&^I'"L#\O(+M9GZ9F^5-^V (Z 6T8 :S/(0BW3"U@+K0*U&BKZ#<FC&S%
M=S"X %4R8\VUIJ&^*=9IS%#[P_3JO-2H]#>+N?N-(T\&,P?2(C">#7D[OZN@
M,SZ,MP]*I_!>H>7EM8SL4B<7AU5!^R^?J9,Z]GQ:]CI[?!9<MOQ5FE>_VWM=
M^7Y1>P 0(^ CC46]+@2C"5LOGZFS_]D>\F6R-D.#XAFOB0L#G2>?4JE]HEI%
M)I>[W",32<S9]$ OD/!35M0HH JZSEP[QX\=9#RS2A&@/SV(0U[>?Q%\#G<\
M?Z]+\F2V78K+N%15M;M_D$KV^9"3[!=C[&^8;9MG.Z';QV%<Y<9"5SCB#T%N
M^*0<Q(8T;W)..+Z#0!#+5B5AJO[)"T/635L[==[KG@W)'65=>F/YKVR?=(YW
M4;%2C.=:!6O,R53[!VQ\^5VGX+WJ4 _;B/IY&::^>G86ECN;,&<2TL(/L+K1
MSTJU68/+&UQ.H 8Q>KH#X!N>K)1B!J<;"0LH(7HK>9#/#@JA"*:K1L<PY((;
M$<8L=.F6456M!"P'X&27 W_=$J,HDW,\&M5_LJ@Y<28R_7I2M_E6LXGO_ 67
MX[.VW/*=VXO/T_S\C/\CYJ5^OMDMKO'A1J_H!W^S.'[_$O%S5R/MSK.#;N@)
M\V^]X9C[KL#&XY%/:O5D!<:!SF)'5#>&'#C9KAZ_/R!DQSA^4,W@7$5QC 4J
MO>[U"* (=0GN>&4+QCSO<MZ0K:X*SGC^_/JTB"'Z$I3L8%&QA5WX#U-W\#:I
MJ'MC#'F,,G[*R:EGVS9 >G3IF)Z;R=#HF9&;EG)^QY&YS E:.7AA^(CFBAI
MB0/M9$E-C@T833JXM9=DWW9@-B"\*V$3SD44F_/HR-KN,IS V-?6.I3+J+CM
M3$:KRL.W*J=B21]@==GK"'(QT:,+')O3&ZV-$074QDR!M^29WAR#Z?DI(-LF
M@:;0]2W\(!J',1Z%S\ 3_A/_V/?@K>TE$T@&GNS->%OJA25;0J)U<-'1@]%C
MP67=MWK9W['5;1O>\E;7>E)ZKO!3,UI?0X*7/;@R[RA[7QV06XYGZ""U1IE7
M!9BO15GOWAV])E%=_G)/4@7-C:B9H,/)$[+I1M=.^]QU;VH>]2GZ]J8_VVN=
M=2;UAS7Z-H.7K!N%DOR3-2]$5HAYAC@1_'R@VND/[N1K05$DS[3*R(SSIY[H
MZN^LQBW!>.R7VO$GFW]GUCS5GVAS>WW>^KQ)=-RH6-]T\_3U*8Z+M#R;+Q@\
M)RSPZ"'GV0AHPA9P8;NSZPQJ %H?OI>@%6[6L]:%K4%'!RJ_G%!14TEB>MO8
M"/=TX.6W>!DMA.RH;.Z=BN5S-LZL^^^;#J*Q;DEFU*U;V(,<%'@>MBJD>>_>
MO.W"G-+RMV]O$S-<;+9XG1Q=-I_+IG<M3M8&<S-]4DITG2[.HQ/&"@2T445K
M?]Q;=4+'U/2[RHLUE=CWQ6\'EQ<FR6<^[+KTZC&7'SCTKVVGY#R3<&\;XK^8
MKSNL+/71SM.%/:>VB]N=+O7)L 2_%$_+#T@9PC)CY$(=_LM>#R(%2K9IL26D
MK&N7N=+E@3ARV+T1E!0@U#%__%M&I]TW*H: -@Y+X9A1C;S$[8I(=M82>34,
MPHN_ZM&D,8-+9_Z;Y;\?\Q;=(NEZO<5LRQ=)56LFD)Z]]6HF;=6L[%"/R!<"
MF,Z?,8@5?\;T<U&$F$@?)N$XXWR)4+8.[,%&?D[A\%,/<28V18L]%;3X[_\R
M0%7R,$#.H[T2U_F_&DS'G2G%=$%-ZGL@B AY@>5F0(*A-P ?)A?0HZCFKK1*
M84R;:K$UU4)9M]3?+GI1O'6=,JQET!\&@^I9/;4/8,%1U'! A+B!@@H E02%
MB,#ATSTK9^$YL=%_^RH[NP+$4P)DCR>4\<0)5PW+_FZY-C^$&YH7<[9R4"E_
M<"/5V>F*0$NS1:'W9[^.DG@!DYL1QC<XKH$8RE@XXA6F/HC.5\S@(E ,J'V8
M2T AS9S1CJZ9^ZH;C]1\K\UH$NK\T\7WGTJY"C9,,'U?[1WWZJEA<8X-RT!9
MV\PD4P/J-M/K;R,O';0RC@'%5"CSRI^I*B'Z)8HS:>@-.'+W$"3J?4^R*>H2
M&1:+-+O5:1?#(,(#DW^$Y5K.XRRG]"RN)_*SZS&& P]!)X/1W3G60Y'$<*'K
M%-ZTT":U9W,/?\PS?CCTJG[C?K5HD^=W(32H MJ&/8XZA;R0L[I,&.Z$L@/G
MUF[<W]-%0<B;;XM=7"Z<QK=FB06^OK_,$80H J'D4?UH\B7,]/.Q([JAPN@]
M*G8:N8%27H5R\%:19AH5&M(Y:[8@P?->M>I\SD[6PK\-+!&/JR*."UM,1XH(
M9%+L&2>/"J5>\X1PM\K#OZFO#V3M]R20]WJ^5?S7V25:UO!+BXFTO'6?"W$+
M9YRV.CE^4\NKS8/KO#GLS_52B 9;>ACF'M9V^:;+)8E?M;_*QS5<9ES;Y6JH
M8U*>'G7Y.LG$BWONAD^O#HI)MYV;,F*Z62,FLK.%+N3!JE.Z*F/FY0X^,521
MLN.YI.5V< I8M^,0Q+]J?F/LT4AA??VX6XS%WW^&-=^VOU*6?GX\T6[H03MY
MT(KU5-6D.A[$H[TJ<6#[&(-<VV@L)QU6>9!S2R/,_R"/:O?S^,.BQ:RPAMC7
MQ@]U06#MO] 7##& FU >W9--WND0%8K2.KA,V@AZCA(?*_\[$_9FR,K%\/F?
M5X_[I#_<MQ%I@?\[JJSSF\EKQ;&^ZG&0ZA3ZZ=B%V%BZ_4? BJ00KX5XA:U9
M[E:&<Y>A>0!G@D*,FNFOGBCC"NR?O8RU>$>YL?'-@&K4<V*$%'.X=XPY@#)"
M$/WTGBT015P3_-)Z4&BL$DPB\4:S!B+8US*<30OFD_5=7_DN]OH4L";;_FWF
M7.?E$#%R9A7#%AM2[GF14PB(*&,F42$+M0_'XA[5Q2U@8UH%1I!*A+ES/Z!J
M!D;JYC7)$XJDNZ0+^LW;]^\W5\!'L_U% G$#3\T"UCGW(T<C)/Z_-S8+E Y+
MM5U:#0OSJ/0&$5IE@1WF-'#1CY,@<2CM<>E1I-("C'<U7W&RUB"*EJMJ8%F7
MODGT6'1_DN+)L278<^EBY<XNN8?I8(\SB4G4:Y0VW1XH(N^0)$MI>J@N+&\S
M(HCI5CAG5G*2J!CXYQ5JT.C,H,]#E<<)M"MW8T9N,8B6.9?$7$,>656L,B;1
M"Q\A'(8PVB4FB(-BGX!?M(+R/9$>%)D%V^1F74*CSZ-IOYS,B6R5U%<PF2<#
M9]V3GG(;'!<91!M#R=ZV&YED]GZJ^#C6'2P$E'6@>1@&2#X 0])KMB78GEK5
M,19OFBA';-U_,>.0N/H4Q]VT4J'J>[\E(>!ZI2C!AA=D_!#(9E*U?,9/8]!/
M*0IDO9(YK., \\BMK^/U&RT,Q^6)WFR(E\N!RL[,]JPZK5](MS!VO-&?LS_#
M.'GPOTRL,1RF%YV,)E^K!!3-BJJIR0 +3P;2>#+0 [$Q+.J)<WNU:ZVCY/ZO
MDC3VMX$P^;XY_+>5U;RKJZ3&@0V3V)QI%0DVM_ )ZCH$G6KF*_A#I?3I_=).
MX?>DVN5?MQC[3NGW#Q$=5KR4)BXW%W-,29:5?I?1AS_S%P(HQM(EY(@I."NJ
MU\A&H.T+:#6X$WP&<.[%GWY6XZ#2;!L81FAQ[J@3K;80,)ZF'CS_NY):I2[C
M/'5";&DF KQY0<?M;:=<;A"'E-IYWG5D[\?GI/F/)>UV3TUPMQ>Y&F?J2]G"
M?\Y\>6K $^Y><"Q>\?_^7$\D82&5_Y;'6I6XW3CJ+^Z2Q*-7389E64UXW^<V
M^'\786EUJSFN(-+7*TOF<,E_O05#[/16$G) BB73/]+U2&LKF#'L@_G<W^ZL
MF>ULR:&1X\DA='UJP8F2DOH\UHBG31'B59)-E^;PHT7_IT=L'AXWR;#396J;
M"="G<X[V4A\?=J[\\^/_XYL"\)^!7>AM^HJ2[>U=Z%!Z!)?B^\B2^O+UK(,7
M\9IC^")^]N%"^HL,SZ'-@)69CTK>%\6X 48+MM>HRO3#7[L=Q/O6NIWC [/V
MY^(16W:V?P]"9V]OOYUOAC#JERQ$XMIZ#T'..Q]#8B.EI-R";,#WS?27#4-3
MO&]T^O>:&#^89<6S[GNT7'W]"3]]3:G#Y>MFSA)]']::DUK,OG1\<%BYP=7
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M40RN;*'>E%<3^:<IT5&,P9SN-<@I;Y_ =R+))4]R'*]ZF-4%CF>G]FCDAT:
MUZ(O<1QO?=#XBI7K1V])KY\%1%>AW/*FVOJ+:9Z9!AG$=_"/\WINB6?RT(96
M_T](X%'(\YF]&T5O9#MFHF $$%K,5X J9O?*3('QJ $LV08M^ ?#46NDWH45
M@7I6"CHDX,%T&2#,$S=1QA:@N^D^,?K=Y9[#A^\5_:(=+M*.$.]COVB6OR$:
M/;,79$Z%"=SYD5+AX/ZLDFC X)0I#$93QXYJ.:';[0Y!3[824,)CAE[E@%5W
M;SN&!U%+N_-+E2[M_S$XF=:Y7TD]ZZI2-1->;#VF^G[F](;)(W<63" (E7*T
MP2_Y*7I]EU)-BHV&>D!Q$ *D"SR-(-JF:'-;Z[:;]X8^FBN.W4VZS'CTHM<6
M/GA96'PX+$A+P\1GH'#PT2T60_2U0KY=-DH[.+7;\J&,2!^NV>V+ /THVV0"
M4PWME+!BG.@.H-W\PQ =8[*;7*HOD$'>@9$YDIIU?7@SRE9BG2EF;XN^IP1Z
MB3^]7K<S>'+PBQLMM^"K$HEUKYIZ F!Z'=%#T$/,=  Q>KY4OKH4R%U =^8.
M(FZG#63@X2. FW7=Q.;B?^F#_L:E OW#,A)#Z]W)EM\Y)JIGS8]9^ON?[6;S
MZPO0VN:WD*F]JZZ2??KB,47"C7OFWSN.6;;)HC6QM1YT\4[:1;HL,%*!/'Z0
M:WR&B6BHY93AJ$"K%H4>W?ECHQ6[D)->0G;)#[-P^!MCTF\#>$K/5L\:6IT]
M!'V:J\DXX$ &DQ7B4(I((> =&=]AK&A\@J*03#]3&6QO3GGF5]Z5PX8;?+D?
M@DV6[VC^*;MYK([=9GV1BWY4JL.8J2HIAC#SJ,XX!I\_/O%XQ%B%[D;!)NQB
M^9$F0-4GSZS15?UUH>STUMABMH8S6DK%N&LC/V[9A<6Y%J7%:;$L0<BV,$"/
M@^IQ4&]\7F%]D@3A!)JHSP[>^T;JZT8PSCH,?^@EPI.YIOX$X$T1@?X!6@\6
MXRY?N%95U]-F@$4U;DUB)[#16.!B9<>\8#53IDATN_H&])&K@NWH(<CGK161
M#>[=RA8_VG_/A\L(829J2_W5$F$I0*\N4:VI]GE<13/YGIA5N6EP5:C_@Y=R
MJ:]^Q.C?7]C9IZA9E0*AJQB8H87#3D:&B>CX+?=CNCJL$I]T#D%"$K;_)+QF
MTP.J94 +:5MMAN$A&R8G8$.(#?@A2%F,J0_FC]8'45KH58_RR;\>*<6_H3W8
M/"QNG,3@/2ICYI-8 B7W8$593N8=@KXOES_K%5E.9OK?OYZAF%+&L]?%I6OC
MR[*8'^E)H<JM"=A4HYAJM]UNL1AV6X4""?+%-B94.ZG+H2 C8T09@[XAU2+[
M:!ZKDOJCZ$?0%%QVI\+X.R#J$7FRZS:@[R/F]ZMPTNXX3<R+ 1M2$S@$_?J:
M&I#_JTXPL<KAL_QI]?2/RGQ6O$6WYZ)U[3YXE?8=@LX];5J#KS]UJX+<:7]8
M97GM?>>#M8?B#RCC=Y3T*_CLGK_^%W)W8G]J/R#XSQ767K?XY^;8170'-JH,
MDH@AVP4@3F0X MONGN\OA"2$-:&SN#W4(X?]^Q@J]E_IQX"CQYFFS< .V6ZX
M>[^^)YN<.=D-YG0.?J?-UL08]F%WO:514O[/8X9Z!=$T+ O)OE@Y[2_)0_HR
M%5J[W!7"DRENY+1]\_-LT?J[H95N)?A%N4?PZ9903#S!T./=JTJ;1+V B_=&
M:T6OW;;*/%<=;?QX3CW&$+=7E^2)AM-B-#'%+2&P'D1\JP2@2I[I09]I=@R0
MR(I=V. ]!#DTP&,M1I?*R^<V-@1F7SJJ5;#Y27'XAX VCX<^R'C@5C6K";K#
M4B-1*.L+??;4DI6UTHDA D5@$C"UE5UX7#:I<GW)BX@6#^[LP)/3#9SI.C7Y
M1.*\M<X%WW*99!R'9Y=&1'JI3T$)2R.Q%=Z9SU;6>W&F7<547%Z(K?1A5>VY
M/MH4S$O@YN4A2F[2K_FT%AK$D6@K8?[BZ[G@7V85"@+Q >]>1$,#/U\M-397
M>S:>'DJK_+B_=G"4KZD"77A72!TE;W6Y<G?_GN@D<D31;4OP4X[BY3U%"TFW
M-BW_AK6SW"B5?".>NO+T2UNZJ7V["GRW-V]SIC:R,VRWE] 3,#[YK]]S EN+
M6<>H;G6]!5\'HL@OPLV^ Z%[76DSLUY]LEQ8SYBN?I$[BB)7B _/R%R<ZT;[
MX<DV,,'@F5Y(U5;[(4B0;CJA3K]";$%8I%.9*AWW\/)%L VWBGBD5@O.QBJ>
M:+MGL+/;>AYX$$'@N;JSGB)F?B;5C7+'KZ;TIL]X8<*=8J7VVN#MG=N9M=^L
M_UJJIY&CN@8Z$[S0[A[!YUYK(M4DZY1GK BEL;<_%C3RAS1FZS>UEEG=VT8'
M((3;3_[Q.]%;>9U$*6+7IGU8V'YJP(!,YC!0V(6:5KV#+\U*1&R$!FI %W/*
M1VONBA4EFR[OT6ZE%V-)S.FE*=6>.>%:7C^T7<\:V21AC9)5Z%$'E&6J[DZ@
M#'PORDJUMOGGR?\.)+42.L,FHSL80@\;,*J%;VX-7T"RG:-9C?3<]?Y\49ZP
M9;;2U+ "_YACE"Q'>8PY^3OSZX\W\AY);W4EG::\$=/C6&67^@\;_6'7]N>,
MLO!SFYLFNRMY4;T%,IBAMY-1L.%Z.A^L!U\'CJ<[4[;5<2_V>B>?"^J;OY0E
M(^CR_7ZE ET[]Y(<G[!U9TO;0<Z7N2>Z/\06Y  J-,4L\S?$"],/%8E%L=YJ
MK9*;B5O\6^PS/G"/WV_V(;S+L)E_=WD&'Y0],&HY!/F[.GVX^*1E37'K#YH?
M0PZYT=0 !#"!Q^J(3ZW1[>M5DUA/S&G/[%&OH#U]Y/;TJJADBI=?C)77V8RG
MIAH:@M_M'[8];FT'@IA ZBNZ70MI12:U2<J-^Z+TT%Y 0CM*:#)0)(.8\HK>
MN%4;SMM_LRGPI>O&57A"]K-$OV;[[UAR")@>=_3^,.OX(:CSAG=;_C)#+I0C
ME-'.X%F@BP%7-1+I&F3) ;\@,)>7._A=C]Y>I? >F*#,X!*@<=*9_48%M4HA
MSQ]MT'@_)0%R&FE%TT=W( H](6(H 2#7?CQPS4$K9$I&PG5+/N?BWT$S@?0A
MG%6^:JW2??^( MV],S1-9N"KW] F<Q @&ZP+HW$$?'PK*WDO\7-!\B5-KZVR
MJ2M! 44_;(\YBRR%.7(N]HE)OO38WF'P:B6/(@ 9H8UNZGA]ZB7R(<@D:W:@
MY&I080]#Q$$4C[:*3B,7&?M]7O"S1C(Y-9O$06&K*&H83[ZR-9U-1&\842"7
M ,>%C8N&IA_0'?8D^(I*S??RC'N-L68)&^P7':_645B.1??\D@XN /]9,=L6
MKOK'2R6)1;+Y^.GG>:3XUM*5'=<8TLPH<H>Y\'_N)\=5!&/NY2Y -FC<JVFM
MY0'/\D6_,.%S''V*&#6(J%8D?RSVH89_OU!6>DGPZ@-3M.V^/5U0DW$BH&(U
M2U0G@_84R3ZN[?J8T6\]]MF';BTS&%9R[WK6Q/-4]:DVKTU?N63%,3^5];+(
M'/H5IMIKL8]/VG=#OV+:83/%!-*L.46,:@&D?/#&>HV2W!L1)X+C-V=N-/Q2
M^/;RA-V8Z;=15;D',IR_U#F_<_"S'/@KJETS,\]:;"4,L;3'_<I^(7L+C (7
MH<] ZLVJB.K .31=_#;-@-'- %..K\..0Q_TPQ&OT/R#&4.X)ZV*/S\F=-V3
M&@F\N&'Y$OW$Z<K'/U3*]6O?O\[*&PYV8-_91N+)-[%LP86,$TH$+*"(J@TO
M[O_H!:U^B>4SO L_/N[ITVQ;X,F3_8TGWB$D-#'GI6(2G-&@18EH? !+19/A
MT/4UHBJ<,+FAQ(Q2YX&JD[O#W>HSSL3DIJ "O'=5; .4]UGYK=\[UUOJ\B_]
M_A"4':0YO95(V%B_:74*>YYCJ9(N$4G>ZL8(0A<*L5]2VM L\)RZ:#0%0E D
MHV-\GB5=WAR:KH4/"WD+ZE]P,46<]9/7Z(K-6(HP6MM39YQ\=E 8"(O#DFT/
MPJC/**\S^B@*5$6@A02+8*@W8L?E6EK&EVI_;>UZ5DY7N*=O;&PD#>"03UNO
M';QU>RC\$'L>NX#]_!/='GH(6D@Y(V5\_U<S9R,A]3W]9H9RS2[B3;+%HL!P
M49CZ>A KNET7O;"DCDNAPL/EMSJ@Q]&(+2YF=P1CC$HQ[?16%\V^6U)JO)SU
M_,UP-%$OD,8B)?EXPOEQFXT)U)+9_"(,IWD3T&::]V8S8$XXL?49)<>8PIQN
M%J#I(8U^::W,<Y>K.U(>-SZ2FRAPY)JUB"MV'GS28?BV.N+"M2CZ/M-R2_!@
MP[MD>P;7(]HS.B_%KJ5\%9?2@8DI[-!_'9I5'!0&ILZG$3=TQFXU)BLM^@OE
M7K@H#"KXI[<"*T'7L0W3T.CV;O17\/K@>PN&+&#%%&6?;(@71UT,OGWGF"T8
M++9ZX:"I(_2%4YU;XR^5?%HGY40>>W30N6T EH)>B/A:@R7#H("*2FS2_G+7
M,1,J4 2"%*R80+@8@Y OL>U'B=KJ='$F7CI^#H#0S-?N09L!],*@!]$V\5FX
M0><]M5]_=6,=:BC&N<5.#ZT,7AI;M[0LCG*F7?O>'Y5J!BUPM6*</"KK[3&W
MLC<QH8_I55:]3!P-?H(8[MKBNUC;D"]R>B* KYEO*'7@;M<COW:=+^W:]$7D
ML8-RE"&J%T/V@]'Y.XG@=1I-.;B26D_QK26"XXPEQPV/$\0Z/4K_X R",=8M
MN5VFU;7E&XO5R:-7[YNI60H__8!: $@,;B82/1Y+F8Q51RJ08QF<N_][\"/A
MF61PF5*<Z!M32MCBM=:84J]<Q[@'7&ZJ]WV, PUUF-QGV4ZABRU1UDCVZ]',
M%NP/RM$+B8>@TX9H(C3!F(7,TVK0 /A4P+\EUD=URA!*ZK%Y3BKIWQ^XNEV?
M4"W,DOMG1YR;>6<*F1VZ<!X-V6%HTYE$LIT'NI"*K^%H@^!829-T_FPJM64,
M 66*F+(7.FNG+Y]^=2+_U!C2]H)MI??3(52(VNZ4W="0\Q5:F87*P[LJ3WOW
MWXJT#2NP*HR3,H!\3U;Z+M,&UPY!(&",I$OGQU/E 9F%83YXJ$X517.!! 1<
MCK4:5U<]VTAASE]"K8-6E9;=T N3R>,"0R>X ?O-93J3F-$LO8\*CB[DYQ2W
M@46TMI%F!_&M2D#_@E!"!0(QO[USIV%LUWGN'@YX,[<I.7_F.96O3^DB[;S]
MN;9X>L-1,HFU+(3L%T3G8]QY],^#K'?_CL$#AOP]M9^QE3FZ\J&\N^OH*NUF
M#-F::4L7%:AU!]F/1]7HTF1G*I4\CA4P!J]\G=7X6=%\I9YQVC7LSE=[GX02
MV-K/M7V4?TOAU0A,5@34[&BM;>&4;P&F1P:>L!#[4GY<!:7 P&'XD=PT/;KQ
M>$U3J>KFWR3G+MS$FX!P5/YME1^8:;*MC]3+R(084%8@!YEIB 9DCG@4#[J=
MV0H"%LE0I/!6E^/IRF1;NO1^Q"]M[K(V[;=GNNMT]),&;@ZM2^.UGI[;:,=U
MV:]4;MPUQ-3OT<6]:/*,H7UE\&FD/'/HSX/9ETGV/1B>51-;PCAELTS&!; !
MG.O^>/SZC+GQ\ZZDZ4F.US<MU690S"40%;9X5%;V*7,L51?2+3.ZYXUE]Y0/
M0=P6F1P2L0]P$<;/#\JQ[BDQAZ!Z-%U"C*))A0,SY<"$>HQ3?0>,&ZXKBH@Q
MM"SU3#?ZG4L(OUB0)%>3HW$J*/_R\V2K:AT_T$$) M"&,$[$L,SH]BKN\6P>
M@J*+B*I1D&>G$"P*>3N3:7DY=+&#)OHEFF<PG,$;#A25HMIS;%_N8E+6R)@.
MOA5!8^VZY"V3<"6Z>G&2Z>:[5(&''%E"47MQW6'HC:.2RL[,860RL0:6W0O*
MQS!&R@#:B(63-AYUXX8/"# 61^]]]1@%YU>$.*2IBG_U2E]@<Q]"V4Q:HX?Q
MY)4?IQ@*DES\)AC6!N-C*B$*0KZ7,HVG(@!IBELW$YJ^.03!N?$G//=3(I"W
M*^:\,[QPZ,0MO'F(6KFOQW_](06SBMD6+6G('O-O7-UUI%4(8)C.W7]@SSA1
M3@!JK6'68\WFE"M$]H220] CV*Q#OS\"A93PTJ_)VI9)3YW]'A_"56U\L=OW
M?_N3YV(EL0OOT+5[+Z +U=CZV)XM%J1][M4<_ W <F$X-JAJ_H^=:'[*:6RL
MW=*5S9]CG9JS@U#JM8XXE>W%NJD>3?0">7F.I [(%4;U ?VDRYS#89ACRVP+
M"VG[8&\0#=^.(7OOT<] 7<A!+[5G2AFZ%>\^ _:7QC??HA2#7\G,>>N;%OV:
MC<? Q=C2!]9?<?(M<^?9+PIM;-%$Z<BC?6Q;5>GG#KY!'X+CL:>0=VGGX,::
MH\T*E&P"++XVW!96_76L4B'16O+SY(5!_B^K-YJS<(\&VFITE[@R ^]#F_$Q
M3- 5#2?O% Q'(F4=TH:Z?S[A!H5N&K7\VV=(HML'?ZZD,XU1&.H]AJSZKQ 6
M6^VHU6XEMQV\9D;CBT6?)0T]C*@<7*H2Z?%CH6F3P22%:+0GY 66QU@7T"$J
MT2]2#-J-(92DV.D/CNG\$\]FPIH2CG5*]17;JF1E!(&Y68?@$_T^C^)LKD3)
M+_7(7&F;=5Z:0OT^,60A]1";5WFTA<%&(%F,ZLA<14JHCGSM@\^MFL&V"_,9
MQ+?@>^3AV-T4R55-ATN?\)U$B:=A/N>&$&<]O,:L(GUU?$ F19$XY;_+A&*Z
MP!7&B5^4W%Z4&.!,KJ:V 9HD["MC=2QCF%S_TM"HLF6^L@(F:RW]M:I>IZJ\
MBW$'H71;2OIF'C@KPDB]E[G0/-83R)U$1"+C)/(JL+$ XT3: B$+GJVR0%.'
MZ-*_ZE]:4#9;KEGGM7IYAXF1\N+H$<+5M\4^:Z^2X0NVQY@:[("1K:"2].MU
M@-M'U,]]TYCB3]X^'U:<)BK%'#U#R_ORG)UKBU941,5*;::*3'$7=!?X8$.V
M&WVT<\'.5*8$495G%C!=W'/7P#'?*ML.02]%*[N,A*ZUYO0U/R"4*[?;U:<#
M3_<=DE'=Z&"5[G%W <_[,XD: OM,Q1VG,Y5GC>ID@)EG1R0:*")G+WB\0/$#
MM 7>R.)@IG0,1?+S;,',3STXB;F6JM'!I09+9$)U@'CUN09568,XN2\@Z*<9
MU<O]=ZMJQO_.E,'GSE$Y*Y]4EC].AAN472P\<\6?AU)M+NLC%A*YQS_3IS>(
MLD"-HLFN8$!^<KV%='"%@.X"I^3PEI+*!3UJ)VJ@W!8Y SFJ'1)?G>ZY.%N,
M_*/DQ1D6/V/S4<V40JFM8<DWT?'0ZJVC K--U,CZ"6T(X(R2 6X2U"/R12B)
M]A?JRHOA#&4AG$TN,4Y-%Q'6[VS@=<7"62Z^\:)PY0 4D*O?D&.& #!P@J82
M++I'+25_Q%(RJ$64I0^M*LPP"!8%)+>ZLP49YWY5R&7MV(QL_5ZFZ9RZTZ,I
ME?GA\;^G3UD.?C%^0.NVUGMI/L&2, G&($S04),"L?AZOO>SDY=]FF699\!W
M/]5 *PF\9^2$2=_O#8VJ?U>C@0H,->W@4RN(\1W/N\E00HW SB ODOO;)Y)'
MPJOOM5@HM#3?Q0ODYW(^,)K=YO&+O^%[S/S2#GC!=B%H(Y,F16=G3M(&:G!>
MGWEV07>X$? 1T%JYB3=D/*F^(R$)<G,4*?01R.X.0D]K>.\_3KR[X?.P[O2E
M<!_AQSI[#[WXHQ_+;&)PM]M%B^F""@Q>S5]H-VPBUB>7>O,@RM  'D*$L.!6
MSW1_#.Z\[2/9W_5\,K0E?TM^<57_8R6B>%:S\.LT[K_LI>=LK/NG#O*A"]\@
M9&M;G'/7?G84DH]V&4"84T[&9)?"_1V#/ST:B2DO\J3NW/.VUW^V8[ET7;7\
M?EA4%DR#_[/I["?=/] VIB +'AOJY'6Z(W"&(M.)YV.(B]1RVU/R8PT.0>Z?
M<<[?5OFL_(,D6L<>+%7;*I=<O2-;-Y)#%V<.OA'=SH-V&X[#?UGN4853PP%+
M C02+\+@!82ZT*>0W"08VPSZP7Q12K06/,G9E;SY@9KODNWTO/C]U%R'U/.V
MM-=EZ7 FKY'::T^18(Q R;Z57> HV,E6]?HV&#^PTX4^7>/ ."?]$L*UDD0T
M\WF\\J$A2['\?=.85%--SN+W&+T*UZ_G3X)0_?^KT'T(8JZ3\RCVX!D[ %W)
M^.D$C4-:%<SV%Z]5!=]E+_<J=IUI='R7M7E6.D1&,8C_>6*TG'"$=7@T3?)H
MJ\I#D-O63*_E>"UX.I<D%-,J[>UT5@4W&5->04KHTG>WF3KCLC+4CAM?9%61
M)MD)IY:V0?OQZX<@ AK0S6:<R"2+60&:E$FB1P<$UTMZE#F/K4!>IM1F)>9K
M4.RJRN:\]3)LW[+69TO4_S?B-/-A-(/S=;8,&_WH.<P,L$%3<CG:+6>?]^B5
M^1TRM6H!,EU-+.Z  6:52.6 #[/!3T?HEP(_S@P2XX@_?TO)Y^]'?VI]HR9^
MUD +L5-5 /XY#*C:TP4,"&IQ3']RA-.]D=IDW0W[XA4H%X,+&8P]!,6T_:QQ
MO;<Y8TG.*GH/%_5V;B?]]W [_<J#XO[2*-YIMZ3DH"P396H3@TOHJ*RK!MH7
M.P7O:-4^^(#V=-6T/4BCFU/ '=]2HAE*@'-73FO<1^]YU9IQD6=68JZVUA'W
M] >?\3Q)XDR*SY!F8;5?X* +F5,5#C+_5@(J,/KI6)LO@#9!S-6 ^AZ8K)A#
M_12L<I3U1U[[UDQ1BSO9-2_#XKPA3Q2+BVKR50C+X]I/8?"^!13(]51F$'VA
M'RQ#@+97LGMBP0S)8 3U!>#!&TVP!<]P&VE:6VISQWBN;[AU*#W<UC"L$NG;
M-($6A@=1FPXRC(_!L:S&K,&])&@,78Z(CY.4)%?$D1$F$YMJ&3<H%=ERF1]S
M"RR+YYK9<;]=+W.6CX>,%?[[>HQFM7CP\E@60TN]T4%</)I-=RC$!$3*\TA;
M@WU'T,5]:*IK\Q>.R!"C#U,7VY' '0WTTP1P= G*YIM2+\\U)G#ID LB'().
M2MB%O2%*>DP]$U&Y??O??T^>/V=[:KYJGXQ>*$9QCV$7XD:9*/9)K9*JZN[6
M=+EZC4AQIO4D725W0X?43E66S7T9$T!2%&FN.W9+P!*BX0TZ. G(T!XS!F U
ML<G&TG0MX/\B[SV#FHR^=]$@TJ1$D=Z"TI0JTJ1&1$!$1$2Z$!7I B)= D$0
MD"X@H* $I8DTZ5)#KRI2)!0A(:C40"(87DGR<L/OS)Q[/YS_N9_NW'/F?-C,
M,._DS2YK/6L]V7L_"T9.Z,'QZOF2\M9]$,]:H0F+!,)R#U9S/W:-U\D[<]0O
MA^#YEWUQMBC)Z_:5XN=\[IU7Z)5P? .*9 F;P0UD,E[10IZ\"#ON>[NZ:@D&
MO:J1:F?B)C3_OJ1-_6&+-JN,1]B,;[95_#AM&=6M.MD/(UU+!R1AQ,/"[J?)
MFJ]^TX+H9;_(J#X@V*.)JO5,?9!<6B+W5$_U0L%%V3]%6!6&CTC'B"\Y+F4&
MSE;LE($<4.I5AGD)& C16/,):"*U#"A:+B,^(0?V[>\E&DCY+*J14K')Q :9
M_!LOURB.QC^HMO#&^2O*RDF"U@K\HJI#;'OH_SCM)09"I<_77\9,_T<T>E&4
MO+"8R1^\#75ROE0@-7%AR(>HC?M\(MK$+=%1W3_G4DU_9"WB=RXCS"S0GQH<
M!GT;E*O*'*-+JM!D&D<Q@.W?A_<R('$IN/1)N:<+*YD[K:URWE- 4'/_F-2\
M8>O\#:KQ/U9#C9]FCZY&7SR F'//OSSQ7-BF%OS#"C8PR?Q_+2OTOT-S]S8/
MF]Y3*-,+0#26C-A;Z&S'*QDN!==E%($7!'SC@_#G8Q2NYXV^_GNTFIFGZ-^R
MQ!M["?9^" J-H_&)@L>R#B!LK&&J&&_T[/8 K"[M527MU(02S1?_QI6 C3<0
MOI)G,18C[5#EU*\34L_U>U$(8?%*[/;6$2TNW%G^?X<R[H=4MI2QMKYP#]BL
MKA'@1H5%C6 1P@;'UD!ELFUY&;"XO?07FU2&=OSN=R_7OB[R]C6N1%^]JU*)
MGY[=5UG4 )^A258#9.>:35&JTP^ L\N'K#(P3)(;1)'2 7%%VRU_/H2X1+"%
MJN\4AUSX\?9R"4(W@>7ZQ9J5'9";#:B')6'NJ"0BN/_2 XV:R'*]F-1%A620
M?W>8I:!C:4'+,6QKN7VJTN]R:*+8GJ5^9G@MF2*9\GZ3+SK*HX8F* CRV/Y+
MH)T[):<M#&@'G5/M0>.8@#\^E8QAR48-PT@WX7-9(*<P 0W(FQ)K2*.W 16>
MV%+@[5]NN3Z=6W-<(I1: IQ=Z^GF;CK[&J]N9-;5R<)S"S^.'QDB?_PI/DB=
M<_)1Y+U3)R4\TLNJ$TFXLG9EC=W8^,_GNQ\W8#E)AEWL0T\]"EX.Z!2\@/Q<
M^.VVGRT=.,#)>ZZ#]=NE^Q[/O;WO")TRZV7*+/O=LWNC^(ZR8'J Y7\_;,UN
MR#(3ZGHZ=<%T:VQ!?(!)KDD!8*Q%K,VV'"F=:,. #"] M_KBM(L,:6R@RJ-?
M,.=1]>A+]07704=:B'(HDBA&+GRA*C[XP([28.+&U;7%?"\%60*+&:3."/^+
M;-&@!8*S\(\,2T& '+V,M\D!;8R_ARJB7F%P<Z"--+D,9OFJ$#E(5\.EG)+7
M""<&?(.<Q8^8(>\4_/#."S14]/6(E!J.N:][T6"/T:_21DX?.'!ZCRAX-"UI
M+C<1Y)USE&JMT$U_)J(___+[,^7N4UD/;]B?Y;HHEO[-$I#VB/:/$D)U:V!<
M,9S>@O=^KX!\Z*<:I7?Z,<$$<4V<8QR3Y/&/O8\+R=%APE]0*C ! ^'_5"_&
M,\(OGP$O\@R]L)-UF'HZJ@\%I044A3430K*K7@41(P94O29[]:=?4VX.[7AC
MO..D&QK=Y'/.?\KW.;^$J8;/2?5URM$S,:YC)WU@]64]&V.)(GO=*@F.; F@
M$$UY<CDBF>@WV/O<JU7@3=&EY-JR'''-!;<=U@G0W( %$OGXK?T9IJ^&#TP*
MSPIINV_AZ=_@<Q*-A_H@+'<8<_<=R4A#8D*]5&EG2!8O#B BF >6XC,=Z;W0
M& F>Q,8J$YQ]IY5_R0*0HPO3<=:!Z007*(3?$(V+^UQRG$FN%*E/KT=Y'T">
MP4GF,-&H:9V5S>\$2R9P*B-,=_#1*IQI;L*:P/YW 6Z7;T3:,73?O)]1EG1%
M(_C2(#(@:R3%CGR*>F2=8=?^L_Z4%*"->N=0:CO&$VE&+X-[01/S1M<?RZ4A
M(PLMR\WQSU3NY_AL1/**-N6)JJE7E@H\L1M)N]#C*V\& 5_ \6DHDME8BA9"
MF,%'Y,=H?)W["&%P!G?ROJ_K$OI)(X?(B@4@M40T"FI%/IP;^MK4^K>C,N:,
MY#/)21."<,$US%_%Z^$U/Z&FC.\GH+H=MX,7>'MV0 Y+\I&O(U2'\8;1BJ:)
MZI@U2FAK:E7)K^EMM5])<W->RD*OJV?26)EJ-C 6G_*V+2:WMNYJ[@G::H9J
M":Q4GASS%ZOKB>2ZJ2M'8XV^ $UQ4<6"$DAE(&X9PPE<W1E<E"(EQ/X=.['J
M<FSRQV $(=+:K"[G-]:H_OG]DND2>9G&EL'] 8ELVH(<35 -/*:);Z9IUR][
MIWX^HEEU*J/H:!SJ[UW3!S&652BK,NT+XA?9SCXWE#QN-B1%6L[TLKH44'?N
MDVC(.WEJ3.']$]AJ[4+HKTD0=EC/1>@ 4JR)]&-8:-$!A-SZCQ./)<:1ERG]
MC.'3P3Z#L\!?ZAD 0[&:IHE359$WOP5!N8 >_,)B6/-5S+2&Q<T51'V(S9\J
MQ>J?$;SMM=D/^U[;45YET/L.()T^_X;H57P'D#Y3!C^93&&EIW:>YX4PZR*]
M*HE=$+&*X.$+5O3Q) B8\NUG,/?POQBBW$;:ITW4<, :5F(WJ>U\D?21@#6
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M8&EBQ(HN52).-3=?XG>_-ZKQI6]BR$RZK=Z]/1>?N\E/E8OZBA,&SS"&R&8
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M8AX;78-&VW]+<T;EHT./F',]_#1H/:D?< #9J%F"4]H.[QW5(4A&SN<'*4.
M#0/P3>@-!Q"/,68?@5C"RE,#Q87;&SK9Z#CWMC3M;3\E97_EI:;)XI1_)Q&7
M'7]/_[:?O6B(P-IM0JGN2 TZ!N[F'P=OA/5L5 2^11J-OT,[C2_EF960T"F;
M19?)*G$J!<:V@GE*&_]XM.UL4Y/=/D(,1@L?/6Q?W@X97,$6G!G;&5Q>^TNI
M#KU%1L4%65B;C6M@3@*!)M-_-]+K/$5,JJJ]6D/*JGYD9#=/!&U4/*O^JST&
M;VE(\N+A$:R&Z(C]]%L6'I0QO?YII5$%"3&C)4S*0= E827;1"FJOE?K9H'0
M5)0V[70=F:6=Z!-0M("\2'HM^-!%ZF5Q?8&PADWF(E'Z\R.G$=[[ ;7/=;)K
M[IN__)6F?2\X4]M*)BXCYXILDC%.[..UI\5)ZT8F2TD?3SWY'2TG+)T21#V\
M0)1^?2IDC.0AVJ&]N^$2O)R>C#G6*43/!P6T^M*9 >Z:4S[YY@@!H,+XFXJ*
MI*FJ1G]54TFD;T#PL1$1K1RA10W4\[IF?I4GG8K(<\ K_B^#O>AGG>SD"?NR
M5X_UI BIHGW<OB=\D[ /UYJ;K1V/])T)G]!P[[J=E039E5@6V[K QE; ,79]
MYO?SUQ[5A@.0L>L=%^@^,'OLKC_/6K/C=J+&&[G>.?&G*,_V[W\[3+!7)BKO
M#EG)_"Z*5!3(&3)_OZ ^7BY7<_6/N"ZED)[_-_6F/O0JPX*C]NPR[QYU#,;T
M61YKK_]*;#R5X%<.9JBU<(I9"4N8G+(QN_L<&K0P++0">3\TFGD>(O[IZ$\\
M5V"_>CVMW5<I_7E&6_G1Y<P0TG7=J$X6JC5-"TU8V=P@%RVE-O?[6N/=<&GM
M3-5A+M"4/'%Z4VXE4BOW1I.G*]DE_[V+I9>O6T2I_T[5EMNG>(V'Q4-J>8""
M):;U\"C;H;00+:)*BW@.[C4F0#L.Z"\?0 3"+)?9^J$":X)Y"7TJ)SSG]+?*
MB[W^>./FFI^OU^M1UGSYJSI^+7P9<'W&<3_K.11[Y*>K=$KJCR=[9O+%^T=,
MEZ;^EFF]?*FT9S9PD4W,HU 8GE 2Q83J[H WC_6ESS=3+DP9J(+C<-YV*0(L
MM?,\4+/LW"GX<:K!%WYSD@8OGE];<_,I#3/AK"%R^IX>^?Y'.NW+73<'CWO'
M6F!7HGIP=3(KFVWD04HI4$^P!,ZHI&"\J@0)OGUS*6CN]L!E[B,'D%XTTUOG
MQSNWLG>_-T\KSU]NC!'&U(EO%]6F*E6YVDK<049'?4I2*"!M)[6K$;YHBB-Z
M"DY_0]H4?PXQK@CSM_^(#9IU"+N3._=@3_-KU]\C-P.GWY%A*;13>*!*60]!
MJ.$.NXZ[T6HNRD&SJ/%ZS*6%G8@<53BKH5MQO[4U2G.^Q\5VJ$<$LI8X^.\
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MD;DN9E-E&9F2!QS_!%9?D,[R#OH4Y*2_;%?]\,.0M_"[!J!W\<N'=2U>7VA
MH/Z/.M8"PTZ+#U\C#<H99O8VZ@P.R<?H0?:A_KB!LE<4[Y1>^'N:.CDG8=D<
MSK(FZUH>5KIQB>R<5N3[UD%1WDU0YT7.P-PI=H_/KY@#(1Z,CXX0$8 V8R(-
MCGPHCE($)%M@/? EM5Q/SF^R;/"MD&6#BL.SV<9B:)(#"I#2N7HZ["<PCD=H
M:H^[I122M[+>C%\X0_YX]/S'4TD%VH4\%8,X4K!_OTJ\"/]VDL$I1K_40#7
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M^0JL#H)N*^UIOZUN@7+B7CGZ>!_L&:[GT-O=^6RN(_QTI@\Y/C71/Z$LIRF
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M<&&, L7;HK/E^.!&7*-*V8.C'V\1LXXWX&NF K+V=EHH<.?36BNFL< Q*=H
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M%H^;%G_[<JPE]4K5SRYNR3&IRZ%?%,X)Y*\ML;KN4+/#Y. BJ"L@3L>2?A,
M%21;W((IP"GE\F..<>*Y2N[< Z 72P@31*)'[7]NB$1S)1C>?XK+;BUM)517
MW79<F@C+>R2[?'X!.J::+#%N5/+@OLJF/W<OCN4+RF[?3LP> U!G$"EJ+_ZJ
M8JG6QJ5 $%74_?$UCY<+8>J#6J%+@?B&P:,V<5?3URTLX=="M?8=D]I_T%<*
MWH=B2ZU>&=1:!=1ZV**F%T>7*<.:JCXB AYZS9'#GEIELY';D$X'5FB<QSNO
M*//D;WII$]190\]Y G#D3$4)MQM.MU8#3E6P1:E=09E7T\]B;(>Q[JAHNY'R
M>U$,@]M:A5-ZDCC/\^V?QM"(&T,NV0XF7YFE%@EMF,IPD6D$H+(-H>531,94
MF#S +.LB(+-D\8S2DE;H,2,+6!8O7E?:>LB%,V!E;OD+OK<]4B*T'.*0M>;O
ME=Z8KJ</=RY55B(CB'3O"K:$,W<?E(4.&\)5(]K5)NTHL"1*J4@45*AZVA_Q
MTXO-0Z[@7PPQ?5$>V*MO\334[^W8F+E:*M\/WMM3ES'U1KKW'W]@P=E2"M=V
M4NB+X[D"QJ!,"4,S#MZBJY2R"IHEP\)Q<,6>]E&S(CH5><<![79[R%GU4/7P
MZ8"LTM?%S0?_^3O::UY\78;Q ,T-8V)\;">E')Q4P;0/_%0]M-QD3@W5E[69
M]:9YARF?/GNICO<%Q?AZZ\(%^626>]@T:%EN85\0Z Y)X!]+XI@;,P6PIJ=V
MA&"?&NA25O<7=^*BPZ1_53=*>._J8]DE+MW*ZFCX@P\T_/'C:\JA$>UKZN)^
M+JXMK^LY&7#2$MK[3PH(XI#+CH&G_2Q.VS+89S]'.<2]&*Y^G&RNW3Y/MO9M
MO5RAF7PY\NFC6$&1;TD3SLQ&0)9U$!SS+ZPH3"_L)_<DBI^M,\@]B$9>:1E)
MGW$HBEBWIM=FJXI]B;P]?;ASMK6'5UKZ1]C?AU!Z@!1;5'2F;VL!9NA(-/=*
ML4JWS91CW7':>_&HJNAE8^USU(.7;VNK\WYWJN:AV['%5KF"H$*Q=P(UGP+^
M7(&=HV<L@"4C!=BF0.R1)')Q%T>^3TB%A74<44HAMM6F3X3%"C\]'T,9?Y>I
M;S%XK[XFDU=N^%KP^\^A(*ZJ!ZL?X=1B[YXDW$\08>H ;\@@"9W(Z$%* Y/M
MW-/U(TW29*+$Q5 M'%OA[+S_GE$O5$O'[H\3A<,96-<8ES=.!BT*$\1D>3E&
M12>X#PAL*10S@%-$<.M_GJM)EUK.8RGWDVBAUL ;*F&_Q;O>)\6 Z8T,F^P[
MCA8O5K341!TUK\W+N(A.9;FG6^N;?)?C%H#.O!,D"Z *X>$;M]EN_9PF )HG
MSK.QDLS2 4'QUEQT=?.C7NX^*9;4Z\ R*&*D["TJZKS*HV3D>%<P"O6GN'W=
MF^#R(>G8MWMJ*9\;[B4]9^\\'DKZKQ? 23G$&K>.U?$@KN!UNEM'+9<'J"RY
M^ Y09F;2Y2);WI!9O6^TE :\-][G#3'G$_)5R1J+GZ8X&7:?:Z$/':Y[OY':
MX@)>;3 9MO[2,Q)JK[+5G@!9^9;?+R'S"'MN*-C!(B&B90^0!TX@'JBG(D0]
M_)#H8E)Q# 9*149OY2?]S1&[V<P0SGGG"3."6&D)"?]9'+Q>)U08_(WG G2@
M-J=D_.'6XYR/'AF?D LA-6E%A45(^[I03QJ,R]?PN0D?2";5UZ;KOO/U_;)H
M>MU>,:?W:4*K*[J?=S6$M0W18^_<AI)DWV>8]E0 2MK+W@R1K@QM[8GIN0ZS
M)D._T$#-C(SC_>W:FV'2G\2L_@6A:9IUQRQ[3KVHT[G"0:D<.?6X]J;7_DOI
M$^"V3ME[5^2TR:W-'Y"C:NO>=J[=R^])O^E2];#&BSTA8:.DS\EXOMSF8*J<
M68].?XL*  *QB*R=2W+TF[+;$- JQFU#[O6/^5-6:O*Z&)XDMPX1H7D]6-43
M#4",[,Z0BCI&8" ZO_RE7ST_$9E]W5&GJ7NUYL[D-B1 ;"AL'$ZW !M126*+
MA9)NXFKGEO\3!W(-X+#,  +)L1I^H.446P'(*7F(EQ<;KBY5W]_PUTEN8&YD
MP\(QY-O)H@RN$OZ\K:CA.Y^X;V.4LR(K$(1L@.'8(_64Y@M]&DE>K)NO_;\]
MB^>=).C*F5,'"3B< +;-KP7ZD$@WWIE)X9*>5@HZPX2>,!JUH;:KJ<+3.91U
M:<%7Z7G+@<JZ/XC*Z8=$0D(X7]<?H^H/*_ D9"5B67#G'A18MYFM7\MIQ'I
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MD+&UGTA9<J(C4',0^ 4.<$Y#73.7T## $OF(Q5!<SD8PP";*_=-!'F-@#-?
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M2GY-7&H*?@V?NNKE<=6_XKXN<^5N_[&VOTVUU%J4>.KNT+ ;^)%_N_'" R*
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MS@=QYY?,188OIF06%S&V&?Z;_\D7\O]+_B.2^F51UGAS86)F')<S!!C1:8^
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MT+/?9B)45!YY8&M,[7C.@:-SM-Y=L-DL ROCU.'^DVN"LA\$>@<4_(]>S*6
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MX93$Y#,"1JR?I,G;1HN)C85'>YG6J:V6/:6[C\I:]=4NJWU4\#6[^$1>6E8
M%..S?]7S'B@^AJ6%&H8W!DZLCK)->A/ ^U":%_Z\OZ$"8,CDZJ&RWU&U58$\
MF7.*P]A[.]RKC:PRKOLYS>,;X/J^IN':.>?$[Z'H3HO]+$Y-X-@G-]D)]I[0
MTDT497$C#JX'V$6:.+X@S'OJ=']0B[3\,*8[HQ#Y>FI26_YI[:+XP)$;(Q?%
M.*#.Z,YS9MKL&;X ):7N@2A78+*L:;VC$MW0:0F:(3 <'193@G"2"J_Q[MR5
MRYVWE533:#T1>*=]V"R[QD]D<B#"/S3#.NCGZEUZW,%-R$PN2S",TKQJ0]<&
MFFGAS+_W0-[0%"\- $^=Z6(3J35U9""I\)K?[B'$*,Q(+6OISH>(M;6:H+52
MNEHNHNGQ*8^^I3=O8]$7V9K88-D\&\_&IVLK92]97]!@I%'1H3%U74.&^L(:
M]SFETPCOGO$0ZY"PZP&*8>KU,Y\/4UHR5S(/V"S#R\486^C.1C0%EIZ$H<#0
M@,H:0Y$HK>XS;'8<>9/Z=;$'+H2P6O!_3\GT],\QTL.4SKX53QFBR9I)/VG2
M.G#5?0[WPNW_?U#O7P("6S"C4+JI57YN9FU!:EO?(!?':\3B:YJJ? +10;5&
M1CWW,N6O&<Q*Z-9;@AR;WS8W),U-C\P=LC6^=P3O'RAL$<Q_0D'XA/>!,Y:R
M8I=/_%+5UCP$W)>U"KQ%Q.\>:V]40NZV'O4IC2K876N_\@A_4UCPIGP:;VW"
M,YG[C%^<J@XC#=^<QB9_-^GE9Z?TOYT?<&A*6A\/ES2^U5SH=?+@BI"4Y$W^
M,ZLJ=L.KWG4C9P8$CO<>CT@;LFN,^SBNGY5[K[GYRKQ+V$"VPY7UT,B:"R<X
M4ZFP6!.)A0*$NHD_61.,>,FKK> 9=J%^#)D-Q4M,*X56%16?YAFI1-B2@_$8
M#CO=H;C60^3@0[.?I.26SPW?N4=_HA2V43+ =>''%1"O>IRQ*YI0K%*G9%"B
MDE88K:%C+G:S.<WO1X)?2;[4UTS$36?$#RO)F]G2/\*O=_(8RMY.R'WAMRNC
M/?,KWRRWQ/VSCH?=P6SOP.N')P2VRW-4;Z;*>7_IZW@O(Y(T]3)6>TM6U6Y<
M77DT/-6(X#RZV)E/<&Q,6!_T+)?O#S9JU;B<4NEC8)(6XN2V-)Y_1VAZJ8GV
M(3#[W2'NLE*^8']>6:[[U%.]\:\.5$BMNHFBX(_[&!6<'\/9/(IGRPZ!*'$$
M?$DS6&'I[!;63!;^0]B<Z63(J6^Z0]D_=;L^FG2>--XF914%O,O"R\D5."=[
M8LR'52:N32J,_Q@-5/YZ0ZOR_*>H^+^"'%X*5S:=;43(N&P7+\IV&G)%<4RG
MEU\ )0\H"]T].WCV5\0!:>B:H/282'[/*$.3O*HX_W/M_)>&0,4_E#\M+:-G
MEMV-"[+Z/ZUW"IL0E)_W7?F.N>2^Z<"CCP5@^':U-T:N3QH$5+JCK@<2O<?O
MJ*_5;$<$'[]W;]8:9=A?*V()"%!\\5%QM_,A75A._]Q?S@MM]92?!6+=H4I!
MUFF6L=K/@BZGG?TN,X'=R+!1D4V'=3NE1"$).%B? ]<1)0V;N^8<SGJ/)DN*
M)5E'OG!T[(Z-10S"YA'_CO.U?\F_Y/^Q0/>F_AM02P,$%     @ [X-/5"'R
M?:MB40( F:@" !8   !G-&)D:VQL=&PU>C4P,# P,3(N:G!G[+MW4)/A%RX8
MI"N"H#1I*B!=I'<B*B @(+T3E0[2!4)+%*1(E2Y=I(,0Z9W0J_0FH?=F(*&$
M0 K+[^[.W3L[^\>=>V=W[Q_[3LY\D_G.O%^>\[[G.>>9-]_5WZM5P!U--0TU
M ,GU$"81!@"N%@ O_LNW_YGQGTG^9^<@N>H T%.1T9+EDI(\ MR@)R&E)[GJ
M 7 ! "3D_[L#X/\8)#=(R<@I**FH;]ZZ=JB[ [A!0DIZ@XR4G)R,[/IN\/5]
M !D].<-#,16*NWKO*!]YWA/_G)!'Q?V\JI-1?P+%(_'>*X3Z)A,S"^M]WL=\
M_ *"DE+2,K)R\B]>JJJIO]+0-# T,C8Q-3.WL;6S=W!T<O;^Z./K!_8/"/T2
M%AX1^34J,2DY)37M>WK&S_R"PJ+BDM*RZIK:NOJ&QJ;FKNZ>WK[^@<&AR:GI
MF=FYO_.(M?6-S:WMG=V]??3QR>D9YAQ[<?D?7"0 TO\*_?\6%_TUKAMD9*1D
ME/_!17+#[S\.]&3D#\4H&%3T*-]YWGTD_IGJWO.$O*I.:FX)?13C>Z^)FTP\
MDFN\Z/] ^R_(_ON A?P/(?NOP/Y/7 @ #2G)]>*1T@.  "*>_V<4X/^W_]_^
ME[ SY:P,@5\D[.&R<EU9G,#OF*-G])*-N/;"0,Y A_' T_-2^G,Z2_:[($%L
M/B9[7%$$9QPD0TCEG3AT0#/WP,C!N7WFOK^;F.I3K5D_.^2P4K[@/NP8DSW?
M.WOM:#.4VW.9,(USJ !HJ-Z[0:5T!>B/WWM&?D^?B;0"('(OG67,^5G'YJ7/
M#TJ]UT\4O(_V+@V2$RF@8Y* 6H-;GZ=R3TX+5I"75X"SDAN: B1CFN;_W\?K
M_U&+P=T]905^.KH.4?I8^U,/N;?%31R1BO0Y2DZZ'.+!'G*L>_UM@'MZ.9XK
MK)A^MV"= +UKU_^KS6YR>L9!6C^6[6L]M5;A*Y)(6&IY*\JJ>/;CEME/^%.@
M4SQ6T*1C;'X!4T;(A=K2B;3ZH=TW(B)'8_V+'3,*2!1)[=$]LQGA;77V"I4%
M_O0BU%%O;"XB>4H(BL_]!B)^?G2WIN0B?,@)_\2EYBQ@:[J6J&'V_M7XP-'#
M'N?HF?3+)V*CZJ09>#I"!7 5S@6X C@<1=^'=^J&<5%#'D.F..50R7U<;!9!
M<M4)IU< VE>_7GX5.5Y84E7H(94H^\+MQ*$-@%Q.@#)!OT7Q]PXPD"M R!?'
MC(T@"2("U1"G^.B ,IK(!:Z<^5='8 BRRQ?3Y/:?8?-*,YT![XW1$U?@*$.N
M>1R1^B3?Z0Y>77XENIT'^\NF,_<6GMN%]PH063>OL7!'@"JA@L&XP\PV=BHG
MZSZ (##F=OJ%-"9F=3-8/0!_A_#M"K#:SD4"=XR/-J?L.(J"4K?S0D:XZ/$.
ML@THXTPTTY!1-9ILDAW12_L#9=[-WG K\6OX6X\B> "3T0!/4A.I />1 ,G7
M%TDM-X? 9S_H!H#15X#C=/=Y('& JT^4(-T#S89TY13O7U\4@ZS=L8NP?SD>
MZGA3W>A5TKF=J8<'N]U3\#I(]W]Q 4@>4YW]H*&#6NI/LJ]N5/"-. RC/YZ1
M(6%N73L-T-GO_RADR7"8ZT29IOQC/"HQ]OJ4L_4,^'HG(URK1*^*M_>7@P<M
M3W.8ID/1"]FWW5Q^I#EG-[.U]&.SLD"21+XV6* S;@&N,R5@/B(K AM[8KWL
M=(:'N6K1]'RBF-GAVUIJX6!49['YN]/0]E3LIEB3QE9RI6;<_LC!'D$.%@9T
MT5VX#7< WL,+H99SB_<RIL!7 %-M98QZ6ZAO+GN:V,*O7R7(K4_53+1+'OZD
M&3CG6<SL^NCLGIOPHN4+\@$!;[I1VUC+WZZ;XD\.Q1+BOFRW"1N;Q72]0X'3
M)[+E6:X 3L)2.F8:&@:^KO6Y@EX3_E)+[./][XKU"[F<-'WX54<+WBD]%% ;
MM,:D!9\C2XMHG7JR -0LH\$GB"K8&>&N1BW.K;!L;Y:I2 ^0LWY(%CIB4R_I
M).-JG! W8S#(3=KFR#O24I+@]O!XTW19QBG?*(&==%M-"S]Q3.79[0N3/MZ.
M[]3_)>*C<>H+EW2WVX)D2I1EYOXNMNJ5=]-*U&L)C=+0\#Y@YIEM;O%W<KD'
M8<64A/56L3)+]\>@%97BZ/"UA #?HLS,-P69T:X_&%;VGMH O).V WPP%?IE
M.T-[RF96FGM/U)"%Q.!+QSL?-PMF*]U?YC0C9AM (J(-Y6DW::V(:DMU6)N$
M;XQ]7OFR_7+L9]M%9JQI?$T#_>_VSCBH8>%7 )=<Q#IP?J53GB^Z5>1=(7C&
M75'7?6T!BQ1]E/*!)SM9?+#NJQFC*;X-8G &- 8S]VJMKU""'7JJ"^X'+3^8
MK) 2>^_VR(P9J2<<9G0K7$%CEU('TE8S7&7H(5EUG*^?<[].72UYRHB]4!=<
MLG\I?=I6N301VC,%+OMN9LV(&@_3S)D5+_PW7>$BP'\2H"2?C94#7$Y9_98]
M(D+ER]@/WXCK?;;[8)/0N5&I1'VPL/SV%O3L('S0=<ZXKMD]L+BA*'4_+LU5
M^#!#-UVAV*=Y>3F-\TO"& QKL'?/E>5@1.3&3?Z?G_Z'32 P<*?XK.#'C2C^
M__4L9B-IW*>_.(#_H+./CE()R.5N#CB!1X,8\ HHE[7X^'8A<.TB'4V0/*H>
MMDX(FN^Q;]+F4ZU))9Y:], E:_SII6<H$SVCCH_FH9A:[&W<._S3R78AR-BR
MTD2KZUJP3M_D\;806V.NR<1V\R==0G:%4^<?#/.W\.,_7G%F8)Y5+DMLPBJ0
M!J^'XHJ!L(%GNW%:G40YU&'%6BZ#T]"6-C'^%T+#)MB9Q^#;Y,+002O[CP<8
MV(;6QA&>_@J 6;[F9^T@C19"\35G)N4HHKFB(<SJHICXK^VDSC)^,G[2EY9D
MEI9[5X#W^ACSRIQW=.Z426YN7<C;#S;?4&*Z>$GNE7@5)[*\FZ@:C^MFO7R?
MPD.SX.$=V[T4*#.U#*<$KF9 45:@3]#ZQEJL!MJ>!$6'R9MD=^)\@ W>$.">
M$JFS<EZ\, ']]5ID4<_FV1^JIVNV<Y-E-SE<].KR;6P,ZX*3%T=O$@^1Q=G=
M9/RR.[)[SY@E8G ^F,M+/;TC2N'*Q,':.WDS*1IC;[W#V4OEN$0Y1N1D]0:5
M-T/ LLBIO;_CI"7_39E^#I:[)EJ<R9\K0%UQ6+LB=F/5/5J1 R<-[M?%^J-=
M>DJ9DO*P&WJA2'JP->+?]Z.ZR/=7@-0TZ=^)[U0&?<F\A/92-U9BT =[?<YW
MV7ZS>; %G/V3&RO=F5K( !#I(=>S=P(_PO\:$&^F7P'(AN+UL4GKL!@H,T04
M>[EAB:U#W^V526,V,3]L(?4?G=7PX8FU*WKA93D_GZ==E9 5/$%8I377M0?F
M/LM?6;B8.RZ] I!'7)-H"!S:R:O^()[%V;^3E$?\$XDB;6X*U$C84,%AFZ1Z
M?L,1U_%$CL=V!_9A(P. N@(@;/K\N.@@)$$@=%L.TT%W.RF:MI#VY!MOJ$YV
M2ISR&MGMIJ.XG=R>(ZQ,]RK\\R'4#L:.!\])WF:SQH:AX]=SHWR0WCT!]>DN
MI<[VX_O,G*HABU:]DC^72%&?/M>I?]C!1&/R485S\4 'W5AENKI8N[:YZ[J>
M.H20]G&7VIJJO%'FNO/@D\<\4(;Q@NX*0('"+JA,7^\B9.!:;-U9*^0)U@BM
MWMO.B6:*2NK+B,WZ6K(H+#'HSNU?3A-5S/!4X!N%RELJRM$<A?$@&9SP=52#
ME.^-H:9>_T:%A^)4L#0(\/#+R;RX?JV9NE#9>.3*^P;ZKC0%+:8D!R4 6:C1
M]6_152&4 %?;KP#,/K#(5";(HTF@0_P-<R=.EO&Z5S_A4Q4^<B8!*X4I7</,
M&;2:]8M%P>4NF$^N"AM //,*)@ U%^;V[ZP?J[K*O4YW3Z/X50.]8QK]'Y;.
M8,D/$[V^;]@[>G54-D*<X1W!)II8@>MUPA%^!/&NMT1^S(3'6E/4SK7R>G_L
MXJ\3>!33+U6M]= 48<^#5)53>K;]2>$*@)5M6:,+D83/TW6":BG#/W+P=0,9
ME:F#K%$Z-6M EMV,X,KT\K\6[57NF /1>G/56VQF&]I%,HLW:UP['L,M3]T1
MT"XB&2%&\2%.%Z\>;=F,&HGH@M&":WJBUZPX=WK,\56QTF3-:9J3(E1-TY7V
M'NPOJ&ETO,"PX7BLW-W>2^44'*D%ED%K]S':I <6S4E^O6G"6H%W?R$J:X0O
M9VJ];PD9*MN&+%GZ5Y>)_QA39(=T$D=R +KDQ)%<<B+704!P[<I?X&U%H6*0
MJ;/8BV#;:@YI:IZH;0'Z]11(D'CUNC3[,<D/NB[=+T#4&[I/5X#Z*P">B0UC
M-PVYY70%N/>A B^%8EO_$Q =I(X-_ 6F3Z_\^/<F[R_S&N:6AY9<8M166Y]X
MGNB>CK7PMGTG*LZMG_<LD:I.7+-4=6YUE-/])_$%0G@*;/VAY(CX:*^M4%&7
MLHT3C44]\H82KFJ!E!&GW#3LV<D3_X>HG.U(,CVK2)\%O=R;81.PQYQ= 91/
MK1&86PO6"$*/R.<'%W$4M-[C60Y3:/RER0DES@W/3Z@X.T+P]=^'A9[J1EY&
MA#]QX\():E/L&$5U_A!>-HO_=U)@=NO\=^O=HR2"<C5-U@Z>Z'-K(=QCRRAN
M$F#'ZT'%OI&U<9V\!SN[C:"O^=U@1&-Q:/YWG*F7(/B[VL<U^^P-\)AUVA14
M*$?9*77JSQZ_3H6IB$_1HCGVXP0L+=>Z&'6&OMN1RXY7*-ME C+4NK.;'S!/
M\L(B*LZVIY^XN=D[,=($!*4Q2'Q]_2MT\V$W+57Y>8X<%K>V</'QMD%OCNSD
MV6U:&QOI%.]?^_2Z[\O*S)=2BOZXW2L^_"Y!SIWC#9K61?KA.%U6:B.BE>G!
MN2_1<;%K8J@%RVBS]H:VJ4JWS9G\N$.AA-LM%HS'H/- /ZV4P;T8>[H8.$I7
M]_-U4ITI07OFI/5W(5*SOR8*9VL'S5RW9L)^1PGMK0J_H+8BR774[PB"2P7O
ML(!+05S=DJAY:Z,T89_74@$^CM/Y5%/=HS\]HKJ'Y_E\"T<K7-W:9,$6G\'.
M]:(2Q;TLK>LYE'^U]I,Z=?3*!88$A;++$GSU6^!Y^&E'+K9V\<$?RV!U:S0T
MLA(OXE-FZF(28+=<["E$@.MFCC:(+4JDVYQ0*]M0'E^&M+G L4B<?I U-JD2
M#('28B-ZVCDF6H%K2\"7=555,SMBK9@!^B+[S]-BLJ,[(F,-4J?J_2M8OOY8
MH#T0,(RFZP7=_0AB---8#Q2A&'LU*9EY8)97,UUI+J98;:40<4<UA.(6)8V6
MS>>SM.ZQ>6X,XTP0]5K@RIT@Y_$?:,;#;'>_TAILBV9]:]3^%DGB)-CZ@^K6
M0._-VG>?60:E\#4=US6"$54$C>U[[V2'C9II.P__XV\%M-].Q#C_]&POMPL,
MX!K'RR5CV1*Q"BFV>-T>N>S[9S6M'_:,LLVAB#<%.Q;S??DIIG#;'S,P$3L7
M$&R]"0M#3PE;]"^+=ZSN6+:^IR)CE$TF&>2A>PUY&A\-Y)"A >-ZBSU98@[2
M\B%@TO0X<>^DW6"A2\G)Z]1*7:FQ;[!Q+=EKQC24[C7H?:T0E22HW8JV^.+=
M9!MG>EQ=2OF51-![CJ6L^1S/T+^JEOW#.6D>A(U &M>;^#T=<%#[Z)B7^+)_
M>)!<C=)[(8/092WLF6(I+9BQ5LE)N'3+VM!,.G<MBUVKS#EHRSD\G]X8EI79
M/3=@#<<HJO<>%R)_'\;:J><P&"2+ 'W+8Y,SYAPX LJA<O>O +'MCYPYN:+5
M9GP.AI?D?, ^)@W-+:EVQ*EGTG++/1*A5P 16A5NV<K\'JY:722I3QD69-V&
M_;S.9J7>]7L> 78TV_?FS?YE+,LT/DQVFYWA<>^;K8G&U3-8<_M-2-=]=R2;
MW<;2_?Z^*;"!\74GQ1V/TS5L"&R3/^C&3+JW-CRUN#"XK;H>V_5JU"8FJQKE
ML@Y%:'6WW\1ZHQ5,45RA9X-!&C\=9:JXG6OX'TB^K>C13[%,8L]W_@0QDG4[
M.U/F1&^[I*L+=MF(!Q55IRK0LQM3ZQ<RZV0MI55GORH?FFUN7@@48EZ'1N1P
MJ7/U,@R=!"V#L^"B'5KDL<[ZQ2"$BER@XZ3WK&(+#[(RJO_T#$<*F9!/0W*C
MV#31NI'?H5T6^9;#>=C83LM%R_E/7P-VY6(6/XV6?VZ\X=_/Y>&?"3EDFULX
MB$L_/X5MPC ,A):'A"0I.,L>D0>%O )$!9%O4-NT''\\B%R;D1S1G)>V&/PP
M&>J.$= KD%![\P=9&PZ;2;[N0CKQ]QJG"J8?H4RB?GBR)3<DNCBE+QE>O%_M
M^_38@E7ILRPL=R,FKE([:S0_3XLR](]+']C<K4+.:[2LM:3DN5>B1V)=EJ%^
M778]OB',RW)*.<\\W.A+[S:=:*RN:V08:U]2ON8*?#LC9*N>8+";$W_6\&;F
MUVFYDWN=4$NP<M>RA,C(UF(T>2O]$QD-8=CQSTI_GE7/ _V_^\;FA07WP]/]
M78-M?.X/N_LY">JZ>K*.\D09\EK1R3Z8.\&A7Q!O1A0$.6&Y-E9(K?#*LT$B
MZZX>ED[-=M/,XY6YTMD*[V\A#[Z^RWA*JL4F*^Y )3OB1OP#1>D#(ZX E.T,
M8+^UZSBUBJZSC1B\C%11.I6Q#O)[2_KU1,[ID4@65;78- DH=5M1]?-0C9.=
M*6*ZU#",U]C;S;+*W5'&=?E 6_XO(4(0)1KO77FGN-?,32NFIZ]>:<UQ3:!,
MIU"36IU0)E-20?YXHUSGP+8.&.Q%*\=^>GZI/[<9@5?J7QT0A*[1H95)'G")
MTT_[=A$YFRZGK@!KAT"*@3'\PV6!_I;>*T#/)316?STH]@KP9_C627+M M3O
MLOGBX@J )E,TL$"YN4+:D72BEX$'!$O"A]$  [/?S^/,:CZ?7O?#<YO%>*7N
MU8E!$"4XB^MRCY)+-XD/F/WTNNVRA-#\1@1QK7O)\8D_E_A\?@_)(L>E(W=:
MU)CYR!F(*GRQO) RB#PF!(O.B)(I&F[I6+)E%&$T)7U\VU(.'I\N+1P##7V@
M=QTA7%%LL8'&4[6.3QY;N/C7L94@;7+61AFH$,9O)JM6^7F2^LWC-GK;V:N;
M?U?#9T];%-I,B"J^#<P)JLIYXU> GVHCZ=54?7_..,HOI@BU0#<0-63B/C"D
M%D;AB)A-7.9 \X:W^'@'^DZ\Q&"2"JK-23[8_!FE'+#@]F =\5QAAKN,D/:#
M[A%O@L=>18#JIR"<""?H@H"G+TJX09/QR8-C$OTNCB^UQ5MIW!Q"?17]K';R
M*3/RT\Y3>?I9[,D%!1=;+ WVB>?N)\#G0Y 81;_8X>I_]C*B?:L'-H[;4D)K
MA&R!86IA7H$QNIM9-:F-Z;UJ"KCJEBWG_E,LSQ@J(2< <Y!AH^EU(R;I+SM!
MP6082'$M^F$A<.;"J=/X6^#JV>  %UD^>>T)IK07YTYMTG^\!=0H#X.U#0AE
M0*<6]_FYK@"32(,7[G>U2IPQS=[FW=XTU!^J!_)R]/MYW[!74NU4!"M*O&;4
MO'57IY;ON5ZTT;WU]:P,8U<E*=^YYB9LL!OMNB!KJY?\A8X"7;JF@5ZW2?=H
MBD:@LIN3FKA&(Z[:<D'9Q#[8OGHGZ7-\VUQ4DL=!#JU<YY&EZ&=%/=<-(-6N
MLM KY3\9?9FN);>@3[6V6#?,7FL:1,S#63O9O7,('MGB+V@$2(Z1X?8#B+*V
MJOYW_;J:1S&K>WWYK38\6=:Q&I+94]JGP= U/(T.0SLSO<%M\^0-XUC-9!<U
M1%>%W+$FM8MOAM_I$S?6G;AG9)>7P4XR7MY=,2?8*\#E?N:R>7^CAN>=M^TV
M#Q.H=* QH9UD&XJ^E'PE26JKK3I\!J.[WS_L5)JFTFPH44(4#$]ZZ^QS$MU&
M9 HK"H^*6A%F3J6AQ69>0#O9+FU1)_[&?B,?^W]U5OCHJ)X<#Q+6,7?89-(?
MS.XSQ7-%FV++&;641X(GBDX=B\?22S^.98[O.?P8V/0>NU?^2#XMAIM\31,^
MV  \(-TLQ]G,55B:NUII"B5E6CQ><2Q?1APB=Z5T"@\W<.UNUG8PB:FUU.6&
M&=\J%VC#P15@MG 1V@P=6].[.\63T_FW5%@^E<PSWMUMNOVMWC"_7O9"'"4K
M'Q\W!W34B2]00;8_+;W)S IC?GE4=5,\0$CAQ*SX(Z(^PZK^J!K?GRXV;?,W
M!RIL,'T(B%/9B8/4Z=E'J3UB-J,/J&[^/HWAF*^Z1!_I!\5\$2-CX"+=,GKF
M+\>^%8_:B3GK%?0RT#A1#_;W65I07T8<$$U*NSQ]-U.0,[*G.HB"TX/B@:P[
M 7>"GR'/+J?\CI^Q<I=P0(6-;#S=X</B_6T1PU1O_S6RD/W$K]I09J$O2]^%
MF'[^/ A\9*/X>45N8T'Q;-5 NQ%A$NV76!-W4'%N(;5,"'F3I>_VY-ACR[+:
M)"9#9\[$5=DUY5=22WOJ"UM;]-_MV(Y-FD1:6I(-#A=%D-E%N)B/6^53)C%Q
MA=*=+5*_L18."IW Z>M-6KP"WD@B"TOYXK]#RMI/J7B#>F-/8VPI.5%?3V./
M?P6DAMPWJ<GP_5C^>&;RXV8A3W.OU-'CYO+Y%J;HCZ>CM(%W%PZ(@>,6["0Y
M$E@H$+5>8]M6_24M9WU>#:)_(A@^L/,^]6#?HE+A^$8_U.Y)4.9?-AX&AG4F
MSS- (O-T%H!24LYK+'7.."Y*;UM'0\D@T+T,_D.><=+KHXNLF;EFK%J2Z^-"
M7F9&EU/W/Y-+88M@#KF]G&[EHD_=[22G?+DGRV4B(^UT1ZL=0#$3 TXH0B%^
MY)!N+>IM4_USC01N(U(7_^@(@ZG$5XLZS)SI187^9K((C'LZU(H0&*M7<MB6
MK75J&0LR6AD\%;W;9T()7Y7/B-'Z1M5'![C,51DS+^3M_8VP;?K*.C84]$?B
M[OES+Q+B4=-&5I1_SK(BMZ*GF$*BC(_P_+5 _B@W2F[54)==>"][8^BHV7PE
MW;>AXIM:BCI:ORS3/6W158IC:1(:6MU>6+%YNS]/EBR&YK3?S0D7R>V!H'M]
M+G5C(/_)C<]#/T#?%2Y+SDXW8F@NF:A7:>\-Q#Z>$Z'W&#7E]"UY$ ),TPFO
MV4Y*3=!4Q$=G:&B-Z1[X[+^TX8-Z!6B4\]?_:Y^J/C?)Q-]J.D#.?F=/FHH'
MZ<(N&.__[@H3- 1HW?!?FA9/M'@ L4YF-GP71VF Y;P"["S,E@Y:.WEK]%>;
M'UQK^[GMGP4+B&$?3"K"HAW#L^C=E>LV3Q#X^>89=]8./*\3:63L^)AO.)6U
M4/W!A9=#0M;J#8AMQ^KF3C$IH_AOCU=R>EUB+"(A+]STQG=D5ST'\V0;GVMJ
M'BX.SZZ0P_PJ<][FZ1_'K.^U!$8Y%5=CD^9&APM;!X/&,-ZCLD"",\WW?84-
M&'3HAX/1J(X\34ZH<FO,'5JH,%K;[*?[F3AUR&]UJB$+7[$Z LE!0N@BICMT
MNVU-MD)DQ'89L5#?+%/8VC\T[9]E]S-V,VFS-4-S\NP([K7MW]GQED1HD72%
M,^?4*\!+X?STM,Q^_9Y=])]8AS<0[8XT]L3203G65?;M<K8%,N%$D$6Y+;-Z
M.M.;;CE:K=N-R'[=H4+#H@5-"POC29-F7;^E*X"6?I[FKTSKH?*@5O1FH9RU
MR+PKQXJ6(Q'G8A^S4ZBO]=WAK;[IUIN6%\_6-L:4S#0H<X<O&H&E^,^$X"N
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M3AKXZ _:7^V=^E\;#R.K^Z?)UT#8K 2LQR 9OKPT="^TC+3"SL;>#?#M94&
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ME]:TGFZGKL"B8-]H0VD#6N3<5HD3.YRDR=;!?#D\M'C"IA^7^[^?.S;+OF<
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MQZ>LGR]Z]IK:'3+3ID23^SQDEE$"%2#>IR-+*\O(W?(O^+>:,>$#<P\=-^[
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ME;^QA?M]W$G\RI]5KD9>GT#:T*HJ^W5Y8LIYHA2Q%A3+,T"H.:S5/ICM'-M
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MW#M:>(>;3+^OM=P>NXD=0L5=+5&F,MKFAZX)WTMADJJZT&V3^YJ!7#5W!M@
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MD>$-?%]G*V<I-X_Y/D#YQYK4"_R;R%$GIGHA:E?!E;E7G03^FLW56"X)W!S
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MK$1*.L@B=Y(2>;APF/1T8?<\JZ<^CHPUZ;< T\_^D)Y?JDC8X-1\D0RS0L2
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MR4K"J\).O0'5!NH UO^A0%6#7Y\!OO10NV</'JL]/ .L-G"=1JKJC_QW#%(
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MZZT"BT;,P+HUP_=HZ6VAG+.<!K?\I&B:H7.4JZ>Y+2S0@6/?B@**"(D?4M/
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MQ)4&H+"[UG68$M<+'M<!G2:U/I\C@/>FC!#Q".X%$E9TC%.>G"_'VBU<+4#
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M=%C3A7Z5KC2^9J>G-AYW3^6_OZC.9">970[KS_<7"G0@;)W'D]D=@)2!3DO
MR%P:)V<H)UBHE>"2/Y,8(+X_=$:X65J[Z/.T7V9=L0VY+70FY N\O VZ1"@=
MR()$#\0T23ECX/UDT639<J9VR/O'RQYK!3=G 4@QC\1- 90X"(/2G$3:0^Y
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M_PG45-??Z!/3+E6G=1\\\Y!S"-@H/FJRVHBOO'1EAL^'79%W%;E\P8O@\,I
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M!T%ZYR6($LNC=+X>ZF%+&N<.!K]%R@ZW;)$;A0UW_RE![$FQ;1'CSV-;*2\
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M\EWE=&FO%!;SH+(KEWK6++MD/"A$W) C[[&KC.*<0#[1[4P@D(:H60'KTEB
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M)MH$M_'6T2.@0#BS9>&W57H['AV4&H^! $0):GBH=8[56_L>Q+Y/HWC7ER]
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M84B6C"G()RC-N+R:0DBUZ0#,L;I5W?VF\<U9?6^S!7<W2 :R ;L-P<5WP6K
MG[RP81< JK(\/#2SQ';G+>9ZHA-X^\#<SP?.(#;.&Q,T^Y9>"T$P9]#RIW\K
M>P$X;3XN04LFS/?@S'H9>NCTY9\I5_?7NBLJ7U?[N17C3^=@UL_3L:;=][+B
M(;W.$A]OEQZ"2=C!?0#A[(3Q;_GKB:>_AIL/4GGXH,F9[DV6!6.A571Q9-BF
MLK?:@'[2FJ:,G<V!#_HD];P09C-GB"58G<<4XO:Z-39:#8HW?0QSA*/[U6PF
M:6OKH>^U[?.8_+]ROKW]ZV4IZWL:=!JTXP) W>H%A_[)H0^RZ7RPFVD)W_0?
M-QL-* *SE7\-D;GV]-=N^QMM!ETI&K5DYLK->4W%/MNE.%,YH]LTO<W,!-,%
M2Q-.WI=2S%R265<,=@YCGV L?6Y\M6+HX/JU87/?_:2\TT7"R,V&3/"CS#B9
M5:&PY/GZMH:*?8A>\ '"5UG2RT""W4GWS'#RL+V\9K_,YN-7":TG QX8YC\+
M]N^/JB:#4OGY12N/O+1,).ZO<B^MS,W-^#25 +@ *\5;,>[W<OR69=CX7=T5
MGO8I/-46N)<*2ZFY8>:&_DYJ.NK5NOE7>A?$OM2^J.>O:<YS?7>>L%IW"'5
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M/V0IP9$8QVVA"GCT/&]EQC/WWV56+FG5V_U<X&N (,@%X)H;T>J2(DU#>R\
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M'\U.&I"&,8N\]<2%PG^K%)ZY+UN5KZN%CZ]ZJJ=J<[[.>/7[;Z#\"0T&EB!
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M?WL[[7G*'MIS#N &*OUEAN@2M.+7"(Q9GC_;OK15-S:%GSZTK.=^PJURW&N
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M+-OEA^B2NH/Q4M?_-B=^?8=^-AW F.O^;Y#ZF7T@ES!=WU")8'6P>9_=U7.
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M,X\-")R'J)#2<,%E3$QH>#0NQ>K4,>-]RM\?.![MB(-QMCT1)PZ>KXU*\0
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M=G[X7_F2?XGK+6HP$73=O#OS:&L6^]^8/Y9V<8@R42#6W3_N0H]T-XU&_?F
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M'U0(+;PDN8@%H&?343NC^<Q2&7N$!?$-^)SK(0UI\/0A69.0%T,6PN5?2<S
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MNK+ 6*OL822) 9N'%N^0(8.(^KT+E5D20QRY_F6IXA*M9?<B.[D&1>?RB/!
M!Y&EN7, W"A-J7.$20EE[3LWEBYPTX[!-@>BKF50IRQBX+K5\A)A!M]@<^J^
M:?#"1;PON +NZ']4"^-J)<ECYQ#AOF3VQMP=0T84]CL6V<;,XI=>=B,>)/+3
M]'<IJ.8<T+'+$(I",+D!><'&+Y>T?R7K1>\X"@T[.Z05H+TWK/*>_8/[S.T[
M<MI_\)(>/W9<@NN::IXNA+[I8$F:\0-^017O58BO@DM&*Z+2!5L5;C?#8ZWV
MI\V.:C>'3D.+7A!J>?-?]HUW]X[#BM(;W('!115EI''\VI8-8?#P$RD!BXBF
M*.2>29$5L7-+C$@'EY4WC=6-,CH\;#1G;_0%?9$+<)5P"MTP(7$:<Q5Q"BHJ
M+&V(:M7"<[8Z^T,<S@&Z4<^?"7MU^2;=^'3?C<8K*/:,23Q1A7=-_7@M_"1$
M:=O@Q2WO;%ZXVB\3) VO_XB6NF%;@ E.;2J=A2X\\;6MQ;,[ALX??V1Y%YI\
M74#6>.@?.I<)Y09Z7/57+^T6,?/,]'$Y2G'9#9FK^3=GDDO(B]PB"V+S&$FV
M@X$UA,6$XK_IO4OWIYK=R\U^]4LI20YRJN^G+#8_;+(^ N$?QE^AVKTAG7X<
M<Y(RS5<S?OGSCM$T;'_35C5[XT6)&80R5I!=/+2XN^@9T)H5$&+X6$Q3.C;J
MMI6X5<-*%?_%@A/OHZA"> A+2%B42G&W'=N@+V-"Z;"[VKAE_6Q^L./\)WZ@
M24+QYKKMH);M["&29B81/S=C-@,Q=6,+LFA5*^0F!?85BCTZ'<UV=]8\,K>1
MS.U*M5<:8(')"6>FNH<ZM4T/"S!?^/[76A=J%HGD1B5"&"1VT745DNC>[9VW
MQZ].5;87.2B9!R)\>]Z6(!:0/?0J1/?L&_GFZ4.7H(KM^A9,8\7D?<$W$AYO
M:^]J!U1>!.(U =N#PU?QGN^\Z/S1CY9OKB>&PYY=XQ;LM\;'5QK0\1'G<6WW
M6I]DF?:TVKBY![XIQ?)S^\\=M:4>%0:W>-9M;>5F9K-6SS.H\'<ELFE&U9HJ
M@]97IMHDQNWVU3@.$T@<V"4T"&O;0LCOY9!]Z:Q2?L@!=:O#Z07/T0T/US,)
MM"S!9*L TTD4U%)55#CE,IF3>-29H&J*F/3SC/9U8=DXJEQ6TR^9@;[335]3
M$XVC_K<FDKU_F"]X[>H#98P]=>Z6:EX%C\'H"&#Y4L?:2H?MAP"AZ<P1KBE'
M/:JSKU$]NDI2%4BV+>%MCNC"K95K@Z4N1O'-985%4VB+ZW)5(%NP4ZM>]YF9
MOG ;RN8PI'Y!0(DR#*KQO "T=P( ?8SAE?G%!><C[JP-*8GE3TD*:FVELG\$
M0<4>N0UX%)WS.> &A _'='4C3/O?.>#F>D.0Z:CAP:_"'G<>[6+XE6IEU(K-
M]\??&FBR,>0.@>\'ARBY7+L%%!?R?[#WWD%-1?^^:! %*1J1(CTH M)$0'H)
M%KH8&Z* 1$6D"8B(M) @"$@7$) :$0&1$I4F-710A" @'1)"DYI$(&Q(>_&\
M>7?FO'?N_?W.W#-SWSWW_/%E,F%GE[77^I2]U_I^+R4&_S''%%_&1JM\WOXL
MBL'<[-!SUIO3LUT,H'ZV-.^U/HT-\@1;Y8GK!EV_6I0:;JGZ/B74<)HTBBQA
M^C!_8,F7(5'XRH .>2#AO:=]^N?2KHPCM]HUF1NB1?<=S^!,%8JE]$<'(%70
M-2P!-Z%!F]TFQ7ECRAX"J+)#/I>TKWEI_$@IBQ-K_;:_Z% H=.&+NDN/PK.0
MQ& &5(5912A>:*%E@L(XEO*:_(:R-CJ6=HN4Q?B1RF**<R5#U!L>JQM#5WTM
M'3Q+M,IGFB]>[_UT5I%Q^2S)"D.Z,UB94EGI&7K-L@F6WJR'_#[#"5#4VFHH
M%W=^%K>5WU1U-:<9OA![<#%&V]'OFX^<GQ.*@J?* *&4):)KNUI,\$S!!_>)
MXO:B(55B^'12&LKU?>_BA,-S^FG)W#^''YLLPY_L/D@)NM.A>??5K:4DIS!I
M@X?9)QTWKD:\XG[;?06TW%!'FJG,SWL8J-M6+GDC[9**,DTB-"VFH<,AQ$_/
MBNGN]3@(R5O@ER=B..2;>F>:3RE@]9T]W#IXN=_3&#*TC3^TDB?2E/0LN\3=
M[W<&)V9/L@;_T!=G]Z='@E8[E/2"W2UP@ *Z'3;>3GQ60M$T^47:EK(B.%7D
M^NA-905['#6 2<2C7W<?MY7JEK3['5QPFOM>"A=/J]Z*D?XG*<V^P]$RC*&<
M'-2Q?!^20*+F[=G*G"&.%YWW/MR?-I1V%OK\^M=H];7**[7P!9^/NQF&7(?+
M+VF?J!!/S95?L,X,^?FZNF&E;)I:,^F_:T<M8+Q&'*+9 M<OD?'Q\HV?4\WJ
M4G8L&JJ?)!V8++GSYY2L^ES.@X YX4V%YU!".@O$W2C%'9'055KBD=%\A"*$
ME(E]-NM=<4(N97H4DWX9;.2["O_0JH]^DV*BH"<KU>2;J AZ,FTA\6RN&+*1
MQR&5='6K8DU-T'5,LFD!D'SZFS#A=^/ZS0R-4=OF1(:_Z\D_"&&/H0[BF>%<
M_^M9V0E55B/+X\CLM,@<^9[EW[SGJ#>KE5YP\ML(Q-@&@VS]=A_8_8#LP[J@
MN>C<E.@.Z#'@X1_JGTVB= %U';:N(2BIX>U<K<=&LLC0RT_".%:KYCG9G3$'
MC6S,"RK9IVXJ>6 NW@M71-#/^N,VIW[CPZ]\:X%3@YV>\3;8&8<9)WL]8PRN
M9(0\\,1V]6=\CLK;*D3M@MTN>\ >N'/HQOXCZDF(G2WZ1YV7:<F\ZV;7> Z%
M(UIZ_"+H,A2\EG97SUSQ$#T$9>\IJ\G%9FTN\.CHI$+L8I*.9JZ!PK4<5Q3I
M7"F\%T>^-.)[<]YZVEU5N"RW/AC:LGN= %LK(,#"\$>:3]%-R+G3:[5XH8T3
M7W_E-SSYV4%Q_!; 3#3@4"E[PGU9>1"IBX"02=T^T?K8=JRPU@]QXR_:?5IU
MQL$]+UXD/PEQEMD;_12D&O^LBYMS ;*V^0?M&YOJ/">F-W%,;VM#;W5*QWZE
M](WS4FP4-+?1UOCFXGJ?W,$V]91Q/SGIB;6M286(0E[OA+12G6/SN358:_R0
MWW<D'T)Y@,E+-R2S0.UHL%%G5\;L&/\1V+/=KW?U=G<-CVB&&Q";O8!(&C_]
M+&6TPT<,<;EN6(O/"-75+%I'GMY)P7\U_<KMV04^_EK'I]B#ENW>LO]!\O#S
MU.2(5*9OELF+G%.BCARO#E*/7SYC;H7GRW$FCV6]^2%W>Q#STGVDY.G[P@*;
M94]%Y66?[]\KN,$O\U54B#E_J\2E9ROO09<A!L@?;'4W&@U]B(H6P1^F*_K[
MASH?F!\=%9Q1U_CF_Z3+4CN5?I(R.33S==V':DH6J:.9_6:!JA[MU.<X*0^6
M#8ZK('!;]T]<*PV[K"_MB[YB[E.!*.Y?[T#[=5\*4&"!1B^[Q<"S%5Y9?ION
MOH"&/=I:M=*K,1KI&$T\[2D<$Q=UHAQ/RE=VV_YU^S2IJ$%.19AGJ.V:K^/7
M(/EZ^Y&)R75\B=/"->($D4=#A#CCB>!,"7?+4E )^7#8BIFV:;[VBZ86J$9]
M0-Z):X02=BM(&9UY)WYI,:P\V^SA51[7>_U.7LE!3U_<5(]W'0+9#:V\R)GU
M"\N<X.9\:\0XI?3CLE_/7,X1308*ZC%?'-]Q[U/UJ?,U:<4V1.>0S1"]DNN[
MII,^\NY*0JZZP^[,U;RS$Y,[66?1N3M8\ZE= P)F+8T "T<)&A]'7"$O3*_M
MX3KXD@RNQ\XOGLI<U$@6E6I7!VWMV8W(X@OE#^(<YWP,$P^?VUM"=^4)O\1!
MYNR)E#=E7CY>L>5*O_046W4:[UU6-%/[Z;FY*0+A,>>&C?VTSLBS%;=>M]F$
MYC7?W"?T6',H\<T2NTUMEHK++3CWGC-]E\T@F/T,[LV6"DO+-M729:]CV18S
MWW[_&IIZ&9^(+-#K#.+NAD?4<W<G136? )R)S^JB+2BJR>$KGJX=R4KK)RR^
MF!F%!C^/I;)[4NW"^G(B>DGHQ]$;\0N7[23Y ^!L]^I:Z 01>-EJFX PS'&-
MKOAXWGX:?D?K5_&?Y8<5+M=RE0:>3H5V%]2O>Z]B<O>V+#:37L /5V%>H/@;
MA<FX"VD;9WT.N-VL/YQM6*S1Z^XF:O8'37K5 2D,UGBW(1F\MW?]EWH7B+.&
M>U>H^+$N-\8(5*R?6JIPLZ#)*L6OA*F]F[WYJ_9)R5#"*;,<8U$YX=\UZS4=
M&I("5<Y#1N96NTDVC'0$N @1. QU$SVM]H!BPX@>*Z[10+W;WX\T5>!(*@\U
MN_ZU"YD#:7];%&0^YO=*'Q0:QF[Z*UU$<O.@;M!7)?)3#RTO9RU/@_)J5+[6
MJ=F5KY>K@@HO;Z!3GV'AJXLG[^I"%4TEO114S+AG<+.KE]7?]DHR<X'E:Z=D
M_.+W$HM7@K/LVS8T+MOW9B17[Y VL;W->Z:;RJ;VRCYIN<WK@C*B4F;FQ597
M^ 1WA]\_>(9[%+OO>;\>R:1C0M]YEP7*&W[+,9@>D3?\/WXN]__$]C)^>286
M+!.1(_UU%0@9X$Y$H(#K7I110E)G4H2.?DZ6%*:#!=H7&-=Z=&6$$O-^Z!U%
M)->WN#?P4QWOYOG*S*,:CZV>)V<Q;<["@+,^[1.'<[V*W*$U2QT)^C-39B5<
MV07=KOL=CIC=OA>U??UD!4P2:US-2/W>RJDG (I )!WGN&<+$H,8(DHWI7W#
MD-7T3W\3'T )C7B!1AU*!8VJP@*%>]+5&H$YVL4+R GC)J*!E]CVNL*YIOL_
MOWD5CY<6-JUW:*3(I5L6.'A%=MVVD($8S:!:"Y"BV'2);!9H$DH\71#D/;N.
M43OKDK4RW=H/%*:O-;HF\N8D@K;+N5B@")NR-'.ZJWFG5\/M@UY&S#E_-87)
MRO7XQQ:8TY6,'"SA-R;V9G&7/;;+2*U%Y]C<NG/[T< L*:6-O@<2@S_&WVOP
MF<>]>'"89J%T6:_LS=]J@61'&" 755?@P0+5+K59(C60N*,K A.>S6<'5:!5
M\U]JW07DO]925&M<8HFZF\=K0AZGY%D_-X'4HLF6)$!6+8H%(J3/* &5Q&G(
MW.4&BOTJL;,HV3U8JTE#V?+IXN"<R^W&A?3;IZ4O[$S \C%3<ANP:Y:&2^CE
MK?G#4VQ6_F*^[DR.H^( Y5EH(HK+WV==C1]X]^UDB&>X\?3[&8V2NB'_4SLB
MB8&2:[MAAD_%.D--N$"M)_UQ/NV3@V$B_Z#^![@;\V]7188G046A"QK_K<2(
M]_],B9%_;^2[D9YM7\;=*/=J>/3<;6AFPG-T&(9Q0N$6K$V%'7%WJ@.>W7G*
M LF0WMD%_+QUZEULG+M7L/^ZSQ_P)FR#WR_'SX(+).7N5NSR?<[%M3GO^<\*
M4N9N$_3; <@29"3VE-/*@N7)\@?U#A^E\ %__B8WM=1J+%2C&$P.57=BGM''
MKIH*6U9M<)@*7;-;7&P(GL'=J!E_.B;HZ77,Y>W UWXC_6>X<OW84\&]V>4I
MM/+-WP:]NWDC[,ZWN@@ZT^\+"##/7C55-I6O<RYM&*K(VENN4[S]I&8>V[BQ
M]X@)'^0]]2Y.]73%J!WV,O9X^=$[-:'!_KO<L^:[V^]B/:U_H[5WQK3J X*]
M*B:1H:C9,O;05CW[Q;-RW.O+[KX9VMY*^J3:*_:764V84,/U8A\;;>[2:^.E
M7D4C@IP#8 0'?=GM7:EUM^D&"]32U!T0L@G%P@#HF7>QBL^"2[WNJ:KMK>XX
M*D(SAO:6]J[]-*OW^)6')IME7V:!T,L,_WM3TH1Y\5/OHC']HS49U>C?D7A:
M/XF\_CL\]E31&O/[S8GON*+Z8/<QD9CWM7@FMU?4)]7GI#[]6$5EA1#EY:%J
MK!17[NMKM-.KJ&[*D?BYL:7B96M3(2]&D,.6<+5/:< ]4Z$K^Z3-BV>SK@[1
M]:^:@AUV-QIVL= ?A?)I9<TD&QK^ _OBC@JQ_W,C?20E/=V^LPBS@]B+=GVP
M_C>KK7FH3Y"?Y\_EVBDP7/G9T)^9V7]/8E<;[VCRBH;^CE3W!]+E]_?29/-R
MZYG26QR4 +J0PIQ\"5F"JL9XUZSX^Q%EM5D<N$>\?5;YQ6QY=<G3A@];M+>H
MEZ9Z9K+A#>:&?D !"\2%8WYS$AW NMS&>J'%QB> [+FD=0A1"MYQS$FY.<I@
MW=SR$^UZ7(.RN]S-E%_%P]+$:[]G:XY@GXYNC*Z7D&U8(+>D<8>YXM8>*PF2
M%-V (A]75,FOY)&ZG-I=C/UD.1[\Q,%P#Z6+)WLGK5?.XB.;]U.2Z((!U.>_
M[I&/=:H]GU'\]13#<QM(=!ER'GGZ4LTE_$:59ZI8BG7VF[YA$VTGA?U'#X%0
M#E<KD[\V+^S?-QLCE;$@QKU@:.SWC=B(FU-H@QY ^ .^1$PD7*!* BH P#KW
M;*D9'\;@[4(K442>XU&+6IF2YB=59@N2]WV1?/78)EBJ<+IIWMB_L+-PH?*#
MV\.:NMA;><;%SK+")M@N2^]S&+:U\41-<A-P:Y'DI"Z(,%,>Z+TX9-=>K\KH
MC$H9'5G]L))!Y!'_/C(RV:=Q:5V[TZMD(.?N /<FV^3O/]I  :^UTGR14ZA/
M@A['Q#/"Z >(I;F>K9^SPW^Z7YGIV>P3LGKR4<C+1 BDGF.W/?7BR/E$H?7^
M]<G/](L$_ZU.E!P+1/;Q:<=+T9\"FS1[5*L9(K1PVFT/U94D/'T;.#&R(G8_
MW>8TS\F+37<)8B?2-2KBL8H,S[T!4;DW^_2Z:[W-BP>V_O72[W\C.(!M2@3S
MNC)- 36^'VAG@8I^>U)%MZ'7Z:N4I3EN>I$=E3V>OO!0HED@FX'1-?459/'N
MP+Y_BL7_LT6.WS)NP51,]I6&N4PP,>S$JQR-R%T.L6O&F] #(-)P3:@GV9G)
M>X%]]]4 '9H7T R-QQ^B7_ G*\Q-UV>Z4#(B[4,-:/<M6O[(#6>USK[Z+JF4
M>21^H5:P#[D4B'8:0LC--@5T3'1\\RD$4-9-(UI\)9)*%WSN<4[;R!XUX4W.
MGZ>T;&.(<5U8LBT+!"@5TX5DY^ =6!Y4JP&"QZ<(H0YX$8W,SZ.$WCA='+Z<
MZZ]R?.'K#?6D*M'&#IMQI<G/,V%ROZ"$9#SY,;B]-/DM0H912_)!'!<,31_'
M-%YW%Z),F+7)J63\V/SL%N674Q,@F)Q%)47 R=X9ZU*4@LYF"(5]2!CU T6G
M4]D(<KUJV)7L*%[=MUXX-/F]TE#C40;-V.*D"R^AZ\E[8I,RDZ>5;8N?,4H;
MC6C7[)D=6/(U&(\I 2.]>I/$ AW,B*^0U4X_-MB==G!P2LG\[#6OUJ</E1NX
MFK!,7D_V#\EDR-H"40_EFC1^X8)/(J0JJO!LUL6;P8=]R@RA(<?/="9[+C+>
M6<SKN7#$$N8?NW'N;,[:M6.B\%P(U7<(!<#YO5NSQ !"M6CRMGT@RLHA,(\O
M\/Z-6.***'FRR':FOUW%<JDP&,W8Q$'5+J W6: 1S)(G\V J.9K)RZ,3UZS#
M'$;7FC5]D,^GO!NU-#Y"MAG>+'.2_E1YX<\%%TWPEX;H.Y-7-6.9+U])<L8K
M\W_,^VC N6&0@QX,@_P#[.:>&^T"[U["K.6R0 \$Y\#,['S,F/,P [:)Z4;_
MVR+&A.??PPW_6<)\M!@1?-7<J)ZZ-\#= R5?X9LLUZ1*,\K\^13C ]*A',9R
MC@Y6+[I^XL!16F*RQS,.W#KC>&;>'].% [1*V_;DT]AC<6*HT=;%F=])AH*)
M]]&"'UUQ$7+$WV%D:=ELKF]*RI/FG-/O=ZO"V0J??/4(EMP&K5XVR A8HU'T
MLL,.RK;59_1KCFXL2<>U?.M$R<#)%[' :?B:.^T0LSWO,*! 26YT1,"=/VCG
M^S)2B]NUPFKKPK5CZ-W^_CZOCS8XZ$G&/^$@H<A^+%#8]FI2(N2+=A.YLRN2
M NLPEHEKMW_8X/S2.U]G5)&WX4>DRR,Q'7 VR7D&>P=*R,"3S5!A;.B%13V%
MQ$./;/4@E9 _D4J5$1U[._'TZSY2] FGDH]=M1J=+M3(Y.<Q^ 5$BI'R[D>V
M,ZEDNY5[*!?(I.!<]%KA'#Z2NZ.O@"Y+:483P4*Y-_M/O4_Y/K&A6.DNJE(V
M>4Q706\1Z[<%!?2/,7EZB]WJM5Z3* <V'CUM,NXG)"CA^8R:RGQ_?$"TIME=
MJ"*X6$"N@)?=96_87LD_?\KVAL15H:<WKH9]Y+[7:0G/0'U2H NG4A^P3R+)
M$VDPT,R!:K.FXJ*?U>@TR^@OO->F[!Y;?7.@SOP^:>#,&JP0F:^HH#>9PP+Q
M]'3[= ]?X?SP#U+;T(,!-JHHIC%2L6OAB'LLT-!3+1I_,+J$Z0]L_G>8[#?'
M/Y4TYS];0);H>:<*$AD&# /F:X[^P-JV/7!"HU8%8-UI[U+1,(LYZAZ095;W
M'OXA??3Z(.9=2$BIP<M$V[=?8R;TSA'R]>9BF<]0G@8X0*>!>I(MTZ*[2 <0
M!X<:/?+]" G@\U]&#<^YBX$X_3R/B-1\__CXJ'O'&R8'O!Y>A>_PQ+ U4&5M
M%RGV6>0UTNQ.NYIHX,<A@: 9QSVSA( @L2[SS/088Z<S(:,4"GN(_DW>8LO$
M8<E7X <1-HQF%NA1D_(5X!L1$H,_XE]GJ#X;BOSS\*=JU6KF?*/.L9%$TI(E
M.$>U_/@A\0M'_7=-[H)'P>/'6M'D<_C)<,7[C#QC".( Q0SK6K=(SNV/<[Y'
M5';ID8>O+8?=UIT"U:8[.HMBFAR8/%KL8V_(5=*4$(HJ9@,.[<]B.3DVU3E"
M6*"<37AO-%VXDLDS3<8R>>"4':H'XQ/J_A8%W-:G? M(>/>[^30Y+[MLJB;B
M41)J7^7D[0\)QS]G/A@;*7O #S=(5*8]!&R)[G1W\E"+DTH=GQP^AB[W=C4@
M<-;)8=V8)\]T2Z7?<E^881(!NA9$TT;^L(]J**%S :8$%BAJAWG2XOBH GDC
M^W V%2CODKUM+\QE@FZ3*-+M\EQ.NR2Y)=8C*B;)&,(I,"JVY;D=^1F*;O\H
ML08G9?6_I^=&YW#_'4)ZN_\_,+7'_S91 (W&%F-G32%+62!@E,D+Z5Z3I=V9
M_80GXU@@04N5P$N P]564+S2MD\%LAHH8?NGGW0X<)U  N3AX4\Q0O2+Y.CH
M;=.1C?@:_>8&9]? =PY/Q]:]#+^='FD7OOM5=T47MZ5)(<W:8+IAX6@AYB&X
MA]K[VXC+9.A+A*!_24?>@W3M"6:V<:Y6RZ6(XPD*#WEYEYXGCV!?>ZDQ#QT'
M?-^/32Z/P*O1'0Y\MV1C#C1G[36CO?DM!&[+5/V:C;&8X'KV()'G+=B1[>13
MFU41:A34VA+9K+<-?\10CBB1#8]SDLX+L5%V^-)<ERBZS7=GR%KRJ('*U; ?
M 7?O61IRH&>2QG'4YX"$"UF0\*M\M!,#<I@^1R:U46#[F^6&9%/D;90.)-^Q
M#_UI5?%5B2 U+KH,[]_/)E!WG?;2!=MAMG&"O+3/>I]WW_0#R@-O\CYTQ *C
MY9YV4E)J-0IWHER!+NY"T$TKB*,V %F?!2+CG3Q_?RC8>/?1,S;VI:ZM+>BN
M;RR(^<50EJ+3(FV4]0??*JU%'HW=4)$U;XPS_56N-M/W8%&A/G%Z_M1),5E?
M$+&AXV1$SI)OO]F94-#6%J83!\BAZ *KY]BX\B PB9CT\BPJP5CE[XWB4\)=
MJLP:ZJA<N2Z?7N_A=<B3NDKK:_:A>(UWBV$F3,[H@V"J\82\I10W#K?_XJ+_
MX%#DX2SA7+6^0;I#K&Y,0VYI9VAT)W<!LZ[P;V'02)!#C]Z\[^BDE-]R?*P]
M,Q1*2$>S*6$"0BUEU$*]X<_Q(EI&XJ06]+[J7@DHI_W8[?+JA2K-AO#32S?,
MOLZ&5/K!!Z[L@(X\]AU('J:%GOI7-]"(%CSH+?E$;_Z)GG3!2-K7"PEX_T0#
MP589I!ZFC^VF%-'KI'Q4*Q3E.@KD["E2 CK (I[Z/N'-HH"X0N=,'3'7_L*!
MMS?$GE6'FYE]'=.YE_&V#X1,FO?MF7\0DG1UQ>CW?ND7TIK=AD]Q0T:KNZ*4
M8^O);!=# 01G'S(PS2KT4V0N+,W8W@1A351[8>_UI3C^+(3O3K=0KU;?8(>$
MN']ET.";,9'IZLH(^*#YF@\-!FA2>QC93#'D ).KLR)ICL$K915J6+/\-,&4
M)Y$%LDZ5)-5F.OKUJ^>]YMCFOK14JS 6C+;2CT_,:\+J/T@I>_Q-EO_]U<:4
M>'KKE6-&,/^KR6@/ICG=EN:+:KV+\D!-JE$3 &L:SPJ6O\Q8@BXXXOSSQXS2
MX,A\9?K8',XB^VEL"T8E:*X<A'(,^FV0&F8$>[M]-C)LQ61Y;XN^2E%@\M"X
MZ2+::G$[Q=3E$:8HGJ[ [,Y84P?,+XO4O\XJ(A;X'4RN47-JY.CTQ9.OD0!%
M5+<:6Q=((*1HQY"=6'!9(XIF 6Q>NF-O3=L.VB+Q+&]^ND52N\?1&L/)=7?N
MW39G+(BQ.-.DPT^CT)<M0817X'P"TY9> AC\B\T^H,^(,3Y+ER.;TX5P+<9'
MAIF"=%>*7$;467QLWJ$:D:R *"W5F[:Q_5(696[)54_27I)D4N9&L"4-UJ4A
MO2$.DV9@SR O+W\O>9+ZP]JZ&(5P"_Q)X0>O!"-Z9/:N<,^[=G&RSS:=D1J-
M JZ@10/9KE5F[+\]'<$3=UF@A!_,;U-L<<\+GI-&D>T.(3O^YZJD_&\=D.O/
MI_; \+98]3SU'$H$WN@#1Z97G>X!,XO5-.YP&#E=*@GD9W4R3FSSR!)Z^_/.
M_&'=N2)SQX>-(=1(LGE\\TD$+U!+ILWNO 1'&OK-J7$$IK8CA2CZ,-720)33
MKZK>.!N=6SHB2[BDM6,:W<:_OQ#,M.E=V"1E*""#IXM42#BXP9F\Y_R4V_E]
M+4]1NN-Z4BY>P<AK)C>&3P;'#W!3"=*R(Q<AU)^'0[&8V1M:BK(BXE'C!;)K
M.CEBLBP0VMV($<P"1:*$\&0B&% U>XPB%(PJ)RYU,4^WTC63@2$8_4@ D\]:
MQ@5*OMH0;<9?AIK5I039W3QPY^ W6LNKP+]5V6' <7D<$+1$%SZKT)<DZ-:7
MUH7+79@J<U@":9]QUEWNUX2/GCAR0WCBQI;+[_;1/;]E>%\Q78!MO?PH*";/
M-B6.^HJBQKXJ%+CY#( C1A:]W"NLC?+O^H6 %4[;R_+(4_BO8R<(.MRJ KE"
MM7 K9DKJ1N*^Q,<?02#IQ^K+I+Y_59:=2[VGI]?K<&LPXKOOZ%=21)=F+-,1
M2JC7@6&8,Q"R%6Z?A]7IIWSH^-(/T^ZI"=0 G1-/E4_V^$DFB,4_.GSPP!/E
MO>2[CRT,'I\YK/] :GSC2<@>+],%2YA%_WU( _97&RNF3G\>)&FA>)A]6+&M
M!O3+\+;QBH>5 ]O6;W[YB^U3#M*F?LU=R&SK%B^Z\UQ6!C*@TX4[[-ZL  A3
MH.WBD54ZP688\FB'O4M?5?YM<:X!!9L4V?"\F\*6<Z"*X$UX%(K\J*LR((1V
M !@R3;_MA&N#0HSE -0E,Y7[-565HVI'=;U^?;6X*@RZ(6%B>+BH:93*=OWA
M_<R6O6-KSG,^,3/'&/D(,#'4KX,%XJ]8-SP^JRIQ11.(LZ5H8PJR':3$5$34
M-2[Y/#S3^U7@S92BGE@O6S6%(@\#Q80ENB"F;6(IL:H7!_:$"#=>)6+C=/2]
M"]WE$F;018&Q>XM[TQ6J1;?FS<X84S=M \QL6V3"3:!N"!_MHCP^BN7/<G$6
MZ)8X5R$CT^71K&MCH_:7E\X),1*WYUN^R>:,4E9I8D@V]Y =2%%Q-#,/^#ZF
M-$(3$"Q'6 $-%4"ZCR#B;HQ6N0/\I_'TDZ<43^&LJ0N2!WC/GNM)36:+P8\T
M>&(S'U!*'B4JQ$)=U<0"'8AF=;/*H0_;1'[ZW-S[KB:\[/OC<'(P.9SR(^.J
MZ,-H,7[>^!WZ.\8++*$:?Q"IY@X5H//1[@9B6[&5V'4.,J9+OS9ZF\05F+B^
MY48ZVV"0>:_RU]J!B8M#JC]\?61<GIV1/4D,T\..N;+QEW;-'5HMRHAD@0CO
MD(<&&E4IF*N?F,-DG42$EO@DX-I]I/01S[U]2F5@9=#Y=6Y^G</5<Y OC@*!
M."9?+\T>B.A05!TI(: /CO_.DZ[/#6#$]M_*I7\-F'^G'[\/A)&EH#O !_X6
M24,1*K$@P^LT%4_S+O1AU,/LD\-,&80=^>]"BC8=*O"F\C=/B<K5N#KMDET^
MX7M)]H, AH)AN\'+&.#TZ5H*9.YA/@MT$-6*FG!N&0E&(/6&G0.W0N!'S=[I
M%F0]+I*SU0-7+CKF$,.,V5TD(JFJU  /*!A7ETZU2];.B -IA%!/ZSK;'R,!
M-_>:&I).7/*Q\RIMN-?KU>W!D ;4*).MS1R,:&-!A#_02CP^BS[X&\N-4*T
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MV:3,S\QEOKXF';T\$Z8(G[DU?MMQQB- )#T+H?WEFY]?R,FK$YU>1S/R;O_
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M5@76QP=U8+ITZLO7E#,7^(^<:^E_#"W)HO_-MSM'H1U5E!2@9,\:@XL0UMP
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M'#A<1P"%)K-A/S"@35PD>Q;#ZY;E$[UE)#]AX&5@-;A&_/*Y)DJ8MU325ZF
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M?Z:OQ.>H(GL^1G*ZR=R]*YA#V_E_J8B\O/E3>^CE%3=V=QM-1 0"N^0"JAL
M)\+C4>*(>T4 9'8ITJN1X7!G^/U!G6;2B?Z?QMN=TS^O?9KLXD\YTY;X'A0B
M8!B<DR;[DZ:6C\/ !C/"'@?/<[2V*M0$HZR8WH9L4\UMR&P77^IH0/&MX@]!
MW= <"/5A+9VAL_@)B<X9SA"U%UGAE2_+2*K5MXI3%LK5IM)J7DUR[SHV#RCO
M29%]XNEJ%'!;,X2"#=?JA0BR^Y"]2\7G?,]ZT[8[[O7IF4&B*3,K(_X/I]-D
M921+OG^)N@;BOG;;CB09R@6;UV.!] KGZN;B)24EMY9[5O%8X9ON-T7G7W__
MW'G4,-5&'A0I>^U2 WI_0@&_PP(H5)F,IK+Y.^(%]CYI/(FH74 N.$?&=8$G
M+G1-[._S(?;I$'1>H#O5 Q\NZAG6G?CES?^I5;!@G^/%M8_?S4) X)G3OJE=
MAR5>/6/XKG9Q.[DWU$U&?)U_GLB;6)X7(1V=0\7TH\:LF;QQ-&4VRYT_ZV7F
M$YYW8G@++^YFSE1*BG)2_R(.33Q[PKP_8\+!8-]]O<-7:MJB4QW-Z4))3-Y>
M,I3)DP%N_]!\*I"/F-$Q[4-\-.H;Z-,.X7T:9^1G[_/9ZM/W(7O'Z<E+UGJZ
M-XZ*=/,-AD%O/(%J=HOV;"_5UL(?77UER9GC3]B>@^(P%\9&-]4).$"OFZ 0
M3W>81?/8(SN@M;:1W3';?3JFM<-:D!>KAS.=?4NFNCUJCP4<>L9_<R!S?VH=
M2.5>;#PG?+ 9C:Q/1!=[* N].IWOXH6LV:SH?7/TS\$-V=IT]3\Q]S9YK>H,
M[EAP1YA DJ&B!UF@Z%[DMW9#%JCM!="^R@*9C'E2)?]O@3HTQP6CB\"I-CL
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M'-27/2U]-'&W'UAL]VO[>U'):4%X!U.LXWE&YO @>R"742<7"Q-D\E5IB -
M_/=#H\YUQ%5NBRSM_<C7X>2MW96M)J-5NS?+;_")RJ^>?K4U6DJ,D4<C/5Q#
MNLG]\CP["CN U1-26*"S\Y_TN2G2[IJER*@SCVG1M9U^^-2:DU:BDY#\ #8A
M@&W')>AG\R'+M52][..3G5SF48_.R@ *,K*]D:FVA+=*B,K)8C1'U9WI0:YQ
M,V$,>?\[^YNRRRV5:[W_Z/H6IZ[]/8!F29QC0,K5=I;5K3H(P'K=""BZI!+S
MP@/XC-]?1_);#3VV_967\ $NZP/ !XMG!X"RTU<:;OX&;K&-@M:%*N K_.+5
M_\E GXLLHV^M)!3V+%&U2.'XL-[/$9EML<"T1=XINJ_%PVO5FLR*YP*IO;3I
M.>O$NI$[CZ0(+H,:4(ZIK=Y@%MA[0FWQBWP(JN]FMB58Y+PD4W@8_%-$[5KK
M2U7IOG/2.R^%UMX08N:E$SG6Y66+Y+L_R<-YR]]Y]H9?APO@;52R^UXD')Z_
M!Z!LSSH$GQS*[X-YI^F<#>405Y9+@0P>96%S5;S2IWP:D![<*47HGLW+LR<(
M?"!(+T^XI=-#65_GH ,/ +.27;/(+O0,%\68FNV/9ZWX+/CE6;QC^-D?-UXX
MA)Q1K<_S=+_ *7DR3UO'_MAALPS "@C[@-(<=I_U6G^ D"YJ\='-MZK-N.Y6
M>WD-^Y<7S[HWNSUI?&?W(&G0-^N.G=,31G'*X(9.0NW( OMWMVW6GL'QMW7V
M7;HM(]="(?X,=8%F-0>6[$<@/%K6/.B&\-;V<:*?WY.C*@\#W&-2O4)-/P_#
M;<Z^6C;N&+R>W$_#(/[@_R%Q0JKCT=RY+UE'PD>A2G3U/XE_(P?T31$L:2S]
MM^4)Z*/%6S,TJ8:I&7]G/%)(_O?:47?]I_4OWI1]:/ID><:!5^Q1XSKA:V3G
M?/!^\@V#I;OUU\C??BVC*F.97G!L*P5.2F5.P4D.F]FS':>IAMU(&>(.\DA0
MW2V-^I704"5/O^8B^@<>&>>&Z=V!W9=",_#93(H)E8^L1#&D/B&=6L:Y)>%)
M]2#>2$^0X(P[-.Q"G8S\KQ>EHI6K,K[=A]JJ%XI&5;H&4KT'50;]_$!(%@,+
M%>IQ#.]#DYRJ5;N>+[Z<?4"U(0/[, +UZ3H2!0+JEC\VKGU,G<Z#7:Q$A,^B
MO9@6]'.D_F2XO]9#C(A^",2IGD0I)-5Y3QX ZLM;FQSL0S"6,4<TVOTW9;#V
M,K:2%GX_#Z&E0-C9,+Z% #@)3 SO*93XZ.%!MZ(ND"7[/%R^5O]<6)DM:(K1
MK/YJG=0LZ3:@]!.;V_E2:/$ \  FTTY&))M=QIF#//.[FQ95OF_6QX6$<A<$
M9VNBKD$%YD\N\?BEQ]R\HGA3T 8&@W6@21=0R<@/A2EFGB^G;7S)#OT*AF2G
M:CQ2@NY #DVO',8+7''T" Q5F+RJ;-_:(B7C[YIZ<UKH:W<28NP5^=6Y;4?!
M@2,M%VYZY[YA$ J7WKL#MIRX*:CE;<H8RXR>L0P(3>9R8SP 88N?FU+W"-4[
M'P,6C:B(0_Y=2(';I^1F(=[V;SB/P /FJH8&RC_6).;LL&WE/",= #JXF()<
M8YOPF]7JX-'Z83X<S9Y, 7-H1"U*R=S_6/!$WR'N2#.<DGG#<A73NH2+<WO\
M]]@:%!B6IL!"E^2A>,Y"?,V+]]"J3LPA.G^\&S#-S+C,>VV_Y&TU>K.TMG$\
MA+C!D3^O;::3&GA:*@G2PEI;)R&J*OP^Z#H"@/&"!(U#-PG(GLRT2:9ZO/7D
M*:5/Z$G]N3R_3XW)9\9 T\2?T>Y/9$,/D2^Q2*?<W]:2,K!YA:-4_7 LY) 6
MT0U7+1\VU^.C2/KVM%VQ=9P3%.G[WL>*\B(5C,LQOLIIX2JOQLYZH6?FF'Q5
M-"%Z,+7R5?PI,KP3_@!=E_Z ;O-&$Y&RT6Y(-VT@):2UQ+7:'')?< C*Y?%/
M>#4],#@(/&T.CU<LD3YVYJ/UC>=&E<F6.*LT%R%I.\C"?367OJ%>]SM@*\@(
MBBX7AX7?;X)\.(XB"/C;DQ:0/1@A**'S8[SNU'OB>RSY0NQ$['/]ZIQGT8"<
MW=(\[V2HK\9+C@ZO[7UA$AR'R88'A%%56>(N'7VD-1B_F0XS(.]U@@3<H8B^
M$JGV@O[>60'"547#V03RG)YAFEXF?X^OJK)@H@(?.3*3M2*W0#<GL_'0_@Y(
M9D;OS>P!T,P'^KMW]I!-;<)/8VDIU/18C-DR1S+L";V++LQXJ,QXA,9^0-=Y
M/T8"VT_'AX9$8R&];MO,D\'Y:Z(KR0(G9\)OC+6DBA+XV;!W8E K,[J%W\(_
M[:X:Z[']+P]EY=JP/P!X8?XX6]'RX%.&3!<V*O*?GNNYSW H//U9#*.,CR;\
M/7"?1/6"J2IN]"(P72R:^:4=\7^2K<#H,+;8<QVZH=C#\OV^FW_&XC%^\=DQ
M/DP?*V#LW92FMN@H8JAKW)_V+[NU[$.9BOX1-DL"Z[HC%Y;(JT+C"O6O5L4T
M:;\3E4 QL3O?=/,2X!:'80[,^2/,J2]D/D=XLM8[P]1O3P7& LG+DK<*GP'O
MY=W=LS5B%R?'L#BZF;LVHJ=["?L':MQ_F382ON_7;B?;J]MUHS*5V=N'7W9$
M+XZ5TIJ"32OK$N(+%V%KW24"8WBY_,,O+ QP60TW2K]^@'X]GW82>?+2S[>'
M(U!^^0E3SQB'J5_Z9/R3Z:;5T-?."^&W7@9.R62MA*Y1TAUNGEJ3.>2:*0A0
M79O\!$X&RL7KDD<Z#6"FI-V&C1>5B\-FSK.K/'*&TFEV]UM+W;$%3C-2G;NH
M#K"T)PRSW!5+H+8P18SHIHSBNXR/,HKL[D3&AI>Q(L=J5(FY*1G(@6/4*9-"
MFN@G<'AVG*[YD"=WOG;Z?/S4P\RLTH1I+WZ#<!\Y*KZRZ2*S[ZLD="CSTD)P
MV$^TMTCL/&T?8J=1@>(E;,L417?K]ETG3P=<1H%E)A7$EDJ'G8(. #UAGE$+
M!L\8%\I_?/9>C <=[8M.CEE64E5H?Z;WLZ4IS[$J4@%\-/J4=@Z=O+F?P;QS
M 4*ZQ/:@@VS,ENOU-,:8)26^.*4@0A?4JT@-E72Q\T#1WUR7F9@0S0;3L_!F
MX=K;/0-^(LC3/Z,X%T$/_-I.>GF:/'E[&2GD>P"(Q3]Q<["!N<8$OLK><YI5
M;D&>R"0=RP$*9/2"CA@Y5;T^[WKT3(DNYFU Q1.CW7RF)\4C@IG.(SU_AQ?Q
M(A W0:I$O-FGC5_65+P$F+?BRCO/]HGM &!&NCNQQ?8>+LBH#VB^'*1D6-$U
M:]K0?\P_]>HWT_@_?^(B!M<\@P1]EXA#&TK)[G(GF][T.26H$TO?WYB_Q7.>
MUZM@U&?Q^<XT,Z9*R/=*M:212\2JD_9;^7*I=L^*^L"&BI4JW3]ZY&6ZV#BE
ME1K&XH:A9-4N;TC_;#SF(SH]WKL4ZN!*6F<JU.8DZ,"/<$%/+4^R2S>><+5\
M?[JW+9BRS>1UH%U>1=:IKA?C$0KQQFU@ZM5% T\(;SS0/]FT!RX1W'@ "*QM
M== YUY*V*+5HFREK&XL-I^]#][!RF'I#(@N<#M\@U13D&6;2]7$H >I:9^$1
M?K#@9]R I/.Y:I7+;7*=88;J@_J[E=V8AQYAQ)\$X P0-_E6[WDY:IU!*KQ"
M32)+C-]]Y$E==AH-K=XQF#B2]RI@S#A<KJCVSR<SUT=0Q/H<ZR%<C$_TJRP<
M"&.\.@ $ !_ Q>IIJ%G=#G@]9PMKG[,B/T'=WYF+2]!RR+P\3E1L#)$R:O@4
M;-V2,'9^:,.-7WTGNA-8>P"@BR%[,4*MZOC?:&SE;*M,X4.ZZFMHJL9-JB2V
MHB%MSW5<<Y>-+9^8!J[K5\:KGBQO/''K<(X0WK\KT^\3"WZ.,S&-!1]E_3\S
M&ML5K]I$9(!&O:BO'=-,/XDF>LP_N2/X_>?=WH01\ASE%.ON_'@31HX9B&Q'
MB60TTWT)Q&!K$E<JW:J**D+KI)C$[UGPF<A7?WL;B,M\$3?C_\+UXX<%\0<!
M^.@\\R_(%P"@%[,/W;!'U'U/C::L4(5I9]:8DF2[?JT9Z4BU=:8*U6-4Z7O\
M6=]3A2I]N7$J&8B3LDNW[+4T;0V,;_9Q!G? KR,/_<T@/P#<1L\< "Y0R7_[
ME,E,M H9/HBWP;]P$.*;BQ<AA9;ZE\T%>C0LE%=_:B\A>0VS:P24/V/_N*'H
MUZ;%Y/ERG::S!B2!M7+@8LS#U/0>YFGR9H\6/[6$0&AO(W/BEJCWT4=N[U2]
M\/9T)(M\O4 Y -QJR;@;S"?"<?*IN>X.D'YDC[6[)\/IH) A'C(XAT\RXA(O
M-=-9*KS%3-#64DGZMR# &#0#I+QB5,%DF3_VI];M:($+ORU.DP68*:H/VD7H
MUTB,K%@7!8-Q1;^KBA,1 ^3#V5B;^4&VVR!Y;4A]AH&:Y2'^1X"?F<(#9V*7
MW]RSVD5U@7+V?STC:S'YI&FZT.".J<;]M"I22^=^7RWA2XNJ0^KX>FB!^\NZ
MU@*1W_?K#GT8P#U<2H(T,57J?NB#A=9,8*EO&O/?0Z:]/5<\7GA6=ZT4YO5]
M"8L?U7;-,YI.T\[OD))_PZ[:#Q>F\Y#0ELB>$@LR+!4G(/)#N<#;H4<FN_B^
M8A]/Q.5P#3__?E+%+XO[^$_ 9&0]L LS*VL[$6]/>M'#@P]A=YPH&Y=U3>9[
MLUZS4>U>-ABHWZ.M,?D3(6KM8[ ^W0OC@S910O_&'V@]?#Z2@0X32O<YQ?@(
MDYQ;,S1I2@NE"[SW >.R19WL/<ZY]?AP9/6R<U\^=%LO^ZCTR6!*)<6:^IFD
MBT=W+2&QP#0E$B2U%12U;]-___IWV>ZZ@-C4VAGSHN8XJ["MJCO?Q-*4WJKJ
ML:VRB!A,&PJBP*@0/#Q3P3C$IM48YW V.B[X];174&SYE\$> X^0[+++X+N1
MX2?<\3E&@X/$053WR#20R6M*N\"<!)(N [/0/,RCT#,' !RH4T 49U&,'TE#
M"\2?+>L-P3_<F?NL3!-ZN/LEKP_/5^W,]FAE'9!V5,%2.8G![;-",<FZZ+%Z
MY<H492U<?JPWDB.\(_1HR/?/&38WMWV-9WO!YH?A%G .2PC5"$PIG$XV2E\?
MQ5E;7WQ7FF??>3,;Z@5@5]#]Q O8P61CY$#!R%D$98D,7T^AJ<9?'_O;Z?8P
M788$0^*U,D B/TF+2/S"O80H)K93(:4B4.9%.3)/U+?UZ^IJ94YR\P%@&D7)
M993%\]!LZ! & AT"4H!Z]NYCDB/.M09BP1E1C06+TN C5,NOOH&1P="9V^\W
M")UYMZY&G20)B1/0'WX\;O^;L(R&=UKO($47;!1>$[QUNTM42,,-]$RQS=<\
MA/LOU(I2]&NHTQM9CYR@\L&H0EO27J\650.=H>>0*:_5"Y/_SAKT3 1+[*U$
M\\AO%(DP?YT[6C\A['!FXVH3MXJQ8J)+"DNSPK&E[<?(B'Z@6#P'J;*3V^(4
M_1+5VZ I#DXVV*/XDY=B%3[>:!"L#;Q'33F/SL;J'.,$M2K[S[;C&0]W,>DR
MZ=U\"WRX'9!HQ#8NY,::/5DPE1S7TYR>00][%?3=V/YV@SSD4LEJS/G'L,,]
MF?U<4T*]H%I0ZGHDA'<-4C>5R=+;?B\V^=HZ0U0[9!R;Z,>>ST>K9(+?0V]_
M$2C^\5VHT?A+U7%.*R5-(IH-QAF(8:_7#.W3C-WLE=G+T'^VNRFRMC?Y-M"B
M\JV7KEE^PG.#B%3I(KR^'[O1X#K;)D_6-A6.+'=TKNDREK)8/@"@+OUCU",D
M!TWR0OS1.<I"GQ<X$+/LP]2Z*\R$A7_W0$L#Z8R"OVI^/Z_;$ECSG(N>& &F
ML:\@]\\>#K[BE'0 4)0797;L^S,?=7I,_.><U5,YSP@6CR\F?.-"5:)QEM+-
M#=EIU94+@<_+J]M+*X,,/LY!5O8"ZF8Q'@,5QM7^21-EN</2:K_G'B=;<8A"
M>.G./^#8$OAA?6_);KB(7EB2A2SY>$M<8$6@@NP+V^^"M>&148-BPG;7'CV[
MV_9$Y\SNRI0"F>8:'U3+*('[PUG[K@PJ69R:@ 4="::,G@:N&!;(Q&_/])3M
M;%>Z6JV-Z].3X9TJ<.SS=B66^;V O@)33R"(X63)WN;[)H4]IJ@C= U2[&HT
M_$;:4/\EP\::[S$E9V;GA.4;OW_Z(\C%F0BJ,8_#5JY7X]#\BU!T#YR7*1JP
M*/UA_ #0$!:98-<=JU_]6 :>=\KB^Y@];XT9ZBG_,AGU!2S$^L/]0-A':"&F
M&J@;S@NM^YNHI0\F6KTV:'L-]04WC)>V;_=PF>19U=O\NA;SKCOYWEV(,+QS
M"%V?GM-JC(4D(6O3NQ+N[9V9M# (G@U-?P_W RN;%%*4A@\_M\[O&L(;GN$#
M:#>!$'5TE0- RCWT#5GT]+(=R3"##@R'DQ$])=P(]U9JBOZ7 T#P52J++H!I
M%T)"[ZBH"XQ>'$9'K1?=%.@ CL)3Z-=Q80]D)(KQ&,ZU6;>'\:;O9GLC*]9,
M'+\:%K@9Y*M!>RY9][*GSGV.K;F3P.6AG964.)\T-XYP[O=1_Z/'>G1L^\EX
M,-6*_)I2QOJ/H^(ODSG+\=(6G- T6Y+K8F6XRM?&68L__%=:?OG!CG$?6IXK
MAU]5;[B7(2B:$X?=1MS^-]&6DT;+TXBW3!%8HB\9E0%BO4[3E3@D<87$!:'*
MDQ7L=W"1,9P-.+B8^UOORUWMQVK#-7/>7C=!:O-?*O[VP)8D::Y.3#;D=SEV
M=- ,9@US8:._ %*/:A%QA*>WV_GC?1AM9G8US*]7W [U+5LE4W[N$L.Z#<HM
MOE0$:26.J?>47'@#D3TM>!<RAN[83%+@9!2U<T,]L> N<Q-SKJY%;E(378DI
M#^!GE&KRWV N9SVK:/8KL34VOL&CO^%SCD,N_UL<?[A5Y@?@ \!%KI^(#JV9
M:$H_26C])\V.;D2M)N/G^I%B%BK!%IJ?J-?QC;D%0.X5CZ^%Z79US\^\1%$B
MW(XHLL5:GPXFY6/1]".&3-ZK)'97<EH;"4D9)$VEZF\"5Z--^C/U'VC.)MA=
M:FMY]NNQ?119NK7ZV_3%(<YPR SX2:+1R)1"/?$INWR"$0">;PD<T5K/99'&
M/ZSE*8M7IJ[AM.3CPQAUU3 ENO'83:ZKI.>Z#[6<P0MG!G1SYXRE-H(Q:.PK
M.,E^3FMVJI\ISW@%XZ:?GX =8HXQA>L,9**S=\SF*E !@KBP*CUK:4Y;G=49
MZ6'8<,S- P#W"#8POJ@H?^1NCKD:^Y]Z*@N(.,#430+B(>S(7XJN17GY@T5=
M(8+QYC]\)\WT28/^3ZDW-IWKBOT^M/]0[.HW>W3NH:+;Y6VU=?5]Z_KQ:HUJ
MS=LA1S,6OPWQQ3DX0 D\8A)1HQI7**LI27(!25&)G-H[5;)2PKE]<.VU2]^Y
M".C>'6<6ORMDY.>,P?%=\=?YTF9%96XJY::@S;7[U"G*_WVB?[*2/LS9NLAI
MW;!?3: Q]:F5__2$ -*7,!+&;!#*K7*()J'7]J]_);SW'3Z5.;2ZO^-M<5,H
M1"PK^QC7+(!W2%![1'FW<^4 ,(7S6)Q)XQ>FOZ[H99^2-]U;H[HPM#'TO;VR
MT/25JWTGXCX4)91O;#0$>I#_5)L$SP=56^>UN;?$/;H4Y7F[9')JJ7479Q:,
M<]"2@GI"2&U3A<&"+95>@4VBW4=T;,1G]4)_S].'3.+VR3YP$A!;D4G2[9CT
MX1[=//[C]ON?)3;-+1?K<O50ZOY*RLD]_)3^MKA\Q;L#^\#SPE&)VBDCV[OO
M5Z^?WG[SKN'PE9&%CQ_;BEM6-YO;*U_S8^3!7&;O2HZUWH&^[1;VR"S)K[*W
ML875-A2\"%Q2;&I4O9O$W=FY->'_/0'#;&H,' P!N"IX' #BHGX,J#9=(,C!
MS$]:+K#U:><@1^@YK1,I\LUP)*D:_]EM4U5<M<QWJ-[#,^3RW.C>/)8R5FC0
MD# U5*A;YW$5LCVVYAW[P.4F438\!Y8"\/T.+]D9^_J>&Q01(2]5\$VHM,_2
MC.S$%26DB/JS<P  #2.D;GB^)>24+#;X;'G5V3?4>7J"U^(2!K)#)TJ_J,VH
MMF<?'T\8QS /61RFVM.XH*HX0Z(AS0HV-@D[.;$;XDE)'*O>*0[N-C3 13!.
M+JK[-]P--MBZJ6.GQ*DBJ?AD\_E/^$T(]3BF"S7#UXN6;[V. QY9DZ%4D8<.
M !<+*-ZN.F:&E3Z]>G=7GGL4W/;T>#A_K&:AXY$E:LP*^!TFE@RZ9DX"E2N"
MCO[U5G,@J"$XR(PZP6V],(2LVE.H($,=)<,]J-WOJ#D.KMX.%R9V$RX).._,
MN;>.R<P:*[H(M=F#<=\.P]Y"';JC%H5)Z6EFLK+EQ/3T>-,*Z!T'O>#,.4=#
MIQ3'*Y\>Y*';,HZ,]45S:EAABW;Y>+HC=U88<%3#B4QEX,@<'<X+H'=2?5F#
M^$(2ZD1F >O!"*84E>9#JDR$!VH"79O(B,XU]8MF*I5K^_67E)E*8T<<,CW[
M\FP+SHTIUC@(S/]J-Z-&LW[O2BTFY5O"N>(-&&B8#O1R)WRVN:8J&+< <LK6
M?'_S!\J_];F:G,\A9_[UJD>?._09@#\GPP>7I3KZ0$*Q8$4XE.G"1D*N(V@<
M\2J,O)H&I,2*2=IG,A^^/_.8*SFL!R/EU;#15O7(:D;VO-=,AZ?&]>RAK*0Y
M_1UD'^3A1[HRB?,M(<!,]SVTSUN;-9YKO^^:]Y5']#\ZFLV)U]TB*"&J8Z?R
MM+/VPW.@%5)65[)S;]HJBN=*6!M]X7]]B,>(,)8(4GK!Y$6@3 X74LY3OZ_V
MNG3-\O^,>C1S3_J\$2&IR>+/RB8+SU!$!W]R4V^)TJA&.P#:@E.RD0TJ;*Y!
ME];D!K[W.F>H6W".</64D/2\],,-'?5-B8]-OKDA :#43(\NV.;U+7^2,NUB
MP:#LB0RU8V=T\(M2^'NO*_#O>.2A4L. X^<5I+#7;O>YW5MZR+8;]O5&NR0)
MOFZ( _/ YM'"H%!/N,1J/K0%#^P>UL(Q]E)5FH S5ZX\]QT8]>ZTH#^[I?60
MJX 3L$1 ML1_7+B:WGX//*7PN/0<AT+Z6XL4M _C-_LV'Z6%A5\AU'!* 36_
MC'Z'I-6+D(:-8&0B%A2T!+VA:QW5SQH2#JD&<KYXXQGSJ+SG^F"D?\B0.]M8
MFRA%DY%,YZ,IH#):SP*SS!S)E_$H1'D.6";^/#FK+\'_ZKDRC,!'+G^:2NL%
M=F[?>Y_E8U#M9NTOK[W=Z5C^<[/D\+'>%,SJG;N6HM>$D9O\VNR!2BCY.^'[
MO(Z960 [8[.EHCN"L.+:\YR<)P+87G"A_]!/[/R;D]M_0K8AM:[_S&4)@#4'
M_(,S\E\2GOX?2OZ?:X]PX7:18']-;-0:<0W\>E7'- - /<OD]235^5"':;PP
MEM(3HNLI)X1?^=O])^*-[^'RDE_C3I^?:;QF5V[H=,S@\IZ/0O4CJ(:7*3^H
MXH&T0]0P2CSY )!#/T':QD,Z--T\2,L9]4"QU:AFE7'K)K#9WMV$1O?6G]GT
MW\ISVX=24N;V@UO33)^J-'[* H>9W3MKIJ,6L)SA&C![0BQ+AZB:0U^NANNS
M"/,(7=:-ILO\CA$W<R 'XPI[D'+Q'%/QM^)8!#8C8O/P?'7CD[=>3ILJ$ZC0
M^QR!7P:\U%Q-'RI% F#7XR^1;X)(KF%4K;#N8DG<CP&R9.?(3/]ZWW)/HQ+Q
MN4KW2A,DJ.#Z78G?5V7<.9QK;^.2OJG3=*B#Y$(<8GV;M.G#FE$/6.RWC]AW
M,Y67"PNVS27EP4&AHN!ZOX;ZQ@Q[X:4\_QP]:QME[>4,*H3)T\;"BS<,) C[
MPD?FQTMJ, 4C2IWJ^?JZ!V8R%37\/HCW]5-KM*YM:M(]Z,(BV@*-?0DGG45E
M IL. $1GU9Y-:=CX?G^:!<!!H%X2R*_G4.UGO+SU0J?O1C!BO?ICJ=KPTC*7
M'ML6B'[$8*T'V*!*%^.C_&9\YGRFF9[4>AU_8@<NZ"-V3/[2.85S/M:/U![^
ML!6\N+.\B/X0\0VLG ,+[2_ZF?#9?"3V3SC%AI$'.P+KQ7#234F7L>T/!1$X
M(J^RI*2/RPV:2\OL*T_:X'<8\Y<?1ZU*TF#'[CYR9;R)XXCI(:'*IO\A%_EO
M'C_=*/X?>%6N6WJIO<HX1(C:+MH;(10Q?28VM\<RU-BT!\RU2[37'&S$#F-6
MQ9QMV.Z\*EQ#AE6K ,2<Z0< !H01>U?NYKW3NN,I*Y8"_]_-M<@ G-'M%/N>
M*&+)9>Z2)<CHU]M7.Z3$*]S1;]SQNYW0'G>-G&+WN*SQ3@=6K9,-L/;H-(_%
M_/Y$_47V\Z?LO%]F)]TYY)MC15NLWP*'(^/9]GG/_P]G^;]IYX'_;)S3;5W(
M?T#2IXWDP@=7!EFD[[+=8-/H\2>+Q>[F1T^$_GC?LE;SXG>#@I.1><()L/P]
M$#M3W'U0ILFH?V_F@Z'@R_!OL>2\ %$NE2=-B3P#8873!-!IX(6Q_)]NH=IQ
M6Y]5M3Y[;.[/5(#KRX>EPOMT@S9.V;=X>HNB,7L2.IP$!J8MYQS=/)!=\//
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M5/P8&J%43MS^-1GRJQ'YA3N^(O66JIPV5A'T=E.0^J6K77OT*-DPI=45AY:
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M')5(LZ;?J&6IE(?T0)I1$)"[5?]614(ESC4]8U<*T@L[WAI\M2P[,C/8WD/
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M,76H'E.T<-#>G4!1Z%!,?>3XNIYIG_#"ZOZ-MOYBC>2%Z3G.BZX=*K8\BL
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MLKPE6?SBI1N)I7IW+>VJSK0^IU_WV1-9ADZ!M15#[YWG!YQF27W?RN#.\!,
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M:%! IYNH>2%+]O8HS'_N?C$EOS\!N"*F=O0)4E@;8\)@J?^>#:$9VX+OGGE
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M;T:R WU7W@*3@'RU280KB,UL7=V=4"A?A]TOYPK.ZRF>3!(:SWT9RJ%/TTN
M^"3A$MSJ(A%(@-1N9LX>.:(DN@%E26EOG#TQSL@^!5W]M6Q7O&1$:MMZD FM
M4T';/BB-7RMZ-X<N-YWA%^7!DV/@SU#.N$= G:/[$;^AEP%WI#R#V9=UV3^3
MBF@D_W[\_Z/'!QE^0]/W]O^?M]AH[Q,<L0L/&S-. )98AHAJPXUH=LWYS^C^
M2]LKEF8=/Y3P2:)UF!4'B<0QJQ .DN2 <0?PE$\FC'#[I=G&(,D_NV42KO^O
MYMA53@"1>M@<1R"K!LL!5>E;WEJENB%)ZJ\&V#Q*;%(8%)LV!#HZU0S\U\)J
M8"@\$NU)QY>T3I\ VBVIOF*)&80VA5!?RK5#@4GB+XTIVG"]?YO'O[661'@
M8P;]_D"@^CRFQUS4_BT]A/U?J&D'_F(M[Z\Y[D/^M<;V_FKN;P!_ _@O ;##
M1J,-EB!7L2+^Q'F>H:M4[J,#2KL"8M+BF1D4[@2=:6*GP^D+BT=WG%-R3Y&F
MM]2UD?_9T\IM?[X8$&&;_,<((W)$9<D.;IRC59@4"' 2]&0  #[KG@H%T (
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M2 @NV[!.V%SSX/9\V+JG=+4JGBZUST2/]8[ TBOFDLR)O5@B;<@LL/H$L"5
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MZ#3(97!&9Q&>]-+UC'K; C_)P.ZK/^?QC%E52UU336U;@&R9V]R7JB<EA^X
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MRL[^2E*C^$N[A.)KEGRVV4"6.QF-Q:9Y\9;*]KP4B85[]X^? U66]EH'14X
MZ0<%ZC&G'])KL@5YJN)/ &(3/<"J="1(T%^N4XN98(5-OSOB"XX3 04M?(.^
M4"89*MFP2-X=<4GO35[1S;M<P9FK>Z^Q'JY.L,<A,841%!DG,!/(Z0V0U5 N
M_L4*K'U>!MMWJ?OG]O;T]90@*3>6'Q5CYC'B1_A2B4]/BRWQ'*;>!;V,H[7;
ML_4!#UP,<QLG!HB;/N:+D(;$)]]DLZ!S1DJNX\M0BP+;_T'9>T8UU45M@$&0
M)D6:@)2H5$4Z2!$(B/07$!20&A60+KV'A*(@78J@=)4B-2J]AHZ"$'H@E!!
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M/2UN$I%LGH2HW\"MD24I/J=%YXZ:G71SHS_5AMA.8L>"!-U/@NL]U'O[O%:
MESUY+R_,;=OE9 @^GGYB6YIJ$Y0<S\^08D,,Q9Z:F\TV"/':3O(U955[6%_-
M>6>\(V+>V92V.N[]8^&UJ)F"_Y1$+<#KOU3+/GP<+6=TL<4AHNC]$=@N6#E;
M,*N YB P/;<3 +$APZBS=S!?0W=^K&%2:\^Q4IT[L?@IOCR[3^JS%VKXZ=3'
M-VS_//<K"%WZ>P90:4;P@%96?)DI-].)2]-'9P#:)0C(BP_B&XE_O:!_T+.R
M4 "^H?,T=>26Q\]6Z*E?(+@2A <_Y3A]0^&_N/UJ<ITTL<(SC0GI]S+'O389
M/-75']G';>Z-0C]M$]NDJ,/HU,))NZ98#* C_9:5[G-B\LJ3:P[ I6PTEZ_W
M&X,O#(ID'NH$\0S0&+JS@%]8"WJ@XPI;';W*%#RJM=1LX%PS<%7LM OSU_5;
MU/8OXD"47>D;16HX?""==)T+-LBAY/>>-07(10FD+^S(_#BK^7S]QD!1ANQ]
MVM229PB/+%4B[F]1 V#KOT95_^V4:&F9Z;^=%ANMH)RJ:(I2(G=*/*I/?C %
MQZW'[D^Z2K/@O_ G6:TH&'V_=@3_<:Y![NIN"8B5TG\M4JWP(,ITJI;*Z67B
MZ^7JR]-@$6[NWWCY7E6)#S._X>T59\WMH[*Q,#5:M361N^9PP<#CB*:PS:$?
MPK=.\Y6!'- 9)Z;33]<(8@U782\I(E'81(JT6$W\ZKY74T8.SE<E_ 'C<<K@
M=UNRL%XX_R";:AZW@QP>_CI-/"6W/;PW6VA]KXOX#7<,3UG=*2KW8&E['"%?
M"69__]33V$-,_=$'R6'+  ^,O4<9Z@.6"K+_?FZ#/B*897Q#8<\=*'(SM8<$
MB<L&G\OZD>KI>\.S<ST/LQG>1%@WX_R!"U UZ&C3E=M@B_P!E5O#W^B"ONS#
M)K69:5?O+Z?&JEZ+BW.:)]^G(B/@ R-P^K#V'BUIWPL0/?Q%RG$$^VN7I@/<
M[Z3=ZSQCA9^U7PFO#ELMEBM?3S.B>][B&W\&J%?I=^^Z]9CB2,(2A(>&G*[A
MC[*;NK@F#TW5'25T)O*P=G?SRYK;PEW"UU.^R+;@GIFKPF\UL7/<?/9EY)+L
MTZ3^J>I;NZ@'QPXE>:%&1M*<=N*[->^Q:PH=OU:__C7NMJI.^*FHH27_G*/
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MW$TV*@O6K5AFJMM0A_ R+]#MSHVP$% S"$_0A3 8%K%S@(_K=>+O\AJ5^(<
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M^VR?)F;);?%[4L^(C ZU*2TR^ R@U0&%6&3*'SQAJS)1+/[ D$']LR$XSG
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M73&<_^%<$N7?,/0'ZO 9H.E* OD^Y=]4[$1J+UHE 7H=\H0DC5VRZ2VZ23*
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MQRFBO^B.+!#2:)3^+)%B9'%O _'D)[TQ8?KXY+B,,7J7N236S$^]>1F4'O%
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M+U%$E.#R3L#MT,,5'K+S)L9SZBX*K<<\,D=EWOOO+I$KZ:*IS$,VY.DV*N2
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M*H)>K<#^EAOT>C/G:^CX?MW?=[[.QS/7I>X!2=;#M2E3,RWV3UQIG*^-C5I
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M=[392K^,%Y636KV#O,H >ECY; IH+[DW1<OEZ76]\_17P-\::3P4L34&[3X
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MT7_\Y )=D#/LY0!<7G/H"9,CJ+Y$%%W&9D1CV46#?7\_Z(IF\W_6BNDB+JF
MKIAM".8 2'#F_4B$O@<]D)]#[60QP+,RP$BY1)U"T?<*+Z,/0'^90IE"2HOB
M_TZ_YOMF_^6U*D*/H($$>"=D:P7&/I_/.M<9R0&FCT%K$7]R@->B'("BCWZ'
M(M3#6#Q_@"-[/^V?^PC+=#]7!^K*!77M_*6+.':9 _1W1Y#9K*\<H$L451RQ
M"F7N3J#U/D1O'$&S^40VD_ZY+[:L\@(P'LY"&'2UM7"& &KG%$8&1?R VCX2
M^_H[5SK#*H+X[RMZN+#C.NW[5T>L#/+R.@,GWBBQJ+#,_#\_&'& 5JN(:=3$
M*5!5*0=H@5+Y;*G6Z3,<8 \"1;4?I<6_WM<PX#)IPY_P+=TA:-?5R;LA$P5>
M#Z?].I[*A<J'?\G%YC1F!UL:D1?"LBZFODG9]+4-<W%I2!OYV5"EE 0:O3I=
MM/?C,2;.]B]'B#6#$Z2;OD1)@&*;*M=#V$US8, /);#YLZD3N.7 =RCB(IIM
M"(NU>111*B;%_I99/:^,]I?"?K"?"<PQZ6=893.9YAP@IB]@*0'JG<9F8)(X
MP,PX6C:-.5D+)FM4!8J^"0;!?4]FF'P:8>(:.!2C4&94$<N+A-D1 WVTZV'T
M!?17>OY2YY"?:(!>L+^]0@8Y\=C*\JJK9:YE7,8I<<WZDV?D7HW^7%T.I<#(
MJTL%J+<O+<EAC66.OOU?Y.NM["*&SC_[GBR8D*RU%G'*)&L!N@LZ7=HD1A%^
M4 ,!Z$4SY?2:@9JQY;=X[ >',(_3VN_O#3&H-TZ*MU^4E2%%"$XEM5[8NPP/
M8QDX.R?J%Z_?[KK&6)PUY@!.6JV-B!>H:0RZFATN+!"1"0:^&SB#G\2R!;88
M4)',&8V#J.EC,.;MIGSV$25>,"8\H"(V@98?-O/6S6:-!+;UV'+K#!.PO8!D
MP]P-NB;U$G0: ZO^=0HL-99M:/I><0X@ P;3 9%8U"\M;MH0 ^WH.B]$[=)=
M2V :K]-08"S_TWF%:+H:\1,W!]!"/X)2#FFP3YDS_[3>!T;EYY@E8ZSZW(AT
M6KDD= J3B9I9!?NLA5 BP?[ZV:1RB "J^2J2.^)CVXB)> V%^/"/W$OUY^4S
MX-ZT,LU/2L(#+XS.3N]D7DK5$@_X>HE6PT#;ON:-V_=1\=5]TJEAQ7.MZ@[4
MDM:*4ZXP5ZDG/TN]^T+YBG2Z(-RJ+55,1Y(N92Y^<U]HGP5-[932VI9[V/#Q
M-#]2UH6ADN8O5HY<Y6L;!9+=KG2U=GY2K\!\D^(U(S1NO!.:^?&HGK(?$ON^
MBIKA,UAB7:ZK;UC(\P1$3X'/\\Y=O6MA"OSPL$U_<0N$1Y]EK7BHZ:=WBPZ[
MYUG)X_2[ 9/$6^MY-1][+__&3![<!88Z@*VIZ/]1N>S"DU0S6/Q**"PP'B(<
M8'+$F>F<W>P$IQ>.6OBK$]OV>:#AJ5UO#^K6?TUIT9K6O$X.ZC9WIZ!G\G*I
M0ELDVLMI*W6(J.]5S7$B_;ZAJ//7I CV#QMU/2V-F]:[[PQ=XKL_AFK6QM_,
M%28<L2'4=M*N4EZ@]LO-5^2V6=X,3[I_3OK>H55EJW2TSF'$^HL,N#NMB!6+
M]X!.N+5:#>)]H7<)2LD.YE[^ZOYG/%+A_F2ADF/',G8;CX8-#B725)6YA3]-
M<5$<6H7WS+.YZ,$SQZ'G^C9R/7&#=UXJ#A_&89/O_/DGUQ6D&+67>4A-G@Q9
M<H(NK.A 62<7[+?$$(8@0$@$LV4G PS&\4EOU([_4#'WBJKRF[O2BL*\N?=2
M]UF8<9UJ!\PTYRUC68084> ;9*5_L'3PE[R\*)?T*_GTG5'M8L11NGLIT:+8
M%RU\QSGI4:Z6U<GG(H80NPOK+F;#4'655T!(8FFHZF6ZPFAAG)E=[);SC00-
M#B!P>4:<)7(<C'X>"EBE=5 M3^BF'.#/KZ=!S&D$95J%.@9>WK9]N@G-\M]L
M,%__NGH+?:V<V;OJI?9W70QQ;D,9-=$@_Q^\-I-N2IQY>@_,IA$H>LY"U531
M6K[2$/M*$^XA.Q+, (V!LZCH4R?I*I08,]3,-3J*V@]6#A*\A0/XKHZ+M]W0
M&-Z B2'V]VTTFL2<JE8X1)OGFI*^;?&IN7D34WQ2I,<G0_6)OD3%=[Q^I^=8
M\<B#BE'SL)PHWQ1O<K".5[<DM(&Y1$U;YF?<9/Y!#9V['PI]=*FSU&G)T<'N
MD4?<F4O$3Z_F>*Z&,T^BE]/3ME61$KV!&^*8#XAHAA93F/X<HY=HY#.]%_YU
M7NRJ9=K)/[TZ+R[=%#*VT9U%RT'=4''R,WE%2BV8^/>%=7_L<Z]:L!O_//^!
M.F@,7PEJ.-,2^:#DG$A\<&Z5OW(Q$1\M)Q3=LFTCZIY_HT*]4?+VV^%3RIW6
MM;C+WXR@9:AFVX;+^4[TI#,C1KK!GC&[NN%&P<GGD[6D5\/%@LOQTV6?4)W$
M!'-6-81I#VV6PB^SIH4%QB*@I^F1OK51,55G?*LF>&\FGM!"-$^,V3>BR!"F
MJ'"KD^X(OIRN87._I^=0#NE6]<P!,PL.X#A_?:UY),M+ .;@N^-;,6KS?-JR
M14_U:5'.*+QH%34M@VG3B,-3[ (3V;*9+=#]=V#\"U=%M#[<)P%A[W]]BO]\
M>(M'YJ#0F2,-M$[:'E;Y,3]R%4302%KOR3U$%T[<3^AM@LSH!+HJO!U_ .%-
M-_0DP\3.!>"Z@W6T62_$KHZU[>*:3R<TZA7/Y]#?#0IG=T*4W4]<*; 33PI0
M:90;U?><F43(.MJQ!]H4<_&K&CN0+)AT$P\SBI7'/-*D3X^C=#93QV-*#K.&
MU+L_W/OT*7-L=!S"Q0$\-,9Q)$@S1H ^=X-N6<#Z>)6R^7*2?-;CBE:7@*&8
M=)VDL2J>*28.1EBRR6%VSSD;2GA"1:AAL6Y2Y%M<=7)#+N_,"R$;!8<DI@X+
MBX*OQJ.$:P(3:)"JK,UO!NK/ SW%VM)[RH]T2KURXT&(U-9F[_WQH0DFV=]B
MFSR4$Y9\]>FZR=F$@VX1?$F+,]6"IE%UD9>3DH)#C1<_+HH5/C7)XP#Q^UA9
M#\&$9 ."2N)M%/6*QI(D0VV# \3]U6('(B82BA<UG4\\Q+2A3OQ)-Z1:3I?^
MTGAW_D#X!9*]X'D'PH*)W1EFV5*9@Y:<*8*M]Z#JN^ 0W/7FAZQ!VZ3!'\BB
M5H3//=([H\6;JB=?;7M^>^$4Y7,+,[2FS>!%?FEE^YB!_""FBP.T7W:F@9VI
M[&Q)@;(9($Y(Q'B.-3U)!60$R)%"(&X\#=*I3P[;$(O-=^;KVBV(RPP!]K>G
M33)-'P:1(M>VJ83S_?X^VG4JG52'N53,6_C3'./RA(0&S:-Y)44+'3.!3WOA
MZGVG81_'UGM,D9]J?*.2A_BL!KNZ*A.@F]\<8O."K*U>NK*RJY/%(]J58K;Z
MMK2^K^]-:!YI=0]B$[2QN5DO_,?'MZ!J;JRW>/\V^_-L-;B Z$WARDX.T $2
M$\H 'L>'2G+J9'/];BG;_-.G'AE"4\:OCN4S#$#"\S49NK7DT-O9:G*MS'T!
M!-HVS&_L#ZTQ)VZ#B2R- Z1#U="T)RP<E0,<]7($;3W/ >C#(7(:]$<,.WJ3
M3R#3@JK6EAGPX%UQ=D9+\K,?HFD"$9MB.RN$T'L0ZD]A%D-,MB.SL)?GL551
MR\*"?5:^Q.'4,Q4(A[C*=MLG<@9E8?VG#)$>]NU!/R\$J/$K$(@$*/M/9ALK
M$^_7K3'M:U%"GT6)+#HL,LJN*8Z^A5^;Z>3^@KAK[GYC"3K]7DZ FWNF?92]
M6X#VM7=,A&8^''AK*-!$\-KSPL<-\89E#W@R\^Y?%'ZUZS648F,S1D].NT]#
MT2$AOPD76FF&>/#V,=&@9]=-Q?<L_?PVL1YE;*,GG%1T-J.00LFJQZFQA3K3
MQE'-UQ%JI=^/9V6W2G=YW PJ"=)NCRY:PC&L?N%K.N,V-?;[&.SK0"MF%\=D
M+$R%[5OW%]PC7[L/\9)QGMT&E6R2080$BB&[V+O@5G_4;%JB*K\IK#TK'#\C
M<HA!3)NYKM>,X@%=?;:!6[WR+>)P]=#2R'%GMM(EA4LGHA_SAC3:^ F=4.MN
M#2:*>YY"#U=?/#;W53&W:&][F??PU[9;S_TO0JJOW;C0,-&.$Y<;\6.=/GMV
ML^"S8M.1)%(14RQ*!R2_<;#"VF%NQ38/%BIZY .(0+;8 BHEB-/HF1A,7(W9
MR/+CFA'8.%V5U_!Y3'O,@P;3YG;3KWL=88PT9*>8Q-5WZ.H'+[,FGW[]QN*!
M7A]T?"B30\]F'P)31 0"3RG;0&/&4(Q0-<15L'QAW-D6 > LN0L6M]1A#M!V
M%BQ1?4<#F5S/HCW'69V$<)R:/USA1U!2'5LL;1HB[<,!]C<<]2+ODU1PAO]Z
M\/B1*._>7Z:(<V2;_:CF:PT7D0-W'M749<A8"#V'[\I/_?%([P5;/O$G4FX"
MU7S)C1*:C.1I&CDRP$RG*0_L=7EM&/.CQP3[PX&J56#D^T!K9^4DRJT;CU_7
M?JH&NP\+WC3OM*$K.[1 [D(/!#1)T3]>'#[:5)-X2@'N'/3YW"O7GIA]P7-L
M 2+#V%WIW"B>LA],-!1B)TN)_(,#B%3\H,][H8))\H(PWPSGT.\.-\>@8;M8
MW\,JI-9Z:-]NK71XG_.2\_,,1X9N"P63A:5LOY4:7'FAHO3FB:YE]Y:^KWOE
M@=PMOX;>"1@WO;2U@RTRB' M3'#VM^Y0*PO-C-^S(.%%Y*T5CV]'(L"(T,/[
M!"8A%>BO(?<0(515RS3AL8@PSYK!%?DX^>0.UVOLFZ_K[,P5FUZPTJ"^*BAO
M,&U614RT'PHS,"4L#!".OM#+C56-:]Y^'SDY#_L8E ;Q-+*(S5>K&WHY_!(;
MC)UZ:2B7(D4IX>GU>Y-_=?KFT(-[0Z._5,J\ T1M<[1[5.[^GX;<O\6A%?^O
MEF&;2)@$U'0E; VDE" I8QB6"W, J_HL(*;]?U\H-3,D_?L+F%R8NU&7'<_(
ME%LD;XJZ$^[*[P$^.[72T]X0Z+&?<CJ20CWG.D.+K*3/]?8^D9>)&CUC]>R6
M(D]8N<I0ED$B/-]F1?5@<$[&+T0ZB-,FJ=]VW!?QO+H?I9\%^BOJ?:F.&;J,
ME3P1)3/-UMTLIF&>($5]UGY!*+904<?FVQV&W>H^;UWJ.IQ$<!1,V9-=P3D[
M0JJTD&ZQB++H\V;^D5@,*2JR);GRPAN&A6:YU/MFV^W+'K4/B@YHL-:O[N$K
M+KR.*L/D&B5(K/1O+S."Z>NF]-^K>.*4[#:-@YVJ/CL!25ZZK>?XW>QOU?4
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MB2(J#TEL#U>_$%ZD.XC2D72O ^<T/[]6?9$YZ[MJ^M'FC7GK\&=JS>+E%(/
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MF$9)"._7=Y"V"[I6;)XU[D)8_&#;9IM])7J*EO_-N#TBFVFD3;/B &\P< Z
MG&"JF#-%P895JM,HFX6C.Y2P<4&=+-[+'.#38Q86.FM>Z[%56//1FA^SOP%T
MY4-V%\79P@!A@WO<*7DSO6TBE_L5N3SR!N[W=A4=1N8 CY 2,& \(G'>+Z 0
M/F'H?.BXUI-/+;'K(=U!9/W%^*"&4OV'%ZS&%5:ZLJ*"!^;&BD\;Y3R621Y5
MH^23C-'M$$%,HE^-L:6-658^PZ3$U_6)OW[/(*'^50C,_FR-VD#R](;WF/*;
MQ+%=B<JO_LO2) O:TH[J<F<E<8"EE9K_Q*UQ G^O&&R"[(:_QEUL-ZLA?+^1
M4(-!5IGHN+5(@7CMZ]JB#E@-^,L^,^@XM-"J43!EP=\-OHK-CU31UA?H73_(
M]TJQ,9NF2&]"BR(/3!!L?(S"G>2^2I>H*WSW]#RSSH:BQ1:E6"_THHS;#II_
M1!P[228TR;.>X+V)W.P>PERRCLW#V[ .7,X;Z?,W<<1J]_,RZ>FQ7UCPE:!-
MS1>FK9L^5@99/OIU6SZ_1G,LKN\(A)3G> XF8U\XX:+#3'X)M?VXDAC9 8>T
MF*@.(/QG)J!BWI<E_59?B3AWX7A*Q,I%#D9BXI]X6@=H786CUHSX54S'Y]TN
M_$>L\(]+DS[>KW@(7-VFRLWSEZ^$>!E=XDMG?W>'5J%3]3G ,T'BER8Y.HKA
M0U?[!/(]Z+TFL?F<VG*O=]Y(56S#B-S(]P?15^HCCYX>WZYZ&SR%MVCPG'&1
M[C01'S*2)1D;!QS35;,XCODCD)PR5"8<L ^Q38;2CQ*7B!BG\=:9[MTUSX]O
M[O&J>WKR^%Q+T>R#N5>NS<;P7U7OPIQM!'^Y#481;<Y1V<8SR!.=7E?6C1*#
M[*Y\5RB(7E384(_09@M$,U0B\B2=YCKTI)S/U8@-'R- 3Z0S]7N"4Y'8!NAT
M/K1*68(#Q'WPY  (/ <0<>P')[$NWH-R@B@T7+<XI^>$8AK:T*R-TA+VTB\2
MR8Z]+)<G$VD&C-0&5:KO2S$IM,-M9WPD<C=8<7]K,^@8$$ZZZH\-P;HCT,RP
MALOD!*8H>3HA<>6.!// N\6^\OB28,57+6W%3^4]0PZ2T<\B,9),;4+CW=^_
M"_68&9WY_4##[#LT6.B:0?Y\J]M^:>)/2N\8(C?!9T3O^%S)HSZ5WHO::JQ+
M4:-FAXJ$!HI?/"%.!M:M:W_72)98$BRQS=HS>6?6?\?X&"*)K#%Q.\9]QCP6
MH?DV8O"ZE;-%7ZBTOZ^;(V+BD6MH',YKMC6]UW?-V)UT*)O*YSR$U7C(/CH<
M@&@4-'_[^>NLUN0Q[UTOT%F6O%T;LTT+P_CI= [ KUZS3]MR<'/QF?J[I;E$
M&MU,S\6PA/\/6:ZS9R2F2=4;4+H"7^OBWMQY+%3:Q<4\N$CG9"6V/NV(VUU^
M\Q*>0\V;&#MLP+Z.FS<@!VSR-*Z^S1PV1*?/ON CGS342O'I49]\.X24]D?-
MH_<P-6KI@2@2JAKA0)4K*?2Y88EZ.Q^69)3+V/<N.'$#P[T(K<0_,()5*-;M
MC#Z\$YW"%Y!^\G7A@Z=JD]^9I=^595F+"[WQ4,KYM'@3,:H&#9/"M _!.&Y?
MQ+OF')!:,996FW=1+  9#(Z5U]&(JCA3H#767;A]LCX,>4V1)_.$L84\MZP^
MYGD[931>_]W$XD!SD9YH109N$C<=]5R8E]Z>Y5&:9FRHI+2JI^*+=EX>VUZG
M>=./,A39_>%3,I3">TH/R<,U#!_GZZYOA:NO?_2\FW&1^?%T"UD2$T,991[,
MG8Y/.X26*RB;].4=O*;G<-!*(#94Z'O,\\I^KCGYG&DPIK*0$K'-:'&3HQ%G
M^0G7-B;:<:EF$M_%QKAAP<JV[8BPR!G,KIEUQPNI L:;ZZ/^:80&[4[W]3SQ
MHD??3KE8UOUZEZV&>SF5D PR<OQ2=A[RX#@87E9LG0PPO(SQ'N^?PQ[0D.A(
M?$?C^^"I^^_(NRH1\JWJ)R,NH.@"'$!^0\/=IHJ1EH< TRK/".LY4_=MMV=%
MA)VQFX_&T2SUBFSX$6U/=T N45\TCQ=,S7[(;A/)P5N5HPC%^F\#-[YJ77=!
MO$NO]G23CE:>=NAK/U'7J5/Z0#'X>O]TA5CRFQ$AN96IA<7MA,K\ ;45DYAZ
M4$4 ^UMF1 ^QS39"2W_)K3K"8\#!Y'JJ\Y&S(2_NM?N9@_W89&6\\& J5G.
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MH3.Z5 TVSYG?S_(1=K:$9I^97#?5/?LF2M]LZ^KX9%["B-9W>^DK:0KX^K1
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MKBVPQ$KZJC4IDB(!G-5N78^2G,LOLRCR2?9!'B$;UX>=U.2#77DFH/:=<,[
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M/(X#^07'?1_%Y:T]WOESH\THHDNZ,I7W^P&S'SX/ ?NWX[U@DOGZ-(1@LO:
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M_);>7U EEPD2W_)B@MQ8;6&O5&E/EW;1@@1MVO,0'(E1M(WY3\YYY#_ "NE
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MXC8];7J=+E>)R5-FQ6Y <9N6B /C5FOPJ"61K/!#EGH#;$:G7WN!AB343EF
M3"WU!C,2G-W9BDZ>6SHG9&U6%ZSQYD?^'R#@^4.!K/EKY %O^ \&!28M$+IS
M^6<ZZX&M*#*R';$%_]@285#PK[@9[X,)P=&:*#% C]J6(?8$?:F^\:D<U.1
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M4B@:Y>5#"//0DMMAEHWOK@/(W8T+/\<$G=7:WV1?>I>0.V%GTH8!E'!Q*)C
MDXR8"";('1=C5VL7QE^J$K@6T#'>^HDPJ72]J<20^GW'T.T)C^4I_W-@YY]0
MQ]ZD#D>..?G,5FN8Z%IQBV?ZO8E82,BSRHH3CU'W*S[T%VD&:L_ODZG')#,$
M$1)5 (L?[.4 RLI"[-OGCI#WY6,0BL.:$IGM&3TNM=GIZ<72UK?8I&\<3WCS
M(/LV^V(//($)XE1M"F*"]JNP9ET05,CDN<)#V4KN)AN]2-&U'7%=\>XR*VF?
MVBGM1UL)3I9,$!26WZ]QY%>,PP1&9F</3EU#]3'KRYMH0*&P#3H%,2;M8^$K
MKQ8T-L.S='=#A#&$MJT;#7(V'@>O@)6/Q+F?,-;I$ME]Z'.DH0):W:YMQO7+
MW:/[DW3D.;#H[_T^L,HT0[))HN@P83L^L(?U:&39*LG20;62A+G)+N%T]4YG
M)6M**.]A65?3J1*\YO9>5A#DQ7GU1T+W56?9.@%N)*+%H%_@JZ8^8YC.$V]+
MLZXC:\[)02>%A2S5+(+_ YOIT</0"H+-63$N,(4)LE*!VOZGIG-@VW]U!:ML
MZOX(]R-71\8E9)3V-'358,^3?6 LI(',YU(<8Z\* K%E-%R(X]XH;,Q]7^A-
M/0\]^]\U?9PMZ 2]_LX$,:)J:SR79XKI\#5#T[9M&_G&6Y$C!YB@_'!MGI&W
MY5M*H\EQQ=R=&U-KWD!VC95.^,VKWX=LXAT9G,/==V>&7[S_R8? 4T60(W/'
M@<:2Y6PV((X15.Y3X6(2N/^\_($2XTR=]?JD!=<. C1.$AZ-/;P(%O#S_0I+
M0)Y)JWV%7$5>=IN&.(^GOO00;ZJ5.J%R;=VD9JSZ9Z*S,7^-U('%GOM!((SC
ME7MAXQG.R($Y<.T@PJD,Y3DC3$H8-KS?_.TPNP=*[V<5GZ.,EUG-V.$9H>59
M!2._-Z>Z&8%=M@*N3^$Z.T@QW6_&^9I!"<>/%7U,K%KN[OV-X\<P*Y8%N$L@
MOV\RL-^%_Y/]JUNW(W[1*\7V8"M2N;YZ8?Q&?Q6ND:F'9AF#6'X7]];=K';'
MN4Q!K;'U>W,7W^D>*KPP%\-2&V<O:?PZ'E"TFF*@V'[YI%OB/,UEO[#N\B6]
MWTL;6I F 53QD%:()+(/*3@V=30J;\C=EG^5".^A*X_)NV6]Q;K08R'N=-X6
MJ !"E=@O#!:\#L2-"?G=WZGV-FHP,&V).>.?.+JY54'.GBW9WZD3F)"9JUPP
M.=M2V?NMK2XP,:^X[\+Q\<9!E4T[Y$460? '7_GOE9&=U_G*XL2'/)8R'$%*
M>7/8*KCKJS=[_\EZI+9F_S&L[!^7U,K3IQQ-J%5LO^"K7.TAT\2?8G^#XT&Z
MB1PV@/4M%!/4O4*F)NV4_<7#@9I>X0CGE'MTULALO"@78WV.CX>K[]CY"9O!
M9_Q*>]0<M'@&/O<^OIGW-L+ "04<T5[U\"=U]B^P5'YD-2R!OXMP;3S1+=K7
MHZ>FS%\[ZYAGY^6C3- W]&5_%WP[?,)J7K%#&2+A/:<\6*T0WY4NZ3QWR,G%
M+'=F*D1NVI.S&Z3_<*RY( [T"Q^/JL0\0JK?1LH,-%D'O)LV60B_UV\W^'UH
MBQU^W-D)53+S$=$S@?%WY7S/ZF(QG$<6S(4L6BB6B#VV1#%0'C\Z&LB:@$N0
M WXJF]3&6'&-S)QS!G9=AV1-1+:VA-GZ:%J VSPZDK%O&"F%T";U85/>>FN5
M[$,73KV7C^*$,^I7G%4[K":2*(% /:$$_$221<$75Q%F!7-& 3""Q3[/<NS^
M1##,3%2_0Z?%CN. *<;U;<1AT]EK=YMUWGL.+VA'E3*4YQ!>CZ;F8>E3^R7/
MMD>[?\MT*$B^RJ;'CK7_4?>^(@ZT@SO/ZH$;R#X&&(CQ)CXX1KLZA4038A$F
M!<!)N&#WKDQ!WK=7[^6K.D5JU4_] +U^"#4^%(Y7&WGQ.Z/[=Z76)Y9Q&Z]F
M51E]8U9T_>IPBW]H (5;_*OO-6 =H(!$97!G!@=6@33Z/5)D<ZPLT&\P/CYH
M:NGYB.1$T7=%^)YW0JFZQTY&&;/B['W(V4W4Y# E&P@@WZ2>)^VO%<U(<6C"
M3XE6NMVJ57?W6W4_^NAU(.%]2.1"\%JI?FA.EI?S2,'HTV#(9+#Q//C0'?K\
M;%+Z/7*_(W7 J>O[JZ8<G)]Z;88M_+N.]^%/SFOZ]M,]B>34X\=3E6Q?E'G.
M^,VEG5W?BFY,OO?8J?8J,LR9ID$O$S,B6]<UCF2,.&M35CVM@%W?2)6G"";H
M)*?("IYDA9-F(4UPW%8?;^><T@@<4KZ6IJ3R7G%'OLUWNE:F? Q;U%#U>,I"
MR@GSI3"X9PQ[G1[Y,8GXHSU/G)UZ"0E9^WYIK1A]8EN^X]C 8^>KCOYV856O
M!D]T40W9KEWB=NPW7%&^[P%]>?7%P#S/W4.;FCNM$SMWW\8=B[ YO1;GJ,26
M+^"30+@94%/ &BR))_@/QB6?.K]TB?NLT4E+_SBVVZ5_:)C_*T?)LEY"]BL/
M3?K69\/]@AHI%O)NUJ!/-Q^ =$LX\T,%UKX5 ;^,Z?'88S[0_7>P@YBV>1>S
MJCH(3G$2G]2CP4;(_AU)",CV.7D@OP!A4%U#'M&SJR; 5_G !+[QQQY);>GI
M'35R)@\:.<XDO)L^IX@+H^X+OS#&:]*4<>-YJ<>4X8"21/\W:!JD&A6#%%^$
MD'Q/ION2=D/PYI4D)BCJY D_]\ZO=7K-L2<**^&>$M(;L,VZQ0;[6*0$$]1Z
M!E,.DS$TI&INK_-X'CL\Q02=HC8=[/<![7@*L&;$JOG)9KC4$M8@J=5>;WXH
M%\C1COP&W;_30:L."'/B%4P7W(D*6M?YHOM^FM+(NH]\!!L]@7%D"<+5Y#$/
M?6)P@KP/\[:F3!9-VFY5+3E;C7DI+W19L.6I^MV\K1;,"^29I;!@FG ,)6P$
M-_^""2)9XB/[\F@':]/P%\GI'2N+B#*U+V-C/W6S50Y;:0^+/<Y)ISL<>5VC
MN[6>B"-9HJ?$".BU!8+ E/V\R5H=4C:_O\U%L74\K4$A760LAW?:N<^__FE>
MJ?>AYR$\W.SOE=B7P)/*E')2\%H4Z3,\+IL3>$"TXIML*3&[,2:K1R(N!4<-
M"O8\<4YVESO'[I4L'H1YC9LO/R'0:371R/CRX^)?K'V78)I0(>45_0U6*\26
M &_!3=6LFV/)K*"(BQW'"HT&TOGQ/=5COLE*!=5-O,E"QG%79#B/7_5*AGV'
M L?$$B!^?3 *F9Y.TR7WSV,>;L*C**CJ,9::X;**U8 (]OF_\Y'R#=P;N::U
M^O#F+%O0G8/1('X^$++HWQ,*.J@6".YK($!G@CQJJ$R0:>G*(@&8M_\"_L F
MWXD#HU9KH7^Q>J3D'W8+@]:($KF]$IW'(:>YEF&JG<CCM214M&J3A;_?L$I"
MR>>!$I"#TA=ER>KBP<)^[3=2>XS.*LV82=O!8ZKKMNA"PT[1\I*S3GF?GTX>
M%V=/&JM2J_NR?&RDT.:X=;#558ZG+:'N9O4!3X?U1ZAU.:_9LZKS)X2LK8_.
MV @)5E8M? BS/3KBFWSLJ#>;0WV*GQ,X]<I!_>XL"VZE,!)^&D)YFS(/7?U!
M$(C-9D^$E3FVZB1_T1KZEL)WI$3\1I3)2^/5J'[%./BJ(CFR"R="8R^!=*B*
M]17#,BSKCY:-5F_'#)LWE;N\*0UHD6J(;ND^?O>\S*]SLFM&I[Y$S$O>2A\C
M&P]?6GZ7>Z)W8D^$PMLW\=;5&0+51OJ^HK.M1C?L9>LWBPK(_#%P'F>KDJDN
MZ=>=&\Y*?)NZWR-.6E_SK<Y2H\B?S:*I&^-""<].@9\43 $Q1MCT[O)1W^_P
MGVUZY;2';WA?V%[LMASP#L:4@52$QU\=N)61 #\4TOY)KN+YL\\S[F,1"HHR
MW@GZL)%1%Q.7X<T>\!IOO6E,4H;.E-7@><U?M6N3U/,('Y) C#X/NM(NEB!C
MO.Y,KDK#'H'S W9GC3?&S>,O8;/R34]FZ/3OVEP_?+,M5DI"_PKG$/)>D.;&
M]V(FZ%C6$(N"S-YB#<X>^TID'T[P#O(D0H TWNXD((JMERTNY':ZFFDEFFQ^
MZ.9[6<%VO]+2*!-0,?M96&>@U7_#I_O;D><[6_Q[;Z2O=Y6,NJPMWWP-R !A
M[K/%ODA:P#QG@KRL#@)6"_UK+L02/JLK3@Y;?%?.>Y:AYRSD?TYO'<G8S>V\
M$I*XTK9])<1R@S?<*$=N"%;4TXF9>#YC_\.D@T7J8_&\6)UEQ^_--PH8?#[*
M_57TYVD2MR[P5/P  M:A_BVA]P-,"7??>^MV?G+MJWYG$"/?UB4B6;5>8K)T
MH?=5BZ;2'5GE7I0G5 SX10"W9<*E0\:O5M2Y7-),^W+&R5TB]IZA\JW7&\K#
M@I8!<<",G:S#Y8M%GU9$A_6/CWA<R(U<RCFD*\,BS^V]?W8=Y9]*G6?7OYT(
MB3=N' A\X)$QMCME_J#(*>]Y0ZH'[;SFO3@0H-T&)AGM&RH<-A  8BC%9.,R
MDK+AN-QH%>:Q?=!@^$N+_2OZIWJTM#_Y)>^Y>)%X&-6@O(B31G:?#IGNS-8G
M7\2+TUR\O(A)>[2C+6.\WHE4#EGGA"3,OD/UZ))V\,N<^0_."K.1%5O7 ?D$
M? L<Y(WFQ8HQ9L B5>&<)C4.&FM:_3:Q[M&GLT'3^/</7H_;4\U_;R*/502V
MB2K]:YS4$\@QY&' FE &LZC]0+XZ)NKOZKA<?D[@Q=K^-^\^JR<0.8K8WV!*
ME=X(B-*?L!AT4@P3](&%.&OF"^N/-/ML';%DL3C5)C,"3@B6+NO['?/.Y8/W
M^Z-P&Q%AMH]7'4E6P(E+(D '5?0I$]0WLXC^2_7<I7]6/7?A.6--A46^03N-
ME#U,T/-AXCH];>4O)GA.]=7&< ./"M]*\<P>1>H$<0N3C;O!AI:DA8.WG#"X
MS;@OV,3GY\45WN:%OB'B/X"%S>=1@#*O::>JI+=3L QNR>RU%Z-^U_X@69'R
M>P>$E[":]*GU./T[PX:4>WXJ)P+OB8SPGTNP33;QV]H5CV=\\<9(@3-P.ITA
M\*A.8^OBI^^'<=-AT.X?:9)JRXQ?OYB@A>V/5L Q?%29VTB3+K%:\)-/"5\S
MY;V#\>/]?$]?"\8MXQ:X6">J^,$PL5!D@O:P9'+"^%1WE)'.+V-PVQT%R>,:
MY-0A.R8H_:&TOCL%/7</SZ6""'<GK9A4 ^@ Z:G-H#<^*<:3=BF*SR/.ED [
MQER/C#2IH@H!<Z>DW^]]]"C'9<Q<^F"6*)VS$+%9!E9]FG']3$7VZ*ZH9,SH
M8J>8W^?QL&8][.HB!((5".DGLKH>,WF0\FY4WX2,A N%]+<R]$??EI./SM8E
M7)N:FNBTT]RQMNW[:$V?V2K%\"\QY.A/4#[@R=S+)'R[E1!L"'$[,5R]:Q F
M^;76;COX0K>EJJ#T<ZD8#KXZ*4OE95]ERG%2>'^DP2G$67)!I59^'LV5O'<N
MO]@0_#-C5+$V#JSB<,]T(W+?EF8'@N^WA@I9;\4?U-]+5$U$2^60\Y-:FQ5@
MJFP3-9'20DZ-F!>UZN;)MU+=V-C$9;K[[K-M"G0(1,V) EWS3DQ0S-SIFM 3
MJL\X-Z9AN7LD7*P\[4"1R\IB+"!B]8P52\":C)S0X#.Y,H+1C*<TCVDFV!%[
MZYM>1FB?>0 "R8XN<LM^";"H<YEX(_ $=1L,*"EV.J&2@E&5>90&KX]K)\^,
MU%8#S\F2DWG5HX.I]14OV'RE[G_,:KMUER\L>*U^7^T"!E!0;7^HF%0P#B]#
MBN%/DX_<.]Y,I+]&ZXL#$LL\Y,342G+\?/":(=G2U_P"*C:;K9[41U3K>+O"
MX*1Z3G1WCJDH<+?H1^B-X1(A'@ M@"JQC*YP;DA-3)4MGM^ID@_.76)<:_X0
M\MDO3CKKG7KK]P@#*7HV5@N@+GC1#@K8T./A^N;!_L19Q2O#-,&%Z<;XQ81O
MH]&%PO><9B.<_.7&S/BM=!UWDCIW%1_) Q94;H0V0'T;@N_,EA+-/E(SMHGF
M[=&?BGX[\.[=Z:O/);KE%54ZD!FJM(,'6Y>H]B%BE#2X)&.EU4"L<AA3!5[M
MIC7;_!QCVZ_-4HZA+K:'! RO(GA_O\ZAD@1-8+ #G9"X  LFB,>B.D6DOASD
M X6+Z_[X.@FP+MN&GG&"=O -S1?XM("?% 7+("  /)?&TY#>#N5GR!D&[Z5_
M+U?_<G.DS";H[F&'],\G$^\MGV>'GT6@29;PA] ]N'ET(:478"\"<EMQ0AH0
MMBZ"SM:TJI"+&>65FU%=\C&Y8*6EDZWYIHNC6\&=Z E'(N''&C20>DFQ_=,F
M #?@FP.$B(;F+MV,\-Z4LK'5+:O3$<[VJ4L0TF7H%+H#R3W$V(,(I3?X56.B
MM>ZVP5$+X6)M!R;ZBIQ:%\DM1S\>;95YZ5MW@EN8;8LS$JL)V.$IX8.,,PB;
M\56$>H'S;=':W6I*?4C:A\F=(O2*[ 41I!>/6N@1MD\B'31%>EV3-HM8$HZF
MQQCLHZF0+9L77MD98\E;G6D4O:MN5T4V+B_<JINQ9+O*G6@HN0EGQ5EV V$$
M%+@62C(G8"*JUE"M&0EY=N.[_,5^"C5UB5IV1H'ZTFJ'99>5>Y%\C([=_E4\
M,5P%RX.X3Q;!1)3Y3O$FQ31\Q?M51VFQ':A.OOS)[T!2'?^,?QQHAMY0QCAA
M3E4"UJT!9;(R0_!LL 6I;VM5;VBR=%VRS?=(U!5MGJ[;;(WV'5H0888B2_Q9
MK$] YZ="?ERI9@F1%MA"@FIGV+=F:ENX9M$@<OB4V?D96;LD[[-W+9"Q"'O2
M!80%X$2 1I<A?.W;'?F^O_2[X+?QF*3O1,9+50+V_0UHVD&4%6JB?Y[%=XBY
M"$.J:BR6:VJQ;!XG:59X)$'D6U3#]$Z9X'QI^;JQ\P_^N[?9!2C\-61T2]*T
M/26"GI24X%>-8@>@5B3TDR8!T>)BL^#0 I-B1^<6_]L;W>9W#GJ7'3^VJ&A0
MO2G6V<^* \; 6(9KCFKL5@*GPZ#"JZIFN&'3:6=#Z<]"MYLE9*[=X](Y7GKJ
MJB0!=0LU,8>*R-8'$L@_"(J)N(5C0#S9UJZZGNS9+/.R)L+I>AOE@93.88['
MB>+W=(^^RIK(ALV.!CV]PJE+:EN(B<(>"!&[#,#G'PA4+.E9X%*]>74].\U%
M;X:>Z#47"DNV"MO9OL8$O?BRA*+X5:"6OI4L^^QX_5U+$?NRS__MXA38HS">
M0([7)*4]$KDS=?) 22L3!+?:?]L>#-K*0JZ81ZT?%N3RDS (E+V]#HPW=C^X
MV02G+-5DH"9K74WE@ST<,@6+=?88':&?=BTPTK7]HJ2QMM[EM)/;J)J2J)>5
M56V$F9B^4@&=I+;IW6Y,6N.T\MHPYYM&C/V035WA:<]6_C6\H+CVZ@&I1D:!
M"P&6&:?X)5,.57T-?9C_2_L^ILZ &V$:0QAOLU E[-=">S$&HK)R5LHC4^5_
MB2R3C<^_]'A9?!-F// Z*VMXM'%S0^_7'9Q@=-&*V8.*.ZO[_/N$'\:4J2#*
MB7\M8]C#/3_(^LA,'WMQ($SR?XS._<O;9[!TG/GOU'V$P>_L(@KUVQ%D]/R;
M4TC=%P#]K?'Z:7;_,6]ORJX! HGE<WA%&ANK9UBLK)S;U[&9Z[-[15I26[4,
M=$Q"7&/VT0N][$T_V2I0MHV7QO'CK^,")=[L>?Y,6R&A9\54AGM*0 /$-7(_
MM\<Q4!@T+)D]$FKV>P<.J:_Y4OL"6'_L43MM<3KR]YX<-VW/)YAVZ,6!1"X\
M93,2]HS@^8<15[)\Y;,E&R:M^K^3Z__'XY!LM2NC=6QWMNQ]V9@I/L9,^(#)
M4*G-Z2Y'U:/O>*=M/S)!OJK1V;S#6"X80[F<1&_2'IPH/7;$/XH-T7&64Z)[
M9:P6=U-@1\N*-YH)0H?B-A$OT+7L!ZG:(4_8ASB8H(&.4"A+L?/ H]![#"1O
M2QHN5:)\?(2<?)0#M/O@$FFVC8].A042,ZB2&OZO8G@[7ZLJKJ$7V.<*+6N4
MCYGY[#!!ALN;=_%!V=R+RHJF9./(LL+,/)A6[>&[1ZCZR]-6.2V$*NPPUX\^
M*'71ODOGBWJEA:QTKHV>AL7OWGYY\H9^K!AC5WCR?<[5V>^8'U9I+I%I+E&Z
MMJ^'TJ7J?>:1"@BO0<31O:^&-9O5O!5&WM;6)9JG&CB>;I/>-Q\W9P AW:VA
M6M&.9OC-9280W VR8,&1[9W'_4Y^H0P,+V^59F47[%;*O@!VOC>-SW=UF0L\
M"?/8ZJQ_MQ2T?6#EX)13&U^W[*W;$W9MIX^@_:J7#M2[=7@Y1MTY:WDIKN^@
MS>LE\S33Y#BETM[6_ZXK]N]%8__B:Q1,J%5525E-5SC[6$3<0 .@J3-!FG_S
M.(BMOZ ZC(^A3-#C82*9_=\3W1E]O90PEX[94H-;SUO[I%%SA^XJU6H]_N+S
M6AIM8=;VE1A,VU<$Q+L,(T[GSL"F^OI38#")9.]3EL+\5M+C[?9@TA7(]*N3
MDIKT%R>U2@Y "";APXIS=9 X=/7V&IVHS+NHBA3TD31(\?=QKZM-:CLH;-35
M&]R0K+.-02;Q$Y8UOBGE,XXRO+[NI,>_XA=Z.GM<,U]IUFG2$O_ "9PG:5?H
M]<[[@T^:^OHC@F:R8LLWAUNRX>_:GG'NP^DBI1F3>-(5.,^44Q>D)=S0X4/B
MJ'Q-M!7OEW?";-61QFSZ#\:O,T$">^D-W-WTE)\0DDDX0^/:PLRM6R,>K$<'
M5_VEO)>P+4 X14Z]I$F8K:*HTX;"P$%[N#N]N_W;)+\BN8"V#N19P",7:.QD
MR/@J7L56"[EZKQU43-ZAUL%?WE]WRE9K)MNA%YRHZ^RW1<,*RD4JM;(*?213
M',_[J]X*3=.][//@0T+WIN;"U?A"ZXZ?M9 KK83#<6V=55K)%B[7I_O4'4RS
MM(<]L\7?>GND7KOJ\2H39-^.XL#!^J<:VYB@BNTU03*,^#TAIY^(BF&<&EFK
MZA=8U'N:LD2)2R-5-S<%]$@VQ>EWG.B-3U/Y*"Z20/I!M%\[3]5E#(#W(<2H
MYK2[#>0Y-/6\4P_?6&3HVZEV_;/%96_[:^9,KT$&R?67U,K/!MC<!]LRAB%5
MZY$H+_BCAA^=4K%WMJX-KHV.=00:/;G4VR*L\1#:X_P\;6I"FI!+3T;=-E^?
M@BQDAFQ?&VY2<5>;:Q)R!*PZ%9UJ+>H6"K7& &0H5#7)UHZA@NQOL$^@L1>%
M>"W01S%1U;!46UC9]:6[GP<J/MS@T4L-/'(C<H*<6)U%/<GX$H;["%,5@LF>
M)"/TQIH)?;[59V\N]U@XG?%X5G3E^86\U2N@93/%XC<"CK\.4D="8^G+.TY=
M4)*-,O@@S6,4Y\$$3> 7;N$/, [=3HD/#[.PMW41,QF8??',3_&51?O$QQW?
M-R]DHX;+ IF@ZO$D S7$[Y?7((%?A),Y[QV6LG4&D> Y5[/PA8$5N"_B6=HL
M9\;U1]&+#BF=X47L<]M%7ZOWO@C&]%M-KE"^ WUN+ J>-ZJI&LO0C;D"]"VD
M)[5L.^8]GU%WA8F=$1I:I3V,O?72(I7#C0^Q0@!/X2AIXTAA1B?C -!%#8>A
M^>R[TL*6$1?)W[(Q>S-=+7SBOZ4G!TZPW2'*ZP]PKA9L+F7H3Y"3&5L[F:2#
MQ/4N. ?-!<@BH>?7US*+$2C -Q]QN'%\G7'41R\JZRM6G Q2X]( WJL\*GVX
M<.U%SMR5^>3&^H%JP)KJA^"A/\^A-S6Q-/]>/C(^3I-/L=4?B+E&@B<:]/GG
MN4[SI3@;1CTVC?DLQ.%QP]#]M6<$Q(R=O5O#[_]C[[W#FOJZ==$@*@+2I-<H
M((B4J/0:_"$@(J*@=(B*2!,0$0@0$A4A4B.@H* $I4N3WHETD28U%"$D43J2
M4,+2A'#BM_<]>]]]SO?=>\_=Y^Q_OC_F\\!ZLN:::XXQYWC?L<884Z:FGZ%-
M;7U)E23^C*=R7WH>F>XX,M^2^*S[V 6^/=_7L.D>6F@#T.)'X;, 2@M\C"#U
M2>;,CA&#OEZ_<=% [WZNU7MGS([FL0L^3NT"A5]-YC/+Z;^26?R998B@SZ R
M1H+,?B0$B*7KP&T[&NOB-")Y5VC38"&?D>EI4ZFKS9@3F^]?YGK<T,%PB9%5
MWK<ZU>Y5[8.\$DV8G,OTDUWOX:TD @FRSE8 H*S&FCUH#F625\*V<35SKK\>
M))9\ESOT^;@Z>Q0+*!+J,A(3GRJ0:#2QJU*B&<8?H()N,+HU<C2#8^T7)?0:
MD)BS7$1*=$R[:*!.?&OTR\[O[J_;WJ:5.CQ5W\U"'QQ)T@@U4"J7V4M 1%*S
MZ+1H8)A^%#FJ-X!/XNC086@7PV'=T^-O2Q[XZKD5W)YTE'TL?#G9S=&MZ'G"
M1X]YO[YP3 ]VTI,6N)?ST%<:0N+HF+R<<5F[[_WLY&?:AOO),>6C(Y"T#I5K
MUX.R#NL=.\7>")R@"C#5$#(43)?GJ"F&(3\G43%NE?YV(0SL56>!:)F4K-WH
MOJ\>1W']OZ>?E#\ ."A!K&VC:K$-P\7@I23@CWEG"7WUJV[2+<N=E8\]ZO-X
M<A\$)RN*B1L$NDE^V =]\7R(HVL[0K<WQ]AV-/__%#+2W!O0R]A3-Y8*Z ''
M6%+1Q+(""IU^F44%O$QJ_"]$U&H]X-7'?&DU_U.Z.8@4@@[-GUF2@<3;Q464
MJZUXK3'**WJBZ/T:6&W#&#[-7?43J\8V5P+=:-:=4[7F'$=54N+'\U/M:QK+
MQ[;OAY6ILXM*6)L/KR!B<U%MVJTGO88_CC"AD>G];<$Q[3>&?FBZ0BG6V 17
MG+<NCL(;P#2$.81%8&3?_KA)\?W@XH[]XC(8N _Z=&(?]#EC'^3O_J/8=Q_$
M!OO^)_>1%P#:PYDC#_9!\T=QC/ , L4Z(,'0?%T1PF2SW ?U%*]:0^8RJ+M%
M^R 7]8U%&' 0^HN?.=T3"OO;:1PDS)\Z29I&LC._0K4(@L2Q.QG+%WK65/+8
M#!IF(3K;Q?L@REJ >#P*PA2]HW^C[AZS+U5\9Q_D#'-_*?XK+8:C4+CN-[4S
MY8G;"!0XB/J,IT><"[1\'=G'P&!1=\%3HL842$P=PX(27=-=XUE\F3;]-(Z[
M^18NA'PTL*?5-)+=1]SL[":MX-ZM8>_A(MN1UE#)I,Z[8FBGJJ;P7Y&S?,H"
MSXJ>%2YJ%_\IDZ_T[+_HX/I_&'N;DVN\=!T_R!+AQB]I)!0UY?<O*8.__WJD
M;%@2Z71R']3JP[VG;#U6*E_1_#'&ZXY-I:G\S6+VR?'V$FOKD42TU(T@RW>9
M>9><NR*[(E2-1D9F5;.KDG3(5XLDLMF,I8U>JCNW'[8[R1#)$J@84".D'TC7
MJ*LW>ZNSEO[-[(-QMY++L=S;V(])8^X%?18M#S6VC=Q'4;>Q$@"&B%GGI QU
M_69(W$.)&#A'HMZM2#SLME!]ES8QIS,[_@)$),F77>P))S)%D9\)->@N2"++
M$L/H3H!MNU,D]M.>$;%ZUK:#>3QKA>PZY@2N,K\_7'VVM#',/>*$-R_)6*>\
MIC#["-&&3^-* IG;YIHQ^"1SC*6:K;*,AU0#W#3V8\#3X/S1']!)I'H=4*J0
M^J&K[<"%%&G=W*>;R&MR?"[X0"IZ7K23$(NC6)<+( <GSOXR.C71S!:8:]S8
MW8R/2X=PFF[Y,_*\S0)?&WRT=K%O93V#JXTEA'%@&+P>.0^-Y2Q=#@0.C)J,
M^#/\<LN*[I_$NHZN'ZH^9RXFXVQ>5Z1CP*O,T8:B6 XE3K3J[Z4'PR26F<*M
M(ZT"O201:G0UWNI4ZGK.KLRE:H=4Z5V_GGOX)5,A-FI=5\"D":F).6TD#U11
M]/^BU*+G42*,0TV4[A9/?Q8)RMAR$577+!F2"KPU?#O=^WDM\:O2@7H>N7D(
M0YA,&OKD#)OL(V&?L&PHN$U;0LK)J(&TSM%IWYB5IQIW3B56ZIB)E,]FIS3W
MV1.A#S5_"YB"PK!=V"EL.TX$=Y<^-)6V"L-K2$ML6=2-=K\C1EJL!?B1HW,\
MSEJ)\X@;.7!(7_^XY,LR37>&IB#DQ;5;)%=M(B:JC"%*@L:4"ZI.O-.*:PQI
M\I;-GMR0Y_XQ)V)P-MA^HWZ[_,.I;%X(N>Z)YM ?#U*S!V6W8\Z&L#HG/*:Q
M*A=XPJ%S=,9"0N3XL<,+XCJ:FV][&(*+Y+)4.A=R0.8P93M#:A\DN _R+ [@
MFYV9=/&QR<\LG'6:Y-9O"M++IV D+2K_0A]4.AUN_TV(A>O!%9BU62J^'04V
M@B#QA.J$:3],+%/)U=O.SDC@:XT21*5:&FP9XU J*_@Y^;5'<D%]EMF1. F_
M;$0#]%+/;IB+;>%_:B[*WVGL!"'DOS,-',3_A6B._^QZ??\]N C-$*0SS6$8
M LTYX&_?+YZ79^)N'C!/;#5B&5+_?]UH#'J3O-C&; UVNDW-@PJ=G?["B]J4
M!'[XD9O\\8-A;S;G4B&Q,0[^]./GDI)S)06%.P4</4?_W' P^XU-U>.11]*F
MQV^:.YG(\I8:\[Y/#=\'A3_J6S7F-M6XB :*3)26O-B\LM\<_9LC@ON\CKC&
MR,KAH!O!KFX=%J-EFH97%G142XG>_@HO/Q;&G7/ &I\Z,!GL'Y/63*!Y[Q48
M"3,G9 ZEDD+;9J]$K L'Z\>?VE"L\VI>C/ZB?LK@I;R4#*E%]M]<5/^#[^$_
MT__U?ZK]KX9\LT2KCI% ('7V01G_5\BWZ<Z(XU1OV"E]]X0FO]5/ X@M.N@4
MBO4C#F9\\+]XD2K_PH@G)$1U*Y6V!11ML7ATVQ4FKZD<VSQ,$%%BSHB8V1J$
M+M8$8H^Q,$*>'BQ6H^D/; @@WNAPFG5ZE?9SU];ACK@T^7K@+ZCF#IJA# 6E
M8H'SVUB&*$M9.\<DRMOYT!+=;[5>A\Z7:O>]YH*F>TK4\KUCEZ.4%[4O&$#,
M+MFV];9 ?Y#K2E/VK&\G*2L5R,^R*.MCU">C6Q0.AA#>9*2D=!LE@E!IB9F;
M&)>S3(1>LYC^B_7JJV+B/;N)P1Q,KDA*D.0^B,A!A3+99_9!U)7=^#^!L+QK
M?K<KT6UZL'2A6T(U"??N']:5#[(%QZ#XZ'#%2ZQ71: 85L)5,L+%VB>?9FP7
M,;VC+]O9VEA]4$7-=$)YFP,+$!<I_EBRJ\P<W*_FR,&/7?<Y7N5\G4_&OBOM
M3]Z24-EN,C0Z6%U9FR3F+I:D\^)TX3;H89&,BBJBQ?KNBK9PWO:&>V\Z1/W'
M5P#*Y/Q3D-D)>$L/!8K)]E%(*&#2P91I @+)D9=ZSM=_K6YJBH@8D)U8N7AT
MLZ5SI/ABGFV@V8T^3R_AQ? "AH@[K70<Y5$^+4F+HV [K-&T@D]9IT956X5[
M(@/"@GEHKT/EGY=V_8I;/IKDIN"QF6!\PHWS.V#='C %I4T#)RAJJSW[("ZH
M9X"0.=E:B.%#Q<4$6VFYBJQ(%FY+V]'/KF3&<DL=@<)//O20>[?AUD"_A>R"
M"J_A/(:F)>?1'=91,O(3JAOW&-RWB$V^T@H6V.MQ(R*6,?%]L+DUIM:U-EV=
M(OD=0V=:]Y_X'N27/ZDQ6&GFY 0,Q'"<A\C G_281.H3W6++O'_OY0TLR5P>
M+EV?[53O$E\P_249<.(#N@,\W<?D5J*;^^#X&0%TPV66]OO"G3\Q#7##JLVZ
MI$0^6-2-L5LUM^HCRR3Q,;K2<+M-KB?G3YLZ[[W#W88<10Z&>[9!,-!*]-I.
M*301 26_E2'8Q9O0/69,"[X=C]LI>%I5UN5F*2QY]DW<%F[*EE8$;-!%?5$B
MK9Q_ZLH,[^48N);!,:2R\B)X@ .%T+$M(=T?>M0 '4'/?&:CLVGD>3Q::LL8
M'(+LQ55_1]5HKU$+&'XU%!Y:8N'EJHX/\+L6=0/>$>SG+/VE)\[L@\[-ZQXY
M<IRBS$XL8 A!:"@J)E&4&)!$< !"R:+/<]V$@?B\VO0@W4&.YS\O:Q^GQL28
M<\CF[,6T'D.X I)TI8X\AD=C%:8[X^GN]&"="-;'7ZZRH3XDO9=3L [[XSOD
M,T%7REVV-6S4@)NNQ7"CMJ(_(*?PT&K1;FM^[XSM4#T5I,)>5K-M 1QUJ?D8
MYK27ZHG18W/\3Y4$O_R\KK;P/"$#1*_J-E+!M,N(M%(O3&OE%*HF5EV><#*-
MGW6]S$'I.79@L.<CNR85M9;#4ETX5;0'\A16C>Y!/2-4T8J(D=KSV$2UAWZ*
M[>D3#\Z7NLAK474L.U56I3:4R3YE_/R\FYS0^Z;'7G(%QC%(>UDX#\@TQ(&2
MODXD2@:@0QO5BLD;B;^3BN<YFZT\3^:551R)X8ASR/7HZ-R0:9/]$31&L0*%
M#[7!9F"T[#$C=0 V;[Z.HZ#;D(*CS'/+VHWH]CUG%J!.*,^M?WPS25=^-, .
M?ORY:XE-"=8+?<_O,U?>@T@,";;F3(0]@_'N8$'.# _@=8Y:G<]SJR(G@$3Z
M[7#U4HKPQ1IHC3,_T:"6C_M)TNIP(F)\7EJ=9+U>1W=&#H'Y:UB6DD"R?T0&
MA-^MX%M/XZCIT;R9GD9%H0&'WCO,:%0>;OP4YWCT*^<)[JK%OIN1C(Y0(;:M
M.H9@ 0T*Q-,E$!IX(S##&.@+(^V#UOF$W'ST(ER<)[O3TC8_7WH?;REYK3[)
M0?BFV/.G:J#?"L^/2XU\_=\<//J_O9W768@;H(;&/B1P .[7J&X??]:&NR;@
M0R_'I\@E<M=R!#WR8C?I=R&]$1-X[KL5\"?4%L?$AQ#XMK$S.23%M7?$%G6:
M)UZSSUDL>++Y^B8<;5W3T.3L$&RQ?L'-^7Q+^MEN)]A<05^'^_:U'6?(6LS$
MT>C2+MS;>MZBNA#4:5#S29.YJ-.\^3C--=1\%;C& '7T/>L9C^#Q-'O*#GJM
M6/&97$5FUS%XA@E)V<IP(^VS[SG'$@^K^J#48VF9!V_*U*S!:D37A^@W+.G6
MY6M_SC39!P'21)0PO,F2\D;F)/5N#;GE@:^T\I6J++.D.6&O:]_#OA5K:26P
MI8Y)@.ABE]#LAKXLU?S;=Q[KR6;4^*R7YSY(J?%EA.<:#_VN-[9VJ$UY ]Q+
M%&^&D *X@3I;2@&F&1S\0"']+[S&KWY[K4191F5@I:G'9^73NY]E6"3PT+.;
MR+/(K@+HUG\_V"+I3S"+YJ"H!ML6YG^&].:Q:QR)K5 ^6.*_1I#_FV9=_/3R
M4][[1[*;SH:'3CU=5#E]Z=2!L]RGYO=,3\0^:W-*BP/%?[ZW+14Y>C[J(R;/
MTA1D)A?X>3N[(RMP+O?]([F+(1]OUYS\CRCU/VCKY2N'K1#E'W2@%,<_%Z?_
M16.O_9_2PO\OS<V<#@<4N\ ".'=(G PG!5GV.Z2H""YI$_.%=B[TPL+L+[&-
M;JC$SI<[2W<2\@>FQ(Y_Y?BAN&Y!#2#B.H< +7K'\KR#JHA?A#6E#).S=*9R
M[_WJ55>G7J<C)+!Z'[T!?//0QUQR''V&7#/XFFI/"Z/NKHVSV&<X$DLN-2%&
M[I2(5*QPTF;/669RRC[YD</Q +1VY+:^O=S[/TE@J/FW63+ 1@#]DC>XDID*
MCE?57 XNUL5>;XU0]C,[OS7;<W,T4^?'//_JD=-M#C<+Y<8T,%.^\Z@_F=!6
MGK0/(P9L4FY&U,/Q ;F^,K*B^$-E]^:'7@K$YIX]Y;)S_6A$JC$X?1]4#>O<
M8&-<W@=%7;/OR.)($OC@@SSTM1F2OW2&O!XZW>^4E\MW\/[>8I:%;'([6WW"
M&XG?MC3-# (1Q1">H:51($D[-UQMN_]4@(YM-JCC2<RX8V?VY6*;46KGFGWY
M0,;.$@M )F,IUF*MT()U(ZC'WLEF=_ S:-V[1C^;G9*<\3/047MK];U$S\]\
M"T=,.-BVFA;*<F@?_IQ[A.P%US8W6@VMJU+\P?RN7H%#(NE%SJNBC7[?SO0W
M>:"'*K/$G13 X5JWT?26)?9%*'#B\( SB^C7\'7RJ#)'W\&K:(-46CDQT6VV
MSMDGC2?PH'?PP:@?:0KPW*LK%T\>X8ARLV6ML>-[F:PY@Z&A=9BU)FH4"S#5
MXF(-O(D0?B3>*8#&U^%GV1$B,H&4V5(-YG3?]#]Q7J/UNL\MF5OZ+_MDC,M'
M^*)@!YEBR"'8T8<!4="#C$/Y@&<[$UPE,FT6G]LN%S-GD!(X^_I5NN=MQZG7
MKZJ.6?>B* [)F 18Q?U]4/&_*_(V]?AL<EPP1\$E$+!%+*U;SZ-K(FR!(CX6
MIKTSR;B5 V\B"?VFI1;/ ",3^#.]?@<CG'1%'WSTRIP19L'?#@OD+'8;$XNB
MD!U88%ASVV[DBI7>(Z.@?5!,REX3=!G, O/$[HI]$,GK?[SDN_3EU)\I](;,
M5#&3J1"FE"^8J8#Y#_^W)KS_9X?_ISM4IU]DSCYU9TI3%?^EAP;L$[<#>X5,
M>21AD98+]%#4")]^JV$I%<V: 3YS)V.8OIDQ.&W)3\] Q=7DK)V=U#L)7%Y_
M\7JQ=3R.^Z_FN?^//#B(R2U$9HK^>\)K6UX_>/%3.=]>_3[H)B'ZSU$<'>L<
MGP@"#'M2 .\LW+;+;DZ6@HM%2!9'8JZ-U!RQN>#X_GGQ*2.72LAIN/\9X^/L
MWTZ5Q_0P!,3-&=_W0;1"UFIYR2)FLL,LMF@.^VW! FG7]D'HTV"F:39? ^NW
M+ E\7MT'64#W/D I/TSV09^K41W)>&8*BGX=1?S"VF23O=A_7E(FXH '>ON@
M$1:5\,$P=*_N@S95P93OP2PBCF6.@X$'K!?X[@2BI\0! 4RI)-QVZCYHFH6K
M>:]#&?'F#%UIU+(B:\,R9TH5HGZ)/#+Z_KZ516G1<N5[\O\<YS_'^<]Q_G.<
M_QSG?_TX.=E+$=K_DSY80%T '0"<YOC;)86_=5N?<?TO=ID"(?FX?5!(JR0*
MD%4@/F;!3.,_C_C>P7I$#8VC#8?FH:")(5&43J#'B2I*XTWE2:=M/"L_U+6W
M#TI[C%B-!5W=K#W7#^I5?&PL_8\_7-_-; Z_REZ8^TV)_3M9"+2BQ/THT&PG
M^]#[5'@N+^?ROQ;^??Y1*$"\"Z0J%/U))W=+5#R;XYK5EGW- 5/% X^D_ZNY
MV/_KIO$Y^\[P@F(I2"_.*WBGX%^O'GP4: H2TI9-V(KSU=+)/ERA'WA9S7OP
MHGCYJ;TBIA:\8!X3O3WKWMZHHKTKFO&D_>OGR2]D17"TATV)=]N@J[;>F7JG
M^F\7O$:=>I<G=\R>9P59+@C,U;]FJCE VLH!9X&7\)G+],N!Q7=$>F;!%#7E
M/@--^@TXO1,&,N\<)M+U(R]9H>B&?KEW)XMQ7HH)"Y5IIU\X66WC/O]\E^)>
M(? @X:'-U= 0?-U\)+]4VH!^H*)NN0B5T F=EB,.1=VA_GR7OR0Z$?*A<M9Y
MIG]5,3VY_HGY57W;9G/J4$_C4!("0@2C0T).M1[_BKUZ;D6_U2H74<\^]Z;B
M.GF.^;3G5-<E@R\6I<&M$_:AAIF!X*XK/),9FW[*I-U.:TZ$^2B#@QIJ5A$G
M[?Y@62\&*R>4<O7<M2BVJ*27*VV5)IYS-05VFEJZ9W4NO7(TO33ALUQJ:_KX
M3=#%'FZ\\*&NL<"RA9<WS.WNDI+S9L%'U9VD:,*YO VS9IL<,&9-V!4T_8(E
M"3(MQA"KHOSH%*E8JG*SB @53WP[<MV87Z8XQN#W,#D@ 2Q0CCQ.0!@"YL1X
M_:GJS)-8F_HQA;/YBP=S?8QU_76W/Y>A2J_]\'/=_O66^H6:-7X^-_.24_7+
MK(&J">[Y.Q*+1B?A-#QQ,=J#*OS=9W$P2<S=6PN=9GXD._7KG:TE9?#\;F=L
MZSFXD,\NOV4>P6FVU[O(V>2X O>SR>+\^P_.*6'%C8X-4/G:K-['+ZO]B-N<
M6^&.Z(:I3BNQKQL\O,FUU:/QP\8F]P=/A* U'Y?.N*5@7E8>YNF<)M4Z_F:C
M!$/"-TSEJ+:3WWR:+IOJRYVC]6U#+O@$UNJ_@/,FQ.&J"CIA4U4=V*,;]X@U
MP$OZ>6^D$/6O6>>P&"LM7^4I5W==23#B+.,;Y4B/Y@KX<"O8AP7FS8I)$4-<
M4TM:NQ.U%-/<R;6I1JWGKY,^'5[@Y2@3S1JG:C.$"+1R@(\:16O;>VET$&%$
M_::'CD. Z<[>$)+T:8V;$T^4K?Z:[96_2;*_06[X\/X[N2A+2X/L^"'"N^*W
MG0[IM4'Q42N5).'K'J\QYZT__&Z)3BO.M\[W.5.2MLM?'=0]*RYV$]-I5Z#4
MCTT"<^@S7"A#H_1PPCXHOM2R_)G;X8JO[E2KQ42-PH<-,_PK-CX"*L>DDJ.?
MUXY^-N3S812Q2/KS/ZX*Z'Q:UL&19D7Z:>3 /JC"/L8/J<RX,YYY@=*:VYB6
MW=-!>\?MYJN"\SI>6NWX_, 1S^GFA?R]7.A=ZZG4^=#U'+H&LA-<;9WN2]>!
MFQ/+LA\:ZG=*O'B^[(2.=<^ GK;,_W8P5>M7[I&!NJ#:PSK9?./E?/#,CM;3
M%<Q1RF"+9Y%S6+31L/O#5//Z8,GGR5GFPN]@Z?L@BB58C#D(X\7-E^"D]D%W
MK2=#.^TV$7+U%)G7)%V-2(5?/S56(?R2!3%+TVFW!8XBW7Y<3OPE_LL87/ Q
MQ5XWFV/X[P2"V'HFWX[-2W[RH<SQ%>607O%*K59&UNO _!7^7W^;5K.@K9RC
M CV%V;Q^3&V&3#3-DNK;<?I\FQV^M-NP=<]K@,K^B?:;"YX?(.%];3GEC,..
MXMAMD9]A\Q9-WDL1M/*^(4!)FW$LE<GI2$GMT.-KVWA,^%@7O8&$,&Y.S%R@
M7++XX'/RWE0,O<7FJAK?S_7W!(C<4:)]BSMS%%>)6ANF:S"'4:P_M.EF*ZFF
M='T@HLTIU;"L-$RU-?D#/%_7?5-B/>K6ZZA+JY):W[(.GSO"L:H8P[A!'!)Q
MW =Y >Z=(GHO6S=C2.WK"L8=P(.G"72[ET@;EJ"A3$5F/^X@;KX6QP_U0$VF
M=P:"8Y J0/#AAN#L)>UUHU1OTI&"X(84?@N!5/&$<^]FL-GL.VZR%__!7-X-
M3CKW<^;Z@_X(VP_2?\W-;7ZQM*R>%:IXD6Q-51*3V\SF]2>3K=N5O;,XF<IP
M/_G$VNJ LID8NVTYE%,&+![%7:I"' LP.NEU=N:;/]U@TY?_M&52DT.MI,SX
MKRZ6U86PE-0=U2;?"D*H9G9-P];.$DL]2;!."+]"XGRIP8K3X]1K$VJOB#3N
MYUSYES%)!XK*8<"?X$<UUHV1WM#*GL=(#N8P@?WAD 2J73"_3W;.IS&ZW]=/
M@]!</_7C<GV"EO&W*P>2O-C75,&D](Z 8S[<>?  DDQLH>NYE-H)O>ISGXU7
M0HH%G9-U%0_B%R!_$^PZ79J G)11WFM$W84\RO!\PA E-J@AU.>%1W^J8>DV
M%_S2[3L'E!%-,5T]8N+EHYF(?1!_-J?7W\DN4*K4&A_0RVGXH9M]U#"(%-!!
MX";PJ'<R#8>K5V.,5P,B/YAROS3DQ=\,;"OEW@<)+(7;I4W3"DJ=9B9+;INU
MU-=??Z:T--,[$]6CNP%[3:@%KYVG"S+[F9S +-V-)7BK;4W@72G"C'KW'<?3
MG8MK 6IJU7X*EM<C#!6$36K!JNNYMTX_[G]3UW_>>JJ )@ODT -1;:=8_!T5
M@Q)GGNN(F)\5[++[O0]*V.XH&@A4?-:LSG[%;SLB]MV]ALGAL->WMDPQ/J"]
M4Y1]$(8A3C[\$B%'YE&_OAFXB/*$]6CU;P]VZS!\W41GVS1_*=(%6*A.B86C
M#K4S/[.$% H\(+0A!4>8PK.3C(O#3KIKI/&RE#O.08>J2]-3#'/.1<OY_WS0
MB5^UJNA=-A;\1R%>4\ZW/371X,Z  [WE8*Z"Q.VT<8-V[%2.3?RZ)%H^+*+.
MDU+&1UL'\(7,06@%H1.;U&AP&9\E2HG<V<L?.5>9:^Y[-.JSO,S;XBW/;BSE
M,BP:Q[,/FD^!T(.7^U10U5I1Q)= +*3KZ5@9;TY@(2C=MOAL9)Y\[&5]KI=L
MC<&?.5:_7W'8LK%GIZLQ+)N! ;H!H$B:R/'[_@V>VEZKE_#UYV!WVJ$'ZH14
MUYU_*U C\V;X_/( Z,$^2,SHY!+T<*L($$7JB9V*P1)G%2+_VO*TE;KH\OAG
M8!RC?Y0UF@8HY2I&&G$)")K'H@D4JR8X&>AZOQ(^U"&$-[A^'&M;49EX]T5C
MM*SVYFL7M7 !6"ZJ6K%CB(?A $B2-F*0Y\;E*D9VAOAFIV!NO8FUP[V"2B\V
M.?K>SD;8+PX^I@O^T1?$2;H:0HIJ_VAG(X:I![RF0P$ UU%ZU373$B8,U_/3
M+?E>EW$/+.MX[%[%$B):+N44^](0<))O/8ANP9R"\C0'DLNG SZ%0YX&)XKV
MV$L8EC^M;LK1^'W]OMGCG ;WH5<N5;P<G_M@CO8]6(H%]"D!C&#/9[A1%]>U
MF )5U(*D5L6!4E\920JR!'+KZY;O0<M[FX^TC<;X1G4",^B<;^V+6.CX->W9
M[[LO!OAUU)2"CDN9"\NLA>8/1?KZ<5L'ZN7Z[KY]!5+.HI8G/9P%MX>GU>2N
MV%5]<W+H/6=6%?5&R9"M1/FVTK7X%UF?'IY(AX;GSO1HSJ/86F5]IX<2-6[@
MF_W*-#(&4^47K<=+0F9<M/D:9VE/M*)&WR3YSDU<"<>K.;^ZUO^1.9(U%R+D
M,5"8PIZ0085.;T[K]S8+'ZPH-E>,NV5NYY8=E4%KN&L-\QF<T% 5=3[36EI@
M<G^B,O;F5@Y/!=I,)J9)V3;QDK_A8+.,K(/+!9\R=+_(KL0' F[MW<-12UJ
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M2J05>-R2"IKU_SCVMKD'I/[CQ=E>W>,2OZOFH7'V-JWC!M B'Z2"7E[)_8%
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M7=>\F-R8=BKPA'Q]#!7ZW=% ]N8@GTD%6CJHQXD:,!7*Y%JE*R#'<4+KK7S
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M32%N$&=:M"Y;U+V^?9HWC!P"Y6),XIDGD#,LWGX3SAI]ZBZL2C$AG12]D!I
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MN_&L]>559'3(_/TW2/0,+$"PX\$)C^CK^4[\'4_F/'4TGR'$/ZR *YDYV3#
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MH'Q@\49\5'!,LWBQ=ZLXI>5;^OH'']K=V;+\4U?-DNMTQ'456E))Z*<($W+
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M?9"RVU17GC@YQGI#]LN[3RRM:?+KUBU/V@=Y;$S&TXI8,% 2.J-,HP-8(DH
MJ&K_S=.-F7<%MXL<,RE8#OPF0(LOL4A3;\1 Y!XU2*^N792[(Y]L?.P??"]E
MF\=1KD-%X<6?8!1K< (20KF\:?YAD@$=<QN\B%>1[)5[O*W0Z@IT4,#S"]'[
MH,.+*V[<(]4SL+6WBO.-JTZ^/^TV=\1NBEZ[+$EGAD=E%>ALP+*A @SQ]PAS
MBEHY"RIUUO9I84N]JQP(9E]XW5]R:;L!!A'X154LXY@E;:<5..])9X/GT(HI
M8X2J\:0BWH6ZD3LP_F_>R2Z<.17>G)NT%&'.U>JK'#/[H(\;L9H;8LS/T*,,
M>U)\KUHPC\FG1M>N]<ZHA12[VK_Z(S=]QXNUVY'@40.E["G W;0Z:6[(NB9I
M;D)L[/1[V6@0V]>;=B__S1MYMGW+5,L]>@!T'U4=6?:ND,%.3<Q/);TU,:W?
M!SWUIY;N^"G([FKYR]Z63S3N.Y?\G,/F+.S5/JBRG"&*GN_&THTF&6)[)7_*
M.L4QY2<>/I.KG*A9Q42'VHLP%5)43K5ZS<F(CU\GMAW?.Q19P9*Y9"/+8B0X
M(8SL]YYH;!SN7[PPAJO+[$SIKPOL_5$PQ>RI>K(/6D7N4@_NEF.-1(%1)O<4
M$?=D3G2,$1E D1BTT"C6R6NDAA0%\HP.+F5SQIY D,(+5[YQ@7YCF)S[(+H#
MX]A>*5.0 "^>A[27!K3]5L,4:\:.U)1S&24A!N)/P(EW7(IX=A^UZ9:'O\"X
MC6\-,00W/D'K^*(8AF0K=]K*GUS4U<;%>(E=DPK*MT%:N"LF68(;OIOPN,6Q
M@;D3R:FBCU$U%@_OB648OG-QFO'5>Z.U";MRHMI1\O4=N9\8!!>FRPA"Z7E2
M_5IS2,0WK3'R#:+7\%N;$#)R]1-2GZ$X7ET^#6Z#'0MHE5W!/_\&?RU7.ZSP
M/#)C4NSS+^.-'I33,$#,]48=P_ELL#'.4#W>?UL^LUP7GN.$4U*AKM^8:SDB
M6344OBWW..=GT])HP)49+-CY647U7K-ABDT"^8CKSQ]W,FMGLKIN447;&_%/
MAQ*:Y1"-XUGMGZ<M.5_3YT'A6Z.E01)U7;T(ZVP?I\LRPA/586#K5V7OBKV[
M]>$7;?NTK,(VVES5K8% NB= (&*B_$2&3)LIZUGE)Q-0@6H99HFOS4T/A3^>
M:XUI'%4-YC:K:'U\)\E42=Z_P::@4//MI8>4FF.7=JNL:P;[>>5$W]S,_=;@
MXO).OM;/:^TW$CT( VGHXYXRU2GEZ+(UAFXA"PF<SQLDVPVO_]7/5?[*-1-(
M;O0<B_NM^=*(!OT]/@!HSP]U8&+PJ3Y&_)2NEC=5:A/PS8OB@Z+RZ^)K9Y0Q
M>P6M9Q@7 ?O<:>MYR &+(NY\CX8QK:J\Y^#NSSAUOKS3N/7Q,7<@-:I 1O++
M#Q7S]JP^NUI7D<;5H''NCGJV.H8R>P]6L)F=TOV%<)6Z$>OW\+-_F1UWF)K#
MHTUMT^4Q_"L$9U45@"[O8($7?D9(:J=$="U9!G-W'^09@Y?+,=F-!9$7-ER&
M&$*H#BW6>Q4\12C=O]*W#Q+LXOMR_\%U,K9,:?C3\.\QK]XIPVWU?G6&J4I,
MF5&T)GSFI7;$[YD DZ6&8"L]_&4_-^]AOPFP9OZ:H/CL+WL%E!?V"9;RQ(*J
M@C >9:W^6PU>\F-U8-4['(>"DAK*CX'%-7GL:4;H]CE?R#/Y)M:2]2&=NU39
M#^Z3#P4?_ZQ8&@9]NEV/.$GG&WC?ZW'R>SBJTSR1.-.2SQWX97Y'H<GK^_:B
MR )S/#WC)^+GK1Z'#,U;4@:"5U(S W)?MLP:A6X;E7Q%W<-.I7;^;M8['$]%
M662LD*P^FB_Z?0L<50&58F.AU> VS--4IQG&!2H-F]<;)D*_7A]$']\1XXC[
ME4I>[$2AI^O:5C&\?%/MNR:I5S?]WD_\K(83D\:G\,?4"[\\GFCL(QQV^(9D
MO=Y1!(1$D'-R0' \J.P-YOI<=>;.+XJ9DJ5*N]?WMS5S0_[]&0:.F>,+>;P6
MEM^J2^73]6LRPG]E[5((9,]V;#R_ 8L#( (+5OK$.^-]SZC@KN&WRZH7.0ZW
MW@,6B>"C#,6]=ZT20!_Q9WQ [JS/='7&W5P5DD N;4%VTL/EP'GI</S71GRL
MAO51KQ'?UA/CQZMJ8LYM604>OW&5XX%O3*W$&R%7Y6E7/2SLQ8)#7%F-@>?I
MEXIW)P:<EE<K?/NX#MQ]6U.5.*O<^WVOL)1A7VR:RY"DW'U',EG\8(5(?N7G
M#GN1NJ ]]\O9(-R^6"7%\AC:JL16E=G;Y6Z3L.PXX+28\[3_3/W,GIO+%T._
MG.W(RU,,1V*]@0G'TY,3I=T%@?YX_JD-&?<+N8<1X0<^(36MNW%"1M(,/7Y<
M$@)6L(SS2G9'KZ=S1;]Z<Y1]@Y!=_I:A."]MSS)JURSAP0'2*TZ+,\V'PH(%
M?=3XIE[,'=],!;>?)4PT0M!, 18LADP[D\"QB- \<T0CM\G[Y8FZ8<YC8HP*
MN<;#R\T?A^@U,SM']<9Q(5]@2'1?3ZPZU_!#LH593N%\:KC3Z75<\KK;"6I+
MTF/B),/B5OZ<S]?+7TZX*D!TWSH<$P,A-W M]YD&P#HIG>*QWO/$2 C(L#)Y
M8,KEXMT4LN&7;ZR-F#%SP/BT[3U5*^/H(/ #WF5W? WYNC/2L/D7UIQ[ZY+<
M*]@,'\U'V#>$W>0E)-ZRT: $OY$*\&3QWIV/-8&Z"XX2E$+BX-OQ<L\(??4V
MU.W,IQ^Q/6YBKOJ.]I@N)0-\1N=)-T=)Z\HYE^^,M9E,Z2C><3*!XG 72JG'
MW69Q9ON@?\W1JGI8SKNLISJ[,Y=^2^J8CSW,N_4A>#5O<^3,(N&.%\Y4^%_B
M\8!0NB7@21O<2VMVIEJ3L[ DOL,KL)K:E_N@(^4Q?M6:=9F7[M;@X'V#O!XS
M1^![?9XUGL^*)<;?C%1,I?[8^K+Y&^[=][K[-V-HU.D>FO-*">S9[X52(I9M
M5>;$UX>QFMRKTN<BXO7%S <"3YLYNLNL&8,3;X>C>W 46RB@?#>1+HSP JSH
M&@BCKR?P"'>J8$_XE=<?E,]Z/;326Z">\,Z?V74S=C'C/7<#HU-6Q1IGC=%9
MN" MBH)9NT%7!$0O3AC) WTF+1-V6YW_K;TW#X?Z_?_%1TAE*_L^E82$RAHR
ME0I)%+*;9"=4DL&8L>]+*(HR"5&6R5YHQBXD(28C9@L5PXQEO#*+,WV^Y_Q^
MYWN=[_O[QSG_?*]SG3_NZYKE?KVN>=WW\_EX/AYSW_?SZ7C)6/A8]^QCC\A=
MK,\1;;$)2]"'.Z"FB %LIIQJCV@*4FP'Y!_Z+85<D=,'E41,*,G1(9F;(U96
M:<%U1?@ _I8<KW6Q70-)63;\K>*#Z"\Y> %SH)A.8#P&#)@!G"&.QAA"D76O
MN"NJ-A.R%Z%Q;G[DM3_54#QT[;/#&,5<WO*/Z_<O AA$[PZH):7/)@TLU^')
M5$1\G>.=V "G>PB,U^IE)']9./5K&U-XARKG<=Y&G=GKK18I,Q)SJ4;&VW%!
ME26.N\PN1R.)K5CIYAT0WJ_/1>0U.2,T;EL34P].I,[>9Q\JVKZ4WFE\;YQ_
M]J3FH+C("1UHY36MR1<"_\0,[;P-SP=,HLBSEW= YK26LNJ J&CW69=I*\T/
M;S:?3EK:@^T&*&?!TG]+5^^ B-54)NBGAR+-L1NR;P8H&W!A-%?6E7KW-ADI
M%6I^M]6;GR*\4T0-9RJ$',GMK!MF=+%;.!IP0Z"0")XV8_@#R,HE@@1&V;]5
MKK8XR$[7!5'HN;NOX/?UTW"+WZ4"JGI_#)A0%A(8#F4JP\_3%ZG*3!&X?2/P
MG+*:ZJ(XFFH"K0K(U4(%^P6\Z9TJ@O/IG^?CL8^(&%R"PN#!#4 6\SS+'A!E
MWN2,<([]K4X6TD@+J:C\N0,2Y!P[-]]27V%<65+I.=36=CSVM:H,1?:%*(R=
MA;R]FEERC/VBPYHIB< IB8QMH-)*I&GLNO>*A.05.2MAJ/7S.;WG!F'R>R5>
MF_TJVBY5@!QTG#=?3J*M,^IPW%'!R WT@O&A_2["N+3[T#C&,%E05*"?8EV?
M'50IQ2C.MK+0[ZA$B*C(R,BB)YU$95[L_:?E077%%B%RP9L@G-VWGZV.4RVU
M)@]G.G*[/WC?+$\"V_6!X"E_\PQPN>5+_%\I;LJ'](<)G(7NAY^?I 0T*?+U
MNQ]N2BND2C=25GKD2FSNG7V%P!-:%_M78[%""#[MKISD;9O4C@ ZVJU^_#Y3
M\?+/GF"A=6?!9)64<U_WL2;9C4A_2)9<SC*%:<FZP7Z%]82D5U-RY /6 XR@
M:>C[[V:L:)\S)+O_V)Z?;\C%?%DYRY\AA)LN6NRVF>[A[(NFE3&":*-4%<JJ
M-/SXI&X[7P>-$!NB76CSM;DE>>10Y*W<J_/\D?Q[;BNI\?Y"3ZL.$&BV.R )
M8&Y[F/$.T"&!17[F?ENI;Z-QZG!B'7^8%19$KP\QDKQ^Z:SO;)2I3.#?RE(H
MX)A?"M(;$DL0[[A&MDF![F>!(]XL*<G3]=OU*PU25FX>5/E8=,OYNANU_VX1
M^W"K4DD3C^8_BM*[W7ZLHKRR=Z!*S9SN6-,#7W= (3DS XP"X#W=H ?[-J7;
M1H!+W71H$?WY@%^O7&N6=KES\X?+<VH5[UI:+^R ["4L8BV^*U+&/TPP!-G-
M338SQ@S[1G:Y'E@$)6P5&EGE!,NP>O?$Z)O[]%7:=ZT=$-EVK$7^W4('> #;
MM$K=R[1C.0-)3$UDEXZ)8"G@.]SCH9Q_A0LM&7:-%UN;)TM4UBG-22 #Q]2:
MI.> C%M^;LYAKEOQPJ'L)*P7,@E)LT%-8TD1O:&*,(.^-BJ5T!\J"SO'5]34
MP@ETF^WMJ.N).5XK"^D!/\VV>"$:\?>_+*[QV&U"9E89W< DK;T'(YX]VHG@
MJQ]?I#VH/W*\,>C Y_6R65$GYU)CT3LZ<Y@91Z$[_(@+R"Y-;" LE&OQ]1 I
MN#@)\JU]P'3/6//J+@!ZN7$B5/<=*:-'GW''/3+XWAO"D7NBCT_F70V#UA7\
M:!VA_N?J-(?.V\^%X57^0(PQ77.\I_(G'HYKS=/A%U2P<']OVHTU1I)^[X!:
M10II'@.<?=)HQ*BI/#0V*FFS*;BRI\J2_3Z@<N3>(7?K./G+Q&J9[=CISSSH
M&@BQJF0_W3P'22R!RG0<(KZ3L[[.[)1+=QZ0[3I^^ @G%O<))8O0A:M-<9]I
M5MBUORV\%S)MU-IU8;QI<^WL;(R)8)"$9_3)YX^BQ8M ;%Y:W8<*H/)"$_UH
M6KABWW-V31A^5#S96=GG^Q[EA(=!ESNJ&4HT3#L1/2U 0B5VV/BHM)2] J2O
MM&!:\U?-C[D>O!FSIC'Y_Y=<-Z%?*4ZLG/"5O6(KL+ #RF:!N=0;4*]D2>(&
ML#PFSO2$/B5IP)&I_8LCW_:.ADT.-_-333,Y][H?-S9Z][ G?LY0^<#R9][=
MRPL=JW;L@J900'. )8&C5.10Y;FWDFGM0L<NVM#0\:PSI-E;,5KJS8N[HF?R
MCQPW&3SDW_*,47#X9 LFF^OVQ")4DWG6#BA0DMV$O:F-?TD@:?<*N_94<UF#
MHM9K+FWP_]7&SO0<Z<@[]QXY[JEU?A#5'L<Z7/5W6U\\G#.)?&O $I_H!0M@
MO48SBB"II@8P=)\P&I8QX'&J%>+=_K5N,2UDI:,.,=_V,#4L+R-_\ 77K;K$
MFK&I'DHT='_.=$X_6*P9*AD $<"<\( %=1N]^@!Y#FOSCY<=5Z\P^6@[-"2S
M'JNQ(C"HJK>.9HE[,60GD;? B5%3CRF$M'S8Q("' 5UO()6%)*<=6LMC7G]R
M+%\"N?99S\'!8<-E6Z\P(@JTCLX$BX2/*L(RNMOJ'A_14,JH4YG]\OB]?_=;
M"J&H%_A%0PVX5&:Q3M.C2?8/@FO]K8\X[I\U'0L+.OB',COS#%R%=F5"3NL*
MWEX+>EERK,+8]15*]3V%?.^*TC$]B;KW^.#*-W>;B]9OF$000[LA2LYP>[KJ
M@':&H(](8TV/< '*[Q:S8&K(Y.TE2&_?X.F^Z$.CY_!%4YW/R.7XL/&7S<XW
M'O\(]P'V.2/ TW;MDRUSU \S,D/.)X(*Z;,[H%[!DT(>^VC/2\IK*JG@VQ_6
M6A I>I./CDS LP.5M9P]!I]+5KWY^ET[:-/\(>!(*FF$],Y E8 4XDI&Q=R%
M[(; %J-D[X/92>>SIK>JP4W0KAW0 9;C>]HSCE+!K*,97<$ APCS.HFV/;,T
M>23GV:V.+<K6@!4XM@3<B%MMDD6/KVS>5!>*N^Q7??]T)]7=WB>U]];AU]7#
MWME&D2)*S7L];Q7;1?Q\SJ%\IF*]1\7[F-9N\ O6ER1IM7T#C&*GFH'H0"6/
MD;ZHX-7--_K0AIQ>#63\%E1T9#YGY@B]Y_?'N;LS/V19G4;A X%;5F@E?QI,
MDL4%.>'[Z^$HAYFB=7<-QKO6*8P@%XWG)DR$[QZEVDZ;O6*_CF@/Q8LL>Z$J
M(L8+@E*S*/+35:QM;;O1LL[W0=?G$X"*F*CA\)_W"8H8B3G6-4#C-<MH8C[9
M>+A:Q4+IVEJ:1+P.-=<C@,Y+Q%+%0RFK_"Q;X*[7BY&JGZ:*,:;;N.MMGDH+
M_9<?_Z $ATM#FM Y':>]\5O9&-[ (M]\&>$P>.O8R/SK,P\RE2J+QKA ?M$#
MB.XU@B1W'" *YAQP"W()\IAAE]"5>V]FLDFCU^RN%A@]>Q1I1WA0-.,>\L!7
M 9PR<)DZI#7HH:EQ[S?*_=H(8$P<Z-\!I6(E=5%IA"8'3HZ0!]C1R#2E;,6?
M*Y[\?$,BO&(U<*:'X :TE#[1?>XPG?YM(VC UK7'!;*&VTK&V?WO(;M8D3%!
MO30 /(#8AZ&MH.\*6@7Q4ZK+AXRHX133R1E881]>.F%CE(H4@U;4HI](OLHW
M=C2M;+Y++E&_D7.JI4BE]2-.N > 8Q[]'%I?!)XUW_M38LY%@UB")&>?5; /
M#3HP'%-J?OCU%_@%S,W6Q&#W^LNFGK%[03]\/[S9198\Y15YK7W)]E=;26&U
M:^U"88SD)\VA0:&X.-:;3[&JDDE1DQIZGYM9"*_.>1B\^;)$R,MM@Y<;F*JU
M6ALB(5WK[_*E,>51V,P.R!L/Z =K.4UCHQ?UACZ*G#EA-!6:AI&'N]$,^H-=
MR7[=Q<9G+H_VNL"O!<H%S^/R?WPW7ZMY<_?C,<3M]<ZZ5DM@G9B%)-<@][*,
MX:V%"=8%*^2@2-[CAX[8?T/B!T=)5A1DMI2I#%T'IF%&&V$TOS8+U*JC;FR"
MWZ682!W9-"%&]#TP7\JM*AM&1OC-M)_^?6=$#F=5I#E<\NMW\0UDI W##X"\
M9BG2%/ 1J:NWBF],-EMEV3G!PN;9+R/FAA*8989HLSRR(25 @?7F5$QU[A=6
M9 1=ITN?HPYX1OLV6!^5#;> 'CCP\.=0^?Y.^E1#AR,)DEURC#8YE:"=?E_^
MTO.'LK>I?O)ELX5FA3^'^R^)'GW_^[Q#4*O#-,&UI$1 LRRV3$C7_=%]'(+Z
M7+6'D%:B #S>71I)>EIBH<NVK,'[NAVO4<[:TGZ3>[!K%:K\-U4I\L=;3A_V
M?V0JW=8A:B=W!)"R'/MNE!QIGB WQ]P5?O-MIDV#_'GZ7GO:'U-WS/L;Z"?<
M*%DWIT:;0]-Q#+VQ#>Q^9[<Y%PY.3AM?&[R2^R-%[D%Y953"XQ]Q'W_?=28'
M3%0Z]XO._@R?2C*T#Y0'1XI)>'^]U];@);'UN2>=Q>$&#B;K[[IH.LN(G6T2
M7<49C%)-.,Z2!L>NE-,K,YK/W/#??&YZYMO3X[>NO6T_]UA,;%_C_!U[N=[>
M[7;&8_8C4Q'.5)1-TOW0S")W:A\V@>53"91==)5?2!C^>OM;DT@?8CO^JCTM
M&F? ]/Q;:=-W!S23CCM;3 G)>F/V!N;"I"+ =.GD\+3[U,M]'WN.N9TW2_3<
M*BSM1 NPWV&#1=.P]8NL RD]!'F$++3'(*<9Q0=XF=-J\*D!+M:7.!I.5X8@
M\^55#98G!)+]_WS\B#8 RFC%%#^66 +%H','E.DASWX#CZ34RI.E>S4AW6#I
M)J14$"0PQPG[57HPQ39.X<#M0;7!"YTSN5\78DW'V0^QM\#33,8A6LQ6HBD_
M#+$I[XAA>KRO78IZ5H@OJ#S!I_'=;<AJL/GJY&!W'0A]*_VBLN2?2GHKL;(W
M-+7D*%#*_)LR\R(R:%4<+CM^GR#A'K #XH5#7@"] 5-3^BWUMQ0M6YZY#1O[
MVFAV@>#E=S1^Y0!'I/M065@%+/$Y6,A4C3/FV&K@H?6UJ3B'JL%<0AX+^DCI
M*-&(G(7]*8\[_!!%)OQ=T>O[1SI]/'V,58F^',W& WX<P1RZ &??(2)T6J,?
MAZS')<,EI5,.T10W.)KTJ^]KK$4J*X]5AS(E+/0;_Y@E>_48R"CK\FRL4D\S
M3[%4V74<23>X%##\:G;VIZ-<UO.-A]_F]#J2@P+&8=F;/W@.:YG?[;N';!Y=
MYF<:</ 8>=I< KW2;%*YC5;PHK5$'M<!J;&J_.UR/^X!ZMB"F*)#LH&V65S1
M'RX!)U!SZ.(,[EC%"P= FPV2M1QMZ4FH[EFQ,T<IU[S4\VT[]!G#.GZ%WCJR
M=Q#T*TK-\Q Q4RG.%S#-BFU#-*?:5"*F$/KT'OAY(.LES(ZR.X$<?.6[RU(8
MEZ*VI:_-&7QL\O?NPC\9R@P_\D5@!M4@L"S+-$+TRGG4!]-L+DS*<8-Y848X
M670_+,6IT/9K^%[0(9/I>94G:B3SLQHSAWRH<QAIH(*I@!A#M9A3P^GZ%,8C
M8)B"XF<=HC5C2E!"MSO 9,CRM] *_;G@/M:JK(B+>D.[4^*QC@07%,T,B]<@
M5PZ@XB!B)CIT'?*SN3.M0 "]&DI#)G7$A"<8I&X4FV?.S!G7B5TZ?+ZX,.%M
MQ @HIOZ?M@Y?0>TV#=C<71$F_#RSM5"TQ=#+[P'G=UP>\AB(A/5'Q4)%(($V
M\7,' 1[ZO:'?E![$T7JFUNM0O_M?+M-7!/8M#3V+&[D#:5IDB:,8;NPZ4QG
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MU$!(Y7U41Y%*]Z+\VAT>Y4*/5ZJSM?$=N&$(S65&OGH'!*B !S*$C<8MZXX
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M.2)I;M!I5=OW>6L[(,[>'N9%:]U/+@&O !X=G?H5R]^!C PN\5UA%\-/\[K
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M"/'L+Z;PO^ DY+\4JOU7Z5QL\!T=AR0?$HWC12\;_.W^^%_=(=P)[/3J8J=
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M2([I.R!_"%\ 0NW]NW1!I/!O)8W&9(ZSS\%+&2%K>P5/'U03+#CB=?IOKO=
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MQ65^DDW.QQT6)G050V:&76&.R)'#D6ICC2=,/GX2 #G^'*Y;^4I00RV=!1^
MJ[.?8F]#\"F,'IH?U9H9#HAW<V3'$>(_C1X7QL.5RWX'(W!RM3_WNP76:O5^
MDYN^$B0EPI=2*FOJ'LD4XF*.J1Q<$."&4+ZO@&H0L9XK=_BGJH-*66?;.GQ0
MW2XB9>K21K!ZM0N?#Q7<STP!2?$]/#OPZTYJPK-]4J=VVTRD@^8Y_'!E+J4
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M!'1%CB;#J Y86]1C"+YHSTHS@PL&F42'M-*#1H&^EH;PD+[JH;PCS#VK7A#
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MEBUVB735D(+YDU^[(S_+T$NQV3\$,TXSWU5,T9&I9[N7*J%O370:RN;5/JD
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M >&&!5:(?O7 KJH9\Q2_K&^9W"J-);.8Z07P8<R*8S-V>ELKI_,<P"@EY1T
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M=K;L\.V0V+TL&+9:I58^F*>3CK)QR,JJ'>X3@=N>54MW]KYX[%U?@0AK%4%
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M6[YP@\7!L#;5B=/_EHB!<P7:J:,KEF\"I4 ,ZIQU"K;VO2)72^!"H35<6@=
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M9:MNIQ<W^Z3OUMNVBAR%X=T&+0</F-5YT1(3?G&9HJC&MHD@O:U#JZ Q!W!
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M309QG+?3UL#)\X$3G9,9U9ICN[>9F#0;ML@\HV>*'V0/%.VVN+C=N!JQ ^<
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MP5^3);.>AZ3/LJ=9KX3?KBSQ!7>&]Z'JM7H-,$"L:1U9+;0+?0*+0$590"6
M%(?)^C- X\;)9>)0D=YXU9'PID7R'2;=[^U#KBRF$&FMO:LA9%#H+]1EE),0
M4E5]B?[!OBG!$4GG@@5]N">,"M&UF7K6PQS0_"-;VJV;,>E2$/<3%*^S8O7
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M]T!Q,G1]M$;Q9GT+(=553O/4/5_79T.NC;Z\Y\1_4+2BO2O&C6I(_KUAUO<
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M=R-'\NJE6T'AE@MUB;%MZLLC[^;9"5$QAPP-FQ:16;7S5@%"P$_'JKA'S*&
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M2#4A@E]<F\0]U#+P(BC*G3^XJTPO8%V;YV<7Z%<V6P[EO;U=SNUWHZ9:86U
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MNR[$$!?[[I='A#(DQB$Y[.6?DGV=(#?^I@SH(A8UND2N:1&-3=R-399GO28
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M2W/3#,U*CO1;,\L/OZABP"[OJ>Z%3Y?DA"-=*'AE]N@V#0)P5#L<%N*?WR;
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M]"->Z@"[99%&U-/=-1QY^M%)15MF@M-JNY#\>"[/SX7,8KODQ0/GJ; ,<;D
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M\+YB%6WSNCI>>=?FTVO(%9;E9*45JR_0L>)_NU.XT/JVM7)S$.RV1@@>:G)
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MG1))%56A;J;V!2\Y!9\=%A68TC#"?$V \=:+=FF(=8VT=VUB&C],])OS9-8
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MN7:7Z,R[)(B-2Y%O8]D"NC8^!SQ?Z4=O!/ NUPGGLV/;"(-'-!F?Y9^+V%\
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MY]'=8A $WM(LRVD)9LV43FR?BBN)$-8P=GX)I5*ZM1"7L21T1<F *:W@J3;
M^N?8DW1/B,O+.O00GZ9C?(YF3];EA#Q7E66(-C)!>IVR1Q$#[1TT1>B@&+ZX
M&DP_7/UC.FSD6>;8_L3'!LH<LL(?EC;%&QT+4VKW[75W%WO?#P -!+)7TOT3
M-\S4-GU*R3)$NN8X 0.253%5GU_%5(YB>*H2_DJR@G[0A-G/D($W]V]\C0#F
M6(YE<A+@IFUD4$3IYCR1(7Q)QQ@]<%SKE[RNJ(:N]SB>BZI\;2LL6:KJK$Z?
M]-4B>6GX<'46N<S$M;54EF$G^P/F^JOENA/?R*N_^D\EC3*;;R<T.5UJS$:R
M#8K$=8EYYTE(O%].!!AE20W&G2KYB5T.3DVD8NB9297.6)Y2>/!PDY(G1\4#
MS+N,K:B=!Q&<J]@+VGE">9@QCG/LDY*D'#RDH[XO[CU1E%SHG'0?ON"I@:@3
M$W>AN/Y1=?8G=/]YD\?E\\!D;EC('$$+]*F)*G,K/W6CM7P#0GTXJY>;&HLH
M9/WNOXW8 AIJ"_0-4#S;MS%7Z]=)I'EP:<U+>O_O:=CESFEE259%I--SR@XW
M?#W5ZH^8%J#<\$'QWT7=U\2>%8<6EC\[&-63^UP;.T*[2"QBWH4L7; 91.2=
M#\)$EAYH7 #N^ (/N6@'UEW$9$?'>45CDOEN3'I^D>>;O\NV(*._U"?=D[ <
MH_:.8(6W32(6S!]].I>P-]Q]884?I#':D'7M.TH0+O;,N'L:[DKCB2(.DN\$
M+!22YBZ7>9+@E+==Z17TT_?A^DX;>VZ*SD+?J7*F3<DK6!1#;X ,1?4P***I
M,UMG*?%%S'+<I406L0T&FF%(T%RR,%$,24R=TTYI9?:G6>J*YAW;[.@H&AEF
MAB(4'Y3P(7KI:KVK<?%APTT:9_"F&^?3(*I@6@<0 _"6[XYV!>&\T7MB"M1L
M&1T7Q ?D^I/YRK!S@$:_QR/ RHLK5MTZ:J$&#<[W?/7@KW$CRV':G?,Q4!5%
M).R]IOP+'UP030GY'3''TTWS;K*$EJ7Z$#_X7A+'5HKK\>Y]>^QF-4.1?(W9
MV7T3RV39;>WVP?21\]N"/P)EAJQKS\HQ=K#/<[><13SK-4HUWHPJ*SVL_U'<
M:V[..R;]SNL6?45@YZ)I]83JWRM* 5FTY].8<DA,&?-@ZQQJIXWKN<^;/A>[
MA7X@^''0&\V:X >-6C5S4:!*Y.8I,17G?/XX\#;!)7HISKM+($I9PB&PM^GC
M(,=;_=/&L%EA4N+A/V>I@1SOI[)B0?:P:PZR?7UFCA8BE:$2%X"K?@!DOR5)
MA*?S4M-R B5\(68D7B*BC?NQ*8A&FOWK.<O$O=$'U2#[^!R(+UN\T=+ ]'9S
M#X!)8%])_>P3[-W9[6.9)XR'LB0#.P^VWS[,&#KIOXO:.2* :-+1.55+GI'#
M("'WKTG7[=*F\JMJ##?TXX!MJ*?7/LIQTH8VQD;HP!VNU\WMVBTV*>@<9K);
M\9WWY5X =DM8UH,#AE283NC)M/\3-(HI3)_MADV=)Z&,?*S3:J4N $\XCB?2
MOF-F5/RR(*V7?L^'(O'M<R=8/!?8]E5]#,_>'Y@B/+>*K3[FO$Y\#_D@B\CR
M$XAE*F.&]IRK+MW5L=0-5OZ?V0^19(XG\Z5:VVT+!5U6+E1KW/>(AEGY#G)J
MWZF3^[R4^T;")P,<_7?]$5\AK99WE)\K"\YGZ+7SV!OEHBL]KE4L^N4ZQ5K-
M]"(Z,>:@^4^65V$X-5B+;""'!^R'F<-)05R96(/VSRXWV1VE+<D/J.^JKPP"
M6#_\?=1E%I\ 7?)-116U9@V>D+77LW(L#$"'Y%X-;?=T2XW+#:)HP>6_\>>4
MX=*YC /]_&_8?.CB,?-U(-H"4LREQ+61XK@S<,NC+E4J(P<!,MJ-SK\LFYT%
M..$,H].,YP/;!X/!G>=/4O"PS2S"0A<D^-[Y:,.H,DM^=1ZL1DK#MWHUA:.<
M_-SFB]SITXEQ& >09<V2XYR:5#_?5%]H9OR7A&EC.>%?&LN?DV4M*UT,F9&[
M*G?C2_P7U:?=,L=YE\]_3=PNAIT*S)$9B4ZA:W4K;0@6RS6Y5.7UH1FL&E_$
MBE3G7WOL8/*Z\AW0*/TH^XD65W&?R9MM#'+T./A13G]XG,K0.6P8^(LH\*D*
MR="5ECLI6<9;H]W0-+N G5Y@*Q/7(SGA-2BLH+=G5"5?M#=S!A2M -MDUNY"
ML#J=AMDEF1G?"65":O&8"/++-R'_6.Q? +(@%X#;C3ED(%&LE--#I@+;]> F
MP^NV8^KTLZ=(K9(+ $UO1*^I],QYC!>?@(\%!^_^@SK^[X9N0WSBMM'G; 3;
M%%SN'N_905O01A1+_&;.K[.@C?>7L"L#K)\BG3'Y;VOQCZMYR92&OOSVBW%A
M:@\D;AAYWCN46>!A 3(&&I&XB,Y'A_MGD542?OBB-W(=@Y_^V(@V>%GGIC2@
M7NHM.0HF>Y2#X]&*Q4H:-!,5(__49([;U%9_STF0I>&,+Z?.];GN*=/$0Z]'
MI=,K" :[]TJ.2\7,2IK8;Z8Z%#!_S1Y-@/HSY:F"-QKW9V0J+:#;CFOY:6H_
MSGLO "A,\PZ6!Q>'[A /Y1;1V+![R9Z<!F0X4D^/30OX5A&(OD[_15V>(S[C
ME=6:%T&[DVY2P(*'J> ,"7L/8C$-!)%^4VD4_QUHD:9CS[EC%[HK7D\]_)''
MEX/;AC:PULA,;76N$D9FTL!A8KR*=T+F4 ,1<[?.14C>7'5'$0U/9\WS?PA5
M_R_.WC.JJ:AK%XVB@B BO1>E2A<I4DQ4I L(2 T0E0X&D%Y"@E3I @(" M)[
M;U)#1T! .H2>4*0GU  A7'S/N=_]=<<][\T8\\?ZL7?V6&OO^3S/7'/-.7_V
M8>;!BMI7+_2-IC#2KX[4K_+7#[1HC[\DBO&O%6HZ"#J9U%SHXC>.B^D=XU\G
MALZMGJX*5K[NJF4<!2M#$)VB.*<A40U=!%Z@MQ<9ED(:<J0=Q'FKMK!FW@1!
MI2D[?CC;23DZ5Z5Z/YCGAC?_?;8*KK1^B2(FF94WR+J]G>1' \1)!$WO>:L<
M$K(J7EX/<D+.RBROATBU:*"/,[-/)>R9 A5'#)P.2]4PSS(7X^Y=JVD"Z#/:
MGLZ570)^@ZAA9I/-3N@=E>YT_LI:1I/< U/51FAC)YM5C&"!W/%*6M=*]>-'
M]H<'VF1>J:#E.:"80/YYO_U88%Q$J@>TNRYKSCQZ7QW%[VYSQABT(.P<<\>&
MJ9GS7K><E(ES\:_UOOZ4FJSX).&$E(^&NEH;A>:@7,9+ &,KC]<4\783UAKT
M&2@V?G1>?L\AY>+BN+3,GF9^7G4R*0[<D6=L_*U ;?IM^O4R.</12T"%]O;5
ME63>E?AU'%+Y$A#6.P *)8!<.0F!YZ5=FXA5I)LBL3@$U-P684.\W7 NQA=V
MSD3@A* HEA42.42PD3YIQZGY6W=>HAS,(8/.43SWZ\)@U20[L9X=2]=IE+C\
M-"$!BH'>7N%>V]V%ZFR5D8XY61BZ5*B9V@'_@#7FN&S6X"S] 29%JF*B0E:E
M22O79-15(RF%MI#_)GUVN//'EE&$=1\_'(&FZN2\2= >!54IO,M6<2XJ$=DE
M'9!J>#*@?&'XX]=?9PDR=*LG/O:<P6OV65HYD&.>K]9Z>'_V]P;E;T61J8]D
M2P"D.%><US/9\B*! G0T8#E=] 174ZIGI<NQ370<U.A3DW>KQ,V8(Y*MY'02
M,(1_J:4D*R.G!Z6V<HLA>Z#J9J7,^6E3*.6*^:RD=LWAD[=W!3,&-B"9)F6Q
MN0YU$G8^"\E.WE#^LP'? @/5Q<T2,JD#[9W\);&;>+GUSI,%>NQ$>BKOWT9P
MI@59&!M_0OV*J0"WKPN 7V'].C+=:ZK];$[HZ\3OO^@$]3>G3HR,S+ZC.@;5
M=C.UA!:W$<BA<%+$<LK[Y> T46/ULWSW+*3EY'##4CV+1ZH7T6HAXT[IQ0:W
M =$-;'<&366LJ0CA>_KJ8]'Z?EF@T:C;N=-,!)JJR^C!;(FMKIV%1M."=ORZ
M68X+K $UHZOR^ZY<) L:\6Z/QOX20'L)L,N@PLOTQO<6VGE2>!S,##BQE(3(
M&UN:[@"^,#_O<?XXI$*/DW6ZM3:3,3XNJ"2LV>"XFN7.J_TF>T%DPT]D2NF8
MNO"A%?Z[+MX6DNP.JXB<;X3RU-;5'\E1.'COB7+75-=YYR4$]++9-:2%M0'N
MYK6(+>]MI^+ /</L0\6Y4>3=J6L_Q\=+?LX'UG$BTY>DVU04!_UL?GAI=+32
MJ7%CD2$U%U+67+_K&.S(7.1H*^Y,!L.78_$4B>\V!9/+^/01#3?[.+^7K4SE
M"QWLG4;+QSS2YQX(SLM>.T+P9D'DOXMU(&;VED\Z;!.W7E6>.^;7KT\XT4GZ
M[W"=^F61"HLW?W'NKM0'@F#71X&/["@\;7$H!X^/L58^ _N-1_LYO;RW^4GC
M<N(>QU%E33W&E:.CH["@I<4(H*17>+]O&J@#R-(ZZ00M]3BM5G)P/*CB0]]:
M(WO61\)CN'7T1#NTR#*N;Y)%Z.Y$@VX=<M#OM+Q<ZK2\=#@V&OI-A:TR?:0Q
MHIC0HE '>G()6(J"WTGM06+U,E"^&(/FJNE-."48<:LN)=>854:$+EIU^'>^
MTJNWF)/2J?"+%^4!5U?,QX28#(=< MX.E$>:"S36-H^W\N*W]"93=?3GW84?
M2<Q\2'\AT64*-E.]I7K=19E"RF_#?)*15%&D?;1]!/]063SJ_(6@$%:%7GWB
M$;V5B6]? \A@]XK].#[[7ZT9_M_-0"6&0+'L%,YQ8[*5Q6M=G1$E]KDF->VQ
M494=,W#$04&3KG+W!;,G=T7_%V4OKLD6NFNGJU>83X*[\C<*UY8N >%(K'9,
M6./HG%?\TG",XW+MC/@^1X]=C@I#4;NE;? <(RVC%9MY]Y@S_1DK) 59+SR5
M@=7FQ LM=L;,'KVL0U(118S*@^!\]J2NBE"Y'.>2>'5<%;CG07C/L@Z30N"K
MQC82#X1ZL7KC?UK</F %_S\M;HV0-)*I%[[+:RV9&P8+[A-K$>XW2\ !>[%H
M*_T^KCMQLCSDJ*S*[G?+X9U:07MV^8S0[8FTYL&'XPF"L2GSDD3,.N<=8A^'
M##:F%QF,8. >A^Z)$.2S(7:M7/6FW&!F[M9$V=?QYQ,'HLW9D>(=XC<>?SB3
MSW^N1+^^,B-*>K_] DR6$I(BX^O2(6[2XA%^NOAG]_>51H7JTG9)SAD*VH&U
M[#0@WS/Z%S*C\5GAH:_'A253;]>:&1RS.H"-3, 1$6'75>CL)89^>^D#:-26
MR(]BI)KL^PK*4X@RB';E5A8"!VX]T#T-9#P"T\&.==&:V36>1,#$8/67@.G&
M<&^Q>[$_/%_DR5C;5O *,H]Y)EK #8^_7DG0'L(UO'QA?3"19D,;1Z(7]M74
M=.-DP"FO"_CADVLM89U)\;S&]A?BR#^@=EY;I&=R=240-NLQ,FLXM@:S?H=F
MO+4*7-SZ]NOYR$==K5WM%$&=C^%:>II/V?0,-1W36L:ZKUA&4GM&Z"6 KG8X
M*/W)5.[HD0AI.PB;8*;Q\</@'91+<['02SU7A=C3MS6^BN*Q'J2=.]M 5J\M
M=7PF=N\Y/BD3;'JE)$48IO2J0W#Z5JKY859*SB7]3$)W_%6'7_A,H1$[M.?F
M,,6+'.(C-5QV-XHAQJ) )F3U#Z9V[-W7%W5E_,SR*]82[SU.JQBY8"W/SSB/
M_U5K'?*J7A8+@H&P36BG]GG0FS^'3X&=&C6M?QQ7ZII"AL@FN;ES\E[^3'H?
M0LY"+_PH@91[O+ASNF!Y_$>Y:-$6%B3>#_-=;M;RTXV6R*_N=.@#JIG5B\C&
M-:F)2!_ (05NAGT@%N12&;+Z)!1XTP2/6?*[!!!X.<2GOIO8 N_%+;S\6=\D
MV"#SL?PW-<6G?1J^=U7\W&YAAZ!.9"22"N;D>0769DE=Y12;'$)CVR=>5R3$
M_:<H7U4R><YREJ&-DAKXW?R?+U1\S>K?/BB)18O 8F8J%#2_K"6TI--2W]Y@
M^&Z9 INJTCIV[&L2T9THU6H-%RBA^I]&/T(#EP#;/:H%1(>L)R;-QCAE2W/T
M/I7-\BSX,3'>95KUY*??8#+S<]0U,B-1ICB_%U5 +J^MCD4* FDI3 ,W5"#L
M!KF[(2.77NGSW@XX['!#4[@*^LRX+NM11X#6DQM3!E3TPAQ\4N_+G0:*M(8&
M2T5K5:3%*.^8LX\E089S)R9&%X:5X7H$WRNJ'H.*)Y(G8!\?R^/B[$X26UE=
M,4Z?4Z M*68FJ.ZFG8?YBV!1[L_-TCAE&6=&@TBH;">Q?FH=0;@WVT84P^/0
MEX!_!YB'(U"OOFQ!Z E*TAG+JH[,.0XB'+?A7NA4+@VJ;U],RG2,$55GRY60
M+/H\BXC"J&ZY^-I%I:I]<XWWSD],O!3D\BF;3^!.4\Y9X4)!6_]-ESM621W3
MEW^T:9H=<\W879@X?D2CD>R(I0PB^23(:AB5A DET Z_KFZR6(;0M-8O>ZV]
M2=_<>O5%.<Q5\LN:0DOU1A6TXXNUL[ZJ(+(RX33^7SXD=H#8BZP+;2_'/]P+
M=3LRXSVBQV9TV>[LC+G]J7'YFOI>XFG7CNV4?<FV/DO_. = [W\:V(KV-OY=
M . 82A\D0UDF118EDRAJ8K*.^/<YCC;D#(/=A^^8M%LL/Q7W:UU0W;U?TQRT
MMO-\P.5CG/,3C"#3=;+7?@X=<":LS+%?&7*YN[XU9(ULO7J<X9W<("N@[X$X
MKRI7 +,7]PV#Q-S,#53)\8FA#OQXTBJ.F3'D!AOFKV_XKRI.<H<#?+Q2C%[C
MB.CA1LS T[05X2C6Z!^6E -_.PL.94G4_V75%>(#C0,[4>R33:ZT"AX>.\(1
M'#+T.G&W?"?\A+K/E.N]G1QR-==%NOV;C$D!RJH]O@&N8[4 >T-:W,GR;B5.
ML0V"#?U;SN9B:G]/,EX5;I1-F0CS;-N6(];.ZIC*ID-"!ZO.?@HKG0HJ]1AX
M>/@\]6%=_D@O_NWS9#Y.:=XGNY<(( ZC>MO+HR&TS88MUB/-[]S?(7('UV_%
M6@V.F;[<\E>>^G+/^;FAN=H=TBO\,">]&3J )7:$USCQ.\Z-NB"$ZIVX33WD
MJ;^]?]IBXVTB= FX%AY^.B-T&@+X*Y!51=!$6V&/ C9U9B^RGNS2BR9*LV;K
MI<,;>DG+M>2FC'OL]2D-NQJ5PPJF-U+2AA/XLKF5[ =/3)Y=FTGO6H_1Z]6]
M5EA(>(ZM2[5BWQA_N>#B&"[_L6':9BP*B15V>]HC-$QP16,P0H.B.&'@;[>F
M$5<.R\4U<2Y_+R:VUZ0%=C[=B97'@6]7$Q>6,SUZ;_K?P(R[1I[[N!H4_U:@
MQ@&\=/MJ9J-DAJ(U,A[EJ$DGW!!0L$A/SVHB(_)Y*?P=<_"4*YKM=>+8R/[V
M;JKN$<'X"9M-W$V XS#-W(L_JD9"A0:/&@R8#[D"J'[*TB]QLB L*,3".+BQ
MY8'-#WH[6RDK?V:\QBD:S=6CQ-;T[M5_9N"MRAZZ'W9?II*$QP8%HT9/PZR6
M!Q#4O)7UX/RDOA!EUCKAR!\9+K=\CS9])KN]O1,U$M=P&O2::J5I21*:>>C<
M1MTJ7;4RJ^RG=Y"2/:ON+64<!CYGYH/\T%1#1Y'M(Y5 @M;%YT/*=QDZ>*NB
MLE1N]S&GF9QZD!NL?" ?1_OEE)_$EOX@IAOAOX7--DM5QY7%0MEB-W9\K*I_
M6K"""V _*0)'93"V_.RRS!>WRAC15&V<I+#7N%NYI5[M.2E/%3OV;<.N]S34
M&]]I6E=^.QW_X9M>3-(:2'HY9L"KND,A5=R^54]SI/AA;VJB:<7J5'+!9GQ=
MF!*OK[S)^KBEJ55T^_A*][A+ .3X1,/ARG&9Q:3 *>#=/DE=9A2O<#L)"ZGY
M&W)IC7,F<[\MTUV9F56,ADD4W*VX#\OMIQ 6Y60S>#E6!&"3T0#^H#)^N'HR
MMQ$ZJG[W&;3YP6'[:_(ESM2U^;\99 222P!Y^7)T*';)'NG((II*_Z-Y7P$I
M_Q[C,3]8#TR6&C&LCL,;=GBQ(>-:2'5+T%]S96751?L)478,Z44Z:J?3F,$G
MU=+=%M\+)TZX^?OCJNQWYZ8FYAW3TU4HL*%+AIT9(31]Z$4*+_*ISK.>2@NR
M*1&WAISHB1P S0WR->K:B)N"#==22>_,[!9D(94ZEFV7_@I*QJEYJ)D=.?8)
MU1>/&< FN6DAC,83I?Q\9W4+$5:>GI8UYL\AWT%8D\*,XY*+ J1-!IY/]+.Y
M+4$?G8M3B7I0IRVZ-OOJLP99"G/&B3?#0''#J\>. :*RUY!*M5$6:MCC>/=R
M!U1N2U145-.<N?G"J\I.)_*'-K'SG_7U7ZN]?P:@<3B((=ZF=O(^=X3/(EF1
M2X7$AV,VQ+Z?X\/!0.9>=S:'E9FL'N,4FE')QZ4E'NKF,F3#GAZW7%X<CYTX
M 1>3!Y[Z+:QO\-+I&#/\-YU\_AD<>@EH?V)V"7B/P N>],9,<QM95V+WHODX
M)/!.3MQJ#I9T\8_!QL].C8V>.X\H5*8C*K^Q;7? XPS7;0B,%&T+ OB;.))E
M*@*]]K)6Q,>/Q3 A''UK*H;LPVY.\%Z-<1[?DW1(,E=0<Y)T28>T-7&<^=<S
MH3UDZ((\MKQ;[)IM!JT"19%?TTL<0RRT\.])%G_,#D-U5U4WW]2U)!>Y[^(W
M;&Z0=#OH+:A?/:+D2[=FS? 5(! &Q6IO+V,=NB!LP >:@AL<K&/FFVA6:+K?
MV(JPP9]0*\-T.^/[4124HZH1L2E;6^M43#G(VIB=PGR"3,3O^#;0]3)H+9(6
MF238783OL"4,R@V( -0,.F:Z#]--NVZ7;7N*6KQ]('C^=0AY+(Q_A($$(\AW
M%<"XU/YXM$H7I8$V+4PIA9E]E%)Y^0UOD%)>Z@5'_SQ7U6?A8'(P*8#1_IA<
M(&=^OO?*)]/Y"QT@B10S4\O:%[V@$\XK8#\]O0+/U9'<C$[D'<*+:S,.OD7@
M^CPK#0-VY$;8WNGQ417_A\F,X4N FLUJNI2R'K977(.8!FJLE;X$D!R$APN4
MC\0<X/^'(-W=(P)S+@%E480MEXI=K:UD5F(*Y[JYN1U69?QLE_H2X%5$2%I3
MT37Y;MJ#^-=W22XZC14:"QZI-G_%GI-\/)$]J*S1B(AM4:(SG.",^K];RK-E
M1"NPHT%1<-#55(\L103'&.#6PT4D_UI^88BFC[.,5,A\_HZENB3H4T=7;RU"
MA>,6%A("9_424L&[+Z7Q"DN:D6C4C]5$,,TD0W?>1KT/%S>*>Y%5M*^&B7.X
M4EE$,GKLK1/,\$XJNGR6'SPZ0Y#%;FG'*V/39B6+JC8]!4:JN_JS9%^8U+:[
MO5=G_4M&&@*942=LR77[.; +?:B!3&$.0'_VR']:FXJT/_D@980JF:K)@-MM
MV:PS[5]1^:"KN=FG&@GX+Z+/UY'\CDL-%Y^12_6@>T2&'_L$*=R8"H1N0WKM
M34)NJX7DJ!KW%Q;JXZ")B=>6U#S/ O<3+MZ7#R_BG_ O485)+?J;4U]4M[)\
M1","@'P1>OH/6\P[O'_<77O$RFPB]+F49S6!0:PF/OW1?-)[8'%DY,+4U!_,
M;_%+ +A]*,D=?TC0MAV3BA Q>'I<!>O<4YX3)PA.>)VT(R* '/AN[+_^3$P*
MMWT;>TW'WC?7S4K(O_@-]#+-M#K@]AMI7-EQLWI*Z1,=6-99W%Y;4?WC8@7>
MBID]A1M?\.7R9.53ZH&$['7B(^N5@RV,YOUB>DY0;^)^P6=LZ.<$#5=9$6X8
M8+/*Z>2@*Q#XTX]*_T^S"0N$;U:7(:G)BCR ];M*P\'X;5C\V7ED]C3UV)50
MY?J?;8@#S]YR%(1XN^_<D*#VYQ+P3CM<;B$)Q]V-"IJ2/A,I#\ZCM>=@$Z+K
M0;\9?WTJG4?]P5S#CCV9\&V\G4]?.X\XNGC/#7&;(-N C<<_6.Q&345PI:K]
M@=%^=(SGJQ>.3?#*4SF]693-D*[2P0.N4A,L7496#!-H%ML7*_=ZY\$8 F@&
M6KQE?K-^K#PZBG.F%%FS/BY:=L08/F)A!-WI$$VE;.RNOWVC*5;#T;%$_HW5
MSOAW&_:WZ.VQW90)6*F?H:N]RTK$P48CO/#OR,J_NBI+\2 :("/,>)3X^*^<
M!_)<D2 [DK?HNU1P5%^-XY$6&'I?;37S,)U>[)YUK=FH]>O*V155I NQ,X,-
MN?25DT-!TZH4/@BA('+@57KK>I1"GS5BS3.RMX[+JR"/WI,E?_T<.S/8](O^
M+EN9:ED9<UY]LJ/(ZO\*MDLS_R?8WD;\LUB5L3UU;@*6(8@A0\3G[%?UW^'R
M @P&P/6HHB+XGR*#E0=E]/S&=+2Q@8,^R7GNAI^Q%9W6M?:B;S L7]-J?,_5
M9:+D(IHB\H6$@!;5(ETC YNRND'Z\ZBXQD:BL8/ F10OO'?FJV%;([#\WYF(
MBXB=V==X5XP PFXO]#BVN=H+819;0H"\X^#_$I1T$N4=8ONU_NQ5C']L)\T^
MT/\B$;&4DU&%W+$J5EN*N8EO77^.2ZO9;_=;XF1"18&, HQ0;W&?D\.'^BOD
M&SOVF:8XWK[PB!ER%:7]7>'&&]Y9:Q[DF2;?JG\)T.8:30,9=RNUY S_;%]G
M>O7F*^^NYG8N%-'),V>U[[D;N_=&Y_MA5JOI44"KYT4+<3WX\<76WD4FY*6A
M%"8CB'@7'U-J>S8< >5I9!&.:VE)%=^WLIDE5JJ>^@ODW/'WN?>\&Q;#;NDU
MQ+ML?^K(G"L7?5LF2^U-4"H\3&:]<LO2:U/6T4Z;5D<Z>[#NK#L77]T%(SV7
M-O<Z/U;&:0<=D<&B%'L86N'):^JO2>[RU$C \LFMS7H!:]),Z_D#BUAM/R'=
M/TBH)JGB9 E?34NUW%?&Q'KJA#AFFE%W2RN% #*NP#_A%Y)EG'H7Z:W,FQ#6
MFD44I5NA2+-&'FK <8JAC%J,'OV(1 ZS;OE"W^B>\S/>@!\0%@42E6O:(D:R
M#L'.6F>NW1HIVGT'LNJS]A.'4YL2NY()"J+O0KJZ]]'<0+## #_'F^8Q \-Y
M8[O9G_^205R77K1270(" X 2#BRDV\'9Q(%%JIV[F>B]R 71JC^'40_FOYO.
M@;LE7=7?S7;2@J9W^BM9$[>QWKT+]*?E2QIAB*7L#*QI*:27SVH<R$+\+8>8
MKIE>B>R#2C?_QNT]4L=8+MHS2HATV>HGJ=:O?[7(%8M(/AQ/WG%<7^2L7FR?
M9SSVP=,O70(^I7/\I)W!JW1Z^+SRA-@81?4%T$?E6YF3_.JW=#)P\>:7FM91
MLG[]_Q7(^]]V;?D2@-5QFB%1O?B)M'2BA]U*9]6?%!6!SR[+G^>^%JZUE3C>
M:\[^%COTU])-E_AJ_]. 8>(5L6% ?C!S.$Z^2)A:3NI^V5J+C\6F+"L\QD!!
M^B%&NY< -Q9YA["@G%^\;F&8>.^[-G7?$UZ_,9S6/TV]^BYN8$$1B*4D1+U6
MQ-5('W]_62BB'(!OU1]I?6+KHY5$2Y9HQSWOD>VR;3?#_06TV][D?YL7]$'
M/13)H?TSS+?\VX5$5K4"(X;S#N$EUB,>1])NTNP3$E5F5V'/HI5YU\,4-<C2
M1U?\Y2XSLY$E2: Y!:[Z./@*'#O*9V4TL1ZI"+8%]G$@VZ"G7[[9>C_XFW*F
ML"XW8D"6/5,UQH8R@.*&$,9ZIHZ1MU-8F6^3K5^D+&D$I+5>F+CZ,W*R9&.D
M%L.L85XDN",F#UWS8U5RO@14QWRN+6> L8W"5- BRAI-6PVB"VBT5@E\0H#M
M+N#JUW9E)/1S!C/F[[2E^_]:%.9E&U"G:+OETO.DU31JZR71AR8RTLI)>#H[
MBBYHM2M)R]*\,>9V[N\4'/@3[N[)])_#3>Q>DH:A,)5+0$ TL1=Q&_:N" ;$
M!^.TMC2F)+U1K#O2F([&C&_1MY2I9NJJJK[T+WUUM[)ZGT-;*BA5W#^.7B'$
M(V+7UHQ[].)&]%WOO!3H;N+7_1C@Y,O/%^]A6#5.6+NZ<Y(7>%FE#8GR[>:D
M0MAH7MU[[&A>=%*;S<MC/*$B!)?+*$1G^P;P@\R:O,$(I:PD^)@%UNOI2YE%
MQ!)Z=PLV'2"]P$>3S>[H>0LT5;@H U3%>-Q1BEW9%D/.X6UIQ_,V^U/B>^<G
M]+\T)>/[1W_!K:7.**_FS[DRE]T*"LDP)*J<GD05<TBB%;2 .L=NWAG"#.&/
MH#^[W<#U0L:NTJ.&HU<*E;<J5IDTV_(28.)F,M>.]"-/N 381.JS",5L?4MW
M..#(J5+(>[UZK(%#+OJF>08H?"S'/S:KQ\4$N"<+NPOI)T"=,DD&ZVVBLJU?
M/)_A,H26_;1\8B78)GX1=#4#)GC&)>T0A.4@:3?G+9%$C5*?&5Z<=;8LI;MH
M+I.0L 3;]<JN\TF>MFM,3_IBTRX!=(?G\5"7TJ95BY#U(X+0'A6>YQ*PTX?U
M/;; KD<J4%Z]=VBAOXU*1T>EQP'(Z1-&04=U!4^>5*^T=LOHV3T8\G[/;=EA
MR?5>JS)G?-;$Z"9RR9QHDF&\#)2_V0'SU@J1ZIV>"!KGEX[+YXN'2H]&Q,5P
MVP\9AJ/^7JAG-7 &(-B!3,01("DD#$0F-1NEIQBWJ>$E=;LFHE@J&=/FRM00
M+AVK2-,T3C]7TC!70FH&H><5:'I\KAYE_R3\4;&ZNDY<HUU>RF[*R(^L< R1
MBP#Y5YA^JZ.5:F*;/1NGU#6)G<]&%"2_TF!):/_E\?7."G33Y7&4[;NM]T6^
M<NJ[@[-]?(M+&7_I'?0R[_I$]V_X[?#BJRNR&A9#+@'W1.#<&TDI@U'QBC=;
M<WEK>%/Y]/65[RK?FMO=&'KJD%58JIQ+'IVF9%W_7+E6[G!"53Z_FIRP<[4*
M2S!S7'[/)8"&\/1JI T#M$01C'%@P_IFG&6ZL57%R/+7/N:D$\U]YOMQJR@9
M&AX?U^LEU9$7J>>&\#'D':3%L'\KU\4/N/ F)4-2)FHW9)+#>ESTVT[ Z/W
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M%"E(TB*N@?VQ/X@%L ;DP)MCS'&:O3T9M#D9CJVUTHWTQ16S[_(2[]Z:^'7
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M07-"X?ER1$8 "A%JJ V54:N?D/3:JU6IN3ETTOASC"?NME%3A9&ETN<*\NY
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M@M2:% IV?TB*ZMSJ$E#]A_2/B6$/56CC9#%#<)Y#G*:W9"K#_ >;^:96^"N
MN(LVX+HV_9@A^]+>37QV)^.62V%VB8M@Z52L8R%WC.X DW#G19:+S]F4Q3.V
MC*Y2H1[4&'@&;_%\9/>^O@AO3R[WK@'_[@_3MV_O?/^^_J,7Z.UK@\B?[[,J
M;&?SI*[CBV;;IEQT])[=V#%?-/?$.3U+G'H#N?<BH['A=;RTCRHI9\JG4Q;
M:7HX"K<0+!I6]FL9]-%ED$>8E(0_@7";4&E4<\5UC,8DMTK-B2)R@S)J0N]<
M__C$;PN0C+4R_!WS2NT\@\>LJ#S67(/O+G\VT/=XPL.&H4"UI"Y? D+YL;5!
M*19_6?Q2'.?*WVOO@1:'U( KZ4\P; ?(FPI\PN]9BE_"4KUNMJ2J9HOX7_MP
MMF3!76;20NY/_@%;VD7EN!KP*]>H][X!,_OG=M(YMG!W";17*72E(>VXEX7!
MXZD_,Y^_@FM7HV&8@E2YF9>O'DYQ<Q*F:2.R,LC;W8HYH:#M!5BZ@80 .9/6
MA<4F1B_/HLMA!;EA=KR.QHT7:J#D8KG)<M[Y[J'ZPL$!QT3KE6!VOR' QK;0
M+X(F6GZ8QI[2TV5%N>&>(DKJ$D [=W(& )"^\\:!%8.3H<*[?*CIN6?ZW..N
M&;_)\:%=8UX91 K7<_/.\T<PJ2FP-IX:.[G)KMV;SE.IQ^W R%4E+-X/-$7N
MO0\*K+<?=H8MQ2I?N=48$!U0F+AX"6#)O@0$P(A=/@&#-U$5^"B,J@PKF/7>
MBT'F!,3JEZ$IE*N01$=.B/-B$6>5]G8F%G$LBN?,A9'AA7Z4EJ6^;84>;8=3
M#A5[]6>!!Y(XM_C\LOFSBG)LZ:FI/2"-40L7"LV_%Y'YBLW8X9#FITM(R@TB
M%38ZS"%O0TXSTL#'.M6"O)>RM%F5YDFV4MN;-Z\SG[4!KAD69%7^_W(EY-&[
MHU.O:Q([B).R/ZZ$O:UUY!4+?EM(&D"V%-A>*/"#:H#5KA:!Y\K8J?QX<R*Q
MA7^[&.=R"A_@<6W9-J>9Z(],9-58I6>"7@*,G_[0:UP#2]2>1>78GQE^EDPU
M\WT^OK-7XE0ZBA[:'[**$_J<ILCS>5.]JNJ+XO7G-ZA-8W:8SX&PQQ=%0 J'
MQ6MPL0T)<UO@@^I]Q\3;US5)0JC8<(]N"%?^*GX01S:7?3_D.8%P$8NTBXF
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MXNK5*L:Z[MI?+Y<&*1P^I$_D>&^M6_4$P)!0>(^.;, Z&JTS'_*@2T"X;B2
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MJ4Y^W_Y^ 3L'V;AUQ6GTL1 !P66L!29D5P6F>OH!2Q![XH<G*3D?*&N#4H4
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M-8H)_9FJ1'=;_?DR^!6@1*_G5%U=<\9A^3=<K5 ?A:B.3,Z*AOL\?8J!\]S
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MQY<^@L2$A\F5. M!!6*B=&VM'A?EVO.77G^4X*$0>%KD1[K>J^N%\MJ0^;%
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M*=Y:,'1J6ZB=(9:JSDW%^FOM#5(OE)UI/\C=LX4'*D#<8, 93(<JOU=37FP
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M>YS:JG'C]O&D*X'N]^^(W#II*/5Q']0^B%G(0OUYA7V. 8)J80SS#]R/\TJ
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M8]P(Q^V#J-+3#HQWF@J,M+(])L^+_+(/6I*;!S-5V\5"Y&K[C0_<'Y +4V!
M63%_]2 W*WEZ!F\X#6^&14I(CA?]"K'[*>$&A+\R"_=+QQ#&>7:T:>+,X7OL
M7</!3!:<*8^C88#0TV'X/?)&HO04MONT':DR8RG/[TI*W^UFI3C_R$..$@XZ
M<5(H @S0*6.P=N-5.9U-F7?0IZ?"%457M[THNRC!@%."? *=49-V<JY1?-&F
M.MJRA@%I=)E-WMOFW$QAU"K"[.]LL !FH1Y2MQN+\0'/0#L-I,@LS_Y<=+J0
M+.[S-ZHC B;@?>ED>X'IH^Y,T0ZI[2M7- 09UVSV# +43 YM:=/XN-YB%@HQ
M-7WG>YA12,;\XCX(_\0'.ED<][]H>\^HIKIN;3@*2A/I("!$.DI3J@(2&^U&
MQ$J'J'00(DH)$K.E%RD"-Z @1$5$D")=BL10E2)2!*DA(*"0P(YHV)K"N[G/
M^7&^<\X8WSO.>=X?.X,PQMY9>ZTYKWE=:ZTY%XQ9Y-U0V!:BBZ,S7EY7H?97
M3<[&Y<\&&L^C9S_.*NLH#[__JAG\[*"W]P%U[DQ$U:*#]7!(!1=G[\GZ3W5:
MNK.]W7V,&2M-*DW!<3Y:F7[O<JK("?ZR)X@G",2[*K(.I#U.[8'YY NXQT*P
MM>V !,H/XHCY->\'5\]#69=')P55YY<$9VUSGLJPQH5ME%XZ?M)_%LS5G=G,
MZXF >QC6N' 7R"] !5L(_E1BX!9""";=6X@;J3JT@*(52YN-E$+W+01-(9"A
MHQ2.\MMH?4 T8Q,-[F(H!#$(T]TF.\+RFB,+.ZY,FE5X"*YEEWW/M0X.C @\
MQ)/L6WS*WFI&VLG-VOXBK[(,QP'E3][>N6D7CZJ=\D/56M( >L>\49?]4)%A
M\V="#*4>9/JKEWE*2>:"SJXG,0?WOEJTO0E&)/?0Y)VL41;P.'T<3">+M6)
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MO?S'N(.Q[=N9LGQ?X1C9WDW1J4#=1252_HU4T<XYY!"!1("T?5BB,0N;728
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MCJGT,[*Y7;QJK-/A=FAL[:/7,2?%''6)A9MWX'?S_F_F^>ZA\N! DLL2UV/
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M!S9P&PK:7C.MU5J/-T[(EVQ7M/NQR73&;BXTLD0Z.'MYZ>$TRWED?-B=@7Y
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M^QIB,S@/5EYK!@TJE7Y0N(Q/Q7FQ[[/LF-P J7Q6FTTP4W ZB9G_PE*1?[7
M^\0+HW&A=>S F\@PSXRA26XL+26CVM*0.1Y?-03$DJL=J(&@6!< %N($V)DP
M$NBX,O6F@!N0W;L[806A7]N,>I:FVM.K7^LVD=X-_D7#'\"90 #=@[1)%C([
M",$ZR"CAE]78<9O3]-V/)!8+)G?OD73TMK=&>-GOB))&_(+!4!YV^___A2+
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MG?(S.PS2&DH")7J+NFO+'=17:K@SS??NGJLY_''?4GUCC*D>\QAN;QM(IDZ
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M"A8_+"Z_H*6FGSXAGVN.E]E"=/J0?Z4.LOK1[.4BCI+9%J(\"%BZOH58/X[
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M-BE/J>"$W1:>VEZNY''@#!)VH'PPDZL48CS19SU:7AC4SK\+DFE&DT!,JT'
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M)J5]V.!W!CMG>A^(^YR3,UB4=H%_X7" ^%*]]$DJ8XLYWPM MRX2UWCB;PA
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M95GY7DB+#C;<])H,]S2E1J;\K&[].-[6M? =:87N&R2BPR*+O 4LW0L5!!%
MDWA>1IC04X(JJ+/]_C$UF71S6_UJB-$8WU SQMK85C.VG+;3+_.#8[,QSE56
M1 LTQQ07?=+,Q:?;/,"BGG:>\[DC5V/__QM*]]OZ=:V#N7\"4$L#!!0    (
M .^#3U1L>@T_<O4! --+ @ 6    9S1B9&ML;'1L-7HU,# P,#$U+FIP9[2Z
M!U03W[<V' 5$04$$I$I4>E>Z@$1%0$! 0'J)2 E%0*1#2!2E2(N"@-(B @(B
M1'HUD2X@(+UW 6F24&(@[1M^__M_[UWKN^M;]WW7]T[6F95D9LZ<??;>SWZ>
M,T,?I\^#SAKHZNN"CAT[!IH&/B#Z%$@;=/S8T7:T/WZT,3(<[9D8&1D83S"=
M./%/8SYU$FC,)TZ<9#UYBN5H [Z=9F4Y??3CJ)-_77J<B8&!B87Y!#/+__9&
M_P;B.,EPC@G/<.PRZ#C',0:.8_0V$!@$.L;TS_".@?YC.W:<@9'I!#,P#%;@
MA.JSP/ 9&(!!,P$C!HY& ,=!C!Q,YRY=O7F"T]2)^;(?E\*SU[DGA6^5-W.;
M#>!%%!\^B3S%<IZ'EX]?5$Q<0E)*25E%5>V:NO9M'5V]._H&YO<M+*VL;6R=
M75S=8.X>GOX!@4'!(:%ASU]$1<?$OHQ+3GF3FI;^]EW&A[S\@H^%1<6?*BJK
MJFMJZ^H;6EK;VCLZOW=U#PX-CXR.C4],+BPN_5I>6?V]MD[8V=W;)_XE'1P>
MV74,Q'#LW]M_:Q<'8-?Q(Q\P']EU['CPT0D<C$R7KIXX=].4V<F/\[+"LY-<
MMU[GEC>?$E8TPW,_?#+ <EY$:4&4<&3:/Y;]SPR+_#^R['\9]I]V38).,QP#
MG,?  8* J)0/<1*@_W<[QIS[_GB<A C;QZ<L$HQ"T7$@B0__-UJDWRAP@^GK
M[L#=)%79;4&VP-W>W#NFP_5_U!B#@^_9V.D'^TLDJ8W)]/YD\2X=YO$3;6_*
M'$B7FJW:2(^2G?EC8ZEL7PFY(2F;PR>L+QM7]:C>TO@M\?TI]_]?+4OXOS5E
M_^[X?5;@^RO7_SOGL7KS*8%,C3PL=(W@G>2[=%"S/=+%9$)Q<62UV3<^'7L9
M95=>$QD>-;1GKG33]<9:S+1"T.L<M;+-1ND?_G"]+\UFJ?J3Q#CO"9_-!L\D
MN*XT^_/"?EM/*6+CD/G:NO0BF!3+0SN%9V,K7&*GB*'H(!YC,/ZQ.(7SU]XP
MQ8D.>M%%!RUNS-)!IB$]M*A])/X4\G4K]6LR'?3S-F(OHEXGE [:["$;4!2I
MGVD<XY1')'WEW=]A46WXJ9I<KU\]#7S\JMTN2ROF2:%EI#K,NS:G#2>O[D3W
MNC[9CQF51NY##D/7U0,E1S\6,@?L&P5J%Q<>*YJ5%N_ 7L,C6W%G9D(Z.W/$
MRP?V,KG8@XL\K:1/7XF\E5!Y]IC,#89BD6/)7A(=@2)Y3$%[?^X7\);4>/%<
M2%1266BF2B\@XZ%XZ-QXRC>K6GYH9&>LIIWRU\XTMZ%'FIFA/'RSR0:Z>EK/
M"[PHG'10Y!]$*Y)[7T.6H2UCI71!8.-'9. 4>,\]LZ+J^QU&XI)0OM50SS-2
M0P[GAL*WD5_5V]W;/L0YO&;1ZKO;G\@0;X%#M$?2.-=ZWON0F)L$+93WHCR;
MU_DQ(L^KSZ/I:?XRKTT$3I?D25YZDW23\3GT,FF.QEI,/DF!$))*YJ%GU[6D
M>2:U<I6SYV-:"]X8"KQY=(&2\+PWU,9'/\MM7]20Z5:@Z 7;!#L/[Z"TR>RW
M"4'LI[BE1KC,)VKKB3K<!![*;58ZB/& #GJ/3H#@,R 4AV!D)8S"O4&\02W1
MDE_#,6IQ.9)>[O>:2?ZJ=M"^?:7-DM?6JN>/VH%I>:?85TV3$P0W=G:I?;RR
M\\F2F@619+N:K=Q>$_5NK_OWHMQK]O2O3^QS<^^N;@7304P*U'>0AU"^M1P&
MTEQ@F5Z1YR1L:NM$>G[FBRL'B6#QQ\W3,7'[X GR$N89Q,/WA;IJQW;T$P>M
M&(R.2-J9"-]E PO1D,PG0#SH;@\V94P8N\9\&^H8R9,8S'F=::1KTK5)A-E?
M?6O[]N6]A*&L8*N1L.Q4KA,GFFJ)M=0O6NR(=LB939H4W!MMAM+'CN8-SGO+
M=6Z=B\A=3+-@>G*ET0D1X;=A3[*7$[X0FWA:4W!5W)6K;&HSW=]@I/CGQ_7[
M07$S7U^OW[=*0G320;60;YBIYS=&X?IXE26+Y+%;34F3=!#9W$1E4R1@ME'7
M6)<IG$]M,<&1G?MIFR'[R^<O%C<71S(0[A*C!;$?/YDE^X4K?S$UVF4N@ .7
M.2";[R+=3,;3VR=]([&J,QNOYSQ'98/=E;Z*3$LFJ REU#U8K?9XUD.8R+GD
MA'\SH_\UCSMHZ]?+MH<23AX-J?EYW"._4>^+,+$HBN"I(W\R0"815^B@%A<Z
MB!" ;+N!PYMDS:__\Y<[\%?@'GA=G@_Y$XNA'9/?T:2#MC8S:<C.;;VI*JLH
M"C<0U+&(/AQ8ZWA()?$5"1GX&1)-X?$*U*H:"W-*"KQS4;&K7/5"YP.U7RX$
M&V0%E,)%)CI2JRB!X?C=^8*51K$\IT)JQ;QGV,U:$^G'C@)^75V"5BF:,>J%
M_(-I0AZF0<5_<'[$=-]W(X*M#)(WI>+G2(%S/P\OQQFU\F'>8*\!..4&<6:?
M6%W$EN-AB[)TT,MTVY]_FN*7*W_>+6?^!I'VY>/52DUR2%VQ^6IER*1K(9(Z
M&>==,&<<_3;!48"96VK7U,0H0*OL0STDD0[BU^0F:U'$1[&*E%O):P$.)\:V
M^)_;3!U4O)@NV2G3-;8.QJ3\>^(N!$)XD0M*2%+#6D](\/4^C^Z/S&?4/\GU
M=LCFDS7X'OK+G& S4%Z7J*V>0=6Z8V)QBQ=-2.+]5,;_ G=(9SIHJF3>9*LU
MU\OQ,HG/_U.7]_M9'>^B"_^$QVM#N8&4UT^][%NC0E*D6YIT%4^997%C)'4*
MRN(M&U[']%9,6^@8)UIWFWP(R^G2@2,)&C36*/(9BC#I]2)[E*/<,-RLH39Z
MOZ14WMS.E_V=,,]9@X$[W+6)/?7&['[64,)9>0KGJAIMB! #V9<%T^0:BO$F
M/):%_*^^C?AY* V+NN44EZKG2<+>:;HL;G1L! 9$-.J$XC:WR;:T?G2U531R
M09(D0!!KM4U2,@_T$LST\=8';:6)M4IV=?A%WFQ6P^@H2JQ!-6);%Z^D9DOA
M_9)GE(8<BW,2U:LVS,T_#IE\ NN$JF[YDSW@'-27%*9"BBYI#EFD4[@>UK)6
M\_*C#?6#V[L/R?:;TVP_RU7LRJ4TXJ 3\L2?)#ZR9XC0W\XYANKXGOCKZJ1)
MJ':1S5NQ:*/<Z.6N^>>O^Y6'J.GOD# J<KQG?'::"*_=BBB#[?^0'[T>H[Y:
MO17A_3NLG6ON2IA5#[+*BG*>AZA.3<?*>\XQ(B2A(:^5>P6ZR9[C[F[N,>_.
M&=1Y+T&DDV8\ENN-7;.L AXKN5IZ.!1]G&F<"!@Y(<X7U3QDCE'FKIZ-&1ZV
M:H/\:TYK"I88Z* G T=>_HV:0!-'J9E(K]+S1M!YJ[9P!UN[$.$T\EW7JPZ3
MS(*G+OOHY0I+YR@Z3,2P$LZ;ZTTY7TF5;&WZ,$C>=(KI59BV,#90=A:?4 JK
MYEZ@@VI4*5P"Q#!JU%QK,6%RU3J!]-XA6YXL?E>5CPQ)6?$YB)[;)RR-H0T(
M\O_4W!WDBOA1S34!:J[%LP4ML1_X\K:%*X%2YJE;$NU5FYN;@[^';H_U5OR0
MM3(N=>\P#)@M!)+[WY;0(AW_#0^!>VGU9!NX"/[O9C/[5F!1?Q$[<^_"=^6J
MUX\J_8DVSC9G#VS(4]:N_LV?"=/*;7R/BCMYHK)532<U![S>$:UFTO64>@A2
MQJG6/:D.$YN-.>]T0DPV@;K.Q$G-HH-\C P=![%,,UYF1@OCWK^&<=4!E3['
M?[B<JEW1P(W41*AA H-.%J \=_WJ!-WL7J:!N8U:O$*Z;$HV/L%T3NL(6HB:
MO7GSX; TZ@/6D*0/]%I C4,HPVT&L*PAE^F@MMY2K\F,<6O9T4CGV!_Z($5?
M-<' =GU"/XU5E<R#Z =S!Z*>HSE\*7<;1F/\?T%E<R)=8U6.'=B%?&_>P]@\
M1G,:<GWI83:??++[9$=C9W9ZM&9LW8\.\EI&]$^&N^_,CF'3-R.<=.#:=!#'
M<0"7M!116Q >.N@?B(#^XXK=+*0'J94..I5'![6/P0[C.Z![\B5TT%-#2@)0
M*"J@AR=1LT=@<8KT&C#@'#5;BYOV0^L"M0QNY5\J_YQB*EH59I]V:!,>.937
MX(,*[FGSS@E9K,:YR$_%S\.V&A<2[=KG&/X$ZLOLV>U78FG#0[2^%MT;2^Y=
MWYLW')7OIJL4/$^3"Q I[K OLX1_,C2V)'X]O/"Z\\&JC6GB[5\C@]C2X.M/
M]XK^2B4968WN4SE;,RPZ:A?/6,YV]$TJBO:._.H1]+NX_N/'#=,_QM)+X$0P
MWH$.&H<M(/)"<TDPZU%-AW"W[L8JC7.R^2)/SGN<9&9^WNGX3G#$-53(-^=^
M )Y+W*+TP#QH/US^[<-RDN;IT))ATWW8Y/Q9CWU\?PN8)-^YJ4TX09LR).0W
M_'T!JWN7_F-$B0Y2F15EL?/OXE!CYETP$;&:%&(AK#['"I,<^SNP# 31'$S^
M^MF#FK!H]..*=JE5OM/L#T\*%UU\'GFRI/?)Z0WAY"0(NWKP5(:L^&^BRX*B
M()NZ:JZIX4#&Y_L1ZV[+_<QQ.W.3Z<0?U!R<\QRK]B(F*4<CQL@NS<FI\!;6
M>V;I6/+EV"?C^VKW'BLF'SNP[*2Q"5$3_L!-Q%+#%R \=A[%=9V?Z"!8WI].
MDYD3TXK[90FU+T@I:JT-)!F9]9N!ID%#X<$'?(O^CVJ9S9.K+7@F5^>ZMHPQ
MRM0LB)?)4W U],58.QW$@+T\OG'VA7D@3&"SH>KA^ZTTX=U+?!U^5:]NB'.O
M'=>Y?B:D+D%+F-5F$,/,)SMDI+S^;L*X5/WG/SAZ08>OWT":\\9_K\S^/]MQ
MC;=.=;7N<L*6B>FG/ZM=SO0Z?>7VJZD.[K/>%HY/32,\F/:STH)-?9-T)C?6
M)65*2S_/)XT.!'7R+U@-/A7_G]WD5.>1N&!3O\^?AG'.]QCC+\M53??U9C54
MBB&9ZNI3F%AG@VX&5,L,0&4H9P!.T8;H@%3I=<S(SX-;C7P=Z\:4XXOGAY;K
M!Q(L!ZM,]26UG'R.64_Y"B8SAQV^,HC)Q6A?Z=Z5^?BI,#%/ZHF'OJ18IHD;
M9DC7?X$08N]B7]2K+PZ#1>B9.IJ0'6@3N!, M02MS9U#J/87ZWU<SVA92RLT
M+"??C@Z*T]>U$F9X9-)?=MWK(XF;L+10N'4!WVE$:L3G.3AHZXP(R_NJJ#2<
M??Q]@R+'SF2B;=,CWZG'(.A<(.\R%9>-EO8*C,#\,FM;F G6T?<O",*4-HYO
M%GU\R97P''IU\DA4T4$N&OV3QB83Q@+;',@6&W!< 7[WTH#)!&U"L)>573%X
M>K9PI=/@,YO56S> []TOD,J*S[ OQEJ73M7T_,@@?5;A29_LU7LWX?"'+ P(
MJQ7<))K&4DF60'0B.9$+9A27)@)C&&[<N7'JX^^.$$IMG]:#UASI7N3B12A)
MO/._LH_1%CR2V_D+ 1/3;)$E4I;_?M)C<ZB\QURM^_=PP*JM9.E06-X6(-W^
M549VZ:";_R8\1!0[LODV$@;E1'1EQ&P5?+3?@.!?K%6H.^B+I5G^YLJZX7?^
M#R+HPJ&_S2+)Y.47*7:.Y\5L'A(=!,^=<!V/D@B.^T R< 0:5SFDSJ!U&J^/
MQN%-QND@&LM-L@IMFI]8N=#_K-9V.%W]S&<K $(G,VQJ[R4K2FUI)!G?'_&=
M7*6Q>).O(MIH2D,4)D+#MCWJWO >4!EM$^7U54\^G+4"6/ O(>D<34B.H4)H
M6&O_5&GH-:AR:43ME!D=5/4%8GG8666?Z0\U:3H\%T>*139_ VAORK=_*=%_
MBO97:@YR_@OTR_:6]%(),GJ6A1056NC%,R3"[X")#=AUER]XM*CV-KF@[PK7
M*WVI$_K'&Z_:@]NMU15*H4R65Y-*ZPRZ0G\[_R]U0[32&^8RO_T]S$J<$+]4
MVV(R 01#,N4FJ6?I*Z3U\*X<YY;MBZG@>L87.N2^MN-!1>*@G*=C_8-YEE]U
MC+/L\V>2#;:P74()Z[> 'YOIEH$)CR?R'OM$8QE(,700,QNM4TAP>+2G&7&>
M8!4KS-:E_,-2WZ<D^B+W[,2#L*34#>B14OM+%*46*&\@3X0$+PIFR%4'#'1Z
M?R0E3VU^7+2D@]+\ZD6M5Y?7%?P25K HGF:XS;,6JAN6)=_IZX%C?.,Z%I9I
MHM'M94&\5\HC;[ZN+!)GFRAF5-_['ZK$".DF/Y[>R>_;NIWX-^-76'1) 1WD
M;GOFR"-.NT):Q@O/ZP50!H0K? @-I;;/6N?>?#*:'8CS;O3<<TC:U!5FC\I?
MMTQ.L+(JWQ/E)@ ,^_DSY#R:@?;P/Z7('!SX.[(5T3P'KE[&XV*P,BKQ1?J/
MOTQ.DG)^3D3D9D+\WJ9N)=U9/?XU0>\$P9$MOM2.P?*J7>TI&P3S&<T-R5+E
MDU;QOKW@>Z;VZ Y(@B,/21B?9T?J6BS1V"@%MQZ&0SU9"^Q>?CR_T?.]Y'6=
MU'(_)%"?[S=<G.@#W!B+Z,!50]J]Y)]#3E=O^5SW-XW6*X^W'#S3Y,_ET,Y=
M"\[TN7.A!6VP^[A>RRNQ9;AMX7=WP!K%3+]:J &;$:S^:>GQ&R_=5/T"R4>9
M(X=@4T#3I0 B1DL9V>R.>PA^!N:N1CU'R(]1;@9^=@]&NPR?2,FM&I"9/S,0
M/:W0;3ST;)BCU]CAS4KH?Q4R,U/O"6H_Y-BD+%8^Y,3]F41;#UC33A"R8U#P
M"Q])4\9#F%+9?3N)/Z5;^P)(L0"]>]T7%()J3GX'D&-NDI/&RD<60/Q \P:B
MG^$XMYON-! C\67O:]3Y,BZZ1EX;\_K#=R!J3VC^_JEG!SZDW-:DQ9;PR4AL
M^F&FA[C;9H/8( OIA]SYC&);SZOA*IO56I\^8 &J%7OD.? >)P%)X]2C@^+S
M:)>9@/D# N6G80>8=!=-D_N*V>=)P/V&6M%!H/0#0>C4A#R54>\?51E)BJ&Q
M:)!523"BP2 =Y&UDO&$+9*6X=<-YXA.]@I0 ^WX1P?;&9UBQ[:$3I8A."/Z>
MR<0V\;?69?#QLNJ7D 4>LCBQD%B3X4T@HC1ZIG8OS*V+]!<*52\-?]^-LS9X
M6_PSH]#8^%RZ=)5+=I;=[Z&@\A%!!)M%GOY]^T$K@\/JF5"A!1VE[R QK-47
M8-CMM([#],X.:F:I+P6@E:<42!E&C"7NL._DAW>=G'#(F2/ -O:28;-ZYY;U
MGXC=*/=G2E[QKJXB:]0R<<BTL:)Q!FUAZAA.-D8,(4\C7= O:M'\"#G#"*&7
MSGZ,G#5HCU4#?AM&CQ??^W^T:A*@"O^AQ9?()L"<&0'BK%%A5F#Q]&)\Z;.6
MOL_FE7[QGM2RAK>+_IHX@%9\M6XG^G0>\78]&ML_LYW4@(ZG@_Y9J(D X_6(
MM20]\@U:?RGY+OQZIJGO:1F>%,59FU#SK6J8#3(XI<_YD7^O9FMT2(QD_J>E
M*]62[8WB$E69$<KK,EH>Z8OY2[J?70:Q28="V3IPG2.*BVS6"J.#/$BX_^"S
MPX<P"L\J[=16T;KEH3\IIOU\B9]ZAX]/DWH/EUV2:CW;'=/A+,ZDCD;<,.**
MZ<IAE!TR$OK+B=J8LK6U]#=ORU,ZE:1#J%RPZD0S35&T29"E;$@;__56KB2R
M2>:3&-[N*_-YH)N3WP3/^GTORW6Q_&7UXWZA6:(>R\N/51Z_AS8'UG5-B[DE
M&@N' [GGYZK_4KB01%=J;&"B>.N<H'*IF<:6Y\0?F:V 4J5IM2@[CZ!?(%87
MMG#^/?:)*6(T*9!\#WYY$*%"D:EK2-<>;=HNKU[&I5[960EYJ^"RI?'J[]KS
MV4;/99O4TXQ7JR6Z3#.KW(:6?2O"K[]+\'MK^S;FEJ*QER7FDT:&9,&W6[14
M CH.-]\$^0)]WF1:'*)M,]QD+:]4>LM+(Q<<8RC_CO.?Q;?BE:H>!?LI]6*)
M!Q(&)7&-IO%!CD'BW$G-\Q^R0XOFO!K!,%/HN4ED,Q(WG_/7RM3N@F_[Z] *
MJ8,*DG>DF+&",>WYUP@+O-72=C-0(\6;.2@Z).FE&6#6-).KH%[EF5KV<8^_
MKS_^WEHV"II__C,RZ$==L%;76O'2EZ&/.2^[9:4/JW0%%+XYB_;<^NQ"%@OB
MLNK%5>M1N.V(9M0DFJA\"RHA/><BRM*+]T_+6L.U'(CL+BKS\6I2Z@KZW^+P
M/]%Y)&J>)MGIM 1ECRQ6TW?0OUDU%K#I:G6MN^C^X^(C-@$#HK.=)@C$YBZM
M64B2<"8F6NFK83O:<QASN;KF7,CC3^]$'L>GX)XE2\\BO9!3\O/]F^9XL@GI
M':'!V^"ZO-DHY]UJ=8>7=2G][OEO7)]<46FC'"Z-UA,$%=MX-2TT9>&R=X:+
M\3KMA?(ZPX,Y'NFC!5)?2GAX_PP-A.5@=$*M-M^1G>'\U*HFUF "YWS^X9L,
M[VQ"U=OU( @,>>4TOOX:[W6O$M($(;YY#H3@]D+S:5V\WOT;*U3N]?7FY_E=
M$8[(8Y- #;NNZ.C]B$V1/2'$H&K:L[![<>PK8O1/@#:';@'8FT]<P)$J.[U>
MA,G"N<R1I$PVR\GN\-M8DA/><M<QY?[0WK5 KZ@1)7]?\,12&F_FF;KE6N.L
M,-A@$[D-R%9'R+ATBY;8L*9XR;JC#$^&P]YH^BT(6YJIB(_IE^ =!7;EC2%
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M=K4!:WF__31<(%)_?VHL8-+#VWGP>_D[-ND+C^3 R1[7;6NRP]"OD%5C+_8
M&$0V&](NAHA;Y[AO!?HFVI86_$C[<5Y'7UF?*U7F)#-S0N3U1$1B"(YVIIGZ
MYD^3;"C/,RUE^*WRD<GI3(%2V_6.]<EK&J&O];PXU8G?7IM<Z_>D3%++FFR0
M\Q"2!+JM7\ CB&#DET]Y,"I_,>Y!D$9GL<$WE9-JWS>]UAR0-#99:EDUDGW6
M@Q_6LLVP5LMS_HG.B0(OIJ$NSQ_YIRQ<LHJE$ ]X.5Y_OXPS793!M0FZL<JD
MLXT\CLQC"]<7#=?M+6RH.51<WJ'HZNC6B#HO_#C(KFK<J-2$$%E(\00P41U
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MAS1R&)48*[F55F>\L5J)D!>XGWCWXYN4@3[Y9;?^VC^X^6GT!-@2GV*TL)V
MX_B\;Y@("2SHW5]!^_F>;E?X3)#-?[3.;G'NDG!B:Q%E[4L#J10@CM^H32Z#
MZ>V*G44AX+;7K<7V'I^O%GOTF=UB\9&Z7?.GM/SEY(]CR_Y0F"<$_R3A%<G
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M>*C?QQ#H D7=$:WU_O=0UVF._#N#7!9FR_?/6=R'O;\@O?-0GB0%HW %YEM
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M[7!G9R-@8&DLS<KN6BL=Y%QJ_C?#>+1A>SD\#3D_7PW!3[^B@\8+84>/S@:
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M,(M>[+H39D>/(;9]:3K+T13!'%XLU&OP?'NN-V &_\Y(X6.3<F"&P3@:^P3
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M<-HD5?[/_1QDB/<%$^X6?,&7IV<GL7Y(SV3@HLL/5%*^6 ,0388 .30>4GG
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MO, 1$KI8G&_>=.?8=45L[G&.MWBF]=N,R0+%NZ]LC9#G1[ZR\!4PK/=8V]$
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M+3!ZDWG?__,I$V8W*JI%"<Y++:&#/&$\\(> ;ZGKBZ $FIK=6OZ%1LQK2?=
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M:(T]E]_H7YO(+[PI# P%/0"Q.#<64KCAG)],AKFBWKR%6I+M@/QY^C"6:'L
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MTHA)QF_=5=CSI8AO[$R@AZ8R9NROIU4NQR79=&/])&M'R\D-R$*L-%TUF\)
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M??3"U*3>^=TX,9FB>H\,$(A%$IUK?%'F?9D.L$/<P@NVEQSQ4V"#EXYWSAZ
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MPZHA^[Y5);@ILP5(6\*T+YV50D0MF'7$\4'AJ'8T"*'H$<HE.JJ:X!5UZDU
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M&Y7A''E93D.,PCR0II_]25RE11WBHY'J,J=("B>J18YJ23F+:E'5\J(<]SP
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MJ""]J/0:D2]=BG1!B-*+@'20D"A(;X(*"DA$FD@3:4I)I(N 2)<@)B04:9*
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MQ[_GC3QY[W&_0R2G2&+R:^#WJM0((M>[<,>GOQ;L#O2L=+VU\RHK+' 9[4<
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ML+.=?>S/0WC^K;-E*?789R7.4:V;&B?I@N3@C1OMA)'"0-W9+=7HH2Z?,_P
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M8MSL4[S?3^1Q*[]@B(O&__LW7=UT+?(_]=U:.61;=R1H$.G?&LB==4,D*NA
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M"^L:W/JBU[JFYJVPN8ZY;1'_!M>MMS5QYE?>/=/Z5+]=A;M-*X?&$@V[080
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M1)^/X)L.,9A14TXCNOAK+X5N!^FOF+TVK3^Q%'SED]. <=1>O1/ID/8(C&4
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MCI'>3#H"&/G#"69Q1X"!P%WA=#!.8 FU2ZK"@.C__&>7GD-..E"FTJKW!X\
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MP"UO/&A''R/3[]'X0G"F3[*XY</69-3@32/^Q9(7QRAMMEN3_IS, $BG]@C
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MU/<#$)WK"$!^!-S<I9C QA$$*WCFN8PR\OHLSF@U0_6C;^[G:85EY\4GW9\
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M94+;_K&7QQ,9/D"_35>X]>THU8^O =KL_[-@320WO9N<@G43P6DDM%B?C$D
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M<QU>2 HX):B-!R[HGC?_H2X;(2:UV3_#-W=S4K0GVC#^V=RMN5>O1KF/(=W
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MVL<'\^6Y&5_"<XX<+\GW^5FP)*#<<V!M\--*CAC@ G/'X G\UQ&7;^LXD',
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M!XQMJ1.!%=A #>C8(%BJI5VBY>OKQO+;@<#^EW-B8G[@ZL,6$#MY  B$&F&
M7?>U5\.D3<46ZF^%</JN,I]N.9'AU']6_;)E1Q%4]G+DO"'N"_S=125;QG9Z
MW0LJ/R0U-0ZU+8$OQ@N%V2WERPVJCLY2JV2]M_^2^88)+#3SXY3QU_+(P\!J
M]"OD&>?CSO$<VP5+"S,+J\F2-&O+Z.DWLEQ'05BK9\&25H1?[6,'B4HB\_>-
M*8"T+/B^8?(\5D8821OFX;/6G^)1*"\X6;1&WJL"%7)/;#Q+;_34VG5:':,
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MLUM-7A3 35XA"F"90_@XK)T"J$&]H@">0O""<5MC%= 'PZYN4)&%+X+W,!1
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MD,DCG9R#5(!>QG1W(U[#^/'RBT)1CLBKPRN?&JZ\9?LA!T]^0RP/;;'.M"F
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MD <A'-Y9EM6H<U'4)%AE-"]MR^TT.H/E<?[;_(O&4W,W^>-%]F:=X4EWC&D
M)H7A<RX5* []0>N=+VIZF2[ER@[U,T>3NV-FJ[>5-MD9*QX)8F:DCDL5UY<H
M )J#O X@._PQ""^*:&4^-TWTP==88P87<L)<-2VT@P-XZQE](W[3OL7RA3&F
MYJ7]@#XS#ZL'C [>JH1ZC)I0[ Z$;],35&'?T_G*B_UU'T89#GL'"SY\89HE
M$/,.?HUKY<T.K7">X[G$.Z?0RQ$&F9%,N.5IP5'T5]0YC[?0VP^8SDH4:]'+
M[&KV3H(C;R6-"?H5-+OY40!E;(5RX^5AT26E06@GW&3-6#:6FE[QDTJ51 BV
MY#&S[J[94VM^Z;#DV\DU69FRT]!)#O8IWN<]^K,SO=W-_O?7M2<4TI_-F:QS
MZ9B&]'[:>"0JX<0V'/D9&8ZY]2CR;=EOI;H!BB%L>E8OOOZS#PCXWCR<N76'
M_JL<8AR%EW7':4>I8>+"P<X(5E-XP2;CL6P8%VHYJT1.$GG;2M5HM1H:O A)
MG3U)/N]?NKC;N<L,Y<78YFD7^;\RC!P^G[=SQD4J["-#PQ,= $VFR7XIYMZ\
M8*CR::@ YK"-^8Q96:![6'6]2WG;ZLI$O5BO (=+G4$T>HXL[W&WY2FF3P@%
MJVHJ'Z8&R^U!S -"-GT?N3+:OP'D>PERA)KCU;S1K7-P-3/2KLM*];9773I9
M%VS"\2_,!O_3Z,QY+T@B$..ANY7=R!D)E25 _+4>=-96J$4L=$6H]WM'FHW;
M?-7P'[_?;W-VJ4LRE?UXKD]7<X\"F$J:8PZE !Q1DQ1 )X1&R0RUEGUEV.KT
M&\;J"W'97*G@CL02N:]JAC[K$*-6"U6#D/K$4&4P@V_Z+FU^:K_/2L+2:IJW
MUX-:;SX"XGHM!<!_E)Q;BQ0@*F--VB! 9R CT>.#AGVI@UETK<DWC4OB FK\
M_,]HG9_UW><RIFU^LAI)QK^W2KD:[33L%YWH6%&\-=BZ2F^0$9V<_DTH3\JN
MEOUEI*2:P]G3;';1WS@8A+YPO1-ETTN7O//HU[?//^JI.7PY\3@W>BC]9.NO
MAYRG_Z-_+LA&=Z-"YX:*#1$<XDJ4P/LM(**!YZLAH7RT(_F-8S4SFB**%_-B
M9E=]:3P8Z*?R1+MYA 1K;,(16N?"DIUBAR)=D;U.?:]M]9UNS:S%#5/]#()3
M"[YGA.7<CED@"07(!%7KTE8/O7R03^/GV6 14Z+/[B.GN&K0A][D$>X+J*#%
M6>'9YQ&3>7/ $#*MO\Y-,27%?'67IPPGLMV;J3=S"^#Z3JA$W(F3)I[MRE0U
MB91+1"I#&+-R/ZLIJ 9/H60&?WA:(.6M+!E$@BR/FW\UE/BY6O+W?B[Y7XJH
M8?!7R^HN%%X.C-/@.XEO+2"/(MF&[SHBQ:+-G,M/73$"+4)2U"Y[/HUKD+_&
M7 #S#.UV(N<J"Q&Y\:;8NO9[K2A.XHE\?*J&>4B]I:)9I5;X;R5T)E-S,2VW
M (3T/13>CW.+BP)0"\%0/8[>W)U\%06?V^46PI!5M$!=ULOZACMODK1FUFK0
MVLVBT#,>K<FW)HY,WNNI:AFG!QU,-Q!G=H!+Z;+,/[7A]^&8'>8)$#GF[/PJ
MF;5VEJ@*_-L3P6#B@S/4(OF.$1@CE&U__"*: L@9(J01?[C]&[@ L3>YP*03
MAA1 2RYPXXPD&:Z^8[\74 ]/=/@.[I4F7:$ VNO!CU''4J"P'+SF-!S+!O_=
MB8Z6IQ3 _FD#"N!D.+SHXN 1"=B0\V5EGJR1]XP"$$#OAU$ 3'.DEQ3 VC<D
M'WQ>Q/77^L0_/G?A1!(%\(U=E\APA?S.!KRZ#UN!RV:$'5V/:2<F08:!1,57
MN+,40-Y=?  %\+J\C@)@4?_#<W\!)^Q_L?EOAHTV%W )O?_B5U/<[Z27'T)R
MP9] [0??Z[]G<];J*[\&L?WJ]_Z#]#(WY@GPDVP[CJ&^'V\U&4'TI;**>-Y+
MQ8VID'SZ/ 7PT"-G[QCL!<X@41%2HX*.6&<F\[823E, 0^^A2A1 F_$T!1">
M]P?G"OX'X?T_T1;A_[VQ82#'4P#SWX$?(21NSO9!XC57%#X2//\=_!'B/OE/
MH%$GG1C]I]#XM2X"S4C4HO=5( 7P]+Z2#Q;\B%J26!8(U/)Q *TQAU.7C8V1
M"9X_*Y:5NL*X3IVW\)4^5J7JND!Z1==*BO]'74WRH+?PJIC!.52H26L.?=.Y
M KR?AFFZ[8AW$%O=Z_NS ;7O: 1YTH_<)+"Y<><Q) L4;5B6O.%0;R_8K\1X
MM^[]^A*1RX#FK3J+F9.FPJ0@2IO >S+/OEQ>SNEA_:[FF3,B&/[=MO\"B?=_
M/;HX9]?4C6OZIBSKGX?SP%IE$.3P/S?;D7)Q6HGP<QO&W^Y=D;T5TW8UB;^8
M.::^92E6W6PX!NQJ?+/1Q-%R"S%V=$'>4Z4/7;D^:K*G5?2K-\E<&;=.GDQR
M$7D\,-^/8T1)ED4V;+\IK[B5EL19='G4AGPVBEJ[Z@N2=3:IKM8&UZ( ELQ(
M"LH7/!@7"KBKRPY^+0KOR;E%KGW,$<M*2#W*&3Y@)P[!V['PN1+(OI]"#OG"
M,80"N/JKMUOGKW]FP(>^;\#QNNMP8I0Z\:[55:J!5R./X#^I'\P]J=Q3Y\GV
M^Y]5X5(0#!&"%TXE\7XMI#H'.95ZG^H_Y'L^-1RUN@U"0HCA\/(&^$\M# 4@
M>6R9BTH'X6$@(KL6.7;5X!^%!\_C41@CT+%B%M7-Z$D@"B#!@1KYM3H@>[C4
M61#Y-_#X=]31-3P\C20^!/G"201SDAFH2JI[%5-]#TS]]%,,^$>B=5Q; !T1
MM'93_]3ES@U"3"2"!\BI#HB5*#+P3RA2/;V!ZI68G&$*X(@C[H^$6V#%<A))
M!8?]?^JL60<B:\" *W"M:I,]U3\$\(^$P]+[1Y%APX3E/W7,FZ;*(X!BW@,7
M3(D<Y5( 80L40*LA:FW'!TP4W$>15?/^&>E>-U%O"78,_OFGEH&N5(D2(6'4
M\=W^]XWO%7(M5:!>4#MQ<-TWDNR ^L-Q^ /IKH!8X(-3$"CJ5Y_3_U 3,4&^
MJ"A;JC5-E]B,DP W(1<R;$_4ALHQ?KD^UG6X\>. .$9E!OZ]GAU_UC/G'_74
M^:^LY_^ZPO^ZPK_"1(!X&/ ?1H$:ZEO/_&)1(Y-%Q:.:J@S":2H&F?"!/)Y>
M5L=I("J#C:'1.IH)!\"[$9Y.MO/@\VKB.N4BH%WJV"6(D%Q:Y$WO0CQ_<7Z4
MVS2"NT^]21>*@3S(QTZ%U"&'U\(_JBLFOULV_$#D[96(F)&8+Q<?Z9T_]?4'
MK9%2^GXRXZ5TXM=J=N%/(2-5->.#7P* VO1>K9KC]1M"N55"?UG_]K_T9[I1
M4<*65;WADO-L:(5VCVJAM&?(7:RP 51MYBQ'D_2'BTT@K(;MV-:DRC13;HCJ
MEKQHP(_UFRU&9^6,@%<0K]3922!XJPW\R1*I!O4$?-X?K#I"W&7#VY,%?["X
M]I2AG_&[A7E]$C)]XLA_]%9(O,+SH<G>O3 -AL9%=]HI5*&2_""J5D)H.*-9
M4WESOZZ1O.QN.#C@'T5SH!24;K5U8-7\D#ITJ#M*YW/_8__/>:*PXA8$^FO5
MQFRE/5&J;OL-B@MJ4!B0S8DWX5'(7Q[=KA_C^?@I+,R@72 I*12R_RRZ/IX;
MSZMOFF43*F-GUU92H:'\W&3_5SLO&"E6C )X,CL1UZY\:K2ZXU5'^KZ-.=9F
MF2MFN^W&SZ@;PFU"'1XGF>@>'%Q'W<;R*Y-[>RPO*AJ6^B.$2(6'CGNWR;PM
MP5Y\!==VVDV.@7K"PM$AA2^#AH<@ X7K[_]SVK;\=Z(SM.^I2:QC@D=KWA>^
M-X"-&[DJ/U(#C[^='+IS>5_JKW;&X;J8&RK )'12GMW43/(;>N]7@\\!4HSZ
M5C+!W6FJ,$RJ*ZR-K#A3X=#IJ2__U 87_D)@/]5C:?7<-T:3_6!!X6<B"W%X
M\=TM"'C;D7!^ WD%DQV#R^& W@8A'$IY@O+KZWZC +3JK-3%SN\!3J1EGWHH
M,8:#TN; K;&GK@D2&K.WD$'@)**X?QJ.=K.>UG97W1 N/YDGU7)K),[)D^1\
M7.!4 ;,0^[=TDOH_T)D[&PZ,S/>TY;\ A8X<D*DTV[KX*[I;1AX$4]A4NDE$
MDT9>K^QK,O"3L\) ^:4 3PM^>)Y*O4W2Y7/1JW0Z=%_@ZF?K=OX?]MX#JJEW
MRQL^2@<%49!.E*(@(")502*B%!%#45"*41'I345:( ("2A404!"B%.E$>I70
M(RH@O4H(*$@)))002'+RQCOWSLPW]\XW,]][9_[SS?NNE2=KY:SG[+.?77_[
MG)WSA,*%F(ZPCP$X<"'OP<;"#3 DW00R\K _]<LH[;S,4\4/AE)\%9.:""S_
MONOUUJEZ$\U]=JO+\,]- 5D,P)/$^I,CT'M;>M(4UP,>AEI\\H::MW2JKYE8
M;XP%"YC#18/T+@E(OOFVY\UF=KJHRK>!-?W^@CW.N4R^3?[%@LR,)$P! 3-A
MR<@_1ZC<J>:JC$&M[^=Y_\[^_]]FG#N#9J'H4SWT2$[D<4HF50Q+_%XBAF].
M<_2?/GH6DZ[.5R7C4?EI/>WS)$9D0TSKERJV6?,R+8923/5T07W T02VR=DD
M>FKD[FAT=1S+A4$=(?R8@U,0=;OV2<'$VZ1G>^YC[8 S=VPL$]2[7]:[!Y=2
M[S.U;5B%&\^9Q3(]Y'X?\XM]BR\:+J#C^#B[K[7A:D'-W=ZA<##1Q[O_TX<R
M@Q!'[H(*(X)H@5)0!ZK6,)8F37WD;TM6'&:>;._Z4\<8_W+X&*DLH4"-K&&!
MIXU];N)JEAO?^]I/(82D*MRKT,T 9F+@')MH89KJ$-0+]PS"7TKS($G/ODS2
M+2\I<1"](D<!^V*:[AB)O;SMG0.14R\O!K\Q -&W3 "!<T%6ZMR"-L#W]A$C
MJF\V:?_$_JB>"8C*S&S<OF-(<HA_N5(V7'.,4)R)7(FB!E(RR"\IWZGZB!/#
M32P.[UN)UATY5P97"669DQ9P#;KF)SY.Y+?14/K&+X5#+2BB!5+"/PWDZIF%
M3V8KCZ][!%D05XN#/*?W$^F;H65':H<NE20_URD4$912ULY\>N(B]@F7I#8S
MY!=98&J4"8NH73DF\,NS^>X(,A?)3_,A1H&<ETB'9OW:X0=,<Y<GCN7,QI0J
M6X1>SYJ^4V@<M2>4-7:;':7HM1UR))>PC?(#/Z/$JA,F5,E!Q%JL\@&:^I .
MQ'?60Y,0A_]^U2"@5*"1]8OPG*+$WD^E'QSMC>;2-R$J?(&T'7H3QATR 9M)
MH!W"S$"P7A'@B:8ZTOWF:>&,F_%:YBB[@%*I5-O'>WAU%F2OMO#U=6D5(<49
M@!.,<@+7CAN?-*/G;ZY-XBP;2+UI3AJ51?Z'V_5J1(V>'GXU;KMZGHGX"/:]
M =Q3L=$HIQ'ZY7GHQ:8Q!O#1\%4XI1@/B8,2KR.%*(8@5\ ,? +5JBM<T4AY
M3CIA<N[0^0&+T\3.XBOH>9.?"XCGD)<4\S>-!OF1A2O(N\QK9Z+;?U(BE&D"
MJ>NP9\]K2#J:Q\(]Z&&]G,DK5Q 8U3ON779(/K5ZM>$HS7O!_1^#78Q9DN'L
M3',59 "N?!-,W9(@6!/8!.I6G8=M&Z@5_UEBK]$<_Z^K]QH/W>PRVVNE<?Y)
MN<,S[/%":FN=G<5+.\?[_&FGZY;XI 7,+<R^YV:]'#<3:"V4K]AK'0V CDR[
M_(!AIG^5XP3TK#('Q<^8"GV*,""44O0<GI6837SM^%A$B\[I3G[ 9C'IL%YA
M[  _J5R*U$,2O1-6K!A 5=1*"$X8(9^CCGW>+-;H>B FZ''2S4UR2UTL&^L+
MX*!#_B=C+4':3GX!>BED;Q^R5BN$]^J6/+5B[7W??.E&_8YG4.AN_%ECQ.EA
M)A3YY,L,EJ[^?Z^$SQ+\"5V$G(F'EVO1:Z$>P1QMS=(#(?TS#("G8CGKY(:#
M@P#QX@S6&?OED>ZCQFLY'M\/]E2'[X$K.,VW[%IOJC"# CVD*Q'L@9=GHCO6
M#CDCG4B&'?=%,R=A7#?O5BQZ"'UE :R5XZ/\I4L1,(A3C,RG8S,$B_Q&R=U5
MT(143KCG#RF;Y[<841FFU>@2;V1R CX6K&?RS>%?CB_I_6;R9K,RR3JRB0=?
MO"9"Z>LX''@U.6^\V[?0U2:BK9VMA+,QRUCB&7?1VR1C8(_-]9UE)CCE\*_L
MR#I*N4-,(QM_JSX\.$.I)DE-8"V'7C][?C32Z +VR&JS1X?%EOAD= $VW>H8
M+,7.&#-3!^$/4?'/,:ND1T)GLN '=.7]'[?-M#*+II!%Q=*%%ZI.KDI-C>8O
MV?6E<Y]*.EBHV.-6F-4@6PP1U@6)?0'V(*NP+7R""'Y*:$C'KP9HK&!S3\'[
ML:_.E<8")RO/.$W$';A0T'COOG?*EE,;+C*$BW*&N&9 L2<N7(@R_;8IH:M]
M3J-W^E118O83KA81A^W7"8H=R=WJ&21#<C#E."GG)K/,>::KB%#NI^D%X.WU
M"<V0NJ&5CCA'%6'%^B5>]FL_C:_+'"RZ]-!R19*\K3.*QQ&0990O(#<7B86L
MBFHE>R^"/,1X5(GMLOG4F?1YDY1GK\9AGX$-7LZ%Z&V\E-R>C-I 6C4E#P^?
MB)IUH@E)SSJUP<;#9TLQH67J7E&[2GW1.G8C,>H]\:^])-[=JS%DNS)@(F.\
ML8_M9-#=1GO8K"'A-3/JS=!K0\3\.>90!&4D21MOW6E_Y5=J[00Y8Y]?X*VW
M'9PMZ\ 7M?CP]]\3)CV@3A**NQPJNR=D]:=?GLV*;.:DYV.<(9,<Y,S?;^1W
MA1-AZ+&U6024CUDFLOPZW(!.H#D>>Y-L[_GZSFNI)[K7T&DZ"H.RF1MM88@^
MD%O>B:D/@]_[!8?TV6QW,,M<2(UNWAR.Z[M2W/N\8K=TC]RSZ,ACFN:$^J=%
MK$GR-^B9+XM/;5R;"VL]X5?3&*6QL"3TZG67\X;#.5',&>3,6TAU&@%)')WI
M6\DH )DHGC]UM!-U<.%#Y5#\.W'D_6'ED^XK'4B7'2[^G<%5CU<SZ;]T%=T@
MU<JT@WUD-Y(A08G42*X:;E:BA%$OQY@,JDF8F$2*R54_S[\>Z6]U"OWAF+Z\
M3/HY5&-=?5_S/P3/3.$EMQE,%*:\CR:H.<O1]I12. >CR!_+RZ;,6=8(-?A%
M/?J^=[PJ1CW%(7EEP#/AJ[MXV8R_,!:Q@2'"E">CR-E-E&KJ%5=XK62U&C/Z
M<&T^6UM#:.9AQ3\L%GOM6[<3<P=Z98QJBRJ1!\3-5[8K(9J)N\H?#0/OQ9:&
M[0]Y '[^O>NP&%.&&<ZU\&JK/.KU)0A'B*2;T*'V&<P^?VO3FKJZ=,[[CPY=
M7B]&BE9(1D2+RPGWY2$$*.K,$V]&0B5#>I&BS#J\6/[1H]__JSA$RC IC_!5
M?; MFUOK]B#/UMWU\]?/>Q,47#P('\C!8P\#)$NI'.#4"+*F!]7!4XR,1.,Q
M%#W$PX?X+NOAYE'RX,'PA83OAC\7H _GL=MQ0:M;6V@LDB)3N])(M:)9#H"G
M3(EH\B\27VCR94IIL&/Q,53V1*^Z;=[U[X_!NQ(EN.]VO K32%>OB6)R"BF-
M ,7W48X+K:R1F#"=F+D0V:3M%$ RG!UY_TWQ,V@Q+Q.'3:TT4CEJ=WLG1WCO
MFT(J^4H*]/$*G??@T1_JDN[^O4NT0<HB*>=/)NI%0;7#)9#X!CQEG#@;;($S
M)=5&58^K;34-C@0\TWQ1W<P[K"W@W>'E'M<4@R*:PYE9?&@$.?,.PTQ8]W%C
M^7-^9*6$#O2>;I\&-Z.\:I[CDU?20ZWM._$UL5^C.;]<".=X=SG#\2'$.@3'
M *K!:NH!&O/,B/%LA."0SN/E$MMQXYS%T:ZQKHI523>M2 O@R#[W,XIG).A.
M+=,R&5VW]O73['WQDP1)#TO3L%73X]<OV18?2Q3\JLIZWUS*R8WMOEAHJW0Z
MC<Q<2V0?E>D_K=K0&51#;7P)Q@-YT+^XTR8J=O-I KQID)"3U'U+/J)#12X6
M_7*EJ%U:6G SGR!!50>'<&(ZYGF4R9DU0C>:IC$P1]QJ$DH_F9$S87=)O25
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MO_=/^]+7D]]W[.C+C="?4Z?+O(T/Q7^!/W,9S$/>('H&B%./YMLW]@15;MG
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MYRIZH-;,A4/<:1UMHMQ;Z5YT.OY@56&AS:*V?4X:?VCK[(_,&_*V]3NE#.!
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M\;]#P(M=TP[P1-11%!S>MSJ*).K0U^UL"Q03T^XDO$P!7O :YB!;X0BE.12
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M=K6)S$SOD7 -EPLOBT?BM+:@#S$SS"/ELE$KRE0.?QB>OIKZ@9(!K[7WZ]Q
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M!+FZ24[XVBX'IF2TF;JX_VH3'I-^S1W4(#XZ<1B+M=)1*V]"*$_<D#NC=?!
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MC1S+%P;@W#>&(=O22TL]W)D_&$!HLP0I;*QKV>%8=7Y)DBV'L)<2N+Y+#-R
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M08EDQXACJJMO@OH0O=]NOL$,_:[H:CNA,,1I6"@4PJ]P$H;HQ'PWWR12C]'
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M>4WC9KF.>Y20_8S&X.#:@:&_D\L%T:5;QA;F&?DCWG\0!?]M;DSGBH84XC3
MZG8O9H:SOE3_7\GTYS#B)ZH]7(D>R>3#X8&4#&#(M]@4C^7N]T@;^Q/L?:-?
M7?"JO4&-T"@XRVKXX6.7W3B;[E91)CX+(+B/PA2,>[8C^EWZ W4;3M'TK#S\
MP]81G]Q#4$GR0'W(O%9F8>^H\%]N0(/R7RR#_1A9RU9W?5T<+,,<:*HJ09>%
MV4PLDX1\:(1NMF?3),A[O>^".GUQVN$2=B3Z:H2CM\,=W_1.U:KH:R(]@(OV
M*XO2$:%RY+&TB?)75N%QWXSZ>Q>#*XV5J[9&U/FB,W4,9+1B:O8<,;\1'^ 7
M@&[2S-)JIYC@DDP[1L0V-*I3]V*E?0O89N+WHEB7>P+@XOIXH*]-2ZORN[4%
M:Q)C'DNR1,U.,-BI3]CHN8PK]IX'W<NQCIY9 A-+ZG9Y?V]^/_->YJ>^2Y"M
ME)R(BDKDP'M=4Z81LOU<AQS#X%+ 9S$>]E!N3\H!UWZTCA[AZ#(N;?-IZPVJ
MVK"V:RA1,D,!3^DHCM8-?R6*ROK&M+932)=#T''$F..)%F8[#8R)>P4H746X
M&5F*WI-6'!HCU0 ]8V?G>*/$R".AR>F#B(]"S+$$J1C9YAI>U@%;A BW7?6W
M_OI;A7,>"R$3E369V)\/_%6].C@X;>4W*AU&S.B9&-Q2.2#-2N1:8K)NFJ*8
M?;NZI8I4Y@RJNKJBJMYM!.QAY)*@X)SZ*<?QYHDL^?7M^=>4)!+K9B*)NPM3
MC>S6J!%JAN#M^9NF^ SK;,N$KUTRV)%0.:7].>A)MPMB!EH1M;E,#8!?:@54
MJ?HTK2IF=/GXR!;ZW+AN_F[O^89J],DO'_@=;2)9G(MS5,"?F2O]#7N2)O._
MM--IQ"4:.XE_JT@W%@^)HKQP^R1=\\WH^;/1[B"_XE9;=IF$F"OOKA06QA1>
M>:-"T[_TP;- W%-R(F2LIJJ2%B^E8"4<^&%SLPR-3M<AC##.,"<TPGG14<];
M*86LMNB2:%4F3:II[6O74%CPZV];?\K.C*$RFX-4.\0(LE:]LX8),C6XY03-
MZBO]R\*(OY.#2^U'T%V+[@NVE^!G@QLC;IUP.6L>R^A&UJ VD_&P60D\ KV$
MGI=H4\ONQ2,2!4I=PPAAUR3M?9QX#23U;\^)1M2/^ 0?$3'<Z]U0OFYL+3?Q
M"=F9XC/JI\#@VLB2GQ!L1WG[*/YM*'OO()+LS?'V@8@C7\?KZB^22RP%/*\[
M!M[:3A3(!J@6AYC;V[NZSQ3%"^^E&,H9F60,6N51,7?V3@;6I=OI01050]US
M_[<-IH<Q"F5MAI"9KQQYUWHF-)M $(&<]0RP,[I1VMDMJ1<U@/_PNO/QTM<>
MM@N)#BEJ?C9"VW;W2RVYK54?;Q(FS*OLLKUNJUY8DLJ!L".=H E9-YAS>)?Q
MRRZM Q9?'N2.+XZ_N>8H9RN!5.Y7I,8;\83X@9ZT.O0Z:RR_Y/\-(=FAYM((
M^TQUQ."PS64L,&7+GMBM:K! Z+O0V$Z[ZAW3IXJJ9^\\FC6ZMM7GTW0I&2TW
M\.K=+O0KE/2T?#,#5QJ&M\ZDVJ\%VLYNS"M.:CD6EA2)> 6/\RW'D<9-1,ZP
M0B[ZO7J^"YV[UJGE3N,/8; ;+9G/SBRY?4Y<AW#YM)/<$U39D($%/O%9DT*Q
M\?FJ^M&-%Z(\+A UZ0MJW?=&5.Q$;<W8U;TT/NZ_D%+%%O3GC:%9WA98LL05
MI1AAGT\@XS\=R%-/(6;1W$@_[!RLX^B"Y,ZF/GBIVP^ETH)>M=4)V$1LK*T&
M:X!NV),/Q:>+CX<G7.M&,N,MR6>;6$66H832:Y0P3D6E6S48=II1<Z)D346J
M4?+=*46G][%_[JFUBW1E2#]M<$D04'QW&_TG^Y*Q&T9L1 6[V=SQ(*UC#Y6S
ML*4[<2SF8%K,:*L:D5,H>:;:,C!US?&:]AF;)?-N-!>-'8 01A)TU6+6JJ&G
M "_JHZG4GHN21&]/O]T!"8L'US;CO[.#/@=HS8B0FBAC@!$91M$Q7T!V3,]W
M *HTY?#R$IM4CS2,:XWMW=>#9VP0%^%<@$Z ]A%UN/OR$!3UE#$*.@2-G2/;
M,-*5BE?0LP_=&5S=M8>@2D$"DBY8://5@-LLG^=!*HV,ZB]@&"@:CR=(I!7(
M(_WWU#=-J'XT3CJ&<=(>,0JMVBI][I\]5/CHH8.=E_4&_W+\I(+Z'1VO+9Z8
MZP''ZE<T[V-BCZ.(<]0P&N_1ITFXW#A"!?ZB>L9M/*C\G/T?@=@O#WO]KS2F
M"ZW<'MC1/^Y;ERPC^;KN]6=4#Q*0?@811.*89+F*NP,"7"[OM'<(ZT*?UI6\
M4^1Q" +K7#N-SYF(KZUY[NU>U/7R#*]&V^#Q^\WMS0J_E:>QI$#W!)H\69O!
MGD,J)PB^JBE4503; 4-??WG63>^<,OH:KOS ];%!1;E9_OW;FM6>>G7&%OX8
M*]^)76C,Y'*"5N[W!(MQ(^C@%!C!F$768#NV9U_C=(NH>G#7NJG?)$:R@MRS
M1L7TD:=W$WB"<[18^AFD\@0=/F:(.ZIRH=0,)7C#N-?3"U!P[1.;=];GL6]M
M-D?]T>C-71,9^D[\=.,VH#&)["EH?F; 9+Z>V .+FCU*!@[+>I1-I*!Q(V*A
MYJ;3U>$F=R+$[IA,E3@WU#;$=34874HT;D3?9BO3NDZZ3KI:;'?&S,+;R*Y?
M:GRD84S.2<JVATLR*>P1- (IRN!EC*'/7-^.Q; P+JRURI!^%0MYB]F;H.&P
MUY&6HSG%QTOB6.1.G&6[U%BKH,4'_=");\UDPID9GB(ZX-=(J+;8_'$$&V-B
MXI&G5EK$9#-Y;?ZWMH6<XH=:)_&@H2^+2:V/=I4FEGL&#[[GJL.&&_QG/>Y]
M<#7]Q6L3^^(&T7TEO2*/8SC;/ZG*[ =M'Q@[^C2";-=!G( [D]W;#D'"?Y"\
M(G8D6#3LKZ)M"5S=5Y(KT/,I9>?C[.+Q_E:U]@N\5PS%+B-?04@!,!H?EA(%
MC."A+QG'QUHEI!N6N%[,&(R[3.JHPT2/$YY;7U<:?-9M$WCZ_1E69^@E1@>8
M]  U)\)@GZ.&(.:%#8CJA!MV/3!^.'S*;:SG4W9_4,OC*56]]Q7F3:\O.]\(
MA.9BO\_0^)TI1YO-WH6B'4GHS3'"#:<#:F?PE<5U[Z(_ 7:7#20^6.2UDG\6
MQ%"NSI[6/</T^NX9UN89&:86(77*(3_QG02OZ926[!9*G?.:JY/^>O!27#KM
M'[T<@JMD#A?I/K*P^X#^&L&%Z+9#=0WYPD4$BK]D<C^4N]$]F<BN-APO/OOE
MGLBSC.CAT7/),7\@[F! GK5'&S._9'Y4HAP&G;O!X &*N]6(RB_+2X.VB6(0
M>]F,W&C7G8DS*J VB0L1!D([F$IRUN!\0+%JT+>6IOE]VIGMTK'5Y=:ZVD7S
MAI#$OB&Y #UX =4?L<BDJVWH6%TP'8UTV9[-Z8+PPVU+/(N_81U;VK^/52^
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M*'),\@OX5$_Z],]#.R)#RS1AM$ A&3'WAB[./O"0NP_*4@72F ;C;&N6*F8
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M%Y<7X%/)E#)- 1_/#;3,WI^6T5A4ZO"@LB/@[M@7LQ<!(Q>'[<87%["J<UC
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MU#XV[%J?S#NFS>L9W?/QN)Q0AY\2_Y#[C?<QB@:AE7;M<:?8H+R'KK03X"Z
MIV2 IO-S"006FFT!:IK8D_BG4-F>W7[$V=K.,,ZYLCD&30FBF'.S+.6M5>E<
M:3,O36P5[=)%S?5@IIB)_!M#0$<G0:!%!36A#T@\U9)TOCQ;4.K)+\D4;(8)
M<'1B.MS<//P9>9%!":V#@NRGSRKBMR^3J72./6 E&AWD5T ?P%0.H_:(7:7(
M8R@\*3K>1XNM9(V?_&WHC71UEI2((7>!G=Z'4/><]?XKOP29^B$8#R5KH&O^
M" )J:7;MS8H/;=(05$'4S9YVEP,FDM'6:=K=YO& ]>M7/K]\\Z=,P?BB %).
M#!NJBY0>DOID*:O@>V@:WDH S.<F7>FG5.?9"4+A@SFR.<9.NMXYTJ O*>;=
M,!I#Y!JL90LH$Y2H/S:PX5CFL_FQ/K;-[$+L%T,(E1X'JM)/65"=/.&?7#?"
MR/J4G.]:; 6T6Z-TF.U]4R3QC(5UULVJT?Z91:M\Y]%W=9_3YQX\F2^52U;)
M:< O_F9 CR)I]"0>OJ$#;+.@T3NT!V,7X[D4GP^^E]-^S;K^#VRFAI>F@I*C
M0]G),I0&'FWEPX0F.6?BED1 _TJD]A4'SY!2"W[[F'0+]VO=7X;8A'U?H8G6
M[]7HB83Y'#AP#_?C"$(_I<^7FX<^1^8H(2)B0[2, XK0DF"D-T<":>]3+/>F
M4$L*\MP>IT?(W2?REIF25D_JDS9?<?$P[[K$ <@IS(+(U@:5JD9#@JL%;M=0
MF4<0HD3[E@#M9A6PM#2]2IF:Z8G\8]1O(R)+HEQ*-[J%%_UQ<R?OB9+ATG,N
M>43_$83&U4/G4 <9]8B%\[""+A3>ER-VF-8D!A ,R5L1-#_22ZR .YQ36>ZL
MPVHE2K\CURYJ6$9AX59UG'_SJ\,< R%_>;F!XIXX"+W<+?>MZSE76#Y&B@'\
M<J!: 0E.XZZBE).#-A:(@Y/(=@1/]=QI$*D[\9!L549F-0=V9Q8SRS/XWE&V
M"FQ757V[/U7GF->_3F<.9#6$T(O<\%F$1Z:)>T>0ZL&-,2!T8;:(V(<XB4";
M BXII*Q!COMS!D4VO[;7[DB7N;/\J="Y//SOM[.&9#W;(F;E'0R-1XY^*HMZ
M%=.FTB12L$X0:3(*+D3U=$HIY7" %O,@<0P=1KHW?ZK*0>>C4H7,QS?'DV]6
MS=KWGIT67W?[??K)<<CAA0^$2+FSF#:2@W;5A+*G/3_E&L!S<-6#JSPVJ(1F
M,^JE+%PF^?HP.4ROU]_55K,;>V*9Q351XFO)IS8\'N.$ #6A\X0NG,A]4)%2
M 5X[@E31LTDBMK>':9H+<VR>(ZBYM@/WYE<=,GOQ6[(R&^+#2K^6W-)\2DG-
M<'5Q[OA"UEVB+AI/-:,/!V*8"(_@##Q!1'C[(V(.D!VX%P<37; SD_JE,K61
MI'6C,TH>?)SE-5YU;&?2WPL7V7ZQLH]KJUWDQ2\\'Z%#8>![7T^D)KT+<]K*
MX'V4U5UPL/"SE)%0;X4M%2JMM\$<?RZ A^EP80C1[LY PC;ZM9/Q/101@#6]
M^!R!)M-O)]L>3EEX-R^K_M/DN_HEYOO6& !U!.EBMS5ZB0,?XJ-D**A'21%H
MMU%>HXOIEC.',?IJD .7I_"F$*DNC"OT)3]"I(4)+0(.!N=.@^'K)&S'X&G4
M[(I.=:,GU5X<>=8]\.#E#]O9SWH3OK;5RVHKCW0N%C[)5<-[O#L6=^7_\W*<
MF3DE)R13?;!6_5 38[.@?0'<Z\"QT\Z0!F-FY1OI@T#!\VH1G<ZI7<KPIF?>
MJM560*CO4N*]KM->;3=Z5V<)L@\9-7N!404UEVXM81<X_J1QC@C9?__Z1566
M[1\H(FN$=WT)K8Y;25W7PDGU+!01ETX]R6%EM^#=F/GW+:_^R>JLJLI GY[8
M3+*X?M+=W--SRJU+NU+=QOK\,9'\2IL\I+R19&-;DWZ?ZL/@E41:P.:^'SW$
MK-Y59'U;&PK*K-"X6X(?)IK&5TQ?2C1;R3+]?+;UQKJ*F(M9XA/.9P=D1 "-
MZ;"8X(J;PNHVDZ&MR+@6?A#KE/^U]J#X5X;KYF>O@:PT.6E9L:A-)A%Q3B7!
M_7\;G]FL]@ X+F>U@+A^!:T)MN@7N:=>EYJ<:+XJGYJY9%[TI:BM]U=J9J.5
M??RU<Y8=;VK<AKY6;=0)QQ3NI_,E7HTO,4Q/J#=_0DE>JFU*"E4-&WQ/.!BU
M'L158S95@6B*!7 )P]6BA'H!(MM3/!Z[D>=.BH9-C.3VGM/EX8ZZ>PD&X"-8
M:?SL=+:%NB<T1##'?*/>&[_LGK>G"U>FX5]SI8D.EP<*M5PLDY91&T*%ORS*
M(MHMRW1'$QJ*OCY^D9Q>MT10(82YH,TZ@K4O/]BYO2[;^M#^LKU9UT-'PZKX
M[(91EY''@1ZK:JN> 7#[0OP7!K5D:6<X$04QI<GLO/*M7@VZ/Q/_;,\4L2TU
M26=BN-8,[K0UY40RP0$91%BG(@DJO):N^CDR_;77QZ<&G@7%-:,Y3D]94T4,
M1!<R-SH!!/]\H54G"42JO->!BGKLELQ+M:>=U!5?4O_L?BFEL7'2@:+^J<FS
M'?53]YP*?TSEYUTRE]E[O42%^#7KE,#%./.Q&9L^?-*!@%_W]> C"'QE*N7Q
M[GIKS[[HV+;^IAG5ASZ(J\C&1_B$:Z/J4>9RHK,>Z=J"R*H^7\K^'T^4#W)!
MU+S"*DZ2Y//XI,^'%AT$* NE<;="3+M(3]\^6LVX3H[8,SWW[.WX_2!6LH-W
M=$%"7SU&J6?>]ZIO?DP[4<HRU_QNP<;:DZ]G0]H-N@WW3 [$['I>@HBKG4;,
MKUTG79A%]%,RH\2X3P5(%A6.VI%3C&;CR[-&;''E;Y^-YC3MY<(SZM4'%[!+
MB!2A(!K?')UM!A,LDC<GM.G?]4J>ZO#>,8BW](&_@I;OK:_"H+9=Q4($(AS-
M<_BAY21]*%P8R4?C!-\0,;%"/$].NC0"NT".D;IAT72HZ]6N4"^%-JW)LG%Q
MKU*?SG..6&+BQ=Y?I7J.R<OW3L-5JR@_OO%=S#Y9/;Q(J7P>EZ%XQ]"B,40J
MR_FG:<=DLZNI]*#"-V^]\D^@G?VIFN5AZZ6/>6MJDRH_G3Y2Q::O%._,W/ \
M/J%J<<,;Z2G<'^#K>U7G3)/OTV$#I6&%GG.WWK_^\HT'8J"\_Y>=L2.I)]$L
MXP&F' 8+S18DG\8/O;[>Q0P$/UV].)$Y0)]"B'N>R G>V%QJ2(C@<DR_=<NB
MUJKT"3I":]"75_+1I(FJ4M')HKL'Z:)EKL:U#?;Z)^LM+"8RWI1[NH<JHJ>U
M>[>ORN/?NJ"T:GE%BK2<0_R;/PXX#)PIZN\^*"SRP4[<ICX/TPC3&&;.>0<\
M]LWI8/!X_,$$2;4= <K-;7"2%:U?&HS7X,_1)!,#V43+R+".BM40)T6-#R?2
MN]?O!,AN0 ['K_FM8R=-V5"#[2U:P'(:B9$'G@>(.+1\N4U'<-YZB,Q/:XHJ
M9>1\LFH<ZGZJ]KCP^Y1'%;6+:6*/[WIG/Q[ =%2^V_E9H/"U^0.VJB2^PR1-
MHWABR>+QW6F/W[T[E\.XY'OKL\Z3&*2OJ_^3X,N7)G<__8@Q+)-2VVD8\3;6
M-<JPYDD)U/@WK#7G*486TX'_)=FCM@O/V,D3&$2D9$]".'OL..KI8F\AGCNV
ME%1&@E:'=Q(JZ26%**=N!$^9EM%"V$7G"$L \<PLX-#3](DZ_V4A*=X?X=;_
M-@6+/;;2M6+1%[5,<=D?N'A/ND2FV\5R_WJ!+"O4JHG(7N:AQYEQR6>L0$JW
M6;4R+#C'+_71'Z?X?K_3*O=OF*;+\<<4&"JD970$2ZAC E4S_),.K ?!X0=
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M!XM\'>&;^8(3C944$\.K>3ZCP44-^F^F]AK&,EPG5;PC4=_P"NTN AX&&C5
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MAI8C:[9^1D8'F,)0IL;DR[-)SD'$;'/2[QZ3K#MQ9I['=W3.;7>=95FT#)2
M6$_!@" 5U@U=ZO5Y1P(QMWKF?=2EGVCUPI2ZP]Q>=3H*OZA*D2%#:;S6':(L
MX)M2AB_@RM IC 'H5[ 6$C;7U6PQ_Z^#:_2&,LJK'':[@6QQ/&F8K#3VF2JO
MZT3!*$(R(4<075,L!F#@#BB.Z,)%TB6 J#*J#%H:]'-53IU8Z$9P^-LKMFI?
M&5JNJLN\VQ#=:8/F-$)Z"Z/WS+YM(J_*7IHZ0:1[$XY+C,%=D> 53,=[P,^^
MGFQ_!&F?FS(U&::QDT1DK:CZL3+^AR&V4BX)CO#F1-+D8MPCEF&79WE3?O;1
M<83Y/#A@OA6C]_?]G,[!:23EA;=<I[5^NX,8,(?5<I)-R;-E+[(:7QOIC)E"
M\U^S09ZW,TC[$=?)Q8(Q.H( NH.@*K:+?A*L %8H7P]+:$A@O<M!%,A+=] "
MU><'(^F7L=TAT#AESR\LRR]),YY=G!T\1J*9VZI32@A9I^O?L#R5>H!!-?.N
M&)WC7D-]$R.P=5 #OY=N6P<1SFJ?LK/[=_*89E;"/2.EV\V/*Q5]+'K%RC!:
M<, 3LS$&,%/202+5YA>NFK5M+GI.P!_+CE8 3N03RS1)K-'26D;.[^9FP<2U
MJ8-UHX@[B??*7)M>7++F^H!\E&#QV+Z-\&$.5._$=!=H7V:Y(T"S /]5V144
MO?#*T?0?%6C&IVXI\.)A]!\X>,6DD82!W?C[[+ 6W/1=8 ]COX6)?0F<3RH6
M?SJ1+!NO#,A__C+W1K?H.%15B8F>/0>LX4'QO4-!Z,8, YL('0A:M'U=!P*4
MJ-N  \CN*8E.7"2B$M>Z%9VC#4S;$:*;$$0XQ,U&FY![?5$&Z>\5P'Y++.=$
M_;-,]=->S.^G6I<)@[_06HR$3?^R<INQ1I'/ME*.(%76OZ-I9UG;&8ZPOLY-
M*0'SX9L[KE3S&\!'1.19B4C6[B4XD(#EQWC#Y*M)]XX@G5\F=X\@'^^]X^"F
M<^P(@F'4*Q'5,- HH'3QF%IDI7P/#,O**T<3UJ?RTWLQU=8;[@M'$#Y:X&%V
M.!?Z'MD$1];VUA[IU-8  C-(UZU$X!M^E9,]?H6Z4OK'O=[<6V#KW:]S]$70
M.;:__,?8R1U=-MT&B[@9^.S>%ZV]WC_X0LS\R!#NAP7IP1&DN$YBU=4?DV]\
MN-R(:65F+!5R"U3-H' ??@B'H2:Z8"=:A.^'#\X)^6..>YR9#],G?BY_-N]4
M[/[)( !YV#S?)V!A0JAON3<U5@X/7) 4\W%V@7?/T3@QE#KRU@:#I[ (@\@"
MS\RQN1=:S L$$5P$1O2/B _)UIACQ*"^)</4E'--X[XV@C*;XL=21W'N8[K$
MAEI[<F[BX-T#>:8&CEL_UG=8NB?,H:=/:CU7O^-)>W4$F<^WJ@UQI?$Z45IK
MAMX]'S&I/JQ$RFP\&)D4JZJL$[WZ'1/D]G#_+E=_]NL[IB<*H;OU=<F"I,3E
M*=WTV56N9<&SZ$I]C4M)7Z(_:WE%8K@M$G/7I-X ]X\@<9KM8M*W $)T-R+#
M\3#%/<KOD&0P\YMMR_[:FO:'I_ ^/SJ'J*LI>!6W*4ZL?6AZYD'B/>C&=6D^
MYJIS:<>Y?+NEJ)Z'$83Y3$8PF!Y!1.G=B*J"EVA'JDCX8,L%LEQ,"Q_*]<[X
M;K\I<3DVJ&CM<]I8G'+7X>8&T/PMP_KT[91;SC.$9?LF)IH1IJU#7GH.L,1-
MW;P^$)D/_.+"',>0+P[W/F)]?N-X_9\3+25_*QFK6O@$@X/2.5"L\XS*2X?2
MM$>5,-$Y_",TB5P/C:C8PJ:Z] /O^JC9Y:#(<767\\&)Q:RO"[;NL/ZECSTP
MP( PV4'AK03UJ3KA_:_L4'(=C&!K\BP&8=TP=I<6C70<7^/UFNX:5Y(<>Q[U
MT="?EYH".(:BM08R?*;B@:F*D7 \!G!W[<(*@(,4!7 2&'$872( A#;$RRF?
ME_.:]R>7PJ1,R#ZQ?OBU\57-*L4NV3R'>R.1T=)QQS+I>G!/_'0098F13LVT
M1P O/E%+K@1<Z,JT+)T5!3V!*B(RHB94YB*\UB[L@U'D2-Z.]^]=ZZ3H*>7[
M/I;I/ZN=V"+Q6U3Z25L&,.Q-P.=S"!7A6"(TIE;*D5Q%*B^ =<K%43XYA'V<
M-AUUJ7.CP7/W+_!ZR_DG</E7C%WD6/1@N\IUZ@D3/01>4Y;VL8@1KF:'[ZO[
M;XX+SVA:''Y6+F/06=/Z&Y=KWSN'DB6,:YNJZK%YW^UO2+_J%Q3S]^F=)8Q<
MG*.S63*FG]N^($.%AO>O#5_B,L0!)6CM?-A7\UD7JGX0(\\8S3)F\.8W-OBR
M!#4PVQDSGXNI64=Y;F* 9.C4 HF?)B9F IEEE U&+6+SQ_R8FSPD5,.KZ7T4
MQR,(7-LRS)N,HW0REFF7WF]00-AD)F]1ED!Y9+&T>[[10@EE6!I_,:!33_/%
MI_IG)[X?U_:*;0Y-G(<5,R+Q20:-6Y^B<9C2=!WH6]C:V,]S1[!I!9%9N_EM
MH#':7+^"?'6)V:Y&MI[_?!Z,TI(7N-5T733I0KKW/]/GZYJI-\^?='2&^3#"
M)==!FUQ;!, HB:!GX?7-GJ=HL87I,T$=BG;!6">.&M*%QYF;94D/S>4KOWYO
M,GMUEEB+QRQC*;Z'67 D#)3!=+G[KQ]!IDS_!=,6""=M=45V>WJ0L4;0EW^V
M3KWADMJT: \7]=0YK$.ZGGMN<+%6-^D57](+CP'"+QQC>7L8MH?0X']WL="_
MM8B";//]-DA>5*)M(X&+=HN\U%58E=75HCAJ+A\6BG0Q4LG.TZE4JSZ$?TO5
M.Y["=T;Q(@3#AP'\!C<72(1$6,THH5+O9<F@(X"CN+*SQBBIL7<=-I)5K>NB
M2&$ZYCFJ,*_*NF$?K_-5U6FG;OAQ#[ %720P&-]\' &X 9WL:YVKPC^'N\E-
M48DM6#)V ='%8-@])&7 .K$:5#9EHFD#'\N3!M^O\N6(-!AX[9[QL%7XG)JY
MV;X_:T\+7!789K;>_@N.=S&;<N!5U\T'LQ>2,C5QV&NVZU!Y[0=UR(U?;_(E
M<%6E5Y^Z/E7#[SJ XJ]T 2?B::LLXU($>Q.32(5IO?=(>Z9YQZ=$E7U'WT3Y
M^#NLRZR;C/[BN-3?317TH2/(*65\]&?X!AE@*%X0LU37V 00L'1N-Q51S@DE
MS%EAS9CJ_1I!I4;40$6>SA.RG;U[D'HB1LZCDBOH"(++:#.-08@2YAGT#3 #
MG6K&D=4P+MH%\$/+,3#"\TJH,7\/X4SY+G9CNM_4;MC<].+O[AV=Y+ @HV>#
M!\K#;5>UG2"8TN]J8NIK&B$KV E>N@T!\%W4\,;3>%,H)5BC*Q6]1&24*K_+
M'*2KR&C^5D'CH^EX4\J'63<!;1<]ORX(QHTQLP->T W#"9]/P C2PHA9V!HP
MJ#OG-(",\S?Z<,U'J>Q)Z!F][H>LQI0]>9@7B9 A!ZH845 @-U6//@H3I,F3
MUXFPI^%R*(PA:'N8^]%=6QO8Q<645D\?039E-!2#G)%H_&G%U]D+LDZ89/WI
MFD\=>UGT4X*^0;Z,MF8,94+:?_NS;J,?N*5I].IW2=ZO6';MT&HI85BY)WF'
M?D;R$GT")Z(^2+M/#R=,A2#W#QX^A1=BIB3H)_]RE2^''VCRKL3UK<F>#MBI
M<J61(-DW#/.?PZ(UBNHS+R?.U.@/S5N.E7FML&D%9EQEII.%_DGTI8?@^&F\
MY"PZ&Y01(N?&JDU9P0RSZ&Y,U6"7IK%1&UU<-\6XFMSSW.I T!MG47FSR.^#
M1XC_(#+,6_QA0ZCY9O4R8;RIPC(V2LU*"] ,N-[<3-[%[S!2.**H;)/1J<T7
M/FXN-=.]Q& OB*?E/LF0"N7^OC4-FNGE7@0!GISTJ!;6=W=-_3QLJF?3E.S7
M01!EW).,@6DK@A9W:L>TX&0IBAIY+TX:7TJFW']$ $3?(3N/<ZGH%++7LQX^
MH4F!_S#F<AF SY<1JNIW02,R(X/O\'9A[L.KQ%EIPI>)/T4ZZ"+[9%BRP1'D
MM?7+JMY+;T45<\9HF9BVJ@BZRC15$W>0-R>H3[]W\2E\9"LY[(DG[2MF?IE!
M\CL&Z5<Y>HA;$=MABL1&N_!@_)^QZ]#O$_NIF+9^9PQQ98[7+VH:H+8M/OON
MVJ'2Z7/PV ^\P[IGP?#'#%F9\)PPGX&IVDKPV<Q<FVAC+$&3J$1#+396UOL/
ME&.PQ/AX\)<=\<3>)(&(*+$(Q(HR28X;;<?(J%Y,FXE2G^T6YTQ/.7V(P >-
MTCH7\,;^/0#O2% )?:-T***:;A0XU*3I'G#,,.YC<%/E8@YNEC7R-]I[?@L\
M;X4+FM\OGR?[(RIFJL>Y5O,.RRZ,5@M8K7^](K"3;V=WJ1ZV%A^16$.[_?<A
M2(?A$22ZF/Y-G)9K&-#O6-V=70>GO!E1OMFNM>"XW303H_ XY#OK7A4 I9_,
M9A@V"_("C1V8,\(4!.A(OKFE5^=4A%HA8:.4\'RHNDZAA.YQPN?FL5WA8%>^
MV<<71TS,SU>]*#7[?2$/LV)+9]=DQ/K6>@BV"\I"8[04SWW1L(:&D?!+ZT+9
M!$;1B0J1:G,G0IGL>W@+AW>SCTW(Z^>Y66,OD;PU9DY;Z9U(YIT^;TDG]5Y(
MU%BDWU_AY2#A:\*I7$9.6]VY!:=5OT:H,;]U56("&QF:OCA\A?G;.L,_Z?9L
M_-U9<'R8QK9PJ#) M07FHK24^0IGI8?%08.B#LXJ !GSH"FB+S3THH^3VR.%
MDOVE>XY6+441_[7@3B>8JQU!&.5Q\O.E?^_&0R/I0OMF)XX=07IP CU?_9*O
M>6YMI/3.]"X\/D\_I7<W%(8/>1)&!(\@8O_ %L\ ^'8'OE'X?!X&2H=Y:(L.
MXYO80JF^4Z#*7ML>7XGLLV"B!-@<D*\:M5)Q23I3TSTF7<[EEEZU&<?-'<3J
MK@2-*Y?.5OT+J-NX0571NGVJR1L@=#@**,S3< \OU*MI/9:B];:</8)\O4L7
MPDS=E('O!MI/'&S 9^'1VSQ,$43<&12F+4=T"'V9:"S:T3$K!"QGN^?^LN%+
M\TH/<4G*_]&>3@D)QWF?Y6SS]#XE_;C]Z26W]W<A4D_^AS;K_K]>F!>ATV2C
M\,ZY&OC71@)1CW;3TDJ0T:^WPP,-),!G?\3>AE@#ZG]IUV$J#4YU#Q]V8 %9
M2:9GYU!&NF38BZ8;)?VE[N-#,[/3A&@ERY9$@0=^0A)3,^B/T@L>V9/X+1R%
MND*Y<EB$V8BFW8!G1/_NQYR$ X:$*3]BQL8SJC7(O)#112$?0PGK ,C8/]DW
MFN1R6QI+998;WK^4@7\=&7:SN6<S_TQ1JKQSO^2@I#6SH1;V5,NXY)5)Y8 [
MT=*N5LTFG '"9]O[AQ*$GL3GJNLA3@?;SZ:'PKYJJ^O(EI!@T7=W7H\$WU[1
MRW&ZNI6>\2E=UC"O^*N,P67AF8(/ZQ]Q3>'*#!1U:SHC$:TL!_Y#</,.F>CR
MO3_3E_>QBI@EZ#^]_F,^L+*B*=6^.KUVY*>TKYU]%T]E&[=BJ8^U-T:;@6S0
M+G@\X5/&9BZQ *"4S@J3Y5Z$7YFFR8,1'V]<RM" QOC?#_CS?1?TV6"_)%3V
MLGU"];/T]LDI3:SX_-E_S XU:#8,!1*.((^:A=LSZC L33"R!(DU$=U@U6=$
MAD=? @*3>+#<,:[UHROUC?>/FZ<JV!2+]0H\J"Q2QR]#*4%@,!E!^758TZ0.
MC5*ZKXSC!/=(7]$WR>@RL6GW3-9HBTY/_'I?:%'>$QTGEIKDGU/N-ZHN[93>
M*=Q_AF^>/Q<DZE3O%%^,JBPN%PQ66GAQ?T"8+:I$6K=8GW/#O3M-<NY'X;9)
M*?+;R,<]UUYR"_]3X*U!>Q+PV3>#LW0:*FU-,;[M?$]:VL,L&^:VN"1,U;?.
MN8:N'<X+MAQ<ZZ%SL([*!.!^2'1,U7PTSBE:V#JSIC*](-STLEEE&?5FXO*=
MC<<"Q_Z1P//2#AB(?)4PGS5[BH%;$;,TZRHR$JN,989&1QMXRFV\/(G,I*WY
M!N,O1=UW//LZY.KS(-E@UHC#XXS;6C/M/\92CZ$P>I]FI:OQ(BA/T^H=MB!;
MS^L:I)-I<R77$G@4'_"=?VN]7<5H$N=PU:X;\@$+FKBG*BU\]4A182AX:ZZS
M!=I"MNHHZ'2JX<,_(M>D+\$55/[%[W",+:,LC&)*4,K9'1$5OJTN?3&^BGT5
M]^)2W=K/%EQ52"[2^M=9U^#[\':!7.B_6-,NFR:X:5>.,([_P4IB'WSLX&Z5
MM+8H=Y&YI8>>C_8 C[-0I6%IRI[XN]Q&FYI#@2-(IQ(#GGE$"+ F+_D);5A%
M>$A0TZ"ZV)S$;$O)X4O"?"SB-,$)CK61Z\&>0=\C2\0IA_'KC?Y!*27HZ]?4
MU*)J[NHFZZ5KOD&$; RHT";;-A'/HND<+'\WD$8+CK3PT4H&MEZ$T)><AA6I
M1Y"6N8YID7W\)!84TZ?QY%+R#^OHE]!V +ZG#\.JDX]2U!W>/7,6]&P+P4:6
M]X_-;FEK%N$?^=<S,[/!Q!JN>\[7?W90):+\E+K(4)YYWS=*1=WIVI&G'>Z;
MY]\;\SA7D6]TYE2R'=Z:GZ?&/7=#[3I*/IZD5<?V"JAU?-9/5+=LG>ATK!A=
M'4Z[4OQVN,BJ:3X'FV9@N-+/:!H^67T_@CA]OUF+MB3#F5+E+U?+B#TU-:[7
M.NWZT9-D"HKST[BXB3V;*P#4!FPFX6-GSP,N[_- ZGW 2\@DY>/T[%1S[1MW
M5PV[1B,EB6]ORE_S0")/^HU:3^, OX]S&_ ?5#\O"4:AY?X$K@11.%[]T[-G
MH#8X3! [@CPT!:6LNP=_V!)5BH!<XMYS+56\6R8V;A?&WU^X;I5BH,4?DM;<
MW/1=J:CV>G'ME[72UJ>F1?@AE 2T^S6>:?LD('HU!ZKV/MOEJJ6]#<\R,'BM
MTS#/HM.BB+U732[2H(PGQ76ER=7VQ;59-5=4HGK[(&^*OER;PULG<]](ZXRA
M.T^B1,W>-J]KUDW<W0BOH5DS(,$;+9Q'@Y.MJH"=!3I!+L[_.O3NV)]^U7O
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MQ/$1\6RS@_*8KD!>N6^^"DW!]S>S]SU;O.7EU@0$=>SJTZZY*YBA*AG?(>2
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M^2KE@+J7%$QD)GWI9VB?C?Q"7['/>()Z@61][Y0X.Q>N+%B6K@@EO)EKQ+Z
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M<=7T'7"Z)U =QO$WRRKV7\"W-)<;B_\-U0]/U7801(\H41\07D*3.'K[A+0
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M=M/VAA#4Z1W;1%-4J6X'92[X<+E(;+\IG84!NW;=*_WNUNP4(' 2G@YN)HU
M[#16P([G #,@^4FYI?=5B_7\DR+Q=,NITI:-Z'WYI%6<3.G[PNS6435?3]^=
M%M-67U\_=:Y#X,>BP$-@OABG415G%G1X+WP#&=Z^$_M?S>YBSL[T;*9"76U'
M@9-C967)FTWS-6].M\J%^(S9+U0MP^:!VPZRWF$+Z(&O(35CKW"?C<J*LSUV
M\(BCMGKTRJN)>8U]=?6!L5;PZ=AH[>C6TYJZ/[2- /=TPXL>D)L:I%,P1XH]
M+4M/'OM/[7. P[&.U/PE>G-4^W6-;0.=B/*5E,<9@1D(Z??%:(1"[\3V0GNX
M>U!Z4*"W26ZQ32M^PU<>A\QJY $(9$J\3%E*GY^]3D@;OD2C/@SJ+#"[I4/4
M.-Q8)*SEWQWQT]FP!29TB;6Y5,Z@*TR<CB=8S:QFUW)'C2UL4K<[.*G.\;7U
M3;&W6@8 VH+4/)B3*K8Z&+WG.%QT)<N!$&<%-0MN<Z\1X<&]G'F-O;@7^9/R
M805R6M[S:7U5!\:S#8:O\Y0VLZVL!IHM++>"U,MC'%4V8C5]BR5;#;PM\U:?
M-<L$;?C7J6:=V3O:\P4MQF3MTG3>2%2_Z.+B58!"3Y"P@A&G%B.8D7. _4%)
M:?I[$3/S@JU<:UQ$$Z*Z,1Q]**U=;08R9L6$&X_5.7(=M=;9.YMROL[_HZX.
ME.1=4:MC0697\;]59XH*?*V^%!2YXEXC(/3B43E@77U]W.L$ K<+K[6L=RPN
M?)]9T&BG$PF?G[)F-%C%B<_G6@>>J;;X;0[A.-=79J>N[UY\=PY0*!2)+RC>
M/SG8,<X+3O^DYVIP7V/8R#U+5NG/$<K.81\V=1H+TI 00=#J:.#@OP])TIPY
MENOO9_WG+5;;TXWEG'[V1..JCBZ618N-*63^K*_>D1BJB );ZX4;=<X]4>2Y
MOI22NJBH0X]8Z%,;U&IR?T$S^S*^(.P<T)IW*MQ=0DM;RAH#T8:OSD 75\"?
MJX'LQ]Z&9]63$.9*=%CR=%4-&&%DJ^.]%RQ>GYSYN;KRP.F@8<>SS#3-EI""
M;::7H#W[8@/-;^]X_RFW8Q^1]L-AE\*FNS&[JP[,I(4"R2$QTSLPE'*&40./
M,6ZYUK)N=%[U</&_CIW$2OCM.CNQ7W./[$+FZPM.G?'7#*(+BG>?7UC<+M#]
M^[>Y<RLIG'=@!< +-6 )G%7?5"?M&RY!1GZ/N>NT0.RJ?6I2$279,M91_KZ'
MX5&GD6.F_KM5!S'DZO;=TTMKZM?S0K01PFG"9+_Z%(_K";)&.E"&FN_: D'F
M,>&%T ]:L8DQT1!XB69Z&SHE6S03KAWBJ#5S?&/ $B[C\*UV=<W$L67^$+%@
MP,VTN.-:&YPM0ANXR5U(%UB 3;*T%Z4;$3P%@]^?2H'WS 9 DM,:RLVKC5N?
M&R>WLS^&K\Z+YU=Q?DU&.UIZ'W>,.%O$![T(X@[HHN7EV7X5(GB"&Q]['<3"
M^_;O993^NNZ+ O*(=^"*.PD$0 $@\/W)@KPA_=F6Z-:]S8SC\,T&F\DU_TRM
M#I]=Q$I[XQC.7VR]Y)781S-:TF"GZ*U3F)*ZSK?8B!$/AH5\F%:'IWMJ+ZRE
M<ST%#'CTM\3K(MIOY#&W3^.9+CP*L6Z2Y6N\N>49/EB"Z#BU7Y_\"_N-'(EO
M_L82=M2)#?SQ\U'&U+>R*SP)&EI&UPGU+P(X7FCT1X?B%O)'3LX!AQ9Z&:"[
MW6%CH]$'[7GV!TA'A=\:&1,UHDNYC@H1]96'Z,;-XYLWW@Z;N B4#_,JI0@_
M2MEAN!V]GN-DKG-),7/X0JA%775TQA3<./T=DQ#Q@ 31C3PLQOH]%O+B% N5
M\\O/</3W] K41RVN'CLV9ZO%"JM594W^<9??SO.XJM2U\A)U<1_7#UBR%%&]
M]6L.$-5X9?CRCY,XZ+3H\0I#I+I?<$HPK,;N0GS>ROZN(A%B)U1KGJ9KG)=D
M1F4@;-9F4^L3#4\+D!&9&#%.RP$?>)J^L6505!,"OX.>^'YA1T) 2D/J)_^(
M5B*D? -5)>G@L2YZC#HHLWCL*27U4TH986/D756ZNP ZWK8;58G4UPD-SVUO
M#/?9G3D+D_R<=+$>C0CX/SJ/O%P$1QT3M!B&Q)"?7="D4E.&_[?\KRKYT]K?
MVT\>3PXOWOJ<).5L$K+SNX8(V=J]Y^*EOI:5)#5_#,%W1>.^1)]:Z',@A\\!
MNI1/#54E]4Y.^7%)DF7A\TD#I$D;G"^DBLKX/N-&HDEGIS!D 07<WB.([$^2
M+.D@AX!]OLFQF?S7>)^J'?('>[.#O^56.T[]."ST^7%?*EL5FJC7N7)!X!EZ
M:;,-F6/$X1_JA?#8/T?_ON7/ 55GX#O4RC+([D7YA;A:1^[8_]'U>NF"7N/N
M#")\K?M?UZV[,O*#N]1'RD2@8P\6IY"_PCHVSP'7J2IGYUMF2@/Z.GI")TY?
M=K).,I7C"&UOP$WA&-M;=$C=4/APDF2K]=[L#VOC4_^*?4HEM3<:S^GP/U**
M9'KPO-2SS[-:WOE3&<+^$J$K9S6W4'H;: *UW5;R71FMDJ>G5?\&L$VK;*&O
M/#/];6<5D5U(E5;U\=8<52A%)2U.1_N[-/H<%N&G4)Q/*QVU]=E%ISCJJ/Y5
MDY/-ROHCU+HU]9 Z ?NZ.!QSO"!KF3E5=L6'B\Z.AN$^(=O4.[CV2!<Y/O".
M0/JSDDR#;8T<Y:JO-#2^I+;JV9#9_F^WOX]I_<%OJMBH;>X>M[9PD]0&O_V;
M-$P/J6IO9V.%V@CW_V2(]^[P:K.LHT\I5H#Z1WH5DJ&K1C3F#S+^> E $]77
M\N_0<3PTTZ%\I)+S? #'PPA4S#[*OSKP]/]VYMW_187^TQ:Z<#,VL9W.WJ0Q
MG9+5E:-D /AA$;>H=-TA8U;6G#8O+_ TZ0[/N_O:!\/A@?T ;4GL(JP[SB9_
MK!'6,:\CN-OW&98;R",R#K@/M$$M_(URI]UW5Q.-&:J'M>ZUK)=A^G4_JN.,
M6F6.S@%:%TRWZW=G;" P4R1F)I:#MN#](V'9JK#T0W ^-0!O_4V=+KH:^Y@&
M\M7_]9+YOU#NLU+='S";&BQRU,]_KI'P(.4BJB=)8/+%$NZZCL:PV;+N4]QD
ME[Z$^N'!#FD#I)I1^RC:9W"W"A$^MN66WC&DU:XR'[ZWM;:SSR#%$H'"4F)!
MS^KLJXX:ORXTVIT#[)(-ZTP/'6UB@17__YS/E@)'_<]P*[FUVU44R N?T%)<
MV'9+**YZ-EE?/$"#%)AC9S,Y_SR_ #I2U1IY&LZH.P-ZVAAN,SI-O?T!U0#+
M0*"0ZC.MZH*XG;*6!=CN)!7J,O*.4%@X_AR@7E)DXBM6,Y/:ZG.,W*H2S25^
MQC44U.B'HIWA62_UE=,UH3J&)UMF]-KC"UH2.(FO=8[LE ;^9*>L=M)N9A61
M.LP'[SXG/0@R#SX'3%(-86KC7F!&O;-J=JR<EZ^_3^A9AYNOZ$EU0=[7$<<&
M\W5_M7$[R6+@.!BX?F+1D39QUKK1CC0,RJH2JYHX!\B0I[B2[L)CW)'.J TR
M"#2]^!01[O/9!^=W*G,.Z+0XSFC(=4"8^(;742'P 1FBL#660LA _6/T9"F9
M,X2I>,UZK#("0@S4,!@#S=^=L=/14EM==*3[G#+&A"VH'\L<"VQ ^RYLJOX]
M.$L$V;8^RV];F.D+/9M:K!TUFB6![HX8VR3NHRBL97##\3#(H,S1*M*O_(3B
M2L69%DMCTRCO]L='NZ?R<5%:/K%"7P>=LG%CDR>%_Y-[QY$=0(XEBZ1J#HL"
M32\J1\T@@D'H=',)6C0P\T$93P.A]1P@Z^]KB:N;<I9'W#"RW8^NEA_;PH$^
MGU$MS(_R/GB11(G+1S?DM'; _LMI3-VJR4R*<IRNSYEV;-W>&0T?ERRFU]$2
MH+*@9V8;NN< Q08O_RT?ZD18-9"U%_WA=WU&'21+L<B[")Z#D9,^S733?1G;
M_ADU9%DV?#!0/*_Y4<=;TFP#<HE$=2,EO^!=D2H=J6((9_G"^>+/F0O9&SZS
M4QT8?=X-W%@2N[G/1E$+8GXNW-PK#('V^N>17/ZGER[<UE%;H^'4YY;J5P+I
M6E5GI1Z?A% IG6#NY.(8U1=E6*8V9\&^AB,&35]1JPM!MYH6LSJHTGQX_?\H
M1/K?EAHE8A_!ONL<0$OA)2*6D;#=]6_X\+CZU0F5K<%G*5-<1_ZA=!\B/M.9
M(.#!5SM=N[2/:Q[4O 0NE0M0.B'UG2(BE*O/@(?71S=*PK+#LA<Z"51EBQL"
M]R2*D;R6+TH69OHRPX]C?-->PJMCKXCHOC\'$&.FMK7. 7KP-T#\O7, "8Q,
M^C$1IC#0#FR1.N,^JS@'Q,#P%4=@2"+I*K!!F!BSN*UY"8BY/45!_E& DX6=
M!O'<% :],T7*&)!-5I>#)$L0JBHG]EBB573L9H;W353?J;Q.8S.'W/@P0'RV
M'/ X<)_=N=NLCT+UV8LB))G#9,KEKU^!_LC+5PN%B3;PJRT X!JOOUY"1OCL
M(.6R\(S&C^?"RP"8'Q)C<E\37G/ T?#A?]\S"1*&S>]"[Q\*%88?%%[*.GGA
M=/]GX-^F,RHA>Y _WKSZ\JPSC\5("BH,\,KX':JC];3<6S,5FN$9^=4[O#$*
M_+%T9FYATV8*C?(%@4"^O%G1%;D?C5%,7(0*(V7HK 6-:!+I,K'L'$#'2?X"
M]%U,XCL';,^> RZFX:LSOQ!MNK.GG/B($V<A$93A)Q0V(KNUFN4?;SOA[BW0
M!6$A8MG=AF<-ALW?L^PM1-/L>KAS^>\O"3<OZ!*S\?L8Y\109VZ2,0'Q6IL9
M$\M&US(1NLB^I<JGF^_JUTNC,M&W/2KKO7W_;MR3^)3E#D4@_C&.*-[Q1&&G
MX4S[9T,2(I- :_3A@OKU>LO;*>[5@<Y",=20*HZ+1#=^""<^.0<@6'L7DY (
MF[XA9U/5!:EV8NORO)MP(C?W@[[C9Q2:T>J#,QG[9Z):.^[-65A7!D%;J]=G
M_S+0XDW]_W!W17G8&;X&>L#B[*SSK]+(N>-]7VT6,K$N.":_M0>PMM\8F7RA
MR9I K?U0X4\RUCGI.A[8[3]3M 2#Q;B&I,K5),;H8(>X]JV;[O>O[U5V_$[_
M^8)UCJZNTS("Z"A:(6NB_""][_I FWQM(<_9P-]?M?*Q_*4^^\!E9](U%.5*
M'<% T.C0>=H&LYZH<G8&JL(0LE^ZC;?Q+[?+E5KRK3^8".$_DVC,#PJ#RXT+
MA874O#H<^>-%8?BW!7 +$=\/Q)M!8%'G@!TY?' /85 ><28$1NO>]'4ZK ])
MPS5P$ST)%UPO'MFUV-G'QC_XCE32&>K[Q=#A8L-!0V99_9:*TKC(4JE.7H8V
MG0.\%G%6F7CN;2I0TUTE*IZ%1MA;.S-.;\&9.I2);.Y%)%<R''Q3GYQ!4, D
MOO6%9<:6>MN%;%S,@>;3=7HB)I^[<(6G9::I^CT&QI;S&XJ4WN>E%2H4"ISB
M &Q*4F)195._1^_0W;A..R4"?TZ3;K2MF+;X+IK!#G1Q!7\9$SP"-M/T%>%]
M--(.N/[NZN6_\U3W^IVB$-ROZ9:?EG)T6+-^3&',IXY-EEQ^#E@JH/JJVJ/,
M,QFB%\;F;9OKV1V2:2TQ\,@_256S\HC>:K+:%1UR?V<W9.A>UW.17(MF!#0Z
M.5[T8>_(#2?F""!)EHH0FK@RDI("B;VB0.D<P&BP)=0,)&AO3!%.4U[6N)]&
M6HMZ</KG FJL'Z$9"RZC+".WS-9_I^S'4W0H;;$R)W;D',A2$Z0!T2T\R]V]
M^-V0Q%ES]!R_W@GGB7DX,76/&$@([JR=MX]11HY;I#!EY4"+ L-:=I-U1J$<
MD[*>4/[(E3@I6EX-RI>>^!\WL@&[3C8@FLRW*S$#=WG414IHZQ86IPY0%O=1
MWKO7R9>ND%XJ%XEZ,*5@M6E.TR@:A7?O_^*FZWAHIN8NS0),+M6!1FH'3KXG
MI!P/LUX4"/\A"G'V)EE1#85JQ5UF8!'JIXHN/4EL0I>1)/>=^(D .WI%_ #F
MC%%MF/3,,J6_3[AH_= [6;ZDV*Y-\W7]Z7NQ@S-&>YDW'B;E7#9S\1P<&;YR
MH;-FL_ &^Y?]FNS0*/(=RHVY@\Y=T*>NS<@YPT+U8YTKM.%Z+YV'N7MJDA;Q
M0<BWNHP1QWVZ-\CY2#=!_F7K3Y\BPBV)6I@-;>=07\[>EKS)8\WTB,D%K..K
MC7!K.X=A8%UI<_T[[\LN64_POW1@%(8=ZG1?)E= EO+AWVRZX- ./CRJNP(V
M0]MK=]R#8XAY^)MT]U)1982P*4&H'(-LB!B8[1D#(1H1;'8S6]\=>TKF&GK?
MRN7TH\#;OP5:II47)O<I2+/UW2678-AZ&E$(NP@=;\ *UR%@A_ D. V%F?2
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M;KPQH+9./ V:#?/=$QVP,!CC5[XT3_^I\?K3EZW''GE+AH:NY@+@C,CK2[R
M;.C&50)L4V@O%6=#;*%3,OS5B[;2B9L.WHT5]E?,'F0+5(]_SNM*,ZE(X;JO
MDA_8'9E&9(:7?0\>%[UM :0SN:(P,+D(/KUVUO64FSD]UX!O'9LO A@3BC(A
MBC511MX<F4>@KO$$R9<E#8+^73M]YX5[(1\PG!@WY1DW0D8-*5(9X"7A.SH(
MO 8F>MINR. 0_[_ZW0M?L_85)36<C/^BFU0%W-Y8?2-%JF?MT&'B28-5?F];
M6L3JU$C36OUGJY/\]R8][9,P*\L*TG*F]0U?'2'@]5R+U+QO[\0$[%]DQQ1!
MKP9TN4D+!]1*QY3(&?28Z=0/E4=<3K< 0P"F:.JCLL(_'52X 0<?_BA(JE3B
M$WV4=Q6U2H4E-[-"%L6>\?(,C%=&O2=U+GET6"4["9$U.Z )C%- +)'ROM+^
M+NEKD_N7V=K^^WT<5TP<Q4\B[C3H+4F)P!(0[#0)<DA:V <@APCKW(0:3UQX
M E-0:I;\*%1L+.3>[U!>NO)%IQ69P$FC TR!P)I,ST;!?)K=J 96B_@9\\60
MA/W01K97"&YXC/6H@J C/,_G:^TPS]R<JZ=(WJ=^PK!OW8A:VO)-ED&Q9MFD
M2A&OL'Q3D6^AF9?O_DWD*'<*O%M&*#=2-I06LDI3BC"E?LJM+V$3OOMK0#6+
MHSO .NE[?W.CJ^Q0\>6W%?-+PEH-=9]P3JA)@:<7'A8F/4H*7.T-:.@=3#&(
M*URI;]_2^5O@1+,E@3>?4TT9W:WZI-YV94"F)?\]BF9 #OZEP]NQ/<O;7H<"
MO]BS,-,V&/3^'.DPGO43QNT=WG<Q0O\&<:G6W=CHAJ,#8LAA34,D(SF_J,2E
M/:H$[]P9[!'A+6?E$^BMPQ;W6_CS8],+&>R/TH3*C[/K80O>_YK^B9J>J)0+
M)KTK;2!4U3O*U>M9J!U OY>+?S$LM_U\YTJE&6*#4 ,;Z?^;>]E3;N()U4FH
M6:WAZCON6RYBEA(H!9<2TVU!42W;5T$KH@%ULV9[YT*&*R^']8;O^-9.>C[>
M<X)ZTU>^*C+Y GO@[ ZHX ADO>59VIVB0QX)EFY8;5M/L8(Y+;5*P:.I'4A>
MO=#%O*OWHXP[77G(2IB2WA#A2JF6,;6( >K=1ENY0=_Q:]'N=G?<%%A8!I$J
MX.]8VCEG!I<RU7,:3G6EYR'X$/V-C.>D]6Z/#M?S!5VAN*S8DM2[^7-X9\5"
M>UQY3NG@>[LW01T'+U #SPO*?L!OJ@Z3'.,\8KN6M<1X'&U.Q?>X!3[M28'>
MR+CEH?K14K6<;/FY1/Y25-!";Q^936#Y_4G58\^ZB=5/?3558KW>Z5VV>5:6
M4JGU8"RX1,OFC=<5.Y^6+/<RNM6V:,*/(:'G,:_/T68,RN>X Q<R1,.WA,ZG
M1Y=<>/8GZJ704J[]7W=R*&7JWP,@1#]"',R/>0*>22<()B $GJ"OFB^^!>R_
M+'@W#GY]]_U\?MAR',6AIO3>F;,+<SVD;DE9=[E3B"E$+[(6V3D\JTFPBC70
MCM1)W+8<#Y[,'K ;4;^87 J$=NF$_*C-$UETF'1K$M"4ZN;?-7D]_^%LUP<Q
MKJ%Z38T^/[5 KXR GP-*77:9XH^UE1X8JW3<:.;S2KE8Q$NP?=/TXG&6RJNZ
MNH8W_BFV>6[>[F_+'CN&/##*KMBA+9VP4>X>RFILJ12QE9HW\QQ8\/>=&Z@V
M*/ST^HK6+^Y=[AL%$XF:W$MZ?]NWV.[H7]M#I3OAC8M1QNA!Y/L])FBK^>85
M--<@PE?K&XH;VE;3YH*6L!@6<+*P-0^[EMZFG']NB$V^BKX5T0$AC=V(E"?2
M85V'[_U+@%"3B>#R^427[N("[TN3[0Z]"CTR*?@[,B5&MG(VR6JXTB5V:U.:
M16%M1*"N5*6/W;Y18!GGW;6)8,&MLH:AZG"9;I<FES*GJZ&SC[U[""G\#+)K
M;EG/394C$*_P^K1(5@B;]A]MB89?A #!$6K,N#J-@!A$DFXC 5G49@,YIDMD
M>&.29$YX"ZG6C#90<H)+]S1B4M2]7X&%' #?65N3VIQD'5B=L7>9M[3AJ3)G
M1\.3UGUBEA5AD,J"[W75U "O5@5@@&W3AS <*R%$<D]-JM5"L+O2M":=;T\$
M%[!>VNTT:R'?.^6O.5VK'41FS3I](DEJ.<M#"%4Q5*][Y8>TJW"^LG118H?U
M1Z>O+N:JGVW O!7U,J/P)R72"=;^97:9;TK,S'RTJI=5$"IM'M\[>X_%#'E9
M=]^M-,OTT/M>J')0H7ZP5F%5LTSA\?(KLO&\F_2IUBFJZ,U,+^C^BF0)N#N%
M'ICJ!>]1X3$R.P+A]8] X!T+A!VR78TIR\&O"FJQB4>@I_.2BX@<XBF= 0)O
M+]V8B'Q^!"+R?V^NB1CFF34,D](4(3<WU LZY8C"A_.>7H@_477Z!VIB[_XQ
MA?[C;W@OV/IO^7W6OR9]'J&^Y"%L +GXTWLY+#JQ>X2B6BX2:/O@Q,O.VUUC
M]\ACYM-3,<@!^=[/'K7IOP]"0I\59=^_="FV<G-U/,-!)S!KTI__REX4-N*2
M7891WEZB5=FE<SEQQ^Z(2<2RWX_:X353,;B7ZTLMW#68V=-_OJO^6],;;ZZK
M6^[8&E_9>,?.RZDXVQ-U.2Y3+[GDO,"0"CNM5Y(&+V3-Y:/=]#N_Q?''N81-
M"U()C]]4)'.Y H94",T-*"(Z!!W03 G*\0O29,M7/"BQ:L]J+R?+/,7)BM"1
M+O+ I8]O( N%OBEW:14\\@=_Z$Q\AH$!1?1F.NDW,A%YG,'+Z&O$Q_C4#N!Y
M!@,7%1]2.[.@N,9(Z\' LS,N:\GR_PDL*GZGCSE/8R=_W1/-7CFP>Y!CT_VH
MGANCW#72_O!J6)V'L7*)SG1IX%B1Q23P>TE8X]-NDDL6+'U8:T"1N#%\(L.N
MPT.(AG"_ <\6>EJB5)9:6CH262MG>L.TAZ-XMMKL\ !IG6AUS_TESGC?I$^*
M;L3NROOTL 'OM<5Z/UCZV94(CS+]*SI,69N-3("0[D  .>R&6]DJ0Y9>>P1Z
MM!V/6^E@?2\(Q3+8Y^?QN-4K+N?0Z,SU+I4YEVD'4[$MD",15B/^K7A*&X7G
MG=E?0G4>@7 >1,$8A!I-95+0EH1,#BI%;3C65787=3!^[ULV7&=\7>Q9?11]
MX]J"FU*!9'3@$ !1__%M^A[B N'JS..+A4^,K_9??1LHQEJ^8V3]T>;,]9WQ
M\@WZLG#ALN"@A(]/L56/L&O8JV[WW4R(\D^_7=NPY8-B'@?N(#^REU*M#K]8
MT1VQJ?U/\SFFNYCJZ*X5S^7K+!*M)8!94@QVZFU5SS6I1TE+(+>RPY!A_[\@
M'?!O).4!,S,OP)G<J@"=FG($>@S#W;P%!!)A<7<B#<FAG=!X"8612M1N>8YX
MH!'YQ%#!9\U$V!Y7W\8O%TN<5)4#(>7X87+'%7GA6>@XR.J=K-:I9^<D3FKW
M'_X"1SX*#XP_XU<7V%'[+:@Z5_F;8QQ/G.Z)C=]?1BOCNHP4[\::>,H:OP\<
M]S03M/_N=4C:/O>(9GM34*]$4&Y J?MNQ\,,APBYB?*Q@DX=BP:9/L/ZOE6U
MO(S)6*,3@;/Z*?ZS3QC[^KU6/4DK!YO2,):OO('C*9- )54%V7Z-H15YGSFP
MO$@D/57/MA#@P1.AG<I<ZX>]<7OBDA:8F.[T>ZO9+<G)]1.HXJ8W8P[YHB^Y
MRT[5/'60/86^B/$(YOJC1M<Y MUNE!>OR_$,C/);^>3L>&.?[RS\(%-K]O>/
M7SOR.5H_5,7B16,ZEB0-I[K= ;&.K.\57\J(JD)R[WP]^)],67OG\SHT74[>
M\;TX\'=#0EDP)CA#X;*N:-8B?[A!/Y#4TJ/UTL9B(#]+U9)OU,+[D=.!N<1U
M%MUGU%][!(EWC&WDO8GW?<?">OZIU-Z!@X*_Z[0QQ$\\R1G\$BQX!/)UT21B
MDYM5B5%<%'.@C,S2@^%&L &MO*?62,"  SDD6<$NW"CG"W0@/&A7-I1_9K+(
M.=CAH<;F,]&"5=O0.+G>D+NEB).;+5=4T]-HKC%CC4!JK.K0Z6[KCI5W7@[A
MTQ4G]*).F-5X=4[;XC+"KM>*&6IDEW,MG"J<S(4-=C;;OO5W%6F5E^ZV0]T\
ME0S7J:HT'2O;=)/*</(/#>B8\/P2K):TJ9\=DG,^E\>S0>Z:)$MNM,8^X3F^
M -&5>'=(6P*S<H#MA-0*-% C/9%G&:=F&7T+[,#UQ=18;#CC/6_/H/&BQ/<@
MS&E/"3$?BY/EP<0GD4#WWB\GC_>7FG7!P6U<,6/-3P4$' Y?%VWZ.80UJLO+
MU:]5=8[<+N'QM?+4UZ\86RX"HS7/H?63.OFY3PDF9' 'P^4F5AL=1&!GG.[D
M)-K<';=[H5FZ]?:.+PX<&&TR=+5O._<O=E:2]7%2[O/4WG':$>BPK*DQ:47\
M)$_8AM6-P-41ORC/MJ37CH$%V\HEMSPDQ7?TU[/2J"\-2Y I*N%%+;LSNZY1
MEJ43KYHPC0U! <Y-P9AN_L:=*,-/.?4\#6+/WUQ1"0,7>&ERGU7QGW#+W>O1
M69EEPK%2[4XM#55+#Q?8]31H"EN-,G!*^90NJ:5W9KW7X+V>1\-*D6@6M8W.
M#OMEH7)O$?W6?I#+I UM<-#K-NR_:=H2->0??>S\KZ74$J299E):@WY8$-L(
M.9<!7\%E=>7Z7"ZN'.2/D(>Z9L=X:@UD7PWY':]J:K:&<Z$@5^:,GIYF6^KQ
MTUD1!W;5)@-,SR=7[IMHLXBYU3FS2#]_IA(%Z@Q4/@\RUI)*GGLD\>QO;OZ5
M8ZA!Y',(NN8()(:$@5.1W^W2"<4C-'V2:)M=^.1^(FI;LJ&5K)F@'/Q#C?34
MYR'G4[59;T]A5]W8-XZ_Z8LF?%PN@%[UE=[;O0_])AI(!T8<;E>K1V6(>69!
M]JKI5N\GR]@OG9L-:+J'1O,HJW7<E\XBKEM>*<M^V%H4_RI\@&] +G<JO*DG
MMVC</#@$8J9)I)YXD)O^QG^"$'1O'W(KM.RDE=YQ?^ (I,Q KT YX9^=Z:U$
M^K=FY4*X51N>;0OY\*7"IG,W0G&B-M,J,1,7,VV&+2_^PX"?O99=D"%F>?^A
MS\ 5/19HL 0=?IZ0QKBVO:&]Z;CH9].AH [U>8X2F7[R\ 'W)7?'$0J&7\%>
MD9Y_6:-Y52T75HDJ>G"UA@SCLYI>^J,C]/Y!B8WP]1';7,CR%G\=O5@$^?C3
MZ SMV8R46YIE(:L8\>T^,0:,.":=.I:,=]4A!>@/?]@] NUAY9OOW,F8RD5;
MJ.7WX]:/0*=&MBR5B<N3ZP.7I!:R\:,?/9.HUZ7"W7)7I,5!/R1*T/=$[(*@
MS6NZ8J^OP'_H)K2WBR$^I>UH#XN:BKGS"B\WNDD PS9FGC)_+4Q+J7U26W,^
MG\:C@G#TKB+AP-Y\S=O[M5.RN,&B<=O6Z$?5O#=T/#(.4Q$?4\$)1:X<0_ V
MUD->Y!1&EW$),>?1#B59PYX5?)LO>/Z[.6=Q^!G-A<QB1][8)W.Y:/1V4C3/
MSGH*.#VYKGMO,)!G%2:\P)^Z;Y9(3$8D//IZD]OOBJZ;^-\MO_"_4TW^,R&:
MB@X*1BHY1>:J;38__?K-%"?;;<OO)&M_M6/(CGUYXV,V.B7O-MSVV^$><FKU
MP8I(QA6'!O?Z?..?90]E;^0Y&L$:DQWPP2'TVTW+"L>T^GIOUCPZJ[-2;(S&
MQMK-'1-G_V'0.UL;N4JU0XR(A&[44@TB;],_J%OQN@(H*\#[P[\L"D=:-B;V
M4^V/0&9UU2FXA9T@N,^/-\M<NCWV7G77"?DW*1+TS^H0')H22$+VNCC_5TOZ
MN:#9..51/>)3_+<GI[@=/NI)J9X[;K>XHP42Y.M-^/5:/%''ME.A=Z(?4[<Z
M]C:@?G'I&:6YS' Q3]!Y>F'_]]TLW7$/\6#1GZ37/Y%5+@X* 9V]@CJ^IG=3
M1&R2M2:7(XQL^9(BQW']1R"7]/$8 .GD=#TW$)N[DG2,$871X0)Q=/I/^&@/
M^3]?B_(>3JWQVC&G5CF7_F'2%M61R#0O^>*L5>E'\XVNLX>S'VKN>(C#>^^1
M4RLO+S-VF%S7C/?K%<L-ZL.\/)0'S'+Q=_+&,G_1WALGG\F/$S:AW!Y5# K?
M$>C&^9"]7X%&!$LV;6'6 -YO#UY;?;N<E[?IL8]HXLK6B1B==/%"^:C7429A
M<\'G7CP?$/\\V7K[()=3I>1U.V;^0M7>;#YRN%(Y?6%6O_<G:B!X$+=V! I9
M'#6M#]Y<G_V["C""GC^GEH1&'N=H(^1Z:$G4]TIF>VGF.EO]AQNMK:Q<7MGA
M^OKHZ]>M-SZ7*5N,+3J+M-0C[C3T>?(Z8Q]Q\NJZT49,$LI:DP<N;K)AT**_
MRE6J?WU)B/416H][M\=RNY-,ZZ=_0\+6"V9Z*:_H69C'\WQMGZ'8(] 3*XD_
MV9>V$[>5)5--2%//@^&C7B#/-L7!WR7^(B^^!V7U1U]S<L"?MW=E4>KY#4]\
M^^UUGF=/GM-0GOZ2,:]$>*WXWNWBC%^;E71+!81;_(!G1[%2K9Z^7*WGZ(NU
M/B.52EM<GM9\^5"(I^)N1#!=C>>G%J=09 7+(_G[N2O%X9%Y46N6$7O;/=J'
M=X_]YXS6'*A/VM<^,'YW[2!'BRL)/%3$7?*LWZIX>?Z +Y=1VW?BDFQ/8&!R
MPZ=-Q9KPUF2$]%WIH(;LI+R*'+/5C<G-B/59C^*8TL)ARQ*#&"V*P8O0W?6Q
MK+T54$I\$GD]A1%78F(89"H/M:#,C1V!L'MK_XJ^47O[C(_H8>CK_[,L59QT
M3+KUI/]XS)^PU:EG1Z X3MFFM[O:*V(!@;D2;'JAE,_P/K9H7K)_P7X@EO2)
MKO-L369U>G?(+QR9GU_S2")>NA[TQJ#9'Q@17!^OOVUX_C[R/>5PM!47;[3[
M?9XBD"CS04=Z=*UYY/]>#6O?5D"ZBSRX L&Y,;K^I[IN?;L1X&-PIAV!+K-1
M;TETMHUXS#+D3H$K[R)DCD O$?>1'&1Z]Z'-:L(UPP$9 F%+2$N/L+_>6ZGK
MMP?.>WIJ-DK?$#4%!BZB:07X%Y"-_,@;1Z!QGQ:$Y:_PZ)#J^V?2T<*@\%R2
M+N5_?O5QGAH%UTOZ2]I>%# .ALS4'=B)W^19?%N'2.+=% N&0/_(/L$9+:4L
M[;'4\C_[?RJ.&P_H1A]7F;V;NI5$^!YZ$(]\.EZ^@L>5+P47;(Q3-6@^ +74
M,RM[.:O#*FY!AOQQ3&T_17?>9-4I\GN[-^L;VI=!OX><T+JM7]9L2R6;O63S
M12CM'(3R%4(R@\Z,=V49< $6A"=J>$$$'B,6)+_OXFU(BAHXR(:U;;/7YB@T
MVB<V.UW,UG<ZW$NZO;IC+,(J+P_9C&]#/2_@9/)Z?&S^:> JR;[]T.HY0@R0
M-(LQ'8V$%#H6-4,;#?F\-*OE7L+V7*Z/S'EI[ELH=O_<<IQ+_H+)@9(,>9]E
MHSJ5IY?,@%'RR; ]6$I![?9+=11.<A&;4-ND^Q]9U,M H_E-%%<G%DWN44(I
M[)[BT=6J>)B'TQ+Q;*YUH3':SVK+UX=<"INO\3@?."X50; ^9JBJ'RZ@)\OV
MU?CB#2T[<3]V_?I!Q"UDN\._GN='(#8,(1//5DES7(SP1DK0G,GW&%;/$&<\
M<1D5.D-5L"=Z\S<=)B0](^F:-^O0IM90R[1N=:*#V]O691 S2 *GCT=XH#'$
MJ68,(;4+!MP#GVSEHSDRAG1N1EH"_@04.$\>F:TVNKC-LWJX-AW68/"@6A#O
MH?(H_NH6:XSKQ][(I5:=$3;B"NW</H6#/+F?H#8,R(1NZ"IBGB-]8,_/2"?4
M1LFU._5>HW]F@/^T?U4_ L4S5.MJ9T[];O O-E:!1]BWFKY0B3G5EA[I6_"Q
MX-L1:-.'D#H;2O$"HJ@W@,L<:MUDQ>9&Z*O(J_X7+4KANKWA%U*&NUMY)[+/
M\VTV:A0Z:1Z[OI,OK37_?*_:Y\+W:.OU.I,?)R*_L\O9ULNU$=_&I+4OJ=,
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M]])HL+[**<ENH_Y34,.IRAR;3&<'GV9M\&S0],7QLZ./KJ6J&3JK'WB36F&
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MNMJ8EVN?B:[+.KWNFR6P?^7GF]D?*?T/[UM:'/-VF9<.K41A87\W'R/^!:L
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M[2Q]]/=Z9Y ^Y0N>"]R-HS]/Z)E0<-#W)5&%A7U7"P9?1SN#BR D9PQN@')
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M9B!2_&F_][R]MDF/:\+ >G.8R]S5S4G[]W:UYKPOY8>M[*7%OO4$5"J$F3/
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MVDWVN((DAA=4M#F<&:/>(1:FU)$S?4Q#0@3(#<I\)T^.\%\V\^+>.],PWB
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M]#GGOV)9M8^;;I#]^T0F>&QE9%*/A!EL-ZG6C$DC<?J''M"_W=3' /]=H-H
MD(<F$\]*S$X7NSR;IH)Q3<_4K;>_.UHI*6OA6@QJ?OT(7[J:9796I.$'FG+)
M-IL2@=YYSBK>P[OI^DG]&W(JBE!R,&B8"7-FC.:8((F/A0D.)]_+72]MDU]P
M1F+%/IUJ.WS%C=/]I312$&QM< Q(27CA.-SX4=4N#Z.I#+.\R1I?;5+OG#H2
M8E-M]21$W6-A+NLA2;&BJF+Y[0YF333ZBD:7B0W7&=S9=1V:E7>QUV4=@X5Z
M:;XMN^_R^)H:>?ORCZ"0%CDN=_%0RPH\*7L(,8\B[V8SV">)Q=BW]*:=\2&T
M!$4.%YD*XZ$%!I]%R&&#48@6_S8$L6'MIT&)/]="6+I:ZVGO//WE9P^UZ)$T
M.>)A)DV&B.Z%25+R<?ND8T!6<Q#[\,B AV;6=Z?JE /?MVQA-74%K/,#_4^'
M+[*LGG+$-@R-P3$8^-RRE3:8:D S^T]W52OIS=?LR3+ZD>.^^*_0M6?B1.V3
M(6V7LBZ#YE<C5QW'H)FO<2$Z4B?*;;/$Y^LY1I3V;/JPOX8/U*%'CZ85[#)*
MC9RJWJ/G3?S#;&Q?5C 24!EMW(G?==;K]%X5R@Q0AC4R_0\>OO1,[IU9)X?F
MF5N.5CLL_<E6#/4#IJ.);KLG8GU)X!UG/)HO5H_2POV4QHJIDVD!I1MQY%E0
M76E6Q+V5^9M2SSA_W:27?(N\).P1(@_\-N=:]#>!<?: .$)N(%KO-+VG!9)8
M"3+"J3 6=*PH:2)6G2+-FEPPL?M52F42_Z6[E<1*7LHYW>E;MCQ\S1F_+'^_
M.V _@,'..,FT+VVD_\<U)"[A:2N7$]YC(@43\H-+@"7C4! /)][&2\-[Y0RT
MGCIGHX)3-@+N2696;D$!+/GB47?0VEX>!9 L)E;F>5?&:]MKGFAE4)E8$VLH
M;#\9%23VC0KF>@2+,I=:V?KHQUBSM#NTUM8:^07N[XKP)'PV[P'&,[Y8FM09
MBUKB _I^5L98\=S)Z,[_(M%]*"P7NDOCU<0? P:#%VZ2-8\!B:FDV:$B1#]$
M(CN5^;@G)J0SM:=?:LN93[3D!5?-1[D\$?H1Y? 81H",K-"=LT[40QCLHE1C
M6@C%@LITD+U7&,*Q5RFI'Z#6V,-!M=3#([G^8P#'W.+<J!^.?E%&7/F 3?5-
MP;K\%"*_[M(SRM]7LV7,NSH=R6&,WDBA%^Z+(U%>I&2<66=SFK$?@6_;+;*U
M8.NR!9B<>./GF:]/;.VDM5:9Q,$.+?[+I8TFF,Y@\\+H6[2C(41X_XB[CULC
M^ QT)]9$E=\B[R',]&& V2 9D%L=;/[Q#/AY+<Z19VWBJTV!\+F7(:>AF#4K
M(Q3G06!22[366U%POH[]G5+=2M*?895EC9"_@QI&X@_F,PWB3.]_UAVTL<3A
M70^G/5T-*\WK9"?7'SVYB]5YA*DH2_G-1$DMH%9N@B95/M::GL6]LXFKI<J1
MLM,/?AD88T0(*FI7D"F-KL;!4J_?^G^[PH>.RZDJK0RI_L;QG<?S<]%?37(2
M_04(\Q')920!S28O32&#\'%X.#LEJBOJ0ZS^Q)5%PE5)ENO%#-G(:)ER-_6?
MJOS7/KUT#2KZ5EEZ3[U6^!O(#M[K\29^FTQD^FS3Z^$GK3F0S5<^=X7*0U?!
M3AKU']D;U\*23L4\F-VJI@D(WF#TPUOD[S#ML>\5"?D#N!,U"-AA#8P.<:=P
MS"2!"Z'N8);\![N\98H_Q]3SB5<^BV3 ^.KA!BR].!G;S>MV&02=]],319FW
MWGKE 5].C^ZI\86(+(UH'O6 %05#2R25[_ZZTWO?;S5G4-G2R".KKCBCN'+7
MLMT=D8!@;V8R1H5"FN Q .N03;(VI>QY4Q5B)28_,D,(EV^T26GEEJ,V1%#+
M_:K(:@]I;7KM^8NE_DEWT0N+P7K.9?>=KH,%]ZMI?,%X),&9";?@Y-Q_J:S^
MXQ)J_<L^F(CD<F@A"G:Y="+F5S/]!DXI1DFD_MVY]<VV:*^!FHONKX//E]GQ
MCZ!8R-PT7A"0N .<!T6*$+56'AMJT>^6O1I_! :-]2C2"P7':<+)#':NFC__
M'0/88%**)T:$KNK!9D3^&[+BABTY6BF))W[?II2BU)1&+CN#N3%-$H\LD_NP
MTE95D,R1ID!9OK*+(IDA_/G1]O[4<-NP[!ZLX-E:(V55?L$"3YH.+EHWRRMC
M-&S)@RLK3(]2;5NF>2Y]^+-(V\UY..<-03];LL>8PB]$UU^7/]FIZ&;6_ZU4
MZ-)K8<J,,?3GAGXDY0ZD::@WH/@8P [=QL7[_;$ZZNGTN5+049KT!B->H[IP
M=";9NGE2KBU?>9%@]U!=&GB%4EK)'&>W09AL/XQUAI0,_:TKN9A>9)T:]!$F
M^TNX*&XN >5P.*GHAEX1WS.JVW.FO]LZ-Z>*;TZ#>K7E6.AM; 93SC,ZW[E0
MMAGL:IBHW1T"S0/= DJ-M92-_W.VQ7KG5GO7),0AP.QLNU[,%JB=>@<B_QVG
M%==_XJ"-)JS6SY#Z <<4P9MEDKY$^IP^!J1?$0_F@MZ?67]@IL7-8PD/BA2L
M>_ZH][=J17-S1XYG>FRBX*<*!18U@NX]:*T*IDA4RM$N^0-*I<^AU_J$596T
M1H$FJWFXILNKUS(I!7)%U:W5+J5.@^P9 E[E/2. SUU:KT/JW/8TC@%."O=#
MIGUQ#JIWW]^[D#RH:#,R(S56^-F&/OD<JP *^-ALP,I@/P90 V.=*.%4*=@8
M'(CT5DLI0L8_H%3B$2S^#HX1$5?SK'% 3DK\A*'YY/7.MIZV=MZ!#YI#?J""
M=(V*#.GP2_9J\W"R!7, OJ2TX:U[$8L6N$)"^.F";+Q",S=?K#$=H;QO:3YK
M^8DH2$\W9YQJTOS\V:39)][QRQ\APKI*:V 6[#+S[JRO1'BO$@CSZJ>%TO V
M#CW?CX.2=<WLP!<EGW+6G@0JLXHJGHEJV.8WN^6N9'XV+:TC*.VY,7O*NQD#
MQ?=?[5D  !V))YNK&TY+:IQ$*W#RR&,=^?M[;N/IGT1VANN%\F\;QR)9TU'8
M7]BX2B?=/LZ[=N34P<=/)K;&[>3Z''!9ET?51;,TA3:]7UNSX2_/R=_WL>8$
M2Z;VS=0Y\I5;N37FMGR!L=4LUU:X<VB6MB^A,D(-P^C+*)9Z*+D!7\U@KR3"
MR540B@+BJXXP.:_-%9D&YW_R%_2P]MF;5I!/<WO.^2:+G#5X/^5ZG.3 HN">
M&3^^P7K'.X5%=S5AJ'W-&IM'80C2IIFF>O<LB'@71)']^M=J/*4,>.^CJ>_>
M>U-MB7!EHSO<HA*S.5@/#:C$H7JM>9E4FS:GST1R:R5[\]0,?Y'1ZE3WU$RM
MO:U*G]E >]ELF@B[TQAP9'.ZSB59-28?O'#C$6?-M+];G;.'!3:ZW76Y:>H0
MO1A);J-7@# (2"/K5^N$1FBG)?T-/ B1/ON'ICG!N&A656HT;D_BF-6T!J7.
MHDC/E!T'!\DK(S<S!H,&W_I*05<S&A$O]YG^3=:1)MCD.E'7H^,![[VF^F0\
MH]!%')JTV*<Q!ZGM_6B8C?##CJ0GAA-ICL;]#K)K'XTK.W,?NK]?;P%A6GC<
M?@';F-0]9DAO>GASA2,9SYJD G3L?NFZ&>$8(8;S@(QJ?:^\E[PS$Y@[O)9?
M?EN3YW+ D7<23CPEZ'>=3]KZ D[K2UOI [,+N0N^M/^JTVX]=$R[=0'_@N_C
MQ_J*&M&#$-'I1SS8,;&!!^T2K="52Y79WYLR8-)JY2GAA3.&"<,7V#\72&7Q
M95RLU+MRP:IR2RV:??:/[^I4>WD*)8&[V"M,S,E#TNDV4K'/9L@\-_ZEG!W5
M\D^+0[UL;;.]>?WCV-;<@F1\(8W/BTRF)%*M?Z'Y8*<9/QW4_>#-R!UZ34\J
M_E3\Q72<I>KP!E45PMN5D]BR-U8KOC!\_U9:6'H*O]?L3EK!?]2AW7!6_6P=
M:6K/\Q.Y>K-[/L> 4TNS-$/2.<:Y?_-'G*1=% ;U%4Y\_FM%DG]AH,D:T2^F
MG7:Q:08C<5J#WLI6_="Z[.8>GV,1(V_V_.]+K5 '@]@,-E'6>AT6%IV#A@*2
M,$OB"*6HFT.673?.X-$YM4$+M?BUI#,]:BPFW2[J65TYY+R76"D_^9KW:&/!
M P\@7MTYF>LGM,O^=OAM(6WAQ.J,]W\W,MZ:-&4H#INYA-IXC';*_M6:OFH0
MUGPH(KT]4Y"FA%.+4?WLUGC0"',_!@"E";\7>[9=C=*#PV'_RF">,!;XF0N[
M)@Z*;85MW*C)"/L=[5,V#["]=OXS^XE!7$C&/LWLZY#=HB3XVS&@18X )]:2
M;8C+235X9S4M.-_V'P,C0:+0<X=@7DK2&M?H3U<:(<@?PI/^S>LRV]ELF2-;
M>BTR,#L1W=CP##]+N_FX1Y%TM0VV 'K>Q?W6W74E0&_FD[2*9.< 6T1SHJNO
MGYPQUZJQJ :?,'&W%Z9%BB1P4P,#@((P XH\5/LND'.G!9AH)# MJ[DXEQZ3
MLK/N?E5\>41KZ47!EYYG-D7ZI7\\G<-<;2L5"_S\8N)FJ$Q4)!7A\\INY''+
M9TO%%K_!_5][E0H]P_I_N[-;E>&8AC^;>0-PTCFR"Z46R\WZ772Q7_6BY_V/
MZB>7;]U;(BCMI!_&A+KIZ)LHP+%$1ZY#80=XH_9@0!W?/?1<45KZ?2V.8T"-
MLM%W<V4\)]#JC%)S5Q+:YEE=R[F8.)-IHLO,D?SO.L0C]G6V:;R^J<@PK5ID
M4 &C?$>93<(O2&K:E/^<Q"WNY>8068/N4I[SDI_4)QMU3 _<02,,[IM[<R2&
M4L[(EG!)V2?DUP;)_ 9ZW"9QG,'^$U,:-E!DG<C0BI4D'7ZM#8K8TK>4ZV<H
M\(Z\;=G9$9I9(.'3KC[][[OPV$,%H'BRUM&(9Y3/>Q>7+2'AB*/$Q!WU%6>(
MZW">Z_)-Q525C7BG5Q4Y>JW73V5(Y$8[8N #QX#Y77,*J78#I]KT?@EJ9]84
M#^*&1G]55CGSX3]TT'0X6^6)JB+=DUI%_1&R7$0NI1&:, :XV(:5>AV%03]'
M-#>[.*+HY^YT=!!A>;ASW(3BOT&_SZK/+;N[@PUR^BMOPSQ(P2+G^]-'O>PX
M9FJM"P_:\O>GCCC:,CX);LIE%*&^S8>VU.UOSS#B8G?&-_41I"'S:X!+1[-K
M0SLJ5'\*'M>086!,-8#]*%)I2.[1AEX=LQA1HBJK(#+WT[UE-VS:,L$OFU!"
MW[RA+UWUKLX= Z!UB*EPW1WPYRV05')EJ'[?YB\FB6&9_>_H2*MF-K[6W/QN
M@,S#KIT\B$IP6U5\7E:SCZ'\NYS*NM_[6>EQ'^/3Y-^<_/]?7<< 7"$*>";6
MA\B="A.FW9RP<R/Z9"B;%#=L6BOUM;4&&&A?E+ZHT9&M=[98\?I?X^C3NC B
M?O;O'=8]-%49WGL%_@"1ZL%%2:RE-&!ID6W1PD/<J3T\$VL!(UT+4#BJZ$?3
MA/+C-O;VIC85D8>GBW7OFX[&,6D1UPMZ\C'@5V$VC9O9AM4T,O=<,,,,.5"O
MQY@X!HCM/9ME*!IO0Q[.7G^YC*[>'Q_]EYZ;14^19,+3Q'NO5$3N+"3^9E-)
M>*%Z?9#[TA-@%=/'#Y$-*-S$(;PU01B?S0:UT@<*,-DD"C>>[,&!%!;FDP3V
M'A99%3VZ4N%\R3O'K2LY]FVE>#ML^BB?&VT%6JN 'XDTY".]K/]*P0,15%T(
MSS%@L]JB!M''@!0IBL<> V[%S9CI%[?2R_>!]&CY=Y^5_U]U$T53*@,X4UXC
MO4N!NP"RD&?A&!R:AU)MS$0@(>Z_5GBG=Z]T9J<@F]6^(I)=1IPM+ZG$8<<%
MH&5.!YD7,8-W6TKW'5(EOZM0V]R2;74:EK=HTL> A#2:-J[;B\$V%%Y'N=$7
M=&,#NTLX1U3#636KO//+'4&MB)*NC-=N:1)8O2M+'&VZ^S]>?9<[=NW4#U8"
M&%5Z==&4 L>X:XPMK$S,6A,CDY0)A+JW6?+GDQ9-&C/OIUVZD_,N7X>=57"^
M]6K;Z*<_]HW7'(Q0#3HZZ^WH9+W\GL]$ZM>BNH_$)=<M#R[BP(XVCVGNXO="
M/9F,8>)P8OF3>Z@ )9X81V^4ZN.S&Z([T3ZL+\"?_MN29\'N4N0+,YDLXAC
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MFDZN(U7&>LJ)3OZV7RO3.KZP>\'GTP(X&G.&'F*\O_RW^X*UP68N\HVQ16>
MH=7*^O#1@M*H$8-MYW==M7$N&Z;L:IJ3ZL7'-X<,'FW&7\TI677\@\!94RZ
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MT@.__(E461U_^_S[%8@X&E0@$;CQ#FQ/YR.CZ1?=".B-()JE%T;@&. -3=*
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M%8R[X_N7"#DQ@GOP.>C7_6[?N.PE.@^.4D?B[H!&07G4$!M$//=;D-"H[IV
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MGI>3V%5W'CU%X9QO_H?4E>KU0T-/:N-T^ Q([1N9$TGGR:&(6)&7-C#D\?;
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M'<K*XK-.035^T.28Q&"_,V_.D6+\RTYW\=YB G"+7XME7FCSA^?:'&PCVON
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M7Q9.QJ\M5[;<*758$7*/^]/RJ'/N_U#VG5%-/=&W\6>AB8CTK@*B5)&.D-@
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MEN;1N]G.3TC1@?[26[QRK@4SFE>YE.2Z+VWLW(*=SJ%A]P/,:3#&C234BZG
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M+[G9[$<(TNK\@_C)>\/AKF@M0P]KF5VD'%G3?H\: #V'=*T!F<C;4UARC"=
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MJ^Z-XMP9^%_P:MRF E! -@3AI103L ;;G>^<POK11X_Q=XK'14255;+.*E4
M(*>%_G8)2,EY971]A/[3U2>.[]_4 -@-.<!@H:X;&V5[A0;R$.K81&P>10-\
MEY?)-Z_5\5G)G,(&PEXA!Z 3?WC8>9KM%ZZ?,0L8WY'T?M"FZ5U/=!?JU#K+
MX*EHISW:OK1FU#:*:9)$N7QI+=()&\\[KV[[R%;<>9J]2-7/5%R#->O94LP'
M93\Z0UVNF ^<BJ_</=L=1C[87O4]\(VI8#\HWWWZ>TD\RLW+!I./8:*<(LR%
MP2XT<P$S'0$O>6$1:JR$ 8G.-,UTMQ^<*9:^N8]+#+.8Q#Z*O'Q_RSQM:^RI
M/6FP5$&N[HP]/T1?7S5X;I-_!U^CS$^EX]A1*#"J,2@9S,ISJ4IV2?R0[I6L
M-6#85^>OHJ/OMC6[//(XCU$9\3@_=7Q%D]VY6\)2_L!.3_J=IKCX;\G-(<OK
M7W+';LC]O(U2]Z>^&1<P,ZH8WAVX;S8N\W349T#\^[+16 U3 >N,^2KY<4OW
MTN_..B;FEF8O7>%+_WWAW(0/XB-I"K .!0/?DF[W"C(=TV[MA82H8U0>T%]T
M;9TJ5SZ6.R05H_IRT /]U;Q7M(2,MS1,X-5ER&EP+BNMU;E\;T:K*?%5CU^7
M%TTF.-@YC^6%?/GZK,(\0Y_O=&AGT7=QP5&NF.+[+ R#LV2?WZ9&>>DQUL^F
M@:HRT>^(P$E=N2Z3F IC'P!\">6ME>.PU/DU4A#6,5H<^2HNRE=%Y?)&1MD(
M^NL)Y"+.#1X,9T8[&X2=0"H+WFWO/0=+2;[2(D!0+N=5-T5TE56_]XWF9FG>
M7[FO6F_&)KV-P>-=FTZ+"(:H91"QL/X][.)_Z^1* +:9? (YZT>#DS]2!\CZ
M5(8PMAI=PJO!2*?;4&*C>:,4C?E!3O.5Z1B_-+=%+OI$]= R[+5/2 C7Q/IR
M:/P5K5VE(R_J+(X.]O0$$A& CH8*M^:5@>E=>,='@-@;-17W_5D1DGY!N&;B
M;?,JR0"]DC_7M[=9G]_D^<+$MB6*BHY$B'&DV",\;K03*GSED,0;'<_6"4*2
MN16^2T_D0D5*S]YC3'?/P5P-_I!QH !7Z?SE%C%PL_G^IX4*98</#A_7Z@.X
M<_.8#/.S$>.AJ=7DYI$Z,?'TU_$RBA&_WBC=,U!S,!!7Z=L\UA?G>1['G9ME
M<>FZJ:59PB\-_L>:3,U5MY]>9F00C1LZM0G_^9)&459STQ)MG%FL8#QIG\HP
M19(C1&P<+P2N!V'8B!-BX\LV@JMO(TQJAX7+M3&RMWX^:W+5,._<2O"$?Q:J
MP6\2";!SU/8JU!B&GJ+@1ZKK@,(B[@-;2?D@RJ+UMT!\[-.FRB3CIJ,S?DJ<
MHRL/N)IKW@O?OQJ6/.2%$ >X6)]6--BRL8;EYZ39.SO4!TPB4:=YP@_'=1+R
M5TRZ")X*UPV+N0)'2XW2]QT"O?I3FYA[?]V.ZWQA"M1_+<NW"BV*[[(K7@)_
M*%X9RKN =M5EL8V16+C1(J7Z.,VYV$8=M0A:D7(('CV92EV\N X,[\KL[1&*
MS$*L;GO6Y3'Y&XM9HX](FG%7J,,C:5H/-+-&?\;H+<I7_#=IP1U,]U4Z2$L=
MPMT++F^C%"B9)Y#V5ES-;(Y=X1SUFRN M4[7)Q7$MDHCK1K 0MZ_>BS:]4ZE
MOAS []&:)JN:PTKZ6_NR _69W^:N"^7#:H4H'*.=)Y#_J'+FU!\GD*K>#M@E
MU+A0-:\V/8DKI%E8LG;:,2)KR6QCVF:KRH/Y!T-I*[@8>&."^]G;!.K0"&=L
MT*,32&?)LCCQ?&_X37G!6P@G<:!+ES4T]OH2I3B5+;HKT-SNU?L/'[Y0*U2-
MHCWU)+IAL,LDIFL_0-U378C&$\@3\DXRPU!!>+=.->DKNJ/#[K<*ODM!T )F
MSQOU$^\F1WX219$'_YW[E]"( S>SJ3\QM9B-&2)L<G^!+F:QK@JPIEYK2GH"
M_,GY^OL;9[_NF$)R7?C$SW6C6_<Y,X0#0Q1^1+,'BT"?'=/R\[.GCYM]X)-B
M;3AFBM\""X-2U"Z&GZ)1 4@1KV6318=*R]S2_A*ML@S96U\JIJR,:/.^42QJ
M_Z^9\=>5+G/K0;HD TA!S(^1HC<F$D-=CWLU+7<(GA_$QSHF+"WJGR3&)&>5
M#?[.Z9XZ)R;5Y0BSR904/(<:%-B+X@!JRN-_C[)%8/4S \R2UO5L FZC0D;L
M>81Q<#P%/6A)40-OTWKG"':3>HD&;^1E3E&[X1?=<2^VWPG>; ;@-&9QBFXZ
M*-TMO6\XNEGF+N/^=,2AFDWAC96S2$U3VL//]:$><8\VC;M^H]N]=_DPERB.
MH.G\W!M!*=)R;_QIY)-ZT![ $SS"I0O&%%@B__P8$%B.=)=.P7\?JBYVC0R]
MI*WB<^GA9QPVC\9GR]&"5VMX+=QXD\O'5DV[>^+L4_#FRD]* %+6+1.2<1SO
MN/WU,?+/] +N!A/#J)<[)Y"%*Z^JG8:*C84BP_A-7>J18C7]I+&\Z.)[,9Z7
MXCAT0AUL5*7T+T2E96YR[FEMXPD:J+-(/AK/+3@!E >DWHZY&;_Y%U5' @A<
M!XH/T_7D=:O(V)\)N_'FT-FTJSHICPO(LY\?ZBG._OI9QY+L?)$(]25Z@-+H
M'GA$R ,00Q2:Y%J AZ,=L&RN"5.@-U&Q[JN!J]_7E2IK;KNQ'&!A4EN2K8_;
M-2QX[>%CK9J8$(4:&+/R2)[V8PL;,:BY?JSV"YZ7UY^-C7ZP?U-&$H^#8D5$
MQ73IC&HT./RXN[L_Z7;%L1;HF1T>^PKZZN?!-BC(-<+TTG[%!U,N,P;]31G7
M=V'*MA,TCQY0;,!, B;X!,*LYDUR[1G190EM%00]#$FP2+'J&#WO"TEYG<N_
M^L\_*$Q\'G/I8KG@<3'3/%W/">0,:D2(KODT"4^H&1_??D,57?$$0SKP7 G^
M7-ZK6$]/%Y'ZNE\=-QY-_/TO>^:-1#?U!G5HCA%Y_X@%L4Q.K1EZ"96@7!UK
M97')@L&9762%G:DRP/*DI?-NT#T>(_,?WIN)TXA%K<?#Y>*:&OXL[=AI7#NO
M$(7M=CNF!MNY'9KF\;:9R0&(6NY%"8+JV7W,X:G9J[5^EC1+[)S_6EGE*I+D
MW^O>E)T1+WXT^2@$(\C#*9UO)OZ^OX))B%IN_"W9V?1+H>2#0I7F5G-_F >_
M53&/P72?N&SP!Y&Q3;2^_]+9M)$(_(JN#+4MZS5 "C.+],FQE#5?LI0E&] 7
M:?=.S649N[A(2QB,A"3M&^#QE#CG<0II50BP'N1&/A]2X_$X$J;VX"ZBG>#O
MN&;YH%? 6$*LX*$>3 /@N?"]T9]TOK;4K? W_9OZ%-DEG01EJ-5YMCT8A6V4
MRMA",)BQ[[%5 &\O;(=;TLA2*"[K3'7JXW$UMC)=T9\87U<.0GE]3?G8EEUU
M5I#M"$'4?Z,[O[L*7IU;\MEQJ!<,[&[0Y^**[W%P2>9G-\,_K4"H3OX0@#EO
MM-0*G]5L)IDXZ;N02E5E\T0:QAH4E,MM+[^J=7C7\?3F5+R"M<\7(%F0BT.+
M(<HKOCJ6E_O[6$Y$L5720@%CG'.9U354X^F,> ,X&D\Y-,+_$=L\IG& ,FA_
MQ%P0@;S"%;Z'CA;BIW@+GD#HD#> ^L3 _DC*;AV7ZAC9V1>:_/(O+O5\I97L
MA_<4K51LQ.X@*+7<#0NCR@&H3T<NJ$[T)?2+^-/@RK1,!,51="/KFK8PKCYJ
MFNDH';'YM*YF](N<2)W<KU\:(C<CT-<WNQU27XFQO4 P(C:NP?7+!$M<)CHU
M6V7H[G/%A''/YCT2/-<2@"@QL<=*EN^Z% 6EKSA_]!P\[_#Q\%,0TA?NJC><
M$YG,+RC#&M9I4H*7]%3^SEX0D:U0G6Q9ON0^4M6"R_ZLK\H:-T=8MTBKS3N7
MD+<6,$"LM%RU=-O*\WZ[$^W*YR_M>%LVN)]=K]I/9:_0!W;1:?;ZL ^&%>%G
M7#U>+?6Z8]!L>,^5X6QW2G;^[+TJ*YN[XA3L>5)C8[E:2*+J.)H#/KU*Y2(I
MY@0Z-89E1D3L!<[T<SU^UEI7/;J<%JBB32?AR^_&]E^NV_M@B27G>ZC96 ;C
MQ/2O12:Y>*D7!P0&X^I$'2_W@29I5QNGX3V%/+WAK*MRU<(:IF&F$B/PIN70
M3;XZ[MPE-_^42  SI4LN [6/[)%RK2 6>'9X C$$4FA$= G!N4 TK.5,%9II
MY6B(PYO&/!#HBU)Y;LB7R!22^:7U(_8[%A2+W]0 L L%&YXD(:)C!\M;5:YV
M(490;H&E._TV+B*+/VKB>Z\I7DU45;&X##:YZ;80M6WS7C*I?[$Z/=PF(PHD
MWJ-QY\8:C&-77:ASKBI^(YN(C1,2\O!0J/J*E 3&=T,,AGULKBX@H'-^"XXU
M5CY-'^^,*&0D]-A;<\]JBK!4%+=]^@-3^/GJ0-_X74[$]XI^NNCPVWPA!9(U
M TKZW!O/UPP[-409O/%_PCCR%LN2P.]JKDE/_VY@6--?/.XV&[AIW$U8>UK^
M,;]B.$_")(N+@=<+NY5?JMTYK4V1=5G>5='"'9Q H'O@62""RC0,5)D"F!XF
MV+000>L=E1[I YIZ.SO2M2.RUKLL\3%[ CKSDU-.K0(IMQ^*-DR4;K,+&(U^
M8YVV^):J*]G Z.]#,Y9(>03:D>X3R&^/K%!=6;>/,Z@<%-V6&H,+R <3>^%C
M[GPZ8U/"Y1/+(_95YO-5H3JIO!E>-B+DU_TB6<:WWC@C''IDL9$=_==/("[M
M1?V3NGS!<$N:>ME)L4%J[,@7*==)LM1%XR20?9]/()'Q':S9$655JABS;AU9
M<D*[O=!XGLJ1<B=O2_1A3,/"6&OUJH5$=9+6KJX&4N/("365)K21=*2"[M28
M1@1!+R-0_M6G[<[F9Y-ONP[(=4F=MG1E"GCV/OV^JR?')-10BE7$&_Y14))F
MUASR$0F:5(J8(9L>OX->00:!9O-N5W^N+RAU)14.$ 9.=Z9EE =]H4Y,S7XG
M[%E)7!2!U\Y(;#$TY,0G\_O#SGA" R,*HML<=I?"4\3S&973P!_7+D3U&#^&
MFR4_L@F0-<THX!XM$.,QP33HZ6CGU"D3]?GZ)([-!&)+BDTZ.GD+"<#'##?X
M5Y/1F4*[(M/TW ]6F;I>'4I>SN;4<-)/S_49/(5:_4M@2O@R]=,)!/8#3U O
MH' )$PJZ9$(QYWUA4_L$EEB4/'5$Z)(#KB*:_'KH:IJZ1V=C7+Q,0I%VV1K*
MRFIJ5>Z[H![O(<V,WX]**F[2!QA,;E.9SIY F.K(X:W'R6AGV)OIY8T*4MEB
M9/,5PC:K2Z++>T2$D:G4M;=24]5UG(?C'1$I/;-RGAP_;G[O<! _-5(0D6%U
MGRZ^NU^\2$?E6:F5@+YYAJ3GV(I1T<;Z0LJI\<-?0+EG<H5\H4Y(J#]!2>#1
M"OBVHZ;"7))?[OJ8?T157FAA^>2[I\N6N?;B/J(Q9+AI^#5]P_B*3%-3[;_U
M139"M<OOT8.VURDGD,&#U1&<O!I-E9V]6 %H4=C9VM'E'W L[C(>S38$ :%N
M76+-6,QC2V;S7YN5JDYO0V-9IDA__(FO"7]#X ZH(1QG#L@,W%[H[?'?3<43
M_^WS=1'Q4X]'[$C"I?CSE&X V5D:?Y&GX^4E GGYMH$.\'5Q*I;WDZGJ1V>Q
MC-$\M1H58U<VS19T\4AA>N9"P9.A_5]23=HN@2;>S96E:M];)+54OXL9\<1D
MO&C%2BHH6;9 35+EBT9#<P]4L*X2&X%B[B>0B3<( ;0@+A8I#!23\=5@^M%_
M,]1?AJ"XF^)/(D$:1WJ $,#^J!*Q9*[9ZU_%3 L:)8XR73-62OJ[+72E1V+'
MJG,.L/X=2(2%0/DTCB10WZCJQ]E0!02F<U]0C+3<Z7'>=N!<,C"G'V7QI:YR
MK-E8ZJNEM6L2_<B:WFT7-<6XRJ6ZLUC:A.?7BRN*B^,[33_ZW?,$,N4?9OFQ
M1%"(.:3G^EA20637,XG1'!VFR9_0:5,.NNN%.SLZ-PZ49Q4)):?;FO5O8:L'
M;LK^ -@!T-KV*BWT*IWE_>!D6"!>(^9?/!H3]$5_2U$/,]3JKQ;@O87^=@)1
MSA$6P[>@%%%M-"UI!KM G3B!<% ,C]21)J!A"6H0+=2LYIY7#4@W!$IG>WSM
MM&]V47R_=FEFNGZ\A%+T(G'@J=/ UX/5V^=/;\"!QS+@#5P'?!*F/R3/?%][
M'"6*?$GJTA-[0^4 7<2R:/3_H#'N]W9-4>F3!:+.:*><%G/O5$&BQ3V9#Q45
M'[Q-YW^*=CJ:5#(LC=LZ*Q\YW&/+?O(!&#=QY 6ZC8LDY3HL_R;[6DVVWU#1
M$_5VL89W)O]U:=CUIB^I_%"@F6<QBM6IEAA-C"D<9#*28-W\5<H]0G;/<9=(
MP.2;> \*'0=0?7-I;#*/M >URD"9Q\<5Z*=S[^!5^ X8WP =V:_KR9@#"4+]
MV6SR5\'.CCG7L]OM8AK/5M@B&<M1]^GRK_YR*N ,YVP56$>?=VN]M2HH->++
M$E[7R@GGG@;+F K3=9(Z!U_(3!P-/BO,G?&Q4%3MC_QM^NX_[RRV02^9KVJ=
M#/1&/?U3!%GE\YILLIU/2O+ZQ-DKE'D_1D&G;SU)EG'Z*MJL]<'SB49FB67;
ML[5 :W8[8[;[0A%=\[+L3M_%7>HJND>S#4<J#:8+ZUL.DO=VX_QWJ>@Q(_Q.
M@3]MWGT#<TBWNVU5A"KF-A1(;.0HT '86Q84)FU89C2RU@8/YUJM=U4$ZD8N
MU\;W^[US*WN1G-,F&_(F*(1L11N6:00+.9^&5WX*!!CL$&)'>%B0H.\0LS)-
M))%$9SR4C62;TC"VZR0_]=G"H^39"Y,ZW(>9YE[/FU]C,$^PX13[\(YGGC5>
MA4?G1;FB>KSL7YFZ$JY?U\S)4F+6916?A/NN\I:'YFXE-CKM%"*2.I1C],X+
M\'\OJ.DVB^-B4GGJ^2H[JDOI6W9XETDVKW)T'PR547 F>:;BZ--#371GQ6$4
M9? 8!YO/QS&B[7"@%E+@6D0I#:)$(H(R1T>Y!F3(6;ND<I9136MS2OH]V$><
MTX(6UT5K,K]%V4FN7JV/?2P+NO[;&F(*:0V:$@W.3J-F<.6]71Y3$01,[.)#
M^<%([[5;B#0^>,T&IV5XMK.'*[OB]&/I4G]O3T_^6M)2"I==94,Y/U/75/Y_
M/'%,T@5JZ@C3K L*G@@UJ P/+X-*_ZG@KH4;"Z0$ PU)==XH/4NE  &+"(%7
M6Q;Q_B@Q ;.9X2+]N&L^KQ EFEP,JBG5GO7?Y1W#.]33?==&ERR_]WNLF%^8
M%.H7*KM./H&LX[OAM;#-9,+<E =9FZ2T:??%:1CY&)A-<"#$ZFJ.[@9I7XZ
M5Y#TL^T='3W=@BX]*BSFV/!>=KXL(7SVJ>=!=BDMA7>%7D7>6R;+'<= +Z/&
M.+-X@93,!99WU,O#-0P^\/,(L\=-E7'D;9V1&N=-'@52;HA":[9"Y4'"[WL
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M\.(C$R249$/.B!>C7)V[4/:'A(ORR.2(#.[5&G[V<?#5XLLXI:R+?V]]K5
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MX-P]C[)/>&_PB"A2M&>],X%+&02E: 'B[9$!R$7^<IP&FR^AH<P@6$V;!%_
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M'&#$,H,CFQ_'4^DHO" /C7RO'G]!NM$8O(/*.+JY.Q<YRTNZ%N_J0.(1=2Z
M2MY"VP^HC[JXR3[=YU*2XM>ID.ZZRXN*0PK1V (-II++:*/H#X6@>F"7U)1*
M$:<7TJD#AZ>=;05)U@;9+B@NL(#@VF+P&!BH>R?E:!;X,'M,4#:0/5U'0[Q!
MF!O;CYY<IC*])453&50 UTY8!1V%O8IL!-9E(Z+GLS#^!*%P.+N/E#@U"+8
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MP]\YW.] (0=T^_V\,-S\GT%0]*](154/27)8V#U9H%FLI%K3M,>$X^</,IT
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MW,E).J>>G'TPXB5QZ$PCCA)0M]L6^F__.NHTE0F 1?C&<R%P73B:HHO?15\
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M)];0WVE"G Z#KHGNV&4+[4<T(K?MB,%="W5_.Y*8-\!L==(*MZJSC4:TQ6P
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MX^<_<OA@P7R8&<63+BGRH23W9I/_82FD,:D3&>LH3>NQAM:C2BL"AX@.E9R
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MD8+4!KL>\R3]J2MY2LBK*;.][2QS\!MB(=+C$_SB9[_B%3K^_QB6,K7YR#)
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M=2%M12<3 [LQ]EO3HI:SIZ#6O\GI#:,4)..F 5M4&UN9[N9!8;%DZ(KJG<F
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M*RV]PAC["701Q D"X7-UCQ:?'?W/C\EE>6QT\\S:JAGK94@,W52SYZ&2_NK
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M,X :-N6]\.<3P7/DF-63H]U'HOT21I\>$N/2H>HM,C"C@X-7PY)NOD^) V>
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M*-$"[@_:VS>H(8=?S7/SUOZ(+7IG@XC[+2T4Z>>JDF_-$IRX=](Y/M>!+AM
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M[MY:5]=)0F9SVY>K^@O9MNH&WW3,[=.=@-VP7KGD?YV*<?]:U-E2X/\B0JH
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MZ@-LGA=6RYY'MI@FR_<C>F'3Y?^ZGNN""U:F<)D%>-L^@F<6CL9M!#1\?(K
MR5C/,T"2]$$,Y'HV[D];])<.KN@+I$@D=\6$2'V:6;T'Y^_,KNW*?D4&R:E
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M#K]V..4.%RW@Q79VLPH=/QJ3AS!>[15E%9<$+;&PV1:B,]X[@JRS@KD&@9*
M3LM"C$8RB)C#0E+TLD>+IR3UUH!?>8I;Z="MS>U-)V/QS^A .HOYCSYD)*RC
M2O!.;0-^G7P=O@3J0L3Q)O>8SG0MLW8/J4+.3^VR&7EX8"Z#L[0) O/90Y$1
M.&6)RF/.?6.N+#ZO,)XL'Z7C2AJ8_6N@YPWYY\^60!W#-'A%G!H#8R"F>-LE
MH9X@?WOUI;:\,ON_4"X"+!X56K(5> U<T)T5_(HX^^%(4) Z -N>_MTN\ZYG
MFJZ#8; <K3<6&(I*WA$B!E!:T*^\9]MVCAZ3SA%6VH6N*55J#'M!-(L]GCS
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MULL7$#8D*-H$%$\%M/%/?(D#L8 >$[N>H>+^ZA)QWT9\56]+C#%&"Z6"\.[
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MFJ;&^6O#RWIZ>\6>"9?KN:^!.K*V]_$TPJ&'AW4@+O\%U;'BA)=&$H5XY?S
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MDS\S[F/N*,W(Z]9F3*$%S@E_:PT33/JZ*8,]2[XNYI52XF8T2$G\>E]X,&#
M@9+6TU.2EI:=U?!*61UN6Z0HZV)+HG'D?<,W$$RAM &:Q%?"J3XBK4EI$3Z0
M2]/[[.T3> %'5I 8:GS^RT;*L&+]3/X?3#(6EC6UWM-EV S :I'?H4?5C%S"
MM!YRL<GVF,O<].S<-:I$XJ9#2[:UP3?3"*73<^Y]=U!YUA6INPU6XUN=(3VC
M#L,1TFI0R[&3F:LV8UN#[S2VF,P ,^_6ALZFJ.#:4RA2MI*'M.014Z04?)1S
M6(7)"_F$$5DV@,5I2W0I8^*:5%YT*2X :2X?QQ;IKT=E_]@*ST\9SP8T?)Y)
M#B@>?AT46]-R(&.;.]II5K8S4+(NC@#(PZC\% \W)Y-3$UA?E! +2DMZI-@U
M6.\"-_EQ:CBX0E-,0-CSY9G#)BN?'<S^F\Q-)\F>^/H@P-=([N6OUC; :%;C
M"[WQ D)6FF]E?$A1V=G(47!EO KKK9SSL\*F82DU<&"YN$LD+8S5KIO(D[HQ
MU\*?U.>CQZ+L=U/!._4.G!L,&*U*Z2&+1M^Z^?[-3:/ZBB%QQ:#V.783T,GT
MXPPN[-MF@OE8MX!A(IH/R.8LJTY>:1VG_M&VTO]Y-5M[_!Y5-F#K]?+I:QGO
M%-H:[\GS>!W"RJ("8*F1\Z>X93/*^31$!*<4%%?11O'H RR[]TWH!"-H6!@Q
M2U@Y<*?J!!6?61@]HUZEZG7U3H!<'OS:QD:99988]U1?5+=R%X@S"6Y8S*>B
MF+>G5L#2)J<YPRWY'+WZCUCZT:; W:-I$:A(X>46<9V=<W/S[C@MS9[B>UDG
M.G-T:#T=B"Y'B'?&?H;:_];QQ?, EXP%A;%.T\$)'?9D2)+)B0F-BK$WM(.)
M7VHT$$JE<QX6\I5>"AM#2)&3PLS/\V%0#UP'I-L%Z5.\V(J8/?=ULP.3""1*
MM$5LL P&ZN#)/H2BQ7%V0^]EN,&KD5\U9IOI"LK!6NL;[I>*Z9D^>3_U\Q15
M/_G\5??J_7OPNNH[[Z"QK[]O[&[=.I51MI;+(W-+)F1Y+#1+I]+#;9?DRY^G
MN#@7]8<G!/1E22[3'.6Z9&1.T> %#&TXD_2D%!:$9*Q(L()1(<*K!@^3*@I3
MCIZ*@VFKI 4]++#?.2TLR4M4A]<F,!83SSF]6;ED_'!G-3W;<->)E,62D=2=
M1MW.L&%=Q9@443S -UI<1"5-Q[.MC(3/Z;OS>IO=>V 6UJW]5_R(SS'R]3V0
MRI?8!APJP/?X?;#SK9R5FQ$*$F%] OTOHSS4^U=?F;]"5?T]XUW(!(=LS(FZ
MWWVGK]=7&E"F[F"H4VBS:AZ;-8)-0S7WK]71-#<M1[L4$4$TW:2($W?=OGC=
MUB[TN$RG_F$4NGVLJ98O#HJQRO62%[_PUE0UZIG$:U7CI6ZD,<VI%R4X!6 ^
MR2I_1WB3.J^"ZX.0)\95MST,S&X8366,YXQ>S3^6QZ_=7C\D<J+^=+$*+8SQ
M;UL*+60_6!SB2TA B79!_$WD !P=2FYY% Z6"$+J37985$TO3%6D:+V W=,Z
MH3XQ0+U'W<(>Q8<Q/-0UT_\SWRP_.D G *<?M;*+]T !,."LWUI3Q8I4;25M
MD&2>M5Y.*VM^$RG_+"#/4]IBPKRA:7Z"T2)5>O-O/D'X38$S.?++C2!JZ!P8
M)[K1)5>)F^X*2AO2L^N)R@D%9$RD#Z:_48W^9%-^Z%:=:)#I2-79>>V17U"!
MCVB-WD665V_CINR)S-A<'[A[0RKIIDOP]3,:0DXB"3GG5,X]"0VM-#O&IH(C
M=X(WOK2O%*"^+^#1F=C#)@?]P;3G"'<@@83:%Z 9A?5YWBM54Y/Q[2WMX(7^
M<A>KTS\"-2^?.%+E=[SOY,#=&4D+"I*7,X%JJ* *AW@#NG2_'A/MK@;-O[LV
MZ,INV4:Y1_NU>Z.M<>8H[<9+<=ED/:GCG^<H<I#/OY+H_8R3[(8]T#WHS'X*
M#^OX("6\ (5;. 1_O-2#;2!T=YJACETB_38R//Y\UB/0=$O"+WORYJAOL_4&
M;O%+);LD@H)]FCK70@WE<J8SX$]"M$E&,C=A4$18? ]$MDL:H%SM*.PN4-@#
MI9]IHG^+BXJ1"I2[6>B9*,\\6@0*4 \?57%;.=]J\=;P4.RNB:C7Z<I%B8)7
M5K)RF"=E*65I;YXS/<5+[$6?5*2_>8+)6F)\<\PY.XGALTF0J@^\V:0O*VHK
M>OY]1P/?\0WPFH'>S OE%P8?BZ[YC>>J7L'=ZAWN>1<C*JHW4&80@M@^6R:/
M44#],;-XFZKDEW>-_/B IJU69AV>[Z2:W,"?BU<S]OGY?MJ??9\7D]5AM0<Z
M^!\[HT.!XM\ENXIM!./:8<>M_LT;WR3WIH[ZU"AYH<,AVF[FA38MS^0-?5Q"
MG+Z<>E)H^0&< Z5QZ<FL"-FFDRF-'.!&0*1R[C?G%+M5NU.Z)X^C,OI'H7%L
M:]%:IV?]5G.#3OK[0W6A86$^^F:'SMZ*\J"O<#D BAB'_F!31'N.*Q#LM4UJ
MPZ8C3_X 'OQ@V5.8ZT(KC.C.]90(:5BCQP([\1M5:SMO8N.A\[.W=W.]G%J/
M?OO5Y;:_9_JH6RZIP5/K:YB[S 69$%W>1]UWIXS4582Q#8%L)^GD7B/K:*TW
MEGD*EMD5X@:Y4@^L\NU70E_9H7^Y%"%:GCQ@'576.V(B+I35YPL4 -%\SE^-
M0B5<)2(N%[E81O@/:.O_S#GNEA;DS2!<HHO%DVM.#_;*2DZ$8X_]-LCQ1!;5
M_&YAM)7GH@X_3"EKP-;G!;F]F+AZUR_1Z<;*BLWBZ8XDBB)5GR;(0-7%K'.9
MHZC1">+CM[H>NHX3]T;="_2O\6H92%G.O/H@$[]4UG!UGR32%,F'ZE;<1DLA
M/T-:8%1#+MF9G62%15*@B1RAQ@_T+-R5**W1C--+CM>VCX^JWFE[*!618["_
M+U]'[-+M8 N?CV==!L%76KFE>0O!-[D'\H=FHJ6YLJ1T#R3-XJ6[V=&1&-0[
MEC*MMH823^*A13XB%P<5.K0VM8]IK7X)J5;M":#CRZJ;-?LE<S=-/KD#5^0'
M+PP ]U9U^SHJF(8\A8L.FJ]X)L)4*3POE,-Z+N=)5;^Q$G2X64E(B0C<L,]Q
MEU/Z 55V]R[\]5) QLPZ__8>J/G4RSOUU=_TR]5(FG,M(G$A$B]MA0X:Y"JU
M/0L2'!0,N*G[RZ(?.I45CVX&K_73=XG.K+, @0@3"QRZ<.5H"JQZ9B8H_^9I
MK6K5QK0OM\<T_NNK7@M^DZ-<=?[4);G9#CL*ZA!PYMOH#7I%FI$VB9^??7G!
MHJ&3;O.Q_+=.9$$9Y>_# I^R;Y5AP0+?WG +6Z'IE?KFMP75T/90:&\2%?/O
MXS0M))<>L(M8P=QP+P!5L!)6*(W01SC@CU2GH9]L0X^M\.LF-,4^&.&&\EAS
MW?N,ITVEIHU]S1_:X;6O.\,T#UUO6>-AR?C 3#!,,18X<?).H%06E9\V8:QC
MW]T\KG$3WLA\X8X8MCVX]7U0YDO2Y;*Q1- DQ@V':!<MIOE*[\\:.A<%$W?J
M\RHQVM%(%#\W&'C;1V*RZ)Z6,E-Y['V867C@Y0"]^3_+"HLWZ"):N)\=3BE?
MSTGZ*FJ2N&SI*BF'4G7GOL1O[U>QZ0%W%&VT3^DI*-PT*M"^BWF(;&8YL%M0
M/AJ/NTXWT_)[L1F<@[2=%,57KE_>=F%@,:B*N?,73XV_KH]:L'JZ;E__]W;L
M$WWI*,S#41,Y%F0"<7;>> 0!(UE?^42?'D1!TM6TV>JP([/35\ OU?#SC2V*
MMDV9!V]/"FCW'+Z0\K!8A>Y$[&<=PS$NC2./ &%.[+<=XM4(&V"'G,4_NPH1
M0IX*Y&A,]E5$D6/-;5UD*ENZG"O2;)Z6ZFRXR]<;]![!Q]\#<\E.MW275/F[
M!9H= 5!,PDM/<_,A1]H#I=KW//W]?,XV<'2Y^#QGQ./!A'25BW#,M1"UVXU/
M#I_@DXBLE7PQ^3*=%")4\]RW]>MSO2'ZBTQ9/-'_UZIH/LG?*]09X:A *DL?
M<#"ZM:)M4RI#LL$V1)S2T]=;(5@)X-W=S'4&[[_LLWM.\E^:<G= U#M?]SU3
M?CK!5>N4:['T>7M<S[D(_9%7RP;%0Q4^9ZHY>>QX5'!L&#F+=5R:\9?6C[?-
M,A$:ZY(!G%QI3@G(?0'B7:=IG*+7S2^U\3_KIP$#H@=./$5=W??I2[^FH/8O
M5F^S!Q^9T,<A?K"D2&Q+Q1-NQ[Y$!:#%9A"71A#[:N$A!(:?[8D ._@5]]$(
M:;-$E(@[7 !C5A896=%CVBN5ZMQX[L.F[ U]<!R49KT *"ZMH2FVP-DL:@/1
M]AA+)V\3!Z[/RC+B?X_@&5WH->C!Q%=D!F6?N8 W>K#2CQ Z9Y"2Z^0%5:OG
M8\/(@_[YG*.JP#FR7N\PYYN)2<K=62;AC!K?Q63GS8P7OVW,/;?7_1#&V7<N
MS&TD"5+J6J6B(@\Y?J5K5?E,7;N,&7_P]81Y0MD:733*4:5HH#/$V2;7;,SX
M/6)]Z8'-:<+9GRXZ<B:?O$(W^D.1TJIEKHD04>4<Q>1^A](Z[:C*T9O.00J6
MA3G+WW26K$@0!$>.Y0@$TV)P]4 [.2NC0Y<8^Y^0:E E/,NA<832EGUVWK'Q
M0RK9>7Z7ZGV9/#/NB_9U/G7CVH9M(K09O59%1UF/-4'W(2(!6.5,@/#QL:YI
M<K"&66NC- *GE3?3A"]=#6Y1J+V.M'QZJ]48LM_D%$(MC<-7R9V' 4 +S9YB
MGHQ18!=![@H*!.@Z8@7#9U>K@F#'W8,>R N&ZC[MD=#6&BOVKQB[ PF4>J@V
M#O"[0&@.!$ .NS9$,V38TI?ZLZ8C<088G*TXR[ A<;77P#JQ_7V@CJ<>;9S:
M*R;NZK/.R!T;XID:PGDD)F=I71V@E".^8AZWFL'3GY\F-'R=W-\K.78_A)_W
MT9O40<W?E#ED55+?M]K3N5&35;SV#W+U#,)_./^8#H- +U!LE&Z%=:R?'-!\
M%2EXM^D\OY"JHZZ0.3B]^.CYO-.ULD7*(F52-P('"P(&<W]O6^WF#F]3Q7M=
M@VN;2%0WZ\FMH"UAYY49!79M9?D\?M[*:E7)MZGX?'K4LX'/MF:8/.09SCRV
M'MR]!SIN3B2 69$TV2RR_?U[?[1:F^#:DEM,_(M+"N45[.))_@IWG-S!8OZ^
M1.>CB#%W*98]D,"\!;0S_GV>!T:<FD!*+4"26)%T0=P$5-!(CJPW'$8:S/#P
MR5ZR=[#+?7;O5&NFDO=?4H 1\/G9\:P,B!]A/ZH;5(T4@@=@_1<RQ, B''WX
M\^M);D )&7LLT!/2-*%(]\0<B8SN*UZR;&8:K99[=DS402\,&9/?#H6=\E5N
M\T&>N$VR.O>U(1)-J7\O.6$H]^E*XL:4=^CXZNV[7,:5G&#Q7N^>BF.Z?4Z%
M0?Z3V/%(?6PRO"EY\(.D_9=S4S-_;43T^\<(H4WGX ;'ZY0U,\4%E<.7'+M.
M;89I#^0$S-B^AWQ8X 4(/<5&W]<ZK(EHH=](-=JOU]43T4M)VE9J?M=?O?GO
M&J7]0P'<U?_%6L')11*B-+7ZL&1T/AZ<6&!2]OYW&Z97X\!RV[>$<I.6FM\[
M'*7A8&T/L&ERR'.G\?!ES,U-V]$;QUQW5R2HB68^7S"+S_]MUSY+@G1#@+,5
MO=!I&",0F-3%0Z9%R-@D"$D%B KYQ9H&H'W-P'D@S*)Y_*8D57A@;LZT<J[[
M"&KF^0MUQ?GAQQ?^D8-IC"V[^M^7+TA%0 &S.M.71*R!DLP*R;;)$QQP>[YU
M)QWZ1.LJ?@_T!+->,Z^/;= V*Y9O37%.//S1/E4\<<I5?\+O\=<PU[](^\>?
M\X5(]/$/ G>J;BOHF4\[=3M4VMPZG[-N$%;^$QMC\T4]2 V</#7P5PSZ8O&C
M)UC\I7<8:LW"2RX==2M164W!->_,*_D5TLJ9\K(O0Y]_/%]LYZ1U'&1&(C^C
M11#!$;3-;K0L$APXK];<&G-UU*8EP%\CY%FS=+#FRI]KP1%*<WN@]ZD#+L6P
MO[[5UWA6TJCFMB/5(4W&EAL$Z]%[K_,VF#>ZVAY/]'P;.!#@U]'6430R/S\C
M,5Z:'7#7>7B?K\\-:Y32'HCF9 LH)*T5,9607RHHDVO#Q!-72/V]*!"PV7W.
M); M,GD[J#_89--NXX^"P#N/KQ/YCJM27T3'*RWJ+8L^T?] :7:"J5C)?SX=
MW2(F$@BSD:4)3R9^UPGG@CR[4BP1:V8<PQ%J&A/(V#P=0+E7$+O=V;5P3'K.
M5=K7KZBY0>I7U:?IHP%6B9M')8?HA'V%2["3?5=T>KSN3WV5U=$:]]$SRW#Y
M7F73Q-\6RJ AQWORM7^QT::RVH2-F8^<_2F:'4?"CE2I9@8G%+NE]#IVDVE-
M"C:%Z3\LS]?PVM78*=?<S&:<+[))L=HF<XNG9<U.,8. 6V2_19Y ]5QAX&[S
M!SDNETJ_WG=6N\^K-*<;W"6.M."P8],J F="ZGP"*G]/,J*;\V/YYEQ6HH/'
MQ-MBYX2/]&O7+'9DN\WA3W:[>#TKD7O:G[X'DM\#_8<$H;KW8P,PB09@' :T
M:B)%B^S7$$88YP;/XKM4Z":%D"1$@&Q&?:SE[JI= 83OZ\3N.UVL3^KBFP(Q
M(5,)^=,<&JI;!^4'3H'6MZR12EGR0!S]N3DP71%@D/ 5+<BR?OMYQS46G7!F
M$%]QZ9V^;U=&R)%ZN74XV7'CM)?4D0?T)/[[#(O$RNTCYD*D!J,S&BOC&_.G
M!WX3W]]95H=W^/[7+%43>*%"\O)(>OFZV!*OA49,R1-X">3;>:UY[Z3/=?J^
M&H*JIC+(*R_&\=4GW'#YO!EEGD7*'XK*?!1L+50L5)9W!8OO'S(S8! J]D#O
MMLO*_S,0(;R6[<@T6)+X++F]/&0H3P$G&T<MKT(+]!^<M733G[$./CZ?ST9D
MC8AW*LHZ\4C4,/)F6+MIIC)[(/3F3&J-^DAV7LOHVZ"KNR:E%?"*()V9AHTF
M+&$XX;C=Q9Y_WBW_YY$9$T'=?IL*NO3JR$: 3L:T["MV#/U[_(H9RC+B^'_#
M'R.7&4YO?X=QY&E=\903_+=HA-3PPA.1%R>H"O7CC9V6!]H:.YMS;O?+:RK=
MN!4FDY9R^CY&TND&;F.IG]L&YIAI#+2]"PM$5L,II ,[Y^>TQ)#')FHA#=X=
M!;J]Z?D/A@RZ%7"\?IGZQY_EFGD*(!OLTFG1X$U.J(.DI0&^\2J)+Z6OU%NO
M,\HWYVU;@%B!4W,SI(!?97T&RKB0MTY2Q&?%(_4![@A2WZ7_VXEYO]O<ZD[T
M1/9=F-JV&6^XVJ<;;TX^>X(#$DT# 3_&-.V)Z]"?.'IAS[P<<*IR4,H#B-:0
M"(C4P;Q?'LT8]G$].Z/?0S\EX='KUX2RN-3\CBM.P\_*I/OIK45'Z!GO%B,:
MR)!N= )*[+885H@#AKOAF;=4G0S*L_PBWLWV2X?P'WI-EW[W3/ID7_83V)_L
M@^'FDC<A(M;1T1JK%2180=_]1/N,7(N^^ K':HK^P(505^.HX!"WA8I\[[_-
M]&]UE<@IJ+@)&"['L/B0S<1SCH\MV(UQ+N"]C0QLGU Y6WD[.Q92[/H1N]YF
M)QM. /_/4P[:NWY,+2Y,Z&S#>%G7FX %IAWB:CTP3I>V].@2'R'694-X?]=[
MA2+#F;U3D[1@6==>M,^=OT_/WU#9:O@$/=(EB] <A5X#8HD+ L#E'H=D]S/Q
M9:X!]9ZJ@8ZZG7D3ATL_YIH][""<NO[JMHQ3S./_CH ..7SZF0G'R5I0T,CB
MOV,UREE6ZZCBPB"N[-G^(.DHHE8A=;],C!1DX[E]M9'YH+VY@.&THFUW^3V%
M[]7I=WRIK[UN[,MXW_E?)@CTL.PD/3[S(S&2E;1L97I[Y'G[Q(+ZCTY!BY!B
M:G L GOQ;:I2DB.S/>'_[N"N_$J3^4IPDSJ1_5Q/9?;7?I.7>Z!5RNK%D?:6
M[?(*F@/S^M.%QOQ^HKXB13!#K_NSW,VP1N8K]D%X32P_TQ.(=*!E4>WH>Z!K
MDS4S\QO0E&+Y\3>.CF;!$,?.H R#56_00X^KNJ4O9G!_FE66:HT;%F976:NL
M+KILD7/H@JAUEY,;I*_)NGOY:$Q?20@AWUH^MZ@)LGSE]VHZ[DZ'(*TG7(7M
MA7OR(-TX4E1<PBGCL)(9/=I2S?7&P\55+W.($D7_).-OC"QK*?UHT_]\F?CU
MV"^1I_]\4J/'0X,_+MI.U^SC:?$:P>;+)<P-Y4A(HVOM6_<;'3, #R[LEO_C
M00#LU@C$QU8D,#JW'1=$AJ1ZGAP+=Y%T$=NT<JX1-GSW(OU:UNFV]>MOSE[T
M3G=:W0.9!49 )M(15%U3'VI;JE(3X2TCQ?-<",$FF.I3!<F!^/] J$$$@) G
MJW@'3)'9+26/&(OW-L+5?Z6=;CA.Z$Y,?F<7OGU>;F%T]^%O&Q3Z3!ZV-5\[
M7W,QLL%#9".FO0HV;@@F_XQPGV?4?EN-+.\<9R+;_SFG_W_94*A<#,3"7_QY
M>[M;1I.B>*IMZZ3@EZTG^\?-8D,)6!-*/!4/0HE#:-#UXWCZ*(</QA3A]* ;
MG?JM442>M2MTD1[7O":ZBM/HNF+CL)%5K=L*TC?E:!N_0M-<=/';9HZD2[G
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M2QX,XVL79>WC-D,XTJ"?>1W5[0PAED!E@\D?FT>0\G";=3?:5]VZPS#!)Z5
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M0M5RG/K^FH!=5T9*Q0TZ<5&AOT,#!KRS[0Y^NB@?P7D&"12<-B?:4C-H:1[
M">9E^.G^?K#@]D^'&"7;:5AC5<Y?K['P$Y:B%Y:ETE5>D-N;9Y:EC\N$0I]"
M!5'$*2P@C\9!I0!8OP&L!YUB<K*+]@T#JW;U+SX/?"2C1>#V-SXV&Y;$N]$6
M*?P"-_OEEAI:;17:4P\L(FN"8@TX;L$;'_]RV^C09\0E $H1G.WG\&E7LA2'
M?]((_ZZ;N8Y?X$5H*[R*=@L "[@YIAH?FEO^+>*?^8/B0>]?%, %A4$#N<'
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MX(S5#4<4Z>SN@2P)3YI:GT3G%06'J4V\ZG,N2PO^>:[!X!RHV13IAY!AO^R
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ME7>.#@\G2[P6_HHD=!S$GDM5!\^K1)Y+_MTLP=>U!W&(7H0W \\@0+ :  '
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MS$"L@P,*_90I]__J>PN1WBK,18Z+RCK;JQXO_3MN11SH12:@"186\Y0^)&]
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M;1@I=/\^(CFF^I=TUH[ENM3\]39/#G-(CRDS'FPURE1U(X'EP9CXLSQHK*L
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M!R5=%DL5ON*N)O?A9!Y[\JRW2MTOWJ[V4?3;CUPUZIJO B9X!5T4E?S1$OY
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MOEA=;F8OL5+UIK0][0?'BJVYF?]1XR'<<V&6NMM@9?.:]?MOH;^CYX1O2ES
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M.O,0Y;.]*[P$2)E8WS<CVG:3"E8_F]KKVGB_U#D^E (*^O$Y"?P>U !JC]8
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M\++OQ'[@$8M 4X6NPLDA=CO V%!-0A./QK(1F*@5_\FP8H!PL1GI"68FQP]
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MI!#4),O)"Z4V6>TC=H#$0QH;TTE<)RO9CO25W/>5]A,ITBE$-EDSFD9Z!<3
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M3T0V'%=[\NFCS-_FEA!PI[Q=I+L[^1O7&,?2+!59+B&JFQ^5_F-/E($GX!)
MO:,[$7N*!Y8!U/Y?4(OY_YM)[8X?*3O^S_=XW;!\1*WI=N3%+=P5U+2MZ[.Y
MX+@B!*@0_M?TORBC[1#& B\!!15X_:O@%/6.&'A&O?EW3QW8&3^.5ZXN4,QP
M/_R\<ZKJJ)R#031^B,_/X6.9TZTT=-'HW;-8FCH<S8YORLT6,B_'+\!?E\$^
MGE0VM<(;-I&,QP,'E'@9++2B8.M\HZS0Q#%&>%=19H"QPI.WLU3HA.RMFN[[
M$&UT?^6>(?.-+T"64C;=P!Z9Q^=&P?[V*V+A!7H11$J@16.R$7&HSEY\">9D
M(EB:[5AOXO/"VF&UKG<P'_FAQ?-7[QU5 \AF8#O/T1%)X'B>G>F?CQS1QSU%
MSKF.OYV,M"H#GBD8&Q[J!(J\+^0=5CL]4W(^F^X!WI04HZOR3^=X'H:.T^];
ML!)\WV%89.J^&;3.K\. OCUI'BX85R#-UL)JOXV_MB)*&OA(+H;M@L6FV,9&
MH*@_]T&>B%)_G-<:(7%Q_7;U8E)!7]J'6 1$N[K,QG+\;87SC)[#WU@OZQ [
MKV7>O(G ];"<3<9]BBAE ^X, @E*!-QE=.+A]-'[) ?M/!#.-1*OJEI1DR4]
M$LMFNN#[8]/NME]*(@DGR-S(VZ=@UND68VMMQ!XJ09M.YX=V)6+A/9M0XHV8
MC-.2B.O!UUX+K@D*!AGHX^_04XB])_4$EZ^;2Q/20SK1%<QUT9UZG>-Z>;*U
M.\,T6G/]1E.Y:9-7:3-I^R"DIU9NNOOB-AJ;:+?.KLI8ZNC'ZK(D=?]6[EJ.
MGR??G\1^"3,+L,73@/(=>7@8HFR@IJ:G2'#PW6,KS7F5N^IAJ*^[4?V>(3?T
MUW0]W?,=0]3W5'.*9N<69##][^Q3A$<!2 GI-CN:H[BU3TZC-_*-! .]@J*N
M1><]V]_ZJ@;P/H@'RPZL<*BI8!/'<<E[:0&+>Q/4CL[T)6M/.MXD^6PI;(B)
MSK[PN<='TU??^J1\L+^%HNXFNZ(-NXBBZ8?,L8*;0KP\F;GS4Z.@'%D))]F,
M'>:*E.W#+H/V888\G:H-2%AWP<# VQI3S8$C0\*36LQ)8,%,>3Q5;$$D_[U'
M#UI*J8:H-"M'A+XG#[JJ[EV$%O50#Y@N9=X*7T'0_C%UYYH]=YE,K:SCC4H:
M73(C3_V=Q!/?@/2@YC1F]RZ2.H W3GQT:<F(<]!W,KIV1?KXC!A/,<^6GC8T
MU5)N*,;KM.K&*:H>TCWX='M8C[R()^M"-W'_6/OIT-)WCRZW)$/9F!L]XC>+
M8SGJ[]4E%5-Y>*ZO011M%>UK#>3^=)M("W67<4R=5U^T&A3$'OM;I;P17,=\
M6[UI^"-8O?^1[JF>[CIH(+%7RW*@XN-B1]/=VZ1?J2D BB0'(T"0TU]$J 03
MEB2*=MDJF81+;-G2^,*>^?3<**5#YR#%0TT_<U9VV,]>>@M(I2.]%0#M%%,B
MGKMO19R_'!(KF4)V\R/&-T^5,^&A?3PY41W\_H(_D %36?_ZC&I@"J_"' HW
M0Z;V@/J&[6NK)Q<W3V]6Q:3N$*7WSY-:OF_)LI87V-L!^LNZ^M@N7 9LAS^Z
MXW=0;,O,N$!-W"(V6WU<C#(QMQ'\.3>A[9O6?6>%FC?#3^\QV-THH@R<>"TY
MHC10G2PYY,Z=D9QEE'*Q.F1/GOU&Z$C^ZJK9B"V;TX]"J6I:T'W1G9:<HS/P
M]^.",*(TQ.TE-6-*O#-3CH*!B<O>].?P&\,LM@!X?3W?O#3*D@<'7T'05/6Z
M?WSW][3O@C&+\W8_[8>0>V<AST?3/XS/&-THIE^[MGV-_1:P2XGZVQ_QL>0L
M7\6,;(\ 6+ZX"8>XH=;X7_!:T(UR]M(45WI[ST=*:SRTZGU]/!M)453?WIPJ
M;F[U]=;I)+QZI:M"#_A/T\N1D%"/?M#'<M,^/)7CO<>C_N?N&D^OV,?#3TKZ
MG4"F9M"WA"_[+Z:\UN83FO3$'JBT"=SL>5;,P&$NOC@"#9A_BFM"4UKHNHJ"
M-3);\8\[:>R_ )I^16/[SI[\143[W=S^MLF^BH?EW0?$@>28V]<A6Y\@I N>
M3](:H?9_RF)R; M[3Z*53^9.9( [>^LF-KVG4/U>9+Y<22C?^HVB/D6 06@=
MYZ+04?F([H34EG56Q_GVF+JZ0Y3DK[ H.<KU6S05I!?]*GYJP429[:F724O<
M\ O5WXG4A1U-;@_XUNW=/\79?'F@LM#FWW+(<JA^7B='0D*2(>:^DXUPTNP?
M/2X#6HRC)ZOG$QJKLAUH>U37VLZ"^J98Z#,478[XW(>%C#ZI\[S]<$RZ'[LU
M8DZDI_W[F_]'Q(W_A1JH_\$TQ8<]]^ [3]C=NH#TYA"^-J@X-C@KO! 7=]K)
MR38E/2!&[7BWIJ>@;,FQEF[1S-'PD:C6PO(0K=F+C]P:S1AQ\#!3!^@VK/TM
M$O5MU!G)O@]T:#J8 ;6QUN8$.*/$0@V5.;6&+$JEYE/?C7J7T6X_;AF7OK:^
ML7_HNRAF2RE,(_SVVL7!A1;^(P:QVX=YOL+72\WJ&_H$PQCH6:QQ0U-K&2QQ
M)F^7Q?8CH)&H+D)1=JBR<>!?*(W?Q_-BU?",.<0[?/E;EP".5F:\-J9@%XY1
MZSI:XB+9.G\I_R&/=R/=V4>ZOFE"RKG).5-/H05;E^WU]JY%/ZOS>^Y[U./U
M0M?"?97=4E23*:WX2U79R-F/PNTU7V,F.>2FLLA)@DITJH562CH$<[*KDJL*
M=#1$'2V!J>ZUDM3"RT(#%N:G#(;&3C.I;QMX!6,3O5FKT>R&8DQDO;.O\@;1
M SD)!4R#M<G?H?W+-=1[ZQ=\T"4B-2$,Z )C%>M9)%DUU4%2MCY0=\F;U!Z*
MSCWE-H@Q,_ZFY2* KG,X^+L3M@1!6  A3=H?J?$,B!,4(0]F*S97=Z*).6B[
M*%GT4\5V9[5*(X)/5H"5N!WCN VEQ^K5$QPYCM]K:^L;8U9\'T!.NLGCG(_*
M.U%U/6Z?81B3D9GT3F0UU][#[&IX=YG;JXEC.(TSS1RH@)IB3NN[$WBVT60\
MWR7)$7;+=?6NRAV=8I[Y>/ W+HSNO+'H%:-%<&$TF\Q^,4)XL4SAJ6-/$(S=
M$>A)WNC/)M=LC2S:4-^D3V4';ST/62E-Y] 7Z:\2?LCWV<ENII'9G/(EE06\
M6R_'A& =PEI6K*]_XNY>M.^9FULZ5]=FY6F^C:2P3Y$W'NPE-Z/L_EO9+&*N
MRFLX^(A>4%MEM"1<=RV9=ZXRT$+:-.LI=@>UB6<<1X/:_\D,3YXG[X6[*3>@
M?VU@"R*!]FY4<S.(D&8@^I=%>;F(5XOCWEO6Y@]W;^?(OU.PSY*)U;-HKSAW
MO+@':U>3@D?!," .K9-?N%3K-&@.9OP)5JFNFUQ;<%C+66N$'B(Z]7@2]O.=
M;6R^F=^6?:WQ/7N[(]8GS0#267!-@GO=;A]VB(7D.\YYQ>"V_GO!1O]OUT.+
M3\W]XK1A0N"J??A*IAF1\I3P0[_#>KU<N%7)'S0I?5#)9,?)6#$A=>8=DCS
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MH:E)<7YMR@R_%1G02A+3JICE$*D22CJ5<>'O,4M+(Z#QLIR:VO 'X;J/;^>
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M?D$"^+ 9\RU./#Z+F)7P^<DUHW5 W!.B\"7 3VZD#.#K,M).'>23Q8WABCR
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M*@3H:XDO:CA\ZA:I.+K?/#[K\P13/Y+)8JX95R0D<?=U92Q8(]8P6+!XT2T
MUKF^M)C4Z.1OSV(E:/U>][WVH09(I]:PZN+@QUD66XPD82^7VJ5%?2]K=I-]
MS#,FP^O\0F^7)^PDGMM== D6,.,-[(PA??EFXA)@W2 $KQJ8QX%  ^5JXPRG
MHGD*[8N/.1"C3>#:Y?S--9H\2SH]=Z2@<V(!OW/>7.LI;*-&:-10N<_G$J!\
M"%OFP_-?\/[>N1%(O.X0_3JQ87^^*;[*1<%2; #;<OR1MG"Z,BI'H%W95F>X
MKTDYXL1"^H]1[OG%9':E^25@A QXD*;<=^7I%'DN :W:5*6L4T;0C48+_MWJ
ML>']<]=J/XL+LD59]#I'P(Z WXXVKU^)(\&$OB!Y%]/G\5M+H2UN@/X5EJ?5
MW#;VMMMBB/"C8E50@28^#GB7R \I6+'+N1BP !MC@3'YF,S0$%[:A6ZT@A C
MG<6V.(CSSUIXJ3H3S77__"7C:^/':V8+@C\?5?29L/FDUB.?M-%TWF,FP95$
M_2:RX("=/LGR,>'H= 6V,T2YMZ]KT%,$X\FQ8E-3&)]M?WK8X<,G;;$]"ER]
M>!V4Y;W5ER-!0NN*:OH\;6NX[<DC4ZG,;9N?AZ\SZ"TK#.ZMBIH5T"_.^0"?
MH;+X!NJM0USTZ>)ZQ7M6'TW\00D9;"2\G_RV-A^WI^Q0M.<5I\V>!<<TSFM,
M_MUI<-/>RTJ\KFBH?[U#:)=$HHN@W&$W.-K3]76-W;KEC?>(_X&=XA=E;+2:
M6_HG$%>>NM[3E)/6)=Y7UZX][=BS69X0A5Q-8"L]66[.98+;-\3D>V-F5)&P
MDE!O<MQI7'Q\%#<3WVS_PIB9G)(P/'A04KY^]T6Q-5WR@P3'W.HHV\?*QF=\
M?"Y+T0HQ&C))'_24S1.WGUC?[A$:@[+="O#P!2@8=G>RLU,.-ZDID;4K'V]$
M^)X]9R&['5C%**L[?L.^ +UCN8=:5*:^XV"4ME3N#Q==<C'2C:U_9#SS[%0R
MT9#99NW%;N$UT1F5FV'E_E.E NC\=,)ZG)9M2?3!*>$2P/,QXW%065@O>EMJ
M4E;SW$(YYO&AFW;3GIU_<FG<)8!+^5&_\N:)T>?OE+^9S,Q:!O;5GD<L;K;X
MCG26:1YU87!U*S>'NHQ.H(K8K)IR".CU76T7Z>G/O)E&G5\73!<$06Y*S8[O
MR^-^5*[=!4C_F3R;M/\8_7?G*KTA;'RID7V,?&!IREM,K,8_B^ OC?Z_U<7_
M!PO,>*_>HUR6W0)'WX"1665_Y/]&=8$^B,[#6%:Q*:B?BZ"-$7N5@^$M7\+'
M1&&0H U5DLT1.41MV48$Y$<6*=U380?,X.W[*]Y4Z>K;MW;MIV,FSP;?NV>L
MX8O53N%/8+,\'GYOC"9A-_Q5YT+@[M\LU,<6_NRQ/=OMJJA.O 1X7O=QX_TL
M]H?9[]6+'YE+R.F!\[]*<U<#^\7_GXK"_QN& <X%HIA"D(Z7@,]<-,1;N.J$
M,46_;^9;/U8S:S\FV.S)J^ CD K=MD4JSIX\CD?JL0D<SF=HG.2%!*S='?;6
M0IEK-A35&P9EQ_6BNEN&NA'!4*'M\ZQT=LY;%1-\:8[E(E(B3VI;_-A]F&@M
M6ZH[M"LW^.E?/$%L.T6<+X1&B<\RDC,DE=[23UN?:?S=-7 S'46L>Y8DFL'!
M;_TG3R_A>UBTS-:1G*:HZ+!,"U%?$<W.Z!O3L0'B2%U/P8NPH',B^[$TWTWS
M67/1<NCMAHY<6TV]+R[\!=Y8$1'\'[S(5?XG[>^/ >T%7R@09Y;D"3E2!Y$P
MFF:1\NTE;MPQ#+%U'B2)2WZ5-K<#&BUKOA5;W)VW56MHY"$\-8UFL'AM]J-'
M'.Q%G,C^B803%: +V17P/8UOD*;.-% 0TJY%WZ@5"PJ5UG+>\BX+D&9>-QY7
MR9IG_)HR&/'VPIZ9U!;Z8]0@>M7_$B#>/=:S@J4O-LI)FNK;DOU=H$-_N#V:
MP,E*OU4X'B30X1$L:EQPN[JF(HGZ\R$[%6,Y';5F91Z83>U1V9#!L(%X@G2T
MKZ9CG5R+W>+^2:5BTZK1YV.N<!A9ZWT<B493W?@QD!D',L80HH]7FF9G%YQD
M1FYX+O32'%G>,_/Z(ME$ C#:/,#3[1#)MF 74L0>945"?*NB4RLK+CG?_RD6
MWA4 ZB)'__'F *JW8'ICFH/D]2/SM;H;U'/<%8O[2[L_U%YC."]0@<R\.WC4
M86L<E4YM-/L&*[O[T$97!7IL_5/3F5J/00SB(1@_ZNV8GZ;T3N=Y\LK1.U%/
MTXR\R(XW6,@=PP_Y&-SDS; HM/W@VK>XILJ]"CSRSR7@YR4 SQ!Z I@Z1H8L
M_QR)P2M@W4Y\L5DMQ4L0'U5L2$[!5O(E@,QJ(I>PN-ZQPT=\*&&B5LE<)@7_
MJQIQ>Z9WXX!OX1)@QX7C&=ECPE2=+.',+AS]W^ N?OCK8WTQB+!UW.]D&?D@
MICJH]/2N:<_2<GOZL]E9G*=V-2-&J7F;)\XAUTLO*I%P:_0@QGE'G)-W\Q@S
MDZ9%G?"J:Q4C78F?EOB>W)%EE?ZJ[*9V\P?NU*.)(*,&0=V\\BK]2F7KT) S
M#M8903A=FN'W)!NKF'Z,=(4_3K&QFF]/)"1_%:HFM/@Z8;%:VR)JKCLU$N#;
M0]H7M5E@"3(_&KF%?(1$%2QC=/[ W. AT+NA'<2'X_[7L 5HM?#29C"FMZ<Q
M*>MTBC$MNK1(X.?DS<K,Y[M:@I'SH,K*:A]LQT'"DO/Q]0C< D*RY^W,KHS-
MI\+"E9]5FWF/&:3.-26##E@Z<MU8.C1Z-%I$ V*<DZPD,ZBX17N?CE"&A_*J
MD,EJNPSHT9GVY++J124-">57 U.F<&Z7 -)K$*1&]@EDJED-<]2Y1)O%-D*U
M!!VE<S)E(.85.?C<58H?<$?O>+NHV-17VSWK8VZ]_FP=O\M*T"7$7P)0Z<MW
M+@'VV3/3AH0X?UTQO+ (<(4JNX0KTO1X4'4)1+<CCY6TU'BG3E<6DNCA^8-W
MU/='C"R>T-68/<8JM"49(SOH^5))493K6L+::^[P@N@RT(,.$,EQLRUCWG.Z
MB/0R0V_!5XF;&JJO@N7A68_T-! 9_?7<P@/.(#HP4\HFPQ(CA-5;\B.VJY%9
M/G:]).1'PKT<G5+V[PH% JK:<E)SP.1%TI-_NE(UL'9%NZEFNHN[N.6.;$[H
M36?YC0H_-.(FI.G5S]\U8J0J1=JM"H1G!\9"'-WGMQ:EY/5%TJL=#"33SLW^
MHV.,"W1\.KLZ$[%7<>&/MX[O@3%4MXC.+;=S4>'%_7QL?T#L(,\)F?@G[WA#
M7TY2?>68U@D999US$Y\[YIF+!+<D&!D^[GJYR1;8A5[_TN>P*E[O'=R[*>O?
MF*DXS_%L- H=UG4D:UD<Q* QEJ?CL6:: R=%3^D&]EA5D'-D&+6C2@;H/O<+
MK=H*5Y$:] W)2]DP3ZP'Y?'=UBE%(1/S1W$U_VI&KX;IZO\*UX -[8#5/M[U
MQ7).H[GVE% B#RPD?.H_Y2>N9@K.>_W>\@':&P3NG<8<W)B63XF;,VZNR7[_
M% SGPKQR"T)B])?#ERM#HZ#BT$5E <Q!Y\@MO,B$E)8(-6HDR)M<6X>+>?NT
MSK&@(+(F0$L3:&/+K)4P?L 2W1S-_21L%K&+J-B;SMX!4UX"VE5@MLO,T)GE
MRNR8UNL0IJXL+@PBW-\@X+OY[$X6?P0Q@'52JNRIZZ996/5DW%Z:\?1;J.E7
MKH.[0F.H2\!=[)FEU=??O:/]6&/S*H;@[UHR/6]RP@8E%FJF"X2U*7A]A'KN
M1!7W2"3*UPCT>)Q(!#68^[<^NLJ.25/?>"ZH6H0-8E*:>ZE-2P\''_*.=]@Q
MKVM..!M^'^ 3Z/\1Z$3[)5Y3;QE,1?A$9-\"L\!0"6 R9:8=A$AK,I845=Z
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M1)/'M N,Y68O_'3/9?!ZJBJQL*7I#L8_\T;:,N6'%F"A.T[RW6YQAJ5:7>C
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M>O(XAE5OP]3TZ$G?BNW .A?)N0B_IA@VY>)=T]#3BAUG7X,GM(GB<J^9F$.
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MNT%T)Y^LW"YW/Y]/T/',=DFV0X[$:RW&'&6@[G6%3QREUXR)0GNF\\!_L.A
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M5H-9D 6[L%;= 7":XY@&RPGT<WB^L)8:N-B_T3VHK!FXFCVE4]CH:U=L+AC
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M2!>@/Z2DM'UCW*3"7E20,)3(X@H41%;]C_<GLU%BW4V''TT<)G)/M'>QZ+L
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M!LEQ"*X,IR1,V)L7.WE:RXJ<I5F8#_WE/[SX9!W(T_:9ND:;^L2$3#,&QI#
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MV_=!L3A_/;$4<KBY#V)1=C7]Q)O\!D^'QT9!'_S_M95N?BHHT":G,"0YVZ&
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MQ=S3=S*KO_WW8*;&)36:/'40=5C3TM+L[]#(7HC@/LA]YFGW.-M'OW:5_DB
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M9*CJPWGK@-(M^S\=]!M?K5:M+&V:G/%E#?/'D=L8IG\#NC-"C,6#IWXE60L
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M+70?^&WQXS76^=P;X\4"LTOHL@IQ4G4:KZ/OM>HKG8*;7B-=/+\\[ \X^ D
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M/O-"@FT^*:$/^&+N1*YY=?.$VDHTB,K9V6R*EJXK &G.>;P*_W2C_+=EBF1
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MBN1]2-#ZNBDWZ9O L(Q*4Q^SLK+0$/^/''1X%OT] @ _.OX-^ 6<$F#(11B
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MMII<1*L]=SFUU3/V OF($35D6%*]D;JJMC:I\]!I$$4Q&3X-;^A 4FQ <7,
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M-8X"I4W0[:!4+\)<$ZW-6$^BJ]L#T+H_U$*,"13K<H/HU[T[/PY=$VGXE!*
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MF>("E]28;"XS7(-29D#P/0^K=;7I&[1B.I3AR12E8/L <<$>.@F&-VCY!FG
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M0;*_*M<ASO6>>#+E6XW*6&7)^V=T=,B\O<?WH,Q4*;'$U#RQ7%I"34+.J"L
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M]3K"81SBFBX4ZAH>+M&#U3UK?6>:92#&N/QJ4WB?)-_6&]W_#!A_R9(^G52
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M,9\>(H.%/ZZK;IR!"U=Z7Y..D7N&W3L:RIH>?V0^)>^^0B_3- :II'$#QH-
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MA5\/QN[AI-UG%0U5M.5=!)B#MZ.?)8$CI >JZIZ%HUHQ#5 *=_@&9C^<2#8
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M5XVHE"$ESB0&6XKK@JUI;QN(9J%J4RE<Z;@="N<@E05*JTN=!<3-W84 ^']
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M_;Z77/JN>#<LN-TZ2\ ZWP4J7)F%<O%A%E>=?YXU=8^A_=)5?5;%8O,/'UZ
M3($%6K-13Y*07F@N42&XQTD>@AO8&4BY;(SBWBO@GF'#?+SWM- 7/_OK;I-#
MV\_H6[;1L[49=\P-S#(B360/*Z87.K*63^EZ4;TH"B\CE5F-+(:8HO(!"H0B
M$A-@MT%&+J5VBXIV<L-U:9"@!^/$5:;2E$ILIP3PTO63;6?TQH&L1=-4D%F]
M\ZYF^!YRV?R)>?]-H\<.06^N'+/OEU&$,/A*P7XPP2!UJ:R_U?TD?SZQ"C&%
MJ2TM+UM;-N/*^JU:)]<_^FS9!.-6$ZK85E=T4<SZV?-(G[^RC2>I8'<MLQ@B
M7#B*] R0 7%W5RP#D>#8([@ZH7V-6_,DST/6Z9FO@*^F\;5?<:Z>5K-?X]'^
M@[^7Q!<\\8<O4 S:R(UD7APZI9.#IA=3>]<O.'JK(80)X'BXV(?O(,[)'S\O
MZR4'%'_3C,X?R"V;*(Y*UG3PNG0 WHY/K0:YEV5#TD]"%JAGU_\#(2.1YY>8
M\RAJ!&\;H90@0:',[RGL:]\BOO^A#:BH1*KH'JIN(17S> *0V7D19'BH EZ"
MX-?>E,!M$@W:"WJMB-"H8#L!!5; [RM^_F[FSW@5[T/0.OV/QJ-5[=FS,>@]
M]T=U4T$E3=7UQC[",H/NF=%)LEP!#K;+HI+#TV?_4TZ^FC@2>?$_UR>/Z!B0
M7*($BW7@FE0B>*,&:Q:+V<C"U.KOUY!OPQ1HN +@BK"4AT T$=GU-S9&^^9&
M!SV.U-'Y_6%=9Q/9%(4L7GM;&D[.?;?QYJEX4]HXDYM'UWVGG-W?5!3!;,H,
M4!W<*(N#=IZ#AYQT=LIX^ZWS@/U$$SNEB0VHN)T"'/H0Q*5;L>H(Z!L77#N?
MA'1?=5S#WE,.59)H1RK2I9_(19YGN$W?>)MQI@RJNW=;Y]A9D:P#YR$T[1,)
M6CC/KO6SBPZ["%[ =:.2MR?'/?ISFO%9!=>GE7""B32GLHU 4K::S"CW8([>
M'!\]5J-KPI$N_$B:28M&*QT4@'^6V0;_?)O_CZX%B-G<F>/# W.=U=@NT7B!
M^5R/!>Q@;+UYY;=JF3H,*3]S5$3W@Z3=.ZNM#?IN*>Z==9;'K34G'[1M/D'&
M'S<2%[HG8I2\>0ZH5;[&NO4M**<T%;!BED1[]#O_@*:OZ(I?%>*S]?GZ9FE\
M?@P'F7.UW?Z)XAPC<NV)S,-)S+6A)68ZYQG%^-%C:#H?&P2WV=)ZO[,*48@J
M1@SI00O"LDE!0%I07(%!,7$]Y<>H*@N<BXO'G@&U6."0!F_FN<4BW5U97J;Y
M+&$]W-<'N^#T(WO<N338E_F3_3V=M0ZY;7? =RMU)H\*VL%T< 5+T;]PD$JB
MTPF=T&E69LU<30I,$L%LI2 R8SZWH;]O4[WN=)]YKOY0<+%@N+V&PH (!R(]
M<B$+\B)WOLN7P[ZL!O+G]X01.$LB=M F6U[VH_U]X<HCTU6F-T[I/-,?,<XV
MTJ$G3,9/Z;11RM,USZUW\GBT6L3DEL')PKYS^VT'5(]Z;",9\YWX^$3S^5]S
M,^GNZH?E&YF/]+IZGQVJ][@CW%EONV_?_M@]'C!30R50"<+^H0-ADS^?AY.4
M>>J##C1][Z&MKZ?6+$Z$'29]-%!L1F@(A__\?%@5L"X<<'#HW+]A<FF]&Z$S
MC^46]TZS6QI"O57VR2W95]);>71*I_D?:878%4*W]CY(*@^9M_&S/"?461T?
MRE\4]Y7KL5'ON%D&.$JJ2O/WQXLN#\/._-G,":8#77./--B.L1/+TED6M[DR
M@(OZLO,_Q'U75%-/^&VL=%#I7:5WI9<((@)2([T3 1$ATEN0D(@(2$>J=&D"
M4B*]@Q"*=.D=4BC2$U ($N#F][_K/M^GN^[#K*R5<\[DS,R>;^^=Y'Q?"<AP
M:L9Q?T)I:53'<6G?*;MZS()_K=$XJ*C@G4!F4!4SBZL]2/Q&;.V=\5(VZM@@
MH_@?$T/>P*[K$VT%<G.Y3JP+A05E;Q(I'!;K-30!AAY5^D;=+NE#46%]K8N4
M.^.3%.L.<_&:5A?34]X)#4M.'I-G,YM+1R<) =L0U6A C91DS^IK5IF@LR=!
M*TY!^10\ECZ!U^]BTA4=NJZ;&AG(WLG I#US%H@GSA6*>+:9)K2 ?)3DN)D
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M<G_MB"7>(Q0>X__[JS%Y/$_]>*/S:'<[!"_&R/LG(=(#^.@20&605J@0)7M
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MDE0,K/;:SK(\'^0W)ON&^):2 66I]E\BU0;PWB-T A4<Q4M)<D!+A<M4991
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MY;/)>36Y%N:5SYZ8VMJZ&57MZ)A]R$R0S/P:;%5"KRTW*KTT"-V><UW__":
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M([1AZ5%*!Y78 J1T^C_$'1"0&>Z)(QK!6R.="$\/@E.OM*Q+>XSD?\_<IE_
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M"F/@+=6(\_,7_]1/RP6U:#H$@D]X$4:%6+&B$TQ#@4MXU<;3!TVS=8>-K\J
M@5S>RHXH9%[D68#V?6'^#T[#5L/T!!$VC%MM].R&,JD+SH,3'VF)'G6BO-*C
MP!M$J2]8H]S:J9=;Z3Q_.+/7%XJ8$PVM\]6RN-P+[+*+0O5N1(X\;6S>.KSS
M@S!BO?12AATB\-#\OI*$59=^N_3=E?[M+T67@ V9P'AM/<_5V.E>^@PTG<Q7
M;+RZ ([9(ZGZ7:-HX#1DMCRN8K?.2"I@VW>0:L_LMRTDM'N?U'2<1JE<1IG6
M=<*_B&UP&= 4F2'Z(=/IP#V#IPLK:>]04?Q&"_]6]U4L[4 8/TQI$8UL@P7*
M=UN)KJ[,N0@%9 6[].=+?49)LWJO6"4$2\K>:52@-;/IC35NZNA(I?XN,6NO
M[OVZQCBGO#!%:@8,?/!GT<+M\?,B?>)><DG)MO*$06;.\_6YWY8F!GEMXSV+
M>Z5.M >ER?BF5-%9_(?"LE+*.SI,.[^C#WR*CB)M?^P^XN>/T?N&663^""B^
MS=]@[*BRO]H'-7/*A[528N*Q'JB=@S<71H12O OA#.G$"L[\"J4CF@_:$* H
M=K<%=95Z6] L7%;[=0>#,4U31LLHS8>1KVZ)'%=P<2."\ ;=F+2)-6I<[AD%
M,A+MZL$[([8["0JB)YO,X Q<&X^'>:=#I%F\(_Z@IB#)E!V=ZI#EK&#Q1WRE
M=K#SAZ:VF<J0?K +S8R*/38$9%0L: GV1$65[)AXR:9D,0=GK_^[<)24$NBW
MFOB<_;.>:MX+*9B:&J%PWXK^H'K\0Z6(BO@&9OG4KO0?NFH+_9-T)<?IJW?.
M3D<)5C]@'% ?OV47?$1G4S-A&K>#'!WL(3T:D_"!:Z'4K*5</?O.ZQ1'D%O!
M@$,;%O;&5]F[EP":OH=$*<(T<M^)F2B*.TI0CT+NM]E\GH/+U*QZR<2]0/2*
M<YWA^(^N0SZ(J&@<.UK8]SQ,XU0>^TACH<Y=3DEU\C#;Q0BREJ1@,[K<OCI=
MK7A0OW12_?NCV!*L6HLG+D?VX4XQ;_&#K)HGJQO<1#QT?!RJ-;.$!J!A)K#]
M9QJXN%?QB90:S:JRZ+ ;I\H3+]8(M8.6N<<@*]X'/^M.O,&T:RN^&Y5N-T]Z
MDZM#NW-F#.+S)&.DMHOF7:CNK#M2;OFMRN'-"-GH>C-DXIMH(/$A#IC^SSL/
M$P*DVHWF;XDRFMF;;S=XA>L1"#3@(KYQR7CR"WF=V\28(KU:IVSW!8Y%Y4'-
M6/"?N5IVL^;3'>7^JOXJ!/3I4?W[\O2O,]5&3"//R\5FME.\G$']1A'B.DR@
M,=O:8?']5:W=+^% Z3$VKIB:IBD^T7U8-3NZ5_@)A8"O6M(]F@O7$,W> @3+
M7R?,.&[0CE0,=+T$I -9(?PU?VS]TN%L6/20YGVL*?B-;V5+]^+!EE.3S@ID
M]K^0AP+^T>,<Z_>_[CJI_J_AW"7 DX\1$DU*[^,#SZ+\AKB,62 6.#]\7W7]
M%=IYK931REBY=<Q8F@6Y5"[_NBV)9XZ1B2'<6VPT2 RB(@+?HA0,)=H37FI)
M9$;/KHPSJ/+9!*6$<^+EMW+5CSPGIYO5\^&ZN<^G/+$7698OK2BL9+;MDPL]
M1SKFT:QSF19>AI%-VPAA>&/0R?5[Z&*UQOW,V-'&-I'1QU_9@3"-_>-T_#,"
M"^KH]28CT)/^+=]=A&^1-SX6NY,J== @/W6+4+'_-%:'H.9WJSQ2_?VRGF^5
MO;R,?=FN\T1H.YJU1D7E^C]APWGY]5=CJZ8S"ER&QH9P8]6IY[,-SETMO6]Y
M>DJZ.L+O?[A^R[ZTN>EFT!R]M,Q G6#(@:"ZMHB8S/G:EWG/Q]VM+B:SVS59
MC73N;3->FC.:^[JEN6B/U$_E297&](YEM4^4@7Y&K5DBEL&DVBREW]NFT&^_
M/DN:R9])IJT%!EUI(=ZHZD 9C/UA-2J=YL]INZIC$TJ2WV!.0='X *-Y;-K:
MC.C5?)$B65377'<JYGIV)UF)*VUC#@P;CN;".J9"44 V[V[CA'\:4BJOI-L,
M'<G4U-2>)3K9&S8-O K^33$73++<_A5="[RU18('-?-%'EYLE4H8H7S'[<P=
M>%U&<N3?H])]<+)ZF[#*3#F-0I%.C<[<0?8:;+EY ]\T':R,9K_2; )!'\@1
M_X@X)P7B U+3)< -D9[?5_X)PDO 8%=1O%VEC/DY!<BCNW;&8=[WHN*?R9X]
M.[1+?7^6J**ATOB_GJ>9RWLMY%$$6YL&'SHW">H1>16K%><9X0-2&8*)&#/X
MS[,N>%^9@F['$I&_,$WS^!>MB)M6;+H6?0XJNB?AJ\MG]>[RB"_E4X[QGJH!
MU8+L<]D<.@H"C25Z:KU=$?X6/[#3XTT?B3RVX5G^N&Q=H_B(H)UL#0<%914!
M3!1?QF+CAD<:PMA+990[H/]*2$SV/2,EM1FS.T:/;K:TU^+D+.?:Z-FGL+"!
M14>)18BQ"F?O81G^_I7,<OR]I6/Z]]?-SDZ0A2;HM@^#J3UY[1+0=)(^%(M-
M/L*G$BPHAQK;+@$>Z93 ) RP57OY7E1!C"]\!BSA,<JCHSP9[BA;#K'DH]9B
M2@'K-\=[+7DI>&GKL'"K'.G+X0-R!></<A;E*_.1_(D#SC+*A8HW741FJPWH
MD^J-LK55!N3PON99=M6\W@I<Z[6;GT^B;X7QKFM4WP$DJ SL\/[PIQAMB,37
MY)PJ+F('PSR"?,.]_4OL(@M42CO;LOD.X59W6W3%E,D"SC(Q=VK.RPM/5QS(
M,-\@A933'*50?Z=*)=8@^R<XK;"[RFO8IRAMCNOQO^&$2HZQ0M3G*671P TC
MVAY]TW=Z&XH]C@Y&IT*HFO[CX0%#2989O:K^O5Z,KR3+N>S%W=LDU#W[&#[O
M@)0<P XE/P\E9;G8%^[66!Z H/_8V@X'X,6O-[M?&[_Z6I'OL%UX[MGVM52M
M0/]W@)UGI+B&L?5<&U>4JL:M8=27MEYX/HI6]0Y=&4?]@?,'W_N"C_^BN*]Y
M'SOAZ4G%4-_T56\[4DFP'R'<"D.)/2$#()8+9(ZZ+V+>]:BWK9&K!<:8/-JA
MA=K*5M02@QO'>UUXH+]A=&*NOZ+)Q^VN=F^ME(<(B^^B+]P^=FUWDKT,>.R6
M7I(*P\-K5"S?Q17)KR3_!NF:'?M N78Z)<:EQ[W]4YWJW#-&M*2V__<I#'&>
MJCP_I%]KOBDMR3$ ,@?U+#M40%U+V;]M/QIY?,.EZ4P/0&Z-CXFQQE#)6F,_
M463HJ0/4,I.)OTC)4-?T%%@S#V+(T!L=ADG'L>$_SH;4FO>T0=^&6IY'=<1*
M!'][=KK(VD@[_-7-TSG<W9VZ]181^$ A/>T2T XELJSBLPF)V'2\->%S0_0D
MM#FLWX]!,QYU]*Z/)<3!>X@MZ?<3R85?S446"@2+PU;2O;?.K,X&B9UF'%,%
MN?Y9<A =]S\[[+8V0B9/%)K.\$+97NQ@T[IY5?-=Y#:;8X-0F\?!GVD3TVI!
MG,XNT(EG>%X6KFA#M:PI9#/B9[7\,M!>OM2QNZIN;[[:0O#VR]V9UKWY"&TG
M7??%?_L>* 2U%UM])8@LA"61/]5]6V"-6"@(B6C(VZCWIIV=Y%!9JU!O4&'I
MMKN!O][(6[KX";/(9V]U[(*B)]Q3N 2\\:D@Q%^H12\@V.!<N+V1C7T+8W;#
M*@<9G%1?D_K?LA*#[_PSEX V*8!.CG*%]3LT5^#@+CU!0!C3@RM &T"L2=F7
M *]:@X\(3_KE62M-GKY%OSH_WU?J'F4K/5KR'2T:B*6C-E\>RTW,Z?1:#EPI
MX/MVPX)PK0Q2HO%"F*G0?_/N]-27Y<"2%G4-",^S%KZX> ].DZ&9P;EJ"^>'
MQ3,F%7LC)5FN:^4WV5MH.I*/A0M>-A?S?Q-W;6OZ6TO3PJ#%QOV*GLDT(\1-
MI]YZMO) 7/7ASJ^,++<RL[!GI#Z!%ZSW:'94MB*8?I(+CY\^O4<<,X_]=B\"
M36B&4N23M=0M*#$>%];_:Z !!$DO1_;#VA-'G-YH,OP,<6+:=^1]-V@%6U%U
M+ "5V(!F&C+=2O5_:O' $Y#)B**/WYP_Y5SK^P7$/C5>]11'DZEV+_X+A\GI
M()8LQ1F;^.[=\Q*HN=4O0<&?H2$.@5[;7I;X\G""T'CS]8@[A[M#OH3<5Y<F
M.G:?D-N6@S5MGD_\@YZ'%L'D?59-?J+Z Q8\\L?9)&#Q =9$1<J'(VZ;UFF*
M\2+C#'$UNQ:M7E*O[&J'!69]Q=?ESNGM;]I[T,YJ&"-\L+(!^5%0!2C6V&G%
M /_UJF;]-*#D.Z,7MH15,\(L:T^9=Y\0(03';]_%%K%F><Y;1*J4O 3@/UAD
M'.G-2^2K6<P6*T_$GX^W+=VB/#>CY*_0J-T!9R8&<"ND5\;4V]$F5[[M1[;0
M\,I1JAC3ONM'B]9DB9L&IKAF6AG))GOIU5L4G$=SH;B!#%LUJ#^SC8F-"<-6
M7]%?P%4BS@\_PN7/Q&;RWX%JEP?TQTQ RVIE__MQX.S?_?_3,OW_/OZ?[=.9
M__\8SXTH@.26 PWC-J'MPT<JURD;T$3E$_RGFR7I6DN%'E].A;_L3S7]*Z/4
M #*L17(";$5*7LN&]'H;8_&9U=[YO7.6MH[9/J=AN::%$OXCY1\; OIT?+2Y
M;6YNNST/G#]#HV&K+D.+EP#O-H(O<E6#5^0PR]J;+*@%.<7'^H=&L0K%V.D%
M?CKS57M_6ZUV]1+@4V]*'D?*6[*NIE;T-"[OKI0@NYK^_BJL=AO-Z0LV:7)9
MBUS<+O'_%/0E12K<5;CN ^()G$ZU>)29\[%0P\4E(%.32 BX\/HN>9A="C'Z
M6=*:\)N?9S$E.,;RNU]9L(%Y%/M1/I>'0-*AX<AJ0.K8<B-"\I"_ISUA;^5I
MP[W.>.$$ST+YH)&MAYY+_N:UU^CYZZ,I?C!KB5B8?72PELVQ&BN:M+KXX;^\
M)?K<&Z^%]^DJ1F\E#J(# B2'OOR9?I+Q8T2O6*3LO1 >*/>:;BU#SX(WBPHD
M7/(G\J-:T@K[:^8=[FO&_, A\\!'H[9>&7I3CU2KQLY/T# \]$$D6'BT,;V8
ME\!7NGOL:#V%XF/V#OQ1S(FM3_GNK5DIH%^O9AQR#WR V7K"<RAH6F3%"Z/8
MVVR7QO"$U7P/*Q,>=.#2SH[#_5&M2*K>BR@J!()7#:KMG ;]U-\NFZC^=_<]
MW8:GH!!>=W]1/:#X4UI1 C7O$Q<-E2E]<;3Q&V!;:NXP_5W=+3X.3R=L$G@$
M3+,B$7.H5L\W7.O-5@ .WN4'+&_8O78G3^65?7QT_5!#_.!3T&SC<[4/A:[T
MS](0V==8DRGO%3*D=:'Y[+'*.[N&QTP<F[R;1^$?T,?K^Z,+KWFTY1]JR!I1
M\'=./=*MQNP;?;J6%DF_R!T9 7N\D9R,0HD;A!\V"#SUQ7S."-]^CWF*3#+X
MMIU.Q?)8,/UQYB.Z=5C>8_%"FA0/TN>Y$S3['JWZ+>6M-YMB@;W1>=RA)SS>
M?\=1.QAC-)3!ZSSAPQ:/T<Y --_LH7N"AN6W!X08LJ?#^V^N'UR3Q2E7LXS%
M(Z_QA=X>_4@(PB<2%I&]3S1,_?B\-H32'O2TIC/*,RW9"W,M^L(??O_-<"I
M'R_@RO38,M30NY>(:)S]'3VQTV@R9;Q??'9.$SGMZ(9-1RGD#DO?W"6+M;U>
ML3?NIM6?*%1;V1@*_5:6]J'I9@D[GY!<_K^5._]?[1J@KZ*<U4BO.BVCNO7P
MX2U_M1=XHIKI]".65P<^C:B_TO62C2\GD;3K<"49<8K7WS+Y:[X<?'6-6$R?
MNE ATL),R<NYR-R$7W,;9O=[/!L@@U)'2@$F_OP"WX).(W I 8[SALYK%'-W
MQP\?GR$>B58L3#0^TC0E+/+DY%9[YNOD5BZ!\-@E>0Q>7"TR7(]&<EXP7V3&
MQH6AIDJ/X_5V'\X9(I]R>B]0,:WPY'0'H3$1X30\7GT(B:S3%?^M)M_>\2:H
MD/^_C([9'>$KU:90MAJYO^>3T3P;7'#Q/NH6Y2>,03\?5E#EZ$UQ5E8IXF?F
M/SX2Y+GIM(TO*5K3HQ'"-L-F@@O.;1[NII5:6O-COZ7V%1AHCCY\;Z2+<#2,
MB@;3OAF_Q2.74OW]^F):E/?OS>4S/3\F3?!P\7':7_&'UU=_G35M)I\;%Q:F
MW!1@@N%M8T6!X42$3G0TH42&/DFA,^NEF0GL^JR$'LF;YA7YKDTGA8[L,OJZ
MNM5CU&S/L"J.AZY4Y1(PFAJT_I@G?2MH*7:5F5,RMP2H> G8JH[(J:0_F/?[
MM+),G4X/;AF)D"I"D<PK"U<$X\O7Y)8G)64U%V;6?]^_UAK9OO5PBL\% FSO
M:,;2Q]1+_!":X;M%<+_][&$9 YP!I/CIV8LGEL*Y7/DT.:E+U<XZWN/ 5\8)
M$4?#4\MA*%@L4?$G3] !:_2]U@RWLPUI.D-2>1B-G;_AC_=#XSY5UUL[.83@
M3'@@J;J/>M_IIB8WP<\&5_%NJY%]]QP2(7@)B(?8- PI?&SC"A^."SAK>5GL
M\,3B^$&K>-_]>T\"Q1&4@EP=O:?MJW8X<@\Y:K13=2E%D[-<>?)YR2I,@KLC
M([+2=1U^&(5_^)CVQZM/V7R*Q,*;(5_O4<QY:!P[Y2*PYK6^O/2)T-LG'R\!
M+?5P-V\<=" 55*.;CIDN>1QR-T<\\&,1QM3A]5!]ZM*-+13"D,UBIGC#X'/M
M;BKH=KY5L=IX2$>JI!9U18;9_>?M_0X-=,!0EJ1)\;_2*&@*A.G")GH5T3(5
M"[_K!X_<,D[(+Z[89&P(7E<-EU>3HYD*<ZN^!("N+>0J?K ?I"IXK?@K7D,[
M&%7)\21JIN_"L_MT9>I0TRSN2V=^%X;;W,52OOIOT/$30Q!S?F"HGN-I:&0X
MK,61&QYY": G1/\%"2FQY2OF2C3;_^><[Q'Y]%A^+SREDV,E4"=@HQWT0_%N
M)VFFI$;$I'7HDX3VD]>*)9^>U\:(MJ%A[?^G61J5:NQNAN8G;JM2HE!Z6%IK
MJ'IV&"3]*%P"*,%;#/_'\GNT8_&<\]]1G#!9O$C)?ZLV_N1;R@GSG0,2!SZ/
MJ[E^K'/%_-\*^ 7EQ:/W$3@G2O"QOJK2N[8"P^0/>N&"/QCN?34 ];D!Z&+O
MH7&-<&]T>NJ'<$>U#^\])F=].J";DN?_Y#D&P_Z$2P7-_N2;(HH^'I5_C6L]
M,=4U6G,YG_GIQ;&+N03L-S:2[WBE1VU->^V/I(9K9#"<Y@L[ 8,B"KL YS1!
MR6?7^F))L",ASO2W$C1Y[:P_'01<7VO^G#E[%;!V&S<5<;MX?.X\3+B"CHZ=
MSUDU"CJ0;)_9,QMF;/20\I?<)6"Q[-.W_W=[NC+C <$\:I< 5:GL7PM)\MO>
M?RM?%;O\;=O&";:TVO;"HBS3H>.O"478Q2NWS:Y^';69X'17_IT#M']#?MHO
M6"-(KR?5+>WW)%XH*=F/TA7'*)!@,?3A6_(W+<!5&F[ICD!YH?T/(0%^%R+D
M!;;NM/(+F3W5LNGHB<W6D#'CL%(P]&EWEWL+(0I])3 V>%A]I7_<M9D 3\8
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M<(J[7<($J-KJ1^G%@:;*@/?>DFJVBIN>7I#J4H27?;W0G,EIN*5%OXWQW1?
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M 7][$>_;9,E/_C1R3^4/Z*FJ"^GI6Q)QCH;[FEZN/$/-<5%BM17A[>$_(?7
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M#E8",": AF7CA*\XO^#)BXZ6%-1DWSW*I[QG]^^O9M_2#Q^&==T_OT/(]Q#
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MS#8C ?+PM -DMQ3)KT9"8<N '& ?[C_A$K73*WID":_>Q2M-4:/K/:R=5^+
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M^$*MIL/_PZI _^%Q[&'P>9H1ML3_M,K_]#B+_[W^*W",$EI/=]XFQ70>\1<
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MZ^2K4Q0J9QH43X;ZQ#XK3=8]]YT>B)2W-/!C(2!N0  H_>U76R$QU\^AO;<
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M,ZG:3"H\-4*%D1NJ]9'4\+04DO^+M/^,:NJ+XD71*"HB B*]1@4ITA3I+39
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MQGM,M?6!4?E[#.H2VD,3-%!#])8),9F42BE&OP(G0-C<R5?=E^1F=G$^6G)
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MDLW<1"Y&I8G20(1'R3%I]PQT%4(U XZN)^C>04__89OS:I3-9K +GO0G"Y1
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M))A:'R@+FEK']CG;WMQ+0'L*:KC&O$?YE,^ZUR#]&>EA@OP$2S $QW?9UR\
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M2]J462?%>%RT']]7@!V?H >0IJQTISA&/H245OWZ_4M(=0/J$NQ0BG>W\3;
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M0=GF&[J%S@WX[!,.(UNU2ZWN(Y?4I:R#A'1>LWC(%K2VS9,"\WUN:K/-\])
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M[G0$J1WX[[1B%;I&N) UB49??&D@GO5#&HBWC1TA.NH;7V:5RZ4M'U)F,H$
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MW;3^3DB/&&S &62K]P8)C:N)I;7/AI3H7;::3645\^$=\,DE/ ,#TH=THO.
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M]B [K;!SUI)YW^.50HC./_U"%'T'FG<&V"7U:!YIQ?Y$<KHWL6J=?0E:;KT
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M DG&\^FQH>JD$N0Q1B:_=9I$26+M<B\ S)<P4]MTZ ( ,"(*G.._[!1V-5T
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M_BJM.X-Z4M;;E5W5&K1<K^RHN9]\MYEE9/YGQTWF\!4K06/L!R0VYG)EVLM
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M P13?J[#HJ$(Z0M W\- AQ-LVO+<);,1R[!L<#+WP:,EX*[7)1[2FP"V ^U
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MPT&H1B@2(:'2?K9_-'Q5"GQ(;.:-QUY*U!VY:. ND]RA.59!9?D"T S[:;H
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MH[G3 82R*9Y?'K46W@_C@YB?"X2RX@W6SG@NZ<CWGWFR__WS:85C@Y53,3O
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M'^ &UM\\]HE!.Y>&G5Q$H!YCF@H;AB9BF3W [Y9H\9&>>;]Q".*9'&5A:E]
M6/RCUA_OZ7[!)*Y6JMP.?(KU0><]' \TP@CV97.@32..6A3$][VH(49UE2^<
M>3JR/:,=5$;>1QK<H<P'NS&/";VJ8G+GZGVU$^#]F4G1#5I?*KO\F5?OGEW0
MN,_DO!>B4)"639?IKAYYQ&I+F?"89W%^LI=R7E*,MIC7X8/??AM'6ZKS'SXD
MQP=1C!T2O0[D.J&S8R>*A!P99P,UK!SN<: TYG=9?C]'PZ2B=WUJ\NR/6-X$
M4N/XG_J_5\FU;E2,K?4&.:V_=.%_M,2YM YL:<R:'T_X(K'T(?.XS/V+DO75
MW'!1JLBNR>+!/ ,&C4(NG7L+IW>7OU8WPTK,)=T:=[E>X7:Y!*FC"ZB*]</\
MO1R*S>\ICGT>=5"I;Z[A<M/D@6Z<LQG^L;D _( H00\7&G43HD$WR@23)O>7
MQ3^@]IQ7[\-=Y:*/6-Y&J\O;%T3K'B<),Z)_#G+<#"'YKMD+#8M@Q:8LB?7G
M5L34WF"8)B7D))'T!1S"&=7$^^6\POK,RJU](DH%)K<*\TK\S[V:,FONME\W
M])UC%*3PH8@NR$\IS\\<TW,XW4U?_,1>]#0 Y\5=T3 )-3M1#$LM<&4B9OG8
M%9M9\MB+2^.^5(@)/'-O9__JDR1,X9HX>'X\;&\J^4R[N&\L-M-V=_RK=J!V
M_AABY^>._KW1CV<K\L+JPAZJZL<QYC(;?P,IA?X>J2):."+W9-X_LY$!\?]9
M'.9G+VY#_):PIN$Q]^]@I>Q_R3E>W"B$Z/^[+.2)6A6F0_PTS9S$]G,S4(3&
M<]^O@. ^8:8\OM,;L=0\B)C(VW7U9VY=B-^C,R\V4N],LLC=)][!?=CIU_%7
MOQO\926Q8]N0-?A\B</(C$\M(FY,62[O'CB=5'[?^$K>E_G( 8TN2?3S%>**
M1N>GD/=69F:V+(-H$8GOWP<X9"<'>_8MV"V<R#XS=&O55_:5K^!^L23_]AC6
MJAJ\ +P7YO 8Y)5@.>9A8U-@?)/G!5A*U0!P/_FD<++S\.9NY,M\V9$FP!"?
M["1::97KED\XGU]TPLKG%C;OE>#8R@'V)"Z%5_&Z?B\24FS#W_AFTB(U--C/
M5F1X0KQ)4EG-#'@BYT*/>%Y.?0KTQYS&M#/@>;"A&.:."P!5'3R6*('VB:CP
MRJ) &D1DSCJURXX[YR3I!M'J9H:N+EAKE=XPJ$79&84^Y*J7)9^E5W4ID7C9
M$+* X%C="+R%Z67.4+A=GRH"F!_F)4\,;,JMRQ9'QN_]1F#H5ND'.,>?Y=[B
M_50Z=^#TBTCE.]8+8@ S8FG[B9)8GQ^!PAC7&"690B?P;>R;<BT7F0HR1^;Z
M2KA[SG9U&->;=2AOW8^]AW.8^\MMCSOEK?I8'ZT\B'5AYFKJNZ\S5(T+CD5&
M4SR^7_C8[6.<,Y)L+<3BSEUVEEB6+A'44C&'\1L&K$TX.5EE/&*!ZH41=\_M
MAGBA<*(<4E)?4GN]4&LU^0&O3[]5]'!".4FOO,6<4F7/;;<#G2B61'-I.V_$
MMR:.)+<KN/4O=)1_R&9=R5R8?\V[NKHZ5L#VM85"I \+Y5F3GC3M9!\U<B U
M%VE^7  >"%84+M.J]:^ 1 *O$ZI5J(@CBZP7  ?7#XLW[M4-[;. !XAW1I3X
M,>]7GHZNUHR)!>J5:RI%Y6^9QNXV!]>^8/^=^%SV"@VM:ZD00/06@:A7(R7*
M5UU74-R8;A%2/<<2N&7#^T.R)8=X%Q/^;:;*YL4*U:G)@A#JM6IF4I7%#_=O
MI-4EX1N\2E^Y[1IY;I)-*X6NJ5 ><XN!P>!%6,,38&5[')KV^5?D1Q@##.D?
M^ X-[^QI2  9T%X NB2(MUL;:KEN^UFSMB/JPY<4JDB>S'J[D(4^RTV&@7;.
MS^+J4:M!>-E[.JI.#$VN]U$H,;&B+$H>0JX]3[P9&NP,Y[7=X%G]]"4!F]/@
M\Y/+P^+A*&4G+G$04XO.#%IAC.3&1LB()TJH\EKH,#Z.2V1(R%"G8>4F\].1
M?TN\(R)MXE''V'3T\ 513>#[(^?(=G,JARLA#/"ZD%5/Y&<#CA!A"O54Y?(\
M^5>](O3?8H7-I-;[1?C0C?(/S%G5- 6_+>33JHW+]XNLUCX3XN[YV0F1%'JQ
M^O)ZW^XUQ/4\.HL_= HJ\_8DI9<T6PZG>FPB5CU**?;T,.FZA3ICP&QKF*[W
ML-R[EQCRZB2*=#X3M-K=+UOK XP.?+M%\GY9T[:)6\_\WKL>X!L.[V=]90<K
M>Z_(XX7L"U2;EA,IGE1+QI[;?H#7W9I0*7W9^+O;?>Z%Q%E-BWW?\@N:AS_[
MGX 9\^]\ L,=#@\6WJ3DU0V0KOG%/ 2/\W;PS)VUA[+DF)C>>*W-#CCDL$VB
M6#!YR0*8.=.0[.?QK( #.< +Q4LPK'!%)Q KR!!X-^,<% LE5S+ Q('O<=^\
M*XJ$8S5RLNW0A[XO9IE;+: \&N)AXV#+I)7!H!^&TE]-YQUA ."CK^LWXXKI
M'U^CZ^1P>VRK<)8;S1@O1*%4(D2V2GBBP2+MULE FO0RA,K+1057UNI^EKR1
M["YPQIZC-#H><^.W'-\SB6/CM]Q?R(S8]';#Z5E3-:(GUM1Z]M_8GSZT23BJ
MH45$D2719DJH6'_^"GUP6JWP>XODP?0*H,9.7O0 M:L?8#3#]X@I<2)!_0T/
M]!L/@^[J;_V1&P7-=#>Q\-/&0;3]34HJKHWX!<0ULC=LOKLH>N3-> U<?I@+
M_ULX1L<C6U]3A.11GW+G[\"-V%W3./<Z6[7N1+Q5)!]=P%E:7T5,.R4AFTB/
MU\ B,;+;^_I8"#JO:XIX#Y.:XV1_:BJ+X,I._X1 _#?"WCN<K3?^_T^+*EK4
MWFEM157M4>E"4;1&;:FJ6D6MBHJDM;?:K96JD:J2VCLI@J*H7:-(4M1.C @B
MOGE_OK__/M?O]_LCUW6N<UWGSCFO^S4>SW.?^[[+'Q>NEGH0DMP"MIAY=V2Z
M4V<SNB?!U2&=\%ENLNW)!YHD;%*9^BSO>TMLM!X7)>3GB.[S0A92Z5R:$Z31
M(G:@*2PL_-R,<G#HB^^H['_/LC4'[I>7'##L75:0 -A[SMN=^2E?9EM9]Y6E
M2Y7-]UMSE_NPQ\S#T L<JF?J;ESCU3C'^N7L$;48='E8V";IS-C'A!Z3Q%D=
MM@^*SQJ;6L<VE'P5[BM*(_Q#W)D&>PH7W5>J<VWJWYT"AN_;YC^O?"_C_*U?
M4^;]W$OM0L/;<^0B>?G+S;P\>T:2/^Z%2*1?,G%=?^-_MU<2LB!<]MK/P/'D
M!M-U07W00&:TN)RMQI^9I)#PZUI4.4')!WZ&#_;F2P,/W]ZZ6$H0O.Q*:<WV
M6V0 !</;PJ-U[RIW</;?_G?/UW"9&3;>&57]N#^+^:4N)Z3GMHCK_!L]OI,J
MU?>5^ZASWNJ31N1DX[%']1-*(R#(^E,>.X?64P"787M4J$2YYC+ZO@2 NR?L
M=;CW'C^YHEH#=-%'J2@UB%QX92Q=@RWVOHPG4X]PS3>VII!>3=0P(D>Q[HF&
M@,NO ]!D36Y=N\7S;[,K1Q)W--U. 5'^VW:W#4B\FS7J@3\?IZ'GM5\&,%N$
M:WW=8580^?QC2-L=J+=$^P=N@;<[IX:552(Z"U@7WP ?D0HK]>ZO##B<K]X7
M9$[8%4[,;(QQ:.Q7.+]SOU=2]:K>L]Z#3+?8J9F/_CX5Z)5Y3,VK2"ED#%0?
M+USQ)-VKY>M+SYQ;)/]2?78[Z]#.RM\ZS9K0"= L*\6.8OG=GQO1"!DRD:4Y
MVYT":I\51(H0 2(B@0D'H$BT<&(GZ )5])/#'[4-S[*+IKY@+8_Z6*&$[B'V
MIRJ,@G_/)#UM4R'WCI6@B:E=S813P'MPJC0Z(Q6G[?@MZ=@-DU/J1>!!')X"
M'&AE9J:M"/:EMQ?.LPOP0*$CG+>9S(L$+=YK+:XD'$[A'R>ZNKF70_RLXC"Q
M;795JZ]38Y&VS]--9;KYM=OS0T@?/J88B:U;&F:'*8Y$-^SL< BB/M46AH>B
M D_R@@;"'?"#7VTF&W(>O_:-A%?<:\PFS?7R%?LI>/K=D/SR+UU<QR=#.#,C
MQ=].R&B>?P=<1"A4HP1^HBI,0!\M#IZI/U>=POT%16X?<UZS*+AK;M1VN/7G
MKNFN?(#URR;FTI=@CGR-"*AZEV:X6MPIX'M\"\UZ;V53WT4*T>T# RMT,VU'
M!Q'\Q%%<][-#SN&OO^85=+Q^_#U( )6-%LDX!9SGC^'P+_O1!I\:WV/\;Q!Z
M$Q3]5N198?[>BMC"4+,2Y^]A8"Q,DI(P%MI<!X\6<O1M%K-PHG2,_I4#[HY*
MQ#.3Y%8J@U=T8@5U +T^2%V$A0YYU3D:9\[NX(UA@&FM52605IVO_CI0OW&'
M$DR8B%A!]6/S@]9,K:QGS;\9F]HO3"Y,_5R49C01+P>$IGS?9/;\=T>$^I%0
MV*PE$G+_#/<]\S,?M L7JP*WNVT:FQW6(==<CW.^Z0<@11F+GE$-!T]"RW_A
M1G:;RKGVUSC?A$,(^]_+Y5ZT7UH!LC^)V>VTCV[[*!R&X8*@)Q??:+Q?'G=+
M'L_?R7-$^=1P=I6&ZB6[^'VB9&!IET:"+QH[68);1X..7<M5CY+0HK\4KCQK
M2Q?^X'I?3([()7S[RK.+;>X>O.L(MJ?I0+8'*2PW(*AN?@:@TH!ZN<17,[.0
ML\B Q0LBER;1T9,*=$3!(:ALK]_=RYD"\:K)KK2D"#PF+<:[6T>$1H0."D5&
M/0YOA<>J<BZ/>9L.\Q%/4--!L[]-H-^&X7Y>LXV7O/V$%1L+Y_S>19@ +3>=
MW*-5&4\!T0[N^%ZFE*+RN\4]CA=I;E$UB65)8A^WS*]'C@E674$!:9<J TQN
MB.$%_5[@WL*.37D2OL)%$+#.]H7N!OF/% 8<1TQE[5F3CPN08HO:)1,OH?G1
MX]@3E9T:)$.Y!!*P.-M.3=42_#[L')AB:/GK1/E^**'03&6U<&5V,E-DM^XS
M* AH]H:F69Q^GN%SQ]&S9[_LU#-1,HFZS$(19TB-L?F;:USR%!9-*@OSN$TE
M[->KZ@Y2<>_G-[VBW4OY?=&=-]2^R%]*<OL0+X-R]N[?:RURK:3 +5Q. 9<K
MX4;-.3/SDZM2KZAO#T[D__G-Q'28IP0I<3GX'&O$4S68:)!S)F5IQF'O+KNL
MK]Y6K,.W8G;T'OV:?#96R#F[];2UW9;[BV[Z@P7WY%0WR<^K'83<D]<4<]P/
MJ")QO?/(2IGM>=CY8/DFSB>*M%*!IK:9<$9DY/@*TI[Z@?C>+OCB#:/KKAG8
M%DA:&&=NIHEXX8+&Y803). \WNJV$&-<9V*2PM6$Z\H](ZNS2*\F^3_D>@SJ
M7=G,XVW_FIY:0P73G5(LU^S]6X=82RSI/H-[SLR*-WD]<A2C%8R@2(5L(%'>
M0E7-GV\3=N%?P7-K-F5 OCE]EN:60,DR6=K0/0];XIM%FW^;O,5&6\]@'O"N
M,M S^.'!?P-VT=&]IP )BU2*)&8CJ??< EZ: YGD>WOU=^*+R&UPZ7@ 1*!O
M7Q 8MVV2%GH* $\15I_0'E)-C_FH#T@AFQ=),CCP=Q3C^NO8J#89O.V>-YS+
M>U")K)?!F'9O0+JVTBSMP_51T9IND2Z)].O>^V RO9&(1]#K1,Y:$G//H V-
MSSU!XEF3$",;&<ZRFB&+;; YW^ST>OH]E]0[_;TU^?T8-HC/SYA1X3!_%>:T
MQ03-Y %WQOND3SJM(DD_GVGVG.\V-C,S@%^*N&EP,U6,,G@IP2(:D[<G]"H3
M^@?#?!*:J:OV\9^S0,U8D-)%3SXA]GADC;Y+\>KC=<^RW]W-\&!/+X2"T7ID
MW]^52C@7HLZ/FG,*2 :2+:@.IP"D=P)M41%#P',<K2&..%&X8_)_:[&_H8P&
M3N'!B9"]4T!\?3=<]T0:]#?Z._SW6BPM[PL<2AO"'-[40IZD:^70RA;-!?_O
MT+3;36T:<-R&^ "4:/C?2M#&)?"&WZB#UYC]+20M3>+(DFX7!7A?"V6%UJ]>
M2<6C?G^A!O_O<Z< *TTVVOTAH5- M1G_*> ^:#FL!W6H(W89/FV22L7S/-(/
M]S_\GRF/L45'P"7G2KKWB_&!]S?Y=U!R_WMJ\0,:_P[U%]^_3PG8_Y=ID?_?
M/_03RGX)F*Z+/.V)R0YF?*#I;?'\-INSCS-#*WI^SXE^GCY$)+$>P6J"!\6&
ML4).RVFP!/)!FL#O=VQW_@*O!@T;)A,'U@QDA7Q>P$*K-R Z(4\(E\6TQ- +
ME<'VCV,K(35,D<;Q2F#]^@!RW,*JGF/-WQN&/=OY*:> _L^0Q+OMQ'E42#'X
M\@V[.9^$5YK<#K[2<F=Z?[+BWM.!RXP#XTK,L$"8D] (5E .'W+%[@_?%>B/
M+/O[W^;^'K[UISSTYIMIW7JMU#D<8]^0\]40;\[Y75%L0L#.064Y^#VUI ^H
M8^-Z?0B> [J?%A$J61C>7DT)_N@+X&Y29[<;NG-F2C3%?PKCO!<$8#=\N# _
MC/QVE'LAK[6Y%WKW%) FW TDL^8=5D+%WFR8OV0>$Q Y!11F':!2^>$15&/,
M_)@T\ ,OT?:X^'?:X1.X\<4KC<-[M_4O"PB4?OSV/V_)TPU4\LE'EX8;M$<,
M;(.H,,0*SYF-4\!9ES\$X0\<\GP9+Q-[;NF]<"7^D%D[7\76*Y\J!*E@:WQ>
M&Q17O/5V)XT2O+KN7$L\^QM=7/7G#/;2W?,W3P$P!CJKB*XZ!Y+T!BMU_2I1
M$L/-#L7Y$0\^[NYI4CU4EJ&3JV$PG7S!-7,9&5TRN:2$&270T:UX[NW_,WK&
M2,:0#NA !VZ 'UGRPI*4_I@?<)\";O,>#GN? H"OP/O'[J> 4F6;?YTGXZ<
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MM(W-3>W"G*6 .Z;FK[54MY%N]L;N#?AH[;=6:@^^4+@6?*[QWN/TT3[].ET
M)SN'=+W>E?4</4%*. '#;9=&'F:G:&!G_J1E+-]K':USF%UW?_?D6>BO*Z>
M$ F4VJ&8UA-EN_RB#%RUIB/OZV\Q?#$WVOP%$KQ\.8TK;2V1@AIR&L&BUQI_
MGW@S[U.O60LU-\A<3.AYB+0H$V_@RB@V+O'L'MP9S2Q9G6?9#PG9#"'%;H)/
M 4RZ)^\PKGFK;3=)YKT[:VB=1A//4HK/HCPW'B,FU3Z:'?/J5Z54\H3@;4G5
M3NN./P)5D60S>G5*A/4O- 3<1'2@Q+9)P>TEC0<+'+J/O* @0KM>/Y]^^O+N
MK>:TOREJ-ZXMUK0E(C[PL%+?T"^[3!M8X !Y@)FI)B?M:!U*R!U*'BD0W]@]
MS&OT:0Z",!-*H,C5"1]^1:6D^ G9CJ@)2AEE7R]T:BFZ]U XM1TF3L\;LC3@
M FP:Q(3QWGX+DZJE7*J$,&!-OU+-B,CH.D;: *7QQ1D6-]BON5G#L@^-3>.B
M3SY<2_C^P.-A]O'&MM3BB^PJUZ[WN=-8%6I+?OFPYDJI0D.9IYERU@.A[P:(
M1EN89Y@ /KPBW7\Y4\/]^Y+@MI"[ !031\R\L38M[?I8!9G9DU^<'..D/MJM
M&Y0;4>&Q^^6:T(*A7]"Q*SGK! 5R1TTK=8Y D 0DUH>_8_)@9 X=6S)G5N--
MDR@<X5VJ^;57JA>^-,+^257/7D=$?D4<??LDGYZ4:D#?MC?E\4UM''1\<:8$
MX@<-'\::$+<226&W<[[G.,NU-;WK982):F0,BVZ_?_GC)\G@Q_<MK6[81:CK
MR6>X6]X"19YY4XH I,CJI>%/ 7%BYRG "A-BU^)P%X8#(F%).HCU1TIRPWV]
M<]6BRGFS3B*')2</ A;G6A=CK+[317G$6]HLAFB$F4E<A,>I@F,P['K2$!5"
M:NS&5R4T+V7!E'*QBO+\%& V7J?%U(,H@?O.;'I?E'^DG&C2W*]\OWGHEMI>
M$Y#M)>9Q_W7*SYP$Y??Y*\P1O>:@[Q9E.TGEKJ[#9GG%LLVN?$+L*MU6UIZE
M/_&5 Q[4(1=\RC7-K\.\T4,W+H@)7^W&7\^L$7']7.LX]7O'^:M7SPU;&[O^
M1\7FV= A]0S[QJ-9NF!C3*)[@BI-4M6&0]!/D*J3KG4YU]9NBL9U_G=T[OS]
M!<; G29V#B3O$IQH6T:_YP@U#XMX]^19NDIDZ("X-T4$)@/OKNO>D.Q:/NY]
M99M?[>N][#=K@Q].@FG06VX#7]23HMX*=2.EQBG0^*O:1F=-/!5RA&P2MX+>
M%^":V*Z[>+OX.OT]4ZI3(K&"*J/W7[4CO$,H2$2,(P+-+':.92CYDQAH&&G\
M#_>5?QP8"U&X)V%1QHTMO-(Q42XK=P?UK33#TFL2.M*R_,BGPB3\_K#R]G54
M[^^UP J#&*6NI!SN\W*:5LC'7W?E9$ZF*S[W&\D? FL7:OU[-[:)/'R2IX#.
M#Q2W@_>MZ;J"Q1=RGMKU;=FF]Z8;#;K2QC!"NFQ$[D4X%AB'UB4EY[RM*]#I
M$IKCT[N"*:@LKI^J4FUMVG.+>?CU,6G_7*/#"[FSX5FH8XT5FN#LHBQS)-$/
M]U[^#P:?-(+^M_$]?VMO\"EM',@&/4/R6P1AMUFAIL241$(J.\<Y"L*:AB4Q
M?4./H1=*/7*F'O-+7^]K"/..*\Z5F1.4TG?YL4+ZT7N1]DTC,=G\2]M,B;=!
M8D3^OQ.ZIH1.1?AJ2\E+['\(]R>BCD56O[J3%05=3FK:-2=26/.+AO!;"S>6
M,Q9^4%GHG<<)FZ:=&=^@B5-U*<.DXF-O<A2EEV2':M,HI518Y1YTZUVM;ZS'
MI$LWA-[FZN9MDCI[Z%4MUYE;_%_I.BE"<]!^G@+J<ZB\77BEGE, <!5VGI@)
MKKM579_GA,X9' ]6-VF^/*KJ()-NY!O,EB&8(!SFD269E6;W[DD<O6OGX=.[
MBSF):#'*-@$8#Q. F-A1RHG;^)+L>5;2?%&9 EJ".,[A%\Z?40K.&6Q1 +<>
MVF0]97]M\Y[V'5XCTX68L:&QTJ&#B94TU=W.9DSJC=;CIKJ2'O#-,Y-X%,-*
MP!"$ SIA^P&)L<%M<MZSKB3"NL$SK5\U/[B#%C'X[^5/%02?[&=7#[<Z3?@5
M"!I<<6PWA4P<0)IEGU,,&(GV.+ZJ.R'\,J_<<CXZG:JA6(E%*1#1R+K.QS^]
MW;4.OOE;W\QT45#SZ(=4J*^994X8?U%NR;1R+<G ;( W%NCWE7I"?TQ/%!#5
MQ<$*Z<(6LI%*MXKY<G G$OC8V.?$%_-RZ"9W!X@NB-R\<NS2='Z8P>BO9$5$
MDA$KW%S-R=OHU][LIJO=N*)JN\R#NNSC1^.H*O&&FIJZMQ=JS?W]Y;_Z]XH\
M:55^X?.7&_QS@<H_2WY"N4O<Q1EV F?@.$QTW7#L*8 /RD\*P9T"HBY/MDDP
MVE^9""H(M*YOL T&U5Q5&/4@V3>2';]PW3?]^;UVZ_L>!^7:0N\P)T6%K$SA
M( Z83NZ#.;I)A(?$"4QBV^UBP5G+U"ZTV&A0@:%]=8K\*Z.JX@E\:[K<QZ2M
MG*=O#%["=5*9W$2,4G!2G:G7NQ[BC2ESBE!IO2"2;9*H8W78@[NESOF>AIQ?
M<)D5%I%)BGKV9L:;J.98H>5#NM@HPB8RQ6.))PK7I%,DF%E<RO'EKEF:H^1Q
ML$KQ1L5$U%7C'6C^A,)&VCYS*GRQ#4PT'SY+V:,(*?%#"#W?]#^7?0@G(,Y2
MU%>P0(Z]:>JN7\ !3=(D#^*S6/-.8V;)XV7"UX&V"U-K(9W@)- %FC8%>)^2
M1DSM>0U,H?)6]3P;JS\Y2U)26'([!=BQU>#PA=P[ Q<^IY0 <P1D#M,I-X_A
M] S& >.!\HS!6#J(2GCU6MS!KXT74-NCJ0U2I=<!6FX<W9]8#EX7RLC*)7M6
M"5FXG5->>B&@*?B#'FQ7H:\H[D6P/Z> NIP.\^F=7?P=V@"<NZZ!!.\X!;!!
MIHPG@F3;Y+ZL=IH:.N1[:D<)^_Q-OSAC_='H'9N 8H>!UC"R !(<1<,.51_"
M#+&'4KXB11?TO0Z/2O=?+.=,>KJLM>FZL/HQQT?)[$?'!%8.FQ<8F';,#O5!
M#;#C0S>@8DI:..I:2KB%E41L7_.DA'35MUT4AY^6_HDWAYQET,W6)*[/^*5^
M)+_2+#!A@6B]_3L6IQ&IZT(0-<</-L:G1K19!BXFFW06LM7E.)-*#Q)?.%;2
MHHLI,) TX6%[];UT[X\IU88\+Z"=+Y$3,)'_QDQJMK'PZ0FX5Q@\7@@>A;YX
MSUG1'.NL]9BXD:NX81$G.1:L8T3M$Q_G>BKN;6N*?;MS_M !.-1(O31%#J7X
MD%S)1R?U;3XD[DYMF\1B2C#!G&]P<=W4EP==.P(U#"<4W!$>=!86O-T8-OU5
M8#81F5SP\! J8K.^3>51(?.=9,.NP(;GV7[I^A#^<)#=*1K$#+QU(S9Q75-H
MUH0"KQP,*:>KEK@7NK<_Q?L48_*<N?]\#]A5]7FU8\ARV?7GL*9[9$W^@ASN
MP$8W6X;;7*'GN6"6@&7WG:P+L+,"J"]/B#SEQUX3ATBSZ^5R=EK]Q/08=)4)
M%NJ2ZR:(Y+P:>N_EGDQ2UY,;:_MZ7]<>=^*+;^.5!0XUSELLK2#$$P-JC'KS
MWB^J*5&4%JC<].)/0E+%#:TIR%!D'F7#LI<,YJA:HH2)__ G_Z/>]^.2_O8@
M^4#,[);$7[6C/F(> =0%3"ED&$-+0Z5)*:D$!*/7IT6[]2/>'RVUH5]GW99J
M.7D)S?70DA%M>7F&J03J64K[,93NO]RZ2L3&1Q0M)%1SA.J/*RI9$_)-^P35
MHY@KQ:L..#0K2B5,;A_?Z6X[OI5Q&*CX-^G5C:]-.OH!"T1?I;A2#)%Y,_&C
MQU',%]J97S3)?QIB9W_MR^57Q9>N:U^K"+GV0_1V75.;6X+##W+D\N6Y9MX_
M"**T SMWKS\[AP3>3*0\B["S(8\LM"ZU%ZS4]3&R+-=F5?4TY[C*KIQ)5SAL
M5DL6.=U '2G"USZ2.E"B>\6.#WZABR4%J_]WS]W8SLE1P47V(=:H6<&PSLP_
ML4[R,#3?-<R$S-R+(%J:_Z[ +433)"!(9\HTKOD*Q0%%K^9R^ *@>595VRU=
MJUFLGLA84&7U\&>OL9H;AHS@*[Y"^E669!-Z<%; >A<:S.,DB>Y=( $OFBAI
M^?BMZZ)YO) .!-2=6Z=>K#*W^MIZ?/?F^%76&KQ^NKZ;<@^50'*EL40?"U+%
M3XK@OL!9%![3 [XP39DUHSPB(1Z.Z0KB1-WTIG ?U"H#['RWJ(;P,O7+K1-!
MO;6V>[,?LI+.VKCQ;H"(CJG3[KC4[XA8\ 6,K_G;&>D<8C$!U+F=!&,:DYR@
M I')8N8\M_&B!O)L(1.Y(X3D6?V$&<OG93?30[<D+P#.KA%#&.^"8L]98E=4
MADCK;.8L>696+CF+I*8OERH,61Q8RUN:XJQ\66WCS%C%IG!UDGAX99OG2;QE
MHI2Y'#)S4<K9MJWJ8<Z4LJ:CFFUGE7BV-+7N68:O:KYPF]#D>MY!1C>P'O0=
MQ$3U)BYL;.-1<4=\T:38[J,'V@LQ;<*?327YCWH0_KK9OXR>VX.D#;,]GL6+
M<QU&_Z(V=8>5%7W^[:FND5N&#&%**4 ZF(>&AP6+=_EX>KY(ENKNQE;=,;P@
M^W54AY/WMLP;[T/L?R_H**XVK12V8R#=6_7;6$KIYSAA $H>O88EU&?&3+U"
MXA55L(^/@AXYK-E'V;Y;U58DMHY+Q?=FY<6X3J)KZ4UDPZ9GS*/@B^]G$-T(
M!J_7P+A]OU0T\PCT"@ZB@-1XZ.U'.#Z_A^)13_R;%;I5!T$IZ6(D#]\- S3G
MZG=J%LN?>A!+=M;2"QRW;W3_A:RII/NQY"[Z\^#L- 1F"H3>OQY?'UL.R)'T
M,CJN,/]\"G"D55K&9VOS$"X47^M:T>0WWL374-WD=&]N#PP^>ERV.I"^VBP5
MM D?Q42 Z@P[%F8T[DY138BN/2WN*74<%R$QNYTS594EM7UN?(TN=(QZ[/]@
MY-/04T9N2?WBRTG*E? DC!!:$#:,X0A&)"#XJ98NBR@ )?1)N#LVMRCHV]CD
MLEL$PTM22=(G(Z=',,O=Z\R\.U-4;B6R7]U)-OPIXBV&S=KGV:0$$9:'!W*N
M7>]=<O1ZG1/W5*BI"?WN<[IW15C8CQ=+H8$R6]?_R/_&>-,MF O:Y#]6@;I1
M;GY==;6)[4:S3%VI'EN*NB\SN:FPA!GA4WL1^V[MG7UH./O+,ZL(1&5T'PX[
MS"!$3ZC55SYTL=APK0C:V-I.1%^=(,CJ=[2&&5?7^?2Y>1?N*8?6-?FXMF<I
M;<8OC79;=NW UFQC32>1^MUU)_^:;E?\FW5OI5AV"W$D4]4^0C"=1UGH:AR&
MQY-/:"OVRXQF^N0IP&1\D]!:W1+=:UW(XIIV^\R;)P)R/\3 Q&)R*D6)U(4%
M<4'EB(V]KT&)T+O$6"P*!XQK>9RG'(:Z 'G+D#.&&LE2[T<[Q,BUWP:XYU*U
MZ8_K#9NZ!)7]GT^Z?$X!T5DH[Q'(+%DM%L_\5C>X?'ZKJ7VT?C8&;<XR:Q=Q
M]U*I::"+1QKQV_EO9ZS%T?^M4??P-^440#8ZJ:.)=)&0V -N#HJL8<<Q(EZ(
MX8TO'"=-FBP*8:_@I16+;SZ"!(UHI?WF%KL3Y'7,B_M;CJ,,6:]-V.:G?"U?
MXGE:!(6^W)L$\=\4R2\VE"U0<,P,3FU(]+'#'LKY'V?+1Y7_ZNHLO3"?F^UO
M;;3 <'5"C)E]JB4+^>%.E6CK]KGT:<P: YY_4Y@N-MRQ2M&G %;=0$*R4A<]
MAF@J8"=/S$5=I:"-8!#/@NWA\[693I['3+A=[M"TM)=FDU(.0#;8T ('Z(DY
M*VP.6(=(H7%0;TVI^<WDV&.FKL$T*(]/ 3TM596E_S0>G9>:9$+%;(D[B(H^
ML8J+;GRUT_'"71JM1S$JU=A,I;-O.:699 ^1G(+QPKKU!,?0P'^KH:_*@!>I
MS],$3,/+[#,UC]UJG/I4#+J6DT.X]"&-5.[Y^?EM&IL3_6)V;H-D,HH+,B3\
M^>?=@W+9L=%;.T1'XZ]K(X6)[\R19MS1Y8L[5>)1RI0-/0V&CB81@GJ7Q><B
M@S92<S;OR'?KJ-#V4@$7[U\HR1G?+Y:-5^_O5K=9Z[YRZ\J B/!"U4&)U<V/
M'\55F@Y5B6D^8,QZX23HV6=O^]ZZK*!@M>=1F'K;,-UBQ$?FD=SPCF?[B$0]
MI9-//M= [J"+4$T2/)(J5>$E--@%43(DB1(C31&F8XJ=YT>/UL@LBB6NPBKW
MH\YJ#8^ B;:#WJ9YY :Z?UA24FZ:5M;9P6YZ"+6N>8=+)4?E.O8,D:YM2QH]
MC:Y$_UQ7VCX%O/IL!GDJOPP^"Z/S8JUZ*]T0G:3A[X,VBSE=Z\-1ZIB+;=;X
M>Q2_X*)88AOL<K1B\'FUWR]RG8H?\H^:!H%?\7G:=28EA?%3^2-Q95DD?D((
ME;MX<>NP+IRC!\'SD<B,*+L_V2CT..MSK\^3LIY[.I4_^3J>QMR[\NG\]=="
M)\PL=V.!8B^31:2%N2-+KS%]V14T_SV!9.6M4;#*>FU%$-A]ZGG'^NI4@&,M
M0CZZ4@)?_3N?AF3P=WKQ^%J,^"?\&L^WUT/YI?8I@5&1I7*M.P_S,Z\P5HU;
M'19_P2PX_Q=F?V'?]9@HU4J=%0LB$*0#YYI?B1>8DZJ#"TLVQ[W*^CP[Y.-;
MN=WF6-OK(SP])]^KF2+X<J3:7%D?5D8GE-A%1 *:_5=;.'$%VV*3!!7$F[B$
M%T%2[S8[M&L\JM\54D]GR1&<%J_1;BF6/\L:H0QF@'J>O($_0UR$]6)XT+S_
M3@$,,.",1RZP"\BU]IA?XD[CL1<%84R<&+.G?') ^R[8'@<9?;XY-M3CD"'1
M4M +HH-91TNAQ%0PQ^^#7F?N"36==I,'1.;N2L,NM$C*VN/W=JLKY@G+'D7#
M1TU_FT*E=GK[1?,$4/V!NAE1I#G%Q&%(@& 5']KZ_6+-7+AN?R4KZ:=$(E+#
M1-!D^@X'Z_BJ'E0GT%BE4:7.[@CF5.BOQY'X4HN9L^V<>(Q?%CY0083(LV+T
MQ-L%>=Z$R9K.X&W/9RJV=HV5:_XH_>-L$@Y$O-\$D_-^A1$0I=";!#^*'/.&
M)_'8G)(3C@<G%PK4Y>#4D7K1!%$I7\']1##G79&4%J;2U.P:9Z^Q]S]?.MR[
MGWZ'__6.X=R9.VBBR=FP1LQC, IP]&H=_ .YH7%\!:IW@@0MEH,:W./T%/_)
MX1=B@6QZXMY'FX@HO^=T7).N)*RJ-0CY+#<C>>6^V-NM#JIT77AOW9(B_=2*
M5U=7..W9=/V%4X!HH76W"]&.W>;"P/2BJ-;C;LQ7BT_?ZOZ8W&%'@:YFC++E
MOMZ9/O"'!1>X!>^(8,1CN!HTM'J&F:Z^QQ(,V7C/#Z^K)"QG%IL[=&KW-55,
MKQ^['%^C]PL8]'1X!M/#0J0?BUTG,4?J^H4&*:J"V*A6OX =VHWQTD]^%M^)
MV,&[0$0O%=X8YGBO7.M_V>8?" N.=SY+,5S<],9S8(=Y_\VS$&UB?7)W'4AB
MF%#1E _(611I4#?J;_7W^W@[R7?O+@GGPYCI?_+R%/"4KJ-;##?&-#8-B:T=
MN3+T+)$(9E##<%"RH(8X[WNCOL%*')[\E_I.,B"3!ASJDKDZ;M%3K@H&'K]K
M&L4V26,X\ZYMBJP2E=N;'$Y";6J0LOTB<YEZHV&B4&O2JV:Q<K'4Q?5UBB*^
MT$-M4]WND\._YV!U84AA@ 3WSWL6?,+ACB'L+]'2L1SN'ZQ?C#&E/S\L@*)$
MWZ($"+L/F%Y<16J9118+*-AC+3X7J&T4R5J-E%=RJ+!@H491A?",YU8!&\\#
MLY_(/=>\\,)]_T*CH'%%DJ-\\ZZ"SJ<%S+7GN>@*@S$L@@@>ILALQ[;1$_'Y
M-GM,MQ+G[_ J>4L"BAVJUS8.9>0S_.T[BWV^)<"4?W<E&ZPD&R5:0@*7B;&<
M?-$#4 TI:A54.%$#.WR1DH/3B*W;O&LUU>:$=#H\@B6>2_-JS/WB9?@D?3)<
MFYDC6+CG%>!5]CHXKE#UI VT&(=A0PL,$OU,B3*Q>E<@=X:PJ_*XA5@$:PG)
MN>"SD[ZO2\I66)[TL<7=P!N'E=#AZ&O/.F83Z Y T1A:Z )S[L%G+7%9$QG>
M(*;@$Q?),2I+U>W+H_!O5//P+]W!R'E/B[2_E9/O?3:V/DKR)5P1!,G)S TV
M\5]-92-0$CG2_-7U1?+X<RPJ3FHMLHQ#ZT7<0HR+NZ2,,[]->.@;!)@^CMUV
M%6X,@])L>C^TXAWY[H*U<!O+=@UL0/M4LI6;694UF,U !2ET$&";&_Q\SJI]
M6LW,8BGU1OLI8/HNC56?: I:1&(:#+&@>$1=<OU"!UAPE<9.[-TX_KR>.[Y+
M<3;Q4Q>\MC=\7G\IJC%V,\!X6ZA'L*!O+K!W?2&Y#7C,"XFDL5XB2N#=XZ@A
M7V9I4T2H[%0QQ1!GXL?KQ3=SK9VX:]&0Z^-@E=-9SD^&E8L[F$BF.0]>'0#,
M6'%% I/I;&:X$79\'8*DL78=PZ&R)([OP[$MC5U^4>6+8=O1-#;T2+8/Q_>#
MJ@;4S:G8%P_R7BPU!3B]5^XZ^<7,N\_<JR-L J0H;6^8>[K[B;8W(.B$>+>Z
MNO'6V9GI#N3:I2Y&HPC7%-EQ\2K8&N$CZJ[60, #7S^+E+N6:OWSW%U)CUWC
MERL,+G4_*LJRP%IV]JNF'WC/^_=H.:NY?57D"ST4<\]WN1'LH'T4XRUB#EQ\
M*6!GIG;5.-K13,VB +(;\+D_PLOV&:)IZV^#.3F'T$BG' >R!S&X-Q6F3L>O
M6T3^6.MY^;#*I_N7\ZQ:;0OU:\8489Y55?E7[MUSBNXO#Q[RWIU=7*#RT5&-
MA=)+@%-NNY!0"6B1!4?G7J3'$:8;S.8(T>B:O]+>U.3@H*EJ^G@Y%-^N4=,2
M_J&SQ+?JJY--+O4%O8Q%T$86&((7*/(^!S$87WES;CHQUZ9NS.)\Q(8[Y\\2
M0Z+V07P=^$%W;(NC/0&3J.JD[:;2[1VF]V_;46G+:D;^0J13R&;(,82>5 1.
M 9[PMV)2%">.SM3X>2&26F.T;]!PC-[5$8Q[9:#!9)MHQ71GS;_15>VL9B[;
M+DGB73=_G<-2A94/%+>+=FXP0;HNJMDQ;II+3 BTG[O[IHLP[YEA&3D08*S9
MDL)S4B+%FM%K76RD8":>FR4L)VMPI#&1"\F*#\WV$^$+Z6IVNY#*[W"NYNM(
M'V$WMPEB$$BVML[FXG5_S8/ ;"M.KNPKDW3PPUT+D7!VJ"')#V\>7W<*N #5
M(69GJZ$X(9_(3C.^B-*ZM'LY-:: 3%WVW<Y+>';AGQ8WM(  :AC=6)VP+G@M
M+0-7:>A 28436K=Y_N7:Q.\M7(0JC"R3D'%XXGPCQXQJ9>##L:_S2M6>!]]B
MTK5DLIZQ)CU+T+U ,X7<)2@ET?Y;7KCY%""\[Q>G87-4UKZXS0B)[7BZ8A6Q
M))-QA[B0$)1HRBJ'_B,TK-DX-JD9\D.@5E8JKS*\^Q3 ^/HDBG:.HD%6H[B2
MA.DGV*E7"."X!=XV+3U,!07C-/IIHOZ#K@J>]R*2XCK<M@NM!)G6_?'-)I9X
M<[4RSK![T[.\%210O&]7=RS>Z[E W]*<I>7E&(9KY<81/:,IK )->%&OZHH-
MBZ0L$]G!@3](ZNC-K.XV_<)ERH7:6)?(CKN"75:!+4T_PP4GCTKM\"LQ65)&
M =I]0^RY&/':E<FUA4^(FL;-ZF-=V#2:IY5D_ATA:@^)/+ZF8T-BCJVZ54,R
MC#'=^3%)7&\QT4UU5TT43EOJNY'<I""<0(/"_?QF$[^3Z.:Q ;E[/Z:LK1+E
M%QNJ/V&P@WR*SAY4&1Q<T'-*@^.SZ5=[\2\-I8Q*OI)I!U&'+X5Y_RW4''0@
M6&@#8*(S*!Y^GL9YBR9 \2' W[0,8\.&S_W^,?+OE7W5-Y]2!Q-YSE?Z[L@6
M'=M[LVUIJD7G+9U5CE_!AA!GE^A=/ 0;I#'GX,PC@9T@7OROX-1XM%CX]0*=
M7J$&9%BHZ"89P]K/]*?[I[^^2!6KK^V4A 3B"PZ:&'UCZ$9/=Q<PI=\__U+2
MT(V98">EKRY%\0/N%O571_T?9;U6)E<7V2LG.2QECOZAHB[Y,W,O.TJ\\<_F
M9GN/@[1R9"^KR1EX%80^PG:/5A@,_T%:/$IM^#3CZ3S\B59.$Z8:$\V[%\Y2
MO/'N7>VP 2R-F113&.S'#HDT#Y1**4=^>!;EY( ^]Z_0ML1*LT^\U3W-,N?0
MAJFQD!/0&J_P$L"0;@;8TH>&H6B_,-7F&ZX^.+^W>N*48F+DHE356]SO*EU1
M(L%RZBM5MR4DVGD-4KDRIMH7[[$WV<9_-:DT9Y"]/K&<-@IB/ 5X<T0O"*,%
M:0- ,9@H]3:E.(38V)W]VKHQ@FKM&1S^:2UW,AF.]'A=\).\--_#._XW3FI:
M('[J);,O,]Y_0-ZZZLM8U]/5I2P2BT6W33'(/;9SZ*N+T,1ZS]7,+"FI32F^
MXJ!1[^#C>[4O;@IQ%5GR1U;DCG0UZDI=_65=+? ER,GH4=$=T_%V0Q99&?9G
MN2/M-,C)1_AB/? ;:F.?P$Q4KR0H\4 -IC90UU1/8,"H0H$F4CTF>MOGN7=8
MHA^GHX.IGVA2M7%*ZL\OK(A<],^3#Z> %\#I;7(KL;TW <8(O3/:YGKN_221
M$GD_YC8[!I=7\9[ZNU)M\^H=Z9K\(H9(!8?AG.7M_M2_QS264\#Q$U@_Z%M,
M#@'S!M3HOM%7^6]!4)4N4-?L;5+0LG\HTF"!-9A*^G*(7=E$\KA_R:OTUIO=
M[>,A6DV-.9M2,#<&LBN-I9NH0>;)([^G]!Y;P7J!@GN#!L-X4%1=LOKV8DCT
M5O'HWL+9:<'B%C3"CKB-4$@.#/L2&2P89/GB9QK+!P/Y?3W%Q0>IL35S3X]2
M+UE6QA;%EF>3^+?\F]G#M-/+RCX1B>"'23BY\9(U*Y\ V6&[;I-=,SX"=%OG
MYS?T&/"=%3(1:Y:M%'NR(1V8WI.;FZ-24:7]*?,I\KSD:(9GJ_'"QT*=DW:Z
M\HAYO8U-O0 A$&RBH#IX8%3+/?NIE+UD@[V.L.+IN3-D-V55U^&FEH!JAPZ6
MD%!1&X$^H"IMB*X][?Q^AY#3_IO9QHKII*F1.")U'4)A+>XQE7HR$)CYN0Z"
M3J^D(7^TKV^5=*HE]]5:[(;/J'[/I,(=1-\"*ZP/P0[RPE"N\6_*ET'M1Z>P
M>F<H@3@E=L@\G'5.B]9#TJM[JWIL"L(^3GS[V?._*7&^?*,%$1[<E]/ KO".
MYR"7X6F:^6\,GKF'KD(A$ET+%]%2M*$9]0("XCRDHE/;\;59A10JUG<37T^<
MRWGU7-I)W7,Y A8]X&# %NW^\S'.EV&@^H.8?FJW>U:MV>7^FJ_VO2XG2==#
MS>152I!WN#_AY A7+"QBU4K-I\LKM-3D'2&(%.7W#U:T.RWZKQ\^-_S@2AR^
M:'^C/.XGD<(Z$AW:6>/IDG_EY^(FR/-YNED?;6_NSZS=S'!8J/_%TH(Z\YO=
M$S_+F=HX#6*,9+(][5Q3>&XY_7UE;2THC1%'*\([_$%/_*+FM<S/]A'\>*%W
MFE/^3J_-7Z:XX!P0_!";KBGE?I>F6*?)RN4(^7/UP7YU7"F?>=X-@EEI,_#Z
MWF[A5,J5E0Y,O+)W2 5^(4E]X0*,CXX<6'$[4+VO:N5KX3PX75 &8$?ZV)'^
M3*D?6 P6,'\9MU'")Q_@?BB*.&9CEVARA_(8<9XF"4FT:"'V(,J@]TC7*HYU
MUE]7(0D%3D^8K<:#D^^\"FGUK'J6R5(LUW*]<OM1&B4 E_.T]L&8]'#@@;EF
M[[/,G;FWG04/;CHRUQ[UR O&96GW7_?UCV9]E!@LG!%04^>N2Q("S00%Y&,T
M^W;X3](BAF12AXJTZ];'>N5'BF*+>$5M% KLFJNLOJ+(F#+SMPMU2AVH&9..
MA_2L)$4X!7!0[Q#K:L.S'4[.[E_+[3]\).; ]N_<=*4O;I[+]N\MAABKD!G3
M4*5-Z^,0V,^%ZJHTW@.Z@\3QY>I5AWL<M&A$[-4+(9/V_TD\M_&1N!L_Z9!>
M:NM2DOCJ>MX0$UQG@6AR"DB!G^.FL7;0_0C6<QTR<.<D!ZT%U29I).[#F2 Y
M'3.]D7NG #9*;>?1Z_EN5]SF->K-]H;"VK9TA;0?0L]S[W7Y $+@WY"=8$9X
MQUW,8@F\@7E3]/@6)1P:CD-%H2^G=BVP0*7PPL5AN,%S6Z,T@F'[L5FLK+)9
M0T2W4EWC?,7%C9K^#HI]$CBV&6;^?OE]_DR5RX7_P]E[!S79O5& X5-$BD1
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MW<NFCC3[E;G?_#VGNN;R[TD['C)')#PQ<"X"?XVL&J=^7'6;KE<Q;^CE]+#
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M:(R,,>#S/FAXMP^?!5.)K/D.(WDF6R^2K:A1XTQN)%\#4.M[+".?[D:6RM7
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M035\NPH9B[^2G1U"/[.(X#(.XM'4^CMFQ_D^VH3/4);X:G!WY&'H[J A=1#
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MN305^L-#4$P@Y=,&7,PGOE5_L4F]+.%]%26P^84!A3UW8'!U*.W# ']!#%[
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MN?R9QR[]=;6UK:"GMN?QJ0"B8FO-)+W^\F+]=*CUAT2EYWOHB\#T(4C&E;3
M> 670!/PMED':YX'QP]!41=8?GGC$.0"_I[5 :ESC6V' =E=H4*U2YBD2>;I
MX?>C2-6/&\/V[IDZ>F-%09]K9UY^;52TZG^8^_FI[SOF4* DE&!9U3ZZ+QZ\
MO<>X/;0*Q]6_=E'*5OKZCKLLA"-X)69>2W(B?A#IKD47R*:>SK-Z!Y^N)=;V
M25_YNE5LDA4B[O\J*<=Y-E-[ _&>7,+_E(IXN4J'=5GSC(F^&/(5?796K9\B
M@KSJ<7]@V=)T)?-LKK5VW[C5[1/3ZN^:#E:%GJZ>7!%=,<0\W;YROO/1;R14
M,^Z<T_6*4 U+M?1+R+I/9NF^R0X836JSQVIO-)-[CK45Q"%X%TPB&OU7+G1Z
M:;?W8 _K0_'9<B#[4+\PHIE0I"4@6>[1/!4MT!%Q8=B1=G^D,L"S _70N\\/
M\[#YVP?U1__U/Q5YC/VOC;5L'=JXAZ,78"Z8V.=_8-/^_H>@5QR'H(GN,%P4
MRI40=0CBU64KI:N087@L+^!)W*ZG+FPA.-TS"4)IR!DT'25*NJ36.(-:QA((
M3RRMO^&?5Q&.)'Z]M"V3_^:A+Z"S&Y('.Y+020!?+_<P+Q)Y2![W4'RU?#LG
MIT(\K&_;)_*+[[;<1K#](>CB5Z4'GLO[:WK.WY7O0O@D3&R1+W-*K/AL>5^+
M(T?NK60%5K#V'[4XSP^F"]3T9>4#&Y2X#,MKON4SOK&BVC)"5\$>!TO4/$78
M(@Y5:WI:&'8\0$@F5LJ:9EE\A/>"D;0(09*"&([K)+R G( >!TQU3Y +.IIA
MD:W24D6H<L/W;D_KA+A+?_DI-_Z)T@SRT5FY8971^*!*PM(22Q9>I.(H6D;
M0 42-JRAFFA[(MG6.V4I+/N95Q"\.C(WO[XQ1_MFHF9:?ZE^U.ID(UKL7DDW
MTJ(+8?ZIZH IH(N_]_[7S4D6%_#4,Q HN_)YX#NC,&.9>B>+XQ%LPEN$N!Q?
M^.FG=6N9@%ESDODO%NL=\BY\*#X7=E/SP_S4GQ;(<Q39E #<P3U8 .1W.A"
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MNID"NQ9P'P(-FD]K+^"AKLYEM@K1)8B=A9+$.J%T\'EFL24^2-ZE[H=Z)L;
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M_#&EXD>6DL\MDXA^EXTD7M+H*G:4Q$]H+?)JXF=&@E,8P1IT6,3KDY#D5YW
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MOYWZLYXR60?O/_J?#1CO6&,5JI*HCGT9)R_MCHV)58#5J6K<0;URB?VN_<^
MWLY4E<1XX^V<V0$\E'M_=LKNIK+=O^\'C#4?KPNJ](?3(PJ?%!'(>L.7ZIB#
M,'Z,7A1#S&=\-%X<\]_':%Y$"TYU!CSX!?/\X5?$UCWS1W RHX#RTU?=N\_-
MEBAA4,^;__,QA2()^L; 7@VF%HF6)8BSYJ?7AYO@V3%+$GG:PT5D.&$5WXXC
M[YDC\J)OQL^F@=D+A,EC9%<>0R1-6 K()"6UM>7D5-VZ9G^>'!=O<_&E665/
M-M@K&0O=.*NH=&H6W,LX %%!YZ3?8D3>"GI821;0(3,1*M^#9U@UZ=<>;)$A
M._TDCKQ6-V OKP"%=PC9XT<:MJT_HJ"Z?6:^@Y3D'!3G%_0QS11(6R@[;80\
MEB( 3M!J^(SB,&5CSKQ+;U7 >3UECPLDCO0/[RW <C>.W,%R81Q)/W9^TC(,
M(6U(;"WIZ&S4#LL&J-?F"4/9NZV"RV\"[3QG?Z$5"9C17ANB'*Y_9*+X@U:A
MG>[/FK_Z?U/%+':ICY35W''5_:LQWW]< 6ZOUWU+2(E5G<9^H><2<VP450U(
M?IMS^8Y W(>30^]_Z =B/K;^C<%N8A:%0HFMU8/5,4HR:E!I]35< 8)1>9=M
M=N3/R>%<(ZOJ]=-^_ 0# O[(!\8U/BDDA-K,=+\D#4^5=IH_LVHU+'*;2/._
MO18$J@71R>?2D77S44Z=M/19D*'"S?<##A:8#(UZ>35-:E[_([>DH7<XES>W
M3D*\*MW)0CV?Q3!O<YGW=Q55+]9<TZBBA:=UH,=O>XY_ON=-?@!JX-+JKUQ)
M*G2P*AV6Z&36:YM:YW^IKHCI7?%2?LT3D77 XSSEH^QS?,EHKLJ?LG)WJ@A[
M!4CN$B X,;%?T/2S&]QSOC3;33S_:!?>7$ E^%D-9U<=+Q>A7C[@W[XO[>,L
M6'H1FZ.^=='B!N!'>)[*))PILO/SD&0NHQGNK^'H/[$AA#5LRY'["8'I(E^M
M\(6#(2HGU;(XV2M /,SBNNY9%FG&JR+#ILO(Y8J-]E-'F3<1R'L@^NY9&_H8
ML@^3BSL6%G^,C>4D7.U^GXD@C4[W5-]/VD4P8^$Q7.B>J8Z KUX'7$J/CKHE
M@J+-VC_S.S1NJ KUKFM/(L8BEN5&!Q$?L65CE.H,QZ=5& .5N9[PR)WQ>;A)
M^_N@J1%)FCL:12PQDWRURIW:5-52-A*Q1?E/9Z?NZ19&M H6"-.G"0LEI5-2
M*)H^%NR,9+CXQ[INU^'F;%,%:+& >O*S;B&W!7#_%W73R/J-YHCYO>3PN?%F
M[H[/@(V">?9F.6,FDEW\!3L^#;O?Y$!%,"__7F*4XIDC->6<?YZGZ],S_M5B
M$;Z50W4!PY_M1H2^[)4 4_Y[4:'CP"O[\O2'T!;K'HA+OGFBP[EPD9Q*FDA9
MZ/E&1W,*\!DWH#L0]/W0P8;50=>\RV/%X\Q=&=CYSS+LXQ6 Z_PA/M_*<F"%
MC?%UG0RJ\D;XC8O.A#?CWD>BBAI!5H:_\8IWV7WTSQ<-XRS3-QV^UY*?<.?C
M6G!CD>7[# LQ/5D6#GR$D*J2##*+VJA%5/.<EAQT%(S0'JKCB21L_',+N<>P
M1-?4Y4L(*AJO)C[!NJ5ZZ'P2;@67R3I^<)HL>%263+732+6^V!AY!;AX:B5U
M!>@U9K(3EUB^EK0K-K(.YL4=5J42@_QMXTWBZPV=P&K@WL\QA#%\.^(A%J9C
M#\/ WLGO? %_3KL"'+![+_T-6.AS2QK_>NQ\0^>9:LZEC?/PC9FF9N"R2?,I
MQWJ5UW$1WC+1CFB$?+].C]?@2#=-PMY.?A(N-:ZN[>P\B=12$?H=3'UCT.GA
M;+[&E^SY5=?+\ 0M%HMWY"PF_URO)SXBON6974,V(!R-"ACJ<.A5U8=?Q>%N
M;/$%ARFKN<:(_ R?N]X-%SIHF(=,DB"2* EG<^?Y?07PLN//YA3Z$/1F3&4'
MM/C;]_LV*JFBPC8E0VQY"-Y!+QN.A682W\%Z=#0HO4#D2/ JN[V!LYH#"R'E
M)4D&VU3>^+YD8Q3M/GO7FF&H#A4JH-5,.>9*'K5_*Z5'(U7%XJ'LFEBDEFK=
M<, O.R-A,25O*?&'"+'&Y:& T%6_1U< G\N;RND2W]7\/M<_=9'E7[2F5Q(=
MWC I_K:^ :)3-?%IZ-PV+?O[)T+D,=JZA8SCQWI>(OVK A12(^.Y$E/L,Y4+
M](Q@;%(OQEI7]S/@)$?'55=;;@0%V(*OJ?%Q=4FP1Z/03KM.[JK/OZ+_^DYO
M*%0V'^\<=Z:<*<F/^/^BK>=,'G ".XHZUBCLSO1/IUF%/T 8-IN:^@ZQP9@)
MN9;3I"S86OP($)U/#"Y*TQ#T_'WA^N7P<(ZW'5_]:X%X+2BBG(B,LUW4T&$-
MOH1^MGHKR-O!G,S#I,VI/X(>O@U[4B^*L[*4:I4M##Z:*,G5O6V<7J.^I*D^
M-7LG&W)$8O_N#X&?)6K8QB!L@#],GJPD-#9: C<M^R6G;N=#D@;"JF[6][VH
M77J<4AU=05H6>][@>ESO1?S#8J(5R8D5T&)Y=I/O__(Q[2@^ 3XAEL]4 -=[
MATF=7TCF#PF@X>-_;+_$2]RA%OWR^O_/NMO&7>F;S3G:L'X<MW=<-G@H3:%J
M;Q^PZI='O(B4. '/!0?*G!6EPN0=004Y(Q3C5C,^NH/ID0%\ZA27JW!Y+I0?
M?#MQ*A$WF?;_&(:*JG-/48K\#!E'^HJ6-C_9>YNBZ0^1OX$/[2FW:,+RIKX(
M"@H-\W\X/2A1Y,Z;$A&"KR+#OW[W24W&G_T-_CN\B_Y.]5S+^MY*9W;W'1H8
M!23LYH$,8O&[#IEP\/)U<?:"'()PFXNP&/G%GP_QD5KW)!D>:SR^ OR$G.X\
M3B>0O,ZO  \W[LI2T+_:PI&"&]Z^>;.0]?;9EWA10%%BXLGW\2TM@5N)]*T<
MQ&VR6D*D;S:?(O8W4R"_&;^,M_BCY'"^3WL@"+2SS1G!BIU#*?_.'83RB"6B
M(B95!I6IUOGR-KLV/O^O)UP7C,+Q_XN=[#-C1LAO^Z*S6OT\5R/7I S_!]UC
MMWW#OJMQ%12Y=_=XTPT5AJ=='L':='?IU<']"P&O;/VDS#KQ%LVFKGR0(> H
M.[?4\DQ%]9S9$9QT.TCQ$WH;YCW^WB^B&H.\19KG9_,['29?FD0Y8SA.K$_*
MNX_8P$YM=T9KWO8D\-)!RV\"E-4Y:H/:P4[*$CO)ZRJ4&ID$Y)J'),R5@2!A
MV8>D7P%/[CB07;81F1$$)*I+9$9!B"UTE8U(G2V% ='O* []C=_],W T\*+N
M+CC./+9K*64!P.%HK4T16/2>,C6O .K[<>SQEG)_)"6K9N737I7WZ!]YCOZM
ME2H2@6TML9H*CC[/(PN$\ZU4 V?%-,_E5\?\&[5X.C=281U##ZP2FXJ\C#R9
M-M_EU'5X:@9LI-5EYMB4<M>U+A^5B?@OL!)^!_U:K_8-6YM+A/Z$D9^,+W"C
M&9*@#)Y=(CB1MPU(;O > D1(Z&47<Z_>P7&::I[[+!8-LB2R%'7-]KH#^+SJ
M"'$(2+T9EC(I&'G3BQ$"&Y@K8)OS)MZOUO/C'0G7B9/V%DG1GLY9>#%[/.@:
M/O$4IU_)$Z4F*SZ S%G]I42B$:@F\N*J!T#SQ_]ERO";3D$%" ;]H7YH/]Y=
M$F."3IV/],1 GKR*?#7#KX2HLR3?A9G2POOM6@J5D_=^)!6'8 ]IM^9'>2R\
M/@1B@FBC2MF9:EI ,#E?<V9$;(^CBA#N09&R0X5SF):UZ(]VC@!^1I=6<SMI
M:[A^ 3]EOEFU9JET1:LL]4^3?%I#7X\+!B_.P*E<L#TRS+H>A?2"$^XK)0+7
ML@MXFR^;@<Z'"6VK\:?&[^NL=_D>-1#JG8L(Z=8=C?!GS4U1KR2B:XX,,\;E
M;'8EG54S'@Q-+3PM>0S:7L1377Z['HG>J_.AZ/'!Z8F8F$9^YH7E'9+ I'.&
MH9\/1ITZJ'3/STE/3CI7@?C0$%'\>TQ**%'?^L@+^]\[G<8K +GWY2<-)>A(
ME^!E#M(-Q&@7X4J(PWVQ9:#788LIV7WYH^@)7Z'7*_8_?E)2?V1\#S>B'BD[
M-\0_YOC0?@6H/Y^Y MPJO,SK,+^0)O4!J: <A!6%9EQP5GA*@D+[?:9R\#BF
MO+Y\<:=93.;!R@[^N!\<W,+?F=3R7>%<A$MMG;>;4\-QX*1\"M.R!4GDL[7D
M-72L5S/2HI52&2L0H;W,U'U6E!"BGJ2C#62*MTC/0P+7#O?SE/C<($8T^=1$
MJ<O,)_^'LN^*:JJ+P@RB(B B33KQ%P0!*2J]16PT 0$!Z2HB'00$ H1$07J3
MKK2H@*$':9$:.B("4B,]!41Z(A "*4R<F9>9-2_S<->Z+^>N?<_9^_N^?>\^
M^_"\&V"SQBOS!R78O/C=,]UN%C[^H;PE:\'6HUEE*HM[;/RZ-NG;@-@QH&B_
M#W*G%55+%$Q!*JXF3L\"V<'9O[]^#1 [?V5LYX94W9<S2477>X-2-05F7Z<Y
M-Q\#0/1PVC"37.H@#L> F$CJ1?!0EXA4Z $#1*'"BIF2\5QNB>&]>K56@D-O
MHWJ(&NDY_EEM;>K?B+@$LR[4CXLBM#CI;IC';SLHS^+YZJ12XVK#R@K^;$.J
MX]W"K/:8RYJM@[*![38#ZX?]_SW^6P"5F;=ZY/7EC=^.+9_&WY\?=J N_I8/
MHHS4FI'>CH1C #9)CV.2!J2>A(!\C1<=W$FV"6T!>.HUY?\0$_O(\X[MI9./
MCP%#PN.\)(ED98/3Z$>Y&EU" P(X>+U2MZ'>"1J HD_TFB6O6B7A1E\U<'-Q
MW2-9^_E+-3;8%GF^^O,[[/+)B A,R\MBK=X!@:+GJL6J-BD0&[F7WO;?2U7M
M*JRO[CON$=AGC506\MK'-"4$<-<A*+9O?UHTO'@K3==Q]@^SC2?G,+A*V<M^
M^:%,HFJ;P'!<*94#B[.O,72"^CU8M%DG7GP;=8S4&EL",I"CB UC-M(3<]^N
MI'.%KT'9TJ*B :V@[D?E0C)--_O#>::3@L+L$#6O7[;\V6RH;Y]M?!4$]W<&
M7=VG72F6+_"[F,I!T/0Y&Q1-.QQ5X4GV.\/MTRS>O+/T]Q-FXH@6^GBA<7;!
M>=$EH;#<,QQ:[QKTV>LH,A6)<$Q!J6D55K?O)Z^?<1.T05D,G5T7UI_]<^]F
MY[?3S5RB./\>\[-+!A44?QSZ59MN1=E_J@K<W1+ <>3/:X=O0J=MSCM>'+QJ
M_.U&YI+JXNNW8C%7S%@ J>P#,"CE@)]8%0C]6W9H(#QJ05G>I1!JJY_$5Y_2
M\BH-?UG2&*-5_^;YGNE(H5IC4U+^)]1M=MR?D0>5<AKAC7C<D/U#SQ$+8_O
MR2P'"Y.0JJ-D#OV5A(O);^^)IE*TTQ Z1P>(L>ZWCRIV.CFCS/3WQ79_[NV5
M/F8!*HI*GA4%?O0W'O3ID'\9N' ,R$7<CE@\ZFML;T!E.NVC$6^SK!)1EK(
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M@R.[57H&.28JO2Z_QJIOO2FPS*6.2.>( +UD:\+3J?:ZR'IZIMAKS.NYHL(
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M2)R_Z$:@R=6,^P?KJ*/ .1,Y>L[U.M^ Q#WN66 OC >-S8$3K4 7_C4Q*Z:
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MS6N<CB:&$@9Z0/$BPY7QB+$](.]:AA<T0$I*^=%0@/CP\E8CN<>-_V_'#92
M.WYGRX2J"6&9]%%!IL"%VH2)0Q93C[VKU0;Z[+/"@X>G:D=WLB_W"UY<+@)L
M1/=%HEK)CS]&:,M7_LG>G%NZ_=<6^B7@&" P7TK_O7@0&KHQ?Y GW\O@@8ZC
MZU<'=L/1)SNN43CQ#UL"^E90_YH;1D1<T-M-.@G?RN@M\,\3<KXR,"PIM^L\
M&T#3E/QLV&^X\7H3?+"Q6+A3^^93XA46[MM[H._M]CT,G:OHC5FE%6?+<.!'
MAO7Z-)"$<SL&.(_!Y-[3E%8./RB,W16(_W_^'_S_N2 \A/BV-"%*W@6A8T!"
MV[>.CX8N[Z"0W>F. V0"].JLJ+F85T2'2^/UA7+6BA$-F354]!*Z^O3;#3K,
MB5L32/<?2I0U,SCY-"/ZYK^-38C^6*-+R<%AKOK[H=:,AN_HTMZ)]?"7QNHW
MEF;/NFJ>P*N!/JBP'&S'^).=! T;+\I&]8\H?'#U-/SR2IO'.8*4-S]/D5A]
M/-C8BFKVT_L3WV'>I.ZNNMYYZE$GX*1UIT3^358BS3N5$L,[B(7S_>?4ZYGQ
M551?$QN]#RIETR2"+RXC+V(94F?')QX\L?US8[\3\>#EQ?^YX^HH:&UB,5&O
M6(?G,!E:Z,&*T6._F4F9; 78BVN%9::F_*Z9ED@9%-X8N>'R5.30%GOY8Z;S
M%/*5S.;LBR:=@/=V3B]^86E?5YN\UVLB=G?TLPY^7?F4>.;_:X^;I["8ZULV
M%-MA2)_6VX )#!&X.M?.F=UAIU[EG%0Q?@P(QBQ*CZ^$-F3A"9$H!_+^[EP0
MUIQRQ64350T=6V+;#$Z+#775IW_HX/3.0?-!V2AY0A<C*D$7/-Y]U>(;O'&%
MB7+I=Z[ZDVM].RRZ^KRAW: FM3BJ$TU:)(5VGN)" +VJ<>E:$H&*.MV8V]#C
M(Q5E00?+&EJ"?Z8>JLP=NE)MX"^)\<^,HBI;7@ULZ\1*/2X0"W<M:A8CTZ\M
MHA68*?RO&_W.,I0TMBT[JCAX<0(+V[(H[;PXO>IA0+L(%W[Y3?G)N)ZD)P\#
MO[Y]E<>[4JBD^;\<S?RGLD#S'#PQ+/:$L(2OC9"!<5!U]O,;TT+&4Y,"CHK2
MLT.G$E[B%PR=</+.%98(S3):O]N;?K?FZ)&_+=;R$>![J6ZY$Q;^/&:YQ "5
M9WNIDMS#\MW&^]A)O2ORC)(OCCRO;'7.%LX0%*('!TBGL$@?3#^\ 4;C.P:0
MC>E5V_^A*3AB]&W2A::J&WA.5L5HO/S7\<N)JI.J*9>KD4J2J2J<O/,F,CFO
MK6^] ARZXFQI B8]$J)3CRFVU! PGP,]@Z'BF5/KL"X2E["W=6L'9Y" O/Q5
M[<42^'9_2-.!VB>NAW).M\^5D#\+_7ZH:)SI@B@2H>025_O(.;8= J2#Z#8#
M[TB.85?%3+SI)=J\@1R;@;YWF'S3BN:OSNM[G9("HU9LO1#5A-1+&?V/$2%E
MKG^/)LBJLE\1C-'4[H=D@6*5FGDY=+!3B:^8RSF2A/C/&N*C7S,1CJ>ULJ]@
MWF1G6BN_>U<QN5RRV?P).>P6,4,+IH)@7<JPIRXS2;VL?7!VQID_37J7;D9-
MV)#$^Y:2%/<.$O7E'#TSO-/ /GY3KV:8"9:U4 \VX&#:(4QSWH5M]9 Y$7/9
M*W 9#3\VR<2AR6 ZFW'<\-3^@LS]Z)/OD8T.HD*I[&L*O:0KK A'B7O>>-@L
M&X,#1+T,'>5Q6FLY!O16*HF B;?Y6_Q[N&,#!@G^HAOF.DG\#Q[]\D@(.^DW
M\KUTNZ8ZBE==65A2#K[!S?O4U=)R^$:RS]-F<?]J5W?C+,>7A4::+2\/2PX1
MTN5][1,JQ?3HGJS(' EA/XN8LAVY%REGU57OY'Q!G.FV7K^R65YN;EJX&5F*
M]^<#P[H6):8AUOB4YSTWB:MQFW[[INX.4XJ6(SWW)S8)GC7;-34R;HE7<"E"
M*^^>X6ROW@0EH>O?D[AI_%;D=MB<3*\6]*,W50XZJIX7%W,,<!.5W[#S>4J)
MQA_ ZBEQ^$FUW:NA@FKGC0"H,3^_3SQ"*PN>D@-?$XV($>3&8T!4'CC7:!KD
MV2YH0<\_!CSU%M=7+50BAZ/:,I;P<?WR$9QO\N\RA0F\;.ZKKU)/>)6"^,KO
M)'^=F!_>K -Q(< F"6%B_VOL,8#;HX.?6).&H$3T.$M,^+Y,X;L][EM</]&P
M</W[Y:CQD?'%BU_ZSEZ[\J"B;=\G(VC#]">N0"&<OV*BEW1:+:N6DOC./KWZ
MMG2WC>/71!7Y\8)RS,!3V<%QI!9DCSB)L,QRJ%@F_+;*ADKU3O2:91O;7;A0
M5WTO5CKKC_5PP,,")Y']CY9R+U\T>-TU2[X\:-EH>,M_ODZMYX).(*=8^D++
M^1M3]T#=)<> ?1@\@.Z9U,!;K .XMGE=XQB@,W$,R/VL?83I1RC:Z4'!Y3/V
M6C-_J>T[(0W&LZJ?<ZA<_OR8^CSC2/S*=J5G>_$GC"W2U/C*IS+W:.CD; PC
MDZH*"9U2J:0.RUO54JP(E:U<YN9Y)MX;HE]U-,N,_(/= WCL'C?'6MM=RKLN
MHFX=?+'&F_+]7T,M9^@\'"6=3UB:,=>G(R"1S%D\,1I00C.C9)+,;4GWVFL@
MMQK&/A@V7&F3P:8\70\#FD>T)DA.^GW@ZSO[6G@IU9LJ2Z_^<@PXVTK5?Y:>
M]D9/3R=8"NQMT;FW*J2YKJ%*FX1UU9V_Y4[_Z-=62C7/_'#[-^'Z56FA^4YV
M0%4$D:HO^8+F?;!T;N/G4)L2B5,SE9,E?OCZ9HBU3E.3.OMM?F+C\XS@\HJ]
MU0N3#@U.A BCOME5+.,B3NZY\^47BK8ZS]6Y7_5COQ ''G3CO7X^JI"K\C>#
M?C?JV]JA&?F,':Z1./&K6V/'@),]]"::-?%&SU)#;H*>S :<=-]#*QB3W%AM
MU<L0GWKI'[]H#[;;V6MWMOLTT3BLNUU=HZJY64R?_W+]%O6<]Q(:^PE>!]SJ
MH_+1I(@&6P9X])PWWB )8D50$EF;=>_EXC0EY2:H+,C<(B'C[0E6XV@<WY?8
M%85E8M^'+SGR&]HQ3HCOJ2>5!_.60=@*8H\2[4+=PN5465??VV2P$N?GY1"J
M;H)-L*1/S N.W6P-F;?RY-N,<UI"].@V$5LQ")@2D4I@Z,_^%%Y-3UM;<RD[
M!O@:N>N=O>MV:%PYH GEIGM4U15PJ[F:.?<7>"K-?_V9;!U>1__Q]'"Y<+J<
MX4!/\0.2 H.O'2*^X,Y"+SFJFU,-!(:C"KSU/(V-2]<1FVL+#S.-[J[-K:?]
MBB,W4N9(!PSV>G?2JB$Q'V)(V?T(=NC5$Z\E+O,Z> X3=D0H3Z_X;/FU#<7%
MS@XV:KJ;)-S^EL[*M^U?D$?SIOSKY'S(]*YTQCB3^>)(_F0"O9PA QT,P>2B
MU.WUWKN1S@T8F<R5BQ@]2<7<;YCFZSFR27 #SFPM_WV6&O+ 43:D+U*&>@("
MP<">FU/^&TUAJ%#NG:F!6..X7/#6 W&6?V_HEFC]0.6<MQ]^62)._BEX_?S\
M!0YV0!Z-1H\'N<)3841;&!O$F-)*O<6898"(F)B76R'>IXE%[\OFO%/KNOLW
M+")O]^15[[?GQM$T'@?F^?RLM<N^_!04XDWX^Z,)P>U*,QA6SOYK)H&CL?%-
M?<\)3AQ<=[<K$C;@T^@YE8.3E!V/T=SM,[.^8M0T;FDLG[L9Y-.=&A:%%2OF
M,] 8O?'#_US/=<90S_.WWVL%\DO9=/RT^13M:TH>^A5SC*4IS"7GIX_].X0,
MY'D,^%<LPIRM3"^7.O=>I;19](!2;!XZ/GCTY'I>3#\ZE* K:HNY,"NKHX"D
MN-I-RC3GC'R_T +T31WN#;I??VO Z[43@B;&1YH@"':;S[%AYUVX.^1H=XDV
M"6S=G I>U%M$5'(PG-LCKW!90AZ=!OWHB7#L$]LU%_,\F:GBPS#D,%OD[H/7
ML?5PQQT#SAP#L'50"8H)<=7)7 "B0PDER:W>(2+C9]<U,3:)W?U]RRW4.^92
MELWM$:^Z924N/OQTC4-^$81=L59@JB;9SD6#SJ\!$GKD'4$O#B/75\J:8I@_
M*M<AJ8@4L8N,TC>5<<,4WHX;P*V_1X_L'VW>[K)QL:]\56YZFSNAK%A8"Y)>
M;F:32M(3Y,ESYV\3P2N19TF];O/>,=U/Q,_Z;%AW_3SJ RT8"+*C;/("O=\/
M=SOOO=\#]IK_<F"2*6F([#)]#/ 9C4<W(E(ADJ3KP!.W";[<..XW-).*/WHB
M*(IW\1_XK#>9/+[-PYVPK9+T)#RS5\CQ/4MS@/979"D:NPB?D\2C!T"G(?<I
MUTBN?2*8-$4]"44X'G0&G-EKR^NRH=8A/KG@NSH>K&L9FK%AV>)PF+RF,%1_
M5W#[-8"#'DJZ=/)?B8%7$B\1_87V1P#J"*0\#),O.K.*OK^[X3+B3A.5^LH$
M5]K9,A=6CYC<%YJN50Y88F]F*J(=:FVED<L/]L5S_*@5-E7MF?G,2N7!73\2
M\GHGI_HEHW@?;);E:M&M'&TT_-V\R"LPSU-I_(I;+0YYGG):,T1&N6*WK:AX
MN$A2U+Y=Q]J_LMRL%:&IY;F C)*;MJFWU2DF2U*62#U.3/O&UQD<&+T;$,OI
M-EX]$,1U M/5@DAI'%KBK(&[!533$[M>&FTO]MK9O='W]:N-Q_+4] D-0\MA
M7;W'@/.,2S1->JZ>L!>,BP8C*,7--B[U>8LZM)MT02]-0C3+G.S4\D-V/'6G
M\U5N#/D]DE>Y;^RF+RFI2BFE\KITE<"Z AM9RX;]GRF"/(')Q-.M>=K/>,T#
M:MX],+IQR>^=\J/)IC7Q;,GY'Q4P2Z8SKNP P7>A++3_*%[!"SJ4V1W\"? G
M(+=^D.CZX,>U:<NNX+)1OS>#IRI, GB59D\^]9U)"^D?^.4NK,?KK QVBNM9
M^6K_SM&<_=D^2<A>R-ZYN_XH1]':V_9S>4NP5',8PI(9@6$+GG^%I7WC$4R=
M*N#]_%W+HPI'J_<_/\8C[9%-Q<+3/1,(XZP5U2NR0:HG"QO'G#:FAXA <AF]
MCFE?QC&@/N9?8_FT6>1KG<B26612FSO!GP?<VA=RA$K8TU6;7G>@R^W:C#OM
M["QN7W3U0!;,:8#:\6@6$#;?I8Y[RYQJ0UG%F\&9) Z.QM84$U=MQ_S:@@,7
MI4BV<?!>XD"U1CH;3?)VY)XO6;LX"9=LGD,==L&DT?CTR4P,N=9Q8?LBK*\:
M@WDQ,E$HO2DF]HQG_K%BV*@Q[?$Q(-H3X]_G/[NI#!C4RPO[KS!J(WS@;&?&
MS5%-25WO'X-?\U6^?_7NU[G H2'T)-"GWZJS;X5BG AR&O[R<$-N/%N6F4IP
M52B7@Q^$D(VU)/H#>C1#?)F9^V3_], 03\J0+#W06]2&SY\S=ZS:9*91:>&[
M56*VP:EA"^>MA:4U$.4*JH>;(H?>DB4M=:)/,MC6]#0H+E15BM=2CY8BBN1N
M2O++QPU%FKB@FE)U80,B,8S\\@&\0QI7YZL&M>NWW++'EL&W-9$_N.=VL>Y;
MW/^."&BF.)!8<6@:OR@>V)=/';8^Q4@+(UU8M9C:<^'QO'8WXBIJ4;QQ<A75
M1OPQ?BWVU.0G.QE6M^X3 <XX*A0ZM=0HL^5Z##@EW4Z/TSE%BJ5B97K2."#Z
M<3A(J 00X_[3]F%KQI7+DSH&>"XSS?^\FQ4_M3RZ^M(SU+Z7&%7]G@LRQQS\
MD!E#OC05>C3M%);+EZ%+J2>X]X,2G.4FKR+]VAQG(W,0B#^ST$)_\.919,S*
MY+B]B4I-NO.B 3M<5%\A[\B,M6MJJ)(H?1=.N*[#=94J7W2#L^>=HAAX]K!&
MD.]6<''B<%!X15T/I@S>9(FX8F6J<671")E'\#&]Z@=,WJW**0I**D___5(Y
M>W?>+\R<TT2Q]P'2&#[Y=[,FZ:-6UH29[$.$I<U!<[,%70.LSO027T$&^VL<
M<BX)'].4?ZY=O8>E?!C1.2[]OI(RNF5K+Y'"^BUZ.$K<W1:%\DX7H@_,2CVJ
MY?%FDC@]I8.+J1&)C[CY(#84.L%E%C-P##A- Q9[UWO(EE"4'*;VXJN#FZ]B
M+"9>#HL:U.<H7/S3$ES01*Y?.J^X^LQ3]'J&_ 8Z08(/T_:$.1 'UC8B-J4%
M5RW,4K1[\GZ00]*W,\25#"C1H65>N54LW7./9OM4?VR;\?+_#\K>,ZBI/GH7
MC5B0)M*+0%2D-Y$J+2K2A4COY$5Z%P&)$A(1 >D" E(C(B)=I!<)D$ $I/<B
MD$1 *9* A A)N/%_[Y<S]]Z9<S[L#YG,[%GEMY_U/%G9:WGKRLVB5A='@= 0
M)UIVESA%<2%*$*:/0R4J*'PO=5U,'K;JW3=^CN=PNG0'C]L&A#2PE:6^V^>Y
MU!(*84XH,WH!M<?H7?WZB"K2  .*S'XE4O+G_!VFL]<N8CH,LUG'_^VP472"
M3]P/N)O5:-NUU[D5"N$EGKN-]*BW'"#!1,'J%:9%_G/V>=[%O7(K&*ML/3]K
MZT<_K+Z< #HG=:+H+"L,,M]C#O("+89A5AJ F&D2%@MZ%GDX[($/212FT<NJ
M_."7CMTRU,O>4LIOST;D!K0\*7%0B%"0G4\MM#(>N95W"_@20K1,?W8"$-83
MH"^[21,%,.F)EA1T/UV;M)Y;0U'"5%4%""=!PXQ)'^K8H&86.?N6)P#S3T%G
M@X/0^MYG^+TO!O8SV9/-JA$]UBAO<R"Y-9>LU%: .43P(9H:HX5'#LT^-4SI
M*$4_J?)#+'0$'IC)M5T+V9Z2G+4Q?&D6\"A=)+')C'.]CLYFNU9.Y0OK#A)_
MXK&#.(.(*OIXVK_]YM^7&Y>+V@*EA3;X#N#\I'.(),*2H8H FB*?S)5'M) 2
M_J[#/(W+UQ'5"BM]8YTR7='?&6 R76YB6&3[]4/9-B'D#4GC\L##)<[X7J_Y
M93GMDF<$5L%KE?CO/KFR!]Z5.(DA1;_!Y*0469N@_M&<I6\T6TH-,81<1$M&
MK::> "[!I$@AA/X6 BC%*?QH!.5!DD.+*9#N'345(RO]'S_Z-</O=F7F6K)S
M3,WE%2[6+6$F._%/^W\$J!=5^I<U*#$,P*".=]XFG>Z',R#HY0]*!TEVPAS1
M=S3]&U7=5-3TN[BY.?WC)H_YHZ":[+S_7G3-H2^^/;<Q@UK]_)\&E2>6'!,:
M;T L*A"P;K,#-3JNWV.OV&8>;OP1]G5T $4,3D_]<VEESLR*&.A4]&R&>HD$
M[L]O;GIP:%FSEH.L'0X*\XE\PN+^P[G3[O>0W .%JDQT"75#2"MO]H703)0U
M<WRQ%R3]XVS_@Y_N'^^3PS<2*LPG7LA8IU181E3VR=KL6.SHN?)U[9\^OZ:G
MX.FH($MYN38%O<3%JKJ%K[*U+I2*SW^]=K/5M-%=:.%]5E%=;36UC%)*0A&B
MZZ@"SOI$OKI^2))ZUVE&WM'Y=[N88_O;E]RXHR5OQ9O+-/*U"T?]FO#9:+C^
M5R$KN^X38I4 3D+RP2_Y(QN<8)J4(@;([OG;Z\EHO8:?)UE4X>HKFFJJN9UK
MB).UEP7N:)S^[_5UMUM8Q+"2 "77E!1"%4#?G?[CW.&J;P9L]H[S"?KHZ*(?
MZ057>"XW[!<6O*<O&[STHBJCS7B4[S"$*K)T:QKD-<::&0*SS1A995?_<DXY
M:_"(H"OWI_J<]?,$,8IC7$V.NX)UC,Q,GWM9_+N2EY@[*>\WW++BRNVV["VU
MB@Y 6GW>;[Z!ST)+DDI3,=+H9)P1QTN'_-FRA/77SJ6:P](]*Q9V)1^P!?1O
MD,^S5#XI<A<)TCVZJ,_@,,*=]J5411)G&O52%&*U(.02)?GNEZDN("5H)S!$
M[>,?N:B/C9C))NGPOQ[Y0I;!N\&=\V6)F?<W:FA=B(#TA03R(JUC&[2*!'T.
MP6@C3U/ =Z=&4B51N.@'^V;MI+/TU ?MN8DP_8^4^%[CNI+/Q+6W;4W%_2SL
M8(G&S^W!'I!)Y';YA[F?#.H0V;W(H3ZO(/^ XH/S3CK_S/C=?KBSW_M3AC?<
M_$1'AP[?%!]096 W:,4P9Q"5S[H/!.@,(Y5CD T"24TAB2A>27#2,G_7\Q7,
MLHCPG_:TMK>.OV9S[=6)1B< %K6RG>;BY>AOD(Y"P*TZC=@P=BD!DI+P.I0J
M:99C]OS&O85RSO]^>IE^X.&0<&J4F2UV-52I>6/3TYNJ*U-A4C$@O7S?;!J_
MC1+H+=3N%8)#7@Z3B 21%47'[X[KLCFRC1+@"\MB:3>J2\V8P3RRF?992>G7
M/'^\=J5_I]7!!>#?(40CD #U&F4'-[K0@D4)ZG#@.1[,ZG=-PGSJ_!>&BTOP
MYW<L2JNAP<>&4SZ9W7Y'<:E?\'/^)D)?$A]"LZ^#:DX \QV$QZG'=V$7* &D
M7/V+$G7I.LIE6P*/[2:%2B8.'(,\M&H+,S5&K\ZM"-7TA!3&G>U_BM!8:4)0
MN7-7-V+"TYD=Z/-(HCTX965N8:9!!2IE0:GW>[\UTR+\S>Z13DN^UXO<P_AE
MA^V[+X]BC41.F:2/+O=P_AZE\BRN@AG@X<VPP C7TCN: .%3ZE*#RIF;0^R(
M*QA7(_-8\];9:C6::9"IN&A9!=2CN=F16A"IGWCEU C+91CSR[QX@\*'.0:I
M<;X$2J8@U8#=(C(6M_W8+-=;D*5BA/=O/:^,>\"#ATU6R>3'F2[#!@;FP#!<
M/S-HD(+4[>D$DGTXASCN0%V0?$B<2G4PFW"VYDB-\5B--9<I'^&)A*7$T%!'
M),*2:E8<$)*@!VIO+C8+^*C#AV_;^?WV<1K4)^'VU+5X7R](GD3<M&?JU&^C
M^]T_[/=9&!7X)]6)TD"2PR(:"X'<73*PVY3$<WFT;%H><VJG?14T353SR_3R
M"> 3ML+%HOGX^<<0><5;0K_RZ45ZLO7@>-!%(K/>&1)T1-/N!/ "<1^+F_JS
M'?#W'H-I^ES701S?#QN@#W2?3F'KZ ;?[C?&/M*:S>MI];?MU";)<>GHRC:@
MW3^#O-S*I"V:!.2]' 9M_#7;K,E)2R,<KA+1G/K))#YWO%$"%#I3R&>:5U5C
M6N38FVJ,9;,8+-/^.)5)*0W?'LW6B3K6I\\__I?7!3:<?3<B1>PZ@W O$D)2
MNO@IS'=(X*2F&GW<8:RS:]J$=)-OI^;D0+D!?SJW*3E#7C9#>^UZP%L&@4OX
MM_VV>9?*LX\&78#?!.T4D$+PG.3E&FY*LP<A"+X\JT^J&B#W-7^JCVJ,WT*'
M+7TE+O1I/2G@*\W@LS6PH_@QF9T F,]"?W[6?GD"\$=QFW )+JX;\;6=>KU*
M9+E4C_580'F@5O$_4E'N'>I>AA&4$IR$%5J^\O!&PASV=U8*MW;4 U1X58'U
M  75VYG D?OC\Q T]L5>4MX2OV-<$2RDJ<>4O\+.9L.2(8RKGL(RL^VE9,S>
M4,',.=/#FF:8PBV>_/6Q;S<LI+ZYOYYR.!HOC;F/:?$/36GSOV/>-*3G=;XQ
MT^BG#Y7'A_R,!-[1.!:@7J!T$-JZ9@FI46BX4;(2-V]STK[3Y$9K2U0K/GGM
M;K[@JO<J_^NOV&O[A_KJTPJ%KX#I[[(FYV)2:&!_:CXC:M=$442+].=!>\@_
MKL:[][:QBY[W;0Y86WO$7STR<J(]B&07LH$MFK _TO>Z;H\LT.74"=N"#(EX
MO>A=A:)>7G<P52Z/Z]UPV%2]_#ZS[/:#\FV<(.U-GZ.!TX $WSSB/O&#9)?<
MBST1.\G.2OR6IX-6D[^?C%V-O+RHZ03";]!M/[LE*VL3@8Q(V.$Y?A0 :L[M
M1[P ,M$5818DYI2N:U1CT@;Z!,#V2[@\I:G(R(RXG!>*5S!</CHTG?C]>V%P
MRN\HX//[\<H!=W8SM68Q->QOSFTD,8%<S'#-%J9"JT7X(1>5\+,I>O*_Z.>)
M>ED?*.+WQ)1F=:QQ-?Y!)C6*01':<N;!N(W&CL^SP0J-KE9XX])7W<%B*]]N
M:< 9@K7GYHY[*^-F2[T3LC=C\>G8/''16[D#LP\=N Z?IW838I^?5Z,I(GK\
M&HNL_VWC"X!/-!_=M6\1"(5&WFT[EDAMG,U:0G,FAN=)@67/9%J*6)YKS9XV
M[<_@?W!1A?.GF.Z(W_@PU"SFH]<3.S9I/'M#?'G1 X\8-/:2FV;^'_&S['?=
M1PUZ><O-1_C#(LID4_<J@*.=+%GXRC41Z_Y'V/4WG;/7L!L!,NA.+S]WO\%"
M6=/@< GURN,)J_M9_HJLRB:-Z=VC\VRK"3L[#*'SA"305[< [(<T0=+I[)0;
M:"OZU[$_#!39RE_.*EO:"O%1Z,\K]Q4V2*G_Y8%>N'%^NREJGD_MYL;?WHX]
MW2HZ2]^Q&WP*57\"V!D-8Y"Q'5IUIU<M[,YXTPF :QF*^/?WZ-K: W.[44@7
MMYMO^V]DS6;U4?9&W$&'F9]$2]*O9PFR5USL1Q%$$\ZY4D=:71<KI7@+MTOE
M92:L;._70O4QZZ,8%"M=Z/O<[;);LY^:OJ<UG;'V5V_1D'D27%9;;NPF^$'/
MVIB3>4OI!9 (1LU?!2[Z='=)H/ZM((#6$>QW%(B[V,=VJ3@$G^]3O1I\4(C]
MF'C^,HC]^Y:AG^/,C+B\)2W_R=WS@H:8\ -HN0 ZO)X:U#M?*\[Q<O 1M=T!
M5B4Y"#43/?B6P&=8Q!S7-_WMI[MNX<<J"]L F^I?7;YE<@:E(SB8$I==[\-(
M'J\W@=X"&OT>70UYWG]S>5?%>'304Q5*->[N.79U0KWO#FVD)Q(:DZS7*1E_
MC*A\0%P=E4^<G$=[IR- !)&#)CL-B"UDKV8MOOYZ$M*0Y"(F&M.4W)<?Y&,U
MNSY9AR=QDM7C$]>P7CYGD/Z9MHIQ^AY[(>2_M*(3@&\=10J>2SP!X'.?(59+
MQ'0I-8AS;7YB7W 5=(DEMX"G;DW<[S.^+8NV3$L(+/!8B-W,NO_,6U[(1NUI
M.I472!ZBE3$P#D*1+D)N@XGEA',HH@IN'4GBQZX>?)G)K33'A6=ASCH$+%\E
M*=:=[E.C9T,S/DY6EW.PFC5+#]QX!3.CL^8R3L \1?OX/%5\K%._@OJ$A.@?
M76##@U[BDTW;27X-GU"?B+^13&"\3&I<ZO<A-X.KHX*-7U .R8$AT@WGG'ZN
MLBO VNN8?N3-2%WKM1[YQ%,7C_L&Y#032A[Y%%$Q75B?5QMDQU=RIZ5C9$GB
MO!2+H>S>ZV*7D)>E>4.I*BDM+ 4>E5X.9>R&3Y)'2_19LA]4#(J\<6E00 ^^
MV.QUVW.;4),(=IYWDOJMT9^>NBQ'>W<"6$V8I/J2OCZCH+&0<SM-0.Y+QACU
M/?^ L# O^0%NG*V7LV?>*Z:2[_5N8,93,:&X,L>(\,B8 S ULB?T,.T[&UA*
MQR.VD--"5[;K-1,#'CJ[>#VUAV#LZ?_]0FDU?] 07?)<?1Y%&+/G^2>K??6N
MD,!4GEGR&^)H[('[.TJ=*VDWN3&=8POD5_S-+W^Y#,<6X*IA>6S^.6_'O.Q'
MAMG&+?:,P.5G^91J-$=<"<Y'S-W74#!038F[ O>KK^(1CCC69_6"9ZVEPU2W
MQ70H !B0\R#4%F:R&N@FGM]U%78ZL<YJ6J8]NXKF.M"Z[[]FM5 #4<W*M3YZ
MO+!!,=W?YRHN9/^HN:DI7O\WP9^NQ @(#OP,=(EZA60!7.#I.P'P7)W5.TN]
M1=++P"$ U.O"_1T14G%4@P]0]_=3:C[CP0UOYVCU"CYL8>[T5_A;#5RM27^.
MZRC7D%3^=G?H UIGMK#?;^%S0,$N\=JO/Q[O/>M+&*IGI2V_",W?1JQVPB^0
M9M&[%"GL=MAJ72+\"H-S5.$YX[NN.O]RDR-Q+@8W2<Q$."/.N95]_]79:=O>
MX?=&@,?BN:&45$TH-"1FB&*?WFK8!>YSE.*Q&58..97<Z_[0@4%QQVIN#X_8
M*C<26,,V4F3Z:_C+^8N*RN1V\(KN:?BN<_BG-UO8-UR4P?*EX$OQ??A0&U?Y
M\ J\^ 7C_M1"/&Y8BC5IA)2)DEED)!2(\ (OY.)\>I$O08WE*70M)#>,E[2[
M/4G@T,:UH O /-#\S:T>)RK(;^K!C/6]3M#<4\\Q_:!KH2Y^WQ0)WO<>J//M
M,U,O2A$@_>DO02U&F#I.!BGK(6E@VSG^9V/E\N)/-V52<0M>X>KRD1+_G+XH
ME5\K]=O,N*N\Q;B1:D#;50_AYHF 0R4ZR^X3OZA_BXR(X3F'_(?*R.==NBF"
MCJP:6:6;&1:5O*^6;6('7Z=L9_W0#);[N\D@;1&#R,5]?/%-.:(U9O#<0SME
M@JB&;P_=(VUZTXZ1W:!5G?!O*B*2K!^46(F40 4GJ"DOO498*.UJBH1)/TO_
M^XH>V>Q2/]N _& K/]0-0<$?4$;5(-YT4Q)EYU?B.JBVO8FOG"+O5\6A32T+
M'AW^;/.O&,I7G?YK921*BB*L[.0*4/D0>&0OZAE22">4,UG'G92.T3M#9$Z(
M0/+[SRXSCTE,);_[WI(@U:;U8-%A7@&38;1V-G':]?J@G!&=5?18E[X (EJP
M,5Q!\JW3&O048;<[2*E_%M(:5+L49M.*WD%;+*!*=8W['\S#%10[U<+W"Z*,
MRZROO-3Z[,[+1C]_"[&Z^I'M?&'Z0I1#L V_)3EJ&S <DTU@OKE!K!M?H=P,
M)*R&] 1^VNC7JKWX7/^!X.,?ST)3#@G%E+HO96^PI_J+^8@'(BTR93D^U"O/
MJ@KN. :S1M0O3[(DIBLX3;S[\=K+Q"8Y-J5P3<9D\!=0>.^(TL5)DM*MR5N_
M@?W1:9E8^GHJ39O'-(>;C<?T?9'FL:V03)2C=6@13K#/M[C\VV-4PPJ5%T*F
MTPI@7L>AE UR$2F]MS^Y-\R?P3V[^*%2]E,PC9*M8J$QA;S?=1%J$Q\219M"
M9/W"MR8XEAKRS@ZP7D26HU:70Q9&"8A^.<ZT$P 379Y2;DVJS2/"1^_,P$!X
M,#=D:;-+,CXZP!(U>2 JMDDG_<C?&QRO-G,VEVN(][&Z?A:> ,=HG@ 2;E$%
MOK*DSV=N?=)A<[77%#T/RKTW2Y"B7O*/AZ0BF_?NPEIR]8D+,FO%ZB%\E(S;
MUI.^4K)O#[ XXM\T=S/=53"O[X-'2Y5Q8D)X$4D!\:/:TYP)%;GNI?E6O8_N
ME D_S#:0-=F_>=-T[_7CL6,=U&GG*P0@A[+#/?0-C#U>)[Y+3M.6%!%@B<5+
MY4SW56C92N+X*Q\9ZB3)],GH.OM('!O1IY!-(52^T^0CQ#PSV8]24DF]3#%?
M_>+A-!D4$7+!OSTG.2HZ"!<GW@>7(O&7E1GGACP2OM2AH&2R1-9,NNE\6-O?
MQKD ,:"U_9NR"A*&"U/-&VBE, 0)O;J2\GOGSU8,H0AB.7ME.K.'T$EBCJMM
MW#'U4Z6![*.NJ/7%'63FV<V72L2FV&,@GZ6Z77WP]O_&IS%W[S@3-M)!7B"!
MS6552O6"3QI57%78)_%#:[KC=(1T8YX7JK7!&-%4(Y%RF_USZ5+BQ;MU&<@9
M\$('G26(*->K@ LY0Y]#$>U/ "E*DN]FM5IBJ=JD!Y,FLSDR&,-+-?86C3GD
M7X&>OI%W@R4O)J3+5J.3CN7OM0;$*U-OHB,V5R$<!*AWW#WTE9+>-]19U6$[
M.3;+Z6\5WM! -<_-8[AI;KGFL=KH3G;9)9@W,^T!7D<L&CE1\L8&+Z+$99O&
MIE6#:95O41AR _((3G;;#-7S^76!W4?!RQ:VU][]VMZEW8%)4)+?4YTI'JM*
MB>V2TY,Z$3AS-LP,,?$,RE.KOR@D6B+YJZ9?X/N\?V^ !ZM U.$KB(:9+\<F
M])$N.:)1@IX"973U.[D@"('W(8%BZHK1MIVQQA-U/M'\Z[YEB07@*<!>[5CS
MI)".6/8*';O"JJ-+-",'4^R)B[W%NAT,;87@I#PZ]9:R>33!QD+5+W/-BO2(
M(IL]]O5(K"F[S?P:HWK;(:+.G9+10N?#IA\%AIR&MH@S7^,X1Q4SQL++?R71
MP6E7;]KS1 56#-I<?])9S.30SF4;G:T#EA" <+KQ;]C4C)J&_T9JJ%JW0Z:M
MT:.JN,3[PU9IX@)9>X22^-II"2=HA%;78).07)FEM@5/ _BO(S4&T<,.\E+B
M8< B%BY#.6;>.4OBZ5X6HR'A,LY#>$C\D5B)0DLL7?+VA8)*H0U27.6WC.7W
MRH9["=#U,S3HD6-3W0*"SB9Z[ 0+(H+1J 4VS H Y(F<G\0DXJ*"0G"IWY<+
M\)Q\D*^2_/EK-4=?VC<];/GW5<FY%C,S;H9S2?$;%0QLC*ZNC0B)8<C=VFQ?
M-A=_-XW.R>K2$>?ASK&(+:CX ($6^+*T6&66J85QZ%<X[DQV!QR[T$?T9*__
M0O'!+U$=V],ADW6*5]*MIOC-B@Q]U,>$=(Y?-I9E:OYV4@M_.1*3%)M$.P$D
MA[G<#=OE:DW/98%HX1:>2)Z62 T4$_O<Z]X@6%?K04LJ'[!KYI/@>UDC5&E:
M+D_K&T2=PHE4L>GD/MOC#$HLS0KE<%GD*GSD(6=]- T3P7]J-9Y*-1Y\+2=C
MWAXNP:S!O_OM=Z<S.9LB= QA5%Y112K'L35,B5:E)T4?1YQ[1_*.Q4&2&!(!
MC0BM=#'SJUU6:%<H>V_MXN3HI/4^T[RRN^I)P)J,G6LW\E_'?8X^[28U<0+P
MX9P[).QVCP*WCA0+\*-\1GA?;V(.JN+GC-[EYM;)<*RKBDT <Y+SCAY;VUJ2
ML;?]'0^8C&37/Y6W0S4@HIZ#_@.*_%SXD9,5X':3Q)G0J8#[<M7DK>N=K?M3
MP<5GIX(4/$-5/_T:&6_"D$KV[ SD;[LC^U$4Z5F&4.6F,CC5<\=_?3PZD#)Q
M.@AOSF3&9NXV$31Q,W,M_/CG>/(>>GOV>I<(@9FY+)18C<.\07)JQFKW_K>U
MWM2:KC%8-0N]I\OZI):9(]?P"^N;0C6MAZ5VT*=[KZ.K_?J5\D=7S(O+N>XC
M.4\ =3J@5P1E!]AG(3'[-V,),W(/0 W*3:0;Y9H3%581RKR$E\_-^R. LL^?
M2N8=]?Q[6[/G1M=UWV)MBNVQ-=6?UDS7@.[VM6>GB*F1P+TUVBX=311KM9$V
M+[[?Z1]^$=4&OP^[E_5(?,K1?L/D8BRI;<KG3<,^%LF1X#T(Y+[PR#:4JFLD
M/IM/@ N_!7)TB<:=N@,5Z+T%.+>$^,]!D2DVC9FMF'FBX\9;!)1T^/!2)OR8
MY_"3RJNPEH]ZJ/A0_N@W/D^0,RJR4YLV+RK'$SZC<0\;?XVG.CZ:3+G^I^+.
M^+CAK^%KI9$!R*:'9).8KWN5X3?F;-Y5#N9(5E5!N!*S_2?*3$8L')*R??AD
M)!=B4T(:K4#%G!1IQ(XX:9><0ZN#:3.8TR0MFWZECYBT/&G:1&+>X2']YV96
MYM]UZ5-KDJX%UF@B0OI'&GYQYZF#8XU/(T(KVKRTJ=4RJ'4V!?;O1/G!)R&?
MD3&U(%_0O#V=E8W40&#NXXQ+U$B^1@DC2?4[1<_$X5.5P#$?IFLFP<*E\Y E
M(^^&P: FD=XQHRO)$=VISNN@A1!R< .%\3B=[: ,$:OZ5H2I0<<J*$P=.^7.
M,6XVE:H2XI\KIM(VH:/DG]M^C]O?GO_QYT5QC+N12;(N>='F[%?F;; 0(WGG
MMSOY<*Z1?7I:#-/>P!!C.J*E<ZXKE&2[V3^T"[-F39,YZ@)6$)VCS^6OW!4N
M&0P@(W,^;C]&+G^RA2*N#$'ESK1F<;Z^CUT39,<J#WKU1C2@=@HM%*NG(^T%
M+%Y7V6ZL01W<B0>_!G,_'RI(YE-Y1,U HV&*U_N[1.L*I[O7H=7\KGF3>/^;
M-H_\H4_O9TM7R]59<*6J+U^U55;=E EKI$W!8ZB2M,8N%?@4D'BO(WW!B!Q,
M5(6KT-XI=DI4_'PJ%7LOISGG* $3S;JN(&6?*?[DFGK&(DOG\;%#K>C5P?=!
M+R2[F"C.C+Q%TRKUKD.%A_"C.^['</CX"EN7(G0$3\ L2Q"-8CK-6*&0WD?^
M@5())@C0??Z<W&;W%/N<HS!1=1E>-L?SU]*2%O$KO2B*1"25.]:2)+5=3OH
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MX(,]:HGK!.-V8W(A?#7A2'8S1"23K]56: /'58-V3NG&^\*786.WKW:-,,2
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MM?.$\;S*Z(?P<=;KLK_85\VX-77BC>=M*M:,99_:[V=4T7L@1&OD8A:Y@U8
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M!C//[4:KU!XZ\&G")&L>Q\[?1X,J[,V4%2+P8EWB6QERAV[:3I9BBRF/@5E
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MO>B>[0C!NZ>:1/5N. PA4M#?OAV\'"Y\K/#.C$12G2-/I$"\ _?7N)U:2BB
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M<X2SC\GMAS#^[>T6$6<82]JR;Y?+8#1+WVE&OZ7)D[K+$5ZE;X&1=N<@GUN
M8)*X5B5E[;E+AS:9U0-P74&82SV<=VEC^[^:I:@+*'HYH\LVM+JK'X":[Q@:
M2KM,]\V+ZEY?*(0;F$NV/;TQ9=U=+2SI?EY!,+1D#OFZ2"<UUPB<:KUYY&E0
M6FE'<^[H&5]%0N<3V$T0*Z2;6NVWJY#5DT0.E\.OV'/P3C ;\3H.%JX)W-14
MQ0?B!-LFI<[7HL \CYT59Z#PP@XNO]35"TN-&2J?/H3(OIYZ_A!!$)@-R8Y.
MG%(OIZF#%#$%!ZM.ML(83I\-()DT.:'3BRS4!*,ATLE#6HPG"^,-U]HS"B+]
MI;U<]"4:MP+74N=!$1Z*TW?Y'+GYGK<TOJDK(CWZW#F.>CS2\YP/9"7=_WN]
MO<D^)D>"48&[/5\U>8Y?W-/X\,/+21O7(!@O=L!0!,YDE*Q1P$P#M\-]Q!?^
M2LX/"><I^XHRSOILK,"V<CY;,<.\U@SJ<$KU0P2)EKBU>*(8NG0V[[ =GT"X
MBX>@_C1DU$:T\&^>Q)ZDIL.$/(7;K2'.G%)\-32K(><39RX(/_9AEPQ-.EDD
M.$*[%JE1Z\8\O65,@C?92PU&RG])TAUK$BYYT<?=B"UI1/V>S;5M>]$M6H*1
M:C'2S-GA4Q+]QIWVI+2L1Z(JT;]-N7L>2317UAS;?JT!Z+Y!#I88_%FW%N4I
MV4&3CKZ!RW_7]VTTQZQ,V5J:EOEMX2!/4C:?-$><^$63+)-"E=&L;U+B*CUW
M1_N5)2(KYFJYTQZVFQ;>E?NL^CBL_&/TU)RV=*)9F(1YIV&^BY:AWI78W,]-
M;+:(/:TE)%Z0&=/F(9\#P(&);' T.1MK_*MMW\6&H>-HU("4]XEYGI_#AL?I
M6DUY95/-\PBM>%3&/ /7D>Q%Z PIB6K,#U!Z4BP5J";A!I<&N^ LTWB!O;8C
M :X),JL+CU9)(:G:5Z',XB 3R6W@3?IZ/<;$Z0 D-',3KFR5MCMT@Q26VRC'
M? 5?>S,_NN-1#VK=[A4^X&.0#_!<F@->SZ_7;.6PLI-P25W$K*H>%J>B^GX5
M7IFL\>6XKH+*4_%6TL5WKX#IHTK?M4^$NTJYVH*XWZ7RF!X@>,3SS7F\T'^.
M!=D07HB?N0FMI;.!Y L4 $YGF1,C54@>AU3T8*ZAP6\@+.J.]N?ARU%>C86N
M)5\R9B;4V,;VXRSG+?U87$039UP80ZZK?%2[<34X$RV#%SE8C(4Y(Z>HB+02
M!^R:-X-Q0/LI +H5O-LW/[=]*ZOUEK^<:P^!CN/JX$*_")?DILJFN@;_$EOE
MXF><3+YR8L]+1Z(E(DIY7S%:*]J$I]Z\R&UK$_/C9;5@1,?W._VOJFR!5T(+
M(=,$O2H';>,PMMD4!3%EO9M)'B7PLUB2I"&(DT]!Q^1FCYV<^@.'=\7B($C;
MHT=E^&^FUL=BX^&/?AZ;2VXGHT?*CQ<),"H:4B5S0!?(S$/%ZEJ%FR!FLIC?
M18P,F9=H,7155P%Y:>[[EI=4CLQ-((;Q1HF@[LS$XT=/&TWK;]GHU:ZP(;%:
M.[,(-'"VB08')U]4PUEU ND4%*PT/.X'6VZ9N?G>#S'U'BWQ"@P]5Z>['&5Z
MH^X\W<P2_QO@1DWT9E_0;710)"U8IA5=-MIAMR*VE*HDTV:_Z7 @(J("IC7G
MO/,=BQG8^]JUJPW=?YJ9@ONE3!?A^=/E)S5)/7CUB,U,W.\!5.;<)>=HHQKI
M5)YB5>]2]A\KHGMUA!(#88\W,J E.)S!"SYEU0TI*VW?FAV,S+F(\PU5D+FD
MC_ZX_7F\VD)!XZF+2QRXLW)Z3MW(F?.HEH/LVB=97B@5MRCM,D0!/ 5.FRT>
MRI%RFL2P3/W=OCF@R Y.I4G:+LX3@Y88#5RSW]R7C.#OHVT @X_'PL'S!L'^
M6GX*=:$JG4OECZ$B_,8MG+SI^LI=HUEV <?)GS9(SIY&)FN';ATING=F=@L"
M+=R!?=B/VXKVD6UW<F3H4K\CZ(WT?#J6V$B(LEB5>J%L_8%?1IYNC3]FH0'X
MA,.+93@Z(ANP'59;2Y1L-AXTQB+;ZS6Y$!WR0ZZ+^LU1.;[DJ32($L@MPFXM
MR[*X_!T&J*E+VWNZ/DYE! 88W\-E(+VZ"W81'=[3+A,#/*\0TPSIL"05?TMW
M7ZF/EZ_R&DM.WR\:$'ARY&,NJW/MIB*3K-S)@);W"M$\QZ%NN_1&ASU/US.\
M8VC_BG$*S_O\T,2OW^P0AEYS$L99SF.Q>8\,9MQ$JNM?S8DE/E>6[)?NM(.,
MRP5LL7^\P^YLDN*JERS"@ROD%ALIY&Z_:3N0[U6E:4M*T.0(@N#E"!I$$-X-
M-XE^M-C-_([,7557/:D>6&@@/)%?[-&4L[H0N#5]*^UA?92P!73TYO<(H7N"
M])"'PUI^=4V/'KA?;Q'_[M1=\M?W+5-3I^X48=7$UVF5^0;:V<J>2OT7M&]$
M#TL(SK2AG)9>?@SBYS0V+1O[K)WU[=<C<3TV=!ZG\9?9Y#6''4.#>@T+(RWV
MGU[A_]I!R;I 6,?)F/<_/E*^=67X?_ VK,G;-CXJ4]H:=3)/M7U)L[8UQNP,
MV+7*RRQJ"J4 @"P?X :8AV8%E>Z'1WMB=PG=3CJN$:[$O!::=0FYT%X5HZ.H
MI5*4E<[]TJ:SN='B;T1SHP'_7M'0*3V?)@+W80J>ND2+9VY/I%YJ#B'3U-+@
M63,>T,*AS8'&P[?HGLH:WOZENGLCZX0),?6T";$,#E6 "P2I3:C+?=)W$]YN
MT>]Q\%MEL+G7NB'O0P$XBQS1_KPUFWE5D7XY^L =.9&F\=HWEMAX\G;C0\+>
MP2?FWC@P"MF)4=7/Y-V)S!%/];O!5[&AR/SU,;?/4W#E_#4&R?N+(AGG@1&M
M&Q $D,&K<8 7M1/VW1M8E;_Y8J)8H7HFN:[RYJ=9!TG'Y$!W;=7XP,E/Z<(B
MZ7P(@\RI<T;#IF?4EK+6$'J.K^_S9=5:LZB=A 0D)<U4QEHZ51_3K *Y]XO!
MYG@W=*:-P(@5YIZEW.R45<G&CC5;5\-5PO;MIVQ/LNM*>V!77F20(CLI@#,P
MEQ<\)=%>&-K.XF".(N<)<XZMPML7IPW?5\K)FTO'?^AK?5)_!NG=X)"F5M:E
MH^QT)HEC^S7GS^YM&+TST1<?Y8%C&45[Q)<&62WMO%NX-EE:G9XA9:Z+'2?7
M%TC'< .G3WRBO.G^<((K'WR4:KV9U]1B7[:^FEF=!AMZY>-\PJ_4EMGO)K*\
MUF$ ?GBC"Q$,[SPQ2O0!-HX=!'*Y[4\956@Z%9R]^@=<7CIATF'7?;%2/,L^
MZTJ(QN.WM$-[D 0!&BQ=7(L0?JV-QR<-!>3V<V9FPB/OX'P017[PV\U#KL8]
MMQL(#U)?&7AW#0PL7;_!0AK1M(.4FZ@.RMU/?Y:>GL<E>)$KM9=,Q]AK?]#C
M_-) *C#>$#-[,D0\(%7*8!28>8BBV(/\3MDM32!Y N>>STFLK1ORP!@FG37>
M5=+A/[2Q%]QA[(C&40"A,^$M2;A1E,' EK]9;4-+/J()0ZASFW%3M/.0'&&M
M44C5OO]4ZF@^)-YEE.I).[3XBEDT-!,'-,!.E*)A3 MX0Q!3[P+_Z.J$=PRC
M(>_>:[LD<"UIY]#S;E\=U]T;=F/F/RR+2Z.J7;@EI<B\08\3C%(M*( *1PH@
M3,*L6C$C^36]_%:;[X=#K<J6*X:5];O+]"VWAD,*^!Q\$>937_N$J#3C?&!:
M#V\E#.?9/<GB9GK3:>)52-N7.$E,RR H$WA.GZ^,ZW=01_2F-YQ_;@XZ:,N%
MG?F+=P_=7Z0V[LAK<BNL+,+!HU&BG+[F2L0MPP#S24T!_%V4&^P6MJ >)]$^
M ZW$G<5[ZH9V!LQ/>WZU6>QPY'EPY.:.LS)0TZTO>']'J>5^JW))*C@4>>G9
ML"M1,XB_@%&\_<3&>.2G_X*U9>RVI<NG;HA";+I*7%;/X(6FA[E_2JI:&MV.
MWA]!O^,##YW'[$=;I#?R(],/20PFH^VA35WR/V/?WNI[<H<OJ3V^66(_TJB^
MMK)L3'I'V,I/JHHP+9P(;F2#.7[0*U_O7'NQ4;>_,<B)0H;#F8C\7P>*\)#V
M />D;V!@DO#^7T[7;P";>8XK5 MV+-IK B?,NV. K)L0)F^,1+L/TF7,6\W>
MP9L^.*D@L<?[]^$#Z,JVQ6V/*_TJDG0*01\PQQ3 QX10D&/]=D(WC-':@$ER
M089-BZ57TTYCK/30QVZZC3>IA/:9-_L!'&.&30C_65$#)'CH6\":[LRQH#R)
MMSP_S#W#0?B#E(?5/?.)=[&N.+Q(UTM29F>#JU*MDJ7P>#%RFC:YOC[5EY<%
M*'57_>/,G,#!@1+&T0DM@0&V<P0()'S;4JQPX?ERDJ5JD-P0>KWW"D; -"89
MK"3!*L!?<9Z1HR)17R<PN)>*]IY9]3_'EL9XS:4T0MAX=T3(ELV5TSTLUHJJ
M=$],?%03+$]FB7L0.NA/5;H$^01NB+.Y@,"X%X01LH$IV&(LL=*U\TG2'M#X
M5%/UT2.K_\;LFL@%Q*JZ^8+@F_,7>KC4/\1WGL3OWY:O_D.CQ?;H_RP3/CWN
M,*/0$^-SM)_X%0G+H_)5)AN!1&3I%@Z@'L)\]0USG2T\!;BVW[.;&WWK&N -
M\U7&O"E'99)H:_>-[AL)>\23D6&M)BHCKB"\8=;P_YWC_YO*QC0:C0&<RES]
M'* =/L\#=&JTU H>9I,V1S-$,\678+^UI<5FM O(C1:EH5\B,0:4Y,"&7'OR
MJT#?)M/NLNJ_XG.F=S+\R72?+HX">.!3:A$B\Q>7W2]+97MM94%A'6N!]*_)
M*1G( Z^S549:S_Z]7^N<"='1PX(2?'I/.%)>FCZ?V<^%H\\$G:$KGQU$V1Y-
M)EAB@0E)-YU4A6B5<W;-/0C/6/F@\IS,,;OD9NF@)L^<8&2*L-CAVD)BZ,/3
M"04S*?,![_Z"I;'_@=&X"7NP.!\M:SX(>%QMEY"LGO@E+Z>' =/EYZBF ^JF
M6WM+ 4R2U"9'(95$24EU?14^!<SW^Z]^L7 P#WY6[EF^+8>']._I#%6AXG[<
M" G C7W]#2Q6C(>:P!L;$7D^AR=#3X-$<!QTM3CDNXZ0LPUA2=I41TIU+8H-
M%'B%G^2TK<:5+/;BJDKR8N(4)Y9PL8T<QG)#\#2AR22!,Q]^!1">//3@3\ME
MB1;]9*?%Q@,@@%%G)&W/CD8:N[M/L8[)Z8;H(#UML_R$ GAV=T*+D:V6/B@*
M0(;SVXUNQ1\W3B:_/K27B:*"E-O7_KU?3)V*#J0WH76-"%[38AL=3=5/EX('
MMP1C$#\]%H[JLT16=D<'D43&GUGV91@M-I-&\'QB;* "=''B=[Y'E IR%9Q6
MJU_2L+#XW@AOI"4Q2(;J4  T4%O(.$F2-/@[4*9Z8VUD]O3S)*VU4B20>(X"
M2#LFALY3 /#7%$ K%9L>R]1108H,:,VJM(+8A&1J.+IS!$NT*@HDR>_M[AU8
MTJ&TV(S=@Y=EU*RHW/F OY "&*R'+4%(M4^H=F]"-M1,+*1M;.'//!P]\H"M
MSKKY3HX2VZ-%$?X;.SW4L<!6R+?__*,/#!N4-@>D&A\4=SH>Q XGF7:CH'^'
MV?-8F )X>S"RZ-('2V*F=OZL0NW15;N+P3M+W 5323<#F?GX')"J\_]R5^H,
M5\B&5(X ]Z!"A[V#(=!%T=R8P>-E"N -<I?<U""PMJL)=QD=[,?^XX>)+4/S
ME=\RON3@?L0LM4+^1BY1E:*W1W[1O^*^8 N!YATI' FWY!P9@)H+%J"?J9$Z
M /I#6LBQA:0].9(_.AU@ "P0@K]PJBV9/_L;&P4+-<?G/E, F@L4P,#&&BFH
M/8&J4'AWM!@"M!H;5.]Q$A!93_UYA=H5=DA5^4]1XNE8P,%NQ$:WE=+2TE>!
M#8&)LQ!82>K6[\8 5ZI2..%[/1XKL!42%7C\EZY4CK@+>0EE@Y[JC$BM[JV0
MM+0#:(;%$>C#=LLD J[O\?NT9TX+$8;E)$/6=IE/9TD!T)Y.LV7IU$H40+9[
M2__N+E%U:_[BJ=9>+X(#"W*@MM"O(%HRC.=T6%37@9W^'\F7X2XYF*IR"J"&
M^6]#4@#JU#NOK)"@!J^=_FA0 )EN30>S'E=SH\5L P+_'M$Q['T@<N\/! \D
M H6/Z)9@@\M:I\8B=%$-<N)40>B8(^O"EH*]:F=V(;\[L-1!&<+V<%1%0'EB
MYD>/_JLS2G<^XY\-B5TNA<(M_09M_6D%YRXQ_TA]?^FEF+"P,.@%0MHL([%B
M _NE:G:<A,K/^!UM/8SW36S9]=F8;"!,R2VVR&HHDP+)IE5&.O<QN?H&^Z.0
M4?-=8.#,T4:MN'Z*\,C,(=4AWOP/)&S.VZKY<'?G4U!8:QO7TK(F?N/8Y/ZC
MOAZAT+%='5C'/F)8MUO1S7TBQD;H*"W)<C,;4S8:X)S;4"1EEF9;:N ]=7NL
M?'-J$#4$%<CCSL^-9F.S_[&HD&C^9[^I=*50Z75+M(QVPTR?D_=B*5&66HBZ
MJ98#_%OEW[I#TZU6E;70I/AZS-O%6CW13Y?BK/1MM(55&+S"JL#=S%PS/4-O
M_#2V!MVE1*I3$M$BQG))H>7D,"R,:7P+E":0FRXI.Q<+OG@?-$.D^N![Y^7K
MS8!=<8F1S+LC4;V5X* F^++.(<<'JGNZ4 #!2/SH6C"R=),"&!E3GXC>+]V6
M$B0'39(),%P>@>$^U=<4*("61>*+_VSUGZW^]VXU]2P'8+]N.!1<.?-%=]7:
M->/1V6_:CZ;.21Q5U,_1N88F;*TCIRQUB,>EI$,*X)\'V3 &^$1]9;4NY;%#
MAHZ9*Q078T\G0@,&P-%'!6?\9NO]K>/Z]L2]S362XS]V"*Q-CL#*JA*.]R $
M# 70G?#?QH;XU2BKOB+T3'RX\9[N$[U4,^NUT*HW#PN[E0^/OX&KK.VCUM9]
MD^2N5&79F=:@ZY8*V\1?JBBL0_Z'XQJ<!O436_>,7^MVRQT'VM=Q;?OS'^<V
M2_PS'9#;1T!K ["=6@J QW;XD(PLH@"L(C-&8N-^TC_45R0FA:@ 1187F/S7
M#9DNE.K^T^:@?SJ/%P2:-6V=]^Q.0BI3E]6P]\DB$M.WCTV]-3QK,KB'6^[<
MD9/(_DDC>>$LL?F\9W5 J<E  .B?C984_@4VF$$!+'J0Y8\GG]-EI@NI"&<1
M<VR[W?#GHH34GA%;W_"J6"=]B/8P!+3RTZB0 DF!D_DP.R?@WBKRB(H<XH#_
M1!6Z@Q6$UCU+B1'DOZ[MO.Q_S%7_X7\VHC8*>K%;,V;FN9[WBAA^:I@4HN(;
M@4XUQP-EXN9OQ=2:CLNM[^''ZX#G.P<'6SI5N^26)5DO*=[M7O<_VAL?GRL(
MKC[8Y]J451ZL]N;+L>*^Z@A$Z('X""<$LL:+[ZW_$6MU$FOP!**EG[=G6WW3
M5OQFRKZ"'UW/5-" R-VZ[GOFE9<(O6R^@G4DD&Q=D$[_F#$3/(JDF_]I[+2K
M2N]&_-P>U=<F2LLTZ2TOJ/.D70V:G$R3[!F[>^T6M7)WL./V^"1ND"^#1V-A
MMBE'2AU6S-L[Y];?7PDY7'2B J!$H8/]KK.#*$=?:A5_&M2(.^PL*,QUOJA2
M]V9VC?\>\,8:*;M#,WNK]=U5@AO=GL@>!F)$#*I(M '>0T(.?'P].\2V-2>^
MAF[4%6ALK30EJFS2TY*&8V&6C!/]P]#3C05D<Z/O#JWE X+A6%<*H.L<0F#1
MN05XS&5>:)Y*Y+7)H1D-A0VN;'#W$ ^6<2<PRP/Q2PXXT-8G*E)A^;^#5/[_
M+O]6)'8JY !8W+^VH/V_@O#OD96)#=#D_\!;^O7TB.9YG-=1L>YG*G+^4 /=
M[/W)9_^Y%Q 0?1C$L3P&7+%5PW7"NBZ!25K?F9<&KX,D/4^>O^WQWDQX_R(W
MFI'*.#[1=5VIRUF8\CS,?%><H-R3M<6S-ZGV\<K6"/*N?.#UT:KLFUV#@XYV
M;E0?MGAJ>O3[R5K.:PE4PCFGJ.]^E7=&O[P,<1G[Z(C/F#UJO$T^%.P=Y&(_
MZML.O'PCI^GEZ79C\MP&C;,((@TU;"^H]Z#)F8KY2VZWGW1O6<58;=  =]NG
MT[\(3/?^?BTK@1X^@D)YE8TV 72UGS0&\Z&A^/C>S8#SI8@SM+86UK=B/=\,
M<*L3@O):@B7V5H9TA#[\AE]_?&WG/4XEKN_0K0G*QM/A 5\/HQ(>23'>SR<P
M<<MGD;\]\@&'CG-(!HS98AN/JEOW?BJTR?W#6Q$*H'ATIG%S1?U<E1_HMK@R
M^5<XF+"BO;R_O)6QN:YRJILS_RG_3;XD(%$D9]5$30H@\N#3A?7_@ KP_V51
MP;1A;!5P(\\$&';I%E2S/](B1 =Z=[I?O[+MMSV'6WUNPZL3<]8_#=Q' 3QA
M>M4-!GWZ]+4(:0!=#:KOW<)0L]7I&@0@ -1N[ZKNG\?=L\/VRPVY51X^1I(-
M@Y=(8/+F$AI>WMKO[3OA2Z  'D&#_>R-,O5Q C$PUU=2+9_=> .+.V.N_#ZA
M4SBY= M@7[C24K=UL!K*_8<"*'GGQF9T6^AURNZ7^2&A<.3\U"(IB&"^YO-I
MF )X 3D&;<X<KN__$8%MD0V"U]"SA9)-<J7S=\DUC-*;6@=SK&]S>I*B\72!
MR%]SZ70?>W)LIM,K]Z^'6KCMD2Y3RQ,'6^3G$^"*_GU#N@>$A\RFDYY_P!%R
MF0EGUP>S,''+FTSJ%6Q,JO8CC3.[.Z&.9%$I-170AN_B%R0IX(#G$D]E&?4>
M%_Z;+A/V%K)+,$#_XA/A]1-2F]_NGIYUT7#+?/-#:KO7@\=>HSY(X9?S-O*3
MWC 9&6I9%8-8!?6,'$W^=_?YWT?$[Q/(P(F\0L$=/,P2$/\_.S/\OR9W6NTU
M=%OY!TOH:DTV],>8;C+=)M8/(I#Y@*LJ@K4/'Y%-R'B-;C7?@SSE7YXY4.SL
MFRP.VCJ/KUU0 _(,#&L!GXX\!.*HH+D=]NX$U)FM@S:H24<X3P081(;M%!/5
MBIQFDL^_R!]I,I=U8:B_QFO7$,_F4YM><]_T@-@]3@$LK0/#?6H]M7+)/^"7
M%3)?3%U82^O)8 ^+/Z\<Z+]?;\OQYRYK(]^>X6"@$PGV$8(P.<EF3(1:._[9
M&V/*AS4QHQ*Z4Y'"U/MD@K#&I:='?6D5X!#17O#ITD[8!<TK>*GED9[X(%UT
M,,@FLBM'.%V_)1VU6#8](U2^86LE_=U4:?I9*IM]^CEHU<5;_PPC[4WVH#)E
MF&7[3.OJ1( +#@^8!T'AP9=4CXBJDV%$OUI'[$+VZT\I(0?V0CY.3.=5O3LN
M[9]]:"H5[*5I0B>(.!Z0XLX-/5UD/C.0Y!\0 ;_^JF)W_ 3&,M<3XCG)I1[P
M''GO4])@"'T;W4"(B#*?0YIZ !.8_7C<-;_D^QC-GJW5VZV?Y0=D>!PT<F.I
M!/[L @609O72<_)U-RTS(O^\R0*) NCCH-:,"\J0*"4IEZ4!MVZZ=%<[E3\5
MSZ[@*8 <"91WZSVZA&390>M:HWW:6F>")[K)E4PW[A.+V9U[.R9>W@>*! ?@
MD\\\TNTVYSHRS@.N$=_/ )G@(,C6Z5,14='<#PU\^YLPIA>TVQ1 J#6>#JR9
MYMM! 0C"#L(#4OQ+VT5M@6><G+>J^C1^1FN8/6:X1M0*>/BIVW#7AUQU430W
MY,X_'"TO6''O_';F]O4 ]FL5@9<P?"14SH6=#0/&IE>C('_#[?BLY3_#$<IG
M4;ZAX<J""9DB^!:/VY!(2&T/D8.U$U+&V5U'YL O'C[%B<01U4HVS (F0Z!_
M;0A(C'II"';*_@BO-E!=^'7X S6S=^=#;LC^<8?G_7"SYMC(JP/*F?RD#TEV
M^7$_>5XC[K"+C18_NMTU.$W0;;_Y$IRAGT,L[!.Q[QJ4(]9&O 3.'+=<0Y6)
M=1GFA2$NNNOA5G\;0P^JW!5;#D&O7BNW==^?X0U]VP8 -N?(P@0'I/VO_K%5
MOM3D&*+I>K V@TQG9H"U]</HO!F0$EW(RM)X=;D7#O=<IM2-\K>4M;N/U3-=
MN. W8E=HC/T :QFD$%(,;"D76$D!8.:=T-/0\]0@<G; 2@;8^YT>T>2"86E?
M"+;X<;5RU-LJ(C#8&"W'$!->VQ;EDT;[LM1# [L3Y^?!*&GKVW$<814:BN!&
M.YN$88<]*T)3+#V333(-A!8J*IH76C2UT,QT."D_N]?6A'-QG6.KO]O%ZM"E
M9^M'\D0+JWF+&E\DY_Q8F]\W/J/*0K,,R#$,UH V#W ?"FZJDB26V=SF&VU)
M;@A4[>?# ,N-@E+'%>GV82TV:".#V_[_Q5+TJ<3L;_(T&X_646O*-N;O^'4^
MI-(X8X;]S?_9#.C_>385]J%7S3!@6?DDX<'#,\/W.QE'E/[D:DGNR8F7='$'
MS_9.1=,\MQ^B_26Q%NQYB"0EJ\L56J\O7",5D&G6+8N3!_@7TK\'66,%,F%N
MDL_RNEZY^);TR'OPGHF-XZEX?_<)[A;PWK!MX!(HF@)@((M/6R\29? )2Q[O
M:A0)!EV+(4'FG_$Y"XS;BE&.PSNE?T4!RWUX$QBR)C_)L;UFH/EUZZR[8$69
M2.T3%<&)-_S_$<\!_]<2S]E2CV( FS$+$\V/\[U7/>O>3E$ XNTXD:@@-10C
M!Z$S1WS2"\[@YZD;@[$L:$3S:X_>'W%]<LZ>Q79Q<>!<=86'./M*"GMZ"LW<
MK:N\\;>XKRZ_-U0&%/X*C(T_?Z'T(P7@M#C+<!A$BB>R*\5KJE/SK2XV&S$M
M5#>RK_#>U@_1>4;$(JB9H0.KYLP3+^00_?AI3%]XPLXS:QXB!ZGE].QX"H 6
M?\$O 96P[5@P@S_J>E_R.7\QR'9BXGX0^^?Y<ZF_G+P8..F]OSMSR"6]<@@R
MMOEKJ3,N2O"E"S9AB6[;B7#Z+8H%60C^+J#E,]KC\HN&G-/W]-X'O<)G:Z#Q
M.F"=E('YP?#]([%S:/]-W* ]ZLMM_AX6G63ENNZ39F2O^<2\P2!>W(/(E@Y:
MRH.QJLOGL."U[% 0.OR5DOT=FDW/.S/P3HR[V&'_5^IL#1QC[/(@U0WS,T[H
M<W45]ZXM_G3B1H(T 4$,N".,!"ZM%4(+Y7/R56J1PBV^D]R_D2*K]<5"_[JW
M@8EQ^EB,J*ODB"_!%'_OHW9<_T7R,05@)X,78MZN)US>P+D<GEP"<FC*0IST
M$5MP%O57=AZ% W0S+"+(T2!0O@&KQ923C)<006AWMJ]0JNQ>XKK'!^9@@B*L
M[2;T#/0GL(H"Z/&8@;5EF'+:2N"1WF=GV*O']/D@3,4>1W-^M?I#3R,=LLQX
M)CZE^AJYO3-P+9._\(B_0L7&<G&$P05*.,:0=49A%0G;BTNGY[TIO8&>]3L_
M;:*#M?UP5FGF;:S4+R2:?CFN.BZ E'3A:":N_3BICO:E*=>/+!*[@?%]KG5E
ME4WP4;>LRA\F"Y-OY_]I9A!U:\I9)'_;E8DK5\-S&$331YJ4"2WG1B3Y[A^6
MVO#ED$Z\-ZQE.C.]&[#:#5R)=M5*P73G-3\.TO)[C@6_H$7%T\UO_!(M^/PC
M1 5(\C3\-._:S'GZL)16V@FYRSY2H:R:DIBUG&?=J4:87,\9RKQ\Z6RLS"C7
M\BY0#R_2IOIZ<T%J2/Z(4#D?*3*ZO38X2%:!!-4:R[[Z VKL.B^'A_?OWGV1
M&TVO @1J5_C)='[N8<@?_ NNK24",NH*8@?.]U@#8&?.@]J1=[T)U[ZN6S:_
MW?"V5[<X^ '$ BV)1W8K3</+O,*)<@?1VN"./T,NC"VP7%YJ %J8ODX4?!_?
MN_CC"Z*+$RXOZT6X-WQ+L_)^.06P/4:_3>(^0H3^=5]=$-49=XON?EF20(6Z
MN'66[]SXV,3SF*?R) G],J'54<.:ZMX_QL) @AC1Q3#T],63O^53EJ<6F_.^
MC1>S3<.)-P^OAH8<"90-=:'&@S'LJ93,X2PI/4@?I<8@.M@%/G\7%-/"[ARS
M<E<9QP2_\GZ]<JXBC<>V^/*SANJXE!*1^+E8S Q,3_<BZ#T%<-'E&?MK&L *
M]-"S%3-:"AU??S;=(A>Y]^"Z1YIY8<1/6:YHA8U'H2DIEFY*@<*$;S$9["8^
MR4++^8,RBC]>IJ\^COE1OG\-0I.09QQ^7]>%RU0_M:_9D5Y86==U\I$GL;"T
M20$=+-/INT"/Q/ZI=%R64C-O&9(A2KJ*\/SF&4].8.^*V?@>L:J6?Z7I6VQ6
MM]+^%H$*MLZF40 A+7B&0WGL')Q&\P91H:("[_AU"_-U-D@/ZY!)A0TZ^9NU
MB5P'C:5\%OTM6Y:QO>_SL\PTS:?4"X]"OM"09-9!6 /P6QYF3!N: IAUYY7P
M;])%)S#JYO<O%15K_MKKZ.FL77:O7%:YUA)M3ZJ'1D<G=E3=R35H]%T*>DL(
MH&J6L846.HJPQ$=A'TP%,>('@GV]"VVM-R;<6^AQ;I@I@1>3^U8O&;^7<"KN
M?"FNHI?@R+A^R1)9(E?*BV=(P'))LZ.;*GDC?[SZ&'1>A#W3;K-_9DGN7<&W
M.[*Z>J9?ZQ6W"/L%6;D;KPL&5]3A;5#5)6MWD6AE1]FVB9]E%M\=^#0?FS$D
M<:?H=G5_^:9;A;#5W'9Z;!JC6ZA4NPUIA\5"&#55_>3 N%,:PKUNJX)-+7@W
MM)DA?-"\V2:GPU?L&/1!3=?!_V)O+OK7D\K.UUQG7$:3G]#T]K@^@38MC\X6
M_Q_$O5=44UWT+QI%1*4)2"]!:2)=FK3$\DD5$*0H+2)2 H8B+0@D"@+2!00$
M*2H@(@+2$9!(%Y'>0TNAUX02MJ1P\-QQ'_X/][Z=<1[VZQI[[37GKZRUUYSH
MW+R!:2KC[ ER7L^"F 3@/;1FHAS?EV\%W"#SF_$P244:M[C%I7E^*_3QX_WF
MZ(;5O/G8YJ[782 ]$HK[CCYQC)"?AFDGR,VK\R<92C,W5XJM?AB&,1%D<?KP
MHN' Z>^GGAE'[8P+(QX1M(I?IR?NG 3_NM;;FC AW=:\&ZWR!FB*\H)QF2OW
M2I8^NFQ9%=:0H">E>>V>4:CQJ&5$6/_=3P7^^TGGR?$*_2KG>Y!I9VVCKF6\
MF1/[Q*EBEB'VPY0[H-1J,2YGD629W613,PT'-VEUV]U9< W9^S(^8N#'QJ]L
MRMY7UF$Q /?WN=3'V]G\2S*.H%6@(/*M3_AKBN'+ CDYINBE,93B:.Z[B+CX
M&LOQ8%.E>(_U3R7[WZFZ3[Y^'YW)5'L'+]7Q'-]\]FS^,]O!QSC98]6CQT"Y
M,&JF%_X_I)'8P52]ILDF6GE_NJ+XV%$D^ZZ9<&YS%TN9W^'(2>OYT(-YZK>4
M9GO L[,_L7!H[WQM;OC-7XGE8I_=U6-%)<5[_G$/"XE!QBWD=T.CKJFPP$5R
MGE[841G,RS6 +3XH,LO-2;]==["X.KVS4RDWU<-8^^AC5K+M'6\].T\&W[Y@
M71:^L,U?EU^Q.EB6FWW0V&2W?OWXO1/^;^\U_)_:LY"]JFSN/)H42DP(7!ZY
MMGW]C#W;>YRB8-9;'(C%*90C6*P]FZ9++\#@RB"7R09=CJ$4G7^-CVE2YMAZ
MRIO![7E]\G;20I.7TG/H*6_G$[5P73CQ<JY"H"G,J"9#YW- N/26V_=&F\J.
M:KF.YGK:A7Q*%K!)O8X:1'$>CW.7T>%T;,1?WB*8=SBR-YM0[]&>C3 YS=*8
M  E?7N\--:W->.Q]Y'8G93W8Q2,[8;P^HZX_=;+@SQ_^?56*/OTUY#2J \.B
MJT4RQQF\_-H,Q=.EQV75?SPUM$3S /,.B!U/I\MD5/VEVJ7ZLK7Z-(=94[\0
MW;E[9CU<5L*&+(N0J&.HC*1_/ )YF,QS( \8YQ2HH6&.0#JA2="[Z#M@2^*T
M:@%,2$%MO[?T7Z\,M21@W3!?I)HMA6T;6A##%^!<A4HI&^S_6M*B6R6W'+?4
MS:=4V['TO;XEA[46<;)!PGZBY8[-DM%6147ME+=TMMN?U&K-_H4Z9E1O2JH)
M3\;%EH<GH^X-NI3Z:D%J2+=<8\R@;'M@QA<0[3K9G29,IS(7Q_BH;3\?#'.@
MIP?V1NLG=\PS,>0 XLUL+:[(_]R&I<>7AK<Z?+Y]];^QB$.X/C33]>FH1+<^
M0.,RR3T$J@\/&)#-W(C"=WZK'P^3"_]DOP*NE6G?/K-* 5K&:Z:^7HHW)G?^
MD7&;ONFS;2<5_/@G\?"2..F&!'O"B;2\UC?D^I9G))5.6446T$G.ON^O>@;D
M5;H$*'L;S*"P-*H08QI\ NV=_Y(RSP=A!G(#A>V]T@J0 ZV-7]U-R1/M:'Z[
MKH)[I/S$,!U?FR.0P>B&XIW7+ T1.J&M7-G#1A+L]>O.>?N (!7%^"6F2T]E
M2'GFDZSF 9FM7+Y(LDN;K&LXU1K5?XAHP@),E(^ D;MTF$E(8 $\[F,O(3/F
MZXT?@[5-PC#(06^.XV]1ZP5Z(/TM%*X4G5^+^5D1,U_#V19NJLYY.NS&T(?1
MLD<A[U.IMS&LU?=(C*K7.F7EE06S9Q64-O,?IQCG7Y7>OW!B>]0BASCC3CH,
M!"=> %FZIVH[&PWHNNCF,'4_"5^S\XIH9Y*;2)G0>Q:@16WP6;P.OH":G"?=
M/0)-"5-.#>M*E*/&P7Q/6GCA+5HM#2/-*GXA'[T.?Z\%9PQEN25"O]70K[=)
M))I4.YR9\+CV9*)5!=W: R/I&^5='J'\(?6DPBTE65KGH(X#%\\UUT<_MY8/
M<7MRHN>G8$5?/J!]SVBD=IL/W:JFJ_<5*T6))RAA\W]BI:M=%(58-Y6LR(KI
MSFC7*R+)5[:&X>(I^K<DZFXL8?P5,;AD#,FT]VUYV2(]K87_;["RJ<_E>/VD
M2Y5]7$9BLN>_IO34OK*UF2F_I7CF%+/ZQ[GMP^D=ZL GJ'LR]H#B12^E:8+C
MT.X5"7FG@=QB77_C\6R.6D_L9K/OKQ3=@Q:Q/,/ )CG'G4ME?7TO[WY_R'T3
M65%0S_.SZX;6LL[S-5M19>3?4L#Z.-/+T:V0,B@N9OX"ZNRQ-#"!XO*TN\I(
MW?B^S(YD#L"6"&Z+&E,W-6LSK-5JGFX:H?04,T9(6T6%[:6L="7+U/ORV\0J
MK\?W9Y@9G30>JE781;+Y1CW>!TNU(;-C(B%LQZX(E4YV(W:(2094Q_]'ZBHH
MZBS)VN=+ENA/%)'K%JK6C;)1EV_U$$[J>T)=/=S:AZ2SR("#TYYWA/70Y#G\
M=@/$WFH5NK5M@7+J!G6V]$YL7 VE;,-ZM^J/0"QFJ![X5V05- 9:5;_Y@9S?
M*B8\5O%5'"@@$?$/)G19*^PGOQNIF^I8)_E30EG.;4$FZX8O70Q.U#]++Z1'
M_+OUCJE&TR[8XQ8Q7>93TYWYV*"Z8'<C,CJRUD6T(D'W!($9Y+ "N3R<8>#A
M?3="HBGJ4V7#E77F]F;++R<7O>Q1!B:D:<H:/;-%$34,Y4<_]HDY O$H!&YC
M.7$WI_+C\CF)P^I-7OFLK,#%QMJ06IVF,VJE':FLKW+"(W86:/,:(Z_5($(,
M[!&H&M:YC=4ANF]DDJB$V\6O(-#C_ I*_D)S)$G:V50CH%'R@2,(^COY[/2Q
M!&UKZATEA0<?1K:]W6+=8S\9ML<Q C&XG#@T03(9D/OPUY^>CV?3X 2M:!LN
M!,AK,T5N=Z(^H_I@-14;,<1CY G>W"7=P\O\!',A_2FE@ H.<V8=+0J1;<DJ
MF,:&V8YLCT_5B,K<:(F_FWJXLR/H-,<K%%64<^;GRY2ZRKLVX8VP!51K1'&>
M(5'@U..<UUH4D;QNO4I#@:<AXKZ3Q%-["R2#1P;/:&/_"@.A6^]"SOPK,"4#
M'!2&:9#JDR!BR&I*")!>0E,GUT<P)#N+[B-3"43C]#)WLEBFRZ?Y>;4\L=1#
MK2<NS6F]L_Z"-S^\8@EEG%,Y C%?!*#'Q# *P'#H6!B?K@H1+69$EB'PI9/:
M6YW8@5"O8D?@G2,94O<U8-W>"V%&Z9HQD"P5Q;S=O<S=)[3;^+QZ@T'<TVD!
M241TZT5?!75;&A2;$=YA%BU/+*_HAQ KA)MX1H#2W65*[;^2EZC^(U EY\8
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MFS>*]CH$KOO$#L_E.W4*]X*VQAA'DPR.0%B6_RWXHU$#Z+I@&K<<?FP_+Y(
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M<X7R?$@UXE0FGYSH#&6WF[L]6#)>\JKDYZ@09K=&: -=7I$)=$+\1>0@=_@
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M,^I+["\@(A1/"O^WHUZ8;Z#<WP;WOACBK%\KJ\JTF+IZR##8=MHZ<8WIP_;
MDQ,C,H(LK[7>U]^+4 XA^DI<FSE'3II<B-!'+F' &-P[-,D./!7#./?@F.)?
MY;-#Q  8P;T-'(_FD,>-U4*C80(U]FA.9!7U>K8S0KK"Q?W"[@O1VO7PI"4L
MKC-<./IUQR/+_;5YD@44N-*]470$.C5(2LKZ0O.?V'=TZ9Z3CN\G<;8.G+*7
M+B%S=I^K]YTRH2<Z2W2Z"MV0QWF/*I;1ED^(/[C_XA_O-M"OS/8,]$:<%HZ,
M7IE:::?/[';;!2$E.1OU_;O\I_R3##"\M-](.09''#U)'2R*!+?E\V/<D[$3
M%%]2_;$+18C-$_*[MJ-3 =C/;.LQ<N?7B<QME8:&"+B82B)$^--_:?TJKVY=
MH^?1RS&(^2AHE=)& 0&,/0(=:]CYCN0H+%]4$3)Z#"4FK&!PC\R75B;I#Z_'
M@J<5R[YN*6P]S- J2"FW$IBUE[RK*0AC",.ZT<.,THUQ5P=:^R*+!(OXH<OZ
M<\Y;>=I"<-^KPHO73C%-!P5%//,F2AE(!@A6+ 5M,SA>T5_[U'*>ZB8M4_SI
M7R$*JTZ7A\/D-&H)R2":3K(-:>!%F '!) 4.C:#9EDGU?*N;:(9L"WNN99X>
M5T^YHVKH#QO.2 \5*RN"-WZ\+<_E&:3Q+,'FX-Q'0SX*5NXS,6<A/>.BLH'$
M1<?[LKIWI;.'"LSB;@R&Z_@?#@^*_[__0_W_/ZK7F2_,MB<]6Q81FPTYEAP5
MM==(UW5Y<D*)%7K0[EK^'<S\X=G9_6_ON9&'@:V'NZ,<./\[EG\$7N3XJJ3W
M,NUROF,1]T\!A$C)6!;*6T"8JH2\=$#@[%9ZU<CYG 9U%UM)LVPTWT28V>[R
M":CE7KITF+A7U2/\7QES4ULRH\4P,YNAB_$Q!Y3^W:O%<M@/1*&KW+)*P\!
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M([ Y:!, 1"N2.Q>RI*\D%,!OK26S6LJ9/TL/DU\QLK)H3%;->3B[: :71$#
M);R"SOY?USF=5CNI=M;P77B1L?7EWR2S_B"_>T:%8WO !,6>WGP\J7SLL,ZL
M$OX@3G((=6GE_&2R0)@TN;:H.XHA#L L?M1Z?1HI#]"STS')O8Y]M6BTK?9K
MZ^OH)SNK7[P4V%O5>@D_&_'7K3=N,IU^I-PRU<K G$"-_VM,CXF"U32V$P<X
M9QS#!.@?=36DFDDRW>8Q*]D&<0%]CZ3MXV]5O#._&&929.3/;1 ,_R)8C9!L
M57E=/(!^A)YF)4ACB-#SJ&/E72>6XHK+QT[@PR,<I(L>5MW&#20QSB3\U0[N
M2&::,3[EXQ]RKEL:\U&6!SZ1FIX$5;IXQ\DVH@M_9<D!LK9SU_@3]$JGL;H?
M4NBJGSG/S4)>]?@V_Q8C,V5KWX.(CMLE5\I]O]?I,,469[B3"ZZ,58B(N<?\
M$%&\\@SJ;,?CCWQB'+ED_-1J75U*?[C&=NUDI9X^],/>0??GO^:>?@,"8+L;
M,RX">E?-11N/0(I^^T7+R;MT@_V*G/6BPMJ6^N"1QWD9^\%[D(_#"+4T"V/L
MJEQ1T%P_%MM;5,,7=[E00LEA/&";PZ,1\RHP_@6\T$/;D5']9?9",!\V*,M+
M:G&SJX-MZV)=](-S'ZN_.7YA/2^W4[?.8/WWR^ZOZCPOKPJLO5$$4B9U[OX"
MJ3Z^U>B1I*$P0[(!I"RNU9;V4^821A^EGCA_FJ$@NS+/1@O,64#_J2X)%CF@
M>?U%'+/<.51O/@CC81Z#KN4H):?A,Z-I@24>8"'Y@$3I7;OJI"43!0W$V:TY
M+(NKXB6O"->'?OW:#R=6:%+M-*5X?(LD 2*5%X!/>[33+ UF3QMK'<EU?QOZ
M>-EV_8UG=T9.2:>3!MQHA0+5(FP<@6*_Z=YHG^)D_YJG7ATGL#;FN;17:0UO
M==;+*6..+C6W/:LG%5J33B@?F-V.0).LDB=U*)%CBGL^T= :\XA]]IO#AH^0
MM3W>8=+)ZJVL;,JFA/LUO[:DTN.^>K%JR=]\6'T"%MY]U42HET>RLD?(A$=_
M;57-C$FRTK"PBUSUVOK-ZY\1URI^*6%#&6>JJ7QA_B2.)F=\<@S?$8@-(FX/
MYX>17B)'6O]0ZK.E?WABX"/E2=F/32%'H/ _LJ?7:WQD)>$?G:]<_'=3.@+,
M&(;R-C_ 0Y.@5<'=X0[K^=QH5ZAP?01^PF?[<>-8H./EOVTF#[+=X8J/!K&7
M%2P7^!Y)T8ELE[_Z<XC@9]HE_ZC.\72YA7V_?4=2]4ZQYF%SY>CJHYQT76^Q
M%C[E EN.+[?OE7&Z"K:_RZKE>U/7Z\^X^'-9P"$S[EL#K_QO]3G'K,6D0N5T
MSR&*]_UG-2K<)7:Y-I]RI1=[Y!K*W2K <X\F15]H8<VN0YY'1G!6>%Y?2&T*
M8=)[JCIEIAJADY?^MX^*0+>:H=V3)U%'H'8&+[D&=06()-_J2/:1SB*]P]?E
MBGTG&@5,/P?&W"K=3BA<O],M@(8\-#$0/C'P9YX9BOL.JY;IA,8Q^ !;XD ,
M3 CM[GBKJQKM!M@Z 1-X-U)>Y%?/X==U6 =;5>5I]1%7YC]Q==]>MX0-G;[G
M) :.!#+Y7Q9G.>\\:?O$728X7GS-TJ'V\W!UB5V4=+HG.6XB^XV4H SRQX 7
M5R=-)ZI+E_T)D=F<QX3KG$"<MV6.\OX5^XST9T-FB8+>V:77U/;2DT?RL3*4
M'$".*HOD4XJ%BNFZLKQH%H14%*]8K*M.>@J]1&.S"WM]7#P'X74'FCK%61%R
MK^ID%W\G96%$CT!>T.>8:FB;/30))JP;B,!51&L_'^K+C%54HQO_E79$72L:
MQ@SNK7N5_IDUT%5D2=EA$::\]OMK<01B8158HD>IE;@$IDH#%3A!E]>/K%)5
M2V^NX!(["QY?S/BO_P9[#A?,!#4#$T2[^[R ?:MX'A9(-:/)CT&4PJ[6#T($
MI_KP[$*_NPXW]X5S>4R2^A<OC;K7O_K*C7@4-CBYPFE,40Y3BNQP#9-*3!<9
MX8?I]NT^P7!%_C1+D+,ISNP^L]I]8E.V5F@WXY+#5G6.4$*(Y<2[WFX_C2O1
MSIW7KMGT?JNY^B13X<\W8.:QG'&B%E$F[EY)G-5RG[RNQ$T%_=POGENS8QC3
M/7:T"1D2]0%X=^L[/Q;\:B]<TW%H.]U.O7EX/_1:(#N$S'W;]K^\88)LG6'I
MI=-8G C12FMY*^EJ<6JAN^ ,!%:$\@IS.LZ,N# Q>K:N$56&IDDV:/=YQ>?$
M2R]LUL--0Z/GE(8W:B9(Q=%;M9-/$#5@EO4[!U[!'*7,+RFI1J(U/#<S<,[]
M6O2+#7G88Q>RM84L>Z(@GK>VMN1^%N'#W(R0W#6^'V5(B!*R5=CYS)P,(BZH
MA+C)G?XVYHDGJWTFRECCZ!]-;8O,J@LL2O1IPT67&TS<^[]F-E?L"\B/L"90
M]DH(EZW+7D:=(>KEJ^E%V;WY8.UH56WLEZDKBEV$._9<[<[:9>ZZBG3YG:?:
M-6<PBKO[6/?AXU2MUBX.WZ=^_?H:^P,^QSCY6&FZ&Q^\F:G4'1+&A!_@0_K?
M!)B(TP,GO/)DR%;/PEMB"#KO=$+C,\=I.L%>@;K!=I?KZT(8(RKQCQ[^*H5Q
MA%D=?R82ZL\<*Y!&R(]!<T+X:('T#P22]6B077=""QM2J]D4CPP,9,NT@7J\
M_#OG^C7.)<1)JBZW)30X!>*\>A</D>@@^"&U!?6U W?&]#]I<T?$M[=S"9@E
MUW_>-,NLN1?_TE5*ZU/9^%P@2NZ7\MLG&E=;O&*L_*K*V$3*M,)=)IW4PW,%
M]*T]+YNI6N9(_/H>7%M!36SFN/^B?OMRCW/K"HOW6YD*_,U*UU]8E=9EW4,V
M_^Z*I]=Y_QY0S__K.<H H68UG"[6 4_G+I*".\!G9TW!<2A>)&-(+5G4(V/P
M%[>>_K(YQR^*_S8L73)$(;G'_X+\;\X4U!"&9(N9FJ<X T<@PO84D: 4Q;B8
MSX]TP6_39.R""@I6,S*QM@E*G^X&;)\" B\V:.XB\VW^CO\6+!L>;7XBY-QY
M 3"/E<FR^0U?%%C+RA/*KK!GV@_IJM7F65SX@AOQ?F<9'RB!G-J5?;K6X^?#
M<:^WQ&U,->Q*;^DH1:W2(BU=:\)L^&.V*=7DTW<AR_BATA74MQAY7_[U?+R6
M%LL,A:GX&>O>]/PH3](SOU&Z:M+^,5"RHEMOTWBH 9[SW&KF;&&BP  I@XHO
MRH^I9==7BG<Z9H.7\%I#VG_>XX-P%9V0S-/@*DVLXZ@X1]3]R.S#96)WEYX$
MCJ4-)A0&&Z\!GT<6FY(@:7ZE3AX0GAI^QL715*DC4'+XU=Z+[@UAS+?ESQ^2
MO 8Z7!]$\Z@P>CJ<K]S[H[72OD8;?+-HV9A<7<S"1Y2!(&NVQDL"]42D?9YW
M/836^@*OS)EZ;+R_EHS&W7V/+=$H?),IEU#^/7A(&FF[^>_P\0(]"?HXUZV[
M?5ZL10/P:K5;^MCY</BDT[I=8LL8AUF1^\?I>?-/KF8+_#W>CH:NORZUE)(,
MDG35R<)M3F#R1&2@P'X^*[+ I':\1L%&+?5R1<WTKPPOK_0D5R,+U\3T4>U2
MD/YU+5Z:"DV&7G($<DV.G2?=]<%R$N<WF:FJ-"?@!SXYH;Y%L!;PPV6%Z=&+
M"4HQC8D;0_?GYX!E(R41C:!4;,C=Z_??XA\_*FG8 H]QMD.GIW%9]-),QEDZ
M[@@4DZ=*.HAM!N/Z>*RK1DV3LA"X4CVQY>N1MM7#[U5FA">7:JN1FT7)&U].
MK>@3M"J&D-/M7W(TS9DBVYQ5P_1=V0K8<Y8:?B>?V_F-#,&O6'70G7(ER5SW
MM1OB E2XRZ"$^91K-0/]@&H'=#^Z3I,WOM,5&=;XR2OV=U6"4''L@W2[T5(S
M-2F[IYF5F>/P>[EV%L6<07SWX-N')FFM A(BE(6]5ET7D8G784'  :F"X@7X
ME=/L@3["J^:+)&I[+,_:X5Y=9N;05.P#"Q/[R1O^_N**:RSIK#E<^^4ZE#IZ
M(4V**HX:0'.A/09$5XYUY*MF.5*O2?W8?B)/VY"]:?G:^9EYN]7*SN+.$(4?
MU8:ILQ)7>Z]P*H@LZZ%5T;@R,(\:.A%,,L0(ACT8E%>JZ>,G\$<TJQ!^R)B.
M65XL>?# RQ0>Z..#^E;SNFQ4Y1>?\X6D+S]?NHE,=/MNW=(EJOQ>)5RTR[-/
M_O,A8X!7?V[3EL6B[9VGT1@%1<]Y_!T1;F> =?^^=[7YM,L5L=^?7%[\-!!F
MD]\.L0R4'0GT5)MH+-*H\;+^LGWH2L1@B3C^=O,70K!-!2),M+4@C&]\+QSL
M.$Q[?.A6ZL<^GE7>5B_D^&MDLTQJ]+7CS=]KR9[ESPFW[SFUDZC=<_Q  0[#
M%G:39%/8V/U2U^7C)!#3GEW5KM<P6I.H?U&]B& _4^C?4:T??*8H40KVU^.+
M(2^-CIHM@))N#D3E*D-X:!*S$>W7AC:K5 ]B(+GFM>%2'U!S*! ]"NJ\/>G?
M ;Z@RTJ</X\T(8!?T)AQ1$+R.7OX@;9[5"#">+A_PE2(ZN0XW1__V<0OWMFS
MJI++^ '*CJ(2!@Y+8T[L;:F-^Z,R<^O=XYIO*19OBLP5$V3.CAC+-HZ8[I8V
M[!DYBIGQQVNIRIN!K^8)LSYO>QP2Y&[++R59,MJMGSLZB[4B+(P&-#8VYWVE
M%["OO_@Y(!$1ZO*9!N>-9]85V3'L/],#2MCMXO"?J+4<V4;LR[$J&,O<0X2[
M(- B;V%YK&^YES1G5(=E3[A,1-P.LZ;J,F:/I2L:;H[EI$31\QE@I'\G&@NM
M3MQZ5PP4=QU4WD\^O5ZO_4[7KQM?6AJ:Y?[=XW&<5<,#_*NNH3J#.[1 70Y-
M+G-^N_2SH?+<"97J%]#!-ZPR)7F-0DN,_1V^)?XM'+&(KX;4/8CF>$.J*;;A
M*%?I<?Z8NPA+T;?T-;%YXQJB\[0($829J>GK3DGR-5R[RI^ANT=,,ES.>]O;
M%=*OL[MQ&MV%$6%('Y.&YS$L;$>)J0!$TF[GG#"0R)^ 8EL[1$7"W]]?K;,]
MS.S8]#Z\S5Z,Y,/.K=G'QY9=\O.[UF+BZI$T>5#)ZOC R2C'_6F9N5ROG\#4
MT%W*M_8;_47JEL8Y,I(9*6]&C.WTKVR9RM7V9BV'V-P^=[6OLD8YKJ+&:MG.
MH;+D\N7?%N;V#<6D,J<XV7H7BB144-?O]75)\'N1?>)\N5\?,ZDH^4;_=<F'
M3Y&"XL11EV+="0+ZYQ$(4$S>Z":[$S Q#"Y@!+_=A9XZ>$!^&,W)[IDO&*9P
M!#HSEUFZIJG)"O<JMHMV"9#,"S8L:-BY74ZQNAJMBVH%IKLA/( __ACUM[OM
M&/_."I#N=]Y9C>_3C?'.5=^^U3MN!LO38A*C3WF^R+-U3;3.^JGYUI<1\H;@
M.QG6+=_IO$8DLCPON&+YM+/8XEZ+V-VE1+@QBI"H,:^>J=3\IJH7&2_9YPLD
M.#%=;2?X D;J<5^*>M@TY2\L;HX9=@Y&),ZN3:D']Q5H8Y1Q&A";Q9!6N58V
M_Y'(".U(X\<@MOU'-Y]S7KNF)?,B.8R#@QUUPC.?Y!N\L>&S?T"RW=BFW@V[
M0\J(^>+)9S,');D_3RK"*WBRLCQ.LZP:Y:4UE#E(+YE@I TSLU).^QU64B51
MD[!31R $-*HN_T(+*_#2TX:U:J*C1;1Y!T_FC]S/3=CU0(E7V4#=?KPLN(R,
MGYYA=HNVO=L1Z*8KU9%EQH><Z9;IQ/O6N)LEVE7'Y<!MOKPI&2G'3;]?*N(%
M>Q:$&!D0X) P3-P.V\#Y;_=%>MEAO)!G-25SOH$>K=BG!;*?NZHB$[96M2YW
M^GNF#Y34AW.@5E@$]Q?(>0W+V4P1-R.T3S[;S=GY05(96)[#<-'\CHEQF)[5
MS$D82$1S+ ,^Y&)'()+DTQV4QPQC KS:ZQKGFHBKBXJ-2;5X5GO!Y1"U1,Y'
M=>\/;LZY\ER,T]2I7'MF2^-CHOC#IF[9TDMI_GB?6"AKC9>YL!>,,P 6S= :
M>C3,D 1*.X6NV#5G"/$E//X[O.#P.>Y!ED1"@6"V;L+FO8B&JH1OW\I27$H&
M1#=<(B,_CMVY56%D6W!%>=S:65OS\UIGZ+7;YGDF&39=^4*D'P\FK*J_BA2\
M3'Q */HSJVW\9E8H)=?D\DV_LJTKB-U^H\NW=V]CQF_V)?YN>D.?\7V&2\MK
M7S5CD6'*9]3+0'("#@XG=K>/;3_+.<: C?_* 42-_@[JZ1.#XANKU=/HVNUB
M*)($AVE*!;<^_RKA^!#\>>#*+:FJK?FJJ<)4[SNR,KS4=SC,JQ86(!;G*$QP
MCZ29%GM!F";VG D*FAV#,_K9KEVO'UW],3WSVT(\FMG *V(C@D?D!67CB9];
MCGK^XYK/8WU79_0Y\J0+VD?*+G]YX^BQLMI6)'/MRL3<NWS5L<]8RMIOX)UD
MOZBAZ_=H,+]EHHQ-P+MTH35-<^SO7%<SIS99FJ>BK/?6T&RI.^J,Y'F6)V+4
MW9$D@SM$47BT]:F32,F$0ZZ<A<!ND?-G5@=T4<(TLV.QO8/J;>$ 7A#,3]#4
M 7=R+R4FLBU3%7XX$8]B!TQI!OA)=9,'0JP_]!8M%7EQ6:(V[K'.6?Q]L5@-
M-M0W>BP&]VF^NGBSQ[\,&?JSH@(I3+"-X>D?;^&EW:Z-^8^<GI<G=;YHP>;#
M;_,L/^'IKLVG<<'--YBN[A$ G3AE 4$B64M1.X\OX;)5J5V9HKF+_I=D*;N]
MT5P[O\^Y?[_HGS4JQ(XNM_G%L+FH[#VE0?RC*^)*M$:BA+P=:CV[9].UK7.L
MKU2_S!M=EBL*#"PYU&SZL-ZJ\U03?+/L((B8ZM]MML>/O6J5_^;\^^=F?GGF
MO?-)(2(32RS= \"5^0T\59TQ"%$\9@<E.V1%^T0+&TDT,UFI^0GB:Q&I=JRE
M^&3O)P^^,YDL]QK'O9=2A0T1+C6(D5_%0<>&D3+"X#A/SRFKS>7F%$$-S-=,
MM*/9UAL[RS/!B30OG.M0LXIG/3<BYJ[7=(D+SW2(^X!5S=4_0Z*$2R?*/OM"
M^1Y]'JR([E$9@Q,_&W"]R/$H??2Y3W:D)'HI-=W;0];HBZ>EB4WZGW5R!>O_
MHNQ+XZ'\PK^G4LA69%^F0LA6EF2;2;*'(NM@*EG')"'*F$FV[$7X14RR)<N0
M-=O8HI)D#V$69>>>TK@SBV?Z/V^>Y\7SXGDQK^9SG\\YU_6]KNO[/>>^KW.C
M\EH1\GRO8T5BW[! <G)H9J]3J>+A)WW69T)>/9MQJ5 N'UD>7N:1>YEZ!IY@
MR++\(^,@UK4<^E&>$3N^!XDZH+!!)RAW@G- 32_Y&%&.@/$N,P'R-'D'J$E&
M:/D/8=G X&Q*]H3)):W_Y,XY-IB[_9?QK%"5%NJX!XF-V8/XK>C:^D+WL;\@
M&Y7Z."5U)2]^HA2?WBX L-'(7H-UYT5->D+^_:/>=+<[UFIKTO%0+8)H=RXP
MB<L?.*K6IM;GG"X<F*-2XWHQS:VAF'?\#544'L[>9*XR5(LKSU)2$Y7I?&<^
MKS@6GLZO3BB7^%*UYO#(SNF$U-D*);M1+X9'TX3>&SC6YH[EP/D9^T^\QN^Z
M/VQE7$6>%YJ9)4FRBC8XI=.,-O$._!WZ<@[,@>[?@_BN%D;Y3UYAO5K=7H7[
ML#\??2\T7#N7Y'KG-2*&A*LE,(]ED: ;:RC*+#+Q7.<I(#@=(V"D2@E.8,,:
M4FQIZ+3X,2WW0**/E6)\=5FF_M5B*X&A=_;;CY^(*OT.,<>1R-'\)!DF#\UK
M4N)3W.A=TXAN65Y)IB#J^Z=(ZP8:QNSAL#+EU_IMBR>^;F]>CJM\<0+"*JX5
M2;T)>5UJ3C#X2;^MX;*CT&ST>3A%N4K,]+];X;7/$_CTO]R1Q#7OE$S(.%G8
MU3^RT]"M^#5G'K*C>7_ *?A;)6'6AG[[+:M4)V-:>(VB6X)K./6N= $EY=>[
M!UD?<IWS"-A%QXP3_*2>U!LX\%0]^R*Z)3K-_2EUVGWWV;FH6T];#NKW+'%E
M[=@9[]LF?%2WH2>P,J]SHK\8M">I+W3+W@V>R7< B(]U!92HRF/;DR-!8;.:
M@OES%S\29A8#E6^'D=!7Q::S\3_NBI]J'Z3F,L7V(!SIT85+*3P'FE2QO^ :
M!I(:X5RKMF7SJ$)1X')$)W3<1Q+FFQ_QLR)'+5TB)N]'1<]T@D:-IZGRIWK]
M2<*S&[^EQNODW@\>W7CCE/+^AHP,.B8OOB+*9N)GZM^"J@#[9$#".G)UNM/G
M8?QA_<:@SNS+.JILZK1CJ68EQ3'U;UT(_<48'=<6$G*U[1WC#A+2=.9ES*KE
M@,*^8:]8R?>G.^_#VJEC<GN0]QO?%N\1ED*=.7A.XZ"#Q3^;%DP/9I7KZ&O,
M.?2AY,3&=(JCM#_4JMU#HCL??O\T>B;)0?;SET_)?&=$=[=HTO0^4!N(HM\=
MP07@4PS>#_02]Z]UBH\:F7F7KP%_8?(Y2QYCCE?K@)F5ASH9%%Y35D'U"&(P
M_Q[]&O_$< 9I\]1@>>YH_ZUO3-W+7]I?DVX8&/WN=[+2LTL-:%:YVTRXU#BM
M7;ZO7T;_N5KX9;G@.(*-QLLWU$#WZM.1_GH^IS,K)6I\9VR5HC/GER;BNPZ^
MW9_. X\\NRQT60B;6%?R6[QH]=R6\3NV*+QO('4?_@$[^CAGH?&<P/WQ2 !Y
ME?6<&%@-[28HX )H\^6DHT+Q0=M3S\QU46DW2AG2 2LBT<6?W?YKOW[ZT0 :
M.X\Y 78 2U1"+T$ XPPZ40JTW[,/TGP+Y,I+UF;">EQOF5_\9:9S::N^LX'1
M?"]71>;K^=Z77'ZYVN0JAG*Q76= SLT[8:>=LGFF,AOA58[6=G'EXHI2[4D?
M1_-3)_*;3_N9N_7]E0MUOJ;UN3_A5*D!TO6%OA]OJX'%3(]VJN)ICRG6XK4B
M]!__/_M!I?,0;ZY%(4SA?!]M"%-'TZ9/L/([A9@!@/CZ'YH019&8V*G!M$W_
M@CP8:6VKY-J6[V9[<6,]Z)/7C-O@C=N^[]*H^W]2U%L&K]_%&;'U."S[+L?Y
M&?%0,2-[(+<;*@C387^=(<1*S$26NX.JY!C*G+C5^,2T1MC''_$SYGG3XY7?
M>88JS]]*]KV%P9IBPEE5G>+L:2AP#?]-E5+>LS-116D*YO&'J0,92=LK.H1C
MH'S?5S#])P4G&)G>;^8H6!$<K.;0DMI^P;(8:\[][<Y HF2G]^,W]57U.MW7
M57Y(,#_>/"%A7N7)+WK96616I=^AU.8(J;&")]2LD=<3#^V;5_CAAA478J6E
M=WF'2CWO%]&D:SO)2CVI]+S2=]HQ)2[0Z67!8I%^J3IEA)6]>:=+:^<X]<7V
M(I0\ (\B!$W8L.SM1]<W_\C:[8[9CE6A?[SK(!);DD<_?9GGTK(-"8\P5.SH
M:#];D>GF\]1!Y^#SAUP3HV?6[Q\(%8G=29*]$\U]?C&\:U@7-.10P2U6Z4O0
MA2$/9I'""U.H(Q3-M-T@*6P&59-?X6MD1.^3Z<"FL=6SD97.\3D(58Y8E$[1
MC;%$%)WN6ZSP@4-[G\NI/@ZMJE?L4=H(E;$U@FM;.Y3S?@R=G+R:<JWB][7,
MVQLF?_RF0TY%Q9._9YSY0CMM)W%8ZW5%J>*&DNB@A+$TZX>-.;UQ,?^>.WM"
M* EV.*NK%=_79G]D928W)JQ WFFJAFE5>KDUY\6,>1+7CD'VGZI)WQOW^<_1
M?UNG!?D(OV&OOSLNITG'L%YU'F&/+_ U9*02#QBYB:>Q95'-K87XTC7@VZK4
M78^YY1U[G]?OZ6B[^<E5[>"P-$FMGIC'GS+/H( Q-F\](Q#4INJMPVGR=)^O
M,&GF9:"_&7"D(VB=Q14@L2]/P=F+GW:$W3^^;I3!%ZB2T?A!SB?KAH?:Z2\>
M /<0'+B\!:I,=1&_];)Y%P!3,KV93'R,%.\\C8*I@FG1]X$!$CL&GF3D4N2?
M&9GI)\4F^!V919?IGWW]I"[32D'AU*@KJU^S5VU0((Z2?.W,NP1MW0_G4P[F
M.!3S]$Y?&ZR+Q$3[I/4-F;VYFCL18! N:SEV]4V1[H:B"!GH5+R.\FYY$/G"
M3H@[>\D#GO(9Y?SZY^K(YS.-P+/.\HMY.V_<=5?U^\^\**&\D+):V!WB;P_]
M8QPC^6% 89OTT&Q?]\W*WT>$3,=3[VBO#<,F_KHP)'#="+@?85:/XO4.B#('
MIOHTXY#'&@9%Q]>9DC0_JY3>W<XV[R/[(T8WXJIZ$$%ID[\5'#^\BYR8<)T:
MQ37I;30"FG1Y\)[1?5J6^W.-\'.9PSU8@9&1VT9N5'4S:Z'U+:%I'Z>R[U2M
MS[0+<?'W]UTOIZ#N?,$E?O9?G-"J"@KUN*0R412;+;8Z$3>EHV2?[1Y6]JQT
MX^;W8S>_YUDUTK?/YY_L\VD,S=-/D"IS,6L-/YO\)M[ ,?%TA51=9BKU?%-F
MK#6Z3;EI%-;EK'8O5=CD>"K)NS["8UMR -;PZ(*5XZ]F>?S5J?/;'XS\DID"
M7SD%CQ0\W6\;VCN).]*Y'SL&YV:J$ )SW,,6CF*/@X=MH3U2)AW7<W8BIA8W
M\_:[W6D:-$HOOUNL/(1M9'JS2K!0S'$6WLB486WH 5+)/^/)EDS/ Z"!#6+E
MS\9)USC (T#$ZC3BRUA_U\,Q9<=G=R7=3/OO#!SQF3ASC39M=SKU]^'17M+X
MS7+[HY[6*J/ESN)E2^(*+_3?907X?[O>@C_^63XY,J@_V[["(2WHFF/VZ6<J
MNI\K[0HNO8DZE86AV9U#K&:\TDLWV8V-C65A2_BQ+:+=JQ=IF8*1'J1"@QUY
M:!J69Q[7W;50C_Z")PO8=\.YX/[$I"-@UJ7&\3]4$O&0194)2<!\E5P]D(!Q
MB^8:=7-;.WI)^)=9<D3\]6RAYVTG.R=8-?!_@F!X_3YI>#\*?B0Q*7Q8!F,-
MT),HN$,8.2#GA6;GB<!6<X*,AH_-2>=I]R\![O,_]96$%)9'^C*%M4<0L><+
M$S3Y'E9G_CSSGBKK8B%8,5]//Q)OW5SVHM2N0-G*[F[%IV>W2GX,^MZ]2M60
MZKMQ-G)&LE/,-8CO5>74B])U7+2*^8L;>A+]U>Z9J<42CDO9$U7S>Y#B_1=<
ME;<R0Z=#NJDU]N5VB4]M6A(@%0<D/\H_?7'=&\RX8@QK9#+PX'E'.F:TIN$C
M)I2APYZ "S*-HZ."41$4HC@3AH9>&JU>S'9 S+:EE#_.C[IU*L"[6<MR.7'0
M7.$PRP5<8]S$J(-*#"4PE_X>N0%]C#S,U"<+:/9/KI (;^=6"X^/-*:DP?A.
ME):.?^UIOC]^(^!X2Z92G-K3#Q6GLR5OMM@\!ISN''G_PS7/YFQ-[?.HJZGD
MU/?6(66U0*6=8[G!%X?DJS]3[!!NY]!QE'FY@='^B>Z?8:<']B7F*,E*,JS#
MSS3(RP4X%ZCTZ(HJ9#6\<T<;WQZ%U2W$9*U]@  \YS<^4O%[$&?W6\>%K]$A
M?@IU7-1T\=N"H:O&:P!U  EX:4[G]SX%+T3JD2T&@E.E:CK(ZIKO"Q5'.B4B
M'=G"*$(BJJJKV>#>4\J*FF+>_+!S2[/OL_?\-4_C3IH[0 @-\)M"H#*^2W-V
MT)0F,-"STHCG \>ZFX<"* L),-T$ ;W^UL-U?>(N.6<'3]H$G%%XE[28.4T?
M"*O]\*G\<O AFCDBKCIY8+%E75U&N^EDM>NIVDW'Q<1)>2@V]=:"FI_#V=2&
M^NB[W2$9@KZNR:YJ8NBX/DK(T9^]CJ]^\-Z4ESB=]K5"=WW-2O5W3_ZS[(+)
ME>A?5=:+I# E[GO<&.\MF1V9?9,O>)7VV?B=[SYPH.YX(7L"V-HH9V P!UD)
MF!.E:WBQ1G6;:S2EQYMRL]U$02,EK@BV+LVSSPRS')8/^=3FS7]FK!U[[][[
M]@0G)A/ ,<5_TX/&VZ^2AT0HR.[@&7G2O1B*ZK+.']H>A*.5#@P6@78]E(VG
MZF*KRYLY3L^GG<S:[];]:*+FN6H<I5P>Y+67??2Q[K\7NDZ.WYS+^2Q$UEVV
M?IA8C]94G/]H?>W:E-8=L";GOTT-<GNSQ"_F;51"48HUOK'D>QGPY55LJ<RE
MEZ52VJ]+)16=WD__]B]8V#IZMSA[T&\S_0ZWUW,N*C2LL!C@2BIX-WA]4?!A
MS-J8[*$'?L=O)?\-IO_'JF3+L3\OU$_6,:S7<AX0TI@'RQ KXDU?0?5JC3\"
M#H.(,#$]@]#O]J(-=4^5(S2ULCUB/QP/WX/4ZPT0!+#C\/UL&28&N/>T:ADF
M!3XO*@BV'C4RE6U_,)?6TO;N[2\"M2$3%?Z?5=!6D[[D/:T7/]N3?%IV7>$;
MDN0W+-,U30A-.#E5/C5-,\! .*N>7O?H;L@/Y[D.(>="[YC*%%<>RG$:@?=/
MBT-*,%Y I?](WZEBQ8]*BBB;B%=-Y6V'8'@]J.8=H<M[D SKQ48H%-2VHL&>
MDJHM^G9%"2GM%]X.O@)];:V_HF;BVWF&C<>E7/+I_0V)WJIS?^%^+M)\B2?L
M/\CQLSJP,I%C]%;P!T,V8/XHK0IF! J0.2"5.TD3G>O(8,I+O4^O\)-=/Y>G
M4.?1L3WU2-])2G]CA*OXL.5^8BY1F,,IK8RD_W494<6GP%$""')$_X9?3Z'H
MB"(@B ?H HHUS'!OC>SRP9(%SX '_'&]Z.+ !W%^#H\O7OM^L2= ^KXFTJ\7
M)N?G8:(V W<A7+P?(31H7"IY$;X16!)@?]!<X--I/O'#F04J;16G[SK;SF&0
M1\&DK,4KGUX$#HBPB@H'%*N5]?7B"U3L)-[4)Z<MU%6(VI6(-6<&M+FR&XC^
MP[.J]%!65BF@ Y5CGW2/%$,^WMW(36B7E>U__F95H'+-('[]G%B.?]BL3=$!
MF_"08XBE7]2+C(*>1ZB5KXL/0]*ZSG#].L"?NDN;XF++JM(&Z,NL:N(M'%^D
M*=V>-K A#@B]QQVE@(/5H/Q5T*\<=RN@?A7+/<&T#2^U+[6I>8\+YYX.UIFM
MG(WHL+Q,./:DL\LZ!AF"G8(V673M0;X1R$D@GM;69U7Z[?MWLS(PPJ1N.H0B
M)+HFTM<_:SFBYIH0X'/8]+NU=V,2O2JK\J-$L'"S$&7UQB^#2!F"3B%<IR*M
M5/"V]7C]X99 6ADYUZ%4*+ C?L[(^O428]!:W43[6W%?Y'G*[];_OH]I)B!S
M'+LF=^3=LSUDC6SU=-5ZPJ'UV 6K*]?&D9IM"C]'857\][_L6]9?Q19<,/(V
MPO<_.Q<2\^2N]HOKZ8MREO0#NLP]R H2N(-;7]Y-?XCQ9AACQXB"&*6:5><'
M(;2MU'9>5@$9#>-K.BEK_9-5<G38?Y^P[]<A^1/?DR^<(H8S1:GV_$PSH#P1
M$T[J<)CMDSM&<\X.J/:7FLO*K1]O:/O6E[/C_/D"^JW*!P5!"V.!D)_?]0MO
M?2U"Z@R&N$HY+1F$O;$S&O<S\.B<3'XA\W+-D=@AZ*.S%5D9,/>,=LJV<()@
MJCIPM6^B2.)+J>*P=<,-0^6)L-5^+7KP^I#2H?E,%PLWLV,NJ5$Q_S\MKQTL
M%@!VHZP5%->[^Y4KG(IK$.JW%V!_X20WK!HSA':_ *,'$+HZ3]*:&H*HOS=A
M@\6N-N%-,QJIHP:GJ>7ZW0?PMPB]./"\'T4\]=_EJ5RS-/-LTO.\F34*L1\>
MNP<YU/C>^?1.H0AMZG%)PY1:S"H1U=3@^MS@F)^LQ-=#P\RC0J3"=^7883EE
MUMM.E4]Y P/#L\W]><,#4,G(Y#7[]"F7MT X:QL #W0W'SB8.75II,CMY<.S
M%W;>-R409NH:MF8\H\*YE&28Y9!%86NJ1-=F2!=3 =C,)4/C<0),S5>NB( \
MET2F -E6H[]G5#%A?I3/5K!?-UGYZ\'#/&J6,FUGC3)17WFVN_05,"]_QWZC
M97UG&_L?B /3:/+=>!Z, &4X"2=L9%4*VG=U\HZ$"^#Z6NF$4-'&PH*R , J
MQ*A:X7/RJ$'1D0OYI87H)Q<SY-_@%^VIFDS9Z H/\-/N,-V0E<0,H V0^_-?
MVY;94ST?S/:+^?[=*#D^YV9"-N;S:$R>H7_G&^394DK^4;V85!IOXTLL'@:5
ME];-RC@YR!3G,RR!'9R9ZBL()?O&4 TWQ':NT:")#971+E>Y+Q$SKC8T(Q"5
M^98ES9F;BMKFHW%/KQWB+G5B9<-]B=/E;%X<0R,217;.)8"&W9V"0'3\T%8*
M[ 18S)#N=6&?FZPFY6PYTC0ZU,8.W*]0?*-E@0I6[$5,F\E<.35^LPLJPYG"
M60XY;N$4!P+S&*I/C\@KW3NO"$(9ILMY=^<#\7S,X'UUT1'KRT.O<3U*QM\>
M[0*N6LUX]'T4.C))Y,--U0)BLU)6RXT.ER?G8G<&H-$APV./4*!W4Q;99>/I
M'H1;!G/\7Y,4KJVO"C3QWN%$,?K\*7"#EM]U3OPJYBRQ/:OW]_3J@U<+?"@$
M3XU2IIM.M+G"H6@+AW<B50>AGPF;D4=;%D,;UH_G_!52.DY=@!4F/%3U, F.
M./B^^G/(G/OWGJ^>[Q50)SUFAJ5-=;3-%U3-=.P^4 L^V9&'<#!<[35';"\<
M<-R::6;SSAU>A0(E[/,!F>PI>/T]O.!_>;@$(^'=CKY82L2C]6 >,R*>86X+
M6S>%1,2(*#K)Y+'C=[UEKE_WKMV&9F,/<XQEG]N'/;('>92!ZY;%JBR[G)H<
M1:;/JX*F%'O5G5"O /C1!L9!A-LM#Z.FV>UIB:[%@1PUB,+B@9VBT(_K W=I
MOP\N[V.V2%(*K.T5;H4K0,[&O A=O:L5\.]KBK18,;Z6Q<4:K?,'GH3,CK3&
MYAUJ]K(-7LU8C&4+XO8@F8D<,S9Q/-4!HO<@%>DIR"GMI:4!SW=RSR76EHWM
M;PSACN.!<,'B<'*'*9MWEHH'+=K=*.KRY)T-67*&]!I]_B@P64WQM-)!'EYS
MEOI2]A01X!QQRW,HP.^TF]I/Q9R5XM2WCVRC5>%,65,&U_J]6!)R8UB-+--[
M #O4>3S>M^#*>G..??/@CZKT_89O+E\19DAS77&<L/#[@;,W;=N#Q+YL-R%W
MB+-YC6EV4YZ9HNTTH60=69'>1Y>LI.R/VA\JTJTZ1['_[\N("3S'^V!MB6 [
MVQC7[0+3BLSJA@/!.*:(*MDW7Z.R; 5WK%T=X&:+.)8-AP2$5H$NO3/&+UH)
M<4H)Q@0CK^./:*]RIL>3-.2;#Y<^%(VB<"<1T7A07X\ZU8T_&+ 'V8=Q87!P
MW0W#\H*_AOL+=6C$=#6"F+WX:IY&Z<&-J@,VD^K;C"2FC6Z#TN5$,S'\=3&]
MB+N#D9*\P3/!H*8X4X38M]"HQQ19L :"UT=(@VYL!?9GMA+@UY<1S^;^BK[1
MB':\! AJU+2+D^?.WIO5G2RB(^3] G^9QZM[J?]8W/=H,J=U+8+@*9J_1<@=
M6MV#J,+VX;I[D6]WUB< 9 ]R/_L(KEN;&$#@9QI\-=(K]X=/BQ&YF98 *DVP
M0*"L-+S*&F.$<&L=5_B]^*YMW&BRQ>I.J.2,D1Z;)YI&61J  AZX=*P*" 4T
M*;CUOPQ]]AA1J#V8"C^"@=$T>]-PW?-2HQ@SLJW6S))E4[W(RCD#C<(R-F*V
M,LJ?WSQ@L_P7Y6]31B/.=Q@T\/OW<64W_C#H2/\$GJ7M=!,;<'$Z']KUJ4/R
M/7#NS:T&8Y3KR"L;D>B2QL\S*%/C]2?G6\9(S3E\5DZ?1=J#'N.1'%L?Y^21
M5[CF<N8Q''5K0"BY4!DT\0/JZ0>^_N%C:9,%AI/:9942,>CJP%EY&UL-/D8+
M:5S7IEHV6X-IHM;TQ+U?E\]?O>0__BLJQ@NJZ7EKV!0?UH,%LU\$IDA&!//2
MTW_OY&^SAX%$Z,[^T1"6ZE<<*;\;1Y&'@FH,F4/(!.*A9)E;+[ZO1,48M\C@
MGGH@F2+EMI.<2"%1%T!5W^+P5ZB<!TX3&7$.4\[M([H(VU,,*<%,"SJV,B1
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M5[Y9D<>HI7L[R"3+=^K=B_?A?T]!N6AI7_CE%A0.'KG(0-+NEA7P4#H"1T+
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M4=V\R[Q+7_D7G_)R150X3/FY@ _#*6CDY=9?TA"R'U.;D2(0N)I<_*/)B=_
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MIM1Q<YVE710@$K0]L^P]0U,;PH"R9X&;M>)P#-(!]Z;%D&8XC\W&U-M2(.'
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M9+ME >&]7EDNZJ3]E7$(C!34DW-F*C!Y>8]I?<\SI&!=N7[]R""W>/WHA<%
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M$HI'(V$D])\(QW3+K_4>O#)UXE+OVY::!^.N\X9KE01YJE8*_GNN&7 A#T_
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M\+%WUL 76GJT?V_E_/[J%;C9IH!]YY_,ID:1IX%61L>XA,J3@R^* (Y<LV#
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M^4GM/7XLR]W7GKPJ9!,IYCJWVE:#VDXA*\%^S@NUX%.V)_#@=OBEVML6A-U
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MW/GK$2[L/5:>A>A^#@MGZ=>LO*^;8^OF8O:4 !XXPATMLKT%X7V#_V6*7CH
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M?JZ2*=_2I?4VSYCTHTM_ON%DWSWOKY9A?>_WAK?QBQ<_4"1X7J/;!#2H/ZY
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M.[U5U3!TUN!*R8.6FRT!64$?W,V$V]L7:B[TX[\;)-3=>*O.\1-YP(&X^>^
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M32,6 54P0P2+'MHTNEA7SDGS9.9M/UDB@+I(MF)7#CA._^EAQ.URIZS^9L(
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MB= E\]QS96$/8M2O!<$$K:YX+SAF77$=J/H+U8ATF][=^ O.!U,"11@*O-;
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MO8/<RLW20!&JP3H,(1CMRQ<;TRZHJ$#6,PC)E=!H]G-))HW[B,,*CB'X(NZ
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M_P32\,Q,R%T5Y2749C:[X^E_!U!F/M0R6BP5C$/S ?ELQMS7ZG85>FK>V9)
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MVK P%AX2'ASTD1^,<.MH+9OWC8C$6>XT#EHVM&<V_3QUVUB=)VBQ"9+[!W?
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M]]SC?<GY^%3'>_<<-*_*C]X93KR4UG!J=VT*?Z/!4@/=K?,@W7]W9CI3Y([
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MPG>BU=C.Z;^>D7$LC4A67O;YZ4,&,VMQ=JHV"=8)B6ZD8_!2X.Y6W0G]X-
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M93'Z491WM-]]*L\3UN_=\FM:<E0[Z6Y)GJ5?N^^@L?V);B [@.1P,6G ]VW
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M>JPRWV#S=:96U3V#P5+?(\%D-7.V =GS^D5/8K+I(JT7!@A@X!R6*FJ)C&2
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MGYG2BX;CLZA0!R*T90];7?#<6U_EL8T9X=$1^?2/Z<4W!8,]2G?U+U1'#,_
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M!\\Z+E8W#DK6%M0FA5_:5U[+N!0979O9<0_Y9WLOXON5VY9V:@MR_">PC P
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MI=NYH*M!KS:A(@)W>5V05W\^[<>' /I=&H+B@]P(M'K/-5YB$:-6$0I\!?K
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M#EX)QRL6_X=A/#"4N&TP;.FT^,NR/N+4?[?CNH];+DIA+:1L@P@E89VR)S?
M)O$+W?8H^C'=>UAU6>"$\5R&2:QK50_1S%I%S+#9 Z,PAUD"](E5Q$#Z79@)
M!"-%2C'56^4-:X!\H&IG3#AG:B4=V <;U</MGTP149$$3,?*XM+/_#>L[2S%
M583EU-XG&U81%52\V97% TN&19E_G["&/PX7&L(V$W.PQ0*Y0"-^ROGO=J?M
MM'&1*]O7NO'6P5&K@@)B_G_PN6:ZQS.M+3(^WY.R>J2,E[U_<AUADKB*<'G"
M58[X/^O!_+_C\[_6%_J?YY_GOYY_X8$O(?_1Q_D@:G7DOP%02P,$%     @
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MJ/K+E/D?,I#75!=J>,59/EY>"G]6(,EN5F'YX_!5!(F6CCL+V)]G3V@[VM&
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M89]2XXJ >  %]6S>JC% S,9'(3]4_;-]\7R7+_<-)0]CHT+R%9 ['86-+?7
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M5H9J?Q2/;HUL"=WGY!W^O61+JT$WW'TEBLM/EAL24<%=)8R1R=^80]PF&^M
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M^-\^W/X_%QB0)_VO*3L0H48Z<JL/OWG^P:F Z&O'(D<Z"\./XL/2HH@;-I>
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MT9R$/&56]B@E./2"%\F:1XVA+,FJ00@JP)T#!3.(C_D, F%?SK&HY7A%!MM
M\7 *EV],$-\]-2:/:PE[CY/"19,_T+%*&2[QX$Y=PTL65 ,<WV_Q.#0_5\+L
MV^ (8HGP:._=T-N$[W"50=7G:N/'%U2C4?<S_%^NIP(*7]7UI<@C[FU%C<E'
M?,6P=R#E59 /PJY/0(T;C(OKI71\3X;N/@P%PD2/CSW:^)(3]E:AN)H5EN!
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MX7$*T F<57<>][B0H.TG#-ARRQ_S=K9/_&T!8S\#>1D76^@V++J5Z1(@7>I
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M[:N-ZN>_YLX@3?M9>JV?*!6&@I^ K>@[0$LE. (IB"U3T>0[EMZJYFVY<.%
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MB6%J>QQY 6:V9&ULC%6]CUXOVW#9T7_+>,F5B!MZA9%:[FX=U].5SV.??;T
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M4- 2&OHJW/DZ^G3U&[/8Z&_8&(\O8U'AHU4W#OP)KR5N@XB!1/)')*/5Z.N
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M>IA8R#[MNI#(_[NB\WGHZ[I>JO#KP#SEUM#U#&I'9%H@3ORN^I^G"K\8J,#
MBRS1;!2IONX_VO5'G^S=)?4VTQ[$<"@)0]EJ_^',G\A;WV9X?]?_KO[;QT\P
MV:O2G]".B(-(04AB,5,0E31!&]=^+RH&$+OUV6F7!__8/3!(*<2.;Q!Z$US
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M<DRVR<>ZM7?:P18(^?I-7+JEWT$/_W%I1W6-ULMEG3UO,AI<"[,BXW&ANWY
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M8T]V@G5 LNOE0\X6_*U;;F$>LV F.2V;WP"'F;H8K4I3N+!^)$K[%/^TWUM
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M[>."!<1E^V;,7(+0<YKXC/Y6!V[DI0?L/W+_Z9MZ]-^44ZN2KJ-__1$HDJ^
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MQXW=UY/"?*IQ/RKWX;TJZT#]O-P1'X/X4(WSR#'YJP7$W1MLSR$$V)2:OYC
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MQ21E_'FCLH+-#CAQL/; BD->B]^N/+W>9+]#W]<PA9Z1:CFLB( 32"1UQRN
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MZ-DJJE*7T0&<W!5FP-A0;$)X:G6D!(TB:E/(8@8/_4>@I^,.B DZ\=^^]#\
MN-X9']J&GO"1S!X39)SH#IY^O;3/H[=2<_N\9U6WM<QD:+:U?HUJD"AEQ=?K
M0GC) J+?5MX,;8Z4WC5-X3FBH0(@JGE /-@D'!CT;<H.JD?#LZ,X'2 >#)=T
M-<Y]VV=[+I;?9%SH]JXD&'W]%?J6X\_L^LW*$GHP9BGMG8DYM';8G2@.:UI
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M9L*\6?B)5_PC_)YGN&/9DCRE['5]@7_H2L_3N1=='&VH(=#)>3OJOE[';8H
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M>FWG.4_> B(>A:RWH%P4-'-7.I#$^+M^2&Z6O+>ER42CKQ)V'09I=J'=J9Z
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M(%YIJ&G!G,=*&N38;I:IF@+,=P=>F%$>A:KD-&/(MM5F'?]-?-]&3?%,JU$
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M5"67,JCNY ,_@^A' +Y=:JY#$#1$N6&5$ZS&+M%@M'J;UA1TKKKR-*)]?,O
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M!ZM/KC@(Y M:5G;:*NQE78754$DH=R@N6DCB]!F1$P-%YT2_S/#CL%]^LN_
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MPQXUOBYZ4BI.MRI]F6Z$+.!/W*=Z@=@.UFB>=OWE2>P6BJ<8;03UA? T1=M
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MMY[QVCQ/R]XZE1^77/\=+'4'F.W%P'/D;F]RFR<Y!)VR"M&5'Y%> W5>$(.
M[K:%-/+:6I(N,81#4O:0GNL+09CS=#B+D@R9\B6:WMY!<T71G^^7VCP+4C<
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MLEP+X)6*2CT>=*!VZ+-G(8VB+AHBO[K1.JO%U^Q#Y9>K/LZ4Z7[,=EH:_L:
MJ<_<S8!_EU84E_3&[[/8Y6U.M<7J\-F'P)_3QG+?1O*:*?5 G:9QPH737NW3
M3Z!CIEG[9WX2NU%>,SQUH#L=84@A:'1HJ^:] ,TZ?'0'B 84\/I\OV%?!'QK
MT$H(U[*\Y.KP']4JY3RLNP;VE^>&*YEEF9O.I>SH4ZC?NE%RFREYO-BMGA6F
M-5L.4,J2[>]K_G =P.^Y>?'O [26@4I:T[U5R/:++'W7H^&^G7&9X[ 4'PAX
M69 !WT \K*@7AAX!Y1+[. 0!'R]6G4)J ;(R3GWKI[D.;8<TK+^O[J>Y@1QO
MGR_&>G%C'W.N7GUGW&_3Z&\/B28G(I6)1@ T"[F/Z R0X\UQRMU,S5#JRYY4
MGA$U*W((X85,V=&A?6+0--3PT:/%R=":?;3XL6OQ^@\",S85Q)U,5T03I*I4
M";21("<]>Y+D6Z0(@,_"J!(2.O(8IH-4^):1AN*R+V#&N7KVXDRKD[&F8P,U
MVMB<8OD)-UO:2$WFON?M-)G(LO#\R4PGOZJ=C1;5=^3QCH EDF/$0Z* #)K3
MLS>#THMA@E@;J%JP^[91@R=F,S&\O\UESA[Y1J=+&K)<+GR?ZU>.#?PGL?&N
MWPHC'2+] ;(5FOY:EL4P)EHIR$V0G6QM^-8;WQXSQ\Q ;!#9C-^\_PS4$$(3
M$9>#Q'"]6KU&OTIJ_F2S-BY1.U%[>?0;8<YXP7STDY$WVQP7?'8%*G8%SXNR
MQXO;QN""GFYH)H=/-<P(5W&_F. */GZ)O3T5PZL4G!"']QHO#30S!FL7(C)V
M^CW&TVS17IP(H__T?]5:9(RDW5JD;%\SP==F!BA8%T4-^'WPWT8I'HP6+*0A
M=_9'-"&<*B;E^Y*C<=6TT6 =F:6*ZY=1-,X\ZI#OBR#-EL063YTWEQ_6'1Y'
M*G E/H34QH .5=/M2DCO%8Q\?9 Z5?+F==, \6BSU++1\E=G&#YB1Q8367FM
M\4_TUMLG;HDOFAM7?HC8*F#P%:*)UB;HM&/4B+I": K/LC>$:#_.W!&X[ ,3
M05/P][L*7TPV]A;$MEH*]A"N>KFL.7S$7C\@8(N]DP"UD>#UE@=5S/ ["(.2
MX<FBK4#-W4J"%XNWFY99X-(OM2T;[JR8XIY2<V6;>7"'[7:\T._9&_BW\;W_
M]!<5Z:8CC-QF2;[V>.FK2$?^CKR.<\[I5#L/MAZ;N[+YKUU_R7<TGJ8?UK\2
M]DB_CZM^\G7V[;T8:G5("+7%R,7*I9ZFB,C*@<:SQL8X(;6NKKXAT[>!2J4U
MGAYO:&A4F-6>9//T@WT7+"Z?V_ [6=B2Q7#9/]+SHIOLB1HFH"%H*!?=[O9D
M$YV@6=\!67,P6FBRZ^D#)\[\QP-&7C*\:^Y0?["MYPKWNYP7Z^PTT>1!P?%0
M9\'7@+- J1L/M1.@[_&W2C5$*%9#7C'7S1J323]608CGGQV0]U@\'5C,'3#Y
M7N TT%G^Z=/S@? 1$[P;5TA8+SQ4YK"TY>"Z;] DYJO&V6C@8D>DWI\@YG>1
M \49U(*TFD7R=B[H^5[2$6/QJ?/EE4_(S)H@UKF!Q33]^IS@FSC+Z8%'H:87
MY[]\V6R;(F2VX1/)ND0KK03Y$:DE@.E8V#K*KW@94 IR6%Q\JHFYS-/&Z^7!
M)9QQD.8OI_+IOA&,STAWU50/+DZ7\FVL^:JQE<;^E8CM:WXMM/WN5ALJ*[PY
M8"K?I$BPL<#H^<&GFOE%]8(>*/=$+6:DNBOB=0OGAU=F4.R&1_]5^1E(/(T2
M_1.WN[36)LL5M JD=&!@4D^ $[^8"1,Z=AZD[D3N 9O[3#>^%#XG'KZ>?_-.
M?BEB89V*:;MY0\//:XFI WC3V^B*ON-Z_L+?W"K%B+3>PC3ISHJ@>@6\#S28
MQ"AJTK3%.>$%Z ;3&&8\KJW(?6=]O/32J_MS-<3) P<L;;;LWC86]IL<U*7G
M '1786R;M6F5Z**@JX 2*-\HH@V$(>L%A58=;NXKH8W8BJ./KZ7;GF%=&L"9
M>HSG.,3_O.%^;O!WUGY$O S"@?J)Y/M/ U&:1(UGX,QIH#$CO%B/$,/RRL+N
M[4?XEIP@!Y<1XC^VF4/U2GQQ+Z;_/''@9]'EKY/_MLW4B#")=).)'M4@^381
M,WD1K@5>[-"\/<5=2*:[E W/Y&N^]OUSK9<M^LS TS>O6QN):_NNGM@7NF7X
MR].LY'0(.-I6#*#1PRF"Y?1J.DX &R&/RQ\*,^$7&X:HF9?I!@%5R(SJ*SS3
M$M\7@9'<QM%JJK>=*R/+B&*Y<*:!6NQ:M%._+F=CO'KQ6>)QD#S>DUZT501E
M]:22]%Z),/%T]VOA/6J$J(L>GBRW5]CKA930W,V^_W3X)QON-;#[9_?$'K&Y
M@AX$?"40TTZ"]M+7",:47?NE6H):E:DBQ7.S#<T-#RH)&(?^\;[P3UMT/.@#
M..L>IX8$=!8/<]B%>OV8U;T?7\E@9,^LAJQ5$98,I4<P;U<A<U"KSQ*4=,]*
M@%A5Z@<#TF=7(8F8]]W25_+NGV:_HF/?U#8JTFS6*@2ONVXBJTJB+;T%<&8;
M\MQ@.TV)&L'EX(%1%KN[+*AORLZCKT1TLUC@G'I/R56TE;<&HS8,7G#>; (W
MB7ACSJZX.L(KIXI(MXB'P&6%['\%NM]"-TCWB5"S 2)U3H>>#N#SX-ET\3I$
M@&0;V-.%M!DDVI6.LJ)B561S');,B\78P[' Q?#B<!&M?AU_NT0_=Y:]KOI0
MZ4-]"5U0V;[F/XSB5?\!X2*K\57(V^*T/*0-<+,%*&Y76#+#5C'JY4# >'9:
MJ"G&![0'BCM6(2.U J;RC+8W&U&T<U#Y1$18E*!BG_#??QB#^V@<"UNWS_Q_
M&5K$8V2NDEQYEZA;G#2 6(>\/TX>L1-@4D@JH$W'2G+&BRN=$\7IUE^LJ=;=
M:=29EW.6G[LO%+0WWZR:X&_@.07<JOI/\R_"Q7-9WX\NS%V <;D'(35*PI1V
M?@I?FZA<(S4#JP0N1EWRM:(_V7D^ *-Q=]U4_J-^BUB5V+.2DW;&1[Y_N-*_
M*',8R[ETXPTUJ>V_OV*G#Z[K(9X'*@7\3)*.CQ0F<D]<;,4+BDH%$M06'F@M
M"K!VZ4FA@G,E]?UE5[YGC7-'NP."4M<+1%M"PS['H+> &)9<"6 F*^K'Y #[
M!%";:*X+:Y?OZIW=UNW[#"2S5N(8#TJQEN?K;0PJ"BNX7AZC^\UV)&^_T'&O
M4/'F'Y%J1"W0 ]!JFQJ')C V]Y%@X!&3,ZN0*]FLYO5A=I6.54%9.4%:V-V_
M7-\9?.C<%>&NEOETWT$AW:\+]2I@UE^DU!V%T4 $2\RD>B*KS-KYS/FJZFG>
MUOYY=T_&C4,&\ZWECY(S:WW>JP:T#)E+9M+&+CB51>_/S)L)4KR[U% 1@Z/N
M(O 3_#0]*.":)EC833R7T0X0)!V>-]1/1 L#$3O*&1F"T_@'GRRK-)/*3XLU
MU;AMH?='"ZMU(%DZ$ZC9 HFYO$_+S3.EBQ^/4F7LG^;BZH:'@QG[@&]/>/OJ
M7SEEMD^)Y?L:G>-NFR!<>_Y\Y7+<X[^<CSS7FWGD7NHYI42BCBQO%1) 'IFJ
M_0;N!S "#LOHD^=G%93;(,)0D&GE,K04K.RQOD'L6='\=\/KY]S./[64-\PM
MBN)*97NJ'CV&G@?J?\MBO.?-UE*I$>"6/=X"VT$HO2BJ3>,X.Z>9TNV%8U@<
M^[)(L_$Y'QWU?+JY]:?G**5S;FG@EW5[1M.:]$4%![^G&P(V OA=Y%Z"1-B8
M0%=Z"@8+M3KAL[]$T(Z54^HC/ +#!4X>-HUX?OW1E3$?KUT'_%LM7T;VW+K]
M\^Q"V%_],:4'_?]XO^O*#O]K6^KNQV]";'-<K[=IO%^1N/<.R]^27_L43 A$
MR&ZQ+VB!GP@?O.B3<@6] >N@XWW;IFEI$ZW 9)<0M^6#6[+\X,+3 9SYO_@]
M](W3AW(B _!18!20)V"VXU6G?=3!6P(5PW:DSI#%6&P'-S>[K.Q=0%0-6"2H
M69*=.96/?70U*,^X_\NL?_8M&S6E'9.*,2X@'@!10,^X>[R"OU)0FZ2Z92#T
M[8KWY]+H2A!_RBN133&E!;^+4'$(S/T>FV8WQNLQZ7CS3X+^O4N06^=!]#A'
M,?77$1:$\-\G4L)/]])C14&X+>14^<$ZY[M5A&:\BN>7D4#X"VK].PW=(T/S
MWY7Q^PX>=WIT-"S>UC(=\E_M!.S_7 ^,64I)9YA)-X.W1-!.;1Q5TY*GSZ';
MAJS\PHIKC1N:_7FO@\4XN_/]<S>:FG)&SPZ8FE:;\(0"0:-#T7599(+$1JH*
MU*8A-@L7E*4F0%0R;162C-08H"L#\E\L[BEK?:0:D/7:L.!%H+5I845<WEGJ
M*T;>D2_[1O)R+O1K\3JSZW^WK".W+\3SM\BW< E%W8* >'/\!B\"IS._,HM^
MI?E4V']%>T0D:N[4"T+"I:;FHN_"F7.MSE?6UR%:R)&6^W)QO!)[B!]!,4.U
M,J2V-2"ZT]JA6 C="I8Z#")LA+9*[M1DB=/0HDEH5YR5>[^%C4X2 :Z@=_2;
MIKI66J&>3@:V/-G^1J12"J#4ADY<A2@SM#VE.@#L#M%&L I)RG5;&7RBMR[]
M7PP!/TO:/X!?PD5^QME<"IZLH5AXVUT:"*W%*9C ,/;=8.G/+^4QF=O7_"2S
MF,,7Q3:@BW 5 J+EN^6?%,Y$-YS0CWUL3+>O(+BR)(X.L1]B6VPJ@=D\(VL"
MML:XMF:V @^MR+]1UY3SJ3[DE!T7N8L( _V!X+?:4>W,9#WE/B(,6'#2KIN2
MJ['WW%^,#>=$*(^Y7SFQX6NCBWY,5LESOK>WH]F_.;8?7U(=3D)//[N#/ G4
MSFZ0["# NLY+CP/%LRP@^*0(1Q-.:VJ7Y\53R[-/,TYZ&GU2/INSR[QP[?>-
M-I3O?2'&/F.O>G<.K[6.^Y]8%D?F/KN#@JY"_D?7QO>.PU,8ZT%WA<.\+59!
MZ BR(2#<SNM^&<&];46O4#"VSM6*DZ>=^8N+];S<2OG'##-M%>69M#BS*5\L
MG_[^<^K;FR(/S"O%"-T$6R3:OP.,GM3==Z+X'GF-?#?QI(A4@,/Z*:72[9Z>
MN/5[A[N1BW_EM/OAG5Y77M&B];==F>;CJ%G';B;Y;OMDC)]"&H(F0&T7R1+$
MBV"=>IOZ:,6[B7MP6/DN,&?Z6%?)^'?1CD)*<J/L[^M%!\\%64:Z-?Q*>_:8
MV'1NCZO3;R[/%37&$PU%^]M]]@*PK$45FTZDJL@G+^+W#2E<.BR0'1%G*D*T
M%!@UW2Y_=C_VI5'I!L*8]^5DK?;B1(P*<B-HY *& =EM^89WZ&IE/>2(2C#L
M^._V=+P?E^BYJY!S31TYSN;U8V,]QK]<S.M.?VR+6G_I\J+"=?YE_$E< QI*
MC@=&\G:#'*"Q#:9!S=A<T<0VD?H*)"K7O?=-"_>O7XXQ6>HP/->'-TA\5-;2
M7U,][XGZ^_VE-3ZQP /Q'[('I/7!0W(CT%&"))H J/2Y_<W)'SH],4G5-T6V
MB>ZOG?#1FL5"DQ/PB()-\W/?<KG?C!>N><S=B,7:'>\R6Y1M_[\T>_W_]G!_
M)+VQ"LG!"U&21/*4Q+G6M?8P^&X5HL_O("]O6H6PQ7G'%2ZO^)>(DE4(Q]MK
M%>*Z/#@=\:WX?[O)Z7_D[JK_/QY$D<29-%"\<15RHWA=('.;W'(FOR9)P%0C
M?' &-J:N6"73%G8$:6>G+Q6:>0V%RTQ5S%A#VDGCV,4%U>E?:=_2;7#BER$&
M5NZ6KUQ^_6[HA;KA K_<&]ZC%[P*T6"HG1#B7&VU'$30+M1=IA9I%\%AXO)#
MO4OU32),NA16.6D=NL\Q/YCBNO*Y:VA];$;+\SV.]TG>JY#XJ>E(;85E2P[/
M6%,&W*Q]'DC"B%H#2T8C[ZXH$C1"310Y_7/Z)N1A.H]WZ,#?=TZ?,MSX\O<-
M,*A0YC!+R)Q]++(9+[XC_X.( &=$\ G[W$)@1I!]!Z'U'$OZH[4)O%LSHQV.
MW#$T/Z]_JY00-,J*Z1ZQF*2-W5R%N#C'4I#;V3?S+L5>V;UN:4'X>P?)!JD!
MB!,N9) L!SU9;TE*P.<2A4)O"]:TS(MI2SG!QFF+O__L[W%.GE\X]ZEY(=GF
MZ,WH97CNIF,5TH-@R3@_$Z,BW27R$\R7(%^.%\,"+7WT@:'2B$K>5)15S.45
MS7B/Q3D'G=A1)X(_(72OH]O%M@L[I55/46E,OUKP@/PA_!ZU<'\WTDCV!'6C
MP$-J)QB!+Q/(/H,,'>(1#SS",K]R.."7N6.!,TY;^5?E&7]VOTTR]7K7'S,,
M'?D@:3-^N+*MF/:CH\7%2I =;XI4#>1K2.W*IOH;2OP%+3J?CNBD(E#/A-PN
M[POS7FD4*FY+E[)-;.;%\V_J7E$;-+YTJD%65M*ESX&4N0Q))!$#DI!6TMVR
M1(1%%%#@R1:(X*Q,':'AG$8IZ"CD=_ W^ QSISWA:>8]4"Q#101-)AXAGO"_
M;<@.'R-WM ><^D7YSGC=S,;C93WCQ7-)9(F;_+.>/E@K.2I%I2H">7<:7($&
MT'B^-NU#3TJCCZI(?K=ZJH%W".BY1Z,8GA1=_EQH4G0WRK*U],/&-//\#*=*
MK"=53W?@QN!XWW$DIVY@<<YY#C/"$;NO0GQ;<MN79]W/><?EK/#QQ?X17YT,
M1^8%7Q@X>LN![-L+)^Z[!__W45%T:$*]N+5> 2+/: "FC9_@^2,I CU:*HSH
M[HSS\@8;:R=CNA/I3M$* _N'9,8F[BWC@DJ7&T4^!<^FVFT*U>6KD/.]_D.F
MCRDU)K-JQ!79)5G%*B3$>2&!N8T!DZX!CP&E%V5/5R%8?-H*CI]F#DVV#D@+
MYRM-,K2  X]CC&GH5+*Z-."YY_3?H$W[_0\[9#79MTP?A//V#87_1S723!:?
M?G0GCFE/NN$E_T+>)=\FQ8(7@6SQ>]F3Q=I$KE:W=XPB0,(58LP2.A/1H!^\
MP^;5!!J 9:*H"!.!;EB[=</K0[2&WOD?U)8$MR;Z$<_1A@>EA&+WWCBTF"&K
M[YGE4Z3&BM?\(?"AB23B^^#4\^E(S!:DRF2,O%"PDV8$A7;J+J1)G87D7=-B
M3G- $E57RT7BTG_5V]-%_%_(?*XC.[Q )=B[[RWR:^T_TG423X*-$#KG)1H5
MGV$C+(3!\)W2M0#GKM1%B%;GD_VSM\Y8\FQZ$<>$)M:CIS27?P4EQ]J@U;EV
M,?C9D G)*:VUZXQ/'M(7,+2D)-D+/[!%0$XJI@;,5N+'"V'=#3$%!/0$M&T5
MDLH$:')=[,I\9LD,:1\3Z.XX6HLP$Z"V@=K1BZVJYY_-<!JT/#>^><F_$FAI
MY?+<>5_G?V&E4KQ(JQT-&O/G%IX1D:"3L#:3O%V^GW@4U"@#-=JT-\REI%#/
M6V8#*0(%G@0SD**A:H-^J=+XIWU#ITECM5]&@J(T,-[8%>2#\J"8KDI?OZ-*
MB^[VI "IB>P-X]"(?+ 9/GM7XB:%U($F$_Q4WLX!Q&7@8I=\DVBLNZ,VF:DN
M[*6VVET1F:9HUEHET<VB2H(]#9(?5"'N!_VE7_?%(]4T)'R2EKW)&ZQ$B]_*
MF :R!PQ;TN??)VF"Z%KB&;;<>I*O?B!%ONV=*9Y^&X$6X$QAH!T1+BC>ZGA#
M'-/:?8]^GEPVJ<&;MJZY[_O4R^<3A?\E0UDGYRFLE.K^M3L=A>_AVHUKW2-M
MS.;.B$_WDG80C<"EB6*HU)Q-#QA'95FC.UJ=!=E9B,O)?51T:BY<@-^*=7?:
M?IC/"UK)2Z8%MVPR_Z3EQ>CW'YK'F2RV\.M0P1ANXUM4G5+[,$.?,.HD@F?
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MU#.])#/.A.4XJF^I3/L*9>^[-_V'.8G6+^VM>VBO@X(,ZI3HJ5W:B6M^'I0
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M%LO>2K\(CGC5\I&WS> )<'6$,0E5#6;$7HUOCJ[*ARCM#--!^F$S!4N.5O/
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M@D4LK KY &2!X9L_4T,]A6YT>"/[Z#MQ4Z%#VE01W,'B5G2&>9%FN>[?M/%
M!79 G<FX;8$!:REKI1B* 7]P*//C_.I.K-+B4AEV+8XB+\1HOLS,'X[#E^N6
MYT[,F&NJU29_/1%Y=I#N6HP=(X:?[!^D-3**2D9GAOE=9H/^$T7MBY%4>02"
MA!QAJ @O@MXI//8:*'W-QG*.R%=/L7J/86!$$7L4C2N=;FR_%],S8-:M(D /
M!Y<5H,K-Q<.?MCE#_]PA<]=9W#YV?E(UP1F$)Y(B.,SU7C8WIQ9CV$IB(Z$3
ME !VL1Z.C:-]KZ1CMTC3]PFG5@OSVE#5;>_'1P,:SSR[4EO^B;:%'  (Y\'
MNR3[*6-(&L#[A(ZR-<PAA S4TS%LGE^VB6[!AW$GRWG,S6\K\J/5J-%"VX*Y
M'7L\M(H?[5!2O"*Z*XJF?'S-].D1F%%'?T@ 9^-[^&&I MH@LA,>C3"&D'R8
M ]41U$LVO?$4BOGC!;.I[TO]@'PO^B.&/=,_/C&JJ$.SNER3;N'L5?J[MLL7
MUN(ZX@U.S&VZ(CC0,OSGC'@K=),#4R"JM]8J37Q@]_APF++^PQX;8_S,EN>K
MO;V["(6XE1>OP\),ZRR,HG&?'KJ&[H8_H(#'5'RD3E70>T?['E3)/WA^VREG
MB[$;A+/DZ0]OW^]0?YQR#K^23-=:N2'*(BN1WU 4GD(.(.8$$Y2.K.%R.:9M
MZTQC<D,I%,T]BL(\W&\FBZ2%9)5U?4X^>??H ^OY!\#Q-:G>B_\IA3W_2^AF
M2@?ZIZY82P+4VXFIM,:EV7]9< M>H_HO54N]W4&LV'Y8&IR\0@)%5FS7DMXU
MMMO/_D]%;B:0:^L/"YYS S@9&50JL\5L_U($ @/R#@?=U&GRE-EY.-!$2T\F
M<_+_?.5R7U?!3"I[/* :-VP2D.[8I9!38)A-SUBY__9YM2V!R,^*U4KS&CX?
M?\)=^?UO>Y(#_SLX$O$_5V'<7_3+E_RB_QKR]N&GBNV9L1+@JZ($*%HP:K:D
M=_+TA*D4Z>,'Z8Q CWD!MO]JZY'T_WBF+/@_[5#;+_JOH__, X3*D)1E@_4_
M-^22M" M$,.ELJBC$F E!ER"UQ0D28"88.:6]Q 2%=D9R,&(]+BZ=PB\!2OL
MH!^X&$>&X]2&,J*?"QWSV?X([:9(3%43;IO^/K-3AF_(+TB$E_S/!: /]VLV
M6,&50\=)L:F\=80OR/WZV?7NV$AGAO?VH:=@5'L;/_^AS7K$GM0S#]U]DB8/
M#V4[/MJ O(T%3]!$]WPA0SC+>"<1Q5&.64@H@BH[5K%MV>K<GN@E9RCK^7Z^
M=E<^CK$#<:0NZVS&R8%@!ZOC \L46<ASW+:0F'**.6A6OEGCW#<')T= 5"7*
M8.)AMZDUV+L9WI .W^\XE&T1,Q\<3MEAAR=$/(-2;0<#MZT,ZZ<H$FTP TL1
MX<=2W)O[EF/Z"YOZ"321BY5^R1)NT2!7R4D"^%/'55?\1'^9SCG8\!;;V0K$
MC5ZGU]W(GS91L//DDZNO&OE4X\NU6AAJ5</63L5NG2$'C@658'"P(O?L;]X3
MXZSM_7:C)$-1-GD="38H1)4)U2 D.,=Q6$PD+(5CE21 *QU,3YJ:.WI%8\WR
M$=,0^H"I'$KAM^;(.<O'\6[S_9>,/KIKA[BU7L_9*TI$7L&JD?R'F/XP.&D/
MF-*&CE<KS.)DZ[(]^.(T/$\.#AN%;+7%[8'R_I9+KHVZ,13Y;S4?,YNS[\XN
MAE:=JOO[!6O7A5WL>9Z 0OZ;69->'L'IN8/=24.K$(O.U.6L\%H]HM.X:!FH
M$"47N._#K&5H),]0_??!D&S+0?2:)D;?4R:M^E"N5]?Z>T]78]K%!T$J2P(H
MX#5-^"-QP<8R$(HU_&> Y6(<R:%TU#]3\X&/RKJ) ,O"/+/F[/P]C\]:#^R^
MJ:'ET&]9(@ZD3.5B-XAWD/;^<TF(!&@Q"T&/-K58(ED]\60$5%4XB]QFRHRR
M#";O3'4&A^K:>M:W,K2&K9&<FNH7\89^=H.,?6,0"YO9JLR7B9D/\:>CPR(*
M<:ER%#8[!5Z]V,H<P[2$4K8P#A%O"EVGLK#*1$K[#TT-PG$!NFJHQEC^0_/G
MQ_BR; 0>GS"A_:'^X0\'D\X-J[DMP=JUN(OWU_$B+,1R"O\44ADB7;)6"A38
M3]\/,"YQR.\LF_6&04GYQ".+NT/C[1!F0]9[<!Q_TW[^WWM&C$+\3?7_<LX9
M/Y<Y&8Z[(MI/H],&#0T#YXW*%Z\&$CA-+YMIF599J";4HV%\>!DFUIU37U<?
MU>]V)6[RB$_(0W/?"^A/QL+MZ)53HA13Y'L;WJ</[+5D!:(.8J=0EU_8#(Y[
M_'/>S7A*FF;FF*-\(CBQ2QKXXR_ZE^7,^7I)>;WSRP1+=68U5(%AOIA3&;O?
M1,R/$<LZ<Q<5(76Q+!K,Z,1NW5)M+-S#6 <U<[.PD+U? XH)'1.:\+#P .^=
MR?MK=)5:GNI%S1OX@#PKPT2$NII[_\ITUP7_=3/,,7WQ9D6!)OG-K4]U4>3#
M)'PO_2!WKCBO7@+<LSO=+[3G8;>[8]!JZ,"0<O\<V3[ZL0C.'+Y>VWU>;X0[
MH#5XL>N]V;L!KY[Y&<$%<K=T!CXHQL.K)4 [!2;\W6O'B;'/#]9[%,9PRV7U
MTO'A-Y>IFZ!TUDF^>;9OR-'F-G/+M'=_95[+[3T]%O%I$,]@ZDB J61X-9*U
MF(C=1'(27"=1P,HH\6_"4-%3\C[2L1'7=K(EN) 2BVE=U<TH8Q.]>6CP4TZ]
MF97&@?"%*^-MW4'%.)<Q4M[OC?U"H_C&*\EE05^H-8&M/3'(%Y5"99L5&6@$
M1+)>"(_T,7$]*G/4S61=2*\E]^BZ%H^_ZAJI=^D;PI\;1P>S"$4>+4'P-B:,
M&.G2;TBXU%=!MYD26;1OQ16U'PI02WLOLT3YW\-[D+=)/_UBJ>T%AN)(.6W_
MQ8=3[*-MQQUOJ#\_ON$LP>B%C^_]'"6K3KVZ=1)@$[4C976?I9]XK9X$.+!O
MW8?I2GGI8*-Y=J+M&B828(W4A:1MI[3J\?/$\5L>2X#;<1+@33SPPU*?A>0H
M07T2P%;F#PGPZH0$^&0+!^.$_A(@-[*0,K67\BWW]M%W\6 /=$)L2ND[-H $
M%9$_'>V$>REJR.FG,U1H$U58_!1V(Y=N(E9$)L&7S@;W"->CQ><=?^GU2Z]?
M>OW2ZY=>O_3ZI=<OO7[I]4NO7WK]TNN77K_T^C_0J\R]H,TEO6KBC5YC\MCZ
MAL<G5?#WXEQPYPE_R&K+\SYZPR:\[W;_)RYV*?B=/_?U36R>P=OCI2GGVF[+
M#(ZTL&D_A$JHE2.B<IVAY4II)V67%DRX&RL57F5PBV[[2L?$A"LS7O BP:%V
M:/DHRB%Q)L=HT'0<@S^UQ.$UP]O-7?K&,.,)YC5.ZR*0_$Z.>1R?/?6CK2<2
MH3UHYJ!W'*).56XEZCD/F;K6.6#.5/,W9B.H.E]S G<WTBQ<&-<S31OJ,B?/
MY7CVT:ZU,K,AAJ($:#DCWB(>@F]A7EB,@8..@LIM,]Y:D%4%Z4)J!\,<-,]X
M#F6T>BL,".V>$X-;@G"\?>3=Q/3E1;-3>ZK!#^;LK2=4^@R7:=A1%4N%QW3@
M!_N]?AL2CI1V!MJ';.^!] *3Q"9XB@9"3FJTS1AN3&NS3\=W= EQH&6808DJ
MZEMR*O7T[#*KR9U>71:G/I^^^-74O3(X6[4-L>,EF*^67)TW*2X4CU!KC5LJ
MWU=S?-EM[(1&EM8']2SX1L@"=="!6ZE)C%:_DG-4]?>JL+.*E."QG*K0B_W!
MF)L^.>)/:GC_:]8F*[LEP-VP:?A+OUAZ")_2B=U.<A;8B/O9VY_B8;N$ ?SG
MA\8G&;'&AE]S>TWEY+J=VM32HIZ4%?G'E7D&:.X9TAVD'N^/>GX+\=@/EX\A
MI0H\*"TF%'QE,KR6*'I.WDD>9&P"\=!IC6WC4Y,Q/-@&>RX;<DE?R5&N[0_Q
M7UJ NPR8L3<[!(5S99<7%<=G37"IWN.SEDD5>?+I8^F/BWK\UTS#031[U(?+
M3&8<@*CBS28"'/%F,'M,CQO20(.0X#L)L/"G+;B.\\?J.=RJ[Q/+DT6?'3B!
MJG,>#NW+Y>]2'Y1.-R**2NVYZWRY$F G-'!B 'DQQ,')H<]TPL9].$3.4.]4
M_]6*&D.G\X,5SZH&:!.6'3(-S0P&O8%8OF"P8,A[&)[U^&/RCCU)'Q\,;7\
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M0'/O$+E'WK'+H%H4>8;Z)OEP_H./8R7J59LI3Z@;A=M$3=)H6"4!UH50XR6
M]%4(H,J3MHBR$7I0GK.F+*3("8SIA6K?*.B_RC$@6(Y:VT0H+T:&A(\:T!TX
MKP,O-@T);2K1$12\J$ A/>:B673JY36B@[@Z<#8S)+KH6JH.(\\7'['6\T2O
MI[;%=;N@;3URI-ZW)7OC+@5F6LC'/'#%<P+?LS@6"\_ Z\+?P:(%>[X4)4H
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M]=&E"9D3_<M)H?A]7UZ(QQH'YND6FF6%7G.A=55 Q)PM>=T,Y:6K4,6G30+
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M2_0OT?^5HND6W,4%>X&54";^"E3'3WB5(T>/GD0]>S:K]JEY)/[:[GN^'ZO
MY/1 .KKX0MI9@^"L:+_+2<?"G)%IU!W,J4;J6M)O1O,(>=)A?E&[P\FC)1NK
MN+($,9QXQDOD5Q?^*(2YW3/6SI 0QFG>]9;7A7DT^)/5U>EWT\4K)+&3,_W.
MJO_+2IH$ &UU+-D_]_S89<*IU R*+(3"HJI)K5$G_SK(=B'^43/Q;>XQSUO=
MV"6\**[1OLG=Y(?JO^NO?C*?F8Q0$YKV%?)A;6AER/A5X_;-'E[8]K%W"9R)
M(]=_'S-:QB><\CYYY7RR=FBZO896TLZ)\Q)@+W,'9>H%LS:L'5XSZJ]YH!<!
M\W?=YIGK1C+KY=4..3R)2I^T2E$F1A/"O9-7-IV.,Z99E0,.U]7\%PCW.]=C
M,\7Z_(Q$ZYO/45SX+F)96X[)R!?;^(@;[;<^EW -+_D_^/A *\-IZ&NE\67;
MA^Y>CE\.5!HD GZ7R$@-KN9FJNGU'9;O'P>DG?[F=LMU1F=[J7/FMX?YPN$O
M2TCY",7#&3OGYX*PBKX-.GI=^R]\:W0V(849BF:=#PP2#50T\UQK3CL?!).3
M.CS:Q/7D@Y262\Q+TM0K^G-GJP5Y#]1=WJ*/R:*L(081@O<5NG4MUO.1\6=B
M+@9=.:484<GB$V_OU AM^_NE->4OIM24=4R::J++-Q8'?IL,)VD,^"7[3PU^
M)<BTP7=@5'0NY2C8N-,&A >2X[[?=((.@;(WO[MO'!:.0+:"_>1_]NM=KI,
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M5AIGS2!6F6$^N#9NF/RVC+H1@S]]_J,-XJCM;HG'/;=KMH_JHVP.D@RA%1N
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MSAE1,>W,U&(V8P5Q8XI,KBKZE7]>.8>^-!#;Q@)58+(YO;&RJJT],#M)J0K
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M5YTBJ4\I#+W6%;4C*0C@2"_\CW,*&\3,M?EG2:/%O):=[2!%<VJ&7OE/_F0
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M7ZA60(G=82]].MV:L.I#5V28 C/N;FX?T,6FE>64G=8].4O;EQ9#D$!R;.4
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M .0WUA#T:U7,M)"Y3_IB@.1:I@B;:'./;[0*6XVGG1GCJ2 8^6K'^ W*\$K
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M'/8>SV+>^-+66=;JCG%NH;21&DZC./7- =.KZ"L]G5"G?3EQ8L.E)W16HGI
MM]Y4/+!7\-H/;5&5S^AFL@UF2_OJ>#K@AG2[Z6+Z2_3J7-+=/&H"8/D37OSF
M.BC2DL'W:E6,U9/)/!4WRDE?>I2ALN"[X:H?^C0=K#%%0W]6B*_M8"]R(SA&
M.=#VT;8&"W=DM%K.78["6'M&(0D#*M6QFC-D,2K/^G=?)S-6LT.R\[-T;AIE
MROVFULHZF@+>'^86QT@-Q[(QMNCO)5?2#;<QJDE\]+#7/ZXS6AM0+UI.RMYJ
MB6MIX2?V@/0RZ_BRI&P!6]FA1_-U:0Y_-_UDOFJ?%<^0C:"TO8$WU2:I8DU1
MUDD_U^A<8H52029SXSH) %HYNM+YP2MQVF$(&4^94M=E>[6F+ I-4FY&?V7I
ME4HZW FVZ,0?N[3<^1MA12;G;'_-5\1RSL''KSZ-369_TM,3/JZ?]95Y@QZ0
M_$-7-4Y&3@OS(X8UOH8COBG)TY/3Y*[Q=4-#$I-GUVXK B*;%$"8/65=1B@/
M\@W'&H.C2AOMHQ]5-=6G29GVEI$I)1>?>(J7C)M+R:2ZQP+J-A3G/%=D] )/
MFPB /JIM1M9WJO<.;J[>]KOM4+DV3FS['3PGEKN?C1IS&BTG?>>I2_V8G/+7
M&9/;C9T:MA1C,T.,(^<E7Q(4+IPWJ<CPBTNU/F%7.7^''VDS*#*QW,>HA@EP
MR#Z^B//)@;W<$GVUFIIUH%;MQ@$ */SF/U=#5W"G2-=K?%[S\&[YMD^69HTL
M;)F4+R2C=EX0,N?(6"C>:=K\[<F)4S?@/>M-R3<J/04NT$,O1ZT2LNB(RN^S
M>4DLD"6 /^C%XT,OJEO8H&>WXJ//_!3*;=^V2*B1U"%XW^6K-;M? I%66!Z&
MG5T4D%-<4P_11IZE6VR+X0X3LH^PX^"YOMVE"PFB"_F$JQE^J1QWFGIU_CK9
MN8(1:CK,!,[7]5;+0LF= $CU32Q/ZM/0]LD0*0@IXO9.6"T1%_0UJVEPD>LE
MT9VO6Z$_USK"&Z5K[+VY<(\\U"8+L,-JKMB4(+7#\633W"[P#4/+!V-SNA8X
M[K1"^7XG:O"]#X>"B1[\?*NE5S:]3G^]L61@43/J0+EAFT2PSM:E>I7JAJ.S
M!;Q:E".:3--,/4[HI%?-W27"K21W="Q(_H=R>?P]D'NT];>+!#VO,'3 SKA-
M@9=>D_"C_4#+(DN3OV<,^GE%F4[WXD75V"X7?&+?16R;Q:W0?V#[DXO@/<IM
M&J8*(38I6RK^?">+:8^F+P,/KUU=N#/A%4__;,;BKL'HSU!5E2O)R4D?^]N#
MRDB)T[-;YG_]4=[_7X\-_V@3#@C BJ-IE<#4N)?8>*35%<<"#F>#:7&IO$EQ
ME1@VE8:?1SQREV#+YAF6;S6C1Q?;"<4[#V:C59&GNPQ$RID<+=,\>7_Q$">5
M:)9IZL".C<!(<WT;<X^F=O4$7W-,U=EJ0&N%K-4W3HN77X<PL3.87D,NBAUX
ML![R]^<N2C)H?=[U4A*>M>&<G; >$LM64U.YNYI2M.3F$RKGT9MLR\;RX]&G
M,OYLSN=C+894O'GV^Q?/>VDVD6M2@G9*'[9M3 V+5-RK83\-Z\HW%EG&]O]]
M\TUPKF/*@<66:4\=S+E@TR^P3-W4+&-7Z=Q84% 0]<)4K2A=:E11H/T6+N4R
ME\CD-: :[D[AAHUL,F4"H'>$<0X< D,R9%\ VR6FU1FN[O<R3*62E2C7(>*'
MD)KL"$.])&>?"<%7Y*,$P",K5I@3*&ZI%EIR681)1(5%M-BR>C#MU/)6I&JB
MLY*Y7LV>:W^H#=\)D"X:+KD?42EX--F6Q1GC6E'$DR^Y[+,#QQR>Q$W"JO$4
M 8\PPM$)O-VM)XU@IW18B%B:!^7J),ZD5,T6N2#C%0OY3>\CDV"E2;DI6/[Z
MEG( I6PL!CN;;? #+?IA_<Q:MP!4ABJ8&>\:URTB]5GWFFP2'-G",YX+NC50
M6H/J<2]0?G0;UGG,WS^S,=!7OXD,*8?8B@;H%]L^NK-8(L//E^Y=6U@+>P8=
MA:'U]F='3B(D9RWV8X'(HB"AK*=6UW!"SDOD,T,.%IV*Y<Y]/J!(\05TDL:<
M?ZN%F'/)BR'Z* ?&I]ED$+U.-@',8J,=,NX:Q!;!]A##E3N8PGPC5,SEB>44
MV$3%W'0SW:)U<O6"8?UC+]DU\YJ/7]+Q42![;>Q]PT3[D[NPDVQL]#EB:U2;
MNPL>2J-I5T!1R<[B8M]S7I!OFGFDIV*M4>I"I3S*V1#_VDP3BC25GCZE(OH.
M[<+!($ M"7JZ8RF,C0%-_\DV0BCCZ7B\EX5!3JS46*"/9:,D\Q[<IYIGLE(\
M4^5\,TAH4VLT^N$\,-M>W#9R&)/XI:"\5!/UUKS2TE@WNC7Y9MV)^7APW<;&
MZ*8]\!F83$ZZ0_]'BPAR7L%9!KJ=91$6JYT@\TV+;9HZMD3%&#=6>W??P'I+
ME?K.O >9VG/\:[B]%?:!5>]^>&&7!7:M8M/JFMPCWDA?,0[Z10%LA _XMUT.
M?FA\;[IKEK2I_EJO1_&V3\,)C1IP%B?+GE^_?3'P;Y%#.9"=U<QG8R<%4JR'
M/0K(;%SV7.$!A #X@;&/ZIYXZZOI7SCDX\(6CRQ9H^#^M$@_)J;]R.Y5ZN#S
M*R?'=*>^]N2OSHP$-JP-3#$-%UI<DZ46@<4+?)[9F7QN@7.@E.]S/?O44OMS
M+P8/FSZ1?ZT4\152&TE9&_Y<ZUGZU8L[JE?/>><U8YD^N,SV=FXD_P95G]*_
MA;EYF9+ITO[]IE8#@[\X_RR1,W&@;W"]HT_?B\_K8Q=XVU.VM]>A0ZWXVN?U
M?0,#10'$.P#'9Z-U^UUI(F7H7GY6  @5( D ,B=G3!%*OBC354Y\V?_"![V>
M&LB4+LH0$>#.WCRZTQ(5SM'04C7Z $/?8.].S[++-P0<T?X==Y)"M*[!^#%8
M[?:2HR4OQAFB@;P<?Q:!7FHO]\K!NCJKB'SMJAQNH''"\[T.^6FN6F$UO^DB
MI[0^H#[>=S!]S$:+3HS\GCV#<OJ)1_3_=@ST?U0D95"J.7-H_5!A[T'KN.Z'
MK4 K*IT J= CA;_"6U21.\%9'_AA3J^IF\ZSKK_]S#L4^%F+?S%/97A+)ZZ^
M\GKKEKSVAME)&K%99=!AX!50;0 (*?@$SV"%T-"6H=JANF8UETWNF%IU5K(&
M">M5L%A,!*]ITRIZ.7[I0@D:CEFO63J>9+1TGS4LI^+H5]K9Q# I44AP% %P
MBPMKE.=TJF,,CQ/;9\JFVVC2[.XY#ETQ'[-#UX<%%FT^ '/)9BI-'1HXZR=7
MV-?%SI+: 8?M@^7^6J$*EXD?:[F?8^',0/VI;=J-;;97;6SE<U/7V_+MIJ03
M/ZX0>_:>C8:FX1S;UZ_8K+);0A3>H[)G5E"P$"__\OM'"]R(JU.R]O@)=$.X
MIPOXV?<+Y1:]%N\&MX4\3<ZR!/F"'P?Z9.&<#VNG>EC2X+J#4L(=E+1YK%&1
MV!J. 8]!@QNZ*=SRJ,'K&I^*Q!E[ZAG^LKH;TL7C,21S9QM9I3"NOV:AI DU
MQCU=V8$^D,ZR"DIR[_?*H_IJ7=T;V3FI5K\YA>A/?OZ\<,*T1(:NF$>BG%GK
MK?9%W;<) 2\S%GEMC9:Z"<\%E2FR.0JE'A1_,_^<;'&*LW.S1C';,R&7BON>
M*:1(GTCC!0NFY/<2VV=>?RZ4P<\ 60B UV:[LLBP;FUR;&(W[$IEQ13/K3XP
MK +W*'WOS5 )UD_4<]P*XO!CUZ,,8BIB*?)Z4DXAJKAN/;,"IFBX5*>]L^M]
MSZ%-&"*NW!Z3=Z'U9<KNZ1>ZPZD#1N;)=];K@C]"<J1-@NA>@M*D<ALHW-;M
M]6ZH1F,UI#J&&I</R1O"W0,,^([,3@V,K3%U62RT+ 6Z(:I>PGY)7\?<2H3G
MI6#AZ+.]JXPE+RI3;6P=4-^,9SUR=&/,^"^D#4+$+:,;BDS3:Q/5WQ;IJ'^&
MOLMMT<,S/UFFNJ37#@-B#3>6<,GJ\%I8.]=]U1[MT#,;P +JDDY%K5=@VEK?
MK^8V8/4C_V\"8$H(2 #D[!']DC YH@47/K3RW;OP QV>I^+)P\ZR)I5])7'"
M(^]A1Z906ABR!PTC (3^K.:?H87Q4=J=8)S4(A4!L-9M=((GFLLG944$ *44
M"&\.<M' 0\>)5+R"MR\;-6? "5J%$ !'NG(DQ,)A8? S6]7_^),%;)81>$[1
M"4-J O'/H6/9AUT$P%6K=9]:(Z$L*;1Y>+4JBL@333*E>87P_&J9A^1E90VO
M1+[=*[VJ>.WV6RT"X .1\H\DL/8$P(U9*P* TS#;A%C%3V4J' NQBPG$WIF/
MXNU.*[>_7@RG1_;'6?Y<C^$,,QDKB%2F8(W?DDA0V?(3D1DT2#JY]]&1 )B3
M4;TD\5S"4=81 "MU1;7!LVX^<XN6EE#G?<7!YLJ6L=R\4 =7=I/RM5A(MBQG
MR)3QG#.=2T5(<GUULA0W^4VY8%V#HD##DJWTK7_/Z-,2UP-CPY/C% X3NY=H
M6K@++,Q*?&L1D_<GCO,-1D"__+3GCD/[# W(;+IGU O7KQG]>]CX(P[X)VP,
M1"[18Q<W[WQR96.!D6_4--PWVDV/,M^F7GUGW! 6;O#2R-]5^<S\=RP$%'8V
M]1;AJT59)CP4"FGRJHJ<(P"JK!?>F-7/OO#;;!PQ8@C-PZE/H*9GUK6LL.1@
MX?9+REPXU9^-2"1WL2,5OC\AJLKH[/>[%L]"D0+K&*ZZOUACEMY,9GKZ2L04
M/(% *-I3%_,?X#)60+%6C KW??N(%(,7G')QO9,_:[MU2N_'7VKOAN\:3Q]7
MM6A/MJGG,W&+23;XZR#@]R9+QW<VB!VCP)S<U\H^'=U0L^!L\)+-7'</WM=_
M/-!3[KQQBAG4%:)>V9KT ._> C]X<DZ/R>Z%!X.H6E8Q/HA*TDTCPRU+ET?B
MS[SD'>D\1D[8$D\NK:L-DI5^57GKEC2^ISL 1Q.E7#[HQI&5#-4-K$]WFV23
M,A=+6.A2EXS [@^#B]>YTS((WWOT@D@4G3'=XEP\C"8GU#G-IJ$ATN1WNG(D
MHW7,6HJ)15#^6Y7W66IWPPV4=0<1 %+Q_3;RRV2X _#NF:Y#-KF<FHLCOY X
M%;4B0\B;EL(.2>H!E+1G3_-[_3U!V[OC"E//$M2N]^/6X;&+[!AQ$R1$-73C
MI\N, .6_1=OW&\1523ZH"9IE6:8:3KC&<J>O.+>9R],!T4H&K]N\U_XXN3DM
M_U^/R.[^=5B'*,X+MJ:Y,A*NP(I>54Y>'.BJEUSD:GWD9LK+W:( K*G/;+.C
M49I->H2KMG&UK2QK82( KIU?9K>(KFF6SV 3>XT<!NZ#J9W=9TU(C1@/=N2D
MV2++KR._SRUI0BM33$R?#7?$G4>L-+ X9ZU_:H&3FIGH#7EX!75^;]U/LKM5
MR5'NF6=$HG;4%/6]K20=!8^25A(N4/]<110]GOO@S]18>7)1\P&ZUA;=$;DQ
M@1==Y&"!ZOX=.O9(L3\K(4I?^5)>WP.H50:B[7?*+QYC]_L3GV*M41K.:B9O
MBR&1-UOX[=8D2+_'6E$/%(K/WRIZZ\RXEW92_33AF831$2<2% :DPMU@2%R&
MDT"L.K=C*L[9PHH<IVD#<C3,%\S,"H8F0AX;)J <7]D!1&\#*L;:*KG.1=>.
MSK@1K!I1B%96])D*?0HE[W%D-VI1Q.#!.?RK3G)]S<1&07RWLVE+P:(8*H\
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MW6U6OCP:Y)B?>GHZ:[H()9#+L*#Q:HIF1.%9L5&PL[WO6+9FH^\4 ;"X 77
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M?^'9 _035";H02385[A K*UPUTA(DTIF<8U&C@E6XW%+J. 3C<O=R>051>1
MN8;A-W1AV%N&;6"[,!N\$X[EO-%%%8&)"N;NBOOUY EFQV9,+&4''HR_P1VN
M;]K-.93D;DX_'I;(LFC*WE=GND["I0\X.T7YX.BL>HFJNA?,AA^!5S'L9*Q0
MS38@8*25>T?9$6UB<8BI-DHT?4CI[+/Z V/'V9QQ+V?_6N:8BM:<RQJKB0">
MZ=F>]\7<H64XM<(O$W&!%VS$L=0B )#^ 6^F87:5Q,EJ% FRRY[5T A^ 1^5
MHT:5Z]3)\_?,>B>^:FC81UZJZHSBQ*%>3^PIBRH<IR32O6ORMMGNC-MCZ&-0
M@>HS0@\:4*#E8/PUHJ4. 2UGX<DP0HEVK,P-B"5@@ 8&'"ETJLDQ/9L2CRI=
M"CMA27>TN]WAD@,1U8AD,3-HJ%'3'/K9<.&R>SPT$@KK, P*4/@3Z(1U<$'Y
M(38\GB-,D+ 5BOVN2YAI;4-]E.XDCLD10[N,3\>SM;1"7OMZGGE61N"EQE$Q
M*[:OLNY/K-<^&G&W> SZXO??UGOXS2U-33Y(^AA.Y2HIL42@WDF;N]ZTLYLW
M8I<:%A&=^DH N&PL'=&/@] *TP1 [)1P)(XN!S(LRU/W8^^5QHUT#5C-O'@C
MA4Q/-9B/$AF>"#CZ/?4=CM7)ND( 9+MH$^<943EBQ*YL+LWY25Z2U([@J/Z$
M46IA_U+M]"<"H#,:386[<()A15()@(@\_!W[=[#?<WK$T4B"XS0!?CXGBS$$
M@**+* 'PURX,NPO\EPKKUD'H/+F_" "%V6P\>0$!@'(@XLVT##P[F2  T';"
M! #M8[;,RX8\V$^SYP1 ^X457E;U;U7ZQN%X1@ $P$A]$0$0S O#IH.0*I ;
M^, Z$(Y)@P! _+Q1]*\-'_W7"BUM"8!;HNV@P]T2 F"YWPK/%?</%/] \0\4
M_T#Q#Q3_0/$/%/] \0\4_T#Q#Q3_AT#AW*G #VDXD<&R)A KG\8V(H5)+)7O
MU,!LMJ!B#:F(&E6 87(9CO\E6$XM0,_O:KVI09=K@M@MRZ>&P^5.^O>V#$NU
M8J1P>J52XT''2;.19S65).]ZUR'AUB+S],(/NR?P; PDH>51"/UZ7)*#4H&:
MV465_2_X_V,WEV]TP[%\O3LF2&#=3  O&M@-BII-<DNMFWC=:!6&O]V8'/7U
MJ===;_X1.D3?-S4) N":@(WT VH-CE#]X$-95#:.CF&E,H:CN1Y]/0P)_.#W
MM"QWIC;*OY(.DLY331X_OPWE2=A72UL]^ZAMBPP4,HZOH39)?@T4CUD1"+[A
M605FT($-M+#>=3XW<&7TF5-?>G^A2G')BC-$"=M+OWKTXV&=('X28?S);IBA
M[@Q].Y9=(DIMH<1NTV$%:F=[P=V*40VMW3;9KZ.ZO>%-;_C#KK&E=;),T,4%
MQ7A=;8_[^[/<Q\\&?FSEL:=C2U%PW)W>$Q[L4ZY@$RP2.4*W->J[U<3=I=R(
M#?/E.,%IO#G%,T5>=,T&=L+W6EJMS,;#TAK)_F+- $7ML^#TL8D8OK4*7. *
ML6M-3QYE21TON.+QP[-*M]8'M-,];%^^5S.([)^]^9&&^@X-7VI0&QN$..9:
MI9=AZ/T.-B',8EUXWUC 762K+6(VLJQ,5])?D'GX!$D]3V<$F22]L;Z\LO;(
M\KZ-T\",7=H;_?Q=4AM.F6/.V0D>/N_DRJ*ZDJ6"[+TSX"@#5_OH^6]F3*9?
M4HFR/D*G;\/Z8%#P3H/>X"%WE$?AZI@'1$"@?*^(29SSDA1G1  $G?QZ,&\:
M0(&E\G7;)8?;86YT!WJSB <M8TB_HV$?.-LD7P0?]K-CNC/JY?)YLZ6@-CA3
M8JD"Z!R(06'2Q0<#O6B7$9R ZOS$T\V88=D8]?<.Y<K]NH8P&;Y?.SA,<-IR
M_G?X'NPEPG)QW,2",OA9& UTQ*L2:]8%NGD44?"N[C<"3&/66UQ7NNNX'MRU
M2!^&:$+XW.XQYLRJ<LECLB=CT22W^QUW]!NIBKOMCZ2,K)_.9E)X")GK32VY
MEV[!W6'JG;:L29+J<'UX?9T P-.TNI[?F^':&MY7S.SY6=55UW!P(20[HB!M
M\ZV6$W<0:Z:F?.2Y7(+B4]XOXUOP-3[%PX],T0.7LUG*6:\]75'HH]*W61(&
MUO9#VG26QH.E-TR%1LT_13,(5"1HZML?TI5MFXZ$U\D.@1',]445VS(?VJ Y
MI=N2IZ9918$/E:,U?6'^ J=&(N&CM(/I1H'AI9]Y_MJ#S2SA2>LNM/ _QTR<
M)+*8JK'VRZ6I*HD]\#N55"'E;'.#40%-JF%KD59TSJ'/V-3>5 @<V8VZYH=W
M"=4Y?G\&*LD. Z&U*F?(D&JUV1U6I)ZE@NI]#7/.LTF'V#"$SG,S#TW*5M3U
MB6,S^]<<N[5-03S3U%VL;_E4VL[^SG6M O"N7R5\C?7B4S[KR>3<8K:\KF<8
M.ML1CH5QG0(M;2\=R2($QF=LO65#C@& GG??X&G2KQ&XF#$H54DP3YIBX6F?
M@)B*?M!U\ZKZU?1HC(J"I^< -_3GH'$< 5 -_O>3QN+Y__=)8_-9AR6J7=?D
M5^1O<+36@=(3N0_T6.,AE<88DJ0>G@KV\;(U$M7MUY%R3,A6OMXGZ UTSY_L
M=YP5&7D;>>K_?3*L'[6U0>+(^T&,*XJ=Q72=_QD%!Y[<$&RWJ[U,N4&F2L5B
MJD5]N;H[56!B6:#Z6]?=_B";%I--]S9%>+M%.VN=J?O57!&K@?VQN:0$IO-E
M"1]$CI5MC]'TSLN%.<WZ$2W\W"A\0[ 0MAQ820#<S;L JQ  7^K3"(#W)W"<
M=TOOW_X:^'=N_WX6/ ZO/P*?DSEF8X'.!$"OP[]66?GH/UA"U;_;.<#1_FXK
M"SYHUAY_8Y9HI69!_U*C\R#L7PWAI"RQ()S<LU2M\EC-?OR-RT1K]R[^N\#N
M/<4^WPHA<C?$%W>3A<?'^:NYG_,G;!)=&EXE+-0?J7F]$?*;_IOUNC\M9D"2
M830VJ4\S"-X% ,@3U%(!5_JXW_$?RJYP[][XLX6[OJD:_<HONSN.[FM_RA0;
M*^9*';J%X:H@6J)\1;*NI89>3W)O<)&Y"J,YH8V8TBE9!+'C!; #*.V>@8P!
M& .D9[_+DNR[CS&>+4#>N9Q!.>%G[3M3;+!IZ_<)\:4[3/=?:<!KAXHV$_H8
ML\95QW_M N_'8MB[WJ3H^NXSKT&4M5%==A\K$4R9:L*1,0+T>LQ'&]/U5?C)
M[C6(?2[D4Z,RB.K1\.8R:B6D:V+PD2R?_E>]/"7AUC<&1GV,2VI\MQ%3401
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M\$A;C I'YPC"57X=N6"#CK@_\L8&Y@?U<G#6Y3MC.;S[HXX,_H*;=E\RU1
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M+M]?%OR&#;+OXJWVO8T606@M*Q+\%(P&9J.'WCZ)B%H>)#*C7. %/Y:_PPJ
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MV#9YE!#(GW13PZ/;A6:?>7@_3E=]T1)/3N@Q3G^Z,ZC_GLXMTS;WYQ:UFLX
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MTT9:4AB@'MS!990L _36>XXV:7*$(V_1@[*8T?.V]0R0XMB)S1K+8#2"YL\
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M*EG%#S')\_MV6QQ1G>/%5H6<6Z'!WB7M:O:K"H'WJ> V327J)Y(:^!Q* RC
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M>AS-'4!'!UZG\5$_S<>&\BLU4A$+6^Q4&>@PBG>A7[DY8J$C4+!U="GTP:1
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MZ9#KENM6Q>3OK)]PBOA1$<WWT,PJ< 8,/)2Y1+T)C=!D L9F.:@20"BQ;-2
M*!-"\:'P1&=0<GW=.08&RKO&9.%T 0.#\XH(+G5"2+52M0^F)M7N/:SP3>#
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M^B0GPB\#EG0%6L9K4-_1I\[+ZSF:/3D"V6;!NYB"SB5?%=Z?\/XV4O YX)%
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MHG[9R!5)8L(C,[J3643,)T)W0MS/1/YB7+>M/B/]M]%.%&TPPE0J6C/E0^0
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MSGSTQQNA7^M(]'O"@GRR@_\L#E3.\>3X')X#V);0[ 6!$DGS)M'ZR-QQGG/
M=B@CD5&02'OG'&!.FF>,M$D2E"NCMM#+9%&L8O,,\/ME*'LE5ZS6R=#8K&K_
MV28'J,:,$H)SI!DCR?)0Z@EEL,=])FE5JF:^Y6*RX7.E4II5THZ.> \]_[P(
MQ8%!/?X5\,QF7W)B$3W<G?'2%IB)PD;*G!XHY)Z]E+@H]&-;3:N$6VC9O>,H
M=Q-OJU7OLB&V*/TQQ7I(6,5RS-_EE<\KE1HK0N>I0N@,DAWD N)'K<&CWHZ(
M-'^)PJ U;LZ\*(300H?T8T="HFVGIYX(>+P#(LJ]V =ES'0S;0S*/K>V=[=T
M4#I!+^J6Q+ J^*!5)'[_RLHYX 6T4R?L.W0>.U?CST3DB-P7,::KBHSQTA!H
MS_*;!FHZWVQN%_AY_,_68JW56Y>Z'Z&WH4XY?CXV:Y\*Y^6PVVEG<TI:OS\9
MOFP2=Y4+TV/ /RJ4E$NDV<]0TJJ=93E,HEW;I6(U2^)@VB78S B=C@IE5.'2
MG8,L^_0,VFO$)+ _ECUU=2D'^0YF.Y[B'Y!2H(?_:R^@+H\B1OD&:CCN2PMD
M'"A*PM##[E5^Z_>]\_H2SD[&#6W2#^SE@XG\JUR#"WK<9%HJR">JE6N](O[X
M<VV)9/-/[.JV58U>HE+7]DRBJJR-P:#4OGH#N5%^K)ZIWR4H5%T>K?>]S1M)
M#>:*R5C4STSB+]!+PI<B^!;MBG1,P/%(%N1J&Z9A(F(,78>JHR7KDNI@*>I+
MCG9;ECTTA-$#^K[;:<9$Z1V<_LN!R^- /OE2;TZ(WW.!@B(6^&H'O"DZ]ND<
MAJZ''Z9,<G*6?BGIX$E=#3T'#&0>J% +<R>2.SBBDS.[=ML)B;V!EV*ILR<F
MGI-0T80L(S[>)_/?^A\%[&^92AB?;I?\W@W_2<2-P[^H$L:>%C&J@YF*<.XN
ML"P*C$]W0L'Q3:_>DKIRRIGM? SYZ5D9W&T_W*6$5$+,P[:^W[<027F=&(Q>
M5&I!JO4U/?4! EM?>F7UZ$+G'GI4C)N4)EI?3[D"9RUB ?GL+R[AS@'9A1IG
M_VH(;UN^$DZ9*-GBWBUD)/SNUT_$;:)"Z9-1)]<FN,P5MAHXOQ8(B2=M8^1L
MK#&>5G(V'G.!5L=I+=]\I!$;'>TYR$[6F\*IGU<^1\R/.,.T*ZZ)A8]@) U.
MO7W<ITWTQMI-2TL17LMG3B(E\Q5X&[&OEYLDSMSBH?.T415Z=P)^OLB6,*_@
MU-0=AR_FY!/JRSB%2]>!#7K?Y_W7.RGMH:+P/F^D,^9Z='@?$UF3U!ITVL?:
MPT-H)$$TK9+WXFO. 7Q&V#%3U76@<.;;Z\6]KBXFK?!-R "&),LXN P9;2$9
M$>#8XW<R.64F(;@Q?1M2>.V-=B9];Q\0EF[*QU=-O6PNK[K_7@+54"XF(Y3I
MP@&\18H>:9NS7.JW9'@H4U74M/TT0F*9/<OS-"-*1P[\_9L.3?Y'FK3?'!%P
M-\9H#>Z#S1GI#:+EO]FB(7ZEF;>/WJU8IMW05V"ZE:&/#=UJPYF]3QY6#1_\
M';5903?.YKE+^"-#\TKW9P8QPT459?=+_+F+$F+U4#LO?^Y$C.0PH0?AP"D'
M1G=9<M G90:RF3C8L<3TFX^H/I?0/;"(Z*F/*?N,CWIEH!]#U,;GG8:$?DT=
M\_ GQN-"\!&-3UT^$>Z/"C# [G&K>EMCOJQ^ \I5V"]I\T0FT?MN;Y5*IGZ>
MMF=4_*7!<Y;1[*.',S##,<;QN77FVM6,.(@LG@-,V]L*'TM/KWBIA2G"/3*U
M@L2</& N@7=\57S%\#HRJ\U1ZL'6MUO"1*A9;S[Y!\6=%,_K7_U!?)?M 7_&
MX3Q*=D%HK14-$MS4(OB,1WZ8".L1),9FH7*-,H>Y1,/4LX5G?TL%CK.'".G-
M""[_,]JF2LY$\A(QW,]7&&_UKA'9RGSNSA"Y6M28\EJ5[#5U]#+Y"W-GCLPM
M%/,"$#QUGW_MEPFPS9=921*FHU2#4;!JCS[I9)D^7&/0=">X"PWDH[O&[Q+T
MRGAX:[Y$0G>(0S1]'AW*0K);!5V-"+F":C%>$;^U':@'^?VXDZ<^!.I:R/:R
MVE;*-8SNW9-'W<Z/"$=(7*(>'P_*5A2!X[/=U-#*^> QGUM>?/>:>?;NKE,A
M=E9?W-5Z^".V+6%^UPT%(HG^/9)&^[F'5'!!RB&5D>@0'MU?,!7LK##]Y(0B
MBWX=./+6;ENX\==PJ9M'^5? ,.CCWE!:PO5<Q>2K)+M'A)ZB@QR90P?EQ2$\
M0[A[[H&UL\V^KQS*?GGD/NIW$.?\P@^0]KC,^/80'_I/-[!:H:E"?[$+HYR[
MW/\R$5PUV?$F84Z6&2M59=Q@16:1R[KI+ZH<5,3LQDF>X+,B97=-\,2,^C=:
M(840,34F@S1X+<F2!&5CO<]D,P(CF65^+3I>>LF8*%PH0 J^TCOAX?9QN:>D
MUE[/PO;2G:(/B!_*=S6LGT)D/R!;7&A>?Z%6OW<.8*?TG@.:P%&/1YS^_1DJ
MWYI0[]$EA:/5_N?63]P(V. ZY3F4WP&!&&@'^55*@T+%ZV8W#P,)%&M)J/L(
ML"(FS-,F08$3:&&C[F6:\52:("%:4*)/;:2KN 3[*'>6&+&^WFTAN[EI/_$#
MMW:L"?D)E^Z1(% E=3'*]ZW)4D&+^AO4N_P9;[K;%J:F-0AD+^F'^-!924S6
M9NX+^Y:J*4A=#@H.SHN_A^MH*O2RR^;5O8;N:G@(E)>5$C9[,B+L6_'/Y[YH
M9_#L+N'Q*[J6^;MH?P@00D<PXM:G^ZI3]B+.NI0N56M;KT,MPT7X[JWY4<K]
MLR2D&SSF4AF2%%0!#319N!5O3GB22GH$+4U//6:V=A^#%'NJ7(N%*%A-*0GD
MI5+7333"2[24TP+: N/$9_)?E.E%^4341*;SVGJ<!5^3-EB?57I?,2+</$=$
MG=+<T4]CW]HI*1"=<6QYF7'OE7#!1ZS>2[V#A!=X#E(C5G:Q]2B* $[/U4:#
MF)?MG@QK5L1LM!(=ZA/?A/O6X*R5;&1671S>^XBTNL^D71D@^?^FB@2MEB%9
M%"=32*C>'B;B4]WW&ULJ:EF1=>N</T846F.D ].^%D_?>J!Z,&&[0$K^6V>.
MZ))K[PCC(Y65>@FJYNT6\I(JR@W*EHW$787P_&H$'P2Z5N]+P]T4LK*WJ@>W
M3Y)0\BHD5N RTOT<$,%L_V4-\\X15*39\HPQOH?7;O&"LU#H>IN//_A9,M?0
M;UUR&Q5=0X+[WZHR\OB:6[TO_Q.78Y3<Q5 7-;#Y+4&$[[:TJ'S6S=425L3>
MLWJ0_>N2J>F^*8.RLMVW;8YL.&_-3*.8OHTZ=RRAO9!=M2-M^M@:5J-0R"B/
MGC"?ZG_F-6A[T/YR&/.)G_D<$)8$8YF+>XP+$1K4H,N/E#?RK[#;Z3!E>3><
MI79_H*,TTM#0,)934E[#^5,(""NPR+$:G=2501A",U)A[.T!DUO'MDUJ&G6W
M5$\[E%O/"JI_O+ANYLI%?>F=L-5!=RG,A!2"&#NR$V#WH W> (H9SHBI:94V
M#MJXO-M:;%APC,6]\!=VU#H47WK7]Q'OX/"X1*J&KD:"KO;^0ZZKP>$.V0*E
MLGPN+(D,M[[([[Z,/Y[UOB,K/F0XL6)/3"=\G=JRNU0RBW%.DXMF]CL+B)PX
M>(J2&H!/),S?&73)CO:=(9I7Z6&.Z2@-;!FS#EP.?(^E+H:NE;_XT'RZ%49]
ME3<N '['D>4"" CU)@J0;_>H$]VBG!-'P^:UYYNEI#B>OX2=:?!$UK=;BLGP
MH;LJAS)-'RA=X.0(^.J_ DV@J*ZVWP96J![EED<E;K%=( C;4/I=+O9?J%1W
M#D;1R3<3;WR_WUN^E:$U?,8C?J+K]U%"Z]Z@2;Z+$E][Q>/M/X7LW%(KM2X1
M ]T07WO6CQG+>?61P+V(IAJ],I"29XICW7+6,GOHL0DXDY_E;[;GGZGI\4-@
MVF:[F\I_LE98YO!*SF+'<1ZV ]RR:4G*X;43G<"&M8T3>#^X!;.+Q<W%,:VA
M+USM:I[=0IFIWWQ,SN/R(C,KU(?"+F)7X5Z\!U8OPV9/0LUPT0 W6,T5]#W3
M*G7QKT.6F5:.IH''3OKR4<P!(B53N1G'5@8*/84@*LOOS=C *<@"4M] :W_J
M>.O5#HT4[2.B=E27F6?K"A>1/1*GSF$1T#79[$7O.)O2;FF7J('#,=?>D.S[
M?&]U#A\RJY:^W:\D8<@F,2;QJ.R>1+__VRHM$U]Y \]<'X4JQ2F/\L(JA-FA
MDR:K1<+?RBSB'[J"<<BAHDCDM5V-^34DR^("6)<Z=PC58CT#U*_ZJ&/F5M)+
M>=N_5RX7 O51G(%G>GU+?.E<3Y)NI+7CR\81OM'QW?@UAWZ^8X;";FE[C2-L
MM)@Z&W0[OS1E+.GDC+/B-N]I,=D-&PCW>!]Q$V03P$W(?G"8\L$0#G-S* #'
MQ)CGLWI&.SS3I>OG0-OOVJAK*B-)W:MAL5'O[^0C3G<KU8,J$RY-^9M4XX&&
M,.GX;U*-F%*2#S8VL!^"*+=+YO*\>?.GK8\-(/J)#6MI&!\;^\GB V.O0#EF
MQM[ UBF]8]NDLC<'ND)C@<$AP7[C!^J9F<%Y-57?&]7E/$1SW41BW=X(IX''
MOGL<QO8Z\=E377-B=XN98U09FJ[1OT3M Q.E[["NM0.[!JRPIZ8:F U,OR6U
M)2R_"I;F4[%\Z2F7%^_QI5/$,/>X?.F-54NGEFZ1-\SKK"-4&F9\ZIB,#;J
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MF1$^[NL6PM:6[EU__8NY'@H[L,$RE(R:_?N]=;B;U3=W&:N@097%/U?5,IZ
MX-P/D6; V(GXH(<?=B,_TX"([%1^,(/G(ZRIZ094PEFOU,5J80EJND%8^(!N
MKF>@M/1K9HG,O!"=8$&@EGAQ*3+^0#^*F[9%,PB;P.HB]3NU?C+NHV=%%FKF
MH-5P\,C*-4/C,_MOA8C,0,ZZ>H/G"EY/YE7S]EO"PLGVW_)R'$PVL%)SRC)Z
M,J7JCUI%1A)D29Y^VDCI@G/J.Q#[.'!>>L):J<R ],$UA#O%6>DA-MYS+VLA
MY:F>OJ5GR!!=_X>-?E/X=G7^;[M2\=ON2HW&\QN3<2*5+/:G!R.0[^.+!!N&
MV$)%DSJ GS D;SC#UYJT;$94[YQ;$,&YQ;C@&M$G_"UQ^YINO M:UW];[MC6
M#KLN$JP1,X_LKY#8.MM#%;P-!&<B*HJ ?4LIIM7?*@]KB#UO2"^X^/<OA6X-
M+G*-,:0N>.$(!*,NZCYAQY\*6HL+.<ZA/J8SE*$*K:!94?7=BI294XT0$6\'
MNSD?("/.<B0"$FL8X.8%U<YZV3J_@M:;\M<_CLAM3W%K!\1[\6[>Q7<)7E]U
M_LI/==._"L?/_*WQ5_MLF\""$,UXH&M<<A_O7]429Z E]&(=W7?7]QOMEP](
M])R#T*4*GQ7':U^[SE?P'MDOVW8=?>:INM\:W@O#0HH!CE[/J:(4C3/0X,<*
MY4"7 4)C&-'M+>N$U)6--VE;!MR35"SD)%M$AP/"@^8C^TV8:L3,RUCCF#+5
M"U_W/QE2F]BH&;;5W>WMG\5/_R-HS_LB4AYQKIRPTX8=O$!]/1"%S9: /GK;
M_@7P6RJ1P/<W-=XK+,K;?"!F8]RUZ%*==<E?Z,;?20($ G?<JJ?K-(MBLTIP
MR-UI&PGG;0*+M%E;6DHRVJH:/MR]PQ3M'^%AV$^*H$_R. .)_.I^:(,O,YBR
ML/QU>*J.8-\[ W48GX&\H'EPY/+X&P?#6#L 2O"G!KT(-711X=:4UETG-BGD
MF+Q9JX90KOF=P!0D9?$7*D";W[3A^M@YSXM_45OP$EY]BPO;:Y)LRI+\\IP.
MALH[ ]U\73X6,54H*IWVZX/F\=9L.C" 4;YW:^L0X[AU!GKE3ADN1N$^G?_Y
M^2OTP/22I55C?Q_4$99.-2(3#UF&SD"85R'3D -?;A8$H:#Q#(1S<SGE;LA>
M1,I_LZ]M=/RH?;H;3"N^VDJ.75V692CS74T?V!W4I^)N^MD'.2?48/Q:-(75
M\135[G:K(,GLM$C5Y=[HM[U[,<N"74]X:+?-WV$CNPPPU_YZ\B0WCB?..S&W
M&&0_<*(?,IK\;5_WY!'9-\/")D?+$:A9GN9+_+F:/7^X-[2M)?9=BV\E:\HA
M),$" S3$B$.PG78%*)M5[G:4@V\[N^]0NH#R,>[>U@%BRNBD+;<]-(JB3'[9
ME+XC$2(=;-&08]2D]0N(6:8N3/QRV59+)B) #N3X,0ND:$KWJYL[JNDM'H8@
MLOTIMLIBN[;?O?"GV*J0,9WT3-BW#F:J9^;AST!?6= A"?)A ("\<EMER,+R
M%6F*C4YVBC#U='79E"I8GEY\BU2%_A-#5;M'UM^=+)YW?>41(P)Q97W@N=5X
M8W.'QA]VA2K%*9%&2,GA+ZG><T:I<FID,7$X$-XR66NC8][\)'5>HE9GJ^(1
M]KE&P!/3H$:G%#O-5$USS"73Q)]"$EUK4]8J\4-]X[B5 J]7][Y9:?W6L^BR
MLO6D^;&:%A>-5XO(C#OP'1RWLO6Q<$@*20YI93BX4S=Q4-87G*FLK]_\L>0%
M2RT>O9<":5FP-I3"6^_YO%E BY*/T(-&1B,R-+I6&N->!W&FG8X-5>,' \TQ
M=(_ZL2HKI+34:G4_#TD'?.HMQBFE>Z@?R#!5PKGDSM)@0>BJ!N*V*C-9V94G
MU@7)XKY"E*88WELPZGYFO;$@*?6QAE,W$$>S9?Y$XX3SC;9L>N9K;K]893 T
MV;E!;"C7+(76B;700EYEW)G]Y[%A\FA_>;$F N%V?,LK=MKF559ZH5', &X^
MSXK.]B8@+EO&IG/%4!2![437'<'\*3U"J"Y$&()@E1"Z(/A@)J '&;D@ M@@
M[E)+-&-_F_7F,%O;P[K'_4DSD&@QD_V4VNH?AZ2GUZ?$,=RCNZ"0R<6:@&[1
MQRT @HCHM!4RC=4F9;SNGMF<_&;F?1(2Y0?U*H<.HIFJCWOF"=2S':AO4FWT
MN!!.7\K//I^?"@;^<*0CGJ"+WUGV'JICJ2]J*O-SK4P\-C7IFK[LGT9R<GO;
MK5MV0F4T;9>T*R;NJ,_$LK;!'U2V_II%/?#7OQP.?$#\Z[&1=%#1YQ';P']U
MY+G_DZ__[,J_<?_&_9^!,WBH9'9/S>]BU)V&:'GL^\L7<"F7$AMH+X*^=7SY
MRICSMY(Q^K^]*)VOBBI!+YP(_AKR /##9?HW$X83R+PX_4M _,03T\8?+29Y
MMNN6K4TUEZ^-08^.&$--_A%/NHIKS]E]TR9\VM*^E!C"CEQ*ZT).#YB=EIV!
M'/!L7<=K14L),=P7\"N-Q,A0M++G&<AD"A8QI23LYE@,T706_Y9ITU1%?&FI
MDIWKEK&65S!--B;2IYU&.3J>S!+;<6V)!##V2A<JMNW.:&VVWR/@Q=)@4,_Q
M4#(6J'":1*';Z7_JED#4BC2#_!R=/%4&+U46;N[,S+-8K.7(360%(Y:\ -$K
M9*:MWAS6F&Y_)+K^3; L8_A*\X\6/_XS4%B+T0MI@\":&9U/;O[^4_5CZM^A
M$M%-!7$K>4[(P, 4L0N;B]6R^+X31<JL"G,[4?#K&8AE;L'5\B_H(N$CG*TK
M(\C%5I[@?IS%]3K?<N']F(WEO&6_J9L+;)%^TW(WHA+EX>5>?E@64Z98_/FX
MX^7)I?9,$QT.F0D),3SZ)$[+X[/5[VVQM>;&FJH,PIV&U*%1'.4XR,TY\7.H
MVT"CG7I05/H9*!O\DVO_*Q+-0&;)(R6=EB(<VZD6H9 :+4 ?AH7<@),8&!8!
M-4R(-%"$TT%><,THGWS%57 Y.X +A5/$\YQT';>6C.(E\AO&%KM5^.IK)L@&
MSA)E)VY$-U+5:8;*12"BMQ-QJTT^6!IPQGGH:X1U68:$+7.S0#,D*@(^6R]"
M-NIF6A[(^O'AB^9<V4V+'*DF.VCK%5ZOW*]11G\&J<J<L](XR/Y[[A.5X1C(
M"?2/B%.5C'LHJ1.M*-1I!$7;L3L3P=Q$35))S7BPKN,K\<J7)[/Z]$ "%O&6
M;PR,;BZ3Q[6'&8Q2A+88M06RQ5,O92S@A@Z]6/!*& JUR8E=R #D&@);IXIU
M# X"[)<0@)ZJ.R3*5H802>9K$QX[0 %/R(*EIYDGBEWLFC/Y^G70M$SN;XTQ
M0C_QB<@\Q%(=Y2)Q#76B''S[-+_MQD85/-GV-(4B"=@OBU5A/%Z7JG&_Y7FK
M[X>[Z)5?/3^_?JS1^ *KJV^32E,F5-YR+Z.M]D&>LT=AGQSHM JU)DKB(@[E
M$2)[%@F05K6_F>K2"&5="#:R'[;UAF(/NA8]'LQ=%C)N-!NG_%36E-W]:/)8
M(@T*@V=8;X]L-#U/NH6MBIZCI)]K.\&\_>>-K:569(_H<%R&;;IR3_CE/#]"
M=9#.5D+, _:5JG(_N#;DBH75G(U^B96K(WIJTL,ALU-2Y+8KF%$U4GOSUYH7
MP.?U=9@9.%KZA8\ZT0K6)W3OAL*X 2'N+M5;<*3>"#@'FJ$:J=!'+%A++[?2
M]/.P]R:Q%]821;O/0-,!HS,S9Z#.AY]_NAP?EFL^'7^YL0HZ/ ,!=Q&1+U\S
M4:B'"?5&8V+B'N#@%\O<T0N\1+KNUI9[ Z5NK&VJDV1^JL.#1(TDFWG-3W K
MM;$;N-6"='?TEJ+Z>ZN9V6[N856"&=21<(1O/P-="B?J)?*E6HZ?@="L1?ES
M"U9:_"U3"B;M78O3.*E":UWW'W,Z+V >.#JGH;V1PCT)]UK1 6=]D358\K#J
MT@=$721&?YKM:_L-U1?ZLTS=KS2_#D<M7@CAA[? 0W[U)$+6;=F(#.&'6^N'
M00WE+>HEB%RM8G4<1ZL99'2M.>Q1#5$VE*R/]3##,+H]$O?=6U3K564.YCZ7
M4Y4S4&@VI9]=_ZMQ.[']:\+/^'TS $6DP<T7Y)05P7TA-W4JUV>&4O+,58H*
MIV,&.!:9@F4)MIEY0Y7Z,1YK1*?/^5;6\ !,\I;L'>Z1VO_G9N&;&5.1TJJ,
M_$UNKQSK\E,K>&<K^FNN9CS+?91I$>C]CM[O2/TYHK.&P'9Z;09R>I)\!HHW
M@ZF#O-L)Y>1SN_RH+NT,%+)R!EK^\#\9%>)!&57]8@&DX_*6$>%-D^'8.".#
MT)Y9R ^EAZ=E7 D!,N'5TVIE/UU9[VT>L<I>[ISI&?*X_S(/ZNU!F9/PV'%H
M9(.H")*95'$=LVOP(RS.F8.D&L4W>XIO1@N="^6MZ>8&VS!23C2Y5XX0A"$?
M276O_8[0D;>OFLCA95.X%6$?7F3;4H$7U8ZC?2K\J,"TL;0_ZRY>1-XX95//
M+TV,(*=0 Q/!YAGZ0ON:4I:#+%Q+)D*G+=#)00O'R-@_]1^_ ^F)S3C!-X]^
M)=4=GUQ7_K"Q24V:4ZGE171(MO&RW%7AA_-; 3K0F:UBE<V[CT+>3&U!:HS-
M:(-I"!U>F%I^U,R0WW"?D_#KC11.>BM6),F?2U=Z2L;=SS( 8FW@U@0MJAE3
M(PZI @(,<>R7),D.A!8V_@NPA [VBG'&/O)#/B]FBSY)^C>QWO<W#5X92R(Z
MP,&OGKUKDX.K\RV[:1&F+%*N\,K'!;^F>6!VQTZ]XT[6&S2ES\!*LP-,R^OF
MW653>U1CO6-VV.8PU3^YIR",H=%:N!5B>[K*5_I"V-3,=.RHOV"YL"H@IKDI
M0)7M3RZ -=G Y:-5<#"!V>AV,Q\2R_W.DP?RT7.>%L&,MZENI(D:<[O>ZTWU
M],&YA=$^ T6/EH<>D5((=(D<2D55 !6.9LW3ZON"1)NB13Z\DZISL$7*>4"H
MX P$7:]\!Y?!YC_ NHM.4BA24LAE)??L%I27N,6ZX7?EZ%JEFDB*A-L$]GO,
M]=V=<\:B![&0.VF_J,<^,-_<"-0*DF\DX^PK)T[+E,09O_U>/LU"Z3"XZQ#W
M'O]J,T8^$LEO)V@-1QM*C)]6'MRD?[C(MKU0\$71SBMN3( !D:SRU@P?SH(.
MODN84?3.@;2>;C9,(S;,BX[<_4=QM+JBOJO!?'@)1SR<(W3+K9 R>Z<$5M2Y
M>_M@ AEU']'!UR;00CKWT4^KWUOD]Q]IY5.&9ECBR(1_.CZ'[AL"F94S5E(W
M. 9?2Z[$?;K4(3^?3*&^6_;MKWJ\W_*7"\,[%%:R\KM?EWQ'W.WD3_*7LC@=
M:$.^C]@8MX@3]I+0<IH""T<ED3!'A/!$UDI:DO_>^,89R$J*ID='=*E!FYOV
M,W819)0T>=0BYRK>-E@W.J+H$B*A=2Z<;\<++EB16H!HD/SI(@9UJ=,O5-[%
MD_'=KYTD#6^?]_<-O0#>UI4E4<K4&8CY;Z/$%4 4P_I+KE?\<A['/9*=1F"/
M&ZDI>D&%PYLSA(NY+\^CT3L1DJRPX3.)T%CH2:,S7/7HG?;6I#*J":KMPVP.
M'KJ0;<Y_$A(IX;$4?T*J ,C[/:6.:?K)F!EC7YUZ^@&6UK+O54Q)[P=A/C64
M5U)T/?E(@CKRTN ;,-[@1+V?C8]:YC4_,:=AWMTG!T#-S(@6*E%U?-%2BY1L
MX*^.OZVQZ#>W68 SN_FC_LMW;VFQV>@\S)R\EGH_>:XTQXB%8WXQ17RX*TIU
M*0K!X-2;?:(7\D,2/[0H]>S'RFR6,T?YD-2;+-C78>V1/S5)HU6OE=L4(DF)
MI_GLWF9]:;I$A@CT:+2\XWL=+/[O@8;P.Y?C_KXDV::Q..,JJG_(^[;":YNV
M::9,0;S79I=- #D'T^F.5\T6?I8:W!J;;)A?G97XL'!G+'K $(WLJDN9"=!%
M?FB"D&\@L#NI(\ND?P!B\>./@VW%BS0HUK\5J 55Z6\<;1INW#P2:-(9!@0T
M_Z%KZBT,UB?FLUV4;YB0'KQH:+H5VV'OE0OR2VB^<XGV.5/BL8=Z(!Q)HZ34
MO3CKG6K@7[ZJ\?;+:$@P !U-.0.UAGA)8:6>&M=$YTS=CAAP-"&;W&O4,$LS
MSMPU# QAH!&IIAQJ"GM4OB-[$-G(3**]_L5XK'Y4#O/4K;]%,DB)97"'QOE]
MB2UJ)>/267G=7C>MMTYQ?D*$!$9*)Q*-C)R.Y:*M)O(W><W#L,.,+FFB>P>S
MSL4+T(S\S![M0']:^,S)[12K8^K<-MG[QRKP@-CV"1>GWSI0J\U;V=K]XHH+
MTP5*W6T>^5EU0*!MT1LEY!5PN''1?Y1<T!.F..^=XL!AY_R6S.=X!GJ;AJV/
MES;'=@1EGCLL6_>F/92Y%/>=W N>DML<C)H\:3/K12_\8CEU,+N%4XWD9FBQ
MK50R6_*Z"D_^OMA8.TRW?IR?B>3(=FRMR3!^_[Z<7].")<7&7+*$F_KCZ2VA
M-JBCDH4IZ]I*WL=5[[)!5%-!%,9N?6\:*O EN7E"0Y&SYML4N;E+56NLG:)[
M"WS*1S&!B=.H3=J[U,9Q:$_8(5JY"HIF(+S//6Y9?72\0O/UVY*WZ! ,\@9R
M#1;B3'@=7I;0=&Q<GZ&WT/+[%6RPA6$J/U%NH_<B]UCONW:[A&E4E^>^%F&-
MCFOU#+3:'@G+#M!0O[F>RMKT?E33'KF]-\UYG>;B4AO/N;5U";[7PB0;3@Y:
M]K@,O?@QS312G7@[B[Y7B/6F&%D5QB<\YI"&%Z6OO[76IL:XI!K5J.C;MZ_4
MSL8\^]9W>Y'M3?FHSG)13%Y8'IMX>=EXPKYV;U6*,Z<?)AX<V9"GU&]\&\M9
MI/3==WV]PEDO_!7SC-N\3T",F:XT0C$C8+N6 #G1T(F#J?#,0<L_ZBIB<L $
M2J28X:Y1 V3+]A(Q2-KQ(BJ5M%J?@E!T_;@XVR)_(DKYFF9W'U=[BD++.LW>
M_='RFN#6]:7G*O9H,9B7T%+^N0TPIREUR/WV4^TG98S"2$S83EN^V:)*5.O,
MF&MCGUC["-?$"49^BC0@(*/N)(!7J0MS1I=U)O%+F$U+JCG=0-?9 O1K35VW
MU]K+&.G=. B=C !C4=0+]/LST.4\Z.OG>5L^/NZI.3]/'BJ][+ATG+@$R4?2
M+Q4O%WWE?)CC:%B$OQO=0:"PQ7R)IVZ#3GR'A]P*-]^3$3(F_?QV(BQ(7:SW
M(*&R+9E+:*F*:6 +0&8^Z\+.%"D]>!'U6>=Z=G),F^1;49.UN +V:#\3GO'Q
M_(S$P\5(U>=> '_:NZ<^]?@+)UKK;))O>6:[ BCT8YVL/:8Z0!NUS0;CQ^G0
M-OQCX=7W+:Y#RLL8)$$3"0BVQW2>$V#QD\?!%E/S\4K9@CA41^9LRHNP:AUS
M%5;E[_JA' Y5O'A'CV8++2!/JZ9EZH )ETT_NF5!^)H3Y$1D3?.2H434/^A/
M\',_KBW5L4MC[>.1Z:*32[V^Z:A.*V7;XAIRS\E"Y2Y6+A/S/=L.JFU0%DFR
MJ-2,B4EHFM"&]]EG"=X2*#CY6+;1QYK@GS8*[OYU<Y!8YV'*%/U!4*]5J*2[
MK$3#MC_?(6-";GVB/"0!@7EW[EE['0NUHP,H+(NT[;]_&)R!Z'E/$]O7<RDC
MBX#9G^CM7P\A=$  +K(+>?6J4>>"*A$9:?=/CUV8!O%!39'E&[:YN H/+Y[Z
MI#LJ1K2)TGKAB2.)Z?HM0 !IZ;1 2>D;0T)/JWNTV78.SX^7M]6M4VEO[QKI
MUTU,1W[/HP@\]*_J3ZKZ<$+;W+-++^I;/A8F17NIP&$U'&[=$\LQWV_4]5RD
MH9+P65B&I'#[_;$Z//\,%-63I<9 F,3H@C/SK@!<4_^C'FN2Y1)(&G\REDXT
M$5B;/^E=V52VA%]DYEZ<<LX$T0PS?'FKOUQRAG^M!EN2<^^R6NO<@D#DH'B2
M@\[+A)L&H![]%G@ Y1J$T'GPN$V(P!V'IK862CPH>>G%:/GWKUW/#+?!OS9P
MD-W>YZ-</\P6'!?N N(?]XJ7O<U%DFHWG.0X,5<& AP*; O8WBZ&6#].LJS+
M*YEBR&>+\CL#9;[)>4C*VN@E'C<GX(R \Y9+L:<1%&Z.H!ADQ*NB+F6-:4:V
M9T <;M#-XD9UJ>B 3R[4R$6%M2$P/: A[6^7B?0N1LRMGRJ#A-VOJF_:+H[%
M(<-5;L+9.HY-6AZWMH5]WCBF^^#=)2O5G\HXT\GR:#>0[T "GY4!<."\R,S5
M"_=]BLB\!+6A,Y"2#Y#<L[OZZ*I'CD=]I'19LMBW@?0[J?N6M3!%E9$B[AP1
M\CZ03/Q3\+F$_]R0_^IE[RDIZKL+^^&Q:@/&?'ES-XE?ET'7RD;!+.PN3U-3
M*.Z@%)P)XPW]%:E,Q&"&;IH(>>]0.W_\)I \<.^ 8$X/\_*O=+1,RGX\@:SM
MQ!*_^-=DN.E'XL",#6'O^!8"NBS6$*+S:MSI]O=OPF7\4Q1@F_TI?)7;Q2.K
M9OY/3H. S)/'(7W<="%C+FQ/B97-%UXJ@$/OV#B[?UNPB/]E(>OM\J!'7K*>
M$0$="+RJI?ICOK/G#)2CRJ3J_CJ@6]S'<8GA+\ ,VY.Z4AX _0N(Z4)Q$0<6
M-PTD4KS6>AJ$/7)C8OQX?P?L;'&6[0V'*['A=F^[0O/@LAC+Q:A#6>%,92;=
MYG''J-MU494A@\Q14'?ZIVEFXBPMVK=64Q@M(A<@M(BE+.0-LCHIZ%Q,+7=2
MENCD2<T;IAK@&_#T-#ZT(7\^<=U?Q0Y/+3<!NV4GM@"+6/EY!DHS7MZ]I?2T
M1$F6YOE]>2<;0\,BD709X>?K';:#=O#(6W)-L%P4+*(+RR^-%+_";[_,!9;L
ME65G_'#GX'1T58=L4E"S9QAWXA(2M)G15E(QWX<H=Y5MRM[.WVUJ:\S8M*,6
M= G,[O_$AX][\IA3Y$UWT!6,ZC1F6;:[YM("/4&C1")1WN@,1,U5'O:8L![7
M-,!:5A)X??%=#PVF@.;DT[5$S]D(A*?*34KOX@4*V^N<+7W"6Q6!*7'2/>*5
M.';P=4B4$;]3?4W&5;2NBH/=4S_HL4E%)[FYT#<:L['Z/[J.<(1P-()ABBJN
MFG/K8LJVK";5$BQT4EP/^46U3NUE>CH6O+"E)4N;-N?NO,V'A0-?"ZU]G)OK
M_)SPYF*%%FR!%+.7^-OK3\I3V>?IUYG/@-IEQ6Q7;' C/^%76,H!7DSNFBU'
M]BL*4\FB5958Y':&?Y3<M5L2&KBR(\'P=F=4Z (-VDJ5+EB10,F(CN&POEHI
M44L]\?=%O&4!OKLGSQ\^Y.E9(,]W**@RH([XVWOQ@G<"=8_JST N!CI;D>';
MA@PL'X=UM(%MG;*HZ-2=;(7WN9E'T&X+KE9: 6X&+T=MX3.0HO48@D2NG#@1
M2'.(9Z.P(/]I7S<]YZF[<TBR;P)@&O+7&>BSE<X9J-T70>S?*4:A%/3^"[!/
M]/\&_9= # IM@!9AS*@VH]>08/JFV'SN<SQNZ+C/$^\<>ZA5L4/[OC^RJ>D>
M"17=)H'H$$;8(6(,;,Z?OU9/86FK]TTJ=3O_?JB30#WHN9>]X/[JHD3>4J.#
MV6_,'&#GI%3B4<1R+*/NB_MBKN2NG"-%H\9$YUXV&JYG=1B3Y,DP)"XSDK.F
MV36GCC%/J/"F!&:LU/[^4*!4?SNJ4R1UVC2<_7TX7":_9#(6*W12'6/)_3VM
M1Q^X\RL!W=,R'G(IV(%P%",N&R4>+$7DU6TBU%71-20P7 KA_Y%L-0ISZ_GH
M%54IK4\[\]LWT/=)Q95,G]^:Q 02_VEIVU^GI8@HY*46MX)U4I2?](+0J/0A
MT?FM75VMN_+$<!195*(F=V.DR<YE>0(LYAFKF(T?&_@@>)2L'IRJ^$^UN[[T
MEVK4/\4[4S7(NKR A12G7YXCX:X^5OQN_"=G(-K7(F3UOM9LSKU4LVYS<Z$>
MP^X?%IX.6!:'SW$#>?H,@XZ[QEV./S.20PX*5^:0OZ?7V^X3G2.5JCX!Y_VV
MCQLH9U5(F6,MB!*;Q=\P\!!RLK-PC)J(XG\CT%3AM@SNVKUN_B"]%-YND-2'
MNZY#5VZJ ,T16^GU>9 .=5;N;-=2^NVP;[:2_,H',HOHT?\)(>D"^Z2RA'>+
MEX)O!93/8PN)FI'E^02O&+Z4RSP9O[ILF=(T)F0NLG'<G9  5V@G2.@$\O9S
MI[7=/@-U<+3;H4#P'&ZF^745.2#" Z9UJ AF(#\FJN>486,\5MFG]#.?C+P$
M,TA4%9I+)E,5O7.:H$S>'C-+-DIP!7?9M8B6*5F+E%H\$-XOK$HA$.-Y,@UU
M=4N>E<GPG:Z?*-0$#YC=OG7<"L[W"K- FP9V<7$-*>F$U08KE3I87/9Z!T?&
M@ZFR)^'!ZO(:^48IKNA[U0G-<L)]<JBU+9+AZ1N$B]?,VO'"UM<0#O8KF-6F
M>ZY(YA;+>@6OM^*FU-]EOVS<$).T!8J,ZQU2P=OXRPL;=YH?AYFVCMKYO42.
MU6^CSOE$TVG&&<@I4Y3.=/\Q)/H,Q(2+EVT"(I<5C>WM U;Q'P UC,^P2CK6
M+1@=*AJ>;$@$15N([\B<Q/COF1U ],<.3GEZQG1&R]T/!J7TZZ-',7IC^!?5
M5=7H-Y>\+6<LK?C\29.$GC+.9QAV378AXV>?KC5"<AU:>%,=.5,*N"N7[9T/
M,PC6Z)4F[/K)2(%GLB?,M*XX>57U(E%PXT)/VYW7]N \"\(BW81O)$G%PC9D
MBD5]WG>M,=JX;/E#LNO+N[0/+KO._=0:$LG#(K 6  TEW -,.>T[ _7^R:=S
M7@(?LZ#;3XX$ST"<E9O1QWF$Y/!_;<_[%SO17"IT\3^!4 I 50"!;2GAGY:'
M1%&<25T8MIT:[CD^!X%8\R7(= WO64(S''.?.(_7OM;V36WRS'1-LIZ?^U;5
MTS W,!-L"[02SD!+9IA3!,ZY:S!D$;/ 3#ALS_3SD^!K;FM^?Z]ZY"#H3J>'
MOL7XVE^+^F/XCE2HEM/]#LXQ=3*,,H.H0W8QS-+@+DP<^OE@=R.YN!H:8[!'
MF/7*IZD9ROEO>V9ZOHPDTA?A*O2N%ST;O_:Q@H=7=^RQOT^-=4C".?XC1;9W
M?V#F^9X2_Y-RS+W520]+?:K0-3V9^S">L0\9*4KB\B*UQEG%(R@B)[3GHPIS
MQ[2OG9_[4_Y#,;8'46[<Y;A&B(R2].UM= Z/S\L2=(HENKK=G7L&8W5:W'9'
MM]1BG0B(8G,B?914J C\>:%B>"V7,U =64W:D[BI(C2>B[%Y6D[*<* [32]8
M8VEL'E>.)%T^]W,1\'I2(U&(*/MNZ#,6\J:-<YPWILM6\$FLV8)0RYOE),0U
M^,-"(\XT%.-LJ1N_8,V/W$2:7AB"OS5Y^ 1TKI^JP18GEN?ZR0*4WM;!</^E
MI%Q,-45^4CPYU2;14@N#M@ACJ1T?5<_),FXIC(JE-O&)?5/"ZST1=SM>(WB%
M!8L3CCIGV$*#F3Y#*>P$5 0:D&YE>#RZ9!4D2B,*Z]1DIZWYMFWI%A.5H9/9
MG,[?U)3J%E60<JXORSNJ W),XD4=+6S7F'V 5RJ=%9:<-07)8Z^&]H(7%F7*
M9TODC?U2A(=,B/0FJS>1'[T#+B\#S;=5A'$E)F5O*\QF#0LLB3G.,OG<(JLD
M"QC?!^'.:_?+;I:^_.#2W>ACRPPP$B*_4CA'R/Q8_0LNEN!(-(<0^A2LBXYX
MP=+:P@OD:.6<=RNKY<@L0%('%NC'5V]FI.LCG22K=KX>#7^%'(A"$4<[^A1Y
MFPD6<IEA@?:$H&GY+],*B_X"[11^X?$20X]^OZR5N2)YK49M0T]#C[I9YP.^
MN]>\XQ2\8X4[[[^]>[6X\WJT0:S]S8*;/?>U-(3YDK1$.<%D4=4+B!\5!6>@
MQ4958)7[7[?[4^8-GAG\\6[_7YO^!O^I4\P7_@WZ-^C?H/\-0&8K1WCH.1-X
M#2"(:5U3B.LJ5X$T74 59_/L]\(=0NMD@D\QG-MZ_'9?FAF:U<QG ;"EK-Q/
M?J8CJJRCVYY-U;E!DDU>6+ )&1RQ77O8E3Y%:Q_2GF1?^MSG1EB!4:KTI@%*
MJ[D)MFX:IRWS&3;(!9>EMGPY)_ A+3G+(= 6$7Z<X_&V*.93?JE:^A"+L+&E
M\$B%WK,R;=.1!ET_]09=;?$B<A^*?!VS[*^Q&Z=ZK7/%4_0%;O*.<Q+SANO-
M-S]8G^ES1%JN([!=9Z#K9Z#U)?*M,]!;O<8ST$ I)6D=U9 6QW57>W*00*C?
M6[6P;T>IL$+"ZP_J^S4[=ZY9K<(<*6*]]_Y$D'?U$E6S5L\7I>OP2)?Y$YWU
MCB^R5(!9<#\'YS^]O?WF%[_R&R?V&8S6YIUCZ)[8QPZ<&/-H&SPMX>Y@395^
M7[Q0U;_(=A?*:'77P277^=G-GK=X[A_S+#'$A"ZS^NM"QX[R@I3YU!IU;-HE
M\.^D^JUTI\5">>XW) 3AD3Y5 5H8<:(.Y*X1G]%$;5.XH \>C Z0]>GR%X3'
M^>O59N3!GN8!*<TO39&$1XMA?9XQ"&(OSF3PQ_R:+C07;ML_O[=MY(C^L7E#
MLTZY=+9R=0&;=8F6%S*W*9H4(@H/4]SWD1"V69SK7!T_W"/!Y:81L*"R7(4\
M[*_+CR:_?=GI [^JDWPE00;2;3;* KS*)I!1J4B"&F2:R--]U#T<6\_DQ:<%
M!8>*X:;?U :GMPB'K';,Z?Q>NG?GDO6-&5([0:U]&L88OMN%3$B[P=HO@WJG
MPF616WBEOT\6H[CF-)_<\B3L$ETZ5<+V*LLPF*F!9-;.M*9P!@)/+!_YCI@>
M0$I*ER08K!QNBBN6HO9+=_=5[QX@ 9ZT[? BZNZU5F*]K=3-[QYE\&',]<QG
M;XZNJGYIH<XMHZX73L:+>C^,4\J[+DFMX,8 \$9N6SGMR?0D$CE,Z#^;*IZ!
MN.9[$J_[VDH5FF\,643V/T:)V.\4*TUMIK ,&G5)R)6NK'9;S*S5GN8H5/ 7
MM+%H=6@ZAABCRE[5AT0'W^K\,&J W2[86U@8H](HFSQIJLI,/?:3];@QS9U^
M/A-/$#_]9S22O"(IPN/,GQ_2+79!;N:[=G^(,O[IFFKD]:P !+54KIR._:*A
M&^,%\$UMW[V4JQ7"X"K[[L)E&F04DMF4Y\E7.P\E>[<'9L5='7Y'8?2B!_[1
M:VF</EGUN"%>_,XO^;>(@ZQ'-?N6F1),6%@]O0-"J>PB^%0DC-)J\?NW\[G:
M5I^&B7G:-44N\=<,4-O%!!*9<).?W75$[^Z[[Y*#_)SE,#?*I&]0>51^4BBC
M3^4&!':W'UZJ^HZLF7IK@?/>%!@/-O-C%/&]]-X:'FHNH&^^&C<229OO _$R
ML#Z4:X[>;)[ A=PMQ@^\2I]TE!UH![=&O;*I]ZB5+<)D*6M9IJHE&YFMU2JA
M+E*]ED&[B+^TW,W=#O9'$O2'?S;>MD$XJT:LY(F"CAV[WFF__]MEI<4!]NUW
MXD1BA,F'4'4W!(8FI!=RX-%^%4&(.Z??P.!K&W4_E;O#JT3GP*Z*VGTQ-_(6
M1SE2*'[:U++UGIS);T,5:6(]F6F1=)^XEG2L47*B3%8965;J?KV4+08PF(8^
M#:TN+%CZ_=(JW?_>E;[FH$RS6UH5*W'I'/NBRX+DZU/J32=.!02&9;J=%&&=
M$H]@8:)&AXPB6X/?FI65YC(#G96E[0;)P \DR\4TY4FN3M+QDZYJ1!Z#<ENS
M,KOH[W]S*DC[]?,,Y#PX*/9  C5%J&[OI@S'DL:75M ?-D1@#URA^5-I&=X!
MM+^NK_:L "I!EC*$@TDF1@X/5P#B:*@--J%NQ)AF67JHXA#+8#+3+U(]P'4D
M!11AK[R3F;^\8!.#:X\DGIMHV*>^Z^_ZO005_IIWG9')2(''+O".OO1:%-)M
M;ZN7"O;Q@ 46V:@%./OXV0=!10:H!M'5LS96^AR.#A$NZ0(1YC\=;6[9F'L_
M1!T(HC)5)$.^<== >KL:DW$)G=Q7MYIJQX.XNUG]=;&[-R4X!VYQB1(.,FQ;
M1;J%)2M:!\FDV&&> 2\^OZ=)(9BDUW=<9Z3A:3Q%EG1"X]VK,O)\R^BL+S<;
MM;,U^<LKX@IHYH7X1A/6 E%AQBB1:58OP]@QWZ+([R^&6<1Q>;$8#1GAXO;P
M%G&+F:G,)$](WV(G]^P9B!0-:),F]]Q>@;L&+\_Q()Z3#4;UHU@2S1W [SPJ
M7[;?Y+VZSZP=_(A450(Y,/WY*:0BF/W<[-93OK?QG$AD$IN70@H("Z?#:>!W
MP4*_>BBLWT"99<T\TB@F:)7J]S(/^R(@U>1Y>)%C8JR9BB2B@XXL&")QR/U/
M.QL,0C]7E6.N)$Z4[!</T').%J<KYQ(FG-8A2Z&IWJH[B95D59P.AMHT%0?-
M=4;N!2USDYF*2*V (*FY_3J9=S)8_Y-E%I(Y6)ZW5T&M\X(X3*8NNAH(TZF-
M#:W6KW1Y97BW0Y6W9_B@#=/AJ=I<)';9*MWT#(3T/0.9[3- Q:4+9/0OQI7/
M-KOF2.Y:M>HSS,*+.MHY?0(C+J=9H/!9'$4<7H82YG/B?*WC!4HB.@YHYT,;
M0A[NRG8ZL7]$HHT)7H-MC\O.M5@9DZXPE".K09F*/E84 W;'5OJ,&^E/LYOB
MTUR_YD?_[3('KOW7X!N"J)<?(G]1#0957DLOV9C2DFD=;*FQ6#1?L/S&+O\B
M0R >-[.YX$ ;'YO4S1-:8 $_&5Y:)#/_(G4!DJF3IL@;*T#DIYG>U5[L;C2I
M&CXZZ^+][7(S_WQ"'$\\_SSM Q)%*&)2[J;&EPO,7&9]OY":9)B*:XMB]K-N
M#!PKI>U%9Z&9&P]F8$>[Z1[\PF!?+#PYYBSJL;ZM9QFX8&9%HUSP[JNNG; \
MS!<S^7)S-'KJR627SD#]X>Z_\!C-?W%#0F3^0SH6R1)3&5-/@65";Q>" <7W
M7DTP2ND6C#N6+,W\F'-A$9I&G0\DZ(07,%R;V?@!+X6=?H\P3-(A(290;Q'H
MQ:_<\22B+B$3-QRFY.C'CS;SR+5P';$ <B>I/Z"]BN'ZQJPJ F-^M>,5E!3/
M_@V>>[2Q5Y;3?U'YZ-/+*RWR]6"+>X.MH>5Z-$%@TIQ4183N06QISZNR;NXB
M1R4CS.]%D0$I:P&>_#I,XPFGZ11BNW9"3#V%PJ_;<Z2MUQOP_S'$ &.S@9S?
M_ZNYXK]!_\> ..]K>M$^>Q0J]SSN;K3,20FSZPUIB*/)->5P+77F__8H;LG'
M6@:XE!M/5C3BGZP\V^"1$UE?_UK&*RS2_S7B4NA5F=^"RRA 0+6SG2-DP?8Z
M,!)$8/AS]!4!&Z5< T+'NKG8Z@EU:2^*@?;ERGK<J2$!B.GFHJ\=8<-PW:VJ
M(QR0DJVV9&.;RC-:ILY ,Q#/:$5&MJW7S!>&X#H=E!L$ALB#16HX6R?E-L$Y
M_*45##U"EL'JLND22&\*+#]U6FW,J"1Z0(NF'^7EFTX2/QV@;@.U)P*406XN
M)75[W&+LXL40]N"G1)7,W%G %V-+3 A'S[L9HW]X>-7>UIM]$K&WPY8N??):
MS70"?+>.;E73!Q$@4@Q=$3\09[Y U"<KAI%HST!Y6@#3^9#.0(_/7\^K$QDQ
M/&^-KHJBU<LO\=/N27TO8BTK<A_?L3+PJN]GQ5WGN8[?(U?5>"Z(##)?V'MV
M&MIN]P)W$8<$SN=D^NC$>P'APE%#R.N( -<'YB+J:"[FWY;W#"8([J?^T/KE
M9+/P0BRD.NX&WY/<Q_%R(_;Q<N,\&N_^RN41NE9<^E=I\86_02 JE6@0P2N&
MNWIQ&TN<?5;])ZF5%K @@BW'*L)3XAN7&2ZM*TPVNME5[HF_51B<3]Z$/J_^
MME?QKOGD3LJ,P55_L2!$1#MU"%LP.^&(S .A5KD-B&*+(BQWK'Y+@_\"G#4)
M;6DJGR4U.6?"!W/BG)WI)L@CW<Q^MG-B]8;Y!OE)U3W_O&+YOV7MO^ESH2-8
M%WBQ!(X-N39)X0K6(0R=6^NK\-"YV4T%O0)&1_I&MZ MT8\SBJVRQE5I'D/9
MI1O[LZ[LKT<U_9Q]:+]5JG[@GFVG4&.6AZ?UG[40A\,T"I91;V2G/M82V3L%
M)LD,_..?/5XF<#[T8,_]>T]A9F-!J#Y"6?199G]M:X+V>&5Y^:XJJJF@!-KD
M7U,$@;)WAZ>6%;CZI[&RIZ87SV""BC9997VDV4S-Z@*$Q5LG*K[3$X:]E+R8
M1Q0U>22KKNP O G[.=0]^U@'HH7-JVCS[5+TS&<;*)MEV%%;1<PS+8T6GO$/
M]M<(97HBHBL-J+#J(='./3N[+\"Q@1OUQ]%06'&K99%!4-LB[6IY\9#VU(<2
MO0^SZ62YD.^06D@W<EJMUP<^C*VLU U?GL7@AJDVO:3;6(FIZ31)8H=!?+#[
MME:1*>A6U^^84JAAGU!]=H6$5SE*M?1<X@:6O;91)R\!(2!&A^ <ZA5L5JCF
M=0:B1OY#-OODPM8&)L1MYSU/&T[Z;@U9KS>\8@/NRH#J6/T\LK(6CR]@(:6Y
M_18]02 ZA [!EQXT$M-(ST?!,LC+B/S-'%% UZG&=LOVQM_L;A7Z'<+I$K7M
M]$(,_+V19Z#7Y2X-X*+;^CI^7KD42?(]H&!Y-\Q69J3M+EF*^*  J\JZ;A18
MIU"9?8<*YTO5'7Z*+N,O+"A8^+3G=3  >(IYO1 0?<=G?>%DEY&01@6?3E1:
M%('+K1&*V/U211FT?4V,O3C;E3L:QM>T-%/C143R/]\L_?CJ8Y;2ZP]G(-8!
MJ<J[A"E)2L_PO='NE0D1;=>4TP)A0U]T5;H)=$9V0J^2-3C1-[CV160%V+6]
M!L5(P2!K(.\RM,R^5J^S28J&^6 '$=9C$SHK99HOQ \7DCDTM(1K]*_YLJJ_
M-%8G0!C/0!U2*MPV4?KA*GSP=C5_CY&X +T1L@ZMQ17ANFXEL&BQJC?Z9.+R
M[0+W1L2V\!F(BI/ @(<46L#!W46Z!,%>-T6-DX#PIWC6N&4^]+O6H9HEBYV5
M0*?34>7YHPA/P4RST7,B&&%CI5N;:009W:3PX-JI /TK'^U\AWB6@LNNQ!>N
MXE50;^-M1$:R1[L,NU91U[9&RYPV<,+C22G9^?GY:;N!,/=DY0[#[Y)GH#*<
M=^W$LF$2R3>VO+%D(C904!L-AHX5Y\FU3I:T=WO]&8\T1=1\!T$+7_Q*N1NE
M=CLC@30<B7+@W2E_5A!1ZV1^M ^[:8)HF5BB\)S&J$+UZ=&%D(BC5ZUHA[?-
MA)V*SULZ<C0-:%/_C&373S"0;E'G-N9:I"AR/2*:W'[_6 F.B&WN1'@X2AS%
M>@=&HW2A;G)KYL$P3;;FT\T4/+3@Y6&.[MNTSLVQ,Q#M&.2WTKFQ9/I] "!.
MZ"D_;.6;:0*Q#@2)CTF7D";$BJ]C#_XQ^\YZK-MDZV8FZ<Z?Z[4-E.?[K+8>
M6%=30LGWSQFC?S _ 36-(B-*7-L9#\W[GY"2;BDI8]^F6#A80YM>?\\H6$S%
MV+^NMPQ2;-@3&#.QR>7^-&Y6@0FY0F!@T)8I=3R4VK:V688H9]U_B=L-TKRH
ME\)Y44='X:?K!*^'B.MN 6T9M:89FZ7-9BW_7JBV*G C>?]>BSP600=7>QJI
M3BA\DP=X:85]1.,9=-&CVQ/O?N>?*&?=ZQEMM^!WA#K8V6HZ\67/"*&FA,>*
M-+*$#8JN&9=T/\K^CSUZ1M/8%U<+;O:(JM_,3QKA'?ES4PE_KI8%^#&S@;KY
M_^^"4RWUR^ >2&3[!16NK7:F$(&M+RXJ;#^>S^W,.K1/@%=,3^BC<LUW+&#B
MSH8I3Q^8/LNJ6E0:ILIG8[N.(:*6G3&HZ2/L6CU1%A?2S!J)K6"]5PJRJ%5V
M-DRW_KEN21=QD&PT"6.+2YH<?6!BK%6YLU;[I;:Y.0S8/:U1=1]^!ZECZ!*8
MJEU#/B1<#E/^SLU X>[P'35W>7#C0<\XC%6WRM56<#S7V,/(V*&3KHZ5ANHM
M8\]B/A" 75"-J^JO4#>B?H]UY4_HW9N>^!#H0# 7Y%M6,L9-*<VD*(GQE9H8
M?B@QJ""0W7H:5)@[?363F3)Q=RA%H6WO];:VS"M-"VB5N#$</? HE+-NCTB%
MI2%E>K$.V069I>D-,YNRA#"0E0BGW>,A%X#7'K[#]KDSVM\C32:RM7M+@4(*
M**;8U3U4CO<OC&[TPJ"Y[K8J01\%"$Y%(=Q4;W0O@V^I%P->2[(1AXQ<C94:
M7)-GH)YZ4B5*]BU94 HU(C,/NXC)ZUQ;F!LH'>#TMCX7TE?G6J<<K'YB!H_F
MO@WLT&EBVD%DQ>+M"9G'^V*'W-R;#WPOJIY[V/+7B-,]6RM 3->S5>D5<!%T
MZ!C3)Y!^Z@8WZ\SA(,A&2GM=A:NJC07+8A,8S!\6K&>P)D!94C,+?UI5_JS
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M*US:PF9P<L'AN1T>4J.+"]@G5U4GU'@^\;^6_E0SLI6(%QDC,'C-]WE![4D
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MYMRG6<1T@T_Y8*%QW"K4(&YC6"?CY&3)%-^.6HY9:^@,M<(8QW?<K@Q/9[L
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M0*&"/*I,%$N17]?O9D^<?C+99RIL&J1EP9P%',@8 .'Y679B,9[N>XYX)Q*
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MAK TSAQ9>*-$U[867!2I MQV@<I9FU8/]HPPH9N"(G+VV\D2"Q8;'S],- 6
MC=J89^NK2V_@KF!54(ZO%26A J9X?ZP$0LX_5H&WYMF:E7-@G-V)-[]F\\?2
MQ>?CBQM957&18Y-'&N15>Y6EE\T"5EW73T#GG[M7<H"T)("]A=;> #>-IC'Z
MQI?YD6C+L7Y:Y'FA&>:ES1ASQFI[T%V]NTP,QWY= LUON3ATA)C1CWA.G7Q.
M0.4/5?HX0_O,/V-*V:UKD[Y5#$BN;!9KD&=.Q;E1X-6C^U>\'S8O.$^F<I:<
MU'H?KT46$T[Z<MAR7FG)G]N@P/CHE\XRL@/44WTOK?ES-FQN.]1!R4TMO>,^
MVR3WJ2P8KI^3$Z3Q$R&B4 TU;,T;$L I/_PT/;8"V>_+;HY_BW@QW7B<XM69
MWE#HPD[=55KD<D^-LW;,,=B-JAQ[_PF?$I\'N+$)WQ#RDAG$2& )=$^S_ EV
M\9OE1W$I]$$5\FFZLZKSY1J#0@6^D7/.8@:5 GXF%@[0&PHIB#/9W!WW3BG6
MZM+59M"C]5B,VT3<ZQTH*FA,757/2IE^*L_5"(/T*><PA7 7ZQ7$&:I-?%M7
M9LC2R-(I5: .T(_U]PPMT^V7S%F#=.^._$.PJ/Q#G'1'! OT=?'^,++[<70.
M4=9(5VG5%##LFDSWB[L77V(FBZ)OM/YY^U7_LWMZEZ0636&^^,62\_PS^55@
MOP9-78&*,TX\RE*LZ4S$LS2-TX^H7 -\ES1PU:G.S?!)W6-+X=&*0^@ _WDD
M(ZI<+*%:WR@V4'3J_M'$S)9_<=Y>FK\^MH)B M<!B@IK*P\(ERN#3.CUZGIH
MAC!5YSGB.O]9X%L-*)7N&)_I_!2N2MSAQ>Z.VMTN,M.. ]'N3/^DNHP&TMVR
MN72+>0BP8AQ40ESJ;C9*%;U6LW,;JV=5I\1Y[X*A0!."[=I46))+MK?(8;[D
MZMY\Q[]_!]B?$^H52(".:O9NE6\GX@OK)THJR"I.>Z86J'[U\?Z\%6]U1CR;
M/+QKZ$ .HNELT#L=M%54KKO1W-8IN4#LZOY'1&&$_^]8<B+5<"&0THD+Z4);
M-#LWT"KTM&8[631OI:Y?>W+%UH6;Y;-3I$*E/5,"Y>7'O)63\)6*[I:(_$>-
MR027EFFWG0SKNJDN#IBPDYC!<UM=;T_[E0I1S3DU4]C4%&^6F@Y;41)8*80-
M?ZE_0X9J+%( TI@G_""LV+Z^RP"='2@\))J=/+/X"IL28:8.Y=QG<98Y<J4J
MY.A<;."&B"X6+#9K_H'K+_\G8)+P_2>\QQ;N)B^5Y"[5'1E8YJ=7 U_A8$72
M7KIFRVZ_E!-NLK_DHCYW!7+WZR/[4@(S M?>?"^S0Q:C2'A>7MT20HVUH4QF
M< [H0F O#Z5E=D-[%^9+B$S,H.16@14KSD&4Z2-MC .]U:DWM?;DVL_MQ%@8
MK^A:YK-A$[X+2UX;9=00N&C^S/\S_\[O%"92IIPI(1@+S?&Z&&/=]U^IZ)V-
M\F3'"Q)$6P5%C/,>S%HZ4]I%TSLQB@_;V,CD_1XA4M9A+TMXG!>>/<++_1&Z
MV\9L*3M3235!AAEU=_S1=-LUPBI73ZG-/O'80<5C:9;:ZEK'DQ)DA'%X=0;8
MM,0R9>(TR%6)I2NKN'S'X70#7]SCK3;RH$:MNT%??%"ZJ;EK.-SDY,]27B#P
M,_P_\:7Q+1?ZY-IJEY)G\)D8>$'6NJXJ1$+3H;SUE]PHIAG?SO#U)?;U0V3@
M;'#)!07T4^0:=H,WD0".R^PFD=&:&Y,PR,?-DB7;F^L)4^9_D*!Y'E,L^ZA@
MG5_D\>^KGCAOA'&O.-W=BI%((34(063P;N6A,=[9=EU<8]"XX/.L1E\"1?D.
MYWZ.97Y_SV_)]"[?5Z]B#QK\%G^>._QCNM;]QX"M^18$PHM9;1,W?Y, *)8!
M84>JJQ"'+HHN(W,OB]]8Y3S=-RM"1:\3_*_T^[9Y$)A7<9J=K<TMG1C'P7@N
M>_WUI46\]I=C9NGJ.HEWZYKXI*!/ZO$\4390GW4'?Y7TA[8'W(IL>,?!QDDO
M5-S0?LDRG]-TH/"?LNGLE.V"; \E_X^S-Q50Y(V%^2L,;G?&A%)GJI%MJ>B"
MINFAHO2JHLQ3EG^*,*P;RQB3FI_EA_<_SQ)O;5RS,Z#\A+^BE]I6^]N0.)2O
MKQ,]'EJOKGK":QUJ68'JQ@ON;4N@ Y@IM1/9C;)?J5^/[<MCPJY'%#[CJZ)W
M[YHAB-N7W'M(+QMS^N3JBYI7UAS-)TUX@;A7XUY5O0M/6%706</W)\-@:P]U
M4O6FA5L@&Y\7-6):'1I3G3VO:PIJH")QZ=1:ENH/*HN6DXT?K?\3WR_[ VQ:
MWZY!1UNW_+A(7V-O,UK\>:5Q-]!686Y2;-T^![6Q6IW3535%4%2,&K]2B_AE
M7K:T^Y;SA?A"A.)MI93'6.;P:F6$,']BQ<9IUCVRY.0J>T^Y=[SIL@]H%I*
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MQ>Z-B3<[FW*_K:HT9$EXU$"^U@W41_O$\_M/31"#.3Y=9'$?>(^<5"(28M*
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MWJ,OA.Y'!^BC,Z[-*+[0V6C(MF0CT"U.T,/9UM;1 ^6TTMS<$D[_L"":R=
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M6'J7^"::@MKY?]8'@!/R(5['IZYH6=ZD#]W-+9FZX\A[U45$_6Q,#=TO41+
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MDA)6PZ8R?\TSA.I!7TZI&+G6)\3#X.:HT4M?R>7%0\!H:JSX<8";20?7?]^
M3?K-SE;^J?HU;L>6711O'TML0\DM4A-3V#<D7S"6W$X)3R&K+GME;C@) Y]
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M@Y=,J!50@D?CKHM>N/W#D[^%Q,AGJ<^F"&CZ7 M\E>(#MF8HC60XZ6]7EWP
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MX4-2L1<12R9]XW<YC>X;+ K7F![=AEA_&_54?I\<AD7@R?I1W>^'I$- 40)
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MT2=#+N\F'H=^+L6KL$%?1? /2],A[>@R0NK]'91#0#*E&-P06G;Q8\>:/&G
M,?"\?99.:_7DS<%OC!(O_4&ORV-$A!*V2I5*XV\I>J[#[REA*YF'0757:#=H
M=!;< H9S:'=4G"]S$[)O8_7'>;;.[AS#PDJVR'?M$W9]7V2Z?\=Y>C5/IO<<
MPAR]9W9_>*2KH',3YANV!?N^6UH(%8(NTE?R7,4N7+;*ZI'?5V'E]20[V4V0
M51$49Y<S1N63#T%W;HARJ*ME-D![;?&IC8^!,BP\.#NL'H1S^1?>8$/L?;@T
MN(3?P35$IWIR:#T&B3*DJ'L5%'$82+YKXVS)0>D#[QX%/(5B.7SC=%9._D0C
M*B?<N# II^B]CXL>HS"WD'Z6LTJKO=1P%^S,2BB @S(&L,F1Z+4$ER-],EM1
M^(9).T.#9";ZF??!HDE#Z_3"D;_7G&2')I:Y_%U5&[_AC.\(Q]!EZ_&R)RM\
M?_^?*[:;D$&DN(.#2/#?DM..U2=M(Z!%[,1+>9;'AF1XL3&2D^T[>GKSR/N6
MJ+(/(RY1Y!O5BNZ :X%-+W]HW7PQWG+<<6XE<8N\"F5&ZE)Q6G("RSH8K4M<
M!VBX0Y1RB,Q1: [-5^D1U/S \;1(O_T'583TW+4@9/\P58_H$#]TP6^]\2$-
M2K/)M!\[>S4OC)M^ _Q7G@9T:_F "GA/E#/145[NM%U$3C$,;YV[C=:P)0];
MBMA<*[L1+DN]WTE7_,<IMA%J&Q]"^L:YM_)I% .QS@C!9]RKJ4^R$/%LPH>X
ME__!ET :.E<?+EF]K$?(D9X$4:7_5:OU9YESN BA3R!C?)6P=')-1[)DSHJU
MF4@$3!+P>X8R3;8 _NFK>H(16I%->HTTC@=K"^\W_ZE]IY;,LVWEKNYTT$O]
MDHI8XH#N)#HR'KT>'>+X(-OE'CH0SD<(V=Q0W3:[.HIYA7JR;7B*OS'032$Z
MA/T2[^<V[WS!UMC2NY_>9)#.,.K6Q.%WO+U/UU'\1CP"M0$<T1[6^@2Q2_H\
M0OV#[!A8E K,O:K+;NY-^];F;P/JO?&>6%I#Q>FX1D1'1]TP"_FZY]!@E]]5
MULNZQ+O)7\>D7> #U9<[PA8^0&@YW5JV@;!M)C_UL[9/D-1!\V2A&QJ#(P:M
M*1<B*:.;FJ$[HHC\VQ8#"X(-OH2(MA\Y <\J9EB[LMSJ'K:Z5A15Y%<^E0AJ
MX3,<$-&&UN9)W\EK'V(&R,%=GIB&6L@;J'GW.0JS0O'&1&U CRK;@=)^_:#[
M I15-ORGKMB :P9WYL[=>#)AKY%?\?D+?<7,J(&<2D0$+)^!NJ6UX&+J@A*6
M)M"I"MT!S+5:ANMS+CLY+J.A[?0_);9QZB+6_9!XOB:>&_U@ZM?IO/TO[^%K
M)^VKGOG:%D2/[FX",4/T?]B&@&!QCQU"'2X6"3*>DS9#W\;&6^'JQ,/]/GV.
MV#50EM@@<3Y<Z['M2DI1VXTB[-3UB]Y=I?3[15EZXH/F!;.EE^LW'*C,'RNJ
M'A/ B3I06Y7,DO=L0+$KF*R!VHY':,X_%KJ61&%,)O-T!N:(B&*W4*NV?WEJ
M^T-)F@[\XV9-C!/GW(T^''@>B.U$O$=+'>0IZ&#V^P!1.$7F#5!$X^T8?:(O
M$"6M BDJLS!?PCP(DCV@VLH/_A9MCA1VFD,\N97;N] $W\RJU2P<S:GRNNCS
ME]U2[MW91<L2/Q@IA=2-K2U* ,R5L+'H5"OBP1("KPUM0MI/:!I33Y7Y5=RQ
M?B'ERW[K$)'7M$4&-70G$?\OOMXTJJFL>_>-98,*B/0*0FQ 5(242D !$SM$
MI#"B)4B;4D0($5,61@*$1$$(C9!22U HB$HO3:0)*(0$"$TI(CU($-*@*$W(
MW@IAOZ3AQO^]=XPSSGGK?,@8&0/8[&3/^<S?L]9<:ZU\VDQ0$Y3FB%^-26PN
MPQ29D_;XU8-MH$,37 O""^D*PTA9 X07[<_R>B@_HNJF:J%QH_3U([XV%?=#
MQ+'Z[5D=/.:FL*'?^4<-'S6.ORZ;7H8!]_%Z'XU_]%>T>M<%7GO9]"9\DJKI
M[ WN4*V+!QM$=;,L,*@UT +*E!N3(T [U#KE8Y0M_H8@3+4#LIQ(?6-3/H]6
MZ_1&HA/^9!UA0QC!V8NCQ;D4KIV3;^R;D-.8F7@3:\ 3[>+B,7?1M;'+,(4!
M_1B8.5LG&@0F'X'QLCW+L 1M,8)_(* VX'@+=Y4+HWV*'#*!T/7[T+8U_'A'
M!L>4QLO(_0E0B].(<:M)1]+5P;T5< \@,X5IMU6G7Q+9H=H(O6.845:1+:'A
M8!'W7N Z8(Q#$^<$M?P^0J*U8C587'.<XTL@ET4L$EC)3BS5K&F1GJ6=SOCJ
M?TQV%+&!L;?VVP"U&C,["'3+O*"08&!85/YH-ME2\IX[ =\TLXCFYSI #R=B
MSU]3UY)T123SG]*("E*F_VOL_JA/(^'!US+X@9GAP04^/B--E"YTM3<//>(G
MRLGD81-KO:LL,NL<EV'WR$',C\NP,)) C$E;\*C"JYS <>[V\O>OQ0%_?":_
M^?(PF/6HR@\7'<#*>!0<$J+18_=?AT(O:)^_T&]WV'X9YC.T8*H-=^V36'$'
M%@+.?1/\ST3!13Z^=%0^\WH;J[JF-L'<9^ZZ9?JF(*\HLPMNQC/?7%7K@P_G
M<L$@V0K(!;QT#UT5V<:@+\D>@FT[.8W]-51]TN@)H*NB"%@I6DR9K.34.8SK
M@9@TOPO<0;O88WU?7%\W N./2K#^4\P\_L>?-7K0^D3I2*=J_68@0HR=701*
M95F 5VW6%/#)W/ZA"$&WLXEI]82P[N"MM+(97^18;7+9SB+C1 6^:,IX7&^
M98W3>[MX>I"X5B_F'Y,8-R5#E@BM$R+N<:N]6YFW'3D)!7XDIU:T-@NS_NO0
MSU-#._M;ADTH?_*:ESBTD,/LH5O>XQL&R^9S@GC?;!IL$F29(7MQ\J>L;QB)
MOIHO&B##B1R$*U@TVRN2:JK>8&L(O*@*9/==@2%%DQ3I#E%QN(JD8]1@:)2G
MTJ]\V<?V$(U=ME-U#7QB]U>P_/PT2S^$?W[=CU@HU_&5H"\Q^=VMU!H*#705
M#G<@UKL#4EFA,A?I1UVA( %DK\A;6:A\XBF""%AL):SV_\C[% !Y=]A'$R>+
M"LMKAMW#-]=Q:V,8VC,4XT'6;2T!9$7M@&M]_-& 0PUAW#-'@['I]T54#;*9
M(R9%@14[E>S=6].)27#,8 JUS\R<8P^L_T=PY6'+'WZF<5<<[_:6\DWI-<V3
MT8@V[LAW49'DC4X3W&Q&L'&!;JSJ6@INY+;MXNA.W3BNP>.F>]<W%J:5D9&@
M!GUGEG5LD!?00;/I>E^J$S<W$6 =P.96A5__Z'<Q8(J?^1FNT)^1;5;FH7:3
MC:"C $TV )1+>821(EDPB$@W/JK,15PLS),?(Y]^*"ZZQ[YDE::RM=CO%AX+
MY+5X+WV11<:1$03D>"JX(1:MTOO/50Y G'P\OD.5>BG1FG2YKB[EX-8XN\2U
MVUQ2-EU*/N9JX/GTU_2#O1=T=8\]O_T"!CN[0FN?'\^PD>W9O$HW_^>CZ_>>
MY6F=UCOX/.VG_!OM*<5)*88&J\_"?LK_EPFV;]A4N+EJG6)M_[S$>P+=1J6I
M9;,,F9I1TSL)=J?4$#:8^4[^7!AZ\Q71J2$FS472.^3^+,2@94C_B_^FY_^9
M>:-P4FL\MPW.M^;!:XMHJNT?R.Y]Y1P-AQ9IHGV6;7D1E-GDNRJZ+D7J["(F
MF$/H\WW2N?DG2('1AS>%$,%K0!*$[^BS\\/K%[N%"J[$"]$C\2)"BPX_1%:G
M)MZ$:30KDT=?H?""1(!@XF^J#MM4J"ZC@?!^\HT"DK[L,JMOVVMH=S$)T:+:
M;2)+>'9\PMT'23? UR<F:S=^'GI=\G':NP<7Z?L)&!.3@Z!MXF489%F4S%J&
M\;ME)WH7<B)D/@,LRR&JNH0ZMHOE9_MKM/?/3?)'/2$><+WO:@X9'2EJN)SI
M*'O<;43/ARAO$MX-H33Z#4C.*W^,?2[#U"5%]$62H,ZA,661S?K07-L&Y3.-
MV3;FM)%7BJWS!1$]S=P0M*31YG/^P%\T65KJ/SJ\8\#;)26*6SW_ANW]0H#9
MN"E7,!_?2MW$V41R%1OSU$IO;@%RXO,5IZ!"Y"04*VS(?DY<ANFWB=+V?/$=
MKKAV[;*;V=YYB?W[R2B"K:HK3*KO=]2NCG1;%:1.D9/PCF48G!O"_<"4Q2L?
MH.#3 G@%>YO<F_(>74-((!_.M\@*FLG5]K!N]<XZ/,<D%*<>QKCT6PXC&>NF
M5)8-KVM3"&MPPTN%=>*#-\>LC@TQYP4%U"OTD1T7(>\R4J;LCO(IV3U$K8U-
M4&6(%G4C9YNK%@.@DW1XXY?'+BK,(*=+-Y\I#@%?>.G;4WPNIXR> Q,+KB&[
M?M\5X.#1U^1$CV-4H>^J#!1^4+7\""F[=4G:UIV.-ES(.;T;M1WJT[3D &C>
MON+#W0F<C9#&F2K/2R+Z6A*E-]S;T_&/XY'BKL"593-[3T3?8A3&XO^M9?:Q
MXLHR[ %!C);?I4[)W9EG_H^-48[H_I\K^XF?&:N789]R0JD+PU[JWVI<B,[Y
MKZ.K_^O+\#,*#?4"WT5?>#K) F,D=N,4GWX7I1?*00PJ0B*>!?KA]::^0]O;
M)Q<#>[*<UMFNA^(&)5WQ7Z6U2S;'3LU^OF,5_FAZ$)(+I3I?J=54A8'FA/%L
MOUBI<6J >U4=LKN8"0I/D-&TI),D[EN K^\&NX^]I)]6/D.9OQ')._V8DE#4
M5NC<'*_=ES]C8W3O3Y=\4LRIZL:8QF-.9W5,A^<9T%Y$NFJ3SBBB&6OF;"CT
M."UWJX)*1(@/.,[FJ4A^0!V/6>DW<XNR K1*1X[9=K8Y9M(7J-I/58)*=DTO
M@2O:,8 HLR/HDBP?GF'U.BW#S!2[:]4IFJ-ZSZAF2,;D!TAQB-L"=6+%SQ\H
M)Q\ %VJ&5]@I\<<'%G+T.]!KR/ABU ,KT/C.9=#??'>_7>?8>=Y2(@.9IBHZ
MU$-@VTRH/39_6+)EGPO!X.Q1$Q>M??EGVTP2T@_FG;W?GO*SH:[!GF(8#+;%
M6T2=+9*?(_^LO$<-@ILOPZ[A#DP[\$,D,7)W\BY($SC?;+3?'QH6.R111=>F
M2T1T&'2 )[OQ<>R7F9C2HT'(MH+X49S7.=\3M<..=V5&CK<U8H0"R-I5L2W+
MIHB'X'-EH=!_@!E90TTUNT\$.0D)B8Y?TFX*TLQW]$JNXCNE<;Z<3%11<.G7
M^LP_,]]G.N9,,IX?)]?**%9@\*-GP]<YS!_#SPHMD#F[#),C2)$M5%UG=![)
MNAUE!5);T<E+7!Y#>ZPM2L1-M 9-VTV8R35<6K1%1N_Q($-N@AV^R^D,A]4W
MY+%SU,?CG-E^J6?E*:0I-Y^R!H\U)KL"#YOJ%SL8&E"(FG';NK G36AI9$.1
M]G6J[M? S=S7]:\S^D^E7LR!U0_8W,SH[P]P=T]S_Z5ZF%I35I-&".R3E"V4
M+L.\__MRA"IB%_48T)YM7RWV"#D-J.X3;/+UI[.&GN$*IGJZJ9%K&)>TZNKZ
MCUY_B,6.^5T<:>U;9\NT_8UUYTIN:"^KM D=1KT=N$593 WI3F'\Y'QV1WJ'
M6">A8GY4^^C@WU\I.ZL>V/BUH+:G_9H8Y8P6IZ'=AE9M37CM9\]Z;*?_S[T5
M(FHMK0-^+W#+$$J/TH6M-OE:RZWQEIA&BE_=1)M"V;\T#"H00)!H..[F*Z2.
MF<)O:!ZJZ<)@N)R^]&?YH;G:?<C!U).#"N_2#VU1YJ5FU:&^1>V4+6HH)U!:
MN#5US1AU@6/5M2OALCSEW^@PA.$'\A[@2QL<.EK#6 %EB@CMX3X_%GJ$N-7W
ML@\'_V[5ZQP0:\G)>$-],>UX\]:^ "C1E+F>22-Z.+4NP_RIS<ZJO0X2'0#1
M3+&%RD5C.]'\&!GE%5@W.PBF?#^;>FI $21BJ 7Q?)\=?<LHZG5(R-H:NG@]
M*:3%?#^X@?'\U,UU+&)==6*L&QF-O\EF* RC^]Y1N@+7@7;UL063Y4(,GZ9F
M"4+B=5OA=VX5\0-E[U?'30-;MY;]V;GS8<4TW[_*Q>(<,K> >-U"T^FG%=]=
M[Z%6*:+4$1A*#@4=.K@?%IM\.]J681]FQ.FU2"8=6V45?SF*[ :,^M<G7V)#
M.8#U$1?2O5N=JS2)HAR3;:93EP4MBWS_0,,^\@$Q/0$D>ROSG'?\6,/S4-C1
MI/86>:*BUO! G75D*D0 T1/PMNXDU(I!MO:/]4A#':(SE?@*TD,7%KBA:%6K
MXH]!&RF\Q021J+ ?9MKD,BL.CY?BGBJY%VKEV%9N[1F6F,%G\M!5W;.#PAR$
M^'V)4(+%#'+#!$F.B261120-H?>=ZZC^C3W+L#H[>4SK( <Q$W'<2K&#HIVR
M>['[4A3^1:JF*58?S]&6B_^E'_KY[?W>V)[L@(<M,V53'N*+-XM9(VSG^H0\
M_.]?'XYU7EI3:?O73H?>J0C!T<-_.TA_XG<15\G MWV\[8A/#BGLX_+?51^I
M&RFVZ-E24.ZB_(NS@JP-=B=3=$/-K5]!1,($U4 1 ^6(=*J.3@0$YX/FC/ U
M=]3%SV09QA"9&9\#NMKSLW*4C"0"8F+HLWNX Z\1(_F/8<=L+]@M(Z@?%2W4
MOML\7AA^M5-V2UEBD2+6Q,?01R;$M0W:A71Q[(6"Q,G)4,IFQ2E./[+3R6S[
M&.MPR*^#=@VF3R3S,3$-V=@!@A9$;1DW[;]2"U#2GGV-/EGR H^RRA#P:HT<
M*3G4,A+SUP;0B,NT\[WIZ><_;;Y]B&4MB;@P4,M>JBBB$DL"/ YW#50?U)B@
M-A<3N,(\[HIE6"CC UXF ^;HQI+-<GNH[B0P?(_L)XKQ(P5ZN'KU+E@S$]!P
M]D805W\K,W\FBY5O,BW +3D;\0-+G[OO#W.T3Q4)S#I%FLZ81&QM9@<"LAI,
MZ&[JAG;#$Q6Q8NEJ$OIM%71!CH?@/,?N-,6V">E:R<;0>DR;V[6AB8M]SK'!
M6^-/^BF/VI*/,CTLK+ UW <_AHBXU1](P^I84X<BM!LCR9P0; [+TKA#-D3/
MW@'@8H=6K&%8PK6G,0)M$J,=I5LUB B!(S^/]$CFE1N&5B7.G.7$V%C_\M)M
MY\91]_DOLT3Y"?(993$9/4%(C9:V8*$+/V:0QB(PZ.KP.6Y4E$XK-4GUD_NA
MS+-0O+A;T_UZN+/#,U+*0CA"L:IWG#59_=S_8Z#;;S=)\SIZ4-G*YF58D)E.
M&]H(C6.J(9;?  6(X?'H#1R$6J_I/$2B.1RL2$/<56U7N/533%U+7<O(6' Q
M_G.2/V[=BS<W"B"J:'ZID3>3.;ZA+R@7;ZV]=^I &+7X7PZA7'L*]N ([,K#
M)AC1(O>V]SML#5V"%F'OP*MIJ>HG:+-A+6J7WX>+'T84J![VMFAB D2?H.OC
MO3CZ ":AQDFR9M0WAB&1&H79FUP9C@[.+;(L>-U0GS[TN?R>S?S'I =Y;7LL
M[O^3MN7^/\_Z3OQ^H;?WCM?)<Q<>W=%:MVHC'I3+;("Y>,!U@BXQ_<&_T)VG
M.),ZGE2#]-!5^6(9=D7BT KBHKOR!6O) 1-K%:ZVC_)PF4;5V5$H37)(OT=[
M:EF8]WY2.D'W(Q:?X>G##UT*GV\RWP;>00LKJ%4=<511E;.?VCTY0X+GI)-8
MR -UD/+6!,.3Z+=P= $I;S01MZ T;5(=I&/8H/ESSMJJ5P)S[N]#OF,%%0^(
M.:>_=/S97()S7'RIZEV&5=/NJ7X>5^Q2)]QC-24[$<><>/":<"FO6YN4.W%L
M,,_1-8&+D]Y=6E2C>L@O@%5K.$H\X<$B;'SSW*5@RLC!1-+^:']Y;NJE&+&.
M5EBN#D!(9ELNY8 QQ_L4&"!;3$MD=:$$7KW.QP%I>[UY9<%82YU1?49F*0E_
M_N6 G?RQF8]5';OF5=9X:(#/E?23)\]M2E$+AZ8\K V J]9]D>M#\":5T<,)
M'0D&)(@"Z2+T'>I*NW5H<9#8M'';@LUVA %4<3YB(R#@2;4_3!%*2(S6K+3Q
M[-]JZRGY,[&%'WS"Z@M35C#%!&@/(D%E2T: F4V;J<%P^D/*<.XAP/RU<)0[
M@FB#:RZXS_BP= P^H._.L3"ZI+SS-?WL@Y3U;2733/.Z"?1&EV?/>K:Q7W-Z
MR_*(VDL>\NUD\V%TB%K@4X7>S53]::\E;C)EB\(.Z$ADN\0&$2-B"SF-N*+V
MI583E[&QQH+!]M2@XLZ(H.>=-T)"K'%>0\&S$C][4!Z28 DZJXR CRK[JEX[
MZ>:NIZ'?H 8,,*B<*Q5UZNB_*?)#<8-%RO/G7O:QS-Q/L 8]/II<4*HR"\?'
M+UH8&WL91;RQ9,?,_U?B]T)5BVU6\NY/?2?1_/OL=K'"@]R!N4>VE24^4Y73
MOJK7-S,<;6E%C9]ZRB>9I8%OS JS"T>?(! 5 9=J$WW6^GY@IJ,)B)&^[[(L
M998B6$C7>K=$:$-K^N.X!AP-*'V<5,:":RFN0+$66<-Q+!N'<QG\V:GS8?KE
M@D0$:],V^05.FEC[K)^;5D7U5HT_58,,0W4.<I.PIN1#\DV4?SA[>CE&D$S:
MM')"HYU.YR_#$N%M0]RU*C,WL0[DJD \A4*.</J_ $.5$]*DK,;<<C-6874L
MP9XA2H-[#]A!E^NSS&*._&<9)J2V$O@APD7)P6782V,)*.Y>3^GCZG!Q"!@D
M. \9@]$SS7RO>YQ]\<=Z/E&3N&L5D2)3[9^_]HWXDRX1TTZ26"4+:VJ_7YN_
M7T%*[V_+NIXIHK.I0=14E;:R"*5)TI$][E?8Y(6JP94H'$.H14W?@N[FCM:;
M0EE"L2]FZBE<H4V@;/)]OU_F:2 S#<$.0--FD<A3SVJ'O@Q>DX@#PGRNHZC*
M!IMK9=10)K23EMK7TK4@.2 K'2);!K_H7HM/M='L@*]G^V@D[]WVM\&#72S$
M;,#.R8NM<8>NVV7OOIKN>:WT"'PW*8;'J+%2Z#EU1(]GB]"K%2>4^>J/_[?Y
M@2%D ,$-$,252YV#P B9Y]""4^8 <UO_?.J3+A47F#G[*G>*>92MZCY@#3T\
M.\ ^+)XBWH2*OOJ&M*5IJM8?E6-4;QBZW!#!"HC%64MY9VX%UK4*C%5]Y@>
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M$32RS],P_7S'6\^*7(O48%+R?.8\KV3:.!#>QPX6PP<(\;E[(2+HWL39 HF
M\?Y?'%W;Z5J0=P=Z]%86V<@WMP$?\\Q7>QO[R)26=\1T_<F_+_<6IGIV369=
M2W^RG2<[NHK*X-9,UFG<I0J+J< 9&XSC=89&*F>+:@2U"0RLI'B-;0>Z$RF;
MIP(=:_<'LGN.AAMEOY@JG'2;>Y?1XQN S3C%O_ J:>47+(Q\5/D<+7PP'+D,
M6X=RA/!B;XFI7..B^Q:N!C>4L :'$W.W*#2 SNY=C&;LIIN:.)N*X99 O<JC
M1*-&@H%C>&+VEM])SF&[8PG 1!.E$RAJ/4\90]<.-W/YW2)FO#-5R!CY(B-
M?J#&L1Z*%<0[S@5L!!)],?>>;T#.7[YPF@+Y8F1G>85B-V!^KY^4B- 5N 41
MT.E?$FWVM^-C=B/F.%G*[&48'J&G&EB&&;*IQ60;P"R?486(NX8@(YZ224.V
MTED6(E5@."^YJAF.51G>2@I7=;U0V *?_W;,S2Z&6D#)\*^@R>CH5X\H[0JF
M6>;'?]TK=\5D+@)J!F::42NA/'"'-W@F\X:ZO/AZIQ"Q28N^-@.^G[L3,?%D
M9^?SS"G?A,2_AB/OXV71%AG#\4=#3Y;O&?^P]]:]X=H63'MV-@*R7H:U"Q)J
M!;56/&9:( RZ$/4B5";00VVBM-FK5O0MY#CY0#$_>T2X !UIE.W0@_?:7E\Z
M5#L!]G/3XL".DY79%W)[;8@8FE[ *>=#<UEGT@HHG0S@K-24C!RR:W"CA@B@
MW1ONE$$=I_M8:_6D+4L$B8TP9\\5Z)E(GF8QQ1CY^2A(:_9.%@=X35QLR/W2
MJMI9&VN/S#GA54FIXOOZ3LDR:HWL ;Z/CQ\/%X(GF+01PO'A)CP"8=6IGURU
M]FUW-0C]Z?F>%[=A!BL@GABQPD7-!5[*#'0(?=1:Z)HT":V0^Y.=Z@99S(3<
M@]6-#7)CFG-(_K2WKTZZ:A/$$K/J8_$B01(RQ_SS-0+A9NR9Z<[3[/1I#_BY
M7N(R;!/)M;6.K*N^YN4&*.82'BB5O55F<0Z3?U:67K,;KJF&HH3PQ$45ND=U
M:*8^_*]OX]T ^@*@5!5<*K7LC1L7S_$G?LT\TFLQ6%YNHPBN:,85AQEQ(N5;
M58,"'70P840N>S/H'*&UN _"J-:CY1BR%;0/X#7+]@L@J1B31-3V:ZD?IE'@
MT $>4+/H6/$ZMIR4-3EHTL=W\G X\VUGP[THRSDJEO/3C/IFR>>!S.;Q'=""
MD*FM. 25E(\$A%$L 36+EM)U<11#]ZZ3WV+U3S NODHS^N[_L@?N'M_*O+KH
MZ LE(.WZKL_5#+)RFE _#JO^@[P!E#8C;H]O?P5EY\,UH.&)D'9"LJ#&J!S@
M:%] QEH)YZGZ"^[X,80H/35".^>>NN3%G.J?M47ZX?'$6EJ;2097=NO!3E<T
M^5_Z[(.@^%9?C;OS :ZME-W#=G1M]=_7.417-###O*)/T@M]2_>8IBK=SV:-
MOW\/FTN>_.AA0B &C#Y>"7I+2D"Y6'#;5J5-7JG,^K$EO(#21ZTI2G8^FD>R
MN@"6UY80A5*:^1K _KY1 V@M+DIZVE]V_1D'JS42^)5_-?6YX.-(84'9C&SQ
MSV9F1UX@*>+7)5-9,K1#A.:[JFVB] ['_JZ;2)",,N "BD7S7_4Q^6&NG8W
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MN]<K;!BG&P;#:\P"RBOH=]FHC,"M8$C*;' ?,=;)/?7,X/8L=!D1GL*HIDM
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M*$9KC4V86768G%W7I;(=9;OL\4FBZ5V8#(FDLA?':IC6 2U>6%%3SD=UZ;I
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M5H>T-"8>-,$LF)%PI$%:74)GKH_DFFI$6$?K),,51LK'3.>?0T6(VU2'W+B
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M/<.Z$UD:4A'GG(1;I<O-2?VK9&F0NN[MA)15XYV5KT&-;_?=H[9/-ORW4:V
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M*U:7Z/6$E1_-J9IF'_A*:RG<2/5C#\7J%TZV\>[<:(@)OU[U%XU&<HL=VY+
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M_IRV?V0P[%_&WW)VE.(Q.82<AJB#R[?R$MIE-",<:BT05+^DF.-J.;8O%68
M8I'9["]3B]=_0F]TL2_=E-?AGT"I<W48\>ECS#2618J:]#1_IT=^CK;>N70\
M$T8/#P\OY?F_.^<_-GIN-( ;'A(2OC)^.#<WM^^9@[2^'J@X@L?CU^T\R=7=
M>?5HUI:(BD>:_ZR+(X$FT0(0:@BEMS8%"!;;#-GJP',. C5NU'7_\K;-[X?A
MK8 AE64KANQ,#EO*/+NNS0?^LL@UX)UE:ORUMJMX?+RXJKWJ=:8(':G6NM9H
M-?]^QQ7I\]M,T%*>(B-.R[F97(^Y,2_$5W_R76V)6:X<4*ZJRQS"DS;)3[QP
M](]+?5L;<Z'4[QV$:V..Y*[OOE 4[E]=]P3SA&#<B=8J "J5ZP9DSO(C@.,-
MQ.E^5OAC4B_; BHHEF\$D;-%(4682GDT@&_C2#8QY@RJ)M.BO8\VY34'Z=R,
M,TD\"8Y+JG-"3.^7C$\9I>8^$,\$'FEQ0)>-H,-E]IWOY-3Z:[J*/ DJ=)0]
M\(%Y5TJU7&2[%S"[OZA@USY\'OUZD;U<<9=\L8MV:\(!5,$DCJ#,&Z"W<<80
M8J_?&Z 4<8]VN%>($+[R4Y^?7[B_+Y>6ZI!0G]N0FI<6FZ1WO#^VH"K1.]7%
M2Y0^/^87]YK?M:;99*X9^<Y32E3\QK8AXJ!) 1H^_?W4DA.A$0OZ9KCXB+*Z
MDBZJ8%RI<M?@V\9GD'?++YJ69WN)>\L(R9[9T4O\N(G2\L#7.'SY-#,_.NO1
MN2EL\'^1-/__3YS_Q_X;V_^%AJW_8_\]+2@8S%%Z<-)5L,\Z*EBIQ*;)B=4I
M-I?GD-4OWZL] L,+A+G]Y[D>R?W[7?"Q_\?M]?]C__WL_\:1A_^2^:8K^[%;
M6(XR>Z(&5 Z.M>/6+[ES,1K3I&V!3HD0@R.1A/A8L6R%N*3#A(^9PRI8>Z%9
M8[^+?<F;WA-DAGU B.>U\5QSD/Z.)JT=)D?0ULB/D4V(NP=)JXE^D"OH[ M=
M ,V%EROI8U#NI-M@Y+S"T;<_+M'Z,A_3GW>ZSW[<V5OCQ* O)JU_*5'S&Z,R
MV_.8@U$5H,&+/84MX-=1.S&9'&UT%!DRA[?25Q.JO0R;$5M8'K(CYXC>P)<I
M?Y-9DF4=@$UQT2LG!%G$:;G_U#@T3Y\M4 2??'6T=T%K;W7AE;R/GS<]OO,#
MO-_H_Q%\EK^S-\CCU$/CP=,3U#K]$#+] N0+8MHYJ^17OGSB360K<D##YJD2
M#U&@MOWPO.+ PNYG>KX#;R)X$>-3AH77#!(&?BU>>U. SN#HNWB"'#&>R]E(
MU!UR,51KU%F4!CF-ORF:Z!9%+I6?+VASLAATP6C=N=$05=613C0K)[>5N.,4
MIY";C1)PMCM/_J#!_@_GP"Y7]I'K$CKH%#0#S:6.=@FPS7 M^64P@8HRA$I%
MMQ=)NZ!&1.N8">(84,T)?C1Q<">MA61Q9\ECUV#DA&OM(8M]]PT^[O_SP56V
MEG),Z3J$#JNRE9Y1E*I@H5[NTAB(*49JXB;LH%/EX7R=6&0F68MM\:EP\U%:
MX(M>%Y^2*9))XPLPZ$&PFM#D!6U^V6]C4Q4;:"KV&3+OSSO99QVW%=[G9-DL
M8>^2GRF0WA]$Z;P&W,^D"(9HK6$N41J2E1/;F<K7+'"6O2/%$ZUU$6@,+[\2
MG>-^+REJ(:SN&JNX[HO90*YS^F=#_G>9\F6.PME,,B6>'B&9$V):C-XWU-.!
MQ(Y^HC.4$K7K?F5XUQ.HP<2&ZY?GF9ETXDV_EH_>B<'94!GIOMGGP@Z\A4U^
MV(=LF.O1?ZMZ)*1"NRGM/>GD5>A0]6@ ;MLO4$ ['*0($M("?+).]-L[.B&R
M4!:$4*YRVW.9#;-T^JQSG(FI\G-WJ0$_G.EWNS[GT)7R/3>2>OX#KO6!SK:Y
M+-J&>?C8C#0 .O"4<"< G<;?0(++DT#'VR[[&N+OVOF_?240"Q'0T3G^Z9<#
M'X8CQWY2]C>-KJ:5\0+.?YN4_.5])/5GC??S?XN[\Z%MY V$G%8RW.6:B*9!
M.$Q.-[4!1E)<3M$AW^:S#;>ON_9DR]V+PA)X=RA"XR1_'.Y=["NY1_F8_Z>^
MB'VCXYW!9M/OFQ@S.AG-SDZ6?Y#6$[@=M TH?4BO@Z9#,IF0FX&=&2ZNH16$
M B&[J.)(%9: /O-R?#)LT>FIP;#'M9U[=+TDH>'[GCVQS I(O)6[<W[ZWU8\
M_]:6]R"@%CM\ XCN-T!T%E+7ARWEI;NXT6<,KTPMG<AX_$D:$V%4757./\^*
ME\8;)66S%A,2;!O<5NIX[+RM[T'_@[I>.4%FT#L333P[.2]\9Y'5Q-/0MNC\
MNP"SC9Y),V)9 ]MEHF<-7@L+O_4 BRWY/6ERSPHM/6^#J^P4$6;C^T]G1Z*N
M_1F1ZV_=G?WGNF5+16X$3C/^MB'"V$6-*N7$[]R_%:D3WJ!\)43K$UV@^R4!
MX1.[@+ETHFN"-.#=<!1J6G9\>-[ZJ&']D-Q1Y&7Z1?S3R+RE3.O$4)$>8V_B
M/P)""W&/,803TFZR0D%$1WY*.$H;(@LQ.@1^>WZ%W\0TLH2 :\UW_=A4/:U9
M.E6_>#W[JU]XO*&O96@I+S#H_:]M#O5?3X =O41G]>A2V7L@S1:.GHM6&8HN
MZ$% H3^"E-0X/RLZ8]0> 8<H&.:07=;DP()SHM?1U]7/HA_]RN/[CP4V8]^\
M3+;PN7O0>8_EY-QH@8C23LU2P=;-$L/!(L'E<IDS]%$<,,*8H:4U<#*B7/P2
MPDNG\N9PI1'<<XR!V%NY)F=7V?Y(+0WX85U(UMNZW D1]M&_7K+[#^/LIJ,%
M9?Z^%#*>HTOJ*+2',&@*2_\IU-A,UK)"N2*S<F>.H765YD17:B<-+D>*X%K=
MPJY-\][BS=8NAX1-VCBRSC13;[HAA$6_G.MH.#"%O4 :PC)^Y-=BDXE:(HAH
MAK@=T($U8F\D[L"MC6/VYF&H(FR& )C-__*^Y'YE06E?;G!\?GCR./[-MUU+
MO0@[6)*CVY&8F%4/U2[F[8['X=8S'6W?M&Q/7J-3G!\>^%QWO_ALPL6#/J<Q
MRSFV*MA%#K2[03E,UB=& 6)_R",!R%_KHHGH0-_@55>)/!9<CX@Q+>90JHA#
MH8@V 0N3:2QTHG#-B=+'X;X&#2%RYHBOM($_5I40_H/?]/5'&E-U^E_PDJNR
MLU/8%SVI+IM=Z3==W,!0]:30C$:)=I C4-#*C/>_7"ZFF43$CQ@:Q.<U?'[Z
MXATAF!M?LHG#E&-B<&33K%6#CN8G&E<^^A.E0R0HGM?U9+"W )A.S+L\I7["
M+1=,:82A!^C;@D"XZ(,!7+;!X"SC(>:,%[PC?XN_>:J+6ZGKV%3O5&Y#QUU<
MU53,=$-'7L2="T:I0^D:[^U\)PT[OLO?TC0R[K[B'FFY\FV0/M0B(J!@[^2D
MP3K.1GD8-E4ZW+!>Z=((Z'^DK=<C:+8![WMP90Y4NTAD?\"O"YJW WZL-_OX
M.\"7;]3H4*Z [@J^+[K6,V?;1=A1_Z\B;*:-RS:@2Q15V@;7(@9!%J)Q(B.\
MZ-/(Q '@0^%==(H]7X?&8&<4$:CNF>%1UNR1) =:P4LK&-IK=TGCL[#^8V_2
M,]]^_G//]MU6?_S1MLH'EGOQ($SWA.578RGZ>XOV%MEI>31(;GUX1.C6R6U:
M<1*@9;#-23VFS@5M7V9R:28D/0@CHJ4K]:=)^Y@#6.[UO4 Q-R+?OEC!I,PA
M\0L6D='5].VZ4P[#^=5/EBTEN%WS[>!G8[71H=0T4RN("X:V_0 %-Q>NK_$<
MQYZ^Y_BRT,/&9MN+@?ENAS<;1HSNT"LC# UX\7FE 9:8A,28]<=@5C- 5*DD
M0Q8/#7"]B<<@-0-;.3I4AZ0PXZ7^>;=BZ1ED!N4FRE >"%ZF7%OU5'RVH%D/
MPK8Y!.G^U>R/%[NRJJ!<+W]<XF8S9G)BUIBE!0Q]ZA/]KYQ+>-ZB<$22*K!.
M:"_4['<)$'!T(>/V_-(;)',Y$DI]:J+1R=&2XXL.>(YKMOEC'^R#3:^O3[CR
MYLC&AH&X378]&\+])S**%>?^T/?<NZY"TW;O,I^#KW<6PE;<P\!^"5L61N^2
M(<9D(FHG4A_*\U10."%=')ZYL"<YKMN;:[H#6A2I8)E*!'0 *#@+FOXU-QOU
M$.B7?CT,1C-!W3<'HFVLH^-D6K8G^H7YP\Y9#H.,)(S7T.12H_0*-">:RS;R
MS8PD[92OA6[*7.1>@'9Q<7C07@"1'<T@;Y@ZW?4L?,/TL-/(#=)6*#I<#84:
MK;:YK $][$!PS3W7@..#\S+)OC>B,=R-)+._TT7Z[MZO7KT8B-/L<K:PMVST
M-&XL"'2R,-B,_[PUV>/G%W?.^IY[VG#?8.7=N_>-#K:?6[]!<]#W#XZFTA7*
MGY%>*I#>4CQ5&D9@:],>"SGK"+(.%4S79479M#=A["2 266MC1$9-V:?]LPV
M=J\;M'=G X49AADY/S%Z.\J2%V)_C[+Y')S]V;5(R*?*K4'?YB MZ($@ZM "
M>35!!>,ZF=]VL:QX'9)4\KH,(K<Y);'+GV)1M/(Q7H2#5UQPW,J.X:5AWN?E
M2I\VG>//,I>-_AN9,R.])S/D_)K.V1[Q',^ WW**>#BOQ9&D78]=VRW2 %C7
M_P+Z9MO!US;6U^<[IAOUCNZJ'WE3=/R5[$A U:L?,GYZO5#U[_EITE"^$2/.
M:T<GFTOWHC7EOLA4CC",-*;V2]1&"' O#KO^"-3@SNF36P^I8&LU*&;*L0'[
M'<':Q5+GJ,6E4S5#C[Y01O&"]V,<]_]J2K!$A_$ABR;*[( LB("5DD!F*XX"
MN<4](;H,H;:1>O="-8(!DB&YM7O8Q5/(UXY [0;&")<]/?'KW:K#<G/S2YJN
MB:I0FLZXJ<^'NQ+PH241Y#/?R^,P."_@LRV@HS2K'HC%;C"#KKML"@9^:_A*
MB+#&*G7GTDTW @X!YZG'1O+_.(?,N%/F,.6+C7 XW.,@$DM.WDCR=?-YWB"+
MRG[XL<=2$E^_B J2*+&T=9ZUI$%^+6E\S#?>EA&ZXJNCT%>^D30F<I?<K5!V
M)V#75;O8 F.^(+P#"Y-O@3XDBL+S^:*1-OJ-'PBG\9E!F_KDVV*$E6NC&)(U
M,_Y_7B$46O^B@AT;,N]%O2Y^G91@+W<ZIC'U0?\K7W)$=@PREIZ$'$7(VQ.H
MVI&X;%OWQK[Y)$MND$$M]22(SG+!B%R/\X_U$AT?^7G9LVRGC5(_-%\,*=PO
MJ$V>GLKZ9AH@GQ(@>-[2CQS0G5N&LB"WN'X 0F^Z)#R;\C_+%&$T2/VD95"*
M")EZ)6)QV.'*M-(!($YL 7Y;7/*YY?L".^,-!9\:K&94:MF>O!;YE.40;W@0
M\7C>MYE31Y'$@4<$E(Z>T5J!8<M<LA&\ V.J[!OF&'R.#6.Y@P>)^P9BR="9
M"9-^EG?94^:<8$Z?>U4J,9KTSG?XZ^BWF"D@8/O;D9N/OW3CE.LTP +!+GHH
M6E(K,X%2!)C6*._ /A?7*'!1.-F.U";&0/C'_)G,[<EDA/\G'C)-[B/(-G(]
M'N!E8O_PB/NK.XNG7Q*BJM9;A%\M@Y%*^GR>S5G;&SL''F[]."%M7>)I=EEV
M>02_K&MD-&2$UC?4%^X**V46&GI<R'<(^S-[J"_SN?VW/ $-LEA%SR)'><Z-
MWL&G>H?3-!>06X@8Z! P*;V!W>@Z\5!,SD:L)IH)T1OEQP%C@K=2IROFB4UR
MG 1SC#E<;2\KT H]W?^8V6_T95JD'#@.4[@^>=6SB<#A!L& TG3Y5;%K!)=;
MJ O<R2@G4-ORI>7[QJ:6CF85\3R3RJ8-8QS7:M4]TSW^;KV$>2GB[9O2KU@N
MF8F48$#NL5<016:E;.&-4$GK/4-C$@1\$WD0-"Y$W\SGMQ^33#;=<>Y9 >WP
M!A8SZ!*&R5ECS\3L%6U!>P9CG4W\34[S?.^T6N*8)^&##98BS.@.Z3M@4>)<
M23P.X41("FHOI"<[+-=C#5BA;(@ZX%1]X^"\7F6 U;#18JK<X\(6HX1LHF'9
ML4 [CJX_+_S>!*^^X%E]#OXQE,5URJV5CJO!X\_29'0T9VR%V*84_(*_H8+5
M8))1VR", -N)S20OKT8N8'@Q7H![NLLI$2+-T8"Z]WG? CT-$QQL4U<RG>\R
M7/+53_FVOJGIWK#X])<HLP;T>64GORZ-(O,GHD%D^D4@NA'HZ53!M(C7Z')S
MB MPVA+B&TJ*!/",PHTR)XARD!)8DSG1U7;]O.[[BJFEA;KB&TTZ;_.,XFG7
M\%=#UV@,G_'MX=<ZML.S$(9*_7?0@-B]N=M;F@!V=S#IX2-HK3BR+H_PXO,
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MDN=G]'+RW]_4> ^T<U*2 89*'P"=WW=&$7]NPNA!*<+;2H.F ?D5*RN&;#S
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MP:M.7C&)+H<%-O5]5]3B]E.TMK,8%(P68)8'4G:I\V"2C+$2"B>[<&EU3ZO
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MH?[=A.5Z[)+BLV/YMV@L3SJ',)/2-/>Q9_IF.7E&]@?*/!:-B/#+=WM:)BU
MFO^=*?,.(AB\G]C,9=OD1N(./_CG;M,^RK/6U,Y,+4)4*AWINKE!_2?;&+:$
M'@%?CP(\9;*,I <)94L; !T.NRA/?<YEKWX)Y*45 _,9[BXV26'%AYA!D_F7
MJY\R88%#CG-!HE%;;&3"U]*I -4V2@#D#Z*5G=]W4/IRQ2LPEE".LGS '9EP
M'@B3?%1\8DI)2[HD5:LFE?Z!]=4R-Z8EUZ^)D]D25DG..S78XNG >%Q2,/ES
M1/[7B#A?*)MHN%Y/ADM><&A5'=+)\:4%G0QCS7;*Q0'W("D^"<OB=WBU>!/
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M,(5M0OD5,E4=@4:_RN;3,$AHILNBM'W&@H*!VBJ?&,C4<=PBQYS](/5^!93
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M,3(S,2YH=&U02P$"% ,4    " #O@T]4*G-/-C\:   +-@$ $0
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M="UE>#(S,5\Q-"YH=&U02P$"% ,4    " #O@T]4P);7)[P)  !E:P  $
M            @ %[V@4 861P="UE>#,Q,5\V+FAT;5!+ 0(4 Q0    ( .^#
M3U2L9.7 G0D  $!P   0              "  67D!0!A9'!T+65X,S$R7S@N
M:'1M4$L! A0#%     @ [X-/5$LEIC5>!@  !2\  !$              ( !
M,.X% &%D<'0M97@S,C%?,3$N:'1M4$L! A0#%     @ [X-/5*%5,_I[!@
M\C,  !$              ( !O?0% &%D<'0M97@S,C)?,3,N:'1M4$L! A0#
M%     @ [X-/5(\TH9)/MP$ M,$! !8              ( !9_L% &<T8F1K
M;&QT;#5Z-3 P,# P,2YJ<&=02P$"% ,4    " #O@T]4O8^]DXXV 0!?6 $
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M-&)D:VQL=&PU>C4P,# P,#DN:G!G4$L! A0#%     @ [X-/5/V)#>;C@ (
M[+8" !8              ( !?X8? &<T8F1K;&QT;#5Z-3 P,# Q,"YJ<&=0
M2P$"% ,4    " #O@T]4)GFMNWI]! ![Y00 %@              @ &6!R(
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9:G!G4$L%!@     > !X S0<  +2W.@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
